ntineoplastic agents|mesh-ancestor
25385605|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385606|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385607|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385608|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385609|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385610|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
25385611|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
25385612|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385613|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385614|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385615|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
25385616|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385617|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25385618|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25385619|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385620|NCT04516148|Clindamycin|clindamycin|mesh-list
25385621|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
25385622|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
25385623|NCT04516148|Cefazolin|cefazolin|mesh-list
25385624|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25385625|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385626|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25385627|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385628|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385629|NCT04516057|Nabilone|nabilone|mesh-list
25385630|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
25385631|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
25385632|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385633|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385634|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25385635|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25385636|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25385637|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385638|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385639|NCT04515901|Lidocaine|lidocaine|mesh-list
25385640|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
25385641|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
25385642|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385643|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385644|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
25385645|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385646|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25385647|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25385648|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25385649|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385650|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385651|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
25385652|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385657|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385658|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385659|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
25385660|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385661|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
25385662|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385663|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
25385664|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385665|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25385666|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25385667|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25385668|NCT04514497|Irinotecan|irinotecan|mesh-list
25385669|NCT04514497|Topotecan|topotecan|mesh-list
25385670|NCT04514497|Camptothecin|camptothecin|mesh-list
25385671|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25385672|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385673|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385674|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385675|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385676|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385677|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25385678|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25385679|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385680|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
25385681|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25385682|NCT04514302|Antibodies|antibodies|mesh-list
25385683|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
25385684|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385685|NCT04513951|Leucovorin|leucovorin|mesh-list
25385687|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
25385688|NCT04513951|Irinotecan|irinotecan|mesh-list
25385689|NCT04513951|Cetuximab|cetuximab|mesh-list
25385690|NCT04513951|Avelumab|avelumab|mesh-list
25385691|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
25385693|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385694|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385695|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385696|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385697|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
25385698|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385699|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25385700|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385701|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385702|NCT04513951|Antidotes|antidotes|mesh-ancestor
25385703|NCT04513951|Protective Agents|protective agents|mesh-ancestor
25385704|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
25385705|NCT04513951|Vitamins|vitamins|mesh-ancestor
25385706|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
25385707|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385712|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25385713|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
25385714|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385715|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25385716|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25385717|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385718|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385719|NCT04513808|Anesthetics|anesthetics|mesh-list
25385720|NCT04513808|Propofol|propofol|mesh-list
25385721|NCT04513808|Sevoflurane|sevoflurane|mesh-list
25385722|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385723|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385724|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25385725|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25385726|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
25385727|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25385728|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25385729|NCT04513717|Leuprolide|leuprolide|mesh-list
25385730|NCT04513717|Goserelin|goserelin|mesh-list
25385731|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25385732|NCT04513717|Flutamide|flutamide|mesh-list
25385733|NCT04513717|Bicalutamide|bicalutamide|mesh-list
25385734|NCT04513717|Tryptophan|tryptophan|mesh-list
25385735|NCT04513717|Buserelin|buserelin|mesh-list
25385736|NCT04513717|Hormones|hormones|mesh-list
25385737|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385738|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385739|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25385740|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
25385741|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25385742|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385743|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385744|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
25385745|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
25385746|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
25385747|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25385748|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
25385749|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25385750|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25385751|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
25385752|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385753|NCT04513652|Carticaine|carticaine|mesh-list
25385754|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
25385755|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
25385756|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385757|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385758|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
25385759|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385760|NCT04513639|Dexamethasone|dexamethasone|mesh-list
25385761|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
25385762|NCT04513639|Daratumumab|daratumumab|mesh-list
25385763|NCT04513639|BB 1101|bb 1101|mesh-list
25385764|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25385765|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385766|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
25385767|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
25385768|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385769|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385770|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25385771|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
25385772|NCT04513639|Hormones|hormones|mesh-ancestor
25385773|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385774|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385775|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385776|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
25385777|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385778|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385779|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
25385780|NCT04513522|Nivolumab|nivolumab|mesh-list
25385781|NCT04513522|Ipilimumab|ipilimumab|mesh-list
25385782|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385783|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385784|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25385785|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385786|NCT04512365|Dronabinol|dronabinol|mesh-list
25385787|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
25385788|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385789|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385790|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25385791|NCT04512365|Analgesics|analgesics|mesh-ancestor
25385792|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
25385793|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385794|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25385795|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25385796|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25385797|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385798|NCT04512365|Hormones|hormones|mesh-ancestor
25385799|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385800|NCT04512235|Dexamethasone|dexamethasone|mesh-list
25385801|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
25385802|NCT04512235|Bortezomib|bortezomib|mesh-list
25385803|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385804|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
25385805|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385806|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385807|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385808|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
25385809|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385810|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385811|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385812|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385813|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
25385814|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
25385815|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385816|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25385817|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
25385818|NCT04512235|Hormones|hormones|mesh-ancestor
25385819|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385820|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385821|NCT04510922|Droxidopa|droxidopa|mesh-list
25385822|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25385823|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25385824|NCT04510844|Evolocumab|evolocumab|mesh-list
25385825|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25385826|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25385827|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
25385828|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385829|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25385830|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
25385831|NCT04510428|Antibodies|antibodies|mesh-list
25385832|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
25385833|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25385834|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25385835|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
25385836|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385837|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
25385838|NCT04510285|Trastuzumab|trastuzumab|mesh-list
25385839|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385840|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385841|NCT04510194|Metformin|metformin|mesh-list
25385842|NCT04510194|Ivermectin|ivermectin|mesh-list
25385843|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
25385844|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25385845|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385846|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25385847|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385848|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25385849|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25385850|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385851|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385852|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25385853|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25385854|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385855|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385856|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25385857|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
25385858|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25385859|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
25385860|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25385861|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25385862|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385863|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25385864|NCT04509674|Empagliflozin|empagliflozin|mesh-list
25385865|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25385866|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385867|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25385868|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385869|NCT04508244|Propranolol|propranolol|mesh-list
25385870|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25385871|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25385872|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
25385873|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25385874|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385875|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385876|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25385877|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25385878|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
25385879|NCT04507919|Dabrafenib|dabrafenib|mesh-list
25385880|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385883|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385885|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385886|NCT04507477|Rituximab|rituximab|mesh-list
25385887|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385888|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385889|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
25385890|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385891|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385892|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
25385893|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25385894|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
25385895|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385896|NCT04506086|Blinatumomab|blinatumomab|mesh-list
25385897|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385898|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
25385899|NCT04505878|Vitamins|vitamins|mesh-ancestor
25385900|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
25385901|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385902|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
25385903|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385904|NCT04505878|Protective Agents|protective agents|mesh-ancestor
25385905|NCT04504825|Dexamethasone|dexamethasone|mesh-list
25385906|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
25385907|NCT04504825|Bortezomib|bortezomib|mesh-list
25385908|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385909|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
25385910|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385911|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385912|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385913|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
25385988|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
25385914|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385915|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385916|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385917|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385918|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
25385919|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
25385920|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385921|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25385922|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
25385923|NCT04504825|Hormones|hormones|mesh-ancestor
25385924|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385925|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385926|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25385927|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25385928|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25385929|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385930|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385931|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25385932|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385933|NCT04504812|Analgesics|analgesics|mesh-ancestor
25385934|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
25385935|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385936|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
25385937|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385938|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
25385942|NCT04503694|Nivolumab|nivolumab|mesh-list
25385943|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385944|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385945|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25385946|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385947|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
25385948|NCT04503616|Abatacept|abatacept|mesh-list
25385949|NCT04503616|Tacrolimus|tacrolimus|mesh-list
25385950|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385951|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
25385952|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385953|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385954|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385955|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
25385956|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385957|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385958|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385959|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25385960|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385961|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25385962|NCT04503551|Ranibizumab|ranibizumab|mesh-list
25385963|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25385964|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25385965|NCT04503551|Growth Substances|growth substances|mesh-ancestor
25385966|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385967|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
25385968|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385969|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25385970|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25385971|NCT04503161|Estradiol|estradiol|mesh-list
25385972|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25385973|NCT04503161|Estrogens|estrogens|mesh-ancestor
25385974|NCT04503161|Hormones|hormones|mesh-ancestor
25385975|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385976|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385977|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25385978|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
25385979|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25385980|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25385981|NCT04502693|Vaccines|vaccines|mesh-list
25385982|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
25385983|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385984|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
25385985|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385986|NCT04501978|Remdesivir|remdesivir|mesh-list
25385987|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
25385989|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385991|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385992|NCT04501614|Ponatinib|ponatinib|mesh-list
25385993|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385994|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25385995|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385996|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385997|NCT04501406|Pioglitazone|pioglitazone|mesh-list
25385998|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25385999|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386000|NCT04500860|Tadalafil|tadalafil|mesh-list
25386001|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25386002|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
25386003|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25386004|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25386005|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386006|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386007|NCT04500860|Urological Agents|urological agents|mesh-ancestor
25386008|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25386009|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25386010|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
25386011|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25386012|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386013|NCT04500847|Emtricitabine|emtricitabine|mesh-list
25386014|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
25386015|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386016|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25386017|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25386018|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386019|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386020|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25386021|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25386022|NCT04500613|Dexamethasone|dexamethasone|mesh-list
25386023|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
25386024|NCT04500613|Bupivacaine|bupivacaine|mesh-list
25386025|NCT04500613|BB 1101|bb 1101|mesh-list
25386026|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386027|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
25386028|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
25386029|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386030|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386031|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25386032|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
25386034|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386035|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386036|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386037|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
25386038|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386039|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386040|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
25386041|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
25386042|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386043|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
25386044|NCT04500548|Nivolumab|nivolumab|mesh-list
25386045|NCT04500548|Ipilimumab|ipilimumab|mesh-list
25386046|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386047|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386048|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25386049|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386050|NCT04500275|Vancomycin|vancomycin|mesh-list
25386051|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25386052|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386053|NCT04499924|Paclitaxel|paclitaxel|mesh-list
25386054|NCT04499924|Trastuzumab|trastuzumab|mesh-list
25386055|NCT04499924|Ramucirumab|ramucirumab|mesh-list
25386056|NCT04499924|Tucatinib|tucatinib|mesh-list
25386057|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25386058|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386059|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
25386060|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
25386061|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
25386062|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386063|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386064|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386065|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386066|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25386067|NCT04499859|Ezetimibe|ezetimibe|mesh-list
25386068|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25386069|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25386070|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
25386071|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386072|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25386073|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25386074|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386075|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25386076|NCT04499495|Mesalamine|mesalamine|mesh-list
25386077|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25386078|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25386079|NCT04499495|Analgesics|analgesics|mesh-ancestor
25386080|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
25386081|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386082|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386083|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386084|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386085|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
25386086|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25386087|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386088|NCT04499248|Bimatoprost|bimatoprost|mesh-list
25386089|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25386090|NCT04498117|Paclitaxel|paclitaxel|mesh-list
25386091|NCT04498117|Carboplatin|carboplatin|mesh-list
25386092|NCT04498117|Oregovomab|oregovomab|mesh-list
25386093|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25386094|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386095|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25386096|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25386097|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25386098|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386099|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386100|NCT04497961|Lenalidomide|lenalidomide|mesh-list
25386101|NCT04497961|Daratumumab|daratumumab|mesh-list
25386102|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
25386103|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386104|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25386105|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25386106|NCT04497961|Growth Substances|growth substances|mesh-ancestor
25386107|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
25386113|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
25386114|NCT04497844|Hormones|hormones|mesh-ancestor
25386115|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386116|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386117|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386118|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386119|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25386120|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386121|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386122|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
25386123|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25386124|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25386125|NCT04497116|Gemcitabine|gemcitabine|mesh-list
25386126|NCT04497116|Talazoparib|talazoparib|mesh-list
25386127|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25386128|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
25386129|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386130|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386131|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
25386132|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386133|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386134|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386135|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
25386136|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386137|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25386142|NCT04496401|Tacrolimus|tacrolimus|mesh-list
25386143|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386144|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
25386145|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386146|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25386159|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386160|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386161|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386162|NCT04495452|Fentanyl|fentanyl|mesh-list
25386163|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25386164|NCT04495452|Narcotics|narcotics|mesh-ancestor
25386165|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386166|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386167|NCT04495452|Analgesics|analgesics|mesh-ancestor
25386168|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
25386169|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386170|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25386171|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25386172|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
25386173|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
25386174|NCT04495179|Durvalumab|durvalumab|mesh-list
25386175|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386176|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386177|NCT04495088|Leucovorin|leucovorin|mesh-list
25386178|NCT04495088|Folic Acid|folic acid|mesh-list
25386179|NCT04495088|Capecitabine|capecitabine|mesh-list
25386180|NCT04495088|Fluorouracil|fluorouracil|mesh-list
25386181|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
25386182|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
25386183|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25386184|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
25386185|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386186|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386187|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386188|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
25386189|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386190|NCT04495088|Antidotes|antidotes|mesh-ancestor
25386191|NCT04495088|Protective Agents|protective agents|mesh-ancestor
25386192|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
25386193|NCT04495088|Vitamins|vitamins|mesh-ancestor
25386194|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
25386195|NCT04495088|Hematinics|hematinics|mesh-ancestor
25417421|NCT02878798|Topiramate|topiramate|mesh-list
25386196|NCT04494958|Palbociclib|palbociclib|mesh-list
25386197|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386198|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386199|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386200|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386201|NCT04494503|Rituximab|rituximab|mesh-list
25386202|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386203|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386204|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
25386205|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386206|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386220|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
25386221|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386222|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25386223|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386224|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386225|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
25386226|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386227|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386228|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25386229|NCT04493216|Dolutegravir|dolutegravir|mesh-list
25386230|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25386231|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25386232|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386233|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386234|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25386235|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25386236|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
25386237|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386238|NCT04493060|Niraparib|niraparib|mesh-list
25386239|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
25386240|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
25386241|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
25386242|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386243|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25386244|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386245|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386246|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386247|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
25386248|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25386249|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386250|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25386251|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386252|NCT04491942|Gemcitabine|gemcitabine|mesh-list
25386253|NCT04491942|Cisplatin|cisplatin|mesh-list
25386254|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386255|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25386256|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
25386257|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386258|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
25386259|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386260|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386261|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386262|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
25386263|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386264|NCT04491682|Megestrol|megestrol|mesh-list
25386265|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
25386266|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25386267|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25386268|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25386269|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
25386270|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386271|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25386272|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25386273|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386274|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25386275|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25386276|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25386277|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
25386278|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25386279|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724255|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417496|NCT02872116|Antidotes|antidotes|mesh-ancestor
25386280|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25386281|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25386282|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386283|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386284|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
25386285|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25386286|NCT04491643|Megestrol|megestrol|mesh-list
25386287|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
25386288|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25386289|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25386290|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25386291|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
25386292|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386293|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25386294|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25386295|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386447|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25386296|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25386297|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25386298|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25386299|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
25386300|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25386301|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386302|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25386303|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25386304|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386305|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386306|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
25386307|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25386308|NCT04491383|Tocovid|tocovid|mesh-list
25386309|NCT04491383|Vitamins|vitamins|mesh-ancestor
25386310|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
25386311|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386312|NCT04490499|Vaccines|vaccines|mesh-list
25386313|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
25386314|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386315|NCT04489589|Midodrine|midodrine|mesh-list
25386316|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
25386317|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
25386318|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386319|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386320|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25386321|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25386322|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25386323|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25386324|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
25386325|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25386326|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386327|NCT04488874|Mannitol|mannitol|mesh-list
25386328|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25386329|NCT04488874|Diuretics|diuretics|mesh-ancestor
25386330|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
25386331|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386332|NCT04488315|Dexamethasone|dexamethasone|mesh-list
25386333|NCT04488315|Ropivacaine|ropivacaine|mesh-list
25386334|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386335|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
25386336|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
25386337|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386338|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386339|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25386340|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
25386341|NCT04488315|Hormones|hormones|mesh-ancestor
25386342|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386343|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386344|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386345|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
25386346|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
25386347|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386348|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
25386349|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
25386350|NCT04487652|Vitamins|vitamins|mesh-ancestor
25386351|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
25386352|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724256|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
25386353|NCT04487080|Osimertinib|osimertinib|mesh-list
25386354|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25386356|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386357|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386358|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386359|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386360|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386361|NCT04487067|Bevacizumab|bevacizumab|mesh-list
25386362|NCT04487067|Atezolizumab|atezolizumab|mesh-list
25386363|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386364|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386365|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25386366|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25386367|NCT04487067|Growth Substances|growth substances|mesh-ancestor
25386368|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386369|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25386370|NCT04486911|Letrozole|letrozole|mesh-list
25386371|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386372|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25386373|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25386374|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386375|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386376|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25386377|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
25386378|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386379|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386380|NCT04486833|Osimertinib|osimertinib|mesh-list
25386381|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386382|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386383|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386384|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386385|NCT04486352|Bevacizumab|bevacizumab|mesh-list
25386386|NCT04486352|Trastuzumab|trastuzumab|mesh-list
25386387|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25386388|NCT04486352|Atezolizumab|atezolizumab|mesh-list
25386389|NCT04486352|Maytansine|maytansine|mesh-list
25386390|NCT04486352|Talazoparib|talazoparib|mesh-list
25386391|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25386392|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386393|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386394|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25386395|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25386396|NCT04486352|Growth Substances|growth substances|mesh-ancestor
25386397|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386398|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
25386399|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
25386400|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25386401|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
25386402|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
25386403|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25386404|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386405|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25386406|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386407|NCT04485559|Everolimus|everolimus|mesh-list
25386408|NCT04485559|Trametinib|trametinib|mesh-list
25386409|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386410|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386411|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
25386412|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386413|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386414|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386415|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386416|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
25386417|NCT04485013|Cetuximab|cetuximab|mesh-list
25386418|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386419|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386420|NCT04484818|Leuprolide|leuprolide|mesh-list
25386421|NCT04484818|Goserelin|goserelin|mesh-list
25386422|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25386423|NCT04484818|Tryptophan|tryptophan|mesh-list
25386424|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
25386425|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386426|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386427|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25386428|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
25386429|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25386430|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386431|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386432|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
25386433|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25386434|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
25386435|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25386436|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25386437|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
25386438|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25386439|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
25386440|NCT04484337|Cabotegravir|cabotegravir|mesh-list
25386441|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25386442|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25386443|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25386444|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25386445|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386446|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386448|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25386449|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
25386450|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386451|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25386452|NCT04484337|Analgesics|analgesics|mesh-ancestor
25386453|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
25386454|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386455|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386456|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386457|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
25386458|NCT04484272|Narcotics|narcotics|mesh-ancestor
25386459|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386460|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386461|NCT04484272|Analgesics|analgesics|mesh-ancestor
25386462|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
25386463|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386465|NCT04483960|Enoxaparin|enoxaparin|mesh-list
25386466|NCT04483960|Dalteparin|dalteparin|mesh-list
25386467|NCT04483960|Tinzaparin|tinzaparin|mesh-list
25386468|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25386469|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
25386470|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25386471|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25386472|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386473|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25386474|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25386475|NCT04483960|Analgesics|analgesics|mesh-ancestor
25386476|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
25386477|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386478|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386479|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386480|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386481|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
25386482|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386483|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25386484|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25386485|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25386486|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386487|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
25386488|NCT04483739|Dexamethasone|dexamethasone|mesh-list
25386489|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
25386490|NCT04483739|Lenalidomide|lenalidomide|mesh-list
25386491|NCT04483739|BB 1101|bb 1101|mesh-list
25386492|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386493|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
25386494|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
25386495|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386496|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386497|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25386498|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
25386499|NCT04483739|Hormones|hormones|mesh-ancestor
25386500|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386501|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386502|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386503|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
25386504|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408391|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25386505|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386506|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
25386507|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25386508|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25386509|NCT04483739|Growth Substances|growth substances|mesh-ancestor
25386510|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
25386511|NCT04483466|Methotrexate|methotrexate|mesh-list
25386512|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25386513|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
25386514|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25386515|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386516|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25386517|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
25386518|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386519|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386520|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
25386521|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386522|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25386523|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386524|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
25386525|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386526|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25386527|NCT04482621|Decitabine|decitabine|mesh-list
25386528|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25386529|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
25386530|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386531|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386532|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386533|NCT04482309|Trastuzumab|trastuzumab|mesh-list
25386534|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386535|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386536|NCT04481451|Ropivacaine|ropivacaine|mesh-list
25386537|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
25386538|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
25386539|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386540|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386541|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
25386542|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386543|NCT04481113|Niraparib|niraparib|mesh-list
25386544|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25386545|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386546|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386547|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386548|NCT04480554|Naltrexone|naltrexone|mesh-list
25386549|NCT04480554|Buprenorphine|buprenorphine|mesh-list
25386550|NCT04480554|Methadone|methadone|mesh-list
25386551|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25386552|NCT04480554|Naloxone|naloxone|mesh-list
25386553|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25386554|NCT04480554|Narcotics|narcotics|mesh-ancestor
25386555|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386556|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386557|NCT04480554|Analgesics|analgesics|mesh-ancestor
25386558|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
25386559|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386560|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25386561|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25386562|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
25386563|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
25386564|NCT04480086|Navitoclax|navitoclax|mesh-list
25386565|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386566|NCT04479306|Osimertinib|osimertinib|mesh-list
25386567|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386568|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386569|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386570|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386571|NCT04479072|Aspirin|aspirin|mesh-list
25386572|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25386573|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25386574|NCT04479072|Analgesics|analgesics|mesh-ancestor
25386575|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
25386576|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386577|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386578|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386579|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386580|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25386581|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25386582|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386583|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25386584|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25386585|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386586|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
25386587|NCT04478266|Letrozole|letrozole|mesh-list
25386588|NCT04478266|Palbociclib|palbociclib|mesh-list
25386589|NCT04478266|Goserelin|goserelin|mesh-list
25386590|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386591|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25386592|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25386593|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386594|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386595|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25386596|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
25386597|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386598|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386599|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386600|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386601|NCT04478084|Vaccines|vaccines|mesh-list
25386602|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
25386603|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25386604|NCT04478084|Antibodies|antibodies|mesh-list
25386605|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
25386606|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386607|NCT04477850|Luspatercept|luspatercept|mesh-list
25386608|NCT04477850|Hematinics|hematinics|mesh-ancestor
25386609|NCT04477343|Nivolumab|nivolumab|mesh-list
25386610|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386611|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386612|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25386613|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386614|NCT04476446|Esketamine|esketamine|mesh-list
25386615|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
25386616|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25386618|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
25386619|NCT04476277|Vitamins|vitamins|mesh-ancestor
25386620|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
25386621|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386622|NCT04476199|Decitabine|decitabine|mesh-list
25386623|NCT04476199|Venetoclax|venetoclax|mesh-list
25386624|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25386625|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
25386626|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386627|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386628|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386629|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
25386630|NCT04475939|Niraparib|niraparib|mesh-list
25386631|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386632|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386633|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25386634|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386635|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386636|NCT04475224|Mitogens|mitogens|mesh-list
25386637|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
25386638|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386639|NCT04474600|Propofol|propofol|mesh-list
25386640|NCT04474600|Desflurane|desflurane|mesh-list
25386641|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25386642|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386643|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386644|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25386645|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
25386646|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
25386647|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25386648|NCT04474353|Temozolomide|temozolomide|mesh-list
25386649|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25386650|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
25386651|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386652|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386653|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
25386654|NCT04474002|Cathartics|cathartics|mesh-ancestor
25386655|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25386656|NCT04472949|Carboplatin|carboplatin|mesh-list
25386657|NCT04472949|Etoposide|etoposide|mesh-list
25386658|NCT04472949|Durvalumab|durvalumab|mesh-list
25386659|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386660|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25386661|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25386662|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25386663|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386664|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386665|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386666|NCT04472598|Navitoclax|navitoclax|mesh-list
25386667|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386668|NCT04472429|Paclitaxel|paclitaxel|mesh-list
25386669|NCT04472429|Carboplatin|carboplatin|mesh-list
25386670|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25386671|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386672|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
25386673|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25386674|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25386675|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386676|NCT04472000|Ascorbic Acid|ascorbic acid|mesh-list
25386677|NCT04472000|Vitamins|vitamins|mesh-ancestor
25386678|NCT04472000|Micronutrients|micronutrients|mesh-ancestor
25386679|NCT04472000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386680|NCT04472000|Antioxidants|antioxidants|mesh-ancestor
25386681|NCT04472000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386682|NCT04472000|Protective Agents|protective agents|mesh-ancestor
25386683|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
25386684|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386685|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386687|NCT04471818|Analgesics|analgesics|mesh-ancestor
25386688|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
25386689|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386690|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386691|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25386692|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25386693|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
25386694|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
25386695|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386696|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25386697|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25386698|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25386699|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386700|NCT04471428|Docetaxel|docetaxel|mesh-list
25386701|NCT04471428|Atezolizumab|atezolizumab|mesh-list
25386702|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386703|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25386704|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25386705|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25386706|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386707|NCT04470973|Amikacin|amikacin|mesh-list
25386708|NCT04470973|Cefuroxime|cefuroxime|mesh-list
25386709|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
25386710|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25386711|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386712|NCT04470843|Acetazolamide|acetazolamide|mesh-list
25386713|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
25386714|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25386715|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386716|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386717|NCT04470843|Diuretics|diuretics|mesh-ancestor
25386718|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
25386719|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386720|NCT04470622|Aprepitant|aprepitant|mesh-list
25386721|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
25386722|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
25386723|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386724|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386725|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25386726|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25386727|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25386728|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386729|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
25386730|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25386731|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25386732|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25386733|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386734|NCT04469075|Clindamycin|clindamycin|mesh-list
25386735|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
25386736|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
25386737|NCT04469075|Triamcinolone|triamcinolone|mesh-list
25386738|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25386739|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25386740|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25386741|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386742|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
25386743|NCT04469075|Hormones|hormones|mesh-ancestor
25386744|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386745|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386746|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386747|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
25386748|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386749|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386750|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25386751|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386752|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25386753|NCT04468984|Navitoclax|navitoclax|mesh-list
25386754|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386755|NCT04467957|Xenon|xenon|mesh-list
25386756|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25386757|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
25386758|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
25386759|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386760|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386761|NCT04467905|Etripamil|etripamil|mesh-list
25386762|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25386763|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25386764|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386765|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25386766|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386767|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25386768|NCT04466475|Melphalan|melphalan|mesh-list
25386769|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
25386770|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25386771|NCT04466475|Daratumumab|daratumumab|mesh-list
25386772|NCT04466475|Antibodies|antibodies|mesh-list
25386773|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
25386774|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25386775|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
25386776|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386777|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386778|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25386779|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
25386780|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386781|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25386782|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386783|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
25386784|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
25386785|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25386786|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25386787|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386788|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386789|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386790|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386791|NCT04465864|Dexamethasone|dexamethasone|mesh-list
25386792|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386793|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
25386794|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
25386795|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386796|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386797|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25386798|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
25386799|NCT04465864|Hormones|hormones|mesh-ancestor
25386800|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386801|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386802|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386803|NCT04465318|Nicotine|nicotine|mesh-list
25386804|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25386805|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
25386806|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386807|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386808|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25386809|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25386810|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
25386811|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25386812|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386814|NCT04464980|Buprenorphine|buprenorphine|mesh-list
25386815|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25386816|NCT04464980|Narcotics|narcotics|mesh-ancestor
25386817|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386818|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386820|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
25386821|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386822|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25386823|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25386824|NCT04464798|Rituximab|rituximab|mesh-list
25386825|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
25386826|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386827|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386828|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
25386829|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386830|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25386831|NCT04464265|Propofol|propofol|mesh-list
25386832|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25386833|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386834|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386835|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25386836|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
25386837|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
25386838|NCT04463680|Rifampin|rifampin|mesh-list
25386839|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25386840|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
25386841|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25386842|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386843|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
25386844|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25386845|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386846|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386847|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25386848|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25386849|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25386850|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25386851|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25386852|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25386853|NCT04463615|Leflunomide|leflunomide|mesh-list
25386854|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386855|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386856|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386857|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
25386858|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386859|NCT04463498|Methamphetamine|methamphetamine|mesh-list
25386860|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25386861|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386862|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
25386863|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
25386864|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386865|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
25386866|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25386867|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386868|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
25386869|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25386870|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25386871|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25386872|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25386873|NCT04463030|Vitamins|vitamins|mesh-list
25386874|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
25386875|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
25386876|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386877|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
25386878|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386879|NCT04463030|Protective Agents|protective agents|mesh-ancestor
25386880|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
25386881|NCT04462406|Nivolumab|nivolumab|mesh-list
25386882|NCT04462406|Ipilimumab|ipilimumab|mesh-list
25386883|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386884|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386885|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25386886|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386887|NCT04462328|Durvalumab|durvalumab|mesh-list
25386888|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
25386889|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386890|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386891|NCT04462315|Cobalt|cobalt|mesh-list
25386892|NCT04462315|Chromium|chromium|mesh-list
25386893|NCT04462315|Everolimus|everolimus|mesh-list
25386894|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386895|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386896|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
25386897|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386898|NCT04462315|Trace Elements|trace elements|mesh-ancestor
25386899|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
25386900|NCT04461639|Factor VIII|factor viii|mesh-list
25386901|NCT04461639|Coagulants|coagulants|mesh-ancestor
25386902|NCT04461288|Nicotine|nicotine|mesh-list
25386903|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25386904|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
25386905|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386906|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386907|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25386908|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25386909|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
25386910|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25386911|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386913|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386914|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386915|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
25386916|NCT04460872|Testosterone|testosterone|mesh-list
25386917|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
25386918|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
25386919|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25386920|NCT04460872|Androgens|androgens|mesh-ancestor
25386921|NCT04460872|Hormones|hormones|mesh-ancestor
25386922|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386923|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386924|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386925|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386926|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
25386927|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
25386928|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
25386929|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386930|NCT04459715|Cisplatin|cisplatin|mesh-list
25386931|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386932|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
25386933|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386934|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
25386935|NCT04459416|Narcotics|narcotics|mesh-ancestor
25386936|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25386937|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386938|NCT04459416|Analgesics|analgesics|mesh-ancestor
25386939|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
25386940|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386941|NCT04459273|FAPI-46|fapi-46|mesh-list
25386942|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25386943|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386944|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
25386945|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25386946|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
25386947|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386948|NCT04459052|Expectorants|expectorants|mesh-ancestor
25386949|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
25386950|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25386951|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
25386952|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386953|NCT04459052|Protective Agents|protective agents|mesh-ancestor
25386954|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386955|NCT04459052|Antidotes|antidotes|mesh-ancestor
25386956|NCT04458922|Atezolizumab|atezolizumab|mesh-list
25386957|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25386958|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386959|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
25386960|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386961|NCT04458909|Gemcitabine|gemcitabine|mesh-list
25386962|NCT04458909|Cisplatin|cisplatin|mesh-list
25386963|NCT04458909|Carboplatin|carboplatin|mesh-list
25386964|NCT04458909|Nivolumab|nivolumab|mesh-list
25386965|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386966|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25386967|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
25386968|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386969|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
25386970|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25386971|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386972|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25386973|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
25386974|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386975|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25386976|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25386977|NCT04458831|Dexamethasone|dexamethasone|mesh-list
25386978|NCT04458831|Pomalidomide|pomalidomide|mesh-list
25386979|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386980|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
25386981|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
25386982|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25386983|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386984|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25386985|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
25386987|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25386988|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25386989|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386990|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
25386991|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25386992|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25386993|NCT04458831|Growth Substances|growth substances|mesh-ancestor
25386994|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
25386995|NCT04458259|Axitinib|axitinib|mesh-list
25386996|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386997|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25386998|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386999|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387000|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
25387001|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387002|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
25387003|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387004|NCT04457284|Cisplatin|cisplatin|mesh-list
25387005|NCT04457284|Nivolumab|nivolumab|mesh-list
25387006|NCT04457284|Temozolomide|temozolomide|mesh-list
25387007|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387008|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387009|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25387010|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387011|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25387012|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
25387013|NCT04457258|FAPI-46|fapi-46|mesh-list
25387014|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25387015|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387016|NCT04457232|FAPI-46|fapi-46|mesh-list
25387017|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25387018|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387019|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25387020|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387021|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387022|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25387023|NCT04456699|Leucovorin|leucovorin|mesh-list
25387024|NCT04456699|Bevacizumab|bevacizumab|mesh-list
25387025|NCT04456699|Fluorouracil|fluorouracil|mesh-list
25387026|NCT04456699|Capecitabine|capecitabine|mesh-list
25387027|NCT04456699|Olaparib|olaparib|mesh-list
25387028|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
25387029|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387030|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387031|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25387032|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25387033|NCT04456699|Growth Substances|growth substances|mesh-ancestor
25387034|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387035|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
25387036|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
25387037|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387038|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387039|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387042|NCT04456699|Protective Agents|protective agents|mesh-ancestor
25387043|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
25387044|NCT04456699|Vitamins|vitamins|mesh-ancestor
25387045|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
25387046|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25387047|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387048|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
25387049|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25387050|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387051|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387052|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387053|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25387054|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
25387055|NCT04456296|Testosterone|testosterone|mesh-list
25387056|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
25387057|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
25387058|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25387059|NCT04456296|Androgens|androgens|mesh-ancestor
25387060|NCT04456296|Hormones|hormones|mesh-ancestor
25387061|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387062|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387063|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387064|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387065|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
25387066|NCT04455750|Leuprolide|leuprolide|mesh-list
25387067|NCT04455750|Goserelin|goserelin|mesh-list
25387068|NCT04455750|Rucaparib|rucaparib|mesh-list
25387069|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25387070|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
25387071|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25387072|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387073|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387074|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387075|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25387076|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387077|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387080|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
25387081|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387082|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387083|NCT04452747|Dinoprostone|dinoprostone|mesh-list
25387084|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
25387085|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25387086|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387087|NCT04452461|Leucovorin|leucovorin|mesh-list
25387088|NCT04452461|Gemcitabine|gemcitabine|mesh-list
25387089|NCT04452461|Paclitaxel|paclitaxel|mesh-list
25387090|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
25387091|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25387092|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387093|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387094|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387095|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387096|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387097|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387098|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
25387099|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
25387100|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387101|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387102|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387103|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
25387104|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387105|NCT04452461|Antidotes|antidotes|mesh-ancestor
25387106|NCT04452461|Protective Agents|protective agents|mesh-ancestor
25387107|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
25387108|NCT04452461|Vitamins|vitamins|mesh-ancestor
25387109|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
25387110|NCT04451187|Zopiclone|zopiclone|mesh-list
25387111|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25387112|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387113|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387114|NCT04450953|Eplerenone|eplerenone|mesh-list
25387115|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25387116|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
25408392|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25387117|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387118|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387119|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25387120|NCT04450953|Diuretics|diuretics|mesh-ancestor
25387121|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
25387122|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25387123|NCT04450836|Trifluridine|trifluridine|mesh-list
25387124|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
25387125|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387126|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
25387127|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387129|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
25387130|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
25387131|NCT04450199|Vitamins|vitamins|mesh-list
25387132|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
25387133|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387134|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25387135|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25387136|NCT04449874|Bevacizumab|bevacizumab|mesh-list
25387137|NCT04449874|Cetuximab|cetuximab|mesh-list
25387138|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25387139|NCT04449874|Atezolizumab|atezolizumab|mesh-list
25387140|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387141|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387142|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25387143|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25387144|NCT04449874|Growth Substances|growth substances|mesh-ancestor
25387145|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387146|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
25387147|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387148|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387149|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387150|NCT04449861|Durvalumab|durvalumab|mesh-list
25387151|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387152|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387153|NCT04449549|Paclitaxel|paclitaxel|mesh-list
25387154|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25387155|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387156|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387157|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387158|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387159|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387160|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25387161|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25387162|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387163|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25387164|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25387165|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25387166|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387167|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
25387168|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387169|NCT04448873|Sirolimus|sirolimus|mesh-list
25387170|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25387171|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387172|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25387173|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387174|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
25387175|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387176|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
25387177|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387178|NCT04448392|Valacyclovir|valacyclovir|mesh-list
25387179|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
25387180|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387181|NCT04447911|Empagliflozin|empagliflozin|mesh-list
25387182|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25387183|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387184|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25387185|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387186|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
25387187|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25387188|NCT04447352|Leucovorin|leucovorin|mesh-list
25387189|NCT04447352|Cisplatin|cisplatin|mesh-list
25387190|NCT04447352|Docetaxel|docetaxel|mesh-list
25387191|NCT04447352|Fluorouracil|fluorouracil|mesh-list
25387192|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
25387193|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387194|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387195|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387196|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387197|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387199|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387200|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387201|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
25387202|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387203|NCT04447352|Antidotes|antidotes|mesh-ancestor
25387204|NCT04447352|Protective Agents|protective agents|mesh-ancestor
25387205|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
25387206|NCT04447352|Vitamins|vitamins|mesh-ancestor
25387207|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
25387208|NCT04447235|Ivermectin|ivermectin|mesh-list
25387209|NCT04447235|Losartan|losartan|mesh-list
25387210|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25387211|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25387212|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25387213|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25387365|NCT04440371|Calcipotriene|calcipotriene|mesh-list
25387214|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387215|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25387216|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387217|NCT04447027|Dexamethasone|dexamethasone|mesh-list
25387218|NCT04447027|Lenalidomide|lenalidomide|mesh-list
25387219|NCT04447027|Azacitidine|azacitidine|mesh-list
25387220|NCT04447027|Romidepsin|romidepsin|mesh-list
25387222|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387223|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
25387224|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
25387225|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387226|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387227|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25387228|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
25387229|NCT04447027|Hormones|hormones|mesh-ancestor
25387230|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387231|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387232|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387233|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
25387234|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25387235|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25387236|NCT04447027|Growth Substances|growth substances|mesh-ancestor
25387237|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
25387238|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387239|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
25387240|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387241|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387242|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25387243|NCT04446871|Methylene Blue|methylene blue|mesh-list
25387244|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387245|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387246|NCT04446117|Prednisone|prednisone|mesh-list
25387247|NCT04446117|Atezolizumab|atezolizumab|mesh-list
25387248|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
25387249|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387250|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
25387251|NCT04446117|Hormones|hormones|mesh-ancestor
25387252|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387253|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387254|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387255|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387256|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25387257|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387258|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387259|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
25387260|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25387261|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25387262|NCT04446039|Vortioxetine|vortioxetine|mesh-list
25387263|NCT04446039|Mirtazapine|mirtazapine|mesh-list
25387264|NCT04446039|Citalopram|citalopram|mesh-list
25387265|NCT04446039|Bupropion|bupropion|mesh-list
25387266|NCT04446039|Fluoxetine|fluoxetine|mesh-list
25387267|NCT04446039|Paroxetine|paroxetine|mesh-list
25387268|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25387269|NCT04446039|Sertraline|sertraline|mesh-list
25387281|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25387282|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387283|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25387284|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
25387285|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25387286|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25387287|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387288|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25387289|NCT04446039|Analgesics|analgesics|mesh-ancestor
25387290|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
25387291|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25387292|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25387293|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387294|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25387295|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25387296|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25387297|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25387298|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25387299|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
25387300|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
25387301|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25387302|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25387303|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25387304|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
25387305|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25387306|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25387307|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
25387308|NCT04445714|Saxagliptin|saxagliptin|mesh-list
25387309|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25387310|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387311|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25387312|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387313|NCT04445714|Incretins|incretins|mesh-ancestor
25387314|NCT04445714|Hormones|hormones|mesh-ancestor
25387315|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387316|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25387317|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
25387318|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387319|NCT04445519|Latanoprost|latanoprost|mesh-list
25387320|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25387321|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25387334|NCT04444830|Ketorolac|ketorolac|mesh-list
25387335|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25387336|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25387337|NCT04444830|Analgesics|analgesics|mesh-ancestor
25387338|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
25387339|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387340|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387341|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387342|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25387343|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25387344|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387345|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387346|NCT04443673|Glycine|glycine|mesh-list
25387347|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
25387348|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387349|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387350|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387352|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387353|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387354|NCT04442412|Vitamin D|vitamin d|mesh-list
25387355|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
25387356|NCT04442412|Vitamins|vitamins|mesh-ancestor
25387357|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
25387358|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387359|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25387360|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25387361|NCT04441138|Durvalumab|durvalumab|mesh-list
25387362|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387363|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387364|NCT04440371|Betamethasone|betamethasone|mesh-list
25387367|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387368|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
25387369|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387370|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25387371|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387372|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387373|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387374|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
25387375|NCT04440371|Hormones|hormones|mesh-ancestor
25387376|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387377|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25387378|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
25387379|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
25387380|NCT04440176|Vaccines|vaccines|mesh-list
25387381|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
25387382|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387383|NCT04439539|Tenofovir|tenofovir|mesh-list
25387384|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
25387385|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25387386|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
25387387|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387388|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25387389|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25387390|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387391|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387392|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25387393|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25387394|NCT04439357|Trametinib|trametinib|mesh-list
25387395|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25387396|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387397|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387398|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387399|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387400|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25387401|NCT04439357|Protective Agents|protective agents|mesh-ancestor
25387402|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387403|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25387404|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
25387405|NCT04439318|Trametinib|trametinib|mesh-list
25387406|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25387407|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387408|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387409|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387410|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387411|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25387412|NCT04439318|Protective Agents|protective agents|mesh-ancestor
25387413|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387414|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25387415|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
25387416|NCT04439292|Trametinib|trametinib|mesh-list
25387417|NCT04439292|Dabrafenib|dabrafenib|mesh-list
25387418|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25387419|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387420|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387421|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387422|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387423|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25387424|NCT04439292|Protective Agents|protective agents|mesh-ancestor
25387425|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387426|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25387427|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
25387428|NCT04439279|Trametinib|trametinib|mesh-list
25387429|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25387430|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387431|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387432|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387433|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387434|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25387435|NCT04439279|Protective Agents|protective agents|mesh-ancestor
25387436|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387437|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25387438|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
25387439|NCT04439266|Crizotinib|crizotinib|mesh-list
25387440|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387441|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387442|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387443|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387445|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387446|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387447|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387448|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387449|NCT04439227|Adavosertib|adavosertib|mesh-list
25387450|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387451|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387452|NCT04439201|Palbociclib|palbociclib|mesh-list
25387453|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387454|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387455|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387456|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387457|NCT04439188|GSK2636771|gsk2636771|mesh-list
25387458|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387459|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387460|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387461|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387462|NCT04439149|GSK2636771|gsk2636771|mesh-list
25387463|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387464|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387465|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387466|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387467|NCT04439110|Trastuzumab|trastuzumab|mesh-list
25387468|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25387469|NCT04439110|Maytansine|maytansine|mesh-list
25387470|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
25387471|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387472|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387473|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25387474|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387475|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387476|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387477|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387478|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
25387479|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387480|NCT04438824|Palbociclib|palbociclib|mesh-list
25387481|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387482|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387483|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387484|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387485|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25387486|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
25387487|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387488|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25387489|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
25387490|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387491|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387492|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25387493|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25408393|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
25387501|NCT04438382|Antibodies|antibodies|mesh-list
25387502|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
25387503|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25387504|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
25387505|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387506|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
25387507|NCT04438382|Hormones|hormones|mesh-ancestor
25387508|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387509|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387510|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387511|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387512|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
25387513|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25387514|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25387515|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25387523|NCT04437888|Ketamine|ketamine|mesh-list
25387524|NCT04437888|Analgesics|analgesics|mesh-ancestor
25387525|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
25387526|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387527|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387528|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25387529|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25387530|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
25387531|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
25387532|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387533|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25387534|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25387535|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387536|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387537|NCT04437017|Dexamethasone|dexamethasone|mesh-list
25387538|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
25387539|NCT04437017|Olanzapine|olanzapine|mesh-list
25387540|NCT04437017|Serotonin|serotonin|mesh-list
25387541|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387542|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
25387543|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
25387544|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387545|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387546|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25387547|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
25387548|NCT04437017|Hormones|hormones|mesh-ancestor
25387549|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387550|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387551|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387552|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25387553|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25387554|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387555|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25387556|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25387557|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25387558|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25387559|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387560|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387561|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
25387562|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25387563|NCT04436913|Fluorides|fluorides|mesh-list
25387564|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
25387565|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
25387566|NCT04436913|Protective Agents|protective agents|mesh-ancestor
25387567|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387568|NCT04436250|Ketamine|ketamine|mesh-list
25387569|NCT04436250|Esketamine|esketamine|mesh-list
25387570|NCT04436250|Analgesics|analgesics|mesh-ancestor
25387571|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
25387572|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387573|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387574|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25387575|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25387577|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
25387578|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387579|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25387580|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25387581|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387582|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387583|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
25387584|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25387585|NCT04436107|Lenalidomide|lenalidomide|mesh-list
25387586|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
25387587|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
25387588|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387589|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25387590|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25387591|NCT04436107|Growth Substances|growth substances|mesh-ancestor
25387592|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
25387593|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387594|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387595|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387596|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387597|NCT04435782|Selexipag|selexipag|mesh-list
25387598|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25387599|NCT04434664|Metoprolol|metoprolol|mesh-list
25387600|NCT04434664|Amlodipine|amlodipine|mesh-list
25387601|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25387602|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25387603|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25387604|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387605|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25387606|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387607|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
25387608|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25387609|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
25387610|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
25387611|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387612|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25387613|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25387614|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25387615|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
25387616|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387617|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
25387618|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387619|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387620|NCT04434092|Eculizumab|eculizumab|mesh-list
25387621|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25387622|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387623|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
25387624|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387625|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
25387626|NCT04432662|Hematinics|hematinics|mesh-ancestor
25387627|NCT04432584|Eculizumab|eculizumab|mesh-list
25387628|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25387629|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387630|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
25387631|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387632|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
25387633|NCT04432506|Fludarabine|fludarabine|mesh-list
25387634|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25387635|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387636|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
25387637|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387638|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25387639|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25387640|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
25387641|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387642|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387643|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25387644|NCT04431895|Tofacitinib|tofacitinib|mesh-list
25387645|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387646|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387647|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387649|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
25387650|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387651|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
25387652|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387653|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
25387654|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
25387656|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387657|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387658|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
25387659|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387660|NCT04430738|Leucovorin|leucovorin|mesh-list
25387661|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
25387662|NCT04430738|Trastuzumab|trastuzumab|mesh-list
25387663|NCT04430738|Fluorouracil|fluorouracil|mesh-list
25387664|NCT04430738|Capecitabine|capecitabine|mesh-list
25387665|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
25387666|NCT04430738|Tucatinib|tucatinib|mesh-list
25387667|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387668|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387669|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
25387670|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387671|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387672|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387673|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
25387674|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387675|NCT04430738|Antidotes|antidotes|mesh-ancestor
25387676|NCT04430738|Protective Agents|protective agents|mesh-ancestor
25387677|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
25387678|NCT04430738|Vitamins|vitamins|mesh-ancestor
25387679|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
25387680|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387681|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387682|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
25387683|NCT04429893|Bupivacaine|bupivacaine|mesh-list
25387684|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
25387685|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
25387686|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387687|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387688|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
25387689|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387690|NCT04429893|Analgesics|analgesics|mesh-ancestor
25387691|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25387692|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
25387693|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25387694|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25387695|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387696|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25387697|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
25387698|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25387699|NCT04429555|Ibudilast|ibudilast|mesh-list
25387700|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25387701|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
25387702|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387703|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387704|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25387705|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
25387706|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25387707|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387708|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387709|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25387710|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
25387711|NCT04429347|Gabapentin|gabapentin|mesh-list
25387712|NCT04429347|Tizanidine|tizanidine|mesh-list
25387713|NCT04429347|Analgesics|analgesics|mesh-ancestor
25387714|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
25387715|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387716|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387717|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
25387718|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25387719|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25387720|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387721|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25387722|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25387723|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25387724|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387725|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387726|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
25387727|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25387728|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25387729|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
25387730|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
25387731|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25387732|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25387733|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25387734|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
25387736|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387737|NCT04428307|Artemisinins|artemisinins|mesh-list
25387738|NCT04428307|Artemisinin|artemisinin|mesh-list
25387739|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
25387740|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25387741|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25387742|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387743|NCT04428151|Paclitaxel|paclitaxel|mesh-list
25387744|NCT04428151|Docetaxel|docetaxel|mesh-list
25387745|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
25387746|NCT04428151|Capecitabine|capecitabine|mesh-list
25387747|NCT04428151|Cetuximab|cetuximab|mesh-list
25387748|NCT04428151|Lenvatinib|lenvatinib|mesh-list
25387749|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25387750|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387751|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387752|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387753|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387754|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387755|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387756|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387757|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
25387758|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387759|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387760|NCT04428008|Thymalfasin|thymalfasin|mesh-list
25387761|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25387762|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
25387763|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387764|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
25387765|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
25387766|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387767|NCT04426890|Omalizumab|omalizumab|mesh-list
25387768|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25387769|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25387770|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25387771|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
25387772|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
25387773|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387774|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
25387775|NCT04425655|Fludarabine|fludarabine|mesh-list
25387776|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387777|NCT04425382|Ritonavir|ritonavir|mesh-list
25387778|NCT04425382|Lopinavir|lopinavir|mesh-list
25387779|NCT04425382|Darunavir|darunavir|mesh-list
25387780|NCT04425382|Cobicistat|cobicistat|mesh-list
25387781|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25387782|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25387783|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25387784|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
25387785|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387786|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387787|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25387788|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25387789|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
25387790|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387791|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25387792|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25387793|NCT04425070|Gemcitabine|gemcitabine|mesh-list
25387794|NCT04425070|Carboplatin|carboplatin|mesh-list
25387795|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
25387796|NCT04425070|Etoposide|etoposide|mesh-list
25387797|NCT04425070|Ifosfamide|ifosfamide|mesh-list
25387798|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387799|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387800|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
25387808|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25387810|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25387811|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25387812|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
25387899|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
25387827|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
25387828|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25387829|NCT04424654|Androgens|androgens|mesh-ancestor
25387830|NCT04424654|Hormones|hormones|mesh-ancestor
25387831|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387832|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387833|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387834|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387835|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
25387836|NCT04424303|Tofacitinib|tofacitinib|mesh-list
25387837|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387838|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387839|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387840|NCT04423731|Leucovorin|leucovorin|mesh-list
25387841|NCT04423731|Gemcitabine|gemcitabine|mesh-list
25387842|NCT04423731|Paclitaxel|paclitaxel|mesh-list
25387843|NCT04423731|Fluorouracil|fluorouracil|mesh-list
25387844|NCT04423731|Folfirinox|folfirinox|mesh-list
25387845|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25387846|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387847|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387848|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387849|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387850|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387851|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387852|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
25387853|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
25387854|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387855|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387856|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387857|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
25387858|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387859|NCT04423731|Antidotes|antidotes|mesh-ancestor
25387860|NCT04423731|Protective Agents|protective agents|mesh-ancestor
25387861|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
25387862|NCT04423731|Vitamins|vitamins|mesh-ancestor
25387863|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
25387864|NCT04423718|Aflibercept|aflibercept|mesh-list
25387865|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25387866|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25387867|NCT04423718|Growth Substances|growth substances|mesh-ancestor
25387868|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387869|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
25387870|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387871|NCT04423367|Dexamethasone|dexamethasone|mesh-list
25387872|NCT04423367|Bortezomib|bortezomib|mesh-list
25387873|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387874|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
25387875|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
25387876|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387877|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387878|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25387879|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
25387880|NCT04423367|Hormones|hormones|mesh-ancestor
25387881|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387882|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387883|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387885|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387886|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387887|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25387888|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387894|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
25387895|NCT04421196|Analgesics|analgesics|mesh-list
25387896|NCT04421196|Narcotics|narcotics|mesh-ancestor
25387897|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387898|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387900|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387901|NCT04420624|Colchicine|colchicine|mesh-list
25387902|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
25387903|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25387904|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387905|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387906|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387907|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387908|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387909|NCT04419181|Carboplatin|carboplatin|mesh-list
25387910|NCT04419181|Docetaxel|docetaxel|mesh-list
25387911|NCT04419181|Trastuzumab|trastuzumab|mesh-list
25387912|NCT04419181|Pertuzumab|pertuzumab|mesh-list
25387913|NCT04419181|Maytansine|maytansine|mesh-list
25387914|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25387915|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387916|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
25387917|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
25387918|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
25387919|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387920|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387921|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25387922|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25387923|NCT04418999|Dexamethasone|dexamethasone|mesh-list
25387924|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25387925|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
25387926|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
25387927|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387928|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387929|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25387930|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
25387931|NCT04418999|Hormones|hormones|mesh-ancestor
25387932|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25387933|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25387934|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387935|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25387936|NCT04418856|Methamphetamine|methamphetamine|mesh-list
25387937|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25387938|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387939|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
25387940|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
25387941|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387942|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
25387943|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387944|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387945|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
25387946|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25387947|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25387948|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25387949|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25387950|NCT04418531|Antibodies|antibodies|mesh-list
25387951|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
25387952|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25387953|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
25387954|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387955|NCT04418167|Dabrafenib|dabrafenib|mesh-list
25387956|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387957|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387958|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387959|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387960|NCT04417621|Trametinib|trametinib|mesh-list
25387961|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387962|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387963|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387964|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387965|NCT04417257|Fenretinide|fenretinide|mesh-list
25387966|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387967|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25387968|NCT04417257|Protective Agents|protective agents|mesh-ancestor
25387969|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387970|NCT04416633|Durvalumab|durvalumab|mesh-list
25387971|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387972|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387973|NCT04416451|Rituximab|rituximab|mesh-list
25387974|NCT04416451|Venetoclax|venetoclax|mesh-list
25387975|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25387976|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387977|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
25387978|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387979|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25387980|NCT04415853|Irinotecan|irinotecan|mesh-list
25387981|NCT04415853|Tegafur|tegafur|mesh-list
25387982|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25387983|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25387984|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387985|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387986|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387987|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25387988|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
25387989|NCT04415151|Tofacitinib|tofacitinib|mesh-list
25387990|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25387991|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387992|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387993|NCT04414943|Ketamine|ketamine|mesh-list
25387994|NCT04414943|Esketamine|esketamine|mesh-list
25387995|NCT04414943|Analgesics|analgesics|mesh-ancestor
25387996|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
25387997|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25387998|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387999|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25388000|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25388001|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
25388002|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
25388003|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25388004|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25388005|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25388006|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388007|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388008|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
25388009|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25388010|NCT04413266|Curcumin|curcumin|mesh-list
25388011|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25388012|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388013|NCT04413266|Analgesics|analgesics|mesh-ancestor
25388014|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
25388015|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388016|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388017|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388018|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388019|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388020|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388021|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388022|NCT04413123|Nivolumab|nivolumab|mesh-list
25388023|NCT04413123|Ipilimumab|ipilimumab|mesh-list
25388024|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388025|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388026|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388027|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388028|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25388029|NCT04412876|Imipramine|imipramine|mesh-list
25388030|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25388031|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25388032|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25388033|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388034|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388035|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388037|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
25388038|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388039|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
25388040|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25388041|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
25388042|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25388043|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25388044|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
25388045|NCT04412707|Dexamethasone|dexamethasone|mesh-list
25388047|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388048|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
25388049|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
25388050|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388051|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388052|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388053|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
25388054|NCT04412707|Hormones|hormones|mesh-ancestor
25388055|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388056|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25388057|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388058|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388059|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
25388060|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388061|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25388062|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388063|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
25388064|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
25388065|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
25388066|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25388067|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388068|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388069|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388070|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25388071|NCT04411836|Primaquine|primaquine|mesh-list
25388072|NCT04411836|Tafenoquine|tafenoquine|mesh-list
25388073|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
25388074|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25388075|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25388076|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388077|NCT04411758|Propolis|propolis|mesh-list
25388078|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388079|NCT04411654|Sirolimus|sirolimus|mesh-list
25388080|NCT04411654|Prednisone|prednisone|mesh-list
25388081|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
25388082|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25388083|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25388084|NCT04411654|Prednisolone|prednisolone|mesh-list
25388085|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
25388086|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25388087|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
25388088|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388089|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
25388090|NCT04411654|Hormones|hormones|mesh-ancestor
25388091|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388092|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388093|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25388094|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388095|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25388096|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388097|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25388098|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
25388099|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388100|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
25388101|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
25388102|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
25388103|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388104|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388105|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25388106|NCT04411654|Protective Agents|protective agents|mesh-ancestor
25388107|NCT04410991|Teriflunomide|teriflunomide|mesh-list
25388108|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25388109|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388110|NCT04410991|Analgesics|analgesics|mesh-ancestor
25388111|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
25388112|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388113|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388115|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388116|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388117|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
25388118|NCT04410978|Teriflunomide|teriflunomide|mesh-list
25388119|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25388120|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388121|NCT04410978|Analgesics|analgesics|mesh-ancestor
25388122|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
25388123|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388124|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388125|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388126|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388127|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388128|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
25388130|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388131|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25388132|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388133|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388134|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25388135|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25388136|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388137|NCT04409002|Niraparib|niraparib|mesh-list
25388138|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25388139|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388140|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388141|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388142|NCT04408638|Gemcitabine|gemcitabine|mesh-list
25388143|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
25388144|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
25388145|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388146|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
25388147|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388148|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388149|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
25388150|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388151|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388152|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388153|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
25388154|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388155|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388156|NCT04408560|Acetaminophen|acetaminophen|mesh-list
25388157|NCT04408560|Analgesics|analgesics|mesh-list
25388158|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388159|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
25388160|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388161|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388162|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
25388163|NCT04407650|Metformin|metformin|mesh-list
25388164|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25388165|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25388166|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388167|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25388168|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388169|NCT04407442|Dexamethasone|dexamethasone|mesh-list
25388170|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
25388171|NCT04407442|Azacitidine|azacitidine|mesh-list
25388172|NCT04407442|Daratumumab|daratumumab|mesh-list
25388173|NCT04407442|Ichthammol|ichthammol|mesh-list
25388174|NCT04407442|BB 1101|bb 1101|mesh-list
25388175|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388176|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
25388177|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
25388178|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388179|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388180|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388181|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
25388182|NCT04407442|Hormones|hormones|mesh-ancestor
25388183|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388184|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25388185|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388186|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
25388187|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388188|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388189|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388190|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
25388191|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
25388194|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
25388195|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
25388196|NCT04407390|Vitamins|vitamins|mesh-ancestor
25388197|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
25388198|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388199|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25388200|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
25388201|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388202|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25388203|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
25388204|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
25388205|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25388206|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
25388207|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
25388208|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388209|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388210|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388211|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388212|NCT04406649|Analgesics|analgesics|mesh-ancestor
25388213|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
25388214|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388215|NCT04406389|Heparin|heparin|mesh-list
25388216|NCT04406389|Calcium heparin|calcium heparin|mesh-list
25388217|NCT04406389|Enoxaparin|enoxaparin|mesh-list
25388218|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
25388219|NCT04406389|Argatroban|argatroban|mesh-list
25388220|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
25388221|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25388222|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25388223|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388224|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
25388225|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25388226|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
25388227|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388228|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25388229|NCT04405596|Ambroxol|ambroxol|mesh-list
25388230|NCT04405596|Expectorants|expectorants|mesh-ancestor
25388231|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
25388232|NCT04405037|Alvimopan|alvimopan|mesh-list
25388233|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388234|NCT04404283|Rituximab|rituximab|mesh-list
25388235|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25388236|NCT04404283|Lenalidomide|lenalidomide|mesh-list
25388237|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388238|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388239|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
25388240|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388241|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388242|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25388243|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25388244|NCT04404283|Growth Substances|growth substances|mesh-ancestor
25388245|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
25388246|NCT04404140|Docetaxel|docetaxel|mesh-list
25388247|NCT04404140|Atezolizumab|atezolizumab|mesh-list
25388248|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388249|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388250|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388251|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388252|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388253|NCT04404088|Rituximab|rituximab|mesh-list
25388254|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25388255|NCT04404088|Lenalidomide|lenalidomide|mesh-list
25388256|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
25388257|NCT04404088|Antibodies|antibodies|mesh-list
25388258|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
25388259|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25388260|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
25388261|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388262|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388263|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388264|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25388265|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25388266|NCT04404088|Growth Substances|growth substances|mesh-ancestor
25388267|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
25388268|NCT04402788|Atezolizumab|atezolizumab|mesh-list
25388269|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25388270|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388271|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
25388272|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388274|NCT04402346|Pancreatin|pancreatin|mesh-list
25388275|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388276|NCT04401995|Nivolumab|nivolumab|mesh-list
25388277|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388278|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388279|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388280|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388281|NCT04401761|Aspirin|aspirin|mesh-list
25388282|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
25388283|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25388284|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388285|NCT04401761|Analgesics|analgesics|mesh-ancestor
25388286|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
25388287|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388288|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388289|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388290|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388291|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25388292|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25388293|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388294|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25388295|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25388296|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388297|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
25388298|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25388299|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
25388300|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25388301|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
25388302|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
25388303|NCT04401748|Azacitidine|azacitidine|mesh-list
25388304|NCT04401748|Venetoclax|venetoclax|mesh-list
25388305|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388306|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
25388307|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388308|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388309|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388310|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25388311|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25388312|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
25388313|NCT04400994|Rituximab|rituximab|mesh-list
25388314|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388315|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388316|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
25388317|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388318|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388319|NCT04400201|Propofol|propofol|mesh-list
25388320|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25388321|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25388322|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388323|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25388324|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
25388325|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
25388326|NCT04400175|Silicon|silicon|mesh-list
25388327|NCT04400175|Trace Elements|trace elements|mesh-ancestor
25388328|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
25388329|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388330|NCT04398719|Capsaicin|capsaicin|mesh-list
25388331|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
25388332|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25388333|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
25388334|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388335|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388336|NCT04398706|Vaccines|vaccines|mesh-list
25388337|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25388338|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
25388339|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388340|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25388341|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25388342|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
25388343|NCT04398537|Hormones|hormones|mesh-ancestor
25388344|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388347|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388349|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388350|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388352|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
25388353|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388354|NCT04397991|Furosemide|furosemide|mesh-list
25388355|NCT04397991|Diuretics|diuretics|mesh-ancestor
25388356|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
25388357|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388358|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25388359|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25388360|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388361|NCT04397679|Chloroquine|chloroquine|mesh-list
25388362|NCT04397679|Temozolomide|temozolomide|mesh-list
25388363|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388364|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
25388365|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388366|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388367|NCT04397679|Amebicides|amebicides|mesh-ancestor
25388368|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25388369|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25388370|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388371|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
25388372|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388373|NCT04397107|Aldesleukin|aldesleukin|mesh-list
25388374|NCT04397107|Interleukin-2|interleukin-2|mesh-list
25388375|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388376|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388377|NCT04397107|Analgesics|analgesics|mesh-ancestor
25388378|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
25388379|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388380|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388381|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25388382|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25388383|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
25388384|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388388|NCT04396860|Nivolumab|nivolumab|mesh-list
25388389|NCT04396860|Ipilimumab|ipilimumab|mesh-list
25388390|NCT04396860|Temozolomide|temozolomide|mesh-list
25388391|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388392|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388393|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388394|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388395|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388396|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
25388397|NCT04396574|Lasmiditan|lasmiditan|mesh-list
25388398|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25388399|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
25388400|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388401|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388402|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388403|NCT04396236|Lasmiditan|lasmiditan|mesh-list
25388404|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25388405|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
25388406|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388407|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388408|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388409|NCT04395222|Fludarabine|fludarabine|mesh-list
25388410|NCT04395222|Melphalan|melphalan|mesh-list
25388411|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
25388412|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25388413|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388414|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388415|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388416|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
25388417|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388418|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388419|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
25388420|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25388421|NCT04394858|Temozolomide|temozolomide|mesh-list
25388422|NCT04394858|Olaparib|olaparib|mesh-list
25388423|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25388424|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388425|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
25388426|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388427|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388428|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388429|NCT04394663|Omeprazole|omeprazole|mesh-list
25388430|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25388431|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388432|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25388433|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388434|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388436|NCT04393298|Leucovorin|leucovorin|mesh-list
25388437|NCT04393298|Trifluridine|trifluridine|mesh-list
25388438|NCT04393298|Fluorouracil|fluorouracil|mesh-list
25388439|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388440|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
25388441|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388442|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388443|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388444|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388445|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
25388446|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
25388447|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388448|NCT04393298|Antidotes|antidotes|mesh-ancestor
25388449|NCT04393298|Protective Agents|protective agents|mesh-ancestor
25388450|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
25388451|NCT04393298|Vitamins|vitamins|mesh-ancestor
25388452|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
25388453|NCT04393285|Letrozole|letrozole|mesh-list
25388454|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388455|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25388456|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25388457|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388458|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388459|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25388460|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
25388461|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388462|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388463|NCT04393207|Dexamethasone|dexamethasone|mesh-list
25388464|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
25388465|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
25388466|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25388467|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25388468|NCT04393207|Prednisolone|prednisolone|mesh-list
25388469|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
25388470|NCT04393207|Bupivacaine|bupivacaine|mesh-list
25388471|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25388472|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
25388473|NCT04393207|BB 1101|bb 1101|mesh-list
25388474|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388475|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
25388476|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
25388477|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388478|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388479|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25388480|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
25388481|NCT04393207|Hormones|hormones|mesh-ancestor
25388482|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388483|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25388484|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388485|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
25388486|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388487|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388488|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
25388489|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
25388490|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25388491|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
25388492|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25388493|NCT04393207|Protective Agents|protective agents|mesh-ancestor
25388495|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25388496|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388497|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388498|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388499|NCT04392011|Midazolam|midazolam|mesh-list
25388500|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
25388501|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25388502|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25388503|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25388504|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388505|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25388506|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25388507|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25388508|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25388509|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
25388510|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
25388511|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
25388512|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
25388513|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388514|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388515|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
25388516|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
25388517|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25388518|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25388519|NCT04391049|Paclitaxel|paclitaxel|mesh-list
25388520|NCT04391049|Carboplatin|carboplatin|mesh-list
25388521|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25388522|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25388523|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388524|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388525|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388526|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388527|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388528|NCT04390763|Gemcitabine|gemcitabine|mesh-list
25388529|NCT04390763|Paclitaxel|paclitaxel|mesh-list
25388530|NCT04390763|Spartalizumab|spartalizumab|mesh-list
25388531|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25388532|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388533|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388534|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388535|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388536|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388537|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388538|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
25388539|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
25388540|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388541|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388542|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388543|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
25388544|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388545|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388546|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25388547|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388548|NCT04389840|Heparin|heparin|mesh-list
25388549|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
25388550|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25388551|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25388552|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388553|NCT04388852|Ipilimumab|ipilimumab|mesh-list
25388554|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388555|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388556|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388557|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388558|NCT04388839|Dactinomycin|dactinomycin|mesh-list
25388559|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
25388560|NCT04388839|Vincristine|vincristine|mesh-list
25388561|NCT04388839|Vinorelbine|vinorelbine|mesh-list
25388562|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388563|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
25388564|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388565|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388566|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388567|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
25388568|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388569|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388570|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25388571|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25388572|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388573|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388574|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388575|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25388576|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388577|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25388578|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25388579|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388580|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25388581|NCT04388475|Temozolomide|temozolomide|mesh-list
25388582|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388583|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
25388584|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388585|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388586|NCT04388163|Gentian Violet|gentian violet|mesh-list
25388587|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25388588|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388589|NCT04387942|Aldesleukin|aldesleukin|mesh-list
25388590|NCT04387942|Interleukin-2|interleukin-2|mesh-list
25388591|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388592|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388593|NCT04387942|Analgesics|analgesics|mesh-ancestor
25388594|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
25388595|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388596|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388597|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25388598|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25388599|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
25388600|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388601|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
25388602|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
25388603|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388604|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
25388605|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388606|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388607|NCT04387227|Carboplatin|carboplatin|mesh-list
25388608|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
25388609|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388610|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388611|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
25388612|NCT04387084|Nivolumab|nivolumab|mesh-list
25388613|NCT04387084|Durvalumab|durvalumab|mesh-list
25388614|NCT04387084|Avelumab|avelumab|mesh-list
25388615|NCT04387084|Cemiplimab|cemiplimab|mesh-list
25388616|NCT04387084|Atezolizumab|atezolizumab|mesh-list
25388617|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
25388618|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25388619|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
25388620|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388621|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388622|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388623|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388624|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
25388625|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388626|NCT04386746|Gemcitabine|gemcitabine|mesh-list
25388627|NCT04386746|Docetaxel|docetaxel|mesh-list
25388628|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388629|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
25388630|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388631|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388632|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
25388633|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388634|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388635|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388636|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
25388637|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388638|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388639|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388640|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388641|NCT04386317|Terazosin|terazosin|mesh-list
25388642|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25388643|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25388644|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25388645|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
25388646|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388647|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388648|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388649|NCT04386317|Urological Agents|urological agents|mesh-ancestor
25419855|NCT02669901|Naloxone|naloxone|mesh-list
25388650|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
25388651|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
25388652|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
25388653|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25388654|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388655|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
25388656|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388657|NCT04385940|Vitamin D|vitamin d|mesh-list
25388658|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
25388659|NCT04385940|Vitamins|vitamins|mesh-ancestor
25388660|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
25388661|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388662|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25388663|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25388664|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
25388665|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25388666|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25388667|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388669|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
25388670|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
25388671|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25388672|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
25388673|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25388674|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388675|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25388676|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25388677|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25388678|NCT04385368|Durvalumab|durvalumab|mesh-list
25388679|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388680|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388681|NCT04385277|Vitamin A|vitamin a|mesh-list
25388682|NCT04385277|Irinotecan|irinotecan|mesh-list
25388683|NCT04385277|Temozolomide|temozolomide|mesh-list
25388684|NCT04385277|Tretinoin|tretinoin|mesh-list
25388685|NCT04385277|Dinutuximab|dinutuximab|mesh-list
25388686|NCT04385277|Isotretinoin|isotretinoin|mesh-list
25388687|NCT04385277|Sargramostim|sargramostim|mesh-list
25388688|NCT04385277|Vitamins|vitamins|mesh-ancestor
25388689|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
25388690|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388691|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25388692|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25388693|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388694|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388695|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388696|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388697|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
25388698|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
25388699|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
25388700|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
25388701|NCT04384484|Gemcitabine|gemcitabine|mesh-list
25388702|NCT04384484|Rituximab|rituximab|mesh-list
25388703|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25388704|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
25388705|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388706|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388707|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
25388708|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388709|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388710|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388711|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
25388712|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388713|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
25388714|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388715|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388716|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388717|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
25388718|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
25388719|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388720|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388721|NCT04383743|Cisplatin|cisplatin|mesh-list
25388722|NCT04383743|Doxorubicin|doxorubicin|mesh-list
25388723|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25388724|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
25388725|NCT04383743|Methotrexate|methotrexate|mesh-list
25388726|NCT04383743|Daunorubicin|daunorubicin|mesh-list
25388727|NCT04383743|Vinblastine|vinblastine|mesh-list
25724257|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388728|NCT04383743|Lenograstim|lenograstim|mesh-list
25388729|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388730|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25388731|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25388732|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25388733|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388734|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388735|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388736|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25388737|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
25388738|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25388739|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388740|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388741|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
25388742|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
25388743|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25388744|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388745|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
25388746|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388747|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25388748|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25388749|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25388750|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388751|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388752|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388753|NCT04383574|Vaccines|vaccines|mesh-list
25388754|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
25388755|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388756|NCT04382898|Cemiplimab|cemiplimab|mesh-list
25388757|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388758|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388759|NCT04382664|Nivolumab|nivolumab|mesh-list
25388760|NCT04382664|Ipilimumab|ipilimumab|mesh-list
25388761|NCT04382664|Sargramostim|sargramostim|mesh-list
25388762|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388763|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388764|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388765|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388766|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
25388767|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388768|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
25388769|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25388770|NCT04382404|Velpatasvir|velpatasvir|mesh-list
25388771|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
25388772|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388773|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25388774|NCT04382352|Trastuzumab|trastuzumab|mesh-list
25388775|NCT04382352|Antibodies|antibodies|mesh-list
25388776|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
25388777|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25388778|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
25388779|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388780|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388781|NCT04382326|Vaccines|vaccines|mesh-list
25388782|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25388783|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
25388784|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388785|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
25388786|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25388787|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
25388788|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388789|NCT04381897|Expectorants|expectorants|mesh-ancestor
25388790|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
25388791|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25388792|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
25388793|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388794|NCT04381897|Protective Agents|protective agents|mesh-ancestor
25388795|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388796|NCT04381897|Antidotes|antidotes|mesh-ancestor
25388797|NCT04381832|Docetaxel|docetaxel|mesh-list
25388798|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388799|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388800|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388801|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388802|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388803|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
25388804|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388805|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388806|NCT04381143|Aspirin|aspirin|mesh-list
25388807|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25388808|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388809|NCT04381143|Analgesics|analgesics|mesh-ancestor
25388810|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
25388811|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388812|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388813|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388814|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388815|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25388816|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25388817|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388818|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25388819|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25388820|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388821|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
25388822|NCT04380636|Paclitaxel|paclitaxel|mesh-list
25388823|NCT04380636|Etoposide|etoposide|mesh-list
25388824|NCT04380636|Cisplatin|cisplatin|mesh-list
25388825|NCT04380636|Carboplatin|carboplatin|mesh-list
25388826|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
25388827|NCT04380636|Pemetrexed|pemetrexed|mesh-list
25388828|NCT04380636|Durvalumab|durvalumab|mesh-list
25388829|NCT04380636|Olaparib|olaparib|mesh-list
25388830|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25388831|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388832|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388833|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388834|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388835|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388836|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388837|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25388838|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25388839|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388840|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25388841|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25388842|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25388843|NCT04380545|Interferons|interferons|mesh-list
25388844|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
25388845|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
25388846|NCT04380545|Fluorouracil|fluorouracil|mesh-list
25388847|NCT04380545|Nivolumab|nivolumab|mesh-list
25388848|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
25388849|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388850|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388851|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388852|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388853|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
25388854|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388855|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388856|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25388857|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
25388858|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388859|NCT04380207|QPX7728|qpx7728|mesh-list
25388860|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25388861|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388862|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388863|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25388864|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388865|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
25388866|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388867|NCT04379713|Vaccines|vaccines|mesh-list
25388868|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25388869|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
25388870|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388871|NCT04379635|Paclitaxel|paclitaxel|mesh-list
25388872|NCT04379635|Cisplatin|cisplatin|mesh-list
25388873|NCT04379635|Carboplatin|carboplatin|mesh-list
25388874|NCT04379635|Pemetrexed|pemetrexed|mesh-list
25388875|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25388876|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388877|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388878|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388879|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388880|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388881|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388882|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25388883|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25388886|NCT04379596|Fluorouracil|fluorouracil|mesh-list
25388887|NCT04379596|Capecitabine|capecitabine|mesh-list
25388888|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
25388889|NCT04379596|Trastuzumab|trastuzumab|mesh-list
25388890|NCT04379596|Durvalumab|durvalumab|mesh-list
25388891|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388892|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388893|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
25388894|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388895|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388896|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388897|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
25388898|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388899|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
25388900|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
25388901|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388902|NCT04377087|Olaparib|olaparib|mesh-list
25388903|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25388904|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388905|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388906|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388907|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25388908|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
25388909|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388910|NCT04375813|Sirolimus|sirolimus|mesh-list
25388911|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25388912|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388913|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25388914|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388915|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
25388916|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388917|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
25388918|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388919|NCT04375631|Cytarabine|cytarabine|mesh-list
25388920|NCT04375631|Cyclosporine|cyclosporine|mesh-list
25388921|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
25388922|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
25388923|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
25388924|NCT04375631|Cladribine|cladribine|mesh-list
25388925|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25388926|NCT04375631|Cyclosporins|cyclosporins|mesh-list
25388927|NCT04375631|Lenograstim|lenograstim|mesh-list
25388928|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25388929|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
25388930|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388931|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25388932|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25388933|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
25388934|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388935|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388936|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25388937|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25388938|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
25388939|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
25388940|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25388941|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25388942|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25388943|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
25388944|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
25388945|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25388946|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25388947|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25388948|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
25388949|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25388950|NCT04375631|Analgesics|analgesics|mesh-ancestor
25388951|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
25388952|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388953|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25388954|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25388955|NCT04375384|Cetuximab|cetuximab|mesh-list
25388956|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388957|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388958|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
25388959|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25388960|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388961|NCT04374773|Dronabinol|dronabinol|mesh-list
25388962|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
25388963|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388964|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25388965|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25388966|NCT04374773|Analgesics|analgesics|mesh-ancestor
25388967|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
25388968|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25388969|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25388970|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25388971|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388972|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388973|NCT04374773|Hormones|hormones|mesh-ancestor
25389126|NCT04360889|Vitamins|vitamins|mesh-ancestor
25388987|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388988|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25388989|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
25388990|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
25388991|NCT04374474|Hormones|hormones|mesh-ancestor
25388992|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388993|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25388994|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
25388995|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388996|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25388997|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25388998|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388999|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
25389000|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389001|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389002|NCT04372628|Ritonavir|ritonavir|mesh-list
25389003|NCT04372628|Lopinavir|lopinavir|mesh-list
25389004|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25389005|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25389006|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
25389007|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389008|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389009|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25389010|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25389011|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
25389012|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389013|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25389014|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25389015|NCT04372108|Ustekinumab|ustekinumab|mesh-list
25389016|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
25389031|NCT04370483|Leflunomide|leflunomide|mesh-list
25389032|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389033|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389034|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389035|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
25389036|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389037|NCT04370054|Factor VIII|factor viii|mesh-list
25389038|NCT04370054|Coagulants|coagulants|mesh-ancestor
25389039|NCT04368403|Brodalumab|brodalumab|mesh-list
25389040|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25389041|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
25389042|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25389043|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389044|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389045|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25389046|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25389047|NCT04367935|Protective Agents|protective agents|mesh-ancestor
25389127|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
25389048|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389049|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
25389050|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25389051|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
25389052|NCT04367311|Cisplatin|cisplatin|mesh-list
25389053|NCT04367311|Docetaxel|docetaxel|mesh-list
25389054|NCT04367311|Pemetrexed|pemetrexed|mesh-list
25389055|NCT04367311|Atezolizumab|atezolizumab|mesh-list
25389056|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389057|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389058|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389059|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25724258|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25389060|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389061|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389062|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25389063|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25389064|NCT04367168|Colchicine|colchicine|mesh-list
25389065|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
25389066|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389067|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389068|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389069|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
25389070|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389071|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389072|NCT04365933|Interferons|interferons|mesh-list
25389073|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
25389074|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
25389075|NCT04365933|Entecavir|entecavir|mesh-list
25389076|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25389077|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389078|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
25389079|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389080|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
25389081|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389082|NCT04364620|Docetaxel|docetaxel|mesh-list
25389083|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389084|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389085|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389086|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
25389087|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389088|NCT04364230|Poly ICLC|poly iclc|mesh-list
25389089|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
25389090|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389091|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
25389092|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
25389093|NCT04363164|Testosterone|testosterone|mesh-list
25389094|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
25389095|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
25389096|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25389097|NCT04363164|Androgens|androgens|mesh-ancestor
25389098|NCT04363164|Hormones|hormones|mesh-ancestor
25389099|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25389100|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389101|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25389102|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389103|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
25389104|NCT04362839|Nivolumab|nivolumab|mesh-list
25389105|NCT04362839|Ipilimumab|ipilimumab|mesh-list
25389106|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389107|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389108|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389109|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389110|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25389111|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389112|NCT04361162|Nivolumab|nivolumab|mesh-list
25389113|NCT04361162|Ipilimumab|ipilimumab|mesh-list
25389114|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389115|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389116|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389117|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389118|NCT04360889|Tocopherols|tocopherols|mesh-list
25389119|NCT04360889|Vitamin E|vitamin e|mesh-list
25389120|NCT04360889|Tocotrienols|tocotrienols|mesh-list
25389121|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
25389122|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
25389123|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389124|NCT04360889|Protective Agents|protective agents|mesh-ancestor
25389125|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389136|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389137|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
25389138|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25389139|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
25389140|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389141|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389142|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25389143|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
25389144|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25389145|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
25724259|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25389146|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389147|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25389148|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25389149|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
25389150|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
25389151|NCT04358588|Protective Agents|protective agents|mesh-ancestor
25389152|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
25389153|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389154|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389155|NCT04357951|Cycloserine|cycloserine|mesh-list
25389156|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25389157|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389158|NCT04357951|Renal Agents|renal agents|mesh-ancestor
25389159|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25389160|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
25389161|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25389162|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
25389163|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389164|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
25389165|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389166|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
25389167|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25389168|NCT04357795|Cyclosporine|cyclosporine|mesh-list
25389169|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25389170|NCT04357795|Cyclosporins|cyclosporins|mesh-list
25389171|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389172|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389173|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389174|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
25389175|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389176|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
25389177|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389178|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
25389179|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389180|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25389181|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25389182|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
25389183|NCT04357587|Capecitabine|capecitabine|mesh-list
25389184|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389185|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389186|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25389187|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
25389188|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389189|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25389190|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389199|NCT04356729|Bevacizumab|bevacizumab|mesh-list
25389200|NCT04356729|Atezolizumab|atezolizumab|mesh-list
25389201|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389202|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389203|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25389204|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25389205|NCT04356729|Growth Substances|growth substances|mesh-ancestor
25389206|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389207|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
25389208|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25389209|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
25389210|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25389211|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
25389212|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25389213|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389214|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25389215|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25389216|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389217|NCT04356430|Prednisone|prednisone|mesh-list
25389218|NCT04356430|Goserelin|goserelin|mesh-list
25389219|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
25389220|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389221|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
25389222|NCT04356430|Hormones|hormones|mesh-ancestor
25389223|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25389224|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389225|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25389226|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389227|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25389229|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389230|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
25389231|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25389232|NCT04356352|Lidocaine|lidocaine|mesh-list
25389233|NCT04356352|Esmolol|esmolol|mesh-list
25389234|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
25389235|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
25389236|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389237|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389238|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
25389239|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389240|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25389241|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25389242|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25389243|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25389244|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389245|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25389246|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25389247|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25389248|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
25389249|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25389250|NCT04355572|Vitamin D|vitamin d|mesh-list
25389251|NCT04355572|Vitamins|vitamins|mesh-ancestor
25389252|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
25389253|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389254|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25389255|NCT04354428|Folic Acid|folic acid|mesh-list
25389256|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
25389257|NCT04354428|Ritonavir|ritonavir|mesh-list
25389258|NCT04354428|Lopinavir|lopinavir|mesh-list
25389259|NCT04354428|Azithromycin|azithromycin|mesh-list
25389260|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
25389261|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25389262|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25389263|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
25389264|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389265|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389266|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25389267|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25389268|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
25389269|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389270|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25389271|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25389272|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25389273|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
25389274|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25389275|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25389276|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389277|NCT04354428|Hematinics|hematinics|mesh-ancestor
25389278|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
25389279|NCT04354428|Vitamins|vitamins|mesh-ancestor
25389280|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
25389281|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389282|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
25389283|NCT04354428|Protective Agents|protective agents|mesh-ancestor
25389284|NCT04354012|Gentian Violet|gentian violet|mesh-list
25389285|NCT04354012|Methylene Blue|methylene blue|mesh-list
25389286|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389287|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389288|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25389289|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389290|NCT04353661|Azithromycin|azithromycin|mesh-list
25389291|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25389292|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389293|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25389294|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25389295|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
25389296|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389297|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389298|NCT04353492|Ofatumumab|ofatumumab|mesh-list
25389299|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389300|NCT04352439|Aspirin|aspirin|mesh-list
25389301|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25389302|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389303|NCT04352439|Analgesics|analgesics|mesh-ancestor
25389304|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
25389305|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389306|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389307|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389308|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389309|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25389310|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25389311|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389312|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25389313|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25389314|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389316|NCT04351555|Cisplatin|cisplatin|mesh-list
25389317|NCT04351555|Carboplatin|carboplatin|mesh-list
25389318|NCT04351555|Pemetrexed|pemetrexed|mesh-list
25389319|NCT04351555|Osimertinib|osimertinib|mesh-list
25389320|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389321|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389322|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389323|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25389324|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25389325|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25389326|NCT04350463|Nivolumab|nivolumab|mesh-list
25389327|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
25389328|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389329|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389330|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389331|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389332|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389333|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
25389334|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389335|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389336|NCT04348292|Sirolimus|sirolimus|mesh-list
25389337|NCT04348292|Durvalumab|durvalumab|mesh-list
25389338|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
25389339|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25389340|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
25389341|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25389342|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389343|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25389344|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389345|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
25389346|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389347|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
25389348|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389349|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389350|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
25389351|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25389352|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389353|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389354|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389355|NCT04346290|Analgesics|analgesics|mesh-ancestor
25389356|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
25389357|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389358|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25389359|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25389360|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25389361|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
25389362|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25389363|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389364|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
25389365|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
25389366|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
25389367|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389368|NCT04344717|Apixaban|apixaban|mesh-list
25389369|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25389370|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
25389371|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25389372|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
25389373|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389374|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389375|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
25389376|NCT04343872|Metformin|metformin|mesh-list
25389377|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25389378|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420532|NCT02619682|Lenalidomide|lenalidomide|mesh-list
25389379|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
25389380|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
25389381|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25389382|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25389383|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389384|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389385|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389386|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389387|NCT04341350|Analgesics|analgesics|mesh-list
25389388|NCT04341350|Propofol|propofol|mesh-list
25389389|NCT04341350|Isoflurane|isoflurane|mesh-list
25389390|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25389391|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389392|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389393|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25389394|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
25389395|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
25389396|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
25389397|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389398|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25389399|NCT04340843|Decitabine|decitabine|mesh-list
25389400|NCT04340843|Azacitidine|azacitidine|mesh-list
25389401|NCT04340843|Belinostat|belinostat|mesh-list
25389402|NCT04340843|Guadecitabine|guadecitabine|mesh-list
25389403|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25389404|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
25389405|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389406|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389407|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389408|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25389409|NCT04340193|Nivolumab|nivolumab|mesh-list
25389410|NCT04340193|Ipilimumab|ipilimumab|mesh-list
25389411|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389412|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389413|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389414|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389415|NCT04340141|Leucovorin|leucovorin|mesh-list
25389416|NCT04340141|Fluorouracil|fluorouracil|mesh-list
25389417|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
25389418|NCT04340141|Irinotecan|irinotecan|mesh-list
25389419|NCT04340141|Calcium|calcium|mesh-list
25389420|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
25389421|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25389422|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389423|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
25389424|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389425|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25389426|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389427|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389428|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
25389429|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25389430|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25389431|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389432|NCT04340141|Antidotes|antidotes|mesh-ancestor
25389439|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
25389445|NCT04339738|Paclitaxel|paclitaxel|mesh-list
25389446|NCT04339738|Nivolumab|nivolumab|mesh-list
25389447|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25389448|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25389449|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389450|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389451|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389452|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
25389453|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389454|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389455|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389456|NCT04339036|Capecitabine|capecitabine|mesh-list
25389457|NCT04339036|Temozolomide|temozolomide|mesh-list
25389458|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25389459|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
25389460|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389461|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389462|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25389463|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
25389464|NCT04338984|Fentanyl|fentanyl|mesh-list
25389465|NCT04338984|Ropivacaine|ropivacaine|mesh-list
25724260|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420606|NCT02611323|Rituximab|rituximab|mesh-list
25389466|NCT04338984|Anesthetics|anesthetics|mesh-list
25389467|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
25389468|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
25389469|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389470|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389471|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
25389472|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389473|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25389474|NCT04338984|Narcotics|narcotics|mesh-ancestor
25389475|NCT04338984|Analgesics|analgesics|mesh-ancestor
25389476|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25389477|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25389478|NCT04338659|Antibodies|antibodies|mesh-list
25389479|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25389480|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
25389481|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389482|NCT04338399|Paclitaxel|paclitaxel|mesh-list
25389483|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25389484|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389485|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389486|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389487|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25389488|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389489|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25389490|NCT04338321|Esketamine|esketamine|mesh-list
25389491|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
25389492|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25389493|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25389494|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25389495|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389496|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389497|NCT04338269|Atezolizumab|atezolizumab|mesh-list
25389498|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389499|NCT04338061|Teriflunomide|teriflunomide|mesh-list
25389500|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25389501|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389502|NCT04338061|Analgesics|analgesics|mesh-ancestor
25389503|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
25389504|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389505|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389506|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389507|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389508|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389509|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
25389510|NCT04338022|Teriflunomide|teriflunomide|mesh-list
25389519|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389520|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
25389522|NCT04337970|Talazoparib|talazoparib|mesh-list
25389523|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389524|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25389525|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389526|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389527|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25389528|NCT04336982|Azacitidine|azacitidine|mesh-list
25389529|NCT04336982|Venetoclax|venetoclax|mesh-list
25389530|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25389531|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
25389532|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389533|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389534|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389535|NCT04336943|Durvalumab|durvalumab|mesh-list
25389536|NCT04336943|Olaparib|olaparib|mesh-list
25389537|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25389538|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
25389539|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25389540|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
25389541|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389542|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389543|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
25389544|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389545|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389546|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389547|NCT04336241|Nivolumab|nivolumab|mesh-list
25389548|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389549|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724261|NCT02536248|Incretins|incretins|mesh-ancestor
25389550|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389551|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389561|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
25389562|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25389563|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389564|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25389565|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25389566|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
25389567|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389568|NCT04334759|Cisplatin|cisplatin|mesh-list
25389569|NCT04334759|Carboplatin|carboplatin|mesh-list
25389570|NCT04334759|Pemetrexed|pemetrexed|mesh-list
25389571|NCT04334759|Durvalumab|durvalumab|mesh-list
25389572|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389573|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389574|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389575|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25389576|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25389577|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389578|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
25389579|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
25389580|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25389581|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25389582|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389583|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25389584|NCT04332874|Dactinomycin|dactinomycin|mesh-list
25389585|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
25389586|NCT04332874|Melphalan|melphalan|mesh-list
25389587|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389588|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389589|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25389590|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
25389591|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389592|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25389593|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389594|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
25389595|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389596|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25389597|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389598|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25389599|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25389600|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389601|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25389602|NCT04331691|Amiloride|amiloride|mesh-list
25389603|NCT04331691|Spironolactone|spironolactone|mesh-list
25389604|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25389605|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
25389606|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25389607|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389608|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25389609|NCT04331691|Diuretics|diuretics|mesh-ancestor
25389610|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
25389611|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25389612|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25389613|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25389614|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389615|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25389616|NCT04331652|Anesthetics|anesthetics|mesh-list
25389617|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389618|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389619|NCT04331639|Vitamin D|vitamin d|mesh-list
25389620|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
25389621|NCT04331639|Vitamins|vitamins|mesh-ancestor
25389622|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
25389623|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389624|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25389625|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25389626|NCT04331288|Ethanol|ethanol|mesh-list
25389627|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25389628|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389629|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389630|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389631|NCT04331132|Tolvaptan|tolvaptan|mesh-list
25389632|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25389633|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389634|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
25389635|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389637|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25389638|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389639|NCT04330729|Analgesics|analgesics|mesh-ancestor
25389640|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
25389641|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389642|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389643|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389644|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389645|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25389646|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25389647|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389648|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25389649|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25389650|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389651|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
25389652|NCT04330690|Artesunate|artesunate|mesh-list
25389653|NCT04330690|Dexamethasone|dexamethasone|mesh-list
25389654|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
25389655|NCT04330690|Infliximab|infliximab|mesh-list
25389656|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389657|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
25389658|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
25389659|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389660|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389661|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25389662|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
25389663|NCT04330690|Hormones|hormones|mesh-ancestor
25389664|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25389665|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25389666|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389667|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25389668|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389669|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389670|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
25389671|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389672|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
25389673|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25389674|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25389675|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389676|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
25389677|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
25389678|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25389679|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
25389680|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
25389681|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25389682|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389683|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25389684|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389685|NCT04329806|Amlodipine|amlodipine|mesh-list
25389686|NCT04329806|Moxonidine|moxonidine|mesh-list
25389687|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25389688|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25389689|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25389690|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389691|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25389692|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389693|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
25389694|NCT04329728|Dexamethasone|dexamethasone|mesh-list
25389695|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25389696|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389697|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
25389698|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
25389699|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389700|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389701|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25389702|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
25389703|NCT04329728|Hormones|hormones|mesh-ancestor
25389704|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25389705|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25389706|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389707|NCT04329624|Simendan|simendan|mesh-list
25389708|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25389709|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
25389710|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25389711|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25389712|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389713|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389714|NCT04329624|Protective Agents|protective agents|mesh-ancestor
25389715|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389717|NCT04329065|Trastuzumab|trastuzumab|mesh-list
25389718|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25389719|NCT04329065|Pertuzumab|pertuzumab|mesh-list
25389720|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25389721|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25389722|NCT04329065|Vaccines|vaccines|mesh-list
25389723|NCT04329065|Antibodies|antibodies|mesh-list
25389724|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
25389725|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25389726|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
25389727|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
25389728|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389729|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25389730|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389731|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389732|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389733|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
25389734|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389735|NCT04328727|Cyclosporine|cyclosporine|mesh-list
25389736|NCT04328727|Cyclosporins|cyclosporins|mesh-list
25389737|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25389738|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
25389739|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389740|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389741|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389742|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
25389743|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389744|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
25389745|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389746|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
25389747|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389748|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25389749|NCT04327206|Vaccines|vaccines|mesh-list
25389750|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
25389751|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
25389752|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389753|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25389754|NCT04326283|Trametinib|trametinib|mesh-list
25389755|NCT04326283|Riluzole|riluzole|mesh-list
25389756|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389757|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25389758|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389759|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389760|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
25389761|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25389762|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25389763|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25389764|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389765|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25389766|NCT04326283|Protective Agents|protective agents|mesh-ancestor
25389767|NCT04325503|Levodopa|levodopa|mesh-list
25389768|NCT04325503|Carbidopa|carbidopa|mesh-list
25389769|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25389770|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25389771|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
25389772|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25389773|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389774|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389775|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25389776|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389777|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
25389778|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
25389779|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25389780|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25389781|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389782|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389783|NCT04325243|Urological Agents|urological agents|mesh-ancestor
25389784|NCT04325217|Nintedanib|nintedanib|mesh-list
25389785|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389786|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25389787|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389788|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389790|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25389791|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
25389792|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389793|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389794|NCT04324463|Aspirin|aspirin|mesh-list
25389795|NCT04324463|Interferons|interferons|mesh-list
25389796|NCT04324463|Interferon-beta|interferon-beta|mesh-list
25389797|NCT04324463|Colchicine|colchicine|mesh-list
25389798|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
25389799|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389800|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
25389801|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389802|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25389803|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389804|NCT04324463|Analgesics|analgesics|mesh-ancestor
25389805|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
25389806|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389807|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389808|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389809|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389810|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25389811|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25389889|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389813|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25389814|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25389816|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
25389817|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25389818|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
25389819|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25389820|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
25389821|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
25389822|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
25389823|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
25389824|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389825|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389826|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
25389827|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
25389828|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389829|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389830|NCT04323046|Nivolumab|nivolumab|mesh-list
25389831|NCT04323046|Ipilimumab|ipilimumab|mesh-list
25389832|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389833|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389834|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389835|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389836|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
25389837|NCT04322318|Ifosfamide|ifosfamide|mesh-list
25389838|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
25389839|NCT04322318|Carboplatin|carboplatin|mesh-list
25389840|NCT04322318|Doxorubicin|doxorubicin|mesh-list
25389841|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25389842|NCT04322318|Irinotecan|irinotecan|mesh-list
25389843|NCT04322318|Etoposide|etoposide|mesh-list
25389844|NCT04322318|Vincristine|vincristine|mesh-list
25389845|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
25389846|NCT04322318|Daunorubicin|daunorubicin|mesh-list
25389847|NCT04322318|Topotecan|topotecan|mesh-list
25389848|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
25389849|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389850|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
25389851|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389852|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389853|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25389854|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
25389855|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389856|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389857|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25389858|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25389859|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25389860|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25389861|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389862|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25389892|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389893|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389894|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389895|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389896|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25389897|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389898|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389899|NCT04320602|Eculizumab|eculizumab|mesh-list
25389900|NCT04320602|Ravulizumab|ravulizumab|mesh-list
25389901|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25389902|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389903|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
25389904|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389905|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
25389906|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389907|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25389908|NCT04319627|Calcium|calcium|mesh-list
25389909|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25389910|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389911|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25389912|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25389913|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
25389914|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389915|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25389916|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25389917|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389918|NCT04319224|Nivolumab|nivolumab|mesh-list
25389919|NCT04319224|Ipilimumab|ipilimumab|mesh-list
25389920|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389921|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389922|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389923|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389924|NCT04318548|Vaccines|vaccines|mesh-list
25389925|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
25389926|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389927|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
25389928|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389929|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389930|NCT04317105|Nivolumab|nivolumab|mesh-list
25389931|NCT04317105|Ipilimumab|ipilimumab|mesh-list
25389932|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389933|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389934|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25389935|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389936|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
25389937|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389938|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389939|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
25389940|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
25389962|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389963|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25389964|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25389966|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25389967|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25389968|NCT04315558|Bromides|bromides|mesh-list
25389969|NCT04315558|Ipratropium|ipratropium|mesh-list
25389970|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
25389971|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25389972|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
25389973|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389974|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389975|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25389976|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
25389977|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25389978|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
25389979|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25389980|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389981|NCT04315272|Azithromycin|azithromycin|mesh-list
25389982|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25389983|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25389984|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
25389985|NCT04314843|Fludarabine|fludarabine|mesh-list
25389986|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25389987|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
25389988|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389989|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389990|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25389991|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
25389992|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389993|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25389994|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25389995|NCT04314375|Budesonide|budesonide|mesh-list
25389996|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389997|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25389998|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
25389999|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390000|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390001|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25390002|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
25390003|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
25390004|NCT04314375|Hormones|hormones|mesh-ancestor
25390005|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390014|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
25390015|NCT04313153|Hematinics|hematinics|mesh-ancestor
25390081|NCT04310930|Bedaquiline|bedaquiline|mesh-list
25390082|NCT04310930|Clofazimine|clofazimine|mesh-list
25390083|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25390084|NCT04310930|Cefoxitin|cefoxitin|mesh-list
25390085|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25390086|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390087|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25390088|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25390089|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390090|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390091|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390092|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25390093|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25390094|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25390095|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
25390096|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25390097|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25390098|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
25390099|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25390100|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390101|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
25390102|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25390103|NCT04310930|Renal Agents|renal agents|mesh-ancestor
25390104|NCT04310397|Trametinib|trametinib|mesh-list
25390105|NCT04310397|Dabrafenib|dabrafenib|mesh-list
25390106|NCT04310397|Spartalizumab|spartalizumab|mesh-list
25390107|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390108|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390109|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390110|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390111|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25390112|NCT04310020|Atezolizumab|atezolizumab|mesh-list
25390113|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25390114|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390115|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
25390116|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390117|NCT04310007|Gemcitabine|gemcitabine|mesh-list
25390118|NCT04310007|Paclitaxel|paclitaxel|mesh-list
25390119|NCT04310007|Docetaxel|docetaxel|mesh-list
25390120|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25390121|NCT04310007|Nivolumab|nivolumab|mesh-list
25390122|NCT04310007|Ramucirumab|ramucirumab|mesh-list
25390123|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25390124|NCT04310007|Antibodies|antibodies|mesh-list
25390125|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
25390126|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25390127|NCT04310007|Lexatumumab|lexatumumab|mesh-list
25390128|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25390129|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390130|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
25390131|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25390132|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
25390133|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390134|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
25390135|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390136|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25390137|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
25390138|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
25390139|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390140|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390141|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390142|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25390143|NCT04309409|Nivolumab|nivolumab|mesh-list
25390144|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390145|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390146|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25390147|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390148|NCT04308785|Atezolizumab|atezolizumab|mesh-list
25390149|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390150|NCT04307576|Dexamethasone|dexamethasone|mesh-list
25390151|NCT04307576|Doxorubicin|doxorubicin|mesh-list
25390152|NCT04307576|Vincristine|vincristine|mesh-list
25390153|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
25390154|NCT04307576|Blinatumomab|blinatumomab|mesh-list
25390155|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25390156|NCT04307576|Thioguanine|thioguanine|mesh-list
25390157|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390158|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
25390159|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
25390160|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390161|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390162|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25390163|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
25390164|NCT04307576|Hormones|hormones|mesh-ancestor
25390165|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390166|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25390167|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390168|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25390169|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25390170|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25390171|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390172|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390173|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25390174|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25390175|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25390176|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25390177|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390178|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390179|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25390180|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
25390181|NCT04307550|Ethanol|ethanol|mesh-list
25390182|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25390183|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390184|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390185|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390186|NCT04307511|Aspirin|aspirin|mesh-list
25390187|NCT04307511|Ticagrelor|ticagrelor|mesh-list
25390188|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25390189|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25390190|NCT04307511|Analgesics|analgesics|mesh-ancestor
25390191|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
25390192|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390193|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390194|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390195|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390196|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25390197|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25390198|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390199|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25390200|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25390201|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390202|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
25390203|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25390204|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25390205|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25390206|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
25390207|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390208|NCT04307485|Ticagrelor|ticagrelor|mesh-list
25390209|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25390210|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25390211|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25390212|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25390213|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
25390214|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390215|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390216|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390217|NCT04307238|Anesthetics|anesthetics|mesh-list
25390218|NCT04307238|Propofol|propofol|mesh-list
25390219|NCT04307238|Sevoflurane|sevoflurane|mesh-list
25390220|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390221|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390222|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25390223|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25390224|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
25390225|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25390226|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25390227|NCT04306315|Brodalumab|brodalumab|mesh-list
25390228|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390229|NCT04305496|Fulvestrant|fulvestrant|mesh-list
25390230|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25390231|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390232|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25390233|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25390234|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
25390235|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390236|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390237|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25390238|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25390239|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390240|NCT04305405|Benralizumab|benralizumab|mesh-list
25390241|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25390242|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
25390243|NCT04305327|Ustekinumab|ustekinumab|mesh-list
25390244|NCT04305327|Brodalumab|brodalumab|mesh-list
25390245|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390246|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
25390247|NCT04305054|Lenvatinib|lenvatinib|mesh-list
25390250|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390251|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390252|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390253|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
25390254|NCT04305041|Lenvatinib|lenvatinib|mesh-list
25390255|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390256|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390257|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390258|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390259|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390260|NCT04305002|Exenatide|exenatide|mesh-list
25390261|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25390262|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390263|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25390264|NCT04305002|Incretins|incretins|mesh-ancestor
25390265|NCT04305002|Hormones|hormones|mesh-ancestor
25390266|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390267|NCT04304820|Cyclosporine|cyclosporine|mesh-list
25390268|NCT04304820|Cyclosporins|cyclosporins|mesh-list
25390269|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25390270|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390271|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390272|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390273|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
25390274|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390275|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
25390276|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390277|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390278|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390279|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25390282|NCT04303780|Docetaxel|docetaxel|mesh-list
25390283|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390284|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
25390285|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
25390286|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
25390287|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390288|NCT04303689|Colchicine|colchicine|mesh-list
25390289|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
25390290|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390291|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
25390292|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
25390293|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
25390294|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390295|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390296|NCT04303195|Metopimazine|metopimazine|mesh-list
25390297|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
25390298|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
25390299|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390300|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390301|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25390302|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
25390303|NCT04303169|Tretinoin|tretinoin|mesh-list
25390304|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390305|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390306|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
25390307|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390308|NCT04302181|Ropivacaine|ropivacaine|mesh-list
25390309|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
25390310|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
25390311|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390312|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390313|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
25390314|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390315|NCT04302025|Atezolizumab|atezolizumab|mesh-list
25390316|NCT04302025|Vemurafenib|vemurafenib|mesh-list
25390317|NCT04302025|Pralsetinib|pralsetinib|mesh-list
25390318|NCT04302025|Entrectinib|entrectinib|mesh-list
25390319|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390320|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390321|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390322|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390396|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390397|NCT04300192|Vaccines|vaccines|mesh-list
25390398|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
25390399|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390400|NCT04300140|Nivolumab|nivolumab|mesh-list
25390401|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390402|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390403|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25390404|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390405|NCT04300049|Glucagon|glucagon|mesh-list
25390406|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25390407|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25390408|NCT04300049|Hormones|hormones|mesh-ancestor
25390409|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390410|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390411|NCT04300049|Incretins|incretins|mesh-ancestor
25390412|NCT04299867|Metronidazole|metronidazole|mesh-list
25390413|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390414|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25390415|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25390416|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25390417|NCT04298853|Morphine|morphine|mesh-list
25390418|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25390419|NCT04298853|Narcotics|narcotics|mesh-ancestor
25390420|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390421|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390422|NCT04298853|Analgesics|analgesics|mesh-ancestor
25390423|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
25390424|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390425|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25390426|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25390574|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
25390427|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25390428|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390429|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390430|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
25390431|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390432|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25390433|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25390434|NCT04298567|Aspirin|aspirin|mesh-list
25390435|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
25390436|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25390437|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
25390438|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25390439|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
25390440|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390441|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390442|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
25390443|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25390444|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25390445|NCT04298567|Analgesics|analgesics|mesh-ancestor
25390446|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
25390447|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390448|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390449|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390450|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390451|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25390452|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25390453|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25390454|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25390455|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
25390456|NCT04297254|Lenvatinib|lenvatinib|mesh-list
25390457|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390458|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390459|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390460|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390461|NCT04297176|Vancomycin|vancomycin|mesh-list
25390462|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25390463|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390464|NCT04296890|Maytansine|maytansine|mesh-list
25390465|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25390466|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390467|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
25390468|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25390469|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
25390470|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390471|NCT04296396|Oxycodone|oxycodone|mesh-list
25390472|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25390473|NCT04296396|Narcotics|narcotics|mesh-ancestor
25390474|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390475|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390476|NCT04296396|Analgesics|analgesics|mesh-ancestor
25390477|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
25390478|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390479|NCT04295941|Trazodone|trazodone|mesh-list
25390480|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25390481|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25390482|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390483|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390484|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25390485|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25390486|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25390487|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25390488|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390489|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390490|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
25390491|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25390492|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
25390493|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
25390494|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
25390495|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390496|NCT04295850|Aspirin|aspirin|mesh-list
25390497|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25390498|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25390499|NCT04295850|Analgesics|analgesics|mesh-ancestor
25390500|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
25390501|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390502|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390503|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390504|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390505|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25390506|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25390507|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390508|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25390509|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25390510|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390511|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
25390512|NCT04295772|Islatravir|islatravir|mesh-list
25390513|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
25390514|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390515|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390516|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390517|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25390518|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25390519|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25390520|NCT04295330|Lidocaine|lidocaine|mesh-list
25390521|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
25390522|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
25390523|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390524|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390525|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
25390526|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390527|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25390528|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25390529|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25390530|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25390531|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390532|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25390533|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390534|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390535|NCT04294654|Vortioxetine|vortioxetine|mesh-list
25390536|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
25390537|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25390538|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25390539|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25390540|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390541|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390542|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25390543|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25390544|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25390545|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390546|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390547|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
25724262|NCT02536248|Hormones|hormones|mesh-ancestor
25390548|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25390549|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25390550|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25390551|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25390553|NCT04294628|Camptothecin|camptothecin|mesh-list
25390554|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
25390555|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390556|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390557|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25390558|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25390559|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25390560|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390561|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390562|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
25390563|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390564|NCT04292756|Triamcinolone|triamcinolone|mesh-list
25390565|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25390566|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25390567|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25390568|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390569|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
25390570|NCT04292756|Hormones|hormones|mesh-ancestor
25390571|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390572|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390573|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390575|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390576|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390577|NCT04292743|Leucovorin|leucovorin|mesh-list
25390578|NCT04292743|Fluorouracil|fluorouracil|mesh-list
25390579|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
25390580|NCT04292743|Irinotecan|irinotecan|mesh-list
25390581|NCT04292743|Folfirinox|folfirinox|mesh-list
25390582|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
25390583|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390584|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25390585|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390586|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390587|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
25390588|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390589|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25390590|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25390591|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390592|NCT04292743|Antidotes|antidotes|mesh-ancestor
25390593|NCT04292743|Protective Agents|protective agents|mesh-ancestor
25390594|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
25390595|NCT04292743|Vitamins|vitamins|mesh-ancestor
25390596|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
25390597|NCT04292223|Pimavanserin|pimavanserin|mesh-list
25390598|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25390599|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25390600|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25390601|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25390602|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390603|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390604|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25390605|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25390606|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25390607|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
25390608|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390609|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390610|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25390611|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390612|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390613|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
25390614|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390615|NCT04292054|Cefazolin|cefazolin|mesh-list
25390616|NCT04292054|Tazobactam|tazobactam|mesh-list
25390617|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25390618|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390619|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25390620|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390621|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390622|NCT04291885|Avelumab|avelumab|mesh-list
25390623|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390624|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390625|NCT04291508|Acetaminophen|acetaminophen|mesh-list
25390626|NCT04291508|Ascorbic Acid|ascorbic acid|mesh-list
25390627|NCT04291508|Vitamins|vitamins|mesh-ancestor
25390628|NCT04291508|Micronutrients|micronutrients|mesh-ancestor
25390629|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390630|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25390631|NCT04291508|Analgesics|analgesics|mesh-ancestor
25390632|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
25390633|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390634|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
25390635|NCT04291508|Antioxidants|antioxidants|mesh-ancestor
25390636|NCT04291508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390637|NCT04291508|Protective Agents|protective agents|mesh-ancestor
25390638|NCT04290624|Listerine|listerine|mesh-list
25390639|NCT04290624|Fluorides|fluorides|mesh-list
25390640|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
25390641|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
25390642|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
25390643|NCT04290624|Protective Agents|protective agents|mesh-ancestor
25390644|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390645|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25390646|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390647|NCT04289805|Letrozole|letrozole|mesh-list
25390648|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390649|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25390650|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25390651|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390652|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390653|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25390654|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
25390655|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390656|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390657|NCT04289779|Atezolizumab|atezolizumab|mesh-list
25390658|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390659|NCT04288778|Metformin|metformin|mesh-list
25390660|NCT04288778|Canagliflozin|canagliflozin|mesh-list
25390661|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25390662|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390663|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25390664|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390665|NCT04288089|Palbociclib|palbociclib|mesh-list
25390666|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390667|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390668|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390669|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390670|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
25390671|NCT04287829|Lenvatinib|lenvatinib|mesh-list
25390672|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390673|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390674|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390675|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390676|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390677|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
25390678|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25390679|NCT04285567|Rituximab|rituximab|mesh-list
25390680|NCT04285567|Fludarabine|fludarabine|mesh-list
25390681|NCT04285567|Venetoclax|venetoclax|mesh-list
25390682|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
25390683|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390684|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
25390685|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390686|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390687|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25390688|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
25390689|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390690|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390691|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25390692|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390693|NCT04285450|Vitamin K|vitamin k|mesh-list
25390694|NCT04285450|Vitamins|vitamins|mesh-ancestor
25390695|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
25390696|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390697|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25390698|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25390699|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390700|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
25390702|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
25390703|NCT04284787|Azacitidine|azacitidine|mesh-list
25390704|NCT04284787|Venetoclax|venetoclax|mesh-list
25390705|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390706|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390707|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25390708|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
25390709|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390710|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390711|NCT04284774|Tipifarnib|tipifarnib|mesh-list
25390712|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390713|NCT04283500|Buprenorphine|buprenorphine|mesh-list
25390714|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25390715|NCT04283500|Naloxone|naloxone|mesh-list
25390716|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25390717|NCT04283500|Narcotics|narcotics|mesh-ancestor
25390718|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390719|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390720|NCT04283500|Analgesics|analgesics|mesh-ancestor
25390721|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
25390722|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390723|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25390724|NCT04282668|Tretinoin|tretinoin|mesh-list
25390725|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390726|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
25390727|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390728|NCT04282187|Azacitidine|azacitidine|mesh-list
25390729|NCT04282187|Decitabine|decitabine|mesh-list
25390730|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25390731|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25390732|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
25390733|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390734|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390735|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390736|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25390737|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
25390738|NCT04282174|Melphalan|melphalan|mesh-list
25390739|NCT04282174|Busulfan|busulfan|mesh-list
25390740|NCT04282174|Thiotepa|thiotepa|mesh-list
25390741|NCT04282174|Fludarabine|fludarabine|mesh-list
25390742|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390743|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
25390744|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390745|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390746|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25390747|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
25390748|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390749|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390750|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25390751|NCT04282109|Paclitaxel|paclitaxel|mesh-list
25390752|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25390753|NCT04282109|Nivolumab|nivolumab|mesh-list
25390754|NCT04282109|Cetuximab|cetuximab|mesh-list
25390755|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25390756|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390757|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
25390758|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
25390759|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
25390760|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390761|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390762|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25390763|NCT04281420|Niacin|niacin|mesh-list
25390764|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25390765|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
25390766|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390767|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25390768|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
25390769|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
25390770|NCT04281420|Vitamins|vitamins|mesh-ancestor
25390771|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
25390772|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390773|NCT04281108|Fluticasone|fluticasone|mesh-list
25390774|NCT04281108|Xhance|xhance|mesh-list
25390775|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390776|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25390777|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
25390778|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390779|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390780|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25390781|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
25390782|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390783|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25390784|NCT04280406|Azithromycin|azithromycin|mesh-list
25390785|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25390786|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390787|NCT04280055|Psilocybin|psilocybin|mesh-list
25390788|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
25390789|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390790|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25390791|NCT04279847|INCB057643|incb057643|mesh-list
25390792|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390793|NCT04279561|Edetic Acid|edetic acid|mesh-list
25390794|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25390795|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
25390796|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
25390797|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390798|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
25390799|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25390800|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25390801|NCT04279054|Morphine|morphine|mesh-list
25390802|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25390803|NCT04279054|Narcotics|narcotics|mesh-ancestor
25390804|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390805|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390806|NCT04279054|Analgesics|analgesics|mesh-ancestor
25390807|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
25390808|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390809|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
25390810|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25390811|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
25390812|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390813|NCT04278898|Expectorants|expectorants|mesh-ancestor
25390814|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
25390815|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25390816|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
25390817|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390818|NCT04278898|Protective Agents|protective agents|mesh-ancestor
25390819|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390820|NCT04278898|Antidotes|antidotes|mesh-ancestor
25390821|NCT04278729|Apixaban|apixaban|mesh-list
25390822|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25390823|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
25390824|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25390825|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
25390826|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390827|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390828|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
25390829|NCT04277845|Dexamethasone|dexamethasone|mesh-list
25390830|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
25390831|NCT04277845|Lenalidomide|lenalidomide|mesh-list
25390832|NCT04277845|Bortezomib|bortezomib|mesh-list
25390833|NCT04277845|BB 1101|bb 1101|mesh-list
25390834|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25390835|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
25390836|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
25390837|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390838|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390839|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25390840|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
25390841|NCT04277845|Hormones|hormones|mesh-ancestor
25390842|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390843|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25390844|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390845|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
25390846|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390847|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390848|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
25390849|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25390850|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25390851|NCT04277845|Growth Substances|growth substances|mesh-ancestor
25390852|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
25390853|NCT04277442|Nivolumab|nivolumab|mesh-list
25390854|NCT04277442|Decitabine|decitabine|mesh-list
25390855|NCT04277442|Venetoclax|venetoclax|mesh-list
25390856|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390857|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390862|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390863|NCT04276155|Anticoagulants|anticoagulants|mesh-list
25390864|NCT04275999|Ivermectin|ivermectin|mesh-list
25390865|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25390866|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390867|NCT04275518|Cytarabine|cytarabine|mesh-list
25390868|NCT04275518|Azacitidine|azacitidine|mesh-list
25390869|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25390870|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
25390871|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390872|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390873|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
25390874|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390875|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25390876|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
25390877|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390878|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390879|NCT04275375|Anesthetics|anesthetics|mesh-list
25390880|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390881|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390882|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25390883|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
25390884|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390885|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
25390886|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25390887|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25390888|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390889|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
25390890|NCT04274335|Coagulants|coagulants|mesh-ancestor
25390891|NCT04274179|Lamotrigine|lamotrigine|mesh-list
25390892|NCT04274179|Valproic Acid|valproic acid|mesh-list
25390893|NCT04274179|Ethosuximide|ethosuximide|mesh-list
25390894|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
25390895|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25390896|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25390897|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390898|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25390899|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390900|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25390901|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25390902|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390903|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25390904|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25390905|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390906|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
25390907|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390908|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
25390909|NCT04273945|Macitentan|macitentan|mesh-list
25390910|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25390911|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25390912|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390913|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25390914|NCT04273607|Heparin|heparin|mesh-list
25390915|NCT04273607|Calcium heparin|calcium heparin|mesh-list
25390916|NCT04273607|Enoxaparin|enoxaparin|mesh-list
25390917|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
25390918|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25390919|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25390920|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390921|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
25390922|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25390923|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
25390924|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25390925|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
25390926|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390927|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390928|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
25390971|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390972|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25390973|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25390974|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25390976|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
25390977|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390978|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390979|NCT04270747|Aflibercept|aflibercept|mesh-list
25390980|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25390981|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25390982|NCT04270747|Growth Substances|growth substances|mesh-ancestor
25390983|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390984|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
25390985|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390990|NCT04269200|Paclitaxel|paclitaxel|mesh-list
25390991|NCT04269200|Carboplatin|carboplatin|mesh-list
25390992|NCT04269200|Durvalumab|durvalumab|mesh-list
25390993|NCT04269200|Olaparib|olaparib|mesh-list
25390994|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25390995|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25390996|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390997|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25390998|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25390999|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391000|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391001|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391002|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
25391003|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391004|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25391005|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391006|NCT04268407|Amoxicillin|amoxicillin|mesh-list
25391007|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
25391008|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
25391009|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25391010|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25391011|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391057|NCT04266249|Paclitaxel|paclitaxel|mesh-list
25391058|NCT04266249|Maytansine|maytansine|mesh-list
25391059|NCT04266249|Docetaxel|docetaxel|mesh-list
25391060|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25391061|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25391062|NCT04266249|Trastuzumab|trastuzumab|mesh-list
25391063|NCT04266249|Pertuzumab|pertuzumab|mesh-list
25391064|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25391065|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25391066|NCT04266249|Antibodies|antibodies|mesh-list
25391067|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
25391068|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25391069|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
25391070|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391071|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391072|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391073|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391074|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391075|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391076|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
25391077|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391078|NCT04266236|Ropivacaine|ropivacaine|mesh-list
25391079|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
25391080|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391081|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391082|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
25391083|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
25391084|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391085|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25391086|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
25391165|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25391087|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25391088|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25391089|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391090|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391091|NCT04266197|Urological Agents|urological agents|mesh-ancestor
25391092|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
25391093|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25391094|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391095|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391096|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25391097|NCT04266145|Analgesics|analgesics|mesh-ancestor
25391098|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
25391099|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391100|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25391101|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25391102|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25391103|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
25391104|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391105|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391106|NCT04265950|Vaccines|vaccines|mesh-list
25391107|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
25391108|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391109|NCT04265534|Folic Acid|folic acid|mesh-list
25391110|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
25391111|NCT04265534|Hydroxocobalamin|hydroxocobalamin|mesh-list
25391112|NCT04265534|Dexamethasone|dexamethasone|mesh-list
25391113|NCT04265534|Carboplatin|carboplatin|mesh-list
25391116|NCT04265534|Vitamins|vitamins|mesh-ancestor
25391117|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
25391118|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391119|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391120|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
25391121|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
25391122|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391123|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25391124|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
25391125|NCT04265534|Hormones|hormones|mesh-ancestor
25391126|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391127|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25391128|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391129|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391130|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391131|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391132|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25391133|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25391134|NCT04265534|Hematinics|hematinics|mesh-ancestor
25391135|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
25391136|NCT04263909|Sufentanil|sufentanil|mesh-list
25391137|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25391138|NCT04263909|Narcotics|narcotics|mesh-ancestor
25391139|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391140|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391141|NCT04263909|Analgesics|analgesics|mesh-ancestor
25391142|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
25391143|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391144|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25391145|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25391146|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
25391147|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
25391148|NCT04262934|Vitamin D|vitamin d|mesh-list
25391149|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
25391150|NCT04262934|Vitamins|vitamins|mesh-ancestor
25391151|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
25391152|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391153|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25391154|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25391155|NCT04262843|Vidarabine|vidarabine|mesh-list
25391156|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
25391157|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
25391158|NCT04262843|Fludarabine|fludarabine|mesh-list
25391159|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
25391160|NCT04262843|Tacrolimus|tacrolimus|mesh-list
25391161|NCT04262843|Lenograstim|lenograstim|mesh-list
25391162|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391163|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
25391164|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391166|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25391167|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
25391168|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391169|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391170|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25391171|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391172|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
25391173|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
25391174|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391175|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25391176|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391177|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25391178|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25391179|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
25391180|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25391181|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25391182|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
25391183|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25391184|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391185|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
25391186|NCT04262492|Apixaban|apixaban|mesh-list
25391187|NCT04262492|Edoxaban|edoxaban|mesh-list
25391188|NCT04262492|Dabigatran|dabigatran|mesh-list
25391189|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25391190|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
25391191|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25391192|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
25391193|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391194|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391195|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
25391196|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
25391197|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
25391198|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391199|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
25391200|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391201|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25391202|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25391203|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
25391204|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391205|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391206|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25391207|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391208|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
25391209|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
25391210|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25391211|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
25391212|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391213|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
25391214|NCT04262336|Protective Agents|protective agents|mesh-ancestor
25391215|NCT04262336|Antidotes|antidotes|mesh-ancestor
25391216|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
25391217|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391218|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
25391219|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25391220|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391221|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
25391222|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
25391223|NCT04262154|Prednisone|prednisone|mesh-list
25391224|NCT04262154|Atezolizumab|atezolizumab|mesh-list
25391225|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391226|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
25391227|NCT04262154|Hormones|hormones|mesh-ancestor
25391228|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391229|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391230|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25391231|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391232|NCT04261855|Avelumab|avelumab|mesh-list
25391233|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25391234|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391235|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391236|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25391237|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391238|NCT04261075|Durvalumab|durvalumab|mesh-list
25391239|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391240|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391241|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
25391242|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391252|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391253|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
25391254|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391255|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391256|NCT04259255|Edaravone|edaravone|mesh-list
25391257|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25391258|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
25391259|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391260|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25391261|NCT04259255|Protective Agents|protective agents|mesh-ancestor
25391262|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391263|NCT04258111|Antibodies|antibodies|mesh-list
25391264|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
25391265|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
25391266|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391267|NCT04257682|Bupivacaine|bupivacaine|mesh-list
25391268|NCT04257682|Ropivacaine|ropivacaine|mesh-list
25391271|NCT04257682|Anesthetics|anesthetics|mesh-list
25391272|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391273|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391274|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
25391275|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391276|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
25391277|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391278|NCT04256941|Letrozole|letrozole|mesh-list
25391279|NCT04256941|Fulvestrant|fulvestrant|mesh-list
25391280|NCT04256941|Palbociclib|palbociclib|mesh-list
25391281|NCT04256941|Anastrozole|anastrozole|mesh-list
25391282|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391283|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25391284|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25391285|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391286|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391287|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25391288|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
25391289|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391290|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391291|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25391292|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25391293|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25391294|NCT04256707|Docetaxel|docetaxel|mesh-list
25391295|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
25391296|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391297|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391298|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391299|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391300|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391301|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391311|NCT04256213|Nivolumab|nivolumab|mesh-list
25391312|NCT04256213|Ipilimumab|ipilimumab|mesh-list
25391313|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391314|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391315|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25391316|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391317|NCT04255433|Dulaglutide|dulaglutide|mesh-list
25391318|NCT04255433|Tirzepatide|tirzepatide|mesh-list
25391319|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25391320|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391321|NCT04255433|Incretins|incretins|mesh-ancestor
25391322|NCT04255433|Hormones|hormones|mesh-ancestor
25391323|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391324|NCT04253457|Triamcinolone|triamcinolone|mesh-list
25391325|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391326|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
25391327|NCT04253457|Hormones|hormones|mesh-ancestor
25391328|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391329|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391330|NCT04253262|Rucaparib|rucaparib|mesh-list
25391331|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25391332|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391333|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391334|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391335|NCT04252768|Paclitaxel|paclitaxel|mesh-list
25391336|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391337|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391338|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391339|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391340|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391341|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391355|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25391356|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391357|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391358|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25391360|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
25391361|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391362|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25391363|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25391364|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25391365|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
25391366|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391367|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391368|NCT04251533|Paclitaxel|paclitaxel|mesh-list
25391369|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391370|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391371|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391372|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391373|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391374|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391375|NCT04251065|Daratumumab|daratumumab|mesh-list
25391376|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391377|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25391378|NCT04250155|Atezolizumab|atezolizumab|mesh-list
25391379|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391380|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
25391381|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25391382|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25391383|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391384|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
25391385|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391386|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391387|NCT04249622|Rifaximin|rifaximin|mesh-list
25391388|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25391389|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391390|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25391391|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
25391392|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25391393|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25391394|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391395|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
25391396|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391397|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391398|NCT04249401|Warfarin|warfarin|mesh-list
25391399|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
25391400|NCT04249401|Dabigatran|dabigatran|mesh-list
25391401|NCT04249401|Apixaban|apixaban|mesh-list
25391402|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
25391403|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25391404|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
25391405|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25391406|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
25391407|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391414|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391421|NCT04248595|Azacitidine|azacitidine|mesh-list
25391422|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
25391423|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391424|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
25391425|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391426|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391427|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391428|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391429|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25391430|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
25391431|NCT04248452|Leucovorin|leucovorin|mesh-list
25391432|NCT04248452|Folic Acid|folic acid|mesh-list
25391433|NCT04248452|Fluorouracil|fluorouracil|mesh-list
25391434|NCT04248452|Capecitabine|capecitabine|mesh-list
25391435|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
25391436|NCT04248452|Calcium|calcium|mesh-list
25391437|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
25391438|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25391439|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391440|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25391441|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
25391442|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391443|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391444|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391445|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391446|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
25391447|NCT04248452|Antidotes|antidotes|mesh-ancestor
25391448|NCT04248452|Protective Agents|protective agents|mesh-ancestor
25391449|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
25391450|NCT04248452|Vitamins|vitamins|mesh-ancestor
25391451|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
25391452|NCT04248452|Hematinics|hematinics|mesh-ancestor
25391453|NCT04247542|Vancomycin|vancomycin|mesh-list
25391454|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25391455|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391456|NCT04247165|Gemcitabine|gemcitabine|mesh-list
25391457|NCT04247165|Paclitaxel|paclitaxel|mesh-list
25391458|NCT04247165|Nivolumab|nivolumab|mesh-list
25391459|NCT04247165|Ipilimumab|ipilimumab|mesh-list
25391460|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391461|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391462|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391463|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391464|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391465|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391466|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391467|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
25391468|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
25391469|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391470|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391471|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391472|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
25391473|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391474|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391475|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25391476|NCT04247126|Gemcitabine|gemcitabine|mesh-list
25391477|NCT04247126|Paclitaxel|paclitaxel|mesh-list
25391478|NCT04247126|Fulvestrant|fulvestrant|mesh-list
25391479|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391480|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391481|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391482|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391483|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391484|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391485|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391486|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
25391487|NCT04247126|Antiviral Agents|antiviral agents|mesh-ancestor
25391488|NCT04247126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391489|NCT04247126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391490|NCT04247126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391491|NCT04247126|Immunologic Factors|immunologic factors|mesh-ancestor
25391492|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391493|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25391494|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25391495|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25391496|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
25391497|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391498|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
25391499|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25391500|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25391501|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25391502|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391503|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25391504|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391505|NCT04246684|Leucovorin|leucovorin|mesh-list
25391506|NCT04246684|Folic Acid|folic acid|mesh-list
25391507|NCT04246684|Capecitabine|capecitabine|mesh-list
25391508|NCT04246684|Fluorouracil|fluorouracil|mesh-list
25391509|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
25391510|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
25391511|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391512|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
25391513|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391514|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391515|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391516|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
25391517|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391518|NCT04246684|Antidotes|antidotes|mesh-ancestor
25391519|NCT04246684|Protective Agents|protective agents|mesh-ancestor
25391520|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
25391521|NCT04246684|Vitamins|vitamins|mesh-ancestor
25391522|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
25391523|NCT04246684|Hematinics|hematinics|mesh-ancestor
25391524|NCT04246372|Tofacitinib|tofacitinib|mesh-list
25391525|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25391526|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391527|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391528|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
25391529|NCT04246177|Lenvatinib|lenvatinib|mesh-list
25391530|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391531|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391532|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25391533|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391534|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391535|NCT04246151|Vancomycin|vancomycin|mesh-list
25391536|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25391537|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391538|NCT04246086|Lenalidomide|lenalidomide|mesh-list
25391539|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
25391540|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391541|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25391542|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25391543|NCT04246086|Growth Substances|growth substances|mesh-ancestor
25391544|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
25391545|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391546|NCT04246047|Dexamethasone|dexamethasone|mesh-list
25391547|NCT04246047|Bortezomib|bortezomib|mesh-list
25391548|NCT04246047|Daratumumab|daratumumab|mesh-list
25391549|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391550|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
25391551|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
25391552|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391553|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391554|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25391555|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
25391556|NCT04246047|Hormones|hormones|mesh-ancestor
25391557|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391558|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25391559|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391562|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391563|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
25391564|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391565|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25391566|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25391567|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
25391568|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391569|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391570|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25391572|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25391573|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25391574|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
25391575|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391576|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391577|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391578|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25391579|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
25391580|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391581|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25391582|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
25391583|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
25391587|NCT04245085|Paclitaxel|paclitaxel|mesh-list
25391588|NCT04245085|Bevacizumab|bevacizumab|mesh-list
25391589|NCT04245085|Carboplatin|carboplatin|mesh-list
25391590|NCT04245085|Pemetrexed|pemetrexed|mesh-list
25391591|NCT04245085|Atezolizumab|atezolizumab|mesh-list
25391592|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391593|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391594|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391595|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391596|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391597|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391598|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391599|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25391600|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25391601|NCT04245085|Growth Substances|growth substances|mesh-ancestor
25391602|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391603|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
25391604|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391605|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25391606|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25391607|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25391608|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25391609|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391610|NCT04243837|Pirfenidone|pirfenidone|mesh-list
25391611|NCT04243837|Analgesics|analgesics|mesh-ancestor
25391612|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
25391613|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391614|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391615|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25391616|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25391617|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391618|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25391619|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391620|NCT04242173|Cemiplimab|cemiplimab|mesh-list
25391770|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
25391621|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391622|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391623|NCT04241640|Nefopam|nefopam|mesh-list
25391624|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25391625|NCT04241640|Analgesics|analgesics|mesh-ancestor
25391626|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
25391627|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391628|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391629|NCT04241549|Azacitidine|azacitidine|mesh-list
25391630|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391631|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
25391632|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391633|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391634|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391635|NCT04241185|Gemcitabine|gemcitabine|mesh-list
25391636|NCT04241185|Cisplatin|cisplatin|mesh-list
25391637|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
25391638|NCT04241185|Fluorouracil|fluorouracil|mesh-list
25391639|NCT04241185|Mitomycins|mitomycins|mesh-list
25391640|NCT04241185|Mitomycin|mitomycin|mesh-list
25391641|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391642|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391643|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
25391644|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391645|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
25391646|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391647|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391648|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391649|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
25391650|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391651|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391652|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25391653|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
25391654|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25391655|NCT04240821|Theophylline|theophylline|mesh-list
25391656|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25391657|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
25391658|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391659|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391660|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25391661|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
25391662|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25391663|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391664|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391665|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
25391666|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25391667|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25391668|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
25391669|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391670|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
25391671|NCT04240171|Glimepiride|glimepiride|mesh-list
25391672|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25391673|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391674|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25391675|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391676|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25391677|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391678|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
25391680|NCT04240002|Fludarabine|fludarabine|mesh-list
25391681|NCT04240002|Lenograstim|lenograstim|mesh-list
25391682|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391683|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391684|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
25391685|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391686|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391687|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
25391688|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391689|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
25391690|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391691|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25391692|NCT04239313|Vaccines|vaccines|mesh-list
25391693|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
25391694|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391695|NCT04238819|Irinotecan|irinotecan|mesh-list
25391696|NCT04238819|Temozolomide|temozolomide|mesh-list
25391697|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25391698|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25391699|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391700|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391701|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391702|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25391703|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
25391704|NCT04238416|Lactulose|lactulose|mesh-list
25391705|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25391706|NCT04236414|Olaparib|olaparib|mesh-list
25391707|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25391708|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391709|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391710|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391711|NCT04236141|Rituximab|rituximab|mesh-list
25391712|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25391713|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391714|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391715|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
25391716|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391717|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25391718|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25391719|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
25391720|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391721|NCT04235101|Trastuzumab|trastuzumab|mesh-list
25391722|NCT04235101|Niraparib|niraparib|mesh-list
25391723|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391724|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391725|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25391726|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391727|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391728|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
25391729|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25391730|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391731|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25391732|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391733|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25391734|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391735|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25391736|NCT04233892|Estrogens|estrogens|mesh-list
25391737|NCT04233892|Hormones|hormones|mesh-ancestor
25391738|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391739|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391740|NCT04233879|Tenofovir|tenofovir|mesh-list
25391741|NCT04233879|Emtricitabine|emtricitabine|mesh-list
25391742|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25391743|NCT04233879|Islatravir|islatravir|mesh-list
25391744|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
25391745|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391746|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25391747|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25391748|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391749|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391750|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25391751|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25391752|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
25391753|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25391754|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25391755|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391756|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
25391757|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
25391758|NCT04233216|Islatravir|islatravir|mesh-list
25391759|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
25391760|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391761|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391762|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391763|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25391764|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25391765|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25391766|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
25391767|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25391768|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25391769|NCT04233164|Prednisolone|prednisolone|mesh-list
25391771|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25391772|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
25391773|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391774|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
25391775|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
25391776|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391777|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391778|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25391779|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
25391780|NCT04233164|Hormones|hormones|mesh-ancestor
25391781|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391782|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25391783|NCT04233164|Protective Agents|protective agents|mesh-ancestor
25391784|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25391785|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391808|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391809|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
25391810|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25391811|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
25391812|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391813|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391814|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25391815|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
25391816|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25391817|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
25391818|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391819|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391820|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25391821|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
25391822|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
25391823|NCT04231760|Protective Agents|protective agents|mesh-ancestor
25391825|NCT04230980|Analgesics|analgesics|mesh-ancestor
25391826|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
25391827|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391828|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391829|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
25391830|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25391831|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25391832|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391833|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25391834|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25391835|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25391836|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391837|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391838|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
25391839|NCT04230759|Fluorouracil|fluorouracil|mesh-list
25391840|NCT04230759|Durvalumab|durvalumab|mesh-list
25391841|NCT04230759|Mitomycins|mitomycins|mesh-list
25391842|NCT04230759|Mitomycin|mitomycin|mesh-list
25391843|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25391844|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
25391845|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391999|NCT04226365|Nortriptyline|nortriptyline|mesh-list
25391846|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391847|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391848|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391849|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
25391850|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391851|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391852|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25391853|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
25391854|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25391855|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391856|NCT04230499|Sirolimus|sirolimus|mesh-list
25391857|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25391858|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391859|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25391860|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391861|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
25391862|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391863|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
25391864|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391866|NCT04230408|Carboplatin|carboplatin|mesh-list
25391867|NCT04230408|Durvalumab|durvalumab|mesh-list
25391868|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391869|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391870|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391871|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391872|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391873|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391874|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391875|NCT04230213|Adalimumab|adalimumab|mesh-list
25391876|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391877|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25391878|NCT04230148|Triclabendazole|triclabendazole|mesh-list
25391879|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25391880|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
25391881|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25391882|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391883|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
25391884|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25391885|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25391886|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
25391887|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
25391888|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391889|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391890|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
25391891|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391892|NCT04229381|Coal Tar|coal tar|mesh-list
25391893|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
25391894|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
25391895|NCT04229004|Gemcitabine|gemcitabine|mesh-list
25391896|NCT04229004|Paclitaxel|paclitaxel|mesh-list
25391897|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25391898|NCT04229004|Spartalizumab|spartalizumab|mesh-list
25391899|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25391900|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391901|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25391902|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25391903|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25391904|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391905|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391906|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
25391907|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
25391908|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391909|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391910|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25391911|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
25391912|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391913|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25391914|NCT04228965|Varenicline|varenicline|mesh-list
25391915|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25391916|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25391917|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
25391918|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391919|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391920|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391921|NCT04228289|Oxytocin|oxytocin|mesh-list
25391922|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
25391923|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25391924|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391925|NCT04227847|Azacitidine|azacitidine|mesh-list
25391926|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391927|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
25391928|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391929|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391930|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391931|NCT04227678|Heparin|heparin|mesh-list
25391932|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
25391933|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25391934|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25391935|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391936|NCT04227288|Betamethasone|betamethasone|mesh-list
25391937|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
25391938|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25391939|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
25391940|NCT04227288|Calcipotriene|calcipotriene|mesh-list
25391941|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25391942|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25391943|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
25391944|NCT04227288|Hormones|hormones|mesh-ancestor
25391945|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391946|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391947|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25391948|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25391949|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
25391950|NCT04227028|Bevacizumab|bevacizumab|mesh-list
25391951|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25391952|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
25391953|NCT04227028|Antibodies|antibodies|mesh-list
25391954|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
25391955|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25391956|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
25391957|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391958|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25391959|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25391960|NCT04227028|Growth Substances|growth substances|mesh-ancestor
25391961|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391962|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25391963|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
25391964|NCT04226950|Interferons|interferons|mesh-list
25391965|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
25391966|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
25391967|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25391968|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391969|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
25391970|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391971|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
25391972|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391973|NCT04226690|Dronabinol|dronabinol|mesh-list
25391974|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
25391975|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391976|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25391977|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25391978|NCT04226690|Analgesics|analgesics|mesh-ancestor
25391979|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
25391980|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25391981|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25391982|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25391983|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25391984|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391985|NCT04226690|Hormones|hormones|mesh-ancestor
25391986|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25391987|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
25391988|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25391989|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
25391990|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391991|NCT04226456|Expectorants|expectorants|mesh-ancestor
25391992|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
25391993|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25391994|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
25391995|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391996|NCT04226456|Protective Agents|protective agents|mesh-ancestor
25391997|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391998|NCT04226456|Antidotes|antidotes|mesh-ancestor
25392000|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25392001|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
25392002|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25392003|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25392004|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25392005|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25392006|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392007|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
25392008|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392009|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392010|NCT04226248|Rivastigmine|rivastigmine|mesh-list
25392011|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25392012|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392013|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392014|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
25392015|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392016|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392017|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25392018|NCT04226248|Protective Agents|protective agents|mesh-ancestor
25392019|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25392021|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392022|NCT04225598|Buprenorphine|buprenorphine|mesh-list
25392023|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25392024|NCT04225598|Narcotics|narcotics|mesh-ancestor
25392025|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392026|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392027|NCT04225598|Analgesics|analgesics|mesh-ancestor
25392028|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
25392029|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392030|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25392031|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
25392032|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25392033|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25392034|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25392035|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392036|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
25392037|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392038|NCT04224987|Azithromycin|azithromycin|mesh-list
25392039|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25392040|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392041|NCT04224740|Cisplatin|cisplatin|mesh-list
25392042|NCT04224740|Carboplatin|carboplatin|mesh-list
25392043|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
25392044|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392045|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392046|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
25392047|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392048|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
25392049|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392050|NCT04224545|Colchicine|colchicine|mesh-list
25392051|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
25392052|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392053|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392054|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392055|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392056|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392057|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392058|NCT04223856|Gemcitabine|gemcitabine|mesh-list
25392059|NCT04223856|Cisplatin|cisplatin|mesh-list
25392060|NCT04223856|Carboplatin|carboplatin|mesh-list
25392061|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
25392062|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392063|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392064|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
25392065|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392066|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
25392067|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392068|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392069|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392070|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
25392071|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392072|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392073|NCT04223791|Islatravir|islatravir|mesh-list
25392074|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
25392075|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392076|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392077|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392078|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25392079|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25392080|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25392081|NCT04223778|Islatravir|islatravir|mesh-list
25392082|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
25392083|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392084|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392085|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392086|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25392087|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25392088|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25392089|NCT04223752|Tazobactam|tazobactam|mesh-list
25392090|NCT04223752|Ceftolozane|ceftolozane|mesh-list
25392091|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25392092|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25392093|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392094|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25392095|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392096|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392097|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25392098|NCT04223752|Renal Agents|renal agents|mesh-ancestor
25392099|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
25392100|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25392101|NCT04223518|Antibodies|antibodies|mesh-list
25392102|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
25392103|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392104|NCT04222972|Gemcitabine|gemcitabine|mesh-list
25392105|NCT04222972|Paclitaxel|paclitaxel|mesh-list
25392106|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25392107|NCT04222972|Cisplatin|cisplatin|mesh-list
25392108|NCT04222972|Carboplatin|carboplatin|mesh-list
25392109|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
25392110|NCT04222972|Pemetrexed|pemetrexed|mesh-list
25392111|NCT04222972|Pralsetinib|pralsetinib|mesh-list
25392112|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392113|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392114|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392115|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392116|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392117|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392118|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392119|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
25392120|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
25392121|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392122|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392123|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392124|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
25392125|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392126|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392127|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25392128|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25392129|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
25392130|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25392131|NCT04222023|Antibodies|antibodies|mesh-list
25392132|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
25392133|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25392134|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
25392135|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392136|NCT04221945|Cisplatin|cisplatin|mesh-list
25392137|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
25392138|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392139|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392140|NCT04221542|Pembrolizumab|pembrolizumab|mesh-list
25392141|NCT04221542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392142|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392143|NCT04221503|Niraparib|niraparib|mesh-list
25392144|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25392145|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392146|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392147|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392148|NCT04221477|Acetaminophen|acetaminophen|mesh-list
25392149|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
25392150|NCT04221477|Promethazine|promethazine|mesh-list
25392151|NCT04221477|Prednisone|prednisone|mesh-list
25392152|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
25392153|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
25392154|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25392155|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
25392157|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392158|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392159|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25392160|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392161|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25392162|NCT04221477|Analgesics|analgesics|mesh-ancestor
25392163|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
25392164|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392165|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
25392166|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
25392168|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25392169|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25392170|NCT04221477|Protective Agents|protective agents|mesh-ancestor
25392171|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392172|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25392173|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25392174|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392175|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
25392176|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
25392177|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25392178|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
25392179|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
25392180|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392181|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392182|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25392183|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
25392184|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
25392185|NCT04221438|Alovudine|alovudine|mesh-list
25392186|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
25392187|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392188|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
25392189|NCT04221035|Melphalan|melphalan|mesh-list
25392190|NCT04221035|Busulfan|busulfan|mesh-list
25392191|NCT04221035|Ifosfamide|ifosfamide|mesh-list
25392192|NCT04221035|Thiotepa|thiotepa|mesh-list
25392193|NCT04221035|Dacarbazine|dacarbazine|mesh-list
25392194|NCT04221035|Carboplatin|carboplatin|mesh-list
25392195|NCT04221035|Doxorubicin|doxorubicin|mesh-list
25392196|NCT04221035|Etoposide|etoposide|mesh-list
25392197|NCT04221035|Vincristine|vincristine|mesh-list
25392198|NCT04221035|Vindesine|vindesine|mesh-list
25392199|NCT04221035|Dinutuximab|dinutuximab|mesh-list
25392200|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392201|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
25392202|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392203|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392204|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392205|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
25392206|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392207|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392208|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25392209|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25392210|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25392211|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25392212|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392213|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392214|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392215|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392216|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392217|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
25392218|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392219|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392220|NCT04220775|Atezolizumab|atezolizumab|mesh-list
25392221|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392222|NCT04220125|Midazolam|midazolam|mesh-list
25392223|NCT04220125|Ketamine|ketamine|mesh-list
25392224|NCT04220125|Analgesics|analgesics|mesh-ancestor
25392225|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
25392226|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392227|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392228|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25392229|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25392230|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
25392231|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
25392232|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392233|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25392234|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25392235|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392236|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392237|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25392238|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25392239|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25392240|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25392241|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25392242|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
25392243|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
25392245|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25423355|NCT02384668|Vitamin D|vitamin d|mesh-list
25392246|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392247|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
25392248|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25392249|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25392250|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392251|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
25392252|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
25392253|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392254|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
25392255|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25392256|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25392257|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392258|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
25392259|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
25392260|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392261|NCT04218968|Carvedilol|carvedilol|mesh-list
25392262|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25392263|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25392264|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
25392265|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392266|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392267|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392268|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25392269|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
25392270|NCT04218968|Protective Agents|protective agents|mesh-ancestor
25392271|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25392272|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25392273|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25392274|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
25392275|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25392276|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25392277|NCT04218851|Posaconazole|posaconazole|mesh-list
25392278|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
25392279|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392280|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25392281|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25392282|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25392283|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25392284|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25392285|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392286|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392287|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25392288|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
25392289|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392290|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392291|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
25392292|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
25392293|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392294|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392295|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392296|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
25392297|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25392298|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392299|NCT04218539|Psilocybin|psilocybin|mesh-list
25392300|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
25392301|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392302|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25392303|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
25392304|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25392305|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
25392306|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392307|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392308|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25392309|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
25392310|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25392311|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
25392312|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392313|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392314|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25392315|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
25392316|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
25392317|NCT04216927|Protective Agents|protective agents|mesh-ancestor
25772323|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392318|NCT04216797|Diazepam|diazepam|mesh-list
25392319|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25392320|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
25392321|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
25392322|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
25392323|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392324|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392325|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25392326|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25392327|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392328|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25392329|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25392330|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25392331|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25392332|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25392333|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25392334|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
25392335|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
25392336|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
25392337|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
25392338|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392339|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392340|NCT04216693|Digoxin|digoxin|mesh-list
25392341|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25392342|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25392343|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392344|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392345|NCT04216693|Protective Agents|protective agents|mesh-ancestor
25392346|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392347|NCT04216524|Cytarabine|cytarabine|mesh-list
25392348|NCT04216524|Dexamethasone|dexamethasone|mesh-list
25392349|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
25392350|NCT04216524|Prednisone|prednisone|mesh-list
25392351|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
25392352|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25392353|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25392354|NCT04216524|Prednisolone|prednisolone|mesh-list
25392355|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
25392356|NCT04216524|Cortisone|cortisone|mesh-list
25392357|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
25392358|NCT04216524|Rituximab|rituximab|mesh-list
25392359|NCT04216524|Doxorubicin|doxorubicin|mesh-list
25392360|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25392361|NCT04216524|Methotrexate|methotrexate|mesh-list
25392362|NCT04216524|Vincristine|vincristine|mesh-list
25392363|NCT04216524|Daunorubicin|daunorubicin|mesh-list
25392364|NCT04216524|Venetoclax|venetoclax|mesh-list
25392365|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
25392366|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25392367|NCT04216524|Antibodies|antibodies|mesh-list
25392368|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
25392369|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25392370|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25392371|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
25392372|NCT04216524|BB 1101|bb 1101|mesh-list
25392373|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392374|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
25392375|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392376|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392377|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392378|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
25392379|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392380|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392381|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25392382|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25392383|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
25392384|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
25392385|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392386|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25392387|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
25392388|NCT04216524|Hormones|hormones|mesh-ancestor
25392389|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392390|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25392391|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
25392392|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392393|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25392394|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25392395|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25392396|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25392417|NCT04216316|Gemcitabine|gemcitabine|mesh-list
25392418|NCT04216316|Carboplatin|carboplatin|mesh-list
25392419|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
25392420|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392421|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392422|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
25392423|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392424|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
25392425|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392426|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392427|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392428|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
25392429|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392430|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392454|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25392455|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25392456|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25392457|NCT04215848|Budesonide|budesonide|mesh-list
25392458|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
25392459|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25392460|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25392461|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
25392462|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392463|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392464|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25392465|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
25392466|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
25392467|NCT04215848|Hormones|hormones|mesh-ancestor
25392468|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392469|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25392470|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25392471|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25392477|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392478|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392479|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392480|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392481|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392482|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392483|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392484|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
25392485|NCT04214886|Fludarabine|fludarabine|mesh-list
25392486|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392487|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
25392563|NCT04210115|Calcium|calcium|mesh-list
25392488|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392489|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392490|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392491|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
25392492|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392493|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392494|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25392495|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25392496|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25392497|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
25392499|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392500|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392501|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392502|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392503|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25392504|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25392505|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392511|NCT04214249|Cytarabine|cytarabine|mesh-list
25392512|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
25392513|NCT04214249|Daunorubicin|daunorubicin|mesh-list
25392514|NCT04214249|Idarubicin|idarubicin|mesh-list
25392515|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392516|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392517|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392518|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
25392519|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392520|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
25392521|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392522|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392523|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
25392524|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392525|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25392526|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25392527|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25392528|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392529|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
25392530|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392531|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392532|NCT04212416|Leflunomide|leflunomide|mesh-list
25392533|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392610|NCT04207931|Triamcinolone|triamcinolone|mesh-list
25392534|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392535|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392536|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
25392537|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392538|NCT04212039|Bupivacaine|bupivacaine|mesh-list
25392539|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
25392540|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
25392541|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392542|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392543|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
25392544|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392546|NCT04211675|Temozolomide|temozolomide|mesh-list
25392547|NCT04211675|Dinutuximab|dinutuximab|mesh-list
25392548|NCT04211675|Sargramostim|sargramostim|mesh-list
25392549|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25392550|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25392551|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392552|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392553|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392554|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392555|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
25392556|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
25392557|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392558|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
25392559|NCT04210115|Leucovorin|leucovorin|mesh-list
25392560|NCT04210115|Cisplatin|cisplatin|mesh-list
25392561|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
25392564|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
25392565|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392566|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25392567|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392568|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25392569|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392570|NCT04210115|Antidotes|antidotes|mesh-ancestor
25392571|NCT04210115|Protective Agents|protective agents|mesh-ancestor
25392572|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
25392574|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
25392575|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25392576|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
25392577|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
25392578|NCT04209660|Lenvatinib|lenvatinib|mesh-list
25392579|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392580|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392581|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25392582|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392583|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392584|NCT04209595|Rucaparib|rucaparib|mesh-list
25392585|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25392586|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392587|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392588|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392589|NCT04209218|Dexamethasone|dexamethasone|mesh-list
25392590|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
25392591|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25392592|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
25392593|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
25392594|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392595|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392596|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25392597|NCT04209218|Hormones|hormones|mesh-ancestor
25392598|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392599|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25392600|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392601|NCT04209114|Nivolumab|nivolumab|mesh-list
25392602|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392603|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392604|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25392605|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392606|NCT04209075|Metformin|metformin|mesh-list
25392607|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25392608|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392609|NCT04207931|Fluocinonide|fluocinonide|mesh-list
25392611|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25392612|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25392613|NCT04207931|Betamethasone|betamethasone|mesh-list
25392614|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
25392615|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25392616|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
25392617|NCT04207931|Clobetasol|clobetasol|mesh-list
25392618|NCT04207931|Minoxidil|minoxidil|mesh-list
25392619|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25392620|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25392621|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25392622|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
25392623|NCT04207931|Hormones|hormones|mesh-ancestor
25392624|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392625|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392626|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392627|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
25392628|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392629|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392630|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25392631|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
25392632|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25392633|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
25392634|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25392635|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25392636|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392637|NCT04206787|Afatinib|afatinib|mesh-list
25392638|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392639|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25392640|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392641|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392642|NCT04206319|Listerine|listerine|mesh-list
25392643|NCT04206319|Fluorides|fluorides|mesh-list
25392644|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
25392645|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
25392646|NCT04206319|Protective Agents|protective agents|mesh-ancestor
25392647|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392648|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25392649|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392650|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
25392651|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25392652|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392653|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392654|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25392655|NCT04206059|Analgesics|analgesics|mesh-ancestor
25392656|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
25392657|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392658|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25392659|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25392660|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25392661|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
25392662|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392663|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392664|NCT04205994|Tolcapone|tolcapone|mesh-list
25392665|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25392666|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25392667|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25392668|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392669|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392670|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
25392671|NCT04205968|Leucovorin|leucovorin|mesh-list
25392672|NCT04205968|Folic Acid|folic acid|mesh-list
25392673|NCT04205968|Paclitaxel|paclitaxel|mesh-list
25392674|NCT04205968|Camptothecin|camptothecin|mesh-list
25392675|NCT04205968|Fluorouracil|fluorouracil|mesh-list
25392676|NCT04205968|Irinotecan|irinotecan|mesh-list
25392677|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25392678|NCT04205968|Ramucirumab|ramucirumab|mesh-list
25392679|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25392680|NCT04205968|Antibodies|antibodies|mesh-list
25392681|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
25392682|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25392683|NCT04205968|Lexatumumab|lexatumumab|mesh-list
25392684|NCT04205968|Calcium|calcium|mesh-list
25392685|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
25392686|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392687|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392688|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392689|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392690|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392691|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392692|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
25392693|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392694|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25392695|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25392696|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
25392697|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392698|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392699|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25392700|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423812|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
25392701|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392702|NCT04205968|Antidotes|antidotes|mesh-ancestor
25392703|NCT04205968|Protective Agents|protective agents|mesh-ancestor
25392704|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
25392705|NCT04205968|Vitamins|vitamins|mesh-ancestor
25392706|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
25392707|NCT04205968|Hematinics|hematinics|mesh-ancestor
25392708|NCT04205929|Curcumin|curcumin|mesh-list
25392709|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25392710|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25392711|NCT04205929|Analgesics|analgesics|mesh-ancestor
25392712|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
25392713|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392714|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392715|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25392716|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392717|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392718|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392719|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392720|NCT04205812|Paclitaxel|paclitaxel|mesh-list
25392721|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25392722|NCT04205812|Cisplatin|cisplatin|mesh-list
25392723|NCT04205812|Carboplatin|carboplatin|mesh-list
25392724|NCT04205812|Pemetrexed|pemetrexed|mesh-list
25392725|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392726|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392727|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392728|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392729|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392730|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392731|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392732|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25392733|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25392734|NCT04205643|Infliximab|infliximab|mesh-list
25392735|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
25392736|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25392737|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392738|NCT04205630|Trastuzumab|trastuzumab|mesh-list
25392739|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392740|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392741|NCT04205552|Nivolumab|nivolumab|mesh-list
25392742|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25392743|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392744|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392745|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25392746|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392747|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
25392748|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25392749|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392750|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392751|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25392752|NCT04205539|Analgesics|analgesics|mesh-ancestor
25392753|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
25392754|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392755|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25392756|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25392757|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25392758|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
25392759|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392760|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392761|NCT04205409|Nivolumab|nivolumab|mesh-list
25392762|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392763|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392764|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25392765|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392767|NCT04204967|Remifentanil|remifentanil|mesh-list
25392768|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25392769|NCT04204967|Narcotics|narcotics|mesh-ancestor
25392770|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392771|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392772|NCT04204967|Analgesics|analgesics|mesh-ancestor
25392773|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
25392774|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392775|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25772324|NCT03679975|Riluzole|riluzole|mesh-list
25392776|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25392777|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
25392778|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
25392779|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25392780|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
25392781|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25392782|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25392783|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
25392784|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392785|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392786|NCT04203901|Nivolumab|nivolumab|mesh-list
25392787|NCT04203901|Ipilimumab|ipilimumab|mesh-list
25392788|NCT04203901|Everolimus|everolimus|mesh-list
25392789|NCT04203901|Lenvatinib|lenvatinib|mesh-list
25392790|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392791|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392792|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25392793|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392794|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392795|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
25392796|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392797|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25392798|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392799|NCT04203160|Gemcitabine|gemcitabine|mesh-list
25392800|NCT04203160|Cisplatin|cisplatin|mesh-list
25392801|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392802|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392803|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
25392804|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392805|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
25392806|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392807|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392808|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392809|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
25392810|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392811|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25392812|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392813|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392814|NCT04201496|Empagliflozin|empagliflozin|mesh-list
25392815|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25392816|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392817|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25392818|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392819|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
25392820|NCT04201457|Trametinib|trametinib|mesh-list
25392821|NCT04201457|Dabrafenib|dabrafenib|mesh-list
25392822|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25392823|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
25392824|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25392825|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25392826|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392827|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392828|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392829|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392830|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392831|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25392832|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25392833|NCT04201457|Protective Agents|protective agents|mesh-ancestor
25392834|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392835|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25392836|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
25392837|NCT04201197|Dronabinol|dronabinol|mesh-list
25392838|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
25392839|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392840|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25392841|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25392842|NCT04201197|Analgesics|analgesics|mesh-ancestor
25392843|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
25392844|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392845|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25392846|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25392847|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392848|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392849|NCT04201197|Hormones|hormones|mesh-ancestor
25392850|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392851|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
25392854|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392858|NCT04200066|Tamoxifen|tamoxifen|mesh-list
25392859|NCT04200066|Temozolomide|temozolomide|mesh-list
25392860|NCT04200066|Maprotiline|maprotiline|mesh-list
25392861|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392862|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
25392863|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392864|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392865|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25392866|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
25392867|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392868|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392869|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25392870|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25392871|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25392872|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25392873|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25392874|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
25392875|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25392876|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25392877|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25392878|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25392879|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
25392880|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392881|NCT04199572|Acetaminophen|acetaminophen|mesh-list
25392882|NCT04199572|Diclofenac|diclofenac|mesh-list
25392883|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25392884|NCT04199572|Analgesics|analgesics|mesh-ancestor
25392885|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
25392886|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392887|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392888|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
25392889|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25392890|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25392891|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392892|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25392893|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392894|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392895|NCT04199468|Ketamine|ketamine|mesh-list
25392896|NCT04199468|Dronabinol|dronabinol|mesh-list
25392897|NCT04199468|Analgesics|analgesics|mesh-ancestor
25392898|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
25392899|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25392900|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392901|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25392902|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25392903|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
25392904|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
25392905|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25392906|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25392907|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25392908|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392909|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392910|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
25392911|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25392912|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25392913|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25392914|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25392915|NCT04199468|Hormones|hormones|mesh-ancestor
25392916|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25392917|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
25392918|NCT04199104|Lenvatinib|lenvatinib|mesh-list
25392919|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25392920|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392921|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25392922|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392923|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392924|NCT04199026|Sirolimus|sirolimus|mesh-list
25392925|NCT04199026|Doxorubicin|doxorubicin|mesh-list
25392926|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25392927|NCT04199026|Daunorubicin|daunorubicin|mesh-list
25392928|NCT04199026|Irinotecan|irinotecan|mesh-list
25392929|NCT04199026|Vincristine|vincristine|mesh-list
25392930|NCT04199026|Everolimus|everolimus|mesh-list
25392931|NCT04199026|Temozolomide|temozolomide|mesh-list
25392932|NCT04199026|Ifosfamide|ifosfamide|mesh-list
25392933|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
25392934|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25392935|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25392936|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392937|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25392938|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25392939|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25392940|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392941|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25392942|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392943|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392944|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392945|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392946|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392947|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
25392948|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392949|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392950|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
25392951|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25392952|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392953|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
25392954|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
25392955|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392956|NCT04198649|Azithromycin|azithromycin|mesh-list
25392957|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25392958|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392959|NCT04197986|Infigratinib|infigratinib|mesh-list
25392960|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392961|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25392962|NCT04197687|Trastuzumab|trastuzumab|mesh-list
25392963|NCT04197687|Pertuzumab|pertuzumab|mesh-list
25392964|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25392965|NCT04197687|Maytansine|maytansine|mesh-list
25392966|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25392967|NCT04197687|Vaccines|vaccines|mesh-list
25392968|NCT04197687|Antibodies|antibodies|mesh-list
25392969|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
25392970|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25392971|NCT04197687|Sargramostim|sargramostim|mesh-list
25392972|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
25392973|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
25392974|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392975|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392976|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392977|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392978|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392979|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392980|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392981|NCT04197089|Vitamin D|vitamin d|mesh-list
25392982|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
25392983|NCT04197089|Vitamins|vitamins|mesh-ancestor
25392984|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
25392985|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392986|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25392987|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25392988|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
25392989|NCT04196491|Fludarabine|fludarabine|mesh-list
25392990|NCT04196491|Lenalidomide|lenalidomide|mesh-list
25392991|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392992|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
25392993|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25392994|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25392995|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392996|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
25392997|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392998|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392999|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25393000|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25393001|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25393002|NCT04196491|Growth Substances|growth substances|mesh-ancestor
25393003|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
25393004|NCT04196257|Paclitaxel|paclitaxel|mesh-list
25393005|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25393006|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393007|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25393008|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25393009|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25393010|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393011|NCT04195945|Cytarabine|cytarabine|mesh-list
25393012|NCT04195945|Daunorubicin|daunorubicin|mesh-list
25393013|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
25393014|NCT04195945|Cladribine|cladribine|mesh-list
25393015|NCT04195945|Lenograstim|lenograstim|mesh-list
25393016|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393017|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
25393018|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393019|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393020|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
25393021|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393022|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393023|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
25393024|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393025|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393026|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25393027|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25393028|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393029|NCT04195945|Analgesics|analgesics|mesh-ancestor
25393030|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
25393031|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393032|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25393033|NCT04195750|Everolimus|everolimus|mesh-list
25393034|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393035|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393036|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
25393037|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393038|NCT04195698|Upadacitinib|upadacitinib|mesh-list
25393039|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25393040|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393041|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393042|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393043|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393044|NCT04195633|Cyclosporine|cyclosporine|mesh-list
25393045|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
25393046|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
25393047|NCT04195633|Treosulfan|treosulfan|mesh-list
25393048|NCT04195633|Busulfan|busulfan|mesh-list
25393049|NCT04195633|Fludarabine|fludarabine|mesh-list
25393050|NCT04195633|Cyclosporins|cyclosporins|mesh-list
25393051|NCT04195633|Lenograstim|lenograstim|mesh-list
25393052|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393053|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
25393054|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393055|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393056|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25393057|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
25393058|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393059|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393060|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25393061|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25393062|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393063|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
25393064|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393065|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
25393066|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25393067|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393068|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25393069|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
25393070|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25393071|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
25393072|NCT04195568|Antacids|antacids|mesh-ancestor
25393073|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393074|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25393075|NCT04195555|Ivosidenib|ivosidenib|mesh-list
25393076|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393077|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393078|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393079|NCT04195399|Imidazole|imidazole|mesh-list
25393080|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393081|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393082|NCT04194944|Cisplatin|cisplatin|mesh-list
25393083|NCT04194944|Carboplatin|carboplatin|mesh-list
25393084|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
25393085|NCT04194944|Pemetrexed|pemetrexed|mesh-list
25393086|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393087|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393088|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393089|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393090|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25393091|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25393092|NCT04194424|Metformin|metformin|mesh-list
25393093|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25393094|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393095|NCT04194203|Paclitaxel|paclitaxel|mesh-list
25393096|NCT04194203|Bevacizumab|bevacizumab|mesh-list
25393097|NCT04194203|Carboplatin|carboplatin|mesh-list
25393098|NCT04194203|Pemetrexed|pemetrexed|mesh-list
25393099|NCT04194203|Atezolizumab|atezolizumab|mesh-list
25393100|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25393101|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393102|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
25393103|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
25393104|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
25393105|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393106|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393107|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25393108|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25393109|NCT04194203|Growth Substances|growth substances|mesh-ancestor
25393110|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393111|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
25393112|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393113|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25393114|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25393115|NCT04193878|Budesonide|budesonide|mesh-list
25393116|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
25393117|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25393118|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25393119|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
25393120|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393121|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393122|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25393123|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
25393124|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
25393125|NCT04193878|Hormones|hormones|mesh-ancestor
25393126|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393127|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25393128|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25393129|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25393130|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
25393131|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393132|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393133|NCT04193215|Vaccines|vaccines|mesh-list
25393134|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
25393135|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393136|NCT04192981|GDC-0084|gdc-0084|mesh-list
25393137|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393138|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393139|NCT04192773|Lidocaine|lidocaine|mesh-list
25393140|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
25393141|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
25393142|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25393143|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393144|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
25393145|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393146|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25393147|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25393148|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25393149|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25393150|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393151|NCT04192136|Niacinamide|niacinamide|mesh-list
25393152|NCT04192136|Niacin|niacin|mesh-list
25393153|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
25393154|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
25393155|NCT04192136|Vitamins|vitamins|mesh-ancestor
25393156|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
25393157|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393158|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25393159|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
25393160|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393161|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25393162|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
25393163|NCT04191499|Fulvestrant|fulvestrant|mesh-list
25393164|NCT04191499|Palbociclib|palbociclib|mesh-list
25393165|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25393166|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393167|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25393168|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25393169|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
25393170|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393171|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393172|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393173|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393174|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393175|NCT04191447|Budesonide|budesonide|mesh-list
25393176|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
25393177|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25393178|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25393179|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25393180|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
25393181|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393182|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393183|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25393184|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
25393185|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
25393186|NCT04191447|Hormones|hormones|mesh-ancestor
25393187|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393188|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25393189|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25393190|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25393191|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
25393192|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393193|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393194|NCT04191434|Budesonide|budesonide|mesh-list
25393195|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
25393196|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25393197|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25393198|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25393199|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
25393200|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393201|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393202|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25393203|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
25393204|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
25393205|NCT04191434|Hormones|hormones|mesh-ancestor
25393206|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393207|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25393208|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25393209|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25393210|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
25393211|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393212|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393213|NCT04191304|Benralizumab|benralizumab|mesh-list
25393214|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25393215|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25393216|NCT04191187|Fludarabine|fludarabine|mesh-list
25393217|NCT04191187|Melphalan|melphalan|mesh-list
25393218|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393219|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393220|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393221|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
25393222|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393223|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25393224|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
25393225|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25393226|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
25393227|NCT04191096|Androgens|androgens|mesh-list
25393228|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393229|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393230|NCT04191096|Hormones|hormones|mesh-ancestor
25393231|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393232|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393233|NCT04190550|Cytarabine|cytarabine|mesh-list
25393234|NCT04190550|Idarubicin|idarubicin|mesh-list
25393235|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393236|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
25393237|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393238|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393239|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
25393240|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393241|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393242|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
25393243|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393244|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393245|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25393246|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25393247|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393248|NCT04190433|Carvedilol|carvedilol|mesh-list
25393249|NCT04190433|Lisinopril|lisinopril|mesh-list
25393250|NCT04190433|Spironolactone|spironolactone|mesh-list
25393251|NCT04190433|Pravastatin|pravastatin|mesh-list
25393252|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25393253|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
25393254|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393255|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393256|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25393257|NCT04190433|Diuretics|diuretics|mesh-ancestor
25393258|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
25393259|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25393260|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25393261|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
25393262|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393263|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393264|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25393265|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
25393266|NCT04190433|Protective Agents|protective agents|mesh-ancestor
25393267|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25393268|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25393269|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25393270|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
25393271|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25393272|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25393273|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25393274|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25393275|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
25393276|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25393277|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25393278|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393279|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25393280|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
25393281|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25393282|NCT04189952|Rituximab|rituximab|mesh-list
25393283|NCT04189952|Carboplatin|carboplatin|mesh-list
25393284|NCT04189952|Etoposide|etoposide|mesh-list
25393285|NCT04189952|Ifosfamide|ifosfamide|mesh-list
25393286|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
25393287|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393288|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393289|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
25393290|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393291|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393369|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25393292|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25393293|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25393294|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25393295|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393296|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393297|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25393298|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
25393299|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
25393300|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393301|NCT04188548|Trastuzumab|trastuzumab|mesh-list
25393302|NCT04188548|Pertuzumab|pertuzumab|mesh-list
25393303|NCT04188548|Everolimus|everolimus|mesh-list
25393304|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25393305|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393306|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393307|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393308|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
25393309|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393310|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25393311|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393312|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393313|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25393314|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
25393315|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393316|NCT04188392|Pimavanserin|pimavanserin|mesh-list
25393317|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25393318|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25393319|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25393320|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25393321|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25393322|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393323|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25393324|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25393325|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25393326|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
25393327|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393328|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393330|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
25393331|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393332|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
25393333|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393334|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393335|NCT04187703|Azacitidine|azacitidine|mesh-list
25393336|NCT04187703|Decitabine|decitabine|mesh-list
25393337|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393338|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
25393339|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393340|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393341|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393342|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
25393343|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
25393344|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393345|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393346|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393347|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
25393348|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
25393349|NCT04185883|Bevacizumab|bevacizumab|mesh-list
25393350|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
25393351|NCT04185883|Panitumumab|panitumumab|mesh-list
25393352|NCT04185883|Carboplatin|carboplatin|mesh-list
25393353|NCT04185883|Docetaxel|docetaxel|mesh-list
25393354|NCT04185883|Pemetrexed|pemetrexed|mesh-list
25393355|NCT04185883|Everolimus|everolimus|mesh-list
25393356|NCT04185883|Atezolizumab|atezolizumab|mesh-list
25393357|NCT04185883|Palbociclib|palbociclib|mesh-list
25393358|NCT04185883|Trametinib|trametinib|mesh-list
25393359|NCT04185883|Afatinib|afatinib|mesh-list
25393360|NCT04185883|Loperamide|loperamide|mesh-list
25393361|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393362|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393363|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25393364|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25393365|NCT04185883|Growth Substances|growth substances|mesh-ancestor
25393366|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393367|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
25393368|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25393370|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25393371|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393372|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393373|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25393374|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25393375|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393376|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
25393377|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393378|NCT04185883|Antidiarrheals|antidiarrheals|mesh-ancestor
25393379|NCT04185883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25393380|NCT04185402|Azithromycin|azithromycin|mesh-list
25393381|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25393382|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393384|NCT04185311|Ipilimumab|ipilimumab|mesh-list
25424493|NCT02250937|Fludarabine|fludarabine|mesh-list
25393385|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25393386|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393387|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393388|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25393389|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393390|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25393392|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25393393|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25393394|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
25393395|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393396|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393397|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25393398|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25393399|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
25393400|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393401|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393402|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25393403|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
25393404|NCT04182984|Prednisone|prednisone|mesh-list
25393405|NCT04182984|Azathioprine|azathioprine|mesh-list
25393406|NCT04182984|Bromides|bromides|mesh-list
25393407|NCT04182984|Tacrolimus|tacrolimus|mesh-list
25393408|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25393409|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25393410|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25393411|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
25393412|NCT04182984|Hormones|hormones|mesh-ancestor
25393413|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393414|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393415|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25393416|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393417|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
25393418|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25393419|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393420|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393421|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393422|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25393423|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
25393424|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25393425|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393426|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
25393427|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
25393428|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393429|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393430|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25393431|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
25393432|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393433|NCT04182555|Bilirubin|bilirubin|mesh-list
25393434|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
25393435|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393436|NCT04182555|Protective Agents|protective agents|mesh-ancestor
25393437|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393438|NCT04182204|Gemcitabine|gemcitabine|mesh-list
25393439|NCT04182204|Rituximab|rituximab|mesh-list
25393440|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
25393441|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393442|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393443|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
25393444|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393445|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393446|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393447|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
25393448|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393449|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
25393450|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393451|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393452|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393453|NCT04181827|Dexamethasone|dexamethasone|mesh-list
25393454|NCT04181827|Bortezomib|bortezomib|mesh-list
25393455|NCT04181827|Daratumumab|daratumumab|mesh-list
25393456|NCT04181827|Pomalidomide|pomalidomide|mesh-list
25393457|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25393458|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
25393459|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
25772325|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
25393476|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393477|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393478|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25393479|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
25393480|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25393482|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393483|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393484|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25393485|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
25393486|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
25393487|NCT04181359|Protective Agents|protective agents|mesh-ancestor
25393506|NCT04180371|Nivolumab|nivolumab|mesh-list
25393507|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393508|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393509|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25393510|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393511|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
25393512|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25393513|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393514|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393515|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393516|NCT04179162|Gemcitabine|gemcitabine|mesh-list
25393517|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
25393518|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393519|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
25393520|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393521|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393522|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
25393523|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393524|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393525|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393526|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
25393527|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393528|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25393529|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
25393530|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393531|NCT04178642|Idarubicin|idarubicin|mesh-list
25393532|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
25393533|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393534|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393535|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25393536|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25393537|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393538|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393539|NCT04178005|Cladribine|cladribine|mesh-list
25393540|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393541|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393542|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
25393543|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393544|NCT04177810|Plerixafor|plerixafor|mesh-list
25393545|NCT04177810|Cemiplimab|cemiplimab|mesh-list
25393546|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25393547|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25393548|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
25393549|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393550|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393551|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393552|NCT04177498|ON 01910|on 01910|mesh-list
25393553|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393554|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393555|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393556|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393558|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
25393559|NCT04177082|Vitamins|vitamins|mesh-ancestor
25393560|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
25393561|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393562|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25393563|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25393564|NCT04177004|Sirolimus|sirolimus|mesh-list
25393565|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
25393566|NCT04177004|Etoposide|etoposide|mesh-list
25393567|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
25393568|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
25393569|NCT04177004|Tacrolimus|tacrolimus|mesh-list
25393570|NCT04177004|Mitogens|mitogens|mesh-list
25393571|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393572|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
25393573|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393574|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393575|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25393576|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
25393577|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393578|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393579|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25393580|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25393581|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25393582|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25393583|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393584|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25393585|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25393586|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393587|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393588|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
25393589|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25393590|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
25393591|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
25393592|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25393593|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25393594|NCT04176705|Triamcinolone|triamcinolone|mesh-list
25393595|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25393596|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25393597|NCT04176705|Lidocaine|lidocaine|mesh-list
25393598|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25393599|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
25393600|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
25393601|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25393602|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393603|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
25393604|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393605|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25393606|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25393607|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25393608|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25393609|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393610|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25393611|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
25393612|NCT04176705|Hormones|hormones|mesh-ancestor
25393613|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393614|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393616|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393617|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25393618|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25393619|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393620|NCT04176172|Nicotine|nicotine|mesh-list
25393621|NCT04176172|Varenicline|varenicline|mesh-list
25393622|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25393623|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
25393624|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393625|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393626|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25393627|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25393628|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
25393642|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25393643|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
25393644|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393645|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393646|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25393647|NCT04176016|Edetic Acid|edetic acid|mesh-list
25393648|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
25393649|NCT04176016|Antidotes|antidotes|mesh-ancestor
25393650|NCT04176016|Protective Agents|protective agents|mesh-ancestor
25393651|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393652|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
25393653|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
25393654|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393655|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25393656|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
25393657|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25393659|NCT04175912|Carboplatin|carboplatin|mesh-list
25393660|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25393661|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25393662|NCT04175912|Pevonedistat|pevonedistat|mesh-list
25393663|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25393664|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393665|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
25393666|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
25393667|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
25393668|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393682|NCT04175600|Selexipag|selexipag|mesh-list
25393683|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25393692|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
25393693|NCT04173416|Narcotics|narcotics|mesh-ancestor
25393694|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25393695|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393696|NCT04173416|Analgesics|analgesics|mesh-ancestor
25393697|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
25393698|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393699|NCT04173247|Mineral Oil|mineral oil|mesh-list
25393700|NCT04173247|Emollients|emollients|mesh-ancestor
25393701|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
25393702|NCT04172844|Azacitidine|azacitidine|mesh-list
25393703|NCT04172844|Venetoclax|venetoclax|mesh-list
25393704|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25393705|NCT04172844|Pevonedistat|pevonedistat|mesh-list
25393706|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393707|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
25393708|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393709|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393710|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
25393711|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25393712|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
25393713|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25393714|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25393715|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393716|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25393717|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393718|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25393719|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25393720|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25393721|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393722|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393723|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393724|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393725|NCT04172675|Gemcitabine|gemcitabine|mesh-list
25393727|NCT04172675|Mitomycin|mitomycin|mesh-list
25393728|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393729|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
25393730|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393731|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393732|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
25393733|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393734|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393735|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393736|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
25393737|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393738|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393739|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
25393740|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25393741|NCT04172532|Peposertib|peposertib|mesh-list
25393742|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393743|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393744|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393745|NCT04171726|Edoxaban|edoxaban|mesh-list
25393746|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25393747|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
25393748|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25393749|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
25393750|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393751|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393752|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
25393753|NCT04171700|Rucaparib|rucaparib|mesh-list
25393754|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25393755|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393756|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393757|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393758|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
25393759|NCT04171622|Lenvatinib|lenvatinib|mesh-list
25393760|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393761|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393762|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393763|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393764|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393765|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
25393766|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393767|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393768|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
25393769|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25393770|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393771|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25393772|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393773|NCT04170517|Progesterone|progesterone|mesh-list
25393774|NCT04170517|Progestins|progestins|mesh-ancestor
25393775|NCT04170517|Hormones|hormones|mesh-ancestor
25393776|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393777|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393778|NCT04170465|Metformin|metformin|mesh-list
25393779|NCT04170465|Paclitaxel|paclitaxel|mesh-list
25393780|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
25393781|NCT04170465|Doxorubicin|doxorubicin|mesh-list
25393782|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25393783|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393784|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
25393785|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
25393786|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
25393787|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393788|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393789|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
25393790|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393791|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393792|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25393793|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
25393794|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25393795|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25393796|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393797|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25393798|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25393799|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393800|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
25393801|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393802|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393803|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393804|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393805|NCT04169737|Venetoclax|venetoclax|mesh-list
25393806|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
25393807|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
25393808|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393809|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393810|NCT04169373|Upadacitinib|upadacitinib|mesh-list
25393811|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25393812|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25393813|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393814|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393815|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25393816|NCT04169347|Leucovorin|leucovorin|mesh-list
25393817|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
25393818|NCT04169347|Irinotecan|irinotecan|mesh-list
25393819|NCT04169347|Panitumumab|panitumumab|mesh-list
25393820|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393821|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25393822|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25393823|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393824|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393825|NCT04169347|Antidotes|antidotes|mesh-ancestor
25393826|NCT04169347|Protective Agents|protective agents|mesh-ancestor
25393827|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393828|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
25393830|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
25393831|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393832|NCT04168190|Vaccines|vaccines|mesh-list
25393833|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25393834|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
25393835|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393836|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
25393837|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25393838|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
25393839|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393840|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393841|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25393842|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25393843|NCT04166773|Tirzepatide|tirzepatide|mesh-list
25393844|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25393845|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393846|NCT04166773|Incretins|incretins|mesh-ancestor
25393847|NCT04166773|Hormones|hormones|mesh-ancestor
25393848|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393849|NCT04166669|Itraconazole|itraconazole|mesh-list
25393850|NCT04166669|Rifampin|rifampin|mesh-list
25393851|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
25393852|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393853|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25393854|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25393855|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393856|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393857|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25393858|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
25393859|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393860|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393861|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25393862|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25393863|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
25393864|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25393865|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
25393866|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25393867|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25393868|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25393869|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25393870|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25393871|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25393872|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25393880|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393889|NCT04166383|Nivolumab|nivolumab|mesh-list
25393890|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393891|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393892|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25393893|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393894|NCT04166318|Fluorouracil|fluorouracil|mesh-list
25393895|NCT04166318|Capecitabine|capecitabine|mesh-list
25393896|NCT04166318|Mitomycins|mitomycins|mesh-list
25393897|NCT04166318|Mitomycin|mitomycin|mesh-list
25393898|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
25393899|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393900|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393901|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393902|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393903|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
25393904|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393905|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25393906|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
25393907|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25393908|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393909|NCT04165824|Edaravone|edaravone|mesh-list
25393910|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25393911|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
25393912|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393913|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25393914|NCT04165824|Protective Agents|protective agents|mesh-ancestor
25393915|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393916|NCT04165772|Capecitabine|capecitabine|mesh-list
25393917|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393918|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
25393919|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393920|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393921|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
25393922|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25393923|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
25393924|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393925|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
25393926|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
25393927|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393928|NCT04165239|Protective Agents|protective agents|mesh-ancestor
25393929|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393930|NCT04165096|Acetaminophen|acetaminophen|mesh-list
25393931|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
25393932|NCT04165096|Promethazine|promethazine|mesh-list
25393933|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
25393934|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393935|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393936|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25393937|NCT04165096|Analgesics|analgesics|mesh-ancestor
25393938|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
25393939|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393940|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393941|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
25393942|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25393943|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25393944|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25393945|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25393946|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
25393947|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
25393966|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393967|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
25393968|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
25393969|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
25393970|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393971|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393972|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393973|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25393974|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25393975|NCT04164082|Gemcitabine|gemcitabine|mesh-list
25393976|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
25393977|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25393978|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
25393979|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393980|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393981|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
25393982|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25393983|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25393984|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393985|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
25393986|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393987|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393988|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
25393989|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25393990|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
25393991|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393992|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394011|NCT04161989|Progesterone|progesterone|mesh-list
25394012|NCT04161989|Progestins|progestins|mesh-ancestor
25394013|NCT04161989|Hormones|hormones|mesh-ancestor
25394014|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394015|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394016|NCT04161898|Prednisolone|prednisolone|mesh-list
25394017|NCT04161898|Upadacitinib|upadacitinib|mesh-list
25394018|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394019|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
25394020|NCT04161898|Hormones|hormones|mesh-ancestor
25394021|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394022|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394023|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394024|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394025|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25394026|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394027|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394028|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394029|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394030|NCT04161885|Azacitidine|azacitidine|mesh-list
25394031|NCT04161885|Venetoclax|venetoclax|mesh-list
25394032|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394033|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
25394034|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394035|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394036|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394037|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25394038|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25394039|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394040|NCT04161430|Incretins|incretins|mesh-ancestor
25394041|NCT04161430|Hormones|hormones|mesh-ancestor
25394042|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394043|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25394044|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
25394045|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394046|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394047|NCT04161066|Psilocybin|psilocybin|mesh-list
25394048|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
25394049|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394050|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25394051|NCT04160546|Aspirin|aspirin|mesh-list
25394052|NCT04160546|Ponatinib|ponatinib|mesh-list
25394053|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25394054|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25394055|NCT04160546|Analgesics|analgesics|mesh-ancestor
25394056|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
25394057|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394058|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394059|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394060|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394061|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25394062|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25394063|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394064|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25394065|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25394066|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394067|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
25394068|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394069|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394070|NCT04160117|Colchicine|colchicine|mesh-list
25394071|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
25394072|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394073|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25394074|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25394075|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25394076|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394077|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394078|NCT04159519|Budesonide|budesonide|mesh-list
25394079|NCT04159519|Albuterol|albuterol|mesh-list
25394080|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
25394767|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25394081|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25394082|NCT04159519|Benralizumab|benralizumab|mesh-list
25394083|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394084|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25394085|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
25394086|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394087|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394088|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25394089|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
25394090|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
25394091|NCT04159519|Hormones|hormones|mesh-ancestor
25394092|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394093|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25394094|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25394095|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25394096|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
25394097|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394098|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394099|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
25394100|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25394101|NCT04158739|Cytarabine|cytarabine|mesh-list
25394102|NCT04158739|Antibodies|antibodies|mesh-list
25394103|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
25394104|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25394105|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
25394106|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394107|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394108|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
25394109|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394110|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394111|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
25394112|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394113|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394114|NCT04158258|Bevacizumab|bevacizumab|mesh-list
25394115|NCT04158258|Trastuzumab|trastuzumab|mesh-list
25394116|NCT04158258|Pertuzumab|pertuzumab|mesh-list
25394117|NCT04158258|Capecitabine|capecitabine|mesh-list
25394118|NCT04158258|Atezolizumab|atezolizumab|mesh-list
25394119|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394120|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394121|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25394122|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25394123|NCT04158258|Growth Substances|growth substances|mesh-ancestor
25394124|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394125|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
25394126|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394127|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
25394128|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394129|NCT04158141|Cisplatin|cisplatin|mesh-list
25394130|NCT04158141|Carboplatin|carboplatin|mesh-list
25394131|NCT04158141|Pemetrexed|pemetrexed|mesh-list
25394132|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394133|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394134|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394135|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25394136|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25394137|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
25394138|NCT04157985|Nivolumab|nivolumab|mesh-list
25394139|NCT04157985|Ipilimumab|ipilimumab|mesh-list
25394140|NCT04157985|Cemiplimab|cemiplimab|mesh-list
25394141|NCT04157985|Atezolizumab|atezolizumab|mesh-list
25394142|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25394143|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394144|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394145|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394146|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
25394147|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394148|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394149|NCT04157348|Benralizumab|benralizumab|mesh-list
25394150|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25394151|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
25394152|NCT04157335|Benralizumab|benralizumab|mesh-list
25394153|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25394154|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
25394155|NCT04157036|Ibuprofen|ibuprofen|mesh-list
25394156|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
25394768|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25394157|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25394158|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25394159|NCT04157036|Prednisolone|prednisolone|mesh-list
25394160|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
25394161|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25394162|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
25394163|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25394164|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25394165|NCT04157036|Analgesics|analgesics|mesh-ancestor
25394166|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
25394167|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394168|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394169|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394170|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394171|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25394172|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394173|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394189|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394190|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394192|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
25394193|NCT04156581|Hormones|hormones|mesh-ancestor
25394194|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394195|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394196|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394197|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
25394198|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
25394199|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25394200|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
25394201|NCT04155580|Decitabine|decitabine|mesh-list
25394202|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394203|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
25394204|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394205|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394206|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394208|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394209|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394210|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394211|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394218|NCT04154293|Isotretinoin|isotretinoin|mesh-list
25394219|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
25394220|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
25394221|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25394231|NCT04153136|Valsartan|valsartan|mesh-list
25394232|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25394233|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25394234|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25394235|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25394236|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394237|NCT04152564|Bupivacaine|bupivacaine|mesh-list
25394238|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
25394239|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
25394240|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
25394241|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25394242|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394243|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
25394244|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394245|NCT04152200|Lumasiran|lumasiran|mesh-list
25394246|NCT04152200|Renal Agents|renal agents|mesh-ancestor
25394247|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
25394248|NCT04151680|Apixaban|apixaban|mesh-list
25394249|NCT04151680|Edoxaban|edoxaban|mesh-list
25394250|NCT04151680|Dabigatran|dabigatran|mesh-list
25394251|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25394252|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
25394253|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25394254|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
25394255|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394256|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394257|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
25394258|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
25394259|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394260|NCT04150887|Azacitidine|azacitidine|mesh-list
25394261|NCT04150887|Venetoclax|venetoclax|mesh-list
25394262|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394263|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
25394264|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394265|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394266|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394267|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
25394268|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394269|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394270|NCT04150029|Azacitidine|azacitidine|mesh-list
25394271|NCT04150029|Venetoclax|venetoclax|mesh-list
25394272|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394273|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
25394274|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394275|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394276|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394277|NCT04149574|Nivolumab|nivolumab|mesh-list
25394278|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
25394279|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394280|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394281|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25394282|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394283|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25394284|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
25394285|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394286|NCT04149470|Omeprazole|omeprazole|mesh-list
25394287|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25394288|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394289|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25394290|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394291|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394292|NCT04148911|Paclitaxel|paclitaxel|mesh-list
25394293|NCT04148911|Atezolizumab|atezolizumab|mesh-list
25394294|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25394295|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394296|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
25394297|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
25394298|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
25394299|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394300|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
25394301|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25394302|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25394303|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394304|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25394305|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394306|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
25394307|NCT04147533|Dasatinib|dasatinib|mesh-list
25394308|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394309|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394310|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394311|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394312|NCT04147494|Edetic Acid|edetic acid|mesh-list
25394313|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25394314|NCT04147494|FAPI-46|fapi-46|mesh-list
25394315|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
25394316|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
25394317|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394318|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
25394319|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25394320|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25394321|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25394322|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
25394323|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394324|NCT04146207|Prednisone|prednisone|mesh-list
25394325|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394326|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
25394332|NCT04145440|Felzartamab|felzartamab|mesh-list
25394333|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394334|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
25394335|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394336|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
25394337|NCT04145349|Vinorelbine|vinorelbine|mesh-list
25394338|NCT04145349|Ramucirumab|ramucirumab|mesh-list
25394339|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394340|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
25394341|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394342|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394343|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25394344|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
25394345|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394346|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394347|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25394348|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25394349|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
25394350|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
25394351|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
25394358|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
25394359|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394360|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394361|NCT04143061|Vaccines|vaccines|mesh-list
25394362|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
25394363|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394364|NCT04142658|Warfarin|warfarin|mesh-list
25394365|NCT04142658|Apixaban|apixaban|mesh-list
25394366|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
25394367|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25394368|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
25394369|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25394370|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
25394371|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394372|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394373|NCT04142125|Aspirin|aspirin|mesh-list
25394374|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
25394375|NCT04142125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25394376|NCT04142125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25394377|NCT04142125|Analgesics|analgesics|mesh-ancestor
25394378|NCT04142125|Sensory System Agents|sensory system agents|mesh-ancestor
25394379|NCT04142125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394380|NCT04142125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394381|NCT04142125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394382|NCT04142125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394383|NCT04142125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25394384|NCT04142125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25394385|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394386|NCT04142125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25394387|NCT04142125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25394388|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394389|NCT04142125|Antipyretics|antipyretics|mesh-ancestor
25394390|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25394391|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
25394392|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25394393|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
25394394|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
25394395|NCT04141904|Tofacitinib|tofacitinib|mesh-list
25394396|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394397|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394398|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394400|NCT04141696|Ketamine|ketamine|mesh-list
25394401|NCT04141696|Analgesics|analgesics|mesh-ancestor
25394402|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
25394403|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394404|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394405|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25394406|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25394407|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
25394409|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25394410|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25394411|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25394412|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394413|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394414|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25394415|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25394416|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25394417|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25394418|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25394419|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
25394420|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
25394421|NCT04141020|Sirolimus|sirolimus|mesh-list
25394422|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25394423|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394424|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25394425|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394426|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
25394427|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394428|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
25394429|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394430|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
25394431|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394432|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394433|NCT04140305|Ozanimod|ozanimod|mesh-list
25394434|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25394435|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394436|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394437|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
25394438|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394439|NCT04139395|Citric Acid|citric acid|mesh-list
25394440|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
25394441|NCT04139395|Gallium citrate|gallium citrate|mesh-list
25394442|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
25394443|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25394444|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
25394445|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
25394446|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394447|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25394448|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
25394449|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394450|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394451|NCT04139304|Prednisone|prednisone|mesh-list
25394452|NCT04139304|Cortisone|cortisone|mesh-list
25394453|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
25394454|NCT04139304|Doxorubicin|doxorubicin|mesh-list
25394455|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25394456|NCT04139304|Etoposide|etoposide|mesh-list
25394457|NCT04139304|Vincristine|vincristine|mesh-list
25394458|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
25394459|NCT04139304|Daunorubicin|daunorubicin|mesh-list
25394460|NCT04139304|Daratumumab|daratumumab|mesh-list
25394461|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
25394462|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394463|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
25394464|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394465|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394466|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25394467|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
25394468|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394469|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394470|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25394471|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25394472|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25394473|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25394474|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394475|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394476|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
25394477|NCT04139304|Hormones|hormones|mesh-ancestor
25394478|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394479|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394480|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25394482|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
25394483|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
25394484|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
25394485|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
25394486|NCT04139213|Naltrexone|naltrexone|mesh-list
25394487|NCT04139213|Buprenorphine|buprenorphine|mesh-list
25394488|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25394489|NCT04139213|Naloxone|naloxone|mesh-list
25394490|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25394491|NCT04139213|Narcotics|narcotics|mesh-ancestor
25394492|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25394493|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394494|NCT04139213|Analgesics|analgesics|mesh-ancestor
25394495|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
25394496|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394497|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25394498|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25394499|NCT04138628|Atezolizumab|atezolizumab|mesh-list
25394500|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394501|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
25394502|NCT04138394|Vitamins|vitamins|mesh-ancestor
25394503|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
25394504|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394505|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
25394506|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394507|NCT04138394|Protective Agents|protective agents|mesh-ancestor
25394508|NCT04138212|Paclitaxel|paclitaxel|mesh-list
25394509|NCT04138212|Cisplatin|cisplatin|mesh-list
25394510|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25394511|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394512|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
25394513|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
25394514|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
25394515|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394516|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25394517|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
25394518|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394519|NCT04137120|Aflibercept|aflibercept|mesh-list
25394520|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25394521|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25394522|NCT04137120|Growth Substances|growth substances|mesh-ancestor
25394523|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394524|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
25394525|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394526|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
25394527|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25394528|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394529|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25394530|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25394531|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25394532|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394533|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394534|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394535|NCT04137107|Analgesics|analgesics|mesh-ancestor
25394536|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
25394537|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394998|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
25394540|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
25394541|NCT04136756|Rituximab|rituximab|mesh-list
25394542|NCT04136756|Daratumumab|daratumumab|mesh-list
25394543|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394544|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394545|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
25394546|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394547|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394548|NCT04136353|Hormones|hormones|mesh-list
25394549|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25394550|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394551|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394552|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
25394553|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25394554|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394555|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
25394556|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394557|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394558|NCT04134923|Corticosterone|corticosterone|mesh-list
25394559|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394560|NCT04134884|Talazoparib|talazoparib|mesh-list
25394561|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25394562|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394563|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394564|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394565|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
25394566|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394567|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394568|NCT04134260|Hormones|hormones|mesh-list
25394569|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394570|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394571|NCT04133636|Dexamethasone|dexamethasone|mesh-list
25394572|NCT04133636|Lenalidomide|lenalidomide|mesh-list
25394573|NCT04133636|Bortezomib|bortezomib|mesh-list
25394574|NCT04133636|Daratumumab|daratumumab|mesh-list
25394575|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394576|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
25394577|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
25394578|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394579|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394580|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394581|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
25394583|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394584|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394585|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394586|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
25394587|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25394588|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25394589|NCT04133636|Growth Substances|growth substances|mesh-ancestor
25394590|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
25394591|NCT04133480|Cannabidiol|cannabidiol|mesh-list
25394592|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
25394593|NCT04133376|Nicotine|nicotine|mesh-list
25394594|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25394595|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
25394596|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394597|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394598|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25394599|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25394600|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
25394601|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394602|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394606|NCT04130464|Ketorolac|ketorolac|mesh-list
25394607|NCT04130464|Ropivacaine|ropivacaine|mesh-list
25394608|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
25394609|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
25394610|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25394611|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394612|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
25394613|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394614|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25394615|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25394616|NCT04130464|Analgesics|analgesics|mesh-ancestor
25394617|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394618|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394619|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25394620|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394621|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394622|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
25394623|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
25394624|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394625|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394626|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394627|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394628|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25394629|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
25394630|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394631|NCT04129502|Cisplatin|cisplatin|mesh-list
25394632|NCT04129502|Carboplatin|carboplatin|mesh-list
25394633|NCT04129502|Pemetrexed|pemetrexed|mesh-list
25394634|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394635|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394636|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394637|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25394638|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25394639|NCT04129398|Letermovir|letermovir|mesh-list
25394640|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25394641|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394642|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394643|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394644|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
25394645|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394646|NCT04129151|Palbociclib|palbociclib|mesh-list
25394647|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394648|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394649|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394650|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394651|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
25394652|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394653|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394654|NCT04128501|Azacitidine|azacitidine|mesh-list
25394655|NCT04128501|Venetoclax|venetoclax|mesh-list
25394656|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394657|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
25394658|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394659|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394660|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394661|NCT04128436|Progesterone|progesterone|mesh-list
25394662|NCT04128436|Progestins|progestins|mesh-ancestor
25394663|NCT04128436|Hormones|hormones|mesh-ancestor
25394664|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394665|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394666|NCT04128176|Omalizumab|omalizumab|mesh-list
25394667|NCT04128176|Rituximab|rituximab|mesh-list
25394668|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394669|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394670|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
25394671|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394672|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394673|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25394674|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25394675|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
25394676|NCT04127786|Vaccines|vaccines|mesh-list
25394677|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
25394678|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394679|NCT04126681|Interferons|interferons|mesh-list
25394680|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
25394681|NCT04126681|Dasatinib|dasatinib|mesh-list
25394682|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
25394683|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
25394684|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394685|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
25394686|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394687|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394688|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394689|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394690|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
25394691|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25394692|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25394693|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25394694|NCT04126200|Dexamethasone|dexamethasone|mesh-list
25394695|NCT04126200|Lenalidomide|lenalidomide|mesh-list
25394696|NCT04126200|Pomalidomide|pomalidomide|mesh-list
25394697|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394698|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
25394699|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
25394700|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394701|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394702|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394703|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
25394704|NCT04126200|Hormones|hormones|mesh-ancestor
25394705|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394706|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394707|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394708|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
25394709|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25394710|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25394711|NCT04126200|Growth Substances|growth substances|mesh-ancestor
25394712|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
25394714|NCT04126031|Avibactam|avibactam|mesh-list
25394715|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25394716|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25394717|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394718|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25394719|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394720|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394721|NCT04125836|Octreotide|octreotide|mesh-list
25394722|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394723|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394724|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394725|NCT04125472|Lumasiran|lumasiran|mesh-list
25394726|NCT04125472|Renal Agents|renal agents|mesh-ancestor
25394727|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
25394728|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394729|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
25394730|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394731|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25394732|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25394733|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25394734|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394735|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394736|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25394737|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25394738|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394739|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
25394740|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394741|NCT04124926|Lansoprazole|lansoprazole|mesh-list
25394742|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
25394743|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25394744|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394745|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25394746|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394747|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394748|NCT04124432|Nicotine|nicotine|mesh-list
25394749|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25394750|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
25394751|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394752|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394753|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25394754|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25394755|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
25394756|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394757|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394758|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
25394759|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25394760|NCT04124367|Protective Agents|protective agents|mesh-ancestor
25394761|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394762|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
25394763|NCT04124198|Nimorazole|nimorazole|mesh-list
25394764|NCT04124198|Cisplatin|cisplatin|mesh-list
25394765|NCT04124198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394766|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25394769|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394770|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
25394771|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394772|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
25394773|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394774|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394775|NCT04123561|Dexamethasone|dexamethasone|mesh-list
25394776|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
25394777|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25394778|NCT04123561|BB 1101|bb 1101|mesh-list
25394779|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394780|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
25394781|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
25394782|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394783|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394784|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394785|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
25394786|NCT04123561|Hormones|hormones|mesh-ancestor
25394787|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394788|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394789|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394791|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394792|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394793|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
25394794|NCT04123366|Olaparib|olaparib|mesh-list
25394795|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394796|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394797|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25394798|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394799|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394800|NCT04123067|Pioglitazone|pioglitazone|mesh-list
25394801|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25394802|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394803|NCT04122443|Acetaminophen|acetaminophen|mesh-list
25394804|NCT04122443|Oxycodone|oxycodone|mesh-list
25394805|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25394806|NCT04122443|Analgesics|analgesics|mesh-ancestor
25394807|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
25394808|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394809|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394810|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
25394811|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25394812|NCT04122443|Narcotics|narcotics|mesh-ancestor
25394813|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25394814|NCT04121260|Daratumumab|daratumumab|mesh-list
25394815|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394816|NCT04120961|Hirudins|hirudins|mesh-list
25394817|NCT04120961|Bivalirudin|bivalirudin|mesh-list
25394818|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
25394819|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25394820|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
25394821|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394822|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394823|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
25394824|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25394825|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25394826|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
25394827|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394828|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394829|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25394830|NCT04117945|Cetuximab|cetuximab|mesh-list
25394831|NCT04117945|Panitumumab|panitumumab|mesh-list
25394832|NCT04117945|Irinotecan|irinotecan|mesh-list
25394833|NCT04117945|Antibodies|antibodies|mesh-list
25394834|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
25394835|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25394836|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
25394837|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394838|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394839|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25394840|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25394841|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394842|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394843|NCT04117087|Nivolumab|nivolumab|mesh-list
25394844|NCT04117087|Ipilimumab|ipilimumab|mesh-list
25394845|NCT04117087|Poly ICLC|poly iclc|mesh-list
25394846|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394847|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394848|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25394849|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394850|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
25394851|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
25394852|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394853|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
25394854|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394855|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394856|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394857|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394858|NCT04116073|Antibodies|antibodies|mesh-list
25394859|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
25394860|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394861|NCT04115878|Oxybutynin|oxybutynin|mesh-list
25394862|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25394863|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25394864|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25394865|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25394866|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394867|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
25394868|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394869|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394870|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
25394871|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
25394872|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394873|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25394874|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25394875|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
25394876|NCT04115878|Urological Agents|urological agents|mesh-ancestor
25394877|NCT04115631|Cytarabine|cytarabine|mesh-list
25394878|NCT04115631|Rituximab|rituximab|mesh-list
25394879|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25394880|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25394881|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
25394882|NCT04115631|Antibodies|antibodies|mesh-list
25394883|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
25394884|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25394885|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
25394886|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394887|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394888|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25394889|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394890|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
25394891|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394892|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
25394893|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394894|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394895|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25394896|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
25394897|NCT04115384|Insulin|insulin|mesh-list
25394898|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25394899|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25394900|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394901|NCT04113616|Cytarabine|cytarabine|mesh-list
25394902|NCT04113616|Decitabine|decitabine|mesh-list
25394903|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25394904|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
25394905|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394906|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394907|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
25394908|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25394909|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25394910|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
25394911|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394912|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394913|NCT04113317|Lenograstim|lenograstim|mesh-list
25394914|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25394915|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
25394916|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394917|NCT04112823|Dexamethasone|dexamethasone|mesh-list
25394918|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
25394919|NCT04112823|BB 1101|bb 1101|mesh-list
25394920|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394921|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
25394922|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
25395225|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
25394923|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25394924|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394925|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394927|NCT04112823|Hormones|hormones|mesh-ancestor
25394928|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394929|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394930|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394931|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
25394932|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394933|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394934|NCT04112368|Estradiol|estradiol|mesh-list
25394935|NCT04112368|Progesterone|progesterone|mesh-list
25394936|NCT04112368|Estrogens|estrogens|mesh-ancestor
25394937|NCT04112368|Hormones|hormones|mesh-ancestor
25394938|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394939|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394940|NCT04112368|Progestins|progestins|mesh-ancestor
25394941|NCT04112199|Terlipressin|terlipressin|mesh-list
25394942|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25394943|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25394944|NCT04112043|Niacinamide|niacinamide|mesh-list
25394945|NCT04112043|Niacin|niacin|mesh-list
25394946|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
25394947|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
25394948|NCT04112043|Vitamins|vitamins|mesh-ancestor
25394949|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
25394950|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394951|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25394952|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
25394953|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394954|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25394955|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
25394956|NCT04111978|Letrozole|letrozole|mesh-list
25394957|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394958|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25394959|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25394960|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394961|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394962|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25394963|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
25394964|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394965|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394966|NCT04111458|Trametinib|trametinib|mesh-list
25394967|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394968|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25394969|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394970|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394971|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25394972|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25394973|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
25394974|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25394975|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394976|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394977|NCT04110301|Lenalidomide|lenalidomide|mesh-list
25394978|NCT04110301|Antibodies|antibodies|mesh-list
25394979|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25394980|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
25394981|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394982|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25394983|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25394984|NCT04110301|Growth Substances|growth substances|mesh-ancestor
25394985|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
25394986|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394987|NCT04108676|Omeprazole|omeprazole|mesh-list
25394988|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25394989|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394990|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25394991|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25394992|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25394993|NCT04108481|Durvalumab|durvalumab|mesh-list
25394994|NCT04108481|Methamphetamine|methamphetamine|mesh-list
25394995|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25394996|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25394997|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394999|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395000|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25395002|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
25395003|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395004|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
25395005|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395006|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395007|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
25395008|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25395009|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25395010|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25395011|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25395012|NCT04108208|Androgens|androgens|mesh-list
25395013|NCT04108208|Hormones|hormones|mesh-ancestor
25395014|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395015|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395016|NCT04108195|Daratumumab|daratumumab|mesh-list
25395017|NCT04108195|Pomalidomide|pomalidomide|mesh-list
25395018|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395019|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
25395020|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395021|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25395022|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25395023|NCT04108195|Growth Substances|growth substances|mesh-ancestor
25395024|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
25395026|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25395027|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25395028|NCT04108156|Growth Substances|growth substances|mesh-ancestor
25395029|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395030|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
25395031|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395032|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
25395033|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
25395034|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395035|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
25395036|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395037|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395038|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
25395039|NCT04106219|Topotecan|topotecan|mesh-list
25395040|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395041|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
25395042|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395043|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395044|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395045|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
25395046|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395047|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395048|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25395049|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25395050|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25395051|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395052|NCT04106115|Durvalumab|durvalumab|mesh-list
25395053|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25395054|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395055|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395056|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25395057|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
25395058|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395059|NCT04105998|Oxytocin|oxytocin|mesh-list
25395060|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
25395061|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25395062|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395063|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
25395064|NCT04105946|Remifentanil|remifentanil|mesh-list
25395065|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25395066|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25395067|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395068|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25395069|NCT04105946|Analgesics|analgesics|mesh-ancestor
25395070|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
25395071|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395072|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25395089|NCT04102618|Atezolizumab|atezolizumab|mesh-list
25395090|NCT04102618|Letrozole|letrozole|mesh-list
25395091|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395092|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395093|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25395094|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25395095|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395096|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395097|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25395098|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
25395099|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395100|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395117|NCT04102098|Bevacizumab|bevacizumab|mesh-list
25395118|NCT04102098|Atezolizumab|atezolizumab|mesh-list
25395119|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395120|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395121|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25395122|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25395123|NCT04102098|Growth Substances|growth substances|mesh-ancestor
25395124|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395125|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
25395141|NCT04101357|Carboplatin|carboplatin|mesh-list
25395142|NCT04101357|Etoposide|etoposide|mesh-list
25395143|NCT04101357|Atezolizumab|atezolizumab|mesh-list
25395144|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395145|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395146|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25395147|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25395148|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395149|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395150|NCT04100018|Prednisone|prednisone|mesh-list
25395151|NCT04100018|Docetaxel|docetaxel|mesh-list
25395152|NCT04100018|Nivolumab|nivolumab|mesh-list
25395153|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395154|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395155|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395156|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395157|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395158|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395159|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
25395160|NCT04100018|Hormones|hormones|mesh-ancestor
25395161|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395162|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395163|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25395164|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395165|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25395166|NCT04099888|Gemcitabine|gemcitabine|mesh-list
25395167|NCT04099888|Cisplatin|cisplatin|mesh-list
25395168|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395169|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395170|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
25395171|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395172|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
25395173|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395174|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395175|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395176|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
25395177|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395178|NCT04099797|Cyclophosphamide|cyclophosphamide|mesh-list
25395179|NCT04099797|Fludarabine|fludarabine|mesh-list
25395180|NCT04099797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395181|NCT04099797|Immunologic Factors|immunologic factors|mesh-ancestor
25395182|NCT04099797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395183|NCT04099797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395184|NCT04099797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395185|NCT04099797|Alkylating Agents|alkylating agents|mesh-ancestor
25395186|NCT04099797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395187|NCT04099797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395188|NCT04099797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25395189|NCT04099251|Nivolumab|nivolumab|mesh-list
25395190|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395191|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395192|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25395193|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395194|NCT04098744|Artesunate|artesunate|mesh-list
25395195|NCT04098744|Artemisinins|artemisinins|mesh-list
25395196|NCT04098744|Artemisinin|artemisinin|mesh-list
25395197|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
25395198|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25395199|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25395200|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395201|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395202|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
25395203|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
25395204|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25395205|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
25395206|NCT04098718|Prednisolone|prednisolone|mesh-list
25395207|NCT04098718|Benralizumab|benralizumab|mesh-list
25395208|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395209|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
25395210|NCT04098718|Hormones|hormones|mesh-ancestor
25395211|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395212|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395213|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25395214|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395215|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25395216|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
25395217|NCT04098666|Metformin|metformin|mesh-list
25395218|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25395219|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395220|NCT04097561|Belimumab|belimumab|mesh-list
25395221|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395222|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
25395223|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395224|NCT04097028|Trifluridine|trifluridine|mesh-list
25395226|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395227|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
25395228|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395229|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
25395230|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395231|NCT04095715|Hemostatics|hemostatics|mesh-list
25395232|NCT04095715|Coagulants|coagulants|mesh-ancestor
25395233|NCT04095364|Paclitaxel|paclitaxel|mesh-list
25395234|NCT04095364|Carboplatin|carboplatin|mesh-list
25395235|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25395236|NCT04095364|Letrozole|letrozole|mesh-list
25395237|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395238|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395239|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395240|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395241|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395242|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395243|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25395244|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25395245|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395246|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25395247|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
25395248|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395249|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395250|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
25395251|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395252|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395253|NCT04094948|Clenbuterol|clenbuterol|mesh-list
25395254|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25395255|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25395256|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
25395257|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395258|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395259|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395260|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25395261|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
25395262|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395263|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25395264|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
25395265|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
25395266|NCT04094688|Vitamin D|vitamin d|mesh-list
25395267|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
25395268|NCT04094688|Leucovorin|leucovorin|mesh-list
25395269|NCT04094688|Bevacizumab|bevacizumab|mesh-list
25395270|NCT04094688|Fluorouracil|fluorouracil|mesh-list
25395271|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
25395272|NCT04094688|Irinotecan|irinotecan|mesh-list
25395273|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
25395274|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395275|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395276|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25395277|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25395278|NCT04094688|Growth Substances|growth substances|mesh-ancestor
25395279|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395280|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
25395281|NCT04094688|Vitamins|vitamins|mesh-ancestor
25395282|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
25395283|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25395284|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25395285|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
25395286|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395287|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395288|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395289|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
25395290|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25395291|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25395292|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395293|NCT04094688|Antidotes|antidotes|mesh-ancestor
25395294|NCT04094688|Protective Agents|protective agents|mesh-ancestor
25395295|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
25395296|NCT04094584|Naltrexone|naltrexone|mesh-list
25395297|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25395298|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25395299|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395300|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
25395301|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395302|NCT04094558|Lactulose|lactulose|mesh-list
25395330|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
25395331|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395332|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
25395333|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395334|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
25395335|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395336|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25395337|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25395338|NCT04093323|Analgesics|analgesics|mesh-ancestor
25395339|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
25395340|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395341|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395342|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395343|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25395344|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25395345|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395346|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395347|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25395376|NCT04092270|Doxorubicin|doxorubicin|mesh-list
25395377|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25395378|NCT04092270|Peposertib|peposertib|mesh-list
25395379|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25395380|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395608|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
25395381|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25395382|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25395383|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395384|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395385|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25395386|NCT04091880|Vaccines|vaccines|mesh-list
25395387|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
25395388|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395389|NCT04091386|Factor VIII|factor viii|mesh-list
25395390|NCT04091386|Coagulants|coagulants|mesh-ancestor
25395391|NCT04091217|Bevacizumab|bevacizumab|mesh-list
25395392|NCT04091217|Atezolizumab|atezolizumab|mesh-list
25395393|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395394|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395395|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25395396|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25395397|NCT04091217|Growth Substances|growth substances|mesh-ancestor
25395398|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395399|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
25395400|NCT04090736|Azacitidine|azacitidine|mesh-list
25395401|NCT04090736|Pevonedistat|pevonedistat|mesh-list
25395402|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395403|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
25395404|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395405|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395406|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395407|NCT04090398|Paclitaxel|paclitaxel|mesh-list
25395408|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25395409|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25395410|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395411|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395412|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395413|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395414|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395415|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395416|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
25395417|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25395418|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
25395419|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
25395420|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25395421|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395422|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25395423|NCT04089852|Analgesics|analgesics|mesh-ancestor
25395424|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
25395425|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395426|NCT04089553|Durvalumab|durvalumab|mesh-list
25395427|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395428|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395429|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
25395430|NCT04088864|Fludarabine|fludarabine|mesh-list
25395431|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395432|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
25395433|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395434|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395435|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395436|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
25395437|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395438|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395439|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25395440|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25395441|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25395442|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395443|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395444|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
25395445|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395446|NCT04088305|Vancomycin|vancomycin|mesh-list
25395447|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25395448|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395449|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
25395450|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
25395451|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25395452|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
25395453|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395454|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395455|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25395461|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395462|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395463|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25395464|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25395465|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25395466|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
25395467|NCT04086745|Adalimumab|adalimumab|mesh-list
25395468|NCT04086745|Etanercept|etanercept|mesh-list
25395469|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25395470|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395471|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395472|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25395473|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25395474|NCT04086745|Analgesics|analgesics|mesh-ancestor
25395475|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
25395476|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395477|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395478|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25395479|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395480|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
25395486|NCT04085315|Osimertinib|osimertinib|mesh-list
25395487|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395488|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25395489|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395490|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395491|NCT04085276|Paclitaxel|paclitaxel|mesh-list
25395492|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25395493|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395494|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395495|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395496|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395497|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395573|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395498|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395499|NCT04085172|Guanfacine|guanfacine|mesh-list
25395500|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25395501|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25395502|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25395503|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25395504|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395505|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
25395506|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395507|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395508|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25395509|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25395510|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25395511|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25395512|NCT04084951|Nivolumab|nivolumab|mesh-list
25395513|NCT04084951|Ipilimumab|ipilimumab|mesh-list
25395514|NCT04084951|Atezolizumab|atezolizumab|mesh-list
25395515|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395516|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395517|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25395518|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395519|NCT04084210|Nicotine|nicotine|mesh-list
25395520|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25395521|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
25395522|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395523|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395524|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25395525|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25395526|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
25395527|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395912|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395528|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395529|NCT04083898|Prednisone|prednisone|mesh-list
25395530|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25395531|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395532|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
25395533|NCT04083898|Hormones|hormones|mesh-ancestor
25395534|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395535|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395536|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25395537|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395538|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395539|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
25395540|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395541|NCT04083599|Gemcitabine|gemcitabine|mesh-list
25395542|NCT04083599|Paclitaxel|paclitaxel|mesh-list
25395543|NCT04083599|Cisplatin|cisplatin|mesh-list
25395544|NCT04083599|Carboplatin|carboplatin|mesh-list
25395545|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
25395546|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395547|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395548|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395549|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395550|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395551|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395552|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395553|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
25395554|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
25395555|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395556|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395557|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395558|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
25395559|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395560|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395561|NCT04083235|Leucovorin|leucovorin|mesh-list
25395562|NCT04083235|Gemcitabine|gemcitabine|mesh-list
25395563|NCT04083235|Paclitaxel|paclitaxel|mesh-list
25395564|NCT04083235|Fluorouracil|fluorouracil|mesh-list
25395565|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
25395566|NCT04083235|Irinotecan|irinotecan|mesh-list
25395567|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395568|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395569|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395570|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395571|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395572|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395574|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
25395575|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
25395576|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395577|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395578|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395579|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
25395580|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395581|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25395582|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25395583|NCT04083235|Antidotes|antidotes|mesh-ancestor
25395584|NCT04083235|Protective Agents|protective agents|mesh-ancestor
25395585|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
25395586|NCT04083235|Vitamins|vitamins|mesh-ancestor
25395587|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
25395588|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
25395589|NCT04083183|Sirolimus|sirolimus|mesh-list
25395590|NCT04083183|Vidarabine|vidarabine|mesh-list
25395591|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
25395592|NCT04083183|Fludarabine|fludarabine|mesh-list
25395593|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
25395594|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25395595|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
25395596|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25395597|NCT04083183|Antibodies|antibodies|mesh-list
25395598|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
25395599|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25395600|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
25395601|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25395602|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25395603|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395604|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
25395605|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395606|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395607|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395609|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395610|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395611|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25395612|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395613|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
25395614|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25395615|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25395616|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
25395617|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25395618|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395619|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395620|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
25395621|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
25395622|NCT04083170|Vidarabine|vidarabine|mesh-list
25395623|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
25395624|NCT04083170|Thiotepa|thiotepa|mesh-list
25395625|NCT04083170|Fludarabine|fludarabine|mesh-list
25395626|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
25395627|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395628|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
25395629|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395630|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395631|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395632|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
25395633|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395634|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395635|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25395636|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395637|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
25395638|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
25395639|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395640|NCT04082897|Atezolizumab|atezolizumab|mesh-list
25395641|NCT04082897|Venetoclax|venetoclax|mesh-list
25395642|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
25395643|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395644|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395645|NCT04082767|Midazolam|midazolam|mesh-list
25395646|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
25395647|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25395648|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25395649|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395650|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25395651|NCT04082767|Analgesics|analgesics|mesh-ancestor
25395652|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
25395653|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395654|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25395655|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25395656|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25395657|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
25395658|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395659|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395660|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25395661|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25395662|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25395663|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25395664|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25395665|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
25395666|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
25395667|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
25395668|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
25395669|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
25395670|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395671|NCT04082364|Trastuzumab|trastuzumab|mesh-list
25395672|NCT04082364|Margetuximab|margetuximab|mesh-list
25395673|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395674|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395675|NCT04081389|Interferons|interferons|mesh-list
25395676|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
25395677|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
25395678|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25395679|NCT04081389|Celecoxib|celecoxib|mesh-list
25395680|NCT04081389|Paclitaxel|paclitaxel|mesh-list
25395681|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
25395682|NCT04081389|Doxorubicin|doxorubicin|mesh-list
25395683|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25395684|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25395685|NCT04081389|Daunorubicin|daunorubicin|mesh-list
25395686|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
25395687|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395688|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395689|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395690|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395691|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395692|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395693|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395694|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
25395695|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395696|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395697|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395698|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
25395699|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25395700|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25395701|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25395702|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25395703|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395704|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
25395705|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395706|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25395707|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25395709|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
25395710|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395711|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395712|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25395713|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25395714|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25395715|NCT04081337|Tirzepatide|tirzepatide|mesh-list
25395716|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25395717|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395718|NCT04081337|Incretins|incretins|mesh-ancestor
25395719|NCT04081337|Hormones|hormones|mesh-ancestor
25395720|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395721|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25395722|NCT04080908|Hematinics|hematinics|mesh-ancestor
25395723|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25395724|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25395725|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25395726|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25395727|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25395728|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25395805|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395729|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395730|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
25395731|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395732|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395733|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25395734|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395735|NCT04080076|Tacrolimus|tacrolimus|mesh-list
25395736|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395737|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
25395738|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395739|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25395740|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395741|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395742|NCT04079686|Cefazolin|cefazolin|mesh-list
25395743|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25395744|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395745|NCT04079257|Eculizumab|eculizumab|mesh-list
25395746|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25395747|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395748|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
25395749|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395750|NCT04079192|Umirolimus|umirolimus|mesh-list
25395751|NCT04079192|Paclitaxel|paclitaxel|mesh-list
25395752|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395753|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395754|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
25395755|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
25395756|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
25395757|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395758|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395759|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395760|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
25395761|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395762|NCT04078152|Durvalumab|durvalumab|mesh-list
25395763|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395764|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395765|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
25395766|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395767|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395768|NCT04077515|Sirolimus|sirolimus|mesh-list
25395769|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25395770|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395771|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25395772|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395773|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
25395774|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395775|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
25395776|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395777|NCT04077463|Carboplatin|carboplatin|mesh-list
25395778|NCT04077463|Pemetrexed|pemetrexed|mesh-list
25395779|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25395780|NCT04077463|Lazertinib|lazertinib|mesh-list
25395781|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395782|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395783|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395784|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25395785|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25395786|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25395787|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395788|NCT04077190|Cortisone|cortisone|mesh-list
25395789|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395790|NCT04076462|Octreotide|octreotide|mesh-list
25395791|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25395792|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25395793|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395794|NCT04076059|Androgens|androgens|mesh-list
25395795|NCT04076059|Hormones|hormones|mesh-ancestor
25395796|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395797|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395798|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25395799|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
25395800|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395801|NCT04075747|Venetoclax|venetoclax|mesh-list
25395802|NCT04075747|Midostaurin|midostaurin|mesh-list
25395803|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395804|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25395806|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395808|NCT04075604|Palbociclib|palbociclib|mesh-list
25395809|NCT04075604|Anastrozole|anastrozole|mesh-list
25395810|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395811|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395812|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25395813|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395814|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25395815|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395816|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25395817|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25395818|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25395819|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25395820|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
25395821|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395822|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395823|NCT04075396|Lazertinib|lazertinib|mesh-list
25395824|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25395825|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395826|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395827|NCT04075292|Rituximab|rituximab|mesh-list
25395828|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
25395829|NCT04075292|Chlorambucil|chlorambucil|mesh-list
25395830|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395831|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395832|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
25395833|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395834|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395835|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395836|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
25396295|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
25395837|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395838|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
25395839|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
25395840|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395841|NCT04075240|Aspirin|aspirin|mesh-list
25395842|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
25395843|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25395844|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25395845|NCT04075240|Analgesics|analgesics|mesh-ancestor
25395846|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
25395847|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395848|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395849|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395850|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395851|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25395852|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25395853|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395854|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25395855|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25395856|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395857|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
25395858|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25395859|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
25395860|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25395861|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
25395862|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
25395863|NCT04075149|Spironolactone|spironolactone|mesh-list
25395864|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25395865|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
25395866|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395867|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395868|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25395869|NCT04075149|Diuretics|diuretics|mesh-ancestor
25395870|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
25395871|NCT04075136|Triamcinolone|triamcinolone|mesh-list
25395872|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25395873|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25395874|NCT04075136|Ranibizumab|ranibizumab|mesh-list
25395875|NCT04075136|Verteporfin|verteporfin|mesh-list
25395876|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25395877|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25395878|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25395879|NCT04075136|Growth Substances|growth substances|mesh-ancestor
25395880|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395881|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
25395882|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395883|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395884|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
25395885|NCT04075136|Hormones|hormones|mesh-ancestor
25395886|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395887|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395888|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
25395889|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395890|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395891|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25395892|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
25395893|NCT04075110|Montelukast|montelukast|mesh-list
25395894|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25395895|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25395896|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25395897|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
25395898|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395899|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395900|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25395901|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25395902|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395903|NCT04074746|Vidarabine|vidarabine|mesh-list
25395904|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
25395905|NCT04074746|Fludarabine|fludarabine|mesh-list
25395906|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
25395907|NCT04074746|Antibodies|antibodies|mesh-list
25395908|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25395909|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395910|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
25395911|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395913|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25395914|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
25395915|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395916|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395917|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25395918|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395919|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
25395920|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
25395921|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395922|NCT04074330|Rituximab|rituximab|mesh-list
25395923|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395924|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395925|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
25395926|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395927|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395928|NCT04073316|Warfarin|warfarin|mesh-list
25395929|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
25395930|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
25395931|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25395932|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
25395933|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25395934|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
25395935|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395936|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395937|NCT04072835|Etripamil|etripamil|mesh-list
25395938|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25395939|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25395940|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395941|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25395942|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395943|NCT04072822|Prednisone|prednisone|mesh-list
25395944|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25395945|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25395946|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
25395947|NCT04072822|Hormones|hormones|mesh-ancestor
25395948|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25395949|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395950|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25395951|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395956|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25395957|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25395958|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395959|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395960|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395961|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25395962|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
25395963|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
25395964|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395965|NCT04071236|Avelumab|avelumab|mesh-list
25395966|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25395967|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25395968|NCT04071236|Peposertib|peposertib|mesh-list
25395969|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395970|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395971|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
25395972|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395973|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25395974|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395975|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395978|NCT04070833|Vitamin D|vitamin d|mesh-list
25395979|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
25395980|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
25395981|NCT04070833|Vitamins|vitamins|mesh-list
25395982|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
25395983|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395984|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25395985|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25395986|NCT04069936|Nivolumab|nivolumab|mesh-list
25395987|NCT04069936|Tadalafil|tadalafil|mesh-list
25395988|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25395989|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395990|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25395991|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395992|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
25395993|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25395994|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25395995|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395996|NCT04069936|Urological Agents|urological agents|mesh-ancestor
25395997|NCT04069273|Paclitaxel|paclitaxel|mesh-list
25395998|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
25395999|NCT04069273|Ramucirumab|ramucirumab|mesh-list
25396000|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25396001|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396002|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
25396003|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
25396004|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
25396005|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396006|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396007|NCT04069156|Aspirin|aspirin|mesh-list
25396008|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25396009|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25396010|NCT04069156|Analgesics|analgesics|mesh-ancestor
25396011|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
25396012|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396013|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396014|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25396015|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25396016|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25396017|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25396018|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396019|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25396020|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25396021|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396022|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
25396023|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
25396024|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25396025|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
25396026|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396027|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427009|NCT01942135|Fulvestrant|fulvestrant|mesh-list
25396028|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25396029|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
25396030|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25396032|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396033|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396034|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25396035|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
25396036|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
25396037|NCT04069052|Protective Agents|protective agents|mesh-ancestor
25396038|NCT04068610|Leucovorin|leucovorin|mesh-list
25396039|NCT04068610|Durvalumab|durvalumab|mesh-list
25396040|NCT04068610|Fluorouracil|fluorouracil|mesh-list
25396041|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
25396042|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396043|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396044|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396045|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
25396046|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396047|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396048|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396049|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
25396050|NCT04068610|Antidotes|antidotes|mesh-ancestor
25396051|NCT04068610|Protective Agents|protective agents|mesh-ancestor
25396052|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
25396053|NCT04068610|Vitamins|vitamins|mesh-ancestor
25396054|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
25396055|NCT04068597|Dexamethasone|dexamethasone|mesh-list
25396056|NCT04068597|Azacitidine|azacitidine|mesh-list
25396057|NCT04068597|Venetoclax|venetoclax|mesh-list
25396058|NCT04068597|Pomalidomide|pomalidomide|mesh-list
25396059|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25396060|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
25396061|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
25396062|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396063|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396064|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25396065|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
25396066|NCT04068597|Hormones|hormones|mesh-ancestor
25396067|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396068|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396069|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396070|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396071|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
25396072|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396073|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396074|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
25396075|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25396076|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25396077|NCT04068597|Growth Substances|growth substances|mesh-ancestor
25396078|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
25396079|NCT04068194|Avelumab|avelumab|mesh-list
25396080|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25396081|NCT04068194|Peposertib|peposertib|mesh-list
25396082|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396083|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396084|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
25396085|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396086|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25396087|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396088|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396089|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
25396090|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25396091|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396092|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396093|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
25396094|NCT04068103|Leucovorin|leucovorin|mesh-list
25396095|NCT04068103|Folic Acid|folic acid|mesh-list
25396096|NCT04068103|Fluorouracil|fluorouracil|mesh-list
25396097|NCT04068103|Capecitabine|capecitabine|mesh-list
25396098|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
25396099|NCT04068103|Calcium|calcium|mesh-list
25396100|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
25396101|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25396102|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396103|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25396104|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
25772326|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25396105|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396106|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396107|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396108|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396109|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
25396111|NCT04068103|Protective Agents|protective agents|mesh-ancestor
25396112|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
25396113|NCT04068103|Vitamins|vitamins|mesh-ancestor
25396114|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
25396115|NCT04068103|Hematinics|hematinics|mesh-ancestor
25396116|NCT04067518|Pegaspargase|pegaspargase|mesh-list
25396117|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396118|NCT04067115|Alovudine|alovudine|mesh-list
25396119|NCT04067115|Irinotecan|irinotecan|mesh-list
25396120|NCT04067115|Trabectedin|trabectedin|mesh-list
25396121|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25396122|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396123|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396124|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396125|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396126|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25396127|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
25396128|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
25396129|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396130|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25396131|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396132|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396133|NCT04066764|Nadroparin|nadroparin|mesh-list
25396134|NCT04066764|Warfarin|warfarin|mesh-list
25396135|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
25396136|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
25396137|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25396138|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
25396139|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25396140|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
25396141|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396142|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396143|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25396144|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25396145|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
25396146|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
25396147|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396148|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396149|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396150|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
25396151|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
25396152|NCT04065555|Cetuximab|cetuximab|mesh-list
25396153|NCT04065555|Avelumab|avelumab|mesh-list
25396154|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25396155|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396156|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396157|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
25396158|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396159|NCT04065399|Cobicistat|cobicistat|mesh-list
25396160|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25396161|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25396162|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
25396163|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396164|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25396165|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25396166|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396167|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396168|NCT04064060|Luspatercept|luspatercept|mesh-list
25396169|NCT04064060|Hematinics|hematinics|mesh-ancestor
25396170|NCT04063267|Nicotine|nicotine|mesh-list
25396171|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25396172|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
25396173|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396174|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396175|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25396176|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25396177|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
25396178|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396179|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396180|NCT04062669|Vaccines|vaccines|mesh-list
25396181|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
25396182|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396184|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396185|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396186|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
25396187|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396188|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25396189|NCT04062266|Azacitidine|azacitidine|mesh-list
25396190|NCT04062266|Venetoclax|venetoclax|mesh-list
25396191|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396192|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
25396193|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396194|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396195|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396196|NCT04062123|Fentanyl|fentanyl|mesh-list
25396197|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
25396198|NCT04062123|Propofol|propofol|mesh-list
25396199|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25396200|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25396201|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396202|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25396203|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
25396204|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
25396205|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25396206|NCT04062123|Analgesics|analgesics|mesh-ancestor
25396207|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
25396208|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396209|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25396210|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25396211|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25396212|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
25396213|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396214|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396215|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25396216|NCT04062123|Narcotics|narcotics|mesh-ancestor
25396217|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25396218|NCT04061980|Nivolumab|nivolumab|mesh-list
25396219|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396220|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396221|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396222|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396223|NCT04061239|Cytarabine|cytarabine|mesh-list
25396224|NCT04061239|Azacitidine|azacitidine|mesh-list
25396225|NCT04061239|Daunorubicin|daunorubicin|mesh-list
25396226|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396227|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
25396228|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396229|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396230|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
25396231|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396232|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396233|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
25396234|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396235|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396236|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25396237|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25396238|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396239|NCT04060862|Fulvestrant|fulvestrant|mesh-list
25396240|NCT04060862|Palbociclib|palbociclib|mesh-list
25396241|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396242|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396243|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25396244|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25396245|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
25396246|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396247|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396248|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25396249|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396250|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396251|NCT04060849|Ethanol|ethanol|mesh-list
25396252|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25396253|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25396254|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396255|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25396256|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396257|NCT04060394|Prednisone|prednisone|mesh-list
25396258|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25396259|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
25396260|NCT04060394|Hormones|hormones|mesh-ancestor
25396261|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396262|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396263|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396264|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396265|NCT04060342|Gemcitabine|gemcitabine|mesh-list
25396266|NCT04060342|Paclitaxel|paclitaxel|mesh-list
25396267|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
25396268|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25396269|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396270|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
25396271|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
25396272|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
25396273|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396274|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396275|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
25396276|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
25396277|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396278|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396279|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396280|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
25396281|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396282|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396283|NCT04060277|Acetic Acid|acetic acid|mesh-list
25396284|NCT04060277|Letermovir|letermovir|mesh-list
25396285|NCT04060277|Vaccines|vaccines|mesh-list
25396286|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
25396287|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396288|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25396289|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396290|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396291|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396292|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396293|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25396294|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
25396299|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25396300|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396301|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25396302|NCT04060030|Antidotes|antidotes|mesh-ancestor
25396303|NCT04060030|Protective Agents|protective agents|mesh-ancestor
25396304|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
25396305|NCT04060030|Vitamins|vitamins|mesh-ancestor
25396306|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
25396307|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
25396308|NCT04060017|Leucovorin|leucovorin|mesh-list
25396309|NCT04060017|Calcium|calcium|mesh-list
25396310|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
25396311|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25396312|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396313|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25396314|NCT04060017|Antidotes|antidotes|mesh-ancestor
25396315|NCT04060017|Protective Agents|protective agents|mesh-ancestor
25396316|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
25396317|NCT04060017|Vitamins|vitamins|mesh-ancestor
25396318|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
25396319|NCT04058756|Spartalizumab|spartalizumab|mesh-list
25396320|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396321|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396322|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396323|NCT04058678|Danazol|danazol|mesh-list
25396324|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25396325|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
25396326|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396327|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396328|NCT04058366|Ivacaftor|ivacaftor|mesh-list
25396329|NCT04058366|Elexacaftor|elexacaftor|mesh-list
25396330|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25396331|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25396332|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396333|NCT04058067|Aflibercept|aflibercept|mesh-list
25396334|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25396340|NCT04058054|Histamine|histamine|mesh-list
25396341|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
25396342|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
25396343|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396344|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396345|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396346|NCT04057898|Ibudilast|ibudilast|mesh-list
25396347|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25396348|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
25396349|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396350|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396351|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25396352|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
25396353|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25396354|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396355|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396356|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25396357|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
25396358|NCT04055909|Nangibotide|nangibotide|mesh-list
25396359|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25396360|NCT04055428|Valsartan|valsartan|mesh-list
25396361|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25396362|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25396363|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25396364|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25396365|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396374|NCT04053712|Glucagon|glucagon|mesh-list
25396375|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25396376|NCT04053712|Hormones|hormones|mesh-ancestor
25396377|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396378|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396379|NCT04053634|Benralizumab|benralizumab|mesh-list
25396380|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25396381|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
25396382|NCT04052568|Psilocybin|psilocybin|mesh-list
25396383|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
25396384|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396385|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25396386|NCT04051957|Isosorbide|isosorbide|mesh-list
25396387|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25396388|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25396389|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25396390|NCT04051957|Diuretics|diuretics|mesh-ancestor
25396391|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
25396392|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396393|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
25396394|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25396395|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396396|NCT04051619|Oxytocin|oxytocin|mesh-list
25396397|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
25396398|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25396399|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396400|NCT04051320|Leuprolide|leuprolide|mesh-list
25396401|NCT04051320|Estradiol|estradiol|mesh-list
25396402|NCT04051320|Progesterone|progesterone|mesh-list
25396403|NCT04051320|Estrogens|estrogens|mesh-ancestor
25396404|NCT04051320|Hormones|hormones|mesh-ancestor
25396405|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396406|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396407|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25396408|NCT04051320|Progestins|progestins|mesh-ancestor
25396409|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25396410|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
25396411|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396412|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427397|NCT01896999|Nivolumab|nivolumab|mesh-list
25396413|NCT04050436|Cemiplimab|cemiplimab|mesh-list
25396414|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396415|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396416|NCT04049851|Ivermectin|ivermectin|mesh-list
25396417|NCT04049851|Moxidectin|moxidectin|mesh-list
25396418|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25396419|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396420|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
25396421|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
25396422|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
25396423|NCT04049669|Temozolomide|temozolomide|mesh-list
25396424|NCT04049669|Lomustine|lomustine|mesh-list
25396425|NCT04049669|Etoposide|etoposide|mesh-list
25396426|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396427|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
25396428|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396429|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25396430|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25396431|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
25396432|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396433|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396434|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25396435|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25396436|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25396437|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396438|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396439|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
25396440|NCT04049331|Testosterone|testosterone|mesh-list
25396441|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
25396442|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
25396443|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25396444|NCT04049331|Androgens|androgens|mesh-ancestor
25396445|NCT04049331|Hormones|hormones|mesh-ancestor
25396446|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396447|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396448|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396449|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396457|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25396458|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
25396459|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396460|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396461|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25396462|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25396463|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
25396464|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396465|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396473|NCT04047446|Dexamethasone|dexamethasone|mesh-list
25396474|NCT04047446|Bupivacaine|bupivacaine|mesh-list
25396475|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25396476|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
25396477|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
25396478|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396479|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396480|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25396481|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
25396483|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396484|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396485|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396486|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
25396487|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
25396715|NCT04036188|Vitamin D|vitamin d|mesh-list
25396488|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25396489|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
25396490|NCT04046744|Lidocaine|lidocaine|mesh-list
25396491|NCT04046744|Analgesics|analgesics|mesh-list
25396492|NCT04046744|Ropivacaine|ropivacaine|mesh-list
25396493|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
25396494|NCT04046744|Anesthetics|anesthetics|mesh-list
25396495|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25396496|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396497|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
25396498|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396499|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25396500|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25396501|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772327|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25396508|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396509|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
25396510|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396511|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25396512|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
25396513|NCT04046263|Hematinics|hematinics|mesh-ancestor
25396514|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
25396515|NCT04046094|Vitamins|vitamins|mesh-ancestor
25396516|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
25396517|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396518|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
25396519|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396520|NCT04046094|Protective Agents|protective agents|mesh-ancestor
25396521|NCT04045665|Anticoagulants|anticoagulants|mesh-list
25396522|NCT04045613|Atezolizumab|atezolizumab|mesh-list
25396523|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25396524|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396525|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
25396526|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396535|NCT04044859|Nivolumab|nivolumab|mesh-list
25396536|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396537|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396538|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396539|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396540|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
25396541|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25396542|NCT04044690|Antibodies|antibodies|mesh-list
25396543|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
25396544|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
25396545|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396546|NCT04044222|Carboplatin|carboplatin|mesh-list
25396547|NCT04044222|Etoposide|etoposide|mesh-list
25396548|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
25396549|NCT04044222|Ifosfamide|ifosfamide|mesh-list
25396550|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
25396551|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396552|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25396553|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25396554|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396555|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396556|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396557|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25396558|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
25396559|NCT04044131|Sorbitol|sorbitol|mesh-list
25396560|NCT04044131|Cathartics|cathartics|mesh-ancestor
25396561|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25396562|NCT04044001|Isoniazid|isoniazid|mesh-list
25396563|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
25396564|NCT04044001|Ethambutol|ethambutol|mesh-list
25396565|NCT04044001|Dolutegravir|dolutegravir|mesh-list
25396566|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
25396567|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25396568|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396569|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396570|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396571|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25396572|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25396573|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
25396574|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25396575|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25396576|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25396577|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25396578|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25396579|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
25396594|NCT04041973|Artemether|artemether|mesh-list
25396595|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25396596|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
25396597|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25396598|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25396599|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396615|NCT04040621|Ceftazidime|ceftazidime|mesh-list
25396616|NCT04040621|Avibactam|avibactam|mesh-list
25396617|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25396618|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25396619|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396620|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25396621|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396622|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396623|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
25396624|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25396625|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25396626|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396627|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25396628|NCT04040439|Analgesics|analgesics|mesh-ancestor
25396629|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
25396630|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396631|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25396632|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25396633|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25396634|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
25396635|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396636|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396637|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25396638|NCT04039750|Clindamycin|clindamycin|mesh-list
25396639|NCT04039750|Gentamicins|gentamicins|mesh-list
25396640|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396641|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25396642|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396643|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396644|NCT04039607|Nivolumab|nivolumab|mesh-list
25396645|NCT04039607|Ipilimumab|ipilimumab|mesh-list
25396646|NCT04039607|Sorafenib|sorafenib|mesh-list
25396647|NCT04039607|Lenvatinib|lenvatinib|mesh-list
25396648|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396649|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396650|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396651|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396652|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25772328|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396653|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396654|NCT04039464|Bosentan|bosentan|mesh-list
25396655|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
25396656|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
25396657|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25396658|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25396659|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396660|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396661|NCT04039464|Urological Agents|urological agents|mesh-ancestor
25396662|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25396663|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25396664|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
25396665|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
25396666|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25396667|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25396668|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396669|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396670|NCT04039087|Urological Agents|urological agents|mesh-ancestor
25396671|NCT04038437|Venetoclax|venetoclax|mesh-list
25396672|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396673|NCT04037527|Gemcitabine|gemcitabine|mesh-list
25396674|NCT04037527|Docetaxel|docetaxel|mesh-list
25396675|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396676|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
25397280|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
25396677|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396678|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396679|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
25396680|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396681|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396682|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396683|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
25396684|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396685|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
25396686|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
25396687|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
25396688|NCT04037254|Niraparib|niraparib|mesh-list
25396689|NCT04037254|Hormones|hormones|mesh-list
25396690|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25396691|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25396692|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396693|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396694|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25396695|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396696|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396697|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396698|NCT04037176|Omalizumab|omalizumab|mesh-list
25396699|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25396700|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25396701|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
25396702|NCT04036305|Lidocaine|lidocaine|mesh-list
25396703|NCT04036305|Bupivacaine|bupivacaine|mesh-list
25396704|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
25396705|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
25396706|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25396707|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396708|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
25396709|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396710|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25396711|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25396712|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25396713|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25396714|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396716|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
25396717|NCT04036188|Triamcinolone|triamcinolone|mesh-list
25396718|NCT04036188|Vitamins|vitamins|mesh-ancestor
25396719|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
25396720|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396721|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25396722|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25396723|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25396724|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
25396725|NCT04036188|Hormones|hormones|mesh-ancestor
25396726|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396727|NCT04035278|Vaccines|vaccines|mesh-list
25396728|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
25396729|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396731|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25396732|NCT04034927|Tremelimumab|tremelimumab|mesh-list
25396733|NCT04034927|Ipilimumab|ipilimumab|mesh-list
25396734|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396735|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396736|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396737|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396738|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396739|NCT04034095|Prednisolone|prednisolone|mesh-list
25396740|NCT04034095|Docetaxel|docetaxel|mesh-list
25396741|NCT04034095|Bicalutamide|bicalutamide|mesh-list
25396742|NCT04034095|Androgens|androgens|mesh-list
25396743|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396744|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
25396745|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
25396746|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
25396747|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396748|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25396749|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
25396750|NCT04034095|Hormones|hormones|mesh-ancestor
25396751|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397281|NCT04008030|Irinotecan|irinotecan|mesh-list
25396752|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396753|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396754|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
25396755|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
25396756|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
25396757|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396758|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396759|NCT04033575|Listerine|listerine|mesh-list
25396760|NCT04033575|Fluorides|fluorides|mesh-list
25396761|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
25396762|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
25396763|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
25396764|NCT04033575|Protective Agents|protective agents|mesh-ancestor
25396765|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396766|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25396767|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396768|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
25396769|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396770|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396771|NCT04032119|Epinephrine|epinephrine|mesh-list
25396772|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25396773|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25396774|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
25396775|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396776|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396777|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396778|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25396779|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25396780|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
25396781|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396782|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25396783|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
25396784|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
25396785|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
25396786|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25396787|NCT04032067|Finasteride|finasteride|mesh-list
25396788|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25396789|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25396790|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396791|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396792|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
25396793|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396794|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396795|NCT04032067|Urological Agents|urological agents|mesh-ancestor
25396796|NCT04031833|Amphotericin B|amphotericin b|mesh-list
25396797|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25396798|NCT04031833|Amebicides|amebicides|mesh-ancestor
25396799|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25396800|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25396801|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396802|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25396803|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
25396805|NCT04030455|Carboplatin|carboplatin|mesh-list
25396806|NCT04030455|Docetaxel|docetaxel|mesh-list
25396807|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
25396808|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396809|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
25396810|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
25396811|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
25396812|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396813|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396814|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25396815|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
25396816|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396817|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25396818|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
25396819|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396820|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396821|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25396822|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25396823|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25396824|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
25396825|NCT04030026|Nalbuphine|nalbuphine|mesh-list
25396826|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25396827|NCT04030026|Narcotics|narcotics|mesh-ancestor
25396828|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25396829|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396830|NCT04030026|Analgesics|analgesics|mesh-ancestor
25396831|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
25396832|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25396833|NCT04029688|Cytarabine|cytarabine|mesh-list
25396834|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
25396835|NCT04029688|Fludarabine|fludarabine|mesh-list
25396836|NCT04029688|Topotecan|topotecan|mesh-list
25396837|NCT04029688|Venetoclax|venetoclax|mesh-list
25396838|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396839|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
25396840|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396841|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25396842|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25396843|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
25396844|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396845|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396846|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25396847|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396848|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
25396849|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
25396850|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396851|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25396852|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396853|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396854|NCT04029480|Metformin|metformin|mesh-list
25396855|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
25396856|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25396857|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396858|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25396859|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396860|NCT04028050|Carboplatin|carboplatin|mesh-list
25396861|NCT04028050|Etoposide|etoposide|mesh-list
25396862|NCT04028050|Atezolizumab|atezolizumab|mesh-list
25396863|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396864|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25396865|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25396866|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396867|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396868|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396869|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
25396870|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396871|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396872|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
25396873|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25396874|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25396875|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396876|NCT04026412|Nivolumab|nivolumab|mesh-list
25396877|NCT04026412|Ipilimumab|ipilimumab|mesh-list
25396878|NCT04026412|Durvalumab|durvalumab|mesh-list
25396879|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396880|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396881|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396882|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396883|NCT04026256|Denosumab|denosumab|mesh-list
25396884|NCT04026256|Teriparatide|teriparatide|mesh-list
25396885|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25396886|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396887|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25396888|NCT04026113|Linaclotide|linaclotide|mesh-list
25396889|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25396890|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
25396891|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396892|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25396893|NCT04025879|Paclitaxel|paclitaxel|mesh-list
25396894|NCT04025879|Docetaxel|docetaxel|mesh-list
25396895|NCT04025879|Cisplatin|cisplatin|mesh-list
25396896|NCT04025879|Carboplatin|carboplatin|mesh-list
25396897|NCT04025879|Nivolumab|nivolumab|mesh-list
25396898|NCT04025879|Pemetrexed|pemetrexed|mesh-list
25396899|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25396900|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396901|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
25396902|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
25396903|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397358|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
25396904|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396905|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396906|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396907|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396908|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25396909|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25396910|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25396911|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25396913|NCT04025489|Vitamins|vitamins|mesh-ancestor
25396914|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
25396915|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396916|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25396917|NCT04024891|Phentolamine|phentolamine|mesh-list
25396918|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25396919|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25396920|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25396921|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25396922|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
25396923|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396924|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396925|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396926|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25396927|NCT04024696|Abexinostat|abexinostat|mesh-list
25396928|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25396929|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396930|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396931|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
25396932|NCT04024462|Docetaxel|docetaxel|mesh-list
25396933|NCT04024462|Doxorubicin|doxorubicin|mesh-list
25396934|NCT04024462|Trastuzumab|trastuzumab|mesh-list
25396935|NCT04024462|Pertuzumab|pertuzumab|mesh-list
25396936|NCT04024462|Hormones|hormones|mesh-list
25396937|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25396938|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
25396939|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396940|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25396941|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25396942|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
25396943|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396944|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396945|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25396946|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
25396947|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25396948|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25396949|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25396950|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25396951|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396952|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396953|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396954|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396956|NCT04024436|Futibatinib|futibatinib|mesh-list
25396957|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25396958|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396959|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25396960|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25396961|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
25396962|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25396963|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396964|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25396965|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396966|NCT04023526|Azacitidine|azacitidine|mesh-list
25396967|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25396968|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
25396969|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396970|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396971|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396972|NCT04023227|Valsartan|valsartan|mesh-list
25396973|NCT04023227|Enalapril|enalapril|mesh-list
25396974|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25396975|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25396976|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25396977|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25396978|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396979|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25396980|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
25396981|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396982|NCT04023110|Carvedilol|carvedilol|mesh-list
25396983|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25396984|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25396985|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25396986|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396987|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396988|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396989|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25396990|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
25396991|NCT04023110|Protective Agents|protective agents|mesh-ancestor
25396992|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25396993|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25396994|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25396995|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
25396996|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25396997|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25396998|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
25396999|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25397000|NCT04023071|Rituximab|rituximab|mesh-list
25397001|NCT04023071|Fludarabine|fludarabine|mesh-list
25397002|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
25397003|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397004|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
25397005|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397006|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397007|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397008|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
25397009|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397010|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397011|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397012|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397013|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
25397014|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
25397015|NCT04022239|Melphalan|melphalan|mesh-list
25397016|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25397017|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
25397018|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25397019|NCT04022239|Rituximab|rituximab|mesh-list
25397020|NCT04022239|Fludarabine|fludarabine|mesh-list
25397021|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25397022|NCT04022239|Tacrolimus|tacrolimus|mesh-list
25397023|NCT04022239|Antibodies|antibodies|mesh-list
25397024|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
25397025|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397026|NCT04022239|Lenograstim|lenograstim|mesh-list
25397027|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397028|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
25397029|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397030|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397031|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397032|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
25397033|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397034|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397035|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397036|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25397037|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397038|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25397039|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25397040|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25397041|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
25397042|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25397043|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397044|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25397045|NCT04021043|Nivolumab|nivolumab|mesh-list
25397046|NCT04021043|Ipilimumab|ipilimumab|mesh-list
25397047|NCT04021043|Antibodies|antibodies|mesh-list
25397048|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
25397049|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397050|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
25397051|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397052|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397053|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25397054|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397055|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
25397056|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25397057|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397058|NCT04020341|Renal Agents|renal agents|mesh-ancestor
25397059|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25397060|NCT04019834|Bupivacaine|bupivacaine|mesh-list
25397061|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
25397062|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
25397063|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397064|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397065|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
25397066|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397067|NCT04019327|Temozolomide|temozolomide|mesh-list
25397068|NCT04019327|Talazoparib|talazoparib|mesh-list
25397069|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397070|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
25397071|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397072|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397073|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25397074|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397075|NCT04019288|Durvalumab|durvalumab|mesh-list
25397076|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
25397077|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397078|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
25397079|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397080|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397081|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
25397082|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397083|NCT04018937|Fludarabine|fludarabine|mesh-list
25397084|NCT04018937|Melphalan|melphalan|mesh-list
25397085|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
25397086|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397087|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397088|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397089|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
25397090|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397091|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397092|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
25397093|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397627|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
25397094|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397095|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25397096|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397097|NCT04018105|Metformin|metformin|mesh-list
25397098|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25397099|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397100|NCT04017962|Letermovir|letermovir|mesh-list
25397101|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25397102|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397103|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397104|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397105|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
25397106|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397107|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25397109|NCT04017650|Cetuximab|cetuximab|mesh-list
25397110|NCT04017650|Antibodies|antibodies|mesh-list
25397111|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
25397112|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397113|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
25397114|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397115|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397116|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25397117|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397118|NCT04017013|Lidocaine|lidocaine|mesh-list
25397119|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
25397120|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
25397121|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397122|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397123|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
25397124|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397125|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25397126|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25397127|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25397128|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25397129|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397131|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
25397132|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397133|NCT04015739|Bevacizumab|bevacizumab|mesh-list
25397134|NCT04015739|Durvalumab|durvalumab|mesh-list
25397135|NCT04015739|Olaparib|olaparib|mesh-list
25397136|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397137|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397138|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25397139|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25397140|NCT04015739|Growth Substances|growth substances|mesh-ancestor
25397141|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397142|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
25397143|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25397144|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397145|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397146|NCT04015700|Coal Tar|coal tar|mesh-list
25397147|NCT04015700|Vaccines|vaccines|mesh-list
25397148|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
25397149|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397150|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
25397151|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
25397152|NCT04015180|Aflibercept|aflibercept|mesh-list
25397153|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25397154|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25397155|NCT04015180|Growth Substances|growth substances|mesh-ancestor
25397156|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397157|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
25397158|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397159|NCT04014075|Trastuzumab|trastuzumab|mesh-list
25397160|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397161|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397162|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
25397163|NCT04013672|Sargramostim|sargramostim|mesh-list
25397164|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25397165|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397166|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397167|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
25397168|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397703|NCT03989414|Bortezomib|bortezomib|mesh-list
25397169|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25397171|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25397172|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25397173|NCT04012996|Analgesics|analgesics|mesh-ancestor
25397174|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
25397175|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397176|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397177|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397178|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397179|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25397180|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25397181|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397182|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397183|NCT04012931|Rilpivirine|rilpivirine|mesh-list
25397184|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25397185|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25397186|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397187|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397188|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
25397189|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397190|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25397191|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25397192|NCT04012827|Doxorubicin|doxorubicin|mesh-list
25397193|NCT04012827|Apatinib|apatinib|mesh-list
25397194|NCT04012827|Ifosfamide|ifosfamide|mesh-list
25397195|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25397196|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397197|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25397198|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397199|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397200|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397201|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397202|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397203|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
25397204|NCT04011748|Minoxidil|minoxidil|mesh-list
25397205|NCT04011748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25397206|NCT04011748|Vasodilator Agents|vasodilator agents|mesh-ancestor
25397207|NCT04011163|Morphine|morphine|mesh-list
25397208|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25397209|NCT04011163|Narcotics|narcotics|mesh-ancestor
25397210|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397211|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397212|NCT04011163|Analgesics|analgesics|mesh-ancestor
25397213|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
25397214|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397215|NCT04010968|Venetoclax|venetoclax|mesh-list
25397216|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397217|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
25397218|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25397219|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397220|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397221|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25397222|NCT04010305|Analgesics|analgesics|mesh-ancestor
25397223|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
25397224|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397225|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25397226|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25397227|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25397228|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
25397229|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397230|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397231|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
25397232|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397233|NCT04009668|Adalimumab|adalimumab|mesh-list
25397234|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397235|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397236|NCT04009109|Dexamethasone|dexamethasone|mesh-list
25397237|NCT04009109|Lenalidomide|lenalidomide|mesh-list
25397238|NCT04009109|Daratumumab|daratumumab|mesh-list
25397239|NCT04009109|Ixazomib|ixazomib|mesh-list
25397240|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397241|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
25397242|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
25397243|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397244|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397245|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25397246|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
25397247|NCT04009109|Hormones|hormones|mesh-ancestor
25397248|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397249|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25397250|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397251|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
25397252|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25397253|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25397254|NCT04009109|Growth Substances|growth substances|mesh-ancestor
25397255|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
25397256|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
25397257|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397258|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397259|NCT04008264|Scopolamine|scopolamine|mesh-list
25397260|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25397261|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25397262|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
25397263|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
25397264|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397265|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397266|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25397267|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
25397268|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25397269|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
25397270|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397271|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397272|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25397273|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
25397274|NCT04008030|Leucovorin|leucovorin|mesh-list
25397275|NCT04008030|Bevacizumab|bevacizumab|mesh-list
25397276|NCT04008030|Nivolumab|nivolumab|mesh-list
25397277|NCT04008030|Cetuximab|cetuximab|mesh-list
25397278|NCT04008030|Ipilimumab|ipilimumab|mesh-list
25397279|NCT04008030|Fluorouracil|fluorouracil|mesh-list
25397282|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397283|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397284|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25397285|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25397286|NCT04008030|Growth Substances|growth substances|mesh-ancestor
25397287|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397288|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
25397289|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
25397290|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397291|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397292|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397293|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
25397294|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25397295|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25397296|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397297|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397298|NCT04008030|Antidotes|antidotes|mesh-ancestor
25397299|NCT04008030|Protective Agents|protective agents|mesh-ancestor
25397300|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
25397302|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
25397303|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
25397304|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397305|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397306|NCT04007393|Topiramate|topiramate|mesh-list
25397307|NCT04007393|Phentermine|phentermine|mesh-list
25397308|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
25397309|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25397310|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397311|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25397312|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
25397313|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25397314|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
25397315|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
25397316|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397317|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
25397318|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397319|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397320|NCT04007224|Oxytocin|oxytocin|mesh-list
25397321|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
25397322|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25397323|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397324|NCT04007055|Ticagrelor|ticagrelor|mesh-list
25397325|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25397326|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25397327|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25397328|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25397329|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
25397330|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397331|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397332|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397334|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
25397335|NCT04007029|Fludarabine|fludarabine|mesh-list
25397336|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
25397337|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
25397338|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
25397339|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397340|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
25397341|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397342|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397343|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397344|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
25397345|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397346|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397347|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397348|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397349|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
25397350|NCT04007029|Antiviral Agents|antiviral agents|mesh-ancestor
25397351|NCT04007029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397352|NCT04006522|Atezolizumab|atezolizumab|mesh-list
25397353|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397354|NCT04006457|Vaccines|vaccines|mesh-list
25397355|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
25397356|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397357|NCT04005859|Lidocaine|lidocaine|mesh-list
25397359|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
25397360|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397361|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397362|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
25397363|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397364|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25397365|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25397366|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25397367|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25397368|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397369|NCT04005339|Leucovorin|leucovorin|mesh-list
25397370|NCT04005339|Fluorouracil|fluorouracil|mesh-list
25397371|NCT04005339|Irinotecan|irinotecan|mesh-list
25397372|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
25397373|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397374|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397375|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397376|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397377|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
25397378|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397379|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25397380|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397381|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397382|NCT04005339|Antidotes|antidotes|mesh-ancestor
25397383|NCT04005339|Protective Agents|protective agents|mesh-ancestor
25397384|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
25397385|NCT04005339|Vitamins|vitamins|mesh-ancestor
25397386|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
25397387|NCT04005170|Paclitaxel|paclitaxel|mesh-list
25397388|NCT04005170|Cisplatin|cisplatin|mesh-list
25397389|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397390|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397391|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
25397392|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
25397393|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397394|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397395|NCT04004611|Mirikizumab|mirikizumab|mesh-list
25397396|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25397397|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25397398|NCT04004611|Analgesics|analgesics|mesh-ancestor
25397399|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
25397400|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397401|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397402|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397403|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397404|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25397405|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25397406|NCT04004416|Lorazepam|lorazepam|mesh-list
25397407|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
25397408|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
25397409|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
25428384|NCT01728805|Vorinostat|vorinostat|mesh-list
25397410|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397411|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397412|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25397413|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25397414|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397415|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25397416|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25397417|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25397418|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
25397419|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
25397420|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397421|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397422|NCT04003948|Ibogaine|ibogaine|mesh-list
25397423|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
25397424|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397425|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25397426|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25397427|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25397428|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397429|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397430|NCT04003922|Adalimumab|adalimumab|mesh-list
25397431|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397432|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397433|NCT04003636|Gemcitabine|gemcitabine|mesh-list
25397434|NCT04003636|Cisplatin|cisplatin|mesh-list
25397435|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
25397436|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397437|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397438|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
25397439|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397440|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
25397441|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397442|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397443|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397444|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
25397445|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397446|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397448|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397449|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397450|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397451|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
25397452|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397453|NCT04003103|Islatravir|islatravir|mesh-list
25397454|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
25397455|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397456|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397457|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397458|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25397459|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25397460|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25397461|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25397462|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397463|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
25397464|NCT04002401|Rituximab|rituximab|mesh-list
25397465|NCT04002401|Fludarabine|fludarabine|mesh-list
25397466|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397467|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
25397468|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397469|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397470|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397471|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
25397472|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397473|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397474|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397475|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397476|NCT04002297|Rituximab|rituximab|mesh-list
25397477|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25397478|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
25397479|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397480|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397481|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
25397482|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397483|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397484|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397485|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
25397486|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397487|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397488|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397489|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
25397490|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
25397491|NCT04002115|Busulfan|busulfan|mesh-list
25397492|NCT04002115|Fludarabine|fludarabine|mesh-list
25397493|NCT04002115|Clofarabine|clofarabine|mesh-list
25397494|NCT04002115|Tacrolimus|tacrolimus|mesh-list
25397495|NCT04002115|Lenograstim|lenograstim|mesh-list
25397496|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397497|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
25397498|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397499|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397500|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397501|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
25397502|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397503|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397504|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397505|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397506|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
25397507|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25397508|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397509|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25397510|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25397511|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
25397512|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25397513|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397514|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25397515|NCT04002011|Warfarin|warfarin|mesh-list
25397516|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
25397517|NCT04002011|Dabigatran|dabigatran|mesh-list
25397518|NCT04002011|Apixaban|apixaban|mesh-list
25397519|NCT04002011|Edoxaban|edoxaban|mesh-list
25397520|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
25397521|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25397522|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
25397523|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25397524|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
25397525|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397526|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397527|NCT04001504|Vaccines|vaccines|mesh-list
25397528|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
25397529|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397530|NCT04001413|Durvalumab|durvalumab|mesh-list
25397531|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397532|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397533|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25397534|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
25397535|NCT03999710|Durvalumab|durvalumab|mesh-list
25397536|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397537|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397538|NCT03999216|Diuretics|diuretics|mesh-list
25397539|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25397540|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
25397541|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
25397542|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397543|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25397544|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397545|NCT03998813|Ropivacaine|ropivacaine|mesh-list
25397546|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
25397547|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
25397548|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397549|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397550|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
25397551|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397552|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25397553|NCT03998709|Somatostatin|somatostatin|mesh-list
25397554|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397555|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25397556|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25397557|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25397558|NCT03998709|Hormones|hormones|mesh-ancestor
25397559|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397560|NCT03997968|Gemcitabine|gemcitabine|mesh-list
25397561|NCT03997968|Rituximab|rituximab|mesh-list
25397562|NCT03997968|Capecitabine|capecitabine|mesh-list
25397563|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25397564|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397565|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397566|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
25397567|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397568|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397569|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397570|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
25397571|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397572|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
25397573|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397574|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397575|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397576|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397577|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
25397578|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
25397579|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397580|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397581|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397582|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397583|NCT03997786|Etanercept|etanercept|mesh-list
25397584|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397660|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397585|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25397586|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25397587|NCT03997786|Analgesics|analgesics|mesh-ancestor
25397588|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
25397589|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397590|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397591|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397592|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397593|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25397594|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397595|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
25397596|NCT03997370|Carboplatin|carboplatin|mesh-list
25397597|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397598|NCT03997266|Gentamicins|gentamicins|mesh-list
25397599|NCT03997266|Ampicillin|ampicillin|mesh-list
25397600|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25397601|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397602|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25397603|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397604|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397605|NCT03997123|Paclitaxel|paclitaxel|mesh-list
25397606|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397607|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397608|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
25397609|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
25397610|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397611|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397612|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
25397613|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25397614|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397615|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397616|NCT03994627|Olaratumab|olaratumab|mesh-list
25397617|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397618|NCT03994601|Nivolumab|nivolumab|mesh-list
25397619|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397620|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397621|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25397622|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397623|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
25397624|NCT03993353|Tadalafil|tadalafil|mesh-list
25397625|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397626|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397628|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25397629|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25397630|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397631|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397632|NCT03993353|Urological Agents|urological agents|mesh-ancestor
25397633|NCT03993262|Bortezomib|bortezomib|mesh-list
25397634|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397635|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397636|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
25397637|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397639|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25397640|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25397641|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25397642|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25397643|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25397644|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397645|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
25397646|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397647|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397648|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25397649|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397650|NCT03992196|Rotigotine|rotigotine|mesh-list
25397651|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
25397652|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
25397653|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397654|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397655|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397656|NCT03992131|Rucaparib|rucaparib|mesh-list
25397657|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25397658|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397659|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397670|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
25397671|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25397672|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397673|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
25397674|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397675|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397676|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397677|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
25397678|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397679|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397680|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397681|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25397682|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25397683|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397684|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397685|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397686|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
25397687|NCT03991884|Hormones|hormones|mesh-ancestor
25397688|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397689|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25397690|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397691|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
25397692|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
25397693|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397694|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
25397695|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
25397696|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397697|NCT03990896|Talazoparib|talazoparib|mesh-list
25397698|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25397699|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397700|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397701|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397702|NCT03989414|Dexamethasone|dexamethasone|mesh-list
25397704|NCT03989414|Daratumumab|daratumumab|mesh-list
25397705|NCT03989414|Elotuzumab|elotuzumab|mesh-list
25397706|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397707|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
25397708|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
25397709|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397710|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397711|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25397712|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
25397713|NCT03989414|Hormones|hormones|mesh-ancestor
25397714|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397715|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25397716|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397717|NCT03989362|Ipilimumab|ipilimumab|mesh-list
25397718|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397719|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397720|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25397721|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397722|NCT03989115|Osimertinib|osimertinib|mesh-list
25397723|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397724|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397725|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397726|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397733|NCT03987711|Warfarin|warfarin|mesh-list
25397734|NCT03987711|Apixaban|apixaban|mesh-list
25397735|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
25397736|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25397737|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
25397738|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25397739|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
25397740|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397741|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397742|NCT03986970|Tenofovir|tenofovir|mesh-list
25397743|NCT03986970|Emtricitabine|emtricitabine|mesh-list
25397744|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
25397745|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397746|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25397747|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25397748|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397749|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397750|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25397751|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25397752|NCT03986034|Venetoclax|venetoclax|mesh-list
25397753|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397754|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25397755|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
25397756|NCT03985514|Tazobactam|tazobactam|mesh-list
25397757|NCT03985514|Piperacillin|piperacillin|mesh-list
25397758|NCT03985514|Metronidazole|metronidazole|mesh-list
25397759|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25397760|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25397761|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397762|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
25397763|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25397764|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397765|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397766|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397767|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397768|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25397769|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25397770|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25397771|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25397772|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25397773|NCT03984448|Prednisone|prednisone|mesh-list
25397774|NCT03984448|Cortisone|cortisone|mesh-list
25397775|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
25397776|NCT03984448|Rituximab|rituximab|mesh-list
25397777|NCT03984448|Doxorubicin|doxorubicin|mesh-list
25397778|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25397779|NCT03984448|Etoposide|etoposide|mesh-list
25397781|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
25397782|NCT03984448|Venetoclax|venetoclax|mesh-list
25397783|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
25397784|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25397785|NCT03984448|Antibodies|antibodies|mesh-list
25397786|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
25397787|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25397788|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397789|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
25397790|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397791|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397792|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25397793|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
25397794|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397795|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397796|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25397797|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25397798|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25397799|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397800|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397801|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397802|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
25397809|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397810|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
25397811|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
25397813|NCT03984097|Lenalidomide|lenalidomide|mesh-list
25397814|NCT03984097|Bortezomib|bortezomib|mesh-list
25397815|NCT03984097|Pomalidomide|pomalidomide|mesh-list
25397816|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397817|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
25397818|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
25397819|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397820|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397821|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25397822|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
25397823|NCT03984097|Hormones|hormones|mesh-ancestor
25397824|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397825|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25397826|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397827|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
25397828|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25397829|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25397830|NCT03984097|Growth Substances|growth substances|mesh-ancestor
25397831|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
25397840|NCT03983824|Cytarabine|cytarabine|mesh-list
25397841|NCT03983824|Etoposide|etoposide|mesh-list
25397842|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
25397843|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
25397844|NCT03983824|Peposertib|peposertib|mesh-list
25397845|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397846|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397847|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25397848|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397849|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397850|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397851|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397852|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
25397853|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
25397854|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397855|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397856|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
25397857|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397858|NCT03983824|Analgesics|analgesics|mesh-ancestor
25397859|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
25397860|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397861|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397862|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
25397863|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25397864|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
25397865|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397866|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25397867|NCT03981900|Tofacitinib|tofacitinib|mesh-list
25397868|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397869|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397870|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397871|NCT03981796|Paclitaxel|paclitaxel|mesh-list
25397872|NCT03981796|Carboplatin|carboplatin|mesh-list
25397873|NCT03981796|Niraparib|niraparib|mesh-list
25397874|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397875|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397876|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
25397877|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
25397878|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397879|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397880|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25397882|NCT03981744|Ustekinumab|ustekinumab|mesh-list
25397883|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25397884|NCT03980925|Carboplatin|carboplatin|mesh-list
25397885|NCT03980925|Nivolumab|nivolumab|mesh-list
25397886|NCT03980925|Etoposide|etoposide|mesh-list
25397887|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397888|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397889|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25397890|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397891|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397892|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25397893|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25397894|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397896|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397897|NCT03980509|Curcumin|curcumin|mesh-list
25397898|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25397899|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25397900|NCT03980509|Analgesics|analgesics|mesh-ancestor
25397901|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
25397902|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397903|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397904|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25397905|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397906|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397907|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397908|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397909|NCT03980483|Methotrexate|methotrexate|mesh-list
25397910|NCT03980483|Tofacitinib|tofacitinib|mesh-list
25397911|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25397912|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
25397913|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25397914|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397915|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25397916|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
25397917|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397918|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397919|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
25397920|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397921|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25397922|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25397923|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
25397924|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397925|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25397926|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397927|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
25397928|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397929|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397930|NCT03978611|Ipilimumab|ipilimumab|mesh-list
25398005|NCT03976310|Benralizumab|benralizumab|mesh-list
25397931|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397932|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397933|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25397934|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397935|NCT03978598|Etonogestrel|etonogestrel|mesh-list
25397936|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25397937|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
25397938|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25397939|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397940|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25397941|NCT03978520|Upadacitinib|upadacitinib|mesh-list
25397942|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25397943|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397944|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397945|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397946|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25397947|NCT03978442|Bupropion|bupropion|mesh-list
25397948|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25397949|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
25397950|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25397951|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25397952|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25397953|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25397954|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397955|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
25397956|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25397957|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397958|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25397959|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25397960|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397961|NCT03977454|Ropivacaine|ropivacaine|mesh-list
25397962|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
25397963|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
25397964|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25397965|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397966|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
25397967|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397968|NCT03976375|Docetaxel|docetaxel|mesh-list
25397969|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
25397970|NCT03976375|Lenvatinib|lenvatinib|mesh-list
25397971|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397972|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
25397973|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
25397974|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397975|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397976|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397977|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25397978|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397979|NCT03976362|Paclitaxel|paclitaxel|mesh-list
25397980|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25397981|NCT03976362|Carboplatin|carboplatin|mesh-list
25397982|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
25397983|NCT03976362|Olaparib|olaparib|mesh-list
25397984|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397985|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397986|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
25397987|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
25397988|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
25397989|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25397990|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25397991|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25397992|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397993|NCT03976323|Cisplatin|cisplatin|mesh-list
25397994|NCT03976323|Carboplatin|carboplatin|mesh-list
25397995|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
25397996|NCT03976323|Pemetrexed|pemetrexed|mesh-list
25397997|NCT03976323|Olaparib|olaparib|mesh-list
25397998|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25397999|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398000|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398001|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398002|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25398003|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25398004|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25398006|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25398007|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
25398008|NCT03976258|Naltrexone|naltrexone|mesh-list
25398009|NCT03976258|Buprenorphine|buprenorphine|mesh-list
25398010|NCT03976258|Methadone|methadone|mesh-list
25398011|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25398012|NCT03976258|Heroin|heroin|mesh-list
25398013|NCT03976258|Naloxone|naloxone|mesh-list
25398014|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25398015|NCT03976258|Narcotics|narcotics|mesh-ancestor
25398016|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25398017|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398018|NCT03976258|Analgesics|analgesics|mesh-ancestor
25398019|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
25398020|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398021|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25398022|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25398023|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
25398024|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
25398025|NCT03976063|Nifedipine|nifedipine|mesh-list
25398026|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25398027|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25398028|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398029|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25398036|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398037|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398038|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398114|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398045|NCT03974828|Anesthetics|anesthetics|mesh-list
25398046|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25398047|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398048|NCT03973489|Methamphetamine|methamphetamine|mesh-list
25398049|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25398050|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398051|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
25398052|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
25398053|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398054|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
25398055|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398056|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398057|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
25398058|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25398059|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25398060|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25398061|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25398062|NCT03972657|Cemiplimab|cemiplimab|mesh-list
25398063|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398064|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398065|NCT03972527|Analgesics|analgesics|mesh-list
25398066|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
25398067|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398068|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398069|NCT03972488|Octreotide|octreotide|mesh-list
25398070|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25398071|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398072|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398073|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398074|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25398075|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398076|NCT03971734|Regadenoson|regadenoson|mesh-list
25398077|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25398078|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25398079|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
25398080|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
25398081|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398082|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398083|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398084|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25398085|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25398086|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398087|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
25398088|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398089|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
25398090|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398091|NCT03971253|Peficitinib|peficitinib|mesh-list
25398092|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398093|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398094|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398095|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
25398096|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398097|NCT03971110|Goserelin|goserelin|mesh-list
25398098|NCT03971110|Bicalutamide|bicalutamide|mesh-list
25398099|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398100|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398101|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
25398102|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
25398104|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398106|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398107|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398108|NCT03970954|Analgesics|analgesics|mesh-ancestor
25398109|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
25398110|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398111|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398112|NCT03970837|Tofacitinib|tofacitinib|mesh-list
25398113|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398115|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398116|NCT03970720|Metoclopramide|metoclopramide|mesh-list
25398117|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
25398118|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
25398119|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398120|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398121|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398122|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25398123|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25398124|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
25398125|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398126|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398127|NCT03970616|Durvalumab|durvalumab|mesh-list
25398128|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398129|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398130|NCT03970447|Temozolomide|temozolomide|mesh-list
25398131|NCT03970447|Lomustine|lomustine|mesh-list
25398132|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
25398133|NCT03970447|GDC-0084|gdc-0084|mesh-list
25398134|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25398135|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
25398136|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398137|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398138|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398139|NCT03970382|Aldesleukin|aldesleukin|mesh-list
25398140|NCT03970382|Nivolumab|nivolumab|mesh-list
25398141|NCT03970382|Interleukin-2|interleukin-2|mesh-list
25398142|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398143|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398144|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25398145|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398146|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398147|NCT03970382|Analgesics|analgesics|mesh-ancestor
25398148|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
25398149|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398150|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398151|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25398152|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25398153|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
25398154|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398155|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
25398156|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25398158|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25398159|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
25398160|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398161|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398162|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
25398163|NCT03969901|Relebactam|relebactam|mesh-list
25398164|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25398165|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398166|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398167|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25398168|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398169|NCT03969212|Baloxavir|baloxavir|mesh-list
25398170|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
25398171|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398172|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398173|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398176|NCT03968393|Anticoagulants|anticoagulants|mesh-list
25398177|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
25398178|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25398179|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
25398180|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398181|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
25398182|NCT03967444|Protective Agents|protective agents|mesh-ancestor
25398183|NCT03967288|Bupivacaine|bupivacaine|mesh-list
25398184|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
25398185|NCT03967288|Procaine|procaine|mesh-list
25398186|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
25398187|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
25398188|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25398189|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398190|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
25398191|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398192|NCT03967054|Ivermectin|ivermectin|mesh-list
25398193|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25398194|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398195|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25398196|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25398197|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398198|NCT03965845|Palbociclib|palbociclib|mesh-list
25398199|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398200|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398201|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398202|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398203|NCT03965689|Paclitaxel|paclitaxel|mesh-list
25398204|NCT03965689|Carboplatin|carboplatin|mesh-list
25398205|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25398206|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25398207|NCT03965689|Pevonedistat|pevonedistat|mesh-list
25398208|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398209|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398210|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
25398211|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
25398212|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
25398213|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398214|NCT03965468|Paclitaxel|paclitaxel|mesh-list
25398215|NCT03965468|Carboplatin|carboplatin|mesh-list
25398216|NCT03965468|Durvalumab|durvalumab|mesh-list
25398217|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398218|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398219|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
25398220|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
25398221|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
25398222|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398223|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398224|NCT03965234|Cisplatin|cisplatin|mesh-list
25398225|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398226|NCT03964090|Cytarabine|cytarabine|mesh-list
25398227|NCT03964090|Isavuconazole|isavuconazole|mesh-list
25398228|NCT03964090|Methotrexate|methotrexate|mesh-list
25398229|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25398230|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
25398231|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25398232|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398233|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25398234|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
25398235|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398236|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398237|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
25398238|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398239|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25398240|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398241|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
25398242|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398243|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25398244|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
25398245|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398246|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
25398247|NCT03964051|Omalizumab|omalizumab|mesh-list
25398248|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25398249|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25398250|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
25398251|NCT03963375|Cladribine|cladribine|mesh-list
25398252|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398253|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398254|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
25398255|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398256|NCT03962647|Letrozole|letrozole|mesh-list
25398257|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398258|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25398259|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25398260|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398261|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398262|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25398263|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
25398264|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398265|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398266|NCT03962465|Cytarabine|cytarabine|mesh-list
25398267|NCT03962465|Prednisone|prednisone|mesh-list
25398268|NCT03962465|Methotrexate|methotrexate|mesh-list
25398269|NCT03962465|Vincristine|vincristine|mesh-list
25398270|NCT03962465|Daunorubicin|daunorubicin|mesh-list
25398271|NCT03962465|Pegaspargase|pegaspargase|mesh-list
25398272|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25398273|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398274|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
25398275|NCT03962465|Hormones|hormones|mesh-ancestor
25398276|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398277|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398278|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398279|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398280|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25398281|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
25398282|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25398283|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25398284|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
25398285|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398286|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
25398287|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398288|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25398289|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398290|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
25398291|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398292|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25398293|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
25398294|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398295|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398296|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
25398297|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
25398298|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
25398299|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25398300|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25398301|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398302|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398303|NCT03961971|Spartalizumab|spartalizumab|mesh-list
25398304|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25398305|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398306|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398307|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25398308|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25398309|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25398310|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25398311|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398312|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
25398313|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398314|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398315|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25398316|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398317|NCT03960125|Imipramine|imipramine|mesh-list
25398318|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25398319|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
25398320|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25398321|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25398322|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25398323|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25398324|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398325|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
25398326|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398327|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398328|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
25398329|NCT03959566|Bedaquiline|bedaquiline|mesh-list
25398331|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25398332|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25398333|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25398334|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398335|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25398336|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25398337|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25398338|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25398339|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
25398340|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
25398341|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
25398342|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
25398343|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398344|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398345|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25398346|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398347|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25398348|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398349|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398350|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398351|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
25398353|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
25398354|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398355|NCT03959293|Durvalumab|durvalumab|mesh-list
25398356|NCT03959293|Tremelimumab|tremelimumab|mesh-list
25398357|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398358|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398359|NCT03958721|Capecitabine|capecitabine|mesh-list
25398360|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25398361|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
25398362|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398363|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398364|NCT03958383|Nivolumab|nivolumab|mesh-list
25398365|NCT03958383|Ipilimumab|ipilimumab|mesh-list
25398366|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398367|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398368|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25398369|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398370|NCT03957681|Brodalumab|brodalumab|mesh-list
25398371|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
25398372|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
25398373|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398374|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398375|NCT03956797|Anesthetics|anesthetics|mesh-list
25398376|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25398377|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398378|NCT03956056|Poly I-C|poly i-c|mesh-list
25398379|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25398380|NCT03956056|Poly ICLC|poly iclc|mesh-list
25398381|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
25398382|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
25398611|NCT03944772|Etoposide|etoposide|mesh-list
25398383|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398384|NCT03956056|Laxatives|laxatives|mesh-ancestor
25398385|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398386|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
25398387|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398389|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398390|NCT03955471|Niraparib|niraparib|mesh-list
25398391|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25398392|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398393|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398394|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398395|NCT03955198|Durvalumab|durvalumab|mesh-list
25398396|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398397|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398398|NCT03955042|Pemetrexed|pemetrexed|mesh-list
25398399|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398400|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398401|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398402|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25398403|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25398404|NCT03954483|Triazolam|triazolam|mesh-list
25398405|NCT03954483|Buspirone|buspirone|mesh-list
25398406|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25398412|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
25398413|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398414|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398415|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25398416|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
25398417|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
25398418|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
25398419|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25398420|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25398421|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398422|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
25398423|NCT03954314|Coagulants|coagulants|mesh-ancestor
25398424|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
25398425|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398426|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398427|NCT03954041|Glyburide|glyburide|mesh-list
25398428|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25398429|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398430|NCT03953898|Olaparib|olaparib|mesh-list
25398431|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25398432|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398433|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398434|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398435|NCT03953833|Antibodies|antibodies|mesh-list
25398436|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25398437|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
25398438|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398439|NCT03953807|Dexamethasone|dexamethasone|mesh-list
25398440|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398441|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
25398442|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
25398443|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398444|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398445|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398446|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
25398447|NCT03953807|Hormones|hormones|mesh-ancestor
25398448|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398449|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398450|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398451|NCT03953300|Benralizumab|benralizumab|mesh-list
25398452|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25398453|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
25398454|NCT03953261|Curcumin|curcumin|mesh-list
25398455|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25398456|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398457|NCT03953261|Analgesics|analgesics|mesh-ancestor
25398458|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
25398459|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398460|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398461|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398462|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398463|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398464|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398465|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398472|NCT03950674|Folic Acid|folic acid|mesh-list
25398473|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
25398474|NCT03950674|Hydroxocobalamin|hydroxocobalamin|mesh-list
25398475|NCT03950674|Dexamethasone|dexamethasone|mesh-list
25398476|NCT03950674|Carboplatin|carboplatin|mesh-list
25398477|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
25398478|NCT03950674|Pemetrexed|pemetrexed|mesh-list
25398479|NCT03950674|Vitamins|vitamins|mesh-ancestor
25398480|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
25398481|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398482|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398483|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398484|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
25398485|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
25398486|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398487|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398488|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
25398489|NCT03950674|Hormones|hormones|mesh-ancestor
25398490|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398491|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398492|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398493|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398494|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398495|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25398496|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25398497|NCT03950674|Hematinics|hematinics|mesh-ancestor
25398498|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
25398499|NCT03950609|Everolimus|everolimus|mesh-list
25398500|NCT03950609|Lenvatinib|lenvatinib|mesh-list
25398501|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398502|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398503|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
25398504|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398505|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398506|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398507|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398508|NCT03950427|Bupropion|bupropion|mesh-list
25398509|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25398510|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
25398511|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25398512|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25398513|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25398514|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25398515|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398516|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
25398517|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398518|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398519|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25398520|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25398521|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398522|NCT03949855|Rituximab|rituximab|mesh-list
25398523|NCT03949855|Belimumab|belimumab|mesh-list
25398524|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398525|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398526|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
25398527|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398528|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398529|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398530|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
25398531|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25398532|NCT03949764|Velpatasvir|velpatasvir|mesh-list
25398533|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
25398534|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398535|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
25398536|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398537|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398538|NCT03948581|Vedolizumab|vedolizumab|mesh-list
25398539|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398540|NCT03948074|Dronabinol|dronabinol|mesh-list
25398541|NCT03948074|Cannabidiol|cannabidiol|mesh-list
25398542|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
25398543|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
25398544|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398545|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25398546|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398547|NCT03948074|Analgesics|analgesics|mesh-ancestor
25398548|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
25398549|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398550|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25398551|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25398552|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398553|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398554|NCT03948074|Hormones|hormones|mesh-ancestor
25398555|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398556|NCT03947827|Minocycline|minocycline|mesh-list
25398557|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25398558|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398559|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25398560|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398561|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398562|NCT03946878|Venetoclax|venetoclax|mesh-list
25398563|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
25398564|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398565|NCT03946800|Durvalumab|durvalumab|mesh-list
25398566|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398567|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398568|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25398569|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25398570|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398571|NCT03945903|Golimumab|golimumab|mesh-list
25398572|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25398573|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398574|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398575|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
25398576|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398577|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
25398578|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25398579|NCT03945656|Insulin|insulin|mesh-list
25398580|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25398581|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
25398582|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25398583|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398584|NCT03945604|Apatinib|apatinib|mesh-list
25398585|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398586|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398587|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398588|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398589|NCT03945513|Dienogest|dienogest|mesh-list
25398590|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25398591|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25398592|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25398593|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25398594|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
25398595|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25398596|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398597|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25398598|NCT03945513|Estrogens|estrogens|mesh-ancestor
25398599|NCT03945513|Hormones|hormones|mesh-ancestor
25398600|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398601|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25398602|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
25398603|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398604|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398605|NCT03945019|Infliximab|infliximab|mesh-list
25398606|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
25398607|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398608|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398609|NCT03944772|Cisplatin|cisplatin|mesh-list
25398610|NCT03944772|Carboplatin|carboplatin|mesh-list
25398612|NCT03944772|Pemetrexed|pemetrexed|mesh-list
25398613|NCT03944772|Durvalumab|durvalumab|mesh-list
25398614|NCT03944772|Gefitinib|gefitinib|mesh-list
25398615|NCT03944772|Osimertinib|osimertinib|mesh-list
25398616|NCT03944772|Necitumumab|necitumumab|mesh-list
25398617|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398618|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398619|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25398620|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398621|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398622|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398623|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25398624|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25398625|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398626|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398627|NCT03944434|Leuprolide|leuprolide|mesh-list
25398628|NCT03944434|Goserelin|goserelin|mesh-list
25398629|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25398630|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25398631|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25398632|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
25398633|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25398634|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398635|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398636|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398637|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25398638|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398639|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398640|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25398641|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
25398642|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398643|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
25398644|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25398645|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
25398646|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25398647|NCT03944356|Trametinib|trametinib|mesh-list
25398648|NCT03944356|Dabrafenib|dabrafenib|mesh-list
25398649|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398725|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25398650|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398651|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398652|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398653|NCT03943537|Insulin|insulin|mesh-list
25398654|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25398655|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398656|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25398657|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25398658|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398659|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25398660|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
25398661|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398662|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
25398663|NCT03942653|Goserelin|goserelin|mesh-list
25398664|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398665|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398666|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398667|NCT03942211|Selexipag|selexipag|mesh-list
25398668|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25398669|NCT03941860|Lenalidomide|lenalidomide|mesh-list
25398670|NCT03941860|Ixazomib|ixazomib|mesh-list
25398671|NCT03941860|Glycine|glycine|mesh-list
25398672|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
25398673|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398674|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25398675|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25398676|NCT03941860|Growth Substances|growth substances|mesh-ancestor
25398677|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
25398678|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398679|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398680|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
25398681|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398682|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
25398683|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398684|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25398685|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25398686|NCT03941730|Estradiol|estradiol|mesh-list
25398687|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25398688|NCT03941730|Estrogens|estrogens|mesh-ancestor
25398689|NCT03941730|Hormones|hormones|mesh-ancestor
25398690|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398691|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398692|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25398693|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
25398694|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25398695|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25398696|NCT03941496|Azacitidine|azacitidine|mesh-list
25398697|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25398698|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
25398699|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398700|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398701|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398702|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
25398703|NCT03941262|Avelumab|avelumab|mesh-list
25398704|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398705|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398706|NCT03940703|Osimertinib|osimertinib|mesh-list
25398707|NCT03940703|Tepotinib|tepotinib|mesh-list
25398708|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398709|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398710|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398711|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398713|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25398714|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398715|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398716|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398717|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
25398718|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398719|NCT03940352|Venetoclax|venetoclax|mesh-list
25398720|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398721|NCT03939897|Fulvestrant|fulvestrant|mesh-list
25398722|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398723|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398724|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25398726|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
25398727|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398728|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398729|NCT03939767|Aflibercept|aflibercept|mesh-list
25398730|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25398731|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25398732|NCT03939767|Growth Substances|growth substances|mesh-ancestor
25398733|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398734|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
25398735|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398736|NCT03939182|Abexinostat|abexinostat|mesh-list
25398737|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25398738|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398739|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398740|NCT03937843|Cisplatin|cisplatin|mesh-list
25398741|NCT03937843|Carboplatin|carboplatin|mesh-list
25398742|NCT03937843|Etoposide|etoposide|mesh-list
25398743|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398744|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398745|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25398746|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398747|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398748|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398749|NCT03937830|Bevacizumab|bevacizumab|mesh-list
25398750|NCT03937830|Durvalumab|durvalumab|mesh-list
25398751|NCT03937830|Doxorubicin|doxorubicin|mesh-list
25398752|NCT03937830|Tremelimumab|tremelimumab|mesh-list
25398753|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398754|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398755|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25398756|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25398757|NCT03937830|Growth Substances|growth substances|mesh-ancestor
25398758|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398759|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
25398760|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25398761|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25398762|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398763|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398764|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398765|NCT03935451|Apixaban|apixaban|mesh-list
25398766|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25398767|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
25398768|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25398769|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
25398770|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398771|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398772|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
25398773|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25398774|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25398775|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25398776|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25398777|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398778|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
25398779|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398780|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398781|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25398782|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398783|NCT03934814|Rituximab|rituximab|mesh-list
25398784|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
25398785|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398786|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398788|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398789|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398790|NCT03934372|Ponatinib|ponatinib|mesh-list
25398791|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398792|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25398793|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398794|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398795|NCT03934307|Irbesartan|irbesartan|mesh-list
25398796|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25398797|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25398798|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25398799|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398800|NCT03933631|Ofloxacin|ofloxacin|mesh-list
25398801|NCT03933631|Prednisolone|prednisolone|mesh-list
25398802|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
25398803|NCT03933631|Pilocarpine|pilocarpine|mesh-list
25398804|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398805|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
25398806|NCT03933631|Hormones|hormones|mesh-ancestor
25398807|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398808|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398809|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25398810|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398811|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
25398812|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398813|NCT03933631|Miotics|miotics|mesh-ancestor
25398814|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25398815|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25398816|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
25398817|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398818|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398819|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25398820|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398821|NCT03933631|Renal Agents|renal agents|mesh-ancestor
25398822|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25398823|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25398824|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398825|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398826|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25398827|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25398828|NCT03933449|Paclitaxel|paclitaxel|mesh-list
25398829|NCT03933449|Docetaxel|docetaxel|mesh-list
25398830|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
25398831|NCT03933449|Irinotecan|irinotecan|mesh-list
25398832|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398833|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398834|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25398835|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25398836|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25398837|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398838|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398839|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25398840|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398841|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398842|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
25398843|NCT03932643|TIC10 compound|tic10 compound|mesh-list
25398844|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398845|NCT03932409|Paclitaxel|paclitaxel|mesh-list
25398846|NCT03932409|Carboplatin|carboplatin|mesh-list
25398847|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
25398848|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398849|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398850|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
25398851|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
25398852|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
25398853|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398854|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398855|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
25398856|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398857|NCT03932201|Factor VIII|factor viii|mesh-list
25398858|NCT03932201|Coagulants|coagulants|mesh-ancestor
25398859|NCT03931642|Blinatumomab|blinatumomab|mesh-list
25398860|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398861|NCT03930953|Rituximab|rituximab|mesh-list
25398862|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
25398863|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398864|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398865|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
25398866|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398867|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398868|NCT03930771|Capecitabine|capecitabine|mesh-list
25398869|NCT03930771|Temozolomide|temozolomide|mesh-list
25398870|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25398871|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
25398872|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398873|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398874|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25398875|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
25398876|NCT03929640|Acetaminophen|acetaminophen|mesh-list
25398878|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398879|NCT03929640|Analgesics|analgesics|mesh-ancestor
25398880|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
25398881|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398882|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398883|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
25398884|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25398885|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398886|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398887|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25398888|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398889|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398890|NCT03929224|Bacitracin|bacitracin|mesh-list
25398891|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25398892|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398893|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25398894|NCT03928314|Paclitaxel|paclitaxel|mesh-list
25398895|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25398896|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398897|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
25398898|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
25398899|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
25398900|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398901|NCT03928288|Cabergoline|cabergoline|mesh-list
25398902|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25398903|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25398904|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
25398905|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
25398906|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398907|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398908|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398909|NCT03928015|Analgesics|analgesics|mesh-list
25398910|NCT03928015|Dronabinol|dronabinol|mesh-list
25398911|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
25398912|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398913|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398914|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
25398915|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25398916|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398917|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25398918|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25398919|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25398920|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398922|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398923|NCT03927690|Ranibizumab|ranibizumab|mesh-list
25398924|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25398925|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25398926|NCT03927690|Growth Substances|growth substances|mesh-ancestor
25398927|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398928|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
25398929|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398930|NCT03927274|Topotecan|topotecan|mesh-list
25398931|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25398932|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25398933|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398934|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398935|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398936|NCT03927222|Temozolomide|temozolomide|mesh-list
25398937|NCT03927222|Molgramostim|molgramostim|mesh-list
25429911|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
25398938|NCT03927222|Sargramostim|sargramostim|mesh-list
25398939|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
25398940|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398941|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25398942|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
25398943|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398944|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398945|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25398946|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
25398947|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398948|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25398949|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398950|NCT03926338|Celecoxib|celecoxib|mesh-list
25398951|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
25398952|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25398953|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25398954|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398955|NCT03926338|Analgesics|analgesics|mesh-ancestor
25398956|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
25398957|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398958|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398959|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398960|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398961|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25398962|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398963|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25398964|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398965|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25398966|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
25398967|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398968|NCT03926130|Mirikizumab|mirikizumab|mesh-list
25398969|NCT03926130|Ustekinumab|ustekinumab|mesh-list
25398970|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
25398971|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25398972|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25398973|NCT03926130|Analgesics|analgesics|mesh-ancestor
25398974|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
25398975|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25398976|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398977|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25398978|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25398979|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25398980|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398981|NCT03925480|Azithromycin|azithromycin|mesh-list
25398982|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25398983|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25398984|NCT03924947|Pancrelipase|pancrelipase|mesh-list
25398985|NCT03924947|Pancreatin|pancreatin|mesh-list
25398986|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25398987|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
25398988|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398989|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398990|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
25398991|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25398992|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398993|NCT03924856|Gemcitabine|gemcitabine|mesh-list
25398994|NCT03924856|Cisplatin|cisplatin|mesh-list
25398995|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
25398996|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398997|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25398998|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
25398999|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399000|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
25399001|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399002|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399003|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25399004|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
25399005|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399006|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399007|NCT03924635|Budesonide|budesonide|mesh-list
25399008|NCT03924635|Albuterol|albuterol|mesh-list
25399009|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
25399010|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25772329|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399011|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399012|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25399013|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
25399014|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399015|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399016|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25399017|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
25399018|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
25399019|NCT03924635|Hormones|hormones|mesh-ancestor
25399020|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399021|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25399022|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25399023|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25399024|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
25399025|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399026|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399027|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
25399028|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25399029|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
25399030|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25399031|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25399032|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399033|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
25399034|NCT03923959|Coagulants|coagulants|mesh-ancestor
25399035|NCT03923699|Anesthetics|anesthetics|mesh-list
25399036|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25399037|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399038|NCT03922997|Atezolizumab|atezolizumab|mesh-list
25399039|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399040|NCT03922945|Topiramate|topiramate|mesh-list
25399041|NCT03922945|Phentermine|phentermine|mesh-list
25399042|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
25399043|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25399044|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399045|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25399046|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
25399047|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25399048|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
25399049|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
25399050|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399051|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
25399052|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399053|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399054|NCT03922542|Riboflavin|riboflavin|mesh-list
25399055|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
25399056|NCT03922542|Vitamins|vitamins|mesh-ancestor
25399057|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
25399058|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399059|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25399060|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
25399061|NCT03921242|Metformin|metformin|mesh-list
25399062|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25399063|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25399064|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25399065|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399066|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399067|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
25399068|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399069|NCT03920722|Rituximab|rituximab|mesh-list
25399070|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399071|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399072|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
25399073|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399074|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399075|NCT03919955|Oxybutynin|oxybutynin|mesh-list
25399076|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25399077|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25399078|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25399079|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25399080|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399081|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
25399082|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399083|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399084|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
25399085|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
25399086|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399087|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25399088|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25399089|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
25399090|NCT03919955|Urological Agents|urological agents|mesh-ancestor
25399091|NCT03919799|Belumosudil|belumosudil|mesh-list
25399092|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25399093|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399094|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399095|NCT03919292|Valproic Acid|valproic acid|mesh-list
25399096|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
25399097|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399098|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399099|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
25399100|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399101|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399102|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
25399103|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25399104|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25399105|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25399106|NCT03919071|Trametinib|trametinib|mesh-list
25399107|NCT03919071|Dabrafenib|dabrafenib|mesh-list
25399108|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25399109|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399110|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25399111|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399112|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399113|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25399114|NCT03919071|Protective Agents|protective agents|mesh-ancestor
25399115|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399116|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25399117|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
25399118|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
25399119|NCT03918798|Procaine|procaine|mesh-list
25399120|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25399121|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
25399122|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
25399123|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25399124|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399125|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
25399126|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399127|NCT03918278|Gemcitabine|gemcitabine|mesh-list
25399128|NCT03918278|Paclitaxel|paclitaxel|mesh-list
25399129|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25399130|NCT03918278|Carboplatin|carboplatin|mesh-list
25399131|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
25399132|NCT03918278|Pemetrexed|pemetrexed|mesh-list
25399133|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25399134|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399135|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
25399136|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
25399137|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
25399138|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399139|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25399140|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
25399141|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
25399142|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399143|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399144|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25399145|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
25399146|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399147|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399148|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25399149|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25399150|NCT03917472|Aflibercept|aflibercept|mesh-list
25399151|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25399152|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25399153|NCT03917472|Growth Substances|growth substances|mesh-ancestor
25399154|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399155|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
25399156|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399157|NCT03917303|Adalimumab|adalimumab|mesh-list
25399158|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399159|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399160|NCT03916341|Nicotine|nicotine|mesh-list
25399161|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25399196|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399197|NCT03914742|Temozolomide|temozolomide|mesh-list
25399198|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25399199|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25399200|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
25399201|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399202|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399203|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399333|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399334|NCT03912428|Celecoxib|celecoxib|mesh-list
25399335|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25399336|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25399337|NCT03912428|Analgesics|analgesics|mesh-ancestor
25399338|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
25399339|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399340|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399341|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399342|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399343|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25399344|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25399345|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399346|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399347|NCT03910244|Pomalidomide|pomalidomide|mesh-list
25399348|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
25399349|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399350|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25399351|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25399352|NCT03910244|Growth Substances|growth substances|mesh-ancestor
25399353|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
25399354|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399355|NCT03909412|Dexamethasone|dexamethasone|mesh-list
25399356|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
25399357|NCT03909412|Lenograstim|lenograstim|mesh-list
25399358|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25399359|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
25399360|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399361|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399362|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25399363|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
25399364|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399365|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399366|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25399367|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399368|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
25399369|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
25399370|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399371|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25399373|NCT03909412|Hormones|hormones|mesh-ancestor
25399374|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399375|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399376|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25399377|NCT03909334|Osimertinib|osimertinib|mesh-list
25399378|NCT03909334|Ramucirumab|ramucirumab|mesh-list
25399379|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399380|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25399381|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399382|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399383|NCT03909165|Atropine|atropine|mesh-list
25399384|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
25399385|NCT03909165|Neostigmine|neostigmine|mesh-list
25399386|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25399387|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25399388|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25399389|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
25399390|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399391|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399392|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25399393|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
25399394|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
25399395|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
25399396|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25399397|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25399398|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
25399399|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399400|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399401|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25399402|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399403|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25399404|NCT03909152|Anastrozole|anastrozole|mesh-list
25399405|NCT03909152|Onapristone|onapristone|mesh-list
25399406|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399407|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399408|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25399409|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25399410|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399411|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399412|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25399413|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
25408467|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25399470|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399471|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25399472|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25399473|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399474|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
25399475|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25399476|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
25399477|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25399478|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
25399479|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
25399480|NCT03905798|Lorazepam|lorazepam|mesh-list
25399481|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
25399482|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
25399483|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
25399484|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399485|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399486|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25399487|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25399488|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25399489|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25399490|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25399491|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25399492|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
25399493|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
25399494|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399495|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399496|NCT03905694|Lumasiran|lumasiran|mesh-list
25399497|NCT03905694|Renal Agents|renal agents|mesh-ancestor
25399498|NCT03905135|Avelumab|avelumab|mesh-list
25399499|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399500|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399501|NCT03904693|Tadalafil|tadalafil|mesh-list
25399502|NCT03904693|Macitentan|macitentan|mesh-list
25399503|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25399504|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25399505|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25399506|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399507|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399508|NCT03904693|Urological Agents|urological agents|mesh-ancestor
25399509|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25399510|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25399511|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25399512|NCT03904550|Rocuronium|rocuronium|mesh-list
25399513|NCT03904550|Cisatracurium|cisatracurium|mesh-list
25399514|NCT03904550|Neostigmine|neostigmine|mesh-list
25399515|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25399516|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25399517|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25399518|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399519|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399520|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25399521|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399522|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399523|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
25399524|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399525|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25399526|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
25399527|NCT03904498|Tolcapone|tolcapone|mesh-list
25399528|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25399529|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25399530|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25399531|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399532|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399533|NCT03904446|Methylergonovine|methylergonovine|mesh-list
25399534|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
25399535|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25399536|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399537|NCT03904329|Anticoagulants|anticoagulants|mesh-list
25399538|NCT03904199|Insulin|insulin|mesh-list
25399539|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25399540|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25399541|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399542|NCT03903835|Prednisone|prednisone|mesh-list
25399543|NCT03903835|Carboplatin|carboplatin|mesh-list
25399544|NCT03903835|Docetaxel|docetaxel|mesh-list
25399545|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
25399546|NCT03903835|Niraparib|niraparib|mesh-list
25399547|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25399548|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25399549|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399550|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25399551|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
25399552|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25399553|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399554|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399555|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
25399556|NCT03903835|Hormones|hormones|mesh-ancestor
25399557|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399558|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399559|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399560|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25399561|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399562|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
25399563|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25399564|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25399565|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
25399566|NCT03903809|Hematinics|hematinics|mesh-ancestor
25399568|NCT03903185|Ledipasvir|ledipasvir|mesh-list
25399569|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25399570|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
25399571|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399572|NCT03902951|Leuprolide|leuprolide|mesh-list
25399573|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
25399574|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25399575|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
25399576|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25399577|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399578|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399579|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399580|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25399581|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399582|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399583|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
25399584|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399585|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25399586|NCT03901963|Lenalidomide|lenalidomide|mesh-list
25399587|NCT03901963|Daratumumab|daratumumab|mesh-list
25399588|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
25399589|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399590|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25399591|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25399592|NCT03901963|Growth Substances|growth substances|mesh-ancestor
25399593|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
25399594|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399595|NCT03901573|Atezolizumab|atezolizumab|mesh-list
25399596|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399597|NCT03900715|Luspatercept|luspatercept|mesh-list
25399598|NCT03900715|Hematinics|hematinics|mesh-ancestor
25399599|NCT03900624|Dexamethasone|dexamethasone|mesh-list
25399600|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399601|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
25399602|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
25399603|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399604|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399605|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25399606|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
25399607|NCT03900624|Hormones|hormones|mesh-ancestor
25399608|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399609|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399610|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399611|NCT03899987|Aspirin|aspirin|mesh-list
25399612|NCT03899987|Interferons|interferons|mesh-list
25399613|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
25399614|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
25399615|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25399616|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399617|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
25399618|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399619|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25399620|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25399621|NCT03899987|Analgesics|analgesics|mesh-ancestor
25399622|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
25399623|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399624|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399625|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399626|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399627|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25399628|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25399629|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399630|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25399631|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25399632|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399633|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
25399634|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
25399635|NCT03899467|Androgens|androgens|mesh-list
25399636|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
25399637|NCT03899467|Hormones|hormones|mesh-ancestor
25399638|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399639|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399640|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
25399641|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
25399646|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399653|NCT03898180|Lenvatinib|lenvatinib|mesh-list
25399654|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399655|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399656|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25399657|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399658|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399659|NCT03898037|Metformin|metformin|mesh-list
25399660|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25399661|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399662|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
25399663|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399664|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399665|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
25399666|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25399667|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25399668|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399669|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
25399670|NCT03897621|Coagulants|coagulants|mesh-ancestor
25399671|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25399672|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25399673|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
25399674|NCT03897309|Vaccines|vaccines|mesh-list
25399675|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
25399676|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399677|NCT03897127|Cytarabine|cytarabine|mesh-list
25399678|NCT03897127|Daunorubicin|daunorubicin|mesh-list
25399679|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25399680|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
25399681|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399682|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399683|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
25399684|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399685|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25399686|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
25399687|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399688|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25399689|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25399690|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25399691|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399692|NCT03896737|Thalidomide|thalidomide|mesh-list
25399693|NCT03896737|Dexamethasone|dexamethasone|mesh-list
25399694|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
25399695|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
25399696|NCT03896737|Bortezomib|bortezomib|mesh-list
25399697|NCT03896737|Daratumumab|daratumumab|mesh-list
25399698|NCT03896737|BB 1101|bb 1101|mesh-list
25399699|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25399700|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
25399701|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399702|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399703|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25399704|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
25399705|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399706|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399707|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25399708|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399709|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
25399710|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
25399711|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399712|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25399713|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
25399714|NCT03896737|Hormones|hormones|mesh-ancestor
25399715|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399716|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399717|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
25399718|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399719|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
25399720|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25399721|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399722|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25399723|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25399724|NCT03896737|Growth Substances|growth substances|mesh-ancestor
25399725|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
25399726|NCT03896503|Topotecan|topotecan|mesh-list
25399727|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25399728|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25399729|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399730|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399731|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399732|NCT03896230|Ketamine|ketamine|mesh-list
25399733|NCT03896230|Analgesics|analgesics|mesh-ancestor
25399734|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
25399735|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399736|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399737|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25399738|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25399739|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
25399740|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
25399741|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25399742|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25399743|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25399744|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399745|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399746|NCT03895801|Prednisone|prednisone|mesh-list
25399747|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
25399748|NCT03895801|Vilobelimab|vilobelimab|mesh-list
25399749|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399750|NCT03895801|Hormones|hormones|mesh-ancestor
25399751|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399752|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399753|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399754|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399755|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25399756|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25399757|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
25399758|NCT03895502|Edoxaban|edoxaban|mesh-list
25399759|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25399760|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
25399761|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25399762|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
25399763|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399764|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399765|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
25399766|NCT03895203|Adalimumab|adalimumab|mesh-list
25399767|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399768|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399769|NCT03894540|Paclitaxel|paclitaxel|mesh-list
25399770|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
25399771|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25399772|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399773|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
25399774|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
25399775|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
25399776|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399777|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399778|NCT03891901|Isoniazid|isoniazid|mesh-list
25399779|NCT03891901|Rifabutin|rifabutin|mesh-list
25399780|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
25399781|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399782|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25399783|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399784|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399785|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
25399786|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25399787|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399788|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25399789|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25399790|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
25399791|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25399792|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25399793|NCT03891706|Interleukin-2|interleukin-2|mesh-list
25399794|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399795|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25399797|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
25399798|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399799|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399800|NCT03891576|Niraparib|niraparib|mesh-list
25399801|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25399802|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399803|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399804|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399805|NCT03891355|Dexamethasone|dexamethasone|mesh-list
25399807|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399808|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
25399809|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
25399810|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399811|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399812|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25399813|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
25399814|NCT03891355|Hormones|hormones|mesh-ancestor
25399815|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399816|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399817|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399818|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
25399819|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25399820|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25399821|NCT03891355|Growth Substances|growth substances|mesh-ancestor
25399822|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
25399823|NCT03891173|Cisplatin|cisplatin|mesh-list
25399824|NCT03891173|Vinorelbine|vinorelbine|mesh-list
25399825|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399826|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25399827|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
25399828|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
25399829|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
25399830|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399831|NCT03890666|Albuterol|albuterol|mesh-list
25399832|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25399833|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
25399834|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399835|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399836|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25399837|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
25399838|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
25399839|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25399840|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25399841|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25399842|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25399843|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
25399844|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399845|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399846|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
25399847|NCT03890289|Idelalisib|idelalisib|mesh-list
25399848|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399849|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399850|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399851|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399852|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
25399853|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25399854|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
25399855|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399856|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
25399857|NCT03889925|Protective Agents|protective agents|mesh-ancestor
25399858|NCT03889912|Cemiplimab|cemiplimab|mesh-list
25399859|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399860|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399861|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25399862|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25399863|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
25399864|NCT03889418|Narcotics|narcotics|mesh-ancestor
25399865|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25399866|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399867|NCT03889418|Analgesics|analgesics|mesh-ancestor
25399868|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
25399885|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25399886|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25399888|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399889|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25399890|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25399891|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
25399892|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25399893|NCT03883828|Mupirocin|mupirocin|mesh-list
25399894|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25399895|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399896|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
25399897|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
25399898|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25399899|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25399900|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399901|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399903|NCT03882177|Pyridoxal|pyridoxal|mesh-list
25399904|NCT03882177|Pyridoxine|pyridoxine|mesh-list
25399905|NCT03882177|Pravastatin|pravastatin|mesh-list
25399906|NCT03882177|Vitamins|vitamins|mesh-ancestor
25399907|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
25399908|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399909|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
25399910|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25399911|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25399912|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
25399913|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399914|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25399915|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25399916|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399917|NCT03881696|Omalizumab|omalizumab|mesh-list
25399918|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
25399919|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25399920|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399921|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25399922|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25399923|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
25399924|NCT03881345|Anticoagulants|anticoagulants|mesh-list
25399925|NCT03880019|Temozolomide|temozolomide|mesh-list
25399926|NCT03880019|Olaparib|olaparib|mesh-list
25399927|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25399928|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25399929|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
25399930|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399931|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399932|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399933|NCT03879798|Irinotecan|irinotecan|mesh-list
25399934|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25399935|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25399936|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399937|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399938|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399939|NCT03879694|Octreotide|octreotide|mesh-list
25399940|NCT03879694|Sargramostim|sargramostim|mesh-list
25399941|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25399942|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
25399943|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
25399944|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399945|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399946|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25399947|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25399948|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25399950|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25399951|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25399952|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
25399953|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399954|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399955|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399956|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25399957|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
25399958|NCT03879629|Protective Agents|protective agents|mesh-ancestor
25399959|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25399960|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25399961|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25399962|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
25399963|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25399964|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25399965|NCT03878316|Oxytocin|oxytocin|mesh-list
25399966|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
25399967|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25399968|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399969|NCT03878069|Elapegademase|elapegademase|mesh-list
25399970|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25399971|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399972|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399973|NCT03877406|Empagliflozin|empagliflozin|mesh-list
25399974|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25399975|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25399976|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399977|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399978|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25399979|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25399980|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25399981|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
25399982|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399983|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25399984|NCT03876262|Ivermectin|ivermectin|mesh-list
25399985|NCT03876262|Moxidectin|moxidectin|mesh-list
25399986|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25399987|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399988|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
25399989|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
25399990|NCT03875755|Inositol|inositol|mesh-list
25399991|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
25399992|NCT03875755|Vitamins|vitamins|mesh-ancestor
25399993|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
25399994|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399995|NCT03875664|Bupivacaine|bupivacaine|mesh-list
25399996|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
25399997|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
25399998|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25399999|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400000|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
25400001|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400002|NCT03875092|Paclitaxel|paclitaxel|mesh-list
25400003|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25400004|NCT03875092|Carboplatin|carboplatin|mesh-list
25400005|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
25400006|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400007|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400008|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400009|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400010|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400011|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400012|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400013|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
25400014|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400015|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400016|NCT03874052|Venetoclax|venetoclax|mesh-list
25400017|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25400018|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400019|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400020|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400021|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400022|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
25400023|NCT03873818|Ipilimumab|ipilimumab|mesh-list
25400024|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400025|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400026|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400027|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400028|NCT03873480|Epinephrine|epinephrine|mesh-list
25400029|NCT03873480|Bupivacaine|bupivacaine|mesh-list
25400030|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25400031|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25400032|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
25400033|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25400034|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400035|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400036|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25400037|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25400038|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
25400039|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400040|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25400041|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
25400042|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
25400043|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
25400044|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25400045|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
25400046|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
25400047|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25400048|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
25400049|NCT03873337|Nicotine|nicotine|mesh-list
25400058|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400059|NCT03871829|Dexamethasone|dexamethasone|mesh-list
25400060|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
25400061|NCT03871829|BB 1101|bb 1101|mesh-list
25400062|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400063|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
25400064|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
25400065|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400066|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400067|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25400068|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
25400069|NCT03871829|Hormones|hormones|mesh-ancestor
25400070|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400071|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400072|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400073|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
25400074|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400075|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400076|NCT03871348|Cemiplimab|cemiplimab|mesh-list
25400077|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400078|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400087|NCT03870919|Palbociclib|palbociclib|mesh-list
25400088|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400089|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400090|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400091|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400092|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25400093|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
25400094|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400095|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
25400096|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400098|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25400099|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400100|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400101|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400102|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
25400103|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400104|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25400105|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25400106|NCT03869996|Cytarabine|cytarabine|mesh-list
25400107|NCT03869996|Methotrexate|methotrexate|mesh-list
25400108|NCT03869996|Etoposide|etoposide|mesh-list
25400109|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400110|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
25400111|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400112|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400113|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
25400114|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400115|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400116|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
25400117|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400118|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400119|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25400120|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25400121|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400122|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25400123|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
25400124|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25431050|NCT01212822|Vitamins|vitamins|mesh-ancestor
25400125|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
25400126|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400127|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25400128|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400129|NCT03869450|Lidocaine|lidocaine|mesh-list
25400130|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
25400131|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
25400132|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
25400133|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25400134|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400135|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
25400136|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400137|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25400138|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25400139|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25400140|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25400141|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400142|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25400143|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
25400144|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
25400145|NCT03869450|Protective Agents|protective agents|mesh-ancestor
25400146|NCT03869190|Gemcitabine|gemcitabine|mesh-list
25400147|NCT03869190|Cisplatin|cisplatin|mesh-list
25400148|NCT03869190|Atezolizumab|atezolizumab|mesh-list
25400149|NCT03869190|Niraparib|niraparib|mesh-list
25400150|NCT03869190|Magrolimab|magrolimab|mesh-list
25400151|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400152|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400153|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
25400154|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400155|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
25400156|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400157|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400158|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400159|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
25400160|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400161|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25400162|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400163|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25400164|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
25400165|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400166|NCT03867201|Erenumab|erenumab|mesh-list
25400167|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25400168|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400169|NCT03867201|Analgesics|analgesics|mesh-ancestor
25400170|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
25400171|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400172|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400173|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
25400174|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400175|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400176|NCT03866772|Misoprostol|misoprostol|mesh-list
25400177|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25400178|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
25400179|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25400180|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400181|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25400182|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25400183|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
25400184|NCT03866538|Budesonide|budesonide|mesh-list
25400185|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400186|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25400187|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
25400188|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400189|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400190|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25400191|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
25400192|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
25400193|NCT03866538|Hormones|hormones|mesh-ancestor
25400194|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400195|NCT03866382|Nivolumab|nivolumab|mesh-list
25400196|NCT03866382|Ipilimumab|ipilimumab|mesh-list
25400197|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25772330|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400198|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400199|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400200|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400201|NCT03866239|Atezolizumab|atezolizumab|mesh-list
25400202|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
25400203|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400204|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400205|NCT03865992|Curcumin|curcumin|mesh-list
25400206|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25400207|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25400208|NCT03865992|Analgesics|analgesics|mesh-ancestor
25400209|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
25400210|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400211|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400212|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400213|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25400214|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400215|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400216|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400217|NCT03865732|Pregnanolone|pregnanolone|mesh-list
25400218|NCT03865732|Ganaxolone|ganaxolone|mesh-list
25400219|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
25400220|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25400221|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400222|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400223|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
25400224|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
25400225|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
25400226|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25400227|NCT03865212|Interferons|interferons|mesh-list
25400228|NCT03865212|Interferon-beta|interferon-beta|mesh-list
25400229|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400230|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
25400231|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400232|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
25400233|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400234|NCT03864926|Tacrolimus|tacrolimus|mesh-list
25400235|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400236|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
25400237|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400238|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25400239|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400240|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400241|NCT03864419|Prednisone|prednisone|mesh-list
25400242|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
25400243|NCT03864419|Rituximab|rituximab|mesh-list
25400244|NCT03864419|Doxorubicin|doxorubicin|mesh-list
25400245|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25400246|NCT03864419|Methotrexate|methotrexate|mesh-list
25400247|NCT03864419|Etoposide|etoposide|mesh-list
25400248|NCT03864419|Vincristine|vincristine|mesh-list
25400249|NCT03864419|Daunorubicin|daunorubicin|mesh-list
25400250|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
25400251|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25400252|NCT03864419|Antibodies|antibodies|mesh-list
25400253|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
25400254|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25400255|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400256|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
25400257|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400258|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25400259|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25400260|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
25400261|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400262|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400263|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25400264|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25400265|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25400266|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25400267|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400268|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400269|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
25400270|NCT03864419|Hormones|hormones|mesh-ancestor
25400271|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400272|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400273|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25400274|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
25400311|NCT03864042|Omeprazole|omeprazole|mesh-list
25400312|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25400313|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25400314|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25400315|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25400316|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400317|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25400318|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25400319|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25400320|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25400321|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
25400322|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
25400323|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
25400324|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
25400325|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25400326|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400327|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25400328|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25400329|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
25400330|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25400331|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25400332|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400333|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25400334|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25400335|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25400336|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25400337|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25400338|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25400339|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25400340|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25400341|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25400342|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25400343|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25400344|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
25400345|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25400346|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
25400347|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25400348|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25772331|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25400349|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25400350|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
25400351|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25400352|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25400353|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25400354|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25400355|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25400357|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
25400358|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25400359|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25400360|NCT03862950|Metformin|metformin|mesh-list
25400361|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25400362|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400363|NCT03862716|Insulin|insulin|mesh-list
25400364|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25400365|NCT03862716|Metformin|metformin|mesh-list
25400366|NCT03862716|Liraglutide|liraglutide|mesh-list
25400367|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
25400368|NCT03862716|Xultophy|xultophy|mesh-list
25400369|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25400370|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400371|NCT03862716|Incretins|incretins|mesh-ancestor
25400372|NCT03862716|Hormones|hormones|mesh-ancestor
25400373|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400374|NCT03861988|Ketamine|ketamine|mesh-list
25400375|NCT03861988|Analgesics|analgesics|mesh-ancestor
25400376|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
25400377|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400378|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400379|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25400380|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25400381|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
25400382|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
25400383|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25400384|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25400385|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25400386|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25400387|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400388|NCT03861767|Metformin|metformin|mesh-list
25400389|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25400390|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400391|NCT03861702|Irinotecan|irinotecan|mesh-list
25400392|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25400393|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25400394|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400395|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400396|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400397|NCT03861390|Prednisone|prednisone|mesh-list
25400398|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400399|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
25400400|NCT03861390|Hormones|hormones|mesh-ancestor
25400401|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400402|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400403|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400404|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400405|NCT03861299|Anesthetics|anesthetics|mesh-list
25400406|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25400407|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400408|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
25400409|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25400410|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25400411|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400412|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25400413|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400414|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25400415|NCT03860844|Cytarabine|cytarabine|mesh-list
25400416|NCT03860844|Dexamethasone|dexamethasone|mesh-list
25400417|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
25400418|NCT03860844|Doxorubicin|doxorubicin|mesh-list
25400419|NCT03860844|Methotrexate|methotrexate|mesh-list
25400420|NCT03860844|Fludarabine|fludarabine|mesh-list
25400421|NCT03860844|Etoposide|etoposide|mesh-list
25400422|NCT03860844|Vincristine|vincristine|mesh-list
25400423|NCT03860844|Daunorubicin|daunorubicin|mesh-list
25400424|NCT03860844|Asparaginase|asparaginase|mesh-list
25400425|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
25400426|NCT03860844|Idarubicin|idarubicin|mesh-list
25400427|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
25400428|NCT03860844|Pegaspargase|pegaspargase|mesh-list
25400429|NCT03860844|Montelukast|montelukast|mesh-list
25400430|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400431|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
25400432|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400433|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25400434|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25400435|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
25400436|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400437|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400438|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25400439|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400440|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
25400441|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
25400442|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400443|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25400444|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
25400445|NCT03860844|Hormones|hormones|mesh-ancestor
25400446|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400447|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400448|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25400449|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25400450|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25400451|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400452|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25400453|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
25400454|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25400455|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400456|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
25400457|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
25400458|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400459|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400460|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400461|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
25400462|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400463|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400464|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400465|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400466|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25400467|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
25400468|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25400469|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
25400470|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25400471|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25400472|NCT03860844|Analgesics|analgesics|mesh-ancestor
25400473|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
25400474|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
25400475|NCT03860597|Memantine|memantine|mesh-list
25400476|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25400477|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25400478|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
25400479|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25400480|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400481|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400482|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25400483|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25400484|NCT03859973|BI 425809|bi 425809|mesh-list
25400485|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
25400486|NCT03858491|Cobicistat|cobicistat|mesh-list
25400487|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25400488|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25400489|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
25400490|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400491|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25400492|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25400493|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400494|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400495|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
25400496|NCT03855007|Prednisone|prednisone|mesh-list
25400497|NCT03855007|Methotrexate|methotrexate|mesh-list
25400498|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400499|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
25400500|NCT03855007|Hormones|hormones|mesh-ancestor
25404056|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25400501|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400502|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400503|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400504|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400505|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25400506|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
25400507|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25400508|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400509|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
25400510|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400511|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
25400512|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400513|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400514|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400515|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
25400516|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25400517|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400518|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
25400519|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25400520|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25400521|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400522|NCT03854799|Capecitabine|capecitabine|mesh-list
25400523|NCT03854799|Avelumab|avelumab|mesh-list
25400524|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400525|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
25400526|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400527|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400528|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400529|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
25400530|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400531|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400532|NCT03854227|Docetaxel|docetaxel|mesh-list
25400533|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400534|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400535|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400536|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400537|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400538|NCT03853707|Paclitaxel|paclitaxel|mesh-list
25400539|NCT03853707|Carboplatin|carboplatin|mesh-list
25400540|NCT03853707|Capecitabine|capecitabine|mesh-list
25400541|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25400542|NCT03853707|Atezolizumab|atezolizumab|mesh-list
25400543|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25400544|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400545|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400546|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400547|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400548|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400549|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400701|NCT03842228|Olaparib|olaparib|mesh-list
25400550|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400551|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
25400552|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
25400553|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400554|NCT03852901|Empagliflozin|empagliflozin|mesh-list
25400555|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25400556|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400557|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25400558|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400559|NCT03850782|Bimatoprost|bimatoprost|mesh-list
25400560|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25400561|NCT03850574|Venetoclax|venetoclax|mesh-list
25400562|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400563|NCT03850444|Paclitaxel|paclitaxel|mesh-list
25400564|NCT03850444|Carboplatin|carboplatin|mesh-list
25400565|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
25400566|NCT03850444|Pemetrexed|pemetrexed|mesh-list
25400567|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400568|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400569|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400570|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400571|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400572|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404057|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400573|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400574|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400575|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400576|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400577|NCT03850067|Cisplatin|cisplatin|mesh-list
25400578|NCT03850067|Carboplatin|carboplatin|mesh-list
25400579|NCT03850067|Nivolumab|nivolumab|mesh-list
25400580|NCT03850067|Etoposide|etoposide|mesh-list
25400581|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
25400582|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400583|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400584|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400813|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400585|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400586|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400587|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25400588|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25400589|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400590|NCT03848832|Cannabidiol|cannabidiol|mesh-list
25400591|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
25400592|NCT03847649|Prednisone|prednisone|mesh-list
25400593|NCT03847649|Durvalumab|durvalumab|mesh-list
25400594|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400595|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
25400596|NCT03847649|Hormones|hormones|mesh-ancestor
25400597|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400598|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400599|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400600|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400601|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400602|NCT03847428|Bevacizumab|bevacizumab|mesh-list
25400603|NCT03847428|Durvalumab|durvalumab|mesh-list
25400604|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400605|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400606|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25400607|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25400608|NCT03847428|Growth Substances|growth substances|mesh-ancestor
25400609|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400610|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
25400611|NCT03846310|Carboplatin|carboplatin|mesh-list
25400612|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
25400613|NCT03846310|Pemetrexed|pemetrexed|mesh-list
25400614|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400615|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400616|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400617|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400618|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400619|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400620|NCT03845894|Bupivacaine|bupivacaine|mesh-list
25400621|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
25400622|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
25400623|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25400624|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400644|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400645|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400646|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25400647|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
25400648|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400649|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400650|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
25400651|NCT03844061|Rituximab|rituximab|mesh-list
25400652|NCT03844061|Belimumab|belimumab|mesh-list
25400653|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400654|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400655|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
25400656|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400657|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25400658|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25400659|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25400660|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
25400661|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25400662|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400663|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400664|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400665|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400666|NCT03844048|Venetoclax|venetoclax|mesh-list
25400667|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400668|NCT03843528|Azacitidine|azacitidine|mesh-list
25400669|NCT03843528|Vorinostat|vorinostat|mesh-list
25400670|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400671|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
25400672|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400673|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400674|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400675|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25400676|NCT03843294|Nivolumab|nivolumab|mesh-list
25400677|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400678|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400679|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400680|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400700|NCT03842228|Durvalumab|durvalumab|mesh-list
25400720|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
25400721|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400722|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25400744|NCT03840915|Gemcitabine|gemcitabine|mesh-list
25400745|NCT03840915|Paclitaxel|paclitaxel|mesh-list
25400746|NCT03840915|Docetaxel|docetaxel|mesh-list
25400747|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25400748|NCT03840915|Cisplatin|cisplatin|mesh-list
25400749|NCT03840915|Carboplatin|carboplatin|mesh-list
25400750|NCT03840915|Pemetrexed|pemetrexed|mesh-list
25400751|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400752|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400753|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400754|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400755|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400756|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400757|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400758|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
25400759|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
25400760|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400761|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400762|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400763|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
25400764|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400765|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400766|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400767|NCT03840239|Capecitabine|capecitabine|mesh-list
25400768|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
25400769|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400770|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
25400771|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400772|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400773|NCT03839940|Dexamethasone|dexamethasone|mesh-list
25400774|NCT03839940|Everolimus|everolimus|mesh-list
25400775|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400776|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
25400777|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
25400778|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400785|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400786|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400787|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
25400789|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25400790|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25400791|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25400792|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25400793|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400794|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
25400795|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25400796|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400797|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25400798|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400799|NCT03839459|Denosumab|denosumab|mesh-list
25400800|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25400801|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400802|NCT03838796|Lenvatinib|lenvatinib|mesh-list
25400803|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400804|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400805|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400806|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400807|NCT03838159|Paclitaxel|paclitaxel|mesh-list
25400808|NCT03838159|Carboplatin|carboplatin|mesh-list
25400810|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400811|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400812|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400814|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400815|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400816|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400817|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400818|NCT03837899|Durvalumab|durvalumab|mesh-list
25400819|NCT03837899|Tremelimumab|tremelimumab|mesh-list
25400820|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25400821|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400822|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400823|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
25400824|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400825|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25400826|NCT03836261|Venetoclax|venetoclax|mesh-list
25400827|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
25400828|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
25400829|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400830|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400831|NCT03836209|Cytarabine|cytarabine|mesh-list
25400832|NCT03836209|Daunorubicin|daunorubicin|mesh-list
25400833|NCT03836209|Midostaurin|midostaurin|mesh-list
25400834|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400835|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
25400836|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400837|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400838|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
25400839|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25400840|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25400841|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
25400842|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400843|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25400844|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25400845|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25400846|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400847|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400859|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400860|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400861|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400862|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400863|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
25400864|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
25400865|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400867|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
25400868|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400869|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400870|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400871|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400872|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400873|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400874|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400875|NCT03834883|Ibutilide|ibutilide|mesh-list
25400876|NCT03834883|Progesterone|progesterone|mesh-list
25400877|NCT03834883|Progestins|progestins|mesh-ancestor
25400878|NCT03834883|Hormones|hormones|mesh-ancestor
25400879|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400880|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400881|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25400882|NCT03834623|Nivolumab|nivolumab|mesh-list
25400883|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400884|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400885|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400886|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400887|NCT03834506|Dexamethasone|dexamethasone|mesh-list
25400888|NCT03834506|Prednisone|prednisone|mesh-list
25400889|NCT03834506|Docetaxel|docetaxel|mesh-list
25400890|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
25400891|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25400892|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
25400893|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
25400894|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400895|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400896|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25400897|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
25400898|NCT03834506|Hormones|hormones|mesh-ancestor
25400899|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400900|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400901|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400902|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400903|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400904|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400905|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400906|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400907|NCT03833440|Docetaxel|docetaxel|mesh-list
25400908|NCT03833440|Durvalumab|durvalumab|mesh-list
25400909|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400910|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400911|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400912|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400913|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400914|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400915|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
25400916|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400917|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400918|NCT03833154|Durvalumab|durvalumab|mesh-list
25400919|NCT03833154|Osimertinib|osimertinib|mesh-list
25400920|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400921|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400922|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400923|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400924|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400925|NCT03832998|Erenumab|erenumab|mesh-list
25400926|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25400927|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25400928|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400929|NCT03832998|Analgesics|analgesics|mesh-ancestor
25400930|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
25400931|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400932|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400933|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
25400934|NCT03832361|Maytansine|maytansine|mesh-list
25400935|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400936|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400937|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400938|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400939|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400940|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400941|NCT03831425|Ubiquinone|ubiquinone|mesh-list
25400942|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
25400943|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
25400944|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400945|NCT03831425|Vitamins|vitamins|mesh-ancestor
25400946|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25400947|NCT03830723|Hormones|hormones|mesh-ancestor
25400948|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400949|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400950|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
25400951|NCT03829683|Vitamins|vitamins|mesh-ancestor
25400952|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
25400953|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400954|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
25400955|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400956|NCT03829683|Protective Agents|protective agents|mesh-ancestor
25400957|NCT03829501|Atezolizumab|atezolizumab|mesh-list
25400958|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400959|NCT03829436|Nivolumab|nivolumab|mesh-list
25400960|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400961|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400962|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400963|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400964|NCT03829410|Bevacizumab|bevacizumab|mesh-list
25400965|NCT03829410|Onvansertib|onvansertib|mesh-list
25400966|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400967|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400968|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25400969|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25400970|NCT03829410|Growth Substances|growth substances|mesh-ancestor
25431816|NCT00978562|Hematinics|hematinics|mesh-ancestor
25400971|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400972|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
25400973|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400974|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400975|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400976|NCT03829319|Cisplatin|cisplatin|mesh-list
25400977|NCT03829319|Carboplatin|carboplatin|mesh-list
25400978|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
25400979|NCT03829319|Pemetrexed|pemetrexed|mesh-list
25400980|NCT03829319|Lenvatinib|lenvatinib|mesh-list
25400981|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400982|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400983|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400984|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400985|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400986|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400987|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400988|NCT03829111|Nivolumab|nivolumab|mesh-list
25400989|NCT03829111|Ipilimumab|ipilimumab|mesh-list
25400990|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400991|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400992|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400993|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400994|NCT03829020|Metformin|metformin|mesh-list
25400995|NCT03829020|Nelfinavir|nelfinavir|mesh-list
25400996|NCT03829020|Bortezomib|bortezomib|mesh-list
25400997|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25400998|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400999|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401000|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25401001|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25401002|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
25401003|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401004|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401005|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25401006|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25401007|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
25401008|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401009|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25401010|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
25401011|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401012|NCT03826992|Cytarabine|cytarabine|mesh-list
25401013|NCT03826992|Daunorubicin|daunorubicin|mesh-list
25401014|NCT03826992|Venetoclax|venetoclax|mesh-list
25401015|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401016|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
25401017|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401018|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401019|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
25401020|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401021|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401022|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
25401023|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401024|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401025|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25401026|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401027|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401028|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
25401029|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25401030|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
25401031|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
25401032|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25401033|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401034|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25401035|NCT03826693|Analgesics|analgesics|mesh-ancestor
25401036|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
25401037|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401038|NCT03826628|Sirolimus|sirolimus|mesh-list
25401039|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25401040|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401041|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401042|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401043|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
25401044|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401045|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
25772332|NCT03679975|Protective Agents|protective agents|mesh-ancestor
25401046|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401048|NCT03825796|Daunorubicin|daunorubicin|mesh-list
25401049|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401050|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
25401051|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401052|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401053|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
25401054|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401055|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401056|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
25401057|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401058|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401059|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25401060|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401061|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401062|NCT03825757|Aspirin|aspirin|mesh-list
25401063|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
25401064|NCT03825757|Salicylates|salicylates|mesh-list
25401065|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401066|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
25401067|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
25401068|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
25401069|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25401070|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25401071|NCT03825757|Analgesics|analgesics|mesh-ancestor
25401072|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
25401073|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401074|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401075|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401076|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401077|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25401078|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401079|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401080|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25401081|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25401238|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
25401082|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25401083|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
25401084|NCT03825198|Dexamethasone|dexamethasone|mesh-list
25401085|NCT03825198|Ketorolac|ketorolac|mesh-list
25401086|NCT03825198|Sufentanil|sufentanil|mesh-list
25401087|NCT03825198|Morphine|morphine|mesh-list
25401088|NCT03825198|Bromides|bromides|mesh-list
25401089|NCT03825198|Propofol|propofol|mesh-list
25401090|NCT03825198|Sevoflurane|sevoflurane|mesh-list
25401091|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
25401092|NCT03825198|Rocuronium|rocuronium|mesh-list
25401093|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401094|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
25401095|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
25401096|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401097|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401098|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401099|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
25401100|NCT03825198|Hormones|hormones|mesh-ancestor
25401101|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401102|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25401103|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401104|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25401105|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25401106|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25401107|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
25401108|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
25401109|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25401110|NCT03825198|Narcotics|narcotics|mesh-ancestor
25401111|NCT03825198|Analgesics|analgesics|mesh-ancestor
25401112|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
25401113|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25401114|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25401115|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25401116|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25401117|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401118|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25401119|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401120|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401122|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25431968|NCT00936832|Irinotecan|irinotecan|mesh-list
25401123|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25401124|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25401125|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25401126|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
25401127|NCT03824938|Aspirin|aspirin|mesh-list
25401128|NCT03824938|Acetaminophen|acetaminophen|mesh-list
25401129|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25401130|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25401131|NCT03824938|Analgesics|analgesics|mesh-ancestor
25401132|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
25401133|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401134|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401135|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401136|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401137|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25401138|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25401139|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401140|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25401141|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25401142|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401143|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
25401144|NCT03824483|Venetoclax|venetoclax|mesh-list
25401145|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
25401146|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
25401147|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401148|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401149|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25401150|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401151|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401152|NCT03824106|Vitamin D|vitamin d|mesh-list
25401153|NCT03824106|Vitamins|vitamins|mesh-ancestor
25401154|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
25401155|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401156|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25401157|NCT03823300|Aflibercept|aflibercept|mesh-list
25401158|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25401159|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25401160|NCT03823300|Growth Substances|growth substances|mesh-ancestor
25401161|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401162|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
25401163|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401164|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
25401165|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401166|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401167|NCT03822468|Letrozole|letrozole|mesh-list
25401168|NCT03822468|Anastrozole|anastrozole|mesh-list
25401169|NCT03822468|Goserelin|goserelin|mesh-list
25401170|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401171|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25401172|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25401173|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401174|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401175|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25401176|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
25401177|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401178|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401179|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25401180|NCT03822351|Durvalumab|durvalumab|mesh-list
25401181|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25401182|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401183|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401184|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
25401185|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401186|NCT03821792|Prednisone|prednisone|mesh-list
25401187|NCT03821792|Cortisone|cortisone|mesh-list
25401188|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
25401189|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401190|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
25401191|NCT03821792|Hormones|hormones|mesh-ancestor
25401192|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401193|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401194|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25401195|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401196|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25772333|NCT03680521|Nivolumab|nivolumab|mesh-list
25401197|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401198|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401199|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
25401200|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25401201|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
25401202|NCT03820986|Lenvatinib|lenvatinib|mesh-list
25401203|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401204|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401205|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25401206|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401207|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401208|NCT03820726|Nintedanib|nintedanib|mesh-list
25401209|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401210|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25401211|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401212|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401213|NCT03820141|Trastuzumab|trastuzumab|mesh-list
25401214|NCT03820141|Durvalumab|durvalumab|mesh-list
25401215|NCT03820141|Pertuzumab|pertuzumab|mesh-list
25401216|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401217|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401218|NCT03819530|Micronutrients|micronutrients|mesh-list
25401219|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401220|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25401221|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
25401222|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401223|NCT03818672|Rifaximin|rifaximin|mesh-list
25401224|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25401225|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401226|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401227|NCT03818191|Acamprosate|acamprosate|mesh-list
25401228|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25401229|NCT03817853|Prednisone|prednisone|mesh-list
25401230|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
25401231|NCT03817853|Prednisolone|prednisolone|mesh-list
25401232|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
25401233|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25401234|NCT03817853|Doxorubicin|doxorubicin|mesh-list
25401235|NCT03817853|Vincristine|vincristine|mesh-list
25401236|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
25401237|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401239|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401240|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401241|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25401242|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
25401243|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401244|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401245|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25401246|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401247|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25401248|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401249|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401250|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401251|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
25401252|NCT03817853|Hormones|hormones|mesh-ancestor
25401253|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401254|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25401255|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401256|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401257|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401258|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401259|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
25401260|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
25401261|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401262|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401263|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25401264|NCT03817853|Protective Agents|protective agents|mesh-ancestor
25401265|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401266|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25401267|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401268|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401270|NCT03817320|Cytarabine|cytarabine|mesh-list
25401271|NCT03817320|Dexamethasone|dexamethasone|mesh-list
25401272|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
25401273|NCT03817320|Doxorubicin|doxorubicin|mesh-list
25401274|NCT03817320|Methotrexate|methotrexate|mesh-list
25401275|NCT03817320|Vincristine|vincristine|mesh-list
25401276|NCT03817320|Asparaginase|asparaginase|mesh-list
25401277|NCT03817320|Ixazomib|ixazomib|mesh-list
25401278|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401279|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
25401280|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
25401281|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401282|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401283|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401284|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
25401285|NCT03817320|Hormones|hormones|mesh-ancestor
25401286|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401287|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25401288|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401289|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401290|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25401291|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401292|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401293|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401294|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25401295|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
25401296|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25401297|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401298|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
25401299|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
25401300|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25401301|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401302|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
25401303|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401304|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25401305|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
25401306|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401307|NCT03817320|Antidotes|antidotes|mesh-ancestor
25401308|NCT03817320|Protective Agents|protective agents|mesh-ancestor
25401309|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
25401310|NCT03817320|Vitamins|vitamins|mesh-ancestor
25401311|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
25401312|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401313|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401314|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401315|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401316|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
25401317|NCT03816358|Gemcitabine|gemcitabine|mesh-list
25401318|NCT03816358|Nivolumab|nivolumab|mesh-list
25401319|NCT03816358|Ipilimumab|ipilimumab|mesh-list
25401320|NCT03816358|Maytansine|maytansine|mesh-list
25401321|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401322|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
25401323|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401324|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401325|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
25401326|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401327|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401328|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401329|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
25401330|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401331|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401332|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25401333|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401334|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401335|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401336|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401337|NCT03816345|Nivolumab|nivolumab|mesh-list
25401338|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401339|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401340|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25401341|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401342|NCT03816176|Isavuconazole|isavuconazole|mesh-list
25401343|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
25401344|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401345|NCT03816163|Gemcitabine|gemcitabine|mesh-list
25401346|NCT03816163|Paclitaxel|paclitaxel|mesh-list
25401347|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401348|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401349|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401350|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401351|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401352|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401353|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401354|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
25401355|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
25401356|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401357|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401358|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401359|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
25401360|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401361|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
25401362|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401363|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401364|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
25401365|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401366|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401367|NCT03814954|Epinephrine|epinephrine|mesh-list
25401368|NCT03814954|Albuterol|albuterol|mesh-list
25401369|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25401370|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25401371|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
25401372|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401373|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401374|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401375|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25401376|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25401377|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
25401378|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401379|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25401380|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
25401381|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
25401382|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
25401383|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25401384|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
25401385|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25401386|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25401387|NCT03814941|Anesthetics|anesthetics|mesh-list
25401388|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25401389|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401390|NCT03814590|Vaccines|vaccines|mesh-list
25401391|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
25401399|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25401400|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25401401|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401402|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25401403|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
25401404|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25401405|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
25401406|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
25401407|NCT03814109|Vitamins|vitamins|mesh-ancestor
25401408|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
25401409|NCT03813160|Dronabinol|dronabinol|mesh-list
25401410|NCT03813160|Lenabasum|lenabasum|mesh-list
25401411|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25401412|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25401413|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401414|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401415|NCT03813160|Hormones|hormones|mesh-ancestor
25401416|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401417|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401418|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
25401419|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25401420|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25401421|NCT03813160|Analgesics|analgesics|mesh-ancestor
25401422|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
25401423|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401425|NCT03813121|Ketamine|ketamine|mesh-list
25401426|NCT03813121|Analgesics|analgesics|mesh-ancestor
25401427|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
25401428|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401429|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401430|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25401431|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25401432|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
25401433|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
25404212|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
25401451|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401453|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
25401454|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401455|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401482|NCT03810495|Naltrexone|naltrexone|mesh-list
25401483|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25401484|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25401485|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401486|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
25401487|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401488|NCT03810313|Aflibercept|aflibercept|mesh-list
25401489|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25401490|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25401491|NCT03810313|Growth Substances|growth substances|mesh-ancestor
25401492|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401493|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
25401494|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401495|NCT03808818|Nicotine|nicotine|mesh-list
25401496|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25401497|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
25401498|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401499|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401500|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25401501|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25401502|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
25401503|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401504|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401506|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25401507|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401508|NCT03807856|Dabigatran|dabigatran|mesh-list
25401509|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
25401510|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25401511|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
25401512|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401513|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401514|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
25401515|NCT03807843|Vaccines|vaccines|mesh-list
25401516|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
25401517|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401519|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401520|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25401521|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401522|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401523|NCT03807037|Tocotrienols|tocotrienols|mesh-list
25401524|NCT03807037|Vitamin E|vitamin e|mesh-list
25401525|NCT03807037|Tocopherols|tocopherols|mesh-list
25401526|NCT03807037|Tocovid|tocovid|mesh-list
25401527|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
25401528|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401529|NCT03807037|Protective Agents|protective agents|mesh-ancestor
25401530|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401531|NCT03807037|Vitamins|vitamins|mesh-ancestor
25401532|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
25401533|NCT03806985|Psilocybin|psilocybin|mesh-list
25401534|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
25401535|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401536|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25401537|NCT03806530|Gabapentin|gabapentin|mesh-list
25401538|NCT03806530|Ropinirole|ropinirole|mesh-list
25401539|NCT03806530|Analgesics|analgesics|mesh-ancestor
25401540|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
25401541|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401542|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401543|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
25401544|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25401545|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25401546|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25401547|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25401548|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25401549|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25401550|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401551|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401552|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
25401553|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25401554|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25401555|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
25401556|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
25401557|NCT03805932|Rituximab|rituximab|mesh-list
25401558|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
25401559|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401560|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401561|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
25401562|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401563|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401564|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
25401565|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25401566|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
25401567|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401568|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401569|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25401570|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25401571|NCT03805607|Ketorolac|ketorolac|mesh-list
25401572|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25401573|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25401574|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25401575|NCT03805607|Analgesics|analgesics|mesh-ancestor
25401576|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
25401577|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401578|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401579|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401580|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401581|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25401582|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401583|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401584|NCT03805399|Sirolimus|sirolimus|mesh-list
25401585|NCT03805399|Paclitaxel|paclitaxel|mesh-list
25401586|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25401587|NCT03805399|Capecitabine|capecitabine|mesh-list
25401588|NCT03805399|Everolimus|everolimus|mesh-list
25401589|NCT03805399|Apatinib|apatinib|mesh-list
25401590|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25401591|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401592|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401593|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401594|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401595|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401596|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401597|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401598|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
25401599|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401600|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
25401601|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401602|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401603|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25401604|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25401605|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401606|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401607|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
25401608|NCT03805022|Doxorubicin|doxorubicin|mesh-list
25401609|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25401610|NCT03805022|Ifosfamide|ifosfamide|mesh-list
25401611|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
25401612|NCT03805022|Dacarbazine|dacarbazine|mesh-list
25401613|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401614|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401615|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25401616|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401617|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401618|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401619|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25401620|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
25401621|NCT03802799|Cannabidiol|cannabidiol|mesh-list
25401622|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
25401623|NCT03802630|Aflibercept|aflibercept|mesh-list
25401624|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25401625|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25401626|NCT03802630|Growth Substances|growth substances|mesh-ancestor
25401627|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401628|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
25401629|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401630|NCT03802604|Atezolizumab|atezolizumab|mesh-list
25401631|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25401632|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401633|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401634|NCT03802591|Capecitabine|capecitabine|mesh-list
25401635|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
25401636|NCT03802591|Antibodies|antibodies|mesh-list
25401637|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25401638|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
25401639|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401640|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401641|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
25401642|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401643|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401644|NCT03802240|Cisplatin|cisplatin|mesh-list
25401645|NCT03802240|Pemetrexed|pemetrexed|mesh-list
25401646|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401647|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401648|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401649|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25401650|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25401651|NCT03801876|Paclitaxel|paclitaxel|mesh-list
25401652|NCT03801876|Docetaxel|docetaxel|mesh-list
25401653|NCT03801876|Carboplatin|carboplatin|mesh-list
25401654|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25401655|NCT03801876|Fluorouracil|fluorouracil|mesh-list
25401656|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401657|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401658|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401659|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401660|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401661|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401662|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
25401663|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401664|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401665|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
25401666|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401667|NCT03801525|Venetoclax|venetoclax|mesh-list
25401668|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401669|NCT03801369|Durvalumab|durvalumab|mesh-list
25401670|NCT03801369|Olaparib|olaparib|mesh-list
25401686|NCT03800134|Durvalumab|durvalumab|mesh-list
25401687|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401688|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401689|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401690|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401691|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401692|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401693|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401694|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
25401695|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
25401696|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401697|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401698|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401699|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
25401700|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401701|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25401702|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25401703|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401704|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
25401705|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
25401706|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401707|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
25401708|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401709|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401710|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
25401711|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401712|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401713|NCT03798678|Dexamethasone|dexamethasone|mesh-list
25401714|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
25401715|NCT03798678|Ichthammol|ichthammol|mesh-list
25401716|NCT03798678|BB 1101|bb 1101|mesh-list
25401717|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401718|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
25401719|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
25401720|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401721|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401722|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401723|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
25401724|NCT03798678|Hormones|hormones|mesh-ancestor
25401725|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401726|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25401727|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401728|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
25401729|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401730|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401731|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
25401786|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401787|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401788|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401789|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25401790|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
25401791|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
25401792|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401793|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401794|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25401795|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25401796|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25401797|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401798|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25401800|NCT03794037|Progesterone|progesterone|mesh-list
25401801|NCT03794037|Progestins|progestins|mesh-ancestor
25401802|NCT03794037|Hormones|hormones|mesh-ancestor
25401803|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25401804|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401805|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25401806|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
25401807|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25401808|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
25401809|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25401810|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25401811|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401812|NCT03793478|Cytarabine|cytarabine|mesh-list
25401813|NCT03793478|Fludarabine|fludarabine|mesh-list
25401814|NCT03793478|Etoposide|etoposide|mesh-list
25401815|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401816|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25401817|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
25401818|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401819|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401820|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
25401821|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401822|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401823|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25401824|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401825|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401826|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
25401827|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401850|NCT03792841|Analgesics|analgesics|mesh-ancestor
25401851|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
25401852|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25401853|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401854|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25401855|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401856|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401857|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401858|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
25401859|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401861|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25401862|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25401863|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401864|NCT03791736|Octreotide|octreotide|mesh-list
25401865|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401866|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25401867|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401868|NCT03791593|Evolocumab|evolocumab|mesh-list
25401869|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25401870|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25401871|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
25401872|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401873|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25401874|NCT03790800|Urapidil|urapidil|mesh-list
25401875|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25401876|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
25401877|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25401878|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
25401879|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401880|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401881|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401882|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25401883|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25401884|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25401885|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
25401886|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25401887|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401888|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401889|NCT03790137|Fenfluramine|fenfluramine|mesh-list
25401890|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25401891|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25401892|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25401893|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401894|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401895|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
25401896|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401897|NCT03789240|Rituximab|rituximab|mesh-list
25401898|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401899|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401900|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
25401901|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401902|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401903|NCT03789214|Suvorexant|suvorexant|mesh-list
25401904|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25401905|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25401906|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25401907|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401908|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25401909|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401910|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401911|NCT03789110|Nivolumab|nivolumab|mesh-list
25401912|NCT03789110|Ipilimumab|ipilimumab|mesh-list
25401913|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401914|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401915|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25401916|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401917|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
25401918|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
25401919|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401920|NCT03788759|Protective Agents|protective agents|mesh-ancestor
25401921|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401922|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
25401923|NCT03788759|Vitamins|vitamins|mesh-ancestor
25401924|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
25401925|NCT03787602|Avelumab|avelumab|mesh-list
25401940|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
25401941|NCT03786783|Daunorubicin|daunorubicin|mesh-list
25401942|NCT03786783|Topotecan|topotecan|mesh-list
25401943|NCT03786783|Tretinoin|tretinoin|mesh-list
25401944|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
25401945|NCT03786783|Dinutuximab|dinutuximab|mesh-list
25401946|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
25401947|NCT03786783|Razoxane|razoxane|mesh-list
25401948|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
25401949|NCT03786783|Isotretinoin|isotretinoin|mesh-list
25401950|NCT03786783|Sargramostim|sargramostim|mesh-list
25401951|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25401952|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
25401953|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401954|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401955|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25401956|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
25401957|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401958|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401959|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25401960|NCT03786783|Vitamins|vitamins|mesh-ancestor
25401961|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
25401962|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25401963|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25401964|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401965|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401966|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25401967|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
25401968|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
25401969|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
25401970|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25401971|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
25401972|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
25401973|NCT03786783|Protective Agents|protective agents|mesh-ancestor
25401974|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25401985|NCT03785210|Vancomycin|vancomycin|mesh-list
25401986|NCT03785210|Nivolumab|nivolumab|mesh-list
25401987|NCT03785210|Tadalafil|tadalafil|mesh-list
25401988|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401989|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401990|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25401991|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401992|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25401993|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25401994|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
25401995|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25401996|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25401997|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401998|NCT03785210|Urological Agents|urological agents|mesh-ancestor
25401999|NCT03783715|Ketoprofen|ketoprofen|mesh-list
25402000|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25402001|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25402002|NCT03783715|Analgesics|analgesics|mesh-ancestor
25402003|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
25402004|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402005|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402006|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402007|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402008|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25402009|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402010|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402011|NCT03783403|Rituximab|rituximab|mesh-list
25402012|NCT03783403|Cetuximab|cetuximab|mesh-list
25402013|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402014|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402015|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
25402016|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402017|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402018|NCT03782415|Temozolomide|temozolomide|mesh-list
25402019|NCT03782415|Ibudilast|ibudilast|mesh-list
25402020|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402021|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
25402022|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402023|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402024|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25402025|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
25402026|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402027|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402028|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25402029|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
25402030|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25402031|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402032|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25402033|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
25402034|NCT03782376|Ustekinumab|ustekinumab|mesh-list
25402035|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
25402036|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
25402037|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25402038|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402039|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25402040|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402041|NCT03782207|Atezolizumab|atezolizumab|mesh-list
25402042|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402043|NCT03782064|Nivolumab|nivolumab|mesh-list
25402044|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402045|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402046|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25402047|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402048|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
25402049|NCT03781934|Lenvatinib|lenvatinib|mesh-list
25402050|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402051|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402052|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25402053|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402054|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402055|NCT03781388|Bupivacaine|bupivacaine|mesh-list
25402056|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
25402057|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
25402058|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25402059|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402060|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
25402061|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402062|NCT03779854|Vidarabine|vidarabine|mesh-list
25402063|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
25402064|NCT03779854|Busulfan|busulfan|mesh-list
25402065|NCT03779854|Thiotepa|thiotepa|mesh-list
25402066|NCT03779854|Methotrexate|methotrexate|mesh-list
25402067|NCT03779854|Fludarabine|fludarabine|mesh-list
25402068|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
25402069|NCT03779854|Tacrolimus|tacrolimus|mesh-list
25402070|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402071|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
25402072|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402073|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402074|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402075|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
25402076|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402077|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402078|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25402079|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25402080|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
25402081|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25402082|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402083|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
25402084|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
25402085|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402086|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25402091|NCT03779646|Bisoprolol|bisoprolol|mesh-list
25402092|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25402093|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
25402094|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
25402095|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402096|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402097|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25402098|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25402099|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25402100|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
25402101|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402102|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402107|NCT03779048|Phentermine|phentermine|mesh-list
25402186|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
25402108|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25402109|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402110|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
25402111|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25402112|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
25402113|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
25402114|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402115|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
25402116|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402117|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402118|NCT03778957|Bevacizumab|bevacizumab|mesh-list
25402119|NCT03778957|Durvalumab|durvalumab|mesh-list
25402120|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402121|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402122|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25402123|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25402124|NCT03778957|Growth Substances|growth substances|mesh-ancestor
25402125|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402126|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
25402127|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
25402128|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
25402129|NCT03778580|Vitamins|vitamins|mesh-ancestor
25402130|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
25402131|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402132|NCT03778294|Temozolomide|temozolomide|mesh-list
25402133|NCT03778294|Levodopa|levodopa|mesh-list
25402134|NCT03778294|Fluorides|fluorides|mesh-list
25402135|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402136|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
25402137|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402138|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402139|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
25402140|NCT03778294|Protective Agents|protective agents|mesh-ancestor
25402141|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402142|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
25402143|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402144|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25402145|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25402146|NCT03778229|Osimertinib|osimertinib|mesh-list
25402147|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402148|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25402149|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402150|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402151|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25402152|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25402231|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
25402153|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402154|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
25402155|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402156|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402157|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
25402158|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402159|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
25402160|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25402161|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
25402162|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402163|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
25402164|NCT03777917|Protective Agents|protective agents|mesh-ancestor
25402166|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
25402167|NCT03777813|Durvalumab|durvalumab|mesh-list
25402168|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
25402169|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402170|NCT03777813|Antidotes|antidotes|mesh-ancestor
25402171|NCT03777813|Protective Agents|protective agents|mesh-ancestor
25402172|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402173|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
25402174|NCT03777813|Vitamins|vitamins|mesh-ancestor
25402175|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
25402176|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402177|NCT03777657|Cisplatin|cisplatin|mesh-list
25402178|NCT03777657|Capecitabine|capecitabine|mesh-list
25402179|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
25402180|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402181|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402182|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
25402183|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402184|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
25402185|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
25402187|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402188|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402189|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
25402190|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402191|NCT03775460|Prednisolone|prednisolone|mesh-list
25402192|NCT03775460|Methotrexate|methotrexate|mesh-list
25402193|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25402194|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
25402195|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25402196|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402197|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402198|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
25402199|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402200|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402201|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
25402202|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402203|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25402204|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402205|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
25402206|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402207|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25402208|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402209|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
25402210|NCT03775460|Hormones|hormones|mesh-ancestor
25402211|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402212|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402213|NCT03775265|Gemcitabine|gemcitabine|mesh-list
25402214|NCT03775265|Cisplatin|cisplatin|mesh-list
25402215|NCT03775265|Fluorouracil|fluorouracil|mesh-list
25402216|NCT03775265|Atezolizumab|atezolizumab|mesh-list
25402217|NCT03775265|Mitomycins|mitomycins|mesh-list
25402218|NCT03775265|Mitomycin|mitomycin|mesh-list
25402219|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25402220|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402221|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402222|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
25402223|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402224|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
25402225|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402226|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402227|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402228|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
25402229|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402230|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25402232|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25402233|NCT03775096|Carvedilol|carvedilol|mesh-list
25402234|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25402235|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25402236|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
25402237|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402238|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402239|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402240|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25402241|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
25402242|NCT03775096|Protective Agents|protective agents|mesh-ancestor
25402243|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25402244|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25402245|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25402246|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
25402247|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25402248|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25402249|NCT03775070|Simvastatin|simvastatin|mesh-list
25402250|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25402251|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25402252|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
25402253|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402254|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25402255|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25402256|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402257|NCT03774875|Apremilast|apremilast|mesh-list
25402258|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25402259|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25402260|NCT03774875|Analgesics|analgesics|mesh-ancestor
25402409|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
25402261|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
25402262|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402263|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402264|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402265|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402266|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25402267|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25402268|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402269|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402270|NCT03774732|Paclitaxel|paclitaxel|mesh-list
25402271|NCT03774732|Cisplatin|cisplatin|mesh-list
25402272|NCT03774732|Carboplatin|carboplatin|mesh-list
25402273|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
25402274|NCT03774732|Pemetrexed|pemetrexed|mesh-list
25402275|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402276|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402277|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402278|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402279|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402280|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402281|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402282|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402283|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25402284|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25402285|NCT03774654|Cyclophosphamide|cyclophosphamide|mesh-list
25402286|NCT03774654|Fludarabine|fludarabine|mesh-list
25402287|NCT03774654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402288|NCT03774654|Immunologic Factors|immunologic factors|mesh-ancestor
25402289|NCT03774654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402290|NCT03774654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402291|NCT03774654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402292|NCT03774654|Alkylating Agents|alkylating agents|mesh-ancestor
25402293|NCT03774654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402294|NCT03774654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402295|NCT03774654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25402296|NCT03774394|Clopidogrel|clopidogrel|mesh-list
25402297|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25402298|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25402299|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25402300|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25402301|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
25402302|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402303|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402304|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402305|NCT03773666|Durvalumab|durvalumab|mesh-list
25402306|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402307|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402308|NCT03773562|Erenumab|erenumab|mesh-list
25402309|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25408468|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
25402310|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402311|NCT03773562|Analgesics|analgesics|mesh-ancestor
25402312|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
25402313|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402314|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402315|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
25402316|NCT03773484|Narcotics|narcotics|mesh-ancestor
25402317|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25402318|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402319|NCT03773484|Analgesics|analgesics|mesh-ancestor
25402320|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
25402321|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402322|NCT03773302|Gemcitabine|gemcitabine|mesh-list
25402323|NCT03773302|Cisplatin|cisplatin|mesh-list
25402324|NCT03773302|Infigratinib|infigratinib|mesh-list
25402325|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402326|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402327|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
25402328|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402329|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
25402330|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402331|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402332|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402333|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
25402334|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402335|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25402336|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
25402337|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
25402338|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402339|NCT03773107|Dexamethasone|dexamethasone|mesh-list
25402340|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402341|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
25402342|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
25402343|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402344|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402345|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25402346|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
25402347|NCT03773107|Hormones|hormones|mesh-ancestor
25402348|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402349|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402350|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402351|NCT03772925|Belinostat|belinostat|mesh-list
25402352|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25402353|NCT03772925|Pevonedistat|pevonedistat|mesh-list
25402354|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402355|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402356|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25402357|NCT03772834|Methylphenidate|methylphenidate|mesh-list
25402358|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25402359|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402360|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25402361|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25402362|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25402363|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402364|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
25402365|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402366|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
25402367|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25402368|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
25402369|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25402370|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
25402371|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402372|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25402373|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25402374|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402375|NCT03770286|Fluorides|fluorides|mesh-list
25402376|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
25402377|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
25402383|NCT03769766|Analgesics|analgesics|mesh-ancestor
25402384|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
25402385|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402386|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402387|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402388|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402389|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402390|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402391|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402393|NCT03769090|Albuterol|albuterol|mesh-list
25402394|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402395|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25402396|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
25402397|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402398|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402399|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25402400|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
25402401|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
25402402|NCT03769090|Hormones|hormones|mesh-ancestor
25402403|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402404|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
25402405|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25402406|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25402407|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25402408|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25402410|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402411|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402412|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25402413|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25402414|NCT03769025|Narcotics|narcotics|mesh-ancestor
25402415|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25402416|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402417|NCT03769025|Analgesics|analgesics|mesh-ancestor
25402418|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
25402419|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402420|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25402421|NCT03768960|Daratumumab|daratumumab|mesh-list
25402422|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402423|NCT03768570|Durvalumab|durvalumab|mesh-list
25402424|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402425|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402426|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25402427|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25402428|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402429|NCT03768063|Atezolizumab|atezolizumab|mesh-list
25402430|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402436|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25402437|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25402438|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25402439|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
25402440|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402441|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25402442|NCT03767244|Androgens|androgens|mesh-list
25402443|NCT03767244|Hormones|hormones|mesh-ancestor
25402444|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402445|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402446|NCT03766763|Venetoclax|venetoclax|mesh-list
25402447|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402448|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
25402449|NCT03766750|Linagliptin|linagliptin|mesh-list
25402450|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25402451|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402452|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25402453|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402454|NCT03766750|Incretins|incretins|mesh-ancestor
25402455|NCT03766750|Hormones|hormones|mesh-ancestor
25402456|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402457|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25402458|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
25402459|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402460|NCT03765918|Cisplatin|cisplatin|mesh-list
25402461|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
25402462|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402463|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402464|NCT03765541|Cytarabine|cytarabine|mesh-list
25402465|NCT03765541|Dexamethasone|dexamethasone|mesh-list
25402466|NCT03765541|Azacitidine|azacitidine|mesh-list
25402467|NCT03765541|Amsacrine|amsacrine|mesh-list
25402468|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402469|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
25402470|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
25402471|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402472|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402473|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25402474|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
25402475|NCT03765541|Hormones|hormones|mesh-ancestor
25402476|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402477|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402478|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402479|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402480|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
25402481|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402482|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
25402483|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402484|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402485|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
25402486|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402487|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
25402488|NCT03765229|Entinostat|entinostat|mesh-list
25402489|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402490|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402491|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25402492|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402493|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402494|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25402495|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25402496|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402497|NCT03762564|Paclitaxel|paclitaxel|mesh-list
25402498|NCT03762564|Ramucirumab|ramucirumab|mesh-list
25402499|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402500|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402501|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402502|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402503|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402504|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402505|NCT03762018|Bevacizumab|bevacizumab|mesh-list
25402506|NCT03762018|Carboplatin|carboplatin|mesh-list
25402507|NCT03762018|Pemetrexed|pemetrexed|mesh-list
25402508|NCT03762018|Atezolizumab|atezolizumab|mesh-list
25402509|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402510|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402511|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25402512|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25402513|NCT03762018|Growth Substances|growth substances|mesh-ancestor
25402514|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402515|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
25402516|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402517|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402518|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25402519|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25402520|NCT03760666|Ribavirin|ribavirin|mesh-list
25402521|NCT03760666|Brequinar|brequinar|mesh-list
25402522|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
25402523|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402524|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
25402525|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402526|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402527|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402528|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402529|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
25402530|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402531|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
25402532|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25402533|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402534|NCT03760458|Lamivudine|lamivudine|mesh-list
25402535|NCT03760458|Abacavir|abacavir|mesh-list
25402536|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
25402537|NCT03760458|Dolutegravir|dolutegravir|mesh-list
25402538|NCT03760458|Triumeq|triumeq|mesh-list
25402539|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25402540|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25402541|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402542|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402543|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
25402544|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402545|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25402546|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25402547|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25402548|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25402549|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
25402550|NCT03759366|Eculizumab|eculizumab|mesh-list
25402551|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25402552|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402553|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
25402554|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402555|NCT03759288|Adalimumab|adalimumab|mesh-list
25402556|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402557|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402558|NCT03759041|Vancomycin|vancomycin|mesh-list
25402559|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25402560|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402561|NCT03757715|Dexamethasone|dexamethasone|mesh-list
25402562|NCT03757715|Bupivacaine|bupivacaine|mesh-list
25402563|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402565|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
25402566|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402567|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402568|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25402569|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
25402570|NCT03757715|Hormones|hormones|mesh-ancestor
25402571|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402572|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402573|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402574|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
25402575|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
25402576|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25402577|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
25402578|NCT03755804|Prednisone|prednisone|mesh-list
25402579|NCT03755804|Prednisolone|prednisolone|mesh-list
25402580|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
25402581|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25402582|NCT03755804|Dacarbazine|dacarbazine|mesh-list
25402583|NCT03755804|Doxorubicin|doxorubicin|mesh-list
25402584|NCT03755804|Etoposide|etoposide|mesh-list
25402585|NCT03755804|Vincristine|vincristine|mesh-list
25402586|NCT03755804|Bleomycin|bleomycin|mesh-list
25402587|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25402588|NCT03755804|Vinblastine|vinblastine|mesh-list
25402589|NCT03755804|Imidazole|imidazole|mesh-list
25402590|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402591|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
25402592|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402593|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402594|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402595|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
25402596|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402597|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402598|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25402599|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25402600|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25402601|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25402602|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402603|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402604|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
25402605|NCT03755804|Hormones|hormones|mesh-ancestor
25402606|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402607|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402760|NCT03748134|Cisplatin|cisplatin|mesh-list
25402608|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402609|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402610|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402611|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402612|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402613|NCT03755440|Antibodies|antibodies|mesh-list
25402614|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
25402615|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402616|NCT03755102|Osimertinib|osimertinib|mesh-list
25402617|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402618|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25402619|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402620|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402621|NCT03754933|Fludarabine|fludarabine|mesh-list
25402622|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
25402623|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402624|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402625|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
25402626|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402627|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402628|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
25402629|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402630|NCT03754725|Deferiprone|deferiprone|mesh-list
25402631|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25402632|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
25402633|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
25402634|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402635|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
25402636|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402637|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402638|NCT03752684|Calcium|calcium|mesh-list
25402639|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25402640|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402641|NCT03752216|Niraparib|niraparib|mesh-list
25402642|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25402643|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402644|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402645|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402646|NCT03751436|Venetoclax|venetoclax|mesh-list
25402647|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402648|NCT03751423|Fentanyl|fentanyl|mesh-list
25402649|NCT03751423|Ketamine|ketamine|mesh-list
25402650|NCT03751423|Morphine|morphine|mesh-list
25402651|NCT03751423|Analgesics|analgesics|mesh-ancestor
25402652|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
25402653|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402654|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402655|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25402656|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25402657|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
25402658|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
25402659|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25402660|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25402661|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25402662|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402663|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402664|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25402665|NCT03751423|Narcotics|narcotics|mesh-ancestor
25402666|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25402667|NCT03750968|Carotenoids|carotenoids|mesh-list
25402668|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
25402669|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402670|NCT03750968|Protective Agents|protective agents|mesh-ancestor
25402671|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402672|NCT03749902|Misoprostol|misoprostol|mesh-list
25402673|NCT03749902|Oxytocin|oxytocin|mesh-list
25402674|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
25402675|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25402676|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402677|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25402678|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
25402679|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25402680|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25402681|NCT03749460|Nivolumab|nivolumab|mesh-list
25402682|NCT03749460|Ipilimumab|ipilimumab|mesh-list
25402683|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402684|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402685|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25402686|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402687|NCT03749109|Quinagolide|quinagolide|mesh-list
25402688|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
25402689|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
25402690|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402691|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402692|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402693|NCT03749070|Silymarin|silymarin|mesh-list
25402694|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
25402695|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402696|NCT03749070|Protective Agents|protective agents|mesh-ancestor
25402697|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402698|NCT03749018|Prednisone|prednisone|mesh-list
25402699|NCT03749018|Cortisone|cortisone|mesh-list
25402700|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
25402701|NCT03749018|Rituximab|rituximab|mesh-list
25402702|NCT03749018|Doxorubicin|doxorubicin|mesh-list
25402703|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25402704|NCT03749018|Nivolumab|nivolumab|mesh-list
25402705|NCT03749018|Etoposide|etoposide|mesh-list
25402706|NCT03749018|Vincristine|vincristine|mesh-list
25402707|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
25402708|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
25402709|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25402710|NCT03749018|Antibodies|antibodies|mesh-list
25402711|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
25402712|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25402713|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402714|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
25402715|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402716|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402717|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402718|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
25402719|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402720|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402721|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25402722|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25402723|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25402724|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25402725|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402726|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402727|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
25402728|NCT03749018|Hormones|hormones|mesh-ancestor
25402729|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402730|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402731|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25402732|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402733|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402734|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402735|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402736|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
25402737|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
25402738|NCT03748953|Ixazomib|ixazomib|mesh-list
25402739|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402740|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
25402741|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402742|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402743|NCT03748641|Prednisone|prednisone|mesh-list
25402744|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
25402745|NCT03748641|Niraparib|niraparib|mesh-list
25402746|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402747|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
25402748|NCT03748641|Hormones|hormones|mesh-ancestor
25402749|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402750|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402751|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402752|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402753|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25402754|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402755|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402756|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
25402757|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25402758|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25402759|NCT03748134|Paclitaxel|paclitaxel|mesh-list
25402761|NCT03748134|Fluorouracil|fluorouracil|mesh-list
25402762|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402763|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402764|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402765|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402766|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402767|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402768|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
25402769|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402770|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402771|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
25402772|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402773|NCT03747939|Thalidomide|thalidomide|mesh-list
25402774|NCT03747939|Apremilast|apremilast|mesh-list
25402775|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25402776|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25402777|NCT03747939|Analgesics|analgesics|mesh-ancestor
25402778|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
25402779|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402780|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402781|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402782|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402783|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25402784|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25402785|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402786|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402787|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402788|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
25402789|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
25402790|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25402791|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402792|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25402793|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25402794|NCT03747939|Growth Substances|growth substances|mesh-ancestor
25402795|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25402796|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402797|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
25402798|NCT03747432|Propofol|propofol|mesh-list
25402799|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25402800|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25402801|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402802|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25402803|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
25402804|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
25402805|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25402806|NCT03747432|Analgesics|analgesics|mesh-ancestor
25402807|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
25402808|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402809|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25402810|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25402811|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25402812|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
25402813|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402814|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402815|NCT03747120|Paclitaxel|paclitaxel|mesh-list
25402816|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
25402817|NCT03747120|Trastuzumab|trastuzumab|mesh-list
25402818|NCT03747120|Pertuzumab|pertuzumab|mesh-list
25402819|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402820|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402821|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402822|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402823|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402824|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402825|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402826|NCT03746041|Abaloparatide|abaloparatide|mesh-list
25402827|NCT03746041|Bevacizumab|bevacizumab|mesh-list
25402828|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402829|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402830|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25402831|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25402832|NCT03746041|Growth Substances|growth substances|mesh-ancestor
25402833|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402834|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
25402835|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25402836|NCT03745729|Allopurinol|allopurinol|mesh-list
25402837|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
25402838|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402839|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402840|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
25402841|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402842|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25402843|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
25402844|NCT03745729|Protective Agents|protective agents|mesh-ancestor
25402845|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402846|NCT03745430|Ramucirumab|ramucirumab|mesh-list
25402847|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402848|NCT03745326|Aldesleukin|aldesleukin|mesh-list
25402849|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
25402850|NCT03745326|Fludarabine|fludarabine|mesh-list
25402851|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402852|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
25402853|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402854|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402855|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402856|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
25402857|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402858|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402859|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25402860|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25402861|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25402862|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
25402863|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25402864|NCT03745170|Capecitabine|capecitabine|mesh-list
25402865|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
25402866|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25402867|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
25402868|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402869|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402870|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25402871|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25402872|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402873|NCT03744793|Pemetrexed|pemetrexed|mesh-list
25402874|NCT03744793|Avelumab|avelumab|mesh-list
25402875|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25402876|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402877|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402878|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402879|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25402880|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25402881|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402882|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
25402883|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402884|NCT03744026|Carboplatin|carboplatin|mesh-list
25402885|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402886|NCT03743662|Bevacizumab|bevacizumab|mesh-list
25402887|NCT03743662|Nivolumab|nivolumab|mesh-list
25402888|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402889|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402890|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25402891|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25402892|NCT03743662|Growth Substances|growth substances|mesh-ancestor
25402893|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402894|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
25402895|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25402896|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402897|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
25402898|NCT03743246|Fludarabine|fludarabine|mesh-list
25402899|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402900|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
25402901|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402902|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402903|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402904|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
25402905|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402906|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402907|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25402908|NCT03743025|Dulaglutide|dulaglutide|mesh-list
25402909|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25402986|NCT03740165|Bevacizumab|bevacizumab|mesh-list
25402910|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402911|NCT03742895|Olaparib|olaparib|mesh-list
25402912|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25402913|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402914|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402915|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402916|NCT03742349|Spartalizumab|spartalizumab|mesh-list
25402917|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25402918|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402919|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402920|NCT03742297|Dexamethasone|dexamethasone|mesh-list
25402921|NCT03742297|Prednisone|prednisone|mesh-list
25402922|NCT03742297|Lenalidomide|lenalidomide|mesh-list
25402923|NCT03742297|Bortezomib|bortezomib|mesh-list
25402924|NCT03742297|Melphalan|melphalan|mesh-list
25402925|NCT03742297|Daratumumab|daratumumab|mesh-list
25402926|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25402927|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
25402928|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
25402929|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25402930|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402931|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25402932|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
25402933|NCT03742297|Hormones|hormones|mesh-ancestor
25402934|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25402935|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25402936|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402937|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
25402938|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25402939|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25402940|NCT03742297|Growth Substances|growth substances|mesh-ancestor
25402941|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
25402942|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402943|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
25402944|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402945|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25402946|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25402947|NCT03742245|Olaparib|olaparib|mesh-list
25402948|NCT03742245|Vorinostat|vorinostat|mesh-list
25402949|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25402950|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402951|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402952|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402953|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25402954|NCT03742193|Apatinib|apatinib|mesh-list
25402955|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402956|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25402957|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25402958|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402959|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
25402960|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25402961|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25402962|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25402963|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
25402964|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25402965|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402966|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402967|NCT03742102|Paclitaxel|paclitaxel|mesh-list
25402968|NCT03742102|Trastuzumab|trastuzumab|mesh-list
25402969|NCT03742102|Durvalumab|durvalumab|mesh-list
25402970|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402971|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402972|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402973|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402974|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402975|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402976|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402977|NCT03740529|Rituximab|rituximab|mesh-list
25402978|NCT03740529|Venetoclax|venetoclax|mesh-list
25402979|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402980|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402981|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
25402982|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402983|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25402984|NCT03740165|Paclitaxel|paclitaxel|mesh-list
25402985|NCT03740165|Docetaxel|docetaxel|mesh-list
25402987|NCT03740165|Carboplatin|carboplatin|mesh-list
25402988|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
25402990|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25402991|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25402992|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
25402993|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
25402994|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
25402995|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25402996|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25402997|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25402998|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25402999|NCT03740165|Growth Substances|growth substances|mesh-ancestor
25403000|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403001|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403002|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25403003|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403004|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25403005|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25403006|NCT03739814|Blinatumomab|blinatumomab|mesh-list
25403007|NCT03739814|Antibodies|antibodies|mesh-list
25403008|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
25403009|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25403010|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
25403011|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25403012|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
25403013|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403014|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403015|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403016|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403017|NCT03739619|Gemcitabine|gemcitabine|mesh-list
25403018|NCT03739619|Nivolumab|nivolumab|mesh-list
25403019|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25403020|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403021|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
25403022|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403023|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403024|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
25403025|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403026|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403027|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403028|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
25403029|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403030|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403031|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25403032|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403033|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
25403034|NCT03739203|Cariprazine|cariprazine|mesh-list
25403035|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
25403036|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25403037|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25403038|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25403039|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403040|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403041|NCT03738917|Bromides|bromides|mesh-list
25403042|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
25403043|NCT03738917|Ipratropium|ipratropium|mesh-list
25403044|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25403045|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
25403046|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
25403047|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
25403048|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25403049|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25403050|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403051|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403052|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403053|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25403054|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
25403055|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403056|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25403057|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
25403058|NCT03737994|Cisplatin|cisplatin|mesh-list
25403059|NCT03737994|Carboplatin|carboplatin|mesh-list
25403060|NCT03737994|Pemetrexed|pemetrexed|mesh-list
25403061|NCT03737994|Crizotinib|crizotinib|mesh-list
25403062|NCT03737994|Ceritinib|ceritinib|mesh-list
25403063|NCT03737994|Ensartinib|ensartinib|mesh-list
25403064|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403065|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403066|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403067|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25403068|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25403069|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25403070|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
25403071|NCT03737955|Calicheamicins|calicheamicins|mesh-list
25403072|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403073|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403074|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403075|NCT03737643|Paclitaxel|paclitaxel|mesh-list
25403076|NCT03737643|Bevacizumab|bevacizumab|mesh-list
25403077|NCT03737643|Carboplatin|carboplatin|mesh-list
25403078|NCT03737643|Durvalumab|durvalumab|mesh-list
25403079|NCT03737643|Olaparib|olaparib|mesh-list
25403080|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25403081|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403082|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403083|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403084|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403085|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403086|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403087|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403088|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403089|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403090|NCT03737643|Growth Substances|growth substances|mesh-ancestor
25403091|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403092|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403093|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
25403172|NCT03732677|Cisplatin|cisplatin|mesh-list
25403094|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25403095|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403096|NCT03737240|Insulin|insulin|mesh-list
25403097|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25403098|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
25403099|NCT03737240|Liraglutide|liraglutide|mesh-list
25403100|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
25403101|NCT03737240|Xultophy|xultophy|mesh-list
25403102|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25403103|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403104|NCT03737240|Incretins|incretins|mesh-ancestor
25403105|NCT03737240|Hormones|hormones|mesh-ancestor
25403106|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403107|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25403108|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25403109|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25403110|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25403111|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403112|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
25403113|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403114|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403115|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25403116|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403117|NCT03736720|Leucovorin|leucovorin|mesh-list
25403118|NCT03736720|Fluorouracil|fluorouracil|mesh-list
25403119|NCT03736720|Irinotecan|irinotecan|mesh-list
25403120|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
25403121|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403122|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403123|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403124|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403125|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
25403126|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403127|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25403128|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403129|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403130|NCT03736720|Antidotes|antidotes|mesh-ancestor
25403131|NCT03736720|Protective Agents|protective agents|mesh-ancestor
25403132|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
25403133|NCT03736720|Vitamins|vitamins|mesh-ancestor
25403134|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
25403135|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
25403136|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25403137|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
25403138|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
25403139|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403150|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25403151|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403152|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
25403153|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
25403154|NCT03735316|Vitamins|vitamins|mesh-ancestor
25403155|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
25403156|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403157|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
25403158|NCT03735316|Hematinics|hematinics|mesh-ancestor
25403161|NCT03733314|Quetmolimab|quetmolimab|mesh-list
25403162|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403171|NCT03732677|Gemcitabine|gemcitabine|mesh-list
25403174|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403175|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403176|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
25403177|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403178|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
25403179|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403180|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403181|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403182|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
25403183|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403184|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403185|NCT03730012|Atezolizumab|atezolizumab|mesh-list
25403186|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403187|NCT03729349|Golimumab|golimumab|mesh-list
25403188|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25403189|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403190|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403191|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
25403192|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403193|NCT03729011|Propofol|propofol|mesh-list
25403194|NCT03729011|Sevoflurane|sevoflurane|mesh-list
25403195|NCT03729011|Desflurane|desflurane|mesh-list
25403196|NCT03729011|Isoflurane|isoflurane|mesh-list
25403197|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25403198|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403199|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403200|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25403201|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
25403202|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
25403203|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25403204|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25403205|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
25403206|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403207|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403208|NCT03728933|Rotigotine|rotigotine|mesh-list
25403209|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
25403210|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
25403211|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403212|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403213|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403214|NCT03728673|Dexetimide|dexetimide|mesh-list
25403215|NCT03728673|Citalopram|citalopram|mesh-list
25403216|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25403217|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25403218|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25403219|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403220|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403221|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
25403222|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403223|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25403224|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
25403225|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25403226|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25403227|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25403228|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
25403229|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
25403230|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403231|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25403232|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25403233|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
25403234|NCT03727776|Hormones|hormones|mesh-list
25403235|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25403236|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25403237|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
25403238|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403239|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403240|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403241|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403242|NCT03727061|Cisplatin|cisplatin|mesh-list
25403243|NCT03727061|Carboplatin|carboplatin|mesh-list
25403244|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
25403245|NCT03727061|Fluorouracil|fluorouracil|mesh-list
25403246|NCT03727061|Nivolumab|nivolumab|mesh-list
25403247|NCT03727061|Cetuximab|cetuximab|mesh-list
25403248|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25403249|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
25403251|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403252|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403253|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
25403254|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403255|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403256|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403257|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
25403258|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403259|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25403260|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
25403261|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25403262|NCT03726879|Paclitaxel|paclitaxel|mesh-list
25403263|NCT03726879|Maytansine|maytansine|mesh-list
25403264|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25403265|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
25403266|NCT03726879|Doxorubicin|doxorubicin|mesh-list
25403267|NCT03726879|Trastuzumab|trastuzumab|mesh-list
25403268|NCT03726879|Atezolizumab|atezolizumab|mesh-list
25403269|NCT03726879|Pertuzumab|pertuzumab|mesh-list
25403270|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403271|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403272|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403273|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403274|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403275|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403276|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403277|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
25403278|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403279|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403280|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403281|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
25403282|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403283|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403284|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25403285|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403286|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403287|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403288|NCT03726268|Fentanyl|fentanyl|mesh-list
25403289|NCT03726268|Sufentanil|sufentanil|mesh-list
25403290|NCT03726268|Morphine|morphine|mesh-list
25403291|NCT03726268|Methadone|methadone|mesh-list
25403292|NCT03726268|Hydromorphone|hydromorphone|mesh-list
25403293|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25403294|NCT03726268|Narcotics|narcotics|mesh-ancestor
25403295|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403296|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403297|NCT03726268|Analgesics|analgesics|mesh-ancestor
25403298|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
25403299|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403300|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25403301|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25403302|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
25403303|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
25403304|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
25403305|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
25403306|NCT03725930|Clonidine|clonidine|mesh-list
25403307|NCT03725930|Analgesics|analgesics|mesh-ancestor
25403308|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
25403309|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403310|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403311|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25403312|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
25403313|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
25403314|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25403315|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25403316|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25403317|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
25403318|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403319|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403320|NCT03725501|Ranibizumab|ranibizumab|mesh-list
25403321|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403322|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403323|NCT03725501|Growth Substances|growth substances|mesh-ancestor
25403324|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403325|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403326|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403327|NCT03725436|Paclitaxel|paclitaxel|mesh-list
25403328|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25403329|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403330|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403331|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403332|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403345|NCT03725059|Epirubicin|epirubicin|mesh-list
25403346|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403347|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403348|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403349|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403350|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403351|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403352|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403353|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
25403354|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403355|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403356|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403357|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
25403358|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403359|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403360|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25403361|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403362|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403363|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403364|NCT03724890|Avelumab|avelumab|mesh-list
25403365|NCT03724890|Peposertib|peposertib|mesh-list
25403366|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403367|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403368|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25403369|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403370|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403371|NCT03724019|Ketamine|ketamine|mesh-list
25403372|NCT03724019|Analgesics|analgesics|mesh-ancestor
25403373|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
25403374|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403375|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403376|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25403377|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25403378|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
25403379|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
25403380|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403381|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25403382|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25403383|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403384|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403385|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
25403386|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403387|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403388|NCT03722108|Irinotecan|irinotecan|mesh-list
25403389|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25403390|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403391|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403392|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403393|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403394|NCT03721653|Leucovorin|leucovorin|mesh-list
25403395|NCT03721653|Bevacizumab|bevacizumab|mesh-list
25403396|NCT03721653|Fluorouracil|fluorouracil|mesh-list
25403397|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
25403398|NCT03721653|Irinotecan|irinotecan|mesh-list
25403399|NCT03721653|Atezolizumab|atezolizumab|mesh-list
25403400|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
25403401|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403402|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403403|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403404|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403405|NCT03721653|Growth Substances|growth substances|mesh-ancestor
25403406|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403407|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403408|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
25403409|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403410|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403411|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403412|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
25403413|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25403414|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403415|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403416|NCT03721653|Antidotes|antidotes|mesh-ancestor
25403417|NCT03721653|Protective Agents|protective agents|mesh-ancestor
25403418|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
25403419|NCT03721653|Vitamins|vitamins|mesh-ancestor
25403420|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
25403421|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
25403422|NCT03721497|Testosterone|testosterone|mesh-list
25403423|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
25403424|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
25403425|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25403426|NCT03721497|Androgens|androgens|mesh-ancestor
25403427|NCT03721497|Hormones|hormones|mesh-ancestor
25403428|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403429|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403430|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403431|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403432|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
25403433|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
25403434|NCT03721068|Fludarabine|fludarabine|mesh-list
25403435|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403436|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
25403437|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403438|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403439|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403440|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
25403441|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403442|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403443|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403444|NCT03720717|Baclofen|baclofen|mesh-list
25403445|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25403446|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403447|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25403448|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403449|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25403451|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
25403452|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403453|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403454|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
25403455|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403456|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403457|NCT03719768|Avelumab|avelumab|mesh-list
25403458|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403459|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403460|NCT03719105|Dexamethasone|dexamethasone|mesh-list
25403461|NCT03719105|Prednisone|prednisone|mesh-list
25403462|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
25403463|NCT03719105|Ifosfamide|ifosfamide|mesh-list
25403464|NCT03719105|Doxorubicin|doxorubicin|mesh-list
25403465|NCT03719105|Methotrexate|methotrexate|mesh-list
25403466|NCT03719105|Etoposide|etoposide|mesh-list
25403467|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25403468|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403469|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
25403470|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403471|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403472|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403473|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
25403474|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403475|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403476|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403477|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403478|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
25403479|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
25403480|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403481|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25403482|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
25403483|NCT03719105|Hormones|hormones|mesh-ancestor
25403484|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403485|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403486|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403487|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25403488|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403489|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403490|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25403491|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
25403492|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25403493|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403494|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
25403495|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25403496|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25403497|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25403498|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403499|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403500|NCT03718767|Nivolumab|nivolumab|mesh-list
25403501|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403502|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403503|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25403504|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403505|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
25403506|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25403507|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25403508|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25403509|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
25403510|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403511|NCT03718234|Hormones|hormones|mesh-ancestor
25403512|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403513|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403514|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
25403515|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25403516|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403517|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25403518|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403519|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
25403520|NCT03716739|Testosterone|testosterone|mesh-list
25403521|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
25403522|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
25403523|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25403524|NCT03716739|Androgens|androgens|mesh-ancestor
25403525|NCT03716739|Hormones|hormones|mesh-ancestor
25403526|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403527|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403528|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403529|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403530|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
25403531|NCT03716180|Paclitaxel|paclitaxel|mesh-list
25403532|NCT03716180|Trastuzumab|trastuzumab|mesh-list
25403533|NCT03716180|Pertuzumab|pertuzumab|mesh-list
25403534|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403535|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403536|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403537|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403538|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403539|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403540|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403541|NCT03715933|Cisplatin|cisplatin|mesh-list
25403542|NCT03715933|Carboplatin|carboplatin|mesh-list
25403543|NCT03715933|Fluorouracil|fluorouracil|mesh-list
25403544|NCT03715933|Irinotecan|irinotecan|mesh-list
25403545|NCT03715933|Pemetrexed|pemetrexed|mesh-list
25403546|NCT03715933|Temozolomide|temozolomide|mesh-list
25403547|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403548|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
25403549|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403550|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403551|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403552|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
25403553|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403554|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25403555|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403556|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403557|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25403558|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25403559|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403560|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
25403562|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
25403563|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403564|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403565|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
25403566|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403567|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25403568|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403569|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403571|NCT03714620|Analgesics|analgesics|mesh-ancestor
25403572|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
25403573|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403574|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403575|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25403576|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25403577|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
25403578|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
25403579|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403580|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25403581|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25403582|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403583|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403584|NCT03714308|Aflibercept|aflibercept|mesh-list
25403585|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403586|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403587|NCT03714308|Growth Substances|growth substances|mesh-ancestor
25403588|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403589|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403590|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403591|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
25403592|NCT03713593|Lenvatinib|lenvatinib|mesh-list
25403593|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403594|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403595|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25403596|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403597|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403598|NCT03713580|Venetoclax|venetoclax|mesh-list
25403599|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403600|NCT03713294|Dexamethasone|dexamethasone|mesh-list
25403601|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
25403602|NCT03713294|Pomalidomide|pomalidomide|mesh-list
25403603|NCT03713294|Elotuzumab|elotuzumab|mesh-list
25403604|NCT03713294|Ichthammol|ichthammol|mesh-list
25403605|NCT03713294|BB 1101|bb 1101|mesh-list
25403606|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403607|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
25403608|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
25403609|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403610|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403611|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25403612|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
25403613|NCT03713294|Hormones|hormones|mesh-ancestor
25403614|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403615|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403616|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403617|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
25403618|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403619|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403620|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
25403621|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403622|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403623|NCT03713294|Growth Substances|growth substances|mesh-ancestor
25403624|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403625|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
25403626|NCT03712904|Aflibercept|aflibercept|mesh-list
25403627|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
25403628|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403629|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403630|NCT03712904|Growth Substances|growth substances|mesh-ancestor
25403631|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403632|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403633|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403634|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
25403635|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
25403636|NCT03712878|Tacrolimus|tacrolimus|mesh-list
25403637|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403638|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
25403639|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403640|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403641|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403642|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
25403643|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403644|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403645|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403646|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25403647|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403648|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403649|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25403650|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
25403651|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25403652|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403653|NCT03712787|Tilavonemab|tilavonemab|mesh-list
25403654|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
25403655|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
25403656|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403657|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403658|NCT03711058|Nivolumab|nivolumab|mesh-list
25403659|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403660|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403661|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25403662|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403663|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
25403664|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403665|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403666|NCT03710824|Nintedanib|nintedanib|mesh-list
25403667|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403668|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25403669|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403670|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403671|NCT03710603|Dexamethasone|dexamethasone|mesh-list
25403672|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
25403673|NCT03710603|Lenalidomide|lenalidomide|mesh-list
25403674|NCT03710603|Bortezomib|bortezomib|mesh-list
25403675|NCT03710603|Daratumumab|daratumumab|mesh-list
25403676|NCT03710603|BB 1101|bb 1101|mesh-list
25403677|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403678|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
25403679|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
25403680|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403681|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403682|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25403683|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
25403684|NCT03710603|Hormones|hormones|mesh-ancestor
25403685|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403686|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403687|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403688|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
25403689|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403690|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403691|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
25403692|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403693|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403694|NCT03710603|Growth Substances|growth substances|mesh-ancestor
25403695|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403696|NCT03710122|Vancomycin|vancomycin|mesh-list
25403697|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25403698|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403699|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
25403700|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403701|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403702|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
25403703|NCT03709680|Temozolomide|temozolomide|mesh-list
25403704|NCT03709680|Irinotecan|irinotecan|mesh-list
25403706|NCT03709680|Palbociclib|palbociclib|mesh-list
25403707|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403708|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
25403709|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403710|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403711|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403712|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
25434525|NCT00098475|Thalidomide|thalidomide|mesh-list
25403713|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403714|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403715|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403716|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25403717|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403718|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403719|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25403720|NCT03709043|Ethanol|ethanol|mesh-list
25403721|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25403722|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403723|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403724|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403725|NCT03709017|Ponatinib|ponatinib|mesh-list
25403726|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403727|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25403728|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403729|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403730|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
25403731|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25403732|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
25403733|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403734|NCT03707951|Expectorants|expectorants|mesh-ancestor
25403735|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
25403736|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25403737|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
25403738|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403739|NCT03707951|Protective Agents|protective agents|mesh-ancestor
25403740|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403741|NCT03707951|Antidotes|antidotes|mesh-ancestor
25403742|NCT03706690|Durvalumab|durvalumab|mesh-list
25403743|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403744|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403745|NCT03706365|Prednisone|prednisone|mesh-list
25403746|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
25403747|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403748|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
25403749|NCT03706365|Hormones|hormones|mesh-ancestor
25403750|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403751|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403752|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403756|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403757|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
25403758|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25403759|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
25403760|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403761|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
25403762|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25403763|NCT03705429|Paclitaxel|paclitaxel|mesh-list
25403764|NCT03705429|Docetaxel|docetaxel|mesh-list
25403765|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25403766|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
25403767|NCT03705429|Trastuzumab|trastuzumab|mesh-list
25403768|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403769|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403770|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403771|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403772|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403773|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403774|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403775|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
25403776|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403777|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403778|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403779|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
25403780|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403781|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403782|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25403783|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
25403784|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403785|NCT03704766|Defensins|defensins|mesh-list
25403786|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
25403787|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403788|NCT03704714|Prednisone|prednisone|mesh-list
25403789|NCT03704714|Cortisone|cortisone|mesh-list
25772334|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403790|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
25403791|NCT03704714|Rituximab|rituximab|mesh-list
25403792|NCT03704714|Doxorubicin|doxorubicin|mesh-list
25403793|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25403794|NCT03704714|Nivolumab|nivolumab|mesh-list
25403795|NCT03704714|Vincristine|vincristine|mesh-list
25403796|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25403797|NCT03704714|Antibodies|antibodies|mesh-list
25403798|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
25403799|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25403800|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403801|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
25403802|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403803|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403804|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403805|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
25403806|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403807|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403808|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403809|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403810|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25403811|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403812|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403813|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403814|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
25403815|NCT03704714|Hormones|hormones|mesh-ancestor
25403816|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403817|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403818|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25403819|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403820|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403821|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403822|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403827|NCT03703297|Durvalumab|durvalumab|mesh-list
25403828|NCT03703297|Tremelimumab|tremelimumab|mesh-list
25403829|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403830|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403831|NCT03703167|Rituximab|rituximab|mesh-list
25403832|NCT03703167|Lenalidomide|lenalidomide|mesh-list
25403833|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403834|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403835|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
25403836|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403837|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403838|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25403839|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25403840|NCT03703167|Growth Substances|growth substances|mesh-ancestor
25403841|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
25403842|NCT03702179|Durvalumab|durvalumab|mesh-list
25403843|NCT03702179|Tremelimumab|tremelimumab|mesh-list
25403844|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403845|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403846|NCT03701763|Apremilast|apremilast|mesh-list
25403847|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25403848|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25403849|NCT03701763|Analgesics|analgesics|mesh-ancestor
25403850|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
25403851|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403852|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403853|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25403854|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403855|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25403856|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25403857|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403858|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403859|NCT03701490|Progesterone|progesterone|mesh-list
25403860|NCT03701490|Progestins|progestins|mesh-ancestor
25403861|NCT03701490|Hormones|hormones|mesh-ancestor
25403862|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25403863|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403864|NCT03701308|Cytarabine|cytarabine|mesh-list
25403865|NCT03701308|Daunorubicin|daunorubicin|mesh-list
25403866|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25403867|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
25403868|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403869|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403870|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
25403871|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25403872|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403873|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
25403874|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403875|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25403876|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25403877|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403878|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403879|NCT03701282|Venetoclax|venetoclax|mesh-list
25403880|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
25403881|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403882|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403883|NCT03700099|Docetaxel|docetaxel|mesh-list
25403884|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403885|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403886|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403887|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403888|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403889|NCT03699865|Nicotine|nicotine|mesh-list
25403890|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25403891|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
25403892|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403893|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403894|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25403895|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25403896|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
25403897|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25403898|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403899|NCT03699319|Leucovorin|leucovorin|mesh-list
25403900|NCT03699319|Folic Acid|folic acid|mesh-list
25403901|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
25403902|NCT03699319|Irinotecan|irinotecan|mesh-list
25403903|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
25403904|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403905|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403906|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25403907|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25403908|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403909|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403910|NCT03699319|Antidotes|antidotes|mesh-ancestor
25403911|NCT03699319|Protective Agents|protective agents|mesh-ancestor
25403912|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
25403913|NCT03699319|Vitamins|vitamins|mesh-ancestor
25403914|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
25403915|NCT03699319|Hematinics|hematinics|mesh-ancestor
25403916|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
25403917|NCT03698669|Narcotics|narcotics|mesh-ancestor
25403918|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403919|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403920|NCT03698669|Analgesics|analgesics|mesh-ancestor
25403921|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
25403922|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403923|NCT03698552|Epratuzumab|epratuzumab|mesh-list
25403924|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403925|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403926|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
25403927|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403928|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403929|NCT03696355|GDC-0084|gdc-0084|mesh-list
25403930|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403931|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403932|NCT03696199|Anesthetics|anesthetics|mesh-list
25403933|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25403934|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403935|NCT03695380|Atezolizumab|atezolizumab|mesh-list
25403936|NCT03695380|Niraparib|niraparib|mesh-list
25403937|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403938|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25403939|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25403940|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403941|NCT03695237|Leuprolide|leuprolide|mesh-list
25403942|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25403943|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
25403944|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25403945|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403946|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25403947|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403948|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
25403949|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403950|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403951|NCT03693781|Colchicine|colchicine|mesh-list
25403952|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
25403953|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403954|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403955|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403956|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403957|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403958|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403959|NCT03693612|Paclitaxel|paclitaxel|mesh-list
25403960|NCT03693612|Docetaxel|docetaxel|mesh-list
25403961|NCT03693612|Cetuximab|cetuximab|mesh-list
25403962|NCT03693612|Tremelimumab|tremelimumab|mesh-list
25403963|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25403964|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403965|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25403966|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25403967|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403968|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403969|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403970|NCT03693170|Cetuximab|cetuximab|mesh-list
25403971|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403972|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403973|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25403974|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
25403975|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403976|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
25403977|NCT03692663|Fludarabine|fludarabine|mesh-list
25403978|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25403979|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
25403980|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403981|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25403982|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25403983|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
25403984|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403985|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403986|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25403987|NCT03692325|Nivolumab|nivolumab|mesh-list
25403988|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403989|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403990|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25403991|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403992|NCT03691350|Nicotine|nicotine|mesh-list
25403993|NCT03691350|Dimercaprol|dimercaprol|mesh-list
25403994|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25403995|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
25403996|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403997|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403998|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25403999|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25404000|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
25404001|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404002|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404003|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
25404004|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
25404005|NCT03690986|Nivolumab|nivolumab|mesh-list
25404006|NCT03690986|Ipilimumab|ipilimumab|mesh-list
25404007|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404008|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404009|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404162|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25404010|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404012|NCT03689855|Ramucirumab|ramucirumab|mesh-list
25404013|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404014|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25404015|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25404016|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25404017|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404018|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548582|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040779|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040853|NCT02804035|Furosemide|furosemide|mesh-list
24978233|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978234|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
24419134|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419135|NCT00211328|Anecortave|anecortave|mesh-list
24419136|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25040700|NCT02933671|Ropivacaine|ropivacaine|mesh-list
24978298|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
24978299|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24978300|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
24978301|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978302|NCT04745845|Norepinephrine|norepinephrine|mesh-list
24419619|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24419620|NCT00213109|Miglitol|miglitol|mesh-list
24419621|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419622|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419623|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25040725|NCT02920008|Guadecitabine|guadecitabine|mesh-list
25041225|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419811|NCT00214084|Protective Agents|protective agents|mesh-ancestor
25404019|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
25404020|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404021|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404022|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25404023|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404024|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25404025|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25404026|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25404027|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25404028|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
25404029|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404030|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404031|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404032|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
25724263|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724264|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25724265|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
25724266|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724267|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724268|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
25724269|NCT02536313|Velpatasvir|velpatasvir|mesh-list
25724270|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
25724271|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724272|NCT02536664|Rituximab|rituximab|mesh-list
25724273|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25724274|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724275|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
25724276|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724277|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724278|NCT02536833|Lorecivivint|lorecivivint|mesh-list
25724279|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724280|NCT02536846|Olanzapine|olanzapine|mesh-list
25724281|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
25724282|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
25724283|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724284|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724285|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724286|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25724287|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25724288|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724289|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25724290|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25724291|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25724292|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25724293|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724294|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724296|NCT02536976|Mirabegron|mirabegron|mesh-list
25724297|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25724298|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25724299|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25724300|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
25724301|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724302|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724303|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724304|NCT02536976|Urological Agents|urological agents|mesh-ancestor
25724305|NCT02537015|Bimatoprost|bimatoprost|mesh-list
25724306|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25724307|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
25724308|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
25724309|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25724310|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724311|NCT02537873|Cocaine|cocaine|mesh-list
25724312|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
25724313|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
25724314|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724315|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724316|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
25724317|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724318|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25724319|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25724320|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25724321|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25724322|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724323|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
25724324|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724325|NCT02537951|Lidocaine|lidocaine|mesh-list
25724326|NCT02537951|Prilocaine|prilocaine|mesh-list
25724327|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25724328|NCT02537951|Capsaicin|capsaicin|mesh-list
25724329|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
25724330|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
25724331|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724332|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724333|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
25724334|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724335|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25724336|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25724337|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25724338|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25724339|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724340|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
25724341|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
25724342|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25724343|NCT02538016|Tolvaptan|tolvaptan|mesh-list
25724344|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25724345|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724346|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
25724347|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724348|NCT02538042|Nicotine|nicotine|mesh-list
25724349|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25724350|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
25724351|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724352|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724353|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25724354|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25724355|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
25724356|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724357|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724358|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
25724359|NCT02538107|Hematinics|hematinics|mesh-ancestor
25724360|NCT02538354|Riboflavin|riboflavin|mesh-list
25724361|NCT02538354|Vitamins|vitamins|mesh-ancestor
25724362|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
24419812|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419813|NCT00214110|Tamoxifen|tamoxifen|mesh-list
24978562|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
24978563|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24458577|NCT00338390|Abacavir|abacavir|mesh-list
25105818|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724363|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724364|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
25724365|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25724366|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
25724367|NCT02538614|Idelalisib|idelalisib|mesh-list
25724368|NCT02538614|BI 836826|bi 836826|mesh-list
25724369|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724370|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724371|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724372|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25724373|NCT02538679|Epinephrine|epinephrine|mesh-list
25724374|NCT02538679|Racepinephrine|racepinephrine|mesh-list
25724375|NCT02538679|Bupivacaine|bupivacaine|mesh-list
25724376|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
25724377|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
25724378|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
25724379|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724380|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724381|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
25724382|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724383|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25724384|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25724385|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
25724386|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724387|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724388|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25724389|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25724390|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
25724391|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25724392|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
25724393|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
25724394|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
25724395|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25724396|NCT02538965|Lenalidomide|lenalidomide|mesh-list
25724397|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
25724398|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724399|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25724400|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25724401|NCT02538965|Growth Substances|growth substances|mesh-ancestor
25724402|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
25724403|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724404|NCT02539108|Vaccines|vaccines|mesh-list
25724405|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
25724406|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724407|NCT02539342|Calcium|calcium|mesh-list
25724408|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25724409|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724410|NCT02539368|Infliximab|infliximab|mesh-list
25724411|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
25724412|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724413|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724414|NCT02539459|Everolimus|everolimus|mesh-list
25724415|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724416|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724417|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
25724418|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724419|NCT02539511|Ketamine|ketamine|mesh-list
25724420|NCT02539511|Analgesics|analgesics|mesh-ancestor
25724421|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
25724422|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724423|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724424|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25724425|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25724426|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
25724427|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
25724428|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724429|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25724430|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25724431|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724432|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422515|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422516|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
24422517|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24422518|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24422519|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422520|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25724433|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25724434|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
25724435|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724437|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25724438|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25724439|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724440|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
25724441|NCT02540226|Coagulants|coagulants|mesh-ancestor
25724442|NCT02540265|Meloxicam|meloxicam|mesh-list
25724443|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25724444|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25724445|NCT02540265|Analgesics|analgesics|mesh-ancestor
25724446|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
25724447|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724448|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724449|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724450|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724451|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25724452|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25724453|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724454|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724455|NCT02540356|Antibodies|antibodies|mesh-list
25724456|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
25724457|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
25724458|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772335|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772336|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25772337|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772338|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
25772339|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25772340|NCT03681093|Growth Substances|growth substances|mesh-ancestor
25772341|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772342|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
25772343|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25772344|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772345|NCT03682302|Bupivacaine|bupivacaine|mesh-list
25772346|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772347|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
25772348|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772349|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772350|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
25772351|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772352|NCT03682705|Upadacitinib|upadacitinib|mesh-list
25772353|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25772354|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25772355|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772356|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772357|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772358|NCT03684044|Baloxavir|baloxavir|mesh-list
25772359|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
25772360|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772361|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772362|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772363|NCT03684265|Meloxicam|meloxicam|mesh-list
25772364|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772365|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772366|NCT03684265|Analgesics|analgesics|mesh-ancestor
25772367|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
25772368|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772369|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772370|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772371|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772372|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25772373|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772374|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772375|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772376|NCT03684642|Metformin|metformin|mesh-list
25772377|NCT03684642|Dulaglutide|dulaglutide|mesh-list
25772378|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
25772379|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24431442|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
24979537|NCT03907826|Antibodies|antibodies|mesh-list
25043760|NCT01205061|Lidocaine|lidocaine|mesh-list
24842066|NCT02219672|Lopinavir|lopinavir|mesh-list
25724460|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
25724461|NCT02540954|Aflibercept|aflibercept|mesh-list
25724462|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25724463|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25724464|NCT02540954|Growth Substances|growth substances|mesh-ancestor
25724465|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724466|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
25724467|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724468|NCT02541409|Interferons|interferons|mesh-list
25724469|NCT02541409|Ribavirin|ribavirin|mesh-list
25724470|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
25724471|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
25724472|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25724473|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
25724474|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724475|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
25724476|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724477|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
25724478|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724479|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
25724480|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724481|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
25724482|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25724483|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
25724484|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724485|NCT02541422|Expectorants|expectorants|mesh-ancestor
25724486|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
25724487|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25724488|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
25724489|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724490|NCT02541422|Protective Agents|protective agents|mesh-ancestor
25724491|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724492|NCT02541422|Antidotes|antidotes|mesh-ancestor
25724493|NCT02541565|Prednisone|prednisone|mesh-list
25724494|NCT02541565|Cortisone|cortisone|mesh-list
25724495|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
25724496|NCT02541565|Rituximab|rituximab|mesh-list
25724497|NCT02541565|Doxorubicin|doxorubicin|mesh-list
25724498|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25724499|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
25724500|NCT02541565|Vincristine|vincristine|mesh-list
25724501|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25724502|NCT02541565|Antibodies|antibodies|mesh-list
25724503|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
25724504|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25724505|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724506|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
25724507|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724508|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724509|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25724510|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
25724511|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724512|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724513|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25724514|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25724515|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25724516|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25724517|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724518|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724519|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
25724520|NCT02541565|Hormones|hormones|mesh-ancestor
25724521|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724522|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25724523|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25724524|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
25724525|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
25724526|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
24825957|NCT02131246|Insulin|insulin|mesh-list
24844961|NCT02235402|Diuretics|diuretics|mesh-ancestor
24980499|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24980500|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980502|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
25724527|NCT02541604|Atezolizumab|atezolizumab|mesh-list
25724528|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724529|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25724530|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25724531|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25724532|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724533|NCT02541864|Amoxicillin|amoxicillin|mesh-list
25724534|NCT02541864|Metronidazole|metronidazole|mesh-list
25724535|NCT02541864|Clarithromycin|clarithromycin|mesh-list
25724536|NCT02541864|Tetracycline|tetracycline|mesh-list
25724537|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25724538|NCT02541864|Pantoprazole|pantoprazole|mesh-list
25724539|NCT02541864|Bismuth|bismuth|mesh-list
25724540|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25724541|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724542|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25724543|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25724544|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25724545|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724546|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724547|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25724548|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25724549|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25724550|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724551|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25724552|NCT02541864|Antacids|antacids|mesh-ancestor
25724553|NCT02541903|Afatinib|afatinib|mesh-list
25724554|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724555|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25724556|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724557|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724558|NCT02542150|Ethanol|ethanol|mesh-list
25724559|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25724560|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724561|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724562|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724563|NCT02542410|Cabergoline|cabergoline|mesh-list
25724564|NCT02542410|Norethindrone|norethindrone|mesh-list
25724565|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
25724566|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25724567|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25724568|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25724569|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
25724570|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25724571|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724572|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25724573|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25724574|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25724575|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25724576|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
25724577|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
25724578|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724579|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724580|NCT02542462|Vaccines|vaccines|mesh-list
25724581|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
25724582|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724583|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
25724584|NCT02542605|Erenumab|erenumab|mesh-list
25724585|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25724586|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724587|NCT02542605|Analgesics|analgesics|mesh-ancestor
25724588|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
25724589|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724590|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724591|NCT02542605|Growth Substances|growth substances|mesh-ancestor
25724592|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
25724593|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448679|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24448680|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24448681|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25724594|NCT02542631|Insulin|insulin|mesh-list
25724595|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25724596|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25724597|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724598|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
25724599|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25724600|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724601|NCT02542943|Fluorides|fluorides|mesh-list
25724602|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
25724603|NCT02542943|Protective Agents|protective agents|mesh-ancestor
25724604|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724605|NCT02543346|Cetirizine|cetirizine|mesh-list
25724606|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25724607|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25724608|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25724609|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
25724610|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
25724611|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724612|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724613|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724614|NCT02543658|Neostigmine|neostigmine|mesh-list
25724615|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25724616|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724617|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724618|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
25724619|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724620|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724621|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25724622|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
25724623|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724624|NCT02543801|Ketorolac|ketorolac|mesh-list
25724625|NCT02543801|Clonidine|clonidine|mesh-list
25724626|NCT02543801|Epinephrine|epinephrine|mesh-list
25724627|NCT02543801|Bupivacaine|bupivacaine|mesh-list
25724628|NCT02543801|Ropivacaine|ropivacaine|mesh-list
25724629|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
25724630|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
25724631|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724632|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724633|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
25724634|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724635|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25724636|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25724637|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
25724638|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724639|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724640|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25724641|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25724642|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
25724643|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25724644|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
25724645|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
25724646|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
25724647|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25724648|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25724649|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25724650|NCT02543801|Analgesics|analgesics|mesh-ancestor
25724651|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724652|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724653|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25724654|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724655|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25724656|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
25724657|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25724658|NCT02543918|Ixekizumab|ixekizumab|mesh-list
25724659|NCT02543918|Vaccines|vaccines|mesh-list
25724660|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25724661|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
25724662|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048405|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24862462|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
24981925|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24981926|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981927|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862607|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
24759903|NCT01755403|Benzonidazole|benzonidazole|mesh-list
25724663|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
25724664|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
25724665|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25724666|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
25724667|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724668|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724669|NCT02544152|Lubiprostone|lubiprostone|mesh-list
25724670|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25724671|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25724672|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724673|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
25724674|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
25724675|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724676|NCT02544217|Protective Agents|protective agents|mesh-ancestor
25724677|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724678|NCT02544321|Bromocriptine|bromocriptine|mesh-list
25724679|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25724680|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25724681|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
25724682|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724683|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724684|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
25724685|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
25724686|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724687|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724688|NCT02544451|Ivacaftor|ivacaftor|mesh-list
25724689|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25724690|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25724691|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724692|NCT02544607|Ketamine|ketamine|mesh-list
25724693|NCT02544607|Analgesics|analgesics|mesh-ancestor
25724694|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
25724695|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724696|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724697|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25724698|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25724699|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
25724700|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
25724701|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724702|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25724703|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25724704|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724705|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724706|NCT02544984|Azithromycin|azithromycin|mesh-list
25724707|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25724708|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724709|NCT02545075|Ipilimumab|ipilimumab|mesh-list
25724710|NCT02545075|Dacarbazine|dacarbazine|mesh-list
25724711|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25724712|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724713|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25724714|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724715|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25724716|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
25724717|NCT02545504|Leucovorin|leucovorin|mesh-list
25724718|NCT02545504|Fluorouracil|fluorouracil|mesh-list
25724719|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
25724720|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
25724721|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724722|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25724723|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724724|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724725|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
25724726|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724727|NCT02545504|Antidotes|antidotes|mesh-ancestor
24445035|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24983692|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25724728|NCT02545504|Protective Agents|protective agents|mesh-ancestor
25724729|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
25724730|NCT02545504|Vitamins|vitamins|mesh-ancestor
25724731|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
25724732|NCT02545907|Thalidomide|thalidomide|mesh-list
25724733|NCT02545907|Dexamethasone|dexamethasone|mesh-list
25724734|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724735|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
25724736|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
25724737|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724738|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724739|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724740|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
25724741|NCT02545907|Hormones|hormones|mesh-ancestor
25724742|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724743|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25724744|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724745|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724746|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
25724747|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
25724748|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25724749|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724750|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25724751|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25724752|NCT02545907|Growth Substances|growth substances|mesh-ancestor
25724753|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
25724754|NCT02545933|Aspirin|aspirin|mesh-list
25724755|NCT02545933|Ticagrelor|ticagrelor|mesh-list
25724756|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25724757|NCT02545933|Vorapaxar|vorapaxar|mesh-list
25724758|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25724759|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25724760|NCT02545933|Analgesics|analgesics|mesh-ancestor
25724761|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
25724762|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724763|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724764|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724765|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724766|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25724767|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25724768|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724769|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25724770|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25724771|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724772|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
25724773|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25724774|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25724775|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25724776|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
25724777|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724778|NCT02546193|Misoprostol|misoprostol|mesh-list
25724779|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25724780|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
25724781|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25724782|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724783|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25724784|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724785|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
25724786|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25724787|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25724788|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25106755|NCT03144947|Pertuzumab|pertuzumab|mesh-list
25106756|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106757|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
25106758|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
25724789|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
25724790|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724791|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25724792|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25724793|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724794|NCT02546570|Oxytocin|oxytocin|mesh-list
25724795|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
25724796|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25724797|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724798|NCT02546765|Acetaminophen|acetaminophen|mesh-list
25724799|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
25724800|NCT02546765|Propofol|propofol|mesh-list
25724801|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25724802|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724803|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724804|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25724805|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
25724806|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
25724807|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25724808|NCT02546765|Analgesics|analgesics|mesh-ancestor
25724809|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
25724810|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724811|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25724812|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25724813|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25724814|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
25724815|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724816|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724817|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
25724818|NCT02547012|Amoxicillin|amoxicillin|mesh-list
25724819|NCT02547012|Levofloxacin|levofloxacin|mesh-list
25724820|NCT02547012|Ofloxacin|ofloxacin|mesh-list
25724821|NCT02547012|Tetracycline|tetracycline|mesh-list
25724822|NCT02547012|Esomeprazole|esomeprazole|mesh-list
25724823|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25724824|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724825|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25724826|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724827|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25724828|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724829|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724830|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25724831|NCT02547012|Renal Agents|renal agents|mesh-ancestor
25724832|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25724833|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25724834|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724835|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25724836|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25724837|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25724838|NCT02547038|Amoxicillin|amoxicillin|mesh-list
25724839|NCT02547038|Metronidazole|metronidazole|mesh-list
25724840|NCT02547038|Clarithromycin|clarithromycin|mesh-list
25724841|NCT02547038|Tetracycline|tetracycline|mesh-list
25724842|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25724843|NCT02547038|Pantoprazole|pantoprazole|mesh-list
25724844|NCT02547038|Bismuth|bismuth|mesh-list
25724845|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25724846|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724847|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25724848|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25724849|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25724850|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724851|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724852|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25724853|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25724854|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25724855|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724856|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25724857|NCT02547038|Antacids|antacids|mesh-ancestor
25724858|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25724859|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24784774|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
24784780|NCT01910285|Dsuvia|dsuvia|mesh-list
25000988|NCT05462236|Irinotecan|irinotecan|mesh-list
25106910|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106911|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25106912|NCT03143972|Narcotics|narcotics|mesh-ancestor
25724860|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724861|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
25724862|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724863|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
25724864|NCT02547454|Hematinics|hematinics|mesh-ancestor
25724865|NCT02547623|Dexamethasone|dexamethasone|mesh-list
25724866|NCT02547623|Prednisolone|prednisolone|mesh-list
25724867|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724868|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
25724869|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
25724870|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724871|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724872|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724873|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
25724875|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724876|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25724877|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724878|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25724879|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
25724880|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724881|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25724882|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724883|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
25724884|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25724885|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25724886|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
25724887|NCT02547935|Saxagliptin|saxagliptin|mesh-list
25724888|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25724889|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724890|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25724891|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724892|NCT02547935|Incretins|incretins|mesh-ancestor
25724893|NCT02547935|Hormones|hormones|mesh-ancestor
25724894|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724895|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25724896|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
25724897|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724898|NCT02547974|Vaccines|vaccines|mesh-list
25724899|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
25724900|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724901|NCT02547987|Carboplatin|carboplatin|mesh-list
25724902|NCT02547987|Docetaxel|docetaxel|mesh-list
25724903|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724904|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
25724905|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
25724906|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
25724907|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724908|NCT02548078|Vaccines|vaccines|mesh-list
25724909|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
25724910|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724911|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25724912|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25724913|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
25724914|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25724915|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724916|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25724917|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25724918|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25724919|NCT02548650|Aspirin|aspirin|mesh-list
25724920|NCT02548650|Clopidogrel|clopidogrel|mesh-list
25724921|NCT02548650|Vorapaxar|vorapaxar|mesh-list
25724922|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25724923|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25724924|NCT02548650|Analgesics|analgesics|mesh-ancestor
25724925|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
25724926|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724927|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724928|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724929|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724930|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25724931|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24796915|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796916|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
24988769|NCT00867178|Vitamins|vitamins|mesh-ancestor
25724932|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724933|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25724934|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25724935|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724936|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
25724937|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25724938|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25724939|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25724940|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
25724941|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724942|NCT02548728|Oxytocin|oxytocin|mesh-list
25724943|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
25724944|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25724945|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724946|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
25724947|NCT02548910|Citric Acid|citric acid|mesh-list
25724948|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
25724949|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25724950|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
25724951|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
25724952|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724953|NCT02548962|Dexamethasone|dexamethasone|mesh-list
25724954|NCT02548962|Pomalidomide|pomalidomide|mesh-list
25724955|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724956|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
25724957|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
25724958|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724959|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724960|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724961|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
25724962|NCT02548962|Hormones|hormones|mesh-ancestor
25724963|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724964|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25724965|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724966|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
25724967|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25724968|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25724969|NCT02548962|Growth Substances|growth substances|mesh-ancestor
25724970|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
25724971|NCT02549196|Donepezil|donepezil|mesh-list
25724972|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
25724973|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25724974|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724975|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724976|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
25724977|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724978|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724979|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
25724980|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25724981|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25724982|NCT02549196|Urological Agents|urological agents|mesh-ancestor
25772380|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772381|NCT03685344|Durvalumab|durvalumab|mesh-list
25772382|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25772383|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25772384|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25772385|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772386|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
25772387|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772388|NCT03685396|Hemostatics|hemostatics|mesh-list
25772389|NCT03685396|Coagulants|coagulants|mesh-ancestor
25772390|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25772391|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25772392|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772393|NCT03687827|Insulin|insulin|mesh-list
25772394|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25772395|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
25772396|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25772397|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772398|NCT03691779|Ivacaftor|ivacaftor|mesh-list
25772399|NCT03691779|Elexacaftor|elexacaftor|mesh-list
25772400|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24785398|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
25107445|NCT03139708|Tropicamide|tropicamide|mesh-list
25107446|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25724983|NCT02549573|Apomorphine|apomorphine|mesh-list
25724984|NCT02549573|Emetics|emetics|mesh-ancestor
25724985|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724986|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
25724987|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724988|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724989|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
25724990|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
25724991|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724992|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724993|NCT02550106|Omalizumab|omalizumab|mesh-list
25724994|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25724995|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25724996|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
25724997|NCT02550743|Capecitabine|capecitabine|mesh-list
25724998|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25724999|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
25725000|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725001|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725002|NCT02550795|Dexamethasone|dexamethasone|mesh-list
25725003|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
25725004|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725005|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
25725006|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
25725007|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725008|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725009|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725010|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
25725011|NCT02550795|Hormones|hormones|mesh-ancestor
25725012|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725013|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25725014|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725015|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25725016|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25725017|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25725018|NCT02550795|Analgesics|analgesics|mesh-ancestor
25725019|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
25725020|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25725021|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25725022|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25725023|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
25725024|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725025|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725026|NCT02551055|Paclitaxel|paclitaxel|mesh-list
25725027|NCT02551055|Docetaxel|docetaxel|mesh-list
25725028|NCT02551055|Serabelisib|serabelisib|mesh-list
25725029|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25725030|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725031|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725032|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725033|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725034|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725035|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725036|NCT02551094|Colchicine|colchicine|mesh-list
25725037|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
25725038|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725039|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725040|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725041|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725042|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725043|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725044|NCT02551159|Cisplatin|cisplatin|mesh-list
25725045|NCT02551159|Carboplatin|carboplatin|mesh-list
25725046|NCT02551159|Fluorouracil|fluorouracil|mesh-list
25725047|NCT02551159|Cetuximab|cetuximab|mesh-list
25725048|NCT02551159|Durvalumab|durvalumab|mesh-list
25725049|NCT02551159|Tremelimumab|tremelimumab|mesh-list
25725050|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25725051|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725052|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
25725053|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994502|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24994503|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994504|NCT04022226|Ketamine|ketamine|mesh-list
24994505|NCT04022226|Methohexital|methohexital|mesh-list
25725054|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25725055|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725056|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
25725057|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725058|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25725059|NCT02551432|Paclitaxel|paclitaxel|mesh-list
25725060|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
25725061|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25725062|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725063|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725064|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725065|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725066|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725067|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25725068|NCT02551692|Nicotine|nicotine|mesh-list
25725069|NCT02551692|Varenicline|varenicline|mesh-list
25725070|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25725071|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
25725072|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725073|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725074|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25725075|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25725076|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
25725077|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725078|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725079|NCT02551731|Cannabidiol|cannabidiol|mesh-list
25725080|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
25725081|NCT02551744|Pantoprazole|pantoprazole|mesh-list
25725082|NCT02551744|Famotidine|famotidine|mesh-list
25725083|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25725084|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
25725085|NCT02551744|Histamine|histamine|mesh-list
25725086|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25725087|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725088|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725089|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725090|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
25725091|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
25725092|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725093|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725094|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
25725095|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25725096|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725097|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725098|NCT02551874|Metformin|metformin|mesh-list
25725099|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
25725100|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
25725101|NCT02551874|Saxagliptin|saxagliptin|mesh-list
25725102|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725103|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725104|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25725105|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725106|NCT02551874|Incretins|incretins|mesh-ancestor
25725107|NCT02551874|Hormones|hormones|mesh-ancestor
25725108|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725109|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25725110|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725111|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725112|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
25725113|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25725114|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725115|NCT02552147|Nicotine|nicotine|mesh-list
25725116|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25725117|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
25725118|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725119|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725120|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25725121|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25725122|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
25725123|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725124|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941560|NCT03989778|Vitamin D|vitamin d|mesh-list
24941561|NCT03989778|Vitamins|vitamins|mesh-ancestor
24941562|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
24941563|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725126|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25725127|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
25725128|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25725129|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25725130|NCT02552225|Analgesics|analgesics|mesh-ancestor
25725131|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
25725132|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725133|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725134|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25725135|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25725136|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25725137|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725138|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
25725139|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725140|NCT02552303|Modafinil|modafinil|mesh-list
25725141|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25725142|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725143|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25725144|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25725145|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25725146|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725147|NCT02552355|Metformin|metformin|mesh-list
25725148|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725149|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725150|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
25725151|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25725152|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725153|NCT02553629|Rocuronium|rocuronium|mesh-list
25725154|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25725155|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25725156|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25725157|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725158|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725159|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25725160|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25725161|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25725162|NCT02553772|Laxatives|laxatives|mesh-ancestor
25725163|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725164|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
25725165|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25725166|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25725167|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25725168|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
25725169|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725170|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725171|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725172|NCT02553928|Memantine|memantine|mesh-list
25725173|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25725174|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25725175|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
25725176|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725177|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725178|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725179|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25725180|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25725181|NCT02554279|Menotropins|menotropins|mesh-list
25725182|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25725183|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
25725184|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25725185|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725186|NCT02554721|Aspirin|aspirin|mesh-list
25725187|NCT02554721|Cilostazol|cilostazol|mesh-list
25725188|NCT02554721|Clopidogrel|clopidogrel|mesh-list
25725189|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25725190|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25725191|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25725192|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25725193|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
25725194|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725195|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725196|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725197|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25725198|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25725199|NCT02554721|Analgesics|analgesics|mesh-ancestor
25725200|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
25725201|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725202|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725203|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725204|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25725205|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25725206|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25725207|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725208|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
25725209|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25725210|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
25725211|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25725212|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
25725213|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
25725214|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25725215|NCT02554721|Protective Agents|protective agents|mesh-ancestor
25725216|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25725217|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25725218|NCT02554786|Fluticasone|fluticasone|mesh-list
25725219|NCT02554786|Xhance|xhance|mesh-list
25725220|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
25725221|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25725222|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725223|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25725224|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
25725225|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725226|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725227|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25725228|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
25725229|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725230|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25725231|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25725232|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25725233|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25725234|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
25725235|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725236|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725237|NCT02554890|Valsartan|valsartan|mesh-list
25725238|NCT02554890|Enalapril|enalapril|mesh-list
25725239|NCT02554890|Enalaprilat|enalaprilat|mesh-list
25725240|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25725241|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25725242|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25725243|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25725244|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725245|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25725246|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725247|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725248|NCT02554903|Macitentan|macitentan|mesh-list
25725249|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25725250|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25725251|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725252|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25725253|NCT02554981|Cyclosporine|cyclosporine|mesh-list
25725254|NCT02554981|Cyclosporins|cyclosporins|mesh-list
25725255|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725256|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725257|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725258|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
25725259|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041397|NCT02547818|Ibuprofen|ibuprofen|mesh-list
25041398|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25041399|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041400|NCT02547818|Analgesics|analgesics|mesh-ancestor
25725260|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
25725261|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725262|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725263|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725264|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25725265|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25725266|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725267|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725268|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
25725269|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725270|NCT02555228|Simethicone|simethicone|mesh-list
25725271|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
25725272|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725273|NCT02555228|Emollients|emollients|mesh-ancestor
25725274|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725275|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
25725276|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25725277|NCT02555683|Growth Substances|growth substances|mesh-ancestor
25725278|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725279|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
25725280|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25725281|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
25725282|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25725283|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725284|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725285|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725286|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
25725287|NCT02556203|Aspirin|aspirin|mesh-list
25725288|NCT02556203|Vitamin K|vitamin k|mesh-list
25725289|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
25725290|NCT02556203|Clopidogrel|clopidogrel|mesh-list
25725291|NCT02556203|Vitamins|vitamins|mesh-ancestor
25725292|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
25725293|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725294|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25725295|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25725296|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25725297|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25725298|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
25725299|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725300|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725301|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25725302|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
25725303|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25725304|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725305|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725306|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
25725307|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25725308|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25725309|NCT02556203|Analgesics|analgesics|mesh-ancestor
25725310|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
25725311|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725312|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725313|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725314|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25725315|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25725316|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25725317|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
25725318|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25725319|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
25725320|NCT02556203|Coagulants|coagulants|mesh-ancestor
25725321|NCT02556307|Ribavirin|ribavirin|mesh-list
25725322|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25725323|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
25725324|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725325|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
25725326|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725327|NCT02556333|Tenofovir|tenofovir|mesh-list
25725328|NCT02556333|Emtricitabine|emtricitabine|mesh-list
25725329|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
25725330|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725331|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24947474|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25725332|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25725333|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725334|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725335|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25725336|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25725337|NCT02556632|Curcumin|curcumin|mesh-list
25725338|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25725339|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25725340|NCT02556632|Analgesics|analgesics|mesh-ancestor
25725341|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
25725342|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725343|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725344|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725345|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725346|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725347|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725348|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725349|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
25725350|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25725351|NCT02556775|Antibodies|antibodies|mesh-list
25725352|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
25725353|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25725354|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
25725355|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725356|NCT02556788|Trifarotene|trifarotene|mesh-list
25725357|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725358|NCT02556918|Insulin|insulin|mesh-list
25725359|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25725360|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
25725361|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25725362|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
25725363|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
25725364|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725365|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725366|NCT02556918|Incretins|incretins|mesh-ancestor
25725367|NCT02556918|Hormones|hormones|mesh-ancestor
25725368|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725369|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25725370|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725371|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725372|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725373|NCT02557035|Dexamethasone|dexamethasone|mesh-list
25725374|NCT02557035|Palonosetron|palonosetron|mesh-list
25725375|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725376|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
25725377|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
25725378|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725379|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725380|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725381|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
25725382|NCT02557035|Hormones|hormones|mesh-ancestor
25725383|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725384|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25725385|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725386|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25725387|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25725388|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
25725389|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725390|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725391|NCT02557100|Adalimumab|adalimumab|mesh-list
25725392|NCT02557100|Methotrexate|methotrexate|mesh-list
25725393|NCT02557100|Abatacept|abatacept|mesh-list
25725394|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25725395|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
25725396|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25725397|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725398|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25725399|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
25725400|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540550|NCT00668356|Didanosine|didanosine|mesh-list
25725401|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725402|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725403|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725404|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25725405|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725406|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
25725407|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725408|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25725409|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725410|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25725412|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25725413|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
25725414|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725415|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
25725416|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725417|NCT02558231|Selexipag|selexipag|mesh-list
25725418|NCT02558231|Tadalafil|tadalafil|mesh-list
25725419|NCT02558231|Macitentan|macitentan|mesh-list
25725420|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
25725421|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25725422|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25725423|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725424|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725425|NCT02558231|Urological Agents|urological agents|mesh-ancestor
25725426|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25725427|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25725428|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25725429|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25772401|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772402|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772403|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25772404|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25772405|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772406|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
25772407|NCT03691948|Narcotics|narcotics|mesh-ancestor
25772408|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772409|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772410|NCT03691948|Analgesics|analgesics|mesh-ancestor
25772411|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
25772412|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772413|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
25772414|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25772415|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
25772416|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772417|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772418|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25772419|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
25772420|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
25772421|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25772422|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772423|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772424|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772425|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
25772426|NCT03693950|Hematinics|hematinics|mesh-ancestor
25772427|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
25772428|NCT03693989|Difluprednate|difluprednate|mesh-list
25772429|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
25772430|NCT03693989|Hormones|hormones|mesh-ancestor
25772431|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25772432|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772433|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772434|NCT03695094|Lamotrigine|lamotrigine|mesh-list
25772435|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
25772436|NCT03695094|Levetiracetam|levetiracetam|mesh-list
25772437|NCT03695094|Brivaracetam|brivaracetam|mesh-list
25772438|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
25772439|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
25772440|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25772441|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772442|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860975|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860976|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24861017|NCT02314351|Fentanyl|fentanyl|mesh-list
24861018|NCT02314351|Metoclopramide|metoclopramide|mesh-list
25725430|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
25725431|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725432|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725433|NCT02558374|Timolol|timolol|mesh-list
25725434|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25725435|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25725436|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25725437|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25725438|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
25725439|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725440|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725441|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725442|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25725443|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25725444|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25725445|NCT02558400|Latanoprost|latanoprost|mesh-list
25725446|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25725447|NCT02558829|Insulin|insulin|mesh-list
25725448|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25725449|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725450|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725451|NCT02558894|Durvalumab|durvalumab|mesh-list
25725452|NCT02558894|Tremelimumab|tremelimumab|mesh-list
25725453|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25725454|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25725455|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725456|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
25725457|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725458|NCT02559206|Linaclotide|linaclotide|mesh-list
25725459|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25725460|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
25725461|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725462|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725463|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
25725464|NCT02559310|Linezolid|linezolid|mesh-list
25725465|NCT02559310|Lefamulin|lefamulin|mesh-list
25725466|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25725467|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725468|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25725469|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25725470|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725471|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725472|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725473|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25725474|NCT02559414|Aspirin|aspirin|mesh-list
25725475|NCT02559414|Clopidogrel|clopidogrel|mesh-list
25725476|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25725477|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25725478|NCT02559414|Analgesics|analgesics|mesh-ancestor
25725479|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
25725480|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725481|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725482|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725483|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725484|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25725485|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25725486|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725487|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25725488|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25725489|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725490|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
25725491|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25725492|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25725493|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25725494|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
25725495|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725496|NCT02559505|Vaccines|vaccines|mesh-list
25725497|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
25725498|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725499|NCT02559570|Linaclotide|linaclotide|mesh-list
25725500|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24446976|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24446977|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725501|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
25725502|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725503|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725504|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25725505|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
25725506|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725507|NCT02559713|Vedolizumab|vedolizumab|mesh-list
25725508|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725509|NCT02559817|Linaclotide|linaclotide|mesh-list
25725510|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25725511|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
25725512|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725513|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725514|NCT02560012|Sirolimus|sirolimus|mesh-list
25725515|NCT02560012|Everolimus|everolimus|mesh-list
25725516|NCT02560012|Sorafenib|sorafenib|mesh-list
25725517|NCT02560012|Sunitinib|sunitinib|mesh-list
25725518|NCT02560012|Axitinib|axitinib|mesh-list
25725519|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725520|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725521|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
25725522|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725523|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25725524|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725525|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725526|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25725527|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25725528|NCT02560012|Growth Substances|growth substances|mesh-ancestor
25725529|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
25725530|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25725531|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725532|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25725533|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
25725534|NCT02560025|Cytarabine|cytarabine|mesh-list
25725535|NCT02560025|Daunorubicin|daunorubicin|mesh-list
25725536|NCT02560025|Idarubicin|idarubicin|mesh-list
25725537|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25725538|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
25725539|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725540|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725541|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
25725542|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725543|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725544|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
25725545|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725546|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25725547|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25725548|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25725549|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725550|NCT02560038|Gemcitabine|gemcitabine|mesh-list
25725551|NCT02560038|Paclitaxel|paclitaxel|mesh-list
25725552|NCT02560038|Cisplatin|cisplatin|mesh-list
25725553|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25725554|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725555|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725556|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725557|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725558|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725559|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25725560|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
25725561|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
25725562|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725563|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725564|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725565|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
25725566|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725567|NCT02560051|Ketoconazole|ketoconazole|mesh-list
25725568|NCT02560051|Docetaxel|docetaxel|mesh-list
25725569|NCT02560051|Doxorubicin|doxorubicin|mesh-list
25725570|NCT02560051|Estramustine|estramustine|mesh-list
25725571|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725572|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725573|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
24807011|NCT02019329|Risperidone|risperidone|mesh-list
24807012|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24807013|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
24807014|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725574|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725575|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725576|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25725577|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25725578|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25725579|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725580|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
25725581|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725582|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25725583|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25725584|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25725585|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
25725586|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725587|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725588|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25725589|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25725590|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
25725591|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25725592|NCT02560389|Levodopa|levodopa|mesh-list
25725593|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25725594|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25725595|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
25725596|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725597|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725598|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725599|NCT02560558|Abatacept|abatacept|mesh-list
25725600|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25725601|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725602|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725603|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725604|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
25725605|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725606|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725607|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25725608|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25725609|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725610|NCT02560779|Sorafenib|sorafenib|mesh-list
25725611|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725612|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25725613|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725614|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725615|NCT02561078|Insulin|insulin|mesh-list
25725616|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25725617|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725618|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725619|NCT02561130|Metformin|metformin|mesh-list
25725620|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
25725621|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
25725622|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725623|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725624|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25725625|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725626|NCT02561273|Prednisone|prednisone|mesh-list
25725627|NCT02561273|Cortisone|cortisone|mesh-list
25725628|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
25725629|NCT02561273|Doxorubicin|doxorubicin|mesh-list
25725630|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25725631|NCT02561273|Etoposide|etoposide|mesh-list
25725632|NCT02561273|Vincristine|vincristine|mesh-list
25725633|NCT02561273|Lenalidomide|lenalidomide|mesh-list
25725634|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
25725635|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
25725636|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725637|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
25725638|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725639|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725640|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25725641|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
25725642|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725643|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725644|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24807723|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24807724|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
24480106|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
25725645|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25725646|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25725647|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25725648|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725649|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725650|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
25725651|NCT02561273|Hormones|hormones|mesh-ancestor
25725652|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725653|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25725654|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25725655|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725656|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725657|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725658|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25725659|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25725660|NCT02561273|Growth Substances|growth substances|mesh-ancestor
25725661|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
25725662|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
25725663|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725664|NCT02561481|Sulforaphane|sulforaphane|mesh-list
25725665|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25725666|NCT02561481|Protective Agents|protective agents|mesh-ancestor
25725667|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725668|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725669|NCT02561702|Mexiletine|mexiletine|mesh-list
25725670|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25725671|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25725672|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25725673|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25725674|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725675|NCT02561806|Ustekinumab|ustekinumab|mesh-list
25725676|NCT02561806|Ixekizumab|ixekizumab|mesh-list
25725677|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725678|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
25725679|NCT02561832|Carboplatin|carboplatin|mesh-list
25725680|NCT02561832|Olaparib|olaparib|mesh-list
25725681|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725682|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
25725683|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725684|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725685|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25725686|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
25725687|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725688|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725689|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25725690|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25725691|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725692|NCT02561897|Warfarin|warfarin|mesh-list
25725693|NCT02561897|Edoxaban|edoxaban|mesh-list
25725694|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
25725695|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25725696|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
25725697|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25725698|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725699|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725700|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725701|NCT02562066|Amifampridine|amifampridine|mesh-list
25725702|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25725703|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725704|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725705|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25725706|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25725707|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725708|NCT02562521|Nicotine|nicotine|mesh-list
25725709|NCT02562521|Varenicline|varenicline|mesh-list
25725710|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25725711|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
25725712|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500447|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500448|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24500449|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501157|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
24943287|NCT03972592|Sirolimus|sirolimus|mesh-list
24501969|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725713|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725714|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25725715|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25725716|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
25725717|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725718|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725719|NCT02562755|Sorafenib|sorafenib|mesh-list
25725720|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725721|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25725722|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725723|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725724|NCT02562898|Gemcitabine|gemcitabine|mesh-list
25725725|NCT02562898|Paclitaxel|paclitaxel|mesh-list
25725726|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25725727|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725728|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725729|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725730|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725731|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725732|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25725733|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
25725734|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
25725735|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725736|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725737|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725738|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
25725739|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725740|NCT02562924|Prednisone|prednisone|mesh-list
25725741|NCT02562924|Budesonide|budesonide|mesh-list
25725742|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725743|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
25725744|NCT02562924|Hormones|hormones|mesh-ancestor
25725745|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725746|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725747|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25725748|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725749|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25725750|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
25725751|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725752|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25725753|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
25725754|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
25725755|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25725756|NCT02563067|Growth Substances|growth substances|mesh-ancestor
25725757|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725758|NCT02563093|Vaccines|vaccines|mesh-list
25725759|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
25725760|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725761|NCT02563496|Chloroquine|chloroquine|mesh-list
25725762|NCT02563496|Tafenoquine|tafenoquine|mesh-list
25725763|NCT02563496|Amebicides|amebicides|mesh-ancestor
25725764|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25725765|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25725766|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725767|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
25725768|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725769|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
25725770|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25725771|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725772|NCT02563561|Apaziquone|apaziquone|mesh-list
25725773|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725774|NCT02563834|Insulin|insulin|mesh-list
25725775|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725776|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725777|NCT02563860|Lovastatin|lovastatin|mesh-list
25725778|NCT02563860|L 647318|l 647318|mesh-list
25725779|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
25725780|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25725781|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25725782|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
25725783|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725784|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25725785|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25725786|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725787|NCT02564029|Lorazepam|lorazepam|mesh-list
25725788|NCT02564029|PF-06372865|pf-06372865|mesh-list
24462634|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
25725789|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
25725793|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725794|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725795|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25725796|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25725797|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25725798|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25725799|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25725800|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
25725801|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
25725802|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725803|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725804|NCT02564198|Ramucirumab|ramucirumab|mesh-list
25725805|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725806|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25725807|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
25725808|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725809|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725810|NCT02564211|Incretins|incretins|mesh-ancestor
25725811|NCT02564211|Hormones|hormones|mesh-ancestor
25725812|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725813|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25725814|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725815|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725816|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725817|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25725818|NCT02564471|Doxycycline|doxycycline|mesh-list
25725819|NCT02564471|Chloroquine|chloroquine|mesh-list
25725820|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25725821|NCT02564471|Atovaquone|atovaquone|mesh-list
25725822|NCT02564471|Proguanil|proguanil|mesh-list
25725823|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25725824|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725825|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
25725826|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25725827|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25725828|NCT02564471|Amebicides|amebicides|mesh-ancestor
25725829|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725830|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25725831|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25725832|NCT02564471|Analgesics|analgesics|mesh-ancestor
25725833|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
25725834|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725835|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725836|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725837|NCT02564471|Filaricides|filaricides|mesh-ancestor
25725838|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
25725839|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
25725840|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725841|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725842|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
25725843|NCT02564497|Abatacept|abatacept|mesh-list
25725844|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25725845|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725846|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725847|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725848|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
25725849|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725850|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725851|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
25725852|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25725853|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
25725854|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25725855|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725856|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725857|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725858|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
25725859|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
25725860|NCT02564926|Glimepiride|glimepiride|mesh-list
25725861|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25725862|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725863|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25725864|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725865|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25725866|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725867|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
25725868|NCT02565147|Heparin|heparin|mesh-list
25725869|NCT02565147|Bivalirudin|bivalirudin|mesh-list
25725870|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
25725871|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25725872|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25725873|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725874|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
25725875|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25725876|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
25725877|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725878|NCT02565186|Lasmiditan|lasmiditan|mesh-list
25725879|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25725880|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
25725881|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725882|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725883|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725884|NCT02565381|Nicotine|nicotine|mesh-list
25725885|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25725886|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
25725887|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725888|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725889|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25725890|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25725891|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
25725892|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725893|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725894|NCT02565511|CNP520|cnp520|mesh-list
25725895|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725896|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725897|NCT02565628|PF-06669571|pf-06669571|mesh-list
25725898|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
25725899|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
25725900|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725901|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725902|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725903|NCT02565810|Adalimumab|adalimumab|mesh-list
25725904|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25725905|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725906|NCT02565901|Sirolimus|sirolimus|mesh-list
25725907|NCT02565901|Carboplatin|carboplatin|mesh-list
25725908|NCT02565901|Docetaxel|docetaxel|mesh-list
25725909|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725910|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725911|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725912|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725913|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725914|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25725915|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25725916|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25725917|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
25725918|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725919|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
25725920|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725921|NCT02566005|Misoprostol|misoprostol|mesh-list
25725922|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25725923|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
25725924|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25725925|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725926|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25725927|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725928|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
25725929|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
25725930|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
25725931|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25725932|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
25725933|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725934|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725935|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25725936|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
24451579|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24451581|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25725937|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
25725938|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25725939|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
25725940|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725941|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725942|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25725943|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25725944|NCT02566369|Trifarotene|trifarotene|mesh-list
25725945|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
25772443|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25772444|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772445|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25772446|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25772447|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772448|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25772449|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772450|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772451|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25772452|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25772453|NCT03695367|Acetaminophen|acetaminophen|mesh-list
25772454|NCT03695367|Ibuprofen|ibuprofen|mesh-list
25772455|NCT03695367|Ketorolac|ketorolac|mesh-list
25772456|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772457|NCT03695367|Analgesics|analgesics|mesh-ancestor
25772458|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
25772459|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772460|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772461|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
25772462|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772463|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772464|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772465|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772466|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772467|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772468|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
25772469|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
25772470|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25772471|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772472|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25772473|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25772474|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25772475|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25772476|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772477|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772478|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772479|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
25772480|NCT03696758|Metoprolol|metoprolol|mesh-list
25772481|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
25772482|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
25772483|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25772484|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25772485|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772486|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772487|NCT03696758|Urological Agents|urological agents|mesh-ancestor
25772488|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772489|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25772490|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
25772491|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
25772492|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772493|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772494|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25772495|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25772496|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25772497|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772498|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772499|NCT03697252|Xanomeline|xanomeline|mesh-list
25772500|NCT03697252|Trospium chloride|trospium chloride|mesh-list
25772501|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
25772502|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
25772503|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407021|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
24407022|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820038|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
25725947|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
25725948|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25725949|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725950|NCT02566902|Albuterol|albuterol|mesh-list
25725951|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25725952|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
25725953|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25725954|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725955|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25725956|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
25725957|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
25725958|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25725959|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25725960|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25725961|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25725962|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
25725963|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25725964|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725965|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
25725966|NCT02566993|Doxorubicin|doxorubicin|mesh-list
25725967|NCT02566993|Vincristine|vincristine|mesh-list
25725968|NCT02566993|Topotecan|topotecan|mesh-list
25725969|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25725970|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
25725971|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725972|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25725973|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25725974|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
25725975|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725976|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25725977|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25725978|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25725979|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25725980|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25725981|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725982|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25725983|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25725984|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25725985|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25725986|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25725987|NCT02567552|Progesterone|progesterone|mesh-list
25725988|NCT02567552|Progestins|progestins|mesh-ancestor
25725989|NCT02567552|Hormones|hormones|mesh-ancestor
25725990|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25725991|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25725992|NCT02567656|Tenalisib|tenalisib|mesh-list
25725993|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
25725994|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725995|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25725996|NCT02567708|Nemiralisib|nemiralisib|mesh-list
25725997|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25725998|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25725999|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726000|NCT02567968|Caffeine|caffeine|mesh-list
25726001|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
25726002|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726003|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25726004|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726005|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25726006|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726007|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25726008|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25726009|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
25726010|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726011|NCT02568046|Leucovorin|leucovorin|mesh-list
25726012|NCT02568046|Fluorouracil|fluorouracil|mesh-list
24846995|NCT02244567|Metformin|metformin|mesh-list
24459185|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25726013|NCT02568046|Irinotecan|irinotecan|mesh-list
25726014|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
25726015|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726016|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25726017|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726018|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25726019|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
25726020|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726021|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25726022|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25726023|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726024|NCT02568046|Antidotes|antidotes|mesh-ancestor
25726025|NCT02568046|Protective Agents|protective agents|mesh-ancestor
25726026|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
25726027|NCT02568046|Vitamins|vitamins|mesh-ancestor
25726028|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
25726029|NCT02568397|Dabigatran|dabigatran|mesh-list
25726030|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
25726031|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25726032|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726033|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726034|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726035|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
25726036|NCT02568644|Ketoprofen|ketoprofen|mesh-list
25726037|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25726038|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25726039|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25726040|NCT02568644|Analgesics|analgesics|mesh-ancestor
25726041|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
25726042|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726043|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726044|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25726045|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25726046|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726047|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726048|NCT02568683|Vincristine|vincristine|mesh-list
25726049|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25726050|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726051|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
25726052|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
25726053|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
25726054|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726055|NCT02568852|Anesthetics|anesthetics|mesh-list
25726056|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726057|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726058|NCT02569437|Fluticasone|fluticasone|mesh-list
25726059|NCT02569437|Doxycycline|doxycycline|mesh-list
25726060|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
25726061|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25726062|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25726063|NCT02569437|Prednisolone|prednisolone|mesh-list
25726064|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
25726065|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25726066|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
25726067|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726068|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
25726069|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
25726070|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726071|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726072|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25726073|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
25726074|NCT02569437|Hormones|hormones|mesh-ancestor
25726075|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726076|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25726077|NCT02569437|Protective Agents|protective agents|mesh-ancestor
25726078|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25726079|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726080|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25726081|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726082|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
25726083|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25726084|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25726085|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25726086|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25726087|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
25726088|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
25726089|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25726090|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
25726091|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25726092|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726093|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25726094|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726095|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726096|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
25726097|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25726098|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25726099|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726100|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
25726101|NCT02569658|Coagulants|coagulants|mesh-ancestor
25726102|NCT02569710|Simeprevir|simeprevir|mesh-list
25726103|NCT02569710|Odalasvir|odalasvir|mesh-list
25726104|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
25726105|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726106|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726107|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726108|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726109|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
25726110|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726111|NCT02569801|Fulvestrant|fulvestrant|mesh-list
25726112|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25726113|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726114|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25726115|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25726116|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
25726117|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726118|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726119|NCT02569996|Rituximab|rituximab|mesh-list
25726120|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726121|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726122|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
25726123|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726124|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25726125|NCT02570022|Bupivacaine|bupivacaine|mesh-list
25726126|NCT02570022|Ropivacaine|ropivacaine|mesh-list
25726127|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
25726128|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
25726129|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726130|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726131|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
25726132|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726133|NCT02570074|Fosfomycin|fosfomycin|mesh-list
25726134|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25726135|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726136|NCT02570139|Protective Agents|protective agents|mesh-list
25726137|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726138|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25726139|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25726140|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
25726141|NCT02570711|Gemcitabine|gemcitabine|mesh-list
25726142|NCT02570711|Paclitaxel|paclitaxel|mesh-list
25726143|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
25726144|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25726145|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726146|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
25726147|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
25726148|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
25726149|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726150|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25726151|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
25726152|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
25726153|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726154|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726155|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25726156|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
25726157|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726158|NCT02571049|Sumatriptan|sumatriptan|mesh-list
25726159|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24542618|NCT00679601|Tavaborole|tavaborole|mesh-list
25041708|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
25726160|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25726161|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25726162|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
25726163|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726164|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726165|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726166|NCT02571153|Ketamine|ketamine|mesh-list
25726167|NCT02571153|Analgesics|analgesics|mesh-ancestor
25726168|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
25726169|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726170|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726171|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25726172|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25726173|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
25726174|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
25726175|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726176|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25726177|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25726178|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726179|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726180|NCT02571439|Ropivacaine|ropivacaine|mesh-list
25726181|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
25726182|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
25726183|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726184|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726185|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
25726186|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726187|NCT02571634|Fentanyl|fentanyl|mesh-list
25726188|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25726189|NCT02571634|Narcotics|narcotics|mesh-ancestor
25726190|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726191|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726192|NCT02571634|Analgesics|analgesics|mesh-ancestor
25726193|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
25726194|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726195|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25726196|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25726197|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
25726198|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
25726199|NCT02571777|Fluticasone|fluticasone|mesh-list
25726200|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25726201|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726202|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25726203|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
25726204|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726205|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726206|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25726207|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
25726208|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
25726209|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25726210|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25726211|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25726212|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25726213|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
25726214|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726215|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726216|NCT02571972|Timolol|timolol|mesh-list
25726217|NCT02571972|Dorzolamide|dorzolamide|mesh-list
25726218|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25726219|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25726220|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
25726221|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726222|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726223|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726224|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25726225|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25726226|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25726227|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726228|NCT02572167|Nivolumab|nivolumab|mesh-list
25726229|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25726230|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24482979|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482980|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726231|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726232|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25726233|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726234|NCT02572609|Ambroxol|ambroxol|mesh-list
25726235|NCT02572609|Expectorants|expectorants|mesh-ancestor
25726236|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
25726237|NCT02572752|Nintedanib|nintedanib|mesh-list
25726238|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726239|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25726240|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726241|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726242|NCT02573012|Prednisone|prednisone|mesh-list
25726243|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726244|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
25726245|NCT02573012|Hormones|hormones|mesh-ancestor
25726246|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726247|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726248|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25726249|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726250|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
25726251|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25726252|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
25726253|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726254|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726255|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25726256|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
25726257|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
25726258|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25726259|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
25726260|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726261|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726262|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25726263|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
25726264|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726265|NCT02573311|Tamsulosin|tamsulosin|mesh-list
25726266|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25726267|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25726268|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25726269|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
25726270|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726271|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726272|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726273|NCT02573311|Urological Agents|urological agents|mesh-ancestor
25726274|NCT02573857|Artefenomel|artefenomel|mesh-list
25726275|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
25726276|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25726277|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25726278|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726279|NCT02573870|Fluticasone|fluticasone|mesh-list
25726280|NCT02573870|Xhance|xhance|mesh-list
25726281|NCT02573870|Albuterol|albuterol|mesh-list
25726282|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726283|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25726284|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
25726285|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726286|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726287|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25726288|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
25726289|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
25726290|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25726291|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
25726292|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25726293|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25726294|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25726295|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25726296|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25726297|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726298|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726299|NCT02573883|Clobetasol|clobetasol|mesh-list
25726300|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726301|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
25726302|NCT02573883|Hormones|hormones|mesh-ancestor
25772504|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500081|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
24500082|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726303|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726304|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726305|NCT02574078|Gemcitabine|gemcitabine|mesh-list
25726306|NCT02574078|Paclitaxel|paclitaxel|mesh-list
25726307|NCT02574078|Docetaxel|docetaxel|mesh-list
25726308|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25726309|NCT02574078|Bevacizumab|bevacizumab|mesh-list
25726310|NCT02574078|Carboplatin|carboplatin|mesh-list
25726311|NCT02574078|Nivolumab|nivolumab|mesh-list
25726312|NCT02574078|Pemetrexed|pemetrexed|mesh-list
25726313|NCT02574078|Crizotinib|crizotinib|mesh-list
25726314|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25726315|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726316|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25726317|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25726318|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25726319|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726320|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726321|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25726322|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25726323|NCT02574078|Growth Substances|growth substances|mesh-ancestor
25726324|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726325|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
25726326|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25726327|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
25726328|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
25726329|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726330|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726331|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25726332|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
25726333|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25726334|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25726335|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25726336|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25726337|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25726338|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726339|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726340|NCT02574520|Bupivacaine|bupivacaine|mesh-list
25726341|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25726342|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
25726343|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
25726344|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726345|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726346|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
25726347|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726348|NCT02574598|Docetaxel|docetaxel|mesh-list
25726349|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
25726350|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726351|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
25726352|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25726353|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25726354|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726355|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726356|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25726357|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
25726358|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726359|NCT02574832|Lidocaine|lidocaine|mesh-list
25726360|NCT02574832|Fentanyl|fentanyl|mesh-list
25726361|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
25726362|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
25726363|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726364|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726365|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
25726366|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726367|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25726368|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25726369|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25726370|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25726371|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726372|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25726373|NCT02574832|Narcotics|narcotics|mesh-ancestor
25726374|NCT02574832|Analgesics|analgesics|mesh-ancestor
25726375|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24820201|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
24820202|NCT02099240|Tazobactam|tazobactam|mesh-list
24820203|NCT02099240|Linezolid|linezolid|mesh-list
25726376|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25726377|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
25726378|NCT02574845|Metformin|metformin|mesh-list
25726379|NCT02574845|Furosemide|furosemide|mesh-list
25726380|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25726381|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726382|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726383|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25726384|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25726385|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
25726386|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726387|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25726388|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25726389|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726390|NCT02574845|Diuretics|diuretics|mesh-ancestor
25726391|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
25726392|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25726393|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25726394|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
25726395|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726396|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726397|NCT02575833|Erenumab|erenumab|mesh-list
25726398|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25726399|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726400|NCT02575833|Analgesics|analgesics|mesh-ancestor
25726401|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
25726402|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726403|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726404|NCT02576067|Methotrexate|methotrexate|mesh-list
25726405|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25726406|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
25726407|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25726408|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726409|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25726410|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
25726411|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726412|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726413|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
25726414|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726415|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25726416|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25726417|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
25726418|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25726419|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25726420|NCT02576145|Daclizumab|daclizumab|mesh-list
25726421|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25726422|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
25726423|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726424|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
25726425|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25726426|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25726427|NCT02576249|Prednisolone|prednisolone|mesh-list
25726428|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
25726429|NCT02576249|Ropivacaine|ropivacaine|mesh-list
25726430|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25726431|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
25726432|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
25726433|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
25726434|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726435|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726436|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
25726437|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726438|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822414|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24415069|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24965110|NCT03779061|Propofol|propofol|mesh-list
24415223|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415224|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
24822707|NCT02112916|Antidotes|antidotes|mesh-ancestor
24416751|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25142796|NCT02946944|Apixaban|apixaban|mesh-list
24416769|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726439|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
25726440|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
25726441|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25726442|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
25726443|NCT02576249|Hormones|hormones|mesh-ancestor
25726444|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726445|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25726446|NCT02576249|Protective Agents|protective agents|mesh-ancestor
25726447|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25726448|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772505|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25772506|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25772507|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772508|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772509|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772510|NCT03697252|Urological Agents|urological agents|mesh-ancestor
25772511|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25772512|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25772513|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25772514|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25772515|NCT03697993|Levofloxacin|levofloxacin|mesh-list
25772516|NCT03697993|Ofloxacin|ofloxacin|mesh-list
25772517|NCT03697993|Fosfomycin|fosfomycin|mesh-list
25772518|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25772519|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772520|NCT03697993|Renal Agents|renal agents|mesh-ancestor
25772521|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25772522|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25772523|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25772524|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772525|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772526|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772527|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25772528|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25772529|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
25772530|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25772531|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772532|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25772533|NCT03700892|Protective Agents|protective agents|mesh-ancestor
25772534|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772535|NCT03701061|Vaccines|vaccines|mesh-list
25772536|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
25772537|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772538|NCT03701074|Acetaminophen|acetaminophen|mesh-list
25772539|NCT03701074|Ibuprofen|ibuprofen|mesh-list
25772540|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772541|NCT03701074|Analgesics|analgesics|mesh-ancestor
25772542|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
25772543|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772544|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772545|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
25772546|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772547|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772548|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772549|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772550|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772551|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772552|NCT03704376|Clonidine|clonidine|mesh-list
25772553|NCT03704376|Ropivacaine|ropivacaine|mesh-list
25772554|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772555|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
25772556|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772557|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772558|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
24419151|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419152|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419160|NCT00211380|Aripiprazole|aripiprazole|mesh-list
24805621|NCT02011191|Biotin|biotin|mesh-list
24419321|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823076|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823077|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823078|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
24689702|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
25726450|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726451|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726452|NCT02576652|Tetracycline|tetracycline|mesh-list
25726453|NCT02576652|Demeclocycline|demeclocycline|mesh-list
25726454|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25726455|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726456|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25726457|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726458|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726459|NCT02576678|Apremilast|apremilast|mesh-list
25726460|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25726461|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25726462|NCT02576678|Analgesics|analgesics|mesh-ancestor
25726463|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
25726464|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726465|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726466|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726467|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25726468|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25726469|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25726470|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726471|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726472|NCT02576938|Triamcinolone|triamcinolone|mesh-list
25726473|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726474|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
25726475|NCT02576938|Hormones|hormones|mesh-ancestor
25726476|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726477|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726478|NCT02576977|Dexamethasone|dexamethasone|mesh-list
25726479|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
25726480|NCT02576977|Pomalidomide|pomalidomide|mesh-list
25726481|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726482|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
25726483|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
25726484|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726485|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726486|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25726487|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
25726488|NCT02576977|Hormones|hormones|mesh-ancestor
25726489|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726490|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25726491|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726492|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726493|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
25726494|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25726495|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25726496|NCT02576977|Growth Substances|growth substances|mesh-ancestor
25726497|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
25726498|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
25726499|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726500|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726501|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25726502|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
25726503|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726504|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726505|NCT02577003|Incretins|incretins|mesh-ancestor
25726506|NCT02577003|Hormones|hormones|mesh-ancestor
25416010|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726507|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726508|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25726509|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726510|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726511|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726512|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25726513|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25726514|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
25726515|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726516|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726517|NCT02577016|Incretins|incretins|mesh-ancestor
25726518|NCT02577016|Hormones|hormones|mesh-ancestor
24421778|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926933|NCT04137185|Hormones|hormones|mesh-list
24421899|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421901|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
25726519|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726520|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25726521|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726522|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726523|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726524|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25726525|NCT02577029|Interferons|interferons|mesh-list
25726526|NCT02577029|Tenofovir|tenofovir|mesh-list
25726527|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
25726528|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
25726529|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25726530|NCT02577029|Entecavir|entecavir|mesh-list
25726531|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
25726532|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25726533|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726534|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
25726535|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726536|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25726537|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25726538|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726539|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726540|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726541|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726542|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
25726543|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726544|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
25726545|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726546|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
25726547|NCT02577042|Atorvastatin|atorvastatin|mesh-list
25726548|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25726549|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25726550|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
25726551|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726552|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25726553|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25726554|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726555|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726556|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726557|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
25726558|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726559|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25726560|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25726561|NCT02577107|Ranibizumab|ranibizumab|mesh-list
25726562|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25726563|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25726564|NCT02577107|Growth Substances|growth substances|mesh-ancestor
25726565|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726566|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
25726567|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726568|NCT02577315|Metformin|metformin|mesh-list
25726569|NCT02577315|Empagliflozin|empagliflozin|mesh-list
25726570|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726571|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726572|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25726573|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726574|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
25726575|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25726576|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
25726577|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
25726578|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25726579|NCT02577601|Estradiol|estradiol|mesh-list
25726580|NCT02577601|Estrogens|estrogens|mesh-ancestor
25726581|NCT02577601|Hormones|hormones|mesh-ancestor
25726582|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823955|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24823956|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24823957|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24823958|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
24823959|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823960|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423552|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24423553|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
24423554|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24423558|NCT00226330|Pioglitazone|pioglitazone|mesh-list
25726583|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726584|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25726585|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
25726586|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25726587|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25726588|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25726589|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25726590|NCT02577718|Ethanol|ethanol|mesh-list
25726591|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
25726592|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25726593|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726594|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726595|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726596|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
25726597|NCT02577991|Triamcinolone|triamcinolone|mesh-list
25726598|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726599|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726600|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
25726601|NCT02577991|Hormones|hormones|mesh-ancestor
25726602|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726603|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
25726604|NCT02578186|Promethazine|promethazine|mesh-list
25726605|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25726606|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25726607|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726608|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726609|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
25726610|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
25726611|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
25726612|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726613|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
25726614|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
25726615|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25726616|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25726617|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
25726618|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
25726619|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726620|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726621|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25726622|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
25726623|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
25726624|NCT02578316|Lenvatinib|lenvatinib|mesh-list
25726625|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726626|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25726627|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726628|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726629|NCT02578706|Aspirin|aspirin|mesh-list
25726630|NCT02578706|Clopidogrel|clopidogrel|mesh-list
25726631|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25726632|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25726633|NCT02578706|Analgesics|analgesics|mesh-ancestor
25726634|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
25726635|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726636|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726637|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726638|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25726639|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25416011|NCT02977780|Temozolomide|temozolomide|mesh-list
25726640|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25726641|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726642|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25726643|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25726644|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726645|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
25726646|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25726647|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25726648|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25726649|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
25726650|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726651|NCT02578862|Propofol|propofol|mesh-list
25726652|NCT02578862|Sevoflurane|sevoflurane|mesh-list
25726653|NCT02578862|Isoflurane|isoflurane|mesh-list
25726654|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25726655|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424873|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24424874|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25726656|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726657|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25726658|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
25726659|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
25726660|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25726661|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25726662|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
25726663|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25726664|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25726665|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726666|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
25726667|NCT02578901|Coagulants|coagulants|mesh-ancestor
25726669|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25726670|NCT02579057|Diuretics|diuretics|mesh-ancestor
25726671|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
25726672|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726673|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25726674|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25726675|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726676|NCT02579343|Dexetimide|dexetimide|mesh-list
25726677|NCT02579343|Citalopram|citalopram|mesh-list
25726678|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25726679|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25726680|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25726681|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726682|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726683|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
25726684|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726685|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25726686|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
25726687|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25726688|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25726689|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25726690|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
25726691|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
25726692|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726693|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25726694|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25726695|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
25726696|NCT02579382|Vesatolimod|vesatolimod|mesh-list
25726697|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
25726698|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726699|NCT02579421|Progesterone|progesterone|mesh-list
25726700|NCT02579421|Progestins|progestins|mesh-ancestor
25726701|NCT02579421|Hormones|hormones|mesh-ancestor
25726702|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726703|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726704|NCT02579603|Pirfenidone|pirfenidone|mesh-list
25726705|NCT02579603|Nintedanib|nintedanib|mesh-list
25726706|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726707|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25726708|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726709|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726710|NCT02579603|Analgesics|analgesics|mesh-ancestor
25726711|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
25726712|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726713|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726714|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25726715|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25726716|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726717|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25726718|NCT02579616|Lenvatinib|lenvatinib|mesh-list
25726719|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726720|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25726721|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726722|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726723|NCT02579629|Ropivacaine|ropivacaine|mesh-list
25726724|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
25726725|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
25726726|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825222|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24624935|NCT01079364|Insulin|insulin|mesh-list
24930865|NCT04095754|Anesthetics|anesthetics|mesh-list
24762773|NCT01769703|Dabigatran|dabigatran|mesh-list
25726727|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726728|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
25726729|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726730|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
25726731|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25726732|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
25726733|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726734|NCT02579772|Expectorants|expectorants|mesh-ancestor
25726735|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
25726736|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25726737|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
25726738|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726739|NCT02579772|Protective Agents|protective agents|mesh-ancestor
25726740|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726741|NCT02579772|Antidotes|antidotes|mesh-ancestor
25726742|NCT02579863|Dexamethasone|dexamethasone|mesh-list
25726743|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
25726744|NCT02579863|Lenalidomide|lenalidomide|mesh-list
25726745|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726746|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
25726747|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
25726748|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726749|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726750|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25726751|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
25726753|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726754|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25726755|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726756|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726757|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
25726758|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25726759|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25726760|NCT02579863|Growth Substances|growth substances|mesh-ancestor
25726761|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
25726762|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
25726763|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726764|NCT02579928|Midazolam|midazolam|mesh-list
25726765|NCT02579928|Ketamine|ketamine|mesh-list
25726766|NCT02579928|Analgesics|analgesics|mesh-ancestor
25726767|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
25726768|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726769|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726770|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25726771|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25726772|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
25726773|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
25726774|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726775|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25726776|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25726777|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726778|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726779|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25726780|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25726781|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25726782|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25726783|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25726784|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
25726785|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
25726786|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
25726787|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726788|NCT02580591|Empagliflozin|empagliflozin|mesh-list
25726789|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25726790|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726791|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726792|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766625|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443391|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513579|NCT00583869|Pregabalin|pregabalin|mesh-list
25726794|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25726795|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
25726796|NCT02580877|Methamphetamine|methamphetamine|mesh-list
25726797|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726798|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726799|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25726800|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
25726801|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
25726802|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726803|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
25726804|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726805|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726806|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
25726807|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25726808|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25726809|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25726810|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25726811|NCT02581111|Naloxone|naloxone|mesh-list
25726812|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25726813|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726814|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
25726815|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726816|NCT02581163|Ritonavir|ritonavir|mesh-list
25726817|NCT02581163|Ribavirin|ribavirin|mesh-list
25726818|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25726819|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25726820|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726821|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726822|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726823|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726824|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726825|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
25726826|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726827|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25726828|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25726829|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
25726830|NCT02581189|Ritonavir|ritonavir|mesh-list
25726831|NCT02581189|Ribavirin|ribavirin|mesh-list
25726832|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25726833|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25726834|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726835|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726836|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726837|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726838|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726839|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
25726840|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726841|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25726842|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25726843|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
25726844|NCT02581202|Ritonavir|ritonavir|mesh-list
25726845|NCT02581202|Lopinavir|lopinavir|mesh-list
25726846|NCT02581202|Lamivudine|lamivudine|mesh-list
25726847|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25726848|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25726849|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726850|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726851|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726852|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726853|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726854|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
25726855|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726856|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25726857|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25726858|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25726859|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25726860|NCT02581345|Adalimumab|adalimumab|mesh-list
24826993|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24827028|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827029|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
24827182|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24827183|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827184|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714328|NCT01530152|Lidocaine|lidocaine|mesh-list
25726861|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726862|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25726863|NCT02581839|Dexamethasone|dexamethasone|mesh-list
25726864|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
25726865|NCT02581839|Ondansetron|ondansetron|mesh-list
25726867|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25726868|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
25726869|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
25726870|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25726871|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726872|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25726873|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
25726874|NCT02581839|Hormones|hormones|mesh-ancestor
25726875|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25726876|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25726877|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726878|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726879|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726880|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726881|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
25726882|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
25726883|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25726884|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
25726885|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25726886|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25726887|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25726888|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25726889|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25726890|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25726891|NCT02581891|Aflibercept|aflibercept|mesh-list
25726892|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25726893|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25726894|NCT02581891|Growth Substances|growth substances|mesh-ancestor
25726895|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726896|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
25726897|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726898|NCT02581995|Aflibercept|aflibercept|mesh-list
25726899|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25726900|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25726901|NCT02581995|Growth Substances|growth substances|mesh-ancestor
25726902|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726903|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
25726904|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726905|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
25726906|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
25726907|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25726908|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726909|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726910|NCT02582515|Cycloserine|cycloserine|mesh-list
25726911|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25726912|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726913|NCT02582515|Renal Agents|renal agents|mesh-ancestor
25726914|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25726915|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
25726916|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25726917|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
25726918|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726919|NCT02582632|Ritonavir|ritonavir|mesh-list
25726920|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25726921|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25726922|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726923|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726924|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726925|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726926|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726927|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
25726928|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726929|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25726930|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25726931|NCT02582671|Ritonavir|ritonavir|mesh-list
25726932|NCT02582671|Ribavirin|ribavirin|mesh-list
25726933|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24851920|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24851922|NCT02259829|Amlodipine|amlodipine|mesh-list
25726934|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25726935|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
25726936|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726937|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726938|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726939|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726940|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
25726941|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726942|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25726943|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25726944|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
25726945|NCT02582684|Lamivudine|lamivudine|mesh-list
25726946|NCT02582684|Dolutegravir|dolutegravir|mesh-list
25726947|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25726948|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25726949|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726950|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726951|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
25726952|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25726953|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726954|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726955|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25726956|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25726957|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
25726958|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25726959|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726960|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726961|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726962|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
25726963|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25726964|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726965|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25726966|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726967|NCT02582866|Lacosamide|lacosamide|mesh-list
25726968|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
25726969|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25726970|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25726971|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25726972|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726973|NCT02582970|Bevacizumab|bevacizumab|mesh-list
25726974|NCT02582970|Fluorouracil|fluorouracil|mesh-list
25726975|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
25726976|NCT02582970|Irinotecan|irinotecan|mesh-list
25726977|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25726978|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25726979|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25726980|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25726981|NCT02582970|Growth Substances|growth substances|mesh-ancestor
25726982|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25726983|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
25726984|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
25726985|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726986|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25726987|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25726988|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
25726989|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25726990|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25726991|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25726992|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
25726993|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25726994|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25726995|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25726996|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25726997|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25726998|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
25726999|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727000|NCT02583399|Ibuprofen|ibuprofen|mesh-list
25727001|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25727002|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25727003|NCT02583399|Analgesics|analgesics|mesh-ancestor
25727004|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
25169754|NCT01774578|Gemcitabine|gemcitabine|mesh-list
24459326|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
25727005|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727006|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727007|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727008|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727009|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25727010|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727011|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727012|NCT02583477|Gemcitabine|gemcitabine|mesh-list
25727013|NCT02583477|Paclitaxel|paclitaxel|mesh-list
25727014|NCT02583477|Durvalumab|durvalumab|mesh-list
25727015|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25727016|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25727017|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727018|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
25727019|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
25727020|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
25727021|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727022|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25727023|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
25727024|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
25727025|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727026|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727027|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727028|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
25727029|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727030|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727031|NCT02584257|Albuterol|albuterol|mesh-list
25727032|NCT02584257|Procaterol|procaterol|mesh-list
25727033|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
25727034|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25727035|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
25727036|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727037|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727038|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25727039|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
25727040|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
25727041|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25727042|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25727043|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25727044|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25727045|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727046|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727047|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727048|NCT02584257|Miotics|miotics|mesh-ancestor
25727049|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25727050|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25727051|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25727052|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25727053|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
25727054|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
25727055|NCT02584452|Dexamethasone|dexamethasone|mesh-list
25727056|NCT02584452|Fentanyl|fentanyl|mesh-list
25727057|NCT02584452|Bupivacaine|bupivacaine|mesh-list
25727058|NCT02584452|Ropivacaine|ropivacaine|mesh-list
25727059|NCT02584452|Mepivacaine|mepivacaine|mesh-list
25727060|NCT02584452|Propofol|propofol|mesh-list
25727061|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727062|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
25727063|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
25727064|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727065|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727066|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25727067|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
25727068|NCT02584452|Hormones|hormones|mesh-ancestor
25727069|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727070|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25727071|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727072|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
25727073|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
25727074|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727075|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
25727076|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25727077|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24495861|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24810217|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
25179734|NCT03153527|Prednisone|prednisone|mesh-list
25179990|NCT02783092|Cannabidiol|cannabidiol|mesh-list
25727078|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
25727079|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25727080|NCT02584452|Narcotics|narcotics|mesh-ancestor
25727081|NCT02584452|Analgesics|analgesics|mesh-ancestor
25727082|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25727083|NCT02584504|Atorvastatin|atorvastatin|mesh-list
25727084|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25727085|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25727086|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
25727087|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727088|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25727089|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25727090|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727091|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
25727092|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
25727093|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727094|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
25727095|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25727096|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
25727097|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25727098|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
25727099|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727100|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727101|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
25727102|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
25727103|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25727104|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25727105|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25727106|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25727107|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727108|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
25727109|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727110|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727111|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25727112|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772559|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772560|NCT03704376|Analgesics|analgesics|mesh-ancestor
25772561|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25772562|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
25772563|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
25772564|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25772565|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25772566|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25772567|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772568|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772569|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772570|NCT03704467|Carboplatin|carboplatin|mesh-list
25772571|NCT03704467|Avelumab|avelumab|mesh-list
25772572|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772573|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25772574|NCT03705273|Dexamethasone|dexamethasone|mesh-list
25772575|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
25772576|NCT03705273|BB 1101|bb 1101|mesh-list
25772577|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772578|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
25772579|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
25772580|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772581|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772582|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25772583|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
25772584|NCT03705273|Hormones|hormones|mesh-ancestor
25772585|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25772586|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25772587|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772588|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
25772589|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772590|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777487|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777488|NCT03490916|Acetazolamide|acetazolamide|mesh-list
25777489|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
24423981|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423982|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190811|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
25727113|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
25727114|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25727115|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25727116|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727117|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
25727118|NCT02584725|Coagulants|coagulants|mesh-ancestor
25727119|NCT02584855|Ixekizumab|ixekizumab|mesh-list
25727120|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
25727121|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25727122|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
25727123|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
25727124|NCT02584959|Complement C1s|complement c1s|mesh-list
25727125|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25727126|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25727127|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
25727128|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727129|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25727130|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727131|NCT02585713|Dalteparin|dalteparin|mesh-list
25727132|NCT02585713|Tinzaparin|tinzaparin|mesh-list
25727133|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25727134|NCT02585713|Apixaban|apixaban|mesh-list
25727135|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25727136|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
25727137|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25727138|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
25727139|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727140|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727141|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
25727142|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25727143|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25727144|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25727145|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727146|NCT02585843|Spironolactone|spironolactone|mesh-list
25727147|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25727148|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
25727149|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727150|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727151|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25727152|NCT02585843|Diuretics|diuretics|mesh-ancestor
25727153|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
25727154|NCT02585895|Evolocumab|evolocumab|mesh-list
25727155|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25727156|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25727157|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
25727158|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727159|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25727160|NCT02585960|Factor VIII|factor viii|mesh-list
25727161|NCT02585960|BAX 855|bax 855|mesh-list
25727162|NCT02585960|Coagulants|coagulants|mesh-ancestor
25727163|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
25727164|NCT02585999|Ortho Evra|ortho evra|mesh-list
25727165|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25727166|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727167|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25727168|NCT02586155|Atorvastatin|atorvastatin|mesh-list
25727169|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25727170|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25727171|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25727172|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
25727173|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727174|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25727175|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25727176|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727177|NCT02586727|Aflibercept|aflibercept|mesh-list
25727178|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25727179|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25727180|NCT02586727|Growth Substances|growth substances|mesh-ancestor
25727181|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727182|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
25727183|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727184|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25727185|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
25727186|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727187|NCT02587065|Interferons|interferons|mesh-list
25727188|NCT02587065|Interferon-beta|interferon-beta|mesh-list
25727189|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
25727190|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727191|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
25727192|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727193|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
25727194|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727195|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25727196|NCT02587117|Prednisolone|prednisolone|mesh-list
25727197|NCT02587117|Lycopene|lycopene|mesh-list
25727198|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727199|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
25727200|NCT02587117|Hormones|hormones|mesh-ancestor
25727201|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727202|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727203|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25727204|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727205|NCT02587117|Protective Agents|protective agents|mesh-ancestor
25727206|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
25727207|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727208|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25727209|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25727210|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
25727211|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
25727212|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
25727213|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727214|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727215|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
25727216|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727217|NCT02587351|Metoprolol|metoprolol|mesh-list
25727218|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25727219|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25727220|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
25727221|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
25727222|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727223|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727224|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25727225|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25727226|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25727227|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727228|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727229|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727230|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
25727231|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727232|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727233|NCT05249556|Ganaxolone|ganaxolone|mesh-list
25727234|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
25727235|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727236|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727237|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727238|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
25727239|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
25727240|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
25727241|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727242|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
25727243|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727244|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727245|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25727246|NCT05249231|Fluorides|fluorides|mesh-list
25727247|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
25727248|NCT05249231|Protective Agents|protective agents|mesh-ancestor
25727249|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727250|NCT05249153|Sufentanil|sufentanil|mesh-list
25727251|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
25727252|NCT05249153|Dsuvia|dsuvia|mesh-list
25727253|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25727254|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727255|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727256|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25727257|NCT05249153|Analgesics|analgesics|mesh-ancestor
25727258|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
25727259|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727260|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25727261|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25727262|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24460522|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460524|NCT00348582|Ketorolac|ketorolac|mesh-list
25727263|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727264|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727265|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727266|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25727267|NCT05249153|Narcotics|narcotics|mesh-ancestor
25727268|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25727269|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25727270|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
25727271|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
25727272|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25727273|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25727274|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727275|NCT05249023|Butyric Acid|butyric acid|mesh-list
25727276|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
25727277|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
25727278|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727279|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727280|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727281|NCT05248932|Norepinephrine|norepinephrine|mesh-list
25727282|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25727283|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25727284|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727285|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727286|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727287|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727288|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
25727289|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
25727290|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727291|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25727292|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25727293|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25727294|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727295|NCT05248152|Acetaminophen|acetaminophen|mesh-list
25727296|NCT05248152|Ibuprofen|ibuprofen|mesh-list
25727297|NCT05248152|Pregabalin|pregabalin|mesh-list
25727298|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25727299|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25727300|NCT05248152|Analgesics|analgesics|mesh-ancestor
25727301|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
25727302|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727303|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727304|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727305|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727306|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25727307|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727308|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727309|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
25727310|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25727311|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25727312|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25727313|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25727314|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25727315|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727316|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25727317|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
25727318|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25727319|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727320|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772591|NCT03706313|Bupivacaine|bupivacaine|mesh-list
25772592|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772593|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
25772594|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772595|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772596|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
25772597|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772598|NCT03708211|Esomeprazole|esomeprazole|mesh-list
25772599|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25772600|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25772601|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25772602|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772603|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772604|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
25772605|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
24578126|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578471|NCT00849160|Darunavir|darunavir|mesh-list
25727322|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25727323|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727324|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727325|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727326|NCT05247697|Mirtazapine|mirtazapine|mesh-list
25727327|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
25727328|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25727329|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25727330|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
25727331|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
25727332|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727333|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727334|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727335|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25727336|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25727337|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727338|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25727339|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25727340|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25727341|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727342|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25727343|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25727344|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
25727345|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25727346|NCT05247684|Paclitaxel|paclitaxel|mesh-list
25727347|NCT05247684|Cisplatin|cisplatin|mesh-list
25727348|NCT05247684|Carboplatin|carboplatin|mesh-list
25727349|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25727350|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727351|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
25727352|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
25727353|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
25727354|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727355|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
25727356|NCT05247554|Prednisone|prednisone|mesh-list
25727357|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727358|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
25727359|NCT05247554|Hormones|hormones|mesh-ancestor
25727360|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727361|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727362|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25727363|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727364|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
25727365|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25727366|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25727367|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727368|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727369|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727370|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727371|NCT05220813|Lidocaine|lidocaine|mesh-list
25727372|NCT05220813|Bupivacaine|bupivacaine|mesh-list
25727373|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
25727374|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
25727375|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727376|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727377|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
25727378|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727379|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25727380|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25727381|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25727382|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25727383|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727384|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
25727385|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
25727386|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727387|NCT05184348|Acitretin|acitretin|mesh-list
25727388|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
25727389|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
25727390|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
25727391|NCT05159193|Carboplatin|carboplatin|mesh-list
25727392|NCT05159193|Docetaxel|docetaxel|mesh-list
24672956|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672957|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25727394|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25727395|NCT05159193|Trastuzumab|trastuzumab|mesh-list
25727396|NCT05159193|Pertuzumab|pertuzumab|mesh-list
25727397|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727398|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
25727399|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727400|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727401|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25727402|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
25727403|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727404|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727405|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25727406|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
25727407|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
25727408|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
25727409|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25727410|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25727411|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25727412|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727413|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727414|NCT05156437|Amoxicillin|amoxicillin|mesh-list
25727415|NCT05156437|Vancomycin|vancomycin|mesh-list
25727416|NCT05156437|Levofloxacin|levofloxacin|mesh-list
25727417|NCT05156437|Rifampin|rifampin|mesh-list
25727418|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
25727419|NCT05156437|Linezolid|linezolid|mesh-list
25727420|NCT05156437|Daptomycin|daptomycin|mesh-list
25727421|NCT05156437|Cephalexin|cephalexin|mesh-list
25727422|NCT05156437|Ampicillin|ampicillin|mesh-list
25727423|NCT05156437|Cefepime|cefepime|mesh-list
25727424|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25727425|NCT05156437|Oxacillin|oxacillin|mesh-list
25727426|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
25727427|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25727428|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727429|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25727430|NCT05156437|Renal Agents|renal agents|mesh-ancestor
25727431|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25727432|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25727433|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727434|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727435|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727436|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25727437|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25727438|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25727439|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
25727440|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
25727441|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25727442|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25727443|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25727444|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25727445|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25727446|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25727447|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25727448|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25727449|NCT05143424|Morphine|morphine|mesh-list
25727450|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25727451|NCT05143424|Narcotics|narcotics|mesh-ancestor
25727452|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727453|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727454|NCT05143424|Analgesics|analgesics|mesh-ancestor
25727455|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
25727456|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727457|NCT05132166|Sirolimus|sirolimus|mesh-list
25727458|NCT05132166|Everolimus|everolimus|mesh-list
25727459|NCT05132166|Vedolizumab|vedolizumab|mesh-list
25727460|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25727461|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727462|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727463|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
25727464|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727465|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25727466|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727467|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25727468|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
25727469|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25727470|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25727471|NCT05078606|Anesthetics|anesthetics|mesh-list
25727472|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727473|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727474|NCT04932915|Niclosamide|niclosamide|mesh-list
25727475|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
25727476|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25727477|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
25727478|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25727479|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727480|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
25727481|NCT04874038|Lidocaine|lidocaine|mesh-list
25727482|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
25727483|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
25727484|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727485|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727486|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
25727487|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727488|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25727489|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25727490|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25727491|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25727492|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727493|NCT04867785|Dulaglutide|dulaglutide|mesh-list
25727494|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25727495|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727496|NCT04845490|Mitomycins|mitomycins|mesh-list
25727497|NCT04845490|Mitomycin|mitomycin|mesh-list
25727498|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25727499|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727500|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
25727501|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727502|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25727503|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727504|NCT04830397|Timolol|timolol|mesh-list
25727505|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25727506|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25727507|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727508|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727509|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727510|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727511|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25727512|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25727513|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
25727514|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25727515|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25727516|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727517|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727518|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25727519|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25727520|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727521|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
25727522|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727523|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25727524|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25727525|NCT04819360|Urological Agents|urological agents|mesh-ancestor
25727526|NCT04808466|Paclitaxel|paclitaxel|mesh-list
25727527|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25727528|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727529|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
25727530|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
25727531|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
25727532|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727533|NCT04787354|Capecitabine|capecitabine|mesh-list
25727534|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
25727535|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25727536|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
25727537|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704209|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704213|NCT01477203|Citalopram|citalopram|mesh-list
24556301|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24556304|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25129356|NCT03042182|Vaccines|vaccines|mesh-list
25727539|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
25727540|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25727541|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727542|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25727543|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727544|NCT04730206|Camostat|camostat|mesh-list
25727545|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
25727546|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727547|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727548|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25727549|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25727550|NCT04670679|Cetuximab|cetuximab|mesh-list
25727551|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727552|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727553|NCT04631510|Gabapentin|gabapentin|mesh-list
25727554|NCT04631510|Analgesics|analgesics|mesh-ancestor
25727555|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
25727556|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727557|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727558|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
25727559|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25727560|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25727561|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727562|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25727563|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25727564|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25727565|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727566|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727567|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
25727568|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
25727569|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
25727570|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727571|NCT04603898|Protective Agents|protective agents|mesh-ancestor
25727572|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727573|NCT04603898|Vitamins|vitamins|mesh-ancestor
25727574|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
25727575|NCT04590664|Verteporfin|verteporfin|mesh-list
25727576|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25727577|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
25727578|NCT04571619|Buprenorphine|buprenorphine|mesh-list
25727579|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25727580|NCT04571619|Narcotics|narcotics|mesh-ancestor
25727581|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727582|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727583|NCT04571619|Analgesics|analgesics|mesh-ancestor
25727584|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
25727585|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727586|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25772606|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25772607|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25772608|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
25772609|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772610|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772611|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772612|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772613|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25772614|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772615|NCT03710161|Vitamin D|vitamin d|mesh-list
25772616|NCT03710161|Vitamins|vitamins|mesh-ancestor
25772617|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
25772618|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772619|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25772620|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
25772621|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772622|NCT03710590|Nicotine|nicotine|mesh-list
25772623|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25772624|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
25772625|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772626|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772627|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25772628|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25772629|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772630|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940938|NCT03996564|Ketorolac|ketorolac|mesh-list
25727587|NCT04563923|Avdoralimab|avdoralimab|mesh-list
25727588|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727589|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
25727590|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727591|NCT04542434|Niclosamide|niclosamide|mesh-list
25727592|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
25727593|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25727594|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
25727595|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25727596|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727597|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
25727598|NCT04477733|Butorphanol|butorphanol|mesh-list
25727599|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25727600|NCT04477733|Narcotics|narcotics|mesh-ancestor
25727601|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727602|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727603|NCT04477733|Analgesics|analgesics|mesh-ancestor
25727604|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
25727605|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727606|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
25727607|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
25727608|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25727609|NCT04436731|Phentolamine|phentolamine|mesh-list
25727610|NCT04436731|Phenylephrine|phenylephrine|mesh-list
25727611|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
25727612|NCT04436731|Norepinephrine|norepinephrine|mesh-list
25727613|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
25727614|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25727615|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727616|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727617|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25727618|NCT04436731|Analgesics|analgesics|mesh-ancestor
25727619|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
25727620|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727621|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25727622|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25727623|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25727624|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727625|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727626|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727627|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25727628|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
25727629|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
25727630|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
25727631|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25727632|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
25727633|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
25727634|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25727635|NCT04436731|Protective Agents|protective agents|mesh-ancestor
25727636|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25727637|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25727638|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25727639|NCT04436458|Niclosamide|niclosamide|mesh-list
25727640|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
25727641|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25727642|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
25727643|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25727644|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727645|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
25727646|NCT04428385|Artemisinins|artemisinins|mesh-list
25727647|NCT04428385|Artemisinin|artemisinin|mesh-list
25727648|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
25727649|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25727650|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25727651|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727652|NCT04336098|Gemcitabine|gemcitabine|mesh-list
25727653|NCT04336098|Paclitaxel|paclitaxel|mesh-list
25727654|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
25727655|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25727656|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25727657|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727658|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
25727659|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
25727660|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
25727661|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727662|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25727663|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
25727664|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
24740751|NCT01690104|Rifampin|rifampin|mesh-list
25727665|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727666|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727667|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727668|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
25727669|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727670|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727671|NCT04321954|Lenvatinib|lenvatinib|mesh-list
25727672|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727673|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25727674|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727675|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727676|NCT04283656|Tenofovir|tenofovir|mesh-list
25727677|NCT04283656|Lamivudine|lamivudine|mesh-list
25727678|NCT04283656|Spironolactone|spironolactone|mesh-list
25727679|NCT04283656|Estradiol|estradiol|mesh-list
25727680|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
25727681|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727682|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25727683|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25727684|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727685|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727686|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25727687|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25727688|NCT04283656|Estrogens|estrogens|mesh-ancestor
25727689|NCT04283656|Hormones|hormones|mesh-ancestor
25727690|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727691|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727692|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25727693|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
25727694|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25727695|NCT04283656|Diuretics|diuretics|mesh-ancestor
25727696|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
25727697|NCT04250805|Lidocaine|lidocaine|mesh-list
25727698|NCT04250805|Ropivacaine|ropivacaine|mesh-list
25727699|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
25727700|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
25727701|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25727702|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727703|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
25727704|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727705|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25727706|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25727707|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25727708|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25727709|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727710|NCT04218773|Phenylephrine|phenylephrine|mesh-list
25727711|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
25727712|NCT04218773|Norepinephrine|norepinephrine|mesh-list
25727713|NCT04218773|Synephrine|synephrine|mesh-list
25727714|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25727715|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
25727716|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
25727717|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727718|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727719|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
25727720|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25727721|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
25727722|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
25727723|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25727724|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25727725|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25727726|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727727|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727728|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727729|NCT04218773|Protective Agents|protective agents|mesh-ancestor
25727730|NCT04186286|Propranolol|propranolol|mesh-list
25727731|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25727732|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25727733|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
25727734|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727735|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752603|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752731|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
24752732|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753352|NCT01714856|Ropinirole|ropinirole|mesh-list
25727736|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727737|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25727738|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25727739|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
25727740|NCT04044560|Blinatumomab|blinatumomab|mesh-list
25727741|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727742|NCT03952130|Insulin|insulin|mesh-list
25727743|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25727744|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
25727745|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
25727746|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25727747|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727748|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25727749|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25727750|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
25727751|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727752|NCT03922477|Atezolizumab|atezolizumab|mesh-list
25727753|NCT03922477|Magrolimab|magrolimab|mesh-list
25727754|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727755|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727756|NCT03907176|Acetaminophen|acetaminophen|mesh-list
25727757|NCT03907176|Ibuprofen|ibuprofen|mesh-list
25727758|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25727759|NCT03907176|Analgesics|analgesics|mesh-ancestor
25727760|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
25727761|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727762|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727763|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
25727764|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25727765|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727766|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727767|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25727768|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727769|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727770|NCT03807440|Empagliflozin|empagliflozin|mesh-list
25727771|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25727772|NCT03807440|Linagliptin|linagliptin|mesh-list
25727773|NCT03807440|Metformin|metformin|mesh-list
25727774|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25727775|NCT03807440|Glucagon|glucagon|mesh-list
25727776|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25727777|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727778|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25727779|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727780|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25727781|NCT03807440|Hormones|hormones|mesh-ancestor
25727782|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727783|NCT03807440|Incretins|incretins|mesh-ancestor
25727784|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
25727785|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727786|NCT03777436|Apremilast|apremilast|mesh-list
25727787|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25727788|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25727789|NCT03777436|Analgesics|analgesics|mesh-ancestor
25727790|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
25727791|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727792|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727793|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727794|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727795|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25727796|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25727797|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727798|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727799|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
25727800|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727801|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727802|NCT03753919|Durvalumab|durvalumab|mesh-list
25727803|NCT03753919|Tremelimumab|tremelimumab|mesh-list
25727804|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727805|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727806|NCT03675672|Misoprostol|misoprostol|mesh-list
25727807|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25727808|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
25727809|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25727810|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727811|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25727812|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25727813|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
25727815|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25727816|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25727817|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
25727818|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727819|NCT03619707|Progesterone|progesterone|mesh-list
25727820|NCT03619707|Progestins|progestins|mesh-ancestor
25727821|NCT03619707|Hormones|hormones|mesh-ancestor
25727822|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727823|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727824|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
25727825|NCT03539900|Naltrexone|naltrexone|mesh-list
25727826|NCT03539900|Bupropion|bupropion|mesh-list
25727827|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25727828|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25727829|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727830|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
25727831|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727832|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25727833|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
25727834|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25727835|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25727836|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25727837|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25727838|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727839|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
25727840|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25727841|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25727842|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25727843|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727844|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25727845|NCT03500380|Capecitabine|capecitabine|mesh-list
25727846|NCT03500380|Lapatinib|lapatinib|mesh-list
25727847|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25727848|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
25727849|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727850|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727851|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25727852|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727853|NCT03494569|Fludarabine|fludarabine|mesh-list
25727854|NCT03494569|Melphalan|melphalan|mesh-list
25727855|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
25727856|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25727857|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727858|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727859|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727860|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
25727861|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727862|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25727863|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
25727864|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25727865|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
25727866|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727867|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727868|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
25727869|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727870|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727871|NCT03389620|Dexamethasone|dexamethasone|mesh-list
25727872|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727873|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
25727874|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
25727875|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727876|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727877|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143144|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
24461280|NCT00351832|Vildagliptin|vildagliptin|mesh-list
24461281|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24461282|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461287|NCT00351871|Ribavirin|ribavirin|mesh-list
25143496|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
25727878|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
25727880|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25727881|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25727882|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727883|NCT03386721|Gemcitabine|gemcitabine|mesh-list
25727884|NCT03386721|Atezolizumab|atezolizumab|mesh-list
25727885|NCT03386721|Vinorelbine|vinorelbine|mesh-list
25727886|NCT03386721|Antibodies|antibodies|mesh-list
25727887|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
25727888|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727889|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25727890|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
25727891|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727892|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727893|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
25727894|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727895|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727896|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727897|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25727898|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
25727899|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
25727900|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
25772631|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772632|NCT03710889|Abaloparatide|abaloparatide|mesh-list
25772633|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25772634|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772635|NCT03711578|Tenalisib|tenalisib|mesh-list
25772636|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
25772637|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772638|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772639|NCT03712280|Rifaximin|rifaximin|mesh-list
25772640|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
25772641|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25772642|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772643|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25772644|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25772645|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
25772646|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772647|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772648|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25772649|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25772650|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25772651|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772652|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772653|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25772654|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772655|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772656|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772657|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772658|NCT03712917|Topiramate|topiramate|mesh-list
25772659|NCT03712917|Flunarizine|flunarizine|mesh-list
25772660|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
25772661|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25772662|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772663|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25772664|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772665|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772666|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25772667|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25772668|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
25772669|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
25772670|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772671|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
25772672|NCT03714022|Abatacept|abatacept|mesh-list
25772673|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24557429|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557430|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24557431|NCT00752479|Protective Agents|protective agents|mesh-ancestor
25145085|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24557625|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557626|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557627|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25727901|NCT03345849|Upadacitinib|upadacitinib|mesh-list
25727902|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25727903|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25727904|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727905|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727906|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727907|NCT03342001|Calcitonin|calcitonin|mesh-list
25727908|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
25727909|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25727910|NCT03342001|Katacalcin|katacalcin|mesh-list
25727911|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25727912|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727913|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25727914|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
25727915|NCT03317119|Trifluridine|trifluridine|mesh-list
25727916|NCT03317119|Trametinib|trametinib|mesh-list
25727917|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727918|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25727919|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727920|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727921|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
25727922|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
25727923|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727924|NCT03297710|Trifluridine|trifluridine|mesh-list
25727925|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
25727926|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727927|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
25727928|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727929|NCT03256916|Nelfinavir|nelfinavir|mesh-list
25727930|NCT03256916|Cisplatin|cisplatin|mesh-list
25727931|NCT03256916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727932|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25727933|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25727934|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
25727935|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727936|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727937|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25727938|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25727939|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
25727940|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727941|NCT03241771|Naloxone|naloxone|mesh-list
25727942|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25727943|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727944|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
25727945|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25727946|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25727947|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
25727948|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25727949|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
25727950|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25727951|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727952|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25727953|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25727954|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727955|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
25727956|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
25727957|NCT03128359|Melphalan|melphalan|mesh-list
25727958|NCT03128359|Busulfan|busulfan|mesh-list
25727959|NCT03128359|Fludarabine|fludarabine|mesh-list
25727960|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
25727961|NCT03128359|Tacrolimus|tacrolimus|mesh-list
25727962|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25727963|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
25727964|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727965|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25727966|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25727967|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
25727968|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727969|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727970|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25727971|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25727972|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
25727973|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25727974|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25727975|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24951016|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24580557|NCT00862264|Hormones|hormones|mesh-ancestor
25727976|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25727977|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
25727978|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25727979|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25727981|NCT03113487|Vaccines|vaccines|mesh-list
25727982|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
25727983|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25727984|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25727985|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727986|NCT03094884|Paclitaxel|paclitaxel|mesh-list
25727987|NCT03094884|Carboplatin|carboplatin|mesh-list
25727988|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25727989|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25727990|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
25727991|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
25727992|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
25727993|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25727994|NCT03009240|Decitabine|decitabine|mesh-list
25727995|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25727996|NCT03009240|Pevonedistat|pevonedistat|mesh-list
25727997|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25727998|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
25727999|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728000|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728001|NCT03002103|Gemcitabine|gemcitabine|mesh-list
25728002|NCT03002103|Paclitaxel|paclitaxel|mesh-list
25728003|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728004|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728005|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728006|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728007|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728008|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728009|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728010|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
25728011|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
25728012|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728013|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728014|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728015|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
25728016|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728017|NCT02865135|Vaccines|vaccines|mesh-list
25728018|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
25728019|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728020|NCT02859558|Tenofovir|tenofovir|mesh-list
25728021|NCT02859558|Emtricitabine|emtricitabine|mesh-list
25728022|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25728023|NCT02859558|Cobicistat|cobicistat|mesh-list
25728024|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25728025|NCT02859558|Elvitegravir|elvitegravir|mesh-list
25728026|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25728027|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
25728028|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728029|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25728030|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25728031|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728032|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728033|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25728034|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25728035|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25728036|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25728037|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
25728038|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25728039|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728040|NCT02632045|Fulvestrant|fulvestrant|mesh-list
25728041|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24592569|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
25200744|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24951916|NCT03899337|Rituximab|rituximab|mesh-list
25152616|NCT03912337|Erenumab|erenumab|mesh-list
25152696|NCT03864068|Inositol|inositol|mesh-list
25152764|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
25152767|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594284|NCT00933374|Everolimus|everolimus|mesh-list
24594285|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24594298|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728042|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728043|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25728044|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25728045|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
25728046|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25728047|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728048|NCT02481310|Cytarabine|cytarabine|mesh-list
25728049|NCT02481310|Prednisone|prednisone|mesh-list
25728050|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
25728051|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25728052|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25728053|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25728054|NCT02481310|Cortisone|cortisone|mesh-list
25728055|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
25728056|NCT02481310|Rituximab|rituximab|mesh-list
25728057|NCT02481310|Doxorubicin|doxorubicin|mesh-list
25728058|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25728059|NCT02481310|Methotrexate|methotrexate|mesh-list
25728060|NCT02481310|Etoposide|etoposide|mesh-list
25728061|NCT02481310|Vincristine|vincristine|mesh-list
25728062|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
25728063|NCT02481310|Ixazomib|ixazomib|mesh-list
25728064|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
25728065|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25728066|NCT02481310|Antibodies|antibodies|mesh-list
25728067|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
25728068|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25728069|NCT02481310|Glycine|glycine|mesh-list
25728070|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728071|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
25728072|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728073|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728074|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728075|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
25728076|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728077|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728078|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25728079|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25728080|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25728081|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25728082|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728083|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25728084|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
25728085|NCT02481310|Hormones|hormones|mesh-ancestor
25728086|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25728087|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25728088|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25728089|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
25728090|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25728091|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728092|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
25728093|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25728094|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25728095|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25728096|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728097|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
25728098|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728099|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728100|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728101|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728102|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
25728103|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
25728104|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
25728105|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728106|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
24813775|NCT02060305|Bevacizumab|bevacizumab|mesh-list
24909372|NCT04310293|Hormones|hormones|mesh-list
24813830|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24813831|NCT02060604|Analgesics|analgesics|mesh-ancestor
24864028|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24864029|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625795|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
24625797|NCT01083589|Docetaxel|docetaxel|mesh-list
24864138|NCT00602667|Cisplatin|cisplatin|mesh-list
25052867|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052868|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052869|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052870|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25728107|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25728108|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728109|NCT02205762|Cytarabine|cytarabine|mesh-list
25728110|NCT02205762|Prednisone|prednisone|mesh-list
25728111|NCT02205762|Indomethacin|indomethacin|mesh-list
25728112|NCT02205762|Methotrexate|methotrexate|mesh-list
25728113|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
25728114|NCT02205762|Vinblastine|vinblastine|mesh-list
25728115|NCT02205762|Cladribine|cladribine|mesh-list
25728116|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
25728117|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25728118|NCT02205762|Antibodies|antibodies|mesh-list
25728119|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
25728120|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25728121|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25728122|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
25728123|NCT02205762|Hormones|hormones|mesh-ancestor
25728124|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25728125|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728126|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25728127|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728128|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25728129|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
25728130|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25728131|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728132|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
25728133|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728134|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25728135|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728136|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25728137|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728138|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
25728139|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728140|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25728141|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
25728142|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728143|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728144|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728145|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728146|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728147|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25728148|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25728149|NCT02205762|Analgesics|analgesics|mesh-ancestor
25728150|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
25728151|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728152|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
25728153|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
25728154|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25728155|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
25728156|NCT02159495|Fludarabine|fludarabine|mesh-list
25728157|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
25728158|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728159|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
25728160|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728161|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728162|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728163|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
25728164|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728165|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728166|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25728167|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728168|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
25728169|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
25728170|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25728171|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
25728172|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728173|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
24574792|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
24544874|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544876|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544877|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865039|NCT04901754|Apatinib|apatinib|mesh-list
24865040|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865041|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24858622|NCT02298530|Caffeine|caffeine|mesh-list
25728174|NCT02136901|Protective Agents|protective agents|mesh-ancestor
25728175|NCT02134301|Oritavancin|oritavancin|mesh-list
25728176|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25728177|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728178|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
25728179|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25728180|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
25728181|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728182|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
25728183|NCT02108496|Protective Agents|protective agents|mesh-ancestor
25728184|NCT02056236|Midazolam|midazolam|mesh-list
25728185|NCT02056236|Levetiracetam|levetiracetam|mesh-list
25728186|NCT02056236|Valproic Acid|valproic acid|mesh-list
25728187|NCT02056236|Lorazepam|lorazepam|mesh-list
25728188|NCT02056236|Thiopental|thiopental|mesh-list
25728189|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
25728190|NCT02056236|Propofol|propofol|mesh-list
25728191|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25728192|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728193|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728194|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25728195|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
25728196|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
25728197|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25728198|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25728199|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25728200|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25728201|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
25728202|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
25728203|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728204|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728205|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
25728206|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728207|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
25728208|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
25728209|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
25728210|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728211|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25728212|NCT01962246|Capecitabine|capecitabine|mesh-list
25728213|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
25728214|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728215|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
25728216|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728217|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728218|NCT01810705|Asparaginase|asparaginase|mesh-list
25728219|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728220|NCT01568918|Tamsulosin|tamsulosin|mesh-list
25728221|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25728222|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25728223|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25728224|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
25728225|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728226|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728227|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728228|NCT01568918|Urological Agents|urological agents|mesh-ancestor
25728229|NCT01269190|Proflavine|proflavine|mesh-list
25728230|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25728231|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728232|NCT00667121|Tamoxifen|tamoxifen|mesh-list
25728233|NCT00667121|Gabapentin|gabapentin|mesh-list
25728234|NCT00667121|Dexetimide|dexetimide|mesh-list
25728235|NCT00667121|Citalopram|citalopram|mesh-list
25728236|NCT00667121|Sertraline|sertraline|mesh-list
25728237|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25728238|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728239|NCT00667121|Analgesics|analgesics|mesh-ancestor
25728240|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
25728241|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053687|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936792|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
24999397|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999398|NCT04469868|Analgesics|analgesics|mesh-ancestor
24920947|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053806|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
25728242|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728243|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
25728244|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25728245|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25728246|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728247|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25728248|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25728249|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25728250|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728251|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
25728252|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25728253|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25728254|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25728255|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
25728256|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25728257|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
25728258|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25728259|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25728260|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
25728261|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
25728262|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25728263|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25728264|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
25728265|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25728266|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
25728267|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25728268|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25728269|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728270|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25728271|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25728272|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25728273|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25728274|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
25728275|NCT00641381|Carmustine|carmustine|mesh-list
25728276|NCT00641381|Etoposide|etoposide|mesh-list
25728277|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728278|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
25728279|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728280|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728281|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728282|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
25728283|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728284|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728285|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25728286|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728287|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25728288|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25728289|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728290|NCT00544414|Leucovorin|leucovorin|mesh-list
25728291|NCT00544414|Gemcitabine|gemcitabine|mesh-list
25728292|NCT00544414|Cisplatin|cisplatin|mesh-list
25728293|NCT00544414|Docetaxel|docetaxel|mesh-list
25728294|NCT00544414|Fluorouracil|fluorouracil|mesh-list
25728295|NCT00544414|Calcium|calcium|mesh-list
25728296|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
25728297|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728298|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728299|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
25728300|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728301|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
25728302|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728303|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728304|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728305|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
25728306|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728307|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728308|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728309|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728310|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25728311|NCT00544414|Antidotes|antidotes|mesh-ancestor
25728312|NCT00544414|Protective Agents|protective agents|mesh-ancestor
25728313|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
25728314|NCT00544414|Vitamins|vitamins|mesh-ancestor
25728315|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
25728316|NCT00534469|Cytarabine|cytarabine|mesh-list
25728317|NCT00534469|Aldesleukin|aldesleukin|mesh-list
25728318|NCT00534469|Etoposide|etoposide|mesh-list
25728319|NCT00534469|Idarubicin|idarubicin|mesh-list
24865940|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546092|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25728321|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728322|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728323|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25728324|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25728325|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728326|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728327|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728328|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
25728329|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
25728330|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728331|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728332|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
25728333|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728334|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
25728335|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728336|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25728337|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25728338|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25728339|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25728340|NCT00534430|Cyclosporine|cyclosporine|mesh-list
25728341|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
25728342|NCT00534430|Etoposide|etoposide|mesh-list
25728343|NCT00534430|Busulfan|busulfan|mesh-list
25728344|NCT00534430|Cyclosporins|cyclosporins|mesh-list
25728345|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728346|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728347|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25728348|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25728349|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728350|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728351|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728352|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
25728353|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728354|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
25728355|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728356|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
25728357|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728358|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25728359|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25728360|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25728361|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
25728362|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25728363|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
25728364|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728365|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25728366|NCT00003927|Paclitaxel|paclitaxel|mesh-list
25728367|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
25728368|NCT00003927|Doxorubicin|doxorubicin|mesh-list
25728369|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25728370|NCT00003927|Amifostine|amifostine|mesh-list
25728371|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728372|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728373|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728374|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728375|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728376|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728377|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728378|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
25728379|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728380|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728381|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728382|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
25728383|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25728384|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25728385|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25728386|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25728387|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728388|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24548269|NCT00708656|Mesalamine|mesalamine|mesh-list
24868287|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
24868288|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728389|NCT00003927|Protective Agents|protective agents|mesh-ancestor
25728390|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25728392|NCT02588261|Naquotinib|naquotinib|mesh-list
25728393|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728394|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25728395|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728396|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728397|NCT02588339|Sirolimus|sirolimus|mesh-list
25728398|NCT02588339|Panobinostat|panobinostat|mesh-list
25728399|NCT02588339|Tacrolimus|tacrolimus|mesh-list
25728400|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728401|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
25728402|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728403|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25728404|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728405|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728406|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25728407|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728408|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25728409|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728410|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
25728411|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25728412|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25728413|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
25728414|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728415|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
25728416|NCT02588612|Fludarabine|fludarabine|mesh-list
25728417|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728418|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
25728419|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728420|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728421|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728422|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
25728423|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728424|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728425|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25728426|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
25728427|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25728428|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
25728429|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728430|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
25728431|NCT02588872|Protective Agents|protective agents|mesh-ancestor
25728432|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
25728433|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25728434|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25728435|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728436|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
25728437|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
25728438|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25728439|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
25728440|NCT02589626|Empagliflozin|empagliflozin|mesh-list
25728441|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25728442|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728443|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25728444|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728445|NCT02589639|Empagliflozin|empagliflozin|mesh-list
25728446|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25728447|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728448|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25728449|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728450|NCT02589665|Mirikizumab|mirikizumab|mesh-list
25728451|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25728452|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25728453|NCT02589665|Analgesics|analgesics|mesh-ancestor
25728454|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
24869671|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24869672|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869673|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869674|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055391|NCT03521245|Trastuzumab|trastuzumab|mesh-list
25728455|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728456|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728457|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25728458|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728459|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25728460|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25728461|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25728462|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25728463|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728464|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
25728465|NCT02589977|Regadenoson|regadenoson|mesh-list
25728466|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25728467|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25728468|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
25728469|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
25728470|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728471|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728472|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728473|NCT02590003|Paclitaxel|paclitaxel|mesh-list
25728474|NCT02590003|Carboplatin|carboplatin|mesh-list
25728475|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728476|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728477|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728478|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728479|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728480|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728481|NCT02590432|Linaclotide|linaclotide|mesh-list
25728482|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25728483|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
25728484|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728485|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25728486|NCT02590588|Idelalisib|idelalisib|mesh-list
25728487|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728488|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728489|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772674|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772675|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772676|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25772677|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
25772678|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772679|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772680|NCT03714672|Diclofenac|diclofenac|mesh-list
25772681|NCT03714672|Tramadol|tramadol|mesh-list
25772682|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772683|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772684|NCT03714672|Analgesics|analgesics|mesh-ancestor
25772685|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
25772686|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772687|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772688|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772689|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772690|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772691|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772692|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772693|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25772694|NCT03714672|Narcotics|narcotics|mesh-ancestor
25772695|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772696|NCT03714919|Acetaminophen|acetaminophen|mesh-list
25772697|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
25772698|NCT03714919|Ketamine|ketamine|mesh-list
25772699|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
25772700|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25772701|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772702|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772703|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772704|NCT03714919|Analgesics|analgesics|mesh-ancestor
25772705|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
25055477|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
25055478|NCT03520946|Ramucirumab|ramucirumab|mesh-list
25055479|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055480|NCT03520595|Diclofenac|diclofenac|mesh-list
25055481|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25055482|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25055483|NCT03520595|Analgesics|analgesics|mesh-ancestor
25728490|NCT02591238|Melatonin|melatonin|mesh-list
25728491|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
25728492|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728493|NCT02591238|Protective Agents|protective agents|mesh-ancestor
25728494|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728495|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728496|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
25728497|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25728498|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728499|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25728500|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728501|NCT02592434|Tofacitinib|tofacitinib|mesh-list
25728502|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25728503|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728504|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728505|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25728506|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
25728507|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728508|NCT02592629|Triamcinolone|triamcinolone|mesh-list
25728509|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25728510|NCT02592629|Lidocaine|lidocaine|mesh-list
25728511|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
25728512|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
25728513|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
25728514|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728515|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728516|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
25728517|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728518|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25728519|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25728520|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25728521|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25728522|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728523|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25728524|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
25728525|NCT02592629|Hormones|hormones|mesh-ancestor
25728526|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25728527|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728528|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
25728529|NCT02592798|Abatacept|abatacept|mesh-list
25728530|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25728531|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728532|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728533|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728534|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
25728535|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728536|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728537|NCT02592876|Rituximab|rituximab|mesh-list
25728538|NCT02592876|Carboplatin|carboplatin|mesh-list
25728539|NCT02592876|Etoposide|etoposide|mesh-list
25728540|NCT02592876|Ifosfamide|ifosfamide|mesh-list
25728541|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25728542|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728543|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
25728544|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728545|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728546|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728547|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25728548|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25728549|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728550|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728551|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25728552|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
25728553|NCT02593097|Metformin|metformin|mesh-list
25728554|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25728555|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728556|NCT02593305|Methamphetamine|methamphetamine|mesh-list
25728557|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25728558|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728559|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
24814781|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814782|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
24870501|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
25728560|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
25728561|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728562|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
25728563|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728564|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728565|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
25728566|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25728567|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25728568|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25728569|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25728570|NCT02593396|Bupropion|bupropion|mesh-list
25728571|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25728572|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
25728573|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25728574|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25728575|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25728576|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25728577|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728578|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
25728579|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728580|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728581|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25728582|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25728583|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728584|NCT02593539|Nemiralisib|nemiralisib|mesh-list
25728585|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25728586|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728587|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728588|NCT02593773|Interferons|interferons|mesh-list
25728589|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
25728590|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728591|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
25728592|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728593|NCT05372536|Cytarabine|cytarabine|mesh-list
25728594|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25728595|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
25728596|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728597|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728598|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
25728599|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728600|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728601|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
25728602|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728603|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
25728604|NCT05372224|Vitamin D|vitamin d|mesh-list
25728605|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25728606|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728607|NCT05372224|Vitamins|vitamins|mesh-ancestor
25728608|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
25728609|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25728610|NCT05372133|Morphine|morphine|mesh-list
25728611|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25728612|NCT05372133|Narcotics|narcotics|mesh-ancestor
25728613|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728614|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728615|NCT05372133|Analgesics|analgesics|mesh-ancestor
25728616|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
25728617|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728618|NCT05371574|Clonidine|clonidine|mesh-list
25728619|NCT05371574|Analgesics|analgesics|mesh-ancestor
25728620|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
25728621|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728622|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728623|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25728624|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
25728625|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
25728626|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25728627|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25728628|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25728629|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
25728630|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728631|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728632|NCT05371340|Quercetin|quercetin|mesh-list
25728633|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
25728634|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728635|NCT05371340|Protective Agents|protective agents|mesh-ancestor
25728636|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728637|NCT05371301|Paclitaxel|paclitaxel|mesh-list
25728638|NCT05371301|Carboplatin|carboplatin|mesh-list
25728639|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25728640|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728641|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728642|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728643|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728644|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728645|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
25728646|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
25728647|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25728648|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
25728649|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728650|NCT05371288|Protective Agents|protective agents|mesh-ancestor
25728651|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728652|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
25728653|NCT05371288|Vitamins|vitamins|mesh-ancestor
25728654|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
25728655|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
25728656|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728657|NCT05371288|Expectorants|expectorants|mesh-ancestor
25728658|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25728659|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25728660|NCT05371288|Antidotes|antidotes|mesh-ancestor
25728661|NCT05371275|Palbociclib|palbociclib|mesh-list
25728662|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728663|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25728664|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728665|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728666|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25728667|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728668|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728669|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
25728670|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25728671|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
25728672|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25728673|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25728674|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728675|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
25728676|NCT05370820|Coagulants|coagulants|mesh-ancestor
25728677|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25728678|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25728679|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728680|NCT05366777|Acetaminophen|acetaminophen|mesh-list
25728681|NCT05366777|Ibuprofen|ibuprofen|mesh-list
25728682|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25728683|NCT05366777|Analgesics|analgesics|mesh-ancestor
25728684|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
25728685|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728686|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728687|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
25728688|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25728689|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25728690|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728691|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25728692|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728693|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728694|NCT05365880|Lidocaine|lidocaine|mesh-list
25728695|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
25728696|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
25728697|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728698|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728699|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
25728700|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728701|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25728702|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25728703|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25728704|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25728705|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772706|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728706|NCT05365802|FAPI-46|fapi-46|mesh-list
25728707|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25728708|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728709|NCT05363007|Leucovorin|leucovorin|mesh-list
25728710|NCT05363007|Irinotecan|irinotecan|mesh-list
25728711|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25728712|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25728713|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728714|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728715|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728716|NCT05363007|Antidotes|antidotes|mesh-ancestor
25728717|NCT05363007|Protective Agents|protective agents|mesh-ancestor
25728718|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728719|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
25728720|NCT05363007|Vitamins|vitamins|mesh-ancestor
25728721|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
25728722|NCT05362994|Sirolimus|sirolimus|mesh-list
25728723|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25728724|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728725|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25728726|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728727|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
25728728|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25728729|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
25728730|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728731|NCT05359835|Edetic Acid|edetic acid|mesh-list
25728732|NCT05359835|Calcium|calcium|mesh-list
25728733|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
25728734|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25728735|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728736|NCT05359835|Antidotes|antidotes|mesh-ancestor
25728737|NCT05359835|Protective Agents|protective agents|mesh-ancestor
25728738|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
25728739|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
25728740|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728741|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25728742|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
25728743|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25728744|NCT05343429|Aspirin|aspirin|mesh-list
25728745|NCT05343429|Benzydamine|benzydamine|mesh-list
25728746|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25728747|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25728748|NCT05343429|Analgesics|analgesics|mesh-ancestor
25728749|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
25728750|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728751|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728752|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25728753|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25728754|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25728755|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25728756|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728757|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25728758|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25728759|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728760|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
25728761|NCT05330754|Caffeine|caffeine|mesh-list
25728762|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25728763|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728764|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25728765|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728766|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728767|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25728768|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25728769|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
25728770|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728771|NCT05323396|Metronidazole|metronidazole|mesh-list
25728772|NCT05323396|Albendazole|albendazole|mesh-list
25728773|NCT05323396|Praziquantel|praziquantel|mesh-list
25728774|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
25728775|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728776|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25728777|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25728778|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
25728779|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
25728780|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25728781|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728782|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728783|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728784|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728785|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728787|NCT05319873|Docetaxel|docetaxel|mesh-list
25728788|NCT05319873|Trastuzumab|trastuzumab|mesh-list
25728789|NCT05319873|Fulvestrant|fulvestrant|mesh-list
25728790|NCT05319873|Pertuzumab|pertuzumab|mesh-list
25728791|NCT05319873|Tucatinib|tucatinib|mesh-list
25728792|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25728793|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25728794|NCT05319873|Antibodies|antibodies|mesh-list
25728795|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
25728796|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25728797|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
25728798|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728799|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728800|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
25728801|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
25728802|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
25728803|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728804|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25728805|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25728806|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25728807|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
25728808|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25728809|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25728810|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728811|NCT05315271|Ketamine|ketamine|mesh-list
25728812|NCT05315271|Bupivacaine|bupivacaine|mesh-list
25728813|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
25728814|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
25728815|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728816|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728817|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
25728818|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728819|NCT05315271|Analgesics|analgesics|mesh-ancestor
25728820|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25728821|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25728822|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
25728823|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25728824|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25728825|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728826|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728827|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
25728828|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25728829|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25728830|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728831|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
25728832|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
25728833|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
25728834|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25728835|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728836|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
25728837|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
25728838|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25728839|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728840|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
25728841|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25728842|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728843|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
25728844|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
25728845|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25728846|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728847|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
25728848|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
25728849|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25728850|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728851|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
25728852|NCT05213832|Isoflurane|isoflurane|mesh-list
25728853|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25728854|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
25728855|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
25728856|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728857|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728858|NCT05193591|Autoantibodies|autoantibodies|mesh-list
25291661|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
25728859|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
25728860|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728861|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
25728862|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25728863|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728864|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25728865|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728866|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25728867|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25728868|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25728869|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728870|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728871|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25728872|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25728873|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728874|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
25728875|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728876|NCT05119166|Niacinamide|niacinamide|mesh-list
25728877|NCT05119166|Niacin|niacin|mesh-list
25728878|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
25728879|NCT05119166|Azithromycin|azithromycin|mesh-list
25728880|NCT05119166|Vitamins|vitamins|mesh-ancestor
25728881|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
25728882|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728883|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25728884|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25728885|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
25728886|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25728887|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
25728888|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728889|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25728890|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
25728891|NCT05105074|Morphine|morphine|mesh-list
25728892|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25728893|NCT05105074|Narcotics|narcotics|mesh-ancestor
25728894|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728895|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728896|NCT05105074|Analgesics|analgesics|mesh-ancestor
25728897|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
25728898|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728899|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
25728900|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25728901|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25728902|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728903|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25728904|NCT05099055|Analgesics|analgesics|mesh-ancestor
25728905|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
25728906|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728907|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25728908|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25728909|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25728910|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
25728911|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728912|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728913|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
25728914|NCT05081193|Testosterone|testosterone|mesh-list
25728915|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
25728916|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
25728917|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25728918|NCT05081193|Androgens|androgens|mesh-ancestor
25728919|NCT05081193|Hormones|hormones|mesh-ancestor
25728920|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25728921|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728922|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25728923|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728924|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
25728925|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
25728926|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25728927|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25728928|NCT05068349|Protective Agents|protective agents|mesh-ancestor
25728929|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728930|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
25728931|NCT04947553|Bupropion|bupropion|mesh-list
25728932|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25728933|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
25728934|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25728935|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25728936|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25728937|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25728938|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728939|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
25728940|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728941|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728942|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25728943|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25728944|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728945|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
25728946|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
25728947|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25728948|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25728949|NCT04945122|Atorvastatin|atorvastatin|mesh-list
25728950|NCT04945122|Pitavastatin|pitavastatin|mesh-list
25728951|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25728952|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25728953|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
25728954|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728955|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25728956|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25728957|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728958|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25728959|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25728960|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728961|NCT04932382|Misoprostol|misoprostol|mesh-list
25728962|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25728963|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
25728964|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25728965|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728966|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25728967|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25728968|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
25728969|NCT04921982|Propranolol|propranolol|mesh-list
25728970|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25728971|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25728972|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
25728973|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25728974|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728975|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728976|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25728977|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25728978|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
25728979|NCT04882774|Treprostinil|treprostinil|mesh-list
25728980|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25728981|NCT04870034|Palbociclib|palbociclib|mesh-list
25728982|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25728983|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25728984|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25728985|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728986|NCT04853147|Dexamethasone|dexamethasone|mesh-list
25728987|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
25728988|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
25728989|NCT04853147|Aprepitant|aprepitant|mesh-list
25728990|NCT04853147|BB 1101|bb 1101|mesh-list
25728991|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25728992|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
25728993|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
25728994|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25728995|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728996|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25728997|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
25728998|NCT04853147|Hormones|hormones|mesh-ancestor
25728999|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729000|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729001|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729002|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
25729003|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729004|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729005|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25729006|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291859|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
25729007|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25729008|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729009|NCT04833023|Olanzapine|olanzapine|mesh-list
25729010|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
25729011|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
25729012|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729013|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729014|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729015|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25729016|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25729017|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729018|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25729019|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25729020|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25729021|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25729022|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729023|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729024|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
25772707|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25772708|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25772709|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25772710|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772711|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772712|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772713|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25772714|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25772715|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
25772716|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
25772717|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25772718|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25772719|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
25772720|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
25772721|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
25772722|NCT03716024|Linezolid|linezolid|mesh-list
25772723|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25772724|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772725|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25772726|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772727|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772728|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
25772729|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
25772730|NCT03716076|Carbetocin|carbetocin|mesh-list
25772731|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
25772732|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25772733|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772734|NCT03717012|Nintedanib|nintedanib|mesh-list
25772735|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772736|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25772737|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772738|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772739|NCT03717051|Nicotine|nicotine|mesh-list
25772740|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25772741|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
25772742|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772743|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772744|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25772745|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25772746|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772747|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772748|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772749|NCT03717064|Pitavastatin|pitavastatin|mesh-list
25772750|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25772751|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25772752|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25772753|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
25772754|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772755|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772756|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25772757|NCT03717506|Clindamycin|clindamycin|mesh-list
25772758|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
25772759|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
25772760|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25772761|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772762|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25772763|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729025|NCT04804735|Anesthetics|anesthetics|mesh-list
25729026|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729027|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729028|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
25729029|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729030|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
25729031|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729032|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729033|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25729034|NCT04532372|Leflunomide|leflunomide|mesh-list
25729035|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729036|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729037|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25729038|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
25729039|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729040|NCT04491877|Vaccines|vaccines|mesh-list
25729041|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
25729042|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729043|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25729044|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25729045|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729046|NCT04395196|Choline|choline|mesh-list
25729047|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
25729048|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25729049|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
25729050|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729051|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729052|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25729053|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
25729054|NCT04394624|Ramucirumab|ramucirumab|mesh-list
25729055|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729056|NCT04375527|Nivolumab|nivolumab|mesh-list
25729057|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729058|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729059|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25729060|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729061|NCT04276363|Nicotine|nicotine|mesh-list
25729062|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25729063|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
25729064|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729065|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729066|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25729067|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25729068|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
25729069|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729070|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729071|NCT04267809|Vitamin D|vitamin d|mesh-list
25729072|NCT04267809|Metformin|metformin|mesh-list
25729073|NCT04267809|Calcium|calcium|mesh-list
25729074|NCT04267809|Vitamins|vitamins|mesh-ancestor
25729075|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
25729076|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729077|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25729078|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25729079|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25729080|NCT04227366|Methotrexate|methotrexate|mesh-list
25729081|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25729082|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
25729083|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25729084|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729085|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25729086|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
25729087|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729088|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729089|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25729090|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729091|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25729092|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25729093|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
25292079|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25292080|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25292081|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
25292082|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292083|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292084|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
25729094|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729095|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25729096|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
25729097|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25729098|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25729099|NCT04177433|Prednisolone|prednisolone|mesh-list
25729100|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
25729101|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25729102|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
25729103|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729104|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
25729105|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
25729106|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729107|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729108|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729109|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
25729110|NCT04177433|Hormones|hormones|mesh-ancestor
25729111|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729112|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25729113|NCT04177433|Protective Agents|protective agents|mesh-ancestor
25729114|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729115|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729116|NCT04158362|Paclitaxel|paclitaxel|mesh-list
25729117|NCT04158362|Capecitabine|capecitabine|mesh-list
25729118|NCT04158362|Letrozole|letrozole|mesh-list
25729119|NCT04158362|Fulvestrant|fulvestrant|mesh-list
25729120|NCT04158362|Anastrozole|anastrozole|mesh-list
25729121|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25729122|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729123|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
25729124|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
25729125|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729126|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729127|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25729128|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
25729129|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25729130|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25729131|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729132|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25729133|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
25729134|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729135|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729136|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729137|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25729138|NCT04143607|Gefitinib|gefitinib|mesh-list
25729139|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729140|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25729141|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729142|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729143|NCT04142242|Vaccines|vaccines|mesh-list
25729144|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
25729145|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729146|NCT04104139|Trifluridine|trifluridine|mesh-list
25729147|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
25729148|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729149|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
25729150|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729151|NCT04082806|Trazodone|trazodone|mesh-list
25729152|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25729153|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25729154|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729155|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729156|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25729157|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25729158|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25729159|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25729160|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292212|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25292213|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292214|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292215|NCT02675842|Hormones|hormones|mesh-ancestor
25292216|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292217|NCT02615119|Isoproterenol|isoproterenol|mesh-list
25729161|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729163|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25729164|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
25729165|NCT04080739|Ropivacaine|ropivacaine|mesh-list
25729166|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
25729167|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
25729168|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729169|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729170|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
25729171|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729172|NCT04055649|Paclitaxel|paclitaxel|mesh-list
25729173|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25729174|NCT04055649|TIC10 compound|tic10 compound|mesh-list
25729175|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25729176|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729177|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
25729178|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
25729179|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729180|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729181|NCT04025060|Caffeine|caffeine|mesh-list
25729182|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25729183|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729184|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25729185|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729186|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729187|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25729188|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25729189|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
25729190|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729191|NCT04001881|Anesthetics|anesthetics|mesh-list
25729192|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729193|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729194|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
25729195|NCT03970252|Leucovorin|leucovorin|mesh-list
25729196|NCT03970252|Folic Acid|folic acid|mesh-list
25729197|NCT03970252|Fluorouracil|fluorouracil|mesh-list
25729198|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
25729199|NCT03970252|Nivolumab|nivolumab|mesh-list
25729200|NCT03970252|Irinotecan|irinotecan|mesh-list
25729201|NCT03970252|Camptothecin|camptothecin|mesh-list
25729202|NCT03970252|Calcium|calcium|mesh-list
25729203|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
25729204|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25729205|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729206|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25729207|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
25729208|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729209|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25729210|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729211|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25729212|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
25729213|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729214|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25729215|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25729216|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25729217|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729218|NCT03970252|Antidotes|antidotes|mesh-ancestor
25729219|NCT03970252|Protective Agents|protective agents|mesh-ancestor
25729220|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
25729221|NCT03970252|Vitamins|vitamins|mesh-ancestor
25729222|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
25729223|NCT03970252|Hematinics|hematinics|mesh-ancestor
25729224|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25729225|NCT03947385|Crizotinib|crizotinib|mesh-list
25729226|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729227|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25729228|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292304|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25292305|NCT05103813|Beraprost|beraprost|mesh-list
25292306|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25292307|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
24816098|NCT02074189|Gemcitabine|gemcitabine|mesh-list
25292308|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
25292309|NCT05103501|Fluorouracil|fluorouracil|mesh-list
25292310|NCT05103501|Cisplatin|cisplatin|mesh-list
25292311|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25292329|NCT05103397|Hormones|hormones|mesh-ancestor
25729229|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729231|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
25729232|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772764|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772765|NCT03719586|Remdesivir|remdesivir|mesh-list
25772766|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
25772767|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
25772768|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772769|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
25772770|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772771|NCT03720119|Lidocaine|lidocaine|mesh-list
25772772|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772773|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
25772774|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772775|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772776|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
25772777|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772778|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772779|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772780|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772781|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772782|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772783|NCT03720470|Abrocitinib|abrocitinib|mesh-list
25772784|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25772785|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772786|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772787|NCT03720847|Estradiol|estradiol|mesh-list
25772788|NCT03720847|Progesterone|progesterone|mesh-list
25772789|NCT03720847|Estrogens|estrogens|mesh-ancestor
25772790|NCT03720847|Hormones|hormones|mesh-ancestor
25772791|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25772792|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772793|NCT03720847|Progestins|progestins|mesh-ancestor
25772794|NCT03722238|Ibuprofen|ibuprofen|mesh-list
25772795|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772796|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772797|NCT03722238|Analgesics|analgesics|mesh-ancestor
25772798|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
25772799|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772800|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772801|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772802|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772803|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772804|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772805|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772806|NCT03722524|Amlodipine|amlodipine|mesh-list
25772807|NCT03722524|Perindopril|perindopril|mesh-list
25772808|NCT03722524|Indapamide|indapamide|mesh-list
25772809|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
25772810|NCT03722524|Diuretics|diuretics|mesh-list
25772811|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25772812|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25772813|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25772814|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772815|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772816|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25772817|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772818|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
25772819|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
25772820|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
25772821|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772822|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25772823|NCT03722576|Calcium|calcium|mesh-list
25772824|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25292372|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292373|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292374|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25292375|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292376|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
25292377|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25729233|NCT03904251|Cytarabine|cytarabine|mesh-list
25729234|NCT03904251|Daunorubicin|daunorubicin|mesh-list
25729235|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
25729236|NCT03904251|Calicheamicins|calicheamicins|mesh-list
25729237|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25729238|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
25729239|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729240|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729241|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
25729242|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729243|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25729244|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
25729245|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729246|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25729247|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25729248|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25729249|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729250|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729251|NCT03874936|Dexamethasone|dexamethasone|mesh-list
25729252|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25729253|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729254|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
25729255|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
25729256|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729257|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729258|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729259|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
25729260|NCT03874936|Hormones|hormones|mesh-ancestor
25729261|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729262|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729263|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729264|NCT03834688|Rituximab|rituximab|mesh-list
25729265|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25729266|NCT03834688|Venetoclax|venetoclax|mesh-list
25729267|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729268|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729269|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
25729270|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729271|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729272|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25729273|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
25729274|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729275|NCT03801304|Atezolizumab|atezolizumab|mesh-list
25729276|NCT03801304|Vinorelbine|vinorelbine|mesh-list
25729277|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729278|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25729279|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
25729280|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
25729281|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729282|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729283|NCT03782532|Prednisone|prednisone|mesh-list
25729284|NCT03782532|Prednisolone|prednisolone|mesh-list
25729285|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729286|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
25729287|NCT03782532|Hormones|hormones|mesh-ancestor
25729288|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729289|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729290|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729291|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729292|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
25729293|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25729294|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729295|NCT03769181|Cemiplimab|cemiplimab|mesh-list
25729296|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729297|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729298|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
25729299|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292438|NCT04949412|Vitamins|vitamins|mesh-ancestor
25292439|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
25292440|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292441|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25292442|NCT04904614|Letermovir|letermovir|mesh-list
25292443|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25292444|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729300|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729301|NCT03708627|Bimatoprost|bimatoprost|mesh-list
25729302|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25729303|NCT03630705|Vaccines|vaccines|mesh-list
25729304|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
25729305|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729306|NCT03602157|Fludarabine|fludarabine|mesh-list
25729307|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25729308|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729309|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729310|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25729311|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
25729312|NCT03560466|Prednisone|prednisone|mesh-list
25729313|NCT03560466|Prednisolone|prednisolone|mesh-list
25729314|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729315|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
25729316|NCT03560466|Hormones|hormones|mesh-ancestor
25729317|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729318|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729319|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729320|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729321|NCT03545035|Rituximab|rituximab|mesh-list
25729322|NCT03545035|Idelalisib|idelalisib|mesh-list
25729323|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729324|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729325|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
25729326|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729327|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729328|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729329|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729330|NCT03528941|Lamivudine|lamivudine|mesh-list
25729331|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25729332|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25729333|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729334|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729335|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
25729336|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729337|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25729338|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25729339|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25729340|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25729341|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729342|NCT03422861|Nabilone|nabilone|mesh-list
25729343|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
25729344|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
25729345|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729346|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729347|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729348|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25729349|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25729350|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729351|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25729352|NCT03376698|Colchicine|colchicine|mesh-list
25729353|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
25729354|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729355|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
25729356|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
25729357|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729358|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729359|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729360|NCT03351244|BI 409306|bi 409306|mesh-list
25729361|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25729362|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729363|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729364|NCT03295734|Losartan|losartan|mesh-list
25729365|NCT03295734|Perindopril|perindopril|mesh-list
25729366|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25292500|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25292501|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25292502|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25292503|NCT04667780|Colchicine|colchicine|mesh-list
25292504|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
25292505|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292506|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
25292507|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
25292508|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729367|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25729368|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25729369|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25729370|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729371|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25729372|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
25729373|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729374|NCT03275285|Dexamethasone|dexamethasone|mesh-list
25729375|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729376|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
25729377|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
25729378|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729379|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729380|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729381|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
25729382|NCT03275285|Hormones|hormones|mesh-ancestor
25729383|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729384|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729385|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729386|NCT03246750|Cisplatin|cisplatin|mesh-list
25729387|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729388|NCT03192345|Cemiplimab|cemiplimab|mesh-list
25729389|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729390|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729391|NCT03119012|Aspirin|aspirin|mesh-list
25729392|NCT03119012|Clopidogrel|clopidogrel|mesh-list
25729393|NCT03119012|Ticagrelor|ticagrelor|mesh-list
25729394|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25729395|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25729396|NCT03119012|Analgesics|analgesics|mesh-ancestor
25729397|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
25729398|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729399|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729400|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729401|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729402|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25729403|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25729404|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729405|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25729406|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25729407|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729408|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
25729409|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25729410|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25729411|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25729412|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
25729413|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729414|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
25729415|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
25729416|NCT03096782|Melphalan|melphalan|mesh-list
25729417|NCT03096782|Busulfan|busulfan|mesh-list
25729418|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
25729419|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25729420|NCT03096782|Rituximab|rituximab|mesh-list
25729421|NCT03096782|Fludarabine|fludarabine|mesh-list
25729422|NCT03096782|Clofarabine|clofarabine|mesh-list
25729423|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25729424|NCT03096782|Tacrolimus|tacrolimus|mesh-list
25729425|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
25729426|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25729427|NCT03096782|Antibodies|antibodies|mesh-list
25729428|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
25729429|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25729430|NCT03096782|Lenograstim|lenograstim|mesh-list
25729431|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25729432|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
25729433|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729434|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729435|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25729436|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
25729437|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729438|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729439|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25292574|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292575|NCT04318392|Dimercaprol|dimercaprol|mesh-list
25292576|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
25292577|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
25729440|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25729441|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
25729442|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25729443|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729444|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25729445|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25729446|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25729447|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
25729448|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25729449|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729450|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
25729452|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729453|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729454|NCT02982954|Nivolumab|nivolumab|mesh-list
25729455|NCT02982954|Ipilimumab|ipilimumab|mesh-list
25729456|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729457|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729458|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25729459|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729460|NCT02961257|Prednisone|prednisone|mesh-list
25729461|NCT02961257|Lenograstim|lenograstim|mesh-list
25729462|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729463|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
25729464|NCT02961257|Hormones|hormones|mesh-ancestor
25729465|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729466|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729467|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729468|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729469|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25729470|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
25729471|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
25729472|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729473|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729474|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25729475|NCT02791568|Hematinics|hematinics|mesh-ancestor
25729476|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25729477|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25729478|NCT02454543|Androgens|androgens|mesh-list
25729479|NCT02454543|Hormones|hormones|mesh-ancestor
25729480|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729481|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729482|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25729483|NCT02429375|Mocetinostat|mocetinostat|mesh-list
25729484|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729485|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729486|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25729487|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729488|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729489|NCT02377492|Vasopressins|vasopressins|mesh-list
25729490|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
25729491|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
25729492|NCT02377492|Coagulants|coagulants|mesh-ancestor
25729493|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25729494|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25729495|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
25729496|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729497|NCT02377479|Letrozole|letrozole|mesh-list
25729498|NCT02377479|Clomiphene|clomiphene|mesh-list
25729499|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729500|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25729501|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25729502|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729503|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729504|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25729505|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
25729506|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729507|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729508|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25729509|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
25729510|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25729511|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25729512|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25729513|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
25729514|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25729515|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
25729516|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729517|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
25729518|NCT01891396|Protective Agents|protective agents|mesh-ancestor
25729520|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25729521|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729522|NCT01525901|Mitogens|mitogens|mesh-list
25729523|NCT01525901|Mecasermin|mecasermin|mesh-list
25729524|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729525|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729526|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729527|NCT01525901|Growth Substances|growth substances|mesh-ancestor
25729528|NCT01354431|Nivolumab|nivolumab|mesh-list
25729529|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729530|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729531|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25729532|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729533|NCT02593903|Trimethoprim|trimethoprim|mesh-list
25729534|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25729535|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
25729536|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25729537|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729538|NCT02593903|Renal Agents|renal agents|mesh-ancestor
25729539|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
25729540|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25729541|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25729542|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25729543|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729544|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729545|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25729546|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25729547|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25729548|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25729549|NCT02594163|Rituximab|rituximab|mesh-list
25729550|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25729551|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25729552|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729553|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729554|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
25729555|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729556|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729557|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25729558|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
25729559|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729560|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25729561|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25729562|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
25729563|NCT02595398|Triamcinolone|triamcinolone|mesh-list
25729564|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25729565|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25729566|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25729567|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729568|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
25729569|NCT02595398|Hormones|hormones|mesh-ancestor
25729570|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729571|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729572|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25729573|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
25729574|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729575|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729576|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25729577|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729578|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25729579|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729580|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729581|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25729582|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25729583|NCT02595684|Tadalafil|tadalafil|mesh-list
25729584|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
25729585|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25292874|NCT05105347|Prednisone|prednisone|mesh-list
25729586|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25729587|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729588|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729589|NCT02595684|Urological Agents|urological agents|mesh-ancestor
25729590|NCT02595723|Megestrol|megestrol|mesh-list
25729591|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
25729592|NCT02595723|Phenytoin|phenytoin|mesh-list
25729593|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25729594|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25729595|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25729596|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
25729597|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25729598|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729599|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25729600|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25729601|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729602|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729603|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
25729604|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25729605|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
25729606|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25729607|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25729608|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25729609|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729610|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25729611|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25729612|NCT02595749|Oxytocin|oxytocin|mesh-list
25729613|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
25729614|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25729615|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729616|NCT02596022|Ketamine|ketamine|mesh-list
25729617|NCT02596022|Analgesics|analgesics|mesh-ancestor
25729618|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
25729619|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729620|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729621|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25729622|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25729623|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
25729624|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
25729625|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729626|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25729627|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25729628|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729629|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729630|NCT02596451|Diclofenac|diclofenac|mesh-list
25729631|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25729632|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25729633|NCT02596451|Analgesics|analgesics|mesh-ancestor
25729634|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
25729635|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729636|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729637|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729638|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729639|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25729640|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729641|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729642|NCT02596620|Amoxicillin|amoxicillin|mesh-list
25729643|NCT02596620|Metronidazole|metronidazole|mesh-list
25729644|NCT02596620|Levofloxacin|levofloxacin|mesh-list
25729645|NCT02596620|Esomeprazole|esomeprazole|mesh-list
25729646|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25729647|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729648|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25729649|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25729650|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25729651|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729652|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25729653|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729654|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729655|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25729656|NCT02596620|Renal Agents|renal agents|mesh-ancestor
25729657|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25292958|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25729658|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25729659|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729660|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25729661|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25729663|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
25729664|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25729665|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
25729666|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729667|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729668|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25729669|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25729670|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
25729671|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729672|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729673|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
25729674|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
25729675|NCT02596867|Propranolol|propranolol|mesh-list
25729676|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25729677|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25729678|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
25729679|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729680|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729681|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729682|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25729683|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25729684|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
25729685|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
25729686|NCT02596945|Hematinics|hematinics|mesh-ancestor
25729687|NCT02596958|Bevacizumab|bevacizumab|mesh-list
25729688|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729689|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729690|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25729691|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25729692|NCT02596958|Growth Substances|growth substances|mesh-ancestor
25729693|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729694|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
25729695|NCT02596971|Prednisone|prednisone|mesh-list
25729696|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
25729697|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25729698|NCT02596971|Rituximab|rituximab|mesh-list
25729699|NCT02596971|Doxorubicin|doxorubicin|mesh-list
25729700|NCT02596971|Vincristine|vincristine|mesh-list
25729701|NCT02596971|Atezolizumab|atezolizumab|mesh-list
25729702|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
25729703|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25729704|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
25729705|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729706|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729707|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25729708|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
25729709|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729710|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729711|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25729712|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729713|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25729714|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25729715|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25729716|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729717|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729718|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
25729719|NCT02596971|Hormones|hormones|mesh-ancestor
25729720|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729721|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25729722|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25729723|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
25729724|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25729725|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729726|NCT02597049|Metformin|metformin|mesh-list
25729727|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
25729728|NCT02597049|Empagliflozin|empagliflozin|mesh-list
25729729|NCT02597049|Canagliflozin|canagliflozin|mesh-list
25729730|NCT02597049|Dulaglutide|dulaglutide|mesh-list
25729731|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25729732|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25729733|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729734|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729736|NCT02597101|Saxagliptin|saxagliptin|mesh-list
25729737|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25729738|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729739|NCT02597101|Incretins|incretins|mesh-ancestor
25729740|NCT02597101|Hormones|hormones|mesh-ancestor
25729741|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25729742|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25729743|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
25729744|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729745|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729746|NCT02597478|Fentanyl|fentanyl|mesh-list
25729747|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25729748|NCT02597478|Narcotics|narcotics|mesh-ancestor
25729749|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729750|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729751|NCT02597478|Analgesics|analgesics|mesh-ancestor
25729752|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
25729753|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729754|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25729755|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25729756|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
25729757|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
25729758|NCT02597543|Regadenoson|regadenoson|mesh-list
25729759|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25729760|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25729761|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
25729762|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
25729763|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729764|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729765|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729766|NCT02597855|Aflibercept|aflibercept|mesh-list
25729767|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25729768|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25729769|NCT02597855|Growth Substances|growth substances|mesh-ancestor
25729770|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729771|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
25729772|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729773|NCT02597907|Aprepitant|aprepitant|mesh-list
25729774|NCT02597907|Palonosetron|palonosetron|mesh-list
25729775|NCT02597907|Ramosetron|ramosetron|mesh-list
25729776|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
25729777|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
25729778|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729779|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729780|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729781|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25729782|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729783|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729784|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25729785|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25729786|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
25729787|NCT02597933|Nintedanib|nintedanib|mesh-list
25729788|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729789|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25729790|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729791|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729792|NCT02597946|Paclitaxel|paclitaxel|mesh-list
25729793|NCT02597946|Afatinib|afatinib|mesh-list
25729794|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25729795|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729796|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
25729797|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
25729798|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
25729799|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729800|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25729801|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729802|NCT02598193|Pirfenidone|pirfenidone|mesh-list
25729803|NCT02598193|Nintedanib|nintedanib|mesh-list
25729804|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729805|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25729806|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293111|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25293117|NCT04194775|Lenvatinib|lenvatinib|mesh-list
25729807|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729809|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
25729810|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729811|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729812|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25729813|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25729814|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729815|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25729816|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
25729817|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25729818|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729819|NCT02599402|Nivolumab|nivolumab|mesh-list
25729820|NCT02599402|Ipilimumab|ipilimumab|mesh-list
25729821|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729822|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729823|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25729824|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729825|NCT02599649|Nivolumab|nivolumab|mesh-list
25729826|NCT02599649|Azacitidine|azacitidine|mesh-list
25729827|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729828|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729829|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25729830|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729831|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25729832|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
25729833|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729834|NCT02600325|Grazoprevir|grazoprevir|mesh-list
25729835|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25729836|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
25729837|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729838|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
25729839|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25729840|NCT02600351|Ledipasvir|ledipasvir|mesh-list
25729841|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
25729842|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729843|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
25729844|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25729845|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729846|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25729847|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25729848|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729849|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729850|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729851|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25729852|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25729853|NCT02600611|Vancomycin|vancomycin|mesh-list
25729854|NCT02600611|Iclaprim|iclaprim|mesh-list
25729855|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25729856|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729857|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25729858|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729859|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729860|NCT02600715|Morphine|morphine|mesh-list
25729861|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25729862|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25729863|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25729864|NCT02600715|Narcotics|narcotics|mesh-ancestor
25729865|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729866|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729867|NCT02600715|Analgesics|analgesics|mesh-ancestor
25729868|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
25729869|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729870|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25729871|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25729872|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25729873|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729874|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
25729875|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729876|NCT02600767|Lumefantrine|lumefantrine|mesh-list
25729877|NCT02600767|Artemether|artemether|mesh-list
25729878|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25729879|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
25293186|NCT03349281|Dexamethasone|dexamethasone|mesh-list
25729880|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25729881|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25729882|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729883|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25729885|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25729886|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
25729887|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729888|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
25729889|NCT02600871|Povidone|povidone|mesh-list
25729890|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
25729891|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
25729892|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25729893|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729894|NCT02601027|Acetaminophen|acetaminophen|mesh-list
25729895|NCT02601027|Oxycodone|oxycodone|mesh-list
25729896|NCT02601027|Hydromorphone|hydromorphone|mesh-list
25729897|NCT02601027|Ondansetron|ondansetron|mesh-list
25729898|NCT02601027|Bupivacaine|bupivacaine|mesh-list
25729899|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
25729900|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
25729901|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25729902|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729903|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
25729904|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729905|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25729906|NCT02601027|Narcotics|narcotics|mesh-ancestor
25729907|NCT02601027|Analgesics|analgesics|mesh-ancestor
25729908|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
25729909|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
25729910|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25729911|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
25729912|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
25729913|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25729914|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
25729915|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729916|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729917|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25729918|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25729919|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25729920|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25729921|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25729922|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
25729923|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
25729924|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25729925|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
25729926|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729927|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
25729928|NCT02601170|Protective Agents|protective agents|mesh-ancestor
25772825|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772826|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
25772827|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25772828|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772829|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25772830|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
25772831|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772832|NCT03746002|Metolazone|metolazone|mesh-list
25772833|NCT03746002|Furosemide|furosemide|mesh-list
25772834|NCT03746002|Diuretics|diuretics|mesh-ancestor
25772835|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
25772836|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772837|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25772838|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772839|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772840|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25772841|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25772842|NCT03789292|Adalimumab|adalimumab|mesh-list
25772843|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772844|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772845|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
25772846|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772847|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
25772848|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772849|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772850|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
25772851|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772852|NCT03828422|Calcium|calcium|mesh-list
25729930|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
25729931|NCT02601573|Grazoprevir|grazoprevir|mesh-list
25729932|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
25729933|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729934|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
25729935|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729936|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25729937|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
25729938|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729939|NCT02601833|Fluorides|fluorides|mesh-list
25729940|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
25729941|NCT02601833|Protective Agents|protective agents|mesh-ancestor
25729942|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729943|NCT02601976|Ribavirin|ribavirin|mesh-list
25729944|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25729945|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
25729946|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729947|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
25729948|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729949|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25729950|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729951|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729952|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
25729953|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729954|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25729955|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25729956|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25729957|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25729958|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
25729959|NCT02603120|Tenofovir|tenofovir|mesh-list
25729960|NCT02603120|Emtricitabine|emtricitabine|mesh-list
25729961|NCT02603120|Lamivudine|lamivudine|mesh-list
25729962|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25729963|NCT02603120|Triumeq|triumeq|mesh-list
25729964|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
25729965|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25729966|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25729967|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25729968|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25729969|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729970|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25729971|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25729972|NCT02603393|Fluticasone|fluticasone|mesh-list
25729973|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
25729974|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25729975|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25729976|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25729977|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
25729978|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25729979|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729980|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25729981|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
25729982|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
25729983|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25729984|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
25729985|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25729986|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
25729987|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25729988|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25729989|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25729990|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25729991|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25729992|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
25729993|NCT02603419|Avelumab|avelumab|mesh-list
25729994|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25729995|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25729996|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25729997|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
25729998|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25729999|NCT02603809|Lisinopril|lisinopril|mesh-list
25730000|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25293362|NCT05106803|Cefepime|cefepime|mesh-list
25293363|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25293364|NCT05106803|Norfloxacin|norfloxacin|mesh-list
25730001|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
25730002|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730003|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730004|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25730005|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25730006|NCT02603809|Protective Agents|protective agents|mesh-ancestor
25730007|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730008|NCT02603926|Pregnanolone|pregnanolone|mesh-list
25730009|NCT02603926|Brexanolone|brexanolone|mesh-list
25730010|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
25730011|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730012|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730013|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
25730014|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730015|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730016|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
25730017|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
25730018|NCT02603952|Oseltamivir|oseltamivir|mesh-list
25730019|NCT02603952|MEDI8852|medi8852|mesh-list
25730020|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
25730021|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730022|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730023|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730024|NCT02604173|Budesonide|budesonide|mesh-list
25730025|NCT02604173|Acetazolamide|acetazolamide|mesh-list
25730026|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730027|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25730028|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
25730029|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730030|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730031|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25730032|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
25730033|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
25730034|NCT02604173|Hormones|hormones|mesh-ancestor
25730035|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730036|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
25730037|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25730038|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730039|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730040|NCT02604173|Diuretics|diuretics|mesh-ancestor
25730041|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
25730042|NCT02604199|Tenofovir|tenofovir|mesh-list
25730043|NCT02604199|Entecavir|entecavir|mesh-list
25730044|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
25730045|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25730046|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
25730047|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730048|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25730049|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25730050|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730051|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730052|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25730053|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25730054|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
25730055|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730056|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730057|NCT02604212|Tenofovir|tenofovir|mesh-list
25730058|NCT02604212|Entecavir|entecavir|mesh-list
25730059|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
25730060|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25730061|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
25730062|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730063|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25730064|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25730065|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730066|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730067|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25730068|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25730069|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
25730070|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730071|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730072|NCT02604342|Docetaxel|docetaxel|mesh-list
25730073|NCT02604342|Pemetrexed|pemetrexed|mesh-list
25730074|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730075|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
25293457|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293463|NCT04903093|Famotidine|famotidine|mesh-list
25730076|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
25730077|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
25730078|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730079|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730080|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25730081|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25730082|NCT02604550|Naproxen|naproxen|mesh-list
25730083|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25730084|NCT02604550|Ropivacaine|ropivacaine|mesh-list
25730085|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730086|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
25730087|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730088|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730089|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
25730090|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730091|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25730092|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25730093|NCT02604550|Analgesics|analgesics|mesh-ancestor
25730094|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730095|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730096|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
25730097|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25730098|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730099|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730100|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25730101|NCT02604550|Narcotics|narcotics|mesh-ancestor
25730102|NCT02604589|Hydromorphone|hydromorphone|mesh-list
25730103|NCT02604589|Bupivacaine|bupivacaine|mesh-list
25730104|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730105|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
25730106|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730107|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730108|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
25730109|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730110|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25730111|NCT02604589|Narcotics|narcotics|mesh-ancestor
25730112|NCT02604589|Analgesics|analgesics|mesh-ancestor
25730113|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
25730114|NCT02604810|Antibodies|antibodies|mesh-list
25730115|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
25730116|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25730117|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25730118|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
25730119|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
25730120|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730121|NCT02605122|Amoxicillin|amoxicillin|mesh-list
25730122|NCT02605122|Azithromycin|azithromycin|mesh-list
25730123|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
25730124|NCT02605122|Erythromycin|erythromycin|mesh-list
25730125|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
25730126|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25730127|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
25730128|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
25730129|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
25730130|NCT02605122|Ampicillin|ampicillin|mesh-list
25730131|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25730132|NCT02605122|Solithromycin|solithromycin|mesh-list
25730133|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
25730134|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730135|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730136|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730137|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25730138|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730139|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730140|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25730141|NCT02605174|Lasmiditan|lasmiditan|mesh-list
25730142|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25730143|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
25730144|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730145|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730146|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730147|NCT02605187|Acetaminophen|acetaminophen|mesh-list
25730148|NCT02605187|Ibuprofen|ibuprofen|mesh-list
25730149|NCT02605187|Morphine|morphine|mesh-list
25293574|NCT04576767|Anesthetics|anesthetics|mesh-list
25730150|NCT02605187|Gabapentin|gabapentin|mesh-list
25730151|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25730152|NCT02605187|Narcotics|narcotics|mesh-ancestor
25730153|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730154|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730155|NCT02605187|Analgesics|analgesics|mesh-ancestor
25730156|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
25730157|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730158|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25730159|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
25730160|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25730161|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730162|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730163|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25730164|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730165|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730166|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
25730167|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25730168|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25730169|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25730170|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25730171|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25730172|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730173|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
25730175|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
25730176|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25730177|NCT02605304|Ledipasvir|ledipasvir|mesh-list
25730178|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
25730179|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730180|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
25730181|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730182|NCT02605395|Rabeprazole|rabeprazole|mesh-list
25730183|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25730184|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730185|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25730186|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730187|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730188|NCT02605642|Infliximab|infliximab|mesh-list
25730189|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
25730190|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730191|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730192|NCT02605837|Budesonide|budesonide|mesh-list
25730193|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730194|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25730195|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
25730196|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730197|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730198|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25730199|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
25730200|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
25730201|NCT02605837|Hormones|hormones|mesh-ancestor
25730202|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730203|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25730204|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
25730205|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730206|NCT02606253|Metolazone|metolazone|mesh-list
25730207|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
25730208|NCT02606253|Tolvaptan|tolvaptan|mesh-list
25730209|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25730210|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730211|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
25730212|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730213|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25730214|NCT02606253|Diuretics|diuretics|mesh-ancestor
25730215|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25730216|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730217|NCT02606877|Pirfenidone|pirfenidone|mesh-list
25730218|NCT02606877|Nintedanib|nintedanib|mesh-list
25730219|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730220|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25730221|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730222|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730223|NCT02606877|Analgesics|analgesics|mesh-ancestor
25730224|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
25730225|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730226|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730227|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25730228|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25730229|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730230|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730231|NCT02607254|Pregabalin|pregabalin|mesh-list
25730232|NCT02607254|Analgesics|analgesics|mesh-ancestor
25730233|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
25730234|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730235|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730236|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
25730237|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25730238|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730239|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730240|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25730241|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25730242|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25730243|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730244|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25730245|NCT02607306|Insulin|insulin|mesh-list
25730246|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25730247|NCT02607306|Liraglutide|liraglutide|mesh-list
25730248|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
25730249|NCT02607306|Xultophy|xultophy|mesh-list
25730250|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25730251|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730252|NCT02607306|Incretins|incretins|mesh-ancestor
25730253|NCT02607306|Hormones|hormones|mesh-ancestor
25730254|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730255|NCT02607618|Vancomycin|vancomycin|mesh-list
25730256|NCT02607618|Iclaprim|iclaprim|mesh-list
25730257|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730258|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730259|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25730260|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730261|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730262|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
25730263|NCT02607735|Velpatasvir|velpatasvir|mesh-list
25730264|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
25730265|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730266|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
25730267|NCT02607800|Velpatasvir|velpatasvir|mesh-list
25730268|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
25730269|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730270|NCT02608099|Apixaban|apixaban|mesh-list
25730271|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25730272|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
25730273|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25730274|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
25730275|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730276|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730277|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
25730278|NCT02608177|Linagliptin|linagliptin|mesh-list
25730279|NCT02608177|Glipizide|glipizide|mesh-list
25730280|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25730281|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730282|NCT02608177|Incretins|incretins|mesh-ancestor
25730283|NCT02608177|Hormones|hormones|mesh-ancestor
25730284|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730285|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25730286|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25730287|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730288|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730289|NCT02608229|Gemcitabine|gemcitabine|mesh-list
25730290|NCT02608229|Paclitaxel|paclitaxel|mesh-list
25730291|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25730292|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25730293|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730294|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
25730295|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
25730296|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
25730297|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730298|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25730299|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
25730300|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
25730301|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730302|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730303|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25730304|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
25730305|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730306|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
25730307|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25730308|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
25730309|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730310|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
25730311|NCT02608489|Protective Agents|protective agents|mesh-ancestor
25730312|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
25730313|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25730314|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730315|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
25730316|NCT02609399|Oseltamivir|oseltamivir|mesh-list
25730317|NCT02609399|Peramivir|peramivir|mesh-list
25730318|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
25730319|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730320|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730321|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730322|NCT02609607|Bisacodyl|bisacodyl|mesh-list
25730323|NCT02609607|Cathartics|cathartics|mesh-ancestor
25730324|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730325|NCT02609607|Laxatives|laxatives|mesh-ancestor
25730326|NCT02609659|Ritonavir|ritonavir|mesh-list
25730327|NCT02609659|Ribavirin|ribavirin|mesh-list
25730328|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25730329|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25730330|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
25730331|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730332|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730333|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25730334|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25730335|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
25730336|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730337|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25730338|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25730339|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
25730340|NCT02609984|Atezolizumab|atezolizumab|mesh-list
25730341|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730342|NCT02610140|Vinorelbine|vinorelbine|mesh-list
25730343|NCT02610140|Maytansine|maytansine|mesh-list
25730344|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25730345|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730346|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25730347|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25730348|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25730349|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730350|NCT02610231|Istradefylline|istradefylline|mesh-list
25730351|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25730352|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25730353|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25730354|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
25730355|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730356|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730357|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730358|NCT02610816|Fluticasone|fluticasone|mesh-list
25730359|NCT02610816|Xhance|xhance|mesh-list
25730360|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730361|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25730362|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
25730363|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730364|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730365|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25730366|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
25730367|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
25730368|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25730369|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25730370|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
25730371|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25730372|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730373|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730374|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
25730375|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730376|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730377|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25730378|NCT02611154|Testosterone|testosterone|mesh-list
25730379|NCT02611154|Androgens|androgens|mesh-ancestor
25730380|NCT02611154|Hormones|hormones|mesh-ancestor
25730381|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293817|NCT02982668|Metoclopramide|metoclopramide|mesh-list
25730382|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730383|NCT02611752|Buprenorphine|buprenorphine|mesh-list
25730384|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25730385|NCT02611752|Narcotics|narcotics|mesh-ancestor
25730386|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730387|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730388|NCT02611752|Analgesics|analgesics|mesh-ancestor
25730389|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
25730390|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730391|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25730392|NCT02611765|Penicillins|penicillins|mesh-list
25730393|NCT02611765|Penicillin G|penicillin g|mesh-list
25730394|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25730395|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
25730396|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730397|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730398|NCT02611778|Ranibizumab|ranibizumab|mesh-list
25730399|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25730400|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25730401|NCT02611778|Growth Substances|growth substances|mesh-ancestor
25730402|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730403|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
25730404|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730405|NCT02611882|Edetic Acid|edetic acid|mesh-list
25730406|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
25730407|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25730408|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
25730409|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
25730410|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730411|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
25730412|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25730413|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25730414|NCT02612064|Fluorides|fluorides|mesh-list
25730415|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
25730416|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
25730417|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
25730418|NCT02612064|Protective Agents|protective agents|mesh-ancestor
25730419|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730420|NCT02612077|Bevacizumab|bevacizumab|mesh-list
25730421|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25730422|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730423|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25730424|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25730425|NCT02612077|Growth Substances|growth substances|mesh-ancestor
25730426|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730427|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
25772853|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25772854|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772855|NCT03829618|Lidocaine|lidocaine|mesh-list
25772856|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772857|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
25772858|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772859|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772860|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
25772861|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772862|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772863|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772864|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772865|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772866|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772867|NCT03830333|Metronidazole|metronidazole|mesh-list
25772868|NCT03830333|Meropenem|meropenem|mesh-list
25772869|NCT03830333|Tazobactam|tazobactam|mesh-list
25772870|NCT03830333|Ceftolozane|ceftolozane|mesh-list
25772871|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25772872|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772873|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25772874|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25772875|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25772876|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25772877|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772878|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772879|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25772880|NCT03830333|Renal Agents|renal agents|mesh-ancestor
25772881|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
25772882|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
25772883|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730428|NCT02612779|Dexamethasone|dexamethasone|mesh-list
25730429|NCT02612779|Nivolumab|nivolumab|mesh-list
25730430|NCT02612779|Pomalidomide|pomalidomide|mesh-list
25730431|NCT02612779|Elotuzumab|elotuzumab|mesh-list
25730432|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730433|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
25730434|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
25730435|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730436|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730437|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730438|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
25730439|NCT02612779|Hormones|hormones|mesh-ancestor
25730440|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730441|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25730442|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730443|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25730444|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25730445|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730446|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
25730447|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25730448|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25730449|NCT02612779|Growth Substances|growth substances|mesh-ancestor
25730450|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
25730451|NCT02613117|Fluorides|fluorides|mesh-list
25730452|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
25730453|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
25730454|NCT02613117|Protective Agents|protective agents|mesh-ancestor
25730455|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730456|NCT02613169|Isoniazid|isoniazid|mesh-list
25730457|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
25730458|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730459|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730460|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25730461|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25730462|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
25730463|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730464|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25730465|NCT02613208|Paclitaxel|paclitaxel|mesh-list
25730466|NCT02613208|Bevacizumab|bevacizumab|mesh-list
25730467|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25730468|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730469|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
25730470|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
25730471|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
25730472|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730473|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25730474|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25730475|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25730476|NCT02613208|Growth Substances|growth substances|mesh-ancestor
25730477|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730478|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
25730479|NCT02613221|Panitumumab|panitumumab|mesh-list
25730480|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25730481|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730482|NCT02613403|Ribavirin|ribavirin|mesh-list
25730483|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
25730484|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
25730485|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730486|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
25730487|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730488|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
25730489|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
25730490|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730491|NCT02613572|Protective Agents|protective agents|mesh-ancestor
25730492|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730493|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
25730494|NCT02613572|Vitamins|vitamins|mesh-ancestor
25730495|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
25730496|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
25730497|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25730498|NCT02613871|Ledipasvir|ledipasvir|mesh-list
25730499|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
25730500|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730501|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
25730502|NCT02613897|Saxagliptin|saxagliptin|mesh-list
25730503|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25772884|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
25730504|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730505|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25730506|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730507|NCT02613897|Incretins|incretins|mesh-ancestor
25730508|NCT02613897|Hormones|hormones|mesh-ancestor
25730509|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730510|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25730511|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
25730512|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730513|NCT02613910|Acetaminophen|acetaminophen|mesh-list
25730514|NCT02613910|Cetirizine|cetirizine|mesh-list
25730515|NCT02613910|Prednisone|prednisone|mesh-list
25730516|NCT02613910|Prednisolone|prednisolone|mesh-list
25730517|NCT02613910|Ofatumumab|ofatumumab|mesh-list
25730518|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
25730519|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25730520|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730521|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
25730522|NCT02613910|Hormones|hormones|mesh-ancestor
25730523|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730524|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730525|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25730526|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730527|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25730528|NCT02613910|Analgesics|analgesics|mesh-ancestor
25730529|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
25730530|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730531|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
25730532|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25730533|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25730534|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
25730535|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730536|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730537|NCT02614560|Fludarabine|fludarabine|mesh-list
25730538|NCT02614560|Melphalan|melphalan|mesh-list
25730539|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730540|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730541|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25730542|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
25730543|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730544|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25730545|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
25730546|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25730547|NCT02614703|Acetic Acid|acetic acid|mesh-list
25730548|NCT02614703|Retinol acetate|retinol acetate|mesh-list
25730549|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730550|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730551|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25730552|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
25730553|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730554|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25730555|NCT02614703|Protective Agents|protective agents|mesh-ancestor
25730556|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730557|NCT02615535|Alprostadil|alprostadil|mesh-list
25730558|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25730559|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
25730560|NCT02615535|Urological Agents|urological agents|mesh-ancestor
25730561|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25730562|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25730563|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25730564|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
25730565|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730566|NCT02616250|Ivermectin|ivermectin|mesh-list
25730567|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25730568|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25730569|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730570|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25730571|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25730572|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25730573|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25730574|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
25730575|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730576|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772885|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25294040|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730577|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730578|NCT02616523|Lidocaine|lidocaine|mesh-list
25730579|NCT02616523|Fentanyl|fentanyl|mesh-list
25730580|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
25730581|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730582|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
25730583|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730584|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730585|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
25730586|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730587|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25730588|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25730589|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25730590|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730591|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730592|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25730593|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25730594|NCT02616523|Analgesics|analgesics|mesh-ancestor
25730595|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25730596|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25730597|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25730598|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
25730599|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730600|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25730601|NCT02616523|Narcotics|narcotics|mesh-ancestor
25730602|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25730603|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25730604|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
25730605|NCT02616601|Fluorouracil|fluorouracil|mesh-list
25730606|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
25730607|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730608|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25730609|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730610|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25730611|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
25730612|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730613|NCT02616614|Clindamycin|clindamycin|mesh-list
25730614|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
25730615|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
25730616|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25730617|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730618|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730619|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25730620|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730621|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730622|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
25730623|NCT02616783|Lamivudine|lamivudine|mesh-list
25730624|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25730625|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25730626|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730627|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730628|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
25730629|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730630|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25730631|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25730632|NCT02617628|Naltrexone|naltrexone|mesh-list
25730633|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25730634|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25730635|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730636|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
25730637|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730638|NCT02617667|Cyclosporine|cyclosporine|mesh-list
25730639|NCT02617667|Cyclosporins|cyclosporins|mesh-list
25730640|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730641|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730642|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25730643|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
25730644|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730645|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
25730646|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730647|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
25730648|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294177|NCT04339218|Carboplatin|carboplatin|mesh-list
25730649|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25730650|NCT02617784|Oseltamivir|oseltamivir|mesh-list
25730651|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
25730652|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730653|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730654|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730655|NCT02617888|Bismuth|bismuth|mesh-list
25730656|NCT02617888|Antacids|antacids|mesh-ancestor
25730657|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730658|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730659|NCT02618187|Vancomycin|vancomycin|mesh-list
25730660|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730661|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730662|NCT02618343|Ondansetron|ondansetron|mesh-list
25730663|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
25730664|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
25730665|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730666|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730667|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730668|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
25730669|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
25730670|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25730671|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
25730672|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730673|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730674|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25730675|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25730676|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730677|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25730678|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25730679|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
25730680|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25730681|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25730682|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730683|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
25730684|NCT02618382|Coagulants|coagulants|mesh-ancestor
25730685|NCT02618772|Midazolam|midazolam|mesh-list
25730686|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25730687|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25730688|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730689|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730690|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25730691|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25730692|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25730693|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25730694|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
25730695|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
25730696|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
25730697|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
25730698|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730699|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730700|NCT02619409|Bupivacaine|bupivacaine|mesh-list
25730701|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730702|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
25730703|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730704|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730705|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
25730706|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730707|NCT02619617|Pasireotide|pasireotide|mesh-list
25730708|NCT02619617|Hormones|hormones|mesh-ancestor
25730709|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730710|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730711|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
25730712|NCT02619799|Midazolam|midazolam|mesh-list
25730713|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25730714|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25730715|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730716|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730717|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25730718|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25730719|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25730720|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25730721|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
25730722|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
25730723|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
25730724|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
25730725|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730726|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730727|NCT02619799|Analgesics|analgesics|mesh-ancestor
25294332|NCT03682224|Epinephrine|epinephrine|mesh-list
25730728|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
25730729|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730730|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25730731|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
25730732|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25730733|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730734|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25730735|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
25730736|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25730737|NCT02620020|Fasinumab|fasinumab|mesh-list
25730738|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25730739|NCT02620020|Analgesics|analgesics|mesh-ancestor
25730740|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
25730741|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730742|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730743|NCT02620384|Metolazone|metolazone|mesh-list
25730744|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25730745|NCT02620384|Diuretics|diuretics|mesh-ancestor
25730746|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
25730747|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730748|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25730749|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730750|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730751|NCT02620683|Lidocaine|lidocaine|mesh-list
25730752|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730753|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
25730754|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730755|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730756|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
25730757|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730758|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25730759|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25730760|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25730761|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730762|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730763|NCT02620774|Tazobactam|tazobactam|mesh-list
25730764|NCT02620774|Ceftolozane|ceftolozane|mesh-list
25730765|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25730766|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730767|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730768|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25730769|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730770|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730771|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25730772|NCT02620774|Renal Agents|renal agents|mesh-ancestor
25730773|NCT02620787|Tedizolid|tedizolid|mesh-list
25730774|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25730775|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730776|NCT02620878|Pancrelipase|pancrelipase|mesh-list
25730777|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730778|NCT02620904|Mifepristone|mifepristone|mesh-list
25730779|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25730780|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
25730781|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25730782|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730783|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25730784|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25730785|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25730786|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
25730787|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25730788|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25730789|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
25730790|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730791|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
25730792|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25730793|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25730794|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
25730795|NCT02621060|Antacids|antacids|mesh-ancestor
25730796|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730797|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730798|NCT02621619|Acetaminophen|acetaminophen|mesh-list
25730799|NCT02621619|Hydromorphone|hydromorphone|mesh-list
25730800|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25730801|NCT02621619|Analgesics|analgesics|mesh-ancestor
25730802|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
25730803|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730804|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730805|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
25730806|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25730807|NCT02621619|Narcotics|narcotics|mesh-ancestor
25730808|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730809|NCT02621931|Calcitonin|calcitonin|mesh-list
25730810|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25730811|NCT02621931|Katacalcin|katacalcin|mesh-list
25730812|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25730813|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730814|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25730815|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
25730816|NCT02622074|Paclitaxel|paclitaxel|mesh-list
25730817|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25730818|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
25730819|NCT02622074|Carboplatin|carboplatin|mesh-list
25730820|NCT02622074|Doxorubicin|doxorubicin|mesh-list
25730821|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
25730822|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25730823|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730824|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
25730825|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
25730826|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
25730827|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730828|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25730829|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
25730830|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730831|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730832|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25730833|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
25730834|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25730835|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25730836|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25730837|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25730838|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730839|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25730840|NCT02622113|Canagliflozin|canagliflozin|mesh-list
25730841|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25730842|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730843|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25730844|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730845|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25730846|NCT02622321|Coagulants|coagulants|mesh-ancestor
25730847|NCT02622724|Interferons|interferons|mesh-list
25730848|NCT02622724|Interferon-beta|interferon-beta|mesh-list
25730849|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
25730850|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730851|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
25730852|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730853|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
25730854|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730855|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25772886|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772887|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
25772888|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772889|NCT03862755|Heparin|heparin|mesh-list
25772890|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25772891|NCT03862755|Tinzaparin|tinzaparin|mesh-list
25772892|NCT03862755|Dalteparin|dalteparin|mesh-list
25772893|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
25772894|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25772895|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25772896|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772897|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
25772898|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25772899|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772900|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25772901|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772902|NCT03885596|Acetaminophen|acetaminophen|mesh-list
25772903|NCT03885596|Celecoxib|celecoxib|mesh-list
25772904|NCT03885596|Ketorolac|ketorolac|mesh-list
25772905|NCT03885596|Lidocaine|lidocaine|mesh-list
25772906|NCT03885596|Fentanyl|fentanyl|mesh-list
25772907|NCT03885596|Bupivacaine|bupivacaine|mesh-list
25772908|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730856|NCT02623803|Lidocaine|lidocaine|mesh-list
25730857|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730858|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
25730859|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730860|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730861|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
25730862|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730863|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25730864|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25730865|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25730866|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730867|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730868|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
25730869|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25730870|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25730871|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25730872|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730873|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
25730874|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730875|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730876|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25730877|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730878|NCT02624050|Propofol|propofol|mesh-list
25730879|NCT02624050|Methohexital|methohexital|mesh-list
25730880|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25730881|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730882|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730883|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25730884|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
25730885|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
25730886|NCT02624180|Colchicine|colchicine|mesh-list
25730887|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
25730888|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730889|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
25730890|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
25730891|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
25730892|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730893|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730894|NCT02624492|Rituximab|rituximab|mesh-list
25730895|NCT02624492|BI 836826|bi 836826|mesh-list
25730896|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25730897|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730898|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
25730899|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730900|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730901|NCT02624700|Pemetrexed|pemetrexed|mesh-list
25730902|NCT02624700|Sorafenib|sorafenib|mesh-list
25730903|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730904|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25730905|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730906|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25730907|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25730908|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25730909|NCT02624843|Ethanol|ethanol|mesh-list
25730910|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
25730911|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25730912|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25730913|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730914|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730915|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
25730916|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
25730917|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
25730918|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730919|NCT02624986|Rituximab|rituximab|mesh-list
25730920|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
25730921|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25730922|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730923|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
25730924|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730925|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25730926|NCT02625181|Promethazine|promethazine|mesh-list
25730927|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
25730928|NCT02625181|Meclizine|meclizine|mesh-list
25730929|NCT02625181|Dexamethasone|dexamethasone|mesh-list
25730930|NCT02625181|Fentanyl|fentanyl|mesh-list
25730931|NCT02625181|Sufentanil|sufentanil|mesh-list
25730932|NCT02625181|Scopolamine|scopolamine|mesh-list
25730933|NCT02625181|Oxymorphone|oxymorphone|mesh-list
25730934|NCT02625181|Meperidine|meperidine|mesh-list
25730935|NCT02625181|Droperidol|droperidol|mesh-list
25730936|NCT02625181|Ketamine|ketamine|mesh-list
25730937|NCT02625181|Morphine|morphine|mesh-list
25730938|NCT02625181|Remifentanil|remifentanil|mesh-list
25730939|NCT02625181|Oxycodone|oxycodone|mesh-list
25730940|NCT02625181|Methadone|methadone|mesh-list
25730941|NCT02625181|Hydromorphone|hydromorphone|mesh-list
25730942|NCT02625181|Hydrocodone|hydrocodone|mesh-list
25730943|NCT02625181|Alfentanil|alfentanil|mesh-list
25730944|NCT02625181|Haloperidol|haloperidol|mesh-list
25730945|NCT02625181|Ondansetron|ondansetron|mesh-list
25730946|NCT02625181|Aprepitant|aprepitant|mesh-list
25730947|NCT02625181|Palonosetron|palonosetron|mesh-list
25730948|NCT02625181|Metoclopramide|metoclopramide|mesh-list
25730949|NCT02625181|Granisetron|granisetron|mesh-list
25730950|NCT02625181|Ramosetron|ramosetron|mesh-list
25730951|NCT02625181|Tropisetron|tropisetron|mesh-list
25730952|NCT02625181|Dolasetron|dolasetron|mesh-list
25730953|NCT02625181|Anesthetics|anesthetics|mesh-list
25730954|NCT02625181|Propofol|propofol|mesh-list
25730955|NCT02625181|Sevoflurane|sevoflurane|mesh-list
25730956|NCT02625181|Desflurane|desflurane|mesh-list
25730957|NCT02625181|Isoflurane|isoflurane|mesh-list
25730958|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25730959|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25730960|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
25730961|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
25730962|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25730963|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25730964|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25730965|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
25730966|NCT02625181|Hormones|hormones|mesh-ancestor
25730967|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25730968|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25730969|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25730970|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25730971|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25730972|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25730973|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
25730974|NCT02625181|Analgesics|analgesics|mesh-ancestor
25730975|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
25730976|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25730977|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25730978|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25730979|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25730980|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25730981|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25730982|NCT02625181|Narcotics|narcotics|mesh-ancestor
25730983|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25730984|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25730985|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25730986|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
25730987|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
25730988|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25730989|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
25730990|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25730991|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25730992|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25730993|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25730994|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
25730995|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
25730996|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25730997|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25730998|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
25730999|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25731000|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25731001|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25731002|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
25731003|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25731004|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
25731005|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25294669|NCT04774237|Carbachol|carbachol|mesh-list
25294670|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25294671|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25294683|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
25731006|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
25731007|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25731008|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
25731009|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
25731010|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25731011|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25731012|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
25731013|NCT02625207|Maraviroc|maraviroc|mesh-list
25731014|NCT02625207|Darunavir|darunavir|mesh-list
25731015|NCT02625207|Cobicistat|cobicistat|mesh-list
25731016|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25731017|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25731018|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25731019|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731020|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25731021|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25731022|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
25731023|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731024|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25731025|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25731026|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25731027|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
25731028|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731029|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25731030|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25731031|NCT02625259|Lansoprazole|lansoprazole|mesh-list
25731032|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
25731033|NCT02625259|Serabelisib|serabelisib|mesh-list
25731034|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25731035|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731036|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25731037|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731038|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731039|NCT02625298|Pemetrexed|pemetrexed|mesh-list
25731040|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731041|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731042|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731043|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25731044|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25731045|NCT02625623|Paclitaxel|paclitaxel|mesh-list
25731046|NCT02625623|Irinotecan|irinotecan|mesh-list
25731047|NCT02625623|Avelumab|avelumab|mesh-list
25731048|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25731049|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731050|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
25731051|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
25731052|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
25731053|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731054|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25731055|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25731056|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731057|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25731058|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
25731059|NCT02625909|Velpatasvir|velpatasvir|mesh-list
25731060|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
25731061|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731062|NCT02625974|Nifurtimox|nifurtimox|mesh-list
25731063|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25731064|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25731065|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25731066|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731067|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
25731068|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25731069|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25731070|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731071|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
25731072|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731073|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
25731074|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
25731075|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25731076|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25731077|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731078|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731079|NCT02626182|Urological Agents|urological agents|mesh-ancestor
25731080|NCT02626611|Omalizumab|omalizumab|mesh-list
25731081|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25731082|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25731083|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
25731084|NCT02627144|Interferons|interferons|mesh-list
25731085|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
25731086|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
25731087|NCT02627144|Bevacizumab|bevacizumab|mesh-list
25772909|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
25731088|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25731089|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731090|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25731091|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25731092|NCT02627144|Growth Substances|growth substances|mesh-ancestor
25731093|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731094|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
25731095|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
25731096|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731097|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
25731098|NCT02627677|Ponatinib|ponatinib|mesh-list
25731099|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731100|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25731101|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731102|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731103|NCT02628106|Alprostadil|alprostadil|mesh-list
25731104|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25731105|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
25731106|NCT02628106|Urological Agents|urological agents|mesh-ancestor
25731107|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25731108|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25731109|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731110|NCT02628600|Amikacin|amikacin|mesh-list
25731111|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25731112|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731113|NCT02628769|Solithromycin|solithromycin|mesh-list
25731114|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25731115|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731116|NCT02629094|Eplerenone|eplerenone|mesh-list
25731117|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25731118|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
25731119|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731120|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731121|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25731122|NCT02629094|Diuretics|diuretics|mesh-ancestor
25731123|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
25731124|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25731125|NCT02629354|Ibuprofen|ibuprofen|mesh-list
25731126|NCT02629354|Caffeine|caffeine|mesh-list
25731127|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25731128|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731129|NCT02629354|Analgesics|analgesics|mesh-ancestor
25731130|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
25731131|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731132|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731133|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731134|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731135|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25731136|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731137|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731138|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25731139|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25731140|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25731141|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25731142|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
25731143|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731144|NCT02629822|Tenofovir|tenofovir|mesh-list
25731145|NCT02629822|Lamivudine|lamivudine|mesh-list
25731146|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
25731147|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731148|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25731149|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25731150|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731151|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731152|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25731153|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25731154|NCT02629861|Calcitonin|calcitonin|mesh-list
25731155|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25731156|NCT02629861|Katacalcin|katacalcin|mesh-list
25731157|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25731158|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731159|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25731160|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
25731161|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
25731162|NCT02629965|Olodaterol|olodaterol|mesh-list
25731163|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25731164|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
25731165|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731166|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731167|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25731168|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
25731169|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
25731170|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25731171|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
25731172|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731173|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731175|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
25731176|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25731177|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731178|NCT02630017|Methylphenidate|methylphenidate|mesh-list
25731179|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25731180|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731181|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25731182|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731183|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731184|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731185|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
25731186|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731187|NCT02630030|Ixazomib|ixazomib|mesh-list
25731188|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731189|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
25731190|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731191|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731192|NCT02630186|Atezolizumab|atezolizumab|mesh-list
25731193|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731194|NCT02630563|Cyclosporine|cyclosporine|mesh-list
25731195|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
25731196|NCT02630563|Cyclosporins|cyclosporins|mesh-list
25731197|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731198|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731199|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731200|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
25731201|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731202|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
25731203|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731204|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731205|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731206|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25731207|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25731208|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731209|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25731210|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
25731211|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25731212|NCT02630693|Tamoxifen|tamoxifen|mesh-list
25731213|NCT02630693|Fulvestrant|fulvestrant|mesh-list
25731214|NCT02630693|Palbociclib|palbociclib|mesh-list
25731215|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25731216|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25731217|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
25731218|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731219|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731220|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25731221|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731222|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25731223|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25731224|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25731225|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25731226|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25731227|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731228|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731229|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25731230|NCT02630706|Metformin|metformin|mesh-list
25731231|NCT02630706|Glimepiride|glimepiride|mesh-list
25731232|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
25731233|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25731234|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731235|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294922|NCT03661632|Nivolumab|nivolumab|mesh-list
25731236|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731237|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
25731238|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25731239|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731240|NCT02630719|Timolol|timolol|mesh-list
25731241|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25731242|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
25731243|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25731244|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25731245|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25731246|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
25731247|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731248|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731249|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731250|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25731251|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25731252|NCT02630966|Vedolizumab|vedolizumab|mesh-list
25731253|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731254|NCT02630992|Amoxicillin|amoxicillin|mesh-list
25731255|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
25731256|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
25731257|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25731258|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25731259|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731260|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25731261|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731262|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731263|NCT02631057|Warfarin|warfarin|mesh-list
25731264|NCT02631057|Dabigatran|dabigatran|mesh-list
25731265|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
25731266|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
25731267|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25731268|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
25731269|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731270|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731271|NCT02631525|Propofol|propofol|mesh-list
25731272|NCT02631525|Desflurane|desflurane|mesh-list
25731273|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25731274|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731275|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731276|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25731277|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
25731278|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
25731279|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25731280|NCT02631538|Rituximab|rituximab|mesh-list
25731281|NCT02631538|Belimumab|belimumab|mesh-list
25731282|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25731283|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731284|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
25731285|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731286|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731287|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731288|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
25731289|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25731290|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731291|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731292|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25731293|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25731294|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731295|NCT02631551|Analgesics|analgesics|mesh-ancestor
25731296|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
25731297|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731298|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731299|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731300|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25731301|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25731302|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
25731303|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
25731304|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731305|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731306|NCT02631590|Gemcitabine|gemcitabine|mesh-list
25731307|NCT02631590|Cisplatin|cisplatin|mesh-list
25731308|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731309|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25295004|NCT05116228|Rituximab|rituximab|mesh-list
25731310|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
25731311|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731312|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
25731313|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731314|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731315|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731316|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
25731317|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731319|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25731320|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731321|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25731322|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731323|NCT02631772|Ribavirin|ribavirin|mesh-list
25731324|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
25731325|NCT02631772|Ledipasvir|ledipasvir|mesh-list
25731326|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
25731327|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731328|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
25731329|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731330|NCT02631876|Paclitaxel|paclitaxel|mesh-list
25731331|NCT02631876|Maytansine|maytansine|mesh-list
25731332|NCT02631876|Doxorubicin|doxorubicin|mesh-list
25731333|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25731334|NCT02631876|Topotecan|topotecan|mesh-list
25731335|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25731336|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731337|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
25731338|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
25731339|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
25731340|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731341|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25731342|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25731343|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25731344|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731345|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25731346|NCT02631954|Voriconazole|voriconazole|mesh-list
25731347|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
25731348|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731349|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25731350|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25731351|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731352|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731353|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25731354|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
25731355|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731356|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731357|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25731358|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25731359|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25731360|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731361|NCT02632747|Empagliflozin|empagliflozin|mesh-list
25731362|NCT02632747|Ramipril|ramipril|mesh-list
25731363|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25731364|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731365|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25731366|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731367|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25731368|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
25731369|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731370|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25731371|NCT02632812|Naproxen|naproxen|mesh-list
25731372|NCT02632812|Rebamipide|rebamipide|mesh-list
25731373|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25731374|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731375|NCT02632812|Analgesics|analgesics|mesh-ancestor
25731376|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
25731377|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731378|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731379|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731380|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731381|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
25731382|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25731383|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295086|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
25731384|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731385|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25731386|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731387|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
25731388|NCT02632812|Protective Agents|protective agents|mesh-ancestor
25731389|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25731391|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731392|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731393|NCT02633371|Oxybutynin|oxybutynin|mesh-list
25731394|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
25731395|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
25731396|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731397|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731398|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25731399|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25731400|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
25731401|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731402|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731403|NCT02633371|Urological Agents|urological agents|mesh-ancestor
25731404|NCT02633488|Metformin|metformin|mesh-list
25731405|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25731406|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772910|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772911|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772912|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
25772913|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772914|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772915|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772916|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772917|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772918|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772919|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25772920|NCT03885596|Narcotics|narcotics|mesh-ancestor
25772921|NCT03885596|Analgesics|analgesics|mesh-ancestor
25772922|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25772923|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25772924|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
25772925|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772926|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
25772927|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772928|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772929|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772930|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25772931|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772932|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772933|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25772934|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25772935|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25772936|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
25772937|NCT03889158|Vaccines|vaccines|mesh-list
25772938|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
25772939|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772940|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
25772941|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772942|NCT03889158|Protective Agents|protective agents|mesh-ancestor
25772943|NCT03889158|Vitamins|vitamins|mesh-ancestor
25772944|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
25772945|NCT03907033|Bupivacaine|bupivacaine|mesh-list
25772946|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772947|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
25772948|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772949|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772950|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
25772951|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772952|NCT03920215|Varenicline|varenicline|mesh-list
25772953|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25772954|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25772955|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772956|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772957|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772958|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772959|NCT03921151|Mirtazapine|mirtazapine|mesh-list
25772960|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
25731407|NCT02633800|Cisplatin|cisplatin|mesh-list
25731408|NCT02633800|Carboplatin|carboplatin|mesh-list
25731409|NCT02633800|Cetuximab|cetuximab|mesh-list
25731410|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731411|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25731412|NCT02633956|Atorvastatin|atorvastatin|mesh-list
25731413|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25731414|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25731415|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
25731416|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731417|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25731418|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25731419|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731420|NCT02634073|Lamivudine|lamivudine|mesh-list
25731421|NCT02634073|Sorbitol|sorbitol|mesh-list
25731422|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25731423|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25731424|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731425|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731426|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
25731427|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731428|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25731429|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25731430|NCT02634073|Cathartics|cathartics|mesh-ancestor
25731431|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731432|NCT02634320|Aripiprazole|aripiprazole|mesh-list
25731433|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
25731434|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
25731435|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25731436|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25731437|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25731438|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731439|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731440|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
25731441|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
25731442|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731443|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731444|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25731445|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25731446|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
25731447|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25731448|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25731449|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25731450|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25731451|NCT02634346|Olanzapine|olanzapine|mesh-list
25731452|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
25731453|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
25731454|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731455|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731456|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731457|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25731458|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25731459|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731460|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25731461|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25731462|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731463|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731464|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731465|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731466|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
25731467|NCT02634580|Ezetimibe|ezetimibe|mesh-list
25731468|NCT02634580|Evolocumab|evolocumab|mesh-list
25731469|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25731470|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25731471|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25731472|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
25731473|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731474|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25731475|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
25731476|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731477|NCT02634684|Amphetamine|amphetamine|mesh-list
25731478|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
25731479|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25731480|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731481|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
25295382|NCT04748250|Hormones|hormones|mesh-ancestor
25731482|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
25731483|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731484|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
25731485|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731486|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731487|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
25731488|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25731489|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731490|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731491|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25731492|NCT02634788|Buprenorphine|buprenorphine|mesh-list
25731493|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25731494|NCT02634788|Narcotics|narcotics|mesh-ancestor
25731495|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731496|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731497|NCT02634788|Analgesics|analgesics|mesh-ancestor
25731498|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
25731499|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731500|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25731501|NCT02634801|Methotrexate|methotrexate|mesh-list
25731503|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25731504|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
25731505|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25731506|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731507|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25731508|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
25731509|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731510|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731511|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731512|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731513|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25731514|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731515|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
25731516|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731517|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25731518|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25731519|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25731520|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731521|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25731522|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731523|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731524|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731525|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
25731526|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731527|NCT02635204|Clobetasol|clobetasol|mesh-list
25731528|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731529|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
25731530|NCT02635204|Hormones|hormones|mesh-ancestor
25731531|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731532|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731533|NCT02635386|Metformin|metformin|mesh-list
25731534|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
25731535|NCT02635386|Exenatide|exenatide|mesh-list
25731536|NCT02635386|Topiramate|topiramate|mesh-list
25731537|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25731538|NCT02635386|Phentermine|phentermine|mesh-list
25731539|NCT02635386|Glucagon|glucagon|mesh-list
25731540|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25731541|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25731542|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731543|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731544|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25731545|NCT02635386|Incretins|incretins|mesh-ancestor
25731546|NCT02635386|Hormones|hormones|mesh-ancestor
25731547|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731548|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
25731549|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731550|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25731551|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
25731552|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
25731553|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
25731554|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731555|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
25731556|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731557|NCT02635542|Cisatracurium|cisatracurium|mesh-list
25731558|NCT02635542|Succinylcholine|succinylcholine|mesh-list
25731559|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25731560|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25731561|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731562|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731563|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25731564|NCT02635724|Peramivir|peramivir|mesh-list
25731565|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
25731566|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731567|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731568|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731569|NCT02635828|Promethazine|promethazine|mesh-list
25731570|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
25731571|NCT02635828|Dexamethasone|dexamethasone|mesh-list
25731572|NCT02635828|Palonosetron|palonosetron|mesh-list
25731573|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731574|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
25731575|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
25731576|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731577|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731578|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731579|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
25731580|NCT02635828|Hormones|hormones|mesh-ancestor
25731581|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731582|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25731583|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731584|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25731585|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25731586|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
25731587|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731588|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731589|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
25731590|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731591|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25731592|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
25731593|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
25731594|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25731595|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25731596|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25731597|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731598|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
25731599|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
25731600|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
25731601|NCT02635984|Olanzapine|olanzapine|mesh-list
25731602|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
25731603|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
25731604|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731605|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731606|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731607|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25731608|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25731609|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731610|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25731611|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25731612|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731613|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731614|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731615|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731616|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
25731617|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
25731618|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25731619|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731620|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
25731621|NCT02636725|Axitinib|axitinib|mesh-list
25731622|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25731623|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731624|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25731625|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731626|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731627|NCT02637037|Metformin|metformin|mesh-list
25731628|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
25731629|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25731630|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772961|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25731631|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25731632|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731634|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25731635|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25731636|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
25731637|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
25731638|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731639|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731640|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25731641|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25731642|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25731643|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25731644|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25731645|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
25731646|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731647|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731648|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731649|NCT02637323|Triamcinolone|triamcinolone|mesh-list
25731650|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25731651|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25731652|NCT02637323|FX006|fx006|mesh-list
25731653|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25731654|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731655|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
25731656|NCT02637323|Hormones|hormones|mesh-ancestor
25731657|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731658|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731659|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731660|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
25731661|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731662|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731663|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
25731664|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
25731665|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731666|NCT02637895|Vortioxetine|vortioxetine|mesh-list
25731667|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
25731668|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25731669|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25731670|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25731671|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731672|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731673|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25731674|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731675|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731676|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731677|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731678|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
25731679|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25731680|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25731681|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25731682|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25731683|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25731684|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
25731685|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
25731686|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731687|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731688|NCT02638012|Hemostatics|hemostatics|mesh-list
25731689|NCT02638012|Coagulants|coagulants|mesh-ancestor
25731690|NCT02638168|Methylphenidate|methylphenidate|mesh-list
25731691|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25731692|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731693|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25731694|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731695|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731696|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731697|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
25731698|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731699|NCT02638259|GP2015|gp2015|mesh-list
25731700|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731701|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
25731702|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25731703|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
25731704|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731705|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25731706|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25731707|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25731708|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731709|NCT02638948|Methotrexate|methotrexate|mesh-list
25731710|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25731711|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
25731712|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25731713|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731714|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25731715|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
25731716|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731717|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731718|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
25731719|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731720|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25731721|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731722|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
25731723|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731724|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25731725|NCT02639182|Axitinib|axitinib|mesh-list
25731726|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731727|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25731728|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731729|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731730|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
25731731|NCT02639247|Velpatasvir|velpatasvir|mesh-list
25731732|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
25731733|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731734|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
25731735|NCT02639338|Velpatasvir|velpatasvir|mesh-list
25731736|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
25731737|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731738|NCT02639429|Misoprostol|misoprostol|mesh-list
25731739|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25731740|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
25731741|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25731742|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731743|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25731744|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731745|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
25731746|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25731747|NCT02639637|Valsartan|valsartan|mesh-list
25731748|NCT02639637|Enalaprilat|enalaprilat|mesh-list
25731749|NCT02639637|Enalapril|enalapril|mesh-list
25731750|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25731751|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731752|NCT02639637|Incretins|incretins|mesh-ancestor
25731753|NCT02639637|Hormones|hormones|mesh-ancestor
25731754|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731755|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25731756|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
25731757|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731758|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731759|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25731760|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25731761|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25731762|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25731763|NCT02640053|Paclitaxel|paclitaxel|mesh-list
25731764|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25731765|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25731766|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731767|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
25731768|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
25731769|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
25731770|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731771|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
25731772|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
25731773|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731774|NCT02640404|Vaccines|vaccines|mesh-list
25731775|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
25731776|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731777|NCT02640755|Paclitaxel|paclitaxel|mesh-list
25731778|NCT02640755|Fulvestrant|fulvestrant|mesh-list
25295775|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731779|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25731780|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731781|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
25731782|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
25731783|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
25731784|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731785|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25731786|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25731787|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25731788|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25731789|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25731790|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731791|NCT02641080|Aspirin|aspirin|mesh-list
25731792|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25731793|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731794|NCT02641080|Analgesics|analgesics|mesh-ancestor
25731795|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
25731796|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731797|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731798|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731799|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731800|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25731801|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25731802|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731803|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25731804|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25731805|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731806|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
25731807|NCT02641353|Thalidomide|thalidomide|mesh-list
25731808|NCT02641353|Apremilast|apremilast|mesh-list
25731809|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25731810|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731811|NCT02641353|Analgesics|analgesics|mesh-ancestor
25731812|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
25731813|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731814|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731815|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731816|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731817|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25731818|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25731819|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731820|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731821|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731822|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
25731823|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
25731824|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25731825|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731826|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25731827|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25731828|NCT02641353|Growth Substances|growth substances|mesh-ancestor
25731829|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
25731830|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731831|NCT02641379|Ribavirin|ribavirin|mesh-list
25731832|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25731833|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
25731834|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731835|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
25731836|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25731837|NCT02641522|Siltuximab|siltuximab|mesh-list
25731838|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731839|NCT02641561|Indomethacin|indomethacin|mesh-list
25731840|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25731841|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731842|NCT02641561|Analgesics|analgesics|mesh-ancestor
25731843|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
25731844|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731845|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731846|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731847|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731848|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
25731849|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
25731850|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25731851|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25731852|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731853|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731855|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25731856|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
25731857|NCT02641691|Fluorouracil|fluorouracil|mesh-list
25731858|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
25731859|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
25731860|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
25731861|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731862|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25731863|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25731864|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25731865|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
25731866|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731867|NCT02641691|Antidotes|antidotes|mesh-ancestor
25731868|NCT02641691|Protective Agents|protective agents|mesh-ancestor
25731869|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
25731870|NCT02641691|Vitamins|vitamins|mesh-ancestor
25731871|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
25731872|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
25731873|NCT02642159|Niacin|niacin|mesh-list
25731874|NCT02642159|Niacinamide|niacinamide|mesh-list
25731875|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25731876|NCT02642159|Ezetimibe|ezetimibe|mesh-list
25731877|NCT02642159|Fenofibrate|fenofibrate|mesh-list
25731878|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25731879|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25731880|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
25731881|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731882|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25731883|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
25731884|NCT02642159|Vitamins|vitamins|mesh-ancestor
25731885|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
25731886|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731887|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
25772962|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25772963|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
25772964|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
25772965|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772966|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772967|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772968|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25772969|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25772970|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772971|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25772972|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25772973|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25772974|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772975|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25772976|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25772977|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
25772978|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25772979|NCT03927911|Bupivacaine|bupivacaine|mesh-list
25772980|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772981|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
25772982|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772983|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772984|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
25772985|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772986|NCT03938857|Fentanyl|fentanyl|mesh-list
25772987|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
25772988|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25772989|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772990|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772991|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772992|NCT03938857|Analgesics|analgesics|mesh-ancestor
25772993|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
25772994|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772995|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25772996|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25772997|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25772998|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772999|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773000|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773001|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25773002|NCT03938857|Narcotics|narcotics|mesh-ancestor
25731888|NCT02642653|Lovastatin|lovastatin|mesh-list
25731889|NCT02642653|L 647318|l 647318|mesh-list
25731890|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
25731891|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25731892|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25731893|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
25731894|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731895|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25731896|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25731897|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731898|NCT02643251|Clonidine|clonidine|mesh-list
25731899|NCT02643251|Analgesics|analgesics|mesh-ancestor
25731900|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
25731901|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731902|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731903|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25731904|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
25731905|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
25731906|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25731907|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25731908|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25731909|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
25731910|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731911|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731912|NCT02643355|Clonidine|clonidine|mesh-list
25731913|NCT02643355|Olanzapine|olanzapine|mesh-list
25731914|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
25731915|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
25731916|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731917|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731918|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731919|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25731920|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25731921|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731922|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25731923|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25731924|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25731925|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25731926|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731927|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731928|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
25731929|NCT02643355|Analgesics|analgesics|mesh-ancestor
25731930|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
25731931|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25731932|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
25731933|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25731934|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25731935|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25731936|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
25731937|NCT02643394|Acetaminophen|acetaminophen|mesh-list
25731938|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731939|NCT02643394|Analgesics|analgesics|mesh-ancestor
25731940|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
25731941|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731942|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731943|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
25731944|NCT02643615|Propofol|propofol|mesh-list
25731945|NCT02643615|Desflurane|desflurane|mesh-list
25731946|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25731947|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731948|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731949|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25731950|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
25731951|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
25731952|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25731953|NCT02643862|Omalizumab|omalizumab|mesh-list
25731954|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25731955|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25731956|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25731957|NCT02643979|Ketamine|ketamine|mesh-list
25731958|NCT02643979|Propofol|propofol|mesh-list
25731959|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25731960|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731961|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731962|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25731963|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
25731964|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
25731966|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
25731967|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731968|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25731969|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25731970|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25731971|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731972|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731973|NCT02645617|Imidacloprid|imidacloprid|mesh-list
25731974|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
25731975|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25731976|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731977|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731978|NCT02646124|Naproxen|naproxen|mesh-list
25731979|NCT02646124|Diazepam|diazepam|mesh-list
25416012|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25731980|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25731981|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25731982|NCT02646124|Analgesics|analgesics|mesh-ancestor
25731983|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
25731984|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25731985|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25731986|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25731987|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25731988|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
25731989|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25731990|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25731991|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25731992|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25731993|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
25731994|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
25731995|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
25731996|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25731997|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25731998|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25731999|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25732000|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25732001|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25732002|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25732003|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732004|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732005|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
25732006|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
25732007|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
25732008|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
25732009|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732010|NCT02646332|Amoxicillin|amoxicillin|mesh-list
25732011|NCT02646332|Metronidazole|metronidazole|mesh-list
25732012|NCT02646332|Clarithromycin|clarithromycin|mesh-list
25732013|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
25732014|NCT02646332|Lansoprazole|lansoprazole|mesh-list
25732015|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25732016|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732017|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25732018|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25732019|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25732020|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732021|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732022|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25732023|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25732024|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25732025|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732026|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25732027|NCT02646449|Mirtazapine|mirtazapine|mesh-list
25732028|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
25732029|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732030|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25732031|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
25732032|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
25732033|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732034|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732035|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732036|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25732037|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25732038|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296247|NCT01061515|Bevacizumab|bevacizumab|mesh-list
25732039|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25732040|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25732041|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25732042|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732043|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25732044|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25732045|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
25732046|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25732047|NCT02647203|Fluorides|fluorides|mesh-list
25732048|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
25732049|NCT02647203|Protective Agents|protective agents|mesh-ancestor
25732050|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732051|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25732052|NCT02647320|Firuglipel|firuglipel|mesh-list
25732053|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25732054|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732055|NCT02647320|Incretins|incretins|mesh-ancestor
25732056|NCT02647320|Hormones|hormones|mesh-ancestor
25732057|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732058|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25732059|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
25732060|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732061|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732062|NCT02647788|Acetaminophen|acetaminophen|mesh-list
25732063|NCT02647788|Ibuprofen|ibuprofen|mesh-list
25732064|NCT02647788|Codeine|codeine|mesh-list
25732065|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25732066|NCT02647788|Analgesics|analgesics|mesh-ancestor
25732067|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
25732068|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732069|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732070|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
25732071|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25732072|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25732073|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25732074|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25732075|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732076|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732077|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732078|NCT02647788|Narcotics|narcotics|mesh-ancestor
25732079|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732080|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
25732081|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
25732082|NCT02647866|KHK4083|khk4083|mesh-list
25732083|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
25732084|NCT02647944|Liraglutide|liraglutide|mesh-list
25732085|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25732086|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732087|NCT02647944|Incretins|incretins|mesh-ancestor
25732088|NCT02647944|Hormones|hormones|mesh-ancestor
25732089|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732090|NCT02648204|Dulaglutide|dulaglutide|mesh-list
25732091|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25732092|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732093|NCT02648217|Insulin|insulin|mesh-list
25732094|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25732095|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
25732096|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
25732097|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25732098|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
25732099|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25732100|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732101|NCT02649192|Vitamin D|vitamin d|mesh-list
25732102|NCT02649192|Vitamin A|vitamin a|mesh-list
25732103|NCT02649192|Vitamins|vitamins|mesh-ancestor
25732104|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
25732105|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732106|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25732107|NCT02649231|Ketamine|ketamine|mesh-list
25732108|NCT02649231|Analgesics|analgesics|mesh-ancestor
25732109|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
25732110|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732111|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732112|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25732113|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732114|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
25296315|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25732115|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
25732116|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732117|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25732118|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25732119|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732120|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732121|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
25732122|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25732123|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732124|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
25732125|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25732126|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25732127|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732128|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
25732129|NCT02650856|Coagulants|coagulants|mesh-ancestor
25732130|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
25732131|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732132|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732133|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
25732134|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
25732135|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
25732136|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25732137|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25732138|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732139|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732140|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732141|NCT02651155|Lubiprostone|lubiprostone|mesh-list
25732142|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25732143|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25732144|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732145|NCT02651220|Adapalene|adapalene|mesh-list
25732146|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25732147|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25732148|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
25732149|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25732150|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25732151|NCT02651220|Analgesics|analgesics|mesh-ancestor
25732152|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
25732153|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732154|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732155|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25732156|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25732157|NCT02651259|Vitamins|vitamins|mesh-list
25732158|NCT02651259|Pyridoxine|pyridoxine|mesh-list
25732159|NCT02651259|Pyridoxal|pyridoxal|mesh-list
25732160|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
25732161|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
25732162|NCT02651259|Isoniazid|isoniazid|mesh-list
25732163|NCT02651259|Rifapentine|rifapentine|mesh-list
25732164|NCT02651259|Rifamycins|rifamycins|mesh-list
25732165|NCT02651259|Hydrazine|hydrazine|mesh-list
25732166|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
25732167|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732168|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
25732169|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25732170|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732171|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25732172|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25732173|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
25732174|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732175|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25732176|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25732177|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
25732178|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732179|NCT02651272|Macitentan|macitentan|mesh-list
25732180|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25732181|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25732182|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732183|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25732184|NCT02651415|Perindopril|perindopril|mesh-list
25732185|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25732186|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
25732187|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732188|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732189|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25732190|NCT02651428|Taurolidine|taurolidine|mesh-list
25732191|NCT02651428|Heparin|heparin|mesh-list
25732192|NCT02651428|Calcium heparin|calcium heparin|mesh-list
25732193|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
25732194|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732195|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25732196|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25732197|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732198|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25732199|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732200|NCT02651584|Buprenorphine|buprenorphine|mesh-list
25732201|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732202|NCT02651584|Narcotics|narcotics|mesh-ancestor
25732203|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732204|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732205|NCT02651584|Analgesics|analgesics|mesh-ancestor
25732206|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
25732207|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732208|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25773003|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25773004|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25773005|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
25773006|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
25773007|NCT03945981|Lamivudine|lamivudine|mesh-list
25773008|NCT03945981|Dolutegravir|dolutegravir|mesh-list
25773009|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25773010|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25773011|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773012|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773013|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
25773014|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773015|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25773016|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25773017|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25773018|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25773019|NCT03954834|Tirzepatide|tirzepatide|mesh-list
25773020|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25773021|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773022|NCT03954834|Incretins|incretins|mesh-ancestor
25773023|NCT03954834|Hormones|hormones|mesh-ancestor
25773024|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773025|NCT03958071|Pirfenidone|pirfenidone|mesh-list
25773026|NCT03958071|Nintedanib|nintedanib|mesh-list
25773027|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773028|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25773029|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773030|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773031|NCT03958071|Analgesics|analgesics|mesh-ancestor
25773032|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
25773033|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773034|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773035|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773036|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773037|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773038|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773039|NCT03968159|Pimavanserin|pimavanserin|mesh-list
25773040|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25773041|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25773042|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25773043|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773044|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773045|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773046|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773047|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25773048|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25773049|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
25773050|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773051|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773052|NCT03970824|Adalimumab|adalimumab|mesh-list
25773053|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773054|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773055|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
25773056|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25773057|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25773058|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
25732209|NCT02651688|Enclomiphene|enclomiphene|mesh-list
25732210|NCT02651688|Clomiphene|clomiphene|mesh-list
25732211|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
25732212|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25732213|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
25732214|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732215|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732216|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25732217|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
25732218|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25732219|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25732220|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25732221|NCT02651987|Lanreotide|lanreotide|mesh-list
25732222|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732223|NCT02652156|Bupivacaine|bupivacaine|mesh-list
25732224|NCT02652156|Ropivacaine|ropivacaine|mesh-list
25732225|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732226|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
25732227|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732228|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732229|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
25732230|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732231|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
25732232|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25732233|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25732234|NCT02652390|Prednisolone|prednisolone|mesh-list
25732235|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
25732236|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25732237|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
25732238|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25732239|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
25732240|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
25732241|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732242|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732243|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732244|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
25732245|NCT02652390|Hormones|hormones|mesh-ancestor
25732246|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732247|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25732248|NCT02652390|Protective Agents|protective agents|mesh-ancestor
25732249|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25732250|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732251|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25732252|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
25732253|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732254|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25732255|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25732256|NCT02653144|Dexamethasone|dexamethasone|mesh-list
25732257|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
25732258|NCT02653144|Ropivacaine|ropivacaine|mesh-list
25732259|NCT02653144|Anesthetics|anesthetics|mesh-list
25732260|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25732261|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
25732262|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
25732263|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732264|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732265|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732266|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
25732267|NCT02653144|Hormones|hormones|mesh-ancestor
25732268|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732269|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25732270|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732271|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25732272|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732273|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25732274|NCT02653144|Analgesics|analgesics|mesh-ancestor
25732275|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
25732276|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25732277|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25732278|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25732279|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732280|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732281|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732282|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
25296545|NCT04425174|Anesthetics|anesthetics|mesh-list
25732283|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25732284|NCT02653183|Laxatives|laxatives|mesh-ancestor
25732285|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732286|NCT02653300|Insulin|insulin|mesh-list
25732287|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25732288|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732289|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25732290|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25732291|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
25732292|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
25732293|NCT02653560|Citric Acid|citric acid|mesh-list
25732294|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
25732295|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
25732296|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25732297|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
25732298|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
25732299|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732300|NCT02653560|Diuretics|diuretics|mesh-ancestor
25732301|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
25732302|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732303|NCT02653560|Expectorants|expectorants|mesh-ancestor
25732304|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
25732305|NCT02653560|Cathartics|cathartics|mesh-ancestor
25732306|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732307|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
25732308|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25732309|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732310|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25732311|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25732312|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
25732313|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732314|NCT02653872|Itraconazole|itraconazole|mesh-list
25732315|NCT02653872|Verapamil|verapamil|mesh-list
25732316|NCT02653872|Diltiazem|diltiazem|mesh-list
25732317|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
25732318|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732319|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25732320|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25732321|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732322|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732323|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25732324|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
25732325|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732326|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732327|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25732328|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25732329|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25732330|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25732331|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25732332|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
25732333|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25732334|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25732335|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25732336|NCT02654054|Norethindrone|norethindrone|mesh-list
25732337|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
25732338|NCT02654054|Estradiol|estradiol|mesh-list
25732339|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25732340|NCT02654054|Estrogens|estrogens|mesh-ancestor
25732341|NCT02654054|Hormones|hormones|mesh-ancestor
25732342|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732343|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732344|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25732345|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
25732346|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25732347|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25732348|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25732349|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25732350|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25732351|NCT02654145|Omalizumab|omalizumab|mesh-list
25732352|NCT02654145|Albuterol|albuterol|mesh-list
25732353|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25732354|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
25732355|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732356|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732357|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25732358|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
25732359|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
25732360|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25732361|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25732362|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25732363|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25732364|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732365|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732366|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732367|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25732368|NCT02654483|Serlopitant|serlopitant|mesh-list
25732369|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25732370|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732371|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732372|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732373|NCT02654860|Acetaminophen|acetaminophen|mesh-list
25732374|NCT02654860|Bupivacaine|bupivacaine|mesh-list
25732375|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732376|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
25732377|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732378|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732379|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
25732380|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732381|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25732382|NCT02654860|Analgesics|analgesics|mesh-ancestor
25732383|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
25732384|NCT02655224|Relugolix|relugolix|mesh-list
25732385|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
25732386|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
25732387|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732388|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732389|NCT02655237|Leuprolide|leuprolide|mesh-list
25732390|NCT02655237|Relugolix|relugolix|mesh-list
25732391|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25732392|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
25732393|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25732394|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732395|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25732396|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732397|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
25732398|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
25732399|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732400|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
25732401|NCT02655354|Promethazine|promethazine|mesh-list
25732402|NCT02655354|Prazosin|prazosin|mesh-list
25732403|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25732404|NCT02655354|Mirtazapine|mirtazapine|mesh-list
25732405|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
25732406|NCT02655354|Trazodone|trazodone|mesh-list
25732407|NCT02655354|Sertraline|sertraline|mesh-list
25732408|NCT02655354|Fluoxetine|fluoxetine|mesh-list
25732409|NCT02655354|Paroxetine|paroxetine|mesh-list
25732410|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25732411|NCT02655354|Citalopram|citalopram|mesh-list
25732412|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25732413|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25732414|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25732415|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732416|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732417|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732418|NCT02655354|Analgesics|analgesics|mesh-ancestor
25732419|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
25732420|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732421|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
25732422|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732423|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
25732424|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25732425|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
25732426|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25732427|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25732428|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25732429|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732430|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
25296726|NCT03717129|Cobicistat|cobicistat|mesh-list
25732431|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25732432|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25732433|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732434|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732435|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
25732436|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
25732437|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732438|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25732439|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
25732440|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
25732441|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25732442|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
25732443|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
25732444|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25732445|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25732446|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25732447|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25732448|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25732449|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732450|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25732451|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25732452|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25732453|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25732454|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25732455|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25732456|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25732457|NCT02655419|Metronidazole|metronidazole|mesh-list
25732458|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732459|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25732460|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25732461|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25732462|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
25732463|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
25732464|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25732465|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25732466|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732467|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
25732468|NCT02655653|Coagulants|coagulants|mesh-ancestor
25732469|NCT02655679|Ether|ether|mesh-list
25732470|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25732471|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
25732472|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
25732473|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732474|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732475|NCT02656069|Glucagon|glucagon|mesh-list
25732476|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25732477|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732478|NCT02656069|Hormones|hormones|mesh-ancestor
25732479|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732480|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732481|NCT02656069|Incretins|incretins|mesh-ancestor
25732482|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
25732483|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25732484|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25732485|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732486|NCT02656173|Tamsulosin|tamsulosin|mesh-list
25732487|NCT02656173|Mirabegron|mirabegron|mesh-list
25732488|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25732489|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25732490|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25732491|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732492|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732493|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732494|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732495|NCT02656173|Urological Agents|urological agents|mesh-ancestor
25732496|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25732497|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25732498|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25732499|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25732500|NCT02656329|Lugol's solution|lugol's solution|mesh-list
25732501|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732502|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732503|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732504|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25732505|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
25732506|NCT02656329|Coagulants|coagulants|mesh-ancestor
25732507|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
25732508|NCT02657031|Promethazine|promethazine|mesh-list
25732509|NCT02657031|Ketamine|ketamine|mesh-list
25732510|NCT02657031|Ondansetron|ondansetron|mesh-list
25732511|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
25732512|NCT02657031|Analgesics|analgesics|mesh-ancestor
25732513|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
25732514|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732515|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732516|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25732517|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732518|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
25732519|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
25732520|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732521|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25732522|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25732523|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732524|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732525|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
25732526|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
25732527|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732528|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
25732529|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
25732530|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25732531|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
25732532|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25732533|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25732534|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732535|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25732536|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25732537|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25732538|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732539|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25732540|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
25732541|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
25732542|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25732543|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25732544|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
25732545|NCT02657252|Polidocanol|polidocanol|mesh-list
25732546|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25732547|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25732548|NCT02657369|Lenvatinib|lenvatinib|mesh-list
25732549|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732550|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25732551|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732552|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732553|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
25732554|NCT02657889|Niraparib|niraparib|mesh-list
25732555|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732556|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732557|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25732558|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732559|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732560|NCT02657928|Letrozole|letrozole|mesh-list
25732561|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732562|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25732563|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25732564|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732565|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732566|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25732567|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
25732568|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732569|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732570|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
25732571|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732572|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732573|NCT02658084|Trastuzumab|trastuzumab|mesh-list
25732574|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25732575|NCT02658084|Vinorelbine|vinorelbine|mesh-list
25732576|NCT02658084|Maytansine|maytansine|mesh-list
25732577|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732578|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732579|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25732580|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
25732581|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
25732582|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
25732583|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732584|NCT02658149|Ketorolac|ketorolac|mesh-list
25732585|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25732587|NCT02658149|Morphine|morphine|mesh-list
25732588|NCT02658149|Ropivacaine|ropivacaine|mesh-list
25732589|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732590|NCT02658149|Narcotics|narcotics|mesh-ancestor
25732591|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732592|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732593|NCT02658149|Analgesics|analgesics|mesh-ancestor
25732594|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
25732595|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732596|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732597|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
25732598|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25732599|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25732600|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732601|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416013|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
25732602|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732603|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25732604|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25732605|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
25732606|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25732607|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25732608|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
25732609|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
25732610|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25732611|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25732612|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25732613|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25732614|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25732615|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25732616|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732617|NCT02658240|Epinephrine|epinephrine|mesh-list
25732618|NCT02658240|Ropivacaine|ropivacaine|mesh-list
25732619|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732620|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
25732621|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732622|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732623|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
25732624|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732625|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25732626|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25732627|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732628|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732629|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732630|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25732631|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25732632|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
25732633|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25732634|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
25732635|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
25732636|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
25732637|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25732638|NCT02658461|Trastuzumab|trastuzumab|mesh-list
25732639|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732640|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732641|NCT02658487|Cytarabine|cytarabine|mesh-list
25732642|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25732643|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
25732644|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732645|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732646|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
25732647|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732648|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25732649|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
25732650|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732651|NCT02658734|Trastuzumab|trastuzumab|mesh-list
25732652|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25732653|NCT02658734|Maytansine|maytansine|mesh-list
25732654|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732655|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732656|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25732657|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25732658|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25732659|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25732660|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732661|NCT02659501|Acetaminophen|acetaminophen|mesh-list
25732662|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25732664|NCT02659501|Diazepam|diazepam|mesh-list
25732665|NCT02659501|Morphine|morphine|mesh-list
25732666|NCT02659501|Hydrocodone|hydrocodone|mesh-list
25732667|NCT02659501|Bupivacaine|bupivacaine|mesh-list
25732668|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732669|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
25732670|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732671|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732672|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
25732673|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732674|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732675|NCT02659501|Narcotics|narcotics|mesh-ancestor
25732676|NCT02659501|Analgesics|analgesics|mesh-ancestor
25732677|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25732678|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
25732679|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25732680|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25732681|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
25732682|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732683|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732684|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25732685|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25732686|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
25732687|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25732688|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
25732689|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
25732690|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
25732691|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25732692|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
25732693|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25732694|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
25732695|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
25732696|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732697|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25732698|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25732699|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25732700|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25732701|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25732702|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732703|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732704|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
25732705|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
25732706|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
25732707|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25732708|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25732709|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25732710|NCT02659540|Nivolumab|nivolumab|mesh-list
25732711|NCT02659540|Ipilimumab|ipilimumab|mesh-list
25732712|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732713|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732714|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25732715|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732716|NCT02659787|Buprenorphine|buprenorphine|mesh-list
25732717|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732718|NCT02659787|Narcotics|narcotics|mesh-ancestor
25732719|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732720|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732721|NCT02659787|Analgesics|analgesics|mesh-ancestor
25732722|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
25732723|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732724|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25732725|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
25732726|NCT02659943|Fludarabine|fludarabine|mesh-list
25732727|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25732728|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
25732729|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732730|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25732731|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25732732|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
25732733|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732734|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732735|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25732736|NCT02660229|Morphine|morphine|mesh-list
25732737|NCT02660229|Oxycodone|oxycodone|mesh-list
25732738|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732739|NCT02660229|Narcotics|narcotics|mesh-ancestor
25732740|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732741|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732742|NCT02660229|Analgesics|analgesics|mesh-ancestor
25732743|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
25732744|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732745|NCT02660242|Glucagon|glucagon|mesh-list
25732746|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25732747|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732748|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732749|NCT02660242|Hormones|hormones|mesh-ancestor
25732750|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732751|NCT02660242|Incretins|incretins|mesh-ancestor
25732752|NCT02660580|Adalimumab|adalimumab|mesh-list
25732753|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25732754|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25732755|NCT02660918|Bupivacaine|bupivacaine|mesh-list
25732756|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732757|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
25732758|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732759|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732760|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
25732761|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732762|NCT02660983|Donepezil|donepezil|mesh-list
25732763|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25732764|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732765|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732766|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
25732767|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732768|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732769|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
25732770|NCT02661061|Midazolam|midazolam|mesh-list
25732771|NCT02661061|Ketamine|ketamine|mesh-list
25732772|NCT02661061|Analgesics|analgesics|mesh-ancestor
25732773|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
25732774|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732775|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732776|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25732777|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732778|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
25732779|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
25732780|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732781|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25732782|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25732783|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732784|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732785|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25732786|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25732787|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25732788|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25732789|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732790|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
25732791|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
25732792|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
25732793|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
25732794|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773059|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773060|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773061|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773062|NCT03979807|Bromides|bromides|mesh-list
25773063|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
25773064|NCT03979807|Olodaterol|olodaterol|mesh-list
25773065|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25773066|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
25773067|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773068|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773069|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25773070|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773071|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
25773072|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25773073|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773074|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773075|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773076|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
25773077|NCT03982069|Vaccines|vaccines|mesh-list
25773078|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
25773079|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732795|NCT02661178|Emodepside|emodepside|mesh-list
25732796|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25732797|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732798|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25732799|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25732800|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732801|NCT02661490|Vaccines|vaccines|mesh-list
25732802|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
25732803|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732804|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
25732805|NCT02661594|Amisulpride|amisulpride|mesh-list
25732806|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25732807|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732808|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25732809|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25732810|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732811|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732812|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732813|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732814|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25732815|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25732816|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732817|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732818|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25732819|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
25732820|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732821|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25732822|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
25732823|NCT02661815|Paclitaxel|paclitaxel|mesh-list
25732824|NCT02661815|Bevacizumab|bevacizumab|mesh-list
25732825|NCT02661815|Ricolinostat|ricolinostat|mesh-list
25732826|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25732827|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732828|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
25732829|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
25732830|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25732831|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732832|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732833|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25732834|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25732835|NCT02661815|Growth Substances|growth substances|mesh-ancestor
25732836|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732837|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25732838|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25732839|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732840|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
25732841|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25732842|NCT02662036|Bupivacaine|bupivacaine|mesh-list
25732843|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732844|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
25732845|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732846|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732847|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
25732848|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732849|NCT02662556|Sufentanil|sufentanil|mesh-list
25732850|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732851|NCT02662556|Narcotics|narcotics|mesh-ancestor
25732852|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732853|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732854|NCT02662556|Analgesics|analgesics|mesh-ancestor
25732855|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
25732856|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732857|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25732858|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732859|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
25732860|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
25732861|NCT02662569|Atorvastatin|atorvastatin|mesh-list
25732862|NCT02662569|Evolocumab|evolocumab|mesh-list
25732863|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25732864|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25732865|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
25732866|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732867|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25732868|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25732869|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732870|NCT02662764|Sufentanil|sufentanil|mesh-list
25732871|NCT02662764|Dsuvia|dsuvia|mesh-list
25732872|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732873|NCT02662764|Narcotics|narcotics|mesh-ancestor
25732874|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732875|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732876|NCT02662764|Analgesics|analgesics|mesh-ancestor
25732877|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
25732878|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732879|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25732880|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732881|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
25732882|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
25732883|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25732884|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25732885|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25732886|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25732887|NCT02663674|Fluconazole|fluconazole|mesh-list
25732888|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
25732889|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732890|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25732891|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25732892|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732893|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732894|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25732895|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
25732896|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25732897|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732898|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25732899|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25732900|NCT02663687|Complement C1s|complement c1s|mesh-list
25732901|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25732902|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25732903|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
25732904|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732905|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25732906|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25732907|NCT02663895|Treprostinil|treprostinil|mesh-list
25732908|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25732909|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
25732910|NCT02664220|Povidone|povidone|mesh-list
25732911|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
25732912|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
25732913|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25732914|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25732915|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
25732916|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25732917|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25732918|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732919|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
25732920|NCT02664909|Coagulants|coagulants|mesh-ancestor
25732921|NCT02664922|Ketamine|ketamine|mesh-list
25732922|NCT02664922|Remifentanil|remifentanil|mesh-list
25732923|NCT02664922|Propofol|propofol|mesh-list
25732924|NCT02664922|Sevoflurane|sevoflurane|mesh-list
25732925|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25732926|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732927|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732928|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25732929|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
25732930|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
25732931|NCT02664922|Analgesics|analgesics|mesh-ancestor
25732932|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
25732933|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732934|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25732935|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25732936|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25732937|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732938|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732939|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25732940|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25732941|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25732942|NCT02664922|Narcotics|narcotics|mesh-ancestor
25732943|NCT02664961|Bevacizumab|bevacizumab|mesh-list
25732944|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25732945|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732946|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25732947|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25732948|NCT02664961|Growth Substances|growth substances|mesh-ancestor
25732949|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732950|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
25732951|NCT02665260|Cantharidin|cantharidin|mesh-list
25732952|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732953|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732954|NCT02665273|Bupivacaine|bupivacaine|mesh-list
25732955|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
25732956|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
25732957|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25732958|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732959|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
25732960|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732961|NCT02665286|Naproxen|naproxen|mesh-list
25732962|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25732963|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25732964|NCT02665286|Orphenadrine|orphenadrine|mesh-list
25732965|NCT02665286|Methocarbamol|methocarbamol|mesh-list
25732966|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25732967|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25732968|NCT02665286|Analgesics|analgesics|mesh-ancestor
25732969|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
25732970|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25732971|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732972|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25732973|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
25732974|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25732975|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25732976|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25732977|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
25732978|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25732979|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25732980|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25732981|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25732982|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25732983|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
25732984|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
25732985|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25732986|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25732987|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25732988|NCT02665689|Ranibizumab|ranibizumab|mesh-list
25732989|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25732990|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25732991|NCT02665689|Growth Substances|growth substances|mesh-ancestor
25732992|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25732993|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
25732994|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25732995|NCT02665728|Laxatives|laxatives|mesh-list
25732996|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25732997|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
25732998|NCT02666352|Ruzasvir|ruzasvir|mesh-list
25732999|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
25733000|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733001|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25733002|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25733003|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
25733004|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733005|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25733006|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733007|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733008|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733009|NCT02666846|Ibuprofen|ibuprofen|mesh-list
25733010|NCT02666846|Diclofenac|diclofenac|mesh-list
25733011|NCT02666846|Salicylates|salicylates|mesh-list
25733012|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
25733013|NCT02666846|Menthol|menthol|mesh-list
25733014|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25733015|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733016|NCT02666846|Analgesics|analgesics|mesh-ancestor
25733017|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
25733018|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733019|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733020|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733021|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733022|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25733023|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733024|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733025|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
25733026|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
25733027|NCT02666950|Cytarabine|cytarabine|mesh-list
25733028|NCT02666950|Adavosertib|adavosertib|mesh-list
25733029|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25733030|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
25733031|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733032|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733033|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
25733034|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733035|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25733036|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
25733037|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733038|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733039|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25733040|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25733041|NCT02667704|Nintedanib|nintedanib|mesh-list
25733042|NCT02667704|Bosentan|bosentan|mesh-list
25733043|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733044|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25733045|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733046|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733047|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25733048|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25733049|NCT02668393|Docetaxel|docetaxel|mesh-list
25733050|NCT02668393|Nintedanib|nintedanib|mesh-list
25733051|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733052|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
25733053|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
25733054|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
25733055|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733056|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25733057|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733058|NCT02668432|Amiodarone|amiodarone|mesh-list
25733059|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25733060|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
25733061|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25733062|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25733063|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733064|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25733065|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25733066|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25733067|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733068|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25733069|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25733070|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25733071|NCT02668640|Adalimumab|adalimumab|mesh-list
25733072|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733073|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733074|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25733075|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25733076|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733077|NCT02669043|Ketamine|ketamine|mesh-list
25733078|NCT02669043|Analgesics|analgesics|mesh-ancestor
25733079|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
25297628|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
25297629|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25297630|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25297631|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297632|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297633|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25297634|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25297635|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297636|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297638|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
25297639|NCT03225547|Mifepristone|mifepristone|mesh-list
25297640|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25297641|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297642|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25297643|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
25733080|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733081|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733082|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25733083|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733084|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
25733085|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
25733086|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733087|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25733088|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25733089|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733090|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733091|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25733092|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25733093|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733094|NCT02669407|Lidocaine|lidocaine|mesh-list
25733095|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
25733096|NCT02669407|Anesthetics|anesthetics|mesh-list
25733097|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733098|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733099|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
25733100|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733101|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25733102|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25733103|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25733104|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25733105|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733106|NCT02669615|Melphalan|melphalan|mesh-list
25733107|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25733108|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
25733109|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733110|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733111|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25733112|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25733113|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
25733114|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733115|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25733116|NCT02669914|Durvalumab|durvalumab|mesh-list
25733117|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25733118|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733119|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
25733120|NCT02670343|Testosterone|testosterone|mesh-list
25733121|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
25733122|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
25733123|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25733124|NCT02670343|Androgens|androgens|mesh-ancestor
25733125|NCT02670343|Hormones|hormones|mesh-ancestor
25733126|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733127|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733128|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25733129|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733130|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
25733131|NCT02670538|Cariprazine|cariprazine|mesh-list
25733132|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25733133|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25733134|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733135|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733136|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25733137|NCT02670551|Cariprazine|cariprazine|mesh-list
25733138|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25733139|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25733140|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733141|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733142|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773080|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
25773081|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
25773082|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773083|NCT04011592|Ketamine|ketamine|mesh-list
25773084|NCT04011592|Analgesics|analgesics|mesh-ancestor
25773085|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
25773086|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773087|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773088|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25773089|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733143|NCT02670915|Insulin|insulin|mesh-list
25733144|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25733145|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
25733146|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
25733147|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25733148|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733149|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733150|NCT02671266|Oxytocin|oxytocin|mesh-list
25733151|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
25733152|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25733153|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733154|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
25733155|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25733156|NCT02671500|Velpatasvir|velpatasvir|mesh-list
25733157|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
25733158|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733159|NCT02672111|Buprenorphine|buprenorphine|mesh-list
25733160|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733161|NCT02672111|Narcotics|narcotics|mesh-ancestor
25733162|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733163|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733164|NCT02672111|Analgesics|analgesics|mesh-ancestor
25733165|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
25733166|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733167|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25733168|NCT02673138|Canagliflozin|canagliflozin|mesh-list
25733169|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25733170|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733171|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733172|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733173|NCT02673372|Ketamine|ketamine|mesh-list
25733174|NCT02673372|Morphine|morphine|mesh-list
25733175|NCT02673372|Analgesics|analgesics|mesh-ancestor
25733176|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
25733177|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733178|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733179|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25733180|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733181|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
25733182|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
25733183|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733184|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25733185|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25733186|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733187|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733188|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733189|NCT02673372|Narcotics|narcotics|mesh-ancestor
25733191|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
25733192|NCT02674399|Protective Agents|protective agents|mesh-ancestor
25733193|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733194|NCT02674412|Buspirone|buspirone|mesh-list
25733195|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25733196|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25733197|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733198|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733199|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25733200|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25733201|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
25733202|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733203|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733204|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25733205|NCT02674854|Latanoprost|latanoprost|mesh-list
25733206|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25733207|NCT02675907|Meloxicam|meloxicam|mesh-list
25733208|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25733209|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733210|NCT02675907|Analgesics|analgesics|mesh-ancestor
25733211|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
25733212|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733213|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733214|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733215|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733216|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25733217|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25733218|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733219|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733220|NCT02676375|Bupropion|bupropion|mesh-list
25733221|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25733222|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
25733223|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25733224|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25733225|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25733226|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25733227|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733228|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
25733229|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733230|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733231|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25733232|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25733233|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733234|NCT02676466|Losartan|losartan|mesh-list
25733235|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25733236|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25733237|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25733238|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25733239|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733240|NCT02676895|Vaccines|vaccines|mesh-list
25733241|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
25733242|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733243|NCT02677116|Doxorubicin|doxorubicin|mesh-list
25733244|NCT02677116|Irinotecan|irinotecan|mesh-list
25733245|NCT02677116|Vincristine|vincristine|mesh-list
25733246|NCT02677116|Ifosfamide|ifosfamide|mesh-list
25733247|NCT02677116|Olaratumab|olaratumab|mesh-list
25733248|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25733249|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733250|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25733251|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25733252|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733253|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733254|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25733255|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25733256|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
25733257|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
25733258|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
25733259|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25733260|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
25733261|NCT02677493|Vaccines|vaccines|mesh-list
25733262|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
25733263|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733264|NCT02677623|Mannitol|mannitol|mesh-list
25733265|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25733266|NCT02677623|Diuretics|diuretics|mesh-ancestor
25733267|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
25733268|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733269|NCT02677701|Azithromycin|azithromycin|mesh-list
25733270|NCT02677701|Tobramycin|tobramycin|mesh-list
25733271|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25733272|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733273|NCT02677844|Loperamide|loperamide|mesh-list
25733274|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
25733275|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25733276|NCT02678286|Meloxicam|meloxicam|mesh-list
25733277|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25733278|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733279|NCT02678286|Analgesics|analgesics|mesh-ancestor
25733280|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
25733281|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733282|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733283|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733284|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733285|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25733286|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25733287|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733288|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733289|NCT02678416|Acetaminophen|acetaminophen|mesh-list
25733290|NCT02678416|Morphine|morphine|mesh-list
25733291|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733292|NCT02678416|Narcotics|narcotics|mesh-ancestor
25733293|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773090|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
25733294|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733295|NCT02678416|Analgesics|analgesics|mesh-ancestor
25733296|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
25733297|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733298|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733299|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
25733300|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
25733301|NCT02679274|Testosterone|testosterone|mesh-list
25733302|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
25733303|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
25733304|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25733305|NCT02679274|Androgens|androgens|mesh-ancestor
25733306|NCT02679274|Hormones|hormones|mesh-ancestor
25733307|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733308|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733309|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25733310|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733311|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
25733312|NCT02679469|Nalmefene|nalmefene|mesh-list
25733313|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25733314|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733315|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
25733316|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733317|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
25733318|NCT02679573|Linezolid|linezolid|mesh-list
25733319|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25733320|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733321|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25733322|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25733323|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733324|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733325|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733326|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25733327|NCT02679911|Amorolfine|amorolfine|mesh-list
25733328|NCT02679911|Ciclopirox|ciclopirox|mesh-list
25733329|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
25733330|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733331|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25733332|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25733333|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
25733334|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733335|NCT02680054|Insulin|insulin|mesh-list
25733336|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
25733337|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733338|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733339|NCT02680301|Triamcinolone|triamcinolone|mesh-list
25733340|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25733341|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25733342|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25733343|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733344|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
25733345|NCT02680301|Hormones|hormones|mesh-ancestor
25733346|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733347|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733348|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25733349|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
25733350|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733351|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733352|NCT02680457|Insulin|insulin|mesh-list
25733353|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25733354|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
25733355|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733356|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733357|NCT02680756|Ferric maltol|ferric maltol|mesh-list
25733358|NCT02680756|Hematinics|hematinics|mesh-ancestor
25733359|NCT02680847|Naltrexone|naltrexone|mesh-list
25733360|NCT02680847|Oxycodone|oxycodone|mesh-list
25733361|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733362|NCT02680847|Narcotics|narcotics|mesh-ancestor
25733363|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733364|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733365|NCT02680847|Analgesics|analgesics|mesh-ancestor
25733366|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
25733367|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297971|NCT05111717|Desflurane|desflurane|mesh-list
25733368|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25733369|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25733370|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
25733371|NCT02681094|Saxagliptin|saxagliptin|mesh-list
25733372|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25733373|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733374|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733375|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733376|NCT02681094|Incretins|incretins|mesh-ancestor
25733377|NCT02681094|Hormones|hormones|mesh-ancestor
25733378|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733379|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25733380|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
25733381|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733382|NCT02681510|Nicotine|nicotine|mesh-list
25733383|NCT02681510|Varenicline|varenicline|mesh-list
25733384|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25733385|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
25733386|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733387|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733388|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25733389|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25733390|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
25733391|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733392|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733393|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25733394|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733395|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
25733396|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25733397|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25733398|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773091|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
25773092|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773093|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25773094|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25773095|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773096|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773097|NCT04032327|Bupivacaine|bupivacaine|mesh-list
25773098|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
25773099|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
25773100|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773101|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773102|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
25773103|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773104|NCT04036292|Varenicline|varenicline|mesh-list
25773105|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25773106|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25773107|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773108|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773109|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773110|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773111|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
25773112|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25773113|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773114|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25773115|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25773116|NCT04052204|Avelumab|avelumab|mesh-list
25773117|NCT04052204|Talazoparib|talazoparib|mesh-list
25773118|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25773119|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773120|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25773121|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773122|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773123|NCT04067011|Doxycycline|doxycycline|mesh-list
25773124|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
25773125|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25773126|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773127|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
25773128|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773129|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773130|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25773131|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25773132|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773133|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773134|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773135|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25773136|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25733399|NCT02682381|Teduglutide|teduglutide|mesh-list
25733400|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25733401|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25733402|NCT02682381|Protective Agents|protective agents|mesh-ancestor
25733403|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733404|NCT02682498|Bupivacaine|bupivacaine|mesh-list
25733405|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
25733406|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
25733407|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733408|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733409|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
25733410|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733411|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
25733412|NCT02682563|Gliclazide|gliclazide|mesh-list
25733413|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25733414|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733415|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733416|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733417|NCT02682602|Tacrine|tacrine|mesh-list
25733418|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25733419|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733420|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733421|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
25733422|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733423|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733424|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25733425|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
25733426|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733427|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
25733428|NCT02682784|Oxytocin|oxytocin|mesh-list
25733429|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
25733430|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25733431|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733432|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
25733433|NCT02683109|Olodaterol|olodaterol|mesh-list
25733434|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25733435|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
25733436|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733437|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733438|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25733439|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
25733440|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
25733441|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25733442|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
25733443|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733444|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733445|NCT02683161|Varenicline|varenicline|mesh-list
25733446|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25733447|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25733448|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25733449|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733450|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733451|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733452|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25733453|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733454|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733455|NCT02683187|Incretins|incretins|mesh-ancestor
25733456|NCT02683187|Hormones|hormones|mesh-ancestor
25733457|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733458|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25733459|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
25733460|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733461|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733462|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25733463|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733464|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733465|NCT02683525|Incretins|incretins|mesh-ancestor
25733466|NCT02683525|Hormones|hormones|mesh-ancestor
25733467|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733468|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25733469|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
25733470|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733471|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298233|NCT04987099|Choline|choline|mesh-list
25733472|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
25733473|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25733474|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
25733475|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733476|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733477|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25733478|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
25733479|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
25733480|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25733481|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
25733482|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733483|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733484|NCT02683707|Lidocaine|lidocaine|mesh-list
25733485|NCT02683707|Fentanyl|fentanyl|mesh-list
25733486|NCT02683707|Midazolam|midazolam|mesh-list
25733487|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
25733488|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
25733489|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733490|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733491|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
25733492|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733493|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25733494|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25733495|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25733496|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25733497|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733498|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733499|NCT02683707|Narcotics|narcotics|mesh-ancestor
25733500|NCT02683707|Analgesics|analgesics|mesh-ancestor
25733501|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25733502|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733503|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
25733504|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25733505|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25733506|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25733507|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25733508|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
25733509|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
25733510|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733511|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
25733512|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25733513|NCT02683746|Incretins|incretins|mesh-ancestor
25733514|NCT02683746|Hormones|hormones|mesh-ancestor
25733515|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733516|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733517|NCT02683941|Lanreotide|lanreotide|mesh-list
25733518|NCT02683941|Somatostatin|somatostatin|mesh-list
25733519|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733520|NCT02683941|Hormones|hormones|mesh-ancestor
25733521|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733522|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733523|NCT02684136|Suvorexant|suvorexant|mesh-list
25733524|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25733525|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25733526|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733527|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733528|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25733529|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733530|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733531|NCT02684344|Tamsulosin|tamsulosin|mesh-list
25733532|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25733533|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25733534|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25733535|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
25733536|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733537|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733538|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733539|NCT02684344|Urological Agents|urological agents|mesh-ancestor
25733540|NCT02684357|Ustekinumab|ustekinumab|mesh-list
25733541|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25733542|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
25733543|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
25733544|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733545|NCT02684370|Ustekinumab|ustekinumab|mesh-list
25733546|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25733547|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
25733548|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
25733549|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733550|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
25733551|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25733552|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733553|NCT02684942|Fentanyl|fentanyl|mesh-list
25733554|NCT02684942|Meperidine|meperidine|mesh-list
25733555|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733556|NCT02684942|Narcotics|narcotics|mesh-ancestor
25733557|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733558|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733559|NCT02684942|Analgesics|analgesics|mesh-ancestor
25733560|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
25733561|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733562|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25733563|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733564|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
25733565|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
25733566|NCT02685033|Dalbavancin|dalbavancin|mesh-list
25733567|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25733568|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733569|NCT02685072|Progesterone|progesterone|mesh-list
25733570|NCT02685072|Progestins|progestins|mesh-ancestor
25733571|NCT02685072|Hormones|hormones|mesh-ancestor
25733572|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733573|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733574|NCT02685267|Prednisone|prednisone|mesh-list
25733575|NCT02685267|Docetaxel|docetaxel|mesh-list
25733576|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733577|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
25733578|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
25733579|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
25733580|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733581|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733582|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
25733583|NCT02685267|Hormones|hormones|mesh-ancestor
25733584|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733585|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733586|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25733587|NCT02685436|Domperidone|domperidone|mesh-list
25733588|NCT02685436|Omeprazole|omeprazole|mesh-list
25733589|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25733590|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25733591|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25733592|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733593|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733594|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
25733595|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
25733596|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733597|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733598|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25733599|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
25733600|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733601|NCT02686164|Lenvatinib|lenvatinib|mesh-list
25733602|NCT02686164|Midazolam|midazolam|mesh-list
25733603|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25733604|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25733605|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733606|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733607|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25733608|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25733609|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25733610|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733611|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
25733612|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
25733613|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
25733614|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
25733615|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733616|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733617|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733618|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25733619|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733620|NCT02687451|Oxymorphone|oxymorphone|mesh-list
25733621|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733622|NCT02687451|Narcotics|narcotics|mesh-ancestor
25733623|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733624|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733625|NCT02687451|Analgesics|analgesics|mesh-ancestor
25733626|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
25733627|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733628|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25733629|NCT02687815|Vitamin D|vitamin d|mesh-list
25733630|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
25733631|NCT02687815|Vitamins|vitamins|mesh-ancestor
25733632|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
25733633|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733634|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25733635|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25733636|NCT02688387|Ambrisentan|ambrisentan|mesh-list
25733637|NCT02688387|Tadalafil|tadalafil|mesh-list
25733638|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
25733639|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25733640|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25733641|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733642|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733643|NCT02688387|Urological Agents|urological agents|mesh-ancestor
25733644|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25733645|NCT02688764|Calcium|calcium|mesh-list
25733646|NCT02688764|Calcium acetate|calcium acetate|mesh-list
25733647|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25733648|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733649|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
25733650|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
25733651|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733652|NCT02688829|Sirolimus|sirolimus|mesh-list
25733653|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25733654|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733655|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25733656|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733657|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
25733658|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25733659|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
25733660|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733661|NCT02688842|Sirolimus|sirolimus|mesh-list
25733662|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25733663|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733664|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25733665|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733666|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
25733667|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25733668|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
25733669|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733670|NCT02689063|Acetaminophen|acetaminophen|mesh-list
25733671|NCT02689063|Ibuprofen|ibuprofen|mesh-list
25733672|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733673|NCT02689063|Analgesics|analgesics|mesh-ancestor
25733674|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
25733675|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733676|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733677|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
25733678|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25733679|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733680|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733681|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25733682|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733683|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733684|NCT02689206|Glycine|glycine|mesh-list
25733685|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
25733686|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733687|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733688|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733689|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25733690|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25733691|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733692|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
25733693|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
25733694|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
25733695|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
25733696|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25733697|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733698|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25733699|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25298509|NCT03952143|Insulin|insulin|mesh-list
25733700|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25733701|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25733703|NCT02690558|Cisplatin|cisplatin|mesh-list
25733704|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
25733705|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733706|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25733707|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
25733708|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733709|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
25733710|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733711|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733712|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25733713|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
25733714|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733715|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25733716|NCT02690714|Plasminogen|plasminogen|mesh-list
25733717|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25733718|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25733719|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733720|NCT02690727|Tenalisib|tenalisib|mesh-list
25733721|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
25733722|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733723|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733724|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
25733725|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25733726|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733727|NCT02690974|Valsartan|valsartan|mesh-list
25733728|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25733729|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25733730|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25733731|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25733732|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733733|NCT02691416|Propofol|propofol|mesh-list
25733734|NCT02691416|Sevoflurane|sevoflurane|mesh-list
25733735|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25733736|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733737|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733738|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733739|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
25733740|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
25733741|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25733742|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25773137|NCT04085341|Sunitinib|sunitinib|mesh-list
25773138|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773139|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25773140|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25773141|NCT04085341|Growth Substances|growth substances|mesh-ancestor
25773142|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773143|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
25773144|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25773145|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773146|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773147|NCT04094870|Sertraline|sertraline|mesh-list
25773148|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
25773149|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773150|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25773151|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25773152|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773153|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773154|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773155|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
25773156|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773157|NCT04103515|Cimetidine|cimetidine|mesh-list
25773158|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25773159|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773160|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25773161|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
25773162|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
25773163|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773164|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773165|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298610|NCT03679780|BQ 788|bq 788|mesh-list
25733743|NCT02691468|Silicon|silicon|mesh-list
25733744|NCT02691468|Trace Elements|trace elements|mesh-ancestor
25733745|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
25733746|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733747|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25733748|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25733749|NCT02691494|Norethindrone|norethindrone|mesh-list
25733750|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
25733751|NCT02691494|Estradiol|estradiol|mesh-list
25733752|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25733753|NCT02691494|Estrogens|estrogens|mesh-ancestor
25733754|NCT02691494|Hormones|hormones|mesh-ancestor
25733755|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733756|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733757|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25733758|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
25733759|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25733760|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25733761|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25733762|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25733763|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25733764|NCT02691507|Decanoic acid|decanoic acid|mesh-list
25733765|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
25733766|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733767|NCT02691572|Acetaminophen|acetaminophen|mesh-list
25733768|NCT02691572|Ketorolac|ketorolac|mesh-list
25733769|NCT02691572|Fentanyl|fentanyl|mesh-list
25733770|NCT02691572|Bupivacaine|bupivacaine|mesh-list
25733771|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
25733772|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
25733773|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733774|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733775|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
25733776|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733777|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733778|NCT02691572|Narcotics|narcotics|mesh-ancestor
25733779|NCT02691572|Analgesics|analgesics|mesh-ancestor
25733780|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25733781|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733782|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
25733783|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733784|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
25733785|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25733786|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733787|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733788|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25733789|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733790|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733791|NCT02691702|Melatonin|melatonin|mesh-list
25733792|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
25733793|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733794|NCT02691702|Protective Agents|protective agents|mesh-ancestor
25733795|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733796|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733797|NCT02691936|Estrogens|estrogens|mesh-list
25733798|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25733799|NCT02691936|Hormones|hormones|mesh-ancestor
25733800|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733801|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733802|NCT02692391|Indomethacin|indomethacin|mesh-list
25733803|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25733804|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733805|NCT02692391|Analgesics|analgesics|mesh-ancestor
25733806|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
25733807|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733808|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733809|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733810|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733811|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
25733812|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
25733813|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25733814|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25733815|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733816|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733817|NCT02692755|Letrozole|letrozole|mesh-list
25733818|NCT02692755|Fulvestrant|fulvestrant|mesh-list
25733819|NCT02692755|Palbociclib|palbociclib|mesh-list
25733820|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733822|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25733823|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733824|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733825|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25733826|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25733827|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733828|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733829|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25733830|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25733831|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25733832|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25733833|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25733834|NCT02694328|Olanzapine|olanzapine|mesh-list
25733835|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
25733836|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
25733837|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733838|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733839|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25733840|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25733841|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25733842|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733843|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25733844|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25733845|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25733846|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25733847|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733848|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733849|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
25733850|NCT02694523|Adalimumab|adalimumab|mesh-list
25733851|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25733852|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733853|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733854|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
25733855|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733856|NCT02694536|Gemcitabine|gemcitabine|mesh-list
25733857|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25733858|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25733859|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
25733860|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733861|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733862|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
25733863|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733864|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733865|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25733866|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
25733867|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733868|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25733869|NCT02694601|Caffeine|caffeine|mesh-list
25733870|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25733871|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733872|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25733873|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733874|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733875|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25733876|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25733877|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
25733878|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733879|NCT02694718|Capecitabine|capecitabine|mesh-list
25733880|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
25733881|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25733882|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
25733883|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733884|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733885|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25733886|NCT02694978|Hematinics|hematinics|mesh-ancestor
25733887|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25733888|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25733889|NCT02695290|Afatinib|afatinib|mesh-list
25733890|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733891|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25733892|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733893|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733894|NCT02695446|Minocycline|minocycline|mesh-list
25733895|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25733896|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733897|NCT02695537|Cannabidiol|cannabidiol|mesh-list
25733898|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
25733899|NCT02695628|Misonidazole|misonidazole|mesh-list
25733900|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733901|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25733902|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25733903|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25733904|NCT02695719|Lubiprostone|lubiprostone|mesh-list
25733905|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25733906|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25733907|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733908|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25733909|NCT02696434|Naltrexone|naltrexone|mesh-list
25733910|NCT02696434|Buprenorphine|buprenorphine|mesh-list
25733911|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25733912|NCT02696434|Narcotics|narcotics|mesh-ancestor
25733913|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733914|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733915|NCT02696434|Analgesics|analgesics|mesh-ancestor
25733916|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
25733917|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733918|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25733919|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25733920|NCT02696785|Adalimumab|adalimumab|mesh-list
25733921|NCT02696785|Ixekizumab|ixekizumab|mesh-list
25733922|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733923|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733924|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25733925|NCT02696798|Ixekizumab|ixekizumab|mesh-list
25733926|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25733927|NCT02696850|Budesonide|budesonide|mesh-list
25733928|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733929|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25733930|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
25733931|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733932|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733933|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25733934|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
25733935|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
25733936|NCT02696850|Hormones|hormones|mesh-ancestor
25733937|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733938|NCT02697071|Ketamine|ketamine|mesh-list
25733939|NCT02697071|Analgesics|analgesics|mesh-ancestor
25733940|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
25733941|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733942|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733943|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25733944|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25733945|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
25733946|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
25733947|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25733948|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25733949|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25733950|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25733951|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733952|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
25733953|NCT02697188|Testosterone|testosterone|mesh-list
25733954|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
25733955|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
25733956|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25733957|NCT02697188|Androgens|androgens|mesh-ancestor
25733958|NCT02697188|Hormones|hormones|mesh-ancestor
25733959|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25733960|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733961|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25733962|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25733963|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
25733964|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
25733965|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25733966|NCT02697292|Antibodies|antibodies|mesh-list
25733967|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
25298873|NCT02737046|Zidovudine|zidovudine|mesh-list
25733968|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25733969|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
25733970|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733971|NCT02697617|Pioglitazone|pioglitazone|mesh-list
25733972|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25733973|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733974|NCT02697773|Tanezumab|tanezumab|mesh-list
25733975|NCT02697773|Analgesics|analgesics|mesh-ancestor
25733976|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
25733977|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733978|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733979|NCT02697916|Aspirin|aspirin|mesh-list
25733980|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25733981|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25733982|NCT02697916|Analgesics|analgesics|mesh-ancestor
25733983|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
25733984|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25733985|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25733986|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25733987|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25733988|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25733989|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25733990|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25733991|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25733992|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25733993|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25733994|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
25733995|NCT02698215|Naltrexone|naltrexone|mesh-list
25733996|NCT02698215|Varenicline|varenicline|mesh-list
25733997|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25733998|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25733999|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734000|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
25734001|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734002|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25734003|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25734004|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
25734005|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734006|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734007|NCT02698410|Temozolomide|temozolomide|mesh-list
25734008|NCT02698410|Lanreotide|lanreotide|mesh-list
25734009|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25734010|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
25734011|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734012|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734013|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25734014|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
25734015|NCT02698475|Ustekinumab|ustekinumab|mesh-list
25734016|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25734017|NCT02698566|Ranibizumab|ranibizumab|mesh-list
25734018|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25734019|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25734020|NCT02698566|Growth Substances|growth substances|mesh-ancestor
25734021|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734022|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
25734023|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734024|NCT02698735|Gentamicins|gentamicins|mesh-list
25734025|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25734026|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734027|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25734028|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734029|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734030|NCT02699099|Vitamin A|vitamin a|mesh-list
25734031|NCT02699099|Vaccines|vaccines|mesh-list
25734032|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
25734033|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734034|NCT02699099|Vitamins|vitamins|mesh-ancestor
25734035|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
25734036|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25734037|NCT02699125|Guanfacine|guanfacine|mesh-list
25734038|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25734039|NCT02699125|Diuretics|diuretics|mesh-ancestor
25734040|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
25734041|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734042|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25734043|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734044|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734045|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25734046|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25734047|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25734048|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
25734049|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734050|NCT02699450|Ranibizumab|ranibizumab|mesh-list
25734051|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25734052|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25734053|NCT02699450|Growth Substances|growth substances|mesh-ancestor
25734054|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734055|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
25734056|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734057|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25734058|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25734059|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25734060|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734062|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734063|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734064|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
25734065|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734066|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25734067|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
25734068|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25734069|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734070|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734071|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773166|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25773167|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25773168|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773169|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
25773170|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25773171|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
25773172|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773173|NCT04123405|Expectorants|expectorants|mesh-ancestor
25773174|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773175|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25773176|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
25773177|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773178|NCT04123405|Protective Agents|protective agents|mesh-ancestor
25773179|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773180|NCT04123405|Antidotes|antidotes|mesh-ancestor
25773181|NCT04138758|Bromides|bromides|mesh-list
25773182|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
25773183|NCT04138758|Olodaterol|olodaterol|mesh-list
25773184|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25773185|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
25773186|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773187|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773188|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25773189|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773190|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
25773191|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25773192|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773193|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773194|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773195|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
25773196|NCT04147715|Dolutegravir|dolutegravir|mesh-list
25773197|NCT04147715|Midazolam|midazolam|mesh-list
25773198|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25773199|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25773200|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773201|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773202|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25773203|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773204|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773205|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25773206|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
25773207|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
25773208|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
25773209|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
25773210|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773211|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773212|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25773213|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25773214|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773215|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25734073|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
25734074|NCT02700815|Diclofenac|diclofenac|mesh-list
25734075|NCT02700815|Capsaicin|capsaicin|mesh-list
25734076|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25734077|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25734078|NCT02700815|Analgesics|analgesics|mesh-ancestor
25734079|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
25734080|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734081|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734082|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25734083|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25734084|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25734085|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734086|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734087|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
25734088|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25734089|NCT02701062|Warfarin|warfarin|mesh-list
25734090|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
25734091|NCT02701062|Dabigatran|dabigatran|mesh-list
25734092|NCT02701062|Apixaban|apixaban|mesh-list
25734093|NCT02701062|Anticoagulants|anticoagulants|mesh-list
25734094|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25734095|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
25734096|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25734097|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
25734098|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734099|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734100|NCT02701257|Glucagon|glucagon|mesh-list
25734101|NCT02701257|Pancrelipase|pancrelipase|mesh-list
25734102|NCT02701257|Pancreatin|pancreatin|mesh-list
25734103|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25734104|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734105|NCT02701257|Hormones|hormones|mesh-ancestor
25734106|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734107|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734108|NCT02701257|Incretins|incretins|mesh-ancestor
25734109|NCT02701296|Epinephrine|epinephrine|mesh-list
25734110|NCT02701296|Ropivacaine|ropivacaine|mesh-list
25734111|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
25734112|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
25734113|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734114|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734115|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
25734116|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734117|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25734118|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25734119|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
25734120|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734121|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734122|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25734123|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25734124|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
25734125|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25734126|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
25734127|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
25734128|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
25734129|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25734130|NCT02701400|Durvalumab|durvalumab|mesh-list
25734131|NCT02701400|Ipilimumab|ipilimumab|mesh-list
25734132|NCT02701400|Tremelimumab|tremelimumab|mesh-list
25734133|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734134|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734135|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25734136|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734137|NCT02701582|Phenylephrine|phenylephrine|mesh-list
25734138|NCT02701582|Epinephrine|epinephrine|mesh-list
25734139|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
25734140|NCT02701582|Synephrine|synephrine|mesh-list
25734141|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25734142|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25734143|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
25734144|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734145|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734146|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734147|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25734148|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25734149|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
25734150|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734152|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
25734153|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
25734154|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
25734155|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25734156|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25734157|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
25734158|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25734159|NCT02701582|Protective Agents|protective agents|mesh-ancestor
25734160|NCT02701764|Pregabalin|pregabalin|mesh-list
25734161|NCT02701764|Analgesics|analgesics|mesh-ancestor
25734162|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
25734163|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734164|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734165|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
25734166|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25734167|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734168|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734169|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25734170|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25734171|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25734172|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734173|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734174|NCT02701985|Petesicatib|petesicatib|mesh-list
25734175|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734176|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734177|NCT02702011|Empagliflozin|empagliflozin|mesh-list
25734178|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25734179|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734180|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734181|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734182|NCT02702388|Lenvatinib|lenvatinib|mesh-list
25734183|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734184|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25734185|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734186|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734187|NCT02703259|Acetaminophen|acetaminophen|mesh-list
25734188|NCT02703259|Celecoxib|celecoxib|mesh-list
25734189|NCT02703259|Gabapentin|gabapentin|mesh-list
25734190|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25734191|NCT02703259|Analgesics|analgesics|mesh-ancestor
25734192|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
25734193|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734194|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734195|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
25734196|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25734197|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25734198|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25734199|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25734200|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25734201|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734202|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734203|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
25734204|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25734205|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25734206|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734207|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734208|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25734209|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25734210|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734211|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
25734212|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
25734213|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734214|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734215|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
25734216|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734217|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734218|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
25734219|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734220|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734221|NCT02703636|Rivastigmine|rivastigmine|mesh-list
25734222|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25734223|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734224|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734225|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
25734226|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734227|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734228|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25734229|NCT02703636|Protective Agents|protective agents|mesh-ancestor
25734230|NCT02703779|Plerixafor|plerixafor|mesh-list
25734231|NCT02703779|Bortezomib|bortezomib|mesh-list
25734232|NCT02703779|Lenograstim|lenograstim|mesh-list
25734233|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25734234|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
25734235|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734236|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734237|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25734238|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25734239|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
25734240|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734241|NCT02703909|Rocuronium|rocuronium|mesh-list
25734242|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25734243|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25734244|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25734245|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734246|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734247|NCT02704104|Hemostatics|hemostatics|mesh-list
25734248|NCT02704104|Coagulants|coagulants|mesh-ancestor
25734249|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25734250|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25734251|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25734252|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
25734253|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734254|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25734255|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25734256|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734257|NCT02705352|Fluorouracil|fluorouracil|mesh-list
25734258|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
25734259|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734260|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25734261|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734262|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25734263|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
25734264|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734265|NCT02705716|Fluorides|fluorides|mesh-list
25734266|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
25734267|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
25734268|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
25734269|NCT02705716|Protective Agents|protective agents|mesh-ancestor
25734270|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734271|NCT02705807|Epoprostenol|epoprostenol|mesh-list
25734272|NCT02705807|Tezosentan|tezosentan|mesh-list
25734273|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25734274|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25734275|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
25734276|NCT02706249|Enoxaparin|enoxaparin|mesh-list
25734277|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
25734278|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25734279|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25734280|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734281|NCT02706483|Plecanatide|plecanatide|mesh-list
25734282|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25734283|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
25734284|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734285|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734286|NCT02706886|Lumasiran|lumasiran|mesh-list
25734287|NCT02706886|Renal Agents|renal agents|mesh-ancestor
25734288|NCT02706899|Azacitidine|azacitidine|mesh-list
25734289|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25734290|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
25734291|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734292|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734293|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734294|NCT02707523|Azithromycin|azithromycin|mesh-list
25734295|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25734296|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734297|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
25734298|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25734299|NCT02707601|Ledipasvir|ledipasvir|mesh-list
25773216|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25734300|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25734301|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
25734302|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734303|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25734304|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25734305|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
25734306|NCT02707640|Pirfenidone|pirfenidone|mesh-list
25734307|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25734308|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
25734309|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734310|NCT02707640|Expectorants|expectorants|mesh-ancestor
25734311|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
25734312|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25734313|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
25734314|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734315|NCT02707640|Protective Agents|protective agents|mesh-ancestor
25734316|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734317|NCT02707640|Antidotes|antidotes|mesh-ancestor
25734318|NCT02707640|Analgesics|analgesics|mesh-ancestor
25734319|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
25734320|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734321|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25734322|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25734323|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25734324|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25734325|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734326|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25734327|NCT02707757|Hematinics|hematinics|mesh-ancestor
25734328|NCT02707861|Ibalizumab|ibalizumab|mesh-list
25734329|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25734330|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
25734331|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734332|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25734333|NCT02707952|Ritonavir|ritonavir|mesh-list
25734334|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25734335|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25734336|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
25734337|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734338|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734339|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25734340|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25734341|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
25734342|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734343|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25734344|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25734345|NCT02707965|Topiramate|topiramate|mesh-list
25734346|NCT02707965|Lamotrigine|lamotrigine|mesh-list
25734347|NCT02707965|Zonisamide|zonisamide|mesh-list
25734348|NCT02707965|Carbamazepine|carbamazepine|mesh-list
25734349|NCT02707965|Phenytoin|phenytoin|mesh-list
25734350|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
25734351|NCT02707965|Levetiracetam|levetiracetam|mesh-list
25734352|NCT02707965|Valproic Acid|valproic acid|mesh-list
25734353|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
25734354|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734355|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734356|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
25734357|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25734358|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734359|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734360|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25734361|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25734362|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25734363|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734364|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734365|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25734366|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
25734367|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25734368|NCT02707965|Analgesics|analgesics|mesh-ancestor
25734369|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
25734370|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734371|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25734372|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25734373|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734374|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
25734375|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734376|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25734377|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25734378|NCT02708238|Simethicone|simethicone|mesh-list
25734379|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
25734380|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734381|NCT02708238|Emollients|emollients|mesh-ancestor
25734382|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
25734383|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
25734384|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25734385|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734386|NCT02708355|Esomeprazole|esomeprazole|mesh-list
25734387|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25734388|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734389|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25734390|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734391|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734392|NCT02708433|Lidocaine|lidocaine|mesh-list
25734393|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
25734394|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
25734395|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734396|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734397|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
25734398|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734399|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25734400|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25734401|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25734402|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734403|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734404|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
25734405|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734406|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734407|NCT02709005|Monolaurin|monolaurin|mesh-list
25734408|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
25734409|NCT02709005|Protective Agents|protective agents|mesh-ancestor
25734410|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734411|NCT02709018|Losartan|losartan|mesh-list
25734412|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25734413|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25734414|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25734415|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25734416|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734417|NCT02709109|Ivacaftor|ivacaftor|mesh-list
25734418|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25734419|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734420|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734421|NCT02709486|Tanezumab|tanezumab|mesh-list
25734422|NCT02709486|Analgesics|analgesics|mesh-ancestor
25734423|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
25734424|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734425|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773217|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
25773218|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773219|NCT04160091|FX006|fx006|mesh-list
25773220|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773221|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
25773222|NCT04160091|Hormones|hormones|mesh-ancestor
25773223|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773224|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773225|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25773226|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
25773227|NCT04164758|Pimavanserin|pimavanserin|mesh-list
25773228|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25773229|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
25773230|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773231|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25773232|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773233|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773234|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773235|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25773236|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25773237|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25773238|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25773239|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
25773240|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773241|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734427|NCT02709746|Fluoxetine|fluoxetine|mesh-list
25734428|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25734429|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25734430|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734431|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734432|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734433|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
25734434|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734435|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25734436|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
25734437|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734438|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25734439|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25734440|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734441|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25734442|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25734443|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734444|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25734445|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25734446|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25734447|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25734448|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
25734449|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25734450|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734451|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
25734452|NCT02709889|Dexamethasone|dexamethasone|mesh-list
25734453|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25734454|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
25734455|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
25734456|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734457|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734458|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734459|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
25734460|NCT02709889|Hormones|hormones|mesh-ancestor
25734461|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734462|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25734463|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734464|NCT02710045|Vaccines|vaccines|mesh-list
25734465|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
25734466|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734467|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25734468|NCT02710071|Nebivolol|nebivolol|mesh-list
25734469|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25734470|NCT02710071|Diuretics|diuretics|mesh-ancestor
25734471|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
25734472|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734473|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25734474|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734475|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734476|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
25734477|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25734478|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25734479|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25734480|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
25734481|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734482|NCT02710214|Estrogens|estrogens|mesh-list
25734483|NCT02710214|Hormones|hormones|mesh-ancestor
25734484|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734485|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734486|NCT02710526|Buprenorphine|buprenorphine|mesh-list
25734487|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25734488|NCT02710526|Narcotics|narcotics|mesh-ancestor
25734489|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734490|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734491|NCT02710526|Analgesics|analgesics|mesh-ancestor
25734492|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
25734493|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734494|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25734495|NCT02710630|Dabigatran|dabigatran|mesh-list
25734496|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
25734497|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25734498|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
25734499|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734500|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734501|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
25734502|NCT02710890|Lacosamide|lacosamide|mesh-list
25734503|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
25734504|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25734505|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25734506|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734507|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734508|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
25734509|NCT02710981|Clomiphene|clomiphene|mesh-list
25734510|NCT02710981|Enclomiphene|enclomiphene|mesh-list
25734511|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
25734512|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734513|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
25734514|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25734515|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25734516|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734517|NCT02710981|Urological Agents|urological agents|mesh-ancestor
25734518|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25734519|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
25734520|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734521|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734522|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25734523|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
25734524|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25734525|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25734526|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25734527|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
25734528|NCT02711306|Cathartics|cathartics|mesh-ancestor
25734529|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734530|NCT02711553|Gemcitabine|gemcitabine|mesh-list
25734531|NCT02711553|Cisplatin|cisplatin|mesh-list
25734532|NCT02711553|Ramucirumab|ramucirumab|mesh-list
25734533|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734534|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25734535|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
25734536|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734537|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
25734538|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734539|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734540|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25734541|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
25734542|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734543|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25734544|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
25734545|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25734546|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734547|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734548|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
25734549|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734550|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734551|NCT02711995|Laxatives|laxatives|mesh-ancestor
25734552|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734553|NCT02712008|Aflibercept|aflibercept|mesh-list
25734554|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25734555|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25734556|NCT02712008|Growth Substances|growth substances|mesh-ancestor
25734557|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734558|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
25734559|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734560|NCT02712047|Fluticasone|fluticasone|mesh-list
25734561|NCT02712047|Xhance|xhance|mesh-list
25734562|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25734563|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25734564|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
25734565|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734566|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734567|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25734568|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
25734569|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
25734570|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25734571|NCT02712788|Milrinone|milrinone|mesh-list
25734572|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25734573|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25299714|NCT03704610|Infliximab|infliximab|mesh-list
25734574|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
25734575|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25734576|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25734577|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734578|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734579|NCT02712788|Protective Agents|protective agents|mesh-ancestor
25734580|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734581|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25734582|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25734583|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734584|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25734585|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25734586|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734587|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734588|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
25734589|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734590|NCT02713178|Bupivacaine|bupivacaine|mesh-list
25734591|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25734592|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
25734593|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734594|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734595|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
25734596|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734597|NCT02713204|Aflibercept|aflibercept|mesh-list
25734598|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25734599|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25734600|NCT02713204|Growth Substances|growth substances|mesh-ancestor
25734601|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734602|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
25734603|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734604|NCT02713230|Bupivacaine|bupivacaine|mesh-list
25734605|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
25734606|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
25734607|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734608|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734609|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
25734610|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734611|NCT02713490|Bupivacaine|bupivacaine|mesh-list
25734612|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
25734613|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
25734614|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734615|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734616|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
25734617|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734618|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
25734619|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734620|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734621|NCT02713698|Propofol|propofol|mesh-list
25734622|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25734623|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734624|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734625|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25734626|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
25734627|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
25734628|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25734629|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25734630|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734631|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734632|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
25734633|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734634|NCT02714283|Azithromycin|azithromycin|mesh-list
25734635|NCT02714283|Erythromycin|erythromycin|mesh-list
25734636|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25734637|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734638|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734639|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25734640|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734641|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734642|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25734643|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25734644|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25734645|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299805|NCT03061474|Niacin|niacin|mesh-list
25734646|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734647|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734648|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734649|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25734650|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
25734651|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734652|NCT02714504|Voriconazole|voriconazole|mesh-list
25734653|NCT02714504|Posaconazole|posaconazole|mesh-list
25734654|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
25734655|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734656|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25734657|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25734658|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734659|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734660|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25734661|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
25734662|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734663|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734664|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25734665|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25734666|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25734667|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25734668|NCT02714569|Atorvastatin|atorvastatin|mesh-list
25734669|NCT02714569|Simvastatin|simvastatin|mesh-list
25734670|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25734671|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25734672|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
25734673|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734674|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25734675|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25734676|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734677|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
25734678|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734679|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734680|NCT02715700|Methadone|methadone|mesh-list
25734681|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25734682|NCT02715700|Narcotics|narcotics|mesh-ancestor
25734683|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734684|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734685|NCT02715700|Analgesics|analgesics|mesh-ancestor
25734686|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
25734687|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734688|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
25734689|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
25734690|NCT02715726|Atorvastatin|atorvastatin|mesh-list
25734691|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25734692|NCT02715726|Simvastatin|simvastatin|mesh-list
25734693|NCT02715726|Ezetimibe|ezetimibe|mesh-list
25734694|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25734695|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25734696|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25734697|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
25734698|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734699|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25734700|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25734701|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734702|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
25734703|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734704|NCT02715804|Gemcitabine|gemcitabine|mesh-list
25734705|NCT02715804|Paclitaxel|paclitaxel|mesh-list
25734706|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25734707|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734708|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
25734709|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
25734710|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
25734711|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734712|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25734713|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
25734714|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
25734715|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734716|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734717|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25734718|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
25734719|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734720|NCT02716194|Factor VIII|factor viii|mesh-list
25734721|NCT02716194|Coagulants|coagulants|mesh-ancestor
25734722|NCT02716779|Interferons|interferons|mesh-list
25734723|NCT02716779|Ribavirin|ribavirin|mesh-list
25734724|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734725|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
25734726|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734727|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
25734728|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734729|NCT02716805|Melphalan|melphalan|mesh-list
25734730|NCT02716805|Durvalumab|durvalumab|mesh-list
25734731|NCT02716805|Tremelimumab|tremelimumab|mesh-list
25734732|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25734733|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
25734734|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734735|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734736|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25734737|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25734738|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
25734739|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734740|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734741|NCT02716818|Dexamethasone|dexamethasone|mesh-list
25734742|NCT02716818|Prednisone|prednisone|mesh-list
25734743|NCT02716818|Prednisolone|prednisolone|mesh-list
25734744|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
25734745|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25734746|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25734747|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25734748|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
25734749|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25734750|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
25734751|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
25734752|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734753|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734754|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734755|NCT02716818|Hormones|hormones|mesh-ancestor
25734756|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734757|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25734758|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734759|NCT02717195|Olanzapine|olanzapine|mesh-list
25734760|NCT02717195|Risperidone|risperidone|mesh-list
25734761|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25734762|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
25734763|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734764|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734765|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734766|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25734767|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25734768|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734769|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734770|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25734771|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
25734772|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
25734773|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
25734774|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734775|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734776|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25734777|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25734778|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734779|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25734780|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25734781|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734782|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
25734783|NCT02717754|Oseltamivir|oseltamivir|mesh-list
25734784|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
25734785|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734786|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734787|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734788|NCT02718326|Aflibercept|aflibercept|mesh-list
25734789|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25734790|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25734791|NCT02718326|Growth Substances|growth substances|mesh-ancestor
25734792|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734793|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
25734794|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734795|NCT02718417|Paclitaxel|paclitaxel|mesh-list
25734796|NCT02718417|Carboplatin|carboplatin|mesh-list
25734797|NCT02718417|Avelumab|avelumab|mesh-list
25734798|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25734799|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25734800|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734801|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
25734802|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
25734803|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
25734804|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734805|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734806|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
25734807|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734808|NCT02718898|Ixekizumab|ixekizumab|mesh-list
25734809|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
25734810|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
25734811|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25734812|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734813|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25734814|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25734815|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734816|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734817|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734818|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25734819|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25734820|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25734821|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
25734822|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734823|NCT02720081|Albuterol|albuterol|mesh-list
25734824|NCT02720081|Montelukast|montelukast|mesh-list
25734825|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25734826|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
25734827|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25734828|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
25734829|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734830|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734831|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25734832|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25734833|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734834|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25734835|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
25734836|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734837|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
25734838|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25734839|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25734840|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25734841|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25734842|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25734843|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734844|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25734845|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25734846|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734847|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25734848|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
25734849|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734850|NCT02720198|Milnacipran|milnacipran|mesh-list
25734851|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25734852|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
25734853|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
25734854|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734855|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25734856|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25734857|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734858|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734859|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25734860|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25734861|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25734862|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734863|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734864|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25734865|NCT02720198|Analgesics|analgesics|mesh-ancestor
25734866|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
25734867|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300165|NCT04921189|Thiamine|thiamine|mesh-list
25734868|NCT02720484|Nivolumab|nivolumab|mesh-list
25734869|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734870|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734871|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25734872|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734873|NCT02720536|Deferasirox|deferasirox|mesh-list
25734874|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25734875|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
25734876|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
25734877|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734878|NCT02721017|Fentanyl|fentanyl|mesh-list
25734879|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25734880|NCT02721017|Narcotics|narcotics|mesh-ancestor
25734881|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734882|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734883|NCT02721017|Analgesics|analgesics|mesh-ancestor
25734884|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
25734885|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25734886|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25734887|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25734888|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
25734889|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
25734890|NCT02721641|Trastuzumab|trastuzumab|mesh-list
25734891|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734892|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734893|NCT02721875|Azacitidine|azacitidine|mesh-list
25734894|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25734895|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
25734896|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734897|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734898|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734899|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25734900|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
25734901|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734902|NCT02722044|Adalimumab|adalimumab|mesh-list
25734903|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25734904|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25734905|NCT02722239|Metformin|metformin|mesh-list
25734906|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
25734907|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25734908|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734909|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25734910|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734911|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
25734912|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25734913|NCT02722278|Testosterone|testosterone|mesh-list
25734914|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
25734915|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
25734916|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25734917|NCT02722278|Androgens|androgens|mesh-ancestor
25734918|NCT02722278|Hormones|hormones|mesh-ancestor
25734919|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25734920|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734921|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25734922|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734923|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
25734924|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
25734925|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25734926|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734927|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734928|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25734929|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25734930|NCT02722564|Ethanol|ethanol|mesh-list
25734931|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25734932|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734933|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734934|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734935|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
25734936|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25734937|NCT02722837|Velpatasvir|velpatasvir|mesh-list
25734938|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
25734939|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734940|NCT02722967|Aripiprazole|aripiprazole|mesh-list
25734941|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
25734942|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25734943|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25734944|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25734945|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25734946|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734947|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
25734948|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
25734949|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25734950|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734951|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25734952|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25734953|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
25734954|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25734955|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25734956|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25734957|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25734958|NCT02723006|Nivolumab|nivolumab|mesh-list
25734959|NCT02723006|Ipilimumab|ipilimumab|mesh-list
25734960|NCT02723006|Vedolizumab|vedolizumab|mesh-list
25734961|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25734962|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734963|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25734964|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734965|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25734966|NCT02723084|Ribavirin|ribavirin|mesh-list
25734967|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
25734968|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
25734969|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734970|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
25734971|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25734972|NCT02723591|Tacrolimus|tacrolimus|mesh-list
25734973|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25734974|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
25734975|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734976|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25734977|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734978|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734979|NCT02723630|Lenvatinib|lenvatinib|mesh-list
25734980|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734981|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25734982|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734983|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734984|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
25734985|NCT02723786|Azathioprine|azathioprine|mesh-list
25734986|NCT02723786|Tacrolimus|tacrolimus|mesh-list
25734987|NCT02723786|Basiliximab|basiliximab|mesh-list
25734988|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25734989|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
25734990|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25734991|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25734992|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25734993|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25734994|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25734995|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25734996|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25734997|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
25734998|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25734999|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735000|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
25735001|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25735002|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25735003|NCT02724020|Everolimus|everolimus|mesh-list
25735004|NCT02724020|Serabelisib|serabelisib|mesh-list
25735005|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735006|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25735007|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
25735008|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735009|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735010|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735011|NCT02724033|Dexamethasone|dexamethasone|mesh-list
25735012|NCT02724033|Ondansetron|ondansetron|mesh-list
25735013|NCT02724033|Antiemetics|antiemetics|mesh-list
25735014|NCT02724033|Bupivacaine|bupivacaine|mesh-list
25735015|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735016|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
25735017|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735018|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735019|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735020|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
25735021|NCT02724033|Hormones|hormones|mesh-ancestor
25735022|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735023|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25735024|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735025|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735026|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
25735027|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
25735028|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735029|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
25735030|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
25735031|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
25735032|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25735033|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
25735034|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735035|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25735036|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25735037|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25735038|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25735039|NCT02724111|Rocuronium|rocuronium|mesh-list
25735040|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25735041|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25735042|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25735043|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735044|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735045|NCT02724423|Diazepam|diazepam|mesh-list
25735046|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25735047|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
25735048|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
25735049|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
25735050|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735051|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735052|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735053|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25735054|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735055|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25735056|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25735057|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25735058|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25735059|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25735060|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25735061|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
25735062|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
25735063|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
25735064|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
25735065|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735066|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735067|NCT02724592|Fluorides|fluorides|mesh-list
25735068|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
25735069|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
25735070|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
25735071|NCT02724592|Protective Agents|protective agents|mesh-ancestor
25735072|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735073|NCT02725008|Dexamethasone|dexamethasone|mesh-list
25735074|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735075|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
25735076|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
25735077|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735078|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735079|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735080|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
25735081|NCT02725008|Hormones|hormones|mesh-ancestor
25735082|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735083|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25735084|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735085|NCT02725268|Paclitaxel|paclitaxel|mesh-list
25735086|NCT02725268|Serabelisib|serabelisib|mesh-list
25735087|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25735088|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735089|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
25735090|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
25735091|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
25735092|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735093|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735094|NCT02725411|Celecoxib|celecoxib|mesh-list
25735095|NCT02725411|Tanezumab|tanezumab|mesh-list
25773242|NCT04165031|Docetaxel|docetaxel|mesh-list
25735096|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25735097|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25735098|NCT02725411|Analgesics|analgesics|mesh-ancestor
25735099|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
25735100|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735101|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735102|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735103|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25735104|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25735105|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25735106|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735107|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735108|NCT02725710|Gabapentin|gabapentin|mesh-list
25735109|NCT02725710|Analgesics|analgesics|mesh-ancestor
25735110|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
25735111|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735112|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735113|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
25735114|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25735115|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25735116|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735117|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25735118|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25735119|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25735120|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735121|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735122|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
25735123|NCT02725866|Ritonavir|ritonavir|mesh-list
25735124|NCT02725866|Ribavirin|ribavirin|mesh-list
25735125|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25735126|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25735127|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
25735128|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735129|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735130|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25735131|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25735132|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
25735133|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735134|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25735135|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25735136|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
25735137|NCT02726022|Ribavirin|ribavirin|mesh-list
25735138|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25735139|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
25735140|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735141|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
25735142|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735143|NCT02726113|Vitamin D|vitamin d|mesh-list
25735144|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
25735145|NCT02726113|Vitamins|vitamins|mesh-ancestor
25735146|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
25735147|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735148|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25735149|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25735150|NCT02726178|Ibuprofen|ibuprofen|mesh-list
25735151|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25735152|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25735153|NCT02726178|Analgesics|analgesics|mesh-ancestor
25735154|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
25735155|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735156|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735157|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735158|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25735159|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25735160|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735161|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735162|NCT02726620|Lidocaine|lidocaine|mesh-list
25735163|NCT02726620|Atropine|atropine|mesh-list
25735164|NCT02726620|Terlipressin|terlipressin|mesh-list
25735165|NCT02726620|Phenylephrine|phenylephrine|mesh-list
25735166|NCT02726620|Dobutamine|dobutamine|mesh-list
25735167|NCT02726620|Dopamine|dopamine|mesh-list
25735168|NCT02726620|Milrinone|milrinone|mesh-list
25735169|NCT02726620|Isoproterenol|isoproterenol|mesh-list
25735170|NCT02726620|Vasopressins|vasopressins|mesh-list
25735171|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
25735172|NCT02726620|Epinephrine|epinephrine|mesh-list
25735173|NCT02726620|Norepinephrine|norepinephrine|mesh-list
25735174|NCT02726620|Ephedrine|ephedrine|mesh-list
25735175|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
25735176|NCT02726620|Bupivacaine|bupivacaine|mesh-list
25735177|NCT02726620|Ropivacaine|ropivacaine|mesh-list
25735178|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
25735179|NCT02726620|Tetracaine|tetracaine|mesh-list
25735180|NCT02726620|Prilocaine|prilocaine|mesh-list
25735181|NCT02726620|Mepivacaine|mepivacaine|mesh-list
25735182|NCT02726620|Benzocaine|benzocaine|mesh-list
25735183|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
25735184|NCT02726620|Procaine|procaine|mesh-list
25735185|NCT02726620|Anesthetics|anesthetics|mesh-list
25735186|NCT02726620|Propofol|propofol|mesh-list
25735187|NCT02726620|Sevoflurane|sevoflurane|mesh-list
25735188|NCT02726620|Desflurane|desflurane|mesh-list
25735189|NCT02726620|Isoflurane|isoflurane|mesh-list
25735190|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25735191|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
25735192|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
25735193|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735194|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735195|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
25735196|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735197|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25735198|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25735199|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25735200|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25735201|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735202|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25735203|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25735204|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
25735205|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25735206|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25735207|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25735208|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25735209|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
25735210|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735211|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25735212|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735213|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
25735214|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735215|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735216|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
25735217|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
25735218|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25735219|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25735220|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
25735221|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25735222|NCT02726620|Protective Agents|protective agents|mesh-ancestor
25735223|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25735224|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
25735225|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25735226|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25735227|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
25735228|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
25735229|NCT02726620|Coagulants|coagulants|mesh-ancestor
25735230|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25735231|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
25735232|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25735233|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25735234|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25735235|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
25735236|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
25735237|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25735238|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25735239|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735240|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25735241|NCT02726789|Interferons|interferons|mesh-list
25735242|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
25735243|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
25735244|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25735245|NCT02726789|Entecavir|entecavir|mesh-list
25735246|NCT02726789|REP 2139|rep 2139|mesh-list
25735247|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735248|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
25735249|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735250|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
25735251|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735252|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
25773243|NCT04165031|Cetuximab|cetuximab|mesh-list
25735253|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25735254|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735256|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735257|NCT02727660|Budesonide|budesonide|mesh-list
25735258|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
25735259|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735260|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735261|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
25735262|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735263|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735264|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735265|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735266|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
25735267|NCT02727660|Hormones|hormones|mesh-ancestor
25735268|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735269|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25735270|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25735271|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25735272|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
25735273|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735274|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735275|NCT02728089|Tazobactam|tazobactam|mesh-list
25735276|NCT02728089|Ceftolozane|ceftolozane|mesh-list
25735277|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735278|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735279|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25735280|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735281|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735282|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
25735283|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25735284|NCT02728206|Velpatasvir|velpatasvir|mesh-list
25735285|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
25735286|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735287|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
25735288|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735289|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735290|NCT02728895|Vedolizumab|vedolizumab|mesh-list
25735291|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735292|NCT02729051|Albuterol|albuterol|mesh-list
25735293|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735294|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
25735295|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735296|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735297|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735298|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735299|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
25735300|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25735301|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25735302|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25735303|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25735304|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
25735305|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735306|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735307|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
25735308|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25735309|NCT02729545|Cyproterone|cyproterone|mesh-list
25735310|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25735311|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25735312|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25735313|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
25735314|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25735315|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735316|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25735317|NCT02729545|Estrogens|estrogens|mesh-ancestor
25735318|NCT02729545|Hormones|hormones|mesh-ancestor
25735319|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735320|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
25735321|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
25735322|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735323|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25735324|NCT02729896|Rituximab|rituximab|mesh-list
25735325|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
25735326|NCT02729896|Atezolizumab|atezolizumab|mesh-list
25735327|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735328|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735329|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
25735330|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735331|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25735332|NCT02729909|Lubiprostone|lubiprostone|mesh-list
25735333|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25735334|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25735335|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735336|NCT02730195|Pioglitazone|pioglitazone|mesh-list
25735337|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25735338|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735339|NCT02730208|Ivacaftor|ivacaftor|mesh-list
25735340|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25735341|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25735342|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735343|NCT02730247|Paclitaxel|paclitaxel|mesh-list
25735344|NCT02730247|Ramucirumab|ramucirumab|mesh-list
25735345|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25735346|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735347|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
25735348|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
25735349|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
25735350|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735351|NCT02730351|Fluticasone|fluticasone|mesh-list
25735352|NCT02730351|Xhance|xhance|mesh-list
25735353|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735354|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735355|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
25735356|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735357|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735358|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735359|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735360|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
25735361|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25735362|NCT02730377|Liraglutide|liraglutide|mesh-list
25735363|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25735364|NCT02730377|Meglitinide|meglitinide|mesh-list
25735365|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25735366|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25735367|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25735368|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25735369|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735370|NCT02730377|Incretins|incretins|mesh-ancestor
25735371|NCT02730377|Hormones|hormones|mesh-ancestor
25735372|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735373|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735374|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
25735375|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735376|NCT02730455|Natalizumab|natalizumab|mesh-list
25735377|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
25735378|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773244|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25773245|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773246|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
25773247|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
25773248|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
25773249|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773250|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25773251|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25773252|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773253|NCT04171414|Adalimumab|adalimumab|mesh-list
25773254|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773255|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773256|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
25773257|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25773258|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773259|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25773260|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25773261|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773262|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773263|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773264|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
25773265|NCT04184297|Olodaterol|olodaterol|mesh-list
25773266|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25773267|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
25735379|NCT02730871|Timolol|timolol|mesh-list
25735380|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25735381|NCT02730871|Travoprost|travoprost|mesh-list
25735382|NCT02730871|Brinzolamide|brinzolamide|mesh-list
25735383|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25735384|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25735385|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
25735386|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735387|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735388|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735389|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25735390|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25735391|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25735392|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25735393|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25735394|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25735395|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735396|NCT02730884|ON 01910|on 01910|mesh-list
25735397|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735398|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25735399|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735400|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735401|NCT02730962|Vancomycin|vancomycin|mesh-list
25735402|NCT02730962|Clindamycin|clindamycin|mesh-list
25735403|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
25735404|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
25735405|NCT02730962|Neomycin|neomycin|mesh-list
25735406|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735407|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735408|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25735409|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735410|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735411|NCT02731131|Ribavirin|ribavirin|mesh-list
25735412|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25735413|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
25735414|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735415|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
25735416|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735417|NCT02731313|Trastuzumab|trastuzumab|mesh-list
25735418|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735419|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735420|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
25735421|NCT02731469|Hematinics|hematinics|mesh-ancestor
25735422|NCT02731638|Voriconazole|voriconazole|mesh-list
25735423|NCT02731638|Natamycin|natamycin|mesh-list
25735424|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
25735425|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735426|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25735427|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25735428|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735429|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735430|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25735431|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
25735432|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735433|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735434|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25735435|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25735436|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735437|NCT02731729|Nivolumab|nivolumab|mesh-list
25735438|NCT02731729|Ipilimumab|ipilimumab|mesh-list
25735439|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735440|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735441|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25735442|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735443|NCT02731820|Vitamin D|vitamin d|mesh-list
25735444|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
25735445|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
25735446|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
25735447|NCT02731820|Calcium|calcium|mesh-list
25735448|NCT02731820|Vitamins|vitamins|mesh-ancestor
25735449|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
25735450|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735451|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25735452|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25735453|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735454|NCT02731820|Antacids|antacids|mesh-ancestor
25735455|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735456|NCT02731820|Diuretics|diuretics|mesh-ancestor
25735457|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
25735458|NCT02731820|Expectorants|expectorants|mesh-ancestor
25735459|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735460|NCT02731833|Fluorides|fluorides|mesh-list
25735461|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
25735462|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
25735463|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
25735464|NCT02731833|Protective Agents|protective agents|mesh-ancestor
25735465|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735466|NCT02732015|Dexamethasone|dexamethasone|mesh-list
25735467|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
25735468|NCT02732015|Doxorubicin|doxorubicin|mesh-list
25735469|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25735470|NCT02732015|Vincristine|vincristine|mesh-list
25735471|NCT02732015|Daunorubicin|daunorubicin|mesh-list
25735472|NCT02732015|Ifosfamide|ifosfamide|mesh-list
25735473|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
25735474|NCT02732015|Ondansetron|ondansetron|mesh-list
25735475|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
25735476|NCT02732015|Aprepitant|aprepitant|mesh-list
25735477|NCT02732015|BB 1101|bb 1101|mesh-list
25735478|NCT02732015|Rolapitant|rolapitant|mesh-list
25735479|NCT02732015|Mesna|mesna|mesh-list
25735480|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735481|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
25735482|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
25735483|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735484|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735485|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735486|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
25735487|NCT02732015|Hormones|hormones|mesh-ancestor
25735488|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735489|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25735490|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735491|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
25735492|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735493|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735494|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25735495|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25735496|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25735497|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25735498|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
25735499|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
25735500|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
25735501|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
25735502|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
25735503|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25735504|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
25735505|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735506|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25735507|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25735508|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735509|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25735510|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25735511|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25735512|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
25735513|NCT02732015|Protective Agents|protective agents|mesh-ancestor
25735514|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25735515|NCT02732119|Everolimus|everolimus|mesh-list
25735516|NCT02732119|Exemestane|exemestane|mesh-list
25735517|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735518|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25735519|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
25735520|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735521|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25735522|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25735523|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735524|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735525|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25735526|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
25735527|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735528|NCT02732587|Saracatinib|saracatinib|mesh-list
25735529|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735530|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735531|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735532|NCT02732639|Interferons|interferons|mesh-list
25735533|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735534|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
25735535|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735536|NCT02732899|Sirolimus|sirolimus|mesh-list
25735537|NCT02732899|Aflibercept|aflibercept|mesh-list
25735538|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735539|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735540|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25735541|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735542|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
25735543|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25735544|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
25735545|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735546|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25735547|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25735548|NCT02732899|Growth Substances|growth substances|mesh-ancestor
25735549|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
25735550|NCT02732912|Zopiclone|zopiclone|mesh-list
25735551|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25735552|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735553|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735554|NCT02732938|Gemcitabine|gemcitabine|mesh-list
25735555|NCT02732938|Paclitaxel|paclitaxel|mesh-list
25735556|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25735557|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735558|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
25735559|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
25735560|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
25735561|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735562|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25735563|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
25735564|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
25735565|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735566|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735567|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25735568|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
25735569|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735570|NCT02733588|Glucagon|glucagon|mesh-list
25735571|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25735572|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735573|NCT02733588|Hormones|hormones|mesh-ancestor
25735574|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735575|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735576|NCT02733588|Incretins|incretins|mesh-ancestor
25735577|NCT02733757|Clonidine|clonidine|mesh-list
25735578|NCT02733757|Analgesics|analgesics|mesh-ancestor
25735579|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
25735580|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735581|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735582|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25735583|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
25735584|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
25735585|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25735586|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25735587|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25735588|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
25735589|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735590|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735591|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
25735592|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
25735593|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735594|NCT02734147|Protective Agents|protective agents|mesh-ancestor
25735595|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735596|NCT02734147|Vitamins|vitamins|mesh-ancestor
25735597|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
25735598|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
25735599|NCT02734238|Testosterone|testosterone|mesh-list
25735600|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
25735601|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
25735602|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25735603|NCT02734238|Androgens|androgens|mesh-ancestor
25735604|NCT02734238|Hormones|hormones|mesh-ancestor
25735605|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735606|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735607|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25735608|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735609|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
25735610|NCT02734355|Amlodipine|amlodipine|mesh-list
25735611|NCT02734355|Telmisartan|telmisartan|mesh-list
25735612|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25735613|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25735614|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25735615|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25735616|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735617|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25735618|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735619|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
25735620|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25735621|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25735622|NCT02734862|Fluconazole|fluconazole|mesh-list
25735623|NCT02734862|Caspofungin|caspofungin|mesh-list
25735624|NCT02734862|Rezafungin|rezafungin|mesh-list
25735625|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
25735626|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735627|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25735628|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25735629|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735630|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735631|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25735632|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
25735633|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735634|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735635|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25735636|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25735637|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
25735638|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735639|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
25735640|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735641|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735642|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735643|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735644|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25735645|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
25735646|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735647|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735648|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25735649|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
25735650|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
25735651|NCT02734953|Protective Agents|protective agents|mesh-ancestor
25735652|NCT02735187|Vitamin D|vitamin d|mesh-list
25735653|NCT02735187|Vitamins|vitamins|mesh-ancestor
25735654|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
25735655|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735656|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25735657|NCT02735200|Vitamin D|vitamin d|mesh-list
25735658|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
25735659|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
25735660|NCT02735200|Vitamins|vitamins|mesh-list
25735661|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
25735662|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735663|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25735664|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25735665|NCT02735577|Disulfiram|disulfiram|mesh-list
25735666|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25735667|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25735668|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735669|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735670|NCT02736175|Dexamethasone|dexamethasone|mesh-list
25735671|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735672|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
25735673|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
25735674|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735675|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735676|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735677|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
25735678|NCT02736175|Hormones|hormones|mesh-ancestor
25735679|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735680|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25735681|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735682|NCT02736409|Budesonide|budesonide|mesh-list
25735683|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25301049|NCT04901988|Nivolumab|nivolumab|mesh-list
25735684|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735685|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
25735686|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735687|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735688|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735689|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735690|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
25735691|NCT02736409|Hormones|hormones|mesh-ancestor
25735692|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735693|NCT02736474|Naltrexone|naltrexone|mesh-list
25735694|NCT02736474|Bupropion|bupropion|mesh-list
25735695|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25735696|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25735697|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735698|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
25735699|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735700|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25735701|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
25735702|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25735703|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25735704|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25735705|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25735706|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735707|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
25735708|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735709|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25735710|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25735711|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735712|NCT02736578|Cetuximab|cetuximab|mesh-list
25735713|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735714|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735715|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25735716|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
25735717|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735718|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
25735719|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25735720|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25735721|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25735722|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25735723|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735724|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
25735725|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735726|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735727|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25735728|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735729|NCT02737072|Durvalumab|durvalumab|mesh-list
25735730|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735731|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735732|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
25735733|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735734|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25735735|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735736|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735737|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
25735738|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735739|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735740|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25735741|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
25735742|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25735743|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
25735744|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735745|NCT02737358|Expectorants|expectorants|mesh-ancestor
25735746|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735747|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25735748|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
25735749|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735750|NCT02737358|Protective Agents|protective agents|mesh-ancestor
25735751|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735752|NCT02737358|Antidotes|antidotes|mesh-ancestor
25735753|NCT02737501|Crizotinib|crizotinib|mesh-list
25735754|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735755|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25735756|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735757|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735758|NCT05446493|Tadalafil|tadalafil|mesh-list
25735759|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
25735760|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25735761|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25735762|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735763|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735764|NCT05446493|Urological Agents|urological agents|mesh-ancestor
25735765|NCT05446480|Desloratadine|desloratadine|mesh-list
25735766|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25735767|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
25735768|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735769|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735770|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735771|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25735772|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25735773|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
25735774|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
25735775|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
25735776|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735777|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735778|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
25735779|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735780|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
25735781|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735782|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735783|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735784|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735785|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25735786|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
25735787|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735788|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735789|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25735790|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
25735791|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
25735792|NCT05446090|Protective Agents|protective agents|mesh-ancestor
25773268|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773269|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773270|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25773271|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773272|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
25773273|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25773274|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773275|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773276|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773277|NCT04189848|Dulaglutide|dulaglutide|mesh-list
25773278|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25773279|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773280|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
25773281|NCT04211909|Velpatasvir|velpatasvir|mesh-list
25773282|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
25773283|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773284|NCT04218110|Ethanol|ethanol|mesh-list
25773285|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
25773286|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25773287|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25773288|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773289|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773290|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773291|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
25773292|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25773293|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25773294|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25773295|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
25773296|NCT04223843|Olodaterol|olodaterol|mesh-list
25773297|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25773298|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
25773299|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773300|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773301|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25773302|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773303|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
25773304|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25773305|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773306|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735794|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25735795|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25735796|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25735797|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25735798|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
25735799|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735800|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735801|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735802|NCT05445661|Mannitol|mannitol|mesh-list
25735803|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25735804|NCT05445661|Diuretics|diuretics|mesh-ancestor
25735805|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
25735806|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735807|NCT05445479|Doxycycline|doxycycline|mesh-list
25735808|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735809|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735810|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
25735811|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25735812|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25735813|NCT05445440|Leucovorin|leucovorin|mesh-list
25735814|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
25735815|NCT05445440|Methotrexate|methotrexate|mesh-list
25735816|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25735817|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
25735818|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25735819|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735820|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25735821|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
25735822|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735823|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735824|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
25735825|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735826|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25735827|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25735828|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
25735829|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25735830|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25735831|NCT05445440|Antidotes|antidotes|mesh-ancestor
25735832|NCT05445440|Protective Agents|protective agents|mesh-ancestor
25735833|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
25735834|NCT05445440|Vitamins|vitamins|mesh-ancestor
25735835|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
25735836|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735837|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25735838|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25735839|NCT05445440|Analgesics|analgesics|mesh-ancestor
25735840|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
25735841|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735842|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735843|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25735844|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25735845|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735846|NCT05445297|Amiodarone|amiodarone|mesh-list
25735847|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25735848|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
25735849|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25735850|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25735851|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735852|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25735853|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25735854|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25735855|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735856|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25735857|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25735858|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25735859|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25735860|NCT05445076|Antibodies|antibodies|mesh-list
25735861|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
25735862|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25735863|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
25735864|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735865|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735866|NCT05445024|Sufentanil|sufentanil|mesh-list
25735867|NCT05445024|Nalbuphine|nalbuphine|mesh-list
25735868|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25735869|NCT05445024|Narcotics|narcotics|mesh-ancestor
25735870|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735871|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735872|NCT05445024|Analgesics|analgesics|mesh-ancestor
25735873|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
25735874|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735875|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25735876|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25735877|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
25735878|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
25735879|NCT05445011|Vidarabine|vidarabine|mesh-list
25735880|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
25735881|NCT05445011|Fludarabine|fludarabine|mesh-list
25735882|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
25735883|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25735884|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
25735885|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735886|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25735887|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25735888|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
25735889|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735890|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735891|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25735892|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25735893|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
25735894|NCT05445011|Antiviral Agents|antiviral agents|mesh-ancestor
25735895|NCT05445011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735896|NCT05444998|Paclitaxel|paclitaxel|mesh-list
25735897|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25735898|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735899|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
25735900|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
25735901|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
25735902|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735903|NCT05444946|Itraconazole|itraconazole|mesh-list
25735904|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25735905|NCT05444946|Prednisone|prednisone|mesh-list
25735906|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735907|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
25735908|NCT05444946|Hormones|hormones|mesh-ancestor
25735909|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735910|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735911|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25735912|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735913|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
25735914|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735915|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25735916|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25735917|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25735918|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735919|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25735920|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
25735921|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25735922|NCT05444842|Insulin|insulin|mesh-list
25735923|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25735924|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25735925|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735926|NCT05444751|Anesthetics|anesthetics|mesh-list
25735927|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
25735928|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25735929|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735930|NCT05444738|Oxytocin|oxytocin|mesh-list
25735931|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
25735932|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25735933|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735934|NCT05444673|Cisplatin|cisplatin|mesh-list
25735935|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735936|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
25735937|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25735938|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
25735939|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25735940|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735941|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25735942|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25301505|NCT03693807|Gemcitabine|gemcitabine|mesh-list
25735943|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25735945|NCT05444543|Xhance|xhance|mesh-list
25735946|NCT05444543|Budesonide|budesonide|mesh-list
25735947|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25735948|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25735949|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
25735950|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735951|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735952|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25735953|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
25735954|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
25735955|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25735956|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
25735957|NCT05444543|Hormones|hormones|mesh-ancestor
25735958|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25735959|NCT05444452|Sirolimus|sirolimus|mesh-list
25735960|NCT05444452|Everolimus|everolimus|mesh-list
25735961|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735962|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25735963|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
25735964|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735965|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735966|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735967|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25735968|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
25735969|NCT05444374|Bevacizumab|bevacizumab|mesh-list
25735970|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735971|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735972|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25735973|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25735974|NCT05444374|Growth Substances|growth substances|mesh-ancestor
25735975|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735976|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
25735977|NCT05444218|Amoxicillin|amoxicillin|mesh-list
25735978|NCT05444218|Metronidazole|metronidazole|mesh-list
25735979|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25735980|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25735981|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25735982|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25735983|NCT05444101|Nicotine|nicotine|mesh-list
25735984|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25735985|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
25735986|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25735987|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25735988|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25735989|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25735990|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
25735991|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25735992|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25735993|NCT05444088|Bevacizumab|bevacizumab|mesh-list
25735994|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25735995|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25735996|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25735997|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25735998|NCT05444088|Growth Substances|growth substances|mesh-ancestor
25735999|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736000|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
25736001|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
25736002|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25736003|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25736004|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736005|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25736006|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736007|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25736008|NCT05443932|Diuretics|diuretics|mesh-ancestor
25736009|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
25736010|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25736011|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773307|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773308|NCT04229303|Voriconazole|voriconazole|mesh-list
25773309|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
25773310|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773311|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25773312|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25736013|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25736014|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25736015|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736016|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25736017|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736018|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736019|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
25736020|NCT05443425|Leflunomide|leflunomide|mesh-list
25736021|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736022|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736023|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25736024|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
25736025|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736026|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25736027|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25736028|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
25736029|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25736030|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
25736031|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
25736032|NCT05443360|Calcium|calcium|mesh-list
25736033|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25736034|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736035|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25736036|NCT05443360|Antacids|antacids|mesh-ancestor
25736037|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736038|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25736039|NCT05443308|Acetazolamide|acetazolamide|mesh-list
25736040|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
25736041|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25736042|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736043|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736044|NCT05443308|Diuretics|diuretics|mesh-ancestor
25736045|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
25736046|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736047|NCT05443282|Hormones|hormones|mesh-list
25736048|NCT05443282|Estradiol|estradiol|mesh-list
25736049|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25736050|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736051|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736052|NCT05443282|Estrogens|estrogens|mesh-ancestor
25736053|NCT05443178|Isoniazid|isoniazid|mesh-list
25736054|NCT05443178|Ethambutol|ethambutol|mesh-list
25736055|NCT05443178|Chloroquine|chloroquine|mesh-list
25736056|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
25736057|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25736058|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25736059|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736060|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25736061|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25736062|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
25736063|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25736064|NCT05443178|Amebicides|amebicides|mesh-ancestor
25736065|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25736066|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25736067|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
25736068|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736069|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
25736070|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25736071|NCT05442996|Antibodies|antibodies|mesh-list
25736072|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
25736073|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25736074|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
25736075|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736076|NCT05442983|Probenecid|probenecid|mesh-list
25736077|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
25736078|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
25736079|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736080|NCT05442983|Renal Agents|renal agents|mesh-ancestor
25736081|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
25736082|NCT05442931|Pregabalin|pregabalin|mesh-list
25736083|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
25736084|NCT05442931|Analgesics|analgesics|mesh-ancestor
25736085|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
25736086|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736087|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301743|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
25736088|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
25736089|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25736090|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25736091|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736092|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25736093|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25736094|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25736095|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736096|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25736097|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
25736098|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25736099|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
25736100|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25736101|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
25736102|NCT05442801|Tropicamide|tropicamide|mesh-list
25736103|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
25736104|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
25736105|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
25736106|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736107|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736108|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25736109|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25736110|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
25736111|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736112|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736113|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
25736114|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
25736115|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25736116|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25736117|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25736118|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25736119|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736120|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736121|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736122|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25736123|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25736124|NCT05442463|Angiotensin II|angiotensin ii|mesh-list
25736125|NCT05442463|Giapreza|giapreza|mesh-list
25736126|NCT05442463|Angiotensinogen|angiotensinogen|mesh-list
25736127|NCT05442463|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25736128|NCT05442463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25736129|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
25736130|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736131|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736132|NCT05442411|Parecoxib|parecoxib|mesh-list
25736133|NCT05442411|Ropivacaine|ropivacaine|mesh-list
25736134|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
25736135|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
25736136|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736137|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736138|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
25736139|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736140|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25736141|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25736142|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736143|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736144|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25736145|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736146|NCT05442411|Analgesics|analgesics|mesh-ancestor
25736147|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736148|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736149|NCT05441150|Ketamine|ketamine|mesh-list
25736150|NCT05441150|Analgesics|analgesics|mesh-ancestor
25736151|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
25736152|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736153|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736154|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25736155|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25736156|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
25736157|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
25736158|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736159|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25736160|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25736161|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736162|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736163|NCT05440968|Chrysarobin|chrysarobin|mesh-list
25736164|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25736165|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736166|NCT05440968|Analgesics|analgesics|mesh-ancestor
25736167|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
25736168|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736169|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736170|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736171|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736172|NCT05439993|Paclitaxel|paclitaxel|mesh-list
25736173|NCT05439993|Tepotinib|tepotinib|mesh-list
25736174|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25736175|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736176|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25736177|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25736178|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25736179|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736180|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
25736181|NCT05439564|Morphine|morphine|mesh-list
25736182|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25736183|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736184|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736185|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736186|NCT05439564|Analgesics|analgesics|mesh-ancestor
25736187|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
25736188|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736189|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25736190|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25736191|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25736192|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
25736193|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736194|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736195|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25736196|NCT05439564|Narcotics|narcotics|mesh-ancestor
25736197|NCT05439499|Letrozole|letrozole|mesh-list
25736198|NCT05439499|Anastrozole|anastrozole|mesh-list
25736199|NCT05439499|Goserelin|goserelin|mesh-list
25736200|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736201|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25736202|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25736203|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736204|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736205|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25736206|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
25736207|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736208|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736209|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25736210|NCT05438810|Fulvestrant|fulvestrant|mesh-list
25736211|NCT05438810|Goserelin|goserelin|mesh-list
25736212|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25736213|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736214|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25736215|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25736216|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25736217|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736218|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736219|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
25736220|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25736221|NCT05438277|Triamcinolone|triamcinolone|mesh-list
25736222|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25736223|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25736224|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25736225|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736226|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
25736227|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
25736228|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736229|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736230|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25736231|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
25736232|NCT05438277|Hormones|hormones|mesh-ancestor
25736233|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736234|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25736235|NCT05438277|Protective Agents|protective agents|mesh-ancestor
25736236|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302052|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
25736237|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
25736238|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736239|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736240|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
25736241|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25736242|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25736243|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736244|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
25736245|NCT05437822|Coagulants|coagulants|mesh-ancestor
25736246|NCT05437601|Carotenoids|carotenoids|mesh-list
25736247|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
25736248|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736249|NCT05437601|Protective Agents|protective agents|mesh-ancestor
25736250|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773313|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773314|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773315|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25773316|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
25773317|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773318|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773319|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25773320|NCT04256603|Gabapentin|gabapentin|mesh-list
25773321|NCT04256603|Analgesics|analgesics|mesh-ancestor
25773322|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
25773323|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773324|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773325|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
25773326|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25773327|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773328|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773329|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773330|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25773331|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25773332|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773333|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773334|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
25773335|NCT04290494|Plasminogen|plasminogen|mesh-list
25773336|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25773337|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25773338|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773339|NCT04303156|Islatravir|islatravir|mesh-list
25773340|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
25773341|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773342|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773343|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773344|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25773345|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25773346|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25777490|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25777491|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777492|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777493|NCT03490916|Diuretics|diuretics|mesh-ancestor
25777494|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
25777495|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777496|NCT03477903|Metoclopramide|metoclopramide|mesh-list
25777497|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
25777498|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
25777499|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777500|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777501|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777502|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25777503|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25777504|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
25777505|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777506|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777507|NCT03469258|Pancrelipase|pancrelipase|mesh-list
25777508|NCT03469258|Pancreatin|pancreatin|mesh-list
25777509|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777510|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
25777511|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25777512|NCT03465891|Atezolizumab|atezolizumab|mesh-list
25777513|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777514|NCT03465735|Heparin|heparin|mesh-list
25302126|NCT04969731|Gemcitabine|gemcitabine|mesh-list
25736251|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
25736252|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25736253|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25736254|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736255|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
25736256|NCT05434533|Coagulants|coagulants|mesh-ancestor
25736257|NCT05434065|Celecoxib|celecoxib|mesh-list
25736258|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25736259|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736260|NCT05434065|Analgesics|analgesics|mesh-ancestor
25736261|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
25736262|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736263|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736264|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736265|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736266|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25736267|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25736268|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736269|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736270|NCT05432843|Pregabalin|pregabalin|mesh-list
25736271|NCT05432843|Analgesics|analgesics|mesh-ancestor
25736272|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
25736273|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736274|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736275|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
25736276|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25736277|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25736278|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736279|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25736280|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25736281|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25736282|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736283|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25736284|NCT05432089|Oxytocin|oxytocin|mesh-list
25736285|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
25736286|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25736287|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736288|NCT05429866|Nivolumab|nivolumab|mesh-list
25736289|NCT05429866|Durvalumab|durvalumab|mesh-list
25736290|NCT05429866|Avelumab|avelumab|mesh-list
25736291|NCT05429866|Cemiplimab|cemiplimab|mesh-list
25736292|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25736293|NCT05429866|Atezolizumab|atezolizumab|mesh-list
25736294|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25736295|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736296|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736297|NCT05429814|Menthol|menthol|mesh-list
25736298|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
25736299|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
25736300|NCT05428969|Azacitidine|azacitidine|mesh-list
25736301|NCT05428969|Venetoclax|venetoclax|mesh-list
25736302|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25736303|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
25736304|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736305|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736306|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736307|NCT05424523|Omalizumab|omalizumab|mesh-list
25736308|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25736309|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25736310|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
25736311|NCT05423340|Nicotine|nicotine|mesh-list
25736312|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25736313|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
25736314|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736315|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736316|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25736317|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25736318|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
25736319|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736320|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736321|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
25736322|NCT05418088|Fludarabine|fludarabine|mesh-list
25736323|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
25736324|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25736325|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
25736326|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736327|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736328|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25736329|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
25736330|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736331|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736332|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25736333|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25736334|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
25736335|NCT05411471|Vaccines|vaccines|mesh-list
25736336|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
25736337|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736338|NCT05407961|Dulaglutide|dulaglutide|mesh-list
25736339|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25736340|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736341|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
25736342|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25736343|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25736344|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736345|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
25736346|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736347|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736348|NCT05401097|Azacitidine|azacitidine|mesh-list
25736349|NCT05401097|Venetoclax|venetoclax|mesh-list
25736350|NCT05401097|Ivosidenib|ivosidenib|mesh-list
25736351|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25736352|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
25736353|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736354|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736355|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736356|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
25736357|NCT05395195|Hematinics|hematinics|mesh-ancestor
25736358|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
25736359|NCT05389995|Methamphetamine|methamphetamine|mesh-list
25736360|NCT05389995|Citric Acid|citric acid|mesh-list
25736361|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
25736362|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
25736363|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25736364|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
25736365|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
25736366|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736367|NCT05389995|Diuretics|diuretics|mesh-ancestor
25736368|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
25736369|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736370|NCT05389995|Expectorants|expectorants|mesh-ancestor
25736371|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25736372|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25736373|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
25736374|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
25736375|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736376|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
25736377|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736378|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
25736379|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25736380|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25736381|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25736382|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25736383|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25736384|NCT05387811|Diuretics|diuretics|mesh-list
25736385|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
25736386|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736387|NCT05351762|Paclitaxel|paclitaxel|mesh-list
25736388|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
25736389|NCT05351762|Nedaplatin|nedaplatin|mesh-list
25736390|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25736391|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736392|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25736393|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25736394|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25736395|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736396|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25736397|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
25736398|NCT05351489|Bupivacaine|bupivacaine|mesh-list
25736399|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
25736400|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
25736401|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736402|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736403|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
25773347|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25736404|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736405|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25736406|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736407|NCT05351489|Analgesics|analgesics|mesh-ancestor
25736408|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25736409|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25736410|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25736411|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
25736412|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736413|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736414|NCT05345899|Ascorbic Acid|ascorbic acid|mesh-list
25736415|NCT05345899|Vitamins|vitamins|mesh-ancestor
25736416|NCT05345899|Micronutrients|micronutrients|mesh-ancestor
25736417|NCT05345899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736418|NCT05345899|Antioxidants|antioxidants|mesh-ancestor
25736419|NCT05345899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736420|NCT05345899|Protective Agents|protective agents|mesh-ancestor
25736421|NCT05340673|Petrolatum|petrolatum|mesh-list
25736422|NCT05340673|Mineral Oil|mineral oil|mesh-list
25736423|NCT05340673|Emollients|emollients|mesh-ancestor
25736424|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
25736425|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25736426|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736427|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736428|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
25736429|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25736430|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25736431|NCT05339542|Prednisolone|prednisolone|mesh-list
25736432|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
25736433|NCT05339542|Lidocaine|lidocaine|mesh-list
25736434|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25736435|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
25736436|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
25736437|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
25736438|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736439|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736440|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
25736441|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736442|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25736443|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25736444|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25736445|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25736446|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736447|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736448|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
25736449|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
25736450|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25736451|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
25736452|NCT05339542|Hormones|hormones|mesh-ancestor
25736453|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736454|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25736455|NCT05339542|Protective Agents|protective agents|mesh-ancestor
25736456|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25736457|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736458|NCT05339373|Aceclofenac|aceclofenac|mesh-list
25736459|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25736460|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736461|NCT05339373|Analgesics|analgesics|mesh-ancestor
25736462|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
25736463|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736464|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736465|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736466|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736467|NCT05335252|Dronabinol|dronabinol|mesh-list
25736468|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
25736469|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736470|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25736471|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736472|NCT05335252|Analgesics|analgesics|mesh-ancestor
25736473|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
25736474|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736475|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25736476|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25736477|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736478|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736479|NCT05335252|Hormones|hormones|mesh-ancestor
25736480|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736481|NCT05333458|Atezolizumab|atezolizumab|mesh-list
25736482|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25736483|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736484|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
25736485|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736486|NCT05326464|Tofacitinib|tofacitinib|mesh-list
25736487|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25736488|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736489|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773348|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25773349|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25773350|NCT04323852|Vitamin D|vitamin d|mesh-list
25773351|NCT04323852|Vitamins|vitamins|mesh-ancestor
25773352|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
25773353|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773354|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25773355|NCT04327843|Haloperidol|haloperidol|mesh-list
25773356|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
25773357|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
25773358|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
25773359|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773360|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773361|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773362|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25773363|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773364|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773365|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773366|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25773367|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
25773368|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773369|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773370|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25773371|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
25773372|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
25773373|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773374|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773375|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773376|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773377|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773378|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773379|NCT04347954|Iodine|iodine|mesh-list
25773380|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
25773381|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
25773382|NCT04347954|Povidone|povidone|mesh-list
25773383|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25773384|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773385|NCT04347954|Trace Elements|trace elements|mesh-ancestor
25773386|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
25773387|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773388|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
25773389|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
25773390|NCT04358068|Azithromycin|azithromycin|mesh-list
25773391|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
25773392|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25773393|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773394|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
25773395|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773396|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773397|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773398|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773399|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773400|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
25773401|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25773402|NCT04373421|Benzydamine|benzydamine|mesh-list
25773403|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25773404|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773405|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
25773406|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
25773407|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773408|NCT04398732|Etanercept|etanercept|mesh-list
25773409|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773410|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773411|NCT04398732|Analgesics|analgesics|mesh-ancestor
25773412|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
25773413|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773414|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736491|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25736492|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
25736493|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
25736494|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736495|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736496|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736497|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25736498|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25736499|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
25736500|NCT05303636|Drospirenone|drospirenone|mesh-list
25736501|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25736502|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
25736503|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736504|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736505|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25736506|NCT05303636|Diuretics|diuretics|mesh-ancestor
25736507|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
25736508|NCT05284214|Ipilimumab|ipilimumab|mesh-list
25736509|NCT05284214|Sargramostim|sargramostim|mesh-list
25736510|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25736511|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736512|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25736513|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736514|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
25736515|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736516|NCT05278715|Carboplatin|carboplatin|mesh-list
25736517|NCT05278715|Vincristine|vincristine|mesh-list
25736518|NCT05278715|Endostatins|endostatins|mesh-list
25736519|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736520|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25736521|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
25736522|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
25736523|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
25736524|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736525|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25736526|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25736527|NCT05278715|Growth Substances|growth substances|mesh-ancestor
25736528|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736529|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
25736530|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25736531|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
25736532|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25736533|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736534|NCT05266404|Incretins|incretins|mesh-ancestor
25736535|NCT05266404|Hormones|hormones|mesh-ancestor
25736536|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736537|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25736538|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
25736539|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736540|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736541|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25736542|NCT05266027|Nalbuphine|nalbuphine|mesh-list
25736543|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25736544|NCT05266027|Narcotics|narcotics|mesh-ancestor
25736545|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736546|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736547|NCT05266027|Analgesics|analgesics|mesh-ancestor
25736548|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
25736549|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736550|NCT05261672|Midazolam|midazolam|mesh-list
25736551|NCT05261672|Bupivacaine|bupivacaine|mesh-list
25736552|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
25736553|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
25736554|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736555|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736556|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
25736557|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736558|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25736559|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25736560|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25736561|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25736562|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25736563|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25736564|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
25736565|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
25736566|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
25736567|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736568|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736569|NCT05257018|Doxorubicin|doxorubicin|mesh-list
25736570|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25736571|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736572|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25736573|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25736574|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736575|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736576|NCT05248984|Ketorolac|ketorolac|mesh-list
25736577|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25736578|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736579|NCT05248984|Analgesics|analgesics|mesh-ancestor
25736580|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
25736581|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736582|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736583|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736584|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736585|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25736586|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736587|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736588|NCT05243823|Estradiol|estradiol|mesh-list
25736589|NCT05243823|Estrogens|estrogens|mesh-ancestor
25736590|NCT05243823|Hormones|hormones|mesh-ancestor
25736591|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736592|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736593|NCT05234684|Prednisone|prednisone|mesh-list
25736594|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
25736595|NCT05234684|Vincristine|vincristine|mesh-list
25736596|NCT05234684|Rituximab|rituximab|mesh-list
25736597|NCT05234684|Doxorubicin|doxorubicin|mesh-list
25736598|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25736599|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
25736600|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736601|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736602|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25736603|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
25736604|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736605|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736606|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25736607|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736608|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
25736609|NCT05234684|Hormones|hormones|mesh-ancestor
25736610|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736611|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25736612|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25736613|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
25736614|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
25736615|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
25736616|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25736617|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25736618|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25736619|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25736620|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736621|NCT05221502|Bedaquiline|bedaquiline|mesh-list
25736622|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
25736623|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
25736624|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25736625|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25736626|NCT05215925|Carboplatin|carboplatin|mesh-list
25736627|NCT05215925|Docetaxel|docetaxel|mesh-list
25736628|NCT05215925|Pemetrexed|pemetrexed|mesh-list
25736629|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736630|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
25736631|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
25736632|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
25736633|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736634|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736635|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25736636|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25736637|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25736638|NCT05204550|Heparin|heparin|mesh-list
25736639|NCT05204550|Calcium heparin|calcium heparin|mesh-list
25736640|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
25736641|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25736642|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25736643|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736644|NCT05176626|Phentermine|phentermine|mesh-list
25736645|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25736646|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736647|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
25736648|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25736649|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
25736650|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
25736651|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736652|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
25736653|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736654|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736655|NCT05175235|Nivolumab|nivolumab|mesh-list
25736656|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25736657|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736658|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25736659|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736660|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25736661|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25736662|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25736663|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25736664|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736665|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
25736666|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736667|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773415|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773416|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773417|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773418|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25773419|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
25773420|NCT04401293|Heparin|heparin|mesh-list
25773421|NCT04401293|Enoxaparin|enoxaparin|mesh-list
25773422|NCT04401293|Calcium heparin|calcium heparin|mesh-list
25773423|NCT04401293|Dalteparin|dalteparin|mesh-list
25773424|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
25773425|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
25773426|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25773427|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25773428|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773429|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
25773430|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
25773431|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773432|NCT04420572|Betamethasone|betamethasone|mesh-list
25773433|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773434|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
25773435|NCT04420572|Hormones|hormones|mesh-ancestor
25773436|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773437|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773438|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25773439|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773440|NCT04428411|Etanercept|etanercept|mesh-list
25773441|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773442|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773443|NCT04428411|Analgesics|analgesics|mesh-ancestor
25773444|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
25773445|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773446|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773447|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773448|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773449|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773450|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25773451|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
25773452|NCT04495283|Acetaminophen|acetaminophen|mesh-list
25773453|NCT04495283|Pregabalin|pregabalin|mesh-list
25773454|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773455|NCT04495283|Analgesics|analgesics|mesh-ancestor
25773456|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
25773457|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773458|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773459|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
25773460|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
25773461|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25777515|NCT03465735|Enoxaparin|enoxaparin|mesh-list
25736668|NCT05145400|Dexamethasone|dexamethasone|mesh-list
25736669|NCT05145400|Lenalidomide|lenalidomide|mesh-list
25736670|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736671|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
25736672|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
25736673|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736674|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736675|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25736676|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
25736677|NCT05145400|Hormones|hormones|mesh-ancestor
25736678|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736679|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25736680|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736681|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
25736682|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25736683|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25736684|NCT05145400|Growth Substances|growth substances|mesh-ancestor
25736685|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
25736686|NCT05144945|Vaccines|vaccines|mesh-list
25736687|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
25736688|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736689|NCT05122494|Capecitabine|capecitabine|mesh-list
25736690|NCT05122494|Lapatinib|lapatinib|mesh-list
25736691|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25736692|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
25736693|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736694|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736695|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25736696|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736697|NCT05120895|Pravastatin|pravastatin|mesh-list
25736698|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25736699|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25736700|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
25736701|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736702|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25736703|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25736704|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736705|NCT05116241|Vaccines|vaccines|mesh-list
25736706|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
25736707|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736708|NCT05109143|Indomethacin|indomethacin|mesh-list
25736709|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25736710|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736711|NCT05109143|Analgesics|analgesics|mesh-ancestor
25736712|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
25736713|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736714|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736715|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736716|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736717|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
25736718|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
25736719|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25736720|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25736721|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736722|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736723|NCT05107427|Avelumab|avelumab|mesh-list
25736724|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25736725|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736726|NCT05090371|Ofatumumab|ofatumumab|mesh-list
25736727|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736728|NCT05067998|Vitamins|vitamins|mesh-list
25736729|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
25736730|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736731|NCT05065970|Felzartamab|felzartamab|mesh-list
25736732|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736733|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
25736734|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736735|NCT05063604|Citalopram|citalopram|mesh-list
25736736|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25736737|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25736738|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25736739|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736740|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736741|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
25303006|NCT04263350|Cobicistat|cobicistat|mesh-list
25736742|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736743|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25736744|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
25736745|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25736746|NCT05052957|Temozolomide|temozolomide|mesh-list
25736747|NCT05052957|Carmustine|carmustine|mesh-list
25736748|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25736749|NCT05052957|Lenograstim|lenograstim|mesh-list
25736750|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25736751|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
25736752|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736753|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25736754|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
25736755|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736756|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736757|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736758|NCT05049226|Vaccines|vaccines|mesh-list
25736759|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
25736760|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736761|NCT05044936|Cannabidiol|cannabidiol|mesh-list
25736762|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
25736763|NCT05023993|Niacinamide|niacinamide|mesh-list
25736764|NCT05023993|Niacin|niacin|mesh-list
25736765|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
25736766|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
25736767|NCT05023993|Vitamins|vitamins|mesh-ancestor
25736768|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
25736769|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736770|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25736771|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
25736772|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736773|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25736774|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
25736775|NCT05020145|Vaccines|vaccines|mesh-list
25736776|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
25736777|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736778|NCT05005000|Triamcinolone|triamcinolone|mesh-list
25736779|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25736780|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25736781|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25736782|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736783|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
25736784|NCT05005000|Hormones|hormones|mesh-ancestor
25736785|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736786|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736787|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25736788|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
25736789|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736790|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736791|NCT05002114|Cannabidiol|cannabidiol|mesh-list
25736792|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
25736793|NCT04978428|Cannabidiol|cannabidiol|mesh-list
25736794|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
25736795|NCT04976595|Testosterone|testosterone|mesh-list
25736796|NCT04976595|Androgens|androgens|mesh-ancestor
25736797|NCT04976595|Hormones|hormones|mesh-ancestor
25736798|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736799|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736800|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
25736801|NCT04973566|Etanercept|etanercept|mesh-list
25736802|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
25736803|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25736804|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25736805|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25736806|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736807|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736808|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736809|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25736810|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25736811|NCT04973566|Analgesics|analgesics|mesh-ancestor
25736812|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
25736813|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736814|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736815|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736816|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25736817|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25736818|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
25736819|NCT04968054|Propofol|propofol|mesh-list
25736820|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25736821|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736822|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736823|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25736824|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
25736825|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
25736826|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25736827|NCT04964544|Calcium|calcium|mesh-list
25736828|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25736829|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736830|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25736831|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25736832|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
25736833|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736834|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25736835|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25736836|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736837|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
25736838|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25736839|NCT04947020|Metformin|metformin|mesh-list
25736840|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25736841|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736842|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
25736843|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25736844|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
25736845|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736846|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
25736847|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25736848|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736849|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25736850|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
25736851|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25736852|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25736853|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736854|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736855|NCT04915508|Hormones|hormones|mesh-list
25736856|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736857|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736858|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
25736859|NCT04901169|Giapreza|giapreza|mesh-list
25736860|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
25736861|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25736862|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25736863|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
25736864|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736865|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773462|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773463|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773464|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25773465|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25773466|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773467|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773468|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773469|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
25773470|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773471|NCT04501640|Mirabegron|mirabegron|mesh-list
25773472|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25773473|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25773474|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25773475|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
25773476|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773477|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773478|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773479|NCT04501640|Urological Agents|urological agents|mesh-ancestor
25773480|NCT04501952|Remdesivir|remdesivir|mesh-list
25773481|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
25773482|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773483|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
25773484|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773485|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
25773486|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25773487|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
25773488|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25773489|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
25773490|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736867|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736868|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
25736869|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
25736870|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736871|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736872|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25736873|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
25736874|NCT04898920|Hormones|hormones|mesh-ancestor
25736875|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736876|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25736877|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736878|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
25736879|NCT04897321|Fludarabine|fludarabine|mesh-list
25736880|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25736881|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
25736882|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736883|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736884|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25736885|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
25736886|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736887|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736888|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25736889|NCT04880395|Lamivudine|lamivudine|mesh-list
25736890|NCT04880395|Emtricitabine|emtricitabine|mesh-list
25736891|NCT04880395|Dolutegravir|dolutegravir|mesh-list
25736892|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25736893|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25736894|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736895|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736896|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
25736897|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25736898|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25736899|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25736900|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25736901|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25736902|NCT04868409|Rocuronium|rocuronium|mesh-list
25736903|NCT04868409|Succinylcholine|succinylcholine|mesh-list
25736904|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25736905|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25736906|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25736907|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736908|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736909|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25736910|NCT04859764|Betamethasone|betamethasone|mesh-list
25736911|NCT04859764|Bupivacaine|bupivacaine|mesh-list
25736912|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
25736913|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
25736914|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736915|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736916|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
25736917|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736918|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736919|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
25736920|NCT04859764|Hormones|hormones|mesh-ancestor
25736921|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736922|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25736923|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
25736924|NCT04821817|Rocuronium|rocuronium|mesh-list
25736925|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25736926|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25736927|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25736928|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736929|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736930|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
25736931|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25736932|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736933|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25736934|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736935|NCT04780464|Prednisone|prednisone|mesh-list
25736936|NCT04780464|Prednisolone|prednisolone|mesh-list
25736937|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
25736938|NCT04780464|Doxorubicin|doxorubicin|mesh-list
25736939|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25303241|NCT05133791|Annexin A5|annexin a5|mesh-list
25736940|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25736941|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
25736942|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736943|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25736944|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25736945|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
25736946|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736947|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736948|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25736949|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25736950|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25736951|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25736952|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736953|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25736954|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
25736955|NCT04780464|Hormones|hormones|mesh-ancestor
25736956|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25736957|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25736958|NCT04772235|Osimertinib|osimertinib|mesh-list
25736959|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25736960|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25736961|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736962|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736963|NCT04770155|Bosentan|bosentan|mesh-list
25736964|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
25736965|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
25736966|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25736967|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25736968|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25736969|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736970|NCT04770155|Urological Agents|urological agents|mesh-ancestor
25736971|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25736972|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25736973|NCT04766463|Morphine|morphine|mesh-list
25736974|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25736975|NCT04766463|Narcotics|narcotics|mesh-ancestor
25736976|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736977|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736978|NCT04766463|Analgesics|analgesics|mesh-ancestor
25736979|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
25736980|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25736981|NCT04748523|Mirtazapine|mirtazapine|mesh-list
25736982|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
25736983|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25736984|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25736985|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
25736986|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
25736987|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25736988|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25736989|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25736990|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25736991|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25736992|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25736993|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25736994|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25736995|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25736996|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
25736997|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25736998|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25736999|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
25737000|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25737001|NCT04744181|Folic Acid|folic acid|mesh-list
25737002|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
25737003|NCT04744181|Vitamins|vitamins|mesh-ancestor
25737004|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
25737005|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737006|NCT04744181|Hematinics|hematinics|mesh-ancestor
25737007|NCT04725188|Docetaxel|docetaxel|mesh-list
25737008|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
25737009|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737010|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
25737011|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
25737012|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
25737013|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777516|NCT03465735|Dalteparin|dalteparin|mesh-list
25737014|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737015|NCT04718389|Benralizumab|benralizumab|mesh-list
25737016|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25737017|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
25737018|NCT04704453|Amitriptyline|amitriptyline|mesh-list
25737019|NCT04704453|Capsaicin|capsaicin|mesh-list
25737020|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
25737021|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
25737022|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
25737023|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737024|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737025|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25737026|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
25737027|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25737028|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25737029|NCT04704453|Analgesics|analgesics|mesh-ancestor
25737030|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25737031|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25737032|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25737033|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737034|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
25737035|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737036|NCT04704024|Tenofovir|tenofovir|mesh-list
25737037|NCT04704024|Lamivudine|lamivudine|mesh-list
25737038|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
25737039|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737040|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25737041|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25737042|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737043|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737044|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25737045|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25737046|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
25737047|NCT04700761|Anesthetics|anesthetics|mesh-list
25737048|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737049|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737050|NCT04700761|Narcotics|narcotics|mesh-ancestor
25737051|NCT04700761|Analgesics|analgesics|mesh-ancestor
25737052|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
25737053|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737054|NCT04695340|Psyllium|psyllium|mesh-list
25737055|NCT04695340|Cathartics|cathartics|mesh-ancestor
25737056|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737057|NCT04677504|Gemcitabine|gemcitabine|mesh-list
25737058|NCT04677504|Bevacizumab|bevacizumab|mesh-list
25737059|NCT04677504|Cisplatin|cisplatin|mesh-list
25737060|NCT04677504|Atezolizumab|atezolizumab|mesh-list
25737061|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737062|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737063|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25737064|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25737065|NCT04677504|Growth Substances|growth substances|mesh-ancestor
25737066|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737067|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
25737068|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25737069|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
25737070|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737071|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
25737072|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737073|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737074|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737075|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
25737076|NCT04670432|Troxerutin|troxerutin|mesh-list
25737077|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
25737078|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
25737079|NCT04661852|Topotecan|topotecan|mesh-list
25737080|NCT04661852|Mitogens|mitogens|mesh-list
25737081|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737082|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
25737083|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737084|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737085|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25737086|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
25737087|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303394|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25303395|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25303398|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
25737088|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737089|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25737090|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25737091|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25737092|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737093|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
25737094|NCT04652193|Anesthetics|anesthetics|mesh-list
25737095|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737096|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737097|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
25737098|NCT04651088|Diuretics|diuretics|mesh-ancestor
25737099|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
25737100|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737101|NCT04651088|Expectorants|expectorants|mesh-ancestor
25737102|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773491|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773492|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
25773493|NCT04507763|Etanercept|etanercept|mesh-list
25773494|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773495|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773496|NCT04507763|Analgesics|analgesics|mesh-ancestor
25773497|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
25773498|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773499|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773500|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773501|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773502|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773503|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25773504|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
25773505|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
25773506|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
25773507|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773508|NCT04854707|Menotropins|menotropins|mesh-list
25773509|NCT04854707|Hormones|hormones|mesh-list
25773510|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25773511|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773512|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773513|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25773514|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
25773515|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25773516|NCT04926233|Bromides|bromides|mesh-list
25773517|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
25773518|NCT04926233|Olodaterol|olodaterol|mesh-list
25773519|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25773520|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
25773521|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773522|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773523|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25773524|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773525|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
25773526|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25773527|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773528|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773529|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773530|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
25773531|NCT04943159|Afamelanotide|afamelanotide|mesh-list
25773532|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25773533|NCT04525157|Afamelanotide|afamelanotide|mesh-list
25773534|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
25773535|NCT04523831|Doxycycline|doxycycline|mesh-list
25773536|NCT04523831|Ivermectin|ivermectin|mesh-list
25773537|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25773538|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773539|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
25773540|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773541|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773542|NCT04511520|Trimetazidine|trimetazidine|mesh-list
25773543|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
25773544|NCT04507776|Etanercept|etanercept|mesh-list
25773545|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773546|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773547|NCT04507776|Analgesics|analgesics|mesh-ancestor
25773548|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
25773549|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773550|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773551|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773552|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773553|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737103|NCT04635839|Heparin|heparin|mesh-list
25737104|NCT04635839|Calcium heparin|calcium heparin|mesh-list
25737105|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
25737106|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25737107|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25737108|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737109|NCT04635826|Adderall|adderall|mesh-list
25737110|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25737111|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737112|NCT04626635|Cemiplimab|cemiplimab|mesh-list
25737113|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737114|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737115|NCT04595617|Antibodies|antibodies|mesh-list
25737116|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
25737117|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737118|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
25737119|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25737120|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
25737121|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25737122|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737123|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25737124|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737125|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737126|NCT04562792|Daunorubicin|daunorubicin|mesh-list
25737127|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25737128|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737129|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25737130|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25737131|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737132|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737133|NCT04553367|Meropenem|meropenem|mesh-list
25737134|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25737135|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737136|NCT04551950|Paclitaxel|paclitaxel|mesh-list
25737137|NCT04551950|Bevacizumab|bevacizumab|mesh-list
25737138|NCT04551950|Cisplatin|cisplatin|mesh-list
25737139|NCT04551950|Carboplatin|carboplatin|mesh-list
25737140|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25737141|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737142|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
25737143|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
25737144|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
25737145|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737146|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737147|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25737148|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25737149|NCT04551950|Growth Substances|growth substances|mesh-ancestor
25737150|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737151|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
25737152|NCT04545151|Verapamil|verapamil|mesh-list
25737153|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25737154|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25737155|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25737156|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737157|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25737158|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737159|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
25737160|NCT04541173|Bevacizumab|bevacizumab|mesh-list
25737161|NCT04541173|Atezolizumab|atezolizumab|mesh-list
25737162|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737163|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737164|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25737165|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25737166|NCT04541173|Growth Substances|growth substances|mesh-ancestor
25737167|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737168|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
25737169|NCT04537793|Ivacaftor|ivacaftor|mesh-list
25737170|NCT04537793|Elexacaftor|elexacaftor|mesh-list
25737171|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25737172|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25737173|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737174|NCT04523701|SMOFlipid|smoflipid|mesh-list
25737175|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25737176|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25061554|NCT03470363|Sufentanil|sufentanil|mesh-list
25737177|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25737178|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25737179|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25737180|NCT04521348|Antibodies|antibodies|mesh-list
25737181|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
25737182|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
25737183|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737184|NCT04495608|Fluconazole|fluconazole|mesh-list
25737185|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
25737186|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737187|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25737188|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25737189|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737190|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737191|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25737192|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737193|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737194|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737195|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25737196|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25737197|NCT04485039|Sevelamer|sevelamer|mesh-list
25737198|NCT04485039|Calcium acetate|calcium acetate|mesh-list
25737199|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
25737200|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
25737201|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737202|NCT04484623|Dexamethasone|dexamethasone|mesh-list
25737203|NCT04484623|Bortezomib|bortezomib|mesh-list
25737204|NCT04484623|Pomalidomide|pomalidomide|mesh-list
25737205|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737206|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
25737207|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
25737208|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737209|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737210|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737211|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
25737212|NCT04484623|Hormones|hormones|mesh-ancestor
25737213|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737214|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737215|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737216|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
25737217|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25737218|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25737219|NCT04484623|Growth Substances|growth substances|mesh-ancestor
25737220|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
25737221|NCT04458545|Heroin|heroin|mesh-list
25737222|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25737223|NCT04458545|Narcotics|narcotics|mesh-ancestor
25737224|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737225|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737226|NCT04458545|Analgesics|analgesics|mesh-ancestor
25737227|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
25737228|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737229|NCT04431635|Rituximab|rituximab|mesh-list
25737230|NCT04431635|Nivolumab|nivolumab|mesh-list
25737231|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737232|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737233|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
25737234|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737235|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737236|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25737237|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737238|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
25737239|NCT04418661|Adagrasib|adagrasib|mesh-list
25737240|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737241|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737242|NCT04408625|Sirolimus|sirolimus|mesh-list
25737243|NCT04408625|Prednisone|prednisone|mesh-list
25737244|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
25737245|NCT04408625|Rituximab|rituximab|mesh-list
25737246|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737247|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737248|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
25737249|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737250|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737251|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737252|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
25737253|NCT04408625|Hormones|hormones|mesh-ancestor
25737254|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737255|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737256|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25737257|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737258|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25737259|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
25737260|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737261|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
25737262|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
25737263|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737264|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737265|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25737266|NCT04408625|Protective Agents|protective agents|mesh-ancestor
25737267|NCT04405167|Dexamethasone|dexamethasone|mesh-list
25737268|NCT04405167|Lenalidomide|lenalidomide|mesh-list
25737269|NCT04405167|Ixazomib|ixazomib|mesh-list
25737270|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737271|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
25737272|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
25737273|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737274|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737275|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737276|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
25737277|NCT04405167|Hormones|hormones|mesh-ancestor
25737278|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737279|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737280|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737281|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
25737282|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737283|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737284|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
25737285|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25737286|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25737287|NCT04405167|Growth Substances|growth substances|mesh-ancestor
25737288|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
25737289|NCT04395508|Trastuzumab|trastuzumab|mesh-list
25737290|NCT04395508|Pertuzumab|pertuzumab|mesh-list
25737291|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737292|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737293|NCT04375605|Leucovorin|leucovorin|mesh-list
25737294|NCT04375605|Docetaxel|docetaxel|mesh-list
25737295|NCT04375605|Fluorouracil|fluorouracil|mesh-list
25737296|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
25737297|NCT04375605|Calcium|calcium|mesh-list
25737298|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
25737299|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737300|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
25737301|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
25737302|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
25737303|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737304|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25737305|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737306|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
25737307|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25737308|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737309|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
25737310|NCT04375605|Antidotes|antidotes|mesh-ancestor
25737311|NCT04375605|Protective Agents|protective agents|mesh-ancestor
25737312|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
25737313|NCT04375605|Vitamins|vitamins|mesh-ancestor
25737314|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
25737315|NCT04362761|Ivacaftor|ivacaftor|mesh-list
25737316|NCT04362761|Elexacaftor|elexacaftor|mesh-list
25737317|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25737318|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25737319|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737320|NCT04356690|Etoposide|etoposide|mesh-list
25737321|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25737322|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737323|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25737324|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25737325|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737326|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737327|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
25737328|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25737329|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25777517|NCT03465735|Warfarin|warfarin|mesh-list
25737330|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737331|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
25737332|NCT04344860|Coagulants|coagulants|mesh-ancestor
25737333|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
25737334|NCT04344184|Vitamins|vitamins|mesh-ancestor
25737335|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
25737336|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737337|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
25737338|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737339|NCT04344184|Protective Agents|protective agents|mesh-ancestor
25737340|NCT04315948|Interferons|interferons|mesh-list
25737341|NCT04315948|Ritonavir|ritonavir|mesh-list
25737342|NCT04315948|Lopinavir|lopinavir|mesh-list
25737343|NCT04315948|Interferon-beta|interferon-beta|mesh-list
25737344|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
25737345|NCT04315948|Remdesivir|remdesivir|mesh-list
25737346|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
25737347|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737348|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
25737349|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737350|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25737351|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25737352|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
25737353|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737354|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737355|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25737356|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25737357|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25737358|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25737359|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
25737360|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25737361|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25737362|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737363|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
25737364|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737365|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25737366|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
25737367|NCT04306965|Apremilast|apremilast|mesh-list
25737368|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25737369|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25737370|NCT04306965|Analgesics|analgesics|mesh-ancestor
25737371|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
25737372|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737373|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737374|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737375|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737376|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25737377|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25737378|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737379|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737380|NCT04291664|Prednisone|prednisone|mesh-list
25737381|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
25737382|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737383|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
25737384|NCT04291664|Hormones|hormones|mesh-ancestor
25737385|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737386|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737387|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737388|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737389|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25737390|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737391|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737392|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737393|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25773554|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25773555|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
25773556|NCT04495374|Pregabalin|pregabalin|mesh-list
25773557|NCT04495374|Analgesics|analgesics|mesh-ancestor
25773558|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
25773559|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773560|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773561|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
25773562|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25773563|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773564|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303905|NCT05122169|Iodine|iodine|mesh-list
25737394|NCT04270409|Dexamethasone|dexamethasone|mesh-list
25737395|NCT04270409|Lenalidomide|lenalidomide|mesh-list
25737396|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737397|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
25737398|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
25737399|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737400|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737401|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737402|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
25737403|NCT04270409|Hormones|hormones|mesh-ancestor
25737404|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737405|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737406|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737407|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
25737408|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25737409|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25737410|NCT04270409|Growth Substances|growth substances|mesh-ancestor
25737411|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
25737412|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25737413|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25737414|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25737415|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737416|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
25737417|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737418|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737419|NCT04265053|Ketorolac|ketorolac|mesh-list
25737420|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25737421|NCT04265053|Estradiol|estradiol|mesh-list
25737422|NCT04265053|Testosterone|testosterone|mesh-list
25737423|NCT04265053|Ganirelix|ganirelix|mesh-list
25737424|NCT04265053|Estrogens|estrogens|mesh-ancestor
25737425|NCT04265053|Hormones|hormones|mesh-ancestor
25737426|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737427|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737428|NCT04265053|Androgens|androgens|mesh-ancestor
25737429|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25737430|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25737431|NCT04265053|Analgesics|analgesics|mesh-ancestor
25737432|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
25737433|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737434|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737435|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737436|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25737437|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737438|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737439|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737440|NCT04239703|Antibodies|antibodies|mesh-list
25737441|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
25737442|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737443|NCT04238780|Fentanyl|fentanyl|mesh-list
25737444|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25737445|NCT04238780|Narcotics|narcotics|mesh-ancestor
25737446|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737447|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737448|NCT04238780|Analgesics|analgesics|mesh-ancestor
25737449|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
25737450|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737451|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25737452|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25737453|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
25737454|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
25737455|NCT04238754|Cannabidiol|cannabidiol|mesh-list
25737456|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25737457|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
25737458|NCT04238624|Trametinib|trametinib|mesh-list
25737459|NCT04238624|Dabrafenib|dabrafenib|mesh-list
25737460|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737461|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25737462|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737463|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737464|NCT04227184|Trospium chloride|trospium chloride|mesh-list
25737465|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
25737466|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
25737467|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303982|NCT05014334|Antacids|antacids|mesh-ancestor
25737468|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737469|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25737470|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25737471|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
25737472|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737473|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737474|NCT04227184|Urological Agents|urological agents|mesh-ancestor
25737475|NCT04197713|Olaparib|olaparib|mesh-list
25737476|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25737477|NCT04197713|Adavosertib|adavosertib|mesh-list
25737478|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737479|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737480|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737481|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
25737482|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25737483|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737484|NCT04189445|Futibatinib|futibatinib|mesh-list
25737485|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737486|NCT04156347|Topotecan|topotecan|mesh-list
25737487|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25737488|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25737489|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737490|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737491|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737492|NCT04154956|Docetaxel|docetaxel|mesh-list
25737493|NCT04154956|Maytansine|maytansine|mesh-list
25737494|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737495|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
25737496|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
25737497|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
25737498|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737499|NCT04154956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25737500|NCT04134442|Bupivacaine|bupivacaine|mesh-list
25737501|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
25737502|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
25737503|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737504|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737505|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
25737506|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737507|NCT04130438|Nebivolol|nebivolol|mesh-list
25737508|NCT04130438|Diltiazem|diltiazem|mesh-list
25737509|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25737510|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
25737511|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25737512|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25737513|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25737514|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
25737515|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737516|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737517|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737518|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25737519|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25737520|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25737521|NCT04127578|Sirolimus|sirolimus|mesh-list
25737522|NCT04127578|Prednisone|prednisone|mesh-list
25737523|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
25737524|NCT04127578|Rituximab|rituximab|mesh-list
25737525|NCT04127578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737526|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737527|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
25737528|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737529|NCT04127578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737530|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737531|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
25737532|NCT04127578|Hormones|hormones|mesh-ancestor
25737533|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737534|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737535|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25737536|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737537|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25737538|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
25737539|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737540|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
25737541|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
25304065|NCT04780932|Macitentan|macitentan|mesh-list
25737542|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737543|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737544|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25737545|NCT04127578|Protective Agents|protective agents|mesh-ancestor
25737546|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
25737547|NCT04103476|Estrogens|estrogens|mesh-list
25737548|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25737549|NCT04103476|Hormones|hormones|mesh-ancestor
25737550|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737551|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737552|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25737553|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25737554|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737555|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25737556|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25737557|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
25737558|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737559|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25737560|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25737561|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737562|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737563|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25737564|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25737565|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25737566|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737567|NCT04070768|Venetoclax|venetoclax|mesh-list
25737568|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
25737569|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737570|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737571|NCT04063124|Dasatinib|dasatinib|mesh-list
25737572|NCT04063124|Quercetin|quercetin|mesh-list
25737573|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737574|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25737575|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737576|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737577|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
25737578|NCT04063124|Protective Agents|protective agents|mesh-ancestor
25737579|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737580|NCT04048850|Grazoprevir|grazoprevir|mesh-list
25737581|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25737582|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
25737583|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737584|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
25737585|NCT04048161|Tacrolimus|tacrolimus|mesh-list
25737586|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737587|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
25737588|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737589|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25737590|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737591|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737592|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25737593|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737594|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25737595|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
25737596|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25737597|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737598|NCT04036435|BMS-986165|bms-986165|mesh-list
25737599|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
25737600|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25737601|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737602|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737603|NCT04023331|Copper|copper|mesh-list
25737604|NCT04023331|Trace Elements|trace elements|mesh-ancestor
25737605|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
25737606|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737607|NCT04017468|Vancomycin|vancomycin|mesh-list
25737608|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25737609|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737610|NCT04003987|Bupivacaine|bupivacaine|mesh-list
25737611|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
25737612|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
25737613|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737614|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737615|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
25737616|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737617|NCT03974217|Talazoparib|talazoparib|mesh-list
25737618|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25737619|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777518|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
25737620|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737621|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737622|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
25737623|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737624|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737625|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25737626|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737627|NCT03965091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25737628|NCT03965091|Immunologic Factors|immunologic factors|mesh-ancestor
25737629|NCT03965091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737630|NCT03941093|Leucovorin|leucovorin|mesh-list
25737631|NCT03941093|Gemcitabine|gemcitabine|mesh-list
25737632|NCT03941093|Paclitaxel|paclitaxel|mesh-list
25737633|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25737634|NCT03941093|Irinotecan|irinotecan|mesh-list
25737635|NCT03941093|Fluorouracil|fluorouracil|mesh-list
25737636|NCT03941093|Folfirinox|folfirinox|mesh-list
25737637|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
25737638|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25737639|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737640|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25737641|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
25737642|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25737643|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737644|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25737645|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
25737646|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
25737647|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737648|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737649|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737650|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
25737651|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737652|NCT03941093|Antidotes|antidotes|mesh-ancestor
25737653|NCT03941093|Protective Agents|protective agents|mesh-ancestor
25737654|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
25737655|NCT03941093|Vitamins|vitamins|mesh-ancestor
25737656|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
25737657|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25737658|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25737659|NCT03934216|BMS-986165|bms-986165|mesh-list
25737660|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
25737661|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25737662|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737663|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773565|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25773566|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25773567|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773568|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773569|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773570|NCT04495712|Spironolactone|spironolactone|mesh-list
25773571|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25773572|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
25773573|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773574|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773575|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25773576|NCT04495712|Diuretics|diuretics|mesh-ancestor
25773577|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
25773578|NCT04490239|Heparin|heparin|mesh-list
25773579|NCT04490239|Calcium heparin|calcium heparin|mesh-list
25773580|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
25773581|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25773582|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25773583|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773584|NCT04467424|Lidocaine|lidocaine|mesh-list
25773585|NCT04467424|Ketamine|ketamine|mesh-list
25773586|NCT04467424|Propofol|propofol|mesh-list
25773587|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
25773588|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
25773589|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773590|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773591|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
25773592|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773593|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25773594|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25773595|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25773596|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777519|NCT03465735|Dabigatran|dabigatran|mesh-list
25737665|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25737666|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737667|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737668|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
25737669|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737670|NCT03889106|Ribavirin|ribavirin|mesh-list
25737671|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
25737672|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737673|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
25737674|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737675|NCT03879109|Folfirinox|folfirinox|mesh-list
25737676|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737677|NCT03838042|Nivolumab|nivolumab|mesh-list
25737678|NCT03838042|Entinostat|entinostat|mesh-list
25737679|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737680|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737681|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25737682|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737683|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25737684|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737685|NCT03833921|Prednisone|prednisone|mesh-list
25737686|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
25737687|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737688|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
25737689|NCT03833921|Hormones|hormones|mesh-ancestor
25737690|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737691|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737692|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737693|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737694|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25737695|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737696|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737697|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737698|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25737699|NCT03828773|Fluconazole|fluconazole|mesh-list
25737700|NCT03828773|Posaconazole|posaconazole|mesh-list
25737701|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
25737702|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737703|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25737704|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25737705|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737706|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737707|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25737708|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737709|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737710|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737711|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25737712|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25737713|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25737714|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25737715|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25737716|NCT03816982|Bupivacaine|bupivacaine|mesh-list
25737717|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25737718|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
25737719|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737720|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737721|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
25737722|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737723|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
25737724|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25737725|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25737726|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737727|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
25737728|NCT03780894|Coagulants|coagulants|mesh-ancestor
25737729|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
25737730|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25737731|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737732|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737733|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25737734|NCT03770130|Analgesics|analgesics|mesh-ancestor
25737735|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
25304403|NCT03659539|Desflurane|desflurane|mesh-list
25737736|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737737|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25737738|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25737739|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25737740|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
25737741|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737742|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737743|NCT03697850|Atezolizumab|atezolizumab|mesh-list
25737744|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737745|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
25737746|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737747|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737748|NCT03689374|Insulin|insulin|mesh-list
25737749|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25737750|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
25737751|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
25737752|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25737753|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737754|NCT03668340|Adavosertib|adavosertib|mesh-list
25737755|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737756|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737757|NCT03649061|Etanercept|etanercept|mesh-list
25737758|NCT03649061|Leflunomide|leflunomide|mesh-list
25737759|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25737760|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25737761|NCT03649061|Analgesics|analgesics|mesh-ancestor
25737762|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
25737763|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737764|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737765|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737766|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737767|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737768|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737769|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
25737770|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737771|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737772|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
25737773|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737774|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737775|NCT03615547|Clomiphene|clomiphene|mesh-list
25737776|NCT03615547|Enclomiphene|enclomiphene|mesh-list
25737777|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
25737778|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25737779|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737780|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737781|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737782|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25737783|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
25737784|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25737785|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25737786|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25737787|NCT03614663|Cannabidiol|cannabidiol|mesh-list
25737788|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
25737789|NCT03613532|Fludarabine|fludarabine|mesh-list
25737790|NCT03613532|Azacitidine|azacitidine|mesh-list
25737791|NCT03613532|Busulfan|busulfan|mesh-list
25737792|NCT03613532|Decitabine|decitabine|mesh-list
25737793|NCT03613532|Venetoclax|venetoclax|mesh-list
25737794|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737795|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25737796|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
25737797|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737798|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737799|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
25737800|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737801|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737802|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
25737803|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25737804|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25737805|NCT03609008|Cromakalim|cromakalim|mesh-list
25737806|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25737807|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25737808|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
25737809|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737810|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737811|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25737812|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
25737813|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
25737814|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
25737815|NCT03595059|Paclitaxel|paclitaxel|mesh-list
25737816|NCT03595059|Docetaxel|docetaxel|mesh-list
25737817|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25737818|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737819|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25737820|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25737821|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25737822|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737823|NCT03593317|Spironolactone|spironolactone|mesh-list
25737824|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25737825|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737826|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737827|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737828|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25737829|NCT03593317|Diuretics|diuretics|mesh-ancestor
25737830|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
25737831|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25737832|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25737833|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25737834|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25737835|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25737836|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
25737837|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737838|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737839|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737840|NCT03586284|Valganciclovir|valganciclovir|mesh-list
25737841|NCT03586284|Ganciclovir|ganciclovir|mesh-list
25737842|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25737843|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
25737844|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737845|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25737846|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737847|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737848|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25737849|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
25737850|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
25737851|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25737852|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737853|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
25737854|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737855|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25737856|NCT03568656|Atezolizumab|atezolizumab|mesh-list
25737857|NCT03568656|Olaparib|olaparib|mesh-list
25737858|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
25737859|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737860|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25737861|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737862|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737863|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25737864|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737865|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737866|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737867|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25737868|NCT03567642|Etoposide|etoposide|mesh-list
25737869|NCT03567642|Osimertinib|osimertinib|mesh-list
25737870|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25737871|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737872|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25737873|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25737874|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737875|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737876|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25737877|NCT03562195|Albuterol|albuterol|mesh-list
25737878|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25737879|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
25737880|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737881|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737882|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25737883|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
25304550|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
25737884|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
25737885|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25737886|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25737887|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25737888|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25737889|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
25737890|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737891|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737892|NCT03538457|Acetaminophen|acetaminophen|mesh-list
25737893|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25737894|NCT03538457|Analgesics|analgesics|mesh-ancestor
25737895|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
25737896|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737897|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737898|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
25737899|NCT03535376|Valsartan|valsartan|mesh-list
25737900|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25737901|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25737902|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25737903|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737904|NCT03526679|Lenvatinib|lenvatinib|mesh-list
25737905|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737906|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25737907|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737908|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737909|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
25737910|NCT03516968|Vitamin D|vitamin d|mesh-list
25737911|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25737912|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737913|NCT03516968|Vitamins|vitamins|mesh-ancestor
25737914|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
25737915|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25737916|NCT03502733|Nivolumab|nivolumab|mesh-list
25737917|NCT03502733|Ipilimumab|ipilimumab|mesh-list
25737918|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737919|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737920|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25737921|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773597|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773598|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25773599|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25773600|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
25773601|NCT04467424|Analgesics|analgesics|mesh-ancestor
25773602|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25773603|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25773604|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25773605|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773606|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
25773607|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773608|NCT04448561|Morphine|morphine|mesh-list
25773609|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25773610|NCT04448561|Narcotics|narcotics|mesh-ancestor
25773611|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773612|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773613|NCT04448561|Analgesics|analgesics|mesh-ancestor
25773614|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
25773615|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773616|NCT04459585|Dabigatran|dabigatran|mesh-list
25773617|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
25773618|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25773619|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
25773620|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773621|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773622|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
25773623|NCT04456634|Lumefantrine|lumefantrine|mesh-list
25773624|NCT04456634|Artemether|artemether|mesh-list
25773625|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25773626|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
25773627|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773628|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773629|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777520|NCT03465735|Apixaban|apixaban|mesh-list
25777521|NCT03465735|Edoxaban|edoxaban|mesh-list
25777522|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
25777523|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25777524|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25737922|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25737923|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
25737924|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
25737925|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737926|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25737927|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
25737928|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737929|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25737930|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737931|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25737932|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25737933|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25737934|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25737935|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25737936|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25737937|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25737938|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25737939|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25737940|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25737941|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737942|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737943|NCT03418727|Laxatives|laxatives|mesh-ancestor
25737944|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737945|NCT03417895|Apatinib|apatinib|mesh-list
25737946|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737947|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25737948|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737949|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737950|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25737951|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25737952|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737953|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
25737954|NCT03374085|Dexamethasone|dexamethasone|mesh-list
25737955|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25737956|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
25737957|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
25737958|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25737959|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737960|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25737961|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
25737962|NCT03374085|Hormones|hormones|mesh-ancestor
25737963|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25737964|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737965|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737966|NCT03357224|Atezolizumab|atezolizumab|mesh-list
25737967|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737968|NCT03333616|Nivolumab|nivolumab|mesh-list
25737969|NCT03333616|Ipilimumab|ipilimumab|mesh-list
25737970|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25737971|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737972|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25737973|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737974|NCT03321643|Gemcitabine|gemcitabine|mesh-list
25737975|NCT03321643|Rituximab|rituximab|mesh-list
25737976|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25737977|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
25737978|NCT03321643|Atezolizumab|atezolizumab|mesh-list
25737979|NCT03321643|Antibodies|antibodies|mesh-list
25737980|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
25737981|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25737982|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
25737983|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25737984|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737985|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25737986|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25737987|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
25737988|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25737989|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
25737990|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25737991|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25737992|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25737993|NCT03310541|Fulvestrant|fulvestrant|mesh-list
25737994|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25737995|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25737996|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25737997|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25737998|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
25737999|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738000|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738001|NCT03298061|Prednisolone|prednisolone|mesh-list
25738002|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25738003|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
25738004|NCT03298061|Hormones|hormones|mesh-ancestor
25738005|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738006|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738007|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25738008|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738009|NCT03297593|Nivolumab|nivolumab|mesh-list
25738010|NCT03297593|Ipilimumab|ipilimumab|mesh-list
25738011|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738012|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738013|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25738014|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738015|NCT03201458|Atezolizumab|atezolizumab|mesh-list
25738016|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25738017|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738018|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
25738019|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738020|NCT03193684|Dapagliflozin|dapagliflozin|mesh-list
25738021|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25738022|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738023|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25738024|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738025|NCT03190668|Cefazolin|cefazolin|mesh-list
25738026|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
25738027|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25738028|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25738029|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25738030|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
25738031|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738032|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738033|NCT03166228|Glycine|glycine|mesh-list
25738034|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
25738035|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738036|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738037|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738038|NCT03154996|Topotecan|topotecan|mesh-list
25738039|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25738040|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25738041|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738042|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738043|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738044|NCT03148327|Durvalumab|durvalumab|mesh-list
25738045|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738046|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738047|NCT03141359|Paclitaxel|paclitaxel|mesh-list
25738048|NCT03141359|Etoposide|etoposide|mesh-list
25738049|NCT03141359|Carboplatin|carboplatin|mesh-list
25738050|NCT03141359|Durvalumab|durvalumab|mesh-list
25738051|NCT03141359|Cisplatin|cisplatin|mesh-list
25738052|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738053|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738054|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738055|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738056|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738057|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738058|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25738059|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25738060|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738061|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738062|NCT03134118|Nivolumab|nivolumab|mesh-list
25738063|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738064|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738065|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25738066|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738067|NCT03122509|Durvalumab|durvalumab|mesh-list
25738068|NCT03122509|Tremelimumab|tremelimumab|mesh-list
25738069|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738070|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738071|NCT03113695|Lenalidomide|lenalidomide|mesh-list
25738072|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
25738073|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
25738074|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738075|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25738076|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25738077|NCT03113695|Growth Substances|growth substances|mesh-ancestor
25738078|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
25738079|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738080|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738081|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25738082|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
25738083|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738084|NCT03080883|Apixaban|apixaban|mesh-list
25738085|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25738086|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
25738087|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25738088|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
25738089|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738090|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738091|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
25738092|NCT03040973|Gefitinib|gefitinib|mesh-list
25738093|NCT03040973|Nazartinib|nazartinib|mesh-list
25738094|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738095|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738096|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738097|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738098|NCT03033303|Isotretinoin|isotretinoin|mesh-list
25738099|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
25738100|NCT02994784|Melphalan|melphalan|mesh-list
25738101|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25738102|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
25738103|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738104|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738105|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25738106|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738107|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
25738108|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738109|NCT02971501|Bevacizumab|bevacizumab|mesh-list
25738110|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25738111|NCT02971501|Osimertinib|osimertinib|mesh-list
25738112|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
25738113|NCT02971501|Antibodies|antibodies|mesh-list
25738114|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
25738115|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25738116|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
25738117|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738118|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25738119|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25738120|NCT02971501|Growth Substances|growth substances|mesh-ancestor
25738121|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738122|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
25738123|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
25738124|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738125|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738126|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738127|NCT02952534|Rucaparib|rucaparib|mesh-list
25738128|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25738129|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738130|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738131|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738132|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
25738133|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738134|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738135|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
25738136|NCT02936752|Entinostat|entinostat|mesh-list
25738137|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25738138|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738139|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738140|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738141|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738142|NCT02927067|Valganciclovir|valganciclovir|mesh-list
25738143|NCT02927067|Maribavir|maribavir|mesh-list
25738144|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
25738145|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25738146|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
25738147|NCT02921763|Progestins|progestins|mesh-ancestor
25738148|NCT02921763|Hormones|hormones|mesh-ancestor
25773630|NCT04439214|Nivolumab|nivolumab|mesh-list
25738149|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738150|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738151|NCT02908750|Fexofenadine|fexofenadine|mesh-list
25738152|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738153|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25738154|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25738155|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25738156|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
25738157|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
25738158|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738159|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738160|NCT02904291|Amlodipine|amlodipine|mesh-list
25738161|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25738162|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25738163|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25738164|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738165|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25738166|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738167|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
25738168|NCT02890329|Ipilimumab|ipilimumab|mesh-list
25738169|NCT02890329|Decitabine|decitabine|mesh-list
25738170|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738171|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738172|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25738173|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738174|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738175|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
25738176|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738177|NCT02883062|Paclitaxel|paclitaxel|mesh-list
25738178|NCT02883062|Carboplatin|carboplatin|mesh-list
25738179|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25738180|NCT02883062|Atezolizumab|atezolizumab|mesh-list
25738181|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25738182|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738183|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738184|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738185|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738186|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738187|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738188|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
25738189|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738190|NCT02867865|Gemcitabine|gemcitabine|mesh-list
25738191|NCT02867865|Cisplatin|cisplatin|mesh-list
25738192|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738193|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738194|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
25738195|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738196|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
25738197|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25738198|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738199|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738200|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
25738201|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738202|NCT02863055|Nintedanib|nintedanib|mesh-list
25738203|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738204|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738205|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738206|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738207|NCT02833233|Nivolumab|nivolumab|mesh-list
25738208|NCT02833233|Ipilimumab|ipilimumab|mesh-list
25738209|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738210|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738211|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25738212|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738213|NCT02817633|Cisplatin|cisplatin|mesh-list
25738214|NCT02817633|Carboplatin|carboplatin|mesh-list
25738215|NCT02817633|Docetaxel|docetaxel|mesh-list
25738216|NCT02817633|Nivolumab|nivolumab|mesh-list
25738217|NCT02817633|Pemetrexed|pemetrexed|mesh-list
25738218|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738219|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738220|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738221|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738222|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305099|NCT05303090|Lenvatinib|lenvatinib|mesh-list
25738223|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738224|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25738225|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738226|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25738227|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25738228|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
25738229|NCT02811861|Everolimus|everolimus|mesh-list
25738230|NCT02811861|Sunitinib|sunitinib|mesh-list
25738231|NCT02811861|Lenvatinib|lenvatinib|mesh-list
25738232|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738233|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738234|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738235|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
25738236|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738237|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25738238|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25738239|NCT02811861|Growth Substances|growth substances|mesh-ancestor
25738240|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25738241|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738242|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738243|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738244|NCT02777190|Misoprostol|misoprostol|mesh-list
25738245|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25738246|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
25738247|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25738248|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738249|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25738250|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25738251|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
25738252|NCT02759185|Dronabinol|dronabinol|mesh-list
25738253|NCT02759185|Cannabidiol|cannabidiol|mesh-list
25738254|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
25738255|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
25738256|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738257|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738258|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738259|NCT02759185|Analgesics|analgesics|mesh-ancestor
25738260|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
25738261|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738262|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25738263|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25738264|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738265|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738266|NCT02759185|Hormones|hormones|mesh-ancestor
25738267|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738268|NCT02757313|Dronabinol|dronabinol|mesh-list
25738269|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
25738270|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738271|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738272|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738273|NCT02757313|Analgesics|analgesics|mesh-ancestor
25738274|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
25738275|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738276|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25738277|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25738278|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738279|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738280|NCT02757313|Hormones|hormones|mesh-ancestor
25738281|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773631|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25773632|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773633|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25773634|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773635|NCT04428502|Etanercept|etanercept|mesh-list
25773636|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773637|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773638|NCT04428502|Analgesics|analgesics|mesh-ancestor
25773639|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
25773640|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773641|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773642|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773643|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773644|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773645|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738282|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
25738283|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
25738284|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738285|NCT02711735|Vaccines|vaccines|mesh-list
25738286|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
25738287|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738288|NCT02629159|Adalimumab|adalimumab|mesh-list
25738289|NCT02629159|Upadacitinib|upadacitinib|mesh-list
25738290|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25738291|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25738292|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25738293|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738294|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738295|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738296|NCT02586025|Docetaxel|docetaxel|mesh-list
25738297|NCT02586025|Trastuzumab|trastuzumab|mesh-list
25738298|NCT02586025|Pertuzumab|pertuzumab|mesh-list
25738299|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738300|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738301|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738302|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738303|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738304|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738305|NCT02569242|Paclitaxel|paclitaxel|mesh-list
25738306|NCT02569242|Docetaxel|docetaxel|mesh-list
25738307|NCT02569242|Nivolumab|nivolumab|mesh-list
25738308|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738309|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738310|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738311|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738312|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738313|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738314|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738315|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25738316|NCT02524379|Glyburide|glyburide|mesh-list
25738317|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25738318|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738319|NCT02514278|Capecitabine|capecitabine|mesh-list
25738320|NCT02514278|Folfirinox|folfirinox|mesh-list
25738321|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738322|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
25738323|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738324|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738325|NCT02496663|Osimertinib|osimertinib|mesh-list
25738326|NCT02496663|Necitumumab|necitumumab|mesh-list
25738327|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25738328|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738329|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738330|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738331|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738332|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738333|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
25738334|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738335|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
25738336|NCT02457598|Idelalisib|idelalisib|mesh-list
25738337|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738338|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738339|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738340|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738341|NCT02451111|Rituximab|rituximab|mesh-list
25738342|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738343|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738344|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
25738345|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738346|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25738347|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25738348|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
25738349|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738350|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738351|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
25738352|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738353|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738354|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25738355|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25305250|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738356|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25738357|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738358|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
25738359|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25738360|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738361|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738362|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738363|NCT02409810|Analgesics|analgesics|mesh-ancestor
25738364|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
25738365|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738366|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25738367|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25738368|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25738369|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738370|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738371|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738373|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
25738374|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25738375|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25738376|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738377|NCT02358356|Capecitabine|capecitabine|mesh-list
25738378|NCT02358356|Temozolomide|temozolomide|mesh-list
25738379|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738380|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
25738381|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738382|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738383|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25738384|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
25738385|NCT02345265|Olaparib|olaparib|mesh-list
25738386|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25738387|NCT02345265|Cediranib|cediranib|mesh-list
25738388|NCT02345265|Maleic acid|maleic acid|mesh-list
25738389|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738390|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738391|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738392|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738393|NCT02340676|Interleukin-2|interleukin-2|mesh-list
25738394|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738395|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738396|NCT02340676|Analgesics|analgesics|mesh-ancestor
25738397|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
25738398|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738399|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738400|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
25738401|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738402|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738403|NCT02282345|Talazoparib|talazoparib|mesh-list
25738404|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25738405|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738406|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738407|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738408|NCT02162810|Prednisolone|prednisolone|mesh-list
25738409|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25738410|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
25738411|NCT02162810|Hormones|hormones|mesh-ancestor
25738412|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738413|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738414|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25738415|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738416|NCT02120469|Everolimus|everolimus|mesh-list
25738417|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738418|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738419|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
25738420|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738421|NCT02109744|Decitabine|decitabine|mesh-list
25738422|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738423|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
25738424|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738425|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738426|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738427|NCT02101905|Lapatinib|lapatinib|mesh-list
25738428|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738429|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738430|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738431|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738432|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
25738433|NCT02061293|Promethazine|promethazine|mesh-list
25738434|NCT02061293|Psilocybin|psilocybin|mesh-list
25738435|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25738436|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25738437|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738438|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738439|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
25738440|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
25738441|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
25738442|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738443|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
25738444|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
25738445|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25738446|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25738447|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
25738448|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
25738449|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738450|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738451|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25738452|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
25738453|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
25738454|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
25738455|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738456|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25738457|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
25738458|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738459|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738460|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
25738461|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738462|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738463|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25738464|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25738465|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25738466|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738467|NCT02000622|Olaparib|olaparib|mesh-list
25738468|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25738469|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738470|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738471|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738472|NCT01970345|Mecasermin|mecasermin|mesh-list
25738473|NCT01970345|Growth Substances|growth substances|mesh-ancestor
25738474|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738475|NCT01954966|Progesterone|progesterone|mesh-list
25738476|NCT01954966|Progestins|progestins|mesh-ancestor
25738477|NCT01954966|Hormones|hormones|mesh-ancestor
25738478|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738479|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738480|NCT01937468|Interleukin-2|interleukin-2|mesh-list
25738481|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738482|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738483|NCT01937468|Analgesics|analgesics|mesh-ancestor
25738484|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
25738485|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738486|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738487|NCT01873326|Paclitaxel|paclitaxel|mesh-list
25738488|NCT01873326|Etoposide|etoposide|mesh-list
25738489|NCT01873326|Cisplatin|cisplatin|mesh-list
25738490|NCT01873326|Ifosfamide|ifosfamide|mesh-list
25738491|NCT01873326|Bleomycin|bleomycin|mesh-list
25738492|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738493|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738494|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738495|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738496|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738497|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738498|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25738499|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25738500|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738501|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25738502|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
25738503|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25738504|NCT01871766|Dactinomycin|dactinomycin|mesh-list
25738505|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
25738506|NCT01871766|Ifosfamide|ifosfamide|mesh-list
25738507|NCT01871766|Bevacizumab|bevacizumab|mesh-list
25738508|NCT01871766|Doxorubicin|doxorubicin|mesh-list
25738509|NCT01871766|Irinotecan|irinotecan|mesh-list
25738510|NCT01871766|Etoposide|etoposide|mesh-list
25738511|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
25738512|NCT01871766|Vincristine|vincristine|mesh-list
25738513|NCT01871766|Sorafenib|sorafenib|mesh-list
25738514|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
25738515|NCT01871766|Razoxane|razoxane|mesh-list
25738516|NCT01871766|Mitogens|mitogens|mesh-list
25738517|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738518|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
25738519|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738520|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25738521|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25738522|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
25738523|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738524|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738525|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25738526|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738527|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25738528|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25738529|NCT01871766|Growth Substances|growth substances|mesh-ancestor
25738530|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
25738531|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25738532|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25738533|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25738534|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738535|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25738536|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738537|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738538|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738539|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738540|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738541|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25738542|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25738543|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25738544|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25738545|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25738546|NCT01871766|Protective Agents|protective agents|mesh-ancestor
25738547|NCT01866657|Phenylephrine|phenylephrine|mesh-list
25738548|NCT01866657|Dopamine|dopamine|mesh-list
25738549|NCT01866657|Ephedrine|ephedrine|mesh-list
25738550|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25738551|NCT01866657|Propofol|propofol|mesh-list
25738552|NCT01866657|Sevoflurane|sevoflurane|mesh-list
25738553|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
25738554|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738555|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738556|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25738557|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25738558|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
25738559|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25738560|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25738561|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25738562|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
25738563|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
25738564|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738565|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
25738566|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
25738567|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
25738568|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25738569|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25738570|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25738571|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738572|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738573|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738574|NCT01866657|Protective Agents|protective agents|mesh-ancestor
25738575|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25305605|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25305606|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25305607|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25738576|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
25738577|NCT01729455|Belimumab|belimumab|mesh-list
25738578|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738579|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
25738580|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738581|NCT01705977|Belimumab|belimumab|mesh-list
25738582|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738583|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
25738584|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738585|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25738586|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
25738587|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738588|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738589|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
25738590|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738591|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738592|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25738593|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25738594|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25738595|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738596|NCT01366092|Interleukin-2|interleukin-2|mesh-list
25738597|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738598|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738599|NCT01366092|Analgesics|analgesics|mesh-ancestor
25738600|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
25738601|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738602|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738603|NCT01222247|Betamethasone|betamethasone|mesh-list
25738604|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25738605|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
25738606|NCT01222247|Hormones|hormones|mesh-ancestor
25738607|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738608|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738609|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25738610|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
25738611|NCT01141309|Everolimus|everolimus|mesh-list
25738612|NCT01141309|Sorafenib|sorafenib|mesh-list
25738613|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738614|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738615|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
25738616|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738617|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738618|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738619|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738620|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
25738621|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738622|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
25738623|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738624|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25738625|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25738626|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
25738627|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738628|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738629|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25738630|NCT01107626|Paclitaxel|paclitaxel|mesh-list
25738631|NCT01107626|Bevacizumab|bevacizumab|mesh-list
25738632|NCT01107626|Carboplatin|carboplatin|mesh-list
25738633|NCT01107626|Pemetrexed|pemetrexed|mesh-list
25738634|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738635|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738636|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
25305702|NCT04989660|Phenol|phenol|mesh-list
25305703|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25305704|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305705|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
25305706|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25305707|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25305708|NCT04969237|Vitamin D|vitamin d|mesh-list
25305709|NCT04969237|Vitamins|vitamins|mesh-ancestor
25305710|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
25305711|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305712|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25305713|NCT04965454|Choline|choline|mesh-list
25305714|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
25305715|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25305716|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
25305717|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305724|NCT04951986|Levofloxacin|levofloxacin|mesh-list
25738637|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738638|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738639|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738640|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738641|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25738642|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25738643|NCT01107626|Growth Substances|growth substances|mesh-ancestor
25738644|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738645|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
25738646|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738647|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25738648|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25738649|NCT00961142|Fludarabine|fludarabine|mesh-list
25738650|NCT00961142|Melphalan|melphalan|mesh-list
25738651|NCT00961142|Thiotepa|thiotepa|mesh-list
25738652|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
25738653|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738654|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738655|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738656|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
25738657|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738658|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25738659|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
25738660|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25738661|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25738662|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
25738663|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738664|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738665|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25738666|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
25738667|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738668|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738669|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25738670|NCT00914823|Hormones|hormones|mesh-list
25738671|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738672|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738673|NCT00823563|Adenosine|adenosine|mesh-list
25738674|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
25738675|NCT00823563|Analgesics|analgesics|mesh-ancestor
25738676|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
25738677|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738678|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738679|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25738680|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
25738681|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25738682|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
25738683|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
25738684|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738685|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738686|NCT00619931|APD791|apd791|mesh-list
25738687|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25738688|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25738689|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
25738690|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738691|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738692|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738693|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25738694|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
25738695|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738696|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738697|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
25738698|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738699|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738700|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25738701|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25738702|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25738703|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738704|NCT00251433|Docetaxel|docetaxel|mesh-list
25738705|NCT00251433|Trastuzumab|trastuzumab|mesh-list
25738706|NCT00251433|Lapatinib|lapatinib|mesh-list
25738707|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738708|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738709|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738710|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738711|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738712|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738713|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738714|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738715|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25738716|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
25738717|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738718|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738719|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
25738720|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738721|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738722|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25738723|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25738724|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25738725|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738726|NCT00059930|Leucovorin|leucovorin|mesh-list
25738727|NCT00059930|Dexamethasone|dexamethasone|mesh-list
25738728|NCT00059930|Fluorouracil|fluorouracil|mesh-list
25738729|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
25738730|NCT00059930|Floxuridine|floxuridine|mesh-list
25738731|NCT00059930|Calcium|calcium|mesh-list
25738732|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
25738733|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25738734|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
25738735|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
25738736|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738737|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738738|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25738739|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
25738740|NCT00059930|Hormones|hormones|mesh-ancestor
25738741|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738742|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25738743|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738744|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25738745|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
25738746|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738747|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738748|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738749|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
25738750|NCT00059930|Antidotes|antidotes|mesh-ancestor
25738751|NCT00059930|Protective Agents|protective agents|mesh-ancestor
25738752|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
25738753|NCT00059930|Vitamins|vitamins|mesh-ancestor
25738754|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
25738755|NCT05452785|Minocycline|minocycline|mesh-list
25738756|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25738757|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773646|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
25773647|NCT04428424|Etanercept|etanercept|mesh-list
25773648|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773649|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773650|NCT04428424|Analgesics|analgesics|mesh-ancestor
25773651|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
25773652|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773653|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773654|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773655|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773656|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773657|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25773658|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
25773659|NCT04428359|Vitamin D|vitamin d|mesh-list
25773660|NCT04428359|Vitamins|vitamins|mesh-ancestor
25773661|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
25773662|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773663|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25773664|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
25773665|NCT04410159|Listerine|listerine|mesh-list
25773666|NCT04410159|Povidone|povidone|mesh-list
25773667|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
25773668|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
25773669|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25773670|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773671|NCT04425850|Ivermectin|ivermectin|mesh-list
25773672|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773673|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773674|NCT04425863|Aspirin|aspirin|mesh-list
25773675|NCT04425863|Ivermectin|ivermectin|mesh-list
25773676|NCT04425863|Dexamethasone|dexamethasone|mesh-list
25738758|NCT05452577|Estazolam|estazolam|mesh-list
25738759|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
25738760|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25738761|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25738762|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738763|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738764|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738765|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
25738766|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
25738767|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738768|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738769|NCT05452512|Vitamin D|vitamin d|mesh-list
25738770|NCT05452512|Vitamins|vitamins|mesh-list
25738771|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
25738772|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738773|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25738774|NCT05452434|Mirabegron|mirabegron|mesh-list
25738775|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25738776|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25738777|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25738778|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738779|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738780|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738781|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738782|NCT05452434|Urological Agents|urological agents|mesh-ancestor
25738783|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25738784|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
25738785|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738786|NCT05451472|Calcium|calcium|mesh-list
25738787|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
25738788|NCT05451472|Hormones|hormones|mesh-list
25738789|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25738790|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738791|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738792|NCT05451290|Gemcitabine|gemcitabine|mesh-list
25738793|NCT05451290|Tegafur|tegafur|mesh-list
25738794|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
25738795|NCT05451290|Apatinib|apatinib|mesh-list
25738796|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738797|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
25738798|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738799|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738800|NCT05451290|Antiviral Agents|antiviral agents|mesh-ancestor
25738801|NCT05451290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25738802|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738803|NCT05451290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738804|NCT05451290|Immunologic Factors|immunologic factors|mesh-ancestor
25738805|NCT05451290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738806|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25738807|NCT05451173|Durvalumab|durvalumab|mesh-list
25738808|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738809|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738810|NCT05451147|Metformin|metformin|mesh-list
25738811|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25738812|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738813|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
25738814|NCT05451121|Propofol|propofol|mesh-list
25738815|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25738816|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738817|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738818|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25738819|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
25738820|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
25738821|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738822|NCT05451121|Analgesics|analgesics|mesh-ancestor
25738823|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
25738824|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738825|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25738826|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25738827|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25738828|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738829|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738830|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738831|NCT05451043|Gemcitabine|gemcitabine|mesh-list
25738832|NCT05451043|Paclitaxel|paclitaxel|mesh-list
25738833|NCT05451043|Cisplatin|cisplatin|mesh-list
25738834|NCT05451043|Durvalumab|durvalumab|mesh-list
25738835|NCT05451043|Tremelimumab|tremelimumab|mesh-list
25738836|NCT05451043|Propranolol|propranolol|mesh-list
25738837|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738838|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738839|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738840|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738841|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738842|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738843|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738844|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
25738845|NCT05451043|Antiviral Agents|antiviral agents|mesh-ancestor
25738846|NCT05451043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25738847|NCT05451043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738848|NCT05451043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738849|NCT05451043|Immunologic Factors|immunologic factors|mesh-ancestor
25738850|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738851|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738852|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25738853|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25738854|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738855|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738856|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25738857|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25738858|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
25738859|NCT05450978|Lamotrigine|lamotrigine|mesh-list
25738860|NCT05450978|Levetiracetam|levetiracetam|mesh-list
25738861|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
25738862|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
25738863|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25738864|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25738865|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738866|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25738867|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738868|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25738869|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25738870|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738871|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738872|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25738873|NCT05450900|Biotin|biotin|mesh-list
25738874|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25738875|NCT05450900|Vitamins|vitamins|mesh-ancestor
25738876|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
25738877|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738878|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
25738879|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25738880|NCT05450718|Buprenorphine|buprenorphine|mesh-list
25738881|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25738882|NCT05450718|Naloxone|naloxone|mesh-list
25738883|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25738884|NCT05450718|Narcotics|narcotics|mesh-ancestor
25738885|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738886|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738887|NCT05450718|Analgesics|analgesics|mesh-ancestor
25738888|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
25738889|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738890|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25738891|NCT05450692|Docetaxel|docetaxel|mesh-list
25738892|NCT05450692|Durvalumab|durvalumab|mesh-list
25738893|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738894|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738895|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738896|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738897|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738898|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25773677|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
25773678|NCT04425863|Enoxaparin|enoxaparin|mesh-list
25773679|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25773680|NCT04425863|BB 1101|bb 1101|mesh-list
25773681|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773682|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
25773683|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
25773684|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773685|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773686|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773687|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
25773688|NCT04425863|Hormones|hormones|mesh-ancestor
25773689|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25738899|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
25738900|NCT05450497|Propofol|propofol|mesh-list
25738901|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25738902|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738903|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738904|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25738905|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
25738906|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
25738907|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25738908|NCT05450497|Analgesics|analgesics|mesh-ancestor
25738909|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
25738910|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738911|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25738912|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25738913|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25738914|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
25738915|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738916|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738917|NCT05450484|Durvalumab|durvalumab|mesh-list
25738918|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25738919|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738920|NCT05450458|Sorbitol|sorbitol|mesh-list
25738921|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
25738922|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25738923|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
25738924|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738925|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
25738926|NCT05450458|Protective Agents|protective agents|mesh-ancestor
25738927|NCT05450458|Cathartics|cathartics|mesh-ancestor
25738928|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25738929|NCT05450432|Ketamine|ketamine|mesh-list
25738930|NCT05450432|Esketamine|esketamine|mesh-list
25738931|NCT05450432|Analgesics|analgesics|mesh-ancestor
25738932|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
25738933|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25738934|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738935|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25738936|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25738937|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
25738938|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
25738939|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25738940|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25738941|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25738942|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25738943|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738944|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
25738945|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25738946|NCT05450328|Epoprostenol|epoprostenol|mesh-list
25738947|NCT05450328|Milrinone|milrinone|mesh-list
25738948|NCT05450328|Tezosentan|tezosentan|mesh-list
25738949|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25738950|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25738951|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
25738952|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25738953|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25738954|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738955|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738956|NCT05450328|Protective Agents|protective agents|mesh-ancestor
25738957|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738958|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25738959|NCT05450042|Paclitaxel|paclitaxel|mesh-list
25738960|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25738961|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738962|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25738963|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25738964|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25738965|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738966|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
25738967|NCT05449899|Busulfan|busulfan|mesh-list
25738968|NCT05449899|Fludarabine|fludarabine|mesh-list
25738969|NCT05449899|Decitabine|decitabine|mesh-list
25738970|NCT05449899|Lenograstim|lenograstim|mesh-list
25738971|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25738972|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
25738973|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738974|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25738975|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25738977|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25738978|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738979|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25738980|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25738981|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
25738982|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25738983|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25738984|NCT05449548|Lenalidomide|lenalidomide|mesh-list
25738985|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
25738986|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25738987|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25738988|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25738989|NCT05449548|Growth Substances|growth substances|mesh-ancestor
25738990|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
25738991|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25738992|NCT05449535|Omalizumab|omalizumab|mesh-list
25738993|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25738994|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25738995|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
25738996|NCT05449522|Vitamin D|vitamin d|mesh-list
25738997|NCT05449522|Vitamins|vitamins|mesh-ancestor
25738998|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
25738999|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739000|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25739001|NCT05449483|Paclitaxel|paclitaxel|mesh-list
25739002|NCT05449483|Cisplatin|cisplatin|mesh-list
25739003|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739004|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739005|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739006|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
25739007|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739008|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739009|NCT05449366|Paclitaxel|paclitaxel|mesh-list
25739010|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25739011|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739012|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739013|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739014|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
25739015|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739016|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739017|NCT05449171|Vitamin D|vitamin d|mesh-list
25739018|NCT05449171|Vitamins|vitamins|mesh-list
25739019|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
25739020|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
25739021|NCT05449171|Pyridoxal|pyridoxal|mesh-list
25739022|NCT05449171|Pyridoxine|pyridoxine|mesh-list
25739023|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
25739024|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
25739025|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739026|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25739027|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
25739028|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25739029|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
25739030|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
25739031|NCT05449171|Protective Agents|protective agents|mesh-ancestor
25739032|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
25739033|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739034|NCT05449145|Vitamin D|vitamin d|mesh-list
25739035|NCT05449145|Vitamins|vitamins|mesh-ancestor
25739036|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
25739037|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739038|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25739039|NCT05449028|Bismuth|bismuth|mesh-list
25739040|NCT05449028|Antacids|antacids|mesh-ancestor
25739041|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739042|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25739043|NCT05449015|Atropine|atropine|mesh-list
25739044|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25739045|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25739046|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25739047|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
25739048|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739049|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739050|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25739051|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
25739052|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
25739053|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
25739054|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25739055|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25739056|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
25739057|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739058|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739059|NCT05448937|Eugenol|eugenol|mesh-list
25739060|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
25739061|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
25739062|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
25739063|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25739064|NCT05448937|Protective Agents|protective agents|mesh-ancestor
25739065|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739066|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739067|NCT05448924|Hormones|hormones|mesh-list
25739068|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739069|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739070|NCT05448885|Gemcitabine|gemcitabine|mesh-list
25739071|NCT05448885|Cisplatin|cisplatin|mesh-list
25739072|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739073|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739074|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
25739075|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739076|NCT05448885|Antiviral Agents|antiviral agents|mesh-ancestor
25739077|NCT05448885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739078|NCT05448885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739079|NCT05448885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25739080|NCT05448885|Immunologic Factors|immunologic factors|mesh-ancestor
25739081|NCT05448885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739082|NCT05448872|Valsartan|valsartan|mesh-list
25739083|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25739084|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25739085|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25739086|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25739087|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739088|NCT05448820|Doxorubicin|doxorubicin|mesh-list
25739089|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25739090|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739091|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25739092|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25739093|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739094|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739095|NCT05448807|Phentolamine|phentolamine|mesh-list
25739096|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25739097|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25739098|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
25739099|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739100|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739101|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739102|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25739103|NCT05448781|Paclitaxel|paclitaxel|mesh-list
25739104|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25739105|NCT05448781|Carboplatin|carboplatin|mesh-list
25739106|NCT05448781|Pemetrexed|pemetrexed|mesh-list
25739107|NCT05448781|Endostatins|endostatins|mesh-list
25739108|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739109|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739110|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739111|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
25739112|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739113|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739114|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739115|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25739116|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25739117|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25739118|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25739119|NCT05448781|Growth Substances|growth substances|mesh-ancestor
25739120|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739121|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
25739122|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
25739123|NCT05448586|Narcotics|narcotics|mesh-ancestor
25739124|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739125|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739126|NCT05448586|Analgesics|analgesics|mesh-ancestor
25739127|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
25739128|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773690|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25773691|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773692|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
25773693|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773694|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773695|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773696|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773697|NCT04425863|Analgesics|analgesics|mesh-ancestor
25773698|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
25773699|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773700|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25773701|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25773702|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25773703|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25773704|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
25773705|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
25773706|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773707|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773708|NCT04425746|Afamelanotide|afamelanotide|mesh-list
25773709|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
25773710|NCT04422561|Ivermectin|ivermectin|mesh-list
25773711|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773712|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773713|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
25773714|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25773715|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25773716|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
25773717|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773718|NCT04407507|Ivermectin|ivermectin|mesh-list
25773719|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773720|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773721|NCT04406194|Favipiravir|favipiravir|mesh-list
25773722|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
25773723|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773724|NCT04403399|Varenicline|varenicline|mesh-list
25773725|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25773726|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25773727|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773728|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773729|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773730|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773731|NCT04400682|Favipiravir|favipiravir|mesh-list
25773732|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
25773733|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773734|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
25773735|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25773736|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773737|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
25773738|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
25773739|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773740|NCT04399122|Acetaminophen|acetaminophen|mesh-list
25773741|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25773742|NCT04399122|Oxycodone|oxycodone|mesh-list
25773743|NCT04399122|Codeine|codeine|mesh-list
25773744|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773745|NCT04399122|Analgesics|analgesics|mesh-ancestor
25773746|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
25773747|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773748|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773749|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
25773750|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25773751|NCT04399122|Narcotics|narcotics|mesh-ancestor
25773752|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773753|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
25773754|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
25773755|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773756|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773757|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773758|NCT04397445|Ranitidine|ranitidine|mesh-list
25773759|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25773760|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25773761|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25773762|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25773763|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
25773764|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
25773765|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773766|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739129|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25739130|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25739131|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739133|NCT05448365|Vitamins|vitamins|mesh-list
25739134|NCT05448365|Inositol|inositol|mesh-list
25739135|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
25739136|NCT05448365|Pyridoxal|pyridoxal|mesh-list
25739137|NCT05448365|Pyridoxine|pyridoxine|mesh-list
25739138|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25739139|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
25739140|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739141|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25739142|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
25739143|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
25739144|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739145|NCT05448365|Protective Agents|protective agents|mesh-ancestor
25739146|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25739147|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25739148|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739149|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25739150|NCT05448183|Gemcitabine|gemcitabine|mesh-list
25739151|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
25739152|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739153|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
25739154|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739155|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739156|NCT05448183|Antiviral Agents|antiviral agents|mesh-ancestor
25739157|NCT05448183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739158|NCT05448183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739159|NCT05448183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25739160|NCT05448183|Immunologic Factors|immunologic factors|mesh-ancestor
25739161|NCT05448183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739162|NCT05448001|Lansoprazole|lansoprazole|mesh-list
25739163|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
25739164|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25739165|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25739166|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25739167|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739168|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739169|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
25739170|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
25739171|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
25739172|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739173|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739174|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
25739175|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739176|NCT05447936|Vitamin D|vitamin d|mesh-list
25739177|NCT05447936|Vitamins|vitamins|mesh-ancestor
25739178|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
25739179|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739180|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25739181|NCT05447871|Bupivacaine|bupivacaine|mesh-list
25739182|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
25739183|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
25739184|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739185|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739186|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
25739187|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739188|NCT05447780|Anesthetics|anesthetics|mesh-list
25739189|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739190|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739191|NCT05447702|Paclitaxel|paclitaxel|mesh-list
25739192|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
25739193|NCT05447702|Apatinib|apatinib|mesh-list
25739194|NCT05447702|Epirubicin|epirubicin|mesh-list
25739195|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739196|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739197|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739198|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
25739199|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739200|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739201|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25739202|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
25739203|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739204|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739205|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25739207|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25739208|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25739209|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739210|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25739211|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25739212|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25739213|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
25739214|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25739215|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25739216|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739217|NCT05447559|Cefazolin|cefazolin|mesh-list
25739218|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25739219|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739220|NCT05447520|Montelukast|montelukast|mesh-list
25739221|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25739222|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
25739223|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25739224|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
25739225|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739226|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739227|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25739228|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25739229|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739230|NCT05447455|Anesthetics|anesthetics|mesh-list
25739231|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
25739232|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739233|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739234|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
25739235|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739236|NCT05447364|Pregabalin|pregabalin|mesh-list
25739237|NCT05447364|Analgesics|analgesics|mesh-ancestor
25739238|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
25739239|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739240|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739241|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
25739242|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25739243|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25739244|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739245|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25739246|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25739247|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25739248|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739249|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25739250|NCT05447208|Hormones|hormones|mesh-list
25739251|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739252|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739253|NCT05447169|Antibodies|antibodies|mesh-list
25739254|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
25739255|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739256|NCT05447039|Montelukast|montelukast|mesh-list
25739257|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25739258|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25739259|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25739260|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
25739261|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739262|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739263|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25739264|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25739265|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739266|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
25739267|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25739268|NCT05446883|Paclitaxel|paclitaxel|mesh-list
25739269|NCT05446883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25739270|NCT05446883|Bevacizumab|bevacizumab|mesh-list
25739271|NCT05446883|Cisplatin|cisplatin|mesh-list
25739272|NCT05446883|Carboplatin|carboplatin|mesh-list
25739273|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739274|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739275|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739276|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25739277|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739278|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739279|NCT05446883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25739280|NCT05446883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25739281|NCT05446883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25739282|NCT05446883|Growth Substances|growth substances|mesh-ancestor
25739283|NCT05446883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739284|NCT05446883|Growth Inhibitors|growth inhibitors|mesh-ancestor
25739285|NCT05446805|Corticosterone|corticosterone|mesh-list
25739286|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739287|NCT05446727|Ropivacaine|ropivacaine|mesh-list
25739288|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
25739289|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
25739290|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739291|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739292|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
25739293|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773767|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773768|NCT04396639|Factor VIII|factor viii|mesh-list
25773769|NCT04396639|Coagulants|coagulants|mesh-ancestor
25773770|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
25773771|NCT04393493|Furosemide|furosemide|mesh-list
25773772|NCT04393493|Spironolactone|spironolactone|mesh-list
25773773|NCT04393493|Diuretics|diuretics|mesh-ancestor
25773774|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
25773775|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773776|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25773777|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773778|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773779|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25773780|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
25773781|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25773782|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25773783|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25773784|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25773785|NCT04392362|Adenosine|adenosine|mesh-list
25773786|NCT04392362|Analgesics|analgesics|mesh-ancestor
25773787|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
25773788|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773789|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773790|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25773791|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
25773792|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25773793|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
25773794|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
25773795|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773796|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773797|NCT04392141|Colchicine|colchicine|mesh-list
25773798|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
25773799|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773800|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
25773801|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
25773802|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
25773803|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773804|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773805|NCT04391842|Diclofenac|diclofenac|mesh-list
25773806|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773807|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773808|NCT04391842|Analgesics|analgesics|mesh-ancestor
25773809|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
25773810|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773811|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773812|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25773813|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773814|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25773815|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773816|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773817|NCT04390022|Ivermectin|ivermectin|mesh-list
25773818|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773819|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773820|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
25773821|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773822|NCT04374500|Verapamil|verapamil|mesh-list
25773823|NCT04374500|Nitroprusside|nitroprusside|mesh-list
25773824|NCT04374500|Acetylcholine|acetylcholine|mesh-list
25773825|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
25739294|NCT05446623|Sufentanil|sufentanil|mesh-list
25739295|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
25739296|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25739297|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739298|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739299|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25739300|NCT05446623|Analgesics|analgesics|mesh-ancestor
25739301|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
25739302|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739303|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25739304|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25739305|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25739306|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
25739307|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739308|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739309|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25739310|NCT05446623|Narcotics|narcotics|mesh-ancestor
25739311|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25739312|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25739313|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
25739314|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
25739315|NCT05446415|Glucagon|glucagon|mesh-list
25739316|NCT05446415|Incretins|incretins|mesh-list
25739317|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25739318|NCT05446415|Hormones|hormones|mesh-ancestor
25739319|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739320|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739321|NCT05444777|Ketamine|ketamine|mesh-list
25739322|NCT05444777|Analgesics|analgesics|mesh-ancestor
25739323|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
25739324|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739325|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739326|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25739327|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25739328|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
25739329|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
25739330|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739331|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25739332|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25739333|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739334|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739335|NCT05442905|Anesthetics|anesthetics|mesh-list
25739336|NCT05442905|Propofol|propofol|mesh-list
25739337|NCT05442905|Sevoflurane|sevoflurane|mesh-list
25739338|NCT05442905|Atracurium|atracurium|mesh-list
25739339|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739340|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739341|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25739342|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25739343|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
25739344|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25739345|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25739346|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25739347|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25739348|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25739349|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739350|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25739351|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25739352|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
25739353|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739354|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739355|NCT05442749|Niraparib|niraparib|mesh-list
25739356|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25739357|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739358|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739359|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739360|NCT05442684|Vaccines|vaccines|mesh-list
25739361|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
25739362|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739363|NCT05441254|Paclitaxel|paclitaxel|mesh-list
25739364|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739365|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739366|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739367|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
25306995|NCT05188313|Paclitaxel|paclitaxel|mesh-list
25739368|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739369|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739370|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
25739371|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25739372|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739373|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739374|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25739375|NCT05439005|Analgesics|analgesics|mesh-ancestor
25739376|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
25739377|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739378|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25739379|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25739380|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25739381|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
25739382|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739383|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739384|NCT05438264|Donepezil|donepezil|mesh-list
25739385|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25739386|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739387|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739388|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
25739389|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739390|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739391|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
25739392|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
25739393|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25739394|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
25739395|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739396|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
25739397|NCT05436288|Protective Agents|protective agents|mesh-ancestor
25739398|NCT05433961|Xenon|xenon|mesh-list
25739399|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25739400|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
25739401|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
25739402|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739403|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739404|NCT05432791|Temozolomide|temozolomide|mesh-list
25739405|NCT05432791|Trabectedin|trabectedin|mesh-list
25739406|NCT05432791|Olaparib|olaparib|mesh-list
25739407|NCT05432791|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25739408|NCT05432791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25739409|NCT05432791|Alkylating Agents|alkylating agents|mesh-ancestor
25739410|NCT05432791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739411|NCT05432791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739412|NCT05432791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739413|NCT05431673|Doxycycline|doxycycline|mesh-list
25739414|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
25739415|NCT05431673|Rifampin|rifampin|mesh-list
25739416|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25739417|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739418|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
25739419|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25739420|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25739421|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25739422|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25739423|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739424|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739425|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739426|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25739427|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25739428|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25739429|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
25739430|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
25739431|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25739432|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25739433|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25739434|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25739435|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25739436|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25739437|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25739438|NCT05430867|Memantine|memantine|mesh-list
25739439|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25739440|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25739441|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
25739442|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739443|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739444|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739445|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25739446|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25739447|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
25739448|NCT05430750|Sevoflurane|sevoflurane|mesh-list
25739449|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25739450|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25739451|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
25739452|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
25739453|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739454|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739455|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25739456|NCT05430750|Analgesics|analgesics|mesh-ancestor
25739457|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
25739458|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739459|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25739460|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25739461|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739462|NCT05418036|Sotalol|sotalol|mesh-list
25739463|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25739464|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25739465|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
25739466|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739467|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739468|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739469|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25739470|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
25739471|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
25739472|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773826|NCT04374500|Bradykinin|bradykinin|mesh-list
25773827|NCT04374500|Substance P|substance p|mesh-list
25773828|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25773829|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25773830|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773831|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773832|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25773833|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773834|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25773835|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25773836|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25773837|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
25773838|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773839|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
25773840|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
25773841|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
25773842|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773843|NCT04370548|Clindamycin|clindamycin|mesh-list
25773844|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
25773845|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
25773846|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25773847|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773848|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25773849|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773850|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773851|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25773852|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
25773853|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773854|NCT04358991|Ceftazidime|ceftazidime|mesh-list
25773855|NCT04358991|Avibactam|avibactam|mesh-list
25773856|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25773857|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25773858|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773859|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25773860|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773861|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773862|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
25773863|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
25773864|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25307259|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25307260|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307261|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739473|NCT05404724|Itraconazole|itraconazole|mesh-list
25739474|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
25739475|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739476|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25739477|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25739478|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739479|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739480|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25739481|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
25739482|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739483|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739484|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25739485|NCT05394142|Metformin|metformin|mesh-list
25739486|NCT05394142|Pioglitazone|pioglitazone|mesh-list
25739487|NCT05394142|Spironolactone|spironolactone|mesh-list
25739488|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25739489|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739490|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25739491|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
25739492|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739493|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25739494|NCT05394142|Diuretics|diuretics|mesh-ancestor
25739495|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
25739496|NCT05393050|Methotrexate|methotrexate|mesh-list
25739497|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25739498|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
25739499|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25739500|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739501|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739502|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
25739503|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739504|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739505|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
25739506|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739507|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25739508|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25739509|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
25739510|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739511|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25739512|NCT05388877|Dabrafenib|dabrafenib|mesh-list
25739513|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739514|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25739515|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739516|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739517|NCT05388058|Cannabidiol|cannabidiol|mesh-list
25739518|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
25739519|NCT05383495|Midazolam|midazolam|mesh-list
25739520|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
25739521|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
25739522|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25739523|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739524|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739525|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25739526|NCT05383495|Analgesics|analgesics|mesh-ancestor
25739527|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
25739528|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739529|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25739530|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25739531|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25739532|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
25739533|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739534|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739535|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25739536|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25739537|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25739538|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25739539|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25739540|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
25739541|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
25739542|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
25739543|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
25739544|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25739545|NCT05379166|Azacitidine|azacitidine|mesh-list
25739546|NCT05379166|Venetoclax|venetoclax|mesh-list
25307429|NCT04140292|Vitamin D|vitamin d|mesh-list
25739547|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739548|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
25739549|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739550|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739551|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739552|NCT05377424|Istradefylline|istradefylline|mesh-list
25739553|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25739554|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25739555|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25739556|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
25739557|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739558|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739559|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739560|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
25739561|NCT05365893|Losartan|losartan|mesh-list
25739562|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
25739563|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25739564|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25739565|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739566|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739567|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739568|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739569|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25739570|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25739571|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25739572|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25739573|NCT05364515|Clobetasol|clobetasol|mesh-list
25739574|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739575|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
25739576|NCT05364515|Hormones|hormones|mesh-ancestor
25739577|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739578|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739579|NCT05362955|Fluorouracil|fluorouracil|mesh-list
25739580|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
25739581|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739582|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739583|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739584|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25739585|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
25739586|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739587|NCT05359731|Dexamethasone|dexamethasone|mesh-list
25739588|NCT05359731|Bupivacaine|bupivacaine|mesh-list
25739589|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739590|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
25739591|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
25739592|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739593|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739594|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25739595|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
25739596|NCT05359731|Hormones|hormones|mesh-ancestor
25739597|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739598|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25739599|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739600|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
25739601|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
25739602|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739603|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
25739604|NCT05358873|Antibodies|antibodies|mesh-list
25739605|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
25739606|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739607|NCT05349188|Melatonin|melatonin|mesh-list
25739608|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
25739609|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739610|NCT05349188|Protective Agents|protective agents|mesh-ancestor
25739611|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739612|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739613|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
25739614|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25739615|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
25739616|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739617|NCT05340504|Expectorants|expectorants|mesh-ancestor
25739618|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
25739619|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25739620|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
25307520|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739621|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739622|NCT05340504|Protective Agents|protective agents|mesh-ancestor
25739623|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739624|NCT05340504|Antidotes|antidotes|mesh-ancestor
25739625|NCT05338801|Menthol|menthol|mesh-list
25739626|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
25739627|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25739628|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
25739629|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25739630|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
25739631|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739632|NCT05321251|Insulin|insulin|mesh-list
25739633|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25739634|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739635|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25739636|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25739637|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25739638|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739639|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739640|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25739641|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25739642|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739643|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
25739644|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739645|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
25739646|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25739647|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
25739648|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739649|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
25739650|NCT05316233|Protective Agents|protective agents|mesh-ancestor
25739651|NCT05315947|Brivaracetam|brivaracetam|mesh-list
25739652|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
25773865|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773866|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773867|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773868|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773869|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773870|NCT04352660|Mitomycins|mitomycins|mesh-list
25773871|NCT04352660|Mitomycin|mitomycin|mesh-list
25773872|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25773873|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773874|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
25773875|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773876|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25773877|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773878|NCT04349917|Methylphenidate|methylphenidate|mesh-list
25773879|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25773880|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773881|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25773882|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25773883|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773884|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773885|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
25773886|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773887|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
25773888|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773889|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
25773890|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
25773891|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773892|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773893|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773894|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773895|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773896|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773897|NCT04343222|Bromfenac|bromfenac|mesh-list
25773898|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
25773899|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25773900|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25773901|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25773902|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25773903|NCT04343222|Analgesics|analgesics|mesh-ancestor
25773904|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
25773905|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773906|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773907|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739653|NCT05285358|Gemcitabine|gemcitabine|mesh-list
25739654|NCT05285358|Paclitaxel|paclitaxel|mesh-list
25739655|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25739656|NCT05285358|Cisplatin|cisplatin|mesh-list
25739657|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739658|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739659|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739660|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25739661|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739662|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739663|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739664|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
25739665|NCT05285358|Antiviral Agents|antiviral agents|mesh-ancestor
25739666|NCT05285358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739667|NCT05285358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739668|NCT05285358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25739669|NCT05285358|Immunologic Factors|immunologic factors|mesh-ancestor
25739670|NCT05285358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739671|NCT05274048|Trastuzumab|trastuzumab|mesh-list
25739672|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25739673|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739674|NCT05272384|Nivolumab|nivolumab|mesh-list
25739675|NCT05272384|Decitabine|decitabine|mesh-list
25739676|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25739677|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739678|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25739679|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739680|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739681|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
25739682|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739683|NCT05270733|Ustekinumab|ustekinumab|mesh-list
25739684|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
25739685|NCT05264974|Vaccines|vaccines|mesh-list
25739686|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
25739687|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739688|NCT05243953|Cromakalim|cromakalim|mesh-list
25739689|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25739690|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25739691|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
25739692|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739693|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739694|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25739695|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
25739696|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
25739697|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
25739698|NCT05243654|Metformin|metformin|mesh-list
25739699|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25739700|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739701|NCT05242315|Tacrolimus|tacrolimus|mesh-list
25739702|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25739703|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
25739704|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739705|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25739706|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739707|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739708|NCT05227131|Capecitabine|capecitabine|mesh-list
25739709|NCT05227131|Tucatinib|tucatinib|mesh-list
25739710|NCT05227131|Margetuximab|margetuximab|mesh-list
25739711|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25739712|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
25739713|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739714|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739715|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25739716|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739717|NCT05225961|Aspirin|aspirin|mesh-list
25739718|NCT05225961|Tirofiban|tirofiban|mesh-list
25739719|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25739720|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25739721|NCT05225961|Analgesics|analgesics|mesh-ancestor
25307897|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307898|NCT02577120|Decanoic acid|decanoic acid|mesh-list
25307899|NCT02577120|Petrolatum|petrolatum|mesh-list
25307900|NCT02577120|Emollients|emollients|mesh-ancestor
25307901|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
25307902|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
25307918|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25307936|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25739722|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
25739723|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739724|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739725|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739726|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739727|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25739728|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25739729|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739730|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25739731|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25739732|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739733|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
25739734|NCT05223673|Trifluridine|trifluridine|mesh-list
25739735|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
25739736|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739737|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
25739738|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739739|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25739740|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25739741|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739742|NCT05208944|Cemiplimab|cemiplimab|mesh-list
25739743|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25739744|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739745|NCT05202158|Gentamicins|gentamicins|mesh-list
25739746|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25739747|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25739748|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25739749|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739750|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739751|NCT05193071|Aspirin|aspirin|mesh-list
25739752|NCT05193071|Clopidogrel|clopidogrel|mesh-list
25739753|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25739754|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25739755|NCT05193071|Analgesics|analgesics|mesh-ancestor
25739756|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
25739757|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739758|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739759|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739760|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739761|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25739762|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25739763|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739764|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25739765|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25739766|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739767|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
25739768|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25739769|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25739770|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25739771|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
25739772|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739773|NCT05191784|Bevacizumab|bevacizumab|mesh-list
25739774|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25739775|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739776|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25739777|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25739778|NCT05191784|Growth Substances|growth substances|mesh-ancestor
25739779|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739780|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
25739781|NCT05180994|Infliximab|infliximab|mesh-list
25739782|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
25739783|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25739784|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739785|NCT05180825|Trametinib|trametinib|mesh-list
25739786|NCT05180825|Vinblastine|vinblastine|mesh-list
25739787|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739788|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25739789|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739790|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739791|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25739792|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25739793|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25739794|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25739795|NCT05177848|Nicotine|nicotine|mesh-list
25739796|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25739797|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
25739798|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739799|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739800|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25739801|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25739802|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
25739803|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739804|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739805|NCT05174884|Etonogestrel|etonogestrel|mesh-list
25739806|NCT05174884|Desogestrel|desogestrel|mesh-list
25739807|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25739808|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
25739809|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25739810|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739811|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25739812|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25739813|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25739814|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25739815|NCT05174884|Progestins|progestins|mesh-ancestor
25739816|NCT05174884|Hormones|hormones|mesh-ancestor
25739817|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739818|NCT05172817|Adalimumab|adalimumab|mesh-list
25739819|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739820|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25739821|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
25739822|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25739823|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739824|NCT05162053|Clopidogrel|clopidogrel|mesh-list
25739825|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25739826|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25739827|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25739828|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25739829|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
25739830|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739831|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739832|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739833|NCT05161637|Bupivacaine|bupivacaine|mesh-list
25739834|NCT05161637|Ropivacaine|ropivacaine|mesh-list
25739835|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
25739836|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
25739837|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739838|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739839|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
25739840|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773908|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773909|NCT04343092|Ivermectin|ivermectin|mesh-list
25773910|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773911|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773912|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
25773913|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25773914|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25773915|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773916|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773917|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25773918|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25773919|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25773920|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25773921|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773922|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25773923|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
25773924|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25773925|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
25773926|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25773927|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25773928|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773929|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25773930|NCT04342897|Zansecimab|zansecimab|mesh-list
25773931|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
25773932|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773933|NCT04342130|Morphine|morphine|mesh-list
25773934|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25773935|NCT04342130|Narcotics|narcotics|mesh-ancestor
25773936|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739842|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25739843|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739844|NCT05139095|Apatinib|apatinib|mesh-list
25739845|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739846|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25739847|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739848|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739849|NCT05124171|Vaccines|vaccines|mesh-list
25739850|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
25739851|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739852|NCT05109442|Atezolizumab|atezolizumab|mesh-list
25739853|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739854|NCT05103410|Aripiprazole|aripiprazole|mesh-list
25739855|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
25739856|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25739857|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25739858|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25739859|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739860|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739861|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
25739862|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
25739863|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739864|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739865|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25739866|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25739867|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
25739868|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25739869|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25739870|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25739871|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25739872|NCT05084586|Epirubicin|epirubicin|mesh-list
25739873|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25739874|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25739875|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739876|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25739877|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25739878|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739879|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739880|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25739881|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25739882|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25739883|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739884|NCT05074290|Taxane|taxane|mesh-list
25739885|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739886|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25739887|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739888|NCT05064878|Fenfluramine|fenfluramine|mesh-list
25739889|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25739890|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25739891|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25739892|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739893|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739894|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
25739895|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739896|NCT05064319|Gabapentin|gabapentin|mesh-list
25739897|NCT05064319|Analgesics|analgesics|mesh-ancestor
25739898|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
25739899|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739900|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739901|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
25739902|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25739903|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25739904|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739905|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25739906|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25739907|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25739908|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739909|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739910|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
25739911|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
25739912|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25739913|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25739914|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25739915|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739917|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25739918|NCT05062577|ASP8062|asp8062|mesh-list
25739919|NCT05062577|Naloxone|naloxone|mesh-list
25739920|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25739921|NCT05062577|Narcotics|narcotics|mesh-ancestor
25739922|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739923|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739924|NCT05062577|Analgesics|analgesics|mesh-ancestor
25739925|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
25739926|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739927|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25739928|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
25739929|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
25739930|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739931|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739932|NCT05061901|Lisinopril|lisinopril|mesh-list
25739933|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25739934|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
25739935|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25739936|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739937|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25739938|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25739939|NCT05061901|Protective Agents|protective agents|mesh-ancestor
25739940|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739941|NCT05059873|Prednisone|prednisone|mesh-list
25739942|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25739943|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
25739944|NCT05059873|Hormones|hormones|mesh-ancestor
25739945|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25739946|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739947|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25739948|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25739949|NCT05056142|Anesthetics|anesthetics|mesh-list
25739950|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739951|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739952|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25739953|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25739954|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739955|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739956|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25739957|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25739958|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739959|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
25739960|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739961|NCT05031520|Metoprolol|metoprolol|mesh-list
25739962|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
25739963|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25739964|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25739965|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
25739966|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
25739967|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739968|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739969|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25739970|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25739971|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25739972|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
25739973|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739974|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739975|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
25739976|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25739977|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25739978|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25739979|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25739980|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25739981|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739982|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739983|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25739984|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
25739985|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25739986|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
25739987|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25739988|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25739989|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25739990|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25739992|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
25739993|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25739994|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25739995|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25739996|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25739997|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
25739998|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25739999|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740000|NCT04997993|Leflunomide|leflunomide|mesh-list
25740001|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740002|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740003|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740004|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
25740005|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740006|NCT04989946|Nivolumab|nivolumab|mesh-list
25740007|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740008|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740009|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25740010|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773937|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773938|NCT04342130|Analgesics|analgesics|mesh-ancestor
25773939|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
25773940|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773941|NCT04340557|Losartan|losartan|mesh-list
25773942|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25773943|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25773944|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25773945|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25773946|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773947|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25773948|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
25773949|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773950|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773951|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
25773952|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25773953|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25773954|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773955|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
25773956|NCT04338074|Coagulants|coagulants|mesh-ancestor
25773957|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
25773958|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25773959|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25773960|NCT04335552|Azithromycin|azithromycin|mesh-list
25773961|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
25773962|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25773963|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773964|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
25773965|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773966|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773967|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773968|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773969|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773970|NCT04334876|Antibodies|antibodies|mesh-list
25773971|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
25773972|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
25773973|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773974|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
25773975|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
25773976|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773977|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773978|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773979|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773980|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773981|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25777525|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777526|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25777527|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
25740011|NCT04976543|Nadroparin|nadroparin|mesh-list
25740012|NCT04976543|Warfarin|warfarin|mesh-list
25740013|NCT04976543|Calcium|calcium|mesh-list
25740014|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25740015|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740016|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
25740017|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25740018|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25740019|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740020|NCT04969211|Iloperidone|iloperidone|mesh-list
25740021|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25740022|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25740023|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740024|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740025|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25740026|NCT04967443|Prazosin|prazosin|mesh-list
25740027|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25740028|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25740029|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25740030|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25740031|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
25740032|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740033|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740034|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740035|NCT04964466|Becaplermin|becaplermin|mesh-list
25740036|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
25740037|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25740038|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25740039|NCT04964466|Growth Substances|growth substances|mesh-ancestor
25740040|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740041|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
25740042|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25740043|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740044|NCT04956484|Belimumab|belimumab|mesh-list
25740045|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740046|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
25740047|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740048|NCT04947527|Fluorides|fluorides|mesh-list
25740049|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
25740050|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
25740051|NCT04947527|Protective Agents|protective agents|mesh-ancestor
25740052|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740053|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
25740054|NCT04938765|Analgesics|analgesics|mesh-ancestor
25740055|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
25740056|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740057|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740058|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
25740059|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740060|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25740061|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
25740062|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25740063|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740064|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740065|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25740066|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
25740067|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25740068|NCT04937452|Rotigotine|rotigotine|mesh-list
25740069|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
25740070|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
25740071|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740072|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740073|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740074|NCT04921007|Bupivacaine|bupivacaine|mesh-list
25740075|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
25740076|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
25740077|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740078|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740079|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
25740080|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740081|NCT04920994|Bupivacaine|bupivacaine|mesh-list
25740082|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
25740083|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
25740084|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25773982|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
25308566|NCT03493646|Cc-486|cc-486|mesh-list
25740085|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740086|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
25740087|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740088|NCT04920838|Acetaminophen|acetaminophen|mesh-list
25740089|NCT04920838|Ciclesonide|ciclesonide|mesh-list
25740090|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
25740091|NCT04920838|Budesonide|budesonide|mesh-list
25740092|NCT04920838|Telmisartan|telmisartan|mesh-list
25740093|NCT04920838|Fluoxetine|fluoxetine|mesh-list
25740094|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740095|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25740096|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
25740097|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740098|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740099|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25740100|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
25740101|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
25740102|NCT04920838|Hormones|hormones|mesh-ancestor
25740103|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740104|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25740105|NCT04920838|Analgesics|analgesics|mesh-ancestor
25740106|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
25740107|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
25740108|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25740109|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25740110|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25740111|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740112|NCT04920838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25740113|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25740114|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740115|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740116|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
25740117|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25740118|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
25740119|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25740120|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25740121|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25740122|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740123|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25740124|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740125|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25740126|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25740127|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25740128|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25740129|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
25740130|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740131|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25740132|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25740133|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740134|NCT04900623|Paclitaxel|paclitaxel|mesh-list
25740135|NCT04900623|Cisplatin|cisplatin|mesh-list
25740136|NCT04900623|Carboplatin|carboplatin|mesh-list
25740137|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25740138|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740139|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
25740140|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
25740141|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
25740142|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740143|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25740144|NCT04895566|Antibodies|antibodies|mesh-list
25740145|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
25740146|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25740147|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
25740148|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740149|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740150|NCT04895410|Dexamethasone|dexamethasone|mesh-list
25740151|NCT04895410|Daratumumab|daratumumab|mesh-list
25740152|NCT04895410|Pomalidomide|pomalidomide|mesh-list
25740153|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740154|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
25740155|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
25740156|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308637|NCT03345173|Ketamine|ketamine|mesh-list
25740157|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740158|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25740159|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
25740161|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740162|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25740163|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740164|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
25740165|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25740166|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25740167|NCT04895410|Growth Substances|growth substances|mesh-ancestor
25740168|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
25740169|NCT04891718|Nivolumab|nivolumab|mesh-list
25740170|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740171|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740172|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25740173|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740174|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
25740175|NCT04880889|Thiamine|thiamine|mesh-list
25740176|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
25740177|NCT04880889|Vitamins|vitamins|mesh-ancestor
25740178|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
25740179|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740180|NCT04880850|Insulin|insulin|mesh-list
25740181|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25740182|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
25740183|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
25740184|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25740185|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740186|NCT04871529|Gemcitabine|gemcitabine|mesh-list
25740187|NCT04871529|Carboplatin|carboplatin|mesh-list
25740188|NCT04871529|Avelumab|avelumab|mesh-list
25740189|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
25740190|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
25740191|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25740192|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740193|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25740194|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
25740195|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740196|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
25740197|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740198|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740199|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740200|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
25740201|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740202|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740203|NCT04857931|Colchicine|colchicine|mesh-list
25740204|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
25740205|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25740206|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
25740207|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
25740208|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
25740209|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740210|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740211|NCT04850638|Furosemide|furosemide|mesh-list
25740212|NCT04850638|Diuretics|diuretics|mesh-ancestor
25740213|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
25740214|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740215|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25740216|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740217|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740218|NCT04849377|Cisplatin|cisplatin|mesh-list
25740219|NCT04849377|Carboplatin|carboplatin|mesh-list
25740220|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740221|NCT04845139|Nivolumab|nivolumab|mesh-list
25740222|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740223|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740224|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25740225|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740226|NCT04835623|Cyclosporine|cyclosporine|mesh-list
25740227|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25740228|NCT04835623|Cyclosporins|cyclosporins|mesh-list
25740229|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740230|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740231|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740232|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
25740233|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740234|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
25740235|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740236|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
25740237|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25740238|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25740239|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25773983|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
25773984|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25773985|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25773986|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25773987|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25773988|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25773989|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25773990|NCT04322968|Ketorolac|ketorolac|mesh-list
25773991|NCT04322968|Ketamine|ketamine|mesh-list
25773992|NCT04322968|Analgesics|analgesics|mesh-ancestor
25773993|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
25773994|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25773995|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25773996|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25773997|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25773998|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
25773999|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
25774000|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774001|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25774002|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25774003|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774004|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774005|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25774006|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25774007|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774008|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774009|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25774010|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774011|NCT04332107|Azithromycin|azithromycin|mesh-list
25774012|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774013|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774014|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
25774015|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25774016|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25774017|NCT04323592|Prednisolone|prednisolone|mesh-list
25774018|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
25774019|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25774020|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
25774021|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774022|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
25774023|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
25774024|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774025|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774026|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774027|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
25774028|NCT04323592|Hormones|hormones|mesh-ancestor
25774029|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774030|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25774031|NCT04323592|Protective Agents|protective agents|mesh-ancestor
25774032|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25774033|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774034|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
25774035|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
25774036|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25774037|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774038|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774039|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774040|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774041|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774042|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
25774043|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
25774044|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25774045|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774046|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774047|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774048|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774049|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774050|NCT04322526|Naltrexone|naltrexone|mesh-list
25774051|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25774052|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25774053|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774054|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
25740241|NCT04817254|Ipilimumab|ipilimumab|mesh-list
25740242|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740243|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740244|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25740245|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740246|NCT04806919|Progesterone|progesterone|mesh-list
25740247|NCT04806919|Progestins|progestins|mesh-ancestor
25740248|NCT04806919|Hormones|hormones|mesh-ancestor
25740249|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740250|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740251|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25740252|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
25740253|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740254|NCT04793659|Fasudil|fasudil|mesh-list
25740255|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
25740256|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25740257|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740258|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740259|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25740260|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740261|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
25740262|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25740263|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740264|NCT04789070|Sirolimus|sirolimus|mesh-list
25740265|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25740266|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740267|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25740268|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740269|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
25740270|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740271|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
25740272|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740273|NCT04783194|Dexamethasone|dexamethasone|mesh-list
25740274|NCT04783194|Bupivacaine|bupivacaine|mesh-list
25740275|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740276|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
25740277|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
25740278|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740279|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740280|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25740281|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
25740282|NCT04783194|Hormones|hormones|mesh-ancestor
25740283|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740284|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25740285|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740286|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
25740287|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
25740288|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740289|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
25740290|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
25740291|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
25740292|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25740293|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
25740294|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25740295|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25740296|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740297|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25740298|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740299|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740300|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25740301|NCT04783051|Renal Agents|renal agents|mesh-ancestor
25740302|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
25740303|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740304|NCT04766762|Flunarizine|flunarizine|mesh-list
25740305|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
25740306|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25740307|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740308|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740309|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25740310|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740311|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25740312|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
25740313|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
25740314|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740315|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
25740316|NCT04763759|Antibodies|antibodies|mesh-list
25740317|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25740318|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
25740319|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740320|NCT04747496|Edoxaban|edoxaban|mesh-list
25740321|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25740322|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
25740323|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25740324|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
25740325|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740326|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740327|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
25740328|NCT04743505|Osimertinib|osimertinib|mesh-list
25740329|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740330|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25740331|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740332|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740333|NCT04739384|Ticagrelor|ticagrelor|mesh-list
25740334|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25740335|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25740336|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25740337|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25740338|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
25740339|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740340|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740341|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740342|NCT04738292|Fulvestrant|fulvestrant|mesh-list
25740343|NCT04738292|Onapristone|onapristone|mesh-list
25740344|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25740345|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740346|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25740347|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25740348|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
25740349|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740350|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740351|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25740352|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
25740353|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25740354|NCT04732455|Lidocaine|lidocaine|mesh-list
25740355|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25740356|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
25740357|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
25740358|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740359|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740360|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
25740361|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740362|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25740363|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25740364|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25740365|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740366|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740367|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25740368|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25740369|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740370|NCT04732455|Analgesics|analgesics|mesh-ancestor
25740371|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
25740372|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25740373|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
25740374|NCT04727424|Budesonide|budesonide|mesh-list
25740375|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
25740376|NCT04727424|Fluoxetine|fluoxetine|mesh-list
25740377|NCT04727424|Maleic acid|maleic acid|mesh-list
25740378|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740379|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25740380|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
25740381|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740382|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740383|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25740384|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
25740385|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
25740386|NCT04727424|Hormones|hormones|mesh-ancestor
25740387|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740388|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740389|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740390|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25740391|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25740392|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740393|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740394|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
25740395|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25740396|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
25740397|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25740398|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25740399|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25740400|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25740401|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25740402|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740403|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25740404|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25740405|NCT04719273|Anastrozole|anastrozole|mesh-list
25740406|NCT04719273|Onapristone|onapristone|mesh-list
25740407|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25740408|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740409|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25740410|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25740411|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740412|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740413|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25740414|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
25740415|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740416|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740417|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25740418|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
25740419|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25740421|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740422|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740423|NCT04716881|Naltrexone|naltrexone|mesh-list
25740424|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25740425|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25740426|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740427|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
25740428|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740429|NCT04715646|Brivaracetam|brivaracetam|mesh-list
25740430|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
25740431|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25740432|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
25740433|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740434|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25740435|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
25740436|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740437|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740438|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25740439|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25740440|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25740441|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
25740442|NCT04713657|Propranolol|propranolol|mesh-list
25740443|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25740444|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25740445|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
25740446|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740447|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740448|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740449|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25740450|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25740451|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
25740452|NCT04704596|Anesthetics|anesthetics|mesh-list
25740453|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740454|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740455|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
25740456|NCT04703426|Sargramostim|sargramostim|mesh-list
25740457|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740458|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740459|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
25740460|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740461|NCT04701333|Cabergoline|cabergoline|mesh-list
25740462|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25740463|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25740464|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
25740465|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
25740466|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740467|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740468|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740469|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
25740470|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740471|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
25740472|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
25740473|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
25740474|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
25740475|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740476|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740477|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25740478|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
25740479|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740480|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25740481|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25740482|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740483|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740484|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740485|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25740486|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25740487|NCT04678661|Insulin|insulin|mesh-list
25740488|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25740489|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774055|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774056|NCT04322682|Colchicine|colchicine|mesh-list
25774057|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
25774058|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774059|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
25774060|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
25774061|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
25774062|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774063|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774064|NCT04322396|Azithromycin|azithromycin|mesh-list
25774065|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
25774066|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774067|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774068|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
25774069|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25774070|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774071|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774072|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774073|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774074|NCT04318535|Griseofulvin|griseofulvin|mesh-list
25774075|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
25774076|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774077|NCT04314037|Praziquantel|praziquantel|mesh-list
25774078|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
25774079|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774080|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774081|NCT04310085|Lumefantrine|lumefantrine|mesh-list
25774082|NCT04310085|Artemether|artemether|mesh-list
25774083|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25774084|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
25774085|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25774086|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774087|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774088|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
25774089|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
25774090|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25774091|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774092|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774093|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774094|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774095|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774096|NCT04307940|Acetaminophen|acetaminophen|mesh-list
25774097|NCT04307940|Naproxen|naproxen|mesh-list
25774098|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25774099|NCT04307940|Hydrocodone|hydrocodone|mesh-list
25774100|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25774101|NCT04307940|Analgesics|analgesics|mesh-ancestor
25740490|NCT04657068|Gemcitabine|gemcitabine|mesh-list
25740491|NCT04657068|Irinotecan|irinotecan|mesh-list
25740492|NCT04657068|Camptothecin|camptothecin|mesh-list
25740493|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25740494|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
25740495|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740496|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740497|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
25740498|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740499|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740500|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740501|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
25740502|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740503|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25740504|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25740505|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25740506|NCT04635189|Dexamethasone|dexamethasone|mesh-list
25740507|NCT04635189|Lenalidomide|lenalidomide|mesh-list
25740508|NCT04635189|Daratumumab|daratumumab|mesh-list
25740509|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740510|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
25740511|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
25740512|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740513|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740514|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25740515|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
25740516|NCT04635189|Hormones|hormones|mesh-ancestor
25740517|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740518|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25740519|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740520|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
25740521|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25740522|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25740523|NCT04635189|Growth Substances|growth substances|mesh-ancestor
25740524|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25740525|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
25740526|NCT04627012|Lenvatinib|lenvatinib|mesh-list
25740527|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740528|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740529|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740530|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25740531|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740532|NCT04624854|Aspirin|aspirin|mesh-list
25740533|NCT04624854|Clopidogrel|clopidogrel|mesh-list
25740534|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25740535|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25740536|NCT04624854|Analgesics|analgesics|mesh-ancestor
25740537|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
25740538|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740539|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740540|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740541|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25740542|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25740543|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25740544|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740545|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25740546|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25740547|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740548|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
25740549|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25740550|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25740551|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25740552|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
25740553|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740554|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25740555|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740556|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25740557|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25740558|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
25740559|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25740560|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25740561|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740562|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
25740563|NCT04560010|Coagulants|coagulants|mesh-ancestor
25309303|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
25740564|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25740566|NCT04539626|Estrogens|estrogens|mesh-list
25740567|NCT04539626|Hormones|hormones|mesh-ancestor
25740568|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740569|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740570|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25740571|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
25740572|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25740573|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25740574|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25740575|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25740576|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25740577|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740578|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25740579|NCT04526574|Vaccines|vaccines|mesh-list
25740580|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25740581|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
25740582|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740583|NCT04522206|Oxycodone|oxycodone|mesh-list
25740584|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25740585|NCT04522206|Narcotics|narcotics|mesh-ancestor
25740586|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740587|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740588|NCT04522206|Analgesics|analgesics|mesh-ancestor
25740589|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
25740590|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740591|NCT04519944|Edoxaban|edoxaban|mesh-list
25740592|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25740593|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
25740594|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25740595|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
25740596|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740597|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740598|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
25740599|NCT04505592|Tenecteplase|tenecteplase|mesh-list
25740600|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25740601|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25740602|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740603|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
25740604|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25740605|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740606|NCT04502407|Cisplatin|cisplatin|mesh-list
25740607|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740608|NCT04485104|Cannabidiol|cannabidiol|mesh-list
25740609|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
25740610|NCT04483583|Clopidogrel|clopidogrel|mesh-list
25740611|NCT04483583|Ticagrelor|ticagrelor|mesh-list
25740612|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25740613|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25740614|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25740615|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25740616|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
25740617|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740618|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740619|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740620|NCT04480450|Rituximab|rituximab|mesh-list
25740621|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740622|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740623|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
25740624|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740625|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25740626|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
25740627|NCT04477200|Temozolomide|temozolomide|mesh-list
25740628|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25740629|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740630|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25740631|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
25740632|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25740633|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740634|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740635|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740636|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25740637|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
25740638|NCT04476628|Budesonide|budesonide|mesh-list
25740639|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740640|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25740641|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
25740642|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740643|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740644|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25740645|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
25740646|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
25740647|NCT04476628|Hormones|hormones|mesh-ancestor
25740648|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740649|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25740650|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25740651|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
25740652|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25740653|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
25740654|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740655|NCT04472494|Abatacept|abatacept|mesh-list
25740656|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25740657|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740658|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740659|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740660|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
25740661|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740662|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774102|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
25774103|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774104|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774105|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
25774106|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25774107|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774108|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774109|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
25774110|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25774111|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774112|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774113|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25774114|NCT04307940|Narcotics|narcotics|mesh-ancestor
25774115|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774116|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
25774117|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
25774118|NCT04297631|Tobramycin|tobramycin|mesh-list
25774119|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774120|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774121|NCT04297241|Isosorbide|isosorbide|mesh-list
25774122|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25774123|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25774124|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25774125|NCT04297241|Diuretics|diuretics|mesh-ancestor
25774126|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
25774127|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774128|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
25774129|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25774130|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774131|NCT04292535|Insulin|insulin|mesh-list
25774132|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25774133|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
25774134|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
25774135|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25774136|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25774137|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774138|NCT04292171|Gabapentin|gabapentin|mesh-list
25774139|NCT04292171|Analgesics|analgesics|mesh-ancestor
25774140|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
25774141|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774142|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774143|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
25774144|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25774145|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25774146|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774147|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25774148|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25774149|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25774150|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774151|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774152|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
25740663|NCT04450316|Naltrexone|naltrexone|mesh-list
25740664|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25740665|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25740666|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740667|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
25740668|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740669|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
25740670|NCT04449965|Povidone|povidone|mesh-list
25740671|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
25740672|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
25740673|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25740674|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740675|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
25740676|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740677|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
25740678|NCT04415892|Capsaicin|capsaicin|mesh-list
25740679|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
25740680|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
25740681|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
25740682|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740683|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740684|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25740685|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740686|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25740687|NCT04415892|Protective Agents|protective agents|mesh-ancestor
25740688|NCT04398368|Gemcitabine|gemcitabine|mesh-list
25740689|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25740690|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
25740691|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740692|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740693|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
25740694|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740695|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740696|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740697|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
25740698|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740699|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
25740700|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25740701|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25740702|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740703|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
25740704|NCT04387305|Coagulants|coagulants|mesh-ancestor
25740705|NCT04359953|Azithromycin|azithromycin|mesh-list
25740706|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
25740707|NCT04359953|Telmisartan|telmisartan|mesh-list
25740708|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25740709|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740710|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
25740711|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25740712|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25740713|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740714|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740715|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25740716|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25740717|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25740718|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25740719|NCT04345367|Abrocitinib|abrocitinib|mesh-list
25740720|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25740721|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740722|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740723|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
25740724|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
25740725|NCT04339777|Busulfan|busulfan|mesh-list
25740726|NCT04339777|Fludarabine|fludarabine|mesh-list
25740727|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
25740728|NCT04339777|Tacrolimus|tacrolimus|mesh-list
25740729|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740730|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
25740731|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740732|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25740733|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25740734|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
25740735|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740736|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740737|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25740738|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25740739|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740740|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25740741|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25740742|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
25740743|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25740744|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740745|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740746|NCT04337580|Omeprazole|omeprazole|mesh-list
25740747|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25740748|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25740749|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25740750|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740751|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740752|NCT04332744|Talazoparib|talazoparib|mesh-list
25740753|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25740754|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740755|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740756|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740757|NCT04316676|Regadenoson|regadenoson|mesh-list
25740758|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25740759|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25740760|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
25740761|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
25740762|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740763|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740764|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740765|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25740766|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
25740767|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740768|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
25740769|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740770|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25740771|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740772|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740773|NCT04276857|Leucovorin|leucovorin|mesh-list
25740774|NCT04276857|Gemcitabine|gemcitabine|mesh-list
25740775|NCT04276857|Paclitaxel|paclitaxel|mesh-list
25740776|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
25740777|NCT04276857|Irinotecan|irinotecan|mesh-list
25740778|NCT04276857|Folfirinox|folfirinox|mesh-list
25740779|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25740780|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740781|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25740782|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25740783|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25740784|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740785|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25740786|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
25740787|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
25740788|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740789|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740790|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740791|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
25740792|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740793|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25740794|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25740795|NCT04276857|Antidotes|antidotes|mesh-ancestor
25740796|NCT04276857|Protective Agents|protective agents|mesh-ancestor
25740797|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
25740798|NCT04276857|Vitamins|vitamins|mesh-ancestor
25740799|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
25740800|NCT04271904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25740801|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
25740802|NCT04267887|Prednisone|prednisone|mesh-list
25740803|NCT04267887|Cortisone|cortisone|mesh-list
25740804|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
25740805|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
25740806|NCT04267887|Hormones|hormones|mesh-list
25740807|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25740808|NCT04267887|Androgens|androgens|mesh-list
25740809|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
25740810|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25740811|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
25740812|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740813|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740814|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25740815|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774153|NCT04292899|Remdesivir|remdesivir|mesh-list
25740816|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25740817|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740818|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740819|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
25740820|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25740822|NCT04267887|Protective Agents|protective agents|mesh-ancestor
25740823|NCT04267887|Vitamins|vitamins|mesh-ancestor
25740824|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
25740825|NCT04267887|Estrogens|estrogens|mesh-ancestor
25740826|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
25740827|NCT04262206|Atorvastatin|atorvastatin|mesh-list
25740828|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25740829|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25740830|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
25740831|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740832|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25740833|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25740834|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740835|NCT04261439|Spartalizumab|spartalizumab|mesh-list
25740836|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25740837|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740838|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740839|NCT04196530|Atezolizumab|atezolizumab|mesh-list
25740840|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740841|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
25740842|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25740843|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
25740844|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740845|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
25740846|NCT04192630|Protective Agents|protective agents|mesh-ancestor
25740847|NCT04189783|Bupivacaine|bupivacaine|mesh-list
25740848|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
25740849|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
25740850|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740851|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740852|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
25740853|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740854|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
25740855|NCT04187105|Fludarabine|fludarabine|mesh-list
25740856|NCT04187105|Tacrolimus|tacrolimus|mesh-list
25740857|NCT04187105|Complement Factor H|complement factor h|mesh-list
25740858|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740859|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
25740860|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740861|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25740862|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25740863|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
25740864|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740865|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740866|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25740867|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25740868|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740869|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25740870|NCT04177108|Paclitaxel|paclitaxel|mesh-list
25740871|NCT04177108|Atezolizumab|atezolizumab|mesh-list
25740872|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25740873|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25740874|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740875|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
25740876|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
25740877|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
25740878|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740879|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
25740880|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740881|NCT04176354|Letrozole|letrozole|mesh-list
25740882|NCT04176354|Palbociclib|palbociclib|mesh-list
25740883|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25740884|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740885|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25740886|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740887|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740888|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25740889|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
25740890|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25740891|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740892|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25774154|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
25774155|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774156|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
25774157|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774158|NCT04292730|Remdesivir|remdesivir|mesh-list
25774159|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
25774160|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774161|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
25774162|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774163|NCT04290676|Dexamethasone|dexamethasone|mesh-list
25774164|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
25774165|NCT04290676|BB 1101|bb 1101|mesh-list
25774166|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774167|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
25774168|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
25774169|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774170|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774171|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774172|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
25774173|NCT04290676|Hormones|hormones|mesh-ancestor
25774174|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774175|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25774176|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774177|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
25774178|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774179|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774180|NCT04290039|Atropine|atropine|mesh-list
25774181|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25774182|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25774183|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25774184|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25774185|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25774186|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
25774187|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774188|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774189|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25774190|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25774191|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
25774192|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
25774193|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25774194|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25774195|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
25774196|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774197|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774198|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
25774199|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25774200|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774201|NCT04284930|Bupivacaine|bupivacaine|mesh-list
25774202|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
25774203|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
25774204|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774205|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774206|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
25774207|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774208|NCT04283773|Antibodies|antibodies|mesh-list
25774209|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
25774210|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25774211|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
25774212|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774213|NCT04277936|Levetiracetam|levetiracetam|mesh-list
25774214|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
25774215|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
25774216|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25774217|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
25774218|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
25774219|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774220|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774221|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
25774222|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774223|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25774224|NCT04272775|Dexamethasone|dexamethasone|mesh-list
25774225|NCT04272775|Lenalidomide|lenalidomide|mesh-list
25774226|NCT04272775|Ixazomib|ixazomib|mesh-list
25774227|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774228|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
25740893|NCT04173780|Atropine|atropine|mesh-list
25740894|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25740895|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25740896|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25740897|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
25740898|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740899|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740900|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25740901|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
25740902|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
25740903|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
25740904|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25740905|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25740906|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
25740907|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25740908|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740909|NCT04168203|Apixaban|apixaban|mesh-list
25740910|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25740911|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
25740912|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25740913|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
25740914|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740915|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740916|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
25740917|NCT04164732|Valsartan|valsartan|mesh-list
25740918|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25740919|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25740920|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25740921|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25740922|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740923|NCT04154189|Etoposide|etoposide|mesh-list
25740924|NCT04154189|Ifosfamide|ifosfamide|mesh-list
25740925|NCT04154189|Lenvatinib|lenvatinib|mesh-list
25740926|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25740927|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740928|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25740929|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25740930|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740931|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740932|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25740933|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
25740934|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25740935|NCT04135989|Everolimus|everolimus|mesh-list
25740936|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740937|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740938|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
25740939|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740940|NCT04129554|Tenofovir|tenofovir|mesh-list
25740941|NCT04129554|Entecavir|entecavir|mesh-list
25740942|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
25740943|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
25740944|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740945|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25740946|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25740947|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740948|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740949|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25740950|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25740951|NCT04128540|Fentanyl|fentanyl|mesh-list
25740952|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25740953|NCT04128540|Narcotics|narcotics|mesh-ancestor
25740954|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25740955|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740956|NCT04128540|Analgesics|analgesics|mesh-ancestor
25740957|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
25740958|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25740959|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25740960|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25740961|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
25740962|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
25740963|NCT04104438|Everolimus|everolimus|mesh-list
25740964|NCT04104438|Basiliximab|basiliximab|mesh-list
25309959|NCT05155007|Cyclosporins|cyclosporins|mesh-list
25309960|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309961|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309962|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740965|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740966|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740967|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
25740968|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740969|NCT04093531|Ustekinumab|ustekinumab|mesh-list
25740970|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
25740971|NCT04065841|Licogliflozin|licogliflozin|mesh-list
25740972|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25740973|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740974|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25740975|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740976|NCT04052698|Factor VIII|factor viii|mesh-list
25740977|NCT04052698|Coagulants|coagulants|mesh-ancestor
25740978|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25740979|NCT04048304|Vancomycin|vancomycin|mesh-list
25740980|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25740981|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
25740982|NCT04047628|Ofatumumab|ofatumumab|mesh-list
25740983|NCT04047628|Cladribine|cladribine|mesh-list
25740984|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
25740985|NCT04047628|Natalizumab|natalizumab|mesh-list
25740986|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25740987|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740988|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
25740989|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25740990|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25740991|NCT04046575|Paclitaxel|paclitaxel|mesh-list
25740992|NCT04046575|Carboplatin|carboplatin|mesh-list
25740993|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25740994|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25740995|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
25740996|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
25740997|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
25740998|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25740999|NCT04027322|Dexamethasone|dexamethasone|mesh-list
25741000|NCT04027322|Budesonide|budesonide|mesh-list
25741001|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741002|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
25741003|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
25741004|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741005|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741006|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741007|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
25741008|NCT04027322|Hormones|hormones|mesh-ancestor
25741009|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741010|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25741011|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741012|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25741013|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25741014|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
25741015|NCT04025359|Dronabinol|dronabinol|mesh-list
25741016|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
25741017|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741018|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25741019|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25741020|NCT04025359|Analgesics|analgesics|mesh-ancestor
25741021|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
25741022|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741023|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25741024|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25741025|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741026|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741027|NCT04025359|Hormones|hormones|mesh-ancestor
25741028|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741029|NCT04021121|Linezolid|linezolid|mesh-list
25741030|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25741031|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741032|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25741033|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741034|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741035|NCT04009681|Antibodies|antibodies|mesh-list
25741036|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
25741037|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741038|NCT04002947|Rituximab|rituximab|mesh-list
25741039|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
25741040|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741041|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741042|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
25741043|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741044|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25741046|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25741047|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741048|NCT03996057|Methenamine|methenamine|mesh-list
25741049|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
25741050|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
25741051|NCT03996057|Estrogens|estrogens|mesh-list
25741052|NCT03996057|Hormones|hormones|mesh-ancestor
25741053|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741054|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741055|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25741056|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741057|NCT03996057|Renal Agents|renal agents|mesh-ancestor
25741058|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25741059|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
25741060|NCT03983850|Sirolimus|sirolimus|mesh-list
25741061|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
25741062|NCT03983850|Busulfan|busulfan|mesh-list
25741063|NCT03983850|Fludarabine|fludarabine|mesh-list
25741064|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741065|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
25741066|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741067|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25741068|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25741069|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
25741070|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741071|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741072|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25741073|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25741074|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25741075|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
25741076|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25741077|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741078|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741079|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
25741080|NCT03973268|Complement Factor H|complement factor h|mesh-list
25741081|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25741082|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741083|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
25741084|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741085|NCT03970655|Dexamethasone|dexamethasone|mesh-list
25741086|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
25741087|NCT03970655|Epinephrine|epinephrine|mesh-list
25741088|NCT03970655|Racepinephrine|racepinephrine|mesh-list
25741089|NCT03970655|Bupivacaine|bupivacaine|mesh-list
25741090|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
25741091|NCT03970655|BB 1101|bb 1101|mesh-list
25741092|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741093|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
25741094|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
25741095|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741096|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741097|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741098|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
25741099|NCT03970655|Hormones|hormones|mesh-ancestor
25741100|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741101|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25741102|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741103|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
25741104|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741105|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741106|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
25741107|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
25741108|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25741109|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
25741110|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25741111|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25741112|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
25741113|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741114|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25741115|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25741116|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25741117|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
25741118|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
25741119|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
25741120|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25741121|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25741122|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741123|NCT03952637|Sirolimus|sirolimus|mesh-list
25741124|NCT03952637|Prednisone|prednisone|mesh-list
25741125|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
25741126|NCT03952637|Rituximab|rituximab|mesh-list
25741127|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741128|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741129|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
25741130|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741131|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25741132|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741133|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
25741134|NCT03952637|Hormones|hormones|mesh-ancestor
25741135|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741136|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25741137|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25741138|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741139|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25741140|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
25741141|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741142|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
25741143|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
25741144|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741145|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741146|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25741147|NCT03952637|Protective Agents|protective agents|mesh-ancestor
25741148|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25741149|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25741150|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741151|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741152|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
25741153|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741154|NCT03929068|Levodopa|levodopa|mesh-list
25741155|NCT03929068|Carbidopa|carbidopa|mesh-list
25741156|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25741157|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25741158|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25741159|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
25741160|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741161|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741162|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741163|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25741164|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741165|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25741166|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
25741167|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
25741168|NCT03924518|Granisetron|granisetron|mesh-list
25741169|NCT03924518|Serotonin|serotonin|mesh-list
25741170|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
25741171|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
25741172|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741173|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741174|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741175|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25741176|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
25741177|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741178|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741179|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25741180|NCT03913104|Mifepristone|mifepristone|mesh-list
25741181|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25741182|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
25741183|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25741184|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741185|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25741186|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25741187|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25741188|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
25741189|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25741190|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25741191|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
25774229|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
25310255|NCT04126135|Nicotine|nicotine|mesh-list
25741192|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741193|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
25741194|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25741195|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25741196|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25741197|NCT03910972|Vaccines|vaccines|mesh-list
25741198|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
25741199|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741200|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25741201|NCT03910972|Antacids|antacids|mesh-ancestor
25741202|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741203|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741204|NCT03908593|Pantoprazole|pantoprazole|mesh-list
25741205|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25741206|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741207|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25741208|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741209|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774230|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774231|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774232|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774233|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
25774234|NCT04272775|Hormones|hormones|mesh-ancestor
25774235|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774236|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25774237|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774238|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
25774239|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25774240|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25774241|NCT04272775|Growth Substances|growth substances|mesh-ancestor
25774242|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
25774243|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
25774244|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774245|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774246|NCT04267770|Insulin|insulin|mesh-list
25774247|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25774248|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25774249|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774250|NCT04249336|Listerine|listerine|mesh-list
25774251|NCT04249336|Calcium|calcium|mesh-list
25774252|NCT04249336|Fluorides|fluorides|mesh-list
25774253|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
25774254|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25774255|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774256|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
25774257|NCT04249336|Protective Agents|protective agents|mesh-ancestor
25774258|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25774259|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774260|NCT04238650|Bevacizumab|bevacizumab|mesh-list
25774261|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25774262|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774263|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25774264|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25774265|NCT04238650|Growth Substances|growth substances|mesh-ancestor
25774266|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774267|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
25774268|NCT04238663|Bevacizumab|bevacizumab|mesh-list
25774269|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25774270|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774271|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25774272|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25774273|NCT04238663|Growth Substances|growth substances|mesh-ancestor
25774274|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774275|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
25774276|NCT04203225|Lidocaine|lidocaine|mesh-list
25774277|NCT04203225|Epinephrine|epinephrine|mesh-list
25774278|NCT04203225|Tetracaine|tetracaine|mesh-list
25774279|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
25774280|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
25774281|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774282|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774283|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
25774284|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774285|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25774286|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25741210|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25741211|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25741212|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
25741214|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25741215|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25741216|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
25741217|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741218|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741219|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25741220|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
25741221|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
25741222|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
25741223|NCT03871036|Paclitaxel|paclitaxel|mesh-list
25741224|NCT03871036|Durvalumab|durvalumab|mesh-list
25741225|NCT03871036|Tremelimumab|tremelimumab|mesh-list
25741226|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25741227|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741228|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
25741229|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
25741230|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
25741231|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741232|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741233|NCT03860038|Dexamethasone|dexamethasone|mesh-list
25741234|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741235|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
25741236|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
25741237|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741238|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741239|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741240|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
25741241|NCT03860038|Hormones|hormones|mesh-ancestor
25741242|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741243|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25741244|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741245|NCT03845257|Dimercaprol|dimercaprol|mesh-list
25741246|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
25741247|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
25741248|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741249|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
25741250|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741251|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741252|NCT03821857|Corticosterone|corticosterone|mesh-list
25741253|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741254|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25741255|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25741256|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741257|NCT03818776|Durvalumab|durvalumab|mesh-list
25741258|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741259|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741260|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
25741261|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25741262|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741263|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
25741264|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
25741265|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741266|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741267|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741268|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
25741269|NCT03818737|Hormones|hormones|mesh-ancestor
25741270|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741271|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25741272|NCT03818737|Protective Agents|protective agents|mesh-ancestor
25741273|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
25741274|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25741275|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25741276|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741277|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
25741278|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25741279|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
25741280|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741281|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741282|NCT03776487|Fluorouracil|fluorouracil|mesh-list
25741283|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
25741284|NCT03776487|Nivolumab|nivolumab|mesh-list
25741285|NCT03776487|Ipilimumab|ipilimumab|mesh-list
25741286|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
25741287|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741288|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25741289|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741290|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741291|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
25741292|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741293|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741294|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25741295|NCT03770689|Capecitabine|capecitabine|mesh-list
25741296|NCT03770689|Peposertib|peposertib|mesh-list
25741297|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25741298|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
25741299|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741300|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741301|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741302|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741303|NCT03754049|Dexamethasone|dexamethasone|mesh-list
25741304|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
25741305|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25741306|NCT03754049|BB 1101|bb 1101|mesh-list
25741307|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741308|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
25741309|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
25741310|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741311|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741312|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741313|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
25741314|NCT03754049|Hormones|hormones|mesh-ancestor
25741315|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741316|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25741317|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741318|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
25741319|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741320|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741321|NCT03749187|Temozolomide|temozolomide|mesh-list
25741322|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25741323|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25741324|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
25741325|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741326|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741327|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741328|NCT03746080|Plerixafor|plerixafor|mesh-list
25741329|NCT03746080|Temozolomide|temozolomide|mesh-list
25741330|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25741331|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
25741332|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741333|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741334|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25741335|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25741336|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
25741337|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741338|NCT03745950|Olaparib|olaparib|mesh-list
25741339|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25741340|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741341|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741342|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741343|NCT03737604|Bupivacaine|bupivacaine|mesh-list
25741344|NCT03737604|Ropivacaine|ropivacaine|mesh-list
25741345|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
25741346|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
25741347|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25741348|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741349|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
25741350|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741351|NCT03737461|Lidocaine|lidocaine|mesh-list
25741352|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
25741353|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
25741354|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25741355|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741356|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
25741357|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741358|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25741359|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25741360|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25741361|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25741362|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741363|NCT03716349|Anesthetics|anesthetics|mesh-list
25741364|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
25741365|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25741366|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741367|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
25741368|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741369|NCT03710642|Prazosin|prazosin|mesh-list
25741370|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25741371|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25741372|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25741373|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25741374|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
25741375|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741376|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741377|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741378|NCT03703492|Estradiol|estradiol|mesh-list
25741379|NCT03703492|Estrogens|estrogens|mesh-ancestor
25741380|NCT03703492|Hormones|hormones|mesh-ancestor
25741381|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741382|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741383|NCT03703206|Anesthetics|anesthetics|mesh-list
25741384|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
25741385|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25741386|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741387|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
25741388|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741389|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25741390|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
25741391|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741392|NCT03698461|Leucovorin|leucovorin|mesh-list
25741393|NCT03698461|Bevacizumab|bevacizumab|mesh-list
25741394|NCT03698461|Fluorouracil|fluorouracil|mesh-list
25741395|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
25741396|NCT03698461|Atezolizumab|atezolizumab|mesh-list
25741397|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
25741398|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741399|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741400|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25741401|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25741402|NCT03698461|Growth Substances|growth substances|mesh-ancestor
25741403|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741404|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
25741405|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
25741406|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741407|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25741408|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741409|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
25741410|NCT03698461|Antidotes|antidotes|mesh-ancestor
25741411|NCT03698461|Protective Agents|protective agents|mesh-ancestor
25741412|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
25741413|NCT03698461|Vitamins|vitamins|mesh-ancestor
25741414|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
25741415|NCT03691610|Vaccines|vaccines|mesh-list
25741416|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
25741417|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741418|NCT03689244|Selexipag|selexipag|mesh-list
25741419|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25741420|NCT03682289|Olaparib|olaparib|mesh-list
25741421|NCT03682289|Adenosine|adenosine|mesh-list
25741422|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25741423|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741424|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741425|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741426|NCT03682289|Analgesics|analgesics|mesh-ancestor
25741427|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
25741428|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741429|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741430|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25741431|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
25741432|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25741433|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
25741434|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
25741435|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741436|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25741437|NCT03653546|Gefitinib|gefitinib|mesh-list
25741438|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741439|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741440|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741441|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741442|NCT03647774|Naltrexone|naltrexone|mesh-list
25741443|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25741444|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25741445|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741446|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
25741447|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741448|NCT03643510|Fulvestrant|fulvestrant|mesh-list
25741449|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25741450|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741451|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25741452|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25741453|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
25741454|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741455|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741456|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
25741457|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
25741458|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741459|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741460|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741461|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
25741462|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
25741463|NCT03605901|Methadone|methadone|mesh-list
25741464|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25741465|NCT03605901|Narcotics|narcotics|mesh-ancestor
25741466|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25741467|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741468|NCT03605901|Analgesics|analgesics|mesh-ancestor
25741469|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
25741470|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741471|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
25741472|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
25774287|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25774288|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25774289|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774290|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25774291|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25774292|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
25774293|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774294|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25774295|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25774296|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
25774297|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25774298|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
25774299|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
25774300|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
25774301|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25774302|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
25774303|NCT04222699|Mupirocin|mupirocin|mesh-list
25774304|NCT04222699|Calcium|calcium|mesh-list
25774305|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25774306|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774307|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25774308|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774309|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
25774310|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774311|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25774312|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774313|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774314|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
25774315|NCT04218799|Mupirocin|mupirocin|mesh-list
25774316|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25774317|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774318|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
25774319|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774320|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25774321|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774322|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774323|NCT04204057|Tenalisib|tenalisib|mesh-list
25774324|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
25741473|NCT03592576|Venetoclax|venetoclax|mesh-list
25741474|NCT03592576|Navitoclax|navitoclax|mesh-list
25741475|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741476|NCT03558087|Gemcitabine|gemcitabine|mesh-list
25741477|NCT03558087|Cisplatin|cisplatin|mesh-list
25741478|NCT03558087|Nivolumab|nivolumab|mesh-list
25741479|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741480|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25741481|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
25741482|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741483|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
25741484|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741485|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741486|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741487|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
25741488|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741489|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741490|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25741491|NCT03534323|Venetoclax|venetoclax|mesh-list
25741492|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741493|NCT03532295|Bevacizumab|bevacizumab|mesh-list
25741494|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741495|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741496|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25741497|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25741498|NCT03532295|Growth Substances|growth substances|mesh-ancestor
25741499|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741500|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
25741501|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
25741502|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741503|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
25741504|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741505|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25741506|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25741507|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
25741508|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741509|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741510|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25741511|NCT03490760|Durvalumab|durvalumab|mesh-list
25741512|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741513|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741514|NCT03490344|Lenalidomide|lenalidomide|mesh-list
25741515|NCT03490344|Daratumumab|daratumumab|mesh-list
25741516|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
25741517|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741518|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25741519|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25741520|NCT03490344|Growth Substances|growth substances|mesh-ancestor
25741521|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
25741522|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741523|NCT03448718|Olaparib|olaparib|mesh-list
25741524|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25741525|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741526|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741527|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741528|NCT03443856|Nivolumab|nivolumab|mesh-list
25741529|NCT03443856|Ipilimumab|ipilimumab|mesh-list
25741530|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741531|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741532|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25741533|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741534|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25741535|NCT03409718|Cimetidine|cimetidine|mesh-list
25741536|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25741537|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741538|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25741539|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
25741540|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
25741541|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741542|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741543|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741544|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25741545|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25741546|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741547|NCT03404778|Cimetidine|cimetidine|mesh-list
25741548|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25741549|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741550|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25741551|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
25741552|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
25741553|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741554|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741555|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741556|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25741557|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25741558|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741559|NCT03401320|Letrozole|letrozole|mesh-list
25741560|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741561|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25741562|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25741563|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741564|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741565|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25741566|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
25741567|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741568|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741569|NCT03401294|Leucovorin|leucovorin|mesh-list
25741570|NCT03401294|Bevacizumab|bevacizumab|mesh-list
25741571|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
25741572|NCT03401294|Irinotecan|irinotecan|mesh-list
25741573|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741574|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741575|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25741576|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25741577|NCT03401294|Growth Substances|growth substances|mesh-ancestor
25741578|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741579|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
25741580|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25741581|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25741582|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741583|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741584|NCT03401294|Antidotes|antidotes|mesh-ancestor
25741585|NCT03401294|Protective Agents|protective agents|mesh-ancestor
25741586|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
25741587|NCT03401294|Vitamins|vitamins|mesh-ancestor
25741588|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
25741589|NCT03387670|Simvastatin|simvastatin|mesh-list
25741590|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25741591|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25741592|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
25741593|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741594|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25741595|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25741596|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741597|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
25741598|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
25741599|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25741600|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25741601|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741602|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741603|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741604|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25741605|NCT03365622|Acetaminophen|acetaminophen|mesh-list
25741606|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25741607|NCT03365622|Analgesics|analgesics|mesh-ancestor
25741608|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
25741609|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741610|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741611|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
25741612|NCT03338920|Sumatriptan|sumatriptan|mesh-list
25741613|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25741614|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25741615|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25741616|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
25741617|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741618|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741619|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741620|NCT03326245|Methylphenidate|methylphenidate|mesh-list
25741621|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25741622|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741623|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25741624|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25741625|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25741626|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741627|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
25741628|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741629|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25741630|NCT03325959|Analgesics|analgesics|mesh-ancestor
25741631|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
25741632|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741633|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741634|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25741635|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741636|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25741637|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25741638|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25741639|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741640|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
25741641|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
25741642|NCT03323398|Durvalumab|durvalumab|mesh-list
25741643|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741644|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741645|NCT03298451|Sorafenib|sorafenib|mesh-list
25741646|NCT03298451|Durvalumab|durvalumab|mesh-list
25741647|NCT03298451|Tremelimumab|tremelimumab|mesh-list
25741648|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25741649|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741650|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741651|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741652|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741653|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741654|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
25741655|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741656|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25741657|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
25741658|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741659|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25741660|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
25741661|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741662|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741663|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25741664|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25741665|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25741666|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
25741667|NCT03273023|Chromium|chromium|mesh-list
25741668|NCT03273023|Everolimus|everolimus|mesh-list
25741669|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741670|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741671|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
25741672|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741673|NCT03273023|Trace Elements|trace elements|mesh-ancestor
25741674|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
25741675|NCT03269136|Thalidomide|thalidomide|mesh-list
25741676|NCT03269136|Dexamethasone|dexamethasone|mesh-list
25741677|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
25741678|NCT03269136|Lenalidomide|lenalidomide|mesh-list
25741679|NCT03269136|Pomalidomide|pomalidomide|mesh-list
25741680|NCT03269136|Antibodies|antibodies|mesh-list
25741681|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
25741682|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25741683|NCT03269136|BB 1101|bb 1101|mesh-list
25741684|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
25741685|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741686|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741687|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
25741688|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
25741689|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741690|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741691|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
25741692|NCT03269136|Hormones|hormones|mesh-ancestor
25741693|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741694|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25741695|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741696|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
25310950|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
25741697|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741698|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741699|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25741700|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25741701|NCT03269136|Growth Substances|growth substances|mesh-ancestor
25741702|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
25741703|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741704|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
25741705|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25741706|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741707|NCT03260712|Gemcitabine|gemcitabine|mesh-list
25741708|NCT03260712|Cisplatin|cisplatin|mesh-list
25741709|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
25741710|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741711|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25741712|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
25741713|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741714|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
25741715|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741716|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741717|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741718|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
25741719|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741720|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741721|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25741722|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741723|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741724|NCT03258567|Nivolumab|nivolumab|mesh-list
25741725|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741726|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741727|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25741728|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741729|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
25741730|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741731|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741732|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
25741733|NCT03251651|Propofol|propofol|mesh-list
25741734|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25741735|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25741736|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741737|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25741738|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
25741739|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
25741740|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25741741|NCT03251651|Analgesics|analgesics|mesh-ancestor
25741742|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
25741743|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741744|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25741745|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25741746|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25741747|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25741748|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741749|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741750|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
25741751|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
25741752|NCT03249831|Pentostatin|pentostatin|mesh-list
25741753|NCT03249831|Tacrolimus|tacrolimus|mesh-list
25741754|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
25741755|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25741756|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741757|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
25741758|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741759|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25741760|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25741761|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
25741762|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741763|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741764|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25741765|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25741766|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741767|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25741768|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25741769|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
25741770|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25741771|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741772|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25741773|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
25741774|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741775|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774325|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774326|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777528|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25777529|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
25777530|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777531|NCT03455556|Atezolizumab|atezolizumab|mesh-list
25777532|NCT03455556|Maytansine|maytansine|mesh-list
25777533|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25777534|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777535|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
25777536|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777537|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25777538|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25777539|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25777540|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25777541|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777542|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
25777543|NCT03447639|Povidone|povidone|mesh-list
25777544|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
25777545|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
25777546|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25777547|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777548|NCT03426137|Ketorolac|ketorolac|mesh-list
25777549|NCT03426137|Oxycodone|oxycodone|mesh-list
25777550|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25777551|NCT03426137|Narcotics|narcotics|mesh-ancestor
25777552|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777553|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777554|NCT03426137|Analgesics|analgesics|mesh-ancestor
25777555|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
25777556|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777557|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25777558|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25777559|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777560|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25777561|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25777562|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777563|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777564|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
25777565|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25777566|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25777567|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777568|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
25777569|NCT03425799|Coagulants|coagulants|mesh-ancestor
25777570|NCT03382925|Triamcinolone|triamcinolone|mesh-list
25777571|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25777572|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25777573|NCT03382925|Lidocaine|lidocaine|mesh-list
25777574|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25777575|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
25777576|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
25777577|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777578|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777579|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
25777580|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777581|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25777582|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25777583|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25777584|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777585|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777586|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777587|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
25777588|NCT03382925|Hormones|hormones|mesh-ancestor
25777589|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777590|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777591|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
25777592|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777593|NCT03370536|Ibutilide|ibutilide|mesh-list
25777594|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25777595|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
25777596|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25741776|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25741777|NCT03233347|Nivolumab|nivolumab|mesh-list
25741778|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25741779|NCT03233347|Doxorubicin|doxorubicin|mesh-list
25741780|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25741781|NCT03233347|Daunorubicin|daunorubicin|mesh-list
25741782|NCT03233347|Dacarbazine|dacarbazine|mesh-list
25741783|NCT03233347|Vinblastine|vinblastine|mesh-list
25741784|NCT03233347|Antibodies|antibodies|mesh-list
25741785|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
25741786|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25741787|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
25741788|NCT03233347|Imidazole|imidazole|mesh-list
25741789|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
25741790|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741791|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741792|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25741793|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25741794|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25741795|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741796|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741797|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25741798|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25741799|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
25741800|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25741801|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
25741802|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
25741803|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25741804|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
25741805|NCT03225664|Trametinib|trametinib|mesh-list
25741806|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741807|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741808|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741809|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741810|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741811|NCT03215719|Cisplatin|cisplatin|mesh-list
25741812|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741813|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25741814|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25741815|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741816|NCT03182426|Liraglutide|liraglutide|mesh-list
25741817|NCT03182426|Plerixafor|plerixafor|mesh-list
25741818|NCT03182426|Etanercept|etanercept|mesh-list
25741819|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
25741820|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25741821|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25741822|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741823|NCT03182426|Incretins|incretins|mesh-ancestor
25741824|NCT03182426|Hormones|hormones|mesh-ancestor
25741825|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25741826|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25741827|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25741828|NCT03182426|Analgesics|analgesics|mesh-ancestor
25741829|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
25741830|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741831|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741832|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25741833|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741834|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741835|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
25741836|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741837|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741838|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25741839|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25741840|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
25741841|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741842|NCT03173950|Nivolumab|nivolumab|mesh-list
25741843|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741844|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741845|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25741846|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741847|NCT03172975|Albendazole|albendazole|mesh-list
25741848|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25741849|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
25741850|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25741851|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741852|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
25741853|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25741854|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25741855|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
25741856|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
25741857|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
25741858|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741859|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741860|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25741861|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
25741862|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741863|NCT03172975|Antacids|antacids|mesh-ancestor
25741864|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25741865|NCT03167437|Vorinostat|vorinostat|mesh-list
25741866|NCT03167437|Ustekinumab|ustekinumab|mesh-list
25741867|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741868|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25741869|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741870|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741871|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
25741872|NCT03160911|Hemostatics|hemostatics|mesh-list
25741873|NCT03160911|Coagulants|coagulants|mesh-ancestor
25741874|NCT03137771|Gemcitabine|gemcitabine|mesh-list
25741875|NCT03137771|Docetaxel|docetaxel|mesh-list
25741876|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
25741877|NCT03137771|Pemetrexed|pemetrexed|mesh-list
25741878|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25741879|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25741880|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
25741881|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741882|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741883|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
25741884|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741885|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741886|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741887|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
25741888|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741889|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
25741890|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
25741891|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
25741892|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741893|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25741894|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25741895|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741896|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
25741897|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741898|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
25741899|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25741900|NCT03125928|Paclitaxel|paclitaxel|mesh-list
25741901|NCT03125928|Trastuzumab|trastuzumab|mesh-list
25741902|NCT03125928|Atezolizumab|atezolizumab|mesh-list
25741903|NCT03125928|Pertuzumab|pertuzumab|mesh-list
25741904|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25741905|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741906|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
25741907|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
25741908|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
25741909|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741910|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741911|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25741912|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25741913|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25741914|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25741915|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
25741916|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741917|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741918|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25741919|NCT03087071|Panitumumab|panitumumab|mesh-list
25741920|NCT03087071|Trametinib|trametinib|mesh-list
25741921|NCT03087071|Antibodies|antibodies|mesh-list
25741922|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
25741923|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25741924|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
25741925|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741926|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741927|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741928|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741929|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741930|NCT03086616|Irinotecan|irinotecan|mesh-list
25741931|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25741932|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25741933|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741934|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741935|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741936|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
25741937|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741938|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741939|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741940|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741941|NCT03045341|Naltrexone|naltrexone|mesh-list
25741942|NCT03045341|Bupropion|bupropion|mesh-list
25741943|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25741944|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25741945|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741946|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
25741947|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741948|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25741949|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
25741950|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25741951|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25741952|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25741953|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25741954|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741955|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
25741956|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25741957|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25741958|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25741959|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741960|NCT03042611|Apatinib|apatinib|mesh-list
25741961|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741962|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25741963|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741964|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741965|NCT03041883|Riboflavin|riboflavin|mesh-list
25741966|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
25741967|NCT03041883|Vitamins|vitamins|mesh-ancestor
25741968|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
25741969|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741970|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25741971|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
25741972|NCT03041181|Gemcitabine|gemcitabine|mesh-list
25741973|NCT03041181|Docetaxel|docetaxel|mesh-list
25741974|NCT03041181|Nivolumab|nivolumab|mesh-list
25741975|NCT03041181|Pemetrexed|pemetrexed|mesh-list
25741976|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25741977|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
25741978|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25741979|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25741980|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
25741981|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25741982|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25741983|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25741984|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
25741985|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25741986|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
25741987|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
25741988|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
25741989|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25741990|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25741991|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25741992|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25741993|NCT03040596|Fluticasone|fluticasone|mesh-list
25741994|NCT03040596|Xhance|xhance|mesh-list
25741995|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25741996|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25741997|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
25741998|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25741999|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742000|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25742001|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
25742002|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
25742003|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25742004|NCT03037385|Pralsetinib|pralsetinib|mesh-list
25742005|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742006|NCT03036488|Paclitaxel|paclitaxel|mesh-list
25742007|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
25742008|NCT03036488|Carboplatin|carboplatin|mesh-list
25742009|NCT03036488|Doxorubicin|doxorubicin|mesh-list
25742010|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
25742011|NCT03036488|Epirubicin|epirubicin|mesh-list
25742012|NCT03036488|Lenograstim|lenograstim|mesh-list
25742013|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25742014|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742015|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25742016|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25742017|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25742018|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742019|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742020|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
25742021|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742022|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742023|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25742024|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
25742025|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25742026|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742027|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25742028|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25742029|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742030|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742031|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25742032|NCT03004183|Valacyclovir|valacyclovir|mesh-list
25742033|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
25742034|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742035|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742036|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
25742037|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742038|NCT02966756|Venetoclax|venetoclax|mesh-list
25742039|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742040|NCT02963831|Durvalumab|durvalumab|mesh-list
25742041|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742042|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742043|NCT02956382|Venetoclax|venetoclax|mesh-list
25742044|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742045|NCT02955940|Capecitabine|capecitabine|mesh-list
25742046|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742047|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
25742048|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742049|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742050|NCT02952924|Midazolam|midazolam|mesh-list
25742051|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25742052|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25742053|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742054|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742055|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25742056|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25742057|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25742058|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25742059|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
25742060|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
25742061|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
25742062|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
25742063|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742064|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742065|NCT02941926|Letrozole|letrozole|mesh-list
25742066|NCT02941926|Leuprolide|leuprolide|mesh-list
25742067|NCT02941926|Goserelin|goserelin|mesh-list
25742068|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742069|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25742070|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25742071|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742072|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742073|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25742074|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
25742075|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742076|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742077|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25742078|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
25742079|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25742080|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25311408|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
25742081|NCT02939872|Aspirin|aspirin|mesh-list
25742082|NCT02939872|Clopidogrel|clopidogrel|mesh-list
25742083|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25742084|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25742085|NCT02939872|Analgesics|analgesics|mesh-ancestor
25742086|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
25742087|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742088|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742089|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742090|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742091|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25742092|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25742093|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742094|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25742095|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25742096|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742097|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
25742098|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25742099|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25742100|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25742101|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
25742102|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742103|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
25742104|NCT02905578|Gemcitabine|gemcitabine|mesh-list
25742105|NCT02905578|Paclitaxel|paclitaxel|mesh-list
25742106|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25742107|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742108|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
25742109|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
25742110|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
25742111|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742112|NCT02905578|Vitamins|vitamins|mesh-ancestor
25742113|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
25742114|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742115|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742116|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
25742117|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
25742118|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742119|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742120|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742121|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
25742122|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
25742123|NCT02905578|Protective Agents|protective agents|mesh-ancestor
25742124|NCT02859064|Lanreotide|lanreotide|mesh-list
25742125|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742126|NCT02768727|Xenon|xenon|mesh-list
25742127|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25742128|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
25742129|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
25742130|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742131|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774327|NCT04207840|Epinephrine|epinephrine|mesh-list
25774328|NCT04207840|Racepinephrine|racepinephrine|mesh-list
25774329|NCT04207840|Albuterol|albuterol|mesh-list
25774330|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
25774331|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25774332|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25774333|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
25774334|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774335|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774336|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774337|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25774338|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25774339|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
25774340|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774341|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25774342|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
25774343|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
25774344|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
25311503|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311504|NCT03363893|Fulvestrant|fulvestrant|mesh-list
25311505|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25311506|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311507|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25311508|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25311513|NCT05072405|Simvastatin|simvastatin|mesh-list
25774345|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25774346|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
25774347|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25742133|NCT02697344|Dexamethasone|dexamethasone|mesh-list
25742134|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
25742135|NCT02697344|Lenalidomide|lenalidomide|mesh-list
25742136|NCT02697344|Retinol acetate|retinol acetate|mesh-list
25742137|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
25742138|NCT02697344|Gossypol|gossypol|mesh-list
25742139|NCT02697344|BB 1101|bb 1101|mesh-list
25742140|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742141|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
25742142|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
25742143|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742144|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742145|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742146|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
25742147|NCT02697344|Hormones|hormones|mesh-ancestor
25742148|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742149|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742150|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742151|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
25742152|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25742153|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25742154|NCT02697344|Growth Substances|growth substances|mesh-ancestor
25742155|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
25742156|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
25742157|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742158|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742159|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25742160|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742161|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25742162|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25742163|NCT02697344|Protective Agents|protective agents|mesh-ancestor
25742164|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25742165|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
25742166|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25742167|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25742168|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25742169|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25742170|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25742171|NCT02688309|Dexamethasone|dexamethasone|mesh-list
25742172|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742173|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
25742174|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
25742175|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742176|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742177|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742178|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
25742179|NCT02688309|Hormones|hormones|mesh-ancestor
25742180|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742181|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742182|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742183|NCT02661971|Leucovorin|leucovorin|mesh-list
25742184|NCT02661971|Docetaxel|docetaxel|mesh-list
25742185|NCT02661971|Fluorouracil|fluorouracil|mesh-list
25742186|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
25742187|NCT02661971|Ramucirumab|ramucirumab|mesh-list
25742188|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742189|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
25742190|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25742191|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
25742192|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742193|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
25742194|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742195|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742196|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
25742197|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742198|NCT02661971|Antidotes|antidotes|mesh-ancestor
25742199|NCT02661971|Protective Agents|protective agents|mesh-ancestor
25742200|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
25742201|NCT02661971|Vitamins|vitamins|mesh-ancestor
25742202|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
25742203|NCT02656511|Tenofovir|tenofovir|mesh-list
25742204|NCT02656511|Emtricitabine|emtricitabine|mesh-list
25742205|NCT02656511|Dolutegravir|dolutegravir|mesh-list
25742206|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
25742207|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742208|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25742209|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25742210|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742211|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742212|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25742213|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25742214|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25742215|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25742216|NCT02626130|Tremelimumab|tremelimumab|mesh-list
25742217|NCT02626130|Ipilimumab|ipilimumab|mesh-list
25742218|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742219|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742220|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25742221|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742222|NCT02618720|Ornidazole|ornidazole|mesh-list
25742223|NCT02618720|Amebicides|amebicides|mesh-ancestor
25742224|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25742225|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25742226|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742227|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25742228|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25742229|NCT02616965|Romidepsin|romidepsin|mesh-list
25742230|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742231|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742232|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742233|NCT02588027|Ibuprofen|ibuprofen|mesh-list
25742234|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25742235|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25742236|NCT02588027|Analgesics|analgesics|mesh-ancestor
25742237|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
25742238|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742239|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742240|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742241|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742242|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25742243|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742244|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742245|NCT02582749|Bicalutamide|bicalutamide|mesh-list
25742246|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25742247|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
25742248|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
25742249|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742250|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742251|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742252|NCT02572323|Tesamorelin|tesamorelin|mesh-list
25742253|NCT02572323|Growth Substances|growth substances|mesh-ancestor
25742254|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742255|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
25742256|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742257|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742258|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25742259|NCT02520141|Ramucirumab|ramucirumab|mesh-list
25742260|NCT02520141|Antibodies|antibodies|mesh-list
25742261|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
25742262|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25742263|NCT02520141|Lexatumumab|lexatumumab|mesh-list
25742264|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
25742265|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742266|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742267|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
25742268|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742269|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742270|NCT02475772|Cisplatin|cisplatin|mesh-list
25742271|NCT02475772|Doxorubicin|doxorubicin|mesh-list
25742272|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25742273|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742274|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742275|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25742276|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25742277|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742278|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742279|NCT02471430|Interferons|interferons|mesh-list
25742280|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
25742281|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
25742282|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25742283|NCT02471430|Panobinostat|panobinostat|mesh-list
25742284|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742285|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
25742286|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742287|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
25742288|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742289|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25742290|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742291|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742292|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
25742293|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
25742294|NCT02466581|Prednisolone|prednisolone|mesh-list
25742295|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25742296|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
25742297|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25742298|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
25742299|NCT02466581|Abatacept|abatacept|mesh-list
25742300|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
25742301|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25742302|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
25742303|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742304|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
25742305|NCT02466581|Hormones|hormones|mesh-ancestor
25742306|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742307|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742308|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742309|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742310|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
25742311|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
25742312|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742313|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742314|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25742315|NCT02466581|Protective Agents|protective agents|mesh-ancestor
25742316|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
25742317|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25742318|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25742319|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742320|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742321|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742322|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742323|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25742324|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742325|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
25742326|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25742327|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25742328|NCT02466581|Analgesics|analgesics|mesh-ancestor
25742329|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
25742330|NCT02450331|Atezolizumab|atezolizumab|mesh-list
25742331|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742332|NCT02420613|Sirolimus|sirolimus|mesh-list
25742333|NCT02420613|Vorinostat|vorinostat|mesh-list
25742334|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25742335|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742336|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742337|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742338|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
25742339|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742340|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
25742341|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742342|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25742343|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742344|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742345|NCT02419040|Lidocaine|lidocaine|mesh-list
25742346|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
25742347|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
25742348|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742349|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742350|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
25742351|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742352|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25742353|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25742354|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25742355|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742356|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742357|NCT02377271|Bosentan|bosentan|mesh-list
25742358|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25742359|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25311743|NCT05067153|Heparin|heparin|mesh-list
25742360|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742361|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
25742362|NCT02344355|Temozolomide|temozolomide|mesh-list
25742363|NCT02344355|Vitamins|vitamins|mesh-ancestor
25742364|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
25742365|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742366|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25742367|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
25742368|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742369|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742370|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
25742371|NCT02344355|Protective Agents|protective agents|mesh-ancestor
25742372|NCT02332850|Dexamethasone|dexamethasone|mesh-list
25742373|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742374|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
25742375|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
25742376|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742377|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742378|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742379|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
25742380|NCT02332850|Hormones|hormones|mesh-ancestor
25742381|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742382|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742383|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742384|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
25742385|NCT02278887|Fludarabine|fludarabine|mesh-list
25742386|NCT02278887|Ipilimumab|ipilimumab|mesh-list
25742387|NCT02278887|Interleukin-2|interleukin-2|mesh-list
25742388|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742389|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
25742390|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742391|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742392|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25742393|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
25742394|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742395|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742396|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25742397|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742398|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25742399|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25742400|NCT02278887|Analgesics|analgesics|mesh-ancestor
25742401|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
25742402|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742403|NCT02229578|Lidocaine|lidocaine|mesh-list
25742404|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
25742405|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
25742406|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742407|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742408|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
25742409|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742410|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25742411|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25742412|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25742413|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742414|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742415|NCT02042989|Vorinostat|vorinostat|mesh-list
25742416|NCT02042989|Ixazomib|ixazomib|mesh-list
25742417|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742418|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25742419|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742420|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742421|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
25742422|NCT02028221|Metformin|metformin|mesh-list
25742423|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25742424|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742425|NCT02011971|Vinpocetine|vinpocetine|mesh-list
25742426|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25742427|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742428|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742429|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
25742430|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25742431|NCT02011971|Protective Agents|protective agents|mesh-ancestor
25742432|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742433|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
25742434|NCT02007044|Rituximab|rituximab|mesh-list
25742435|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25742436|NCT02007044|Antibodies|antibodies|mesh-list
25742437|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
25742438|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25742439|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
25742440|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742441|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742442|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742443|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25742444|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
25742445|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742446|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25742447|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
25742448|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742449|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742450|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25742451|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25742452|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742453|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
25742454|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
25742455|NCT01854814|Losartan|losartan|mesh-list
25742456|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742457|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742458|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25742459|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
25742460|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25742461|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742462|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742463|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742464|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25742465|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25742466|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25742467|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25742468|NCT01854255|Cisplatin|cisplatin|mesh-list
25742469|NCT01854255|Doxorubicin|doxorubicin|mesh-list
25742470|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25742471|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742472|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742473|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25742474|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25742475|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742476|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742477|NCT01835041|Leucovorin|leucovorin|mesh-list
25742478|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
25742479|NCT01835041|Fluorouracil|fluorouracil|mesh-list
25742480|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
25742481|NCT01835041|Irinotecan|irinotecan|mesh-list
25742482|NCT01835041|Calcium|calcium|mesh-list
25742483|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
25742484|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25742485|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742486|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
25742487|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742488|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742489|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742490|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742491|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
25742492|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25742493|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25742494|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742495|NCT01835041|Antidotes|antidotes|mesh-ancestor
25742496|NCT01835041|Protective Agents|protective agents|mesh-ancestor
25742497|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
25742498|NCT01835041|Vitamins|vitamins|mesh-ancestor
25742499|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
25742500|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
25742501|NCT01809379|Cisplatin|cisplatin|mesh-list
25742502|NCT01809379|Doxorubicin|doxorubicin|mesh-list
25742503|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742504|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742505|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25742506|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25742507|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742508|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742509|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25742510|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
25742511|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742512|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25742513|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
25742514|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742515|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742516|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25742517|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25742518|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742519|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
25742520|NCT01780545|Docetaxel|docetaxel|mesh-list
25742521|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742522|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
25742523|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
25742524|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
25742525|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742526|NCT01743742|Vitamins|vitamins|mesh-list
25742527|NCT01743742|Ascorbic Acid|ascorbic acid|mesh-list
25742528|NCT01743742|Vitamin E|vitamin e|mesh-list
25742529|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
25742530|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742531|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
25742532|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742533|NCT01743742|Protective Agents|protective agents|mesh-ancestor
25742534|NCT01681433|Prednisone|prednisone|mesh-list
25742535|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
25742536|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742537|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
25742538|NCT01681433|Hormones|hormones|mesh-ancestor
25742539|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742540|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742541|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742542|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742543|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25742544|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742545|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742546|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
25742547|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25742548|NCT01555281|Nelfinavir|nelfinavir|mesh-list
25742549|NCT01555281|Dexamethasone|dexamethasone|mesh-list
25742550|NCT01555281|Lenalidomide|lenalidomide|mesh-list
25742551|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742552|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
25742553|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
25742554|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742555|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742556|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742557|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
25742558|NCT01555281|Hormones|hormones|mesh-ancestor
25742559|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742560|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742561|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742562|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
25742563|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25742564|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25742565|NCT01555281|Growth Substances|growth substances|mesh-ancestor
25742566|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25742567|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25742568|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25742569|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
25742570|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742571|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742572|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25742573|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25742574|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
25742575|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774348|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25774349|NCT04198948|Gliclazide|gliclazide|mesh-list
25774350|NCT04198948|Omeprazole|omeprazole|mesh-list
25774351|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25774352|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774353|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25774354|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774355|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774356|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25774357|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774358|NCT04204200|Vitamins|vitamins|mesh-list
25774359|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
25774360|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
25742577|NCT01524991|Cisplatin|cisplatin|mesh-list
25742578|NCT01524991|Ipilimumab|ipilimumab|mesh-list
25742579|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742580|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742581|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
25742582|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742583|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
25742584|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742585|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742586|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742587|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
25742588|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742589|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742590|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25742591|NCT01491815|Abatacept|abatacept|mesh-list
25742592|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25742593|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742594|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742595|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742596|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
25742597|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742598|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742599|NCT01438073|Hormones|hormones|mesh-list
25742600|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742601|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742602|NCT01265030|Sirolimus|sirolimus|mesh-list
25742603|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25742604|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742605|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25742606|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742607|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
25742608|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742609|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
25742610|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742611|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25742612|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
25742613|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742614|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25742615|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
25742616|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742617|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742618|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25742619|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25742620|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742621|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
25742622|NCT01084252|Dexamethasone|dexamethasone|mesh-list
25742623|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
25742624|NCT01084252|BB 1101|bb 1101|mesh-list
25742625|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742626|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
25742627|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
25742628|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742629|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742630|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742631|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
25742632|NCT01084252|Hormones|hormones|mesh-ancestor
25742633|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742634|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742635|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742636|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
25742637|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742638|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742639|NCT01034631|Everolimus|everolimus|mesh-list
25742640|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742641|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742642|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
25742643|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742644|NCT00783510|Adalimumab|adalimumab|mesh-list
25742645|NCT00783510|Methotrexate|methotrexate|mesh-list
25742646|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25742647|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
25742648|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25742649|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742650|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742651|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
25742652|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742653|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742654|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
25742655|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742656|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25742657|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742658|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
25742659|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742660|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25742661|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742662|NCT00677586|Liver Extracts|liver extracts|mesh-list
25742663|NCT00677586|Hematinics|hematinics|mesh-ancestor
25742664|NCT00673335|Letrozole|letrozole|mesh-list
25742665|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742666|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25742667|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25742668|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742669|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742670|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25742671|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
25742672|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742673|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742674|NCT00481091|Navitoclax|navitoclax|mesh-list
25742675|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742676|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25742677|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
25742678|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742679|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25742680|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
25742681|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742682|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742683|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25742684|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25742685|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742686|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
25742687|NCT00392756|Hormones|hormones|mesh-list
25742688|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742689|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742690|NCT00212134|Dipivefrin|dipivefrin|mesh-list
25742691|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25742692|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
25742693|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742694|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742695|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742696|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25742697|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742698|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742699|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742700|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25742701|NCT05454709|Glucagon|glucagon|mesh-list
25742702|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742703|NCT05454709|Hormones|hormones|mesh-ancestor
25742704|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742705|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742706|NCT05454683|Melatonin|melatonin|mesh-list
25742707|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
25742708|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742709|NCT05454683|Protective Agents|protective agents|mesh-ancestor
25742710|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742711|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742712|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
25742713|NCT05454345|Rifampin|rifampin|mesh-list
25742714|NCT05454345|Isoniazid|isoniazid|mesh-list
25742715|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
25742716|NCT05454345|Ethambutol|ethambutol|mesh-list
25742717|NCT05454345|Rifapentine|rifapentine|mesh-list
25312253|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
25312254|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312255|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312256|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312257|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312258|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25742718|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
25742719|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25742720|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742721|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25742722|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25742723|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742724|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742725|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742726|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25742727|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
25742728|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
25742729|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25742730|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25742731|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25742732|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25742733|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25742734|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25742735|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25742736|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25742737|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25742738|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
25742739|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25742740|NCT05454332|Caffeine|caffeine|mesh-list
25742741|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25742742|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742743|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25742744|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742745|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742746|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25742747|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25742748|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
25742749|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742750|NCT05454085|Bisphenol A|bisphenol a|mesh-list
25742751|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25742752|NCT05454085|Estrogens|estrogens|mesh-ancestor
25742753|NCT05454085|Hormones|hormones|mesh-ancestor
25742754|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742755|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742756|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25742757|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
25742758|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742759|NCT05454085|Protective Agents|protective agents|mesh-ancestor
25742760|NCT05453968|Berotralstat|berotralstat|mesh-list
25742761|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742762|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742763|NCT05453929|Rocuronium|rocuronium|mesh-list
25742764|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25742765|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25742766|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25742767|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742768|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742769|NCT05453851|Pancrelipase|pancrelipase|mesh-list
25742770|NCT05453851|Pancreatin|pancreatin|mesh-list
25742771|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742772|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
25742773|NCT05453552|Busulfan|busulfan|mesh-list
25742774|NCT05453552|Fludarabine|fludarabine|mesh-list
25742775|NCT05453552|Decitabine|decitabine|mesh-list
25742776|NCT05453552|Lenograstim|lenograstim|mesh-list
25742777|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25742778|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
25742779|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742780|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25742781|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25742782|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
25742783|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742784|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742785|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25742786|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742787|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
25742788|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742789|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25774361|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774362|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
25742790|NCT05453448|Tenofovir|tenofovir|mesh-list
25742791|NCT05453448|Entecavir|entecavir|mesh-list
25742792|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
25742793|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742794|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25742795|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25742796|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742797|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742798|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25742799|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25742800|NCT05453435|Entecavir|entecavir|mesh-list
25742801|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
25742802|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742803|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25742804|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742805|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742806|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
25742807|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25742808|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25742809|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25742810|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742811|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
25742812|NCT05453266|Coagulants|coagulants|mesh-ancestor
25742813|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
25742814|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742815|NCT05452928|Valacyclovir|valacyclovir|mesh-list
25742816|NCT05452928|Acyclovir|acyclovir|mesh-list
25742817|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
25742818|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25742819|NCT05451719|Capecitabine|capecitabine|mesh-list
25742820|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25742821|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
25742822|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742823|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742824|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
25742825|NCT05451381|Propofol|propofol|mesh-list
25742826|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25742827|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742828|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742829|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25742830|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
25742831|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
25742832|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25742833|NCT05451381|Analgesics|analgesics|mesh-ancestor
25742834|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
25742835|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742836|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25742837|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25742838|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25742839|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
25742840|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742841|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742842|NCT05450913|Lidocaine|lidocaine|mesh-list
25742843|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
25742844|NCT05450913|Anesthetics|anesthetics|mesh-list
25742845|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742846|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742847|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
25742848|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742849|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25742850|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25742851|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25742852|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742853|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742854|NCT05450419|Vitamin D|vitamin d|mesh-list
25742855|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
25742856|NCT05450419|Vitamins|vitamins|mesh-ancestor
25742857|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
25742858|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742859|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25742860|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25742861|NCT05448989|Atropine|atropine|mesh-list
25742862|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25742863|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25742864|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25742865|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
25742866|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742867|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742868|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25742869|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
25742870|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
25742871|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
25742872|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25742873|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25742874|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
25742875|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742876|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742877|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
25742878|NCT05446779|Epinephrine|epinephrine|mesh-list
25742879|NCT05446779|Racepinephrine|racepinephrine|mesh-list
25742880|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
25742881|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742882|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25742883|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25742884|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25742885|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742886|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742887|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742888|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25742889|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25742890|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
25742891|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742892|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25742893|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
25742894|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
25742895|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
25742896|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25742897|NCT05444478|Lenvatinib|lenvatinib|mesh-list
25742898|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742899|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25742900|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742901|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742902|NCT05443009|Lidocaine|lidocaine|mesh-list
25742903|NCT05443009|Carticaine|carticaine|mesh-list
25742904|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
25742905|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
25742906|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742907|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742908|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
25742909|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742910|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25742911|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25742912|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25742913|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25742914|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742915|NCT05413369|Metformin|metformin|mesh-list
25742916|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
25742917|NCT05413369|Lixisenatide|lixisenatide|mesh-list
25742918|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25742919|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25742920|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742921|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742922|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25742923|NCT05400265|Antibodies|antibodies|mesh-list
25742924|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
25742925|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25742926|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
25742927|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742928|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742929|NCT05378971|Pomalidomide|pomalidomide|mesh-list
25742930|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
25742931|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742932|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25742933|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25742934|NCT05378971|Growth Substances|growth substances|mesh-ancestor
25742935|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
25742936|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742937|NCT05354466|Neostigmine|neostigmine|mesh-list
25742938|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25742939|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25742940|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742941|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
25742942|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742943|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742944|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25742945|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
25742946|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742947|NCT05323019|Ketamine|ketamine|mesh-list
25742948|NCT05323019|Esketamine|esketamine|mesh-list
25742949|NCT05323019|Analgesics|analgesics|mesh-ancestor
25742950|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
25742951|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742952|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742953|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25742954|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25742955|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
25742956|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
25742957|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25742958|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25742959|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25742960|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25742961|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25742962|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
25742963|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25742964|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25742965|NCT05285904|Ofatumumab|ofatumumab|mesh-list
25742966|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742967|NCT05283837|Pertuzumab|pertuzumab|mesh-list
25742968|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25742969|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742970|NCT05277727|Fucoidan|fucoidan|mesh-list
25742971|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25742972|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742973|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
25742974|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774363|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774364|NCT04204200|Protective Agents|protective agents|mesh-ancestor
25774365|NCT04194151|Propofol|propofol|mesh-list
25774366|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25774367|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774368|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774369|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25774370|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
25774371|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
25774372|NCT04186806|Muramidase|muramidase|mesh-list
25774373|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774374|NCT04184999|Dexamethasone|dexamethasone|mesh-list
25774375|NCT04184999|Prednisolone|prednisolone|mesh-list
25774376|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25774377|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
25774378|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25774379|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
25774380|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25774381|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
25774382|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774383|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
25774384|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
25774385|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774386|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774387|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774388|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
25774389|NCT04184999|Hormones|hormones|mesh-ancestor
25774390|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774391|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25774392|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774393|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25774394|NCT04184999|Protective Agents|protective agents|mesh-ancestor
25774395|NCT04184271|Fluorides|fluorides|mesh-list
25774396|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
25774397|NCT04184271|Protective Agents|protective agents|mesh-ancestor
25774398|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774399|NCT04179461|Vitamin D|vitamin d|mesh-list
25774400|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
25774401|NCT04179461|Fluticasone|fluticasone|mesh-list
25774402|NCT04179461|Xhance|xhance|mesh-list
25774403|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
25774404|NCT04179461|Cetirizine|cetirizine|mesh-list
25312620|NCT05048914|Acetaminophen|acetaminophen|mesh-list
25774405|NCT04179461|Loratadine|loratadine|mesh-list
25774406|NCT04179461|Azithromycin|azithromycin|mesh-list
25742976|NCT05259839|Lenalidomide|lenalidomide|mesh-list
25742977|NCT05259839|Daratumumab|daratumumab|mesh-list
25742978|NCT05259839|Pomalidomide|pomalidomide|mesh-list
25742979|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25742980|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
25742981|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
25742982|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25742983|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25742984|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25742985|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
25742986|NCT05259839|Hormones|hormones|mesh-ancestor
25742987|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25742988|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25742989|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742990|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
25742991|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25742992|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25742993|NCT05259839|Growth Substances|growth substances|mesh-ancestor
25742994|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
25742995|NCT05244993|Paclitaxel|paclitaxel|mesh-list
25742996|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25742997|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25742998|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25742999|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743000|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743001|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743002|NCT05241275|Xenon|xenon|mesh-list
25743003|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25743004|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
25743005|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
25743006|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743007|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743008|NCT05203562|Letrozole|letrozole|mesh-list
25743009|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743010|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25743011|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25743012|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743013|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743014|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25743015|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
25743016|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743017|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743018|NCT05144542|Nicotine|nicotine|mesh-list
25743019|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25743020|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
25743021|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743022|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743023|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25743024|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25743025|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
25743026|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743027|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743028|NCT05132439|Metformin|metformin|mesh-list
25743029|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25743030|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743031|NCT05116891|Leucovorin|leucovorin|mesh-list
25743032|NCT05116891|Gemcitabine|gemcitabine|mesh-list
25743033|NCT05116891|Cisplatin|cisplatin|mesh-list
25743034|NCT05116891|Docetaxel|docetaxel|mesh-list
25743035|NCT05116891|Fluorouracil|fluorouracil|mesh-list
25743036|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
25743037|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743038|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25743039|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
25743040|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743041|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
25743042|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743043|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743044|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743045|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
25743046|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743047|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743048|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743049|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743050|NCT05116891|Antidotes|antidotes|mesh-ancestor
25312738|NCT05047991|Antidotes|antidotes|mesh-ancestor
25743051|NCT05116891|Protective Agents|protective agents|mesh-ancestor
25743052|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
25743053|NCT05116891|Vitamins|vitamins|mesh-ancestor
25743054|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
25743055|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
25743056|NCT05114421|Lenvatinib|lenvatinib|mesh-list
25743057|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743058|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743059|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25743060|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743061|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743062|NCT05100160|Gabapentin|gabapentin|mesh-list
25743063|NCT05100160|Analgesics|analgesics|mesh-ancestor
25743064|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
25743065|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743066|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743067|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
25743068|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25743069|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25743070|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743071|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25743072|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25743073|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25743074|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743075|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743076|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
25743077|NCT05083845|Anesthetics|anesthetics|mesh-list
25743078|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
25743079|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743080|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743081|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
25743082|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743083|NCT05071833|Peppermint oil|peppermint oil|mesh-list
25743084|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
25743085|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
25743086|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743087|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743088|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743089|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
25743090|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
25743091|NCT05064280|Lenvatinib|lenvatinib|mesh-list
25743092|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743093|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743094|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25743095|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743096|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743097|NCT05057689|Fentanyl|fentanyl|mesh-list
25743098|NCT05057689|Midazolam|midazolam|mesh-list
25743099|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
25743100|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25743101|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743102|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743103|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25743104|NCT05057689|Analgesics|analgesics|mesh-ancestor
25743105|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
25743106|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743107|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25743108|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25743109|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25743110|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
25743111|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743112|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743113|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25743114|NCT05057689|Narcotics|narcotics|mesh-ancestor
25743115|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25743116|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25743117|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
25743118|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
25743119|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25743120|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25743121|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25743122|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
25743123|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
25743124|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25743125|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
25743126|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25743127|NCT05055050|Imiquimod|imiquimod|mesh-list
25743128|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25743129|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
25743130|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743131|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743132|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
25743133|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
25743134|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743135|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743136|NCT05039736|Nivolumab|nivolumab|mesh-list
25743137|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743138|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743139|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25743140|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743141|NCT05035836|Tamoxifen|tamoxifen|mesh-list
25743142|NCT05035836|Letrozole|letrozole|mesh-list
25743143|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743144|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25743145|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25743146|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743147|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743148|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25743149|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
25743150|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743151|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743152|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743153|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25743154|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25743155|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25743156|NCT05034562|Edetic Acid|edetic acid|mesh-list
25743157|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25743158|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
25743159|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
25743160|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743161|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
25743162|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25743163|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25743164|NCT05032183|Leucovorin|leucovorin|mesh-list
25743165|NCT05032183|Cytarabine|cytarabine|mesh-list
25743166|NCT05032183|Dexamethasone|dexamethasone|mesh-list
25743167|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
25743168|NCT05032183|Prednisone|prednisone|mesh-list
25743169|NCT05032183|Cortisone|cortisone|mesh-list
25743170|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
25743171|NCT05032183|Rituximab|rituximab|mesh-list
25743172|NCT05032183|Methotrexate|methotrexate|mesh-list
25743173|NCT05032183|Vincristine|vincristine|mesh-list
25743174|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
25743175|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25743176|NCT05032183|Antibodies|antibodies|mesh-list
25743177|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
25743178|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25743179|NCT05032183|Lenograstim|lenograstim|mesh-list
25743180|NCT05032183|BB 1101|bb 1101|mesh-list
25743181|NCT05032183|Mesna|mesna|mesh-list
25743182|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743183|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
25743184|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743185|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743186|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25743187|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
25743188|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743189|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743190|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25743191|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743192|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
25743193|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
25743194|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743195|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743196|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
25743197|NCT05032183|Hormones|hormones|mesh-ancestor
25743198|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743199|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743200|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
25743201|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743202|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25743203|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
25743204|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25743205|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25743206|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
25743207|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
25743208|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25743209|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25743210|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
25743211|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743212|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25743213|NCT05032183|Antidotes|antidotes|mesh-ancestor
25743214|NCT05032183|Protective Agents|protective agents|mesh-ancestor
25743215|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
25743216|NCT05032183|Vitamins|vitamins|mesh-ancestor
25743217|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
25743218|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743219|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743220|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743221|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743222|NCT05027633|Cisplatin|cisplatin|mesh-list
25743223|NCT05027633|Carboplatin|carboplatin|mesh-list
25743224|NCT05027633|Docetaxel|docetaxel|mesh-list
25743225|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
25743226|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743227|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743228|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743229|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743230|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743231|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743232|NCT05016310|Vitamin D|vitamin d|mesh-list
25743233|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
25743234|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
25743235|NCT05016310|Vitamins|vitamins|mesh-list
25743236|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
25743237|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743238|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25743239|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25743240|NCT05006677|Vitamin K|vitamin k|mesh-list
25743241|NCT05006677|Anticoagulants|anticoagulants|mesh-list
25743242|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25743243|NCT05006677|Vitamins|vitamins|mesh-ancestor
25743244|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
25743245|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743246|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25743247|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25743248|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743249|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
25743250|NCT05006677|Coagulants|coagulants|mesh-ancestor
25743251|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
25743252|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743253|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743254|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
25743255|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25743256|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
25743257|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743258|NCT04978584|Prednisone|prednisone|mesh-list
25743259|NCT04978584|Cortisone|cortisone|mesh-list
25743260|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
25743261|NCT04978584|Rituximab|rituximab|mesh-list
25743262|NCT04978584|Doxorubicin|doxorubicin|mesh-list
25743263|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25743264|NCT04978584|Vincristine|vincristine|mesh-list
25743265|NCT04978584|Lenalidomide|lenalidomide|mesh-list
25743266|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
25743267|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25743268|NCT04978584|Antibodies|antibodies|mesh-list
25743269|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
25743270|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25743271|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743272|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
25743273|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743274|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743275|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25743276|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
25743277|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743278|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743279|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25743280|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25743281|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25743282|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25743283|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774407|NCT04179461|Budesonide|budesonide|mesh-list
25743284|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743286|NCT04978584|Hormones|hormones|mesh-ancestor
25743287|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743288|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743289|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743290|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743291|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743292|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743293|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25743294|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25743295|NCT04978584|Growth Substances|growth substances|mesh-ancestor
25743296|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
25743297|NCT04965714|Nivolumab|nivolumab|mesh-list
25743298|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743299|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743300|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25743301|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743302|NCT04906096|GDC-0084|gdc-0084|mesh-list
25743303|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743304|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774408|NCT04179461|Beclomethasone|beclomethasone|mesh-list
25774409|NCT04179461|Emollients|emollients|mesh-list
25774410|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
25774411|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
25774412|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25774413|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25774414|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
25774415|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25774416|NCT04179461|Vitamins|vitamins|mesh-ancestor
25774417|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
25774418|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774419|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25774420|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774421|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25774422|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
25774423|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774424|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25774425|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
25774426|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
25774427|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25774428|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25774429|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
25774430|NCT04179461|Hormones|hormones|mesh-ancestor
25774431|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774432|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774433|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774434|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25774435|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25774436|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25774437|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
25774438|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774439|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774440|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
25774441|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25774442|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
25774443|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25774444|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
25774445|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
25774446|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
25774447|NCT04179474|Erenumab|erenumab|mesh-list
25774448|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25774449|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774450|NCT04179474|Analgesics|analgesics|mesh-ancestor
25774451|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
25774452|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774453|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774454|NCT04177862|Fentanyl|fentanyl|mesh-list
25774455|NCT04177862|Sufentanil|sufentanil|mesh-list
25774456|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25774457|NCT04177862|Narcotics|narcotics|mesh-ancestor
25774458|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774459|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774460|NCT04177862|Analgesics|analgesics|mesh-ancestor
25743305|NCT04852484|Ketamine|ketamine|mesh-list
25743306|NCT04852484|Morphine|morphine|mesh-list
25743307|NCT04852484|Anesthetics|anesthetics|mesh-list
25743308|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
25743309|NCT04852484|Analgesics|analgesics|mesh-ancestor
25743310|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
25743311|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743312|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743313|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25743314|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25743315|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
25743316|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743317|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25743318|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25743319|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743320|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743321|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25743322|NCT04852484|Narcotics|narcotics|mesh-ancestor
25743323|NCT04809662|Imiquimod|imiquimod|mesh-list
25743324|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25743325|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
25743326|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743327|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743328|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
25743329|NCT04790474|Dexamethasone|dexamethasone|mesh-list
25743330|NCT04790474|Pomalidomide|pomalidomide|mesh-list
25743331|NCT04790474|Ixazomib|ixazomib|mesh-list
25743332|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743333|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
25743334|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
25743335|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743336|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743337|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743338|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
25743339|NCT04790474|Hormones|hormones|mesh-ancestor
25743340|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743341|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743342|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743343|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
25743344|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25743345|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25743346|NCT04790474|Growth Substances|growth substances|mesh-ancestor
25743347|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
25743348|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
25743349|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743350|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743351|NCT04781855|Nivolumab|nivolumab|mesh-list
25743352|NCT04781855|Ipilimumab|ipilimumab|mesh-list
25743353|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743354|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743355|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25743356|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743357|NCT04762680|Vaccines|vaccines|mesh-list
25743358|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
25743359|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743360|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25743361|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25743362|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743363|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743364|NCT04718116|Tramadol|tramadol|mesh-list
25743365|NCT04718116|Tapentadol|tapentadol|mesh-list
25743366|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25743367|NCT04718116|Narcotics|narcotics|mesh-ancestor
25743368|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743369|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743370|NCT04718116|Analgesics|analgesics|mesh-ancestor
25743371|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
25743372|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743373|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25743374|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25743375|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25743376|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743377|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
25743378|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743379|NCT04717193|Epinephrine|epinephrine|mesh-list
25743380|NCT04717193|Racepinephrine|racepinephrine|mesh-list
25743381|NCT04717193|Bupivacaine|bupivacaine|mesh-list
25743382|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
25743383|NCT04717193|Anesthetics|anesthetics|mesh-list
25743384|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
25743385|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743386|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743387|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
25743388|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743389|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25743390|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25743391|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
25743392|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743393|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743394|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25743395|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25743396|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
25743397|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25743398|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
25743399|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
25743400|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
25743401|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25743402|NCT04712942|Azacitidine|azacitidine|mesh-list
25743403|NCT04712942|Pevonedistat|pevonedistat|mesh-list
25743404|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25743405|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
25743406|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743407|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743408|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743409|NCT04679831|Praziquantel|praziquantel|mesh-list
25743410|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
25743411|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25743412|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743413|NCT04674462|Vaccines|vaccines|mesh-list
25743414|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
25743415|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743416|NCT04659616|Cytarabine|cytarabine|mesh-list
25743417|NCT04659616|Daunorubicin|daunorubicin|mesh-list
25743418|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25743419|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
25743420|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743421|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743422|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
25743423|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743424|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743425|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
25743426|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743427|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25743428|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25743429|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25743430|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743431|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
25743432|NCT04587973|Ropivacaine|ropivacaine|mesh-list
25743433|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25743434|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743435|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743436|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25743437|NCT04587973|Analgesics|analgesics|mesh-ancestor
25743438|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
25743439|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743440|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25743441|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25743442|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25743443|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
25743444|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743445|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743446|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
25743447|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
25743448|NCT04551300|Sevelamer|sevelamer|mesh-list
25743449|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
25743450|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
25743451|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743452|NCT04536298|Vitamin D|vitamin d|mesh-list
25743453|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
25743454|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
25743455|NCT04536298|Vitamins|vitamins|mesh-list
25743456|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
25743457|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743458|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25743459|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25743461|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743462|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
25743463|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
25743464|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743465|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743466|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743467|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
25743468|NCT04527887|Hormones|hormones|mesh-ancestor
25743469|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743470|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743471|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743472|NCT04516915|Oseltamivir|oseltamivir|mesh-list
25743473|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
25743474|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743475|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743476|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743477|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
25743478|NCT04491617|Narcotics|narcotics|mesh-ancestor
25743479|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743480|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743481|NCT04491617|Analgesics|analgesics|mesh-ancestor
25743482|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
25743483|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743484|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
25743485|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25743486|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
25743487|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25743488|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
25743489|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743490|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743491|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
25743492|NCT04480138|Interferons|interferons|mesh-list
25743493|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743494|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
25743495|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743496|NCT04474847|Abatacept|abatacept|mesh-list
25743497|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25743498|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743499|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743500|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743501|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
25743502|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743503|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743504|NCT04459611|Paclitaxel|paclitaxel|mesh-list
25743505|NCT04459611|Carboplatin|carboplatin|mesh-list
25743506|NCT04459611|Pemetrexed|pemetrexed|mesh-list
25743507|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25743508|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743509|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743510|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743511|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743512|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743513|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743514|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743515|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25743516|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25743517|NCT04458610|Rituximab|rituximab|mesh-list
25743518|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25743519|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
25743520|NCT04458610|Antibodies|antibodies|mesh-list
25743521|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
25743522|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25743523|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
25743524|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743525|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743526|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743527|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25743528|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743529|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743530|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25743531|NCT04422431|Choline|choline|mesh-list
25743532|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
25743533|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25743534|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
25743535|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743536|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743537|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25743538|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
25743539|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
25743540|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
25743541|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743542|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25743543|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25743544|NCT04422431|Growth Substances|growth substances|mesh-ancestor
25743545|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743546|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
25743547|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743548|NCT04421560|Rituximab|rituximab|mesh-list
25743549|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
25743550|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743551|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743552|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
25743553|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743554|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743555|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25743556|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743557|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743558|NCT04404959|Ropivacaine|ropivacaine|mesh-list
25743559|NCT04404959|Anesthetics|anesthetics|mesh-list
25743560|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
25743561|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743562|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743563|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
25743564|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743565|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
25743566|NCT04403711|Anesthetics|anesthetics|mesh-list
25743567|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
25743568|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25743569|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743570|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743571|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25743572|NCT04403711|Analgesics|analgesics|mesh-ancestor
25743573|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
25743574|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743575|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25743576|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25743577|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25743578|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
25743579|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743580|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743581|NCT04403087|Trimebutine|trimebutine|mesh-list
25743582|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743583|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
25743584|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
25743585|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743586|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743587|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25743588|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
25743589|NCT04358393|Azacitidine|azacitidine|mesh-list
25743590|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25743591|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
25743592|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743593|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743594|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774461|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
25774462|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774463|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25774464|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25774465|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
25774466|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
25774467|NCT04175262|Sunitinib|sunitinib|mesh-list
25774468|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774469|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25774470|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25774471|NCT04175262|Growth Substances|growth substances|mesh-ancestor
25774472|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313483|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
25313512|NCT05035069|Propofol|propofol|mesh-list
25743595|NCT04330040|Olaparib|olaparib|mesh-list
25743596|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25743597|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743598|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743599|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743600|NCT04320745|Testosterone|testosterone|mesh-list
25743601|NCT04320745|Androgens|androgens|mesh-ancestor
25743602|NCT04320745|Hormones|hormones|mesh-ancestor
25743603|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743604|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743605|NCT04303702|Oxytocin|oxytocin|mesh-list
25743606|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
25743607|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25743608|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743609|NCT04293393|Paclitaxel|paclitaxel|mesh-list
25743610|NCT04293393|Docetaxel|docetaxel|mesh-list
25743611|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
25743612|NCT04293393|Doxorubicin|doxorubicin|mesh-list
25743613|NCT04293393|Letrozole|letrozole|mesh-list
25743614|NCT04293393|Leuprolide|leuprolide|mesh-list
25743615|NCT04293393|Goserelin|goserelin|mesh-list
25743616|NCT04293393|Taxane|taxane|mesh-list
25743617|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743618|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743619|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743620|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743621|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743622|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743623|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743624|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
25743625|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743626|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743627|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25743628|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
25743629|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25743630|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25743631|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25743632|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25743633|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743634|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25743635|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25743636|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25743637|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
25743638|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743639|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25743640|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
25743641|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25743642|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743643|NCT04260022|Blinatumomab|blinatumomab|mesh-list
25743644|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743645|NCT04241562|Mitogens|mitogens|mesh-list
25743646|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743647|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743648|NCT04210037|Paclitaxel|paclitaxel|mesh-list
25743649|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743650|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743651|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743652|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743653|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743654|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743655|NCT04184609|Bromides|bromides|mesh-list
25743656|NCT04184609|Albuterol|albuterol|mesh-list
25743657|NCT04184609|Ipratropium|ipratropium|mesh-list
25743658|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
25743659|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25743660|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
25743661|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743662|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743663|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25743664|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
25743665|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
25743666|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25743667|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25743668|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25313565|NCT05034055|Atezolizumab|atezolizumab|mesh-list
25743669|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25743670|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25743671|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743672|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743673|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25743674|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
25743675|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25743676|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
25743677|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25743678|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
25743679|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743681|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743682|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743683|NCT04105114|Buspirone|buspirone|mesh-list
25743684|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25743685|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25743686|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743687|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743688|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25743689|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25743690|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
25743691|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743692|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743693|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
25743694|NCT04095624|Narcotics|narcotics|mesh-ancestor
25743695|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743696|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743697|NCT04095624|Analgesics|analgesics|mesh-ancestor
25743698|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
25743699|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743700|NCT04092452|PF-06700841|pf-06700841|mesh-list
25743701|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25743702|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743703|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743704|NCT04077424|Vaccines|vaccines|mesh-list
25743705|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
25743706|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
25743707|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743708|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
25743709|NCT04016779|Viloxazine|viloxazine|mesh-list
25743710|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25743711|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
25743712|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25743713|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25743714|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25743715|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25743716|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743717|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25743718|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743719|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743720|NCT04015622|Docetaxel|docetaxel|mesh-list
25743721|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743722|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743723|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743724|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743725|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743726|NCT04000737|Sorafenib|sorafenib|mesh-list
25743727|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743728|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25743729|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743730|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743731|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
25743732|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
25743733|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743734|NCT03952650|Chloroquine|chloroquine|mesh-list
25743735|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25743736|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
25743737|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25743738|NCT03952650|Ibuprofen|ibuprofen|mesh-list
25743739|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25743740|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25743741|NCT03952650|Analgesics|analgesics|mesh-ancestor
25743742|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
25743743|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313632|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743744|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743745|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743746|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743747|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25743748|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743749|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743750|NCT03952650|Amebicides|amebicides|mesh-ancestor
25743751|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25743752|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25743753|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743754|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
25743755|NCT03952650|Filaricides|filaricides|mesh-ancestor
25743756|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
25743757|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
25743758|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25743759|NCT03921008|Paclitaxel|paclitaxel|mesh-list
25743760|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743761|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743762|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743763|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743764|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743765|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743766|NCT03920267|BMS-986165|bms-986165|mesh-list
25743767|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
25743768|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25743769|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743770|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743771|NCT03893955|Paclitaxel|paclitaxel|mesh-list
25743772|NCT03893955|Carboplatin|carboplatin|mesh-list
25743773|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743774|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743775|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743776|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743777|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743778|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743779|NCT03758989|Prednisone|prednisone|mesh-list
25743780|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
25743781|NCT03758989|Rituximab|rituximab|mesh-list
25743782|NCT03758989|Doxorubicin|doxorubicin|mesh-list
25743783|NCT03758989|Vincristine|vincristine|mesh-list
25743784|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743785|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
25743786|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743787|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743788|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25743789|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
25743790|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743791|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743792|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25743793|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743794|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25743795|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25743796|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25743797|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743798|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743799|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
25743800|NCT03758989|Hormones|hormones|mesh-ancestor
25743801|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743802|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743803|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25743804|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
25743805|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
25743806|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
25743807|NCT03745716|Azacitidine|azacitidine|mesh-list
25743808|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25743809|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
25743810|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743811|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743812|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743813|NCT03708237|Gabapentin|gabapentin|mesh-list
25743814|NCT03708237|Ropinirole|ropinirole|mesh-list
25743815|NCT03708237|Analgesics|analgesics|mesh-ancestor
25743816|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
25743817|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313709|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743818|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743819|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
25743820|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25743821|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25743822|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743823|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25743824|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25743825|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25743826|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743827|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743828|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
25743829|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25743830|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25743831|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
25743832|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
25743833|NCT03697408|Everolimus|everolimus|mesh-list
25743834|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743835|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743836|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
25743837|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743838|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
25743839|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743840|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743841|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
25743842|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743843|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743844|NCT03629171|Cytarabine|cytarabine|mesh-list
25743845|NCT03629171|Daunorubicin|daunorubicin|mesh-list
25743846|NCT03629171|Venetoclax|venetoclax|mesh-list
25743847|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25743848|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
25743849|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743850|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743851|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
25743852|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743853|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743854|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
25743855|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743856|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25743857|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25743858|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25743859|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743860|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
25743861|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743862|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743863|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
25743864|NCT03576001|Testosterone|testosterone|mesh-list
25743865|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
25743866|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
25743867|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25743868|NCT03576001|Androgens|androgens|mesh-ancestor
25743869|NCT03576001|Hormones|hormones|mesh-ancestor
25743870|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743871|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743872|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743873|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743874|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
25743875|NCT03559868|Digoxin|digoxin|mesh-list
25743876|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25743877|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25743878|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25743879|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743880|NCT03559868|Protective Agents|protective agents|mesh-ancestor
25743881|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743882|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
25743883|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743884|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
25743885|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743886|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743887|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25743888|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
25743889|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743890|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743891|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25743892|NCT03547999|Nivolumab|nivolumab|mesh-list
25743893|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743894|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743895|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25743896|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743898|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
25743899|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743900|NCT03540485|Protective Agents|protective agents|mesh-ancestor
25743901|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743902|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743903|NCT03475277|Ketamine|ketamine|mesh-list
25743904|NCT03475277|Analgesics|analgesics|mesh-ancestor
25743905|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
25743906|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743907|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743908|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25743909|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25743910|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
25743911|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
25743912|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25743913|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25743914|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25743915|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743916|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743917|NCT03465111|Hormones|hormones|mesh-list
25743918|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25743919|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25743920|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
25743921|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743922|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743923|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743924|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774473|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
25774474|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25774475|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774476|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774477|NCT04173429|Nadroparin|nadroparin|mesh-list
25774478|NCT04173429|Warfarin|warfarin|mesh-list
25774479|NCT04173429|Calcium|calcium|mesh-list
25774480|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25774481|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774482|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
25774483|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25774484|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25774485|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774486|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25774487|NCT04169061|Hormones|hormones|mesh-ancestor
25774488|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774489|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774490|NCT04157738|Insulin|insulin|mesh-list
25774491|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25774492|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
25774493|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
25774494|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25774495|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774496|NCT04156646|Esomeprazole|esomeprazole|mesh-list
25774497|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25774498|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774499|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25774500|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774501|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774502|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
25774503|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25774504|NCT04169113|Narcotics|narcotics|mesh-ancestor
25774505|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774506|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774507|NCT04169113|Analgesics|analgesics|mesh-ancestor
25774508|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
25774509|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774510|NCT04167189|Lidocaine|lidocaine|mesh-list
25774511|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
25774512|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
25774513|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313906|NCT05027594|Hormones|hormones|mesh-ancestor
25743925|NCT03368664|Interferons|interferons|mesh-list
25743926|NCT03368664|Acyclovir|acyclovir|mesh-list
25743927|NCT03368664|Interferon-beta|interferon-beta|mesh-list
25743928|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
25743929|NCT03368664|Prednisolone|prednisolone|mesh-list
25743930|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
25743931|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
25743932|NCT03368664|Ranitidine|ranitidine|mesh-list
25743933|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
25743934|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
25743935|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743936|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
25743937|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25743938|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743939|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
25743940|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
25743941|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743942|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743943|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743944|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
25743945|NCT03368664|Hormones|hormones|mesh-ancestor
25743946|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743947|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25743948|NCT03368664|Protective Agents|protective agents|mesh-ancestor
25743949|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743950|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743951|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25743952|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
25743953|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25743954|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25743955|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25743956|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25743957|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
25743958|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
25743959|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25743960|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25743961|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25743962|NCT03366142|Ustekinumab|ustekinumab|mesh-list
25743963|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
25743964|NCT03341676|Dexamethasone|dexamethasone|mesh-list
25743965|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743966|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
25743967|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
25743968|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743969|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743970|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743971|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
25743972|NCT03341676|Hormones|hormones|mesh-ancestor
25743973|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743974|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743975|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743976|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
25743977|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25743978|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743979|NCT03289299|Dexamethasone|dexamethasone|mesh-list
25743980|NCT03289299|Lenalidomide|lenalidomide|mesh-list
25743981|NCT03289299|Daratumumab|daratumumab|mesh-list
25743982|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25743983|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
25743984|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
25743985|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25743986|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25743987|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25743988|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
25743989|NCT03289299|Hormones|hormones|mesh-ancestor
25743990|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25743991|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25743992|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25743993|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
25743994|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25743995|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25743996|NCT03289299|Growth Substances|growth substances|mesh-ancestor
25743997|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
25743998|NCT03274414|Cisplatin|cisplatin|mesh-list
25743999|NCT03274414|Etoposide|etoposide|mesh-list
25744000|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744001|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25744002|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25744003|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25744004|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744005|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744006|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
25744007|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25744008|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744009|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744010|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744011|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744013|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25744014|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744015|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744016|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744017|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
25744018|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744019|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744020|NCT03151707|Niacinamide|niacinamide|mesh-list
25744021|NCT03151707|Niacin|niacin|mesh-list
25744022|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
25744023|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
25744024|NCT03151707|Vitamins|vitamins|mesh-ancestor
25744025|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
25744026|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744027|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25744028|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
25744029|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744030|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25744031|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
25744032|NCT03121716|Gemcitabine|gemcitabine|mesh-list
25744033|NCT03121716|Cisplatin|cisplatin|mesh-list
25744034|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744035|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
25744036|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744037|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744038|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
25744039|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744040|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744041|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744042|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
25744043|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744044|NCT03109288|Pioglitazone|pioglitazone|mesh-list
25744045|NCT03109288|Clemastine|clemastine|mesh-list
25744046|NCT03109288|Pirfenidone|pirfenidone|mesh-list
25744047|NCT03109288|Dantrolene|dantrolene|mesh-list
25744048|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25744049|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744050|NCT03109288|Analgesics|analgesics|mesh-ancestor
25744051|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
25744052|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744053|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25744054|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25744055|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744056|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744057|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744058|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
25744059|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744060|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25744061|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
25744062|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
25744063|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744064|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744065|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25744066|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25744067|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25744068|NCT03058978|Etonogestrel|etonogestrel|mesh-list
25744069|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25744070|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
25744071|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744072|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744073|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25744074|NCT03031821|Metformin|metformin|mesh-list
25744075|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25744076|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744077|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
25744078|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744079|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744080|NCT02876302|Paclitaxel|paclitaxel|mesh-list
25744081|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
25744082|NCT02876302|Doxorubicin|doxorubicin|mesh-list
25744083|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25744084|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744085|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744086|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744087|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744088|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744089|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744090|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
25744091|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744092|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744093|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744094|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
25744095|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25744096|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25744097|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25744098|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25744099|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744100|NCT02860039|Vaccines|vaccines|mesh-list
25744101|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
25744102|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744103|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
25744104|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
25744105|NCT02833805|Fludarabine|fludarabine|mesh-list
25744106|NCT02833805|Tacrolimus|tacrolimus|mesh-list
25744107|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
25744108|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25744109|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744110|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
25744111|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744112|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744113|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744114|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
25744115|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744116|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744117|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25744118|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25744119|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744120|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25744121|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25744122|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
25744123|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25744124|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744125|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
25744126|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
25744127|NCT02714634|Methotrexate|methotrexate|mesh-list
25744128|NCT02714634|Leflunomide|leflunomide|mesh-list
25744129|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25744130|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
25744131|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744132|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744133|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744134|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
25744135|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744136|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744137|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744138|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744139|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25744140|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744141|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
25744142|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744143|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25744144|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
25744145|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25744146|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25744147|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744148|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25744149|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25744150|NCT02714634|Analgesics|analgesics|mesh-ancestor
25744151|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
25744152|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744153|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744154|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25744155|NCT02708394|Olanzapine|olanzapine|mesh-list
25744156|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
25744157|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
25744158|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744159|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744160|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25744161|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25744162|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25744163|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744164|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25744165|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25744166|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25744167|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744168|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744169|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744170|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
25744171|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
25744172|NCT02623972|Doxorubicin|doxorubicin|mesh-list
25744173|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25744174|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744175|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
25744176|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744177|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744178|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744179|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
25744180|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744181|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744182|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25744183|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25744184|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25744185|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25744186|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744187|NCT02582905|Choline|choline|mesh-list
25744188|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25744189|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
25744190|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25744191|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
25744192|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744193|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25744194|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25744195|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
25744196|NCT02499146|Letrozole|letrozole|mesh-list
25744197|NCT02499146|Palbociclib|palbociclib|mesh-list
25744198|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744199|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25744200|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25744201|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744202|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744203|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25744204|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
25744205|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744206|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744207|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25744208|NCT02499120|Cetuximab|cetuximab|mesh-list
25744209|NCT02499120|Palbociclib|palbociclib|mesh-list
25744210|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744211|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744212|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25744213|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744214|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744215|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
25744216|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25744217|NCT02425306|Poly ICLC|poly iclc|mesh-list
25744218|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
25744219|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744220|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744221|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744222|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744223|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
25744224|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744225|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744226|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25314191|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314192|NCT05023941|Diuretics|diuretics|mesh-ancestor
25744227|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25744228|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
25744229|NCT02340221|Fulvestrant|fulvestrant|mesh-list
25744230|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25744231|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744232|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25744233|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25744234|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
25744235|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744236|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744237|NCT02327195|Methylphenidate|methylphenidate|mesh-list
25744238|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25744239|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744240|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25744241|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25744242|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744243|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744244|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
25744245|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744246|NCT02288247|Prednisolone|prednisolone|mesh-list
25744247|NCT02288247|Docetaxel|docetaxel|mesh-list
25744248|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744249|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744250|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744251|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744252|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744253|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744254|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
25744255|NCT02288247|Hormones|hormones|mesh-ancestor
25744256|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744257|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744258|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25744259|NCT02177175|Carvedilol|carvedilol|mesh-list
25744260|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25744261|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25744262|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
25744263|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744264|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744265|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744266|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25744267|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
25744268|NCT02177175|Protective Agents|protective agents|mesh-ancestor
25744269|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25744270|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744271|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25744272|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
25744273|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25744274|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25744275|NCT02049138|Upadacitinib|upadacitinib|mesh-list
25744276|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25744277|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25744278|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744279|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744280|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744281|NCT01721772|Nivolumab|nivolumab|mesh-list
25744282|NCT01721772|Dacarbazine|dacarbazine|mesh-list
25744283|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744284|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744285|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25744286|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744287|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744288|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
25744289|NCT01682616|Rituximab|rituximab|mesh-list
25744290|NCT01682616|Venetoclax|venetoclax|mesh-list
25744291|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744292|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744293|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
25744294|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744295|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744296|NCT01614665|Tacrolimus|tacrolimus|mesh-list
25744297|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744298|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
25314259|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744299|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744301|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744302|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744303|NCT01412333|Interferons|interferons|mesh-list
25744304|NCT01412333|Interferon-beta|interferon-beta|mesh-list
25744305|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
25744306|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
25744307|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744308|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
25744309|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744310|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
25744311|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744312|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25744313|NCT01306331|Nonoxynol|nonoxynol|mesh-list
25744314|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25744315|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25744316|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744317|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25744318|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
25744319|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744320|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25744321|NCT01247324|Interferons|interferons|mesh-list
25744322|NCT01247324|Interferon-beta|interferon-beta|mesh-list
25744323|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
25744324|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
25744325|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744326|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
25744327|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744328|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
25744329|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744330|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25744331|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
25744332|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
25744333|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744334|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
25744335|NCT01190930|Leucovorin|leucovorin|mesh-list
25744336|NCT01190930|Folic Acid|folic acid|mesh-list
25744337|NCT01190930|Cytarabine|cytarabine|mesh-list
25744338|NCT01190930|Dexamethasone|dexamethasone|mesh-list
25744339|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
25744340|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
25744341|NCT01190930|Doxorubicin|doxorubicin|mesh-list
25744342|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25744343|NCT01190930|Methotrexate|methotrexate|mesh-list
25744344|NCT01190930|Vincristine|vincristine|mesh-list
25744345|NCT01190930|Asparaginase|asparaginase|mesh-list
25744346|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
25744347|NCT01190930|Pegaspargase|pegaspargase|mesh-list
25744348|NCT01190930|Thioguanine|thioguanine|mesh-list
25744349|NCT01190930|BB 1101|bb 1101|mesh-list
25744350|NCT01190930|Calcium|calcium|mesh-list
25744351|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
25744352|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
25744353|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744354|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
25744355|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744356|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744357|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744358|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
25744359|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744360|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744361|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25744362|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744363|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
25744364|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
25744365|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744366|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25744367|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
25744368|NCT01190930|Hormones|hormones|mesh-ancestor
25744369|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744370|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25744371|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
25744372|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744373|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25744374|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25744375|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25744376|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25744377|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25744378|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25744379|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
25744380|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744381|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744382|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
25744383|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744384|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25744385|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25744386|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
25744387|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744388|NCT01190930|Antidotes|antidotes|mesh-ancestor
25744389|NCT01190930|Protective Agents|protective agents|mesh-ancestor
25744390|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
25744391|NCT01190930|Vitamins|vitamins|mesh-ancestor
25744392|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
25744393|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25744394|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744395|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744396|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744397|NCT01190930|Hematinics|hematinics|mesh-ancestor
25744398|NCT01190306|Riboflavin|riboflavin|mesh-list
25744399|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
25744400|NCT01190306|Vitamins|vitamins|mesh-ancestor
25744401|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
25744402|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744403|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25744404|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744405|NCT00779324|Amantadine|amantadine|mesh-list
25744406|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25744407|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25744408|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
25744409|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744410|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
25744411|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744412|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744413|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744414|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25744415|NCT00779324|Analgesics|analgesics|mesh-ancestor
25744416|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
25744417|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744418|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
25744419|NCT00554788|Thiotepa|thiotepa|mesh-list
25744420|NCT00554788|Cisplatin|cisplatin|mesh-list
25744421|NCT00554788|Carboplatin|carboplatin|mesh-list
25744422|NCT00554788|Etoposide|etoposide|mesh-list
25744423|NCT00554788|Vincristine|vincristine|mesh-list
25744424|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
25744425|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
25744426|NCT00554788|Lenograstim|lenograstim|mesh-list
25744427|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744428|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
25744429|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744430|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744431|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744432|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
25744433|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744434|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744435|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25744436|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25744437|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25744438|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25744439|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744440|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25744441|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744442|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744443|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744444|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
25744445|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744446|NCT00553800|Bevacizumab|bevacizumab|mesh-list
25744447|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25744448|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744449|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744450|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25744451|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25744452|NCT00553800|Growth Substances|growth substances|mesh-ancestor
25744453|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744454|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25744455|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25744456|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744457|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744458|NCT00336024|Leucovorin|leucovorin|mesh-list
25744459|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
25744460|NCT00336024|Thiotepa|thiotepa|mesh-list
25744461|NCT00336024|Carboplatin|carboplatin|mesh-list
25744462|NCT00336024|Methotrexate|methotrexate|mesh-list
25744463|NCT00336024|Etoposide|etoposide|mesh-list
25744464|NCT00336024|Vincristine|vincristine|mesh-list
25744465|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
25744466|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
25744467|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744468|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
25744469|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744470|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744471|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25744472|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
25744473|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744474|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744475|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25744476|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25744477|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
25744478|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744479|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744480|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
25744481|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744482|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744483|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25744484|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25744485|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25744486|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25744487|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25744488|NCT00336024|Antidotes|antidotes|mesh-ancestor
25744489|NCT00336024|Protective Agents|protective agents|mesh-ancestor
25744490|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
25744491|NCT00336024|Vitamins|vitamins|mesh-ancestor
25744492|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
25744493|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744494|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744495|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744496|NCT00274937|Cisplatin|cisplatin|mesh-list
25744497|NCT00274937|Fluorouracil|fluorouracil|mesh-list
25744498|NCT00274937|Amifostine|amifostine|mesh-list
25744499|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744500|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
25744501|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744502|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744503|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744504|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
25744505|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744506|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25744507|NCT00274937|Protective Agents|protective agents|mesh-ancestor
25744508|NCT02737826|Buprenorphine|buprenorphine|mesh-list
25744509|NCT02737826|Gabapentin|gabapentin|mesh-list
25744510|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25744511|NCT02737826|Narcotics|narcotics|mesh-ancestor
25744512|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744513|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744514|NCT02737826|Analgesics|analgesics|mesh-ancestor
25744515|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
25744516|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744517|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25744518|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
25744519|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25744520|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25744521|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25744522|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25744523|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25744524|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744525|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744526|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
25744527|NCT02737891|Metoprolol|metoprolol|mesh-list
25744528|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25744529|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25744530|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
25744531|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
25744532|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744533|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744534|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25744535|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25744536|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25744537|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
25744538|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744539|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744540|NCT02737930|Fluoxetine|fluoxetine|mesh-list
25744541|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25744542|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25744543|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744544|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744545|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744546|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
25744547|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744548|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25744549|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
25744550|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25744551|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25744552|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25744553|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774514|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774515|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
25774516|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774517|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25774518|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25774519|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25774520|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25774521|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774522|NCT04162795|Loratadine|loratadine|mesh-list
25774523|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
25774524|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
25774525|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25774526|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25774527|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25774528|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
25774529|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
25774530|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774531|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774532|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774533|NCT04161144|Sirolimus|sirolimus|mesh-list
25774534|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774535|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774536|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25774537|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774538|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
25774539|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25774540|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
25774541|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774542|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25774543|NCT04150861|Hormones|hormones|mesh-ancestor
25774544|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774545|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774546|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25774547|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774548|NCT04150224|Macozinone|macozinone|mesh-list
25774549|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
25774550|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774551|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774552|NCT04149405|Diphosphonates|diphosphonates|mesh-list
25774553|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25774554|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774555|NCT04141930|Baloxavir|baloxavir|mesh-list
25774556|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
25774557|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774558|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774559|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774560|NCT04139018|Timolol|timolol|mesh-list
25774561|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25774562|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25774563|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
25774564|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774565|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744554|NCT02738008|Tenofovir|tenofovir|mesh-list
25744555|NCT02738008|Entecavir|entecavir|mesh-list
25744556|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
25744557|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25744558|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
25744559|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744560|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25744561|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25744562|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744563|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744564|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25744565|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25744566|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
25744567|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744568|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744569|NCT02738151|Insulin|insulin|mesh-list
25744570|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25744571|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
25744572|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25744573|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744574|NCT02738203|Lidocaine|lidocaine|mesh-list
25744575|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
25744576|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
25744577|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744578|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744579|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
25744580|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744581|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25744582|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25744583|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25744584|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744585|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744586|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
25744587|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
25744588|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744589|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25744590|NCT02738580|Hormones|hormones|mesh-ancestor
25744591|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744592|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744593|NCT02738879|Metformin|metformin|mesh-list
25744594|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
25744595|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25744596|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25744597|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744598|NCT02738879|Incretins|incretins|mesh-ancestor
25744599|NCT02738879|Hormones|hormones|mesh-ancestor
25744600|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744601|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25744602|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
25744603|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744604|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744605|NCT02739360|Idelalisib|idelalisib|mesh-list
25744606|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744607|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744608|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744609|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
25744610|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
25744611|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25744612|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744613|NCT02739698|Paclitaxel|paclitaxel|mesh-list
25744614|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25744615|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744616|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744617|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744618|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744619|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744620|NCT02739828|Adalimumab|adalimumab|mesh-list
25744621|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744622|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744623|NCT02739984|Evolocumab|evolocumab|mesh-list
25744624|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25744625|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25744626|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25744627|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
25744628|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744629|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25744630|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
25744631|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744632|NCT02739997|Metronidazole|metronidazole|mesh-list
25744633|NCT02739997|Tazobactam|tazobactam|mesh-list
25744634|NCT02739997|Ceftolozane|ceftolozane|mesh-list
25744635|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744636|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25744637|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25744638|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25744639|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25744640|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744641|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744642|NCT02740114|Oxycodone|oxycodone|mesh-list
25744643|NCT02740114|Bupivacaine|bupivacaine|mesh-list
25744644|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
25744645|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
25744646|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744647|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744648|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
25744649|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744650|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25744651|NCT02740114|Narcotics|narcotics|mesh-ancestor
25744652|NCT02740114|Analgesics|analgesics|mesh-ancestor
25744653|NCT02740543|Fluticasone|fluticasone|mesh-list
25744654|NCT02740543|Xhance|xhance|mesh-list
25744655|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744656|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25744657|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
25744658|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744659|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744660|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25744661|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
25744662|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744663|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25744664|NCT02740582|Tolcapone|tolcapone|mesh-list
25744665|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25744666|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25744667|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25744668|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744669|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744670|NCT02740660|Caffeine|caffeine|mesh-list
25744671|NCT02740660|Albuterol|albuterol|mesh-list
25744672|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25744673|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744674|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25744675|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744676|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744677|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25744678|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25744679|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
25744680|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744681|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25744682|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
25744683|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744684|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25744685|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
25744686|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
25744687|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744688|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25744689|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25744690|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25744691|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
25744692|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
25744693|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744694|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744695|NCT02741076|Oxymorphone|oxymorphone|mesh-list
25744696|NCT02741076|Morphine|morphine|mesh-list
25744697|NCT02741076|Oxycodone|oxycodone|mesh-list
25744698|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
25744699|NCT02741076|Narcotics|narcotics|mesh-ancestor
25744700|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744701|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744702|NCT02741076|Analgesics|analgesics|mesh-ancestor
25744703|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
25744704|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744705|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25744707|NCT02741310|Erenumab|erenumab|mesh-list
25744708|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25744709|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25744710|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25744711|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
25744712|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744713|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744714|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744715|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25744716|NCT02741310|Analgesics|analgesics|mesh-ancestor
25744717|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
25744718|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744719|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25744720|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
25744721|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744722|NCT02741687|Insulin|insulin|mesh-list
25744723|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25744724|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
25744725|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25744726|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
25744727|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
25744728|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
25744729|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25744730|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744731|NCT02741687|Incretins|incretins|mesh-ancestor
25744732|NCT02741687|Hormones|hormones|mesh-ancestor
25744733|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744734|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25744735|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
25744736|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744737|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744738|NCT02741713|Lidocaine|lidocaine|mesh-list
25744739|NCT02741713|Clonidine|clonidine|mesh-list
25744740|NCT02741713|Epinephrine|epinephrine|mesh-list
25744741|NCT02741713|Racepinephrine|racepinephrine|mesh-list
25744742|NCT02741713|Bupivacaine|bupivacaine|mesh-list
25744743|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25744744|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
25744745|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
25744746|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
25744747|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744748|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744749|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
25744750|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744751|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25744752|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25744753|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25744754|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744755|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744756|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25744757|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25744758|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
25744759|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744760|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25744761|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25744762|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
25744763|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25744764|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
25744765|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
25744766|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
25744767|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25744768|NCT02741713|Analgesics|analgesics|mesh-ancestor
25744769|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25744770|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
25744771|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25744772|NCT02742519|Ivacaftor|ivacaftor|mesh-list
25744773|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25744774|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744775|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744776|NCT02742532|Oxytocin|oxytocin|mesh-list
25744777|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
25744778|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744779|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744780|NCT02742649|Timolol|timolol|mesh-list
25744781|NCT02742649|Bimatoprost|bimatoprost|mesh-list
25744782|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25744783|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25744784|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
25744785|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744786|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744787|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744788|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25744789|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25744790|NCT02742987|Clopidogrel|clopidogrel|mesh-list
25744791|NCT02742987|Ticagrelor|ticagrelor|mesh-list
25744792|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25744793|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25744794|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25744795|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25744796|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
25744797|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744798|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744799|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744800|NCT02743078|Bevacizumab|bevacizumab|mesh-list
25744801|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744802|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744803|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25744804|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25744805|NCT02743078|Growth Substances|growth substances|mesh-ancestor
25744806|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744807|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
25744808|NCT02743221|Trifluridine|trifluridine|mesh-list
25744809|NCT02743221|Bevacizumab|bevacizumab|mesh-list
25744810|NCT02743221|Capecitabine|capecitabine|mesh-list
25744811|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744812|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744813|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25744814|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25744815|NCT02743221|Growth Substances|growth substances|mesh-ancestor
25744816|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744817|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
25744818|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744819|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
25744820|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744821|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
25744822|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744823|NCT02743377|Rolipram|rolipram|mesh-list
25744824|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
25744825|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25744826|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25744827|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25744828|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744829|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744830|NCT02743780|MGV354|mgv354|mesh-list
25744831|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
25744832|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744833|NCT02743949|Esomeprazole|esomeprazole|mesh-list
25744834|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25744835|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25744836|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25744837|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744838|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744839|NCT02744391|Levodopa|levodopa|mesh-list
25744840|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25744841|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25744842|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
25744843|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744844|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744845|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744846|NCT02744755|Adalimumab|adalimumab|mesh-list
25744847|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744848|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744849|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25744850|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25744851|NCT02744898|Paclitaxel|paclitaxel|mesh-list
25744852|NCT02744898|Carboplatin|carboplatin|mesh-list
25744853|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25744854|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25744855|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744856|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744857|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744858|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744859|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744860|NCT02745080|Adalimumab|adalimumab|mesh-list
25744861|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744862|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744863|NCT02745353|Naloxegol|naloxegol|mesh-list
25744864|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25744865|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744866|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
25744867|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744868|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
25744869|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25744870|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25744871|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
25744872|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744873|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744874|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744875|NCT02746575|Metoprolol|metoprolol|mesh-list
25744876|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25744877|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25744878|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
25744879|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
25744880|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744881|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744882|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25744883|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25744884|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25744885|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
25744886|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744887|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744888|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25744889|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744890|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
25744891|NCT02746991|Hormones|hormones|mesh-ancestor
25744892|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744893|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744894|NCT02747186|Lidocaine|lidocaine|mesh-list
25744895|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
25744896|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
25744897|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744898|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744899|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
25744900|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744901|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25744902|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25744903|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25744904|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25744905|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744906|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
25744907|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25744908|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25744909|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744910|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
25744911|NCT02747615|Coagulants|coagulants|mesh-ancestor
25744912|NCT02747628|Melatonin|melatonin|mesh-list
25744913|NCT02747628|Nicotine|nicotine|mesh-list
25744914|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25744915|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
25744916|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744917|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744918|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25744919|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25744920|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
25744921|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25744922|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744923|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
25744924|NCT02747628|Protective Agents|protective agents|mesh-ancestor
25744925|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744926|NCT02747875|Fentanyl|fentanyl|mesh-list
25744927|NCT02747875|Methadone|methadone|mesh-list
25314988|NCT05011487|Pemetrexed|pemetrexed|mesh-list
25744928|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25744929|NCT02747875|Narcotics|narcotics|mesh-ancestor
25744930|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25744931|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744932|NCT02747875|Analgesics|analgesics|mesh-ancestor
25744933|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
25744934|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744935|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25744936|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25744937|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
25744938|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
25744939|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
25744940|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
25744941|NCT02748070|Fluticasone|fluticasone|mesh-list
25744942|NCT02748070|Prednisone|prednisone|mesh-list
25744943|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744944|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
25744945|NCT02748070|Hormones|hormones|mesh-ancestor
25744946|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744947|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744948|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25744949|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744950|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25744951|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
25744952|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25744953|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25744954|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
25744955|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744956|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25744957|NCT02748213|Docetaxel|docetaxel|mesh-list
25744958|NCT02748213|Capecitabine|capecitabine|mesh-list
25744959|NCT02748213|Trastuzumab|trastuzumab|mesh-list
25744960|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744961|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
25744962|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
25744963|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
25744964|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744965|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744966|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
25744967|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25744968|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25744969|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25744970|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
25744971|NCT02748512|Hormones|hormones|mesh-ancestor
25744972|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25744973|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744974|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
25744975|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25744976|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774566|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774567|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25774568|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25774569|NCT04131556|Maribavir|maribavir|mesh-list
25774570|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
25774571|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774572|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25774573|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25774574|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774575|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25774576|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25774577|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25774578|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774579|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
25774580|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774581|NCT04137627|Melatonin|melatonin|mesh-list
25774582|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
25774583|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774584|NCT04137627|Protective Agents|protective agents|mesh-ancestor
25774585|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774586|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774587|NCT04136145|Belimumab|belimumab|mesh-list
25774588|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25774589|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
25774590|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774591|NCT04132336|Naproxen|naproxen|mesh-list
25774592|NCT04132336|Caffeine|caffeine|mesh-list
25774593|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25744978|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25744979|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
25744980|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25744981|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744982|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25744983|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
25744984|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25744985|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25744986|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25744987|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25744988|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25744989|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25744990|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
25744991|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25744992|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25744993|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25744994|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
25744995|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25744996|NCT02748889|Carboplatin|carboplatin|mesh-list
25744997|NCT02748889|Etoposide|etoposide|mesh-list
25744998|NCT02748889|Atezolizumab|atezolizumab|mesh-list
25744999|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745000|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25745001|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25745002|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25745003|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745004|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745005|NCT02749370|Etanercept|etanercept|mesh-list
25745006|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25745007|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25745008|NCT02749370|Analgesics|analgesics|mesh-ancestor
25745009|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
25745010|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745011|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745012|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745013|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745014|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25745015|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25745016|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
25745017|NCT02749721|Vortioxetine|vortioxetine|mesh-list
25745018|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
25745019|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25745020|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25745021|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25745022|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745023|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745024|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25745025|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25745026|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25745027|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745028|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745029|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
25745030|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25745031|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25745032|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25745033|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25745034|NCT02749799|Betamethasone|betamethasone|mesh-list
25745035|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
25745036|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25745037|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
25745038|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25745039|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745040|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
25745041|NCT02749799|Hormones|hormones|mesh-ancestor
25745042|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745043|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745044|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25745045|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
25745046|NCT02750306|Suvorexant|suvorexant|mesh-list
25745047|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25745048|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25745049|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745050|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745051|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25745052|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745053|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745054|NCT02750332|Nitisinone|nitisinone|mesh-list
25745055|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745056|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745057|NCT02750345|Nitisinone|nitisinone|mesh-list
25745058|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745059|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745060|NCT02750410|Dulaglutide|dulaglutide|mesh-list
25745061|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745062|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745063|NCT02750514|Nivolumab|nivolumab|mesh-list
25745064|NCT02750514|Ipilimumab|ipilimumab|mesh-list
25745065|NCT02750514|Dasatinib|dasatinib|mesh-list
25745066|NCT02750514|Linrodostat|linrodostat|mesh-list
25745067|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745068|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745069|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25745070|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745071|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25745072|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745073|NCT02750709|Nitisinone|nitisinone|mesh-list
25745074|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745075|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745076|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
25745077|NCT02750761|Tedizolid|tedizolid|mesh-list
25745078|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
25745079|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25745080|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745081|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25745082|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745083|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745084|NCT02750800|Adalimumab|adalimumab|mesh-list
25745085|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745086|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745087|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
25745088|NCT02750930|Incretins|incretins|mesh-ancestor
25745089|NCT02750930|Hormones|hormones|mesh-ancestor
25745090|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745091|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745092|NCT02750943|Fluorides|fluorides|mesh-list
25745093|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
25745094|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
25745095|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
25745096|NCT02750943|Protective Agents|protective agents|mesh-ancestor
25745097|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745098|NCT02751320|Citric Acid|citric acid|mesh-list
25745099|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
25745100|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
25745101|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25745102|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
25745103|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
25745104|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745105|NCT02751359|Cannabidiol|cannabidiol|mesh-list
25745106|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
25745107|NCT02751385|Nintedanib|nintedanib|mesh-list
25745108|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25745109|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25745110|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745111|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25745112|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745113|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745114|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25745115|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
25745116|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25745117|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745118|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25745119|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25745120|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25745121|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25745122|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25745123|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25745124|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25745125|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25745126|NCT02751450|Fluorides|fluorides|mesh-list
25745127|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
25745128|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
25745129|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
25745130|NCT02751450|Protective Agents|protective agents|mesh-ancestor
25745131|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745132|NCT02751931|Mirabegron|mirabegron|mesh-list
25745133|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25745134|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25745135|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25745136|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
25745137|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745138|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745139|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745140|NCT02751931|Urological Agents|urological agents|mesh-ancestor
25745141|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
25745142|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745143|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745144|NCT02752256|Plasminogen|plasminogen|mesh-list
25745145|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25745146|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25745147|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25745148|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745149|NCT02752633|Allopurinol|allopurinol|mesh-list
25745150|NCT02752633|Febuxostat|febuxostat|mesh-list
25745151|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
25745152|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745153|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745154|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
25745155|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745156|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25745157|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
25745158|NCT02752633|Protective Agents|protective agents|mesh-ancestor
25745159|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745160|NCT02752958|Fluorides|fluorides|mesh-list
25745161|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
25745162|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
25745163|NCT02752958|Protective Agents|protective agents|mesh-ancestor
25745164|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745165|NCT02753075|Fluorides|fluorides|mesh-list
25745166|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
25745167|NCT02753075|Protective Agents|protective agents|mesh-ancestor
25745168|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745169|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
25745170|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25745171|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25745172|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745173|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
25745174|NCT02753816|Coagulants|coagulants|mesh-ancestor
25745175|NCT02753881|Doxorubicin|doxorubicin|mesh-list
25745176|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25745177|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25745178|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745179|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25745180|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25745181|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745182|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745183|NCT02753946|Tazobactam|tazobactam|mesh-list
25745184|NCT02753946|Piperacillin|piperacillin|mesh-list
25745185|NCT02753946|Fosfomycin|fosfomycin|mesh-list
25745186|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25745187|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25745188|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745189|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25745190|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745191|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745192|NCT02754518|Valsartan|valsartan|mesh-list
25745193|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25745194|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25745195|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25745196|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25745197|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745198|NCT02754570|Pilocarpine|pilocarpine|mesh-list
25745199|NCT02754570|Miotics|miotics|mesh-ancestor
25745200|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
25745201|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745202|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745203|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25745204|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25745205|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
25745206|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745207|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745208|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
25745209|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25745210|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
25745211|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
25745212|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745213|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745214|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25745215|NCT02755090|Analgesics|analgesics|mesh-ancestor
25745216|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
25745217|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745218|NCT02755116|Olanzapine|olanzapine|mesh-list
25745219|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
25745220|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
25745221|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745222|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745223|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25745224|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25745225|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25745226|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745227|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25745228|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25745229|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25745230|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25745231|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745232|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745233|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
25745234|NCT02755818|Heparin|heparin|mesh-list
25745235|NCT02755818|Calcium heparin|calcium heparin|mesh-list
25745236|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
25745237|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25745238|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25745239|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745240|NCT02756364|Fulvestrant|fulvestrant|mesh-list
25745241|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25745242|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745243|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25745244|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25745245|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
25745246|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745247|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745248|NCT02756572|Cytarabine|cytarabine|mesh-list
25745249|NCT02756572|Cyclosporine|cyclosporine|mesh-list
25745250|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
25745251|NCT02756572|Sirolimus|sirolimus|mesh-list
25745252|NCT02756572|Fludarabine|fludarabine|mesh-list
25745253|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
25745254|NCT02756572|Melphalan|melphalan|mesh-list
25745255|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
25745256|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
25745257|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25745258|NCT02756572|Cladribine|cladribine|mesh-list
25745259|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25745260|NCT02756572|Cyclosporins|cyclosporins|mesh-list
25745261|NCT02756572|Lenograstim|lenograstim|mesh-list
25745262|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745263|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25745264|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
25745265|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745266|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25745267|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
25745268|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745269|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
25745270|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745271|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25745272|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745273|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
25745274|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25745275|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745276|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25745277|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25745278|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25745279|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
25745280|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25745281|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25745283|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25745284|NCT02756572|Analgesics|analgesics|mesh-ancestor
25745285|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
25745286|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745287|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25745288|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25745289|NCT02756624|Cetirizine|cetirizine|mesh-list
25745290|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25745291|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25745292|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25745293|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
25745294|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
25745295|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745296|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745297|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745298|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25745299|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25745300|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25745301|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745302|NCT02756832|Alogliptin|alogliptin|mesh-list
25745303|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745304|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745305|NCT02756832|Incretins|incretins|mesh-ancestor
25745306|NCT02756832|Hormones|hormones|mesh-ancestor
25745307|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745308|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25745309|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
25745310|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745311|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745312|NCT02757105|Ondansetron|ondansetron|mesh-list
25745313|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
25745314|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
25745315|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745316|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745317|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25745318|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
25745319|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25745320|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25745321|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
25745322|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745323|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745324|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25745325|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25745326|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745327|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25745328|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25745329|NCT02757352|Ixekizumab|ixekizumab|mesh-list
25745330|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
25745331|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
25745332|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25745333|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745334|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745335|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25745336|NCT02757625|Analgesics|analgesics|mesh-ancestor
25745337|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
25745338|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745339|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25745340|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25745341|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25745342|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
25745343|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745344|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745345|NCT02757768|Tamsulosin|tamsulosin|mesh-list
25745346|NCT02757768|Mirabegron|mirabegron|mesh-list
25745347|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25745348|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25745349|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25745350|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
25745351|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745352|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745353|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745354|NCT02757768|Urological Agents|urological agents|mesh-ancestor
25745355|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25745356|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25745357|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25745359|NCT02758171|Linagliptin|linagliptin|mesh-list
25745360|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25745361|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745362|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745363|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745364|NCT02758171|Incretins|incretins|mesh-ancestor
25745365|NCT02758171|Hormones|hormones|mesh-ancestor
25745366|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745367|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25745368|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
25745369|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774594|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774595|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25774596|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774597|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774598|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25774599|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25774600|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
25774601|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774602|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25774603|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25774604|NCT04132336|Analgesics|analgesics|mesh-ancestor
25774605|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
25774606|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774607|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774608|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774609|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
25774610|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25774611|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25774612|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25774613|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25774614|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
25774615|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25774616|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774617|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25774618|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25774619|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25774620|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25774621|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25774622|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25774623|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25774624|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25774625|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
25774626|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774627|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774628|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25774629|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25774630|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774631|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774632|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774633|NCT04123665|Fluorides|fluorides|mesh-list
25774634|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
25774635|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
25774636|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
25774637|NCT04123665|Protective Agents|protective agents|mesh-ancestor
25774638|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774639|NCT04121078|Rifampin|rifampin|mesh-list
25774640|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25774641|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
25774642|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774643|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774644|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
25774645|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25745370|NCT02759016|BI 836826|bi 836826|mesh-list
25745371|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745372|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745373|NCT02759120|Doxycycline|doxycycline|mesh-list
25745374|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25745375|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25745376|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
25745377|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
25745378|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25745379|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25745380|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25745381|NCT02759120|Renal Agents|renal agents|mesh-ancestor
25745382|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
25745383|NCT02759315|Ruzasvir|ruzasvir|mesh-list
25745384|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
25745385|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745386|NCT02759575|Cisplatin|cisplatin|mesh-list
25745387|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
25745388|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745389|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745390|NCT02760069|Ondansetron|ondansetron|mesh-list
25745391|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
25745392|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
25745393|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745394|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745395|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25745396|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
25745397|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
25745398|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25745399|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
25745400|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745401|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745402|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25745403|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25745404|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745405|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25745406|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25745407|NCT02760407|Adalimumab|adalimumab|mesh-list
25745408|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745409|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745410|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
25745411|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25745412|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25745413|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25745414|NCT02760862|Mannitol|mannitol|mesh-list
25745415|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745416|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25745417|NCT02760862|Diuretics|diuretics|mesh-ancestor
25745418|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
25745419|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745420|NCT02761252|Montelukast|montelukast|mesh-list
25745421|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25745422|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
25745423|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25745424|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
25745425|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745426|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745427|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25745428|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25745429|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745430|NCT02761330|Ketamine|ketamine|mesh-list
25745431|NCT02761330|Analgesics|analgesics|mesh-ancestor
25745432|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
25745433|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745434|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745435|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25745436|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25745437|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
25745438|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
25745439|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745440|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25745441|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25745442|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745443|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745444|NCT02761629|Interferons|interferons|mesh-list
25745445|NCT02761629|Ribavirin|ribavirin|mesh-list
25315692|NCT05002270|Cetuximab|cetuximab|mesh-list
25745446|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
25745447|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
25745448|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25745449|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745450|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
25745451|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745452|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
25745453|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745454|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
25745455|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745456|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
25745457|NCT02761642|Hematinics|hematinics|mesh-ancestor
25745458|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
25745459|NCT02761915|Fludarabine|fludarabine|mesh-list
25745460|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25745461|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
25745462|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745463|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745464|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25745465|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
25745466|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745467|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745468|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25745469|NCT02761980|Acetaminophen|acetaminophen|mesh-list
25745470|NCT02761980|Ibuprofen|ibuprofen|mesh-list
25745471|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25745472|NCT02761980|Analgesics|analgesics|mesh-ancestor
25745473|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
25745474|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745475|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745476|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
25745477|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25745478|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745479|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745480|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25745481|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745482|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745483|NCT02762071|Bupivacaine|bupivacaine|mesh-list
25745484|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
25745485|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
25745486|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745487|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745488|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
25745489|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745490|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
25745491|NCT02762331|Vitamins|vitamins|mesh-ancestor
25745492|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
25745493|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745494|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
25745495|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745496|NCT02762331|Protective Agents|protective agents|mesh-ancestor
25745497|NCT02762370|Triamcinolone|triamcinolone|mesh-list
25745498|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25745499|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25745500|NCT02762370|FX006|fx006|mesh-list
25745501|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25745502|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745503|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
25745504|NCT02762370|Hormones|hormones|mesh-ancestor
25745505|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745506|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745507|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25745508|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
25745509|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745510|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745511|NCT02762513|Axitinib|axitinib|mesh-list
25745512|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745513|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25745514|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745515|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745516|NCT02762578|Insulin|insulin|mesh-list
25745517|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25745518|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
25745519|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
25745520|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25315770|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
25745521|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
25745522|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745523|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745524|NCT02762799|Lenograstim|lenograstim|mesh-list
25745525|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25745526|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
25745527|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745528|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25745529|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
25745530|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745531|NCT02764333|Durvalumab|durvalumab|mesh-list
25745532|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745533|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745534|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25745535|NCT02764697|Hormones|hormones|mesh-ancestor
25745536|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745537|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745538|NCT02765100|Minocycline|minocycline|mesh-list
25745539|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25745540|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745541|NCT02765165|Lomustine|lomustine|mesh-list
25745542|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25745543|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
25745544|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745545|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745546|NCT02765256|Promethazine|promethazine|mesh-list
25745547|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
25745548|NCT02765256|Vancomycin|vancomycin|mesh-list
25745549|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
25745550|NCT02765256|Neomycin|neomycin|mesh-list
25745551|NCT02765256|Fluconazole|fluconazole|mesh-list
25745552|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25745553|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25745554|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745555|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25745556|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25745557|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745558|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745559|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745560|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25745561|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25745562|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
25745563|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25745564|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25745565|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
25745566|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745567|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745568|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25745569|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25745570|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
25745571|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
25745572|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25745573|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
25745574|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
25745575|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745576|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25745577|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25745578|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25745579|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745580|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
25745581|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
25745582|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
25745583|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745584|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
25745585|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
25745586|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25745587|NCT02765256|Laxatives|laxatives|mesh-ancestor
25745588|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25745589|NCT02765490|Simeprevir|simeprevir|mesh-list
25745590|NCT02765490|Odalasvir|odalasvir|mesh-list
25745591|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
25745592|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745593|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
25745594|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745595|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745596|NCT02766023|Metronidazole|metronidazole|mesh-list
25745597|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745598|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25745599|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25745600|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25745601|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25745602|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745603|NCT02766517|Capsaicin|capsaicin|mesh-list
25745604|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
25745605|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
25745606|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
25745607|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745608|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745609|NCT02766608|Budesonide|budesonide|mesh-list
25745610|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
25745611|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25745612|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745613|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25745614|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
25745615|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745616|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745617|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25745618|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
25745619|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
25745620|NCT02766608|Hormones|hormones|mesh-ancestor
25745621|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745622|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25745623|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25745624|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25745625|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
25745626|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745627|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745628|NCT02766673|Albuterol|albuterol|mesh-list
25745629|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25745630|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
25745631|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745632|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745633|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25745634|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
25745635|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
25745636|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25745637|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25745638|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25745639|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25745640|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
25745641|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745642|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745643|NCT02766777|Lubiprostone|lubiprostone|mesh-list
25745644|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25745645|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25745646|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745647|NCT02767128|Citric Acid|citric acid|mesh-list
25745648|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
25745649|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
25745650|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25745651|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
25745652|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
25745653|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745654|NCT02767271|Luliconazole|luliconazole|mesh-list
25745655|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
25745656|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745657|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
25745658|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25745659|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25745660|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745661|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
25745662|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
25745663|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25745664|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745665|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
25745666|NCT02767492|Hormones|hormones|mesh-ancestor
25745667|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745668|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745669|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25745670|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
25745671|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
25745672|NCT02767765|Hematinics|hematinics|mesh-ancestor
25745673|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
25745674|NCT02767869|Antacids|antacids|mesh-ancestor
25745675|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745676|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25745677|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
25745678|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745679|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745680|NCT02767947|Luliconazole|luliconazole|mesh-list
25745681|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
25745682|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745683|NCT02768194|Fluorides|fluorides|mesh-list
25745684|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
25745685|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
25745686|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
25745687|NCT02768194|Protective Agents|protective agents|mesh-ancestor
25745688|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745689|NCT02768298|Enalapril|enalapril|mesh-list
25745690|NCT02768298|Enalaprilat|enalaprilat|mesh-list
25745691|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25745692|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25745693|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
25745694|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745695|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745696|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25745697|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25745698|NCT02768558|Cisplatin|cisplatin|mesh-list
25745699|NCT02768558|Nivolumab|nivolumab|mesh-list
25745700|NCT02768558|Etoposide|etoposide|mesh-list
25745701|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745702|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745703|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25745704|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745705|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25745706|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25745707|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25745708|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745709|NCT02769065|Donepezil|donepezil|mesh-list
25745710|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25745711|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745712|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745713|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
25745714|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745715|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745716|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
25745717|NCT02769247|Naproxen|naproxen|mesh-list
25745718|NCT02769247|Lidocaine|lidocaine|mesh-list
25745719|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
25745720|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
25745721|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745722|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745723|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
25745724|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745725|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25745726|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25745727|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25745728|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25745729|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745730|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25745731|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25745732|NCT02769247|Analgesics|analgesics|mesh-ancestor
25745733|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745734|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745735|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
25745736|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25745737|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774646|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774647|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774648|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25774649|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25774650|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25774651|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25774652|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25774653|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25745739|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
25745740|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25745741|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745742|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745743|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25745744|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
25745745|NCT02769624|Treprostinil|treprostinil|mesh-list
25745746|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25745747|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25745748|NCT02769702|Hormones|hormones|mesh-ancestor
25745749|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745750|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745751|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25745752|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745753|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25745754|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745755|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745756|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25745757|NCT02770248|Brinzolamide|brinzolamide|mesh-list
25745758|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25745759|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25745760|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25745761|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25745762|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
25745763|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745764|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745765|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745766|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25745767|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745768|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25745769|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25745770|NCT02770365|Estradiol|estradiol|mesh-list
25745771|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25745772|NCT02770365|Estrogens|estrogens|mesh-ancestor
25745773|NCT02770365|Hormones|hormones|mesh-ancestor
25745774|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745775|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745776|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25745777|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
25745778|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25745779|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25745780|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
25745781|NCT02770521|Treprostinil|treprostinil|mesh-list
25745782|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745783|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745784|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25745785|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
25745786|NCT02770612|Narcotics|narcotics|mesh-ancestor
25745787|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745788|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745789|NCT02770612|Analgesics|analgesics|mesh-ancestor
25745790|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
25745791|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745792|NCT02770820|Aldesleukin|aldesleukin|mesh-list
25745793|NCT02770820|Interleukin-2|interleukin-2|mesh-list
25745794|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745795|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25745796|NCT02770820|Analgesics|analgesics|mesh-ancestor
25745797|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
25745798|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745799|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745800|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25745801|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25745802|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
25745803|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745804|NCT02771093|Alogliptin|alogliptin|mesh-list
25745805|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745806|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745807|NCT02771093|Incretins|incretins|mesh-ancestor
25745808|NCT02771093|Hormones|hormones|mesh-ancestor
25745809|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745810|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25745811|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
25745812|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745813|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745814|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25745815|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25745816|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
25745817|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745818|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
25745819|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
25745820|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745821|NCT02772783|Insulin|insulin|mesh-list
25745822|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25745823|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745824|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745825|NCT02772978|Tolcapone|tolcapone|mesh-list
25745826|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25745827|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25745828|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25745829|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745830|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745831|NCT02773368|Insulin|insulin|mesh-list
25745832|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25745833|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
25745834|NCT02773368|Liraglutide|liraglutide|mesh-list
25745835|NCT02773368|Xultophy|xultophy|mesh-list
25745836|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745837|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745838|NCT02773368|Incretins|incretins|mesh-ancestor
25745839|NCT02773368|Hormones|hormones|mesh-ancestor
25745840|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745841|NCT02773758|Fluorides|fluorides|mesh-list
25745842|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
25745843|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
25745844|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
25745845|NCT02773758|Protective Agents|protective agents|mesh-ancestor
25745846|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745847|NCT02774226|Vitamins|vitamins|mesh-list
25745848|NCT02774226|Vitamin E|vitamin e|mesh-list
25745849|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
25745850|NCT02774226|Antioxidants|antioxidants|mesh-list
25745851|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
25745852|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745853|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745854|NCT02774226|Protective Agents|protective agents|mesh-ancestor
25745855|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
25745856|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25745857|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745858|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25745859|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745860|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745861|NCT02774343|Pioglitazone|pioglitazone|mesh-list
25745862|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745863|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745864|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25745865|NCT02774681|Trastuzumab|trastuzumab|mesh-list
25745866|NCT02774681|Palbociclib|palbociclib|mesh-list
25745867|NCT02774681|Antibodies|antibodies|mesh-list
25745868|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
25745869|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25745870|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
25745871|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745872|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745873|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25745874|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745875|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745876|NCT02775240|Maribavir|maribavir|mesh-list
25745877|NCT02775240|Digoxin|digoxin|mesh-list
25745878|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
25745879|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25745880|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25745881|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745882|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745883|NCT02775240|Protective Agents|protective agents|mesh-ancestor
25745884|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745885|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
25745886|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
25745887|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25745888|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25745889|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25745890|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
25745891|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745892|NCT02775617|Azithromycin|azithromycin|mesh-list
25745893|NCT02775617|Ivermectin|ivermectin|mesh-list
25745894|NCT02775617|Permethrin|permethrin|mesh-list
25745895|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25745896|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25745897|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25745898|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745899|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745900|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
25745901|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
25745902|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25745903|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25745904|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745905|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745906|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25745907|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
25745908|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25745909|NCT02776683|Bevacizumab|bevacizumab|mesh-list
25745910|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25745911|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745912|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25745913|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25745914|NCT02776683|Growth Substances|growth substances|mesh-ancestor
25745915|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745916|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
25745917|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
25745918|NCT02777242|Testosterone|testosterone|mesh-list
25745919|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
25745920|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
25745921|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25745922|NCT02777242|Androgens|androgens|mesh-ancestor
25745923|NCT02777242|Hormones|hormones|mesh-ancestor
25745924|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745925|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745926|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25745927|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745928|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
25745929|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
25745930|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745931|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
25745932|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25745933|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25745934|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25745935|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745936|NCT05349929|Ibuprofen|ibuprofen|mesh-list
25745937|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25745938|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25745939|NCT05349929|Analgesics|analgesics|mesh-ancestor
25745940|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
25745941|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745942|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745943|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745944|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25745945|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25745946|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25745947|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745948|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25745949|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
25745950|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745951|NCT05349903|Protective Agents|protective agents|mesh-ancestor
25745952|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745953|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25745954|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25745955|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745956|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25745957|NCT05349825|Losartan|losartan|mesh-list
25745958|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25745959|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25745960|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25745961|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25745962|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745963|NCT05349474|Metformin|metformin|mesh-list
25745964|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25745965|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745966|NCT05349396|Eszopiclone|eszopiclone|mesh-list
25745967|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25745968|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25745969|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774654|NCT04117607|Rezafungin|rezafungin|mesh-list
25774655|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
25774656|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774657|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
25774658|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25774659|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
25774660|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774661|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
25774662|NCT04115358|Protective Agents|protective agents|mesh-ancestor
25774663|NCT04114058|Bupivacaine|bupivacaine|mesh-list
25774664|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
25774665|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
25774666|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774667|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774668|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
25774669|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774670|NCT04112160|Ketorolac|ketorolac|mesh-list
25774671|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25774672|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25774673|NCT04112160|Analgesics|analgesics|mesh-ancestor
25774674|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
25774675|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774676|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774677|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774678|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774679|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25774680|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774681|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774682|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
25774683|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
25774684|NCT04112069|Pancrelipase|pancrelipase|mesh-list
25774685|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25774686|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774687|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777597|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25777598|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
25777599|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25777600|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777601|NCT03360903|Caffeine|caffeine|mesh-list
25777602|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25777603|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777604|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25777605|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777606|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777607|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25777608|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25777609|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
25777610|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777611|NCT03359174|Tretinoin|tretinoin|mesh-list
25777612|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777613|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
25777614|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
25777615|NCT03348904|Gemcitabine|gemcitabine|mesh-list
25777616|NCT03348904|Paclitaxel|paclitaxel|mesh-list
25777617|NCT03348904|Cisplatin|cisplatin|mesh-list
25777618|NCT03348904|Carboplatin|carboplatin|mesh-list
25777619|NCT03348904|Nivolumab|nivolumab|mesh-list
25777620|NCT03348904|Pemetrexed|pemetrexed|mesh-list
25777621|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25777622|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777623|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
25777624|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25777625|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25777626|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777627|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25777628|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
25777629|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
25777630|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777631|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777632|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777633|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
25777634|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745970|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
25745971|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25745972|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25745973|NCT05349071|Prednisolone|prednisolone|mesh-list
25745974|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
25745975|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25745976|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
25745977|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25745978|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
25745979|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
25745980|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25745981|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745982|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25745983|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
25745984|NCT05349071|Hormones|hormones|mesh-ancestor
25745985|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25745986|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25745987|NCT05349071|Protective Agents|protective agents|mesh-ancestor
25745988|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25745989|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745990|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25745991|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25745992|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25745993|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25745994|NCT05349045|Antibodies|antibodies|mesh-list
25745995|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
25745996|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25745997|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25745998|NCT05349045|Growth Substances|growth substances|mesh-ancestor
25745999|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
25746000|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746001|NCT05349032|Curcumin|curcumin|mesh-list
25746002|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25746003|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25746004|NCT05349032|Analgesics|analgesics|mesh-ancestor
25746005|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
25746006|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746007|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746008|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746009|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746010|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746011|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746012|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746013|NCT05349006|Azathioprine|azathioprine|mesh-list
25746014|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
25746015|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746016|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25746017|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746018|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25746019|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
25746020|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746021|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746022|NCT05348980|Phenylephrine|phenylephrine|mesh-list
25746023|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
25746024|NCT05348980|Synephrine|synephrine|mesh-list
25746025|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25746026|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
25746027|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
25746028|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746029|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746030|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
25746031|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25746032|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
25746033|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746034|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25746035|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25746036|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25746037|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
25746038|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746039|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746040|NCT05348980|Protective Agents|protective agents|mesh-ancestor
25746041|NCT05348434|Ether|ether|mesh-list
25746042|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25746043|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
25746044|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
25316469|NCT04991181|Zamicastat|zamicastat|mesh-list
25746045|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746046|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746047|NCT05348239|Copper|copper|mesh-list
25746048|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
25746049|NCT05348239|Trace Elements|trace elements|mesh-ancestor
25746050|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
25746051|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746052|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25746053|NCT05348239|Protective Agents|protective agents|mesh-ancestor
25746054|NCT05348213|Decitabine|decitabine|mesh-list
25746055|NCT05348213|Pomalidomide|pomalidomide|mesh-list
25746056|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
25746057|NCT05348213|Tofacitinib|tofacitinib|mesh-list
25746058|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25746059|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
25746060|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746061|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746062|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746063|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
25746064|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746065|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25746066|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25746067|NCT05348213|Growth Substances|growth substances|mesh-ancestor
25746068|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
25746069|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25746070|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
25746071|NCT05348148|Cetirizine|cetirizine|mesh-list
25746072|NCT05348148|Phenylephrine|phenylephrine|mesh-list
25746073|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
25746074|NCT05348148|Levocetirizine|levocetirizine|mesh-list
25746075|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746076|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
25746077|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25746078|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25746079|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25746080|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
25746081|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
25746082|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746083|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746084|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746085|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25746086|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25746087|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
25746088|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
25746089|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
25746090|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746091|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
25746092|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25746093|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746094|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25746095|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
25746096|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25746097|NCT05348148|Protective Agents|protective agents|mesh-ancestor
25746098|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
25746099|NCT05339581|Lenvatinib|lenvatinib|mesh-list
25746100|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746101|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746102|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25746103|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746104|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746105|NCT05337436|Calcium|calcium|mesh-list
25746106|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25746107|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746108|NCT05334017|Cocaine|cocaine|mesh-list
25746109|NCT05334017|Xylometazoline|xylometazoline|mesh-list
25746110|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
25746111|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
25746112|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746113|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746114|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
25746115|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746116|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25746117|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25746118|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25746119|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25774688|NCT04105972|Ivacaftor|ivacaftor|mesh-list
24891122|NCT04476069|Analgesics|analgesics|mesh-ancestor
25746120|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746121|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
25746122|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746123|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
25746124|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746125|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25746126|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25746127|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
25746128|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746129|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746130|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746131|NCT05320718|Ropivacaine|ropivacaine|mesh-list
25746132|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
25746133|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
25746134|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746135|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746136|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
25746137|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746138|NCT05273359|Benralizumab|benralizumab|mesh-list
25746139|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25746140|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746141|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25746142|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25746143|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
25746144|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746145|NCT05257590|Nivolumab|nivolumab|mesh-list
25746146|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746147|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746148|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25746149|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746150|NCT05233956|Chrysarobin|chrysarobin|mesh-list
25746151|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25746152|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25746153|NCT05233956|Analgesics|analgesics|mesh-ancestor
25746154|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
25746155|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746156|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746157|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746158|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746159|NCT05223231|Antibodies|antibodies|mesh-list
25746160|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
25746161|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
25746162|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774689|NCT04105972|Elexacaftor|elexacaftor|mesh-list
25774690|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25774691|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25774692|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774693|NCT04102956|Kallikreins|kallikreins|mesh-list
25774694|NCT04102956|Coagulants|coagulants|mesh-ancestor
25774695|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25774696|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
25774697|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25774698|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774699|NCT04102345|Zolpidem|zolpidem|mesh-list
25774700|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25774701|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25774702|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774703|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774704|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25774705|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
25774706|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
25774707|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774708|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774709|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25774710|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25774711|NCT04089982|Varenicline|varenicline|mesh-list
25774712|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25774713|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25774714|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
25774715|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774716|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774717|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774718|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
25774719|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746163|NCT05221021|Mirabegron|mirabegron|mesh-list
25746164|NCT05221021|Estradiol|estradiol|mesh-list
25746165|NCT05221021|Estrogens|estrogens|mesh-list
25746166|NCT05221021|Hormones|hormones|mesh-ancestor
25746167|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746168|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746169|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25746170|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25746171|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25746172|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
25746173|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746174|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746175|NCT05221021|Urological Agents|urological agents|mesh-ancestor
25746176|NCT05215535|Liver Extracts|liver extracts|mesh-list
25746177|NCT05215535|Hematinics|hematinics|mesh-ancestor
25746178|NCT05201183|Fludarabine|fludarabine|mesh-list
25746179|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746180|NCT05191446|Ethanol|ethanol|mesh-list
25746181|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25746182|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746183|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746184|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746185|NCT05180318|Ketamine|ketamine|mesh-list
25746186|NCT05180318|Esketamine|esketamine|mesh-list
25746187|NCT05180318|Analgesics|analgesics|mesh-ancestor
25746188|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
25746189|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746190|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746191|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25746192|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25746193|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
25746194|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
25746195|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746196|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25746197|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25746198|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746199|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746200|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
25746201|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25746202|NCT05177991|Bupivacaine|bupivacaine|mesh-list
25746203|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
25746204|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
25746205|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746206|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746207|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
25746208|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746209|NCT05158153|Furosemide|furosemide|mesh-list
25746210|NCT05158153|Diuretics|diuretics|mesh-ancestor
25746211|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
25746212|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746213|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25746214|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25746215|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746216|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
25746217|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25746218|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25746219|NCT05113901|Prednisolone|prednisolone|mesh-list
25746220|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
25746221|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25746222|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
25746223|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746224|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
25746225|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
25746226|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746227|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746228|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746229|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
25746230|NCT05113901|Hormones|hormones|mesh-ancestor
25746231|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746232|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25746233|NCT05113901|Protective Agents|protective agents|mesh-ancestor
25746234|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746235|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746236|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
25746237|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746238|NCT05456932|Iron|iron|mesh-list
25746239|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
25746240|NCT05456932|Ferric maltol|ferric maltol|mesh-list
25746241|NCT05456932|Trace Elements|trace elements|mesh-ancestor
25746242|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
25746243|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746244|NCT05456932|Hematinics|hematinics|mesh-ancestor
25746245|NCT05456763|Butyric Acid|butyric acid|mesh-list
25746246|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
25746247|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
25746248|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746249|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746250|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746251|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25746252|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746253|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746254|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25746255|NCT05456685|Carboplatin|carboplatin|mesh-list
25746256|NCT05456685|Maytansine|maytansine|mesh-list
25746257|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746258|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25746259|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
25746260|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
25746261|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
25746262|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746263|NCT05456542|Dexamethasone|dexamethasone|mesh-list
25746264|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746265|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
25746266|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
25746267|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746268|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746269|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746270|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
25746271|NCT05456542|Hormones|hormones|mesh-ancestor
25746272|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746273|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746274|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746275|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
25746276|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25746277|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746278|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25746279|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25746280|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746281|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746282|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
25746283|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25746284|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746285|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25746286|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25746287|NCT05456022|Doxorubicin|doxorubicin|mesh-list
25746288|NCT05456022|Quercetin|quercetin|mesh-list
25746289|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25746290|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746291|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25746292|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25746293|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746294|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746295|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
25746296|NCT05456022|Protective Agents|protective agents|mesh-ancestor
25746297|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774720|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774721|NCT04098575|Empagliflozin|empagliflozin|mesh-list
25774722|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25774723|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774724|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25774725|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774726|NCT04094883|Vaccines|vaccines|mesh-list
25774727|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
25774728|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774729|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
25774730|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25774731|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
25774732|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774733|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
25774734|NCT04081610|Protective Agents|protective agents|mesh-ancestor
25774735|NCT04081324|Lasmiditan|lasmiditan|mesh-list
25774736|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25746299|NCT05455918|Cisplatin|cisplatin|mesh-list
25746300|NCT05455918|Ifosfamide|ifosfamide|mesh-list
25746301|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25746302|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746303|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25746304|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
25746305|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25746306|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746307|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25746308|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
25746309|NCT05455359|Famotidine|famotidine|mesh-list
25746310|NCT05455359|Prucalopride|prucalopride|mesh-list
25746311|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25746312|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746313|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25746314|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
25746315|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
25746316|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746317|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746318|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746319|NCT05455359|Laxatives|laxatives|mesh-ancestor
25746320|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25746321|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25746322|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
25746323|NCT05455073|Folic Acid|folic acid|mesh-list
25746324|NCT05455073|Hematinics|hematinics|mesh-ancestor
25746325|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
25746326|NCT05455073|Vitamins|vitamins|mesh-ancestor
25746327|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
25746328|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746329|NCT05453916|Rifaximin|rifaximin|mesh-list
25746330|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
25746331|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25746332|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746333|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746334|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25746335|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25746336|NCT05453500|Prednisone|prednisone|mesh-list
25746337|NCT05453500|Cortisone|cortisone|mesh-list
25746338|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
25746339|NCT05453500|Rituximab|rituximab|mesh-list
25746340|NCT05453500|Doxorubicin|doxorubicin|mesh-list
25746341|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25746342|NCT05453500|Etoposide|etoposide|mesh-list
25746343|NCT05453500|Vincristine|vincristine|mesh-list
25746344|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
25746345|NCT05453500|Daunorubicin|daunorubicin|mesh-list
25746346|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
25746347|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25746348|NCT05453500|Antibodies|antibodies|mesh-list
25746349|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
25746350|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25746351|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25746352|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
25746353|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746354|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746355|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25746356|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
25746357|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746358|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746359|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25746360|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25746361|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25746362|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25746363|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746364|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746365|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
25746366|NCT05453500|Hormones|hormones|mesh-ancestor
25746367|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746368|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746369|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25746370|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
25746371|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
25316915|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
25746372|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
25746373|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
25746374|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
25746375|NCT05451771|Dexamethasone|dexamethasone|mesh-list
25746376|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
25746377|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25746378|NCT05451771|Venetoclax|venetoclax|mesh-list
25746379|NCT05451771|Daratumumab|daratumumab|mesh-list
25746380|NCT05451771|Pomalidomide|pomalidomide|mesh-list
25746381|NCT05451771|Ixazomib|ixazomib|mesh-list
25746382|NCT05451771|BB 1101|bb 1101|mesh-list
25746383|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746384|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
25746385|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
25746386|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746387|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746388|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746389|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
25746390|NCT05451771|Hormones|hormones|mesh-ancestor
25746391|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746392|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746393|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746394|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
25746395|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746396|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746397|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25746398|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
25746399|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
25746400|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25746401|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25746402|NCT05451771|Growth Substances|growth substances|mesh-ancestor
25746403|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
25746404|NCT05450055|Lidocaine|lidocaine|mesh-list
25746405|NCT05450055|Analgesics|analgesics|mesh-list
25746406|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
25746407|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
25746408|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746409|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746410|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
25746411|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746412|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25746413|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25746414|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25746415|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25746416|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746417|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25746418|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746419|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746420|NCT05448547|Hormones|hormones|mesh-list
25746421|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746422|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746423|NCT05443984|Esomeprazole|esomeprazole|mesh-list
25746424|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25746425|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746426|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25746427|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746428|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746429|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
25746430|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25746431|NCT05437965|Hormones|hormones|mesh-ancestor
25746432|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746433|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746434|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
25746435|NCT05437094|Itraconazole|itraconazole|mesh-list
25746436|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
25746437|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746438|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25746439|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25746440|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746441|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746442|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25746443|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
25774737|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
25316985|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25316986|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316987|NCT04985110|Renal Agents|renal agents|mesh-ancestor
25316988|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25316989|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
25746444|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746445|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746446|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25746448|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746449|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746450|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25746451|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746452|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25746453|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
25746454|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774738|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774739|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774740|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774741|NCT04076787|Sunitinib|sunitinib|mesh-list
25774742|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774743|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25774744|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25774745|NCT04076787|Growth Substances|growth substances|mesh-ancestor
25774746|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774747|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
25774748|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25774749|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774750|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774751|NCT04042324|Heparin|heparin|mesh-list
25774752|NCT04042324|Calcium heparin|calcium heparin|mesh-list
25774753|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
25774754|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774755|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25774756|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25774757|NCT04070287|Antibodies|antibodies|mesh-list
25774758|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
25774759|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
25774760|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774761|NCT04050722|Listerine|listerine|mesh-list
25774762|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
25774763|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
25774764|NCT04050722|Protective Agents|protective agents|mesh-ancestor
25774765|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774766|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25774767|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774768|NCT04069221|Cobicistat|cobicistat|mesh-list
25774769|NCT04069221|Artefenomel|artefenomel|mesh-list
25774770|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25774771|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25774772|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
25774773|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774774|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25774775|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25774776|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774777|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774778|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
25774779|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25774780|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774781|NCT04066647|Dexamethasone|dexamethasone|mesh-list
25774782|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774783|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
25774784|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
25774785|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774786|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774787|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774788|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
25774789|NCT04066647|Hormones|hormones|mesh-ancestor
25774790|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774791|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25774792|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774793|NCT04066426|Acetaminophen|acetaminophen|mesh-list
25774794|NCT04066426|Dexamethasone|dexamethasone|mesh-list
25774795|NCT04066426|Naproxen|naproxen|mesh-list
25774796|NCT04066426|Codeine|codeine|mesh-list
25774797|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774798|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
25774799|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
25774800|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774801|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746456|NCT05323721|Piperaquine|piperaquine|mesh-list
25746457|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
25746458|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25746459|NCT05323721|Amodiaquine|amodiaquine|mesh-list
25746460|NCT05323721|Artenimol|artenimol|mesh-list
25746461|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
25746462|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25746463|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25746464|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746465|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25746466|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746467|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746468|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25746469|NCT05323721|Renal Agents|renal agents|mesh-ancestor
25746470|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
25746471|NCT05288075|Charcoal|charcoal|mesh-list
25746472|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25746473|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25746474|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25746475|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
25746476|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746477|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746478|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746479|NCT05288075|Antidotes|antidotes|mesh-ancestor
25746480|NCT05288075|Protective Agents|protective agents|mesh-ancestor
25746481|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
25746482|NCT05283499|Analgesics|analgesics|mesh-list
25746483|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25746484|NCT05283499|Narcotics|narcotics|mesh-ancestor
25746485|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746486|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746487|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
25746488|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746489|NCT05273814|Bevacizumab|bevacizumab|mesh-list
25746490|NCT05273814|Pemetrexed|pemetrexed|mesh-list
25746491|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25746492|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746493|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746494|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25746495|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25746496|NCT05273814|Growth Substances|growth substances|mesh-ancestor
25746497|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746498|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
25746499|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746500|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746501|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25746502|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25746503|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
25746504|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25746505|NCT05272787|Protective Agents|protective agents|mesh-ancestor
25746506|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746507|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
25746508|NCT05258773|Azasetron|azasetron|mesh-list
25746509|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
25746510|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
25746511|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746512|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746513|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746514|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25746515|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
25746516|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746517|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746518|NCT05251259|Montelukast|montelukast|mesh-list
25746519|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25746520|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746521|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25746522|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
25746523|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746524|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746525|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25746526|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25746527|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746528|NCT05207722|Aldesleukin|aldesleukin|mesh-list
25317201|NCT04982055|Nadroparin|nadroparin|mesh-list
25746529|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
25746530|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
25746531|NCT05207722|Trastuzumab|trastuzumab|mesh-list
25746532|NCT05207722|Fludarabine|fludarabine|mesh-list
25746533|NCT05207722|Interleukin-2|interleukin-2|mesh-list
25746534|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25746535|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
25746536|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746537|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746538|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25746539|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
25746540|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746541|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746542|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25746543|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746544|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25746545|NCT05207722|Analgesics|analgesics|mesh-ancestor
25746546|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
25746547|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746548|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25746549|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25746550|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
25746551|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746552|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
25746553|NCT05199493|Giapreza|giapreza|mesh-list
25746554|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
25746555|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25746556|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25746557|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
25746558|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746559|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746560|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25746561|NCT05145569|Paclitaxel|paclitaxel|mesh-list
25746562|NCT05145569|Carboplatin|carboplatin|mesh-list
25746563|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25746564|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746565|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
25746566|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
25746567|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
25746568|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746569|NCT05125237|Amiloride|amiloride|mesh-list
25746570|NCT05125237|Triamterene|triamterene|mesh-list
25746571|NCT05125237|Diuretics|diuretics|mesh-ancestor
25746572|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
25746573|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746574|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25746575|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25746576|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25746577|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746578|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25746579|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25746580|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
25746581|NCT05114590|Lixisenatide|lixisenatide|mesh-list
25746582|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25746583|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746584|NCT05100628|Doxorubicin|doxorubicin|mesh-list
25746585|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25746586|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746587|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25746588|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25746589|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746590|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746591|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
25746592|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25746593|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746594|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
25746595|NCT05076682|Choline|choline|mesh-list
25746596|NCT05076682|Antibodies|antibodies|mesh-list
25746597|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
25746598|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746599|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
25746600|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25746601|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
25746602|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746603|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746604|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25746605|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
25746606|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25746607|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746608|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25746609|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746610|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
25746611|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25746612|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25746613|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25746614|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25746615|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746616|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
25746617|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746618|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746619|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25746620|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746621|NCT05018273|Atezolizumab|atezolizumab|mesh-list
25746622|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746623|NCT05013255|Pioglitazone|pioglitazone|mesh-list
25746624|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25746625|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746626|NCT04998006|Ethanol|ethanol|mesh-list
25746627|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25746628|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746629|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746630|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746631|NCT04986631|Topiramate|topiramate|mesh-list
25746632|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
25746633|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25746634|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746635|NCT04949516|Aspirin|aspirin|mesh-list
25746636|NCT04949516|Colchicine|colchicine|mesh-list
25746637|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25746638|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25746639|NCT04949516|Analgesics|analgesics|mesh-ancestor
25746640|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
25746641|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746642|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746643|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746644|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746645|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25746646|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25746647|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746648|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25746649|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25746650|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746651|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
25746652|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
25746653|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
25746654|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
25746655|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
25746656|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746657|NCT04919317|Dexamethasone|dexamethasone|mesh-list
25746658|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746659|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
25746660|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
25746661|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746662|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746663|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746664|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
25746665|NCT04919317|Hormones|hormones|mesh-ancestor
25746666|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746667|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746668|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746669|NCT04869449|Ketoconazole|ketoconazole|mesh-list
25746670|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
25746671|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746672|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25746673|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25746674|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746675|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899063|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899064|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
24899065|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25317343|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
25746676|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25746677|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
25746678|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746679|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746680|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25774802|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774803|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
25774805|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774806|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25774807|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774808|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25774809|NCT04066426|Analgesics|analgesics|mesh-ancestor
25774810|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
25774811|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
25774812|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25774813|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774814|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
25774815|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25774816|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774817|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774818|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25774819|NCT04066426|Narcotics|narcotics|mesh-ancestor
25774820|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774821|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
25774822|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
25774823|NCT04060654|Buprenorphine|buprenorphine|mesh-list
25774824|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25774825|NCT04060654|Narcotics|narcotics|mesh-ancestor
25774826|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774827|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774828|NCT04060654|Analgesics|analgesics|mesh-ancestor
25774829|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
25774830|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774831|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25774832|NCT04058353|Ivacaftor|ivacaftor|mesh-list
25774833|NCT04058353|Elexacaftor|elexacaftor|mesh-list
25774834|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25774835|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25774836|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774837|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
25774838|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25774839|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774840|NCT04051684|Ropivacaine|ropivacaine|mesh-list
25774841|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
25774842|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
25774843|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774844|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774845|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
25774846|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774847|NCT04045964|Nicotine|nicotine|mesh-list
25774848|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25774849|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
25774850|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774851|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774852|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25774853|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25774854|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
25774855|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774856|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774857|NCT04054193|Dexamethasone|dexamethasone|mesh-list
25774858|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
25774859|NCT04054193|Aprepitant|aprepitant|mesh-list
25774860|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
25774861|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774862|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
25774863|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
25774864|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774865|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774866|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774867|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
25774868|NCT04054193|Hormones|hormones|mesh-ancestor
25774869|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774870|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746681|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
25746682|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746683|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746684|NCT04826133|Calcitriol|calcitriol|mesh-list
25746685|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25746686|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25746687|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746688|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25746689|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25746690|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746691|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25746692|NCT04826133|Vitamins|vitamins|mesh-ancestor
25746693|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
25746694|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25746695|NCT04822337|Dexamethasone|dexamethasone|mesh-list
25746696|NCT04822337|Lenalidomide|lenalidomide|mesh-list
25746697|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746698|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
25746699|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
25746700|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746701|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746702|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746703|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
25746704|NCT04822337|Hormones|hormones|mesh-ancestor
25746705|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746706|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746707|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746708|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
25746709|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25746710|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25746711|NCT04822337|Growth Substances|growth substances|mesh-ancestor
25746712|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
25746713|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
25746714|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25746715|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746716|NCT04784208|Hormones|hormones|mesh-list
25746717|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746718|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746719|NCT04777643|Cannabidiol|cannabidiol|mesh-list
25746720|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
25746721|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
25746722|NCT04767074|Guaifenesin|guaifenesin|mesh-list
25746723|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25746724|NCT04767074|Expectorants|expectorants|mesh-ancestor
25746725|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746726|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25746727|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25746728|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
25746729|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746730|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746731|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746732|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
25746733|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25746734|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
25746735|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
25746736|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746737|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
25746738|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25746739|NCT04762381|Dexamethasone|dexamethasone|mesh-list
25746740|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
25746741|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25746742|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746743|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
25746744|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
25746745|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746746|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746747|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746748|NCT04762381|Hormones|hormones|mesh-ancestor
25746749|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746750|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746751|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746752|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
25746753|NCT04741620|Capsaicin|capsaicin|mesh-list
25746754|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
25746755|NCT04741620|Citric Acid|citric acid|mesh-list
25746756|NCT04741620|Piperine|piperine|mesh-list
25746757|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
25746758|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
25746759|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
25746760|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746761|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746762|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
25746763|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25746764|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
25746765|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
25746766|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746767|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25746768|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746769|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25746770|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746771|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25746772|NCT04741620|Protective Agents|protective agents|mesh-ancestor
25746773|NCT04711252|Palbociclib|palbociclib|mesh-list
25746774|NCT04711252|Anastrozole|anastrozole|mesh-list
25746775|NCT04711252|Hormones|hormones|mesh-list
25746776|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25746777|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746778|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746779|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746780|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25746781|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746782|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746783|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746784|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25746785|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25746786|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25746787|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
25746788|NCT04706507|Ganciclovir|ganciclovir|mesh-list
25746789|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25746790|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
25746791|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746792|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25746793|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746794|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746795|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25746796|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746797|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746798|NCT04647110|Crizotinib|crizotinib|mesh-list
25746799|NCT04647110|Ceritinib|ceritinib|mesh-list
25746800|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746801|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25746802|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746803|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746804|NCT04603183|Paclitaxel|paclitaxel|mesh-list
25746805|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25746806|NCT04603183|Letrozole|letrozole|mesh-list
25746807|NCT04603183|Fulvestrant|fulvestrant|mesh-list
25746808|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25746809|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746810|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
25746811|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
25746812|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
25746813|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746814|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25746815|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25746816|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746817|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25746818|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
25746819|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746820|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746821|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25746822|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25746823|NCT04564339|Ravulizumab|ravulizumab|mesh-list
25746824|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25746825|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25746826|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
25746827|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746828|NCT04533737|Brodalumab|brodalumab|mesh-list
25746829|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
25746830|NCT04405349|Atezolizumab|atezolizumab|mesh-list
25746831|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746832|NCT04346628|Favipiravir|favipiravir|mesh-list
25746833|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
25746834|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25746835|NCT04282954|Esomeprazole|esomeprazole|mesh-list
25746836|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25746837|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746838|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25746839|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746840|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746841|NCT04233229|Insulin|insulin|mesh-list
25746842|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25746843|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746844|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
25746845|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
25746846|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25746847|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746848|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746849|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
25746850|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25746851|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25746852|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746853|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
25746854|NCT04208347|Apatinib|apatinib|mesh-list
25746855|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746856|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25746857|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746858|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746859|NCT04200443|Temozolomide|temozolomide|mesh-list
25746860|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25746861|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
25746862|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746863|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746864|NCT04173533|Azacitidine|azacitidine|mesh-list
25746865|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25746866|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
25746867|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746868|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746869|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774871|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774872|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25774873|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774874|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774875|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25774876|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
25774877|NCT04053270|Afamelanotide|afamelanotide|mesh-list
25774878|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
25774879|NCT04049552|Sirolimus|sirolimus|mesh-list
25774880|NCT04049552|Petrolatum|petrolatum|mesh-list
25774881|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774882|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774883|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25774884|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774885|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
25774886|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25774887|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
25774888|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774889|NCT04049552|Emollients|emollients|mesh-ancestor
25774890|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
25774891|NCT04050865|Dexamethasone|dexamethasone|mesh-list
25774892|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25774893|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
25774894|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
25774895|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774896|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774897|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25774898|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
25774899|NCT04050865|Hormones|hormones|mesh-ancestor
25774900|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25774901|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25774902|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774903|NCT04050371|Tenofovir|tenofovir|mesh-list
25774904|NCT04050371|Emtricitabine|emtricitabine|mesh-list
25774905|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
25774906|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774907|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25746870|NCT04153760|Aspirin|aspirin|mesh-list
25746871|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25746872|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25746873|NCT04153760|Analgesics|analgesics|mesh-ancestor
25746874|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
25746875|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746876|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746877|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746878|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746879|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25746880|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25746881|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746882|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25746883|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25746884|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746885|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
25746886|NCT04120415|Vedolizumab|vedolizumab|mesh-list
25746887|NCT04120415|Vaccines|vaccines|mesh-list
25746888|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
25746889|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746890|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746891|NCT04098874|Bupropion|bupropion|mesh-list
25746892|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25746893|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
25746894|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25746895|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25746896|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25746897|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25746898|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746899|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
25746900|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746901|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746902|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25746903|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25746904|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746905|NCT04080843|Capecitabine|capecitabine|mesh-list
25746906|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
25746907|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25746908|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
25746909|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746910|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746911|NCT04066348|Etanercept|etanercept|mesh-list
25746912|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25746913|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25746914|NCT04066348|Analgesics|analgesics|mesh-ancestor
25746915|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
25746916|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746917|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746918|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746919|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25746920|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25746921|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25746922|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
25746923|NCT04064684|Budesonide|budesonide|mesh-list
25746924|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25746925|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25746926|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
25746927|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746928|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746929|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25746930|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
25746931|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
25746932|NCT04064684|Hormones|hormones|mesh-ancestor
25746933|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25746934|NCT04035486|Cisplatin|cisplatin|mesh-list
25746935|NCT04035486|Carboplatin|carboplatin|mesh-list
25746936|NCT04035486|Pemetrexed|pemetrexed|mesh-list
25746937|NCT04035486|Osimertinib|osimertinib|mesh-list
25746938|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746939|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25746940|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746941|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25746942|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25746943|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25746944|NCT04024878|Nivolumab|nivolumab|mesh-list
25746945|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746946|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746947|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25746948|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746949|NCT03875235|Durvalumab|durvalumab|mesh-list
25746950|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25746951|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746952|NCT03860207|Antibodies|antibodies|mesh-list
25746953|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
25746954|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25746955|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
25746956|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746957|NCT03845010|Verapamil|verapamil|mesh-list
25746958|NCT03845010|Sotalol|sotalol|mesh-list
25746959|NCT03845010|Flecainide|flecainide|mesh-list
25746960|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25746961|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25746962|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25746963|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746964|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25746965|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746966|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
25746967|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25746968|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25746969|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
25746970|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25746971|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
25746972|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
25746973|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746974|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25746975|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25746976|NCT03837353|Docetaxel|docetaxel|mesh-list
25746977|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25746978|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
25746979|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
25746980|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
25746981|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746982|NCT03829046|Evolocumab|evolocumab|mesh-list
25746983|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25746984|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25746985|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
25746986|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25746987|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25746988|NCT03808077|Rocuronium|rocuronium|mesh-list
25746989|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25746990|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25746991|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25746992|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25746993|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25746994|NCT03763175|Lovastatin|lovastatin|mesh-list
25746995|NCT03763175|L 647318|l 647318|mesh-list
25746996|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
25746997|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25746998|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25746999|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
25747000|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747001|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25747002|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25747003|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747004|NCT03762395|CXA-10|cxa-10|mesh-list
25747005|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747006|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
25747007|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747008|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747009|NCT03713437|Insulin|insulin|mesh-list
25747010|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25747011|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747012|NCT03568890|Aspirin|aspirin|mesh-list
25747013|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
25747014|NCT03568890|Apixaban|apixaban|mesh-list
25747015|NCT03568890|Edoxaban|edoxaban|mesh-list
25747016|NCT03568890|Dabigatran|dabigatran|mesh-list
25747017|NCT03568890|Clopidogrel|clopidogrel|mesh-list
25747018|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25317847|NCT04973319|Pertuzumab|pertuzumab|mesh-list
25747019|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25747020|NCT03568890|Analgesics|analgesics|mesh-ancestor
25747021|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
25747022|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747023|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747024|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747025|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747026|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25747027|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25747028|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747029|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25747030|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25747031|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747033|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25747034|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25747035|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25747036|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
25747037|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747038|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25747039|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
25747040|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25747041|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
25747042|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
25747043|NCT03439670|Prednisone|prednisone|mesh-list
25747044|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747045|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
25747046|NCT03439670|Hormones|hormones|mesh-ancestor
25747047|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747048|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747049|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25747050|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747051|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25747052|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747053|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747054|NCT03392376|Haloperidol|haloperidol|mesh-list
25747055|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
25747056|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
25747057|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
25747058|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747059|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747060|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25747061|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25747062|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25747063|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747064|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25747065|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25747066|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
25747067|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747068|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747069|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25747070|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25747071|NCT03340129|Nivolumab|nivolumab|mesh-list
25747072|NCT03340129|Ipilimumab|ipilimumab|mesh-list
25747073|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747074|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747075|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25747076|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747077|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
25747078|NCT03339635|Testosterone|testosterone|mesh-list
25747079|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
25747080|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
25747081|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25747082|NCT03339635|Androgens|androgens|mesh-ancestor
25747083|NCT03339635|Hormones|hormones|mesh-ancestor
25747084|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747085|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747086|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25747087|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747088|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
25747089|NCT03335163|Topiramate|topiramate|mesh-list
25747090|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
25747091|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25747092|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747093|NCT03289910|Carboplatin|carboplatin|mesh-list
25747094|NCT03289910|Topotecan|topotecan|mesh-list
25747095|NCT03289910|Veliparib|veliparib|mesh-list
25747096|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747097|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25747098|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25747100|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747101|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25774908|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25774909|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774910|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774911|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25774912|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25774913|NCT04048681|Cocaine|cocaine|mesh-list
25774914|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
25774915|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
25774916|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25774917|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774918|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
25774919|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25774920|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25774921|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25774922|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25774923|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25774924|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774925|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
25774926|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25774927|NCT04041453|Ivermectin|ivermectin|mesh-list
25774928|NCT04041453|Albendazole|albendazole|mesh-list
25774929|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25774930|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774931|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
25774932|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
25774933|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25774934|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25774935|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
25774936|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
25774937|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
25774938|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774939|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774940|NCT04041219|Tacrolimus|tacrolimus|mesh-list
25774941|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25774942|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
25774943|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774944|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25774945|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774946|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774947|NCT04039867|Gemcitabine|gemcitabine|mesh-list
25774948|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
25774949|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25774950|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
25774951|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774952|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774953|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
25774954|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774955|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774956|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25774957|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
25774958|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774959|NCT04039412|Levofloxacin|levofloxacin|mesh-list
25774960|NCT04039412|Ofloxacin|ofloxacin|mesh-list
25774961|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25774962|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774963|NCT04039412|Renal Agents|renal agents|mesh-ancestor
25774964|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25774965|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25774966|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25774967|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25774968|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774969|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774970|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25774971|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25777635|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318056|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25318057|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
25747102|NCT03277729|Vidarabine|vidarabine|mesh-list
25747103|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
25747104|NCT03277729|Fludarabine|fludarabine|mesh-list
25747105|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
25747106|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25747107|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
25747108|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747109|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747110|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25747111|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
25747112|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747113|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747114|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25747115|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25747116|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
25747117|NCT03277729|Antiviral Agents|antiviral agents|mesh-ancestor
25747118|NCT03277729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747119|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
25747120|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25747121|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25747122|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
25747123|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747124|NCT03241732|Expectorants|expectorants|mesh-ancestor
25747125|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747126|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25747127|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
25747128|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747129|NCT03241732|Protective Agents|protective agents|mesh-ancestor
25747130|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747131|NCT03241732|Antidotes|antidotes|mesh-ancestor
25747132|NCT03229057|Metformin|metformin|mesh-list
25747133|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25747134|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747135|NCT03093922|Gemcitabine|gemcitabine|mesh-list
25747136|NCT03093922|Cisplatin|cisplatin|mesh-list
25747137|NCT03093922|Atezolizumab|atezolizumab|mesh-list
25747138|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747139|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25747140|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
25747141|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747142|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
25747143|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747144|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747145|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25747146|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
25747147|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747148|NCT03069131|Rifaximin|rifaximin|mesh-list
25747149|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25747150|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747151|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25747152|NCT03054896|Venetoclax|venetoclax|mesh-list
25747153|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747154|NCT03023046|Prednisone|prednisone|mesh-list
25747155|NCT03023046|Cortisone|cortisone|mesh-list
25747156|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
25747157|NCT03023046|Rituximab|rituximab|mesh-list
25747158|NCT03023046|Doxorubicin|doxorubicin|mesh-list
25747159|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25747160|NCT03023046|Etoposide|etoposide|mesh-list
25747161|NCT03023046|Vincristine|vincristine|mesh-list
25747162|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
25747163|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
25747164|NCT03023046|Daunorubicin|daunorubicin|mesh-list
25747165|NCT03023046|Dasatinib|dasatinib|mesh-list
25747166|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
25747167|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25747168|NCT03023046|Antibodies|antibodies|mesh-list
25747169|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
25747170|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25747171|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25747172|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
25747173|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747174|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747175|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25747176|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
25747177|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747178|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747179|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25747180|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25747181|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25747182|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25747183|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747184|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747185|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
25747186|NCT03023046|Hormones|hormones|mesh-ancestor
25747187|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747188|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25747189|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25747190|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25747191|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25747192|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25747193|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25747194|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
25747195|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
25747196|NCT03018080|Paclitaxel|paclitaxel|mesh-list
25747197|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
25747198|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25747199|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747200|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
25747201|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
25747202|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
25747203|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747204|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747205|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
25747206|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25747207|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25747208|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25747209|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747210|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747211|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
25747212|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747213|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747214|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25747215|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747216|NCT02782949|Curcumin|curcumin|mesh-list
25747217|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25747218|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25747219|NCT02782949|Analgesics|analgesics|mesh-ancestor
25747220|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
25747221|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747222|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747223|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747224|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747225|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747226|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747227|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747228|NCT02633397|Riociguat|riociguat|mesh-list
25747229|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
25747230|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747231|NCT02581527|Rifampin|rifampin|mesh-list
25747232|NCT02581527|Isoniazid|isoniazid|mesh-list
25747233|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
25747234|NCT02581527|Ethambutol|ethambutol|mesh-list
25747235|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25747236|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
25747237|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25747238|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747239|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
25747240|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25747241|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747242|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747243|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25747244|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25747245|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25747246|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25747247|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25747248|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25747249|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25747250|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25747251|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
25318210|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318211|NCT04967859|Gentamicins|gentamicins|mesh-list
25318212|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25747252|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25747253|NCT02529930|Vaccines|vaccines|mesh-list
25747254|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
25747255|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747256|NCT02522715|Prednisone|prednisone|mesh-list
25747257|NCT02522715|Cortisone|cortisone|mesh-list
25747258|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747259|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
25747260|NCT02522715|Hormones|hormones|mesh-ancestor
25747261|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747262|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747263|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25747264|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747265|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
25747266|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747267|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
25747268|NCT02453373|Plasminogen|plasminogen|mesh-list
25747269|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25747270|NCT02453373|Propofol|propofol|mesh-list
25747271|NCT02453373|Etomidate|etomidate|mesh-list
25747272|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25747273|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747274|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747275|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25747276|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
25747277|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
25747278|NCT02453373|Analgesics|analgesics|mesh-ancestor
25747279|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
25747280|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747281|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25747282|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
25747283|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25747284|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747285|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747286|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25747287|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
25747288|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25747289|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25747290|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25747291|NCT02415712|Fomepizole|fomepizole|mesh-list
25747292|NCT02415712|Antidotes|antidotes|mesh-ancestor
25747293|NCT02415712|Protective Agents|protective agents|mesh-ancestor
25747294|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747295|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747296|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747297|NCT02398773|Estradiol|estradiol|mesh-list
25747298|NCT02398773|Estrogens|estrogens|mesh-ancestor
25747299|NCT02398773|Hormones|hormones|mesh-ancestor
25747300|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747301|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747302|NCT02374242|Nivolumab|nivolumab|mesh-list
25747303|NCT02374242|Ipilimumab|ipilimumab|mesh-list
25747304|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747305|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747306|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25747307|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747308|NCT02012296|Mifepristone|mifepristone|mesh-list
25747309|NCT02012296|Androgens|androgens|mesh-list
25747310|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25747311|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
25747312|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25747313|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747314|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25747315|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25747316|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25747317|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
25747318|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25747319|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25747320|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
25747321|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747322|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
25747323|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25747324|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25747325|NCT02012296|Hormones|hormones|mesh-ancestor
25747326|NCT01972347|Trametinib|trametinib|mesh-list
25747327|NCT01972347|Dabrafenib|dabrafenib|mesh-list
25747328|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747329|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25747330|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747331|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747332|NCT01674140|Tamoxifen|tamoxifen|mesh-list
25747333|NCT01674140|Everolimus|everolimus|mesh-list
25747334|NCT01674140|Letrozole|letrozole|mesh-list
25747335|NCT01674140|Anastrozole|anastrozole|mesh-list
25747336|NCT01674140|Leuprolide|leuprolide|mesh-list
25747337|NCT01674140|Exemestane|exemestane|mesh-list
25747338|NCT01674140|Goserelin|goserelin|mesh-list
25747339|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747340|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747341|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25747342|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
25747343|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747344|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25747345|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25747346|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747347|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25747348|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
25747349|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747350|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25747351|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25747352|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25747353|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25747354|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25747355|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
25747356|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25747357|NCT01163383|Iodine|iodine|mesh-list
25747358|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
25747359|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25747360|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25747361|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747362|NCT01163383|Trace Elements|trace elements|mesh-ancestor
25747363|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
25747364|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747365|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747366|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747367|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747368|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25747369|NCT01148849|Margetuximab|margetuximab|mesh-list
25747370|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747371|NCT00966914|Paclitaxel|paclitaxel|mesh-list
25747372|NCT00966914|Docetaxel|docetaxel|mesh-list
25747373|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25747374|NCT00966914|Cisplatin|cisplatin|mesh-list
25747375|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
25747376|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25747377|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747378|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
25747379|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
25747380|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
25747381|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747382|NCT00966914|Protective Agents|protective agents|mesh-ancestor
25747383|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747384|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
25747385|NCT00039780|Protective Agents|protective agents|mesh-ancestor
25747386|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747387|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
25747388|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25747389|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
25747390|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747391|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747392|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25747393|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747394|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25747395|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
25747396|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747397|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747398|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25318405|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318406|NCT04965324|Anesthetics|anesthetics|mesh-list
25318407|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318409|NCT04965051|Insulin|insulin|mesh-list
25747399|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
25747400|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
25747401|NCT05101746|Protective Agents|protective agents|mesh-ancestor
25747402|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
25747403|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25747404|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25747405|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
25747406|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747407|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747408|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25747409|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747410|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25747411|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
25747412|NCT05088369|Protective Agents|protective agents|mesh-ancestor
25747413|NCT05080322|Fluticasone|fluticasone|mesh-list
25747415|NCT05080322|Azelastine|azelastine|mesh-list
25747416|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747417|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25747418|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
25747419|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747420|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747421|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25747422|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747423|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
25747424|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25747425|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25747426|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747427|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747428|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25747429|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25747430|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
25747431|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
25747432|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747433|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
25747434|NCT05063396|Anesthetics|anesthetics|mesh-list
25747435|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747436|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747437|NCT05063396|Narcotics|narcotics|mesh-ancestor
25747438|NCT05063396|Analgesics|analgesics|mesh-ancestor
25747439|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
25747440|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747441|NCT05062317|Leucovorin|leucovorin|mesh-list
25747442|NCT05062317|Bevacizumab|bevacizumab|mesh-list
25747443|NCT05062317|Fluorouracil|fluorouracil|mesh-list
25747444|NCT05062317|Capecitabine|capecitabine|mesh-list
25747445|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
25747446|NCT05062317|Irinotecan|irinotecan|mesh-list
25747447|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747448|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747449|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25747450|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25747451|NCT05062317|Growth Substances|growth substances|mesh-ancestor
25747452|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747453|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
25747454|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
25747455|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747456|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25747457|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25747458|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
25747459|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25747460|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25747461|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747462|NCT05062317|Antidotes|antidotes|mesh-ancestor
25747463|NCT05062317|Protective Agents|protective agents|mesh-ancestor
25747464|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
25747465|NCT05062317|Vitamins|vitamins|mesh-ancestor
25747466|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
25747467|NCT05055752|Aspirin|aspirin|mesh-list
25747468|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25747469|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25747470|NCT05055752|Analgesics|analgesics|mesh-ancestor
25747471|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
25747472|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318510|NCT04963998|Copper|copper|mesh-list
25747473|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747474|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747475|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747476|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25747477|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25747478|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747479|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25747480|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25747481|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747483|NCT05051527|Silymarin|silymarin|mesh-list
25747484|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
25747485|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747486|NCT05051527|Protective Agents|protective agents|mesh-ancestor
25747487|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747488|NCT05045937|Vitamin D|vitamin d|mesh-list
25747489|NCT05045937|Vitamins|vitamins|mesh-list
25747490|NCT05045937|Ivermectin|ivermectin|mesh-list
25747491|NCT05045937|Remdesivir|remdesivir|mesh-list
25747492|NCT05045937|Ibuprofen|ibuprofen|mesh-list
25747493|NCT05045937|Budesonide|budesonide|mesh-list
25747494|NCT05045937|Melatonin|melatonin|mesh-list
25747495|NCT05045937|Albuterol|albuterol|mesh-list
25747496|NCT05045937|Quercetin|quercetin|mesh-list
25747497|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747498|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
25747499|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25747500|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25747501|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25747502|NCT05045937|Analgesics|analgesics|mesh-ancestor
25747503|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
25747504|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747505|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747506|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747507|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747508|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25747509|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747510|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25747511|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
25747512|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25747513|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747514|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
25747515|NCT05045937|Hormones|hormones|mesh-ancestor
25747516|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747517|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
25747518|NCT05045937|Protective Agents|protective agents|mesh-ancestor
25747519|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747520|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
25747521|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25747522|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25747523|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25747524|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25747525|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
25747526|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747527|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25747528|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747529|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
25747530|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
25747531|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25747532|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747533|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747534|NCT05037032|Naltrexone|naltrexone|mesh-list
25747535|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25747536|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25747537|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747538|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
25747539|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747540|NCT05029726|Clonidine|clonidine|mesh-list
25747541|NCT05029726|Epinephrine|epinephrine|mesh-list
25747542|NCT05029726|Bupivacaine|bupivacaine|mesh-list
25747543|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
25747544|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
25747545|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747546|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747547|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
25747548|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747549|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25747550|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25747551|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
25747552|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747553|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747554|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25747555|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25747556|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
25747557|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25747558|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747559|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
25747560|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
25747561|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25747562|NCT05029726|Analgesics|analgesics|mesh-ancestor
25747563|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25747564|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
25747565|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25747566|NCT04982237|Paclitaxel|paclitaxel|mesh-list
25747567|NCT04982237|Bevacizumab|bevacizumab|mesh-list
25747568|NCT04982237|Cisplatin|cisplatin|mesh-list
25747569|NCT04982237|Carboplatin|carboplatin|mesh-list
25747570|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25747571|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747572|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25747573|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25747574|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25747575|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747576|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747577|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25747578|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25747579|NCT04982237|Growth Substances|growth substances|mesh-ancestor
25747580|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747581|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
25747582|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25747583|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25747584|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25747585|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747586|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747587|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747588|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747589|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25747590|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
25747591|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25774972|NCT04036110|Vitamins|vitamins|mesh-list
25774973|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
25774974|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
25774975|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774976|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
25774977|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25774978|NCT04036110|Protective Agents|protective agents|mesh-ancestor
25774979|NCT04024501|Verinurad|verinurad|mesh-list
25774980|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
25774981|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25774982|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
25774983|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25774984|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
25774985|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774986|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774987|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
25774988|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774989|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
25774990|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25774991|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
25774992|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25774993|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25774994|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
25774995|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25774996|NCT04031885|Paclitaxel|paclitaxel|mesh-list
25774997|NCT04031885|Docetaxel|docetaxel|mesh-list
25774998|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25774999|NCT04031885|Capecitabine|capecitabine|mesh-list
25775000|NCT04031885|Fulvestrant|fulvestrant|mesh-list
25775001|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25775002|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318644|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
25318645|NCT04961970|Vitamins|vitamins|mesh-ancestor
25318646|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
25318647|NCT04961684|Amorolfine|amorolfine|mesh-list
25318648|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
25775003|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
25775004|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
25747592|NCT04958811|Bevacizumab|bevacizumab|mesh-list
25747593|NCT04958811|Atezolizumab|atezolizumab|mesh-list
25747594|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747595|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747596|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25747597|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25747598|NCT04958811|Growth Substances|growth substances|mesh-ancestor
25747599|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747600|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
25747601|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
25747602|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25747603|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25747604|NCT04900220|Prednisolone|prednisolone|mesh-list
25747605|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
25747606|NCT04900220|Betamethasone|betamethasone|mesh-list
25747607|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25747608|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
25747609|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747610|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
25747611|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
25747612|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747613|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747614|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25747615|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
25747616|NCT04900220|Hormones|hormones|mesh-ancestor
25747617|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747618|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25747619|NCT04900220|Protective Agents|protective agents|mesh-ancestor
25747620|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25747621|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747622|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25747623|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747624|NCT04887194|Nivolumab|nivolumab|mesh-list
25747625|NCT04887194|Digoxin|digoxin|mesh-list
25747626|NCT04887194|Midazolam|midazolam|mesh-list
25747627|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
25747628|NCT04887194|Warfarin|warfarin|mesh-list
25747629|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25747630|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747631|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747632|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25747633|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747634|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25747635|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25747636|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747637|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747638|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25747639|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25747640|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25747641|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25747642|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
25747643|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
25747644|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
25747645|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
25747646|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747647|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25747648|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25747649|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
25747650|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25747651|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25747652|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747653|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
25747654|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25747655|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25747656|NCT04887194|Protective Agents|protective agents|mesh-ancestor
25747657|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
25747658|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747659|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25318711|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
25318712|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25318713|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318714|NCT04960657|Growth Substances|growth substances|mesh-ancestor
25318715|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
25318716|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318717|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318718|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25747660|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25747661|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
25747662|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747663|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25747664|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747665|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747666|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
25747667|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747668|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747669|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25747671|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25747672|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747673|NCT04817501|Edetic Acid|edetic acid|mesh-list
25747674|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
25747675|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25747676|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
25747677|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
25747678|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747679|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25747680|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747681|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
25747682|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25747683|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
25747684|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747685|NCT04792021|Expectorants|expectorants|mesh-ancestor
25747686|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747687|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25747688|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
25747689|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747690|NCT04792021|Protective Agents|protective agents|mesh-ancestor
25747691|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747692|NCT04792021|Antidotes|antidotes|mesh-ancestor
25747693|NCT04771299|Cariprazine|cariprazine|mesh-list
25747694|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25747695|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25747696|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747697|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747698|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25747699|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
25747700|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25747701|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
25747702|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747703|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
25747704|NCT04766918|Protective Agents|protective agents|mesh-ancestor
25747705|NCT04763226|Furosemide|furosemide|mesh-list
25747706|NCT04763226|Diuretics|diuretics|mesh-ancestor
25747707|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
25747708|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747709|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25747710|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747711|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747712|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
25747713|NCT04757675|Ketamine|ketamine|mesh-list
25747714|NCT04757675|Esketamine|esketamine|mesh-list
25747715|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25747716|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747717|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747718|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25747719|NCT04757675|Analgesics|analgesics|mesh-ancestor
25747720|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
25747721|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747722|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25747723|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25747724|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25747725|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
25747726|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747727|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747728|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25747729|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25747730|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
25747731|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
25747732|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25318787|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747733|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25747734|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
25747735|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25747736|NCT04755712|Sufentanil|sufentanil|mesh-list
25747737|NCT04755712|Morphine|morphine|mesh-list
25747738|NCT04755712|Bupivacaine|bupivacaine|mesh-list
25747739|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
25747740|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
25747741|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747742|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747743|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
25747744|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747745|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25747746|NCT04755712|Narcotics|narcotics|mesh-ancestor
25747747|NCT04755712|Analgesics|analgesics|mesh-ancestor
25747748|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25747749|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25747750|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
25747751|NCT04752475|Furosemide|furosemide|mesh-list
25747752|NCT04752475|Diuretics|diuretics|mesh-ancestor
25747753|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
25747754|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747755|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25747756|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747757|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747758|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
25747759|NCT04751812|Narcotics|narcotics|mesh-ancestor
25747760|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747761|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747762|NCT04751812|Analgesics|analgesics|mesh-ancestor
25747763|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
25747764|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747765|NCT04733937|Caseins|caseins|mesh-list
25747766|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
25747767|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
25747768|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747769|NCT04705662|Lactulose|lactulose|mesh-list
25747770|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25747771|NCT04682366|Tamsulosin|tamsulosin|mesh-list
25747772|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25747773|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25747774|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25747775|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
25747776|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747777|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747778|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747779|NCT04682366|Urological Agents|urological agents|mesh-ancestor
25747780|NCT04665089|Erythromycin|erythromycin|mesh-list
25747781|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
25747782|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25747783|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
25747784|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25747785|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747786|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25747787|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25747788|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747789|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747790|NCT04654988|Prednisone|prednisone|mesh-list
25747791|NCT04654988|Azathioprine|azathioprine|mesh-list
25747792|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747793|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
25747794|NCT04654988|Hormones|hormones|mesh-ancestor
25747795|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747796|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747797|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25747798|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747799|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
25747800|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747801|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25747802|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25747803|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
25747804|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747805|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
25747806|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25747807|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747808|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747810|NCT04645823|Fentanyl|fentanyl|mesh-list
25747811|NCT04645823|Citric Acid|citric acid|mesh-list
25747812|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
25747813|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
25747814|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
25747815|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747816|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747817|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
25747818|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747819|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25747820|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25747821|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25747822|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747823|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747824|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25747825|NCT04645823|Narcotics|narcotics|mesh-ancestor
25747826|NCT04645823|Analgesics|analgesics|mesh-ancestor
25747827|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25747828|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25747829|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
25747830|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
25747831|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25747832|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
25747833|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
25747834|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
25747835|NCT04606901|Neostigmine|neostigmine|mesh-list
25747836|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25747837|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747838|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747839|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
25747840|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747841|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747842|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25747843|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
25747844|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747845|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25747846|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25747847|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25775005|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
25775006|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775007|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25775008|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
25775009|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25775010|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25775011|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25775012|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
25775013|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775014|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775015|NCT04029584|Rifampin|rifampin|mesh-list
25775016|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25775017|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
25775018|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25775019|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775020|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
25775021|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25775022|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775023|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775024|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25775025|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25775026|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25775027|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25775028|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25775029|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25775030|NCT04028960|Insulin|insulin|mesh-list
25775031|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25775032|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25775033|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775034|NCT04023695|Lidocaine|lidocaine|mesh-list
25775035|NCT04023695|Epinephrine|epinephrine|mesh-list
25775036|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
25775037|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
25319013|NCT04952194|Levodopa|levodopa|mesh-list
25747849|NCT04573751|Epinephrine|epinephrine|mesh-list
25747850|NCT04573751|Racepinephrine|racepinephrine|mesh-list
25747851|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
25747852|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25747853|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25747854|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
25747855|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747856|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747857|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747858|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25747859|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25747860|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
25747861|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747862|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25747863|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
25747864|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
25747865|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
25747866|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25747867|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25747868|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25747869|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747870|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25747871|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
25747872|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
25747873|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747874|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747875|NCT04549428|Atezolizumab|atezolizumab|mesh-list
25747876|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747877|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25747878|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25747879|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25747880|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
25747881|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747882|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25747883|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25747884|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747885|NCT04527900|Paclitaxel|paclitaxel|mesh-list
25747886|NCT04527900|Carboplatin|carboplatin|mesh-list
25747887|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25747888|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747889|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
25747890|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
25747891|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
25747892|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747893|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25747894|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25747895|NCT04507022|Estradiol|estradiol|mesh-list
25747896|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25747897|NCT04507022|Progesterone|progesterone|mesh-list
25747898|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25747899|NCT04507022|Estrogens|estrogens|mesh-ancestor
25747900|NCT04507022|Hormones|hormones|mesh-ancestor
25747901|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25747902|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747903|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25747904|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
25747905|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25747906|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25747907|NCT04507022|Progestins|progestins|mesh-ancestor
25747908|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25747909|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747910|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747911|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25747912|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
25747913|NCT04504175|Ketamine|ketamine|mesh-list
25747914|NCT04504175|Analgesics|analgesics|mesh-ancestor
25747915|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
25747916|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747917|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747918|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25747919|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25747920|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
25747921|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
25747922|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747923|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25747924|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25747925|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747926|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747927|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
25747928|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25747929|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25747930|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747931|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
25747932|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25747933|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747934|NCT04430959|Candesartan|candesartan|mesh-list
25747935|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25747936|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25747937|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25747938|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747939|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
25747940|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
25747941|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25747942|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25747943|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747944|NCT04367090|Docetaxel|docetaxel|mesh-list
25747945|NCT04367090|Trastuzumab|trastuzumab|mesh-list
25747946|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25747947|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
25747948|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
25747949|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
25747950|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747951|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25747952|NCT04340856|Bisacodyl|bisacodyl|mesh-list
25747953|NCT04340856|Laxatives|laxatives|mesh-list
25747954|NCT04340856|Cathartics|cathartics|mesh-ancestor
25747955|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25747956|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
25747957|NCT04336189|Piperaquine|piperaquine|mesh-list
25747958|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
25747959|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25747960|NCT04336189|Artenimol|artenimol|mesh-list
25747961|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
25747962|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25747963|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25747964|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25747965|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25747966|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747967|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747968|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25747969|NCT04336189|Renal Agents|renal agents|mesh-ancestor
25747970|NCT04332497|Ibuprofen|ibuprofen|mesh-list
25747971|NCT04332497|Fentanyl|fentanyl|mesh-list
25747972|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25747973|NCT04332497|Narcotics|narcotics|mesh-ancestor
25747974|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25747975|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747976|NCT04332497|Analgesics|analgesics|mesh-ancestor
25747977|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
25747978|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25747979|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25747980|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25747981|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
25747982|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
25747983|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25747984|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25747985|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25747986|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25747987|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25747988|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747989|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747990|NCT04311567|Methotrexate|methotrexate|mesh-list
25747991|NCT04311567|Tofacitinib|tofacitinib|mesh-list
25747992|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25747993|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
25747994|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25747995|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25747996|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25747997|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
25747998|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25747999|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748000|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
25748001|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748002|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25748003|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748004|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
25748005|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748006|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25748007|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748008|NCT04301843|Eflornithine|eflornithine|mesh-list
25748009|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748010|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25748011|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25748012|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25748013|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748014|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25748015|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748016|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748017|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
25748018|NCT04291001|Etonogestrel|etonogestrel|mesh-list
25748019|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25748020|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
25748021|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25748022|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748023|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25748024|NCT04260659|Lidocaine|lidocaine|mesh-list
25748025|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
25748026|NCT04260659|Fentanyl|fentanyl|mesh-list
25748027|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
25748028|NCT04260659|Ketamine|ketamine|mesh-list
25748029|NCT04260659|Remifentanil|remifentanil|mesh-list
25748030|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
25748031|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
25748032|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25748033|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748034|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
25748035|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748036|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25748037|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25748038|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25748039|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25748040|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748041|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25748042|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748043|NCT04260659|Analgesics|analgesics|mesh-ancestor
25748044|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25748045|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25748046|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25748047|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
25748048|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748049|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25748050|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25748051|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
25748052|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25748053|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25748054|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25748055|NCT04260659|Narcotics|narcotics|mesh-ancestor
25748056|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25748057|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
25748058|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25748059|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25748060|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
25748061|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25748062|NCT04259775|Insulin|insulin|mesh-list
25748063|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25748064|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748065|NCT04258397|Pirfenidone|pirfenidone|mesh-list
25748066|NCT04258397|Analgesics|analgesics|mesh-ancestor
25748067|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
25748068|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748069|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748070|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25748071|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748072|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748073|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748074|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748075|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
25748076|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748077|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748078|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
25748079|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748080|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
25748081|NCT04231708|Yohimbine|yohimbine|mesh-list
25748082|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748083|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
25748084|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
25748085|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748086|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748087|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25748088|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25748089|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25748090|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
25748091|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748092|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748093|NCT04231708|Urological Agents|urological agents|mesh-ancestor
25748094|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
25748095|NCT04225078|Loperamide|loperamide|mesh-list
25748096|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
25748097|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748098|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748099|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25748100|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25748101|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748102|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748103|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748104|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775038|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775039|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775040|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
25775041|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775042|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25775043|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25775044|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25775045|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25775046|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775047|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25775048|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25775049|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
25775050|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775051|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25775052|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25775053|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
25775054|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25775055|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775056|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
25775057|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
25775058|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25775059|NCT04018664|Nalbuphine|nalbuphine|mesh-list
25775060|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25775061|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25775062|NCT04018664|Narcotics|narcotics|mesh-ancestor
25775063|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775064|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775065|NCT04018664|Analgesics|analgesics|mesh-ancestor
25775066|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
25775067|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775068|NCT04027803|Eculizumab|eculizumab|mesh-list
25775069|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25775070|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25775071|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
25775072|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775073|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
25775074|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25775075|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775076|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
25775077|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
25775078|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25775079|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
25775080|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748105|NCT04188665|Lectins|lectins|mesh-list
25748106|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
25748107|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
25748108|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748109|NCT04188665|Coagulants|coagulants|mesh-ancestor
25748110|NCT04186247|Azithromycin|azithromycin|mesh-list
25748111|NCT04186247|Metronidazole|metronidazole|mesh-list
25748112|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748113|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748114|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25748115|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25748116|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
25748117|NCT04181515|Yohimbine|yohimbine|mesh-list
25748118|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748119|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
25748120|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
25748121|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748122|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748123|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25748124|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25748125|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25748126|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
25748127|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748128|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748129|NCT04181515|Urological Agents|urological agents|mesh-ancestor
25748130|NCT04181255|Poractant alfa|poractant alfa|mesh-list
25748131|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25748132|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
25748133|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
25748134|NCT04180969|Yohimbine|yohimbine|mesh-list
25748135|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748136|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
25748137|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
25748138|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748139|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748140|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25748141|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25748142|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25748143|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
25748144|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748145|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748146|NCT04180969|Urological Agents|urological agents|mesh-ancestor
25748147|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
25748148|NCT04164069|Leucovorin|leucovorin|mesh-list
25748149|NCT04164069|Folic Acid|folic acid|mesh-list
25748150|NCT04164069|Bevacizumab|bevacizumab|mesh-list
25748151|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25748152|NCT04164069|Fluorouracil|fluorouracil|mesh-list
25748153|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
25748154|NCT04164069|Dasatinib|dasatinib|mesh-list
25748155|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
25748156|NCT04164069|Antibodies|antibodies|mesh-list
25748157|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
25748158|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25748159|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
25748160|NCT04164069|Calcium|calcium|mesh-list
25748161|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
25748162|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748163|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748164|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748165|NCT04164069|Growth Substances|growth substances|mesh-ancestor
25748166|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748167|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748168|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
25748169|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25748170|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25748171|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
25748172|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748173|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25748174|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748175|NCT04164069|Antidotes|antidotes|mesh-ancestor
25748176|NCT04164069|Protective Agents|protective agents|mesh-ancestor
25319453|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748177|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
25748178|NCT04164069|Vitamins|vitamins|mesh-ancestor
25748179|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
25748180|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748181|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748182|NCT04164069|Hematinics|hematinics|mesh-ancestor
25748183|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25748184|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
25748185|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748186|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25748187|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25748188|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748189|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748190|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25748191|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25748193|NCT04101877|Aflibercept|aflibercept|mesh-list
25748194|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748195|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748196|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748197|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748198|NCT04101877|Growth Substances|growth substances|mesh-ancestor
25748199|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748200|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748201|NCT04074161|Liraglutide|liraglutide|mesh-list
25748202|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25748203|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748204|NCT04074161|Incretins|incretins|mesh-ancestor
25748205|NCT04074161|Hormones|hormones|mesh-ancestor
25748206|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25748207|NCT04061330|Ketamine|ketamine|mesh-list
25748208|NCT04061330|Morphine|morphine|mesh-list
25748209|NCT04061330|Analgesics|analgesics|mesh-ancestor
25748210|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
25748211|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748212|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748213|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25748214|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25748215|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
25748216|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
25748217|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25748218|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25748219|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25748220|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748221|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748222|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25748223|NCT04061330|Narcotics|narcotics|mesh-ancestor
25748224|NCT04040790|Phenylephrine|phenylephrine|mesh-list
25748225|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
25748226|NCT04040790|Tropicamide|tropicamide|mesh-list
25748227|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25748228|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
25748229|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
25748230|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748231|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748232|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
25748233|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25748234|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
25748235|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25748236|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25748237|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25748238|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25748239|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
25748240|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748241|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748242|NCT04040790|Protective Agents|protective agents|mesh-ancestor
25748243|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25748244|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25748245|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
25748246|NCT04033354|Paclitaxel|paclitaxel|mesh-list
25748247|NCT04033354|Carboplatin|carboplatin|mesh-list
25748248|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25748249|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748250|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
25748251|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
25748252|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
25748253|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748254|NCT04028063|Doxorubicin|doxorubicin|mesh-list
25748255|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25748256|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748257|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25748258|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25748259|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748260|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748261|NCT04027894|Rifamycins|rifamycins|mesh-list
25748262|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
25748263|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748264|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748265|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748266|NCT04026984|Rifamycins|rifamycins|mesh-list
25748267|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
25748268|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748269|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748270|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748271|NCT03923270|Durvalumab|durvalumab|mesh-list
25748272|NCT03923270|Olaparib|olaparib|mesh-list
25748273|NCT03923270|Tremelimumab|tremelimumab|mesh-list
25748274|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25748275|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748276|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748277|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25748278|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748279|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748280|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
25748281|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748282|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25748283|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25748284|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25748285|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748286|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748287|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25748288|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25748289|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748290|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
25748291|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748292|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
25748293|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25748294|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25748295|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748296|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
25748297|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748298|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748299|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
25748300|NCT03797196|Everolimus|everolimus|mesh-list
25748301|NCT03797196|Tacrolimus|tacrolimus|mesh-list
25748302|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748303|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
25748304|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748305|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25748306|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748307|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748308|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748309|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25748310|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25748311|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
25748312|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748313|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748314|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25748315|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25748316|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748317|NCT03743766|Nivolumab|nivolumab|mesh-list
25748318|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748319|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748320|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25748321|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748322|NCT03628716|Atezolizumab|atezolizumab|mesh-list
25748323|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748324|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
25748325|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25748326|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748327|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25748328|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748329|NCT03611738|Docetaxel|docetaxel|mesh-list
25748330|NCT03611738|Ceritinib|ceritinib|mesh-list
25748331|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748332|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
25748333|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25748334|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
25748335|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748336|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748337|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775081|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775082|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25775083|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775084|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
25775085|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25775086|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
25775087|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775088|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775089|NCT04009577|Lemborexant|lemborexant|mesh-list
25775090|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25775091|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775092|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775093|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25775094|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25775095|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775096|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775097|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
25775098|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
25775099|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775100|NCT03995680|Mebendazole|mebendazole|mesh-list
25775101|NCT03995680|Piperazine|piperazine|mesh-list
25775102|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
25775103|NCT03995680|DMP 777|dmp 777|mesh-list
25775104|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
25775105|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
25775106|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25775107|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775108|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
25775109|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
25775110|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
25775111|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775112|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775113|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775114|NCT04005404|Ropivacaine|ropivacaine|mesh-list
25775115|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
25775116|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
25775117|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775118|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775119|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
25775120|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775121|NCT03993288|Iron|iron|mesh-list
25775122|NCT03993288|Trace Elements|trace elements|mesh-ancestor
25775123|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
25775124|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775125|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
25775126|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25775127|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775128|NCT03978832|Risperidone|risperidone|mesh-list
25775129|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25775130|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
25775131|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775132|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775133|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775134|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25775135|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25775136|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775137|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775138|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25775139|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
25775140|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25775141|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
25775142|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
25775143|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
25775144|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25775145|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775146|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25775147|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25775148|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25775149|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25748339|NCT03581409|Cilostazol|cilostazol|mesh-list
25748340|NCT03581409|Clopidogrel|clopidogrel|mesh-list
25748341|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25748342|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25748343|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748344|NCT03581409|Analgesics|analgesics|mesh-ancestor
25748345|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
25748346|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748347|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748348|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748349|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748350|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25748351|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25748352|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748353|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25748354|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25748355|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748356|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
25748357|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25748358|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25748359|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25748360|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
25748361|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748362|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25748363|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
25748364|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25748365|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
25748366|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
25748367|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25748368|NCT03581409|Protective Agents|protective agents|mesh-ancestor
25748369|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25748370|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25748371|NCT03566667|Metoprolol|metoprolol|mesh-list
25748372|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25748373|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25748374|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
25748375|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
25748376|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748377|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748378|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25748379|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25748380|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25748381|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
25748382|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748383|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748384|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25748385|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25748386|NCT03556800|Estradiol|estradiol|mesh-list
25748387|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25748388|NCT03556800|Estrogens|estrogens|mesh-ancestor
25748389|NCT03556800|Hormones|hormones|mesh-ancestor
25748390|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25748391|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748392|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25748393|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
25748394|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25748395|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25748396|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
25748397|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
25748398|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25748399|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
25748400|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748401|NCT03510741|Expectorants|expectorants|mesh-ancestor
25748402|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
25748403|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25748404|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
25748405|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748406|NCT03510741|Protective Agents|protective agents|mesh-ancestor
25748407|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748408|NCT03510741|Antidotes|antidotes|mesh-ancestor
25748409|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
25748410|NCT03503513|Gentamicins|gentamicins|mesh-list
25748411|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748412|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748413|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25748414|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748415|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748416|NCT03472495|Diltiazem|diltiazem|mesh-list
25748417|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25748418|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25748419|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25748420|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748421|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25748422|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748423|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
25748424|NCT03377699|Insulin|insulin|mesh-list
25748425|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25748426|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
25748427|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
25748428|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25748429|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748430|NCT03377023|Nivolumab|nivolumab|mesh-list
25748431|NCT03377023|Ipilimumab|ipilimumab|mesh-list
25748432|NCT03377023|Nintedanib|nintedanib|mesh-list
25748433|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748434|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748435|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25748436|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748437|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748438|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748439|NCT03365687|Vitamin D|vitamin d|mesh-list
25748440|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
25748441|NCT03365687|Vitamins|vitamins|mesh-ancestor
25748442|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
25748443|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748444|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25748445|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25748446|NCT03275350|Naltrexone|naltrexone|mesh-list
25748447|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25748448|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25748449|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748450|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
25748451|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748452|NCT03272347|Tenofovir|tenofovir|mesh-list
25748453|NCT03272347|Lamivudine|lamivudine|mesh-list
25748454|NCT03272347|Islatravir|islatravir|mesh-list
25748455|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
25748456|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748457|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25748458|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25748459|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748460|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748461|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25748462|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25748463|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
25748464|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748465|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748466|NCT03197194|Aspirin|aspirin|mesh-list
25748467|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25748468|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25748469|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748470|NCT03197194|Analgesics|analgesics|mesh-ancestor
25748471|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
25748472|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748473|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748474|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748475|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748476|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25748477|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25748478|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748479|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25748480|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25748481|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748482|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
25748483|NCT03168880|Paclitaxel|paclitaxel|mesh-list
25748484|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25748485|NCT03168880|Carboplatin|carboplatin|mesh-list
25748486|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25748487|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319949|NCT04942769|Selenium|selenium|mesh-list
25748488|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
25748489|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
25748490|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
25748491|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748492|NCT03092895|Apatinib|apatinib|mesh-list
25748493|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748494|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748495|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748496|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748497|NCT02984384|Aspirin|aspirin|mesh-list
25748498|NCT02984384|Heparin|heparin|mesh-list
25748499|NCT02984384|Enoxaparin|enoxaparin|mesh-list
25748500|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25748501|NCT02984384|Tinzaparin|tinzaparin|mesh-list
25748502|NCT02984384|Dalteparin|dalteparin|mesh-list
25748503|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25748504|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748505|NCT02984384|Analgesics|analgesics|mesh-ancestor
25748506|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
25748507|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748508|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748509|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748510|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748511|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25748512|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25748513|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748514|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25748515|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25748516|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748517|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
25748518|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
25748519|NCT02977299|Aripiprazole|aripiprazole|mesh-list
25748520|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25748521|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
25748522|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25748523|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25748524|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25748525|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25748526|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748527|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
25748528|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
25748529|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748530|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748531|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25748532|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25748533|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
25748534|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25748535|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25748536|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25748537|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25748538|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25748539|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25748540|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25748541|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25748542|NCT02923466|Interferon-beta|interferon-beta|mesh-list
25748543|NCT02923466|Avelumab|avelumab|mesh-list
25748544|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748545|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748546|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
25748547|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748548|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
25748549|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748550|NCT02850874|Gemcitabine|gemcitabine|mesh-list
25748551|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25748552|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
25748553|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748554|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748555|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
25748556|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748557|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748558|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748559|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
25748560|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748561|NCT02827838|Durvalumab|durvalumab|mesh-list
25748562|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
25748563|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25748564|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
25748565|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748566|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748567|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
25748568|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748569|NCT02794337|Sorafenib|sorafenib|mesh-list
25748570|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748571|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748572|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748573|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748574|NCT02773485|Gemcitabine|gemcitabine|mesh-list
25748575|NCT02773485|Cisplatin|cisplatin|mesh-list
25748576|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748577|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25748578|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
25748579|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748580|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
25748581|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748582|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748583|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748584|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
25748585|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748586|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
25748587|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748588|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748589|NCT02721459|Vemurafenib|vemurafenib|mesh-list
25748590|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748591|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748592|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748593|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748594|NCT02638701|Infliximab|infliximab|mesh-list
25748595|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
25748596|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25748597|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748598|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
25748599|NCT02590523|Vancomycin|vancomycin|mesh-list
25748600|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748601|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748602|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25748603|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25748604|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748605|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748606|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748607|NCT02582125|Nivolumab|nivolumab|mesh-list
25748608|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748609|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748610|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25748611|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748612|NCT02440854|Afatinib|afatinib|mesh-list
25748613|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748614|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748615|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748616|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775150|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25775151|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25775152|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25775153|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775154|NCT04004481|Morphine|morphine|mesh-list
25775155|NCT04004481|Tramadol|tramadol|mesh-list
25775156|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25775157|NCT04004481|Narcotics|narcotics|mesh-ancestor
25775158|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775159|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775160|NCT04004481|Analgesics|analgesics|mesh-ancestor
25775161|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
25775162|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775163|NCT03997851|Acetaminophen|acetaminophen|mesh-list
25775164|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25775165|NCT03997851|Analgesics|analgesics|mesh-ancestor
25775166|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
25775167|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775168|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775169|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
25775170|NCT03996694|Oxycodone|oxycodone|mesh-list
25775171|NCT03996694|Buprenorphine|buprenorphine|mesh-list
25748617|NCT02344498|Tenofovir|tenofovir|mesh-list
25748618|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
25748619|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748620|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25748621|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25748622|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748623|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748624|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25748625|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25748626|NCT02278185|Leuprolide|leuprolide|mesh-list
25748627|NCT02278185|Goserelin|goserelin|mesh-list
25748628|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25748629|NCT02278185|Tryptophan|tryptophan|mesh-list
25748630|NCT02278185|Androgens|androgens|mesh-list
25748631|NCT02278185|Hormones|hormones|mesh-ancestor
25748632|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25748633|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748634|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25748635|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
25748636|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25748637|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25748638|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748639|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
25748640|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25748641|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
25748642|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25748643|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25748644|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
25748645|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25748646|NCT02154529|Trastuzumab|trastuzumab|mesh-list
25748647|NCT02154529|XL647|xl647|mesh-list
25748648|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748649|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748650|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748651|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748652|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748653|NCT02149277|Lenograstim|lenograstim|mesh-list
25748654|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25748655|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
25748656|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748657|NCT02120807|Cisplatin|cisplatin|mesh-list
25748658|NCT02120807|Pemetrexed|pemetrexed|mesh-list
25748659|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
25748660|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748661|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748662|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748663|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25748664|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25748665|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748666|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
25748667|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748668|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748669|NCT02062489|Tamoxifen|tamoxifen|mesh-list
25748670|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25748671|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
25748672|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25748673|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748674|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25748675|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748676|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25748677|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25748678|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25748679|NCT02060721|Macitentan|macitentan|mesh-list
25748680|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25748681|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25748682|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748683|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25748684|NCT01821781|Fludarabine|fludarabine|mesh-list
25748685|NCT01821781|Melphalan|melphalan|mesh-list
25748686|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
25748687|NCT01821781|Thiotepa|thiotepa|mesh-list
25748688|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748689|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748690|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748691|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
25748692|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748693|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25748694|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
25748695|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25748696|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748697|NCT01785420|Trastuzumab|trastuzumab|mesh-list
25748698|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748699|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748700|NCT01685814|Lenalidomide|lenalidomide|mesh-list
25748702|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
25748703|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748704|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748705|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748706|NCT01685814|Growth Substances|growth substances|mesh-ancestor
25748707|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748708|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748709|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
25748710|NCT01547468|Narcotics|narcotics|mesh-ancestor
25748711|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25748712|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748713|NCT01547468|Analgesics|analgesics|mesh-ancestor
25748714|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
25748715|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748716|NCT01387763|Interferons|interferons|mesh-list
25748717|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
25748718|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
25748719|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25748720|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25748721|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
25748722|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748723|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
25748724|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748725|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
25748726|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748727|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
25748728|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748729|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748730|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25748731|NCT01330446|Modafinil|modafinil|mesh-list
25748732|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25748733|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748734|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25748735|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25748736|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25748737|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748738|NCT01295645|Cidofovir|cidofovir|mesh-list
25748739|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
25748740|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748741|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748742|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748743|NCT01254864|Prednisone|prednisone|mesh-list
25748744|NCT01254864|Sunitinib|sunitinib|mesh-list
25748745|NCT01254864|Dasatinib|dasatinib|mesh-list
25748746|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
25748747|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748748|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
25748749|NCT01254864|Hormones|hormones|mesh-ancestor
25748750|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25748751|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748752|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25748753|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748754|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748755|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748756|NCT01254864|Growth Substances|growth substances|mesh-ancestor
25748757|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748758|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748759|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748760|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748761|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25748762|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
25748763|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25748764|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
25748765|NCT01246869|Imidazole|imidazole|mesh-list
25748766|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748767|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748768|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
25748769|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
25748770|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748771|NCT01187199|Sirolimus|sirolimus|mesh-list
25748772|NCT01187199|Paclitaxel|paclitaxel|mesh-list
25748773|NCT01187199|Bevacizumab|bevacizumab|mesh-list
25748774|NCT01187199|Carboplatin|carboplatin|mesh-list
25748775|NCT01187199|Sorafenib|sorafenib|mesh-list
25748776|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25748777|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748778|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
25748779|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
25748780|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
25748781|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748782|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748783|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748784|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748785|NCT01187199|Growth Substances|growth substances|mesh-ancestor
25748786|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748787|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748788|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748789|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748790|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748791|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748792|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25748793|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
25748794|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748795|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
25748796|NCT01176474|Nivolumab|nivolumab|mesh-list
25748797|NCT01176474|Ipilimumab|ipilimumab|mesh-list
25748798|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25748799|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
25748800|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748801|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748802|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748803|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25748804|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748805|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25748806|NCT01154920|Paclitaxel|paclitaxel|mesh-list
25748807|NCT01154920|Docetaxel|docetaxel|mesh-list
25748808|NCT01154920|Cisplatin|cisplatin|mesh-list
25748809|NCT01154920|Carboplatin|carboplatin|mesh-list
25748810|NCT01154920|Fluorouracil|fluorouracil|mesh-list
25748811|NCT01154920|Cetuximab|cetuximab|mesh-list
25748812|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25748813|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748814|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
25748815|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
25748816|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
25748817|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748818|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
25748819|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25748820|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748821|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
25748822|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748823|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748824|NCT01015222|Paclitaxel|paclitaxel|mesh-list
25748825|NCT01015222|Bevacizumab|bevacizumab|mesh-list
25748826|NCT01015222|Dasatinib|dasatinib|mesh-list
25748827|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25748828|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748829|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
25748830|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
25748831|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
25748832|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748833|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748834|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748835|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748836|NCT01015222|Growth Substances|growth substances|mesh-ancestor
25748837|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748838|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748839|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748840|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748841|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
25748842|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
25775172|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25748843|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748844|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
25748845|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748846|NCT00800514|Amantadine|amantadine|mesh-list
25748847|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25748848|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25748849|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
25748850|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748851|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
25748852|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748853|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748854|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748855|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748856|NCT00800514|Analgesics|analgesics|mesh-ancestor
25748857|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
25748858|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748859|NCT00788125|Carboplatin|carboplatin|mesh-list
25748860|NCT00788125|Etoposide|etoposide|mesh-list
25748861|NCT00788125|Ifosfamide|ifosfamide|mesh-list
25748862|NCT00788125|Dasatinib|dasatinib|mesh-list
25748863|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
25748864|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748865|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25748866|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25748867|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25748868|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748869|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748870|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25748871|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
25748872|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748873|NCT00745134|Curcumin|curcumin|mesh-list
25748874|NCT00745134|Capecitabine|capecitabine|mesh-list
25748875|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25748876|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
25748877|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748878|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748879|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25748880|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748881|NCT00745134|Analgesics|analgesics|mesh-ancestor
25748882|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
25748883|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748884|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748885|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748886|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748887|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748888|NCT00715442|Sunitinib|sunitinib|mesh-list
25748889|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748890|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748891|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748892|NCT00715442|Growth Substances|growth substances|mesh-ancestor
25748893|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748894|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748895|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25748896|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748897|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748898|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
25748899|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
25748900|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748901|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
25748902|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748903|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
25748904|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
25748905|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748906|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
25748907|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748908|NCT00200200|Bevacizumab|bevacizumab|mesh-list
25748909|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25748910|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748911|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748912|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748913|NCT00200200|Growth Substances|growth substances|mesh-ancestor
25748914|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748915|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748916|NCT00199862|Antibodies|antibodies|mesh-list
25748917|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
25748918|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748919|NCT02777554|Thalidomide|thalidomide|mesh-list
25748920|NCT02777554|Apremilast|apremilast|mesh-list
25748921|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25748922|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748923|NCT02777554|Analgesics|analgesics|mesh-ancestor
25748924|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
25748925|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748926|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748927|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748928|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748929|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25748930|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25748931|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25748932|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748933|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25748934|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
25748935|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
25748936|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25748937|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25748938|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25748939|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25748940|NCT02777554|Growth Substances|growth substances|mesh-ancestor
25748941|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
25748942|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25748943|NCT02777749|Bupivacaine|bupivacaine|mesh-list
25748944|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
25748945|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
25748946|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25748947|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748948|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
25748949|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748950|NCT02777970|Acetaminophen|acetaminophen|mesh-list
25748951|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25748952|NCT02777970|Tramadol|tramadol|mesh-list
25748953|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25748954|NCT02777970|Analgesics|analgesics|mesh-ancestor
25748955|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
25748956|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748957|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748958|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
25748959|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25748960|NCT02777970|Narcotics|narcotics|mesh-ancestor
25748961|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25748962|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25748963|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748964|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25748965|NCT02778100|Phenylephrine|phenylephrine|mesh-list
25748966|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
25748967|NCT02778100|Glucagon|glucagon|mesh-list
25748968|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25748969|NCT02778100|Hormones|hormones|mesh-ancestor
25748970|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25748971|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748972|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25748973|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25748974|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
25748975|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25748976|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748977|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
25748978|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
25748979|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25748980|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
25748981|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25748982|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
25748983|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25748984|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
25748985|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25748986|NCT02778100|Protective Agents|protective agents|mesh-ancestor
25748987|NCT02778113|Glucagon|glucagon|mesh-list
25748988|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25748989|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25748990|NCT02778113|Hormones|hormones|mesh-ancestor
25748991|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775173|NCT03996694|Narcotics|narcotics|mesh-ancestor
25748992|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25748994|NCT02778867|Fluticasone|fluticasone|mesh-list
25748995|NCT02778867|Xhance|xhance|mesh-list
25748996|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25748997|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25748998|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
25748999|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749000|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749001|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25749002|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749003|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
25749004|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25749005|NCT02778880|Fentanyl|fentanyl|mesh-list
25749006|NCT02778880|Ketamine|ketamine|mesh-list
25749007|NCT02778880|Analgesics|analgesics|mesh-ancestor
25749008|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
25749009|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749010|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749011|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25749012|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25749013|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
25749014|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
25749015|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749016|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25749017|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25749018|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749019|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749020|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25749021|NCT02778880|Narcotics|narcotics|mesh-ancestor
25749022|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25749023|NCT02779166|Celecoxib|celecoxib|mesh-list
25749024|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25749025|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749026|NCT02779166|Analgesics|analgesics|mesh-ancestor
25749027|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
25749028|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749029|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749030|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749031|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749032|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25749033|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25749034|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749035|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749036|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25749037|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25749038|NCT02780167|Abrocitinib|abrocitinib|mesh-list
25749039|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25749040|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749041|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749042|NCT02780622|Oseltamivir|oseltamivir|mesh-list
25749043|NCT02780622|Warfarin|warfarin|mesh-list
25749044|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
25749045|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
25749046|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749047|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749048|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749049|NCT02780687|Afatinib|afatinib|mesh-list
25749050|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749051|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25749052|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749053|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749054|NCT02780700|Capecitabine|capecitabine|mesh-list
25749055|NCT02780700|Nintedanib|nintedanib|mesh-list
25749056|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25749057|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
25749058|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749059|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749060|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25749061|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749062|NCT02780869|Thrombin|thrombin|mesh-list
25749063|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25749064|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
25749065|NCT02780869|Coagulants|coagulants|mesh-ancestor
25749066|NCT02781311|Finasteride|finasteride|mesh-list
25320560|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749067|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25749068|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25749069|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749070|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749071|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
25749072|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749073|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749074|NCT02781311|Urological Agents|urological agents|mesh-ancestor
25775174|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775175|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775176|NCT03996694|Analgesics|analgesics|mesh-ancestor
25775177|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
25775178|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775179|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25775180|NCT03988907|Midazolam|midazolam|mesh-list
25775181|NCT03988907|Risdiplam|risdiplam|mesh-list
25775182|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25775183|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25775184|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775185|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775186|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25775187|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25775188|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775189|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25775190|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
25775191|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
25775192|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
25775193|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
25775194|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775195|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775196|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25775197|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775198|NCT03988088|Lasmiditan|lasmiditan|mesh-list
25775199|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25775200|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
25775201|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775202|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775203|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775204|NCT03980522|Rilonacept|rilonacept|mesh-list
25775205|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25775206|NCT03999684|Tretinoin|tretinoin|mesh-list
25775207|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775208|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
25775209|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775210|NCT03993392|Buprenorphine|buprenorphine|mesh-list
25775211|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25775212|NCT03993392|Narcotics|narcotics|mesh-ancestor
25775213|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775214|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775215|NCT03993392|Analgesics|analgesics|mesh-ancestor
25775216|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
25775217|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775218|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25775219|NCT03989427|Listerine|listerine|mesh-list
25775220|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
25775221|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
25775222|NCT03989427|Protective Agents|protective agents|mesh-ancestor
25775223|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775224|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25775225|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775226|NCT03981822|Cantharidin|cantharidin|mesh-list
25775227|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775228|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775229|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
25775230|NCT03992482|Antibodies|antibodies|mesh-list
25775231|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
25775232|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25775233|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25775234|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
25775235|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775236|NCT03993119|Anticoagulants|anticoagulants|mesh-list
25777636|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25777637|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25777638|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25777639|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
25777640|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25749075|NCT02781454|Mexiletine|mexiletine|mesh-list
25749076|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25749077|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25749078|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25749079|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25749080|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749081|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
25749082|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25749083|NCT02781558|Velpatasvir|velpatasvir|mesh-list
25749084|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
25749085|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749086|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
25749087|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25749088|NCT02781571|Velpatasvir|velpatasvir|mesh-list
25749089|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
25749090|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749091|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25749092|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749093|NCT02781649|Ribavirin|ribavirin|mesh-list
25749094|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
25749095|NCT02781649|Grazoprevir|grazoprevir|mesh-list
25749096|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25749097|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
25749098|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749099|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
25749100|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749101|NCT02781818|Triamcinolone|triamcinolone|mesh-list
25749102|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25749103|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25749104|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25749105|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749106|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
25749107|NCT02781818|Hormones|hormones|mesh-ancestor
25749108|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749109|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749110|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25749111|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
25749112|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749113|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749114|NCT02782169|Pregabalin|pregabalin|mesh-list
25749115|NCT02782169|Analgesics|analgesics|mesh-ancestor
25749116|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
25749117|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749118|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749119|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
25749120|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25749121|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25749122|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749123|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25749124|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25749125|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25749126|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749127|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25749128|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
25749129|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25749130|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
25749131|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749132|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
25749133|NCT02782676|Protective Agents|protective agents|mesh-ancestor
25749134|NCT02783170|Vaccines|vaccines|mesh-list
25749135|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
25749136|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749137|NCT02783443|Anesthetics|anesthetics|mesh-list
25749138|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749139|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749140|NCT02783599|Doxorubicin|doxorubicin|mesh-list
25749141|NCT02783599|Olaratumab|olaratumab|mesh-list
25749142|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25749143|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749144|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25749145|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25749146|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749147|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859998|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
25749148|NCT02783729|Zolpidem|zolpidem|mesh-list
25749149|NCT02783729|Lemborexant|lemborexant|mesh-list
25749151|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25749152|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749153|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749154|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25749155|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
25749156|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
25749157|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749158|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749159|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25749160|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25749161|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
25749162|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25749163|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
25749164|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749165|NCT02785159|Tazarotene|tazarotene|mesh-list
25749166|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25749167|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
25749168|NCT02785172|Clobetasol|clobetasol|mesh-list
25749169|NCT02785172|Halobetasol|halobetasol|mesh-list
25749170|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25749171|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749172|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
25749173|NCT02785172|Hormones|hormones|mesh-ancestor
25749174|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749175|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749176|NCT02785185|Clobetasol|clobetasol|mesh-list
25749177|NCT02785185|Halobetasol|halobetasol|mesh-list
25749178|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25749179|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749180|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
25749181|NCT02785185|Hormones|hormones|mesh-ancestor
25749182|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749183|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749184|NCT02785406|Suvorexant|suvorexant|mesh-list
25749185|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25749186|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25749187|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749188|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749189|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25749190|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749191|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749192|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
25749193|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25749194|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749195|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25749196|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25749197|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749198|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749199|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749200|NCT02785900|Azacitidine|azacitidine|mesh-list
25749201|NCT02785900|Decitabine|decitabine|mesh-list
25749202|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25749203|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
25749204|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749205|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749206|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749207|NCT02785939|Docetaxel|docetaxel|mesh-list
25749208|NCT02785939|Palbociclib|palbociclib|mesh-list
25749209|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749210|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25749211|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25749212|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25749213|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749214|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25749215|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749216|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
25749217|NCT02786719|Cisplatin|cisplatin|mesh-list
25749218|NCT02786719|Doxorubicin|doxorubicin|mesh-list
25749219|NCT02786719|Etoposide|etoposide|mesh-list
25749220|NCT02786719|Vincristine|vincristine|mesh-list
25749221|NCT02786719|Topotecan|topotecan|mesh-list
25749222|NCT02786719|Sargramostim|sargramostim|mesh-list
25749223|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25749224|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
25749225|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749226|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749227|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25749228|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
25749229|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749230|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749231|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25749232|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25749233|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25749234|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25749235|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749236|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25749237|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
25749238|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
25749239|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
25749240|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25749241|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25749242|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25749243|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
25749244|NCT02787057|Vancomycin|vancomycin|mesh-list
25749245|NCT02787057|Ceftazidime|ceftazidime|mesh-list
25749246|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25749247|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749248|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25749249|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25749250|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749251|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749252|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749253|NCT02787083|Mirabegron|mirabegron|mesh-list
25749254|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25749255|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25749256|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25749257|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749258|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749259|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749260|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749261|NCT02787083|Urological Agents|urological agents|mesh-ancestor
25749262|NCT02787304|Volixibat|volixibat|mesh-list
25749263|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25749264|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25749265|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
25749266|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749267|NCT02788019|Ropivacaine|ropivacaine|mesh-list
25749268|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
25749269|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
25749270|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749271|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749272|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
25749273|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749274|NCT02788097|Progesterone|progesterone|mesh-list
25749275|NCT02788097|Progestins|progestins|mesh-ancestor
25749276|NCT02788097|Hormones|hormones|mesh-ancestor
25749277|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749278|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749279|NCT02788175|Vedolizumab|vedolizumab|mesh-list
25749280|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25749281|NCT02788279|Atezolizumab|atezolizumab|mesh-list
25749282|NCT02788279|Antibodies|antibodies|mesh-list
25749283|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
25749284|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749285|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749286|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25749287|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25749288|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25749289|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25749290|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749291|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749292|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749293|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749294|NCT02788474|Nintedanib|nintedanib|mesh-list
25749295|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749296|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25749297|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749298|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320891|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749300|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
25749301|NCT02788656|Valsartan|valsartan|mesh-list
25749302|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
25749303|NCT02788656|Giapreza|giapreza|mesh-list
25749304|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
25749305|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25749306|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25749307|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25749308|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25749309|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
25749310|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25749311|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749312|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
25749313|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25749314|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25749315|NCT02789033|Isosorbide|isosorbide|mesh-list
25749316|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25749317|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25749318|NCT02789033|Chitosan|chitosan|mesh-list
25749319|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25749320|NCT02789033|Diuretics|diuretics|mesh-ancestor
25749321|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
25749322|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749323|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
25749324|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25749325|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749326|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25749327|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25749328|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
25749329|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25749330|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
25749331|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
25749332|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
25749333|NCT02789033|Coagulants|coagulants|mesh-ancestor
25749334|NCT02789111|Alvimopan|alvimopan|mesh-list
25749335|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25749336|NCT02789410|Morphine|morphine|mesh-list
25749337|NCT02789410|Hydromorphone|hydromorphone|mesh-list
25749338|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25749339|NCT02789410|Narcotics|narcotics|mesh-ancestor
25749340|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749341|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749342|NCT02789410|Analgesics|analgesics|mesh-ancestor
25749343|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
25749344|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749345|NCT02790736|Propranolol|propranolol|mesh-list
25749346|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25749347|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25749348|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749349|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749350|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749351|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749352|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25749353|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25749354|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
25749355|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
25749356|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25749357|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25749358|NCT02790788|Prednisolone|prednisolone|mesh-list
25749359|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
25749360|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
25749361|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25749362|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25749363|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
25749364|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749365|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
25749366|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
25749367|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749368|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749369|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25749370|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
25749371|NCT02790788|Hormones|hormones|mesh-ancestor
25749372|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749373|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25749374|NCT02790788|Protective Agents|protective agents|mesh-ancestor
25749375|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25749376|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749377|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25749378|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
25749379|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749380|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
25749382|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25749383|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749384|NCT02791308|Analgesics|analgesics|mesh-ancestor
25749385|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
25749386|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749387|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749388|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749389|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749390|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
25749391|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25749392|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
25749393|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25749394|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749395|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749396|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25749397|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25749398|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25749399|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749400|NCT02791490|Metformin|metformin|mesh-list
25749401|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25749402|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25749403|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749404|NCT02791490|Incretins|incretins|mesh-ancestor
25749405|NCT02791490|Hormones|hormones|mesh-ancestor
25749406|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749407|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25749408|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
25749409|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749410|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775237|NCT03988803|Memantine|memantine|mesh-list
25775238|NCT03988803|BI 425809|bi 425809|mesh-list
25775239|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25775240|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25775241|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
25775242|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775243|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775244|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775245|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25775246|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25775247|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
25775248|NCT03987191|Insulin|insulin|mesh-list
25775249|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
25775250|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25775251|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25775252|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775253|NCT03988842|Heparin|heparin|mesh-list
25775254|NCT03988842|Calcium heparin|calcium heparin|mesh-list
25775255|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25775256|NCT03988842|Plasminogen|plasminogen|mesh-list
25775257|NCT03988842|Apixaban|apixaban|mesh-list
25775258|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
25775259|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25775260|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25775261|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775262|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25775263|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
25775264|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25775265|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
25775266|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775267|NCT03981861|Metformin|metformin|mesh-list
25775268|NCT03981861|Spironolactone|spironolactone|mesh-list
25775269|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25775270|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775271|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25775272|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
25775273|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775274|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25775275|NCT03981861|Diuretics|diuretics|mesh-ancestor
25321120|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
25749411|NCT02791763|Glycine|glycine|mesh-list
25749412|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
25749413|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749414|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749415|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749416|NCT02791906|Ascorbic Acid|ascorbic acid|mesh-list
25749417|NCT02791906|Vitamins|vitamins|mesh-ancestor
25749418|NCT02791906|Micronutrients|micronutrients|mesh-ancestor
25749419|NCT02791906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749420|NCT02791906|Antioxidants|antioxidants|mesh-ancestor
25749421|NCT02791906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749422|NCT02791906|Protective Agents|protective agents|mesh-ancestor
25749423|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
25749424|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25749425|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
25749426|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749427|NCT02791945|Expectorants|expectorants|mesh-ancestor
25749428|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749429|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25749430|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
25749431|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749432|NCT02791945|Protective Agents|protective agents|mesh-ancestor
25749433|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749434|NCT02791945|Antidotes|antidotes|mesh-ancestor
25749435|NCT02792062|Relugolix|relugolix|mesh-list
25749436|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
25749437|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
25749438|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749439|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749440|NCT02792192|Atezolizumab|atezolizumab|mesh-list
25749441|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749442|NCT02792218|Teriflunomide|teriflunomide|mesh-list
25749443|NCT02792218|Ofatumumab|ofatumumab|mesh-list
25749444|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25749445|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749446|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
25749447|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749448|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25749449|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749450|NCT02792218|Analgesics|analgesics|mesh-ancestor
25749451|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
25749452|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749453|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749454|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749455|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25749456|NCT02792231|Teriflunomide|teriflunomide|mesh-list
25749457|NCT02792231|Ofatumumab|ofatumumab|mesh-list
25749458|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25749459|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749460|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
25749461|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749462|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25749463|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749464|NCT02792231|Analgesics|analgesics|mesh-ancestor
25749465|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
25749466|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749467|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749468|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749469|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25749470|NCT02792517|Erenumab|erenumab|mesh-list
25749471|NCT02792517|Norgestimate|norgestimate|mesh-list
25749472|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
25749473|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
25749474|NCT02792517|Estradiol|estradiol|mesh-list
25749475|NCT02792517|Estrogens|estrogens|mesh-ancestor
25749476|NCT02792517|Hormones|hormones|mesh-ancestor
25749477|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749478|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749479|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25749480|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25749481|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25749482|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25749483|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749484|NCT02792517|Analgesics|analgesics|mesh-ancestor
25749485|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
25749486|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749487|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25749489|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25749490|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749491|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
25749492|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749493|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749494|NCT02792829|Lenvatinib|lenvatinib|mesh-list
25749495|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749496|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25749497|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749498|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749499|NCT02793128|Mitomycins|mitomycins|mesh-list
25749500|NCT02793128|Mitomycin|mitomycin|mesh-list
25749501|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25749502|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749503|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
25749504|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749505|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25749506|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749507|NCT02793154|Exenatide|exenatide|mesh-list
25749508|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
25749509|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25749510|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749511|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25749512|NCT02793154|Incretins|incretins|mesh-ancestor
25749513|NCT02793154|Hormones|hormones|mesh-ancestor
25749514|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749515|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
25749516|NCT02793622|Piperaquine|piperaquine|mesh-list
25749517|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
25749518|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25749519|NCT02793622|Artenimol|artenimol|mesh-list
25749520|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
25749521|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25749522|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25749523|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749524|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25749525|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749526|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749527|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25749528|NCT02793622|Renal Agents|renal agents|mesh-ancestor
25749529|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25749530|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25749531|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
25749532|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25749533|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
25749534|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749535|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749536|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25749537|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
25749538|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749539|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749540|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25749541|NCT02793947|Epinephrine|epinephrine|mesh-list
25749542|NCT02793947|Morphine|morphine|mesh-list
25749543|NCT02793947|Ropivacaine|ropivacaine|mesh-list
25749544|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25749545|NCT02793947|Narcotics|narcotics|mesh-ancestor
25749546|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749547|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749548|NCT02793947|Analgesics|analgesics|mesh-ancestor
25749549|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
25749550|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749551|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
25749552|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
25749553|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25749554|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25749555|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749556|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749557|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749558|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25749559|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24455181|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25749560|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
25775276|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
25749561|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25749562|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749563|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
25749564|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
25749565|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25749566|NCT02794441|Dexamethasone|dexamethasone|mesh-list
25749567|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749568|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
25749569|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
25749570|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749571|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749572|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25749573|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
25749574|NCT02794441|Hormones|hormones|mesh-ancestor
25749575|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749576|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25749577|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749578|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25749579|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749580|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749581|NCT02794974|Anesthetics|anesthetics|mesh-list
25749582|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749583|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749584|NCT02795117|Ivermectin|ivermectin|mesh-list
25749585|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25749586|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749587|NCT02796144|Metformin|metformin|mesh-list
25749588|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25749589|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749590|NCT02796352|Interleukin-2|interleukin-2|mesh-list
25749591|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749592|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749593|NCT02796352|Analgesics|analgesics|mesh-ancestor
25749594|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
25749595|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749596|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749597|NCT02796560|Travoprost|travoprost|mesh-list
25749598|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25749599|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25749600|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
25749601|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25749602|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
25749603|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749604|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749605|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25749606|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749607|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25749608|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25749609|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25749610|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749611|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749612|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749613|NCT02796677|Bromides|bromides|mesh-list
25749614|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
25749615|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
25749616|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25749617|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
25749618|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749619|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749620|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25749621|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749622|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25749623|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25749624|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25749625|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749626|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749627|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749628|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
25749629|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25749630|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
25749631|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
25749632|NCT02796755|Riluzole|riluzole|mesh-list
25321354|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
25321355|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25321362|NCT04920760|Vitamin A|vitamin a|mesh-list
25749633|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
25749634|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25749635|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25749636|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749637|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749638|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749639|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25749640|NCT02796755|Protective Agents|protective agents|mesh-ancestor
25749641|NCT02797080|Interferons|interferons|mesh-list
25749642|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
25749643|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749644|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
25749645|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749646|NCT02797522|Acetaminophen|acetaminophen|mesh-list
25749647|NCT02797522|Tenofovir|tenofovir|mesh-list
25749648|NCT02797522|Entecavir|entecavir|mesh-list
25749649|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
25749650|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25749651|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749652|NCT02797522|Analgesics|analgesics|mesh-ancestor
25749653|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
25749654|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749655|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749656|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
25749657|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
25749658|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749659|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25749660|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25749661|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749662|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749663|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25749664|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25749665|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
25749666|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749667|NCT02797808|Sertraline|sertraline|mesh-list
25749668|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
25749669|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25749670|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25749671|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25749672|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25749673|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749674|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749675|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
25749676|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749677|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25749678|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
25749679|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749680|NCT02798835|Dexamethasone|dexamethasone|mesh-list
25749681|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
25749682|NCT02798835|Fentanyl|fentanyl|mesh-list
25749683|NCT02798835|Bupivacaine|bupivacaine|mesh-list
25749684|NCT02798835|Ropivacaine|ropivacaine|mesh-list
25749685|NCT02798835|BB 1101|bb 1101|mesh-list
25749686|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749687|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
25749688|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
25749689|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749690|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749691|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25749692|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
25749693|NCT02798835|Hormones|hormones|mesh-ancestor
25749694|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749695|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25749696|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749697|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
25749698|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749699|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749700|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
25749701|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
25749702|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749703|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
25749704|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25749705|NCT02798835|Narcotics|narcotics|mesh-ancestor
25749706|NCT02798835|Analgesics|analgesics|mesh-ancestor
25749707|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25749708|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25749709|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
25749710|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25749711|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25749712|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
25749713|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25749714|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25749715|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25749716|NCT02799381|Levodopa|levodopa|mesh-list
25749717|NCT02799381|Carbidopa|carbidopa|mesh-list
25749718|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25749719|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
25749720|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25749721|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
25749722|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749723|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749724|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749725|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25749726|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749727|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25749728|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
25749729|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
25749730|NCT02799784|Albuterol|albuterol|mesh-list
25749731|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25749732|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
25749733|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749734|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749735|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25749736|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749737|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
25749738|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25749739|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25749740|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25749741|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25749742|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749743|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749744|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749745|NCT02800148|Azelaic acid|azelaic acid|mesh-list
25749746|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749747|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
25749748|NCT02800642|Aflibercept|aflibercept|mesh-list
25749749|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25749750|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25749751|NCT02800642|Growth Substances|growth substances|mesh-ancestor
25749752|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749753|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
25749754|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749755|NCT02800928|Aticaprant|aticaprant|mesh-list
25749756|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25749757|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749758|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
25749759|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749760|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
25749761|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25749762|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749763|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25749764|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25749765|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749766|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749767|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749768|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25749769|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25749770|NCT02801617|Latanoprost|latanoprost|mesh-list
25749771|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25749772|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25749773|NCT02801669|Edoxaban|edoxaban|mesh-list
25749774|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25749775|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
25749776|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25749777|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
25749778|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749779|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749780|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
25749781|NCT02802111|Albuterol|albuterol|mesh-list
25749782|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25749783|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
25749784|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749785|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321531|NCT04918524|Analgesics|analgesics|mesh-ancestor
25749786|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25749787|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749788|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
25749789|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25749790|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25749791|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25749792|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25749793|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749794|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749795|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749796|NCT02802241|Peppermint oil|peppermint oil|mesh-list
25749797|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
25749798|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
25749799|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749800|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749801|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25749802|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
25749803|NCT02802345|Nintedanib|nintedanib|mesh-list
25749804|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
25749805|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
25749806|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25749807|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25749808|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749809|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749810|NCT02802345|Urological Agents|urological agents|mesh-ancestor
25749811|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749812|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25749813|NCT02802449|Vitamin D|vitamin d|mesh-list
25749814|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
25749815|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
25749816|NCT02802449|Calcifediol|calcifediol|mesh-list
25749817|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25749818|NCT02802449|Vitamins|vitamins|mesh-list
25749819|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
25749820|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749821|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25749822|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25749823|NCT02802501|Piperaquine|piperaquine|mesh-list
25749824|NCT02802501|Primaquine|primaquine|mesh-list
25749825|NCT02802501|Artenimol|artenimol|mesh-list
25749826|NCT02802501|Tafenoquine|tafenoquine|mesh-list
25749827|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
25749828|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25749829|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25749830|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749831|NCT02802514|Exenatide|exenatide|mesh-list
25749832|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
25749833|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25749834|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25749835|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749836|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25749837|NCT02802514|Incretins|incretins|mesh-ancestor
25749838|NCT02802514|Hormones|hormones|mesh-ancestor
25749839|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749840|NCT02802735|Apremilast|apremilast|mesh-list
25749841|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25749842|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749843|NCT02802735|Analgesics|analgesics|mesh-ancestor
25749844|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
25749845|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749846|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749847|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749848|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749849|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25749850|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25749851|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749852|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775277|NCT03987074|Firsocostat|firsocostat|mesh-list
25775278|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775279|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775280|NCT03979820|Phenelzine|phenelzine|mesh-list
25775281|NCT03979820|Tyramine|tyramine|mesh-list
25775282|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
25321596|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25775283|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775284|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25775285|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749853|NCT02802865|Letrozole|letrozole|mesh-list
25749854|NCT02802865|Clomiphene|clomiphene|mesh-list
25749855|NCT02802865|Enclomiphene|enclomiphene|mesh-list
25749856|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
25749857|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749858|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749859|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25749860|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25749861|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749862|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25749863|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
25749864|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749865|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749866|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25749867|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
25749868|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25749869|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25749870|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25749871|NCT02803138|Ritonavir|ritonavir|mesh-list
25749872|NCT02803138|Ribavirin|ribavirin|mesh-list
25749873|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25749874|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25749875|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
25749876|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749877|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749878|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25749879|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25749880|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
25749881|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749882|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25749883|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25749884|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
25749885|NCT02803229|Amphetamine|amphetamine|mesh-list
25749886|NCT02803229|Adderall|adderall|mesh-list
25749887|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25749888|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749889|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
25749890|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
25749891|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749892|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
25749893|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749894|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749895|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
25749896|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25749897|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25749898|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25749899|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25749900|NCT02803749|Buspirone|buspirone|mesh-list
25749901|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25749902|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25749903|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25749904|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749905|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25749906|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25749907|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
25749908|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25749909|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749910|NCT02804399|Rifampin|rifampin|mesh-list
25749911|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25749912|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
25749913|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25749914|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749915|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
25749916|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25749917|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749918|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749919|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25749920|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25749921|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25749922|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25749923|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25749924|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25749925|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
25321664|NCT04917484|Octreotide|octreotide|mesh-list
25749926|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25749927|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
25749928|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749929|NCT02804594|Expectorants|expectorants|mesh-ancestor
25749930|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
25749931|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25749932|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
25749933|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749934|NCT02804594|Protective Agents|protective agents|mesh-ancestor
25749935|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749936|NCT02804594|Antidotes|antidotes|mesh-ancestor
25749937|NCT02805179|Temozolomide|temozolomide|mesh-list
25749938|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25749939|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
25749940|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749941|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749942|NCT02805660|Durvalumab|durvalumab|mesh-list
25749943|NCT02805660|Mocetinostat|mocetinostat|mesh-list
25749944|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25749945|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749946|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25749947|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749948|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749949|NCT02805907|Calcifediol|calcifediol|mesh-list
25749950|NCT02805907|Vitamins|vitamins|mesh-ancestor
25749951|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
25749952|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749953|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25749954|NCT02805972|Naloxone|naloxone|mesh-list
25749955|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25749956|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749957|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
25749958|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749959|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
25749960|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25749961|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25749962|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749963|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
25749964|NCT02806024|Coagulants|coagulants|mesh-ancestor
25749965|NCT02806232|Praziquantel|praziquantel|mesh-list
25749966|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
25749967|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25749968|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749969|NCT02806414|Ivermectin|ivermectin|mesh-list
25749970|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25749971|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749972|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25749973|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
25749974|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25749975|NCT02806544|Tamoxifen|tamoxifen|mesh-list
25749976|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25749977|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
25749978|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25749979|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749980|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25749981|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25749982|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25749983|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25749984|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25749985|NCT02806869|Ibuprofen|ibuprofen|mesh-list
25749986|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25749987|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25749988|NCT02806869|Analgesics|analgesics|mesh-ancestor
25749989|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
25749990|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25749991|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25749992|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25749993|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25749994|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25749995|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25749996|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25749997|NCT02806947|Sirolimus|sirolimus|mesh-list
25749998|NCT02806947|Prednisone|prednisone|mesh-list
25749999|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750000|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
25750001|NCT02806947|Hormones|hormones|mesh-ancestor
25750002|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750003|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750004|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25750005|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750006|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25750007|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750008|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25750009|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
25750010|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25750011|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
25750012|NCT02806973|Glucagon|glucagon|mesh-list
25750013|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750014|NCT02806973|Hormones|hormones|mesh-ancestor
25750015|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750016|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750017|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
25750018|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
25750019|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25750020|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25750021|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
25750022|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750023|NCT02807623|Ibuprofen|ibuprofen|mesh-list
25750024|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750025|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750026|NCT02807623|Analgesics|analgesics|mesh-ancestor
25750027|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
25750028|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750029|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750030|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750031|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750032|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25750033|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750034|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750035|NCT02807844|Spartalizumab|spartalizumab|mesh-list
25750036|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25750037|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750038|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750039|NCT02808052|Minocycline|minocycline|mesh-list
25750040|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25750041|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750042|NCT02808819|Benralizumab|benralizumab|mesh-list
25750043|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25750044|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
25750045|NCT02808975|Adalimumab|adalimumab|mesh-list
25750046|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750047|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750048|NCT02809053|Rituximab|rituximab|mesh-list
25750049|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25750050|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750051|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
25750052|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750053|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750054|NCT02810392|Insulin|insulin|mesh-list
25750055|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25750056|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750057|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750058|NCT02810873|Copper|copper|mesh-list
25750059|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
25750060|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25750061|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25750062|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750063|NCT02810873|Trace Elements|trace elements|mesh-ancestor
25750064|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
25750065|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750066|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
25750067|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
25750068|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750069|NCT02810964|Sulforaphane|sulforaphane|mesh-list
25750070|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25750071|NCT02810964|Protective Agents|protective agents|mesh-ancestor
25750072|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750073|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321828|NCT04916093|Incretins|incretins|mesh-ancestor
24571474|NCT00810316|Clonazepam|clonazepam|mesh-list
25321829|NCT04916093|Hormones|hormones|mesh-ancestor
25750074|NCT02812186|Rocuronium|rocuronium|mesh-list
25777641|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
25750075|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25750076|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25750077|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25750078|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750079|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750080|NCT02812238|Niacinamide|niacinamide|mesh-list
25750081|NCT02812238|Niacin|niacin|mesh-list
25750082|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
25750083|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
25750084|NCT02812238|Vitamins|vitamins|mesh-ancestor
25750085|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
25750086|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750087|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25750088|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
25750089|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750090|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25750091|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
25750092|NCT02812342|Tofacitinib|tofacitinib|mesh-list
25750093|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25750094|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750095|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750096|NCT02812771|Efinaconazole|efinaconazole|mesh-list
25750097|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
25750098|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750099|NCT02813070|Flutemetamol|flutemetamol|mesh-list
25750100|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25750101|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750102|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25750103|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25750104|NCT02813551|Torsemide|torsemide|mesh-list
25750105|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25750106|NCT02813551|Diuretics|diuretics|mesh-ancestor
25750107|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
25750108|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750109|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25750110|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750111|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750112|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
25750113|NCT02813694|Lefamulin|lefamulin|mesh-list
25750114|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25750115|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750116|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25750117|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25750118|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750119|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750120|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750121|NCT02814175|Adalimumab|adalimumab|mesh-list
25750122|NCT02814175|Methotrexate|methotrexate|mesh-list
25750123|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25750124|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
25750125|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25750126|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750127|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25750128|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
25750129|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750130|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750131|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
25750132|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750133|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25750134|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25750135|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
25750136|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750137|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25750138|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750139|NCT02814279|Dipyrone|dipyrone|mesh-list
25750140|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
25750141|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25750142|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750143|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
25750144|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750145|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750146|NCT02814279|Analgesics|analgesics|mesh-ancestor
25750147|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
25750148|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750149|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750150|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750151|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750152|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
25750153|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
25750154|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25750155|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
25750156|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25750157|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25750158|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750159|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25750160|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750161|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25750162|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750163|NCT02814643|Benralizumab|benralizumab|mesh-list
25750164|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25750165|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
25750166|NCT02815644|Empagliflozin|empagliflozin|mesh-list
25750167|NCT02815644|Linagliptin|linagliptin|mesh-list
25750168|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25750169|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750170|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750171|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750172|NCT02815644|Incretins|incretins|mesh-ancestor
25750173|NCT02815644|Hormones|hormones|mesh-ancestor
25750174|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750175|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25750176|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
25750177|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750178|NCT02815709|Morphine|morphine|mesh-list
25750179|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25750180|NCT02815709|Narcotics|narcotics|mesh-ancestor
25750181|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750182|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750183|NCT02815709|Analgesics|analgesics|mesh-ancestor
25750184|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
25750185|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750186|NCT02816138|Nicotine|nicotine|mesh-list
25750187|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25750188|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
25750189|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750190|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750191|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25750192|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25750193|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
25750194|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750195|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775286|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775287|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
25775288|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
25775289|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775290|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775291|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25775292|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25775293|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25775294|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
25775295|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775296|NCT03972137|Nicotine|nicotine|mesh-list
25775297|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25775298|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
25775299|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775300|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775301|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25775302|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25775303|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
25775304|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775305|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775306|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
25775307|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
25775308|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775309|NCT03984838|Dolutegravir|dolutegravir|mesh-list
25775310|NCT03984838|Rilpivirine|rilpivirine|mesh-list
25775311|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
25775312|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25775313|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25775314|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750196|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
25750197|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
25750198|NCT02817555|Hematinics|hematinics|mesh-ancestor
25750199|NCT02817763|Dipyrone|dipyrone|mesh-list
25750200|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750201|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750202|NCT02817763|Analgesics|analgesics|mesh-ancestor
25750203|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
25750204|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750205|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750206|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750207|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750208|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
25750209|NCT02817828|Drospirenone|drospirenone|mesh-list
25750210|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25750211|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
25750212|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750213|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750214|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25750215|NCT02817828|Diuretics|diuretics|mesh-ancestor
25750216|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
25750217|NCT02817841|Drospirenone|drospirenone|mesh-list
25750218|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25750219|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
25750220|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750221|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750222|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25750223|NCT02817841|Diuretics|diuretics|mesh-ancestor
25750224|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
25750225|NCT02818036|Naltrexone|naltrexone|mesh-list
25750226|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25750227|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25750228|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750229|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
25750230|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750231|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
25750232|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25750233|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750234|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750235|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750236|NCT02818569|Analgesics|analgesics|mesh-ancestor
25750237|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
25750238|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750239|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25750240|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25750241|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25750242|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
25750243|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750244|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750245|NCT02818777|Cannabidiol|cannabidiol|mesh-list
25750246|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
25750247|NCT02818998|Aflibercept|aflibercept|mesh-list
25750248|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25750249|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25750250|NCT02818998|Growth Substances|growth substances|mesh-ancestor
25750251|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750252|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
25750253|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750254|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25750255|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25750256|NCT02819297|Laxatives|laxatives|mesh-list
25750257|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750258|NCT02819310|Laxatives|laxatives|mesh-list
25750259|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750260|NCT02819726|Rituximab|rituximab|mesh-list
25750261|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25750262|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750263|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
25750264|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750265|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750266|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
25750267|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750268|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322130|NCT04912258|Irinotecan|irinotecan|mesh-list
25750269|NCT02820324|Morphine|morphine|mesh-list
25750270|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25750271|NCT02820324|Narcotics|narcotics|mesh-ancestor
25750272|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750273|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750274|NCT02820324|Analgesics|analgesics|mesh-ancestor
25750275|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
25750276|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750277|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25750278|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750279|NCT02821338|Lamotrigine|lamotrigine|mesh-list
25750280|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
25750281|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25750282|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750283|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750284|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25750285|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750286|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25750287|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25750288|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750289|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25750290|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25750291|NCT02821416|Benralizumab|benralizumab|mesh-list
25750292|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25750293|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
25750294|NCT02821715|Flecainide|flecainide|mesh-list
25750295|NCT02821715|Modafinil|modafinil|mesh-list
25750296|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25750297|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750298|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25750299|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25750300|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25750301|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750302|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25750303|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25750304|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25750305|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750306|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25750307|NCT02821819|Hormones|hormones|mesh-ancestor
25750308|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750309|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750310|NCT02821910|Metformin|metformin|mesh-list
25750311|NCT02821910|Empagliflozin|empagliflozin|mesh-list
25750312|NCT02821910|Linagliptin|linagliptin|mesh-list
25750313|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750314|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750315|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25750316|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750317|NCT02821910|Incretins|incretins|mesh-ancestor
25750318|NCT02821910|Hormones|hormones|mesh-ancestor
25750319|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750320|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25750321|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
25750322|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750323|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
25750324|NCT02822222|Cathartics|cathartics|mesh-ancestor
25750325|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750326|NCT02822794|Ribavirin|ribavirin|mesh-list
25750327|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
25750328|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25750329|NCT02822794|Velpatasvir|velpatasvir|mesh-list
25750330|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
25750331|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750332|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
25750333|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750334|NCT02822950|Ceftazidime|ceftazidime|mesh-list
25750335|NCT02822950|Avibactam|avibactam|mesh-list
25750336|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25750337|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25750338|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750339|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25750340|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750341|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750342|NCT02823080|Cetrorelix|cetrorelix|mesh-list
25750343|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25750344|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
25322218|NCT04910347|Nivolumab|nivolumab|mesh-list
25750345|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25750346|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750347|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25750348|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750349|NCT02823431|Lidocaine|lidocaine|mesh-list
25750350|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
25750351|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
25750352|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750353|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750354|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
25750355|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750356|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25750357|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25750358|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25750359|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750360|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750361|NCT02823470|Ivacaftor|ivacaftor|mesh-list
25750362|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25750363|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750364|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750365|NCT02824224|Tamoxifen|tamoxifen|mesh-list
25750366|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25750367|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
25750368|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750369|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750370|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25750371|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750372|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25750373|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25750374|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25750375|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25750376|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25775315|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775316|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25775317|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25775318|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
25775319|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775320|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25775321|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25775322|NCT03983941|Ropivacaine|ropivacaine|mesh-list
25775323|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
25775324|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
25775325|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775326|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775327|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
25775328|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775329|NCT03976752|Tenofovir|tenofovir|mesh-list
25775330|NCT03976752|Emtricitabine|emtricitabine|mesh-list
25775331|NCT03976752|Cobicistat|cobicistat|mesh-list
25775332|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25775333|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25775334|NCT03976752|Elvitegravir|elvitegravir|mesh-list
25775335|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
25775336|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775337|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25775338|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25775339|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775340|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775341|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25775342|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25775343|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25775344|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25775345|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25775346|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25775347|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25775348|NCT03976466|Calcium|calcium|mesh-list
25775349|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25775350|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775351|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775352|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
25775353|NCT03979066|Atezolizumab|atezolizumab|mesh-list
25750378|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25750379|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25750380|NCT02825212|Ledipasvir|ledipasvir|mesh-list
25750381|NCT02825212|Velpatasvir|velpatasvir|mesh-list
25750382|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
25750383|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750384|NCT02825251|Insulin|insulin|mesh-list
25750385|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25750386|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
25750387|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
25750388|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25750389|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750390|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750391|NCT02825420|Trabectedin|trabectedin|mesh-list
25750392|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25750393|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
25750394|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750395|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750396|NCT02826603|Ustekinumab|ustekinumab|mesh-list
25750397|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
25750398|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
25750399|NCT02828358|Leucovorin|leucovorin|mesh-list
25750400|NCT02828358|Folic Acid|folic acid|mesh-list
25750401|NCT02828358|Cytarabine|cytarabine|mesh-list
25750402|NCT02828358|Dexamethasone|dexamethasone|mesh-list
25750403|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
25750404|NCT02828358|Prednisolone|prednisolone|mesh-list
25750405|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25750406|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
25750407|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25750408|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
25750409|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
25750410|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25750411|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25750412|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25750413|NCT02828358|Cortisone|cortisone|mesh-list
25750414|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
25750415|NCT02828358|Methotrexate|methotrexate|mesh-list
25750416|NCT02828358|Vincristine|vincristine|mesh-list
25750417|NCT02828358|Azacitidine|azacitidine|mesh-list
25750418|NCT02828358|Daunorubicin|daunorubicin|mesh-list
25750419|NCT02828358|Asparaginase|asparaginase|mesh-list
25750420|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
25750421|NCT02828358|Pegaspargase|pegaspargase|mesh-list
25750422|NCT02828358|Thioguanine|thioguanine|mesh-list
25750423|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25750424|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
25750425|NCT02828358|BB 1101|bb 1101|mesh-list
25750426|NCT02828358|Calcium|calcium|mesh-list
25750427|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
25750428|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
25750429|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25750430|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
25750431|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750432|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750433|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25750434|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
25750435|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750436|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750437|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25750438|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750439|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
25750440|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
25750441|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750442|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750443|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
25750444|NCT02828358|Hormones|hormones|mesh-ancestor
25750445|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750446|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25750447|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
25750448|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750449|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25750450|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25750451|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25750452|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
25750453|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25750454|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25750455|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
25750456|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
25750457|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25750458|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25750459|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
25750460|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750462|NCT02828358|Protective Agents|protective agents|mesh-ancestor
25750463|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
25750464|NCT02828358|Vitamins|vitamins|mesh-ancestor
25750465|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
25750466|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25750467|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25750468|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25750469|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25750470|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25750471|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25750472|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25750473|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25750474|NCT02828358|Hematinics|hematinics|mesh-ancestor
25750475|NCT02829034|Ranolazine|ranolazine|mesh-list
25750476|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25750477|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750478|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750479|NCT02829775|Interferons|interferons|mesh-list
25750480|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
25750481|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
25750482|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25750483|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750484|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
25750485|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750486|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
25750487|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750488|NCT02829944|Ketorolac|ketorolac|mesh-list
25750489|NCT02829944|Ropivacaine|ropivacaine|mesh-list
25750490|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
25750491|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
25750492|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750493|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750494|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
25750495|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750496|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750497|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750498|NCT02829944|Analgesics|analgesics|mesh-ancestor
25750499|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750500|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750501|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25750502|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750503|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750504|NCT02829983|Clarithromycin|clarithromycin|mesh-list
25750505|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25750506|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750507|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25750508|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750509|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750510|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25750511|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25750512|NCT02829996|Latanoprost|latanoprost|mesh-list
25750513|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25750514|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25750515|NCT02830776|Bimatoprost|bimatoprost|mesh-list
25750516|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25750517|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25750518|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25750519|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25750520|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25750521|NCT02831569|Loxoprofen|loxoprofen|mesh-list
25750522|NCT02831569|Methocarbamol|methocarbamol|mesh-list
25750523|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750524|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750525|NCT02831569|Analgesics|analgesics|mesh-ancestor
25750526|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
25750527|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750528|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750529|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750530|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750531|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25750532|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25750534|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
25750535|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25750536|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25750537|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750538|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750539|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750540|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
25750541|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
25750542|NCT02831855|Methotrexate|methotrexate|mesh-list
25750543|NCT02831855|Tofacitinib|tofacitinib|mesh-list
25750544|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25750545|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
25750546|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25750547|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750548|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25750549|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
25750550|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750551|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750552|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
25750553|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750554|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25750555|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25750556|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
25750557|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750558|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25750559|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25750560|NCT02831998|Ethanol|ethanol|mesh-list
25750561|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
25750562|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25750563|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25750564|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750565|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750566|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750567|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
25750568|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775354|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775355|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
25775356|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25775357|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775358|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25775359|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
25775360|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775361|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
25775362|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775363|NCT03966365|Timolol|timolol|mesh-list
25775364|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25775365|NCT03966365|Dorzolamide|dorzolamide|mesh-list
25775366|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25775367|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25775368|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
25775369|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775370|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775371|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775372|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25775373|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25775374|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25775375|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25775376|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25775377|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25775378|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775379|NCT03965351|Probenecid|probenecid|mesh-list
25775380|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
25775381|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
25775382|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25775383|NCT03965351|Renal Agents|renal agents|mesh-ancestor
25775384|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
25775385|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25775386|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
25775387|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775388|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775389|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25775390|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775391|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
25775392|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25750570|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
25750571|NCT02832115|Lidocaine|lidocaine|mesh-list
25750572|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
25750573|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
25750574|NCT02832115|Anesthetics|anesthetics|mesh-list
25750575|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750576|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750577|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
25750578|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750579|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25750580|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25750581|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25750582|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750583|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750584|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
25750585|NCT02832375|Fluorides|fluorides|mesh-list
25750586|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
25750587|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
25750588|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
25750589|NCT02832375|Protective Agents|protective agents|mesh-ancestor
25750590|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750591|NCT02833350|Folic Acid|folic acid|mesh-list
25750592|NCT02833350|Adalimumab|adalimumab|mesh-list
25750593|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750594|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750595|NCT02833350|Hematinics|hematinics|mesh-ancestor
25750596|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
25750597|NCT02833350|Vitamins|vitamins|mesh-ancestor
25750598|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
25750599|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750600|NCT02833415|Empagliflozin|empagliflozin|mesh-list
25750601|NCT02833415|Glycerol|glycerol|mesh-list
25750602|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25750603|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750604|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750605|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750606|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25750607|NCT02833415|Protective Agents|protective agents|mesh-ancestor
25750608|NCT02833948|Aspirin|aspirin|mesh-list
25750609|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
25750610|NCT02833948|Clopidogrel|clopidogrel|mesh-list
25750611|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25750612|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25750613|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25750614|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25750615|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
25750616|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750617|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750618|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750619|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25750620|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
25750621|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25750622|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
25750623|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750624|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
25750625|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750626|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750627|NCT02833948|Analgesics|analgesics|mesh-ancestor
25750628|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
25750629|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750630|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750631|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750632|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25750633|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25750634|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25750635|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
25750636|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25750637|NCT02834247|Nivolumab|nivolumab|mesh-list
25750638|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25750639|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750640|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25750641|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750642|NCT02834390|Cytarabine|cytarabine|mesh-list
25750643|NCT02834390|Daunorubicin|daunorubicin|mesh-list
25750644|NCT02834390|Idarubicin|idarubicin|mesh-list
25750645|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25750646|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
25750647|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750648|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750649|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
25750650|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750651|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25750652|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
25750653|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750654|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25750655|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25750656|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25750657|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750658|NCT02834624|Poractant alfa|poractant alfa|mesh-list
25750659|NCT02834624|Calfactant|calfactant|mesh-list
25750660|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25750661|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
25750662|NCT02834663|Ranibizumab|ranibizumab|mesh-list
25750663|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25750664|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25750665|NCT02834663|Growth Substances|growth substances|mesh-ancestor
25750666|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750667|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
25750668|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750669|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
25750670|NCT02835339|Analgesics|analgesics|mesh-ancestor
25750671|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
25750672|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750673|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750674|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
25750675|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750676|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25750677|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
25750678|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25750679|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750680|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750681|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25750682|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
25750683|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25750684|NCT02835846|Estrogens|estrogens|mesh-list
25750685|NCT02835846|Hormones|hormones|mesh-ancestor
25750686|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750687|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750688|NCT02836496|Prednisone|prednisone|mesh-list
25750689|NCT02836496|Prednisolone|prednisolone|mesh-list
25750690|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750691|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
25750692|NCT02836496|Hormones|hormones|mesh-ancestor
25750693|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750694|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750695|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25750696|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750697|NCT02836652|Aspirin|aspirin|mesh-list
25750698|NCT02836652|Warfarin|warfarin|mesh-list
25750699|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750700|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750701|NCT02836652|Analgesics|analgesics|mesh-ancestor
25750702|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
25750703|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750704|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750705|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750706|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750707|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25750708|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25750709|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750710|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25750711|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25750712|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750713|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
25750714|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
25750715|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
25750716|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750717|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750718|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25750719|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
25322703|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
25750720|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
25750721|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750722|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750723|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25750724|NCT02837237|Diuretics|diuretics|mesh-ancestor
25750725|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
25750726|NCT02837237|Hormones|hormones|mesh-ancestor
25750727|NCT02837744|Hemostatics|hemostatics|mesh-list
25750728|NCT02837744|Coagulants|coagulants|mesh-ancestor
25750729|NCT02838134|Rocuronium|rocuronium|mesh-list
25750730|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25750731|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25750732|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25750733|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750734|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750735|NCT02838420|Crizotinib|crizotinib|mesh-list
25750736|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750737|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25750738|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750739|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750740|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
25750741|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750742|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750743|NCT02839200|Zolpidem|zolpidem|mesh-list
25750744|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25750745|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25750746|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750747|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750748|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25750749|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
25750750|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
25750751|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750752|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750753|NCT02839681|Maytansine|maytansine|mesh-list
25750754|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25750755|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750756|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
25750757|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
25750758|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
25750759|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750760|NCT02839772|Glycerol|glycerol|mesh-list
25750761|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25750762|NCT02839772|Protective Agents|protective agents|mesh-ancestor
25750763|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750764|NCT02839876|Acetaminophen|acetaminophen|mesh-list
25750765|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750766|NCT02839876|Analgesics|analgesics|mesh-ancestor
25750767|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
25750768|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750769|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750770|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
25750771|NCT02839889|Naloxegol|naloxegol|mesh-list
25750772|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25750773|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750774|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
25750775|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750776|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
25750777|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25750778|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25750779|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750780|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
25750781|NCT02840097|Coagulants|coagulants|mesh-ancestor
25750782|NCT02840461|Ivermectin|ivermectin|mesh-list
25750783|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25750784|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25750785|NCT02841033|Daratumumab|daratumumab|mesh-list
25750786|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750787|NCT02841241|Esmolol|esmolol|mesh-list
25750788|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25750789|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25750790|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25750791|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
25750792|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750793|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750794|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750795|NCT02842073|Naltrexone|naltrexone|mesh-list
25750796|NCT02842073|Bupropion|bupropion|mesh-list
25750797|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25750798|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25750799|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750800|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
25750801|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750802|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25750803|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
25750804|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25750805|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25750806|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25750807|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750808|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750809|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
25750810|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750811|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25750812|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25750813|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750814|NCT02844439|XL647|xl647|mesh-list
25750815|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750816|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25750817|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750818|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750819|NCT02844582|Prednisone|prednisone|mesh-list
25750820|NCT02844582|Cortisone|cortisone|mesh-list
25750821|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750822|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
25750823|NCT02844582|Hormones|hormones|mesh-ancestor
25750824|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750825|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750826|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25750827|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750828|NCT02845336|Celecoxib|celecoxib|mesh-list
25750829|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
25750830|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25750831|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750832|NCT02845336|Analgesics|analgesics|mesh-ancestor
25750833|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
25750834|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750835|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750836|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750837|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25750838|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25750839|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25750840|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750841|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750842|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25750843|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25750844|NCT02845375|Neostigmine|neostigmine|mesh-list
25750845|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25750846|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750847|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750848|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
25750849|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750850|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750851|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25750852|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
25750853|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750854|NCT02845752|Bromides|bromides|mesh-list
25750855|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
25750856|NCT02845752|Olodaterol|olodaterol|mesh-list
25750857|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25750858|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
25750859|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750860|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750861|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25750862|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
25750863|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
25750864|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25750865|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
25750866|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750867|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750868|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
25750869|NCT02846233|Metformin|metformin|mesh-list
25750870|NCT02846233|Empagliflozin|empagliflozin|mesh-list
25750871|NCT02846233|Dulaglutide|dulaglutide|mesh-list
25750872|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25750873|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
25750874|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750875|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750876|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750877|NCT02846233|Incretins|incretins|mesh-ancestor
25750878|NCT02846233|Hormones|hormones|mesh-ancestor
25750879|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750880|NCT02846792|Nivolumab|nivolumab|mesh-list
25750881|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25750882|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750883|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25750884|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775393|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
25775394|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775395|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775396|NCT03965052|Travoprost|travoprost|mesh-list
25775397|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25775398|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25775399|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25775400|NCT03965039|Fluorides|fluorides|mesh-list
25775401|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
25775402|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
25775403|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
25775404|NCT03965039|Protective Agents|protective agents|mesh-ancestor
25775405|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775406|NCT03963401|PF-06700841|pf-06700841|mesh-list
25775407|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25775408|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775409|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775410|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
25775411|NCT03962634|Tetracaine|tetracaine|mesh-list
25775412|NCT03962634|Carticaine|carticaine|mesh-list
25775413|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
25775414|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
25775415|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775416|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775417|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
25775418|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775419|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25775420|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25775421|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25775422|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775423|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775424|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
25775425|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
25775426|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
25775427|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25775428|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775429|NCT03962738|Lasmiditan|lasmiditan|mesh-list
25775430|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25775431|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
25775432|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775433|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775434|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775435|NCT03946124|Fesoterodine|fesoterodine|mesh-list
25775436|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25775437|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25775438|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
25775439|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775440|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775441|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775442|NCT03946124|Urological Agents|urological agents|mesh-ancestor
25775443|NCT03961308|Vedolizumab|vedolizumab|mesh-list
25775444|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775445|NCT03961295|Vedolizumab|vedolizumab|mesh-list
25775446|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775447|NCT03954444|Phenylephrine|phenylephrine|mesh-list
25775448|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
25775449|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25775450|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25775451|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25775452|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777642|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
25750885|NCT02847260|Treprostinil|treprostinil|mesh-list
25750886|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25750887|NCT02847494|Dexamethasone|dexamethasone|mesh-list
25750888|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
25750889|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25750890|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25750891|NCT02847494|Prednisolone|prednisolone|mesh-list
25750892|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
25750893|NCT02847494|Metoclopramide|metoclopramide|mesh-list
25750894|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25750895|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
25750896|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750897|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
25750898|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
25750899|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750900|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750901|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750902|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
25750903|NCT02847494|Hormones|hormones|mesh-ancestor
25750904|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25750905|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25750906|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750907|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25750908|NCT02847494|Protective Agents|protective agents|mesh-ancestor
25750909|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25750910|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25750911|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
25750912|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750913|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750914|NCT02848599|Morphine|morphine|mesh-list
25750915|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
25750916|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25750917|NCT02848599|Narcotics|narcotics|mesh-ancestor
25750918|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750919|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750920|NCT02848599|Analgesics|analgesics|mesh-ancestor
25750921|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
25750922|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750923|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
25750924|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
25750925|NCT02848651|Atezolizumab|atezolizumab|mesh-list
25750926|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25750927|NCT02848729|Acetaminophen|acetaminophen|mesh-list
25750928|NCT02848729|Morphine|morphine|mesh-list
25750929|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25750930|NCT02848729|Narcotics|narcotics|mesh-ancestor
25750931|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750932|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750933|NCT02848729|Analgesics|analgesics|mesh-ancestor
25750934|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
25750935|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750936|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25750937|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
25750938|NCT02848833|Empagliflozin|empagliflozin|mesh-list
25750939|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25750940|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750941|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25750942|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750943|NCT02849184|Suvorexant|suvorexant|mesh-list
25750944|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25750945|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25750946|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750947|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750948|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25750949|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750950|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750951|NCT02849509|Vitamin K|vitamin k|mesh-list
25750952|NCT02849509|Dabigatran|dabigatran|mesh-list
25750953|NCT02849509|Vitamins|vitamins|mesh-ancestor
25750954|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
25750955|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750956|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
25750957|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25750958|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
25750959|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750960|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750961|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
25750962|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25750963|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25750964|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
25750965|NCT02849509|Coagulants|coagulants|mesh-ancestor
25750966|NCT02849678|Lidocaine|lidocaine|mesh-list
25750967|NCT02849678|Ropivacaine|ropivacaine|mesh-list
25750968|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
25750969|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
25750970|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25750971|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750972|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
25750973|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750974|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25750975|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25750976|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25750977|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25750978|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750979|NCT02849704|Pancrelipase|pancrelipase|mesh-list
25750980|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750981|NCT02850276|Bromides|bromides|mesh-list
25750982|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25750983|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
25750984|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25750985|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25750986|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25750987|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
25750988|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25750989|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750990|NCT02850601|Dexamethasone|dexamethasone|mesh-list
25750991|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25750992|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
25750993|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
25750994|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25750995|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25750996|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25750997|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
25750998|NCT02850601|Hormones|hormones|mesh-ancestor
25750999|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751000|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25751001|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751002|NCT02850965|Adalimumab|adalimumab|mesh-list
25751003|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751004|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751005|NCT02851108|Primaquine|primaquine|mesh-list
25751006|NCT02851108|Phenothiazine|phenothiazine|mesh-list
25751007|NCT02851108|Methylene Blue|methylene blue|mesh-list
25751008|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
25751009|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25751010|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25751011|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751012|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751013|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751014|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
25751015|NCT02852265|Etonogestrel|etonogestrel|mesh-list
25751016|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25751017|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751018|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25751019|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25751020|NCT02852434|Lidocaine|lidocaine|mesh-list
25751021|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
25751022|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
25751023|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751024|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751025|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
25751026|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751027|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25751028|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25751029|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25751030|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751031|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751032|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
25751033|NCT02853123|Olodaterol|olodaterol|mesh-list
25751034|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25751035|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
25751036|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751037|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751038|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25751039|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
25751040|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
25751041|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25751042|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751043|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751044|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751045|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
25751047|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
25751048|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25751049|NCT02853318|Antibodies|antibodies|mesh-list
25751050|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
25751051|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25751052|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
25751053|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
25751054|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751055|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
25751056|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751057|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751058|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25751059|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
25751060|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751061|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751062|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25751063|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25751064|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25751065|NCT02853318|Growth Substances|growth substances|mesh-ancestor
25751066|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
25751067|NCT02854527|Metformin|metformin|mesh-list
25751068|NCT02854527|Digoxin|digoxin|mesh-list
25751069|NCT02854527|Furosemide|furosemide|mesh-list
25751070|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25751071|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25751072|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751073|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25751074|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25751075|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
25751076|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751077|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25751078|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25751079|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751080|NCT02854527|Diuretics|diuretics|mesh-ancestor
25751081|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
25751082|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25751083|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751084|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25751085|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25751086|NCT02854527|Protective Agents|protective agents|mesh-ancestor
25751087|NCT02854631|Prednisolone|prednisolone|mesh-list
25751088|NCT02854631|Selonsertib|selonsertib|mesh-list
25751089|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751090|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
25751091|NCT02854631|Hormones|hormones|mesh-ancestor
25751092|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751093|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751094|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25751095|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751096|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25751097|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751098|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751099|NCT02854800|Varenicline|varenicline|mesh-list
25751100|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25751101|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25751102|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751103|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751104|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751105|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751106|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25751107|NCT02855086|Cetuximab|cetuximab|mesh-list
25751108|NCT02855086|Antibodies|antibodies|mesh-list
25751109|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
25751110|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25751111|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
25751112|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751113|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751114|NCT02855359|Prednisone|prednisone|mesh-list
25751115|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
25751116|NCT02855359|Rituximab|rituximab|mesh-list
25751117|NCT02855359|Doxorubicin|doxorubicin|mesh-list
25751118|NCT02855359|Vincristine|vincristine|mesh-list
25751119|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751120|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
25751121|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751122|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751123|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25751124|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
25751125|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751126|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751127|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25751128|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751129|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25751130|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25751131|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25751132|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751133|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751134|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
25751135|NCT02855359|Hormones|hormones|mesh-ancestor
25751136|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751137|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25751138|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25751139|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
25751140|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
25751141|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
25751142|NCT02856555|Firsocostat|firsocostat|mesh-list
25751143|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751144|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751145|NCT02856802|Sumatriptan|sumatriptan|mesh-list
25751146|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25751147|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25751148|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25751149|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
25751150|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751151|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751152|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751153|NCT02856880|Zinc|zinc|mesh-list
25751154|NCT02856880|Trace Elements|trace elements|mesh-ancestor
25751155|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
25751156|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751157|NCT02858076|Aflibercept|aflibercept|mesh-list
25751158|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
25751159|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25751160|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25751161|NCT02858076|Growth Substances|growth substances|mesh-ancestor
25751162|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751163|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
25751164|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751165|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
25751166|NCT02858180|Ledipasvir|ledipasvir|mesh-list
25751167|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
25751168|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751169|NCT02858401|Vesatolimod|vesatolimod|mesh-list
25751170|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
25751171|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751172|NCT02858713|Betamethasone|betamethasone|mesh-list
25751173|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
25751174|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25751175|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
25751176|NCT02858713|Calcipotriene|calcipotriene|mesh-list
25751177|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25751178|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751179|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
25751180|NCT02858713|Hormones|hormones|mesh-ancestor
25751181|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751182|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751183|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25751184|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
25751185|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751186|NCT02859142|Nicotine|nicotine|mesh-list
25751187|NCT02859142|Varenicline|varenicline|mesh-list
25751188|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25751189|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
25751190|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751191|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751192|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25751193|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25751194|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751195|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751196|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751197|NCT02859246|Guaifenesin|guaifenesin|mesh-list
25751198|NCT02859246|Expectorants|expectorants|mesh-ancestor
25751199|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
25751200|NCT02859324|Nivolumab|nivolumab|mesh-list
25751201|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751202|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751203|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25751204|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751205|NCT02859441|Ranibizumab|ranibizumab|mesh-list
25751206|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25751207|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25751208|NCT02859441|Growth Substances|growth substances|mesh-ancestor
25751209|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751210|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
25751211|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751212|NCT02859454|Avelumab|avelumab|mesh-list
25751213|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751214|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751215|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
25751216|NCT02860507|Neostigmine|neostigmine|mesh-list
25751217|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25751218|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751219|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751220|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751221|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751222|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751223|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25751224|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
25751225|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751226|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25751227|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25751228|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25751229|NCT02860546|Nivolumab|nivolumab|mesh-list
25751230|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751231|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751232|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25751233|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751234|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25751235|NCT02860845|Clindamycin|clindamycin|mesh-list
25751236|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
25751237|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
25751238|NCT02860845|Clotrimazole|clotrimazole|mesh-list
25751239|NCT02860845|Miconazole|miconazole|mesh-list
25751240|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
25751241|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751242|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25751243|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751244|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751245|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25751246|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25751247|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25751248|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25751249|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
25751250|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751251|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751252|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25751253|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25751254|NCT02861131|Neostigmine|neostigmine|mesh-list
25751255|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25751256|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751257|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751258|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751259|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751260|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751261|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25751262|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
25751263|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751265|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
25751266|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751267|NCT02861664|Fluorides|fluorides|mesh-list
25751268|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
25751269|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
25751270|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
25751271|NCT02861664|Protective Agents|protective agents|mesh-ancestor
25751272|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751273|NCT02862106|Vaccines|vaccines|mesh-list
25751274|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
25751275|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751276|NCT02862535|Cisplatin|cisplatin|mesh-list
25751277|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
25751278|NCT02862535|Nivolumab|nivolumab|mesh-list
25751279|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751280|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751281|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25751282|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751283|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25751284|NCT02862574|Methotrexate|methotrexate|mesh-list
25751285|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25751286|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
25751287|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25751288|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751289|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25751290|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
25751291|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751292|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751293|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751294|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751295|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25751296|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751297|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
25751298|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751299|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25751300|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751301|NCT02862600|Perhexiline|perhexiline|mesh-list
25751302|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25751303|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751304|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751305|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25751306|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751307|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
25751308|NCT02862730|Pancrelipase|pancrelipase|mesh-list
25751309|NCT02862730|Pancreatin|pancreatin|mesh-list
25751310|NCT02862730|Hormones|hormones|mesh-list
25751311|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751312|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751313|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751314|NCT02862912|Fentanyl|fentanyl|mesh-list
25751315|NCT02862912|Bupivacaine|bupivacaine|mesh-list
25751316|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
25751317|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
25751318|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
25751319|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751320|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751321|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
25751322|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751323|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25751324|NCT02862912|Narcotics|narcotics|mesh-ancestor
25751325|NCT02862912|Analgesics|analgesics|mesh-ancestor
25751326|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25751327|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25751328|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
25751329|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
25751330|NCT02863263|Povidone|povidone|mesh-list
25751331|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
25751332|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
25751333|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25751334|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751335|NCT02863354|Aflibercept|aflibercept|mesh-list
25751336|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25751337|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25751338|NCT02863354|Growth Substances|growth substances|mesh-ancestor
25751339|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751340|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
25751341|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775453|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775454|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775456|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
25775457|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775458|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
25775459|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25775460|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775461|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25775462|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
25775463|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25775464|NCT03954444|Protective Agents|protective agents|mesh-ancestor
25775465|NCT03953820|Diazepam|diazepam|mesh-list
25775466|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25775467|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
25775468|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
25775469|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
25775470|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775471|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775472|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775473|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25775474|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775475|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25775476|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25775477|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25775478|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25775479|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775480|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25775481|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
25775482|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
25775483|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
25775484|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
25775485|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775486|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775487|NCT03961100|Entrectinib|entrectinib|mesh-list
25775488|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25775489|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775490|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775491|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25775492|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
25775493|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775494|NCT03960658|Ketamine|ketamine|mesh-list
25775495|NCT03960658|Analgesics|analgesics|mesh-ancestor
25775496|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
25775497|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775498|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775499|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25775500|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25775501|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
25775502|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
25775503|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775504|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25775505|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25775506|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775507|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775508|NCT03959332|Baloxavir|baloxavir|mesh-list
25775509|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
25775510|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775511|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775512|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775513|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
25775514|NCT03958656|Fludarabine|fludarabine|mesh-list
25775515|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25775516|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
25775517|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775518|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25775519|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25775520|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
25775521|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775522|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323590|NCT04895007|Vaccines|vaccines|mesh-list
25751342|NCT02863575|Ibuprofen|ibuprofen|mesh-list
25751343|NCT02863575|Caffeine|caffeine|mesh-list
25751344|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25751345|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25751346|NCT02863575|Analgesics|analgesics|mesh-ancestor
25751347|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
25751348|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751349|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751350|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751351|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751352|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25751353|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751354|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751355|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25751356|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25751357|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25751358|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25751359|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
25751360|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751361|NCT02864316|Nivolumab|nivolumab|mesh-list
25751362|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751363|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751364|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25751365|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751366|NCT02864381|Nivolumab|nivolumab|mesh-list
25751367|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751368|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751369|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25751370|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751371|NCT02864706|Cyclosporine|cyclosporine|mesh-list
25751372|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
25751373|NCT02864706|Everolimus|everolimus|mesh-list
25751374|NCT02864706|Cyclosporins|cyclosporins|mesh-list
25751375|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751376|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751377|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751378|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
25751379|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751380|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
25751381|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751382|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751383|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751384|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25751385|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751386|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25751387|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25751388|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
25751389|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25751390|NCT02865499|Acarbose|acarbose|mesh-list
25751391|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25751392|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751393|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751394|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25751395|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751396|NCT02865590|Cimetidine|cimetidine|mesh-list
25751397|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25751398|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751399|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25751400|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
25751401|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
25751402|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751403|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751404|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751405|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25751406|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25751407|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751408|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25751409|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25751410|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751411|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
25751412|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751413|NCT02866175|Vitamin K|vitamin k|mesh-list
25751414|NCT02866175|Edoxaban|edoxaban|mesh-list
25751415|NCT02866175|Clopidogrel|clopidogrel|mesh-list
25751417|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25751418|NCT02866175|Vitamins|vitamins|mesh-ancestor
25751419|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
25751420|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751421|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25751422|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25751423|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25751424|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25751425|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
25751426|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751427|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751428|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25751429|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25751430|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
25751431|NCT02866175|Coagulants|coagulants|mesh-ancestor
25751432|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25751433|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
25751434|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25751435|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
25751436|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751437|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
25751438|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
25751439|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25751440|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25751441|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751442|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
25751443|NCT02867163|Coagulants|coagulants|mesh-ancestor
25751444|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
25751445|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25751446|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751447|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
25751448|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25751449|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
25751450|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751451|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
25751452|NCT02867605|Protective Agents|protective agents|mesh-ancestor
25751453|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25751454|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25751455|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
25751456|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25751457|NCT02868242|Ledipasvir|ledipasvir|mesh-list
25751458|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
25751459|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751460|NCT02869438|Benralizumab|benralizumab|mesh-list
25751461|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25751462|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
25751463|NCT02869451|Bupropion|bupropion|mesh-list
25751464|NCT02869451|Nicotine|nicotine|mesh-list
25751465|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25751466|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
25751467|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751468|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751469|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25751470|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25751471|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751472|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751473|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751474|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25751475|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
25751476|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25751477|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25751478|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25751479|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751480|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
25751481|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25751482|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25751483|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751484|NCT02869893|Secretin|secretin|mesh-list
25751485|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751486|NCT02869893|Hormones|hormones|mesh-ancestor
25751487|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751488|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751489|NCT02870283|Carbamazepine|carbamazepine|mesh-list
25751490|NCT02870283|Valproic Acid|valproic acid|mesh-list
25751491|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25751492|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751493|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751494|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
25751495|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25751496|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751497|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751498|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
25751499|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
25751500|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751501|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25751502|NCT02870283|Analgesics|analgesics|mesh-ancestor
25751503|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
25751504|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751505|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25751506|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751507|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25751508|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25751509|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25751510|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25751511|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25751512|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
25751513|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751514|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751515|NCT02870972|Berotralstat|berotralstat|mesh-list
25751516|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751517|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751518|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
25751519|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25751520|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
25751521|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751522|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751523|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25751524|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
25751525|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25751526|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
25751527|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751528|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751529|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25751530|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
25751531|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
25751532|NCT02871011|Protective Agents|protective agents|mesh-ancestor
25751533|NCT02871492|Acyclovir|acyclovir|mesh-list
25751534|NCT02871492|Pritelivir|pritelivir|mesh-list
25751535|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
25751536|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751537|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751538|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751539|NCT02871635|Adalimumab|adalimumab|mesh-list
25751540|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751541|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751542|NCT02872012|Lidocaine|lidocaine|mesh-list
25751543|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
25751544|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
25751545|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751546|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751547|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
25751548|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751549|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25751550|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25751551|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25751552|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751553|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751554|NCT02872311|Vaccines|vaccines|mesh-list
25751555|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
25751556|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751557|NCT02872857|Galantamine|galantamine|mesh-list
25751558|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25751559|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751560|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751561|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751562|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751563|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751564|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25751565|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
25751566|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751567|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
25751568|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
25751569|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25751570|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25751571|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25751572|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751573|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751574|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751575|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751576|NCT02873338|Cytarabine|cytarabine|mesh-list
25751577|NCT02873338|Idarubicin|idarubicin|mesh-list
25751578|NCT02873338|Heparin|heparin|mesh-list
25751579|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25751580|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
25751581|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751582|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751583|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
25751584|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751585|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751586|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
25751587|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751588|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
25751589|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25751590|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25751591|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25751592|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25751593|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25751594|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751595|NCT02873377|Nicotine|nicotine|mesh-list
25751596|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25751597|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
25751598|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751599|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751600|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25751601|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25751602|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751603|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751604|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751605|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
25751606|NCT02873689|Lansoprazole|lansoprazole|mesh-list
25751607|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25751608|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751609|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25751610|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751611|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751612|NCT02873702|Lansoprazole|lansoprazole|mesh-list
25751613|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
25751614|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25751615|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751616|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25751617|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751618|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751619|NCT02873754|Bupropion|bupropion|mesh-list
25751620|NCT02873754|Nicotine|nicotine|mesh-list
25751621|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25751622|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
25751623|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751624|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751625|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25751626|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25751627|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
25751628|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751629|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751630|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25751631|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
25751632|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25751633|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25751634|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25751635|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751636|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
25751637|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25751638|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25751639|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751640|NCT02874092|Ticagrelor|ticagrelor|mesh-list
25751641|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25751642|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25751643|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25751644|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25751645|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
25751646|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751647|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751648|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751649|NCT02874794|Valsartan|valsartan|mesh-list
25751650|NCT02874794|Enalapril|enalapril|mesh-list
25751651|NCT02874794|Enalaprilat|enalaprilat|mesh-list
25751652|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25751653|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25751654|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25751655|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25751656|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751657|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25751658|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
25751659|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751660|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25751661|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25751662|NCT02874924|Sirolimus|sirolimus|mesh-list
25751663|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25751664|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751665|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25751666|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751667|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
25751668|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751669|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
25751670|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751671|NCT02875028|Vorapaxar|vorapaxar|mesh-list
25751672|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25751673|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
25751674|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
25751675|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751676|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751677|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751678|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
25751679|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
25751680|NCT02875340|Risperidone|risperidone|mesh-list
25751681|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25751682|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
25751683|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751684|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751685|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751686|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25751687|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25751688|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751689|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25751690|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25751691|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
25751692|NCT02875366|Ivacaftor|ivacaftor|mesh-list
25751693|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25751694|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751695|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751696|NCT02875392|Fucoidan|fucoidan|mesh-list
25751697|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25751698|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751699|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
25751700|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751701|NCT02875613|Avelumab|avelumab|mesh-list
25751702|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751703|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751704|NCT02876601|Defibrotide|defibrotide|mesh-list
25751705|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25751706|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25751707|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751708|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25751709|NCT02876900|Asenapine|asenapine|mesh-list
25751710|NCT02876900|Maleic acid|maleic acid|mesh-list
25751711|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751712|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751713|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25751714|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25751715|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751716|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751717|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25751718|NCT02877082|Bortezomib|bortezomib|mesh-list
25751719|NCT02877082|Tacrolimus|tacrolimus|mesh-list
25751720|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
25751721|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25751722|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751723|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
25751724|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751725|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25751726|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751727|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751728|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751729|NCT02877095|Furosemide|furosemide|mesh-list
25751730|NCT02877095|Diuretics|diuretics|mesh-ancestor
25751731|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
25751732|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751733|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25751734|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25751735|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751736|NCT02877485|Triamcinolone|triamcinolone|mesh-list
25751737|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25751738|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25751739|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25751740|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751741|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
25751742|NCT02877485|Hormones|hormones|mesh-ancestor
25751743|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751744|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751745|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751746|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
25751747|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751748|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775523|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25775524|NCT03951805|Insulin|insulin|mesh-list
25775525|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25775526|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
25775527|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25775528|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775529|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25775530|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
25775531|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775532|NCT03949621|Vedolizumab|vedolizumab|mesh-list
25775533|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775534|NCT03949244|Latanoprost|latanoprost|mesh-list
25775535|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25775536|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25775537|NCT03948386|Bupivacaine|bupivacaine|mesh-list
25775538|NCT03948386|Mepivacaine|mepivacaine|mesh-list
25775539|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
25775540|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
25775541|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775542|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775543|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
25775544|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775545|NCT03943095|Fluorides|fluorides|mesh-list
25775546|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
25775547|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
25775548|NCT03943095|Protective Agents|protective agents|mesh-ancestor
25775549|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775550|NCT03942042|Ixekizumab|ixekizumab|mesh-list
25775551|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775552|NCT03923530|Eplerenone|eplerenone|mesh-list
25775553|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25775554|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
25775555|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775556|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775557|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25775558|NCT03923530|Diuretics|diuretics|mesh-ancestor
25775559|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
25775560|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25775561|NCT03914417|Imiquimod|imiquimod|mesh-list
25775562|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25775563|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
25775564|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751749|NCT02877927|Linezolid|linezolid|mesh-list
25751750|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25751751|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751752|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25751753|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751754|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751755|NCT02878057|Apatinib|apatinib|mesh-list
25751756|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751757|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25751758|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751759|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751760|NCT02878382|Calcipotriene|calcipotriene|mesh-list
25751761|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751762|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
25751763|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751764|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751765|NCT02880228|Dexamethasone|dexamethasone|mesh-list
25751766|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
25751767|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
25751768|NCT02880228|Lenalidomide|lenalidomide|mesh-list
25751769|NCT02880228|Ichthammol|ichthammol|mesh-list
25751770|NCT02880228|BB 1101|bb 1101|mesh-list
25751771|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751772|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
25751773|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
25751774|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751775|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751776|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751777|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
25751778|NCT02880228|Hormones|hormones|mesh-ancestor
25751779|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751780|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25751781|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751782|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751783|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
25751784|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25751785|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25751786|NCT02880228|Growth Substances|growth substances|mesh-ancestor
25751787|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
25751788|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
25751789|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751790|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751791|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751792|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
25751793|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751794|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751795|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25751796|NCT02880852|Belimumab|belimumab|mesh-list
25751797|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751798|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
25751799|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751800|NCT02880865|Vaccines|vaccines|mesh-list
25751801|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
25751802|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751803|NCT02881008|Entecavir|entecavir|mesh-list
25751804|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
25751805|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751806|NCT02881567|Daclizumab|daclizumab|mesh-list
25751807|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751808|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
25751809|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751810|NCT02881996|Acetaminophen|acetaminophen|mesh-list
25751811|NCT02881996|Ketorolac|ketorolac|mesh-list
25751812|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25751813|NCT02881996|Analgesics|analgesics|mesh-ancestor
25751814|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
25751815|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751816|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751817|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
25751818|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25751819|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751820|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751821|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25751822|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751823|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324200|NCT04887844|Hormones|hormones|mesh-ancestor
25751824|NCT02882152|Morphine|morphine|mesh-list
25751825|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25751827|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751828|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751829|NCT02882152|Analgesics|analgesics|mesh-ancestor
25751830|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
25751831|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751832|NCT02882633|Bupivacaine|bupivacaine|mesh-list
25751833|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
25751834|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
25751835|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751836|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751837|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
25751838|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751839|NCT02882711|Ketamine|ketamine|mesh-list
25751840|NCT02882711|Analgesics|analgesics|mesh-ancestor
25751841|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
25751842|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751843|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751844|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25751845|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25751846|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
25751847|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
25751848|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25751849|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25751850|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25751851|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751852|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751853|NCT02882854|Guanfacine|guanfacine|mesh-list
25751854|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25751855|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25751856|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25751857|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25751858|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
25751859|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751860|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751861|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751862|NCT02883452|Infliximab|infliximab|mesh-list
25751863|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751864|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751865|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751866|NCT02884089|Metformin|metformin|mesh-list
25751867|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25751868|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751869|NCT02885012|Ambrisentan|ambrisentan|mesh-list
25751870|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25751871|NCT02885025|Fluticasone|fluticasone|mesh-list
25751872|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751873|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25751874|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
25751875|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751876|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751877|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25751878|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
25751879|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751880|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25751881|NCT02885181|Methotrexate|methotrexate|mesh-list
25751882|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25751883|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
25751884|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25751885|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751886|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25751887|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
25751888|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751889|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751890|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751891|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751892|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25751893|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25751894|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
25751895|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751896|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25751897|NCT02885636|Albuterol|albuterol|mesh-list
25751898|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25751899|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
25324310|NCT04885777|Lidocaine|lidocaine|mesh-list
25751900|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751901|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751902|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25751903|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
25751904|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
25751905|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25751906|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25751907|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25751908|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25751909|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
25751910|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25751911|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751912|NCT02886624|Grazoprevir|grazoprevir|mesh-list
25751913|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25751914|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
25751915|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751916|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
25751917|NCT02886702|Tazarotene|tazarotene|mesh-list
25751918|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751919|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
25751920|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
25751921|NCT02886702|Vitamins|vitamins|mesh-ancestor
25751922|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
25751923|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751924|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
25751925|NCT02886715|Tazarotene|tazarotene|mesh-list
25751926|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
25751927|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
25751928|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
25751929|NCT02886715|Vitamins|vitamins|mesh-ancestor
25751930|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
25751931|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751932|NCT02887183|Valsartan|valsartan|mesh-list
25751933|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25751934|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25751935|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25751936|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25751937|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751938|NCT02887404|Analgesics|analgesics|mesh-list
25751939|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
25751940|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25751941|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751942|NCT02888106|Tenofovir|tenofovir|mesh-list
25751943|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25751944|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
25751945|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
25751946|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25751947|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25751948|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25751949|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751950|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751951|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25751952|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25751953|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751954|NCT02888665|Doxorubicin|doxorubicin|mesh-list
25751955|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25751956|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
25751957|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25751958|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25751959|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25751960|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25751961|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751962|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751963|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25751964|NCT02889393|Teduglutide|teduglutide|mesh-list
25751965|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25751966|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25751967|NCT02889393|Protective Agents|protective agents|mesh-ancestor
25751968|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751969|NCT02889510|Liraglutide|liraglutide|mesh-list
25751970|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25751971|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25751972|NCT02889510|Incretins|incretins|mesh-ancestor
25751973|NCT02889510|Hormones|hormones|mesh-ancestor
25751974|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25751975|NCT02889562|Warfarin|warfarin|mesh-list
25751976|NCT02889562|Apixaban|apixaban|mesh-list
25751977|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
25751978|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25751979|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
25751980|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25751981|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
25751982|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25751983|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751984|NCT02889796|Adalimumab|adalimumab|mesh-list
25751985|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25751986|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25751987|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
25751989|NCT02890992|Niacinamide|niacinamide|mesh-list
25751990|NCT02890992|Ezetimibe|ezetimibe|mesh-list
25751991|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
25751992|NCT02890992|Fenofibrate|fenofibrate|mesh-list
25751993|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25751994|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25751995|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
25751996|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25751997|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25751998|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
25751999|NCT02890992|Vitamins|vitamins|mesh-ancestor
25752000|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
25752001|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752002|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
25752003|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25752004|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
25752005|NCT02891070|Coagulants|coagulants|mesh-ancestor
25752006|NCT02891174|Acetaminophen|acetaminophen|mesh-list
25752007|NCT02891174|Ibuprofen|ibuprofen|mesh-list
25752008|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752009|NCT02891174|Analgesics|analgesics|mesh-ancestor
25752010|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
25752011|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752012|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752013|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
25752014|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752015|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752016|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752017|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25752018|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752019|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752020|NCT02891408|Fenofibrate|fenofibrate|mesh-list
25752021|NCT02891408|Firsocostat|firsocostat|mesh-list
25752022|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25752023|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
25752024|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752025|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25752026|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752027|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
25752028|NCT02891850|Tadalafil|tadalafil|mesh-list
25752029|NCT02891850|Riociguat|riociguat|mesh-list
25752030|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
25752031|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25752032|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25752033|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752034|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752035|NCT02891850|Urological Agents|urological agents|mesh-ancestor
25752036|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
25752037|NCT02891915|Amoxicillin|amoxicillin|mesh-list
25752038|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
25752039|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
25752040|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25752041|NCT02891915|Cefdinir|cefdinir|mesh-list
25752042|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25752043|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25752044|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25752045|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752046|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752047|NCT02892110|Varenicline|varenicline|mesh-list
25752048|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25752049|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25324513|NCT04883034|Analgesics|analgesics|mesh-list
25752050|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752051|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752052|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752053|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752055|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752056|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
25752057|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25752058|NCT02892409|Amoxicillin|amoxicillin|mesh-list
25752059|NCT02892409|Clarithromycin|clarithromycin|mesh-list
25752060|NCT02892409|Lansoprazole|lansoprazole|mesh-list
25752061|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
25752062|NCT02892409|Bismuth|bismuth|mesh-list
25752063|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25752064|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25752065|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25752066|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752067|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752068|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25752069|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25752070|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25752071|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752072|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25752073|NCT02892409|Antacids|antacids|mesh-ancestor
25752074|NCT02892734|Nivolumab|nivolumab|mesh-list
25752075|NCT02892734|Ipilimumab|ipilimumab|mesh-list
25752076|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25752077|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752078|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25752079|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752080|NCT02895035|Ketorolac|ketorolac|mesh-list
25752081|NCT02895035|Phenylephrine|phenylephrine|mesh-list
25752082|NCT02895035|Epinephrine|epinephrine|mesh-list
25752083|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
25752084|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25752085|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25752086|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
25752087|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752088|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752089|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752090|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25752091|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25752092|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
25752093|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752094|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25752095|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
25752096|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
25752097|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
25752098|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25752099|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752100|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752101|NCT02895035|Analgesics|analgesics|mesh-ancestor
25752102|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
25752103|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752104|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752105|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25752106|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752107|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25752108|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
25752109|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25752110|NCT02895035|Protective Agents|protective agents|mesh-ancestor
25775565|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775566|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
25775567|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
25775568|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25775569|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
25775570|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775571|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775572|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25775573|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775574|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
25775575|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25775576|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
25775577|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775578|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775579|NCT03936387|Ropivacaine|ropivacaine|mesh-list
25775580|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
25775581|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
25775582|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752111|NCT02895945|Factor VIII|factor viii|mesh-list
25752112|NCT02895945|Coagulants|coagulants|mesh-ancestor
25752113|NCT02896296|Buprenorphine|buprenorphine|mesh-list
25752114|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25752115|NCT02896296|Narcotics|narcotics|mesh-ancestor
25752116|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752117|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752118|NCT02896296|Analgesics|analgesics|mesh-ancestor
25752119|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
25752120|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752121|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25752122|NCT02896400|Nicotine|nicotine|mesh-list
25752123|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25752124|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
25752125|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752126|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752127|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25752128|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25752129|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752130|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752131|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752132|NCT02896595|Anesthetics|anesthetics|mesh-list
25752133|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752134|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752135|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
25752136|NCT02896907|Vitamins|vitamins|mesh-list
25752137|NCT02896907|Leucovorin|leucovorin|mesh-list
25752138|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
25752139|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25752140|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
25752141|NCT02896907|Fluorouracil|fluorouracil|mesh-list
25752142|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
25752143|NCT02896907|Irinotecan|irinotecan|mesh-list
25752144|NCT02896907|Camptothecin|camptothecin|mesh-list
25752145|NCT02896907|Calcium|calcium|mesh-list
25752146|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
25752147|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
25752148|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752149|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25752150|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25752151|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
25752152|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752153|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25752154|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752155|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25752156|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
25752157|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25752158|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25752159|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752160|NCT02896907|Antidotes|antidotes|mesh-ancestor
25752161|NCT02896907|Protective Agents|protective agents|mesh-ancestor
25752162|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
25752163|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
25752164|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25752165|NCT02897115|Adalimumab|adalimumab|mesh-list
25752166|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25752167|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25752168|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752169|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752170|NCT02897115|Analgesics|analgesics|mesh-ancestor
25752171|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
25752172|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752173|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752174|NCT02897349|Linagliptin|linagliptin|mesh-list
25752175|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752176|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752177|NCT02897349|Incretins|incretins|mesh-ancestor
25752178|NCT02897349|Hormones|hormones|mesh-ancestor
25752179|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752180|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25752181|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
25752182|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752183|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752184|NCT02898116|Durvalumab|durvalumab|mesh-list
25752185|NCT02898116|Ensartinib|ensartinib|mesh-list
25752186|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25752187|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752188|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25752189|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752190|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752191|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
25752192|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752193|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
25752194|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25752195|NCT02899156|Flumazenil|flumazenil|mesh-list
25752196|NCT02899156|Antidotes|antidotes|mesh-ancestor
25752197|NCT02899156|Protective Agents|protective agents|mesh-ancestor
25752198|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752199|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
25752200|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
25752201|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752202|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752203|NCT02899195|Durvalumab|durvalumab|mesh-list
25752204|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25752205|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752206|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25752207|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752208|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
25752209|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
25752210|NCT02899988|Mirikizumab|mirikizumab|mesh-list
25752211|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752212|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752213|NCT02899988|Analgesics|analgesics|mesh-ancestor
25752214|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
25752215|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752216|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752217|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752218|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752219|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25752220|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752221|NCT02900092|Ganaxolone|ganaxolone|mesh-list
25752222|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
25752223|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752224|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752225|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752226|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
25752227|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
25752228|NCT02900378|Valsartan|valsartan|mesh-list
25752229|NCT02900378|Enalapril|enalapril|mesh-list
25752230|NCT02900378|Enalaprilat|enalaprilat|mesh-list
25752231|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25752232|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25752233|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25752234|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25752235|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752236|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25752237|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
25752238|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752239|NCT02901054|Ondansetron|ondansetron|mesh-list
25752240|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
25752241|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
25752242|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752243|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752244|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752245|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
25752246|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
25752247|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25752248|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
25752249|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752250|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752251|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25752252|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25752253|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752254|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752255|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25752256|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
25752257|NCT02901249|Sertraline|sertraline|mesh-list
25752258|NCT02901249|Nortriptyline|nortriptyline|mesh-list
25752259|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
25752260|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752261|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25752262|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25324777|NCT04879030|Meropenem|meropenem|mesh-list
25752263|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752264|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752265|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752267|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752268|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752269|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
25752270|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25752271|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752272|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25752273|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25752274|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
25752275|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
25752276|NCT02901899|Guadecitabine|guadecitabine|mesh-list
25752277|NCT02901899|Azacitidine|azacitidine|mesh-list
25752278|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25752279|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752280|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25752281|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
25752282|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752283|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752284|NCT02902081|Cannabidiol|cannabidiol|mesh-list
25752285|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
25752286|NCT02902172|Acetaminophen|acetaminophen|mesh-list
25752287|NCT02902172|Ibuprofen|ibuprofen|mesh-list
25752288|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752289|NCT02902172|Analgesics|analgesics|mesh-ancestor
25752290|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
25752291|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752292|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752293|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
25752294|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752295|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752296|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752297|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25752298|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752299|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752300|NCT02902237|Thromboplastin|thromboplastin|mesh-list
25752301|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
25752302|NCT02902237|Coagulants|coagulants|mesh-ancestor
25752303|NCT02902770|Ketorolac|ketorolac|mesh-list
25752304|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25752305|NCT02902770|Lidocaine|lidocaine|mesh-list
25752306|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
25752307|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
25752308|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752309|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752310|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
25752311|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752312|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25752313|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25752314|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25752315|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752316|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752317|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752318|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752319|NCT02902770|Analgesics|analgesics|mesh-ancestor
25752320|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752321|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752322|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25752323|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752324|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25752325|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
25752326|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752327|NCT02902913|Ibuprofen|ibuprofen|mesh-list
25752328|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752329|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752330|NCT02902913|Analgesics|analgesics|mesh-ancestor
25752331|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
25752332|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752333|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752334|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324933|NCT05257291|Melatonin|melatonin|mesh-list
25752335|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752336|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25752337|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752338|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752339|NCT02902965|Dexamethasone|dexamethasone|mesh-list
25752340|NCT02902965|Bortezomib|bortezomib|mesh-list
25752341|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752342|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
25752343|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
25752344|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752345|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752346|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752347|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
25752348|NCT02902965|Hormones|hormones|mesh-ancestor
25752349|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752350|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25752351|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752352|NCT02903030|Silicon|silicon|mesh-list
25752353|NCT02903030|Trace Elements|trace elements|mesh-ancestor
25752354|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
25752355|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752356|NCT02903121|Tamoxifen|tamoxifen|mesh-list
25752357|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25752358|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
25752359|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752360|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752361|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25752362|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752363|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25752364|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25752365|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25752366|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25752367|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25752368|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25752369|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752370|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752371|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752372|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752373|NCT02903238|Analgesics|analgesics|mesh-ancestor
25752374|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
25752375|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752376|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
25752377|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752378|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
25752379|NCT02903368|Prednisone|prednisone|mesh-list
25752380|NCT02903368|Leuprolide|leuprolide|mesh-list
25752381|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
25752382|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752383|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
25752384|NCT02903368|Hormones|hormones|mesh-ancestor
25752385|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752386|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752387|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25752388|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752389|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25752390|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
25752391|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25752392|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25752393|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752394|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752395|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
25752396|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25752397|NCT02903407|Midazolam|midazolam|mesh-list
25752398|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
25752399|NCT02903407|Propofol|propofol|mesh-list
25752400|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25752401|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752402|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752403|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25752404|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
25752405|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
25752406|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752407|NCT02903407|Analgesics|analgesics|mesh-ancestor
25752408|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
25752409|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752410|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25752411|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25752412|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25752413|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
25752414|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752415|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752416|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25752417|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25752418|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25752419|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752421|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
25752422|NCT02903446|Denosumab|denosumab|mesh-list
25752423|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25752424|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752425|NCT02903511|Metformin|metformin|mesh-list
25752426|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752427|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752428|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
25752429|NCT02903836|Nafithromycin|nafithromycin|mesh-list
25752430|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25752431|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25752432|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25752433|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25752434|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752435|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752436|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752437|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25752438|NCT02904096|Lidocaine|lidocaine|mesh-list
25752439|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25752440|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
25752441|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752442|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752443|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
25752444|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752445|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25752446|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25752447|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25752448|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752449|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752450|NCT02904200|Silicon|silicon|mesh-list
25752451|NCT02904200|Trace Elements|trace elements|mesh-ancestor
25752452|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
25752453|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752454|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
25752455|NCT02904226|Nivolumab|nivolumab|mesh-list
25752456|NCT02904226|Ipilimumab|ipilimumab|mesh-list
25752457|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25752458|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752459|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25752460|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752461|NCT02904265|Acetazolamide|acetazolamide|mesh-list
25752462|NCT02904265|Diazepam|diazepam|mesh-list
25752463|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
25752464|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25752465|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752466|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752467|NCT02904265|Diuretics|diuretics|mesh-ancestor
25752468|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
25752469|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752470|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25752471|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
25752472|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
25752473|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752474|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752475|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25752476|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752477|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25752478|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25752479|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25752480|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25752481|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752482|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25752483|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
25752484|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
25752485|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
25752486|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
25752487|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752489|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752490|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752491|NCT02904915|Lidocaine|lidocaine|mesh-list
25752492|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
25752493|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
25752494|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752495|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752496|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
25752497|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752498|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25752499|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25752500|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25752501|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752502|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752503|NCT02905266|Nivolumab|nivolumab|mesh-list
25752504|NCT02905266|Ipilimumab|ipilimumab|mesh-list
25752505|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25752506|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752507|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25752508|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752509|NCT02905981|Citric Acid|citric acid|mesh-list
25752510|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
25752511|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
25752512|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25752513|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
25752514|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
25752515|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752516|NCT02906566|Vitamin A|vitamin a|mesh-list
25752517|NCT02906566|Vitamins|vitamins|mesh-ancestor
25752518|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
25752519|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752520|NCT02906579|Praliciguat|praliciguat|mesh-list
25752521|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25752522|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
25752523|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752524|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752525|NCT02906644|Nicotine|nicotine|mesh-list
25752526|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25752527|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
25752528|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752529|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752530|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25752531|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25752532|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752533|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752534|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752535|NCT02906709|Insulin|insulin|mesh-list
25752536|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752537|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752538|NCT02906917|Insulin|insulin|mesh-list
25752539|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25752540|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
25752541|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
25752542|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
25752543|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25752544|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752545|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752546|NCT02907177|Ponesimod|ponesimod|mesh-list
25752547|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25752548|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752549|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25752550|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
25752551|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752552|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25752553|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25752554|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25752555|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752556|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752557|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25752558|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752559|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752560|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752561|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752563|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25752564|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25752565|NCT02907918|Trastuzumab|trastuzumab|mesh-list
25752566|NCT02907918|Letrozole|letrozole|mesh-list
25752567|NCT02907918|Palbociclib|palbociclib|mesh-list
25752568|NCT02907918|Goserelin|goserelin|mesh-list
25752569|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25752570|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752571|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25752572|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25752573|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752574|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752575|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25752576|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
25752577|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752578|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752579|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25752580|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25752581|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
25752582|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
25752583|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25752584|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25752585|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752586|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752587|NCT02908490|Urological Agents|urological agents|mesh-ancestor
25752588|NCT02908529|Oxybutynin|oxybutynin|mesh-list
25752589|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25752590|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25752591|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25752592|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752593|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752594|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
25752595|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752596|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752597|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
25752598|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
25752599|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752600|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25752601|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25752602|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752603|NCT02908529|Urological Agents|urological agents|mesh-ancestor
25752604|NCT02908620|Anesthetics|anesthetics|mesh-list
25752605|NCT02908620|Tetracaine|tetracaine|mesh-list
25752606|NCT02908620|Benzocaine|benzocaine|mesh-list
25752607|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752608|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752609|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
25752610|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
25752611|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775583|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775584|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
25775585|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775586|NCT03935399|Oxytocin|oxytocin|mesh-list
25775587|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
25775588|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25775589|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777643|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777644|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
25777645|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777646|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25777647|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25777648|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
25777649|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777650|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777651|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25777652|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777653|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
25777654|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
25777655|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777656|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777657|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
25777658|NCT03342638|Hormones|hormones|mesh-ancestor
25752612|NCT02909140|Lidocaine|lidocaine|mesh-list
25752613|NCT02909140|Phenylephrine|phenylephrine|mesh-list
25752614|NCT02909140|Epinephrine|epinephrine|mesh-list
25752615|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
25752616|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
25752617|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
25752618|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
25752619|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752620|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752621|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
25752622|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752623|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25752624|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25752625|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25752626|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752627|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752628|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25752629|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25752630|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
25752631|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752632|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25752633|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25752634|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
25752635|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25752636|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
25752637|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
25752638|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
25752639|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25752640|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25752641|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
25752642|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25752643|NCT02909140|Protective Agents|protective agents|mesh-ancestor
25752644|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
25752645|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25752646|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25752647|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752648|NCT02909439|Neostigmine|neostigmine|mesh-list
25752649|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25752650|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752651|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752652|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752653|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752654|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752655|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25752656|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
25752657|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752658|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
25752659|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
25752660|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752661|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752662|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752663|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
25752664|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25752665|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752666|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752667|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
25752668|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25752669|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752670|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752671|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752672|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752673|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752674|NCT02909959|Sulforaphane|sulforaphane|mesh-list
25752675|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25752676|NCT02909959|Protective Agents|protective agents|mesh-ancestor
25752677|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752678|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752679|NCT02910011|Doxycycline|doxycycline|mesh-list
25752680|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25752681|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25752682|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
25752683|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25752684|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25752685|NCT02910063|Blinatumomab|blinatumomab|mesh-list
25752686|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752687|NCT02910167|Acetaminophen|acetaminophen|mesh-list
25752688|NCT02910167|Scopolamine|scopolamine|mesh-list
25752689|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25752690|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752691|NCT02910167|Analgesics|analgesics|mesh-ancestor
25752692|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
25752693|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752694|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752695|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
25752696|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25752697|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
25752698|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
25752699|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752700|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
25752701|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25752702|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752703|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752704|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752705|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25752706|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
25752707|NCT02911116|Ustekinumab|ustekinumab|mesh-list
25752708|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
25752709|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
25752710|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25752711|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
25752712|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25752713|NCT02911285|Expectorants|expectorants|mesh-ancestor
25752714|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
25752715|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25752716|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
25752717|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752718|NCT02911285|Protective Agents|protective agents|mesh-ancestor
25752719|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752720|NCT02911285|Antidotes|antidotes|mesh-ancestor
25752721|NCT02911324|Nabilone|nabilone|mesh-list
25752722|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
25752723|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
25752724|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752725|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752726|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752727|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25752728|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25752729|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752730|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752731|NCT02911688|Vitamin E|vitamin e|mesh-list
25752732|NCT02911688|Tocopherols|tocopherols|mesh-list
25752733|NCT02911688|Tocotrienols|tocotrienols|mesh-list
25752734|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
25752735|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
25752736|NCT02911688|Vitamins|vitamins|mesh-ancestor
25752737|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
25752738|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752739|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
25752740|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752741|NCT02911688|Protective Agents|protective agents|mesh-ancestor
25752742|NCT02911818|Liraglutide|liraglutide|mesh-list
25752743|NCT02911818|Phentermine|phentermine|mesh-list
25752744|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752745|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752746|NCT02911818|Incretins|incretins|mesh-ancestor
25752747|NCT02911818|Hormones|hormones|mesh-ancestor
25752748|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752749|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25752750|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
25752751|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25752752|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
25752753|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
25752754|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752755|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
25752756|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752757|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752758|NCT02911844|Fulvestrant|fulvestrant|mesh-list
25752759|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25752760|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752761|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25752762|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25752763|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
25752764|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775590|NCT03928327|Itraconazole|itraconazole|mesh-list
25752765|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752766|NCT02911948|Insulin|insulin|mesh-list
25752767|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25752768|NCT02911948|Liraglutide|liraglutide|mesh-list
25752769|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
25752770|NCT02911948|Xultophy|xultophy|mesh-list
25752771|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752772|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752773|NCT02911948|Incretins|incretins|mesh-ancestor
25752774|NCT02911948|Hormones|hormones|mesh-ancestor
25752775|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752776|NCT02912195|Lidocaine|lidocaine|mesh-list
25752777|NCT02912195|Morphine|morphine|mesh-list
25752778|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
25752779|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
25752780|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752781|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752782|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
25752783|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752784|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25752785|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25752786|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25752787|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752788|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752789|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25752790|NCT02912195|Narcotics|narcotics|mesh-ancestor
25752791|NCT02912195|Analgesics|analgesics|mesh-ancestor
25752792|NCT02912364|Carbamazepine|carbamazepine|mesh-list
25752793|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25752794|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
25752795|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
25752796|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25752797|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752798|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752799|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752800|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752801|NCT02912364|Analgesics|analgesics|mesh-ancestor
25752802|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
25752803|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752804|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25752805|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752806|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752807|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25752808|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25752809|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25752810|NCT02912455|Canagliflozin|canagliflozin|mesh-list
25752811|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25752812|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752813|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752814|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752815|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
25752816|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752817|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
25752818|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25752819|NCT02912650|Acetaminophen|acetaminophen|mesh-list
25752820|NCT02912650|Ibuprofen|ibuprofen|mesh-list
25752821|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752822|NCT02912650|Analgesics|analgesics|mesh-ancestor
25752823|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
25752824|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752825|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752826|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
25752827|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752828|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752829|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752830|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25752831|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752832|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752833|NCT02913326|Warfarin|warfarin|mesh-list
25752834|NCT02913326|Dabigatran|dabigatran|mesh-list
25752835|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
25752836|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
25752837|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25752838|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
25752839|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325708|NCT03300817|Poly ICLC|poly iclc|mesh-list
25752840|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752842|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25752843|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25752844|NCT02913521|Analgesics|analgesics|mesh-ancestor
25752845|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
25752846|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752847|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752848|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752849|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752850|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25752851|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752852|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752853|NCT02913924|Clonazepam|clonazepam|mesh-list
25752854|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
25752855|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
25752856|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
25752857|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752858|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752859|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752860|NCT02914119|Rocuronium|rocuronium|mesh-list
25752861|NCT02914119|Mivacurium|mivacurium|mesh-list
25752862|NCT02914119|Cisatracurium|cisatracurium|mesh-list
25752863|NCT02914119|Succinylcholine|succinylcholine|mesh-list
25752864|NCT02914119|Neostigmine|neostigmine|mesh-list
25752865|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25752866|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25752867|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25752868|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752869|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752870|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25752871|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752872|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752873|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
25752874|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752875|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25752876|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
25752877|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25752878|NCT02914275|Vaccines|vaccines|mesh-list
25752879|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
25752880|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752881|NCT02914509|Travoprost|travoprost|mesh-list
25752882|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25752883|NCT02915159|Abatacept|abatacept|mesh-list
25752884|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25752885|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752886|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752887|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25752888|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
25752889|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752890|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25752891|NCT02915705|Vitamin D|vitamin d|mesh-list
25752892|NCT02915705|Vitamins|vitamins|mesh-ancestor
25752893|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
25752894|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752895|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25752896|NCT02915744|Gemcitabine|gemcitabine|mesh-list
25752897|NCT02915744|Paclitaxel|paclitaxel|mesh-list
25752898|NCT02915744|Vinorelbine|vinorelbine|mesh-list
25752899|NCT02915744|Docetaxel|docetaxel|mesh-list
25752900|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25752901|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
25752902|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25752903|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752904|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25752905|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25752906|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25752907|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752908|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25752909|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
25752910|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
25752911|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25752912|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752913|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25752914|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
25752915|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752916|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25752917|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25752918|NCT02915835|Riociguat|riociguat|mesh-list
25752919|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
25752920|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752921|NCT02915978|Fentanyl|fentanyl|mesh-list
25752922|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25752923|NCT02915978|Narcotics|narcotics|mesh-ancestor
25752924|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752925|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752926|NCT02915978|Analgesics|analgesics|mesh-ancestor
25752927|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
25752928|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752929|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25752930|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25752931|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
25752932|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
25752933|NCT02916407|Sevoflurane|sevoflurane|mesh-list
25752934|NCT02916407|Desflurane|desflurane|mesh-list
25752935|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25752936|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25752937|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
25752938|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
25752939|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752940|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752941|NCT02916433|Octreotide|octreotide|mesh-list
25752942|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25752943|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25752944|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752945|NCT02916693|Mirabegron|mirabegron|mesh-list
25752946|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25752947|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25752948|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25752949|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
25752950|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752951|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752952|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752953|NCT02916693|Urological Agents|urological agents|mesh-ancestor
25752954|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25752955|NCT02916745|Trioxsalen|trioxsalen|mesh-list
25752956|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25752957|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
25752958|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25752959|NCT02916927|Ketamine|ketamine|mesh-list
25752960|NCT02916927|Analgesics|analgesics|mesh-ancestor
25752961|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
25752962|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25752963|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752964|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25752965|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25752966|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
25752967|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
25752968|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25752969|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25752970|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25752971|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752972|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752973|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25752974|NCT02917031|Saxagliptin|saxagliptin|mesh-list
25752975|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25752976|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752977|NCT02917031|Incretins|incretins|mesh-ancestor
25752978|NCT02917031|Hormones|hormones|mesh-ancestor
25752979|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25752980|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25752981|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
25752982|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25752983|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752984|NCT02917122|Sertraline|sertraline|mesh-list
25752985|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
25752986|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25752987|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25752988|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25752989|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25752990|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25752991|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25752992|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
25752993|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25752995|NCT02917941|Lenalidomide|lenalidomide|mesh-list
25752996|NCT02917941|Ixazomib|ixazomib|mesh-list
25752997|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25752998|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
25752999|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
25753000|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753001|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753002|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753003|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
25753004|NCT02917941|Hormones|hormones|mesh-ancestor
25753005|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753006|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753007|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753008|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
25753009|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25753010|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25753011|NCT02917941|Growth Substances|growth substances|mesh-ancestor
25753012|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
25753013|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
25753014|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753015|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753016|NCT02918071|Benralizumab|benralizumab|mesh-list
25753017|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25753018|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
25753019|NCT02918097|Risperidone|risperidone|mesh-list
25753020|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
25753021|NCT02918097|Sertraline|sertraline|mesh-list
25753022|NCT02918097|Nortriptyline|nortriptyline|mesh-list
25753023|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25753024|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
25753025|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753026|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753027|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753028|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25753029|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25753030|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753031|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753032|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25753033|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
25753034|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
25753035|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25753036|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25753037|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25753038|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753039|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
25753040|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25753041|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25753042|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
25753043|NCT02918266|Scopolamine|scopolamine|mesh-list
25753044|NCT02918266|Donepezil|donepezil|mesh-list
25753045|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25753046|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25753047|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753048|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753049|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
25753050|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753051|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753052|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
25753053|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25753054|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
25753055|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
25753056|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753057|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753058|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
25753059|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25753060|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25753061|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
25753062|NCT02918279|Liraglutide|liraglutide|mesh-list
25753063|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25753064|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753065|NCT02918279|Incretins|incretins|mesh-ancestor
25753066|NCT02918279|Hormones|hormones|mesh-ancestor
25326067|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
25753067|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753068|NCT02918318|Esketamine|esketamine|mesh-list
25753069|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
25753070|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753071|NCT02918357|Edetic Acid|edetic acid|mesh-list
25753072|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25753073|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
25753074|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
25753075|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753076|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
25753077|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25753078|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25753079|NCT02918617|Fluorides|fluorides|mesh-list
25753080|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
25753081|NCT02918617|Protective Agents|protective agents|mesh-ancestor
25753082|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753083|NCT02918630|Nicotine|nicotine|mesh-list
25753084|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25753085|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
25753086|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753087|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753088|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25753089|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25753090|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
25753091|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753092|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753093|NCT02918877|Propofol|propofol|mesh-list
25753094|NCT02918877|Sevoflurane|sevoflurane|mesh-list
25753095|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25753096|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753097|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753098|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25753099|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
25753100|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
25753101|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25753102|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25753103|NCT02918968|Flutamide|flutamide|mesh-list
25753104|NCT02918968|Androgens|androgens|mesh-list
25753105|NCT02918968|Hormones|hormones|mesh-ancestor
25753106|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753107|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753108|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
25753109|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
25753110|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753111|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753112|NCT02919111|Edetic Acid|edetic acid|mesh-list
25753113|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25753114|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
25753115|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
25753116|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753117|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
25753118|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25753119|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25775591|NCT03928327|Rifampin|rifampin|mesh-list
25775592|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
25775593|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775594|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25775595|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25775596|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775597|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775598|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25775599|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
25775600|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775601|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775602|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25775603|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25775604|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
25775605|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25775606|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
25775607|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25775608|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25775609|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25775610|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25775611|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25753120|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25753121|NCT02919761|Hormones|hormones|mesh-ancestor
25753122|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753123|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753124|NCT02920528|Ketamine|ketamine|mesh-list
25753125|NCT02920528|Analgesics|analgesics|mesh-ancestor
25753126|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
25753127|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753128|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753129|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25753130|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25753131|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
25753132|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
25753133|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753134|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25753135|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25753136|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753137|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753138|NCT02920749|Anesthetics|anesthetics|mesh-list
25753139|NCT02920749|Propofol|propofol|mesh-list
25753140|NCT02920749|Sevoflurane|sevoflurane|mesh-list
25753141|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753142|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753143|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25753144|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25753145|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
25753146|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25753147|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25753148|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25753149|NCT02920918|Canagliflozin|canagliflozin|mesh-list
25753150|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25753151|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753152|NCT02920918|Incretins|incretins|mesh-ancestor
25753153|NCT02920918|Hormones|hormones|mesh-ancestor
25753154|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753155|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25753156|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
25753157|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753158|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753159|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25753160|NCT02921061|Cytarabine|cytarabine|mesh-list
25753161|NCT02921061|Decitabine|decitabine|mesh-list
25753162|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25753163|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
25753164|NCT02921061|Cladribine|cladribine|mesh-list
25753165|NCT02921061|Lenograstim|lenograstim|mesh-list
25753166|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25753167|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
25753168|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753169|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753170|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
25753171|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753172|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25753173|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
25753174|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753175|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25753176|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753177|NCT02921061|Analgesics|analgesics|mesh-ancestor
25753178|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
25753179|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753180|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25753181|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25753182|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
25753183|NCT02921386|Testosterone|testosterone|mesh-list
25753184|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
25753185|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
25753186|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25753187|NCT02921386|Androgens|androgens|mesh-ancestor
25753188|NCT02921386|Hormones|hormones|mesh-ancestor
25753189|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753190|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753191|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753192|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753193|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
25753194|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25753195|NCT02921750|Laxatives|laxatives|mesh-ancestor
25753196|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753197|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
25753198|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25753199|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25753200|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753201|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
25753202|NCT02922582|Coagulants|coagulants|mesh-ancestor
25753203|NCT02922959|Naloxone|naloxone|mesh-list
25753204|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753205|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
25753206|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753207|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25753208|NCT02923115|Enoxaparin|enoxaparin|mesh-list
25753209|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
25753210|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25753211|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25753212|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753213|NCT02923895|Fluorides|fluorides|mesh-list
25753214|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
25753215|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
25753216|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
25753217|NCT02923895|Protective Agents|protective agents|mesh-ancestor
25753218|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753219|NCT02923921|Leucovorin|leucovorin|mesh-list
25753220|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
25753221|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753222|NCT02923921|Antidotes|antidotes|mesh-ancestor
25753223|NCT02923921|Protective Agents|protective agents|mesh-ancestor
25753224|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753225|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
25753226|NCT02923921|Vitamins|vitamins|mesh-ancestor
25753227|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
25753228|NCT02924350|Fluorides|fluorides|mesh-list
25753229|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
25753230|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
25753231|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
25753232|NCT02924350|Protective Agents|protective agents|mesh-ancestor
25753233|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753234|NCT02924688|Fluticasone|fluticasone|mesh-list
25753235|NCT02924688|Albuterol|albuterol|mesh-list
25753236|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25753237|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25753238|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753239|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25753240|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
25753241|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753242|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753243|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25753244|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
25753245|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
25753246|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25753247|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25753248|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25753249|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25753250|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25753251|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753252|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753253|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
25753254|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25753255|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
25753256|NCT02924688|Hormones|hormones|mesh-ancestor
25753257|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753258|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
25753259|NCT02924883|Trastuzumab|trastuzumab|mesh-list
25753260|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25753261|NCT02924883|Atezolizumab|atezolizumab|mesh-list
25753262|NCT02924883|Maytansine|maytansine|mesh-list
25753263|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25753264|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753265|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25753266|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25753267|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25753268|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25753269|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753270|NCT02925117|Upadacitinib|upadacitinib|mesh-list
25753271|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25753272|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25753273|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753274|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753275|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753276|NCT02925494|Norethindrone|norethindrone|mesh-list
25753277|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
25753278|NCT02925494|Estradiol|estradiol|mesh-list
25753279|NCT02925494|Estrogens|estrogens|mesh-ancestor
25753280|NCT02925494|Hormones|hormones|mesh-ancestor
25753281|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753282|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753283|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25753284|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
25753285|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25753286|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25753287|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25753288|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25753289|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25753290|NCT02925611|Desflurane|desflurane|mesh-list
25753291|NCT02925611|Isoflurane|isoflurane|mesh-list
25753292|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25753293|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
25753294|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
25753295|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753296|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753297|NCT02925858|Ketamine|ketamine|mesh-list
25753298|NCT02925858|Analgesics|analgesics|mesh-ancestor
25753299|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
25753300|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753301|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753302|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25753303|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25753304|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
25753305|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
25753306|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753307|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25753308|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25753309|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753310|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753311|NCT02925923|Clopidogrel|clopidogrel|mesh-list
25753312|NCT02925923|Ticagrelor|ticagrelor|mesh-list
25753313|NCT02925923|Eptifibatide|eptifibatide|mesh-list
25753314|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25753315|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25753316|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25753317|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25753318|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
25753319|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753320|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753321|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753322|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25753323|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25753324|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25753325|NCT02926573|Gabapentin|gabapentin|mesh-list
25753326|NCT02926573|Analgesics|analgesics|mesh-ancestor
25753327|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
25753328|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753329|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753330|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
25753331|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25753332|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25753333|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753334|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753335|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25753336|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25753337|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753338|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753339|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
25753340|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25753341|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25753342|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753343|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25753344|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753345|NCT02926950|Metformin|metformin|mesh-list
25753346|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25753347|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25753348|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753349|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25753350|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753351|NCT02927223|Atropine|atropine|mesh-list
25753352|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25753353|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25753354|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25753355|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
25753356|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753357|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753358|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25753359|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
25753360|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
25753361|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
25753362|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25753363|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25753364|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
25753365|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753366|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753367|NCT02927431|Oseltamivir|oseltamivir|mesh-list
25753368|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
25753369|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753370|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753371|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753372|NCT02927457|GSK2646264|gsk2646264|mesh-list
25753373|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25753374|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753375|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753376|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25753377|NCT02927834|Prednisone|prednisone|mesh-list
25753378|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753379|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
25753380|NCT02927834|Hormones|hormones|mesh-ancestor
25753381|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753382|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753383|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753384|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753385|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25753386|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753387|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25753388|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753389|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753390|NCT02927873|Vaccines|vaccines|mesh-list
25753391|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
25753392|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753393|NCT02927925|Daratumumab|daratumumab|mesh-list
25753394|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753395|NCT02928029|Dexamethasone|dexamethasone|mesh-list
25753396|NCT02928029|Bortezomib|bortezomib|mesh-list
25753397|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25753398|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753399|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
25753400|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
25753401|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753402|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753403|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753404|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
25753405|NCT02928029|Hormones|hormones|mesh-ancestor
25753406|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753407|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753408|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753409|NCT02929498|Azacitidine|azacitidine|mesh-list
25753410|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25753411|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
25753412|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753413|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753414|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753415|NCT02929667|Fluoxetine|fluoxetine|mesh-list
25753416|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25753417|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25753418|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25753419|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753420|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753422|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753423|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25753424|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
25753425|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753426|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25753427|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25753428|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753429|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25753430|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25753431|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
25753432|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
25753433|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
25753434|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25753435|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25753436|NCT02930005|Analgesics|analgesics|mesh-ancestor
25753437|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
25753438|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753439|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753440|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753441|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753442|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25753443|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753444|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753445|NCT02930343|Folic Acid|folic acid|mesh-list
25753446|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
25753447|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
25753448|NCT02930343|Prednisolone|prednisolone|mesh-list
25753449|NCT02930343|Methotrexate|methotrexate|mesh-list
25753450|NCT02930343|Leflunomide|leflunomide|mesh-list
25753451|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
25753452|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25753453|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
25753454|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25753455|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753456|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25753457|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
25753458|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753459|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753460|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
25753461|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753462|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25753463|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25753464|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
25753465|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753466|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25753467|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753468|NCT02930343|Hormones|hormones|mesh-ancestor
25753469|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753470|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753471|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753472|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753473|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
25753474|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25753475|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25753476|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753477|NCT02930343|Hematinics|hematinics|mesh-ancestor
25753478|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
25753479|NCT02930343|Vitamins|vitamins|mesh-ancestor
25753480|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
25753481|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25753482|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25753483|NCT02930343|Analgesics|analgesics|mesh-ancestor
25753484|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
25753485|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25753486|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25753487|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25753488|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753489|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
25753490|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25326639|NCT04869579|Protective Agents|protective agents|mesh-ancestor
25753491|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25753492|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753493|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
25753494|NCT02930941|Coagulants|coagulants|mesh-ancestor
25753495|NCT02931045|Clopidogrel|clopidogrel|mesh-list
25753496|NCT02931045|Ticagrelor|ticagrelor|mesh-list
25753497|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25753498|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25753499|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25753500|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25753501|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
25753502|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753503|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753504|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753505|NCT02931253|Metformin|metformin|mesh-list
25753506|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25753507|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753508|NCT02931539|Valganciclovir|valganciclovir|mesh-list
25753509|NCT02931539|Ganciclovir|ganciclovir|mesh-list
25753510|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25753511|NCT02931539|Cidofovir|cidofovir|mesh-list
25753512|NCT02931539|Foscarnet|foscarnet|mesh-list
25753513|NCT02931539|Maribavir|maribavir|mesh-list
25753514|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
25753515|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753516|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25753517|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753518|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753519|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25753520|NCT02931838|BMS-986165|bms-986165|mesh-list
25753521|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
25753522|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25753523|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753524|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753525|NCT02932267|Adapalene|adapalene|mesh-list
25753526|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25753527|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25753528|NCT02932267|Analgesics|analgesics|mesh-ancestor
25753529|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
25753530|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753531|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753532|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753533|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753534|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775612|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25775613|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25775614|NCT03933774|Tretinoin|tretinoin|mesh-list
25775615|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775616|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
25775617|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775618|NCT03933618|Anastrozole|anastrozole|mesh-list
25775619|NCT03933618|Clomiphene|clomiphene|mesh-list
25775620|NCT03933618|Enclomiphene|enclomiphene|mesh-list
25775621|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
25775622|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775623|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25775624|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775625|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25775626|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25775627|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775628|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25775629|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
25775630|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775631|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775632|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25775633|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
25775634|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25775635|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25775636|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25775637|NCT03927105|Nivolumab|nivolumab|mesh-list
25775638|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25775639|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775640|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25775641|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326727|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753536|NCT02932904|Paroxetine|paroxetine|mesh-list
25753537|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25753538|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25753539|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25753540|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753541|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753542|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
25753543|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753544|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25753545|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
25753546|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753547|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25753548|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25753549|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753550|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25753551|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25753552|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753553|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25753554|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25753555|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25753556|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25753557|NCT02933034|Manganese|manganese|mesh-list
25753558|NCT02933034|Trace Elements|trace elements|mesh-ancestor
25753559|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
25753560|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753561|NCT02933320|Rituximab|rituximab|mesh-list
25753562|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25753563|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753564|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
25753565|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753566|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753567|NCT02933372|Varenicline|varenicline|mesh-list
25753568|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25753569|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25753570|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
25753571|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753572|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753573|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753574|NCT02934191|Acetaminophen|acetaminophen|mesh-list
25753575|NCT02934191|Celecoxib|celecoxib|mesh-list
25753576|NCT02934191|Oxycodone|oxycodone|mesh-list
25753577|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
25753578|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753579|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25753580|NCT02934191|Analgesics|analgesics|mesh-ancestor
25753581|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
25753582|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753583|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
25753584|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25753585|NCT02934191|Narcotics|narcotics|mesh-ancestor
25753586|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753587|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25753588|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753589|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753590|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25753591|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25753592|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753593|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753594|NCT02934191|Antacids|antacids|mesh-ancestor
25753595|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753596|NCT02934698|Ivacaftor|ivacaftor|mesh-list
25753597|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25753598|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25753599|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753600|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
25753601|NCT02935699|Promethazine|promethazine|mesh-list
25753602|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25753603|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25753604|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753605|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753606|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
25753607|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
25753608|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
25753609|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753610|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
25753611|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
25753612|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753613|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25753614|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
25753615|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
25753616|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753617|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753618|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25753619|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
25753620|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
25753621|NCT02935738|Prednisolone|prednisolone|mesh-list
25753622|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753623|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
25753624|NCT02935738|Hormones|hormones|mesh-ancestor
25753625|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753626|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753627|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753628|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753629|NCT02935894|Ibuprofen|ibuprofen|mesh-list
25753630|NCT02935894|Pilocarpine|pilocarpine|mesh-list
25753631|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25753632|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25753633|NCT02935894|Analgesics|analgesics|mesh-ancestor
25753634|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
25753635|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753636|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753637|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753638|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753639|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25753640|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753641|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753642|NCT02935894|Miotics|miotics|mesh-ancestor
25753643|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
25753644|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25753645|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25753646|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
25753647|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753648|NCT02936037|Biotin|biotin|mesh-list
25753649|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
25753650|NCT02936037|Vitamins|vitamins|mesh-ancestor
25753651|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
25753652|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753653|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25753654|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25753655|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25753656|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25753657|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
25753658|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753659|NCT02937116|Gemcitabine|gemcitabine|mesh-list
25753660|NCT02937116|Cisplatin|cisplatin|mesh-list
25753661|NCT02937116|Capecitabine|capecitabine|mesh-list
25753662|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
25753663|NCT02937116|Irinotecan|irinotecan|mesh-list
25753664|NCT02937116|Etoposide|etoposide|mesh-list
25753665|NCT02937116|Pemetrexed|pemetrexed|mesh-list
25753666|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753667|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25753668|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
25753669|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753670|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
25753671|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753672|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753673|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25753674|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
25753675|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753676|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25753677|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25753678|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25753679|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25753680|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25753681|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25753682|NCT02937168|Reslizumab|reslizumab|mesh-list
25753683|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25753684|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25753685|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753686|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25753687|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
25753688|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25753689|NCT02937350|Calcifediol|calcifediol|mesh-list
25753690|NCT02937350|Vitamins|vitamins|mesh-ancestor
25753691|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
25753692|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753693|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25753694|NCT02937506|Fentanyl|fentanyl|mesh-list
25753695|NCT02937506|Midazolam|midazolam|mesh-list
25753696|NCT02937506|Propofol|propofol|mesh-list
25753697|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25753698|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753699|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753700|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25753701|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
25753702|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
25753703|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25753704|NCT02937506|Narcotics|narcotics|mesh-ancestor
25753705|NCT02937506|Analgesics|analgesics|mesh-ancestor
25753706|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
25753707|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753708|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25753709|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25753710|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25753711|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753712|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
25753713|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
25753714|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753715|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753716|NCT02937558|Glucagon|glucagon|mesh-list
25753717|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25753718|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753719|NCT02937558|Hormones|hormones|mesh-ancestor
25753720|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753721|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753722|NCT02937558|Incretins|incretins|mesh-ancestor
25753723|NCT02937623|Calcium|calcium|mesh-list
25753724|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25753725|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753726|NCT02937636|Fluorides|fluorides|mesh-list
25753727|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
25753728|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
25753729|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
25753730|NCT02937636|Protective Agents|protective agents|mesh-ancestor
25753731|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753732|NCT02937701|Infliximab|infliximab|mesh-list
25753733|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
25753734|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753735|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25753736|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
25753737|NCT02937740|Testosterone|testosterone|mesh-list
25753738|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
25753739|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
25753740|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25753741|NCT02937740|Androgens|androgens|mesh-ancestor
25753742|NCT02937740|Hormones|hormones|mesh-ancestor
25753743|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753744|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753745|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25753746|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753747|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
25753748|NCT02938494|Tazarotene|tazarotene|mesh-list
25753749|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
25753750|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
25753751|NCT02938585|Factor VIII|factor viii|mesh-list
25753752|NCT02938585|Coagulants|coagulants|mesh-ancestor
25753753|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25753754|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25753755|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753756|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25753757|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25753758|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753759|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25753760|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
25753761|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753762|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
25753763|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25753764|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753765|NCT02939937|Phenytoin|phenytoin|mesh-list
25753766|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
25753767|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25753768|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25753769|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25753770|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753771|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25753772|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25753773|NCT02940574|Oxytocin|oxytocin|mesh-list
25753774|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
25753775|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25753776|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753777|NCT02940691|Grazoprevir|grazoprevir|mesh-list
25753778|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25753779|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
25753780|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753781|NCT02940730|Dalbavancin|dalbavancin|mesh-list
25753782|NCT02940730|Teicoplanin|teicoplanin|mesh-list
25753783|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25753784|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753785|NCT02940860|Iron|iron|mesh-list
25753786|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25753787|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25753788|NCT02940860|Trace Elements|trace elements|mesh-ancestor
25753789|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
25753790|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753791|NCT02940860|Hematinics|hematinics|mesh-ancestor
25753792|NCT02940886|Iron|iron|mesh-list
25753793|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25753794|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25753795|NCT02940886|Trace Elements|trace elements|mesh-ancestor
25753796|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
25753797|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753798|NCT02940886|Hematinics|hematinics|mesh-ancestor
25753799|NCT02941523|Carboplatin|carboplatin|mesh-list
25753800|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753801|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25753802|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25753803|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
25753804|NCT02941640|Hormones|hormones|mesh-ancestor
25753805|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753806|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753807|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753808|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753809|NCT02941692|Oxytocin|oxytocin|mesh-list
25753810|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
25753811|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25753812|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753813|NCT02942264|Temozolomide|temozolomide|mesh-list
25753814|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25753815|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
25753816|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753817|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753818|NCT02942407|Warfarin|warfarin|mesh-list
25753819|NCT02942407|Apixaban|apixaban|mesh-list
25753820|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
25753821|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25753822|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
25753823|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25753824|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
25753825|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753826|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753827|NCT02942485|Metronidazole|metronidazole|mesh-list
25753828|NCT02942485|Tinidazole|tinidazole|mesh-list
25753829|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753830|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25753831|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25753832|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25753833|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
25753834|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753835|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25753836|NCT02942576|Warfarin|warfarin|mesh-list
25753837|NCT02942576|Edoxaban|edoxaban|mesh-list
25753838|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
25753839|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
25753840|NCT02942576|Fluindione|fluindione|mesh-list
25753841|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
25753842|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25753844|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25753845|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
25753846|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753847|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753848|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
25753849|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25753850|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753851|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
25753852|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
25753853|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
25753854|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753855|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753856|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25753857|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25753858|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25753859|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753860|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753861|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25753862|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
25753863|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753864|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775642|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
25775643|NCT03923933|Bumetanide|bumetanide|mesh-list
25775644|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25775645|NCT03923933|Diuretics|diuretics|mesh-ancestor
25775646|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
25775647|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775648|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25775649|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25775650|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775651|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25775652|NCT03909295|Valsartan|valsartan|mesh-list
25775653|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25775654|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25775655|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25775656|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25775657|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775658|NCT03930264|Azathioprine|azathioprine|mesh-list
25775659|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
25775660|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775661|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25775662|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775663|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25775664|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
25775665|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775666|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25775667|NCT03929367|Oxytocin|oxytocin|mesh-list
25775668|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
25775669|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25775670|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775671|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25775672|NCT03928522|Vancomycin|vancomycin|mesh-list
25775673|NCT03928522|Tobramycin|tobramycin|mesh-list
25775674|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775675|NCT03910439|Avelumab|avelumab|mesh-list
25775676|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25775677|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775678|NCT03927950|Citalopram|citalopram|mesh-list
25775679|NCT03927950|Bupropion|bupropion|mesh-list
25775680|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25775681|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25775682|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25775683|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775684|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775685|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
25775686|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775687|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25775688|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
25775689|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775690|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25775691|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
25775692|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25753865|NCT02943668|Deferasirox|deferasirox|mesh-list
25753866|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25753867|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
25753868|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
25753869|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753870|NCT02944461|Dapsone|dapsone|mesh-list
25753871|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753872|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
25753873|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25753874|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25753875|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25753876|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753877|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753878|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
25753879|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25753880|NCT02944565|Daratumumab|daratumumab|mesh-list
25753881|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25753882|NCT02944656|Gabapentin|gabapentin|mesh-list
25753883|NCT02944656|Analgesics|analgesics|mesh-ancestor
25753884|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
25753885|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753886|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753887|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
25753888|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25753889|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25753890|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753891|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25753892|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25753893|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25753894|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753895|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753896|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
25753897|NCT02945150|Grazoprevir|grazoprevir|mesh-list
25753898|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
25753899|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753900|NCT02945410|Vitamin D|vitamin d|mesh-list
25753901|NCT02945410|Calcium|calcium|mesh-list
25753902|NCT02945410|Vitamins|vitamins|mesh-ancestor
25753903|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
25753904|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753905|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25753906|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25753907|NCT02946034|Ribavirin|ribavirin|mesh-list
25753908|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
25753909|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753910|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
25753911|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753912|NCT02946073|Buprenorphine|buprenorphine|mesh-list
25753913|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25753914|NCT02946073|Narcotics|narcotics|mesh-ancestor
25753915|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753916|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753917|NCT02946073|Analgesics|analgesics|mesh-ancestor
25753918|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
25753919|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753920|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25753921|NCT02946385|Vaccines|vaccines|mesh-list
25753922|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
25753923|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753924|NCT02946489|Ketamine|ketamine|mesh-list
25753925|NCT02946489|Analgesics|analgesics|mesh-ancestor
25753926|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
25753927|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753928|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753929|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25753930|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25753931|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
25753932|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
25753933|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25753934|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25753935|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25753936|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753937|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753938|NCT02946580|Naloxegol|naloxegol|mesh-list
25753939|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25753940|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753941|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
25753942|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25753943|NCT02946892|Carvedilol|carvedilol|mesh-list
25753944|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25753945|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25753946|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
25753947|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753948|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753949|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753950|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25753951|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
25753952|NCT02946892|Protective Agents|protective agents|mesh-ancestor
25753953|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25753954|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25753955|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25753956|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
25753957|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25753958|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25753959|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
25753960|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
25753961|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753962|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
25753963|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25753964|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25753965|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25753966|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25753967|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
25753968|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25753969|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753970|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753971|NCT02948777|Evolocumab|evolocumab|mesh-list
25753972|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25753973|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25753974|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
25753975|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753976|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25753977|NCT02949011|Oseltamivir|oseltamivir|mesh-list
25753978|NCT02949011|Baloxavir|baloxavir|mesh-list
25753979|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
25753980|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25753981|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753982|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753983|NCT02949024|Triamcinolone|triamcinolone|mesh-list
25753984|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25753985|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25753986|NCT02949024|Aflibercept|aflibercept|mesh-list
25753987|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25753988|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25753989|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
25753990|NCT02949024|Hormones|hormones|mesh-ancestor
25753991|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25753992|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25753993|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25753994|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
25753995|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25753996|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25753997|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25753998|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25753999|NCT02949024|Growth Substances|growth substances|mesh-ancestor
25754000|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
25754001|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754002|NCT02949271|Fentanyl|fentanyl|mesh-list
25754003|NCT02949271|Ropivacaine|ropivacaine|mesh-list
25754004|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754005|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
25754006|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754007|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754008|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
25754009|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754010|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25754011|NCT02949271|Narcotics|narcotics|mesh-ancestor
25754012|NCT02949271|Analgesics|analgesics|mesh-ancestor
25754013|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25754014|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25754015|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
25754016|NCT02949362|Teduglutide|teduglutide|mesh-list
25754017|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754018|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25754019|NCT02949362|Protective Agents|protective agents|mesh-ancestor
25754020|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754021|NCT02949674|Bupivacaine|bupivacaine|mesh-list
25754022|NCT02949674|Ropivacaine|ropivacaine|mesh-list
25754023|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754024|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
25754025|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754026|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754027|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
25754028|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754029|NCT02949921|Lidocaine|lidocaine|mesh-list
25754030|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754031|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
25754032|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754033|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754034|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
25754035|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754036|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25754037|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25754038|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25754039|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754040|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754041|NCT02950467|Psilocybin|psilocybin|mesh-list
25754042|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25754043|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
25754044|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754045|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25754046|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25754047|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
25754048|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754049|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754050|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25754051|NCT02950558|Ropivacaine|ropivacaine|mesh-list
25754052|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754053|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
25754054|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754055|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754056|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
25754057|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754058|NCT02951156|Gemcitabine|gemcitabine|mesh-list
25754059|NCT02951156|Rituximab|rituximab|mesh-list
25754060|NCT02951156|Avelumab|avelumab|mesh-list
25754061|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
25754062|NCT02951156|Azacitidine|azacitidine|mesh-list
25754063|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25754064|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25754065|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754066|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
25754067|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754068|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754069|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25754070|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
25754071|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754072|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
25754073|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754074|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754075|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25754076|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25754077|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
25754078|NCT02951182|Ivacaftor|ivacaftor|mesh-list
25754079|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25754080|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754081|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754082|NCT02951195|Ivacaftor|ivacaftor|mesh-list
25754083|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25754084|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754085|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754086|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
25754087|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25754088|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25754089|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25754090|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25327371|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
25327373|NCT04859621|Vitamins|vitamins|mesh-list
25754092|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754093|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754094|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754095|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
25754096|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754097|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
25754098|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754099|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754100|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
25754101|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754102|NCT02951429|Pirfenidone|pirfenidone|mesh-list
25754103|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
25754104|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
25754105|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25754106|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25754107|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754108|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754109|NCT02951429|Urological Agents|urological agents|mesh-ancestor
25754110|NCT02951429|Analgesics|analgesics|mesh-ancestor
25754111|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
25754112|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754113|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754114|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25754115|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25754116|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754117|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754118|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754119|NCT02951702|Vancomycin|vancomycin|mesh-list
25754120|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25754121|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754122|NCT02951819|Dexamethasone|dexamethasone|mesh-list
25754123|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
25754124|NCT02951819|Bortezomib|bortezomib|mesh-list
25754125|NCT02951819|Daratumumab|daratumumab|mesh-list
25754126|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25754127|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
25754128|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754129|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754130|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25754131|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
25754132|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754133|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754134|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25754135|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754136|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
25754137|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
25754138|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754139|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754140|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
25754141|NCT02951819|Hormones|hormones|mesh-ancestor
25754142|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754143|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754144|NCT02951884|Bupivacaine|bupivacaine|mesh-list
25754145|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754146|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
25754147|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754148|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754149|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
25754150|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754151|NCT02952001|Triamcinolone|triamcinolone|mesh-list
25754152|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25754153|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25754154|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25754155|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754156|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
25754157|NCT02952001|Hormones|hormones|mesh-ancestor
25754158|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754159|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754160|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25754161|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
25754162|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754163|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754164|NCT02952586|Avelumab|avelumab|mesh-list
25754165|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25754166|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754167|NCT02952820|Lemborexant|lemborexant|mesh-list
25754168|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25754169|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754170|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754171|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25754172|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25754173|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754174|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754175|NCT02952898|Diclofenac|diclofenac|mesh-list
25754176|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25754177|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25754178|NCT02952898|Analgesics|analgesics|mesh-ancestor
25754179|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
25754180|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754181|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754182|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754183|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754184|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25754185|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754186|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754187|NCT02953314|Ivacaftor|ivacaftor|mesh-list
25754188|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25754189|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754190|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754191|NCT02953561|Azacitidine|azacitidine|mesh-list
25754192|NCT02953561|Avelumab|avelumab|mesh-list
25754193|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25754194|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25754195|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
25754196|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754197|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754198|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754199|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25754200|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
25754201|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754202|NCT02953678|Prednisone|prednisone|mesh-list
25754203|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
25754204|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25754205|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25754206|NCT02953678|Prednisolone|prednisolone|mesh-list
25754207|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
25754208|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25754209|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
25754210|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754211|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
25754212|NCT02953678|Hormones|hormones|mesh-ancestor
25754213|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754214|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754215|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754216|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754217|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
25754218|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
25754219|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754220|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754221|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25754222|NCT02953678|Protective Agents|protective agents|mesh-ancestor
25754223|NCT02953782|Cetuximab|cetuximab|mesh-list
25754224|NCT02953782|Magrolimab|magrolimab|mesh-list
25754225|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25754226|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754227|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25754228|NCT02953821|Hormones|hormones|mesh-ancestor
25754229|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754230|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754231|NCT02953860|Fulvestrant|fulvestrant|mesh-list
25754232|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754233|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754234|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25754235|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25754236|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
25775693|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25327556|NCT04856878|Vancomycin|vancomycin|mesh-list
25754237|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754238|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754239|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
25754241|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
25754242|NCT02953873|Tacrolimus|tacrolimus|mesh-list
25754243|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754244|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
25754245|NCT02953873|Hormones|hormones|mesh-ancestor
25754246|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754247|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754248|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754249|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754250|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25754251|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
25754252|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25754253|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754254|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754255|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25754256|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25754257|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
25754258|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25754259|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754260|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
25754261|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
25754262|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754263|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754264|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25754265|NCT02953873|Protective Agents|protective agents|mesh-ancestor
25754266|NCT02953886|Fluorides|fluorides|mesh-list
25754267|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
25754268|NCT02953886|Protective Agents|protective agents|mesh-ancestor
25754269|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754270|NCT02953938|Ranibizumab|ranibizumab|mesh-list
25754271|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25754272|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25754273|NCT02953938|Growth Substances|growth substances|mesh-ancestor
25754274|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754275|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
25754276|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754277|NCT02954172|Paclitaxel|paclitaxel|mesh-list
25754278|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25754279|NCT02954172|Bevacizumab|bevacizumab|mesh-list
25754280|NCT02954172|Carboplatin|carboplatin|mesh-list
25754281|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25754282|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754283|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
25754284|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
25754285|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
25754286|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754287|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25754288|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25754289|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25754290|NCT02954172|Growth Substances|growth substances|mesh-ancestor
25754291|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754292|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
25754293|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
25754294|NCT02954198|Prednisone|prednisone|mesh-list
25754295|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
25754296|NCT02954198|Everolimus|everolimus|mesh-list
25754297|NCT02954198|Tacrolimus|tacrolimus|mesh-list
25754298|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754299|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
25754300|NCT02954198|Hormones|hormones|mesh-ancestor
25754301|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754302|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754303|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754304|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754305|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25754306|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
25754307|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25754308|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754309|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754310|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25754311|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25754312|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
25754313|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25754314|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754316|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
25754317|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754318|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754319|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25754320|NCT02954198|Protective Agents|protective agents|mesh-ancestor
25754321|NCT02954354|Oseltamivir|oseltamivir|mesh-list
25754322|NCT02954354|Baloxavir|baloxavir|mesh-list
25754323|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
25754324|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754325|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754326|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754327|NCT02954575|Factor VIII|factor viii|mesh-list
25754328|NCT02954575|Coagulants|coagulants|mesh-ancestor
25754329|NCT02954601|Insulin|insulin|mesh-list
25754330|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25754331|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25754332|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754333|NCT02954653|Cytarabine|cytarabine|mesh-list
25754334|NCT02954653|Azacitidine|azacitidine|mesh-list
25754335|NCT02954653|Decitabine|decitabine|mesh-list
25754336|NCT02954653|Daunorubicin|daunorubicin|mesh-list
25754337|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25754338|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
25754339|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754340|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754341|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
25754342|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754343|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25754344|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
25754345|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754346|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754347|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25754348|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25754349|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25754350|NCT02955069|Spartalizumab|spartalizumab|mesh-list
25754351|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25754352|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754353|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754354|NCT02955147|Prednisone|prednisone|mesh-list
25754355|NCT02955147|Ustekinumab|ustekinumab|mesh-list
25754356|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754357|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
25754358|NCT02955147|Hormones|hormones|mesh-ancestor
25754359|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754360|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754361|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754362|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754363|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
25754364|NCT02955186|Saracatinib|saracatinib|mesh-list
25754365|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754366|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754367|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754368|NCT02955212|Upadacitinib|upadacitinib|mesh-list
25754369|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25754370|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25754371|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754372|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754373|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754374|NCT02955329|Nicotine|nicotine|mesh-list
25754375|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25754376|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
25754377|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754378|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754379|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25754380|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25754381|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
25754382|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754383|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754384|NCT02956044|Metformin|metformin|mesh-list
25754385|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25754386|NCT02956044|Glimepiride|glimepiride|mesh-list
25327715|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
25754387|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
25754388|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25754389|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754390|NCT02956044|Incretins|incretins|mesh-ancestor
25754391|NCT02956044|Hormones|hormones|mesh-ancestor
25754392|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754393|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25754394|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
25754395|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754396|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754397|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25754398|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25754399|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
25754400|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
25754401|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
25754402|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
25754403|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754404|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
25754405|NCT02956057|Protective Agents|protective agents|mesh-ancestor
25754406|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754407|NCT02956057|Vitamins|vitamins|mesh-ancestor
25754408|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
25754409|NCT02956057|Cathartics|cathartics|mesh-ancestor
25754410|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754411|NCT02956070|Dexamethasone|dexamethasone|mesh-list
25754412|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
25754413|NCT02956070|BB 1101|bb 1101|mesh-list
25754414|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754415|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
25754416|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
25754417|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754418|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754419|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754420|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
25754421|NCT02956070|Hormones|hormones|mesh-ancestor
25754422|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754423|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754424|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754425|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
25754426|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754427|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754428|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
25754429|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25754430|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25754431|NCT02956122|Prednisolone|prednisolone|mesh-list
25754432|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
25754433|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25754434|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
25754435|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
25754436|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25754437|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754438|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
25754439|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
25754440|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754441|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754442|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754443|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
25754444|NCT02956122|Hormones|hormones|mesh-ancestor
25754445|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754446|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25754447|NCT02956122|Protective Agents|protective agents|mesh-ancestor
25754448|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754449|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754450|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754451|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754452|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25754453|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25754454|NCT02956278|Allopurinol|allopurinol|mesh-list
25754455|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
25754456|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754457|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754458|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
25327792|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25327793|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25327794|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327795|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754460|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25754461|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
25754462|NCT02956278|Protective Agents|protective agents|mesh-ancestor
25754463|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775694|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775695|NCT03927781|Pregabalin|pregabalin|mesh-list
25775696|NCT03927781|Analgesics|analgesics|mesh-ancestor
25775697|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
25775698|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775699|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775700|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
25775701|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25775702|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25775703|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775704|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25775705|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25775706|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25775707|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775708|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775709|NCT03895307|Anesthetics|anesthetics|mesh-list
25775710|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
25775711|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775712|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775713|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
25775714|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775715|NCT03905642|Amikacin|amikacin|mesh-list
25775716|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25775717|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775718|NCT03892889|Aripiprazole|aripiprazole|mesh-list
25775719|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
25775720|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775721|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25775722|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25775723|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775724|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775725|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
25775726|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
25775727|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775728|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775729|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25775730|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25775731|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
25775732|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25775733|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25775734|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25775735|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25775736|NCT03921723|Dolutegravir|dolutegravir|mesh-list
25775737|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25775738|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25775739|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775740|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775741|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25775742|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25775743|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
25775744|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775745|NCT03921190|Anesthetics|anesthetics|mesh-list
25775746|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775747|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775748|NCT03920865|Risdiplam|risdiplam|mesh-list
25775749|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25775750|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775751|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775752|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25775753|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25775754|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25327875|NCT04853199|Quercetin|quercetin|mesh-list
25327876|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
25327877|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327878|NCT04853199|Protective Agents|protective agents|mesh-ancestor
25327879|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327880|NCT04853069|Estradiol|estradiol|mesh-list
25327881|NCT04853069|Estrogens|estrogens|mesh-ancestor
25327882|NCT04853069|Hormones|hormones|mesh-ancestor
25327894|NCT04852315|Caffeine|caffeine|mesh-list
25754464|NCT02956616|Ketorolac|ketorolac|mesh-list
25754465|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25754466|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25754467|NCT02956616|Analgesics|analgesics|mesh-ancestor
25754468|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
25754469|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754470|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754471|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754472|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754473|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25754474|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754475|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754476|NCT02956629|Ribavirin|ribavirin|mesh-list
25754477|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
25754478|NCT02956629|Ruzasvir|ruzasvir|mesh-list
25754479|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
25754480|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754481|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
25754482|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754483|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
25754484|NCT02956746|Antibodies|antibodies|mesh-list
25754485|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
25754486|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25754487|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25754488|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
25754489|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754490|NCT02956837|Vaccines|vaccines|mesh-list
25754491|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
25754492|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754493|NCT02957305|Misoprostol|misoprostol|mesh-list
25754494|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25754495|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
25754496|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25754497|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754498|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25754499|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754500|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
25754501|NCT02957331|Propranolol|propranolol|mesh-list
25754502|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25754503|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25754504|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
25754505|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754506|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754507|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754508|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25754509|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25754510|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
25754511|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
25754512|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25754513|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
25754514|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754515|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
25754516|NCT02958267|Protective Agents|protective agents|mesh-ancestor
25754517|NCT02958345|Vaccines|vaccines|mesh-list
25754518|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
25754519|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754520|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25754521|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25754522|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25754523|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754524|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754525|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754526|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754527|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25754528|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
25754529|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25754530|NCT02958956|Pioglitazone|pioglitazone|mesh-list
25754531|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25754532|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754533|NCT02958969|Apixaban|apixaban|mesh-list
25754534|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25754535|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
25327953|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25327954|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25754536|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25754537|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
25754538|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754539|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754540|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
25754541|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
25754542|NCT02959437|Azacitidine|azacitidine|mesh-list
25754543|NCT02959437|INCB057643|incb057643|mesh-list
25754544|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25754545|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754546|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25754547|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
25754548|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754549|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754550|NCT02959840|Ondansetron|ondansetron|mesh-list
25754551|NCT02959840|Metoclopramide|metoclopramide|mesh-list
25754552|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
25754553|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
25754554|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754555|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754556|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754557|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
25754558|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
25754559|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25754560|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
25754561|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754562|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754563|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25754564|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25754565|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754566|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25754567|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25754568|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25754569|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25754570|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
25754571|NCT02959853|Anastrozole|anastrozole|mesh-list
25754572|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754573|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754574|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25754575|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25754576|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754577|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754578|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25754579|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
25754580|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754581|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754582|NCT02959892|Amphetamine|amphetamine|mesh-list
25754583|NCT02959892|Naxagolide|naxagolide|mesh-list
25754584|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25754585|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754586|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
25754587|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
25754588|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754589|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
25754590|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754591|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754592|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
25754593|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25754594|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25754595|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754596|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25754597|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
25754598|NCT02959970|Dapsone|dapsone|mesh-list
25754599|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754600|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
25754601|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25754602|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25754603|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25754604|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754605|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754606|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
25754607|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25754608|NCT02959983|Eluxadoline|eluxadoline|mesh-list
25754609|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328019|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754610|NCT02959996|Bupivacaine|bupivacaine|mesh-list
25754611|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754612|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
25754613|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754614|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754615|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
25754616|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754617|NCT02960438|Quetmolimab|quetmolimab|mesh-list
25754618|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754619|NCT02960490|Quetmolimab|quetmolimab|mesh-list
25754620|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754621|NCT02960854|Nivolumab|nivolumab|mesh-list
25754622|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25754623|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754624|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25754625|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754626|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
25754627|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25754628|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754629|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25754630|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25754631|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754632|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754633|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754634|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25754635|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25754636|NCT02961764|Dalbavancin|dalbavancin|mesh-list
25754637|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25754638|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754639|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
25754640|NCT02961790|Oxybutynin|oxybutynin|mesh-list
25754641|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
25754642|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
25754643|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754644|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754645|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25754646|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25754647|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
25754648|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754649|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754650|NCT02961790|Urological Agents|urological agents|mesh-ancestor
25754651|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25754652|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754653|NCT02961790|Renal Agents|renal agents|mesh-ancestor
25754654|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
25754655|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
25754656|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
25754657|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25754658|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25754659|NCT02962284|Prednisolone|prednisolone|mesh-list
25754660|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
25754661|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
25754662|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25754663|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
25754664|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754665|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
25754666|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
25754667|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754668|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754669|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754670|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
25754671|NCT02962284|Hormones|hormones|mesh-ancestor
25754672|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754673|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25754674|NCT02962284|Protective Agents|protective agents|mesh-ancestor
25754675|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754676|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754677|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25754678|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754679|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754680|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
25754681|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25754682|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25754683|NCT02962648|Hematinics|hematinics|mesh-ancestor
25754684|NCT02962739|Tenofovir|tenofovir|mesh-list
25754685|NCT02962739|Emtricitabine|emtricitabine|mesh-list
25754686|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
25754687|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754688|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25754689|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25754690|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754691|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754692|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25754693|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25754694|NCT02963701|Ibuprofen|ibuprofen|mesh-list
25754695|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
25754696|NCT02963701|Ephedrine|ephedrine|mesh-list
25754697|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25754698|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25754699|NCT02963701|Analgesics|analgesics|mesh-ancestor
25754700|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
25754701|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754702|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754703|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754704|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754705|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25754706|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754707|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754708|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25754709|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
25754710|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25754711|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
25754712|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
25754713|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25754714|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25754715|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
25754716|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
25754717|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754718|NCT02963922|Liraglutide|liraglutide|mesh-list
25754719|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25754720|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754721|NCT02963922|Incretins|incretins|mesh-ancestor
25754722|NCT02963922|Hormones|hormones|mesh-ancestor
25754723|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754724|NCT02963935|Liraglutide|liraglutide|mesh-list
25754725|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25754726|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754727|NCT02963935|Incretins|incretins|mesh-ancestor
25754728|NCT02963935|Hormones|hormones|mesh-ancestor
25754729|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754730|NCT02964247|Liraglutide|liraglutide|mesh-list
25754731|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25754732|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754733|NCT02964247|Incretins|incretins|mesh-ancestor
25754734|NCT02964247|Hormones|hormones|mesh-ancestor
25754735|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754736|NCT02964416|Tramadol|tramadol|mesh-list
25754737|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25754738|NCT02964416|Narcotics|narcotics|mesh-ancestor
25754739|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754740|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754741|NCT02964416|Analgesics|analgesics|mesh-ancestor
25754742|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
25754743|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754744|NCT02965378|Docetaxel|docetaxel|mesh-list
25754745|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754746|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
25754747|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
25754748|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
25754749|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754750|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
25754751|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25754752|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
25754753|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754754|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
25754755|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25754756|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
25754757|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754758|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25754759|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
25754760|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25754761|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25754762|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754763|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
25754765|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
25754766|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25754767|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
25754768|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
25754769|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754770|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754771|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
25754772|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25754773|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
25754774|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
25754775|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25754776|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25754777|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25754778|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
25754779|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754780|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754781|NCT02965924|Protective Agents|protective agents|mesh-ancestor
25754782|NCT02966002|Aspirin|aspirin|mesh-list
25754783|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25754784|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25754785|NCT02966002|Analgesics|analgesics|mesh-ancestor
25754786|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
25754787|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754788|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754789|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25754790|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754791|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25754792|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25754793|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754794|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25754795|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25754796|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754797|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
25754798|NCT02966275|Glucagon|glucagon|mesh-list
25754799|NCT02966275|Pancrelipase|pancrelipase|mesh-list
25754800|NCT02966275|Pancreatin|pancreatin|mesh-list
25754801|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25754802|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754803|NCT02966275|Hormones|hormones|mesh-ancestor
25754804|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754805|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754806|NCT02966275|Incretins|incretins|mesh-ancestor
25754807|NCT02966314|Omalizumab|omalizumab|mesh-list
25754808|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25754809|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25754810|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
25754811|NCT02966340|Prazosin|prazosin|mesh-list
25754812|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25754813|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25754814|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25754815|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25754816|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
25754817|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754818|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754819|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775755|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775756|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775757|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775758|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25775759|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25775760|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25775761|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
25775762|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775763|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775764|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25775765|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25775766|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
25775767|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25775768|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25775769|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
25775770|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
25775771|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
25775772|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754820|NCT02967354|Tryptophan|tryptophan|mesh-list
25754821|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
25754822|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25754823|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
25754824|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25754825|NCT02967679|Biotin|biotin|mesh-list
25754826|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
25754827|NCT02967679|Vitamins|vitamins|mesh-ancestor
25754828|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
25754829|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754830|NCT02968134|Posaconazole|posaconazole|mesh-list
25754831|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
25754832|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754833|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25754834|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25754835|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25754836|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25754837|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25754838|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754839|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754840|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25754841|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
25754842|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754843|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754844|NCT02968173|Palivizumab|palivizumab|mesh-list
25754845|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
25754846|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754847|NCT02968368|Ferric maltol|ferric maltol|mesh-list
25754848|NCT02968368|Hematinics|hematinics|mesh-ancestor
25754849|NCT02968576|Tenofovir|tenofovir|mesh-list
25754850|NCT02968576|Emtricitabine|emtricitabine|mesh-list
25754851|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25754852|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
25754853|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25754854|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25754855|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25754856|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754857|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754858|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25754859|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25754860|NCT02968914|Benralizumab|benralizumab|mesh-list
25754861|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25754862|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
25754863|NCT02969018|PF-06700841|pf-06700841|mesh-list
25754864|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25754865|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25754866|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754867|NCT02969187|Bupivacaine|bupivacaine|mesh-list
25754868|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
25754869|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
25754870|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754871|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754872|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
25754873|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754874|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
25754875|NCT02969317|Olodaterol|olodaterol|mesh-list
25754876|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25754877|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
25754878|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754879|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754880|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25754881|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
25754882|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
25754883|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25754884|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
25754885|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754886|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754887|NCT02969408|Albuterol|albuterol|mesh-list
25754888|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25754889|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
25328318|NCT04847895|Growth Substances|growth substances|mesh-ancestor
25328319|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328320|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
25328321|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328322|NCT04847947|Vitamin D|vitamin d|mesh-list
25328323|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
25754890|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754891|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754892|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25754893|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
25754894|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
25754895|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25754896|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25754897|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25754898|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25754899|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
25754900|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754901|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754902|NCT02969590|Leuprolide|leuprolide|mesh-list
25754903|NCT02969590|Norethindrone|norethindrone|mesh-list
25754904|NCT02969590|Estradiol|estradiol|mesh-list
25754905|NCT02969590|Estrogens|estrogens|mesh-list
25754906|NCT02969590|Progesterone|progesterone|mesh-list
25754907|NCT02969590|Progestins|progestins|mesh-list
25754908|NCT02969590|Hormones|hormones|mesh-ancestor
25754909|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754910|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754911|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25754912|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
25754913|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25754914|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25754915|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25754916|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
25754917|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25754918|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25754919|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25754920|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25754921|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25754922|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
25754923|NCT02969655|Glycine|glycine|mesh-list
25754924|NCT02969655|Hematinics|hematinics|mesh-ancestor
25754925|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
25754926|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754927|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754928|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754929|NCT02969863|Pancrelipase|pancrelipase|mesh-list
25754930|NCT02969863|Pancreatin|pancreatin|mesh-list
25754931|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25754932|NCT02969876|Vortioxetine|vortioxetine|mesh-list
25754933|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
25754934|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25754935|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25754936|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25754937|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754938|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754939|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25754940|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25754941|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754942|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754943|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754944|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
25754945|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25754946|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25754947|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25754948|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25754949|NCT02970032|Heparin|heparin|mesh-list
25754950|NCT02970032|Calcium heparin|calcium heparin|mesh-list
25754951|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
25754952|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25754953|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25754954|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754955|NCT02970162|Amifampridine|amifampridine|mesh-list
25754956|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25754957|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25754958|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754959|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25754960|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25754961|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754962|NCT02970292|Pimavanserin|pimavanserin|mesh-list
25328390|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
25754963|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25754964|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25754965|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25754966|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25754967|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754968|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754969|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25754970|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25754971|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25754972|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
25754973|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754974|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754976|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25754977|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25754978|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25754979|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25754980|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25754981|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754982|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25754983|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25754984|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25754985|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
25754986|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25754987|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25754988|NCT02970552|Progesterone|progesterone|mesh-list
25754989|NCT02970552|Progestins|progestins|mesh-ancestor
25754990|NCT02970552|Hormones|hormones|mesh-ancestor
25754991|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25754992|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25754993|NCT02970669|Valsartan|valsartan|mesh-list
25754994|NCT02970669|Enalapril|enalapril|mesh-list
25754995|NCT02970669|Enalaprilat|enalaprilat|mesh-list
25754996|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25754997|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25754998|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25754999|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25755000|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755001|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25755002|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
25755003|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755004|NCT02971007|Fluconazole|fluconazole|mesh-list
25755005|NCT02971007|Amphotericin B|amphotericin b|mesh-list
25755006|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25755007|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
25755008|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755009|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25755010|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25755011|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755012|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755013|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25755014|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
25755015|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755016|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755017|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25755018|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25755019|NCT02971007|Amebicides|amebicides|mesh-ancestor
25755020|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25755021|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25755022|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25755023|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
25755024|NCT02971228|Glucagon|glucagon|mesh-list
25755025|NCT02971228|Pancrelipase|pancrelipase|mesh-list
25755026|NCT02971228|Pancreatin|pancreatin|mesh-list
25755027|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25755028|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755029|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755030|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755031|NCT02971228|Hormones|hormones|mesh-ancestor
25755032|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755033|NCT02971228|Incretins|incretins|mesh-ancestor
25755034|NCT02971605|Psilocybin|psilocybin|mesh-list
25755035|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
25755036|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755037|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755038|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
25755039|NCT02972502|Promethazine|promethazine|mesh-list
25755040|NCT02972502|Haloperidol|haloperidol|mesh-list
25755041|NCT02972502|Metoclopramide|metoclopramide|mesh-list
25755042|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
25755043|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25755044|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25755045|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755046|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755047|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
25755048|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
25755049|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
25755050|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755051|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
25755052|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
25755053|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755054|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25755055|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
25755056|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
25755057|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755058|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755059|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25755060|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
25755061|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25755062|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25755063|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25755064|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755065|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25755066|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
25755067|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25755068|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25755069|NCT02972554|Propranolol|propranolol|mesh-list
25755070|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25755071|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25755072|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
25755073|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755074|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755075|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755076|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25755077|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25755078|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
25755079|NCT02972632|Vortioxetine|vortioxetine|mesh-list
25755080|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
25755081|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755082|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25755083|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25755084|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755085|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755086|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25755087|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25755088|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25755089|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755090|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755091|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
25755092|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25755093|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25755094|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25755095|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25755096|NCT02973048|Bupivacaine|bupivacaine|mesh-list
25755097|NCT02973048|Prilocaine|prilocaine|mesh-list
25755098|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
25755099|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
25755100|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755101|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755102|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
25755103|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755104|NCT02973087|Factor VIII|factor viii|mesh-list
25755105|NCT02973087|Coagulants|coagulants|mesh-ancestor
25755106|NCT02973100|Dulaglutide|dulaglutide|mesh-list
25755107|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755108|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755109|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
25755110|NCT02973477|Glimepiride|glimepiride|mesh-list
25755111|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25755112|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755113|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755114|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755115|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25755116|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25755117|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
25755118|NCT02973503|Grazoprevir|grazoprevir|mesh-list
25755119|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25755120|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
25755121|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755122|NCT02974010|Cycloserine|cycloserine|mesh-list
25755123|NCT02974010|Ketamine|ketamine|mesh-list
25755124|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25755125|NCT02974010|Analgesics|analgesics|mesh-ancestor
25755126|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
25755127|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755128|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755129|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25755130|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25755131|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
25755132|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
25755133|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755134|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25755135|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25755136|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755137|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755138|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25755139|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755140|NCT02974010|Renal Agents|renal agents|mesh-ancestor
25755141|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25755142|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
25755143|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25755144|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
25755145|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25755146|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25755147|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755148|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25755149|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25755150|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25755151|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
25755152|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25755153|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25755154|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
25755155|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25755156|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25755157|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
25755158|NCT02974114|Acetaminophen|acetaminophen|mesh-list
25755159|NCT02974114|Caffeine|caffeine|mesh-list
25755160|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755161|NCT02974114|Analgesics|analgesics|mesh-ancestor
25755162|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
25755163|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755164|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755165|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
25755166|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25755167|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25755168|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755169|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755170|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25755171|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25755172|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
25755173|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755174|NCT02974868|PF-06700841|pf-06700841|mesh-list
25755175|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25755176|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755177|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755178|NCT02975206|Serlopitant|serlopitant|mesh-list
25755179|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25755180|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755181|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755182|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755183|NCT02975297|Exenatide|exenatide|mesh-list
25328636|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25328638|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
25328639|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755184|NCT02975297|Nicotine|nicotine|mesh-list
25755185|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25755186|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
25755187|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755188|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755189|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25755190|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25755191|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
25755192|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755193|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755194|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755195|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25755196|NCT02975297|Incretins|incretins|mesh-ancestor
25755197|NCT02975297|Hormones|hormones|mesh-ancestor
25755198|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755199|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25755200|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25755201|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25755202|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
25755203|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755204|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25755205|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
25755206|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25755207|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25755208|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25755209|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25755210|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
25755211|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755212|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755213|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755214|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25755215|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25755216|NCT02976103|Analgesics|analgesics|mesh-list
25755217|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
25755218|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755219|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755220|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
25755221|NCT02977507|Hydroquinone|hydroquinone|mesh-list
25755222|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25755223|NCT02977507|Protective Agents|protective agents|mesh-ancestor
25755224|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755225|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
25755226|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
25755227|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755228|NCT02978157|Amoxicillin|amoxicillin|mesh-list
25755229|NCT02978157|Levofloxacin|levofloxacin|mesh-list
25755230|NCT02978157|Ofloxacin|ofloxacin|mesh-list
25755231|NCT02978157|Tetracycline|tetracycline|mesh-list
25755232|NCT02978157|Esomeprazole|esomeprazole|mesh-list
25755233|NCT02978157|Bismuth|bismuth|mesh-list
25755234|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25755235|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755236|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25755237|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755238|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25755239|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755240|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755241|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25755242|NCT02978157|Renal Agents|renal agents|mesh-ancestor
25755243|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25755244|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25755245|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755246|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25755247|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25755248|NCT02978157|Antacids|antacids|mesh-ancestor
25755249|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25775773|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775774|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775775|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
25775776|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
25775777|NCT03911843|Vitamin D|vitamin d|mesh-list
25775778|NCT03911843|Vitamins|vitamins|mesh-ancestor
25775779|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
25775780|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775781|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25775782|NCT03896633|Brinzolamide|brinzolamide|mesh-list
25755250|NCT02978339|Curcumin|curcumin|mesh-list
25755251|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25755252|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755253|NCT02978339|Analgesics|analgesics|mesh-ancestor
25755254|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
25755255|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755256|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755257|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755258|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25755259|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755260|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755261|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755262|NCT02978417|Naltrexone|naltrexone|mesh-list
25755263|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25755264|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25755265|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755266|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
25755267|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755268|NCT02978508|Permethrin|permethrin|mesh-list
25755269|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755270|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755271|NCT02979197|Celecoxib|celecoxib|mesh-list
25755272|NCT02979197|Amlodipine|amlodipine|mesh-list
25755273|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25755274|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25755275|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25755276|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755277|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25755278|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755279|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
25755280|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25755281|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755282|NCT02979197|Analgesics|analgesics|mesh-ancestor
25755283|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
25755284|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755285|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755286|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25755287|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25755288|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25755289|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755290|NCT02979301|Tamoxifen|tamoxifen|mesh-list
25755291|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25755292|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
25755293|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755294|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755295|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25755296|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755297|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25755298|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25755299|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25755300|NCT02979431|Gontivimab|gontivimab|mesh-list
25755301|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
25755302|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755303|NCT02980042|Rituximab|rituximab|mesh-list
25755304|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
25755305|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25755306|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755307|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
25755308|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755309|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25755310|NCT02980133|Fluticasone|fluticasone|mesh-list
25755311|NCT02980133|Xhance|xhance|mesh-list
25755312|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25755313|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755314|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25755315|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
25755316|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755317|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755318|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25755319|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
25755320|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
25755321|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25755322|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25755323|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25328828|NCT04841096|Glimepiride|glimepiride|mesh-list
25755324|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25755325|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
25755326|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755327|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755328|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
25755329|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
25755330|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
25755331|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25755332|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
25755333|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25755334|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25755335|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755336|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25755337|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25755338|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755339|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755340|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755341|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755342|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25755343|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
25755344|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
25755345|NCT02980523|Protective Agents|protective agents|mesh-ancestor
25755346|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
25755347|NCT02980783|Lidocaine|lidocaine|mesh-list
25755348|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
25755349|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
25755350|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755351|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755352|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
25755353|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755354|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25755355|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25755356|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25755357|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25755358|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755359|NCT02980874|Triamcinolone|triamcinolone|mesh-list
25755360|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25755361|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25755362|NCT02980874|Aflibercept|aflibercept|mesh-list
25755363|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25755364|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755365|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
25755366|NCT02980874|Hormones|hormones|mesh-ancestor
25755367|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755368|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755369|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25755370|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
25755371|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755372|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755373|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25755374|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25755375|NCT02980874|Growth Substances|growth substances|mesh-ancestor
25755376|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
25755377|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755378|NCT02981342|Gemcitabine|gemcitabine|mesh-list
25755379|NCT02981342|Capecitabine|capecitabine|mesh-list
25755380|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25755381|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
25755382|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755383|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755384|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
25755385|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755386|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755387|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25755388|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
25755389|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755390|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
25755391|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
25755392|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
25755393|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755394|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25755395|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25755396|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25755397|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
25328938|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755398|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755399|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755400|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25755401|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25755402|NCT02982590|Warfarin|warfarin|mesh-list
25755403|NCT02982590|Apixaban|apixaban|mesh-list
25755404|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
25755405|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25755406|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
25755407|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25755408|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
25755409|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755410|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755411|NCT02982772|Nicotine|nicotine|mesh-list
25755412|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25755413|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
25755414|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755415|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755416|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25755417|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25755418|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
25755419|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755420|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755421|NCT02983604|Fulvestrant|fulvestrant|mesh-list
25755422|NCT02983604|Exemestane|exemestane|mesh-list
25755423|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25755424|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755425|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25755426|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25755427|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
25755428|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755429|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755430|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25755431|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25755432|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755433|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755434|NCT02983981|Desoximetasone|desoximetasone|mesh-list
25755435|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755436|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
25755437|NCT02983981|Hormones|hormones|mesh-ancestor
25755438|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755439|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755440|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
25755441|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25755442|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755443|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755444|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755445|NCT02984982|Anticoagulants|anticoagulants|mesh-list
25755446|NCT02984982|Atorvastatin|atorvastatin|mesh-list
25755447|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25755448|NCT02984982|Ezetimibe|ezetimibe|mesh-list
25755449|NCT02984982|Fenofibrate|fenofibrate|mesh-list
25755450|NCT02984982|Bezafibrate|bezafibrate|mesh-list
25755451|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25755452|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25755453|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
25755454|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755455|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25755456|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25755457|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755458|NCT02985021|Carboplatin|carboplatin|mesh-list
25755459|NCT02985021|Docetaxel|docetaxel|mesh-list
25755460|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755461|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25755462|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25755463|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
25755464|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755465|NCT02985879|Tilavonemab|tilavonemab|mesh-list
25755466|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
25755467|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25755468|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25755469|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25755470|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25755471|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755472|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755473|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
25755474|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755475|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25755476|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25755477|NCT02986139|Etanercept|etanercept|mesh-list
25755478|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25755479|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755480|NCT02986139|Analgesics|analgesics|mesh-ancestor
25755481|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
25755482|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755483|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755484|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755485|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25755486|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755487|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25755488|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
25755489|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
25755490|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
25755491|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
25755492|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755493|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755494|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25755495|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
25755496|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755497|NCT02988050|Lidocaine|lidocaine|mesh-list
25755498|NCT02988050|Epinephrine|epinephrine|mesh-list
25755499|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
25755500|NCT02988050|Remifentanil|remifentanil|mesh-list
25755501|NCT02988050|Bupivacaine|bupivacaine|mesh-list
25755502|NCT02988050|Propofol|propofol|mesh-list
25755503|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
25755504|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
25755505|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755506|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755507|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
25755508|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755509|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25755510|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25755511|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25755512|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25755513|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755514|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25755515|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25755516|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
25755517|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755518|NCT02988050|Analgesics|analgesics|mesh-ancestor
25755519|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25755520|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25755521|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25755522|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
25755523|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755524|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25755525|NCT02988050|Narcotics|narcotics|mesh-ancestor
25755526|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25755527|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25755528|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
25755529|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25755530|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25755531|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
25755532|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
25755533|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25755534|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25755535|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25755536|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
25755537|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755538|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25755539|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755540|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755541|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755542|NCT02988219|Epinephrine|epinephrine|mesh-list
25755543|NCT02988219|Fentanyl|fentanyl|mesh-list
25755544|NCT02988219|Bupivacaine|bupivacaine|mesh-list
25329122|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755545|NCT02988219|Anesthetics|anesthetics|mesh-list
25755546|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
25755547|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755548|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755549|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
25755550|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755551|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25755552|NCT02988219|Narcotics|narcotics|mesh-ancestor
25755553|NCT02988219|Analgesics|analgesics|mesh-ancestor
25755554|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25755555|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25755556|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
25755557|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25755558|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25755559|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
25755560|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755561|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755562|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25755563|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25755564|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
25755565|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25755566|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
25755567|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
25755568|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
25755569|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25755570|NCT02988349|Listerine|listerine|mesh-list
25755571|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
25755572|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
25755573|NCT02988349|Protective Agents|protective agents|mesh-ancestor
25755574|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755575|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25755576|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755577|NCT02988843|Bevacizumab|bevacizumab|mesh-list
25755578|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25755579|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25755580|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755581|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25755582|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25755583|NCT02988843|Growth Substances|growth substances|mesh-ancestor
25755584|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755585|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
25755586|NCT02988882|Dexamethasone|dexamethasone|mesh-list
25755587|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755588|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
25755589|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
25755590|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755591|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755592|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755593|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
25755594|NCT02988882|Hormones|hormones|mesh-ancestor
25755595|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755596|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25755597|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755598|NCT02988986|Tamoxifen|tamoxifen|mesh-list
25755599|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25755600|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
25755601|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755602|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755603|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25755604|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755605|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25755606|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25755607|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25755608|NCT02989389|Itraconazole|itraconazole|mesh-list
25755609|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
25755610|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755611|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25755612|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25755613|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755614|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755615|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25755616|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
25755617|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755618|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755619|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25755620|NCT02989493|Doxazosin|doxazosin|mesh-list
25755621|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25755622|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25755623|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25755624|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25755625|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
25755626|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755627|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755628|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755629|NCT02989649|Metformin|metformin|mesh-list
25755630|NCT02989649|Pioglitazone|pioglitazone|mesh-list
25755631|NCT02989649|Alogliptin|alogliptin|mesh-list
25755632|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755633|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755634|NCT02989649|Incretins|incretins|mesh-ancestor
25755635|NCT02989649|Hormones|hormones|mesh-ancestor
25755636|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755637|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25755638|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
25755639|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755640|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755641|NCT02989714|Nivolumab|nivolumab|mesh-list
25755642|NCT02989714|Interleukin-2|interleukin-2|mesh-list
25755643|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25755644|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755645|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25755646|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755647|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755648|NCT02989714|Analgesics|analgesics|mesh-ancestor
25755649|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
25755650|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755651|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755652|NCT02989727|Lamotrigine|lamotrigine|mesh-list
25755653|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
25755654|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25755655|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25755656|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755657|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25755658|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755659|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25755660|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25755661|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755662|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755663|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25775783|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25775784|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775785|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775786|NCT03894813|Metronidazole|metronidazole|mesh-list
25775787|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775788|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25775789|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25775790|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25775791|NCT03906448|Temozolomide|temozolomide|mesh-list
25775792|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25775793|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
25775794|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775795|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775796|NCT03909763|Danazol|danazol|mesh-list
25775797|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25775798|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
25775799|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775800|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775801|NCT03903822|PF-06700841|pf-06700841|mesh-list
25775802|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25775803|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775804|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775805|NCT03905096|Donepezil|donepezil|mesh-list
25775806|NCT03905096|BI 425809|bi 425809|mesh-list
25775807|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25775808|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775809|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329428|NCT04835064|Gemcitabine|gemcitabine|mesh-list
25755664|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
25755665|NCT02990910|Narcotics|narcotics|mesh-ancestor
25755666|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755667|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755668|NCT02990910|Analgesics|analgesics|mesh-ancestor
25755669|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
25755670|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755672|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
25755673|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
25755674|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755675|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755676|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
25755677|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755678|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25755679|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25755680|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25755681|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25755682|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755683|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25755684|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25755685|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
25755686|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755687|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25755688|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755689|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25755690|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755691|NCT02991859|Fluticasone|fluticasone|mesh-list
25755692|NCT02991859|Xhance|xhance|mesh-list
25755693|NCT02991859|Budesonide|budesonide|mesh-list
25755694|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755695|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25755696|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
25755697|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755698|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755699|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25755700|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
25755701|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
25755702|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25755703|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
25755704|NCT02991859|Hormones|hormones|mesh-ancestor
25755705|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755706|NCT02992132|Pimavanserin|pimavanserin|mesh-list
25755707|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25755708|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25755709|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25755710|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25755711|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755712|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755713|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755714|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25755715|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25755716|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
25755717|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755718|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755719|NCT02993224|Deferasirox|deferasirox|mesh-list
25755720|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25755721|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
25755722|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
25755723|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755724|NCT02993250|Simeprevir|simeprevir|mesh-list
25755725|NCT02993250|Odalasvir|odalasvir|mesh-list
25755726|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
25755727|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755728|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
25755729|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755730|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755731|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
25755732|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25755733|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25755734|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755735|NCT02993302|Vitamins|vitamins|mesh-ancestor
25755736|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
25755737|NCT02993471|Vitamin K|vitamin k|mesh-list
25755738|NCT02993471|Midazolam|midazolam|mesh-list
25755739|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
25755740|NCT02993471|Caffeine|caffeine|mesh-list
25755741|NCT02993471|Ixekizumab|ixekizumab|mesh-list
25755742|NCT02993471|Omeprazole|omeprazole|mesh-list
25755743|NCT02993471|Warfarin|warfarin|mesh-list
25755744|NCT02993471|Vitamins|vitamins|mesh-ancestor
25755745|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
25755746|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755747|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25755748|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25755749|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755750|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25755751|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25755752|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755753|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25755754|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
25755755|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
25755756|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
25755757|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
25755758|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755759|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755760|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
25755761|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25755762|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755763|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25755764|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755765|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25755766|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25755767|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25755768|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25755769|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
25755770|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25755771|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25755772|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
25755773|NCT02993471|Coagulants|coagulants|mesh-ancestor
25755774|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
25755775|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
25755776|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25755777|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25755778|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
25755779|NCT02993783|Vedolizumab|vedolizumab|mesh-list
25755780|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755781|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
25755782|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25755783|NCT02994056|Velpatasvir|velpatasvir|mesh-list
25755784|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
25755785|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755786|NCT02994394|Tolvaptan|tolvaptan|mesh-list
25755787|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25755788|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755789|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
25755790|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755791|NCT02994940|Acetaminophen|acetaminophen|mesh-list
25755792|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755793|NCT02994940|Analgesics|analgesics|mesh-ancestor
25755794|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
25755795|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755796|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755797|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
25755798|NCT02995915|Bupropion|bupropion|mesh-list
25755799|NCT02995915|Nicotine|nicotine|mesh-list
25755800|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25755801|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
25755802|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755803|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755804|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25755805|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25755806|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
25755807|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755808|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755809|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25755810|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
25755811|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755812|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25755813|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25755814|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25755815|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
25755816|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25755817|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25755818|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755819|NCT02996097|Triamcinolone|triamcinolone|mesh-list
25755820|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25755821|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25755822|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25755823|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755824|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
25755825|NCT02996097|Hormones|hormones|mesh-ancestor
25755826|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755827|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755828|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25755829|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
25755830|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755831|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755832|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
25755833|NCT02996474|Decitabine|decitabine|mesh-list
25755834|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25755835|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755836|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25755837|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
25755838|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755839|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755840|NCT02996500|Tofacitinib|tofacitinib|mesh-list
25755841|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25755842|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755843|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755844|NCT02996591|Dexamethasone|dexamethasone|mesh-list
25755845|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
25755846|NCT02996591|Midazolam|midazolam|mesh-list
25755847|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
25755848|NCT02996591|Ketamine|ketamine|mesh-list
25755849|NCT02996591|Bupivacaine|bupivacaine|mesh-list
25755850|NCT02996591|Mepivacaine|mepivacaine|mesh-list
25755851|NCT02996591|Anesthetics|anesthetics|mesh-list
25755852|NCT02996591|Propofol|propofol|mesh-list
25755853|NCT02996591|Sevoflurane|sevoflurane|mesh-list
25755854|NCT02996591|BB 1101|bb 1101|mesh-list
25755855|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755856|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
25755857|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
25755858|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755859|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755860|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25755861|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
25755862|NCT02996591|Hormones|hormones|mesh-ancestor
25755863|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25755864|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25755865|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755866|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
25755867|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755868|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755869|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
25755870|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755871|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
25755872|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25755873|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25755874|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
25755875|NCT02996591|Analgesics|analgesics|mesh-ancestor
25755876|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25755877|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25755878|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25755879|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755880|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25755881|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25755882|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25755883|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25755884|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
25755885|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
25755886|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25755887|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25755888|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25755889|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25755890|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
25755891|NCT02996682|Ribavirin|ribavirin|mesh-list
25775810|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
25755892|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25755893|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
25755894|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755895|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
25755896|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755897|NCT02997163|Talazoparib|talazoparib|mesh-list
25755898|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25755899|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755900|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755901|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755902|NCT02997176|Talazoparib|talazoparib|mesh-list
25755903|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25755904|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755905|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755906|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755907|NCT02997722|Ketamine|ketamine|mesh-list
25755908|NCT02997722|Analgesics|analgesics|mesh-ancestor
25755909|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
25755910|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755911|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755912|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25755913|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25755914|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
25755915|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
25755916|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25755917|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25755918|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25755919|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755920|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755921|NCT02998151|Minocycline|minocycline|mesh-list
25755922|NCT02998151|Acamprosate|acamprosate|mesh-list
25755923|NCT02998151|Baclofen|baclofen|mesh-list
25755924|NCT02998151|Lovastatin|lovastatin|mesh-list
25755925|NCT02998151|L 647318|l 647318|mesh-list
25755926|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
25755927|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25755928|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25755929|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25755930|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755931|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25755932|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755933|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25755934|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
25755935|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
25755936|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25755937|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755938|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25755939|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25755940|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
25755941|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25755942|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25755943|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755944|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25755945|NCT02998996|Endocine|endocine|mesh-list
25755946|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25755947|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
25755948|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755949|NCT02999100|Oxytocin|oxytocin|mesh-list
25755950|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
25755951|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25755952|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755953|NCT02999178|Nintedanib|nintedanib|mesh-list
25755954|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755955|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25755956|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755957|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755958|NCT02999672|Trastuzumab|trastuzumab|mesh-list
25755959|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25755960|NCT02999672|Maytansine|maytansine|mesh-list
25755961|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25755962|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755963|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25755964|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
25755965|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
25755966|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
25755967|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755968|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25755969|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
25755970|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755972|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25755973|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755974|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
25755975|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755976|NCT03000309|Apremilast|apremilast|mesh-list
25755977|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25755978|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25755979|NCT03000309|Analgesics|analgesics|mesh-ancestor
25755980|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
25755981|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25755982|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25755983|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25755984|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25755985|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25755986|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25755987|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25755988|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755989|NCT03000348|Cysteamine|cysteamine|mesh-list
25755990|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25755991|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25755992|NCT03000452|Durvalumab|durvalumab|mesh-list
25755993|NCT03000452|Daratumumab|daratumumab|mesh-list
25755994|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25755995|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25755996|NCT03000673|Heparin|heparin|mesh-list
25755997|NCT03000673|Enoxaparin|enoxaparin|mesh-list
25755998|NCT03000673|Calcium heparin|calcium heparin|mesh-list
25755999|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
25756000|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25756001|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25756002|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756003|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25756004|NCT03001076|Ezetimibe|ezetimibe|mesh-list
25756005|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25756006|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25756007|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
25756008|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756009|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25756010|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756011|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756012|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756013|NCT03001219|Methotrexate|methotrexate|mesh-list
25756014|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25756015|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
25756016|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25756017|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756018|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25756019|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
25756020|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756021|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756022|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
25756023|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756024|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25756025|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756026|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
25756027|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756028|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25756029|NCT03001453|Epinephrine|epinephrine|mesh-list
25756030|NCT03001453|Bupivacaine|bupivacaine|mesh-list
25756031|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756032|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
25756033|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756034|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756035|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
25756036|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756037|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25756038|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25756039|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
25756040|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756041|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756042|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25756043|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25756045|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25756046|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
25756047|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
25756048|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
25756049|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25756050|NCT03001557|Lemborexant|lemborexant|mesh-list
25756051|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25756052|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756053|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756054|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25756055|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25756056|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756057|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756058|NCT03001843|Ketamine|ketamine|mesh-list
25756059|NCT03001843|Narcotics|narcotics|mesh-list
25756060|NCT03001843|Analgesics|analgesics|mesh-ancestor
25756061|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
25756062|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756063|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756064|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25756065|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25756066|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
25756067|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
25756068|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756069|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25756070|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25756071|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756072|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756073|NCT03002012|Fluconazole|fluconazole|mesh-list
25756074|NCT03002012|Sertraline|sertraline|mesh-list
25756075|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
25756076|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25756077|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25756078|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25756079|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25756080|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756081|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756082|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
25756083|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756084|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
25756085|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756086|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25756087|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25756088|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756089|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25756090|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
25756091|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756092|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25756093|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25756094|NCT03002038|Rituximab|rituximab|mesh-list
25756095|NCT03002038|Azathioprine|azathioprine|mesh-list
25756096|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25756097|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756098|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
25756099|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756100|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756101|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
25756102|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756103|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25756104|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756105|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
25756106|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
25756107|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25756108|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756109|NCT03002506|Tazobactam|tazobactam|mesh-list
25756110|NCT03002506|Ceftolozane|ceftolozane|mesh-list
25330054|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
25756111|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25756112|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25756113|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756114|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25756115|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756116|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756117|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25756118|NCT03002506|Renal Agents|renal agents|mesh-ancestor
25756119|NCT03002974|Triamcinolone|triamcinolone|mesh-list
25756120|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25756121|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25756122|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25756123|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25756124|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756125|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
25756126|NCT03002974|Hormones|hormones|mesh-ancestor
25756127|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756128|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756129|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756130|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
25756131|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756132|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756133|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756134|NCT03003000|Ibuprofen|ibuprofen|mesh-list
25756135|NCT03003000|Caffeine|caffeine|mesh-list
25756136|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25756137|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756138|NCT03003000|Analgesics|analgesics|mesh-ancestor
25756139|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
25756140|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756141|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756142|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756143|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756144|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25756145|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756146|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756147|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25756148|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25756149|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25756150|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25756151|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
25756152|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756153|NCT03003390|Enoxaparin|enoxaparin|mesh-list
25756154|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
25756155|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25756156|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25756157|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756158|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
25756159|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
25756160|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756161|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
25756162|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756163|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756164|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25756165|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
25756166|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756167|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756168|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25756169|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25756170|NCT03003949|Estradiol|estradiol|mesh-list
25756171|NCT03003949|Progesterone|progesterone|mesh-list
25756172|NCT03003949|Estrogens|estrogens|mesh-ancestor
25756173|NCT03003949|Hormones|hormones|mesh-ancestor
25756174|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756175|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756176|NCT03003949|Progestins|progestins|mesh-ancestor
25756177|NCT03004469|Finasteride|finasteride|mesh-list
25756178|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25756179|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25756180|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756181|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756182|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
25756183|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756184|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756185|NCT03004469|Urological Agents|urological agents|mesh-ancestor
25775811|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775812|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775813|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
25775814|NCT03892707|Folic Acid|folic acid|mesh-list
25775815|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
25775816|NCT03892707|Celecoxib|celecoxib|mesh-list
25775817|NCT03892707|Etoricoxib|etoricoxib|mesh-list
25775818|NCT03892707|Meloxicam|meloxicam|mesh-list
25775819|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25775820|NCT03892707|Nimesulide|nimesulide|mesh-list
25775821|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25775822|NCT03892707|Benphothiamine|benphothiamine|mesh-list
25775823|NCT03892707|Vitamins|vitamins|mesh-ancestor
25775824|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
25775825|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775826|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25775827|NCT03892707|Analgesics|analgesics|mesh-ancestor
25775828|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
25775829|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775830|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25775831|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25775832|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25775833|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775834|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775835|NCT03892707|Hematinics|hematinics|mesh-ancestor
25775836|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25775837|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
25775838|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
25775839|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
25775840|NCT03889444|Dexamethasone|dexamethasone|mesh-list
25775841|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25775842|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
25775843|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
25775844|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775845|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775846|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775847|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
25775848|NCT03889444|Hormones|hormones|mesh-ancestor
25775849|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775850|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25775851|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775852|NCT03888755|Icatibant|icatibant|mesh-list
25775853|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25775854|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25775855|NCT03888755|Analgesics|analgesics|mesh-ancestor
25775856|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
25775857|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25775858|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775859|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25775860|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25775861|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25775862|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25775863|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775864|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25775865|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25775866|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
25775867|NCT03888365|Treprostinil|treprostinil|mesh-list
25775868|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25775869|NCT03887442|Paclitaxel|paclitaxel|mesh-list
25775870|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25775871|NCT03887442|Cetuximab|cetuximab|mesh-list
25775872|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25775873|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775874|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25775875|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25775876|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25775877|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775878|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25775879|NCT03873987|Oritavancin|oritavancin|mesh-list
25775880|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25775881|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330272|NCT04824612|Hormones|hormones|mesh-ancestor
25775882|NCT03887299|Disinfectants|disinfectants|mesh-list
25775883|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775884|NCT03886701|Isoniazid|isoniazid|mesh-list
25775885|NCT03886701|Rifapentine|rifapentine|mesh-list
25756186|NCT03006341|Telmisartan|telmisartan|mesh-list
25756187|NCT03006341|Warfarin|warfarin|mesh-list
25756188|NCT03006341|Dabigatran|dabigatran|mesh-list
25756189|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
25756190|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25756191|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25756192|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25756193|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756194|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
25756195|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25756196|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756197|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756198|NCT03006393|Infliximab|infliximab|mesh-list
25756199|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
25756200|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756201|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756202|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
25756203|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25756204|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756205|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756206|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756207|NCT03006562|Heparin|heparin|mesh-list
25756208|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
25756209|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25756210|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25756211|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756212|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
25756213|NCT03006887|Lenvatinib|lenvatinib|mesh-list
25756214|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25756215|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756216|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25756217|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756218|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756219|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
25756220|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25756221|NCT03007225|Estrogens|estrogens|mesh-ancestor
25756222|NCT03007225|Hormones|hormones|mesh-ancestor
25756223|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756224|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756225|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25756226|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756227|NCT03007966|Clonidine|clonidine|mesh-list
25756228|NCT03007966|Epinephrine|epinephrine|mesh-list
25756229|NCT03007966|Bupivacaine|bupivacaine|mesh-list
25756230|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756231|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
25756232|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756233|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756234|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
25756235|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756236|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25756237|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25756238|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
25756239|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756240|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756241|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25756242|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25756243|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
25756244|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25756245|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
25756246|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
25756247|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
25756248|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25756249|NCT03007966|Analgesics|analgesics|mesh-ancestor
25756250|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25756251|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
25756252|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25756253|NCT03008213|Palonosetron|palonosetron|mesh-list
25756254|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
25756255|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
25756256|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756257|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756258|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756259|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25756260|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25756261|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
25756262|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756263|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756265|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25756266|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25756267|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756268|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
25756269|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756270|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
25756271|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25756272|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
25756273|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756274|NCT03008889|Expectorants|expectorants|mesh-ancestor
25756275|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
25756276|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25756277|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
25756278|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756279|NCT03008889|Protective Agents|protective agents|mesh-ancestor
25756280|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756281|NCT03008889|Antidotes|antidotes|mesh-ancestor
25756282|NCT03008915|Aspirin|aspirin|mesh-list
25756283|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25756284|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
25756285|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25756286|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756287|NCT03008915|Analgesics|analgesics|mesh-ancestor
25756288|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
25756289|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756290|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756291|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756292|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756293|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25756294|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25756295|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756296|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25756297|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25756298|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756299|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
25756300|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25756301|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25756302|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756303|NCT03009162|Lasmiditan|lasmiditan|mesh-list
25756304|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25756305|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
25756306|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756307|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756308|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756309|NCT03009396|Clarithromycin|clarithromycin|mesh-list
25756310|NCT03009396|Rifabutin|rifabutin|mesh-list
25756311|NCT03009396|Clofazimine|clofazimine|mesh-list
25756312|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25756313|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756314|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25756315|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756316|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756317|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25756318|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25756319|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25756320|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
25756321|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756322|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
25756323|NCT03010631|Lubiprostone|lubiprostone|mesh-list
25756324|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25756325|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25756326|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756327|NCT03010683|Metformin|metformin|mesh-list
25756328|NCT03010683|Liraglutide|liraglutide|mesh-list
25756329|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756330|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756331|NCT03010683|Incretins|incretins|mesh-ancestor
25756332|NCT03010683|Hormones|hormones|mesh-ancestor
25756333|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756334|NCT03011333|Epinephrine|epinephrine|mesh-list
25756335|NCT03011333|Bupivacaine|bupivacaine|mesh-list
25756336|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756337|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
25756338|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756339|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756340|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
25756341|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756342|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25756343|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25756344|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
25756345|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756346|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756347|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25756348|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25756349|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
25756350|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25756351|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
25756352|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
25756353|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
25756354|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25756355|NCT03011892|Triamcinolone|triamcinolone|mesh-list
25756356|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756357|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
25756358|NCT03011892|Hormones|hormones|mesh-ancestor
25756359|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756360|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756361|NCT03012061|Fluticasone|fluticasone|mesh-list
25756362|NCT03012061|Xhance|xhance|mesh-list
25756363|NCT03012061|Albuterol|albuterol|mesh-list
25756364|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756365|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25756366|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
25756367|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756368|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756369|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25756370|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
25756371|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
25756372|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25756373|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
25756374|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25756375|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25756376|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25756377|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25756378|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
25756379|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756380|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756381|NCT03012191|Gentamicins|gentamicins|mesh-list
25756382|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25756383|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756384|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25756385|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756386|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756387|NCT03012334|Alprazolam|alprazolam|mesh-list
25756388|NCT03012334|Lasmiditan|lasmiditan|mesh-list
25756389|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25756390|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756391|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756392|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25756393|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25756394|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25756395|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
25756396|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
25756397|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756398|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756399|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25756400|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
25756401|NCT03012477|Cisplatin|cisplatin|mesh-list
25756402|NCT03012477|Adavosertib|adavosertib|mesh-list
25756403|NCT03012477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756404|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756405|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756406|NCT03012594|Lanreotide|lanreotide|mesh-list
25756407|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756408|NCT03012828|Moxidectin|moxidectin|mesh-list
25756409|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
25756410|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25756411|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756412|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
25756413|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
25756414|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
25756415|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756416|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756417|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25756418|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756419|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25756420|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756421|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756422|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756423|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756424|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756425|NCT03015220|Dulaglutide|dulaglutide|mesh-list
25756426|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756427|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756428|NCT03015532|Bupivacaine|bupivacaine|mesh-list
25756429|NCT03015532|Ropivacaine|ropivacaine|mesh-list
25756430|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756431|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
25756432|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756433|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756434|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
25756435|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756436|NCT03015961|Bupivacaine|bupivacaine|mesh-list
25756437|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756438|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
25756439|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756440|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756441|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
25756442|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756443|NCT03016598|Oxytocin|oxytocin|mesh-list
25756444|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
25756445|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25756446|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756447|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
25756448|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
25756449|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
25756450|NCT03017235|Citric Acid|citric acid|mesh-list
25756451|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
25756452|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25756453|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
25756454|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
25756455|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756456|NCT03017235|Cathartics|cathartics|mesh-ancestor
25756457|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756458|NCT03017235|Antacids|antacids|mesh-ancestor
25756459|NCT03017508|Riluzole|riluzole|mesh-list
25756460|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
25756461|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25756462|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25756463|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756464|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756465|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756466|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25756467|NCT03017508|Protective Agents|protective agents|mesh-ancestor
25756468|NCT03017846|Cantharidin|cantharidin|mesh-list
25756469|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756470|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756471|NCT03018028|Liraglutide|liraglutide|mesh-list
25756472|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756473|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756474|NCT03018028|Incretins|incretins|mesh-ancestor
25756475|NCT03018028|Hormones|hormones|mesh-ancestor
25756476|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756477|NCT03018106|Estrogens|estrogens|mesh-list
25756478|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25756479|NCT03018106|Hormones|hormones|mesh-ancestor
25756480|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756481|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756482|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
25756483|NCT03018223|Sirolimus|sirolimus|mesh-list
25756484|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
25756485|NCT03018223|Busulfan|busulfan|mesh-list
25756486|NCT03018223|Fludarabine|fludarabine|mesh-list
25756487|NCT03018223|Lenograstim|lenograstim|mesh-list
25756488|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756489|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
25756490|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756491|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756492|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25756493|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
25756494|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756495|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756496|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25756497|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25756498|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25756499|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
25756500|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25756501|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756502|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756503|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
25756504|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25756505|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25756506|NCT03018249|Entinostat|entinostat|mesh-list
25756507|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
25756508|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25756509|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25756510|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25756511|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25756512|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
25756513|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25756514|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756515|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25756516|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25756517|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25756518|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25756519|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756520|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756521|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756522|NCT03018340|Pimavanserin|pimavanserin|mesh-list
25756523|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25756524|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25756525|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25756526|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25756527|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756528|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756529|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25756530|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25756531|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25756532|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
25756533|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756534|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756535|NCT03018925|Golimumab|golimumab|mesh-list
25756536|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25756537|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756538|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756539|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
25756540|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756541|NCT03018938|Insulin|insulin|mesh-list
25756542|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25756543|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756544|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756545|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25756546|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25756547|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25756548|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
25756549|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756550|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25756551|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25756552|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756553|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25756554|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25756555|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25756556|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756557|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756558|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756559|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25756560|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25756561|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
25756562|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756563|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
25756564|NCT03019887|Haloperidol|haloperidol|mesh-list
25756565|NCT03019887|Olanzapine|olanzapine|mesh-list
25756566|NCT03019887|Risperidone|risperidone|mesh-list
25756567|NCT03019887|Aripiprazole|aripiprazole|mesh-list
25756568|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25756569|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25756570|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
25756571|NCT03019887|Perphenazine|perphenazine|mesh-list
25756572|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25756573|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
25756574|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756575|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756576|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756577|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25756578|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25756579|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756580|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25756581|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25756582|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
25756583|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
25756584|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
25756585|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756586|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756587|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25756588|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25756589|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25756590|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
25756591|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
25756592|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25756593|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25756594|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25756595|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25756596|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25756597|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756598|NCT03019887|Analgesics|analgesics|mesh-ancestor
25756599|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
25756600|NCT03019939|Isavuconazole|isavuconazole|mesh-list
25756601|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
25756602|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756603|NCT03019965|Meropenem|meropenem|mesh-list
25756604|NCT03019965|Tazobactam|tazobactam|mesh-list
25756605|NCT03019965|Piperacillin|piperacillin|mesh-list
25756606|NCT03019965|Imipenem|imipenem|mesh-list
25756607|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25756608|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25756609|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756610|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25756611|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756612|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756613|NCT03020004|Ritonavir|ritonavir|mesh-list
25756614|NCT03020004|Ribavirin|ribavirin|mesh-list
25756615|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25756616|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25756617|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25756618|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756619|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756620|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756621|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25756622|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25756623|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
25756624|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756625|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25756626|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25756627|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
25756628|NCT03020082|Ritonavir|ritonavir|mesh-list
25756629|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25756630|NCT03020082|Ribavirin|ribavirin|mesh-list
25756631|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25756632|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25756633|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756634|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756635|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756636|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25756637|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25756638|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
25756639|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756640|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25756641|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25756642|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
25756643|NCT03020095|Ritonavir|ritonavir|mesh-list
25756644|NCT03020095|Ribavirin|ribavirin|mesh-list
25756645|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25756646|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25756647|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756648|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756649|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756650|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25756651|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25756652|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
25756653|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756654|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25756655|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25756656|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
25756657|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25756658|NCT03020407|Dopamine|dopamine|mesh-list
25756659|NCT03020407|Epinephrine|epinephrine|mesh-list
25756660|NCT03020407|Norepinephrine|norepinephrine|mesh-list
25756661|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25756662|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756663|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25756664|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25756665|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
25756666|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756667|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756668|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756669|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25756670|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25756671|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
25756672|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756673|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25756674|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
25756675|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
25756676|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
25756677|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25756678|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
25756679|NCT03020407|Protective Agents|protective agents|mesh-ancestor
25775886|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
25775887|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25775888|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775889|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25775890|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25775891|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
25775892|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775893|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25775894|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25775895|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
25775896|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25775897|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
25775898|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775899|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
25775900|NCT03885154|Valproic Acid|valproic acid|mesh-list
25775901|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
25775902|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775903|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775904|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
25775905|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775906|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775907|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
25775908|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25775909|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25775910|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25775911|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25775912|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
25775913|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
25775914|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25775915|NCT03885154|Analgesics|analgesics|mesh-ancestor
25775916|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
25775917|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777659|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777660|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25777661|NCT03342638|Protective Agents|protective agents|mesh-ancestor
25777662|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25777663|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25777664|NCT03342157|Sennosides|sennosides|mesh-list
25756680|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
25756681|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756682|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
25756683|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756684|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756685|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25756686|NCT03020966|Acetaminophen|acetaminophen|mesh-list
25756687|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756688|NCT03020966|Analgesics|analgesics|mesh-ancestor
25756689|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
25756690|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756691|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756692|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
25756693|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
25756694|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756695|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
25756696|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756697|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756698|NCT03021018|Lorazepam|lorazepam|mesh-list
25756699|NCT03021018|Brivaracetam|brivaracetam|mesh-list
25756700|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
25756701|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
25756702|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
25756703|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756704|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756705|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756706|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25756707|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756708|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25756709|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25756710|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25756711|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
25756712|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
25756713|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756714|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756715|NCT03021343|Colchicine|colchicine|mesh-list
25756716|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
25756717|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756718|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
25756719|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
25756720|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
25756721|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756722|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756723|NCT03022526|Fentanyl|fentanyl|mesh-list
25756724|NCT03022526|Bupivacaine|bupivacaine|mesh-list
25756725|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756726|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
25756727|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756728|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756729|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
25756730|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756731|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25756732|NCT03022526|Narcotics|narcotics|mesh-ancestor
25756733|NCT03022526|Analgesics|analgesics|mesh-ancestor
25756734|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25756735|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25756736|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
25756737|NCT03022617|Apremilast|apremilast|mesh-list
25756738|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25756739|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756740|NCT03022617|Analgesics|analgesics|mesh-ancestor
25756741|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
25756742|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756743|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756744|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756745|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756746|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25756747|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25756748|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756749|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756750|NCT03022916|Efinaconazole|efinaconazole|mesh-list
25756751|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25756752|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
25756753|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756754|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
25756755|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25756756|NCT03022981|Velpatasvir|velpatasvir|mesh-list
25756757|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
25756758|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756759|NCT03023423|Atezolizumab|atezolizumab|mesh-list
25756760|NCT03023423|Daratumumab|daratumumab|mesh-list
25756761|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756762|NCT03023722|Maytansine|maytansine|mesh-list
25756763|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25756764|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756765|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
25756766|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
25756767|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
25756768|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756769|NCT03023878|Dexamethasone|dexamethasone|mesh-list
25756770|NCT03023878|Blinatumomab|blinatumomab|mesh-list
25756771|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756772|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
25756773|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
25756774|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756775|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756776|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756777|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
25756778|NCT03023878|Hormones|hormones|mesh-ancestor
25756779|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756780|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25756781|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756782|NCT03023891|Prednisone|prednisone|mesh-list
25756783|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756784|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
25756785|NCT03023891|Hormones|hormones|mesh-ancestor
25756786|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756787|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756788|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25756789|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756790|NCT03025945|Nepafenac|nepafenac|mesh-list
25756791|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25756792|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756793|NCT03025945|Analgesics|analgesics|mesh-ancestor
25756794|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
25756795|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756796|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756797|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756798|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756799|NCT03026088|Bisoprolol|bisoprolol|mesh-list
25756800|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25756801|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
25756802|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
25756803|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756804|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756805|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25756806|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25756807|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25756808|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
25756809|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756810|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756811|NCT03026166|Nivolumab|nivolumab|mesh-list
25756812|NCT03026166|Ipilimumab|ipilimumab|mesh-list
25756813|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25756814|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756815|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25756816|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756817|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25756818|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
25756819|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25756820|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25756821|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756822|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
25756823|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
25756824|NCT03026556|Apixaban|apixaban|mesh-list
25756825|NCT03026556|Dabigatran|dabigatran|mesh-list
25756826|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25756827|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
25756828|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25756829|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
25756830|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756831|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756832|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
25756833|NCT03026803|Capecitabine|capecitabine|mesh-list
25756834|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
25756835|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25756836|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
25756837|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756838|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756840|NCT03027557|Cinacalcet|cinacalcet|mesh-list
25756841|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25756842|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756843|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25756844|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25756845|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
25756846|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756847|NCT03027661|Bupivacaine|bupivacaine|mesh-list
25756848|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756849|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
25756850|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756851|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756852|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
25756853|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756854|NCT03028012|Dexamethasone|dexamethasone|mesh-list
25756855|NCT03028012|Ketorolac|ketorolac|mesh-list
25756856|NCT03028012|Lidocaine|lidocaine|mesh-list
25756857|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756858|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
25756859|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
25756860|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756861|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756862|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756863|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
25756864|NCT03028012|Hormones|hormones|mesh-ancestor
25756865|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756866|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25756867|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756868|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
25756869|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
25756870|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756871|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
25756872|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25756873|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25756874|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25756875|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25756876|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756877|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25756878|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756879|NCT03028012|Analgesics|analgesics|mesh-ancestor
25756880|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756881|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25756882|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756883|NCT03028025|Hemostatics|hemostatics|mesh-list
25756884|NCT03028025|Coagulants|coagulants|mesh-ancestor
25756885|NCT03028103|Repaglinide|repaglinide|mesh-list
25756886|NCT03028103|Fluconazole|fluconazole|mesh-list
25756887|NCT03028103|Omeprazole|omeprazole|mesh-list
25756888|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25756889|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756890|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25756891|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756892|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756893|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
25756894|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756895|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25756896|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25756897|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25756898|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
25756899|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25756900|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756901|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25756902|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25756903|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25756904|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25756905|NCT03028129|Isoniazid|isoniazid|mesh-list
25756906|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25756907|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
25756908|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25756909|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25756910|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
25756911|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756912|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25756913|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
25756914|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25756915|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
25756916|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756917|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756918|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25756919|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
25756920|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
25756921|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25756922|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
25756923|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756924|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756925|NCT03028467|Folic Acid|folic acid|mesh-list
25756926|NCT03028467|Methotrexate|methotrexate|mesh-list
25756927|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25756928|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
25756929|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25756930|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756931|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25756932|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
25756933|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756934|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25756935|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
25756936|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756937|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25756938|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25756939|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
25756940|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756941|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25756942|NCT03028467|Hematinics|hematinics|mesh-ancestor
25756943|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
25756944|NCT03028467|Vitamins|vitamins|mesh-ancestor
25756945|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
25756946|NCT03028870|Naproxen|naproxen|mesh-list
25756947|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25756948|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756949|NCT03028870|Analgesics|analgesics|mesh-ancestor
25756950|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
25756951|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756952|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756953|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25756954|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25756955|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
25756956|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25756957|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25756958|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756959|NCT03029091|Losartan|losartan|mesh-list
25756960|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25756961|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25756962|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25756963|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25756964|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756965|NCT03029143|Vedolizumab|vedolizumab|mesh-list
25756966|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756967|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
25756968|NCT03029208|Hematinics|hematinics|mesh-ancestor
25756969|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
25756970|NCT03029247|Hematinics|hematinics|mesh-ancestor
25756971|NCT03029650|Scopolamine|scopolamine|mesh-list
25756972|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25756973|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25756974|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
25756975|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
25756976|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25756977|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756978|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25756979|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
25756980|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25756981|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
25756982|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25756983|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25756984|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25756985|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
25756986|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
25756987|NCT03029715|Remifentanil|remifentanil|mesh-list
25756988|NCT03029715|Propofol|propofol|mesh-list
25756989|NCT03029715|Desflurane|desflurane|mesh-list
25756990|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25756991|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25756992|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25756993|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25756994|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
25756995|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
25756996|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25756997|NCT03029715|Analgesics|analgesics|mesh-ancestor
25756998|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
25756999|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757000|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25757001|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25757002|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757003|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757004|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757005|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757006|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25757007|NCT03029715|Narcotics|narcotics|mesh-ancestor
25757008|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25757009|NCT03029819|Nicotine|nicotine|mesh-list
25757010|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25757011|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
25757012|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757013|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757014|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25757015|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25757016|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
25757017|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757018|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757019|NCT03030638|Olodaterol|olodaterol|mesh-list
25757020|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25757021|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
25757022|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757023|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757024|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25757025|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
25757026|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
25757027|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25757028|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25757029|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757030|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
25757031|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
25757032|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25757033|NCT03031496|Amiloride|amiloride|mesh-list
25757034|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
25757035|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25757036|NCT03031496|Diuretics|diuretics|mesh-ancestor
25757037|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
25757038|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757039|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25757040|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757041|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757042|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25757043|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25757044|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25757045|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25757046|NCT03031795|Ketorolac|ketorolac|mesh-list
25757047|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25757048|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25757049|NCT03031795|Analgesics|analgesics|mesh-ancestor
25757050|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
25757051|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757052|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757053|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757054|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25757055|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25757056|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775918|NCT03883386|Loratadine|loratadine|mesh-list
25757057|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757058|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
25757060|NCT03031899|Coagulants|coagulants|mesh-ancestor
25757061|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
25757062|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757063|NCT03032380|Meropenem|meropenem|mesh-list
25757064|NCT03032380|Linezolid|linezolid|mesh-list
25757065|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25757066|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757067|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25757068|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757069|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775919|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
25775920|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775921|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25775922|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25775923|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25775924|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
25775925|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
25775926|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775927|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775928|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775929|NCT03882424|Bevacizumab|bevacizumab|mesh-list
25775930|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25775931|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25775932|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25775933|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25775934|NCT03882424|Growth Substances|growth substances|mesh-ancestor
25775935|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775936|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
25775937|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
25775938|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25775939|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
25775940|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25775941|NCT03881163|Expectorants|expectorants|mesh-ancestor
25775942|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775943|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25775944|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
25775945|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775946|NCT03881163|Protective Agents|protective agents|mesh-ancestor
25775947|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775948|NCT03881163|Antidotes|antidotes|mesh-ancestor
25775949|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
25775950|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25775951|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25775952|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25775953|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
25775954|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25775955|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775956|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775957|NCT03848871|Betamethasone|betamethasone|mesh-list
25775958|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
25775959|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25775960|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
25775961|NCT03848871|Calcipotriene|calcipotriene|mesh-list
25775962|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25775963|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25775964|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
25775965|NCT03848871|Hormones|hormones|mesh-ancestor
25775966|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25775967|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775968|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25775969|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
25775970|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775971|NCT03848403|Ixekizumab|ixekizumab|mesh-list
25775972|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25775973|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25775974|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25775975|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
25775976|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775977|NCT03879603|Antacids|antacids|mesh-ancestor
25775978|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775979|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775980|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
25757070|NCT03032965|Adenosine|adenosine|mesh-list
25757071|NCT03032965|Isoproterenol|isoproterenol|mesh-list
25757072|NCT03032965|Analgesics|analgesics|mesh-ancestor
25757073|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
25757074|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757075|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757076|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25757077|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
25757078|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25757079|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
25757080|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
25757081|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757082|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757083|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25757084|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757085|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757086|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25757087|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
25757088|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25757089|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
25757090|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25757091|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
25757092|NCT03032965|Protective Agents|protective agents|mesh-ancestor
25757093|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25757094|NCT03033394|Penicillins|penicillins|mesh-list
25757095|NCT03033394|Lactams|lactams|mesh-list
25757096|NCT03033394|beta-Lactams|beta-lactams|mesh-list
25757097|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757098|NCT03033511|Dexamethasone|dexamethasone|mesh-list
25757099|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
25757100|NCT03033511|BB 1101|bb 1101|mesh-list
25757101|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
25757102|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757103|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
25757104|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
25757105|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757106|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757107|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757108|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
25757109|NCT03033511|Hormones|hormones|mesh-ancestor
25757110|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757111|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757112|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757113|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
25757114|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757115|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757116|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
25757117|NCT03033784|Oxytocin|oxytocin|mesh-list
25757118|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
25757119|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25757120|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757121|NCT03034135|Copper|copper|mesh-list
25757122|NCT03034135|Temozolomide|temozolomide|mesh-list
25757123|NCT03034135|Disulfiram|disulfiram|mesh-list
25757124|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25757125|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
25757126|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757127|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757128|NCT03034135|Trace Elements|trace elements|mesh-ancestor
25757129|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
25757130|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757131|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25757132|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25757133|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757134|NCT03034577|Neostigmine|neostigmine|mesh-list
25757135|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25757136|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757137|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757138|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
25757139|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757140|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757141|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25757142|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
25757143|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757144|NCT03034772|Timolol|timolol|mesh-list
25757145|NCT03034772|Dorzolamide|dorzolamide|mesh-list
25757146|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
25757147|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25757148|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25757149|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757150|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757151|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757152|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757153|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25757154|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25757155|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25757156|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25757157|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25757158|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757159|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25757160|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25757161|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
25757162|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757163|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757164|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25757165|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
25757166|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25757167|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25757168|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757169|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757170|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757171|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757172|NCT03035032|Leuprolide|leuprolide|mesh-list
25757173|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25757174|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
25757175|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25757176|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757177|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757178|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757179|NCT03035708|Varenicline|varenicline|mesh-list
25757180|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25757181|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25757182|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
25757183|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757184|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757185|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757186|NCT03035760|Oxfendazole|oxfendazole|mesh-list
25757187|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
25757188|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25757189|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757190|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
25757191|NCT03035916|Anesthetics|anesthetics|mesh-list
25757192|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757193|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757194|NCT03035929|Dexamethasone|dexamethasone|mesh-list
25757195|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
25757196|NCT03035929|BB 1101|bb 1101|mesh-list
25757197|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757198|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
25757199|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
25757200|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757201|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757202|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757203|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
25757204|NCT03035929|Hormones|hormones|mesh-ancestor
25757205|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757206|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757207|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757208|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
25757209|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757210|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757211|NCT03035942|Dexamethasone|dexamethasone|mesh-list
25757212|NCT03035942|Ondansetron|ondansetron|mesh-list
25757213|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757214|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
25757215|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
25757216|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757217|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757218|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757219|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
25757220|NCT03035942|Hormones|hormones|mesh-ancestor
25757221|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331460|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25757222|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757223|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757224|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
25757225|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
25757226|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25757227|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
25757228|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757229|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757230|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25757231|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25757232|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757233|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25757234|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25757235|NCT03035955|Azelaic acid|azelaic acid|mesh-list
25757236|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757237|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
25757238|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
25757239|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25757240|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757241|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757242|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757243|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
25757244|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25757245|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757246|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757247|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757248|NCT03036163|Macozinone|macozinone|mesh-list
25757249|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
25757250|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25757251|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757252|NCT03036384|Sufentanil|sufentanil|mesh-list
25757253|NCT03036384|Morphine|morphine|mesh-list
25757254|NCT03036384|Prilocaine|prilocaine|mesh-list
25757255|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25757256|NCT03036384|Narcotics|narcotics|mesh-ancestor
25757257|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757258|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757259|NCT03036384|Analgesics|analgesics|mesh-ancestor
25757260|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
25757261|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757262|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25757263|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25757264|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
25757265|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
25757266|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
25757267|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
25757268|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25757269|NCT03036839|Ledipasvir|ledipasvir|mesh-list
25757270|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
25757271|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757272|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
25757273|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25757274|NCT03036852|Velpatasvir|velpatasvir|mesh-list
25757275|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
25757276|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757277|NCT03037580|Treprostinil|treprostinil|mesh-list
25757278|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25757279|NCT03038308|Ropinirole|ropinirole|mesh-list
25757280|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25757281|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25757282|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
25757283|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
25757284|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757285|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757286|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757287|NCT03038620|Liraglutide|liraglutide|mesh-list
25757288|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757289|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757290|NCT03038620|Incretins|incretins|mesh-ancestor
25757291|NCT03038620|Hormones|hormones|mesh-ancestor
25757292|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757293|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25757294|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25757295|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25757296|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757297|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757298|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757299|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757300|NCT03038867|Analgesics|analgesics|mesh-ancestor
25757301|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
25757302|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757303|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
25757304|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25757305|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
25757306|NCT03038880|Ranibizumab|ranibizumab|mesh-list
25757307|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25757308|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25757309|NCT03038880|Growth Substances|growth substances|mesh-ancestor
25757310|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757311|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
25757312|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757313|NCT03039023|Choline|choline|mesh-list
25757314|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
25757315|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25757316|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
25757317|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757318|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757319|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25757320|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
25757321|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
25757322|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25757323|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757324|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757325|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757326|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757327|NCT03039192|Esketamine|esketamine|mesh-list
25757328|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
25757329|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25757330|NCT03039543|Rocuronium|rocuronium|mesh-list
25757331|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25757332|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25757333|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25757334|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757335|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757336|NCT03040011|Dexamethasone|dexamethasone|mesh-list
25757337|NCT03040011|Bupivacaine|bupivacaine|mesh-list
25757338|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757339|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
25757340|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
25757341|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757342|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757343|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757344|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
25757345|NCT03040011|Hormones|hormones|mesh-ancestor
25757346|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757347|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757348|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757349|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
25757350|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
25757351|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757352|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
25757353|NCT03040024|Ketamine|ketamine|mesh-list
25757354|NCT03040024|Analgesics|analgesics|mesh-ancestor
25757355|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
25757356|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757357|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757358|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25757359|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25757360|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
25757361|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
25757362|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757363|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25757364|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25757365|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757366|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757367|NCT03040362|Lasmiditan|lasmiditan|mesh-list
25757368|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25757369|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
25757370|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757371|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757372|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757373|NCT03040479|Lasmiditan|lasmiditan|mesh-list
25757374|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25757375|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
25757376|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757377|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757378|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757379|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25757380|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
25757381|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
25757382|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757383|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25757384|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25757385|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757386|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757387|NCT03041792|Liraglutide|liraglutide|mesh-list
25757388|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757389|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757390|NCT03041792|Incretins|incretins|mesh-ancestor
25757391|NCT03041792|Hormones|hormones|mesh-ancestor
25757392|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757393|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25757394|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25757395|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25757396|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757397|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
25757398|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25757399|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757400|NCT03042910|Talazoparib|talazoparib|mesh-list
25757401|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25757402|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757403|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757404|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757405|NCT03043105|Thalidomide|thalidomide|mesh-list
25757406|NCT03043105|Prednisone|prednisone|mesh-list
25757407|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
25757408|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25757409|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
25757410|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757411|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25757412|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25757413|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
25757414|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757415|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757416|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25757417|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757418|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
25757419|NCT03043105|Hormones|hormones|mesh-ancestor
25757420|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757421|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757422|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
25757423|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25757424|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757425|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25757426|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25757427|NCT03043105|Growth Substances|growth substances|mesh-ancestor
25757428|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
25757429|NCT03043274|Cangrelor|cangrelor|mesh-list
25757430|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25757431|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25757432|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25757433|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25757434|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
25757435|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757436|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757437|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775981|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25775982|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775983|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25775984|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25775985|NCT03866434|Anagrelide|anagrelide|mesh-list
25775986|NCT03866434|Omeprazole|omeprazole|mesh-list
25757439|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
25757440|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757441|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757442|NCT03043651|Treprostinil|treprostinil|mesh-list
25757443|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25757444|NCT03044418|Propofol|propofol|mesh-list
25757445|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
25757446|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757447|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757448|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25757449|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25757450|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
25757451|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
25757452|NCT03044730|Capecitabine|capecitabine|mesh-list
25757453|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25757454|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757455|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25757456|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
25757457|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757458|NCT03044886|Vitamin D|vitamin d|mesh-list
25757459|NCT03044886|Vitamins|vitamins|mesh-ancestor
25757460|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
25757461|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757462|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25757463|NCT03045328|Venetoclax|venetoclax|mesh-list
25757464|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757465|NCT03045861|Cobicistat|cobicistat|mesh-list
25757466|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
25757467|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25757468|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25757469|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
25757470|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757471|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25757472|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25757473|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757474|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757475|NCT03046446|FX006|fx006|mesh-list
25757476|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757477|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
25757478|NCT03046446|Hormones|hormones|mesh-ancestor
25757479|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757480|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757481|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25757482|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
25757483|NCT03047980|Sirolimus|sirolimus|mesh-list
25757484|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25757485|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757486|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25757487|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757488|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
25757489|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25757490|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
25757491|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757492|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25757493|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
25757494|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
25757495|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757496|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25757497|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25757498|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25757499|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25757500|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757501|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757502|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757503|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757504|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757505|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25757506|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25757507|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25757508|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757509|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757510|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25757511|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757512|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757513|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
25757514|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757515|NCT03048500|Metformin|metformin|mesh-list
25757516|NCT03048500|Nivolumab|nivolumab|mesh-list
25757517|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757518|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757519|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25757520|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757521|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25757522|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757523|NCT03048747|Tolvaptan|tolvaptan|mesh-list
25757524|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25757525|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757526|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
25757527|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757528|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25757529|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25757530|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
25757531|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757532|NCT03049488|Antacids|antacids|mesh-ancestor
25757533|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757534|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757535|NCT03050294|Desoximetasone|desoximetasone|mesh-list
25757536|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757537|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
25757538|NCT03050294|Hormones|hormones|mesh-ancestor
25757539|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757540|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757541|NCT03050307|Lansoprazole|lansoprazole|mesh-list
25757542|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
25757543|NCT03050307|Bismuth|bismuth|mesh-list
25757544|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25757545|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757546|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25757547|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757548|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757549|NCT03050307|Antacids|antacids|mesh-ancestor
25757550|NCT03050359|Lansoprazole|lansoprazole|mesh-list
25757551|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
25757552|NCT03050359|Bismuth|bismuth|mesh-list
25757553|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25757554|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757555|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25757556|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757557|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757558|NCT03050359|Antacids|antacids|mesh-ancestor
25757559|NCT03050450|Lenalidomide|lenalidomide|mesh-list
25757560|NCT03050450|Vorinostat|vorinostat|mesh-list
25757561|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
25757562|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757563|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25757564|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25757565|NCT03050450|Growth Substances|growth substances|mesh-ancestor
25757566|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
25757567|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757568|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25757569|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757570|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757571|NCT03050619|Empagliflozin|empagliflozin|mesh-list
25757572|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25757573|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757574|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757575|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757576|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25757577|NCT03051100|Atorvastatin|atorvastatin|mesh-list
25757578|NCT03051100|Ezetimibe|ezetimibe|mesh-list
25757579|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25757580|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25757581|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
25757582|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757583|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25757584|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25757585|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757586|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757587|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757588|NCT03051256|Methadone|methadone|mesh-list
25757589|NCT03051256|D-methadone|d-methadone|mesh-list
25757590|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25757591|NCT03051256|Narcotics|narcotics|mesh-ancestor
25757592|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757593|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757594|NCT03051256|Analgesics|analgesics|mesh-ancestor
25757595|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
25757596|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757597|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
25757598|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25757599|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25757600|NCT03051620|Alendronate|alendronate|mesh-list
25757601|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25757602|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757603|NCT03051646|Aspirin|aspirin|mesh-list
25757604|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25757605|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25757606|NCT03051646|Analgesics|analgesics|mesh-ancestor
25757607|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
25757608|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757609|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757610|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757611|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25757612|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25757613|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25757614|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757615|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25757616|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25757617|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757618|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
25757619|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
25757620|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25757621|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757622|NCT03052322|Adalimumab|adalimumab|mesh-list
25757623|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757624|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25757625|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
25757626|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25757627|NCT03052517|Growth Substances|growth substances|mesh-ancestor
25757628|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757629|NCT03052725|Reslizumab|reslizumab|mesh-list
25757630|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25757631|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
25757632|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
25757633|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25757634|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
25757635|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757636|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
25757637|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25757638|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25757639|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25757640|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757641|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757642|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
25757643|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757644|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757645|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25757646|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757647|NCT03052816|Hydromorphone|hydromorphone|mesh-list
25757648|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25757649|NCT03052816|Narcotics|narcotics|mesh-ancestor
25757650|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757651|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757652|NCT03052816|Analgesics|analgesics|mesh-ancestor
25757653|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
25757654|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757655|NCT03053050|Selonsertib|selonsertib|mesh-list
25757656|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25757657|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757658|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757659|NCT03053063|Selonsertib|selonsertib|mesh-list
25757660|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25757661|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757662|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757664|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
25757665|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757666|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757667|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
25757668|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757669|NCT03053427|Gabapentin|gabapentin|mesh-list
25757670|NCT03053427|Analgesics|analgesics|mesh-ancestor
25757671|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
25757672|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757673|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757674|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
25757675|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25757676|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25757677|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757678|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25757679|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25757680|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25757681|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757682|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757683|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
25757684|NCT03054103|Midazolam|midazolam|mesh-list
25757685|NCT03054103|Ketamine|ketamine|mesh-list
25757686|NCT03054103|Analgesics|analgesics|mesh-ancestor
25757687|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
25757688|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757689|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757690|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25757691|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25757692|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
25757693|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
25757694|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757695|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25757696|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25757697|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757698|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757699|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25757700|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25757701|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25757702|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25757703|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25757704|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
25757705|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
25757706|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25757707|NCT03054506|Laxatives|laxatives|mesh-ancestor
25757708|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757709|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
25757710|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
25757711|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
25757712|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757713|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757714|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
25757715|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757716|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
25757717|NCT03054805|Antacids|antacids|mesh-ancestor
25757718|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757719|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757720|NCT03054844|Lidocaine|lidocaine|mesh-list
25757721|NCT03054844|Midazolam|midazolam|mesh-list
25757722|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
25757723|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
25757724|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757725|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757726|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
25757727|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757728|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25757729|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25757730|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25757731|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757732|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757733|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25757734|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25757735|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25757736|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25757737|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25757738|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25757739|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
25757741|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
25757742|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757743|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
25757744|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25757745|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757746|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757747|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25757748|NCT03054857|Analgesics|analgesics|mesh-ancestor
25757749|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
25757750|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757751|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25757752|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25757753|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757754|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757755|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757756|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757757|NCT03054870|Xenon|xenon|mesh-list
25757758|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25757759|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
25757760|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
25757761|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757762|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757763|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
25757764|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25757765|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25775987|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25775988|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25775989|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25775990|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25775991|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25775992|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25775993|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25775994|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25775995|NCT03855059|Dexamethasone|dexamethasone|mesh-list
25775996|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
25775997|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25775998|NCT03855059|BB 1101|bb 1101|mesh-list
25775999|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776000|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
25776001|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
25776002|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776003|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776004|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776005|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
25776006|NCT03855059|Hormones|hormones|mesh-ancestor
25776007|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776008|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25776009|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776010|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
25776011|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776012|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776013|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
25776014|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25776015|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25776016|NCT03852537|Prednisolone|prednisolone|mesh-list
25776017|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
25776018|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25776019|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
25776020|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776021|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
25776022|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
25776023|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776024|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776025|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776026|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
25776027|NCT03852537|Hormones|hormones|mesh-ancestor
25776028|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776029|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25776030|NCT03852537|Protective Agents|protective agents|mesh-ancestor
25776031|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757766|NCT03055221|Treprostinil|treprostinil|mesh-list
25757767|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25757768|NCT03055338|Risperidone|risperidone|mesh-list
25757769|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25757770|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
25757771|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757772|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757773|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757774|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25757775|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25757776|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757777|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25757778|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25757779|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
25757780|NCT03055936|Levodopa|levodopa|mesh-list
25757781|NCT03055936|Carbidopa|carbidopa|mesh-list
25757782|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25757783|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25757784|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
25757785|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757786|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757787|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757788|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25757789|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757790|NCT03055988|Fluticasone|fluticasone|mesh-list
25757791|NCT03055988|Xhance|xhance|mesh-list
25757792|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
25757793|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25757794|NCT03055988|Olodaterol|olodaterol|mesh-list
25757795|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757796|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25757797|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
25757798|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757799|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757800|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25757801|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
25757802|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
25757803|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25757804|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
25757805|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25757806|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
25757807|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757808|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757809|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25757810|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25757811|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757812|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757813|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
25757814|NCT03056352|Promethazine|promethazine|mesh-list
25757815|NCT03056352|Metoclopramide|metoclopramide|mesh-list
25757816|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25757817|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25757818|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757819|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757820|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
25757821|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
25757822|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
25757823|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757824|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
25757825|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
25757826|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757827|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25757828|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
25757829|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
25757830|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757831|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757832|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25757833|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
25757834|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
25757835|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25757836|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25757837|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
25757838|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
25757839|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757840|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757841|NCT03057132|Protective Agents|protective agents|mesh-list
25757842|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757843|NCT03057366|Paclitaxel|paclitaxel|mesh-list
25757844|NCT03057366|Docetaxel|docetaxel|mesh-list
25757845|NCT03057366|Carboplatin|carboplatin|mesh-list
25757846|NCT03057366|Pevonedistat|pevonedistat|mesh-list
25757847|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25757848|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757849|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
25757850|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
25757851|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
25757852|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757853|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757854|NCT03057704|Lidocaine|lidocaine|mesh-list
25757855|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
25757856|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
25757857|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757858|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757859|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
25757860|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757861|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25757862|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25757863|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25757864|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757865|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757866|NCT03057977|Empagliflozin|empagliflozin|mesh-list
25757867|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25757868|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757869|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757870|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757871|NCT03058692|Vaccines|vaccines|mesh-list
25757872|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
25757873|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757874|NCT03060447|Vesatolimod|vesatolimod|mesh-list
25757875|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
25757876|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757878|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
25757879|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
25757880|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757881|NCT03060512|Naloxegol|naloxegol|mesh-list
25757882|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25757883|NCT03060512|Laxatives|laxatives|mesh-ancestor
25757884|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757885|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25757886|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757887|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
25757888|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757889|NCT03061188|Nivolumab|nivolumab|mesh-list
25757890|NCT03061188|Veliparib|veliparib|mesh-list
25757891|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25757892|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757893|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25757894|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757895|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25757896|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757897|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25757898|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25757899|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757900|NCT03061214|Incretins|incretins|mesh-ancestor
25757901|NCT03061214|Hormones|hormones|mesh-ancestor
25757902|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757903|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25757904|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
25757905|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757906|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757907|NCT03061331|Ivacaftor|ivacaftor|mesh-list
25757908|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25757909|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25757910|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757911|NCT03061812|Dexamethasone|dexamethasone|mesh-list
25757912|NCT03061812|Topotecan|topotecan|mesh-list
25757913|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757914|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
25757915|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
25757916|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757917|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757918|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25757919|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
25757920|NCT03061812|Hormones|hormones|mesh-ancestor
25757921|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25757922|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25757923|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757924|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25757925|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25757926|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25757927|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757928|NCT03062488|Acetaminophen|acetaminophen|mesh-list
25757929|NCT03062488|Fentanyl|fentanyl|mesh-list
25757930|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25757931|NCT03062488|Narcotics|narcotics|mesh-ancestor
25757932|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757933|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757934|NCT03062488|Analgesics|analgesics|mesh-ancestor
25757935|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
25757936|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757937|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25757938|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25757939|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
25757940|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
25757941|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25757942|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
25757943|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
25757944|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25757945|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25757946|NCT03063086|Fluticasone|fluticasone|mesh-list
25757947|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25757948|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25757949|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25757950|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
25757951|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757952|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757953|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25757954|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
25757955|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25757956|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25757957|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25757958|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25757959|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757960|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757961|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757962|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757963|NCT03063255|Anesthetics|anesthetics|mesh-list
25757964|NCT03063255|Mepivacaine|mepivacaine|mesh-list
25757965|NCT03063255|Rocuronium|rocuronium|mesh-list
25757966|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757967|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757968|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25757969|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25757970|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25757971|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757972|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
25757973|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
25757974|NCT03065179|Nivolumab|nivolumab|mesh-list
25757975|NCT03065179|Ipilimumab|ipilimumab|mesh-list
25757976|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25757977|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757978|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25757979|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757980|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
25757981|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25757982|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25757983|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
25757984|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25757985|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25757986|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25757987|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25757988|NCT03065530|Analgesics|analgesics|mesh-ancestor
25757989|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
25757990|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25757991|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25332498|NCT04794049|Lactulose|lactulose|mesh-list
25757992|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25757993|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25757994|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
25757995|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25757996|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25757997|NCT03066193|Palmidrol|palmidrol|mesh-list
25757998|NCT03066193|Dronabinol|dronabinol|mesh-list
25757999|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
25758000|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758001|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758002|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758003|NCT03066193|Analgesics|analgesics|mesh-ancestor
25758004|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
25758005|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758006|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25758007|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25758008|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758009|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758010|NCT03066193|Hormones|hormones|mesh-ancestor
25758011|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758012|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758013|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758014|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758015|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
25758016|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758017|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25758018|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
25758019|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758020|NCT03066778|Cisplatin|cisplatin|mesh-list
25758021|NCT03066778|Carboplatin|carboplatin|mesh-list
25758022|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
25758023|NCT03066778|Etoposide|etoposide|mesh-list
25758024|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758025|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758026|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25758027|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25758028|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25758029|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758030|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758031|NCT03066804|Valsartan|valsartan|mesh-list
25758032|NCT03066804|Enalapril|enalapril|mesh-list
25758033|NCT03066804|Enalaprilat|enalaprilat|mesh-list
25758034|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25758035|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25758036|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25758037|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25758038|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758039|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25758040|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
25758041|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758042|NCT03066830|Metformin|metformin|mesh-list
25758043|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25758044|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25758045|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758046|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25758047|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758048|NCT03066947|Interferons|interferons|mesh-list
25758049|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
25758050|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
25758051|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
25758052|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25758053|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
25758054|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758055|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758056|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25758057|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
25758058|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758059|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758060|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25758061|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
25758062|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776032|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758063|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25758064|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25758065|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
25758066|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758067|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25758068|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758069|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25758070|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758071|NCT03068312|Ivacaftor|ivacaftor|mesh-list
25758072|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25758073|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758074|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758075|NCT03068455|Nivolumab|nivolumab|mesh-list
25758076|NCT03068455|Ipilimumab|ipilimumab|mesh-list
25758077|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758078|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758079|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25758080|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758081|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25758082|NCT03068754|Hormones|hormones|mesh-ancestor
25758083|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758084|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758085|NCT03068767|Vitamin D|vitamin d|mesh-list
25758086|NCT03068767|Vitamins|vitamins|mesh-ancestor
25758087|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
25758088|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758089|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25758090|NCT03068897|Ibuprofen|ibuprofen|mesh-list
25758091|NCT03068897|Tizanidine|tizanidine|mesh-list
25758092|NCT03068897|Baclofen|baclofen|mesh-list
25758093|NCT03068897|Metaxalone|metaxalone|mesh-list
25758094|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758095|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758096|NCT03068897|Analgesics|analgesics|mesh-ancestor
25758097|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
25758098|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758099|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758100|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758101|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758102|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25758103|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758104|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758105|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25758106|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25758107|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25758108|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
25758109|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
25758110|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758111|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
25758112|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
25758113|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
25758114|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25758115|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25758116|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25758117|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758118|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
25758119|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
25758120|NCT03069313|Vitamins|vitamins|mesh-ancestor
25758121|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
25758122|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758123|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
25758124|NCT03069313|Hematinics|hematinics|mesh-ancestor
25758125|NCT03069482|Nicotine|nicotine|mesh-list
25758126|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25758127|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
25758128|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758129|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758130|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25758131|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25758132|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
25758133|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758134|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758135|NCT03069677|Midazolam|midazolam|mesh-list
25758136|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25758137|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25758138|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758139|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758140|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25758141|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25758142|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758143|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25758144|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
25758145|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
25758146|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
25758147|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
25758148|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758149|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758151|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
25758152|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25758153|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
25758154|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758155|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758156|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
25758157|NCT03070470|Ritonavir|ritonavir|mesh-list
25758158|NCT03070470|Lopinavir|lopinavir|mesh-list
25758159|NCT03070470|Chloroquine|chloroquine|mesh-list
25758160|NCT03070470|Verapamil|verapamil|mesh-list
25758161|NCT03070470|Dofetilide|dofetilide|mesh-list
25758162|NCT03070470|Diltiazem|diltiazem|mesh-list
25758163|NCT03070470|Ranolazine|ranolazine|mesh-list
25758164|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25758165|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25758166|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
25758167|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758168|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758169|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25758170|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25758171|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
25758172|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758173|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25758174|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25758175|NCT03070470|Amebicides|amebicides|mesh-ancestor
25758176|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25758177|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25758178|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
25758179|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758180|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758181|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25758182|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25758183|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758184|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25758185|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
25758186|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25758187|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25758188|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25758189|NCT03070483|Vitamin D|vitamin d|mesh-list
25758190|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
25758191|NCT03070483|Vitamins|vitamins|mesh-ancestor
25758192|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
25758193|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758194|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25758195|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25758196|NCT03070548|Talazoparib|talazoparib|mesh-list
25758197|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25758198|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758199|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758200|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776033|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
25776034|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
25776035|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776036|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25776037|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
25776038|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776039|NCT03873116|Berotralstat|berotralstat|mesh-list
25776040|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776041|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776042|NCT03872843|Ibuprofen|ibuprofen|mesh-list
25776043|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25776044|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776045|NCT03872843|Analgesics|analgesics|mesh-ancestor
25776046|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
25776047|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758201|NCT03070730|Atenolol|atenolol|mesh-list
25758202|NCT03070730|Droxidopa|droxidopa|mesh-list
25758203|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25758204|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25758205|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
25758206|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
25758207|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758208|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758209|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25758210|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25758211|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25758212|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758213|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758214|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758215|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25758216|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25758217|NCT03071094|Nivolumab|nivolumab|mesh-list
25758218|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758219|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758220|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25758221|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758222|NCT03071263|Spironolactone|spironolactone|mesh-list
25758223|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25758224|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
25758225|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758226|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758227|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25758228|NCT03071263|Diuretics|diuretics|mesh-ancestor
25758229|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
25758230|NCT03071276|Vidarabine|vidarabine|mesh-list
25758231|NCT03071276|Cytarabine|cytarabine|mesh-list
25758232|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
25758233|NCT03071276|Methotrexate|methotrexate|mesh-list
25758234|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
25758235|NCT03071276|Fludarabine|fludarabine|mesh-list
25758236|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25758237|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
25758238|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25758239|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758240|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25758241|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
25758242|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758243|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758244|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758245|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758246|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25758247|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25758248|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
25758249|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758250|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25758251|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
25758252|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758253|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758254|NCT03071744|Fentanyl|fentanyl|mesh-list
25758255|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25758256|NCT03071744|Narcotics|narcotics|mesh-ancestor
25758257|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758258|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758259|NCT03071744|Analgesics|analgesics|mesh-ancestor
25758260|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
25758261|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758262|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25758263|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25758264|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
25758265|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
25758266|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
25758267|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758268|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758269|NCT03072719|Fluorides|fluorides|mesh-list
25758270|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
25758271|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
25758272|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
25758273|NCT03072719|Protective Agents|protective agents|mesh-ancestor
25758274|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758275|NCT03073200|Etanercept|etanercept|mesh-list
25758276|NCT03073200|Ixekizumab|ixekizumab|mesh-list
25777665|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
25758277|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758278|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758279|NCT03073200|Analgesics|analgesics|mesh-ancestor
25758280|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
25758281|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758282|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758283|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758284|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758285|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758286|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25758287|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
25758288|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758289|NCT03073213|Ixekizumab|ixekizumab|mesh-list
25758290|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758291|NCT03073876|Donepezil|donepezil|mesh-list
25758292|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25758293|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758294|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758295|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
25758296|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758297|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758298|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
25758299|NCT03074162|Diclofenac|diclofenac|mesh-list
25758300|NCT03074162|Capsaicin|capsaicin|mesh-list
25758301|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758302|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758303|NCT03074162|Analgesics|analgesics|mesh-ancestor
25758304|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
25758305|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758306|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758307|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758308|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758309|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25758310|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758311|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758312|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
25758313|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758314|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
25758315|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25758316|NCT03074331|Velpatasvir|velpatasvir|mesh-list
25758317|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
25758318|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758319|NCT03074409|Oxytocin|oxytocin|mesh-list
25758320|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
25758321|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25758322|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758323|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
25758324|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25758325|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25758326|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25758327|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
25758328|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758329|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25758330|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25758331|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758332|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25758333|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25758334|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758335|NCT03075163|Ondansetron|ondansetron|mesh-list
25758336|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
25758337|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
25758338|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758339|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758340|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758341|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
25758342|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758343|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25758344|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
25758345|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758346|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758347|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25758348|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25758349|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758350|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758351|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25758352|NCT03075267|Budesonide|budesonide|mesh-list
25758353|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
25758354|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
25758355|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758356|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25758357|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
25758358|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758359|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758360|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25758361|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
25758362|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
25758363|NCT03075267|Hormones|hormones|mesh-ancestor
25758364|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758365|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25758366|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25758367|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25758368|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758369|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758370|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758371|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25758372|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25758373|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25758374|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
25758375|NCT03075410|GSK656|gsk656|mesh-list
25758376|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25758377|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758378|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25758379|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758380|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758381|NCT03075553|Nivolumab|nivolumab|mesh-list
25758382|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758383|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758384|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25758385|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758386|NCT03075891|Doxycycline|doxycycline|mesh-list
25758387|NCT03075891|Ivermectin|ivermectin|mesh-list
25758388|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25758389|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758390|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
25758391|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25758392|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25758393|NCT03076970|Sumatriptan|sumatriptan|mesh-list
25758394|NCT03076970|Lasmiditan|lasmiditan|mesh-list
25758395|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25758396|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25758397|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25758398|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
25758399|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758400|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758401|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758402|NCT03077607|Itraconazole|itraconazole|mesh-list
25758403|NCT03077607|Rifampin|rifampin|mesh-list
25758404|NCT03077607|Talazoparib|talazoparib|mesh-list
25758405|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
25758406|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758407|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25758408|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25758409|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758410|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758411|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25758412|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
25758413|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758414|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758415|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25758416|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25758417|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
25758418|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25758419|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
25758420|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25758421|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25758422|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25758423|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25758424|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25758425|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25758426|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25758427|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25758428|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758429|NCT03077659|Paclitaxel|paclitaxel|mesh-list
25758430|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25758431|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758432|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
25758433|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
25758434|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
25758435|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758436|NCT03077711|Trimethoprim|trimethoprim|mesh-list
25758437|NCT03077711|Methenamine|methenamine|mesh-list
25758438|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
25758439|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
25758440|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25758441|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758442|NCT03077711|Renal Agents|renal agents|mesh-ancestor
25758443|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
25758444|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25758445|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25758446|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25758447|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758448|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758449|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25758450|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25758451|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25758452|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25758453|NCT03077919|Ropivacaine|ropivacaine|mesh-list
25758454|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
25758455|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
25758456|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758457|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758458|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
25758459|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758460|NCT03078075|Naltrexone|naltrexone|mesh-list
25758461|NCT03078075|Bupropion|bupropion|mesh-list
25758462|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25758463|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25758464|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758465|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
25758466|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758467|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25758468|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
25758469|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758470|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25758471|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25758472|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758473|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758474|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
25758475|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758476|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25758477|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25758478|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758479|NCT03078556|Lamivudine|lamivudine|mesh-list
25758480|NCT03078556|Dolutegravir|dolutegravir|mesh-list
25758481|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25758482|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25758483|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758484|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758485|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
25758486|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758487|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25758488|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25758489|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25758490|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25758491|NCT03078907|Selexipag|selexipag|mesh-list
25758492|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25758493|NCT03078946|Midazolam|midazolam|mesh-list
25758494|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
25758495|NCT03078946|Morphine|morphine|mesh-list
25758496|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25758497|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758498|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758499|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758500|NCT03078946|Analgesics|analgesics|mesh-ancestor
25758501|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
25758502|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758503|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25758504|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25758505|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25758506|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758507|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758508|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758509|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25758510|NCT03078946|Narcotics|narcotics|mesh-ancestor
25758511|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25758512|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25758513|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25758514|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758515|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25758516|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
25758517|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
25758518|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
25758519|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
25758520|NCT03080142|Bupivacaine|bupivacaine|mesh-list
25758521|NCT03080142|Ropivacaine|ropivacaine|mesh-list
25758522|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
25758523|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
25758524|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758525|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758526|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
25758527|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758528|NCT03080493|Acetaminophen|acetaminophen|mesh-list
25758529|NCT03080493|Ibuprofen|ibuprofen|mesh-list
25758530|NCT03080493|Gabapentin|gabapentin|mesh-list
25758531|NCT03080493|Codeine|codeine|mesh-list
25758532|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25758533|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758534|NCT03080493|Analgesics|analgesics|mesh-ancestor
25758535|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
25758536|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758537|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758538|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
25758539|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758540|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758541|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758542|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25758543|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758544|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758545|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
25758546|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25758547|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25758548|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758549|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758550|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25758551|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25758552|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758553|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
25758554|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25758555|NCT03080493|Narcotics|narcotics|mesh-ancestor
25758556|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
25758557|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
25758558|NCT03080493|Laxatives|laxatives|mesh-ancestor
25758559|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758560|NCT03081117|Insulin|insulin|mesh-list
25758561|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25758562|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758563|NCT03082196|Fluorides|fluorides|mesh-list
25758564|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
25758565|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
25758566|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
25758567|NCT03082196|Protective Agents|protective agents|mesh-ancestor
25758568|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758569|NCT03083132|Modafinil|modafinil|mesh-list
25758570|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25069018|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069028|NCT03429738|Ibuprofen|ibuprofen|mesh-list
25069029|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
25069030|NCT03429738|Ephedrine|ephedrine|mesh-list
25069031|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069032|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069033|NCT03429738|Analgesics|analgesics|mesh-ancestor
25069157|NCT03428529|Capecitabine|capecitabine|mesh-list
25758571|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758572|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25758573|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25758574|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25758575|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758576|NCT03083470|Paclitaxel|paclitaxel|mesh-list
25758577|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25758578|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758579|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
25758580|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
25758581|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
25758582|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758583|NCT03083639|Esomeprazole|esomeprazole|mesh-list
25758584|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25758585|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758586|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25758587|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758588|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758589|NCT03083847|Chloroquine|chloroquine|mesh-list
25758590|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25758591|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
25758592|NCT03083847|Amebicides|amebicides|mesh-ancestor
25758593|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25758594|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25758595|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758596|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
25758597|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758598|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758599|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758600|NCT03083847|Analgesics|analgesics|mesh-ancestor
25758601|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
25758602|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758603|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758604|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758605|NCT03083847|Filaricides|filaricides|mesh-ancestor
25758606|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
25758607|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
25758608|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25758609|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758610|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758611|NCT03083990|Bevacizumab|bevacizumab|mesh-list
25758612|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758613|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758614|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25758615|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25758616|NCT03083990|Growth Substances|growth substances|mesh-ancestor
25758617|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758618|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
25758619|NCT03084315|Nicotine|nicotine|mesh-list
25758620|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25758621|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
25758622|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758623|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758624|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25758625|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25758626|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
25758627|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758628|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758629|NCT03084796|Bromides|bromides|mesh-list
25758630|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
25758631|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25758632|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
25758633|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758634|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758635|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25758636|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
25758637|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
25758638|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24696006|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25019164|NCT03693222|Morphine|morphine|mesh-list
25070257|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
24697071|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25758639|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
25758640|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758641|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758642|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
25758643|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
25758644|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758645|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758646|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25776048|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776049|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776050|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776051|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25776052|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776053|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776054|NCT03861338|Buprenorphine|buprenorphine|mesh-list
25776055|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25776056|NCT03861338|Narcotics|narcotics|mesh-ancestor
25776057|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776058|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776059|NCT03861338|Analgesics|analgesics|mesh-ancestor
25776060|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
25776061|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776062|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25776063|NCT03848416|Ixekizumab|ixekizumab|mesh-list
25776064|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
25776065|NCT03853551|Osimertinib|osimertinib|mesh-list
25776066|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776067|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25776068|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776069|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776070|NCT03859960|Insulin|insulin|mesh-list
25776071|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25776072|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776073|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776074|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
25776075|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25776076|NCT03868059|Testosterone|testosterone|mesh-list
25776077|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
25776078|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
25776079|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25776080|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776081|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
25776082|NCT03868059|Hormones|hormones|mesh-ancestor
25776083|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776084|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776085|NCT03868059|Androgens|androgens|mesh-ancestor
25776086|NCT03865407|Allopurinol|allopurinol|mesh-list
25776087|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
25776088|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776089|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776090|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
25776091|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776092|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25776093|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
25776094|NCT03865407|Protective Agents|protective agents|mesh-ancestor
25776095|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776096|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25776097|NCT03857230|Hormones|hormones|mesh-ancestor
25776098|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776099|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776100|NCT03847610|Penicillins|penicillins|mesh-list
25776101|NCT03847610|Penicillin V|penicillin v|mesh-list
25776102|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25776103|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776104|NCT03850093|Bisoprolol|bisoprolol|mesh-list
25776105|NCT03850093|Gabapentin|gabapentin|mesh-list
25776106|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698057|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25070386|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25029700|NCT03600974|Esomeprazole|esomeprazole|mesh-list
24824142|NCT02121990|Paclitaxel|paclitaxel|mesh-list
24698227|NCT01439997|Coagulants|coagulants|mesh-ancestor
24698228|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24698229|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
24698230|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698231|NCT01440062|Vitamin D|vitamin d|mesh-list
24698481|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
25758647|NCT03086213|Lidocaine|lidocaine|mesh-list
25758648|NCT03086213|Sufentanil|sufentanil|mesh-list
25758649|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
25758650|NCT03086213|Dsuvia|dsuvia|mesh-list
25758651|NCT03086213|Ropivacaine|ropivacaine|mesh-list
25758652|NCT03086213|Propofol|propofol|mesh-list
25758653|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
25758654|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
25758655|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758656|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758657|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
25758658|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758659|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25758660|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25758661|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25758662|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758663|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758664|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25758665|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25758666|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
25758667|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758668|NCT03086213|Analgesics|analgesics|mesh-ancestor
25758669|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25758670|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25758671|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25758672|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758673|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758674|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25758675|NCT03086213|Narcotics|narcotics|mesh-ancestor
25758676|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25758677|NCT03086356|Dabigatran|dabigatran|mesh-list
25758678|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
25758679|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25758680|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
25758681|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758682|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758683|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
25758684|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
25758685|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25758686|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
25758687|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758688|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758689|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25758690|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
25758691|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25758692|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25758693|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25758694|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758695|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758696|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758697|NCT03087604|Lidocaine|lidocaine|mesh-list
25758698|NCT03087604|Epinephrine|epinephrine|mesh-list
25758699|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
25758700|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
25758701|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758702|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758703|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
25758704|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758705|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25758706|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25758707|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25758708|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758709|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758710|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25758711|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25758712|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758713|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758714|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25072364|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072462|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25072463|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072464|NCT03401476|Morphine|morphine|mesh-list
25072465|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25758715|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25758716|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
25758717|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25758718|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
25758719|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
25758720|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
25758721|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25758722|NCT03087786|Nicotine|nicotine|mesh-list
25758723|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25758724|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
25758725|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758726|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758727|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25758728|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25758729|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
25758730|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758731|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758732|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
25758733|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25758734|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758735|NCT03088267|Amphetamine|amphetamine|mesh-list
25758736|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25758737|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758738|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
25758739|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
25758740|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758741|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
25758742|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758743|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758744|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758745|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25758746|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25758747|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758748|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25758749|NCT03088345|Vasopressins|vasopressins|mesh-list
25758750|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
25758751|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
25758752|NCT03088345|Coagulants|coagulants|mesh-ancestor
25758753|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25758754|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25758755|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
25758756|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758757|NCT03088800|Ibuprofen|ibuprofen|mesh-list
25758758|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758759|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758760|NCT03088800|Analgesics|analgesics|mesh-ancestor
25758761|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
25758762|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758763|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758764|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758765|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758766|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25758767|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758768|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758769|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
25758770|NCT03089216|Calcium|calcium|mesh-list
25758771|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25758772|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758773|NCT03089216|Antacids|antacids|mesh-ancestor
25758774|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758775|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758776|NCT03090620|Lorazepam|lorazepam|mesh-list
25758777|NCT03090620|Physostigmine|physostigmine|mesh-list
25758778|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
25758779|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
25758780|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
25758781|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758782|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758783|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758784|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25758785|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758786|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25758787|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25758788|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758789|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
25758790|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
25758791|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758792|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758793|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25758794|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758795|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
25758796|NCT03090620|Miotics|miotics|mesh-ancestor
25758797|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
25758798|NCT03091348|Testosterone|testosterone|mesh-list
25758799|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
25758800|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
25758801|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25758802|NCT03091348|Androgens|androgens|mesh-ancestor
25758803|NCT03091348|Hormones|hormones|mesh-ancestor
25758804|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758805|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758806|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25758807|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758808|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
25758809|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25758810|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25758811|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25758812|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758813|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758814|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758815|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758816|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758817|NCT03091439|Dalbavancin|dalbavancin|mesh-list
25758818|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25758819|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758820|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
25758821|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758822|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758823|NCT03091673|Glucagon|glucagon|mesh-list
25758824|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25758825|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758826|NCT03091673|Hormones|hormones|mesh-ancestor
25758827|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758828|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758829|NCT03091673|Incretins|incretins|mesh-ancestor
25758830|NCT03091777|Metronidazole|metronidazole|mesh-list
25758831|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758832|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25758833|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25758834|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25758835|NCT03091920|Praliciguat|praliciguat|mesh-list
25758836|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25758837|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
25758838|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758839|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25758840|NCT03092375|Ribavirin|ribavirin|mesh-list
25758841|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
25758842|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758843|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
25758844|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758845|NCT03092726|ASP8062|asp8062|mesh-list
25758846|NCT03092726|Analgesics|analgesics|mesh-ancestor
25758847|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
25758848|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758849|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758850|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
25758851|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
25758852|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758853|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758854|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25758855|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758856|NCT03093207|Aspirin|aspirin|mesh-list
25758857|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25758858|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758859|NCT03093207|Analgesics|analgesics|mesh-ancestor
25758860|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
25758861|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758862|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758863|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758864|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25758865|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25758866|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25758867|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758868|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25758869|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25758870|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758871|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
25758872|NCT03093272|Prednisone|prednisone|mesh-list
25758873|NCT03093272|Docetaxel|docetaxel|mesh-list
25758874|NCT03093272|Leuprolide|leuprolide|mesh-list
25758875|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758876|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
25758877|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
25758878|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
25758879|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758880|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25758881|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
25758882|NCT03093272|Hormones|hormones|mesh-ancestor
25758883|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25758884|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758885|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25758886|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25758887|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
25758888|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25758889|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25758890|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758891|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25758892|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
25758893|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758894|NCT03093415|Grazoprevir|grazoprevir|mesh-list
25758895|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25758896|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
25758897|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758898|NCT03093870|Capecitabine|capecitabine|mesh-list
25758899|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25758900|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
25758901|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758902|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758903|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25758904|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25758905|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758906|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25758907|NCT03095508|Menthol|menthol|mesh-list
25758908|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
25758909|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758910|NCT03095521|Menthol|menthol|mesh-list
25758911|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
25758912|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
25758913|NCT03095638|Dolutegravir|dolutegravir|mesh-list
25758914|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25758915|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25758916|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758917|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758918|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25758919|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25758920|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
25758921|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25758922|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
25758923|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25758924|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758925|NCT03096314|Vitamin D|vitamin d|mesh-list
25758926|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
25758927|NCT03096314|Vitamins|vitamins|mesh-ancestor
25758928|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
25758929|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758930|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25758931|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25758932|NCT03096353|Naloxone|naloxone|mesh-list
25758933|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25758934|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758935|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
25758936|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758937|NCT03096444|Lidocaine|lidocaine|mesh-list
24850852|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24937214|NCT04031859|Aspirin|aspirin|mesh-list
24761913|NCT01765296|Analgesics|analgesics|mesh-ancestor
25758938|NCT03096444|Ketamine|ketamine|mesh-list
25758939|NCT03096444|Amitriptyline|amitriptyline|mesh-list
25758940|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
25758941|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
25758942|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758943|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758944|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
25758945|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758946|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25758947|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25758948|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25758949|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25758950|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758951|NCT03096444|Analgesics|analgesics|mesh-ancestor
25758952|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25758953|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25758954|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
25758955|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25758956|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25758957|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758958|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25758959|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
25758960|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25758961|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758962|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25758963|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25758964|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758965|NCT03096730|Sufentanil|sufentanil|mesh-list
25758966|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
25758967|NCT03096730|Remifentanil|remifentanil|mesh-list
25758969|NCT03096730|Nalmefene|nalmefene|mesh-list
25758970|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25758971|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25758972|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25758973|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25758974|NCT03096730|Analgesics|analgesics|mesh-ancestor
25758975|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
25758976|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25758977|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25758978|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25758979|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25758980|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
25758981|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25758982|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758983|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25758984|NCT03096730|Narcotics|narcotics|mesh-ancestor
25758985|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25758986|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25758987|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
25758988|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
25758989|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25758990|NCT03096847|Letrozole|letrozole|mesh-list
25758991|NCT03096847|Goserelin|goserelin|mesh-list
25758992|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25758993|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25758994|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25758995|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25758996|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25758997|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25758998|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
25758999|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759000|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759001|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25759002|NCT03097133|Esketamine|esketamine|mesh-list
25759003|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
25759004|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25759005|NCT03097315|Triamcinolone|triamcinolone|mesh-list
25759006|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25759007|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25759008|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25759009|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759010|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
25759011|NCT03097315|Hormones|hormones|mesh-ancestor
25759012|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759013|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759014|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25759015|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
25759016|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759017|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759018|NCT03097588|Palonosetron|palonosetron|mesh-list
25759019|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
25759020|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
25759021|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759022|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759023|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759024|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25759025|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25759026|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
25759027|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759028|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759029|NCT03097861|Lubiprostone|lubiprostone|mesh-list
25759030|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25759031|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759032|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759033|NCT03098030|Irinotecan|irinotecan|mesh-list
25759034|NCT03098030|Topotecan|topotecan|mesh-list
25759035|NCT03098030|Dinutuximab|dinutuximab|mesh-list
25759036|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25759037|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25759038|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759039|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759040|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759041|NCT03098420|Dexamethasone|dexamethasone|mesh-list
25759042|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
25759043|NCT03098420|Morphine|morphine|mesh-list
25759044|NCT03098420|Bupivacaine|bupivacaine|mesh-list
25759045|NCT03098420|Ropivacaine|ropivacaine|mesh-list
25759046|NCT03098420|BB 1101|bb 1101|mesh-list
25759047|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759048|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
25759049|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
25759050|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759051|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759052|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759053|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
25759054|NCT03098420|Hormones|hormones|mesh-ancestor
25759055|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759056|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25759057|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759058|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
25759059|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759060|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759061|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759062|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
25759063|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759064|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
25759065|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25759066|NCT03098420|Narcotics|narcotics|mesh-ancestor
25759067|NCT03098420|Analgesics|analgesics|mesh-ancestor
25759068|NCT03098550|Nivolumab|nivolumab|mesh-list
25759069|NCT03098550|Daratumumab|daratumumab|mesh-list
25759070|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25759071|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759072|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25759073|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759074|NCT03098615|Efinaconazole|efinaconazole|mesh-list
25759075|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
25759076|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776107|NCT03850093|Analgesics|analgesics|mesh-ancestor
25776108|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
25776109|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776110|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
25776111|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25776112|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25776113|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776114|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25759077|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
25759078|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25759079|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759080|NCT03099187|Pirfenidone|pirfenidone|mesh-list
25759081|NCT03099187|Analgesics|analgesics|mesh-ancestor
25759082|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
25759083|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759084|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759085|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25759086|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759087|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759088|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759089|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759090|NCT03099538|Ixekizumab|ixekizumab|mesh-list
25759091|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759092|NCT03100058|Licogliflozin|licogliflozin|mesh-list
25759093|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25759094|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759095|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759096|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759097|NCT03100123|Aspirin|aspirin|mesh-list
25759098|NCT03100123|Heparin|heparin|mesh-list
25759099|NCT03100123|Enoxaparin|enoxaparin|mesh-list
25759100|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25759101|NCT03100123|Tinzaparin|tinzaparin|mesh-list
25759102|NCT03100123|Dalteparin|dalteparin|mesh-list
25759103|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25759104|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759105|NCT03100123|Analgesics|analgesics|mesh-ancestor
25759106|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
25759107|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759108|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759109|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759110|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759111|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25759112|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25759113|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759114|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25759115|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25759116|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759117|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
25759118|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
25759119|NCT03100838|Nifedipine|nifedipine|mesh-list
25759120|NCT03100838|Omeprazole|omeprazole|mesh-list
25759121|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25759122|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25759123|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759124|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25759125|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759126|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759127|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25759128|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759129|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25759130|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759131|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
25759132|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
25759133|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25759134|NCT03101033|Betamethasone|betamethasone|mesh-list
25759135|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
25759136|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25759137|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
25759138|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25759139|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759140|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
25759141|NCT03101033|Hormones|hormones|mesh-ancestor
25759142|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759143|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759144|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25759145|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
25759146|NCT03101111|Vaccines|vaccines|mesh-list
25759147|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
25759148|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759149|NCT03101150|Vitamin D|vitamin d|mesh-list
25759150|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
25759151|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
25759152|NCT03101150|Vitamins|vitamins|mesh-list
25759153|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
25759154|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759155|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25759156|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25759157|NCT03101358|Paclitaxel|paclitaxel|mesh-list
25759158|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25759159|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25759160|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759161|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25759162|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25759163|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25759164|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759165|NCT03101371|Iodine|iodine|mesh-list
25759166|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
25759167|NCT03101371|Povidone|povidone|mesh-list
25759168|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25759169|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759170|NCT03101371|Trace Elements|trace elements|mesh-ancestor
25759171|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
25759172|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759173|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
25759174|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
25759175|NCT03101462|Vaccines|vaccines|mesh-list
25759176|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
25759177|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759178|NCT03102190|Verapamil|verapamil|mesh-list
25759179|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25759180|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25759181|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759182|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759183|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25759184|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759185|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
25759186|NCT03102645|Imipramine|imipramine|mesh-list
25759187|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25759188|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
25759189|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25759190|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25759191|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25759192|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759193|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759194|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
25759195|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759196|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759197|NCT03102710|Lidocaine|lidocaine|mesh-list
25759198|NCT03102710|Capsaicin|capsaicin|mesh-list
25759199|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759200|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
25759201|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759202|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759203|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
25759204|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759205|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25759206|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25759207|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759208|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759209|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759210|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
25759211|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759212|NCT03102736|Nitroprusside|nitroprusside|mesh-list
25759213|NCT03102736|Ketamine|ketamine|mesh-list
25759214|NCT03102736|Analgesics|analgesics|mesh-ancestor
25759215|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
25759216|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759217|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940039|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
24940040|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625685|NCT01082926|Aldesleukin|aldesleukin|mesh-list
24625689|NCT01082926|Analgesics|analgesics|mesh-ancestor
24444084|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
24444085|NCT00296712|Dexetimide|dexetimide|mesh-list
24444086|NCT00296712|Citalopram|citalopram|mesh-list
25759218|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25759219|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25759220|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
25759221|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
25759222|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759223|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25759224|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25759225|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759226|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759227|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25759228|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
25759229|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25759230|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
25759231|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25759232|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25759233|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25759234|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759235|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759236|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
25759237|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759238|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759239|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25759240|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759241|NCT03102918|Cannabidiol|cannabidiol|mesh-list
25759242|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
25759243|NCT03103061|Regadenoson|regadenoson|mesh-list
25759244|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25759245|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25759246|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
25759247|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
25759248|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759249|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759250|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759251|NCT03103100|Lidocaine|lidocaine|mesh-list
25759252|NCT03103100|Bupivacaine|bupivacaine|mesh-list
25759253|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759254|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
25759255|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759256|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759257|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
25759258|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759259|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25759260|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25759261|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759262|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759263|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759264|NCT03103763|Warfarin|warfarin|mesh-list
25759265|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
25759266|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
25759267|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25759268|NCT03103906|Protective Agents|protective agents|mesh-ancestor
25759269|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759270|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759271|NCT03103919|Rotigotine|rotigotine|mesh-list
25759272|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
25759273|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
25759274|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759275|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759276|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759277|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
25759278|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25759279|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
25759280|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759281|NCT03104725|Expectorants|expectorants|mesh-ancestor
25759282|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
25759283|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25759284|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
25759285|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759286|NCT03104725|Protective Agents|protective agents|mesh-ancestor
25759287|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759288|NCT03104725|Antidotes|antidotes|mesh-ancestor
25759289|NCT03104738|Insulin|insulin|mesh-list
25759290|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759291|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759292|NCT03104816|Acetaminophen|acetaminophen|mesh-list
25759293|NCT03104816|Hydromorphone|hydromorphone|mesh-list
25759294|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759295|NCT03104816|Analgesics|analgesics|mesh-ancestor
25759296|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
25759297|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759298|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759299|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
25759300|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25759301|NCT03104816|Narcotics|narcotics|mesh-ancestor
25759302|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759303|NCT03105479|Vancomycin|vancomycin|mesh-list
25759304|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25759305|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759306|NCT03106077|Maytansine|maytansine|mesh-list
25759307|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25759308|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759309|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
25759310|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
25759311|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
25759312|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759313|NCT03106753|Bupivacaine|bupivacaine|mesh-list
25759314|NCT03106753|Terbutaline|terbutaline|mesh-list
25759315|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759316|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
25759317|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759318|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759319|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
25759320|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759321|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25759322|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
25759323|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25759324|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
25759325|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
25759326|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
25759327|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25759328|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25759329|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25759330|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25759331|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
25759332|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759333|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759334|NCT03106870|Insulin|insulin|mesh-list
25759335|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25759336|NCT03106870|Metformin|metformin|mesh-list
25759337|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
25759338|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759339|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759340|NCT03107091|Terlipressin|terlipressin|mesh-list
25759341|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25759342|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25759343|NCT03107754|Lidocaine|lidocaine|mesh-list
25759344|NCT03107754|Anesthetics|anesthetics|mesh-list
25759345|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759346|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759347|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759348|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
25759349|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759350|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25759351|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25759352|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759353|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456839|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24828186|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25759354|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759355|NCT03107793|Ustekinumab|ustekinumab|mesh-list
25759356|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759357|NCT03108482|Celecoxib|celecoxib|mesh-list
25759358|NCT03108482|Tramadol|tramadol|mesh-list
25759359|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25759360|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759361|NCT03108482|Analgesics|analgesics|mesh-ancestor
25759362|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
25759363|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759364|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759365|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759366|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759367|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25759368|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25759369|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759370|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759371|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25759372|NCT03108482|Narcotics|narcotics|mesh-ancestor
25759373|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759374|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25759375|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759376|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759377|NCT03108521|Incretins|incretins|mesh-ancestor
25759378|NCT03108521|Hormones|hormones|mesh-ancestor
25759379|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759380|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25759381|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
25759382|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759383|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759384|NCT03109015|Sunitinib|sunitinib|mesh-list
25759385|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759386|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25759387|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25759388|NCT03109015|Growth Substances|growth substances|mesh-ancestor
25759389|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759390|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
25759391|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25759392|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759393|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759394|NCT03110003|Bupivacaine|bupivacaine|mesh-list
25759395|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759396|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
25759397|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759398|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759399|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
25759400|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759401|NCT03110029|Efinaconazole|efinaconazole|mesh-list
25759402|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
25759403|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759404|NCT03110562|Dexamethasone|dexamethasone|mesh-list
25759405|NCT03110562|Bortezomib|bortezomib|mesh-list
25759406|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759407|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
25759408|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
25759409|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759410|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759411|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759412|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
25759413|NCT03110562|Hormones|hormones|mesh-ancestor
25759414|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759415|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25759416|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759417|NCT03111108|Grazoprevir|grazoprevir|mesh-list
25759418|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
25759419|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759420|NCT03111316|Dinoprostone|dinoprostone|mesh-list
25759421|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
25759422|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25759423|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759424|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25759425|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25759426|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759427|NCT03111381|Analgesics|analgesics|mesh-ancestor
25759428|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
25759429|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759430|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759431|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759432|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759433|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25759434|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759435|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759436|NCT03111628|Omalizumab|omalizumab|mesh-list
25759437|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25759438|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25759439|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
25759440|NCT03112863|Vitamin A|vitamin a|mesh-list
25759441|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
25759442|NCT03112863|Vitamins|vitamins|mesh-ancestor
25759443|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
25759444|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759445|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
25759446|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759447|NCT03112863|Protective Agents|protective agents|mesh-ancestor
25759448|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25759449|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776115|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25776116|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25776117|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776118|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776119|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
25776120|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25776121|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
25776122|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
25776123|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25776124|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25776125|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25776126|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
25776127|NCT03847389|Clobetasol|clobetasol|mesh-list
25776128|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776129|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
25776130|NCT03847389|Hormones|hormones|mesh-ancestor
25776131|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776132|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776133|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25776134|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776135|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
25776136|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25776137|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25776138|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25776139|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25776140|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776141|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
25776142|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776143|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776144|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25776145|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776146|NCT03857750|Rocuronium|rocuronium|mesh-list
25776147|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25776148|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25776149|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25776150|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776151|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776152|NCT03860753|Pioglitazone|pioglitazone|mesh-list
25776153|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776154|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776155|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25776156|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25776157|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
25776158|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25776159|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25776160|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776161|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
25776162|NCT03856164|Coagulants|coagulants|mesh-ancestor
25776163|NCT03849690|Esomeprazole|esomeprazole|mesh-list
24422257|NCT00221845|Telmisartan|telmisartan|mesh-list
25759450|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25759451|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
25759452|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25759453|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25759454|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
25759455|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25759456|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
25759457|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759458|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759459|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
25759460|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25759461|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
25759462|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759463|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759464|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
25759465|NCT03114969|Hormones|hormones|mesh-ancestor
25759466|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759467|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
25759468|NCT03114995|Tirofiban|tirofiban|mesh-list
25759469|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25759470|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25759471|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759472|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25759473|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25759474|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
25759475|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759476|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759477|NCT03115112|Incretins|incretins|mesh-ancestor
25759478|NCT03115112|Hormones|hormones|mesh-ancestor
25759479|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759480|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25759481|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
25759482|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759483|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759484|NCT03115177|Doxycycline|doxycycline|mesh-list
25759485|NCT03115177|Cefazolin|cefazolin|mesh-list
25759486|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25759487|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759488|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
25759489|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25759490|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25759491|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
25759492|NCT03115801|Nivolumab|nivolumab|mesh-list
25759493|NCT03115801|Atezolizumab|atezolizumab|mesh-list
25759494|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
25759495|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25759496|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759497|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25759498|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759499|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759500|NCT03115827|Carbidopa|carbidopa|mesh-list
25759501|NCT03115827|Droxidopa|droxidopa|mesh-list
25759502|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25759503|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25759504|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
25759505|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759506|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759507|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759508|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25759509|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759510|NCT03116152|Paclitaxel|paclitaxel|mesh-list
25759511|NCT03116152|Irinotecan|irinotecan|mesh-list
25759512|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25759513|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759514|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
25759515|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
25759516|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
25759517|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759518|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25759519|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24830773|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830774|NCT02161354|Buprenorphine|buprenorphine|mesh-list
24830775|NCT02161354|Naloxone|naloxone|mesh-list
25759520|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759521|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25759522|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
25759523|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25759524|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759525|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759526|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759527|NCT03117140|Dexamethasone|dexamethasone|mesh-list
25759528|NCT03117140|Clonidine|clonidine|mesh-list
25759529|NCT03117140|Buprenorphine|buprenorphine|mesh-list
25759530|NCT03117140|Ropivacaine|ropivacaine|mesh-list
25759531|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759532|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
25759533|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
25759534|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759535|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759536|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759537|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
25759538|NCT03117140|Hormones|hormones|mesh-ancestor
25759539|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759540|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25759541|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759542|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759543|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
25759544|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759545|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
25759546|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25759547|NCT03117140|Narcotics|narcotics|mesh-ancestor
25759548|NCT03117140|Analgesics|analgesics|mesh-ancestor
25759549|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25759550|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25759551|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
25759552|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25759553|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25759554|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25759555|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
25759556|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759557|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759558|NCT03117361|Dexamethasone|dexamethasone|mesh-list
25759559|NCT03117361|Bortezomib|bortezomib|mesh-list
25759560|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759561|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
25759562|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
25759563|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759564|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759565|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759566|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
25759567|NCT03117361|Hormones|hormones|mesh-ancestor
25759568|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759569|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25759570|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759571|NCT03117517|Metformin|metformin|mesh-list
25759572|NCT03117517|Pioglitazone|pioglitazone|mesh-list
25759573|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759574|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759575|NCT03117634|Aflibercept|aflibercept|mesh-list
25759576|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25759577|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25759578|NCT03117634|Growth Substances|growth substances|mesh-ancestor
25759579|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759580|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
25759581|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759582|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
25759583|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25759584|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
25759585|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25759586|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759587|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25759588|NCT03118466|Cytarabine|cytarabine|mesh-list
25759589|NCT03118466|Etoposide|etoposide|mesh-list
25759590|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
25759591|NCT03118466|Lenalidomide|lenalidomide|mesh-list
24830904|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
24830905|NCT02162121|Mepivacaine|mepivacaine|mesh-list
25268612|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25759592|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25759593|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759594|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25759595|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25759596|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759597|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759598|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25759599|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
25759600|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
25759601|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759602|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25759603|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
25759604|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759605|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25759606|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25759607|NCT03118466|Growth Substances|growth substances|mesh-ancestor
25759608|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
25759609|NCT03118466|Analgesics|analgesics|mesh-ancestor
25759610|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
25759611|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759612|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25759613|NCT03118739|Febuxostat|febuxostat|mesh-list
25759614|NCT03118739|Verinurad|verinurad|mesh-list
25759615|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
25759616|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759617|NCT03118765|Bromides|bromides|mesh-list
25759618|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25759619|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
25759620|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25759621|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
25759622|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759623|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759624|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25759625|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
25759626|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
25759627|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25759628|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
25759629|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759630|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759631|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
25759632|NCT03118843|Velpatasvir|velpatasvir|mesh-list
25759633|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
25759634|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759635|NCT03118947|Pimavanserin|pimavanserin|mesh-list
25759636|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25759637|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25759638|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25759639|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25759640|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759641|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759642|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25759643|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25759644|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25759645|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
25759646|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759647|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759648|NCT03119168|Simethicone|simethicone|mesh-list
25759649|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
25759650|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759651|NCT03119168|Emollients|emollients|mesh-ancestor
25759652|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759653|NCT03119181|Lidocaine|lidocaine|mesh-list
25759654|NCT03119181|Epinephrine|epinephrine|mesh-list
25759655|NCT03119181|Racepinephrine|racepinephrine|mesh-list
25759656|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25759657|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
25759658|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759659|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
25759660|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759661|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759662|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
25759663|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759664|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25759665|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25759666|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759667|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759668|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759669|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25759670|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25759671|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
25759672|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759673|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25759674|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25759675|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
25759676|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25759677|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
25759678|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
25759679|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
25759680|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25759681|NCT03119610|Oxytocin|oxytocin|mesh-list
25759682|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
25759683|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25759684|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759685|NCT03119701|Interferons|interferons|mesh-list
25759686|NCT03119701|Interferon-beta|interferon-beta|mesh-list
25759687|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
25759688|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759689|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
25759690|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759691|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
25759692|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759693|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25759694|NCT03119831|Ethanol|ethanol|mesh-list
25759695|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
25759696|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25759697|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25759698|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759699|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759700|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759701|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
25759702|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759703|NCT03120351|Lidocaine|lidocaine|mesh-list
25759704|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759705|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
25759706|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759707|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759708|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
25759709|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759710|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25759711|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25759712|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759713|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759714|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759715|NCT03120520|Plecanatide|plecanatide|mesh-list
25759716|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25759717|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
25759718|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759719|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759720|NCT03121820|Memantine|memantine|mesh-list
25759721|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25759722|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25759723|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
25759724|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759725|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759726|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759727|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25759728|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25759729|NCT03122145|Capsaicin|capsaicin|mesh-list
25759730|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
25759731|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759732|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
25759733|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759734|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759735|NCT03122457|C 1027|c 1027|mesh-list
25759736|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25759737|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759738|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25759739|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759740|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
25759741|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25759742|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759743|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
25759744|NCT03122587|Vitamins|vitamins|mesh-ancestor
25759745|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
25759746|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759747|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25759749|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759750|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
25759751|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25759752|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759753|NCT03123471|Apremilast|apremilast|mesh-list
25759754|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25759755|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759756|NCT03123471|Analgesics|analgesics|mesh-ancestor
25759757|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
25759758|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759759|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759760|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759761|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759762|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25759763|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25759764|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759765|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759766|NCT03123588|Anagrelide|anagrelide|mesh-list
25759767|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25759768|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25759769|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759770|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25759771|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25759772|NCT03123614|Prednisolone|prednisolone|mesh-list
25759773|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25759774|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
25759775|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25759776|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
25759777|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25759778|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
25759779|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759780|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
25759781|NCT03123614|Hormones|hormones|mesh-ancestor
25759782|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759783|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759784|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25759785|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759786|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
25759787|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
25759788|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759789|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759790|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25759791|NCT03123614|Protective Agents|protective agents|mesh-ancestor
25759792|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25759793|NCT03123848|Darunavir|darunavir|mesh-list
25759794|NCT03123848|Cobicistat|cobicistat|mesh-list
25759795|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25759796|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25759797|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25759798|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
25759799|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759800|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759801|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25759802|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25759803|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
25759804|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759805|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25759806|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25759807|NCT03123861|Gabapentin|gabapentin|mesh-list
25759808|NCT03123861|Analgesics|analgesics|mesh-ancestor
25759809|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
25759810|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759811|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759812|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
25759813|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25759814|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25759815|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759816|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25759817|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25759818|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25759819|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759820|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759821|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
25759822|NCT03124121|Golimumab|golimumab|mesh-list
25759823|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25759824|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759825|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25759826|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
25759827|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759828|NCT03124199|Rifaximin|rifaximin|mesh-list
25759829|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25759830|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759831|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759832|NCT03124407|Capsaicin|capsaicin|mesh-list
25759833|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
25759834|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
25759835|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
25759836|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759837|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759838|NCT03124758|Chrysarobin|chrysarobin|mesh-list
25759839|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25759840|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759841|NCT03124758|Analgesics|analgesics|mesh-ancestor
25759842|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
25759843|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759844|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759845|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759846|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759847|NCT03125395|Ivacaftor|ivacaftor|mesh-list
25759848|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25759849|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759850|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759851|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25759852|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25759853|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776164|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25776165|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776166|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25776167|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776168|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776169|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25776170|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25776171|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
25776172|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
25776173|NCT03840811|Cefixime|cefixime|mesh-list
25776174|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25776175|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776176|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25776177|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25776178|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776179|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776180|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776181|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25776182|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25776183|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
25776184|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25776185|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25776186|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776187|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
25776188|NCT03825939|Coagulants|coagulants|mesh-ancestor
25776189|NCT03841331|Serlopitant|serlopitant|mesh-list
25776190|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25776191|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776192|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776193|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776194|NCT03840278|Pancrelipase|pancrelipase|mesh-list
25776195|NCT03840278|Pancreatin|pancreatin|mesh-list
25776196|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777666|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777667|NCT03342157|Laxatives|laxatives|mesh-ancestor
25777668|NCT03339401|Brincidofovir|brincidofovir|mesh-list
25777669|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
24766245|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25759854|NCT03125941|Dexamethasone|dexamethasone|mesh-list
25759855|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759856|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
25759857|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
25759858|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759859|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759860|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25759861|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
25759862|NCT03125941|Hormones|hormones|mesh-ancestor
25759863|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759864|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25759865|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759866|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25759867|NCT03126370|Emtricitabine|emtricitabine|mesh-list
25759868|NCT03126370|Tenofovir|tenofovir|mesh-list
25759869|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25759870|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
25759871|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25759872|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25759873|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759874|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759875|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
25759876|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759877|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25759878|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25759879|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25759880|NCT03126682|Bupropion|bupropion|mesh-list
25759881|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25759882|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
25759883|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25759884|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25759885|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25759886|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759887|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759888|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
25759889|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25759890|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759891|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25759892|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25759893|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759894|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25759895|NCT03126760|Hormones|hormones|mesh-ancestor
25759896|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759897|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759898|NCT03126786|Triamcinolone|triamcinolone|mesh-list
25759899|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25759900|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25759901|NCT03126786|Aflibercept|aflibercept|mesh-list
25759902|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25759903|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759904|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
25759905|NCT03126786|Hormones|hormones|mesh-ancestor
25759906|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759907|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759908|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25759909|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
25759910|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759911|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759912|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25759913|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25759914|NCT03126786|Growth Substances|growth substances|mesh-ancestor
25759915|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
25759916|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759917|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25759918|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759919|NCT03127943|Lidocaine|lidocaine|mesh-list
25759920|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
25759921|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
25759922|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25759923|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759924|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
25759925|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759926|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25759927|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25759928|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759929|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759930|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759931|NCT03128008|Paclitaxel|paclitaxel|mesh-list
25759932|NCT03128008|Carboplatin|carboplatin|mesh-list
25759933|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25759934|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25759935|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
25759936|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
25759937|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25759938|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759939|NCT03129945|Indomethacin|indomethacin|mesh-list
25759940|NCT03129945|Nifedipine|nifedipine|mesh-list
25759941|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25759942|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25759943|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759944|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25759945|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759946|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
25759947|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
25759948|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25759949|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25759950|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759951|NCT03129945|Analgesics|analgesics|mesh-ancestor
25759952|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
25759953|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759954|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25759955|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25759956|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
25759957|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25759958|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759959|NCT03130738|Miconazole|miconazole|mesh-list
25759960|NCT03130738|Clotrimazole|clotrimazole|mesh-list
25759961|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
25759962|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25759963|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25759964|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25759965|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759966|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759967|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25759968|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
25759969|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759970|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759971|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25759972|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25759973|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25759974|NCT03131453|CNP520|cnp520|mesh-list
25759975|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25759976|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759977|NCT03131479|Licogliflozin|licogliflozin|mesh-list
25759978|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25759979|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25759980|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759981|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759982|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25759983|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
25759984|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759985|NCT03131687|Dulaglutide|dulaglutide|mesh-list
25759986|NCT03131687|Tirzepatide|tirzepatide|mesh-list
25759987|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25759988|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759989|NCT03131687|Incretins|incretins|mesh-ancestor
25759990|NCT03131687|Hormones|hormones|mesh-ancestor
25759991|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25759992|NCT03131713|Acetaminophen|acetaminophen|mesh-list
25759993|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25759994|NCT03131713|Analgesics|analgesics|mesh-ancestor
25759995|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
25776197|NCT03839355|Warfarin|warfarin|mesh-list
24469831|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470044|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24834810|NCT02181218|Hormones|hormones|mesh-ancestor
25759996|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25759997|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25759998|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
25759999|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
25760000|NCT03131895|Lansoprazole|lansoprazole|mesh-list
25760001|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25760002|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760003|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25760004|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760005|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760006|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
25760007|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760008|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25760009|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760010|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760011|NCT03132571|Naltrexone|naltrexone|mesh-list
25760012|NCT03132571|Bupropion|bupropion|mesh-list
25760013|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25760014|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25760015|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760016|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
25760017|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760018|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25760019|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
25760020|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25760021|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25760022|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25760023|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760024|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760025|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
25760026|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760027|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25760028|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25760029|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760030|NCT03133481|Ropivacaine|ropivacaine|mesh-list
25760031|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
25760032|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
25760033|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760034|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760035|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
25760036|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760037|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25760038|NCT03134183|Misoprostol|misoprostol|mesh-list
25760039|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25760040|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
25760041|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25760042|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760043|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25760044|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760045|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
25760046|NCT03134703|Morphine|morphine|mesh-list
25760047|NCT03134703|Methadone|methadone|mesh-list
25760048|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25760049|NCT03134703|Narcotics|narcotics|mesh-ancestor
25760050|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760051|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760052|NCT03134703|Analgesics|analgesics|mesh-ancestor
25760053|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
25760054|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760055|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
25760056|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
25760057|NCT03135028|Cytarabine|cytarabine|mesh-list
25760058|NCT03135028|Daunorubicin|daunorubicin|mesh-list
25760059|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25760060|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
25760061|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760062|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760063|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
25760064|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760065|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25760066|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
25760067|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760068|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25776198|NCT03839355|Apixaban|apixaban|mesh-list
24837462|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25760069|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25760070|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25760071|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760072|NCT03136068|Digoxin|digoxin|mesh-list
25760073|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25760074|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25760075|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760076|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760077|NCT03136068|Protective Agents|protective agents|mesh-ancestor
25760078|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760079|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
25760080|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25760081|NCT03136107|Protective Agents|protective agents|mesh-ancestor
25760082|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760083|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760084|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
25760085|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25760086|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
25760087|NCT03136198|Diuretics|diuretics|mesh-list
25760088|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25760089|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
25760090|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760091|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760092|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760093|NCT03136328|Edotreotide|edotreotide|mesh-list
25760094|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25760095|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760096|NCT03136484|Canagliflozin|canagliflozin|mesh-list
25760097|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25760098|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760099|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760100|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760101|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25760102|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
25760103|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760104|NCT03137121|Olanzapine|olanzapine|mesh-list
25760105|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
25760106|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
25760107|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760108|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760109|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760110|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25760111|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25760112|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760113|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25760114|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25760115|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25760116|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760117|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760118|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760119|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
25760120|NCT03137303|Albuterol|albuterol|mesh-list
25760121|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25760122|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
25760123|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760124|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760125|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25760126|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
25760127|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
25760128|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25760129|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25760130|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25760131|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25760132|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
25760133|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760134|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760135|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
25760136|NCT03137784|Bromides|bromides|mesh-list
25760137|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
25760138|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25760139|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25760140|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24477498|NCT00418860|Clopidogrel|clopidogrel|mesh-list
24477530|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25760141|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760142|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760143|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760144|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760145|NCT03137992|Bromides|bromides|mesh-list
25760146|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
25760147|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25760148|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
25760149|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760150|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760151|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25760152|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
25760153|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
25760154|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25760155|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760156|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760157|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760158|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
25760159|NCT03138655|Vedolizumab|vedolizumab|mesh-list
25760160|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760161|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
25760162|NCT03138967|Bromides|bromides|mesh-list
25760163|NCT03138967|Rocuronium|rocuronium|mesh-list
25760164|NCT03138967|Neostigmine|neostigmine|mesh-list
25760165|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
25760166|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25760167|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25760168|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25760169|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760170|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760171|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25760172|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760173|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760174|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760175|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760176|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25760177|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
25760178|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25760179|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25760180|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25760181|NCT03139240|Oxycodone|oxycodone|mesh-list
25760182|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25760183|NCT03139240|Narcotics|narcotics|mesh-ancestor
25760184|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760185|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760186|NCT03139240|Analgesics|analgesics|mesh-ancestor
25760187|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
25760188|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760189|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
25760190|NCT03139279|Propofol|propofol|mesh-list
25760191|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25760192|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760193|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760194|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25760195|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
25760196|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
25760197|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25760198|NCT03139279|Analgesics|analgesics|mesh-ancestor
25760199|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
25760200|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760201|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25760202|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25760203|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25760204|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
25760205|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760206|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760207|NCT03139604|Prednisone|prednisone|mesh-list
25760208|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
25760209|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25760210|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25760211|NCT03139604|Prednisolone|prednisolone|mesh-list
25760212|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
25760213|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24478593|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478595|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24478596|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
25760215|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760216|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
25760217|NCT03139604|Hormones|hormones|mesh-ancestor
25760218|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760219|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760220|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25760221|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760222|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
25760223|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
25760224|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760225|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760226|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25760227|NCT03139604|Protective Agents|protective agents|mesh-ancestor
25760228|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
25760229|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25760230|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25760231|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760232|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
25760233|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760234|NCT03140631|Protamines|protamines|mesh-list
25760235|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
25760236|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760237|NCT03140631|Coagulants|coagulants|mesh-ancestor
25776199|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
25776200|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25776201|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
25776202|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25776203|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
25776204|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776205|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776206|NCT03838874|Bupivacaine|bupivacaine|mesh-list
25776207|NCT03838874|Mepivacaine|mepivacaine|mesh-list
25776208|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776209|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
25776210|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776211|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776212|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
25776213|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776214|NCT03822078|Denosumab|denosumab|mesh-list
25776215|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25776216|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776217|NCT03811951|Insulin|insulin|mesh-list
25776218|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776219|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776220|NCT03810235|Lidocaine|lidocaine|mesh-list
25776221|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776222|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
25776223|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776224|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776225|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
25776226|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776227|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25776228|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25776229|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25776230|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25776231|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776232|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
25776233|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25776234|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25776235|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776236|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
25776237|NCT03806556|Coagulants|coagulants|mesh-ancestor
25776238|NCT03836664|Timolol|timolol|mesh-list
25776239|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25776240|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25776241|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25776242|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24457140|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24480210|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
24848252|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
25760238|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
25760239|NCT03140722|Hematinics|hematinics|mesh-ancestor
25760240|NCT03142451|Minocycline|minocycline|mesh-list
25760241|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25760242|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760243|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
25760244|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
25760245|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760246|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
25760247|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760248|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760249|NCT03143166|Telmisartan|telmisartan|mesh-list
25760250|NCT03143166|Dabigatran|dabigatran|mesh-list
25760251|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25760252|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25760253|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25760254|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760255|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
25760256|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25760257|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
25760258|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760259|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
25760260|NCT03143569|Heparin|heparin|mesh-list
25760261|NCT03143569|Calcium heparin|calcium heparin|mesh-list
25760262|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
25760263|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25760264|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25760265|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760266|NCT03144635|Grazoprevir|grazoprevir|mesh-list
25760267|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
25760268|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760269|NCT03144804|Lamivudine|lamivudine|mesh-list
25760270|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25760271|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25760272|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760273|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760274|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
25760275|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760276|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25760277|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25760278|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
25760279|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760280|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25760281|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760282|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760283|NCT03145207|Lidocaine|lidocaine|mesh-list
25760284|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
25760285|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
25760286|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760287|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760288|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
25760289|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760290|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25760291|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25760292|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25760293|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760294|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760295|NCT03145259|Diclofenac|diclofenac|mesh-list
25760296|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
25760297|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25760298|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25760299|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25760300|NCT03145259|Analgesics|analgesics|mesh-ancestor
25760301|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
24486932|NCT00460681|Thymopentin|thymopentin|mesh-list
24812984|NCT02055703|Digoxin|digoxin|mesh-list
24444592|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
24444608|NCT00298597|Hematinics|hematinics|mesh-ancestor
24444609|NCT00298636|Adenosine|adenosine|mesh-list
25760302|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760303|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760304|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760305|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25760306|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25760307|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760308|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760309|NCT03146403|Vaccines|vaccines|mesh-list
25760310|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
25760311|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760312|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25760313|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
25760314|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760315|NCT03146806|Ketamine|ketamine|mesh-list
25760316|NCT03146806|Analgesics|analgesics|mesh-ancestor
25760317|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
25760318|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760319|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760320|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25760321|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25760322|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
25760323|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
25760324|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760325|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25760326|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25760327|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760328|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760329|NCT03147248|Infliximab|infliximab|mesh-list
25760330|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760331|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760332|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25760333|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
25760334|NCT03148236|Vitamins|vitamins|mesh-ancestor
25760335|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
25760336|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760337|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
25760338|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760339|NCT03148236|Protective Agents|protective agents|mesh-ancestor
25760340|NCT03149055|Isavuconazole|isavuconazole|mesh-list
25760341|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
25760342|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760343|NCT03149848|Rifabutin|rifabutin|mesh-list
25760344|NCT03149848|Cabotegravir|cabotegravir|mesh-list
25760345|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25760346|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760347|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25760348|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
25760349|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25760350|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25760351|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760352|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760353|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25760354|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25760355|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
25760356|NCT03149887|Bupivacaine|bupivacaine|mesh-list
25760357|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
25760358|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
25760359|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760360|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760361|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
25760362|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760363|NCT03149991|Ketamine|ketamine|mesh-list
25760364|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
25760365|NCT03149991|Analgesics|analgesics|mesh-ancestor
25760366|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
25760367|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760368|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760369|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25760370|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25760371|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
25760372|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
24850961|NCT02254655|Puerarin|puerarin|mesh-list
25760373|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760374|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25760376|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760377|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760378|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
25760379|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
25760380|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
25760381|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
25760382|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25760383|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760384|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25760385|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25760386|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760387|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760388|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760389|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25760390|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25760391|NCT03150589|Ranibizumab|ranibizumab|mesh-list
25760392|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25760393|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25760394|NCT03150589|Growth Substances|growth substances|mesh-ancestor
25760395|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760396|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
25760397|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760398|NCT03150719|Ivacaftor|ivacaftor|mesh-list
25760399|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25760400|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760401|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760402|NCT03150875|Docetaxel|docetaxel|mesh-list
25760403|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760404|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
25760405|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
25760406|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25760407|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760408|NCT03151434|Hydromorphone|hydromorphone|mesh-list
25760409|NCT03151434|Bupivacaine|bupivacaine|mesh-list
25760410|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
25760411|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
25760412|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760413|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760414|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
25760415|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760416|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25760417|NCT03151434|Narcotics|narcotics|mesh-ancestor
25760418|NCT03151434|Analgesics|analgesics|mesh-ancestor
25760419|NCT03151551|Adalimumab|adalimumab|mesh-list
25760420|NCT03151551|Ixekizumab|ixekizumab|mesh-list
25760421|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760422|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25760423|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760424|NCT03152019|Tacrolimus|tacrolimus|mesh-list
25760425|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25760426|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
25760427|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760428|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25760429|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760430|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760431|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
25760432|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25760433|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760434|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760435|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760436|NCT03152552|Empagliflozin|empagliflozin|mesh-list
24851225|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851228|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
24487628|NCT00464256|Rimonabant|rimonabant|mesh-list
24487630|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24487631|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24487632|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487662|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
24487663|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760437|NCT03152552|Licogliflozin|licogliflozin|mesh-list
25760438|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25760439|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760440|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760441|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760442|NCT03152591|Licogliflozin|licogliflozin|mesh-list
25760443|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25760444|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760445|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760446|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760447|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
25760448|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760449|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
25760450|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
25760451|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25760452|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25760453|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760454|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760455|NCT03154476|Urological Agents|urological agents|mesh-ancestor
25760456|NCT03154658|Ropivacaine|ropivacaine|mesh-list
25760457|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
25760458|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
25760459|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760460|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760461|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
25760462|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760463|NCT03155178|Ethanol|ethanol|mesh-list
25760464|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
25760465|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25760466|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25760467|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760468|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760469|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760470|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
25760471|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760472|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
25760473|NCT03157089|Afatinib|afatinib|mesh-list
25760474|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25760475|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760476|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25760477|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760478|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760479|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
25760480|NCT03157583|Glycerol|glycerol|mesh-list
25760481|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25760482|NCT03157583|Protective Agents|protective agents|mesh-ancestor
25760483|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760484|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760485|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25760486|NCT03158116|Aztreonam|aztreonam|mesh-list
25760487|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25760488|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760489|NCT03158220|Vaccines|vaccines|mesh-list
25760490|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
25760491|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760492|NCT03158272|Nivolumab|nivolumab|mesh-list
25760493|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25760494|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760495|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25760496|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760497|NCT03158311|Fluticasone|fluticasone|mesh-list
25760498|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
25760499|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25760500|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760501|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25760502|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
25760503|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760504|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760505|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25760506|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
25760507|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760508|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25760509|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
25760510|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24741672|NCT05290506|Hormones|hormones|mesh-ancestor
25760511|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760512|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760513|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760514|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25760515|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25760516|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25760517|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
25760518|NCT03159143|Docetaxel|docetaxel|mesh-list
25760519|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
25760520|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760521|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
25760522|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
25760523|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
25760524|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776243|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
25776244|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776245|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776246|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776247|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25776248|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25776249|NCT03823391|Adalimumab|adalimumab|mesh-list
25776250|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776251|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776252|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
25776253|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25776254|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25776255|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776256|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25776257|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25776258|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776259|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776260|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776261|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25776262|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
25776263|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25776264|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776265|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25776266|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25776267|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25776268|NCT03836729|Tenofovir|tenofovir|mesh-list
25776269|NCT03836729|Emtricitabine|emtricitabine|mesh-list
25776270|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
25776271|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776272|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25776273|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25776274|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776275|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776276|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25776277|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25776278|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25776279|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
25776280|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776281|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
25776282|NCT03801148|Lansoprazole|lansoprazole|mesh-list
25776283|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25776284|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776285|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25776286|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776287|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776288|NCT03831854|Lamotrigine|lamotrigine|mesh-list
25776289|NCT03831854|Ketamine|ketamine|mesh-list
25776290|NCT03831854|Analgesics|analgesics|mesh-ancestor
25776291|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
25776292|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776293|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776294|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25776295|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25776296|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
25776297|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
25776298|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776299|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25776300|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25760526|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
25760527|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
25760528|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
25760529|NCT03160703|Protective Agents|protective agents|mesh-ancestor
25760530|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760531|NCT03161158|Diuretics|diuretics|mesh-list
25760532|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
25760533|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760534|NCT03161405|Itraconazole|itraconazole|mesh-list
25760535|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760536|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760537|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
25760538|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760539|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25760540|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25760541|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25760542|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
25760543|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760544|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760545|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25760546|NCT03161938|Dexamethasone|dexamethasone|mesh-list
25760547|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760548|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
25760549|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
25760550|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760551|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760552|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760553|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
25760554|NCT03161938|Hormones|hormones|mesh-ancestor
25760555|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760556|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25760557|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760558|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
25760559|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
25760560|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25760561|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
25760562|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760563|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760564|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25760565|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
25760566|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25760567|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25760568|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25760569|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
25760570|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760571|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760572|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25760573|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25760574|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25760575|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760576|NCT03163303|Nicotine|nicotine|mesh-list
25760577|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25760578|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
25760579|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760580|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760581|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25760582|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25760583|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760584|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760585|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760586|NCT03163472|Anesthetics|anesthetics|mesh-list
25760587|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
25760588|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760589|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760590|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
25760591|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760592|NCT03165981|Vaccines|vaccines|mesh-list
25760593|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25760594|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
25760595|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760596|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
24499010|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760598|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760599|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
25760600|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25760601|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760603|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
25760604|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760605|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760606|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25760607|NCT03167411|Incretins|incretins|mesh-ancestor
25760608|NCT03167411|Hormones|hormones|mesh-ancestor
25760609|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760610|NCT03168022|Amitriptyline|amitriptyline|mesh-list
25760611|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
25760612|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25760613|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
25760614|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25760615|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25760616|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760617|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25760618|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760619|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25760620|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760621|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25760622|NCT03168022|Analgesics|analgesics|mesh-ancestor
25760623|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
25760624|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25760625|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25760626|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760627|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760628|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
25760629|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760630|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
25760631|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25760632|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760633|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760634|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760635|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
25760636|NCT03168308|Neostigmine|neostigmine|mesh-list
25760637|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25760638|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760639|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760640|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760641|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760642|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760643|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25760644|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
25760645|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760646|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25760647|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25760648|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25760649|NCT03168841|Efinaconazole|efinaconazole|mesh-list
25760650|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
25760651|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760652|NCT03168919|Temozolomide|temozolomide|mesh-list
25760653|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25760654|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
25760655|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760656|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760657|NCT03169244|Bupropion|bupropion|mesh-list
25760658|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25760659|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
25760660|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25760661|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25760662|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25760663|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760664|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760665|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
25760666|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520465|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
24520467|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25760667|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760668|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25760669|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25760670|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760671|NCT03170219|Furosemide|furosemide|mesh-list
25760672|NCT03170219|Diuretics|diuretics|mesh-ancestor
25760673|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
25760674|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760675|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25760676|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760677|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760678|NCT03170271|Benralizumab|benralizumab|mesh-list
25760679|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25760680|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
25760681|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
25760682|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760683|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760684|NCT03170661|Rocuronium|rocuronium|mesh-list
25760685|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25760686|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25760687|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25760688|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760689|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760690|NCT03172325|Folic Acid|folic acid|mesh-list
25760691|NCT03172325|Prednisolone|prednisolone|mesh-list
25760692|NCT03172325|Adalimumab|adalimumab|mesh-list
25760693|NCT03172325|Methotrexate|methotrexate|mesh-list
25760694|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25760695|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
25760696|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25760697|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760698|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25760699|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
25760700|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760701|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760702|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
25760703|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760704|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25760705|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25760706|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
25760707|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25760708|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25760709|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760710|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
25760711|NCT03172325|Hormones|hormones|mesh-ancestor
25760712|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760713|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25760714|NCT03172325|Hematinics|hematinics|mesh-ancestor
25760715|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
25760716|NCT03172325|Vitamins|vitamins|mesh-ancestor
25760717|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
25760718|NCT03172494|Insulin|insulin|mesh-list
25760719|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25760720|NCT03172494|Liraglutide|liraglutide|mesh-list
25760721|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
25760722|NCT03172494|Xultophy|xultophy|mesh-list
25760723|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760724|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760725|NCT03172494|Incretins|incretins|mesh-ancestor
25760726|NCT03172494|Hormones|hormones|mesh-ancestor
25760727|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760728|NCT03173170|Itraconazole|itraconazole|mesh-list
25760729|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
25760730|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760731|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25760732|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25760733|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760734|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760735|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25760736|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
24527996|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24527997|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820619|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24528172|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24409485|NCT00182169|Hormones|hormones|mesh-list
25760737|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760738|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760739|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25760741|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25760742|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
25760743|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760744|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760745|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25760746|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25760747|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760748|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760749|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760750|NCT03174366|Denosumab|denosumab|mesh-list
25760751|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25760752|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760753|NCT03175120|Insulin|insulin|mesh-list
25760754|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25760755|NCT03175120|Liraglutide|liraglutide|mesh-list
25760756|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
25760757|NCT03175120|Xultophy|xultophy|mesh-list
25760758|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760759|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760760|NCT03175120|Incretins|incretins|mesh-ancestor
25760761|NCT03175120|Hormones|hormones|mesh-ancestor
25760762|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760763|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
25760764|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25760765|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760766|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25760767|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760768|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760769|NCT03176238|Everolimus|everolimus|mesh-list
25760770|NCT03176238|Exemestane|exemestane|mesh-list
25760771|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760772|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25760773|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
25760774|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760775|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25760776|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25760777|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760778|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760779|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25760780|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
25760781|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760782|NCT03176459|Bupivacaine|bupivacaine|mesh-list
25760783|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
25760784|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
25760785|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760786|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760787|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
25760788|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760789|NCT03176784|Nicotine|nicotine|mesh-list
25760790|NCT03176784|Varenicline|varenicline|mesh-list
25760791|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25760792|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
25760793|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760794|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760795|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25760796|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25760797|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
25760798|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760799|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760800|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
25760801|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25760802|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
25760803|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760804|NCT03177395|Expectorants|expectorants|mesh-ancestor
25760805|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
24823714|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823715|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24823723|NCT02118727|Memantine|memantine|mesh-list
24772493|NCT01834014|Bevacizumab|bevacizumab|mesh-list
24423667|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25156541|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25760806|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25760807|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
25760808|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760809|NCT03177395|Protective Agents|protective agents|mesh-ancestor
25760810|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760811|NCT03177395|Antidotes|antidotes|mesh-ancestor
25760812|NCT03177798|Icatibant|icatibant|mesh-list
25760813|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25760814|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25760815|NCT03177798|Analgesics|analgesics|mesh-ancestor
25760816|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
25760817|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760818|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760819|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760820|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25760821|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25760822|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25760823|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760824|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25760825|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25760826|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
25776301|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776302|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776303|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
25776304|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25776305|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25776306|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25776307|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25776308|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25776309|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25776310|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25776311|NCT03824912|Ketoconazole|ketoconazole|mesh-list
25776312|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
25776313|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776314|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25776315|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25776316|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776317|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776318|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25776319|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
25776320|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776321|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776322|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25776323|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
25776324|NCT03822884|Hematinics|hematinics|mesh-ancestor
25776325|NCT03806270|Midazolam|midazolam|mesh-list
25776326|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
25776327|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25776328|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25776329|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776330|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776331|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25776332|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25776333|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25776334|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25776335|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
25776336|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
25776337|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
25776338|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
25776339|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776340|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776341|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
25776342|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
25776343|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25776344|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
25776345|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
25776346|NCT03830892|Nicotine|nicotine|mesh-list
25776347|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25776348|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
25776349|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776350|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157598|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25157599|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
25157603|NCT04635007|Misoprostol|misoprostol|mesh-list
25760827|NCT03178851|Atezolizumab|atezolizumab|mesh-list
25760828|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25760829|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760830|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
25760831|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760832|NCT03178942|Permethrin|permethrin|mesh-list
25760833|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760834|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760835|NCT03179345|Pregabalin|pregabalin|mesh-list
25760836|NCT03179345|Gabapentin|gabapentin|mesh-list
25760837|NCT03179345|Analgesics|analgesics|mesh-ancestor
25760838|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
25760839|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760840|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760841|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
25760842|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25760843|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25760844|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760845|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25760846|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25760847|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25760848|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760849|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25760850|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25760851|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25760852|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760853|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
25760854|NCT03179410|Avelumab|avelumab|mesh-list
25760855|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25760856|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760857|NCT03179787|Aripiprazole|aripiprazole|mesh-list
25760858|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
25760859|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25760860|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25760861|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25760862|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760863|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760864|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
25760865|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
25760866|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760867|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760868|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25760869|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25760870|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
25760871|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25760872|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25760873|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25760874|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25760875|NCT03179891|Diazepam|diazepam|mesh-list
25760876|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25760877|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
25760878|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
25760879|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
25760880|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760881|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760882|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760883|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25760884|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25760885|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25760886|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25760887|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25760888|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25760889|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25760890|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25760891|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
25760892|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
25760893|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
25760894|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
25760895|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760896|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760897|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
25760898|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25760899|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760900|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760901|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760902|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
25760903|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
25760904|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760905|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25760906|NCT05364619|Bismuth|bismuth|mesh-list
25760907|NCT05364619|Antacids|antacids|mesh-ancestor
25760908|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760909|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25760910|NCT05364567|Vitamin D|vitamin d|mesh-list
25760911|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
25760912|NCT05364567|Vitamins|vitamins|mesh-ancestor
25760913|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
25760914|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760915|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25760916|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25760917|NCT05364385|Budesonide|budesonide|mesh-list
25760918|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25760919|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25760920|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25760921|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
25760922|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760923|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760924|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25760925|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
25760926|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
25760927|NCT05364385|Hormones|hormones|mesh-ancestor
25760928|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760929|NCT05363917|Folic Acid|folic acid|mesh-list
25760930|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
25760931|NCT05363917|Hematinics|hematinics|mesh-ancestor
25760932|NCT05363917|Vitamins|vitamins|mesh-ancestor
25760933|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
25760934|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760935|NCT05363722|Bevacizumab|bevacizumab|mesh-list
25760936|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25760937|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25760938|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25760939|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25760940|NCT05363722|Growth Substances|growth substances|mesh-ancestor
25760941|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760942|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
25760943|NCT05363501|Naloxone|naloxone|mesh-list
25760944|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25760945|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760946|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
25760947|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760948|NCT05361486|Primaquine|primaquine|mesh-list
25760949|NCT05361486|Tafenoquine|tafenoquine|mesh-list
25760950|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
25760951|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25760952|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25760953|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25760954|NCT05360628|Allopurinol|allopurinol|mesh-list
25760955|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
25760956|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760957|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760958|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
25760959|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25760960|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25760961|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
25760962|NCT05360628|Protective Agents|protective agents|mesh-ancestor
25760963|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760964|NCT05359068|Valsartan|valsartan|mesh-list
25760965|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25760966|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25760967|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25760968|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760969|NCT05358626|Antibodies|antibodies|mesh-list
25760970|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
25760971|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
25760972|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760973|NCT05357911|Digoxin|digoxin|mesh-list
25760974|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25760975|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25760976|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25760977|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760978|NCT05357911|Protective Agents|protective agents|mesh-ancestor
25760979|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760980|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
25760981|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25760982|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25760983|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760984|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
25760985|NCT05357079|Coagulants|coagulants|mesh-ancestor
25760986|NCT05353062|Epinephrine|epinephrine|mesh-list
25760987|NCT05353062|Hemostatics|hemostatics|mesh-list
25760988|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25760989|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25760990|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25760991|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25760992|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760993|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25760994|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25760995|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25760996|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
25760997|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25760998|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25760999|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
25761000|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
25761001|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
25761002|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25761003|NCT05353062|Coagulants|coagulants|mesh-ancestor
25761004|NCT05350696|Morphine|morphine|mesh-list
25761005|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25761006|NCT05350696|Narcotics|narcotics|mesh-ancestor
25761007|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761008|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761009|NCT05350696|Analgesics|analgesics|mesh-ancestor
25761010|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
25761011|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761012|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
25761013|NCT05347082|Vitamin D|vitamin d|mesh-list
25761014|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25761015|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761016|NCT05347082|Vitamins|vitamins|mesh-ancestor
25761017|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
25761018|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25761019|NCT05341375|Anesthetics|anesthetics|mesh-list
25761020|NCT05341375|Esketamine|esketamine|mesh-list
25761021|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761022|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761023|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
25761024|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25776351|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25776352|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25776353|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
25776354|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776355|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776356|NCT03823378|Upadacitinib|upadacitinib|mesh-list
25776357|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25776358|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25776359|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776360|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776361|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776362|NCT03830281|Insulin|insulin|mesh-list
25776363|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25776364|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
25776365|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776366|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776367|NCT03818815|Amoxicillin|amoxicillin|mesh-list
25776368|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
25776369|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
25776370|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25776371|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761025|NCT05325099|Azacitidine|azacitidine|mesh-list
25761026|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25761027|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
25761028|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761029|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761030|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761031|NCT05324852|Midazolam|midazolam|mesh-list
25761032|NCT05324852|Loxapine|loxapine|mesh-list
25761033|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25761034|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25761035|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761036|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761037|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25761038|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25761039|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25761040|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25761041|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
25761042|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
25761043|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
25761044|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
25761045|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761046|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761047|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25761048|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25761049|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
25761050|NCT05324384|Sirolimus|sirolimus|mesh-list
25761051|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761052|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761053|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25761054|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761055|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
25761056|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761057|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
25761058|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761059|NCT05312268|Rasburicase|rasburicase|mesh-list
25761060|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
25761061|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761062|NCT05307874|Aldesleukin|aldesleukin|mesh-list
25761063|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761064|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25761065|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25761066|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
25761067|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761068|NCT05304468|Cisplatin|cisplatin|mesh-list
25761069|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761070|NCT05304455|Heparin|heparin|mesh-list
25761071|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25761072|NCT05304455|Tinzaparin|tinzaparin|mesh-list
25761073|NCT05304455|Dalteparin|dalteparin|mesh-list
25761074|NCT05304455|Dipyridamole|dipyridamole|mesh-list
25761075|NCT05304455|Apixaban|apixaban|mesh-list
25761076|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
25761077|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25761078|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25761079|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761080|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25761081|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
25761082|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25761083|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
25761084|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761085|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25761086|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25761087|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
25761088|NCT05293509|Cyclosporine|cyclosporine|mesh-list
25761089|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
25761090|NCT05293509|Dexamethasone|dexamethasone|mesh-list
25761091|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
25761092|NCT05293509|Busulfan|busulfan|mesh-list
25761093|NCT05293509|Rituximab|rituximab|mesh-list
25761094|NCT05293509|Fludarabine|fludarabine|mesh-list
25761095|NCT05293509|Bortezomib|bortezomib|mesh-list
25761096|NCT05293509|Tacrolimus|tacrolimus|mesh-list
25761097|NCT05293509|Cyclosporins|cyclosporins|mesh-list
25761098|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
25761099|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761100|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
25761101|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761102|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761103|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25761104|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
25761105|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761106|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761107|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25761108|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761109|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25761110|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
25761111|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
25761112|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761113|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25761114|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
25761115|NCT05293509|Hormones|hormones|mesh-ancestor
25761116|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25761117|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25761118|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25761119|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761120|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
25761121|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761122|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
25761123|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25761124|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25761125|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
25761126|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761127|NCT05267054|Rituximab|rituximab|mesh-list
25761128|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761129|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761130|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
25761131|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761132|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761133|NCT05201859|Capecitabine|capecitabine|mesh-list
25761134|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25761135|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
25761136|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761137|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761138|NCT05185583|Methylphenidate|methylphenidate|mesh-list
25761139|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25761140|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761141|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25761142|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25761143|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25761144|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761145|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
25761146|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761147|NCT05178043|Nivolumab|nivolumab|mesh-list
25761148|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761149|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761150|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25761151|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761152|NCT05162027|Erenumab|erenumab|mesh-list
25761153|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25761154|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761155|NCT05162027|Analgesics|analgesics|mesh-ancestor
25761156|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
25761157|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761158|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761159|NCT05142228|Erenumab|erenumab|mesh-list
25761160|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25761161|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761162|NCT05142228|Analgesics|analgesics|mesh-ancestor
25761163|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
25761164|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761165|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761166|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
25761167|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
24831866|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
24831938|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24831939|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24831940|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
24831941|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
24970669|NCT03731494|Nickel|nickel|mesh-list
25761168|NCT05113004|Leflunomide|leflunomide|mesh-list
25761169|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25761170|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761171|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25761172|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
25761173|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761174|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761175|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761176|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761177|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
25761178|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25761179|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25761180|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761181|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761182|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
25761183|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761184|NCT05110742|Vidarabine|vidarabine|mesh-list
25761185|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
25761186|NCT05110742|Fludarabine|fludarabine|mesh-list
25761187|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
25761188|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761189|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
25761190|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761191|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761192|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25761193|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
25761194|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761195|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761196|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25761197|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25761198|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
25761199|NCT05110742|Antiviral Agents|antiviral agents|mesh-ancestor
25761200|NCT05110742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761201|NCT05093790|Aspirin|aspirin|mesh-list
25761202|NCT05093790|Ticagrelor|ticagrelor|mesh-list
25761203|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25761204|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25761205|NCT05093790|Analgesics|analgesics|mesh-ancestor
25761206|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
25761207|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761208|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761209|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25761210|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761211|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25761212|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25761213|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761214|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25761215|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25761216|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761217|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
25761218|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25761219|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25761220|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25761221|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
25761222|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761223|NCT05092373|Paclitaxel|paclitaxel|mesh-list
25761224|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25761225|NCT05092373|Atezolizumab|atezolizumab|mesh-list
25761226|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25761227|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25761228|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761229|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
25761230|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
25761231|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
25761232|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761233|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
25761234|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761235|NCT05066061|Analgesics|analgesics|mesh-list
25761236|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
25761237|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
25761238|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761239|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971540|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24971541|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25761240|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25761241|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761242|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25761243|NCT05057949|Itraconazole|itraconazole|mesh-list
25761244|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25761245|NCT05057949|Rifampin|rifampin|mesh-list
25761246|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
25761247|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761248|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25761249|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25761250|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761251|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761252|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25761253|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
25761254|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25761255|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761256|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25761257|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25761258|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
25761259|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761260|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
25761261|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25761262|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25761263|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25761264|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25761265|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25761266|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25761267|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25761268|NCT05048238|Tofacitinib|tofacitinib|mesh-list
25761269|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25761270|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761271|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761272|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
25761273|NCT05027308|Teduglutide|teduglutide|mesh-list
25761274|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25761275|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25761276|NCT05027308|Protective Agents|protective agents|mesh-ancestor
25761277|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761278|NCT05010954|Lansoprazole|lansoprazole|mesh-list
25761279|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
25761280|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25761281|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25761282|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25761283|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761284|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776372|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776373|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25776374|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776375|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776376|NCT03828539|Topiramate|topiramate|mesh-list
25776377|NCT03828539|Erenumab|erenumab|mesh-list
25776378|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25776379|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
25776380|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776381|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776382|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25776383|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776384|NCT03828539|Analgesics|analgesics|mesh-ancestor
25776385|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
25776386|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776387|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
25776388|NCT03824704|Nivolumab|nivolumab|mesh-list
25776389|NCT03824704|Rucaparib|rucaparib|mesh-list
25776390|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25776391|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776392|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25776393|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776394|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25776395|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464458|NCT00365001|Methotrexate|methotrexate|mesh-list
25761285|NCT04960215|Ubiquinone|ubiquinone|mesh-list
25761286|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
25761287|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
25761288|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761289|NCT04960215|Vitamins|vitamins|mesh-ancestor
25761290|NCT04949477|Acetaminophen|acetaminophen|mesh-list
25761291|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
25761292|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25761293|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761294|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761295|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25761296|NCT04949477|Analgesics|analgesics|mesh-ancestor
25761297|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
25761298|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761299|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25761300|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25761301|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25761302|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
25761303|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761304|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761305|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
25761306|NCT04941261|Vaccines|vaccines|mesh-list
25761307|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
25761308|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761309|NCT04941170|Bupivacaine|bupivacaine|mesh-list
25761310|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
25761311|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
25761312|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761313|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761314|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
25761315|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761316|NCT04933344|Daptomycin|daptomycin|mesh-list
25761317|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761318|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761319|NCT04874545|Propofol|propofol|mesh-list
25761320|NCT04874545|Sevoflurane|sevoflurane|mesh-list
25761321|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25761322|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761323|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761324|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25761325|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
25761326|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
25761327|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25761328|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25761329|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
25761330|NCT04873895|Axitinib|axitinib|mesh-list
25761331|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
25761332|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25761333|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25761334|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761335|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761336|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761337|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761338|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761339|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25761340|NCT04830813|Chiauranib|chiauranib|mesh-list
25761341|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761342|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25761343|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761344|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761345|NCT04823156|Calcium|calcium|mesh-list
25761346|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25761347|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761348|NCT04789616|Maraviroc|maraviroc|mesh-list
25761349|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25761350|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25761351|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761352|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25761353|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25761354|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
25761355|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761356|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25761357|NCT05406765|Bupivacaine|bupivacaine|mesh-list
25761358|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
24465691|NCT00370565|Insulin|insulin|mesh-list
25761359|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
25761360|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761361|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761362|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
25761363|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761364|NCT05406752|Acetaminophen|acetaminophen|mesh-list
25761365|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25761366|NCT05406752|Analgesics|analgesics|mesh-ancestor
25761367|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
25761368|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761369|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761370|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
25761371|NCT05406674|Cisplatin|cisplatin|mesh-list
25761372|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761373|NCT05406622|Sirolimus|sirolimus|mesh-list
25761374|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761375|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761376|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25761377|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761378|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
25761379|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761380|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
25761381|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761382|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
25761383|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25761384|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761385|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25761386|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761387|NCT05406388|Fentanyl|fentanyl|mesh-list
25761388|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25761389|NCT05406388|Narcotics|narcotics|mesh-ancestor
25761390|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761391|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761392|NCT05406388|Analgesics|analgesics|mesh-ancestor
25761393|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
25761394|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761395|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25761396|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25761397|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
25761398|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
25761399|NCT05406180|Vaccines|vaccines|mesh-list
25761400|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
25761401|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761402|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
25761403|NCT05406050|Vitamin D|vitamin d|mesh-list
25761404|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25761405|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761406|NCT05406050|Vitamins|vitamins|mesh-ancestor
25761407|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
25761408|NCT05405907|Hemostatics|hemostatics|mesh-list
25761409|NCT05405907|Coagulants|coagulants|mesh-ancestor
25761410|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
25761411|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25761412|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761413|NCT05405751|Tenofovir|tenofovir|mesh-list
25761414|NCT05405751|Emtricitabine|emtricitabine|mesh-list
25761415|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25761416|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
25761417|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761418|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25761419|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25761420|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761421|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761422|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25761423|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25761424|NCT05405608|Ondansetron|ondansetron|mesh-list
25761425|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
25761426|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
25761427|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761428|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761429|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25761430|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
25761431|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
25761432|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25761433|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
24833020|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761434|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761435|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761436|NCT05405608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25761437|NCT05405608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25761438|NCT05405608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761439|NCT05405608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25761440|NCT05405608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25761441|NCT05405478|Omalizumab|omalizumab|mesh-list
25761442|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25761443|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25761444|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
25761445|NCT05405465|Golimumab|golimumab|mesh-list
25761446|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25761447|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25761448|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761449|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
25761450|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761451|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
25761452|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
25761453|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761454|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761455|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
25761456|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
25761457|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761458|NCT05405439|Prednisone|prednisone|mesh-list
25761459|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
25761460|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25761461|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
25761462|NCT05405439|Hormones|hormones|mesh-ancestor
25761463|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25761464|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761465|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25761466|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761467|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25761468|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761469|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761470|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
25761471|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25761472|NCT05405270|Imiquimod|imiquimod|mesh-list
25761473|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25761474|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
25761475|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761476|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761477|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
25761478|NCT05405257|Oxytocin|oxytocin|mesh-list
25761479|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
25761480|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25761481|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776396|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
25776397|NCT03827473|Prednisone|prednisone|mesh-list
25776398|NCT03827473|Cortisone|cortisone|mesh-list
25776399|NCT03827473|Docetaxel|docetaxel|mesh-list
25776400|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
25776401|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
25776402|NCT03827473|Hormones|hormones|mesh-list
25776403|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25776404|NCT03827473|Androgens|androgens|mesh-list
25776405|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
25776406|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776407|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
25776408|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
25776409|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
25776410|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776411|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776412|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
25776413|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776414|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776415|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25776416|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25776417|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776418|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
25776419|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25776420|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
25776421|NCT03827473|Protective Agents|protective agents|mesh-ancestor
25776422|NCT03827473|Vitamins|vitamins|mesh-ancestor
25776423|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
25776424|NCT03827473|Estrogens|estrogens|mesh-ancestor
25776425|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
25761482|NCT05404334|Androgens|androgens|mesh-list
25761483|NCT05404334|Hormones|hormones|mesh-ancestor
25761484|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25761485|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761486|NCT05403580|Olanzapine|olanzapine|mesh-list
25761487|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
25761488|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
25761489|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761490|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761491|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25761492|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25761493|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25761494|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761495|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25761496|NCT05403580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25761497|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25761498|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25761499|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761500|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761501|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
25761502|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
25761503|NCT05400993|Docetaxel|docetaxel|mesh-list
25761504|NCT05400993|Epirubicin|epirubicin|mesh-list
25761505|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761506|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
25761507|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761508|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761509|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25761510|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
25761511|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761512|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761513|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25761514|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25761515|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25761516|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25761517|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25761518|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25761519|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25761520|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761521|NCT05361499|Amoxicillin|amoxicillin|mesh-list
25761522|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761523|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761524|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25761525|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
25761526|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761527|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
25761528|NCT05282069|DA-8010|da-8010|mesh-list
25761529|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25761530|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25761531|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
25761532|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761533|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761534|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761535|NCT05282069|Urological Agents|urological agents|mesh-ancestor
25761536|NCT05262738|Misoprostol|misoprostol|mesh-list
25761537|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25761538|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
25761539|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25761540|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761541|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25761542|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25761543|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
25761544|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25761545|NCT05236738|Cobicistat|cobicistat|mesh-list
25761546|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25761547|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25761548|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
25761549|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402620|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402621|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402622|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24835808|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835809|NCT02183415|Linagliptin|linagliptin|mesh-list
25055120|NCT03523832|Celecoxib|celecoxib|mesh-list
24402708|NCT00158236|Hydromorphone|hydromorphone|mesh-list
25761550|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761554|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761555|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25761556|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25761557|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
25761558|NCT05071183|Trametinib|trametinib|mesh-list
25761559|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761560|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25761561|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761562|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761563|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25761564|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25761565|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25761566|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761567|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761568|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
25761569|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761570|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25761571|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25761572|NCT05019430|Cocaine|cocaine|mesh-list
25761573|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
25761574|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
25761575|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
25761576|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761577|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761578|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
25761579|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761580|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25761581|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25761582|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25761583|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25761584|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761585|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
25761586|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761587|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25761588|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25761589|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
25761590|NCT05013216|Poly ICLC|poly iclc|mesh-list
25761591|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
25761592|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
25761593|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761594|NCT05011188|Antibodies|antibodies|mesh-list
25761595|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
25761596|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
25761597|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
25761598|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761599|NCT05004662|Nicotine|nicotine|mesh-list
25761600|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25761601|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
25761602|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761603|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761604|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25761605|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25761606|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
25761607|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761608|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761609|NCT04964089|Aflibercept|aflibercept|mesh-list
25761610|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25761611|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25761612|NCT04964089|Growth Substances|growth substances|mesh-ancestor
25761613|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761614|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
25761615|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776426|NCT03812328|Enoxaparin|enoxaparin|mesh-list
25776427|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
25776428|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25776429|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25776430|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776431|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25761617|NCT04928703|Analgesics|analgesics|mesh-ancestor
25761618|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
25761619|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761620|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761621|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25761622|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25761623|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
25761624|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
25761625|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761626|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25761627|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25761628|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761629|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761630|NCT04920292|Oxfendazole|oxfendazole|mesh-list
25761631|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
25761632|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25761633|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761634|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
25761635|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25761636|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25761637|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761638|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
25761639|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761640|NCT04807504|Ropivacaine|ropivacaine|mesh-list
25761641|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
25761642|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
25761643|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761644|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761645|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
25761646|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761647|NCT04791943|Melatonin|melatonin|mesh-list
25761648|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
25761649|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761650|NCT04791943|Protective Agents|protective agents|mesh-ancestor
25761651|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761652|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761653|NCT04771156|Ketorolac|ketorolac|mesh-list
25761654|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25761655|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25761656|NCT04771156|Analgesics|analgesics|mesh-ancestor
25761657|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
25761658|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761659|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761660|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25761661|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761662|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25761663|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761664|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761665|NCT04709276|Carboplatin|carboplatin|mesh-list
25761666|NCT04709276|Nivolumab|nivolumab|mesh-list
25761667|NCT04709276|Ipilimumab|ipilimumab|mesh-list
25761668|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761669|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761670|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25761671|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761672|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
25761673|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
25761674|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761675|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
25761676|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761677|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761678|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
25761679|NCT04634669|Bupropion|bupropion|mesh-list
25761680|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25761681|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
25761682|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25761683|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25761684|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25761685|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25761686|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761687|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
25761688|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761689|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761690|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25761691|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25761692|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761693|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
25761694|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
25761695|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25761696|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25761697|NCT04611152|Aflibercept|aflibercept|mesh-list
25761698|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25761699|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25761700|NCT04611152|Growth Substances|growth substances|mesh-ancestor
25761701|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761702|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
25761703|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761704|NCT04603937|Aflibercept|aflibercept|mesh-list
25761705|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25761706|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25761707|NCT04603937|Growth Substances|growth substances|mesh-ancestor
25761708|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761709|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
25761710|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761711|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
25761712|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25761713|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761714|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761715|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25761716|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25761717|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
25761718|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25761719|NCT04586153|Meplazumab|meplazumab|mesh-list
25761720|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
25761721|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761722|NCT04526691|Cisplatin|cisplatin|mesh-list
25761723|NCT04526691|Carboplatin|carboplatin|mesh-list
25761724|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
25761725|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761726|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761727|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25761728|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
25761729|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761730|NCT04468568|Terbutaline|terbutaline|mesh-list
25761731|NCT04468568|Atosiban|atosiban|mesh-list
25761732|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25761733|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
25761734|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761735|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761736|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25761737|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
25761738|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
25761739|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
25761740|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25761741|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25761742|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25761743|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25761744|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
25761745|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761746|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761747|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
25761748|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25761749|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
25761750|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
25761751|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761752|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
25761753|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25761754|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
25761755|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761756|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761757|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25761758|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
25761759|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25761760|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
25776432|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24839440|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417216|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
25761761|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761762|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761763|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25761764|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
25761765|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
25761766|NCT04450108|Protective Agents|protective agents|mesh-ancestor
25761767|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
25761768|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25761769|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761770|NCT04393454|Sirolimus|sirolimus|mesh-list
25761771|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25761772|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761773|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25761774|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761775|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
25761776|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761777|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
25761778|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761779|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
25761780|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25761781|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25761782|NCT04348695|Simvastatin|simvastatin|mesh-list
25761783|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25761784|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25761785|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
25761786|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761787|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25761788|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25761789|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761790|NCT04316871|Morphine|morphine|mesh-list
25761791|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25761792|NCT04316871|Narcotics|narcotics|mesh-ancestor
25761793|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761794|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761795|NCT04316871|Analgesics|analgesics|mesh-ancestor
25761796|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
25761797|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761798|NCT04305691|Ixazomib|ixazomib|mesh-list
25761799|NCT04305691|Glycine|glycine|mesh-list
25761800|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761801|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761802|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
25761803|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761804|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
25761805|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761806|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761807|NCT04263792|Trimethoprim|trimethoprim|mesh-list
25761808|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25761809|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761810|NCT04263792|Renal Agents|renal agents|mesh-ancestor
25761811|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
25761812|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25761813|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25761814|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25761815|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761816|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761817|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25761818|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25761819|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25776433|NCT03822182|Dexamethasone|dexamethasone|mesh-list
25776434|NCT03822182|Bupivacaine|bupivacaine|mesh-list
25776435|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776436|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
25776437|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
25776438|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776439|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776440|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25043421|NCT01262261|Analgesics|analgesics|mesh-ancestor
25043422|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
24839578|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24839579|NCT02205489|Prednisolone|prednisolone|mesh-list
24839580|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
24839581|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
24839582|NCT02205489|Esomeprazole|esomeprazole|mesh-list
24839583|NCT02205489|Ranitidine|ranitidine|mesh-list
25225877|NCT02624531|Taxane|taxane|mesh-list
24839588|NCT02205489|Analgesics|analgesics|mesh-ancestor
25761821|NCT04122170|Ticagrelor|ticagrelor|mesh-list
25761822|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25761823|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25761824|NCT04122170|Analgesics|analgesics|mesh-ancestor
25761825|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
25761826|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761827|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761828|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25761829|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761830|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25761831|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25761832|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761833|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25761834|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25761835|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761836|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
25761837|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25761838|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25761839|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25761840|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
25761841|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761842|NCT04120805|Hemostatics|hemostatics|mesh-list
25761843|NCT04120805|Coagulants|coagulants|mesh-ancestor
25761844|NCT04049266|Aflibercept|aflibercept|mesh-list
25761845|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25761846|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25761847|NCT04049266|Growth Substances|growth substances|mesh-ancestor
25761848|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761849|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
25761850|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761851|NCT03944915|Paclitaxel|paclitaxel|mesh-list
25761852|NCT03944915|Cisplatin|cisplatin|mesh-list
25761853|NCT03944915|Carboplatin|carboplatin|mesh-list
25761854|NCT03944915|Fluorouracil|fluorouracil|mesh-list
25761855|NCT03944915|Nivolumab|nivolumab|mesh-list
25761856|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
25761857|NCT03944915|Lenograstim|lenograstim|mesh-list
25761858|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25761859|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761860|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
25761861|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
25761862|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
25761863|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761864|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
25761865|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25761866|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761867|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
25761868|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761869|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761870|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25761871|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25761872|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
25761873|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761874|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25761875|NCT03937986|Cocaine|cocaine|mesh-list
25761876|NCT03937986|Suvorexant|suvorexant|mesh-list
25761877|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
25761878|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
25761879|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761880|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761881|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
25761882|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761883|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25761884|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25761885|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25761886|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25761887|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761888|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
25761889|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761890|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25761891|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24839656|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
24839657|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839658|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25761892|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25761894|NCT03931551|Olaparib|olaparib|mesh-list
25761895|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761896|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761897|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25761898|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761899|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761900|NCT03872700|Fentanyl|fentanyl|mesh-list
25761901|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25761902|NCT03872700|Narcotics|narcotics|mesh-ancestor
25761903|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761904|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761905|NCT03872700|Analgesics|analgesics|mesh-ancestor
25761906|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
25761907|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761908|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25761909|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25761910|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
25761911|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
25761912|NCT03865615|Oxytocin|oxytocin|mesh-list
25761913|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
25761914|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25761915|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761916|NCT03856515|Nicotine|nicotine|mesh-list
25761917|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25761918|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
25761919|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761920|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761921|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25761922|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25761923|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
25761924|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25761925|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761926|NCT03792490|Fasudil|fasudil|mesh-list
25761927|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25761928|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25761929|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761930|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25761931|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761932|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
25761933|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25761934|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761935|NCT03744663|Buprenorphine|buprenorphine|mesh-list
25761936|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25761937|NCT03744663|Naloxone|naloxone|mesh-list
25761938|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25761939|NCT03744663|Narcotics|narcotics|mesh-ancestor
25761940|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761941|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761942|NCT03744663|Analgesics|analgesics|mesh-ancestor
25761943|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
25761944|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761945|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25761946|NCT03717155|Gemcitabine|gemcitabine|mesh-list
25761947|NCT03717155|Cisplatin|cisplatin|mesh-list
25761948|NCT03717155|Carboplatin|carboplatin|mesh-list
25761949|NCT03717155|Cetuximab|cetuximab|mesh-list
25761950|NCT03717155|Avelumab|avelumab|mesh-list
25761951|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761952|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25761953|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
25761954|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761955|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
25761956|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25761957|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25761958|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761959|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
25761960|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761961|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25761962|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
25761963|NCT03624036|Fludarabine|fludarabine|mesh-list
25761964|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25761965|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
25761966|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761967|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25761969|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
25761970|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761971|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761972|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25761973|NCT03606889|Bupivacaine|bupivacaine|mesh-list
25761974|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25761975|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
25761976|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761977|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761978|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
25761979|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761980|NCT03261193|Bupivacaine|bupivacaine|mesh-list
25761981|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
25761982|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
25761983|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25761984|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25761985|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
25761986|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25761987|NCT03246347|Docetaxel|docetaxel|mesh-list
25761988|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761989|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
25761990|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
25761991|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25761992|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761993|NCT03243461|Temozolomide|temozolomide|mesh-list
25761994|NCT03243461|Valproic Acid|valproic acid|mesh-list
25761995|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25761996|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
25761997|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25761998|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25761999|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
25762000|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762001|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
25762002|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762003|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762004|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
25762005|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25762006|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762007|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25762008|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
25762009|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762010|NCT03137160|Ixekizumab|ixekizumab|mesh-list
25762011|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
25762012|NCT03113500|Prednisone|prednisone|mesh-list
25762013|NCT03113500|Cortisone|cortisone|mesh-list
25762014|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
25762015|NCT03113500|Doxorubicin|doxorubicin|mesh-list
25762016|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25762017|NCT03113500|Etoposide|etoposide|mesh-list
25762018|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
25762019|NCT03113500|Daunorubicin|daunorubicin|mesh-list
25762020|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25762021|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
25762022|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25762023|NCT03113500|Antibodies|antibodies|mesh-list
25762024|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
25762025|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25762026|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
25762027|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762028|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
25762029|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762030|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762031|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762032|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
25762033|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762034|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762035|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25762036|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762037|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25762038|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762039|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762040|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762041|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
25762042|NCT03113500|Hormones|hormones|mesh-ancestor
25762043|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25762044|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25762045|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25762046|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
25762047|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
25762048|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762049|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762050|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762051|NCT03085147|Olaparib|olaparib|mesh-list
25762052|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25762053|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762054|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762055|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776441|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
25776442|NCT03822182|Hormones|hormones|mesh-ancestor
25776443|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776444|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25776445|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776446|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776447|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
25776448|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776449|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
25776450|NCT03822416|Nicotine|nicotine|mesh-list
25776451|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25776452|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
25776453|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776454|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776455|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25776456|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25776457|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
25776458|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776459|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776460|NCT03806231|Dinoprostone|dinoprostone|mesh-list
25776461|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
25776462|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25776463|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776464|NCT03822377|Ticagrelor|ticagrelor|mesh-list
25776465|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25776466|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25776467|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25776468|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25776469|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
25776470|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776471|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776472|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776473|NCT03820388|Propofol|propofol|mesh-list
25776474|NCT03820388|Etomidate|etomidate|mesh-list
25776475|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25776476|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776477|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776478|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25776479|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
25776480|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
25776481|NCT03809182|Fentanyl|fentanyl|mesh-list
25776482|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
25776483|NCT03809182|Morphine|morphine|mesh-list
25776484|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25776485|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776486|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776487|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776488|NCT03809182|Analgesics|analgesics|mesh-ancestor
25776489|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
25776490|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776491|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25776492|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25776493|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25776494|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
25776495|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776496|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776497|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25776498|NCT03809182|Narcotics|narcotics|mesh-ancestor
25776499|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25776500|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25776501|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
25776502|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
24535481|NCT00649233|Metoprolol|metoprolol|mesh-list
25762056|NCT03057951|Empagliflozin|empagliflozin|mesh-list
25762057|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25762058|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762059|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25762060|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762061|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25762062|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25762063|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
25762064|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762065|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25762066|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25762067|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
25762068|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
25762069|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762070|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762071|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25762072|NCT02997761|Blinatumomab|blinatumomab|mesh-list
25762073|NCT02997761|Antibodies|antibodies|mesh-list
25762074|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
25762075|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25762076|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
25762077|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25762078|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
25762079|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762080|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762081|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762082|NCT02971033|Ezetimibe|ezetimibe|mesh-list
25762083|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25762084|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25762085|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
25762086|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762087|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25762088|NCT02949934|Tolcapone|tolcapone|mesh-list
25762089|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25762090|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25762091|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25762092|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762093|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762094|NCT02856126|Sorafenib|sorafenib|mesh-list
25762095|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762096|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25762097|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762098|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762099|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
25762100|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762101|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762102|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
25762103|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762104|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762105|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
25762106|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
25762107|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
25762108|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762109|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762110|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762111|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762112|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
25762113|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762114|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762115|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25762116|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762117|NCT02582008|Bupropion|bupropion|mesh-list
25762118|NCT02582008|Nicotine|nicotine|mesh-list
25762119|NCT02582008|Varenicline|varenicline|mesh-list
25762120|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25762121|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
25762122|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762123|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762124|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25762125|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25762126|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
25762127|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762128|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762129|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25762133|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25762134|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25762135|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
25762136|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25762137|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25762138|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762139|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
25762140|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762141|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762142|NCT02366819|Leucovorin|leucovorin|mesh-list
25762143|NCT02366819|Fluorouracil|fluorouracil|mesh-list
25762144|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
25762145|NCT02366819|Irinotecan|irinotecan|mesh-list
25762146|NCT02366819|Calcium|calcium|mesh-list
25762147|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
25762148|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25762149|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762150|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
25762151|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762152|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762153|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762154|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762155|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
25762156|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25762157|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762158|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762159|NCT02366819|Antidotes|antidotes|mesh-ancestor
25762160|NCT02366819|Protective Agents|protective agents|mesh-ancestor
25762161|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
25762162|NCT02366819|Vitamins|vitamins|mesh-ancestor
25762163|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
25762164|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25762165|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25762166|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25762167|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762168|NCT02218606|Prednisone|prednisone|mesh-list
25762169|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
25762170|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762171|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
25762172|NCT02218606|Hormones|hormones|mesh-ancestor
25762173|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25762174|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762175|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25762176|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762177|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25762178|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762179|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762180|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
25762181|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25762182|NCT02192021|Doxorubicin|doxorubicin|mesh-list
25762183|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25762184|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762185|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762186|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25762187|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762188|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762189|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762190|NCT01801189|Pregabalin|pregabalin|mesh-list
25762191|NCT01801189|Analgesics|analgesics|mesh-ancestor
25762192|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
25762193|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762194|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762195|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
25762196|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25762197|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24842684|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
25043789|NCT01204749|Trebananib|trebananib|mesh-list
24842836|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
24842933|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25762198|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762199|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25762200|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25762201|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25762202|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762203|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25762205|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
25762206|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762207|NCT01461915|Gemcitabine|gemcitabine|mesh-list
25762208|NCT01461915|Paclitaxel|paclitaxel|mesh-list
25762209|NCT01461915|Heparin|heparin|mesh-list
25762210|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25762211|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762212|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762213|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762214|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762215|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762216|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762217|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
25762218|NCT01461915|Antiviral Agents|antiviral agents|mesh-ancestor
25762219|NCT01461915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762220|NCT01461915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762221|NCT01461915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762222|NCT01461915|Immunologic Factors|immunologic factors|mesh-ancestor
25762223|NCT01461915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762224|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
25762225|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25762226|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25762227|NCT01306994|Adenosine|adenosine|mesh-list
25762228|NCT01306994|Analgesics|analgesics|mesh-ancestor
25762229|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
25762230|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762231|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762232|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25762233|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
25762234|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25762235|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
25762236|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
25762237|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762238|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762239|NCT00754312|Entinostat|entinostat|mesh-list
25762240|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762241|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25762242|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762243|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762244|NCT00716755|Olanzapine|olanzapine|mesh-list
25762245|NCT00716755|Risperidone|risperidone|mesh-list
25762246|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25762247|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
25762248|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762249|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762250|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762251|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25762252|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25762253|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762254|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25762255|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25762256|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
25762257|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
25762258|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
25762259|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762260|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25762261|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25762262|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25762263|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25762264|NCT00634504|Leucovorin|leucovorin|mesh-list
25762265|NCT00634504|Methotrexate|methotrexate|mesh-list
25762266|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
25762267|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25762268|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
25762269|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25762270|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762271|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043977|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
25762273|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762274|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762275|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
25762276|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762277|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25762278|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762279|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
25762280|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762281|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25762282|NCT00634504|Antidotes|antidotes|mesh-ancestor
25762283|NCT00634504|Protective Agents|protective agents|mesh-ancestor
25762284|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
25762285|NCT00634504|Vitamins|vitamins|mesh-ancestor
25762286|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
25762287|NCT00392821|Everolimus|everolimus|mesh-list
25762288|NCT00392821|Sorafenib|sorafenib|mesh-list
25762289|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762290|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762291|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
25762292|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762293|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25762294|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762295|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762296|NCT00352027|Prednisone|prednisone|mesh-list
25762297|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
25762298|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
25762299|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
25762300|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25762301|NCT00352027|Doxorubicin|doxorubicin|mesh-list
25762302|NCT00352027|Etoposide|etoposide|mesh-list
25762303|NCT00352027|Vincristine|vincristine|mesh-list
25762304|NCT00352027|Bleomycin|bleomycin|mesh-list
25762305|NCT00352027|Vinblastine|vinblastine|mesh-list
25762306|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762307|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
25762308|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762309|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762310|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762311|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
25762312|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762313|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762314|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25762315|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762316|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25762317|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762318|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762319|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762320|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
25762321|NCT00352027|Hormones|hormones|mesh-ancestor
25762322|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25762323|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25762324|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25762325|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762326|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762327|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762328|NCT00104676|Paclitaxel|paclitaxel|mesh-list
25762329|NCT00104676|Etoposide|etoposide|mesh-list
25762330|NCT00104676|Cisplatin|cisplatin|mesh-list
25762331|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
25762332|NCT00104676|Ifosfamide|ifosfamide|mesh-list
25762333|NCT00104676|Bleomycin|bleomycin|mesh-list
25762334|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25762335|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762336|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762337|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762338|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762339|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762340|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25762341|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762342|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762343|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762344|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
25762345|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24846038|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
24846039|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846105|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25762346|NCT04781673|Lidocaine|lidocaine|mesh-list
25762347|NCT04781673|Ketamine|ketamine|mesh-list
25762348|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
25762349|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
25762350|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762351|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762352|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
25762353|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762354|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25762355|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25762356|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25762357|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25762358|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762359|NCT04781673|Analgesics|analgesics|mesh-ancestor
25762360|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25762361|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25762362|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
25762363|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25762364|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25762365|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762366|NCT04776395|Dexamethasone|dexamethasone|mesh-list
25762367|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
25762368|NCT04776395|Ichthammol|ichthammol|mesh-list
25762369|NCT04776395|BB 1101|bb 1101|mesh-list
25762370|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762371|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
25762372|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
25762373|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762374|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762375|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25762376|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
25762377|NCT04776395|Hormones|hormones|mesh-ancestor
25762378|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25762379|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25762380|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762381|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25762382|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762383|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762384|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
25762385|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25762386|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25762387|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25762388|NCT04735926|Calcifediol|calcifediol|mesh-list
25762389|NCT04735926|Vitamins|vitamins|mesh-ancestor
25762390|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
25762391|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762392|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25762393|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
25762394|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25762395|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
25762396|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762397|NCT04732000|Expectorants|expectorants|mesh-ancestor
25762398|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
25762399|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25762400|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
25762401|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762402|NCT04732000|Protective Agents|protective agents|mesh-ancestor
25762403|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762404|NCT04732000|Antidotes|antidotes|mesh-ancestor
25762405|NCT04731363|Erythritol|erythritol|mesh-list
25762406|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
25762407|NCT04710368|Evolocumab|evolocumab|mesh-list
25762408|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25762409|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25762410|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
25762411|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762412|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25762413|NCT04708171|Anesthetics|anesthetics|mesh-list
25762414|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762415|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762416|NCT04704921|Ranibizumab|ranibizumab|mesh-list
25762417|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25762418|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25762419|NCT04704921|Growth Substances|growth substances|mesh-ancestor
25762420|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762421|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
24452046|NCT00325845|Hylan|hylan|mesh-list
25762425|NCT04682574|Micronutrients|micronutrients|mesh-ancestor
25762426|NCT04682574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762427|NCT04682574|Antioxidants|antioxidants|mesh-ancestor
25762428|NCT04682574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762429|NCT04682574|Protective Agents|protective agents|mesh-ancestor
25762430|NCT04652440|Antibodies|antibodies|mesh-list
25762431|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25762432|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
25762433|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762434|NCT04624295|Aspirin|aspirin|mesh-list
25762435|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25762436|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25762437|NCT04624295|Analgesics|analgesics|mesh-ancestor
25762438|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
25762439|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762440|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762441|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762442|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762443|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25762444|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25762445|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762446|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25762447|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25762448|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762449|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
25762450|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
25762451|NCT04598074|Narcotics|narcotics|mesh-ancestor
25762452|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762453|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762454|NCT04598074|Analgesics|analgesics|mesh-ancestor
25762455|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
25762456|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762457|NCT04593940|Remdesivir|remdesivir|mesh-list
25762458|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
25762459|NCT04593940|Abatacept|abatacept|mesh-list
25762460|NCT04593940|Infliximab|infliximab|mesh-list
25762461|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
25762462|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25762463|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762464|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762465|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762466|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762467|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762468|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
25762469|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762470|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
25762471|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
25762472|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762473|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25762474|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25762475|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25762476|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
25762477|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25762478|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25762479|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25762480|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25762481|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762482|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
25762483|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762484|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762485|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25762486|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776503|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
25776504|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776505|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776506|NCT03805672|Enoxaparin|enoxaparin|mesh-list
25776507|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
25776508|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
25776509|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25776510|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25776511|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762487|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25762488|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25762489|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25762490|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25762491|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762492|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
25762493|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762494|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762495|NCT04535713|Gemcitabine|gemcitabine|mesh-list
25762496|NCT04535713|Docetaxel|docetaxel|mesh-list
25762497|NCT04535713|Doxorubicin|doxorubicin|mesh-list
25762498|NCT04535713|Nivolumab|nivolumab|mesh-list
25762499|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762500|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
25762501|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762502|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762503|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
25762504|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762505|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762506|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762507|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
25762508|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762509|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762510|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762511|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762512|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762513|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25762514|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762515|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762516|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762517|NCT04534218|Aspirin|aspirin|mesh-list
25762518|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
25762519|NCT04534218|Capecitabine|capecitabine|mesh-list
25762520|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762521|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
25762522|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762523|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762524|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762525|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
25762526|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762527|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762528|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25762529|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762530|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
25762531|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25762532|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25762533|NCT04534218|Analgesics|analgesics|mesh-ancestor
25762534|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
25762535|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762536|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762537|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25762538|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25762539|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25762540|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25762541|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762542|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
25762543|NCT04524351|Phenserine|phenserine|mesh-list
25762544|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25762545|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762546|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762547|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
25762548|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762549|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762550|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
25762551|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762552|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762553|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25762554|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
25762555|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25762556|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762557|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762558|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762559|NCT04473482|Ethanol|ethanol|mesh-list
25762560|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25762562|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762563|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762564|NCT04450355|Nefopam|nefopam|mesh-list
25762565|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25762566|NCT04450355|Analgesics|analgesics|mesh-ancestor
25762567|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
25762568|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762569|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762570|NCT04436133|Vaccines|vaccines|mesh-list
25762571|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
25762572|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762573|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25762574|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25762575|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25762576|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762577|NCT04426500|Bupivacaine|bupivacaine|mesh-list
25762578|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25762579|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
25762580|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762581|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762582|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
25762583|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762584|NCT04372433|Azacitidine|azacitidine|mesh-list
25762585|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762586|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
25762587|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762588|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762589|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762590|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
25762591|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
25762592|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25762593|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25762594|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762595|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762596|NCT04356716|Urological Agents|urological agents|mesh-ancestor
25762597|NCT04329494|Leucovorin|leucovorin|mesh-list
25762598|NCT04329494|Cisplatin|cisplatin|mesh-list
25762599|NCT04329494|Doxorubicin|doxorubicin|mesh-list
25762600|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25762601|NCT04329494|Fluorouracil|fluorouracil|mesh-list
25762602|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
25762603|NCT04329494|Irinotecan|irinotecan|mesh-list
25762604|NCT04329494|Daunorubicin|daunorubicin|mesh-list
25762605|NCT04329494|Mitomycins|mitomycins|mesh-list
25762606|NCT04329494|Mitomycin|mitomycin|mesh-list
25762607|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762608|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762609|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25762610|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762611|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762612|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762613|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
25762614|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762615|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762616|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
25762617|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762618|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25762619|NCT04329494|Antidotes|antidotes|mesh-ancestor
25762620|NCT04329494|Protective Agents|protective agents|mesh-ancestor
25762621|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
25762622|NCT04329494|Vitamins|vitamins|mesh-ancestor
25762623|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
25762624|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
25762625|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25762626|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25762627|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25762628|NCT04278781|Ivosidenib|ivosidenib|mesh-list
25762629|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762630|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762631|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762632|NCT04275362|Cimetidine|cimetidine|mesh-list
24472745|NCT00400387|Vitamin E|vitamin e|mesh-list
24805599|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
24481670|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762633|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25776512|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25762635|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25762636|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
25762637|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
25762638|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762639|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762640|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762641|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25762642|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25762643|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762644|NCT04165330|Nivolumab|nivolumab|mesh-list
25762645|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762646|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762647|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762648|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762649|NCT04131192|Gemcitabine|gemcitabine|mesh-list
25762650|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762651|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
25762652|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762653|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762654|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
25762655|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762656|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762657|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762658|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
25762659|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762660|NCT04121403|Rituximab|rituximab|mesh-list
25762661|NCT04121403|Cladribine|cladribine|mesh-list
25762662|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762663|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762664|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
25762665|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762666|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762667|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762668|NCT04088786|Irinotecan|irinotecan|mesh-list
25762669|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25762670|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762671|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762672|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762673|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762674|NCT04023669|Gemcitabine|gemcitabine|mesh-list
25762675|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
25762676|NCT04023669|Lenograstim|lenograstim|mesh-list
25762677|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762678|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
25762679|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762680|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762681|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762682|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
25762683|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762684|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762685|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25762686|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762687|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
25762688|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
25762689|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762690|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762691|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25762692|NCT04004208|Aflibercept|aflibercept|mesh-list
25762693|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25762694|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25762695|NCT04004208|Growth Substances|growth substances|mesh-ancestor
25762696|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762697|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
25762698|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762699|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
25762700|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25762701|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762702|NCT03906071|Docetaxel|docetaxel|mesh-list
25762703|NCT03906071|Nivolumab|nivolumab|mesh-list
25762704|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762705|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762706|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600635|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25762707|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762708|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762709|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762710|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762711|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
25762712|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
25762713|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25762714|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
25762715|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762716|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
25762717|NCT03883074|Protective Agents|protective agents|mesh-ancestor
25762718|NCT03883074|Antacids|antacids|mesh-ancestor
25762719|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762720|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25762721|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25762722|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
25762723|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776513|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25776514|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776515|NCT03802994|Vaccines|vaccines|mesh-list
25776516|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25776517|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
25776518|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776519|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25776520|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25776521|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
25776522|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776523|NCT03807245|Antacids|antacids|mesh-ancestor
25776524|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776525|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776526|NCT03802916|Deferiprone|deferiprone|mesh-list
25776527|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25776528|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
25776529|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
25776530|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777670|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777671|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25777672|NCT03333746|Nivolumab|nivolumab|mesh-list
25777673|NCT03333746|Lenalidomide|lenalidomide|mesh-list
25777674|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25777675|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777676|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25777677|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777678|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
25777679|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777680|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25777681|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25777682|NCT03333746|Growth Substances|growth substances|mesh-ancestor
25777683|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
25777684|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
25777685|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777686|NCT03325114|Diuretics|diuretics|mesh-ancestor
25777687|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
25777688|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777689|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25777690|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777691|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777692|NCT03305055|Fentanyl|fentanyl|mesh-list
25777693|NCT03305055|Ketamine|ketamine|mesh-list
25777694|NCT03305055|Analgesics|analgesics|mesh-ancestor
25777695|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
25777696|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777697|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777698|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25777699|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25777700|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
25777701|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
25777702|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762725|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762726|NCT03795350|Beclomethasone|beclomethasone|mesh-list
25762727|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
25762728|NCT03795350|Bromides|bromides|mesh-list
25762729|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
25762730|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25762731|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
25762732|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762733|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762734|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25762735|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
25762736|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25762737|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25762738|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25762739|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
25762740|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762741|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762742|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
25762743|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25762744|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25762745|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25762746|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
25762747|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762748|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
25762749|NCT03795350|Hormones|hormones|mesh-ancestor
25762750|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25762751|NCT03778996|Sirolimus|sirolimus|mesh-list
25762752|NCT03778996|Phenytoin|phenytoin|mesh-list
25762753|NCT03778996|Methoxsalen|methoxsalen|mesh-list
25762754|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
25762755|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25762756|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762757|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762758|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762759|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
25762760|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762761|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
25762762|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762763|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
25762764|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25762765|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25762766|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25762767|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762768|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25762769|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25762770|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25762771|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
25762772|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762773|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
25762774|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25762775|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
25762776|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25762777|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
25762778|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762779|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762780|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
25762781|NCT03670836|Misoprostol|misoprostol|mesh-list
25762782|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25762783|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
25762784|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25762785|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762786|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25762787|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25762788|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
25762789|NCT03655613|Nivolumab|nivolumab|mesh-list
25762790|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762791|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762792|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762793|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762794|NCT03653338|Rituximab|rituximab|mesh-list
25762795|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
25762796|NCT03653338|Fludarabine|fludarabine|mesh-list
25762797|NCT03653338|Thiotepa|thiotepa|mesh-list
25762798|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
25776531|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
25762802|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762803|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762804|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762805|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762806|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762807|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
25762808|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25762809|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
25762810|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762811|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25762813|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25762814|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762815|NCT03607656|Docetaxel|docetaxel|mesh-list
25762816|NCT03607656|Capecitabine|capecitabine|mesh-list
25762817|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
25762818|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762819|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762820|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762821|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762822|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762823|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762824|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
25762825|NCT03598842|Metronidazole|metronidazole|mesh-list
25762826|NCT03598842|Ivermectin|ivermectin|mesh-list
25762827|NCT03598842|Albendazole|albendazole|mesh-list
25762828|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
25762829|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762830|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25762831|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25762832|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
25762833|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
25762834|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25762835|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762836|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762837|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762838|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762839|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762840|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25762841|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25762842|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
25762843|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762844|NCT03589768|Antacids|antacids|mesh-ancestor
25762845|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762846|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25762847|NCT03525028|Metformin|metformin|mesh-list
25762848|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25762849|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762850|NCT03523312|Capecitabine|capecitabine|mesh-list
25762851|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25762852|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
25762853|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762854|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762855|NCT03505762|Prednisone|prednisone|mesh-list
25762856|NCT03505762|Cortisone|cortisone|mesh-list
25762857|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
25762858|NCT03505762|Rituximab|rituximab|mesh-list
25762859|NCT03505762|Doxorubicin|doxorubicin|mesh-list
25762860|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25762861|NCT03505762|Vincristine|vincristine|mesh-list
25762862|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25762863|NCT03505762|Antibodies|antibodies|mesh-list
25762864|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
25762865|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25762866|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762867|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
25762868|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762869|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762870|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762871|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
25776532|NCT03805386|Narcotics|narcotics|mesh-ancestor
25762872|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762873|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762874|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25762875|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25762876|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25762877|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25762878|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762879|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762880|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
25762881|NCT03505762|Hormones|hormones|mesh-ancestor
25762882|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25762883|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25762884|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25762885|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25762886|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25762887|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25762888|NCT03503942|Metformin|metformin|mesh-list
25762889|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25762890|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762891|NCT03471663|Palbociclib|palbociclib|mesh-list
25762892|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762893|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25762894|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762895|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762896|NCT03458429|Lenograstim|lenograstim|mesh-list
25762897|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25762898|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
25762899|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762900|NCT03447782|Naltrexone|naltrexone|mesh-list
25762901|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25762902|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25762903|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762904|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
25762905|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762906|NCT03425331|Nivolumab|nivolumab|mesh-list
25762907|NCT03425331|Ipilimumab|ipilimumab|mesh-list
25762908|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762909|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762910|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762911|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762912|NCT03410446|Ketamine|ketamine|mesh-list
25762913|NCT03410446|Analgesics|analgesics|mesh-ancestor
25762914|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
25762915|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762916|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762917|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25762918|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25762919|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
25762920|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
25762921|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762922|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25762923|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25762924|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25762925|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762926|NCT03409614|Cemiplimab|cemiplimab|mesh-list
25762927|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762928|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762929|NCT03374839|Nivolumab|nivolumab|mesh-list
25762930|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762931|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762932|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762933|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762934|NCT03347929|Naproxen|naproxen|mesh-list
25762935|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25762936|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25762937|NCT03347929|Analgesics|analgesics|mesh-ancestor
25762938|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
25762939|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762940|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762941|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25762942|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25762943|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
25762944|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24847603|NCT02248051|CXA-10|cxa-10|mesh-list
25762946|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762947|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
25762948|NCT03325647|Testosterone|testosterone|mesh-list
25762949|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
25762950|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
25762951|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25762952|NCT03325647|Androgens|androgens|mesh-ancestor
25762953|NCT03325647|Hormones|hormones|mesh-ancestor
25762954|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25762955|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762956|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25762957|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762958|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
25762959|NCT03324373|Everolimus|everolimus|mesh-list
25762960|NCT03324373|Lenvatinib|lenvatinib|mesh-list
25762961|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762962|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25762963|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
25762964|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762965|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25762966|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762967|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762968|NCT03282669|Morphine|morphine|mesh-list
25762969|NCT03282669|Hydromorphone|hydromorphone|mesh-list
25762970|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25762971|NCT03282669|Narcotics|narcotics|mesh-ancestor
25762972|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762973|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25762974|NCT03282669|Analgesics|analgesics|mesh-ancestor
25762975|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
25762976|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25762977|NCT03247569|Edoxaban|edoxaban|mesh-list
25762978|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25762979|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
25762980|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25762981|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
25762982|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25762983|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762984|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
25762985|NCT03200587|Avelumab|avelumab|mesh-list
25762986|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762987|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762988|NCT03138161|Nivolumab|nivolumab|mesh-list
25762989|NCT03138161|Ipilimumab|ipilimumab|mesh-list
25762990|NCT03138161|Trabectedin|trabectedin|mesh-list
25762991|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762992|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762993|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25762994|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25762995|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762996|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
25762997|NCT03087578|Mirabegron|mirabegron|mesh-list
25762998|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25762999|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25763000|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25763001|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
25763002|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763003|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763004|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763005|NCT03087578|Urological Agents|urological agents|mesh-ancestor
25763006|NCT03041311|Carboplatin|carboplatin|mesh-list
25763007|NCT03041311|Etoposide|etoposide|mesh-list
25763008|NCT03041311|Atezolizumab|atezolizumab|mesh-list
25763009|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763010|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25763011|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25763012|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25763013|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763014|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763015|NCT03020914|Methamphetamine|methamphetamine|mesh-list
25763016|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25763017|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763018|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
25763019|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
25763020|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763021|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
25763022|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763023|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763024|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
25763025|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25763026|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25763027|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25763028|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25763029|NCT03001726|Docetaxel|docetaxel|mesh-list
25763030|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
25763031|NCT03001726|Tegafur|tegafur|mesh-list
25763032|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763033|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
25763034|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
25763035|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
25763036|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763037|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25763038|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
25763039|NCT02849457|Vigabatrin|vigabatrin|mesh-list
25763040|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
25763041|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763042|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763043|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
25763044|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763045|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763046|NCT02807558|Azacitidine|azacitidine|mesh-list
25763047|NCT02807558|Daratumumab|daratumumab|mesh-list
25763048|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25763049|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
25763050|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763051|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763052|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763053|NCT02792465|Fulvestrant|fulvestrant|mesh-list
25763054|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25763055|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763056|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25763057|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25763058|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
25763059|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763060|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763061|NCT02751255|Tretinoin|tretinoin|mesh-list
25763062|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763063|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
25763064|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
25763065|NCT02698891|Paclitaxel|paclitaxel|mesh-list
25763066|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25763067|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763068|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
25763069|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25763070|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
25763071|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763072|NCT02651844|Mifepristone|mifepristone|mesh-list
25763073|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25763074|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
25763075|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25763076|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763077|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25763078|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25763079|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25763080|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
25763081|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25763082|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25763083|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
25763084|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763085|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
25763086|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25763087|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25776533|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776534|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776535|NCT03805386|Analgesics|analgesics|mesh-ancestor
25776536|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
25776537|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763090|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
25763091|NCT02400476|Colestipol|colestipol|mesh-list
25763092|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763093|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25763094|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
25763095|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763096|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763097|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25763098|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25763099|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
25763100|NCT02400476|Hormones|hormones|mesh-ancestor
25763101|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763102|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763103|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25763104|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
25763105|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763106|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25763107|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
25763108|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
25763109|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25763110|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25763111|NCT02283996|Prednisolone|prednisolone|mesh-list
25763112|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
25763113|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25763114|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
25763115|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763116|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
25763117|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
25763118|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763119|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763120|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763121|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
25763122|NCT02283996|Hormones|hormones|mesh-ancestor
25763123|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763124|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25763125|NCT02283996|Protective Agents|protective agents|mesh-ancestor
25763126|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25763127|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763128|NCT02199184|Prednisone|prednisone|mesh-list
25763129|NCT02199184|Cortisone|cortisone|mesh-list
25763130|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
25763131|NCT02199184|Rituximab|rituximab|mesh-list
25763132|NCT02199184|Doxorubicin|doxorubicin|mesh-list
25763133|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25763134|NCT02199184|Etoposide|etoposide|mesh-list
25763135|NCT02199184|Vincristine|vincristine|mesh-list
25763136|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
25763137|NCT02199184|Ofatumumab|ofatumumab|mesh-list
25763138|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
25763139|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25763140|NCT02199184|Antibodies|antibodies|mesh-list
25763141|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
25763142|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25763143|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25763144|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
25763145|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763146|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25763147|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25763148|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
25763149|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763150|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763151|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25763152|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25763153|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25763154|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25763155|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763156|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763157|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
25763158|NCT02199184|Hormones|hormones|mesh-ancestor
25763159|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763160|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25154872|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25154873|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763161|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25763164|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
25763165|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
25763166|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
25763167|NCT02108860|Abatacept|abatacept|mesh-list
25763168|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25763169|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763170|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763171|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25763172|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
25763173|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763174|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25763175|NCT02076217|Copper|copper|mesh-list
25763176|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25763177|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
25763178|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
25763179|NCT02076217|Etonogestrel|etonogestrel|mesh-list
25763180|NCT02076217|Desogestrel|desogestrel|mesh-list
25763181|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25763182|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763183|NCT02076217|Trace Elements|trace elements|mesh-ancestor
25763184|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
25763185|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25763186|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25763187|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25763188|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25763189|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25763190|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25763191|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25763192|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763193|NCT02076217|Progestins|progestins|mesh-ancestor
25763194|NCT02076217|Hormones|hormones|mesh-ancestor
25763195|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763196|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
25763197|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
25763198|NCT02002130|Butyric Acid|butyric acid|mesh-list
25763199|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25763200|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
25763201|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763202|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
25763203|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763204|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763205|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
25763206|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
25763207|NCT01786265|Prednisone|prednisone|mesh-list
25763208|NCT01786265|Cortisone|cortisone|mesh-list
25763209|NCT01786265|Leuprolide|leuprolide|mesh-list
25763210|NCT01786265|Goserelin|goserelin|mesh-list
25763211|NCT01786265|Flutamide|flutamide|mesh-list
25763212|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
25763213|NCT01786265|Bicalutamide|bicalutamide|mesh-list
25763214|NCT01786265|Nilutamide|nilutamide|mesh-list
25763215|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763216|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
25763217|NCT01786265|Hormones|hormones|mesh-ancestor
25763218|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763219|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763220|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25763221|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763222|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25763223|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
25763224|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25763225|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25763226|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763227|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763228|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
25763229|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25763230|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
25763231|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25763232|NCT01664910|Rituximab|rituximab|mesh-list
25763233|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25763234|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25763235|NCT01664910|Methotrexate|methotrexate|mesh-list
25763236|NCT01664910|Fludarabine|fludarabine|mesh-list
24848516|NCT03993912|Dexamethasone|dexamethasone|mesh-list
25763237|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
25763238|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25763239|NCT01664910|Antibodies|antibodies|mesh-list
25763240|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
25763241|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25763242|NCT01664910|Tacrolimus|tacrolimus|mesh-list
25763243|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
25763244|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25763245|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
25763246|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763247|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763248|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25763249|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25763250|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
25763251|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25763252|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25763253|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
25763254|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763255|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25763256|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763257|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25763258|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25763259|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25763260|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25763261|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25763262|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
25763263|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25763264|NCT01658241|Panobinostat|panobinostat|mesh-list
25763265|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763266|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25763267|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763268|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763269|NCT01471106|Dasatinib|dasatinib|mesh-list
25763270|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763271|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25763272|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763273|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763274|NCT01463670|Lenalidomide|lenalidomide|mesh-list
25763275|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
25763276|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763277|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25763278|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25763279|NCT01463670|Growth Substances|growth substances|mesh-ancestor
25763280|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
25763281|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763282|NCT01455051|Ofatumumab|ofatumumab|mesh-list
25763283|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763284|NCT00920816|Sorafenib|sorafenib|mesh-list
25763285|NCT00920816|Axitinib|axitinib|mesh-list
25763286|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763287|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25763288|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763289|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763290|NCT00151398|Donepezil|donepezil|mesh-list
25763291|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25763292|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763293|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763294|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
25763295|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763296|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763297|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
25763298|NCT03181009|Omalizumab|omalizumab|mesh-list
25763299|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25763300|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25763301|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
25763302|NCT03181308|Nivolumab|nivolumab|mesh-list
25763303|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25763304|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763305|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25763306|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763307|NCT03181451|Ferric maltol|ferric maltol|mesh-list
25763308|NCT03181451|Hematinics|hematinics|mesh-ancestor
25763309|NCT03181932|Vancomycin|vancomycin|mesh-list
25763310|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788546|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25763311|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763312|NCT03182920|Lasmiditan|lasmiditan|mesh-list
25763313|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25763314|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
25763315|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763316|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763317|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763318|NCT03183908|Vaccines|vaccines|mesh-list
25763319|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
25763320|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763321|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
25763322|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25763323|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763324|NCT03184987|Albuterol|albuterol|mesh-list
25763325|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25763326|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
25763327|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763328|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763329|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25763330|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
25763331|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
25763332|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25763333|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25763334|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25763335|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25763336|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
25763337|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763338|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763339|NCT03185065|Amantadine|amantadine|mesh-list
25763340|NCT03185065|Methylphenidate|methylphenidate|mesh-list
25763341|NCT03185065|Modafinil|modafinil|mesh-list
25763342|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25763343|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763344|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25763345|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25763346|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25763347|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763348|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
25763349|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763350|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25763351|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25763352|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25763353|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25763354|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25763355|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
25763356|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763357|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25763358|NCT03185065|Analgesics|analgesics|mesh-ancestor
25763359|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
25763360|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763361|NCT03185546|Nicotine|nicotine|mesh-list
25763362|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25763363|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
25763364|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763365|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763366|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25763367|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25763368|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
25763369|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763370|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763371|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
25763372|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25763373|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25763374|NCT03186261|Fluorides|fluorides|mesh-list
25763375|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
25763376|NCT03186261|Protective Agents|protective agents|mesh-ancestor
25763377|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763378|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25763379|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763380|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
25763381|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
25763382|NCT03187197|Dabigatran|dabigatran|mesh-list
25763383|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
25763384|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25763385|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
25763386|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776538|NCT03803475|Edetic Acid|edetic acid|mesh-list
25763387|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763388|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
25763389|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
25763390|NCT03187301|Apomorphine|apomorphine|mesh-list
25763391|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25763392|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763393|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25763394|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25763395|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763396|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763397|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763398|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763399|NCT03187301|Emetics|emetics|mesh-ancestor
25763400|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
25763401|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763402|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763403|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
25763404|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
25763405|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763406|NCT03187678|Selexipag|selexipag|mesh-list
25763407|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25763408|NCT03187730|Nicotine|nicotine|mesh-list
25763409|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25763410|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
25763411|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763412|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763413|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25763414|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25763415|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
25763416|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763417|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763418|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
25763419|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25763420|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
25763421|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763422|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25763423|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25763424|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
25763425|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763426|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763427|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25763428|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
25763429|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25763430|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
25763431|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763432|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763433|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25763434|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
25763435|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
25763436|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25763437|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
25763438|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763439|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763440|NCT03188185|Naltrexone|naltrexone|mesh-list
25763441|NCT03188185|Buprenorphine|buprenorphine|mesh-list
25763442|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25763443|NCT03188185|Narcotics|narcotics|mesh-ancestor
25763444|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25763445|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763446|NCT03188185|Analgesics|analgesics|mesh-ancestor
25763447|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
25763448|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763449|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25763450|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25763451|NCT03189446|Paclitaxel|paclitaxel|mesh-list
25763452|NCT03189446|Carboplatin|carboplatin|mesh-list
25763453|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25763454|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763455|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
25763456|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
25763457|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
25763458|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763459|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
25763460|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763461|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24702720|NCT01467362|Desonide|desonide|mesh-list
25763462|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763463|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763464|NCT03189589|Nemiralisib|nemiralisib|mesh-list
25763465|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25763466|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763467|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763468|NCT03190005|Clopidogrel|clopidogrel|mesh-list
25763469|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25763470|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25763471|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25763472|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25763473|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
25763474|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763475|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763476|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776539|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25776540|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
25776541|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
25776542|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776543|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
25776544|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25776545|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25776546|NCT03802227|Oxycodone|oxycodone|mesh-list
25776547|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25776548|NCT03802227|Narcotics|narcotics|mesh-ancestor
25776549|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776550|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776551|NCT03802227|Analgesics|analgesics|mesh-ancestor
25776552|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
25776553|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776554|NCT03802864|Bupivacaine|bupivacaine|mesh-list
25776555|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776556|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
25776557|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776558|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776559|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
25776560|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776561|NCT03801265|Ropivacaine|ropivacaine|mesh-list
25776562|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776563|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
25776564|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776565|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776566|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
25776567|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776568|NCT03801928|Infliximab|infliximab|mesh-list
25776569|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
25776570|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776571|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776572|NCT03800173|Galidesivir|galidesivir|mesh-list
25776573|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
25776574|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776575|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
25776576|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25776577|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776578|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776579|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776580|NCT03799783|Analgesics|analgesics|mesh-ancestor
25776581|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
25776582|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776583|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25776584|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25776585|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25776586|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
25776587|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776588|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776589|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
25776590|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
25776591|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25776592|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25776593|NCT03797872|Prednisolone|prednisolone|mesh-list
25776594|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
25776595|NCT03797872|Triamcinolone|triamcinolone|mesh-list
25776596|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25776597|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25776598|NCT03797872|Methotrexate|methotrexate|mesh-list
25763477|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
25763478|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25763479|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763480|NCT03191396|Liraglutide|liraglutide|mesh-list
25763481|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763482|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763483|NCT03191396|Incretins|incretins|mesh-ancestor
25763484|NCT03191396|Hormones|hormones|mesh-ancestor
25763485|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763486|NCT03192306|Ethanol|ethanol|mesh-list
25763487|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25763488|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763489|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25763490|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763491|NCT03192488|Cetirizine|cetirizine|mesh-list
25763492|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25763493|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25763494|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25763495|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
25763496|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
25763497|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763498|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763499|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763500|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25763501|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
25763502|NCT03192826|Dipivefrin|dipivefrin|mesh-list
25763503|NCT03192826|Brinzolamide|brinzolamide|mesh-list
25763504|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25763505|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25763506|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25763507|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25763508|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
25763509|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763510|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763511|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763512|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25763513|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25763514|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25763515|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763516|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25763517|NCT03193047|Evolocumab|evolocumab|mesh-list
25763518|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25763519|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25763520|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
25763521|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763522|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25763523|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763524|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763525|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763526|NCT03194373|Carboplatin|carboplatin|mesh-list
25763527|NCT03194373|Palbociclib|palbociclib|mesh-list
25763528|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763529|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25763530|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763531|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763532|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
25763533|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25763534|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763535|NCT03196349|Warfarin|warfarin|mesh-list
25763536|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
25763537|NCT03196349|Apixaban|apixaban|mesh-list
25763538|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
25763539|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25763540|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
25763541|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25763542|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
25763543|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763544|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763545|NCT03196505|Bupivacaine|bupivacaine|mesh-list
25763546|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
25763547|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
25763548|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25763549|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763550|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
25763551|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763552|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25763553|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25763554|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763555|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
25763557|NCT03197025|Interleukin-2|interleukin-2|mesh-list
25763558|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763559|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25763560|NCT03197025|Analgesics|analgesics|mesh-ancestor
25763561|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
25763562|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763563|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763564|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25763565|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25763566|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
25763567|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763568|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
25763569|NCT03197324|Digoxin|digoxin|mesh-list
25763570|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25763571|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25763572|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763573|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763574|NCT03197324|Protective Agents|protective agents|mesh-ancestor
25763575|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763576|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763577|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
25763578|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25763579|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763580|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
25763581|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25763582|NCT03197883|Protective Agents|protective agents|mesh-ancestor
25763583|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763584|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
25763585|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25763586|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25763587|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
25763588|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
25763589|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25763590|NCT03198221|Citric Acid|citric acid|mesh-list
25763591|NCT03198221|Cathartics|cathartics|mesh-ancestor
25763592|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763593|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
25763594|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25763595|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
25763596|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
25763597|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763598|NCT03198221|Antacids|antacids|mesh-ancestor
25763599|NCT03198221|Laxatives|laxatives|mesh-ancestor
25763600|NCT03198507|Amoxicillin|amoxicillin|mesh-list
25763601|NCT03198507|Rifabutin|rifabutin|mesh-list
25763602|NCT03198507|Omeprazole|omeprazole|mesh-list
25763603|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25763604|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763605|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25763606|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763607|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25763608|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763609|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763610|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25763611|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
25763612|NCT03198767|Licogliflozin|licogliflozin|mesh-list
25763613|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
25763614|NCT03198767|Psyllium|psyllium|mesh-list
25763615|NCT03198767|Calcium|calcium|mesh-list
25763616|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25763617|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763618|NCT03198767|Antacids|antacids|mesh-ancestor
25763619|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763620|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763621|NCT03198767|Cathartics|cathartics|mesh-ancestor
25763622|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25763623|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763624|NCT03198871|Acetaminophen|acetaminophen|mesh-list
25763625|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25763626|NCT03198871|Analgesics|analgesics|mesh-ancestor
25763627|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
25763628|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763629|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763630|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
25763631|NCT03198884|Darunavir|darunavir|mesh-list
25763632|NCT03198884|Dolutegravir|dolutegravir|mesh-list
25763633|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25763634|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25763635|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
25763636|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763637|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763638|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25763639|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25763640|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
25763641|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763642|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25763643|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25763644|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25763645|NCT03199911|Erythromycin|erythromycin|mesh-list
25763646|NCT03199911|Bacitracin|bacitracin|mesh-list
25763647|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763648|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763649|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25763650|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763651|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763652|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25763653|NCT03200860|Empagliflozin|empagliflozin|mesh-list
25763654|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25763655|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763656|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763657|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763658|NCT03201211|Vaccines|vaccines|mesh-list
25763659|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
25763660|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763661|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
25763662|NCT03202134|Anesthetics|anesthetics|mesh-list
25763663|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25763664|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763665|NCT03202134|Narcotics|narcotics|mesh-ancestor
25763666|NCT03202134|Analgesics|analgesics|mesh-ancestor
25763667|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
25763668|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763669|NCT03202511|Tenofovir|tenofovir|mesh-list
25763670|NCT03202511|Emtricitabine|emtricitabine|mesh-list
25763671|NCT03202511|Probenecid|probenecid|mesh-list
25763672|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
25763673|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763674|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25763675|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25763676|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763677|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763678|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25763679|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25763680|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
25763681|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
25763682|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25763683|NCT03202511|Renal Agents|renal agents|mesh-ancestor
25763684|NCT03202550|Oxycodone|oxycodone|mesh-list
25763685|NCT03202550|Lorazepam|lorazepam|mesh-list
25763686|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25763687|NCT03202550|Narcotics|narcotics|mesh-ancestor
25763688|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25763689|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763690|NCT03202550|Analgesics|analgesics|mesh-ancestor
25763691|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
25763692|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763693|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
25763694|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
25763695|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
25763696|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763697|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25763698|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25763699|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25763700|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24849565|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
24849568|NCT02249078|Quetmolimab|quetmolimab|mesh-list
24849581|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24849582|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849583|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
25763701|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
25763702|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
25763703|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763704|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763705|NCT03203447|Triamcinolone|triamcinolone|mesh-list
25763706|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25763707|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25763708|NCT03203447|Bevacizumab|bevacizumab|mesh-list
25763709|NCT03203447|Ranibizumab|ranibizumab|mesh-list
25763710|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25763711|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25763712|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763713|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25763714|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25763715|NCT03203447|Growth Substances|growth substances|mesh-ancestor
25763716|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763717|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
25763718|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763719|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
25763720|NCT03203447|Hormones|hormones|mesh-ancestor
25763721|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763722|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25763723|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
25763724|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763725|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763726|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
25763727|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25763728|NCT03203681|Testosterone|testosterone|mesh-list
25763729|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
25763730|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
25763731|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25763732|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763733|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
25763734|NCT03203681|Hormones|hormones|mesh-ancestor
25763735|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763736|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763737|NCT03203681|Androgens|androgens|mesh-ancestor
25763738|NCT03204279|Palonosetron|palonosetron|mesh-list
25763739|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
25763740|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
25763741|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763742|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763743|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763744|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25763745|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25763746|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
25763747|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763748|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763749|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
25763750|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763751|NCT03205150|Licogliflozin|licogliflozin|mesh-list
25763752|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25763753|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763754|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763755|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763756|NCT03205566|Lamivudine|lamivudine|mesh-list
25763757|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
25763758|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25763759|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25763760|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763761|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763762|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
25763763|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763764|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25763765|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25763766|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25763767|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25763768|NCT03206788|Losartan|losartan|mesh-list
25763769|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25763770|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25763771|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25763772|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25763773|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763774|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
25763775|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763776|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25763777|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763778|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763779|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
25763780|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763781|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25763782|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763783|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763784|NCT03207243|Fluticasone|fluticasone|mesh-list
25763785|NCT03207243|Xhance|xhance|mesh-list
25763786|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25763787|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763788|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25763789|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
25763790|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763791|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763792|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25763793|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
25763794|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
25763795|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25763796|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25763797|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25763798|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25763799|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25763800|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763801|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763802|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25763803|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
25763804|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763805|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25763806|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
25763807|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25763808|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25763809|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25763810|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25763811|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763812|NCT03207750|Vaccines|vaccines|mesh-list
25763813|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25763814|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
25763815|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776599|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25776600|NCT03797872|Leflunomide|leflunomide|mesh-list
25776601|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25776602|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
25776603|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25776604|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
25776605|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25776606|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776607|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25776608|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
25776609|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776610|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776611|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
25776612|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776613|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25776614|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25776615|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
25776616|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776617|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25776618|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776619|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
25776620|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
25776621|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776622|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776623|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
25776624|NCT03797872|Hormones|hormones|mesh-ancestor
25776625|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776626|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25776627|NCT03797872|Protective Agents|protective agents|mesh-ancestor
25776628|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25776629|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776630|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25066990|NCT03448588|Selenium|selenium|mesh-list
25763817|NCT03208933|Analgesics|analgesics|mesh-ancestor
25763818|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
25763819|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763820|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763821|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25763822|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25763823|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763824|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25763825|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763826|NCT03209492|Leuprolide|leuprolide|mesh-list
25763827|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25763828|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
25763829|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25763830|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763831|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25763832|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763833|NCT03209518|Leuprolide|leuprolide|mesh-list
25763834|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25763835|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
25763836|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25763837|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763838|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25763839|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763840|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
25763841|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
25763842|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
25763843|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25763844|NCT03209570|Protective Agents|protective agents|mesh-ancestor
25763845|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763846|NCT03210259|Adalimumab|adalimumab|mesh-list
25763847|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763848|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25763849|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25763850|NCT03210376|Neostigmine|neostigmine|mesh-list
25763851|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763852|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25763853|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763854|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763855|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
25763856|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763857|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25763858|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
25763859|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763860|NCT03211117|Docetaxel|docetaxel|mesh-list
25763861|NCT03211117|Doxorubicin|doxorubicin|mesh-list
25763862|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25763863|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
25763864|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763865|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25763866|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25763867|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25763868|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763869|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25763870|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25763871|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25763872|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763873|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25763874|NCT03211156|Amoxicillin|amoxicillin|mesh-list
25763875|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25763876|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763877|NCT03211234|Ranibizumab|ranibizumab|mesh-list
25763878|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25763879|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25763880|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25763881|NCT03211234|Growth Substances|growth substances|mesh-ancestor
25763882|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763883|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
25763884|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763885|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25763886|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25763887|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25763888|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763889|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716488|NCT01541956|Metformin|metformin|mesh-list
25763890|NCT03214367|Insulin|insulin|mesh-list
25763891|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25763892|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
25763894|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763895|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763896|NCT03214380|Insulin|insulin|mesh-list
25763897|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25763898|NCT03214380|Metformin|metformin|mesh-list
25763899|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
25763900|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
25763901|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25763902|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25763903|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763904|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763905|NCT03216226|Glucagon|glucagon|mesh-list
25763906|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25763907|NCT03216226|Hormones|hormones|mesh-ancestor
25763908|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763909|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763910|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25763911|NCT03216902|Latanoprost|latanoprost|mesh-list
25763912|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25763913|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
25763914|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25763915|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
25763916|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763917|NCT03216954|Expectorants|expectorants|mesh-ancestor
25763918|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
25763919|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25763920|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
25763921|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763922|NCT03216954|Protective Agents|protective agents|mesh-ancestor
25763923|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763924|NCT03216954|Antidotes|antidotes|mesh-ancestor
25763925|NCT03218592|Tenofovir|tenofovir|mesh-list
25763926|NCT03218592|Emtricitabine|emtricitabine|mesh-list
25763927|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25763928|NCT03218592|Maraviroc|maraviroc|mesh-list
25763929|NCT03218592|Dolutegravir|dolutegravir|mesh-list
25763930|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
25763931|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763932|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25763933|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25763934|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763935|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763936|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25763937|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25763938|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25763939|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25763940|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25763941|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25763942|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25763943|NCT03219294|Bromides|bromides|mesh-list
25763944|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
25763945|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
25763946|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25763947|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25763948|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25763949|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763950|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763951|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25763952|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25763953|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
25763954|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763955|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763956|NCT03219723|Amoxicillin|amoxicillin|mesh-list
25763957|NCT03219723|Metronidazole|metronidazole|mesh-list
25763958|NCT03219723|Clarithromycin|clarithromycin|mesh-list
25763959|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25763960|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763961|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25763962|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25763963|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25763964|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763965|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006231|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
25763966|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25763967|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25763968|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
25763969|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25763970|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25763971|NCT03219866|Budesonide|budesonide|mesh-list
25763972|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
25763973|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25763974|NCT03219866|Ipratropium|ipratropium|mesh-list
25763975|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25763976|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25763977|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
25763978|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25763979|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763980|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25763981|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
25763982|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
25763983|NCT03219866|Hormones|hormones|mesh-ancestor
25763984|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25763985|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
25763986|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25763987|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
25763988|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25763989|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25763990|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
25763991|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
25763992|NCT03220958|Promethazine|promethazine|mesh-list
25763993|NCT03220958|Metoclopramide|metoclopramide|mesh-list
25763994|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25763995|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25763996|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25763997|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25763998|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
25763999|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
25764000|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
25764001|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764002|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
25764003|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
25764004|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764005|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25764006|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
25764007|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
25764008|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764009|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764010|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25764011|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
25764012|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
25764013|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25764014|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25764015|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
25764016|NCT03221764|Amiodarone|amiodarone|mesh-list
25764017|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25764018|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
25764019|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25764020|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764021|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764022|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25764023|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25764024|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25764025|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764026|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25764027|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25764028|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25764029|NCT03222349|Diazepam|diazepam|mesh-list
25764030|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25764031|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
25764032|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
24444327|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155239|NCT05438979|Calcium|calcium|mesh-list
24643558|NCT01186094|Sirolimus|sirolimus|mesh-list
24444384|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444385|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444386|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25764034|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764035|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764036|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764037|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25764038|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764039|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25764040|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25764041|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25764042|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25764043|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25764044|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25764045|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
25764046|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
25764047|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
25764048|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
25764049|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764050|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764051|NCT03223272|Reserpine|reserpine|mesh-list
25764052|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25764053|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25764054|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25764055|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764056|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764057|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25764058|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25764059|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25764060|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764061|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764062|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764063|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764064|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
25764065|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25764066|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
25764067|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764068|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
25764069|NCT03223909|Protective Agents|protective agents|mesh-ancestor
25764070|NCT03224182|Apaziquone|apaziquone|mesh-list
25764071|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776631|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776632|NCT03797872|Analgesics|analgesics|mesh-ancestor
25776633|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
25776634|NCT03799484|Lidocaine|lidocaine|mesh-list
25776635|NCT03799484|Prilocaine|prilocaine|mesh-list
25776636|NCT03799484|Petrolatum|petrolatum|mesh-list
25776637|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
25776638|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25776639|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25776640|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776641|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
25776642|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776643|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776644|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
25776645|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776646|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25776647|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25776648|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25776649|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25776650|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776651|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25776652|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
25776653|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776654|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25776655|NCT03799484|Emollients|emollients|mesh-ancestor
25776656|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25776657|NCT03796728|Lidocaine|lidocaine|mesh-list
25776658|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776659|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
24850116|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728013|NCT01613963|Adalimumab|adalimumab|mesh-list
25240595|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24850166|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
24850167|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516817|NCT00603824|PENTA|penta|mesh-list
25764072|NCT03224351|Ivacaftor|ivacaftor|mesh-list
25764073|NCT03224351|VX-659|vx-659|mesh-list
25764074|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25764075|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764076|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764077|NCT03224403|Acetaminophen|acetaminophen|mesh-list
25764078|NCT03224403|Ibuprofen|ibuprofen|mesh-list
25764079|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25764080|NCT03224403|Analgesics|analgesics|mesh-ancestor
25764081|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
25764082|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764083|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764084|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
25764085|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25764086|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764087|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25764088|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25764089|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764090|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764091|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25764092|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25764093|NCT03225313|Bupivacaine|bupivacaine|mesh-list
25764094|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25764095|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
25764096|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
25764097|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764098|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764099|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
25764100|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764101|NCT03226223|Methamphetamine|methamphetamine|mesh-list
25764102|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25764103|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764104|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
25764105|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
25764106|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764107|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
25764108|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764109|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764110|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764111|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25764112|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25764113|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764114|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25764115|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
25764116|NCT03226249|Doxorubicin|doxorubicin|mesh-list
25764117|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25764118|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
25764119|NCT03226249|Dacarbazine|dacarbazine|mesh-list
25764120|NCT03226249|Vinblastine|vinblastine|mesh-list
25764121|NCT03226249|Imidazole|imidazole|mesh-list
25764122|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25764123|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25764124|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764125|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25764126|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25764127|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764128|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764129|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25764130|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25764131|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
25764132|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25764133|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25764134|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
25764135|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
25764136|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
25764137|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
25764138|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
24737966|NCT01671982|Tenofovir|tenofovir|mesh-list
24850922|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006822|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
25006823|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006824|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006826|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
25006827|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739351|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24953535|NCT03883919|Vitamin D|vitamin d|mesh-list
25764139|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764140|NCT03226275|Amlodipine|amlodipine|mesh-list
25764141|NCT03226275|Bisoprolol|bisoprolol|mesh-list
25764142|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25764143|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25764144|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764145|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764146|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25764147|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764148|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
25764149|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
25764150|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
25764151|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764152|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25764153|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25764154|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25764155|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764156|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764157|NCT03226457|Empagliflozin|empagliflozin|mesh-list
25764158|NCT03226457|Furosemide|furosemide|mesh-list
25764159|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25764160|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764161|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25764162|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764163|NCT03226457|Diuretics|diuretics|mesh-ancestor
25764164|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
25764165|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25764166|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764167|NCT03226691|Plerixafor|plerixafor|mesh-list
25764168|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25764169|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25764170|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
25764171|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764172|NCT03226899|Colchicine|colchicine|mesh-list
25764173|NCT03226899|Allopurinol|allopurinol|mesh-list
25764174|NCT03226899|Febuxostat|febuxostat|mesh-list
25764175|NCT03226899|Lesinurad|lesinurad|mesh-list
25764176|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
25764177|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25764178|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
25764179|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
25764180|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
25764181|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764182|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764183|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
25764184|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764185|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25764186|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
25764187|NCT03226899|Protective Agents|protective agents|mesh-ancestor
25764188|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764189|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
25764190|NCT03226899|Renal Agents|renal agents|mesh-ancestor
25764191|NCT03228017|Aspirin|aspirin|mesh-list
25764192|NCT03228017|Atorvastatin|atorvastatin|mesh-list
25764193|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25764194|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25764195|NCT03228017|Analgesics|analgesics|mesh-ancestor
25764196|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
25764197|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764198|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764199|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764200|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25764201|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25764202|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25764203|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764204|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25764205|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25764206|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764207|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
25764208|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25764209|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25764210|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
25764211|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25764212|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25764213|NCT03228914|Phenylephrine|phenylephrine|mesh-list
25764214|NCT03228914|Epinephrine|epinephrine|mesh-list
25764215|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
25764216|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25764217|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25764218|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764219|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764220|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764221|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764222|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25764223|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25764224|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
25764225|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764226|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25764227|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
25764228|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
25764229|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
25764230|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25764231|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
25764232|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25764233|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25764234|NCT03228914|Protective Agents|protective agents|mesh-ancestor
25764235|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
25764236|NCT03229486|Neostigmine|neostigmine|mesh-list
25764237|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25764238|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764239|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764240|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
25764241|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764242|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764243|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25764244|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
25764245|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764246|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25764247|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25764248|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25764249|NCT03229759|Octenidine|octenidine|mesh-list
25764250|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764251|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25764252|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25764253|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764254|NCT03230864|Olanzapine|olanzapine|mesh-list
25764255|NCT03230864|Risperidone|risperidone|mesh-list
25764256|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25764257|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
25764258|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764259|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764260|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764261|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25764262|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25764263|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764264|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25764265|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25764266|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
25764267|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
25764268|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
25764269|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764270|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764271|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25764272|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25764273|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764274|NCT03231228|Cefazolin|cefazolin|mesh-list
25764275|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25764276|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764277|NCT03231371|Adenosine|adenosine|mesh-list
25764278|NCT03231371|Analgesics|analgesics|mesh-ancestor
25764279|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
25764280|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764281|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764282|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24750641|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24750964|NCT01701349|Paclitaxel|paclitaxel|mesh-list
24750965|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
24750966|NCT01701349|Combretastatin|combretastatin|mesh-list
24750967|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24750968|NCT01701349|Carboplatin|carboplatin|mesh-list
24750969|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24750972|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
24656788|NCT01264237|Etoricoxib|etoricoxib|mesh-list
25764283|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
25764284|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25764285|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
25764286|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
25764287|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764288|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764289|NCT03231709|Alogliptin|alogliptin|mesh-list
25764290|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25764291|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764292|NCT03231709|Incretins|incretins|mesh-ancestor
25764293|NCT03231709|Hormones|hormones|mesh-ancestor
25764294|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764295|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25764296|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764297|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764298|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764299|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25764300|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
25764301|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25764302|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
25764303|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25764304|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764305|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25764306|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25764307|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764308|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
25764309|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25764310|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764311|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
25764312|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
25764313|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764314|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764315|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764316|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
25764317|NCT03232749|Hormones|hormones|mesh-ancestor
25764318|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764319|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25764320|NCT03232749|Protective Agents|protective agents|mesh-ancestor
25764321|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
25764322|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25764323|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764324|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25764325|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25764326|NCT03233438|Dalbavancin|dalbavancin|mesh-list
25764327|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25764328|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764329|NCT03233737|Anesthetics|anesthetics|mesh-list
25764330|NCT03233737|Tetracaine|tetracaine|mesh-list
25764331|NCT03233737|Benzocaine|benzocaine|mesh-list
25764332|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764333|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764334|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
25764335|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
25764336|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764337|NCT03234036|Ritonavir|ritonavir|mesh-list
25764338|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
25764339|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25764340|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25764341|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764342|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764343|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764344|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25764345|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25764346|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
25764347|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764348|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25764349|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25764350|NCT03234374|Bupivacaine|bupivacaine|mesh-list
25764351|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
25764352|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
25764353|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764354|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764355|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
25764356|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764357|NCT03235050|Liraglutide|liraglutide|mesh-list
25241385|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764359|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764360|NCT03235050|Incretins|incretins|mesh-ancestor
25764361|NCT03235050|Hormones|hormones|mesh-ancestor
25764362|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764363|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
25764364|NCT03235154|Velpatasvir|velpatasvir|mesh-list
25764365|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25764366|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
25764367|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764368|NCT03236168|Ivermectin|ivermectin|mesh-list
25764369|NCT03236168|Permethrin|permethrin|mesh-list
25764370|NCT03236168|Malathion|malathion|mesh-list
25764371|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25764372|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764373|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764374|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764375|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25764376|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
25764377|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764378|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764379|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
25764380|NCT03236506|Grazoprevir|grazoprevir|mesh-list
25764381|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25764382|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
25764383|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764384|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25764385|NCT03237065|Hematinics|hematinics|mesh-ancestor
25764386|NCT03237481|Bupivacaine|bupivacaine|mesh-list
25764387|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
25764388|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
25764389|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764390|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764391|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
25764392|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764393|NCT03238352|Listerine|listerine|mesh-list
25764394|NCT03238352|Fluorides|fluorides|mesh-list
25764395|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
25764396|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
25764397|NCT03238352|Protective Agents|protective agents|mesh-ancestor
25764398|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764399|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25764400|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764401|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25764402|NCT03238911|Hematinics|hematinics|mesh-ancestor
25764403|NCT03238924|Oxytocin|oxytocin|mesh-list
25764404|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
25764405|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25764406|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764407|NCT03239106|Apremilast|apremilast|mesh-list
25764408|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25764409|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25764410|NCT03239106|Analgesics|analgesics|mesh-ancestor
25764411|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
25764412|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764413|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764414|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764415|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25764416|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25764417|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25764418|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764419|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764420|NCT03239483|Dapivirine|dapivirine|mesh-list
25764421|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25764422|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25764423|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
25764424|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764425|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24851399|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
24851401|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
24851402|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
24851403|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851445|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444852|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651476|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
25764426|NCT03239522|Glycine|glycine|mesh-list
25764427|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
25764428|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764429|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764430|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764431|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25764432|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25764433|NCT03240081|Estradiol|estradiol|mesh-list
25764434|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25764435|NCT03240081|Estrogens|estrogens|mesh-ancestor
25764436|NCT03240081|Hormones|hormones|mesh-ancestor
25764437|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764438|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764439|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25764440|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
25764441|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25764442|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25776660|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776661|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776662|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
25776663|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776664|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25776665|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25776666|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25776667|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25776668|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776669|NCT03796260|Entrectinib|entrectinib|mesh-list
25776670|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25776671|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776672|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776673|NCT03780959|Etanercept|etanercept|mesh-list
25776674|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25776675|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776676|NCT03780959|Analgesics|analgesics|mesh-ancestor
25776677|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
25776678|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776679|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776680|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776681|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776682|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776683|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25776684|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
25776685|NCT03796182|Metformin|metformin|mesh-list
25776686|NCT03796182|Abrocitinib|abrocitinib|mesh-list
25776687|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776688|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776689|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25776690|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776691|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776692|NCT03796013|Entrectinib|entrectinib|mesh-list
25776693|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25776694|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776695|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776696|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
25776697|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25776698|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776699|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776700|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776701|NCT03793751|Analgesics|analgesics|mesh-ancestor
25776702|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
25776703|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776704|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25776705|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25776706|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25776707|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
24851507|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069755|NCT03424356|Analgesics|analgesics|mesh-list
24651911|NCT01234506|Vitamin D|vitamin d|mesh-list
24692539|NCT01415011|Afatinib|afatinib|mesh-list
25764443|NCT03240133|Berotralstat|berotralstat|mesh-list
25764444|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764445|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764446|NCT03240575|Fluticasone|fluticasone|mesh-list
25764447|NCT03240575|Xhance|xhance|mesh-list
25764448|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
25764449|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25764450|NCT03240575|Olodaterol|olodaterol|mesh-list
25764451|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764452|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25764453|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
25764454|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764455|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764456|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25764457|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
25764458|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
25764459|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25764460|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
25764461|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25764462|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
25764463|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764464|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764465|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25764466|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25764467|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25764468|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764469|NCT03241030|Acetaminophen|acetaminophen|mesh-list
25764470|NCT03241030|Ibuprofen|ibuprofen|mesh-list
25764471|NCT03241030|Sucralfate|sucralfate|mesh-list
25764472|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25764473|NCT03241030|Analgesics|analgesics|mesh-ancestor
25764474|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
25764475|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764476|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764477|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
25764478|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25764479|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764480|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25764481|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25764482|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764483|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764484|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25764485|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764486|NCT03241485|Morphine|morphine|mesh-list
25764487|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25764488|NCT03241485|Narcotics|narcotics|mesh-ancestor
25764489|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764490|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764491|NCT03241485|Analgesics|analgesics|mesh-ancestor
25764492|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
25764493|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764494|NCT03241810|Fulvestrant|fulvestrant|mesh-list
25764495|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25764496|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764497|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25764498|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25764499|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25764500|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764501|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764502|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
25764503|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25764504|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764505|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25764506|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25764507|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851573|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851576|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24851577|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25007689|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764508|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25764509|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764510|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25764511|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25764512|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764513|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25764514|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764515|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
25764516|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25764517|NCT03242408|Testosterone|testosterone|mesh-list
25764518|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
25764519|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
25764520|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25764521|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764522|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
25764523|NCT03242408|Hormones|hormones|mesh-ancestor
25764524|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764525|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764526|NCT03242408|Androgens|androgens|mesh-ancestor
25764527|NCT03242434|Mannitol|mannitol|mesh-list
25764528|NCT03242434|Lactulose|lactulose|mesh-list
25764529|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25764530|NCT03242434|Diuretics|diuretics|mesh-ancestor
25764531|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
25764532|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764533|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764534|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
25764535|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25764536|NCT03242590|Testosterone|testosterone|mesh-list
25764537|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
25764538|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
25764539|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25764540|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764541|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
25764542|NCT03242590|Hormones|hormones|mesh-ancestor
25764543|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764544|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764545|NCT03242590|Androgens|androgens|mesh-ancestor
25764546|NCT03242759|Pirfenidone|pirfenidone|mesh-list
25764547|NCT03242759|Nintedanib|nintedanib|mesh-list
25764548|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764549|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25764550|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764551|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764552|NCT03242759|Analgesics|analgesics|mesh-ancestor
25764553|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
25764554|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764555|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764556|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25764557|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25764558|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764559|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25764560|NCT03243630|Menthol|menthol|mesh-list
25764561|NCT03243630|Nicotine|nicotine|mesh-list
25764562|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25764563|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
25764564|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764565|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764566|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25764567|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25764568|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
25764569|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764570|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764571|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
24851636|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24851637|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24851638|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24496229|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
24560368|NCT02813824|Aspirin|aspirin|mesh-list
25764572|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
25764573|NCT03244618|Fluorides|fluorides|mesh-list
25764574|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
25764575|NCT03244618|Protective Agents|protective agents|mesh-ancestor
25764576|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764577|NCT03245398|Mebendazole|mebendazole|mesh-list
25764578|NCT03245398|Piperazine|piperazine|mesh-list
25764579|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
25764580|NCT03245398|DMP 777|dmp 777|mesh-list
25764581|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
25764582|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
25764583|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25764584|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764585|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
25764586|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
25764587|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
25764588|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764589|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764590|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764591|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
25764592|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25764593|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
25764594|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764595|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
25764596|NCT03245463|Protective Agents|protective agents|mesh-ancestor
25764597|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
25764598|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25764599|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764600|NCT03245762|Oxytocin|oxytocin|mesh-list
25764601|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
25764602|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25764603|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764604|NCT03246152|Bevacizumab|bevacizumab|mesh-list
25764605|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25764606|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764607|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25764608|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25764609|NCT03246152|Growth Substances|growth substances|mesh-ancestor
25764610|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764611|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
25764612|NCT03246724|Midazolam|midazolam|mesh-list
25764613|NCT03246724|Triazolam|triazolam|mesh-list
25764614|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25764615|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25764616|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764617|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764618|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25764619|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25764620|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25764621|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25764622|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
25764623|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
25764624|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
25764625|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
25764626|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764627|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764628|NCT03247673|Bevacizumab|bevacizumab|mesh-list
25764629|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25764630|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764631|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25764632|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25764633|NCT03247673|Growth Substances|growth substances|mesh-ancestor
25764634|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764635|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25764636|NCT03247738|Cangrelor|cangrelor|mesh-list
25764637|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25764638|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25764639|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25764640|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25764641|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
25764642|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764643|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764644|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764645|NCT03247790|Lasmiditan|lasmiditan|mesh-list
25764646|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25764647|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
25764648|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764649|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764650|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764651|NCT03248947|Buprenorphine|buprenorphine|mesh-list
25764652|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25764654|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25764655|NCT03248947|Narcotics|narcotics|mesh-ancestor
25764656|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764657|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764658|NCT03248947|Analgesics|analgesics|mesh-ancestor
25764659|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
25764660|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764661|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25764662|NCT03249272|Adenosine|adenosine|mesh-list
25764663|NCT03249272|Regadenoson|regadenoson|mesh-list
25764664|NCT03249272|Analgesics|analgesics|mesh-ancestor
25764665|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
25764666|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764667|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764668|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25764669|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
25764670|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25764671|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
25764672|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
25764673|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764674|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764675|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25764676|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25764677|NCT03249909|Laxatives|laxatives|mesh-ancestor
25764678|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764679|NCT03249935|Azithromycin|azithromycin|mesh-list
25764680|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25764681|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764682|NCT03250182|Budesonide|budesonide|mesh-list
25764683|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
25764684|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
25764685|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25764686|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25764687|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
25764688|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764689|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764690|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25764691|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
25764692|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
25764693|NCT03250182|Hormones|hormones|mesh-ancestor
25764694|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764695|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25764696|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25764697|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25764698|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764699|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764700|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764701|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25764702|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25764703|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25764704|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
25764705|NCT03251482|Apixaban|apixaban|mesh-list
25764706|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25764707|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
25764708|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25764709|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764710|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764711|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764712|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
25764713|NCT03251963|Enoxaparin|enoxaparin|mesh-list
24565450|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565451|NCT00780637|Bradykinin|bradykinin|mesh-list
24445351|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
24445354|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445355|NCT00301392|Pitavastatin|pitavastatin|mesh-list
24445356|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24445359|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
25764714|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
25764715|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
25764716|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25764717|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25764718|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764719|NCT03252015|Lasmiditan|lasmiditan|mesh-list
25764720|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25764721|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
25764722|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764723|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764724|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764725|NCT03252353|Octreotide|octreotide|mesh-list
25764726|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25764727|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25764728|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764729|NCT03253094|Fluconazole|fluconazole|mesh-list
25764730|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
25764731|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
25764732|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764733|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25764734|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25764735|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764736|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764737|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25764738|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
25764739|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764740|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764741|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25764742|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25764743|NCT03254108|Tolvaptan|tolvaptan|mesh-list
25764744|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25764745|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764746|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
25764747|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764748|NCT03254134|Warfarin|warfarin|mesh-list
25764749|NCT03254134|Dabigatran|dabigatran|mesh-list
25764750|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
25764751|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
25764752|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25764753|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764754|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764755|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764756|NCT03254147|Warfarin|warfarin|mesh-list
25764757|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
25764758|NCT03254147|Dabigatran|dabigatran|mesh-list
25764759|NCT03254147|Apixaban|apixaban|mesh-list
25764760|NCT03254147|Edoxaban|edoxaban|mesh-list
25764761|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
25764762|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25764763|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
25764764|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25764765|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764766|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764767|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764768|NCT03254459|Morphine|morphine|mesh-list
25764769|NCT03254459|Oxycodone|oxycodone|mesh-list
25764770|NCT03254459|Buprenorphine|buprenorphine|mesh-list
25764771|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25764772|NCT03254459|Narcotics|narcotics|mesh-ancestor
25764773|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764774|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764775|NCT03254459|Analgesics|analgesics|mesh-ancestor
25764776|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
25764777|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764778|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25764779|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25764780|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25109926|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109927|NCT03121222|Protective Agents|protective agents|mesh-ancestor
25109928|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109929|NCT03121222|Antidotes|antidotes|mesh-ancestor
24893233|NCT04452929|Calcitonin|calcitonin|mesh-list
25274146|NCT02380313|Prednisone|prednisone|mesh-list
25274147|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274149|NCT02380313|Hormones|hormones|mesh-ancestor
24445413|NCT00301535|Analgesics|analgesics|mesh-ancestor
24445424|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
25764781|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25764782|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
25764783|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764784|NCT03255824|Fentanyl|fentanyl|mesh-list
25764785|NCT03255824|Midazolam|midazolam|mesh-list
25764786|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
25764787|NCT03255824|Propofol|propofol|mesh-list
25764788|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25764789|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764790|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764791|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25764792|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
25764793|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
25764794|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25764795|NCT03255824|Analgesics|analgesics|mesh-ancestor
25764796|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
25764797|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764798|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25764799|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25764800|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25764801|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764802|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764803|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764804|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25764805|NCT03255824|Narcotics|narcotics|mesh-ancestor
25764806|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25764807|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25764808|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25764809|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25764810|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
25764811|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
25764812|NCT03256136|Carboplatin|carboplatin|mesh-list
25764813|NCT03256136|Nivolumab|nivolumab|mesh-list
25764814|NCT03256136|Pemetrexed|pemetrexed|mesh-list
25764815|NCT03256136|Ipilimumab|ipilimumab|mesh-list
25764816|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25764817|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25764818|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25764819|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764820|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764821|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25764822|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25764823|NCT03256162|Midazolam|midazolam|mesh-list
25764824|NCT03256162|Ketamine|ketamine|mesh-list
25764825|NCT03256162|Analgesics|analgesics|mesh-ancestor
25764826|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
25764827|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764828|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764829|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25764830|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25764831|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
25764832|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
25764833|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764834|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25764835|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25764836|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764837|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764838|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25764839|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25764840|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25764841|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25764842|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497619|NCT00510705|Metformin|metformin|mesh-list
24851932|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24851933|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24851934|NCT02259855|Interferons|interferons|mesh-list
24851947|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851948|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851949|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24851950|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
24851952|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24851953|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25764843|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
25764844|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
25764845|NCT03256253|Pregabalin|pregabalin|mesh-list
25764846|NCT03256253|Analgesics|analgesics|mesh-ancestor
25764847|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
25764848|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764849|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764850|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
25764851|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25764852|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764853|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764854|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25764855|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25764856|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25764857|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25764858|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25764859|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
25764860|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25764861|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25764862|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25764863|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
25764864|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764865|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764866|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764867|NCT03256695|Albuterol|albuterol|mesh-list
25764868|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25764869|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
25764870|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25764871|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764872|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25764873|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
25764874|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
25764875|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25764876|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25764877|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25764878|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25764879|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764880|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764881|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764882|NCT03256799|Ivacaftor|ivacaftor|mesh-list
25764883|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25764884|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764885|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776708|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776709|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776710|NCT03793556|Omeprazole|omeprazole|mesh-list
25776711|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25776712|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776713|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25776714|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776715|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776716|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25776717|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25776718|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25776719|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25776720|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25776721|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25776722|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25776723|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
25776724|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776725|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776726|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776727|NCT03792672|Ketamine|ketamine|mesh-list
25776728|NCT03792672|Analgesics|analgesics|mesh-ancestor
25776729|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
25776730|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776731|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776732|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25776733|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24852074|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852174|NCT02261064|Amlodipine|amlodipine|mesh-list
24812360|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
24852203|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852227|NCT02261129|Telmisartan|telmisartan|mesh-list
25776734|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
25764886|NCT03257202|Clindamycin|clindamycin|mesh-list
25764887|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
25764888|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
25764889|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25764890|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25764891|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764892|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25764893|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764894|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764895|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
25764896|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25764897|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25764898|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764899|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25764900|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
25764901|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764902|NCT03257813|Timolol|timolol|mesh-list
25764903|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25764904|NCT03257813|Dorzolamide|dorzolamide|mesh-list
25764905|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25764906|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25764907|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
25764908|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764909|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764910|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764911|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25764912|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25764913|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25764914|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25764915|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25764916|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25764917|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764918|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
25764919|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
25764920|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764921|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764922|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764923|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
25764924|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
25764925|NCT03257995|Maleic acid|maleic acid|mesh-list
25764926|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764927|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764928|NCT03258645|Dabigatran|dabigatran|mesh-list
25764929|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
25764930|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25764931|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764932|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764933|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764934|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
25764935|NCT03258710|Tenofovir|tenofovir|mesh-list
25764936|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
25764937|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764938|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25764939|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25764940|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764941|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764942|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25764943|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25764944|NCT03258762|Leucovorin|leucovorin|mesh-list
25764945|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
25764946|NCT03258762|Calcium|calcium|mesh-list
25764947|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
25764948|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25764949|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764950|NCT03258762|Antidotes|antidotes|mesh-ancestor
25764951|NCT03258762|Protective Agents|protective agents|mesh-ancestor
25764952|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
24673939|NCT01341262|Melphalan|melphalan|mesh-list
24852326|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24852327|NCT02262143|Fenofibrate|fenofibrate|mesh-list
24852328|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24852329|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24852330|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
24852341|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852342|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764953|NCT03258762|Vitamins|vitamins|mesh-ancestor
25764954|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
25764955|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
25764956|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25764957|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25764958|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25764959|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25764960|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764961|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764962|NCT03259490|Metformin|metformin|mesh-list
25764963|NCT03259490|Empagliflozin|empagliflozin|mesh-list
25764964|NCT03259490|Linagliptin|linagliptin|mesh-list
25764965|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25764966|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764967|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25764968|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764969|NCT03259490|Incretins|incretins|mesh-ancestor
25764970|NCT03259490|Hormones|hormones|mesh-ancestor
25764971|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25764972|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25764973|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
25764974|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25764975|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
25764976|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
25764977|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764978|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764979|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764980|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
25764981|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
25764982|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
25764983|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25764984|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764985|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25764986|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25764987|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764988|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25764989|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25764990|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25764991|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25764992|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
25764993|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25764994|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25764995|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
25764996|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25764997|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
25764998|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25764999|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25765000|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25765001|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765002|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765003|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
25765004|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765005|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765006|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25765007|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765008|NCT03261336|Vitamin D|vitamin d|mesh-list
25765009|NCT03261336|Calcitriol|calcitriol|mesh-list
25765010|NCT03261336|Ketoconazole|ketoconazole|mesh-list
25765011|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
25765012|NCT03261336|Vitamins|vitamins|mesh-ancestor
25765013|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
25765014|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765015|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25765016|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25765017|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25765018|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
25765019|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765020|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25765021|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25765022|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765023|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765024|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25765025|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
25765026|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765027|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25765028|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25765029|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765030|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25765031|NCT03261999|Leuprolide|leuprolide|mesh-list
25765032|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25765033|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
25765034|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25765035|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765036|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25765037|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765038|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25765039|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765040|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765041|NCT03262038|Ondansetron|ondansetron|mesh-list
25765042|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
25765043|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
25765044|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765045|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765046|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765047|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
25765048|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765049|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25765050|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
25765051|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765052|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765053|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25765054|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25765055|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765056|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25765057|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25765058|NCT03262233|Nicotine|nicotine|mesh-list
25765059|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25765060|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
25765061|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765062|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765063|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25765064|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25765065|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
25765066|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765067|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765068|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25765069|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25765070|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765071|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
25765072|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25765073|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765074|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25765075|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
25765076|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25765077|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765078|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765079|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765080|NCT03263442|Thiamine|thiamine|mesh-list
25765081|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
25765082|NCT03263442|Vitamins|vitamins|mesh-ancestor
25765083|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
25765084|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765085|NCT03264066|Atezolizumab|atezolizumab|mesh-list
25765086|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25765087|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765088|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
25765089|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765090|NCT03264157|Vaccines|vaccines|mesh-list
25765091|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
25765092|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928476|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
24928490|NCT04121533|Vitamin D|vitamin d|mesh-list
25013057|NCT03752307|Prednisone|prednisone|mesh-list
24928637|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
24928647|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24624694|NCT01077726|Capecitabine|capecitabine|mesh-list
24527624|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
24527625|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25765093|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25765094|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25765095|NCT03266419|Rocuronium|rocuronium|mesh-list
25765096|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25765097|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25765098|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25765099|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765100|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765101|NCT03267576|Metformin|metformin|mesh-list
25765102|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25765103|NCT03267576|Canagliflozin|canagliflozin|mesh-list
25765104|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765105|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765106|NCT03267576|Incretins|incretins|mesh-ancestor
25765107|NCT03267576|Hormones|hormones|mesh-ancestor
25765108|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765109|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25765110|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
25765111|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765112|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765113|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25765114|NCT03267940|Atezolizumab|atezolizumab|mesh-list
25765115|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765116|NCT03268941|Metoclopramide|metoclopramide|mesh-list
25765117|NCT03268941|Maleic acid|maleic acid|mesh-list
25765118|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765119|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765120|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
25765121|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
25765122|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765123|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765124|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765125|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25765126|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25765127|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
25765128|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765129|NCT03269435|Metoclopramide|metoclopramide|mesh-list
25765130|NCT03269435|Bupivacaine|bupivacaine|mesh-list
25765131|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765132|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
25765133|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765134|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765135|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
25765136|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765137|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
25765138|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
25765139|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765140|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25765141|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25765142|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
25765143|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765144|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765145|NCT03269552|Rituximab|rituximab|mesh-list
25765146|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25765147|NCT03269552|Antibodies|antibodies|mesh-list
25765148|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
25765149|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25765150|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
25765151|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765152|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765153|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25765154|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25765155|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25765156|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25765157|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
25765158|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765159|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25765160|NCT03270332|Albuterol|albuterol|mesh-list
25765161|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25765162|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
25765163|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765164|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765165|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765166|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765167|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
25765168|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25765169|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25765170|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25765171|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25765172|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
25765173|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765174|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765175|NCT03270514|Bupivacaine|bupivacaine|mesh-list
25765176|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765177|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
25765178|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765179|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765180|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
25765181|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765182|NCT03270644|Propranolol|propranolol|mesh-list
25765184|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25765185|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25765186|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
25765187|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765188|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765189|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765190|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25765191|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25765192|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
25765193|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25765194|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
25765195|NCT03271528|Lacosamide|lacosamide|mesh-list
25765196|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
25765197|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25765198|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25765199|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765200|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765201|NCT03273257|Riociguat|riociguat|mesh-list
25765202|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
25765203|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765204|NCT03273387|Trimetazidine|trimetazidine|mesh-list
25765205|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
25765206|NCT03273946|Fluticasone|fluticasone|mesh-list
25765207|NCT03273946|Xhance|xhance|mesh-list
25765208|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25765209|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25765210|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
25765211|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765212|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765213|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765214|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765215|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765216|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25765217|NCT03274076|Tofacitinib|tofacitinib|mesh-list
25765218|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25765219|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765220|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765221|NCT03274453|Ketamine|ketamine|mesh-list
25765222|NCT03274453|Analgesics|analgesics|mesh-ancestor
25765223|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
25765224|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765225|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765226|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25765227|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25765228|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
25765229|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
25765230|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765231|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25765232|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25765233|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765234|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765235|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24455597|NCT00328029|Busulfan|busulfan|mesh-list
24455778|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
24455868|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24937988|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
24456711|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
25765236|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765237|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
25765238|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
25765239|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25765240|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25765241|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765242|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765243|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765244|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25765245|NCT03276026|Neostigmine|neostigmine|mesh-list
25765246|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25765247|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765248|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765249|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
25765250|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765251|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765252|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25765253|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
25765254|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765255|NCT03276078|Bromides|bromides|mesh-list
25765256|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
25765257|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25765258|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
25765259|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765260|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765261|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765262|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765263|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25765264|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25765265|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25765266|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
25765267|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765268|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765269|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
25776735|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
25776736|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776737|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25776738|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25776739|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776740|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776741|NCT03792191|Fentanyl|fentanyl|mesh-list
25776742|NCT03792191|Bupivacaine|bupivacaine|mesh-list
25776743|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
25776744|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
25776745|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776746|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776747|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
25776748|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776749|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25776750|NCT03792191|Narcotics|narcotics|mesh-ancestor
25776751|NCT03792191|Analgesics|analgesics|mesh-ancestor
25776752|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25776753|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25776754|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
25776755|NCT03789175|Niacinamide|niacinamide|mesh-list
25776756|NCT03789175|Niacin|niacin|mesh-list
25776757|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
25776758|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
25776759|NCT03789175|Vitamins|vitamins|mesh-ancestor
25776760|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
25776761|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776762|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25776763|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
25776764|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776765|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25776766|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
25776767|NCT03783702|Acetaminophen|acetaminophen|mesh-list
25776768|NCT03783702|Ibuprofen|ibuprofen|mesh-list
25776769|NCT03783702|Oxycodone|oxycodone|mesh-list
24539701|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24763659|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856275|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
25765270|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25765272|NCT03276975|Coagulants|coagulants|mesh-ancestor
25765273|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
25765274|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25765275|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765276|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25765277|NCT03278106|Trifluridine|trifluridine|mesh-list
25765278|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
25765279|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765280|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
25765281|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765282|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25765283|NCT03278886|Naltrexone|naltrexone|mesh-list
25765284|NCT03278886|Nalmefene|nalmefene|mesh-list
25765285|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25765286|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25765287|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765288|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
25765289|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765290|NCT03279237|Leucovorin|leucovorin|mesh-list
25765291|NCT03279237|Paclitaxel|paclitaxel|mesh-list
25765292|NCT03279237|Carboplatin|carboplatin|mesh-list
25765293|NCT03279237|Fluorouracil|fluorouracil|mesh-list
25765294|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
25765295|NCT03279237|Irinotecan|irinotecan|mesh-list
25765296|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25765297|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765298|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25765299|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25765300|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25765301|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765302|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
25765303|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25765304|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25765305|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
25765306|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765307|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25765308|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25765309|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765310|NCT03279237|Antidotes|antidotes|mesh-ancestor
25765311|NCT03279237|Protective Agents|protective agents|mesh-ancestor
25765312|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
25765313|NCT03279237|Vitamins|vitamins|mesh-ancestor
25765314|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
25765315|NCT03279731|Liraglutide|liraglutide|mesh-list
25765316|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765317|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765318|NCT03279731|Incretins|incretins|mesh-ancestor
25765319|NCT03279731|Hormones|hormones|mesh-ancestor
25765320|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765321|NCT03280537|Omalizumab|omalizumab|mesh-list
25765322|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25765323|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765324|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765325|NCT03280550|Omalizumab|omalizumab|mesh-list
25765326|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25765327|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765328|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765329|NCT03281200|Nintedanib|nintedanib|mesh-list
25765330|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
25765331|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
25765332|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765333|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765334|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
25765335|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
25765336|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25765337|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25765338|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
25765339|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765340|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765341|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765342|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765343|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25765344|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765345|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
25765346|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765347|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25765348|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
25765349|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
25765350|NCT03282357|Protective Agents|protective agents|mesh-ancestor
25765351|NCT03282591|Serlopitant|serlopitant|mesh-list
25765352|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25765353|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765354|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765355|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765356|NCT03283436|Bupivacaine|bupivacaine|mesh-list
25765357|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765358|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
25765359|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765360|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765361|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
25765362|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765363|NCT03283696|Doxorubicin|doxorubicin|mesh-list
25765364|NCT03283696|Ifosfamide|ifosfamide|mesh-list
25765365|NCT03283696|Olaratumab|olaratumab|mesh-list
25765366|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25765367|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765368|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25765369|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25765370|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765371|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765372|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25765373|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
25765374|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
25765375|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
25765376|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765377|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
25765378|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765379|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765380|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
25765381|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765382|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765383|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
25765384|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25765385|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765386|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765387|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25765388|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765389|NCT03285646|Fasinumab|fasinumab|mesh-list
25765390|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25765391|NCT03285646|Analgesics|analgesics|mesh-ancestor
25765392|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
25765393|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765394|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765395|NCT03285984|Listerine|listerine|mesh-list
25765396|NCT03285984|Fluorides|fluorides|mesh-list
25765397|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
25765398|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
25765399|NCT03285984|Protective Agents|protective agents|mesh-ancestor
25765400|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765401|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25765402|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765403|NCT03286218|Alprazolam|alprazolam|mesh-list
25765404|NCT03286218|Lasmiditan|lasmiditan|mesh-list
25765405|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25765406|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765407|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765408|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25765409|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25765410|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25765411|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
25765412|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
24546846|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24546847|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24546848|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765413|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765414|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765415|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25765417|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
25765418|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765419|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765420|NCT03286829|Metoprolol|metoprolol|mesh-list
25765421|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25765422|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25765423|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
25765424|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
25765425|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765426|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765427|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25765428|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25765429|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25765430|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
25765431|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765432|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765433|NCT03287219|Methylene Blue|methylene blue|mesh-list
25765434|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765435|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765436|NCT03287310|Albuterol|albuterol|mesh-list
25765437|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25765438|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
25765439|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765440|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765441|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765442|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765443|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
25765444|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25765445|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25765446|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25765447|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25765448|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
25765449|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765450|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765451|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25765452|NCT03287635|Hormones|hormones|mesh-ancestor
25765453|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765454|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765455|NCT03287674|Vidarabine|vidarabine|mesh-list
25765456|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
25765457|NCT03287674|Nivolumab|nivolumab|mesh-list
25765458|NCT03287674|Fludarabine|fludarabine|mesh-list
25765459|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
25765460|NCT03287674|Ipilimumab|ipilimumab|mesh-list
25765461|NCT03287674|Interleukin-2|interleukin-2|mesh-list
25765462|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25765463|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
25765464|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765465|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25765466|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25765467|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
25765468|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765469|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765470|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25765471|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25765472|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25765473|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25765474|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
25765475|NCT03287674|Antiviral Agents|antiviral agents|mesh-ancestor
25765476|NCT03287674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765477|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25765478|NCT03287674|Analgesics|analgesics|mesh-ancestor
25765479|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
25765480|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765481|NCT03287791|Azelaic acid|azelaic acid|mesh-list
25765482|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
25765483|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25765484|NCT03287791|Protective Agents|protective agents|mesh-ancestor
25765485|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765486|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765487|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765488|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
25765489|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
25765490|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765491|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765492|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765493|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
25765494|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
25765495|NCT03288987|Leucovorin|leucovorin|mesh-list
25765496|NCT03288987|Bevacizumab|bevacizumab|mesh-list
25765497|NCT03288987|Fluorouracil|fluorouracil|mesh-list
25765498|NCT03288987|Irinotecan|irinotecan|mesh-list
25765499|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25765500|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765501|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25765502|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25765503|NCT03288987|Growth Substances|growth substances|mesh-ancestor
25765504|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765505|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
25765506|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
25765507|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765508|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25765509|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25765510|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
25765511|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25765512|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25765513|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765514|NCT03288987|Antidotes|antidotes|mesh-ancestor
25765515|NCT03288987|Protective Agents|protective agents|mesh-ancestor
25765516|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
25765517|NCT03288987|Vitamins|vitamins|mesh-ancestor
25765518|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
25765519|NCT03289208|Edaravone|edaravone|mesh-list
25765520|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25765521|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
25765522|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765523|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25765524|NCT03289208|Protective Agents|protective agents|mesh-ancestor
25765525|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765526|NCT03289234|Edaravone|edaravone|mesh-list
25765527|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25765528|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
25765529|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765530|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25765531|NCT03289234|Protective Agents|protective agents|mesh-ancestor
25765532|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765533|NCT03289533|Avelumab|avelumab|mesh-list
25765534|NCT03289533|Axitinib|axitinib|mesh-list
25765535|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25765536|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765537|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25765538|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765539|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765540|NCT03289676|Nicotine|nicotine|mesh-list
25765541|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25765542|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
25765543|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765544|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765545|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25765546|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25765547|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
25765548|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765549|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765550|NCT03289858|Bupivacaine|bupivacaine|mesh-list
25765551|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765552|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
25765553|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765554|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765555|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
25765556|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765557|NCT03290027|Tazarotene|tazarotene|mesh-list
25765558|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765559|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
25765560|NCT03290378|Tramadol|tramadol|mesh-list
25765561|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25765562|NCT03290378|Narcotics|narcotics|mesh-ancestor
25765563|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765564|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765565|NCT03290378|Analgesics|analgesics|mesh-ancestor
25765566|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
25765567|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765568|NCT03291080|Tretinoin|tretinoin|mesh-list
25765569|NCT03291080|Isotretinoin|isotretinoin|mesh-list
25765570|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765571|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
25765572|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765573|NCT03291197|Bupivacaine|bupivacaine|mesh-list
25765574|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765575|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
25765576|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765577|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765578|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
25765579|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765580|NCT03291288|Tolbutamide|tolbutamide|mesh-list
25765581|NCT03291288|Midazolam|midazolam|mesh-list
25765582|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25765583|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25765584|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765585|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765586|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25765587|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25765588|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25765589|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25765590|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
25765591|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
25765592|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
25765593|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
25765594|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765595|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765596|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765597|NCT03292016|Apomorphine|apomorphine|mesh-list
25765598|NCT03292016|Emetics|emetics|mesh-ancestor
25765599|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765600|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
25765601|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765602|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765603|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
25765604|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
25765605|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765606|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765607|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
25765608|NCT03292640|Tazarotene|tazarotene|mesh-list
25765609|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765610|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
25765611|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
25765612|NCT03292640|Vitamins|vitamins|mesh-ancestor
25765613|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
25765614|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765615|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25765616|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25765617|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765618|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765619|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776770|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776771|NCT03783702|Analgesics|analgesics|mesh-ancestor
25776772|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
25765620|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25765621|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25765622|NCT03293485|Imipenem|imipenem|mesh-list
25765623|NCT03293485|Relebactam|relebactam|mesh-list
25765624|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25765625|NCT03293485|Cilastatin|cilastatin|mesh-list
25765626|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25765627|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765628|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
25765629|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765630|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765631|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25765632|NCT03293654|Bevacizumab|bevacizumab|mesh-list
25765633|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25765634|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765635|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25765636|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25765637|NCT03293654|Growth Substances|growth substances|mesh-ancestor
25765638|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765639|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
25765640|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25765641|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25765642|NCT03294538|Estradiol|estradiol|mesh-list
25765643|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25765644|NCT03294538|Estrogens|estrogens|mesh-ancestor
25765645|NCT03294538|Hormones|hormones|mesh-ancestor
25765646|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765647|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765648|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25765649|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
25765650|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25765651|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25765652|NCT03294850|Cholic Acids|cholic acids|mesh-list
25765653|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765654|NCT03295721|Bupivacaine|bupivacaine|mesh-list
25765655|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765656|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
25765657|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765658|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765659|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
25765660|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765661|NCT03296072|Listerine|listerine|mesh-list
25765662|NCT03296072|Fluorides|fluorides|mesh-list
25765663|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
25765664|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
25765665|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
25765666|NCT03296072|Protective Agents|protective agents|mesh-ancestor
25765667|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765668|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25765669|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765670|NCT03296163|Paclitaxel|paclitaxel|mesh-list
25765671|NCT03296163|Bevacizumab|bevacizumab|mesh-list
25765672|NCT03296163|Carboplatin|carboplatin|mesh-list
25765673|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25765674|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765675|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25765676|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25765677|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25765678|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765679|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25765680|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25765681|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25765682|NCT03296163|Growth Substances|growth substances|mesh-ancestor
25765683|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765684|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
25765685|NCT03296345|Ketamine|ketamine|mesh-list
24451882|NCT00325104|Calcium|calcium|mesh-list
24451525|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
24451526|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765686|NCT03296345|Analgesics|analgesics|mesh-ancestor
25765687|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
25765688|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765689|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765690|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25765692|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
25765693|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
25765694|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765695|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25765696|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25765697|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765698|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765699|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25765700|NCT03296527|Hormones|hormones|mesh-ancestor
25765701|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765702|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765703|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
25765704|NCT03296800|Rifampin|rifampin|mesh-list
25765705|NCT03296800|Probenecid|probenecid|mesh-list
25765706|NCT03296800|Verapamil|verapamil|mesh-list
25765707|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25765708|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
25765709|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25765710|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765711|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
25765712|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25765713|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765714|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765715|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25765716|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25765717|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25765718|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25765719|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25765720|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25765721|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25765722|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25765723|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765724|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25765725|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765726|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
25765727|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
25765728|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
25765729|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25765730|NCT03296800|Renal Agents|renal agents|mesh-ancestor
25765731|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765732|NCT03297021|Ondansetron|ondansetron|mesh-list
25765733|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
25765734|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
25765735|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765736|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765737|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765738|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
25765739|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765740|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25765741|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
25765742|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765743|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765744|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25765745|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25765746|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765747|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25765748|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25765749|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25765750|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25765751|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25765752|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
25765753|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765754|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765755|NCT03297216|Progestins|progestins|mesh-ancestor
25765756|NCT03297216|Hormones|hormones|mesh-ancestor
25765757|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
25765758|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
24701383|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765760|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25765761|NCT03297398|Hormones|hormones|mesh-ancestor
25765762|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765763|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765764|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
25765765|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765766|NCT03297398|Protective Agents|protective agents|mesh-ancestor
25765767|NCT03297398|Vitamins|vitamins|mesh-ancestor
25765768|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
25765769|NCT03297398|Estrogens|estrogens|mesh-ancestor
25765770|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25765771|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765772|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
25765773|NCT03297944|Zolpidem|zolpidem|mesh-list
25765774|NCT03297944|Alprazolam|alprazolam|mesh-list
25765775|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25765776|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25765777|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765778|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765779|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25765780|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
25765781|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
25765782|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765783|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765784|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25765785|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25765786|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25765787|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
25765788|NCT03298113|Protective Agents|protective agents|mesh-list
25765789|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765790|NCT03298412|Blinatumomab|blinatumomab|mesh-list
25765791|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765792|NCT03299244|Cinacalcet|cinacalcet|mesh-list
25765793|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25765794|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765795|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25765796|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
25765797|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765798|NCT03300570|Dolcanatide|dolcanatide|mesh-list
25765799|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25765800|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
25765801|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765802|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765803|NCT03300674|Lidocaine|lidocaine|mesh-list
25765804|NCT03300674|Hydromorphone|hydromorphone|mesh-list
25765805|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765806|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
25765807|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765808|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765809|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
25765810|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765811|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25765812|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25765813|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25765814|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765815|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765816|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25765817|NCT03300674|Narcotics|narcotics|mesh-ancestor
25765818|NCT03300674|Analgesics|analgesics|mesh-ancestor
25765819|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25765820|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25765821|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25765822|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011007|NCT02424851|Dexamethasone|dexamethasone|mesh-list
25765823|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765824|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25765825|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765826|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765828|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765829|NCT03301649|Ivermectin|ivermectin|mesh-list
25765830|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25765831|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765832|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
25765833|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25765834|NCT03302559|Vitamin A|vitamin a|mesh-list
25765835|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
25765836|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
25765837|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25765838|NCT03302559|Protective Agents|protective agents|mesh-ancestor
25765839|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765840|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765841|NCT03302559|Vitamins|vitamins|mesh-ancestor
25765842|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
25765843|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
25765844|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765845|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25765846|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765847|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
25765848|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25765849|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765850|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765851|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
25765852|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765853|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765854|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25765855|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
25765856|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765857|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25765858|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
25765859|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765860|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25765861|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
25765862|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765863|NCT03303196|Pancrelipase|pancrelipase|mesh-list
25765864|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25765865|NCT03303794|Bupivacaine|bupivacaine|mesh-list
25765866|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765867|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
25765868|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765869|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765870|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
25765871|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765872|NCT03304054|Amifampridine|amifampridine|mesh-list
25765873|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25765874|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765875|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765876|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25765877|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765878|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765879|NCT03304626|Prednisone|prednisone|mesh-list
25765880|NCT03304626|Budesonide|budesonide|mesh-list
25765881|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25765882|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
25765883|NCT03304626|Hormones|hormones|mesh-ancestor
25765884|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25765885|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765886|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25765887|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765888|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25765889|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
25765890|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635486|NCT01139723|Bevacizumab|bevacizumab|mesh-list
25011127|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
25765891|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25765892|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
25765893|NCT03304873|Retapamulin|retapamulin|mesh-list
25765894|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25765895|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765896|NCT03305081|Copper|copper|mesh-list
25765897|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
25765898|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25765899|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
25765900|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25765901|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765902|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25765903|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25765904|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25765905|NCT03305081|Trace Elements|trace elements|mesh-ancestor
25765906|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
25765907|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
25765908|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25765909|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
25765910|NCT03305159|Povidone|povidone|mesh-list
25765911|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25765912|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765913|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
25765914|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25765915|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
25765916|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
25765917|NCT03305575|Bupivacaine|bupivacaine|mesh-list
25765918|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
25765919|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765920|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
25765921|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765922|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765923|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
25765924|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765925|NCT03305666|Bupivacaine|bupivacaine|mesh-list
25765926|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765927|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
25765928|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765929|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765930|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
25765931|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765932|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
25765933|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765934|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765935|NCT03306589|Molgramostim|molgramostim|mesh-list
25765936|NCT03306589|Sargramostim|sargramostim|mesh-list
25765937|NCT03306589|Cantharidin|cantharidin|mesh-list
25765938|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
25765939|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765940|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765941|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765942|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765943|NCT03307005|Zolpidem|zolpidem|mesh-list
25765944|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25765945|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25765946|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765947|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765948|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25765949|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
25765950|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
25765951|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25765952|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776773|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776774|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776775|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
25011240|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25011241|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25011242|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24826015|NCT02131688|Analgesics|analgesics|mesh-ancestor
25776776|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25765954|NCT03307174|Bupivacaine|bupivacaine|mesh-list
25765955|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
25765956|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
25765957|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25765958|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765959|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
25765960|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25765961|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25765962|NCT03307174|Narcotics|narcotics|mesh-ancestor
25765963|NCT03307174|Analgesics|analgesics|mesh-ancestor
25765964|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25765965|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25765966|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
25765967|NCT03307252|Metformin|metformin|mesh-list
25765968|NCT03307252|Rifampin|rifampin|mesh-list
25765969|NCT03307252|Probenecid|probenecid|mesh-list
25765970|NCT03307252|Digoxin|digoxin|mesh-list
25765971|NCT03307252|Verapamil|verapamil|mesh-list
25765972|NCT03307252|Furosemide|furosemide|mesh-list
25765973|NCT03307252|Cimetidine|cimetidine|mesh-list
25765974|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25765975|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25765976|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25765977|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25765978|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25765979|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
25765980|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25765981|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25765982|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25765983|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25765984|NCT03307252|Diuretics|diuretics|mesh-ancestor
25765985|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
25765986|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25765987|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25765988|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25765989|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
25765990|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25765991|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25765992|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
25765993|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25765994|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25765995|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25765996|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25765997|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25765998|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25765999|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25766000|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766001|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25766002|NCT03307252|Protective Agents|protective agents|mesh-ancestor
25766003|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25766004|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25766005|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
25766006|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
25766007|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
25766008|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25766009|NCT03307252|Renal Agents|renal agents|mesh-ancestor
25766010|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25766011|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25766012|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25766013|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
25766014|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
25766015|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766016|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25766017|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25766018|NCT03308669|Topiramate|topiramate|mesh-list
25766019|NCT03308669|Lasmiditan|lasmiditan|mesh-list
25766020|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
25766021|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25011352|NCT05215743|Antioxidants|antioxidants|mesh-list
25011353|NCT05215743|Deferoxamine|deferoxamine|mesh-list
25011354|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
25766022|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766023|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25766025|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766026|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766027|NCT03309657|Tazobactam|tazobactam|mesh-list
25766028|NCT03309657|Ceftolozane|ceftolozane|mesh-list
25766029|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25766030|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25766031|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766032|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25766033|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766034|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766035|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25766036|NCT03309657|Renal Agents|renal agents|mesh-ancestor
25766037|NCT03309943|Propranolol|propranolol|mesh-list
25766038|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25766039|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25766040|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
25766041|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766042|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766043|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766044|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766045|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25766046|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
25766047|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
25766048|NCT03310021|Apixaban|apixaban|mesh-list
25766049|NCT03310021|Edoxaban|edoxaban|mesh-list
25766050|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25766051|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
25766052|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25766053|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
25766054|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766055|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766056|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
25766057|NCT03310268|Listerine|listerine|mesh-list
25766058|NCT03310268|Fluorides|fluorides|mesh-list
25766059|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
25766060|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
25766061|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
25766062|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
25766063|NCT03310268|Protective Agents|protective agents|mesh-ancestor
25766064|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766065|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25766066|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766067|NCT03310411|Sumatriptan|sumatriptan|mesh-list
25766068|NCT03310411|Lasmiditan|lasmiditan|mesh-list
25766069|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25766070|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25766071|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25766072|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
25766073|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766074|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766075|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766076|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25766077|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25766078|NCT03310970|Lidocaine|lidocaine|mesh-list
25766079|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
25766080|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
25766081|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766082|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766083|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
25766084|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766085|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766086|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25766087|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24531617|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24531618|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766088|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766089|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766090|NCT03311646|Nicotine|nicotine|mesh-list
25766091|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25766092|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
25766093|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766094|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766095|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25766096|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25766097|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
25766098|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766099|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766100|NCT03311724|Tirzepatide|tirzepatide|mesh-list
25766101|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766102|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766103|NCT03311724|Incretins|incretins|mesh-ancestor
25766104|NCT03311724|Hormones|hormones|mesh-ancestor
25766105|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766106|NCT03311841|Rifampin|rifampin|mesh-list
25766107|NCT03311841|Midazolam|midazolam|mesh-list
25766108|NCT03311841|Dabigatran|dabigatran|mesh-list
25766109|NCT03311841|Atorvastatin|atorvastatin|mesh-list
25766110|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25766111|NCT03311841|Pitavastatin|pitavastatin|mesh-list
25766112|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25766113|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25766114|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25766115|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766116|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766117|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25766118|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766119|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766120|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25766121|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
25766122|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
25766123|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
25766124|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
25766125|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766126|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766127|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25766128|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25766129|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
25766130|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25766131|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25766132|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766133|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
25766134|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25766135|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
25766136|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
25766137|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25766138|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
25766139|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25766140|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766141|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
25766142|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25766143|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25766144|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25766145|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25766146|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25766147|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25766148|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25766149|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
25766150|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25766151|NCT03312023|Ledipasvir|ledipasvir|mesh-list
25766152|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
25766153|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766154|NCT03312114|Avelumab|avelumab|mesh-list
25766155|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25766156|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766157|NCT03312517|Suvorexant|suvorexant|mesh-list
25766158|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25766159|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25766160|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766161|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766162|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25766163|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776777|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25766164|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766165|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25766166|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
25766167|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766168|NCT03313076|Vitamin D|vitamin d|mesh-list
25766169|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
25766170|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
25766171|NCT03313076|Vitamins|vitamins|mesh-list
25766172|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
25766173|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766174|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25766175|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25766176|NCT03314662|Vaccines|vaccines|mesh-list
25766177|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25766178|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
25766179|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766180|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25766181|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
25766182|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25766183|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
25766184|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25766185|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
25766186|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766187|NCT03315559|Nemiralisib|nemiralisib|mesh-list
25766188|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25766189|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766190|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766191|NCT03315780|Dulaglutide|dulaglutide|mesh-list
25766192|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766193|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766194|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25766195|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25766196|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25766197|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766198|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766199|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766200|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766201|NCT03315793|Analgesics|analgesics|mesh-ancestor
25766202|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
25766203|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766204|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
25766205|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766206|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
25766207|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
25766208|NCT03316131|Febuxostat|febuxostat|mesh-list
25766209|NCT03316131|Verinurad|verinurad|mesh-list
25766210|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25766211|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766212|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766213|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766214|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
25766215|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25766216|NCT03316378|Ropivacaine|ropivacaine|mesh-list
25766217|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
25766218|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
25766219|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766220|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766221|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
25766222|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766223|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
25766224|NCT03316976|Lansoprazole|lansoprazole|mesh-list
25766225|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25766226|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25766227|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25766228|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766229|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766230|NCT03318315|Vaccines|vaccines|mesh-list
25766231|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
25766232|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766233|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
25766234|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25766235|NCT03319277|Narcotics|narcotics|mesh-ancestor
24586209|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
24586210|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25766236|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766237|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766238|NCT03319277|Analgesics|analgesics|mesh-ancestor
25766239|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
25766240|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766241|NCT03319719|Lidocaine|lidocaine|mesh-list
25766242|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
25766243|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
25766244|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
25766245|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766246|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766247|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
25766248|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766249|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766250|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25766251|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25766252|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766253|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766254|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25766255|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
25766256|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
25766257|NCT03319719|Protective Agents|protective agents|mesh-ancestor
25766258|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
25766259|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25766260|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25766261|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
25766262|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766263|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
25766264|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766265|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766266|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766267|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766268|NCT03320057|Mifepristone|mifepristone|mesh-list
25766269|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25766270|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
25766271|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25766272|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766273|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25766274|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25766275|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25766276|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
25766277|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25766278|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25766279|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
25766280|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766281|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
25766282|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25766283|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25766284|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
25766285|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25766286|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25766287|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25766288|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766289|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766290|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
25766291|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766292|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766293|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25766294|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766295|NCT03320941|Licogliflozin|licogliflozin|mesh-list
25766296|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25766297|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766298|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766299|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766300|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25766301|NCT03321006|Citalopram|citalopram|mesh-list
25766302|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25766303|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25766304|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766305|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766306|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766308|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766309|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25766310|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
25766311|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766312|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766313|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25766314|NCT03321006|Analgesics|analgesics|mesh-ancestor
25766315|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
25766316|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
25766317|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
25766318|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25766319|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766320|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766321|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
25766322|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766323|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766324|NCT03321396|Calcium|calcium|mesh-list
25766325|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25766326|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766327|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
25766328|NCT03322657|Neostigmine|neostigmine|mesh-list
25766329|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25766330|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766331|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766332|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
25766333|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766334|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766335|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25766336|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
25766337|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766338|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25766339|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25766340|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25766341|NCT03323164|Timolol|timolol|mesh-list
25766342|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25766343|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25766344|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25766345|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
25766346|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766347|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766348|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766349|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766350|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25766351|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25766352|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25766353|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25766354|NCT03323801|Tretinoin|tretinoin|mesh-list
25766355|NCT03323801|Isotretinoin|isotretinoin|mesh-list
25766356|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766357|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
25766358|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25766359|NCT03324451|Insulin|insulin|mesh-list
25766360|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766361|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776778|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776779|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25776780|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776781|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776782|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25776783|NCT03783702|Narcotics|narcotics|mesh-ancestor
25776784|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776785|NCT03781479|Amifampridine|amifampridine|mesh-list
25776786|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25776787|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776788|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776789|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25776790|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25776791|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776792|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
24826221|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826222|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766362|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25766363|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25766364|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25766365|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766366|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766367|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25766368|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766369|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766370|NCT03325556|Pimavanserin|pimavanserin|mesh-list
25766371|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25766372|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25766373|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25766374|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766375|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766376|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766377|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766378|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25766379|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25766380|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
25766381|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766382|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766383|NCT03325816|Nivolumab|nivolumab|mesh-list
25766384|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25766385|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25766386|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766387|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25766388|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766389|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25766390|NCT03326999|Bupivacaine|bupivacaine|mesh-list
25766391|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
25766392|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
25766393|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766394|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766395|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
25766396|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766397|NCT03327051|Omeprazole|omeprazole|mesh-list
25766398|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25766399|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25766400|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25766401|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766402|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766403|NCT03328325|Vaccines|vaccines|mesh-list
25766404|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
25766405|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766406|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
25766407|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
25766408|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
25766409|NCT03328832|Thrombin|thrombin|mesh-list
25766410|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25766411|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25766412|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766413|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
25766414|NCT03328832|Coagulants|coagulants|mesh-ancestor
25766415|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25766416|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
25766417|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25766418|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
25766419|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766420|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
25766421|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
25766422|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766423|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25766424|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25766425|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766426|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766427|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766428|NCT03328897|Omalizumab|omalizumab|mesh-list
25766429|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25766430|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25766431|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
25766432|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
25766433|NCT03329196|Hematinics|hematinics|mesh-ancestor
25766434|NCT03329209|Vedolizumab|vedolizumab|mesh-list
25766435|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25766436|NCT03329573|Paroxetine|paroxetine|mesh-list
25766437|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25766438|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25766439|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766440|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766441|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766443|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766444|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25766445|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
25766446|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766447|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25766448|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25766449|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766450|NCT03329846|Nivolumab|nivolumab|mesh-list
25766451|NCT03329846|Linrodostat|linrodostat|mesh-list
25766452|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25766453|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766454|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25766455|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766456|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766457|NCT03329911|Paclitaxel|paclitaxel|mesh-list
25766458|NCT03329911|Carboplatin|carboplatin|mesh-list
25766459|NCT03329911|Bevacizumab|bevacizumab|mesh-list
25766460|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25766461|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766462|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
25766463|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
25766464|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
25766465|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766466|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25766467|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25766468|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25766469|NCT03329911|Growth Substances|growth substances|mesh-ancestor
25766470|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766471|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
25766472|NCT03329937|Niraparib|niraparib|mesh-list
25766473|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25766474|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766475|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766476|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766477|NCT03330236|Anesthetics|anesthetics|mesh-list
25766478|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766479|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766480|NCT03330457|Betrixaban|betrixaban|mesh-list
25766481|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25766482|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
25766483|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25766484|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
25766485|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766486|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766487|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
25766488|NCT03331315|Celecoxib|celecoxib|mesh-list
25766489|NCT03331315|Ketorolac|ketorolac|mesh-list
25766490|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25766491|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25766492|NCT03331315|Analgesics|analgesics|mesh-ancestor
25766493|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
25766494|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766495|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766496|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25766497|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25766498|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25766499|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25766500|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776793|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
25166547|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
24826417|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766501|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766502|NCT03331666|Evolocumab|evolocumab|mesh-list
25766503|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25766504|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25766505|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
25766506|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766507|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25766508|NCT03331835|Brodalumab|brodalumab|mesh-list
25766509|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
25766510|NCT03331965|Metoclopramide|metoclopramide|mesh-list
25766511|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
25766512|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
25766513|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766514|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766515|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25766516|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25766517|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25766518|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
25766519|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766520|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766521|NCT03332212|Empagliflozin|empagliflozin|mesh-list
25766522|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25766523|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766524|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766525|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766526|NCT03332771|Metformin|metformin|mesh-list
25766527|NCT03332771|Glimepiride|glimepiride|mesh-list
25766528|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25766529|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766530|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766531|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766532|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25766533|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
25766534|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25766535|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766536|NCT03333109|Erenumab|erenumab|mesh-list
25766537|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25766538|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766539|NCT03333109|Analgesics|analgesics|mesh-ancestor
25766540|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
25766541|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766542|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766543|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
25766544|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766545|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766546|NCT03334721|Gabapentin|gabapentin|mesh-list
25766547|NCT03334721|Analgesics|analgesics|mesh-ancestor
25766548|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
25766549|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766550|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766551|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
25766552|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25766553|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766554|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766555|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766556|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25766557|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25766558|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766559|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766560|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
25766561|NCT03334734|Isoniazid|isoniazid|mesh-list
25766562|NCT03334734|Macozinone|macozinone|mesh-list
25766563|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
25766564|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25766565|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766566|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25766567|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25766568|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
25766569|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766570|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25766571|NCT03334747|Lumefantrine|lumefantrine|mesh-list
25766572|NCT03334747|Artemether|artemether|mesh-list
24826475|NCT02134457|Growth Substances|growth substances|mesh-ancestor
25766573|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25766574|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
25766575|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25766576|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25766577|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766578|NCT03334903|Gabapentin|gabapentin|mesh-list
25766579|NCT03334903|Analgesics|analgesics|mesh-ancestor
25766580|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
25766581|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766582|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766583|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
25766584|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25766585|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766586|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766587|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766588|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25766589|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25766590|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766591|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766592|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
25766593|NCT03336450|Midazolam|midazolam|mesh-list
25766594|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25766595|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25766596|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766597|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766598|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25766599|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766600|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766601|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25766602|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
25766603|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
25766604|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
25766605|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
25766606|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766607|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766608|NCT03336502|Posaconazole|posaconazole|mesh-list
25766609|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
25766610|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766611|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25766612|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25766613|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25766614|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25766615|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25766616|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766617|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766618|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25766619|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
25766620|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766621|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766622|NCT03336645|Midazolam|midazolam|mesh-list
25766623|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25766624|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25766625|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766626|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766627|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25766628|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766629|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766630|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25766631|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
25766632|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
25766633|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
25766634|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
25766635|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766636|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766637|NCT03336853|Hybenx|hybenx|mesh-list
25766638|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
25766639|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
25766640|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766641|NCT03337152|Chloroquine|chloroquine|mesh-list
25766642|NCT03337152|Primaquine|primaquine|mesh-list
25766643|NCT03337152|Amebicides|amebicides|mesh-ancestor
25766644|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25166565|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
25766645|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25766646|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766647|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
25766648|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25766649|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25766651|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25766652|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25766653|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
25766654|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766655|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25766656|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766657|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766658|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766659|NCT03337477|Insulin|insulin|mesh-list
25766660|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25766661|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766662|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766663|NCT03337490|Ivermectin|ivermectin|mesh-list
25766664|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25766665|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766666|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
25766667|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766668|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766669|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
25766670|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766671|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766672|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
25766673|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
25766674|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
25766675|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766676|NCT03338400|Dexamethasone|dexamethasone|mesh-list
25766677|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25766678|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
25766679|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
25766680|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766681|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766682|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25766683|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
25766684|NCT03338400|Hormones|hormones|mesh-ancestor
25766685|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766686|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25766687|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766688|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
25766689|NCT03338569|Vitamins|vitamins|mesh-ancestor
25766690|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
25766691|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766692|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
25766693|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766694|NCT03338569|Protective Agents|protective agents|mesh-ancestor
25766695|NCT03338803|Linagliptin|linagliptin|mesh-list
25766696|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766697|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766698|NCT03338803|Incretins|incretins|mesh-ancestor
25766699|NCT03338803|Hormones|hormones|mesh-ancestor
25766700|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766701|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25766702|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
25766703|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766704|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776794|NCT03783039|Coagulants|coagulants|mesh-ancestor
25776795|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25776796|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
25776797|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25776798|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
25776799|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776800|NCT03783130|Antacids|antacids|mesh-ancestor
25776801|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776802|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776803|NCT03773796|Nabilone|nabilone|mesh-list
25776804|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
25776805|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
25776806|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776807|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766706|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25766707|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766708|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766709|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766710|NCT03339297|Defibrotide|defibrotide|mesh-list
25766711|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25766712|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25766713|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766714|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25766715|NCT03339453|Glucagon|glucagon|mesh-list
25766716|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25766717|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25766718|NCT03339453|Hormones|hormones|mesh-ancestor
25766719|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766720|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766721|NCT03339453|Incretins|incretins|mesh-ancestor
25766722|NCT03339583|Zopiclone|zopiclone|mesh-list
25766723|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25766724|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766725|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766726|NCT03339726|Phenylephrine|phenylephrine|mesh-list
25766727|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
25766728|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25766729|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
25766730|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
25766731|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766732|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766733|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
25766734|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25766735|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
25766736|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
25766737|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25766738|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25766739|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25766740|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
25766741|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766742|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766743|NCT03339726|Protective Agents|protective agents|mesh-ancestor
25766744|NCT03340350|Minocycline|minocycline|mesh-list
25766745|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25766746|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766747|NCT03340961|Doxycycline|doxycycline|mesh-list
25766748|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25766749|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766750|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
25766751|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25766752|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25766753|NCT03341273|Azithromycin|azithromycin|mesh-list
25766754|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25766755|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766756|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
25766757|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766758|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766759|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
25766760|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766761|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766762|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
25766763|NCT03341910|Tazarotene|tazarotene|mesh-list
25766764|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25766765|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
25766766|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
25766767|NCT03341910|Vitamins|vitamins|mesh-ancestor
24826533|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826534|NCT02135029|Atorvastatin|atorvastatin|mesh-list
24826535|NCT02135029|Bococizumab|bococizumab|mesh-list
24826536|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24826537|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24826538|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
25766768|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
25766769|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766770|NCT03342690|Eplerenone|eplerenone|mesh-list
25766771|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25766773|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766774|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766775|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25766776|NCT03342690|Diuretics|diuretics|mesh-ancestor
25766777|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
25766778|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25766779|NCT03342963|Aripiprazole|aripiprazole|mesh-list
25766780|NCT03342963|Sertraline|sertraline|mesh-list
25766781|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
25766782|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766783|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25766784|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766785|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766786|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766787|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
25766788|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
25766789|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766790|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766791|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25766792|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25766793|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
25766794|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25766795|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25766796|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25766797|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25766798|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25766799|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25766800|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766801|NCT03343067|Norethindrone|norethindrone|mesh-list
25766802|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
25766803|NCT03343067|Estradiol|estradiol|mesh-list
25766804|NCT03343067|Estrogens|estrogens|mesh-ancestor
25766805|NCT03343067|Hormones|hormones|mesh-ancestor
25766806|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25766807|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766808|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25766809|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
25766810|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25766811|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25766812|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25766813|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25766814|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25766815|NCT03343080|Lidocaine|lidocaine|mesh-list
25766816|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
25766817|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
25766818|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766819|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766820|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
25766821|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766822|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766823|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25766824|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25766825|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25766826|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766827|NCT03343639|Serlopitant|serlopitant|mesh-list
25766828|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25766829|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766830|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766831|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766832|NCT03344172|Gemcitabine|gemcitabine|mesh-list
25766833|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
25766834|NCT03344172|Paclitaxel|paclitaxel|mesh-list
25766835|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25766836|NCT03344172|Avelumab|avelumab|mesh-list
25766837|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25766838|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766839|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
25766840|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
25766841|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
25766842|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766843|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25766844|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
25766845|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
25766846|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25766847|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766848|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25766849|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
25766850|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766851|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
25766852|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25766853|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25766854|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25766855|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25766856|NCT03344510|Anesthetics|anesthetics|mesh-list
25766857|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766858|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766859|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25766860|NCT03344861|Trioxsalen|trioxsalen|mesh-list
25766861|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766862|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
25766863|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25766864|NCT03345407|Albuterol|albuterol|mesh-list
25766865|NCT03345407|Nemiralisib|nemiralisib|mesh-list
25766866|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25766867|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
25766868|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766869|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766870|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25766871|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
25766872|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
25766873|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25766874|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25766875|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25766876|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25766877|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
25766878|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766879|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766880|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25766881|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766882|NCT03345979|Aripiprazole|aripiprazole|mesh-list
25766883|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25766884|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
25766885|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
25766886|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25766887|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25766888|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25766889|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25766890|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766891|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
25766892|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
25766893|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766894|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766895|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25766896|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25766897|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
25766898|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25766899|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25766900|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25766901|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25766902|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
25766903|NCT03346057|Rocuronium|rocuronium|mesh-list
25766904|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
25766905|NCT03346057|Neostigmine|neostigmine|mesh-list
25766906|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25766907|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25766908|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25766909|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766910|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766911|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25766912|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766913|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766914|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
25766915|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766916|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24443588|NCT00295542|Enalapril|enalapril|mesh-list
25766917|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
25766918|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25766919|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25766920|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25766921|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25766922|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
25766923|NCT03346070|Rocuronium|rocuronium|mesh-list
25766924|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
25766925|NCT03346070|Neostigmine|neostigmine|mesh-list
25766926|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25766927|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25766928|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25766929|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766930|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766931|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25766932|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766933|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766934|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
25766935|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766936|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25766937|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
25766938|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25766939|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25766940|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25766941|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25766942|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25766943|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
25766944|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766945|NCT03348683|Propranolol|propranolol|mesh-list
25766946|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25766947|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25766948|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
25766949|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25766950|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766951|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766952|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766953|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25766954|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
25766955|NCT03349060|Abrocitinib|abrocitinib|mesh-list
25766956|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25766957|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766958|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766959|NCT03349333|Folic Acid|folic acid|mesh-list
25766960|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
25766961|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
25766962|NCT03349333|Vitamins|vitamins|mesh-ancestor
25766963|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
25766964|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766965|NCT03349333|Hematinics|hematinics|mesh-ancestor
25766966|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
25766967|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25766968|NCT03349710|Cisplatin|cisplatin|mesh-list
25766969|NCT03349710|Nivolumab|nivolumab|mesh-list
25766970|NCT03349710|Cetuximab|cetuximab|mesh-list
25766971|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766972|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25766973|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25766974|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766975|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25766976|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
25766977|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
25766978|NCT03351231|Nivolumab|nivolumab|mesh-list
25766979|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25766980|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25766981|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25766982|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766983|NCT03351478|Empagliflozin|empagliflozin|mesh-list
25766984|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25766985|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25766986|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25766987|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25766988|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766989|NCT03351608|Atropine|atropine|mesh-list
25766990|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
25766991|NCT03351608|Neostigmine|neostigmine|mesh-list
25766992|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25766993|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25766994|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25766995|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
25766996|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25766997|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25766998|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25766999|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767000|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
25767001|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
25767002|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25767003|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25767004|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
25767005|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767006|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767007|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25767008|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767009|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25767010|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
25767011|NCT03351933|Antibodies|antibodies|mesh-list
25767012|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
25767013|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25767014|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25767015|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
25767016|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767017|NCT03352323|Phenylephrine|phenylephrine|mesh-list
25767018|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
25767019|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25767020|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767021|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767022|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767023|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767024|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767025|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
25767026|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
25767027|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767028|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
25767029|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25767030|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767031|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25767032|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
25767033|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25767034|NCT03352323|Protective Agents|protective agents|mesh-ancestor
25767035|NCT03352414|Alvimopan|alvimopan|mesh-list
25767036|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767037|NCT03353740|Edetic Acid|edetic acid|mesh-list
25767038|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25767039|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
25767040|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
25767041|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767042|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
25767043|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25767044|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25767045|NCT03354429|Ticagrelor|ticagrelor|mesh-list
25767046|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25767047|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25767048|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25767049|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25767050|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
25767051|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767052|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767053|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767054|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
25767055|NCT03354598|Probenecid|probenecid|mesh-list
25767056|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767057|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767058|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25767059|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25767060|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767061|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767062|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767063|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25767064|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25767065|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
25767066|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
25767067|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25767068|NCT03354598|Renal Agents|renal agents|mesh-ancestor
25776808|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776809|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25776810|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25776811|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776812|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25776813|NCT03782233|Bromides|bromides|mesh-list
25776814|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25776815|NCT03782233|Rocuronium|rocuronium|mesh-list
25776816|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
25776817|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25776818|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25776819|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25776820|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776821|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776822|NCT03781375|Etanercept|etanercept|mesh-list
25776823|NCT03781375|Methotrexate|methotrexate|mesh-list
25776824|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25776825|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
25776826|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25776827|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776828|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25776829|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
25776830|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776831|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776832|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
25776833|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776834|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25776835|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25776836|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
25776837|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25776838|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25776839|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25776840|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25776841|NCT03781375|Analgesics|analgesics|mesh-ancestor
25776842|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
25776843|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25776844|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776845|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776846|NCT03780010|Paclitaxel|paclitaxel|mesh-list
25776847|NCT03780010|Carboplatin|carboplatin|mesh-list
25776848|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25776849|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776850|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25776851|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25776852|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25776853|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776854|NCT03774576|Itraconazole|itraconazole|mesh-list
25776855|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
25776856|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25776857|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25776858|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25776859|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776860|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776861|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25776862|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
25776863|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776864|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776865|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25776866|NCT03772041|Tolvaptan|tolvaptan|mesh-list
25776867|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25776868|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776869|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
25776870|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776871|NCT03774745|Mifepristone|mifepristone|mesh-list
25776872|NCT03774745|Progesterone|progesterone|mesh-list
25776873|NCT03774745|Progestins|progestins|mesh-ancestor
25776874|NCT03774745|Hormones|hormones|mesh-ancestor
25776875|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776876|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767069|NCT03355326|Glycerol|glycerol|mesh-list
25767070|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25767071|NCT03355326|Protective Agents|protective agents|mesh-ancestor
25767072|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767073|NCT03355820|Antibodies|antibodies|mesh-list
25767074|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
25767075|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767076|NCT03357341|Albuterol|albuterol|mesh-list
25767077|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25767078|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
25767079|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767080|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767081|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767082|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767083|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
25767084|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25767085|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25767086|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25767087|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767088|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767089|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767090|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767091|NCT03357393|Midazolam|midazolam|mesh-list
25767092|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
25767093|NCT03357393|Scopolamine|scopolamine|mesh-list
25767094|NCT03357393|Morphine|morphine|mesh-list
25767095|NCT03357393|Propofol|propofol|mesh-list
25767096|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25767097|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25767098|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767099|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767100|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25767101|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
25767102|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
25767103|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25767104|NCT03357393|Narcotics|narcotics|mesh-ancestor
25767105|NCT03357393|Analgesics|analgesics|mesh-ancestor
25767106|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
25767107|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767108|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25767109|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25767110|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25767111|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25767112|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
25767113|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
25767114|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767115|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767116|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25767117|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25767118|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
25767119|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
25767120|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
25767121|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767122|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
25767123|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
25767124|NCT03357614|Amoxicillin|amoxicillin|mesh-list
25767125|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
25767126|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
25767127|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
25767128|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25767129|NCT03357614|Ertapenem|ertapenem|mesh-list
25767130|NCT03357614|Lactams|lactams|mesh-list
25767131|NCT03357614|Probenecid|probenecid|mesh-list
25767132|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767133|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767134|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25767135|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25767136|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767137|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767138|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767139|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25767140|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25767141|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25767142|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
25767143|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
25767144|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25767145|NCT03357614|Renal Agents|renal agents|mesh-ancestor
25767146|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
25767147|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
25767148|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
25767149|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25767150|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
25767151|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767152|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767153|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767154|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767155|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
25767156|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25767157|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
25767158|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767159|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767160|NCT03358576|Amoxicillin|amoxicillin|mesh-list
25767161|NCT03358576|Metronidazole|metronidazole|mesh-list
25767162|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
25767163|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
25767164|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
25767165|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25767166|NCT03358576|Ertapenem|ertapenem|mesh-list
25767167|NCT03358576|Lactams|lactams|mesh-list
25767168|NCT03358576|Probenecid|probenecid|mesh-list
25767169|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767170|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767171|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25767172|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25767173|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25767174|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25767175|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767176|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767177|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767178|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25767179|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25767180|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25767181|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
25767182|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
25767183|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25767184|NCT03358576|Renal Agents|renal agents|mesh-ancestor
25767185|NCT03359395|Alfentanil|alfentanil|mesh-list
25767186|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25767187|NCT03359395|Narcotics|narcotics|mesh-ancestor
25767188|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767189|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767190|NCT03359395|Analgesics|analgesics|mesh-ancestor
25767191|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
25767192|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767193|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25767194|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
25767195|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
25767196|NCT03359473|GSK2881078|gsk2881078|mesh-list
25767197|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
25767198|NCT03359473|Hormones|hormones|mesh-ancestor
25767199|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767200|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767201|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25767202|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25767203|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767204|NCT03359590|Incretins|incretins|mesh-ancestor
25767205|NCT03359590|Hormones|hormones|mesh-ancestor
25767206|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767207|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25767208|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
25767209|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767210|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767211|NCT03359850|Niraparib|niraparib|mesh-list
25767212|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25767213|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767214|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767215|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767216|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
25767217|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767218|NCT03361176|Triamcinolone|triamcinolone|mesh-list
25767219|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24443654|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25767220|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25767221|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
25767222|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25767223|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767224|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
25767225|NCT03361176|Hormones|hormones|mesh-ancestor
25767226|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767227|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767228|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25767229|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
25767230|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767231|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767232|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25767233|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767234|NCT03361605|Propofol|propofol|mesh-list
25767235|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25767236|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767237|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767238|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25767239|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
25767240|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
25767241|NCT03363776|Nivolumab|nivolumab|mesh-list
25767242|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767243|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767244|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25767245|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767246|NCT03363906|Dulaglutide|dulaglutide|mesh-list
25767247|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25767248|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25767249|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767250|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
25767251|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
25767252|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767253|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767254|NCT03364309|Ixekizumab|ixekizumab|mesh-list
25767255|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
25767256|NCT03364608|Albuterol|albuterol|mesh-list
25767257|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25767258|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
25767259|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767260|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767261|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767262|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767263|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
25767264|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25767265|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25767266|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25767267|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767268|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767269|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767270|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767271|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
25767272|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25767273|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
25767274|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
25767275|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767276|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767277|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25767278|NCT03365011|Analgesics|analgesics|mesh-ancestor
25767279|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
25767280|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767281|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25767282|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767283|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
25767284|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767285|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767286|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24826649|NCT02135510|Palonosetron|palonosetron|mesh-list
24826650|NCT02135510|Metoclopramide|metoclopramide|mesh-list
24826651|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
24826652|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
24826653|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710096|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767287|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25767288|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767289|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767290|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767291|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25767292|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25767294|NCT03367793|Methamphetamine|methamphetamine|mesh-list
25767295|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25767296|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767297|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
25767298|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
25767299|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767300|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
25767301|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767302|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767303|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767304|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25767305|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25767306|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25767307|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25767308|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767309|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767310|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25767311|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25767312|NCT03368235|Prednisolone|prednisolone|mesh-list
25767313|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767314|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
25767315|NCT03368235|Hormones|hormones|mesh-ancestor
25767316|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767317|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767318|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25767319|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767320|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
25767321|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25767322|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767323|NCT03368859|Leucovorin|leucovorin|mesh-list
25767324|NCT03368859|Bevacizumab|bevacizumab|mesh-list
25767325|NCT03368859|Fluorouracil|fluorouracil|mesh-list
25767326|NCT03368859|Irinotecan|irinotecan|mesh-list
25767327|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767328|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767329|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25767330|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25767331|NCT03368859|Growth Substances|growth substances|mesh-ancestor
25767332|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767333|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
25767334|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
25767335|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767336|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25767337|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25767338|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
25767339|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25767340|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25767341|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767342|NCT03368859|Antidotes|antidotes|mesh-ancestor
25767343|NCT03368859|Protective Agents|protective agents|mesh-ancestor
25767344|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
25767345|NCT03368859|Vitamins|vitamins|mesh-ancestor
25767346|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
25767347|NCT03369704|Omalizumab|omalizumab|mesh-list
25767348|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25767349|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767350|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767351|NCT03369951|Minocycline|minocycline|mesh-list
25767352|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767353|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767354|NCT03370289|Vaccines|vaccines|mesh-list
25767355|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
25767356|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767357|NCT03370770|Osimertinib|osimertinib|mesh-list
25767358|NCT03370770|Afatinib|afatinib|mesh-list
25767359|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767360|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25767361|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826695|NCT02135822|Paclitaxel|paclitaxel|mesh-list
25767362|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767364|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767365|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767366|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25767367|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767368|NCT03371459|Albuterol|albuterol|mesh-list
25767369|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25767370|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
25767371|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767372|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767373|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767374|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767375|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
25767376|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25767377|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25767378|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25767379|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767380|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767381|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767382|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767383|NCT03371836|Clobazam|clobazam|mesh-list
25767384|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
25767385|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25767386|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25767387|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767388|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767389|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25767390|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25767391|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
25767392|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
25767393|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767394|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767395|NCT03372083|Deferasirox|deferasirox|mesh-list
25767396|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25767397|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
25767398|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
25767399|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767400|NCT03372382|Acetaminophen|acetaminophen|mesh-list
25767401|NCT03372382|Ibuprofen|ibuprofen|mesh-list
25767402|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25767403|NCT03372382|Analgesics|analgesics|mesh-ancestor
25767404|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
25767405|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767406|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767407|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
25767408|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25767409|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767410|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25767411|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25767412|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767413|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767414|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25767415|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25767416|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25767417|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767418|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767419|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25767420|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25767421|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767422|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
25767423|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767424|NCT03373591|Bupivacaine|bupivacaine|mesh-list
25767425|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
25767426|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
25767427|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767428|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767429|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
25767430|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767431|NCT03374176|Amoxicillin|amoxicillin|mesh-list
25767432|NCT03374176|Metronidazole|metronidazole|mesh-list
25767433|NCT03374176|Clindamycin|clindamycin|mesh-list
25767434|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
25767435|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
25767436|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767437|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767438|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25767439|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25767440|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25767441|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767442|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767443|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
25767444|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25767445|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25767446|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
25767447|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767448|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25767449|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25767450|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767451|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767452|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
25767453|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767454|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767455|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
25767456|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25767457|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
25767458|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
25767459|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767460|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767461|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25767462|NCT03375294|Analgesics|analgesics|mesh-ancestor
25767463|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
25767464|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767465|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
25767466|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25767467|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25767468|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767469|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
25767470|NCT03376061|Coagulants|coagulants|mesh-ancestor
25776877|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25776878|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
25776879|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25776880|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25776881|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25776882|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25776883|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
25776884|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25776885|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25776886|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
25776887|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
25776888|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25776889|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25776891|NCT03771560|Folic Acid|folic acid|mesh-list
25776892|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
25776893|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776894|NCT03771560|Antidotes|antidotes|mesh-ancestor
25776895|NCT03771560|Protective Agents|protective agents|mesh-ancestor
25776896|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
25776897|NCT03771560|Vitamins|vitamins|mesh-ancestor
25776898|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
24826760|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24826761|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826763|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
24826764|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826765|NCT02135887|Antidotes|antidotes|mesh-ancestor
25014007|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
25014008|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
25776899|NCT03771560|Hematinics|hematinics|mesh-ancestor
25776900|NCT03769896|Nabilone|nabilone|mesh-list
25776901|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
25776902|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
25767471|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
25767472|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25767473|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
25767474|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767475|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767476|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767477|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767478|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
25767479|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25767480|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
25767481|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767482|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767483|NCT03377556|Talazoparib|talazoparib|mesh-list
25767484|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25767485|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767486|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767487|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767488|NCT03378076|Triamcinolone|triamcinolone|mesh-list
25767489|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25767490|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25767492|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25767493|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767494|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
25767495|NCT03378076|Hormones|hormones|mesh-ancestor
25767496|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767497|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767498|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25767499|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
25767500|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767501|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767502|NCT03378635|Glucagon|glucagon|mesh-list
25767503|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767504|NCT03378635|Hormones|hormones|mesh-ancestor
25767505|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767506|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767507|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
25767508|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25767509|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767510|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767511|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25767512|NCT03378973|Analgesics|analgesics|mesh-ancestor
25767513|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
25767514|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767515|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25767516|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25767517|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767518|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767519|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767520|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767521|NCT03379506|Grazoprevir|grazoprevir|mesh-list
25767522|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
25767523|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767524|NCT03380026|Triamcinolone|triamcinolone|mesh-list
25767525|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25767526|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25767527|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
25767528|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25767529|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767530|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
25767531|NCT03380026|Hormones|hormones|mesh-ancestor
25767532|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767533|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767534|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25767535|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
25767536|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443950|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
25767537|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767538|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
25767539|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25767540|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767541|NCT03380091|Vitamin D|vitamin d|mesh-list
25767542|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
25767543|NCT03380091|Metformin|metformin|mesh-list
25767544|NCT03380091|Vitamins|vitamins|mesh-ancestor
25767545|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
25767546|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767547|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25767548|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25767549|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25767550|NCT03380390|Phenylephrine|phenylephrine|mesh-list
25767551|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
25767552|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25767553|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767554|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767555|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767556|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767557|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767558|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
25767559|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
25767560|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767561|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
25767562|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25767563|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767564|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25767565|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
25767566|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25767567|NCT03380390|Protective Agents|protective agents|mesh-ancestor
25767568|NCT03380429|Albuterol|albuterol|mesh-list
25767569|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25767570|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
25767571|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767572|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767573|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767574|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767575|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
25767576|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25767577|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25767578|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25767579|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767580|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767581|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767582|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767583|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
25767584|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25767585|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
25767586|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767587|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
25767588|NCT03381248|Protective Agents|protective agents|mesh-ancestor
25767589|NCT03381742|Clopidogrel|clopidogrel|mesh-list
25767590|NCT03381742|Ticagrelor|ticagrelor|mesh-list
25767591|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25767592|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24826880|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24826881|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826882|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
24826883|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
24583690|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583757|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826888|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
24826889|NCT02136771|Vitamins|vitamins|mesh-ancestor
24826890|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
24826891|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826892|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24826893|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24826894|NCT02136784|Morphine|morphine|mesh-list
25203462|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826897|NCT02136784|Hydromorphone|hydromorphone|mesh-list
24444030|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
24444031|NCT00296608|Leucovorin|leucovorin|mesh-list
24712187|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767593|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25767594|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25767595|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
25767596|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767597|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767598|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767599|NCT03382262|Triamcinolone|triamcinolone|mesh-list
25767600|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25767601|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25767602|NCT03382262|FX006|fx006|mesh-list
25767603|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25767604|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767605|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
25767606|NCT03382262|Hormones|hormones|mesh-ancestor
25767607|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767608|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767609|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25767610|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
25767611|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767612|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767613|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25767614|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25767615|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
25767616|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767617|NCT03382418|Antacids|antacids|mesh-ancestor
25767618|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767619|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767620|NCT03382821|Dexamethasone|dexamethasone|mesh-list
25767621|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
25767622|NCT03382821|Triamcinolone|triamcinolone|mesh-list
25767623|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25767624|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25767625|NCT03382821|Lidocaine|lidocaine|mesh-list
25767626|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25767627|NCT03382821|BB 1101|bb 1101|mesh-list
25767628|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25767629|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767630|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
25767631|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
25767632|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767633|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767634|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767635|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
25767636|NCT03382821|Hormones|hormones|mesh-ancestor
25767637|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767638|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25767639|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767640|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
25767641|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767642|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767643|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
25767644|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
25767645|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767646|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
25767647|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25767648|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25767649|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25767650|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25767651|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25767652|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
25767653|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
25767654|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767655|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767656|NCT03382912|Nivolumab|nivolumab|mesh-list
25767657|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767658|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767659|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25767660|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767661|NCT03383198|Bupivacaine|bupivacaine|mesh-list
25767662|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
25767663|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
25203463|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826992|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826994|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25767664|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767665|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767666|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
25767667|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767669|NCT03383523|Emodepside|emodepside|mesh-list
25767670|NCT03383523|Toltrazuril|toltrazuril|mesh-list
25767671|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
25767672|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25767673|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767674|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
25767675|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25767676|NCT03383588|Epinephrine|epinephrine|mesh-list
25767677|NCT03383588|Fentanyl|fentanyl|mesh-list
25767678|NCT03383588|Morphine|morphine|mesh-list
25767679|NCT03383588|Bupivacaine|bupivacaine|mesh-list
25767680|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
25767681|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
25767682|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767683|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767684|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
25767685|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767686|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25767687|NCT03383588|Narcotics|narcotics|mesh-ancestor
25767688|NCT03383588|Analgesics|analgesics|mesh-ancestor
25767689|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25767690|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25767691|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
25767692|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25767693|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767694|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767695|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767696|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767697|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25767698|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25767699|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
25767700|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767701|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
25767702|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
25767703|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
25767704|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25767705|NCT03383614|Emodepside|emodepside|mesh-list
25767706|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25767707|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767708|NCT03383783|Listerine|listerine|mesh-list
25767709|NCT03383783|Fluorides|fluorides|mesh-list
25767710|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
25767711|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
25767712|NCT03383783|Protective Agents|protective agents|mesh-ancestor
25767713|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767714|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25767715|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767716|NCT03384316|Vaccines|vaccines|mesh-list
25767717|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
25767718|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767719|NCT03384329|Resveratrol|resveratrol|mesh-list
25767720|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
25767721|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767722|NCT03384329|Protective Agents|protective agents|mesh-ancestor
25767723|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767724|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767725|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25767726|NCT03384693|Defibrotide|defibrotide|mesh-list
25767727|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25767728|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25767729|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767730|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25767731|NCT03384940|Trastuzumab|trastuzumab|mesh-list
25767732|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767733|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767734|NCT03386032|Desonide|desonide|mesh-list
25767735|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767736|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25767737|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25767738|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767739|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25767740|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767742|NCT03386448|Naltrexone|naltrexone|mesh-list
25767743|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25767744|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25767745|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25767746|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767747|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
25767748|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767749|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25767750|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
25767751|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
25767752|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767753|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
25767754|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25767755|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
25767756|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767757|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767758|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25767759|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
25767760|NCT03386474|Aflibercept|aflibercept|mesh-list
25767761|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25767762|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25767763|NCT03386474|Growth Substances|growth substances|mesh-ancestor
25767764|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767765|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
25767766|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767767|NCT03387020|Everolimus|everolimus|mesh-list
25767768|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767769|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25767770|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
25767771|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767772|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
25767773|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25767774|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25767775|NCT03387046|Prednisolone|prednisolone|mesh-list
25767776|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
25767777|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25767778|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
25767779|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767780|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
25767781|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
25767782|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767783|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767784|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25767785|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
25767786|NCT03387046|Hormones|hormones|mesh-ancestor
25767787|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767788|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25767789|NCT03387046|Protective Agents|protective agents|mesh-ancestor
25767790|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25767791|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767792|NCT03387462|Tenofovir|tenofovir|mesh-list
25767793|NCT03387462|Emtricitabine|emtricitabine|mesh-list
25767794|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
25767795|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767796|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25767797|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25767798|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767799|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767800|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25767801|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25767802|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
25767803|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25767804|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767805|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25767806|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767807|NCT03388164|Dexetimide|dexetimide|mesh-list
25767808|NCT03388164|Citalopram|citalopram|mesh-list
25767809|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25767810|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24481144|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481145|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
25767811|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25776903|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767812|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767813|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767815|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767816|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25767817|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
25767818|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25767819|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25767820|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25767821|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
25767822|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
25767823|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767824|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25767825|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25767826|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
25767827|NCT03388268|Vancomycin|vancomycin|mesh-list
25767828|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25767829|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767830|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
25767831|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767832|NCT03389555|Vitamins|vitamins|mesh-list
25767833|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
25767834|NCT03389555|Thiamine|thiamine|mesh-list
25767835|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
25767836|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
25767837|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767838|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767839|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
25767840|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767841|NCT03389555|Protective Agents|protective agents|mesh-ancestor
25767842|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
25767843|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25767844|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
25767845|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767846|NCT03390166|Vaccines|vaccines|mesh-list
25767847|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
25767848|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767849|NCT03390426|Anesthetics|anesthetics|mesh-list
25767850|NCT03390426|Mepivacaine|mepivacaine|mesh-list
25767851|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
25767852|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767853|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767854|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
25767855|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767856|NCT03391765|Tilavonemab|tilavonemab|mesh-list
25767857|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
25767858|NCT03393000|Vitamin A|vitamin a|mesh-list
25767859|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25767860|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
25767861|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767862|NCT03393000|Protective Agents|protective agents|mesh-ancestor
25767863|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767864|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25767865|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767866|NCT03393000|Vitamins|vitamins|mesh-ancestor
25767867|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
25767868|NCT03393208|Metformin|metformin|mesh-list
25767869|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25767870|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767871|NCT03393494|Adapalene|adapalene|mesh-list
25767872|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25767873|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
25767874|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25767875|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25767876|NCT03393494|Analgesics|analgesics|mesh-ancestor
25767877|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
25767878|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767879|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767880|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767881|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25767882|NCT03394885|Paclitaxel|paclitaxel|mesh-list
25767883|NCT03394885|Bevacizumab|bevacizumab|mesh-list
25767884|NCT03394885|Carboplatin|carboplatin|mesh-list
25767885|NCT03394885|Atezolizumab|atezolizumab|mesh-list
25767886|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25767887|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014518|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25767888|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
25767889|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
25767890|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
25767891|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767892|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25767893|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25767894|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25767895|NCT03394885|Growth Substances|growth substances|mesh-ancestor
25767896|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767897|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
25776904|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776905|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776906|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25776907|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25776908|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776909|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25776910|NCT03768726|Ziprasidone|ziprasidone|mesh-list
25776911|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25776912|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
25776913|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776914|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776915|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776916|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25776917|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25776918|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25776919|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25776920|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25776921|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
25776922|NCT03767738|Aflibercept|aflibercept|mesh-list
25776923|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25776924|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25776925|NCT03767738|Growth Substances|growth substances|mesh-ancestor
25776926|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776927|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
25776928|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776929|NCT03767062|Topiramate|topiramate|mesh-list
25776930|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
25776931|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776932|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777703|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25777704|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25777705|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777706|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777707|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25777708|NCT03305055|Narcotics|narcotics|mesh-ancestor
25777709|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25777710|NCT03302247|Gemcitabine|gemcitabine|mesh-list
25777711|NCT03302247|Nivolumab|nivolumab|mesh-list
25777712|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25777713|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
25777714|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777715|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777716|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
25777717|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777718|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777719|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777720|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
25777721|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777722|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25777723|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25777724|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
25777725|NCT03277183|Hematinics|hematinics|mesh-ancestor
25777742|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777743|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25777744|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25777745|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777746|NCT03232892|Trametinib|trametinib|mesh-list
25777747|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777748|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25777749|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777750|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777751|NCT03169530|Ethanol|ethanol|mesh-list
25777752|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25777753|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014645|NCT04155710|Interleukin-2|interleukin-2|mesh-list
25767898|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25767899|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25767900|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25767901|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25767902|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767903|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767904|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767905|NCT03395353|Analgesics|analgesics|mesh-ancestor
25767906|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
25767907|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767908|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
25767909|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25767910|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
25767911|NCT03395808|Tramadol|tramadol|mesh-list
25767912|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25767913|NCT03395808|Narcotics|narcotics|mesh-ancestor
25767914|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767915|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767916|NCT03395808|Analgesics|analgesics|mesh-ancestor
25767917|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
25767918|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767919|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
25767920|NCT03395886|Remifentanil|remifentanil|mesh-list
25767921|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25767922|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767923|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767924|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25767925|NCT03395886|Analgesics|analgesics|mesh-ancestor
25767926|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
25767927|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767928|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25767929|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25767930|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25767931|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25767932|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25767933|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767934|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25767935|NCT03395886|Narcotics|narcotics|mesh-ancestor
25767936|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
25767937|NCT03395990|Procaine|procaine|mesh-list
25767938|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
25767939|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
25767940|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767941|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767942|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
25767943|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767944|NCT03397394|Rucaparib|rucaparib|mesh-list
25767945|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25767946|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767947|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767948|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25767949|NCT03398278|Oxycodone|oxycodone|mesh-list
25767950|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25767951|NCT03398278|Narcotics|narcotics|mesh-ancestor
25767952|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767953|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767954|NCT03398278|Analgesics|analgesics|mesh-ancestor
25767955|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
25767956|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767957|NCT03398330|Oxycodone|oxycodone|mesh-list
25767958|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25767959|NCT03398330|Narcotics|narcotics|mesh-ancestor
25767960|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25767961|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767962|NCT03398330|Analgesics|analgesics|mesh-ancestor
25767963|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
25767964|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25767965|NCT03398421|Itraconazole|itraconazole|mesh-list
25767966|NCT03398421|Nemiralisib|nemiralisib|mesh-list
25767967|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
24521413|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24521414|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25767968|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25767969|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25767970|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25767971|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767972|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767973|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25767974|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
25767975|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767976|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767977|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25767978|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25767979|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
25767980|NCT03400033|Hematinics|hematinics|mesh-ancestor
25767981|NCT03400475|Simvastatin|simvastatin|mesh-list
25767982|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25767983|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25767984|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
25767985|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25767986|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25767987|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25767988|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25767989|NCT03400852|Cosyntropin|cosyntropin|mesh-list
25767990|NCT03400852|Hormones|hormones|mesh-ancestor
25767991|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25767992|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25767993|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
25767994|NCT03401229|Benralizumab|benralizumab|mesh-list
25767995|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25767996|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
25767997|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25767998|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25767999|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
25768000|NCT03401450|Bupivacaine|bupivacaine|mesh-list
25768001|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
25768002|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
25768003|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768004|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768005|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
25768006|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768007|NCT03402243|Menthol|menthol|mesh-list
25768008|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
25768009|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
25768010|NCT03403036|Brodalumab|brodalumab|mesh-list
25768011|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
25768012|NCT03403374|Evolocumab|evolocumab|mesh-list
25768013|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25768014|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25768015|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
25768016|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768017|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25768018|NCT03403504|Oxycodone|oxycodone|mesh-list
25768019|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25768020|NCT03403504|Narcotics|narcotics|mesh-ancestor
25768021|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768022|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768023|NCT03403504|Analgesics|analgesics|mesh-ancestor
25768024|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
25768025|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768026|NCT03403517|Dexamethasone|dexamethasone|mesh-list
25768027|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
25768028|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25768029|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25768030|NCT03403517|Prednisolone|prednisolone|mesh-list
25768031|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
25768032|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25768033|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
25768034|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768035|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
25768036|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
25768037|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768038|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768039|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768040|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
25768041|NCT03403517|Hormones|hormones|mesh-ancestor
25768042|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768043|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25768044|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768045|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25768046|NCT03403517|Protective Agents|protective agents|mesh-ancestor
25768047|NCT03403712|Dexamethasone|dexamethasone|mesh-list
25768048|NCT03403712|Palonosetron|palonosetron|mesh-list
25768049|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768050|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
25768051|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
25768052|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768053|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768054|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768055|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
25768056|NCT03403712|Hormones|hormones|mesh-ancestor
25768057|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768058|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25768059|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768060|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25768061|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25768062|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
25768063|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768064|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768065|NCT03404206|Ibuprofen|ibuprofen|mesh-list
25768066|NCT03404206|Naproxen|naproxen|mesh-list
25768067|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25768068|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768069|NCT03404206|Analgesics|analgesics|mesh-ancestor
25768070|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
25768071|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768072|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768073|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768074|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768075|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25768076|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768077|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768078|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
25768079|NCT03404648|Choline|choline|mesh-list
25768080|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
25768081|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25768082|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
25768083|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768084|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768085|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25768086|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
25768087|NCT03404843|Fasudil|fasudil|mesh-list
25768088|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25768089|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768090|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768091|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25768092|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768093|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
25768094|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25768095|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768096|NCT03405259|Fluorides|fluorides|mesh-list
25768097|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
25768098|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
25768099|NCT03405259|Protective Agents|protective agents|mesh-ancestor
25768100|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768101|NCT03405818|Tavaborole|tavaborole|mesh-list
25768102|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
25768103|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768104|NCT03406260|Lasmiditan|lasmiditan|mesh-list
25768105|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25768106|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
25155861|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155862|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155863|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155865|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25155866|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155867|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
25155868|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25155869|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25155987|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25155988|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155989|NCT05189223|Buprenorphine|buprenorphine|mesh-list
25155990|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25115059|NCT03118713|Glimepiride|glimepiride|mesh-list
25768107|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768108|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768109|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768111|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25768112|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768113|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
25768114|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25768115|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768116|NCT03407430|Pregabalin|pregabalin|mesh-list
25768117|NCT03407430|Analgesics|analgesics|mesh-ancestor
25768118|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
25768119|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768120|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768121|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
25768122|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25768123|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768124|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768125|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25768126|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25768127|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25768128|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768129|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25768130|NCT03407625|Misoprostol|misoprostol|mesh-list
25768131|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25768132|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
25768133|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25768134|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768135|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25768136|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768137|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
25768138|NCT03408483|Epinephrine|epinephrine|mesh-list
25768139|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
25768140|NCT03408483|Bupivacaine|bupivacaine|mesh-list
25768141|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
25768142|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
25768143|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768144|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768145|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
25768146|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768147|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25768148|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25768149|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
25768150|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768151|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768152|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25768153|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25768154|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
25768155|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25768156|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
25768157|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
25768158|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
25768159|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25768160|NCT03408483|Narcotics|narcotics|mesh-ancestor
25768161|NCT03408483|Analgesics|analgesics|mesh-ancestor
25768162|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
25768163|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
25768164|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
25768165|NCT03408639|Vitamins|vitamins|mesh-ancestor
25768166|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
25768167|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768168|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
25768169|NCT03408639|Hematinics|hematinics|mesh-ancestor
25768170|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
25768171|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25768172|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768173|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768174|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25768175|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768176|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25768177|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
25768178|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25768179|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768180|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
25768181|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
25768182|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25768183|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
25768184|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25768185|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
25768186|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768187|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768188|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
25768189|NCT03414359|Lidocaine|lidocaine|mesh-list
25768190|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
25768191|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
25768192|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
25768193|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768194|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768195|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
25768196|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768197|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25768198|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25768199|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25768200|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768201|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768202|NCT03415178|Atorvastatin|atorvastatin|mesh-list
25768203|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25768204|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25768205|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25768206|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
25768207|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768208|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25768209|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25768210|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776933|NCT03765502|Glucagon|glucagon|mesh-list
25776934|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25776935|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25776936|NCT03765502|Hormones|hormones|mesh-ancestor
25776937|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776938|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776939|NCT03765502|Incretins|incretins|mesh-ancestor
25776940|NCT03765138|Pramipexole|pramipexole|mesh-list
25776941|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
25776942|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776943|NCT03765138|Protective Agents|protective agents|mesh-ancestor
25776944|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776945|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25776946|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25776947|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
25776948|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
25776949|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25776950|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25776951|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
25776952|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776953|NCT03763929|Protective Agents|protective agents|mesh-ancestor
25776954|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776955|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25776956|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776957|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
25776958|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25776959|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776960|NCT03760250|Imiquimod|imiquimod|mesh-list
25776961|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25776962|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
25776963|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776964|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776965|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
25776966|NCT03759600|Niraparib|niraparib|mesh-list
25776967|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25776968|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776969|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776970|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25776971|NCT03758365|Triamcinolone|triamcinolone|mesh-list
25776972|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25776973|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25776974|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
25776975|NCT03758365|Betamethasone|betamethasone|mesh-list
25776976|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
25776977|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25776978|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
25776979|NCT03758365|Clobetasol|clobetasol|mesh-list
25776980|NCT03758365|Desonide|desonide|mesh-list
25776981|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
25777726|NCT03248141|Factor VIII|factor viii|mesh-list
25768211|NCT03415243|Acetaminophen|acetaminophen|mesh-list
25768212|NCT03415243|Phenylephrine|phenylephrine|mesh-list
25768213|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
25768214|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
25768215|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768216|NCT03415243|Analgesics|analgesics|mesh-ancestor
25768217|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
25768218|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768219|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768220|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
25768221|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25768222|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
25768223|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
25768224|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
25768225|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25768226|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
25768227|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
25768228|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25768229|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25768230|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25768231|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25768232|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768233|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768234|NCT03415243|Protective Agents|protective agents|mesh-ancestor
25768235|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
25768236|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25768237|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25768238|NCT03415581|Oxycodone|oxycodone|mesh-list
25768239|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25768240|NCT03415581|Narcotics|narcotics|mesh-ancestor
25768241|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768242|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768243|NCT03415581|Analgesics|analgesics|mesh-ancestor
25768244|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
25768245|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768246|NCT03416127|Metformin|metformin|mesh-list
25768247|NCT03416127|Propolis|propolis|mesh-list
25768248|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25768249|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768250|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768251|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
25768252|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
25768253|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768254|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25768255|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768256|NCT03418571|Gontivimab|gontivimab|mesh-list
25768257|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
25768258|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768259|NCT03418714|Salvinorin A|salvinorin a|mesh-list
25768260|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
25768261|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768262|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25768263|NCT03419403|Temozolomide|temozolomide|mesh-list
25768264|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25768265|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25768266|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25768267|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
25768268|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768269|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768270|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25768271|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25768272|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
25768273|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768274|NCT03421210|Nicotine|nicotine|mesh-list
25768275|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25768276|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
25768277|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768278|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768279|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25768280|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25768281|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
25768282|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768283|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768284|NCT03421379|Glucagon|glucagon|mesh-list
25768285|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25768286|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768287|NCT03421379|Hormones|hormones|mesh-ancestor
25768288|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768289|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768290|NCT03421379|Incretins|incretins|mesh-ancestor
25768291|NCT03421730|Budesonide|budesonide|mesh-list
25768292|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768293|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25768294|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
25768295|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768296|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768297|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25768298|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
25768299|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
25768300|NCT03421730|Hormones|hormones|mesh-ancestor
25768301|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768302|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
25768303|NCT03422159|Thiamine|thiamine|mesh-list
25768304|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
25768305|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25768306|NCT03422159|Vitamins|vitamins|mesh-ancestor
25768307|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
25768308|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768309|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768310|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
25768311|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768312|NCT03422159|Protective Agents|protective agents|mesh-ancestor
25768313|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
25768314|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
25768315|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768316|NCT03424044|Glucagon|glucagon|mesh-list
25768317|NCT03424044|Pancrelipase|pancrelipase|mesh-list
25768318|NCT03424044|Pancreatin|pancreatin|mesh-list
25768319|NCT03424044|Hormones|hormones|mesh-list
25768320|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768321|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768322|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768323|NCT03424239|Vitamin D|vitamin d|mesh-list
25768324|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
25768325|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
25768326|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
25768327|NCT03424239|Vitamins|vitamins|mesh-list
25768328|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
25768329|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768330|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25768331|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25768332|NCT03424681|Modafinil|modafinil|mesh-list
25768333|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25768334|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768335|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25768336|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25768337|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25768338|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768339|NCT03425097|Fexofenadine|fexofenadine|mesh-list
25768340|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25768341|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25768342|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25768343|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
25768344|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
25768345|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768346|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768347|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768348|NCT03425253|Lidocaine|lidocaine|mesh-list
25768349|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
25768350|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
25768351|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768352|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768353|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
25768354|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768355|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25768356|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24550264|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24550265|NCT00719875|Vorinostat|vorinostat|mesh-list
24831507|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
24831508|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25110785|NCT05360576|NuvaRing|nuvaring|mesh-list
24831509|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768357|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25768358|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768359|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768361|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25768362|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768363|NCT03425396|Renal Agents|renal agents|mesh-ancestor
25768364|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25768365|NCT03426228|Progesterone|progesterone|mesh-list
25768366|NCT03426228|Estrogens|estrogens|mesh-list
25768367|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768368|NCT03426228|Hormones|hormones|mesh-ancestor
25768369|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768370|NCT03426228|Progestins|progestins|mesh-ancestor
25768371|NCT03426995|Cantharidin|cantharidin|mesh-list
25768372|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768373|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768374|NCT03427619|Picibanil|picibanil|mesh-list
25768375|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768376|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
25768377|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
25768378|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768379|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768380|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768381|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
25768382|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
25768383|NCT03428230|Acetaminophen|acetaminophen|mesh-list
25768384|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
25768385|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25768386|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768387|NCT03428230|Analgesics|analgesics|mesh-ancestor
25768388|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
25768389|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768390|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768391|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
25768392|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
25768393|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
25768394|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768395|NCT03428360|Diazepam|diazepam|mesh-list
25768396|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25768397|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
25768398|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
25768399|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
25768400|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768401|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768402|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768403|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25768404|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768405|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25768406|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25768407|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25768408|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25768409|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25768410|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25768411|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
25768412|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
25768413|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
25768414|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
25768415|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768416|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768417|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
25768418|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25768419|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768420|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768421|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
25768422|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768423|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768424|NCT03430050|Progesterone|progesterone|mesh-list
25768425|NCT03430050|Progestins|progestins|mesh-ancestor
25768426|NCT03430050|Hormones|hormones|mesh-ancestor
25768427|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768428|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768429|NCT03430856|Insulin|insulin|mesh-list
25768430|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25768431|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
24832736|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768436|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
25768437|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768438|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768439|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
25768440|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768441|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25768442|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25768443|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25768444|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768445|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768446|NCT03431337|Amoxicillin|amoxicillin|mesh-list
25768447|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25768448|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768449|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25768450|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
25768451|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768452|NCT03432858|Vancomycin|vancomycin|mesh-list
25768453|NCT03432858|Cefazolin|cefazolin|mesh-list
25768454|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25768455|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768456|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
25768457|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25768458|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768459|NCT03433703|Lenvatinib|lenvatinib|mesh-list
25768460|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768461|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25768462|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768463|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768464|NCT03433755|Evolocumab|evolocumab|mesh-list
25768465|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25768466|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25768467|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
25768468|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768469|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25768470|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25768471|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25768472|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25768473|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776982|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25776983|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25776984|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25776985|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
25776986|NCT03758365|Hormones|hormones|mesh-ancestor
25776987|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25776988|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25776989|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25776990|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
25776991|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25776992|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25776993|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25776994|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
25776995|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
25776996|NCT03757234|Levofloxacin|levofloxacin|mesh-list
25776997|NCT03757234|Ofloxacin|ofloxacin|mesh-list
25776998|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25776999|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777000|NCT03757234|Renal Agents|renal agents|mesh-ancestor
25777001|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25777002|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25777003|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25777004|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777005|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777006|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777007|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25777727|NCT03248141|Coagulants|coagulants|mesh-ancestor
25015908|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768474|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
25768475|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25768476|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
25768477|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
25768478|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768479|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768480|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768481|NCT03435055|Analgesics|analgesics|mesh-ancestor
25768482|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
25768483|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768484|NCT03435614|Analgesics|analgesics|mesh-list
25768485|NCT03435614|Narcotics|narcotics|mesh-list
25768486|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768487|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768488|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
25768489|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768490|NCT03435692|Acetaminophen|acetaminophen|mesh-list
25768491|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
25768492|NCT03435692|Promethazine|promethazine|mesh-list
25768493|NCT03435692|Fentanyl|fentanyl|mesh-list
25768494|NCT03435692|Morphine|morphine|mesh-list
25768495|NCT03435692|Oxycodone|oxycodone|mesh-list
25768496|NCT03435692|Lorazepam|lorazepam|mesh-list
25768497|NCT03435692|Ondansetron|ondansetron|mesh-list
25768498|NCT03435692|Ropivacaine|ropivacaine|mesh-list
25768499|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25768500|NCT03435692|Narcotics|narcotics|mesh-ancestor
25768501|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768502|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768503|NCT03435692|Analgesics|analgesics|mesh-ancestor
25768504|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
25768505|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768506|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
25768507|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
25768508|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25768509|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25768510|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
25768511|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768512|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
25768513|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
25768514|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
25768515|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768516|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
25768517|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
25768518|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25768519|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
25768520|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768521|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768522|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25768523|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25768524|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25768525|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25768526|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25768527|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25768528|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25768529|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
25768530|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
25768531|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25768532|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
25768533|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
25768534|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
25768535|NCT03436420|Calcium|calcium|mesh-list
25768536|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25768537|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768538|NCT03437044|Clopidogrel|clopidogrel|mesh-list
25768539|NCT03437044|Ticagrelor|ticagrelor|mesh-list
25768540|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25768541|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25768542|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25768543|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25768544|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
25768545|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768546|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768547|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768548|NCT03437447|Praziquantel|praziquantel|mesh-list
25768549|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
25768550|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25768551|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768552|NCT03437564|Vortioxetine|vortioxetine|mesh-list
25777728|NCT03219372|Pravastatin|pravastatin|mesh-list
25768553|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
25768554|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25768555|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25768556|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25768557|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768558|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768559|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25768560|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25768561|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768562|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768563|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768564|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
25768565|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25768566|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25768567|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25768568|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25768569|NCT03437577|Tacrolimus|tacrolimus|mesh-list
25768570|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25768571|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
25768572|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768573|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25768574|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768575|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768576|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
25768577|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25768578|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
25768579|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768580|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
25768581|NCT03438266|Protective Agents|protective agents|mesh-ancestor
25768582|NCT03439072|Glucagon|glucagon|mesh-list
25768583|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25768584|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768585|NCT03439072|Hormones|hormones|mesh-ancestor
25768586|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768587|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768588|NCT03439072|Incretins|incretins|mesh-ancestor
25768589|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
25768590|NCT03439137|Hematinics|hematinics|mesh-ancestor
25768591|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25768592|NCT03440229|Laxatives|laxatives|mesh-ancestor
25768593|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768594|NCT03440411|Dexamethasone|dexamethasone|mesh-list
25768595|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
25768596|NCT03440411|Pomalidomide|pomalidomide|mesh-list
25768597|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25768598|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
25768599|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768600|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768601|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25768602|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
25768603|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768604|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768605|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25768606|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768607|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
25768608|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
25768609|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768610|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768611|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
25768612|NCT03440411|Hormones|hormones|mesh-ancestor
25768613|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768614|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25768615|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25768616|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25768617|NCT03440411|Growth Substances|growth substances|mesh-ancestor
25768618|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
25768619|NCT03440424|Lemborexant|lemborexant|mesh-list
25768620|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25768621|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768622|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768623|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25768624|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25768625|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768626|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768627|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
25768628|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25768629|NCT03441269|Ibuprofen|ibuprofen|mesh-list
25768630|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25768631|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768632|NCT03441269|Analgesics|analgesics|mesh-ancestor
25768633|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
25768634|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768635|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768636|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768637|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768638|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25768639|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768640|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768641|NCT03441581|Eluxadoline|eluxadoline|mesh-list
25768642|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768643|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
25768644|NCT03441633|Apixaban|apixaban|mesh-list
25768645|NCT03441633|Dabigatran|dabigatran|mesh-list
25768646|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25768647|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
25768648|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25768649|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
25768650|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768651|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768652|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
25768653|NCT03441789|Betamethasone|betamethasone|mesh-list
25768654|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
25768655|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25768656|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
25768657|NCT03441789|Calcipotriene|calcipotriene|mesh-list
25768658|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25768659|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768660|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
25768661|NCT03441789|Hormones|hormones|mesh-ancestor
25768662|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768663|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768664|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25768665|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
25768666|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
25768667|NCT03442569|Nivolumab|nivolumab|mesh-list
25768668|NCT03442569|Ipilimumab|ipilimumab|mesh-list
25768669|NCT03442569|Panitumumab|panitumumab|mesh-list
25768670|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25768671|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768672|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25768673|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768674|NCT03443063|Lemborexant|lemborexant|mesh-list
25768675|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25768676|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768677|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768678|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25768679|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25768680|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768681|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768682|NCT03444155|Folic Acid|folic acid|mesh-list
25768683|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
25768684|NCT03444155|Vitamins|vitamins|mesh-ancestor
25768685|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
25768686|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768687|NCT03444155|Hematinics|hematinics|mesh-ancestor
25768688|NCT03444584|Metformin|metformin|mesh-list
25768689|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25768690|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768691|NCT03444766|Nivolumab|nivolumab|mesh-list
25768692|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25768693|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768694|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25768695|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768696|NCT03445195|Imipenem|imipenem|mesh-list
25768697|NCT03445195|Sulbactam|sulbactam|mesh-list
25768698|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25768699|NCT03445195|Cilastatin|cilastatin|mesh-list
25768700|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848849|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065982|NCT04614714|Niacin|niacin|mesh-list
25768701|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768702|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
25768703|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768704|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768705|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25768706|NCT03445390|Acetaminophen|acetaminophen|mesh-list
25768707|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768708|NCT03445390|Analgesics|analgesics|mesh-ancestor
25768709|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
25768710|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768711|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768712|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
25768713|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25768714|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25768715|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768716|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25768717|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25768718|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768719|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768720|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
25768721|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768722|NCT03447249|Ivacaftor|ivacaftor|mesh-list
25768723|NCT03447249|VX-659|vx-659|mesh-list
25768724|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25768725|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768726|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768727|NCT03447353|Acetaminophen|acetaminophen|mesh-list
25768728|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25768729|NCT03447353|Hydrocodone|hydrocodone|mesh-list
25768730|NCT03447353|Alprazolam|alprazolam|mesh-list
25768731|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768732|NCT03447353|Analgesics|analgesics|mesh-ancestor
25768733|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
25768734|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768735|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768736|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
25768737|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25768738|NCT03447353|Narcotics|narcotics|mesh-ancestor
25768739|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768740|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
25768741|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
25768742|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25768743|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25768744|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25768745|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25768746|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
25768747|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
25768748|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768749|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768750|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25768751|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768752|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768753|NCT03447821|Rifamycins|rifamycins|mesh-list
25768754|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
25768755|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25768756|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768757|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768758|NCT03448068|Ketamine|ketamine|mesh-list
25768759|NCT03448068|Analgesics|analgesics|mesh-ancestor
25768760|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
25768761|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768762|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768763|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25768764|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25768765|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
25768766|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
25768767|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768768|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25768769|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25768770|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768771|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768772|NCT03448406|Empagliflozin|empagliflozin|mesh-list
25768773|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25768774|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768776|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768777|NCT03448419|Empagliflozin|empagliflozin|mesh-list
25768778|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25768779|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768780|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25768781|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768782|NCT03448536|Acetaminophen|acetaminophen|mesh-list
25768783|NCT03448536|Naproxen|naproxen|mesh-list
25768784|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768785|NCT03448536|Analgesics|analgesics|mesh-ancestor
25768786|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
25768787|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768788|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768789|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
25768790|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25768791|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768792|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768793|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
25768794|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25768795|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768796|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768797|NCT03449433|Insulin|insulin|mesh-list
25768798|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25768799|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
25768800|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
25768801|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25768802|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
25768803|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25768804|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768805|NCT03449446|Firsocostat|firsocostat|mesh-list
25768806|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768807|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768808|NCT03450083|Benralizumab|benralizumab|mesh-list
25768809|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25768810|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
25777008|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25777009|NCT03756883|Fluticasone|fluticasone|mesh-list
25777010|NCT03756883|Xhance|xhance|mesh-list
25777011|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25777012|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25777013|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777014|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25777015|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
25777016|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777017|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777018|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25777019|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
25777020|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
25777021|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25777022|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25777023|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25777024|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25777025|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
25777026|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777027|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777028|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
25777029|NCT03756883|Hormones|hormones|mesh-ancestor
25777030|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777031|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
25777032|NCT03756129|Ketamine|ketamine|mesh-list
25777033|NCT03756129|Analgesics|analgesics|mesh-ancestor
25777034|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
25777035|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777036|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777037|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24812222|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24812223|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
24812235|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24812236|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812237|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
24812238|NCT02050802|Macitentan|macitentan|mesh-list
24812239|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25016477|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25768811|NCT03451773|Gemcitabine|gemcitabine|mesh-list
25768812|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25768813|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
25768814|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768815|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768816|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
25768817|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768818|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768819|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25768820|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
25768821|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768822|NCT03452189|Vancomycin|vancomycin|mesh-list
25768823|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25768824|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768825|NCT03452527|Aflibercept|aflibercept|mesh-list
25768826|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
25768827|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25768828|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25768829|NCT03452527|Growth Substances|growth substances|mesh-ancestor
25768830|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768831|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
25768832|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768833|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
25768834|NCT03453060|Thrombin|thrombin|mesh-list
25768835|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
25768836|NCT03453060|Coagulants|coagulants|mesh-ancestor
25768837|NCT03453151|Anesthetics|anesthetics|mesh-list
25768838|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
25768839|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768840|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768841|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
25768842|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768843|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
25768844|NCT03454048|Piperaquine|piperaquine|mesh-list
25768845|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
25768846|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25768847|NCT03454048|Atovaquone|atovaquone|mesh-list
25768848|NCT03454048|Proguanil|proguanil|mesh-list
25768849|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25768850|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
25768851|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25768852|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25768853|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768854|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25768855|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768856|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768857|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25768858|NCT03454048|Renal Agents|renal agents|mesh-ancestor
25768859|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
25768860|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
25768861|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25768862|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
25768863|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768864|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768865|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25768866|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
25768867|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25768868|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
25768869|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768870|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768871|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25768872|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
25768873|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
25768874|NCT03455218|Protective Agents|protective agents|mesh-ancestor
25768875|NCT03456960|Aspirin|aspirin|mesh-list
25768876|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25016509|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24851924|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24851925|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24851926|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24445834|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24445835|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25016528|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
25071381|NCT03410784|Paclitaxel|paclitaxel|mesh-list
25768877|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768878|NCT03456960|Analgesics|analgesics|mesh-ancestor
25768879|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
25768880|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768881|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768882|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768883|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768884|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25768885|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25768886|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768887|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25768888|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25768889|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768890|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
25768891|NCT03457636|Doxycycline|doxycycline|mesh-list
25768892|NCT03457636|Adapalene|adapalene|mesh-list
25768893|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25768894|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25768895|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25768896|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768897|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
25768898|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25768899|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25768900|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
25768901|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25768902|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25768903|NCT03457636|Analgesics|analgesics|mesh-ancestor
25768904|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
25768905|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768906|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768907|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768908|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25768909|NCT03457727|Omeprazole|omeprazole|mesh-list
25768910|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25768911|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768912|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25768913|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768914|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768915|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25768916|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
25768917|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25768918|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25768919|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
25768920|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768921|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768922|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
25768923|NCT03459612|Promethazine|promethazine|mesh-list
25768924|NCT03459612|Lasmiditan|lasmiditan|mesh-list
25768925|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25768926|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25768927|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25768928|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768929|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
25768930|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
25768931|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
25768932|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768933|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
25768934|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
25768935|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768936|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25768937|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
25768938|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
25768939|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25768940|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768941|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25768942|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
25768943|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
25768944|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25768945|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
25768946|NCT03459794|Ivermectin|ivermectin|mesh-list
25768947|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25768948|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25768949|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
25768950|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24852064|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24655233|NCT01255358|Dexamethasone|dexamethasone|mesh-list
24852165|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768951|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768952|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25768953|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768954|NCT03460990|Ivacaftor|ivacaftor|mesh-list
25768955|NCT03460990|VX-659|vx-659|mesh-list
25768956|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25768957|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768958|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768959|NCT03462680|Niacin|niacin|mesh-list
25768960|NCT03462680|Vitamins|vitamins|mesh-ancestor
25768961|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
25768962|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768963|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
25768964|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25768965|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
25768966|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768967|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25768968|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
25768969|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
25768970|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25768971|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25768972|NCT03463512|Racecadotril|racecadotril|mesh-list
25768973|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
25768974|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25768975|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
25768976|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768977|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768978|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25768979|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25768980|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768981|NCT03463915|Triamcinolone|triamcinolone|mesh-list
25768982|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25768983|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25768984|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25768985|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25768986|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
25768987|NCT03463915|Hormones|hormones|mesh-ancestor
25768988|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25768989|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768990|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25768991|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
25768992|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25768993|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768994|NCT03464383|Citalopram|citalopram|mesh-list
25768995|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25768996|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25768997|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25768998|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25768999|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769000|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
25769001|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769002|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25769003|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
25769004|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769005|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
25769006|NCT03465436|Lasmiditan|lasmiditan|mesh-list
25769007|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25769008|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769009|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25769010|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25769011|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769012|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769013|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769014|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769015|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25769016|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
25769017|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769018|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
25769019|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769020|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769021|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25769022|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24586663|NCT00891670|Cilostazol|cilostazol|mesh-list
25769023|NCT03467217|Losartan|losartan|mesh-list
25769024|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25769025|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25769026|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25769027|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25769028|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769029|NCT03467685|Anesthetics|anesthetics|mesh-list
25769030|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769031|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769032|NCT03467763|Metformin|metformin|mesh-list
25769033|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769034|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769035|NCT03467945|Metformin|metformin|mesh-list
25769036|NCT03467945|Gliclazide|gliclazide|mesh-list
25769037|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769038|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769039|NCT03467971|Metformin|metformin|mesh-list
25769040|NCT03467971|Gliclazide|gliclazide|mesh-list
25769041|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769042|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769043|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
25769044|NCT03468075|Gemcitabine|gemcitabine|mesh-list
25769045|NCT03468075|Vitamins|vitamins|mesh-ancestor
25769046|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
25769047|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769048|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25769049|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
25769050|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769051|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769052|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
25769053|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769054|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769055|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25769056|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
25769057|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
25769058|NCT03468075|Protective Agents|protective agents|mesh-ancestor
25769059|NCT03468543|Memantine|memantine|mesh-list
25769060|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25769061|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25769062|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
25769063|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769064|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769065|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769066|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25769067|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25769068|NCT03468920|Acetaminophen|acetaminophen|mesh-list
25769069|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769070|NCT03468920|Analgesics|analgesics|mesh-ancestor
25769071|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
25769072|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769073|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769074|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
25769075|NCT03468933|Plasminogen|plasminogen|mesh-list
25769076|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25769077|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25769078|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25769079|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769080|NCT03469336|Betamethasone|betamethasone|mesh-list
25769081|NCT03469336|Calcipotriene|calcipotriene|mesh-list
25769082|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769083|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
25769084|NCT03469336|Hormones|hormones|mesh-ancestor
25769085|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769086|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769087|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25769088|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
25769089|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
25769090|NCT03469349|Actovegin|actovegin|mesh-list
25769091|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25769092|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769093|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25769094|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769095|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
25769096|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812442|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769097|NCT03469349|Protective Agents|protective agents|mesh-ancestor
25769098|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25769099|NCT03471871|Lemborexant|lemborexant|mesh-list
25769100|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25769101|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769102|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769103|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25769104|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25769105|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769106|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769107|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
25769108|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769109|NCT03472326|GS-9131|gs-9131|mesh-list
25769110|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769111|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769112|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25769113|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25769114|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
25769115|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769116|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25769117|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25769118|NCT03472469|Acetaminophen|acetaminophen|mesh-list
25769119|NCT03472469|Ketorolac|ketorolac|mesh-list
25769120|NCT03472469|Naproxen|naproxen|mesh-list
25769121|NCT03472469|Celecoxib|celecoxib|mesh-list
25769122|NCT03472469|Lidocaine|lidocaine|mesh-list
25769123|NCT03472469|Pregabalin|pregabalin|mesh-list
25769124|NCT03472469|Gabapentin|gabapentin|mesh-list
25769125|NCT03472469|Tramadol|tramadol|mesh-list
25769126|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769127|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
25769128|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769129|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769130|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
25769131|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769132|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25769133|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25769134|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25769135|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25769136|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769137|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769138|NCT03472469|Analgesics|analgesics|mesh-ancestor
25769139|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
25769140|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
25769141|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25769142|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25769143|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25769144|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25769145|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769146|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25769147|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25769148|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769149|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
25769150|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25769151|NCT03472469|Narcotics|narcotics|mesh-ancestor
25769152|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769153|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769154|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769155|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25769156|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769157|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
25769158|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25769159|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
25769160|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769161|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
25769162|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769163|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
25769164|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769165|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
25769166|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777038|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25777039|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
25777040|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
25777041|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777042|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25777043|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25777044|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777045|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597996|NCT00953303|BB 1101|bb 1101|mesh-list
25777046|NCT03756038|Lorazepam|lorazepam|mesh-list
25769167|NCT03473665|Celecoxib|celecoxib|mesh-list
25769168|NCT03473665|Diclofenac|diclofenac|mesh-list
25769169|NCT03473665|Indomethacin|indomethacin|mesh-list
25769170|NCT03473665|Meloxicam|meloxicam|mesh-list
25769171|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769172|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769173|NCT03473665|Analgesics|analgesics|mesh-ancestor
25769174|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
25769175|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769176|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769177|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769178|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769179|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25769180|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25769181|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769182|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769183|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
25769184|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
25769185|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25769186|NCT03474081|Albuterol|albuterol|mesh-list
25769187|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
25769188|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25769189|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
25769190|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769191|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769192|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25769193|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
25769194|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
25769195|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25769196|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
25769197|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769198|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769199|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
25769200|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25769201|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25769202|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25769203|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25769204|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25769205|NCT03478163|Clindamycin|clindamycin|mesh-list
25769206|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
25769207|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
25769208|NCT03478163|Cefazolin|cefazolin|mesh-list
25769209|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25769210|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769211|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25769212|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769213|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769214|NCT03478683|Budesonide|budesonide|mesh-list
25769215|NCT03478683|Albuterol|albuterol|mesh-list
25769216|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
25769217|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
25769218|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25769219|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769220|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25769221|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
25769222|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769223|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769224|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25769225|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
25769226|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
25769227|NCT03478683|Hormones|hormones|mesh-ancestor
25769228|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769229|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25769230|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25769231|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25769232|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
25769233|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769234|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769235|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
25769236|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25769237|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
25769238|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
25769239|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25769240|NCT03478696|Budesonide|budesonide|mesh-list
25769241|NCT03478696|Albuterol|albuterol|mesh-list
25769242|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
25769243|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
25769244|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25769245|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769246|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25769247|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
25769248|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769249|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769250|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25769251|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
25769252|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
25769253|NCT03478696|Hormones|hormones|mesh-ancestor
25769254|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769255|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25769256|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25769257|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25769258|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
25769259|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769260|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769261|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
25769262|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25769263|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
25769264|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
25769265|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25769266|NCT03478891|Ansuvimab|ansuvimab|mesh-list
25769267|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
25769268|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769269|NCT03478969|Insulin|insulin|mesh-list
25769270|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769271|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769272|NCT03478982|Alprazolam|alprazolam|mesh-list
25769273|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25769274|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769275|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769276|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25769277|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25769278|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769279|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
25769280|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
25769281|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769282|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769283|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
25769284|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
25769285|NCT03479216|Bupivacaine|bupivacaine|mesh-list
25769286|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769287|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
25769288|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769289|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769290|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
25769291|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769292|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25769293|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769294|NCT03479216|Analgesics|analgesics|mesh-ancestor
25769295|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25769296|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25769297|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25769298|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
25769299|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769300|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769301|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25769302|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
25769303|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25769304|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25769305|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25769306|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
25769307|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25769308|NCT03480009|Oxycodone|oxycodone|mesh-list
25769309|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
25769310|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25769311|NCT03480009|Narcotics|narcotics|mesh-ancestor
25769312|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769313|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769314|NCT03480009|Analgesics|analgesics|mesh-ancestor
25769315|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
25769316|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769317|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
25769318|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
25769319|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25769320|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25769321|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769322|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769323|NCT03480022|Liraglutide|liraglutide|mesh-list
25769324|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769325|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769326|NCT03480022|Incretins|incretins|mesh-ancestor
25769328|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769329|NCT03480243|Erythromycin|erythromycin|mesh-list
25769330|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
25769331|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25769332|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
25769333|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25769334|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769335|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769336|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25769337|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769338|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769339|NCT03480750|Carboplatin|carboplatin|mesh-list
25769340|NCT03480750|Doxorubicin|doxorubicin|mesh-list
25769341|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25769342|NCT03480750|Trientine|trientine|mesh-list
25769343|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769344|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25769345|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25769346|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25769347|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769348|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769349|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
25769350|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
25769351|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25769352|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
25769353|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769354|NCT03480932|Interferons|interferons|mesh-list
25769355|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
25769356|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
25769357|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25769358|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
25769359|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769360|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
25769361|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769362|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
25769363|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769364|NCT03481725|Coal Tar|coal tar|mesh-list
25769365|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
25769366|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
25769367|NCT03481816|Vaccines|vaccines|mesh-list
25769368|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
25769369|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769370|NCT03482011|Mirikizumab|mirikizumab|mesh-list
25769371|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769372|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769373|NCT03482011|Analgesics|analgesics|mesh-ancestor
25769374|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
25769375|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769376|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769377|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769378|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769379|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25769380|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769381|NCT03482583|Nicotine|nicotine|mesh-list
25769382|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25769383|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
25769384|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769385|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769386|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25769387|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25769388|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
25769389|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769390|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769391|NCT03482882|Pimavanserin|pimavanserin|mesh-list
25769392|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25769393|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25769394|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25769395|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25769396|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769397|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769398|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769399|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25769400|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25769401|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
25769402|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769403|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769404|NCT03482973|Bupivacaine|bupivacaine|mesh-list
25769405|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769406|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
25769407|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769408|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769409|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
25769410|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769411|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25769412|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
25769413|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769414|NCT03485222|Empagliflozin|empagliflozin|mesh-list
25769415|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25769416|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769417|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769418|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769419|NCT03485976|Ixekizumab|ixekizumab|mesh-list
25769420|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
25769421|NCT03486392|Liraglutide|liraglutide|mesh-list
25769422|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769423|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769424|NCT03486392|Incretins|incretins|mesh-ancestor
25769425|NCT03486392|Hormones|hormones|mesh-ancestor
25769426|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769427|NCT03486834|Vaccines|vaccines|mesh-list
25769428|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
25769429|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769430|NCT03487276|Vilobelimab|vilobelimab|mesh-list
25769431|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25769432|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25769433|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
25769434|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769435|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25769436|NCT03487549|Cantharidin|cantharidin|mesh-list
25769437|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769438|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769439|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
25769440|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
25769441|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769442|NCT03488108|Minoxidil|minoxidil|mesh-list
25769443|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25769444|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
25769445|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
25769446|NCT03488225|Leucovorin|leucovorin|mesh-list
25769447|NCT03488225|Folic Acid|folic acid|mesh-list
25769448|NCT03488225|Cytarabine|cytarabine|mesh-list
25769449|NCT03488225|Dexamethasone|dexamethasone|mesh-list
25769450|NCT03488225|Prednisone|prednisone|mesh-list
25769451|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
25769452|NCT03488225|Cortisone|cortisone|mesh-list
25769453|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
25769454|NCT03488225|Rituximab|rituximab|mesh-list
25769455|NCT03488225|Doxorubicin|doxorubicin|mesh-list
25769456|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25769457|NCT03488225|Methotrexate|methotrexate|mesh-list
25769458|NCT03488225|Vincristine|vincristine|mesh-list
25769459|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
25769460|NCT03488225|Ofatumumab|ofatumumab|mesh-list
25769461|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25769462|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25769463|NCT03488225|Antibodies|antibodies|mesh-list
25769464|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
25769465|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25769466|NCT03488225|BB 1101|bb 1101|mesh-list
25769467|NCT03488225|Calcium|calcium|mesh-list
25769468|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
25769469|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25769470|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
25769471|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769472|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769473|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25769474|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
25769475|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769476|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769477|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25769478|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769479|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
25769480|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
25769481|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769482|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769483|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
25769484|NCT03488225|Hormones|hormones|mesh-ancestor
25769485|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769486|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25769487|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25769488|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25769489|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25769490|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769491|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25769492|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25769493|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25769494|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
25769495|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25769496|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25769497|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
25769498|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
25769499|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25769500|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25769501|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
25769502|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769503|NCT03488225|Antidotes|antidotes|mesh-ancestor
25769504|NCT03488225|Protective Agents|protective agents|mesh-ancestor
25769505|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
25769506|NCT03488225|Vitamins|vitamins|mesh-ancestor
25769507|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
25769508|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25769509|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25769510|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25769511|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25769512|NCT03488225|Hematinics|hematinics|mesh-ancestor
25769513|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
25769514|NCT03489304|Zaleplon|zaleplon|mesh-list
25769515|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
25769516|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25769517|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769518|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769519|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
25769520|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
25769521|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769522|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769523|NCT03489551|Haloperidol|haloperidol|mesh-list
25769524|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
25769525|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
25769526|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769527|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769528|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769529|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25769530|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25769531|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769532|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769533|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25769534|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
25769535|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769536|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769537|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25769538|NCT03489850|Ibudilast|ibudilast|mesh-list
25769539|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25769540|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
25769541|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769542|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769543|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25769544|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
25769545|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25769546|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769547|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999585|NCT03912220|Niacin|niacin|mesh-list
25769548|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25769549|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
25769550|NCT03489863|Ticagrelor|ticagrelor|mesh-list
25769551|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25769552|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25769553|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25769554|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25769555|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25769556|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
25769557|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769558|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769559|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769560|NCT03490942|Glucagon|glucagon|mesh-list
25769561|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25769562|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769563|NCT03490942|Hormones|hormones|mesh-ancestor
25769564|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769565|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769566|NCT03490942|Incretins|incretins|mesh-ancestor
25769567|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25769568|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25769569|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25769570|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
25769571|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769572|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769573|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769574|NCT03492281|Urological Agents|urological agents|mesh-ancestor
25769575|NCT03493386|Glycine|glycine|mesh-list
25769576|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
25769577|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769578|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769579|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777047|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
25777048|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
25777049|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
25777050|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777051|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777052|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777053|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25777054|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777055|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25777056|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25777057|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777058|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
25777059|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
25777060|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777061|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777062|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
25777063|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25777064|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
25777065|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25777066|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777067|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25777068|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25777069|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25777070|NCT03753113|Minoxidil|minoxidil|mesh-list
25777071|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777072|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
25777073|NCT03751657|Insulin|insulin|mesh-list
25777074|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25777075|NCT03751657|Metformin|metformin|mesh-list
25777076|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
25777077|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25777078|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25777079|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777080|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
25777081|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777082|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777083|NCT03747497|Linezolid|linezolid|mesh-list
25777084|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25777085|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777086|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25777087|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777088|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769580|NCT03493542|Vaccines|vaccines|mesh-list
25769581|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
25769582|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769583|NCT03493698|Midazolam|midazolam|mesh-list
25769584|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25769585|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25769586|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769587|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769588|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25769589|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25769590|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769591|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25769592|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
25769593|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
25769594|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
25769595|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
25769596|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769597|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769598|NCT03493828|Bupivacaine|bupivacaine|mesh-list
25769599|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769600|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
25769601|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769602|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769603|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
25769604|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769605|NCT03494816|Axitinib|axitinib|mesh-list
25769606|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769607|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25769608|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769609|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769610|NCT03494985|Muramidase|muramidase|mesh-list
25769611|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769612|NCT03495102|Dulaglutide|dulaglutide|mesh-list
25769613|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769614|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769615|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
25769616|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769617|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769618|NCT03496324|Ibuprofen|ibuprofen|mesh-list
25769619|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769620|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769621|NCT03496324|Analgesics|analgesics|mesh-ancestor
25769622|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
25769623|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769624|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769625|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769626|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769627|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25769628|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769629|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769630|NCT03496467|Nepafenac|nepafenac|mesh-list
25769631|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769632|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769633|NCT03496467|Analgesics|analgesics|mesh-ancestor
25769634|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
25769635|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769636|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769637|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769638|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769639|NCT03496545|Acetaminophen|acetaminophen|mesh-list
25769640|NCT03496545|Bromocriptine|bromocriptine|mesh-list
25769641|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769642|NCT03496545|Analgesics|analgesics|mesh-ancestor
25769643|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
25769644|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769645|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769646|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
25769647|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25769648|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25769649|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
25769650|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769651|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
25769652|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
25769653|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769654|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777089|NCT03743038|Minocycline|minocycline|mesh-list
25769655|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25769656|NCT03496974|Antibodies|antibodies|mesh-list
25769657|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
25769658|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25769659|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
25769660|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769661|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769662|NCT03497039|Diclofenac|diclofenac|mesh-list
25769663|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769664|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769665|NCT03497039|Analgesics|analgesics|mesh-ancestor
25769666|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
25769667|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769668|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769669|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769670|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769671|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25769672|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769673|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769674|NCT03497429|Niraparib|niraparib|mesh-list
25769675|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25769676|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769677|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769678|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769679|NCT03497845|Vaccines|vaccines|mesh-list
25769680|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
25769681|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769682|NCT03498196|Avelumab|avelumab|mesh-list
25769683|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25769684|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769685|NCT03499353|Talazoparib|talazoparib|mesh-list
25769686|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25769687|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769688|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769689|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769690|NCT03499873|Nepafenac|nepafenac|mesh-list
25769691|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769692|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769693|NCT03499873|Analgesics|analgesics|mesh-ancestor
25769694|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
25769695|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769696|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769697|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769698|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769699|NCT03500211|Lidocaine|lidocaine|mesh-list
25769700|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769701|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
25769702|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769703|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769704|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
25769705|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769706|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25769707|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25769708|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25769709|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25769710|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769711|NCT03500289|Midazolam|midazolam|mesh-list
25769712|NCT03500289|Ketamine|ketamine|mesh-list
25769713|NCT03500289|Analgesics|analgesics|mesh-ancestor
25769714|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
25769715|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769716|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769717|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25769718|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25769719|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
25769720|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
25769721|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017765|NCT03704623|Analgesics|analgesics|mesh-ancestor
25017766|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
25017767|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017768|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017769|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
25769722|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25769723|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25769724|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769725|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769726|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25769727|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25769728|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25769729|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25769730|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769731|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
25769732|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
25769734|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25769735|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25769736|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
25769737|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769738|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25769739|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25769740|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25769741|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25769742|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769743|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
25769744|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769745|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769746|NCT03501277|Pioglitazone|pioglitazone|mesh-list
25769747|NCT03501277|Alogliptin|alogliptin|mesh-list
25769748|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769749|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769750|NCT03501277|Incretins|incretins|mesh-ancestor
25769751|NCT03501277|Hormones|hormones|mesh-ancestor
25769752|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769753|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25769754|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
25769755|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769756|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769757|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25769758|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
25769759|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769760|NCT03502616|Tofacitinib|tofacitinib|mesh-list
25769761|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25769762|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769763|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769764|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
25769765|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25769766|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
25769767|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
25769768|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769769|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769770|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769771|NCT03502915|Analgesics|analgesics|mesh-ancestor
25769772|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
25769773|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769774|NCT03503292|Ondansetron|ondansetron|mesh-list
25769775|NCT03503292|Granisetron|granisetron|mesh-list
25769776|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
25769777|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
25769778|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769779|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769780|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769781|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
25769782|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
25769783|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25769784|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
25769785|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769786|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769787|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25769788|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25769789|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769790|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25769791|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25769792|NCT03503578|Ketamine|ketamine|mesh-list
25769793|NCT03503578|Sevoflurane|sevoflurane|mesh-list
25769794|NCT03503578|Analgesics|analgesics|mesh-ancestor
25769795|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
25769796|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769797|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769798|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25769799|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25769800|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
25769802|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769803|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25769804|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25769805|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769806|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769807|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25769808|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25769809|NCT03506347|Vancomycin|vancomycin|mesh-list
25769810|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25769811|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769812|NCT03506724|Labetalol|labetalol|mesh-list
25769813|NCT03506724|Nifedipine|nifedipine|mesh-list
25769814|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25769815|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25769816|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769817|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25769818|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769819|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
25769820|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
25769821|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25769822|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25769823|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25769824|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
25769825|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769826|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25769827|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
25769828|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
25769829|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769830|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25769831|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25769832|NCT03508830|Bupivacaine|bupivacaine|mesh-list
25769833|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769834|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
25769835|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769836|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769837|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
25769838|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769839|NCT03509350|Vitamins|vitamins|mesh-list
25769840|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
25769841|NCT03509350|Thiamine|thiamine|mesh-list
25769842|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
25769843|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25769844|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25769845|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25769846|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
25769847|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769848|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769849|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
25769850|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769851|NCT03509350|Protective Agents|protective agents|mesh-ancestor
25769852|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
25769853|NCT03509675|Ibuprofen|ibuprofen|mesh-list
25769854|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25769855|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769856|NCT03509675|Analgesics|analgesics|mesh-ancestor
25769857|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
25769858|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769859|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769860|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769861|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25769862|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25769863|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769864|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769865|NCT03509766|Histamine|histamine|mesh-list
25769866|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
25769867|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
25769868|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769869|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923829|NCT04166578|Lidocaine|lidocaine|mesh-list
25769870|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769871|NCT03509883|Apixaban|apixaban|mesh-list
25769872|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25769873|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
25769874|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25769875|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
25769876|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769877|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769878|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
25769879|NCT03510455|Infigratinib|infigratinib|mesh-list
25769880|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769881|NCT03510481|Lumefantrine|lumefantrine|mesh-list
25769882|NCT03510481|Artemether|artemether|mesh-list
25769883|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
25769884|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25769885|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25769886|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769887|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
25769888|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25769889|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25769890|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25769891|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25769892|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769893|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769894|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769895|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
25769896|NCT03510715|Niacin|niacin|mesh-list
25769897|NCT03510715|Niacinamide|niacinamide|mesh-list
25769898|NCT03510715|Atorvastatin|atorvastatin|mesh-list
25769899|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25769900|NCT03510715|Simvastatin|simvastatin|mesh-list
25769901|NCT03510715|Ezetimibe|ezetimibe|mesh-list
25769902|NCT03510715|Pravastatin|pravastatin|mesh-list
25769903|NCT03510715|Lovastatin|lovastatin|mesh-list
25769904|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
25769905|NCT03510715|Fenofibrate|fenofibrate|mesh-list
25769906|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25769907|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25769908|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
25769909|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769910|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25769911|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25769912|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25769913|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
25769914|NCT03510715|Vitamins|vitamins|mesh-ancestor
25769915|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
25769916|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769917|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
25769918|NCT03510910|Acetaminophen|acetaminophen|mesh-list
25769919|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769920|NCT03510910|Analgesics|analgesics|mesh-ancestor
25769921|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
25769922|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769923|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769924|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
25769925|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25769926|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25769927|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25769928|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25769929|NCT03511521|Insulin|insulin|mesh-list
25769930|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25769931|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
25769932|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
25769933|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
25769934|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
25769935|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769936|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777090|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25777091|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777092|NCT03742154|Varenicline|varenicline|mesh-list
25777093|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25777094|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25777095|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
25777096|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777097|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777098|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777099|NCT03740659|Levofloxacin|levofloxacin|mesh-list
25777100|NCT03740659|Ofloxacin|ofloxacin|mesh-list
25777101|NCT03740659|Dexamethasone|dexamethasone|mesh-list
25777102|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
25777103|NCT03740659|BB 1101|bb 1101|mesh-list
25769937|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25769938|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
25769939|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769940|NCT03512353|Dexamethasone|dexamethasone|mesh-list
25769941|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769942|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
25769943|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
25769944|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769945|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769946|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25769947|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
25769949|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25769950|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25769951|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25769952|NCT03513757|Lidocaine|lidocaine|mesh-list
25769953|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
25769954|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
25769955|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
25769956|NCT03513757|Propofol|propofol|mesh-list
25769957|NCT03513757|Sevoflurane|sevoflurane|mesh-list
25769958|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769959|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
25769960|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769961|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769962|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
25769963|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769964|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25769965|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25769966|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25769967|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25769968|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25769969|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25769970|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25769971|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
25769972|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25769973|NCT03513757|Analgesics|analgesics|mesh-ancestor
25769974|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25769975|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25769976|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25769977|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
25769978|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25769979|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25769980|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25769981|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25769982|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25769983|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25769984|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
25769985|NCT03514277|Bupivacaine|bupivacaine|mesh-list
25769986|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
25769987|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
25769988|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25769989|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769990|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
25769991|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25769992|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
25769993|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25769994|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25769995|NCT03515941|Leucovorin|leucovorin|mesh-list
25769996|NCT03515941|Fluorouracil|fluorouracil|mesh-list
25769997|NCT03515941|Capecitabine|capecitabine|mesh-list
25769998|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
25769999|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
25770000|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770001|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25770002|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770003|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25770004|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
25770005|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770006|NCT03515941|Antidotes|antidotes|mesh-ancestor
25770007|NCT03515941|Protective Agents|protective agents|mesh-ancestor
25770008|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
25770009|NCT03515941|Vitamins|vitamins|mesh-ancestor
25770010|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
25770011|NCT03518125|Vaccines|vaccines|mesh-list
25770012|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
24925073|NCT04154722|Meropenem|meropenem|mesh-list
25770013|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770014|NCT03519204|Lidocaine|lidocaine|mesh-list
25770015|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
25770016|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
25770017|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770018|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770019|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
25770020|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770021|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25770022|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25770023|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25770024|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770025|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770026|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
25770027|NCT03519243|Hematinics|hematinics|mesh-ancestor
25770028|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
25770029|NCT03519516|Levofloxacin|levofloxacin|mesh-list
25770030|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25770031|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25770032|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25770033|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770034|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25770035|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25770036|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770037|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770038|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770039|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25770040|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25770041|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25770042|NCT03519516|Renal Agents|renal agents|mesh-ancestor
25770043|NCT03519854|Bromides|bromides|mesh-list
25770044|NCT03519854|Rocuronium|rocuronium|mesh-list
25770045|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
25770046|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25770047|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25770048|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25770049|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770050|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770051|NCT03519867|Bromides|bromides|mesh-list
25770052|NCT03519867|Rocuronium|rocuronium|mesh-list
25770053|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
25770054|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25770055|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25770056|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25770057|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770058|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770059|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
25770060|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
25770061|NCT03520348|Vitamins|vitamins|mesh-ancestor
25770062|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
25770063|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770064|NCT03520920|Rituximab|rituximab|mesh-list
25770065|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
25770066|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25770067|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770068|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
25770069|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770070|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770071|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25770072|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770073|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770074|NCT03521141|Nicotine|nicotine|mesh-list
25770075|NCT03521141|Varenicline|varenicline|mesh-list
25770076|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25770077|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
25770078|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770079|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770080|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25770081|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25770082|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770083|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770084|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399357|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25770085|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
25770086|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25770087|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
25770088|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770089|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
25770090|NCT03521505|Propofol|propofol|mesh-list
25770091|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25770092|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770093|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770094|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25770095|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
25770096|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
25770097|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770098|NCT03521505|Analgesics|analgesics|mesh-ancestor
25770099|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
25770100|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770101|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25770102|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25770103|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25770104|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
25770105|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770106|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770107|NCT03521635|Pramipexole|pramipexole|mesh-list
25770108|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
25770109|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770110|NCT03521635|Protective Agents|protective agents|mesh-ancestor
25770111|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770112|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25770113|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25770114|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
25770115|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
25770116|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770117|NCT03521791|Bromfenac|bromfenac|mesh-list
25770118|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770119|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770120|NCT03521791|Analgesics|analgesics|mesh-ancestor
25770121|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
25770122|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770123|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770124|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770125|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770126|NCT03521817|Ethanol|ethanol|mesh-list
25770127|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25770128|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770129|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770130|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770131|NCT03522441|Clindamycin|clindamycin|mesh-list
25770132|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
25770133|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
25770134|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25770135|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770136|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25770137|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770138|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770139|NCT03522506|Modafinil|modafinil|mesh-list
25770140|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25770141|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770142|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25770143|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25770144|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25770145|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770146|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25770147|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
25770148|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770149|NCT03523988|Acetaminophen|acetaminophen|mesh-list
25770150|NCT03523988|Ibuprofen|ibuprofen|mesh-list
25770151|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770152|NCT03523988|Analgesics|analgesics|mesh-ancestor
25770153|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
25770154|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770155|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770156|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
25770157|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770158|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770159|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770160|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25770161|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770162|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770163|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25770164|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25770165|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
25770166|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25770167|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
25770168|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770169|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
25770170|NCT03524157|Protective Agents|protective agents|mesh-ancestor
25770171|NCT03524339|Tamsulosin|tamsulosin|mesh-list
25770172|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25770173|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25770174|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25770175|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
25770176|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770177|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770178|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770179|NCT03524339|Urological Agents|urological agents|mesh-ancestor
25770180|NCT03525444|Ivacaftor|ivacaftor|mesh-list
25770181|NCT03525444|Elexacaftor|elexacaftor|mesh-list
25770182|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25770183|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770184|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770185|NCT03525548|Ivacaftor|ivacaftor|mesh-list
25770186|NCT03525548|Elexacaftor|elexacaftor|mesh-list
25770187|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25770188|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770189|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770190|NCT03525834|Everolimus|everolimus|mesh-list
25770191|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770192|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25770193|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
25770194|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770195|NCT03527173|Vaccines|vaccines|mesh-list
25770196|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
25770197|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770198|NCT03527745|Albendazole|albendazole|mesh-list
25770199|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
25770200|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25770201|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770202|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
25770203|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25770204|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25770205|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
25770206|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
25770207|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
25770208|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770209|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770210|NCT03528174|Pancrelipase|pancrelipase|mesh-list
25770211|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770212|NCT03528369|Capsaicin|capsaicin|mesh-list
25770213|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
25770214|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
25770215|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
25770216|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770217|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770218|NCT03528512|Fentanyl|fentanyl|mesh-list
25770219|NCT03528512|Midazolam|midazolam|mesh-list
25770220|NCT03528512|Ketamine|ketamine|mesh-list
25770221|NCT03528512|Analgesics|analgesics|mesh-ancestor
25770222|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
25770223|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770224|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770225|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25770226|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25770227|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
25770228|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
25770229|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770230|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25770231|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25770232|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770233|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770234|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25770235|NCT03528512|Narcotics|narcotics|mesh-ancestor
25770236|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24926956|NCT04137380|Analgesics|analgesics|mesh-ancestor
25770237|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25770238|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25770239|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25770240|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25770241|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
25770242|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
25770243|NCT03528551|Factor VIII|factor viii|mesh-list
25770244|NCT03528551|Coagulants|coagulants|mesh-ancestor
25770245|NCT03528577|Albuterol|albuterol|mesh-list
25770246|NCT03528577|Procaterol|procaterol|mesh-list
25770247|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25770248|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
25770249|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770250|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770251|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25770252|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25770253|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
25770254|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25770255|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25770256|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25770257|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25770258|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
25770259|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770260|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770261|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
25770262|NCT03530631|Adderall|adderall|mesh-list
25770263|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25770264|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770265|NCT03531840|Olaparib|olaparib|mesh-list
25770266|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25770267|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770268|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770269|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770270|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25770271|NCT03531905|Ezetimibe|ezetimibe|mesh-list
25770272|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25770273|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25770274|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
25770275|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770276|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25770277|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770278|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25770279|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770280|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
25770281|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25770282|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770283|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
25770284|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
25770285|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
25770286|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
25770287|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
25770288|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770289|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25770290|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25770291|NCT03535194|Mirikizumab|mirikizumab|mesh-list
25770292|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770293|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770294|NCT03535194|Analgesics|analgesics|mesh-ancestor
25770295|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
25770296|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770297|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770298|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770299|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770300|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25770301|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777104|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777105|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
25777106|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
25777107|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777108|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777109|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777110|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
25777111|NCT03740659|Hormones|hormones|mesh-ancestor
25777112|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524793|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770302|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25770303|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25770304|NCT03537274|Interferons|interferons|mesh-list
25770305|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
25770306|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
25770307|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25770308|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770309|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
25770310|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770311|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
25770312|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770313|NCT03537404|Ritonavir|ritonavir|mesh-list
25770314|NCT03537404|Tenofovir|tenofovir|mesh-list
25770315|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
25770316|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25770317|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25770318|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
25770319|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770320|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770321|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25770322|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25770323|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
25770324|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770325|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25770326|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25770327|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25770328|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25770329|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25770330|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25770331|NCT03537651|Ivacaftor|ivacaftor|mesh-list
25770332|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25770333|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770334|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770335|NCT03538431|Buspirone|buspirone|mesh-list
25770336|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25770337|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25770338|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770339|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770340|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25770341|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25770342|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
25770343|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770344|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770345|NCT03538808|Varenicline|varenicline|mesh-list
25770346|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25770347|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25770348|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770349|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770350|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770351|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770352|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
25770353|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25770354|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
25770355|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770356|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25770357|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25770358|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25770359|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770360|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
25770361|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25770362|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770363|NCT03540030|Acetaminophen|acetaminophen|mesh-list
25770364|NCT03540030|Celecoxib|celecoxib|mesh-list
25770365|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25770366|NCT03540030|Lidocaine|lidocaine|mesh-list
25770367|NCT03540030|Gabapentin|gabapentin|mesh-list
25770368|NCT03540030|Propofol|propofol|mesh-list
25770369|NCT03540030|Sevoflurane|sevoflurane|mesh-list
25770370|NCT03540030|Desflurane|desflurane|mesh-list
25770371|NCT03540030|Rocuronium|rocuronium|mesh-list
25770372|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
25770373|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
25770374|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
25770375|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770376|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624516|NCT01076582|Estrogens|estrogens|mesh-ancestor
25770377|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
25770378|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770379|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25770380|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25770381|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25770382|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770383|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770384|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25770385|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25770386|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
25770387|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770388|NCT03540030|Analgesics|analgesics|mesh-ancestor
25770389|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
25770390|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25770391|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25770392|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770393|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770394|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770395|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25770396|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25770397|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770398|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
25770399|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25770400|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25770401|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25770402|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25770403|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25770404|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770405|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
25770406|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25770407|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25770408|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25770409|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25770410|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25770411|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770412|NCT03540160|Serlopitant|serlopitant|mesh-list
25770413|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25770414|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770415|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770416|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770417|NCT03541044|Nicotine|nicotine|mesh-list
25770418|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25770419|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
25770420|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770421|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770422|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25770423|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25770424|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770425|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770426|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770427|NCT03541356|Carbidopa|carbidopa|mesh-list
25770428|NCT03541356|Levodopa|levodopa|mesh-list
25770429|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25770430|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25770431|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25770432|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
25770433|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770434|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770435|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770436|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25770437|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770438|NCT03541941|Bupivacaine|bupivacaine|mesh-list
25770439|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
25770440|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
25770441|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770442|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770443|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
25770444|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770445|NCT03541980|Acetaminophen|acetaminophen|mesh-list
25770446|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770447|NCT03541980|Analgesics|analgesics|mesh-ancestor
25770448|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
25770449|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770450|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770451|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
25770452|NCT03543137|Nicotine|nicotine|mesh-list
25770453|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25770454|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
25770455|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770456|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770457|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25770458|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25770459|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770460|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770461|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770462|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25770463|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
25770464|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25770465|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770466|NCT03545503|Ketamine|ketamine|mesh-list
25770467|NCT03545503|Etomidate|etomidate|mesh-list
25770468|NCT03545503|Analgesics|analgesics|mesh-ancestor
25770469|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
25770470|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770471|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770472|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25770473|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25770474|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
25770475|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
25770476|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770477|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25770478|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25770479|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770480|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770481|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25770482|NCT03545893|Ibuprofen|ibuprofen|mesh-list
25770483|NCT03545893|Oxycodone|oxycodone|mesh-list
25770484|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770485|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770486|NCT03545893|Analgesics|analgesics|mesh-ancestor
25770487|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
25770488|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770489|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770490|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770491|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770492|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25770493|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770494|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770495|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25770496|NCT03545893|Narcotics|narcotics|mesh-ancestor
25770497|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770498|NCT03546621|Tenofovir|tenofovir|mesh-list
25770499|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
25770500|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770501|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25770502|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25770503|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770504|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770505|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25770506|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25770507|NCT03546816|Serlopitant|serlopitant|mesh-list
25770508|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25770509|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770510|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770511|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770512|NCT03547154|Interferons|interferons|mesh-list
25770513|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
25770514|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
25770515|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25770516|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770517|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
25770518|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770519|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
25770520|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927871|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24927872|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526050|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166591|NCT03850535|Cytarabine|cytarabine|mesh-list
25166592|NCT03850535|Daunorubicin|daunorubicin|mesh-list
25770521|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25770522|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
25770523|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770524|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25770525|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25770526|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770527|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25770528|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
25770529|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770530|NCT03551730|Enoxaparin|enoxaparin|mesh-list
25770531|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
25770532|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
25770533|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25770534|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25770535|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770536|NCT03551743|Edoxaban|edoxaban|mesh-list
25770537|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25770538|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
25770539|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25770540|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
25770541|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770542|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770543|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
25770544|NCT03552523|Pancrelipase|pancrelipase|mesh-list
25770545|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770546|NCT03552549|Interferons|interferons|mesh-list
25770547|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
25770548|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
25770549|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25770550|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770551|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
25770552|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770553|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
25770554|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770555|NCT03553758|Ketamine|ketamine|mesh-list
25770556|NCT03553758|Analgesics|analgesics|mesh-ancestor
25770557|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
25770558|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770559|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770560|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25770561|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25770562|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
25770563|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
25770564|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770565|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25770566|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25770567|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770568|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770569|NCT03553940|Vaccines|vaccines|mesh-list
25770570|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
25770571|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770572|NCT03554005|Acetaminophen|acetaminophen|mesh-list
25770573|NCT03554005|Interferons|interferons|mesh-list
25770574|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
25770575|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
25770576|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25770577|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770578|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
25770579|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770580|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770581|NCT03554005|Analgesics|analgesics|mesh-ancestor
25770582|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
25770583|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770584|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770585|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
25770586|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
25770587|NCT03554018|Acetaminophen|acetaminophen|mesh-list
25770588|NCT03554018|Ibuprofen|ibuprofen|mesh-list
25770589|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770590|NCT03554018|Analgesics|analgesics|mesh-ancestor
24928306|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928307|NCT04123652|Lidocaine|lidocaine|mesh-list
24928308|NCT04123652|Ketamine|ketamine|mesh-list
24928309|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
24928382|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770591|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
25770592|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770593|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777902|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777903|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25777904|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25777905|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25777906|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777907|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777908|NCT03007719|Fluorides|fluorides|mesh-list
25777909|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
25777910|NCT03007719|Protective Agents|protective agents|mesh-ancestor
25777911|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777912|NCT03010423|Nicorandil|nicorandil|mesh-list
25777913|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25777914|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777915|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
25777916|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
25777917|NCT03010423|Vitamins|vitamins|mesh-ancestor
25777918|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
25777919|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777920|NCT02985801|Pancrelipase|pancrelipase|mesh-list
25777921|NCT02985801|Pancreatin|pancreatin|mesh-list
25777922|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777923|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
25777924|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25777925|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25777926|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25777927|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777928|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777929|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
25777930|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777931|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777932|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25777933|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777934|NCT02994251|Gemcitabine|gemcitabine|mesh-list
25777935|NCT02994251|Cisplatin|cisplatin|mesh-list
25777936|NCT02994251|Doxorubicin|doxorubicin|mesh-list
25777937|NCT02994251|Mitomycins|mitomycins|mesh-list
25777938|NCT02994251|Mitomycin|mitomycin|mesh-list
25777939|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777940|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25777941|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
25777942|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777943|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
25777944|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777945|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777946|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777947|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
25777948|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777949|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25777950|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25777951|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25777952|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
25777953|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25777954|NCT02971839|Ivacaftor|ivacaftor|mesh-list
25777955|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25777956|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777957|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777958|NCT02985840|Dexamethasone|dexamethasone|mesh-list
25777959|NCT02985840|Ondansetron|ondansetron|mesh-list
25777960|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777961|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
25777962|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
25777963|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777964|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777965|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777966|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
25777967|NCT02985840|Hormones|hormones|mesh-ancestor
25777968|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777969|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25777970|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777971|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
25777972|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
25777973|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25777974|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
25777975|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777976|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777977|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25777979|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777980|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777981|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25777982|NCT02974803|Trametinib|trametinib|mesh-list
25777983|NCT02974803|Dabrafenib|dabrafenib|mesh-list
25777984|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777985|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25777986|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777987|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777988|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
25777989|NCT02974686|Everolimus|everolimus|mesh-list
25777990|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777991|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777992|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
25777993|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777994|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25777995|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25777996|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
25777997|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25777998|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777999|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778000|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778001|NCT02956005|Tacrolimus|tacrolimus|mesh-list
25778002|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778003|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
25778004|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778005|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25778006|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778007|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778008|NCT02966184|Albuterol|albuterol|mesh-list
25778009|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25778010|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
25778011|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778012|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778013|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25778014|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778015|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
25778016|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25778017|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25778018|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25778019|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25778020|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
25778021|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778022|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778023|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25778024|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25778025|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25778026|NCT02954159|Vedolizumab|vedolizumab|mesh-list
25778027|NCT02954159|Tacrolimus|tacrolimus|mesh-list
25778028|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778029|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
25778030|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778031|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25778032|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778033|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778034|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778035|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
25778036|NCT02947022|Zinc|zinc|mesh-list
25778037|NCT02947022|Edetic Acid|edetic acid|mesh-list
25778038|NCT02947022|Calcium|calcium|mesh-list
25778039|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
25778040|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25778041|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778042|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25778043|NCT02947022|Trace Elements|trace elements|mesh-ancestor
25778044|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
25778045|NCT02947022|Antidotes|antidotes|mesh-ancestor
25778046|NCT02947022|Protective Agents|protective agents|mesh-ancestor
25778047|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
25778048|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
25778049|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933585|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
24933586|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
24933587|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778050|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25778051|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
25778052|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25778053|NCT02936999|Vitamin D|vitamin d|mesh-list
25778054|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
25778055|NCT02936999|Vitamins|vitamins|mesh-ancestor
25778056|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
25778057|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778058|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25778059|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25778060|NCT02950480|Zafirlukast|zafirlukast|mesh-list
25778061|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25778062|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778063|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25778064|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
25778065|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778066|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778067|NCT02936206|Tamoxifen|tamoxifen|mesh-list
25778068|NCT02936206|Fulvestrant|fulvestrant|mesh-list
25778069|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25778070|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
25778071|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778072|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778073|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25778074|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778075|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25778076|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25778077|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25778078|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25778079|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
25778080|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
25778081|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778082|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778083|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778084|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
25778085|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
25778086|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
25778087|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25778088|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25778089|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778090|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
25778091|NCT02908516|Coagulants|coagulants|mesh-ancestor
25778092|NCT02920450|Paclitaxel|paclitaxel|mesh-list
25778093|NCT02920450|Carboplatin|carboplatin|mesh-list
25778094|NCT02920450|Gedatolisib|gedatolisib|mesh-list
25778095|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25778096|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778097|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
25778098|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
25778099|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
25778100|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778101|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25778102|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778103|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25778104|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778105|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
25778106|NCT02920177|Hormones|hormones|mesh-ancestor
25778107|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778108|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778109|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778110|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
25778111|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25778112|NCT02926638|Rilotumumab|rilotumumab|mesh-list
25778113|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25778114|NCT02926638|Antibodies|antibodies|mesh-list
25778115|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
25778116|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25778117|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
25778118|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778119|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778120|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25778121|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778122|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531028|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778123|NCT02920242|Rifaximin|rifaximin|mesh-list
25778124|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25778125|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778126|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778127|NCT02892500|Betamethasone|betamethasone|mesh-list
25778128|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
25778129|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25778130|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
25778131|NCT02892500|Bupivacaine|bupivacaine|mesh-list
25778132|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25778133|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25778134|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
25778135|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778136|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778137|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
25778138|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778139|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778140|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
25778141|NCT02892500|Hormones|hormones|mesh-ancestor
25778142|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778143|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25778144|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778145|NCT02899728|Cisplatin|cisplatin|mesh-list
25778146|NCT02899728|Carboplatin|carboplatin|mesh-list
25778147|NCT02899728|Etoposide|etoposide|mesh-list
25778148|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
25778149|NCT02899728|Olaparib|olaparib|mesh-list
25778150|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
25778151|NCT02899728|Cediranib|cediranib|mesh-list
25778152|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25778153|NCT02899728|Maleic acid|maleic acid|mesh-list
25778154|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778155|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25778156|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25778157|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25778158|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778159|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778160|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
25778161|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
25778162|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
25778163|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
25778164|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
25778165|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25778166|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
25778167|NCT02875067|Lenalidomide|lenalidomide|mesh-list
25778168|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25778169|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778170|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
25778171|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778172|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25778173|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25778174|NCT02875067|Growth Substances|growth substances|mesh-ancestor
25778175|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25778176|NCT02868892|Pemetrexed|pemetrexed|mesh-list
25778177|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778178|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778179|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778180|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25778181|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25778182|NCT02828124|Nivolumab|nivolumab|mesh-list
25778183|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25778184|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778185|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25778186|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937079|NCT04033094|Analgesics|analgesics|mesh-ancestor
25778188|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
25778189|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
25778190|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778191|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778192|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
25778193|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778194|NCT02819804|Nivolumab|nivolumab|mesh-list
25778195|NCT02819804|Dasatinib|dasatinib|mesh-list
25778196|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25778197|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778198|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25778199|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778200|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25778201|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778202|NCT02806960|Glucagon|glucagon|mesh-list
25778203|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778204|NCT02806960|Hormones|hormones|mesh-ancestor
25778205|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778206|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778207|NCT02815397|Metformin|metformin|mesh-list
25778208|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25778209|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778210|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
25778211|NCT02802592|Hematinics|hematinics|mesh-ancestor
25778212|NCT02774148|Acetaminophen|acetaminophen|mesh-list
25778213|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778214|NCT02774148|Analgesics|analgesics|mesh-ancestor
25778215|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
25778216|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778217|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778218|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
25778219|NCT02773576|Risperidone|risperidone|mesh-list
25778220|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25778221|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
25778222|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778223|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778224|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778225|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25778226|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25778227|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778228|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778229|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25778230|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
25778231|NCT02730793|Aztreonam|aztreonam|mesh-list
25778232|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25778233|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778234|NCT02744352|Ropivacaine|ropivacaine|mesh-list
25778235|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
25778236|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
25778237|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778238|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778239|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
25778240|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778241|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
25778242|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25778243|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
25778244|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
25778245|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778246|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778247|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778248|NCT02757521|Analgesics|analgesics|mesh-ancestor
25778249|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
25778250|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778251|NCT02758132|Denosumab|denosumab|mesh-list
25778252|NCT02758132|Prednisone|prednisone|mesh-list
25778253|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778254|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
25778255|NCT02758132|Hormones|hormones|mesh-ancestor
25778256|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778257|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778258|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25778259|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778260|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25778261|NCT02734940|Lidocaine|lidocaine|mesh-list
25778262|NCT02734940|Fentanyl|fentanyl|mesh-list
25778263|NCT02734940|Ketamine|ketamine|mesh-list
25778264|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
25778265|NCT02734940|Morphine|morphine|mesh-list
25778266|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
25778267|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
25778268|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778269|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778270|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
25778271|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778272|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25778273|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25778274|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25778275|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25778276|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778277|NCT02734940|Analgesics|analgesics|mesh-ancestor
25778278|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25778279|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25778280|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
25778281|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25778282|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25778283|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778284|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25778285|NCT02734940|Narcotics|narcotics|mesh-ancestor
25778286|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25778287|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25778288|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778289|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25778290|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25778291|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25778292|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
25778293|NCT02749617|Apixaban|apixaban|mesh-list
25778294|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25778295|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
25778296|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25778297|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
25778298|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778299|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778300|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
25778301|NCT02749227|Pasireotide|pasireotide|mesh-list
25778302|NCT02749227|Hormones|hormones|mesh-ancestor
25778303|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778304|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778305|NCT02746263|Acetaminophen|acetaminophen|mesh-list
25778306|NCT02746263|Morphine|morphine|mesh-list
25778307|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25778308|NCT02746263|Narcotics|narcotics|mesh-ancestor
25778309|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778310|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778311|NCT02746263|Analgesics|analgesics|mesh-ancestor
25778312|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
25778313|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778314|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778315|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
25778316|NCT02721277|SMOFlipid|smoflipid|mesh-list
25778317|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25778318|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25778319|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25778320|NCT02732327|Vancomycin|vancomycin|mesh-list
25778321|NCT02732327|Meropenem|meropenem|mesh-list
25778322|NCT02732327|Tazobactam|tazobactam|mesh-list
25778323|NCT02732327|Linezolid|linezolid|mesh-list
25778324|NCT02732327|Piperacillin|piperacillin|mesh-list
25778325|NCT02732327|Cefepime|cefepime|mesh-list
25778326|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25778327|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25778328|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778329|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25778330|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778331|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778332|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25778333|NCT02726399|Cisplatin|cisplatin|mesh-list
25778334|NCT02726399|Capecitabine|capecitabine|mesh-list
25778335|NCT02726399|Trastuzumab|trastuzumab|mesh-list
25778336|NCT02726399|Ramucirumab|ramucirumab|mesh-list
25778337|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778338|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25778339|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
25778340|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778341|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25778342|NCT02720510|Dexamethasone|dexamethasone|mesh-list
25778343|NCT02720510|Lenalidomide|lenalidomide|mesh-list
25778344|NCT02720510|Bortezomib|bortezomib|mesh-list
25778345|NCT02720510|Panobinostat|panobinostat|mesh-list
25778346|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778347|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
25778348|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
25778349|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778350|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778351|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778352|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
25778353|NCT02720510|Hormones|hormones|mesh-ancestor
25778354|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778355|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25778356|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778357|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
25778358|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25778359|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25778360|NCT02720510|Growth Substances|growth substances|mesh-ancestor
25778361|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
25778362|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25778363|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778364|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778365|NCT02717949|Ribavirin|ribavirin|mesh-list
25778366|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
25778367|NCT02717949|Ledipasvir|ledipasvir|mesh-list
25778368|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
25778369|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778370|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
25778371|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778372|NCT02717130|Aripiprazole|aripiprazole|mesh-list
25778373|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
25778374|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778375|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25778376|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25778377|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778378|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778379|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
25778380|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
25778381|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778382|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778383|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25778384|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25778385|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
25778386|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25778387|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25778388|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25778389|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25778390|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
25778391|NCT02709083|Dasatinib|dasatinib|mesh-list
25778392|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778393|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25778394|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778395|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778396|NCT02693171|Dinutuximab|dinutuximab|mesh-list
25778397|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778398|NCT02696226|Aspirin|aspirin|mesh-list
25778399|NCT02696226|Warfarin|warfarin|mesh-list
25778400|NCT02696226|Clopidogrel|clopidogrel|mesh-list
25778401|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25778402|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778403|NCT02696226|Analgesics|analgesics|mesh-ancestor
25778404|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
25778405|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778406|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778407|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778408|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25778409|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25778410|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25778411|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778412|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25778413|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25778414|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778415|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
25778416|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25778417|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25778418|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25778419|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
25778420|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778421|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
25778422|NCT02706691|Infigratinib|infigratinib|mesh-list
25778423|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778424|NCT02708849|Lamotrigine|lamotrigine|mesh-list
25778426|NCT02708849|Analgesics|analgesics|mesh-ancestor
25778427|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
25778428|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778429|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778430|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25778431|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25778432|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
25778433|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
25778434|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778435|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25778436|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25778437|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778438|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778439|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
25778440|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25778441|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25778442|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25778443|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25778444|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25778445|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778446|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25778447|NCT02693717|Pemetrexed|pemetrexed|mesh-list
25778448|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778449|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778450|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778451|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25778452|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25778453|NCT02693002|Norethindrone|norethindrone|mesh-list
25778454|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
25778455|NCT02693002|Estradiol|estradiol|mesh-list
25778456|NCT02693002|Estrogens|estrogens|mesh-ancestor
25778457|NCT02693002|Hormones|hormones|mesh-ancestor
25778458|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778459|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778460|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25778461|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
25778462|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25778463|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25778464|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25778465|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25778466|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25778467|NCT02689518|Aflibercept|aflibercept|mesh-list
25778468|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25778469|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25778470|NCT02689518|Growth Substances|growth substances|mesh-ancestor
25778471|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778472|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
25778473|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778474|NCT02687165|Cycloserine|cycloserine|mesh-list
25778475|NCT02687165|Milnacipran|milnacipran|mesh-list
25778476|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
25778477|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25778478|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778479|NCT02687165|Renal Agents|renal agents|mesh-ancestor
25778480|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25778481|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
25778482|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25778483|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
25778484|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778485|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25778486|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25778487|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25019048|NCT03693976|Xylometazoline|xylometazoline|mesh-list
25019049|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
25019050|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25778488|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778489|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778490|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778491|NCT02687165|Analgesics|analgesics|mesh-ancestor
25778492|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
25778493|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778494|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
25778495|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778496|NCT02679560|Bupivacaine|bupivacaine|mesh-list
25778497|NCT02679560|Ropivacaine|ropivacaine|mesh-list
25778498|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
25778499|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
25778500|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778501|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778502|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
25778503|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778504|NCT02674204|Atorvastatin|atorvastatin|mesh-list
25778505|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25778506|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25778507|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
25778508|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778509|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25778510|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25778511|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778512|NCT02671461|Aspirin|aspirin|mesh-list
25778513|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25778514|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778515|NCT02671461|Analgesics|analgesics|mesh-ancestor
25778516|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
25778517|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778518|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778519|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778520|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25778521|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25778522|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25778523|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778524|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25778525|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25778526|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778527|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
25778528|NCT02663752|Deferasirox|deferasirox|mesh-list
25778529|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25778530|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
25778531|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
25778532|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778533|NCT02658357|Risperidone|risperidone|mesh-list
25778534|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25778535|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
25778536|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778537|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778538|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778539|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25778540|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25778541|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778542|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778543|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25778544|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
25778545|NCT02658877|Omalizumab|omalizumab|mesh-list
25778546|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25778547|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25778548|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778549|NCT02654639|Bevacizumab|bevacizumab|mesh-list
25778550|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25778551|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778552|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25778553|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25778554|NCT02654639|Growth Substances|growth substances|mesh-ancestor
25778555|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778556|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
25778557|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
25778558|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778559|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
25778560|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778561|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778562|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25778563|NCT02634606|Tocotrienols|tocotrienols|mesh-list
25778564|NCT02634606|Vitamin E|vitamin e|mesh-list
25778565|NCT02634606|Tocopherols|tocopherols|mesh-list
25778566|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
25778567|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778568|NCT02634606|Protective Agents|protective agents|mesh-ancestor
25778569|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778570|NCT02634606|Vitamins|vitamins|mesh-ancestor
25778571|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
25778572|NCT02634827|Decitabine|decitabine|mesh-list
25778573|NCT02634827|Midostaurin|midostaurin|mesh-list
25778574|NCT02634827|Staurosporine|staurosporine|mesh-list
25778575|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25778576|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
25778577|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778578|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778579|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778580|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25778581|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25778582|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25778583|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778584|NCT02638129|Naltrexone|naltrexone|mesh-list
25778585|NCT02638129|Bupropion|bupropion|mesh-list
25778586|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25778587|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25778588|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778589|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
25778590|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778591|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25778592|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
25778593|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778594|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25778595|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25778596|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25778597|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778598|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
25778599|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778600|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25778601|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25778602|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778603|NCT02623959|Doxycycline|doxycycline|mesh-list
25778604|NCT02623959|Fentanyl|fentanyl|mesh-list
25778605|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25778606|NCT02623959|Narcotics|narcotics|mesh-ancestor
25778607|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778608|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778609|NCT02623959|Analgesics|analgesics|mesh-ancestor
25778610|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
25778611|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778612|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25778613|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25778614|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
25778615|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
25778616|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25778617|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778618|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
25778619|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25778620|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25778621|NCT02631148|Melatonin|melatonin|mesh-list
25778622|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
25778623|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778624|NCT02631148|Protective Agents|protective agents|mesh-ancestor
25778625|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778626|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778627|NCT02630472|Quinine|quinine|mesh-list
25778628|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
25778629|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25778630|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25778631|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778632|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25778633|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778634|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25778635|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778636|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778637|NCT02630472|Analgesics|analgesics|mesh-ancestor
25778638|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
25778639|NCT02626520|Gemcitabine|gemcitabine|mesh-list
25778640|NCT02626520|Paclitaxel|paclitaxel|mesh-list
25778641|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25778642|NCT02626520|Fluorouracil|fluorouracil|mesh-list
25778643|NCT02626520|Irinotecan|irinotecan|mesh-list
25778644|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25778645|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778646|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
25778647|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
25778648|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
25778649|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778650|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25778651|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
25778652|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
25778653|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778654|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778655|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778656|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
25778657|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778658|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25778659|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25778660|NCT02614898|Eculizumab|eculizumab|mesh-list
25778661|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25778662|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778663|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
25778664|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778665|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
25778666|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25778667|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778668|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25778669|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778670|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25778671|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
25778672|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25778673|NCT02619812|Antibodies|antibodies|mesh-list
25778674|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
25778675|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778676|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25778677|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25778678|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
25778679|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778680|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25778681|NCT02614586|Ondansetron|ondansetron|mesh-list
25778682|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
25778683|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
25778684|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778685|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778686|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778687|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
25778688|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
25778689|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25778690|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
25778691|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778692|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778693|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25778694|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25778695|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778696|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778697|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25778698|NCT02606279|Valsartan|valsartan|mesh-list
25778699|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25778700|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25778701|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25778702|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778703|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
25778704|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25778705|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
25778706|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778707|NCT02605824|Expectorants|expectorants|mesh-ancestor
25778708|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778709|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25778710|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
25778711|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778712|NCT02605824|Protective Agents|protective agents|mesh-ancestor
25778713|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778714|NCT02605824|Antidotes|antidotes|mesh-ancestor
25778715|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
25778716|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
25778717|NCT02598622|Vitamins|vitamins|mesh-ancestor
25778718|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
25778719|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778720|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
25778721|NCT02589145|Pyridoxine|pyridoxine|mesh-list
25778722|NCT02589145|Gemcitabine|gemcitabine|mesh-list
25778723|NCT02589145|Dexamethasone|dexamethasone|mesh-list
25778724|NCT02589145|Rituximab|rituximab|mesh-list
25778725|NCT02589145|Lenalidomide|lenalidomide|mesh-list
25778726|NCT02589145|Melphalan|melphalan|mesh-list
25778727|NCT02589145|Busulfan|busulfan|mesh-list
25778728|NCT02589145|Vorinostat|vorinostat|mesh-list
25778729|NCT02589145|Enoxaparin|enoxaparin|mesh-list
25778730|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25778731|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778732|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
25778733|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778734|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25778735|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778736|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
25778737|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
25778738|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778739|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778740|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
25778741|NCT02589145|Hormones|hormones|mesh-ancestor
25778742|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778743|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25778744|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25778745|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
25778746|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778747|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
25778748|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778749|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778750|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778751|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25778752|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25778753|NCT02589145|Growth Substances|growth substances|mesh-ancestor
25778754|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
25778755|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25778756|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
25778757|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25778758|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
25778759|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25778760|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25778761|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25778762|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
25778763|NCT02589145|Vitamins|vitamins|mesh-ancestor
25778764|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
25778765|NCT02593682|Suvorexant|suvorexant|mesh-list
25778766|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25778767|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25778768|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778769|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778770|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25778771|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778772|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778773|NCT02587650|Ceritinib|ceritinib|mesh-list
25778774|NCT02587650|Entrectinib|entrectinib|mesh-list
25778775|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778776|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25778777|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778778|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778779|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
25778780|NCT02569957|Topotecan|topotecan|mesh-list
25778781|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25778782|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25778783|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25778784|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778785|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778786|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778787|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
25778788|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778789|NCT02569957|Expectorants|expectorants|mesh-ancestor
25778790|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778791|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25778792|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
25778793|NCT02569957|Protective Agents|protective agents|mesh-ancestor
25778794|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778795|NCT02569957|Antidotes|antidotes|mesh-ancestor
25778796|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
25778797|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
25778798|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
25778799|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778800|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25778801|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
25778802|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
25778803|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778804|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778805|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778806|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25778807|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
25778808|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25778809|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25778810|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25778811|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778812|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778813|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
25778814|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778815|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25778816|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25778817|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778818|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
25778819|NCT02549716|Acetaminophen|acetaminophen|mesh-list
25778820|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25778821|NCT02549716|Analgesics|analgesics|mesh-ancestor
25778822|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
25778823|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778824|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778825|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
25778826|NCT02534038|Quinidine|quinidine|mesh-list
25778827|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
25778828|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
25778829|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778830|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25778831|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25778832|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778833|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778834|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778835|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25778836|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25778837|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
25778838|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25778839|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
25778840|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25778841|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25778842|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778843|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778844|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25778845|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25778846|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
25778847|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25778848|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25778849|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25778850|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25778851|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25778852|NCT02520726|Sertraline|sertraline|mesh-list
25778853|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
25778854|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25778855|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25778856|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25778857|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25778858|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778859|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778860|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
25778861|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778863|NCT02518750|Dexamethasone|dexamethasone|mesh-list
25778864|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
25778865|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
25778866|NCT02518750|Methotrexate|methotrexate|mesh-list
25778867|NCT02518750|Etoposide|etoposide|mesh-list
25778868|NCT02518750|Vincristine|vincristine|mesh-list
25778869|NCT02518750|Bortezomib|bortezomib|mesh-list
25778870|NCT02518750|Asparaginase|asparaginase|mesh-list
25778871|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
25778872|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
25778873|NCT02518750|Clofarabine|clofarabine|mesh-list
25778874|NCT02518750|Panobinostat|panobinostat|mesh-list
25778875|NCT02518750|Pegaspargase|pegaspargase|mesh-list
25778876|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778877|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
25778878|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778879|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25778880|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25778881|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
25778882|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778883|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778884|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25778885|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778886|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
25778887|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
25778888|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778889|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25778890|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
25778891|NCT02518750|Hormones|hormones|mesh-ancestor
25778892|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778893|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25778894|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25778895|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
25778896|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25778897|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25778898|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
25778899|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
25778900|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778901|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25778902|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25778903|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25778904|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25778905|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25778906|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
25778907|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778908|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25778909|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25778910|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25778911|NCT02518750|Analgesics|analgesics|mesh-ancestor
25778912|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
25778913|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25778914|NCT02515851|Bupivacaine|bupivacaine|mesh-list
25778915|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
25778916|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
25778917|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778918|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778919|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
25778920|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778921|NCT02506985|Warfarin|warfarin|mesh-list
25778922|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
25778923|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
25778924|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25778925|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
25778926|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25778927|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
25778928|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778929|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778930|NCT02514252|Fentanyl|fentanyl|mesh-list
25778931|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25778932|NCT02514252|Narcotics|narcotics|mesh-ancestor
25778933|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25778934|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778935|NCT02514252|Analgesics|analgesics|mesh-ancestor
25778936|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
25778937|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778938|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25778939|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25778940|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
25778941|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
25778942|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
25778943|NCT02501759|Antidotes|antidotes|mesh-ancestor
25778944|NCT02501759|Protective Agents|protective agents|mesh-ancestor
25778945|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778946|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
25778947|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
25778948|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778949|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25778950|NCT02487277|Gemcitabine|gemcitabine|mesh-list
25778951|NCT02487277|Paclitaxel|paclitaxel|mesh-list
25778952|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25778953|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778954|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
25778955|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
25778956|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
25778957|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778958|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25778959|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
25778960|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
25778961|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778962|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778963|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25778964|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
25778965|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778966|NCT02499887|Prednisone|prednisone|mesh-list
25778967|NCT02499887|Albuterol|albuterol|mesh-list
25778968|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25778969|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
25778970|NCT02499887|Hormones|hormones|mesh-ancestor
25778971|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25778972|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25778973|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25778974|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778975|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25778976|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
25778977|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25778978|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25778979|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
25778980|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
25778981|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25778982|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25778983|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25778984|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25778985|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
25778986|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25778987|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778988|NCT02504099|Ritonavir|ritonavir|mesh-list
25778989|NCT02504099|Ribavirin|ribavirin|mesh-list
25778990|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25778991|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25778992|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
25778993|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25778994|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25778995|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25778996|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25778997|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
25778998|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25778999|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25779000|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25779001|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
25779002|NCT02500901|Niraparib|niraparib|mesh-list
25779003|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25779004|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779005|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779006|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779007|NCT02496039|Quinidine|quinidine|mesh-list
25779008|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
25779009|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
25779010|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25112511|NCT04029038|Fludarabine|fludarabine|mesh-list
25112512|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25112513|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
25112514|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112515|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779011|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25779012|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25779013|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779014|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779015|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779016|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25779017|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25779018|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
25779019|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25779020|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
25779021|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25779022|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25779023|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779024|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779025|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25779026|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25779027|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
25779028|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25779029|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25779030|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25779031|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25779032|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25779033|NCT02492295|Propofol|propofol|mesh-list
25779034|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25779035|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779036|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779037|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25779038|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
25779039|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
25779040|NCT02473445|Cysteamine|cysteamine|mesh-list
25779041|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25779042|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779043|NCT02491411|Dexamethasone|dexamethasone|mesh-list
25779044|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
25779045|NCT02491411|Ichthammol|ichthammol|mesh-list
25779046|NCT02491411|BB 1101|bb 1101|mesh-list
25779047|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779048|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
25779049|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
25779050|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779051|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779052|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779053|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
25779054|NCT02491411|Hormones|hormones|mesh-ancestor
25779055|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779056|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779057|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779058|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
25779059|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779060|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779061|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779062|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25779063|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25779064|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25779065|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25779066|NCT02468583|Triamcinolone|triamcinolone|mesh-list
25779067|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25779068|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25779069|NCT02468583|FX006|fx006|mesh-list
25779070|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25779071|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779072|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
25779073|NCT02468583|Hormones|hormones|mesh-ancestor
25779074|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779075|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779076|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779077|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
25779078|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779079|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779080|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25779081|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779082|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25779083|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779084|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779085|NCT02469415|Azacitidine|azacitidine|mesh-list
25779086|NCT02469415|Decitabine|decitabine|mesh-list
25779087|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779088|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
25779089|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779090|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779091|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779092|NCT02434146|Phenylephrine|phenylephrine|mesh-list
25779093|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
25779094|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25779095|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
25779096|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
25779097|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779098|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779099|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
25779100|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25779101|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
25779102|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
25779103|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25779104|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25779105|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25779106|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
25779107|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779108|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779109|NCT02434146|Protective Agents|protective agents|mesh-ancestor
25779110|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
25779111|NCT02447887|Ixazomib|ixazomib|mesh-list
25779112|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779113|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
25779114|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779115|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779116|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
25779117|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779118|NCT02439970|Valganciclovir|valganciclovir|mesh-list
25779119|NCT02439970|Brincidofovir|brincidofovir|mesh-list
25779120|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
25779121|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779122|NCT02439957|Valganciclovir|valganciclovir|mesh-list
25779123|NCT02439957|Brincidofovir|brincidofovir|mesh-list
25779124|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
25779125|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779126|NCT02436265|Dexamethasone|dexamethasone|mesh-list
25779127|NCT02436265|Ropivacaine|ropivacaine|mesh-list
25779128|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779129|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
25779130|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
25779131|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779132|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779133|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779134|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
25779135|NCT02436265|Hormones|hormones|mesh-ancestor
25779136|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779137|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779138|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779139|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
25779140|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
25779141|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779142|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
25779143|NCT02429583|Vaccines|vaccines|mesh-list
25779144|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
25779145|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779146|NCT02417870|Aldesleukin|aldesleukin|mesh-list
25779147|NCT02417870|Interleukin-2|interleukin-2|mesh-list
25779148|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779149|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25779150|NCT02417870|Analgesics|analgesics|mesh-ancestor
25779151|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
25779152|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779153|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779154|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25779155|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25779156|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
25779157|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779158|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25779159|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779160|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779161|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
25779162|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779163|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25779164|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779165|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779166|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
25779167|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779168|NCT02413047|Methotrexate|methotrexate|mesh-list
25779169|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
25779170|NCT02413047|Azathioprine|azathioprine|mesh-list
25779171|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25779172|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
25779173|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25779174|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779175|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779176|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
25779177|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779178|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779179|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779180|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779181|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25779182|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779183|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
25779184|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779185|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25779186|NCT02422303|Ketamine|ketamine|mesh-list
25779187|NCT02422303|Analgesics|analgesics|mesh-ancestor
25779188|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
25779189|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779190|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779191|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25779192|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25779193|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
25779194|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
25779195|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779196|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25779197|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25779198|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779199|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779200|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25779201|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779202|NCT02410551|Vidarabine|vidarabine|mesh-list
25779203|NCT02410551|Fludarabine|fludarabine|mesh-list
25779204|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
25779205|NCT02410551|Busulfan|busulfan|mesh-list
25779206|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779207|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779208|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
25779209|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779210|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779211|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
25779212|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779213|NCT02410551|Antiviral Agents|antiviral agents|mesh-ancestor
25779214|NCT02410551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779215|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
25779216|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779217|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25779218|NCT02411643|Calcipotriene|calcipotriene|mesh-list
25779219|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779220|NCT02409355|Gemcitabine|gemcitabine|mesh-list
25779221|NCT02409355|Cisplatin|cisplatin|mesh-list
25779222|NCT02409355|Carboplatin|carboplatin|mesh-list
25779223|NCT02409355|Atezolizumab|atezolizumab|mesh-list
25779224|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779225|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779226|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
25779227|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779228|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
25779229|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779230|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779231|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779232|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
25779233|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779234|NCT02392377|Leucovorin|leucovorin|mesh-list
25779235|NCT02392377|Paclitaxel|paclitaxel|mesh-list
25779236|NCT02392377|Carboplatin|carboplatin|mesh-list
25779237|NCT02392377|Fluorouracil|fluorouracil|mesh-list
25779238|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
25779240|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
25779241|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779242|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779243|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779244|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779245|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779246|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779247|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25779248|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779249|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
25779250|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779251|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779252|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
25779253|NCT02392377|Antidotes|antidotes|mesh-ancestor
25779254|NCT02392377|Protective Agents|protective agents|mesh-ancestor
25779255|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
25779256|NCT02392377|Vitamins|vitamins|mesh-ancestor
25779257|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
25779258|NCT02394665|Temozolomide|temozolomide|mesh-list
25779259|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779260|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
25779261|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779262|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779263|NCT02389712|Lamotrigine|lamotrigine|mesh-list
25779264|NCT02389712|Fluoxetine|fluoxetine|mesh-list
25779265|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25779266|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25779267|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25779268|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779269|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779270|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
25779271|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779272|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25779273|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
25779274|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25779275|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25779276|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25779277|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779278|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
25779279|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25779280|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25779281|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25779282|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25779283|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779284|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25779285|NCT02390362|Rituximab|rituximab|mesh-list
25779286|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25779287|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779288|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
25779289|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779290|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779291|NCT02383433|Gemcitabine|gemcitabine|mesh-list
25779292|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779293|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
25779294|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779295|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779296|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
25779297|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779298|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779299|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779300|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
25779301|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779302|NCT02382588|Ganciclovir|ganciclovir|mesh-list
25779303|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
25779304|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779305|NCT02379390|Prednisone|prednisone|mesh-list
25779306|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
25779307|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779308|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
25779309|NCT02379390|Hormones|hormones|mesh-ancestor
25779310|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779311|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779312|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779313|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779314|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25779315|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779316|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779317|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
25779318|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25779319|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25779321|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25779322|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779323|NCT02373865|Incretins|incretins|mesh-ancestor
25779324|NCT02373865|Hormones|hormones|mesh-ancestor
25779325|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779326|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25779327|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
25779328|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779329|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779330|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25779331|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779332|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
25779333|NCT02369744|Tamsulosin|tamsulosin|mesh-list
25779334|NCT02369744|Silodosin|silodosin|mesh-list
25779335|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25779336|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25779337|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25779338|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
25779339|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779340|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779341|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779342|NCT02369744|Urological Agents|urological agents|mesh-ancestor
25779343|NCT02379585|Paclitaxel|paclitaxel|mesh-list
25779344|NCT02379585|Docetaxel|docetaxel|mesh-list
25779345|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
25779346|NCT02379585|Doxorubicin|doxorubicin|mesh-list
25779347|NCT02379585|Trastuzumab|trastuzumab|mesh-list
25779348|NCT02379585|Pertuzumab|pertuzumab|mesh-list
25779349|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779350|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779351|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779352|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779353|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779354|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779355|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779356|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
25779357|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779358|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779359|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779360|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
25779361|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25779362|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25779363|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25779364|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25779365|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779366|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25779367|NCT02370888|Lenalidomide|lenalidomide|mesh-list
25779368|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
25779369|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779370|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25779371|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25779372|NCT02370888|Growth Substances|growth substances|mesh-ancestor
25779373|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
25779374|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779375|NCT02367170|Midazolam|midazolam|mesh-list
25779376|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25779377|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25779378|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779379|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779380|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25779381|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25779382|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25779383|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25779384|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
25779385|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
25779386|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
25779387|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
25779388|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779389|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779390|NCT02365233|Insulin|insulin|mesh-list
25779391|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25779392|NCT02365233|Pioglitazone|pioglitazone|mesh-list
25779393|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25779394|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
25779395|NCT02365233|Saxagliptin|saxagliptin|mesh-list
25779396|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25779397|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25779398|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779399|NCT02365233|Incretins|incretins|mesh-ancestor
25779400|NCT02365233|Hormones|hormones|mesh-ancestor
25779401|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779402|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
25779403|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779404|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779405|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
25779406|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779407|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
25779408|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779409|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779410|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779411|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
25779412|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779413|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779414|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25779415|NCT02353468|Dexamethasone|dexamethasone|mesh-list
25779416|NCT02353468|Lenalidomide|lenalidomide|mesh-list
25779417|NCT02353468|Bortezomib|bortezomib|mesh-list
25779418|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779419|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
25779420|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
25779421|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779422|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779423|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779424|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
25779425|NCT02353468|Hormones|hormones|mesh-ancestor
25779426|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779427|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779428|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779429|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
25779430|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25779431|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25779432|NCT02353468|Growth Substances|growth substances|mesh-ancestor
25779433|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
25779434|NCT02360059|Metformin|metformin|mesh-list
25779435|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25779436|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779437|NCT02345460|Leucovorin|leucovorin|mesh-list
25779438|NCT02345460|Fluorouracil|fluorouracil|mesh-list
25779439|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
25779440|NCT02345460|Irinotecan|irinotecan|mesh-list
25779441|NCT02345460|Calcium|calcium|mesh-list
25779442|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
25779443|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25779444|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779445|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
25779446|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779447|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779448|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779449|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779450|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
25779451|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25779452|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25779453|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779454|NCT02345460|Antidotes|antidotes|mesh-ancestor
25779455|NCT02345460|Protective Agents|protective agents|mesh-ancestor
25779456|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
25779457|NCT02345460|Vitamins|vitamins|mesh-ancestor
25779458|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
25779459|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
25779460|NCT02351063|Diuretics|diuretics|mesh-list
25779461|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25779462|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25779463|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25779464|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
25779465|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779466|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779467|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25779468|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779469|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25779470|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
25779471|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779472|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25779473|NCT02345772|Docetaxel|docetaxel|mesh-list
25779474|NCT02345772|Trastuzumab|trastuzumab|mesh-list
25779475|NCT02345772|Fulvestrant|fulvestrant|mesh-list
25779476|NCT02345772|Pertuzumab|pertuzumab|mesh-list
25779477|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779478|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779479|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779480|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779481|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779482|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25779483|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779484|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25779485|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25779486|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
25779487|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779488|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779489|NCT02353572|Dexamethasone|dexamethasone|mesh-list
25779490|NCT02353572|Bortezomib|bortezomib|mesh-list
25779491|NCT02353572|Melphalan|melphalan|mesh-list
25779492|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779493|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
25779494|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
25779495|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779496|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779497|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779498|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
25779499|NCT02353572|Hormones|hormones|mesh-ancestor
25779500|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779501|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779502|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779503|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779504|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
25779505|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779506|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25779507|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779508|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
25779509|NCT02343263|Bupivacaine|bupivacaine|mesh-list
25779510|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25779511|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
25779512|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
25779513|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779514|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779515|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
25779516|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779517|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
25779518|NCT02343263|Coagulants|coagulants|mesh-ancestor
25779519|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25779520|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779521|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779522|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
25779523|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779524|NCT02341495|Vitamin D|vitamin d|mesh-list
25779525|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
25779526|NCT02341495|Azacitidine|azacitidine|mesh-list
25779527|NCT02341495|Deferasirox|deferasirox|mesh-list
25779528|NCT02341495|Vitamins|vitamins|mesh-ancestor
25779529|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
25779530|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779531|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25779532|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779533|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
25779534|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779535|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779536|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779537|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25779538|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25779539|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
25779540|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
25779541|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
25779542|NCT02318901|Trastuzumab|trastuzumab|mesh-list
25779543|NCT02318901|Cetuximab|cetuximab|mesh-list
25779544|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25779545|NCT02318901|Maytansine|maytansine|mesh-list
25779546|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25779547|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779548|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779549|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779550|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779551|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779552|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779553|NCT02317276|Triamcinolone|triamcinolone|mesh-list
25779554|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25779555|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25779556|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25779557|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779558|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
25779559|NCT02317276|Hormones|hormones|mesh-ancestor
25779560|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779561|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779562|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779563|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
25779564|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779565|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779566|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
25779567|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779568|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
25779569|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25779570|NCT02299206|Protective Agents|protective agents|mesh-ancestor
25779571|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779572|NCT02302859|Nicotine|nicotine|mesh-list
25779573|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25779574|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
25779575|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779576|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779577|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25779578|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25779579|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
25779580|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779581|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779582|NCT02297230|Paclitaxel|paclitaxel|mesh-list
25779583|NCT02297230|Capecitabine|capecitabine|mesh-list
25779584|NCT02297230|Trastuzumab|trastuzumab|mesh-list
25779585|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779586|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779587|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779588|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779589|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779590|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779591|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779592|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
25779593|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25779594|NCT02284906|Pioglitazone|pioglitazone|mesh-list
25779595|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25779596|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779597|NCT02282332|Ticagrelor|ticagrelor|mesh-list
25779598|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25779599|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25779600|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25779601|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25779602|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
25779603|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779604|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779605|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779606|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25779607|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25779608|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779609|NCT02276560|Gemcitabine|gemcitabine|mesh-list
25779610|NCT02276560|Paclitaxel|paclitaxel|mesh-list
25779611|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25779612|NCT02276560|Cisplatin|cisplatin|mesh-list
25779613|NCT02276560|Pemetrexed|pemetrexed|mesh-list
25779614|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779615|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779616|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779617|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779618|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779619|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779620|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779621|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
25779622|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
25779623|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779624|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779625|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779626|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
25779627|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779628|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25779629|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25779630|NCT02280252|Paclitaxel|paclitaxel|mesh-list
25779631|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779632|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779633|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779634|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779635|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779636|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779637|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
25779638|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
25779639|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25779640|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
25779641|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779642|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779643|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25779644|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
25779645|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
25779646|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25779647|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
25779648|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779649|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779650|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25779651|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25779652|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25779653|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
25779654|NCT02273752|Everolimus|everolimus|mesh-list
25779655|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779656|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779657|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
25779658|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779659|NCT02271594|Insulin|insulin|mesh-list
25779660|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25779661|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779662|NCT02263365|Loperamide|loperamide|mesh-list
25779663|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
25779664|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779665|NCT02266797|Dexamethasone|dexamethasone|mesh-list
25779666|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25779667|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
25779668|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
25779669|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779670|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779671|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779672|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
25779673|NCT02266797|Hormones|hormones|mesh-ancestor
25779674|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779675|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779676|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779677|NCT02253394|Ambrisentan|ambrisentan|mesh-list
25779678|NCT02253394|Spironolactone|spironolactone|mesh-list
25779679|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25779680|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
25779681|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25779682|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779683|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25779684|NCT02253394|Diuretics|diuretics|mesh-ancestor
25779685|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
25779686|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25779687|NCT02241551|Gemcitabine|gemcitabine|mesh-list
25779688|NCT02241551|Paclitaxel|paclitaxel|mesh-list
25779689|NCT02241551|Fluorouracil|fluorouracil|mesh-list
25779690|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
25779691|NCT02241551|Irinotecan|irinotecan|mesh-list
25779692|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779693|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779694|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779695|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779696|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779697|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779698|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779699|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
25779700|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
25779701|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779702|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779703|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779704|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
25779705|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779706|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25779707|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25779708|NCT02232880|Abatacept|abatacept|mesh-list
25779709|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25779710|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779711|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779712|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779713|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
25779714|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779715|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779716|NCT02239627|Clonidine|clonidine|mesh-list
25779717|NCT02239627|Analgesics|analgesics|mesh-ancestor
25779718|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
25779719|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779720|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779721|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25779722|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
25779723|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
25779724|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25779725|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25779726|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25779727|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
25779728|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779729|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779730|NCT02244944|Ezetimibe|ezetimibe|mesh-list
25779731|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25779732|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25779733|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
25779734|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779735|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25779736|NCT02241187|Cetuximab|cetuximab|mesh-list
25779737|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25779738|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779739|NCT02239926|Ranolazine|ranolazine|mesh-list
25779740|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25779741|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25779742|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779743|NCT02234011|Ketamine|ketamine|mesh-list
25779744|NCT02234011|Analgesics|analgesics|mesh-ancestor
25779745|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
25779746|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779747|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779748|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25779749|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25779750|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
25779751|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
25779752|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779753|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25779754|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25779755|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779756|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779757|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
25779758|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25779759|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25779760|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779761|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
25779762|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
25779763|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779764|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
25779765|NCT02224599|Imiquimod|imiquimod|mesh-list
25779766|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779767|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
25779768|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779769|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779770|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779771|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
25779772|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779773|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779774|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25779775|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25779776|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
25779777|NCT02200328|Metronidazole|metronidazole|mesh-list
25779778|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779779|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25779780|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25779781|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25779782|NCT02181790|Acitretin|acitretin|mesh-list
25779783|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
25779784|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779785|NCT02177266|Colchicine|colchicine|mesh-list
25779786|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
25779787|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25779788|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779789|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779790|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779791|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779792|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779793|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25779794|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25779795|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779796|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25779797|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25779798|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25779799|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779800|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
25779801|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779802|NCT02177773|Octreotide|octreotide|mesh-list
25779803|NCT02177773|Edotreotide|edotreotide|mesh-list
25779804|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779805|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25779806|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779807|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25037970|NCT03534024|Analgesics|analgesics|mesh-ancestor
25779808|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779809|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
25779810|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
25779811|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25779812|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25779813|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779814|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779815|NCT02162979|Urological Agents|urological agents|mesh-ancestor
25779817|NCT02169830|Nortriptyline|nortriptyline|mesh-list
25779818|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
25779819|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25779820|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779821|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25779822|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
25779823|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25779824|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25779825|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25779826|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25779827|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779828|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
25779829|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779830|NCT02159040|Azacitidine|azacitidine|mesh-list
25779831|NCT02159040|Deferasirox|deferasirox|mesh-list
25779832|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779833|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
25779834|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779835|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779836|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779837|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25779838|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
25779839|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
25779840|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
25779841|NCT02168270|Temozolomide|temozolomide|mesh-list
25779842|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779843|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
25779844|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779845|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779846|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
25779847|NCT02168270|Protective Agents|protective agents|mesh-ancestor
25779848|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779849|NCT02168270|Vitamins|vitamins|mesh-ancestor
25779850|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
25779851|NCT02157116|Cisplatin|cisplatin|mesh-list
25779852|NCT02157116|Docetaxel|docetaxel|mesh-list
25779853|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779854|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779855|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779856|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779857|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779858|NCT02152670|Raclopride|raclopride|mesh-list
25779859|NCT02152670|Methylphenidate|methylphenidate|mesh-list
25779860|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
25779861|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25779862|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779863|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25779864|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25779865|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25779866|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779867|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
25779868|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779869|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25779870|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25779871|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779872|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25779873|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25779874|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779875|NCT02137096|Carboplatin|carboplatin|mesh-list
25779876|NCT02137096|Etoposide|etoposide|mesh-list
25779877|NCT02137096|Ifosfamide|ifosfamide|mesh-list
25779878|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
25779879|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779880|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779881|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25779882|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25779883|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779884|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779885|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25779886|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
25779888|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25779889|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25779890|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779891|NCT02144155|Oxytocin|oxytocin|mesh-list
25779892|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
25779893|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25779894|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779895|NCT02140788|Metformin|metformin|mesh-list
25779896|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25779897|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779898|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
25779899|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25779900|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
25779901|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
25779902|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779903|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779904|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25779905|NCT02145169|Analgesics|analgesics|mesh-ancestor
25779906|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
25779907|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779908|NCT02130622|Promethazine|promethazine|mesh-list
25779909|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
25779910|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
25779911|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25779912|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25779913|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
25779914|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
25779915|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779916|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779917|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779918|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25779919|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25779920|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25779921|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779922|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
25779923|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
25779924|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
25779925|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779926|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
25779927|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
25779928|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25779929|NCT02133534|Atorvastatin|atorvastatin|mesh-list
25779930|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25779931|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25779932|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
25779933|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779934|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25779935|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25779936|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779937|NCT02134912|Pemetrexed|pemetrexed|mesh-list
25779938|NCT02134912|Crizotinib|crizotinib|mesh-list
25779939|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779940|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779941|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779942|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25779943|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25779944|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25779945|NCT02131155|Afatinib|afatinib|mesh-list
25779946|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779947|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25779948|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25779949|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779950|NCT02117050|Interferons|interferons|mesh-list
25779951|NCT02117050|Interferon-beta|interferon-beta|mesh-list
25779952|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
25779953|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779954|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
25779955|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779956|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
25779957|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779958|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25779959|NCT02110069|Sirolimus|sirolimus|mesh-list
25779960|NCT02110069|Vincristine|vincristine|mesh-list
25779961|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25779962|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779963|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
25779964|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
25779965|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
25779966|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779967|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25779968|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779969|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25779970|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
25779971|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779972|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
25779973|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779974|NCT02105116|Cytarabine|cytarabine|mesh-list
25779975|NCT02105116|Fludarabine|fludarabine|mesh-list
25779976|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
25779977|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25779978|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25779979|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
25779980|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25779981|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25779982|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
25779983|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779984|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
25779985|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25779986|NCT02094352|Ketamine|ketamine|mesh-list
25779987|NCT02094352|Analgesics|analgesics|mesh-ancestor
25779988|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
25779989|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25779990|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25779991|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25779992|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25779993|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
25779994|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
25779995|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25779996|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25779997|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25779998|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25779999|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780000|NCT02096042|Azacitidine|azacitidine|mesh-list
25780001|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25780002|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780003|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
25780004|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780005|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780006|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780007|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25780008|NCT02088957|Phenytoin|phenytoin|mesh-list
25780009|NCT02088957|Brivaracetam|brivaracetam|mesh-list
25780010|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25780011|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
25780012|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25780013|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25780014|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780015|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780016|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25780017|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25780018|NCT02075411|Bupivacaine|bupivacaine|mesh-list
25780019|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780020|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
25780021|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780022|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780023|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
25780024|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780025|NCT02074904|Topiramate|topiramate|mesh-list
25780026|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
25780027|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780028|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780029|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
25780030|NCT02081183|Prednisone|prednisone|mesh-list
25780031|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
25780032|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780033|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
25780034|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780035|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780036|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25780037|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
25780038|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780039|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780040|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25780041|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780043|NCT02081183|Hormones|hormones|mesh-ancestor
25780044|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780045|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25780046|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25780047|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25780048|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
25780049|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25780050|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780051|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780052|NCT02075021|Paclitaxel|paclitaxel|mesh-list
25780053|NCT02075021|Lenalidomide|lenalidomide|mesh-list
25780054|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25780055|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780056|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25780057|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25780058|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
25780059|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780060|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
25780061|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780062|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25780063|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25780064|NCT02075021|Growth Substances|growth substances|mesh-ancestor
25780065|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
25780066|NCT02057237|Mitotane|mitotane|mesh-list
25780067|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25780068|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780069|NCT02058537|Bethanechol|bethanechol|mesh-list
25780070|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25780071|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
25780072|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780073|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780074|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25780075|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25780076|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
25780077|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780078|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780079|NCT02038153|Lenalidomide|lenalidomide|mesh-list
25780080|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
25780081|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780082|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25780083|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25780084|NCT02038153|Growth Substances|growth substances|mesh-ancestor
25780085|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
25780086|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780087|NCT02044302|Morphine|morphine|mesh-list
25780088|NCT02044302|Narcotics|narcotics|mesh-list
25780089|NCT02044302|Analgesics|analgesics|mesh-list
25780090|NCT02044302|Bupivacaine|bupivacaine|mesh-list
25780091|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
25780092|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780093|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
25780094|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780095|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780096|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
25780097|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780098|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25780099|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25780100|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780101|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780102|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
25780103|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780104|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25780105|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780106|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780107|NCT02048904|Incretins|incretins|mesh-ancestor
25780109|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780110|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25780111|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
25780112|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780113|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780114|NCT02044822|Rituximab|rituximab|mesh-list
25780115|NCT02044822|Idelalisib|idelalisib|mesh-list
25780116|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25780117|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780118|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
25780119|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780120|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780121|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780122|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780123|NCT02043860|Melphalan|melphalan|mesh-list
25780124|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
25780125|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780126|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25780127|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
25780128|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780129|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780130|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25780131|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780132|NCT02030015|Miglustat|miglustat|mesh-list
25780133|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780134|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780135|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25780136|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25780137|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
25780138|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780139|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25780140|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780141|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780142|NCT02015663|Tobramycin|tobramycin|mesh-list
25780143|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25780144|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780145|NCT02029846|Metformin|metformin|mesh-list
25780146|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25780147|NCT02029846|Incretins|incretins|mesh-list
25780148|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780149|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780150|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
25780151|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780152|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780153|NCT02029846|Hormones|hormones|mesh-ancestor
25780154|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780155|NCT02027272|Dexamethasone|dexamethasone|mesh-list
25780156|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
25780157|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780158|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
25780159|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
25780160|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780161|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780162|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780163|NCT02027272|Hormones|hormones|mesh-ancestor
25780164|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780165|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25780166|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780167|NCT02017379|Erythromycin|erythromycin|mesh-list
25780168|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
25780169|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25780170|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
25780171|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25780172|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780173|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780174|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25780175|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780176|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161493|NCT00611572|Flumazenil|flumazenil|mesh-list
25780177|NCT02008370|Bupivacaine|bupivacaine|mesh-list
25780178|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780179|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
25780180|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780181|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780182|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
25780183|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780184|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25780185|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780186|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780187|NCT02015910|Incretins|incretins|mesh-ancestor
25780188|NCT02015910|Hormones|hormones|mesh-ancestor
25780189|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780190|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25780191|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
25780192|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780193|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780194|NCT01986751|Clonidine|clonidine|mesh-list
25780195|NCT01986751|Ropivacaine|ropivacaine|mesh-list
25780196|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780197|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
25780198|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780199|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780200|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
25780201|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780202|NCT01986751|Analgesics|analgesics|mesh-ancestor
25780203|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25780204|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
25780205|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
25780206|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25780207|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25780208|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25780209|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
25780210|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780211|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780212|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
25780213|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780214|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
25780215|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25780216|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25780217|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780218|NCT01996852|Urological Agents|urological agents|mesh-ancestor
25780219|NCT01997567|Ropivacaine|ropivacaine|mesh-list
25780220|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780221|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
25780222|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780223|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780224|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
25780225|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780226|NCT01977729|Sertraline|sertraline|mesh-list
25780227|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
25780228|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25780229|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25780230|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25780231|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780232|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780233|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780234|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
25780235|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780236|NCT01973062|Rituximab|rituximab|mesh-list
25780237|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25780238|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25780239|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780240|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
25124150|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25166609|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124151|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124152|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25124153|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25124154|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25124155|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25124156|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751381|NCT01703910|Cisplatin|cisplatin|mesh-list
25780241|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780242|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780243|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25780245|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780246|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780247|NCT01974284|Ethanol|ethanol|mesh-list
25780248|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25780249|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780250|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780251|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780252|NCT01971853|Analgesics|analgesics|mesh-list
25780253|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
25780254|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780255|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780256|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
25780257|NCT01980875|Idelalisib|idelalisib|mesh-list
25780258|NCT01980875|Chlorambucil|chlorambucil|mesh-list
25780259|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25780260|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780261|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780262|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780263|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25780264|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
25780265|NCT01980342|Efavirenz|efavirenz|mesh-list
25780266|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25780267|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25780268|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780269|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780270|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
25780271|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780272|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25780273|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25780274|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25780275|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25780276|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25780277|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25780278|NCT01978535|Iron|iron|mesh-list
25780279|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25780280|NCT01978535|Trace Elements|trace elements|mesh-ancestor
25780281|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
25780282|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780283|NCT01978535|Hematinics|hematinics|mesh-ancestor
25780284|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25780285|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780286|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780287|NCT01970462|Incretins|incretins|mesh-ancestor
25780288|NCT01970462|Hormones|hormones|mesh-ancestor
25780289|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780290|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25780291|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
25780292|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780293|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780294|NCT01969565|Dexamethasone|dexamethasone|mesh-list
25780295|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780296|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
25780297|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
25780298|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780299|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780300|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780301|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
25780302|NCT01969565|Hormones|hormones|mesh-ancestor
25780303|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780304|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25780305|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127090|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25127091|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108344|NCT03132610|Analgesics|analgesics|mesh-ancestor
25780306|NCT01962974|Golimumab|golimumab|mesh-list
25780307|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25780308|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780309|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780310|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
25780311|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780312|NCT01951378|Albuterol|albuterol|mesh-list
25780313|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25780314|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
25780315|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780316|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780317|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25780318|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
25780319|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
25780320|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25780321|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25780322|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25780323|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25780324|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
25780325|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780326|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780327|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25780328|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25780329|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25780330|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
25780331|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25780332|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780333|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25780334|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25780335|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25780336|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25780337|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25780338|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25780339|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25780340|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25780341|NCT01935947|Gemcitabine|gemcitabine|mesh-list
25780342|NCT01935947|Azacitidine|azacitidine|mesh-list
25780343|NCT01935947|Docetaxel|docetaxel|mesh-list
25780344|NCT01935947|Irinotecan|irinotecan|mesh-list
25780345|NCT01935947|Pemetrexed|pemetrexed|mesh-list
25780346|NCT01935947|Camptothecin|camptothecin|mesh-list
25780347|NCT01935947|Entinostat|entinostat|mesh-list
25780348|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25780349|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780350|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
25780351|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780352|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780353|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
25780354|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780355|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780356|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780357|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
25780358|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780359|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
25780360|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
25780361|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
25780362|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25780363|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25780364|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25780365|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25780366|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25780367|NCT01938716|Gemcitabine|gemcitabine|mesh-list
25780368|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780369|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
25780370|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780371|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780372|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
25780373|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780374|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780375|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780376|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
25780377|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166610|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483824|NCT00445094|Vancomycin|vancomycin|mesh-list
25780378|NCT01936974|Gemcitabine|gemcitabine|mesh-list
25780379|NCT01936974|Bevacizumab|bevacizumab|mesh-list
25780380|NCT01936974|Cisplatin|cisplatin|mesh-list
25780381|NCT01936974|Carboplatin|carboplatin|mesh-list
25780382|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
25780383|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25780384|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780385|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25780386|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25780387|NCT01936974|Growth Substances|growth substances|mesh-ancestor
25780388|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780389|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
25780390|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780391|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
25780392|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780393|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
25780394|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780395|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780396|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780397|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
25780398|NCT01938833|Paclitaxel|paclitaxel|mesh-list
25780399|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25780400|NCT01938833|Romidepsin|romidepsin|mesh-list
25780401|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25780402|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780403|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
25780404|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
25780405|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
25780406|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780407|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25780408|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25780409|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25780410|NCT01928082|Estradiol|estradiol|mesh-list
25780411|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25780412|NCT01928082|Estrogens|estrogens|mesh-ancestor
25780413|NCT01928082|Hormones|hormones|mesh-ancestor
25780414|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780415|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780416|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25780417|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
25780418|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25780419|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25780420|NCT01928615|Trastuzumab|trastuzumab|mesh-list
25780421|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25780422|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25780423|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780424|NCT01910389|Tadalafil|tadalafil|mesh-list
25780425|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
25780426|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25780427|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25780428|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780429|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780430|NCT01910389|Urological Agents|urological agents|mesh-ancestor
25780431|NCT01916590|Bupivacaine|bupivacaine|mesh-list
25780432|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780433|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
25780434|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780435|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780436|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
25780437|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780438|NCT01913327|Risperidone|risperidone|mesh-list
25780439|NCT01913327|Aripiprazole|aripiprazole|mesh-list
25780440|NCT01913327|Modafinil|modafinil|mesh-list
25780441|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25780442|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
25780443|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780444|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780445|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780446|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25780447|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25780448|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780449|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25780450|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25780451|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
25780452|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
25780453|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
25780454|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25780455|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25780456|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25780457|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25780458|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25780459|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25780460|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25780461|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25780462|NCT01901224|Metformin|metformin|mesh-list
25780463|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780464|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780465|NCT01910441|Metformin|metformin|mesh-list
25780466|NCT01910441|Glimepiride|glimepiride|mesh-list
25780467|NCT01910441|Vildagliptin|vildagliptin|mesh-list
25780468|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780469|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780470|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25780471|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780472|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
25780473|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25780474|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
25780475|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780476|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780477|NCT01902966|Propranolol|propranolol|mesh-list
25780478|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25780479|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25780480|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
25780481|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780482|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780483|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780484|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25780485|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25780486|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
25780487|NCT01901679|Celecoxib|celecoxib|mesh-list
25780488|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25780489|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25780490|NCT01901679|Analgesics|analgesics|mesh-ancestor
25780491|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
25780492|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780493|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780494|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780495|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780496|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25780497|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25780498|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780499|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780500|NCT01900730|Valproic Acid|valproic acid|mesh-list
25780501|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
25780502|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780503|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780504|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
25780505|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780506|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780507|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
25780508|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25780509|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780510|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25780511|NCT01877564|Metformin|metformin|mesh-list
25780512|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780513|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780514|NCT01890694|Tolvaptan|tolvaptan|mesh-list
25780515|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25780516|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780517|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
25780518|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780519|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
25780520|NCT01890577|Hematinics|hematinics|mesh-ancestor
25780521|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
25780522|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25780523|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
25780524|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137205|NCT02986334|Analgesics|analgesics|mesh-ancestor
25137206|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
25137213|NCT02986321|Budesonide|budesonide|mesh-list
25780526|NCT01895959|Protective Agents|protective agents|mesh-ancestor
25780527|NCT01889420|Everolimus|everolimus|mesh-list
25780528|NCT01889420|Pomalidomide|pomalidomide|mesh-list
25780529|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780530|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780531|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
25780532|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780533|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25780534|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25780535|NCT01889420|Growth Substances|growth substances|mesh-ancestor
25780536|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
25780537|NCT01881984|Glycerol|glycerol|mesh-list
25780538|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25780539|NCT01881984|Protective Agents|protective agents|mesh-ancestor
25780540|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780541|NCT01893359|Riboflavin|riboflavin|mesh-list
25780542|NCT01893359|Dextrans|dextrans|mesh-list
25780543|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25780544|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25780545|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
25780546|NCT01893359|Vitamins|vitamins|mesh-ancestor
25780547|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
25780548|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780549|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25780550|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25780551|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
25780552|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
25780553|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
25780554|NCT01887288|Capecitabine|capecitabine|mesh-list
25780555|NCT01887288|Digoxin|digoxin|mesh-list
25780556|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780557|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
25780558|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780559|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780560|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25780561|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25780562|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780563|NCT01887288|Protective Agents|protective agents|mesh-ancestor
25780564|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780565|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
25780566|NCT01878786|Everolimus|everolimus|mesh-list
25780567|NCT01878786|Tacrolimus|tacrolimus|mesh-list
25780568|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780569|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
25780570|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780571|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25780572|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780573|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780574|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780575|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25780576|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25780577|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
25780578|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25780579|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780580|NCT01861717|Lanreotide|lanreotide|mesh-list
25780581|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780582|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
25780583|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
25780584|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
25780585|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780586|NCT01860040|Gemcitabine|gemcitabine|mesh-list
25780587|NCT01860040|Cisplatin|cisplatin|mesh-list
25780588|NCT01860040|Pemetrexed|pemetrexed|mesh-list
25780589|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780590|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780591|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
25780592|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780593|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
25780594|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780595|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780596|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780597|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
25780598|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780599|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25780600|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25780601|NCT01851174|Gemcitabine|gemcitabine|mesh-list
25780602|NCT01851174|Paclitaxel|paclitaxel|mesh-list
25780603|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25780604|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780605|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
25780606|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
25780607|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
25780608|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780609|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780610|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
25780611|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
25780612|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780613|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780614|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780615|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
25780616|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780617|NCT01846182|Pregabalin|pregabalin|mesh-list
25780618|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25780619|NCT01846182|Analgesics|analgesics|mesh-ancestor
25780620|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
25780621|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780622|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780623|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
25780624|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25780625|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780626|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780627|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25780628|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25780629|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25780630|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780631|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25780632|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25780633|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25780634|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780635|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
25780636|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
25780637|NCT01844206|Morphine|morphine|mesh-list
25780638|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25780639|NCT01844206|Narcotics|narcotics|mesh-ancestor
25780640|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780641|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780642|NCT01844206|Analgesics|analgesics|mesh-ancestor
25780643|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
25780644|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780645|NCT01856322|Sulindac|sulindac|mesh-list
25780646|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25780647|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25780648|NCT01856322|Analgesics|analgesics|mesh-ancestor
25780649|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
25780650|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780651|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780652|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780653|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780654|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780655|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25780656|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780657|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780658|NCT01853176|Bupivacaine|bupivacaine|mesh-list
25780659|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780660|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
25780661|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780662|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780663|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
25780664|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780665|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25780666|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780667|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25780668|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780669|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780670|NCT01856361|Ramipril|ramipril|mesh-list
25780671|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25780672|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
25780673|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780674|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780675|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25780677|NCT01853982|Piperacillin|piperacillin|mesh-list
25780678|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25780679|NCT01853982|Ceftolozane|ceftolozane|mesh-list
25780680|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25780681|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25780682|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780683|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25780684|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780685|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780686|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25780687|NCT01853982|Renal Agents|renal agents|mesh-ancestor
25780688|NCT01841931|Buprenorphine|buprenorphine|mesh-list
25780689|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25780690|NCT01841931|Naloxone|naloxone|mesh-list
25780691|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25780692|NCT01841931|Narcotics|narcotics|mesh-ancestor
25780693|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780694|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780695|NCT01841931|Analgesics|analgesics|mesh-ancestor
25780696|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
25780697|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780698|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25780699|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25780700|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
25780701|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780702|NCT01821963|Interferons|interferons|mesh-list
25780703|NCT01821963|Ribavirin|ribavirin|mesh-list
25780704|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
25780705|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
25780706|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25780707|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780708|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
25780709|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780710|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
25780711|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780712|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
25780713|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780715|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780716|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25780717|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
25780718|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780719|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780720|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25780721|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
25780722|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
25780723|NCT01821898|Hormones|hormones|mesh-ancestor
25780724|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780725|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
25780726|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780727|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
25780728|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25780729|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25780730|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780731|NCT01830790|Urological Agents|urological agents|mesh-ancestor
25780732|NCT01829477|Glimepiride|glimepiride|mesh-list
25780733|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25780734|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25780735|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780736|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780737|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
25780738|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25780739|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25780740|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25780741|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780742|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780743|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780744|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780745|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
25780746|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25780747|NCT01821859|Bevacizumab|bevacizumab|mesh-list
25780748|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25780749|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25780750|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780751|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25780752|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25780753|NCT01821859|Growth Substances|growth substances|mesh-ancestor
25780754|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780755|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
25780756|NCT01810302|Nicardipine|nicardipine|mesh-list
25780757|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25780758|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25780759|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780760|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780761|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25780762|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780763|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
25780764|NCT01804166|Golimumab|golimumab|mesh-list
25780765|NCT01804166|Infliximab|infliximab|mesh-list
25780766|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
25780767|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780768|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780769|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25780770|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780771|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780772|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
25780773|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780774|NCT01783015|Etanercept|etanercept|mesh-list
25780775|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25780776|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25780777|NCT01783015|Analgesics|analgesics|mesh-ancestor
25780778|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
25780779|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780780|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780781|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780782|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780783|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780784|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780785|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
25780786|NCT01800162|Methotrexate|methotrexate|mesh-list
25780787|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25780788|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
25780789|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25780790|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780791|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780792|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
25780793|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780794|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780795|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25780796|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780797|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25780798|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780799|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
25780800|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780801|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25780802|NCT01797380|Citalopram|citalopram|mesh-list
25780803|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25780804|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25780805|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780806|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780807|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780808|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
25780809|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780810|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25780811|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
25780812|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25780813|NCT01781026|Vemurafenib|vemurafenib|mesh-list
25780814|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780815|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25780816|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780817|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780818|NCT01788475|Dexamethasone|dexamethasone|mesh-list
25780819|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
25780820|NCT01788475|BB 1101|bb 1101|mesh-list
25780821|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780822|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
25780823|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
25780824|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780825|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780826|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780827|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
25780828|NCT01788475|Hormones|hormones|mesh-ancestor
25780829|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780830|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25780831|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780832|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
25780833|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780834|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780835|NCT01784991|Morphine|morphine|mesh-list
25780836|NCT01784991|Hydromorphone|hydromorphone|mesh-list
25780837|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25780838|NCT01784991|Narcotics|narcotics|mesh-ancestor
25780839|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780840|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780841|NCT01784991|Analgesics|analgesics|mesh-ancestor
25780842|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
25780843|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780844|NCT01777854|Omeprazole|omeprazole|mesh-list
25780845|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25780846|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780847|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25780848|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780849|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780850|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25780851|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25780852|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780853|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25780854|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25780855|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780856|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780857|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
25780858|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468710|NCT00382889|Hormones|hormones|mesh-ancestor
25780859|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
25780860|NCT01772719|Simvastatin|simvastatin|mesh-list
25780861|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25780862|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25780863|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
25780864|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780865|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25780866|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25780867|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780868|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25780869|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780870|NCT01764997|Adalimumab|adalimumab|mesh-list
25780871|NCT01764997|Etanercept|etanercept|mesh-list
25780872|NCT01764997|Methotrexate|methotrexate|mesh-list
25780873|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25780874|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
25780875|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25780876|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780877|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780878|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
25780879|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780880|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780881|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
25780882|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780883|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25780884|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780885|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
25780886|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25780887|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25780888|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780889|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25780890|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25780891|NCT01764997|Analgesics|analgesics|mesh-ancestor
25780892|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
25780893|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780894|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780895|NCT01769443|Bortezomib|bortezomib|mesh-list
25780896|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780897|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25780898|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25780899|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780900|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25780901|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25780902|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25780903|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780904|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
25780905|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25780906|NCT01749826|Morphine|morphine|mesh-list
25780907|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25780908|NCT01749826|Narcotics|narcotics|mesh-ancestor
25780909|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780910|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780911|NCT01749826|Analgesics|analgesics|mesh-ancestor
25780912|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
25780913|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780914|NCT01756586|Dexamethasone|dexamethasone|mesh-list
25780915|NCT01756586|Bupivacaine|bupivacaine|mesh-list
25780916|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25780917|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
25780918|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
25780919|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780920|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780921|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780922|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
25780923|NCT01756586|Hormones|hormones|mesh-ancestor
25780924|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780925|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25780926|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780927|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780928|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
25780929|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780930|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
25780931|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
25780932|NCT01754987|Sorafenib|sorafenib|mesh-list
25780933|NCT01754987|Vitamins|vitamins|mesh-ancestor
25780935|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780936|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780937|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25780938|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780939|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780940|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
25780941|NCT01754987|Protective Agents|protective agents|mesh-ancestor
25780942|NCT01756560|Bupivacaine|bupivacaine|mesh-list
25780943|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780944|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
25780945|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780946|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780947|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
25780948|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780949|NCT01756573|Bupivacaine|bupivacaine|mesh-list
25780950|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
25780951|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
25780952|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780953|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780954|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
25780955|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25780956|NCT01745913|Fludarabine|fludarabine|mesh-list
25780957|NCT01745913|Melphalan|melphalan|mesh-list
25780958|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
25780959|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780960|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780961|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780962|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
25780963|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780964|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25780965|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
25780966|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25780967|NCT01752023|Gemcitabine|gemcitabine|mesh-list
25780968|NCT01752023|Itraconazole|itraconazole|mesh-list
25780969|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25780970|NCT01752023|Cisplatin|cisplatin|mesh-list
25780971|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780972|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25780973|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
25780974|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780975|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
25780976|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25780977|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780978|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25780979|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
25780980|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780981|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
25780982|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25780983|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25780984|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25780985|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
25780986|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780987|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25780988|NCT01740154|Sunitinib|sunitinib|mesh-list
25780989|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25780990|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25780991|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25780992|NCT01740154|Growth Substances|growth substances|mesh-ancestor
25780993|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25780994|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
25780995|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25780996|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25780997|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25780998|NCT01748162|Fluticasone|fluticasone|mesh-list
25780999|NCT01748162|Prednisolone|prednisolone|mesh-list
25781000|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781001|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25781002|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
25781003|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781004|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781005|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25781006|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042724|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781007|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25781008|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25781009|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
25781010|NCT01748162|Hormones|hormones|mesh-ancestor
25781011|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781012|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25781013|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781014|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25781015|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25781016|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781017|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25781018|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25781019|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781020|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781021|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
25781022|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781023|NCT01732926|Rituximab|rituximab|mesh-list
25781024|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25781025|NCT01732926|Idelalisib|idelalisib|mesh-list
25781026|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25781027|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781028|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
25781029|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781030|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781031|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25781032|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
25781033|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781034|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781035|NCT01732913|Rituximab|rituximab|mesh-list
25781036|NCT01732913|Idelalisib|idelalisib|mesh-list
25781037|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25781038|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781039|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
25781040|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781041|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781042|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781043|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781044|NCT01716052|Ibuprofen|ibuprofen|mesh-list
25781045|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25781046|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781047|NCT01716052|Analgesics|analgesics|mesh-ancestor
25781048|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
25781049|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781050|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781051|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781052|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781053|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25781054|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781055|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781056|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25781057|NCT01718444|Clomiphene|clomiphene|mesh-list
25781058|NCT01718444|Enclomiphene|enclomiphene|mesh-list
25781059|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
25781060|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
25781061|NCT01718444|Progestins|progestins|mesh-list
25781062|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25781063|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
25781064|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781065|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781066|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25781067|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
25781068|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25781069|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25781070|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25781071|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25781072|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25781073|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25781074|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
25781075|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25781076|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25781077|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25781078|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25781079|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781080|NCT01718444|Hormones|hormones|mesh-ancestor
25781081|NCT01712854|Budesonide|budesonide|mesh-list
25781082|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25781083|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781084|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25781085|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
25781086|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781087|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781088|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25781089|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
25781090|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
25781091|NCT01712854|Hormones|hormones|mesh-ancestor
25781092|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781093|NCT01717482|Metformin|metformin|mesh-list
25781094|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25781095|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781096|NCT01702896|Interleukin-2|interleukin-2|mesh-list
25781097|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781098|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781099|NCT01702896|Analgesics|analgesics|mesh-ancestor
25781100|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
25781101|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781102|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781103|NCT01709136|Sirolimus|sirolimus|mesh-list
25781104|NCT01709136|Tacrolimus|tacrolimus|mesh-list
25781105|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781106|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
25781107|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781108|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25781109|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781110|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781111|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25781112|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781113|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25781114|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781115|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
25781116|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
25781117|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25781118|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
25781119|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781120|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781121|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25781122|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
25781123|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
25781124|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25781125|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
25781126|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781127|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781128|NCT01705106|Celecoxib|celecoxib|mesh-list
25781129|NCT01705106|Capecitabine|capecitabine|mesh-list
25781130|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25781131|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
25781132|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781133|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781134|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25781135|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781136|NCT01705106|Analgesics|analgesics|mesh-ancestor
25781137|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
25781138|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781139|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781140|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781141|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781142|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25781143|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25781144|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781145|NCT01702909|Interleukin-2|interleukin-2|mesh-list
25781146|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781147|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781148|NCT01702909|Analgesics|analgesics|mesh-ancestor
25781149|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
25781150|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781151|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781152|NCT01701622|Febuxostat|febuxostat|mesh-list
25781153|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
25781154|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781155|NCT01697800|Tadalafil|tadalafil|mesh-list
25781156|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
25781157|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25781158|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25781159|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781160|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781161|NCT01697800|Urological Agents|urological agents|mesh-ancestor
25781162|NCT01692691|Dacarbazine|dacarbazine|mesh-list
25781163|NCT01692691|Carmustine|carmustine|mesh-list
25781164|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25781165|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
25781166|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781167|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781168|NCT01691079|Bromides|bromides|mesh-list
25781169|NCT01691079|Ipratropium|ipratropium|mesh-list
25781170|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
25781171|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25781172|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
25781173|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781174|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781175|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25781176|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
25781177|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25781178|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
25781179|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781180|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781181|NCT01689974|Ipilimumab|ipilimumab|mesh-list
25781182|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25781183|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781184|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25781185|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781186|NCT01663285|Gemcitabine|gemcitabine|mesh-list
25781187|NCT01663285|Cisplatin|cisplatin|mesh-list
25781188|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781189|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25781190|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
25781191|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781192|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
25781193|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781194|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781195|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781196|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
25781197|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781198|NCT01683864|Cisplatin|cisplatin|mesh-list
25781199|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781200|NCT01673061|Lidocaine|lidocaine|mesh-list
25781201|NCT01673061|Epinephrine|epinephrine|mesh-list
25781202|NCT01673061|Norflurane|norflurane|mesh-list
25781203|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
25781204|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
25781205|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781206|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781207|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
25781208|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781209|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25781210|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25781211|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25781212|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781213|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781214|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25781215|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25781216|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
25781217|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781218|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25781219|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25781220|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
25781221|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25781222|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
25781223|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
25781224|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
25781225|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25781226|NCT01675960|Gabapentin|gabapentin|mesh-list
25781227|NCT01675960|Analgesics|analgesics|mesh-ancestor
25781228|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
25781229|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781230|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781232|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25781233|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25781234|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781235|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25781236|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25781237|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25781238|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781239|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781240|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
25781241|NCT01668147|Ritonavir|ritonavir|mesh-list
25781242|NCT01668147|Efavirenz|efavirenz|mesh-list
25781243|NCT01668147|Loperamide|loperamide|mesh-list
25781244|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
25781245|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25781246|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25781247|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
25781248|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781249|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781250|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25781251|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25781252|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
25781253|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781254|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25781255|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25781256|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25781257|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25781258|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25781259|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25781260|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25781261|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25781262|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25781263|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25781264|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25781265|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
25781266|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781267|NCT01662102|Rituximab|rituximab|mesh-list
25781268|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25781269|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781270|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
25781271|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781272|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781273|NCT01659554|Cisplatin|cisplatin|mesh-list
25781274|NCT01659554|Doxorubicin|doxorubicin|mesh-list
25781275|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25781276|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781277|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25781278|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25781279|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25781280|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781281|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781282|NCT01658813|Interferons|interferons|mesh-list
25781283|NCT01658813|Fluorouracil|fluorouracil|mesh-list
25781284|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
25781285|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781286|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25781287|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781288|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781289|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
25781290|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781291|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
25781292|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781293|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25781294|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
25781295|NCT01649505|Coagulants|coagulants|mesh-ancestor
25781296|NCT01642732|Everolimus|everolimus|mesh-list
25781297|NCT01642732|Leuprolide|leuprolide|mesh-list
25781298|NCT01642732|Bicalutamide|bicalutamide|mesh-list
25781299|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781300|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781301|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
25781302|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781303|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25781304|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
25781305|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25781306|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25781307|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
25781308|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
25781309|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781310|NCT01645709|Verapamil|verapamil|mesh-list
25781311|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25781312|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25781313|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781314|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781315|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25781316|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781317|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
25781318|NCT01648270|Buprenorphine|buprenorphine|mesh-list
25781319|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25781320|NCT01648270|Narcotics|narcotics|mesh-ancestor
25781321|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781322|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781323|NCT01648270|Analgesics|analgesics|mesh-ancestor
25781324|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
25781325|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781326|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25781327|NCT01633814|Estradiol|estradiol|mesh-list
25781328|NCT01633814|Estrogens|estrogens|mesh-ancestor
25781329|NCT01633814|Hormones|hormones|mesh-ancestor
25781330|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781331|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781332|NCT01636466|Everolimus|everolimus|mesh-list
25781333|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781334|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781335|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
25781336|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781337|NCT01629329|Aspirin|aspirin|mesh-list
25781338|NCT01629329|Acetaminophen|acetaminophen|mesh-list
25781339|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
25781340|NCT01629329|Caffeine|caffeine|mesh-list
25781341|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25781342|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781343|NCT01629329|Analgesics|analgesics|mesh-ancestor
25781344|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
25781345|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781346|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781347|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781348|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781349|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25781350|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25781351|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781352|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25781353|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25781354|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781355|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
25781356|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25781357|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25781358|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25781359|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25781360|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
25781361|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781362|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
25781363|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
25781364|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25781365|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25781366|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25781367|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781368|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25781369|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25781370|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
25781371|NCT01632020|Metformin|metformin|mesh-list
25781372|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25781373|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781374|NCT01608906|Heparin|heparin|mesh-list
25781375|NCT01608906|Calcium heparin|calcium heparin|mesh-list
25781376|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
25781377|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25781378|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25781379|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781380|NCT01621737|Oxytocin|oxytocin|mesh-list
25781381|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
25781382|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25781383|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781384|NCT01614067|Ganirelix|ganirelix|mesh-list
25781385|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
25781386|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781387|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781388|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25781389|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25781390|NCT01607320|Clomiphene|clomiphene|mesh-list
25781391|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
25781392|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25781393|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
25781394|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781395|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781396|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25781397|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
25781398|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25781399|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25781400|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25781401|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25781402|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25781403|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
25781404|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25781405|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25781406|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25781407|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781408|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25781409|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25781410|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25781411|NCT01609231|Irinotecan|irinotecan|mesh-list
25781412|NCT01609231|Cetuximab|cetuximab|mesh-list
25781413|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25781414|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25781415|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781416|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781417|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781418|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25781419|NCT01602198|Rivastigmine|rivastigmine|mesh-list
25781420|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25781421|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781422|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781423|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
25781424|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781425|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781426|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25781427|NCT01602198|Protective Agents|protective agents|mesh-ancestor
25781428|NCT01606150|Lidocaine|lidocaine|mesh-list
25781429|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
25781430|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
25781431|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781432|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781433|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
25781434|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781435|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25781436|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25781437|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25781438|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781439|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781440|NCT01605370|Metoprolol|metoprolol|mesh-list
25781441|NCT01605370|Nebivolol|nebivolol|mesh-list
25781442|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25781443|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25781444|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
25781445|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
25781446|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781447|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781448|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25781449|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25781450|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25781451|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
25781452|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781453|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781454|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
25781455|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25781456|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25781457|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25781458|NCT01605617|Fesoterodine|fesoterodine|mesh-list
25781459|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25781460|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25781461|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
25781462|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781463|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781464|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781465|NCT01605617|Urological Agents|urological agents|mesh-ancestor
25781466|NCT01606709|Leuprolide|leuprolide|mesh-list
25781467|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25781468|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
25781469|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25781470|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781471|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25781472|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781473|NCT01603121|Lisofylline|lisofylline|mesh-list
25781474|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25781475|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
25781476|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781477|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25781478|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781479|NCT01603121|Analgesics|analgesics|mesh-ancestor
25781480|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
25781481|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781482|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781483|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781484|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781485|NCT01602016|Leucovorin|leucovorin|mesh-list
25781486|NCT01602016|Folic Acid|folic acid|mesh-list
25781487|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
25781488|NCT01602016|Antidotes|antidotes|mesh-ancestor
25781489|NCT01602016|Protective Agents|protective agents|mesh-ancestor
25781490|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781491|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
25781492|NCT01602016|Vitamins|vitamins|mesh-ancestor
25781493|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
25781494|NCT01602016|Hematinics|hematinics|mesh-ancestor
25781495|NCT01603394|Pregabalin|pregabalin|mesh-list
25781496|NCT01603394|Analgesics|analgesics|mesh-ancestor
25781497|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
25781498|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781499|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781500|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
25781501|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25781502|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781503|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781504|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25781505|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25781506|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25781507|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781508|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25781509|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25781510|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781511|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25781512|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781513|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781514|NCT01598025|Fludarabine|fludarabine|mesh-list
25781515|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
25781517|NCT01598025|Thiotepa|thiotepa|mesh-list
25781518|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25781519|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781520|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25781521|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
25781522|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781523|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781524|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
25781525|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781526|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25781527|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
25781528|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25781529|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
25781530|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
25781531|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781532|NCT01587963|Protective Agents|protective agents|mesh-ancestor
25781533|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781534|NCT01587963|Vitamins|vitamins|mesh-ancestor
25781535|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
25781536|NCT01591096|Plasminogen|plasminogen|mesh-list
25781537|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25781538|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25781539|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25781540|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781541|NCT01576575|Rifampin|rifampin|mesh-list
25781542|NCT01576575|Ketoconazole|ketoconazole|mesh-list
25781543|NCT01576575|Buprenorphine|buprenorphine|mesh-list
25781544|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25781545|NCT01576575|Narcotics|narcotics|mesh-ancestor
25781546|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781547|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781548|NCT01576575|Analgesics|analgesics|mesh-ancestor
25781549|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
25781550|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781551|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25781552|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25781553|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
25781554|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25781555|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781556|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
25781557|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25781558|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781559|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781560|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25781561|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25781562|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25781563|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25781564|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25781565|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25781566|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
25781567|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25781568|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25781569|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25781570|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
25781571|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781572|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25781573|NCT01583647|Niacin|niacin|mesh-list
25781574|NCT01583647|Niacinamide|niacinamide|mesh-list
25781575|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
25781576|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25781577|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
25781578|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781579|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25781580|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
25781581|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
25781582|NCT01583647|Vitamins|vitamins|mesh-ancestor
25781583|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
25781584|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781585|NCT01575028|Bupivacaine|bupivacaine|mesh-list
25781586|NCT01575028|Ropivacaine|ropivacaine|mesh-list
25781587|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
25781588|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
25781589|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781590|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781591|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
25781592|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781593|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
25781594|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
25781595|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25781596|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
25781597|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781598|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781599|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781600|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
25781601|NCT01570634|Loperamide|loperamide|mesh-list
25781602|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
25781603|NCT01570634|Calcium|calcium|mesh-list
25781604|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25781605|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781606|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25781607|NCT01566370|Zonisamide|zonisamide|mesh-list
25781608|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
25781609|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25781610|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781611|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781612|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25781613|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781614|NCT01561989|Vitamin D|vitamin d|mesh-list
25781615|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
25781616|NCT01561989|Vaccines|vaccines|mesh-list
25781617|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
25781618|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781619|NCT01561989|Vitamins|vitamins|mesh-ancestor
25781620|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
25781621|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25781622|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25781623|NCT01560507|Bupropion|bupropion|mesh-list
25781624|NCT01560507|Nicotine|nicotine|mesh-list
25781625|NCT01560507|Varenicline|varenicline|mesh-list
25781626|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25781627|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
25781628|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781629|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781630|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25781631|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25781632|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
25781633|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781634|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781635|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25781636|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
25781637|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25781638|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25781639|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25781640|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781641|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
25781642|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25781643|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25781644|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781645|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
25781646|NCT01555489|Vitamins|vitamins|mesh-ancestor
25781647|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
25781648|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781649|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
25781650|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781651|NCT01555489|Protective Agents|protective agents|mesh-ancestor
25781652|NCT01549977|Febuxostat|febuxostat|mesh-list
25781653|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
25781654|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781655|NCT01558492|Paclitaxel|paclitaxel|mesh-list
25781656|NCT01558492|Carboplatin|carboplatin|mesh-list
25781657|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25781658|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781659|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
25781660|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
25781661|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
25781662|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781663|NCT01555073|Celecoxib|celecoxib|mesh-list
25781664|NCT01555073|Pregabalin|pregabalin|mesh-list
25781665|NCT01555073|Analgesics|analgesics|mesh-ancestor
25781666|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
25781667|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781668|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781669|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
25781670|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25781671|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781672|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781673|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25781674|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25781675|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25781676|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781677|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25781678|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25781679|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781680|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781681|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781682|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25781683|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25781684|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781685|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25781686|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25781687|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
25781688|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
25781689|NCT01550510|Irinotecan|irinotecan|mesh-list
25781690|NCT01550510|Camptothecin|camptothecin|mesh-list
25781691|NCT01550510|Vitamins|vitamins|mesh-ancestor
25781692|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
25781693|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781694|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25781695|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25781696|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781697|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781698|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781699|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
25781700|NCT01550510|Protective Agents|protective agents|mesh-ancestor
25781701|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25781702|NCT01547728|Antithrombins|antithrombins|mesh-list
25781703|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
25781704|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25781705|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
25781706|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781707|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781708|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
25781709|NCT01548651|Saxagliptin|saxagliptin|mesh-list
25781710|NCT01548651|Incretins|incretins|mesh-ancestor
25781711|NCT01548651|Hormones|hormones|mesh-ancestor
25781712|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25781713|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781714|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25781715|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
25781716|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781717|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781718|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25781719|NCT01545648|Denosumab|denosumab|mesh-list
25781720|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25781721|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781722|NCT01546883|Dabigatran|dabigatran|mesh-list
25781723|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
25781724|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25781725|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
25781726|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781727|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781728|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
25781729|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25781730|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
25781731|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781732|NCT01536015|Rotigotine|rotigotine|mesh-list
25781733|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
25781734|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
25781735|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781736|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781737|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781738|NCT01533753|Gabapentin|gabapentin|mesh-list
25781739|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25781740|NCT01533753|Analgesics|analgesics|mesh-ancestor
25781741|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
25781742|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781743|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781744|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
25781745|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25781746|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25781747|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781748|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25781749|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25781750|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25781751|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781752|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781753|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
25781754|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25781755|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25781756|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781757|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25781758|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
25781759|NCT01534143|Sirolimus|sirolimus|mesh-list
25781760|NCT01534143|Fludarabine|fludarabine|mesh-list
25781761|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
25781762|NCT01534143|Bortezomib|bortezomib|mesh-list
25781763|NCT01534143|Busulfan|busulfan|mesh-list
25781764|NCT01534143|Tacrolimus|tacrolimus|mesh-list
25781765|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
25781766|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25781767|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
25781768|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781769|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25781770|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
25781771|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781772|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781773|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
25781774|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781775|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25781776|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781777|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25781778|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781779|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25781780|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
25781781|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
25781782|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25781783|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25781784|NCT01530880|Acetaminophen|acetaminophen|mesh-list
25781785|NCT01530880|Ibuprofen|ibuprofen|mesh-list
25781786|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781787|NCT01530880|Analgesics|analgesics|mesh-ancestor
25781788|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
25781789|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781790|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781791|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
25781792|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25781793|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25781794|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781795|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25781796|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781797|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781798|NCT01527942|Acetaminophen|acetaminophen|mesh-list
25781799|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781800|NCT01527942|Analgesics|analgesics|mesh-ancestor
25781801|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
25781802|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781803|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781804|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
25781805|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
25781806|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
25781807|NCT01532635|Tacrolimus|tacrolimus|mesh-list
25781808|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781809|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
25781810|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781811|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781812|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25781813|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
25781814|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781815|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781816|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25781817|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25781818|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781819|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25781820|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25781821|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
25781822|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25781823|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781824|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
25781825|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781826|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
25781827|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781828|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781829|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25781830|NCT01526408|Famciclovir|famciclovir|mesh-list
25781831|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
25781832|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781833|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25781834|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781835|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781836|NCT01525927|Cisplatin|cisplatin|mesh-list
25781837|NCT01525927|Carboplatin|carboplatin|mesh-list
25781838|NCT01525927|Etoposide|etoposide|mesh-list
25781839|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781840|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25781841|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25781842|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25781843|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781844|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781845|NCT01507233|Morphine|morphine|mesh-list
25781846|NCT01507233|Bupivacaine|bupivacaine|mesh-list
25781847|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
25781848|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
25781849|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781850|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781851|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
25781852|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781853|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25781854|NCT01507233|Narcotics|narcotics|mesh-ancestor
25781855|NCT01507233|Analgesics|analgesics|mesh-ancestor
25781856|NCT01500772|Ribavirin|ribavirin|mesh-list
25781857|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25781858|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
25781859|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781860|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
25781861|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781862|NCT01507584|Bimatoprost|bimatoprost|mesh-list
25781863|NCT01507584|Brinzolamide|brinzolamide|mesh-list
25781864|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25781865|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25781866|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781867|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781868|NCT01510756|Sorafenib|sorafenib|mesh-list
25781869|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781870|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25781871|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781872|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781873|NCT01500109|Acetaminophen|acetaminophen|mesh-list
25781874|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25781875|NCT01500109|Analgesics|analgesics|mesh-ancestor
25781876|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
25781877|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781878|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781879|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
25781881|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
25781882|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25781883|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25781884|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25781885|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25781886|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781887|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
25781888|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
25781889|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781890|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781891|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25781892|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25781893|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
25781894|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25781895|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25781896|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25781897|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25781898|NCT01495988|Bevacizumab|bevacizumab|mesh-list
25781899|NCT01495988|Vemurafenib|vemurafenib|mesh-list
25781900|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25781901|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781902|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25781903|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25781904|NCT01495988|Growth Substances|growth substances|mesh-ancestor
25781905|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781906|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
25781907|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25781908|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781909|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781910|NCT01483872|Tigecycline|tigecycline|mesh-list
25781911|NCT01483872|Heparin|heparin|mesh-list
25781912|NCT01483872|Calcium heparin|calcium heparin|mesh-list
25781913|NCT01483872|Anticoagulants|anticoagulants|mesh-list
25781914|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781915|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25781916|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25781917|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25781918|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781919|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25781920|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781921|NCT01487499|Cisplatin|cisplatin|mesh-list
25781922|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781923|NCT01478113|Amphetamine|amphetamine|mesh-list
25781924|NCT01478113|Adderall|adderall|mesh-list
25781925|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
25781926|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25781927|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781928|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
25781929|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
25781930|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781931|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
25781932|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781933|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781934|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25781935|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25781936|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25781937|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781938|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25781939|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
25781940|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25781941|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25781942|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25781943|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781944|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781945|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
25781946|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25781947|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781948|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25117997|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
25117999|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25118000|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118001|NCT04574479|Morphine|morphine|mesh-list
25118002|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25781949|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25781950|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25781951|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781952|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
25781953|NCT01473732|Everolimus|everolimus|mesh-list
25781954|NCT01473732|Tacrolimus|tacrolimus|mesh-list
25781955|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25781956|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
25781957|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781958|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25781959|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25781960|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781961|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781962|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25781963|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25781964|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
25781965|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25781966|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781967|NCT01472692|Febuxostat|febuxostat|mesh-list
25781968|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
25781969|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781970|NCT01465230|Lenalidomide|lenalidomide|mesh-list
25781971|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
25781972|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781973|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25781974|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25781975|NCT01465230|Growth Substances|growth substances|mesh-ancestor
25781976|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
25781977|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781978|NCT01464723|Ranibizumab|ranibizumab|mesh-list
25781979|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25781980|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25781981|NCT01464723|Growth Substances|growth substances|mesh-ancestor
25781982|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781983|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
25781984|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25781985|NCT01446250|Ribavirin|ribavirin|mesh-list
25781986|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25781987|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
25781988|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25781989|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
25781990|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25781991|NCT01457053|Torsemide|torsemide|mesh-list
25781992|NCT01457053|Furosemide|furosemide|mesh-list
25781993|NCT01457053|Bumetanide|bumetanide|mesh-list
25781994|NCT01457053|Diuretics|diuretics|mesh-list
25781995|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25781996|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
25781997|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25781998|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25781999|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782000|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25782001|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25782002|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
25782003|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782004|NCT01451723|Protective Agents|protective agents|mesh-ancestor
25782005|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782006|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25782007|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25782008|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782009|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25782010|NCT01440595|Ribavirin|ribavirin|mesh-list
25782011|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25782012|NCT01440595|Grazoprevir|grazoprevir|mesh-list
25782013|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
25782014|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782015|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
25782016|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782017|NCT01443923|Interferons|interferons|mesh-list
25782018|NCT01443923|Ribavirin|ribavirin|mesh-list
25119196|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25119197|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
25119198|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782019|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
25782020|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
25782021|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25782022|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782023|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
25782024|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782025|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
25782026|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782027|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
25782028|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782029|NCT01439347|Vincristine|vincristine|mesh-list
25782030|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25782031|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782032|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
25782033|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
25782034|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25782035|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025067|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
25025068|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025069|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25025070|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25025071|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025072|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25782036|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
25782037|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25782038|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782040|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25782041|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25782042|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
25782043|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782044|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25782045|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25782046|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782047|NCT01415986|Temoporfin|temoporfin|mesh-list
25782048|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782049|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25782050|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
25782051|NCT01410799|Hormones|hormones|mesh-list
25782052|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25782053|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782054|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782055|NCT01426113|Timolol|timolol|mesh-list
25782056|NCT01426113|Bimatoprost|bimatoprost|mesh-list
25782057|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25782058|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25782059|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25782060|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25782061|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25782062|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782063|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782064|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782065|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25782066|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25782067|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
25782068|NCT01420965|Antibodies|antibodies|mesh-list
25782069|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
25782070|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782071|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
25782072|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782073|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782074|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25782075|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
25782076|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782077|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782078|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25782079|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
25782080|NCT01406860|Promethazine|promethazine|mesh-list
25782081|NCT01406860|Droperidol|droperidol|mesh-list
25782082|NCT01406860|Metoclopramide|metoclopramide|mesh-list
25782083|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25782084|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25782085|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25782086|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782087|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
25782088|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
25782089|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
25782090|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782091|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
25782092|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
25782093|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25782094|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25782095|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
25782096|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
25782097|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782098|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782099|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25782100|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
25782101|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
25782102|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25782103|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25782104|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
25782105|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25782106|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25782107|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25782108|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25782109|NCT01401049|Lidocaine|lidocaine|mesh-list
25782110|NCT01401049|Propofol|propofol|mesh-list
25782111|NCT01401049|Fospropofol|fospropofol|mesh-list
25782112|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
25782113|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
25782114|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25782115|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782116|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
25782117|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782118|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25782119|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25782120|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25782121|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25782122|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782123|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25782124|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25782125|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
25782126|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
25782127|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
25782128|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25782129|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25782130|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782131|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782132|NCT01409031|Urological Agents|urological agents|mesh-ancestor
25782133|NCT01402531|Bevacizumab|bevacizumab|mesh-list
25782134|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782135|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782136|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25782137|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25782138|NCT01402531|Growth Substances|growth substances|mesh-ancestor
25782139|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782140|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
25782141|NCT01397552|Dexamethasone|dexamethasone|mesh-list
25782142|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
25782143|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25782144|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25782145|NCT01397552|Prednisolone|prednisolone|mesh-list
25782146|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
25782147|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25782148|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
25782149|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25782150|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
25782151|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
25782152|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782153|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782154|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25782155|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
25782157|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782158|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782159|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782160|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25782161|NCT01397552|Protective Agents|protective agents|mesh-ancestor
25782162|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25782163|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
25782164|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782165|NCT01397695|Bevacizumab|bevacizumab|mesh-list
25782166|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782167|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782168|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25782169|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25782170|NCT01397695|Growth Substances|growth substances|mesh-ancestor
25782171|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782172|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
25782173|NCT01390181|Losartan|losartan|mesh-list
25782174|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25782175|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25782176|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25782177|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25782178|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782179|NCT01394211|Anastrozole|anastrozole|mesh-list
25782180|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782181|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782182|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24446525|NCT00305201|Pravastatin|pravastatin|mesh-list
25782183|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25782184|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782185|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782186|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25782187|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
25782188|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782189|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782190|NCT01377441|Ibuprofen|ibuprofen|mesh-list
25782191|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25782192|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25782193|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25782194|NCT01377441|Analgesics|analgesics|mesh-ancestor
25782195|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
25782196|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782197|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782198|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782199|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25782200|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782201|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782202|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
25782203|NCT01383447|Entinostat|entinostat|mesh-list
25782204|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25782205|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782206|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25782207|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782208|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782209|NCT01372618|Pasireotide|pasireotide|mesh-list
25782210|NCT01372618|Hormones|hormones|mesh-ancestor
25782211|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782212|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782213|NCT01385280|Exemestane|exemestane|mesh-list
25782214|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25782215|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25782216|NCT01385280|Estradiol|estradiol|mesh-list
25782217|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25782218|NCT01385280|Estrogens|estrogens|mesh-ancestor
25782219|NCT01385280|Hormones|hormones|mesh-ancestor
25782220|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782221|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782222|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25782223|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
25782224|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25782225|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25782226|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782227|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25782228|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25782229|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782230|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782231|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25782232|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
25782233|NCT01379274|Lenalidomide|lenalidomide|mesh-list
25782234|NCT01379274|Azacitidine|azacitidine|mesh-list
25782235|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
25782236|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782237|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25782238|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25782239|NCT01379274|Growth Substances|growth substances|mesh-ancestor
25782240|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
25782241|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782242|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782243|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
25782244|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782245|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782246|NCT01379469|Carbamazepine|carbamazepine|mesh-list
25782247|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
25782248|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
25782249|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25782250|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25782251|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782252|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25782253|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25782254|NCT01379469|Analgesics|analgesics|mesh-ancestor
25782255|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
25782256|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782257|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25782258|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25782259|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782260|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25782261|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25782262|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
25782263|NCT01369641|Cisplatin|cisplatin|mesh-list
25782264|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782265|NCT01369641|Antidotes|antidotes|mesh-ancestor
25782266|NCT01369641|Protective Agents|protective agents|mesh-ancestor
25782267|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782268|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
25782269|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782270|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
25782271|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25782272|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782273|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
25782274|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
25782275|NCT01359254|Vidarabine|vidarabine|mesh-list
25782276|NCT01359254|Fludarabine|fludarabine|mesh-list
25782277|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
25782278|NCT01359254|Melphalan|melphalan|mesh-list
25782279|NCT01359254|Busulfan|busulfan|mesh-list
25782280|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25782281|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782282|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782283|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
25782284|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782285|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782286|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
25782287|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782288|NCT01359254|Antiviral Agents|antiviral agents|mesh-ancestor
25782289|NCT01359254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782290|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25782291|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
25782292|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25782293|NCT01347632|Metronidazole|metronidazole|mesh-list
25782294|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782295|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25782296|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25782297|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25782298|NCT01350232|Cytarabine|cytarabine|mesh-list
25782299|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
25782300|NCT01350232|Rituximab|rituximab|mesh-list
25782301|NCT01350232|Fludarabine|fludarabine|mesh-list
25782302|NCT01350232|Bortezomib|bortezomib|mesh-list
25782303|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782304|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
25782305|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782306|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782307|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25782308|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
25782309|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782310|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782311|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25782312|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782313|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782314|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
25782315|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
25782316|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782317|NCT01352416|Ranolazine|ranolazine|mesh-list
25782318|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25782319|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25782320|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782321|NCT01350258|Vidarabine|vidarabine|mesh-list
25782322|NCT01350258|Fludarabine|fludarabine|mesh-list
25782323|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
25782324|NCT01350258|Melphalan|melphalan|mesh-list
25782325|NCT01350258|Thiotepa|thiotepa|mesh-list
25782326|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782327|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782328|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
25782329|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782330|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782331|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
25782332|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782333|NCT01350258|Antiviral Agents|antiviral agents|mesh-ancestor
25782334|NCT01350258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782335|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25782336|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
25782337|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25782338|NCT01349595|Bortezomib|bortezomib|mesh-list
25782339|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782340|NCT01340573|Interferons|interferons|mesh-list
25782341|NCT01340573|Ribavirin|ribavirin|mesh-list
25782342|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25782343|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782344|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
25782345|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782346|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
25782347|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782349|NCT01335997|Niacinamide|niacinamide|mesh-list
25782350|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
25782351|NCT01335997|Simvastatin|simvastatin|mesh-list
25782352|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25782353|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25782354|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
25782355|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782356|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25782357|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25782358|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782359|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
25782360|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
25782361|NCT01335997|Vitamins|vitamins|mesh-ancestor
25782362|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
25782363|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782364|NCT01340885|Rivastigmine|rivastigmine|mesh-list
25782365|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25782366|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25782367|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25782368|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25782369|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782370|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
25782371|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782372|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782373|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25782374|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782375|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
25782376|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25782377|NCT01340885|Protective Agents|protective agents|mesh-ancestor
25782378|NCT01326923|Cetuximab|cetuximab|mesh-list
25782379|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782380|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782381|NCT01332799|Allopurinol|allopurinol|mesh-list
25782382|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
25782383|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782384|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782385|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
25782386|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782387|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25782388|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
25782389|NCT01332799|Protective Agents|protective agents|mesh-ancestor
25782390|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782391|NCT01329549|Carboplatin|carboplatin|mesh-list
25782392|NCT01329549|Nintedanib|nintedanib|mesh-list
25782393|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782394|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25782395|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782396|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782397|NCT01326845|Deferasirox|deferasirox|mesh-list
25782398|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25782399|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
25782400|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
25782401|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782402|NCT01320683|Leucovorin|leucovorin|mesh-list
25782403|NCT01320683|Bevacizumab|bevacizumab|mesh-list
25782404|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25782405|NCT01320683|Fluorouracil|fluorouracil|mesh-list
25782406|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
25782407|NCT01320683|Irinotecan|irinotecan|mesh-list
25782408|NCT01320683|Antibodies|antibodies|mesh-list
25782409|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
25782410|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25782411|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
25782412|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782413|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25782414|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25782415|NCT01320683|Growth Substances|growth substances|mesh-ancestor
25782416|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782417|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
25782418|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
25782419|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
25782420|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782421|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782422|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782423|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25782424|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25782425|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782426|NCT01320683|Antidotes|antidotes|mesh-ancestor
25782427|NCT01320683|Protective Agents|protective agents|mesh-ancestor
25782428|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
25782429|NCT01320683|Vitamins|vitamins|mesh-ancestor
25782430|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
25782431|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
25782432|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
25782433|NCT01313273|Lanreotide|lanreotide|mesh-list
25782434|NCT01313273|Androgens|androgens|mesh-list
25782435|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25782436|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25782437|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
25782438|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
25782439|NCT01313273|Hormones|hormones|mesh-ancestor
25782440|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782441|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782442|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
25782443|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782444|NCT01313273|Protective Agents|protective agents|mesh-ancestor
25782445|NCT01313273|Vitamins|vitamins|mesh-ancestor
25782446|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
25782447|NCT01313273|Estrogens|estrogens|mesh-ancestor
25782448|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782449|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782450|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
25782451|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
25782452|NCT01321008|Prednisone|prednisone|mesh-list
25782453|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
25782454|NCT01321008|Doxorubicin|doxorubicin|mesh-list
25782455|NCT01321008|Vincristine|vincristine|mesh-list
25782456|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782457|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
25782458|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782459|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782460|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25782461|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
25782462|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782463|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782464|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25782465|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25782466|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25782467|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25782468|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782469|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25782470|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
25782471|NCT01321008|Hormones|hormones|mesh-ancestor
25782472|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782473|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782474|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25782475|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
25782476|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
25782477|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25782478|NCT01310803|Valrubicin|valrubicin|mesh-list
25782479|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782480|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25782481|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25782482|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782483|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782484|NCT01309581|Ketamine|ketamine|mesh-list
25782485|NCT01309581|Methohexital|methohexital|mesh-list
25782486|NCT01309581|Analgesics|analgesics|mesh-ancestor
25782487|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
25782488|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782489|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782490|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25782491|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25782492|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
25782493|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
25782494|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25782495|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25782496|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25782497|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782498|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782499|NCT01315873|Bortezomib|bortezomib|mesh-list
25782500|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25782501|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782502|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25782503|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
25782504|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782505|NCT01313923|Sirolimus|sirolimus|mesh-list
25782506|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25782507|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782508|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25782509|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782510|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
25782511|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782512|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
25782513|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782514|NCT01313416|Gemcitabine|gemcitabine|mesh-list
25782515|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782516|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
25782517|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782518|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782519|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
25782520|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782521|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782522|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782523|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
25782524|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782525|NCT01303003|Dexamethasone|dexamethasone|mesh-list
25782526|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25782527|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
25782528|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
25782529|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782530|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782531|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25782532|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
25782533|NCT01303003|Hormones|hormones|mesh-ancestor
25782534|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782535|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782536|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782537|NCT01302444|Tadalafil|tadalafil|mesh-list
25782538|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
25782539|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25782540|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25782541|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782542|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782543|NCT01302444|Urological Agents|urological agents|mesh-ancestor
25782544|NCT01301963|Plerixafor|plerixafor|mesh-list
25782545|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25782546|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25782547|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
25782548|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782549|NCT01292070|Histamine|histamine|mesh-list
25782550|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
25782551|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
25782552|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782553|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782554|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782555|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
25782556|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782557|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
25782558|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782559|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782560|NCT01290718|Capecitabine|capecitabine|mesh-list
25782561|NCT01290718|Trastuzumab|trastuzumab|mesh-list
25782562|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782563|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
25782564|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782565|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782566|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782567|NCT01293123|Tenofovir|tenofovir|mesh-list
25782568|NCT01293123|Emtricitabine|emtricitabine|mesh-list
25782569|NCT01293123|Efavirenz|efavirenz|mesh-list
25782570|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
25782571|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
25782572|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782573|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25782574|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25782575|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782576|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782577|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25782578|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25782579|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25782580|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25782581|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25782582|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25782583|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25782584|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25782585|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25782586|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25782587|NCT01280643|Leucovorin|leucovorin|mesh-list
25782588|NCT01280643|Bevacizumab|bevacizumab|mesh-list
25782589|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25782590|NCT01280643|Cetuximab|cetuximab|mesh-list
25782591|NCT01280643|Fluorouracil|fluorouracil|mesh-list
25782592|NCT01280643|Capecitabine|capecitabine|mesh-list
25782593|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
25782594|NCT01280643|Irinotecan|irinotecan|mesh-list
25782595|NCT01280643|Antibodies|antibodies|mesh-list
25782596|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
25782597|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25782598|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
25782599|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782600|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25782601|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25782602|NCT01280643|Growth Substances|growth substances|mesh-ancestor
25782603|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782604|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
25782605|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
25782606|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
25782607|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782608|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782609|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782610|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25782611|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25782612|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782613|NCT01280643|Antidotes|antidotes|mesh-ancestor
25782614|NCT01280643|Protective Agents|protective agents|mesh-ancestor
25782615|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
25782616|NCT01280643|Vitamins|vitamins|mesh-ancestor
25782617|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
25782618|NCT01281124|Azacitidine|azacitidine|mesh-list
25782619|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782620|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
25782621|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782622|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782623|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782624|NCT01272141|Everolimus|everolimus|mesh-list
25782625|NCT01272141|Lapatinib|lapatinib|mesh-list
25782626|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782627|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782628|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
25782629|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782630|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25782631|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782632|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782633|NCT01282216|Vaccines|vaccines|mesh-list
25782634|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25782635|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
25782636|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782637|NCT01284504|Celecoxib|celecoxib|mesh-list
25782638|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25782639|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25782640|NCT01284504|Analgesics|analgesics|mesh-ancestor
25782641|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
25782642|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782643|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782644|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25782645|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782646|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25782647|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25782648|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782649|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782651|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25782652|NCT01269034|Exenatide|exenatide|mesh-list
25782653|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
25782654|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
25782655|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
25782656|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25782657|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782658|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25782659|NCT01269034|Incretins|incretins|mesh-ancestor
25782660|NCT01269034|Hormones|hormones|mesh-ancestor
25782661|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782662|NCT01274533|Lenalidomide|lenalidomide|mesh-list
25782663|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
25782664|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782665|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25782666|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25782667|NCT01274533|Growth Substances|growth substances|mesh-ancestor
25782668|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
25782669|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782670|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
25782671|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
25782672|NCT01279616|Busulfan|busulfan|mesh-list
25782673|NCT01279616|Rituximab|rituximab|mesh-list
25782674|NCT01279616|Fludarabine|fludarabine|mesh-list
25782675|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
25782676|NCT01279616|Tacrolimus|tacrolimus|mesh-list
25782677|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
25782678|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782679|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
25782680|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782681|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782682|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25782683|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
25782684|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782685|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782686|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25782687|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782688|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782689|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
25782690|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25782691|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782692|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25782693|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25782694|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
25782695|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25782696|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782697|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25782698|NCT01276054|Methylene Blue|methylene blue|mesh-list
25782699|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25782700|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782701|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782702|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25782703|NCT01264965|Acetaminophen|acetaminophen|mesh-list
25782704|NCT01264965|Oxycodone|oxycodone|mesh-list
25782705|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25782706|NCT01264965|Analgesics|analgesics|mesh-ancestor
25782707|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
25782708|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782709|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782710|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
25782711|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25782712|NCT01264965|Narcotics|narcotics|mesh-ancestor
25782713|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25782714|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
25782715|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25782716|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25782717|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
25782719|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25782720|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782721|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
25782722|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782723|NCT01273064|Interferons|interferons|mesh-list
25782724|NCT01273064|Ribavirin|ribavirin|mesh-list
25782725|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782726|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
25782727|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782728|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
25782729|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782730|NCT01274559|Niacin|niacin|mesh-list
25782731|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25782732|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
25782733|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782734|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25782735|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
25782736|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
25782737|NCT01274559|Vitamins|vitamins|mesh-ancestor
25782738|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
25782739|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782740|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
25782741|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25782742|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25782743|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25782744|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782745|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
25782746|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782747|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782748|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25782749|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782750|NCT01267825|Bupivacaine|bupivacaine|mesh-list
25782751|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
25782752|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
25782753|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25782754|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782755|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
25782756|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782757|NCT01259284|Atorvastatin|atorvastatin|mesh-list
25782758|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25782759|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25782760|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
25782761|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782762|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25782763|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25782764|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782765|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
25782766|NCT01263028|Vitamin D|vitamin d|mesh-list
25782767|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25782768|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782769|NCT01263028|Vitamins|vitamins|mesh-ancestor
25782770|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
25782771|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25045764|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129638|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25782773|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25782774|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
25782775|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782776|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
25782777|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25782778|NCT01259024|Estrogens|estrogens|mesh-ancestor
25782779|NCT01259024|Hormones|hormones|mesh-ancestor
25782780|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782781|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782782|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782783|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782784|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
25782785|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782786|NCT01246011|Warfarin|warfarin|mesh-list
25782787|NCT01246011|Argatroban|argatroban|mesh-list
25782788|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
25782789|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
25782790|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25782791|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
25782792|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782793|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782794|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25782795|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
25782796|NCT01244620|Tadalafil|tadalafil|mesh-list
25782797|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
25782798|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
25782799|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25782800|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25782801|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782802|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782803|NCT01244620|Urological Agents|urological agents|mesh-ancestor
25782804|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25782805|NCT01240304|Gemcitabine|gemcitabine|mesh-list
25782806|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782807|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
25782808|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782809|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782810|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
25782811|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782812|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782813|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782814|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
25782815|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782816|NCT01230788|Rituximab|rituximab|mesh-list
25782817|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782818|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782819|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
25782820|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782821|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782822|NCT01231750|Capsaicin|capsaicin|mesh-list
25782823|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
25782824|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
25782825|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
25782826|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782827|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782828|NCT01230307|Vitamin D|vitamin d|mesh-list
25782829|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
25782830|NCT01230307|Vitamins|vitamins|mesh-ancestor
25782831|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
25782832|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782833|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25782834|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25782835|NCT01222871|Triamcinolone|triamcinolone|mesh-list
25782836|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25782837|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
25782838|NCT01222871|Hormones|hormones|mesh-ancestor
25782839|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782840|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782841|NCT01219673|Minocycline|minocycline|mesh-list
25782842|NCT01219673|Modafinil|modafinil|mesh-list
25782843|NCT01219673|Bupropion|bupropion|mesh-list
25782844|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25782845|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
25782846|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25782847|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25782848|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25782849|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25782850|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782851|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
25782852|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782853|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782854|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25782855|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25782856|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782857|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25782858|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782859|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25782860|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25782861|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25782862|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25782863|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25782864|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25782865|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25782866|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25782867|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782868|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782869|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782870|NCT01223001|Analgesics|analgesics|mesh-ancestor
25782871|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
25782872|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782873|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
25782874|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25782875|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
25782876|NCT01217060|Dexamethasone|dexamethasone|mesh-list
25782877|NCT01217060|Docetaxel|docetaxel|mesh-list
25782878|NCT01217060|Fluorouracil|fluorouracil|mesh-list
25782879|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25782880|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
25782881|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
25782882|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782883|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782884|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25782885|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
25782886|NCT01217060|Hormones|hormones|mesh-ancestor
25782887|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782888|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782889|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782890|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
25782891|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
25782892|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
25782893|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782894|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
25782895|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782896|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782897|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
25782898|NCT01206101|Liraglutide|liraglutide|mesh-list
25782899|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25782900|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782901|NCT01206101|Incretins|incretins|mesh-ancestor
25782902|NCT01206101|Hormones|hormones|mesh-ancestor
25782903|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782904|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
25782905|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25782906|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25782907|NCT01216631|Prednisolone|prednisolone|mesh-list
25782908|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
25782909|NCT01216631|Infliximab|infliximab|mesh-list
25782910|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25782911|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
25782912|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25782913|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
25782914|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
25782915|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25782916|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782917|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25782918|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
25782919|NCT01216631|Hormones|hormones|mesh-ancestor
25782920|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25782921|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25782922|NCT01216631|Protective Agents|protective agents|mesh-ancestor
25782923|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25782924|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782925|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
25782926|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25782927|NCT01211756|Oxytocin|oxytocin|mesh-list
25782928|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
25782929|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25782930|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782931|NCT01209520|Paclitaxel|paclitaxel|mesh-list
25782932|NCT01209520|Vinorelbine|vinorelbine|mesh-list
25782933|NCT01209520|Docetaxel|docetaxel|mesh-list
25782934|NCT01209520|Cisplatin|cisplatin|mesh-list
25782935|NCT01209520|Carboplatin|carboplatin|mesh-list
25782936|NCT01209520|Pemetrexed|pemetrexed|mesh-list
25782937|NCT01209520|Azacitidine|azacitidine|mesh-list
25782938|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25782939|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782940|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
25782941|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
25782942|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
25782943|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782944|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782945|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25782946|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25782947|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782948|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
25782949|NCT01207726|Azacitidine|azacitidine|mesh-list
25782950|NCT01207726|Entinostat|entinostat|mesh-list
25782951|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25782952|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782953|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
25782954|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782955|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782956|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782957|NCT01206296|Gemcitabine|gemcitabine|mesh-list
25782958|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25782959|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
25782960|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782961|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782962|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
25782963|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25782964|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25782965|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25782966|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
25782967|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782968|NCT01207102|Paclitaxel|paclitaxel|mesh-list
25782969|NCT01207102|Carboplatin|carboplatin|mesh-list
25782970|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25782971|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25782972|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782973|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
25782974|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
25782975|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
25782976|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782977|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
25782978|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25782979|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25782980|NCT01202110|Propranolol|propranolol|mesh-list
25782981|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25782982|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25782983|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25782984|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25782985|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782986|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25782987|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25782988|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25782989|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
25782990|NCT01206439|Nebivolol|nebivolol|mesh-list
25782991|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25782992|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
25782993|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25782994|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25782995|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25130831|NCT03030690|Methamphetamine|methamphetamine|mesh-list
25782996|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
25782998|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782999|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783000|NCT01200602|Megestrol|megestrol|mesh-list
25783001|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
25783002|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25783003|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25783004|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25783005|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
25783006|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783007|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783008|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25783009|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25783010|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783011|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783012|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
25783013|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25783014|NCT01198548|Vitamin D|vitamin d|mesh-list
25783015|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
25783016|NCT01198548|Leucovorin|leucovorin|mesh-list
25783017|NCT01198548|Bevacizumab|bevacizumab|mesh-list
25783018|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25783019|NCT01198548|Fluorouracil|fluorouracil|mesh-list
25783020|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
25783021|NCT01198548|Antibodies|antibodies|mesh-list
25783022|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
25783023|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25783024|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
25783025|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783026|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25783027|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25783028|NCT01198548|Growth Substances|growth substances|mesh-ancestor
25783029|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783030|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
25783031|NCT01198548|Vitamins|vitamins|mesh-ancestor
25783032|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
25783033|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
25783034|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25783035|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25783036|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
25783037|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783038|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783039|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783040|NCT01198548|Antidotes|antidotes|mesh-ancestor
25783041|NCT01198548|Protective Agents|protective agents|mesh-ancestor
25783042|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
25783043|NCT01194908|Tamoxifen|tamoxifen|mesh-list
25783044|NCT01194908|Decitabine|decitabine|mesh-list
25783045|NCT01194908|Panobinostat|panobinostat|mesh-list
25783046|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783047|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
25783048|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783049|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783050|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783051|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25783052|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
25783053|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783054|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783055|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783056|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25783057|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25783058|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25783059|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25783060|NCT01194856|Ritonavir|ritonavir|mesh-list
25783061|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25783062|NCT01194856|Efavirenz|efavirenz|mesh-list
25783063|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25783064|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25783065|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
25783066|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783067|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783068|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25783069|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25783070|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
25783071|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783072|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25783073|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25783074|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25783075|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25783076|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25783077|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25783078|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25783079|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25783080|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25783081|NCT01194427|Tamoxifen|tamoxifen|mesh-list
25783082|NCT01194427|Vorinostat|vorinostat|mesh-list
25783083|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25783084|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
25783085|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783086|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783087|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783088|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783089|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25783090|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25783091|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25783092|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25783093|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783094|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783095|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25783096|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783097|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25783098|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783099|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783100|NCT01182610|Paclitaxel|paclitaxel|mesh-list
25783101|NCT01182610|Carboplatin|carboplatin|mesh-list
25783102|NCT01182610|Fluorouracil|fluorouracil|mesh-list
25783103|NCT01182610|Panitumumab|panitumumab|mesh-list
25783104|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25783105|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783106|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25783107|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25783108|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25783109|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783110|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
25783111|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783112|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783113|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
25783114|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783115|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25783116|NCT01189071|Darifenacin|darifenacin|mesh-list
25783117|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25783118|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25783119|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
25783120|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783121|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783122|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783123|NCT01189071|Urological Agents|urological agents|mesh-ancestor
25783124|NCT01183416|Tretinoin|tretinoin|mesh-list
25783125|NCT01183416|Isotretinoin|isotretinoin|mesh-list
25783126|NCT01183416|Antibodies|antibodies|mesh-list
25783127|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25783128|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
25783129|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783130|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783131|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
25783132|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783133|NCT01183221|Oxytocin|oxytocin|mesh-list
25783134|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
25783135|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783136|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783137|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25783138|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
25783139|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25783140|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25783141|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
25783142|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783143|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131877|NCT03022838|Caffeine|caffeine|mesh-list
25783145|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25783146|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783147|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783148|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
25783149|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783150|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783151|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25783152|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
25783153|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783154|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
25783155|NCT01188798|Methotrexate|methotrexate|mesh-list
25783156|NCT01188798|Pentostatin|pentostatin|mesh-list
25783157|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25783158|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
25783159|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783160|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783161|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783162|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
25783163|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783164|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783165|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783166|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783167|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25783168|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783169|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
25783170|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783171|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25783172|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25783173|NCT01183884|Tretinoin|tretinoin|mesh-list
25783174|NCT01183884|Isotretinoin|isotretinoin|mesh-list
25783175|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783176|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
25783177|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783178|NCT01183429|Tretinoin|tretinoin|mesh-list
25783179|NCT01183429|Isotretinoin|isotretinoin|mesh-list
25783180|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783181|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
25783182|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783183|NCT01166178|Vitamin D|vitamin d|mesh-list
25783184|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
25783185|NCT01166178|Calcium|calcium|mesh-list
25783186|NCT01166178|Vitamins|vitamins|mesh-ancestor
25783187|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
25783188|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783189|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25783190|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25783191|NCT01169753|Modafinil|modafinil|mesh-list
25783192|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25783193|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783194|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25783195|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25783196|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25783197|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783198|NCT01169610|Varenicline|varenicline|mesh-list
25783199|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25783200|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25783201|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
25783202|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783203|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783204|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783205|NCT01163084|Leuprolide|leuprolide|mesh-list
25783206|NCT01163084|Goserelin|goserelin|mesh-list
25783207|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25783208|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
25783209|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783210|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783211|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783212|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783213|NCT01166724|Sirolimus|sirolimus|mesh-list
25783214|NCT01166724|Tacrolimus|tacrolimus|mesh-list
25783215|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783216|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
25783217|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783218|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25783219|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783220|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783221|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783222|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783223|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25783224|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783225|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
25783226|NCT01157533|Vancomycin|vancomycin|mesh-list
25783227|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783228|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783229|NCT01162304|Oxycodone|oxycodone|mesh-list
25783230|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25783231|NCT01162304|Narcotics|narcotics|mesh-ancestor
25783232|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25783233|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783234|NCT01162304|Analgesics|analgesics|mesh-ancestor
25783235|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
25783236|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783237|NCT01151904|Timolol|timolol|mesh-list
25783238|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25783239|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25783240|NCT01151904|Latanoprost|latanoprost|mesh-list
25783241|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25783242|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25783243|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25783244|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25783245|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783246|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783247|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783248|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25783249|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25783250|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25783251|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25783252|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25783253|NCT01155518|Clomiphene|clomiphene|mesh-list
25783254|NCT01155518|Testosterone|testosterone|mesh-list
25783255|NCT01155518|Androgens|androgens|mesh-ancestor
25783256|NCT01155518|Hormones|hormones|mesh-ancestor
25783257|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783258|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783259|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25783260|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
25783261|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25783262|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
25783263|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783264|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25783265|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25783266|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
25783267|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783268|NCT01147393|Epratuzumab|epratuzumab|mesh-list
25783269|NCT01147393|Veltuzumab|veltuzumab|mesh-list
25783270|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25783271|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25783272|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783273|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
25783274|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
25783275|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783276|NCT01147042|Interferons|interferons|mesh-list
25783277|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
25783278|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783279|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
25783280|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783281|NCT01139996|Clonidine|clonidine|mesh-list
25783282|NCT01139996|Analgesics|analgesics|mesh-ancestor
25783283|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
25783284|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783285|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783286|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25783287|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
25783288|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
25783289|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25783290|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25783291|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25783292|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25783293|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783294|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783295|NCT01142128|Esomeprazole|esomeprazole|mesh-list
25783296|NCT01142128|Pancrelipase|pancrelipase|mesh-list
25783297|NCT01142128|Pancreatin|pancreatin|mesh-list
25783298|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25783299|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25783300|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25783301|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783302|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783303|NCT01131884|Alendronate|alendronate|mesh-list
25783304|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25783305|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783306|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25783307|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
25783308|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25783309|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25783310|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25783311|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25783312|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783313|NCT01126879|Genistein|genistein|mesh-list
25783314|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25783315|NCT01126879|Protective Agents|protective agents|mesh-ancestor
25783316|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783317|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783318|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25783319|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783320|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783321|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
25783322|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25783323|NCT01126879|Estrogens|estrogens|mesh-ancestor
25783324|NCT01126879|Hormones|hormones|mesh-ancestor
25783325|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783326|NCT01139125|Cysteamine|cysteamine|mesh-list
25783327|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25783328|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783329|NCT01133639|Ketorolac|ketorolac|mesh-list
25783330|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25783331|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25783332|NCT01133639|Analgesics|analgesics|mesh-ancestor
25783333|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
25783334|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783335|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783336|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783337|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783338|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25783339|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783340|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783341|NCT01126801|Estradiol|estradiol|mesh-list
25783342|NCT01126801|Estrogens|estrogens|mesh-ancestor
25783343|NCT01126801|Hormones|hormones|mesh-ancestor
25783344|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783345|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783346|NCT01126957|Fentanyl|fentanyl|mesh-list
25783347|NCT01126957|Ketamine|ketamine|mesh-list
25783348|NCT01126957|Propofol|propofol|mesh-list
25783349|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25783350|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25783351|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783352|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25783353|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
25783354|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
25783355|NCT01126957|Analgesics|analgesics|mesh-ancestor
25783356|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
25783357|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783358|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25783359|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25783360|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25783361|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783362|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783363|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25783364|NCT01126957|Narcotics|narcotics|mesh-ancestor
25783365|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25783366|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
25783367|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783368|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783369|NCT01122511|Dexamethasone|dexamethasone|mesh-list
25783370|NCT01122511|Ranibizumab|ranibizumab|mesh-list
25783371|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783373|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
25783374|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783375|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783376|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25783377|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
25783378|NCT01122511|Hormones|hormones|mesh-ancestor
25783379|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783380|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783381|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783382|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25783383|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25783384|NCT01122511|Growth Substances|growth substances|mesh-ancestor
25783385|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
25783386|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
25783387|NCT01118013|Methotrexate|methotrexate|mesh-list
25783388|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
25783389|NCT01118013|Fludarabine|fludarabine|mesh-list
25783390|NCT01118013|Busulfan|busulfan|mesh-list
25783391|NCT01118013|Tacrolimus|tacrolimus|mesh-list
25783392|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25783393|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25783394|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
25783395|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783396|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783397|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783398|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
25783399|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783400|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783401|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783402|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783403|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25783404|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783405|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
25783406|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783407|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25783408|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25783409|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25783410|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25783411|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
25783412|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783413|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783414|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
25783415|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25783416|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25783417|NCT01122381|Ethosuximide|ethosuximide|mesh-list
25783418|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
25783419|NCT01116232|Sirolimus|sirolimus|mesh-list
25783420|NCT01116232|Rituximab|rituximab|mesh-list
25783421|NCT01116232|Tacrolimus|tacrolimus|mesh-list
25783422|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25783423|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25783424|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783425|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
25783426|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783427|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783428|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783429|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25783430|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783431|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783432|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783433|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783434|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25783435|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
25783436|NCT01108666|Nelfinavir|nelfinavir|mesh-list
25783437|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25783438|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25783439|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
25783440|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783441|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783442|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25783443|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25783444|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
25783445|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783446|NCT01115244|Dapsone|dapsone|mesh-list
25783447|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783448|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
25783449|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25783450|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25783451|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25783452|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783453|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783454|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
25783455|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783456|NCT01106534|Aspirin|aspirin|mesh-list
25783457|NCT01106534|Everolimus|everolimus|mesh-list
25783458|NCT01106534|Clopidogrel|clopidogrel|mesh-list
25783459|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25783460|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25783461|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25783462|NCT01106534|Analgesics|analgesics|mesh-ancestor
25783463|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
25783464|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783465|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783466|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783467|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783468|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25783469|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25783470|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783471|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25783472|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25783473|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783474|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
25783475|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783476|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783477|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
25783478|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25783479|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25783480|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25783481|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
25783482|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783483|NCT01100658|Methylphenidate|methylphenidate|mesh-list
25783484|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25783485|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783486|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25783487|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25783488|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783489|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783490|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
25783491|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783492|NCT01103180|Citalopram|citalopram|mesh-list
25783493|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25783494|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25783495|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783496|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783497|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783498|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
25783499|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783500|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25783501|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
25783502|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25783503|NCT01090141|Micafungin|micafungin|mesh-list
25783504|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
25783505|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783506|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25783507|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
25783508|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783509|NCT01094561|Secretin|secretin|mesh-list
25783510|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25783511|NCT01094561|Hormones|hormones|mesh-ancestor
25783512|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783513|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783514|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25783515|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
25783516|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783517|NCT01078844|Memantine|memantine|mesh-list
25783518|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25783519|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25783520|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
25783521|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783522|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783523|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783524|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25783525|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25783526|NCT01085643|Lubiprostone|lubiprostone|mesh-list
25783527|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25783528|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783529|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783530|NCT01080768|Amlodipine|amlodipine|mesh-list
25783531|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25783532|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25783533|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783534|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783535|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25783536|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783537|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
25783538|NCT01074502|Apremilast|apremilast|mesh-list
25783539|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25783540|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25783541|NCT01074502|Analgesics|analgesics|mesh-ancestor
25783542|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
25783543|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783544|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783545|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783546|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783547|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25783548|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25783549|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783550|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783551|NCT01074437|Prednisolone|prednisolone|mesh-list
25783552|NCT01074437|Propranolol|propranolol|mesh-list
25783553|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783554|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
25783555|NCT01074437|Hormones|hormones|mesh-ancestor
25783556|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783557|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783558|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783559|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783560|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25783561|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25783562|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
25783563|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783564|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783565|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25783566|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25783567|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
25783568|NCT01072526|Cyclosporine|cyclosporine|mesh-list
25783569|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
25783570|NCT01072526|Cyclosporins|cyclosporins|mesh-list
25783571|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783572|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783573|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783574|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
25783575|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783576|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
25783577|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783578|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783579|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783580|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25783581|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25783582|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25783583|NCT01071993|Atorvastatin|atorvastatin|mesh-list
25783584|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25783585|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25783586|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
25783587|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783588|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25783589|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25783590|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783591|NCT01065051|Riociguat|riociguat|mesh-list
25783592|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
25783593|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783594|NCT01058642|Pregabalin|pregabalin|mesh-list
25783595|NCT01058642|Analgesics|analgesics|mesh-ancestor
25783596|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
25783597|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783598|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783599|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
25783600|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25783601|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783602|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783603|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25783604|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25783605|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25783606|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25783607|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25783608|NCT01065818|Telbivudine|telbivudine|mesh-list
25783609|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
25783610|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783611|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25783612|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783613|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783614|NCT01051921|Interferons|interferons|mesh-list
25783616|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783617|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
25783618|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783619|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
25783620|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783621|NCT01048125|Nitroprusside|nitroprusside|mesh-list
25783622|NCT01048125|Phenylephrine|phenylephrine|mesh-list
25783623|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
25783624|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25783625|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
25783626|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
25783627|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783628|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783629|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
25783630|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25783631|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
25783632|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
25783633|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25783634|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25783635|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25783636|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
25783637|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783638|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783639|NCT01048125|Protective Agents|protective agents|mesh-ancestor
25783640|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25783641|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
25783642|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25783643|NCT01058369|Deferasirox|deferasirox|mesh-list
25783644|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25783645|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
25783646|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
25783647|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783648|NCT01048723|Everolimus|everolimus|mesh-list
25783649|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783650|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783651|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
25783652|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783653|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
25783654|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25783655|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783656|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25783657|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
25783658|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783659|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783660|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783661|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783662|NCT01038752|Suramin|suramin|mesh-list
25783663|NCT01038752|Carboplatin|carboplatin|mesh-list
25783664|NCT01038752|Docetaxel|docetaxel|mesh-list
25783665|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783666|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
25783667|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
25783668|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
25783669|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783670|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
25783671|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
25783672|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25783673|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783674|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25783675|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25783676|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25134955|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
25783677|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25783678|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25783679|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783680|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783681|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783682|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783683|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
25783684|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25783685|NCT01045694|Triamcinolone|triamcinolone|mesh-list
25783686|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25783687|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25783688|NCT01045694|Lidocaine|lidocaine|mesh-list
25783689|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
25783690|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25783691|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25783692|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25783693|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
25783694|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
25783695|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25783696|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783697|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
25783698|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783699|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25783700|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25783701|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25783702|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783703|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783704|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25783705|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25783706|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783707|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25783708|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783709|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
25783710|NCT01045694|Hormones|hormones|mesh-ancestor
25783711|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783712|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783713|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
25783714|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783715|NCT01035944|Chitosan|chitosan|mesh-list
25783716|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25783717|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25783718|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
25783719|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783720|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25783721|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
25783722|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
25783723|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
25783724|NCT01035944|Coagulants|coagulants|mesh-ancestor
25783725|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
25783726|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783727|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25783728|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783729|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783730|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25783731|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25783732|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25783733|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783734|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783735|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783736|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783737|NCT01035073|Analgesics|analgesics|mesh-ancestor
25783738|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
25783739|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783740|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
25783741|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25783742|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
25783743|NCT01031550|Propofol|propofol|mesh-list
25783744|NCT01031550|Isoflurane|isoflurane|mesh-list
25783745|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25783746|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25783747|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783748|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25783749|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
25783750|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
25783751|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25783752|NCT01025271|Daptomycin|daptomycin|mesh-list
25783753|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783754|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783755|NCT01022398|Vitamin D|vitamin d|mesh-list
25783756|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
25783757|NCT01022398|Vitamins|vitamins|mesh-ancestor
25783758|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
25783759|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783760|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25783761|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25783762|NCT01019980|Acetaminophen|acetaminophen|mesh-list
25783763|NCT01019980|Diclofenac|diclofenac|mesh-list
25783764|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25783765|NCT01019980|Analgesics|analgesics|mesh-ancestor
25783766|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
25783767|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783768|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783769|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
25783770|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25783771|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783772|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783773|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25783774|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783775|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783776|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
25783777|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25783778|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25783779|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
25783780|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783781|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25783782|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25783783|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
25783784|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25783785|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783786|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25783787|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25783788|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25783789|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783790|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
25783791|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783792|NCT01020903|Aprepitant|aprepitant|mesh-list
25783793|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
25783794|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
25783795|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783796|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783797|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25783798|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25783799|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783800|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783801|NCT01023620|Pioglitazone|pioglitazone|mesh-list
25783802|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25783803|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783804|NCT01018810|Interleukin-23|interleukin-23|mesh-list
25783805|NCT01018810|Antibodies|antibodies|mesh-list
25783806|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
25783807|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
25783808|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783809|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25783810|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25783811|NCT01018810|Growth Substances|growth substances|mesh-ancestor
25783812|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
25783813|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783814|NCT01016561|Cisplatin|cisplatin|mesh-list
25783815|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783816|NCT01016847|Montelukast|montelukast|mesh-list
25783817|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25783818|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
25783819|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25783820|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
25783821|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783822|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783823|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25783824|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25783825|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783826|NCT01014767|Leucovorin|leucovorin|mesh-list
25783827|NCT01014767|Dactinomycin|dactinomycin|mesh-list
25783828|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
25783829|NCT01014767|Temozolomide|temozolomide|mesh-list
25783830|NCT01014767|Cisplatin|cisplatin|mesh-list
25783831|NCT01014767|Carboplatin|carboplatin|mesh-list
25783832|NCT01014767|Doxorubicin|doxorubicin|mesh-list
25783833|NCT01014767|Methotrexate|methotrexate|mesh-list
25783834|NCT01014767|Irinotecan|irinotecan|mesh-list
25783835|NCT01014767|Etoposide|etoposide|mesh-list
25783836|NCT01014767|Vincristine|vincristine|mesh-list
25783837|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783838|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
25783839|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783840|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783841|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25783842|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
25783843|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783844|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783845|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25783846|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25783847|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25783848|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25783849|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783850|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25783851|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
25783852|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783853|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783854|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
25783855|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783856|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25783857|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25783858|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25783859|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25783860|NCT01014767|Antidotes|antidotes|mesh-ancestor
25783861|NCT01014767|Protective Agents|protective agents|mesh-ancestor
25783862|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
25783863|NCT01014767|Vitamins|vitamins|mesh-ancestor
25783864|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
25783865|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
25783866|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
25783867|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
25783868|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25783869|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783870|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25783871|NCT01013701|Fluticasone|fluticasone|mesh-list
25783872|NCT01013701|Xhance|xhance|mesh-list
25783873|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783874|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25783875|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
25783876|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783877|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783878|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25783879|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
25783880|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783881|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25783882|NCT01009931|Dexamethasone|dexamethasone|mesh-list
25783883|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
25783884|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
25783885|NCT01009931|Choline|choline|mesh-list
25783886|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25783887|NCT01009931|BB 1101|bb 1101|mesh-list
25783888|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783889|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
25783890|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
25783891|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783892|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783893|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25783894|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
25783895|NCT01009931|Hormones|hormones|mesh-ancestor
25783896|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783897|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783898|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783899|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
25783900|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783901|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783902|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
25783903|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25783904|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
25783905|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25783906|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
25783907|NCT01009931|Analgesics|analgesics|mesh-ancestor
25783908|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
25783909|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25783910|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25783911|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783912|NCT01006018|Pioglitazone|pioglitazone|mesh-list
25783913|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25783914|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25783915|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783916|NCT01006018|Incretins|incretins|mesh-ancestor
25783917|NCT01006018|Hormones|hormones|mesh-ancestor
25783918|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783919|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25783920|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
25783921|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783922|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783923|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
25783924|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25783925|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783926|NCT01005914|Cytarabine|cytarabine|mesh-list
25783927|NCT01005914|Dexamethasone|dexamethasone|mesh-list
25783928|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
25783929|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25783930|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25783931|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
25783932|NCT01005914|Doxorubicin|doxorubicin|mesh-list
25783933|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25783934|NCT01005914|Methotrexate|methotrexate|mesh-list
25783935|NCT01005914|Vincristine|vincristine|mesh-list
25783936|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
25783937|NCT01005914|Asparaginase|asparaginase|mesh-list
25783938|NCT01005914|Pegaspargase|pegaspargase|mesh-list
25783939|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783940|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
25783941|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783942|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25783943|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25783944|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
25783945|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783946|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783947|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25783948|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25783949|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
25783950|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
25783951|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25783952|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25783953|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
25783954|NCT01005914|Hormones|hormones|mesh-ancestor
25783955|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25783956|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25783957|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25783958|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25783959|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25783960|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783961|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25783962|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
25783963|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25783964|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783965|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
25783966|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
25783967|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25783968|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25783969|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
25783970|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783971|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25783972|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
25783973|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
25783974|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
25783975|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25783976|NCT01005914|Protective Agents|protective agents|mesh-ancestor
25783977|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25136326|NCT02992028|Vitamins|vitamins|mesh-list
25783978|NCT00996333|Gemcitabine|gemcitabine|mesh-list
25783979|NCT00996333|Capecitabine|capecitabine|mesh-list
25783981|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25783982|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
25783983|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25783984|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25783985|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
25783986|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25783987|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25783988|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25783989|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
25783990|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783991|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
25783992|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25783993|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25783994|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
25783995|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
25783996|NCT00998738|Calcium|calcium|mesh-list
25783997|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25783998|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25783999|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25784000|NCT00998738|Analgesics|analgesics|mesh-ancestor
25784001|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
25784002|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784003|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
25784004|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784005|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25784006|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
25784007|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25784008|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25784009|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784010|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
25784011|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25784012|NCT00996502|Prednisone|prednisone|mesh-list
25784013|NCT00996502|Bevacizumab|bevacizumab|mesh-list
25784014|NCT00996502|Docetaxel|docetaxel|mesh-list
25784015|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25784016|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784017|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784018|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25784019|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25784020|NCT00996502|Growth Substances|growth substances|mesh-ancestor
25784021|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784022|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
25784023|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784024|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784025|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784026|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784027|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784028|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
25784029|NCT00996502|Hormones|hormones|mesh-ancestor
25784030|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784031|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784032|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784033|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784034|NCT00997386|Melphalan|melphalan|mesh-list
25784035|NCT00997386|Busulfan|busulfan|mesh-list
25784036|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
25784037|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25784038|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
25784039|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784040|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784041|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25784042|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784043|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
25784044|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784045|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784046|NCT00985738|Dutasteride|dutasteride|mesh-list
25784047|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25784048|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25784049|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784050|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784051|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
25784052|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784053|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784054|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25784055|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25784056|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25784057|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
25784058|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784059|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25784060|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25784061|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784062|NCT00989937|Oxytocin|oxytocin|mesh-list
25784063|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
25784064|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25784065|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784066|NCT00986947|Rituximab|rituximab|mesh-list
25784067|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784068|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784069|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
25784070|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784071|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784072|NCT00982995|Palonosetron|palonosetron|mesh-list
25784073|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
25784074|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
25784075|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784076|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784077|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25784078|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25784079|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25784080|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
25784081|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784082|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784083|NCT00984490|Metformin|metformin|mesh-list
25784084|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25784085|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784086|NCT00986310|Fluoxetine|fluoxetine|mesh-list
25784087|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25784088|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25784089|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25784090|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784091|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784092|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
25784093|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784094|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25784095|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
25784096|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25784097|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25784098|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25784099|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784100|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25784101|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25784102|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784103|NCT00983645|Cyclosporine|cyclosporine|mesh-list
25784104|NCT00983645|Tacrolimus|tacrolimus|mesh-list
25784105|NCT00983645|Cyclosporins|cyclosporins|mesh-list
25784106|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784107|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
25784108|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784109|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25784110|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784111|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784112|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
25784113|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784114|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25784115|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784116|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25784117|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25784118|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25784119|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
25784120|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784121|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25784122|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25784123|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784124|NCT00979550|Imiquimod|imiquimod|mesh-list
25784125|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25784126|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
25784127|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784128|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784129|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
25784130|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
25784131|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25784132|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784133|NCT00981370|Deferasirox|deferasirox|mesh-list
25784134|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25784135|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
25784136|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
25784137|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784138|NCT00975611|Amantadine|amantadine|mesh-list
25784139|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25784140|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25784141|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
25784142|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784143|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
25784144|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784145|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784146|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784147|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25784148|NCT00975611|Analgesics|analgesics|mesh-ancestor
25784149|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
25784150|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784151|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25784152|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25784153|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25784154|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
25784155|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784156|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25784157|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25784158|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784159|NCT00979810|Alovudine|alovudine|mesh-list
25784160|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
25784161|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784162|NCT00974922|Vitamin D|vitamin d|mesh-list
25784163|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
25784164|NCT00974922|Vitamins|vitamins|mesh-ancestor
25784165|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
25784166|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784167|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25784168|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25784169|NCT00976339|Vitamin D|vitamin d|mesh-list
25784170|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
25784171|NCT00976339|Vitamins|vitamins|mesh-ancestor
25784172|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
25784173|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784174|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25784175|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25784176|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25784177|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25784178|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
25784179|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784180|NCT00957827|Cephalexin|cephalexin|mesh-list
25784181|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25784182|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784183|NCT00953329|Alefacept|alefacept|mesh-list
25784184|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
25784185|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
25784186|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784187|NCT00965055|Atorvastatin|atorvastatin|mesh-list
25784188|NCT00965055|Ezetimibe|ezetimibe|mesh-list
25784189|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25784190|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25784191|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
25784192|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784193|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25784194|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25784195|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784196|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
25784197|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
25784198|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784199|NCT00962429|Protective Agents|protective agents|mesh-ancestor
25784200|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784201|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
25784202|NCT00962429|Vitamins|vitamins|mesh-ancestor
25784203|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
25784204|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25784205|NCT00966654|Incretins|incretins|mesh-ancestor
25784206|NCT00966654|Hormones|hormones|mesh-ancestor
25784207|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784208|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784209|NCT00954187|Pregabalin|pregabalin|mesh-list
25784210|NCT00954187|Gabapentin|gabapentin|mesh-list
25784211|NCT00954187|Analgesics|analgesics|mesh-ancestor
25784212|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
25784213|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784214|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784215|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
25784216|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25784217|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25784218|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784219|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25784220|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25784221|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25784222|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784223|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25784224|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25784225|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25784226|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784227|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
25784228|NCT00953615|Thalidomide|thalidomide|mesh-list
25784229|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784230|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
25784231|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784232|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
25784233|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25784234|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784235|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25784236|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25784237|NCT00953615|Growth Substances|growth substances|mesh-ancestor
25784238|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
25784239|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784241|NCT00947284|Naloxone|naloxone|mesh-list
25784242|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25784243|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784244|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
25784245|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784246|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25784247|NCT00947284|Narcotics|narcotics|mesh-ancestor
25784248|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784249|NCT00947284|Analgesics|analgesics|mesh-ancestor
25784250|NCT00957034|Testosterone|testosterone|mesh-list
25784251|NCT00957034|Androgens|androgens|mesh-ancestor
25784252|NCT00957034|Hormones|hormones|mesh-ancestor
25784253|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784254|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784255|NCT00949988|Rituximab|rituximab|mesh-list
25784256|NCT00949988|Dasatinib|dasatinib|mesh-list
25784257|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784258|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784259|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
25784260|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784261|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784262|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784263|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784264|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784265|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
25784266|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25784267|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
25784268|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784269|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784270|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25784271|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
25784272|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25784273|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
25784274|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784275|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784276|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25784277|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
25784278|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
25784279|NCT00948194|Protective Agents|protective agents|mesh-ancestor
25784280|NCT00946985|Risperidone|risperidone|mesh-list
25784281|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25784282|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25784283|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
25784284|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784285|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784286|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784287|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25784288|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25784289|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784290|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25784291|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25784292|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
25784293|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25784294|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25784295|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25784296|NCT00950690|Latanoprost|latanoprost|mesh-list
25784297|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25784298|NCT00941928|Vidarabine|vidarabine|mesh-list
25784299|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
25784300|NCT00941928|Fludarabine|fludarabine|mesh-list
25784301|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
25137808|NCT02982551|Insulin|insulin|mesh-list
25784302|NCT00941928|Interleukin-2|interleukin-2|mesh-list
25784303|NCT00941928|Epratuzumab|epratuzumab|mesh-list
25784304|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784305|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
25784306|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784307|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784308|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25784309|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
25784310|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784311|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784312|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25784313|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25784314|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
25784315|NCT00941928|Antiviral Agents|antiviral agents|mesh-ancestor
25784316|NCT00941928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784317|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25784318|NCT00941928|Analgesics|analgesics|mesh-ancestor
25784319|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
25784320|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784321|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784322|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25784323|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784324|NCT00947791|Midazolam|midazolam|mesh-list
25784325|NCT00947791|Ketamine|ketamine|mesh-list
25784326|NCT00947791|Analgesics|analgesics|mesh-ancestor
25784327|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
25784328|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784329|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784330|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25784331|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25784332|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
25784333|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
25784334|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784335|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25784336|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25784337|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784338|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784339|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25784340|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25784341|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25784342|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25784343|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25784344|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
25784345|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
25784346|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25784347|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25784348|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784349|NCT00947011|Incretins|incretins|mesh-ancestor
25784350|NCT00947011|Hormones|hormones|mesh-ancestor
25784351|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784352|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25784353|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
25784354|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784355|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784356|NCT00936598|Zolpidem|zolpidem|mesh-list
25784357|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25784358|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25784359|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784360|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784361|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25784362|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
25784363|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
25784364|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784365|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784366|NCT00920309|Sirolimus|sirolimus|mesh-list
25784367|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25784368|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784369|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25784370|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784371|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
25784372|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784373|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
25784374|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784375|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
25784376|NCT00934791|Sirolimus|sirolimus|mesh-list
25784377|NCT00934791|Prednisone|prednisone|mesh-list
25784378|NCT00934791|Tacrolimus|tacrolimus|mesh-list
25784379|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784380|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
25784381|NCT00934791|Hormones|hormones|mesh-ancestor
25784382|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784383|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784384|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784385|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784386|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784387|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
25784388|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25784389|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784390|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784391|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25784392|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25784393|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
25784394|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25784395|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784396|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
25784397|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25784398|NCT00932152|Bevacizumab|bevacizumab|mesh-list
25784399|NCT00932152|Fulvestrant|fulvestrant|mesh-list
25784400|NCT00932152|Anastrozole|anastrozole|mesh-list
25784401|NCT00932152|Analgesics|analgesics|mesh-list
25784402|NCT00932152|Antiemetics|antiemetics|mesh-list
25784403|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784404|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784405|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25784406|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25784407|NCT00932152|Growth Substances|growth substances|mesh-ancestor
25784408|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784409|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
25784410|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784411|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784412|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25784413|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25784414|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
25784415|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784416|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25784417|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25784418|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784419|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784420|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
25784421|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784422|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
25784423|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25784424|NCT00924807|Sorafenib|sorafenib|mesh-list
25784425|NCT00924807|Leuprolide|leuprolide|mesh-list
25784426|NCT00924807|Bicalutamide|bicalutamide|mesh-list
25784427|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784428|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784429|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784430|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784431|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25784432|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
25784433|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25784434|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784435|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784436|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
25784437|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
25784438|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784439|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
25784440|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784441|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
25784442|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784443|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784444|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25784445|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
25784446|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784447|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784448|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25784449|NCT00926575|Beclomethasone|beclomethasone|mesh-list
25784450|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784451|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
25784452|NCT00926575|Hormones|hormones|mesh-ancestor
25784453|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784454|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784455|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25784456|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
25784457|NCT00911053|Melatonin|melatonin|mesh-list
25784458|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
25784459|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784460|NCT00911053|Protective Agents|protective agents|mesh-ancestor
25784461|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784462|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784463|NCT00918463|Dasatinib|dasatinib|mesh-list
25784464|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784465|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784466|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784467|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784468|NCT00913692|Glycine|glycine|mesh-list
25784469|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
25784470|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784471|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784472|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784473|NCT00918645|Calcium|calcium|mesh-list
25784474|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25784475|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784476|NCT00907218|Varenicline|varenicline|mesh-list
25784477|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25784478|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25784479|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
25784480|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784481|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784482|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784483|NCT00906035|Aspirin|aspirin|mesh-list
25784484|NCT00906035|Dipyridamole|dipyridamole|mesh-list
25784485|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25784486|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25784487|NCT00906035|Analgesics|analgesics|mesh-ancestor
25784488|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
25784489|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784490|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784491|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784492|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784493|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25784494|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25784495|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784496|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25784497|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25784498|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784499|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
25784500|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25784501|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
25784502|NCT00904423|Vitamin D|vitamin d|mesh-list
25784503|NCT00904423|Vitamins|vitamins|mesh-ancestor
25784504|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
25784505|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784506|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25784507|NCT00903396|Palonosetron|palonosetron|mesh-list
25784508|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
25784509|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
25784510|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784511|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784512|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25784513|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25784514|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25784515|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
25784516|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784517|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784518|NCT00894790|Celecoxib|celecoxib|mesh-list
25784519|NCT00894790|Diclofenac|diclofenac|mesh-list
25784520|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25784521|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25784522|NCT00894790|Analgesics|analgesics|mesh-ancestor
25784523|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
25784524|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784525|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784526|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784527|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784528|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25784529|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25784530|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784531|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784532|NCT00902668|Lovastatin|lovastatin|mesh-list
25784533|NCT00902668|L 647318|l 647318|mesh-list
25784534|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
25784535|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25784536|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25784537|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
25784538|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784539|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25784540|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25784541|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784542|NCT00881205|Rivastigmine|rivastigmine|mesh-list
25784543|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25784544|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784545|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784546|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
25784547|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784548|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784549|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25784550|NCT00881205|Protective Agents|protective agents|mesh-ancestor
25784551|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
25784552|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25784553|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
25784554|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784555|NCT00896025|Expectorants|expectorants|mesh-ancestor
25784556|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
25784557|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25784558|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
25784559|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784560|NCT00896025|Protective Agents|protective agents|mesh-ancestor
25784561|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784562|NCT00896025|Antidotes|antidotes|mesh-ancestor
25784563|NCT00903006|Dasatinib|dasatinib|mesh-list
25784564|NCT00903006|Fulvestrant|fulvestrant|mesh-list
25784565|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784566|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784567|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784568|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784569|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784570|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25784571|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25784572|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
25784573|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784574|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784575|NCT00887315|Cisplatin|cisplatin|mesh-list
25784576|NCT00887315|Docetaxel|docetaxel|mesh-list
25784577|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784578|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784579|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784580|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784581|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784582|NCT00891904|Cetuximab|cetuximab|mesh-list
25784583|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784584|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784585|NCT00889421|Apremilast|apremilast|mesh-list
25784586|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25784587|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25784588|NCT00889421|Analgesics|analgesics|mesh-ancestor
25784589|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
25784590|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784591|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784592|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784593|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784594|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25784595|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25784596|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784597|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784598|NCT00875394|Metformin|metformin|mesh-list
25784599|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25784600|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24761611|NCT01763476|Paclitaxel|paclitaxel|mesh-list
25784601|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784602|NCT00875394|Incretins|incretins|mesh-ancestor
25784603|NCT00875394|Hormones|hormones|mesh-ancestor
25784604|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784605|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25784606|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
25784607|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784608|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784609|NCT00882310|Gemcitabine|gemcitabine|mesh-list
25784610|NCT00882310|Capecitabine|capecitabine|mesh-list
25784611|NCT00882310|Docetaxel|docetaxel|mesh-list
25784612|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25784613|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
25784614|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784615|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784616|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
25784617|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784618|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784619|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784620|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
25784621|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784622|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784623|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784624|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784625|NCT00880542|Sorafenib|sorafenib|mesh-list
25784626|NCT00880542|Ifosfamide|ifosfamide|mesh-list
25784627|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784628|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784629|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784630|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784631|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25784632|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
25784633|NCT00879619|Prednisone|prednisone|mesh-list
25784634|NCT00879619|Cortisone|cortisone|mesh-list
25784635|NCT00879619|Docetaxel|docetaxel|mesh-list
25784636|NCT00879619|Sunitinib|sunitinib|mesh-list
25784637|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784638|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784639|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784640|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784641|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784642|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784643|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
25784644|NCT00879619|Hormones|hormones|mesh-ancestor
25784645|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784646|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784647|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784648|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25784649|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25784650|NCT00879619|Growth Substances|growth substances|mesh-ancestor
25784651|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
25784652|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784653|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784654|NCT00874939|Donepezil|donepezil|mesh-list
25784655|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25784656|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784657|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784658|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
25784659|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784660|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784661|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
25784662|NCT00877071|Doxorubicin|doxorubicin|mesh-list
25784663|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25784664|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784665|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25784666|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25784667|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784668|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784669|NCT00878969|Valsartan|valsartan|mesh-list
25784670|NCT00878969|Ramipril|ramipril|mesh-list
25784671|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25784672|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25784673|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25784674|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25784675|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784676|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
25784677|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784678|NCT00869414|Insulin|insulin|mesh-list
25784679|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25784680|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
25784681|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25784682|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784683|NCT00863512|Gemcitabine|gemcitabine|mesh-list
25784684|NCT00863512|Cisplatin|cisplatin|mesh-list
25784685|NCT00863512|Docetaxel|docetaxel|mesh-list
25784686|NCT00863512|Pemetrexed|pemetrexed|mesh-list
25784687|NCT00863512|Vinorelbine|vinorelbine|mesh-list
25784688|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784689|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25784690|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
25784691|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784692|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
25784693|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784694|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784695|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784696|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
25784697|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784698|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784699|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784700|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784701|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25784702|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25784703|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25784704|NCT00868998|Gemcitabine|gemcitabine|mesh-list
25784705|NCT00868998|Capecitabine|capecitabine|mesh-list
25784706|NCT00868998|Docetaxel|docetaxel|mesh-list
25784707|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25784708|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
25784709|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784710|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784711|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
25784712|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784713|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784714|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784715|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
25784716|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784717|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784718|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784719|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784720|NCT00869258|Gemcitabine|gemcitabine|mesh-list
25784721|NCT00869258|Capecitabine|capecitabine|mesh-list
25784722|NCT00869258|Docetaxel|docetaxel|mesh-list
25784723|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25784724|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
25784725|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784726|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784727|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
25784728|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784729|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784730|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784731|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
25784732|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784733|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784734|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784735|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784736|NCT00853229|Pregabalin|pregabalin|mesh-list
25784737|NCT00853229|Analgesics|analgesics|mesh-ancestor
25784738|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
25784739|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784740|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784741|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
25784742|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25784743|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25784744|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784745|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25784746|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25784747|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25784748|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784749|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25784750|NCT00860158|Dasatinib|dasatinib|mesh-list
25784751|NCT00860158|Leuprolide|leuprolide|mesh-list
25784752|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784753|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784754|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784755|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784756|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25784757|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
25784758|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25784759|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784760|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784761|NCT00843986|Conivaptan|conivaptan|mesh-list
25784762|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25784763|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784764|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
25784765|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784766|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
25784767|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25784768|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25784769|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25784770|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25784771|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784772|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
25784773|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784774|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784775|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25784776|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784777|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
25784778|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25784779|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25784780|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
25784781|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25784782|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
25784783|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784784|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
25784785|NCT00852241|Protective Agents|protective agents|mesh-ancestor
25784786|NCT00851552|Rituximab|rituximab|mesh-list
25784787|NCT00851552|Doxorubicin|doxorubicin|mesh-list
25784788|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25784789|NCT00851552|Bortezomib|bortezomib|mesh-list
25784790|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25784791|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784792|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
25784793|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784794|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784795|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25784796|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25784797|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25784798|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784799|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784800|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
25784801|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25784802|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25784803|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25784804|NCT00850720|Vasopressins|vasopressins|mesh-list
25784805|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784806|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
25784807|NCT00850720|Coagulants|coagulants|mesh-ancestor
25784808|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25784809|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25784810|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
25784811|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784812|NCT00851591|Psyllium|psyllium|mesh-list
25784813|NCT00851591|Cathartics|cathartics|mesh-ancestor
25784814|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25784815|NCT00843310|Dexamethasone|dexamethasone|mesh-list
25784816|NCT00843310|Lenalidomide|lenalidomide|mesh-list
25784817|NCT00843310|Melphalan|melphalan|mesh-list
25784818|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25784819|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
25784820|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
25784821|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784822|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784823|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25784824|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
25784825|NCT00843310|Hormones|hormones|mesh-ancestor
25784826|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784827|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25784828|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784829|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
25784830|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25784831|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25784832|NCT00843310|Growth Substances|growth substances|mesh-ancestor
25784833|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
25784834|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25784835|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
25784836|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784837|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25784838|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784839|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25784841|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25784842|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25784843|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
25784844|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
25784845|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784846|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25784847|NCT00835679|Cetuximab|cetuximab|mesh-list
25784848|NCT00835679|Dasatinib|dasatinib|mesh-list
25784849|NCT00835679|Antibodies|antibodies|mesh-list
25784850|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
25784851|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25784852|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
25784853|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784854|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784855|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784856|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784857|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784858|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25784859|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784860|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25784861|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784862|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784863|NCT00832520|Mirtazapine|mirtazapine|mesh-list
25784864|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
25784865|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25784866|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25784867|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
25784868|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
25784869|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784870|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784871|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784872|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25784873|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25784874|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784875|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25784876|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25784877|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25784878|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
25784879|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25784880|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25784881|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
25784882|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25784883|NCT00833859|Gemcitabine|gemcitabine|mesh-list
25784884|NCT00833859|Capecitabine|capecitabine|mesh-list
25784885|NCT00833859|Docetaxel|docetaxel|mesh-list
25784886|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25784887|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
25784888|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784889|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784890|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
25784891|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784892|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784893|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784894|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
25784895|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784896|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
25784897|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784898|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
25784899|NCT00840827|Cyclosporine|cyclosporine|mesh-list
25784900|NCT00840827|Lenalidomide|lenalidomide|mesh-list
25784901|NCT00840827|Cyclosporins|cyclosporins|mesh-list
25784902|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144560|NCT02935855|Dabigatran|dabigatran|mesh-list
25784903|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784904|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784905|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
25784906|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784907|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
25784908|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784909|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25784910|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25784911|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25784912|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25784913|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25784914|NCT00840827|Growth Substances|growth substances|mesh-ancestor
25784915|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
25784916|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784918|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25784919|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25784920|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784921|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25784922|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25784923|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784924|NCT00832624|Incretins|incretins|mesh-ancestor
25784925|NCT00832624|Hormones|hormones|mesh-ancestor
25784926|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25784927|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25784928|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
25784929|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784930|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784931|NCT00832299|Leucovorin|leucovorin|mesh-list
25784932|NCT00832299|Fluorouracil|fluorouracil|mesh-list
25784933|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
25784934|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
25784935|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784936|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25784937|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784938|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784939|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
25784940|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784941|NCT00832299|Antidotes|antidotes|mesh-ancestor
25784942|NCT00832299|Protective Agents|protective agents|mesh-ancestor
25784943|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
25784944|NCT00832299|Vitamins|vitamins|mesh-ancestor
25784945|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
25784946|NCT00836355|Minocycline|minocycline|mesh-list
25784947|NCT00836355|Enoxaparin|enoxaparin|mesh-list
25784948|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
25784949|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25784950|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25784951|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784952|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25784953|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25784954|NCT00816777|Irinotecan|irinotecan|mesh-list
25784955|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25784956|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25784957|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25784958|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784959|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784960|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
25784961|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25784962|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
25784963|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25784964|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784965|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25784966|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
25784967|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25784968|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
25784969|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784970|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25784971|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25784972|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
25784973|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
25784974|NCT00823095|Protective Agents|protective agents|mesh-ancestor
25784975|NCT00827567|Everolimus|everolimus|mesh-list
25784976|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25784977|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25784978|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
25784979|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784980|NCT00815633|Alefacept|alefacept|mesh-list
25784981|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
25784982|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
25784983|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784984|NCT00825227|Modafinil|modafinil|mesh-list
25784985|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25784986|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784987|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25784988|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25784989|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25784990|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25784992|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25784993|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25784994|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25784995|NCT00809458|Vitamin E|vitamin e|mesh-list
25784996|NCT00809458|Tocopherols|tocopherols|mesh-list
25784997|NCT00809458|Tocotrienols|tocotrienols|mesh-list
25784998|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
25784999|NCT00809458|Vitamins|vitamins|mesh-ancestor
25785000|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
25785001|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785002|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
25785003|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785004|NCT00809458|Protective Agents|protective agents|mesh-ancestor
25785005|NCT00807365|Hormones|hormones|mesh-list
25785006|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25785007|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785008|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785009|NCT00814333|Thrombin|thrombin|mesh-list
25785010|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
25785011|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
25785012|NCT00814333|Coagulants|coagulants|mesh-ancestor
25785013|NCT00809341|Prednisone|prednisone|mesh-list
25785014|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
25785015|NCT00809341|Ifosfamide|ifosfamide|mesh-list
25785016|NCT00809341|Rituximab|rituximab|mesh-list
25785017|NCT00809341|Carboplatin|carboplatin|mesh-list
25785018|NCT00809341|Doxorubicin|doxorubicin|mesh-list
25785019|NCT00809341|Etoposide|etoposide|mesh-list
25785020|NCT00809341|Vincristine|vincristine|mesh-list
25785021|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785022|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
25785023|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785024|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785025|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785026|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
25785027|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785028|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785029|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25785030|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785031|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25785032|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25785033|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25785034|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785035|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25785036|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
25785037|NCT00809341|Hormones|hormones|mesh-ancestor
25785038|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785039|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25785040|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25785041|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25785042|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25785043|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
25785044|NCT00803283|Morphine|morphine|mesh-list
25785045|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25785046|NCT00803283|Narcotics|narcotics|mesh-ancestor
25785047|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785048|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785049|NCT00803283|Analgesics|analgesics|mesh-ancestor
25785050|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
25785051|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785052|NCT00811590|Everolimus|everolimus|mesh-list
25785053|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785054|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785055|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
25785056|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785057|NCT00808899|Sirolimus|sirolimus|mesh-list
25785058|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
25785059|NCT00808899|Cisplatin|cisplatin|mesh-list
25785060|NCT00808899|Doxorubicin|doxorubicin|mesh-list
25785061|NCT00808899|Irinotecan|irinotecan|mesh-list
25785062|NCT00808899|Etoposide|etoposide|mesh-list
25785063|NCT00808899|Topotecan|topotecan|mesh-list
25785064|NCT00808899|Tretinoin|tretinoin|mesh-list
25785065|NCT00808899|Isotretinoin|isotretinoin|mesh-list
25785066|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785067|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
25785068|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785069|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785070|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785072|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785073|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785074|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25785075|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25785076|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25785077|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25785078|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785079|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25785080|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25785081|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25785082|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785083|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
25785084|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
25785085|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
25785086|NCT00808769|Omeprazole|omeprazole|mesh-list
25785087|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25785088|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25785089|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785090|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25785091|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785092|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785093|NCT00803179|Hormones|hormones|mesh-list
25785094|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785095|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785096|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
25785097|NCT00801931|Melphalan|melphalan|mesh-list
25785098|NCT00801931|Busulfan|busulfan|mesh-list
25785099|NCT00801931|Thiotepa|thiotepa|mesh-list
25785100|NCT00801931|Fludarabine|fludarabine|mesh-list
25785101|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
25785102|NCT00801931|Phenytoin|phenytoin|mesh-list
25785103|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
25785104|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
25785105|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25785106|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785107|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
25785108|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785109|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785110|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785111|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
25785112|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785113|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785114|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25785115|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785116|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
25785117|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25785118|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25785119|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785120|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25785121|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25785122|NCT00793520|Milnacipran|milnacipran|mesh-list
25785123|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
25785124|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25785125|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25785126|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785127|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785128|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785129|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785130|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25785131|NCT00793520|Analgesics|analgesics|mesh-ancestor
25785132|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
25785133|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785134|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
25785135|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785136|NCT00795236|Melatonin|melatonin|mesh-list
25785137|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
25785138|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785139|NCT00795236|Protective Agents|protective agents|mesh-ancestor
25785140|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785141|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785142|NCT00799773|Rituximab|rituximab|mesh-list
25785143|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785144|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785145|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
25785146|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785147|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785148|NCT00790452|Aspirin|aspirin|mesh-list
25785149|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25785150|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25785151|NCT00790452|Analgesics|analgesics|mesh-ancestor
25785152|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
25785153|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785154|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785155|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25785156|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785157|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25785158|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25785159|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785160|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25785161|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25785162|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785163|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
25785164|NCT00795665|Bevacizumab|bevacizumab|mesh-list
25785165|NCT00795665|Carmustine|carmustine|mesh-list
25785166|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785167|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785168|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25785169|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25785170|NCT00795665|Growth Substances|growth substances|mesh-ancestor
25785171|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785172|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
25785173|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785174|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
25785175|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785176|NCT00787917|Omalizumab|omalizumab|mesh-list
25785177|NCT00787917|Itraconazole|itraconazole|mesh-list
25785178|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
25785179|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785180|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25785181|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25785182|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785183|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785184|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25785185|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
25785186|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785187|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785188|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25785189|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25785190|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25785191|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
25785192|NCT00798590|Glucagon|glucagon|mesh-list
25785193|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25785194|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785195|NCT00798590|Hormones|hormones|mesh-ancestor
25785196|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785197|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785198|NCT00798590|Incretins|incretins|mesh-ancestor
25785199|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
25785200|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
25785201|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
25785202|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25785203|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25785204|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785205|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785206|NCT00796510|Urological Agents|urological agents|mesh-ancestor
25785207|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25785208|NCT00796861|Sunitinib|sunitinib|mesh-list
25785209|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785210|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25785211|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25785212|NCT00796861|Growth Substances|growth substances|mesh-ancestor
25785213|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785214|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25785215|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25785216|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785217|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785218|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
25785219|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785221|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785222|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785223|NCT00790478|Melatonin|melatonin|mesh-list
25785224|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
25785225|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785226|NCT00790478|Protective Agents|protective agents|mesh-ancestor
25785227|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785228|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785229|NCT00796107|Letrozole|letrozole|mesh-list
25785230|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785231|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25785232|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25785233|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785234|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785235|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25785236|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
25785237|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785238|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785239|NCT00791336|Nelfinavir|nelfinavir|mesh-list
25785240|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25785241|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25785242|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
25785243|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785244|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785245|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25785246|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25785247|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
25785248|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785249|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
25785250|NCT00786682|Docetaxel|docetaxel|mesh-list
25785251|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785252|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
25785253|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
25785254|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
25785255|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785256|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
25785257|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25785258|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25785259|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785260|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785261|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785262|NCT00791843|Hormones|hormones|mesh-list
25785263|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25785264|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785265|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785266|NCT00774306|Phenytoin|phenytoin|mesh-list
25785267|NCT00774306|Levetiracetam|levetiracetam|mesh-list
25785268|NCT00774306|Valproic Acid|valproic acid|mesh-list
25785269|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
25785270|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
25785271|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785272|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785273|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
25785274|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785275|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785276|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
25785277|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25785278|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785279|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785280|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25785281|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25785282|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785283|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25785284|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25785285|NCT00771602|Rituximab|rituximab|mesh-list
25785286|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
25785287|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785288|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785289|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
25785290|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785291|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785292|NCT00779038|Fentanyl|fentanyl|mesh-list
25785293|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25785294|NCT00779038|Narcotics|narcotics|mesh-ancestor
25785295|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785296|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785297|NCT00779038|Analgesics|analgesics|mesh-ancestor
25785298|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
25785299|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785300|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25785301|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25785302|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
25785303|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
25785304|NCT00780455|Interferons|interferons|mesh-list
25785305|NCT00780455|Interferon-beta|interferon-beta|mesh-list
25785306|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
25785307|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785308|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
25785309|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785310|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
25785311|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785312|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25785313|NCT00771316|Meropenem|meropenem|mesh-list
25785314|NCT00771316|Ertapenem|ertapenem|mesh-list
25785315|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25785316|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785317|NCT00780481|Bradykinin|bradykinin|mesh-list
25785318|NCT00780481|Kininogens|kininogens|mesh-list
25785319|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
25785320|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25785321|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
25785322|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785323|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785324|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25785325|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
25785326|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25785327|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785328|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25785329|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25785330|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785331|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785332|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
25785333|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785334|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
25785335|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25785336|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25785337|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
25785338|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25785339|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785340|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25785341|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25785342|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25785343|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25785344|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785345|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25785346|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25785347|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785348|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785349|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785350|NCT00755261|Bevacizumab|bevacizumab|mesh-list
25785351|NCT00755261|Doxorubicin|doxorubicin|mesh-list
25785352|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785353|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785354|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25785355|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25785356|NCT00755261|Growth Substances|growth substances|mesh-ancestor
25785357|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785358|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
25785359|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25785360|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25785361|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25785362|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785363|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785364|NCT00766636|Gemcitabine|gemcitabine|mesh-list
25785365|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25785366|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25785367|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
25785368|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785369|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785370|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
25785371|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785372|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785373|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785374|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
25785375|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785376|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25785377|NCT00768248|Ropivacaine|ropivacaine|mesh-list
25785378|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
25785379|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
25785380|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785381|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785382|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
25785383|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785384|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
25785385|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
25785386|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25785387|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25785388|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785389|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785390|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785391|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785392|NCT00764699|Mecasermin|mecasermin|mesh-list
25785393|NCT00764699|Growth Substances|growth substances|mesh-ancestor
25785394|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785395|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
25785396|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25785397|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25785398|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785399|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785400|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785401|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785402|NCT00759577|Urological Agents|urological agents|mesh-ancestor
25785403|NCT00763009|Dipyridamole|dipyridamole|mesh-list
25785404|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25785405|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785406|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785407|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25785408|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
25785409|NCT00760461|Domperidone|domperidone|mesh-list
25785410|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
25785411|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
25785412|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785413|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785414|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785415|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25785416|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
25785417|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785418|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785419|NCT00749658|Bupropion|bupropion|mesh-list
25785420|NCT00749658|Varenicline|varenicline|mesh-list
25785421|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25785422|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
25785423|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785424|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25785425|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25785426|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785427|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785428|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
25785429|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785430|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785431|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25785432|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25785433|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785434|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25785435|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25785436|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785437|NCT00754793|Dexetimide|dexetimide|mesh-list
25147288|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
25785438|NCT00754793|Citalopram|citalopram|mesh-list
25785439|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25785440|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25785441|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785442|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785443|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785444|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
25785445|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785446|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25785447|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
25785448|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785449|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25785450|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25785451|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
25785452|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
25785453|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785454|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25785455|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25785456|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785457|NCT00754052|Donepezil|donepezil|mesh-list
25785458|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25785459|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785460|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785461|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785462|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785463|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785464|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
25785465|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25785466|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785467|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25785468|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785469|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785470|NCT00752986|Fulvestrant|fulvestrant|mesh-list
25785471|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25785472|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785473|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25785474|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25785475|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
25785476|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785477|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785478|NCT00746239|Dexetimide|dexetimide|mesh-list
25785479|NCT00746239|Citalopram|citalopram|mesh-list
25785480|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25785481|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25785482|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785483|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785484|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785485|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
25785486|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785487|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25785488|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
25785489|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785490|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25785491|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25785492|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
25785493|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
25785494|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785495|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25785496|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25785497|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785498|NCT00754013|Donepezil|donepezil|mesh-list
25785499|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25785500|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785501|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785502|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785503|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785504|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785505|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
25785506|NCT00751933|Vaccines|vaccines|mesh-list
25785507|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
25785508|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785509|NCT00746603|Simvastatin|simvastatin|mesh-list
25785510|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25147446|NCT02913690|Vitamin E|vitamin e|mesh-list
25785512|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
25785513|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785514|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25785515|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25785516|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785517|NCT00736385|Metformin|metformin|mesh-list
25785518|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25785519|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785520|NCT00738972|Valsartan|valsartan|mesh-list
25785521|NCT00738972|Simvastatin|simvastatin|mesh-list
25785522|NCT00738972|Ezetimibe|ezetimibe|mesh-list
25785523|NCT00738972|Pravastatin|pravastatin|mesh-list
25785524|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25785525|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25785526|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
25785527|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785528|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25785529|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25785530|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785531|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25785532|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25785533|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25785534|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25785535|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785536|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25785537|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785538|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785539|NCT00739882|Antibodies|antibodies|mesh-list
25785540|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25785541|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
25785542|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785543|NCT00731770|Fluticasone|fluticasone|mesh-list
25785544|NCT00731770|Xhance|xhance|mesh-list
25785545|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25785546|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25785547|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25785548|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25785549|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
25785550|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785551|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785552|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25785553|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
25785554|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
25785555|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25785556|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25785557|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25785558|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25785559|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
25785560|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785561|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785562|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
25785563|NCT00731770|Hormones|hormones|mesh-ancestor
25785564|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785565|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
25785566|NCT00729365|Ramipril|ramipril|mesh-list
25785567|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25785568|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
25785569|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785570|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785571|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25785572|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
25785573|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25785574|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25785575|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25785576|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785577|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785578|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785579|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785580|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785581|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25785582|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785583|NCT00726180|Trastuzumab|trastuzumab|mesh-list
25785584|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785585|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785586|NCT00724282|Eszopiclone|eszopiclone|mesh-list
25785587|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25785588|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785589|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785590|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
25785591|NCT00728845|Paclitaxel|paclitaxel|mesh-list
25785592|NCT00728845|Bevacizumab|bevacizumab|mesh-list
25785593|NCT00728845|Carboplatin|carboplatin|mesh-list
25785594|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25785595|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785596|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25785597|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25785598|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25785599|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785600|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785601|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25785602|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25785603|NCT00728845|Growth Substances|growth substances|mesh-ancestor
25785604|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785605|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
25785606|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
25785607|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25785608|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25785609|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785610|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785611|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785612|NCT00726830|Morphine|morphine|mesh-list
25785613|NCT00726830|Oxycodone|oxycodone|mesh-list
25785614|NCT00726830|Methadone|methadone|mesh-list
25785615|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25785616|NCT00726830|Narcotics|narcotics|mesh-ancestor
25785617|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785618|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785619|NCT00726830|Analgesics|analgesics|mesh-ancestor
25785620|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
25785621|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785622|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
25785623|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
25785624|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
25785625|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785626|NCT00729560|Flutamide|flutamide|mesh-list
25785627|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
25785628|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
25785629|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785630|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785631|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25785632|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785633|NCT00716807|Nalbuphine|nalbuphine|mesh-list
25785634|NCT00716807|Naloxone|naloxone|mesh-list
25785635|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25785636|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785637|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
25785638|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785639|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25785640|NCT00716807|Narcotics|narcotics|mesh-ancestor
25785641|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785642|NCT00716807|Analgesics|analgesics|mesh-ancestor
25785643|NCT00714948|Gemcitabine|gemcitabine|mesh-list
25785644|NCT00714948|Cisplatin|cisplatin|mesh-list
25785645|NCT00714948|Sorafenib|sorafenib|mesh-list
25785646|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785647|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25785648|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
25785649|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785650|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
25785651|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785652|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785653|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785654|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
25785655|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785656|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25785657|NCT00720343|Choline|choline|mesh-list
25785658|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
25785659|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25785660|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
25785661|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785662|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785663|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25785664|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
25785665|NCT00719914|Eptifibatide|eptifibatide|mesh-list
25785666|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25785667|NCT00718640|Dexamethasone|dexamethasone|mesh-list
25785668|NCT00718640|Bortezomib|bortezomib|mesh-list
25785669|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25785670|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
25785671|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
25785672|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785673|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785674|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785675|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
25785676|NCT00718640|Hormones|hormones|mesh-ancestor
25785677|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785678|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25785679|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785680|NCT00720083|Cisplatin|cisplatin|mesh-list
25785681|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785682|NCT00717275|Temozolomide|temozolomide|mesh-list
25785683|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785684|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
25785685|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785686|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785687|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
25785688|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25785689|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25785690|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25785691|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785692|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785693|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
25785694|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785695|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785696|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25785697|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785698|NCT00706797|Etanercept|etanercept|mesh-list
25785699|NCT00706797|Methotrexate|methotrexate|mesh-list
25785700|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25785701|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
25785702|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25785703|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785704|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25785705|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
25785706|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785707|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785708|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
25785709|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785710|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25785711|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785712|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
25785713|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785714|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25785715|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25785716|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25785717|NCT00706797|Analgesics|analgesics|mesh-ancestor
25785718|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
25785719|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785720|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25785721|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785722|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25785723|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
25785724|NCT00713596|Coagulants|coagulants|mesh-ancestor
25785725|NCT00703885|Alprazolam|alprazolam|mesh-list
25785726|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25785727|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785728|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785729|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25785730|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25785731|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785732|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
25785733|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
25785734|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785735|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785736|NCT00713258|Alendronate|alendronate|mesh-list
25785737|NCT00713258|Hormones|hormones|mesh-list
25785738|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
25785739|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785740|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785741|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25785742|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25785743|NCT00707161|Cisplatin|cisplatin|mesh-list
25785744|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785745|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
25785746|NCT00704496|Ephedrine|ephedrine|mesh-list
25785747|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25785748|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
25785749|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785750|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785751|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25785752|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
25785753|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
25785754|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25785755|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25785756|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
25785757|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
25785758|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785759|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785760|NCT00708916|Apremilast|apremilast|mesh-list
25785761|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25785762|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25785763|NCT00708916|Analgesics|analgesics|mesh-ancestor
25785764|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
25785765|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785766|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785767|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25785768|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785769|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25785770|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25785771|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785772|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785773|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25785774|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25785775|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785776|NCT00699842|Lenalidomide|lenalidomide|mesh-list
25785777|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
25785778|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785779|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25785780|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25785781|NCT00699842|Growth Substances|growth substances|mesh-ancestor
25785782|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
25785783|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785784|NCT00702962|Carboplatin|carboplatin|mesh-list
25785785|NCT00702962|Etoposide|etoposide|mesh-list
25785786|NCT00702962|Vorinostat|vorinostat|mesh-list
25785787|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785788|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25785789|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25785790|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25785791|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785792|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785793|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25785795|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785796|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25785797|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
25785798|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
25785799|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785800|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785801|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785802|NCT00698009|Vidarabine|vidarabine|mesh-list
25785803|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
25785804|NCT00698009|Fludarabine|fludarabine|mesh-list
25785805|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
25785806|NCT00698009|Interleukin-2|interleukin-2|mesh-list
25785807|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785808|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
25785809|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785810|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785811|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785812|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
25785813|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785814|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785815|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25785816|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25785817|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
25785818|NCT00698009|Antiviral Agents|antiviral agents|mesh-ancestor
25785819|NCT00698009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785820|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25785821|NCT00698009|Analgesics|analgesics|mesh-ancestor
25785822|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
25785823|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785824|NCT00703339|Treprostinil|treprostinil|mesh-list
25785825|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25785826|NCT00691444|Melatonin|melatonin|mesh-list
25785827|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
25785828|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785829|NCT00691444|Protective Agents|protective agents|mesh-ancestor
25785830|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785831|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785832|NCT00691652|Rituximab|rituximab|mesh-list
25785833|NCT00691652|Clofarabine|clofarabine|mesh-list
25785834|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785835|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785836|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
25785837|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785838|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25785839|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25785840|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
25785841|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785842|NCT00686972|Glucagon|glucagon|mesh-list
25785843|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25785844|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25785845|NCT00686972|Hormones|hormones|mesh-ancestor
25785846|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785847|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785848|NCT00686972|Incretins|incretins|mesh-ancestor
25785849|NCT00693017|Zonisamide|zonisamide|mesh-list
25785850|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
25785851|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25785852|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785853|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785854|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25785855|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785856|NCT00691574|Melatonin|melatonin|mesh-list
25785857|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
25785858|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785859|NCT00691574|Protective Agents|protective agents|mesh-ancestor
25785860|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785861|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785862|NCT00692094|Melatonin|melatonin|mesh-list
25785863|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
25785864|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785865|NCT00692094|Protective Agents|protective agents|mesh-ancestor
25785866|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785867|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785868|NCT00692003|Zonisamide|zonisamide|mesh-list
25785869|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
25785870|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25785871|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785872|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785873|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25785874|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785875|NCT00678288|Interferons|interferons|mesh-list
25785876|NCT00678288|Sorafenib|sorafenib|mesh-list
25785877|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785878|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
25785879|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785880|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25785881|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785882|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785883|NCT00676026|Zolpidem|zolpidem|mesh-list
25785884|NCT00676026|Fluoxetine|fluoxetine|mesh-list
25785885|NCT00676026|Progesterone|progesterone|mesh-list
25785886|NCT00676026|Progestins|progestins|mesh-ancestor
25785887|NCT00676026|Hormones|hormones|mesh-ancestor
25785888|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785889|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785890|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25785891|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25785892|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785893|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785894|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785895|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
25785896|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25785897|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
25785898|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785899|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25785900|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25785901|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785902|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25785903|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25785904|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785905|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25785906|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
25785907|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
25785908|NCT00689052|Pramipexole|pramipexole|mesh-list
25785909|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
25785910|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785911|NCT00689052|Protective Agents|protective agents|mesh-ancestor
25785912|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785913|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25785914|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25785915|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
25785916|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
25785917|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785918|NCT00678574|Fluoxetine|fluoxetine|mesh-list
25785919|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25785920|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25785921|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785922|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785923|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25785924|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
25785925|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785926|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25785927|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
25785928|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785929|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25785930|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25785931|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25785932|NCT00683917|Leuprolide|leuprolide|mesh-list
25785933|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25785934|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
25785935|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25785936|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785937|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25785938|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148573|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
25785939|NCT00688935|Melatonin|melatonin|mesh-list
25785940|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
25785941|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785942|NCT00688935|Protective Agents|protective agents|mesh-ancestor
25785943|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785944|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785945|NCT00685880|Betamethasone|betamethasone|mesh-list
25785946|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
25785947|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25785948|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
25785949|NCT00685880|Hormones|hormones|mesh-ancestor
25785950|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25785951|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785952|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25785953|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
25785954|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25785955|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
25785956|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25785957|NCT00681044|Melphalan|melphalan|mesh-list
25785958|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
25785959|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785960|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785961|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
25785962|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785963|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785964|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25785965|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785966|NCT00684255|Fludarabine|fludarabine|mesh-list
25785967|NCT00684255|Busulfan|busulfan|mesh-list
25785968|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
25785969|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785970|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785971|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25785972|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
25785973|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785974|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
25785975|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25785976|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25785977|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25785978|NCT00683787|Docetaxel|docetaxel|mesh-list
25785979|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25785980|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
25785981|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
25785982|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
25785983|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25785984|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
25785985|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25785986|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25785987|NCT00678041|Renal Agents|renal agents|mesh-ancestor
25785988|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25785989|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25785990|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
25785991|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25785992|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25785993|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25785994|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25785995|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785996|NCT00669461|Lubiprostone|lubiprostone|mesh-list
25785997|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25785998|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25785999|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786000|NCT00673309|Insulin|insulin|mesh-list
25786001|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25786002|NCT00673309|Itraconazole|itraconazole|mesh-list
25786003|NCT00673309|Propranolol|propranolol|mesh-list
25786004|NCT00673309|Hormones|hormones|mesh-list
25786005|NCT00673309|Oxandrolone|oxandrolone|mesh-list
25786006|NCT00673309|Nandrolone|nandrolone|mesh-list
25786007|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25786008|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786009|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786010|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786011|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25786012|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25786013|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
25786014|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786015|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25786016|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25786017|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
25786018|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
25786019|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786020|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25786021|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25786022|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786023|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25786024|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
25786025|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25786027|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
25786028|NCT00673595|Varenicline|varenicline|mesh-list
25786029|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25786030|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25786031|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
25786032|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786033|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786034|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786035|NCT00673361|Temozolomide|temozolomide|mesh-list
25786036|NCT00673361|Sorafenib|sorafenib|mesh-list
25786037|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25786038|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
25786039|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786040|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786041|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786042|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786043|NCT00668785|Ranibizumab|ranibizumab|mesh-list
25786044|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25786045|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25786046|NCT00668785|Growth Substances|growth substances|mesh-ancestor
25786047|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786048|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
25786049|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786050|NCT00673179|Leucovorin|leucovorin|mesh-list
25786051|NCT00673179|Gemcitabine|gemcitabine|mesh-list
25786052|NCT00673179|Doxorubicin|doxorubicin|mesh-list
25786053|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25786054|NCT00673179|Methotrexate|methotrexate|mesh-list
25786055|NCT00673179|Ifosfamide|ifosfamide|mesh-list
25786056|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
25786057|NCT00673179|Razoxane|razoxane|mesh-list
25786058|NCT00673179|Sargramostim|sargramostim|mesh-list
25786059|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786060|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786061|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
25786062|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786063|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
25786064|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786065|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786066|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786067|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
25786068|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786069|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25786070|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25786071|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25786072|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25786073|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
25786074|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25786075|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
25786076|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25786077|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25786078|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25786079|NCT00673179|Antidotes|antidotes|mesh-ancestor
25786080|NCT00673179|Protective Agents|protective agents|mesh-ancestor
25786081|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
25786082|NCT00673179|Vitamins|vitamins|mesh-ancestor
25786083|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
25786084|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25786085|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
25786086|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25786087|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
25786088|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
25786089|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25786090|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
25786091|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25786092|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25786093|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25786094|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786095|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786096|NCT00660348|Morphine|morphine|mesh-list
25786097|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25786098|NCT00660348|Narcotics|narcotics|mesh-ancestor
25786099|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786100|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786101|NCT00660348|Analgesics|analgesics|mesh-ancestor
25786102|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
25786103|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786104|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
25786105|NCT00664066|Hematinics|hematinics|mesh-ancestor
25786106|NCT00667017|Immunotoxins|immunotoxins|mesh-list
25786107|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
25786108|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786109|NCT00665444|Aripiprazole|aripiprazole|mesh-list
25786110|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
25786111|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25786112|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25786113|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25786114|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786115|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786116|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
25786117|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
25786118|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786119|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786120|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25786121|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25786122|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
25786123|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25786124|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25786125|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25786126|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25786127|NCT00656916|Fluticasone|fluticasone|mesh-list
25786128|NCT00656916|Xhance|xhance|mesh-list
25786129|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786130|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25786131|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
25786132|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786133|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786134|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25786135|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
25786136|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
25786137|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25786138|NCT00660595|Risperidone|risperidone|mesh-list
25786139|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25786140|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25786141|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
25786142|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786143|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786144|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786145|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25786146|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25786147|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786148|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25786149|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25786150|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
25786151|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
25786152|NCT00661466|Bupivacaine|bupivacaine|mesh-list
25786153|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
25786154|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
25786155|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786156|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786157|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
25786158|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786159|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25786160|NCT00646282|Vitamins|vitamins|mesh-ancestor
25786161|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
25786162|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149225|NCT03719092|Vitamins|vitamins|mesh-list
25786163|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25786164|NCT00657553|Bortezomib|bortezomib|mesh-list
25786165|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786167|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25786168|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25786169|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786170|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786171|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786172|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
25786173|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786174|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25786175|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
25786176|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25786177|NCT00648895|Metoprolol|metoprolol|mesh-list
25786178|NCT00648895|Nebivolol|nebivolol|mesh-list
25786179|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25786180|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25786181|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
25786182|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
25786183|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786184|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786185|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25786186|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25786187|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25786188|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
25786189|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786190|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786191|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
25786192|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25786193|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25786194|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25786195|NCT00647426|Carboplatin|carboplatin|mesh-list
25786196|NCT00647426|Docetaxel|docetaxel|mesh-list
25786197|NCT00647426|Sorafenib|sorafenib|mesh-list
25786198|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786199|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
25786200|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
25786201|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
25786202|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786203|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786204|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786205|NCT00637806|Megestrol|megestrol|mesh-list
25786206|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
25786207|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25786208|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25786209|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25786210|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
25786211|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25786212|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786213|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25786214|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25786215|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786216|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786217|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
25786218|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25786219|NCT00652457|Memantine|memantine|mesh-list
25786220|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25786221|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25786222|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
25786223|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786224|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786225|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786226|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25786227|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25786228|NCT00642603|Bevacizumab|bevacizumab|mesh-list
25786229|NCT00642603|Capecitabine|capecitabine|mesh-list
25786230|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
25786231|NCT00642603|Irinotecan|irinotecan|mesh-list
25786232|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25786233|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786234|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25786235|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25786236|NCT00642603|Growth Substances|growth substances|mesh-ancestor
25786237|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786238|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
25786239|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786240|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
25786241|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786242|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25786243|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25786244|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786245|NCT00629798|Fludarabine|fludarabine|mesh-list
25786246|NCT00629798|Melphalan|melphalan|mesh-list
25786247|NCT00629798|Busulfan|busulfan|mesh-list
25786248|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25786249|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786250|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786251|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786252|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
25786253|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786254|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25786255|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
25786256|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25786257|NCT00637728|Megestrol|megestrol|mesh-list
25786258|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
25786259|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25786260|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25786261|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25786262|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
25786263|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25786264|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786265|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25786266|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25786267|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786268|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786269|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
25786270|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25786271|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
25786272|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25786273|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786274|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
25786275|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25786276|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
25786277|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786278|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
25786279|NCT00642382|Protective Agents|protective agents|mesh-ancestor
25786280|NCT00637416|Lansoprazole|lansoprazole|mesh-list
25786281|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
25786282|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25786283|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25786284|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25786285|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786286|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786287|NCT00638222|Carvedilol|carvedilol|mesh-list
25786288|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25786289|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25786290|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
25786291|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786292|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786293|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786294|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25786295|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
25786296|NCT00638222|Protective Agents|protective agents|mesh-ancestor
25786297|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25786298|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786299|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25786300|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
25786301|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25786302|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25786303|NCT00634322|Leucovorin|leucovorin|mesh-list
25786304|NCT00634322|Antidotes|antidotes|mesh-ancestor
25786305|NCT00634322|Protective Agents|protective agents|mesh-ancestor
25786306|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149580|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25149581|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
25149582|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
25149585|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25149587|NCT05466604|Hormones|hormones|mesh-ancestor
25149588|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25149590|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786307|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
25786308|NCT00634322|Vitamins|vitamins|mesh-ancestor
25786309|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
25786310|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
25786311|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
25786312|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786313|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
25786314|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786315|NCT00631137|Testosterone|testosterone|mesh-list
25786316|NCT00631137|Androgens|androgens|mesh-ancestor
25786317|NCT00631137|Hormones|hormones|mesh-ancestor
25786318|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786319|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786320|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25786321|NCT00634972|Ketorolac|ketorolac|mesh-list
25786322|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25786323|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25786324|NCT00634972|Analgesics|analgesics|mesh-ancestor
25786325|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
25786326|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786327|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786328|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786329|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25786330|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25786331|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786332|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786333|NCT00633061|Enoxaparin|enoxaparin|mesh-list
25786334|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
25786335|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25786336|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25786337|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786338|NCT00626444|Ascorbic Acid|ascorbic acid|mesh-list
25786339|NCT00626444|Vitamins|vitamins|mesh-ancestor
25786340|NCT00626444|Micronutrients|micronutrients|mesh-ancestor
25786341|NCT00626444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786342|NCT00626444|Antioxidants|antioxidants|mesh-ancestor
25786343|NCT00626444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786344|NCT00626444|Protective Agents|protective agents|mesh-ancestor
25786345|NCT00634010|Morphine|morphine|mesh-list
25786346|NCT00634010|Methadone|methadone|mesh-list
25786347|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25786348|NCT00634010|Narcotics|narcotics|mesh-ancestor
25786349|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786350|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786351|NCT00634010|Analgesics|analgesics|mesh-ancestor
25786352|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
25786353|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786354|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
25786355|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
25786356|NCT00623974|Teriparatide|teriparatide|mesh-list
25786357|NCT00623974|Calcitriol|calcitriol|mesh-list
25786358|NCT00623974|Calcium|calcium|mesh-list
25786359|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
25786360|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25786361|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786362|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25786363|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25786364|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786365|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786366|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25786367|NCT00623974|Vitamins|vitamins|mesh-ancestor
25786368|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
25786369|NCT00624650|Phenylephrine|phenylephrine|mesh-list
25786370|NCT00624650|Dobutamine|dobutamine|mesh-list
25786371|NCT00624650|Furosemide|furosemide|mesh-list
25786372|NCT00624650|Vasopressins|vasopressins|mesh-list
25786373|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
25786374|NCT00624650|Epinephrine|epinephrine|mesh-list
25786375|NCT00624650|Racepinephrine|racepinephrine|mesh-list
25786376|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
25786377|NCT00624650|Norepinephrine|norepinephrine|mesh-list
25786378|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25786379|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
25786380|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25786381|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25786382|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
25786383|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786384|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786385|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786386|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25786387|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25786388|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
25786389|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786390|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25786391|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
25786392|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
25786393|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
25786394|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25786395|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
25786396|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25786397|NCT00624650|Protective Agents|protective agents|mesh-ancestor
25786398|NCT00624650|Diuretics|diuretics|mesh-ancestor
25786399|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
25786400|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25786401|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786402|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
25786403|NCT00624650|Coagulants|coagulants|mesh-ancestor
25786404|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25786405|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25150629|NCT05144295|Cathartics|cathartics|mesh-ancestor
25786406|NCT00626561|Paclitaxel|paclitaxel|mesh-list
25786407|NCT00626561|Bevacizumab|bevacizumab|mesh-list
25786408|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25786409|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786410|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
25786411|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
25786412|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
25786413|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786414|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25786415|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25786416|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25786417|NCT00626561|Growth Substances|growth substances|mesh-ancestor
25786418|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786419|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
25786420|NCT00613730|Gemcitabine|gemcitabine|mesh-list
25786421|NCT00613730|Panitumumab|panitumumab|mesh-list
25786422|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786423|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
25786424|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786425|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786426|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
25786427|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786428|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786429|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786430|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
25786431|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786432|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25786433|NCT00625586|Gemcitabine|gemcitabine|mesh-list
25786434|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786435|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
25786436|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786437|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786438|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
25786439|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786440|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786441|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786442|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
25786443|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786444|NCT00625703|Linezolid|linezolid|mesh-list
25786445|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25786446|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786447|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25786448|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786449|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786450|NCT00625742|Ibuprofen|ibuprofen|mesh-list
25786451|NCT00625742|Atenolol|atenolol|mesh-list
25786452|NCT00625742|Melatonin|melatonin|mesh-list
25786453|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25786454|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25786455|NCT00625742|Analgesics|analgesics|mesh-ancestor
25786456|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
25786457|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786458|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786459|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786460|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25786461|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25786462|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786463|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786464|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
25786465|NCT00625742|Protective Agents|protective agents|mesh-ancestor
25786466|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786467|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25786468|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25786469|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
25786470|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
25786471|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25786472|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25786473|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25786474|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
25786475|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786476|NCT00619242|Sorafenib|sorafenib|mesh-list
25786477|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786478|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786479|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786480|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786481|NCT00616577|Ropivacaine|ropivacaine|mesh-list
25786482|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
25786483|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
25786484|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786485|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786486|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
25786487|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786488|NCT00616759|Propofol|propofol|mesh-list
25786489|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25786490|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786491|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786492|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25786493|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
25786494|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
25786495|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
25786496|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25786497|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786498|NCT00616343|Zonisamide|zonisamide|mesh-list
25786499|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
25786500|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25786501|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786502|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786503|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25786504|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786505|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
25786506|NCT00612677|Pemetrexed|pemetrexed|mesh-list
25786507|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786508|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786509|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786510|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25786511|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25786512|NCT00616603|Dexamethasone|dexamethasone|mesh-list
25786513|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
25786514|NCT00616603|Ropivacaine|ropivacaine|mesh-list
25786515|NCT00616603|BB 1101|bb 1101|mesh-list
25786516|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786517|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
25786518|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
25786519|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786520|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786521|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25786522|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
25786523|NCT00616603|Hormones|hormones|mesh-ancestor
25786524|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786525|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786526|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786527|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
25786528|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786529|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786530|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
25786531|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
25786532|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786533|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
25786534|NCT00610532|Probenecid|probenecid|mesh-list
25786535|NCT00610532|Phenytoin|phenytoin|mesh-list
25786536|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
25786537|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25786538|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25786539|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786540|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786541|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25786542|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25786543|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
25786544|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
25786545|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25786546|NCT00610532|Renal Agents|renal agents|mesh-ancestor
25786547|NCT00609765|Dexamethasone|dexamethasone|mesh-list
25786548|NCT00609765|Bevacizumab|bevacizumab|mesh-list
25786549|NCT00609765|Doxorubicin|doxorubicin|mesh-list
25786550|NCT00609765|Fluorouracil|fluorouracil|mesh-list
25786551|NCT00609765|Streptozocin|streptozocin|mesh-list
25786552|NCT00609765|Ondansetron|ondansetron|mesh-list
25786553|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24759890|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759891|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24759895|NCT01755377|Benzonidazole|benzonidazole|mesh-list
25786554|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786555|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25786556|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25786557|NCT00609765|Growth Substances|growth substances|mesh-ancestor
25786558|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786559|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
25786560|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786561|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
25786562|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
25786563|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786564|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25786565|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
25786567|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786568|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786569|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25786570|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25786571|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25786572|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786573|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786574|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
25786575|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786576|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786577|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
25786578|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
25786579|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
25786580|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25786581|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
25786582|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786583|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25786584|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25786585|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786586|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25786587|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25786588|NCT00608465|Ramipril|ramipril|mesh-list
25786589|NCT00608465|Eplerenone|eplerenone|mesh-list
25786590|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25786591|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
25786592|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786593|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786594|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25786595|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25786596|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
25786597|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786598|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786599|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25786600|NCT00608465|Diuretics|diuretics|mesh-ancestor
25786601|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
25786602|NCT00608777|Betamethasone|betamethasone|mesh-list
25786603|NCT00608777|Calcipotriene|calcipotriene|mesh-list
25786604|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786605|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
25786606|NCT00608777|Hormones|hormones|mesh-ancestor
25786607|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786608|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786609|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25786610|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
25786611|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
25786612|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25786613|NCT00601848|Trioxsalen|trioxsalen|mesh-list
25786614|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786615|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
25786616|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25786617|NCT00607477|Minoxidil|minoxidil|mesh-list
25786618|NCT00607477|Hydralazine|hydralazine|mesh-list
25786619|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25786620|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
25786621|NCT00595920|Vaccines|vaccines|mesh-list
25786622|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
25786623|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786624|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
25786625|NCT00596947|Prednisone|prednisone|mesh-list
25786626|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
25786627|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25786628|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25031303|NCT03588767|Hormones|hormones|mesh-ancestor
25786629|NCT00596947|Prednisolone|prednisolone|mesh-list
25786630|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
25786631|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25786632|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
25786633|NCT00596947|Tacrolimus|tacrolimus|mesh-list
25786634|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
25786635|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25786636|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786637|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
25786638|NCT00596947|Hormones|hormones|mesh-ancestor
25786639|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786640|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786641|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786642|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786643|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786644|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
25786645|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25786646|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786647|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786648|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25786649|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25786650|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
25786651|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25786652|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786653|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
25786654|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
25786655|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786656|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25786657|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25786658|NCT00596947|Protective Agents|protective agents|mesh-ancestor
25786659|NCT00584012|Docetaxel|docetaxel|mesh-list
25786660|NCT00584012|Lovastatin|lovastatin|mesh-list
25786661|NCT00584012|L 647318|l 647318|mesh-list
25786662|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
25786663|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786664|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25786665|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
25786666|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
25786667|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786668|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25786669|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25786670|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
25786671|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25786672|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25786673|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786674|NCT00599131|Cisplatin|cisplatin|mesh-list
25786675|NCT00599131|Docetaxel|docetaxel|mesh-list
25786676|NCT00599131|Fluorouracil|fluorouracil|mesh-list
25786677|NCT00599131|Cetuximab|cetuximab|mesh-list
25786678|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786679|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
25786680|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
25786681|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
25786682|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786683|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
25786684|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786685|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786686|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
25786687|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786688|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25786689|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
25786690|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
25786691|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786692|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
25786693|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786694|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786695|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
25786696|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786697|NCT00589550|Interferons|interferons|mesh-list
25786698|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
25786699|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
25786700|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25786701|NCT00589550|Sorafenib|sorafenib|mesh-list
25786702|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786703|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
25786704|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786705|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786706|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786707|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786708|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
25786709|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786711|NCT00577772|Lactulose|lactulose|mesh-list
25786712|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25786713|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786714|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25786715|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25786716|NCT00592007|Fulvestrant|fulvestrant|mesh-list
25786717|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786718|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786719|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786720|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786721|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786722|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25786723|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25786724|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
25786725|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786726|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786727|NCT00595582|Curcumin|curcumin|mesh-list
25786728|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25786729|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25786730|NCT00595582|Analgesics|analgesics|mesh-ancestor
25786731|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
25786732|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786733|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786734|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786735|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25786736|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786737|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786738|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786739|NCT00588146|Interferons|interferons|mesh-list
25786740|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
25786741|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
25786742|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25786743|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786744|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
25786745|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786746|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
25786747|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786748|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25786749|NCT00590538|Genistein|genistein|mesh-list
25786750|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786751|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25786752|NCT00590538|Protective Agents|protective agents|mesh-ancestor
25786753|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786754|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786755|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786756|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786757|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
25786758|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25786759|NCT00590538|Estrogens|estrogens|mesh-ancestor
25786760|NCT00590538|Hormones|hormones|mesh-ancestor
25786761|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786762|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
25786763|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786764|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786765|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786766|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786767|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
25786768|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
25786769|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25786770|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786771|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786772|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
25786773|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25786774|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786775|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786776|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
25786777|NCT00586716|Antibodies|antibodies|mesh-list
25786778|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
25786779|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25786780|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25786781|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
25786782|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786783|NCT00588471|Simvastatin|simvastatin|mesh-list
25786784|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25786785|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25786786|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
25786787|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786788|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25786789|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25786790|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786791|NCT00590135|Atorvastatin|atorvastatin|mesh-list
25786792|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25786793|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25786794|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
25786795|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786796|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25786797|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25786798|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786799|NCT00582036|Insulin|insulin|mesh-list
25786800|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25786801|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25786802|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786803|NCT00585585|Betahistine|betahistine|mesh-list
25786804|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
25786805|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
25786806|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
25786807|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25786808|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786809|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786810|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25786811|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
25786812|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786813|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786814|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786815|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786816|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
25786817|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786818|NCT00579254|Amlodipine|amlodipine|mesh-list
25786819|NCT00579254|Atorvastatin|atorvastatin|mesh-list
25786820|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25786821|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25786822|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
25786823|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786824|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25786825|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25786826|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786827|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25786828|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25786829|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786830|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25786831|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786832|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
25786833|NCT00585611|Atorvastatin|atorvastatin|mesh-list
25786834|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25786835|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25786836|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
25786837|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786838|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25786839|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25786840|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786841|NCT00572260|Daptomycin|daptomycin|mesh-list
25786842|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25786843|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786844|NCT00571194|Pravastatin|pravastatin|mesh-list
25786845|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25786846|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25786847|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
25786848|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786849|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25786850|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25786851|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786852|NCT00584935|Rituximab|rituximab|mesh-list
25786853|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25786854|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786855|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
25786856|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786857|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25786858|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
25786859|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25786860|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25786861|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786862|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25786863|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786864|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25786865|NCT00573391|Thalidomide|thalidomide|mesh-list
25786866|NCT00573391|Dexamethasone|dexamethasone|mesh-list
25786867|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
25786868|NCT00573391|Melphalan|melphalan|mesh-list
25786869|NCT00573391|Bortezomib|bortezomib|mesh-list
25786870|NCT00573391|BB 1101|bb 1101|mesh-list
25786871|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786872|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
25786873|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
25786874|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786875|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786876|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25786877|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
25786878|NCT00573391|Hormones|hormones|mesh-ancestor
25786879|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786880|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786881|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786882|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
25786883|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786884|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786885|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25786886|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
25786887|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25786888|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786889|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
25786890|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
25786891|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25786892|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786893|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25786894|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25786895|NCT00573391|Growth Substances|growth substances|mesh-ancestor
25786896|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
25786897|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25786898|NCT00570258|Fulvestrant|fulvestrant|mesh-list
25786899|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786900|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25786901|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786902|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786903|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786904|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25786905|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25786906|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
25786907|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786908|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786909|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
25786910|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786911|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
25786912|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786913|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786914|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25786915|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
25786916|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786917|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
25786918|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786919|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786920|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25786921|NCT00574080|Cytarabine|cytarabine|mesh-list
25786922|NCT00574080|Thalidomide|thalidomide|mesh-list
25786923|NCT00574080|Dexamethasone|dexamethasone|mesh-list
25786924|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
25786925|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
25786926|NCT00574080|Melphalan|melphalan|mesh-list
25786927|NCT00574080|Carmustine|carmustine|mesh-list
25786928|NCT00574080|Cisplatin|cisplatin|mesh-list
25786929|NCT00574080|Etoposide|etoposide|mesh-list
25786930|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
25786931|NCT00574080|Doxorubicin|doxorubicin|mesh-list
25786932|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25786933|NCT00574080|Bortezomib|bortezomib|mesh-list
25786934|NCT00574080|BB 1101|bb 1101|mesh-list
25786935|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786936|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
25786937|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786938|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25786939|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25786940|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
25786941|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786942|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786943|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25786944|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786945|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
25786946|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
25786947|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786948|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25786949|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
25786950|NCT00574080|Hormones|hormones|mesh-ancestor
25786951|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786952|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25786953|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
25786954|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25786955|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25786956|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25786957|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25786958|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25786959|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
25786960|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
25786961|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25786962|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25786963|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
25786964|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25786965|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25786966|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25786967|NCT00574080|Growth Substances|growth substances|mesh-ancestor
25786968|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
25786969|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
25786970|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25786971|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
25786972|NCT00558558|Hormones|hormones|mesh-ancestor
25786973|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25786974|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786975|NCT00577356|Docetaxel|docetaxel|mesh-list
25786976|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786977|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
25786978|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
25786979|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
25786980|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25786981|NCT00573937|Morphine|morphine|mesh-list
25786982|NCT00573937|Methadone|methadone|mesh-list
25786983|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25786984|NCT00573937|Narcotics|narcotics|mesh-ancestor
25786985|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25786986|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25786987|NCT00573937|Analgesics|analgesics|mesh-ancestor
25786988|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
25786989|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25786990|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
25786991|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
25786992|NCT00571922|Acamprosate|acamprosate|mesh-list
25786993|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25786994|NCT00569868|Bortezomib|bortezomib|mesh-list
25786995|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786996|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
25786997|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25786998|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25786999|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25787000|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
25787001|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25787002|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787003|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787004|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787005|NCT00570531|Paclitaxel|paclitaxel|mesh-list
25787006|NCT00570531|Bevacizumab|bevacizumab|mesh-list
25787007|NCT00570531|Cisplatin|cisplatin|mesh-list
25787008|NCT00570531|Fluorouracil|fluorouracil|mesh-list
25787009|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25787010|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787011|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787012|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787013|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787014|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787015|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787016|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25787017|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25787018|NCT00570531|Growth Substances|growth substances|mesh-ancestor
25787019|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787020|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
25787021|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
25787022|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787023|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787024|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
25787025|NCT00561912|Interferons|interferons|mesh-list
25787026|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
25787027|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
25787028|NCT00561912|Decitabine|decitabine|mesh-list
25787029|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787030|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
25787031|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787032|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
25787033|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787034|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787035|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
25787036|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787037|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787038|NCT00561795|Paclitaxel|paclitaxel|mesh-list
25787039|NCT00561795|Carboplatin|carboplatin|mesh-list
25787040|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25787041|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787042|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787043|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787044|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787045|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787046|NCT00564876|Dasatinib|dasatinib|mesh-list
25787047|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787048|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787049|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787050|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787051|NCT00558870|Morphine|morphine|mesh-list
25787052|NCT00558870|Methadone|methadone|mesh-list
25787053|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25787054|NCT00558870|Narcotics|narcotics|mesh-ancestor
25787055|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787056|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787057|NCT00558870|Analgesics|analgesics|mesh-ancestor
25787058|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
25787059|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787060|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
25787061|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
25787062|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
25787063|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
25787064|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25787065|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787066|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787067|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25787068|NCT00521924|Cyclosporine|cyclosporine|mesh-list
25787069|NCT00521924|Chloroquine|chloroquine|mesh-list
25787070|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
25787071|NCT00521924|Methotrexate|methotrexate|mesh-list
25787072|NCT00521924|Infliximab|infliximab|mesh-list
25787073|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
25787074|NCT00521924|Cyclosporins|cyclosporins|mesh-list
25787075|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25787076|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
25787077|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787078|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787079|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787080|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
25787081|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787082|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787083|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787084|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787085|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25787086|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787087|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
25787088|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25787089|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
25787090|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787091|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25787092|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25787093|NCT00521924|Amebicides|amebicides|mesh-ancestor
25787094|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25787095|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25787096|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
25787097|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25787098|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25787099|NCT00521924|Analgesics|analgesics|mesh-ancestor
25787100|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
25787101|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787102|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787103|NCT00548886|Epinephrine|epinephrine|mesh-list
25787104|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25787105|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25787106|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787107|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787108|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787109|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787110|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25787111|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25787112|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
25787113|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787114|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25787115|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
25787116|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
25787117|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
25787118|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25787119|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
25787120|NCT00539838|Prednisone|prednisone|mesh-list
25787121|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
25787122|NCT00539838|Methotrexate|methotrexate|mesh-list
25787123|NCT00539838|Azathioprine|azathioprine|mesh-list
25787124|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25787125|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
25787126|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787127|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
25787128|NCT00539838|Hormones|hormones|mesh-ancestor
25787129|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25787130|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787131|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25787132|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787133|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25787134|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
25787135|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787136|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787137|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
25787138|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787139|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787140|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787141|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25787142|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
25787143|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787144|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25787145|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25787146|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25787147|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
25787148|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25787149|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787150|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
25787151|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
25787152|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787153|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25787154|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25787155|NCT00539838|Protective Agents|protective agents|mesh-ancestor
25787156|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25787157|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24815979|NCT02073149|Iron|iron|mesh-list
25787158|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25787159|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25787160|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787161|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787162|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787163|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787164|NCT00542542|Fentanyl|fentanyl|mesh-list
25787165|NCT00542542|Midazolam|midazolam|mesh-list
25787166|NCT00542542|Propofol|propofol|mesh-list
25787167|NCT00542542|Ropivacaine|ropivacaine|mesh-list
25787168|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25787169|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787170|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787171|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25787172|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
25787173|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
25787174|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
25787175|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
25787176|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787177|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25787178|NCT00542542|Narcotics|narcotics|mesh-ancestor
25787179|NCT00542542|Analgesics|analgesics|mesh-ancestor
25787180|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25787181|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25787182|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25787183|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25787184|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
25787185|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
25787186|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787187|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787188|NCT00547300|Metoprolol|metoprolol|mesh-list
25787189|NCT00547300|Nebivolol|nebivolol|mesh-list
25787190|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25787191|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25787192|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
25787193|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
25787194|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787195|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787196|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25787197|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25787198|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25787199|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787200|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787201|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787202|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
25787203|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25787204|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25787205|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25787206|NCT00539617|Leucovorin|leucovorin|mesh-list
25787207|NCT00539617|Fluorouracil|fluorouracil|mesh-list
25787208|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
25787209|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25787210|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
25787211|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787212|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787213|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787214|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787215|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
25787216|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787217|NCT00539617|Antidotes|antidotes|mesh-ancestor
25787218|NCT00539617|Protective Agents|protective agents|mesh-ancestor
25787219|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
25787220|NCT00539617|Vitamins|vitamins|mesh-ancestor
25787221|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
25787222|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787223|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787224|NCT00546455|Fenretinide|fenretinide|mesh-list
25787225|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787226|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25787227|NCT00546455|Protective Agents|protective agents|mesh-ancestor
25787228|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787229|NCT00538980|Dasatinib|dasatinib|mesh-list
24766562|NCT01795430|Etoposide|etoposide|mesh-list
25787230|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787231|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787232|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787233|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787234|NCT00535262|Selegiline|selegiline|mesh-list
25787235|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
25787236|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25787237|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25787238|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25787239|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25787240|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787241|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787242|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25787243|NCT00535262|Protective Agents|protective agents|mesh-ancestor
25787244|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787245|NCT00536978|Cytarabine|cytarabine|mesh-list
25787246|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
25787247|NCT00536978|Melphalan|melphalan|mesh-list
25787248|NCT00536978|Carmustine|carmustine|mesh-list
25787249|NCT00536978|Rituximab|rituximab|mesh-list
25787250|NCT00536978|Methotrexate|methotrexate|mesh-list
25787251|NCT00536978|Fludarabine|fludarabine|mesh-list
25787252|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
25787253|NCT00536978|Etoposide|etoposide|mesh-list
25787254|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
25787255|NCT00536978|Tacrolimus|tacrolimus|mesh-list
25787256|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787257|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
25787258|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787259|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787260|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25787261|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
25787262|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787263|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787264|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25787265|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787266|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25787267|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
25787268|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787269|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787270|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
25787271|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787272|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787273|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25787274|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25787275|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
25787276|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787277|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25787278|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25787279|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25787280|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25787281|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25787282|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25787283|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787284|NCT00529282|Vancomycin|vancomycin|mesh-list
25787285|NCT00529282|Cefepime|cefepime|mesh-list
25787286|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
25787287|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25787288|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25787289|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787290|NCT00524134|Carvedilol|carvedilol|mesh-list
25787291|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25787292|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25787293|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787294|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787295|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787296|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787297|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25787298|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
25787299|NCT00524134|Protective Agents|protective agents|mesh-ancestor
25787300|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25787301|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25787302|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25787303|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
25787304|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25787305|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24961921|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787306|NCT00517699|Cytarabine|cytarabine|mesh-list
25787307|NCT00517699|Rituximab|rituximab|mesh-list
25787308|NCT00517699|Methotrexate|methotrexate|mesh-list
25787309|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787310|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787311|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
25787312|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787313|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787314|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25787315|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
25787316|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787317|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787318|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
25787319|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787320|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787321|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787322|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25787323|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787324|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25787325|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
25787326|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787327|NCT00528437|Carboplatin|carboplatin|mesh-list
25787328|NCT00528437|Temozolomide|temozolomide|mesh-list
25787329|NCT00528437|Thiotepa|thiotepa|mesh-list
25787330|NCT00528437|Tretinoin|tretinoin|mesh-list
25787331|NCT00528437|Isotretinoin|isotretinoin|mesh-list
25787332|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787333|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25787334|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
25787335|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787336|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25787337|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787338|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
25787339|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787340|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
25787341|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787342|NCT00527982|Celecoxib|celecoxib|mesh-list
25787343|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25787344|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25787345|NCT00527982|Analgesics|analgesics|mesh-ancestor
25787346|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
25787347|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787348|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787349|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787350|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787351|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25787352|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25787353|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787354|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787355|NCT00524459|Docetaxel|docetaxel|mesh-list
25787356|NCT00524459|Doxorubicin|doxorubicin|mesh-list
25787357|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25787358|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787359|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787360|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787361|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787362|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787363|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25787364|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25787365|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25787366|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787367|NCT00517361|Bevacizumab|bevacizumab|mesh-list
25787368|NCT00517361|Carboplatin|carboplatin|mesh-list
25787369|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787370|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787371|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25787372|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25787373|NCT00517361|Growth Substances|growth substances|mesh-ancestor
25787374|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787375|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
25787376|NCT00523939|Cytarabine|cytarabine|mesh-list
25787377|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052473|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25052474|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25052475|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
25052477|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25787378|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
25787379|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787380|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787381|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
25787382|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787383|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787384|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
25787385|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787386|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
25787387|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787388|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787389|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787390|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787392|NCT00523809|Bevacizumab|bevacizumab|mesh-list
25787393|NCT00523809|Fludarabine|fludarabine|mesh-list
25787394|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
25787395|NCT00523809|Melphalan|melphalan|mesh-list
25787396|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
25787397|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25787398|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787399|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787400|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25787401|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25787402|NCT00523809|Growth Substances|growth substances|mesh-ancestor
25787403|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787404|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
25787405|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787406|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
25787407|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787408|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787409|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
25787410|NCT00523809|Antiviral Agents|antiviral agents|mesh-ancestor
25787411|NCT00523809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787412|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25787413|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
25787414|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25787415|NCT00522301|Sorafenib|sorafenib|mesh-list
25787416|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787417|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787418|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787419|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787420|NCT00517192|Ritonavir|ritonavir|mesh-list
25787421|NCT00517192|Darunavir|darunavir|mesh-list
25787422|NCT00517192|Tipranavir|tipranavir|mesh-list
25787423|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25787424|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25787425|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
25787426|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787427|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787428|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25787429|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25787430|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
25787431|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787432|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25787433|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25787434|NCT00503581|Megestrol|megestrol|mesh-list
25787435|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
25787436|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25787437|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25787438|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25787439|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
25787440|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787441|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787442|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25787443|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25787444|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25787445|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787446|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
25787447|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25787448|NCT00509600|Etanercept|etanercept|mesh-list
25787449|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25787450|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25787451|NCT00509600|Analgesics|analgesics|mesh-ancestor
25787452|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
25787453|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787454|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787455|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787456|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787457|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25787458|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787459|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
25787460|NCT00515112|Testosterone|testosterone|mesh-list
25787461|NCT00515112|Androgens|androgens|mesh-ancestor
25787462|NCT00515112|Hormones|hormones|mesh-ancestor
25787463|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25787464|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787465|NCT00508872|Leucovorin|leucovorin|mesh-list
25787466|NCT00508872|Bevacizumab|bevacizumab|mesh-list
25787467|NCT00508872|Fluorouracil|fluorouracil|mesh-list
25787468|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
25787469|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787470|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787471|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25787472|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25787473|NCT00508872|Growth Substances|growth substances|mesh-ancestor
25787474|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787475|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
25787476|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
25787477|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787478|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787479|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787480|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
25787481|NCT00508872|Antidotes|antidotes|mesh-ancestor
25787482|NCT00508872|Protective Agents|protective agents|mesh-ancestor
25787483|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
25787484|NCT00508872|Vitamins|vitamins|mesh-ancestor
25787485|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
25787486|NCT00506064|Melatonin|melatonin|mesh-list
25787487|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
25787488|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787489|NCT00506064|Protective Agents|protective agents|mesh-ancestor
25787490|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787491|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787492|NCT00503880|Cytarabine|cytarabine|mesh-list
25787493|NCT00503880|Clofarabine|clofarabine|mesh-list
25787494|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787495|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
25787496|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787497|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787498|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
25787499|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787500|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787501|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
25787502|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787503|NCT00501228|Lenograstim|lenograstim|mesh-list
25787504|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25787505|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
25787506|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787507|NCT00496782|Maraviroc|maraviroc|mesh-list
25787508|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25787509|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25787510|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787511|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25787512|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25787513|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
25787514|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787515|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25787516|NCT00506909|Oxytocin|oxytocin|mesh-list
25787517|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
25787518|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787519|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787520|NCT00487578|Naratriptan|naratriptan|mesh-list
25787521|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25787522|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25787523|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25787524|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
25787525|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787526|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787527|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787528|NCT00503009|Fluticasone|fluticasone|mesh-list
25787529|NCT00503009|Xhance|xhance|mesh-list
25787530|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25787531|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787532|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25787533|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
25787534|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787535|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787536|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25787537|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
25787538|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787539|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25787540|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25787541|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25787542|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25787543|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787544|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787545|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787546|NCT00500045|Niacin|niacin|mesh-list
25787547|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
25787548|NCT00500045|Niacinamide|niacinamide|mesh-list
25787549|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25787550|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
25787551|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787552|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25787553|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
25787554|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
25787555|NCT00500045|Vitamins|vitamins|mesh-ancestor
25787556|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
25787557|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787558|NCT00499590|Ranibizumab|ranibizumab|mesh-list
25787559|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25787560|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25787561|NCT00499590|Growth Substances|growth substances|mesh-ancestor
25787562|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787563|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
25787564|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787565|NCT00501345|Aspirin|aspirin|mesh-list
25787566|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25787567|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25787568|NCT00501345|Analgesics|analgesics|mesh-ancestor
25787569|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
25787570|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787571|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787572|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787573|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787574|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25787575|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25787576|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787577|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25787578|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25787579|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787580|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
25787581|NCT00496756|Sorafenib|sorafenib|mesh-list
25787582|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787583|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787584|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787585|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787586|NCT00495716|Acyclovir|acyclovir|mesh-list
25787587|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
25787588|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787589|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
25787590|NCT00500890|Carboplatin|carboplatin|mesh-list
25787591|NCT00500890|Etoposide|etoposide|mesh-list
25787592|NCT00500890|Vincristine|vincristine|mesh-list
25787593|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787594|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
25787595|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787596|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787597|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25787598|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
25048936|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25048939|NCT00657501|Androgens|androgens|mesh-ancestor
25048940|NCT00657501|Hormones|hormones|mesh-ancestor
25000818|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
25000819|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25001103|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787599|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787600|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787601|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25787602|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25787603|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25787604|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25787605|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787606|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787607|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787608|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787609|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25787610|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787611|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787612|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787613|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787614|NCT00493025|Paclitaxel|paclitaxel|mesh-list
25787615|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25787616|NCT00493025|Cisplatin|cisplatin|mesh-list
25787617|NCT00493025|Gefitinib|gefitinib|mesh-list
25787618|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25787619|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787620|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787621|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787622|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787623|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787624|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25787625|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787626|NCT00491400|Atorvastatin|atorvastatin|mesh-list
25787627|NCT00491400|Fenofibrate|fenofibrate|mesh-list
25787628|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25787629|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25787630|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
25787631|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787632|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25787633|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25787634|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787635|NCT00490776|Panobinostat|panobinostat|mesh-list
25787636|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787637|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25787638|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787639|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787640|NCT00487162|Insulin|insulin|mesh-list
25787641|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25787642|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787643|NCT00491387|Metoprolol|metoprolol|mesh-list
25787644|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25787645|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25787646|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
25787647|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
25787648|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787649|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787650|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25787651|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25787652|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25787653|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787654|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787655|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787656|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
25787657|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787658|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
25787659|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
25787660|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25787661|NCT00483119|Antibodies|antibodies|mesh-list
25787662|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
25787663|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25787664|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787665|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
25787666|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787667|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787668|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25787669|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
25787670|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787671|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787672|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25787673|NCT00487461|Simvastatin|simvastatin|mesh-list
25787674|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25787675|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25787677|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787678|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25787679|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25787680|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787681|NCT00484718|Celecoxib|celecoxib|mesh-list
25787682|NCT00484718|Oxycodone|oxycodone|mesh-list
25787683|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25787684|NCT00484718|Narcotics|narcotics|mesh-ancestor
25787685|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787686|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787687|NCT00484718|Analgesics|analgesics|mesh-ancestor
25787688|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
25787689|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787690|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25787691|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25787692|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787693|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787694|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25787695|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25787696|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787697|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787698|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25787699|NCT00470067|Carboplatin|carboplatin|mesh-list
25787700|NCT00470067|Doxorubicin|doxorubicin|mesh-list
25787701|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25787702|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787703|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25787704|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25787705|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25787706|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787707|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787708|NCT00476827|Gemcitabine|gemcitabine|mesh-list
25787709|NCT00476827|Paclitaxel|paclitaxel|mesh-list
25787710|NCT00476827|Vinorelbine|vinorelbine|mesh-list
25787711|NCT00476827|Docetaxel|docetaxel|mesh-list
25787712|NCT00476827|Bevacizumab|bevacizumab|mesh-list
25787713|NCT00476827|Irinotecan|irinotecan|mesh-list
25787714|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25787715|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787716|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787717|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787718|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787719|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787720|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787721|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25787722|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25787723|NCT00476827|Growth Substances|growth substances|mesh-ancestor
25787724|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787725|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
25787726|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787727|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
25787728|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
25787729|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787730|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787731|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787732|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
25787733|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25787734|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25787735|NCT00475657|Cisplatin|cisplatin|mesh-list
25787736|NCT00475657|Pemetrexed|pemetrexed|mesh-list
25787737|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787738|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787739|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787740|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25787741|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25787742|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25787743|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25787744|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
25787745|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787746|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
25787747|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
25787748|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25787749|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25787750|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25787751|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787752|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25787753|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25787754|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
25787755|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787756|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787757|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25787758|NCT00459121|Paclitaxel|paclitaxel|mesh-list
25787759|NCT00459121|Carboplatin|carboplatin|mesh-list
25787760|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25787761|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787762|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787763|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787764|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787765|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787766|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
25787767|NCT00450333|Hematinics|hematinics|mesh-ancestor
25787768|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
25787769|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25787770|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787771|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787772|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25787773|NCT00455143|Analgesics|analgesics|mesh-ancestor
25787774|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
25787775|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787776|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25787777|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25787778|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25787779|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787780|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787781|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787782|NCT00456989|Docetaxel|docetaxel|mesh-list
25787783|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787784|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787785|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787786|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787787|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787788|NCT00448682|Leucovorin|leucovorin|mesh-list
25787789|NCT00448682|Docetaxel|docetaxel|mesh-list
25787790|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
25787791|NCT00448682|Floxuridine|floxuridine|mesh-list
25787792|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
25787793|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787794|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
25787795|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
25787796|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
25787797|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787798|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787799|NCT00448682|Antidotes|antidotes|mesh-ancestor
25787800|NCT00448682|Protective Agents|protective agents|mesh-ancestor
25787801|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
25787802|NCT00448682|Vitamins|vitamins|mesh-ancestor
25787803|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
25787804|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787805|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
25787806|NCT00454571|Leuprolide|leuprolide|mesh-list
25787807|NCT00454571|Goserelin|goserelin|mesh-list
25787808|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25787809|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
25787810|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787811|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787812|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25787813|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787814|NCT00452361|Cyclosporine|cyclosporine|mesh-list
25787815|NCT00452361|Sirolimus|sirolimus|mesh-list
25787816|NCT00452361|Tacrolimus|tacrolimus|mesh-list
25787817|NCT00452361|Cyclosporins|cyclosporins|mesh-list
25787818|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25787819|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787820|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
25787821|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787822|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787823|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987431|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
24796674|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25787824|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
25787825|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787826|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787827|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787828|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25787829|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25787830|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787831|NCT00447421|Cisplatin|cisplatin|mesh-list
25787832|NCT00447421|Pemetrexed|pemetrexed|mesh-list
25787833|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787834|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787835|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787836|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25787837|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25787838|NCT00441272|Pioglitazone|pioglitazone|mesh-list
25787839|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25787840|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787841|NCT00440271|Ritonavir|ritonavir|mesh-list
25787842|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
25787843|NCT00440271|Maraviroc|maraviroc|mesh-list
25787844|NCT00440271|Tipranavir|tipranavir|mesh-list
25787845|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
25787846|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25787847|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25787848|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25787849|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
25787850|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787851|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787852|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25787853|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25787854|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
25787855|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787856|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25787857|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25787858|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25787859|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25787860|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25787861|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25787862|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25787863|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25787864|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25787865|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787866|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
25787867|NCT00429026|Melphalan|melphalan|mesh-list
25787868|NCT00429026|Fludarabine|fludarabine|mesh-list
25787869|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787870|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
25787871|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787872|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787873|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25787874|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
25787875|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787876|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787877|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25787878|NCT00428207|Insulin|insulin|mesh-list
25787879|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25787880|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
25787881|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
25787882|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25787883|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
25787884|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25787885|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787886|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25787887|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787888|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
25787889|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25787890|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787891|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25787892|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
25787893|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25787894|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787895|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787896|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787897|NCT00430027|Capecitabine|capecitabine|mesh-list
25787898|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
25787899|NCT00430027|Cetuximab|cetuximab|mesh-list
25787900|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787901|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
25787902|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787903|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787904|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787905|NCT00429858|Gemcitabine|gemcitabine|mesh-list
25787906|NCT00429858|Tegafur|tegafur|mesh-list
25787907|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787908|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
25787909|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787910|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787911|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
25787912|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787913|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787914|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787915|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
25787916|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787917|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
25787918|NCT00425438|Prednisolone|prednisolone|mesh-list
25787919|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
25787920|NCT00425438|Azathioprine|azathioprine|mesh-list
25787921|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787922|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
25787923|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787924|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787925|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25787926|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
25787927|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787928|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787929|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25787930|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25787931|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25787932|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
25787933|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25787934|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25787935|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787936|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25787937|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
25787938|NCT00425438|Hormones|hormones|mesh-ancestor
25787939|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25787940|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25787941|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
25787942|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787943|NCT00421954|Ziprasidone|ziprasidone|mesh-list
25787944|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25787945|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
25787946|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787947|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787948|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787949|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25787950|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25787951|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787952|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25787953|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25787954|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
25787955|NCT00422942|Rituximab|rituximab|mesh-list
25787956|NCT00422942|Methotrexate|methotrexate|mesh-list
25787957|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25787958|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25787959|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
25787960|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787961|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25787962|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25787963|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
25787964|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25787965|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25787966|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
25787967|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787968|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
25787969|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787970|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25787971|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25787972|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24803017|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25787973|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
25787974|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25787975|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787976|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787977|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25787978|NCT00409344|Analgesics|analgesics|mesh-ancestor
25787979|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
25787980|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787981|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25787982|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25787983|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25787984|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
25787985|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25787986|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25787987|NCT00414453|Lidocaine|lidocaine|mesh-list
25787988|NCT00414453|Oxycodone|oxycodone|mesh-list
25787989|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
25787990|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
25787991|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25787992|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25787993|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
25787994|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25787995|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25787996|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25787997|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25787998|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25787999|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788000|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25788001|NCT00414453|Narcotics|narcotics|mesh-ancestor
25788002|NCT00414453|Analgesics|analgesics|mesh-ancestor
25788003|NCT00417248|Cisplatin|cisplatin|mesh-list
25788004|NCT00417248|Etoposide|etoposide|mesh-list
25788005|NCT00417248|Sorafenib|sorafenib|mesh-list
25788006|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788007|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788008|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25788009|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788010|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788011|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788012|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25788013|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
25788014|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25788015|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25788016|NCT00418145|Prednisolone|prednisolone|mesh-list
25788017|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
25788018|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25788019|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
25788020|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788021|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
25788022|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
25788023|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788024|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788025|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25788026|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
25788027|NCT00418145|Hormones|hormones|mesh-ancestor
25788028|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788029|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25788030|NCT00418145|Protective Agents|protective agents|mesh-ancestor
25788031|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25788032|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788033|NCT00409331|Amifostine|amifostine|mesh-list
25788034|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25788035|NCT00409331|Protective Agents|protective agents|mesh-ancestor
25788036|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788037|NCT00391430|Sertraline|sertraline|mesh-list
25788038|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
25788039|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25788040|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25788041|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25788042|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25788043|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788044|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788045|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
25788046|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788047|NCT00384293|Niacin|niacin|mesh-list
25788048|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25788049|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
25788050|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788051|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25788052|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
25788053|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
25788055|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
25788056|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788057|NCT00374543|Ziprasidone|ziprasidone|mesh-list
25788058|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25788059|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
25788060|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788061|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788062|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788063|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25788064|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25788065|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25788066|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25788067|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25788068|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
24885974|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788069|NCT00377455|Bosentan|bosentan|mesh-list
25788070|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25788071|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25788072|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788073|NCT00369265|Lansoprazole|lansoprazole|mesh-list
25788074|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
25788075|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25788076|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25788077|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25788078|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788079|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788080|NCT00364689|Rifaximin|rifaximin|mesh-list
25788081|NCT00364689|Lactulose|lactulose|mesh-list
25788082|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788083|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788084|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25788085|NCT00352118|Cisplatin|cisplatin|mesh-list
25788086|NCT00352118|Docetaxel|docetaxel|mesh-list
25788087|NCT00352118|Fluorouracil|fluorouracil|mesh-list
25788088|NCT00352118|Lenograstim|lenograstim|mesh-list
25788089|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788090|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788091|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788092|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788093|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788094|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
25788095|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788096|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788097|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
25788098|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788099|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25788100|NCT00368654|Methotrexate|methotrexate|mesh-list
25788101|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25788102|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
25788103|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25788104|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788105|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788106|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
25788107|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788108|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788109|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
25788110|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788111|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25788112|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788113|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
25788114|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788115|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25788116|NCT00356421|Insulin|insulin|mesh-list
25788117|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25788118|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
25788119|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25788120|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788121|NCT00356187|Propranolol|propranolol|mesh-list
25788122|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25788123|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25788124|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
25788125|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788126|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788127|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788128|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25788129|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25788130|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
25788131|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
25788132|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788133|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
25788134|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788135|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788136|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25788137|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25788138|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
25788139|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788140|NCT00319839|Paclitaxel|paclitaxel|mesh-list
25788141|NCT00319839|Cetuximab|cetuximab|mesh-list
25788142|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24890558|NCT04482257|Irinotecan|irinotecan|mesh-list
24890781|NCT04480359|Meloxicam|meloxicam|mesh-list
25788143|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788144|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788145|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788146|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788147|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788148|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788149|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788150|NCT00344019|Atorvastatin|atorvastatin|mesh-list
25788151|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25788152|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25788153|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
25788154|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788155|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25788156|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25788157|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788158|NCT00338455|Dobutamine|dobutamine|mesh-list
25788159|NCT00338455|Milrinone|milrinone|mesh-list
25788160|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25788161|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25788162|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
25788163|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
25788164|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788165|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788166|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25788167|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25788168|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25788169|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
25788170|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788171|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788172|NCT00338455|Protective Agents|protective agents|mesh-ancestor
25788173|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
25788174|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25788175|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
25788176|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25788177|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25788178|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788179|NCT00329108|Olanzapine|olanzapine|mesh-list
25788180|NCT00329108|Ziprasidone|ziprasidone|mesh-list
25788181|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
25788182|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
25788183|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788184|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788185|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25788186|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25788187|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25788188|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25788189|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25788190|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25788191|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25788192|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25788193|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788194|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788195|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
25788196|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25788197|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25788198|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
25788199|NCT00325572|Ascorbic Acid|ascorbic acid|mesh-list
25788200|NCT00325572|Vitamins|vitamins|mesh-ancestor
25788201|NCT00325572|Micronutrients|micronutrients|mesh-ancestor
25788202|NCT00325572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788203|NCT00325572|Antioxidants|antioxidants|mesh-ancestor
25788204|NCT00325572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788205|NCT00325572|Protective Agents|protective agents|mesh-ancestor
25788206|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
25788207|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25788208|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788209|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25788210|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25788211|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25788212|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
25788213|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788214|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788215|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788216|NCT00323635|Urological Agents|urological agents|mesh-ancestor
25788217|NCT00329732|Lidocaine|lidocaine|mesh-list
25788218|NCT00329732|Bupivacaine|bupivacaine|mesh-list
25788219|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
25788220|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
25788221|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25788222|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788223|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
25788224|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788225|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25788226|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25788227|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25788228|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25788229|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788230|NCT00314353|Bevacizumab|bevacizumab|mesh-list
25788231|NCT00314353|Capecitabine|capecitabine|mesh-list
25788232|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
25788233|NCT00314353|Irinotecan|irinotecan|mesh-list
25788234|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788235|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788236|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25788237|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25788238|NCT00314353|Growth Substances|growth substances|mesh-ancestor
25788239|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788240|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
25788241|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788242|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
25788243|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788244|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25788245|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788246|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788247|NCT00314327|Risperidone|risperidone|mesh-list
25788248|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25788249|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
25788250|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788251|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788252|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788253|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25788254|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25788255|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25788256|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25788257|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25788258|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
25788259|NCT00308113|Ubiquinone|ubiquinone|mesh-list
25788260|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
25788261|NCT00308113|Prednisone|prednisone|mesh-list
25788262|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788263|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
25788264|NCT00308113|Hormones|hormones|mesh-ancestor
25788265|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788266|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788267|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25788268|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788269|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
25788270|NCT00308113|Vitamins|vitamins|mesh-ancestor
25788271|NCT00305643|Celecoxib|celecoxib|mesh-list
25788272|NCT00305643|Capecitabine|capecitabine|mesh-list
25788273|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788274|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
25788275|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788276|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788277|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25788278|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25788279|NCT00305643|Analgesics|analgesics|mesh-ancestor
25788280|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
25788281|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788282|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788283|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788284|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788285|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25788286|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25788287|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788288|NCT00298740|Insulin|insulin|mesh-list
25788289|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25788290|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788291|NCT00301080|Cycloserine|cycloserine|mesh-list
25788292|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25788293|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788294|NCT00301080|Renal Agents|renal agents|mesh-ancestor
25788295|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25788296|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
25788297|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788298|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
25788299|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788300|NCT00299195|Sulindac|sulindac|mesh-list
25788301|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25788302|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25788303|NCT00299195|Analgesics|analgesics|mesh-ancestor
25788304|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
25788305|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788306|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788307|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788308|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788309|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788310|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25788311|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788312|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788313|NCT00290407|Rituximab|rituximab|mesh-list
25788314|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788315|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788316|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
25788317|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788318|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788319|NCT00268463|Capecitabine|capecitabine|mesh-list
25788320|NCT00268463|Floxuridine|floxuridine|mesh-list
25788321|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
25788322|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788323|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
25788324|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788325|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788326|NCT00276419|Diclofenac|diclofenac|mesh-list
25788327|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25788328|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25788329|NCT00276419|Analgesics|analgesics|mesh-ancestor
25788330|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
25788331|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788332|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788333|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788334|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788335|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25788336|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788337|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788338|NCT00279409|Aripiprazole|aripiprazole|mesh-list
25788339|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
25788340|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25788341|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25788342|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25788343|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25788344|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788345|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
25788346|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
25788347|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788348|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788349|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25788350|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25788351|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
25788352|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25788353|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25788354|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25788355|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25788356|NCT00281879|Cytarabine|cytarabine|mesh-list
25788357|NCT00281879|Cyclosporine|cyclosporine|mesh-list
25788358|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
25788359|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
25788360|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
25788361|NCT00281879|Melphalan|melphalan|mesh-list
25788362|NCT00281879|Busulfan|busulfan|mesh-list
25788363|NCT00281879|Carmustine|carmustine|mesh-list
25788364|NCT00281879|Methotrexate|methotrexate|mesh-list
25788365|NCT00281879|Fludarabine|fludarabine|mesh-list
25788366|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
25788367|NCT00281879|Etoposide|etoposide|mesh-list
25788368|NCT00281879|Tacrolimus|tacrolimus|mesh-list
25788369|NCT00281879|Cyclosporins|cyclosporins|mesh-list
25788370|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25788371|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788372|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
25788373|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788374|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788375|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25788376|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
25788377|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788378|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788379|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25788380|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25788381|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
25788382|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25788383|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788384|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
25788385|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
25788386|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788387|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25788388|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25788389|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788390|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25788391|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788392|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
25788393|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788394|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25788395|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
25788396|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25788397|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25788398|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
25788399|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788400|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788401|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
25788402|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
25788403|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788404|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25788405|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
25788406|NCT00281879|Hormones|hormones|mesh-ancestor
25788407|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788408|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25788409|NCT00281879|Protective Agents|protective agents|mesh-ancestor
25788410|NCT00271011|Irinotecan|irinotecan|mesh-list
25788411|NCT00271011|Cetuximab|cetuximab|mesh-list
25788412|NCT00271011|Mitomycins|mitomycins|mesh-list
25788413|NCT00271011|Mitomycin|mitomycin|mesh-list
25788414|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25788415|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788416|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788417|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788418|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788419|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788420|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25788421|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
25788422|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25788423|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25788424|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
25788425|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788426|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25788427|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
25788428|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788429|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788430|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25788431|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25788432|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25788433|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
25788434|NCT00256295|Gemcitabine|gemcitabine|mesh-list
25788435|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
25788436|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788437|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
25788438|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788439|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788440|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
25788441|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788442|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788443|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788444|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
25788445|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788446|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
25788447|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788448|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25788449|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788450|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788451|NCT00268450|Gemcitabine|gemcitabine|mesh-list
25788452|NCT00268450|Paclitaxel|paclitaxel|mesh-list
25788453|NCT00268450|Bevacizumab|bevacizumab|mesh-list
25788454|NCT00268450|Cisplatin|cisplatin|mesh-list
25788455|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788456|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788457|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788458|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788459|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788460|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788461|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788462|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25788463|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25788464|NCT00268450|Growth Substances|growth substances|mesh-ancestor
25788465|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788466|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
25788467|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788468|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
25788469|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
25788470|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788471|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788472|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788473|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
25788474|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
25788475|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
25788476|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788477|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788478|NCT00250718|Levofloxacin|levofloxacin|mesh-list
25788479|NCT00250718|Ofloxacin|ofloxacin|mesh-list
25788480|NCT00250718|Dexamethasone|dexamethasone|mesh-list
25788481|NCT00250718|Rituximab|rituximab|mesh-list
25788482|NCT00250718|Etoposide|etoposide|mesh-list
25788483|NCT00250718|Vincristine|vincristine|mesh-list
25788484|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788485|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788486|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
25788487|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788488|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788489|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788490|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
25788491|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
25788492|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788493|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25788494|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
25788495|NCT00250718|Hormones|hormones|mesh-ancestor
25788496|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788497|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25788498|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788499|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25788500|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788501|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788502|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788503|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788504|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788505|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788506|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25788507|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788508|NCT00250718|Renal Agents|renal agents|mesh-ancestor
25788509|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788510|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25788511|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25788512|NCT00218036|Dexetimide|dexetimide|mesh-list
25788513|NCT00218036|Modafinil|modafinil|mesh-list
25788514|NCT00218036|Citalopram|citalopram|mesh-list
25788515|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25788516|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25788517|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25788518|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788519|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788520|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
25788521|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788522|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25788523|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
25788524|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25788525|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25788526|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25788527|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
25788528|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
25788529|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788530|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25788531|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25788532|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
25788533|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25788534|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25788535|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25788536|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25788537|NCT00240227|Prazosin|prazosin|mesh-list
25788538|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25788539|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25788540|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25788541|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25788542|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
25788543|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788544|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788545|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788546|NCT00206375|Hormones|hormones|mesh-list
25788547|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788548|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788549|NCT00229931|Triamcinolone|triamcinolone|mesh-list
25788550|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25788551|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25788552|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25788553|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788554|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
25788555|NCT00229931|Hormones|hormones|mesh-ancestor
25788556|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788557|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788558|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788559|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
25788560|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788561|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788562|NCT00209131|Tamsulosin|tamsulosin|mesh-list
25788563|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25788564|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25788565|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25788566|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
25788567|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788568|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788569|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788570|NCT00209131|Urological Agents|urological agents|mesh-ancestor
25788571|NCT00233090|Modafinil|modafinil|mesh-list
25788572|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25788573|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788574|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25788575|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25788576|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25788577|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788578|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
25788579|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25788580|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788581|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788582|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25788583|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25788584|NCT00205049|Protective Agents|protective agents|mesh-ancestor
25788585|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788586|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
25788587|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25788588|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
25788589|NCT00209027|Aripiprazole|aripiprazole|mesh-list
25788590|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
25788591|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24962754|NCT03795597|Busulfan|busulfan|mesh-list
25788592|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25788593|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25788594|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25788595|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788596|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
25788597|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
25788598|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788599|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788600|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25788601|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25788602|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
25788603|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25788604|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25788605|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25788606|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25788607|NCT00182637|Bortezomib|bortezomib|mesh-list
25788608|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788609|NCT00176488|Vinorelbine|vinorelbine|mesh-list
25788610|NCT00176488|Epirubicin|epirubicin|mesh-list
25788611|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788612|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788613|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788614|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788615|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788616|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788617|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25788618|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25788619|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788620|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788621|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
25788622|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25788623|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788624|NCT00183963|Tamoxifen|tamoxifen|mesh-list
25788625|NCT00183963|Fulvestrant|fulvestrant|mesh-list
25788626|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25788627|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
25788628|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788629|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788630|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25788631|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788632|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25788633|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25788634|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25788635|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25788636|NCT00162773|Omalizumab|omalizumab|mesh-list
25788637|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25788638|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25788639|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
25788640|NCT00176631|Docetaxel|docetaxel|mesh-list
25788641|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788642|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788643|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788644|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788645|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788646|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
25788647|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25788648|NCT00177970|Antibodies|antibodies|mesh-list
25788649|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
25788650|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
25788651|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25788652|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
25788653|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788654|NCT00177866|Celecoxib|celecoxib|mesh-list
25788655|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25788656|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25788657|NCT00177866|Analgesics|analgesics|mesh-ancestor
25788658|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
25788659|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788660|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788661|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788662|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788663|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25788664|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25788665|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788666|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788668|NCT00165503|Cisplatin|cisplatin|mesh-list
25788669|NCT00165503|Pemetrexed|pemetrexed|mesh-list
25788670|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788671|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788672|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788673|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25788674|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25788675|NCT00165503|Antidotes|antidotes|mesh-ancestor
25788676|NCT00165503|Protective Agents|protective agents|mesh-ancestor
25788677|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788678|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
25788679|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
25788680|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788681|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788682|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
25788683|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
25788684|NCT00160563|Levocetirizine|levocetirizine|mesh-list
25788685|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25788686|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25788687|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
25788688|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
25788689|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788690|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788691|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788692|NCT00142519|Morphine|morphine|mesh-list
25788693|NCT00142519|Methadone|methadone|mesh-list
25788694|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25788695|NCT00142519|Narcotics|narcotics|mesh-ancestor
25788696|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25788697|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788698|NCT00142519|Analgesics|analgesics|mesh-ancestor
25788699|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
25788700|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788701|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
25788702|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
25788703|NCT00145704|Vitamin D|vitamin d|mesh-list
25788704|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
25788705|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
25788706|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
25788707|NCT00145704|Diphosphonates|diphosphonates|mesh-list
25788708|NCT00145704|Vitamins|vitamins|mesh-list
25788709|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
25788710|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788711|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25788712|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25788713|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25788714|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25788715|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788716|NCT00113386|Cisplatin|cisplatin|mesh-list
25788717|NCT00113386|Docetaxel|docetaxel|mesh-list
25788718|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788719|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788720|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788721|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788722|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788723|NCT00138151|Interferons|interferons|mesh-list
25788724|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
25788725|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
25788726|NCT00138151|Paclitaxel|paclitaxel|mesh-list
25788727|NCT00138151|Isotretinoin|isotretinoin|mesh-list
25788728|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788729|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788730|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788731|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788732|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788733|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788734|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
25788735|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788736|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
25788737|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788738|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25788739|NCT00129974|Gemcitabine|gemcitabine|mesh-list
25788740|NCT00129974|Pemetrexed|pemetrexed|mesh-list
25788741|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788742|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
25788743|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788744|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788745|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
25788746|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788747|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788748|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788749|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
25788750|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788751|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25788752|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25788753|NCT00126659|Sorafenib|sorafenib|mesh-list
25788754|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788755|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25788756|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788757|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788758|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
25788759|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
25788760|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25788761|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25788762|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788763|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788764|NCT00133679|Urological Agents|urological agents|mesh-ancestor
25788765|NCT00113399|Paclitaxel|paclitaxel|mesh-list
25788766|NCT00113399|Docetaxel|docetaxel|mesh-list
25788767|NCT00113399|Cisplatin|cisplatin|mesh-list
25788768|NCT00113399|Fluorouracil|fluorouracil|mesh-list
25788769|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788770|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788771|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788772|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788773|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788774|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788775|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
25788776|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788777|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788778|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
25788779|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788780|NCT00118053|Carboplatin|carboplatin|mesh-list
25788781|NCT00118053|Docetaxel|docetaxel|mesh-list
25788782|NCT00118053|Trastuzumab|trastuzumab|mesh-list
25788783|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788784|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788785|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788786|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788787|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788788|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788789|NCT00107614|Rituximab|rituximab|mesh-list
25788790|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788791|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788792|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
25788793|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788794|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788795|NCT00107315|Bevacizumab|bevacizumab|mesh-list
25788796|NCT00107315|Capecitabine|capecitabine|mesh-list
25788797|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25788798|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788799|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25788800|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25788801|NCT00107315|Growth Substances|growth substances|mesh-ancestor
25788802|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788803|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
25788804|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788805|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
25788806|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788807|NCT00108433|Vancomycin|vancomycin|mesh-list
25788808|NCT00108433|Cefazolin|cefazolin|mesh-list
25788809|NCT00108433|Linezolid|linezolid|mesh-list
25788810|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788811|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788812|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25788813|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788814|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788815|NCT00113919|Busulfan|busulfan|mesh-list
25788816|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
25788817|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788818|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788819|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
25788820|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788821|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25788822|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788823|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25788824|NCT00108342|Nicotine|nicotine|mesh-list
25788825|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25788826|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
25788827|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788828|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788829|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25788830|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25788831|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
25788832|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788833|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788834|NCT00100828|Irinotecan|irinotecan|mesh-list
25788835|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25788836|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788837|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788838|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788839|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788840|NCT00104728|Gefitinib|gefitinib|mesh-list
25788841|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788842|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25788843|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788844|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788845|NCT00089414|Drospirenone|drospirenone|mesh-list
25788846|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25788847|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25788848|NCT00089414|Estradiol|estradiol|mesh-list
25788849|NCT00089414|Progesterone|progesterone|mesh-list
25788850|NCT00089414|Estrogens|estrogens|mesh-ancestor
25788851|NCT00089414|Hormones|hormones|mesh-ancestor
25788852|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788853|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788854|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25788855|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
25788856|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25788857|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25788858|NCT00089414|Progestins|progestins|mesh-ancestor
25788859|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25788860|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25788861|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25788862|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
25788863|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25788864|NCT00089414|Diuretics|diuretics|mesh-ancestor
25788865|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
25788866|NCT00083915|Thalidomide|thalidomide|mesh-list
25788867|NCT00083915|Dexamethasone|dexamethasone|mesh-list
25788868|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
25788869|NCT00083915|Melphalan|melphalan|mesh-list
25788870|NCT00083915|Cisplatin|cisplatin|mesh-list
25788871|NCT00083915|Doxorubicin|doxorubicin|mesh-list
25788872|NCT00083915|Etoposide|etoposide|mesh-list
25788873|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25788874|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788875|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
25788876|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788877|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788878|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25788879|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
25788880|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788881|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788882|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25788883|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788884|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
25788885|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
25788886|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788887|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25788888|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
25788889|NCT00083915|Hormones|hormones|mesh-ancestor
25788890|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788891|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25788892|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25788893|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25788894|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788895|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788896|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788897|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
25788898|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788899|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788900|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25788901|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25788902|NCT00083915|Growth Substances|growth substances|mesh-ancestor
25788903|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
25788904|NCT00090870|Interferons|interferons|mesh-list
25788905|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
25788906|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
25788907|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25788908|NCT00090870|Thalidomide|thalidomide|mesh-list
25788909|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788910|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
25788911|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788912|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
25788913|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788914|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788915|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
25788916|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788917|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25788918|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25788919|NCT00090870|Growth Substances|growth substances|mesh-ancestor
25788920|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
25788921|NCT00088972|Celecoxib|celecoxib|mesh-list
25788922|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25788923|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25788924|NCT00088972|Analgesics|analgesics|mesh-ancestor
25788925|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
25788926|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788927|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788928|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25788929|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25788930|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25788931|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25788932|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788933|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788934|NCT00088829|Paclitaxel|paclitaxel|mesh-list
25788935|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25788936|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25788937|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788938|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
25788939|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
25788940|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
25788941|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788942|NCT00089128|Gemcitabine|gemcitabine|mesh-list
25788943|NCT00089128|Irinotecan|irinotecan|mesh-list
25788944|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25788945|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
25788946|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788947|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788948|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
25788949|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788950|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788951|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788952|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
25788953|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788954|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25788955|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25788956|NCT00075608|Melphalan|melphalan|mesh-list
25788957|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
25788958|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788959|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25788960|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
25788961|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788962|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788963|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25788964|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788965|NCT00074724|Dobutamine|dobutamine|mesh-list
25788966|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25788967|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
25788968|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
25788969|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25788970|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788971|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25788972|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25788973|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25788974|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
25788975|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25788976|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788977|NCT00074724|Protective Agents|protective agents|mesh-ancestor
25788978|NCT00085631|Cisplatin|cisplatin|mesh-list
25788979|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788980|NCT00062751|Sirolimus|sirolimus|mesh-list
25788981|NCT00062751|Letrozole|letrozole|mesh-list
25788982|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25788983|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25788984|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25788985|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25788986|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25788987|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25788988|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
25788989|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25788990|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25788991|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25788992|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788993|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25788994|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
25788995|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25788996|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
25788997|NCT00066807|Tamoxifen|tamoxifen|mesh-list
25788998|NCT00066807|Epirubicin|epirubicin|mesh-list
25788999|NCT00066807|Exemestane|exemestane|mesh-list
25789000|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25789001|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25789002|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789003|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25789004|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25789005|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789006|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789007|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25789008|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
25789009|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789010|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789011|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25789012|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25789013|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25789014|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25789015|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25789016|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25789017|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
25789018|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25789019|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
25789020|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25789021|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25789022|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
25789023|NCT00058188|Vitamin D|vitamin d|mesh-list
25789024|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
25789025|NCT00058188|Calcium|calcium|mesh-list
25789026|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25789027|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789028|NCT00058188|Vitamins|vitamins|mesh-ancestor
25789029|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
25789030|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25789031|NCT00014560|Antibodies|antibodies|mesh-list
25789032|NCT00014560|Sargramostim|sargramostim|mesh-list
25789033|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25789034|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
25789035|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789036|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
25789037|NCT00038142|Doxorubicin|doxorubicin|mesh-list
25789038|NCT00038142|Vincristine|vincristine|mesh-list
25789039|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
25789040|NCT00038142|Razoxane|razoxane|mesh-list
25789041|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25789042|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
25789043|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789044|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789045|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25789046|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
25789047|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789048|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789049|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25789050|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25789051|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25789052|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25789053|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789054|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25789055|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
25789056|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
25789057|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
25789058|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25789059|NCT00038142|Protective Agents|protective agents|mesh-ancestor
25789060|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
25789061|NCT00020722|Ifosfamide|ifosfamide|mesh-list
25789062|NCT00020722|Thiotepa|thiotepa|mesh-list
25789063|NCT00020722|Carboplatin|carboplatin|mesh-list
25789064|NCT00020722|Etoposide|etoposide|mesh-list
25789065|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
25789066|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25789067|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
25789068|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789069|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789070|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25789071|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
25789072|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166962|NCT03540758|Vitamins|vitamins|mesh-ancestor
25789073|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789074|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25789075|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25789076|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25789077|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25789078|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789079|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25789080|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25789081|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
25789082|NCT00006478|Sargramostim|sargramostim|mesh-list
25789083|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25789084|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
25789085|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789086|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25789087|NCT00019747|Thalidomide|thalidomide|mesh-list
25789088|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25789089|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
25789090|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789091|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
25789092|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25789093|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25789094|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25789095|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25789096|NCT00019747|Growth Substances|growth substances|mesh-ancestor
25789097|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
25789098|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789099|NCT00006916|Bleomycin|bleomycin|mesh-list
25789100|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25789101|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789102|NCT00003726|Lepirudin|lepirudin|mesh-list
25789103|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
25789104|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25789105|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
25789106|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789107|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789108|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
25789109|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789110|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789111|NCT04051996|Decitabine|decitabine|mesh-list
25789112|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25789113|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
25789114|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789115|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789116|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789117|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25789118|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789119|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
25789120|NCT02126878|Hormones|hormones|mesh-ancestor
25789121|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789122|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789123|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25789124|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
25789125|NCT02595996|Propranolol|propranolol|mesh-list
25789126|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25789127|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25789128|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25789129|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789130|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789131|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789132|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25789133|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25789134|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
25789135|NCT02009384|Ipilimumab|ipilimumab|mesh-list
25789136|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25789137|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789138|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25789139|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789140|NCT04558125|Heparin|heparin|mesh-list
25789141|NCT04558125|Calcium heparin|calcium heparin|mesh-list
25789142|NCT04558125|Enoxaparin|enoxaparin|mesh-list
25789143|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25789144|NCT04558125|Tinzaparin|tinzaparin|mesh-list
25789145|NCT04558125|Dalteparin|dalteparin|mesh-list
25789146|NCT04558125|Tenecteplase|tenecteplase|mesh-list
25789147|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
25789148|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
25789149|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789150|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789151|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789152|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
25789153|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
25789154|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25789155|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25789156|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25789157|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789158|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789159|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789160|NCT00521885|Enoxaparin|enoxaparin|mesh-list
25789161|NCT00521885|Fondaparinux|fondaparinux|mesh-list
25789162|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
25789163|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789164|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789165|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789166|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25789167|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
25789168|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25789169|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
25789170|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789171|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
25789172|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25789173|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789174|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789175|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
25789176|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789177|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789178|NCT00479167|Bortezomib|bortezomib|mesh-list
25789179|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
25789180|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789181|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
25789182|NCT02212574|Lomustine|lomustine|mesh-list
25789183|NCT02212574|Cisplatin|cisplatin|mesh-list
25789184|NCT02212574|Vincristine|vincristine|mesh-list
25789185|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25789186|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
25789187|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789188|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789189|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25789190|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
25789191|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789192|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789193|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25789194|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25789195|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
25789196|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
25789197|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
25789198|NCT04422210|Carboplatin|carboplatin|mesh-list
25789199|NCT04422210|Etoposide|etoposide|mesh-list
25789200|NCT04422210|Atezolizumab|atezolizumab|mesh-list
25789201|NCT04422210|Venetoclax|venetoclax|mesh-list
25789202|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789203|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25789204|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25789205|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25789206|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789207|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789208|NCT04298918|Trastuzumab|trastuzumab|mesh-list
25789209|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25789210|NCT04298918|Venetoclax|venetoclax|mesh-list
25789211|NCT04298918|Maytansine|maytansine|mesh-list
25789212|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25789213|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789214|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25789215|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25789216|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
25789217|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25789218|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789219|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
25789220|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25789221|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789222|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
25789223|NCT00955929|Alprostadil|alprostadil|mesh-list
25789224|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
25789225|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25789226|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25789227|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789228|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789229|NCT00955929|Urological Agents|urological agents|mesh-ancestor
25789230|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25789231|NCT00402883|Folic Acid|folic acid|mesh-list
25789232|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
25789233|NCT00402883|Hydroxocobalamin|hydroxocobalamin|mesh-list
25789234|NCT00402883|Bevacizumab|bevacizumab|mesh-list
25789235|NCT00402883|Carboplatin|carboplatin|mesh-list
25789236|NCT00402883|Pemetrexed|pemetrexed|mesh-list
25789237|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25789238|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789239|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25789240|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25789241|NCT00402883|Growth Substances|growth substances|mesh-ancestor
25789242|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789243|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
25789244|NCT00402883|Vitamins|vitamins|mesh-ancestor
25789245|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
25789246|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789247|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789248|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25789249|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25789250|NCT00402883|Hematinics|hematinics|mesh-ancestor
25789251|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
25789252|NCT02934503|Cisplatin|cisplatin|mesh-list
25789253|NCT02934503|Carboplatin|carboplatin|mesh-list
25789254|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
25789255|NCT02934503|Etoposide|etoposide|mesh-list
25789256|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789257|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25789258|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25789259|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25789260|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25789261|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789262|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789263|NCT02137252|Naltrexone|naltrexone|mesh-list
25789264|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25789265|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789266|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789267|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
25789268|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789269|NCT01294670|Etoposide|etoposide|mesh-list
25789270|NCT01294670|Vorinostat|vorinostat|mesh-list
25789271|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25789272|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789273|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25789274|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25789275|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789276|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789277|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25789278|NCT03095287|Factor VIII|factor viii|mesh-list
25789279|NCT03095287|Coagulants|coagulants|mesh-ancestor
25789280|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25789281|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789282|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25789283|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
25789284|NCT00000105|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25789285|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25789286|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
25789287|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789288|NCT00000114|Vitamins|vitamins|mesh-list
25789289|NCT00000114|Vitamin E|vitamin e|mesh-list
25789290|NCT00000114|Vitamin A|vitamin a|mesh-list
25789291|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
25789292|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789293|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
25789294|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789295|NCT00000114|Protective Agents|protective agents|mesh-ancestor
25789296|NCT00000115|Acetazolamide|acetazolamide|mesh-list
25789297|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
25789298|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25789299|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789300|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789301|NCT00000115|Diuretics|diuretics|mesh-ancestor
25789302|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
25789303|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789304|NCT00000116|Vitamin A|vitamin a|mesh-list
25789305|NCT00000116|Vitamins|vitamins|mesh-ancestor
25789306|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
25789307|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789308|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
25789309|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25789310|NCT00000117|Antibodies|antibodies|mesh-list
25789311|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
25789312|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789313|NCT00000119|Heparin|heparin|mesh-list
25789314|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
25789315|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789316|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789317|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789318|NCT00000120|Erythromycin|erythromycin|mesh-list
25789319|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
25789320|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25789321|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
25789322|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
25789323|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25789324|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25789325|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25789326|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25789327|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789328|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789329|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25789330|NCT00000122|Fluorouracil|fluorouracil|mesh-list
25789331|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
25789332|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789333|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25789334|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789335|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25789336|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
25789337|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789338|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25789339|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
25789340|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25789341|NCT00000123|Protective Agents|protective agents|mesh-ancestor
25789342|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789343|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25789344|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25789345|NCT00000132|Betaxolol|betaxolol|mesh-list
25789346|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25789347|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
25789348|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
25789349|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789350|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789351|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25789352|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25789353|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25789354|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
25789355|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789356|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789357|NCT00000138|Acyclovir|acyclovir|mesh-list
25789358|NCT00000138|Prednisolone|prednisolone|mesh-list
25789359|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25789360|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
25789361|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25789362|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
25789363|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25789364|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
25789365|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789366|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
25789367|NCT00000138|Hormones|hormones|mesh-ancestor
25789368|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789369|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789370|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25789371|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789372|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
25789373|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
25789374|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789375|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25789376|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789377|NCT00000138|Protective Agents|protective agents|mesh-ancestor
25789378|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
25789379|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25789380|NCT00000139|Acyclovir|acyclovir|mesh-list
25789381|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
25789382|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25789383|NCT00000145|Zinc|zinc|mesh-list
25789384|NCT00000145|Antioxidants|antioxidants|mesh-list
25789385|NCT00000145|Trace Elements|trace elements|mesh-ancestor
25789386|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
25789387|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789388|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789389|NCT00000145|Protective Agents|protective agents|mesh-ancestor
25789390|NCT00000146|Prednisone|prednisone|mesh-list
25789391|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
25789392|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25789393|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25789394|NCT00000146|Prednisolone|prednisolone|mesh-list
25789395|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
25789396|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25789397|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
25789398|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789399|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
25789400|NCT00000146|Hormones|hormones|mesh-ancestor
25789401|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789402|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789403|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25789404|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789405|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
25789406|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
25789407|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789408|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25789409|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789410|NCT00000146|Protective Agents|protective agents|mesh-ancestor
25789411|NCT00000147|Prednisone|prednisone|mesh-list
25789412|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
25789413|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25789414|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25789415|NCT00000147|Prednisolone|prednisolone|mesh-list
25789416|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
25789417|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25789418|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
25789419|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789420|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
25789421|NCT00000147|Hormones|hormones|mesh-ancestor
25789422|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789423|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789424|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25789425|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789426|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
25789427|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
25789428|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789429|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25789430|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789431|NCT00000147|Protective Agents|protective agents|mesh-ancestor
25789432|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25789433|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25789434|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
25789435|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789436|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789437|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789438|NCT00000151|Aspirin|aspirin|mesh-list
25789439|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25789440|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25789441|NCT00000151|Analgesics|analgesics|mesh-ancestor
25789442|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
25789443|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789444|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789445|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789446|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789447|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789448|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789449|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789450|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25789451|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25789452|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789453|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
25789454|NCT00000152|Aspirin|aspirin|mesh-list
25789455|NCT00000152|Beta Carotene|beta carotene|mesh-list
25789457|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25789458|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25789459|NCT00000152|Analgesics|analgesics|mesh-ancestor
25789460|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
25789461|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789462|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789463|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789464|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789465|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789466|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789467|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789468|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25789469|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25789470|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789471|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
25789472|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
25789473|NCT00000152|Protective Agents|protective agents|mesh-ancestor
25789474|NCT00000152|Provitamins|provitamins|mesh-ancestor
25789475|NCT00000152|Vitamins|vitamins|mesh-ancestor
25789476|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
25789478|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25789479|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25789480|NCT00000157|Analgesics|analgesics|mesh-ancestor
25789481|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
25789482|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789483|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789484|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789485|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789486|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789487|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789488|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789489|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25789490|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25789491|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789492|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
25789493|NCT00000160|Xenon|xenon|mesh-list
25789494|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25789495|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
25789496|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
25789497|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789498|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789499|NCT00000161|Aspirin|aspirin|mesh-list
25789500|NCT00000161|Vitamins|vitamins|mesh-list
25789501|NCT00000161|Ascorbic Acid|ascorbic acid|mesh-list
25789502|NCT00000161|Vitamin E|vitamin e|mesh-list
25789503|NCT00000161|Beta Carotene|beta carotene|mesh-list
25789504|NCT00000161|Carotenoids|carotenoids|mesh-list
25789505|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
25789506|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789507|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25789508|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25789509|NCT00000161|Analgesics|analgesics|mesh-ancestor
25789510|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
25789511|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789512|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789513|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789514|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25789515|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25789516|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789517|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25789518|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25789519|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789520|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
25789521|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
25789522|NCT00000161|Protective Agents|protective agents|mesh-ancestor
25789523|NCT00000161|Provitamins|provitamins|mesh-ancestor
25789524|NCT00000170|Atropine|atropine|mesh-list
25789525|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25789526|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25789527|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25789528|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
25789529|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789530|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789531|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25789532|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
25789533|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
25789534|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
25789535|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25789536|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25789537|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
25789538|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789539|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789540|NCT00000171|Melatonin|melatonin|mesh-list
25789541|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
25789542|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789543|NCT00000171|Protective Agents|protective agents|mesh-ancestor
25789544|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789545|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789546|NCT00000172|Galantamine|galantamine|mesh-list
25789547|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25789548|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789549|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789550|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
25789551|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789552|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789553|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25789554|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
25789555|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789556|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
25789557|NCT00000173|Vitamin E|vitamin e|mesh-list
25789558|NCT00000173|Donepezil|donepezil|mesh-list
25789559|NCT00000173|Vitamins|vitamins|mesh-ancestor
25789560|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
25789561|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789562|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25789563|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789564|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789565|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
25789566|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789567|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
25789568|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
25789569|NCT00000173|Protective Agents|protective agents|mesh-ancestor
25789570|NCT00000174|Rivastigmine|rivastigmine|mesh-list
25789571|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25789572|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789573|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789574|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
25789575|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789576|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789577|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789578|NCT00000174|Protective Agents|protective agents|mesh-ancestor
25789579|NCT00000175|Testosterone|testosterone|mesh-list
25789580|NCT00000175|Estrogens|estrogens|mesh-list
25789581|NCT00000175|Androgens|androgens|mesh-ancestor
25789582|NCT00000175|Hormones|hormones|mesh-ancestor
25789583|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789584|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789585|NCT00000176|Progesterone|progesterone|mesh-list
25789586|NCT00000176|Estrogens|estrogens|mesh-list
25789587|NCT00000176|Progestins|progestins|mesh-ancestor
25789588|NCT00000176|Hormones|hormones|mesh-ancestor
25789589|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789590|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789591|NCT00000177|Estrogens|estrogens|mesh-list
25789592|NCT00000177|Hormones|hormones|mesh-ancestor
25789593|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789594|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789595|NCT00000178|Prednisone|prednisone|mesh-list
25789596|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25789597|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
25789598|NCT00000178|Hormones|hormones|mesh-ancestor
25789599|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25789600|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789601|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25789602|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25789603|NCT00000179|Haloperidol|haloperidol|mesh-list
25789604|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
25789605|NCT00000179|Trazodone|trazodone|mesh-list
25789606|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
25789607|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
25789608|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789609|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789610|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25789611|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25789612|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25789613|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789614|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789615|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25789616|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
25789617|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789618|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789619|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25789620|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25789621|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25789622|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25789623|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789624|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
25789625|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25167647|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25167648|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
25789626|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
25789627|NCT00000187|Ritanserin|ritanserin|mesh-list
25789628|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25789629|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
25789630|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789631|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789632|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789633|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25789634|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25789635|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789636|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789637|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25789638|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25789639|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
25789641|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
25789642|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789643|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25789644|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25789645|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25789646|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789647|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789648|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789649|NCT00000188|Protective Agents|protective agents|mesh-ancestor
25789650|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789651|NCT00000189|Gepirone|gepirone|mesh-list
25789652|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
25789653|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789654|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25789655|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25789656|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789657|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789658|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25789659|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
25789660|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789661|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789662|NCT00000191|Carbamazepine|carbamazepine|mesh-list
25789663|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
25789664|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
25789665|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25789666|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789667|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789668|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789669|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25789670|NCT00000191|Analgesics|analgesics|mesh-ancestor
25789671|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
25789672|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789673|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25789674|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789675|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789676|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25789677|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25789678|NCT00000192|Lamotrigine|lamotrigine|mesh-list
25789679|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
25789680|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25789681|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789682|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789683|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25789684|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789685|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25789686|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25789687|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789688|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789689|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25789690|NCT00000194|Cycloserine|cycloserine|mesh-list
25789691|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25789692|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25789693|NCT00000194|Renal Agents|renal agents|mesh-ancestor
25789694|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25789695|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
25789696|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25789697|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
25789698|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789699|NCT00000195|Naltrexone|naltrexone|mesh-list
24767349|NCT01800357|Aspirin|aspirin|mesh-list
25789700|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25789701|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789702|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789703|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
25789704|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789705|NCT00000196|Naltrexone|naltrexone|mesh-list
25789706|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25789707|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789708|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789709|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
25789710|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789711|NCT00000197|Propranolol|propranolol|mesh-list
25789712|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25789713|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25789714|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
25789715|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789716|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789717|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789718|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25789719|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25789720|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
25789721|NCT00000198|Piracetam|piracetam|mesh-list
25789722|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789723|NCT00000198|Protective Agents|protective agents|mesh-ancestor
25789724|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789725|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
25789726|NCT00000199|Piracetam|piracetam|mesh-list
25789727|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789728|NCT00000199|Protective Agents|protective agents|mesh-ancestor
25789729|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789730|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
25789731|NCT00000200|Methadone|methadone|mesh-list
25789732|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789733|NCT00000200|Narcotics|narcotics|mesh-ancestor
25789734|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789735|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789736|NCT00000200|Analgesics|analgesics|mesh-ancestor
25789737|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
25789738|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789739|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
25789740|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
25789741|NCT00000201|Selegiline|selegiline|mesh-list
25789742|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
25789743|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789744|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25789745|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25789746|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25789747|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789748|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789749|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25789750|NCT00000201|Protective Agents|protective agents|mesh-ancestor
25789751|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789752|NCT00000202|Buprenorphine|buprenorphine|mesh-list
25789753|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789754|NCT00000202|Narcotics|narcotics|mesh-ancestor
25789755|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789756|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789757|NCT00000202|Analgesics|analgesics|mesh-ancestor
25789758|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
25789759|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789760|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789761|NCT00000203|Buprenorphine|buprenorphine|mesh-list
25789762|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789763|NCT00000203|Narcotics|narcotics|mesh-ancestor
25789764|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789765|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789766|NCT00000203|Analgesics|analgesics|mesh-ancestor
25789767|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
25789768|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789769|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789770|NCT00000204|Buprenorphine|buprenorphine|mesh-list
25789771|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789772|NCT00000204|Narcotics|narcotics|mesh-ancestor
25789773|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789774|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789775|NCT00000204|Analgesics|analgesics|mesh-ancestor
25789776|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
25789777|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789779|NCT00000205|Buprenorphine|buprenorphine|mesh-list
25789780|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789781|NCT00000205|Narcotics|narcotics|mesh-ancestor
25789782|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789783|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789784|NCT00000205|Analgesics|analgesics|mesh-ancestor
25789785|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
25789786|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789787|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789788|NCT00000206|Buprenorphine|buprenorphine|mesh-list
25789789|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789790|NCT00000206|Narcotics|narcotics|mesh-ancestor
25789791|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789792|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789793|NCT00000206|Analgesics|analgesics|mesh-ancestor
25789794|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
25789795|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789796|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789797|NCT00000207|Buprenorphine|buprenorphine|mesh-list
25789798|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789799|NCT00000207|Narcotics|narcotics|mesh-ancestor
25789800|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789801|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789802|NCT00000207|Analgesics|analgesics|mesh-ancestor
25789803|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
25789804|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789805|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789806|NCT00000208|Buprenorphine|buprenorphine|mesh-list
25789807|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789808|NCT00000208|Narcotics|narcotics|mesh-ancestor
25789809|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789810|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789811|NCT00000208|Analgesics|analgesics|mesh-ancestor
25789812|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
25789813|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789814|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789815|NCT00000209|Buprenorphine|buprenorphine|mesh-list
25789816|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789817|NCT00000209|Narcotics|narcotics|mesh-ancestor
25789818|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789819|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789820|NCT00000209|Analgesics|analgesics|mesh-ancestor
25789821|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
25789822|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789823|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789824|NCT00000210|Buprenorphine|buprenorphine|mesh-list
25789825|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789826|NCT00000210|Narcotics|narcotics|mesh-ancestor
25789827|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789828|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789829|NCT00000210|Analgesics|analgesics|mesh-ancestor
25789830|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
25789831|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789832|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789833|NCT00000211|Buprenorphine|buprenorphine|mesh-list
25789834|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789835|NCT00000211|Narcotics|narcotics|mesh-ancestor
25789836|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789837|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789838|NCT00000211|Analgesics|analgesics|mesh-ancestor
25789839|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
25789840|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789841|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789842|NCT00000212|Desipramine|desipramine|mesh-list
25789843|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25789844|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
25789845|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789846|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789847|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789848|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25789849|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25789850|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789851|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
25789852|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789853|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789854|NCT00000213|Fluoxetine|fluoxetine|mesh-list
25789855|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25789856|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25789857|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789858|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789859|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789860|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
25789861|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789862|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25789863|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
25789864|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789865|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25789866|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25789867|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25789868|NCT00000214|Buprenorphine|buprenorphine|mesh-list
25789869|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789870|NCT00000214|Narcotics|narcotics|mesh-ancestor
25789871|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789872|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789873|NCT00000214|Analgesics|analgesics|mesh-ancestor
25789874|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
25789875|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789876|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789877|NCT00000215|Pergolide|pergolide|mesh-list
25789878|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
25789879|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
25789880|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25789881|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789882|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789883|NCT00000216|Buprenorphine|buprenorphine|mesh-list
25789884|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789885|NCT00000216|Narcotics|narcotics|mesh-ancestor
25789886|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789887|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789888|NCT00000216|Analgesics|analgesics|mesh-ancestor
25789889|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
25789890|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789891|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789892|NCT00000217|Carbamazepine|carbamazepine|mesh-list
25789893|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
25789894|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
25789895|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25789896|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789897|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789898|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789899|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25789900|NCT00000217|Analgesics|analgesics|mesh-ancestor
25789901|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
25789902|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789903|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25789904|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789905|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789906|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25789907|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25789908|NCT00000218|Carbamazepine|carbamazepine|mesh-list
25789909|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
25789910|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
25789911|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25789912|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789913|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789914|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25789915|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25789916|NCT00000218|Analgesics|analgesics|mesh-ancestor
25789917|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
25789918|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789919|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25789920|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25789921|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25789922|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25789923|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25789924|NCT00000219|Buprenorphine|buprenorphine|mesh-list
25789925|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789926|NCT00000219|Narcotics|narcotics|mesh-ancestor
25789927|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789928|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789929|NCT00000219|Analgesics|analgesics|mesh-ancestor
25789930|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
25789931|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789932|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789933|NCT00000220|Buprenorphine|buprenorphine|mesh-list
25789934|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789935|NCT00000220|Narcotics|narcotics|mesh-ancestor
25789936|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789937|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789938|NCT00000220|Analgesics|analgesics|mesh-ancestor
25789939|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
25789940|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789941|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789942|NCT00000221|Buprenorphine|buprenorphine|mesh-list
25789943|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789944|NCT00000221|Narcotics|narcotics|mesh-ancestor
25789945|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789946|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789947|NCT00000221|Analgesics|analgesics|mesh-ancestor
25789948|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
25789949|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789950|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789951|NCT00000222|Buprenorphine|buprenorphine|mesh-list
25789952|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789953|NCT00000222|Narcotics|narcotics|mesh-ancestor
25789954|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789955|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789956|NCT00000222|Analgesics|analgesics|mesh-ancestor
25789957|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
25789958|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789959|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789960|NCT00000223|Buprenorphine|buprenorphine|mesh-list
25789961|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789962|NCT00000223|Narcotics|narcotics|mesh-ancestor
25789963|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789964|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789965|NCT00000223|Analgesics|analgesics|mesh-ancestor
25789966|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
25789967|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789968|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789969|NCT00000224|Buprenorphine|buprenorphine|mesh-list
25789970|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789971|NCT00000224|Narcotics|narcotics|mesh-ancestor
25789972|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789973|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789974|NCT00000224|Analgesics|analgesics|mesh-ancestor
25789975|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
25789976|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789977|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789978|NCT00000225|Buprenorphine|buprenorphine|mesh-list
25789979|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789980|NCT00000225|Narcotics|narcotics|mesh-ancestor
25789981|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789982|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789983|NCT00000225|Analgesics|analgesics|mesh-ancestor
25789984|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
25789985|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789986|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789987|NCT00000226|Buprenorphine|buprenorphine|mesh-list
25789988|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789989|NCT00000226|Narcotics|narcotics|mesh-ancestor
25789990|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25789991|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25789992|NCT00000226|Analgesics|analgesics|mesh-ancestor
25789993|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
25789994|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25789995|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25789996|NCT00000227|Buprenorphine|buprenorphine|mesh-list
25789997|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25789998|NCT00000227|Narcotics|narcotics|mesh-ancestor
25789999|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790000|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790001|NCT00000227|Analgesics|analgesics|mesh-ancestor
25790002|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
25790003|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790004|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790005|NCT00000228|Buprenorphine|buprenorphine|mesh-list
25790006|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790007|NCT00000228|Narcotics|narcotics|mesh-ancestor
25790008|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790009|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790010|NCT00000228|Analgesics|analgesics|mesh-ancestor
25790011|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
25790012|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790013|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790014|NCT00000229|Buprenorphine|buprenorphine|mesh-list
25790015|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790016|NCT00000229|Narcotics|narcotics|mesh-ancestor
25790017|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790018|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790019|NCT00000229|Analgesics|analgesics|mesh-ancestor
25790020|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
25790021|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790022|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790023|NCT00000230|Buprenorphine|buprenorphine|mesh-list
25790024|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790025|NCT00000230|Narcotics|narcotics|mesh-ancestor
25790026|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790027|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790028|NCT00000230|Analgesics|analgesics|mesh-ancestor
25790029|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
25790030|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790031|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790032|NCT00000231|Buprenorphine|buprenorphine|mesh-list
25790033|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790034|NCT00000231|Narcotics|narcotics|mesh-ancestor
25790035|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790036|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790037|NCT00000231|Analgesics|analgesics|mesh-ancestor
25790038|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
25790039|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790040|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790041|NCT00000232|Buprenorphine|buprenorphine|mesh-list
25790042|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790043|NCT00000232|Narcotics|narcotics|mesh-ancestor
25790044|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790045|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790046|NCT00000232|Analgesics|analgesics|mesh-ancestor
25790047|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
25790048|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790049|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790050|NCT00000233|Buprenorphine|buprenorphine|mesh-list
25790051|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790052|NCT00000233|Narcotics|narcotics|mesh-ancestor
25790053|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790054|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790055|NCT00000233|Analgesics|analgesics|mesh-ancestor
25790056|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
25790057|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790058|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790059|NCT00000234|Buprenorphine|buprenorphine|mesh-list
25790060|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790061|NCT00000234|Narcotics|narcotics|mesh-ancestor
25790062|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790063|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790064|NCT00000234|Analgesics|analgesics|mesh-ancestor
25790065|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
25790066|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790067|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790068|NCT00000235|Buprenorphine|buprenorphine|mesh-list
25790069|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790070|NCT00000235|Narcotics|narcotics|mesh-ancestor
25790071|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790072|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790073|NCT00000235|Analgesics|analgesics|mesh-ancestor
25790074|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
25167999|NCT02342249|Oseltamivir|oseltamivir|mesh-list
25168000|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
25168001|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25790075|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790076|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790077|NCT00000236|Buprenorphine|buprenorphine|mesh-list
25790078|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25790080|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790081|NCT00000236|Narcotics|narcotics|mesh-ancestor
25790082|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790083|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790084|NCT00000236|Analgesics|analgesics|mesh-ancestor
25790085|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
25790086|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790087|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790088|NCT00000237|Buprenorphine|buprenorphine|mesh-list
25790089|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790090|NCT00000237|Narcotics|narcotics|mesh-ancestor
25790091|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790092|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790093|NCT00000237|Analgesics|analgesics|mesh-ancestor
25790094|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
25790095|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790096|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790097|NCT00000238|Buprenorphine|buprenorphine|mesh-list
25790098|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790099|NCT00000238|Narcotics|narcotics|mesh-ancestor
25790100|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790101|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790102|NCT00000238|Analgesics|analgesics|mesh-ancestor
25790103|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
25790104|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790105|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790106|NCT00000239|Buprenorphine|buprenorphine|mesh-list
25790107|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790108|NCT00000239|Narcotics|narcotics|mesh-ancestor
25790109|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790110|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790111|NCT00000239|Analgesics|analgesics|mesh-ancestor
25790112|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
25790113|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790114|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790115|NCT00000240|Buprenorphine|buprenorphine|mesh-list
25790116|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790117|NCT00000240|Narcotics|narcotics|mesh-ancestor
25790118|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790119|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790120|NCT00000240|Analgesics|analgesics|mesh-ancestor
25790121|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
25790122|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790123|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790124|NCT00000241|Flupenthixol|flupenthixol|mesh-list
25790125|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25790126|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790127|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790128|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790129|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790130|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790131|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790132|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
25790133|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790134|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790135|NCT00000242|Carbamazepine|carbamazepine|mesh-list
25790136|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
25790137|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
25790138|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790139|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790140|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790141|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790142|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790143|NCT00000242|Analgesics|analgesics|mesh-ancestor
25790144|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
25790145|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790146|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25790147|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790148|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790149|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25790150|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25790151|NCT00000243|Buprenorphine|buprenorphine|mesh-list
25790152|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790153|NCT00000243|Narcotics|narcotics|mesh-ancestor
25790154|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790155|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790156|NCT00000243|Analgesics|analgesics|mesh-ancestor
25790157|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
25790158|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790159|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790160|NCT00000244|Dynorphins|dynorphins|mesh-list
25790161|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790162|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790163|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790164|NCT00000245|Desipramine|desipramine|mesh-list
25790165|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25790166|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790167|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790168|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790169|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790170|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25790171|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790172|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790173|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790174|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790175|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790176|NCT00000246|Flumazenil|flumazenil|mesh-list
25790177|NCT00000246|Antidotes|antidotes|mesh-ancestor
25790178|NCT00000246|Protective Agents|protective agents|mesh-ancestor
25790179|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790180|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
25790181|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
25790182|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790183|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790184|NCT00000248|Pergolide|pergolide|mesh-list
25790185|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
25790186|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
25790187|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790188|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790189|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790190|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
25790191|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790192|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
25790193|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
25790194|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790195|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790196|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790197|NCT00000249|Analgesics|analgesics|mesh-ancestor
25790198|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
25790199|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790200|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
25790201|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790202|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
25790203|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
25790204|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790205|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790206|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790207|NCT00000250|Analgesics|analgesics|mesh-ancestor
25790208|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
25790209|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790210|NCT00000251|Isoflurane|isoflurane|mesh-list
25790211|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790212|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
25790213|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
25790214|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790215|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790216|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
25790217|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790218|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
25790219|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
25790220|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790221|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790222|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790223|NCT00000252|Analgesics|analgesics|mesh-ancestor
25790224|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
25790225|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790226|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
25790227|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790228|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
25790229|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
25790230|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790231|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790232|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790234|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
25790235|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790236|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
25790237|NCT00000254|Isoflurane|isoflurane|mesh-list
25790238|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790239|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
25790240|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
25790241|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790242|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790243|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790244|NCT00000254|Analgesics|analgesics|mesh-ancestor
25790245|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
25790246|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790247|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
25790248|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790249|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
25790250|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
25790251|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790252|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790253|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790254|NCT00000255|Analgesics|analgesics|mesh-ancestor
25790255|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
25790256|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790257|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
25790258|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790259|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
25790260|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
25790261|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790262|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790263|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790264|NCT00000256|Analgesics|analgesics|mesh-ancestor
25790265|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
25790266|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790267|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
25790268|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790269|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
25790270|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
25790271|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790272|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790273|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790274|NCT00000257|Analgesics|analgesics|mesh-ancestor
25790275|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
25790276|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790277|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
25790278|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790279|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
25790280|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
25790281|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790282|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790283|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790284|NCT00000258|Analgesics|analgesics|mesh-ancestor
25790285|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
25790286|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790287|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
25790288|NCT00000259|Sevoflurane|sevoflurane|mesh-list
25790289|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25790290|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790291|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
25790292|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
25790293|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790294|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790295|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790296|NCT00000259|Analgesics|analgesics|mesh-ancestor
25790297|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
25790298|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790299|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
25790300|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790301|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
25790302|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
25790303|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790304|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790305|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168195|NCT02278133|Cetuximab|cetuximab|mesh-list
25790306|NCT00000260|Analgesics|analgesics|mesh-ancestor
25790308|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790309|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
25790310|NCT00000261|Sevoflurane|sevoflurane|mesh-list
25790311|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25790312|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790313|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
25790314|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
25790315|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790316|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790317|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790318|NCT00000261|Analgesics|analgesics|mesh-ancestor
25790319|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
25790320|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790321|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
25790322|NCT00000262|Sevoflurane|sevoflurane|mesh-list
25790323|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25790324|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790325|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
25790326|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
25790327|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790328|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790329|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790330|NCT00000262|Analgesics|analgesics|mesh-ancestor
25790331|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
25790332|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790333|NCT00000263|Ethanol|ethanol|mesh-list
25790334|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
25790335|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25790336|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25790337|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790338|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790339|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790340|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
25790341|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
25790342|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790343|NCT00000263|Analgesics|analgesics|mesh-ancestor
25790344|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
25790345|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790346|NCT00000264|Ethanol|ethanol|mesh-list
25790347|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
25790348|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25790349|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25790350|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790351|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790352|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25790353|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
25790354|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
25790355|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790356|NCT00000264|Analgesics|analgesics|mesh-ancestor
25790357|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
25790358|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790359|NCT00000266|Flupenthixol|flupenthixol|mesh-list
25790360|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25790361|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790362|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790363|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790364|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790365|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790366|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790367|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
25790368|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790369|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790370|NCT00000267|Risperidone|risperidone|mesh-list
25790371|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25790372|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
25790373|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790374|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790375|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790376|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790377|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790378|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790379|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790380|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790381|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
25790382|NCT00000268|Bupropion|bupropion|mesh-list
25790383|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25790384|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790385|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790386|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790387|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790388|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790389|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790390|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
25790391|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790392|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790393|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25790394|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25790395|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790396|NCT00000269|Pergolide|pergolide|mesh-list
25790397|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
25790398|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
25790399|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790400|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790401|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790402|NCT00000270|Cocaine|cocaine|mesh-list
25790403|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
25790404|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
25790405|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790406|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790407|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
25790408|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790409|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25790410|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790411|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790412|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790413|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790414|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
25790415|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790416|NCT00000271|Desipramine|desipramine|mesh-list
25790417|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25790418|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
25081142|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25081143|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25081144|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25081145|NCT03332719|Analgesics|analgesics|mesh-ancestor
25081146|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
25081147|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773829|NCT01842256|Telmisartan|telmisartan|mesh-list
24773830|NCT01842256|Atorvastatin|atorvastatin|mesh-list
24773831|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24773832|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24773833|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
24773882|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24773883|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773884|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774641|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24774642|NCT01847144|Gliclazide|gliclazide|mesh-list
24774643|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24774644|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168274|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168275|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168276|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25168277|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
25168279|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790419|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790420|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790421|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790422|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25790423|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790424|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790425|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790426|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790427|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790428|NCT00000273|Fentanyl|fentanyl|mesh-list
25790429|NCT00000273|Morphine|morphine|mesh-list
25790430|NCT00000273|Oxycodone|oxycodone|mesh-list
25790431|NCT00000273|Buprenorphine|buprenorphine|mesh-list
25790432|NCT00000273|Methadone|methadone|mesh-list
25790433|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790434|NCT00000273|Narcotics|narcotics|mesh-ancestor
25790435|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790436|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790437|NCT00000273|Analgesics|analgesics|mesh-ancestor
25790438|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
25790439|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790440|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25790441|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25790442|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
25790443|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
25790444|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790445|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
25790446|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
25790447|NCT00000274|Flupenthixol|flupenthixol|mesh-list
25790448|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25790449|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790450|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790451|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790452|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790453|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790454|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790455|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
25790456|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790457|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790458|NCT00000275|Flupenthixol|flupenthixol|mesh-list
25790459|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25790460|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790461|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790462|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790463|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790464|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790465|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790466|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
25790467|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790468|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790469|NCT00000276|Bupropion|bupropion|mesh-list
25790470|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25790471|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790472|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790473|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790474|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790475|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790476|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790477|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
25790478|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790479|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790480|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25790481|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25790482|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790483|NCT00000277|Mazindol|mazindol|mesh-list
25790484|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25790485|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790486|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25790487|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790488|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790489|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790490|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790491|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790492|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790493|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
25790494|NCT00000278|Disulfiram|disulfiram|mesh-list
25790495|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25790496|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25790497|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790498|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790499|NCT00000279|Clonidine|clonidine|mesh-list
25790500|NCT00000279|Analgesics|analgesics|mesh-ancestor
25790501|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
25790502|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790503|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790504|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25790505|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
25790506|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
25790507|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25790508|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25790509|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25790510|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790511|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790512|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790513|NCT00000280|Nimodipine|nimodipine|mesh-list
25790514|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25790515|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25790516|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790517|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790518|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25790519|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790520|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
25790521|NCT00000281|Amantadine|amantadine|mesh-list
25790522|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25790523|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25790524|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
25790525|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25790526|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
25790527|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790528|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790529|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790530|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790531|NCT00000281|Analgesics|analgesics|mesh-ancestor
25790532|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
25790533|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790534|NCT00000282|Pemoline|pemoline|mesh-list
25790535|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25790536|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790537|NCT00000285|Phenytoin|phenytoin|mesh-list
25790538|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
25790539|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25790540|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25790541|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790542|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790543|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25790544|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25790545|NCT00000286|Nefazodone|nefazodone|mesh-list
25790546|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25790547|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790548|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790549|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790550|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790551|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790552|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25790553|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790554|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790555|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25790556|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25790557|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
25790558|NCT00000289|Ondansetron|ondansetron|mesh-list
25790559|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
25790560|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
25790561|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790562|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790563|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25790564|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
25168413|NCT02200380|Plerixafor|plerixafor|mesh-list
25790565|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
25790566|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25790567|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
25790568|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790569|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790570|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790571|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790572|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790573|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790574|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25790576|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
25790577|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
25790578|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790579|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790580|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
25790581|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790582|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25790583|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790584|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790585|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790586|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790587|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
25790588|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790589|NCT00000291|Labetalol|labetalol|mesh-list
25790590|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25790591|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25790592|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790593|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790594|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790595|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790596|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25790597|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
25790598|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
25790599|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790600|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25790601|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25790602|NCT00000292|Cocaine|cocaine|mesh-list
25790603|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
25790604|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
25790605|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790606|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790607|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
25790608|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790609|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25790610|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790611|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790612|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790613|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790614|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
25790615|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790616|NCT00000293|Nefazodone|nefazodone|mesh-list
25790617|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25790618|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790619|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790620|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790621|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790622|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790623|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25790624|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790625|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790626|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25790627|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25790628|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
25790629|NCT00000294|Carvedilol|carvedilol|mesh-list
25790630|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25790631|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25790632|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790633|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790634|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790635|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790636|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25790637|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
25790638|NCT00000294|Protective Agents|protective agents|mesh-ancestor
25790639|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25790640|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790641|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25790642|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
25790643|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25790644|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25790645|NCT00000295|Progesterone|progesterone|mesh-list
25790646|NCT00000295|Progestins|progestins|mesh-ancestor
25790647|NCT00000295|Hormones|hormones|mesh-ancestor
25790648|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25790649|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790650|NCT00000297|Labetalol|labetalol|mesh-list
25790651|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25790652|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25790653|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790654|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790655|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790656|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790657|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25790658|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
25790659|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
25790660|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790661|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25790662|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25790663|NCT00000298|Buprenorphine|buprenorphine|mesh-list
25790664|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25790665|NCT00000298|Naloxone|naloxone|mesh-list
25790666|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790667|NCT00000298|Narcotics|narcotics|mesh-ancestor
25790668|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790669|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790670|NCT00000298|Analgesics|analgesics|mesh-ancestor
25790671|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
25790672|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790673|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790674|NCT00000299|Buprenorphine|buprenorphine|mesh-list
25790675|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790676|NCT00000299|Narcotics|narcotics|mesh-ancestor
25790677|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790678|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790679|NCT00000299|Analgesics|analgesics|mesh-ancestor
25790680|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
25790681|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790682|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790683|NCT00000301|Amantadine|amantadine|mesh-list
25790684|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25790685|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25790686|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
25790687|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25790688|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
25790689|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790690|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790691|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790692|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25790693|NCT00000301|Analgesics|analgesics|mesh-ancestor
25790694|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
25790695|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790696|NCT00000302|Buprenorphine|buprenorphine|mesh-list
25790697|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790698|NCT00000302|Narcotics|narcotics|mesh-ancestor
25790699|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790700|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790701|NCT00000302|Analgesics|analgesics|mesh-ancestor
25790702|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
25790703|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790704|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790705|NCT00000303|Baclofen|baclofen|mesh-list
25790706|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25790707|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790708|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25790709|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790710|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25790711|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
25790712|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
25790713|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790714|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790715|NCT00000304|Amphetamine|amphetamine|mesh-list
25790716|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
25790717|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25790718|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790719|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
25790720|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
25790721|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790722|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
25790723|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790724|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790725|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790726|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25790727|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790728|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790729|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790730|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
25790731|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25790732|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790733|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790734|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790735|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790736|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790737|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
25790738|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790739|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
25790740|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25790741|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790742|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790743|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790744|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790745|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790746|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
25790747|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790749|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25790750|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790751|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790752|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
25790753|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790754|NCT00000308|Amphetamine|amphetamine|mesh-list
25790755|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
25790756|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25790757|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790758|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
25790759|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
25790760|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790761|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
25790762|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790763|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790764|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790765|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25790766|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790767|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790768|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790769|NCT00000309|Risperidone|risperidone|mesh-list
25790770|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25790771|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
25790772|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790773|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790774|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790775|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790776|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790777|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790778|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790779|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790780|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
25790781|NCT00000310|Risperidone|risperidone|mesh-list
25790782|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25790783|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
25790784|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790785|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790786|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790787|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790788|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790789|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790790|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790791|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790792|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
25790793|NCT00000311|Buprenorphine|buprenorphine|mesh-list
25790794|NCT00000311|Methadone|methadone|mesh-list
25790795|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790796|NCT00000311|Narcotics|narcotics|mesh-ancestor
25790797|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790798|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790799|NCT00000311|Analgesics|analgesics|mesh-ancestor
25790800|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
25790801|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790802|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790803|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
25790804|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
25790805|NCT00000313|Fenfluramine|fenfluramine|mesh-list
25790806|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25790807|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790808|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790809|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790810|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790811|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
25790812|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790813|NCT00000315|Cocaine|cocaine|mesh-list
25790814|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
25790815|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
25790816|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790817|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790818|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
25790819|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790820|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25790821|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790822|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790823|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790824|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790825|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
25790826|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790827|NCT00000316|Cocaine|cocaine|mesh-list
25790828|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
25790829|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
25790830|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790831|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790832|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
25790833|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790834|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25790835|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790836|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790837|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790838|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790839|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
25790840|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790841|NCT00000317|Risperidone|risperidone|mesh-list
25790842|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25790843|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
25790844|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790845|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790846|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790847|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25790848|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25790849|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790850|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790851|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25790852|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
25790853|NCT00000318|Buprenorphine|buprenorphine|mesh-list
25790854|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790855|NCT00000318|Narcotics|narcotics|mesh-ancestor
25790856|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790858|NCT00000318|Analgesics|analgesics|mesh-ancestor
25790859|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
25790860|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790861|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790862|NCT00000319|Buprenorphine|buprenorphine|mesh-list
25790863|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790864|NCT00000319|Narcotics|narcotics|mesh-ancestor
25790865|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790866|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790867|NCT00000319|Analgesics|analgesics|mesh-ancestor
25790868|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
25790869|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790870|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790871|NCT00000320|Buprenorphine|buprenorphine|mesh-list
25790872|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790873|NCT00000320|Narcotics|narcotics|mesh-ancestor
25790874|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790875|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790876|NCT00000320|Analgesics|analgesics|mesh-ancestor
25790877|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
25790878|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790879|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790880|NCT00000321|Desipramine|desipramine|mesh-list
25790881|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25790882|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790883|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790884|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790885|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790886|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25790887|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790888|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790889|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
25790890|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790891|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790892|NCT00000324|Tryptophan|tryptophan|mesh-list
25790893|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25790894|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790895|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790896|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25790897|NCT00000325|Hormones|hormones|mesh-ancestor
25790898|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25790899|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790900|NCT00000326|Heroin|heroin|mesh-list
25790901|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790902|NCT00000326|Narcotics|narcotics|mesh-ancestor
25790903|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790904|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790905|NCT00000326|Analgesics|analgesics|mesh-ancestor
25790906|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
25790907|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790908|NCT00000327|Heroin|heroin|mesh-list
25790909|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790910|NCT00000327|Narcotics|narcotics|mesh-ancestor
25790911|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790912|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790913|NCT00000327|Analgesics|analgesics|mesh-ancestor
25790914|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
25790915|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790916|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
25790917|NCT00000328|Narcotics|narcotics|mesh-ancestor
25790918|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790919|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790920|NCT00000328|Analgesics|analgesics|mesh-ancestor
25790921|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
25790922|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790923|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
25790924|NCT00000329|Narcotics|narcotics|mesh-ancestor
25790925|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790926|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790927|NCT00000329|Analgesics|analgesics|mesh-ancestor
25790928|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
25790929|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790930|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
25790931|NCT00000330|Narcotics|narcotics|mesh-ancestor
25790932|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790933|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790935|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
25790936|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790937|NCT00000332|Nimodipine|nimodipine|mesh-list
25790938|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25790939|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25790940|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790941|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790942|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25790943|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790944|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
25790945|NCT00000333|Benztropine|benztropine|mesh-list
25790946|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25790947|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25790948|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
25790949|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
25790950|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790951|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790952|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25790953|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25790954|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
25790955|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25790956|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790957|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25790958|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25790959|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25790960|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
25790961|NCT00000334|Buprenorphine|buprenorphine|mesh-list
25790962|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790963|NCT00000334|Narcotics|narcotics|mesh-ancestor
25790964|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790965|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790966|NCT00000334|Analgesics|analgesics|mesh-ancestor
25790967|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
25790968|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790969|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790970|NCT00000335|Morphine|morphine|mesh-list
25790971|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25790972|NCT00000335|Narcotics|narcotics|mesh-ancestor
25790973|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25790974|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790975|NCT00000335|Analgesics|analgesics|mesh-ancestor
25790976|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
25790977|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25790978|NCT00000336|Selegiline|selegiline|mesh-list
25790979|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790980|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790981|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25790982|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25790983|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25790984|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790985|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790986|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25790987|NCT00000336|Protective Agents|protective agents|mesh-ancestor
25790988|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790989|NCT00000337|Selegiline|selegiline|mesh-list
25790990|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
25790991|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25790992|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25790993|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25790994|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25790995|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25790996|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25790997|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25790998|NCT00000337|Protective Agents|protective agents|mesh-ancestor
25790999|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791000|NCT00000338|Lisuride|lisuride|mesh-list
25791001|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25791002|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25791003|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25791004|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
25791005|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791006|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791007|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791008|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
25791009|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
25791010|NCT00000339|Risperidone|risperidone|mesh-list
25791011|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25791012|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
25791013|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791014|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791015|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791016|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791017|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791018|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791019|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791020|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25791021|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
25791022|NCT00000340|Pemoline|pemoline|mesh-list
25791023|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25791024|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791025|NCT00000341|Buprenorphine|buprenorphine|mesh-list
25791026|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25791027|NCT00000341|Narcotics|narcotics|mesh-ancestor
25791028|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791029|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791030|NCT00000341|Analgesics|analgesics|mesh-ancestor
25791031|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
25791032|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791033|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791034|NCT00000342|Risperidone|risperidone|mesh-list
25791035|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25791036|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
25791037|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791038|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791039|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791040|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791041|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791042|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791043|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791044|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25791045|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
25791046|NCT00000344|Buprenorphine|buprenorphine|mesh-list
25791047|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25791048|NCT00000344|Naloxone|naloxone|mesh-list
25791049|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25791050|NCT00000344|Narcotics|narcotics|mesh-ancestor
25791051|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791052|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791053|NCT00000344|Analgesics|analgesics|mesh-ancestor
25791054|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
25791055|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791056|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791057|NCT00000345|Lofexidine|lofexidine|mesh-list
25791058|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25791059|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791060|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791061|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
25791062|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791063|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25791064|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25791065|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25791066|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791067|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791068|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791069|NCT00000347|Risperidone|risperidone|mesh-list
25791070|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25791071|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
25791072|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791073|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791074|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791075|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791076|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791077|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791078|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791079|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25168765|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
25791081|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
25791082|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
25791083|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
25791084|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791085|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791086|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791087|NCT00000349|Flupenthixol|flupenthixol|mesh-list
25791088|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25791089|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791090|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791091|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791092|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791093|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791094|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25791095|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
25791096|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791097|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791098|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
25791099|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
25791100|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
25791101|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25791102|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25791103|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791104|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791105|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791106|NCT00000353|Buprenorphine|buprenorphine|mesh-list
25791107|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25791108|NCT00000353|Naloxone|naloxone|mesh-list
25791109|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25791110|NCT00000353|Narcotics|narcotics|mesh-ancestor
25791111|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791112|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791113|NCT00000353|Analgesics|analgesics|mesh-ancestor
25791114|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
25791115|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791116|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791117|NCT00000354|Lofexidine|lofexidine|mesh-list
25791118|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25791119|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791120|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791121|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
25791122|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791123|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25791124|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25791125|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25791126|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791127|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791128|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791129|NCT00000355|Buprenorphine|buprenorphine|mesh-list
25791130|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25791131|NCT00000355|Narcotics|narcotics|mesh-ancestor
25791132|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791133|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791134|NCT00000355|Analgesics|analgesics|mesh-ancestor
25791135|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
25791136|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791137|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791138|NCT00000357|Buprenorphine|buprenorphine|mesh-list
25791139|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25791140|NCT00000357|Narcotics|narcotics|mesh-ancestor
25791141|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791142|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791143|NCT00000357|Analgesics|analgesics|mesh-ancestor
25791144|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
25791145|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791146|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791147|NCT00000358|Lofexidine|lofexidine|mesh-list
25791148|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25791149|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791150|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791151|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
25791152|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168820|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791153|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25791154|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25791155|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25791156|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791157|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791158|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791159|NCT00000361|Methotrexate|methotrexate|mesh-list
25791160|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25791161|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
25791162|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25791163|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791164|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25791165|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
25791166|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791167|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25791168|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
25791169|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791170|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25791171|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25791172|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
25791173|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25791174|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25791175|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
25791176|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25791177|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
25791178|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791179|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791180|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791181|NCT00000368|Paroxetine|paroxetine|mesh-list
25791182|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791183|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791184|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791185|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791186|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791187|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
25791188|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791189|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25791190|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791191|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791192|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25791193|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791194|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791195|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
25791196|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791197|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791198|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791199|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791200|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
25791201|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791202|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791203|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791204|NCT00000372|Cycloserine|cycloserine|mesh-list
25791205|NCT00000372|Clozapine|clozapine|mesh-list
25791206|NCT00000372|Glycine|glycine|mesh-list
25791207|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25791208|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25791209|NCT00000372|Renal Agents|renal agents|mesh-ancestor
25791210|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25791211|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
25791212|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25791213|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
25791214|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791215|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25791216|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
25791217|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791218|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791219|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791220|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791221|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791222|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791223|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
25791224|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
24912846|NCT04271189|Incretins|incretins|mesh-ancestor
25791225|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
25791226|NCT00000373|Olanzapine|olanzapine|mesh-list
25791227|NCT00000373|Fluoxetine|fluoxetine|mesh-list
25791228|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
25791229|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
25791230|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791231|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791232|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25791233|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791234|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791235|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791236|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791237|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791238|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791239|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791240|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791241|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791242|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
25791243|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25791244|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791245|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25791246|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791247|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282717|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
25791249|NCT00000374|Risperidone|risperidone|mesh-list
25791250|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25791251|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
25791252|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791253|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791254|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791255|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791256|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791257|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791258|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791259|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25791260|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
25791261|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
25791262|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
25791263|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791264|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25791265|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791266|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791267|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791268|NCT00000375|Nortriptyline|nortriptyline|mesh-list
25791269|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791270|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791271|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791272|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791273|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25791274|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25791275|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791276|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791277|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791278|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791279|NCT00000376|Desipramine|desipramine|mesh-list
25791280|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25791281|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791282|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791283|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791284|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791285|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25791286|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791287|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791288|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791289|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791290|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791291|NCT00000377|Nortriptyline|nortriptyline|mesh-list
25791292|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25791293|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791294|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791295|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25791296|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791297|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791298|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791299|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791300|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791301|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791302|NCT00000379|Fluoxetine|fluoxetine|mesh-list
25791303|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791304|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791305|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791306|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791307|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791308|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
25791309|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791310|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25791311|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791312|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791313|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25791314|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791315|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791316|NCT00000381|Fluoxetine|fluoxetine|mesh-list
25791317|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791318|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791319|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791320|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791321|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791322|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
25791323|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791324|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25791325|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791326|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791327|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25791328|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791329|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791330|NCT00000384|Sertraline|sertraline|mesh-list
25791331|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791332|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791333|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791334|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791335|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791336|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791337|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791338|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
25791339|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791340|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
25791341|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791342|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791343|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791344|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791345|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
25791346|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791347|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791348|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791349|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
25791350|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25791351|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791352|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791353|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791354|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791355|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791356|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791357|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791358|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791359|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791360|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
25791361|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25791362|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791363|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25791364|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791365|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791366|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25791367|NCT00000390|Imipramine|imipramine|mesh-list
25791368|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25791369|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791370|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791371|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25791372|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791373|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791374|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791375|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791376|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791377|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791378|NCT00000395|Folic Acid|folic acid|mesh-list
25791379|NCT00000395|Leucovorin|leucovorin|mesh-list
25791380|NCT00000395|Methotrexate|methotrexate|mesh-list
25791381|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
25791382|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25791383|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
25791384|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25791385|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791386|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25791387|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
25791388|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791389|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25791390|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
25791391|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791392|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25791393|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25791394|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
25791395|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25791396|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25791398|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
25791399|NCT00000395|Vitamins|vitamins|mesh-ancestor
25791400|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
25791401|NCT00000395|Antidotes|antidotes|mesh-ancestor
25791402|NCT00000395|Protective Agents|protective agents|mesh-ancestor
25791403|NCT00000399|Hormones|hormones|mesh-list
25791404|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791405|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791406|NCT00000400|Alendronate|alendronate|mesh-list
25791407|NCT00000400|Teriparatide|teriparatide|mesh-list
25791408|NCT00000400|Hormones|hormones|mesh-list
25791409|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
25791410|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791411|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791412|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25791413|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791414|NCT00000402|Calcium|calcium|mesh-list
25791415|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791416|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791417|NCT00000403|Doxycycline|doxycycline|mesh-list
25791418|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25791419|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25791420|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
25791421|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25791422|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25791423|NCT00000412|Alendronate|alendronate|mesh-list
25791424|NCT00000412|Calcitriol|calcitriol|mesh-list
25791425|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25791426|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791427|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791428|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25791429|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791430|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791431|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25791432|NCT00000412|Vitamins|vitamins|mesh-ancestor
25791433|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
25791434|NCT00000415|Calcium|calcium|mesh-list
25791435|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791436|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791437|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25791438|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25791439|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25791440|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
25791441|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25791442|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791443|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25791444|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25791445|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25791446|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25791447|NCT00000419|Estrogens|estrogens|mesh-ancestor
25791448|NCT00000419|Hormones|hormones|mesh-ancestor
25791449|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791450|NCT00000420|Norinyl|norinyl|mesh-list
25791451|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25791452|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25791453|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25791454|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
25791455|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25791456|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791457|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25791458|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25791459|NCT00000421|Prednisone|prednisone|mesh-list
25791460|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25791461|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
25791462|NCT00000421|Hormones|hormones|mesh-ancestor
25791463|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791464|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791465|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25791466|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25791467|NCT00000425|Acetaminophen|acetaminophen|mesh-list
25791468|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25791469|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25791470|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25791471|NCT00000425|Analgesics|analgesics|mesh-ancestor
25791472|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
25791473|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791474|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791475|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
25791476|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25791477|NCT00000426|Calcium|calcium|mesh-list
25791478|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791479|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791480|NCT00000427|Alendronate|alendronate|mesh-list
25791481|NCT00000427|Hormones|hormones|mesh-list
25791482|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
25791483|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791484|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791485|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25791486|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791487|NCT00000428|Amitriptyline|amitriptyline|mesh-list
25791488|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25791489|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791490|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791491|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25791492|NCT00000428|Analgesics|analgesics|mesh-ancestor
25791493|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
25791494|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791495|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791496|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25791497|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791498|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791499|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791500|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791501|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791502|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
25791503|NCT00000429|Calcium|calcium|mesh-list
25791504|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791505|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791506|NCT00000429|Antacids|antacids|mesh-ancestor
25791507|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791508|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25791509|NCT00000430|Alendronate|alendronate|mesh-list
25791510|NCT00000430|Estrogens|estrogens|mesh-list
25791511|NCT00000430|Progestins|progestins|mesh-list
25791512|NCT00000430|Hormones|hormones|mesh-ancestor
25791513|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791514|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791515|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25791516|NCT00000437|Naltrexone|naltrexone|mesh-list
25791517|NCT00000437|Nicotine|nicotine|mesh-list
25791518|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25791519|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
25791520|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791521|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791522|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25791523|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25791524|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
25791525|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791526|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791527|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791528|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791529|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
25791530|NCT00000438|Naltrexone|naltrexone|mesh-list
25791531|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791532|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791533|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791534|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
25791535|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791536|NCT00000439|Valproic Acid|valproic acid|mesh-list
25791537|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
25203625|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
25791538|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791539|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791540|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
25791541|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791542|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791543|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
25791544|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791545|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791546|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791547|NCT00000440|Naltrexone|naltrexone|mesh-list
25791548|NCT00000440|Sertraline|sertraline|mesh-list
25791549|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791550|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791551|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791552|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
25791553|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791554|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791555|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791556|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791557|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791558|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791559|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791560|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791561|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
25791562|NCT00000441|Carbamazepine|carbamazepine|mesh-list
25791563|NCT00000441|Lorazepam|lorazepam|mesh-list
25791564|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
25791565|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
25791566|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
25791567|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791568|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791569|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25791570|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25791571|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791572|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25791573|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791574|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791575|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
25791576|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
25791577|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791578|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791579|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
25791580|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25791581|NCT00000441|Analgesics|analgesics|mesh-ancestor
25791582|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
25791583|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25791584|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791585|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25791586|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25791587|NCT00000442|Naltrexone|naltrexone|mesh-list
25791588|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791589|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791590|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791591|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
25791592|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791593|NCT00000443|Ondansetron|ondansetron|mesh-list
25791594|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
25791595|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
25791596|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791597|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791598|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25791599|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
25791600|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
25791601|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25791602|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
25791603|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791604|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791605|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25791606|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25791607|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25791608|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791609|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25791610|NCT00000444|Nicotine|nicotine|mesh-list
25791611|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25791612|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
25791613|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791614|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791615|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25791616|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25791617|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
25791618|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791619|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791620|NCT00000445|Naltrexone|naltrexone|mesh-list
25791621|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791622|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791623|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791624|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
25791625|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791626|NCT00000446|Sertraline|sertraline|mesh-list
25791627|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791628|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791629|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791630|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791631|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791632|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791633|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791634|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
25791635|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791636|NCT00000447|Naltrexone|naltrexone|mesh-list
25791637|NCT00000447|Nicotine|nicotine|mesh-list
25791638|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25791639|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
25791640|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791641|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791642|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25791643|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25791644|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
25791645|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791646|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791647|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791648|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791649|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
25791650|NCT00000448|Naltrexone|naltrexone|mesh-list
25791651|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791652|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791653|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791654|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
25791655|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791656|NCT00000449|Naltrexone|naltrexone|mesh-list
25791657|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791658|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791659|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791660|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
25791661|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791662|NCT00000450|Naltrexone|naltrexone|mesh-list
25791663|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791664|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791665|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791666|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
25791667|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791668|NCT00000451|Naltrexone|naltrexone|mesh-list
25791669|NCT00000451|Sertraline|sertraline|mesh-list
25791670|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791671|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791672|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791673|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
25791674|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791675|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791676|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791677|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791678|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791679|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791680|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791681|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791682|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
25791683|NCT00000452|Naltrexone|naltrexone|mesh-list
25791684|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791685|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791686|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791687|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
25791688|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791689|NCT00000454|Nicotine|nicotine|mesh-list
25791690|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25791691|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
25791692|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791693|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791694|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25791695|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25791696|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
25791697|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791698|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791699|NCT00000455|Naltrexone|naltrexone|mesh-list
25791700|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791701|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791702|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791703|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
25791704|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791705|NCT00000456|Naltrexone|naltrexone|mesh-list
25791706|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25791707|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25791708|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791709|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
25791710|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791711|NCT00000457|Bupropion|bupropion|mesh-list
25791712|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25791713|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791714|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791715|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25791716|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791717|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791718|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791719|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
25791720|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791721|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791722|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25791723|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791724|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791725|NCT00000458|Sertraline|sertraline|mesh-list
25791726|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791727|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791728|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25791729|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791730|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791731|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791732|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791733|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
25791734|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791735|NCT00000461|Niacin|niacin|mesh-list
25791736|NCT00000461|Pravastatin|pravastatin|mesh-list
25791737|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
25791738|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
25791739|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25791740|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
25791741|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791742|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25791743|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
25791744|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
25791745|NCT00000461|Vitamins|vitamins|mesh-ancestor
25791746|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
25791747|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791748|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25791749|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25791750|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791751|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25791752|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791753|NCT00000463|Warfarin|warfarin|mesh-list
25791754|NCT00000463|Lovastatin|lovastatin|mesh-list
25791755|NCT00000463|L 647318|l 647318|mesh-list
25791756|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
25791757|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
25791758|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
25791759|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25791760|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25791761|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
25791762|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791763|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25791764|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25791765|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791766|NCT00000464|Quinidine|quinidine|mesh-list
25791767|NCT00000464|Amiodarone|amiodarone|mesh-list
25791768|NCT00000464|Sotalol|sotalol|mesh-list
25791769|NCT00000464|Propafenone|propafenone|mesh-list
25791770|NCT00000464|Mexiletine|mexiletine|mesh-list
25791771|NCT00000464|Procainamide|procainamide|mesh-list
25791772|NCT00000464|Imipramine|imipramine|mesh-list
25791773|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25791774|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
25791775|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25791776|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791777|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791778|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25791779|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25791780|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25791781|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791782|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25791783|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25791784|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25791785|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25791786|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25791787|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791788|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791789|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791790|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
25791791|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
25791792|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791793|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25791794|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
25791795|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25791796|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25791797|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25791798|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25791799|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25791800|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
25791801|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25791802|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25791803|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
25791804|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25791805|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25791806|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25791807|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25791808|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
25791809|NCT00000466|Progesterone|progesterone|mesh-list
25791810|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25791811|NCT00000466|Estrogens|estrogens|mesh-list
25791812|NCT00000466|Progestins|progestins|mesh-ancestor
25791813|NCT00000466|Hormones|hormones|mesh-ancestor
25791814|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791815|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791816|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25791817|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25791818|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25791819|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
25791820|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25791821|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25791822|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25791823|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25791824|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25791825|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25791826|NCT00000468|Plasminogen|plasminogen|mesh-list
25791827|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25791828|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25791829|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25791830|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791831|NCT00000469|Aspirin|aspirin|mesh-list
25791832|NCT00000469|Lovastatin|lovastatin|mesh-list
25791833|NCT00000469|L 647318|l 647318|mesh-list
25791834|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
25791835|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25791836|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25791837|NCT00000469|Analgesics|analgesics|mesh-ancestor
25791838|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
25791839|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791840|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791841|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25791843|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25791844|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25791845|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791846|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25791847|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25791848|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791849|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
25791850|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25791851|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25791852|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
25791853|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25791854|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25791855|NCT00000472|Heparin|heparin|mesh-list
25791856|NCT00000472|Plasminogen|plasminogen|mesh-list
25791857|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25791858|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
25791859|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25791860|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25791861|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791862|NCT00000477|Lovastatin|lovastatin|mesh-list
25791863|NCT00000477|L 647318|l 647318|mesh-list
25791864|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
25791865|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25791866|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25791867|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
25791868|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791869|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25791870|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25791871|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778997|NCT01873157|Bortezomib|bortezomib|mesh-list
25791872|NCT00000478|Atenolol|atenolol|mesh-list
25791873|NCT00000478|Diltiazem|diltiazem|mesh-list
25791874|NCT00000478|Nifedipine|nifedipine|mesh-list
25791875|NCT00000478|Isosorbide|isosorbide|mesh-list
25791876|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25791877|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25791878|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25791879|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791880|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791881|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25791882|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791883|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
25791884|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
25791885|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25791886|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25791887|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25791888|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
25791889|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
25791890|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791891|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25791892|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25791893|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25791894|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791895|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791896|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25791897|NCT00000478|Diuretics|diuretics|mesh-ancestor
25791898|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
25791899|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25791900|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25791901|NCT00000482|Niacin|niacin|mesh-list
25791902|NCT00000482|Clofibrate|clofibrate|mesh-list
25791903|NCT00000482|Estrogens|estrogens|mesh-list
25791904|NCT00000482|Hormones|hormones|mesh-ancestor
25791905|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791906|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791907|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25791908|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
25791909|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791910|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25791911|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
25791912|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
25791913|NCT00000482|Vitamins|vitamins|mesh-ancestor
25791914|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
25791915|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25791916|NCT00000483|Niacin|niacin|mesh-list
25791917|NCT00000483|Clofibrate|clofibrate|mesh-list
25791918|NCT00000483|Estrogens|estrogens|mesh-list
25791919|NCT00000483|Hormones|hormones|mesh-ancestor
25791920|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25791921|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791922|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25791923|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
25791924|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791925|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25791926|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
25791927|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
25791928|NCT00000483|Vitamins|vitamins|mesh-ancestor
25791929|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
25791930|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25791931|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
25791932|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25791933|NCT00000484|Diuretics|diuretics|mesh-ancestor
25791934|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
25791935|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791936|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25791937|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25791938|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791939|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
25791940|NCT00000485|Diuretics|diuretics|mesh-list
25791941|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
25791942|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791943|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
25791944|NCT00000487|Diuretics|diuretics|mesh-list
25791945|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
25791946|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791947|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
25791948|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25791949|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25791950|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
25791951|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791952|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25791954|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25791955|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25791956|NCT00000491|Analgesics|analgesics|mesh-ancestor
25791957|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
25791958|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791959|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791960|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25791961|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25791962|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25791963|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25791964|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791965|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25791966|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25791967|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791968|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
25791969|NCT00000492|Propranolol|propranolol|mesh-list
25791970|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25791971|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25791972|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791973|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791974|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791975|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791976|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25791977|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25791978|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
25791979|NCT00000493|Propranolol|propranolol|mesh-list
25791980|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25791981|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25791982|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
25791983|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25791984|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25791985|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791986|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25791987|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25791988|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
25791989|NCT00000494|Indomethacin|indomethacin|mesh-list
25791990|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25791991|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25791992|NCT00000494|Analgesics|analgesics|mesh-ancestor
25791993|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
25791994|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25791995|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791996|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25791997|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25791998|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
25791999|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
25792000|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25792001|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792002|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792003|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792004|NCT00000496|Aspirin|aspirin|mesh-list
25792005|NCT00000496|Dipyridamole|dipyridamole|mesh-list
25792006|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25792007|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25792008|NCT00000496|Analgesics|analgesics|mesh-ancestor
25792009|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
25792010|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792011|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792012|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792013|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792014|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792015|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792016|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792017|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25792018|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792019|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792020|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
25792021|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25792022|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792023|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
25792024|NCT00000499|Metoprolol|metoprolol|mesh-list
25792025|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
25792026|NCT00000499|Hydralazine|hydralazine|mesh-list
25792027|NCT00000499|Reserpine|reserpine|mesh-list
25792028|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792029|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792030|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
25792031|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
25792032|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792033|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792034|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25792035|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25792036|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792037|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792038|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792039|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792040|NCT00000499|Diuretics|diuretics|mesh-ancestor
25792041|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
25792042|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25792043|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792044|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792045|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25792046|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25792047|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25792048|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25792049|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25792050|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25792051|NCT00000500|Aspirin|aspirin|mesh-list
25792052|NCT00000500|Carotenoids|carotenoids|mesh-list
25792053|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25792054|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25792055|NCT00000500|Analgesics|analgesics|mesh-ancestor
25792056|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
25792057|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792058|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792059|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792060|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792061|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792062|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792063|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792064|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25792065|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792066|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792067|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
25792068|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
25792069|NCT00000500|Protective Agents|protective agents|mesh-ancestor
25792070|NCT00000503|Streptokinase|streptokinase|mesh-list
25792071|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
25792072|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792073|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792074|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792075|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792076|NCT00000504|Flecainide|flecainide|mesh-list
25792077|NCT00000504|Moricizine|moricizine|mesh-list
25792078|NCT00000504|Encainide|encainide|mesh-list
25792079|NCT00000504|Imipramine|imipramine|mesh-list
25792080|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792081|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25792082|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25792083|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792084|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792085|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25792086|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
25792087|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25792088|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25792089|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25792090|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792091|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792092|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161780|NCT02352558|Bortezomib|bortezomib|mesh-list
25161781|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
25161782|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25161783|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
25161784|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
25792094|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25792095|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792096|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792097|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792098|NCT00000506|Phentermine|phentermine|mesh-list
25792099|NCT00000506|Fenfluramine|fenfluramine|mesh-list
25792100|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25792101|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792102|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
25792103|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25792104|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
25792105|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
25792106|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792107|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792108|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792109|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792110|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25792111|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25792112|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792113|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
25792114|NCT00000507|Streptokinase|streptokinase|mesh-list
25792115|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792116|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792117|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792118|NCT00000510|Aspirin|aspirin|mesh-list
25792119|NCT00000510|Dipyridamole|dipyridamole|mesh-list
25792120|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25792121|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25792122|NCT00000510|Analgesics|analgesics|mesh-ancestor
25792123|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
25792124|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792125|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792126|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792127|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792128|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792129|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792130|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792131|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25792132|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792133|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792134|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
25792135|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25792136|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792137|NCT00000512|Niacin|niacin|mesh-list
25792138|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
25792139|NCT00000512|Lovastatin|lovastatin|mesh-list
25792140|NCT00000512|L 647318|l 647318|mesh-list
25792141|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
25792142|NCT00000512|Colestipol|colestipol|mesh-list
25792143|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25792144|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
25792145|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792146|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25792147|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792148|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
25792149|NCT00000512|Vitamins|vitamins|mesh-ancestor
25792150|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
25792151|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792152|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25792153|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25792154|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548514|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24548515|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24548516|NCT00709982|Hematinics|hematinics|mesh-ancestor
24548517|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
24548518|NCT00709982|Vitamins|vitamins|mesh-ancestor
24548519|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
24548520|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24548521|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24548522|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24548580|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
25792155|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
25792156|NCT00000513|Atenolol|atenolol|mesh-list
25792157|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
25792158|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792159|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792160|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
25792161|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
25792162|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792163|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792164|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25792165|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25792166|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792167|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792168|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792169|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792170|NCT00000513|Diuretics|diuretics|mesh-ancestor
25792171|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
25792172|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25792173|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792174|NCT00000514|Atenolol|atenolol|mesh-list
25792175|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
25792176|NCT00000514|Reserpine|reserpine|mesh-list
25792177|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792178|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792179|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
25792180|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
25792181|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792182|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792183|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25792184|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25792185|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792186|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792187|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792188|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792189|NCT00000514|Diuretics|diuretics|mesh-ancestor
25792190|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
25792191|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25792192|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792193|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25792194|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25792195|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25792196|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25792197|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25792198|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25792199|NCT00000516|Enalapril|enalapril|mesh-list
25792200|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25792201|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
25792202|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792203|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792204|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792205|NCT00000517|Warfarin|warfarin|mesh-list
25792206|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
25792207|NCT00000518|Quinidine|quinidine|mesh-list
25792208|NCT00000518|Sotalol|sotalol|mesh-list
25792209|NCT00000518|Mexiletine|mexiletine|mesh-list
25792210|NCT00000518|Procainamide|procainamide|mesh-list
25792211|NCT00000518|Imipramine|imipramine|mesh-list
25792212|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25792213|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792214|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792215|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792216|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792217|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792218|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792219|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
25792220|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
25792221|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792222|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24418634|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
24978151|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978152|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24419732|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
24978153|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24978154|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978155|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978156|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25792223|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
25792224|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25792225|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25792226|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792227|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792228|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25792229|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25792230|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
25792231|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25792232|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25792233|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792234|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25792235|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25792236|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25792237|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
25792238|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25792239|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25792240|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25792241|NCT00000520|Aspirin|aspirin|mesh-list
25792242|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
25792243|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25792244|NCT00000520|Antibodies|antibodies|mesh-list
25792245|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
25792246|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25792247|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25792248|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25792249|NCT00000520|Analgesics|analgesics|mesh-ancestor
25792250|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
25792251|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792252|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792253|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792254|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792255|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792256|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792257|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792258|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25792259|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792260|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792261|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
25792262|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
25792263|NCT00000522|Acebutolol|acebutolol|mesh-list
25792264|NCT00000522|Amlodipine|amlodipine|mesh-list
25792265|NCT00000522|Enalapril|enalapril|mesh-list
25792266|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
25792267|NCT00000522|Doxazosin|doxazosin|mesh-list
25792268|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792269|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25792270|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792271|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792272|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25792273|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792274|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792275|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25792276|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
25792277|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792278|NCT00000522|Diuretics|diuretics|mesh-ancestor
25792279|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
25792280|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25792281|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25792282|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25792283|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792284|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792285|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792286|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792287|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
25792288|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
25792289|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418867|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
24418868|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418869|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24418870|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418871|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25792290|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25792291|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25792293|NCT00000524|Prednisone|prednisone|mesh-list
25792294|NCT00000524|Cyclosporins|cyclosporins|mesh-list
25792295|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792296|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
25792297|NCT00000524|Hormones|hormones|mesh-ancestor
25792298|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792299|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792300|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25792301|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792302|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792303|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792304|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25792305|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
25792306|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
25792307|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792308|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
25792309|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792310|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25792311|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25792312|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
25792313|NCT00000525|Triamterene|triamterene|mesh-list
25792314|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792315|NCT00000525|Diuretics|diuretics|mesh-ancestor
25792316|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
25792317|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792318|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25792319|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792320|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792321|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25792322|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25792323|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25792324|NCT00000526|Flecainide|flecainide|mesh-list
25792325|NCT00000526|Moricizine|moricizine|mesh-list
25792326|NCT00000526|Encainide|encainide|mesh-list
25792327|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792328|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25792329|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25792330|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792331|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792332|NCT00000527|Aspirin|aspirin|mesh-list
25792333|NCT00000527|Dipyridamole|dipyridamole|mesh-list
25792334|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25792335|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25792336|NCT00000527|Analgesics|analgesics|mesh-ancestor
25792337|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
25792338|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792339|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792340|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792341|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792342|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25792343|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792344|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792345|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25792346|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792347|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792348|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
25792349|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25792350|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792351|NCT00000529|Tamoxifen|tamoxifen|mesh-list
25792352|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25792353|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
25792354|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792355|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978226|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
24978227|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
24978228|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
25120482|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
24419140|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978241|NCT05018481|Protective Agents|protective agents|mesh-ancestor
24978242|NCT05011149|Ibuprofen|ibuprofen|mesh-list
24978243|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25792356|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25792357|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792358|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25792359|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25792360|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25792362|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25792363|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792364|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792365|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25792366|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792367|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792368|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
25792369|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25792370|NCT00000531|Amiodarone|amiodarone|mesh-list
25792371|NCT00000531|Sotalol|sotalol|mesh-list
25792372|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792373|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792374|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25792375|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792376|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792377|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25792378|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25792379|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25792380|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792381|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25792382|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25792383|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25792384|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25792385|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792386|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792387|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792388|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792389|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
25792390|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
25792391|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792392|NCT00000534|Calcium|calcium|mesh-list
25792393|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25792394|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792395|NCT00000539|Vitamins|vitamins|mesh-list
25792396|NCT00000539|Vitamin E|vitamin e|mesh-list
25792397|NCT00000539|Beta Carotene|beta carotene|mesh-list
25792398|NCT00000539|Warfarin|warfarin|mesh-list
25792399|NCT00000539|Pravastatin|pravastatin|mesh-list
25792400|NCT00000539|Carotenoids|carotenoids|mesh-list
25792401|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
25792402|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792403|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
25792404|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
25792405|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792406|NCT00000539|Protective Agents|protective agents|mesh-ancestor
25792407|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25792408|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
25792409|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25792410|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25792411|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25792412|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792413|NCT00000539|Provitamins|provitamins|mesh-ancestor
25792414|NCT00000541|Vitamins|vitamins|mesh-list
25792415|NCT00000541|Folic Acid|folic acid|mesh-list
25792416|NCT00000541|Vitamin E|vitamin e|mesh-list
25792417|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
25792418|NCT00000541|Hydroxocobalamin|hydroxocobalamin|mesh-list
25792419|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
25792420|NCT00000541|Pyridoxal|pyridoxal|mesh-list
25792421|NCT00000541|Pyridoxine|pyridoxine|mesh-list
25792422|NCT00000541|Beta Carotene|beta carotene|mesh-list
25792423|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
25792424|NCT00000541|Carotenoids|carotenoids|mesh-list
25792425|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
25792426|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161812|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
25161818|NCT02269670|Tamoxifen|tamoxifen|mesh-list
25792427|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
25792428|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792429|NCT00000541|Protective Agents|protective agents|mesh-ancestor
25792430|NCT00000541|Hematinics|hematinics|mesh-ancestor
25792431|NCT00000541|Provitamins|provitamins|mesh-ancestor
25792432|NCT00000542|Amlodipine|amlodipine|mesh-list
25792433|NCT00000542|Lisinopril|lisinopril|mesh-list
25792434|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
25792435|NCT00000542|Doxazosin|doxazosin|mesh-list
25792436|NCT00000542|Pravastatin|pravastatin|mesh-list
25792437|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25792438|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792439|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25792440|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792441|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792442|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25792443|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792444|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792445|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25792446|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25792447|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
25792448|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25792449|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25792450|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792451|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
25792452|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25792453|NCT00000542|Protective Agents|protective agents|mesh-ancestor
25792454|NCT00000542|Diuretics|diuretics|mesh-ancestor
25792455|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
25792456|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25792457|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25792458|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25792459|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792460|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792461|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792462|NCT00000543|Calcium|calcium|mesh-list
25792463|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25792464|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792465|NCT00000547|Enalapril|enalapril|mesh-list
25792466|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25792467|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
25792468|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792469|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792470|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792471|NCT00000549|Hormones|hormones|mesh-list
25792472|NCT00000549|Estrogens|estrogens|mesh-list
25792473|NCT00000549|Progestins|progestins|mesh-list
25792474|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792475|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792476|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25792477|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25792478|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792479|NCT00000553|Niacin|niacin|mesh-list
25792480|NCT00000553|Simvastatin|simvastatin|mesh-list
25792481|NCT00000553|Antioxidants|antioxidants|mesh-list
25792482|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25792483|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25792484|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
25792485|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792486|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25792487|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25792488|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792489|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792490|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
25792491|NCT00000553|Vitamins|vitamins|mesh-ancestor
25792492|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
25792493|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792494|NCT00000553|Protective Agents|protective agents|mesh-ancestor
25792495|NCT00000554|Dobutamine|dobutamine|mesh-list
25792496|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25792497|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
25792498|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
25792499|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792500|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978354|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419349|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419350|NCT00211939|Atorvastatin|atorvastatin|mesh-list
24419351|NCT00211939|Calcium|calcium|mesh-list
24419352|NCT00211939|Sevelamer|sevelamer|mesh-list
24419353|NCT00211939|Calcium acetate|calcium acetate|mesh-list
25792501|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25792502|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25792503|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25792504|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
25792505|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792506|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792507|NCT00000554|Protective Agents|protective agents|mesh-ancestor
25792508|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
25792509|NCT00000555|Vitamin E|vitamin e|mesh-list
25792510|NCT00000555|Hormones|hormones|mesh-list
25792511|NCT00000555|Progesterone|progesterone|mesh-list
25792512|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25792513|NCT00000555|Estrogens|estrogens|mesh-list
25792514|NCT00000555|Vitamins|vitamins|mesh-ancestor
25792515|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
25792516|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792517|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792518|NCT00000555|Progestins|progestins|mesh-ancestor
25792519|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
25792520|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792521|NCT00000555|Protective Agents|protective agents|mesh-ancestor
25792522|NCT00000556|Quinidine|quinidine|mesh-list
25792523|NCT00000556|Digoxin|digoxin|mesh-list
25792524|NCT00000556|Amiodarone|amiodarone|mesh-list
25792525|NCT00000556|Verapamil|verapamil|mesh-list
25792526|NCT00000556|Sotalol|sotalol|mesh-list
25792527|NCT00000556|Flecainide|flecainide|mesh-list
25792528|NCT00000556|Propafenone|propafenone|mesh-list
25792529|NCT00000556|Procainamide|procainamide|mesh-list
25792530|NCT00000556|Moricizine|moricizine|mesh-list
25792531|NCT00000556|Disopyramide|disopyramide|mesh-list
25792532|NCT00000556|Diltiazem|diltiazem|mesh-list
25792533|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25792534|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
25792535|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792536|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25792537|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792538|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792539|NCT00000556|Protective Agents|protective agents|mesh-ancestor
25792540|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792541|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792542|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25792543|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792544|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25792545|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25792546|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25792547|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25792548|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25792549|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25792550|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25792551|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25792552|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25792553|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792554|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792555|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
25792556|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
25792557|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792558|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25792559|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25792560|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
25792561|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25792562|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25792563|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792564|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25792565|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25792566|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
24419671|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
24419672|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419673|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24419674|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24419675|NCT00213252|Protective Agents|protective agents|mesh-ancestor
24774710|NCT01847417|Pantoprazole|pantoprazole|mesh-list
24978414|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
25161847|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25792567|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25792568|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25792569|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792570|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
25792571|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25792572|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
25792574|NCT00000559|Estradiol|estradiol|mesh-list
25792575|NCT00000559|Estrogens|estrogens|mesh-list
25792576|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792577|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792578|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25792579|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
25792580|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25792581|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25792582|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25792583|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25792584|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25792585|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25792586|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25792587|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792588|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
25792589|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25792590|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792591|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792592|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792593|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25792594|NCT00000563|Dexamethasone|dexamethasone|mesh-list
25792595|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792596|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
25792597|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
25792598|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792599|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792600|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25792601|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
25792602|NCT00000563|Hormones|hormones|mesh-ancestor
25792603|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792604|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25792605|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792606|NCT00000568|Ipratropium|ipratropium|mesh-list
25792607|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25792608|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
25792609|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792610|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792611|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25792612|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
25792613|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25792614|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
25792615|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792616|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792617|NCT00000569|Triamcinolone|triamcinolone|mesh-list
25792618|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792619|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
25792620|NCT00000569|Hormones|hormones|mesh-ancestor
25792621|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792622|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792623|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25792624|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
25792625|NCT00000574|Ibuprofen|ibuprofen|mesh-list
25792626|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25792627|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25792628|NCT00000574|Analgesics|analgesics|mesh-ancestor
25792629|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
25792630|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792631|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792632|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792633|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792634|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792635|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792636|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792637|NCT00000576|Beclomethasone|beclomethasone|mesh-list
24978527|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978528|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24978529|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25792638|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792639|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
25792640|NCT00000576|Hormones|hormones|mesh-ancestor
25792641|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792642|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792643|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25792644|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
25792645|NCT00000577|Colchicine|colchicine|mesh-list
25792646|NCT00000577|Albuterol|albuterol|mesh-list
25792647|NCT00000577|Hormones|hormones|mesh-list
25792648|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
25792649|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
25792650|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792651|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792652|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25792653|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
25792654|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792655|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25792656|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25792657|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
25792658|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25792659|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25792660|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25792661|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792662|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792663|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
25792664|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792665|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
25792666|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
25792667|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25792668|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792669|NCT00000578|Beclomethasone|beclomethasone|mesh-list
25792670|NCT00000578|Theophylline|theophylline|mesh-list
25792671|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792672|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
25792673|NCT00000578|Hormones|hormones|mesh-ancestor
25792674|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792675|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792676|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25792677|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
25792678|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25792679|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
25792680|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792681|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25792682|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792683|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792684|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792685|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25792686|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25792687|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
25792688|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978586|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
25792689|NCT00000579|Ketoconazole|ketoconazole|mesh-list
25792690|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
25792691|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25792692|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25792693|NCT00000579|Prednisolone|prednisolone|mesh-list
25792694|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
25792695|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25792696|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
25792697|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792698|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
25792699|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
25792700|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25792701|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792702|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25792703|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
25792704|NCT00000579|Hormones|hormones|mesh-ancestor
25792705|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792706|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25792707|NCT00000579|Protective Agents|protective agents|mesh-ancestor
25792708|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25792709|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792710|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
25792711|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792712|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25792713|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25792714|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792715|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792716|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25792717|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
25792718|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25792719|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
25792720|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25792721|NCT00000580|Antibodies|antibodies|mesh-list
25792722|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
25792723|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25792724|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
25792725|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792726|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
25792727|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25792728|NCT00000584|Antibodies|antibodies|mesh-list
25792729|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
25792730|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792731|NCT00000585|Penicillins|penicillins|mesh-list
25792732|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25792733|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792734|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
25792735|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792736|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
25792737|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792738|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792739|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25792740|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
25792741|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25792742|NCT00000590|Antibodies|antibodies|mesh-list
25792743|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
25792744|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792745|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
25792746|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25792747|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25792748|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
25792749|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792750|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25792751|NCT00000595|Deferoxamine|deferoxamine|mesh-list
25792752|NCT00000595|Siderophores|siderophores|mesh-ancestor
25792753|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25792754|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
25792755|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
25792756|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792757|NCT00000596|Dapsone|dapsone|mesh-list
25792758|NCT00000596|Prednisone|prednisone|mesh-list
25792759|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
25792760|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25792761|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
25792762|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105817|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105828|NCT04850495|Cortisone|cortisone|mesh-list
25105829|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
25792763|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25792764|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25792765|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
25792766|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792767|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792768|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25792769|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25792771|NCT00000596|Hormones|hormones|mesh-ancestor
25792772|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792773|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25792774|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792775|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
25792776|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25792777|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25792778|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25792779|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792780|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
25792781|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25792782|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
25792783|NCT00000597|Nandrolone|nandrolone|mesh-list
25792784|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
25792785|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25792786|NCT00000597|Androgens|androgens|mesh-ancestor
25792787|NCT00000597|Hormones|hormones|mesh-ancestor
25792788|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792789|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792790|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
25792791|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25792792|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
25792793|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25792794|NCT00000599|Niacin|niacin|mesh-list
25792795|NCT00000599|Colestipol|colestipol|mesh-list
25792796|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25792797|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
25792798|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792799|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25792800|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792801|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
25792802|NCT00000599|Vitamins|vitamins|mesh-ancestor
25792803|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
25792804|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792805|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
25792806|NCT00000600|Vitamins|vitamins|mesh-list
25792807|NCT00000600|Ascorbic Acid|ascorbic acid|mesh-list
25792808|NCT00000600|Vitamin E|vitamin e|mesh-list
25792809|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
25792810|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792811|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
25792812|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792813|NCT00000600|Protective Agents|protective agents|mesh-ancestor
25792814|NCT00000601|Hormones|hormones|mesh-list
25792815|NCT00000601|Progesterone|progesterone|mesh-list
25792816|NCT00000601|Estrogens|estrogens|mesh-list
25792817|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792818|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792819|NCT00000601|Progestins|progestins|mesh-ancestor
25792820|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
25792821|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792822|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
25792823|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792824|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792825|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25792826|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25792827|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
25792828|NCT00000605|Hormones|hormones|mesh-list
25792829|NCT00000605|Estrogens|estrogens|mesh-list
25792830|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161851|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
25161852|NCT02240407|Promethazine|promethazine|mesh-list
25161853|NCT02240407|Sirolimus|sirolimus|mesh-list
25161854|NCT02240407|Rituximab|rituximab|mesh-list
25161855|NCT02240407|Lidocaine|lidocaine|mesh-list
25161856|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25161857|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161858|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
25792831|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792832|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25792834|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25792835|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
25792836|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25792837|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25792838|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25792839|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25792840|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25792841|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792842|NCT00000609|Amiodarone|amiodarone|mesh-list
25792843|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25792844|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792845|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25792846|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25792847|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792848|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25792849|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25792850|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25792851|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792852|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25792853|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25792854|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25792855|NCT00000611|Vitamin D|vitamin d|mesh-list
25792856|NCT00000611|Calcium|calcium|mesh-list
25792857|NCT00000611|Hormones|hormones|mesh-list
25792858|NCT00000611|Estrogens|estrogens|mesh-list
25792859|NCT00000611|Progestins|progestins|mesh-list
25792860|NCT00000611|Vitamins|vitamins|mesh-ancestor
25792861|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
25792862|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792863|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25792864|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25792865|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792866|NCT00000612|Estrogens|estrogens|mesh-list
25792867|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25792868|NCT00000612|Hormones|hormones|mesh-ancestor
25792869|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792870|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792871|NCT00000613|Genistein|genistein|mesh-list
25792872|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25792873|NCT00000613|Protective Agents|protective agents|mesh-ancestor
25792874|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792875|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792876|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25792877|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792878|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792879|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
25792880|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25792881|NCT00000613|Estrogens|estrogens|mesh-ancestor
25792882|NCT00000613|Hormones|hormones|mesh-ancestor
25792883|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792884|NCT00000614|Warfarin|warfarin|mesh-list
25792885|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
25792886|NCT00000617|Azithromycin|azithromycin|mesh-list
25792887|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25792888|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792889|NCT00000621|Tretinoin|tretinoin|mesh-list
25792890|NCT00000621|Isotretinoin|isotretinoin|mesh-list
25792891|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792892|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
25792893|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25792894|NCT00000623|Decitabine|decitabine|mesh-list
25792895|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
25792896|NCT00000623|Deferiprone|deferiprone|mesh-list
25792897|NCT00000623|Deferoxamine|deferoxamine|mesh-list
25792898|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25792900|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792901|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792902|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792903|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
25792904|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25792905|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25792906|NCT00000623|Urological Agents|urological agents|mesh-ancestor
25792907|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25792908|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
25792909|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
25792910|NCT00000623|Siderophores|siderophores|mesh-ancestor
25792911|NCT00000625|Zidovudine|zidovudine|mesh-list
25792912|NCT00000625|Didanosine|didanosine|mesh-list
25792913|NCT00000625|Zalcitabine|zalcitabine|mesh-list
25792914|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
25792915|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792916|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25792917|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25792918|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792919|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
25792920|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792921|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25792922|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25792923|NCT00000626|Doxorubicin|doxorubicin|mesh-list
25792924|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25792925|NCT00000626|Bleomycin|bleomycin|mesh-list
25792926|NCT00000626|Dacarbazine|dacarbazine|mesh-list
25792927|NCT00000626|Vinblastine|vinblastine|mesh-list
25792928|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25792929|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25792930|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25792931|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25792932|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792933|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792934|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25792935|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
25792936|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25792937|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
25792938|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25792939|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25792940|NCT00000627|Fluconazole|fluconazole|mesh-list
25792941|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
25792942|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792943|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25792944|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25792945|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792946|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792947|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25792948|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
25792949|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25792950|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792951|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25792952|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25792953|NCT00000628|Zidovudine|zidovudine|mesh-list
25792954|NCT00000628|L-697661|l-697661|mesh-list
25792955|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
25792956|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792957|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25792958|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25792959|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792960|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
25792961|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792962|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24978720|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24978721|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121225|NCT03104010|Hormones|hormones|mesh-list
24978722|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978723|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
24978724|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
24420341|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24420342|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420343|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420345|NCT00215709|Docetaxel|docetaxel|mesh-list
25792963|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25792964|NCT00000629|Zidovudine|zidovudine|mesh-list
25792965|NCT00000629|Valproic Acid|valproic acid|mesh-list
25792966|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
25792967|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792968|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25792969|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25792970|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792971|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
25792972|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792973|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25792974|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25792975|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
25792976|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
25792977|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25792978|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792979|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
25792980|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25792981|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25792982|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25792983|NCT00000633|Vaccines|vaccines|mesh-list
25792984|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
25792985|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25792986|NCT00000634|Nevirapine|nevirapine|mesh-list
25792987|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25792988|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25792989|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25792990|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25792991|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
25792992|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25792993|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25792994|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25792995|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25792996|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25792997|NCT00000635|Trifluridine|trifluridine|mesh-list
25792998|NCT00000635|Polymyxins|polymyxins|mesh-list
25792999|NCT00000635|Bacitracin|bacitracin|mesh-list
25793000|NCT00000635|Polymyxin B|polymyxin b|mesh-list
25793001|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
25793002|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793003|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
25793004|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793005|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793006|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25793007|NCT00000636|Pyridoxine|pyridoxine|mesh-list
25793008|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
25793009|NCT00000636|Rifampin|rifampin|mesh-list
25793010|NCT00000636|Isoniazid|isoniazid|mesh-list
25793011|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
25793012|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25793013|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
25793014|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793015|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793016|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
25793017|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793018|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793019|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793020|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25793021|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25793022|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25793023|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25793024|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25793025|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25793026|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25793027|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25793028|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
25793029|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25793030|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
25793031|NCT00000636|Vitamins|vitamins|mesh-ancestor
24420556|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
24420557|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
24420558|NCT00216294|Secretin|secretin|mesh-list
24420559|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420560|NCT00216294|Hormones|hormones|mesh-ancestor
24420561|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24420562|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793032|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
25793033|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793034|NCT00000637|Zidovudine|zidovudine|mesh-list
25793035|NCT00000637|Didanosine|didanosine|mesh-list
25793036|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
25793037|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793038|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793039|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793040|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793041|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
25793042|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793043|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793044|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793045|NCT00000638|Pyridoxine|pyridoxine|mesh-list
25793046|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
25793047|NCT00000638|Rifampin|rifampin|mesh-list
25793048|NCT00000638|Isoniazid|isoniazid|mesh-list
25793049|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
25793050|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25793051|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
25793052|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793053|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793054|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
25793055|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793056|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793057|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793058|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25793059|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25793060|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25793061|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25793062|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25793063|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25793064|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25793065|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25793066|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
25793067|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25793068|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
25793069|NCT00000638|Vitamins|vitamins|mesh-ancestor
25793070|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
25793071|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793072|NCT00000639|Itraconazole|itraconazole|mesh-list
25793073|NCT00000639|Fluconazole|fluconazole|mesh-list
25793074|NCT00000639|Amphotericin B|amphotericin b|mesh-list
25793075|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25793076|NCT00000639|Flucytosine|flucytosine|mesh-list
25793077|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
25793078|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793079|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25793080|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25793081|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793082|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793083|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25793084|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
25793085|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25793086|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793087|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25793088|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25793089|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25793090|NCT00000639|Amebicides|amebicides|mesh-ancestor
25793091|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793092|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793093|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793094|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
25793095|NCT00000640|Clindamycin|clindamycin|mesh-list
25793096|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
25793097|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
25793098|NCT00000640|Dapsone|dapsone|mesh-list
25793099|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25793100|NCT00000640|Primaquine|primaquine|mesh-list
25793101|NCT00000640|Trimethoprim|trimethoprim|mesh-list
25793102|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
25793103|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793104|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793105|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25793106|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420732|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420736|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
25793107|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793108|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
25793109|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793110|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793111|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25793112|NCT00000640|Renal Agents|renal agents|mesh-ancestor
25793113|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793114|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25793115|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25793116|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25793117|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
25793118|NCT00000641|Azithromycin|azithromycin|mesh-list
25793119|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
25793120|NCT00000641|Rifampin|rifampin|mesh-list
25793121|NCT00000641|Amikacin|amikacin|mesh-list
25793122|NCT00000641|Ethambutol|ethambutol|mesh-list
25793123|NCT00000641|Clofazimine|clofazimine|mesh-list
25793124|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793125|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793126|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25793127|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25793128|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793129|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793130|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793131|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25793132|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25793133|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25793134|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
25793135|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
25793136|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793137|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25793138|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25793139|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25793140|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25793141|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25793142|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25793143|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25793144|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
25793145|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
25793146|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793147|NCT00000643|Leucovorin|leucovorin|mesh-list
25793148|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
25793149|NCT00000643|Calcium|calcium|mesh-list
25793150|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
25793151|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25793152|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793153|NCT00000643|Antidotes|antidotes|mesh-ancestor
25793154|NCT00000643|Protective Agents|protective agents|mesh-ancestor
25793155|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
25793156|NCT00000643|Vitamins|vitamins|mesh-ancestor
25793157|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
25793158|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
25793159|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793160|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793161|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793162|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793163|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793164|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793165|NCT00000644|Clarithromycin|clarithromycin|mesh-list
25793166|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793167|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793168|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25793169|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793170|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793171|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25793172|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25793173|NCT00000645|Hypericin|hypericin|mesh-list
25793174|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
25793175|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25793176|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793177|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
25793178|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421075|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793179|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793180|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793181|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25793182|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
25793183|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793184|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
25793185|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25793186|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793187|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793188|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25793189|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25793190|NCT00000646|Protective Agents|protective agents|mesh-ancestor
25793191|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793192|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
25793193|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25793194|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
25793195|NCT00000647|Interferons|interferons|mesh-list
25793196|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
25793197|NCT00000647|Zidovudine|zidovudine|mesh-list
25793198|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
25793199|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793200|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
25793201|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793202|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
25793203|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793204|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
25793205|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793206|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793207|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793208|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793209|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793210|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793211|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
25793212|NCT00000648|Penicillins|penicillins|mesh-list
25793213|NCT00000648|Penicillin G|penicillin g|mesh-list
25793214|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25793215|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
25793216|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793217|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793218|NCT00000649|Zidovudine|zidovudine|mesh-list
25793219|NCT00000649|Nevirapine|nevirapine|mesh-list
25793220|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
25793221|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793222|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793223|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793224|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793225|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
25793226|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793227|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793228|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793229|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25793230|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25793231|NCT00000650|Ditiocarb|ditiocarb|mesh-list
25793232|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25793233|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
25793234|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793235|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
25793236|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793237|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
25793238|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
25793239|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793240|NCT00000651|Zidovudine|zidovudine|mesh-list
25793241|NCT00000651|Zalcitabine|zalcitabine|mesh-list
25793242|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
25793243|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793244|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793245|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793246|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793247|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
25793248|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421356|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
24421357|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421359|NCT00218374|Analgesics|analgesics|mesh-ancestor
24421360|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
24421361|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421362|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421363|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
25793249|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793250|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793251|NCT00000652|Zidovudine|zidovudine|mesh-list
25793252|NCT00000652|Didanosine|didanosine|mesh-list
25793253|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
25793254|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793255|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793256|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793257|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793258|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
25793259|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793260|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793261|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793262|NCT00000653|Zalcitabine|zalcitabine|mesh-list
25793263|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
25793264|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793265|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793266|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793267|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793268|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
25793269|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793270|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793271|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793272|NCT00000654|Fialuridine|fialuridine|mesh-list
25793273|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
25793274|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793275|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793276|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793277|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793278|NCT00000655|Trimethoprim|trimethoprim|mesh-list
25793279|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25793280|NCT00000655|Atovaquone|atovaquone|mesh-list
25793281|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
25793282|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25793283|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793284|NCT00000655|Renal Agents|renal agents|mesh-ancestor
25793285|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
25793286|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793287|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793288|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793289|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793290|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793291|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25793292|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25793293|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25793294|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793295|NCT00000656|Zidovudine|zidovudine|mesh-list
25793296|NCT00000656|Didanosine|didanosine|mesh-list
25793297|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
25793298|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793299|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793300|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793301|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793302|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
25793303|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793304|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793305|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793306|NCT00000657|Zidovudine|zidovudine|mesh-list
25793307|NCT00000657|Didanosine|didanosine|mesh-list
25793308|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
25793309|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793310|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793311|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793312|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793313|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
25793314|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793315|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793316|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793317|NCT00000658|Leucovorin|leucovorin|mesh-list
25793318|NCT00000658|Cytarabine|cytarabine|mesh-list
25793319|NCT00000658|Dexamethasone|dexamethasone|mesh-list
25793320|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
25793321|NCT00000658|Doxorubicin|doxorubicin|mesh-list
25793322|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25793323|NCT00000658|Methotrexate|methotrexate|mesh-list
25793324|NCT00000658|Vincristine|vincristine|mesh-list
25793325|NCT00000658|Bleomycin|bleomycin|mesh-list
24997434|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25793326|NCT00000658|Allopurinol|allopurinol|mesh-list
25793327|NCT00000658|Sargramostim|sargramostim|mesh-list
25793328|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
25793329|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25793330|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
25793331|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793332|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25793333|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25793334|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
25793335|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793336|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793337|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25793338|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25793339|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
25793340|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
25793341|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25793342|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25793343|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
25793344|NCT00000658|Hormones|hormones|mesh-ancestor
25793345|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25793346|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25793347|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25793348|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25793349|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25793350|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793351|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25793352|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
25793353|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25793354|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25793355|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
25793356|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
25793357|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793358|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793359|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
25793360|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793361|NCT00000658|Antidotes|antidotes|mesh-ancestor
25793362|NCT00000658|Protective Agents|protective agents|mesh-ancestor
25793363|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
25793364|NCT00000658|Vitamins|vitamins|mesh-ancestor
25793365|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
25793366|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25793367|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
25793368|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
25793369|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
25793370|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
25793371|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25793372|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
25793373|NCT00000659|Zidovudine|zidovudine|mesh-list
25793374|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
25793375|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793376|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793377|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793378|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793379|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
25793380|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793381|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793382|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793383|NCT00000660|Etoposide|etoposide|mesh-list
25793384|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25793385|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793386|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25793387|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25793388|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793389|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793390|NCT00000661|Zidovudine|zidovudine|mesh-list
25793391|NCT00000661|Oxazepam|oxazepam|mesh-list
25793392|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
25793393|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421667|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421668|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978877|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24978878|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978879|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24978880|NCT02579265|SMOFlipid|smoflipid|mesh-list
24978881|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25793394|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793395|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793396|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793397|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
25793398|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793399|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793400|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793401|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25793402|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25793403|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793404|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25793405|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25793406|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25793407|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
25793408|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
25793409|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25793410|NCT00000662|Zidovudine|zidovudine|mesh-list
25793411|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
25793412|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793413|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793414|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793415|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793416|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
25793417|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793418|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793419|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793420|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
25793421|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
25793422|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793423|NCT00000664|Zidovudine|zidovudine|mesh-list
25793424|NCT00000664|Interleukin-2|interleukin-2|mesh-list
25793425|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793426|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25793427|NCT00000664|Analgesics|analgesics|mesh-ancestor
25793428|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
25793429|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25793430|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793431|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
25793432|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793433|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793434|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793435|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793436|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
25793437|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793438|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793439|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793440|NCT00000665|Ganciclovir|ganciclovir|mesh-list
25793441|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25793442|NCT00000665|Foscarnet|foscarnet|mesh-list
25793443|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25793444|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
25793445|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793446|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793447|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793448|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793449|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793450|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
25793451|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
25793452|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793453|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793454|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793455|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793456|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793457|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793458|NCT00000668|Ganciclovir|ganciclovir|mesh-list
25793459|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25793460|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
25793461|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793462|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793463|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793464|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422104|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422105|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24422106|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24422123|NCT00221442|Zonisamide|zonisamide|mesh-list
25793465|NCT00000669|Didanosine|didanosine|mesh-list
25793466|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
25793467|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793468|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793469|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793470|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793471|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
25793472|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793473|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793474|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793475|NCT00000670|Zidovudine|zidovudine|mesh-list
25793476|NCT00000670|Probenecid|probenecid|mesh-list
25793477|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
25793478|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793479|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793480|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793481|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793482|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
25793483|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793484|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793485|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793486|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
25793487|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
25793488|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25793489|NCT00000670|Renal Agents|renal agents|mesh-ancestor
25793490|NCT00000671|Zidovudine|zidovudine|mesh-list
25793491|NCT00000671|Didanosine|didanosine|mesh-list
25793492|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
25793493|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793494|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793495|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793496|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793497|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
25793498|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793499|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793500|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793501|NCT00000672|Didanosine|didanosine|mesh-list
25793502|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
25793503|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793504|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793505|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793506|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793507|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
25793508|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793509|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793510|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793511|NCT00000673|Ganciclovir|ganciclovir|mesh-list
25793512|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25793513|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
25793514|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793515|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793516|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793517|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793518|NCT00000674|Leucovorin|leucovorin|mesh-list
25793519|NCT00000674|Clindamycin|clindamycin|mesh-list
25793520|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
25793521|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
25793522|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
25793523|NCT00000674|Calcium|calcium|mesh-list
25793524|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
25793525|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25793526|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793527|NCT00000674|Antidotes|antidotes|mesh-ancestor
25793528|NCT00000674|Protective Agents|protective agents|mesh-ancestor
25793529|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
25793530|NCT00000674|Vitamins|vitamins|mesh-ancestor
25793531|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
25793532|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25793533|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793534|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25793535|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793536|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793537|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
25105871|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25105872|NCT04824274|Narcotics|narcotics|mesh-ancestor
25105875|NCT04824274|Analgesics|analgesics|mesh-ancestor
25793538|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793539|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793540|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793541|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
25793542|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
25793543|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793544|NCT00000676|Fluconazole|fluconazole|mesh-list
25793545|NCT00000676|Clotrimazole|clotrimazole|mesh-list
25793546|NCT00000676|Miconazole|miconazole|mesh-list
25793547|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
25793548|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793549|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25793550|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25793551|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793552|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793553|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25793554|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
25793555|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25793556|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793557|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25793558|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25793559|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25793560|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25793561|NCT00000677|Sch 39304|sch 39304|mesh-list
25793562|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
25793563|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793564|NCT00000678|Zidovudine|zidovudine|mesh-list
25793565|NCT00000678|Zalcitabine|zalcitabine|mesh-list
25793566|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
25793567|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793568|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793569|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793570|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793571|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
25793572|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793573|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793574|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793575|NCT00000679|Zidovudine|zidovudine|mesh-list
25793576|NCT00000679|Zalcitabine|zalcitabine|mesh-list
25793577|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
25793578|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793579|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793580|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793581|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793582|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
25793583|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793584|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793585|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793586|NCT00000680|Zidovudine|zidovudine|mesh-list
25793587|NCT00000680|Aldesleukin|aldesleukin|mesh-list
25793588|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
25793589|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793590|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793591|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793592|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793593|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
25793594|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793595|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793596|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793597|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793598|NCT00000681|Zidovudine|zidovudine|mesh-list
25793599|NCT00000681|Doxorubicin|doxorubicin|mesh-list
25793600|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25793601|NCT00000681|Bleomycin|bleomycin|mesh-list
25793602|NCT00000681|Vincristine|vincristine|mesh-list
25793603|NCT00000681|Sargramostim|sargramostim|mesh-list
24978942|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978944|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121961|NCT03097900|Caffeine|caffeine|mesh-list
24978945|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24978946|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24422521|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422522|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
24422523|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25793604|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25793605|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793606|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25793608|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793609|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793610|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25793611|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
25793612|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
25793613|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
25793614|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
25793615|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793616|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793617|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
25793618|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793619|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793620|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793621|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
25793622|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793623|NCT00000682|Zidovudine|zidovudine|mesh-list
25793624|NCT00000682|Zalcitabine|zalcitabine|mesh-list
25793625|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
25793626|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793627|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793628|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793629|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793630|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
25793631|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793632|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793633|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793634|NCT00000684|Dextrans|dextrans|mesh-list
25793635|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
25793636|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
25793637|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
25793638|NCT00000685|Zidovudine|zidovudine|mesh-list
25793639|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
25793640|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793641|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793642|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793643|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793644|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
25793645|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793646|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793647|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793648|NCT00000686|Stavudine|stavudine|mesh-list
25793649|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
25793650|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793651|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793652|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793653|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793654|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
25793655|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793656|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793657|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793658|NCT00000687|Interferons|interferons|mesh-list
25793659|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
25793660|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
25793661|NCT00000687|Zidovudine|zidovudine|mesh-list
25793662|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793663|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
25793664|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793665|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
25793666|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793667|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
25793668|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793669|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793670|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793671|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793672|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793673|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793674|NCT00000688|Ganciclovir|ganciclovir|mesh-list
25793675|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25793676|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
25793677|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793678|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793679|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793680|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793681|NCT00000689|Leucovorin|leucovorin|mesh-list
25793682|NCT00000689|Cytarabine|cytarabine|mesh-list
25793683|NCT00000689|Dexamethasone|dexamethasone|mesh-list
25793684|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
25793685|NCT00000689|Doxorubicin|doxorubicin|mesh-list
25793686|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25793687|NCT00000689|Methotrexate|methotrexate|mesh-list
25793688|NCT00000689|Vincristine|vincristine|mesh-list
25793689|NCT00000689|Bleomycin|bleomycin|mesh-list
25793690|NCT00000689|Sargramostim|sargramostim|mesh-list
25793691|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
25793692|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25793693|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
25793694|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793695|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25793696|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25793697|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
25793698|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793699|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793700|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25793701|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25793702|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
25793703|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
25793704|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25793705|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25793706|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
25793707|NCT00000689|Hormones|hormones|mesh-ancestor
25793708|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25793709|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25793710|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25793711|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25793712|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25793713|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793714|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25793715|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
25793716|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25793717|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25793718|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
25793719|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
25793720|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793721|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793722|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
25793723|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793724|NCT00000689|Antidotes|antidotes|mesh-ancestor
25793725|NCT00000689|Protective Agents|protective agents|mesh-ancestor
25793726|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
25793727|NCT00000689|Vitamins|vitamins|mesh-ancestor
25793728|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
25793729|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25793730|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
25793731|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
25793732|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
25793733|NCT00000690|Dextrans|dextrans|mesh-list
25793734|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
25793735|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
25793736|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
25793737|NCT00000691|Foscarnet|foscarnet|mesh-list
25793738|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25793739|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
25793740|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793741|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793742|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793743|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793744|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793745|NCT00000692|Miglustat|miglustat|mesh-list
25793746|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793747|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793748|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793749|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793750|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
25793751|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793752|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25793753|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25793754|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793755|NCT00000693|Zidovudine|zidovudine|mesh-list
25793756|NCT00000693|Acyclovir|acyclovir|mesh-list
25793757|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
25793758|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793759|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793760|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793761|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793762|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
25793763|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793764|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793765|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793766|NCT00000694|Interferons|interferons|mesh-list
25793767|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
25793768|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
25793769|NCT00000694|Zidovudine|zidovudine|mesh-list
25793770|NCT00000694|Sargramostim|sargramostim|mesh-list
25793771|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793772|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
25793773|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793774|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
25793775|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793776|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
25793777|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793778|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793779|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423008|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978986|NCT01996436|Verapamil|verapamil|mesh-list
24978987|NCT01996436|Nicardipine|nicardipine|mesh-list
24978988|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
24978989|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
24978990|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24978991|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24978992|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423042|NCT00224471|Vaccines|vaccines|mesh-list
25793780|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793781|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793782|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793783|NCT00000695|Interferons|interferons|mesh-list
25793785|NCT00000695|Interferon-beta|interferon-beta|mesh-list
25793786|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
25793787|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793788|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
25793789|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793790|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
25793791|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793792|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793793|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793794|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793795|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793796|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793797|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
25793798|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793799|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25793800|NCT00000696|Interferons|interferons|mesh-list
25793801|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
25793802|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
25793803|NCT00000696|Zidovudine|zidovudine|mesh-list
25793804|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793805|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
25793806|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793807|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
25793808|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793809|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
25793810|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793811|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793812|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793813|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793814|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793815|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793816|NCT00000697|Foscarnet|foscarnet|mesh-list
25793817|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25793818|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
25793819|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793820|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793821|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793822|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793823|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793824|NCT00000698|Ganciclovir|ganciclovir|mesh-list
25793825|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25793826|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
25793827|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793828|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793829|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793830|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793831|NCT00000699|Ribavirin|ribavirin|mesh-list
25793832|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
25793833|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
25793834|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793835|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
25793836|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793837|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25793838|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
25793839|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793840|NCT00000700|Zidovudine|zidovudine|mesh-list
25793841|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
25793842|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793843|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793844|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793845|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793846|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
25793847|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793848|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793849|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793850|NCT00000701|Zidovudine|zidovudine|mesh-list
25793851|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
25122299|NCT03095079|Endostatins|endostatins|mesh-list
25122300|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25122302|NCT03095079|Growth Substances|growth substances|mesh-ancestor
24423182|NCT00225043|Phenylephrine|phenylephrine|mesh-list
24423183|NCT00225043|Epinephrine|epinephrine|mesh-list
24423184|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
24423185|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24979020|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
25793852|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793853|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793854|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793855|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793856|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
25793857|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793858|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793859|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793860|NCT00000702|Zidovudine|zidovudine|mesh-list
25793861|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
25793862|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793863|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793864|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793865|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793866|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
25793867|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793868|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793869|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793870|NCT00000703|Leucovorin|leucovorin|mesh-list
25793871|NCT00000703|Cytarabine|cytarabine|mesh-list
25793872|NCT00000703|Zidovudine|zidovudine|mesh-list
25793873|NCT00000703|Dexamethasone|dexamethasone|mesh-list
25793874|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
25793875|NCT00000703|Doxorubicin|doxorubicin|mesh-list
25793876|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25793877|NCT00000703|Methotrexate|methotrexate|mesh-list
25793878|NCT00000703|Vincristine|vincristine|mesh-list
25793879|NCT00000703|Bleomycin|bleomycin|mesh-list
25793880|NCT00000703|Allopurinol|allopurinol|mesh-list
25793881|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
25793882|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25793883|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
25793884|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793885|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25793886|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25793887|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
25793888|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793889|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25793890|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25793891|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25793892|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
25793893|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
25793894|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25793895|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25793896|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
25793897|NCT00000703|Hormones|hormones|mesh-ancestor
25793898|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25793899|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25793900|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25793901|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25793902|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25793903|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793904|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25793905|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
25793906|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25793907|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25793908|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
25793909|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
25793910|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25793911|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793912|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
25793913|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793914|NCT00000703|Antidotes|antidotes|mesh-ancestor
25793915|NCT00000703|Protective Agents|protective agents|mesh-ancestor
25793916|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
25793917|NCT00000703|Vitamins|vitamins|mesh-ancestor
25793918|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
24979073|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
24979074|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979075|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979076|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24423190|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423191|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24423204|NCT00225056|Docetaxel|docetaxel|mesh-list
24423221|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
24423222|NCT00225160|Vitamins|vitamins|mesh-ancestor
24423223|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
24423227|NCT00225173|Prednisone|prednisone|mesh-list
25793919|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25793920|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
25793921|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
25793922|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
25793923|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793925|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793926|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
25793927|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25793928|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
25793929|NCT00000704|Zalcitabine|zalcitabine|mesh-list
25793930|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
25793931|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793932|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793933|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793934|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793935|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
25793936|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793937|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793938|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793939|NCT00000705|Zidovudine|zidovudine|mesh-list
25793940|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
25793941|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793942|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793943|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793944|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793945|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
25793946|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793947|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793948|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793949|NCT00000706|Zidovudine|zidovudine|mesh-list
25793950|NCT00000706|Quinine|quinine|mesh-list
25793951|NCT00000706|Probenecid|probenecid|mesh-list
25793952|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
25793953|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25793954|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25793955|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25793956|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793957|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
25793958|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793959|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793960|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25793961|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
25793962|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793963|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793964|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25793965|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793966|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25793967|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25793968|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25793969|NCT00000706|Analgesics|analgesics|mesh-ancestor
25793970|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
25793971|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
25793972|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
25793973|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25793974|NCT00000706|Renal Agents|renal agents|mesh-ancestor
25793975|NCT00000707|Pentamidine|pentamidine|mesh-list
25793976|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
25793977|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793978|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793979|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25793980|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25793981|NCT00000708|Fluconazole|fluconazole|mesh-list
25793982|NCT00000708|Amphotericin B|amphotericin b|mesh-list
25793983|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25793984|NCT00000708|Flucytosine|flucytosine|mesh-list
25793985|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
25793986|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25793987|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25793988|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25793989|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25793990|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979112|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25793991|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25793992|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
25793993|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25793995|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25793996|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25793997|NCT00000708|Amebicides|amebicides|mesh-ancestor
25793998|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25793999|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794000|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794001|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
25794002|NCT00000709|Zidovudine|zidovudine|mesh-list
25794003|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
25794004|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794005|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794006|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794007|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794008|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
25794009|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794010|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794011|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794012|NCT00000710|Didanosine|didanosine|mesh-list
25794013|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
25794014|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794015|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794016|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794017|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794018|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
25794019|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794020|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794021|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794022|NCT00000711|Zidovudine|zidovudine|mesh-list
25794023|NCT00000711|Sargramostim|sargramostim|mesh-list
25794024|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
25794025|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794026|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794027|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794028|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794029|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
25794030|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794031|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794032|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794033|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
25794034|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794035|NCT00000712|Zidovudine|zidovudine|mesh-list
25794036|NCT00000712|Acyclovir|acyclovir|mesh-list
25794037|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
25794038|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794039|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794040|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794041|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794042|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
25794043|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794044|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794045|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794046|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25794047|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
25794048|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794049|NCT00000714|Leucovorin|leucovorin|mesh-list
25794050|NCT00000714|Trimetrexate|trimetrexate|mesh-list
25794051|NCT00000714|Calcium|calcium|mesh-list
25794052|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
25794053|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25794054|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794055|NCT00000714|Antidotes|antidotes|mesh-ancestor
25794056|NCT00000714|Protective Agents|protective agents|mesh-ancestor
25794057|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
25794058|NCT00000714|Vitamins|vitamins|mesh-ancestor
25794059|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
25794060|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
25794061|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794062|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25794063|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
25794064|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794065|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423837|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
24423838|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24423839|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794066|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794067|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794068|NCT00000715|Trimethoprim|trimethoprim|mesh-list
25794069|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25794070|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
25794071|NCT00000715|Pentamidine|pentamidine|mesh-list
25794072|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794073|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794074|NCT00000715|Renal Agents|renal agents|mesh-ancestor
25794075|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
25794076|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794077|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794078|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794079|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794080|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794081|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25794082|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25794083|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794084|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
25794085|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25794086|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794087|NCT00000716|Zidovudine|zidovudine|mesh-list
25794088|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
25794089|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794090|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794091|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794092|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794093|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
25794094|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794095|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794096|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794097|NCT00000717|Clindamycin|clindamycin|mesh-list
25794098|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
25794099|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
25794100|NCT00000717|Primaquine|primaquine|mesh-list
25794101|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794102|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794103|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25794104|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794105|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794106|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
25794107|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794108|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794109|NCT00000718|Zidovudine|zidovudine|mesh-list
25794110|NCT00000718|Zalcitabine|zalcitabine|mesh-list
25794111|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
25794112|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794113|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794114|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794115|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794116|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
25794117|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794118|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794119|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794120|NCT00000719|Zidovudine|zidovudine|mesh-list
25794121|NCT00000719|Zalcitabine|zalcitabine|mesh-list
25794122|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
25794123|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794124|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794125|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794126|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794127|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
25794128|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794129|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794130|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794131|NCT00000720|Zidovudine|zidovudine|mesh-list
25794132|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
25794133|NCT00000720|Antibodies|antibodies|mesh-list
25794134|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
25794135|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794136|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794137|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794138|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794139|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
25794140|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794141|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794142|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794143|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
25794144|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794145|NCT00000722|Pentamidine|pentamidine|mesh-list
25794146|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
25794147|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794148|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794149|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794150|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25794151|NCT00000723|Leucovorin|leucovorin|mesh-list
25794152|NCT00000723|Zidovudine|zidovudine|mesh-list
25794153|NCT00000723|Dexamethasone|dexamethasone|mesh-list
25794154|NCT00000723|Methotrexate|methotrexate|mesh-list
25794155|NCT00000723|Calcium|calcium|mesh-list
25794156|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
25794157|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25794158|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
25794159|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
25794160|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794161|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794162|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25794163|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
25794164|NCT00000723|Hormones|hormones|mesh-ancestor
25794165|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794166|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25794167|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794168|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25794169|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25794170|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
25794171|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25794172|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25794173|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
25794174|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794175|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
25794176|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794177|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794178|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25794179|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
25794180|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25794181|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794182|NCT00000723|Antidotes|antidotes|mesh-ancestor
25794183|NCT00000723|Protective Agents|protective agents|mesh-ancestor
25794184|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
25794185|NCT00000723|Vitamins|vitamins|mesh-ancestor
25794186|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
25794187|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794188|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
25794189|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794190|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794191|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794192|NCT00000724|Leucovorin|leucovorin|mesh-list
25794193|NCT00000724|Trimetrexate|trimetrexate|mesh-list
25794194|NCT00000724|Calcium|calcium|mesh-list
25794195|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
25794196|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25794197|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794198|NCT00000724|Antidotes|antidotes|mesh-ancestor
25794199|NCT00000724|Protective Agents|protective agents|mesh-ancestor
25794200|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
25794201|NCT00000724|Vitamins|vitamins|mesh-ancestor
25794202|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
25794203|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
25794204|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794205|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25794206|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
25794207|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794208|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794209|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794210|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794211|NCT00000725|Interferons|interferons|mesh-list
25794212|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
25794213|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
25794214|NCT00000725|Zidovudine|zidovudine|mesh-list
25794215|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162048|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202823|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202824|NCT02718521|Isosorbide|isosorbide|mesh-list
25202830|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202831|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
25794216|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
25794217|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794218|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
25794219|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794220|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
25794221|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794222|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794223|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794224|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794225|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794226|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794227|NCT00000726|Foscarnet|foscarnet|mesh-list
25794228|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25794229|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
25794230|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794231|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794232|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794233|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794234|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794235|NCT00000727|Zidovudine|zidovudine|mesh-list
25794236|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
25794237|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
25794238|NCT00000727|Trimethoprim|trimethoprim|mesh-list
25794239|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
25794240|NCT00000727|Pentamidine|pentamidine|mesh-list
25794241|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25794242|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
25794243|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794244|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794245|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794246|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794247|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
25794248|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794249|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794250|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794251|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
25794252|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794253|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794254|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794255|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794256|NCT00000727|Renal Agents|renal agents|mesh-ancestor
25794257|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25794258|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25794259|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794260|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
25794261|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25794262|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794263|NCT00000728|Zidovudine|zidovudine|mesh-list
25794264|NCT00000728|Aldesleukin|aldesleukin|mesh-list
25794265|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
25794266|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794267|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794268|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794269|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794270|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
25794271|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794272|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794273|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794274|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794275|NCT00000729|Foscarnet|foscarnet|mesh-list
25794276|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25794277|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
25794278|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794279|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794280|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24424691|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
24424724|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979298|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122835|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122836|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979300|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
24979301|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979302|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
24979303|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794281|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794282|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794283|NCT00000730|Leucovorin|leucovorin|mesh-list
25794284|NCT00000730|Trimethoprim|trimethoprim|mesh-list
25794285|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25794286|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
25794287|NCT00000730|Pentamidine|pentamidine|mesh-list
25794288|NCT00000730|Trimetrexate|trimetrexate|mesh-list
25794289|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
25794290|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
25794291|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794292|NCT00000730|Antidotes|antidotes|mesh-ancestor
25794293|NCT00000730|Protective Agents|protective agents|mesh-ancestor
25794294|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
25794295|NCT00000730|Vitamins|vitamins|mesh-ancestor
25794296|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
25794297|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25794298|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
25794299|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
25794300|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794301|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25794302|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
25794303|NCT00000730|Hormones|hormones|mesh-ancestor
25794304|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794305|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25794306|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794307|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794308|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794309|NCT00000730|Renal Agents|renal agents|mesh-ancestor
25794310|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
25794311|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794312|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794313|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794314|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794315|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794316|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25794317|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25794318|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794319|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
25794320|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25794321|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794322|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25794323|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
25794324|NCT00000731|Acetaminophen|acetaminophen|mesh-list
25794325|NCT00000731|Zidovudine|zidovudine|mesh-list
25794326|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25794327|NCT00000731|Analgesics|analgesics|mesh-ancestor
25794328|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
25794329|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794330|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794331|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
25794332|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
25794333|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794334|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794335|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794336|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794337|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
25794338|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794339|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794340|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794341|NCT00000732|Zidovudine|zidovudine|mesh-list
25794342|NCT00000732|Trimethoprim|trimethoprim|mesh-list
25794343|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
25794344|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25794345|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
25794346|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794347|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794348|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794349|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794350|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
25794351|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794352|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794353|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794354|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794355|NCT00000732|Renal Agents|renal agents|mesh-ancestor
25794356|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
25794357|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794358|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794359|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794360|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25794361|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25794362|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794363|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794365|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
25794366|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794367|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
25794368|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794369|NCT00000734|Zidovudine|zidovudine|mesh-list
25794370|NCT00000734|Trimethoprim|trimethoprim|mesh-list
25794371|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
25794372|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25794373|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
25794374|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794375|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794376|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794377|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794378|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
25794379|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794380|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794381|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794382|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794383|NCT00000734|Renal Agents|renal agents|mesh-ancestor
25794384|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
25794385|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794386|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794387|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794388|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25794389|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25794390|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794391|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794392|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25794393|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
25794394|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794395|NCT00000736|Zidovudine|zidovudine|mesh-list
25794396|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
25794397|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794398|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794399|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794400|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794401|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
25794402|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794403|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794404|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794405|NCT00000737|Megestrol|megestrol|mesh-list
25794406|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
25794407|NCT00000737|Dronabinol|dronabinol|mesh-list
25794408|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
25794409|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794410|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25794411|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25794412|NCT00000737|Analgesics|analgesics|mesh-ancestor
25794413|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
25794414|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794415|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25794416|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25794417|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25794418|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794419|NCT00000737|Hormones|hormones|mesh-ancestor
25794420|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794421|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25794422|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25794423|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25794424|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
25794425|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25794426|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25794427|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25794428|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25794429|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794430|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
24426422|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840608|NCT02211222|Lenvatinib|lenvatinib|mesh-list
25794431|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25794432|NCT00000738|Zidovudine|zidovudine|mesh-list
25794433|NCT00000738|Nimodipine|nimodipine|mesh-list
25794434|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
25794435|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794436|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794437|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794438|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794439|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
25794440|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794441|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794442|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794443|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25794444|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25794445|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25794446|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25794447|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794448|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
25794449|NCT00000739|Dapsone|dapsone|mesh-list
25794450|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794451|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
25794452|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794453|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794454|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794455|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794456|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794457|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
25794458|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794459|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
25794460|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25794461|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25794462|NCT00000741|Prednisolone|prednisolone|mesh-list
25794463|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
25794464|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25794465|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
25794466|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25794467|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
25794468|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
25794469|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794470|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794471|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25794472|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
25794473|NCT00000741|Hormones|hormones|mesh-ancestor
25794474|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794475|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25794476|NCT00000741|Protective Agents|protective agents|mesh-ancestor
25794477|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25794478|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794479|NCT00000742|Zidovudine|zidovudine|mesh-list
25794480|NCT00000742|Didanosine|didanosine|mesh-list
25794481|NCT00000742|Atevirdine|atevirdine|mesh-list
25794482|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
25794483|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794484|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794485|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794486|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794487|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
25794488|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794489|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794490|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794491|NCT00000743|Zidovudine|zidovudine|mesh-list
25794492|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
25794493|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794494|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794495|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794496|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794497|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
25794498|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794499|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794500|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794501|NCT00000744|Fluconazole|fluconazole|mesh-list
25794502|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
25794503|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794504|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25794505|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794506|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794507|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794508|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25794509|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
25794510|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794511|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794512|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25794513|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25794514|NCT00000745|Vaccines|vaccines|mesh-list
25794515|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
25794516|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794517|NCT00000747|Nevirapine|nevirapine|mesh-list
25794518|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794519|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794520|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794521|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794522|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
25794523|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794524|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794525|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794526|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25794527|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25794528|NCT00000748|Trimethoprim|trimethoprim|mesh-list
25794529|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25794530|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
25794531|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794532|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794533|NCT00000748|Renal Agents|renal agents|mesh-ancestor
25794534|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
25794535|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794536|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794537|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794538|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794539|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794540|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25794541|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25794542|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794543|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794544|NCT00000750|Zidovudine|zidovudine|mesh-list
25794545|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
25794546|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794547|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794548|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794549|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794550|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
25794551|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794552|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794553|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794554|NCT00000751|Zidovudine|zidovudine|mesh-list
25794555|NCT00000751|Immune Sera|immune sera|mesh-list
25794556|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
25794557|NCT00000751|Antibodies|antibodies|mesh-list
25794558|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
25794559|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794560|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794561|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794562|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794563|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
25794564|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794565|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794566|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794567|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
25794568|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794569|NCT00000752|Cefuroxime|cefuroxime|mesh-list
24428047|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
24428048|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428049|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428180|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428181|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428182|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
24841172|NCT02214602|Epirubicin|epirubicin|mesh-list
25105982|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783846|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
25794570|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
25794571|NCT00000752|Beclomethasone|beclomethasone|mesh-list
25794572|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
25794573|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
25794574|NCT00000752|Ephedrine|ephedrine|mesh-list
25794575|NCT00000752|Guaifenesin|guaifenesin|mesh-list
25794576|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25794577|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25794578|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
25794579|NCT00000752|Hormones|hormones|mesh-ancestor
25794580|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794581|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794582|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25794583|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
25794584|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25794585|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
25794586|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794587|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
25794588|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25794589|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25794590|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
25794591|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
25794592|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25794593|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794594|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794595|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794596|NCT00000752|Expectorants|expectorants|mesh-ancestor
25794597|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25794598|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25794599|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
25794600|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25794601|NCT00000753|Zidovudine|zidovudine|mesh-list
25794602|NCT00000753|Didanosine|didanosine|mesh-list
25794603|NCT00000753|Zalcitabine|zalcitabine|mesh-list
25794604|NCT00000753|Atevirdine|atevirdine|mesh-list
25794605|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
25794606|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794607|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794608|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794609|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794610|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
25794611|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794612|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794613|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794614|NCT00000754|Interferons|interferons|mesh-list
25794615|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
25794616|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
25794617|NCT00000754|Zidovudine|zidovudine|mesh-list
25794618|NCT00000754|Zalcitabine|zalcitabine|mesh-list
25794619|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794620|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
25794621|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794622|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
25794623|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794624|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
25794625|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794626|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794627|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794628|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794629|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794630|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794631|NCT00000755|Zidovudine|zidovudine|mesh-list
25794632|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
25794633|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794634|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794635|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794636|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794637|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
25794638|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040910|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25040911|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
25040912|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25040913|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25040914|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25040915|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25794639|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794640|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794641|NCT00000758|Fluorouracil|fluorouracil|mesh-list
25794642|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
25794643|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794644|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25794645|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794646|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25794647|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
25794648|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794649|NCT00000760|Zidovudine|zidovudine|mesh-list
25794650|NCT00000760|Didanosine|didanosine|mesh-list
25794651|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
25794652|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794653|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794654|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794655|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794656|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
25794657|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794658|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794659|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794660|NCT00000761|Interferons|interferons|mesh-list
25794661|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
25794662|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794663|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
25794664|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794665|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
25794666|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25794667|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794668|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25794669|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25794670|NCT00000763|Growth Substances|growth substances|mesh-ancestor
25794671|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794672|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
25794673|NCT00000764|Interferons|interferons|mesh-list
25794674|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
25794675|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
25794676|NCT00000764|Isotretinoin|isotretinoin|mesh-list
25794677|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794678|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
25794679|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794680|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
25794681|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794682|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
25794683|NCT00000765|Zidovudine|zidovudine|mesh-list
25794684|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
25794685|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794686|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794687|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794688|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794689|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
25794690|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794691|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794692|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794693|NCT00000766|Ganciclovir|ganciclovir|mesh-list
25794694|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25794695|NCT00000766|Foscarnet|foscarnet|mesh-list
25794696|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25794697|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
25794698|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794699|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794700|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794701|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794702|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794703|NCT00000767|Vaccines|vaccines|mesh-list
25794704|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
25794705|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428571|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24428572|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428577|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
24428578|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428579|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428580|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428581|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24428582|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25794706|NCT00000768|Ganciclovir|ganciclovir|mesh-list
25794707|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25794708|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
25794709|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794710|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794711|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794712|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794713|NCT00000769|Interleukin-4|interleukin-4|mesh-list
25794714|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25794715|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
25794716|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794717|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794718|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25794719|NCT00000770|Zidovudine|zidovudine|mesh-list
25794720|NCT00000770|Nevirapine|nevirapine|mesh-list
25794721|NCT00000770|Didanosine|didanosine|mesh-list
25794722|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
25794723|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794724|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794725|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794726|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794727|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
25794728|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794729|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794730|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794731|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25794732|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25794733|NCT00000771|Paromomycin|paromomycin|mesh-list
25794734|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794735|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794736|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794737|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794738|NCT00000772|Ribavirin|ribavirin|mesh-list
25794739|NCT00000772|Didanosine|didanosine|mesh-list
25794740|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
25794741|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794742|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
25794743|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794744|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794745|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794746|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794747|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794748|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794749|NCT00000773|Atovaquone|atovaquone|mesh-list
25794750|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794751|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
25794752|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794753|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794754|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794755|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794756|NCT00000776|Fluconazole|fluconazole|mesh-list
25794757|NCT00000776|Amphotericin B|amphotericin b|mesh-list
25794758|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25794759|NCT00000776|Flucytosine|flucytosine|mesh-list
25794760|NCT00000776|Dexamethasone|dexamethasone|mesh-list
25794761|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25794762|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
25794763|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
25794764|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794765|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794766|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25794767|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
25794768|NCT00000776|Hormones|hormones|mesh-ancestor
25794769|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794770|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25794771|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794772|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
25794773|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794774|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25794775|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794776|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794777|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794778|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25794779|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
25794780|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25794781|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25794782|NCT00000776|Amebicides|amebicides|mesh-ancestor
25794783|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794784|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794785|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794786|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
25794787|NCT00000778|Pyridoxine|pyridoxine|mesh-list
25794788|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
25794789|NCT00000778|Levofloxacin|levofloxacin|mesh-list
25794790|NCT00000778|Ofloxacin|ofloxacin|mesh-list
25794791|NCT00000778|Isoniazid|isoniazid|mesh-list
25794792|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794793|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794794|NCT00000778|Renal Agents|renal agents|mesh-ancestor
25794795|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794796|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25794797|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25794798|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794799|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794800|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794801|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25794802|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794803|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
25794804|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25794805|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25794806|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
25794807|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25794808|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
25794809|NCT00000778|Vitamins|vitamins|mesh-ancestor
25794810|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
25794811|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794812|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25794813|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25794814|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
25794815|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794816|NCT00000779|Antacids|antacids|mesh-ancestor
25794817|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794818|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25794819|NCT00000781|Zidovudine|zidovudine|mesh-list
25794820|NCT00000781|Nevirapine|nevirapine|mesh-list
25794821|NCT00000781|Didanosine|didanosine|mesh-list
25794822|NCT00000781|Zalcitabine|zalcitabine|mesh-list
25794823|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
25794824|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794825|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794826|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794827|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794828|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
25794829|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794830|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794831|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794832|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25794833|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25794834|NCT00000782|Vaccines|vaccines|mesh-list
25794835|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
25794836|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794837|NCT00000788|Fluconazole|fluconazole|mesh-list
25794838|NCT00000788|Methadone|methadone|mesh-list
25794839|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25794840|NCT00000788|Narcotics|narcotics|mesh-ancestor
25794841|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25794842|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794843|NCT00000788|Analgesics|analgesics|mesh-ancestor
25794844|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
25794845|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794846|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
25794847|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
25794848|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
25794849|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794850|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25794851|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794852|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794853|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794854|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25794855|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
25794856|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25794857|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25794858|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25794859|NCT00000789|Zidovudine|zidovudine|mesh-list
25794860|NCT00000789|Stavudine|stavudine|mesh-list
25794861|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
25794862|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794863|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794864|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794865|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794866|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
25794867|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794868|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794869|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794870|NCT00000790|Thalidomide|thalidomide|mesh-list
25794871|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25794872|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
25794873|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794874|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
25794875|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794876|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794877|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25794878|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25794879|NCT00000790|Growth Substances|growth substances|mesh-ancestor
25794880|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
25794881|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794882|NCT00000791|Zidovudine|zidovudine|mesh-list
25794883|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
25794884|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794885|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25794886|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794887|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794888|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
25794889|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794890|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25794891|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25794892|NCT00000792|Hypericin|hypericin|mesh-list
25794893|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
25794894|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25794895|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794896|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
25794897|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794898|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794899|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794900|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25794901|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
25794902|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794903|NCT00000793|Mexiletine|mexiletine|mesh-list
24430903|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430904|NCT00249704|Vitamin D|vitamin d|mesh-list
24430905|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
24430936|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24430937|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25794904|NCT00000793|Amitriptyline|amitriptyline|mesh-list
25794905|NCT00000793|Benztropine|benztropine|mesh-list
25794906|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25794907|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
25794908|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25794909|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25794910|NCT00000793|Analgesics|analgesics|mesh-ancestor
25794911|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
25794912|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25794913|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794914|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25794915|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25794916|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25794917|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794918|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
25794919|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25794920|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25794921|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25794922|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25794923|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25794924|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25794925|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
25794926|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
25794927|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25794928|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25794929|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
25794930|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25794931|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
25794932|NCT00000794|Leucovorin|leucovorin|mesh-list
25794933|NCT00000794|Clarithromycin|clarithromycin|mesh-list
25794934|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
25794935|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
25794936|NCT00000794|Atovaquone|atovaquone|mesh-list
25794937|NCT00000794|Calcium|calcium|mesh-list
25794938|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
25794939|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25794940|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794941|NCT00000794|Antidotes|antidotes|mesh-ancestor
25794942|NCT00000794|Protective Agents|protective agents|mesh-ancestor
25794943|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
25794944|NCT00000794|Vitamins|vitamins|mesh-ancestor
25794945|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
25794946|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794947|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794948|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25794949|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794950|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794951|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25794952|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794953|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
25794954|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25794955|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25794956|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25794957|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
25794958|NCT00000796|Pyridoxine|pyridoxine|mesh-list
25794959|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
25794960|NCT00000796|Levofloxacin|levofloxacin|mesh-list
25794961|NCT00000796|Cycloserine|cycloserine|mesh-list
25794962|NCT00000796|Rifampin|rifampin|mesh-list
25794963|NCT00000796|Isoniazid|isoniazid|mesh-list
25794964|NCT00000796|Amikacin|amikacin|mesh-list
25794965|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
25794966|NCT00000796|Ethambutol|ethambutol|mesh-list
25794967|NCT00000796|Clofazimine|clofazimine|mesh-list
25794968|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25794969|NCT00000796|Streptomycin|streptomycin|mesh-list
25794970|NCT00000796|Ethionamide|ethionamide|mesh-list
25794971|NCT00000796|Capreomycin|capreomycin|mesh-list
25794972|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25794973|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25794974|NCT00000796|Renal Agents|renal agents|mesh-ancestor
25794975|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25794976|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25794977|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25794978|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25794979|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25794980|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25794981|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24432857|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
25794982|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25794983|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25794984|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
25794985|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
25794986|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25794987|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25794988|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25794989|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25794990|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25794991|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25794992|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25794993|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25794994|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25794995|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
25794996|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25794997|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
25794998|NCT00000796|Vitamins|vitamins|mesh-ancestor
25794999|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
25795000|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795001|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25795002|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25795003|NCT00000799|Cidofovir|cidofovir|mesh-list
25795004|NCT00000799|Probenecid|probenecid|mesh-list
25795005|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
25795006|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
25795007|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25795008|NCT00000799|Renal Agents|renal agents|mesh-ancestor
25795009|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
25795010|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795011|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795012|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795013|NCT00000800|Zidovudine|zidovudine|mesh-list
25795014|NCT00000800|Methadone|methadone|mesh-list
25795015|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
25795016|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795017|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795018|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795019|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795020|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
25795021|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795022|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795023|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795024|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25795025|NCT00000800|Narcotics|narcotics|mesh-ancestor
25795026|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25795027|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795028|NCT00000800|Analgesics|analgesics|mesh-ancestor
25795029|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
25795030|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25795031|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
25795032|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
25795033|NCT00000801|Cytarabine|cytarabine|mesh-list
25795034|NCT00000801|Dexamethasone|dexamethasone|mesh-list
25795035|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
25795036|NCT00000801|Doxorubicin|doxorubicin|mesh-list
25795037|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25795038|NCT00000801|Vincristine|vincristine|mesh-list
25795039|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25795040|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
25795041|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795042|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25795043|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25795044|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
25795045|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795046|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795047|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25795048|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25795049|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
25795050|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
25795051|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25795052|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25795053|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
25795054|NCT00000801|Hormones|hormones|mesh-ancestor
25795055|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25795056|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25795057|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25795058|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25795059|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25795060|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795061|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25795062|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
25795063|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
25795064|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795065|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25795066|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
25795067|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
25795068|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
25795069|NCT00000802|Dapsone|dapsone|mesh-list
25795070|NCT00000802|Atovaquone|atovaquone|mesh-list
25795071|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795072|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
25795073|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25795074|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25795075|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25795076|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795077|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795078|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
25795079|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795080|NCT00000803|Zidovudine|zidovudine|mesh-list
25795081|NCT00000803|Didanosine|didanosine|mesh-list
25795082|NCT00000803|Delavirdine|delavirdine|mesh-list
25795083|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
25795084|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795085|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795086|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795087|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795088|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
25795089|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795090|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795091|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795092|NCT00000804|Indinavir|indinavir|mesh-list
25795093|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795094|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795095|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795096|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795097|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795098|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795099|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795100|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
25795101|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795102|NCT00000805|Ganciclovir|ganciclovir|mesh-list
25795103|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25795104|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
25795105|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795106|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795107|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795108|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795109|NCT00000807|Etoposide|etoposide|mesh-list
25795110|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25795111|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795112|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25795113|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25795114|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795115|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795116|NCT00000808|Nevirapine|nevirapine|mesh-list
25795117|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795118|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795119|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795120|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795121|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
25795122|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795123|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795124|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795125|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25795126|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795127|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25795128|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25795129|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
25795130|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795131|NCT00000809|Antacids|antacids|mesh-ancestor
25795132|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795133|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25795134|NCT00000810|Zidovudine|zidovudine|mesh-list
24979671|NCT03032510|Ertapenem|ertapenem|mesh-list
25123895|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
25795136|NCT00000810|Delavirdine|delavirdine|mesh-list
25795137|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
25795138|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795139|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795140|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795141|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795142|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
25795143|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795144|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795145|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795146|NCT00000811|Azithromycin|azithromycin|mesh-list
25795147|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25795148|NCT00000811|Trimethoprim|trimethoprim|mesh-list
25795149|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
25795150|NCT00000811|Atovaquone|atovaquone|mesh-list
25795151|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795152|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795153|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25795154|NCT00000811|Renal Agents|renal agents|mesh-ancestor
25795155|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
25795156|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25795157|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25795158|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25795159|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795160|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795161|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25795162|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25795163|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795164|NCT00000812|Thalidomide|thalidomide|mesh-list
25795165|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25795166|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
25795167|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795168|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
25795169|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795170|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795171|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25795172|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25795173|NCT00000812|Growth Substances|growth substances|mesh-ancestor
25795174|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
25795175|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795176|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
25795177|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25795178|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
25795179|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795180|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25795181|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795182|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
25795183|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795184|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
25795185|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25795186|NCT00000813|Protective Agents|protective agents|mesh-ancestor
25795187|NCT00000814|Zidovudine|zidovudine|mesh-list
25795188|NCT00000814|Nevirapine|nevirapine|mesh-list
25795189|NCT00000814|Didanosine|didanosine|mesh-list
25795190|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
25795191|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795192|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795193|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795194|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795195|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
25795196|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795197|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795198|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795199|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25795200|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795201|NCT00000816|Trimethoprim|trimethoprim|mesh-list
25795202|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25795203|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
25795204|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25795205|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795206|NCT00000816|Renal Agents|renal agents|mesh-ancestor
25795207|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
25795208|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25795209|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25795210|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25795211|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795212|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795213|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25795214|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25795215|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795216|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795217|NCT00000817|Amitriptyline|amitriptyline|mesh-list
25795218|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25795219|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
25795220|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25795221|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25795222|NCT00000817|Analgesics|analgesics|mesh-ancestor
25795223|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
25795224|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25795225|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795226|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25795227|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25795228|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25795229|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795230|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
25795231|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25795232|NCT00000818|Zidovudine|zidovudine|mesh-list
25795233|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
25795234|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795235|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795236|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795237|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795238|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
25795239|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795240|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795241|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795242|NCT00000819|Prednisone|prednisone|mesh-list
25795243|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25795244|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
25795245|NCT00000819|Hormones|hormones|mesh-ancestor
25795246|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25795247|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795248|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25795249|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795250|NCT00000820|Aldesleukin|aldesleukin|mesh-list
25795251|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795252|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795253|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795254|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
25795255|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795256|NCT00000821|Aldesleukin|aldesleukin|mesh-list
25795257|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795258|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795259|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795260|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
25795261|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795262|NCT00000822|Ritonavir|ritonavir|mesh-list
25795263|NCT00000822|Stavudine|stavudine|mesh-list
25795264|NCT00000822|Didanosine|didanosine|mesh-list
25795265|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795266|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795267|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795268|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795269|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795270|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795271|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795272|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
25795273|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795274|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795275|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795276|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
25795277|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795278|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795279|NCT00000823|Zidovudine|zidovudine|mesh-list
25795280|NCT00000823|Didanosine|didanosine|mesh-list
25795281|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
25795282|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795283|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795284|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795285|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795286|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
25795287|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795288|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795289|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795290|NCT00000825|Aldesleukin|aldesleukin|mesh-list
25795291|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795292|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795293|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795294|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
25795295|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795296|NCT00000826|Clarithromycin|clarithromycin|mesh-list
25795297|NCT00000826|Dapsone|dapsone|mesh-list
25795298|NCT00000826|Rifabutin|rifabutin|mesh-list
25795299|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25795300|NCT00000826|Fluconazole|fluconazole|mesh-list
25795301|NCT00000826|Trimethoprim|trimethoprim|mesh-list
25795302|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
25795303|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795304|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795305|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25795306|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795307|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795308|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795309|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795310|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
25795311|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25795312|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25795313|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
25795314|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25795315|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795316|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25795317|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25795318|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25795319|NCT00000826|Renal Agents|renal agents|mesh-ancestor
25795320|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
25795321|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25795322|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25795323|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25795324|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25795325|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25795326|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
25795327|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25795328|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
25795329|NCT00000827|Immune Sera|immune sera|mesh-list
25795330|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
25795331|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795332|NCT00000829|Vaccines|vaccines|mesh-list
25795333|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25795334|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
25795335|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795336|NCT00000831|Lamivudine|lamivudine|mesh-list
25795337|NCT00000831|Zidovudine|zidovudine|mesh-list
25795338|NCT00000831|Stavudine|stavudine|mesh-list
25795339|NCT00000831|Didanosine|didanosine|mesh-list
25795340|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795341|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795342|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795343|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795344|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
25795345|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795346|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795347|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795348|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
25795349|NCT00000833|Ribavirin|ribavirin|mesh-list
25795350|NCT00000833|Didanosine|didanosine|mesh-list
25795351|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
25795352|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435575|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
24435576|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24435577|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24435578|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435579|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435580|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25106050|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25124186|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795353|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
25795354|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795355|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795356|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795357|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795358|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795359|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795360|NCT00000834|Lamivudine|lamivudine|mesh-list
25795361|NCT00000834|Zidovudine|zidovudine|mesh-list
25795362|NCT00000834|Methotrexate|methotrexate|mesh-list
25795363|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25795364|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
25795365|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25795366|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795367|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25795368|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
25795369|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795370|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795371|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
25795372|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795373|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25795374|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25795375|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
25795376|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25795377|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795378|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795379|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
25795380|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795381|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795382|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795383|NCT00000838|Lamivudine|lamivudine|mesh-list
25795384|NCT00000838|Zidovudine|zidovudine|mesh-list
25795385|NCT00000838|Stavudine|stavudine|mesh-list
25795386|NCT00000838|Didanosine|didanosine|mesh-list
25795387|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795388|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795389|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795390|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795391|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
25795392|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795393|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795394|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795395|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
25795396|NCT00000839|Didanosine|didanosine|mesh-list
25795397|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
25795398|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795399|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795400|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795401|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795402|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
25795403|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795404|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795405|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795406|NCT00000841|Lamivudine|lamivudine|mesh-list
25795407|NCT00000841|Zidovudine|zidovudine|mesh-list
25795408|NCT00000841|Stavudine|stavudine|mesh-list
25795409|NCT00000841|Indinavir|indinavir|mesh-list
25795410|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795411|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795412|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795413|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795414|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
25795415|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795416|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795417|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795418|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
25795419|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795420|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795421|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795422|NCT00000842|Mitogens|mitogens|mesh-list
25795423|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
25795424|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795425|NCT00000843|Adefovir|adefovir|mesh-list
25795426|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25795427|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
25795428|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795429|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795430|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795431|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795432|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795433|NCT00000844|Interferons|interferons|mesh-list
25795434|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
25795435|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795436|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
25795437|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795438|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
25795439|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795440|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
25795441|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25795442|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
25795443|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795444|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25795445|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795446|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
25795447|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795448|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
25795449|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25795450|NCT00000847|Protective Agents|protective agents|mesh-ancestor
25795451|NCT00000848|Indinavir|indinavir|mesh-list
25795452|NCT00000848|Saquinavir|saquinavir|mesh-list
25795453|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795454|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795455|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795456|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795457|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795458|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795459|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795460|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
25795461|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795462|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795463|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795464|NCT00000849|Aldesleukin|aldesleukin|mesh-list
25795465|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795466|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795467|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795468|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
25795469|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795470|NCT00000850|Indinavir|indinavir|mesh-list
25795471|NCT00000850|Sargramostim|sargramostim|mesh-list
25795472|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
25795473|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795474|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795475|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795476|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795477|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795478|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795479|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795480|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795481|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
25795482|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795483|NCT00000851|Stavudine|stavudine|mesh-list
25795484|NCT00000851|Didanosine|didanosine|mesh-list
25795485|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
25795486|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795487|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795488|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795489|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795490|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
25795491|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795492|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795493|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795494|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
25795495|NCT00000854|Nandrolone|nandrolone|mesh-list
25795496|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
25795497|NCT00000854|Androgens|androgens|mesh-ancestor
25795498|NCT00000854|Hormones|hormones|mesh-ancestor
25795499|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25795500|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795501|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
25795502|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25795503|NCT00000855|Zidovudine|zidovudine|mesh-list
25795504|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
25795505|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795506|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795507|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795508|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795509|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
25795510|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795511|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795512|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795513|NCT00000856|Ganciclovir|ganciclovir|mesh-list
25795514|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25795515|NCT00000856|Foscarnet|foscarnet|mesh-list
25795516|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25795517|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
25795518|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795519|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795520|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795521|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795522|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795523|NCT00000857|Interleukin-12|interleukin-12|mesh-list
25795524|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25795525|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
25795526|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795527|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25795528|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25795529|NCT00000857|Growth Substances|growth substances|mesh-ancestor
25795530|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
25795531|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795532|NCT00000859|Ritonavir|ritonavir|mesh-list
25795533|NCT00000859|Nelfinavir|nelfinavir|mesh-list
25795534|NCT00000859|Indinavir|indinavir|mesh-list
25795535|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795536|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795537|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795538|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795539|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795540|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795541|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795542|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
25795543|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795544|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795545|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795546|NCT00000861|Indinavir|indinavir|mesh-list
25795547|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795548|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795549|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795550|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795551|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795552|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795553|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795554|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
25795555|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795556|NCT00000862|Zidovudine|zidovudine|mesh-list
25795557|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
25795558|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795559|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795560|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795561|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795562|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
25795563|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795564|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795565|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795566|NCT00000864|Zidovudine|zidovudine|mesh-list
25795567|NCT00000864|Abacavir|abacavir|mesh-list
25795568|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
25795569|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795570|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795571|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795572|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795573|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
25795574|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795575|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795576|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795577|NCT00000865|Lamivudine|lamivudine|mesh-list
25124326|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
25795578|NCT00000865|Zidovudine|zidovudine|mesh-list
25795579|NCT00000865|Abacavir|abacavir|mesh-list
25795580|NCT00000865|Stavudine|stavudine|mesh-list
25795581|NCT00000865|Didanosine|didanosine|mesh-list
25795582|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795583|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795584|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795585|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795586|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
25795587|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795588|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795589|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795590|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
25795591|NCT00000867|Memantine|memantine|mesh-list
25795592|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25795593|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25795594|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
25795595|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25795596|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795597|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795598|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25795599|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25795600|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25795601|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25795602|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
25795603|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795604|NCT00000868|Antacids|antacids|mesh-ancestor
25795605|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795606|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25795607|NCT00000869|Nevirapine|nevirapine|mesh-list
25795608|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795609|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795610|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795611|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795612|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
25795613|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795614|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795615|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795616|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25795617|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795618|NCT00000870|Lamivudine|lamivudine|mesh-list
25795619|NCT00000870|Zidovudine|zidovudine|mesh-list
25795620|NCT00000870|Stavudine|stavudine|mesh-list
25795621|NCT00000870|Didanosine|didanosine|mesh-list
25795622|NCT00000870|Aldesleukin|aldesleukin|mesh-list
25795623|NCT00000870|Indinavir|indinavir|mesh-list
25795624|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795625|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795626|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795627|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795628|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
25795629|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795630|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795631|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795632|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
25795633|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795634|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795635|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795636|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795637|NCT00000872|Lamivudine|lamivudine|mesh-list
25795638|NCT00000872|Zidovudine|zidovudine|mesh-list
25795639|NCT00000872|Nevirapine|nevirapine|mesh-list
25795640|NCT00000872|Abacavir|abacavir|mesh-list
25795641|NCT00000872|Stavudine|stavudine|mesh-list
25795642|NCT00000872|Nelfinavir|nelfinavir|mesh-list
25795643|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795644|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795645|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795646|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795647|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
25795648|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795649|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795650|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795651|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
25795652|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25795653|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795654|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25124408|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124409|NCT03076684|Allopurinol|allopurinol|mesh-list
25795655|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795656|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795657|NCT00000875|Acetaminophen|acetaminophen|mesh-list
25795658|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
25795660|NCT00000875|Lamivudine|lamivudine|mesh-list
25795661|NCT00000875|Zidovudine|zidovudine|mesh-list
25795662|NCT00000875|Aldesleukin|aldesleukin|mesh-list
25795663|NCT00000875|Indinavir|indinavir|mesh-list
25795664|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25795665|NCT00000875|Analgesics|analgesics|mesh-ancestor
25795666|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
25795667|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25795668|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795669|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
25795670|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795671|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795672|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795673|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795674|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
25795675|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795676|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795677|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795678|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
25795679|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795680|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25795681|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25795682|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25795683|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
25795684|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
25795685|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
25795686|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
25795687|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25795688|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25795689|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
25795690|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
25795691|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25795692|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25795693|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
25795694|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
25795695|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795696|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795697|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795698|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
25795699|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
25795700|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795701|NCT00000877|Indinavir|indinavir|mesh-list
25795702|NCT00000877|Rifabutin|rifabutin|mesh-list
25795703|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795704|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795705|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795706|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795707|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795708|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795709|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795710|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
25795711|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795712|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795713|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25795714|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
25795715|NCT00000878|Lamivudine|lamivudine|mesh-list
25795716|NCT00000878|Zidovudine|zidovudine|mesh-list
25795717|NCT00000878|Stavudine|stavudine|mesh-list
25795718|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795719|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795720|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795721|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795722|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
25795723|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795724|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795725|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795726|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
25795727|NCT00000880|Cyclosporine|cyclosporine|mesh-list
25795728|NCT00000880|Cyclosporins|cyclosporins|mesh-list
25795729|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795730|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979902|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795731|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25795732|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
25795733|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795734|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
25795735|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795736|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
25795737|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25795738|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25795740|NCT00000881|Probenecid|probenecid|mesh-list
25795741|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
25795742|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
25795743|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25795744|NCT00000881|Renal Agents|renal agents|mesh-ancestor
25795745|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
25795746|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795747|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795748|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795749|NCT00000882|Lamivudine|lamivudine|mesh-list
25795750|NCT00000882|Zidovudine|zidovudine|mesh-list
25795751|NCT00000882|Stavudine|stavudine|mesh-list
25795752|NCT00000882|Delavirdine|delavirdine|mesh-list
25795753|NCT00000882|Indinavir|indinavir|mesh-list
25795754|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795755|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795756|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795757|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795758|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
25795759|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795760|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795761|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795762|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
25795763|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795764|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795765|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795766|NCT00000883|Azithromycin|azithromycin|mesh-list
25795767|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795768|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795769|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
25795770|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25795771|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
25795772|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795773|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25795774|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795775|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
25795776|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795777|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
25795778|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25795779|NCT00000884|Protective Agents|protective agents|mesh-ancestor
25795780|NCT00000885|Lamivudine|lamivudine|mesh-list
25795781|NCT00000885|Zidovudine|zidovudine|mesh-list
25795782|NCT00000885|Efavirenz|efavirenz|mesh-list
25795783|NCT00000885|Abacavir|abacavir|mesh-list
25795784|NCT00000885|Stavudine|stavudine|mesh-list
25795785|NCT00000885|Didanosine|didanosine|mesh-list
25795786|NCT00000885|Adefovir|adefovir|mesh-list
25795787|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25795788|NCT00000885|Nelfinavir|nelfinavir|mesh-list
25795789|NCT00000885|Indinavir|indinavir|mesh-list
25795790|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795791|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795792|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795793|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795794|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
25795795|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795796|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795797|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795798|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
25795799|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25795800|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795801|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25795802|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25795803|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795804|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25162131|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25162132|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
25162133|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162134|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979928|NCT04933383|Budesonide|budesonide|mesh-list
25795805|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795806|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795807|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795808|NCT00000887|Lamivudine|lamivudine|mesh-list
25795809|NCT00000887|Zidovudine|zidovudine|mesh-list
25795810|NCT00000887|Nelfinavir|nelfinavir|mesh-list
25795811|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795812|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795813|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795814|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795815|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
25795816|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795817|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795818|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795819|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
25795820|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795821|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795822|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795823|NCT00000888|Ritonavir|ritonavir|mesh-list
25795824|NCT00000888|Lamivudine|lamivudine|mesh-list
25795825|NCT00000888|Zidovudine|zidovudine|mesh-list
25795826|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795827|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795828|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795829|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795830|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795831|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795832|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795833|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
25795834|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795835|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795836|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795837|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795838|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795839|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
25795840|NCT00000889|Aldesleukin|aldesleukin|mesh-list
25795841|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795842|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795843|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795844|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
25795845|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795846|NCT00000891|Ritonavir|ritonavir|mesh-list
25795847|NCT00000891|Saquinavir|saquinavir|mesh-list
25795848|NCT00000891|Lamivudine|lamivudine|mesh-list
25795849|NCT00000891|Zidovudine|zidovudine|mesh-list
25795850|NCT00000891|Stavudine|stavudine|mesh-list
25795851|NCT00000891|Didanosine|didanosine|mesh-list
25795852|NCT00000891|Delavirdine|delavirdine|mesh-list
25795853|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795854|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795855|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795856|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795857|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795858|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795859|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795860|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
25795861|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795862|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795863|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795864|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795865|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795866|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
25795867|NCT00000892|Ritonavir|ritonavir|mesh-list
25795868|NCT00000892|Nelfinavir|nelfinavir|mesh-list
25795869|NCT00000892|Saquinavir|saquinavir|mesh-list
25795870|NCT00000892|Delavirdine|delavirdine|mesh-list
24437515|NCT00273962|Ipratropium|ipratropium|mesh-list
24437516|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437517|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
24437518|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437519|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437520|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437521|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
25124612|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
24979932|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25795871|NCT00000892|Adefovir|adefovir|mesh-list
25795872|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25795873|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795874|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795875|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795876|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795877|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795878|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795879|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795880|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
25795881|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795882|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795883|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795884|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795885|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795886|NCT00000893|Efavirenz|efavirenz|mesh-list
25795887|NCT00000893|Nelfinavir|nelfinavir|mesh-list
25795888|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795889|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795890|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795891|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795892|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
25795893|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795894|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25795895|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795896|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25795897|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25795898|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795899|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25795900|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795901|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795902|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795903|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795904|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795905|NCT00000894|Ganciclovir|ganciclovir|mesh-list
25795906|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25795907|NCT00000894|Cidofovir|cidofovir|mesh-list
25795908|NCT00000894|Probenecid|probenecid|mesh-list
25795909|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
25795910|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795911|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795912|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795913|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795914|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
25795915|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
25795916|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25795917|NCT00000894|Renal Agents|renal agents|mesh-ancestor
25795918|NCT00000895|Azithromycin|azithromycin|mesh-list
25795919|NCT00000895|Nevirapine|nevirapine|mesh-list
25795920|NCT00000895|Nelfinavir|nelfinavir|mesh-list
25795921|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25795922|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795923|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795924|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795925|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795926|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795927|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
25795928|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795929|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795930|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25795931|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795932|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795933|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795934|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795935|NCT00000896|Lamivudine|lamivudine|mesh-list
25795936|NCT00000896|Zidovudine|zidovudine|mesh-list
25795937|NCT00000896|Nevirapine|nevirapine|mesh-list
25795938|NCT00000896|Stavudine|stavudine|mesh-list
25795939|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25795940|NCT00000896|Indinavir|indinavir|mesh-list
25795941|NCT00000896|Interleukin-12|interleukin-12|mesh-list
25795942|NCT00000896|Sargramostim|sargramostim|mesh-list
25795943|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795944|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24437782|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040999|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
24437783|NCT00274508|Bromides|bromides|mesh-list
24437784|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
24437785|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437809|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
25124688|NCT03073317|Mitogens|mitogens|mesh-list
25795945|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795946|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795947|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
25795948|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795949|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795950|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795951|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
25795952|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
25795953|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795954|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25795955|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25795956|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25795957|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795958|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795959|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795960|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25795961|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25795962|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25795963|NCT00000896|Growth Substances|growth substances|mesh-ancestor
25795964|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
25795965|NCT00000897|Zidovudine|zidovudine|mesh-list
25795966|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
25795967|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795968|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25795969|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25795970|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795971|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
25795972|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795973|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795974|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795975|NCT00000898|Ritonavir|ritonavir|mesh-list
25795976|NCT00000898|Nelfinavir|nelfinavir|mesh-list
25795977|NCT00000898|Saquinavir|saquinavir|mesh-list
25795978|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25795979|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25795980|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
25795981|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25795982|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25795983|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25795984|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25795985|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
25795986|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795987|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25795988|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25795989|NCT00000899|Lamivudine|lamivudine|mesh-list
25795990|NCT00000899|Stavudine|stavudine|mesh-list
25795991|NCT00000899|Nelfinavir|nelfinavir|mesh-list
25795992|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
25795993|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25795994|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
25795995|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25795996|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25795997|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25795998|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
25795999|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796000|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796001|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25796002|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796003|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796004|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796005|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
25796006|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796007|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796008|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796009|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
25796010|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796011|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796012|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796013|NCT00000901|Lamivudine|lamivudine|mesh-list
25796014|NCT00000901|Stavudine|stavudine|mesh-list
25796015|NCT00000901|Indinavir|indinavir|mesh-list
25796016|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796017|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796018|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796019|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124733|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25796021|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796022|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796023|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796024|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
25796025|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796026|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796027|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796028|NCT00000902|Ritonavir|ritonavir|mesh-list
25796029|NCT00000902|Nelfinavir|nelfinavir|mesh-list
25796030|NCT00000902|Lamivudine|lamivudine|mesh-list
25796031|NCT00000902|Zidovudine|zidovudine|mesh-list
25796032|NCT00000902|Nevirapine|nevirapine|mesh-list
25796033|NCT00000902|Stavudine|stavudine|mesh-list
25796034|NCT00000902|Didanosine|didanosine|mesh-list
25796035|NCT00000902|Zalcitabine|zalcitabine|mesh-list
25796036|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796037|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796038|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796039|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796040|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796041|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796042|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796043|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
25796044|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796045|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796046|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796047|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796048|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796049|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
25796050|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796051|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796052|NCT00000903|Lamivudine|lamivudine|mesh-list
25796053|NCT00000903|Zidovudine|zidovudine|mesh-list
25796054|NCT00000903|Efavirenz|efavirenz|mesh-list
25796055|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25796056|NCT00000903|Nelfinavir|nelfinavir|mesh-list
25796057|NCT00000903|Indinavir|indinavir|mesh-list
25796058|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796059|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796060|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796061|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796062|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
25796063|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796064|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796065|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796066|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
25796067|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796068|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796069|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796070|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796071|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796072|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796073|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796074|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796075|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796076|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
25796077|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25796078|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
25796079|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796080|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25796081|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796082|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
25796083|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796084|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
25796085|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25796086|NCT00000904|Protective Agents|protective agents|mesh-ancestor
25796087|NCT00000906|Ritonavir|ritonavir|mesh-list
25796088|NCT00000906|Saquinavir|saquinavir|mesh-list
25796089|NCT00000906|Methadone|methadone|mesh-list
25796090|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796091|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796092|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796093|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796094|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796095|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24979993|NCT04767776|Protective Agents|protective agents|mesh-ancestor
25796096|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796097|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
25796098|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796099|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796100|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796101|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25796102|NCT00000906|Narcotics|narcotics|mesh-ancestor
25796103|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25796104|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796105|NCT00000906|Analgesics|analgesics|mesh-ancestor
25796106|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
25796107|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25796108|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
25796109|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
25796110|NCT00000909|Aldesleukin|aldesleukin|mesh-list
25796111|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796112|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796113|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796114|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
25796115|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796116|NCT00000912|Efavirenz|efavirenz|mesh-list
25796117|NCT00000912|Abacavir|abacavir|mesh-list
25796118|NCT00000912|Adefovir|adefovir|mesh-list
25796119|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25796120|NCT00000912|Nelfinavir|nelfinavir|mesh-list
25796121|NCT00000912|Indinavir|indinavir|mesh-list
25796122|NCT00000912|Saquinavir|saquinavir|mesh-list
25796123|NCT00000912|Amprenavir|amprenavir|mesh-list
25796124|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796125|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796126|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796127|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796128|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
25796129|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796130|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796131|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796132|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796133|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796134|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796135|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796136|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796137|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796138|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796139|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796140|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796141|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796142|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25796143|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
25796144|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796145|NCT00000913|Ritonavir|ritonavir|mesh-list
25796146|NCT00000913|Nelfinavir|nelfinavir|mesh-list
25796147|NCT00000913|Saquinavir|saquinavir|mesh-list
25796148|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796149|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796150|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796151|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796152|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796153|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796154|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796155|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
25796156|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796157|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796158|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796159|NCT00000914|Ritonavir|ritonavir|mesh-list
25796160|NCT00000914|Nelfinavir|nelfinavir|mesh-list
25796161|NCT00000914|Indinavir|indinavir|mesh-list
25796162|NCT00000914|Efavirenz|efavirenz|mesh-list
25796163|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796164|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796165|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796166|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796167|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796168|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25124850|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843755|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
24438720|NCT00276705|Doxorubicin|doxorubicin|mesh-list
24438721|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25796169|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796170|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
25796171|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796172|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796173|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796174|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796175|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796176|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796177|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796178|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796179|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796180|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796181|NCT00000916|Lamivudine|lamivudine|mesh-list
25796182|NCT00000916|Zidovudine|zidovudine|mesh-list
25796183|NCT00000916|Stavudine|stavudine|mesh-list
25796184|NCT00000916|Didanosine|didanosine|mesh-list
25796185|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25796186|NCT00000916|Indinavir|indinavir|mesh-list
25796187|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
25796188|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796189|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796190|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796191|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796192|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
25796193|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796194|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796195|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796196|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
25796197|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796198|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
25796199|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796200|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796201|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796202|NCT00000918|Ritonavir|ritonavir|mesh-list
25796203|NCT00000918|Indinavir|indinavir|mesh-list
25796204|NCT00000918|Saquinavir|saquinavir|mesh-list
25796205|NCT00000918|Amprenavir|amprenavir|mesh-list
25796206|NCT00000918|Lamivudine|lamivudine|mesh-list
25796207|NCT00000918|Zidovudine|zidovudine|mesh-list
25796208|NCT00000918|Stavudine|stavudine|mesh-list
25796209|NCT00000918|Didanosine|didanosine|mesh-list
25796210|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25796211|NCT00000918|Efavirenz|efavirenz|mesh-list
25796212|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796213|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796214|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796215|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796216|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796217|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796218|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796219|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
25796220|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796221|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796222|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796223|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796224|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796225|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
25796226|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796227|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796228|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796229|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796230|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796231|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25796232|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
25796233|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796234|NCT00000919|Ritonavir|ritonavir|mesh-list
25796235|NCT00000919|Nelfinavir|nelfinavir|mesh-list
25796236|NCT00000919|Indinavir|indinavir|mesh-list
25796237|NCT00000919|Amprenavir|amprenavir|mesh-list
25796238|NCT00000919|Lamivudine|lamivudine|mesh-list
25796239|NCT00000919|Zidovudine|zidovudine|mesh-list
25796240|NCT00000919|Abacavir|abacavir|mesh-list
25796241|NCT00000919|Stavudine|stavudine|mesh-list
25796242|NCT00000919|Didanosine|didanosine|mesh-list
25796243|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25796244|NCT00000919|Efavirenz|efavirenz|mesh-list
25796245|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
25796246|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796247|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796248|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796249|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796250|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796251|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796252|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796253|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
25796254|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796255|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796256|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796257|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796258|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796259|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
25796260|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796261|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796262|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796263|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796264|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796265|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796266|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
25796267|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25796268|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
25796269|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796270|NCT00000920|Ritonavir|ritonavir|mesh-list
25796271|NCT00000920|Saquinavir|saquinavir|mesh-list
25796272|NCT00000920|Lamivudine|lamivudine|mesh-list
25796273|NCT00000920|Zidovudine|zidovudine|mesh-list
25796274|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796275|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796276|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796277|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796278|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796279|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796280|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796281|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
25796282|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796283|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796284|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796285|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796286|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796287|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
25796288|NCT00000921|Prednisone|prednisone|mesh-list
25796289|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25796290|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
25796291|NCT00000921|Hormones|hormones|mesh-ancestor
25796292|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25796293|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796294|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25796295|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796296|NCT00000922|Lamivudine|lamivudine|mesh-list
25796297|NCT00000922|Efavirenz|efavirenz|mesh-list
25796298|NCT00000922|Nevirapine|nevirapine|mesh-list
25796299|NCT00000922|Abacavir|abacavir|mesh-list
25796300|NCT00000922|Stavudine|stavudine|mesh-list
25796301|NCT00000922|Didanosine|didanosine|mesh-list
25796302|NCT00000922|Nelfinavir|nelfinavir|mesh-list
25796303|NCT00000922|Indinavir|indinavir|mesh-list
25796304|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796305|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796306|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796307|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796308|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
25796309|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796310|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796311|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796312|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796313|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796314|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796315|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796316|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796317|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796318|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
25796319|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796320|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796321|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796322|NCT00000923|Lamivudine|lamivudine|mesh-list
25796323|NCT00000923|Zidovudine|zidovudine|mesh-list
25796324|NCT00000923|Stavudine|stavudine|mesh-list
25796325|NCT00000923|Didanosine|didanosine|mesh-list
25796326|NCT00000923|Aldesleukin|aldesleukin|mesh-list
25796327|NCT00000923|Indinavir|indinavir|mesh-list
25796328|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796329|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796330|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796331|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796332|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
25796333|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796334|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796335|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796336|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
25796337|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796338|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796339|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796340|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796341|NCT00000924|Ritonavir|ritonavir|mesh-list
25796342|NCT00000924|Nelfinavir|nelfinavir|mesh-list
25796343|NCT00000924|Nevirapine|nevirapine|mesh-list
25796344|NCT00000924|Stavudine|stavudine|mesh-list
25796345|NCT00000924|Didanosine|didanosine|mesh-list
25796346|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796347|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796348|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796349|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796350|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796351|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796352|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796353|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
25796354|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796355|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796356|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796357|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796358|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796359|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796360|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796361|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
25796362|NCT00000926|Nonoxynol|nonoxynol|mesh-list
25796363|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25796364|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25796365|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796366|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25796367|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
25796368|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25796369|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25796370|NCT00000929|Nonoxynol|nonoxynol|mesh-list
25796371|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25796372|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25796373|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796374|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25796375|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
25796376|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25796377|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25796378|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
25796379|NCT00000935|Antibodies|antibodies|mesh-list
25796380|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
25796381|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25796382|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25796383|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
25796384|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796385|NCT00000936|Cyclosporine|cyclosporine|mesh-list
25796386|NCT00000936|Cyclosporins|cyclosporins|mesh-list
25796387|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796388|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796389|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25796390|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
25796391|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796392|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
25796393|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796394|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
24440810|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25796395|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25796396|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25796397|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25796398|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796399|NCT00000938|Doxycycline|doxycycline|mesh-list
25796400|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
25796401|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796402|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796403|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
25796404|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25796405|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25796406|NCT00000939|Efavirenz|efavirenz|mesh-list
25796407|NCT00000939|Stavudine|stavudine|mesh-list
25796408|NCT00000939|Didanosine|didanosine|mesh-list
25796409|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
25796410|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796411|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796412|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796413|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796414|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
25796415|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796416|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796417|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796418|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796419|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796420|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796421|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796422|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796423|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
25796424|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
25796425|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796426|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796427|NCT00000940|Ritonavir|ritonavir|mesh-list
25796428|NCT00000940|Amprenavir|amprenavir|mesh-list
25796429|NCT00000940|Lamivudine|lamivudine|mesh-list
25796430|NCT00000940|Abacavir|abacavir|mesh-list
25796431|NCT00000940|Stavudine|stavudine|mesh-list
25796432|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796433|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796434|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796435|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796436|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796437|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796438|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796439|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
25796440|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796441|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796442|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796443|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796444|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796445|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
25796446|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25796447|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
25796448|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796449|NCT00000941|Ritonavir|ritonavir|mesh-list
25796450|NCT00000941|Nelfinavir|nelfinavir|mesh-list
25796451|NCT00000941|Saquinavir|saquinavir|mesh-list
25796452|NCT00000941|Atorvastatin|atorvastatin|mesh-list
25796453|NCT00000941|Simvastatin|simvastatin|mesh-list
25796454|NCT00000941|Pravastatin|pravastatin|mesh-list
25796455|NCT00000941|Calcium|calcium|mesh-list
25796456|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25796457|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796458|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25796459|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25796460|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
25796461|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796462|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25796463|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25796464|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796465|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796466|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796467|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796468|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796469|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796470|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
24441804|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796471|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796472|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796473|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796474|NCT00000942|Nevirapine|nevirapine|mesh-list
25796475|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796476|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796477|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796478|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796479|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
25796480|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796481|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796482|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796483|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796484|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796485|NCT00000943|Vaccines|vaccines|mesh-list
25796486|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
25796487|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796488|NCT00000944|Lamivudine|lamivudine|mesh-list
25796489|NCT00000944|Zidovudine|zidovudine|mesh-list
25796490|NCT00000944|Indinavir|indinavir|mesh-list
25796491|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796492|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796493|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796494|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796495|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
25796496|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796497|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796498|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796499|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
25796500|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796501|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796502|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796503|NCT00000945|Cidofovir|cidofovir|mesh-list
25796504|NCT00000945|Probenecid|probenecid|mesh-list
25796505|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
25796506|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
25796507|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25796508|NCT00000945|Renal Agents|renal agents|mesh-ancestor
25796509|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
25796510|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796511|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796512|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796513|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
25796514|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25796515|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
25796516|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796517|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25796518|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796519|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
25796520|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796521|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
25796522|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25796523|NCT00000946|Protective Agents|protective agents|mesh-ancestor
25796524|NCT00000947|Azithromycin|azithromycin|mesh-list
25796525|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796526|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796527|NCT00000948|Aldesleukin|aldesleukin|mesh-list
25796528|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796529|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796530|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796531|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
25796532|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796533|NCT00000949|Aldesleukin|aldesleukin|mesh-list
25796534|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796535|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796536|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796537|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
25796538|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796539|NCT00000950|Pyridoxine|pyridoxine|mesh-list
25125190|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
25125191|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125192|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442485|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24442486|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24442487|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442575|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24442577|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25796540|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
25796541|NCT00000950|Rifampin|rifampin|mesh-list
25796542|NCT00000950|Isoniazid|isoniazid|mesh-list
25796543|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
25796544|NCT00000950|Ethambutol|ethambutol|mesh-list
25796545|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25796546|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
25796547|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796548|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796549|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
25796550|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796551|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796552|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796553|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25796554|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796555|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25796556|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25796557|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25796558|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796559|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25796560|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25796561|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
25796562|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25796563|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
25796564|NCT00000950|Vitamins|vitamins|mesh-ancestor
25796565|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
25796566|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796567|NCT00000951|Fluconazole|fluconazole|mesh-list
25796568|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
25796569|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796570|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25796571|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796572|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796573|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796574|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25796575|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
25796576|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25796577|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796578|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25796579|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25796580|NCT00000952|Ritonavir|ritonavir|mesh-list
25796581|NCT00000952|Lamivudine|lamivudine|mesh-list
25796582|NCT00000952|Zidovudine|zidovudine|mesh-list
25796583|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25796584|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25796585|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
25796586|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796587|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796588|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796589|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796590|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
25796591|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796592|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796593|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796594|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796595|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796596|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
25796597|NCT00000953|Acyclovir|acyclovir|mesh-list
25796598|NCT00000953|Sorivudine|sorivudine|mesh-list
25796599|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
25796600|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796601|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796602|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796603|NCT00000954|Didanosine|didanosine|mesh-list
25796604|NCT00000954|Zalcitabine|zalcitabine|mesh-list
25796605|NCT00000954|Doxorubicin|doxorubicin|mesh-list
25796606|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25796607|NCT00000954|Bleomycin|bleomycin|mesh-list
25796608|NCT00000954|Vincristine|vincristine|mesh-list
25796609|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25796610|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796611|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25796612|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25796613|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796614|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796615|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25796616|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
25796617|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
25796618|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25796619|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
25796620|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796621|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796622|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
25796623|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796624|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796625|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796626|NCT00000959|Pyridoxine|pyridoxine|mesh-list
25796627|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
25796628|NCT00000959|Isoniazid|isoniazid|mesh-list
25796629|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
25796630|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796631|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796632|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25796633|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25796634|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
25796635|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796636|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25796637|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
25796638|NCT00000959|Vitamins|vitamins|mesh-ancestor
25796639|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
25796640|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796641|NCT00000960|Zidovudine|zidovudine|mesh-list
25796642|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
25796643|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796644|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796645|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796646|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796647|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
25796648|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796649|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796650|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796651|NCT00000961|Zidovudine|zidovudine|mesh-list
25796652|NCT00000961|Immune Sera|immune sera|mesh-list
25796653|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
25796654|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796655|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796656|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796657|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796658|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
25796659|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796660|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796661|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796662|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
25796663|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796664|NCT00000962|Nevirapine|nevirapine|mesh-list
25796665|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796666|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796667|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796668|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796669|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
25796670|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796671|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796672|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796673|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25796674|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25796675|NCT00000963|Didanosine|didanosine|mesh-list
25796676|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
25796677|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796678|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796679|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796680|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796681|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
25796682|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796683|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796684|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796685|NCT00000964|Foscarnet|foscarnet|mesh-list
25796686|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25796687|NCT00000964|Ranitidine|ranitidine|mesh-list
25796688|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25796689|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25796690|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25796691|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25796692|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
25796693|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
25796694|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25796695|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796696|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796697|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
25796698|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796699|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796700|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796701|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796702|NCT00000965|Zidovudine|zidovudine|mesh-list
25796703|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
25796704|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796705|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796706|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796707|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796708|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
25796709|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796710|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796711|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796712|NCT00000966|Leucovorin|leucovorin|mesh-list
25796713|NCT00000966|Azithromycin|azithromycin|mesh-list
25796714|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
25796715|NCT00000966|Calcium|calcium|mesh-list
25796716|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
25796717|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25796718|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796719|NCT00000966|Antidotes|antidotes|mesh-ancestor
25796720|NCT00000966|Protective Agents|protective agents|mesh-ancestor
25796721|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
25796722|NCT00000966|Vitamins|vitamins|mesh-ancestor
25796723|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
25796724|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796725|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796726|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
25796727|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25796728|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25796729|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25796730|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796731|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796732|NCT00000967|Interferons|interferons|mesh-list
25796733|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
25796734|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
25796735|NCT00000967|Zidovudine|zidovudine|mesh-list
25796736|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796737|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
25796738|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796739|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
25796740|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796741|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
25796742|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796743|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796744|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796745|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796746|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796747|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796748|NCT00000969|Didanosine|didanosine|mesh-list
25796749|NCT00000969|Zalcitabine|zalcitabine|mesh-list
25796750|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
25125481|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125482|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25796751|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796752|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796753|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796754|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796755|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
25796756|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796757|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796758|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796759|NCT00000970|Ganciclovir|ganciclovir|mesh-list
25796760|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25796761|NCT00000970|Foscarnet|foscarnet|mesh-list
25796762|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25796763|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
25796764|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796765|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796766|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796767|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796768|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796769|NCT00000971|Zidovudine|zidovudine|mesh-list
25796770|NCT00000971|Didanosine|didanosine|mesh-list
25796771|NCT00000971|Clarithromycin|clarithromycin|mesh-list
25796772|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
25796773|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796774|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796775|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796776|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796777|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
25796778|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796779|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796780|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796781|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796782|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25796783|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25796784|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796785|NCT00000973|Leucovorin|leucovorin|mesh-list
25796786|NCT00000973|Zidovudine|zidovudine|mesh-list
25796787|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
25796788|NCT00000973|Calcium|calcium|mesh-list
25796789|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
25796790|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25796791|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796792|NCT00000973|Antidotes|antidotes|mesh-ancestor
25796793|NCT00000973|Protective Agents|protective agents|mesh-ancestor
25796794|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
25796795|NCT00000973|Vitamins|vitamins|mesh-ancestor
25796796|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
25796797|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
25796798|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796799|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796800|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796801|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796802|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
25796803|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796804|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796805|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796806|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
25796807|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25796808|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25796809|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25796810|NCT00000974|Pentamidine|pentamidine|mesh-list
25796811|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
25796812|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796813|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25796814|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25796815|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25796816|NCT00000975|Itraconazole|itraconazole|mesh-list
25796817|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
25796818|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796819|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25796820|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796821|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796822|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796823|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25796824|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
25796825|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25796826|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796827|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25162225|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796829|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
25796830|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
25796831|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796832|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796833|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796834|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796835|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
25796836|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796837|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796838|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796839|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
25796840|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796841|NCT00000978|Zidovudine|zidovudine|mesh-list
25796842|NCT00000978|Zalcitabine|zalcitabine|mesh-list
25796843|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
25796844|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796845|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796846|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796847|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796848|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
25796849|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796850|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796851|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796852|NCT00000979|Zidovudine|zidovudine|mesh-list
25796853|NCT00000979|Didanosine|didanosine|mesh-list
25796854|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
25796855|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796856|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796857|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796858|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796859|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
25796860|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796861|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796862|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796863|NCT00000980|Spiramycin|spiramycin|mesh-list
25796864|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25796865|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796866|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
25796867|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25796868|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25796869|NCT00000981|Fiacitabine|fiacitabine|mesh-list
25796870|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796871|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
25796872|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796873|NCT00000982|Zidovudine|zidovudine|mesh-list
25796874|NCT00000982|Didanosine|didanosine|mesh-list
25796875|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
25796876|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796877|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796878|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796879|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796880|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
25796881|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796882|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796883|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796884|NCT00000983|Zidovudine|zidovudine|mesh-list
25796885|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
25796886|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796887|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796888|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796889|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796890|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
25796891|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796892|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796893|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796894|NCT00000985|Acyclovir|acyclovir|mesh-list
25796895|NCT00000985|Foscarnet|foscarnet|mesh-list
25796896|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25796897|NCT00000985|Vidarabine|vidarabine|mesh-list
25796898|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
25796899|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796900|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796901|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796902|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796903|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796904|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
25796905|NCT00000986|Zidovudine|zidovudine|mesh-list
25796906|NCT00000986|Aldesleukin|aldesleukin|mesh-list
25796907|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
25796908|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796909|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796910|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796911|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796912|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
25796913|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796914|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796915|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796916|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458674|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24980217|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
24980218|NCT05431075|Esomeprazole|esomeprazole|mesh-list
25796918|NCT00000987|Doxorubicin|doxorubicin|mesh-list
25796919|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25796920|NCT00000987|Bleomycin|bleomycin|mesh-list
25796921|NCT00000987|Vincristine|vincristine|mesh-list
25796922|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25796923|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25796924|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25796925|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25796926|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796927|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796928|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25796929|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
25796930|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
25796931|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
25796932|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
25796933|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796934|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796935|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
25796936|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796937|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796938|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796939|NCT00000988|Stavudine|stavudine|mesh-list
25796940|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
25796941|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796942|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796943|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796944|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796945|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
25796946|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796947|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796948|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796949|NCT00000989|Zidovudine|zidovudine|mesh-list
25796950|NCT00000989|Ganciclovir|ganciclovir|mesh-list
25796951|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25796952|NCT00000989|Sargramostim|sargramostim|mesh-list
25796953|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
25796954|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796955|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796956|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796957|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796958|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
25796959|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796960|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796961|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796962|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
25796963|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25796964|NCT00000990|Zidovudine|zidovudine|mesh-list
25796965|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
25796966|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25796967|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796968|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796969|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25796970|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
25796971|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796972|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796973|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796974|NCT00000991|Zidovudine|zidovudine|mesh-list
25796975|NCT00000991|Trimethoprim|trimethoprim|mesh-list
25796976|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
25796977|NCT00000991|Dapsone|dapsone|mesh-list
25796978|NCT00000991|Pentamidine|pentamidine|mesh-list
25796979|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25796980|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
25796981|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980246|NCT05420467|Carboplatin|carboplatin|mesh-list
24980247|NCT05420467|Trastuzumab|trastuzumab|mesh-list
24980248|NCT05420467|Epirubicin|epirubicin|mesh-list
24980249|NCT05420467|Pertuzumab|pertuzumab|mesh-list
24980250|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24980251|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980252|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
25125853|NCT03066115|Ketorolac|ketorolac|mesh-list
24980253|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
24980254|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
24980255|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844806|NCT02234544|Vitamin D|vitamin d|mesh-list
25796982|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25796983|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25796985|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
25796986|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25796987|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25796988|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25796989|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25796990|NCT00000991|Renal Agents|renal agents|mesh-ancestor
25796991|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
25796992|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25796993|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25796994|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25796995|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25796996|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25796997|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25796998|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
25796999|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797000|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
25797001|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25797002|NCT00000992|Itraconazole|itraconazole|mesh-list
25797003|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
25797004|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797005|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25797006|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797007|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797008|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797009|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25797010|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
25797011|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25797012|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797013|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797014|NCT00000993|Zidovudine|zidovudine|mesh-list
25797015|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
25797016|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797017|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797018|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797019|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797020|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
25797021|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797022|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797023|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797024|NCT00000994|Zidovudine|zidovudine|mesh-list
25797025|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
25797026|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797027|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797028|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797029|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797030|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
25797031|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797032|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797033|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797034|NCT00000995|Zidovudine|zidovudine|mesh-list
25797035|NCT00000995|Ganciclovir|ganciclovir|mesh-list
25797036|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25797037|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
25797038|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797039|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797040|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797041|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797042|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
25797043|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797044|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797045|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25125922|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25125925|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
24980284|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797046|NCT00000996|Doxorubicin|doxorubicin|mesh-list
25797047|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25797048|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25797049|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797050|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25797051|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25797052|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797053|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797054|NCT00000997|Zalcitabine|zalcitabine|mesh-list
25797055|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
25797056|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797057|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797058|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797059|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797060|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
25797061|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797062|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797063|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797064|NCT00000998|Leucovorin|leucovorin|mesh-list
25797065|NCT00000998|Trimetrexate|trimetrexate|mesh-list
25797066|NCT00000998|Calcium|calcium|mesh-list
25797067|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
25797068|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25797069|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797070|NCT00000998|Antidotes|antidotes|mesh-ancestor
25797071|NCT00000998|Protective Agents|protective agents|mesh-ancestor
25797072|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
25797073|NCT00000998|Vitamins|vitamins|mesh-ancestor
25797074|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
25797075|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
25797076|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797077|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25797078|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
25797079|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797080|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797081|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25797082|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797083|NCT00000999|Zidovudine|zidovudine|mesh-list
25797084|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
25797085|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797086|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797087|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797088|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797089|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
25797090|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797091|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797092|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797093|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25797094|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
25797095|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797096|NCT00001001|Zidovudine|zidovudine|mesh-list
25797097|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
25797098|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797099|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797100|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797101|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797102|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
25797103|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797104|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797105|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797106|NCT00001002|Zidovudine|zidovudine|mesh-list
25797107|NCT00001002|Foscarnet|foscarnet|mesh-list
25797108|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25797109|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
25797110|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797111|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797112|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797113|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797114|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
25797115|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797116|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797117|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797118|NCT00001003|Zidovudine|zidovudine|mesh-list
25797119|NCT00001003|Pentamidine|pentamidine|mesh-list
25797120|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
25797121|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797122|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797123|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797124|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797125|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
25797126|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797127|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797128|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797129|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
25797130|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25797131|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797132|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25797133|NCT00001004|Interferons|interferons|mesh-list
25797134|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
25797135|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797136|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
25797137|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797138|NCT00001005|Zidovudine|zidovudine|mesh-list
25797139|NCT00001005|Aldesleukin|aldesleukin|mesh-list
25797140|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
25797141|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797142|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797143|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797144|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797145|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
25797146|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797147|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797148|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797149|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797150|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
25797151|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797152|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
25797153|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797154|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797155|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25797156|NCT00001006|Protective Agents|protective agents|mesh-ancestor
25797157|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797158|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797159|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797160|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797161|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
25797162|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797163|NCT00001007|Zidovudine|zidovudine|mesh-list
25797164|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
25797165|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797166|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797167|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797168|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797169|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
25797170|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797171|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797172|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797173|NCT00001008|Zidovudine|zidovudine|mesh-list
25797174|NCT00001008|Methadone|methadone|mesh-list
25797175|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
25797176|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797177|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797178|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797179|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797180|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
25797181|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797182|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797183|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797184|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25797185|NCT00001008|Narcotics|narcotics|mesh-ancestor
25797186|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25797187|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797188|NCT00001008|Analgesics|analgesics|mesh-ancestor
25797189|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
25797190|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25797191|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
25797192|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
25797193|NCT00001009|Dextrans|dextrans|mesh-list
25797194|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
25797195|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
25797196|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
25797197|NCT00001010|Zidovudine|zidovudine|mesh-list
25797198|NCT00001010|Acyclovir|acyclovir|mesh-list
25797199|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
25797200|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797201|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797202|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797203|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797204|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
25797205|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797206|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797207|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797208|NCT00001011|Zidovudine|zidovudine|mesh-list
25797209|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
25797210|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797211|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797212|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797213|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797214|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
25797215|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797216|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797217|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797218|NCT00001013|Leucovorin|leucovorin|mesh-list
25797219|NCT00001013|Trimethoprim|trimethoprim|mesh-list
25797220|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25797221|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
25797222|NCT00001013|Pentamidine|pentamidine|mesh-list
25797223|NCT00001013|Trimetrexate|trimetrexate|mesh-list
25797224|NCT00001013|Calcium|calcium|mesh-list
25797225|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
25797226|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25797227|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797228|NCT00001013|Antidotes|antidotes|mesh-ancestor
25797229|NCT00001013|Protective Agents|protective agents|mesh-ancestor
25797230|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
25797231|NCT00001013|Vitamins|vitamins|mesh-ancestor
25797232|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
25797233|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25797234|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797235|NCT00001013|Renal Agents|renal agents|mesh-ancestor
25797236|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
25797237|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25797238|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797239|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25797240|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797241|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797242|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25797243|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25797244|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797245|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
25797246|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25797247|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797248|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25797249|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
25797250|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797251|NCT00001014|Leucovorin|leucovorin|mesh-list
25797252|NCT00001014|Trimethoprim|trimethoprim|mesh-list
25797253|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25797254|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
25797255|NCT00001014|Trimetrexate|trimetrexate|mesh-list
25797256|NCT00001014|Calcium|calcium|mesh-list
25797257|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
25797258|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25797259|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797260|NCT00001014|Antidotes|antidotes|mesh-ancestor
25797261|NCT00001014|Protective Agents|protective agents|mesh-ancestor
25797262|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
25797263|NCT00001014|Vitamins|vitamins|mesh-ancestor
25797264|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
25797265|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25797266|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797267|NCT00001014|Renal Agents|renal agents|mesh-ancestor
25797268|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
25797269|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24980543|NCT05182073|Fludarabine|fludarabine|mesh-list
24980544|NCT05182073|Daratumumab|daratumumab|mesh-list
24980545|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24980546|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980547|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
25162297|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
25106081|NCT04509973|Dexamethasone|dexamethasone|mesh-list
25797270|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797271|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25797272|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797273|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797274|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25797275|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25797276|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797277|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797278|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
25797279|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25797280|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
25797281|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797282|NCT00001015|Ribavirin|ribavirin|mesh-list
25797283|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
25797284|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797285|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
25797286|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797287|NCT00001016|Leucovorin|leucovorin|mesh-list
25797288|NCT00001016|Trimetrexate|trimetrexate|mesh-list
25797289|NCT00001016|Calcium|calcium|mesh-list
25797290|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
25797291|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25797292|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797293|NCT00001016|Antidotes|antidotes|mesh-ancestor
25797294|NCT00001016|Protective Agents|protective agents|mesh-ancestor
25797295|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
25797296|NCT00001016|Vitamins|vitamins|mesh-ancestor
25797297|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
25797298|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
25797299|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797300|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25797301|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
25797302|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797303|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797304|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25797305|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797306|NCT00001017|Fluconazole|fluconazole|mesh-list
25797307|NCT00001017|Amphotericin B|amphotericin b|mesh-list
25797308|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25797309|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
25797310|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797311|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25797312|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797313|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797314|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797315|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25797316|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
25797317|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25797318|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797319|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25797320|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25797321|NCT00001017|Amebicides|amebicides|mesh-ancestor
25797322|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25797323|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797324|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797325|NCT00001022|Zidovudine|zidovudine|mesh-list
25797326|NCT00001022|Didanosine|didanosine|mesh-list
25797327|NCT00001022|Zalcitabine|zalcitabine|mesh-list
25797328|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
25797329|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797330|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797331|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797332|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797333|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
25797334|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797335|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797336|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797338|NCT00001023|Clarithromycin|clarithromycin|mesh-list
25797339|NCT00001023|Rifabutin|rifabutin|mesh-list
25797340|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797341|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797342|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25797343|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797344|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797345|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797346|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797347|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25797348|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
25797349|NCT00001024|Zidovudine|zidovudine|mesh-list
25797350|NCT00001024|Didanosine|didanosine|mesh-list
25797351|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
25797352|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797353|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797354|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797355|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797356|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
25797357|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797358|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797359|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797360|NCT00001025|Zidovudine|zidovudine|mesh-list
25797361|NCT00001025|Didanosine|didanosine|mesh-list
25797362|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
25797363|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797364|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797365|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797366|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797367|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
25797368|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797369|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797370|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797371|NCT00001027|Pentamidine|pentamidine|mesh-list
25797372|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
25797373|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797374|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25797375|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797376|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25797377|NCT00001028|Dapsone|dapsone|mesh-list
25797378|NCT00001028|Pentamidine|pentamidine|mesh-list
25797379|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797380|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
25797381|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25797382|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797383|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25797384|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797385|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797386|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
25797387|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797388|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
25797389|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25797390|NCT00001029|Zidovudine|zidovudine|mesh-list
25797391|NCT00001029|Didanosine|didanosine|mesh-list
25797392|NCT00001029|Zalcitabine|zalcitabine|mesh-list
25797393|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
25797394|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797395|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797396|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797397|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797398|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
25797399|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797400|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797401|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797402|NCT00001030|Clarithromycin|clarithromycin|mesh-list
25797403|NCT00001030|Rifabutin|rifabutin|mesh-list
25797404|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797405|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797406|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25797407|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797408|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797409|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24622043|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
25162302|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
24622044|NCT01065272|Hormones|hormones|mesh-ancestor
25797410|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797411|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25797412|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
25797413|NCT00001032|Zidovudine|zidovudine|mesh-list
25797414|NCT00001032|Zalcitabine|zalcitabine|mesh-list
25797415|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
25797416|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797417|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797418|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797419|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797420|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
25797421|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797422|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797423|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797424|NCT00001033|Pyridoxine|pyridoxine|mesh-list
25797425|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
25797426|NCT00001033|Levofloxacin|levofloxacin|mesh-list
25797427|NCT00001033|Rifampin|rifampin|mesh-list
25797428|NCT00001033|Isoniazid|isoniazid|mesh-list
25797429|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
25797430|NCT00001033|Ethambutol|ethambutol|mesh-list
25797431|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25797432|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797433|NCT00001033|Renal Agents|renal agents|mesh-ancestor
25797434|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797435|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25797436|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25797437|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797438|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797439|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797440|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25797441|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797442|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25797443|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
25797444|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
25797445|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797446|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25797447|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25797448|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25797449|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25797450|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25797451|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25797452|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25797453|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25797454|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
25797455|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25797456|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
25797457|NCT00001033|Vitamins|vitamins|mesh-ancestor
25797458|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
25797459|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797460|NCT00001034|Ganciclovir|ganciclovir|mesh-list
25797461|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25797462|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
25797463|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797464|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797465|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797466|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797467|NCT00001035|Interferons|interferons|mesh-list
25797468|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
25797469|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
25797470|NCT00001035|Zidovudine|zidovudine|mesh-list
25797471|NCT00001035|Didanosine|didanosine|mesh-list
25797472|NCT00001035|Zalcitabine|zalcitabine|mesh-list
25797473|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797474|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
25797475|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797476|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
25797477|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797478|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
25797479|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797480|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797481|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797482|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797483|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797484|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25126695|NCT03060070|Ketamine|ketamine|mesh-list
25797485|NCT00001036|Zidovudine|zidovudine|mesh-list
25797486|NCT00001036|Interleukin-2|interleukin-2|mesh-list
25797487|NCT00001036|Thymalfasin|thymalfasin|mesh-list
25797488|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797489|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25797490|NCT00001036|Analgesics|analgesics|mesh-ancestor
25797491|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
25797492|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25797493|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797494|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
25797495|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797496|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797497|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797498|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797499|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
25797500|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797501|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797502|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797503|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797504|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
25797505|NCT00001038|Valacyclovir|valacyclovir|mesh-list
25797506|NCT00001038|Acyclovir|acyclovir|mesh-list
25797507|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
25797508|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797509|NCT00001039|Clarithromycin|clarithromycin|mesh-list
25797510|NCT00001039|Ethambutol|ethambutol|mesh-list
25797511|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797512|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797513|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25797514|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797515|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797516|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797517|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797518|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
25797519|NCT00001040|Zidovudine|zidovudine|mesh-list
25797520|NCT00001040|Zalcitabine|zalcitabine|mesh-list
25797521|NCT00001040|Saquinavir|saquinavir|mesh-list
25797522|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
25797523|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797524|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797525|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797526|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797527|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
25797528|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797529|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797530|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797531|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797532|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797533|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797534|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797535|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797536|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25797537|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25797538|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
25797539|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797540|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
25797541|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797542|NCT00001042|Antacids|antacids|mesh-ancestor
25797543|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797544|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25797545|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25797546|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797547|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
25797548|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797549|NCT00001044|Antacids|antacids|mesh-ancestor
25797550|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797551|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25797552|NCT00001045|Zidovudine|zidovudine|mesh-list
25797553|NCT00001045|Nevirapine|nevirapine|mesh-list
25797554|NCT00001045|Didanosine|didanosine|mesh-list
25797555|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
25797556|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797557|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797558|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24980843|NCT04823052|Sulindac|sulindac|mesh-list
25797559|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797560|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
25797561|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797562|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797563|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797564|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25797565|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25797566|NCT00001047|Clarithromycin|clarithromycin|mesh-list
25797567|NCT00001047|Ethambutol|ethambutol|mesh-list
25797568|NCT00001047|Rifabutin|rifabutin|mesh-list
25797569|NCT00001047|Clofazimine|clofazimine|mesh-list
25797570|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797571|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797572|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25797573|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797574|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797575|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797576|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797577|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
25797578|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25797579|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25797580|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
25797581|NCT00001048|Cytarabine|cytarabine|mesh-list
25797582|NCT00001048|Zidovudine|zidovudine|mesh-list
25797583|NCT00001048|Didanosine|didanosine|mesh-list
25797584|NCT00001048|Zalcitabine|zalcitabine|mesh-list
25797585|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25797586|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
25797587|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797588|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797589|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
25797590|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797591|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25797592|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
25797593|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797594|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797595|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797596|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797597|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797598|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797599|NCT00001049|Zidovudine|zidovudine|mesh-list
25797600|NCT00001049|Didanosine|didanosine|mesh-list
25797601|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
25797602|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797603|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797604|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797605|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797606|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
25797607|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797608|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797609|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797610|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25797611|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797612|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
25797613|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797614|NCT00001052|Antacids|antacids|mesh-ancestor
25797615|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797616|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25797617|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25797618|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797619|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
25797620|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797621|NCT00001053|Antacids|antacids|mesh-ancestor
25797622|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797623|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25797624|NCT00001054|Valacyclovir|valacyclovir|mesh-list
25797625|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
25797626|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797627|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
25797628|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797629|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
25797630|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797631|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25797632|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797633|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
25797634|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797635|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
25797636|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25797637|NCT00001055|Protective Agents|protective agents|mesh-ancestor
25797638|NCT00001057|Zidovudine|zidovudine|mesh-list
25797639|NCT00001057|Didanosine|didanosine|mesh-list
25797640|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
25797641|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797642|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797643|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797644|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797645|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
25797646|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797647|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797648|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797649|NCT00001058|Ritonavir|ritonavir|mesh-list
25797650|NCT00001058|Indinavir|indinavir|mesh-list
25797651|NCT00001058|Clarithromycin|clarithromycin|mesh-list
25797652|NCT00001058|Ethambutol|ethambutol|mesh-list
25797653|NCT00001058|Rifabutin|rifabutin|mesh-list
25797654|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797655|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797656|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797657|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797658|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797659|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797660|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797661|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
25797662|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797663|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797664|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797665|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797666|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25797667|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
25797668|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25797669|NCT00001059|Doxorubicin|doxorubicin|mesh-list
25797670|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25797671|NCT00001059|Bleomycin|bleomycin|mesh-list
25797672|NCT00001059|Vincristine|vincristine|mesh-list
25797673|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25797674|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797675|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25797676|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25797677|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797678|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797679|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25797680|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25797681|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25797682|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25797683|NCT00001061|Ganciclovir|ganciclovir|mesh-list
25797684|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25797685|NCT00001061|Foscarnet|foscarnet|mesh-list
25797686|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25797687|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
25797688|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797689|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797690|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797691|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797692|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797693|NCT00001062|Ganciclovir|ganciclovir|mesh-list
25797694|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25797695|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
25797696|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797697|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797698|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797699|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797700|NCT00001063|Zidovudine|zidovudine|mesh-list
25797701|NCT00001063|Stavudine|stavudine|mesh-list
25797702|NCT00001063|Didanosine|didanosine|mesh-list
25797703|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
25797704|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797705|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797706|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797707|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797708|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
25797709|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797710|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797711|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797712|NCT00001065|Amphotericin B|amphotericin b|mesh-list
25797713|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25797714|NCT00001065|Amebicides|amebicides|mesh-ancestor
25797715|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25797716|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797717|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797718|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797719|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
25797720|NCT00001066|Lamivudine|lamivudine|mesh-list
25797721|NCT00001066|Zidovudine|zidovudine|mesh-list
25797722|NCT00001066|Didanosine|didanosine|mesh-list
25797723|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797724|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797725|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797726|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797727|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
25797728|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797729|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797730|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797731|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
25797732|NCT00001067|Lamivudine|lamivudine|mesh-list
25797733|NCT00001067|Zidovudine|zidovudine|mesh-list
25797734|NCT00001067|Stavudine|stavudine|mesh-list
25797735|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797736|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797737|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797738|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797739|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
25797740|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797741|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797742|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797743|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
25797744|NCT00001068|Lamivudine|lamivudine|mesh-list
25797745|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797746|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797747|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797748|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797749|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
25797750|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797751|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797752|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797753|NCT00001070|Ascorbic Acid|ascorbic acid|mesh-list
25797754|NCT00001070|Vitamins|vitamins|mesh-ancestor
25797755|NCT00001070|Micronutrients|micronutrients|mesh-ancestor
25797756|NCT00001070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797757|NCT00001070|Antioxidants|antioxidants|mesh-ancestor
25797758|NCT00001070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797759|NCT00001070|Protective Agents|protective agents|mesh-ancestor
25797760|NCT00001071|Lenograstim|lenograstim|mesh-list
25797761|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797762|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
25797763|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797764|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
25797765|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797766|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
25797767|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797768|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25797769|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797770|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
25797771|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797772|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
25797773|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25797774|NCT00001072|Protective Agents|protective agents|mesh-ancestor
25797775|NCT00001073|Isotretinoin|isotretinoin|mesh-list
25797776|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
25797777|NCT00001074|Didanosine|didanosine|mesh-list
25797778|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
25797779|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797780|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
25797781|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797782|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797783|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797784|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
25797785|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797786|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
25797787|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797788|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797789|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797790|NCT00001075|Ritonavir|ritonavir|mesh-list
25797791|NCT00001075|Lamivudine|lamivudine|mesh-list
25797792|NCT00001075|Zidovudine|zidovudine|mesh-list
25797793|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797794|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797795|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797796|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797797|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797798|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797799|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797800|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
25797801|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797802|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797803|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797804|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797805|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797806|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
25797807|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
25797808|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25797809|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
25797810|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797811|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25797812|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797813|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
25797814|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797815|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
25797816|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25797817|NCT00001076|Protective Agents|protective agents|mesh-ancestor
25797818|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
25797819|NCT00001079|Megestrol|megestrol|mesh-list
25797820|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
25797821|NCT00001079|Testosterone|testosterone|mesh-list
25797822|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
25797823|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
25797824|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25797825|NCT00001079|Androgens|androgens|mesh-ancestor
25797826|NCT00001079|Hormones|hormones|mesh-ancestor
25797827|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25797828|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797829|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25797830|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25797831|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
25797832|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25797833|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25797834|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25797835|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
25797836|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25797837|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25797838|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25797839|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
25797840|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25797841|NCT00001080|Lamivudine|lamivudine|mesh-list
25797842|NCT00001080|Vaccines|vaccines|mesh-list
25797843|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25797844|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
25797845|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797846|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797847|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797848|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797849|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797850|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
25797851|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797852|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797853|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797854|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
25797855|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25797856|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797857|NCT00001082|Adefovir|adefovir|mesh-list
25797858|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25041138|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
25041139|NCT02626338|Etoposide|etoposide|mesh-list
25041140|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
25041141|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
25041142|NCT02626338|Idarubicin|idarubicin|mesh-list
25797859|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
25797860|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797861|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797862|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797863|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797864|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797865|NCT00001083|Ritonavir|ritonavir|mesh-list
25797866|NCT00001083|Indinavir|indinavir|mesh-list
25797867|NCT00001083|Lamivudine|lamivudine|mesh-list
25797868|NCT00001083|Zidovudine|zidovudine|mesh-list
25797869|NCT00001083|Nevirapine|nevirapine|mesh-list
25797870|NCT00001083|Stavudine|stavudine|mesh-list
25797871|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797872|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797873|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797874|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797875|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797876|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797877|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797878|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
25797879|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797880|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797881|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797882|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797883|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797884|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
25797885|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25797886|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25797887|NCT00001084|Lamivudine|lamivudine|mesh-list
25797888|NCT00001084|Zidovudine|zidovudine|mesh-list
25797889|NCT00001084|Stavudine|stavudine|mesh-list
25797890|NCT00001084|Indinavir|indinavir|mesh-list
25797891|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797892|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797893|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797894|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797895|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
25797896|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797897|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797898|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797899|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
25797900|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797901|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797902|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797903|NCT00001085|Lamivudine|lamivudine|mesh-list
25797904|NCT00001085|Zidovudine|zidovudine|mesh-list
25797905|NCT00001085|Amprenavir|amprenavir|mesh-list
25797906|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797907|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797908|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797909|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797910|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
25797911|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797912|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797913|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797914|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
25797915|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25797916|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
25797917|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25797918|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797919|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797920|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797921|NCT00001086|Efavirenz|efavirenz|mesh-list
25797922|NCT00001086|Abacavir|abacavir|mesh-list
25797923|NCT00001086|Indinavir|indinavir|mesh-list
25797924|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797925|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797926|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797927|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797928|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
25797929|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797930|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25797931|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797932|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25797933|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25797934|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25797935|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25797936|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797937|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797938|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797939|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797940|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797941|NCT00001087|Ritonavir|ritonavir|mesh-list
25797942|NCT00001087|Nelfinavir|nelfinavir|mesh-list
25797943|NCT00001087|Saquinavir|saquinavir|mesh-list
25797944|NCT00001087|Lamivudine|lamivudine|mesh-list
25797945|NCT00001087|Zidovudine|zidovudine|mesh-list
25797946|NCT00001087|Stavudine|stavudine|mesh-list
25797947|NCT00001087|Didanosine|didanosine|mesh-list
25797948|NCT00001087|Zalcitabine|zalcitabine|mesh-list
25797949|NCT00001087|Efavirenz|efavirenz|mesh-list
25797950|NCT00001087|Adefovir|adefovir|mesh-list
25797951|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25797952|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797953|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797954|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797955|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797956|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797957|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797958|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797959|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
25797960|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797961|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797962|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797963|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797964|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797965|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
25797966|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25797967|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25797968|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25797969|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25797970|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24981243|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981244|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25797971|NCT00001088|Bupivacaine|bupivacaine|mesh-list
25797972|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
25797973|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
25797974|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25797975|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797976|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
25797977|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25797978|NCT00001090|Sargramostim|sargramostim|mesh-list
25797979|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
25797980|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25797981|NCT00001091|Ritonavir|ritonavir|mesh-list
25797982|NCT00001091|Nelfinavir|nelfinavir|mesh-list
25797983|NCT00001091|Lamivudine|lamivudine|mesh-list
25797984|NCT00001091|Nevirapine|nevirapine|mesh-list
25797985|NCT00001091|Stavudine|stavudine|mesh-list
25797986|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25797987|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25797988|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
25797989|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25797990|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25797991|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25797992|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25797993|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
25797994|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25797995|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25797996|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25797997|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25797998|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25797999|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25798000|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25798001|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
25798002|NCT00001094|Lamivudine|lamivudine|mesh-list
25798003|NCT00001094|Zidovudine|zidovudine|mesh-list
25798004|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25798005|NCT00001094|Delavirdine|delavirdine|mesh-list
25798006|NCT00001094|Nelfinavir|nelfinavir|mesh-list
25798007|NCT00001094|Saquinavir|saquinavir|mesh-list
25798008|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798009|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798010|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798011|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798012|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
25798013|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798014|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798015|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798016|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
25798017|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25798018|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25798019|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
25798020|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25798021|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798022|NCT00001095|Lamivudine|lamivudine|mesh-list
25798023|NCT00001095|Zidovudine|zidovudine|mesh-list
25798024|NCT00001095|Nevirapine|nevirapine|mesh-list
25798025|NCT00001095|Stavudine|stavudine|mesh-list
25798026|NCT00001095|Indinavir|indinavir|mesh-list
25798027|NCT00001095|Amprenavir|amprenavir|mesh-list
25798028|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798029|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798030|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798031|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798032|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
25798033|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798034|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798035|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798036|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
25798037|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25798038|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25798039|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25798040|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25798041|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
25798042|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25798043|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
25798044|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25798045|NCT00001100|Ganciclovir|ganciclovir|mesh-list
25798046|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25798047|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
25798048|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798049|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798050|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798051|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798053|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
25798054|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25798055|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798056|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
25798057|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25798058|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25798059|NCT00001104|Zidovudine|zidovudine|mesh-list
25798060|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
25798061|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798062|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798063|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798064|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798065|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
25798066|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798067|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798068|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798069|NCT00001105|Antibodies|antibodies|mesh-list
25798070|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25798071|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
25798072|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798073|NCT00001106|Zidovudine|zidovudine|mesh-list
25798074|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
25798075|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798076|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798077|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798078|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798079|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
25798080|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798081|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798082|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798083|NCT00001107|Fluconazole|fluconazole|mesh-list
25798084|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25798085|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
25798086|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798087|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25798088|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798089|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798090|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798091|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25798092|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
25798093|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798094|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798095|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25798096|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25798097|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25798098|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25798099|NCT00001108|Ritonavir|ritonavir|mesh-list
25798100|NCT00001108|Nelfinavir|nelfinavir|mesh-list
25798101|NCT00001108|Saquinavir|saquinavir|mesh-list
25798102|NCT00001108|Lamivudine|lamivudine|mesh-list
25798103|NCT00001108|Nevirapine|nevirapine|mesh-list
25798104|NCT00001108|Stavudine|stavudine|mesh-list
25798105|NCT00001108|Didanosine|didanosine|mesh-list
25798106|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25798107|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25798108|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
25798109|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798110|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798111|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798112|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798113|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
25798114|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798115|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25798116|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798117|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24981426|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981427|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981428|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981429|NCT03382977|Carmustine|carmustine|mesh-list
24981432|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
25798118|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798119|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25798120|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25798121|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
25798123|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
25798124|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
25798125|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798126|NCT00001111|Zidovudine|zidovudine|mesh-list
25798127|NCT00001111|Nevirapine|nevirapine|mesh-list
25798128|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
25798129|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798130|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798131|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798132|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798133|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
25798134|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798135|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798136|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798137|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25798138|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25798139|NCT00001112|Interferons|interferons|mesh-list
25798140|NCT00001112|Zidovudine|zidovudine|mesh-list
25798141|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
25798142|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798143|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
25798144|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798145|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
25798146|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798147|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798148|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798149|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798150|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798151|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798152|NCT00001113|Interferons|interferons|mesh-list
25798153|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
25798154|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
25798155|NCT00001113|Zidovudine|zidovudine|mesh-list
25798156|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798157|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
25798158|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798159|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
25798160|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798161|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
25798162|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798163|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798164|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798165|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798166|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798167|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798168|NCT00001114|Interferons|interferons|mesh-list
25798169|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
25798170|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
25798171|NCT00001114|Didanosine|didanosine|mesh-list
25798172|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798173|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
25798174|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798175|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
25798176|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798177|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
25798178|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798179|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798180|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798181|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798182|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798183|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798184|NCT00001115|Acyclovir|acyclovir|mesh-list
25798185|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
25798186|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798187|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
25798188|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25798189|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25798190|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798191|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24981497|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24981498|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
25798193|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
25798194|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798196|NCT00001119|Indinavir|indinavir|mesh-list
25798197|NCT00001119|Amprenavir|amprenavir|mesh-list
25798198|NCT00001119|Lamivudine|lamivudine|mesh-list
25798199|NCT00001119|Zidovudine|zidovudine|mesh-list
25798200|NCT00001119|Abacavir|abacavir|mesh-list
25798201|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25798202|NCT00001119|Efavirenz|efavirenz|mesh-list
25798203|NCT00001119|Vaccines|vaccines|mesh-list
25798204|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
25798205|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798206|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25798207|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25798208|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
25798209|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798210|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798211|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798212|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798213|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
25798214|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798215|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25798216|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798217|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798218|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798219|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
25798220|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25798221|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25798222|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25798223|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25798224|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25798225|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25798226|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
25798227|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25798228|NCT00001122|Efavirenz|efavirenz|mesh-list
25798229|NCT00001122|Stavudine|stavudine|mesh-list
25798230|NCT00001122|Didanosine|didanosine|mesh-list
25798231|NCT00001122|Nelfinavir|nelfinavir|mesh-list
25798232|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798233|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798234|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798235|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798236|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
25798237|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798238|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25798239|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798240|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25798241|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25798242|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25798243|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25798244|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
25798245|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798246|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798247|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25798248|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25798249|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
25798250|NCT00001123|Ribavirin|ribavirin|mesh-list
25798251|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
25798252|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798253|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
25798254|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798255|NCT00001126|Cidofovir|cidofovir|mesh-list
25798256|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
25798257|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798258|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798259|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798260|NCT00001128|Azithromycin|azithromycin|mesh-list
25798261|NCT00001128|Paromomycin|paromomycin|mesh-list
25798262|NCT00001128|Interleukin-12|interleukin-12|mesh-list
25798263|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25798264|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981552|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24981553|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798265|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25798266|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
25798267|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798268|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25798269|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25798270|NCT00001128|Growth Substances|growth substances|mesh-ancestor
25798271|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
25798272|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798273|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25798274|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25798275|NCT00001131|Aldesleukin|aldesleukin|mesh-list
25798276|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798277|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798278|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798279|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
25798280|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798281|NCT00001132|Abacavir|abacavir|mesh-list
25798282|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798283|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798284|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798285|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798286|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
25798287|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798288|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798289|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798290|NCT00001133|Ritonavir|ritonavir|mesh-list
25798291|NCT00001133|Indinavir|indinavir|mesh-list
25798292|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25798293|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25798294|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
25798295|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798296|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798297|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798298|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798299|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
25798300|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798301|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25798302|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798303|NCT00001135|Nevirapine|nevirapine|mesh-list
25798304|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798305|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798306|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798307|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798308|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
25798309|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798310|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798311|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798312|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25798313|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25798314|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25798315|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25798316|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25798317|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
25798318|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798319|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
25798320|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798321|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798322|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798323|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
25798324|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798325|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798326|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798327|NCT00001165|Doxorubicin|doxorubicin|mesh-list
25798328|NCT00001165|Streptozocin|streptozocin|mesh-list
25798329|NCT00001165|Fluorouracil|fluorouracil|mesh-list
25798330|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25798331|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798332|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25798333|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798334|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798335|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798336|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
25798337|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25798338|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798339|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
25798340|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798341|NCT00001180|Hormones|hormones|mesh-list
25798342|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25798343|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
25798344|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798345|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798346|NCT00001181|Testolactone|testolactone|mesh-list
25798347|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25798348|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798349|NCT00001190|Deslorelin|deslorelin|mesh-list
25798350|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798351|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798352|NCT00001191|Omeprazole|omeprazole|mesh-list
25798353|NCT00001191|Pantoprazole|pantoprazole|mesh-list
25798354|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25798355|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25798356|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25798357|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798358|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798359|NCT00001193|Melphalan|melphalan|mesh-list
25798360|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798361|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
25798362|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798363|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798364|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798365|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798366|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
25798367|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798368|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
25798369|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798370|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
25798371|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798372|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798373|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798374|NCT00001202|Testolactone|testolactone|mesh-list
25798375|NCT00001202|Spironolactone|spironolactone|mesh-list
25798376|NCT00001202|Deslorelin|deslorelin|mesh-list
25798377|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25798378|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
25798379|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798380|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798381|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25798382|NCT00001202|Diuretics|diuretics|mesh-ancestor
25798383|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
25798384|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25798385|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798386|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798387|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798388|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
25798389|NCT00001209|Ifosfamide|ifosfamide|mesh-list
25798390|NCT00001209|Vincristine|vincristine|mesh-list
25798391|NCT00001209|Doxorubicin|doxorubicin|mesh-list
25798392|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25798393|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798394|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
25798395|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798396|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798397|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798398|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
25798399|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798400|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798401|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798402|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798403|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798404|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798405|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798406|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25798407|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25798408|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798409|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798410|NCT00001212|Cyclosporine|cyclosporine|mesh-list
25798411|NCT00001212|Prednisone|prednisone|mesh-list
25798412|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
25798413|NCT00001212|Cyclosporins|cyclosporins|mesh-list
25798414|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798416|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798417|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798418|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798419|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
25798420|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798421|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798422|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798423|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25798424|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
25798425|NCT00001212|Hormones|hormones|mesh-ancestor
25798426|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798427|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25798428|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798429|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
25798430|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798431|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
25798432|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25798434|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798435|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798436|NCT00001228|Interferons|interferons|mesh-list
25798437|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798438|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
25798439|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798440|NCT00001237|Molgramostim|molgramostim|mesh-list
25798441|NCT00001237|Sargramostim|sargramostim|mesh-list
25798442|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
25798443|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798444|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798446|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
25798447|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798448|NCT00001251|Mafosfamide|mafosfamide|mesh-list
25798449|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25798450|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
25798451|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798452|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798453|NCT00001256|Prednisone|prednisone|mesh-list
25798454|NCT00001256|Methotrexate|methotrexate|mesh-list
25798455|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25798456|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
25798457|NCT00001256|Hormones|hormones|mesh-ancestor
25798458|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798459|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798460|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25798461|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798462|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25798463|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
25798464|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25798465|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25798466|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
25798467|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798468|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
25798469|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798470|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25798471|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798472|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
25798473|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798474|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798475|NCT00001259|Leuprolide|leuprolide|mesh-list
25798476|NCT00001259|Estradiol|estradiol|mesh-list
25798477|NCT00001259|Progesterone|progesterone|mesh-list
25798478|NCT00001259|Estrogens|estrogens|mesh-ancestor
25798479|NCT00001259|Hormones|hormones|mesh-ancestor
25798480|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798481|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798482|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25798483|NCT00001259|Progestins|progestins|mesh-ancestor
25798484|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25798485|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
25798486|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25798487|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798488|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
25798489|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25798490|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25798491|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
25798492|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798493|NCT00001266|Suramin|suramin|mesh-list
25798494|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
25798495|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
25798496|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25798497|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798498|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798499|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25798500|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25798501|NCT00001267|Zidovudine|zidovudine|mesh-list
25798502|NCT00001267|Didanosine|didanosine|mesh-list
25798503|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
25798504|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798505|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798506|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798507|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798508|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
25798509|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798511|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798512|NCT00001280|Itraconazole|itraconazole|mesh-list
25798513|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
25798514|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798515|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25798516|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798517|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798518|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798519|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25798520|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
25798521|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798522|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798523|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25798524|NCT00001282|Zidovudine|zidovudine|mesh-list
25798525|NCT00001282|Interleukin-2|interleukin-2|mesh-list
25798526|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798527|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25798528|NCT00001282|Analgesics|analgesics|mesh-ancestor
25798529|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
25798530|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798531|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798532|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
25798533|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798534|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798535|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798536|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798537|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
25798538|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798539|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798540|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798541|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
25798542|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25798543|NCT00001287|Antibodies|antibodies|mesh-list
25798544|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
25798545|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25798546|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
25798547|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798548|NCT00001296|Interferons|interferons|mesh-list
25798549|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
25798550|NCT00001296|Melphalan|melphalan|mesh-list
25798551|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798552|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
25798553|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798554|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798555|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
25798556|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798557|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798558|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798559|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
25798560|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798561|NCT00001300|Doxorubicin|doxorubicin|mesh-list
25798562|NCT00001300|Ifosfamide|ifosfamide|mesh-list
25798563|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25798564|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798565|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25798566|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798567|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798568|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798569|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798570|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
25798571|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
25798572|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25798573|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
25798574|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798575|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798576|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25798577|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
25798578|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25798579|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
25798580|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798581|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629195|NCT01103609|Warfarin|warfarin|mesh-list
25798582|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25798583|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
25798585|NCT00001303|Protective Agents|protective agents|mesh-ancestor
25798586|NCT00001307|Capsaicin|capsaicin|mesh-list
25798587|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
25798588|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
25798589|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
25798590|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798591|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798592|NCT00001311|Heparin|heparin|mesh-list
25798593|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
25798594|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25798595|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25798596|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798597|NCT00001317|Interferons|interferons|mesh-list
25798598|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
25798599|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798600|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
25798601|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798602|NCT00001318|Interferons|interferons|mesh-list
25798603|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
25798604|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798605|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
25798606|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798607|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25798608|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25798609|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798610|NCT00001328|Ganciclovir|ganciclovir|mesh-list
25798611|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25798612|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
25798613|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798614|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798615|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798616|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798617|NCT00001332|Cisplatin|cisplatin|mesh-list
25798618|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798619|NCT00001333|Topotecan|topotecan|mesh-list
25798620|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25798621|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798622|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798623|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798624|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798625|NCT00001335|Topotecan|topotecan|mesh-list
25798626|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25798627|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798628|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798629|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798630|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798631|NCT00001339|Doxorubicin|doxorubicin|mesh-list
25798632|NCT00001339|Etoposide|etoposide|mesh-list
25798633|NCT00001339|Vincristine|vincristine|mesh-list
25798634|NCT00001339|Mitotane|mitotane|mesh-list
25798635|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25798636|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798637|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25798638|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798639|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798640|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798641|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798642|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798643|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798644|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798645|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25798646|NCT00001341|Raltitrexed|raltitrexed|mesh-list
25798647|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25798648|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
25798649|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798650|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798659|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
25798660|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
25798661|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
25798662|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25798663|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25798664|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25798665|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798666|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798667|NCT00001354|Zidovudine|zidovudine|mesh-list
25798668|NCT00001354|Interleukin-2|interleukin-2|mesh-list
25798669|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798670|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25798671|NCT00001354|Analgesics|analgesics|mesh-ancestor
25798672|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
25798673|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798674|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798675|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
25798676|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798677|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798678|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798679|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798680|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
25798681|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798682|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798683|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798684|NCT00001357|Interleukin-2|interleukin-2|mesh-list
25798685|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798686|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25798687|NCT00001357|Analgesics|analgesics|mesh-ancestor
25798688|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
25798689|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798690|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798691|NCT00001359|Penicillins|penicillins|mesh-list
25798692|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25798693|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798694|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
25798695|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
25798696|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
25798697|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25798698|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25798699|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25798700|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798701|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798706|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798707|NCT00001381|Suramin|suramin|mesh-list
25798708|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
25798709|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
25798710|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25798711|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798712|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798713|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25798714|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25798715|NCT00001383|Paclitaxel|paclitaxel|mesh-list
25798716|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798717|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798718|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798719|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798720|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798721|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798722|NCT00001384|Paclitaxel|paclitaxel|mesh-list
25798723|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
25798724|NCT00001384|Doxorubicin|doxorubicin|mesh-list
25798725|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25798726|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798727|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798728|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798729|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798730|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798731|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798732|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798733|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
25798734|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798735|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798736|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798737|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
25798738|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798739|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25798740|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25798741|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798742|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798743|NCT00001387|Paclitaxel|paclitaxel|mesh-list
25798744|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798745|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798746|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798747|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798748|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798749|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798750|NCT00001407|Interferons|interferons|mesh-list
25798751|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
25798752|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798753|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
25798754|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798755|NCT00001409|Interleukin-2|interleukin-2|mesh-list
25798756|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798757|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25798758|NCT00001409|Analgesics|analgesics|mesh-ancestor
25798759|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
25798760|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798761|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798762|NCT00001421|Methimazole|methimazole|mesh-list
25798763|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
25798764|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
25798765|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798766|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798767|NCT00001422|Fludarabine|fludarabine|mesh-list
25798768|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798769|NCT00001426|Paclitaxel|paclitaxel|mesh-list
24981999|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24982001|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982002|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982003|NCT04463394|Vasopressins|vasopressins|mesh-list
25798770|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
25798772|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798773|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798774|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798775|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798776|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798777|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798778|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798779|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
25798780|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798781|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798782|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798783|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
25798784|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798785|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
25798786|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798787|NCT00001428|Fluorouracil|fluorouracil|mesh-list
25798788|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
25798789|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798790|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25798791|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798792|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798793|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
25798794|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798795|NCT00001431|Gemcitabine|gemcitabine|mesh-list
25798796|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25798797|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
25798798|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798799|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798800|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
25798801|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798802|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798803|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798804|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
25798805|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798806|NCT00001436|Tamoxifen|tamoxifen|mesh-list
25798807|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25798808|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
25798809|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798810|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798811|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25798812|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798813|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25798814|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25798815|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25798816|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
25798817|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25798818|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798819|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798820|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25798821|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25798822|NCT00001437|Protective Agents|protective agents|mesh-ancestor
25798823|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798824|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
25798825|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25798826|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
25798827|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
25798828|NCT00001438|Tretinoin|tretinoin|mesh-list
25798829|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798830|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
25798831|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
25798832|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
25798833|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798834|NCT00001440|Interleukin-2|interleukin-2|mesh-list
25798835|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798836|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25798837|NCT00001440|Analgesics|analgesics|mesh-ancestor
25798838|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
25798839|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798840|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798841|NCT00001442|Paclitaxel|paclitaxel|mesh-list
25798842|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798843|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982055|NCT04391855|Narcotics|narcotics|mesh-ancestor
25798845|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798846|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798847|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798848|NCT00001443|Indinavir|indinavir|mesh-list
25798849|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25798850|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25798851|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
25798852|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798853|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798854|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798855|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798856|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
25798857|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798858|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25798859|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798860|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25798861|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798862|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798863|NCT00001446|Thalidomide|thalidomide|mesh-list
25798864|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798865|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
25798866|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798867|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
25798868|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25798869|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798870|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25798871|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25798872|NCT00001446|Growth Substances|growth substances|mesh-ancestor
25798873|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
25798874|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798875|NCT00001449|Leucovorin|leucovorin|mesh-list
25798876|NCT00001449|Gemcitabine|gemcitabine|mesh-list
25798877|NCT00001449|Floxuridine|floxuridine|mesh-list
25798878|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25798879|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
25798880|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798881|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798882|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
25798883|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798884|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798885|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798886|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
25798887|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798888|NCT00001449|Antidotes|antidotes|mesh-ancestor
25798889|NCT00001449|Protective Agents|protective agents|mesh-ancestor
25798890|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
25798891|NCT00001449|Vitamins|vitamins|mesh-ancestor
25798892|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
25798893|NCT00001450|Paclitaxel|paclitaxel|mesh-list
25798894|NCT00001450|Cisplatin|cisplatin|mesh-list
25798895|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798896|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798897|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798898|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798899|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798900|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798901|NCT00001457|Lamivudine|lamivudine|mesh-list
25798902|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25798903|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25798904|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798905|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798906|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
25798907|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798908|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25798909|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798910|NCT00001474|Interleukin-2|interleukin-2|mesh-list
25798911|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798912|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25798913|NCT00001474|Analgesics|analgesics|mesh-ancestor
25798914|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
25798915|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798916|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798917|NCT00001475|Thalidomide|thalidomide|mesh-list
25798918|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798919|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
25798920|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798921|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
25798922|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25798923|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25798924|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25798925|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25798926|NCT00001475|Growth Substances|growth substances|mesh-ancestor
25798927|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
25798928|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798929|NCT00001482|Lamotrigine|lamotrigine|mesh-list
25798930|NCT00001482|Gabapentin|gabapentin|mesh-list
25798931|NCT00001482|Analgesics|analgesics|mesh-ancestor
25798932|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
25798933|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25798934|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798935|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
25798936|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25798937|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25798938|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25798939|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25798940|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25798941|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25798942|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25798943|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798944|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
25798945|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25798946|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25798947|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25798948|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25798949|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25798950|NCT00001483|Sertraline|sertraline|mesh-list
25798951|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25798952|NCT00001483|Bupropion|bupropion|mesh-list
25798953|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
25798954|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25798955|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25798956|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25798957|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25798958|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798959|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25798960|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
25798961|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798962|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25798963|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25798964|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25798965|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
25798966|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25798967|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25798968|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798969|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25798970|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25798971|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
25798972|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798973|NCT00001495|Irinotecan|irinotecan|mesh-list
25798974|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25798975|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25798976|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798977|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798978|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798979|NCT00001498|Leucovorin|leucovorin|mesh-list
25798980|NCT00001498|Paclitaxel|paclitaxel|mesh-list
25798981|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
25798982|NCT00001498|Doxorubicin|doxorubicin|mesh-list
25798983|NCT00001498|Fluorouracil|fluorouracil|mesh-list
25798984|NCT00001498|Methotrexate|methotrexate|mesh-list
25798985|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25798986|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798987|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
25798988|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
25798989|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
25798990|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798991|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25798992|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
25798993|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798994|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25798995|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25798996|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
25798997|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25798998|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25798999|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25799000|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25799001|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799002|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
25799003|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25799004|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25799005|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
25799006|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25799007|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799008|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25799009|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25799010|NCT00001498|Antidotes|antidotes|mesh-ancestor
25799011|NCT00001498|Protective Agents|protective agents|mesh-ancestor
25799012|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
25799013|NCT00001498|Vitamins|vitamins|mesh-ancestor
25799014|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
25799015|NCT00001499|Paclitaxel|paclitaxel|mesh-list
25799016|NCT00001499|Cisplatin|cisplatin|mesh-list
25799017|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25799018|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799019|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
25799020|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
25799021|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
25799022|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799023|NCT00001502|Carboplatin|carboplatin|mesh-list
25799024|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799025|NCT00001504|Tretinoin|tretinoin|mesh-list
25799026|NCT00001504|Alitretinoin|alitretinoin|mesh-list
25799027|NCT00001504|Isotretinoin|isotretinoin|mesh-list
25799028|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799029|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
25799030|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799031|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25799032|NCT00001507|Antibodies|antibodies|mesh-list
25799033|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
25799034|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25799035|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
25799036|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799037|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799038|NCT00001509|Tretinoin|tretinoin|mesh-list
25799039|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799040|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
25799041|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799042|NCT00001520|Neostigmine|neostigmine|mesh-list
25799043|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25799044|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799045|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799046|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
25799047|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799048|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799049|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25799050|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
25799051|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982106|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982108|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
24982111|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
25799052|NCT00001524|Thalidomide|thalidomide|mesh-list
25799053|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799054|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
25799055|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799056|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
25799057|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799058|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799059|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25799060|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25799061|NCT00001524|Growth Substances|growth substances|mesh-ancestor
25799062|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
25799063|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799064|NCT00001526|Daclizumab|daclizumab|mesh-list
25799065|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799066|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
25799067|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799068|NCT00001533|Cyclosporine|cyclosporine|mesh-list
25799069|NCT00001533|Cyclosporins|cyclosporins|mesh-list
25799070|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799071|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799072|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799073|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
25799074|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799075|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
25799076|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799077|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799078|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799079|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25799080|NCT00001534|Losartan|losartan|mesh-list
25799081|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25799082|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25799083|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25799084|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25799085|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799086|NCT00001535|Interleukin-2|interleukin-2|mesh-list
25799087|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799088|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799089|NCT00001535|Analgesics|analgesics|mesh-ancestor
25799090|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
25799091|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799092|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799093|NCT00001542|Fluconazole|fluconazole|mesh-list
25799094|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
25799095|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799096|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25799097|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799098|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799099|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799100|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25799101|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
25799102|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799103|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799104|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25799105|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25799106|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
25799107|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25799108|NCT00001561|Antibodies|antibodies|mesh-list
25799109|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25799110|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
25799111|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799112|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25799113|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799114|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
25799115|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799116|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
25799117|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799118|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
25799119|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25799120|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
25799121|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799122|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
25799123|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799124|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25799125|NCT00001569|Paclitaxel|paclitaxel|mesh-list
25799126|NCT00001569|Cisplatin|cisplatin|mesh-list
25799127|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25799128|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799129|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
25799130|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
25799131|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
25799132|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799133|NCT00001570|Vinblastine|vinblastine|mesh-list
25799134|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25799135|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799136|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
25799137|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
25799138|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
25799139|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799140|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
25799141|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799142|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
25799143|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799145|NCT00001576|Melphalan|melphalan|mesh-list
25799146|NCT00001576|Floxuridine|floxuridine|mesh-list
25799147|NCT00001576|Antidotes|antidotes|mesh-ancestor
25799148|NCT00001576|Protective Agents|protective agents|mesh-ancestor
25799149|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799150|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
25799151|NCT00001576|Vitamins|vitamins|mesh-ancestor
25799152|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
25799153|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25799154|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
25799155|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799156|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799157|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25799158|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799159|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
25799160|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25799161|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
25799162|NCT00001577|Melphalan|melphalan|mesh-list
25799163|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25799164|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
25799165|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799166|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799167|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25799168|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799169|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
25799170|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799171|NCT00001579|Leucovorin|leucovorin|mesh-list
25799172|NCT00001579|Fluorouracil|fluorouracil|mesh-list
25799173|NCT00001579|Eniluracil|eniluracil|mesh-list
25799174|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
25799175|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799176|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25799177|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799178|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799179|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
25799180|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799181|NCT00001579|Antidotes|antidotes|mesh-ancestor
25799182|NCT00001579|Protective Agents|protective agents|mesh-ancestor
25799183|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
25799184|NCT00001579|Vitamins|vitamins|mesh-ancestor
25799185|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
25799186|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799187|NCT00001587|Melphalan|melphalan|mesh-list
25799188|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25799189|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
25799190|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799191|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799192|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25799193|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799194|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
25799195|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799196|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25799197|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799198|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
25799199|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799200|NCT00001599|Thalidomide|thalidomide|mesh-list
25799201|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799202|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
25799203|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799204|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
25799205|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799206|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799207|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25799208|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25799209|NCT00001599|Growth Substances|growth substances|mesh-ancestor
25799210|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
25799211|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799212|NCT00001624|Insulin|insulin|mesh-list
25799213|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25799214|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799215|NCT00001626|Cyclosporine|cyclosporine|mesh-list
25799216|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
25799217|NCT00001626|Cyclosporins|cyclosporins|mesh-list
25799218|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25799219|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799220|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
25799221|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799222|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799223|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25799224|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
25799225|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799226|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799227|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25799228|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799229|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
25799230|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799231|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799232|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25799233|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
25799234|NCT00001628|Giapreza|giapreza|mesh-list
25799235|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
25799236|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
25799237|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25799238|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25799239|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
25799240|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799241|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799242|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25799243|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
25799244|NCT00001629|Giapreza|giapreza|mesh-list
25799245|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
25799246|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
25799247|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25799248|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25799249|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
25799250|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799251|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799252|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25799253|NCT00001644|Lamivudine|lamivudine|mesh-list
25799254|NCT00001644|Zidovudine|zidovudine|mesh-list
25799255|NCT00001644|Nevirapine|nevirapine|mesh-list
25799256|NCT00001644|Indinavir|indinavir|mesh-list
25799257|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25799258|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25799259|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799260|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799261|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
25799262|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799263|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25799264|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25799265|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
25799266|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25799267|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25799268|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25799269|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25799270|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
25799271|NCT00001646|Voriconazole|voriconazole|mesh-list
25799272|NCT00001646|Amphotericin B|amphotericin b|mesh-list
25799273|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25799274|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
25799275|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799276|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25106365|NCT02919683|Ipilimumab|ipilimumab|mesh-list
25799277|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799278|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799279|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799280|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25799281|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
25799282|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799283|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799284|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25799285|NCT00001646|Amebicides|amebicides|mesh-ancestor
25799286|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25799287|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25799288|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799289|NCT00001649|Valacyclovir|valacyclovir|mesh-list
25799290|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
25799291|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799292|NCT00001658|Amoxicillin|amoxicillin|mesh-list
25799293|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799294|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169550|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129396|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129397|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
25129398|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25799296|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25799297|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799298|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
25799299|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
25799300|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799301|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
25799302|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799303|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799304|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
25799305|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25799306|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25799307|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25799308|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25799309|NCT00001669|Mecasermin|mecasermin|mesh-list
25799310|NCT00001669|Growth Substances|growth substances|mesh-ancestor
25799311|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799312|NCT00001676|Fludarabine|fludarabine|mesh-list
25799313|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799314|NCT00001677|Methotrexate|methotrexate|mesh-list
25799315|NCT00001677|Fludarabine|fludarabine|mesh-list
25799316|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25799317|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
25799318|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25799319|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799320|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25799321|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
25799322|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799323|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799324|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799325|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799326|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25799327|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799328|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
25799329|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799330|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25799331|NCT00001680|Thalidomide|thalidomide|mesh-list
25799332|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799333|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
25799334|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799335|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
25799336|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799337|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799338|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25799339|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25799340|NCT00001680|Growth Substances|growth substances|mesh-ancestor
25799341|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
25799342|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799343|NCT00001688|Ritonavir|ritonavir|mesh-list
25799344|NCT00001688|Nevirapine|nevirapine|mesh-list
25799345|NCT00001688|Stavudine|stavudine|mesh-list
25799346|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25799347|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25799348|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
25799349|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799350|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799351|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25799352|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25799353|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
25799354|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799355|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25799356|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799357|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25799358|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25799359|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25799360|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25799361|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
25799362|NCT00001689|Vincristine|vincristine|mesh-list
25799363|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25799364|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799365|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
25799366|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
25799367|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
25799368|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799369|NCT00001693|Celecoxib|celecoxib|mesh-list
25799370|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799371|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799372|NCT00001693|Analgesics|analgesics|mesh-ancestor
25799373|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
25799374|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799375|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799376|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799377|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799378|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25799379|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25799380|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799381|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799382|NCT00001696|Genistein|genistein|mesh-list
25799383|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25799384|NCT00001696|Protective Agents|protective agents|mesh-ancestor
25799385|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799386|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799387|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25799388|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799389|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799390|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
25799391|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25799392|NCT00001696|Estrogens|estrogens|mesh-ancestor
25799393|NCT00001696|Hormones|hormones|mesh-ancestor
25799394|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799395|NCT00001698|Ketorolac|ketorolac|mesh-list
25799396|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799397|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799398|NCT00001698|Analgesics|analgesics|mesh-ancestor
25799399|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
25799400|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799401|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799402|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799403|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799404|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25799405|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799406|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799407|NCT00001713|Heparin|heparin|mesh-list
25799408|NCT00001713|Plasminogen|plasminogen|mesh-list
25799409|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25799410|NCT00001713|Warfarin|warfarin|mesh-list
25799411|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
25799412|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25799413|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25799414|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799415|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
25799416|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
25799417|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25799418|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
25799419|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799420|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799421|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25799422|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
25799423|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25799424|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
25799425|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799426|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799427|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25799428|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
25799429|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
25799430|NCT00001716|Protective Agents|protective agents|mesh-ancestor
25799431|NCT00001720|Alendronate|alendronate|mesh-list
25799432|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25799433|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799434|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
25799435|NCT00001724|Analgesics|analgesics|mesh-ancestor
25799436|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
25799437|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799438|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799439|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799440|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799441|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799442|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799443|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25799444|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799445|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799446|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
25799447|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
25799448|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
25799449|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25799450|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25799451|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799452|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799453|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799454|NCT00001728|Alendronate|alendronate|mesh-list
25799455|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25799456|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799457|NCT00001729|Ribavirin|ribavirin|mesh-list
25799458|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
25799459|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799460|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
25799461|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799462|NCT00001731|Cyclosporine|cyclosporine|mesh-list
25799463|NCT00001731|Cyclosporins|cyclosporins|mesh-list
25799464|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799465|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799466|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799467|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
25799468|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799469|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
25799470|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799471|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799472|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799473|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25799474|NCT00001736|Cysteamine|cysteamine|mesh-list
25799475|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25799476|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799477|NCT00001737|Cyclosporine|cyclosporine|mesh-list
25799478|NCT00001737|Cyclosporins|cyclosporins|mesh-list
25799479|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799480|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799481|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799482|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
25799483|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799484|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
25799485|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799486|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799487|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799488|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25799489|NCT00001741|Losartan|losartan|mesh-list
25799490|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25799491|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25799492|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25799493|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25799494|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799495|NCT00001749|Cyclosporine|cyclosporine|mesh-list
25799496|NCT00001749|Cyclosporins|cyclosporins|mesh-list
25799497|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25799498|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799499|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982821|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982822|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982823|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24982824|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
24982825|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24982826|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24982827|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25799500|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799501|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
25799502|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799503|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
25799504|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799505|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799506|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799507|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25799508|NCT00001752|Estrogens|estrogens|mesh-list
25799509|NCT00001752|Hormones|hormones|mesh-ancestor
25799510|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799511|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799512|NCT00001757|Voriconazole|voriconazole|mesh-list
25799513|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
25799514|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799515|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25799516|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799517|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799518|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799519|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25799520|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
25799521|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799522|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799523|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25799524|NCT00001758|Efavirenz|efavirenz|mesh-list
25799525|NCT00001758|Abacavir|abacavir|mesh-list
25799526|NCT00001758|Amprenavir|amprenavir|mesh-list
25799527|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25799528|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25799529|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799530|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799531|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
25799532|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799533|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25799534|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799535|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25799536|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25799537|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25799538|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25799539|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25799540|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25799541|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25799542|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
25799543|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799544|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25799545|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25799546|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
25799547|NCT00001763|Interleukin-12|interleukin-12|mesh-list
25799548|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799549|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
25799550|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799551|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25799552|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25799553|NCT00001763|Growth Substances|growth substances|mesh-ancestor
25799554|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
25799555|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799556|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
25799557|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25799558|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799559|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25799560|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
25799561|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799562|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799563|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799564|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799565|NCT00001766|Ritonavir|ritonavir|mesh-list
25799566|NCT00001766|Nelfinavir|nelfinavir|mesh-list
24982880|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
24982881|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24982882|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25799567|NCT00001766|Amprenavir|amprenavir|mesh-list
25799568|NCT00001766|Abacavir|abacavir|mesh-list
25799569|NCT00001766|Efavirenz|efavirenz|mesh-list
25799570|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25799571|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25799572|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
25799573|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799574|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799575|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25799576|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25799577|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
25799578|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799579|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25799580|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799581|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25799582|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25799583|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25799584|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25799585|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25799586|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25799587|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25799588|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25799589|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
25799590|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799591|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
25799592|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25799593|NCT00001768|Antibodies|antibodies|mesh-list
25799594|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
25799595|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25799596|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
25799597|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799598|NCT00001777|Sertraline|sertraline|mesh-list
25799599|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
25799600|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25799601|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25799602|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25799603|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25799604|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799605|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799606|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
25799607|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799608|NCT00001784|Mexiletine|mexiletine|mesh-list
25799609|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25799610|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25799611|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25799612|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25799613|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799614|NCT00001785|Interferons|interferons|mesh-list
25799615|NCT00001785|Interferon-beta|interferon-beta|mesh-list
25799616|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
25799617|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799618|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
25799619|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799620|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
25799621|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799622|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799623|NCT00001790|Micafungin|micafungin|mesh-list
25799624|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
25799625|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799626|NCT00001805|Rituximab|rituximab|mesh-list
25799627|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25799628|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799629|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
25799630|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799631|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799632|NCT00001810|Voriconazole|voriconazole|mesh-list
25799633|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
25799634|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799635|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25106530|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
25106531|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129907|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129908|NCT03038009|Pantoprazole|pantoprazole|mesh-list
25799636|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799637|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799638|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799639|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25799640|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25799641|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799642|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799643|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25799644|NCT00001812|Nystatin|nystatin|mesh-list
25799645|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25799646|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799647|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
25799648|NCT00001812|Ionophores|ionophores|mesh-ancestor
25799649|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25799650|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799651|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
25799652|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799653|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
25799654|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799655|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799656|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24444766|NCT00299039|Narcotics|narcotics|mesh-ancestor
24444783|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
24795869|NCT01946555|Methadone|methadone|mesh-list
24795870|NCT01946555|Hydromorphone|hydromorphone|mesh-list
24795871|NCT01946555|Tapentadol|tapentadol|mesh-list
24795872|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24795873|NCT01946555|Narcotics|narcotics|mesh-ancestor
24795874|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24795875|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795876|NCT01946555|Analgesics|analgesics|mesh-ancestor
24983164|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983165|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25799657|NCT00001827|Aldesleukin|aldesleukin|mesh-list
25799658|NCT00001827|Sargramostim|sargramostim|mesh-list
25799659|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
25799660|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
25799661|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799662|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799663|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25799664|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25799665|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
25799666|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799667|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799668|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
25799669|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799670|NCT00001839|Cyclosporine|cyclosporine|mesh-list
25799671|NCT00001839|Cyclosporins|cyclosporins|mesh-list
25799672|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25799673|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799674|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799675|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799676|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
25799677|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799678|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
25799679|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799680|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799681|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799682|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25799683|NCT00001842|Dexamethasone|dexamethasone|mesh-list
25799684|NCT00001842|Lenograstim|lenograstim|mesh-list
25799685|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799686|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
25799687|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
25799688|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799689|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799690|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799691|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
25799692|NCT00001842|Hormones|hormones|mesh-ancestor
25799693|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799694|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25799695|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799696|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799697|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
25799698|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25799699|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25799700|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
25799701|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799702|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799703|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25799704|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25799705|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25799706|NCT00001854|Ribavirin|ribavirin|mesh-list
25799707|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
25799708|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799709|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
25799710|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799711|NCT00001860|Octreotide|octreotide|mesh-list
25799712|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799713|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25799714|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799715|NCT00001862|Etanercept|etanercept|mesh-list
25799716|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799717|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799718|NCT00001862|Analgesics|analgesics|mesh-ancestor
25799719|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
25799720|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799721|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799722|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799723|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799724|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799725|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799726|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
25799727|NCT00001863|Leflunomide|leflunomide|mesh-list
25799728|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799729|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983211|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983212|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24983213|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799730|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799731|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
25799732|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799733|NCT00001864|Atropine|atropine|mesh-list
25799734|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25799735|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25799736|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25799737|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
25799738|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799739|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799740|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25799741|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
25799742|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
25799743|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
25799744|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25799745|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25799746|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
25799747|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799748|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799749|NCT00001865|Daclizumab|daclizumab|mesh-list
25799750|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799751|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
25799752|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799753|NCT00001870|Acetylcholine|acetylcholine|mesh-list
25799754|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
25799755|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25799756|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
25799757|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799758|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799759|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799760|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
25799761|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25799762|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799763|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799764|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25799765|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25799766|NCT00001877|Protective Agents|protective agents|mesh-ancestor
25799767|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799768|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
25799769|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25799770|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
25799771|NCT00001889|Dobutamine|dobutamine|mesh-list
25799772|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25799773|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
25799774|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
25799775|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799776|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799777|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25799778|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25799779|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25799780|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
25799781|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799782|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799783|NCT00001889|Protective Agents|protective agents|mesh-ancestor
25799784|NCT00001890|Estrogens|estrogens|mesh-list
25799785|NCT00001890|Hormones|hormones|mesh-ancestor
25799786|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799787|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799788|NCT00001891|Dobutamine|dobutamine|mesh-list
25799789|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25799790|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
25799791|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
24983364|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24983365|NCT00392327|Vitamins|vitamins|mesh-ancestor
24983366|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
24983367|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25106595|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
25106596|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
25106597|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25106598|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25106599|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25106600|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25799792|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799793|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799794|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25799795|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25799796|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25799797|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
25799798|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799799|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799800|NCT00001891|Protective Agents|protective agents|mesh-ancestor
25799801|NCT00001893|Etanercept|etanercept|mesh-list
25799802|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799803|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799804|NCT00001893|Analgesics|analgesics|mesh-ancestor
25799805|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
25799806|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799807|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799808|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799809|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799810|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799811|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799812|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
25799813|NCT00001901|Etanercept|etanercept|mesh-list
25799814|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799815|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799816|NCT00001901|Analgesics|analgesics|mesh-ancestor
25799817|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
25799818|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799819|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799820|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799821|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799822|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799823|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799824|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
25799825|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
25799826|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25799827|NCT00001903|Antibodies|antibodies|mesh-list
25799828|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
25799829|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799830|NCT00001905|Interferons|interferons|mesh-list
25799831|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
25799832|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799833|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
25799834|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799835|NCT00001906|Interleukin-12|interleukin-12|mesh-list
25799836|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25799837|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799838|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
25799839|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799840|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25799841|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25799842|NCT00001906|Growth Substances|growth substances|mesh-ancestor
25799843|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
25799844|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799845|NCT00001906|Antacids|antacids|mesh-ancestor
25799846|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799847|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799848|NCT00001911|Interleukin-12|interleukin-12|mesh-list
25799849|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25799850|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
25799851|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799852|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25799853|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25799854|NCT00001911|Growth Substances|growth substances|mesh-ancestor
25799855|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
25799856|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799857|NCT00001929|Eliprodil|eliprodil|mesh-list
25799858|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25799859|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25162491|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24983422|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24983423|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
24983424|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
24983425|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983426|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983427|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
24983428|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130302|NCT03034707|Biotin|biotin|mesh-list
25799860|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799861|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799862|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799863|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25799864|NCT00001929|Protective Agents|protective agents|mesh-ancestor
25799865|NCT00001930|Amantadine|amantadine|mesh-list
25799866|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25799867|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25799868|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
25799869|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799870|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
25799871|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799872|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799873|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799874|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799875|NCT00001930|Analgesics|analgesics|mesh-ancestor
25799876|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
25799877|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799878|NCT00001933|Nefiracetam|nefiracetam|mesh-list
25799879|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25799880|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25799881|NCT00001933|Protective Agents|protective agents|mesh-ancestor
25799882|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799883|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
25799884|NCT00001934|Daclizumab|daclizumab|mesh-list
25799885|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799886|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
25799887|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799888|NCT00001937|Fluconazole|fluconazole|mesh-list
25799889|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
25799890|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799891|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25799892|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799893|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799894|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799895|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25799896|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
25799897|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799898|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799899|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25799900|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25799901|NCT00001940|Voriconazole|voriconazole|mesh-list
25799902|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
25799903|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799904|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25799905|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25799906|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799907|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799908|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25799909|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
25799910|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25799911|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799912|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25799913|NCT00001944|Vinorelbine|vinorelbine|mesh-list
25799914|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25799915|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799916|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
25799917|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
25799918|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983483|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
24983484|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983485|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983486|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24983487|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
24983488|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
24983489|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799919|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799921|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799922|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799923|NCT00001954|Analgesics|analgesics|mesh-ancestor
25799924|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
25799925|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799926|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799927|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799928|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799929|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799930|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799931|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
25799932|NCT00001955|Celecoxib|celecoxib|mesh-list
25799933|NCT00001955|Etanercept|etanercept|mesh-list
25799934|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799935|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799936|NCT00001955|Analgesics|analgesics|mesh-ancestor
25799937|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
25799938|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799939|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799940|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799941|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799942|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25799943|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25799944|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799945|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799946|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25799947|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799948|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
25799949|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
25799950|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799951|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
25799952|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799953|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799954|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25799955|NCT00001963|Chrysarobin|chrysarobin|mesh-list
25799956|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
25799957|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25799958|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
25799959|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25799960|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799961|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25799962|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
25799963|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25799964|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
25799965|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799966|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25799967|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25799968|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
25799969|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
25799970|NCT00001963|Protective Agents|protective agents|mesh-ancestor
25799971|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25799972|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25799973|NCT00001963|Analgesics|analgesics|mesh-ancestor
25799974|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
25799975|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25799976|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983528|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
24983529|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983530|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983532|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983533|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983534|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
24983535|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983536|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983537|NCT05184517|Cyclosporine|cyclosporine|mesh-list
24983538|NCT05184517|Cyclosporins|cyclosporins|mesh-list
25799978|NCT00001964|Cyclosporins|cyclosporins|mesh-list
25799979|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799980|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799981|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799982|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
25799983|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799984|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
25799985|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799986|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799987|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25799988|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25799989|NCT00001965|Cyclosporine|cyclosporine|mesh-list
25799990|NCT00001965|Cyclosporins|cyclosporins|mesh-list
25799991|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25799992|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25799993|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25799994|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
25799995|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25799996|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
25799997|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25799998|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
25799999|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25800000|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25800001|NCT00001968|Ritonavir|ritonavir|mesh-list
25800002|NCT00001968|Amprenavir|amprenavir|mesh-list
25800003|NCT00001968|Lamivudine|lamivudine|mesh-list
25800004|NCT00001968|Abacavir|abacavir|mesh-list
25800005|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25800006|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25800007|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
25800008|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800009|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800010|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800011|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800012|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
25800013|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800014|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25800015|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800016|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800017|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800018|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25800019|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
25800020|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800021|NCT00001989|Zidovudine|zidovudine|mesh-list
25800022|NCT00001989|Trichosanthin|trichosanthin|mesh-list
25800023|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
25800024|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800025|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800026|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800027|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800028|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
25800029|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800030|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800031|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800032|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25800033|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
25800034|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25800035|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800036|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25800037|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800038|NCT00001990|Atovaquone|atovaquone|mesh-list
25800039|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800040|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
24983593|NCT05183997|Coagulants|coagulants|mesh-ancestor
24983594|NCT05183841|Fenoterol|fenoterol|mesh-list
24983595|NCT05183841|Ipratropium|ipratropium|mesh-list
24983596|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
24983597|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
24983598|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983599|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983600|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25800041|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800042|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800043|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800044|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800045|NCT00001991|Atovaquone|atovaquone|mesh-list
25800046|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800047|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
25800048|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800049|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800050|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800051|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800052|NCT00001993|Miglustat|miglustat|mesh-list
25800053|NCT00001993|Zidovudine|zidovudine|mesh-list
25800054|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
25800055|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800056|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800057|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800058|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800059|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
25800060|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800061|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800062|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800063|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25800064|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25800065|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800066|NCT00001994|Atovaquone|atovaquone|mesh-list
25800067|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800068|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
25800069|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800070|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800071|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800072|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800073|NCT00001995|Rifabutin|rifabutin|mesh-list
25800074|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800075|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800076|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25800077|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
25800078|NCT00001996|Atovaquone|atovaquone|mesh-list
25800079|NCT00001996|Pentamidine|pentamidine|mesh-list
25800080|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800081|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
25800082|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800083|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800084|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800085|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800086|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
25800087|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25800088|NCT00001997|Zidovudine|zidovudine|mesh-list
25800089|NCT00001997|Didanosine|didanosine|mesh-list
25800090|NCT00001997|Interleukin-2|interleukin-2|mesh-list
25800091|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800092|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25800093|NCT00001997|Analgesics|analgesics|mesh-ancestor
25800094|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
25800095|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25800096|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800097|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
25800098|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800099|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800100|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800101|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800102|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
25800103|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800104|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800105|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800106|NCT00001998|Nystatin|nystatin|mesh-list
25800107|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24795894|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795895|NCT01946594|Acetaminophen|acetaminophen|mesh-list
24795902|NCT01946607|Citalopram|citalopram|mesh-list
25800108|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800109|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
25800110|NCT00001998|Ionophores|ionophores|mesh-ancestor
25800111|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25800112|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800113|NCT00001999|Ganciclovir|ganciclovir|mesh-list
25800114|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25800115|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
25800116|NCT00001999|Antibodies|antibodies|mesh-list
25800117|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
25800118|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800119|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800120|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800121|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800122|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
25800123|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800124|NCT00002000|Valacyclovir|valacyclovir|mesh-list
25800125|NCT00002000|Acyclovir|acyclovir|mesh-list
25800126|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
25800127|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800128|NCT00002001|Zidovudine|zidovudine|mesh-list
25800129|NCT00002001|Didanosine|didanosine|mesh-list
25800130|NCT00002001|Zalcitabine|zalcitabine|mesh-list
25800131|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
25800132|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800133|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800134|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800135|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800136|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
25800137|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800138|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800139|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800140|NCT00002002|Leucovorin|leucovorin|mesh-list
25800141|NCT00002002|Trimethoprim|trimethoprim|mesh-list
25800142|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
25800143|NCT00002002|Calcium|calcium|mesh-list
25800144|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
25800145|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25800146|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800147|NCT00002002|Antidotes|antidotes|mesh-ancestor
25800148|NCT00002002|Protective Agents|protective agents|mesh-ancestor
25800149|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
25800150|NCT00002002|Vitamins|vitamins|mesh-ancestor
25800151|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
25800152|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25800153|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800154|NCT00002002|Renal Agents|renal agents|mesh-ancestor
25800155|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
25800156|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800157|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800158|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25800159|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800160|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800161|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25800162|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25800163|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800164|NCT00002003|Etoposide|etoposide|mesh-list
25800165|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
25800166|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25800167|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800168|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25800169|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25800170|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800171|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800172|NCT00002003|Analgesics|analgesics|mesh-ancestor
25800173|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
25800174|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25800175|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800176|NCT00002006|Zidovudine|zidovudine|mesh-list
25800177|NCT00002006|Sargramostim|sargramostim|mesh-list
25800178|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
25800179|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800180|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800181|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800182|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800183|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
25800184|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800185|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800186|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800187|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
25800188|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800189|NCT00002007|Zidovudine|zidovudine|mesh-list
25800190|NCT00002007|Sargramostim|sargramostim|mesh-list
25800191|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
25800192|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800193|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800194|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800195|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800196|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
25800197|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800198|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800199|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800200|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
25800201|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800202|NCT00002008|Sargramostim|sargramostim|mesh-list
25800203|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
25800204|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800205|NCT00002009|Sargramostim|sargramostim|mesh-list
25800206|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
25800207|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800208|NCT00002010|Fluconazole|fluconazole|mesh-list
25800209|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
25800210|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800211|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800212|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800213|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800214|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800215|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25800216|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800217|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800218|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800219|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800220|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800221|NCT00002011|Methoxsalen|methoxsalen|mesh-list
25800222|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25800223|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
25800224|NCT00002012|Interferons|interferons|mesh-list
25800225|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
25800226|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800227|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
25800228|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800229|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
25800230|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800231|NCT00002013|Zidovudine|zidovudine|mesh-list
25800232|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
25800233|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800234|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800235|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800236|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800237|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
25800238|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800239|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800240|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800241|NCT00002014|Zidovudine|zidovudine|mesh-list
25800242|NCT00002014|Didanosine|didanosine|mesh-list
25800243|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
25800244|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800245|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800246|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800247|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800248|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
25800249|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800250|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800251|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800252|NCT00002015|Ganciclovir|ganciclovir|mesh-list
25800253|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25800254|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
24445493|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445494|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445495|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445496|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
25800255|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800256|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800257|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800258|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800260|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800261|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25800262|NCT00002017|Analgesics|analgesics|mesh-ancestor
25800263|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
25800264|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25800265|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800266|NCT00002018|Interferons|interferons|mesh-list
25800267|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
25800268|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800269|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
25800270|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800271|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
25800272|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800273|NCT00002019|Amphotericin B|amphotericin b|mesh-list
25800274|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25800275|NCT00002019|Amebicides|amebicides|mesh-ancestor
25800276|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800277|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800278|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800279|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800280|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
25800281|NCT00002020|Zidovudine|zidovudine|mesh-list
25800282|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
25800283|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800284|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800285|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800286|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800287|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
25800288|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800289|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800290|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800291|NCT00002021|Foscarnet|foscarnet|mesh-list
25800292|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25800293|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
25800294|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800295|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800296|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800297|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800298|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800299|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
25800300|NCT00002022|Hematinics|hematinics|mesh-ancestor
25800301|NCT00002023|Zidovudine|zidovudine|mesh-list
25800302|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
25800303|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800304|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800305|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800306|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800307|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
25800308|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800309|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800310|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800311|NCT00002024|Ganciclovir|ganciclovir|mesh-list
25800312|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25800313|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
25800314|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800315|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800316|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800317|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800318|NCT00002025|Ganciclovir|ganciclovir|mesh-list
25800319|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25800320|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
25800321|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983703|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24983704|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983705|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
24983706|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
25162492|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24983707|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983708|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983709|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24983710|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
24983711|NCT05177939|Hormones|hormones|mesh-ancestor
25800322|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800323|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800324|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800325|NCT00002026|Acyclovir|acyclovir|mesh-list
25800326|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
25800327|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800328|NCT00002027|Diclazuril|diclazuril|mesh-list
25800329|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
25800330|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800331|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800332|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800333|NCT00002028|Didanosine|didanosine|mesh-list
25800334|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
25800335|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800336|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800337|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800338|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800339|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
25800340|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800341|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800342|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800343|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25800344|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25800345|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25800346|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25800347|NCT00002030|Pentamidine|pentamidine|mesh-list
25800348|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
25800349|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800350|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800351|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800352|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25800353|NCT00002032|Rifabutin|rifabutin|mesh-list
25800354|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800355|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800356|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25800357|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
25800358|NCT00002033|Zidovudine|zidovudine|mesh-list
25800359|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
25800360|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800361|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800362|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800363|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800364|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
25800365|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800366|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800367|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800368|NCT00002034|Zidovudine|zidovudine|mesh-list
25800369|NCT00002034|Ganciclovir|ganciclovir|mesh-list
25800370|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25800371|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
25800372|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800373|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800374|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800375|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800376|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
25800377|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800378|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800379|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800380|NCT00002035|Zidovudine|zidovudine|mesh-list
25800381|NCT00002035|Didanosine|didanosine|mesh-list
25800382|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
25800383|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800384|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800385|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800386|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800387|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
25800388|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983814|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983815|NCT05146674|Tadalafil|tadalafil|mesh-list
24983816|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
24983817|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25800389|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800390|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800392|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
25800393|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800394|NCT00002037|Trifluridine|trifluridine|mesh-list
25800395|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
25800396|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800397|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
25800398|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800399|NCT00002038|Fluconazole|fluconazole|mesh-list
25800400|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
25800401|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800402|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800403|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800404|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800405|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800406|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25800407|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800408|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800409|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800410|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800411|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800412|NCT00002039|Foscarnet|foscarnet|mesh-list
25800413|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25800414|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
25800415|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800416|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800417|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800418|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800419|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800420|NCT00002040|Fluconazole|fluconazole|mesh-list
25800421|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
25800422|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800423|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800424|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800425|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800426|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800427|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25800428|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800429|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800430|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800431|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800432|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800433|NCT00002041|Amphotericin B|amphotericin b|mesh-list
25800434|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25800435|NCT00002041|Amebicides|amebicides|mesh-ancestor
25800436|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800437|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800438|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800439|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800440|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
25800441|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
25800442|NCT00002042|Hematinics|hematinics|mesh-ancestor
25800443|NCT00002043|Dapsone|dapsone|mesh-list
25800444|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800445|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
25800446|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800447|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800448|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25800449|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800450|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800451|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
25800452|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800453|NCT00002044|Zidovudine|zidovudine|mesh-list
25800454|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
25800455|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162494|NCT02904304|Phenylephrine|phenylephrine|mesh-list
25162495|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
25162496|NCT02904304|Desloratadine|desloratadine|mesh-list
25162497|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25162503|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162504|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162505|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25162506|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800456|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800457|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800458|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800459|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
25800460|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800461|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800462|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800463|NCT00002045|Zidovudine|zidovudine|mesh-list
25800464|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
25800465|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800466|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800467|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800468|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800469|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
25800470|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800471|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800472|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800473|NCT00002046|Zidovudine|zidovudine|mesh-list
25800474|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
25800475|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800476|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800477|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800478|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800479|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
25800480|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800481|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800482|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800483|NCT00002047|Zidovudine|zidovudine|mesh-list
25800484|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
25800485|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800486|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800487|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800488|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800489|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
25800490|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800491|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800492|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800493|NCT00002048|Zidovudine|zidovudine|mesh-list
25800494|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
25800495|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800496|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800497|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800498|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800499|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
25800500|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800501|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800502|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800503|NCT00002049|Thymopentin|thymopentin|mesh-list
25800504|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800505|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
25800506|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800507|NCT00002050|Thymopentin|thymopentin|mesh-list
25800508|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800509|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
25800510|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800511|NCT00002051|Thymopentin|thymopentin|mesh-list
25800512|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800513|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
25800514|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800515|NCT00002052|Amoxicillin|amoxicillin|mesh-list
25800516|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
25800517|NCT00002052|Ampicillin|ampicillin|mesh-list
25800518|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800519|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800520|NCT00002053|Pentamidine|pentamidine|mesh-list
25800521|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
25800522|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131209|NCT03027674|Nifedipine|nifedipine|mesh-list
25800523|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800524|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800525|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25800526|NCT00002054|Pentamidine|pentamidine|mesh-list
25800527|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
25800528|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800529|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800530|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800531|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25800532|NCT00002055|Pentamidine|pentamidine|mesh-list
25800533|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
25800534|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800535|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800536|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800537|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25800538|NCT00002056|Pentamidine|pentamidine|mesh-list
25800539|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
25800540|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800541|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800542|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800543|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25800545|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800546|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800547|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
25800548|NCT00002057|Ionophores|ionophores|mesh-ancestor
25800549|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25800550|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800551|NCT00002058|Clofazimine|clofazimine|mesh-list
25800552|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25800553|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
25800554|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800555|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800556|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
25800557|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800558|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
25800559|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800560|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
25800561|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800562|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
25800563|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800564|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
25800565|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800566|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
25800567|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800568|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
25800569|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800570|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
25800571|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800572|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
25800573|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800574|NCT00002062|Spiramycin|spiramycin|mesh-list
25800575|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800576|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800577|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
25800578|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800579|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800580|NCT00002063|Zidovudine|zidovudine|mesh-list
25800581|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
25800582|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800583|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800584|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800585|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800586|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
25800587|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800588|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800589|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800590|NCT00002064|Clindamycin|clindamycin|mesh-list
24784559|NCT01908621|Lenograstim|lenograstim|mesh-list
24784560|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24784561|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
24784562|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048828|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
24999633|NCT03671811|Megestrol|megestrol|mesh-list
24999634|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
25131300|NCT03027115|Tamsulosin|tamsulosin|mesh-list
25162508|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25800591|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
25800592|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
25800593|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
25800594|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800595|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800596|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25800597|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800598|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800599|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
25800600|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800601|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800602|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25800603|NCT00002065|Disulfiram|disulfiram|mesh-list
25800604|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25800605|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25800606|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800607|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800608|NCT00002066|Thymopentin|thymopentin|mesh-list
25800609|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800610|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
25800611|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800612|NCT00002067|Megestrol|megestrol|mesh-list
25800613|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
25800614|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25800615|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25800616|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25800617|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
25800618|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25800619|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800620|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25800621|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25800622|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25800623|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800624|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
25800625|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25800626|NCT00002068|Fluconazole|fluconazole|mesh-list
25800627|NCT00002068|Amphotericin B|amphotericin b|mesh-list
25800628|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25800629|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
25800630|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800631|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800632|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800633|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800634|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800635|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25800636|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800637|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800638|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800639|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800640|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800641|NCT00002068|Amebicides|amebicides|mesh-ancestor
25800642|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800643|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800644|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800645|NCT00002069|Ditiocarb|ditiocarb|mesh-list
25800646|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800647|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
25800648|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800649|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
25800650|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800651|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
25800652|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
25800653|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800654|NCT00002070|Ganciclovir|ganciclovir|mesh-list
25800655|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25131384|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971072|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
24983901|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24983902|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24983903|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25162509|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
25162510|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
25162511|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
25162513|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
25800656|NCT00002070|Sargramostim|sargramostim|mesh-list
25800657|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
25800658|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800659|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
25800660|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800661|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800662|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800663|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800664|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
25800665|NCT00002071|Hematinics|hematinics|mesh-ancestor
25800666|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
25800667|NCT00002072|Hematinics|hematinics|mesh-ancestor
24983942|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
24446246|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446247|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446249|NCT00304226|Valsartan|valsartan|mesh-list
25800668|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
25800669|NCT00002073|Hematinics|hematinics|mesh-ancestor
25800670|NCT00002074|Fluconazole|fluconazole|mesh-list
25800671|NCT00002074|Amphotericin B|amphotericin b|mesh-list
25800672|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25800673|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
25800674|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800675|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800676|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800677|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800678|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800679|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25800680|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800681|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800682|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800683|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800684|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800685|NCT00002074|Amebicides|amebicides|mesh-ancestor
25800686|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800687|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800688|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800689|NCT00002075|Fluconazole|fluconazole|mesh-list
25800690|NCT00002075|Amphotericin B|amphotericin b|mesh-list
25800691|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25800692|NCT00002075|Flucytosine|flucytosine|mesh-list
25800693|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
25800694|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800695|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800696|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800697|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800698|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800699|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25800700|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800701|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800702|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800703|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800704|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800705|NCT00002075|Amebicides|amebicides|mesh-ancestor
25800706|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800707|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800708|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800709|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
25800710|NCT00002076|Fluconazole|fluconazole|mesh-list
25800711|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
25800712|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800713|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800714|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800715|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800716|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800717|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25800718|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800719|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800720|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800721|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800722|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800723|NCT00002077|Fluconazole|fluconazole|mesh-list
25800724|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
25800725|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800726|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25800727|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800728|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800729|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800730|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24784595|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784596|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24784597|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24784599|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784600|NCT01909063|Protective Agents|protective agents|mesh-ancestor
24784601|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
25800731|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800732|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25800733|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800734|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25800735|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25800737|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
25800738|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800739|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
25800740|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800741|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
25800742|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800743|NCT00002079|Miglustat|miglustat|mesh-list
25800744|NCT00002079|Zidovudine|zidovudine|mesh-list
25800745|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
25800746|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800747|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800748|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800749|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800750|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
25800751|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800752|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800753|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800754|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25800755|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25800756|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800757|NCT00002080|Rifabutin|rifabutin|mesh-list
25800758|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800759|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800760|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25800761|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
25800762|NCT00002081|Zidovudine|zidovudine|mesh-list
25800763|NCT00002081|Zalcitabine|zalcitabine|mesh-list
25800764|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
25800765|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800766|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800767|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800768|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800769|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
25800770|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800771|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800772|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800773|NCT00002082|Azithromycin|azithromycin|mesh-list
25800774|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800775|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800776|NCT00002084|Valacyclovir|valacyclovir|mesh-list
25800777|NCT00002084|Acyclovir|acyclovir|mesh-list
25800778|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
25800779|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800780|NCT00002085|Azithromycin|azithromycin|mesh-list
25800781|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800782|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800783|NCT00002086|Interferons|interferons|mesh-list
25800784|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
25800785|NCT00002086|Zidovudine|zidovudine|mesh-list
25800786|NCT00002086|Zalcitabine|zalcitabine|mesh-list
25800787|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800788|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
25800789|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800790|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
25800791|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800792|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
25800793|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800794|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800795|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800796|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800797|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800798|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800799|NCT00002089|Azithromycin|azithromycin|mesh-list
25800800|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800801|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784641|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
25106743|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
25800802|NCT00002090|Azithromycin|azithromycin|mesh-list
25800803|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800804|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800805|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
25800806|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25800807|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800808|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800809|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25800810|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25800811|NCT00002091|Protective Agents|protective agents|mesh-ancestor
25800812|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800813|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
25800814|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25800815|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
25800816|NCT00002092|Cimetidine|cimetidine|mesh-list
25800817|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25800818|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25800819|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25800820|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
25800821|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
25800822|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25800823|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800824|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800825|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25800826|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800827|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800828|NCT00002093|Doxorubicin|doxorubicin|mesh-list
25800829|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25800830|NCT00002093|Daunorubicin|daunorubicin|mesh-list
25800831|NCT00002093|Bleomycin|bleomycin|mesh-list
25800832|NCT00002093|Vincristine|vincristine|mesh-list
25800833|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25800834|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800835|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25800836|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25800837|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800838|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800839|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25800840|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25800841|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
25800842|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25800843|NCT00002094|Atevirdine|atevirdine|mesh-list
25800844|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800845|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800846|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800847|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800848|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
25800849|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800850|NCT00002095|Ganciclovir|ganciclovir|mesh-list
25800851|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25800852|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
25800853|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800854|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800855|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800856|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800857|NCT00002096|Zidovudine|zidovudine|mesh-list
25800858|NCT00002096|Didanosine|didanosine|mesh-list
25800859|NCT00002096|Ganciclovir|ganciclovir|mesh-list
25800860|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25800861|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
25800862|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800863|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800864|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800865|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800866|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
25800867|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800868|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800869|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800870|NCT00002097|Nystatin|nystatin|mesh-list
25800871|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800872|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800873|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
25800874|NCT00002097|Ionophores|ionophores|mesh-ancestor
25800875|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25800876|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984088|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
24984089|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25800877|NCT00002098|Didanosine|didanosine|mesh-list
25800879|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
25800880|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800881|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800882|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800883|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800884|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
25800885|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800886|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800887|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800888|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800889|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
25800890|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800891|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800892|NCT00002099|Didanosine|didanosine|mesh-list
25800893|NCT00002099|Lentinan|lentinan|mesh-list
25800894|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
25800895|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800896|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25800897|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25800898|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800899|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
25800900|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800901|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25800902|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25800903|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25800904|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
25800905|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800906|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800907|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
25800908|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
25800909|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25800910|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25800911|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800912|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
25800913|NCT00002101|Clarithromycin|clarithromycin|mesh-list
25800914|NCT00002101|Ethambutol|ethambutol|mesh-list
25800915|NCT00002101|Rifabutin|rifabutin|mesh-list
25800916|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800917|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800918|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25800919|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800920|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800921|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25800922|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25800923|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
25800924|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25800925|NCT00002102|Leucovorin|leucovorin|mesh-list
25800926|NCT00002102|Trimetrexate|trimetrexate|mesh-list
25800927|NCT00002102|Calcium|calcium|mesh-list
25800928|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
25800929|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25800930|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800931|NCT00002102|Antidotes|antidotes|mesh-ancestor
25800932|NCT00002102|Protective Agents|protective agents|mesh-ancestor
25800933|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
25800934|NCT00002102|Vitamins|vitamins|mesh-ancestor
25800935|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
25800936|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
25800937|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800938|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25800939|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
25800940|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800941|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800942|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25800943|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800944|NCT00002103|Leucovorin|leucovorin|mesh-list
25800945|NCT00002103|Trimetrexate|trimetrexate|mesh-list
25800946|NCT00002103|Calcium|calcium|mesh-list
25800947|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
25800948|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25800949|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800950|NCT00002103|Antidotes|antidotes|mesh-ancestor
25800951|NCT00002103|Protective Agents|protective agents|mesh-ancestor
25800952|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
25800953|NCT00002103|Vitamins|vitamins|mesh-ancestor
25800954|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
25800955|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
25800956|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800957|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25800958|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
25800959|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800960|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800961|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25800962|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800963|NCT00002104|Thalidomide|thalidomide|mesh-list
25800964|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25800965|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
25800966|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800967|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
25800968|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25800969|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25800970|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25800971|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25800972|NCT00002104|Growth Substances|growth substances|mesh-ancestor
25800973|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
25800974|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800975|NCT00002105|Doxorubicin|doxorubicin|mesh-list
25800976|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25800977|NCT00002105|Bleomycin|bleomycin|mesh-list
25800978|NCT00002105|Vincristine|vincristine|mesh-list
25800979|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25800980|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25800981|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25800982|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25800983|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25800984|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800985|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25800986|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
25800987|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
25800988|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
25800989|NCT00002106|Ranitidine|ranitidine|mesh-list
25800990|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25800991|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25800992|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25800993|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25800994|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
25800995|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
25800996|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25800997|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25800998|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25800999|NCT00002107|Aldesleukin|aldesleukin|mesh-list
25801000|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801001|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801002|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801003|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
25801004|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801005|NCT00002108|Lamivudine|lamivudine|mesh-list
25801006|NCT00002108|Zidovudine|zidovudine|mesh-list
25801007|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801008|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801009|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801010|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801011|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
25801012|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801013|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801014|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801015|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
25801016|NCT00002109|Zidovudine|zidovudine|mesh-list
25801017|NCT00002109|Stavudine|stavudine|mesh-list
25801018|NCT00002109|Didanosine|didanosine|mesh-list
25801019|NCT00002109|Zalcitabine|zalcitabine|mesh-list
25801020|NCT00002109|Thymopentin|thymopentin|mesh-list
25801021|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
25801022|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801023|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801024|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801025|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801026|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
25801027|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801028|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801029|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25106773|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25801030|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25801031|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
25801032|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801033|NCT00002110|Zidovudine|zidovudine|mesh-list
25801034|NCT00002110|Cysteamine|cysteamine|mesh-list
25801035|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
25801036|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801037|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801038|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801039|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801040|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
25801041|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801042|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801043|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801044|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25801045|NCT00002111|Saquinavir|saquinavir|mesh-list
25801046|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801047|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801048|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801049|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801050|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801051|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801052|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801053|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
25801054|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801055|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801056|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801057|NCT00002112|Fluconazole|fluconazole|mesh-list
25801058|NCT00002112|Nystatin|nystatin|mesh-list
25801059|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
25801060|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801061|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25801062|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801063|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801064|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801065|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25801066|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
25801067|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25801068|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801069|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25801070|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25801071|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801072|NCT00002112|Ionophores|ionophores|mesh-ancestor
25801073|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25801074|NCT00002113|Fluconazole|fluconazole|mesh-list
25801075|NCT00002113|Flucytosine|flucytosine|mesh-list
25801076|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
25801077|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801078|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25801079|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801080|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801081|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801082|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25801083|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
25801084|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25801085|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801086|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25801087|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25801088|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
25801089|NCT00002115|Adefovir|adefovir|mesh-list
25801090|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
25801091|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801092|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801093|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801094|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801095|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801096|NCT00002116|Cidofovir|cidofovir|mesh-list
24984397|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24984398|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24984399|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24984400|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
24984401|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
24859495|NCT02303886|Methylene Blue|methylene blue|mesh-list
24984462|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24984463|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25801097|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
25801098|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801099|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801100|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801102|NCT00002117|Zalcitabine|zalcitabine|mesh-list
25801103|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
25801104|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801105|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801106|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801107|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801108|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
25801109|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801110|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801111|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801112|NCT00002118|Zalcitabine|zalcitabine|mesh-list
25801113|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
25801114|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801115|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801116|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801117|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801118|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
25801119|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801120|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801121|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801122|NCT00002120|Leucovorin|leucovorin|mesh-list
25801123|NCT00002120|Trimethoprim|trimethoprim|mesh-list
25801124|NCT00002120|Dapsone|dapsone|mesh-list
25801125|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
25801126|NCT00002120|Trimetrexate|trimetrexate|mesh-list
25801127|NCT00002120|Calcium|calcium|mesh-list
25801128|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
25801129|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25801130|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801131|NCT00002120|Antidotes|antidotes|mesh-ancestor
25801132|NCT00002120|Protective Agents|protective agents|mesh-ancestor
25801133|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
25801134|NCT00002120|Vitamins|vitamins|mesh-ancestor
25801135|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
25801136|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25801137|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801138|NCT00002120|Renal Agents|renal agents|mesh-ancestor
25801139|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
25801140|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25801141|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25801142|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25801143|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801144|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801145|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25801146|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25801147|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801148|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
25801149|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801150|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
25801151|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25801152|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
25801153|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801154|NCT00002122|Azithromycin|azithromycin|mesh-list
25801155|NCT00002122|Rifabutin|rifabutin|mesh-list
25801156|NCT00002122|Fluconazole|fluconazole|mesh-list
25801157|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801158|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106816|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106817|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106818|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
25106819|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25106820|NCT03144882|Curcumin|curcumin|mesh-list
24796060|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24796061|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796062|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796063|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796073|NCT01947920|Tramadol|tramadol|mesh-list
24796074|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24796075|NCT01947920|Narcotics|narcotics|mesh-ancestor
24796076|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25801159|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
25801160|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25801161|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801162|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801163|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801164|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25801165|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
25801166|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25801167|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801168|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25801169|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25801170|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25801171|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801172|NCT00002123|Didanosine|didanosine|mesh-list
25801173|NCT00002123|Delavirdine|delavirdine|mesh-list
25801174|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
25801175|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801176|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801177|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801178|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801179|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
25801180|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801181|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801182|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801183|NCT00002124|Lamivudine|lamivudine|mesh-list
25801184|NCT00002124|Zidovudine|zidovudine|mesh-list
25801185|NCT00002124|Delavirdine|delavirdine|mesh-list
25801186|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801187|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801188|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801189|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801190|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
25801191|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801192|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801193|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801194|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
25801195|NCT00002125|Foscarnet|foscarnet|mesh-list
25801196|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25801197|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
25801198|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801199|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801200|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801201|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801202|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801203|NCT00002126|Lenograstim|lenograstim|mesh-list
25801204|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25801205|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
25801206|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801207|NCT00002127|Thalidomide|thalidomide|mesh-list
25801208|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25801209|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
25801210|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801211|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
25801212|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801213|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801214|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25801215|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25801216|NCT00002127|Growth Substances|growth substances|mesh-ancestor
25801217|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
25801218|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801219|NCT00002128|Adefovir|adefovir|mesh-list
25801220|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25801221|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
25801222|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801223|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801224|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801225|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801226|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984648|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984649|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984651|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
24984652|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984653|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24984654|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25801227|NCT00002129|Vesnarinone|vesnarinone|mesh-list
25801228|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25801229|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
25801230|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801231|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801232|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
25801233|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801234|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25801235|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25801236|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801237|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801238|NCT00002129|Protective Agents|protective agents|mesh-ancestor
25801239|NCT00002130|Vesnarinone|vesnarinone|mesh-list
25801240|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25801241|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
25801242|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801243|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801244|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
25801245|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801246|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25801247|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25801248|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801249|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801250|NCT00002130|Protective Agents|protective agents|mesh-ancestor
25801251|NCT00002131|Vesnarinone|vesnarinone|mesh-list
25801252|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25801253|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
25801254|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801255|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801256|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
25801257|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801258|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25801259|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25801260|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801261|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801262|NCT00002131|Protective Agents|protective agents|mesh-ancestor
25801263|NCT00002132|Itraconazole|itraconazole|mesh-list
25801264|NCT00002132|Fluconazole|fluconazole|mesh-list
25801265|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
25801266|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801267|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25801268|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801269|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801270|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801271|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25801272|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
25801273|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25801274|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801275|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801276|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25801277|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25801278|NCT00002133|Itraconazole|itraconazole|mesh-list
25801279|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
25801280|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801281|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25801282|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801283|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801284|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801285|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25801286|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
25801287|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25801288|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984732|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984733|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984734|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
24984735|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
24984736|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
24984742|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24984743|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24984744|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
24984745|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
24984746|NCT04120766|Vitamins|vitamins|mesh-ancestor
25801289|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801290|NCT00002134|Ganciclovir|ganciclovir|mesh-list
25801291|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25801292|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
25801293|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801294|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801295|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801296|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801297|NCT00002135|Ganciclovir|ganciclovir|mesh-list
25801298|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25801299|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
25801300|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801301|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801302|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801303|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801304|NCT00002139|Azithromycin|azithromycin|mesh-list
25801305|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801306|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801307|NCT00002140|Azithromycin|azithromycin|mesh-list
25801308|NCT00002140|Clarithromycin|clarithromycin|mesh-list
25801309|NCT00002140|Ethambutol|ethambutol|mesh-list
25801310|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801311|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801312|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25801313|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801314|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801315|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801316|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801317|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801318|NCT00002141|Abacavir|abacavir|mesh-list
25801319|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801320|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801321|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801322|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801323|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
25801324|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801325|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801326|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801327|NCT00002142|Cidofovir|cidofovir|mesh-list
25801328|NCT00002142|Probenecid|probenecid|mesh-list
25801329|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
25801330|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
25801331|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25801332|NCT00002142|Renal Agents|renal agents|mesh-ancestor
25801333|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
25801334|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801335|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801336|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801337|NCT00002143|Acitretin|acitretin|mesh-list
25801338|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
25801339|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25801340|NCT00002144|Foscarnet|foscarnet|mesh-list
25801341|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25801342|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
25801343|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801344|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801345|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801346|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801347|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801348|NCT00002145|Foscarnet|foscarnet|mesh-list
25801349|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25801350|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
25801351|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801352|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801353|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801354|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801355|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801356|NCT00002146|Foscarnet|foscarnet|mesh-list
25801357|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25801358|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
25801359|NCT00002146|Analgesics|analgesics|mesh-ancestor
25801360|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
25801361|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25801362|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801363|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
25801364|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25801365|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25801366|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
25801367|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25801368|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25801369|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801370|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25801371|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
25801372|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25801373|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
25801374|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801375|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801376|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801377|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801378|NCT00002147|Doxorubicin|doxorubicin|mesh-list
25801379|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25801380|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25801381|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801382|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25801383|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25801384|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801385|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801386|NCT00002148|OPC 14117|opc 14117|mesh-list
25801387|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25801388|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
25801389|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801390|NCT00002148|Protective Agents|protective agents|mesh-ancestor
25801391|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801392|NCT00002149|Amoxicillin|amoxicillin|mesh-list
25801393|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
25801394|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
25801395|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
25801396|NCT00002149|Ephedrine|ephedrine|mesh-list
25801397|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801398|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801399|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25801400|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801401|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801402|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25801403|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
25801404|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25801405|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801406|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25801407|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25801408|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
25801409|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25801410|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25801411|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
25801412|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
25801413|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25801414|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
25801415|NCT00002154|Selegiline|selegiline|mesh-list
25801416|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
25801417|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25801418|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25801419|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25801420|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25801421|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801422|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801423|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25801424|NCT00002154|Protective Agents|protective agents|mesh-ancestor
25801425|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801426|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
25801427|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
25801428|NCT00002154|Vitamins|vitamins|mesh-ancestor
25801429|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
25801430|NCT00002155|Lamivudine|lamivudine|mesh-list
25801431|NCT00002155|Zidovudine|zidovudine|mesh-list
25801432|NCT00002155|Indinavir|indinavir|mesh-list
25801433|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801434|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801435|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801436|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801438|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801439|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801440|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801441|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
25801442|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801443|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801444|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801445|NCT00002156|Ganciclovir|ganciclovir|mesh-list
25801446|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25801447|NCT00002156|Fomivirsen|fomivirsen|mesh-list
25801448|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
25801449|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801450|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801451|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801452|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801453|NCT00002157|Thalidomide|thalidomide|mesh-list
25801454|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25801455|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
25801456|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801457|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
25801458|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801459|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801460|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25801461|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25801462|NCT00002157|Growth Substances|growth substances|mesh-ancestor
25801463|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
25801464|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801465|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
25801466|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25801467|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801468|NCT00002159|Itraconazole|itraconazole|mesh-list
25801469|NCT00002159|Amphotericin B|amphotericin b|mesh-list
25801470|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25801471|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
25801472|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801473|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25801474|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801475|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801476|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801477|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25801478|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
25801479|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25801480|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801481|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801482|NCT00002159|Amebicides|amebicides|mesh-ancestor
25801483|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25801484|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25801485|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801486|NCT00002160|Ziconotide|ziconotide|mesh-list
25801487|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25801488|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25801489|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801490|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25801491|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801492|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25801493|NCT00002160|Protective Agents|protective agents|mesh-ancestor
25801494|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25801495|NCT00002160|Analgesics|analgesics|mesh-ancestor
25801496|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
25801497|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25801498|NCT00002161|Adefovir|adefovir|mesh-list
25801499|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25801500|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
25801501|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801502|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801503|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801504|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801505|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801506|NCT00002162|Lamivudine|lamivudine|mesh-list
25801507|NCT00002162|Zidovudine|zidovudine|mesh-list
25801508|NCT00002162|Stavudine|stavudine|mesh-list
25801509|NCT00002162|Didanosine|didanosine|mesh-list
25801510|NCT00002162|Zalcitabine|zalcitabine|mesh-list
25801511|NCT00002162|Saquinavir|saquinavir|mesh-list
25801512|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801513|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801514|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801515|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801516|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
25801517|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801518|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801519|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801520|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
25801521|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801522|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801523|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801524|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801525|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801526|NCT00002163|Abacavir|abacavir|mesh-list
25801527|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801528|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801529|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801530|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801531|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
25801532|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801533|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801534|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801535|NCT00002164|Nelfinavir|nelfinavir|mesh-list
25801536|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801537|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801538|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801539|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801540|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801541|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801542|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801543|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
25801544|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801545|NCT00002165|Nelfinavir|nelfinavir|mesh-list
25801546|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801547|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801548|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801549|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801550|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801551|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801552|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801553|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
25801554|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801555|NCT00002166|Nevirapine|nevirapine|mesh-list
25801556|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801557|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801558|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801559|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801560|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
25801561|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801562|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801563|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801564|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25801565|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25801566|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
25801567|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25801568|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
25801569|NCT00002168|Lamivudine|lamivudine|mesh-list
25801570|NCT00002168|Zidovudine|zidovudine|mesh-list
25801571|NCT00002168|Stavudine|stavudine|mesh-list
25801572|NCT00002168|Didanosine|didanosine|mesh-list
25801573|NCT00002168|Indinavir|indinavir|mesh-list
25801574|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801575|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801576|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801577|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801578|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
25801579|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801580|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24796146|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801581|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801582|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
25801583|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801584|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801585|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801587|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801588|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801589|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801590|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801591|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801592|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801593|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801594|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
25801595|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801596|NCT00002170|Nelfinavir|nelfinavir|mesh-list
25801597|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801598|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801599|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801600|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801601|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801602|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801603|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801604|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
25801605|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801606|NCT00002171|Nelfinavir|nelfinavir|mesh-list
25801607|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801608|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801609|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801610|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801611|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801612|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801613|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801614|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
25801615|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801616|NCT00002174|Thalidomide|thalidomide|mesh-list
25801617|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25801618|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
25801619|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801620|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
25801621|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801622|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801623|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25801624|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25801625|NCT00002174|Growth Substances|growth substances|mesh-ancestor
25801626|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
25801627|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801629|NCT00002176|Didanosine|didanosine|mesh-list
25801630|NCT00002176|Nelfinavir|nelfinavir|mesh-list
25801631|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
25801632|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801633|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
25801634|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801635|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801636|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801637|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
25801638|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801639|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
25801640|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801641|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801642|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801643|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801644|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801645|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801646|NCT00002177|Stavudine|stavudine|mesh-list
25801647|NCT00002177|Didanosine|didanosine|mesh-list
25801648|NCT00002177|Nelfinavir|nelfinavir|mesh-list
25801649|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
25801650|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801651|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
25801652|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801653|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801654|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801655|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
25801656|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801657|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
25801658|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801659|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801660|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801661|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801662|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801663|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801664|NCT00002178|Ritonavir|ritonavir|mesh-list
25801665|NCT00002178|Nelfinavir|nelfinavir|mesh-list
25801666|NCT00002178|Saquinavir|saquinavir|mesh-list
25801667|NCT00002178|Delavirdine|delavirdine|mesh-list
25801668|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801669|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801670|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801671|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801672|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801673|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801674|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801675|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
25801676|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801677|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801678|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801679|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801680|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801681|NCT00002179|Lamivudine|lamivudine|mesh-list
25801682|NCT00002179|Zidovudine|zidovudine|mesh-list
25801683|NCT00002179|Indinavir|indinavir|mesh-list
25801684|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801685|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801686|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801687|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985050|NCT03715153|Diuretics|diuretics|mesh-ancestor
24985051|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
24985052|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985053|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25801688|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
25801689|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801690|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801691|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801692|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
25801693|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801694|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801695|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801696|NCT00002180|Tenofovir|tenofovir|mesh-list
25801697|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
25801698|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801699|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801700|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801701|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801702|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801703|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801704|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801705|NCT00002181|Cidofovir|cidofovir|mesh-list
25801706|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
25801707|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801708|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801709|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801710|NCT00002182|Megestrol|megestrol|mesh-list
25801711|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
25801712|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25801713|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25801714|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25801715|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
25801716|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25801717|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801718|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25801719|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25801720|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25801721|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801722|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
25801723|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25801724|NCT00002183|Lamivudine|lamivudine|mesh-list
25801725|NCT00002183|Zidovudine|zidovudine|mesh-list
25801726|NCT00002183|Abacavir|abacavir|mesh-list
25801727|NCT00002183|Amprenavir|amprenavir|mesh-list
25801728|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801729|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801730|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801731|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801732|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
25801733|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801734|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801735|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801736|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
25801737|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25801738|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801739|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801740|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801741|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801742|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801743|NCT00002184|Lamivudine|lamivudine|mesh-list
25801744|NCT00002184|Zidovudine|zidovudine|mesh-list
25801745|NCT00002184|Stavudine|stavudine|mesh-list
25801746|NCT00002184|Adefovir|adefovir|mesh-list
25801747|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25801748|NCT00002184|Nelfinavir|nelfinavir|mesh-list
25801749|NCT00002184|Saquinavir|saquinavir|mesh-list
25801750|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801751|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801752|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801753|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801754|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
25801755|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801756|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801757|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801758|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
24796168|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24985119|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24985120|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801759|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801760|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801761|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801762|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801763|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801764|NCT00002185|Nelfinavir|nelfinavir|mesh-list
25801765|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801766|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801767|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801768|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801769|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801770|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801771|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801772|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
25801773|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801774|NCT00002186|Acyclovir|acyclovir|mesh-list
25801775|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
25801776|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801777|NCT00002187|Fomivirsen|fomivirsen|mesh-list
25801778|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
25801779|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801780|NCT00002188|Alitretinoin|alitretinoin|mesh-list
25801781|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801782|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
25801783|NCT00002189|Paclitaxel|paclitaxel|mesh-list
25801784|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25801785|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801786|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
25801787|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
25801788|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
25801789|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801790|NCT00002190|Lamivudine|lamivudine|mesh-list
25801791|NCT00002190|Zidovudine|zidovudine|mesh-list
25801792|NCT00002190|Saquinavir|saquinavir|mesh-list
25801793|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801794|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801795|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801796|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801797|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
25801798|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801799|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801800|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801801|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
25801802|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801803|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801804|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801805|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801806|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801807|NCT00002191|Albendazole|albendazole|mesh-list
25801808|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
25801809|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25801810|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801811|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
25801812|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25801813|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25801814|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
25801815|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
25801816|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
25801817|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801818|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801819|NCT00002192|Azithromycin|azithromycin|mesh-list
25801820|NCT00002192|Clarithromycin|clarithromycin|mesh-list
25801821|NCT00002192|Ethambutol|ethambutol|mesh-list
25801822|NCT00002192|Rifapentine|rifapentine|mesh-list
25801823|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24985190|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985191|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24922908|NCT04175002|Progesterone|progesterone|mesh-list
24985192|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
24985193|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24985194|NCT03578081|Dexamethasone|dexamethasone|mesh-list
24985195|NCT03578081|Ondansetron|ondansetron|mesh-list
24985196|NCT03578081|Olanzapine|olanzapine|mesh-list
24985197|NCT03578081|Palonosetron|palonosetron|mesh-list
24985198|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
24985199|NCT03578081|Aprepitant|aprepitant|mesh-list
25801824|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801825|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25801826|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801827|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801828|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801829|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801830|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801831|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25801832|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
25801833|NCT00002193|Amprenavir|amprenavir|mesh-list
25801834|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25801835|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801836|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801837|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801838|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801839|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801840|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801841|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801842|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801843|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801844|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801845|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
25801846|NCT00002194|Clarithromycin|clarithromycin|mesh-list
25801847|NCT00002194|Erythromycin|erythromycin|mesh-list
25801848|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
25801849|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25801850|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
25801851|NCT00002194|Nevirapine|nevirapine|mesh-list
25801852|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801853|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801854|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25801855|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801856|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801857|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801858|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801859|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801860|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801861|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
25801862|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801863|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801864|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25801865|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25801866|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25801867|NCT00002195|Lamivudine|lamivudine|mesh-list
25801868|NCT00002195|Zidovudine|zidovudine|mesh-list
25801869|NCT00002195|Amprenavir|amprenavir|mesh-list
25801870|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801871|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801872|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801873|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801874|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
25801875|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801876|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801877|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801878|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
25801879|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25801880|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801881|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801882|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801883|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801884|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801885|NCT00002197|Abacavir|abacavir|mesh-list
25801886|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801887|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801888|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801889|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801890|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
25801891|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801892|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801893|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801894|NCT00002198|Abacavir|abacavir|mesh-list
25801895|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801896|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801897|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801898|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985227|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24985228|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801899|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
25801900|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801901|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801902|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801903|NCT00002199|Lamivudine|lamivudine|mesh-list
25801904|NCT00002199|Zidovudine|zidovudine|mesh-list
25801905|NCT00002199|Abacavir|abacavir|mesh-list
25801906|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25801907|NCT00002199|Indinavir|indinavir|mesh-list
25801908|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801909|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801910|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801911|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801912|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
25801913|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801914|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801915|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801916|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
25801917|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801918|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801919|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801920|NCT00002200|Abacavir|abacavir|mesh-list
25801921|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801922|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801923|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801924|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801925|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
25801926|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801927|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801928|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801929|NCT00002201|Ritonavir|ritonavir|mesh-list
25801930|NCT00002201|Nelfinavir|nelfinavir|mesh-list
25801931|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801932|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801933|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801934|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801935|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801936|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801937|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801938|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
25801939|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801940|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25801941|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25801942|NCT00002202|Indinavir|indinavir|mesh-list
25801943|NCT00002202|Amprenavir|amprenavir|mesh-list
25801944|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801945|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801946|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801947|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801948|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801949|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801950|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801951|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
25801952|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801953|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25801954|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801955|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801956|NCT00002203|Lamivudine|lamivudine|mesh-list
25801957|NCT00002203|Zidovudine|zidovudine|mesh-list
25801958|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25801959|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801960|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801961|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801962|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801963|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
25801964|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162609|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25162610|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25162611|NCT02903251|Oxytocin|oxytocin|mesh-list
25162612|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
25162613|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162614|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25801965|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801966|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801967|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
25801968|NCT00002205|Abacavir|abacavir|mesh-list
25801969|NCT00002205|Amprenavir|amprenavir|mesh-list
25801970|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801971|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801972|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801973|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801974|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
25801975|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801976|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25801977|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25801978|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25801979|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
25801980|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25801981|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25801982|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25801983|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
25801984|NCT00002206|Adefovir|adefovir|mesh-list
25801985|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25801986|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
25801987|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25801988|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801989|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801990|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801991|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25801992|NCT00002208|Lamivudine|lamivudine|mesh-list
25801993|NCT00002208|Zidovudine|zidovudine|mesh-list
25801994|NCT00002208|Stavudine|stavudine|mesh-list
25801995|NCT00002208|Indinavir|indinavir|mesh-list
25801996|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25801997|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25801998|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25801999|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802000|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
25802001|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802002|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802003|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802004|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
25802005|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802006|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802007|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802008|NCT00002210|Delavirdine|delavirdine|mesh-list
25802009|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802010|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802011|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802012|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802013|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
25802014|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802015|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802016|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802017|NCT00002211|Stavudine|stavudine|mesh-list
25802018|NCT00002211|Didanosine|didanosine|mesh-list
25802019|NCT00002211|Delavirdine|delavirdine|mesh-list
25802020|NCT00002211|Nelfinavir|nelfinavir|mesh-list
25802021|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
25802022|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802023|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802024|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802025|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802026|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
25802027|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041301|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041302|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
25041303|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041304|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041305|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25041306|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041307|NCT02580305|Memantine|memantine|mesh-list
25041318|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25041319|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
25041320|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25041321|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25041322|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25802028|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802029|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802030|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802031|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802032|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802034|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802035|NCT00002213|Efavirenz|efavirenz|mesh-list
25802036|NCT00002213|Abacavir|abacavir|mesh-list
25802037|NCT00002213|Amprenavir|amprenavir|mesh-list
25802038|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802039|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802040|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802041|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802042|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
25802043|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802044|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802045|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802046|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802047|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802048|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802049|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802050|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802051|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802052|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25802053|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
25802054|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802055|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802056|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802057|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802058|NCT00002214|Capravirine|capravirine|mesh-list
25802059|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802060|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802061|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802062|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802063|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
25802064|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802065|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802066|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802067|NCT00002215|Nelfinavir|nelfinavir|mesh-list
25802068|NCT00002215|Emivirine|emivirine|mesh-list
25802069|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802070|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802071|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802072|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802073|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802074|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802075|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802076|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
25802077|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802078|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802079|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802080|NCT00002216|Lamivudine|lamivudine|mesh-list
25802081|NCT00002216|Zidovudine|zidovudine|mesh-list
25802082|NCT00002216|Abacavir|abacavir|mesh-list
25802083|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25802084|NCT00002216|Nelfinavir|nelfinavir|mesh-list
25802085|NCT00002216|Amprenavir|amprenavir|mesh-list
25802086|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802087|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802088|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802089|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802090|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
25802091|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802092|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802093|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802094|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
24784843|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784844|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24784845|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784846|NCT01910545|OTS167|ots167|mesh-list
24784847|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24784848|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831699|NCT02168075|Mannitol|mannitol|mesh-list
25106952|NCT03143491|Paclitaxel|paclitaxel|mesh-list
25802095|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802096|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802097|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802098|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25802099|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
25802100|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802101|NCT00002217|Lamivudine|lamivudine|mesh-list
25802102|NCT00002217|Zidovudine|zidovudine|mesh-list
25802103|NCT00002217|Abacavir|abacavir|mesh-list
25802104|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25802105|NCT00002217|Amprenavir|amprenavir|mesh-list
25802106|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802107|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802108|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802109|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802110|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
25802111|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802112|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802113|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802114|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
25802115|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25802116|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
25802117|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802118|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802119|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802120|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802121|NCT00002219|Nelfinavir|nelfinavir|mesh-list
25802122|NCT00002219|Adefovir|adefovir|mesh-list
25802123|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25802124|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802125|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802126|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802127|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802128|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802129|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802130|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802131|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
25802132|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802133|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802134|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802135|NCT00002220|Efavirenz|efavirenz|mesh-list
25802136|NCT00002220|Adefovir|adefovir|mesh-list
25802137|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25802138|NCT00002220|Indinavir|indinavir|mesh-list
25802139|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802140|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802141|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802142|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802143|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
25802144|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802145|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802146|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802147|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802148|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802149|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802150|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802151|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802152|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802153|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802154|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802155|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802156|NCT00002222|Valganciclovir|valganciclovir|mesh-list
25802157|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
25802158|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802159|NCT00002223|Ritonavir|ritonavir|mesh-list
25802160|NCT00002223|Indinavir|indinavir|mesh-list
25802161|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802162|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802163|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802164|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802165|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802166|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802167|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802168|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
25802169|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802170|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25802171|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802172|NCT00002225|Efavirenz|efavirenz|mesh-list
25802173|NCT00002225|Stavudine|stavudine|mesh-list
25802174|NCT00002225|Didanosine|didanosine|mesh-list
25802175|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802176|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802177|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802178|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802179|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
25802180|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802181|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802182|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802183|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802184|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802185|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802186|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802187|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
25802188|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802189|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802190|NCT00002226|Semaxinib|semaxinib|mesh-list
25802191|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25802192|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25802193|NCT00002226|Growth Substances|growth substances|mesh-ancestor
25802194|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802195|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
25802196|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802197|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25802198|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802199|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802200|NCT00002227|Lamivudine|lamivudine|mesh-list
25802201|NCT00002227|Efavirenz|efavirenz|mesh-list
25802202|NCT00002227|Stavudine|stavudine|mesh-list
25802203|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802204|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802205|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802206|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802207|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
25802208|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802209|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802210|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802211|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802212|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802213|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802214|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802215|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802216|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802217|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
25802218|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
25802219|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25802220|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25802221|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802222|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802223|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802224|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
25802225|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802226|NCT00002229|Saquinavir|saquinavir|mesh-list
25802227|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802228|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802229|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802230|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802231|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802232|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802233|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802234|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
25802235|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802236|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25802237|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802238|NCT00002230|Efavirenz|efavirenz|mesh-list
25802239|NCT00002230|Stavudine|stavudine|mesh-list
25802240|NCT00002230|Didanosine|didanosine|mesh-list
25802241|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
25802242|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802243|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802244|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802245|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802246|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
25802247|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802248|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802249|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802250|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802251|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802252|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802253|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802254|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802255|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
25802256|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
25802257|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802258|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802259|NCT00002233|Lamivudine|lamivudine|mesh-list
25802260|NCT00002233|Abacavir|abacavir|mesh-list
25802261|NCT00002233|Indinavir|indinavir|mesh-list
25802262|NCT00002233|Amprenavir|amprenavir|mesh-list
25802263|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802264|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802265|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802266|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802267|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
25802268|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802269|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802270|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802271|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802272|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802273|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802274|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25802275|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
25802276|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802277|NCT00002234|Lamivudine|lamivudine|mesh-list
25802278|NCT00002234|Efavirenz|efavirenz|mesh-list
25802279|NCT00002234|Didanosine|didanosine|mesh-list
25802280|NCT00002234|Adefovir|adefovir|mesh-list
25802281|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25802282|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802283|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802284|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802285|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802286|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
25802287|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802288|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802289|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802290|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802291|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802292|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802293|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802294|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802295|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802296|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
25802297|NCT00002235|Efavirenz|efavirenz|mesh-list
25802298|NCT00002235|Nelfinavir|nelfinavir|mesh-list
25802299|NCT00002235|Indinavir|indinavir|mesh-list
25802300|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802301|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802302|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802303|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802304|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
25802305|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802306|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802307|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802308|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802309|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802310|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802311|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802312|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802313|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24985422|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
24985423|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24985424|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985425|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
24985426|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
25802314|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802315|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802316|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802317|NCT00002236|Zidovudine|zidovudine|mesh-list
25802318|NCT00002236|Delavirdine|delavirdine|mesh-list
25802319|NCT00002236|Indinavir|indinavir|mesh-list
25802320|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
25802321|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802322|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802323|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802324|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802325|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
25802326|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802327|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802328|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802329|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802330|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802331|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802332|NCT00002238|Interferons|interferons|mesh-list
25802333|NCT00002238|Zidovudine|zidovudine|mesh-list
25802334|NCT00002238|Interferon-beta|interferon-beta|mesh-list
25802335|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
25802336|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802337|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
25802338|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802339|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
25802340|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802341|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802342|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802343|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802344|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802345|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802346|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
25802347|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802348|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802349|NCT00002239|Ritonavir|ritonavir|mesh-list
25802350|NCT00002239|Amprenavir|amprenavir|mesh-list
25802351|NCT00002239|Abacavir|abacavir|mesh-list
25802352|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
25802353|NCT00002239|Efavirenz|efavirenz|mesh-list
25802354|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802355|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802356|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802357|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802358|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802359|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802360|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802361|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
25802362|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802363|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25802364|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802365|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802366|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802367|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802368|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802369|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25802370|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25802371|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25802372|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25802373|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25802374|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25802375|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
25802376|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802377|NCT00002241|Ritonavir|ritonavir|mesh-list
25802378|NCT00002241|Indinavir|indinavir|mesh-list
25802379|NCT00002241|Lamivudine|lamivudine|mesh-list
25802380|NCT00002241|Stavudine|stavudine|mesh-list
25802381|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802382|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802383|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802384|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802385|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802386|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802387|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802388|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
24831963|NCT02169882|Rifampin|rifampin|mesh-list
25802389|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802390|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25802391|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802392|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802393|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802394|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
25802395|NCT00002243|Calanolide A|calanolide a|mesh-list
25802396|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802397|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802398|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
25802399|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802400|NCT00002245|Lamivudine|lamivudine|mesh-list
25802401|NCT00002245|Abacavir|abacavir|mesh-list
25802402|NCT00002245|Amprenavir|amprenavir|mesh-list
25802403|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802404|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802405|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802406|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802407|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
25802408|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802409|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802410|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802411|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25802412|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
25802413|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802414|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25802415|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25802416|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
25802417|NCT00002247|Ganciclovir|ganciclovir|mesh-list
25802418|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25802419|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
25802420|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802421|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802422|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802423|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802424|NCT00002249|Levofloxacin|levofloxacin|mesh-list
25802425|NCT00002249|Ofloxacin|ofloxacin|mesh-list
25802426|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25802427|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802428|NCT00002249|Renal Agents|renal agents|mesh-ancestor
25802429|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802430|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25802431|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25802432|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802433|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802434|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802435|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25802436|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802437|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
25802438|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
25802439|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802440|NCT00002251|Ganciclovir|ganciclovir|mesh-list
25802441|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25802442|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
25802443|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802444|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802445|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802446|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802447|NCT00002252|Octreotide|octreotide|mesh-list
25802448|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25802449|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25802450|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802451|NCT00002253|Octreotide|octreotide|mesh-list
25802452|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25802453|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25802454|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802455|NCT00002254|Alovudine|alovudine|mesh-list
25802456|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
25802457|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802458|NCT00002255|Zidovudine|zidovudine|mesh-list
25802459|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
25802460|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
25802461|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802462|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802463|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802464|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802465|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
25802466|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802467|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802468|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802469|NCT00002255|Hematinics|hematinics|mesh-ancestor
25802470|NCT00002256|Zalcitabine|zalcitabine|mesh-list
25802471|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
25802472|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802473|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802474|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802475|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802476|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
25802477|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802478|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802479|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802480|NCT00002257|Ganciclovir|ganciclovir|mesh-list
25802481|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25802482|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
25802483|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802484|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802485|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802486|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802487|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
25802488|NCT00002259|Analgesics|analgesics|mesh-ancestor
25802489|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
25802490|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25802491|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802492|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802493|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25802494|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25802495|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802496|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802497|NCT00002260|Alovudine|alovudine|mesh-list
25802498|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
25802499|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802500|NCT00002261|Vaccines|vaccines|mesh-list
25802501|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
25802502|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802503|NCT00002263|Zidovudine|zidovudine|mesh-list
25802504|NCT00002263|Sargramostim|sargramostim|mesh-list
25802505|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
25802506|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802507|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802508|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802509|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802510|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
25802511|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802512|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802513|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802514|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
25802515|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802516|NCT00002265|Zalcitabine|zalcitabine|mesh-list
25802517|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
25802518|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802519|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802520|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802521|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802522|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
25802523|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802524|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802525|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802526|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
25802527|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802528|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
25802529|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802530|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802531|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25802532|NCT00002266|Protective Agents|protective agents|mesh-ancestor
25802533|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802534|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802535|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802536|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802537|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
25802538|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796264|NCT01948921|Analgesics|analgesics|mesh-ancestor
24796265|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
25802539|NCT00002267|Rifabutin|rifabutin|mesh-list
25802540|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802541|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802542|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25802543|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
25802544|NCT00002269|Zidovudine|zidovudine|mesh-list
25802545|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25802546|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
25802547|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802548|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802549|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802550|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802551|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
25802552|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802553|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802554|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802555|NCT00002270|Interferons|interferons|mesh-list
25802556|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
25802557|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
25802558|NCT00002270|Zidovudine|zidovudine|mesh-list
25802559|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802560|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
25802561|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802562|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
25802563|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802564|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
25802565|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802566|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802567|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802568|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802569|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802570|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802571|NCT00002271|Alovudine|alovudine|mesh-list
25802572|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
25802573|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802574|NCT00002272|Foscarnet|foscarnet|mesh-list
25802575|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25802576|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
25802577|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802578|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802579|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802580|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802581|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802582|NCT00002273|Ganciclovir|ganciclovir|mesh-list
25802583|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25802584|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
25802585|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802586|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802587|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802588|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802589|NCT00002274|Didanosine|didanosine|mesh-list
25802590|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
25802591|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802592|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802593|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802594|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802595|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
25802596|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802597|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802598|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802599|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25802600|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25802601|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25802602|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25802603|NCT00002276|Zidovudine|zidovudine|mesh-list
25802604|NCT00002276|Ibuprofen|ibuprofen|mesh-list
25802605|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25802606|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25802607|NCT00002276|Analgesics|analgesics|mesh-ancestor
25802608|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
25802609|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25802610|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802611|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25802612|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25802613|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25802614|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802615|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802616|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
25802617|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802618|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802619|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
25802620|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802621|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802622|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802623|NCT00002277|Fluconazole|fluconazole|mesh-list
25802624|NCT00002277|Amphotericin B|amphotericin b|mesh-list
25802625|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25802626|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
25802627|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802628|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25802629|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802630|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802631|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802632|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25802633|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
25802634|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25802635|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802636|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802637|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802638|NCT00002277|Amebicides|amebicides|mesh-ancestor
25802639|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25802640|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25802641|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802642|NCT00002278|Diclazuril|diclazuril|mesh-list
25802643|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
25802644|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25802645|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25802646|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802647|NCT00002279|Zalcitabine|zalcitabine|mesh-list
25802648|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
25802649|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802650|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802651|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802652|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802653|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
25802654|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802655|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802656|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802657|NCT00002280|Didanosine|didanosine|mesh-list
25802658|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
25802659|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802660|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802661|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802662|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802663|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
25802664|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802665|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802666|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802667|NCT00002281|Zidovudine|zidovudine|mesh-list
25802668|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
25802669|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
25802670|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802671|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802672|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802673|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802674|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
25802675|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802676|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802677|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802678|NCT00002281|Hematinics|hematinics|mesh-ancestor
25802679|NCT00002282|Fluconazole|fluconazole|mesh-list
25802680|NCT00002282|Clotrimazole|clotrimazole|mesh-list
25802681|NCT00002282|Miconazole|miconazole|mesh-list
25802682|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
25802683|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802684|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25802685|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802686|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802687|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802688|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25802689|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
25802690|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25802691|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802692|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802693|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802694|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25802695|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25802696|NCT00002283|Trimethoprim|trimethoprim|mesh-list
25802697|NCT00002283|Dapsone|dapsone|mesh-list
25802698|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
25802699|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25802700|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802701|NCT00002283|Renal Agents|renal agents|mesh-ancestor
25802702|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
25802703|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25802704|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25802705|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25802706|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802707|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802708|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25802709|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25802710|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802711|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
25802712|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802713|NCT00002284|Zidovudine|zidovudine|mesh-list
25802714|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
25802715|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802716|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802717|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802718|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802719|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
25802720|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802721|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802722|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802723|NCT00002285|Zidovudine|zidovudine|mesh-list
25802724|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
25802725|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802726|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802727|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802728|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802729|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
25802730|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802731|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802732|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802733|NCT00002286|Zidovudine|zidovudine|mesh-list
25802734|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
25802735|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802736|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802737|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802738|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802739|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
25802740|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802741|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802742|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802743|NCT00002287|Zidovudine|zidovudine|mesh-list
25802744|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
25802745|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802746|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802747|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802748|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802749|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
25802750|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802751|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802752|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802753|NCT00002288|Zidovudine|zidovudine|mesh-list
25802754|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
25802755|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802756|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802757|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802758|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802759|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
25802760|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802761|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802762|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802763|NCT00002289|Thymopentin|thymopentin|mesh-list
25802764|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802765|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
25802766|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802767|NCT00002290|Zidovudine|zidovudine|mesh-list
25802768|NCT00002290|Acyclovir|acyclovir|mesh-list
25802769|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
25802770|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802771|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802772|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802773|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802774|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
25802775|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802776|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802777|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802778|NCT00002291|Pentamidine|pentamidine|mesh-list
25802779|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
25802780|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802781|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25802782|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25802783|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25802784|NCT00002292|Pentamidine|pentamidine|mesh-list
25802785|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
25802786|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802787|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25802788|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25802789|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25802790|NCT00002293|Nystatin|nystatin|mesh-list
25802791|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802792|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802793|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
25802794|NCT00002293|Ionophores|ionophores|mesh-ancestor
25802795|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25802796|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802797|NCT00002294|Fluconazole|fluconazole|mesh-list
25802798|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
25802799|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802800|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25802801|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802802|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802803|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802804|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25802805|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
25802806|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25802807|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802808|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802809|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802810|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
25802811|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802812|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
25802813|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802814|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
25802815|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802816|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
25802817|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802818|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
25802819|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802820|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
25802821|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802822|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
25802823|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802824|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
25802825|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802826|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
25802827|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802828|NCT00002298|Ribavirin|ribavirin|mesh-list
25802829|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
25802830|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802831|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
25802832|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802833|NCT00002299|Interferons|interferons|mesh-list
25802834|NCT00002299|Interferon-beta|interferon-beta|mesh-list
25802835|NCT00002299|Ganciclovir|ganciclovir|mesh-list
25802836|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25802837|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
25802838|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802839|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
25802840|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802841|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
25802842|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802843|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802844|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802845|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802846|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802847|NCT00002300|Megestrol|megestrol|mesh-list
25802848|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
25802849|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25802850|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25802851|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25802852|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
25802853|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25802854|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802855|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25802856|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25802857|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25802858|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25802859|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
25802860|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25802861|NCT00002301|Foscarnet|foscarnet|mesh-list
25802862|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25802863|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
25802864|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802865|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802866|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802867|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802868|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802869|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
25802870|NCT00002302|Hematinics|hematinics|mesh-ancestor
25802871|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
25802872|NCT00002303|Hematinics|hematinics|mesh-ancestor
25802873|NCT00002304|Fluconazole|fluconazole|mesh-list
25802874|NCT00002304|Ketoconazole|ketoconazole|mesh-list
25802875|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
25802876|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802877|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25802878|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802879|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802880|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802881|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25802882|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
25802883|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25802884|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802885|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802886|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802887|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25802888|NCT00002305|Fluconazole|fluconazole|mesh-list
25802889|NCT00002305|Amphotericin B|amphotericin b|mesh-list
25802890|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25802891|NCT00002305|Flucytosine|flucytosine|mesh-list
25802892|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
25802893|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802894|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25802895|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802896|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802897|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802898|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25802899|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
25802900|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25802901|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802902|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802903|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802904|NCT00002305|Amebicides|amebicides|mesh-ancestor
25802905|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25802906|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25802907|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802908|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
25802909|NCT00002306|Fluconazole|fluconazole|mesh-list
25802910|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
25802911|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802912|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25802913|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25802914|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802915|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802916|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25802917|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
25802918|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25802919|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802920|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25802921|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25802922|NCT00002307|Zidovudine|zidovudine|mesh-list
25802923|NCT00002307|Stavudine|stavudine|mesh-list
25802924|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
25802925|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802926|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802927|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802928|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802929|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
25802930|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802931|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802932|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802933|NCT00002308|Stavudine|stavudine|mesh-list
25802934|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
25802935|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802936|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802937|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802938|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802939|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
25802940|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802941|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802942|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802943|NCT00002309|Azithromycin|azithromycin|mesh-list
25802944|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802945|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802946|NCT00002311|Wobenzym|wobenzym|mesh-list
25802947|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25802948|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
25802949|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802950|NCT00002312|Zidovudine|zidovudine|mesh-list
25802951|NCT00002312|Delavirdine|delavirdine|mesh-list
25802952|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
25802953|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802954|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802955|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802956|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802957|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
25802958|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802959|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802960|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802961|NCT00002313|Didanosine|didanosine|mesh-list
25802962|NCT00002313|Nystatin|nystatin|mesh-list
25802963|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
25802964|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25802965|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25802966|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25802967|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25802968|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
25802969|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802970|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25802971|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25802972|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802973|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
25802974|NCT00002313|Ionophores|ionophores|mesh-ancestor
25802975|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25802976|NCT00002315|Acyclovir|acyclovir|mesh-list
25802977|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
25802978|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
25802979|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802980|NCT00002316|Amphotericin B|amphotericin b|mesh-list
25802981|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25802982|NCT00002316|Amebicides|amebicides|mesh-ancestor
25802983|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25802984|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25802985|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25802986|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25802987|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
25802988|NCT00002317|Leucovorin|leucovorin|mesh-list
25802989|NCT00002317|Trimetrexate|trimetrexate|mesh-list
25802990|NCT00002317|Calcium|calcium|mesh-list
25802991|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
25802992|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25802993|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25802994|NCT00002317|Antidotes|antidotes|mesh-ancestor
25802995|NCT00002317|Protective Agents|protective agents|mesh-ancestor
25802996|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
25802997|NCT00002317|Vitamins|vitamins|mesh-ancestor
25802998|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
25802999|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
25803000|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803001|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25803002|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
25803003|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803004|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803005|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25803006|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803007|NCT00002318|Doxorubicin|doxorubicin|mesh-list
25803008|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25803009|NCT00002318|Bleomycin|bleomycin|mesh-list
25803010|NCT00002318|Vincristine|vincristine|mesh-list
25803011|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25803012|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803013|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25803014|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25803015|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803016|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803017|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25803018|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
25803019|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
25803020|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
25803021|NCT00002319|Doxorubicin|doxorubicin|mesh-list
25803022|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25803023|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25803024|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803025|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25803026|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25803027|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803028|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803029|NCT00002320|Lamivudine|lamivudine|mesh-list
25803030|NCT00002320|Zidovudine|zidovudine|mesh-list
25803031|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803032|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803033|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803034|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803035|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
25803036|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803037|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803038|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803039|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
25803040|NCT00002321|Aldesleukin|aldesleukin|mesh-list
25803041|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803042|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803043|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803044|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
25803045|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803046|NCT00002322|Zidovudine|zidovudine|mesh-list
25803047|NCT00002322|Atevirdine|atevirdine|mesh-list
25803048|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
25803049|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803050|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803051|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803052|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803053|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
25803054|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803055|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803056|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803057|NCT00002323|Zidovudine|zidovudine|mesh-list
25803058|NCT00002323|Nevirapine|nevirapine|mesh-list
25803059|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
25803060|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803061|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803062|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803063|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803064|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
25803065|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803066|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803067|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803068|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803069|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803070|NCT00002324|Zidovudine|zidovudine|mesh-list
25803071|NCT00002324|Nevirapine|nevirapine|mesh-list
25803072|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
25803073|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803074|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803075|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803076|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803077|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
25803078|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803079|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803080|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803081|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803082|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803083|NCT00002325|Fluconazole|fluconazole|mesh-list
25803084|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
25803085|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803086|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25803087|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803088|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803089|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803090|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25803091|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
24509984|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
25803092|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25803093|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803094|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25803095|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25803096|NCT00002326|Zidovudine|zidovudine|mesh-list
25803097|NCT00002326|Adefovir|adefovir|mesh-list
25803098|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
25803099|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803100|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803101|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803102|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803103|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
25803104|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803105|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803106|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803107|NCT00002327|Cidofovir|cidofovir|mesh-list
25803108|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
25803109|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803110|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803111|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803112|NCT00002328|Azithromycin|azithromycin|mesh-list
25803113|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803114|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803115|NCT00002330|Ganciclovir|ganciclovir|mesh-list
25803116|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25803117|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
25803118|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803119|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803120|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803121|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803122|NCT00002331|Clarithromycin|clarithromycin|mesh-list
25803123|NCT00002331|Ethambutol|ethambutol|mesh-list
25803124|NCT00002331|Clofazimine|clofazimine|mesh-list
25803125|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803126|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803127|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25803128|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803129|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803130|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803131|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803132|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
25803133|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25803134|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
25803135|NCT00002332|Thymopentin|thymopentin|mesh-list
25803136|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25803137|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
25803138|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803139|NCT00002333|Saquinavir|saquinavir|mesh-list
25803140|NCT00002333|Zalcitabine|zalcitabine|mesh-list
25803141|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803142|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803143|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803144|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803145|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803146|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803147|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803148|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
25803149|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803150|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803151|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803152|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
25803153|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803154|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803155|NCT00002334|Zidovudine|zidovudine|mesh-list
25803156|NCT00002334|Zalcitabine|zalcitabine|mesh-list
25803157|NCT00002334|Saquinavir|saquinavir|mesh-list
25803158|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
25803159|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803160|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803161|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803162|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803163|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
25803164|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803165|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803166|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803167|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803168|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803169|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803170|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803171|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803172|NCT00002335|Emtricitabine|emtricitabine|mesh-list
25803173|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
25803174|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803175|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803176|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803177|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803178|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803179|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803180|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803181|NCT00002336|Clarithromycin|clarithromycin|mesh-list
25803182|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803183|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803184|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25803185|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803186|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803187|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803188|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803189|NCT00002337|Vesnarinone|vesnarinone|mesh-list
25803190|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25803191|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
25803192|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803193|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803194|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
25803195|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803196|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25803197|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25803198|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803199|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803200|NCT00002337|Protective Agents|protective agents|mesh-ancestor
25803201|NCT00002339|Fluconazole|fluconazole|mesh-list
25803202|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
25803203|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803204|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25803205|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803206|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803207|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803208|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25803209|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
25803210|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25803211|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803212|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25803213|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25803214|NCT00002340|Atovaquone|atovaquone|mesh-list
25803215|NCT00002340|Pentamidine|pentamidine|mesh-list
25803216|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803217|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
25803218|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25803219|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25803220|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803221|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803222|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
25803223|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25803224|NCT00002341|Itraconazole|itraconazole|mesh-list
25803225|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
25803226|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803227|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25803228|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803229|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803230|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803231|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25803232|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
25803233|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25803234|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803235|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803236|NCT00002343|Ethambutol|ethambutol|mesh-list
25803237|NCT00002343|Rifabutin|rifabutin|mesh-list
25803238|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
25803239|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803240|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803241|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25803242|NCT00002344|Azithromycin|azithromycin|mesh-list
25803243|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803244|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803245|NCT00002345|Megestrol|megestrol|mesh-list
25803246|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
25803247|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25803248|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25803249|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25803250|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
25803251|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25803252|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803253|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25803254|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25803255|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25803256|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803257|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
25803258|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25803259|NCT00002346|Adefovir|adefovir|mesh-list
25803260|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25803261|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
25803262|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803263|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803264|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803265|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803266|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803267|NCT00002347|Zidovudine|zidovudine|mesh-list
25803268|NCT00002347|Nevirapine|nevirapine|mesh-list
25803269|NCT00002347|Zalcitabine|zalcitabine|mesh-list
25803270|NCT00002347|Saquinavir|saquinavir|mesh-list
25803271|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
25803272|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803273|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803274|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803275|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803276|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
25803277|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803278|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803279|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803280|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803281|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803282|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803283|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803284|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803285|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803286|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803287|NCT00002348|Mitoguazone|mitoguazone|mesh-list
25803288|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803289|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803290|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803291|NCT00002349|Stavudine|stavudine|mesh-list
25803292|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
25803293|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803294|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803295|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803296|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803297|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
25803298|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803299|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803300|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803301|NCT00002351|Indinavir|indinavir|mesh-list
25803302|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803303|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803304|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803305|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803306|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803307|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803308|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803309|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
25803310|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803311|NCT00002352|Lobucavir|lobucavir|mesh-list
25803312|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986530|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25803313|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803314|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803315|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803316|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
25803317|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803318|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803319|NCT00002354|Stavudine|stavudine|mesh-list
25803320|NCT00002354|Indinavir|indinavir|mesh-list
25803321|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
25803322|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803323|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803324|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803325|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803326|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
25803327|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803328|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803329|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803330|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803331|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803332|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803333|NCT00002355|Fomivirsen|fomivirsen|mesh-list
25803334|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
25803335|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803336|NCT00002356|Fomivirsen|fomivirsen|mesh-list
25803337|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
25803338|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803339|NCT00002357|Zidovudine|zidovudine|mesh-list
25803340|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
25803341|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803342|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803343|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803344|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803345|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
25803346|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803347|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803348|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803349|NCT00002358|Sorivudine|sorivudine|mesh-list
25803350|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
25803351|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803352|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803353|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803354|NCT00002360|Didanosine|didanosine|mesh-list
25803355|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
25803356|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803357|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803358|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803359|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803360|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
25803361|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803362|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803363|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803364|NCT00002361|Ritonavir|ritonavir|mesh-list
25803365|NCT00002361|Indinavir|indinavir|mesh-list
25803366|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803367|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803368|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803369|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803370|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803371|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803372|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803373|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
25803374|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803375|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803376|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803377|NCT00002362|Emtricitabine|emtricitabine|mesh-list
25803378|NCT00002362|Efavirenz|efavirenz|mesh-list
25803379|NCT00002362|Abacavir|abacavir|mesh-list
25803380|NCT00002362|Stavudine|stavudine|mesh-list
25803381|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
25803382|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803383|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803384|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803385|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803386|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803387|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803388|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803389|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25803390|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803391|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25803392|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25803393|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803394|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803395|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
25803396|NCT00002364|Abacavir|abacavir|mesh-list
25803397|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803398|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803399|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803400|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803401|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
25803402|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803403|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803404|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803405|NCT00002366|Ritonavir|ritonavir|mesh-list
25803406|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803407|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803408|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803409|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803410|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803411|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803412|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803413|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
25803414|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803415|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803416|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803417|NCT00002367|Lamivudine|lamivudine|mesh-list
25803418|NCT00002367|Zidovudine|zidovudine|mesh-list
25803419|NCT00002367|Saquinavir|saquinavir|mesh-list
25803420|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803421|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803422|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803423|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803424|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
25803425|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803426|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803427|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803428|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
25803429|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803430|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803431|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803432|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803433|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803434|NCT00002368|Lamivudine|lamivudine|mesh-list
25803435|NCT00002368|Nevirapine|nevirapine|mesh-list
25803436|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803437|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803438|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803439|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803440|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
25803441|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803442|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803443|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803444|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803445|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803446|NCT00002369|Lamivudine|lamivudine|mesh-list
25803447|NCT00002369|Zidovudine|zidovudine|mesh-list
25803448|NCT00002369|Stavudine|stavudine|mesh-list
25803449|NCT00002369|Indinavir|indinavir|mesh-list
25803450|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803451|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803452|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803453|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803454|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
25803455|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803456|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803457|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803458|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
25803459|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803460|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25162796|NCT02902289|Ibuprofen|ibuprofen|mesh-list
25803461|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803462|NCT00002370|Itraconazole|itraconazole|mesh-list
25803463|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
25803464|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803465|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25803466|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803467|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803468|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803469|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25803470|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
25803471|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25803472|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803473|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803474|NCT00002372|Nelfinavir|nelfinavir|mesh-list
25803475|NCT00002372|Indinavir|indinavir|mesh-list
25803476|NCT00002372|Saquinavir|saquinavir|mesh-list
25803477|NCT00002372|Amprenavir|amprenavir|mesh-list
25803478|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803479|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803480|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803481|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803482|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803483|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803484|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803485|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
25803486|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803487|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803488|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803489|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25803490|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
25803491|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803492|NCT00002373|Maribavir|maribavir|mesh-list
25803493|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
25803494|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803495|NCT00002374|Ritonavir|ritonavir|mesh-list
25803496|NCT00002374|Nelfinavir|nelfinavir|mesh-list
25803497|NCT00002374|Saquinavir|saquinavir|mesh-list
25803498|NCT00002374|Stavudine|stavudine|mesh-list
25803499|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803500|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803501|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803502|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803503|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803504|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803505|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803506|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
25803507|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803508|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803509|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803510|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
25803511|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803512|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803513|NCT00002375|Nelfinavir|nelfinavir|mesh-list
25803514|NCT00002375|Indinavir|indinavir|mesh-list
25803515|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803516|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803517|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803518|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803519|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803520|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803521|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803522|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
25803523|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803524|NCT00002376|Lamivudine|lamivudine|mesh-list
25803525|NCT00002376|Zidovudine|zidovudine|mesh-list
25803526|NCT00002376|Stavudine|stavudine|mesh-list
25803527|NCT00002376|Didanosine|didanosine|mesh-list
25803528|NCT00002376|Indinavir|indinavir|mesh-list
25803529|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803530|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803531|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803532|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803533|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
25803534|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803535|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803536|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803537|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
25803538|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803539|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803540|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803541|NCT00002377|Valganciclovir|valganciclovir|mesh-list
25803542|NCT00002377|Ganciclovir|ganciclovir|mesh-list
25803543|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25803544|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
25803545|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803546|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803547|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803548|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803549|NCT00002378|Ritonavir|ritonavir|mesh-list
25803550|NCT00002378|Nelfinavir|nelfinavir|mesh-list
25803551|NCT00002378|Saquinavir|saquinavir|mesh-list
25803552|NCT00002378|Lamivudine|lamivudine|mesh-list
25803553|NCT00002378|Zidovudine|zidovudine|mesh-list
25803554|NCT00002378|Stavudine|stavudine|mesh-list
25803555|NCT00002378|Delavirdine|delavirdine|mesh-list
25803556|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803557|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803558|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803559|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803560|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803561|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803562|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803563|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
25803564|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803565|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803566|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803567|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803568|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803569|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
24512950|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512951|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512952|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24512953|NCT00577798|Doxorubicin|doxorubicin|mesh-list
24512954|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24512955|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24512956|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512957|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24513033|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
24513034|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803570|NCT00002379|Lamivudine|lamivudine|mesh-list
25803571|NCT00002379|Zidovudine|zidovudine|mesh-list
25803572|NCT00002379|Stavudine|stavudine|mesh-list
25803573|NCT00002379|Adefovir|adefovir|mesh-list
25803574|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25803575|NCT00002379|Indinavir|indinavir|mesh-list
25803576|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803577|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803578|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803579|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803580|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
25803581|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803582|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803583|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803584|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
25803585|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803586|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803587|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803588|NCT00002380|Nelfinavir|nelfinavir|mesh-list
25803589|NCT00002380|Saquinavir|saquinavir|mesh-list
25803590|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803591|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803592|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803593|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803594|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803595|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803596|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803597|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
25803598|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803599|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803600|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803601|NCT00002381|Nevirapine|nevirapine|mesh-list
25803602|NCT00002381|Stavudine|stavudine|mesh-list
25803603|NCT00002381|Nelfinavir|nelfinavir|mesh-list
25803604|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803605|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803606|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803607|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803608|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
25803609|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803610|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803611|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803612|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803613|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803614|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
25803615|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803616|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803617|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803618|NCT00002382|Saquinavir|saquinavir|mesh-list
25803619|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803620|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803621|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803622|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803623|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803624|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803625|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803626|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
25803627|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803628|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803629|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803630|NCT00002383|Saquinavir|saquinavir|mesh-list
25803631|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803632|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803633|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803634|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803635|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803636|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803637|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803638|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
25803639|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803640|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803641|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24541667|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
24986840|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
24986841|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803642|NCT00002384|Cidofovir|cidofovir|mesh-list
25803643|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
25803644|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803645|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803646|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803647|NCT00002386|Lamivudine|lamivudine|mesh-list
25803648|NCT00002386|Zidovudine|zidovudine|mesh-list
25803649|NCT00002386|Stavudine|stavudine|mesh-list
25803650|NCT00002386|Didanosine|didanosine|mesh-list
25803651|NCT00002386|Zalcitabine|zalcitabine|mesh-list
25803652|NCT00002386|Indinavir|indinavir|mesh-list
25803653|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803654|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803655|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803656|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803657|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
25803658|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803659|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803660|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803661|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
25803662|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803663|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803664|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803665|NCT00002387|Efavirenz|efavirenz|mesh-list
25803666|NCT00002387|Indinavir|indinavir|mesh-list
25803667|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803668|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803669|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803670|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803671|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
25803672|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803673|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25803674|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803675|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25803676|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25803677|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803678|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803679|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803680|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803681|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803682|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803683|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803684|NCT00002388|Abacavir|abacavir|mesh-list
25803685|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803686|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803687|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803688|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803689|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
25803690|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803691|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803692|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803693|NCT00002389|Lamivudine|lamivudine|mesh-list
25803694|NCT00002389|Zidovudine|zidovudine|mesh-list
25803695|NCT00002389|Abacavir|abacavir|mesh-list
25803696|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803697|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803698|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803699|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803700|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
25803701|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803702|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803703|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803704|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
25803705|NCT00002390|Abacavir|abacavir|mesh-list
25803706|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803707|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803708|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803709|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803710|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
25803711|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803712|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803713|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803714|NCT00002391|Lamivudine|lamivudine|mesh-list
25803715|NCT00002391|Zidovudine|zidovudine|mesh-list
25803716|NCT00002391|Abacavir|abacavir|mesh-list
25803717|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803718|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24513621|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803719|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803720|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803721|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
25803722|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803723|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803724|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803725|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
25803726|NCT00002392|Thalidomide|thalidomide|mesh-list
25803727|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25803728|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
25803729|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803730|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
25803731|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803732|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803733|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25803734|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25803735|NCT00002392|Growth Substances|growth substances|mesh-ancestor
25803736|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
25803737|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803738|NCT00002393|Efavirenz|efavirenz|mesh-list
25803739|NCT00002393|Indinavir|indinavir|mesh-list
25803740|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803741|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803742|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803743|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803744|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
25803745|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803746|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25803747|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803748|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25803749|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25803750|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803751|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803752|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803753|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803754|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803755|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803756|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803757|NCT00002394|Terbinafine|terbinafine|mesh-list
25803758|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
25803759|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803760|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803761|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803762|NCT00002395|Topotecan|topotecan|mesh-list
25803763|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25803764|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25803765|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803766|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803767|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803768|NCT00002396|Tenofovir|tenofovir|mesh-list
25803769|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
25803770|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803771|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803772|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803773|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803774|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803775|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803776|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803777|NCT00002397|Lamivudine|lamivudine|mesh-list
25803778|NCT00002397|Stavudine|stavudine|mesh-list
25803779|NCT00002397|Nelfinavir|nelfinavir|mesh-list
25803780|NCT00002397|Saquinavir|saquinavir|mesh-list
25803781|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803782|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803783|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803784|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803785|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
25803786|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803787|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803788|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803789|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
25803790|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803791|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803792|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803793|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25803794|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803796|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25803797|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
25803798|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803799|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803800|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803801|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803802|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803803|NCT00002399|Fluconazole|fluconazole|mesh-list
25803804|NCT00002399|Posaconazole|posaconazole|mesh-list
25803805|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
25803806|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803807|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25803808|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25803809|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803810|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803811|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25803812|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
25803813|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25803814|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803815|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25803816|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25803817|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25803818|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25803819|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25803820|NCT00002400|Lamivudine|lamivudine|mesh-list
25803821|NCT00002400|Zidovudine|zidovudine|mesh-list
25803822|NCT00002400|Delavirdine|delavirdine|mesh-list
25803823|NCT00002400|Indinavir|indinavir|mesh-list
25803824|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803825|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803826|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803827|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803828|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
25803829|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803830|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803831|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803832|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
25803833|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803834|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803835|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803836|NCT00002401|Lamivudine|lamivudine|mesh-list
25803837|NCT00002401|Zidovudine|zidovudine|mesh-list
25803838|NCT00002401|Delavirdine|delavirdine|mesh-list
25803839|NCT00002401|Indinavir|indinavir|mesh-list
25803840|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803841|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803842|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803843|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803844|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
25803845|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803846|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803847|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803848|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
25803849|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803850|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803851|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803852|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25803853|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25803854|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
25803855|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25803856|NCT00002402|Antacids|antacids|mesh-ancestor
25803857|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803858|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25803859|NCT00002404|Valacyclovir|valacyclovir|mesh-list
25803860|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
25803861|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162851|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25162852|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25162853|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162854|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162855|NCT02901561|Misoprostol|misoprostol|mesh-list
24796552|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796553|NCT01950793|Triamcinolone|triamcinolone|mesh-list
25803862|NCT00002405|Amprenavir|amprenavir|mesh-list
25803863|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25803864|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
25803865|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803866|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803867|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803868|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803869|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803870|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803871|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803872|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803873|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803874|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
25803875|NCT00002406|Indinavir|indinavir|mesh-list
25803876|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803877|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803878|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803879|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803880|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803881|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803882|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803883|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
25803884|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803885|NCT00002407|Lamivudine|lamivudine|mesh-list
25803886|NCT00002407|Nevirapine|nevirapine|mesh-list
25803887|NCT00002407|Stavudine|stavudine|mesh-list
25803888|NCT00002407|Didanosine|didanosine|mesh-list
25803889|NCT00002407|Indinavir|indinavir|mesh-list
25803890|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803891|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803892|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803893|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803894|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
25803895|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803896|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803897|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803898|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25803899|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25803900|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
25803901|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803902|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803903|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803904|NCT00002409|Lamivudine|lamivudine|mesh-list
25803905|NCT00002409|Zidovudine|zidovudine|mesh-list
25803906|NCT00002409|Abacavir|abacavir|mesh-list
25803907|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25803908|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803909|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803910|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803911|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803912|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
25803913|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803914|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803915|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803916|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
25803917|NCT00002410|Lamivudine|lamivudine|mesh-list
25803918|NCT00002410|Zidovudine|zidovudine|mesh-list
25803919|NCT00002410|Indinavir|indinavir|mesh-list
25803920|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803921|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803922|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803923|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803924|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
25803925|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803926|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803927|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803928|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
25803929|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803930|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803931|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803932|NCT00002412|Stavudine|stavudine|mesh-list
25803933|NCT00002412|Didanosine|didanosine|mesh-list
25803934|NCT00002412|Emivirine|emivirine|mesh-list
25803935|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
25803936|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25803937|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
25803938|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162862|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
25803939|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803940|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803941|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
25803942|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803943|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
25803944|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803945|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803946|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803948|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803949|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803950|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803951|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803952|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
25803953|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803954|NCT00002415|Tenofovir|tenofovir|mesh-list
25803955|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
25803956|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803957|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803958|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803959|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803960|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803961|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803962|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803963|NCT00002416|Lamivudine|lamivudine|mesh-list
25803964|NCT00002416|Emtricitabine|emtricitabine|mesh-list
25803965|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803966|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803967|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803968|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803969|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
25803970|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803971|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803972|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803973|NCT00002417|Amprenavir|amprenavir|mesh-list
25803974|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25803975|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
25803976|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25803977|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803978|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25803979|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25803980|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
25803981|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803982|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803983|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803984|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803985|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
25803986|NCT00002418|Nevirapine|nevirapine|mesh-list
25803987|NCT00002418|Stavudine|stavudine|mesh-list
25803988|NCT00002418|Didanosine|didanosine|mesh-list
25803989|NCT00002418|Emivirine|emivirine|mesh-list
25803990|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
25803991|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25803992|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803993|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803994|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25803995|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
25803996|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25803997|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25803998|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25803999|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25804000|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25804001|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804002|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
25804003|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
25804004|NCT00002419|Efavirenz|efavirenz|mesh-list
25804005|NCT00002419|Abacavir|abacavir|mesh-list
25804006|NCT00002419|Adefovir|adefovir|mesh-list
25804007|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25804008|NCT00002419|Amprenavir|amprenavir|mesh-list
25804009|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25162875|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987255|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
24987320|NCT02799212|Hormones|hormones|mesh-ancestor
25804010|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804011|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804012|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804013|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
25804014|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804015|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25804016|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804017|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25804018|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25804019|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25804020|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25804021|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804022|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804023|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25804024|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
25804025|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25804026|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804027|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804028|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804029|NCT00002420|Stavudine|stavudine|mesh-list
25804030|NCT00002420|Didanosine|didanosine|mesh-list
25804031|NCT00002420|Delavirdine|delavirdine|mesh-list
25804032|NCT00002420|Emivirine|emivirine|mesh-list
25804033|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
25804034|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804035|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
25804036|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804037|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804038|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804039|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
25804040|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804041|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
25804042|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804043|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804044|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804045|NCT00002423|Lamivudine|lamivudine|mesh-list
25804046|NCT00002423|Abacavir|abacavir|mesh-list
25804047|NCT00002423|Nelfinavir|nelfinavir|mesh-list
25804048|NCT00002423|Indinavir|indinavir|mesh-list
25804049|NCT00002423|Amprenavir|amprenavir|mesh-list
25804050|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804051|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804052|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804053|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804054|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
25804055|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804056|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804057|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804058|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804059|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804060|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804061|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25804062|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
25804063|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25804064|NCT00002424|Lamivudine|lamivudine|mesh-list
25804065|NCT00002424|Stavudine|stavudine|mesh-list
25804066|NCT00002424|Indinavir|indinavir|mesh-list
25804067|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804068|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804069|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804070|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804071|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
25804072|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804073|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804074|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804075|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
25804076|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804077|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804078|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804079|NCT00002425|Saquinavir|saquinavir|mesh-list
25804080|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804081|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804082|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804083|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804084|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804085|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804086|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804087|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
25804088|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804089|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25804090|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804091|NCT00002426|Adefovir|adefovir|mesh-list
25804092|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25804093|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
25804094|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804095|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804096|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804097|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804098|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804099|NCT00002427|Stavudine|stavudine|mesh-list
25804100|NCT00002427|Didanosine|didanosine|mesh-list
25804101|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
25804102|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804103|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
25804104|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804105|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804106|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804107|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
25804108|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804109|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
25804110|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804111|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804112|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804113|NCT00002428|Vaccines|vaccines|mesh-list
25804114|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
25804115|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804116|NCT00002430|Lamivudine|lamivudine|mesh-list
25804117|NCT00002430|Stavudine|stavudine|mesh-list
25804118|NCT00002430|Nelfinavir|nelfinavir|mesh-list
25804119|NCT00002430|Indinavir|indinavir|mesh-list
25804120|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804121|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804122|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804123|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804124|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
25804125|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804126|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804127|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804128|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
25804129|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804130|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804131|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804132|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
25804133|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25804134|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25804135|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804136|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
25804137|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804138|NCT00002432|Foscarnet|foscarnet|mesh-list
25804139|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
25804140|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
25804141|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804142|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804143|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804144|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804145|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804146|NCT00002433|Interferons|interferons|mesh-list
25804147|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
25804148|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804149|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
25804150|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804151|NCT00002434|Leucovorin|leucovorin|mesh-list
25804152|NCT00002434|Trimetrexate|trimetrexate|mesh-list
25804153|NCT00002434|Calcium|calcium|mesh-list
25804154|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
25804155|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25804156|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804157|NCT00002434|Antidotes|antidotes|mesh-ancestor
25804158|NCT00002434|Protective Agents|protective agents|mesh-ancestor
25804159|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
25804160|NCT00002434|Vitamins|vitamins|mesh-ancestor
25804161|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
25804162|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
25804163|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804164|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804165|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
25804166|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804167|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804168|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804169|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804170|NCT00002435|Zidovudine|zidovudine|mesh-list
25804171|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
25804172|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804173|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804174|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804175|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804176|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
25804177|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804178|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804179|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804180|NCT00002436|Lamivudine|lamivudine|mesh-list
25804181|NCT00002436|Zidovudine|zidovudine|mesh-list
25804182|NCT00002436|Zalcitabine|zalcitabine|mesh-list
25804183|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804184|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804185|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804186|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804187|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
25804188|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804189|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804190|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804191|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
25804192|NCT00002437|Cidofovir|cidofovir|mesh-list
25804193|NCT00002437|Probenecid|probenecid|mesh-list
25804194|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
25804195|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
25804196|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804197|NCT00002437|Renal Agents|renal agents|mesh-ancestor
25804198|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
25804199|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804200|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804201|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804202|NCT00002438|Itraconazole|itraconazole|mesh-list
25804203|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
25804204|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804205|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25804206|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804207|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804208|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804209|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25804210|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
25804211|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804212|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804213|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25804214|NCT00002439|Alitretinoin|alitretinoin|mesh-list
25804215|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804216|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804217|NCT00002440|Ritonavir|ritonavir|mesh-list
25804218|NCT00002440|Nelfinavir|nelfinavir|mesh-list
25804219|NCT00002440|Indinavir|indinavir|mesh-list
25804220|NCT00002440|Saquinavir|saquinavir|mesh-list
25804221|NCT00002440|Amprenavir|amprenavir|mesh-list
25804222|NCT00002440|Abacavir|abacavir|mesh-list
25804223|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804224|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804225|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804226|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804227|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804228|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804229|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804230|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
25804231|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804232|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25804233|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804234|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804235|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804236|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25804237|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
25804238|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25804239|NCT00002442|Lamivudine|lamivudine|mesh-list
25804240|NCT00002442|Stavudine|stavudine|mesh-list
25804241|NCT00002442|Nelfinavir|nelfinavir|mesh-list
25804242|NCT00002442|Indinavir|indinavir|mesh-list
25804243|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804244|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804245|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804246|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804247|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
25804248|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804249|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804250|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804251|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
25804252|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804253|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804254|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804255|NCT00002443|Zidovudine|zidovudine|mesh-list
25804256|NCT00002443|Indinavir|indinavir|mesh-list
25804257|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
25804258|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804259|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804260|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804261|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804262|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
25804263|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804264|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804265|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804266|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804267|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804268|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804269|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
25804270|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25804271|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804272|NCT00002446|Fluconazole|fluconazole|mesh-list
25804273|NCT00002446|Posaconazole|posaconazole|mesh-list
25804274|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
25804275|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804276|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25804277|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804278|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804279|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804280|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25804281|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
25804282|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804283|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804284|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25804285|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25804286|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25804287|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25804288|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25804289|NCT00002447|Ritonavir|ritonavir|mesh-list
25804290|NCT00002447|Saquinavir|saquinavir|mesh-list
25804291|NCT00002447|Efavirenz|efavirenz|mesh-list
25804292|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804293|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804294|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804295|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804296|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804297|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804298|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804299|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
25804300|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804301|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25804302|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804303|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24785022|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24785023|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107106|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107107|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25107108|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25107109|NCT03142516|Leucovorin|leucovorin|mesh-list
25162885|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162886|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
24515080|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25804304|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804305|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25804306|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25804307|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25804308|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25804309|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25804310|NCT00002448|Ritonavir|ritonavir|mesh-list
25804311|NCT00002448|Saquinavir|saquinavir|mesh-list
25804312|NCT00002448|Efavirenz|efavirenz|mesh-list
25804313|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804314|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804315|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804316|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804317|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804318|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804319|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804320|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
25804321|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804322|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25804323|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804324|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804325|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804326|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25804327|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25804328|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25804329|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25804330|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25804331|NCT00002449|Aldesleukin|aldesleukin|mesh-list
25804332|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804333|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804334|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804335|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
25804336|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804337|NCT00002450|Tenofovir|tenofovir|mesh-list
25804338|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
25804339|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804340|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804341|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804342|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804343|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804344|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804345|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804346|NCT00002451|Ritonavir|ritonavir|mesh-list
25804347|NCT00002451|Indinavir|indinavir|mesh-list
25804348|NCT00002451|Lamivudine|lamivudine|mesh-list
25804349|NCT00002451|Stavudine|stavudine|mesh-list
25804350|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804351|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804352|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804353|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804354|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804355|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804356|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804357|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
25804358|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804359|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25804360|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25804361|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804362|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804363|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
25804364|NCT00002452|Indinavir|indinavir|mesh-list
25804365|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25804366|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25804367|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
25804368|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804369|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804370|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804371|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24515143|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515144|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804373|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804374|NCT00002453|Tenofovir|tenofovir|mesh-list
25804375|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
25804376|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804377|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25804378|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804379|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804380|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804381|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25804382|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25804383|NCT00002456|Cyclosporine|cyclosporine|mesh-list
25804384|NCT00002456|Methotrexate|methotrexate|mesh-list
25804385|NCT00002456|Cyclosporins|cyclosporins|mesh-list
25804386|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804387|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804388|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804389|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804390|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804391|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
25804392|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804393|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804394|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804395|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804396|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804397|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804398|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
25804399|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804400|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804401|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
25804402|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804403|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25804404|NCT00002458|Antibodies|antibodies|mesh-list
25804405|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25804406|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
25804407|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804408|NCT00002460|Tamoxifen|tamoxifen|mesh-list
25804409|NCT00002460|Goserelin|goserelin|mesh-list
25804410|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25804411|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
25804412|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804413|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804414|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804415|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804416|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25804417|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25804418|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25804419|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
25804420|NCT00002461|Carmustine|carmustine|mesh-list
25804421|NCT00002461|Cisplatin|cisplatin|mesh-list
25804422|NCT00002461|Etoposide|etoposide|mesh-list
25804423|NCT00002461|Sargramostim|sargramostim|mesh-list
25804424|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804425|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
25804426|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804427|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804428|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804429|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
25804430|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804431|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804432|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804433|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804434|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804435|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804436|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804437|NCT00002462|Cobalt|cobalt|mesh-list
25804438|NCT00002462|Prednisone|prednisone|mesh-list
25804439|NCT00002462|Doxorubicin|doxorubicin|mesh-list
25804440|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804441|NCT00002462|Bleomycin|bleomycin|mesh-list
25804442|NCT00002462|Vincristine|vincristine|mesh-list
25804443|NCT00002462|Vinblastine|vinblastine|mesh-list
25804444|NCT00002462|Procarbazine|procarbazine|mesh-list
25804445|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
25804446|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24515234|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
25804447|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804448|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804449|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804450|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804451|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804452|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25804453|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
25804454|NCT00002462|Hormones|hormones|mesh-ancestor
25804455|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804456|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804457|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804458|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804459|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804460|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804461|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804462|NCT00002462|Trace Elements|trace elements|mesh-ancestor
25804463|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
25804464|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
25804465|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804466|NCT00002463|Leucovorin|leucovorin|mesh-list
25804467|NCT00002463|Prednisone|prednisone|mesh-list
25804468|NCT00002463|Methotrexate|methotrexate|mesh-list
25804469|NCT00002463|Vincristine|vincristine|mesh-list
25804470|NCT00002463|Procarbazine|procarbazine|mesh-list
25804471|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
25804472|NCT00002463|Calcium|calcium|mesh-list
25804473|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
25804474|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25804475|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804476|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25804477|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
25804478|NCT00002463|Hormones|hormones|mesh-ancestor
25804479|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804480|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804481|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804482|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804483|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804484|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804485|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804486|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
25804487|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804488|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804489|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804490|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804491|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804492|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
25804493|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804494|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804495|NCT00002463|Antidotes|antidotes|mesh-ancestor
25804496|NCT00002463|Protective Agents|protective agents|mesh-ancestor
25804497|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
25804498|NCT00002463|Vitamins|vitamins|mesh-ancestor
25804499|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
25804500|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804501|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804502|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804503|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804504|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
25804505|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804506|NCT00002465|Megestrol|megestrol|mesh-list
25804507|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
25804508|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25804509|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25804510|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25804511|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
25804512|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804513|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804514|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25804515|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25804516|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804517|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515509|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515510|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
24515511|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515512|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804518|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
25804519|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25804520|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
25804521|NCT00002466|Ifosfamide|ifosfamide|mesh-list
25804522|NCT00002466|Doxorubicin|doxorubicin|mesh-list
25804523|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804524|NCT00002466|Etoposide|etoposide|mesh-list
25804525|NCT00002466|Vincristine|vincristine|mesh-list
25804526|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804527|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
25804528|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804529|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804530|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804531|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
25804532|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804533|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804534|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804535|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804536|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804537|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804538|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804539|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804540|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804541|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804542|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804543|NCT00002470|Interferons|interferons|mesh-list
25804544|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
25804545|NCT00002470|Fluorouracil|fluorouracil|mesh-list
25804546|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
25804547|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804548|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804549|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804550|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804551|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
25804552|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804553|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
25804554|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804555|NCT00002471|Leucovorin|leucovorin|mesh-list
25804556|NCT00002471|Cytarabine|cytarabine|mesh-list
25804557|NCT00002471|Dexamethasone|dexamethasone|mesh-list
25804558|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
25804559|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
25804560|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25804561|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25804562|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25804563|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
25804564|NCT00002471|Thiotepa|thiotepa|mesh-list
25804565|NCT00002471|Methotrexate|methotrexate|mesh-list
25804566|NCT00002471|Etoposide|etoposide|mesh-list
25804567|NCT00002471|Vincristine|vincristine|mesh-list
25804568|NCT00002471|Daunorubicin|daunorubicin|mesh-list
25804569|NCT00002471|Asparaginase|asparaginase|mesh-list
25804570|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
25804571|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804572|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
25804573|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804574|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804575|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804576|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
25804577|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804578|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804579|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804580|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25804581|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
25804582|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
25804583|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25804584|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25804585|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
25804586|NCT00002471|Hormones|hormones|mesh-ancestor
24515756|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515757|NCT00599222|Ranibizumab|ranibizumab|mesh-list
24515758|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515759|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24515760|NCT00599222|Growth Substances|growth substances|mesh-ancestor
25804587|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804588|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804589|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804590|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804591|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804592|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804593|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
25804594|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804595|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804596|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804597|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804598|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804599|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804600|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804601|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
25804602|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804603|NCT00002471|Antidotes|antidotes|mesh-ancestor
25804604|NCT00002471|Protective Agents|protective agents|mesh-ancestor
25804605|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
25804606|NCT00002471|Vitamins|vitamins|mesh-ancestor
25804607|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
25804608|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804609|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804610|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804611|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25804612|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804613|NCT00002472|Cisplatin|cisplatin|mesh-list
25804614|NCT00002472|Etoposide|etoposide|mesh-list
25804615|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804616|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804617|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804618|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804619|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804620|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804621|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
25804622|NCT00002474|Carboplatin|carboplatin|mesh-list
25804623|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
25804624|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804625|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
25804626|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804627|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804628|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804629|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
25804630|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804631|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804632|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804633|NCT00002474|Analgesics|analgesics|mesh-ancestor
25804634|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
25804635|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25804636|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804637|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804638|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804639|NCT00002475|Interferons|interferons|mesh-list
25804640|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
25804641|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
25804642|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
25804643|NCT00002475|Vaccines|vaccines|mesh-list
25804644|NCT00002475|Sargramostim|sargramostim|mesh-list
25804645|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
25804646|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804647|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804648|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804649|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804650|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
25804651|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804652|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804653|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804654|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
25804655|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804656|NCT00002476|Leucovorin|leucovorin|mesh-list
25804657|NCT00002476|Cobalt|cobalt|mesh-list
25804658|NCT00002476|Fluorouracil|fluorouracil|mesh-list
24796690|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796691|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
24796692|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796693|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24796694|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25804659|NCT00002476|Methotrexate|methotrexate|mesh-list
25804660|NCT00002476|Vincristine|vincristine|mesh-list
25804661|NCT00002476|Bleomycin|bleomycin|mesh-list
25804662|NCT00002476|Calcium|calcium|mesh-list
25804663|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
25804664|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25804665|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804666|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
25804667|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804668|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804669|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804670|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804671|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
25804672|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804673|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804674|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804675|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804676|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804677|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804678|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804679|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804680|NCT00002476|Antidotes|antidotes|mesh-ancestor
25804681|NCT00002476|Protective Agents|protective agents|mesh-ancestor
25804682|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
25804683|NCT00002476|Vitamins|vitamins|mesh-ancestor
25804684|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
25804685|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804686|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804687|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804688|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804689|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804690|NCT00002476|Trace Elements|trace elements|mesh-ancestor
25804691|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
25804692|NCT00002477|Cisplatin|cisplatin|mesh-list
25804693|NCT00002477|Carboplatin|carboplatin|mesh-list
25804694|NCT00002477|Doxorubicin|doxorubicin|mesh-list
25804695|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804696|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804697|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
25804698|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804699|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804700|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804701|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
25804702|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804703|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804704|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804705|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804706|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804707|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804708|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804709|NCT00002478|Etoposide|etoposide|mesh-list
25804710|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804711|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804712|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804713|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804714|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804715|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804716|NCT00002481|Cytarabine|cytarabine|mesh-list
25804717|NCT00002481|Dexamethasone|dexamethasone|mesh-list
25804718|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
25804719|NCT00002481|Cisplatin|cisplatin|mesh-list
25804720|NCT00002481|Etoposide|etoposide|mesh-list
25804721|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804722|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
25804723|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804724|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804725|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804726|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
25804727|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804728|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804729|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804730|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25804731|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
25804732|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
25804733|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25804734|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25804735|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
25804736|NCT00002481|Hormones|hormones|mesh-ancestor
25804737|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804738|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804739|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804740|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804741|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804742|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804743|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804745|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
25804746|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804747|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
25804748|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
25804749|NCT00002482|Antibodies|antibodies|mesh-list
25804750|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804751|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
25804752|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804753|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804754|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804755|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
25804756|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804757|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804758|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804759|NCT00002487|Methotrexate|methotrexate|mesh-list
25804760|NCT00002487|Dipyridamole|dipyridamole|mesh-list
25804761|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804762|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804763|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804764|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804765|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804766|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
25804767|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804768|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804769|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804770|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804771|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804772|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804773|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
25804774|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804775|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804776|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25804777|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25804778|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
25804779|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
25804780|NCT00002488|Cisplatin|cisplatin|mesh-list
25804781|NCT00002488|Etoposide|etoposide|mesh-list
25804782|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804783|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
25804784|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804785|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804786|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804787|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
25804788|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804789|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804790|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804791|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804792|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804793|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804794|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804795|NCT00002489|Leucovorin|leucovorin|mesh-list
25804796|NCT00002489|Dactinomycin|dactinomycin|mesh-list
25804797|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
25804798|NCT00002489|Carboplatin|carboplatin|mesh-list
25804799|NCT00002489|Doxorubicin|doxorubicin|mesh-list
25804800|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804801|NCT00002489|Methotrexate|methotrexate|mesh-list
25804802|NCT00002489|Etoposide|etoposide|mesh-list
25804803|NCT00002489|Vincristine|vincristine|mesh-list
25804804|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
25804805|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804806|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
25804807|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804808|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804809|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804810|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
25804811|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804812|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804813|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804814|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804815|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804816|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804817|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804818|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804819|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804820|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804821|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804822|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
25804823|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804824|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804825|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804826|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804827|NCT00002489|Antidotes|antidotes|mesh-ancestor
25804828|NCT00002489|Protective Agents|protective agents|mesh-ancestor
25804829|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
25804830|NCT00002489|Vitamins|vitamins|mesh-ancestor
25804831|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
25804832|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804833|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804834|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804835|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25804836|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804837|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25804838|NCT00002490|Mitomycins|mitomycins|mesh-list
25804839|NCT00002490|Mitomycin|mitomycin|mesh-list
25804840|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
25804841|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804842|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804843|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
25804844|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804845|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804846|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804847|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25804848|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
25804849|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804850|NCT00002492|Cisplatin|cisplatin|mesh-list
25804851|NCT00002492|Doxorubicin|doxorubicin|mesh-list
25804852|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804853|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804854|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804855|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804856|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804857|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804858|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804859|NCT00002493|Cisplatin|cisplatin|mesh-list
25804860|NCT00002493|Doxorubicin|doxorubicin|mesh-list
25804861|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804862|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804863|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804864|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804865|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804866|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804867|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804868|NCT00002494|Leucovorin|leucovorin|mesh-list
25804869|NCT00002494|Cobalt|cobalt|mesh-list
25804870|NCT00002494|Cytarabine|cytarabine|mesh-list
25804871|NCT00002494|Dexamethasone|dexamethasone|mesh-list
25804872|NCT00002494|Prednisone|prednisone|mesh-list
25804873|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
25804874|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25804875|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25804876|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25804877|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
25804878|NCT00002494|Ifosfamide|ifosfamide|mesh-list
25804879|NCT00002494|Doxorubicin|doxorubicin|mesh-list
25804880|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804881|NCT00002494|Methotrexate|methotrexate|mesh-list
25804882|NCT00002494|Etoposide|etoposide|mesh-list
25804883|NCT00002494|Vincristine|vincristine|mesh-list
25804884|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
25804885|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804886|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
25804887|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804888|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804889|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804890|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
25804891|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804892|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804893|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804894|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25804895|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
25804896|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
25804897|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25804898|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25804899|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
25804900|NCT00002494|Hormones|hormones|mesh-ancestor
25804901|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804902|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804903|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804904|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804905|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804906|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804907|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804908|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804909|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804910|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804911|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
25004192|NCT02503722|Osimertinib|osimertinib|mesh-list
25804912|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804913|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804914|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804915|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804916|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
25804917|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25804918|NCT00002494|Antidotes|antidotes|mesh-ancestor
25804919|NCT00002494|Protective Agents|protective agents|mesh-ancestor
25804920|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
25804921|NCT00002494|Vitamins|vitamins|mesh-ancestor
25804922|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
25804923|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804924|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804925|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804926|NCT00002494|Trace Elements|trace elements|mesh-ancestor
25804927|NCT00002495|Doxorubicin|doxorubicin|mesh-list
25804928|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25804929|NCT00002495|Vinblastine|vinblastine|mesh-list
25804930|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25804931|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804932|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804933|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804934|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804935|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804936|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25804937|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
25804938|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
25804939|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
25804940|NCT00002496|Cobalt|cobalt|mesh-list
25804941|NCT00002496|Cisplatin|cisplatin|mesh-list
25804942|NCT00002496|Fluorouracil|fluorouracil|mesh-list
25804943|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804944|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
25804945|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804946|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804947|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804948|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
25804949|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804950|NCT00002496|Trace Elements|trace elements|mesh-ancestor
25804951|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
25804952|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
25804953|NCT00002498|Fluorouracil|fluorouracil|mesh-list
25804954|NCT00002498|Methotrexate|methotrexate|mesh-list
25804955|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
25804956|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25804957|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
25804958|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804959|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25804960|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25804961|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
25804962|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804963|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804964|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25804965|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
25804966|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25804967|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804968|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804969|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25804970|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25804971|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25804972|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25804973|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25804974|NCT00002498|Analgesics|analgesics|mesh-ancestor
25804975|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
25804976|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25804977|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25804978|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25804979|NCT00002499|Cytarabine|cytarabine|mesh-list
25804980|NCT00002499|Dexamethasone|dexamethasone|mesh-list
25804981|NCT00002499|Prednisone|prednisone|mesh-list
25162940|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162941|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162942|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25162943|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25162944|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25162945|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
25162946|NCT02901301|Capecitabine|capecitabine|mesh-list
24941619|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
25804982|NCT00002499|Methotrexate|methotrexate|mesh-list
25804983|NCT00002499|Vincristine|vincristine|mesh-list
25804984|NCT00002499|Daunorubicin|daunorubicin|mesh-list
25804985|NCT00002499|Asparaginase|asparaginase|mesh-list
25804986|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25804987|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
25804988|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
25804989|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25804990|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25804991|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25804992|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
25804993|NCT00002499|Hormones|hormones|mesh-ancestor
25804994|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25804995|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25804996|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25804997|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25804998|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
25804999|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805000|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805001|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
25805002|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805003|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805004|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805005|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805006|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805007|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
25805008|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805009|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805010|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
25805011|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805012|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805013|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805014|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805015|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805016|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805017|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805018|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805019|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
25805020|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805021|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
25805022|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805023|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805024|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805025|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
25805026|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805027|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805028|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805029|NCT00002502|Cytarabine|cytarabine|mesh-list
25805030|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
25805031|NCT00002502|Busulfan|busulfan|mesh-list
25805032|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805033|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
25805034|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805035|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805036|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805037|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
25805038|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805039|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805040|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805041|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805042|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
25805043|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
25805044|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805045|NCT00002504|Interferons|interferons|mesh-list
25805046|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
25805047|NCT00002504|Aldesleukin|aldesleukin|mesh-list
25805048|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805049|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
25805050|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805051|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
25805052|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805053|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25805054|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25805055|NCT00002505|Interferons|interferons|mesh-list
25805056|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
25805057|NCT00002505|Vaccines|vaccines|mesh-list
25805058|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805059|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
25805060|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805061|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
25805062|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805063|NCT00002506|Interferons|interferons|mesh-list
25805064|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
25805065|NCT00002506|Isotretinoin|isotretinoin|mesh-list
25805066|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805067|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
25805068|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805069|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
25805070|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805071|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805072|NCT00002507|Mitomycins|mitomycins|mesh-list
25805073|NCT00002507|Mitomycin|mitomycin|mesh-list
25805074|NCT00002507|Porfiromycin|porfiromycin|mesh-list
25805075|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805076|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805077|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
25805078|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805079|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805080|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805081|NCT00002508|Carboplatin|carboplatin|mesh-list
25805082|NCT00002508|Etoposide|etoposide|mesh-list
25805083|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805084|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805085|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805086|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805087|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805088|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805089|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
25805090|NCT00002509|Carboplatin|carboplatin|mesh-list
25805091|NCT00002509|Etoposide|etoposide|mesh-list
25805092|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805093|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
25805094|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805095|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805096|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805097|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
25805098|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805099|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805100|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805101|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805102|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805103|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805104|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805105|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
25805106|NCT00002510|Etoposide|etoposide|mesh-list
25805107|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805108|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
25805109|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805110|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805111|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805112|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
25805113|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805114|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805115|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805116|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805117|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805118|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805119|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805120|NCT00002514|Leucovorin|leucovorin|mesh-list
25805121|NCT00002514|Cytarabine|cytarabine|mesh-list
25805122|NCT00002514|Dexamethasone|dexamethasone|mesh-list
25805123|NCT00002514|Prednisone|prednisone|mesh-list
25805124|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
25805125|NCT00002514|Methotrexate|methotrexate|mesh-list
25805126|NCT00002514|Etoposide|etoposide|mesh-list
25805127|NCT00002514|Vincristine|vincristine|mesh-list
25805128|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
25805129|NCT00002514|Daunorubicin|daunorubicin|mesh-list
25805130|NCT00002514|Asparaginase|asparaginase|mesh-list
25805131|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
24517188|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988044|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988045|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988046|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
24988047|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24988048|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988050|NCT04297592|Cephalexin|cephalexin|mesh-list
25805132|NCT00002514|Thioguanine|thioguanine|mesh-list
25805133|NCT00002514|Sargramostim|sargramostim|mesh-list
25805134|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
25805135|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805136|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
25805137|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805138|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805139|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805140|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
25805141|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805142|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805143|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805144|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805145|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
25805146|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
25805147|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805148|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25805149|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
25805150|NCT00002514|Hormones|hormones|mesh-ancestor
25805151|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805152|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805153|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805154|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805155|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805156|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805157|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
25805158|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805159|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805160|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805161|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805162|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805163|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805164|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805165|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
25805166|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805167|NCT00002514|Antidotes|antidotes|mesh-ancestor
25805168|NCT00002514|Protective Agents|protective agents|mesh-ancestor
25805169|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805170|NCT00002514|Vitamins|vitamins|mesh-ancestor
25805171|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
25805172|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805173|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805174|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805175|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25805176|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805177|NCT00002515|Carboplatin|carboplatin|mesh-list
25805178|NCT00002515|Topotecan|topotecan|mesh-list
25805179|NCT00002515|Thiotepa|thiotepa|mesh-list
25805180|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805181|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
25805182|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805183|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25805184|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805185|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805186|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805187|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805188|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
25805189|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805190|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805191|NCT00002516|Cobalt|cobalt|mesh-list
25805192|NCT00002516|Dactinomycin|dactinomycin|mesh-list
25805193|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
25805194|NCT00002516|Ifosfamide|ifosfamide|mesh-list
25805195|NCT00002516|Doxorubicin|doxorubicin|mesh-list
25805196|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805197|NCT00002516|Etoposide|etoposide|mesh-list
25805198|NCT00002516|Vincristine|vincristine|mesh-list
25805199|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805200|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
25805201|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004425|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25004426|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
25004427|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004428|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805202|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805203|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805204|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
25805205|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805206|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805207|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805208|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805209|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805210|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805211|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805212|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805213|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805214|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805215|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805216|NCT00002516|Trace Elements|trace elements|mesh-ancestor
25805217|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
25805218|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25805219|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805220|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25805221|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805222|NCT00002517|Cytarabine|cytarabine|mesh-list
25805223|NCT00002517|Dexamethasone|dexamethasone|mesh-list
25805224|NCT00002517|Etoposide|etoposide|mesh-list
25805225|NCT00002517|Daunorubicin|daunorubicin|mesh-list
25805226|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
25805227|NCT00002517|Idarubicin|idarubicin|mesh-list
25805228|NCT00002517|Thioguanine|thioguanine|mesh-list
25805229|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805230|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
25805231|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
25805232|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805233|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805234|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25805235|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
25805236|NCT00002517|Hormones|hormones|mesh-ancestor
25805237|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805238|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805239|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805240|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805241|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805242|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805243|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805244|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805245|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805246|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
25805247|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
25805248|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805249|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805250|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
25805251|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805252|NCT00002517|Analgesics|analgesics|mesh-ancestor
25805253|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
25805254|NCT00002519|Paclitaxel|paclitaxel|mesh-list
25805255|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805256|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805257|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805258|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805259|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805260|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805261|NCT00002520|Nicotine|nicotine|mesh-list
25805262|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25805263|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
25805264|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805265|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805266|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25805267|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25805268|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
25805269|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25805270|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805271|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
25805272|NCT00002521|Cisplatin|cisplatin|mesh-list
25805273|NCT00002521|Etoposide|etoposide|mesh-list
25805274|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805275|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
25805276|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805277|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805278|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805279|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
25805280|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805281|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805282|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805283|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805284|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805285|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805286|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805287|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
25805288|NCT00002522|Cisplatin|cisplatin|mesh-list
25805289|NCT00002522|Etoposide|etoposide|mesh-list
25805290|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805291|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
25805292|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805293|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805294|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805295|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
25805296|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805297|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805298|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805299|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805300|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805301|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805302|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805303|NCT00002523|Leucovorin|leucovorin|mesh-list
25805304|NCT00002523|Fluorouracil|fluorouracil|mesh-list
25805305|NCT00002523|Calcium|calcium|mesh-list
25805306|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
25805307|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25805308|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805309|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
25805310|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805311|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805312|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805313|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805314|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
25805315|NCT00002523|Antidotes|antidotes|mesh-ancestor
25805316|NCT00002523|Protective Agents|protective agents|mesh-ancestor
25805317|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805318|NCT00002523|Vitamins|vitamins|mesh-ancestor
25805319|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
25805320|NCT00002524|Leucovorin|leucovorin|mesh-list
25805321|NCT00002524|Cytarabine|cytarabine|mesh-list
25805322|NCT00002524|Zidovudine|zidovudine|mesh-list
25805323|NCT00002524|Trimethoprim|trimethoprim|mesh-list
25805324|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
25805325|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25805326|NCT00002524|Pentamidine|pentamidine|mesh-list
25805327|NCT00002524|Prednisone|prednisone|mesh-list
25805328|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
25805329|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25805330|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25805331|NCT00002524|Prednisolone|prednisolone|mesh-list
25805332|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
25805333|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
25805334|NCT00002524|Ifosfamide|ifosfamide|mesh-list
25805335|NCT00002524|Doxorubicin|doxorubicin|mesh-list
25805336|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805337|NCT00002524|Fluorouracil|fluorouracil|mesh-list
25805338|NCT00002524|Methotrexate|methotrexate|mesh-list
25805339|NCT00002524|Etoposide|etoposide|mesh-list
25805340|NCT00002524|Vincristine|vincristine|mesh-list
25805341|NCT00002524|Bleomycin|bleomycin|mesh-list
25805342|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25805343|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
25805344|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
25805345|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805346|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
25805347|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805348|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805349|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805350|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
25805351|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805352|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805353|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805354|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805355|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805356|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805357|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805358|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805359|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
25805360|NCT00002524|Hormones|hormones|mesh-ancestor
25805361|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805362|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805363|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
25805364|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805365|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805366|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805367|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805368|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805369|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805370|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805371|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805372|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
25805373|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805374|NCT00002524|Antidotes|antidotes|mesh-ancestor
25805375|NCT00002524|Protective Agents|protective agents|mesh-ancestor
25805376|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805377|NCT00002524|Vitamins|vitamins|mesh-ancestor
25805378|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
25805379|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805380|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805381|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805382|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
25805383|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
25805384|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805385|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25805386|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25805387|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25805388|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25805389|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25805390|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25805391|NCT00002524|Renal Agents|renal agents|mesh-ancestor
25805392|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
25805393|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25805394|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25805395|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25805396|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25805397|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25805398|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25805399|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
25805400|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25805401|NCT00002526|Doxorubicin|doxorubicin|mesh-list
25805402|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805403|NCT00002526|Ifosfamide|ifosfamide|mesh-list
25805404|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805405|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805406|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805407|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805408|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805409|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805410|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805411|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
25805412|NCT00002527|Aspirin|aspirin|mesh-list
25805413|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25805414|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25805415|NCT00002527|Analgesics|analgesics|mesh-ancestor
25805416|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
25805417|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805418|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805419|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805420|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805421|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25805422|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25805423|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805424|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25805425|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25805426|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805427|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
25805428|NCT00002528|Tamoxifen|tamoxifen|mesh-list
25805429|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25805430|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
25805431|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805432|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517525|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517526|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805433|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805434|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805435|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25805436|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25805437|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25805438|NCT00002529|Tamoxifen|tamoxifen|mesh-list
25805439|NCT00002529|Toremifene|toremifene|mesh-list
25805440|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
25805441|NCT00002529|Doxorubicin|doxorubicin|mesh-list
25805442|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805443|NCT00002529|Epirubicin|epirubicin|mesh-list
25805444|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805445|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
25805446|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805447|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805448|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805449|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
25805450|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805451|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805452|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805453|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805454|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805455|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805456|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805457|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25805458|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
25805459|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805460|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805461|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25805462|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25805463|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25805464|NCT00002531|Leucovorin|leucovorin|mesh-list
25805465|NCT00002531|Cytarabine|cytarabine|mesh-list
25805466|NCT00002531|Dexamethasone|dexamethasone|mesh-list
25805467|NCT00002531|Prednisolone|prednisolone|mesh-list
25805468|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
25805469|NCT00002531|Ifosfamide|ifosfamide|mesh-list
25805470|NCT00002531|Doxorubicin|doxorubicin|mesh-list
25805471|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805472|NCT00002531|Methotrexate|methotrexate|mesh-list
25805473|NCT00002531|Etoposide|etoposide|mesh-list
25805474|NCT00002531|Vincristine|vincristine|mesh-list
25805475|NCT00002531|Daunorubicin|daunorubicin|mesh-list
25805476|NCT00002531|Asparaginase|asparaginase|mesh-list
25805477|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
25805478|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
25805479|NCT00002531|Thioguanine|thioguanine|mesh-list
25805480|NCT00002531|Vindesine|vindesine|mesh-list
25805481|NCT00002531|Teniposide|teniposide|mesh-list
25805482|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
25805483|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805484|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
25805485|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805486|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805487|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805488|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
25805489|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805490|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805491|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805492|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805493|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
25805494|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
25805495|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805496|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25805497|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
25805498|NCT00002531|Hormones|hormones|mesh-ancestor
25805499|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805500|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805501|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805502|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805503|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805504|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805505|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805506|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805507|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805508|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805509|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
25805510|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805511|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805512|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805513|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805514|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
25805515|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805516|NCT00002531|Antidotes|antidotes|mesh-ancestor
25805517|NCT00002531|Protective Agents|protective agents|mesh-ancestor
25805518|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805520|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
25805521|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805522|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805523|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805524|NCT00002531|Analgesics|analgesics|mesh-ancestor
25805525|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
25805526|NCT00002532|Leucovorin|leucovorin|mesh-list
25805527|NCT00002532|Cytarabine|cytarabine|mesh-list
25805528|NCT00002532|Dexamethasone|dexamethasone|mesh-list
25805529|NCT00002532|Prednisolone|prednisolone|mesh-list
25805530|NCT00002532|Methotrexate|methotrexate|mesh-list
25805531|NCT00002532|Etoposide|etoposide|mesh-list
25805532|NCT00002532|Daunorubicin|daunorubicin|mesh-list
25805533|NCT00002532|Ifosfamide|ifosfamide|mesh-list
25805534|NCT00002532|Asparaginase|asparaginase|mesh-list
25805535|NCT00002532|Idarubicin|idarubicin|mesh-list
25805536|NCT00002532|Vindesine|vindesine|mesh-list
25805537|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
25805538|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805539|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
25805540|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
25805541|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805542|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805543|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25805544|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
25805545|NCT00002532|Hormones|hormones|mesh-ancestor
25805546|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805547|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805548|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805549|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805550|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805551|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805552|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805553|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
25805554|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805555|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805556|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805557|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805558|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805559|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
25805560|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805561|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805562|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805563|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805564|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805565|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
25805566|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805567|NCT00002532|Antidotes|antidotes|mesh-ancestor
25805568|NCT00002532|Protective Agents|protective agents|mesh-ancestor
25805569|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805570|NCT00002532|Vitamins|vitamins|mesh-ancestor
25805571|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
25805572|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805573|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805574|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
25805575|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805576|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805577|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805578|NCT00002533|Fluconazole|fluconazole|mesh-list
25805579|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
25805580|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805581|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25805582|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25805583|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805584|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988439|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805585|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25805586|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
25805587|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805588|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805589|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25805590|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25805592|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
25805593|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
25805594|NCT00002534|Thiotepa|thiotepa|mesh-list
25805595|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25805596|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805597|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
25805598|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805599|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805600|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805601|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
25805602|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805603|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805604|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805605|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805606|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
25805607|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
25805608|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805609|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805610|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
25805611|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
25805612|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805613|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25805614|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
25805615|NCT00002534|Hormones|hormones|mesh-ancestor
25805616|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805617|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25805618|NCT00002534|Protective Agents|protective agents|mesh-ancestor
25805619|NCT00002535|Aldesleukin|aldesleukin|mesh-list
25805620|NCT00002535|Indomethacin|indomethacin|mesh-list
25805621|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
25805622|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805623|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
25805624|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805625|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805626|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805627|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
25805628|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805629|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805630|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805631|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25805632|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25805633|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
25805634|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805635|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25805636|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25805637|NCT00002535|Analgesics|analgesics|mesh-ancestor
25805638|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
25805639|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805640|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805641|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
25805642|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
25805643|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805644|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25805645|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805646|NCT00002536|Cisplatin|cisplatin|mesh-list
25805647|NCT00002536|Vincristine|vincristine|mesh-list
25805648|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805649|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805650|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805651|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805652|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805653|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805654|NCT00002537|Topotecan|topotecan|mesh-list
25805655|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25805656|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805657|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805658|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805659|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805660|NCT00002539|Cisplatin|cisplatin|mesh-list
25805661|NCT00002539|Doxorubicin|doxorubicin|mesh-list
25805662|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805663|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805664|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805665|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805666|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805667|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805668|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805669|NCT00002542|Tamoxifen|tamoxifen|mesh-list
25805670|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
25805671|NCT00002542|Doxorubicin|doxorubicin|mesh-list
25805672|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805673|NCT00002542|Fluorouracil|fluorouracil|mesh-list
25805674|NCT00002542|Methotrexate|methotrexate|mesh-list
25805675|NCT00002542|Epirubicin|epirubicin|mesh-list
25805676|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805677|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
25805678|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805679|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805680|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805681|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
25805682|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805683|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805684|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805685|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805686|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805687|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805688|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805689|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
25805690|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805691|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805692|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805693|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805694|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805695|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805696|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805697|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25805698|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
25805699|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805700|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805701|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25805702|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25805703|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25805704|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
25805705|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25805706|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805707|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805708|NCT00002544|Docetaxel|docetaxel|mesh-list
25805709|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
25805710|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805711|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805712|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805713|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805714|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805715|NCT00002544|Analgesics|analgesics|mesh-ancestor
25805716|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
25805717|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805718|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805719|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805720|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805721|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805722|NCT00002545|Carmustine|carmustine|mesh-list
25805723|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805724|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
25805725|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805726|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805727|NCT00002546|Cisplatin|cisplatin|mesh-list
25805728|NCT00002546|Ifosfamide|ifosfamide|mesh-list
25805729|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805730|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805731|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
25805732|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805733|NCT00002547|Cytarabine|cytarabine|mesh-list
25805734|NCT00002547|Cyclosporine|cyclosporine|mesh-list
25046180|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
25805735|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
25805736|NCT00002547|Busulfan|busulfan|mesh-list
25805737|NCT00002547|Methotrexate|methotrexate|mesh-list
25805738|NCT00002547|Cyclosporins|cyclosporins|mesh-list
25805739|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805740|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
25805741|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805742|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805743|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805744|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
25805745|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805746|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805747|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805748|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805749|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805750|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805751|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805752|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
25805753|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805754|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805755|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805756|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805757|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
25805758|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805759|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
25805760|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25805761|NCT00002548|Interferons|interferons|mesh-list
25805762|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
25805763|NCT00002548|Dexamethasone|dexamethasone|mesh-list
25805764|NCT00002548|Prednisone|prednisone|mesh-list
25805765|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
25805766|NCT00002548|Melphalan|melphalan|mesh-list
25805767|NCT00002548|Carmustine|carmustine|mesh-list
25805768|NCT00002548|Doxorubicin|doxorubicin|mesh-list
25805769|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805770|NCT00002548|Vincristine|vincristine|mesh-list
25805771|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805772|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
25805773|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805774|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805775|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805776|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
25805777|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805778|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805779|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805780|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805781|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
25805782|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
25805783|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805784|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25805785|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
25805786|NCT00002548|Hormones|hormones|mesh-ancestor
25805787|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805788|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805789|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805790|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805791|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805792|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805793|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
25805794|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805795|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805796|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805797|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
25805798|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805799|NCT00002549|Cytarabine|cytarabine|mesh-list
25805800|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
25805801|NCT00002549|Busulfan|busulfan|mesh-list
25805802|NCT00002549|Etoposide|etoposide|mesh-list
25805803|NCT00002549|Daunorubicin|daunorubicin|mesh-list
25805804|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
25805805|NCT00002549|Idarubicin|idarubicin|mesh-list
25805806|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805807|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
25805808|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805809|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805810|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805811|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
25805812|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805813|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805814|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805815|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805816|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805817|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805818|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805819|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805820|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
25805821|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
25805822|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805823|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805824|NCT00002549|Analgesics|analgesics|mesh-ancestor
25805825|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
25805826|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25805827|NCT00002550|Cisplatin|cisplatin|mesh-list
25805828|NCT00002550|Etoposide|etoposide|mesh-list
25805829|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805830|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805831|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805832|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805833|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805834|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805835|NCT00002551|Leucovorin|leucovorin|mesh-list
25805836|NCT00002551|Levamisole|levamisole|mesh-list
25805837|NCT00002551|Fluorouracil|fluorouracil|mesh-list
25805838|NCT00002551|Calcium|calcium|mesh-list
25805839|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
25805840|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25805841|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805842|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
25805843|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805844|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805845|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805846|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805847|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
25805848|NCT00002551|Antidotes|antidotes|mesh-ancestor
25805849|NCT00002551|Protective Agents|protective agents|mesh-ancestor
25805850|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805851|NCT00002551|Vitamins|vitamins|mesh-ancestor
25805852|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
25805853|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25805854|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
25805855|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
25805856|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25805857|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805858|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805859|NCT00002552|Leucovorin|leucovorin|mesh-list
25805860|NCT00002552|Cytarabine|cytarabine|mesh-list
25805861|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
25805862|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25805863|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25805864|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25805865|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
25805866|NCT00002552|Carmustine|carmustine|mesh-list
25805867|NCT00002552|Methotrexate|methotrexate|mesh-list
25805868|NCT00002552|Etoposide|etoposide|mesh-list
25805869|NCT00002552|Sargramostim|sargramostim|mesh-list
25805870|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
25805871|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805872|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
25805873|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805874|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805875|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805876|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
25805877|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805878|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805879|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805880|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805881|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805882|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805883|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805884|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
25805885|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805886|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805887|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805888|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805889|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805890|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805891|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805892|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
25805893|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805894|NCT00002552|Antidotes|antidotes|mesh-ancestor
25805895|NCT00002552|Protective Agents|protective agents|mesh-ancestor
25805896|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805897|NCT00002552|Vitamins|vitamins|mesh-ancestor
25805898|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
25805899|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805900|NCT00002553|Cobalt|cobalt|mesh-list
25805901|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
25805902|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805903|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
25805904|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805905|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805906|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805907|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
25805908|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805909|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805910|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805911|NCT00002553|Trace Elements|trace elements|mesh-ancestor
25805912|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
25805913|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
25805914|NCT00002554|Busulfan|busulfan|mesh-list
25805915|NCT00002554|Methotrexate|methotrexate|mesh-list
25805916|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805917|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
25805918|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805919|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805920|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805921|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
25805922|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805923|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805924|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805925|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805926|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805927|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805928|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805929|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
25805930|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805931|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805932|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805933|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805934|NCT00002555|Cobalt|cobalt|mesh-list
25805935|NCT00002555|Cisplatin|cisplatin|mesh-list
25805936|NCT00002555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805937|NCT00002555|Trace Elements|trace elements|mesh-ancestor
25805938|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
25805939|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805940|NCT00002556|Interferons|interferons|mesh-list
25805941|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
25805942|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
25805943|NCT00002556|Prednisone|prednisone|mesh-list
25805944|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
25805945|NCT00002556|Melphalan|melphalan|mesh-list
25805946|NCT00002556|Carmustine|carmustine|mesh-list
25805947|NCT00002556|Vincristine|vincristine|mesh-list
25805948|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805949|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
25805950|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805951|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805952|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25805953|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
25805954|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805955|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805956|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25805957|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25805958|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
25805959|NCT00002556|Hormones|hormones|mesh-ancestor
25805960|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25805961|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25805962|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
25805963|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25805964|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805965|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25805966|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988774|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805967|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25805968|NCT00002557|Leucovorin|leucovorin|mesh-list
25805969|NCT00002557|Doxorubicin|doxorubicin|mesh-list
25805970|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25805971|NCT00002557|Etoposide|etoposide|mesh-list
25805972|NCT00002557|Methotrexate|methotrexate|mesh-list
25805973|NCT00002557|Calcium|calcium|mesh-list
25805974|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
25805975|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25805976|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25805977|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25805978|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25805979|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25805980|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25805981|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25805982|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25805983|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25805984|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
25805985|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25805986|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25805987|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
25805988|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
25805989|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25805990|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25805991|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
25805992|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25805993|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25805994|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25805995|NCT00002557|Antidotes|antidotes|mesh-ancestor
25805996|NCT00002557|Protective Agents|protective agents|mesh-ancestor
25805997|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
25805998|NCT00002557|Vitamins|vitamins|mesh-ancestor
25805999|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
25806000|NCT00002559|Paclitaxel|paclitaxel|mesh-list
25806001|NCT00002559|Cisplatin|cisplatin|mesh-list
25806002|NCT00002559|Ifosfamide|ifosfamide|mesh-list
25806003|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806004|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806005|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806006|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806007|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806008|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806009|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806010|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
25806011|NCT00002560|Antibodies|antibodies|mesh-list
25806012|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25806013|NCT00002560|Sargramostim|sargramostim|mesh-list
25806014|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
25806015|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806016|NCT00002561|Doxorubicin|doxorubicin|mesh-list
25806017|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806018|NCT00002561|Bleomycin|bleomycin|mesh-list
25806019|NCT00002561|Dacarbazine|dacarbazine|mesh-list
25806020|NCT00002561|Vinblastine|vinblastine|mesh-list
25806021|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806022|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806023|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806024|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806025|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806026|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806027|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806028|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
25806029|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806030|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806031|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806032|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806033|NCT00002562|Paclitaxel|paclitaxel|mesh-list
25806034|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806035|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806036|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806037|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806038|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806039|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806040|NCT00002565|Cytarabine|cytarabine|mesh-list
25806041|NCT00002565|Prednisone|prednisone|mesh-list
25806042|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
25806043|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
25806044|NCT00002565|Ifosfamide|ifosfamide|mesh-list
25806045|NCT00002565|Doxorubicin|doxorubicin|mesh-list
25806046|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806047|NCT00002565|Etoposide|etoposide|mesh-list
25806048|NCT00002565|Vincristine|vincristine|mesh-list
25806049|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
25806050|NCT00002565|Idarubicin|idarubicin|mesh-list
25806051|NCT00002565|Bleomycin|bleomycin|mesh-list
25806052|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806053|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
25806054|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806055|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806056|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806057|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
25806058|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806059|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806060|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806061|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806062|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806063|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806064|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806065|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25806066|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
25806067|NCT00002565|Hormones|hormones|mesh-ancestor
25806068|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806069|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806070|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806071|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806072|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
25806073|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
25806074|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806075|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806076|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806077|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806078|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
25806079|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
25806080|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25806081|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25806082|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25806083|NCT00002565|Protective Agents|protective agents|mesh-ancestor
25806084|NCT00002565|Analgesics|analgesics|mesh-ancestor
25806085|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
25806086|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
25806087|NCT00002566|Ifosfamide|ifosfamide|mesh-list
25806088|NCT00002566|Cisplatin|cisplatin|mesh-list
25806089|NCT00002566|Carboplatin|carboplatin|mesh-list
25806090|NCT00002566|Etoposide|etoposide|mesh-list
25806091|NCT00002566|Vinblastine|vinblastine|mesh-list
25806092|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806093|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
25806094|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806095|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806096|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806097|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
25806098|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806099|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806100|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806101|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806102|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806103|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806104|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806105|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806106|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806107|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806108|NCT00002567|Etoposide|etoposide|mesh-list
25806109|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806110|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806111|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806112|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806113|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806114|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806115|NCT00002568|Paclitaxel|paclitaxel|mesh-list
25806116|NCT00002568|Cisplatin|cisplatin|mesh-list
25806117|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806118|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806119|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806120|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806121|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806122|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806123|NCT00002569|Vincristine|vincristine|mesh-list
25806124|NCT00002569|Lomustine|lomustine|mesh-list
25806125|NCT00002569|Procarbazine|procarbazine|mesh-list
25806126|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806127|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806128|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806129|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806130|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806131|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806132|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806133|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
25806134|NCT00002570|Leucovorin|leucovorin|mesh-list
25806135|NCT00002570|Fluorouracil|fluorouracil|mesh-list
25806136|NCT00002570|Calcium|calcium|mesh-list
25806137|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
25806138|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25806139|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806140|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
25806141|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806142|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806143|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806144|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806145|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
25806146|NCT00002570|Antidotes|antidotes|mesh-ancestor
25806147|NCT00002570|Protective Agents|protective agents|mesh-ancestor
25806148|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
25806149|NCT00002570|Vitamins|vitamins|mesh-ancestor
25806150|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
25806151|NCT00002571|Leucovorin|leucovorin|mesh-list
25806152|NCT00002571|Cytarabine|cytarabine|mesh-list
25806153|NCT00002571|Trimethoprim|trimethoprim|mesh-list
25806154|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
25806155|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25806156|NCT00002571|Prednisone|prednisone|mesh-list
25806157|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
25806158|NCT00002571|Doxorubicin|doxorubicin|mesh-list
25806159|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806160|NCT00002571|Methotrexate|methotrexate|mesh-list
25806161|NCT00002571|Etoposide|etoposide|mesh-list
25806162|NCT00002571|Vincristine|vincristine|mesh-list
25806163|NCT00002571|Bleomycin|bleomycin|mesh-list
25806164|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
25806165|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806166|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
25806167|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806168|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806169|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806170|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
25806171|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806172|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806173|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806174|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806175|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806176|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806177|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806178|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25806179|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
25806180|NCT00002571|Hormones|hormones|mesh-ancestor
25806181|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806182|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806183|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806184|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806185|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806186|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806187|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
25806188|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806189|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806190|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806191|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806193|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806194|NCT00002571|Antidotes|antidotes|mesh-ancestor
25806195|NCT00002571|Protective Agents|protective agents|mesh-ancestor
25806196|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
25806197|NCT00002571|Vitamins|vitamins|mesh-ancestor
25806198|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
25806199|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806200|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806201|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806202|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25806203|NCT00002571|Renal Agents|renal agents|mesh-ancestor
25806204|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
25806205|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25806206|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25806207|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25806208|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25806209|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25806210|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25806211|NCT00002572|Aldesleukin|aldesleukin|mesh-list
25806212|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
25806213|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806214|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25806215|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25806216|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
25806217|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806218|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
25806219|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806220|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806221|NCT00002574|Interferons|interferons|mesh-list
25806222|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
25806223|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
25806224|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806225|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
25806226|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806227|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
25806228|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806229|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806230|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25806231|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806232|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806233|NCT00002576|Prednisolone|prednisolone|mesh-list
25806234|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
25806235|NCT00002576|Doxorubicin|doxorubicin|mesh-list
25806236|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806237|NCT00002576|Vincristine|vincristine|mesh-list
25806238|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
25806239|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806240|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
25806241|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806242|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806243|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806244|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
25806245|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806246|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806247|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806248|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806249|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806250|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806251|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806252|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806253|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806254|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806255|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806256|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25806257|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
25806258|NCT00002576|Hormones|hormones|mesh-ancestor
25806259|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806260|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806261|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25806262|NCT00002576|Analgesics|analgesics|mesh-ancestor
25806263|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
25806264|NCT00002578|Leucovorin|leucovorin|mesh-list
24517923|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163009|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25806265|NCT00002578|Cytarabine|cytarabine|mesh-list
25806266|NCT00002578|Methotrexate|methotrexate|mesh-list
25806267|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
25806268|NCT00002578|Calcium|calcium|mesh-list
25806269|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
25806270|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25806271|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806272|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806273|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806274|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806275|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806276|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
25806277|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806278|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806279|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806280|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806281|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806282|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806283|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
25806284|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806285|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806286|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
25806287|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806288|NCT00002578|Antidotes|antidotes|mesh-ancestor
25806289|NCT00002578|Protective Agents|protective agents|mesh-ancestor
25806290|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
25806291|NCT00002578|Vitamins|vitamins|mesh-ancestor
25806292|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
25806293|NCT00002579|Tamoxifen|tamoxifen|mesh-list
25806294|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
25806295|NCT00002579|Fluorouracil|fluorouracil|mesh-list
25806296|NCT00002579|Methotrexate|methotrexate|mesh-list
25806297|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806298|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
25806299|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806300|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806301|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806302|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
25806303|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806304|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806305|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806306|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
25806307|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806308|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806309|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806310|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806311|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806312|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806313|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806314|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806315|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25806316|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
25806317|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806318|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806319|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25806320|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25806321|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25806322|NCT00002580|Tamoxifen|tamoxifen|mesh-list
25806323|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
25806324|NCT00002580|Fluorouracil|fluorouracil|mesh-list
25806325|NCT00002580|Methotrexate|methotrexate|mesh-list
25806326|NCT00002580|Leuprolide|leuprolide|mesh-list
25806327|NCT00002580|Goserelin|goserelin|mesh-list
25806328|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806329|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
25806330|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806331|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806332|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806333|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
25806334|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806335|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806336|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806337|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
25806338|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806339|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806340|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
24518108|NCT05331469|Insulin|insulin|mesh-list
25806341|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806342|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806343|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806344|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806345|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806346|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25806347|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
25806348|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806349|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806350|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25806351|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25806352|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25806353|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25806354|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
25806355|NCT00002581|Tamoxifen|tamoxifen|mesh-list
25806356|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
25806357|NCT00002581|Fluorouracil|fluorouracil|mesh-list
25806358|NCT00002581|Methotrexate|methotrexate|mesh-list
25806359|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806360|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
25806361|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806362|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806363|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806364|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
25806365|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806366|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806367|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806368|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
25806369|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806370|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806371|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806372|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806373|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806374|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806375|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806376|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806377|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25806378|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
25806379|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806380|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806381|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25806382|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25806383|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25806384|NCT00002582|Tamoxifen|tamoxifen|mesh-list
25806385|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
25806386|NCT00002582|Doxorubicin|doxorubicin|mesh-list
25806387|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806388|NCT00002582|Fluorouracil|fluorouracil|mesh-list
25806389|NCT00002582|Methotrexate|methotrexate|mesh-list
25806390|NCT00002582|Leuprolide|leuprolide|mesh-list
25806391|NCT00002582|Goserelin|goserelin|mesh-list
25806392|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806393|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
25806394|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806395|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806396|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806397|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
25806398|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806399|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806400|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806401|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806402|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806403|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806404|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806405|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
25806406|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806407|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806408|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806409|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806410|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806411|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806412|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806413|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25806414|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
25806415|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806416|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806417|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25806418|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25806419|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25806420|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25806421|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
25806422|NCT00002583|Cisplatin|cisplatin|mesh-list
25806423|NCT00002583|Vinorelbine|vinorelbine|mesh-list
25806424|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806425|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806426|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806427|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806428|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806429|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806430|NCT00002585|NSC 366140|nsc 366140|mesh-list
25806431|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806432|NCT00002586|Vitamin E|vitamin e|mesh-list
25806433|NCT00002586|Tocopherols|tocopherols|mesh-list
25806434|NCT00002586|Tocotrienols|tocotrienols|mesh-list
25806435|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
25806436|NCT00002586|Tretinoin|tretinoin|mesh-list
25806437|NCT00002586|Isotretinoin|isotretinoin|mesh-list
25806438|NCT00002586|Vitamins|vitamins|mesh-ancestor
25806439|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
25806440|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806441|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
25806442|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806443|NCT00002586|Protective Agents|protective agents|mesh-ancestor
25806444|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806445|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
25806446|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806447|NCT00002587|Paclitaxel|paclitaxel|mesh-list
25806448|NCT00002587|Topotecan|topotecan|mesh-list
25806449|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806450|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806451|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806452|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806453|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806454|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806455|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25806456|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806457|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806458|NCT00002588|Etoposide|etoposide|mesh-list
25806459|NCT00002588|Topotecan|topotecan|mesh-list
25806460|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806461|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806462|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806463|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806464|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806465|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806466|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25806467|NCT00002589|Aldesleukin|aldesleukin|mesh-list
25806468|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
25806469|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806470|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25806471|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25806472|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
25806473|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806474|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
25806475|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806476|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806477|NCT00002590|Leucovorin|leucovorin|mesh-list
25806478|NCT00002590|Cytarabine|cytarabine|mesh-list
25806479|NCT00002590|Prednisone|prednisone|mesh-list
25806480|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
25806481|NCT00002590|Doxorubicin|doxorubicin|mesh-list
25806482|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806483|NCT00002590|Methotrexate|methotrexate|mesh-list
25806484|NCT00002590|Etoposide|etoposide|mesh-list
25806485|NCT00002590|Vincristine|vincristine|mesh-list
25806486|NCT00002590|Daunorubicin|daunorubicin|mesh-list
25806487|NCT00002590|Asparaginase|asparaginase|mesh-list
24518889|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25806488|NCT00002590|Pegaspargase|pegaspargase|mesh-list
25806489|NCT00002590|Thioguanine|thioguanine|mesh-list
25806490|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
25806491|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806492|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
25806493|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806494|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806495|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806496|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
25806497|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806498|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806499|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806500|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806501|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806502|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806503|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806504|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25806505|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
25806507|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806508|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806509|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806510|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806511|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806512|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806513|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
25806514|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806515|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806516|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806517|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806518|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
25806519|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806520|NCT00002590|Antidotes|antidotes|mesh-ancestor
25806521|NCT00002590|Protective Agents|protective agents|mesh-ancestor
25806522|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
25806523|NCT00002590|Vitamins|vitamins|mesh-ancestor
25806524|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
25806525|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806526|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806527|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806528|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
25806529|NCT00002592|Busulfan|busulfan|mesh-list
25806530|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806531|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
25806532|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806533|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806534|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806535|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
25806536|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806537|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806538|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806539|NCT00002593|Leucovorin|leucovorin|mesh-list
25806540|NCT00002593|Levamisole|levamisole|mesh-list
25806541|NCT00002593|Fluorouracil|fluorouracil|mesh-list
25806542|NCT00002593|Calcium|calcium|mesh-list
25806543|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
25806544|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25806545|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806546|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
25806547|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806548|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806549|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806550|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806551|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
25806552|NCT00002593|Antidotes|antidotes|mesh-ancestor
25806553|NCT00002593|Protective Agents|protective agents|mesh-ancestor
25806554|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
25806555|NCT00002593|Vitamins|vitamins|mesh-ancestor
25806556|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
25806557|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25806558|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
25806559|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
25806560|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25806561|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806562|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806563|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
25806564|NCT00002594|Melphalan|melphalan|mesh-list
25806565|NCT00002594|Molgramostim|molgramostim|mesh-list
25806566|NCT00002594|Sargramostim|sargramostim|mesh-list
25806567|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806568|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
25806569|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796973|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
25806570|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806571|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806572|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
25806573|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806574|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806575|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806576|NCT00002595|Toremifene|toremifene|mesh-list
25806577|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806578|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806579|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25806580|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25806581|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
25806582|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806583|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806584|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25806585|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
25806586|NCT00002596|Cisplatin|cisplatin|mesh-list
25806587|NCT00002596|Carboplatin|carboplatin|mesh-list
25806588|NCT00002596|Etoposide|etoposide|mesh-list
25806589|NCT00002596|Bleomycin|bleomycin|mesh-list
25806590|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806591|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
25806592|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806593|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806594|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806595|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
25806596|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806597|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806598|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806599|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806600|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806601|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806602|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806603|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806604|NCT00002598|Interferons|interferons|mesh-list
25806605|NCT00002598|Cytarabine|cytarabine|mesh-list
25806606|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
25806607|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
25806608|NCT00002598|Methotrexate|methotrexate|mesh-list
25806609|NCT00002598|Etoposide|etoposide|mesh-list
25806610|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
25806611|NCT00002598|Sargramostim|sargramostim|mesh-list
25806612|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806613|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
25806614|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806615|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806616|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806617|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
25806618|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806619|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806620|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806621|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806622|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806623|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806624|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806625|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
25806626|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806627|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806628|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806629|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806630|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806631|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806632|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806633|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
25806634|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806635|NCT00002598|Analgesics|analgesics|mesh-ancestor
25806636|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
25806637|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25806638|NCT00002599|Cobalt|cobalt|mesh-list
25806639|NCT00002599|Interferons|interferons|mesh-list
25806640|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
25806641|NCT00002599|Prednisone|prednisone|mesh-list
25806642|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
25806643|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
25806644|NCT00002599|Melphalan|melphalan|mesh-list
25806645|NCT00002599|Carmustine|carmustine|mesh-list
25806646|NCT00002599|Doxorubicin|doxorubicin|mesh-list
25806647|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806649|NCT00002599|Sargramostim|sargramostim|mesh-list
25806650|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806651|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
25806652|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806653|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806654|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806655|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
25806656|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806657|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806658|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806659|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806660|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806661|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806662|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806663|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25806664|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
25806665|NCT00002599|Hormones|hormones|mesh-ancestor
25806666|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806667|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806668|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
25806669|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806670|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806671|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806672|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806673|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806674|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
25806675|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
25806676|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25806677|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25806678|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25806679|NCT00002599|Protective Agents|protective agents|mesh-ancestor
25806680|NCT00002599|Trace Elements|trace elements|mesh-ancestor
25806681|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
25806682|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
25806683|NCT00002600|Carboplatin|carboplatin|mesh-list
25806684|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806685|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
25806686|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806687|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806688|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806689|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
25806690|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806691|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806692|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806693|NCT00002604|Carmustine|carmustine|mesh-list
25806694|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25806695|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806696|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
25806697|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806698|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806699|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806700|NCT00002608|Tamoxifen|tamoxifen|mesh-list
25806701|NCT00002608|Cisplatin|cisplatin|mesh-list
25806702|NCT00002608|Doxorubicin|doxorubicin|mesh-list
25806703|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806704|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806705|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806706|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806707|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806708|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806709|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806710|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25806711|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
25806712|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806713|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806714|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806715|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25806716|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25806717|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25806718|NCT00002609|Cytarabine|cytarabine|mesh-list
25806719|NCT00002609|Idarubicin|idarubicin|mesh-list
25806720|NCT00002609|Lintuzumab|lintuzumab|mesh-list
24785185|NCT01912677|Labetalol|labetalol|mesh-list
25806721|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806722|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
25806723|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806724|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806725|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
25806726|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806727|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806728|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
25806729|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806730|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806731|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806732|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806733|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806734|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25107309|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863424|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863448|NCT04956302|Bortezomib|bortezomib|mesh-list
24989390|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
25806736|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
25806737|NCT00002610|Carboplatin|carboplatin|mesh-list
25806738|NCT00002610|Doxorubicin|doxorubicin|mesh-list
25806739|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806740|NCT00002610|Etoposide|etoposide|mesh-list
25806741|NCT00002610|Vincristine|vincristine|mesh-list
25806742|NCT00002610|Lenograstim|lenograstim|mesh-list
25806743|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806744|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
25806745|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806746|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806747|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806748|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
25806749|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806750|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806751|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806752|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806753|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806754|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806755|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806756|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806757|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25806758|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806759|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806760|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806761|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25806762|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806763|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25806764|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806765|NCT00002611|Dactinomycin|dactinomycin|mesh-list
25806766|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
25806767|NCT00002611|Doxorubicin|doxorubicin|mesh-list
25806768|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806769|NCT00002611|Etoposide|etoposide|mesh-list
25806770|NCT00002611|Vincristine|vincristine|mesh-list
25806771|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806772|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
25806773|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806774|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806775|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806776|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
25806777|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806778|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806779|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806780|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806781|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806782|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806783|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806784|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806785|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806786|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806787|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806788|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25806789|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806790|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25806791|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806792|NCT00002615|Cisplatin|cisplatin|mesh-list
25806793|NCT00002615|Fluorouracil|fluorouracil|mesh-list
25806794|NCT00002615|Epirubicin|epirubicin|mesh-list
25806795|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806796|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
25806797|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806798|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806799|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806800|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
25806801|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806802|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806803|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806804|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806805|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806806|NCT00002616|Aldesleukin|aldesleukin|mesh-list
25806807|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
25806808|NCT00002616|Thiotepa|thiotepa|mesh-list
25806809|NCT00002616|Carboplatin|carboplatin|mesh-list
25806810|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989434|NCT05261321|Hormones|hormones|mesh-ancestor
25806811|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
25806812|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806813|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806814|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806815|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
25806816|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806817|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806818|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806820|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25806821|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
25806822|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806823|NCT00002618|Leucovorin|leucovorin|mesh-list
25806824|NCT00002618|Cobalt|cobalt|mesh-list
25806825|NCT00002618|Cytarabine|cytarabine|mesh-list
25806826|NCT00002618|Prednisone|prednisone|mesh-list
25806827|NCT00002618|Doxorubicin|doxorubicin|mesh-list
25806828|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806829|NCT00002618|Methotrexate|methotrexate|mesh-list
25806830|NCT00002618|Vincristine|vincristine|mesh-list
25806831|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
25806832|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
25806833|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25806834|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806835|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25806836|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806837|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806838|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806839|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806840|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25806841|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
25806842|NCT00002618|Hormones|hormones|mesh-ancestor
25806843|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806844|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806845|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25806846|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
25806847|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806848|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806849|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
25806850|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
25806851|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25806852|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806853|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
25806854|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806855|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25806856|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
25806857|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806858|NCT00002618|Antidotes|antidotes|mesh-ancestor
25806859|NCT00002618|Protective Agents|protective agents|mesh-ancestor
25806860|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
25806861|NCT00002618|Vitamins|vitamins|mesh-ancestor
25806862|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
25806863|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806864|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806865|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806866|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806867|NCT00002618|Trace Elements|trace elements|mesh-ancestor
25806868|NCT00002619|Carboplatin|carboplatin|mesh-list
25806869|NCT00002619|Thiotepa|thiotepa|mesh-list
25806870|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806871|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
25806872|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806873|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806874|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
25806875|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806876|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806877|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806878|NCT00002620|Cobalt|cobalt|mesh-list
25806879|NCT00002620|Carmustine|carmustine|mesh-list
25806880|NCT00002620|Mitolactol|mitolactol|mesh-list
25806881|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806882|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
25806883|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806884|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806885|NCT00002620|Trace Elements|trace elements|mesh-ancestor
24989457|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25806886|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
25806887|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806888|NCT00002621|Interferons|interferons|mesh-list
25806889|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
25806890|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
25806891|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806892|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
25806893|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25806894|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
25806895|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806896|NCT00002623|Cisplatin|cisplatin|mesh-list
25806897|NCT00002623|Carboplatin|carboplatin|mesh-list
25806898|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806899|NCT00002625|Topotecan|topotecan|mesh-list
25806900|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25806901|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25806902|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806903|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806904|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806905|NCT00002627|Paclitaxel|paclitaxel|mesh-list
25806906|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
25806907|NCT00002627|Carboplatin|carboplatin|mesh-list
25806908|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806909|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806910|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806911|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806912|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806913|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806914|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806915|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
25806916|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806917|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806918|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806919|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
25806920|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806921|NCT00002628|Paclitaxel|paclitaxel|mesh-list
25806922|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
25806923|NCT00002628|Carboplatin|carboplatin|mesh-list
25806924|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806925|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806926|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806927|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806928|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806929|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806930|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806931|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
25806932|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806933|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806934|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806935|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
25806936|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806937|NCT00002630|Cobalt|cobalt|mesh-list
25806938|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
25806939|NCT00002630|Melphalan|melphalan|mesh-list
25806940|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806941|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
25806942|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806943|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806944|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806945|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
25806946|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806947|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806948|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25806949|NCT00002630|Trace Elements|trace elements|mesh-ancestor
25806950|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
25806951|NCT00002631|Cisplatin|cisplatin|mesh-list
25806952|NCT00002631|Fluorouracil|fluorouracil|mesh-list
25806953|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806954|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
25806955|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806956|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25806957|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806958|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
25806959|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806960|NCT00002632|Paclitaxel|paclitaxel|mesh-list
24989500|NCT05143762|Hormones|hormones|mesh-ancestor
24523433|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806961|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25806962|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806963|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
25806964|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
25806965|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
25806966|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806968|NCT00002633|Goserelin|goserelin|mesh-list
25806969|NCT00002633|Flutamide|flutamide|mesh-list
25806970|NCT00002633|Bicalutamide|bicalutamide|mesh-list
25806971|NCT00002633|Nilutamide|nilutamide|mesh-list
25806972|NCT00002633|Buserelin|buserelin|mesh-list
25806973|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25806974|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
25806975|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25806976|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806977|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25806978|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806979|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
25806980|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
25806981|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25806982|NCT00002634|Cobalt|cobalt|mesh-list
25806983|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
25806984|NCT00002634|Cisplatin|cisplatin|mesh-list
25806985|NCT00002634|Doxorubicin|doxorubicin|mesh-list
25806986|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25806987|NCT00002634|Etoposide|etoposide|mesh-list
25806988|NCT00002634|Vincristine|vincristine|mesh-list
25806989|NCT00002634|Antibodies|antibodies|mesh-list
25806990|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25806991|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25806992|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
25806993|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25806994|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25806995|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25806996|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
25806997|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25806998|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25806999|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807000|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807001|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807002|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807003|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807004|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807005|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807006|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807007|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807008|NCT00002634|Trace Elements|trace elements|mesh-ancestor
25807009|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
25807010|NCT00002635|Lenograstim|lenograstim|mesh-list
25807011|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25807012|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
25807013|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807014|NCT00002637|Interferons|interferons|mesh-list
25807015|NCT00002637|Aldesleukin|aldesleukin|mesh-list
25807016|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
25807017|NCT00002637|Vaccines|vaccines|mesh-list
25807018|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807019|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
25807020|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807021|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25807022|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25807023|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
25807024|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807025|NCT00002638|Cytarabine|cytarabine|mesh-list
25807026|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
25807027|NCT00002638|Carmustine|carmustine|mesh-list
25807028|NCT00002638|Etoposide|etoposide|mesh-list
25807029|NCT00002638|Sargramostim|sargramostim|mesh-list
25807030|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807031|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
25807032|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807033|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807034|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807035|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
25807036|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989551|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
24989552|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807037|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807038|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807039|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807040|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807041|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807042|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807043|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807044|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
25807045|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
25807046|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807047|NCT00002639|Suramin|suramin|mesh-list
25807048|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
25807049|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
25807050|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25807051|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807052|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807053|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25807054|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25807055|NCT00002641|Doxorubicin|doxorubicin|mesh-list
25807056|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807057|NCT00002641|Ifosfamide|ifosfamide|mesh-list
25807058|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807059|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807060|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807061|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807062|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807063|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807064|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807065|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
25807066|NCT00002642|Cobalt|cobalt|mesh-list
25807067|NCT00002642|Cisplatin|cisplatin|mesh-list
25807068|NCT00002642|Etoposide|etoposide|mesh-list
25807069|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807070|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807071|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807072|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807073|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807074|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807075|NCT00002642|Trace Elements|trace elements|mesh-ancestor
25807076|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
25807077|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807078|NCT00002643|Cobalt|cobalt|mesh-list
25807079|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
25807080|NCT00002643|Ifosfamide|ifosfamide|mesh-list
25807081|NCT00002643|Doxorubicin|doxorubicin|mesh-list
25807082|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807083|NCT00002643|Etoposide|etoposide|mesh-list
25807084|NCT00002643|Vincristine|vincristine|mesh-list
25807085|NCT00002643|Topotecan|topotecan|mesh-list
25807086|NCT00002643|Amifostine|amifostine|mesh-list
25807087|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807088|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
25807089|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807090|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807091|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807092|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
25807093|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807094|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807095|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807096|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807097|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807098|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807099|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807100|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807101|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807102|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807103|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807104|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25807105|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24785267|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785268|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24785269|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785270|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524433|NCT04922424|Atorvastatin|atorvastatin|mesh-list
24524434|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25807106|NCT00002643|Protective Agents|protective agents|mesh-ancestor
25807107|NCT00002643|Trace Elements|trace elements|mesh-ancestor
25807108|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
25807109|NCT00002644|Tamoxifen|tamoxifen|mesh-list
25807110|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25807112|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807113|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807114|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807115|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807116|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25807117|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25807118|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25807119|NCT00002646|Tamoxifen|tamoxifen|mesh-list
25807120|NCT00002646|Fenretinide|fenretinide|mesh-list
25807121|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25807122|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
25807123|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807124|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807125|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807126|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807127|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25807128|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25807129|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25807130|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25807131|NCT00002646|Protective Agents|protective agents|mesh-ancestor
25807132|NCT00002647|Verteporfin|verteporfin|mesh-list
25807133|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25807134|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807135|NCT00002649|Aldesleukin|aldesleukin|mesh-list
25807136|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
25807137|NCT00002649|Etoposide|etoposide|mesh-list
25807138|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
25807139|NCT00002649|Interleukin-2|interleukin-2|mesh-list
25807140|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807141|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
25807142|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807143|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807144|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807145|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
25807146|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807147|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807148|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807149|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807150|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807151|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807152|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807153|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25807154|NCT00002649|Analgesics|analgesics|mesh-ancestor
25807155|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
25807156|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807157|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25807158|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25807159|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
25807160|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807161|NCT00002650|Folic Acid|folic acid|mesh-list
25807162|NCT00002650|Hematinics|hematinics|mesh-ancestor
25807163|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
25807164|NCT00002650|Vitamins|vitamins|mesh-ancestor
25807165|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
25807166|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807167|NCT00002652|Suramin|suramin|mesh-list
25807168|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
25807169|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
25807170|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25807171|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807172|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807173|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25807174|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25807175|NCT00002653|Prednisone|prednisone|mesh-list
25807176|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
25807177|NCT00002653|Melphalan|melphalan|mesh-list
25807178|NCT00002653|Carmustine|carmustine|mesh-list
25807179|NCT00002653|Doxorubicin|doxorubicin|mesh-list
25807180|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807181|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807182|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
25807183|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807184|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525177|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807185|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807186|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
25807187|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807188|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807189|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807190|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807191|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807192|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807193|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807194|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807195|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
25807196|NCT00002653|Hormones|hormones|mesh-ancestor
25807197|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807198|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807199|NCT00002654|Cobalt|cobalt|mesh-list
25807200|NCT00002654|Cisplatin|cisplatin|mesh-list
25807201|NCT00002654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807202|NCT00002654|Trace Elements|trace elements|mesh-ancestor
25807203|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
25807204|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807205|NCT00002656|NSC 366140|nsc 366140|mesh-list
25807206|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807207|NCT00002657|Interferons|interferons|mesh-list
25807208|NCT00002657|Cytarabine|cytarabine|mesh-list
25807209|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
25807210|NCT00002657|Prednisone|prednisone|mesh-list
25807211|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
25807212|NCT00002657|Doxorubicin|doxorubicin|mesh-list
25807213|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807214|NCT00002657|Methotrexate|methotrexate|mesh-list
25807215|NCT00002657|Etoposide|etoposide|mesh-list
25807216|NCT00002657|Vincristine|vincristine|mesh-list
25807217|NCT00002657|Bleomycin|bleomycin|mesh-list
25807218|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807219|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
25807220|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807221|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807222|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807223|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
25807224|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807225|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807226|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807227|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807228|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807229|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807230|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807231|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807232|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
25807233|NCT00002657|Hormones|hormones|mesh-ancestor
25807234|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807235|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807236|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807237|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807238|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807239|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807240|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
25807241|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807242|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807243|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807244|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807245|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
25807246|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807247|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807248|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807249|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807250|NCT00002658|Cytarabine|cytarabine|mesh-list
25807251|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
25807252|NCT00002658|Etoposide|etoposide|mesh-list
25807253|NCT00002658|Daunorubicin|daunorubicin|mesh-list
25807254|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
25807255|NCT00002658|Idarubicin|idarubicin|mesh-list
25807256|NCT00002658|Tretinoin|tretinoin|mesh-list
25807257|NCT00002658|Thioguanine|thioguanine|mesh-list
25807258|NCT00002658|Amsacrine|amsacrine|mesh-list
25807259|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139496|NCT02970916|Aflibercept|aflibercept|mesh-list
25807260|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
25807261|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807262|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807263|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807264|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
25807265|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807266|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807267|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807268|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807269|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807270|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807271|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807272|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807273|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
25807274|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
25807275|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807276|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807278|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
25807279|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807280|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
25807281|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807282|NCT00002659|Cisplatin|cisplatin|mesh-list
25807283|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807284|NCT00002662|Paclitaxel|paclitaxel|mesh-list
25807285|NCT00002662|Docetaxel|docetaxel|mesh-list
25807286|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807287|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807288|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807289|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807290|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807291|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807292|NCT00002664|Sargramostim|sargramostim|mesh-list
25807293|NCT00002664|Edrecolomab|edrecolomab|mesh-list
25807294|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
25807295|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807296|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25807297|NCT00002665|Leucovorin|leucovorin|mesh-list
25807298|NCT00002665|Cytarabine|cytarabine|mesh-list
25807299|NCT00002665|Dexamethasone|dexamethasone|mesh-list
25807300|NCT00002665|Prednisone|prednisone|mesh-list
25807301|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
25807302|NCT00002665|Doxorubicin|doxorubicin|mesh-list
25807303|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807304|NCT00002665|Methotrexate|methotrexate|mesh-list
25807305|NCT00002665|Etoposide|etoposide|mesh-list
25807306|NCT00002665|Vincristine|vincristine|mesh-list
25807307|NCT00002665|Daunorubicin|daunorubicin|mesh-list
25807308|NCT00002665|Asparaginase|asparaginase|mesh-list
25807309|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
25807310|NCT00002665|Thioguanine|thioguanine|mesh-list
25807311|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
25807312|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807313|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
25807314|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807315|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807316|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807317|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
25807318|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807319|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807320|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807321|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807322|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
25807323|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
25807324|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807325|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807326|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
25807327|NCT00002665|Hormones|hormones|mesh-ancestor
25807328|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807329|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807330|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807331|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24526440|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526441|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989730|NCT04843111|Vaccines|vaccines|mesh-list
24989731|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
24989732|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863740|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24863741|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526443|NCT00611728|Irinotecan|irinotecan|mesh-list
25807332|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807333|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807334|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807335|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807336|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807337|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807338|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
25807339|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807340|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807341|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807342|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807343|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
25807344|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807345|NCT00002665|Antidotes|antidotes|mesh-ancestor
25807346|NCT00002665|Protective Agents|protective agents|mesh-ancestor
25807347|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
25807348|NCT00002665|Vitamins|vitamins|mesh-ancestor
25807349|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
25807350|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807351|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807352|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807353|NCT00002669|Interferons|interferons|mesh-list
25807354|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
25807355|NCT00002669|Aldesleukin|aldesleukin|mesh-list
25807356|NCT00002669|Cisplatin|cisplatin|mesh-list
25807357|NCT00002669|Dacarbazine|dacarbazine|mesh-list
25807358|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807359|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
25807360|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807361|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
25807362|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807363|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25807364|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25807365|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807366|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
25807367|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807369|NCT00002670|Cisplatin|cisplatin|mesh-list
25807370|NCT00002670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807371|NCT00002670|Trace Elements|trace elements|mesh-ancestor
25807372|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
25807373|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807374|NCT00002674|Cytarabine|cytarabine|mesh-list
25807375|NCT00002674|Etoposide|etoposide|mesh-list
25807376|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
25807377|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
25807378|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807379|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807380|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807381|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807382|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807383|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807384|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807385|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
25807386|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
25807387|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807388|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807389|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
25807390|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807391|NCT00002674|Analgesics|analgesics|mesh-ancestor
25807392|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
25807393|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807394|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
25807395|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807396|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
25807397|NCT00002675|Cisplatin|cisplatin|mesh-list
25807398|NCT00002675|Carboplatin|carboplatin|mesh-list
25807399|NCT00002675|Etoposide|etoposide|mesh-list
25807400|NCT00002675|Vincristine|vincristine|mesh-list
25807401|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807402|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
25807403|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807404|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807405|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807406|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
25807407|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526985|NCT00614159|Ketamine|ketamine|mesh-list
24526986|NCT00614159|Propofol|propofol|mesh-list
24527187|NCT00615381|Insulin|insulin|mesh-list
25807408|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807409|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807410|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807411|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807412|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807413|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807414|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807415|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807416|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807417|NCT00002676|Cobalt|cobalt|mesh-list
25807418|NCT00002676|Cytarabine|cytarabine|mesh-list
25807419|NCT00002676|Dexamethasone|dexamethasone|mesh-list
25807420|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
25807421|NCT00002676|Carmustine|carmustine|mesh-list
25807422|NCT00002676|Doxorubicin|doxorubicin|mesh-list
25807423|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807424|NCT00002676|Methotrexate|methotrexate|mesh-list
25807425|NCT00002676|Vincristine|vincristine|mesh-list
25807426|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807427|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
25807428|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807429|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807430|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807431|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
25807432|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807433|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807434|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807435|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807436|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
25807437|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
25807438|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807439|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807440|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
25807441|NCT00002676|Hormones|hormones|mesh-ancestor
25807442|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807443|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807444|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807445|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807446|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807447|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807448|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807449|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807450|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807451|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807452|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
25807453|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807454|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807455|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807456|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
25807457|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807458|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807459|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807460|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807461|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807462|NCT00002676|Trace Elements|trace elements|mesh-ancestor
25807463|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
25807464|NCT00002678|Dexamethasone|dexamethasone|mesh-list
25807465|NCT00002678|Prednisone|prednisone|mesh-list
25807466|NCT00002678|Melphalan|melphalan|mesh-list
25807467|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807468|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
25807469|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
25807470|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807471|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807472|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807473|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
25807474|NCT00002678|Hormones|hormones|mesh-ancestor
25807475|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807476|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807477|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807478|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807479|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
25807480|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807481|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807482|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989834|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
24989835|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25807484|NCT00002679|Tamoxifen|tamoxifen|mesh-list
25807485|NCT00002679|Paclitaxel|paclitaxel|mesh-list
25807486|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
25807487|NCT00002679|Doxorubicin|doxorubicin|mesh-list
25807488|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807489|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807490|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807491|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807492|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807493|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807494|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807495|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807496|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
25807497|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807498|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807499|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807500|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
25807501|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807502|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807503|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807504|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807505|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807506|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25807507|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
25807508|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807509|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807510|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25807511|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25807512|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25807513|NCT00002680|Tamoxifen|tamoxifen|mesh-list
25807514|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
25807515|NCT00002680|Melphalan|melphalan|mesh-list
25807516|NCT00002680|Thiotepa|thiotepa|mesh-list
25807517|NCT00002680|Megestrol|megestrol|mesh-list
25807518|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
25807519|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807520|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
25807521|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807522|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807523|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807524|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
25807525|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807526|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807527|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807528|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25807529|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
25807530|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807531|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807532|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25807533|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25807534|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25807535|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25807536|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25807537|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25807538|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
25807539|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807540|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25807541|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25807542|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
25807543|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25807544|NCT00002681|Aldesleukin|aldesleukin|mesh-list
25807545|NCT00002681|Daclizumab|daclizumab|mesh-list
25807546|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807547|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24527393|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24863846|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863847|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863853|NCT03190174|Sirolimus|sirolimus|mesh-list
24863854|NCT03190174|Nivolumab|nivolumab|mesh-list
24863855|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989890|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
24989891|NCT04620252|Protective Agents|protective agents|mesh-ancestor
25807548|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25807549|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
25807550|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807551|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807552|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
25807553|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807554|NCT00002682|Amoxicillin|amoxicillin|mesh-list
25807555|NCT00002682|Metronidazole|metronidazole|mesh-list
25807556|NCT00002682|Clarithromycin|clarithromycin|mesh-list
25807557|NCT00002682|Tetracycline|tetracycline|mesh-list
25807558|NCT00002682|Omeprazole|omeprazole|mesh-list
25807559|NCT00002682|Bismuth|bismuth|mesh-list
25807560|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25807561|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25807562|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807563|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25807564|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25807565|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25807566|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807567|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25807568|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807569|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807570|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25807571|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25807572|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25807573|NCT00002682|Antacids|antacids|mesh-ancestor
25807574|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
25807575|NCT00002684|Paclitaxel|paclitaxel|mesh-list
25807576|NCT00002684|Cisplatin|cisplatin|mesh-list
25807577|NCT00002684|Ifosfamide|ifosfamide|mesh-list
25807578|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807579|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807580|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807581|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807582|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807583|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807584|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807585|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
25807586|NCT00002687|Aldesleukin|aldesleukin|mesh-list
25807587|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807588|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25807589|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25807590|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
25807591|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807592|NCT00002688|Cyclosporine|cyclosporine|mesh-list
25807593|NCT00002688|Etoposide|etoposide|mesh-list
25807594|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
25807595|NCT00002688|Cyclosporins|cyclosporins|mesh-list
25807596|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807597|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807598|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807599|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807600|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807601|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807602|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807603|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
25807604|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807605|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
25807606|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807607|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807608|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807609|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25807610|NCT00002688|Analgesics|analgesics|mesh-ancestor
25807611|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
25807612|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807613|NCT00002689|Dexamethasone|dexamethasone|mesh-list
25807614|NCT00002689|Fluorouracil|fluorouracil|mesh-list
25807615|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807616|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
25807617|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
25807618|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807619|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807620|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807621|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
24527949|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24527950|NCT00618696|Antibodies|antibodies|mesh-list
24527951|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
24527952|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25139746|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
25807622|NCT00002689|Hormones|hormones|mesh-ancestor
25807623|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807624|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807625|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807626|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
25807627|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807628|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807629|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807630|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
25807631|NCT00002691|Leucovorin|leucovorin|mesh-list
25807632|NCT00002691|Cytarabine|cytarabine|mesh-list
25807633|NCT00002691|Dexamethasone|dexamethasone|mesh-list
25807634|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
25807635|NCT00002691|Methotrexate|methotrexate|mesh-list
25807636|NCT00002691|Etoposide|etoposide|mesh-list
25807637|NCT00002691|Vincristine|vincristine|mesh-list
25807638|NCT00002691|Daunorubicin|daunorubicin|mesh-list
25807639|NCT00002691|Asparaginase|asparaginase|mesh-list
25807640|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
25807641|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807642|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
25807643|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807644|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807645|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807646|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
25807647|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807648|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807649|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807650|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807651|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
25807652|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
25807653|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807654|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807655|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
25807656|NCT00002691|Hormones|hormones|mesh-ancestor
25807657|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807658|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807659|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807660|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807661|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807662|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807663|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
25807664|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807665|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807666|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807667|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807668|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807669|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807670|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807671|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
25807672|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807673|NCT00002691|Antidotes|antidotes|mesh-ancestor
25807674|NCT00002691|Protective Agents|protective agents|mesh-ancestor
25807675|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
25807676|NCT00002691|Vitamins|vitamins|mesh-ancestor
25807677|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
25807678|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807679|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807680|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807681|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807682|NCT00002692|Leucovorin|leucovorin|mesh-list
25807683|NCT00002692|Fluorouracil|fluorouracil|mesh-list
25807684|NCT00002692|Calcium|calcium|mesh-list
25807685|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
25807686|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25807687|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807688|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
25807689|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807690|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807691|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807692|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807693|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
25807694|NCT00002692|Antidotes|antidotes|mesh-ancestor
25807695|NCT00002692|Protective Agents|protective agents|mesh-ancestor
25807696|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
25807697|NCT00002692|Vitamins|vitamins|mesh-ancestor
25807698|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
25807699|NCT00002693|Carboplatin|carboplatin|mesh-list
25807700|NCT00002693|Topotecan|topotecan|mesh-list
25807701|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807702|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25807703|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807704|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807705|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807706|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
25807707|NCT00002696|Doxorubicin|doxorubicin|mesh-list
25807708|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807709|NCT00002696|Fluorouracil|fluorouracil|mesh-list
25807710|NCT00002696|Methotrexate|methotrexate|mesh-list
25807711|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807712|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
25807713|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807714|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807715|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807716|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
25807717|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807718|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807719|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807720|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807721|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807722|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807723|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807724|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
25807725|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807726|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807727|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807728|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807729|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807730|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807731|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807732|NCT00002697|Carboplatin|carboplatin|mesh-list
25807733|NCT00002697|Etoposide|etoposide|mesh-list
25807734|NCT00002697|Ifosfamide|ifosfamide|mesh-list
25807735|NCT00002697|Sargramostim|sargramostim|mesh-list
25807736|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807737|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807738|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807739|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807740|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807741|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807742|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
25807743|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807744|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807745|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
25807746|NCT00002700|Leucovorin|leucovorin|mesh-list
25807747|NCT00002700|Cytarabine|cytarabine|mesh-list
25807748|NCT00002700|Dexamethasone|dexamethasone|mesh-list
25807749|NCT00002700|Prednisone|prednisone|mesh-list
25807750|NCT00002700|Prednisolone|prednisolone|mesh-list
25807751|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
25807752|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25807753|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25807754|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25807755|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
25807756|NCT00002700|Doxorubicin|doxorubicin|mesh-list
25807757|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807758|NCT00002700|Methotrexate|methotrexate|mesh-list
25807759|NCT00002700|Vincristine|vincristine|mesh-list
25807760|NCT00002700|Daunorubicin|daunorubicin|mesh-list
25807761|NCT00002700|Asparaginase|asparaginase|mesh-list
25807762|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
25807763|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
25807764|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
25807765|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807766|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
25807767|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807768|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807769|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807770|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
25807771|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807772|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807773|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807774|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807775|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
25807776|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
25807777|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807778|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807779|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
25807780|NCT00002700|Hormones|hormones|mesh-ancestor
25807781|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807782|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807783|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807784|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807785|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807786|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807787|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807788|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807789|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807790|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807791|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
25807792|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807793|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807794|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807795|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
25807796|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807797|NCT00002700|Antidotes|antidotes|mesh-ancestor
25807798|NCT00002700|Protective Agents|protective agents|mesh-ancestor
25807799|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
25807800|NCT00002700|Vitamins|vitamins|mesh-ancestor
25807801|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
25807802|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807803|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807804|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807805|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807806|NCT00002700|Analgesics|analgesics|mesh-ancestor
25807807|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
25807808|NCT00002701|Cytarabine|cytarabine|mesh-list
25807809|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
25807810|NCT00002701|Busulfan|busulfan|mesh-list
25807811|NCT00002701|Methotrexate|methotrexate|mesh-list
25807812|NCT00002701|Etoposide|etoposide|mesh-list
25807813|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
25807814|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
25807815|NCT00002701|Idarubicin|idarubicin|mesh-list
25807816|NCT00002701|Tretinoin|tretinoin|mesh-list
25807817|NCT00002701|Thioguanine|thioguanine|mesh-list
25807818|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807819|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
25807820|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807821|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807822|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807823|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
25807824|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807825|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807826|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807827|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807828|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807829|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807830|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807831|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
25807832|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807833|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807834|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807835|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807836|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807837|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807838|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807839|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
25807840|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807841|NCT00002701|Analgesics|analgesics|mesh-ancestor
25807842|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
25807843|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807844|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807845|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
25807846|NCT00002702|Aldesleukin|aldesleukin|mesh-list
25807847|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989927|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24989928|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25163035|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24989932|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989933|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
24989934|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807848|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25807849|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25807850|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
25807851|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807852|NCT00002704|Leucovorin|leucovorin|mesh-list
25807853|NCT00002704|Cytarabine|cytarabine|mesh-list
25807854|NCT00002704|Dexamethasone|dexamethasone|mesh-list
25807855|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
25807856|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25807857|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25807858|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25807859|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
25807860|NCT00002704|Thiotepa|thiotepa|mesh-list
25807861|NCT00002704|Methotrexate|methotrexate|mesh-list
25807862|NCT00002704|Etoposide|etoposide|mesh-list
25807863|NCT00002704|Vincristine|vincristine|mesh-list
25807864|NCT00002704|Daunorubicin|daunorubicin|mesh-list
25807865|NCT00002704|Asparaginase|asparaginase|mesh-list
25807866|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
25807867|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
25807868|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807869|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
25807870|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807871|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807872|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807873|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
25807874|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807875|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807876|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807877|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807878|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
25807879|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
25807880|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25807881|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25807882|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
25807883|NCT00002704|Hormones|hormones|mesh-ancestor
25807884|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807885|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807886|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25807887|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
25807888|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25807889|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25807890|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
25807891|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
25807892|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807893|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25807894|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25807895|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807896|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807897|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807898|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
25807899|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25807900|NCT00002704|Antidotes|antidotes|mesh-ancestor
25807901|NCT00002704|Protective Agents|protective agents|mesh-ancestor
25807902|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
25807903|NCT00002704|Vitamins|vitamins|mesh-ancestor
25807904|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
25807905|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807906|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807907|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807908|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807909|NCT00002705|Topotecan|topotecan|mesh-list
25807910|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25807911|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807912|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807913|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807914|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807915|NCT00002707|Tamoxifen|tamoxifen|mesh-list
25807916|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
25807917|NCT00002707|Docetaxel|docetaxel|mesh-list
25807918|NCT00002707|Doxorubicin|doxorubicin|mesh-list
25807919|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25807920|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
25807921|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807922|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25807923|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807924|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
25807925|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807926|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807927|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25807928|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807929|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807930|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807931|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807932|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807933|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807934|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807935|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25807936|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
25807937|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807938|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807939|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25807940|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25807941|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25807942|NCT00002711|Paclitaxel|paclitaxel|mesh-list
25807943|NCT00002711|Cisplatin|cisplatin|mesh-list
25807944|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807945|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807946|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807947|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807948|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807949|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807950|NCT00002714|Prednisone|prednisone|mesh-list
25807951|NCT00002714|Doxorubicin|doxorubicin|mesh-list
25807952|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807953|NCT00002714|Bleomycin|bleomycin|mesh-list
25807954|NCT00002714|Etoposide|etoposide|mesh-list
25807955|NCT00002714|Vincristine|vincristine|mesh-list
25807956|NCT00002714|Vinblastine|vinblastine|mesh-list
25807957|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
25807958|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807959|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807960|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807961|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807962|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807963|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807964|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807965|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
25807966|NCT00002714|Hormones|hormones|mesh-ancestor
25807967|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807968|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807969|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807970|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807971|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807972|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807973|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
25807974|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
25807975|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25807976|NCT00002715|Prednisone|prednisone|mesh-list
25807977|NCT00002715|Doxorubicin|doxorubicin|mesh-list
25807978|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25807979|NCT00002715|Bleomycin|bleomycin|mesh-list
25807980|NCT00002715|Etoposide|etoposide|mesh-list
25807981|NCT00002715|Vincristine|vincristine|mesh-list
25807982|NCT00002715|Vinblastine|vinblastine|mesh-list
25807983|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
25807984|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25807985|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25807986|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25807987|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25807988|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25807989|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807990|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25807991|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
25807992|NCT00002715|Hormones|hormones|mesh-ancestor
25807993|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25807994|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25807995|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25807996|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25807997|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
25807998|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
25807999|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808000|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
24531342|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24531345|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
25808001|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808002|NCT00002716|Leucovorin|leucovorin|mesh-list
25808003|NCT00002716|Dexamethasone|dexamethasone|mesh-list
25808004|NCT00002716|Fluorouracil|fluorouracil|mesh-list
25808005|NCT00002716|Floxuridine|floxuridine|mesh-list
25808006|NCT00002716|Calcium|calcium|mesh-list
25808007|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
25808008|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808009|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
25808010|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
25808011|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808012|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808013|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808014|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
25808015|NCT00002716|Hormones|hormones|mesh-ancestor
25808016|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808017|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808018|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808019|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25808020|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
25808021|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808022|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808023|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808024|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
25808025|NCT00002716|Antidotes|antidotes|mesh-ancestor
25808026|NCT00002716|Protective Agents|protective agents|mesh-ancestor
25808027|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
25808028|NCT00002716|Vitamins|vitamins|mesh-ancestor
25808029|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
25808030|NCT00002717|Paclitaxel|paclitaxel|mesh-list
25808031|NCT00002717|Cisplatin|cisplatin|mesh-list
25808032|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808033|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808034|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808035|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808036|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808037|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808038|NCT00002718|Cytarabine|cytarabine|mesh-list
25808039|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
25808040|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
25808041|NCT00002718|Thiotepa|thiotepa|mesh-list
25808042|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25808043|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808044|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
25808045|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808046|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808047|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808048|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
25808049|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808050|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808051|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808052|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808053|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
25808054|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
25808055|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808056|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808057|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
25808058|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
25808059|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808060|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808061|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
25808062|NCT00002718|Hormones|hormones|mesh-ancestor
25808063|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808064|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25808065|NCT00002718|Protective Agents|protective agents|mesh-ancestor
25808066|NCT00002719|Cytarabine|cytarabine|mesh-list
25808067|NCT00002719|Etoposide|etoposide|mesh-list
25808068|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
25808069|NCT00002719|Idarubicin|idarubicin|mesh-list
25808070|NCT00002719|Carmustine|carmustine|mesh-list
25808071|NCT00002719|Amsacrine|amsacrine|mesh-list
25046708|NCT00836706|Clarithromycin|clarithromycin|mesh-list
24990020|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24990021|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24990022|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24990023|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808072|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808073|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808074|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808075|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808076|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808077|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808078|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808079|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
25808080|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
25808081|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808082|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808083|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
25808084|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808085|NCT00002719|Analgesics|analgesics|mesh-ancestor
25808086|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
25808087|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808088|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808089|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808090|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
25808091|NCT00002720|Tamoxifen|tamoxifen|mesh-list
25808092|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25808093|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
25808094|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808095|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808096|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808097|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808098|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25808099|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25808100|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25808101|NCT00002721|Doxorubicin|doxorubicin|mesh-list
25808102|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808103|NCT00002721|Estramustine|estramustine|mesh-list
25808104|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808105|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808106|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808107|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808108|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808109|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808110|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808111|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
25808112|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808113|NCT00002722|Leucovorin|leucovorin|mesh-list
25808114|NCT00002722|Cisplatin|cisplatin|mesh-list
25808115|NCT00002722|Fluorouracil|fluorouracil|mesh-list
25808116|NCT00002722|Calcium|calcium|mesh-list
25808117|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
25808118|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808119|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25808120|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808121|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
25808122|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808123|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808124|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808125|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
25808126|NCT00002722|Antidotes|antidotes|mesh-ancestor
25808127|NCT00002722|Protective Agents|protective agents|mesh-ancestor
25808128|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
25808129|NCT00002722|Vitamins|vitamins|mesh-ancestor
25808130|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
25808131|NCT00002723|Suramin|suramin|mesh-list
25808132|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
25808133|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
25808134|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25808135|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808136|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808137|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25808138|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25808139|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
25808140|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25808141|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
25808142|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808143|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808144|NCT00002730|Melphalan|melphalan|mesh-list
25808145|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
25808146|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808147|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
25808148|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808149|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472705|NCT00400335|Hormones|hormones|mesh-ancestor
25808150|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808151|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808152|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
25808153|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808154|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
25808155|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808156|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808157|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25808158|NCT00002730|Protective Agents|protective agents|mesh-ancestor
25808159|NCT00002733|Interferons|interferons|mesh-list
25808160|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
25808161|NCT00002733|Aldesleukin|aldesleukin|mesh-list
25808162|NCT00002733|Cimetidine|cimetidine|mesh-list
25808163|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808164|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
25808165|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808166|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
25808167|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808168|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25808169|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25808170|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25808171|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808172|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25808173|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
25808174|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
25808175|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25808176|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808177|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25808178|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25808179|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808180|NCT00002734|Interferons|interferons|mesh-list
25808181|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
25808182|NCT00002734|Paclitaxel|paclitaxel|mesh-list
25808183|NCT00002734|Topotecan|topotecan|mesh-list
25808184|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25808185|NCT00002734|Antibodies|antibodies|mesh-list
25808186|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
25808187|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25808188|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808189|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808190|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808191|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808192|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808193|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808194|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
25808195|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808196|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
25808197|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808198|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25808199|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808200|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808201|NCT00002735|Cobalt|cobalt|mesh-list
25808202|NCT00002735|Cisplatin|cisplatin|mesh-list
25808203|NCT00002735|Fluorouracil|fluorouracil|mesh-list
25808204|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808205|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
25808206|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808207|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808208|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808209|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
25808210|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808211|NCT00002735|Trace Elements|trace elements|mesh-ancestor
25808212|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
25808213|NCT00002737|Interferons|interferons|mesh-list
25808214|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
25808215|NCT00002737|Isotretinoin|isotretinoin|mesh-list
25808216|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808217|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
25808218|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808219|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
25808220|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808221|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808222|NCT00002738|Leucovorin|leucovorin|mesh-list
24785333|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
25808223|NCT00002738|Trimetrexate|trimetrexate|mesh-list
25808224|NCT00002738|Calcium|calcium|mesh-list
25808225|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
25808226|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25808227|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808228|NCT00002738|Antidotes|antidotes|mesh-ancestor
25808229|NCT00002738|Protective Agents|protective agents|mesh-ancestor
25808230|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
25808231|NCT00002738|Vitamins|vitamins|mesh-ancestor
25808232|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
25808233|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
25808234|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808235|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808236|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
25808237|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808238|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808239|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808240|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808241|NCT00002740|Cobalt|cobalt|mesh-list
25808242|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
25808243|NCT00002740|Carboplatin|carboplatin|mesh-list
25808244|NCT00002740|Doxorubicin|doxorubicin|mesh-list
25808245|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808246|NCT00002740|Etoposide|etoposide|mesh-list
25808247|NCT00002740|Vincristine|vincristine|mesh-list
25808248|NCT00002740|Lenograstim|lenograstim|mesh-list
25808249|NCT00002740|Mesna|mesna|mesh-list
25808250|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808251|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
25808252|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808253|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808254|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808255|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
25808256|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808257|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808258|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808259|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808260|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808261|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808262|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808263|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808264|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25808265|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808266|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808267|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808268|NCT00002740|Protective Agents|protective agents|mesh-ancestor
25808269|NCT00002740|Trace Elements|trace elements|mesh-ancestor
25808270|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
25808271|NCT00002742|Amphotericin B|amphotericin b|mesh-list
25808272|NCT00002742|Nystatin|nystatin|mesh-list
25808273|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25808274|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
25808275|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
25808276|NCT00002742|Amebicides|amebicides|mesh-ancestor
25808277|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25808278|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25808279|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808280|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25808281|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
25808282|NCT00002742|Ionophores|ionophores|mesh-ancestor
25808283|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25808284|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808285|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25808286|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808287|NCT00002744|Cobalt|cobalt|mesh-list
25808288|NCT00002744|Cytarabine|cytarabine|mesh-list
25808289|NCT00002744|Dexamethasone|dexamethasone|mesh-list
25808290|NCT00002744|Prednisone|prednisone|mesh-list
25808291|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
25808292|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25808293|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25808294|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25808295|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
25808296|NCT00002744|Doxorubicin|doxorubicin|mesh-list
25808297|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808298|NCT00002744|Methotrexate|methotrexate|mesh-list
25808299|NCT00002744|Vincristine|vincristine|mesh-list
25808300|NCT00002744|Daunorubicin|daunorubicin|mesh-list
25808301|NCT00002744|Asparaginase|asparaginase|mesh-list
25808302|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
25808303|NCT00002744|Pegaspargase|pegaspargase|mesh-list
25808304|NCT00002744|Thioguanine|thioguanine|mesh-list
25808305|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808306|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
25808307|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808308|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808309|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808310|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
25808311|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808312|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808313|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808314|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808315|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
25808316|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
25808317|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808318|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808319|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
25808320|NCT00002744|Hormones|hormones|mesh-ancestor
25808321|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808322|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808323|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808324|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808325|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808326|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808327|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808328|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808329|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808330|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808331|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
25808332|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808333|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808334|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808335|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
25808336|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808337|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808338|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808339|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808340|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808341|NCT00002744|Trace Elements|trace elements|mesh-ancestor
25808342|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
25808343|NCT00002746|Aldesleukin|aldesleukin|mesh-list
25808344|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808345|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25808346|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25808347|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
25808348|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808349|NCT00002747|Cobalt|cobalt|mesh-list
25808350|NCT00002747|Cisplatin|cisplatin|mesh-list
25808351|NCT00002747|Fluorouracil|fluorouracil|mesh-list
25808352|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808353|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
25808354|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808355|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808356|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808357|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
25808358|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808359|NCT00002747|Trace Elements|trace elements|mesh-ancestor
25808360|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
25808361|NCT00002748|Interleukin-2|interleukin-2|mesh-list
25808362|NCT00002748|Vaccines|vaccines|mesh-list
25808363|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808364|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25808365|NCT00002748|Analgesics|analgesics|mesh-ancestor
25808366|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
25808367|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808368|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808369|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
25808370|NCT00002749|Carboplatin|carboplatin|mesh-list
25808371|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808372|NCT00002750|Melphalan|melphalan|mesh-list
25808373|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808374|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
25808375|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808376|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808377|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808378|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808379|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
25808380|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808381|NCT00002751|Antibodies|antibodies|mesh-list
25808382|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25808383|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
25808384|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808385|NCT00002752|Antibodies|antibodies|mesh-list
25808386|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25808387|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
25808388|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808389|NCT00002753|Antibodies|antibodies|mesh-list
25808390|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25808391|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
25808392|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808393|NCT00002754|Antibodies|antibodies|mesh-list
25808394|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25808395|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
25808396|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808397|NCT00002755|Tamoxifen|tamoxifen|mesh-list
25808398|NCT00002755|Cobalt|cobalt|mesh-list
25808399|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
25808400|NCT00002755|Thiotepa|thiotepa|mesh-list
25808401|NCT00002755|Doxorubicin|doxorubicin|mesh-list
25808402|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808403|NCT00002755|Fluorouracil|fluorouracil|mesh-list
25808404|NCT00002755|Methotrexate|methotrexate|mesh-list
25808405|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808406|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
25808407|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808408|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808409|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808410|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
25808411|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808412|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808413|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808414|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808415|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808416|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808417|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808418|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
25808419|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808420|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808421|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808422|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808423|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808424|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808425|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808426|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25808427|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25808428|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808429|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808430|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25808431|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25808432|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25808433|NCT00002755|Trace Elements|trace elements|mesh-ancestor
25808434|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
25808435|NCT00002756|Leucovorin|leucovorin|mesh-list
24531956|NCT00637663|Lamivudine|lamivudine|mesh-list
25808436|NCT00002756|Cytarabine|cytarabine|mesh-list
25808437|NCT00002756|Prednisone|prednisone|mesh-list
25808438|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
25808439|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25808440|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25808441|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25808442|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
25808443|NCT00002756|Methotrexate|methotrexate|mesh-list
25808444|NCT00002756|Etoposide|etoposide|mesh-list
25808445|NCT00002756|Vincristine|vincristine|mesh-list
25808446|NCT00002756|Daunorubicin|daunorubicin|mesh-list
25808447|NCT00002756|Asparaginase|asparaginase|mesh-list
25808448|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
25808449|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
25808450|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808451|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
25808452|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808453|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808454|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808455|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
25808456|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808457|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808458|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808459|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808460|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
25808461|NCT00002756|Hormones|hormones|mesh-ancestor
25808462|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808463|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808464|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808465|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808466|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808467|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808468|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
25808469|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808470|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808471|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808472|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808473|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808474|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808475|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808476|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
25808477|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808478|NCT00002756|Antidotes|antidotes|mesh-ancestor
25808479|NCT00002756|Protective Agents|protective agents|mesh-ancestor
25808480|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
25808481|NCT00002756|Vitamins|vitamins|mesh-ancestor
25808482|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
25808483|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808484|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808485|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808486|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808487|NCT00002757|Cytarabine|cytarabine|mesh-list
25808488|NCT00002757|Prednisone|prednisone|mesh-list
25808489|NCT00002757|Prednisolone|prednisolone|mesh-list
25808490|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
25808491|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25808492|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25808493|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25808494|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
25808495|NCT00002757|Doxorubicin|doxorubicin|mesh-list
25808496|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808497|NCT00002757|Methotrexate|methotrexate|mesh-list
25808498|NCT00002757|Etoposide|etoposide|mesh-list
25808499|NCT00002757|Vincristine|vincristine|mesh-list
25808500|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808501|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
25808502|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808503|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808504|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808505|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
25808506|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808507|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808508|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808509|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808510|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808511|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808512|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808513|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808514|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
25808515|NCT00002757|Hormones|hormones|mesh-ancestor
25808516|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808517|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808518|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808519|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808520|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808521|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808522|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
25808523|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808524|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808525|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808526|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808527|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
25808528|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808529|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808530|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808531|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808532|NCT00002759|Cyclosporine|cyclosporine|mesh-list
25808533|NCT00002759|Irinotecan|irinotecan|mesh-list
25808534|NCT00002759|Phenobarbital|phenobarbital|mesh-list
25808535|NCT00002759|Cyclosporins|cyclosporins|mesh-list
25808536|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25808537|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808538|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808539|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808540|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808541|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808542|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
25808543|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808544|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
25808545|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808546|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808547|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808548|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25808549|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
25808550|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25808551|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25808552|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25808553|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25808554|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25808555|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
25808556|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
25808557|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25808558|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25808559|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25808560|NCT00002760|Ketoconazole|ketoconazole|mesh-list
25808561|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
25808562|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25808563|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25808564|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25808565|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
25808566|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808567|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
25808568|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808569|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25808570|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25808571|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808572|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808573|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25808574|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
25808575|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808576|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808577|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25808578|NCT00002761|Interferons|interferons|mesh-list
25808579|NCT00002761|Cytarabine|cytarabine|mesh-list
25808580|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
25808581|NCT00002761|Cyclosporine|cyclosporine|mesh-list
25808582|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
25808583|NCT00002761|Busulfan|busulfan|mesh-list
25808584|NCT00002761|Idarubicin|idarubicin|mesh-list
25808585|NCT00002761|Cyclosporins|cyclosporins|mesh-list
25808586|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808587|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
25808588|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808589|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808590|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808591|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
25808592|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808593|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808594|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808595|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
25808596|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808597|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808598|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
25808599|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808600|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
25808601|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808602|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25808603|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808604|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808605|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808606|NCT00002763|Interferons|interferons|mesh-list
25808607|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
25808608|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808609|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
25808610|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808611|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
25808612|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808613|NCT00002764|Doxorubicin|doxorubicin|mesh-list
25808614|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808615|NCT00002764|Ifosfamide|ifosfamide|mesh-list
25808616|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808617|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808618|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808619|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808620|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808621|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808622|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808623|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
25808624|NCT00002765|Immunotoxins|immunotoxins|mesh-list
25808625|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
25808626|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808627|NCT00002767|Interferons|interferons|mesh-list
25808628|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
25808629|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
25808630|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808631|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
25808632|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808633|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
25808634|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808635|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25808636|NCT00002768|Cytarabine|cytarabine|mesh-list
25808637|NCT00002768|Methotrexate|methotrexate|mesh-list
25808638|NCT00002768|Etoposide|etoposide|mesh-list
25808639|NCT00002768|Busulfan|busulfan|mesh-list
25808640|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808641|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808642|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808643|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808644|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808645|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
25808646|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808647|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808648|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808649|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808650|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808651|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808652|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
25808653|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808654|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808655|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808656|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808657|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808658|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
25808659|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808660|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
25808661|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808662|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808663|NCT00002771|Interferons|interferons|mesh-list
25808664|NCT00002771|Cytarabine|cytarabine|mesh-list
25808665|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
25808666|NCT00002771|Busulfan|busulfan|mesh-list
25808667|NCT00002771|Idarubicin|idarubicin|mesh-list
25808668|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
25808669|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808670|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
25808671|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808672|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808673|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
25808674|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808675|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808676|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
25808677|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808678|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
25808679|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808680|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808681|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808682|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808683|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808684|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808685|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
25808686|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808688|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
25808689|NCT00002772|Carboplatin|carboplatin|mesh-list
25808690|NCT00002772|Doxorubicin|doxorubicin|mesh-list
25808691|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808692|NCT00002772|Thiotepa|thiotepa|mesh-list
25808693|NCT00002772|Carmustine|carmustine|mesh-list
25808694|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808695|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808696|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808697|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
25808698|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808699|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808700|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808701|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
25808702|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808703|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808704|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808705|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808706|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808707|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25808708|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
25808709|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808710|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808711|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25808712|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25808713|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25808714|NCT00002773|Interferons|interferons|mesh-list
25808715|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
25808716|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
25808717|NCT00002773|Sargramostim|sargramostim|mesh-list
25808718|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808719|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
25808720|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808721|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808722|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808723|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
25808724|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808725|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808726|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808727|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
25808728|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808729|NCT00002774|Cisplatin|cisplatin|mesh-list
25808730|NCT00002774|Fluorouracil|fluorouracil|mesh-list
25808731|NCT00002774|Tirapazamine|tirapazamine|mesh-list
25808732|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808733|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
25808734|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808735|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808736|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808737|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
25808738|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808739|NCT00002775|Docetaxel|docetaxel|mesh-list
25808740|NCT00002775|Estramustine|estramustine|mesh-list
25808741|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808742|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808743|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808744|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808745|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808746|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808747|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
25808748|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808749|NCT00002777|Tamoxifen|tamoxifen|mesh-list
25808750|NCT00002777|Exemestane|exemestane|mesh-list
25808751|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808752|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25808753|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
25808754|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808755|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808756|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808757|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808758|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25808759|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25808760|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25808761|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25808762|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25808763|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808764|NCT00002778|Sargramostim|sargramostim|mesh-list
25808765|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
25808766|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808767|NCT00002779|Fludarabine|fludarabine|mesh-list
25808768|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
25808769|NCT00002779|Octreotide|octreotide|mesh-list
25808770|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808771|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808772|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
25808773|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808774|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808775|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
25808776|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808777|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808778|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808779|NCT00002780|Aldesleukin|aldesleukin|mesh-list
25808780|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
25808781|NCT00002780|Thiotepa|thiotepa|mesh-list
25808782|NCT00002780|Carboplatin|carboplatin|mesh-list
25808783|NCT00002780|Sargramostim|sargramostim|mesh-list
25808784|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808785|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
25808786|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808787|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808788|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808789|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
25808790|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808791|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808792|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808793|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25808794|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25808795|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
25808796|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808797|NCT00002783|Leucovorin|leucovorin|mesh-list
25808798|NCT00002783|Cisplatin|cisplatin|mesh-list
25808799|NCT00002783|Fluorouracil|fluorouracil|mesh-list
25808800|NCT00002783|Floxuridine|floxuridine|mesh-list
25808801|NCT00002783|Calcium|calcium|mesh-list
25808802|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
25808803|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808804|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25808805|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808806|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
25808807|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808808|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808809|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808810|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
25808811|NCT00002783|Antidotes|antidotes|mesh-ancestor
25808812|NCT00002783|Protective Agents|protective agents|mesh-ancestor
25808813|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
25808814|NCT00002783|Vitamins|vitamins|mesh-ancestor
25808815|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
25808816|NCT00002784|Tamoxifen|tamoxifen|mesh-list
25808817|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
25808818|NCT00002784|Doxorubicin|doxorubicin|mesh-list
25808819|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25808820|NCT00002784|Fluorouracil|fluorouracil|mesh-list
25808821|NCT00002784|Methotrexate|methotrexate|mesh-list
25808822|NCT00002784|Epirubicin|epirubicin|mesh-list
25808823|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808824|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
25808825|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808826|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808827|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808828|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
25808829|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808830|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808831|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808832|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808833|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808834|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808835|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808836|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
25808837|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808838|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808839|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808840|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808841|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808842|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808843|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808844|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25808845|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
25808846|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808847|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808848|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25808849|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25808850|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25808851|NCT00002785|Leucovorin|leucovorin|mesh-list
25808852|NCT00002785|Cobalt|cobalt|mesh-list
25808853|NCT00002785|Cytarabine|cytarabine|mesh-list
25808854|NCT00002785|Cyclosporine|cyclosporine|mesh-list
25808855|NCT00002785|Dexamethasone|dexamethasone|mesh-list
25808856|NCT00002785|Prednisone|prednisone|mesh-list
25808857|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
25808858|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
25808859|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25808860|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25808861|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25808862|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
25808863|NCT00002785|Methotrexate|methotrexate|mesh-list
25808864|NCT00002785|Etoposide|etoposide|mesh-list
25808865|NCT00002785|Vincristine|vincristine|mesh-list
25808866|NCT00002785|Daunorubicin|daunorubicin|mesh-list
25808867|NCT00002785|Asparaginase|asparaginase|mesh-list
25808868|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
25808869|NCT00002785|Pegaspargase|pegaspargase|mesh-list
25808870|NCT00002785|Cyclosporins|cyclosporins|mesh-list
25808871|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
25808872|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808873|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
25808874|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808875|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808876|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808877|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
25808878|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808879|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808880|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808881|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808882|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
25808883|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
25808884|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808885|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808886|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
25808887|NCT00002785|Hormones|hormones|mesh-ancestor
25808888|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808889|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808890|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808891|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808892|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808893|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808894|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
25808895|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808896|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808897|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808898|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808899|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808900|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808901|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808902|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
25808903|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808904|NCT00002785|Antidotes|antidotes|mesh-ancestor
25808905|NCT00002785|Protective Agents|protective agents|mesh-ancestor
25808906|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
25808907|NCT00002785|Vitamins|vitamins|mesh-ancestor
25808908|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
25808909|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
25808910|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
25808911|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
25808912|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
25808913|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25808914|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25808915|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25808916|NCT00002785|Trace Elements|trace elements|mesh-ancestor
25808917|NCT00002786|Aldesleukin|aldesleukin|mesh-list
25808918|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808919|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25808920|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25808921|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
25808922|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808923|NCT00002787|Aldesleukin|aldesleukin|mesh-list
25808924|NCT00002787|Interleukin-2|interleukin-2|mesh-list
25808925|NCT00002787|Vaccines|vaccines|mesh-list
25808926|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
25808927|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25808928|NCT00002787|Antibodies|antibodies|mesh-list
25808929|NCT00002787|Sargramostim|sargramostim|mesh-list
25808930|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25808931|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25808932|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
25808933|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808934|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808935|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25808936|NCT00002787|Analgesics|analgesics|mesh-ancestor
25808937|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
25808938|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808939|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25808940|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25808941|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
25808942|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808943|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25808944|NCT00002788|Dexamethasone|dexamethasone|mesh-list
25808945|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
25808946|NCT00002788|Etoposide|etoposide|mesh-list
25808947|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808948|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
25808949|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808950|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808951|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808952|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
25808953|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808954|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808955|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808956|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25808957|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
25808958|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
25808959|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25808960|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25808961|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
25808962|NCT00002788|Hormones|hormones|mesh-ancestor
25808963|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25808964|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25808965|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25808966|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25808967|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25808968|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808969|NCT00002789|Cyclosporine|cyclosporine|mesh-list
25808970|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
25808971|NCT00002789|Busulfan|busulfan|mesh-list
25808972|NCT00002789|Methotrexate|methotrexate|mesh-list
25808973|NCT00002789|Cyclosporins|cyclosporins|mesh-list
25808974|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25808975|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
25808976|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25808977|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25808978|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25808979|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
25808980|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25808981|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25808982|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25808983|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25808984|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
25808985|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25808986|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25808988|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
25808989|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25808990|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25808991|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25808992|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
25808993|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25808994|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25808995|NCT00002790|Cyclosporine|cyclosporine|mesh-list
25808996|NCT00002790|Sirolimus|sirolimus|mesh-list
25808997|NCT00002790|Methotrexate|methotrexate|mesh-list
25808998|NCT00002790|Cyclosporins|cyclosporins|mesh-list
25808999|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809000|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809001|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809002|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809003|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809004|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
25809005|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809006|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809007|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809008|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809009|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809010|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809011|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
25809012|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809013|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809014|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
25809015|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809016|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25809017|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25809018|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809019|NCT00002791|Doxorubicin|doxorubicin|mesh-list
25809020|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809021|NCT00002791|Ifosfamide|ifosfamide|mesh-list
25809022|NCT00002791|Dacarbazine|dacarbazine|mesh-list
25809023|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809024|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809025|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809026|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809027|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809028|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809029|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809030|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
25809031|NCT00002792|Cyclosporine|cyclosporine|mesh-list
25809032|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
25809033|NCT00002792|Busulfan|busulfan|mesh-list
25809034|NCT00002792|Methotrexate|methotrexate|mesh-list
25809035|NCT00002792|Tacrolimus|tacrolimus|mesh-list
25809036|NCT00002792|Cyclosporins|cyclosporins|mesh-list
25809037|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809038|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
25809039|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809040|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809041|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809042|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
25809043|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809044|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809045|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809046|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809047|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809048|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809049|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809050|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
24990583|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
25809051|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809052|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809053|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809054|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809055|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25809056|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
25809057|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809059|NCT00002793|Fluorouracil|fluorouracil|mesh-list
25809060|NCT00002793|Calcium|calcium|mesh-list
25809061|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
25809062|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25809063|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809064|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
25809065|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809066|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809067|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809068|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809069|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
25809070|NCT00002793|Antidotes|antidotes|mesh-ancestor
25809071|NCT00002793|Protective Agents|protective agents|mesh-ancestor
25809072|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
25809073|NCT00002793|Vitamins|vitamins|mesh-ancestor
25809074|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
25809075|NCT00002794|Carboplatin|carboplatin|mesh-list
25809076|NCT00002794|Vincristine|vincristine|mesh-list
25809077|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809078|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809079|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809080|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809081|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809082|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809083|NCT00002796|Interferons|interferons|mesh-list
25809084|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
25809085|NCT00002796|Indomethacin|indomethacin|mesh-list
25809086|NCT00002796|Fluorouracil|fluorouracil|mesh-list
25809087|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25809088|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
25809089|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809090|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809091|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809092|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809093|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
25809094|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809095|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
25809096|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809097|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25809098|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25809099|NCT00002796|Analgesics|analgesics|mesh-ancestor
25809100|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
25809101|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809102|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809103|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809104|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
25809105|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
25809106|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809107|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25809108|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809109|NCT00002798|Cytarabine|cytarabine|mesh-list
25809110|NCT00002798|Aldesleukin|aldesleukin|mesh-list
25809111|NCT00002798|Dexamethasone|dexamethasone|mesh-list
25809112|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
25809113|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25809114|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25809115|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25809116|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
25809117|NCT00002798|Busulfan|busulfan|mesh-list
25809118|NCT00002798|Methotrexate|methotrexate|mesh-list
25809119|NCT00002798|Fludarabine|fludarabine|mesh-list
25809120|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
25809121|NCT00002798|Etoposide|etoposide|mesh-list
25809122|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
25809123|NCT00002798|Daunorubicin|daunorubicin|mesh-list
25809124|NCT00002798|Interleukin-2|interleukin-2|mesh-list
25809125|NCT00002798|Asparaginase|asparaginase|mesh-list
25809126|NCT00002798|Idarubicin|idarubicin|mesh-list
24577564|NCT00844727|Rofecoxib|rofecoxib|mesh-list
25809127|NCT00002798|Thioguanine|thioguanine|mesh-list
25809128|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809129|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
25809130|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809131|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809132|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809133|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
25809134|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809135|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809136|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809137|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809138|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
25809139|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
25809140|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809141|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25809142|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
25809143|NCT00002798|Hormones|hormones|mesh-ancestor
25809144|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809145|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809146|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809147|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809148|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809149|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809150|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
25809151|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809152|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809153|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809154|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809155|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809156|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809157|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809158|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
25809159|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809160|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809161|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25809162|NCT00002798|Analgesics|analgesics|mesh-ancestor
25809163|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
25809164|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25809165|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25809166|NCT00002800|Cytarabine|cytarabine|mesh-list
25809167|NCT00002800|Etoposide|etoposide|mesh-list
25809168|NCT00002800|Idarubicin|idarubicin|mesh-list
25809169|NCT00002800|Lintuzumab|lintuzumab|mesh-list
25809170|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809171|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809172|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809173|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809174|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809175|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809176|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809177|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
25809178|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
25809179|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809180|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809181|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
25809182|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809183|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809184|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25809185|NCT00002801|Leucovorin|leucovorin|mesh-list
25809186|NCT00002801|Tegafur|tegafur|mesh-list
25809187|NCT00002801|Calcium|calcium|mesh-list
25809188|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
25809189|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25809190|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809191|NCT00002801|Antidotes|antidotes|mesh-ancestor
25809192|NCT00002801|Protective Agents|protective agents|mesh-ancestor
25809193|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
25809194|NCT00002801|Vitamins|vitamins|mesh-ancestor
25809195|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
25809196|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809197|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
25809198|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809199|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809200|NCT00002802|Cobalt|cobalt|mesh-list
24990795|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24990796|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24864701|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
25809201|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
25809202|NCT00002802|Melphalan|melphalan|mesh-list
25809203|NCT00002802|Ifosfamide|ifosfamide|mesh-list
25809204|NCT00002802|Dacarbazine|dacarbazine|mesh-list
25809205|NCT00002802|Carboplatin|carboplatin|mesh-list
25809206|NCT00002802|Doxorubicin|doxorubicin|mesh-list
25809207|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809208|NCT00002802|Etoposide|etoposide|mesh-list
25809209|NCT00002802|Vincristine|vincristine|mesh-list
25809210|NCT00002802|Vindesine|vindesine|mesh-list
25809211|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809212|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
25809213|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809214|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809215|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809216|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
25809217|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809218|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809219|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809220|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809221|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809222|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809223|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809224|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809225|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809226|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809227|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809228|NCT00002802|Trace Elements|trace elements|mesh-ancestor
25809229|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
25809230|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
25809231|NCT00002803|Doxorubicin|doxorubicin|mesh-list
25809232|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809233|NCT00002803|Vincristine|vincristine|mesh-list
25809234|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809235|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
25809236|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809237|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809238|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809239|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
25809240|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809241|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809242|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809243|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809244|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809245|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809246|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809247|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809248|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809249|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809250|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809251|NCT00002804|Cobalt|cobalt|mesh-list
25809252|NCT00002804|Doxorubicin|doxorubicin|mesh-list
25809253|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809254|NCT00002804|Vincristine|vincristine|mesh-list
25809255|NCT00002804|Ifosfamide|ifosfamide|mesh-list
25809256|NCT00002804|Lenograstim|lenograstim|mesh-list
25809257|NCT00002804|Mesna|mesna|mesh-list
25809258|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809259|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809260|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809261|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809262|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809263|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809264|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25809265|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
25809266|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809267|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809268|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809269|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809270|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809271|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809272|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
25809273|NCT00002804|Protective Agents|protective agents|mesh-ancestor
25809274|NCT00002804|Trace Elements|trace elements|mesh-ancestor
25809275|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
25809276|NCT00002805|Cobalt|cobalt|mesh-list
25809277|NCT00002805|Cytarabine|cytarabine|mesh-list
25809278|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
25809279|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25809280|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25809281|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25809282|NCT00002805|Methotrexate|methotrexate|mesh-list
25809283|NCT00002805|Etoposide|etoposide|mesh-list
25809284|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
25809285|NCT00002805|Cladribine|cladribine|mesh-list
25809286|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809287|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809288|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809289|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809290|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809291|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
25809292|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809293|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809294|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809295|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809296|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809297|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809298|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
25809299|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809300|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809301|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809302|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809303|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809304|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
25809305|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809306|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809307|NCT00002805|Analgesics|analgesics|mesh-ancestor
25809308|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
25809309|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809310|NCT00002805|Trace Elements|trace elements|mesh-ancestor
25809311|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
25809312|NCT00002806|Vincristine|vincristine|mesh-list
25809313|NCT00002806|Lomustine|lomustine|mesh-list
25809314|NCT00002806|Procarbazine|procarbazine|mesh-list
25809315|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809316|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809317|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809318|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809319|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809320|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809321|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809322|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
25809323|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
25809324|NCT00002809|Methotrexate|methotrexate|mesh-list
25809325|NCT00002809|Tacrolimus|tacrolimus|mesh-list
25809326|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25809327|NCT00002809|Sargramostim|sargramostim|mesh-list
25809328|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
25809329|NCT00002809|Antibodies|antibodies|mesh-list
25809330|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
25809331|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25809332|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25809333|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809334|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
25809335|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809336|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809337|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809338|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
25809339|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809340|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809341|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809342|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809343|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809344|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809345|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809346|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
25809347|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809348|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809349|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809350|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809351|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25809352|NCT00002810|Melphalan|melphalan|mesh-list
25809353|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
24990902|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24990904|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990905|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
24990907|NCT03626376|Valacyclovir|valacyclovir|mesh-list
25809354|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809355|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809356|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
25809357|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809358|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809359|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809360|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809361|NCT00002812|Cytarabine|cytarabine|mesh-list
25809362|NCT00002812|Dexamethasone|dexamethasone|mesh-list
25809363|NCT00002812|Prednisone|prednisone|mesh-list
25809364|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
25809365|NCT00002812|Doxorubicin|doxorubicin|mesh-list
25809366|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809367|NCT00002812|Methotrexate|methotrexate|mesh-list
25809368|NCT00002812|Vincristine|vincristine|mesh-list
25809369|NCT00002812|Daunorubicin|daunorubicin|mesh-list
25809370|NCT00002812|Asparaginase|asparaginase|mesh-list
25809371|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
25809372|NCT00002812|Idarubicin|idarubicin|mesh-list
25809373|NCT00002812|Pegaspargase|pegaspargase|mesh-list
25809374|NCT00002812|Thioguanine|thioguanine|mesh-list
25809375|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809376|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
25809377|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809378|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809379|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809380|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
25809381|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809382|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809383|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809384|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809385|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
25809386|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
25809387|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809388|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25809389|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
25809390|NCT00002812|Hormones|hormones|mesh-ancestor
25809391|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809392|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809393|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809394|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809395|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809396|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809397|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809398|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809399|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809400|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809401|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
25809402|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809403|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809404|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809405|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
25809406|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809407|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809408|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809409|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809410|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809411|NCT00002813|Cisplatin|cisplatin|mesh-list
25809412|NCT00002813|Vinorelbine|vinorelbine|mesh-list
25809413|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809414|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809415|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809416|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809417|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809418|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809419|NCT00002814|Paclitaxel|paclitaxel|mesh-list
25809420|NCT00002814|Topotecan|topotecan|mesh-list
25809421|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809422|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809423|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809424|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809425|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809426|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809427|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25809428|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809429|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809430|NCT00002816|Leucovorin|leucovorin|mesh-list
25809431|NCT00002816|Cobalt|cobalt|mesh-list
25809432|NCT00002816|Cytarabine|cytarabine|mesh-list
25809433|NCT00002816|Dexamethasone|dexamethasone|mesh-list
25809434|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
25809435|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25809436|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25809437|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25809438|NCT00002816|Methotrexate|methotrexate|mesh-list
25809439|NCT00002816|Etoposide|etoposide|mesh-list
25809440|NCT00002816|Vincristine|vincristine|mesh-list
25809441|NCT00002816|Ifosfamide|ifosfamide|mesh-list
25809442|NCT00002816|Asparaginase|asparaginase|mesh-list
25809443|NCT00002816|Idarubicin|idarubicin|mesh-list
25809444|NCT00002816|Pegaspargase|pegaspargase|mesh-list
25809445|NCT00002816|Thioguanine|thioguanine|mesh-list
25809446|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
25809447|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809448|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
25809449|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
25809450|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809451|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809452|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25809453|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
25809454|NCT00002816|Hormones|hormones|mesh-ancestor
25809455|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809456|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809457|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809458|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809459|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809460|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809461|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809462|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
25809463|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809464|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809465|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809466|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809467|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809468|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
25809469|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809470|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809471|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809472|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809473|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809474|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
25809475|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809476|NCT00002816|Antidotes|antidotes|mesh-ancestor
25809477|NCT00002816|Protective Agents|protective agents|mesh-ancestor
25809478|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
25809479|NCT00002816|Vitamins|vitamins|mesh-ancestor
25809480|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
25809481|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809482|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809483|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809484|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809485|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
25809486|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809487|NCT00002816|Trace Elements|trace elements|mesh-ancestor
25809488|NCT00002817|Sargramostim|sargramostim|mesh-list
25809489|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
25809490|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809491|NCT00002818|Cytarabine|cytarabine|mesh-list
25809492|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809493|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
25809494|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809495|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809496|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
25809497|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809498|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809499|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
25809500|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809501|NCT00002819|Paclitaxel|paclitaxel|mesh-list
25809502|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
25809503|NCT00002819|Carboplatin|carboplatin|mesh-list
25141304|NCT02958566|Analgesics|analgesics|mesh-ancestor
25809504|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
25809505|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809506|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809507|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809508|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809509|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809510|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809511|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809512|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
25809513|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809514|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809515|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809516|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
25809517|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809518|NCT00002819|Analgesics|analgesics|mesh-ancestor
25809519|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
25809520|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809521|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809522|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809523|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809524|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
25809525|NCT00002822|Ifosfamide|ifosfamide|mesh-list
25809526|NCT00002822|Cisplatin|cisplatin|mesh-list
25809527|NCT00002822|Carboplatin|carboplatin|mesh-list
25809528|NCT00002822|Doxorubicin|doxorubicin|mesh-list
25809529|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809530|NCT00002822|Etoposide|etoposide|mesh-list
25809531|NCT00002822|Vincristine|vincristine|mesh-list
25809532|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809533|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
25809534|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809535|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809536|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809537|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
25809538|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809539|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809540|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809541|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809542|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809543|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809544|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809545|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809546|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809547|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809548|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809549|NCT00002823|Cisplatin|cisplatin|mesh-list
25809550|NCT00002823|Etoposide|etoposide|mesh-list
25809551|NCT00002823|Vinorelbine|vinorelbine|mesh-list
25809552|NCT00002823|Vinblastine|vinblastine|mesh-list
25809553|NCT00002823|Vindesine|vindesine|mesh-list
25809554|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809555|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809556|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809557|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809558|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809559|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809560|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809561|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809562|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809563|NCT00002824|Ganciclovir|ganciclovir|mesh-list
25809564|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25809565|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
25809566|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809567|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809568|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809569|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809570|NCT00002825|Docetaxel|docetaxel|mesh-list
25809571|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809572|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809573|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809574|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809575|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809576|NCT00002826|Paclitaxel|paclitaxel|mesh-list
25809577|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809578|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809579|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809580|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809581|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809582|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809583|NCT00002827|Cobalt|cobalt|mesh-list
25809584|NCT00002827|Doxorubicin|doxorubicin|mesh-list
25809585|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809586|NCT00002827|Bleomycin|bleomycin|mesh-list
25809587|NCT00002827|Etoposide|etoposide|mesh-list
25809588|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
25809589|NCT00002827|Vincristine|vincristine|mesh-list
25809590|NCT00002827|Razoxane|razoxane|mesh-list
25809591|NCT00002827|Lenograstim|lenograstim|mesh-list
25809592|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809593|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809594|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809595|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809596|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809597|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809598|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809599|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25809600|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
25809601|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809602|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809603|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809604|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809605|NCT00002827|Trace Elements|trace elements|mesh-ancestor
25809606|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
25809607|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25809608|NCT00002827|Protective Agents|protective agents|mesh-ancestor
25809609|NCT00002828|Fluorouracil|fluorouracil|mesh-list
25809610|NCT00002828|Raltitrexed|raltitrexed|mesh-list
25809611|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
25809612|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809613|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809614|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809615|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809616|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
25809617|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809618|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809619|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809620|NCT00002829|Interferons|interferons|mesh-list
25809621|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
25809622|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
25809623|NCT00002829|Etoposide|etoposide|mesh-list
25809624|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809625|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
25809626|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809627|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809628|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809629|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
25809630|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809631|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809632|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809633|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809634|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809635|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809636|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809637|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
25809638|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809639|NCT00002831|Cyclosporine|cyclosporine|mesh-list
25809640|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
25809641|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25809642|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25809643|NCT00002831|Prednisolone|prednisolone|mesh-list
25809644|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
25809645|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
25809646|NCT00002831|Busulfan|busulfan|mesh-list
25809647|NCT00002831|Methotrexate|methotrexate|mesh-list
25809648|NCT00002831|Decitabine|decitabine|mesh-list
25809649|NCT00002831|Tacrolimus|tacrolimus|mesh-list
25809650|NCT00002831|Cyclosporins|cyclosporins|mesh-list
25809651|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25809652|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
25809653|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809654|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
25809655|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809656|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809657|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809658|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
25809659|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809660|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809661|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809662|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809663|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809664|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809665|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809666|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
25809667|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809668|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809669|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809670|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809671|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25809672|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
25809673|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809674|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809675|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
25809676|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
25809677|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809678|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25809679|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
25809680|NCT00002831|Hormones|hormones|mesh-ancestor
25809681|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809682|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25809683|NCT00002831|Protective Agents|protective agents|mesh-ancestor
25809684|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809685|NCT00002832|Cyclosporine|cyclosporine|mesh-list
25809686|NCT00002832|Decitabine|decitabine|mesh-list
25809687|NCT00002832|Cyclosporins|cyclosporins|mesh-list
25809688|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
25809689|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809690|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809691|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809692|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809693|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
25809694|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809695|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809696|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809697|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25809698|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809699|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
25809700|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809701|NCT00002833|Cytarabine|cytarabine|mesh-list
25809702|NCT00002833|Cyclosporine|cyclosporine|mesh-list
25809703|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
25809704|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25809705|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25809706|NCT00002833|Prednisolone|prednisolone|mesh-list
25809707|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
25809708|NCT00002833|Fludarabine|fludarabine|mesh-list
25809709|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
25809710|NCT00002833|Idarubicin|idarubicin|mesh-list
25809711|NCT00002833|Cladribine|cladribine|mesh-list
25809712|NCT00002833|Cyclosporins|cyclosporins|mesh-list
25809713|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25809714|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
25809715|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809716|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809717|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
25809718|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809719|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809720|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
25809721|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809722|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
25809723|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809724|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809725|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
25809726|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809727|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809728|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25809729|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809730|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
25809731|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
25809732|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809733|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25809734|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
25809735|NCT00002833|Hormones|hormones|mesh-ancestor
25809736|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809737|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25809738|NCT00002833|Protective Agents|protective agents|mesh-ancestor
25809739|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809740|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809741|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809742|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809743|NCT00002835|Leucovorin|leucovorin|mesh-list
25809744|NCT00002835|Interferons|interferons|mesh-list
25809745|NCT00002835|Cytarabine|cytarabine|mesh-list
25809746|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
25809747|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
25809748|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25809749|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25809750|NCT00002835|Prednisolone|prednisolone|mesh-list
25809751|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
25809752|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
25809753|NCT00002835|Melphalan|melphalan|mesh-list
25809754|NCT00002835|Ifosfamide|ifosfamide|mesh-list
25809755|NCT00002835|Carmustine|carmustine|mesh-list
25809756|NCT00002835|Cisplatin|cisplatin|mesh-list
25809757|NCT00002835|Methotrexate|methotrexate|mesh-list
25809758|NCT00002835|Etoposide|etoposide|mesh-list
25809759|NCT00002835|Vincristine|vincristine|mesh-list
25809760|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
25809761|NCT00002835|Idarubicin|idarubicin|mesh-list
25809762|NCT00002835|Bleomycin|bleomycin|mesh-list
25809763|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
25809764|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25809765|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
25809766|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809767|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
25809768|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809769|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809770|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809771|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
25809772|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809773|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809774|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809775|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25809776|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
25809777|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25809778|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809779|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
25809780|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
25809781|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809782|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25809783|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25809784|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809785|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809786|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809787|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
25809788|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809789|NCT00002835|Antidotes|antidotes|mesh-ancestor
25809790|NCT00002835|Protective Agents|protective agents|mesh-ancestor
25809791|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
25809792|NCT00002835|Vitamins|vitamins|mesh-ancestor
25809793|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
25809794|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809795|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809796|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809797|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809798|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
25809799|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
25809800|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809801|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25809802|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
25809803|NCT00002835|Hormones|hormones|mesh-ancestor
25809804|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809805|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25809806|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809807|NCT00002835|Analgesics|analgesics|mesh-ancestor
25809808|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
25809809|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809810|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
25809811|NCT00002836|Thiotepa|thiotepa|mesh-list
25809812|NCT00002836|Carmustine|carmustine|mesh-list
25809813|NCT00002836|Cisplatin|cisplatin|mesh-list
25809814|NCT00002836|Etoposide|etoposide|mesh-list
25809815|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809816|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
25809817|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809818|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809819|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809820|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
25809821|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809822|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809823|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809824|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809825|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809826|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809827|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809829|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
25809830|NCT00002837|Doxorubicin|doxorubicin|mesh-list
25809831|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809832|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809833|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809834|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809835|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809836|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809837|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809838|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809839|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
25809840|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809841|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809842|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809843|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
25809844|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809845|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809846|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809847|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809848|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809849|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
25809850|NCT00002838|Fludarabine|fludarabine|mesh-list
25809851|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
25809852|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809853|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
25809854|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809855|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809856|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809857|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
25809858|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809859|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809860|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809861|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809862|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
25809863|NCT00002839|Cisplatin|cisplatin|mesh-list
25809864|NCT00002839|Fluorouracil|fluorouracil|mesh-list
25809865|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809866|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
25809867|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809868|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25809869|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809870|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
25809871|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809872|NCT00002840|Vincristine|vincristine|mesh-list
25809873|NCT00002840|Lomustine|lomustine|mesh-list
25809874|NCT00002840|Procarbazine|procarbazine|mesh-list
25809875|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809876|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809877|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809878|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809879|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809880|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809881|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809882|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
25809883|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
25809884|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809885|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
25809886|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809887|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809888|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809889|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
25809890|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809891|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809892|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809893|NCT00002845|Aldesleukin|aldesleukin|mesh-list
25809894|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809895|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25809896|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25809897|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
25809898|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809900|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809901|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25809902|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25809903|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
25809904|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809905|NCT00002847|Interferons|interferons|mesh-list
25809906|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
25809907|NCT00002847|Aldesleukin|aldesleukin|mesh-list
25809908|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809909|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
25809910|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809911|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
25809912|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809913|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25809914|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25809915|NCT00002849|Interferons|interferons|mesh-list
25809916|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
25809917|NCT00002849|Dexamethasone|dexamethasone|mesh-list
25809918|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809919|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
25809920|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
25809921|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25809922|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809923|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25809924|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
25809925|NCT00002849|Hormones|hormones|mesh-ancestor
25809926|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809927|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809928|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809929|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
25809930|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809931|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
25809932|NCT00002852|Paclitaxel|paclitaxel|mesh-list
25809933|NCT00002852|Carboplatin|carboplatin|mesh-list
25809934|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809935|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809936|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809937|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809938|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809939|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809940|NCT00002854|Paclitaxel|paclitaxel|mesh-list
25809941|NCT00002854|Etoposide|etoposide|mesh-list
25809942|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
25809943|NCT00002854|Cisplatin|cisplatin|mesh-list
25809944|NCT00002854|Carboplatin|carboplatin|mesh-list
25809945|NCT00002854|Ifosfamide|ifosfamide|mesh-list
25809946|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809947|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809948|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809949|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809950|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809951|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809952|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25809953|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
25809954|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809955|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25809956|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809957|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
25809958|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25809959|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809960|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809961|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809962|NCT00002855|Ketoconazole|ketoconazole|mesh-list
25809963|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
25809964|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25809965|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25809966|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25809967|NCT00002855|Doxorubicin|doxorubicin|mesh-list
25809968|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25809969|NCT00002855|Bicalutamide|bicalutamide|mesh-list
25809970|NCT00002855|Vinblastine|vinblastine|mesh-list
25809971|NCT00002855|Flutamide|flutamide|mesh-list
25809972|NCT00002855|Estramustine|estramustine|mesh-list
25809973|NCT00002855|Nilutamide|nilutamide|mesh-list
25809974|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25809975|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25809976|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25809977|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25809978|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25809979|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25809980|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25809981|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
25809982|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25809983|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25809984|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25809985|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25809986|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
25809987|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25809988|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25809989|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25809990|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
25809991|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25809992|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
25809993|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
25809994|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
25809995|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25809996|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25809997|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
25809998|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
25809999|NCT00002858|Cisplatin|cisplatin|mesh-list
25810000|NCT00002858|Doxorubicin|doxorubicin|mesh-list
25810001|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25810002|NCT00002858|Etoposide|etoposide|mesh-list
25810003|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810004|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
25810005|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810006|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810007|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810008|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
25810009|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810010|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810011|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810012|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810013|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810014|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810015|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810016|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810017|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
25810018|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810019|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810020|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810021|NCT00002864|Tamoxifen|tamoxifen|mesh-list
25810022|NCT00002864|Octreotide|octreotide|mesh-list
25810023|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25810024|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
25810025|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25810026|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810027|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25810028|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810029|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25810030|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25810031|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25810032|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25810033|NCT00002865|Leucovorin|leucovorin|mesh-list
25810034|NCT00002865|Cobalt|cobalt|mesh-list
25810035|NCT00002865|Cytarabine|cytarabine|mesh-list
25810036|NCT00002865|Dexamethasone|dexamethasone|mesh-list
25810037|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
25810038|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25810039|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25810040|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25810041|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
25810042|NCT00002865|Ifosfamide|ifosfamide|mesh-list
24991310|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810043|NCT00002865|Doxorubicin|doxorubicin|mesh-list
25810044|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25810045|NCT00002865|Methotrexate|methotrexate|mesh-list
25810046|NCT00002865|Etoposide|etoposide|mesh-list
25810047|NCT00002865|Vincristine|vincristine|mesh-list
25810048|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
25810049|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810050|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
25810051|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810052|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810053|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810054|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
25810055|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810056|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810057|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810058|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25810059|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
25810060|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
25810061|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25810062|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25810063|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
25810064|NCT00002865|Hormones|hormones|mesh-ancestor
25810065|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25810066|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25810067|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810068|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810069|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810070|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810071|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25810072|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
25810073|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25810074|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810075|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
25810076|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
25810077|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810078|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810079|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810080|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
25810081|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810082|NCT00002865|Antidotes|antidotes|mesh-ancestor
25810083|NCT00002865|Protective Agents|protective agents|mesh-ancestor
25810084|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
25810085|NCT00002865|Vitamins|vitamins|mesh-ancestor
25810086|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
25810087|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810088|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810089|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810090|NCT00002865|Trace Elements|trace elements|mesh-ancestor
25810091|NCT00002866|Docetaxel|docetaxel|mesh-list
25810092|NCT00002866|Epirubicin|epirubicin|mesh-list
25810093|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810094|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810095|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810096|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810097|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810098|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810099|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810100|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810101|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810102|NCT00002868|Interferons|interferons|mesh-list
25810103|NCT00002868|Cytarabine|cytarabine|mesh-list
25810104|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
25810105|NCT00002868|Etoposide|etoposide|mesh-list
25810106|NCT00002868|Idarubicin|idarubicin|mesh-list
25810107|NCT00002868|Busulfan|busulfan|mesh-list
25810108|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
25810109|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810110|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810111|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810112|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810113|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810114|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810115|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
25810116|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810117|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810118|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
25810119|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810120|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
25810121|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810122|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
25810123|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810124|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810125|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810126|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
25810127|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810128|NCT00002869|Interferons|interferons|mesh-list
25810129|NCT00002869|Cytarabine|cytarabine|mesh-list
25810130|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
25810131|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
25810132|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810133|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
25810134|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810135|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810136|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
25810137|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810138|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810139|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
25810140|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810141|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
25810142|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810143|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810144|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
25810145|NCT00002870|Thiotepa|thiotepa|mesh-list
25810146|NCT00002870|Fluorouracil|fluorouracil|mesh-list
25810147|NCT00002870|Epirubicin|epirubicin|mesh-list
25810148|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810149|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
25810150|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810151|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810152|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810153|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
25810154|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810155|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810156|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810157|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
25810158|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810159|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810160|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810161|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810162|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810163|NCT00002872|Doxycycline|doxycycline|mesh-list
25810164|NCT00002872|Bleomycin|bleomycin|mesh-list
25810165|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25810166|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810167|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
25810168|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25810169|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25810170|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810171|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810172|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
25810173|NCT00002875|Lomustine|lomustine|mesh-list
25810174|NCT00002875|Cisplatin|cisplatin|mesh-list
25810175|NCT00002875|Vincristine|vincristine|mesh-list
25810176|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810177|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
25810178|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810179|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810180|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810181|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
25810182|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810183|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810184|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810185|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810186|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810187|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810188|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810189|NCT00002876|Cisplatin|cisplatin|mesh-list
25810190|NCT00002876|Etoposide|etoposide|mesh-list
25810191|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810192|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810193|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810194|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810195|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810196|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810197|NCT00002878|Dexamethasone|dexamethasone|mesh-list
25810198|NCT00002878|Doxorubicin|doxorubicin|mesh-list
25810199|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25810200|NCT00002878|Vincristine|vincristine|mesh-list
25810201|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25810202|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
25810203|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
25810204|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25810205|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810206|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25810207|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
25810208|NCT00002878|Hormones|hormones|mesh-ancestor
25810209|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25810210|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25810211|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810212|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810213|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810214|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810215|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810216|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810217|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810218|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810219|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810220|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810221|NCT00002879|Cladribine|cladribine|mesh-list
25810222|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810223|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810224|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
25810225|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810226|NCT00002880|Etoposide|etoposide|mesh-list
25810227|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
25810228|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810229|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810230|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810231|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810232|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810233|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810234|NCT00002881|Suramin|suramin|mesh-list
25810235|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
25810236|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25810237|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25810238|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25810239|NCT00002881|Leuprolide|leuprolide|mesh-list
25810240|NCT00002881|Goserelin|goserelin|mesh-list
25810241|NCT00002881|Flutamide|flutamide|mesh-list
25810242|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25810243|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25810244|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
25810245|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25810247|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25810248|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810249|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
25810250|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
25810251|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25810252|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
25810253|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
25810254|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25810255|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810256|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25810257|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25810258|NCT00002882|Interferons|interferons|mesh-list
25810259|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
25810260|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
25810261|NCT00002882|Aldesleukin|aldesleukin|mesh-list
25810262|NCT00002882|Cisplatin|cisplatin|mesh-list
25810263|NCT00002882|Interleukin-2|interleukin-2|mesh-list
25810264|NCT00002882|Dacarbazine|dacarbazine|mesh-list
25810265|NCT00002882|Vinblastine|vinblastine|mesh-list
25810266|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810267|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
25810268|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810269|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
25810270|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810271|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25810272|NCT00002882|Analgesics|analgesics|mesh-ancestor
25810273|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
25810274|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25810275|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25810276|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25810277|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810278|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
25810279|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810280|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810281|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810282|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810283|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810284|NCT00002883|Cisplatin|cisplatin|mesh-list
25810285|NCT00002883|Fluorouracil|fluorouracil|mesh-list
25810286|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810287|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
25810288|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810289|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810290|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810291|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
25810292|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810293|NCT00002884|Cisplatin|cisplatin|mesh-list
25810294|NCT00002884|Fluorouracil|fluorouracil|mesh-list
25810295|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810296|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
25810297|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810298|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810299|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810300|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
25810301|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810302|NCT00002887|Cisplatin|cisplatin|mesh-list
25810303|NCT00002887|Etoposide|etoposide|mesh-list
25810304|NCT00002887|Vinorelbine|vinorelbine|mesh-list
25810305|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
25810306|NCT00002887|Vinblastine|vinblastine|mesh-list
25810307|NCT00002887|Vindesine|vindesine|mesh-list
25810308|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810309|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810310|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810311|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810312|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810313|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810314|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810315|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810316|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810317|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
25810318|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810319|NCT00002888|Paclitaxel|paclitaxel|mesh-list
25810320|NCT00002888|Cisplatin|cisplatin|mesh-list
25810321|NCT00002888|Fluorouracil|fluorouracil|mesh-list
25810322|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810323|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810324|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810325|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810326|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810327|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810328|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
25810329|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810330|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810331|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
25810332|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810334|NCT00002889|Goserelin|goserelin|mesh-list
25810335|NCT00002889|Flutamide|flutamide|mesh-list
25810336|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25810337|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
25810338|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25810339|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810340|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25810341|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810342|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
25810343|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
25810344|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25810345|NCT00002890|Lintuzumab|lintuzumab|mesh-list
25810346|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25810347|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810348|NCT00002892|Interferons|interferons|mesh-list
25810349|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
25810350|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810351|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
25810352|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810353|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
25810354|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810355|NCT00002893|Leucovorin|leucovorin|mesh-list
25810356|NCT00002893|Fluorouracil|fluorouracil|mesh-list
25810357|NCT00002893|Raltitrexed|raltitrexed|mesh-list
25810358|NCT00002893|Calcium|calcium|mesh-list
25810359|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
25810360|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25810361|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810362|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
25810363|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810364|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810365|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810366|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810367|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
25810368|NCT00002893|Antidotes|antidotes|mesh-ancestor
25810369|NCT00002893|Protective Agents|protective agents|mesh-ancestor
25810370|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
25810371|NCT00002893|Vitamins|vitamins|mesh-ancestor
25810372|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
25810373|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810374|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810375|NCT00002894|Paclitaxel|paclitaxel|mesh-list
25810376|NCT00002894|Cisplatin|cisplatin|mesh-list
25810377|NCT00002894|Carboplatin|carboplatin|mesh-list
25810378|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810379|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810380|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810381|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810382|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810383|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810384|NCT00002896|Leucovorin|leucovorin|mesh-list
25810385|NCT00002896|Cobalt|cobalt|mesh-list
25810386|NCT00002896|Fluorouracil|fluorouracil|mesh-list
25810387|NCT00002896|Calcium|calcium|mesh-list
25810388|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
25810389|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25810390|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810391|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
25810392|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810393|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810394|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810395|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810396|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
25810397|NCT00002896|Antidotes|antidotes|mesh-ancestor
25810398|NCT00002896|Protective Agents|protective agents|mesh-ancestor
25810399|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
25810400|NCT00002896|Vitamins|vitamins|mesh-ancestor
25810401|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
25810402|NCT00002896|Trace Elements|trace elements|mesh-ancestor
25810403|NCT00002897|Cisplatin|cisplatin|mesh-list
25810404|NCT00002897|Fluorouracil|fluorouracil|mesh-list
25810405|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810406|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
25810407|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810408|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810409|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810410|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
25810411|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810412|NCT00002898|Dactinomycin|dactinomycin|mesh-list
25810413|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
25810414|NCT00002898|Ifosfamide|ifosfamide|mesh-list
25810415|NCT00002898|Carboplatin|carboplatin|mesh-list
25810416|NCT00002898|Etoposide|etoposide|mesh-list
25810417|NCT00002898|Vincristine|vincristine|mesh-list
25810418|NCT00002898|Epirubicin|epirubicin|mesh-list
25810419|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810420|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
25810421|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810422|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810423|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810424|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
25810425|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810426|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810427|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810428|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810429|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810430|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810431|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810432|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810433|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810434|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810435|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810436|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25810437|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810438|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25810439|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810440|NCT00002901|Docetaxel|docetaxel|mesh-list
25810441|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810442|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810443|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810444|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810445|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810446|NCT00002902|Irinotecan|irinotecan|mesh-list
25810447|NCT00002902|Raltitrexed|raltitrexed|mesh-list
25810448|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25810449|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810450|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810451|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810452|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810453|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810454|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
25810455|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810456|NCT00002903|Docetaxel|docetaxel|mesh-list
25810457|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810458|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810459|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810460|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810461|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810462|NCT00002904|Trabectedin|trabectedin|mesh-list
25810463|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810464|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
25810465|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810466|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810467|NCT00002905|Zidovudine|zidovudine|mesh-list
25810468|NCT00002905|Didanosine|didanosine|mesh-list
25810469|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
25810470|NCT00002905|Prednimustine|prednimustine|mesh-list
25810471|NCT00002905|Doxorubicin|doxorubicin|mesh-list
25810472|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25810473|NCT00002905|Etoposide|etoposide|mesh-list
25810474|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
25810475|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810476|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
25810477|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810478|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810479|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810480|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
25810481|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810482|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810483|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810484|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810485|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810486|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810487|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810488|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810489|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
25810490|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25810491|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810492|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
25810493|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810494|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25810495|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25810496|NCT00002905|Analgesics|analgesics|mesh-ancestor
25810497|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
25810498|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25810499|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
25810500|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25810501|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
25810502|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810503|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810504|NCT00002908|Vincristine|vincristine|mesh-list
25810505|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
25810506|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810507|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810508|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810509|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810510|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810511|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810512|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25810513|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
25810514|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810515|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25810516|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810518|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810519|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810520|NCT00002912|Etoposide|etoposide|mesh-list
25810521|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
25810522|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810523|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810524|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810525|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810526|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810527|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810528|NCT00002912|Analgesics|analgesics|mesh-ancestor
25810529|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
25810530|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25810531|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810532|NCT00002913|Paclitaxel|paclitaxel|mesh-list
25810533|NCT00002913|Cisplatin|cisplatin|mesh-list
25810534|NCT00002913|Topotecan|topotecan|mesh-list
25810535|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810536|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810537|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810538|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810539|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810540|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810541|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25810542|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24991542|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991543|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
25810543|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810544|NCT00002914|Piritrexim|piritrexim|mesh-list
25810545|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810546|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810547|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810548|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810549|NCT00002915|Penclomedine|penclomedine|mesh-list
25810550|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810551|NCT00002917|Paclitaxel|paclitaxel|mesh-list
25810552|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810553|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810554|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810555|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810556|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810557|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810558|NCT00002919|Cisplatin|cisplatin|mesh-list
25810559|NCT00002919|Doxorubicin|doxorubicin|mesh-list
25810560|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25810561|NCT00002919|Methotrexate|methotrexate|mesh-list
25810562|NCT00002919|Vinblastine|vinblastine|mesh-list
25810563|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810564|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810565|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810566|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810567|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810568|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810569|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25810570|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
25810571|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25810572|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810573|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810574|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
25810575|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
25810576|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810577|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810578|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
25810579|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810580|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810581|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810582|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810583|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810584|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810585|NCT00002920|Tamoxifen|tamoxifen|mesh-list
25810586|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25810587|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
25810588|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25810589|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
25810590|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25810591|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810592|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25810593|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810594|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25810595|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25810596|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25810597|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25810598|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25810599|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25810600|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
25810601|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25810602|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25810603|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25810604|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25810605|NCT00002921|Suramin|suramin|mesh-list
25810606|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
25810607|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25810608|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25810609|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25810610|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25810611|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
25810612|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
25810613|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25810614|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810615|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797388|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25810616|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25810617|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25810618|NCT00002922|Paclitaxel|paclitaxel|mesh-list
25810619|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810620|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810621|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810622|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810623|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810624|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810625|NCT00002923|KRN 5500|krn 5500|mesh-list
25810626|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810627|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25810628|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810629|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810630|NCT00002925|Aldesleukin|aldesleukin|mesh-list
25810631|NCT00002925|Etoposide|etoposide|mesh-list
25810632|NCT00002925|Daunorubicin|daunorubicin|mesh-list
25810633|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810634|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810635|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810636|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810637|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810638|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810639|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810640|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25810641|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25810642|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
25810643|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810644|NCT00002926|Cytarabine|cytarabine|mesh-list
25810645|NCT00002926|Etoposide|etoposide|mesh-list
25810646|NCT00002926|Idarubicin|idarubicin|mesh-list
25810647|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810648|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810649|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810650|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810651|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810652|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810653|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810654|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
25810655|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
25810656|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810657|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810658|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
25810659|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810660|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810661|NCT00002928|Paclitaxel|paclitaxel|mesh-list
25810662|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810663|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810664|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810665|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810666|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810667|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810668|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25810669|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25810670|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810671|NCT00002932|Cisplatin|cisplatin|mesh-list
25810672|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810673|NCT00002933|Irinotecan|irinotecan|mesh-list
25810674|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25810675|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810676|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810677|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810678|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810679|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25810680|NCT00002935|Trioxsalen|trioxsalen|mesh-list
25810681|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810682|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
25810683|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25810684|NCT00002936|Etoposide|etoposide|mesh-list
25810685|NCT00002936|Altretamine|altretamine|mesh-list
25810686|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810687|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810688|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810689|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810690|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810691|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810692|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810694|NCT00002937|Paclitaxel|paclitaxel|mesh-list
25810695|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810696|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810697|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810698|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810699|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810700|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810701|NCT00002939|Paclitaxel|paclitaxel|mesh-list
25810702|NCT00002939|Irinotecan|irinotecan|mesh-list
25810703|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810704|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810705|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810706|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810707|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810708|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810709|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25810710|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810711|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810712|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
25810713|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810714|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
25810715|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810716|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810717|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810718|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
25810719|NCT00002941|Carmustine|carmustine|mesh-list
25810720|NCT00002941|Etoposide|etoposide|mesh-list
25810721|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810722|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
25810723|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810724|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810725|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810726|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
25810727|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810728|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810729|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810730|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810731|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810732|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810733|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810734|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
25810735|NCT00002943|Carboplatin|carboplatin|mesh-list
25810736|NCT00002943|Etoposide|etoposide|mesh-list
25810737|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810738|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
25810739|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810740|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810741|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810742|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
25810743|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810744|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810745|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810746|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810747|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810748|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810749|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810750|NCT00002944|Carboplatin|carboplatin|mesh-list
25810751|NCT00002944|Vincristine|vincristine|mesh-list
25810752|NCT00002944|Thioguanine|thioguanine|mesh-list
25810753|NCT00002944|Lomustine|lomustine|mesh-list
25810754|NCT00002944|Procarbazine|procarbazine|mesh-list
25810755|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810756|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810757|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810758|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810759|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810760|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810761|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810762|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
25810763|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810764|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
25810765|NCT00002945|Cytarabine|cytarabine|mesh-list
25810766|NCT00002945|Aldesleukin|aldesleukin|mesh-list
25810767|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
25810768|NCT00002945|Melphalan|melphalan|mesh-list
25810769|NCT00002945|Etoposide|etoposide|mesh-list
25810770|NCT00002945|Idarubicin|idarubicin|mesh-list
25810771|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810772|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
25810773|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810774|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810775|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810776|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
25810777|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810778|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810779|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810780|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810781|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810782|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810783|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810784|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810785|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
25810786|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
25810787|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810788|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25810789|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25810790|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810791|NCT00002946|Penclomedine|penclomedine|mesh-list
25810792|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810793|NCT00002948|Topotecan|topotecan|mesh-list
25810794|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25810795|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810796|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810797|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810798|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810799|NCT00002949|Paclitaxel|paclitaxel|mesh-list
25810800|NCT00002949|Vinorelbine|vinorelbine|mesh-list
25810801|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810802|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810803|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810804|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810805|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810806|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810807|NCT00002950|Topotecan|topotecan|mesh-list
25810808|NCT00002950|Sargramostim|sargramostim|mesh-list
25810809|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25810810|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810811|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810812|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810813|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810814|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
25810815|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810816|NCT00002951|Fluorouracil|fluorouracil|mesh-list
25810817|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
25810818|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
25810819|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810820|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810821|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810822|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810823|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
25810824|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810825|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
25810826|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810827|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810828|NCT00002952|Interleukin-12|interleukin-12|mesh-list
25810829|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25810830|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
25810831|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810832|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25810833|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25810834|NCT00002952|Growth Substances|growth substances|mesh-ancestor
25810835|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
25810836|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810837|NCT00002953|Paclitaxel|paclitaxel|mesh-list
25810838|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
25810839|NCT00002953|Epirubicin|epirubicin|mesh-list
25810840|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810841|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810842|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810843|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810844|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810845|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810846|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810847|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
25810848|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810849|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810850|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810851|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
25810852|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810853|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810854|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810855|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810856|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810857|NCT00002955|Leucovorin|leucovorin|mesh-list
25810858|NCT00002955|Trimetrexate|trimetrexate|mesh-list
25810859|NCT00002955|Fluorouracil|fluorouracil|mesh-list
25810860|NCT00002955|Calcium|calcium|mesh-list
25810861|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
25810862|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25810863|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810864|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
25810865|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810866|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810867|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810868|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810869|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
25810870|NCT00002955|Antidotes|antidotes|mesh-ancestor
25810871|NCT00002955|Protective Agents|protective agents|mesh-ancestor
25810872|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
25810873|NCT00002955|Vitamins|vitamins|mesh-ancestor
25810874|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
25810875|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
25810876|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810877|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810878|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810879|NCT00002961|Cyclosporine|cyclosporine|mesh-list
25810880|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
25810881|NCT00002961|Busulfan|busulfan|mesh-list
25810882|NCT00002961|Methotrexate|methotrexate|mesh-list
25810883|NCT00002961|Etoposide|etoposide|mesh-list
25810884|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
25810885|NCT00002961|Cyclosporins|cyclosporins|mesh-list
25810886|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810887|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
25810888|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810889|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810890|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810891|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
25810892|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810893|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810894|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810895|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25810896|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
25810897|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25810898|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810899|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
25810900|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
25810901|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810902|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810903|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810904|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810905|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810906|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810907|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
25810908|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810909|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25810910|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25810911|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25810912|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
25810913|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25810914|NCT00002964|Trioxsalen|trioxsalen|mesh-list
25810915|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810916|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
25810917|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25810918|NCT00002965|Interferons|interferons|mesh-list
25810919|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
25810920|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
25810921|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25810922|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810923|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
25810924|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810925|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
25810926|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810927|NCT00002967|Tamoxifen|tamoxifen|mesh-list
25810928|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
25810929|NCT00002967|Doxorubicin|doxorubicin|mesh-list
25810930|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25810931|NCT00002967|Octreotide|octreotide|mesh-list
25810932|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810933|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
25810934|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810935|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810936|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25810937|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
25810938|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810939|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810940|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25810941|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25810942|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25810943|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25810944|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810945|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25810946|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
25810947|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25810948|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25810949|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25810950|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25810951|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25810952|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25810953|NCT00002968|Edrecolomab|edrecolomab|mesh-list
25810954|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25810955|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
25810956|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810957|NCT00002969|Paclitaxel|paclitaxel|mesh-list
25810958|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810959|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810960|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810961|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810962|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810963|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810964|NCT00002970|Cytarabine|cytarabine|mesh-list
25810965|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
25810966|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25810967|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25810968|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25810969|NCT00002970|Methotrexate|methotrexate|mesh-list
25810970|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25810971|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
25810972|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25810973|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810974|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25810975|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
25810976|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810977|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810978|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
25810979|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810980|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25810981|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25810982|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
25810983|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25810984|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25810985|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
25810986|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25810987|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25810988|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25810989|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810990|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25810991|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810992|NCT00002972|Paclitaxel|paclitaxel|mesh-list
25810993|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25810994|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25810995|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
25810996|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
25810997|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
25810998|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25810999|NCT00002973|Melphalan|melphalan|mesh-list
25811000|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811001|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
25811002|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811003|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811004|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811005|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811006|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
25811007|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811008|NCT00002974|Carboplatin|carboplatin|mesh-list
25811009|NCT00002974|Etoposide|etoposide|mesh-list
25811010|NCT00002974|Ifosfamide|ifosfamide|mesh-list
25811011|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811012|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811013|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811014|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811015|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811016|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811017|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811018|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
25811019|NCT00002976|Estrogens|estrogens|mesh-list
25811020|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25811021|NCT00002976|Hormones|hormones|mesh-ancestor
25811022|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811023|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811024|NCT00002977|Melphalan|melphalan|mesh-list
25811025|NCT00002977|Thiotepa|thiotepa|mesh-list
25811026|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
25811027|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811028|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811029|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
25811030|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811031|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811032|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811033|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811034|NCT00002980|Decitabine|decitabine|mesh-list
25811035|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811036|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
25811037|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811038|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811039|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811040|NCT00002982|Cytarabine|cytarabine|mesh-list
25811041|NCT00002982|Carboplatin|carboplatin|mesh-list
25811042|NCT00002982|Etoposide|etoposide|mesh-list
25811043|NCT00002982|Melphalan|melphalan|mesh-list
25811044|NCT00002982|Ifosfamide|ifosfamide|mesh-list
25811045|NCT00002982|Carmustine|carmustine|mesh-list
25811046|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811047|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811048|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811049|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811050|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811051|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811052|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811053|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
25811054|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
25142902|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142903|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142904|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25142905|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25142906|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25142919|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24797531|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591048|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
25811055|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811056|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811057|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
25811058|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811059|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811060|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
25811061|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811062|NCT00002984|Paclitaxel|paclitaxel|mesh-list
25811063|NCT00002984|Cisplatin|cisplatin|mesh-list
25811064|NCT00002984|Fluorouracil|fluorouracil|mesh-list
25811065|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811066|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811067|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811068|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811069|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811070|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811071|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
25811072|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811073|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811074|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
25811075|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811076|NCT00002985|Doxorubicin|doxorubicin|mesh-list
25811077|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811078|NCT00002985|Daunorubicin|daunorubicin|mesh-list
25811079|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811080|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811081|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811082|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811083|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811084|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811085|NCT00002986|Topotecan|topotecan|mesh-list
25811086|NCT00002986|Carmustine|carmustine|mesh-list
25811087|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25811088|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811089|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811090|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811091|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811092|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811093|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
25811094|NCT00002987|Prednisolone|prednisolone|mesh-list
25811095|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
25811096|NCT00002987|Doxorubicin|doxorubicin|mesh-list
25811097|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811098|NCT00002987|Etoposide|etoposide|mesh-list
25811099|NCT00002987|Vincristine|vincristine|mesh-list
25811100|NCT00002987|Bleomycin|bleomycin|mesh-list
25811101|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811102|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
25811103|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811104|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811105|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811106|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
25811107|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811108|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811109|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811110|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811111|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811112|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811113|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811114|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811115|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811116|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811117|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811118|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25811119|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
25811120|NCT00002987|Hormones|hormones|mesh-ancestor
25811121|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811122|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811123|NCT00002988|Irinotecan|irinotecan|mesh-list
25811124|NCT00002988|Carmustine|carmustine|mesh-list
25811125|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25811126|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811127|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811128|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811129|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811130|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811131|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
25811132|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
25811133|NCT00002989|Melphalan|melphalan|mesh-list
25811134|NCT00002989|Busulfan|busulfan|mesh-list
25811135|NCT00002989|Idarubicin|idarubicin|mesh-list
25811136|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811137|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
25811138|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811139|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811140|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811141|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
25811142|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811143|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811144|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811145|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811146|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811147|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811148|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811149|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
25811150|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25811151|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
25811152|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811153|NCT00002993|Cisplatin|cisplatin|mesh-list
25811154|NCT00002993|Doxorubicin|doxorubicin|mesh-list
25811155|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811156|NCT00002993|Mitomycins|mitomycins|mesh-list
25811157|NCT00002993|Mitomycin|mitomycin|mesh-list
25811158|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811159|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811160|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811161|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811162|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811163|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811164|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
25811165|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811166|NCT00002994|Interleukin-2|interleukin-2|mesh-list
25811167|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811168|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25811169|NCT00002994|Analgesics|analgesics|mesh-ancestor
25811170|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
25811171|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25811172|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811173|NCT00002995|Dactinomycin|dactinomycin|mesh-list
25811174|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
25811175|NCT00002995|Vincristine|vincristine|mesh-list
25811176|NCT00002995|Sargramostim|sargramostim|mesh-list
25811177|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811178|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
25811179|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811180|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811181|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811182|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
25811183|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811184|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811185|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811186|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811187|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811188|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811189|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811190|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25811191|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811192|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811193|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25811194|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811195|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811196|NCT00002996|Flecainide|flecainide|mesh-list
25811197|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25811198|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25811199|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25811200|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25811201|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811202|NCT00002998|Gemcitabine|gemcitabine|mesh-list
25811203|NCT00002998|Cisplatin|cisplatin|mesh-list
25811204|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811205|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811206|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
25811207|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811208|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
25811209|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811210|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811211|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811212|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
25811213|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811214|NCT00002999|Cisplatin|cisplatin|mesh-list
25811215|NCT00002999|Fluorouracil|fluorouracil|mesh-list
25811216|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811217|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
25811218|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811219|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811220|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811221|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
25811222|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811223|NCT00003000|Fentanyl|fentanyl|mesh-list
25811224|NCT00003000|Morphine|morphine|mesh-list
25811225|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25811226|NCT00003000|Narcotics|narcotics|mesh-ancestor
25811227|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25811228|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811229|NCT00003000|Analgesics|analgesics|mesh-ancestor
25811230|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
25811231|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25811232|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25811233|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25811234|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
25811235|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
25811236|NCT00003001|Leucovorin|leucovorin|mesh-list
25811237|NCT00003001|Gemcitabine|gemcitabine|mesh-list
25811238|NCT00003001|Fluorouracil|fluorouracil|mesh-list
25811239|NCT00003001|Calcium|calcium|mesh-list
25811240|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
25811241|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811242|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
25811243|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811244|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811245|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
25811246|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811247|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811248|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811249|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
25811250|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811251|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25811252|NCT00003001|Antidotes|antidotes|mesh-ancestor
25811253|NCT00003001|Protective Agents|protective agents|mesh-ancestor
25811254|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
25811255|NCT00003001|Vitamins|vitamins|mesh-ancestor
25811256|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
25811257|NCT00003002|Sargramostim|sargramostim|mesh-list
25811258|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
25811259|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811260|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
25811261|NCT00003003|Mitomycins|mitomycins|mesh-list
25811262|NCT00003003|Mitomycin|mitomycin|mesh-list
25811263|NCT00003003|Sargramostim|sargramostim|mesh-list
25811264|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
25811265|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811266|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811267|NCT00003003|Analgesics|analgesics|mesh-ancestor
25811268|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
25811269|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25811270|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811271|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811272|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811273|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811274|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811275|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
25811276|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811277|NCT00003004|Paclitaxel|paclitaxel|mesh-list
25811278|NCT00003004|Cisplatin|cisplatin|mesh-list
25811279|NCT00003004|Alvocidib|alvocidib|mesh-list
25811280|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811281|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811282|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811283|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811284|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811285|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811286|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
25811287|NCT00003004|Growth Substances|growth substances|mesh-ancestor
25811288|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811289|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25811290|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811291|NCT00003005|Cordycepin|cordycepin|mesh-list
25811292|NCT00003005|Pentostatin|pentostatin|mesh-list
25811293|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811294|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25811295|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811296|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811297|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
25811298|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811299|NCT00003007|Interferons|interferons|mesh-list
25811300|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
25811301|NCT00003007|Dexamethasone|dexamethasone|mesh-list
25811302|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
25811303|NCT00003007|Melphalan|melphalan|mesh-list
25811304|NCT00003007|Sargramostim|sargramostim|mesh-list
25811305|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811306|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
25811307|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811308|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811309|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811310|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
25811311|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811312|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811313|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811314|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25811315|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
25811316|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
25811317|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25811318|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25811319|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
25811320|NCT00003007|Hormones|hormones|mesh-ancestor
25811321|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811322|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811323|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
25811324|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811325|NCT00003008|Ritonavir|ritonavir|mesh-list
25811326|NCT00003008|Nelfinavir|nelfinavir|mesh-list
25811327|NCT00003008|Indinavir|indinavir|mesh-list
25811328|NCT00003008|Saquinavir|saquinavir|mesh-list
25811329|NCT00003008|Paclitaxel|paclitaxel|mesh-list
25811330|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811331|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811332|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811333|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811334|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811335|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811336|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25811337|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25811338|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
25811339|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811340|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25811341|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25811342|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
25811343|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811344|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25811345|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25811346|NCT00003009|Aldesleukin|aldesleukin|mesh-list
25811347|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811348|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25811349|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25811350|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
25811351|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811352|NCT00003010|Marimastat|marimastat|mesh-list
25811353|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811354|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811355|NCT00003011|Marimastat|marimastat|mesh-list
25169564|NCT01811576|Hormones|hormones|mesh-list
25811356|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811357|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811359|NCT00003012|Fluorouracil|fluorouracil|mesh-list
25811360|NCT00003012|Methotrexate|methotrexate|mesh-list
25811361|NCT00003012|Epirubicin|epirubicin|mesh-list
25811362|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811363|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
25811364|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811365|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811366|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811367|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
25811368|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811369|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811370|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811371|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
25811372|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811373|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25811374|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
25811375|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25811376|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
25811377|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811378|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25811379|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811380|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811381|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811382|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811383|NCT00003013|Tamoxifen|tamoxifen|mesh-list
25811384|NCT00003013|Paclitaxel|paclitaxel|mesh-list
25811385|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
25811386|NCT00003013|Doxorubicin|doxorubicin|mesh-list
25811387|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811388|NCT00003013|Fluorouracil|fluorouracil|mesh-list
25811389|NCT00003013|Methotrexate|methotrexate|mesh-list
25811390|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811391|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811392|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811393|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811394|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811395|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811396|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811397|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
25811398|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811399|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811400|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811401|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
25811402|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811403|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811404|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811405|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811406|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811407|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
25811408|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811409|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25811410|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
25811411|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25811412|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
25811413|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25811414|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811415|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25811416|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
25811417|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811418|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811419|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25811420|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25811421|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25811422|NCT00003014|Carboplatin|carboplatin|mesh-list
25811423|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811424|NCT00003015|Carboplatin|carboplatin|mesh-list
25811425|NCT00003015|Vincristine|vincristine|mesh-list
25811426|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811427|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811428|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811429|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811430|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811431|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811433|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25811434|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
25811435|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811436|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811437|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811438|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811439|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25811440|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25811441|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25811442|NCT00003017|Interleukin-12|interleukin-12|mesh-list
25811443|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25811444|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
25811445|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811446|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25811447|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25811448|NCT00003017|Growth Substances|growth substances|mesh-ancestor
25811449|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
25811450|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811451|NCT00003018|Leucovorin|leucovorin|mesh-list
25811452|NCT00003018|Fluorouracil|fluorouracil|mesh-list
25811453|NCT00003018|Mitomycins|mitomycins|mesh-list
25811454|NCT00003018|Mitomycin|mitomycin|mesh-list
25811455|NCT00003018|Dipyridamole|dipyridamole|mesh-list
25811456|NCT00003018|Calcium|calcium|mesh-list
25811457|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
25811458|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25811459|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811460|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
25811461|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811462|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811463|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811464|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811465|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
25811466|NCT00003018|Antidotes|antidotes|mesh-ancestor
25811467|NCT00003018|Protective Agents|protective agents|mesh-ancestor
25811468|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
25811469|NCT00003018|Vitamins|vitamins|mesh-ancestor
25811470|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
25811471|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811472|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
25811473|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811474|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811475|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25811476|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25811477|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
25811478|NCT00003019|Methotrexate|methotrexate|mesh-list
25811479|NCT00003019|Vinblastine|vinblastine|mesh-list
25811480|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25811481|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
25811482|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25811483|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811484|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811485|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
25811486|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811487|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811488|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
25811489|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811490|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25811491|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811492|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
25811493|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811494|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811495|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811496|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811497|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811498|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811499|NCT00003020|Immunotoxins|immunotoxins|mesh-list
25811500|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
25811501|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811502|NCT00003021|Bizelesin|bizelesin|mesh-list
25811503|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811504|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811505|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811506|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
25811507|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811508|NCT00003022|Antibodies|antibodies|mesh-list
25811509|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25811510|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
25811511|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811512|NCT00003023|Vaccines|vaccines|mesh-list
25811513|NCT00003023|Antibodies|antibodies|mesh-list
25811514|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25811515|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
25811516|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
25811517|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811518|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25811519|NCT00003026|Bicalutamide|bicalutamide|mesh-list
25811520|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25811521|NCT00003026|Flutamide|flutamide|mesh-list
25811522|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
25811523|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
25811524|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811525|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811526|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811527|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
25811528|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25811529|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
25811530|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25811531|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25811532|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811533|NCT00003027|Interferons|interferons|mesh-list
25811534|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
25811535|NCT00003027|Aldesleukin|aldesleukin|mesh-list
25811536|NCT00003027|Cisplatin|cisplatin|mesh-list
25811537|NCT00003027|Dacarbazine|dacarbazine|mesh-list
25811538|NCT00003027|Vinblastine|vinblastine|mesh-list
25811539|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811540|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
25811541|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811542|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
25811543|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811544|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25811545|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25811546|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811547|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
25811548|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811549|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811550|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811551|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811552|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811553|NCT00003029|Cisplatin|cisplatin|mesh-list
25811554|NCT00003029|Fluorouracil|fluorouracil|mesh-list
25811555|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811556|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
25811557|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811558|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811559|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811560|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
25811561|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811562|NCT00003031|Voriconazole|voriconazole|mesh-list
25811563|NCT00003031|Amphotericin B|amphotericin b|mesh-list
25811564|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25811565|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
25811566|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
25811567|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
25811568|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811569|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25811570|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25811571|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811572|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811573|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25811574|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
25811575|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811576|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811577|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25811578|NCT00003031|Amebicides|amebicides|mesh-ancestor
24992494|NCT03567057|Analgesics|analgesics|mesh-ancestor
25811579|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25811580|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25811581|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25811582|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25811583|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25811584|NCT00003032|Tamoxifen|tamoxifen|mesh-list
25811585|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
25811586|NCT00003032|Cisplatin|cisplatin|mesh-list
25811587|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
25811588|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811589|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
25811590|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811591|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811592|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811593|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
25811594|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811595|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811596|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811597|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25811598|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
25811599|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811600|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811601|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25811602|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25811603|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25811604|NCT00003032|Analgesics|analgesics|mesh-ancestor
25811605|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
25811606|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25811607|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811608|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811609|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811610|NCT00003034|Doxorubicin|doxorubicin|mesh-list
25811611|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811612|NCT00003034|Ranpirnase|ranpirnase|mesh-list
25811613|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811614|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811615|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811616|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811617|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811618|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811619|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25811620|NCT00003035|Tamoxifen|tamoxifen|mesh-list
25811621|NCT00003035|Paclitaxel|paclitaxel|mesh-list
25811622|NCT00003035|Doxorubicin|doxorubicin|mesh-list
25811623|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811624|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811625|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811626|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811627|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811628|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811629|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811630|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811631|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811632|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811633|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811634|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811635|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25811636|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
25811637|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811638|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811639|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25811640|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25811641|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25811642|NCT00003037|Gemcitabine|gemcitabine|mesh-list
25811643|NCT00003037|Cisplatin|cisplatin|mesh-list
25811644|NCT00003037|Docetaxel|docetaxel|mesh-list
25811645|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811646|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811647|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
25811648|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811649|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
25811650|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811651|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811652|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811653|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
25811654|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811655|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811656|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811657|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811658|NCT00003038|Suramin|suramin|mesh-list
25811659|NCT00003038|Doxorubicin|doxorubicin|mesh-list
25811660|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811661|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811662|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811663|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811664|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811665|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811666|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811667|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
25811668|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
25811669|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25811670|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811671|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25811672|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25811673|NCT00003039|Alvocidib|alvocidib|mesh-list
25811674|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811675|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25811676|NCT00003039|Growth Substances|growth substances|mesh-ancestor
25811677|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811678|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25811679|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811680|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811681|NCT00003041|NSC 366140|nsc 366140|mesh-list
25811682|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811683|NCT00003044|Cisplatin|cisplatin|mesh-list
25811684|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811685|NCT00003046|Interleukin-12|interleukin-12|mesh-list
25811686|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25811687|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
25811688|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811689|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25811690|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25811691|NCT00003046|Growth Substances|growth substances|mesh-ancestor
25811692|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
25811693|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811694|NCT00003048|Amifostine|amifostine|mesh-list
25811695|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25811696|NCT00003048|Protective Agents|protective agents|mesh-ancestor
25811697|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811698|NCT00003049|Leucovorin|leucovorin|mesh-list
25811699|NCT00003049|Fluorouracil|fluorouracil|mesh-list
25811700|NCT00003049|Calcium|calcium|mesh-list
25811701|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
25811702|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25811703|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811704|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
25811705|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811706|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811707|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811708|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811709|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
25811710|NCT00003049|Antidotes|antidotes|mesh-ancestor
25811711|NCT00003049|Protective Agents|protective agents|mesh-ancestor
25811712|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
25811713|NCT00003049|Vitamins|vitamins|mesh-ancestor
25811714|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
25811715|NCT00003050|Tamoxifen|tamoxifen|mesh-list
25811716|NCT00003050|Paclitaxel|paclitaxel|mesh-list
25811717|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
25811718|NCT00003050|Doxorubicin|doxorubicin|mesh-list
25811719|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811720|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811721|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811722|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811723|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811724|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811725|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811726|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811727|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
25811728|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811729|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811730|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811731|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
25811732|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811733|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811734|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811735|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811736|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811737|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25811738|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25811739|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25811740|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811741|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25811742|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25811743|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25811744|NCT00003052|Doxorubicin|doxorubicin|mesh-list
25811745|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25811746|NCT00003052|Etoposide|etoposide|mesh-list
25811747|NCT00003052|Ifosfamide|ifosfamide|mesh-list
25811748|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25811749|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811750|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811751|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811752|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811753|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811754|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811755|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811756|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
25811757|NCT00003053|Cisplatin|cisplatin|mesh-list
25811758|NCT00003053|Etoposide|etoposide|mesh-list
25811759|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811760|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811761|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811762|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811763|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811764|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811765|NCT00003054|Paclitaxel|paclitaxel|mesh-list
25811766|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811767|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811768|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811769|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811770|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811771|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811772|NCT00003055|Cisplatin|cisplatin|mesh-list
25811773|NCT00003055|Irinotecan|irinotecan|mesh-list
25811774|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811775|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25811776|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811777|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811778|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811779|NCT00003056|Cyclosporine|cyclosporine|mesh-list
25811780|NCT00003056|Methotrexate|methotrexate|mesh-list
25811781|NCT00003056|Cyclosporins|cyclosporins|mesh-list
25811782|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25811783|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
25811784|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25811785|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811786|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811787|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
25811788|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811789|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811790|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
25811791|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811792|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25811793|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811794|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
25811795|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811796|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811797|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
25811798|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811799|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25811800|NCT00003057|Octreotide|octreotide|mesh-list
25811801|NCT00003057|Loperamide|loperamide|mesh-list
25811802|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
25811803|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25811804|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811805|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811806|NCT00003058|Troglitazone|troglitazone|mesh-list
25811807|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25811808|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811809|NCT00003060|Cyclosporine|cyclosporine|mesh-list
25811810|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
25811811|NCT00003060|Busulfan|busulfan|mesh-list
25811812|NCT00003060|Methotrexate|methotrexate|mesh-list
25811813|NCT00003060|Cyclosporins|cyclosporins|mesh-list
25811814|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811815|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
25811816|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811817|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811818|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811819|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
25811820|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811821|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811822|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811823|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25811824|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
25811825|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25811826|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811827|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
25811828|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
25811829|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811830|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25811831|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811832|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
25811833|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811834|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25811835|NCT00003061|Cytarabine|cytarabine|mesh-list
25811836|NCT00003061|Methotrexate|methotrexate|mesh-list
25811837|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25811838|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
25811839|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25811840|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811841|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811842|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
25811843|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811844|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811845|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
25811846|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811847|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25811848|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811849|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
25811850|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811851|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25811852|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
25811853|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811854|NCT00003062|Temozolomide|temozolomide|mesh-list
25811855|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811856|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
25811857|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811858|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811859|NCT00003063|Leucovorin|leucovorin|mesh-list
25811860|NCT00003063|Interferons|interferons|mesh-list
25811861|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
25811862|NCT00003063|Levamisole|levamisole|mesh-list
25811863|NCT00003063|Fluorouracil|fluorouracil|mesh-list
25811864|NCT00003063|Calcium|calcium|mesh-list
25811865|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
25811866|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25811867|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811868|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
25811869|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811870|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811871|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811872|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811873|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
25811874|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
25811875|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811876|NCT00003063|Antidotes|antidotes|mesh-ancestor
25811877|NCT00003063|Protective Agents|protective agents|mesh-ancestor
25811878|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
25811879|NCT00003063|Vitamins|vitamins|mesh-ancestor
25811880|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
25811881|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25811882|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
25811883|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
25811884|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25811885|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811886|NCT00003064|Paclitaxel|paclitaxel|mesh-list
25811887|NCT00003064|Etoposide|etoposide|mesh-list
25811888|NCT00003064|Carboplatin|carboplatin|mesh-list
25811889|NCT00003064|Topotecan|topotecan|mesh-list
25811890|NCT00003064|Thiotepa|thiotepa|mesh-list
25811891|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
25811892|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811893|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811894|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811895|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811896|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811897|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811898|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811899|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811900|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811901|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
25811902|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811903|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25811904|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811905|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
25811906|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811907|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811908|NCT00003065|Paclitaxel|paclitaxel|mesh-list
25811909|NCT00003065|Topotecan|topotecan|mesh-list
25811910|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811911|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811912|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811913|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811914|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811915|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811916|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25811917|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811918|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811919|NCT00003066|Docetaxel|docetaxel|mesh-list
25811920|NCT00003066|Estramustine|estramustine|mesh-list
25811921|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811922|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811923|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811924|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811925|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811926|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811927|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
25811928|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25811929|NCT00003067|Aldesleukin|aldesleukin|mesh-list
25811930|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811931|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25811932|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25811933|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
25811934|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811935|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
25811936|NCT00003068|Thiotepa|thiotepa|mesh-list
25811937|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
25811938|NCT00003068|Amifostine|amifostine|mesh-list
25811939|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811940|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
25811941|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811942|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25811943|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25811944|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
25811945|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811946|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811947|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25811948|NCT00003068|Analgesics|analgesics|mesh-ancestor
25811949|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
25811950|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25811951|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25811952|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25811953|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811954|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25811955|NCT00003068|Protective Agents|protective agents|mesh-ancestor
25811956|NCT00003070|Enalapril|enalapril|mesh-list
25811957|NCT00003070|Enalaprilat|enalaprilat|mesh-list
25811958|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811959|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992962|NCT02022982|Palbociclib|palbociclib|mesh-list
25811960|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25811961|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
25811962|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25811964|NCT00003072|Carboplatin|carboplatin|mesh-list
25811965|NCT00003072|Amifostine|amifostine|mesh-list
25811966|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25811967|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811968|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
25811969|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
25811970|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
25811971|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811972|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25811973|NCT00003072|Protective Agents|protective agents|mesh-ancestor
25811974|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811975|NCT00003073|Cytarabine|cytarabine|mesh-list
25811976|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25811977|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
25811978|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811979|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811980|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
25811981|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811982|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25811983|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
25811984|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811985|NCT00003075|Fenretinide|fenretinide|mesh-list
25811986|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811987|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25811988|NCT00003075|Protective Agents|protective agents|mesh-ancestor
25811989|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25811990|NCT00003076|Eflornithine|eflornithine|mesh-list
25811991|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25811992|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25811993|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25811994|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25811995|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25811996|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25811997|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25811998|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25811999|NCT00003078|Cisplatin|cisplatin|mesh-list
25812000|NCT00003078|Fluorouracil|fluorouracil|mesh-list
25812001|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812002|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
25812003|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812004|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812005|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812006|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
25812007|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812008|NCT00003079|Cytarabine|cytarabine|mesh-list
25812009|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
25812010|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812011|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
25812012|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812013|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812014|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
25812015|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812016|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812017|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
25812018|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812019|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812020|NCT00003080|Tamoxifen|tamoxifen|mesh-list
25812021|NCT00003080|Melphalan|melphalan|mesh-list
25812022|NCT00003080|Thiotepa|thiotepa|mesh-list
25812023|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
25812024|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812025|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812026|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
25812027|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812028|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812029|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812030|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
25812031|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812032|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25812033|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25812034|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25812035|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25812036|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25812037|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25812038|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25812039|NCT00003080|Analgesics|analgesics|mesh-ancestor
25812040|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
25812041|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25812042|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812043|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812044|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812045|NCT00003081|Melphalan|melphalan|mesh-list
25812046|NCT00003081|Busulfan|busulfan|mesh-list
25812047|NCT00003081|Thiotepa|thiotepa|mesh-list
25812048|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
25812049|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812050|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812051|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
25812052|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812053|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812054|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812055|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812056|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25812057|NCT00003082|Antibodies|antibodies|mesh-list
25812058|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
25812059|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25812060|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
25812061|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812062|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812063|NCT00003084|Ketoconazole|ketoconazole|mesh-list
25812064|NCT00003084|Paclitaxel|paclitaxel|mesh-list
25812065|NCT00003084|Etoposide|etoposide|mesh-list
25812066|NCT00003084|Vinblastine|vinblastine|mesh-list
25812067|NCT00003084|Doxorubicin|doxorubicin|mesh-list
25812068|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812069|NCT00003084|Estramustine|estramustine|mesh-list
25812070|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812071|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812072|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812073|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812074|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812075|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812076|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812077|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812078|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812079|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812080|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
25812081|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812082|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25812083|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25812084|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25812085|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
25812086|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25812087|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812088|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25812089|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812090|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
25812091|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25812092|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
25812093|NCT00003086|Carboplatin|carboplatin|mesh-list
25812094|NCT00003086|Doxorubicin|doxorubicin|mesh-list
25812095|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812096|NCT00003086|Fluorouracil|fluorouracil|mesh-list
25812097|NCT00003086|Melphalan|melphalan|mesh-list
25812098|NCT00003086|Ifosfamide|ifosfamide|mesh-list
25812099|NCT00003086|Thiotepa|thiotepa|mesh-list
25812100|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
25812101|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812102|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812103|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812104|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
25812105|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812106|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812107|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812108|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
25812109|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812110|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812111|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812112|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812113|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812114|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
25812115|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812116|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25812117|NCT00003086|Analgesics|analgesics|mesh-ancestor
25812118|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
25812119|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25812120|NCT00003087|Paclitaxel|paclitaxel|mesh-list
25812121|NCT00003087|Cisplatin|cisplatin|mesh-list
25812122|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812123|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812124|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812125|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812126|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812127|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812128|NCT00003088|Paclitaxel|paclitaxel|mesh-list
25812129|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
25812130|NCT00003088|Doxorubicin|doxorubicin|mesh-list
25812131|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812132|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812133|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812134|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812135|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812136|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812137|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812138|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812139|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
25812140|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812141|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812142|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812143|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
25812144|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812145|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812146|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812147|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812148|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812149|NCT00003089|Paclitaxel|paclitaxel|mesh-list
25812150|NCT00003089|Carboplatin|carboplatin|mesh-list
25812151|NCT00003089|Amifostine|amifostine|mesh-list
25812152|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812153|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812154|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812155|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812156|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812157|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812158|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25812159|NCT00003089|Protective Agents|protective agents|mesh-ancestor
25812160|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812161|NCT00003090|Aldesleukin|aldesleukin|mesh-list
25812162|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812163|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25812164|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25812165|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
25812166|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812167|NCT00003091|Interferons|interferons|mesh-list
25812168|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
25812169|NCT00003091|Aldesleukin|aldesleukin|mesh-list
25812170|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812171|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
25812172|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812173|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
25812174|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812175|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25812176|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25812177|NCT00003092|Paclitaxel|paclitaxel|mesh-list
25812178|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812179|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812180|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812181|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812182|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812183|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812184|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
25812185|NCT00003093|Carboplatin|carboplatin|mesh-list
25812186|NCT00003093|Doxorubicin|doxorubicin|mesh-list
25812187|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812188|NCT00003093|Etoposide|etoposide|mesh-list
25812189|NCT00003093|Molgramostim|molgramostim|mesh-list
25812191|NCT00003093|Sargramostim|sargramostim|mesh-list
25812192|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812193|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
25812194|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812195|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812196|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812197|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
25812198|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812199|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812200|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812201|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812202|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812203|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812204|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812205|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812206|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812207|NCT00003099|Tamoxifen|tamoxifen|mesh-list
25812208|NCT00003099|Fenretinide|fenretinide|mesh-list
25812209|NCT00003099|Retinamide|retinamide|mesh-list
25812210|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25812211|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
25812212|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25812213|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812214|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25812215|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812216|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25812217|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25812218|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25812219|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25812220|NCT00003099|Protective Agents|protective agents|mesh-ancestor
25812221|NCT00003101|Vincristine|vincristine|mesh-list
25812222|NCT00003101|Busulfan|busulfan|mesh-list
25812223|NCT00003101|Thiotepa|thiotepa|mesh-list
25812224|NCT00003101|Lomustine|lomustine|mesh-list
25812225|NCT00003101|Procarbazine|procarbazine|mesh-list
25812226|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
25812227|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812228|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812229|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812230|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812231|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812232|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812233|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812234|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
25812235|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812236|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812237|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812238|NCT00003103|Docetaxel|docetaxel|mesh-list
25812239|NCT00003103|Oblimersen|oblimersen|mesh-list
25812240|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812241|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812242|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812243|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812244|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812245|NCT00003105|Gemcitabine|gemcitabine|mesh-list
25812246|NCT00003105|Paclitaxel|paclitaxel|mesh-list
25812247|NCT00003105|Cisplatin|cisplatin|mesh-list
25812248|NCT00003105|Doxorubicin|doxorubicin|mesh-list
25812249|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812250|NCT00003105|Ifosfamide|ifosfamide|mesh-list
25812251|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812252|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812253|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812254|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812255|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812256|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812257|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812258|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
25812259|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
25812260|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812261|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812262|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812263|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
25812264|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812265|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812267|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812268|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812269|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
25812270|NCT00003107|Interleukin-12|interleukin-12|mesh-list
25812271|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812272|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
25812273|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812274|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25812275|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25812276|NCT00003107|Growth Substances|growth substances|mesh-ancestor
25812277|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
25812278|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812279|NCT00003108|Cisplatin|cisplatin|mesh-list
25812280|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
25812281|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812282|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812283|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
25812284|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812285|NCT00003109|Irinotecan|irinotecan|mesh-list
25812286|NCT00003109|Raltitrexed|raltitrexed|mesh-list
25812287|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25812288|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812289|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812290|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812291|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812292|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812293|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
25812294|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25812295|NCT00003110|Bleomycin|bleomycin|mesh-list
25812296|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812297|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812298|NCT00003111|Paclitaxel|paclitaxel|mesh-list
25812299|NCT00003111|Cisplatin|cisplatin|mesh-list
25812300|NCT00003111|Carboplatin|carboplatin|mesh-list
25812301|NCT00003111|Irinotecan|irinotecan|mesh-list
25812302|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812303|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812304|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812305|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812306|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812307|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812308|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25812309|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812310|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812311|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
25812312|NCT00003113|Lomustine|lomustine|mesh-list
25812313|NCT00003113|Etoposide|etoposide|mesh-list
25812314|NCT00003113|Procarbazine|procarbazine|mesh-list
25812315|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812316|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
25812317|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812318|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812319|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812320|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
25812321|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812322|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812323|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812324|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812325|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812326|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812327|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812328|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
25812329|NCT00003114|Lomustine|lomustine|mesh-list
25812330|NCT00003114|Etoposide|etoposide|mesh-list
25812331|NCT00003114|Procarbazine|procarbazine|mesh-list
25812332|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812333|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
25812334|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812335|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812336|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812337|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
25812338|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812339|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812340|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812341|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812342|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812343|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812344|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812345|NCT00003115|Hydromorphone|hydromorphone|mesh-list
25812346|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25812347|NCT00003115|Narcotics|narcotics|mesh-ancestor
25812348|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25812349|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812350|NCT00003115|Analgesics|analgesics|mesh-ancestor
25812351|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
25812352|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25812353|NCT00003116|Cyclosporine|cyclosporine|mesh-list
25812354|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
25812355|NCT00003116|Busulfan|busulfan|mesh-list
25812356|NCT00003116|Cyclosporins|cyclosporins|mesh-list
25812357|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812358|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
25812359|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812360|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812361|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812362|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
25812363|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812364|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812365|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812366|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812367|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
25812368|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812369|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
25812370|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25812371|NCT00003117|Paclitaxel|paclitaxel|mesh-list
25812372|NCT00003117|Carboplatin|carboplatin|mesh-list
25812373|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812374|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812375|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812376|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812377|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812378|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812379|NCT00003118|Cisplatin|cisplatin|mesh-list
25812380|NCT00003118|Fluorouracil|fluorouracil|mesh-list
25812381|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812382|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
25812383|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812384|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812385|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812386|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
25812387|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812388|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
25812389|NCT00003119|Carboplatin|carboplatin|mesh-list
25812390|NCT00003119|Doxorubicin|doxorubicin|mesh-list
25812391|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812392|NCT00003119|Etoposide|etoposide|mesh-list
25812393|NCT00003119|Sargramostim|sargramostim|mesh-list
25812394|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812395|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
25812396|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812397|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812398|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812399|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
25812400|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812401|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812402|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812403|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812404|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812405|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812406|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812407|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812408|NCT00003120|Paclitaxel|paclitaxel|mesh-list
25812409|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812410|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812411|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812412|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812413|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812414|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812415|NCT00003123|Amifostine|amifostine|mesh-list
25812416|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25812417|NCT00003123|Protective Agents|protective agents|mesh-ancestor
25812418|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812419|NCT00003124|Leuprolide|leuprolide|mesh-list
25812420|NCT00003124|Flutamide|flutamide|mesh-list
25812421|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25812422|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
25812423|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25812424|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812425|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25812426|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812427|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
25812428|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
25812429|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25812430|NCT00003125|Aldesleukin|aldesleukin|mesh-list
25812431|NCT00003125|Vaccines|vaccines|mesh-list
25812432|NCT00003125|Sargramostim|sargramostim|mesh-list
25812433|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
25812434|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812435|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812436|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25812437|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25812438|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
25812439|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812440|NCT00003126|Aldesleukin|aldesleukin|mesh-list
25812441|NCT00003126|Interleukin-2|interleukin-2|mesh-list
25812442|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812443|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25812444|NCT00003126|Analgesics|analgesics|mesh-ancestor
25812445|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
25812446|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25812447|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812448|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25812449|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25812450|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
25812451|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812452|NCT00003127|Paclitaxel|paclitaxel|mesh-list
25812453|NCT00003127|Carboplatin|carboplatin|mesh-list
25812454|NCT00003127|Amifostine|amifostine|mesh-list
25812455|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812456|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812457|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812458|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812459|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812460|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812461|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25812462|NCT00003127|Protective Agents|protective agents|mesh-ancestor
25812463|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812464|NCT00003128|Paclitaxel|paclitaxel|mesh-list
25812465|NCT00003128|Ifosfamide|ifosfamide|mesh-list
25812466|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812467|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812468|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812469|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812470|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812471|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812472|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812473|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
25812474|NCT00003129|Valrubicin|valrubicin|mesh-list
25812475|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812476|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812477|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812478|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812479|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812480|NCT00003130|Paclitaxel|paclitaxel|mesh-list
25812481|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812482|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812483|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812484|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812485|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812486|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812487|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
25812488|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25812489|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812490|NCT00003132|Cisplatin|cisplatin|mesh-list
25812491|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
25812492|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812493|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812494|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
25812495|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812496|NCT00003133|Gemcitabine|gemcitabine|mesh-list
25812497|NCT00003133|Paclitaxel|paclitaxel|mesh-list
25812498|NCT00003133|Cisplatin|cisplatin|mesh-list
25812499|NCT00003133|Doxorubicin|doxorubicin|mesh-list
25812500|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812501|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812502|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812503|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812504|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812505|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812506|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812507|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812508|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
25812509|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
25812510|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812511|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812512|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812513|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
25812514|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812515|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812516|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812517|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812518|NCT00003134|Irinotecan|irinotecan|mesh-list
25812519|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25812520|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812521|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812522|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812523|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812524|NCT00003135|Doxorubicin|doxorubicin|mesh-list
25812525|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812526|NCT00003135|Fluorouracil|fluorouracil|mesh-list
25812527|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812528|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812529|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812530|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812531|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812532|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812533|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
25812534|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812535|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812536|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
25812537|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812538|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
25812539|NCT00003136|Carboplatin|carboplatin|mesh-list
25812540|NCT00003136|Amifostine|amifostine|mesh-list
25812541|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812542|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
25812543|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812544|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812545|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812546|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
25812547|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812548|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812549|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812550|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25812551|NCT00003136|Protective Agents|protective agents|mesh-ancestor
25812552|NCT00003137|Irinotecan|irinotecan|mesh-list
25812553|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25812554|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812555|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812556|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812557|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812559|NCT00003139|Miotics|miotics|mesh-ancestor
25812560|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
25812561|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25812562|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812563|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25812564|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25812565|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
25812566|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25812567|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812568|NCT00003140|Letrozole|letrozole|mesh-list
25812569|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812570|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25812571|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25812572|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812573|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812574|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25812575|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
25812576|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25812577|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812578|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
25812579|NCT00003141|Thiotepa|thiotepa|mesh-list
25812580|NCT00003141|Cisplatin|cisplatin|mesh-list
25812581|NCT00003141|Carboplatin|carboplatin|mesh-list
25812582|NCT00003141|Etoposide|etoposide|mesh-list
25812583|NCT00003141|Vincristine|vincristine|mesh-list
25812584|NCT00003141|Lenograstim|lenograstim|mesh-list
25812585|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812586|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
25812587|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812588|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812589|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812590|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
25812591|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812592|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812593|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812594|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812595|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812596|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812597|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812598|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812599|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812600|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812601|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812602|NCT00003143|Amifostine|amifostine|mesh-list
25812603|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25812604|NCT00003143|Protective Agents|protective agents|mesh-ancestor
25812605|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812606|NCT00003144|Gemcitabine|gemcitabine|mesh-list
25812607|NCT00003144|Cisplatin|cisplatin|mesh-list
25812608|NCT00003144|Amifostine|amifostine|mesh-list
25812609|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812610|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812611|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
25812612|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812613|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
25812614|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812615|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812616|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812617|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
25812618|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812619|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25812620|NCT00003144|Protective Agents|protective agents|mesh-ancestor
25812621|NCT00003145|Cyclosporine|cyclosporine|mesh-list
25812622|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
25812623|NCT00003145|Fludarabine|fludarabine|mesh-list
25812624|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
25812625|NCT00003145|Cyclosporins|cyclosporins|mesh-list
25812626|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812627|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812628|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
25812629|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812630|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812631|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
25812632|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812633|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812634|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
25812635|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812636|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25812637|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812638|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25812639|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812640|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25812641|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
25812642|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25812643|NCT00003146|Melphalan|melphalan|mesh-list
25812644|NCT00003146|Busulfan|busulfan|mesh-list
25812645|NCT00003146|Thiotepa|thiotepa|mesh-list
25812646|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812647|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
25812648|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812649|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812650|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812651|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812652|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
25812653|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812654|NCT00003148|Aldesleukin|aldesleukin|mesh-list
25812655|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812656|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25812657|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25812658|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
25812659|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812660|NCT00003149|Interleukin-12|interleukin-12|mesh-list
25812661|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812662|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
25812663|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812664|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25812665|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25812666|NCT00003149|Growth Substances|growth substances|mesh-ancestor
25812667|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
25812668|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812669|NCT00003150|Prednisone|prednisone|mesh-list
25812670|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
25812671|NCT00003150|Rituximab|rituximab|mesh-list
25812672|NCT00003150|Doxorubicin|doxorubicin|mesh-list
25812673|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812674|NCT00003150|Vincristine|vincristine|mesh-list
25812675|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812676|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
25812677|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812678|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812679|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812680|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
25812681|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812682|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812683|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812684|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25812685|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812686|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812687|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812688|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812689|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25812690|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
25812691|NCT00003150|Hormones|hormones|mesh-ancestor
25812692|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25812693|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25812694|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812695|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812696|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812697|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812698|NCT00003151|Amoxicillin|amoxicillin|mesh-list
25812699|NCT00003151|Metronidazole|metronidazole|mesh-list
25812700|NCT00003151|Clarithromycin|clarithromycin|mesh-list
25812701|NCT00003151|Tetracycline|tetracycline|mesh-list
25812702|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25812703|NCT00003151|Omeprazole|omeprazole|mesh-list
25812704|NCT00003151|Bismuth|bismuth|mesh-list
25812705|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25812706|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812707|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25812708|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25812709|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25812710|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25812711|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25812712|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812713|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812714|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25812715|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25812716|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25812717|NCT00003151|Antacids|antacids|mesh-ancestor
25812718|NCT00003152|Interferons|interferons|mesh-list
25812719|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
25812720|NCT00003152|Prednisone|prednisone|mesh-list
25812721|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
25812722|NCT00003152|Vincristine|vincristine|mesh-list
25812723|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812724|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
25812725|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812726|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812727|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812728|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
25812729|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812730|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812731|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812732|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25812733|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
25812734|NCT00003152|Hormones|hormones|mesh-ancestor
25812735|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25812736|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25812737|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
25812738|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812739|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812740|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812741|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812742|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812743|NCT00003156|Topotecan|topotecan|mesh-list
25812744|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25812745|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812746|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812747|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812748|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812749|NCT00003157|Gemcitabine|gemcitabine|mesh-list
25812750|NCT00003157|Cisplatin|cisplatin|mesh-list
25812751|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812752|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812753|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
25812754|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812755|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
25812756|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812757|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812758|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812759|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
25812760|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812761|NCT00003158|Paclitaxel|paclitaxel|mesh-list
25812762|NCT00003158|Etoposide|etoposide|mesh-list
25812763|NCT00003158|Carboplatin|carboplatin|mesh-list
25812764|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812765|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812766|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812767|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812768|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812769|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812770|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812771|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812772|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812773|NCT00003159|Gemcitabine|gemcitabine|mesh-list
25812774|NCT00003159|Vinorelbine|vinorelbine|mesh-list
25812775|NCT00003159|Vinblastine|vinblastine|mesh-list
25812776|NCT00003159|Docetaxel|docetaxel|mesh-list
25812777|NCT00003159|Carboplatin|carboplatin|mesh-list
25812778|NCT00003159|Ifosfamide|ifosfamide|mesh-list
25812779|NCT00003159|Mitomycins|mitomycins|mesh-list
25812780|NCT00003159|Mitomycin|mitomycin|mesh-list
25812781|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812782|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812783|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812784|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812785|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812786|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812787|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812788|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
25812790|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812791|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812792|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812793|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
25812794|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812795|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812796|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
25812797|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812798|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25812799|NCT00003160|Paclitaxel|paclitaxel|mesh-list
25812800|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812801|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812802|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812803|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812804|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812805|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812806|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
25812807|NCT00003163|Melphalan|melphalan|mesh-list
25812808|NCT00003163|Sargramostim|sargramostim|mesh-list
25812809|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812810|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
25812811|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812812|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812813|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812814|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
25812815|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812816|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812817|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812818|NCT00003165|Doxorubicin|doxorubicin|mesh-list
25812819|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812820|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812821|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812822|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812823|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812824|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812825|NCT00003166|Vincristine|vincristine|mesh-list
25812826|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
25812827|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812828|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812829|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812830|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812831|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812832|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812833|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812834|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
25812835|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812836|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
25812837|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812838|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
25812839|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812840|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812841|NCT00003172|Interferons|interferons|mesh-list
25812842|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
25812843|NCT00003172|Docetaxel|docetaxel|mesh-list
25812844|NCT00003172|Doxorubicin|doxorubicin|mesh-list
25812845|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25812846|NCT00003172|Fluorouracil|fluorouracil|mesh-list
25812847|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
25812848|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812849|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812850|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812851|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812852|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812853|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812854|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812855|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812856|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812857|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
25812858|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812859|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812860|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
25812861|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812862|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
25812863|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812864|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
25812865|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25812866|NCT00003173|Thiotepa|thiotepa|mesh-list
25812867|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
25812868|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812869|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812870|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
25812871|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812872|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812873|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812874|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812875|NCT00003174|Cladribine|cladribine|mesh-list
25812876|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
25812877|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812878|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812879|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
25812880|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812881|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812882|NCT00003175|Fluorouracil|fluorouracil|mesh-list
25812883|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
25812884|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812885|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812886|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812887|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812888|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
25812889|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812890|NCT00003176|Temozolomide|temozolomide|mesh-list
25812891|NCT00003176|Carmustine|carmustine|mesh-list
25812892|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812893|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
25812894|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812895|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812896|NCT00003178|Idarubicin|idarubicin|mesh-list
25812897|NCT00003178|Cladribine|cladribine|mesh-list
25812898|NCT00003178|Lenograstim|lenograstim|mesh-list
25812899|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812900|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
25812901|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812902|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25812903|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812904|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812905|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812906|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812907|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812908|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812909|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25812910|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
25812911|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25812912|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25812913|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25812914|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
25812915|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25812916|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812917|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25812918|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25812919|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25812920|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25812921|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812922|NCT00003181|Aldesleukin|aldesleukin|mesh-list
25812923|NCT00003181|Vinblastine|vinblastine|mesh-list
25812924|NCT00003181|Sargramostim|sargramostim|mesh-list
25812925|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
25812926|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812927|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812928|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25812929|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25812930|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
25812931|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812932|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25812933|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
25812934|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
25812935|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
25812936|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812937|NCT00003182|Gemcitabine|gemcitabine|mesh-list
25812938|NCT00003182|Cisplatin|cisplatin|mesh-list
25812939|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812940|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812941|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
25812942|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812943|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
25812944|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25812945|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812946|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812947|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
25812948|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812949|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
25812950|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812951|NCT00003183|Analgesics|analgesics|mesh-ancestor
25812952|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
25812953|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25812954|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812955|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812956|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25812957|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812958|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812959|NCT00003184|Vaccines|vaccines|mesh-list
25812960|NCT00003184|Sargramostim|sargramostim|mesh-list
25812961|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
25812962|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
25812963|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812964|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25812965|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
25812966|NCT00003185|Sargramostim|sargramostim|mesh-list
25812967|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812968|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
25812969|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812970|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812971|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812972|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
25812973|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812974|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812975|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812976|NCT00003187|Cytarabine|cytarabine|mesh-list
25812977|NCT00003187|Cyclosporine|cyclosporine|mesh-list
25812978|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
25812979|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
25812980|NCT00003187|Methotrexate|methotrexate|mesh-list
25812981|NCT00003187|Cyclosporins|cyclosporins|mesh-list
25812982|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25812983|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
25812984|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25812985|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25812986|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25812987|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
25812988|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25812989|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25812990|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25812991|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25812992|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
25812993|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25812994|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25812995|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
25812996|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
25812997|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25812998|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25812999|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25813000|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
25813001|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813002|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
25813003|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25813004|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813005|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
25813006|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
25813007|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25813008|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25813009|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
25813010|NCT00003187|Hormones|hormones|mesh-ancestor
25813011|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813012|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25813013|NCT00003187|Protective Agents|protective agents|mesh-ancestor
24994117|NCT04892264|Ichthammol|ichthammol|mesh-list
25813014|NCT00003190|Cytarabine|cytarabine|mesh-list
25813015|NCT00003190|Etoposide|etoposide|mesh-list
25813016|NCT00003190|Daunorubicin|daunorubicin|mesh-list
25813017|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
25813018|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813019|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813020|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813021|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813022|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813023|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813024|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813025|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
25813026|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
25813027|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813028|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813029|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
25813030|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813031|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813032|NCT00003191|Fenretinide|fenretinide|mesh-list
25813033|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813034|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25813035|NCT00003191|Protective Agents|protective agents|mesh-ancestor
25813036|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813037|NCT00003193|Paclitaxel|paclitaxel|mesh-list
25813038|NCT00003193|Amifostine|amifostine|mesh-list
25813039|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813040|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813041|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813042|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813043|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813044|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813045|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813046|NCT00003193|Protective Agents|protective agents|mesh-ancestor
25813047|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813048|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
25813049|NCT00003194|Thiotepa|thiotepa|mesh-list
25813050|NCT00003194|Carboplatin|carboplatin|mesh-list
25813051|NCT00003194|Etoposide|etoposide|mesh-list
25813052|NCT00003194|Topotecan|topotecan|mesh-list
25813053|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813054|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
25813055|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813056|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813057|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813058|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
25813059|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813060|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813061|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813062|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813063|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813064|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813065|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813066|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813067|NCT00003195|Interferons|interferons|mesh-list
25813068|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
25813069|NCT00003195|Busulfan|busulfan|mesh-list
25813070|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813071|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
25813072|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813073|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
25813074|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813075|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
25813076|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813077|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813078|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813079|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813080|NCT00003196|Cyclosporine|cyclosporine|mesh-list
25813081|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
25813082|NCT00003196|Cyclosporins|cyclosporins|mesh-list
25813083|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813084|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813085|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813086|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
25813087|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994268|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813088|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
25813089|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813090|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
25813091|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813092|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25813093|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813094|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813095|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25813096|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
25813097|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25813098|NCT00003198|Topotecan|topotecan|mesh-list
25813099|NCT00003198|Ifosfamide|ifosfamide|mesh-list
25813100|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813101|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813102|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813103|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813104|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813105|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813106|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
25813107|NCT00003200|Docetaxel|docetaxel|mesh-list
25813108|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813109|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813110|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813111|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813112|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813113|NCT00003202|Gemcitabine|gemcitabine|mesh-list
25813114|NCT00003202|Cisplatin|cisplatin|mesh-list
25813115|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813116|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813117|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
25813118|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813119|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
25813120|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813121|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813122|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813123|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
25813124|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813125|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
25813126|NCT00003203|Cisplatin|cisplatin|mesh-list
25813127|NCT00003203|Carboplatin|carboplatin|mesh-list
25813128|NCT00003203|Vincristine|vincristine|mesh-list
25813129|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813130|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
25813131|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813132|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813133|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813134|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
25813135|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813136|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813137|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813138|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813139|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813140|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813141|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813142|NCT00003204|Prednisone|prednisone|mesh-list
25813143|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
25813144|NCT00003204|Rituximab|rituximab|mesh-list
25813145|NCT00003204|Fludarabine|fludarabine|mesh-list
25813146|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
25813147|NCT00003204|Vincristine|vincristine|mesh-list
25813148|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813149|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
25813150|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813151|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813152|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813153|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
25813154|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813155|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813156|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813157|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25813158|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813159|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
25813160|NCT00003204|Hormones|hormones|mesh-ancestor
25813161|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842427|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
24797890|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813162|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813163|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813165|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813166|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813167|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813168|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813169|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
25813170|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25813171|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
25813172|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813173|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813174|NCT00003206|Paclitaxel|paclitaxel|mesh-list
25813175|NCT00003206|Carboplatin|carboplatin|mesh-list
25813176|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813177|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813178|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813179|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813180|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813181|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813182|NCT00003207|Doxorubicin|doxorubicin|mesh-list
25813183|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25813184|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813185|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813186|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813187|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813188|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813189|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813190|NCT00003209|Cisplatin|cisplatin|mesh-list
25813191|NCT00003209|Fluorouracil|fluorouracil|mesh-list
25813192|NCT00003209|Methotrexate|methotrexate|mesh-list
25813193|NCT00003209|Ifosfamide|ifosfamide|mesh-list
25813194|NCT00003209|Mitomycins|mitomycins|mesh-list
25813195|NCT00003209|Mitomycin|mitomycin|mesh-list
25813196|NCT00003209|Bleomycin|bleomycin|mesh-list
25813197|NCT00003209|Vinblastine|vinblastine|mesh-list
25813198|NCT00003209|Vindesine|vindesine|mesh-list
25813199|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813200|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
25813201|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813202|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813203|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813204|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
25813205|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813206|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25813207|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
25813208|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25813209|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
25813210|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813211|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25813212|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813213|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25813214|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813215|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
25813216|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813217|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813218|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813219|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813220|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813221|NCT00003210|Interleukin-12|interleukin-12|mesh-list
25813222|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25813223|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
25813224|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813225|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25813226|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25813227|NCT00003210|Growth Substances|growth substances|mesh-ancestor
25813228|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
25813229|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813230|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
25813231|NCT00003211|Cisplatin|cisplatin|mesh-list
25813232|NCT00003211|Vincristine|vincristine|mesh-list
25813233|NCT00003211|Amifostine|amifostine|mesh-list
25813234|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813235|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
25813236|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813237|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813238|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813239|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
25813240|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813241|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813242|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813243|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813244|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813245|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813246|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813247|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813248|NCT00003211|Protective Agents|protective agents|mesh-ancestor
25813249|NCT00003212|Doxorubicin|doxorubicin|mesh-list
25813250|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25813251|NCT00003212|Ifosfamide|ifosfamide|mesh-list
25813252|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813253|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813254|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813255|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813256|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813257|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813258|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813259|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
25813260|NCT00003213|Dexamethasone|dexamethasone|mesh-list
25813261|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
25813262|NCT00003213|Metoclopramide|metoclopramide|mesh-list
25813263|NCT00003213|Granisetron|granisetron|mesh-list
25813264|NCT00003213|BB 1101|bb 1101|mesh-list
25813265|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813266|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
25813267|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
25813268|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25813269|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813270|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25813271|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
25813272|NCT00003213|Hormones|hormones|mesh-ancestor
25813273|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813274|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813275|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813276|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
25813277|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813278|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813279|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25813280|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25813281|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
25813282|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25813283|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25813284|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
25813285|NCT00003214|Paclitaxel|paclitaxel|mesh-list
25813286|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
25813287|NCT00003214|Cisplatin|cisplatin|mesh-list
25813288|NCT00003214|Carboplatin|carboplatin|mesh-list
25813289|NCT00003214|Doxorubicin|doxorubicin|mesh-list
25813290|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25813291|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813292|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813293|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813294|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813295|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813296|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813297|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813298|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
25813299|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813300|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813301|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813302|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
25813303|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813304|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813305|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813306|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813307|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813308|NCT00003215|Leucovorin|leucovorin|mesh-list
25145260|NCT02931123|Rifaximin|rifaximin|mesh-list
24994426|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
25813309|NCT00003215|Cytarabine|cytarabine|mesh-list
25813310|NCT00003215|Prednisone|prednisone|mesh-list
25813311|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
25813312|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
25813313|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25813314|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25813315|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25813316|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
25813317|NCT00003215|Melphalan|melphalan|mesh-list
25813318|NCT00003215|Doxorubicin|doxorubicin|mesh-list
25813319|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25813320|NCT00003215|Methotrexate|methotrexate|mesh-list
25813321|NCT00003215|Etoposide|etoposide|mesh-list
25813322|NCT00003215|Vincristine|vincristine|mesh-list
25813323|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
25813324|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
25813325|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813326|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
25813327|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813328|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813329|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813330|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
25813331|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813332|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813333|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813334|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813335|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813336|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813337|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813338|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813339|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
25813340|NCT00003215|Hormones|hormones|mesh-ancestor
25813341|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813342|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813343|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25813344|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
25813345|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25813346|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813347|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
25813348|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
25813349|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25813350|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25813351|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813352|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
25813353|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813354|NCT00003215|Antidotes|antidotes|mesh-ancestor
25813355|NCT00003215|Protective Agents|protective agents|mesh-ancestor
25813356|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
25813357|NCT00003215|Vitamins|vitamins|mesh-ancestor
25813358|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
25813359|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813360|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813361|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813362|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
25813363|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
25813364|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25813365|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25813366|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25813367|NCT00003215|Analgesics|analgesics|mesh-ancestor
25813368|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
25813369|NCT00003216|Gemcitabine|gemcitabine|mesh-list
25813370|NCT00003216|Fluorouracil|fluorouracil|mesh-list
25813371|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813372|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
25813373|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813374|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813375|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
25813376|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813377|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813378|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813379|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
25813380|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813381|NCT00003217|Cytarabine|cytarabine|mesh-list
25813382|NCT00003217|Dexamethasone|dexamethasone|mesh-list
25813383|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
25813384|NCT00003217|Doxorubicin|doxorubicin|mesh-list
25813385|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25813386|NCT00003217|Methotrexate|methotrexate|mesh-list
25813387|NCT00003217|Vincristine|vincristine|mesh-list
25813388|NCT00003217|Lenograstim|lenograstim|mesh-list
25813389|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813390|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
25813391|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813392|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813393|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813394|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
25813395|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813396|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813397|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813398|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813399|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
25813400|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
25813401|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25813402|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25813403|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
25813405|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813406|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813407|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813408|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813409|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813410|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813411|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25813412|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
25813413|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25813414|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813415|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
25813416|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
25813417|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25813418|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25813419|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
25813420|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813421|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25813422|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813423|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813424|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813425|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813426|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
25813427|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813428|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813429|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813430|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
25813431|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25813432|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
25813433|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813434|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813435|NCT00003223|Fenretinide|fenretinide|mesh-list
25813436|NCT00003223|Retinamide|retinamide|mesh-list
25813437|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813438|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25813439|NCT00003223|Protective Agents|protective agents|mesh-ancestor
25813440|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813441|NCT00003225|Irinotecan|irinotecan|mesh-list
25813442|NCT00003225|Amifostine|amifostine|mesh-list
25813443|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813444|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813445|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813446|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813447|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813448|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813449|NCT00003225|Protective Agents|protective agents|mesh-ancestor
25813450|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813451|NCT00003229|Aldesleukin|aldesleukin|mesh-list
25813452|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813453|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25813454|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25813455|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
25813456|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813457|NCT00003230|Paclitaxel|paclitaxel|mesh-list
25813458|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813459|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813460|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813461|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813462|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813463|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813465|NCT00003231|Docetaxel|docetaxel|mesh-list
25813466|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813467|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813468|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813469|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813470|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813471|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
25813472|NCT00003232|Prednisone|prednisone|mesh-list
25813473|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
25813474|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813475|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
25813476|NCT00003232|Hormones|hormones|mesh-ancestor
25813477|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813478|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813479|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813480|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813481|NCT00003232|Analgesics|analgesics|mesh-ancestor
25813482|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
25813483|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25813484|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813485|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813486|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813487|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813488|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25813489|NCT00003234|Vinorelbine|vinorelbine|mesh-list
25813490|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813491|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813492|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813493|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813494|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813495|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813496|NCT00003235|Paclitaxel|paclitaxel|mesh-list
25813497|NCT00003235|Carboplatin|carboplatin|mesh-list
25813498|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813499|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813500|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813501|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813502|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813503|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813504|NCT00003236|ISIS 5132|isis 5132|mesh-list
25813505|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813506|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813507|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591642|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145580|NCT02928692|Minocycline|minocycline|mesh-list
24548500|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
25813508|NCT00003237|Paclitaxel|paclitaxel|mesh-list
25813509|NCT00003237|Cisplatin|cisplatin|mesh-list
25813510|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813511|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813512|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813513|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813514|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813515|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813516|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
25813517|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813518|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813519|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813520|NCT00003239|Interferons|interferons|mesh-list
25813521|NCT00003239|Cytarabine|cytarabine|mesh-list
25813522|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
25813523|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
25813524|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
25813525|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813526|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
25813527|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813528|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813529|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
25813530|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813531|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813532|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
25813533|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813534|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813535|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25813536|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813537|NCT00003240|Cisplatin|cisplatin|mesh-list
25813538|NCT00003240|Vinorelbine|vinorelbine|mesh-list
25813539|NCT00003240|Ifosfamide|ifosfamide|mesh-list
25813540|NCT00003240|Mitomycins|mitomycins|mesh-list
25813541|NCT00003240|Mitomycin|mitomycin|mesh-list
25813542|NCT00003240|Vinblastine|vinblastine|mesh-list
25813543|NCT00003240|Vindesine|vindesine|mesh-list
25813544|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813545|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813546|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813547|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813548|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813549|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813550|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813551|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
25813552|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813553|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25813554|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813555|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
25813556|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813557|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
25813558|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813559|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813560|NCT00003242|Paclitaxel|paclitaxel|mesh-list
25813561|NCT00003242|Cisplatin|cisplatin|mesh-list
25813562|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
25813563|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813564|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813565|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813566|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813567|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813568|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813569|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25813570|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
25813571|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813572|NCT00003243|Aldesleukin|aldesleukin|mesh-list
25813573|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
25813574|NCT00003243|Doxorubicin|doxorubicin|mesh-list
25813575|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25813576|NCT00003243|Etoposide|etoposide|mesh-list
25813577|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813578|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
25813579|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813580|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813581|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813582|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
25813583|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813584|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813585|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813586|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813587|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813588|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813589|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813590|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813591|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25813592|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25813593|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
25813594|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813595|NCT00003245|Irinotecan|irinotecan|mesh-list
25813596|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813597|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813598|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813599|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813600|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813601|NCT00003248|Rituximab|rituximab|mesh-list
25813602|NCT00003248|Fludarabine|fludarabine|mesh-list
25813603|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
25813604|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25813605|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813606|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
25813607|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813608|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813609|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813610|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
25813611|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813612|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813613|NCT00003249|Ketoconazole|ketoconazole|mesh-list
25813614|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
25813615|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
25813616|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813617|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25813618|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25813619|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813620|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813621|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25813622|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
25813623|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813624|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813625|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25813626|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813627|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25813628|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25813629|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25813630|NCT00003250|Fenretinide|fenretinide|mesh-list
25813631|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813632|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25813633|NCT00003250|Protective Agents|protective agents|mesh-ancestor
25813634|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813635|NCT00003251|Paclitaxel|paclitaxel|mesh-list
25813636|NCT00003251|Cisplatin|cisplatin|mesh-list
25813637|NCT00003251|Amifostine|amifostine|mesh-list
25813638|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813639|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813640|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813641|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813642|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813643|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813644|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813645|NCT00003251|Protective Agents|protective agents|mesh-ancestor
25813646|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813647|NCT00003252|Amifostine|amifostine|mesh-list
25813648|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813649|NCT00003252|Protective Agents|protective agents|mesh-ancestor
25813650|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813651|NCT00003253|Paclitaxel|paclitaxel|mesh-list
25813652|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
25813653|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813654|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813655|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813656|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813657|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813658|NCT00003254|Fluorouracil|fluorouracil|mesh-list
25813660|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
25813661|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813662|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813663|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813664|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813665|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
25813666|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813667|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813668|NCT00003255|Carboplatin|carboplatin|mesh-list
25813669|NCT00003255|Topotecan|topotecan|mesh-list
25813670|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813671|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813672|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813673|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813674|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813675|NCT00003256|Alvocidib|alvocidib|mesh-list
25813676|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813677|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
25813678|NCT00003256|Growth Substances|growth substances|mesh-ancestor
25813679|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813680|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25813681|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813682|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813683|NCT00003259|Vinorelbine|vinorelbine|mesh-list
25813684|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813685|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813686|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813687|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813688|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813689|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813690|NCT00003260|Leucovorin|leucovorin|mesh-list
25813691|NCT00003260|Fluorouracil|fluorouracil|mesh-list
25813692|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
25813693|NCT00003260|Irinotecan|irinotecan|mesh-list
25813694|NCT00003260|Calcium|calcium|mesh-list
25813695|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
25813696|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25813697|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813698|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
25813699|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813700|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813701|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813702|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813703|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
25813704|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813705|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813706|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813707|NCT00003260|Antidotes|antidotes|mesh-ancestor
25813708|NCT00003260|Protective Agents|protective agents|mesh-ancestor
25813709|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
25813710|NCT00003260|Vitamins|vitamins|mesh-ancestor
25813711|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
25813712|NCT00003261|Zidovudine|zidovudine|mesh-list
25813713|NCT00003261|Methotrexate|methotrexate|mesh-list
25813714|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25813715|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
25813716|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25813717|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813718|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813719|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
25813720|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813721|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813722|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
25813723|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813724|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25813725|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813726|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
25813727|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813728|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25813729|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25813730|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
25813731|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813732|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24994826|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24868758|NCT02944578|Curcumin|curcumin|mesh-list
25813733|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25813734|NCT00003262|Prednisone|prednisone|mesh-list
25813735|NCT00003262|Doxorubicin|doxorubicin|mesh-list
25813736|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25813737|NCT00003262|Epirubicin|epirubicin|mesh-list
25813738|NCT00003262|Bleomycin|bleomycin|mesh-list
25813739|NCT00003262|Etoposide|etoposide|mesh-list
25813740|NCT00003262|Vincristine|vincristine|mesh-list
25813741|NCT00003262|Vinblastine|vinblastine|mesh-list
25813742|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
25813743|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813744|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813745|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813746|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813747|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813748|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813749|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813750|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
25813751|NCT00003262|Hormones|hormones|mesh-ancestor
25813752|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813753|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813754|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813755|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813756|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813757|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813758|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813759|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
25813760|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813761|NCT00003263|Interferons|interferons|mesh-list
25813762|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
25813763|NCT00003263|Cisplatin|cisplatin|mesh-list
25813764|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813765|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
25813766|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813767|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
25813768|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813769|NCT00003264|Gemcitabine|gemcitabine|mesh-list
25813770|NCT00003264|Cisplatin|cisplatin|mesh-list
25813771|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813772|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813773|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
25813774|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813775|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
25813776|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813777|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813778|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813779|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
25813780|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813781|NCT00003266|Methylphenidate|methylphenidate|mesh-list
25813782|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25813783|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813784|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25813785|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25813786|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25813787|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813788|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
25813789|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25813790|NCT00003268|Cytarabine|cytarabine|mesh-list
25813791|NCT00003268|Idarubicin|idarubicin|mesh-list
25813792|NCT00003268|Amifostine|amifostine|mesh-list
25813793|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813794|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
25813795|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813796|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813797|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
25813798|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25813799|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107991|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107992|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107993|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24868893|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
25813800|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
25813801|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813802|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25813803|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813804|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813805|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813806|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813807|NCT00003268|Protective Agents|protective agents|mesh-ancestor
25813808|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
25813809|NCT00003269|Cisplatin|cisplatin|mesh-list
25813810|NCT00003269|Etoposide|etoposide|mesh-list
25813811|NCT00003269|Sargramostim|sargramostim|mesh-list
25813812|NCT00003269|Amifostine|amifostine|mesh-list
25813813|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813814|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
25813815|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813816|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813817|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813818|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
25813819|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813820|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813821|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813822|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813823|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813824|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813825|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813826|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813827|NCT00003269|Protective Agents|protective agents|mesh-ancestor
25813828|NCT00003273|Leucovorin|leucovorin|mesh-list
25813829|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
25813830|NCT00003273|Temozolomide|temozolomide|mesh-list
25813831|NCT00003273|Thiotepa|thiotepa|mesh-list
25813832|NCT00003273|Carboplatin|carboplatin|mesh-list
25813833|NCT00003273|Methotrexate|methotrexate|mesh-list
25813834|NCT00003273|Etoposide|etoposide|mesh-list
25813835|NCT00003273|Vincristine|vincristine|mesh-list
25813836|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
25813837|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813838|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
25813839|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813840|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813841|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813842|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
25813843|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813844|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813845|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813846|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25813847|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
25813848|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25813849|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813850|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
25813851|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
25813852|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813853|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25813854|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25813855|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813856|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813857|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813858|NCT00003273|Antidotes|antidotes|mesh-ancestor
25813859|NCT00003273|Protective Agents|protective agents|mesh-ancestor
25813860|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
25813861|NCT00003273|Vitamins|vitamins|mesh-ancestor
25813862|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
25813863|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813864|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813865|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813866|NCT00003274|Sargramostim|sargramostim|mesh-list
25813867|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
25813868|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
25813869|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451857|NCT00325000|Sertraline|sertraline|mesh-list
24451858|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
25813870|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25813871|NCT00003276|Irinotecan|irinotecan|mesh-list
25813872|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813873|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813874|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813875|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813876|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813877|NCT00003278|Dexamethasone|dexamethasone|mesh-list
25813878|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813879|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
25813880|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
25813881|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25813882|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813883|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25813884|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
25813885|NCT00003278|Hormones|hormones|mesh-ancestor
25813886|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813887|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813888|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813889|NCT00003279|Antibodies|antibodies|mesh-list
25813890|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25813891|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
25813892|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
25813893|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813894|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25813895|NCT00003280|Rituximab|rituximab|mesh-list
25813896|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25813897|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813898|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
25813899|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813900|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813901|NCT00003281|Paclitaxel|paclitaxel|mesh-list
25813902|NCT00003281|Topotecan|topotecan|mesh-list
25813903|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813904|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813905|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813906|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813907|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813908|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813909|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25813910|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813911|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813912|NCT00003283|Prednisone|prednisone|mesh-list
25813913|NCT00003283|Octreotide|octreotide|mesh-list
25813914|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25813915|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
25813916|NCT00003283|Hormones|hormones|mesh-ancestor
25813917|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813918|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813919|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25813920|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813921|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25813922|NCT00003284|Paclitaxel|paclitaxel|mesh-list
25813923|NCT00003284|Etoposide|etoposide|mesh-list
25813924|NCT00003284|Carboplatin|carboplatin|mesh-list
25813925|NCT00003284|Ifosfamide|ifosfamide|mesh-list
25813926|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813927|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813928|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813929|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813930|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813931|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813932|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25813933|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25813934|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813935|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813936|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
25813937|NCT00003287|Leucovorin|leucovorin|mesh-list
24995169|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24995170|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
24995171|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786068|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
25813938|NCT00003287|Fluorouracil|fluorouracil|mesh-list
25813939|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
25813940|NCT00003287|Calcium|calcium|mesh-list
25813941|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
25813942|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25813943|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813944|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
25813945|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813946|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25813947|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813948|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813949|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
25813950|NCT00003287|Antidotes|antidotes|mesh-ancestor
25813951|NCT00003287|Protective Agents|protective agents|mesh-ancestor
25813952|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
25813953|NCT00003287|Vitamins|vitamins|mesh-ancestor
25813954|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
25813955|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
25813956|NCT00003288|Tirapazamine|tirapazamine|mesh-list
25813957|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813958|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
25813959|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813960|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25813961|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813962|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
25813963|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813964|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813965|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25813966|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25813967|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813968|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25813969|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813970|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813971|NCT00003290|Hormones|hormones|mesh-list
25813972|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25813973|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813974|NCT00003292|Ifosfamide|ifosfamide|mesh-list
25813975|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25813976|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
25813977|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813978|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813979|NCT00003293|Procarbazine|procarbazine|mesh-list
25813980|NCT00003293|Leflunomide|leflunomide|mesh-list
25813981|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25813982|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813983|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25813984|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
25813985|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813986|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813987|NCT00003294|Paclitaxel|paclitaxel|mesh-list
25813988|NCT00003294|Carboplatin|carboplatin|mesh-list
25813989|NCT00003294|Amifostine|amifostine|mesh-list
25813990|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25813991|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25813992|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
25813993|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
25813994|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
25813995|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25813996|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25813997|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25813998|NCT00003294|Protective Agents|protective agents|mesh-ancestor
25813999|NCT00003296|Doxorubicin|doxorubicin|mesh-list
25814000|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814001|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814002|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814003|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814004|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814005|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814006|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797963|NCT01959204|Oxycodone|oxycodone|mesh-list
24797964|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24797965|NCT01959204|Narcotics|narcotics|mesh-ancestor
24797966|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108074|NCT03134547|Sevoflurane|sevoflurane|mesh-list
24797967|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797969|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
24603864|NCT00975936|Ketoconazole|ketoconazole|mesh-list
24798003|NCT01959477|Etoposide|etoposide|mesh-list
25814007|NCT00003297|Topotecan|topotecan|mesh-list
25814008|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
25814009|NCT00003297|Thiotepa|thiotepa|mesh-list
25814010|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814011|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814012|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814013|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814014|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814015|NCT00003297|Analgesics|analgesics|mesh-ancestor
25814016|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
25814017|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814018|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814019|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814020|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814021|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
25814022|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814023|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814024|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
25814025|NCT00003299|Paclitaxel|paclitaxel|mesh-list
25814026|NCT00003299|Etoposide|etoposide|mesh-list
25814027|NCT00003299|Cisplatin|cisplatin|mesh-list
25814028|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814029|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814030|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814031|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814032|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814033|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814034|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814035|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814036|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814037|NCT00003301|Irinotecan|irinotecan|mesh-list
25814038|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814039|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814040|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814041|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814042|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814043|NCT00003304|Temozolomide|temozolomide|mesh-list
25814044|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814045|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
25814046|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814047|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814048|NCT00003305|Leucovorin|leucovorin|mesh-list
25814049|NCT00003305|Calcium|calcium|mesh-list
25814050|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
25814051|NCT00003305|Aminopterin|aminopterin|mesh-list
25814052|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25814053|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814054|NCT00003305|Antidotes|antidotes|mesh-ancestor
25814055|NCT00003305|Protective Agents|protective agents|mesh-ancestor
25814056|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
25814057|NCT00003305|Vitamins|vitamins|mesh-ancestor
25814058|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
25814059|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25814060|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814061|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814062|NCT00003307|Amifostine|amifostine|mesh-list
25814063|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25814064|NCT00003307|Protective Agents|protective agents|mesh-ancestor
25814065|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814066|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
25814067|NCT00003309|Cisplatin|cisplatin|mesh-list
25814068|NCT00003309|Etoposide|etoposide|mesh-list
25814069|NCT00003309|Vincristine|vincristine|mesh-list
25814070|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814071|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
25814072|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814073|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814074|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24604805|NCT00981838|Rituximab|rituximab|mesh-list
25814075|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
25814076|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814077|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814078|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814079|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814080|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814081|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814082|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814083|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814084|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814085|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814086|NCT00003311|Cytarabine|cytarabine|mesh-list
25814087|NCT00003311|Dexamethasone|dexamethasone|mesh-list
25814088|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
25814089|NCT00003311|Doxorubicin|doxorubicin|mesh-list
25814090|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814091|NCT00003311|Methotrexate|methotrexate|mesh-list
25814092|NCT00003311|Vincristine|vincristine|mesh-list
25814093|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814094|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
25814095|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814096|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814097|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814098|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
25814099|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814100|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814101|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814102|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814103|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
25814104|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
25814105|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814106|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25814107|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
25814108|NCT00003311|Hormones|hormones|mesh-ancestor
25814109|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814110|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814111|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814112|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814113|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814114|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814115|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25814116|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
25814117|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25814118|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814119|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
25814120|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25814121|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25814122|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25814123|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
25814124|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814125|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814126|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814127|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814128|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814129|NCT00003313|Paclitaxel|paclitaxel|mesh-list
25814130|NCT00003313|Carboplatin|carboplatin|mesh-list
25814131|NCT00003313|Amifostine|amifostine|mesh-list
25814132|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814133|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814134|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814135|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814136|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814137|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814138|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814139|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25814140|NCT00003313|Protective Agents|protective agents|mesh-ancestor
25814141|NCT00003315|Amphotericin B|amphotericin b|mesh-list
25814142|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24605192|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25163100|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146419|NCT02921984|Docetaxel|docetaxel|mesh-list
24995553|NCT05071703|Etoposide|etoposide|mesh-list
24995554|NCT05071703|Topotecan|topotecan|mesh-list
24995555|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163101|NCT02899182|Analgesics|analgesics|mesh-ancestor
25814143|NCT00003315|Sargramostim|sargramostim|mesh-list
25814144|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
25814145|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814146|NCT00003315|Amebicides|amebicides|mesh-ancestor
25814147|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25814148|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25814149|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814150|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25814151|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
25814152|NCT00003316|Gemcitabine|gemcitabine|mesh-list
25814153|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814154|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
25814155|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814156|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814157|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
25814158|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814159|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814160|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814161|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
25814162|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814163|NCT00003317|Paclitaxel|paclitaxel|mesh-list
25814164|NCT00003317|Carboplatin|carboplatin|mesh-list
25814165|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814166|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814167|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814168|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814169|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814170|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814171|NCT00003322|Paclitaxel|paclitaxel|mesh-list
25814172|NCT00003322|Cisplatin|cisplatin|mesh-list
25814173|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814174|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814175|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814176|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814177|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814178|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814179|NCT00003323|Flutamide|flutamide|mesh-list
25814180|NCT00003323|Finasteride|finasteride|mesh-list
25814181|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25814182|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25814183|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814184|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814185|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
25814186|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814187|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814188|NCT00003323|Urological Agents|urological agents|mesh-ancestor
25814189|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
25814190|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814191|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814192|NCT00003326|Paclitaxel|paclitaxel|mesh-list
25814193|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814194|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814195|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814196|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814197|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814198|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814199|NCT00003327|Paclitaxel|paclitaxel|mesh-list
25814200|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814201|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814202|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814203|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814204|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814205|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814206|NCT00003328|Porfiromycin|porfiromycin|mesh-list
25814207|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814208|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814209|NCT00003330|Interleukin-12|interleukin-12|mesh-list
25814210|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25814211|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
25814212|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814213|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25814214|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24941567|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24941568|NCT03989830|Growth Substances|growth substances|mesh-ancestor
24941572|NCT03989336|Manganese|manganese|mesh-list
25814215|NCT00003330|Growth Substances|growth substances|mesh-ancestor
25814216|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25814217|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814218|NCT00003331|Leucovorin|leucovorin|mesh-list
25814219|NCT00003331|Fluorouracil|fluorouracil|mesh-list
25814220|NCT00003331|Topotecan|topotecan|mesh-list
25814221|NCT00003331|Calcium|calcium|mesh-list
25814222|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
25814223|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25814224|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814225|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
25814226|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814227|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814228|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814229|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814230|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
25814231|NCT00003331|Antidotes|antidotes|mesh-ancestor
25814232|NCT00003331|Protective Agents|protective agents|mesh-ancestor
25814233|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
25814234|NCT00003331|Vitamins|vitamins|mesh-ancestor
25814235|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
25814236|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814237|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814238|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814239|NCT00003332|Gemcitabine|gemcitabine|mesh-list
25814240|NCT00003332|Cisplatin|cisplatin|mesh-list
25814241|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814242|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814243|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
25814244|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814245|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
25814246|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814247|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814248|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25337111|NCT05455294|Navitoclax|navitoclax|mesh-list
25814249|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
25814250|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814251|NCT00003334|Paclitaxel|paclitaxel|mesh-list
25814252|NCT00003334|Doxorubicin|doxorubicin|mesh-list
25814253|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814254|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814255|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814256|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814257|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814258|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814259|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814260|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814261|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814262|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814263|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814264|NCT00003335|Cyclosporine|cyclosporine|mesh-list
25814265|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
25814266|NCT00003335|Melphalan|melphalan|mesh-list
25814267|NCT00003335|Busulfan|busulfan|mesh-list
25814268|NCT00003335|Cyclosporins|cyclosporins|mesh-list
25814269|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25814270|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814271|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814272|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814273|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
25814274|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814275|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
25814276|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814277|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
25814278|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814279|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25814280|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814281|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
25814282|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
25814283|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814284|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25814285|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
25814286|NCT00003335|Hormones|hormones|mesh-ancestor
25814287|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146628|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24995964|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995965|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
24995966|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995971|NCT04455815|Gabexate|gabexate|mesh-list
25814288|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25814289|NCT00003335|Protective Agents|protective agents|mesh-ancestor
25814290|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814291|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814292|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
25814293|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814294|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
25814295|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
25814296|NCT00003336|Melphalan|melphalan|mesh-list
25814297|NCT00003336|Busulfan|busulfan|mesh-list
25814298|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25814299|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814300|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
25814301|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814302|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814303|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814304|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
25814305|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814306|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814307|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814308|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814309|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
25814310|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
25814311|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814312|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25814313|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
25814314|NCT00003336|Hormones|hormones|mesh-ancestor
25814315|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814316|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25814317|NCT00003336|Protective Agents|protective agents|mesh-ancestor
25814318|NCT00003337|Epratuzumab|epratuzumab|mesh-list
25814319|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25814320|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814321|NCT00003338|Epratuzumab|epratuzumab|mesh-list
25814322|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25814323|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814324|NCT00003339|Interleukin-12|interleukin-12|mesh-list
25814325|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
25814326|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25814327|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
25814328|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814329|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25814330|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25814331|NCT00003339|Growth Substances|growth substances|mesh-ancestor
25814332|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
25814333|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814334|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
25814335|NCT00003340|Topotecan|topotecan|mesh-list
25814336|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814337|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
25814338|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814339|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814340|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814341|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
25814342|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814343|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814344|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814345|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814346|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814347|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814348|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
25814349|NCT00003341|Hematinics|hematinics|mesh-ancestor
25814350|NCT00003342|Gemcitabine|gemcitabine|mesh-list
25814351|NCT00003342|Paclitaxel|paclitaxel|mesh-list
25814352|NCT00003342|Carboplatin|carboplatin|mesh-list
25814353|NCT00003342|Doxorubicin|doxorubicin|mesh-list
25814354|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814355|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814356|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996126|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24996127|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24996128|NCT04188119|Analgesics|analgesics|mesh-ancestor
24996129|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
24996130|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996156|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24996160|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814357|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814358|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814359|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814360|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814361|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814362|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
25814363|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
25814364|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814365|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814366|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814367|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
25814368|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814369|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814370|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814371|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814372|NCT00003343|Prednisone|prednisone|mesh-list
25814373|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
25814374|NCT00003343|Prinomastat|prinomastat|mesh-list
25814375|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814376|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
25814377|NCT00003343|Hormones|hormones|mesh-ancestor
25814378|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814379|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814380|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814381|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814382|NCT00003343|Analgesics|analgesics|mesh-ancestor
25814383|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
25814384|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814385|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814386|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814387|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814388|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814389|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
25814390|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
25814391|NCT00003344|Irinotecan|irinotecan|mesh-list
25814392|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814393|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814394|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814395|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814396|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814397|NCT00003345|Cisplatin|cisplatin|mesh-list
25814398|NCT00003345|Irinotecan|irinotecan|mesh-list
25814399|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814400|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814401|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814402|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814403|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814404|NCT00003346|Acetaminophen|acetaminophen|mesh-list
25814405|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
25814406|NCT00003346|Carmustine|carmustine|mesh-list
25814407|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25814408|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25814409|NCT00003346|Analgesics|analgesics|mesh-ancestor
25814410|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
25814411|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814412|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814413|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
25814414|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
25814415|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814416|NCT00003346|Expectorants|expectorants|mesh-ancestor
25814417|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
25814418|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25814419|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
25814420|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814421|NCT00003346|Protective Agents|protective agents|mesh-ancestor
25814422|NCT00003346|Antidotes|antidotes|mesh-ancestor
25814423|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814424|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
25814425|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814426|NCT00003348|Carmustine|carmustine|mesh-list
25814427|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25814428|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814429|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
25814430|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146840|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
24996304|NCT03776071|Temozolomide|temozolomide|mesh-list
25814431|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814432|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814433|NCT00003350|Paclitaxel|paclitaxel|mesh-list
25814434|NCT00003350|Doxorubicin|doxorubicin|mesh-list
25814435|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814436|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814437|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814438|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814439|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814440|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814441|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814442|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814443|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814444|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814445|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814446|NCT00003351|Irinotecan|irinotecan|mesh-list
25814447|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814448|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814449|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814450|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814451|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814452|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
25814453|NCT00003352|Docetaxel|docetaxel|mesh-list
25814454|NCT00003352|Doxorubicin|doxorubicin|mesh-list
25814455|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814456|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814457|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
25814458|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814459|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814460|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814461|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
25814462|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814463|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814464|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814465|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814466|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814467|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814468|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814469|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814470|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814471|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814472|NCT00003353|Melphalan|melphalan|mesh-list
25814473|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
25814474|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814475|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814476|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
25814477|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814478|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814479|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814480|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814481|NCT00003356|Aldesleukin|aldesleukin|mesh-list
25814482|NCT00003356|Rituximab|rituximab|mesh-list
25814483|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25814484|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814485|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
25814486|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814487|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814488|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25814489|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25814490|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
25814491|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814492|NCT00003358|Gemcitabine|gemcitabine|mesh-list
25814493|NCT00003358|Cisplatin|cisplatin|mesh-list
25814494|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814495|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814496|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
25814497|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814498|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
25814499|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814500|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814501|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814502|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
25814503|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814504|NCT00003360|Antibodies|antibodies|mesh-list
25814505|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24798164|NCT01961193|Silicon|silicon|mesh-list
25814506|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
25814507|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814508|NCT00003361|Decitabine|decitabine|mesh-list
25814509|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814510|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
25814511|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814512|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814513|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996714|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
25814514|NCT00003362|Sargramostim|sargramostim|mesh-list
25814515|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
25814516|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
25814517|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814518|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25814519|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
25814520|NCT00003364|Cisplatin|cisplatin|mesh-list
25814521|NCT00003364|Doxorubicin|doxorubicin|mesh-list
25814522|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814523|NCT00003364|Etoposide|etoposide|mesh-list
25814524|NCT00003364|Vincristine|vincristine|mesh-list
25814525|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814526|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
25814527|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814528|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814529|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814530|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
25814531|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814532|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814533|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814534|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814535|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814536|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814537|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814538|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814539|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814540|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814541|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814542|NCT00003365|Curcumin|curcumin|mesh-list
25814543|NCT00003365|Sulindac|sulindac|mesh-list
25814544|NCT00003365|Quercetin|quercetin|mesh-list
25814545|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25814546|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25814547|NCT00003365|Analgesics|analgesics|mesh-ancestor
25814548|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
25814549|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814550|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814551|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814552|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814553|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814554|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814555|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814556|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
25814557|NCT00003365|Protective Agents|protective agents|mesh-ancestor
25814558|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25814559|NCT00003367|Vitamin E|vitamin e|mesh-list
25814560|NCT00003367|Vitamins|vitamins|mesh-ancestor
25814561|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
25814562|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814563|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
25814564|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814565|NCT00003367|Protective Agents|protective agents|mesh-ancestor
25814566|NCT00003368|Irinotecan|irinotecan|mesh-list
25814567|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814568|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814569|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814570|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814571|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814572|NCT00003369|Cisplatin|cisplatin|mesh-list
25814573|NCT00003369|Tirapazamine|tirapazamine|mesh-list
25814574|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814575|NCT00003370|Irofulven|irofulven|mesh-list
25814576|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814577|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
25814578|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814579|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814580|NCT00003372|Topotecan|topotecan|mesh-list
24591965|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
24871227|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25814581|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814582|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814583|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814584|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814585|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814586|NCT00003375|Vincristine|vincristine|mesh-list
25814587|NCT00003375|Lomustine|lomustine|mesh-list
25814588|NCT00003375|Procarbazine|procarbazine|mesh-list
25814589|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814590|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814591|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814592|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814593|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814594|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814595|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814596|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
25814597|NCT00003376|Paclitaxel|paclitaxel|mesh-list
25814598|NCT00003376|Vinblastine|vinblastine|mesh-list
25814599|NCT00003376|Cisplatin|cisplatin|mesh-list
25814600|NCT00003376|Carboplatin|carboplatin|mesh-list
25814601|NCT00003376|Doxorubicin|doxorubicin|mesh-list
25814602|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814603|NCT00003376|Methotrexate|methotrexate|mesh-list
25814604|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814605|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814606|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814607|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814608|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814609|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814610|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814611|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814612|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814613|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339084|NCT04313634|Dasatinib|dasatinib|mesh-list
25814614|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25814615|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
25814616|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25814617|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814618|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814619|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
25814620|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
25814621|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25814622|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814623|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
25814624|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814625|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25814626|NCT00003378|Gemcitabine|gemcitabine|mesh-list
25814627|NCT00003378|Paclitaxel|paclitaxel|mesh-list
25814628|NCT00003378|Carboplatin|carboplatin|mesh-list
25814629|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814630|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814631|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814632|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814633|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814634|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814635|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814636|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
25814637|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
25814638|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814639|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814640|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814641|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
25814642|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814643|NCT00003379|Paclitaxel|paclitaxel|mesh-list
25814644|NCT00003379|Cisplatin|cisplatin|mesh-list
25814645|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814646|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814647|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814648|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814649|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814650|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814651|NCT00003380|Doxorubicin|doxorubicin|mesh-list
25814652|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814653|NCT00003380|Etoposide|etoposide|mesh-list
25814654|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814655|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814656|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24857145|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
25814657|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814658|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814659|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814660|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814661|NCT00003382|Gemcitabine|gemcitabine|mesh-list
25814662|NCT00003382|Topotecan|topotecan|mesh-list
25814663|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814664|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
25814665|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814666|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814667|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
25814668|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814669|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814670|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814671|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
25814672|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814673|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25814674|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814675|NCT00003385|Paclitaxel|paclitaxel|mesh-list
25814676|NCT00003385|Carboplatin|carboplatin|mesh-list
25814677|NCT00003385|Doxorubicin|doxorubicin|mesh-list
25814678|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814679|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814680|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814681|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814682|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814683|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814684|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814685|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25814686|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814687|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814688|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814689|NCT00003386|Paclitaxel|paclitaxel|mesh-list
25814690|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
25814691|NCT00003386|Cisplatin|cisplatin|mesh-list
25814692|NCT00003386|Carboplatin|carboplatin|mesh-list
25814693|NCT00003386|Vaccines|vaccines|mesh-list
25814694|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
25814695|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
25814696|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814697|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814698|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814699|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814700|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814701|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814702|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814703|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814704|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814705|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814706|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
25814707|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814708|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25814709|NCT00003387|Paclitaxel|paclitaxel|mesh-list
25814710|NCT00003387|Carboplatin|carboplatin|mesh-list
25814711|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814712|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814713|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814714|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814715|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814716|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814717|NCT00003388|Cytarabine|cytarabine|mesh-list
25814718|NCT00003388|Prednisone|prednisone|mesh-list
25814719|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
25814720|NCT00003388|Doxorubicin|doxorubicin|mesh-list
25814721|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25814722|NCT00003388|Methotrexate|methotrexate|mesh-list
25814723|NCT00003388|Vincristine|vincristine|mesh-list
25814724|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814725|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
25814726|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814727|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814728|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814729|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
25814730|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814731|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814732|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814733|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24800566|NCT01976208|Omalizumab|omalizumab|mesh-list
25814734|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814735|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814736|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814737|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814738|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
25814739|NCT00003388|Hormones|hormones|mesh-ancestor
25814740|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814741|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814742|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25814743|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
25814744|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25814745|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814746|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
25814747|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
25814748|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25814749|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25814750|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
25814751|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814752|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814753|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814754|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814755|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814756|NCT00003390|Irofulven|irofulven|mesh-list
25814757|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814758|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
25814759|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814760|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814761|NCT00003391|Antibodies|antibodies|mesh-list
25814762|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25814763|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
25814764|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814765|NCT00003392|Paclitaxel|paclitaxel|mesh-list
25814766|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
25814767|NCT00003392|Carboplatin|carboplatin|mesh-list
25814768|NCT00003392|Melphalan|melphalan|mesh-list
25814769|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814770|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814771|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814772|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814773|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814774|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814775|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814776|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
25814777|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814778|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814779|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814780|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
25814781|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814782|NCT00003394|Paclitaxel|paclitaxel|mesh-list
25814783|NCT00003394|Carboplatin|carboplatin|mesh-list
25814784|NCT00003394|Leuprolide|leuprolide|mesh-list
25814785|NCT00003394|Goserelin|goserelin|mesh-list
25814786|NCT00003394|Estramustine|estramustine|mesh-list
25814787|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814788|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814789|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814790|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814791|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814792|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814793|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25814794|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
25814795|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25814796|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814797|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814798|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814799|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
25814800|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
25814801|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814802|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
25814803|NCT00003396|Melphalan|melphalan|mesh-list
25814804|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25814805|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814806|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
25814807|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814808|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814809|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814810|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
25814811|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814813|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814814|NCT00003397|Gemcitabine|gemcitabine|mesh-list
25814815|NCT00003397|Dexamethasone|dexamethasone|mesh-list
25814816|NCT00003397|Etoposide|etoposide|mesh-list
25814817|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
25814818|NCT00003397|Rituximab|rituximab|mesh-list
25814819|NCT00003397|Melphalan|melphalan|mesh-list
25814820|NCT00003397|Carmustine|carmustine|mesh-list
25814821|NCT00003397|Sargramostim|sargramostim|mesh-list
25814822|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814823|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814824|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814825|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814826|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
25814827|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814828|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814829|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814830|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
25814831|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814832|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25814833|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814834|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
25814835|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
25814836|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814837|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25814838|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
25814839|NCT00003397|Hormones|hormones|mesh-ancestor
25814840|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814841|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814842|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814843|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
25814844|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
25814845|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814846|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814847|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814848|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814849|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
25814850|NCT00003398|Thiotepa|thiotepa|mesh-list
25814851|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25814852|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814853|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
25814854|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814855|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814856|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814857|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
25814858|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814859|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814860|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814861|NCT00003399|Dexamethasone|dexamethasone|mesh-list
25814862|NCT00003399|Paclitaxel|paclitaxel|mesh-list
25814863|NCT00003399|Etoposide|etoposide|mesh-list
25814864|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
25814865|NCT00003399|Cisplatin|cisplatin|mesh-list
25814866|NCT00003399|Melphalan|melphalan|mesh-list
25814867|NCT00003399|Carmustine|carmustine|mesh-list
25814868|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814869|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814870|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814871|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814872|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814873|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814874|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814875|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
25814876|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814877|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814878|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814879|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
25814880|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814881|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814882|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
25814883|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
25814884|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814885|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25814886|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
25814887|NCT00003399|Hormones|hormones|mesh-ancestor
25814888|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814889|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814891|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814892|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814893|NCT00003400|Cisplatin|cisplatin|mesh-list
25814894|NCT00003400|Melphalan|melphalan|mesh-list
25814895|NCT00003400|Vinorelbine|vinorelbine|mesh-list
25814896|NCT00003400|Carmustine|carmustine|mesh-list
25814897|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814898|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
25814899|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814900|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814901|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
25814902|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814903|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814904|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814905|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814906|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814907|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814908|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814909|NCT00003401|Gemcitabine|gemcitabine|mesh-list
25814910|NCT00003401|Dexamethasone|dexamethasone|mesh-list
25814911|NCT00003401|Paclitaxel|paclitaxel|mesh-list
25814912|NCT00003401|Etoposide|etoposide|mesh-list
25814913|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
25814914|NCT00003401|Cisplatin|cisplatin|mesh-list
25814915|NCT00003401|Melphalan|melphalan|mesh-list
25814916|NCT00003401|Carmustine|carmustine|mesh-list
25814917|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814918|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814919|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814920|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814921|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814922|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814923|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814924|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
25814925|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814926|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814927|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814928|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
25814929|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814930|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814931|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
25814932|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
25814933|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814934|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25814935|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
25814936|NCT00003401|Hormones|hormones|mesh-ancestor
25814937|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814938|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814939|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814940|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
25814941|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
25814942|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814943|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814944|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814945|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814946|NCT00003402|Dexamethasone|dexamethasone|mesh-list
25814947|NCT00003402|Paclitaxel|paclitaxel|mesh-list
25814948|NCT00003402|Etoposide|etoposide|mesh-list
25814949|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
25814950|NCT00003402|Cisplatin|cisplatin|mesh-list
25814951|NCT00003402|Melphalan|melphalan|mesh-list
25814952|NCT00003402|Carmustine|carmustine|mesh-list
25814953|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25814954|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814955|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
25814956|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
25814957|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
25814958|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814959|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814960|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
25814961|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814962|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25814963|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25814964|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
25814965|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25814966|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25814967|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
25814968|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
25814969|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25814970|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25814971|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
25814972|NCT00003402|Hormones|hormones|mesh-ancestor
25814973|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25814974|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25814975|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25814976|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25814977|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25814978|NCT00003405|Interferons|interferons|mesh-list
25814979|NCT00003405|Cytarabine|cytarabine|mesh-list
25814980|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
25814981|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
25814982|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
25814983|NCT00003405|Idoxuridine|idoxuridine|mesh-list
25814984|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
25814985|NCT00003405|Idarubicin|idarubicin|mesh-list
25814986|NCT00003405|Isotretinoin|isotretinoin|mesh-list
25814987|NCT00003405|Amifostine|amifostine|mesh-list
25814988|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814989|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
25814990|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25814991|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25814992|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
25814993|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25814994|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25814995|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
25814996|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25814997|NCT00003405|Analgesics|analgesics|mesh-ancestor
25814998|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
25814999|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815000|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815001|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815002|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815003|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815004|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815005|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25815006|NCT00003405|Protective Agents|protective agents|mesh-ancestor
25815007|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25815008|NCT00003406|Carboplatin|carboplatin|mesh-list
25815009|NCT00003406|Docetaxel|docetaxel|mesh-list
25815010|NCT00003406|Ifosfamide|ifosfamide|mesh-list
25815011|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815012|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815013|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815014|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815015|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815016|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815017|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
25815018|NCT00003407|Cytarabine|cytarabine|mesh-list
25815019|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
25815020|NCT00003407|Amifostine|amifostine|mesh-list
25815021|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815022|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
25815023|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815024|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815025|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
25815026|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815027|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815028|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
25815029|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815030|NCT00003407|Analgesics|analgesics|mesh-ancestor
25815031|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
25815032|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815033|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815034|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815035|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815036|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25815037|NCT00003407|Protective Agents|protective agents|mesh-ancestor
25815038|NCT00003408|Interferons|interferons|mesh-list
25815039|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
25815041|NCT00003408|Sargramostim|sargramostim|mesh-list
25815042|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815043|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
25815044|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815045|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
25815046|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815047|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25815048|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25815049|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
25815050|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815051|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25815052|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815053|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
25815054|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815055|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25815056|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815057|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
25815058|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815059|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25815060|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815061|NCT00003412|Interleukin-12|interleukin-12|mesh-list
25815062|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815063|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
25815064|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815065|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25815066|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25815067|NCT00003412|Growth Substances|growth substances|mesh-ancestor
25815068|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
25815069|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815070|NCT00003413|Paclitaxel|paclitaxel|mesh-list
25815071|NCT00003413|Cisplatin|cisplatin|mesh-list
25815072|NCT00003413|Melphalan|melphalan|mesh-list
25815073|NCT00003413|Carmustine|carmustine|mesh-list
25815074|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815075|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815076|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815077|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815078|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815079|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815080|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
25815081|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815082|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815083|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
25815084|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815085|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815086|NCT00003414|Interferons|interferons|mesh-list
25815087|NCT00003414|Aldesleukin|aldesleukin|mesh-list
25815088|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
25815089|NCT00003414|Cyclosporine|cyclosporine|mesh-list
25815090|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
25815091|NCT00003414|Busulfan|busulfan|mesh-list
25815092|NCT00003414|Cyclosporins|cyclosporins|mesh-list
25815093|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815094|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
25815095|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815096|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815097|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815098|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
25815099|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815100|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815101|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815102|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
25815103|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815104|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815105|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
25815106|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815107|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25815108|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25815109|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25815110|NCT00003415|Topotecan|topotecan|mesh-list
25815111|NCT00003415|Amifostine|amifostine|mesh-list
25815112|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25815113|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815114|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815115|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815116|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815117|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25815118|NCT00003415|Protective Agents|protective agents|mesh-ancestor
25815119|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815120|NCT00003416|Interferons|interferons|mesh-list
25815121|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
25815122|NCT00003416|Dexamethasone|dexamethasone|mesh-list
25815123|NCT00003416|Melphalan|melphalan|mesh-list
25815124|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815125|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
25815126|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
25815127|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815128|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815129|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25815130|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
25815131|NCT00003416|Hormones|hormones|mesh-ancestor
25815132|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815133|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815134|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815135|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
25815136|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815137|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
25815138|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815139|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
25815140|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815141|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815142|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815143|NCT00003417|Carmustine|carmustine|mesh-list
25815144|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815145|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
25815146|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815147|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815148|NCT00003418|Tamoxifen|tamoxifen|mesh-list
25815149|NCT00003418|Exemestane|exemestane|mesh-list
25815150|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815151|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25815152|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
25815153|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815154|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815155|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815156|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815157|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25815158|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25815159|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25815160|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25815161|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25815162|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815163|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
25815164|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815165|NCT00003421|Prednisolone|prednisolone|mesh-list
25815166|NCT00003421|Doxorubicin|doxorubicin|mesh-list
25815167|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25815168|NCT00003421|Bleomycin|bleomycin|mesh-list
25815169|NCT00003421|Etoposide|etoposide|mesh-list
25815170|NCT00003421|Vincristine|vincristine|mesh-list
25815171|NCT00003421|Dacarbazine|dacarbazine|mesh-list
25815172|NCT00003421|Vinblastine|vinblastine|mesh-list
25815173|NCT00003421|Procarbazine|procarbazine|mesh-list
25815174|NCT00003421|Chlorambucil|chlorambucil|mesh-list
25815175|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815176|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815177|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815178|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815179|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815180|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815181|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815182|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815183|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815184|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815185|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815186|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
25815187|NCT00003421|Hormones|hormones|mesh-ancestor
24534221|NCT00646529|Budesonide|budesonide|mesh-list
25815188|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815189|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815190|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815191|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815192|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
25815193|NCT00003422|Leucovorin|leucovorin|mesh-list
25815194|NCT00003422|Fluorouracil|fluorouracil|mesh-list
25815195|NCT00003422|Calcium|calcium|mesh-list
25815196|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
25815197|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25815198|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815199|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
25815200|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815201|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815202|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815203|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815204|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
25815205|NCT00003422|Antidotes|antidotes|mesh-ancestor
25815206|NCT00003422|Protective Agents|protective agents|mesh-ancestor
25815207|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
25815208|NCT00003422|Vitamins|vitamins|mesh-ancestor
25815209|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
25815210|NCT00003423|Cytarabine|cytarabine|mesh-list
25815211|NCT00003423|Dexamethasone|dexamethasone|mesh-list
25815212|NCT00003423|Prednisolone|prednisolone|mesh-list
25815213|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
25815214|NCT00003423|Methotrexate|methotrexate|mesh-list
25815215|NCT00003423|Etoposide|etoposide|mesh-list
25815216|NCT00003423|Vincristine|vincristine|mesh-list
25815217|NCT00003423|Daunorubicin|daunorubicin|mesh-list
25815218|NCT00003423|Asparaginase|asparaginase|mesh-list
25815219|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
25815220|NCT00003423|Thioguanine|thioguanine|mesh-list
25815221|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815222|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
25815223|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815224|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815225|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815226|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
25815227|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815228|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815229|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815230|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815231|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
25815232|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
25815233|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815234|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25815235|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
25815236|NCT00003423|Hormones|hormones|mesh-ancestor
25815237|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815238|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815239|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25815240|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
25815241|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25815242|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815243|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
25815244|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815245|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815246|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25815247|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25815248|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815249|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815250|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815251|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
25815252|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815253|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815254|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815255|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815256|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815257|NCT00003424|Tamoxifen|tamoxifen|mesh-list
25815258|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25815259|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
25815260|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815261|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815262|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815263|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815264|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25815265|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25815266|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25815267|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
25815268|NCT00003425|Melphalan|melphalan|mesh-list
25815269|NCT00003425|Amifostine|amifostine|mesh-list
25815270|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815271|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
25815272|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815273|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815274|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815275|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
25815276|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815277|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815278|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815279|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25815280|NCT00003425|Protective Agents|protective agents|mesh-ancestor
25815281|NCT00003426|Gemcitabine|gemcitabine|mesh-list
25815282|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815283|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
25815284|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815285|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815286|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
25815287|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815288|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815289|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815290|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
25815291|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815292|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
25815293|NCT00003427|Irinotecan|irinotecan|mesh-list
25815294|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815295|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25815296|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815297|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815298|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815299|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25815300|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25815301|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815302|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
25815303|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815304|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
25815305|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815306|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25815307|NCT00003431|Protective Agents|protective agents|mesh-ancestor
25815308|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
25815309|NCT00003435|Melphalan|melphalan|mesh-list
25815310|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25815311|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815312|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
25815313|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815314|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815315|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815316|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815317|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
25815318|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815319|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815320|NCT00003436|Cytarabine|cytarabine|mesh-list
25815321|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
25815322|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25815323|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25815324|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25815325|NCT00003436|Methotrexate|methotrexate|mesh-list
25815326|NCT00003436|Etoposide|etoposide|mesh-list
25815327|NCT00003436|Daunorubicin|daunorubicin|mesh-list
25815328|NCT00003436|Asparaginase|asparaginase|mesh-list
25815329|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
25815330|NCT00003436|Amsacrine|amsacrine|mesh-list
25815331|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25815332|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
25815333|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25815334|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815335|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815336|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
25815337|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815338|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815340|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815341|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25815342|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815343|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
25815344|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815345|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25815346|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815347|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815348|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815349|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
25815350|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815351|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815352|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815353|NCT00003436|Analgesics|analgesics|mesh-ancestor
25815354|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
25815355|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815356|NCT00003437|Cytarabine|cytarabine|mesh-list
25815357|NCT00003437|Dexamethasone|dexamethasone|mesh-list
25815358|NCT00003437|Prednisolone|prednisolone|mesh-list
25815359|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
25815360|NCT00003437|Doxorubicin|doxorubicin|mesh-list
25815361|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25815362|NCT00003437|Methotrexate|methotrexate|mesh-list
25815363|NCT00003437|Vincristine|vincristine|mesh-list
25815364|NCT00003437|Daunorubicin|daunorubicin|mesh-list
25815365|NCT00003437|Asparaginase|asparaginase|mesh-list
25815366|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
25815367|NCT00003437|Pegaspargase|pegaspargase|mesh-list
25815368|NCT00003437|Thioguanine|thioguanine|mesh-list
25815369|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815370|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
25815371|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815372|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815373|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815374|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
25815375|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815376|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815377|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815378|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815379|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
25815380|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
25815381|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815382|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25815383|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
25815384|NCT00003437|Hormones|hormones|mesh-ancestor
25815385|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815386|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815387|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815388|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815389|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815390|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815391|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25815392|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
25815393|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25815394|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815395|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
25815396|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815397|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25815398|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25815399|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
25815400|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815401|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815402|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815403|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815404|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815405|NCT00003439|Interleukin-12|interleukin-12|mesh-list
25815406|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815407|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
25815408|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815409|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25815410|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25815411|NCT00003439|Growth Substances|growth substances|mesh-ancestor
25815412|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
25815413|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815414|NCT00003440|Paclitaxel|paclitaxel|mesh-list
25815415|NCT00003440|Trastuzumab|trastuzumab|mesh-list
25815416|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815417|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815418|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815419|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815420|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815421|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815422|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25815423|NCT00003441|Irofulven|irofulven|mesh-list
25815424|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815425|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
25815426|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815427|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815428|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
25343156|NCT05555667|Propofol|propofol|mesh-list
25343157|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343161|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
25815429|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815430|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
25815431|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815432|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815433|NCT00003444|Interferons|interferons|mesh-list
25815434|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
25815435|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815436|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
25815437|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815438|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
25815439|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815440|NCT00003445|Docetaxel|docetaxel|mesh-list
25815441|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815442|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815443|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815444|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815445|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815446|NCT00003446|Leucovorin|leucovorin|mesh-list
25815447|NCT00003446|Trimetrexate|trimetrexate|mesh-list
25815448|NCT00003446|Fluorouracil|fluorouracil|mesh-list
25815449|NCT00003446|Calcium|calcium|mesh-list
25815450|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
25815451|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25815452|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815453|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
25815454|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815455|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815456|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815457|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815458|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
25815459|NCT00003446|Antidotes|antidotes|mesh-ancestor
25815460|NCT00003446|Protective Agents|protective agents|mesh-ancestor
25815461|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
25815462|NCT00003446|Vitamins|vitamins|mesh-ancestor
25815463|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
25815464|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
25815465|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815466|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25815467|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815468|NCT00003447|Gemcitabine|gemcitabine|mesh-list
25815469|NCT00003447|Vinorelbine|vinorelbine|mesh-list
25815470|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815471|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
25815472|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815473|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815474|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
25815475|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815476|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815477|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815478|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
25815479|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815480|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815481|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815482|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815483|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815484|NCT00003449|Gemcitabine|gemcitabine|mesh-list
25815485|NCT00003449|Dexamethasone|dexamethasone|mesh-list
25815486|NCT00003449|Paclitaxel|paclitaxel|mesh-list
25815487|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815488|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815489|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815490|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815491|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815492|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815493|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815494|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
25815495|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
25815496|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815497|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815498|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25815499|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
25815501|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815502|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815503|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815504|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
25815505|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
25815506|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815507|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815508|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815509|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
25815510|NCT00003451|Interferons|interferons|mesh-list
25815511|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
25815512|NCT00003451|Interleukin-12|interleukin-12|mesh-list
25815513|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815514|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
25815515|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815516|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
25815517|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815518|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815519|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25815520|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25815521|NCT00003451|Growth Substances|growth substances|mesh-ancestor
25815522|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
25815523|NCT00003461|Antibodies|antibodies|mesh-list
25815524|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25815525|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
25815526|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815527|NCT00003462|Busulfan|busulfan|mesh-list
25815528|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
25815529|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815530|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815531|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
25815532|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815533|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815534|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815535|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815536|NCT00003463|Irinotecan|irinotecan|mesh-list
25815537|NCT00003463|Carmustine|carmustine|mesh-list
25815538|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25815539|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815540|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815541|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815542|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815543|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815544|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
25815545|NCT00003464|Temozolomide|temozolomide|mesh-list
25815546|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815547|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
25815548|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815549|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815550|NCT00003465|Temozolomide|temozolomide|mesh-list
25815551|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815552|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
25815553|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815554|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815555|NCT00003466|Temozolomide|temozolomide|mesh-list
25815556|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815557|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
25815558|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815559|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815560|NCT00003467|Carmustine|carmustine|mesh-list
25815561|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815562|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
25815563|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924315|NCT04161014|Nintedanib|nintedanib|mesh-list
25815564|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815566|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25815567|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
25815568|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815569|NCT00003484|Irinotecan|irinotecan|mesh-list
25815570|NCT00003484|Carmustine|carmustine|mesh-list
25815571|NCT00003484|Antibodies|antibodies|mesh-list
25815572|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25815573|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
25815574|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815575|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25815576|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815577|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815578|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815579|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815580|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815581|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
25815582|NCT00003490|Prednisone|prednisone|mesh-list
25815583|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
25815584|NCT00003490|Vincristine|vincristine|mesh-list
25815585|NCT00003490|Sargramostim|sargramostim|mesh-list
25815586|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815587|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
25815588|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815589|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815590|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815591|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
25815592|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815593|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815594|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815595|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815596|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
25815597|NCT00003490|Hormones|hormones|mesh-ancestor
25815598|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815599|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815600|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815601|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815602|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815603|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815604|NCT00003493|Dexamethasone|dexamethasone|mesh-list
25815605|NCT00003493|Doxorubicin|doxorubicin|mesh-list
25815606|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25815607|NCT00003493|Vincristine|vincristine|mesh-list
25815608|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815609|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
25815610|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
25815611|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25815612|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815613|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25815614|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
25815615|NCT00003493|Hormones|hormones|mesh-ancestor
25815616|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815617|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815618|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815619|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815620|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815621|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815622|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815623|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815624|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815625|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815626|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815627|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815628|NCT00003517|Leuprolide|leuprolide|mesh-list
25815629|NCT00003517|Flutamide|flutamide|mesh-list
25815630|NCT00003517|Bicalutamide|bicalutamide|mesh-list
25815631|NCT00003517|Hormones|hormones|mesh-list
25815632|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
25815633|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815634|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815635|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25815636|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
25815637|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25815638|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815639|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815640|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
25815641|NCT00003518|Gemcitabine|gemcitabine|mesh-list
25815642|NCT00003518|Paclitaxel|paclitaxel|mesh-list
25815643|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815644|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815645|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815646|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815647|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815648|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815649|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815650|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
25815651|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
25815652|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815653|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815654|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815655|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
25815656|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815657|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
25815658|NCT00003519|Docetaxel|docetaxel|mesh-list
25815659|NCT00003519|Doxorubicin|doxorubicin|mesh-list
25815660|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25815661|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815662|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
25815663|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815664|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815665|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815666|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
25815667|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815668|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815669|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815670|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815671|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815672|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815673|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815674|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815675|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815676|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815677|NCT00003528|Raltitrexed|raltitrexed|mesh-list
25815678|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815679|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
25815680|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815681|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815682|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25815683|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815684|NCT00003536|Methotrexate|methotrexate|mesh-list
25815685|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25815686|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
25815687|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25815688|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815689|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815690|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
25815691|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815692|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815693|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815694|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815695|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25815696|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815697|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
25815698|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815699|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25815700|NCT00003539|Paclitaxel|paclitaxel|mesh-list
25815701|NCT00003539|Trastuzumab|trastuzumab|mesh-list
25815702|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815703|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815704|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815705|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815706|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815707|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815708|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25815709|NCT00003540|Gemcitabine|gemcitabine|mesh-list
25815710|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815711|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
25815712|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815713|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815714|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
25815715|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815716|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815717|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815718|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
25815719|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815720|NCT00003541|Prednisone|prednisone|mesh-list
25815721|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
25815722|NCT00003541|Ifosfamide|ifosfamide|mesh-list
25815723|NCT00003541|Carboplatin|carboplatin|mesh-list
25815724|NCT00003541|Doxorubicin|doxorubicin|mesh-list
25815725|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25815726|NCT00003541|Etoposide|etoposide|mesh-list
25815727|NCT00003541|Vincristine|vincristine|mesh-list
25815728|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815729|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
25815730|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815731|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815732|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815733|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
25815734|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815735|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815736|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815737|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815738|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815739|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815740|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815741|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815742|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
25815743|NCT00003541|Hormones|hormones|mesh-ancestor
25815744|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815745|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815746|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815747|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815748|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815749|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815750|NCT00003542|Interferons|interferons|mesh-list
25815751|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
25815752|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815753|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
25815754|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815755|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
25815756|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815757|NCT00003543|Fluorouracil|fluorouracil|mesh-list
25815758|NCT00003543|Vincristine|vincristine|mesh-list
25815759|NCT00003543|Carmustine|carmustine|mesh-list
25815760|NCT00003543|Streptozocin|streptozocin|mesh-list
25815761|NCT00003543|Antibodies|antibodies|mesh-list
25815762|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25815763|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
25815764|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815765|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
25815766|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815767|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815768|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815769|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815770|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815771|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815772|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815773|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815774|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815775|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
25815776|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815778|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25815779|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815780|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815781|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815782|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815783|NCT00003546|Gemcitabine|gemcitabine|mesh-list
25815784|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815785|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
25815786|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815787|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815788|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
25815789|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815790|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815791|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815792|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
25815793|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815794|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
25815795|NCT00003549|Fluorouracil|fluorouracil|mesh-list
25815796|NCT00003549|Methotrexate|methotrexate|mesh-list
25815797|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815798|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
25815799|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815800|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815801|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815802|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
25815803|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815804|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815805|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815806|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
25815807|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815808|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25815809|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
25815810|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25815811|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815812|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815813|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25815814|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25815815|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
25815816|NCT00003552|Fludarabine|fludarabine|mesh-list
25815817|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25815818|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815819|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
25815820|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815821|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815822|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815823|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
25815824|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815825|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815826|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815827|NCT00003554|Prednisone|prednisone|mesh-list
25815828|NCT00003554|Rituximab|rituximab|mesh-list
25815829|NCT00003554|Melphalan|melphalan|mesh-list
25815830|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25815831|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815832|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
25815833|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815834|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815835|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25815836|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
25815837|NCT00003554|Hormones|hormones|mesh-ancestor
25815838|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25815839|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25815840|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815841|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
24539205|NCT00662805|Xhance|xhance|mesh-list
25815842|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815844|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815845|NCT00003555|Paclitaxel|paclitaxel|mesh-list
25815846|NCT00003555|Amifostine|amifostine|mesh-list
25815847|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815848|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815849|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815850|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815851|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815852|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815853|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25815854|NCT00003555|Protective Agents|protective agents|mesh-ancestor
25815855|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815856|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
25815857|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815858|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815859|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815860|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815861|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815862|NCT00003558|Leucovorin|leucovorin|mesh-list
25815863|NCT00003558|Paclitaxel|paclitaxel|mesh-list
25815864|NCT00003558|Etoposide|etoposide|mesh-list
25815865|NCT00003558|Carboplatin|carboplatin|mesh-list
25815866|NCT00003558|Fluorouracil|fluorouracil|mesh-list
25815867|NCT00003558|Calcium|calcium|mesh-list
25815868|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
25815869|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815870|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815871|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815872|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815873|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815874|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815875|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25815876|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815877|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
25815878|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815879|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815880|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
25815881|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815882|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815883|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815884|NCT00003558|Antidotes|antidotes|mesh-ancestor
25815885|NCT00003558|Protective Agents|protective agents|mesh-ancestor
25815886|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
25815887|NCT00003558|Vitamins|vitamins|mesh-ancestor
25815888|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
25815889|NCT00003560|Carboplatin|carboplatin|mesh-list
25815890|NCT00003560|Docetaxel|docetaxel|mesh-list
25815891|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815892|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815893|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815894|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815895|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815896|NCT00003561|Interferons|interferons|mesh-list
25815897|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
25815898|NCT00003561|Sargramostim|sargramostim|mesh-list
25815899|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815900|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
25815901|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815902|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
25815903|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815904|NCT00003562|Carboplatin|carboplatin|mesh-list
25815905|NCT00003562|Docetaxel|docetaxel|mesh-list
25815906|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815907|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815908|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815909|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815910|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815911|NCT00003564|Procarbazine|procarbazine|mesh-list
25815912|NCT00003564|Isotretinoin|isotretinoin|mesh-list
25815913|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815914|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815915|NCT00003565|Docetaxel|docetaxel|mesh-list
25815916|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815917|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815918|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815919|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815920|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815921|NCT00003567|Temozolomide|temozolomide|mesh-list
25815922|NCT00003567|Carmustine|carmustine|mesh-list
25815923|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25815924|NCT00003567|Sargramostim|sargramostim|mesh-list
25815925|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
25815926|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815927|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815928|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
25815929|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815930|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815931|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815932|NCT00003568|Aldesleukin|aldesleukin|mesh-list
25815933|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
25815934|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815935|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25815936|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25815937|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
25815938|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815939|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815940|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
25815941|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815942|NCT00003569|Paclitaxel|paclitaxel|mesh-list
25815943|NCT00003569|Cisplatin|cisplatin|mesh-list
25815944|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815945|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815946|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815947|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815948|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815949|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815950|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
25815951|NCT00003572|Tacrolimus|tacrolimus|mesh-list
25815952|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815953|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
25815954|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815955|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25815956|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815957|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815958|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25815959|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815960|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25815961|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
25815962|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25815963|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25815964|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
25815965|NCT00003573|Cisplatin|cisplatin|mesh-list
25815966|NCT00003573|Etoposide|etoposide|mesh-list
25815967|NCT00003573|Vincristine|vincristine|mesh-list
25815968|NCT00003573|Lenograstim|lenograstim|mesh-list
25815969|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25815970|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
25815971|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815972|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25815973|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815974|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
25815975|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815976|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815977|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25815978|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815979|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815980|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25815981|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815982|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815983|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25815984|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25815985|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
25815986|NCT00003575|Etoposide|etoposide|mesh-list
25815987|NCT00003575|Ifosfamide|ifosfamide|mesh-list
25815988|NCT00003575|Interleukin-12|interleukin-12|mesh-list
25815989|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25815990|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25815991|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25815992|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24458527|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458528|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815993|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25815994|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25815995|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25815996|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
25815997|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25815998|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25815999|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
25816000|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25816001|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25816002|NCT00003575|Growth Substances|growth substances|mesh-ancestor
25816003|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
25816004|NCT00003576|Cisplatin|cisplatin|mesh-list
25816005|NCT00003576|Fluorouracil|fluorouracil|mesh-list
25816006|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816007|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
25816008|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816009|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816010|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816011|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
25816012|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816013|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
25816014|NCT00003577|Fluorouracil|fluorouracil|mesh-list
25816015|NCT00003577|Methotrexate|methotrexate|mesh-list
25816016|NCT00003577|Epirubicin|epirubicin|mesh-list
25816017|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816018|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
25816019|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816020|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816021|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816022|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
25816023|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816024|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816025|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816026|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
25816027|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816028|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25816029|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
25816030|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25816031|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816032|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816033|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25816034|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25816035|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816036|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816037|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816038|NCT00003578|Cytarabine|cytarabine|mesh-list
25816039|NCT00003578|Prednisone|prednisone|mesh-list
25816040|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
25816041|NCT00003578|Melphalan|melphalan|mesh-list
25816042|NCT00003578|Carmustine|carmustine|mesh-list
25816043|NCT00003578|Doxorubicin|doxorubicin|mesh-list
25816044|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25816045|NCT00003578|Etoposide|etoposide|mesh-list
25816046|NCT00003578|Vincristine|vincristine|mesh-list
25816047|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816048|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
25816049|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816050|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816051|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816052|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
25816053|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816054|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816055|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816056|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816057|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816058|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816059|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816060|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816061|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
25816062|NCT00003578|Hormones|hormones|mesh-ancestor
25816063|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816064|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816065|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816066|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816067|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
25816068|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
25816069|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816070|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816071|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816072|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816074|NCT00003580|Amifostine|amifostine|mesh-list
25816075|NCT00003580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816076|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25816077|NCT00003580|Protective Agents|protective agents|mesh-ancestor
25816078|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816079|NCT00003582|Paclitaxel|paclitaxel|mesh-list
25816080|NCT00003582|Cisplatin|cisplatin|mesh-list
25816081|NCT00003582|Fluorouracil|fluorouracil|mesh-list
25816082|NCT00003582|Amifostine|amifostine|mesh-list
25816083|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816084|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816085|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816086|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816087|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816088|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816089|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
25816090|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816091|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816092|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
25816093|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816094|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25816095|NCT00003582|Protective Agents|protective agents|mesh-ancestor
25816096|NCT00003583|Cisplatin|cisplatin|mesh-list
25816097|NCT00003583|Etoposide|etoposide|mesh-list
25816098|NCT00003583|Amifostine|amifostine|mesh-list
25816099|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816100|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816101|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816102|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816103|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816104|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816105|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25816106|NCT00003583|Protective Agents|protective agents|mesh-ancestor
25816107|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816108|NCT00003584|Prednisone|prednisone|mesh-list
25816109|NCT00003584|Estramustine|estramustine|mesh-list
25816110|NCT00003584|Vinorelbine|vinorelbine|mesh-list
25816111|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816112|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
25816113|NCT00003584|Hormones|hormones|mesh-ancestor
25816114|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816115|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816116|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816117|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816118|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816119|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816120|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816121|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816122|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816123|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816124|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
25816125|NCT00003585|Interferons|interferons|mesh-list
25816126|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
25816127|NCT00003585|Aldesleukin|aldesleukin|mesh-list
25816128|NCT00003585|Fluorouracil|fluorouracil|mesh-list
25816129|NCT00003585|Isotretinoin|isotretinoin|mesh-list
25816130|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
25816131|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816132|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816133|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816134|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816135|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
25816136|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816137|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
25816138|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816139|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25816140|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25816141|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816142|NCT00003587|Gemcitabine|gemcitabine|mesh-list
25816143|NCT00003587|Paclitaxel|paclitaxel|mesh-list
25816144|NCT00003587|Vinorelbine|vinorelbine|mesh-list
25816145|NCT00003587|Docetaxel|docetaxel|mesh-list
25816146|NCT00003587|Cisplatin|cisplatin|mesh-list
25816147|NCT00003587|Carboplatin|carboplatin|mesh-list
25816148|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816149|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816150|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816151|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816152|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816153|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816154|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816155|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
25816156|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
25816157|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816158|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816159|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816160|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
25816161|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816162|NCT00003589|Gemcitabine|gemcitabine|mesh-list
25816163|NCT00003589|Paclitaxel|paclitaxel|mesh-list
25816164|NCT00003589|Cisplatin|cisplatin|mesh-list
25816165|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816166|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816167|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816168|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816169|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816170|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816171|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816172|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
25816173|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
25816174|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816175|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816176|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816177|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
25816178|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816179|NCT00003591|Paclitaxel|paclitaxel|mesh-list
25816180|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816181|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816182|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816183|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816184|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816185|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816186|NCT00003592|Paclitaxel|paclitaxel|mesh-list
25816187|NCT00003592|Methotrexate|methotrexate|mesh-list
25816188|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816189|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816190|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816191|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816192|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816193|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816194|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25816195|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
25816196|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25816197|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816198|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816199|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
25816200|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816201|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816202|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25816203|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816204|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
25816205|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816206|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25816207|NCT00003593|Cytarabine|cytarabine|mesh-list
25816208|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
25816209|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25816210|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25816211|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25816212|NCT00003593|Methotrexate|methotrexate|mesh-list
25816213|NCT00003593|Thioguanine|thioguanine|mesh-list
25816214|NCT00003593|Daunorubicin|daunorubicin|mesh-list
25816215|NCT00003593|Asparaginase|asparaginase|mesh-list
25816216|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25816217|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
25816218|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25816219|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816220|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816221|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
25816222|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816223|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816224|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816225|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816226|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25816227|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816228|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
25816229|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816230|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25816231|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
25816232|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816233|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816234|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816235|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816236|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816237|NCT00003594|Leucovorin|leucovorin|mesh-list
25816238|NCT00003594|Fluorouracil|fluorouracil|mesh-list
25816239|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
25816240|NCT00003594|Irinotecan|irinotecan|mesh-list
25816241|NCT00003594|Calcium|calcium|mesh-list
25816242|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
25816243|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25816244|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816245|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
25816246|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816247|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816248|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816249|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816250|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
25816251|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25816252|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816253|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816254|NCT00003594|Antidotes|antidotes|mesh-ancestor
25816255|NCT00003594|Protective Agents|protective agents|mesh-ancestor
25816256|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
25816257|NCT00003594|Vitamins|vitamins|mesh-ancestor
25816258|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
25816259|NCT00003595|Prednisone|prednisone|mesh-list
25816260|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
25816261|NCT00003595|Rituximab|rituximab|mesh-list
25816262|NCT00003595|Doxorubicin|doxorubicin|mesh-list
25816263|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25816264|NCT00003595|Vincristine|vincristine|mesh-list
25816265|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816266|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
25816267|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816268|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816269|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816270|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
25816271|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816272|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816273|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816274|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25816275|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816276|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816277|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816278|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816279|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816280|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
25816281|NCT00003595|Hormones|hormones|mesh-ancestor
25816282|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816283|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816284|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816285|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816286|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816287|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816288|NCT00003596|Cisplatin|cisplatin|mesh-list
25816289|NCT00003596|Fluorouracil|fluorouracil|mesh-list
25816290|NCT00003596|Mitomycins|mitomycins|mesh-list
25816291|NCT00003596|Mitomycin|mitomycin|mesh-list
25816292|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816293|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
25816294|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816295|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816296|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816297|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
25163170|NCT02898571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816298|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816299|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816300|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
25816301|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25816302|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816303|NCT00003597|Carboplatin|carboplatin|mesh-list
25816304|NCT00003597|Etoposide|etoposide|mesh-list
25816305|NCT00003597|Ifosfamide|ifosfamide|mesh-list
25816306|NCT00003597|Lenograstim|lenograstim|mesh-list
25816307|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816308|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816309|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816310|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816311|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816312|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816313|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816314|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
25816315|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25816316|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
25816317|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816318|NCT00003598|Tretinoin|tretinoin|mesh-list
25816319|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816320|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
25816321|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816322|NCT00003599|Vitamin E|vitamin e|mesh-list
25816323|NCT00003599|Tocopherols|tocopherols|mesh-list
25816324|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
25816325|NCT00003599|Isotretinoin|isotretinoin|mesh-list
25816326|NCT00003599|Vitamins|vitamins|mesh-ancestor
25816327|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
25816328|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816329|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
25816330|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816331|NCT00003599|Protective Agents|protective agents|mesh-ancestor
25816332|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816333|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
25816334|NCT00003600|Hematinics|hematinics|mesh-ancestor
25816335|NCT00003601|Tretinoin|tretinoin|mesh-list
25816336|NCT00003601|Fenretinide|fenretinide|mesh-list
25816337|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816338|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
25816339|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816340|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25816341|NCT00003601|Protective Agents|protective agents|mesh-ancestor
25816342|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816343|NCT00003602|Cytarabine|cytarabine|mesh-list
25816344|NCT00003602|Etoposide|etoposide|mesh-list
25816345|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
25816346|NCT00003602|Idarubicin|idarubicin|mesh-list
25816347|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816348|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816349|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816350|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816351|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816352|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816353|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816354|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
25816355|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
25816356|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816357|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816358|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
25816359|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816360|NCT00003602|Analgesics|analgesics|mesh-ancestor
25816361|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
25816362|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816363|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816364|NCT00003603|Dexamethasone|dexamethasone|mesh-list
25816365|NCT00003603|Prednisolone|prednisolone|mesh-list
25816366|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
25816367|NCT00003603|Melphalan|melphalan|mesh-list
25816368|NCT00003603|Lomustine|lomustine|mesh-list
25816369|NCT00003603|Idarubicin|idarubicin|mesh-list
25816370|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816371|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
25816372|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458769|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816373|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816374|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816375|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
25816376|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816377|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816378|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816379|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816380|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
25816381|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
25816382|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816383|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25816384|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
25816385|NCT00003603|Hormones|hormones|mesh-ancestor
25816386|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816387|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816388|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816389|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816390|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816391|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816392|NCT00003604|Aldesleukin|aldesleukin|mesh-list
25816393|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816394|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25816395|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25816396|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
25816397|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816398|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
25816399|NCT00003605|Rituximab|rituximab|mesh-list
25816400|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816401|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
25816402|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816403|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816404|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816405|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
25816406|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816407|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816408|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816409|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25816410|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
25816411|NCT00003606|Cisplatin|cisplatin|mesh-list
25816412|NCT00003606|Etoposide|etoposide|mesh-list
25816413|NCT00003606|Epirubicin|epirubicin|mesh-list
25816414|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816415|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
25816416|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816417|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816418|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816419|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
25816420|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816421|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816422|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816423|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816424|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816425|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816426|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816427|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816428|NCT00003610|Capsaicin|capsaicin|mesh-list
25816429|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
25816430|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816431|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
25816432|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816433|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816434|NCT00003611|Acitretin|acitretin|mesh-list
25816435|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
25816436|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816437|NCT00003612|Paclitaxel|paclitaxel|mesh-list
25816438|NCT00003612|Carboplatin|carboplatin|mesh-list
25816439|NCT00003612|Trastuzumab|trastuzumab|mesh-list
25816440|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816441|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816442|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816443|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816444|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
24458809|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24458810|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816445|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816446|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25816447|NCT00003613|Carmustine|carmustine|mesh-list
25816448|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25816449|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816450|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
25816451|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816452|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816453|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816454|NCT00003614|Paclitaxel|paclitaxel|mesh-list
25816455|NCT00003614|Estramustine|estramustine|mesh-list
25816456|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816457|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816458|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816459|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816460|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816461|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816462|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816463|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
25816464|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816465|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
25816466|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816467|NCT00003616|Irinotecan|irinotecan|mesh-list
25816468|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25816469|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816470|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816471|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816472|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816473|NCT00003617|Clarithromycin|clarithromycin|mesh-list
25816474|NCT00003617|Tinidazole|tinidazole|mesh-list
25816475|NCT00003617|Chlorambucil|chlorambucil|mesh-list
25816476|NCT00003617|Omeprazole|omeprazole|mesh-list
25816477|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25816478|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25816479|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25816480|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816481|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816482|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25816483|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816484|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25816485|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25816486|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25816487|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816488|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
25816489|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816490|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25816491|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25816492|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25816493|NCT00003619|Vitamin E|vitamin e|mesh-list
25816494|NCT00003619|Cytarabine|cytarabine|mesh-list
25816495|NCT00003619|Fludarabine|fludarabine|mesh-list
25816496|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
25816497|NCT00003619|Etoposide|etoposide|mesh-list
25816498|NCT00003619|Busulfan|busulfan|mesh-list
25816499|NCT00003619|Topotecan|topotecan|mesh-list
25816500|NCT00003619|Isotretinoin|isotretinoin|mesh-list
25816501|NCT00003619|Vitamins|vitamins|mesh-ancestor
25816502|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
25816503|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816504|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816505|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816506|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
25816507|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816508|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816509|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
25816510|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816511|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816512|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816513|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816514|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
25816515|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816516|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
25816517|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816518|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816519|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25816520|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
25816521|NCT00003619|Protective Agents|protective agents|mesh-ancestor
25816522|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816523|NCT00003620|Alvocidib|alvocidib|mesh-list
25816524|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816525|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
25816526|NCT00003620|Growth Substances|growth substances|mesh-ancestor
25816527|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816528|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25816529|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816530|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816531|NCT00003621|Cisplatin|cisplatin|mesh-list
25816532|NCT00003621|Etoposide|etoposide|mesh-list
25816533|NCT00003621|Carmustine|carmustine|mesh-list
25816534|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816535|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816536|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816537|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816538|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816539|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816540|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816541|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
25816542|NCT00003622|Paclitaxel|paclitaxel|mesh-list
25816543|NCT00003622|Vinorelbine|vinorelbine|mesh-list
25816544|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816545|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816546|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816547|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816548|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816549|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816550|NCT00003624|Paclitaxel|paclitaxel|mesh-list
25816551|NCT00003624|Cisplatin|cisplatin|mesh-list
25816552|NCT00003624|Amifostine|amifostine|mesh-list
25816553|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816554|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816555|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816556|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816557|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816558|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816559|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25816560|NCT00003624|Protective Agents|protective agents|mesh-ancestor
25816561|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816562|NCT00003625|Cyclosporine|cyclosporine|mesh-list
25816563|NCT00003625|Etoposide|etoposide|mesh-list
25816564|NCT00003625|Vincristine|vincristine|mesh-list
25816565|NCT00003625|Cyclosporins|cyclosporins|mesh-list
25816566|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816567|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816568|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816569|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816570|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816571|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816572|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816573|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816574|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816575|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816576|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
25816577|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816578|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
25816579|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816580|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816581|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816582|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25816583|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
25816584|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816585|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816586|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816587|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816588|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816589|NCT00003627|Cisplatin|cisplatin|mesh-list
25816590|NCT00003627|Fluorouracil|fluorouracil|mesh-list
25816591|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816592|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
25816593|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816594|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816595|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816596|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
25816597|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816598|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
25816599|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816600|NCT00003632|Cytarabine|cytarabine|mesh-list
25816601|NCT00003632|Methotrexate|methotrexate|mesh-list
25816602|NCT00003632|Etoposide|etoposide|mesh-list
25816603|NCT00003632|Melphalan|melphalan|mesh-list
25816604|NCT00003632|Carmustine|carmustine|mesh-list
25816605|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25816606|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
25816607|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25816608|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816609|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816610|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
25816611|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816612|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816613|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816614|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816615|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25816616|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816617|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
25816618|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816619|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25816620|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816621|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816622|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816623|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
25816624|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816625|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816626|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
25816627|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816628|NCT00003633|Prednisone|prednisone|mesh-list
25816629|NCT00003633|Docetaxel|docetaxel|mesh-list
25816630|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
25816631|NCT00003633|Estramustine|estramustine|mesh-list
25816632|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816633|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816634|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816635|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816636|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816637|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816638|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
25816639|NCT00003633|Hormones|hormones|mesh-ancestor
25816640|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816641|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816642|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816643|NCT00003633|Analgesics|analgesics|mesh-ancestor
25816644|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
25816645|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816646|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816647|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816648|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816649|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816650|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
25816651|NCT00003634|Oregovomab|oregovomab|mesh-list
25816652|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25816653|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816654|NCT00003636|Cisplatin|cisplatin|mesh-list
25816655|NCT00003636|Carboplatin|carboplatin|mesh-list
25816656|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816657|NCT00003637|Cisplatin|cisplatin|mesh-list
25816658|NCT00003637|Fluorouracil|fluorouracil|mesh-list
25816659|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816660|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
25816661|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816662|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816663|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816664|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
25816665|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816666|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
25816667|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25816668|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
25816669|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816670|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
25816671|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816672|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816673|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816674|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
25816675|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816676|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816677|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816678|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25816679|NCT00003639|Interferons|interferons|mesh-list
25816680|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
25816681|NCT00003639|Dexamethasone|dexamethasone|mesh-list
25816682|NCT00003639|Idarubicin|idarubicin|mesh-list
25816683|NCT00003639|Chlorambucil|chlorambucil|mesh-list
25816684|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816685|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
25816686|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
25816687|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816688|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816689|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25816690|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
25816691|NCT00003639|Hormones|hormones|mesh-ancestor
25816692|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816693|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816694|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816695|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
25816696|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816697|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
25816698|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816699|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816700|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816701|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816702|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816703|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816704|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
25816705|NCT00003640|Cisplatin|cisplatin|mesh-list
25816706|NCT00003640|Doxorubicin|doxorubicin|mesh-list
25816707|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25816708|NCT00003640|Methotrexate|methotrexate|mesh-list
25816709|NCT00003640|Vinblastine|vinblastine|mesh-list
25816710|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816711|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816712|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816713|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816714|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816715|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816716|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25816717|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
25816718|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25816719|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816720|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816721|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
25816722|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816723|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25816724|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816725|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
25816726|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816727|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25816728|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816729|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459036|NCT00343408|Cediranib|cediranib|mesh-list
24459037|NCT00343408|Calcium|calcium|mesh-list
25816730|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816731|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816733|NCT00003642|Fluorouracil|fluorouracil|mesh-list
25816734|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816735|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
25816736|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816737|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816738|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816739|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
25816740|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816741|NCT00003643|Paclitaxel|paclitaxel|mesh-list
25816742|NCT00003643|Etoposide|etoposide|mesh-list
25816743|NCT00003643|Cisplatin|cisplatin|mesh-list
25816744|NCT00003643|Bleomycin|bleomycin|mesh-list
25816745|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816746|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816747|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816748|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816749|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816750|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816751|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816752|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816753|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816754|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816755|NCT00003647|Dacarbazine|dacarbazine|mesh-list
25816756|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816757|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
25816758|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816759|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816760|NCT00003650|Cytarabine|cytarabine|mesh-list
25816761|NCT00003650|Dexamethasone|dexamethasone|mesh-list
25816762|NCT00003650|Prednisone|prednisone|mesh-list
25816763|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
25816764|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
25816765|NCT00003650|Methotrexate|methotrexate|mesh-list
25816766|NCT00003650|Etoposide|etoposide|mesh-list
25816767|NCT00003650|Vincristine|vincristine|mesh-list
25816768|NCT00003650|Daunorubicin|daunorubicin|mesh-list
25816769|NCT00003650|Asparaginase|asparaginase|mesh-list
25816770|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
25816771|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
25816772|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816773|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
25816774|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816775|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816776|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816777|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
25816778|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816779|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816780|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816781|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816782|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
25816783|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
25816784|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816785|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25816786|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
25816787|NCT00003650|Hormones|hormones|mesh-ancestor
25816788|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816789|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816790|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25816791|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
25816792|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25816793|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816794|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
25816795|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816796|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816797|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25816798|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25816799|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816800|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816801|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816802|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
25816803|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816804|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816805|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816806|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816807|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25816808|NCT00003650|Protective Agents|protective agents|mesh-ancestor
25816809|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816810|NCT00003650|Analgesics|analgesics|mesh-ancestor
25816811|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
25816812|NCT00003652|Cisplatin|cisplatin|mesh-list
25816813|NCT00003652|Fluorouracil|fluorouracil|mesh-list
25816814|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816815|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
25816816|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816817|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816818|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816819|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
25816820|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816821|NCT00003653|Leuprolide|leuprolide|mesh-list
25816822|NCT00003653|Goserelin|goserelin|mesh-list
25816823|NCT00003653|Flutamide|flutamide|mesh-list
25816824|NCT00003653|Bicalutamide|bicalutamide|mesh-list
25816825|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
25816826|NCT00003653|Nilutamide|nilutamide|mesh-list
25816827|NCT00003653|Buserelin|buserelin|mesh-list
25816828|NCT00003653|Cyproterone|cyproterone|mesh-list
25816829|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25816830|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
25816831|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25816832|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816833|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816834|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816835|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
25816836|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
25816837|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816838|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25816839|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
25816840|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25816841|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25816842|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816843|NCT00003657|Carboplatin|carboplatin|mesh-list
25816844|NCT00003657|Etoposide|etoposide|mesh-list
25816845|NCT00003657|Ifosfamide|ifosfamide|mesh-list
25816846|NCT00003657|Amifostine|amifostine|mesh-list
25816847|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816848|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816849|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816850|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816851|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816852|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816853|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816854|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816855|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
25816856|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25816857|NCT00003657|Protective Agents|protective agents|mesh-ancestor
25816858|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
25816859|NCT00003658|Rituximab|rituximab|mesh-list
25816860|NCT00003658|Pentostatin|pentostatin|mesh-list
25816861|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816862|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
25816863|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816864|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816865|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816866|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
25816867|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816868|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816869|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816870|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25816871|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25816872|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816873|NCT00003661|Cyclosporine|cyclosporine|mesh-list
25816874|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
25816875|NCT00003661|Melphalan|melphalan|mesh-list
25816876|NCT00003661|Busulfan|busulfan|mesh-list
25816877|NCT00003661|Cyclosporins|cyclosporins|mesh-list
25816878|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25816879|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816880|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816881|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816883|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816884|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
25816885|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816886|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816887|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816888|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25816889|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816890|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
25816891|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
25816892|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816893|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25816894|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
25816895|NCT00003661|Hormones|hormones|mesh-ancestor
25816896|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816897|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25816898|NCT00003661|Protective Agents|protective agents|mesh-ancestor
25816899|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816900|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816901|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
25816902|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816903|NCT00003662|Cyclosporine|cyclosporine|mesh-list
25816904|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
25816905|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
25816906|NCT00003662|Melphalan|melphalan|mesh-list
25816907|NCT00003662|Busulfan|busulfan|mesh-list
25816908|NCT00003662|Cyclosporins|cyclosporins|mesh-list
25816909|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25816910|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816911|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
25816912|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816913|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816914|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816915|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
25816916|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816917|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816918|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816919|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816920|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
25816921|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816922|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
25816923|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25816924|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816925|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
25816926|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
25816927|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816928|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25816929|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
25816930|NCT00003662|Hormones|hormones|mesh-ancestor
25816931|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816932|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25816933|NCT00003662|Protective Agents|protective agents|mesh-ancestor
25816934|NCT00003663|Dexamethasone|dexamethasone|mesh-list
25816935|NCT00003663|Rituximab|rituximab|mesh-list
25816936|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25816937|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816938|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
25816939|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816940|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816941|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25816942|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
25816943|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
25816944|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25816945|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25816946|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
25816947|NCT00003663|Hormones|hormones|mesh-ancestor
25816948|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25816949|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25816950|NCT00003664|Gemcitabine|gemcitabine|mesh-list
25816951|NCT00003664|Interferons|interferons|mesh-list
25816952|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
25816953|NCT00003664|Aldesleukin|aldesleukin|mesh-list
25816954|NCT00003664|Fluorouracil|fluorouracil|mesh-list
25816955|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25816956|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
25163178|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163180|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25816957|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816958|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816960|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25816961|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816962|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816963|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
25816964|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816965|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25816966|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25816967|NCT00003666|Irofulven|irofulven|mesh-list
25816968|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816969|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
25816970|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816971|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816972|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
25816973|NCT00003667|Doxorubicin|doxorubicin|mesh-list
25816974|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25816975|NCT00003667|Vincristine|vincristine|mesh-list
25816976|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
25816977|NCT00003667|Razoxane|razoxane|mesh-list
25816978|NCT00003667|Glycerol|glycerol|mesh-list
25816979|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25816980|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
25816981|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25816982|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25816983|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25816984|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
25816985|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816986|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25816987|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25816988|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25816989|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25816990|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25816991|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25816992|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25816993|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
25816994|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
25816995|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
25816996|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25816997|NCT00003667|Protective Agents|protective agents|mesh-ancestor
25816998|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25816999|NCT00003671|Leucovorin|leucovorin|mesh-list
25817000|NCT00003671|Cytarabine|cytarabine|mesh-list
25817001|NCT00003671|Dexamethasone|dexamethasone|mesh-list
25817002|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
25817003|NCT00003671|Methotrexate|methotrexate|mesh-list
25817004|NCT00003671|Vincristine|vincristine|mesh-list
25817005|NCT00003671|Daunorubicin|daunorubicin|mesh-list
25817006|NCT00003671|Asparaginase|asparaginase|mesh-list
25817007|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
25817008|NCT00003671|Thioguanine|thioguanine|mesh-list
25817009|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
25817010|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817011|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
25817012|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817013|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817014|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817015|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
25817016|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817017|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817018|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817019|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25817020|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
25817021|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
25817022|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817023|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25817024|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
25817025|NCT00003671|Hormones|hormones|mesh-ancestor
25817026|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817027|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817028|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25817029|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
25817030|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817031|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817032|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
25817033|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
25817034|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817035|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817036|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817037|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
25817038|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817039|NCT00003671|Antidotes|antidotes|mesh-ancestor
25817040|NCT00003671|Protective Agents|protective agents|mesh-ancestor
25817041|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
25817042|NCT00003671|Vitamins|vitamins|mesh-ancestor
25817043|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
25817044|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817045|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817046|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817047|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817048|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817049|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817050|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817051|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
25817052|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25817053|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817054|NCT00003674|Dalteparin|dalteparin|mesh-list
25817055|NCT00003674|Tinzaparin|tinzaparin|mesh-list
25817056|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25817057|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
25817058|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25817059|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25817060|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817061|NCT00003675|Topotecan|topotecan|mesh-list
25817062|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817063|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817064|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817065|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817066|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817067|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
25817068|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817069|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817070|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817071|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817072|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817073|NCT00003678|Tamoxifen|tamoxifen|mesh-list
25817074|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25817075|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
25817076|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817077|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817078|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817079|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817080|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25817081|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25817082|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25817083|NCT00003679|Tamoxifen|tamoxifen|mesh-list
25817084|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
25817085|NCT00003679|Docetaxel|docetaxel|mesh-list
25817086|NCT00003679|Doxorubicin|doxorubicin|mesh-list
25817087|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25817088|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817089|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
25817090|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817091|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817092|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817093|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
25817094|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817095|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817096|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817097|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817098|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817099|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817100|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817101|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817102|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817103|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817104|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25817105|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
25817106|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817107|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817108|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25817109|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25817110|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25817111|NCT00003680|Tamoxifen|tamoxifen|mesh-list
25817112|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
25817113|NCT00003680|Thiotepa|thiotepa|mesh-list
25817114|NCT00003680|Fluorouracil|fluorouracil|mesh-list
25817115|NCT00003680|Methotrexate|methotrexate|mesh-list
25817116|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817117|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
25817118|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817119|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817120|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817121|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
25817122|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817123|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817124|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817125|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
25817126|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817127|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25817128|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
25817129|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817130|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
25817131|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817132|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817133|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817134|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25817135|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
25817136|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817137|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817138|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25817139|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25817140|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25817141|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
25817142|NCT00003681|Amifostine|amifostine|mesh-list
25817143|NCT00003681|Hematinics|hematinics|mesh-ancestor
25817144|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25817145|NCT00003681|Protective Agents|protective agents|mesh-ancestor
25817146|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817147|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
25817148|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25817149|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25817150|NCT00003682|Prednisolone|prednisolone|mesh-list
25817151|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
25817152|NCT00003682|Doxorubicin|doxorubicin|mesh-list
25817153|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25817154|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25817155|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
25817156|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817157|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817158|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817159|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817160|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817161|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817162|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25817163|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
25817164|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
25817165|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817166|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817167|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25817168|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
25817169|NCT00003682|Hormones|hormones|mesh-ancestor
25817170|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817171|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25817172|NCT00003682|Protective Agents|protective agents|mesh-ancestor
25817173|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817174|NCT00003683|Doxorubicin|doxorubicin|mesh-list
25817175|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25817176|NCT00003683|Ifosfamide|ifosfamide|mesh-list
25817177|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817178|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817179|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817180|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817181|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817182|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817183|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817184|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
25817185|NCT00003684|Theophylline|theophylline|mesh-list
25817186|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25817187|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
25817188|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817189|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817190|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25817191|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
25817192|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25817193|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817194|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817195|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
25817196|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25817197|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25817198|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
25817199|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25817200|NCT00003686|Pilocarpine|pilocarpine|mesh-list
25817201|NCT00003686|Miotics|miotics|mesh-ancestor
25817202|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
25817203|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817204|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817205|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25817206|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25817207|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
25817208|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25817209|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817210|NCT00003687|Morphine|morphine|mesh-list
25817211|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
25817212|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25817213|NCT00003687|Narcotics|narcotics|mesh-ancestor
25817214|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25817215|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817216|NCT00003687|Analgesics|analgesics|mesh-ancestor
25817217|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
25817218|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817219|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
25817220|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
25817221|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25817222|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25817223|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25817224|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817225|NCT00003688|Dactinomycin|dactinomycin|mesh-list
25817226|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25817227|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817228|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817229|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817230|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25817231|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817232|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817233|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817234|NCT00003690|Cisplatin|cisplatin|mesh-list
25817235|NCT00003690|Carboplatin|carboplatin|mesh-list
25817236|NCT00003690|Alvocidib|alvocidib|mesh-list
25817237|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817238|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
25817239|NCT00003690|Growth Substances|growth substances|mesh-ancestor
25817240|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817241|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25817242|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817243|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817244|NCT00003691|Paclitaxel|paclitaxel|mesh-list
25817245|NCT00003691|Cisplatin|cisplatin|mesh-list
25817246|NCT00003691|Doxorubicin|doxorubicin|mesh-list
25817247|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25817248|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817249|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817250|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817251|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817252|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
24926786|NCT04138719|Epirubicin|epirubicin|mesh-list
25817253|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817254|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817255|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817257|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817258|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
25817259|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817260|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817261|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817262|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817263|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817264|NCT00003694|Cytarabine|cytarabine|mesh-list
25817265|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
25817266|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817267|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
25817268|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817269|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817270|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
25817271|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817272|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817273|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
25817274|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817275|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817276|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25817277|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817278|NCT00003696|Paclitaxel|paclitaxel|mesh-list
25817279|NCT00003696|Etoposide|etoposide|mesh-list
25817280|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
25817281|NCT00003696|Carboplatin|carboplatin|mesh-list
25817282|NCT00003696|Doxorubicin|doxorubicin|mesh-list
25817283|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25817284|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817285|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817286|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817287|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817288|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817289|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817290|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817291|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
25817292|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817293|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817294|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817295|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
25817296|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817297|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817298|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817299|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817300|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817301|NCT00003697|Vadimezan|vadimezan|mesh-list
25817302|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817303|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
25817304|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817305|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817306|NCT00003700|Leucovorin|leucovorin|mesh-list
25817307|NCT00003700|Cytarabine|cytarabine|mesh-list
25817308|NCT00003700|Prednisone|prednisone|mesh-list
25817309|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
25817310|NCT00003700|Methotrexate|methotrexate|mesh-list
25817311|NCT00003700|Vincristine|vincristine|mesh-list
25817312|NCT00003700|Daunorubicin|daunorubicin|mesh-list
25817313|NCT00003700|Asparaginase|asparaginase|mesh-list
25817314|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
25817315|NCT00003700|Allopurinol|allopurinol|mesh-list
25817316|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
25817317|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817318|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
25817319|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817320|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817321|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817322|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
25817323|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817324|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817325|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817326|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25817327|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
25817328|NCT00003700|Hormones|hormones|mesh-ancestor
25817329|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817330|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817331|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25817332|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
25817333|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817334|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817336|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
25817337|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817338|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817339|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817340|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
25817341|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817342|NCT00003700|Antidotes|antidotes|mesh-ancestor
25817343|NCT00003700|Protective Agents|protective agents|mesh-ancestor
25817344|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
25817345|NCT00003700|Vitamins|vitamins|mesh-ancestor
25817346|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
25817347|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817348|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817349|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817350|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817351|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817352|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817353|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817354|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
25817355|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25817356|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
25817357|NCT00003701|Paclitaxel|paclitaxel|mesh-list
25817358|NCT00003701|Vinblastine|vinblastine|mesh-list
25817359|NCT00003701|Cisplatin|cisplatin|mesh-list
25817360|NCT00003701|Carboplatin|carboplatin|mesh-list
25817361|NCT00003701|Doxorubicin|doxorubicin|mesh-list
25817362|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25817363|NCT00003701|Methotrexate|methotrexate|mesh-list
25817364|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817365|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817366|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817367|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817368|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817369|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817370|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817371|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817372|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817373|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817374|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25817375|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
25817376|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817377|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817378|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817379|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
25817380|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
25817381|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817382|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817383|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
25817384|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817385|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817386|NCT00003704|Capecitabine|capecitabine|mesh-list
25817387|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817388|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
25817389|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817390|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817391|NCT00003706|Pemetrexed|pemetrexed|mesh-list
25817392|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817393|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817394|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817395|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817396|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817397|NCT00003707|Gemcitabine|gemcitabine|mesh-list
25817398|NCT00003707|Tipifarnib|tipifarnib|mesh-list
25817399|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817400|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
25817401|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817402|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817403|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
25817404|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817405|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817406|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817407|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
25817408|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817409|NCT00003708|Temozolomide|temozolomide|mesh-list
25817410|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817411|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
25817412|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817413|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817414|NCT00003709|Carbendazim|carbendazim|mesh-list
25817415|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
25817416|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
25817417|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25817418|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817419|NCT00003710|Irinotecan|irinotecan|mesh-list
25817420|NCT00003710|Mitomycins|mitomycins|mesh-list
25817421|NCT00003710|Mitomycin|mitomycin|mesh-list
25817422|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817423|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817424|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817425|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817426|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817427|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817428|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
25817429|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817430|NCT00003711|Irinotecan|irinotecan|mesh-list
25817431|NCT00003711|Pemetrexed|pemetrexed|mesh-list
25817432|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817433|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817434|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817435|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817436|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817437|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817438|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817439|NCT00003712|Sirolimus|sirolimus|mesh-list
25817440|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25817441|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817442|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817443|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817444|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
25817445|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817446|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
25817447|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817448|NCT00003714|NSC 366140|nsc 366140|mesh-list
25817449|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817450|NCT00003715|Interferons|interferons|mesh-list
25817451|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
25817452|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
25817453|NCT00003715|Vaccines|vaccines|mesh-list
25817454|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
25817455|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
25817456|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817457|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817458|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817459|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817460|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
25817461|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817462|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817463|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817464|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
25817465|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817466|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25817467|NCT00003717|Paclitaxel|paclitaxel|mesh-list
25817468|NCT00003717|Estramustine|estramustine|mesh-list
25817469|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817470|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817471|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817472|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817473|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817474|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817475|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817476|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
25817477|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817478|NCT00003718|Temozolomide|temozolomide|mesh-list
25817479|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817480|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
25817481|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817482|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817483|NCT00003719|Irinotecan|irinotecan|mesh-list
25817484|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817485|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817486|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817487|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817488|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817489|NCT00003720|Semaxinib|semaxinib|mesh-list
25817490|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25817491|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25817492|NCT00003720|Growth Substances|growth substances|mesh-ancestor
25817493|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817494|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
25817495|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817496|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25817497|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817498|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817499|NCT00003723|Gemcitabine|gemcitabine|mesh-list
25817500|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817501|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
25817502|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817503|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817504|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
25817505|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817506|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817507|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817508|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
25817509|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817510|NCT00003725|Valrubicin|valrubicin|mesh-list
25817511|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817512|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817513|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817514|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817515|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817516|NCT00003727|Gemcitabine|gemcitabine|mesh-list
25817517|NCT00003727|Interferons|interferons|mesh-list
25817518|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
25817519|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
25817520|NCT00003727|Melphalan|melphalan|mesh-list
25817521|NCT00003727|Carmustine|carmustine|mesh-list
25817522|NCT00003727|Etoposide|etoposide|mesh-list
25817523|NCT00003727|Sargramostim|sargramostim|mesh-list
25817524|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817525|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
25817526|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817527|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817528|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817529|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
25817530|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817531|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817532|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817533|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817534|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
25817535|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
25817536|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817537|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817538|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817539|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817540|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817541|NCT00003728|Leucovorin|leucovorin|mesh-list
25817542|NCT00003728|Cytarabine|cytarabine|mesh-list
25817543|NCT00003728|Dexamethasone|dexamethasone|mesh-list
25817544|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
25817545|NCT00003728|Prednisolone|prednisolone|mesh-list
25817546|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
25817547|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25817548|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25817549|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25817550|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
25817551|NCT00003728|Doxorubicin|doxorubicin|mesh-list
25817552|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24450752|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450753|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450755|NCT00320359|Etoposide|etoposide|mesh-list
25817553|NCT00003728|Methotrexate|methotrexate|mesh-list
25817554|NCT00003728|Etoposide|etoposide|mesh-list
25817555|NCT00003728|Vincristine|vincristine|mesh-list
25817556|NCT00003728|Daunorubicin|daunorubicin|mesh-list
25817557|NCT00003728|Asparaginase|asparaginase|mesh-list
25817558|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
25817559|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
25817560|NCT00003728|Thioguanine|thioguanine|mesh-list
25817561|NCT00003728|Vindesine|vindesine|mesh-list
25817562|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
25817563|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817564|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
25817565|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817566|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817567|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817568|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
25817569|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817570|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817571|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817572|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25817573|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
25817574|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
25817575|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817576|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25817577|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
25817578|NCT00003728|Hormones|hormones|mesh-ancestor
25817579|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817580|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817581|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817582|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817583|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817584|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817585|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25817586|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
25817587|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817588|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817589|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
25817590|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
25817591|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817592|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817593|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817594|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
25817595|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817596|NCT00003728|Antidotes|antidotes|mesh-ancestor
25817597|NCT00003728|Protective Agents|protective agents|mesh-ancestor
25817598|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
25817599|NCT00003728|Vitamins|vitamins|mesh-ancestor
25817600|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
25817601|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817602|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817603|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817604|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25817605|NCT00003728|Analgesics|analgesics|mesh-ancestor
25817606|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
25817607|NCT00003729|Cytarabine|cytarabine|mesh-list
25817608|NCT00003729|Fludarabine|fludarabine|mesh-list
25817609|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
25817610|NCT00003729|Idarubicin|idarubicin|mesh-list
25817611|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817612|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817613|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
25817614|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817615|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817616|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
25817617|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817618|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
25817619|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817620|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817621|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817622|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817623|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817624|NCT00003730|Fluorouracil|fluorouracil|mesh-list
25817625|NCT00003730|Vinorelbine|vinorelbine|mesh-list
25817626|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
25817627|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817628|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817629|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817630|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817631|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
25817632|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817633|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817634|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817635|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817636|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817637|NCT00003731|Temozolomide|temozolomide|mesh-list
25817638|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817639|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
25817640|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817641|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817642|NCT00003732|Paclitaxel|paclitaxel|mesh-list
25817643|NCT00003732|Carboplatin|carboplatin|mesh-list
25817644|NCT00003732|Topotecan|topotecan|mesh-list
25817645|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817646|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817647|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817648|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817649|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817650|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817651|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817652|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817653|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817654|NCT00003733|Paclitaxel|paclitaxel|mesh-list
25817655|NCT00003733|Carboplatin|carboplatin|mesh-list
25817656|NCT00003733|Topotecan|topotecan|mesh-list
25817657|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817658|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817659|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817660|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817661|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817662|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817663|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817664|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817665|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817666|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25817667|NCT00003734|Flutamide|flutamide|mesh-list
25817668|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
25817669|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25817670|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
25817671|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817672|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817673|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25817674|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817675|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817676|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
25817677|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
25817678|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817679|NCT00003735|Topotecan|topotecan|mesh-list
25817680|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
25817681|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817682|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817683|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817684|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817685|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817686|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817687|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
25817688|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817689|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25817690|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25817691|NCT00003739|Lenograstim|lenograstim|mesh-list
25817692|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25817693|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
25817694|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817695|NCT00003740|Trastuzumab|trastuzumab|mesh-list
25817696|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25817697|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817698|NCT00003741|Antibodies|antibodies|mesh-list
25817699|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25817700|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
25817701|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817702|NCT00003742|Paclitaxel|paclitaxel|mesh-list
25817703|NCT00003742|Cisplatin|cisplatin|mesh-list
25817704|NCT00003742|Irinotecan|irinotecan|mesh-list
25817705|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817706|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817707|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817708|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817709|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817710|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817711|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817712|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817713|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817714|NCT00003743|Aldesleukin|aldesleukin|mesh-list
25817715|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817716|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25817717|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25817718|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
25817719|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817720|NCT00003744|Gemcitabine|gemcitabine|mesh-list
25817721|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817722|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
25817723|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817724|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817725|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
25817726|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817727|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817728|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817729|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
25817730|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817731|NCT00003745|Topotecan|topotecan|mesh-list
25817732|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817733|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817734|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817735|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817736|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817737|NCT00003746|Cladribine|cladribine|mesh-list
25817738|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817739|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817740|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
25817741|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459511|NCT00344942|Triamcinolone|triamcinolone|mesh-list
25817742|NCT00003747|Carboplatin|carboplatin|mesh-list
25817743|NCT00003747|Temozolomide|temozolomide|mesh-list
25817744|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817745|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817746|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
25817747|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817748|NCT00003748|Irinotecan|irinotecan|mesh-list
25817749|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817750|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817751|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817752|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817753|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817754|NCT00003751|Penicillamine|penicillamine|mesh-list
25817755|NCT00003751|Antidotes|antidotes|mesh-ancestor
25817756|NCT00003751|Protective Agents|protective agents|mesh-ancestor
25817757|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817758|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
25817759|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
25817760|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817761|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817762|NCT00003752|Bexarotene|bexarotene|mesh-list
25817763|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817764|NCT00003753|Dexamethasone|dexamethasone|mesh-list
25817765|NCT00003753|Irinotecan|irinotecan|mesh-list
25817766|NCT00003753|Floxuridine|floxuridine|mesh-list
25817767|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25817768|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
25817769|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
25817770|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817771|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817772|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25817773|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
25817774|NCT00003753|Hormones|hormones|mesh-ancestor
25817775|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817776|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25817777|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817778|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25817779|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817780|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817781|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817782|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817783|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
25817784|NCT00003754|Thalidomide|thalidomide|mesh-list
25817785|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
25817786|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817787|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
25817788|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817789|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817790|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817791|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
25817792|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817793|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817794|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817795|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
25817796|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25817797|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817798|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25817799|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25817800|NCT00003754|Growth Substances|growth substances|mesh-ancestor
25817801|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
25817802|NCT00003757|Rituximab|rituximab|mesh-list
25817803|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25817804|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817805|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
25817806|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817807|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817808|NCT00003758|Cytarabine|cytarabine|mesh-list
25817809|NCT00003758|Idarubicin|idarubicin|mesh-list
25817810|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817811|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
25817812|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817813|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817814|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
25817815|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817816|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817817|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
25817818|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817819|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817820|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817821|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817822|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817824|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
25817825|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25817826|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
25817827|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817828|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817829|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817830|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817831|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817832|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817833|NCT00003760|Irofulven|irofulven|mesh-list
25817834|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817835|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
25817836|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817837|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817838|NCT00003762|Gemcitabine|gemcitabine|mesh-list
25817839|NCT00003762|Docetaxel|docetaxel|mesh-list
25817840|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817841|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
25817842|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817843|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817844|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
25817845|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817846|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817847|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817848|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
25817849|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817850|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817851|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817852|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817853|NCT00003763|Folic Acid|folic acid|mesh-list
25817854|NCT00003763|Hematinics|hematinics|mesh-ancestor
25817855|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
25817856|NCT00003763|Vitamins|vitamins|mesh-ancestor
25817857|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
25817858|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817859|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
25817860|NCT00003764|Fludarabine|fludarabine|mesh-list
25817861|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
25817862|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817863|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
25817864|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817865|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817866|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817867|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
25817868|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817869|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817870|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817871|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817872|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
25817873|NCT00003765|Carmustine|carmustine|mesh-list
25817874|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25817875|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817876|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
25817877|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817878|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817879|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817880|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25817881|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817882|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817883|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817884|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
25817885|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25817886|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817887|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
25817888|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817889|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817890|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817891|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25817892|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25817893|NCT00003771|Norethindrone|norethindrone|mesh-list
25817894|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
25817895|NCT00003771|Estradiol|estradiol|mesh-list
25817896|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25817897|NCT00003771|Estrogens|estrogens|mesh-ancestor
25817898|NCT00003771|Hormones|hormones|mesh-ancestor
25817899|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25817900|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817901|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25817902|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
25817903|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817904|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25817905|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25817906|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25817907|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25817908|NCT00003775|Leflunomide|leflunomide|mesh-list
25817909|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817910|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817911|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817912|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
25817913|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817914|NCT00003776|Leucovorin|leucovorin|mesh-list
25817915|NCT00003776|Trimetrexate|trimetrexate|mesh-list
25817916|NCT00003776|Doxorubicin|doxorubicin|mesh-list
25817917|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25817918|NCT00003776|Methotrexate|methotrexate|mesh-list
25817919|NCT00003776|Ifosfamide|ifosfamide|mesh-list
25817920|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
25817921|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817922|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25817923|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25817924|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25817925|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817926|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817927|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817928|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25817929|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
25817930|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25817931|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817932|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
25817933|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
25817934|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25817935|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817936|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
25817937|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817938|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25817939|NCT00003776|Antidotes|antidotes|mesh-ancestor
25817940|NCT00003776|Protective Agents|protective agents|mesh-ancestor
25817941|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
25817942|NCT00003776|Vitamins|vitamins|mesh-ancestor
25817943|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
25817944|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817945|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
25817946|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
25817947|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817948|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
25817949|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817950|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817951|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817952|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817953|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817954|NCT00003780|Gemcitabine|gemcitabine|mesh-list
25817955|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25817956|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
25817957|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817958|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817959|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
25817960|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25817961|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25817962|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817963|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
25817964|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817965|NCT00003781|Docetaxel|docetaxel|mesh-list
25817966|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817967|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
25817968|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
25817969|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
25817970|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817971|NCT00003783|Leucovorin|leucovorin|mesh-list
25817972|NCT00003783|Cytarabine|cytarabine|mesh-list
25817973|NCT00003783|Dexamethasone|dexamethasone|mesh-list
25817974|NCT00003783|Prednisone|prednisone|mesh-list
25817975|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
25817976|NCT00003783|Methotrexate|methotrexate|mesh-list
25817977|NCT00003783|Etoposide|etoposide|mesh-list
25817978|NCT00003783|Vincristine|vincristine|mesh-list
25817979|NCT00003783|Daunorubicin|daunorubicin|mesh-list
25817980|NCT00003783|Asparaginase|asparaginase|mesh-list
25817981|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
25817982|NCT00003783|Idarubicin|idarubicin|mesh-list
25817983|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
25817984|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25817985|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
25817986|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25817987|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25817988|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25817989|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
25817990|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25817991|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25817992|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25817993|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25817994|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
25817995|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
25817996|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25817997|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25817998|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
25817999|NCT00003783|Hormones|hormones|mesh-ancestor
25818000|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818001|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25818002|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25818003|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
25818004|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25818005|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818006|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
25818007|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818008|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818009|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25818010|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25818011|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818012|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818013|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818014|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
25818015|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818016|NCT00003783|Antidotes|antidotes|mesh-ancestor
25818017|NCT00003783|Protective Agents|protective agents|mesh-ancestor
25818018|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
25818019|NCT00003783|Vitamins|vitamins|mesh-ancestor
25818020|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
25818021|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818022|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818023|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818024|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818025|NCT00003784|Prednisone|prednisone|mesh-list
25818026|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
25818027|NCT00003784|Doxorubicin|doxorubicin|mesh-list
25818028|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25818029|NCT00003784|Vincristine|vincristine|mesh-list
25818030|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
25818031|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818032|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
25818033|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818034|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818035|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818036|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
25818037|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818038|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818039|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818040|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818041|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818042|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818043|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818044|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25818045|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
25818046|NCT00003784|Hormones|hormones|mesh-ancestor
25818047|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818048|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25818049|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818050|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818051|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818052|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818053|NCT00003786|Irofulven|irofulven|mesh-list
25818054|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818055|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
25818056|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818057|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818058|NCT00003788|Carmustine|carmustine|mesh-list
25818059|NCT00003788|Lomustine|lomustine|mesh-list
25818060|NCT00003788|Procarbazine|procarbazine|mesh-list
25818061|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25818062|NCT00003788|Trioxsalen|trioxsalen|mesh-list
25818063|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818064|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
25818065|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818066|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818067|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818068|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25818069|NCT00003789|Melphalan|melphalan|mesh-list
25818070|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818071|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
25818072|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818073|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818074|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818075|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818076|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
25818077|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818078|NCT00003792|Lenograstim|lenograstim|mesh-list
25818079|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25818080|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
25818081|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818082|NCT00003796|Irofulven|irofulven|mesh-list
25818083|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818084|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
25818085|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818086|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818087|NCT00003797|Gemcitabine|gemcitabine|mesh-list
25818088|NCT00003797|Trastuzumab|trastuzumab|mesh-list
25818089|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818090|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
25818091|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818092|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818093|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
25818094|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818095|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818096|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818097|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
25818098|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818099|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25818100|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
25818101|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818102|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25818103|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818104|NCT00003799|Leucovorin|leucovorin|mesh-list
25818105|NCT00003799|Fluorouracil|fluorouracil|mesh-list
25818106|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
25818107|NCT00003799|Calcium|calcium|mesh-list
25818108|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
25818109|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25818110|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818111|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
25818112|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818113|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818114|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818115|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818116|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
25818117|NCT00003799|Antidotes|antidotes|mesh-ancestor
25818118|NCT00003799|Protective Agents|protective agents|mesh-ancestor
25818119|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
25818120|NCT00003799|Vitamins|vitamins|mesh-ancestor
25818121|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
25818122|NCT00003802|NSC 366140|nsc 366140|mesh-list
25818123|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818124|NCT00003803|Gemcitabine|gemcitabine|mesh-list
25818125|NCT00003803|Cisplatin|cisplatin|mesh-list
25818126|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818127|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818128|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
25818129|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818130|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
25818131|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818132|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818133|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818134|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
25818135|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818136|NCT00003804|Dactinomycin|dactinomycin|mesh-list
25818137|NCT00003804|Vincristine|vincristine|mesh-list
25818138|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818139|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818140|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818141|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818142|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818143|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818144|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25818145|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818146|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818147|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25818148|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818149|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25818150|NCT00003805|Vancomycin|vancomycin|mesh-list
25818151|NCT00003805|Tazobactam|tazobactam|mesh-list
25818152|NCT00003805|Piperacillin|piperacillin|mesh-list
25818153|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25818154|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25818155|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818156|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25818157|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818158|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818159|NCT00003808|Theophylline|theophylline|mesh-list
25818160|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25818161|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
25818162|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25818163|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818164|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25818165|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
25818166|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25818167|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818168|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818169|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
25818170|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25818171|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25818172|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
25818173|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25818174|NCT00003809|Cisplatin|cisplatin|mesh-list
25818175|NCT00003809|Cetuximab|cetuximab|mesh-list
25818176|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818177|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25818178|NCT00003810|Gemcitabine|gemcitabine|mesh-list
25818179|NCT00003810|Docetaxel|docetaxel|mesh-list
25818180|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818181|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
25818182|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818183|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818184|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
25818185|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818186|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818187|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818188|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
25818189|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818190|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818191|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818192|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818193|NCT00003811|Cisplatin|cisplatin|mesh-list
25818194|NCT00003811|Etoposide|etoposide|mesh-list
25818195|NCT00003811|Bleomycin|bleomycin|mesh-list
25818196|NCT00003811|Amifostine|amifostine|mesh-list
25818197|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818198|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818199|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818200|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818201|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818202|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818203|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818204|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25818205|NCT00003811|Protective Agents|protective agents|mesh-ancestor
25818206|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818207|NCT00003812|Paclitaxel|paclitaxel|mesh-list
25818208|NCT00003812|Etoposide|etoposide|mesh-list
25818209|NCT00003812|Carboplatin|carboplatin|mesh-list
25818210|NCT00003812|Topotecan|topotecan|mesh-list
25818211|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818212|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345964|NCT05537090|Midazolam|midazolam|mesh-list
25818213|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818214|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818215|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818216|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818217|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818218|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818219|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818220|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25818221|NCT00003814|Eflornithine|eflornithine|mesh-list
25818222|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818223|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25818224|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25818225|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25818226|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818227|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25818228|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818229|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818230|NCT00003815|Cytarabine|cytarabine|mesh-list
25818231|NCT00003815|Prednisolone|prednisolone|mesh-list
25818232|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
25818233|NCT00003815|Melphalan|melphalan|mesh-list
25818234|NCT00003815|Carmustine|carmustine|mesh-list
25818235|NCT00003815|Doxorubicin|doxorubicin|mesh-list
25818236|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25818237|NCT00003815|Etoposide|etoposide|mesh-list
25818238|NCT00003815|Vincristine|vincristine|mesh-list
25818239|NCT00003815|Bleomycin|bleomycin|mesh-list
25818240|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818241|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
25818242|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818243|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818244|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818245|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
25818246|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818247|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818248|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818249|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818250|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818251|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818252|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818253|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818254|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818255|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
25818256|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
25818257|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818258|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818259|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818260|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818261|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25818262|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
25818263|NCT00003815|Hormones|hormones|mesh-ancestor
25818264|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818265|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25818266|NCT00003817|Ondansetron|ondansetron|mesh-list
25818267|NCT00003817|Granisetron|granisetron|mesh-list
25818268|NCT00003817|Tropisetron|tropisetron|mesh-list
25818269|NCT00003817|Dolasetron|dolasetron|mesh-list
25818270|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
25818271|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
25818272|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25818273|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818274|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25818275|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
25818276|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818277|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25818278|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
25818279|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25818280|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818281|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25818282|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25818283|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25818284|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25818285|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25818286|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25818287|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25818288|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25818289|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
25818290|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818291|NCT00003821|Aminopterin|aminopterin|mesh-list
25818292|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25818293|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818294|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818295|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25818296|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
25818297|NCT00003824|Cephalexin|cephalexin|mesh-list
25818298|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818299|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818300|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818301|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818302|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818303|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818304|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25818305|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25818306|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
25818307|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
25818308|NCT00003827|Cytarabine|cytarabine|mesh-list
25818309|NCT00003827|Topotecan|topotecan|mesh-list
25818310|NCT00003827|Amifostine|amifostine|mesh-list
25818311|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818312|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
25818313|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818314|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818315|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
25818316|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818317|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818318|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
25818319|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818320|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25818321|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818322|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818323|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25818324|NCT00003827|Protective Agents|protective agents|mesh-ancestor
25818325|NCT00003828|Vinorelbine|vinorelbine|mesh-list
25818326|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818327|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818328|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818329|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818330|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818331|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818332|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
25818333|NCT00003829|Fludarabine|fludarabine|mesh-list
25818334|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
25818335|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818336|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
25818337|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818338|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818339|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818340|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
25818341|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818342|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818343|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818344|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818345|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
25818346|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
25818347|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
25818348|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
25818349|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818350|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818351|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818352|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
25818353|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818354|NCT00003834|Leucovorin|leucovorin|mesh-list
25818355|NCT00003834|Fluorouracil|fluorouracil|mesh-list
25818356|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
25818357|NCT00003834|Calcium|calcium|mesh-list
25818358|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
25818359|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25818360|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818361|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
25818362|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818363|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818364|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818365|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818366|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
25818367|NCT00003834|Antidotes|antidotes|mesh-ancestor
25818368|NCT00003834|Protective Agents|protective agents|mesh-ancestor
25818369|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
25818370|NCT00003834|Vitamins|vitamins|mesh-ancestor
25818371|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
25818372|NCT00003835|Leucovorin|leucovorin|mesh-list
25818373|NCT00003835|Fluorouracil|fluorouracil|mesh-list
25818374|NCT00003835|Irinotecan|irinotecan|mesh-list
25818375|NCT00003835|Calcium|calcium|mesh-list
25818376|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
25818377|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25818378|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818379|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
25818380|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818381|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818382|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818383|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818384|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
25818385|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25818386|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818387|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818388|NCT00003835|Antidotes|antidotes|mesh-ancestor
25818389|NCT00003835|Protective Agents|protective agents|mesh-ancestor
25818390|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
25818391|NCT00003835|Vitamins|vitamins|mesh-ancestor
25818392|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
25818393|NCT00003842|Interleukin-4|interleukin-4|mesh-list
25818394|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25818395|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
25818396|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818397|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818398|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818399|NCT00003843|Irinotecan|irinotecan|mesh-list
25818400|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25818401|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818402|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818403|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818404|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818405|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
25818406|NCT00003846|Thiotepa|thiotepa|mesh-list
25818407|NCT00003846|Carboplatin|carboplatin|mesh-list
25818408|NCT00003846|Vincristine|vincristine|mesh-list
25818409|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818410|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
25818411|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818412|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818413|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818414|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
25818415|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818416|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818417|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818418|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818419|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818420|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818421|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818422|NCT00003847|Doxorubicin|doxorubicin|mesh-list
25818423|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25818424|NCT00003847|Vincristine|vincristine|mesh-list
25818425|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818426|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818427|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818428|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818429|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818430|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818431|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818432|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818433|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818434|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818436|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25818437|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818438|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
25818439|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818440|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818441|NCT00003850|Thalidomide|thalidomide|mesh-list
25818442|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818443|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
25818444|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818445|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
25818446|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25818447|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818448|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25818449|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25818450|NCT00003850|Growth Substances|growth substances|mesh-ancestor
25818451|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
25818452|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818453|NCT00003851|Gemcitabine|gemcitabine|mesh-list
25818454|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818455|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
25818456|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818457|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818458|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
25818459|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818460|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818461|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818462|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
25818463|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818464|NCT00003852|Paclitaxel|paclitaxel|mesh-list
25818465|NCT00003852|Etoposide|etoposide|mesh-list
25818466|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
25818467|NCT00003852|Carboplatin|carboplatin|mesh-list
25818468|NCT00003852|Epirubicin|epirubicin|mesh-list
25818469|NCT00003852|Ifosfamide|ifosfamide|mesh-list
25818470|NCT00003852|Thiotepa|thiotepa|mesh-list
25818471|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818472|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818473|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818474|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818475|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818476|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818477|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818478|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
25818479|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818480|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818481|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818482|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
25818483|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818484|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818485|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818486|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818487|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818488|NCT00003853|Esorubicin|esorubicin|mesh-list
25818489|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818490|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818491|NCT00003856|Temoporfin|temoporfin|mesh-list
25818492|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818493|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25818494|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818495|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
25818496|NCT00003858|Analgesics|analgesics|mesh-ancestor
25818497|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
25818498|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25818499|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818500|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818501|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818502|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818503|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818504|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818505|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
25818506|NCT00003859|Carboplatin|carboplatin|mesh-list
25818507|NCT00003859|Etoposide|etoposide|mesh-list
25818508|NCT00003859|Vincristine|vincristine|mesh-list
25818509|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818510|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
25818511|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818512|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818513|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818514|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
25818515|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818516|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818517|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818518|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818519|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818520|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818521|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818522|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818523|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818524|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818525|NCT00003860|Carboplatin|carboplatin|mesh-list
25818526|NCT00003860|Etoposide|etoposide|mesh-list
25818527|NCT00003860|Ifosfamide|ifosfamide|mesh-list
25818528|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818529|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818530|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818531|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818532|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818533|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818534|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818535|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
25818536|NCT00003862|Leucovorin|leucovorin|mesh-list
25818537|NCT00003862|Paclitaxel|paclitaxel|mesh-list
25818538|NCT00003862|Cisplatin|cisplatin|mesh-list
25818539|NCT00003862|Fluorouracil|fluorouracil|mesh-list
25818540|NCT00003862|Calcium|calcium|mesh-list
25818541|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
25818542|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818543|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818544|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818545|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818546|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818547|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818548|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25818549|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818550|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
25818551|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818552|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818553|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
25818554|NCT00003862|Antidotes|antidotes|mesh-ancestor
25818555|NCT00003862|Protective Agents|protective agents|mesh-ancestor
25818556|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
25818557|NCT00003862|Vitamins|vitamins|mesh-ancestor
25818558|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
25818559|NCT00003864|Carboplatin|carboplatin|mesh-list
25818560|NCT00003864|Docetaxel|docetaxel|mesh-list
25818561|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818562|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818563|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818564|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818565|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818566|NCT00003865|Toremifene|toremifene|mesh-list
25818567|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25818568|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818569|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25818570|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25818571|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
25818572|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818573|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818574|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25818575|NCT00003867|Capecitabine|capecitabine|mesh-list
25818576|NCT00003867|Irinotecan|irinotecan|mesh-list
25818577|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818578|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
25818579|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818580|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818581|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25818582|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818583|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818584|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
25818585|NCT00003868|Methotrexate|methotrexate|mesh-list
25818586|NCT00003868|Antibodies|antibodies|mesh-list
25818587|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25818588|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818589|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
25818590|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818591|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818592|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818593|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
25818594|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818595|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818596|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818597|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25818598|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
25818599|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25818600|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818601|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
25818602|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818603|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818604|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25818605|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25818606|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
25818607|NCT00003870|Methotrexate|methotrexate|mesh-list
25818608|NCT00003870|Antibodies|antibodies|mesh-list
25818609|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25818610|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818611|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
25818612|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818613|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818614|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818615|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
25818616|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818617|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818618|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818619|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25818620|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
25818621|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25818622|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818623|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
25818624|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818625|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818626|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25818627|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25818628|NCT00003871|Vaccines|vaccines|mesh-list
25818629|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
25818630|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818631|NCT00003873|Fluorouracil|fluorouracil|mesh-list
25818632|NCT00003873|Eniluracil|eniluracil|mesh-list
25818633|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
25818634|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818635|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818636|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818637|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818638|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
25818639|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818640|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818641|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25818642|NCT00003874|Antibodies|antibodies|mesh-list
25818643|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
25818644|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25818645|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
25818646|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818647|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450541|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818648|NCT00003876|Carmustine|carmustine|mesh-list
25818649|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818650|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
25818651|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818652|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818653|NCT00003877|Paclitaxel|paclitaxel|mesh-list
25818654|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
25818655|NCT00003877|Carboplatin|carboplatin|mesh-list
25818656|NCT00003877|Thiotepa|thiotepa|mesh-list
25818657|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818658|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818659|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818660|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
25346428|NCT05533983|Nivolumab|nivolumab|mesh-list
25818661|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818662|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818663|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818664|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
25818665|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818666|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818667|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818668|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
25818669|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818670|NCT00003878|Carmustine|carmustine|mesh-list
25818671|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818672|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
25818673|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818674|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818675|NCT00003880|Paclitaxel|paclitaxel|mesh-list
25818676|NCT00003880|Carboplatin|carboplatin|mesh-list
25818677|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818678|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818679|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818680|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818681|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818682|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818683|NCT00003881|Paclitaxel|paclitaxel|mesh-list
25818684|NCT00003881|Carboplatin|carboplatin|mesh-list
25818685|NCT00003881|Trastuzumab|trastuzumab|mesh-list
25818686|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818687|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818688|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818689|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818690|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818691|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818692|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25818693|NCT00003883|Itraconazole|itraconazole|mesh-list
25818694|NCT00003883|Fluconazole|fluconazole|mesh-list
25818695|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
25818696|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818697|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25818698|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25818699|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818700|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818701|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25818702|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
25818703|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818704|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818705|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25818706|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25818707|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25818708|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
25818709|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25818710|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818711|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
25818712|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818713|NCT00003888|Cisplatin|cisplatin|mesh-list
25818714|NCT00003888|Docetaxel|docetaxel|mesh-list
25818715|NCT00003888|Fluorouracil|fluorouracil|mesh-list
25818716|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818717|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818718|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818719|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25346534|NCT05533372|Methotrexate|methotrexate|mesh-list
25818720|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818721|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
25818722|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818723|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818724|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
25818725|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818726|NCT00003891|Lurtotecan|lurtotecan|mesh-list
25818727|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818728|NCT00003892|ISIS 5132|isis 5132|mesh-list
25818729|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818730|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818731|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818732|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
25818733|NCT00003893|Doxorubicin|doxorubicin|mesh-list
25818734|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25818735|NCT00003893|Fluorouracil|fluorouracil|mesh-list
25818736|NCT00003893|Methotrexate|methotrexate|mesh-list
25818737|NCT00003893|Epirubicin|epirubicin|mesh-list
25818738|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
25818739|NCT00003893|Mitomycins|mitomycins|mesh-list
25818740|NCT00003893|Mitomycin|mitomycin|mesh-list
25818741|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818742|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
25818743|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818744|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818745|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818746|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
25818747|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818748|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818749|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818750|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818751|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818752|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818753|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818754|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
25818755|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818756|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25818757|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
25818758|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25818759|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818760|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25818761|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25818762|NCT00003893|Analgesics|analgesics|mesh-ancestor
25818763|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
25818764|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25818765|NCT00003894|Thalidomide|thalidomide|mesh-list
25818766|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818767|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
25818768|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818769|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
25818770|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25818771|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818772|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25818773|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25818774|NCT00003894|Growth Substances|growth substances|mesh-ancestor
25818775|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
25818776|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818777|NCT00003897|Sargramostim|sargramostim|mesh-list
25818778|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
25818779|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818780|NCT00003899|Paclitaxel|paclitaxel|mesh-list
25818781|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
25818782|NCT00003899|Melphalan|melphalan|mesh-list
25818783|NCT00003899|Thiotepa|thiotepa|mesh-list
25818784|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818785|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818786|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818787|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818788|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818789|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818790|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818791|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
25818792|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818793|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818794|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818795|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
25818796|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818797|NCT00003900|Docetaxel|docetaxel|mesh-list
25818798|NCT00003900|Irinotecan|irinotecan|mesh-list
25818799|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818800|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818801|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818802|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818803|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818804|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25818805|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818806|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818807|NCT00003902|Capecitabine|capecitabine|mesh-list
25818808|NCT00003902|Vinorelbine|vinorelbine|mesh-list
25818809|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818810|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
25818811|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818812|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818813|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818814|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818815|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818816|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818817|NCT00003906|Tamoxifen|tamoxifen|mesh-list
25818818|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25818819|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25818820|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
25818821|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818822|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818823|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25818824|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818825|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25818826|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25818827|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25818828|NCT00003908|Carboplatin|carboplatin|mesh-list
25818829|NCT00003908|Docetaxel|docetaxel|mesh-list
25818830|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818831|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818832|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818833|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818834|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818835|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
25818836|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818837|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25818838|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818839|NCT00003912|Cisplatin|cisplatin|mesh-list
25818840|NCT00003912|Carboplatin|carboplatin|mesh-list
25818841|NCT00003912|Doxorubicin|doxorubicin|mesh-list
25818842|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25818843|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818844|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25818845|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25818846|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818847|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818848|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818849|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
25818850|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
25818851|NCT00003913|Busulfan|busulfan|mesh-list
25818852|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25818853|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818854|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
25818855|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818856|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818857|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818858|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
25818859|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818860|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818861|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818862|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25818863|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
25818864|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
25818865|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25818866|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25818867|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
25818868|NCT00003913|Hormones|hormones|mesh-ancestor
25818869|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818870|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25818871|NCT00003913|Protective Agents|protective agents|mesh-ancestor
25818872|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
25818873|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818874|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818875|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818876|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818877|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818879|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25818880|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25818881|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818882|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818883|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818884|NCT00003920|Cyclosporine|cyclosporine|mesh-list
25818885|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25818886|NCT00003920|Antibodies|antibodies|mesh-list
25818887|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
25818888|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25818889|NCT00003920|Cyclosporins|cyclosporins|mesh-list
25818890|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
25818891|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818892|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818893|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818894|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818895|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818896|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
25818897|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818898|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818899|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25818900|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25818901|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25818902|NCT00003923|Trioxsalen|trioxsalen|mesh-list
25818903|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818904|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
25818905|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25818906|NCT00003924|Interferons|interferons|mesh-list
25818907|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
25818908|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818909|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
25818910|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818911|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
25818912|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818913|NCT00003925|Leucovorin|leucovorin|mesh-list
25818914|NCT00003925|Gemcitabine|gemcitabine|mesh-list
25818915|NCT00003925|Tegafur|tegafur|mesh-list
25818916|NCT00003925|Calcium|calcium|mesh-list
25818917|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
25818918|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818919|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
25818920|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818921|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818922|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
25818923|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818924|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818925|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818926|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
25818927|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818928|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25818929|NCT00003925|Antidotes|antidotes|mesh-ancestor
25818930|NCT00003925|Protective Agents|protective agents|mesh-ancestor
25818931|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
25818932|NCT00003925|Vitamins|vitamins|mesh-ancestor
25818933|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
25818934|NCT00003926|Melphalan|melphalan|mesh-list
25818935|NCT00003926|Busulfan|busulfan|mesh-list
25818936|NCT00003926|Thiotepa|thiotepa|mesh-list
25818937|NCT00003926|Lenograstim|lenograstim|mesh-list
25818938|NCT00003926|Amifostine|amifostine|mesh-list
25818939|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25818940|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
25818941|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818942|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818943|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
25818944|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818945|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818946|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25818947|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818948|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25818949|NCT00003926|Protective Agents|protective agents|mesh-ancestor
25818950|NCT00003928|Gemcitabine|gemcitabine|mesh-list
25818951|NCT00003928|Cisplatin|cisplatin|mesh-list
25818952|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818953|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818954|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
25818955|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818956|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
25818957|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818958|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818959|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818960|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
25818961|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818962|NCT00003929|Lomustine|lomustine|mesh-list
25818963|NCT00003929|Procarbazine|procarbazine|mesh-list
25818964|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25818965|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
25818966|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818967|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818968|NCT00003930|Gemcitabine|gemcitabine|mesh-list
25818969|NCT00003930|Paclitaxel|paclitaxel|mesh-list
25818970|NCT00003930|Cisplatin|cisplatin|mesh-list
25818971|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25818972|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818973|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
25818974|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
25818975|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
25818976|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818977|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818978|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
25818979|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
25818980|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25818981|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25818982|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25818983|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
25818984|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818985|NCT00003934|Cytarabine|cytarabine|mesh-list
25818986|NCT00003934|Methotrexate|methotrexate|mesh-list
25818987|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
25818988|NCT00003934|Daunorubicin|daunorubicin|mesh-list
25818989|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
25818990|NCT00003934|Tretinoin|tretinoin|mesh-list
25818991|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25818992|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
25818993|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25818994|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25818995|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25818996|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
25818997|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25818998|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25818999|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
25819000|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819001|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25819002|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819003|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
25819004|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819005|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25819006|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
25819007|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819008|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819009|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819010|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819011|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
25819012|NCT00003935|Etoposide|etoposide|mesh-list
25819013|NCT00003935|Vincristine|vincristine|mesh-list
25819014|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819015|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819016|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819017|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819018|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819019|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819020|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819021|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819022|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819023|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
25819024|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25819025|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
25819026|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819027|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819028|NCT00003937|Cisplatin|cisplatin|mesh-list
25819029|NCT00003937|Doxorubicin|doxorubicin|mesh-list
25819030|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819031|NCT00003937|Methotrexate|methotrexate|mesh-list
25819032|NCT00003937|Etoposide|etoposide|mesh-list
25819033|NCT00003937|Ifosfamide|ifosfamide|mesh-list
25819034|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
25819035|NCT00003937|Razoxane|razoxane|mesh-list
25819036|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819037|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819038|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819039|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819040|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819041|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819042|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25819043|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
25819044|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25819045|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819046|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819047|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
25819048|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
25819049|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25819050|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819051|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
25819052|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819053|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25819054|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819055|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819056|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
25819057|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25819058|NCT00003937|Protective Agents|protective agents|mesh-ancestor
25819059|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819060|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819061|NCT00003938|Amphotericin B|amphotericin b|mesh-list
25819062|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25819063|NCT00003938|Amebicides|amebicides|mesh-ancestor
25819064|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25819065|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25819066|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819067|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25819068|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
25819069|NCT00003939|Trabectedin|trabectedin|mesh-list
25819070|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819071|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
25819072|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819073|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819074|NCT00003941|Cisplatin|cisplatin|mesh-list
25819075|NCT00003941|Etoposide|etoposide|mesh-list
25819076|NCT00003941|Ifosfamide|ifosfamide|mesh-list
25819077|NCT00003941|Bleomycin|bleomycin|mesh-list
25819078|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819079|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819080|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819081|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819082|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819083|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819084|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819085|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
25819086|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819087|NCT00003943|Paclitaxel|paclitaxel|mesh-list
25819088|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
25819089|NCT00003943|Carboplatin|carboplatin|mesh-list
25819090|NCT00003943|Topotecan|topotecan|mesh-list
25819091|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819092|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819093|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819094|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819095|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819096|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819097|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819098|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
25819099|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819100|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819101|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819102|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
25819103|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819104|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819105|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819106|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819107|NCT00003944|Paclitaxel|paclitaxel|mesh-list
25819108|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
25819109|NCT00003944|Carboplatin|carboplatin|mesh-list
25819110|NCT00003944|Topotecan|topotecan|mesh-list
25819111|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819112|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819113|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819114|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819115|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819116|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819117|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819118|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
25819119|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819120|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819121|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819122|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
25819123|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819124|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819125|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819126|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819127|NCT00003945|Cisplatin|cisplatin|mesh-list
25819128|NCT00003945|Topotecan|topotecan|mesh-list
25819129|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819130|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819131|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819132|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819133|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819134|NCT00003946|Danazol|danazol|mesh-list
25819135|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25819136|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
25819137|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819138|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819139|NCT00003950|Cyclosporine|cyclosporine|mesh-list
25819140|NCT00003950|Irinotecan|irinotecan|mesh-list
25819141|NCT00003950|Cyclosporins|cyclosporins|mesh-list
25819142|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819143|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819144|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819145|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819146|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819147|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819148|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
25819149|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819150|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
25819151|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819152|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
25819153|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819154|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25819155|NCT00003951|Exatecan|exatecan|mesh-list
25819156|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819157|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819158|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819159|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819160|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819161|NCT00003953|Tamoxifen|tamoxifen|mesh-list
25819162|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
25819163|NCT00003953|Docetaxel|docetaxel|mesh-list
25819164|NCT00003953|Doxorubicin|doxorubicin|mesh-list
25819165|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819166|NCT00003953|Fluorouracil|fluorouracil|mesh-list
25819167|NCT00003953|Methotrexate|methotrexate|mesh-list
25819168|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819169|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
25819170|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819171|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819172|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819173|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
25819174|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819175|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819176|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819177|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819178|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819179|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819180|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819181|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819182|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819183|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819184|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
25819185|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819186|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25819187|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
25819188|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25819189|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
25819190|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25819191|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25819192|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25819193|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
25819194|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819195|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25819196|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25819197|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25819198|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25819199|NCT00003954|Cyclosporine|cyclosporine|mesh-list
25819200|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
25819201|NCT00003954|Melphalan|melphalan|mesh-list
25819202|NCT00003954|Cyclosporins|cyclosporins|mesh-list
25819203|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819204|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819205|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819206|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
25819207|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819208|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
25819209|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819210|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
25819211|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819212|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25819213|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819214|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819215|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25819216|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
25819217|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25819218|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819219|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
25819220|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819221|NCT00003955|Dactinomycin|dactinomycin|mesh-list
25819222|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
25819223|NCT00003955|Irinotecan|irinotecan|mesh-list
25819224|NCT00003955|Vincristine|vincristine|mesh-list
25819225|NCT00003955|Sargramostim|sargramostim|mesh-list
25819226|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819227|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
25819228|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819229|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819230|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819231|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
25819232|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819233|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819234|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819235|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819236|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819237|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819238|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819239|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819240|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819241|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819242|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25819243|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819244|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819245|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25819246|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25819247|NCT00003956|Leucovorin|leucovorin|mesh-list
25819248|NCT00003956|Fluorouracil|fluorouracil|mesh-list
25819249|NCT00003956|Calcium|calcium|mesh-list
25819250|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
25819251|NCT00003956|Lonafarnib|lonafarnib|mesh-list
25819252|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25819253|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819254|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
25819255|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819256|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819257|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819258|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819259|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
25819260|NCT00003956|Antidotes|antidotes|mesh-ancestor
25819261|NCT00003956|Protective Agents|protective agents|mesh-ancestor
25819262|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
25819263|NCT00003956|Vitamins|vitamins|mesh-ancestor
25819264|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
25819265|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819266|NCT00003957|Cytarabine|cytarabine|mesh-list
25819267|NCT00003957|Paclitaxel|paclitaxel|mesh-list
25819268|NCT00003957|Etoposide|etoposide|mesh-list
25819269|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
25819270|NCT00003957|Melphalan|melphalan|mesh-list
25819271|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
25819272|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819273|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819274|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819275|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819276|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819277|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819278|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819279|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
25819280|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819281|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819282|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819283|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
25819284|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819285|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819286|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819287|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819288|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819289|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
25819290|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
25819291|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819292|NCT00003957|Analgesics|analgesics|mesh-ancestor
25819293|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
25819294|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25819295|NCT00003958|Dactinomycin|dactinomycin|mesh-list
25819296|NCT00003958|Cactinomycin|cactinomycin|mesh-list
25819297|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
25819298|NCT00003958|Vincristine|vincristine|mesh-list
25819299|NCT00003958|Topotecan|topotecan|mesh-list
25819300|NCT00003958|Sargramostim|sargramostim|mesh-list
25819301|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819302|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
25819303|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819304|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819305|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819306|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
25819307|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819308|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819309|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819310|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819311|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819312|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819313|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819314|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819315|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819316|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819317|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25819318|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819319|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819320|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25819321|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25819322|NCT00003959|Sargramostim|sargramostim|mesh-list
25819323|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
25819324|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819325|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
25819326|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25819327|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25819328|NCT00003960|Prednisolone|prednisolone|mesh-list
25819329|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
25819330|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
25819331|NCT00003960|Busulfan|busulfan|mesh-list
25819332|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25819333|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
25819334|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819335|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
25819336|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819337|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819338|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819339|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
25819340|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819341|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819342|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819343|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25819344|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
25819345|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
25819346|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25819347|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25819348|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
25819349|NCT00003960|Hormones|hormones|mesh-ancestor
25819350|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819351|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25819352|NCT00003960|Protective Agents|protective agents|mesh-ancestor
25819353|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25819354|NCT00003961|Sargramostim|sargramostim|mesh-list
25819355|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
25819356|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819357|NCT00003962|Aldesleukin|aldesleukin|mesh-list
25819358|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819359|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25819360|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25819361|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
25819362|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819363|NCT00003963|Rituximab|rituximab|mesh-list
25819364|NCT00003963|Vinorelbine|vinorelbine|mesh-list
25819365|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819366|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819367|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
25819368|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819369|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819370|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819371|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819372|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819373|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819374|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819375|NCT00003966|Defibrotide|defibrotide|mesh-list
25819376|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25819377|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25819378|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819379|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25819380|NCT00003967|Etoposide|etoposide|mesh-list
25819381|NCT00003967|Topotecan|topotecan|mesh-list
25819382|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819383|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819384|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819385|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819386|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819387|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819388|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819389|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
25819390|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25819391|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
25819392|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819393|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819394|NCT00003970|Irinotecan|irinotecan|mesh-list
25819395|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819396|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819397|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819398|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819399|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819400|NCT00003972|Tamoxifen|tamoxifen|mesh-list
25819401|NCT00003972|Paclitaxel|paclitaxel|mesh-list
25819402|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
25819403|NCT00003972|Carboplatin|carboplatin|mesh-list
25819404|NCT00003972|Melphalan|melphalan|mesh-list
25819405|NCT00003972|Busulfan|busulfan|mesh-list
25819406|NCT00003972|Thiotepa|thiotepa|mesh-list
25819407|NCT00003972|Sargramostim|sargramostim|mesh-list
25819408|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819409|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819410|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819411|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819412|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819413|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819414|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819415|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
25819416|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819417|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819418|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819419|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
25819420|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819421|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25819422|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
25819423|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819424|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25819425|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25819426|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25819427|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25819428|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
25819429|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819430|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
25819431|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819432|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819433|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819434|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
25819435|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819436|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819437|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819438|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
25819439|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819440|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25819441|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819442|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819443|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
25819444|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819445|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25819446|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819447|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819448|NCT00003984|Lintuzumab|lintuzumab|mesh-list
25819449|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819450|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819451|NCT00003985|KRN 7000|krn 7000|mesh-list
25819452|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25819453|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
25819454|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819455|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819456|NCT00003991|Aldesleukin|aldesleukin|mesh-list
25819457|NCT00003991|Histamine|histamine|mesh-list
25819458|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
25819459|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819460|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25819461|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25819462|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
25819463|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819464|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
25819465|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
25819466|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25819467|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819468|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819469|NCT00003992|Tamoxifen|tamoxifen|mesh-list
25819470|NCT00003992|Paclitaxel|paclitaxel|mesh-list
25819471|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
25819472|NCT00003992|Doxorubicin|doxorubicin|mesh-list
25819473|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819474|NCT00003992|Trastuzumab|trastuzumab|mesh-list
25819475|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819476|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819477|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819478|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819479|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819480|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819481|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819482|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
25819483|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819484|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819485|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819486|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
25819487|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819488|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819489|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819490|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819491|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819492|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819493|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25819494|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
25819495|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819496|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25819497|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25819498|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25819499|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25819500|NCT00003993|Aldesleukin|aldesleukin|mesh-list
25819501|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
25819502|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819503|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25819504|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25819505|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
25819506|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819507|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25819508|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
25819509|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819510|NCT00003994|Cisplatin|cisplatin|mesh-list
25819511|NCT00003994|Carboplatin|carboplatin|mesh-list
25819512|NCT00003994|Fluorouracil|fluorouracil|mesh-list
25819513|NCT00003994|Vincristine|vincristine|mesh-list
25819514|NCT00003994|Amifostine|amifostine|mesh-list
25819515|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819516|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
25819517|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819518|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819519|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819520|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
25819521|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819522|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819523|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819524|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819525|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819526|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25819527|NCT00003994|Protective Agents|protective agents|mesh-ancestor
25819529|NCT00003995|Irinotecan|irinotecan|mesh-list
25819530|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819531|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819532|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819533|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819534|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819535|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819536|NCT00003996|Cisplatin|cisplatin|mesh-list
25819537|NCT00003996|Etoposide|etoposide|mesh-list
25819538|NCT00003996|Carmustine|carmustine|mesh-list
25819539|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819540|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819541|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819542|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819543|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819544|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819545|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819546|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
25819547|NCT00003997|Irofulven|irofulven|mesh-list
25819548|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819549|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
25819550|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819551|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819552|NCT00003998|Paclitaxel|paclitaxel|mesh-list
25819553|NCT00003998|Docetaxel|docetaxel|mesh-list
25819554|NCT00003998|Carboplatin|carboplatin|mesh-list
25819555|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819556|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819557|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819558|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819559|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819560|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819561|NCT00004001|Prednisone|prednisone|mesh-list
25819562|NCT00004001|Docetaxel|docetaxel|mesh-list
25819563|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
25819564|NCT00004001|Estramustine|estramustine|mesh-list
25819565|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819566|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819567|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819568|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819569|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819570|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25819571|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
25819572|NCT00004001|Hormones|hormones|mesh-ancestor
25819573|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819574|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819575|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25819576|NCT00004001|Analgesics|analgesics|mesh-ancestor
25819577|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
25819578|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25819579|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819580|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819581|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819582|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819583|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
25819584|NCT00004002|Bortezomib|bortezomib|mesh-list
25819585|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819586|NCT00004003|Gemcitabine|gemcitabine|mesh-list
25819587|NCT00004003|Cisplatin|cisplatin|mesh-list
25819588|NCT00004003|Fluorouracil|fluorouracil|mesh-list
25819589|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819590|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819591|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
25819592|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819593|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
25819594|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819595|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819596|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819597|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
25819598|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819599|NCT00004004|Procarbazine|procarbazine|mesh-list
25819600|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819601|NCT00004005|Leucovorin|leucovorin|mesh-list
25819602|NCT00004005|Fluorouracil|fluorouracil|mesh-list
25819603|NCT00004005|Irinotecan|irinotecan|mesh-list
25819604|NCT00004005|Calcium|calcium|mesh-list
25819605|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
25819606|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25819607|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819608|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
25819609|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819610|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819611|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819612|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819613|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
25819614|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819615|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819616|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819617|NCT00004005|Antidotes|antidotes|mesh-ancestor
25819618|NCT00004005|Protective Agents|protective agents|mesh-ancestor
25819619|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
25819620|NCT00004005|Vitamins|vitamins|mesh-ancestor
25819621|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
25819622|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
25819623|NCT00004006|Carboplatin|carboplatin|mesh-list
25819624|NCT00004006|Doxorubicin|doxorubicin|mesh-list
25819625|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819626|NCT00004006|Etoposide|etoposide|mesh-list
25819627|NCT00004006|Topotecan|topotecan|mesh-list
25819628|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819629|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
25819630|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819631|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819632|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819633|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
25819634|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819635|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819636|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819637|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819638|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819639|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819640|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819641|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819642|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819643|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
25819644|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25819645|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
25819646|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819647|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819648|NCT00004009|Tipifarnib|tipifarnib|mesh-list
25819649|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819650|NCT00004010|Prednisone|prednisone|mesh-list
25819651|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
25819652|NCT00004010|Dacarbazine|dacarbazine|mesh-list
25819653|NCT00004010|Doxorubicin|doxorubicin|mesh-list
25819654|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819655|NCT00004010|Etoposide|etoposide|mesh-list
25819656|NCT00004010|Vincristine|vincristine|mesh-list
25819657|NCT00004010|Bleomycin|bleomycin|mesh-list
25819658|NCT00004010|Vinblastine|vinblastine|mesh-list
25819659|NCT00004010|Procarbazine|procarbazine|mesh-list
25819660|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819661|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
25819662|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819663|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819664|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819665|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
25819666|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819667|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929115|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
25819668|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819669|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819670|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819671|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819672|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819673|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25819674|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
25819675|NCT00004010|Hormones|hormones|mesh-ancestor
25819676|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819677|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25819678|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819679|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819680|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819681|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819682|NCT00004011|Paclitaxel|paclitaxel|mesh-list
25819683|NCT00004011|Carboplatin|carboplatin|mesh-list
25819684|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819685|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819686|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819687|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819688|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819689|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819690|NCT00004012|Capecitabine|capecitabine|mesh-list
25819691|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819692|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
25819693|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819694|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819695|NCT00004013|Paclitaxel|paclitaxel|mesh-list
25819696|NCT00004013|Trastuzumab|trastuzumab|mesh-list
25819697|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819698|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819699|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819700|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819701|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819702|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819703|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819704|NCT00004014|Doxorubicin|doxorubicin|mesh-list
25819705|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819706|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819707|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819708|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819709|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819710|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819711|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819712|NCT00004016|Interferons|interferons|mesh-list
25819713|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
25819714|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819715|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
25819716|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819717|NCT00004017|Antibodies|antibodies|mesh-list
25819718|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25819719|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
25819720|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819721|NCT00004022|Aldesleukin|aldesleukin|mesh-list
25819722|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
25819723|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819724|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25819725|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25819726|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
25819727|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819728|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
25819729|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819730|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819731|NCT00004024|Aldesleukin|aldesleukin|mesh-list
25819732|NCT00004024|Sargramostim|sargramostim|mesh-list
25819733|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
25819734|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
25819735|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819736|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819737|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25819738|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25819739|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
25819740|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819741|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819742|NCT00004025|Aldesleukin|aldesleukin|mesh-list
25819743|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819744|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25819745|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25819746|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
25819747|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819748|NCT00004028|Carmustine|carmustine|mesh-list
25819749|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819750|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
25819751|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819752|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819753|NCT00004029|Sargramostim|sargramostim|mesh-list
25819754|NCT00004029|Vaccines|vaccines|mesh-list
25819755|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
25819756|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819757|NCT00004030|Doxorubicin|doxorubicin|mesh-list
25819758|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819759|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819760|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819761|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819762|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819763|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819764|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819765|NCT00004032|Interferons|interferons|mesh-list
25819766|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
25819767|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819768|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
25819769|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819770|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
25819771|NCT00004036|Carboplatin|carboplatin|mesh-list
25819772|NCT00004036|Sargramostim|sargramostim|mesh-list
25819773|NCT00004036|Amifostine|amifostine|mesh-list
25819774|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819775|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
25819776|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819777|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819778|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819779|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
25819780|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819781|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819782|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819783|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25819784|NCT00004036|Protective Agents|protective agents|mesh-ancestor
25819785|NCT00004037|Docetaxel|docetaxel|mesh-list
25819786|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819787|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819788|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819789|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819790|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819791|NCT00004039|Interferons|interferons|mesh-list
25819792|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
25819793|NCT00004039|Prednisone|prednisone|mesh-list
25819794|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
25819795|NCT00004039|Rituximab|rituximab|mesh-list
25819796|NCT00004039|Doxorubicin|doxorubicin|mesh-list
25819797|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819798|NCT00004039|Vincristine|vincristine|mesh-list
25819799|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819800|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
25819801|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819802|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819803|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819804|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
25819805|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819806|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819807|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819808|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819809|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819810|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819811|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819812|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819813|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25819814|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
25819815|NCT00004039|Hormones|hormones|mesh-ancestor
25819816|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25819817|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25819818|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
25819819|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819820|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819821|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819822|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819823|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819824|NCT00004040|Interferons|interferons|mesh-list
25819825|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
25819826|NCT00004040|Rituximab|rituximab|mesh-list
25819827|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819828|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819829|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
25819830|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819831|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819832|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
25819833|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819834|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25819835|NCT00004042|Antibodies|antibodies|mesh-list
25819836|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
25819837|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25819838|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
25819839|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819840|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819842|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25819843|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819844|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25819845|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25819846|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819847|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25819848|NCT00004043|Vitamins|vitamins|mesh-ancestor
25819849|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
25819850|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25819851|NCT00004045|Exatecan|exatecan|mesh-list
25819852|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819853|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819854|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819855|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819856|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819857|NCT00004046|Exatecan|exatecan|mesh-list
25819858|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819859|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819860|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819861|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819862|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819863|NCT00004047|Exatecan|exatecan|mesh-list
25819864|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819865|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819866|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819867|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819868|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819869|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25819870|NCT00004048|Doxorubicin|doxorubicin|mesh-list
25819871|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25819872|NCT00004048|Antibodies|antibodies|mesh-list
25819873|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
25819874|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25819875|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
25819876|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819877|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819878|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819879|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819880|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819881|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819882|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819883|NCT00004050|Interleukin-2|interleukin-2|mesh-list
25819884|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819885|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25819886|NCT00004050|Analgesics|analgesics|mesh-ancestor
25819887|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
25819888|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25819889|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819890|NCT00004051|Irinotecan|irinotecan|mesh-list
25819891|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819892|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819893|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819894|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819895|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819896|NCT00004055|Paclitaxel|paclitaxel|mesh-list
25819897|NCT00004055|Topotecan|topotecan|mesh-list
25819898|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819899|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819900|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819901|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819902|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819903|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819904|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819905|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819906|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819907|NCT00004056|Cytarabine|cytarabine|mesh-list
25819908|NCT00004056|Thioguanine|thioguanine|mesh-list
25819909|NCT00004056|Melphalan|melphalan|mesh-list
25819910|NCT00004056|Daunorubicin|daunorubicin|mesh-list
25819911|NCT00004056|Asparaginase|asparaginase|mesh-list
25819912|NCT00004056|Lenograstim|lenograstim|mesh-list
25819913|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819915|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819916|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819917|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
25819918|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819919|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819920|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
25819921|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819922|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25819923|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819924|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
25819925|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819926|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25819927|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819928|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819929|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819930|NCT00004057|Paclitaxel|paclitaxel|mesh-list
25819931|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819932|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819933|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
25819934|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
25819935|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
25819936|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819937|NCT00004059|Fluorouracil|fluorouracil|mesh-list
25819938|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25819939|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
25819940|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819941|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819942|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819943|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819944|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
25819945|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819946|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25819947|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819948|NCT00004060|Exatecan|exatecan|mesh-list
25819949|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25819950|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819951|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819952|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819953|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819954|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
25819955|NCT00004061|Ifosfamide|ifosfamide|mesh-list
25819956|NCT00004061|Etoposide|etoposide|mesh-list
25819957|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819958|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
25819959|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819960|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25819961|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25819962|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
25819963|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819964|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819965|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25819966|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25819967|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25819968|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25819969|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819970|NCT00004062|Azacitidine|azacitidine|mesh-list
25819971|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819972|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
25819973|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819974|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819975|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819976|NCT00004063|Gemcitabine|gemcitabine|mesh-list
25819977|NCT00004063|Interferons|interferons|mesh-list
25819978|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
25819979|NCT00004063|Cisplatin|cisplatin|mesh-list
25819980|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819981|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819982|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
25819983|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819984|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
25819985|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25819986|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25819987|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25819988|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
25819989|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819991|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25819992|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819993|NCT00004066|Gemcitabine|gemcitabine|mesh-list
25819994|NCT00004066|Docetaxel|docetaxel|mesh-list
25819995|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25819996|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
25819997|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25819998|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25819999|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
25820000|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820001|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820002|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820003|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
25820004|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820005|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820006|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820007|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820008|NCT00004067|Paclitaxel|paclitaxel|mesh-list
25820009|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
25820010|NCT00004067|Doxorubicin|doxorubicin|mesh-list
25820011|NCT00004067|Trastuzumab|trastuzumab|mesh-list
25820012|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820013|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820014|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820015|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820016|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820017|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820018|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820019|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820020|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
25820021|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820022|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820023|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820024|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
25820025|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820026|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820027|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820028|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820029|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820030|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820031|NCT00004068|Irinotecan|irinotecan|mesh-list
25820032|NCT00004068|Temozolomide|temozolomide|mesh-list
25820033|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820034|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820035|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820036|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820037|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820038|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820039|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
25820040|NCT00004070|Interleukin-12|interleukin-12|mesh-list
25820041|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25820042|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
25820043|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820044|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25820045|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25820046|NCT00004070|Growth Substances|growth substances|mesh-ancestor
25820047|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
25820048|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820049|NCT00004071|Prednisone|prednisone|mesh-list
25820050|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
25820051|NCT00004071|Leflunomide|leflunomide|mesh-list
25820052|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25820053|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
25820054|NCT00004071|Hormones|hormones|mesh-ancestor
25820055|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25820056|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820057|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25820058|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820059|NCT00004071|Analgesics|analgesics|mesh-ancestor
25820060|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
25820061|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25820062|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820063|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820064|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820065|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820066|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820067|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
25820068|NCT00004072|Carmustine|carmustine|mesh-list
25820069|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25820070|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820071|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
25820072|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820073|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820074|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820075|NCT00004073|Suramin|suramin|mesh-list
25820076|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
25820077|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
25820078|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25820079|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820080|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820081|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25820082|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25820083|NCT00004074|Carboplatin|carboplatin|mesh-list
25820084|NCT00004074|Trastuzumab|trastuzumab|mesh-list
25820085|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25820086|NCT00004074|Interleukin-12|interleukin-12|mesh-list
25820087|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820088|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820089|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25820090|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
25820091|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820092|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25820093|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25820094|NCT00004074|Growth Substances|growth substances|mesh-ancestor
25820095|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
25820096|NCT00004077|Paclitaxel|paclitaxel|mesh-list
25820097|NCT00004077|Cisplatin|cisplatin|mesh-list
25820098|NCT00004077|Ifosfamide|ifosfamide|mesh-list
25820099|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820100|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820101|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820102|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820103|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820104|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820105|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820106|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
25820107|NCT00004078|Irinotecan|irinotecan|mesh-list
25820108|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820109|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820110|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820111|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820112|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820113|NCT00004081|Docetaxel|docetaxel|mesh-list
25820114|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820115|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820116|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820117|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820118|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820119|NCT00004082|Gemcitabine|gemcitabine|mesh-list
25820120|NCT00004082|Carboplatin|carboplatin|mesh-list
25820121|NCT00004082|Docetaxel|docetaxel|mesh-list
25820122|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820123|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820124|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
25820125|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820126|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
25820127|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820128|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820129|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820130|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
25820131|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820132|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820133|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820134|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820135|NCT00004083|Cisplatin|cisplatin|mesh-list
25820136|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820137|NCT00004084|Epratuzumab|epratuzumab|mesh-list
25820138|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820139|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820140|NCT00004085|Antibodies|antibodies|mesh-list
25820141|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25820142|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
25820143|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820144|NCT00004086|Cytarabine|cytarabine|mesh-list
25820145|NCT00004086|Cisplatin|cisplatin|mesh-list
25820146|NCT00004086|Etoposide|etoposide|mesh-list
25820147|NCT00004086|Ifosfamide|ifosfamide|mesh-list
25820148|NCT00004086|Epratuzumab|epratuzumab|mesh-list
25820149|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820150|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820151|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820152|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820153|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820154|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820155|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820156|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
25820157|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
25820158|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820159|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820160|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
25820161|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820162|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820163|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
25820164|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820165|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25820166|NCT00004087|Antibodies|antibodies|mesh-list
25820167|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
25820168|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25820169|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
25820170|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820171|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820172|NCT00004089|Paclitaxel|paclitaxel|mesh-list
25820173|NCT00004089|Fluorouracil|fluorouracil|mesh-list
25820174|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
25820175|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820176|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820177|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820178|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820179|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820180|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820181|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
25820182|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820183|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820184|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
25820185|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820186|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
25820187|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820188|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25820189|NCT00004090|Gemcitabine|gemcitabine|mesh-list
25820190|NCT00004090|Cisplatin|cisplatin|mesh-list
25820191|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820192|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820193|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
25820194|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820195|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
25820196|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820197|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820198|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820199|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
25820200|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820201|NCT00004091|Antibodies|antibodies|mesh-list
25820202|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
25820203|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820204|NCT00004094|Paclitaxel|paclitaxel|mesh-list
25820205|NCT00004094|Carboplatin|carboplatin|mesh-list
25820206|NCT00004094|Fluorouracil|fluorouracil|mesh-list
25820207|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
25820208|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820209|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820210|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820211|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820212|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820213|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820214|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
25820215|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820216|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820217|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
25820218|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820219|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
25820220|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820221|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25820222|NCT00004095|Gemcitabine|gemcitabine|mesh-list
25820223|NCT00004095|Irinotecan|irinotecan|mesh-list
25820224|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820225|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
25820226|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820227|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820228|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
25820229|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820230|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820231|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820232|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
25820233|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820234|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820235|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820236|NCT00004097|Gemcitabine|gemcitabine|mesh-list
25820237|NCT00004097|Paclitaxel|paclitaxel|mesh-list
25820238|NCT00004097|Fluorouracil|fluorouracil|mesh-list
25820239|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820240|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820241|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820242|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820243|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820244|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820245|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820246|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
25820247|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
25820248|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820249|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820250|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820251|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
25820252|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820253|NCT00004099|Leucovorin|leucovorin|mesh-list
25820254|NCT00004099|Cisplatin|cisplatin|mesh-list
25820255|NCT00004099|Fluorouracil|fluorouracil|mesh-list
25820256|NCT00004099|Calcium|calcium|mesh-list
25820257|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
25820258|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820259|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25820260|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820261|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
25820262|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820263|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820264|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820265|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
25820266|NCT00004099|Antidotes|antidotes|mesh-ancestor
25820267|NCT00004099|Protective Agents|protective agents|mesh-ancestor
25820268|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
25820269|NCT00004099|Vitamins|vitamins|mesh-ancestor
25820270|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
25820271|NCT00004100|Gemcitabine|gemcitabine|mesh-list
25820272|NCT00004100|Cisplatin|cisplatin|mesh-list
25820273|NCT00004100|Vinorelbine|vinorelbine|mesh-list
25820274|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820275|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820276|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
25820277|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820278|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
25820279|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820280|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820281|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820282|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
25820283|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820284|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820285|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820286|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820287|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820288|NCT00004102|Leucovorin|leucovorin|mesh-list
25820289|NCT00004102|Fluorouracil|fluorouracil|mesh-list
25820290|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
25820292|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
25820293|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25820294|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820295|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
25820296|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820297|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820298|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820299|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820300|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
25820301|NCT00004102|Antidotes|antidotes|mesh-ancestor
25820302|NCT00004102|Protective Agents|protective agents|mesh-ancestor
25820303|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
25820304|NCT00004102|Vitamins|vitamins|mesh-ancestor
25820305|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
25820306|NCT00004103|Cisplatin|cisplatin|mesh-list
25820307|NCT00004103|Irinotecan|irinotecan|mesh-list
25820308|NCT00004103|Floxuridine|floxuridine|mesh-list
25820309|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820310|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820311|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820312|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820313|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820314|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820315|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
25820316|NCT00004104|Interferons|interferons|mesh-list
25820317|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
25820318|NCT00004104|Interleukin-2|interleukin-2|mesh-list
25820319|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820320|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
25820321|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820322|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
25820323|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820324|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25820325|NCT00004104|Analgesics|analgesics|mesh-ancestor
25820326|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
25820327|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25820328|NCT00004105|Paclitaxel|paclitaxel|mesh-list
25820329|NCT00004105|Vinorelbine|vinorelbine|mesh-list
25820330|NCT00004105|Estramustine|estramustine|mesh-list
25820331|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820332|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820333|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820334|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820335|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820336|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820337|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820338|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
25820339|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25820340|NCT00004107|Epratuzumab|epratuzumab|mesh-list
25820341|NCT00004107|Antibodies|antibodies|mesh-list
25820342|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25820343|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
25820344|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820345|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820346|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820347|NCT00004108|Exatecan|exatecan|mesh-list
25820348|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820349|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820350|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820351|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820352|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820353|NCT00004109|Doxorubicin|doxorubicin|mesh-list
25820354|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820355|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820356|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820357|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820358|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820359|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820360|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820361|NCT00004110|Etoposide|etoposide|mesh-list
25820362|NCT00004110|Isotretinoin|isotretinoin|mesh-list
25820363|NCT00004110|Antibodies|antibodies|mesh-list
25820364|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25820365|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
25820366|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820367|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820368|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820369|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820370|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820371|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820372|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820373|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25820374|NCT00004112|Prednisone|prednisone|mesh-list
25820375|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
25820376|NCT00004112|Rituximab|rituximab|mesh-list
25820377|NCT00004112|Doxorubicin|doxorubicin|mesh-list
25820378|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820379|NCT00004112|Vincristine|vincristine|mesh-list
25820380|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820381|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
25820382|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820383|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820384|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820385|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
25820386|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820387|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820388|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820389|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820390|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820391|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820392|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820393|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820394|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25820395|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
25820396|NCT00004112|Hormones|hormones|mesh-ancestor
25820397|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25820398|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25820399|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820400|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820401|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820402|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820403|NCT00004113|Temozolomide|temozolomide|mesh-list
25820404|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820405|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
25820406|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820407|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820408|NCT00004114|Cytarabine|cytarabine|mesh-list
25820409|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
25820410|NCT00004114|Fludarabine|fludarabine|mesh-list
25820411|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
25820412|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820413|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
25820414|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820415|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820416|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820417|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
25820418|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820419|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820420|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820421|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820422|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
25820423|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
25820424|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820425|NCT00004115|Antibodies|antibodies|mesh-list
25820426|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25820427|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
25820428|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820429|NCT00004122|Interferons|interferons|mesh-list
25820430|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
25820431|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
25820432|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820433|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
25820434|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820435|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
25820436|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820437|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25820438|NCT00004123|Doxorubicin|doxorubicin|mesh-list
25820439|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820440|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820441|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820442|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820443|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820444|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820445|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820446|NCT00004125|Tamoxifen|tamoxifen|mesh-list
25820447|NCT00004125|Paclitaxel|paclitaxel|mesh-list
25820448|NCT00004125|Docetaxel|docetaxel|mesh-list
25820449|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
25820450|NCT00004125|Doxorubicin|doxorubicin|mesh-list
25820451|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820452|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820453|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820454|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820455|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820456|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820457|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820458|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820459|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
25820460|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820461|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820462|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820463|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
25820464|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820465|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820466|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820467|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820468|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820469|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25820470|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
25820471|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25820472|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25820473|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25820474|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25820475|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25820476|NCT00004126|Paclitaxel|paclitaxel|mesh-list
25820477|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
25820478|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820479|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820480|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820481|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820482|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820483|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820484|NCT00004127|Leucovorin|leucovorin|mesh-list
25820485|NCT00004127|Fluorouracil|fluorouracil|mesh-list
25820486|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
25820487|NCT00004127|Calcium|calcium|mesh-list
25820488|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
25820489|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25820490|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820491|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
25820492|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820493|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820494|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820495|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820496|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
25820497|NCT00004127|Antidotes|antidotes|mesh-ancestor
25820498|NCT00004127|Protective Agents|protective agents|mesh-ancestor
25820499|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
25820500|NCT00004127|Vitamins|vitamins|mesh-ancestor
25820501|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
25820502|NCT00004128|Cytarabine|cytarabine|mesh-list
25820503|NCT00004128|Aldesleukin|aldesleukin|mesh-list
25820504|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
25820505|NCT00004128|Busulfan|busulfan|mesh-list
25820506|NCT00004128|Etoposide|etoposide|mesh-list
25820507|NCT00004128|Daunorubicin|daunorubicin|mesh-list
25820508|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820509|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
25820510|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820511|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820512|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820513|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
25820514|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820515|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820516|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820517|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820518|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820519|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820520|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820521|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820522|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
25820523|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
25820524|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820525|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820526|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25820527|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25820528|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
25820530|NCT00004132|Etoposide|etoposide|mesh-list
25820531|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820532|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
25820533|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820534|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820535|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820536|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
25820537|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820538|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820539|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820540|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820541|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820542|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820543|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820544|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
25820545|NCT00004135|Fludarabine|fludarabine|mesh-list
25820546|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
25820547|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820548|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
25820549|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820550|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820551|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820552|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
25820553|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820554|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820555|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820556|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820557|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
25820558|NCT00004137|Paclitaxel|paclitaxel|mesh-list
25820559|NCT00004137|Carboplatin|carboplatin|mesh-list
25820560|NCT00004137|Topotecan|topotecan|mesh-list
25820561|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820562|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820563|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820564|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820565|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820566|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820567|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820568|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820569|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820570|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25820571|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25820572|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820573|NCT00004139|Gemcitabine|gemcitabine|mesh-list
25820574|NCT00004139|Docetaxel|docetaxel|mesh-list
25820575|NCT00004139|Irinotecan|irinotecan|mesh-list
25820576|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820577|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
25820578|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820579|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820580|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
25820581|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820582|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820583|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820584|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
25820585|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820586|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820587|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820588|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820589|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820590|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820591|NCT00004141|Cisplatin|cisplatin|mesh-list
25820592|NCT00004141|Dacarbazine|dacarbazine|mesh-list
25820593|NCT00004141|Molgramostim|molgramostim|mesh-list
25820594|NCT00004141|Sargramostim|sargramostim|mesh-list
25820595|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859098|NCT02301780|Aspirin|aspirin|mesh-list
25820596|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820597|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
25820598|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820599|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
25820600|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820601|NCT00004142|Fluorouracil|fluorouracil|mesh-list
25820602|NCT00004142|Floxuridine|floxuridine|mesh-list
25820603|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
25820604|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820605|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820606|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820607|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820608|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
25820609|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820610|NCT00004144|Gemcitabine|gemcitabine|mesh-list
25820611|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
25820612|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820613|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
25820614|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820615|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820616|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
25820617|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820618|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820619|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820620|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
25820621|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820622|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25820623|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
25820624|NCT00004145|Fludarabine|fludarabine|mesh-list
25820625|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
25820626|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25820627|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820628|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
25820629|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820630|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820631|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820632|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
25820633|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820634|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820635|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820636|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820637|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
25820638|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
25820639|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820640|NCT00004150|Leucovorin|leucovorin|mesh-list
25820641|NCT00004150|Fluorouracil|fluorouracil|mesh-list
25820642|NCT00004150|Calcium|calcium|mesh-list
25820643|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
25820644|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25820645|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820646|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
25820647|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820648|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820649|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820650|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820651|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
25820652|NCT00004150|Antidotes|antidotes|mesh-ancestor
25820653|NCT00004150|Protective Agents|protective agents|mesh-ancestor
25820654|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
25820655|NCT00004150|Vitamins|vitamins|mesh-ancestor
25820656|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
25820657|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25820658|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25820659|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820660|NCT00004154|Fenretinide|fenretinide|mesh-list
25820661|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820662|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25820663|NCT00004154|Protective Agents|protective agents|mesh-ancestor
25820664|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820665|NCT00004157|Oprelvekin|oprelvekin|mesh-list
25820666|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820667|NCT00004158|Melphalan|melphalan|mesh-list
25820668|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820669|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
25820670|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820671|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820672|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820673|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820674|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
25820675|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820676|NCT00004159|Gemcitabine|gemcitabine|mesh-list
25820677|NCT00004159|Paclitaxel|paclitaxel|mesh-list
25820678|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820679|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820680|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820681|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820682|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820683|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820684|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820685|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
25820686|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
25820687|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820688|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820689|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820690|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
25820691|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820692|NCT00004160|Gemcitabine|gemcitabine|mesh-list
25820693|NCT00004160|Paclitaxel|paclitaxel|mesh-list
25820694|NCT00004160|Cisplatin|cisplatin|mesh-list
25820695|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820696|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820697|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820698|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820699|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820700|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820701|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820702|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
25820703|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
25820704|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820705|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820706|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820707|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
25820708|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820709|NCT00004161|Fenretinide|fenretinide|mesh-list
25820710|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820711|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25820712|NCT00004161|Protective Agents|protective agents|mesh-ancestor
25820713|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820714|NCT00004162|Doxorubicin|doxorubicin|mesh-list
25820715|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820716|NCT00004162|Methotrexate|methotrexate|mesh-list
25820717|NCT00004162|Vincristine|vincristine|mesh-list
25820718|NCT00004162|Sargramostim|sargramostim|mesh-list
25820719|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820720|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820721|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820722|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820723|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820724|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820725|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25820726|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
25820727|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25820728|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820729|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820730|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
25820731|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25820732|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25820733|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820734|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
25820735|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820736|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25820737|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820738|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820739|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820740|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820741|NCT00004163|Trastuzumab|trastuzumab|mesh-list
25820742|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820743|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820744|NCT00004164|Leucovorin|leucovorin|mesh-list
25820745|NCT00004164|Cisplatin|cisplatin|mesh-list
25820746|NCT00004164|Docetaxel|docetaxel|mesh-list
25820747|NCT00004164|Fluorouracil|fluorouracil|mesh-list
25820748|NCT00004164|Calcium|calcium|mesh-list
25820749|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
25820750|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820751|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820752|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820753|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820754|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820755|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25820756|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820757|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
25820758|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820759|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820760|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
25820761|NCT00004164|Antidotes|antidotes|mesh-ancestor
25820762|NCT00004164|Protective Agents|protective agents|mesh-ancestor
25820763|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
25820764|NCT00004164|Vitamins|vitamins|mesh-ancestor
25820765|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
25820766|NCT00004173|Paclitaxel|paclitaxel|mesh-list
25820767|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
25820768|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820769|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820770|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820771|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820772|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820773|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820774|NCT00004174|Paclitaxel|paclitaxel|mesh-list
25820775|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
25820776|NCT00004174|Thiotepa|thiotepa|mesh-list
25820777|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820778|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820779|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820780|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820781|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820782|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820783|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820784|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
25820785|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820786|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820787|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820788|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
25820789|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820791|NCT00004176|Etoposide|etoposide|mesh-list
25820792|NCT00004176|Amifostine|amifostine|mesh-list
25820793|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820794|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820795|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820796|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820797|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820798|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820799|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25820800|NCT00004176|Protective Agents|protective agents|mesh-ancestor
25820801|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820802|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25820803|NCT00004177|Antibodies|antibodies|mesh-list
25820804|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
25820805|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25820806|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
25820807|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820808|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820809|NCT00004179|Prednisone|prednisone|mesh-list
25820810|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
25820811|NCT00004179|Rituximab|rituximab|mesh-list
25820812|NCT00004179|Doxorubicin|doxorubicin|mesh-list
25820813|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820814|NCT00004179|Vincristine|vincristine|mesh-list
25820815|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820816|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
25820817|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820818|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820819|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820820|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
25820821|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820822|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820823|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820824|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25820825|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820826|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820827|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820828|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820829|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25820830|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
25820831|NCT00004179|Hormones|hormones|mesh-ancestor
25820832|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25820833|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25820834|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820835|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820836|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820837|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820838|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
25820839|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25820840|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820841|NCT00004183|Capecitabine|capecitabine|mesh-list
25820842|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820843|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
25820844|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820845|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820846|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25820847|NCT00004184|Antibodies|antibodies|mesh-list
24859469|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859471|NCT02303769|Urological Agents|urological agents|mesh-ancestor
24859475|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820848|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25820849|NCT00004184|Sargramostim|sargramostim|mesh-list
25820850|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
25820851|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
25820852|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820853|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25820854|NCT00004184|Antacids|antacids|mesh-ancestor
25820855|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820856|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25820857|NCT00004186|Carboplatin|carboplatin|mesh-list
25820858|NCT00004186|Etoposide|etoposide|mesh-list
25820859|NCT00004186|Topotecan|topotecan|mesh-list
25820860|NCT00004186|Ifosfamide|ifosfamide|mesh-list
25820861|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820862|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820863|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820864|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820865|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820866|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820867|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820868|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820869|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
25820870|NCT00004187|Capecitabine|capecitabine|mesh-list
25820871|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
25820872|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820873|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
25820874|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820875|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820876|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
25820877|NCT00004188|Melphalan|melphalan|mesh-list
25820878|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
25820879|NCT00004188|Cisplatin|cisplatin|mesh-list
25820880|NCT00004188|Carboplatin|carboplatin|mesh-list
25820881|NCT00004188|Doxorubicin|doxorubicin|mesh-list
25820882|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820883|NCT00004188|Etoposide|etoposide|mesh-list
25820884|NCT00004188|Vincristine|vincristine|mesh-list
25820885|NCT00004188|Topotecan|topotecan|mesh-list
25820886|NCT00004188|Isotretinoin|isotretinoin|mesh-list
25820887|NCT00004188|Lenograstim|lenograstim|mesh-list
25820888|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820889|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
25820890|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820891|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820892|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820893|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
25820894|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820895|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820896|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820897|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820898|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820899|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820900|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820901|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820902|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25820903|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820904|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820905|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820906|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25820907|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
25820908|NCT00004189|Cisplatin|cisplatin|mesh-list
25820909|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820910|NCT00004190|Gemcitabine|gemcitabine|mesh-list
25820911|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
25820912|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820913|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
25820914|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820915|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820916|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
25820917|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820918|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820919|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859528|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859530|NCT02304081|Incretins|incretins|mesh-ancestor
25820920|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
25820921|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820922|NCT00004192|Cytarabine|cytarabine|mesh-list
25820923|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
25820924|NCT00004192|Etoposide|etoposide|mesh-list
25820925|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820926|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820927|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820928|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820929|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820930|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820931|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820932|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
25820933|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
25820934|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820935|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820936|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
25820937|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820938|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25820939|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
25820940|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
25820941|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25820942|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25820943|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
25820944|NCT00004192|Hormones|hormones|mesh-ancestor
25820945|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25820946|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25820947|NCT00004192|Protective Agents|protective agents|mesh-ancestor
25820948|NCT00004194|Fludarabine|fludarabine|mesh-list
25820949|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
25820950|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820951|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25820952|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
25820953|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820954|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820955|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
25820956|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820957|NCT00004195|Eniluracil|eniluracil|mesh-list
25820958|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820959|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820960|NCT00004196|Interferons|interferons|mesh-list
25820961|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
25820962|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820963|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
25820964|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25820965|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
25820966|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820967|NCT00004197|Prednisone|prednisone|mesh-list
25820968|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
25820969|NCT00004197|Doxorubicin|doxorubicin|mesh-list
25820970|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25820971|NCT00004197|Vincristine|vincristine|mesh-list
25820972|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
25820973|NCT00004197|Sargramostim|sargramostim|mesh-list
25820974|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25820975|NCT00004197|Vaccines|vaccines|mesh-list
25820976|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25820977|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
25820978|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25820979|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25820980|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25820981|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
25820982|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25820983|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25820984|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25820985|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25820986|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25820987|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25820988|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25820989|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25820990|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
25820991|NCT00004197|Hormones|hormones|mesh-ancestor
25820992|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25820993|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25820994|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25820995|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
25820996|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
25820997|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
25820998|NCT00004197|Analgesics|analgesics|mesh-ancestor
25820999|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
25821000|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821001|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25821002|NCT00004198|Sargramostim|sargramostim|mesh-list
25821003|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25821004|NCT00004198|Vaccines|vaccines|mesh-list
25821005|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
25821006|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821007|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25821008|NCT00004199|Gemcitabine|gemcitabine|mesh-list
25821009|NCT00004199|Cisplatin|cisplatin|mesh-list
25821010|NCT00004199|Prinomastat|prinomastat|mesh-list
25821011|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821012|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821013|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
25821014|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821015|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
25821016|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821017|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821018|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821019|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
25821020|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821021|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
25821022|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
25821023|NCT00004200|Temozolomide|temozolomide|mesh-list
25821024|NCT00004200|Prinomastat|prinomastat|mesh-list
25821025|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821026|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
25821027|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821028|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821029|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
25821030|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
25821031|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821032|NCT00004201|Gemcitabine|gemcitabine|mesh-list
25821033|NCT00004201|Cisplatin|cisplatin|mesh-list
25821034|NCT00004201|Carboplatin|carboplatin|mesh-list
25821035|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821036|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821037|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
25821038|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821039|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
25821040|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821041|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821042|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821043|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
25821044|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821045|NCT00004202|Paclitaxel|paclitaxel|mesh-list
25821046|NCT00004202|Carboplatin|carboplatin|mesh-list
25821047|NCT00004202|Efaproxiral|efaproxiral|mesh-list
25821048|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821049|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821050|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821051|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821052|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821053|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821054|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
25821055|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
25821056|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821057|NCT00004204|Temozolomide|temozolomide|mesh-list
25821058|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821059|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
25821060|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821061|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821062|NCT00004205|Tamoxifen|tamoxifen|mesh-list
25821063|NCT00004205|Letrozole|letrozole|mesh-list
25821064|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821065|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821066|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25821067|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25821068|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821069|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25821070|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
25821071|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821072|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821073|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25821074|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24859746|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24859751|NCT02305654|Paclitaxel|paclitaxel|mesh-list
25821075|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25821076|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25821077|NCT00004206|Leucovorin|leucovorin|mesh-list
25821078|NCT00004206|Fluorouracil|fluorouracil|mesh-list
25821079|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
25821080|NCT00004206|Calcium|calcium|mesh-list
25821081|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
25821082|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821083|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821084|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
25821085|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821086|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821087|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821088|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821089|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
25821090|NCT00004206|Antidotes|antidotes|mesh-ancestor
25821091|NCT00004206|Protective Agents|protective agents|mesh-ancestor
25821092|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
25821093|NCT00004206|Vitamins|vitamins|mesh-ancestor
25821094|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
25821095|NCT00004207|Daunorubicin|daunorubicin|mesh-list
25821096|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821097|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821098|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821099|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821100|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821101|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821102|NCT00004209|Cisplatin|cisplatin|mesh-list
25821103|NCT00004209|Mitomycins|mitomycins|mesh-list
25821104|NCT00004209|Mitomycin|mitomycin|mesh-list
25821105|NCT00004209|Vinblastine|vinblastine|mesh-list
25821106|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821107|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821108|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
25821109|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821110|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25821111|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821112|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821113|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821114|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821115|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821116|NCT00004212|Exatecan|exatecan|mesh-list
25821117|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25821118|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821119|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821120|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821121|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821122|NCT00004215|Cytarabine|cytarabine|mesh-list
25821123|NCT00004215|Daunorubicin|daunorubicin|mesh-list
25821124|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821125|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
25821126|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821127|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821128|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
25821129|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821130|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821131|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
25821132|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821133|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821134|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821135|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821136|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821137|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
25821138|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
25821139|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25821140|NCT00004216|Cefixime|cefixime|mesh-list
25821141|NCT00004216|Trimethoprim|trimethoprim|mesh-list
25821142|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
25821143|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24859781|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24859782|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24859783|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859784|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859785|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
24859786|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
25821144|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821145|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821146|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821147|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821148|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821149|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821150|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25821151|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25821152|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25821153|NCT00004216|Renal Agents|renal agents|mesh-ancestor
25821154|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
25821155|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25821156|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25821157|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25821158|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25821159|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25821160|NCT00004217|Cytarabine|cytarabine|mesh-list
25821161|NCT00004217|Daunorubicin|daunorubicin|mesh-list
25821162|NCT00004217|Sargramostim|sargramostim|mesh-list
25821163|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821164|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
25821165|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821166|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821167|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
25821168|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821169|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821170|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
25821171|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821172|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821173|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821174|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821175|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821176|NCT00004218|Prednisolone|prednisolone|mesh-list
25821177|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
25821178|NCT00004218|Chlorambucil|chlorambucil|mesh-list
25821179|NCT00004218|Doxorubicin|doxorubicin|mesh-list
25821180|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25821181|NCT00004218|Fludarabine|fludarabine|mesh-list
25821182|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
25821183|NCT00004218|Vincristine|vincristine|mesh-list
25821184|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821185|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
25821186|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821187|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821188|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821189|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
25821190|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821191|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821192|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25821193|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821194|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821195|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821196|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821197|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821198|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
25821199|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821200|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821201|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821202|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821203|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25821204|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
25821205|NCT00004218|Hormones|hormones|mesh-ancestor
25821206|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821207|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25821208|NCT00004219|Granisetron|granisetron|mesh-list
25821209|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
25349011|NCT05514912|Paclitaxel|paclitaxel|mesh-list
25821210|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
25821211|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821212|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821213|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821214|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25821215|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
25821216|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25821217|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821218|NCT00004220|Gemcitabine|gemcitabine|mesh-list
25821219|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
25821220|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821221|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
25821222|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821223|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821224|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
25821225|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821226|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821227|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821228|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
25821229|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821230|NCT00004221|Paclitaxel|paclitaxel|mesh-list
25821231|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
25821232|NCT00004221|Carboplatin|carboplatin|mesh-list
25821233|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25821234|NCT00004221|Topotecan|topotecan|mesh-list
25821235|NCT00004221|Lenograstim|lenograstim|mesh-list
25821236|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821237|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821238|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821239|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821240|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821241|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821242|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821243|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
25821244|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821245|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821246|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821247|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
25821248|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25821249|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25821250|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25821251|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821252|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821253|NCT00004223|Gemcitabine|gemcitabine|mesh-list
25821254|NCT00004223|Docetaxel|docetaxel|mesh-list
25821255|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821256|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
25821257|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821258|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821259|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
25821260|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821261|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821262|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821263|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
25821264|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821265|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821266|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821267|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821268|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
25821269|NCT00004224|Etoposide|etoposide|mesh-list
25821270|NCT00004224|Vincristine|vincristine|mesh-list
25821271|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821272|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
25821273|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821274|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821275|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821276|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
25821277|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821278|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821279|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25821280|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821281|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821282|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821283|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821284|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821285|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821286|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821287|NCT00004227|Cetuximab|cetuximab|mesh-list
25821288|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25821289|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821290|NCT00004229|Endostatins|endostatins|mesh-list
25821291|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821292|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25821293|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25821294|NCT00004229|Growth Substances|growth substances|mesh-ancestor
25821295|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821296|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
25821297|NCT00004232|Cyclosporine|cyclosporine|mesh-list
25821298|NCT00004232|Prednisone|prednisone|mesh-list
25821299|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
25821300|NCT00004232|Cyclosporins|cyclosporins|mesh-list
25821301|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25821302|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
25821303|NCT00004232|Hormones|hormones|mesh-ancestor
25821304|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821305|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821306|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25821307|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821308|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
25821309|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821310|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821311|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821312|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
25821313|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821314|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
25821315|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821316|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25821317|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
25821318|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
25821319|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821320|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821321|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25821322|NCT00004232|Protective Agents|protective agents|mesh-ancestor
25821323|NCT00004233|Leucovorin|leucovorin|mesh-list
25821324|NCT00004233|Fluorouracil|fluorouracil|mesh-list
25821325|NCT00004233|Calcium|calcium|mesh-list
25821326|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
25821327|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821328|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821329|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
25821330|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821331|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821332|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821333|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821334|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
25821335|NCT00004233|Antidotes|antidotes|mesh-ancestor
25821336|NCT00004233|Protective Agents|protective agents|mesh-ancestor
25821337|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
25821338|NCT00004233|Vitamins|vitamins|mesh-ancestor
25821339|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
25821340|NCT00004235|Docetaxel|docetaxel|mesh-list
25821341|NCT00004235|Irinotecan|irinotecan|mesh-list
25821342|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821343|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821344|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821345|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821346|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821347|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25821348|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821349|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821350|NCT00004236|Doxorubicin|doxorubicin|mesh-list
25821351|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25821352|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821353|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821354|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821355|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821356|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821357|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821358|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
25821359|NCT00004237|Doxorubicin|doxorubicin|mesh-list
25821360|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25821361|NCT00004237|Vinorelbine|vinorelbine|mesh-list
25821362|NCT00004237|Epirubicin|epirubicin|mesh-list
25821363|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
25821364|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821365|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
25821366|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821367|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163264|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163265|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
25163266|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25163267|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25821368|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821369|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
25821370|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821371|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821372|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25821373|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821374|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821375|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821376|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821377|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821378|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821379|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821380|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821381|NCT00004237|Analgesics|analgesics|mesh-ancestor
25821382|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
25821383|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821384|NCT00004242|Gemcitabine|gemcitabine|mesh-list
25821385|NCT00004242|Fluorouracil|fluorouracil|mesh-list
25821386|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
25821387|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821388|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
25821389|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821390|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821391|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
25821392|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821393|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821394|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821395|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
25821396|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821397|NCT00004243|Docetaxel|docetaxel|mesh-list
25821398|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
25821399|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821400|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821401|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821402|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821403|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821404|NCT00004244|Interferons|interferons|mesh-list
25821405|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
25821406|NCT00004244|Interleukin-12|interleukin-12|mesh-list
25821407|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821408|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
25821409|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821410|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
25821411|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821412|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25821413|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25821414|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25821415|NCT00004244|Growth Substances|growth substances|mesh-ancestor
25821416|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
25821417|NCT00004245|Salicylates|salicylates|mesh-list
25821418|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
25821419|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25821420|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25821421|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25821422|NCT00004245|Analgesics|analgesics|mesh-ancestor
25821423|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
25821424|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821425|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821426|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25821427|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821428|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25821429|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821430|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821431|NCT00004246|Vidarabine|vidarabine|mesh-list
25821432|NCT00004246|Fludarabine|fludarabine|mesh-list
25821433|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
25821434|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821435|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821436|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
25821437|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821438|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821439|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
25821440|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821441|NCT00004246|Antiviral Agents|antiviral agents|mesh-ancestor
25821442|NCT00004246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821443|NCT00004248|Aldesleukin|aldesleukin|mesh-list
25821444|NCT00004248|Doxorubicin|doxorubicin|mesh-list
25821445|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25821446|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821447|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821448|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25821449|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25821450|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821451|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821452|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25821453|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25821454|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
25821455|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821456|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25821457|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25821458|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
25821459|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821460|NCT00004250|Dactinomycin|dactinomycin|mesh-list
25821461|NCT00004250|Melphalan|melphalan|mesh-list
25821462|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821463|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
25821464|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821465|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821466|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25821467|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821468|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
25821469|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821470|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25821471|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821472|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25821473|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25821474|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821475|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25821476|NCT00004251|Letrozole|letrozole|mesh-list
25821477|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821478|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25821479|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25821480|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821481|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821482|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25821483|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
25821484|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821485|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821486|NCT00004252|Leucovorin|leucovorin|mesh-list
25821487|NCT00004252|Fluorouracil|fluorouracil|mesh-list
25821488|NCT00004252|Calcium|calcium|mesh-list
25821489|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
25821490|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821491|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821492|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
25821493|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821494|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821495|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821496|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821497|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
25821498|NCT00004252|Antidotes|antidotes|mesh-ancestor
25821499|NCT00004252|Protective Agents|protective agents|mesh-ancestor
25821500|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
25821501|NCT00004252|Vitamins|vitamins|mesh-ancestor
25821502|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
25821503|NCT00004253|Paclitaxel|paclitaxel|mesh-list
25821504|NCT00004253|Carboplatin|carboplatin|mesh-list
25821505|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821506|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821507|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821508|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821509|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821510|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821511|NCT00004254|Raltitrexed|raltitrexed|mesh-list
25821512|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821513|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
25821514|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821515|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821516|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25821517|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821518|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
25821519|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
25821520|NCT00004255|Fludarabine|fludarabine|mesh-list
25821521|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
25821522|NCT00004255|Tacrolimus|tacrolimus|mesh-list
25821523|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25821525|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
25821526|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821527|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821528|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821529|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
25821530|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821531|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821532|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25821533|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821534|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
25821535|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25821536|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821537|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25821538|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
25821539|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
25821540|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821541|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821542|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
25821543|NCT00004255|Hormones|hormones|mesh-ancestor
25821544|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821545|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25821546|NCT00004255|Protective Agents|protective agents|mesh-ancestor
25821547|NCT00004256|Sargramostim|sargramostim|mesh-list
25821548|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
25821549|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821550|NCT00004257|Fluorouracil|fluorouracil|mesh-list
25821551|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
25821552|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
25821553|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821554|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821555|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821556|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821557|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
25821558|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821559|NCT00004260|Rituximab|rituximab|mesh-list
25821560|NCT00004260|Interleukin-12|interleukin-12|mesh-list
25821561|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25821562|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821563|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
25821564|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821565|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821566|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25821567|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25821568|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25821569|NCT00004260|Growth Substances|growth substances|mesh-ancestor
25821570|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
25821571|NCT00004261|Antibodies|antibodies|mesh-list
25821572|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
25821573|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821574|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
25821575|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821576|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25821577|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
25821578|NCT00004263|Cytarabine|cytarabine|mesh-list
25821579|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25821580|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821581|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
25821582|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821583|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821584|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
25821585|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821586|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821587|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
25821588|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821589|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25821590|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821591|NCT00004264|Cisplatin|cisplatin|mesh-list
25821592|NCT00004264|Docetaxel|docetaxel|mesh-list
25821593|NCT00004264|Amifostine|amifostine|mesh-list
25821594|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821595|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821596|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821597|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821598|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821599|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25821600|NCT00004264|Protective Agents|protective agents|mesh-ancestor
25821601|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821602|NCT00004265|Paclitaxel|paclitaxel|mesh-list
25821603|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25821604|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821605|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821606|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821607|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821608|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821609|NCT00004266|Lisinopril|lisinopril|mesh-list
25821610|NCT00004266|Nifedipine|nifedipine|mesh-list
25821611|NCT00004266|Simvastatin|simvastatin|mesh-list
25821612|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25821613|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25821614|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
25821615|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821616|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25821617|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25821618|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821619|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25821620|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25821621|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821622|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821623|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
25821624|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
25821625|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25821626|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25821627|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
25821628|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25821629|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25821630|NCT00004266|Protective Agents|protective agents|mesh-ancestor
25821631|NCT00004268|Midodrine|midodrine|mesh-list
25821632|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
25821633|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
25821634|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821635|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821636|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25821637|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25821638|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25821639|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25821640|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
25821641|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25821642|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821643|NCT00004274|Estrogens|estrogens|mesh-list
25821644|NCT00004274|Hormones|hormones|mesh-ancestor
25821645|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821646|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821647|NCT00004275|Hormones|hormones|mesh-list
25821648|NCT00004275|Oxandrolone|oxandrolone|mesh-list
25821649|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821650|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821651|NCT00004275|Androgens|androgens|mesh-ancestor
25821652|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
25821653|NCT00004276|Thalidomide|thalidomide|mesh-list
25821654|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821655|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
25821656|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821657|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
25821658|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25821659|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821660|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25821661|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25821662|NCT00004276|Growth Substances|growth substances|mesh-ancestor
25821663|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
25821664|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821665|NCT00004278|Ganciclovir|ganciclovir|mesh-list
25821666|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25821667|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
25821668|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821669|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25821670|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821671|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821672|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
25821673|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
25821674|NCT00004284|Diuretics|diuretics|mesh-ancestor
25821675|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
25821676|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821677|NCT00004284|Expectorants|expectorants|mesh-ancestor
25821678|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
25821679|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
25821680|NCT00004284|Protective Agents|protective agents|mesh-ancestor
25821681|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
25821682|NCT00004286|Antibodies|antibodies|mesh-list
25821683|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
25821684|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25821685|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25821686|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
25821687|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821688|NCT00004288|Olsalazine|olsalazine|mesh-list
25821689|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25821690|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25821691|NCT00004288|Analgesics|analgesics|mesh-ancestor
25821692|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
25821693|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821694|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821695|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25821696|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821697|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821698|NCT00004297|Diazepam|diazepam|mesh-list
25821699|NCT00004297|Lorazepam|lorazepam|mesh-list
25821700|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
25821701|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
25821702|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
25821703|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821704|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821705|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821706|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25821707|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25821708|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25821709|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25821710|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25821711|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
25821712|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
25821713|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25821714|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821715|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25821716|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25821717|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25821718|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25821719|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
25821720|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
25821721|NCT00004300|Bromocriptine|bromocriptine|mesh-list
25821722|NCT00004300|Sertraline|sertraline|mesh-list
25821723|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
25821724|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25821725|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25821726|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25821727|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25821728|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821729|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25821730|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
25821731|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821732|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25821733|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25821734|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
25821735|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821736|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
25821737|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
25821738|NCT00004310|Clomipramine|clomipramine|mesh-list
25349523|NCT05511870|Etripamil|etripamil|mesh-list
25821739|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25821740|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
25821741|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25821742|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25821743|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25821744|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25821745|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821746|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25821747|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
25821748|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821749|NCT00004311|Leuprolide|leuprolide|mesh-list
25821750|NCT00004311|Spironolactone|spironolactone|mesh-list
25821751|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25821752|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
25821753|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25821754|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821755|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25821756|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821757|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25821758|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
25821759|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821760|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25821761|NCT00004311|Diuretics|diuretics|mesh-ancestor
25821762|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
25821763|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25821764|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25821765|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
25821766|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821767|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25821768|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25821769|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821770|NCT00004316|Capsaicin|capsaicin|mesh-list
25821771|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
25821772|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
25821773|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
25821774|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821775|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821776|NCT00004317|Leucovorin|leucovorin|mesh-list
25821777|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
25821778|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
25821779|NCT00004317|Spiramycin|spiramycin|mesh-list
25821780|NCT00004317|Calcium|calcium|mesh-list
25821781|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
25821782|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821783|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821784|NCT00004317|Antidotes|antidotes|mesh-ancestor
25821785|NCT00004317|Protective Agents|protective agents|mesh-ancestor
25821786|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
25821787|NCT00004317|Vitamins|vitamins|mesh-ancestor
25821788|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
25821789|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
25821790|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25821791|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25821792|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821793|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24540532|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
24451152|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
25821794|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821795|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821796|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25821797|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
25821798|NCT00004323|Cyclosporine|cyclosporine|mesh-list
25821799|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
25821800|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
25821801|NCT00004323|Methotrexate|methotrexate|mesh-list
25821802|NCT00004323|Cyclosporins|cyclosporins|mesh-list
25821803|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25821804|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25821805|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
25821806|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821807|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821808|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25821809|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
25821810|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821811|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821812|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25821813|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25821814|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
25821815|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25821816|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25821817|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
25821818|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
25821819|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821820|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25821821|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25821822|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
25821823|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25821824|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25821825|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25821826|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
25821827|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
25821828|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821829|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821830|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
25821831|NCT00004323|Hormones|hormones|mesh-ancestor
25821832|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821833|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25821834|NCT00004323|Protective Agents|protective agents|mesh-ancestor
25821835|NCT00004327|Octreotide|octreotide|mesh-list
25821836|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821837|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25821838|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821839|NCT00004328|Enalapril|enalapril|mesh-list
25821840|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
25821841|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25821842|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
25821843|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821844|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821845|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25821846|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
25821847|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
25821848|NCT00004330|Hormones|hormones|mesh-list
25821849|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821850|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821851|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25821852|NCT00004339|Trientine|trientine|mesh-list
25821853|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
25821854|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
25821855|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821856|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821857|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25821858|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25821859|NCT00004339|Growth Substances|growth substances|mesh-ancestor
25821860|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821861|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
25821862|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821863|NCT00004340|Calcitriol|calcitriol|mesh-list
25821864|NCT00004340|Hormones|hormones|mesh-list
25821865|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821866|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821867|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821868|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24540585|NCT00668603|Estrogens|estrogens|mesh-ancestor
25821869|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25821870|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821871|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25821872|NCT00004340|Vitamins|vitamins|mesh-ancestor
25821873|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
25821874|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25821875|NCT00004344|Leuprolide|leuprolide|mesh-list
25821876|NCT00004344|Testosterone|testosterone|mesh-list
25821877|NCT00004344|Androgens|androgens|mesh-ancestor
25821878|NCT00004344|Hormones|hormones|mesh-ancestor
25821879|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821880|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821881|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25821882|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821883|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25821884|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
25821885|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25821886|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25821887|NCT00004346|Lovastatin|lovastatin|mesh-list
25821888|NCT00004346|L 647318|l 647318|mesh-list
25821889|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
25821890|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25821891|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25821892|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
25821893|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821894|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25821895|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25821896|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821897|NCT00004346|Cathartics|cathartics|mesh-ancestor
25821898|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821899|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
25821900|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25821901|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25821902|NCT00004357|Prednisolone|prednisolone|mesh-list
25821903|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
25821904|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25821905|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
25821906|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25821907|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
25821908|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
25821909|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821910|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821911|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25821912|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
25821913|NCT00004357|Hormones|hormones|mesh-ancestor
25821914|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25821915|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25821916|NCT00004357|Protective Agents|protective agents|mesh-ancestor
25821917|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25821918|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821919|NCT00004358|Calcitonin|calcitonin|mesh-list
25821920|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
25821921|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25821922|NCT00004358|Katacalcin|katacalcin|mesh-list
25821923|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821924|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821925|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25821926|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
25821927|NCT00004359|Methoxsalen|methoxsalen|mesh-list
25821928|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25821929|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25821930|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
25821931|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25821932|NCT00004360|Diuretics|diuretics|mesh-ancestor
25821933|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
25821934|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821935|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25821936|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25821937|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821938|NCT00004361|Citric Acid|citric acid|mesh-list
25821939|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
25821940|NCT00004361|Calcium|calcium|mesh-list
25821941|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25821942|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821943|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
25821944|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25821945|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
25821946|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
25821947|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821948|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
25821949|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25821950|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
25821951|NCT00004363|Coagulants|coagulants|mesh-ancestor
25821952|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25821953|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
25821954|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821955|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25821956|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25821957|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
25821958|NCT00004364|Coagulants|coagulants|mesh-ancestor
25821959|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25821960|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
25821961|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821962|NCT00004368|Colchicine|colchicine|mesh-list
25821963|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
25821964|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25821965|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
25821966|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
25821967|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
25821968|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821969|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25821970|NCT00004373|Alprazolam|alprazolam|mesh-list
25821971|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25821972|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25821973|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821974|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25821975|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25821976|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25821977|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
25821978|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
25821979|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25821980|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821981|NCT00004376|Guanfacine|guanfacine|mesh-list
25821982|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25821983|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25821984|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25821985|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25821986|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
25821987|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25821988|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821989|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821990|NCT00004380|Methocarbamol|methocarbamol|mesh-list
25821991|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25821992|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25821993|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25821994|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25821995|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25821996|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25821997|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25821998|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25821999|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822000|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822001|NCT00004390|Morphine|morphine|mesh-list
25822002|NCT00004390|Methadone|methadone|mesh-list
25822003|NCT00004390|Nortriptyline|nortriptyline|mesh-list
25822004|NCT00004390|Desipramine|desipramine|mesh-list
25822005|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25822006|NCT00004390|Narcotics|narcotics|mesh-ancestor
25822007|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25822008|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822009|NCT00004390|Analgesics|analgesics|mesh-ancestor
25822010|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
25822011|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822012|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
25822013|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
25822014|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25822015|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
25822016|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822017|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25822018|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25822019|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860232|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822020|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822021|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
25822022|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822023|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822024|NCT00004393|Risperidone|risperidone|mesh-list
25822025|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25822026|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
25822027|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822028|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822029|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822030|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25822031|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25822032|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25822033|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822034|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25822035|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
25822036|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25822037|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822038|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822039|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25822040|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822041|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822042|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25822043|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822044|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822045|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
25822046|NCT00004399|Nimodipine|nimodipine|mesh-list
25822047|NCT00004399|Analgesics|analgesics|mesh-ancestor
25822048|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
25822049|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822050|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822051|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
25822052|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25822053|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25822054|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
25822055|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25822056|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822057|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822058|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25822059|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
25822060|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25822061|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25822062|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
25822063|NCT00004400|Testosterone|testosterone|mesh-list
25822064|NCT00004400|Androgens|androgens|mesh-ancestor
25822065|NCT00004400|Hormones|hormones|mesh-ancestor
25822066|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822067|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822068|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
25822069|NCT00004401|Antibodies|antibodies|mesh-list
25822070|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
25822071|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25822072|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25822073|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
25822074|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822075|NCT00004402|Calcitriol|calcitriol|mesh-list
25822076|NCT00004402|Interferons|interferons|mesh-list
25822077|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
25822078|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822079|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
25822080|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822081|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25822082|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822083|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25822084|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822085|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822086|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25822087|NCT00004402|Vitamins|vitamins|mesh-ancestor
25822088|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
25822089|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25822090|NCT00004403|Albendazole|albendazole|mesh-list
25822091|NCT00004403|Dexamethasone|dexamethasone|mesh-list
25822092|NCT00004403|Phenytoin|phenytoin|mesh-list
25822093|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822094|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
25822095|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
25822096|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822097|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822098|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822099|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
25822101|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822102|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822103|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822104|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
25822105|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25822106|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822107|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
25822108|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25822109|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25822110|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
25822111|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
25822112|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
25822113|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822114|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
25822115|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25822116|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25822117|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822118|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25822119|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25822120|NCT00004404|Clotrimazole|clotrimazole|mesh-list
25822121|NCT00004404|Miconazole|miconazole|mesh-list
25822122|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
25822123|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822124|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
25822125|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822126|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822127|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25822128|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25822129|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822130|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
25822131|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25822132|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822133|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25822134|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
25822135|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822136|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822137|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25822138|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25822139|NCT00004406|Hormones|hormones|mesh-list
25822140|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
25822141|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822142|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822143|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25822144|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
25822145|NCT00004407|Antibodies|antibodies|mesh-list
25822146|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
25822147|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25822148|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25822149|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
25822150|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822151|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25822152|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
25822153|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822154|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25822155|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822156|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
25822157|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25822158|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25822159|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25822160|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822161|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822162|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
25822163|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822164|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822165|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25822166|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822167|NCT00004419|Mitogens|mitogens|mesh-list
25822168|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
25822169|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822170|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
25822171|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25822172|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25822173|NCT00004420|Analgesics|analgesics|mesh-ancestor
25822174|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
25822175|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822176|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822177|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822178|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822179|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25822180|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
25822181|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822182|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25822183|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
25822184|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
25822185|NCT00004422|Antibodies|antibodies|mesh-list
25822186|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
25822187|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25822188|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25822189|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
25822190|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822191|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25822192|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
25822193|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822194|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822195|NCT00004424|Fentanyl|fentanyl|mesh-list
25822196|NCT00004424|Midazolam|midazolam|mesh-list
25822197|NCT00004424|Propofol|propofol|mesh-list
25822198|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25822199|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25822200|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822201|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25822202|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
25822203|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
25822204|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25822205|NCT00004424|Narcotics|narcotics|mesh-ancestor
25822206|NCT00004424|Analgesics|analgesics|mesh-ancestor
25822207|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
25822208|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822209|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25822210|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25822211|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25822212|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822213|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
25822214|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
25822215|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822216|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822217|NCT00004426|Leuprolide|leuprolide|mesh-list
25822218|NCT00004426|Hormones|hormones|mesh-list
25822219|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822220|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822221|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25822222|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
25822223|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25822224|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822225|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822226|NCT00004429|Hormones|hormones|mesh-list
25822227|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822228|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822229|NCT00004430|Prednisolone|prednisolone|mesh-list
25822230|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822231|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
25822232|NCT00004430|Hormones|hormones|mesh-ancestor
25822233|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822234|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822235|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822236|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822237|NCT00004431|Baclofen|baclofen|mesh-list
25822238|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25822239|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822240|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25822241|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822242|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25822243|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
25822244|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
25822245|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822246|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822247|NCT00004433|Pergolide|pergolide|mesh-list
25822248|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
25822249|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
25822250|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822251|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822252|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822253|NCT00004436|Prednisone|prednisone|mesh-list
25822254|NCT00004436|Leuprolide|leuprolide|mesh-list
25822255|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822256|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
25822257|NCT00004436|Hormones|hormones|mesh-ancestor
25822258|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822259|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822260|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822261|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822262|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25822263|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
25822264|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25822265|NCT00004438|Leuprolide|leuprolide|mesh-list
25822266|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25822327|NCT00004450|Interferons|interferons|mesh-list
25822267|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
25822268|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25822269|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822270|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822271|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822272|NCT00004440|Ibuprofen|ibuprofen|mesh-list
25822273|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25822274|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25822275|NCT00004440|Analgesics|analgesics|mesh-ancestor
25822276|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
25822277|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822278|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822279|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822280|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822281|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25822282|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822283|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822284|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25822285|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25822286|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25822287|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822288|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
25822289|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822290|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25822291|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25822292|NCT00004442|Cholic Acids|cholic acids|mesh-list
25822293|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25822294|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822295|NCT00004442|Cathartics|cathartics|mesh-ancestor
25822296|NCT00004444|Paromomycin|paromomycin|mesh-list
25822297|NCT00004444|Streptomycin|streptomycin|mesh-list
25822298|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822299|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822300|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25822301|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25822302|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25822303|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822304|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822305|NCT00004446|Fluoxetine|fluoxetine|mesh-list
25822306|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25822307|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25822308|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822309|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822310|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822311|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
25822312|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822313|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25822314|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
25822315|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822316|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25822317|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822318|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822319|NCT00004448|Prednisone|prednisone|mesh-list
25822320|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822321|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
25822322|NCT00004448|Hormones|hormones|mesh-ancestor
25822323|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822324|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822325|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822326|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822328|NCT00004450|Interferon-beta|interferon-beta|mesh-list
25822329|NCT00004450|Thalidomide|thalidomide|mesh-list
25822330|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822331|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
25822332|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822333|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822334|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
25822335|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822336|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
25822337|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822338|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25822339|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25822340|NCT00004450|Growth Substances|growth substances|mesh-ancestor
25822341|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
25822342|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
25822343|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822344|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
25822345|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822346|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822347|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25822348|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
25822349|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822350|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822351|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25822352|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
25822353|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25822354|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822355|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822356|NCT00004466|Atorvastatin|atorvastatin|mesh-list
25822357|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25822358|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25822359|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
25822360|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822361|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25822362|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25822363|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822364|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
25822365|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25822366|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
25822367|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822368|NCT00004467|Expectorants|expectorants|mesh-ancestor
25822369|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
25822370|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25822371|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
25822372|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822373|NCT00004467|Protective Agents|protective agents|mesh-ancestor
25822374|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822375|NCT00004467|Antidotes|antidotes|mesh-ancestor
25822376|NCT00004468|Calcitriol|calcitriol|mesh-list
25822377|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25822378|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822379|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25822380|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822381|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822382|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25822383|NCT00004468|Vitamins|vitamins|mesh-ancestor
25822384|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
25822385|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25822386|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
25822387|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25822388|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822389|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
25822390|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822391|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822392|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25822393|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
25822394|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822395|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822396|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25822397|NCT00004478|Droxidopa|droxidopa|mesh-list
25822398|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25822399|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25822400|NCT00004479|Midodrine|midodrine|mesh-list
25822401|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
25822402|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
25822403|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822404|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822405|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25822406|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25822407|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25822408|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25822409|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
25822410|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822411|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822412|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
25822413|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25822414|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25822415|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25822416|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822417|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822418|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
25822419|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822420|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822421|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25822422|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822423|NCT00004482|Cyclosporine|cyclosporine|mesh-list
25822424|NCT00004482|Prednisone|prednisone|mesh-list
25822425|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
25822426|NCT00004482|Cyclosporins|cyclosporins|mesh-list
25822427|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
25822428|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822429|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
25822430|NCT00004482|Hormones|hormones|mesh-ancestor
25822431|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822432|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822433|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822434|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822435|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822436|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822437|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822438|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
25822439|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
25822440|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822441|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
25822442|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822443|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25822444|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
25822445|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
25822446|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822447|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822448|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25822449|NCT00004482|Protective Agents|protective agents|mesh-ancestor
25822450|NCT00004485|Cyclosporine|cyclosporine|mesh-list
25822451|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
25822452|NCT00004485|Fludarabine|fludarabine|mesh-list
25822453|NCT00004485|Cyclosporins|cyclosporins|mesh-list
25822454|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822455|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822456|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822457|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
25822458|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822459|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822460|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
25822461|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822462|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
25822463|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822464|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25822465|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25822466|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25822467|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
25822468|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822469|NCT00004486|Fluoxetine|fluoxetine|mesh-list
25822470|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25822471|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25822472|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822473|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822474|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822475|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
25822476|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822477|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25822478|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
25822479|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822480|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25822481|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822482|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552098|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
24860481|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24860482|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860483|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860484|NCT02310295|Triamcinolone|triamcinolone|mesh-list
24860485|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24860486|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24860487|NCT02310295|Bevacizumab|bevacizumab|mesh-list
24860488|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24860534|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860535|NCT02310490|Mannitol|mannitol|mesh-list
24860573|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860717|NCT02312115|Diuretics|diuretics|mesh-ancestor
24861040|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861041|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24861042|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25163331|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
25163332|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
24861138|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24541491|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24541493|NCT00673296|Growth Substances|growth substances|mesh-ancestor
24813339|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813340|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861323|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
24861797|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24861798|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861799|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813407|NCT02058433|Paclitaxel|paclitaxel|mesh-list
24813415|NCT02058446|Amlodipine|amlodipine|mesh-list
24850270|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24850271|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850274|NCT02252523|Analgesics|analgesics|mesh-ancestor
24850767|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850768|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25163392|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163393|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163395|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
24862510|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24862511|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862512|NCT05144100|Cisplatin|cisplatin|mesh-list
24542341|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542342|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
24542343|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862553|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24862627|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
24862628|NCT04929847|Emollients|emollients|mesh-list
24862629|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
24542398|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203000|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25203001|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
25203002|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
25203003|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862753|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
24862754|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862755|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862757|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
24862904|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862905|NCT04034459|Leucovorin|leucovorin|mesh-list
24862906|NCT04034459|Folic Acid|folic acid|mesh-list
24862907|NCT04034459|Bevacizumab|bevacizumab|mesh-list
24862908|NCT04034459|Cetuximab|cetuximab|mesh-list
24862909|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
24862910|NCT04034459|Irinotecan|irinotecan|mesh-list
24446640|NCT00305513|Caffeine|caffeine|mesh-list
24446641|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24446642|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446643|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24475222|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24661915|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24600962|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24475448|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475451|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
24806215|NCT02014532|Montelukast|montelukast|mesh-list
24806216|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
24475470|NCT00410592|Lansoprazole|lansoprazole|mesh-list
24475471|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
24475767|NCT00411333|Triamcinolone|triamcinolone|mesh-list
24475768|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24475769|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24475770|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24475771|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415874|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
24827589|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
24827590|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
24806435|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24807076|NCT02019524|Sargramostim|sargramostim|mesh-list
24807091|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586535|NCT00891163|Lidocaine|lidocaine|mesh-list
25163466|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
25163467|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163468|NCT02896023|Menotropins|menotropins|mesh-list
25163469|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25163470|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
25163471|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24476833|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
24476834|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476835|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477521|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24477522|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
24477893|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477894|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
24477895|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477896|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
24807189|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24807190|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807191|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24807192|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477921|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
24588057|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
25163507|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163509|NCT02895672|Hormones|hormones|mesh-ancestor
25163512|NCT02895750|Metformin|metformin|mesh-list
24589189|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
24479534|NCT00427245|Goserelin|goserelin|mesh-list
24807678|NCT02023086|Mydriatics|mydriatics|mesh-list
24479909|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24667724|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25163629|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163630|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163631|NCT02894684|Aztreonam|aztreonam|mesh-list
25163632|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163633|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163634|NCT02894710|Lidocaine|lidocaine|mesh-list
24483338|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24483339|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24483340|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483418|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
24483419|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24484033|NCT00446316|Antacids|antacids|mesh-list
25163640|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484604|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484891|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484892|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484893|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24484967|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24485240|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24485567|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485573|NCT00453778|Xhance|xhance|mesh-list
24486506|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24486507|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24486508|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
24488440|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24490845|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
24491674|NCT00483600|PENTA|penta|mesh-list
24809805|NCT02036281|Substance P|substance p|mesh-list
24497640|NCT00510965|Growth Substances|growth substances|mesh-ancestor
24498437|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498438|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24498583|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24828001|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24828002|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
24828003|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
24585044|NCT00882869|Sorafenib|sorafenib|mesh-list
24828005|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828006|NCT02142751|Meropenem|meropenem|mesh-list
24828007|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
24500441|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24500443|NCT00524199|Protective Agents|protective agents|mesh-ancestor
24500450|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164189|NCT05420350|Bupropion|bupropion|mesh-list
24500978|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24500979|NCT00526318|Etoposide|etoposide|mesh-list
24500980|NCT00526318|Vincristine|vincristine|mesh-list
24500981|NCT00526318|Topotecan|topotecan|mesh-list
24500982|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
24500983|NCT00526318|Vindesine|vindesine|mesh-list
24443381|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24500984|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24500985|NCT00526318|Isotretinoin|isotretinoin|mesh-list
24500986|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500987|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
24623044|NCT01069874|Vitamin D|vitamin d|mesh-list
24535651|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535652|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
24535653|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24535654|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
25164205|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25164207|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25164208|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766884|NCT01797666|Pioglitazone|pioglitazone|mesh-list
24810414|NCT02040142|Mitomycin|mitomycin|mesh-list
24810415|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24810416|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810417|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
24501378|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24501379|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24501647|NCT00530387|Diclofenac|diclofenac|mesh-list
24501962|NCT00531791|Prednisone|prednisone|mesh-list
24501963|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501964|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
24501965|NCT00531791|Hormones|hormones|mesh-ancestor
24828266|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24502050|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24767716|NCT01802814|Epratuzumab|epratuzumab|mesh-list
25164296|NCT05411380|Capecitabine|capecitabine|mesh-list
25164297|NCT05411380|Letrozole|letrozole|mesh-list
25164298|NCT05411380|Fulvestrant|fulvestrant|mesh-list
25164299|NCT05411380|Anastrozole|anastrozole|mesh-list
25164300|NCT05411380|Exemestane|exemestane|mesh-list
25203134|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25203135|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203137|NCT02716038|Paclitaxel|paclitaxel|mesh-list
25203138|NCT02716038|Carboplatin|carboplatin|mesh-list
25203139|NCT02716038|Atezolizumab|atezolizumab|mesh-list
25203140|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25203141|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203142|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25203143|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25203144|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810481|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810482|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502937|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502938|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810487|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24480930|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560141|NCT03492463|Nicotine|nicotine|mesh-list
24503336|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24503337|NCT01840566|Cytarabine|cytarabine|mesh-list
24503338|NCT01840566|Etoposide|etoposide|mesh-list
24503339|NCT01840566|Melphalan|melphalan|mesh-list
24503340|NCT01840566|Carmustine|carmustine|mesh-list
24503341|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24503342|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503343|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24503345|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503346|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810497|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
24810498|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
25080643|NCT03336814|Terlipressin|terlipressin|mesh-list
25164363|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25164365|NCT05392699|Interleukin-12|interleukin-12|mesh-list
25164366|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25164367|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
25164368|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164369|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25164370|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24503484|NCT00971867|Paclitaxel|paclitaxel|mesh-list
24503508|NCT00532116|Protective Agents|protective agents|mesh-ancestor
24503509|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503510|NCT00532142|Triamcinolone|triamcinolone|mesh-list
24810559|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
24810560|NCT02040818|Protective Agents|protective agents|mesh-ancestor
24810562|NCT02040818|Antidotes|antidotes|mesh-ancestor
24503654|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24503655|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
24503656|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24503658|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24503659|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503660|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24536221|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
24810574|NCT02040883|Tandospirone|tandospirone|mesh-list
24810575|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24810576|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
24792677|NCT04843046|Pioglitazone|pioglitazone|mesh-list
25164394|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25164395|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25164396|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164397|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164398|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164399|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
25164400|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25164401|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164402|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164403|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25164404|NCT05376761|Analgesics|analgesics|mesh-ancestor
25164405|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
25164406|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164407|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25164408|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25164409|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25164410|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
25164411|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207787|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25207788|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24503849|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503850|NCT00533169|Tretinoin|tretinoin|mesh-list
24503851|NCT00533169|Isotretinoin|isotretinoin|mesh-list
24503852|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620489|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24504058|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
24504059|NCT00533936|Doxorubicin|doxorubicin|mesh-list
24504060|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24504061|NCT00533936|Fluorouracil|fluorouracil|mesh-list
24504062|NCT00533936|Trastuzumab|trastuzumab|mesh-list
24504063|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620564|NCT01057615|Vitamins|vitamins|mesh-ancestor
24810679|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24810680|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810681|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
24810682|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447693|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447694|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447695|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24828638|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828639|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
24828640|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828641|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828642|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504556|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164522|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24458904|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458906|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24458907|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461821|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24462184|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24462186|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
24462187|NCT00355407|Hematinics|hematinics|mesh-ancestor
24462188|NCT00355446|Bimatoprost|bimatoprost|mesh-list
24462189|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24462190|NCT00355459|Doxycycline|doxycycline|mesh-list
24462262|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462263|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24629016|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629017|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
24629018|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24629076|NCT01103115|Antacids|antacids|mesh-ancestor
25203233|NCT02715531|Antidotes|antidotes|mesh-ancestor
24665169|NCT01310647|Hormones|hormones|mesh-ancestor
24811222|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
24632401|NCT01123551|Morphine|morphine|mesh-list
24633162|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24395057|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395058|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395059|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395498|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24395499|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
24395790|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395791|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24606748|NCT05408845|Docetaxel|docetaxel|mesh-list
24395950|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395977|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395978|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623137|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24623138|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24623139|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623144|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24397460|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455412|NCT01370486|Melatonin|melatonin|mesh-list
24538920|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24455444|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
24971824|NCT03722303|Cortisone|cortisone|mesh-list
24455445|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24455446|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24397734|NCT00142480|Capecitabine|capecitabine|mesh-list
24397735|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
24397736|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25165052|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
25165053|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25165054|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165055|NCT05076838|Diazepam|diazepam|mesh-list
25165056|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25165057|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
25165058|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
24398479|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
24398658|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24399612|NCT00148265|Hormones|hormones|mesh-ancestor
24399788|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399971|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399972|NCT00149162|Aldesleukin|aldesleukin|mesh-list
24539157|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
24539158|NCT00662519|Lenograstim|lenograstim|mesh-list
24400065|NCT00149578|Antidotes|antidotes|mesh-ancestor
24401218|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401449|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24401450|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24539435|NCT00663884|Voglibose|voglibose|mesh-list
24401757|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24401758|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
24401759|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401760|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402020|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24539657|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539658|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24539659|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24403394|NCT00160186|Pancrelipase|pancrelipase|mesh-list
24403395|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403396|NCT00160238|Betahistine|betahistine|mesh-list
25165366|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25165425|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811523|NCT02047136|Histamine|histamine|mesh-list
24404451|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404452|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25099459|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
24811596|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811597|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24811598|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
24724826|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
24811699|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24607158|NCT05129358|Furosemide|furosemide|mesh-list
24405534|NCT00167583|Cyclosporins|cyclosporins|mesh-list
24405535|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405536|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
24405537|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165527|NCT04766996|Narcotics|narcotics|mesh-ancestor
24406085|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406086|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406087|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406088|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24406093|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
24406497|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406724|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406726|NCT00171093|Simvastatin|simvastatin|mesh-list
24572416|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24572417|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24572418|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
24407141|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407142|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407143|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
24407146|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
25102991|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24407230|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407243|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24407436|NCT00174538|Codeine|codeine|mesh-list
24820107|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24408192|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
24408193|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408194|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
24408195|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408196|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408197|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165878|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24829162|NCT02150122|Vitamin D|vitamin d|mesh-list
25165898|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
24448074|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448075|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448076|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25203417|NCT02714543|Protective Agents|protective agents|mesh-ancestor
24448078|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
24448079|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977294|NCT02764268|Apatinib|apatinib|mesh-list
25165959|NCT04517396|Fenofibrate|fenofibrate|mesh-list
25165960|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
25165962|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
25165963|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165964|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25165965|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25165966|NCT04501653|Methylphenidate|methylphenidate|mesh-list
25041598|NCT01619332|Incretins|incretins|mesh-ancestor
25041599|NCT01619332|Hormones|hormones|mesh-ancestor
25041601|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24829420|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829421|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24829422|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24829423|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829425|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448347|NCT00311467|Capecitabine|capecitabine|mesh-list
24448348|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448349|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
24448350|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829483|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24844983|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25165990|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165991|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25165992|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25165993|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25165994|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165995|NCT04491968|Methadone|methadone|mesh-list
25044095|NCT01156415|S 20098|s 20098|mesh-list
25166046|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446171|NCT00303927|Capecitabine|capecitabine|mesh-list
24534742|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
25166148|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166149|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25166150|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
25166151|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166152|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458635|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458636|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24458637|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24458638|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
24450494|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24450495|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25166264|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24459136|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642965|NCT01182636|Adapalene|adapalene|mesh-list
24643758|NCT01187108|Diuretics|diuretics|mesh-ancestor
24459447|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459448|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
24450430|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24820225|NCT02099240|Cefuroxime|cefuroxime|mesh-list
25203435|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24409925|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859590|NCT02304250|Hormones|hormones|mesh-ancestor
24859923|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24540781|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25041724|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24448701|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655287|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655288|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24655289|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
24451396|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24655741|NCT01257828|Riluzole|riluzole|mesh-list
24393739|NCT00130884|Protective Agents|protective agents|mesh-ancestor
24802251|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862259|NCT02324010|Hormones|hormones|mesh-ancestor
24862260|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862261|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24862262|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
24542090|NCT00676845|Olmesartan|olmesartan|mesh-list
24542091|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24542092|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542093|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24601783|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601784|NCT00965926|Mirabegron|mirabegron|mesh-list
25203436|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24542418|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862879|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862880|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
24862881|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24806123|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24474853|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474854|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474856|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24806191|NCT02014454|Propranolol|propranolol|mesh-list
24806192|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24806193|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24475407|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475409|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24475410|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24475411|NCT00410371|Lamotrigine|lamotrigine|mesh-list
24475412|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
24475413|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24475414|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475415|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601673|NCT00965406|Insulin|insulin|mesh-list
24802663|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24477832|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477833|NCT00420524|Epothilone B|epothilone b|mesh-list
24477834|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807944|NCT02024555|Azithromycin|azithromycin|mesh-list
24479725|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24807508|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
24807509|NCT02022358|Hematinics|hematinics|mesh-ancestor
24807510|NCT02022475|Vitamin D|vitamin d|mesh-list
24479754|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24479755|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479756|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
24807709|NCT02023359|Exemestane|exemestane|mesh-list
24807710|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807711|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807712|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
24589620|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
24808046|NCT02024984|Enclomiphene|enclomiphene|mesh-list
24808047|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
24808048|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24808049|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
24808078|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24482535|NCT00439504|Lobeline|lobeline|mesh-list
24482901|NCT00440921|Coagulants|coagulants|mesh-ancestor
24808304|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808305|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24808306|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
24808307|NCT02026479|Hormones|hormones|mesh-ancestor
24808308|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484880|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484881|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24485053|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24486116|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486647|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
24676902|NCT01353209|Letrozole|letrozole|mesh-list
24487107|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24487108|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487109|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
24487143|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
24487144|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474175|NCT00405171|Nevirapine|nevirapine|mesh-list
24487145|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487146|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24809090|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809091|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809092|NCT02031211|Etanercept|etanercept|mesh-list
24809093|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24809094|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678132|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461921|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
24489367|NCT00472823|Calcium|calcium|mesh-list
24489908|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24489909|NCT00475917|Gemcitabine|gemcitabine|mesh-list
24489911|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
24490132|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24490133|NCT00476515|Rituximab|rituximab|mesh-list
24809411|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24809412|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809413|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809414|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604631|NCT00980551|Topotecan|topotecan|mesh-list
24492814|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474753|NCT00407264|Xhance|xhance|mesh-list
24493393|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24493968|NCT00493233|Olanzapine|olanzapine|mesh-list
24494283|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
24494488|NCT00495339|Renal Agents|renal agents|mesh-ancestor
24495060|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
24495125|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495126|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
24495127|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495128|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495129|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
24810076|NCT02037724|Trace Elements|trace elements|mesh-ancestor
24605391|NCT00984828|Bortezomib|bortezomib|mesh-list
24497034|NCT00507845|Ramipril|ramipril|mesh-list
24810169|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810170|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24810171|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
25166407|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497806|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498014|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498337|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498530|NCT00515229|Amitriptyline|amitriptyline|mesh-list
24499944|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500653|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500912|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500913|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24500914|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500915|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500917|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24500918|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500937|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
24500938|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
24714603|NCT01531595|Bevacizumab|bevacizumab|mesh-list
24501153|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501154|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501155|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24501188|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501189|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
24501190|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501191|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501463|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
24501465|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24501466|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
24501467|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501468|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501547|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501548|NCT00529425|Ropivacaine|ropivacaine|mesh-list
24501549|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
24501550|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
24501657|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24810468|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810469|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810470|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24810471|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810472|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24502876|NCT04107675|Cyclosporins|cyclosporins|mesh-list
24502877|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503316|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503317|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
24503318|NCT02143830|Busulfan|busulfan|mesh-list
24503319|NCT02143830|Fludarabine|fludarabine|mesh-list
24503349|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
24503350|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503351|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503352|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
24503353|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503690|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24503691|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
24536227|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
24503721|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24503745|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503746|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503747|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24504006|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
24504007|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24504008|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24504073|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24504074|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
24504075|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25166431|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810812|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24810814|NCT02042690|Dexamethasone|dexamethasone|mesh-list
24629101|NCT01103193|Sevoflurane|sevoflurane|mesh-list
24395457|NCT00135967|Protective Agents|protective agents|mesh-ancestor
24395503|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395990|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
24398497|NCT00144703|Tacrolimus|tacrolimus|mesh-list
24399676|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
24400321|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400323|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400324|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400325|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24400326|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540044|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24405491|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405492|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
24623191|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24623193|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24623194|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24540661|NCT00668941|Teriparatide|teriparatide|mesh-list
24405684|NCT00167947|Cyclosporine|cyclosporine|mesh-list
24540866|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24406150|NCT00169169|Rituximab|rituximab|mesh-list
24406629|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24550697|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550698|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407416|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407417|NCT00174486|Urological Agents|urological agents|mesh-ancestor
24407419|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24820121|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24820122|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24820123|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408104|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24408105|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24408136|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24756315|NCT01732250|Colistin|colistin|mesh-list
24820197|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
24820198|NCT02099240|Gentamicins|gentamicins|mesh-list
24820199|NCT02099240|Isoniazid|isoniazid|mesh-list
24820200|NCT02099240|Meropenem|meropenem|mesh-list
24408472|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24408475|NCT00177996|Sertraline|sertraline|mesh-list
24681563|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408908|NCT00180050|Budesonide|budesonide|mesh-list
24409705|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
24820941|NCT02102711|Vitamin A|vitamin a|mesh-list
24409944|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
24410154|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410155|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410405|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24440432|NCT00283088|Plasminogen|plasminogen|mesh-list
24410407|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24410562|NCT00185991|Gentamicins|gentamicins|mesh-list
24410900|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
24821441|NCT02105350|Gemcitabine|gemcitabine|mesh-list
24411441|NCT00189033|Psyllium|psyllium|mesh-list
24411673|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
24411675|NCT00189683|Capecitabine|capecitabine|mesh-list
24411717|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411718|NCT00189787|Tacrolimus|tacrolimus|mesh-list
24821805|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821806|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24821807|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821808|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412268|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412269|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412270|NCT00191061|Analgesics|analgesics|mesh-ancestor
24412271|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
24412274|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24821924|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24821996|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413084|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413085|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413086|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
24413343|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413344|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413345|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413346|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24822098|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822101|NCT02109861|Melphalan|melphalan|mesh-list
24822102|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822103|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
24822104|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
24822105|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822106|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822107|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822108|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
24822109|NCT02109861|Hormones|hormones|mesh-ancestor
24822110|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822111|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24413680|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413681|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413682|NCT00194909|Urological Agents|urological agents|mesh-ancestor
24413683|NCT00194935|Topotecan|topotecan|mesh-list
24413684|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413685|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413686|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413687|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413688|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413690|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24413714|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24413715|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24413716|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24822157|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24822158|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24822159|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822160|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
24822161|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
24822162|NCT02110082|Cetuximab|cetuximab|mesh-list
24413917|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413918|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413919|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
24413920|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413921|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24413922|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
24413923|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822235|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822236|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
24822237|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24822238|NCT02110719|Acetaminophen|acetaminophen|mesh-list
24822239|NCT02110719|Dexamethasone|dexamethasone|mesh-list
24822241|NCT02110719|Celecoxib|celecoxib|mesh-list
24822242|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24553853|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
24414167|NCT00196534|Coagulants|coagulants|mesh-ancestor
24414168|NCT00196547|Montelukast|montelukast|mesh-list
24414169|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24414170|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
24414171|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24822284|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
24822285|NCT02110784|Piperaquine|piperaquine|mesh-list
24822286|NCT02110784|Artenimol|artenimol|mesh-list
24822313|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822315|NCT02110966|Tramadol|tramadol|mesh-list
24414412|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414413|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414415|NCT00197548|Folic Acid|folic acid|mesh-list
24414477|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822435|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24822436|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822437|NCT02111707|Analgesics|analgesics|mesh-ancestor
24822438|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
24822439|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822440|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822441|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822442|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822456|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
24414600|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24414601|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24554677|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414602|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24414926|NCT00199004|Doxorubicin|doxorubicin|mesh-list
24414927|NCT00199004|Daunorubicin|daunorubicin|mesh-list
24414928|NCT00199004|Asparaginase|asparaginase|mesh-list
24414929|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
24414930|NCT00199004|Thioguanine|thioguanine|mesh-list
24555750|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
24555751|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24555752|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822551|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578637|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
24822552|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24822553|NCT02112552|Paclitaxel|paclitaxel|mesh-list
24822554|NCT02112552|Carboplatin|carboplatin|mesh-list
24822555|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24822556|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822557|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
24555753|NCT00743327|Pioglitazone|pioglitazone|mesh-list
24895768|NCT03123211|Veliparib|veliparib|mesh-list
24555754|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24543654|NCT00684866|Albuterol|albuterol|mesh-list
24415198|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25166458|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
24543691|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
24415319|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
24415320|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24415321|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24415494|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
24415495|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415607|NCT00200382|Bortezomib|bortezomib|mesh-list
24578722|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
24822604|NCT02112721|Vitamin D|vitamin d|mesh-list
24415835|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415836|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416191|NCT00202293|Olanzapine|olanzapine|mesh-list
24416192|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
24416193|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
24416194|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
24416195|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416196|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416197|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416770|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24416772|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24416773|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24416774|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24822847|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822848|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687914|NCT03593434|Xenon|xenon|mesh-list
24417005|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24417008|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417010|NCT00204698|Rabeprazole|rabeprazole|mesh-list
24417011|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24417012|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417013|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24417014|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417040|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24417041|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417043|NCT00204906|Vitamins|vitamins|mesh-ancestor
24417044|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
24417045|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417047|NCT00204919|Vitamin D|vitamin d|mesh-list
24417169|NCT00205751|Thalidomide|thalidomide|mesh-list
24822879|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
24822880|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822881|NCT02114021|Betamethasone|betamethasone|mesh-list
24822882|NCT02114021|Lidocaine|lidocaine|mesh-list
24822883|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
24822884|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
24822885|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822886|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417339|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24417340|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24417341|NCT00206219|Methotrexate|methotrexate|mesh-list
24417342|NCT00206219|Gefitinib|gefitinib|mesh-list
24417343|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24417344|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
24417345|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24822922|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
24822923|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822924|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24417446|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24417448|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24417449|NCT00206505|Docetaxel|docetaxel|mesh-list
24417450|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417451|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
24417452|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
24417652|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417653|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417654|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24417655|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24822942|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417746|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
24417747|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417748|NCT00207558|Folic Acid|folic acid|mesh-list
24417749|NCT00207558|Hematinics|hematinics|mesh-ancestor
24417779|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417780|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
24417781|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
24417782|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24417783|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24417784|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
24417987|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417988|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24417989|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24417990|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418019|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
24418020|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
24418021|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418022|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418023|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24418024|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24418025|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
24418026|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24418027|NCT00208403|Protective Agents|protective agents|mesh-ancestor
24418028|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418029|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
24418169|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24418170|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24418171|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
24418172|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418173|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418174|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418175|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418176|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418177|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418178|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418179|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24418289|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24418290|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24418292|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24418312|NCT00209222|Cisplatin|cisplatin|mesh-list
24418313|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418314|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
24418315|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418484|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563527|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563529|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24563530|NCT00772187|Narcotics|narcotics|mesh-ancestor
24418485|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
24418486|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418487|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
24418488|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418489|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
24418490|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418491|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418537|NCT00209742|Vitamins|vitamins|mesh-ancestor
24418564|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418565|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24418567|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
24418568|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
24418581|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24823027|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418675|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418714|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
24418715|NCT00209924|Gaboxadol|gaboxadol|mesh-list
24418764|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24418765|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418766|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24418767|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418768|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24418966|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418967|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418968|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418969|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418970|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418971|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24418972|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24823041|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24823042|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24823043|NCT02114645|Progestins|progestins|mesh-ancestor
24823044|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24823047|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419101|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
24419102|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419103|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419104|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
24419105|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24419106|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419107|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24419108|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
24419109|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419110|NCT00211302|Aripiprazole|aripiprazole|mesh-list
24564432|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
24419154|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419359|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419361|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24419362|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419363|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
24419365|NCT00211952|Celecoxib|celecoxib|mesh-list
24823095|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24823096|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823128|NCT02115204|Methotrexate|methotrexate|mesh-list
24823129|NCT02115204|Epirubicin|epirubicin|mesh-list
24823130|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24823131|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
24823132|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823133|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823134|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24823135|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
24420038|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420039|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
24420040|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420041|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420042|NCT00215007|Levofloxacin|levofloxacin|mesh-list
24420043|NCT00215007|Ofloxacin|ofloxacin|mesh-list
24823142|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
24823143|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24823144|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24420399|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24420400|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420411|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24420516|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24420517|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420518|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420519|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420520|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420521|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24420522|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24420523|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420524|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420547|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
24823203|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24823204|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420783|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420784|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
24420785|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420786|NCT00216788|Esomeprazole|esomeprazole|mesh-list
24420787|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25166468|NCT04024761|Fludarabine|fludarabine|mesh-list
24420813|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
24420814|NCT00216840|Hormones|hormones|mesh-ancestor
24420936|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24420937|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
24420939|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
24420940|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24420941|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420942|NCT00217373|Interferons|interferons|mesh-list
24420943|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
24420944|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
24420945|NCT00217373|Metronidazole|metronidazole|mesh-list
24420946|NCT00217373|Vaccines|vaccines|mesh-list
24420947|NCT00217373|Sargramostim|sargramostim|mesh-list
24420948|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
24566280|NCT00784966|Etanercept|etanercept|mesh-list
24420949|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420950|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420951|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
24823217|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421439|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421671|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421672|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
24421673|NCT00219882|Turmeric extract|turmeric extract|mesh-list
24421674|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
25144654|NCT02935075|Tenofovir|tenofovir|mesh-list
24421758|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421759|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24421760|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24421761|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421762|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421763|NCT00220155|Gemcitabine|gemcitabine|mesh-list
24421764|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421765|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
24421766|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823290|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
24823291|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823292|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823296|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24823314|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823315|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24823316|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823317|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823318|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823319|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823320|NCT02116569|Daratumumab|daratumumab|mesh-list
24422006|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422008|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422009|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422010|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
24422011|NCT00220909|Lansoprazole|lansoprazole|mesh-list
24422012|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
24422013|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24422014|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24422015|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24422018|NCT00220922|Ethanol|ethanol|mesh-list
24422224|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823428|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24823429|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
24823430|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823431|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823432|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823434|NCT02117362|Ipilimumab|ipilimumab|mesh-list
24823504|NCT02117700|Expectorants|expectorants|mesh-ancestor
24823505|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24823506|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24823507|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
24823508|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823509|NCT02117700|Protective Agents|protective agents|mesh-ancestor
24569793|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
24823614|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
24823615|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422714|NCT00223691|Phenylephrine|phenylephrine|mesh-list
24422715|NCT00223691|Acetazolamide|acetazolamide|mesh-list
24422716|NCT00223691|Midodrine|midodrine|mesh-list
24422717|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
24422718|NCT00223691|Ephedrine|ephedrine|mesh-list
24422719|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
24422720|NCT00223691|Ergotamine|ergotamine|mesh-list
24423067|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423068|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24423071|NCT00224549|Diuretics|diuretics|mesh-ancestor
24423284|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823970|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824027|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24423749|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423750|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423751|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
24423752|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423753|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
24424165|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424166|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424167|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
24824254|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824255|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24572286|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824256|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24424491|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24424492|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425554|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824350|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24824351|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24824352|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
24824353|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
24694700|NCT05379374|Morphine|morphine|mesh-list
24425891|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24425892|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24426754|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426755|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
24426756|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426757|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426758|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24426759|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
24426760|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426761|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
24426795|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426796|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24426809|NCT00236691|Topiramate|topiramate|mesh-list
24575524|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
24427304|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
24427305|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
24427306|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
24427307|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824674|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
24824676|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
24428409|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
24428410|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428411|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24428412|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
24428413|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428414|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
24428415|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428426|NCT00240448|Telmisartan|telmisartan|mesh-list
24428658|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428659|NCT00240851|Analgesics|analgesics|mesh-ancestor
24428660|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
24576758|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576858|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
24428661|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428662|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428663|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
24428664|NCT00240864|Acetaminophen|acetaminophen|mesh-list
24428666|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428667|NCT00240864|Analgesics|analgesics|mesh-ancestor
24428668|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
24428669|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428713|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24428714|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428782|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428783|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24428784|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
24428785|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428786|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428934|NCT00241553|Esomeprazole|esomeprazole|mesh-list
24428966|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24428967|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428968|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
24428969|NCT00242008|Rotigotine|rotigotine|mesh-list
24428970|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
24428971|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
24428972|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428985|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428986|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
24428987|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428992|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
24429083|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429084|NCT00242606|Lamotrigine|lamotrigine|mesh-list
24429085|NCT00242606|Levetiracetam|levetiracetam|mesh-list
24429086|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
24429087|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
24429090|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429092|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792831|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429106|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429107|NCT00242749|Gefitinib|gefitinib|mesh-list
24429108|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430062|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825019|NCT02126956|Ponesimod|ponesimod|mesh-list
24698186|NCT01439399|Analgesics|analgesics|mesh-ancestor
24430078|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24430079|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24430080|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24430081|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430082|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430083|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
24430269|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430270|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24430271|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444047|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
24430602|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24430603|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
24825097|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24431693|NCT00252785|Budesonide|budesonide|mesh-list
24431916|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431917|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
24432522|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24432744|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
24432762|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825180|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825181|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
24433269|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433270|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24433284|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24433286|NCT00258089|Levofloxacin|levofloxacin|mesh-list
24433318|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433319|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433320|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433321|NCT00258193|Linaclotide|linaclotide|mesh-list
24434249|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793197|NCT03814005|Paclitaxel|paclitaxel|mesh-list
24435217|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435417|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435425|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435426|NCT00266253|Metformin|metformin|mesh-list
24435427|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24435444|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
24435445|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
24435446|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
24435447|NCT00266357|Gaboxadol|gaboxadol|mesh-list
24435448|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435449|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435450|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435452|NCT00266357|Analgesics|analgesics|mesh-ancestor
24581527|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25203448|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24825511|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24825512|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
24825513|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825514|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825515|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
24825516|NCT02128893|Isavuconazole|isavuconazole|mesh-list
24825517|NCT02128893|Esomeprazole|esomeprazole|mesh-list
24825518|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24435625|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435626|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
24435627|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
24435683|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435710|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
24435887|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
24436103|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436104|NCT00268970|Paclitaxel|paclitaxel|mesh-list
24436105|NCT00268970|Satraplatin|satraplatin|mesh-list
25203450|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
24436106|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24436107|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436108|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436109|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436182|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436738|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24436739|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
24436740|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436741|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436742|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
24436743|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436744|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436841|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24436842|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24437755|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
24437756|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
24437757|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437758|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437759|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437760|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
24437762|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437763|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24437764|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437765|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
24437766|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24437767|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24437768|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437786|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
24437787|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437788|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437789|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24438337|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24438338|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438339|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438340|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24438341|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24438342|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
24438343|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24438344|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438345|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
24438584|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825669|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
24825670|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825671|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24825672|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24825673|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
24702572|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24438643|NCT00276588|Carboplatin|carboplatin|mesh-list
24438644|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438645|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438646|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438647|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438841|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438842|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438843|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
24438845|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439326|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439327|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439328|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
24439784|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439785|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583395|NCT00874406|Fluorouracil|fluorouracil|mesh-list
24825710|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440317|NCT00282360|Trimetazidine|trimetazidine|mesh-list
24440319|NCT00282386|Rofecoxib|rofecoxib|mesh-list
24440609|NCT00283985|Methotrexate|methotrexate|mesh-list
24441225|NCT00286585|Propofol|propofol|mesh-list
24441573|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24441574|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24441575|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441687|NCT00288028|Bortezomib|bortezomib|mesh-list
24442347|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442348|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24442349|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442350|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442351|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
24442696|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
24442697|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442698|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24442699|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24442700|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442702|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442703|NCT00292214|Analgesics|analgesics|mesh-ancestor
24442704|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
24442705|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825882|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
24825883|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24825884|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825885|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24825886|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825889|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
24825890|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
24825891|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704550|NCT01478724|Caseins|caseins|mesh-list
25110205|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010651|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010652|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010710|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010711|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010712|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
25010713|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24443111|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25268755|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
24903282|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24880899|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880901|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903651|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903652|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
24903653|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24903654|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903655|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
24903656|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903657|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24818372|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818373|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818374|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
25109027|NCT03127371|Analgesics|analgesics|mesh-ancestor
25109028|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
24915294|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
24915295|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065440|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
25065441|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065442|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065443|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25065444|NCT05322265|Epinephrine|epinephrine|mesh-list
25065445|NCT05322265|Racepinephrine|racepinephrine|mesh-list
25065446|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
25065447|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24915304|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726911|NCT01606878|Doxorubicin|doxorubicin|mesh-list
24903880|NCT04359966|Amoxicillin|amoxicillin|mesh-list
24903881|NCT04359966|Metronidazole|metronidazole|mesh-list
24903882|NCT04359966|Clarithromycin|clarithromycin|mesh-list
24904342|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904343|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904433|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24904435|NCT04355806|Antibodies|antibodies|mesh-list
24904436|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
25109095|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24904688|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24904689|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24904690|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24904691|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24904692|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904693|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
24904694|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904758|NCT04353713|Laxatives|laxatives|mesh-ancestor
24915702|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
24915703|NCT04248998|Doxorubicin|doxorubicin|mesh-list
24915704|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24915705|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490420|NCT00478075|Analgesics|analgesics|mesh-ancestor
24623652|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623653|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24905260|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905261|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
24905262|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905263|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905264|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
25268758|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
24905265|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
24905266|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905267|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905268|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905269|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
24905271|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905272|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24905273|NCT04349410|Protective Agents|protective agents|mesh-ancestor
24905274|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
24905275|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905276|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
24905446|NCT04347720|Indomethacin|indomethacin|mesh-list
24905476|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905477|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905478|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905479|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
24905480|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905481|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905485|NCT04347252|Glucagon|glucagon|mesh-list
24905569|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905570|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
24905571|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905572|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905573|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905574|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905575|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076047|NCT03376178|Ropivacaine|ropivacaine|mesh-list
25076048|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25076049|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
25076050|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24394635|NCT00133770|Pantoprazole|pantoprazole|mesh-list
25202046|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24954499|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25202048|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25202049|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25077023|NCT03368391|Racepinephrine|racepinephrine|mesh-list
25077024|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
25077101|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
25077105|NCT03367494|Bromides|bromides|mesh-list
25077294|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077310|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
25077627|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077628|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077686|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25077846|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077847|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25202097|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202099|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24954679|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954681|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24954682|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
24954683|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
24954684|NCT03873298|Protective Agents|protective agents|mesh-ancestor
24884047|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
25066778|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24955062|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
24955098|NCT03868111|Remifentanil|remifentanil|mesh-list
24955099|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24884494|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884495|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24884496|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884498|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24955693|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24884949|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393758|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
24393759|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
24955769|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24520993|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
24520994|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520996|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
24452017|NCT00325767|Albuterol|albuterol|mesh-list
24861861|NCT02320773|Mirabegron|mirabegron|mesh-list
24955802|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
25078238|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25078239|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
25078240|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078241|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078270|NCT03357822|Tenofovir|tenofovir|mesh-list
24626609|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24626610|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24626611|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626612|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626649|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24645729|NCT01199458|Analgesics|analgesics|mesh-ancestor
24626650|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626651|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24956419|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24956421|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25202144|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24956422|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
24956423|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24463055|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463056|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463057|NCT00358488|Albuterol|albuterol|mesh-list
25078338|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078339|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25078341|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078343|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25078344|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
25078345|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078346|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
24957132|NCT03847441|Vitamins|vitamins|mesh-ancestor
24957133|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
24957134|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957135|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24957181|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957182|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957183|NCT03846765|Protective Agents|protective agents|mesh-ancestor
24959206|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785707|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785708|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24960449|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960450|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960451|NCT03816592|Narcotics|narcotics|mesh-ancestor
24477566|NCT00419146|Vitamins|vitamins|mesh-list
24786625|NCT01921010|Niacin|niacin|mesh-list
24961211|NCT03809793|Acipimox|acipimox|mesh-list
24961419|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
24961420|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
24962159|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24962967|NCT03794167|Melphalan|melphalan|mesh-list
25078838|NCT03353324|Growth Substances|growth substances|mesh-ancestor
25078839|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963541|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
24963760|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24808123|NCT02025348|Metoprolol|metoprolol|mesh-list
24808557|NCT02027961|Durvalumab|durvalumab|mesh-list
24965200|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965201|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584940|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584941|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966195|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966197|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24966456|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
24966667|NCT03766594|Vitamins|vitamins|mesh-ancestor
24966886|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24966887|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795331|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627451|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
24627452|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
24796718|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079257|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
25079258|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25079259|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
25079260|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24466338|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466339|NCT00373165|Ganciclovir|ganciclovir|mesh-list
24466340|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24466341|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
24805092|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24805093|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24467664|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24467766|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24467767|NCT00378690|Leuprolide|leuprolide|mesh-list
24467768|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24467769|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
24467770|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24467796|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468576|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24468578|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24468579|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468827|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
24468828|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468830|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468831|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468832|NCT00383682|Mexiletine|mexiletine|mesh-list
24468833|NCT00383682|Morphine|morphine|mesh-list
24808096|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808099|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24808100|NCT02025166|Analgesics|analgesics|mesh-ancestor
24808101|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
24807506|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
24808679|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
24808680|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469002|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
24469003|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24469216|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24469217|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469358|NCT00385463|Hormones|hormones|mesh-ancestor
25202256|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24469519|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24469570|NCT00386399|Mitomycins|mitomycins|mesh-list
24470000|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24470688|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470689|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470693|NCT00391105|Narcotics|narcotics|mesh-ancestor
24470694|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495702|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25202275|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471072|NCT00393263|Hormones|hormones|mesh-ancestor
24628508|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471733|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471734|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24471735|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628578|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628579|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628580|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628581|NCT01100021|Urological Agents|urological agents|mesh-ancestor
24628583|NCT01100060|Azithromycin|azithromycin|mesh-list
24472117|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079446|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202280|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
25079449|NCT03347721|Lidocaine|lidocaine|mesh-list
24813988|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24813989|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
24813990|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24813991|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813992|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24472623|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24472624|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623352|NCT01071057|Morphine|morphine|mesh-list
25202298|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202299|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
24472979|NCT00401427|Trastuzumab|trastuzumab|mesh-list
24472980|NCT00401427|Vinorelbine|vinorelbine|mesh-list
24472981|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24444299|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
24444337|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
25079471|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24628781|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24628782|NCT01101412|Renal Agents|renal agents|mesh-ancestor
24498441|NCT00514657|Mitogens|mitogens|mesh-list
24473271|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24473272|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25079475|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079476|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
25079477|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079478|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
24773561|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
24550486|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
24550487|NCT00720811|Acetaminophen|acetaminophen|mesh-list
24550488|NCT00720811|Amoxicillin|amoxicillin|mesh-list
24473756|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
24473950|NCT00404534|Omeprazole|omeprazole|mesh-list
24499528|NCT00519987|Ketamine|ketamine|mesh-list
24550534|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550535|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24550536|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24550537|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550538|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818900|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
24819045|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24677428|NCT01356329|Heparin|heparin|mesh-list
24819942|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
24759705|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759707|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24759731|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759732|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550528|NCT00720915|Coagulants|coagulants|mesh-ancestor
24550529|NCT00721032|Amiodarone|amiodarone|mesh-list
24759733|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24759734|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25202326|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25202327|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202328|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25202329|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25079549|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
24759863|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24759864|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24774322|NCT01845194|Metoprolol|metoprolol|mesh-list
24760031|NCT01755923|Gefitinib|gefitinib|mesh-list
24760032|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760033|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
24760034|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
24760035|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
24760036|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760037|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24760038|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760039|NCT01756040|Lactulose|lactulose|mesh-list
24760040|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24760041|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24760042|NCT01756105|Insulin|insulin|mesh-list
24760043|NCT01756105|Metformin|metformin|mesh-list
24760099|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760458|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24760459|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760461|NCT01758120|Hormones|hormones|mesh-ancestor
24760462|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760624|NCT01759108|Rebamipide|rebamipide|mesh-list
24760625|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24760626|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079709|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475707|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079754|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25079755|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25079756|NCT03345667|Growth Substances|growth substances|mesh-ancestor
25079757|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079758|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
25079759|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079760|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24761466|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24899114|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761704|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761705|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24761706|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
24761707|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761708|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
24761709|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761715|NCT01764087|Paclitaxel|paclitaxel|mesh-list
24761863|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24761864|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24761865|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
24761866|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761867|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761869|NCT01764893|Urological Agents|urological agents|mesh-ancestor
24761966|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761967|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24761968|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762254|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24762255|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24762256|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24762257|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24762258|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762259|NCT01767298|Diuretics|diuretics|mesh-ancestor
24762261|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762818|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
24762819|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
24480154|NCT00429975|Levofloxacin|levofloxacin|mesh-list
24481610|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966150|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24966151|NCT03770806|Analgesics|analgesics|mesh-ancestor
25080563|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966577|NCT03766984|Tramadol|tramadol|mesh-list
24768018|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400068|NCT00149578|Vitamins|vitamins|mesh-ancestor
24768469|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768470|NCT01808495|Mitomycins|mitomycins|mesh-list
24772420|NCT01833715|Morphine|morphine|mesh-list
24772691|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
24772874|NCT01836341|Pemetrexed|pemetrexed|mesh-list
24773881|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773886|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24773887|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773888|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773889|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
24773905|NCT01842893|Fentanyl|fentanyl|mesh-list
24623534|NCT01072058|Analgesics|analgesics|mesh-ancestor
24623535|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
24602695|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24812706|NCT02054299|Thiamine|thiamine|mesh-list
24606660|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
24671714|NCT01327261|Levodopa|levodopa|mesh-list
25202442|NCT02721043|Lenalidomide|lenalidomide|mesh-list
24678697|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24679387|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
24679388|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
24679399|NCT01368328|Chromium|chromium|mesh-list
24681474|NCT01380600|Molgramostim|molgramostim|mesh-list
25068578|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684335|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24954066|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
25068860|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25068861|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25068883|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069055|NCT03429621|Emollients|emollients|mesh-ancestor
24831739|NCT02168569|Artesunate|artesunate|mesh-list
24689081|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
24690747|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690750|NCT01403740|Rituximab|rituximab|mesh-list
24690751|NCT01403740|Azathioprine|azathioprine|mesh-list
24690752|NCT01403740|Cyclosporins|cyclosporins|mesh-list
24690753|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24690754|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691157|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24691909|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24691910|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24692351|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24692366|NCT01413230|Vitamin D|vitamin d|mesh-list
24692367|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24692566|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
24692368|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692369|NCT01413230|Vitamins|vitamins|mesh-ancestor
24692370|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
24692371|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24692372|NCT01413477|Calcitriol|calcitriol|mesh-list
24692373|NCT01413477|Betamethasone|betamethasone|mesh-list
24692565|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692572|NCT01415336|Doxorubicin|doxorubicin|mesh-list
24692573|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24692574|NCT01415336|Capecitabine|capecitabine|mesh-list
24692575|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692576|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
24692577|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692578|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643455|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
24692835|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692836|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692837|NCT01416870|Bicalutamide|bicalutamide|mesh-list
24692838|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
24642461|NCT01179503|Vitamin D|vitamin d|mesh-list
24693043|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693045|NCT01418118|Epinephrine|epinephrine|mesh-list
24693049|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24693050|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
24693051|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693660|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693661|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24693662|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693667|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
24693882|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
25069906|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
25069907|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069908|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069909|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069910|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069912|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
24612310|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612311|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612313|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24612314|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612315|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24612316|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612317|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24612318|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
24612319|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
24612320|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612321|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612323|NCT01013506|Letrozole|letrozole|mesh-list
24694042|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24694043|NCT01423539|Rituximab|rituximab|mesh-list
24694044|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24694045|NCT01423539|Navitoclax|navitoclax|mesh-list
24694163|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694164|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24694165|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24694180|NCT01424332|Salicylates|salicylates|mesh-list
24694181|NCT01424332|Darexaban|darexaban|mesh-list
24694182|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24694183|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24694184|NCT01424332|Analgesics|analgesics|mesh-ancestor
24694265|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24694266|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24694267|NCT01424761|Ubiquinone|ubiquinone|mesh-list
24694268|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
24694269|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
24642868|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24694379|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24451658|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
24694485|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694486|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
24694487|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24694488|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24694489|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027456|NCT03620149|Denosumab|denosumab|mesh-list
25027457|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25027458|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027459|NCT03620032|Vinorelbine|vinorelbine|mesh-list
25027460|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
25027461|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25027490|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
24694692|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24694747|NCT05370040|Vaccines|vaccines|mesh-list
24694802|NCT05244525|Bupivacaine|bupivacaine|mesh-list
24694803|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
24694824|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694826|NCT05176379|Fluconazole|fluconazole|mesh-list
24694827|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
24694828|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694829|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24694830|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24694831|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694832|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695029|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695030|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695031|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24695032|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24695033|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24695034|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
24695035|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
24695036|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695037|NCT04698525|Valproic Acid|valproic acid|mesh-list
24695038|NCT04698525|Memantine|memantine|mesh-list
24695184|NCT04246762|Caffeine|caffeine|mesh-list
25070102|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25070103|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
25070104|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
25070105|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25070106|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
24695185|NCT04246762|Omeprazole|omeprazole|mesh-list
24695186|NCT04246762|Warfarin|warfarin|mesh-list
24695187|NCT04246762|Vitamins|vitamins|mesh-ancestor
24695295|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695296|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
24695297|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695298|NCT03837626|Amiloride|amiloride|mesh-list
24695299|NCT03837626|Diuretics|diuretics|mesh-ancestor
24695300|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
24612493|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612495|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
24612497|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
24695439|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24695586|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
24695587|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695588|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451787|NCT00324818|Metronidazole|metronidazole|mesh-list
24695596|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24695597|NCT02767882|Dexamethasone|dexamethasone|mesh-list
24695598|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695599|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
24695846|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24695847|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24695848|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24695849|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695850|NCT01425996|Camptothecin|camptothecin|mesh-list
24695851|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24695852|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695853|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24695854|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24695869|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
24695878|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24695879|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24695880|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695882|NCT01426165|Analgesics|analgesics|mesh-ancestor
24695883|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
24695884|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696027|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24612627|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612628|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24643069|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24612629|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24612630|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24612631|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696062|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24696064|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
24696065|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
24696066|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696067|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696237|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
24696238|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
24696239|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696241|NCT01428375|Acetaminophen|acetaminophen|mesh-list
24696242|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24696243|NCT01428375|Analgesics|analgesics|mesh-ancestor
24696244|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
24696338|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696339|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24696340|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696341|NCT01428817|Carbetocin|carbetocin|mesh-list
24696342|NCT01428817|Oxytocin|oxytocin|mesh-list
24696343|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
24643289|NCT01185015|Vitamins|vitamins|mesh-ancestor
24696344|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696345|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696545|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696546|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696548|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24696549|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24696550|NCT01429935|Analgesics|analgesics|mesh-ancestor
24696551|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
24696554|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696681|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
24696682|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202532|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696683|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696684|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696685|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019383|NCT03691662|Timolol|timolol|mesh-list
24696686|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24696687|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24696688|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696689|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24696690|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24696874|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
24696875|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24696876|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
24696877|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070246|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25070247|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25070255|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
24697257|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697258|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25070293|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
25070294|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070320|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070321|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070322|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25070323|NCT03420586|Analgesics|analgesics|mesh-ancestor
25070324|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
25070325|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823901|NCT02120092|Clopidogrel|clopidogrel|mesh-list
24697576|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697577|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25207747|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697702|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697703|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24697704|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24697705|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24697706|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24697707|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24697708|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697710|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25070428|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
25070429|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612894|NCT01015729|Analgesics|analgesics|mesh-ancestor
24953710|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953711|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833199|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698946|NCT01443780|Selenium|selenium|mesh-list
24699022|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699024|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699025|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591337|NCT00915915|Estrogens|estrogens|mesh-ancestor
24699365|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24700077|NCT01450410|Niacin|niacin|mesh-list
25071157|NCT03412682|Hormones|hormones|mesh-ancestor
25073088|NCT03397264|Growth Substances|growth substances|mesh-ancestor
24634702|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25073112|NCT03397173|Vitamins|vitamins|mesh-ancestor
24635258|NCT01137994|Paclitaxel|paclitaxel|mesh-list
24635549|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24635550|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
24636342|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24636343|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24636344|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
24636345|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24636346|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24636347|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
24636348|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636349|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636850|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25073599|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073622|NCT03394001|Analgesics|analgesics|mesh-ancestor
24637967|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637968|NCT01154400|Caseins|caseins|mesh-list
25073743|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073744|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25073745|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073796|NCT03393325|Urological Agents|urological agents|mesh-ancestor
25073816|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073817|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
24702611|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
25073818|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073819|NCT03393117|Analgesics|analgesics|mesh-ancestor
24639696|NCT01163929|Paclitaxel|paclitaxel|mesh-list
25074053|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074054|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074055|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25074056|NCT03390972|Analgesics|analgesics|mesh-ancestor
25074057|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
25074058|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074059|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25074060|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24640719|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640720|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640765|NCT01169909|Growth Substances|growth substances|mesh-ancestor
24940534|NCT04000932|Hormones|hormones|mesh-ancestor
24641687|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641688|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
24641689|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641692|NCT01174914|Emtricitabine|emtricitabine|mesh-list
25074192|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24704064|NCT01476410|Antibodies|antibodies|mesh-list
24704309|NCT01477632|Estradiol|estradiol|mesh-list
24960341|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074621|NCT03387111|Growth Substances|growth substances|mesh-ancestor
25075155|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25075158|NCT03383185|Hormones|hormones|mesh-ancestor
25075284|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24705424|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
24998441|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
24936651|NCT04038125|Hormones|hormones|mesh-ancestor
24937249|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000025|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000709|NCT03777319|Prednisolone|prednisolone|mesh-list
24644615|NCT01192087|Cetuximab|cetuximab|mesh-list
24798519|NCT01964027|Epirubicin|epirubicin|mesh-list
24798520|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24798521|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24798522|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644777|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645073|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24645074|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
24645075|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645076|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25049278|NCT00624858|Bupropion|bupropion|mesh-list
25049305|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
25003390|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798674|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648296|NCT01213433|Artesunate|artesunate|mesh-list
25004483|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
24798838|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
24798839|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24650187|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24650395|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
24650397|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
24651306|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24651307|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
24651308|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651419|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24715477|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651776|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24651777|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24651778|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24651779|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24651780|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
24651781|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
24651782|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
24651989|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651991|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651992|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
24651993|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651994|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24651996|NCT01234974|Pasireotide|pasireotide|mesh-list
24652113|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652114|NCT01236586|Dexamethasone|dexamethasone|mesh-list
24652246|NCT01237262|Etanercept|etanercept|mesh-list
24652470|NCT01238562|Lenograstim|lenograstim|mesh-list
24592831|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
24653253|NCT01242631|Everolimus|everolimus|mesh-list
24653254|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653255|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653256|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
24653383|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24653830|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653831|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24798956|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798957|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24653850|NCT01245959|Cisplatin|cisplatin|mesh-list
24654179|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24654180|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654182|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24654183|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654184|NCT01248117|Growth Substances|growth substances|mesh-ancestor
24654185|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654186|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
24654187|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654188|NCT01248195|Olanzapine|olanzapine|mesh-list
24654270|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654271|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654502|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
24654531|NCT01250249|Vaccines|vaccines|mesh-list
24654598|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24654599|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24654600|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
24654601|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654602|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24654604|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654642|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
24654792|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24654793|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799088|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24654891|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25049668|NCT00578955|Dexamethasone|dexamethasone|mesh-list
24655174|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
24846977|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947007|NCT03933345|Naloxone|naloxone|mesh-list
24947629|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24947630|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24947631|NCT03927313|Analgesics|analgesics|mesh-ancestor
24947632|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
24656070|NCT01259817|Analgesics|analgesics|mesh-ancestor
24656194|NCT01260506|Growth Substances|growth substances|mesh-ancestor
24656195|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656306|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656307|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656308|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24656309|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
24957742|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24957743|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24947892|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24947893|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24947894|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
24947895|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24947896|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
25202741|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656687|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656688|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24719249|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656758|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24657208|NCT01266187|Antidotes|antidotes|mesh-ancestor
24657489|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657490|NCT01267604|Protective Agents|protective agents|mesh-ancestor
24657491|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657492|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657493|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
24657730|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719463|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658004|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
24659277|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24659967|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
24659968|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659969|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24799604|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24799605|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
24799856|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
24799857|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799858|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24957218|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799860|NCT01971658|Dexamethasone|dexamethasone|mesh-list
24661910|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25049895|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663004|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663641|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664116|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
24664117|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664118|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664119|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664240|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24664241|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
24664278|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
24664343|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
24664390|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664391|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455957|NCT00329459|Naproxen|naproxen|mesh-list
24664941|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664942|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664943|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664944|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
24665358|NCT01311882|Suvorexant|suvorexant|mesh-list
24665387|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
24665388|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665737|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666217|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666218|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666219|NCT01318096|Tenofovir|tenofovir|mesh-list
24666220|NCT01318096|Lamivudine|lamivudine|mesh-list
24666221|NCT01318096|Efavirenz|efavirenz|mesh-list
24666222|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
24666223|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
24666224|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666225|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25050116|NCT00540358|Immunologic Factors|immunologic factors|mesh-ancestor
25050117|NCT00540358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050118|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25050120|NCT00539721|Rolapitant|rolapitant|mesh-list
25050121|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
25050122|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
24666498|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666499|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24666500|NCT01319448|Renal Agents|renal agents|mesh-ancestor
24935977|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24935978|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952496|NCT03893591|Dalteparin|dalteparin|mesh-list
25050149|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723867|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050150|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25050151|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
25050152|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24849952|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859051|NCT02301494|Imiquimod|imiquimod|mesh-list
25202770|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
24444743|NCT00299026|Paclitaxel|paclitaxel|mesh-list
24937028|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
24937029|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
24625566|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24937066|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937068|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
24937069|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
24937125|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
24850864|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850865|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24850866|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24850867|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24850868|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24937234|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937235|NCT04031755|Minocycline|minocycline|mesh-list
24937236|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24937237|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937238|NCT04031703|Paclitaxel|paclitaxel|mesh-list
24850937|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24533945|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24533946|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
24937401|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24937409|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
24850995|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
24850996|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850997|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24850998|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24851046|NCT02255045|Analgesics|analgesics|mesh-ancestor
24851047|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
24851048|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649151|NCT01218711|Diuretics|diuretics|mesh-ancestor
24534187|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534188|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851147|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24851213|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812202|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
24937724|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937725|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24625589|NCT01082627|Somatostatin|somatostatin|mesh-list
24937924|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24937925|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
24444221|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937956|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937957|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534834|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938080|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24938081|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
24938082|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938083|NCT04022525|Leflunomide|leflunomide|mesh-list
24938084|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451084|NCT00321802|Simvastatin|simvastatin|mesh-list
24451087|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
24451109|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
24727103|NCT01608009|Paclitaxel|paclitaxel|mesh-list
24938175|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
24938177|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24851716|NCT02258581|Vesatolimod|vesatolimod|mesh-list
24851717|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
24535408|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24535409|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
24535410|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24535459|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
24535460|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535464|NCT00649181|Diuretics|diuretics|mesh-ancestor
24938458|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938459|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938460|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
24938461|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938462|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535923|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24535924|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535926|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
24535927|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
24535928|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938502|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851908|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
24535959|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535961|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24536405|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24536406|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24536583|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050406|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
25050408|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24938830|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938832|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24938833|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24938834|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
24938835|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938837|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536985|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537116|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24537188|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
24537189|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537190|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537191|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
24625609|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24625610|NCT01082705|Artenimol|artenimol|mesh-list
24625611|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
24625612|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24625613|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24537339|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24537340|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24537342|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24938988|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730911|NCT01631357|Cisplatin|cisplatin|mesh-list
24939317|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24539795|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24939360|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24539836|NCT00665756|Mitomycins|mitomycins|mesh-list
24540089|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444902|NCT00299650|Cisatracurium|cisatracurium|mesh-list
24540395|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24939459|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939460|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939461|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24939462|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
24939463|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939464|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939467|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
24540870|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24540872|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541408|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
24541409|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732647|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732689|NCT01640782|Irinotecan|irinotecan|mesh-list
24408492|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543430|NCT00683735|Hormones|hormones|mesh-ancestor
24543431|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733030|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733031|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545329|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939854|NCT04006054|Midazolam|midazolam|mesh-list
24939855|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
24939856|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24939857|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939858|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853235|NCT02266849|Loperamide|loperamide|mesh-list
24545903|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24545904|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
24545905|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24545906|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24625633|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24625634|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603285|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
24546243|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546244|NCT00697372|Sirolimus|sirolimus|mesh-list
24546786|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
24546787|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
24546788|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546789|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546791|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546792|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546793|NCT00700466|Metoprolol|metoprolol|mesh-list
24939966|NCT04005417|Fluorides|fluorides|mesh-list
24547439|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24447536|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
25161736|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447539|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447541|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939993|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939995|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617509|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24547901|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547972|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
24547974|NCT00707083|Methotrexate|methotrexate|mesh-list
24462582|NCT00357045|Paroxetine|paroxetine|mesh-list
24826941|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25267405|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25267406|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25267407|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
25267408|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267409|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267416|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267417|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456831|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456832|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24680183|NCT01373411|Ticagrelor|ticagrelor|mesh-list
24446969|NCT00306774|Vitamins|vitamins|mesh-ancestor
25267543|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267544|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
25267545|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617679|NCT01044992|Levodopa|levodopa|mesh-list
24827600|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827601|NCT02140437|Fulvestrant|fulvestrant|mesh-list
24827602|NCT02140437|Anastrozole|anastrozole|mesh-list
24827604|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267631|NCT02422121|RNS60|rns60|mesh-list
24720704|NCT01570088|Folic Acid|folic acid|mesh-list
25267725|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25267726|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267731|NCT02420782|Miotics|miotics|mesh-ancestor
25267831|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
24828863|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25267920|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25267921|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
25267922|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267923|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267924|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25267925|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
25267926|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
25267949|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
25267958|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
24829288|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
24829308|NCT02151279|Coagulants|coagulants|mesh-ancestor
24829361|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24829362|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829363|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829365|NCT02151812|Paclitaxel|paclitaxel|mesh-list
24738695|NCT01676844|Protective Agents|protective agents|mesh-ancestor
24738696|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738697|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24738698|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
24738699|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738704|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
24829433|NCT02152358|Acyclovir|acyclovir|mesh-list
24829434|NCT02152358|Ganciclovir|ganciclovir|mesh-list
24829435|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24651169|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
24738833|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
24739046|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
24739048|NCT01678963|Squalamine|squalamine|mesh-list
24829580|NCT02153177|Analgesics|analgesics|mesh-ancestor
24829581|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
24829584|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
24739610|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24739645|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24739646|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24739650|NCT01683175|Cisplatin|cisplatin|mesh-list
24739708|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24829628|NCT02153541|Benzocaine|benzocaine|mesh-list
24829629|NCT02153541|Mineral Oil|mineral oil|mesh-list
24829630|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
24829631|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
24692849|NCT01416909|Laxatives|laxatives|mesh-list
24448758|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24448759|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448760|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
24740696|NCT01689896|Testosterone|testosterone|mesh-list
24393464|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24740920|NCT01690702|Paclitaxel|paclitaxel|mesh-list
25268243|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268244|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
25268245|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830056|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24830057|NCT02157077|Growth Substances|growth substances|mesh-ancestor
24830100|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24830142|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
24693974|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24741884|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24741885|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268304|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25268306|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268307|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
25268308|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25268309|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25268310|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25268315|NCT02416232|Trametinib|trametinib|mesh-list
24830296|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830297|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
24830298|NCT02158481|Carotenoids|carotenoids|mesh-list
25268324|NCT02416271|Calcium|calcium|mesh-list
25268325|NCT02416271|Vitamins|vitamins|mesh-ancestor
25268335|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268343|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
24830494|NCT02159599|Ritonavir|ritonavir|mesh-list
24448975|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
24830550|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
24830557|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830558|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830560|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24944049|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24745302|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
24745304|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
24830803|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
24830804|NCT02161653|Metadoxine|metadoxine|mesh-list
25268566|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
25268567|NCT02415257|Gentamicins|gentamicins|mesh-list
25268568|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25268575|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
25268576|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25268598|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
25268599|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268604|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
25268642|NCT02414945|Fludarabine|fludarabine|mesh-list
25169720|NCT01779947|Estradiol|estradiol|mesh-list
25169788|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
25169926|NCT01726946|Ribavirin|ribavirin|mesh-list
24459501|NCT00344851|Exenatide|exenatide|mesh-list
25170509|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
25170511|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171015|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171353|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171360|NCT02888327|Digoxin|digoxin|mesh-list
24618844|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171594|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
24625925|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
24749547|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
24749548|NCT00866918|Tretinoin|tretinoin|mesh-list
24749549|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25172265|NCT02880995|Amisulpride|amisulpride|mesh-list
25204041|NCT02711267|Acyclovir|acyclovir|mesh-list
24792262|NCT05392972|Anesthetics|anesthetics|mesh-list
25172635|NCT02878161|Methotrexate|methotrexate|mesh-list
24808371|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24808372|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173308|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25173309|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25173310|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24862224|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451619|NCT00324467|Vincristine|vincristine|mesh-list
24451620|NCT00324467|Ondansetron|ondansetron|mesh-list
24451621|NCT00324467|BB 1101|bb 1101|mesh-list
25173500|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
25173501|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173502|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204152|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25204153|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204154|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
25204155|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
25204156|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
25204162|NCT02710266|Gabexate|gabexate|mesh-list
24931347|NCT04089657|Apatinib|apatinib|mesh-list
25204176|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
25204177|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204178|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25204179|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25204180|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25204194|NCT02710110|Capsaicin|capsaicin|mesh-list
24944551|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944552|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24944553|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204226|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204227|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25204228|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204230|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25173980|NCT02867904|Bupivacaine|bupivacaine|mesh-list
25174024|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752866|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
24813562|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
25204262|NCT02709590|Analgesics|analgesics|mesh-ancestor
24974057|NCT05175508|Azacitidine|azacitidine|mesh-list
25174449|NCT02865642|Serotonin|serotonin|mesh-list
25174511|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
25174512|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25174513|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25174584|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
25174585|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174586|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174587|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174588|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
25174589|NCT02864602|Hormones|hormones|mesh-ancestor
25174590|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174592|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204329|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25174791|NCT02862977|Amitriptyline|amitriptyline|mesh-list
25174792|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
25174793|NCT02862977|Caffeine|caffeine|mesh-list
25174871|NCT02862691|Analgesics|analgesics|mesh-list
25174938|NCT02862327|BB 1101|bb 1101|mesh-list
25174939|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174940|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
25174941|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
25174980|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
25174981|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175070|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25175302|NCT02859259|Fostemsavir|fostemsavir|mesh-list
25175361|NCT02858804|Cytarabine|cytarabine|mesh-list
25204434|NCT02708251|Lidocaine|lidocaine|mesh-list
25175584|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175585|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175586|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175713|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175714|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
25175715|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175716|NCT02856867|Antidotes|antidotes|mesh-ancestor
25175717|NCT02856867|Protective Agents|protective agents|mesh-ancestor
25204492|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175780|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176083|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
25176085|NCT02853799|Insulin|insulin|mesh-list
24724448|NCT01593137|Liraglutide|liraglutide|mesh-list
24483442|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24483445|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
25176983|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25176984|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25176985|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25176987|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
25176988|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176989|NCT05377788|Lazertinib|lazertinib|mesh-list
25176990|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176991|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176992|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176993|NCT05372380|Atorvastatin|atorvastatin|mesh-list
25176994|NCT05372380|Ezetimibe|ezetimibe|mesh-list
25177656|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177666|NCT04932980|Aflibercept|aflibercept|mesh-list
25177857|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177858|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177859|NCT04811014|Buprenorphine|buprenorphine|mesh-list
25177860|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25177861|NCT04811014|Naloxone|naloxone|mesh-list
25177862|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25177864|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204844|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945151|NCT03953170|Teduglutide|teduglutide|mesh-list
25178214|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178215|NCT04597099|Progestins|progestins|mesh-ancestor
25178216|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
25178553|NCT04273880|Methylphenidate|methylphenidate|mesh-list
25178555|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
25178556|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178557|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25178558|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25207945|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207949|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
25178783|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25178904|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179278|NCT03525795|Ipilimumab|ipilimumab|mesh-list
25179420|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179421|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179422|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179423|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179424|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25179427|NCT03448159|Fluoxetine|fluoxetine|mesh-list
25096759|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25096760|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
25096993|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179458|NCT03400332|Nivolumab|nivolumab|mesh-list
25098812|NCT03195205|Antibodies|antibodies|mesh-list
25180382|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180383|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
25180384|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180385|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180386|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25180387|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180697|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25180698|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180699|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180700|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
25180701|NCT02850211|Ibuprofen|ibuprofen|mesh-list
25180702|NCT02850211|Celecoxib|celecoxib|mesh-list
25180703|NCT02850211|Tramadol|tramadol|mesh-list
25180704|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24945908|NCT03944733|Iron|iron|mesh-list
25181164|NCT02846701|Analgesics|analgesics|mesh-ancestor
25181693|NCT05078502|Vitamin D|vitamin d|mesh-list
25181940|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25183172|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
25183174|NCT00127179|Urological Agents|urological agents|mesh-ancestor
25183338|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
25183550|NCT02841774|Pravastatin|pravastatin|mesh-list
25184362|NCT02836509|Ibuprofen|ibuprofen|mesh-list
24820818|NCT02101931|Levulinic acid|levulinic acid|mesh-list
25185062|NCT02831205|Cobalt|cobalt|mesh-list
25185419|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185423|NCT02828228|Vitamin D|vitamin d|mesh-list
25185632|NCT02826434|Poly ICLC|poly iclc|mesh-list
25205745|NCT04259658|Calcium|calcium|mesh-list
25186885|NCT02817477|Morphine|morphine|mesh-list
25186886|NCT02817477|Analgesics|analgesics|mesh-ancestor
25186887|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
25186888|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186889|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187189|NCT02815475|Curcumin|curcumin|mesh-list
25187527|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
25187528|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187530|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187632|NCT02811497|Durvalumab|durvalumab|mesh-list
25187772|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187773|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25187774|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25187775|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187776|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
25187777|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
25187778|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25187901|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
25188139|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25188140|NCT02807610|Propofol|propofol|mesh-list
24822966|NCT02114476|Hormones|hormones|mesh-ancestor
25188431|NCT02805842|Tacrolimus|tacrolimus|mesh-list
25188837|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188838|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189336|NCT02798510|Capecitabine|capecitabine|mesh-list
25189488|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977570|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977573|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
25189807|NCT02794584|Narcotics|narcotics|mesh-ancestor
25189882|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189883|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189884|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25189885|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
25189887|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189888|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24823477|NCT02117466|Cetuximab|cetuximab|mesh-list
25190045|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25190046|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25190047|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25190048|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25190058|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190059|NCT02792803|Latanoprost|latanoprost|mesh-list
25190060|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25190120|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190121|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423375|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190509|NCT02789397|Azathioprine|azathioprine|mesh-list
25190588|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
25190589|NCT02788305|Misoprostol|misoprostol|mesh-list
25190590|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25190591|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
25190592|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25190593|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424063|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824123|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190796|NCT02786823|Folic Acid|folic acid|mesh-list
25206533|NCT05345327|Metformin|metformin|mesh-list
25191132|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191134|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191135|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191388|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25191390|NCT02783638|Analgesics|analgesics|mesh-ancestor
25191391|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
25191545|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25191546|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191547|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191548|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25191549|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25191550|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
25191615|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
25192178|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
25192179|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192180|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192181|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192182|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
25192183|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192332|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
25192333|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192334|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25192401|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
24429404|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192781|NCT02774499|Analgesics|analgesics|mesh-ancestor
25192782|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
24742821|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
25192879|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25193057|NCT02772419|Benralizumab|benralizumab|mesh-list
25193129|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
25193200|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193201|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25193202|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
25193203|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
25193207|NCT02771457|Infliximab|infliximab|mesh-list
25193418|NCT02770378|Analgesics|analgesics|mesh-ancestor
25193703|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
25193878|NCT02768389|Bevacizumab|bevacizumab|mesh-list
25193880|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447092|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
24447093|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194426|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
24560262|NCT03078010|Cefepime|cefepime|mesh-list
25194920|NCT02761161|Mianserin|mianserin|mesh-list
25051661|NCT00389675|Guanfacine|guanfacine|mesh-list
25195582|NCT02757209|Xhance|xhance|mesh-list
25195643|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25196046|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196293|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196558|NCT02752412|Insulin|insulin|mesh-list
25197202|NCT04384692|Melphalan|melphalan|mesh-list
25197798|NCT02499562|Entecavir|entecavir|mesh-list
25197975|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
25199055|NCT02743572|Iron|iron|mesh-list
25207621|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25207635|NCT03630809|Vaccines|vaccines|mesh-list
24747502|NCT00700882|Dasatinib|dasatinib|mesh-list
24545394|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
24474690|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041033|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24547073|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713937|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
24800524|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
24800525|NCT01976182|Methotrexate|methotrexate|mesh-list
24800526|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547135|NCT00702572|Growth Substances|growth substances|mesh-ancestor
24800789|NCT01978457|Propranolol|propranolol|mesh-list
24548388|NCT00709332|Folic Acid|folic acid|mesh-list
24548389|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24549461|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
24549462|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
24549463|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549582|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25039930|NCT03588884|Vitamin D|vitamin d|mesh-list
24463002|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199309|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
24722868|NCT01583062|Amoxicillin|amoxicillin|mesh-list
24724135|NCT01591226|Mannitol|mannitol|mesh-list
24730035|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25199348|NCT02741232|Epinephrine|epinephrine|mesh-list
24396989|NCT00140530|Paclitaxel|paclitaxel|mesh-list
24431077|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431099|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24431101|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431102|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431103|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431104|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24791753|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442910|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
25007839|NCT02632175|Adalimumab|adalimumab|mesh-list
24551362|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
24553679|NCT00732511|Protective Agents|protective agents|mesh-ancestor
24553680|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24557893|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24560085|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100534|NCT03182088|Norepinephrine|norepinephrine|mesh-list
24561958|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561959|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791577|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791578|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24564353|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
24565342|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25008794|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25008795|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
25008796|NCT04368910|Amebicides|amebicides|mesh-ancestor
24584279|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
24573495|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573557|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573559|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
24575773|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24575774|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
24575775|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24575776|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24575865|NCT00834860|Ribavirin|ribavirin|mesh-list
24576012|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24576013|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24576014|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24576015|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
24576809|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24576810|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576811|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576812|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576813|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24576814|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
24576815|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24576816|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009797|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25009799|NCT05186454|Hormones|hormones|mesh-ancestor
24578684|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578685|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579850|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24580727|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24583256|NCT00873834|Fluoxetine|fluoxetine|mesh-list
24584711|NCT00881400|Cefprozil|cefprozil|mesh-list
24616068|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25121164|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25066147|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25066148|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066153|NCT04179032|Belimumab|belimumab|mesh-list
25066387|NCT03406247|Nivolumab|nivolumab|mesh-list
24917072|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24917074|NCT04233996|Tazobactam|tazobactam|mesh-list
24917075|NCT04233996|Piperacillin|piperacillin|mesh-list
24917076|NCT04233996|Cefepime|cefepime|mesh-list
24920252|NCT04204044|Folic Acid|folic acid|mesh-list
24444785|NCT00299091|Efavirenz|efavirenz|mesh-list
24522284|NCT04004819|Rituximab|rituximab|mesh-list
24609314|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609315|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24672170|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674044|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25199587|NCT02739958|Propofol|propofol|mesh-list
24677327|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
24677681|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24677682|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677684|NCT01357811|Eliglustat|eliglustat|mesh-list
24678279|NCT01360749|Lidocaine|lidocaine|mesh-list
24680406|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24680407|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
24680408|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
24681224|NCT01379001|Scopolamine|scopolamine|mesh-list
24611256|NCT01008046|Metformin|metformin|mesh-list
24682058|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682062|NCT01383668|Sirolimus|sirolimus|mesh-list
24800902|NCT01979510|Etoricoxib|etoricoxib|mesh-list
24863618|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
24682756|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24854984|NCT02276690|Hepcidins|hepcidins|mesh-list
24683570|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24683571|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855032|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24855033|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
24855034|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
24684009|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24684010|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684012|NCT01395147|Vortioxetine|vortioxetine|mesh-list
24611554|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687212|NCT04238845|Vitamins|vitamins|mesh-ancestor
24687213|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
24687259|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
24689188|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24689190|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689191|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24689192|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24690025|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690026|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24690027|NCT01398592|Vildagliptin|vildagliptin|mesh-list
24690028|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690029|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690648|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690649|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
24690650|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690651|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690652|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24692056|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24692057|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694055|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
24694136|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
24633840|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24633841|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24633842|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634839|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634840|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24864223|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24636645|NCT01146535|Oseltamivir|oseltamivir|mesh-list
24637283|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637284|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199642|NCT02739685|Everolimus|everolimus|mesh-list
24637297|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24637298|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
24637299|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637302|NCT01149746|Urological Agents|urological agents|mesh-ancestor
24637782|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639180|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24639181|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639182|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
24639183|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639310|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640524|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645466|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645467|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645468|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
24864640|NCT02907983|Bupivacaine|bupivacaine|mesh-list
24864697|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24812955|NCT02055456|Nandrolone|nandrolone|mesh-list
24665767|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
24665893|NCT01315704|Vitamins|vitamins|mesh-ancestor
24544733|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
24544734|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24549511|NCT00715715|Prednisone|prednisone|mesh-list
24549714|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549715|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
24549716|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
24549717|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
24549718|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549720|NCT00717379|Prednisone|prednisone|mesh-list
24550217|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550218|NCT00719745|Tacrolimus|tacrolimus|mesh-list
24940272|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24940275|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
24940276|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24550219|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199699|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050621|NCT00481325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24701704|NCT01460537|Gemcitabine|gemcitabine|mesh-list
24701705|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701706|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24956415|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812572|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702085|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
24702086|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199704|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25199705|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704059|NCT01476410|Doxorubicin|doxorubicin|mesh-list
24827104|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703665|NCT01473251|Bevacizumab|bevacizumab|mesh-list
24613573|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24613574|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704976|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24704977|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
24704978|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
24704979|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704980|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704981|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24865428|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24705718|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
24705719|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24705720|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706142|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24706144|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
24706145|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706147|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24706432|NCT01490047|Etanercept|etanercept|mesh-list
24706433|NCT01490047|Doxorubicin|doxorubicin|mesh-list
24706434|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24706435|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24706436|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706437|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24706682|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
24706683|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706684|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956799|NCT03851263|Evolocumab|evolocumab|mesh-list
24956800|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24956801|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24956802|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
24707131|NCT01494311|Tetracaine|tetracaine|mesh-list
24707582|NCT01496742|Pemetrexed|pemetrexed|mesh-list
24707981|NCT01499108|Hormones|hormones|mesh-ancestor
24707982|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24707983|NCT01499121|Sunitinib|sunitinib|mesh-list
24707984|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708022|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708023|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24708024|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
24708025|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
25053767|NCT00004231|Antidotes|antidotes|mesh-ancestor
24614246|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
24614247|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050749|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
24710872|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24711247|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711248|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464179|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24712095|NCT01518569|Urinastatin|urinastatin|mesh-list
24714154|NCT01529229|Hormones|hormones|mesh-ancestor
24717554|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24615165|NCT01028261|Growth Substances|growth substances|mesh-ancestor
24719731|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720138|NCT01566643|Rabeprazole|rabeprazole|mesh-list
24720139|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720140|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24720141|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24720460|NCT01568645|Carvedilol|carvedilol|mesh-list
24941949|NCT03985865|Denatonium|denatonium|mesh-list
24723837|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24723838|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723839|NCT01589419|Capecitabine|capecitabine|mesh-list
24723840|NCT01589419|Veliparib|veliparib|mesh-list
24723841|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24723935|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724728|NCT01594346|Vitamin E|vitamin e|mesh-list
24725653|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
24725654|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
24725700|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
24726078|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
24731692|NCT01636128|Sulindac|sulindac|mesh-list
24617100|NCT01041066|Labetalol|labetalol|mesh-list
24942965|NCT03975374|Tobramycin|tobramycin|mesh-list
24943469|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24943470|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24943471|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24943472|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
24639852|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
24639866|NCT01164709|Nelfinavir|nelfinavir|mesh-list
24640077|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
24943729|NCT03967496|Anesthetics|anesthetics|mesh-list
24739940|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
24739941|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24739943|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24739944|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
24740648|NCT01689597|Morphine|morphine|mesh-list
24740881|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24809425|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742012|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24743972|NCT04560972|LB100|lb100|mesh-list
24749242|NCT01396408|Sunitinib|sunitinib|mesh-list
24749243|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749244|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24749245|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24751713|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
24752510|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24752511|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
24752512|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752646|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417231|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24752650|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24752651|NCT01711476|Complement Factor H|complement factor h|mesh-list
24752678|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752679|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
24752680|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
24752688|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752851|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24752852|NCT01712347|Growth Substances|growth substances|mesh-ancestor
24752853|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753170|NCT01714089|Analgesics|analgesics|mesh-ancestor
24753171|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
24753172|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753173|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24753174|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25055348|NCT03521895|Aflibercept|aflibercept|mesh-list
25055349|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25055350|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25055351|NCT03521895|Growth Substances|growth substances|mesh-ancestor
25055352|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055353|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
24753645|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
24418262|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24753800|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
24754471|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24544668|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24544675|NCT00689845|Cytarabine|cytarabine|mesh-list
24754472|NCT01720628|Growth Substances|growth substances|mesh-ancestor
24619458|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24619459|NCT01052584|Amebicides|amebicides|mesh-ancestor
24813097|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755253|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755464|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24755514|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755516|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756174|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
24756184|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756185|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
24756531|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
24756533|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24870013|NCT04491526|Urological Agents|urological agents|mesh-ancestor
24757240|NCT01738763|Inositol|inositol|mesh-list
24757241|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
24757242|NCT01738763|Vitamins|vitamins|mesh-ancestor
24757243|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
24757245|NCT01738802|Micronutrients|micronutrients|mesh-list
24758050|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758051|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
24758053|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24758054|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758055|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
24758056|NCT01743690|Hormones|hormones|mesh-ancestor
24758057|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394537|NCT00133458|Albendazole|albendazole|mesh-list
24870369|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24402747|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402748|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24402749|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24402750|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24402751|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24402752|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
24946365|NCT03940469|Dexamethasone|dexamethasone|mesh-list
24946366|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
24427622|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946658|NCT03936049|Liraglutide|liraglutide|mesh-list
24412594|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412595|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412596|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412597|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413880|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414985|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24414986|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24414987|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
24414988|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871120|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414989|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414990|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24414991|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415825|NCT00201305|Protective Agents|protective agents|mesh-ancestor
24415860|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
24415862|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
24415863|NCT00201344|Leucovorin|leucovorin|mesh-list
24415864|NCT00201344|Antidotes|antidotes|mesh-ancestor
24415865|NCT00201344|Protective Agents|protective agents|mesh-ancestor
24415866|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415903|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415904|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415905|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
24416068|NCT00201955|Rebamipide|rebamipide|mesh-list
24416337|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
24416338|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416339|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416340|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
24416342|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199979|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199980|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199981|NCT02737202|Saracatinib|saracatinib|mesh-list
25199982|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946959|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946978|NCT03933605|Midazolam|midazolam|mesh-list
24430181|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430182|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424314|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424432|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24871704|NCT05039944|Irinotecan|irinotecan|mesh-list
24432511|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24434008|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24434009|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434010|NCT00261183|Melatonin|melatonin|mesh-list
24434011|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
24434012|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434013|NCT00261183|Protective Agents|protective agents|mesh-ancestor
24872274|NCT05397834|Xhance|xhance|mesh-list
24947288|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24436505|NCT00270322|Analgesics|analgesics|mesh-ancestor
24439456|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439457|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439459|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
24439460|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439461|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24439462|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24439463|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
24439464|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
24439466|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24872615|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439841|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24439842|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439843|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24441167|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
24441168|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
24441169|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24441170|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
24441171|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
24441172|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947501|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24947502|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441950|NCT00289250|Renal Agents|renal agents|mesh-ancestor
24442298|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
24442754|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442756|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442757|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
24442758|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24947609|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947610|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24947612|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947613|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947614|NCT03927313|Aspirin|aspirin|mesh-list
24947615|NCT03927313|Rifampin|rifampin|mesh-list
24947616|NCT03927313|Linezolid|linezolid|mesh-list
24947617|NCT03927313|Dexamethasone|dexamethasone|mesh-list
24947618|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24947619|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
24947620|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
24443054|NCT00293514|Thrombin|thrombin|mesh-list
24425201|NCT00232271|Enoxaparin|enoxaparin|mesh-list
25200010|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25142627|NCT02948075|Paclitaxel|paclitaxel|mesh-list
24460751|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460752|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24460753|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460754|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460755|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
24460758|NCT00349440|Cyclosporine|cyclosporine|mesh-list
24963356|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24963357|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25200021|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25200022|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
24947684|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947685|NCT03926806|Vitamins|vitamins|mesh-list
24947686|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
24947687|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
24947688|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947689|NCT03926962|Nafithromycin|nafithromycin|mesh-list
24947690|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24947691|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801786|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
24553452|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553453|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947823|NCT03925662|Piperazine|piperazine|mesh-list
24947824|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
24554324|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556497|NCT00748059|Propranolol|propranolol|mesh-list
24874782|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24874783|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200041|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
24554868|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24554869|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
24554870|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554871|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554877|NCT00738621|Dexamethasone|dexamethasone|mesh-list
24555066|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24947975|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24947977|NCT03924492|Brexanolone|brexanolone|mesh-list
24947978|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
24947979|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947980|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947981|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555164|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555165|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
24555166|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555167|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24555168|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24555169|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24555170|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947999|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
24564581|NCT00776802|Hormones|hormones|mesh-ancestor
24555227|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24555228|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
24555229|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555230|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
25051583|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25051584|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
25051585|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051586|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051587|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25200091|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25200092|NCT02736032|Progesterone|progesterone|mesh-list
25200093|NCT02736032|Estrogens|estrogens|mesh-ancestor
25200094|NCT02736032|Hormones|hormones|mesh-ancestor
24555603|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555619|NCT00742339|Octreotide|octreotide|mesh-list
24555620|NCT00742339|Terlipressin|terlipressin|mesh-list
24555621|NCT00742339|Midodrine|midodrine|mesh-list
24555622|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24555822|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
24555823|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24556395|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556396|NCT00747487|Protective Agents|protective agents|mesh-ancestor
24556830|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948040|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948044|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
24557292|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557294|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24557296|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443283|NCT00294385|Docetaxel|docetaxel|mesh-list
24557330|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
24557331|NCT00752375|Trimethoprim|trimethoprim|mesh-list
24561630|NCT00761722|Azacitidine|azacitidine|mesh-list
24557349|NCT00752401|Vitamins|vitamins|mesh-ancestor
24557528|NCT00752921|Etoricoxib|etoricoxib|mesh-list
24557529|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24557530|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24557531|NCT00752921|Analgesics|analgesics|mesh-ancestor
24557532|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
24557533|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557649|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557650|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557651|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557660|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24557674|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557675|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557676|NCT00753402|Epinephrine|epinephrine|mesh-list
24557867|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24557868|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24557869|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
24557870|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557871|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24557872|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24557873|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557874|NCT00754689|Metformin|metformin|mesh-list
24558129|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24558130|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558131|NCT00755521|Analgesics|analgesics|mesh-ancestor
24558132|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
24558591|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558592|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24558593|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24558594|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24558764|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24558765|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558766|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564254|NCT00775736|Insulin|insulin|mesh-list
24802153|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24596399|NCT00943449|Sorafenib|sorafenib|mesh-list
24802159|NCT01988298|Acetaminophen|acetaminophen|mesh-list
24802160|NCT01988298|Ibuprofen|ibuprofen|mesh-list
24802161|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24802162|NCT01988298|Analgesics|analgesics|mesh-ancestor
24558835|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558836|NCT05428306|Analgesics|analgesics|mesh-ancestor
24559047|NCT05319353|Maribavir|maribavir|mesh-list
25051634|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051635|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
25051636|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25051637|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051638|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
24561804|NCT00762944|Cimetidine|cimetidine|mesh-list
24948408|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948409|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557109|NCT00751257|Antidotes|antidotes|mesh-ancestor
24562303|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562304|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562305|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
24563295|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563296|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563316|NCT00771017|Goserelin|goserelin|mesh-list
24563793|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563794|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565427|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
24565428|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565429|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565523|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566201|NCT00784745|Hormones|hormones|mesh-ancestor
24567503|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
24567525|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
24568437|NCT00795977|Picibanil|picibanil|mesh-list
24568779|NCT00797485|Irinotecan|irinotecan|mesh-list
24569165|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
24569166|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570158|NCT00803699|Selenium|selenium|mesh-list
24570779|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570784|NCT00806754|Azelastine|azelastine|mesh-list
24571165|NCT00808327|Fentanyl|fentanyl|mesh-list
24572428|NCT00814762|Vaccines|vaccines|mesh-list
24572802|NCT00816816|Fluorouracil|fluorouracil|mesh-list
24572905|NCT00817037|Nifedipine|nifedipine|mesh-list
24949223|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051817|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24950233|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
24950234|NCT01883297|Interleukin-2|interleukin-2|mesh-list
24950693|NCT03913182|Apatinib|apatinib|mesh-list
24950694|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950695|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24951101|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
24576466|NCT00838760|Darunavir|darunavir|mesh-list
24577953|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
24578037|NCT00846703|Dexamethasone|dexamethasone|mesh-list
24578220|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578861|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580404|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
24580735|NCT00863460|Busulfan|busulfan|mesh-list
24580745|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
24581801|NCT00866216|Azithromycin|azithromycin|mesh-list
24600317|NCT01026220|Bleomycin|bleomycin|mesh-list
25149847|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25149848|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
24584913|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
24584914|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585198|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24585199|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
24585200|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585592|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585635|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
24586251|NCT00889694|Analgesics|analgesics|mesh-ancestor
25150326|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150327|NCT05293600|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25150328|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
25150329|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25200320|NCT02735031|Exenatide|exenatide|mesh-list
24586551|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586552|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24587023|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24587024|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24587047|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24587498|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587499|NCT00895167|Curcumin|curcumin|mesh-list
24587500|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24587501|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587502|NCT00895167|Analgesics|analgesics|mesh-ancestor
24587503|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
24587504|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587505|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587850|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
24586337|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
24951548|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24951549|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587852|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
24587853|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588016|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24805631|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200405|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24588486|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24588487|NCT00902915|Dexamethasone|dexamethasone|mesh-list
24588540|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
24997479|NCT04799236|Amebicides|amebicides|mesh-ancestor
24997480|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25151759|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25151760|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
24590349|NCT00912171|Hormones|hormones|mesh-ancestor
25200639|NCT02732795|Analgesics|analgesics|mesh-ancestor
25200651|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
24592993|NCT00926705|Analgesics|analgesics|mesh-ancestor
24593356|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24594283|NCT00933374|Paclitaxel|paclitaxel|mesh-list
24594647|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594648|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24635838|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
24594650|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
24594651|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24594939|NCT00936195|Zidovudine|zidovudine|mesh-list
24594948|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24598948|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24598949|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863107|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863108|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542880|NCT00680654|Riociguat|riociguat|mesh-list
25153692|NCT02496585|Nintedanib|nintedanib|mesh-list
25153693|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25153694|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
25153695|NCT02496585|Hormones|hormones|mesh-ancestor
25153696|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153697|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153703|NCT02486367|Clopidogrel|clopidogrel|mesh-list
25153753|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200958|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052151|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052153|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25052260|NCT00313248|Sagopilone|sagopilone|mesh-list
24813692|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24813695|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863522|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863523|NCT04681482|Apixaban|apixaban|mesh-list
24863524|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24863525|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
24863526|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25052606|NCT00250822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052608|NCT00250822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052609|NCT00250822|Immunologic Factors|immunologic factors|mesh-ancestor
25052610|NCT00250822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052611|NCT00243906|Plasminogen|plasminogen|mesh-list
25052612|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25052613|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25052614|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24863701|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863702|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863704|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863705|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24863706|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600303|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052650|NCT00231257|Sirolimus|sirolimus|mesh-list
25052651|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25052659|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
25052745|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25052747|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25052748|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052749|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052750|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
25052751|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807043|NCT02019446|Terbinafine|terbinafine|mesh-list
24863770|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052757|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
24813747|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813748|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
25052779|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25052780|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25052781|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052782|NCT00141284|Lamivudine|lamivudine|mesh-list
25052783|NCT00141284|Zidovudine|zidovudine|mesh-list
25052784|NCT00141284|Nelfinavir|nelfinavir|mesh-list
25052785|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24863894|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
25052796|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052797|NCT00138762|Atorvastatin|atorvastatin|mesh-list
25052798|NCT00138762|Torcetrapib|torcetrapib|mesh-list
25052799|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25052800|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24863895|NCT03026348|Vaccines|vaccines|mesh-list
24863896|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
24863897|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863904|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863905|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24863906|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863963|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24863964|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24813803|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
24864006|NCT02338609|Everolimus|everolimus|mesh-list
24864007|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864008|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813806|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
24813807|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813808|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
24813809|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813810|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
24813811|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813812|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813813|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813814|NCT02060591|Bupivacaine|bupivacaine|mesh-list
24813815|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
24813816|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
24864100|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864102|NCT00960297|Bevacizumab|bevacizumab|mesh-list
24864103|NCT00960297|Carboplatin|carboplatin|mesh-list
24864104|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25207718|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24544033|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544034|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
24625796|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625798|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
24544116|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864191|NCT05147857|Misoprostol|misoprostol|mesh-list
25052875|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25057722|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25052876|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24544129|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864211|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864212|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24864317|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544239|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
24544240|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544241|NCT00688077|Calcitonin|calcitonin|mesh-list
24864337|NCT04825197|Poractant alfa|poractant alfa|mesh-list
24864338|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24864339|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
24864340|NCT04817956|Trastuzumab|trastuzumab|mesh-list
24864559|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201017|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
25201018|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864574|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864575|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
24864576|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864577|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864578|NCT03276468|Atezolizumab|atezolizumab|mesh-list
24952303|NCT03895411|Propafenone|propafenone|mesh-list
24952304|NCT03895411|Metoprolol|metoprolol|mesh-list
24952305|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24544622|NCT00689715|Paclitaxel|paclitaxel|mesh-list
24952306|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24952307|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
24864835|NCT05149378|Azacitidine|azacitidine|mesh-list
25052979|NCT00117650|Etoposide|etoposide|mesh-list
25052980|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
25052981|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25057809|NCT03502005|Tenofovir|tenofovir|mesh-list
24864842|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
24864843|NCT05149339|Vitamin D|vitamin d|mesh-list
24864844|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25053016|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25053017|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25053018|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25053019|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25053020|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25053035|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25053036|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25053037|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24864980|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864981|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864982|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24864984|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544868|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
24544869|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
24544870|NCT00690677|Panobinostat|panobinostat|mesh-list
25053138|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25053139|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053140|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053141|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053149|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053150|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25053168|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25053169|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24807496|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807504|NCT02022358|Antidotes|antidotes|mesh-ancestor
24814030|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25201032|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201033|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25201034|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25201035|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25201036|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25201038|NCT02730364|Ascorbic Acid|ascorbic acid|mesh-list
25201039|NCT02730364|Pheniramine|pheniramine|mesh-list
25201040|NCT02730364|Phenylephrine|phenylephrine|mesh-list
25201041|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
25053214|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25053216|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053217|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24865129|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24865131|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
24865132|NCT04308837|Promethazine|promethazine|mesh-list
24865133|NCT04308837|Dexamethasone|dexamethasone|mesh-list
24865134|NCT04308837|Paclitaxel|paclitaxel|mesh-list
24865135|NCT04308837|Carboplatin|carboplatin|mesh-list
24865136|NCT04308837|Palonosetron|palonosetron|mesh-list
25053252|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
25053253|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053254|NCT00079482|Cytarabine|cytarabine|mesh-list
25053361|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053362|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053365|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25053366|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25053367|NCT00057980|Analgesics|analgesics|mesh-ancestor
25053368|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
25053369|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053370|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053445|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25053446|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
24865176|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865178|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865179|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
24865180|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
24814061|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24445917|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24814084|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24814085|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814086|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24865193|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24865194|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053505|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24865256|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865258|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865259|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865260|NCT04040231|Nivolumab|nivolumab|mesh-list
24865261|NCT04040231|Sargramostim|sargramostim|mesh-list
25053585|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053586|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053587|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053588|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25053589|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25053590|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
25053591|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053592|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865324|NCT03625466|Ivacaftor|ivacaftor|mesh-list
25053641|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053643|NCT00004899|Busulfan|busulfan|mesh-list
25053644|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053645|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053646|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053647|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053648|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053649|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936750|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25053650|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
25053651|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053652|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
24445973|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
24445974|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445975|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24445976|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24445977|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445980|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24445981|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24445982|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445983|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24445984|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24445985|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25014607|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24936923|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936924|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936925|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24936926|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24936927|NCT04034836|Analgesics|analgesics|mesh-ancestor
24936928|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936929|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936930|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
24808045|NCT02024984|Clomiphene|clomiphene|mesh-list
24865536|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865538|NCT00805961|Everolimus|everolimus|mesh-list
24865539|NCT00805961|Temozolomide|temozolomide|mesh-list
24865540|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865541|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053756|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25053757|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25053758|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
25053759|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25053761|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
25015016|NCT03488420|Edoxaban|edoxaban|mesh-list
25053791|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053792|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25053794|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24865588|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24865589|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
24865590|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
24865591|NCT05152355|Hormones|hormones|mesh-ancestor
24865600|NCT05152264|Analgesics|analgesics|mesh-list
25201067|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25201068|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
24865662|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865663|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865664|NCT05151393|Vitamin D|vitamin d|mesh-list
24865665|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
24865666|NCT05151393|Vitamins|vitamins|mesh-ancestor
24865667|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
24865668|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053897|NCT00004093|Paclitaxel|paclitaxel|mesh-list
24937136|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
24937137|NCT04032834|Hormones|hormones|mesh-ancestor
24937138|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24937139|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
24937140|NCT04032548|Propolis|propolis|mesh-list
24865693|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24865694|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865696|NCT05150899|Tamsulosin|tamsulosin|mesh-list
24865697|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24545627|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24505896|NCT00543114|Fludarabine|fludarabine|mesh-list
24952390|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24952391|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24952392|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
24952393|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545741|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
25201075|NCT02730117|Milrinone|milrinone|mesh-list
24408488|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25201076|NCT02730117|Norepinephrine|norepinephrine|mesh-list
25201077|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24952396|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25015632|NCT01286207|Rizatriptan|rizatriptan|mesh-list
25201083|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201084|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
24865862|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865863|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
24545794|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545795|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545797|NCT00694967|Hormones|hormones|mesh-ancestor
24545798|NCT00694980|Etrolizumab|etrolizumab|mesh-list
24545799|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545800|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
24545801|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545802|NCT00695032|Ifosfamide|ifosfamide|mesh-list
25015782|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
24865891|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
24545809|NCT00695045|Narcotics|narcotics|mesh-ancestor
25054032|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25054033|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25054034|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201102|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25201115|NCT02730026|Ketoprofen|ketoprofen|mesh-list
25054100|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25054101|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25054102|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
25054103|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054104|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25015957|NCT00702520|Hormones|hormones|mesh-list
25054134|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054135|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25016018|NCT00647933|Hormones|hormones|mesh-ancestor
25054205|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054206|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
25054207|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054231|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
25054232|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054233|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25054234|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
25054235|NCT03530670|Midazolam|midazolam|mesh-list
25054236|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25054237|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25054238|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866011|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24866012|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24866013|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866014|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24446161|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24866047|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
24866048|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866049|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
24446170|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866071|NCT03717896|Vitamins|vitamins|mesh-ancestor
24866072|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
24866073|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866074|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
24546057|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546082|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546083|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
24546084|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24546085|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
24866110|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24866126|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24866127|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25207721|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24814239|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814240|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
24814241|NCT02063373|Protective Agents|protective agents|mesh-ancestor
24814242|NCT02063425|Fluoxetine|fluoxetine|mesh-list
24814243|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24814244|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24814245|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24866179|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
24866180|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866181|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866182|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
24866183|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866218|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866219|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866220|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
25054501|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054502|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054503|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
25054504|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
24622921|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622922|NCT01069133|Rifaximin|rifaximin|mesh-list
24622923|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24622924|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622925|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622926|NCT01069159|Propranolol|propranolol|mesh-list
24622927|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24622928|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24622929|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
24866323|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866324|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24866325|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24866326|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24866327|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
25054680|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
25054681|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054682|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054683|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054684|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25054685|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25054686|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
25054687|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24866369|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866674|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24866675|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866857|NCT04401553|Vancomycin|vancomycin|mesh-list
24952426|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054898|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
25054899|NCT03526276|Protective Agents|protective agents|mesh-ancestor
25054900|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054902|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25055001|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055002|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446474|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24867711|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24867713|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055044|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055066|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
25055067|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
25055068|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055069|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
25055070|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809362|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24809363|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814464|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24814465|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814466|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814467|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814468|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
25108197|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
24786179|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24446511|NCT00304993|Fenofibrate|fenofibrate|mesh-list
24814484|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
24868312|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24868313|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
24868314|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868315|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868602|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809418|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809419|NCT02033603|Ropivacaine|ropivacaine|mesh-list
24809420|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
24809421|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
24508453|NCT00555607|Hormones|hormones|mesh-ancestor
24868878|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24868879|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24868880|NCT05158699|Ketorolac|ketorolac|mesh-list
24868907|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24868908|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25055227|NCT03522922|Vitamins|vitamins|mesh-ancestor
24869209|NCT04278404|Voriconazole|voriconazole|mesh-list
24869210|NCT04278404|Ceftazidime|ceftazidime|mesh-list
25055249|NCT03522649|Irinotecan|irinotecan|mesh-list
25055270|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
25055271|NCT03522428|Vitamins|vitamins|mesh-ancestor
24869393|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869394|NCT04156698|Docetaxel|docetaxel|mesh-list
25059236|NCT03490019|Metformin|metformin|mesh-list
25201261|NCT02728934|Golimumab|golimumab|mesh-list
24869533|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24869534|NCT03164928|Denosumab|denosumab|mesh-list
24869632|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869633|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869641|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869642|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24809665|NCT02035800|Adalimumab|adalimumab|mesh-list
25055455|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055558|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055559|NCT03519750|Protective Agents|protective agents|mesh-ancestor
25055560|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055561|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055562|NCT03519724|Neostigmine|neostigmine|mesh-list
25055563|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25055564|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201325|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25055618|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24939075|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24939076|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24952561|NCT03893032|Modafinil|modafinil|mesh-list
24870274|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610628|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24870840|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
24871697|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056104|NCT03515369|Liver Extracts|liver extracts|mesh-list
24873133|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
24873134|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24873137|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24873148|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873150|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
24873151|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815130|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24873527|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873528|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25056249|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
25056295|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25056296|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24874409|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24815232|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815233|NCT02069132|Warfarin|warfarin|mesh-list
24815234|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
24815235|NCT02069145|Sorafenib|sorafenib|mesh-list
24815236|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24815237|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874895|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24874896|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875147|NCT04408586|Phentermine|phentermine|mesh-list
24875148|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
24875149|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24875150|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875151|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24875152|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
24875153|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24875720|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056464|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
24876037|NCT03766126|Fludarabine|fludarabine|mesh-list
24876076|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
24876077|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815365|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24815366|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815367|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056523|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
25056594|NCT03511222|Nivolumab|nivolumab|mesh-list
25056595|NCT03511222|Vorolanib|vorolanib|mesh-list
24512317|NCT00574041|Interferons|interferons|mesh-list
24952612|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24815696|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
24878975|NCT05183984|Bevacizumab|bevacizumab|mesh-list
24878976|NCT05183984|Niraparib|niraparib|mesh-list
24878977|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24878978|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878979|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24878980|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24879021|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
24879270|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24879271|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25056754|NCT03509740|Tramadol|tramadol|mesh-list
24879744|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
24952665|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24880353|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
24880598|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24880738|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25056986|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880762|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24888427|NCT04505189|Psilocybin|psilocybin|mesh-list
24880763|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24880764|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
24880766|NCT03391869|Nivolumab|nivolumab|mesh-list
24881020|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24881022|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881023|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25057002|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881101|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881103|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881107|NCT03015610|Lansoprazole|lansoprazole|mesh-list
24823370|NCT02116868|Narcotics|narcotics|mesh-ancestor
24788829|NCT01934088|Midazolam|midazolam|mesh-list
24777622|NCT01865292|Insulin|insulin|mesh-list
25057069|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057071|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25057072|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25057073|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
24881409|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881410|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
24881411|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889124|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24881420|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
24881421|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881422|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816020|NCT02073552|Laxatives|laxatives|mesh-ancestor
24816021|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816022|NCT02073669|Interferons|interferons|mesh-list
24816023|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
24816024|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816025|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
24816026|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816027|NCT02073734|Dexamethasone|dexamethasone|mesh-list
24816028|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816029|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
24816030|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
24816031|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816032|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816033|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816034|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
24816035|NCT02073734|Hormones|hormones|mesh-ancestor
25060968|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24816040|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24816042|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
25057095|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057096|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25057097|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25057098|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
25057099|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
24881518|NCT02101853|Thioguanine|thioguanine|mesh-list
24881519|NCT02101853|Blinatumomab|blinatumomab|mesh-list
24881520|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24881521|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
24881522|NCT02101853|Antibodies|antibodies|mesh-list
24881523|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
24881561|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24881562|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24881563|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
24881576|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
24881585|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
24881586|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881587|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881588|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
24881589|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881590|NCT02065596|Antiviral Agents|antiviral agents|mesh-ancestor
24881591|NCT02065596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881593|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
24881594|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
24881595|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24881596|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881597|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
24881718|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881719|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881720|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24881721|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24881722|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
24881723|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881724|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881726|NCT01434602|Sorafenib|sorafenib|mesh-list
24881727|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881728|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24816100|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24816101|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
24816102|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816103|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
24816104|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816105|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816106|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881803|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881804|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24881805|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
24881806|NCT01239797|Hormones|hormones|mesh-ancestor
24881807|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24881808|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24881809|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881810|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
24881811|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600318|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
24881825|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24881826|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
24881830|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24881831|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881832|NCT01092143|Fluticasone|fluticasone|mesh-list
24881833|NCT01092143|Xhance|xhance|mesh-list
24881834|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881835|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24881850|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24881867|NCT01004029|Hormones|hormones|mesh-ancestor
24952686|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
25201450|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25031137|NCT03590080|Hormones|hormones|mesh-ancestor
24881994|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881995|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
24882003|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24882004|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24882005|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24882006|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882058|NCT02855229|Modafinil|modafinil|mesh-list
24882059|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24882060|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882061|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24882062|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24882063|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057147|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057148|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25057149|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057150|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057151|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811439|NCT02046668|Spironolactone|spironolactone|mesh-list
24882064|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882065|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
25201451|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
24882109|NCT02735707|Lopinavir|lopinavir|mesh-list
24882110|NCT02735707|Interferon-beta|interferon-beta|mesh-list
24882111|NCT02735707|Oseltamivir|oseltamivir|mesh-list
24882112|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
24882113|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
24882114|NCT02735707|Amoxicillin|amoxicillin|mesh-list
24882115|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
24882116|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
24882117|NCT02735707|Levofloxacin|levofloxacin|mesh-list
24882118|NCT02735707|Ivermectin|ivermectin|mesh-list
24882119|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
24882120|NCT02735707|Tazobactam|tazobactam|mesh-list
24882121|NCT02735707|Piperacillin|piperacillin|mesh-list
24882122|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
24882123|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24882124|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24882125|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24882160|NCT02735707|Analgesics|analgesics|mesh-ancestor
24882161|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
24882162|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882163|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24882164|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882165|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24882166|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24882167|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882372|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
24882373|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24882374|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201455|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882391|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24882392|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24882393|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882430|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25113604|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
24505353|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882543|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24882544|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
25057229|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057230|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
25057231|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
25057232|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057233|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882640|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25032048|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
24940725|NCT03998696|Cisplatin|cisplatin|mesh-list
25057234|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25057235|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
25057236|NCT03506789|Hormones|hormones|mesh-ancestor
25057239|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882663|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24882664|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24882665|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
25201459|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201460|NCT02727621|Analgesics|analgesics|mesh-ancestor
24882728|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882730|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
24882731|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882732|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24882733|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25057251|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057252|NCT03506620|Ropivacaine|ropivacaine|mesh-list
24882734|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
24882735|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
24882738|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
24882767|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24882791|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24882793|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
24882794|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24506166|NCT00544219|Hormones|hormones|mesh-ancestor
24882804|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
24882805|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
24882806|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882807|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882808|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24882815|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24882816|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
24882817|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882818|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882819|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
24882820|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882821|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882822|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882823|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24882824|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24882839|NCT04929600|Valsartan|valsartan|mesh-list
24600319|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882855|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
24882856|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354597|NCT05477615|Pemetrexed|pemetrexed|mesh-list
25057268|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25057269|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057270|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057271|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057272|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
25057273|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25061618|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816155|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24882954|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24882955|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882956|NCT04679012|Prednisone|prednisone|mesh-list
24882957|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
24882958|NCT04679012|Rituximab|rituximab|mesh-list
24882959|NCT04679012|Doxorubicin|doxorubicin|mesh-list
24882960|NCT04679012|Etoposide|etoposide|mesh-list
24882961|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24882962|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882963|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
24882964|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882965|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882966|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24883039|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
24883040|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883042|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24883043|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883044|NCT04629781|Docetaxel|docetaxel|mesh-list
24883045|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883046|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
24883047|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
24883048|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
24883049|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507028|NCT00548301|Cyclosporine|cyclosporine|mesh-list
25057346|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25057362|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
24811608|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816254|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816255|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24883365|NCT03926624|Fludarabine|fludarabine|mesh-list
24883366|NCT03926624|Etoposide|etoposide|mesh-list
24883367|NCT03926624|Azacitidine|azacitidine|mesh-list
24883368|NCT03926624|Decitabine|decitabine|mesh-list
24883369|NCT03926624|Venetoclax|venetoclax|mesh-list
24883370|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
24883438|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
24883439|NCT03850366|Bortezomib|bortezomib|mesh-list
24883440|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883441|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
24883442|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883468|NCT03804268|Pilocarpine|pilocarpine|mesh-list
25057449|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24883526|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883527|NCT05238467|Antibodies|antibodies|mesh-list
25057504|NCT03504566|Hormones|hormones|mesh-ancestor
24952707|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952708|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
24952709|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
24952710|NCT03892330|Doxorubicin|doxorubicin|mesh-list
24952711|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25033900|NCT03570294|Atosiban|atosiban|mesh-list
24883598|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24883599|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883617|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24883674|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883676|NCT05181527|Serotonin|serotonin|mesh-list
24883693|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
24883694|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883695|NCT05097768|Dexamethasone|dexamethasone|mesh-list
24883696|NCT05097768|Ibuprofen|ibuprofen|mesh-list
24883697|NCT05097768|Ketorolac|ketorolac|mesh-list
24883698|NCT05097768|Meloxicam|meloxicam|mesh-list
24883699|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883700|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
24883701|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
24883821|NCT04755972|Expectorants|expectorants|mesh-ancestor
25057771|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057821|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057869|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25057870|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
25057871|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057872|NCT03500913|Hormones|hormones|mesh-list
25057873|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057874|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057875|NCT03500900|Vildagliptin|vildagliptin|mesh-list
25057921|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25057923|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057924|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057925|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25057926|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
25057927|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
25057928|NCT03500783|Protective Agents|protective agents|mesh-ancestor
25057929|NCT03500653|Curcumin|curcumin|mesh-list
25058010|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201494|NCT02727504|Protective Agents|protective agents|mesh-ancestor
25058060|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
25058061|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058062|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24505894|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505895|NCT00543114|Rituximab|rituximab|mesh-list
24505901|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506256|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24884318|NCT01889303|Docetaxel|docetaxel|mesh-list
25058249|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816321|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816323|NCT02076477|Pemetrexed|pemetrexed|mesh-list
24506897|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
24506898|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
24506899|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
24506902|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506914|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506916|NCT00547508|Urological Agents|urological agents|mesh-ancestor
24507104|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24507105|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058524|NCT03496246|Calcium|calcium|mesh-list
25058552|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
24507334|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600323|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24463670|NCT00361803|Topotecan|topotecan|mesh-list
24508359|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24508360|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24508361|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
24508362|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508363|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24508364|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24508365|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508366|NCT00555256|Sirolimus|sirolimus|mesh-list
24508367|NCT00555256|Sunitinib|sunitinib|mesh-list
24508368|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508369|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508370|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508371|NCT00555256|Growth Substances|growth substances|mesh-ancestor
24508620|NCT00556270|Narcotics|narcotics|mesh-ancestor
24884889|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
25059349|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24509270|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
24509271|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24509273|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24509274|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509275|NCT00559546|Montelukast|montelukast|mesh-list
25059486|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25059487|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25059488|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24509292|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24509293|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509295|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509296|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24509297|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509298|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509299|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
25059667|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822152|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24822153|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
24822154|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822155|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885206|NCT01481272|Cytarabine|cytarabine|mesh-list
24853494|NCT02268565|Analgesics|analgesics|mesh-ancestor
24952953|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24952959|NCT03890341|Estrogens|estrogens|mesh-ancestor
24511032|NCT00567060|Piracetam|piracetam|mesh-list
24511075|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24511076|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
24511077|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
24886083|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886084|NCT03408886|Vancomycin|vancomycin|mesh-list
24511426|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511483|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24511484|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515601|NCT00598377|Hormones|hormones|mesh-ancestor
25060498|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
25060499|NCT03479411|Itraconazole|itraconazole|mesh-list
25060500|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25060501|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
25060502|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060503|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24886292|NCT01595061|Gemcitabine|gemcitabine|mesh-list
24511994|NCT00572026|Methylphenidate|methylphenidate|mesh-list
24511995|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24511996|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511997|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24511998|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24511999|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24512000|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512075|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886600|NCT04524728|Palbociclib|palbociclib|mesh-list
24886601|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201552|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24886717|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512410|NCT00574756|Ranolazine|ranolazine|mesh-list
25060747|NCT03477136|Vitamin D|vitamin d|mesh-list
24512759|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888687|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24816790|NCT02078869|Hormones|hormones|mesh-ancestor
24512991|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
24460800|NCT00349557|Goserelin|goserelin|mesh-list
24889686|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
24513142|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
24889693|NCT04490980|Butorphanol|butorphanol|mesh-list
24889694|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24889695|NCT04490980|Narcotics|narcotics|mesh-ancestor
24623513|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889955|NCT04487951|Vitamin D|vitamin d|mesh-list
24889956|NCT04487951|Vitamins|vitamins|mesh-ancestor
24890015|NCT04486690|Analgesics|analgesics|mesh-ancestor
25061514|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890113|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890114|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24890115|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24890151|NCT04485429|Prednisolone|prednisolone|mesh-list
24890152|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
24890153|NCT04485429|Heparin|heparin|mesh-list
24890154|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24890155|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
24890156|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890157|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
24891160|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24891161|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24468481|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
25061791|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891504|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24891546|NCT04470050|Analgesics|analgesics|mesh-ancestor
24891547|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
24891551|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24892372|NCT04463966|Coagulants|coagulants|mesh-ancestor
24892373|NCT04463953|Dexamethasone|dexamethasone|mesh-list
24892375|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
24892376|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892377|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
24892378|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
24892431|NCT04463056|Eculizumab|eculizumab|mesh-list
24893356|NCT04451083|Camostat|camostat|mesh-list
24513709|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24894248|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894249|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894295|NCT04442984|Fluorouracil|fluorouracil|mesh-list
24894296|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894297|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24894298|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24894299|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062023|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894468|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894470|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
24476106|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894519|NCT04439890|Carboplatin|carboplatin|mesh-list
24894581|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514169|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
25062286|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457296|NCT00333931|Phenytoin|phenytoin|mesh-list
24514353|NCT00590070|Adenosine|adenosine|mesh-list
24514354|NCT00590070|Nitroprusside|nitroprusside|mesh-list
24514453|NCT00590694|Ranibizumab|ranibizumab|mesh-list
24472126|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514510|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895195|NCT04843462|Esketamine|esketamine|mesh-list
24895196|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
24895205|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
24895224|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24895295|NCT04585711|Etanercept|etanercept|mesh-list
24895296|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24514766|NCT00592917|Vitamin D|vitamin d|mesh-list
24514767|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
24613446|NCT01019109|Cobalt|cobalt|mesh-list
24895597|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24895598|NCT03820466|Analgesics|analgesics|mesh-ancestor
24895599|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
24895600|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895724|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895725|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
24895726|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895727|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24895728|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25062468|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062469|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062470|NCT04594915|Edoxaban|edoxaban|mesh-list
24817349|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24817350|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895836|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895837|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895838|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24895877|NCT02918084|Anastrozole|anastrozole|mesh-list
24895878|NCT02918084|Exemestane|exemestane|mesh-list
24895879|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895880|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24895881|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24895882|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895883|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515340|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
24515341|NCT00596375|Lidocaine|lidocaine|mesh-list
24515342|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
24515343|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
24515344|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515345|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515346|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
24515347|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515393|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515394|NCT00596609|Morphine|morphine|mesh-list
24515395|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24515396|NCT00596609|Narcotics|narcotics|mesh-ancestor
24515397|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515455|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515456|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515457|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24515458|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24515459|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
24515460|NCT00597415|Celecoxib|celecoxib|mesh-list
24515461|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24515462|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24515463|NCT00597415|Analgesics|analgesics|mesh-ancestor
24515464|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
24817367|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24817369|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062589|NCT04317807|Levetiracetam|levetiracetam|mesh-list
25062590|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
25062591|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
24515613|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896399|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515691|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515693|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24515696|NCT00598793|Pioglitazone|pioglitazone|mesh-list
24515697|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
24515698|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
24515699|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515700|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515711|NCT00598858|Hormones|hormones|mesh-ancestor
24515712|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685809|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
24515745|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24515761|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515762|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
24515763|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515764|NCT00599235|Hydralazine|hydralazine|mesh-list
24896480|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
25062715|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062731|NCT04099836|Growth Substances|growth substances|mesh-ancestor
25062732|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062733|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
24901404|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
25062734|NCT04099355|Dronabinol|dronabinol|mesh-list
25062735|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
24896721|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896722|NCT04433572|Sirolimus|sirolimus|mesh-list
24896723|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24896724|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896725|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25062886|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825446|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896757|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24689354|NCT01622998|Nicotine|nicotine|mesh-list
24896817|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896818|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896820|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24896821|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24896822|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24827424|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24902197|NCT04376814|Lopinavir|lopinavir|mesh-list
24529547|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
24516289|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24516290|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24516291|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516292|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24516293|NCT00601328|Vitamins|vitamins|mesh-ancestor
24516294|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
24896956|NCT04431713|Exenatide|exenatide|mesh-list
24896957|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24817613|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
24516353|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
24516354|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516355|NCT00601614|Temozolomide|temozolomide|mesh-list
24516356|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24516357|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
24516359|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516377|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24885880|NCT04282239|Analgesics|analgesics|mesh-ancestor
24897091|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897092|NCT04429295|Vaccines|vaccines|mesh-list
24897093|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
24897094|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063060|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063061|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516491|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24516509|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24692314|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897193|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
24897194|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24818424|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
24897231|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897234|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
24897235|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24897236|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897237|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897238|NCT04426734|Dexamethasone|dexamethasone|mesh-list
24897239|NCT04426734|Prednisolone|prednisolone|mesh-list
24897240|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24474361|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474362|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063145|NCT03029234|Dexamethasone|dexamethasone|mesh-list
25063146|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25063147|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
24897556|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897558|NCT04424459|Narcotics|narcotics|mesh-ancestor
24897559|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063255|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
25063256|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063257|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063258|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063259|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
24516888|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516922|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24516924|NCT00604682|Analgesics|analgesics|mesh-ancestor
25063307|NCT02101034|Palbociclib|palbociclib|mesh-list
25063373|NCT01828112|Docetaxel|docetaxel|mesh-list
25063374|NCT01828112|Pemetrexed|pemetrexed|mesh-list
25063375|NCT01828112|Ceritinib|ceritinib|mesh-list
25063376|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063377|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
25063378|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063379|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
25063380|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063381|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899003|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476070|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476071|NCT00412763|Silymarin|silymarin|mesh-list
24905915|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905916|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25201828|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
24906877|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900563|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
24900564|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
24900565|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518527|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25063869|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063870|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25063871|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25063872|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902668|NCT04371224|Irinotecan|irinotecan|mesh-list
24902669|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
24903497|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903498|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905072|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24908767|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24459625|NCT00345657|Niacin|niacin|mesh-list
24827229|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24623722|NCT01073384|Hormones|hormones|mesh-ancestor
24911631|NCT04285528|Analgesics|analgesics|mesh-ancestor
25065209|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24912550|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913384|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831406|NCT02165098|Cariprazine|cariprazine|mesh-list
24831407|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24831408|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24831409|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786220|NCT01918631|Tenofovir|tenofovir|mesh-list
24786221|NCT01918631|Entecavir|entecavir|mesh-list
24786222|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
24786223|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838492|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838493|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
24838494|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838495|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24838496|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838497|NCT02198248|Hormones|hormones|mesh-ancestor
24751475|NCT01704508|Artemether|artemether|mesh-list
24838533|NCT02198417|Metformin|metformin|mesh-list
25108360|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108361|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25108362|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
24840779|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
24840781|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24840782|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
24840783|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840784|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840785|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24840786|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
24840788|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108371|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25108372|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
25108373|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108374|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108375|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25108376|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
25108377|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108378|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108379|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25108380|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24842896|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
25064943|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
24910800|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108432|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
24845105|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450568|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450569|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
24450570|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
24450571|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
24450218|NCT00318084|Esomeprazole|esomeprazole|mesh-list
24859260|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24859261|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24859262|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24859395|NCT02303483|Vitamins|vitamins|mesh-ancestor
24859396|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
25201945|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
25201946|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25108574|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25108575|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24861374|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861375|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24861376|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24827438|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
24861717|NCT02319616|Clobetasol|clobetasol|mesh-list
24862027|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
24862029|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108591|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
25108592|NCT03131882|Hormones|hormones|mesh-ancestor
25108593|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108595|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637847|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875564|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24875565|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24866938|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25201970|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201971|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
24876055|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24876226|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24876227|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24876229|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24887718|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887719|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24887720|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24887749|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887750|NCT04513015|Protective Agents|protective agents|mesh-ancestor
25108741|NCT03130426|Insulin|insulin|mesh-list
24888490|NCT04503967|Nivolumab|nivolumab|mesh-list
24888491|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24888492|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888493|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24888494|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888495|NCT04503850|Mirabegron|mirabegron|mesh-list
24888496|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24888497|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24889747|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889748|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24623506|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890530|NCT04482543|Methotrexate|methotrexate|mesh-list
24890531|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24890554|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
24890555|NCT04482296|Astringents|astringents|mesh-ancestor
24878562|NCT01425541|Progestins|progestins|mesh-ancestor
24878563|NCT01425541|Hormones|hormones|mesh-ancestor
24878564|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24878565|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878566|NCT01410942|Methylphenidate|methylphenidate|mesh-list
24878567|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24878568|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878569|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24892255|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816973|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816975|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
24816976|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24893387|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893389|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24893390|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
24893391|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893392|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893394|NCT04450134|Famotidine|famotidine|mesh-list
24893395|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25201982|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24894004|NCT04445194|Vaccines|vaccines|mesh-list
24894005|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
24913459|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
24913461|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
24913462|NCT04264039|Melphalan|melphalan|mesh-list
24913463|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913465|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24894053|NCT04444817|Tacrolimus|tacrolimus|mesh-list
24894143|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
24894271|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894272|NCT04442919|Analgesics|analgesics|mesh-ancestor
24894273|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
24894274|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879085|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24879086|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
24879087|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24879088|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24786778|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
24786779|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
24786780|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786781|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786782|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24786783|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
24786785|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786787|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898600|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879461|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24879467|NCT04741997|Nivolumab|nivolumab|mesh-list
24815821|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815823|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24815824|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24819396|NCT02095314|Vaccines|vaccines|mesh-list
24899151|NCT04406506|Erythromycin|erythromycin|mesh-list
24899152|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
24899205|NCT04405622|Gemcitabine|gemcitabine|mesh-list
24879624|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879625|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
24899864|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
25007626|NCT03149809|Urological Agents|urological agents|mesh-ancestor
24786881|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786882|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786883|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24786884|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24901501|NCT04383990|Insulin|insulin|mesh-list
24901502|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24901503|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545413|NCT00693381|Prednisone|prednisone|mesh-list
24545414|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
24545415|NCT00693381|Tacrolimus|tacrolimus|mesh-list
24545416|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545417|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
24545418|NCT00693381|Hormones|hormones|mesh-ancestor
24829843|NCT02154854|Tacrolimus|tacrolimus|mesh-list
25229223|NCT02603783|Capsaicin|capsaicin|mesh-list
24813120|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813121|NCT02056665|Minocycline|minocycline|mesh-list
25229266|NCT02603575|Hormones|hormones|mesh-ancestor
24813132|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813134|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
24813135|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813136|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813137|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813138|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
24813139|NCT02056717|Hormones|hormones|mesh-ancestor
24545526|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545527|NCT00693680|Imipramine|imipramine|mesh-list
24845012|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
24545612|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24712114|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
24712115|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
24712116|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24845236|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
25229448|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24545719|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545726|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24545731|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24545732|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545733|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545734|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
24545735|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24545736|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24545737|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545738|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
24545739|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
24545740|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24858549|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
25043993|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25043994|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24845365|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845367|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845405|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060249|NCT03480945|Nitroprusside|nitroprusside|mesh-list
24845456|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845457|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845547|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845548|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845549|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845550|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845551|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845552|NCT02238262|Telmisartan|telmisartan|mesh-list
25060281|NCT03480646|Prednisone|prednisone|mesh-list
25229670|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25229671|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229672|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229673|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
25229682|NCT02601157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229683|NCT02601157|Antifungal Agents|antifungal agents|mesh-ancestor
25229684|NCT02601157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25229685|NCT02601157|Immunologic Factors|immunologic factors|mesh-ancestor
25229686|NCT02601040|Vaccines|vaccines|mesh-list
25229687|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
25229688|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845592|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24845593|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25229698|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229699|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
25229700|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
25229701|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229702|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
25229703|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25229720|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229721|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25229723|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
25229779|NCT02600741|Thiothixene|thiothixene|mesh-list
25229780|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25229781|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
25229782|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229783|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229784|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229785|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25229838|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25229839|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
25229840|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229841|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229843|NCT02600247|Celecoxib|celecoxib|mesh-list
25229844|NCT02600247|Pregabalin|pregabalin|mesh-list
25229845|NCT02600247|Oxycodone|oxycodone|mesh-list
25229862|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25229863|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25229864|NCT02600247|Narcotics|narcotics|mesh-ancestor
25273462|NCT02385396|Folic Acid|folic acid|mesh-list
24547048|NCT00702130|Pravastatin|pravastatin|mesh-list
24547544|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800619|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24800620|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24800621|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
24800622|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800623|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24800624|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24800625|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800626|NCT01977118|Streptokinase|streptokinase|mesh-list
24800627|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24800628|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24548032|NCT00707330|Clarithromycin|clarithromycin|mesh-list
24800758|NCT01978418|Albuterol|albuterol|mesh-list
24800759|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24800760|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
24551705|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24547920|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
24547921|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547922|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
24547923|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24547924|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24547925|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24547926|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24547927|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
24548025|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548028|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24800803|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
24800804|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595076|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25230041|NCT02598856|Naloxone|naloxone|mesh-list
24800989|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
24800990|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24845878|NCT02239913|Topiramate|topiramate|mesh-list
25230082|NCT02598687|Paclitaxel|paclitaxel|mesh-list
25230083|NCT02598687|Carboplatin|carboplatin|mesh-list
25230084|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25230091|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24875888|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875889|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24548822|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24548823|NCT00712374|Amodiaquine|amodiaquine|mesh-list
24548824|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
24548825|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24548826|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24548827|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548832|NCT00712374|Renal Agents|renal agents|mesh-ancestor
24549067|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24549068|NCT00713271|AZD-3199|azd-3199|mesh-list
24549357|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
24549358|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25230197|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
25230198|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25230218|NCT02597400|Metformin|metformin|mesh-list
24846153|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801329|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801330|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
24570978|NCT00807625|Copper|copper|mesh-list
24549791|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
24549795|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24549889|NCT00717938|Carboplatin|carboplatin|mesh-list
24549891|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
24549892|NCT00717938|Cisplatin|cisplatin|mesh-list
24549946|NCT00718354|Cisplatin|cisplatin|mesh-list
24550011|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24447809|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
24447812|NCT00309673|Lidocaine|lidocaine|mesh-list
24550369|NCT00720447|Etoposide|etoposide|mesh-list
25230509|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
25230510|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25230511|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24892329|NCT04464122|Hormones|hormones|mesh-ancestor
25230634|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
25230658|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25230659|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230660|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25230661|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230662|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
25230663|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
25230664|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230665|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25230666|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24846410|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846412|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24846413|NCT02242656|Narcotics|narcotics|mesh-ancestor
24846414|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846415|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230766|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230767|NCT02593526|Bumetanide|bumetanide|mesh-list
25230949|NCT02592772|Nicotine|nicotine|mesh-list
25230959|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
25231016|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577397|NCT00843908|Imidacloprid|imidacloprid|mesh-list
25231200|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25231201|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231202|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231203|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231204|NCT02590874|Analgesics|analgesics|mesh-ancestor
25231205|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
25231206|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231207|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
25231208|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25231209|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
25231210|NCT02591017|Ketamine|ketamine|mesh-list
25231211|NCT02591017|Morphine|morphine|mesh-list
24846492|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
24801692|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231429|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
25231430|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
25231471|NCT02588937|Entecavir|entecavir|mesh-list
24801788|NCT01985750|Cycloserine|cycloserine|mesh-list
25231580|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231581|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231582|NCT02588131|Durvalumab|durvalumab|mesh-list
25231583|NCT02588131|Tremelimumab|tremelimumab|mesh-list
25231584|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231613|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
25231678|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25231679|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25231680|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
24586646|NCT00891579|Pemetrexed|pemetrexed|mesh-list
25231748|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25231781|NCT02586649|Bromides|bromides|mesh-list
25231782|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
25231783|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25231784|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25231838|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231839|NCT02586454|Morphine|morphine|mesh-list
25231840|NCT02586454|Ropivacaine|ropivacaine|mesh-list
24846663|NCT02243436|Hormones|hormones|mesh-ancestor
24846672|NCT02243553|Midazolam|midazolam|mesh-list
24846673|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
24846674|NCT02243553|Caffeine|caffeine|mesh-list
24846675|NCT02243553|Omeprazole|omeprazole|mesh-list
24846676|NCT02243553|Warfarin|warfarin|mesh-list
24846677|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24801987|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
24801988|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801989|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801990|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622479|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232067|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
25232099|NCT02584751|Protective Agents|protective agents|mesh-ancestor
25232100|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
25232106|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232107|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
25232108|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
25232109|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479287|NCT00426296|Ritonavir|ritonavir|mesh-list
24479363|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479364|NCT00426582|Epothilone B|epothilone b|mesh-list
25232253|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232255|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25232256|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25232257|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
25232258|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232259|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232260|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232261|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25232262|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
25232263|NCT02583698|Protective Agents|protective agents|mesh-ancestor
25232264|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25232265|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232266|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232267|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
25274033|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25232272|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
25232318|NCT02583451|Zopiclone|zopiclone|mesh-list
24393591|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393592|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24393594|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24452035|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232341|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25232342|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
25232343|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232344|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232345|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25232346|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24452337|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452338|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
24452339|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24452346|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24452347|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24452348|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452349|NCT00327197|Prednisolone|prednisolone|mesh-list
24802305|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24802306|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25076917|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24882871|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882872|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24802307|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802383|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
24802384|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24802385|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
24802386|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24802387|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
24802388|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232438|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
24463990|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
25077466|NCT03364348|Maytansine|maytansine|mesh-list
24802924|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355501|NCT05465317|Incretins|incretins|mesh-ancestor
24802996|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622554|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24622555|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
24622556|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803849|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24803850|NCT01998776|Misoprostol|misoprostol|mesh-list
24803851|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24466110|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
24803924|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803925|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24466258|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
24804140|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24804343|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25077941|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077942|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24804573|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466536|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466537|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804905|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804906|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804907|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
24804908|NCT02005770|Propofol|propofol|mesh-list
25078062|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24467309|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
24847053|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847061|NCT02245022|Dolutegravir|dolutegravir|mesh-list
24469225|NCT00384969|Everolimus|everolimus|mesh-list
25233133|NCT02578043|Clindamycin|clindamycin|mesh-list
25233165|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
25233166|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233167|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273602|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24470308|NCT00389636|Becaplermin|becaplermin|mesh-list
25233224|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25233267|NCT02577497|Hormones|hormones|mesh-ancestor
24471788|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471789|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24471790|NCT00396747|Protective Agents|protective agents|mesh-ancestor
24471791|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24471792|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
24471793|NCT00396760|Aprotinin|aprotinin|mesh-list
24471794|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24471860|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24471861|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24471862|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471863|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814090|NCT02062281|Vaccines|vaccines|mesh-list
24472089|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25233334|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233374|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
24473281|NCT00402493|Latanoprost|latanoprost|mesh-list
24473446|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473447|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
24473448|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24473449|NCT00402792|Narcotics|narcotics|mesh-ancestor
24473450|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473451|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
24473491|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24473492|NCT00403039|Growth Substances|growth substances|mesh-ancestor
24473517|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473518|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
24473715|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24473717|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
24473718|NCT00403949|Azelaic acid|azelaic acid|mesh-list
24473719|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233421|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25233422|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25233423|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25233424|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
25233425|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233426|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233427|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24805752|NCT02012049|Risperidone|risperidone|mesh-list
24805753|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24805754|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
24805755|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805756|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805757|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805758|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25233428|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25233447|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
25233448|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233450|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25233451|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473796|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473878|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
24473879|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473880|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473881|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
24446017|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446018|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473885|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
24473886|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473887|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24805826|NCT02012166|Insulin|insulin|mesh-list
24473932|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473933|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24473935|NCT00404508|Valproic Acid|valproic acid|mesh-list
24805843|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805844|NCT02012244|Analgesics|analgesics|mesh-ancestor
24805845|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
24805846|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233480|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
24473958|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24865764|NCT04998981|Fenofibrate|fenofibrate|mesh-list
25233482|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25233483|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24805861|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805862|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805863|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24474065|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
24474066|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474067|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474068|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474093|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446389|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24446390|NCT00304629|Galantamine|galantamine|mesh-list
24805938|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474412|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474413|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
25233603|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233604|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25233605|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393484|NCT00130195|Prednisolone|prednisolone|mesh-list
24393485|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
24393486|NCT00130195|Methotrexate|methotrexate|mesh-list
24806052|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24806053|NCT02013453|Paclitaxel|paclitaxel|mesh-list
24474582|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
24906133|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24906134|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906135|NCT04342065|Celecoxib|celecoxib|mesh-list
24906465|NCT04340388|Tenofovir|tenofovir|mesh-list
24906653|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906654|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907068|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
24907108|NCT04333095|Bupivacaine|bupivacaine|mesh-list
24907109|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
24907476|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907559|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24907560|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24907561|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24907826|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24908831|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233935|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
25233936|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233937|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24909087|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24909088|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24909089|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909189|NCT04312152|Vitamin E|vitamin e|mesh-list
24909462|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
24909463|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910618|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234114|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24914647|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24915024|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915025|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24915048|NCT04962503|Afamelanotide|afamelanotide|mesh-list
24915050|NCT04938882|Lidocaine|lidocaine|mesh-list
24915592|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234266|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234267|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234268|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916446|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25044558|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25154617|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24901983|NCT04379310|Calcium|calcium|mesh-list
24497717|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25109453|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25109454|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24500417|NCT00524186|Irinotecan|irinotecan|mesh-list
24500418|NCT00524186|Sunitinib|sunitinib|mesh-list
24624353|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24624354|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24927662|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24927665|NCT04131322|Adalimumab|adalimumab|mesh-list
24930088|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064316|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958364|NCT03833895|Phenylephrine|phenylephrine|mesh-list
25234913|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
24455626|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455627|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514792|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
24455767|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24455800|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234946|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
25234947|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25234948|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234949|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
25234950|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234951|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
25234964|NCT02567981|Vitamins|vitamins|mesh-ancestor
25234965|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234966|NCT02568033|Paclitaxel|paclitaxel|mesh-list
25234967|NCT02568033|Docetaxel|docetaxel|mesh-list
25234968|NCT02568033|Carboplatin|carboplatin|mesh-list
25234969|NCT02568033|Pemetrexed|pemetrexed|mesh-list
25234979|NCT02567916|Propofol|propofol|mesh-list
25234995|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25154689|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635716|NCT01140971|Misoprostol|misoprostol|mesh-list
25004874|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
24518136|NCT05331131|Ketamine|ketamine|mesh-list
24787911|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235091|NCT02567799|Estrogens|estrogens|mesh-ancestor
25235092|NCT02567799|Hormones|hormones|mesh-ancestor
25273644|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24476948|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
24477090|NCT00417183|Ganirelix|ganirelix|mesh-list
24520429|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
24953323|NCT03886662|LB100|lb100|mesh-list
24959807|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24959809|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25235173|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25235193|NCT02566720|Amantadine|amantadine|mesh-list
25235194|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25235195|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25235196|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
25235197|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235198|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
24457442|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24457443|NCT00334412|Caspofungin|caspofungin|mesh-list
24457444|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24749357|NCT01160107|Prednisone|prednisone|mesh-list
24749542|NCT00866918|Cytarabine|cytarabine|mesh-list
24490883|NCT00480376|Gentamicins|gentamicins|mesh-list
24493901|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
24493933|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493934|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501633|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506056|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506057|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24506058|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
25235514|NCT02563795|Bupivacaine|bupivacaine|mesh-list
25235515|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
25235516|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
25235517|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509822|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24509823|NCT00562224|Abexinostat|abexinostat|mesh-list
24509824|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24511574|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
25064722|NCT03457467|Apatinib|apatinib|mesh-list
24514047|NCT00587496|Valacyclovir|valacyclovir|mesh-list
24788179|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
24788182|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514188|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514201|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24514205|NCT00588926|Analgesics|analgesics|mesh-ancestor
24514679|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
24514726|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514727|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24514728|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514730|NCT00592566|Coagulants|coagulants|mesh-ancestor
24514731|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24517010|NCT00605410|Bromides|bromides|mesh-list
25235783|NCT02562118|Letrozole|letrozole|mesh-list
25154784|NCT05469204|Midazolam|midazolam|mesh-list
25235864|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24522153|NCT04205136|Spironolactone|spironolactone|mesh-list
25005226|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
25236200|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25236597|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236598|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
25154839|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25236631|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236632|NCT02556658|Anesthetics|anesthetics|mesh-list
25236633|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236635|NCT02556814|Dexamethasone|dexamethasone|mesh-list
24394221|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24525782|NCT02746796|Tegafur|tegafur|mesh-list
25236707|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528863|NCT00623207|Atropine|atropine|mesh-list
25236775|NCT02555800|Cidofovir|cidofovir|mesh-list
25236861|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236863|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236864|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236866|NCT02555358|Capecitabine|capecitabine|mesh-list
25273711|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25273712|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273713|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25075691|NCT03378713|Androgens|androgens|mesh-ancestor
24528458|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273719|NCT02383771|Aspirin|aspirin|mesh-list
25237031|NCT02553551|Protective Agents|protective agents|mesh-ancestor
25237035|NCT02553603|Hormones|hormones|mesh-list
24965590|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24965620|NCT03775746|Clopidogrel|clopidogrel|mesh-list
24788349|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237177|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25005387|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
25005388|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25005389|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
25005390|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
25005391|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
25005392|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25237208|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237209|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25237211|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25237222|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
24528921|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528925|NCT00623402|Sorafenib|sorafenib|mesh-list
24788392|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25005518|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005519|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
25005520|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005521|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237307|NCT02550977|Hormones|hormones|mesh-ancestor
25005541|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005543|NCT03793010|Hormones|hormones|mesh-ancestor
25237310|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25237311|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
25237312|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237313|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237314|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25237315|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
24449767|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24449768|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
24449770|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449805|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
24613286|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
24613350|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25237367|NCT02550665|Donepezil|donepezil|mesh-list
25005651|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702620|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702622|NCT01466959|Retinol acetate|retinol acetate|mesh-list
24702623|NCT01466959|Citric Acid|citric acid|mesh-list
24702624|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
24702625|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
24703281|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
24704077|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24704165|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704167|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
24704168|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25237664|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237851|NCT02548533|Epinephrine|epinephrine|mesh-list
25238170|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25238171|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
24710075|NCT01508260|Furosemide|furosemide|mesh-list
24710301|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710613|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24710614|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24849511|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24712029|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712061|NCT01518231|Protective Agents|protective agents|mesh-ancestor
24712062|NCT01518413|Irinotecan|irinotecan|mesh-list
24712063|NCT01518413|Sorafenib|sorafenib|mesh-list
25005874|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005875|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712770|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24712771|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712778|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24712779|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
24712780|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712781|NCT01522846|Heparin|heparin|mesh-list
24713227|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
24713228|NCT01524731|Hormones|hormones|mesh-ancestor
24713229|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005944|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239121|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25239122|NCT03955861|Analgesics|analgesics|mesh-ancestor
25239123|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
25239124|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239126|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715437|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715462|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715594|NCT01537380|Cefazolin|cefazolin|mesh-list
24614902|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
24614903|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24614904|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
24715838|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
24615028|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24615029|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239281|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239282|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25239283|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24717047|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717048|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717322|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717323|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717324|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25239374|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239375|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239376|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
25239377|NCT02542111|Hormones|hormones|mesh-ancestor
25239378|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717890|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25239381|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
25239382|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718154|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718155|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718156|NCT01552330|Artesunate|artesunate|mesh-list
24718200|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24718201|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
24718386|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719016|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719053|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24719054|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719056|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25006191|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719450|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719451|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719452|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
24719453|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006226|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25006265|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
25006266|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006267|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615391|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615392|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615393|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
24615394|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24720594|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24720595|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24720597|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24720598|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24720599|NCT01569256|Cabergoline|cabergoline|mesh-list
24720600|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24817727|NCT02085408|Cytarabine|cytarabine|mesh-list
25006287|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
25006288|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
25006289|NCT05202821|Protective Agents|protective agents|mesh-ancestor
25006290|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006297|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006299|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721073|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721075|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24721076|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
24721077|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721078|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24721114|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721159|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
24721160|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24721161|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
24721162|NCT01572350|Hormones|hormones|mesh-ancestor
24721416|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721417|NCT01573975|Clarithromycin|clarithromycin|mesh-list
24721418|NCT01573975|Rabeprazole|rabeprazole|mesh-list
24721419|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24721420|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006300|NCT05180032|Denosumab|denosumab|mesh-list
25239580|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239582|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24721505|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24721540|NCT01575418|Protective Agents|protective agents|mesh-ancestor
24721541|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239599|NCT02540837|Bupivacaine|bupivacaine|mesh-list
25239600|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
25239601|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
25239602|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239607|NCT02540785|Ofloxacin|ofloxacin|mesh-list
24722083|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24722084|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24722085|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24722087|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
24722088|NCT01578473|Vitamins|vitamins|mesh-list
24722089|NCT01578473|Vitamin E|vitamin e|mesh-list
24722090|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
24722091|NCT01578473|Testosterone|testosterone|mesh-list
24722117|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722344|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722345|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
24722346|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722405|NCT01580163|Methadone|methadone|mesh-list
25239821|NCT02539706|Rocuronium|rocuronium|mesh-list
25239822|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25239823|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25239824|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25239853|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045155|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
24724352|NCT01592279|Liraglutide|liraglutide|mesh-list
24849913|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849914|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849915|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24491991|NCT00484822|Heparin|heparin|mesh-list
24849928|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24849929|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
24444452|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
24444453|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24444454|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24444455|NCT00298025|Cetrorelix|cetrorelix|mesh-list
25067766|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24724658|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724659|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724661|NCT01594047|Narcotics|narcotics|mesh-ancestor
24789553|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789554|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24789555|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
24789557|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24789558|NCT01937767|Narcotics|narcotics|mesh-ancestor
24789560|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
24724779|NCT01594671|Coagulants|coagulants|mesh-ancestor
24724781|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724782|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724783|NCT01594775|Oxytocin|oxytocin|mesh-list
24724800|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24724801|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
24724802|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
24615914|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
24615915|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615916|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615917|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615918|NCT01032798|Mepivacaine|mepivacaine|mesh-list
24615919|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
24615920|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
24615922|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724926|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24724927|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724953|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724954|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724955|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724956|NCT01595828|Pitavastatin|pitavastatin|mesh-list
24725105|NCT01596426|Granisetron|granisetron|mesh-list
24725106|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
24725139|NCT01596647|Omeprazole|omeprazole|mesh-list
24725140|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24725150|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
24725179|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24615989|NCT01033396|Fexofenadine|fexofenadine|mesh-list
24725551|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726307|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24726540|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726542|NCT01604135|Riboflavin|riboflavin|mesh-list
24726980|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726981|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240467|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240468|NCT02535156|Risperidone|risperidone|mesh-list
25240469|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25240470|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
24850058|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850059|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727797|NCT01612871|Anastrozole|anastrozole|mesh-list
24727798|NCT01612871|Exemestane|exemestane|mesh-list
24727799|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727800|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24727801|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24727802|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727804|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25068162|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24727979|NCT01613820|Ketamine|ketamine|mesh-list
24728391|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24728392|NCT01615978|Liraglutide|liraglutide|mesh-list
24728422|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
24728423|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
24728424|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24728425|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24728426|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
24728427|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24728745|NCT01617928|Paclitaxel|paclitaxel|mesh-list
25006610|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
25006611|NCT04843579|Clarithromycin|clarithromycin|mesh-list
25006612|NCT04843579|Dexamethasone|dexamethasone|mesh-list
25006613|NCT04843579|Pomalidomide|pomalidomide|mesh-list
25006614|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25006615|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
25006616|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
25006617|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006618|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006619|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006620|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
25079919|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
24728977|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729275|NCT01620944|Emtricitabine|emtricitabine|mesh-list
24729305|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729306|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
24729307|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24729308|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24729309|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729310|NCT01621100|Hydromorphone|hydromorphone|mesh-list
25240658|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
25240659|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240660|NCT05297968|Oseltamivir|oseltamivir|mesh-list
25240661|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
25240662|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240663|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273937|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729524|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
24729768|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729769|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
24729770|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240664|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850282|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812033|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729771|NCT01623817|Vancomycin|vancomycin|mesh-list
24730028|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24730578|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616810|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24616811|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616812|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730595|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730596|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730628|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24730629|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24730889|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731514|NCT01635296|Cytarabine|cytarabine|mesh-list
24731722|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
24731723|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731725|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24616997|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24396130|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617027|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617028|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617029|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24617030|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25240708|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
25240709|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273938|NCT02382029|Clonazepam|clonazepam|mesh-list
25273939|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
25273940|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
25273941|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
25273942|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273943|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273945|NCT02381899|Rituximab|rituximab|mesh-list
24732525|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24732526|NCT01639898|Growth Substances|growth substances|mesh-ancestor
24732527|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
24732529|NCT01640002|Propantheline|propantheline|mesh-list
25240725|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
25240726|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240727|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240728|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
24732657|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
24732659|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
24732778|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732779|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732780|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24732781|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24732782|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24732783|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24732784|NCT01641406|Growth Substances|growth substances|mesh-ancestor
24732785|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
25240762|NCT05096884|Metoprolol|metoprolol|mesh-list
24481206|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24733042|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
24733043|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
24733044|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24733661|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24398342|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
24736601|NCT01663168|Rifabutin|rifabutin|mesh-list
24737575|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24650988|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
24737576|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737577|NCT01669824|Analgesics|analgesics|mesh-ancestor
24422915|NCT00223860|Hormones|hormones|mesh-list
24737578|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
24737579|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738139|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
24738141|NCT01673399|Atosiban|atosiban|mesh-list
24738142|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
24423132|NCT00224809|Analgesics|analgesics|mesh-ancestor
24738244|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
24738282|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
24743160|NCT04975802|Caffeine|caffeine|mesh-list
24743488|NCT04763564|Hormones|hormones|mesh-ancestor
25241050|NCT04115956|Dexamethasone|dexamethasone|mesh-list
24766800|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766801|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241051|NCT04115956|Melphalan|melphalan|mesh-list
24745480|NCT03760835|Cortisone|cortisone|mesh-list
25241117|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241118|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24748575|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24748598|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748599|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749965|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24752482|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
24752483|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
24619424|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619601|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
24619602|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619603|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24790114|NCT01940965|Biguanides|biguanides|mesh-list
24851279|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851300|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
24851301|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
24851302|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851303|NCT02256319|Analgesics|analgesics|mesh-ancestor
24851304|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
25241576|NCT05300958|Deferoxamine|deferoxamine|mesh-list
24757956|NCT01743118|Calcipotriene|calcipotriene|mesh-list
25241609|NCT05300555|Warfarin|warfarin|mesh-list
25241635|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241636|NCT05300386|Citalopram|citalopram|mesh-list
25241637|NCT05300386|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25241638|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24769551|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
24769552|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
24769553|NCT01814618|Hormones|hormones|mesh-ancestor
25241639|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24758663|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
24620007|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769668|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24769669|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241653|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
25241654|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25241655|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
25241656|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
25241657|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241682|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241684|NCT05300334|Analgesics|analgesics|mesh-ancestor
25241685|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
25241686|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241687|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510937|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
25268803|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
25268820|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24770930|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770932|NCT01823172|Methylene Blue|methylene blue|mesh-list
25268920|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25268921|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831683|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771378|NCT01826916|Analgesics|analgesics|mesh-ancestor
24831790|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
24771750|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269045|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25269046|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
25269047|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24832050|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
24563358|NCT00771303|Coagulants|coagulants|mesh-ancestor
25269340|NCT02410590|Succinylcholine|succinylcholine|mesh-list
25269430|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25269431|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
25269432|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25269438|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
25269488|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25269489|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269491|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
25269492|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269499|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269500|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25269501|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269502|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
25269512|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25269611|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25269614|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25269615|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25269631|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269632|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25269633|NCT02409290|Renal Agents|renal agents|mesh-ancestor
25269634|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25269640|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25269641|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269642|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
24469133|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469134|NCT00384618|Protective Agents|protective agents|mesh-ancestor
25269646|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269647|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
24941737|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
24833006|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452250|NCT00326664|Maleic acid|maleic acid|mesh-list
24469782|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24834141|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452329|NCT00327145|Amlodipine|amlodipine|mesh-list
24834738|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24834739|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24834741|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269827|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25269828|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25269829|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
25269830|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269832|NCT02408146|Parecoxib|parecoxib|mesh-list
25269833|NCT02408146|Fentanyl|fentanyl|mesh-list
24470782|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24941919|NCT03986008|Incretins|incretins|mesh-ancestor
24835424|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835425|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
24835426|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835427|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835435|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835436|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
24835462|NCT02182960|Ibuprofen|ibuprofen|mesh-list
24835619|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835620|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835621|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835622|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835799|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835916|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835918|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835977|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
24835978|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835979|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835980|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
24835987|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
24835988|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835990|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24835991|NCT02183701|Telmisartan|telmisartan|mesh-list
24836081|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
24836082|NCT02184091|Nevirapine|nevirapine|mesh-list
24836083|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24836105|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
24836106|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836107|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836108|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24836109|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
24836160|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24836161|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25269915|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25269916|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25269917|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25269970|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269971|NCT02407366|Carboplatin|carboplatin|mesh-list
25269972|NCT02407366|Pemetrexed|pemetrexed|mesh-list
24836459|NCT02185924|Parecoxib|parecoxib|mesh-list
24452457|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452459|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24836589|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836590|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24836591|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25270016|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837597|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
24837598|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
24837599|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837601|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24840234|NCT02208596|Analgesics|analgesics|mesh-ancestor
24840235|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
24840239|NCT02208778|Remifentanil|remifentanil|mesh-list
24840264|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840266|NCT02208882|BMS-986120|bms-986120|mesh-list
24840267|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24840268|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24840271|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24840404|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24840405|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25270161|NCT02406170|Paclitaxel|paclitaxel|mesh-list
24646776|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24841537|NCT02216487|Irinotecan|irinotecan|mesh-list
24841538|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24842973|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843175|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843176|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
24843177|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843178|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
24843179|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843180|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24843523|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
24843524|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843545|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270246|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
24477070|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477072|NCT00417144|Ganirelix|ganirelix|mesh-list
24477073|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
24844354|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24846139|NCT02241421|Amoxicillin|amoxicillin|mesh-list
25270355|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
24477651|NCT00419601|Narcotics|narcotics|mesh-ancestor
24846762|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
25270676|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847214|NCT02245464|Telmisartan|telmisartan|mesh-list
24691938|NCT01409694|Vitamin D|vitamin d|mesh-list
25270844|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270845|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25270847|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24847903|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
24847904|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847905|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24847906|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270915|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25270916|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
25270948|NCT02402543|Analgesics|analgesics|mesh-ancestor
25069974|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
24848373|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24848374|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
24453725|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24457192|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
24457207|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457208|NCT00333424|Vaccines|vaccines|mesh-list
24487446|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481660|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
24848640|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
24848641|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
25271419|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25271420|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271592|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271421|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25271422|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25271423|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
25271424|NCT02399137|Gemcitabine|gemcitabine|mesh-list
25271425|NCT02399137|Paclitaxel|paclitaxel|mesh-list
25271451|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271453|NCT02398994|Hormones|hormones|mesh-ancestor
25271487|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271488|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
25271489|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25271490|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25271525|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271547|NCT02398539|Triamcinolone|triamcinolone|mesh-list
25271604|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
25271605|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482321|NCT00438737|Cetuximab|cetuximab|mesh-list
24482455|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
25271655|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24849131|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849132|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271784|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
24849255|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849258|NCT01659606|Cyclosporine|cyclosporine|mesh-list
25271917|NCT02395705|Cisplatin|cisplatin|mesh-list
25271933|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25271935|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25271936|NCT02395952|Laxatives|laxatives|mesh-ancestor
25271937|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271938|NCT02395744|Paclitaxel|paclitaxel|mesh-list
25271939|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25271940|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457368|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
25271948|NCT02395458|Omeprazole|omeprazole|mesh-list
25271949|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25271950|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271951|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25271952|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24697555|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
25271953|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25271954|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271955|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25272163|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25272165|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
25272166|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
25272167|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
25272168|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275575|NCT02371096|Rituximab|rituximab|mesh-list
25272216|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25272217|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25275725|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24849916|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849938|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24849939|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24849940|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24849942|NCT02251145|Tenofovir|tenofovir|mesh-list
24849943|NCT02251145|Tipranavir|tipranavir|mesh-list
24849944|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24444465|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
24444466|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24444467|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
24849964|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849966|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849967|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
24849968|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849969|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849970|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850037|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24850038|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850039|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24850040|NCT02251431|Incretins|incretins|mesh-ancestor
24850041|NCT02251431|Hormones|hormones|mesh-ancestor
24659929|NCT01280929|Growth Substances|growth substances|mesh-ancestor
24492743|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492744|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24492746|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
25272420|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
25272421|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272422|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272423|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
25272424|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25272426|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25272427|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272428|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487343|NCT00462787|Thiotepa|thiotepa|mesh-list
24487344|NCT00462787|Clofarabine|clofarabine|mesh-list
25272430|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25272431|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272432|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272439|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272440|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25272441|NCT02392676|Olaparib|olaparib|mesh-list
24851372|NCT02256735|Ritobegron|ritobegron|mesh-list
24487382|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487383|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493388|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
24850640|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850641|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850642|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850643|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850645|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850646|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
24851230|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851231|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851235|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24851236|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851237|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851238|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24851239|NCT02256150|Mizoribine|mizoribine|mesh-list
25272478|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25272486|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25272487|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24487627|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487629|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25272492|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851460|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24851462|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24851463|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24851464|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
24851465|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851467|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24495525|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700117|NCT01450774|Beclomethasone|beclomethasone|mesh-list
24661689|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
24812242|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25070911|NCT03415087|Bupivacaine|bupivacaine|mesh-list
25272500|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272501|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272502|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25272508|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272509|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
25272510|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
25272511|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
25272512|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272516|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272517|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272518|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272519|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
25272520|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496228|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272529|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25272530|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272531|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445713|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24445715|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24445716|NCT00302354|Methylphenidate|methylphenidate|mesh-list
24445766|NCT00302523|Tacrolimus|tacrolimus|mesh-list
24445767|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272532|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25272533|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25272534|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25272535|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24445848|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24445849|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
24445850|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24445851|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24445852|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24445865|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272545|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272554|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25272555|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272556|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
25272567|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
25272568|NCT02391688|Analgesics|analgesics|mesh-ancestor
25272569|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
25272570|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272571|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25272572|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071536|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
24852613|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24852614|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658042|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
25208387|NCT02549170|Antibodies|antibodies|mesh-list
25241761|NCT05299944|Cannabidiol|cannabidiol|mesh-list
24613091|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
24593419|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593877|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24593878|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593880|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24593886|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
24594446|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24594447|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594448|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
24594449|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
24594450|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24594506|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595085|NCT00936793|Ritonavir|ritonavir|mesh-list
24596416|NCT00943540|Emtricitabine|emtricitabine|mesh-list
24596619|NCT00944502|Dexamethasone|dexamethasone|mesh-list
24596783|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596784|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
24596785|NCT00945373|Coagulants|coagulants|mesh-ancestor
24597110|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24597111|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597112|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24597286|NCT00948220|Ribavirin|ribavirin|mesh-list
25208539|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24600237|NCT01590069|Aldesleukin|aldesleukin|mesh-list
24600747|NCT00960349|Capecitabine|capecitabine|mesh-list
24601363|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
24853254|NCT02266927|Xhance|xhance|mesh-list
24603208|NCT00972907|Nifedipine|nifedipine|mesh-list
24603464|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24604421|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
24604859|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605137|NCT00983398|Diuretics|diuretics|mesh-ancestor
24605920|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
24605923|NCT00987974|Atorvastatin|atorvastatin|mesh-list
24606322|NCT00989807|Aztreonam|aztreonam|mesh-list
25208785|NCT00653068|Calcium|calcium|mesh-list
25208786|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
25208787|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208788|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
24491421|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24533551|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533552|NCT00644371|Rituximab|rituximab|mesh-list
24491861|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24491862|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491913|NCT00484510|Vitamins|vitamins|mesh-ancestor
24491914|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
24641052|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641053|NCT01171651|Sorafenib|sorafenib|mesh-list
25208860|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25208861|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208946|NCT02706119|Insulin|insulin|mesh-list
25209047|NCT02705729|Methamphetamine|methamphetamine|mesh-list
24924438|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
24924812|NCT04156464|Lorazepam|lorazepam|mesh-list
25209113|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925101|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
24925102|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
24925103|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925104|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
24925105|NCT04153487|Vitamins|vitamins|mesh-ancestor
24926135|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
24524263|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24524270|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
24926992|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
24926993|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209206|NCT02704923|Atropine|atropine|mesh-list
24498508|NCT00515138|Bortezomib|bortezomib|mesh-list
24525777|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
24525935|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503863|NCT00533247|Analgesics|analgesics|mesh-ancestor
24928071|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928088|NCT04126330|Vitamins|vitamins|mesh-ancestor
24928243|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928801|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24928802|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928810|NCT04118556|Sirolimus|sirolimus|mesh-list
24527799|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527800|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
24527988|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24929039|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24929040|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929042|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
24929914|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24529295|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25209485|NCT02703272|Hormones|hormones|mesh-ancestor
24506420|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
24506707|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25209799|NCT02701179|Lidocaine|lidocaine|mesh-list
25209822|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25209823|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
25209900|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209927|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509407|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457720|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24510388|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511128|NCT00567554|Docetaxel|docetaxel|mesh-list
24511129|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24511130|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
24511131|NCT00567554|Bevacizumab|bevacizumab|mesh-list
24511132|NCT00567554|Trastuzumab|trastuzumab|mesh-list
24625405|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511571|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511572|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511576|NCT00569712|Hormones|hormones|mesh-ancestor
24456355|NCT00330993|Misoprostol|misoprostol|mesh-list
24531448|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
24512821|NCT00577018|Prucalopride|prucalopride|mesh-list
24512961|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
24512963|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24531753|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
24513490|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
24513491|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
24513979|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513980|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
24513981|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24513982|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
24669744|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669745|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24533119|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514315|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
25210346|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
24514718|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210354|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
24455954|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24455955|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24455956|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455958|NCT00329459|Sumatriptan|sumatriptan|mesh-list
24455959|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24455960|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455988|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
24455989|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456031|NCT00329680|Antioxidants|antioxidants|mesh-list
24456095|NCT00329940|Letrozole|letrozole|mesh-list
24456725|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456726|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456727|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24456728|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24456730|NCT00332072|Bimatoprost|bimatoprost|mesh-list
24456731|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24456160|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456277|NCT00330798|Analgesics|analgesics|mesh-ancestor
24456278|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
24456281|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537468|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24451485|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
24517886|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
24540166|NCT00666796|Analgesics|analgesics|mesh-ancestor
24517979|NCT00610948|Everolimus|everolimus|mesh-list
25210458|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210467|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
25210468|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
25210469|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
25210470|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210471|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25210473|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
25210479|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
25210491|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24456778|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
25210528|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25210529|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25210648|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
24422427|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210795|NCT05273632|Oxytocin|oxytocin|mesh-list
24471345|NCT00394693|Interferons|interferons|mesh-list
24471346|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
24471347|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471348|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
24471457|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24471458|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471459|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24471460|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
24471461|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24471696|NCT00396578|Gentamicins|gentamicins|mesh-list
24471697|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24471698|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210836|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24522918|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
24522919|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
24522920|NCT03044613|Paclitaxel|paclitaxel|mesh-list
24522921|NCT03044613|Carboplatin|carboplatin|mesh-list
24522922|NCT03044613|Nivolumab|nivolumab|mesh-list
24523271|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24457133|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457134|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457135|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24480041|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480043|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
24489609|NCT00474435|Efavirenz|efavirenz|mesh-list
24489610|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
24490121|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
24490122|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24490177|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24508043|NCT00553995|Analgesics|analgesics|mesh-ancestor
24508044|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
24508133|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24514321|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514323|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514324|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514325|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24514680|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24514681|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24514682|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
25211169|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211170|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523906|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25211233|NCT04662515|Dabigatran|dabigatran|mesh-list
25211234|NCT04662515|Apixaban|apixaban|mesh-list
25211235|NCT04662515|Edoxaban|edoxaban|mesh-list
24526089|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24526094|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
24526107|NCT01505608|Irinotecan|irinotecan|mesh-list
24526108|NCT01505608|Temozolomide|temozolomide|mesh-list
24526257|NCT00290511|Dexamethasone|dexamethasone|mesh-list
24531130|NCT00634205|Valproic Acid|valproic acid|mesh-list
24533167|NCT00642512|Ondansetron|ondansetron|mesh-list
24533168|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
24533169|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
24533170|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533171|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533172|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24533173|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
24533174|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
24533175|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24526589|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211425|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25211426|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25211427|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25211503|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
25211531|NCT04288206|Cefazolin|cefazolin|mesh-list
24541882|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24820379|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
25211661|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211662|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211663|NCT03936309|Lidocaine|lidocaine|mesh-list
25211664|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
24542026|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
24820536|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24528129|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25211765|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
24528254|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25211826|NCT03664180|Heparin|heparin|mesh-list
24394678|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656071|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
24656072|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542216|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
24410095|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
25211865|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25211874|NCT03563560|Analgesics|analgesics|mesh-ancestor
24821049|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
24821050|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211875|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
25211876|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211877|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24528802|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24528805|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
25212008|NCT02724878|Bevacizumab|bevacizumab|mesh-list
25212009|NCT02724878|Atezolizumab|atezolizumab|mesh-list
25212010|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25212011|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212012|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799152|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
24542871|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212059|NCT02666105|Exemestane|exemestane|mesh-list
24412806|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212303|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212304|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
25212315|NCT01946711|Budesonide|budesonide|mesh-list
24414139|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24414140|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24414142|NCT00196378|Estrogens|estrogens|mesh-list
25212318|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
25156218|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25156219|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25156220|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
25156221|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25115141|NCT03117894|Etoricoxib|etoricoxib|mesh-list
24822453|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822455|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
24414674|NCT00198393|Docetaxel|docetaxel|mesh-list
24414675|NCT00198393|Gefitinib|gefitinib|mesh-list
24414676|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414677|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
25212376|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24415510|NCT00199771|Dextrans|dextrans|mesh-list
24658791|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
24658792|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24658943|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
24658944|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658947|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24416373|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24416375|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24416376|NCT00202969|Cisplatin|cisplatin|mesh-list
24416378|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
24822778|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822779|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707369|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
24822787|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822789|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24822790|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822791|NCT02113540|Atorvastatin|atorvastatin|mesh-list
24417224|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417225|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24417226|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24417232|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417233|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417234|NCT00206050|Esomeprazole|esomeprazole|mesh-list
24417235|NCT00206050|Pantoprazole|pantoprazole|mesh-list
24417541|NCT00206765|Paroxetine|paroxetine|mesh-list
24417551|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417552|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
24659378|NCT01277185|Calcium|calcium|mesh-list
24417920|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417921|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
24544374|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212464|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212465|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212466|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212467|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
25212468|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212469|NCT00980954|Paclitaxel|paclitaxel|mesh-list
25212470|NCT00980954|Carboplatin|carboplatin|mesh-list
25212471|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25115297|NCT03116945|Gallium citrate|gallium citrate|mesh-list
24418218|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24418219|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
24418220|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418221|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418383|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418384|NCT00209495|Analgesics|analgesics|mesh-ancestor
24418385|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
24418386|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
24418458|NCT00209651|Irinotecan|irinotecan|mesh-list
24823037|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823038|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418758|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24418759|NCT00210002|Hematinics|hematinics|mesh-ancestor
24418760|NCT00210028|Tamoxifen|tamoxifen|mesh-list
24418761|NCT00210028|Tipifarnib|tipifarnib|mesh-list
24418762|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24418894|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418895|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418896|NCT00210496|Topiramate|topiramate|mesh-list
24418897|NCT00210496|Almotriptan|almotriptan|mesh-list
24418898|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
24418899|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24418900|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419987|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24419988|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24419996|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419997|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419998|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
25212546|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25212547|NCT02697162|Octenidine|octenidine|mesh-list
25212572|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25212573|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
24420498|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420499|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421917|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24421918|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
24421919|NCT00220584|Donepezil|donepezil|mesh-list
24421920|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24421942|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
24421943|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421944|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24421945|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421946|NCT00220649|Antidotes|antidotes|mesh-ancestor
24421947|NCT00220649|Protective Agents|protective agents|mesh-ancestor
24421948|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
24421950|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
24421951|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
24823626|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823627|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24823628|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
24823630|NCT02118285|Interleukin-2|interleukin-2|mesh-list
24823631|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799468|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799469|NCT01969071|Protective Agents|protective agents|mesh-ancestor
24799470|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799471|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
24799472|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
25212628|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24823722|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
24823724|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24823726|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
24823839|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
24824051|NCT02121197|Dexamethasone|dexamethasone|mesh-list
24824088|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709670|NCT01506635|Timolol|timolol|mesh-list
24423908|NCT00227409|Edetic Acid|edetic acid|mesh-list
24580497|NCT00861952|Mineral Oil|mineral oil|mesh-list
24824101|NCT02121613|Tamsulosin|tamsulosin|mesh-list
24424297|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24424298|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
24424299|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424300|NCT00228605|Fentanyl|fentanyl|mesh-list
24424301|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24424302|NCT00228605|Narcotics|narcotics|mesh-ancestor
24424303|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424304|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424305|NCT00228605|Analgesics|analgesics|mesh-ancestor
24824285|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24824286|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
24824287|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24824288|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24824289|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424547|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424548|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24424549|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212734|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25212735|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156570|NCT05007132|Trifluridine|trifluridine|mesh-list
25156571|NCT05007132|Bevacizumab|bevacizumab|mesh-list
25156572|NCT05007132|Panitumumab|panitumumab|mesh-list
25156573|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25156574|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156575|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24824314|NCT02122731|Diuretics|diuretics|mesh-ancestor
24424897|NCT00231218|Antioxidants|antioxidants|mesh-ancestor
24424916|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424931|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424932|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24425887|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
24425888|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425889|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426690|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426691|NCT00236496|Topiramate|topiramate|mesh-list
24426692|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
24426792|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25212768|NCT05367765|HH-GV-678|hh-gv-678|mesh-list
25212769|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212770|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24426941|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
24427388|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427389|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
24427407|NCT00238173|Etoposide|etoposide|mesh-list
24427413|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427414|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24427415|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24427416|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
24427513|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427803|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824793|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428089|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428090|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
24428091|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24428092|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
24428093|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24947211|NCT03931317|Timolol|timolol|mesh-list
25212805|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
25212806|NCT05367284|Testosterone|testosterone|mesh-list
25212807|NCT05367284|Androgens|androgens|mesh-ancestor
25212808|NCT05367284|Hormones|hormones|mesh-ancestor
25212809|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212810|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824811|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
24824812|NCT02125500|Ledipasvir|ledipasvir|mesh-list
24824813|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
24824814|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428740|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428741|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24775596|NCT01853709|Laxatives|laxatives|mesh-ancestor
24485314|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485315|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212961|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776098|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776099|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24776100|NCT01856621|Charcoal|charcoal|mesh-list
24776110|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
24776111|NCT01856621|Antidotes|antidotes|mesh-ancestor
25213007|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25213008|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25213009|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
25213010|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213025|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213026|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081512|NCT03329248|Avelumab|avelumab|mesh-list
25081513|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24776508|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24776695|NCT01859455|Atorvastatin|atorvastatin|mesh-list
25081533|NCT03329248|Antidotes|antidotes|mesh-ancestor
24777278|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081654|NCT03328234|Paclitaxel|paclitaxel|mesh-list
24627539|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
24777970|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
24777971|NCT01868191|Vitamins|vitamins|mesh-ancestor
25115947|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25213201|NCT05025397|Propofol|propofol|mesh-list
24778834|NCT01872754|Propofol|propofol|mesh-list
24779421|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779423|NCT01876108|Antacids|antacids|mesh-ancestor
25157167|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25081885|NCT03326596|Coagulants|coagulants|mesh-ancestor
24571765|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24627740|NCT01094626|Secretin|secretin|mesh-list
24488194|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488195|NCT00467012|Growth Substances|growth substances|mesh-ancestor
24488196|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488197|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
24780346|NCT01883882|Narcotics|narcotics|mesh-ancestor
24780420|NCT01884415|Vaccines|vaccines|mesh-list
24780697|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24627750|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
24780864|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
24780865|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
24780866|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780867|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780868|NCT01886768|Anesthetics|anesthetics|mesh-list
24780869|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780870|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780902|NCT01887197|Mannitol|mannitol|mesh-list
24489142|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
24489143|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780943|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780945|NCT01887340|Etoposide|etoposide|mesh-list
25213492|NCT04608448|Emollients|emollients|mesh-ancestor
24781366|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
24781374|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
24781425|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781567|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24781568|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489705|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24781893|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
24781894|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781897|NCT01892813|Nicotine|nicotine|mesh-list
24781898|NCT01892813|Varenicline|varenicline|mesh-list
24490093|NCT00476359|Saquinavir|saquinavir|mesh-list
24781931|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24781932|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573919|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
24782407|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782408|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782409|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782411|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24782412|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
24782492|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25213625|NCT04437329|Cisplatin|cisplatin|mesh-list
25213626|NCT04437329|Docetaxel|docetaxel|mesh-list
25213627|NCT04437329|Fluorouracil|fluorouracil|mesh-list
25213628|NCT04437329|Nedaplatin|nedaplatin|mesh-list
25213633|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213634|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
25213635|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491479|NCT00482716|Dextrans|dextrans|mesh-list
25157451|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082147|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782992|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25213749|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213750|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25213751|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25213752|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783802|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24783803|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784178|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
24533998|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24576555|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784694|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784696|NCT01910090|Famotidine|famotidine|mesh-list
24784697|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24785056|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24492991|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785789|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24785790|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24578044|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786513|NCT01920503|Doxorubicin|doxorubicin|mesh-list
24627970|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116763|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788438|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24866427|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
25214088|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214092|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
25157856|NCT04561739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788758|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24788759|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789543|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
25214212|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25214213|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157932|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790714|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
24792199|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792200|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792325|NCT05320406|Leuprolide|leuprolide|mesh-list
24535748|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792565|NCT05022342|Fulvestrant|fulvestrant|mesh-list
24494042|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494048|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
24585931|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494169|NCT00494156|Analgesics|analgesics|mesh-ancestor
24793038|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24925099|NCT04153708|Antibodies|antibodies|mesh-list
24494295|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494296|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
24494297|NCT00494741|Azathioprine|azathioprine|mesh-list
24494298|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24494299|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494575|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494576|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24494949|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494950|NCT00497562|Analgesics|analgesics|mesh-ancestor
24494972|NCT00497601|Amebicides|amebicides|mesh-ancestor
24495532|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495535|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
24495536|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804648|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24804649|NCT02004197|Amoxicillin|amoxicillin|mesh-list
24804651|NCT02004197|Bismuth|bismuth|mesh-list
24968001|NCT03755310|Suvorexant|suvorexant|mesh-list
24968002|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24495991|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24495992|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495995|NCT00502892|Topotecan|topotecan|mesh-list
24968237|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968522|NCT03750669|Folic Acid|folic acid|mesh-list
24537326|NCT00654290|Amiodarone|amiodarone|mesh-list
24968835|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
25214731|NCT02695797|Prednisolone|prednisolone|mesh-list
25214784|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214785|NCT02695459|Everolimus|everolimus|mesh-list
24969053|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24499415|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214823|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
24969208|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969209|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24969305|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24500896|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25214869|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573756|NCT00821912|Docetaxel|docetaxel|mesh-list
24500897|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24500898|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24500899|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
24500916|NCT00526214|Celecoxib|celecoxib|mesh-list
24969457|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24969458|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24969459|NCT03742466|Prednisolone|prednisolone|mesh-list
24969460|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
24969461|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24969462|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
24969463|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969464|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
24830529|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214909|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214910|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
25214911|NCT02694653|Acetaminophen|acetaminophen|mesh-list
25214912|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214913|NCT02694653|Analgesics|analgesics|mesh-ancestor
25214914|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
25214915|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214930|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214931|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25214932|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214933|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
25214989|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
25214990|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214992|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25214993|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
25214994|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214995|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
25214996|NCT02693808|Protective Agents|protective agents|mesh-ancestor
25214997|NCT02693574|Amoxicillin|amoxicillin|mesh-list
25214998|NCT02693574|Clarithromycin|clarithromycin|mesh-list
25215061|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
25272828|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501396|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24501397|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
24501419|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24501420|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24501421|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25215593|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25215641|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25215642|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215692|NCT02688907|Adavosertib|adavosertib|mesh-list
25215777|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969694|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042013|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
25042015|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25216086|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
25216087|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25216088|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
25216131|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216132|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25216133|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
25216134|NCT02686177|Metformin|metformin|mesh-list
25216135|NCT02686177|Liraglutide|liraglutide|mesh-list
25216136|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25216137|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216138|NCT02686177|Incretins|incretins|mesh-ancestor
25216139|NCT02686177|Hormones|hormones|mesh-ancestor
25216154|NCT02685852|Hormones|hormones|mesh-ancestor
24501584|NCT00529646|APD791|apd791|mesh-list
25216175|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216176|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216177|NCT02685748|Analgesics|analgesics|mesh-ancestor
24589276|NCT00906451|Simvastatin|simvastatin|mesh-list
25272853|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
25272854|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25272855|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25272856|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24969729|NCT03740386|Phentolamine|phentolamine|mesh-list
24969758|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24969759|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
25216271|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25216308|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216387|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
25216388|NCT02685059|Durvalumab|durvalumab|mesh-list
25216389|NCT02685059|Epirubicin|epirubicin|mesh-list
25216390|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25216408|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25272879|NCT02389231|Interleukin-2|interleukin-2|mesh-list
25216632|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25216785|NCT02682134|Lidocaine|lidocaine|mesh-list
25216816|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042168|NCT01493505|Carboplatin|carboplatin|mesh-list
24831337|NCT02164825|Narcotics|narcotics|mesh-ancestor
24831338|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831339|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831340|NCT02164825|Analgesics|analgesics|mesh-ancestor
24831341|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
24831435|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
24831436|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24734381|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217078|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25217080|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
25217126|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24831649|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831733|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501885|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501886|NCT00531440|Everolimus|everolimus|mesh-list
24969954|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24969955|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24501893|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501894|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24501895|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501896|NCT00531544|Sunitinib|sunitinib|mesh-list
25217343|NCT02678598|Micafungin|micafungin|mesh-list
24969978|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
24969979|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969980|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24970097|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24970098|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24970099|NCT03736161|Methotrexate|methotrexate|mesh-list
24970100|NCT03736161|Tofacitinib|tofacitinib|mesh-list
24970101|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25217392|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25217393|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25217394|NCT02678221|Analgesics|analgesics|mesh-ancestor
25217395|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
25217396|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217397|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217398|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25217399|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217400|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25217401|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25217402|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217403|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25217415|NCT02678234|Vitamins|vitamins|mesh-ancestor
25217456|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25217457|NCT02678182|Capecitabine|capecitabine|mesh-list
25217458|NCT02678182|Trastuzumab|trastuzumab|mesh-list
25217459|NCT02678182|Durvalumab|durvalumab|mesh-list
25217460|NCT02678182|Ramucirumab|ramucirumab|mesh-list
24621912|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
24502346|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502347|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502348|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24502350|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
24502351|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502352|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502353|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
24502357|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
24970247|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
24970289|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24970290|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970291|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24970300|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970301|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970302|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24939709|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
25217518|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
25217519|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25217520|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25217521|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
25217522|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
25217523|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
24794078|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794079|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24970348|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25083157|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832125|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502512|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
24970472|NCT03732703|Dexamethasone|dexamethasone|mesh-list
24970473|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
24970474|NCT03732703|Venetoclax|venetoclax|mesh-list
24970475|NCT03732703|Daratumumab|daratumumab|mesh-list
24807407|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
24970476|NCT03732703|Pomalidomide|pomalidomide|mesh-list
24970531|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24502660|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502661|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502662|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217605|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
25217606|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449220|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449221|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502690|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502691|NCT04630886|Lidocaine|lidocaine|mesh-list
24449228|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
24449229|NCT00314704|Protective Agents|protective agents|mesh-ancestor
24449230|NCT00314743|Dexamethasone|dexamethasone|mesh-list
24794159|NCT05413551|Isoniazid|isoniazid|mesh-list
24794160|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
24794161|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24794162|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794163|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24794164|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24794165|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
24794166|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794172|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794173|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24794174|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794176|NCT05413330|Triamcinolone|triamcinolone|mesh-list
25083168|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25083169|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
25083170|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25083171|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083172|NCT03317600|Lidocaine|lidocaine|mesh-list
25083173|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
25083174|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
25083175|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24794209|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794210|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24970912|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970989|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24970990|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
24970991|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24970992|NCT03729375|Bupivacaine|bupivacaine|mesh-list
24971224|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971226|NCT03727295|Idebenone|idebenone|mesh-list
25083278|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083279|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083280|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083300|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083301|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083303|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
25083305|NCT03316898|Memantine|memantine|mesh-list
25217740|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217741|NCT02675647|Heparin|heparin|mesh-list
25217742|NCT02675647|Protamines|protamines|mesh-list
25217743|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
25217759|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24794379|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25217789|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
24972213|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972214|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
24972215|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24972216|NCT03719404|Eusol|eusol|mesh-list
24546254|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
24546255|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24546256|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24832409|NCT02171494|Warfarin|warfarin|mesh-list
25217900|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
25217901|NCT02674737|Tramadol|tramadol|mesh-list
24832418|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972753|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
24972940|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24972941|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972942|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972944|NCT03713762|Fentanyl|fentanyl|mesh-list
24973201|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504746|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217962|NCT02673931|Hormones|hormones|mesh-ancestor
25217963|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547902|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547903|NCT00706680|Cyclosporine|cyclosporine|mesh-list
24832497|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832498|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
24832499|NCT02171585|Clarithromycin|clarithromycin|mesh-list
24832500|NCT02171585|Dabigatran|dabigatran|mesh-list
24973878|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24973879|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973880|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24759392|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
25218400|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25218483|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
25218484|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218485|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25218486|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25218501|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
25218504|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
25218573|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25218574|NCT02669303|Protective Agents|protective agents|mesh-ancestor
25218575|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218576|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218577|NCT02669238|Etonogestrel|etonogestrel|mesh-list
25218578|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25218579|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
25218580|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25218613|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218614|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218615|NCT02669004|Morphine|morphine|mesh-list
25083594|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
25083898|NCT03311789|Gemcitabine|gemcitabine|mesh-list
24462709|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
25218732|NCT02668172|Hormones|hormones|mesh-ancestor
25218733|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218734|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218735|NCT02667925|Cisplatin|cisplatin|mesh-list
25218748|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24628987|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24628988|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24628989|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24628990|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24443013|NCT00293475|Rituximab|rituximab|mesh-list
24628991|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084525|NCT03306446|Adalimumab|adalimumab|mesh-list
25084642|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25084643|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25084644|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25084645|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
25084646|NCT03304444|Bupivacaine|bupivacaine|mesh-list
25084647|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084699|NCT03303976|Vaccines|vaccines|mesh-list
24629172|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24629175|NCT01103518|Estrogens|estrogens|mesh-ancestor
24629177|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629180|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
24629324|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
25085110|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25085113|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
25085239|NCT03300362|Vaccines|vaccines|mesh-list
25085240|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
25085357|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25085422|NCT03298464|Pioglitazone|pioglitazone|mesh-list
25085423|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25085424|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085425|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
25085510|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25085511|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25085512|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085513|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
25085514|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25085560|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085561|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25085562|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25085563|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
25085571|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25042475|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042476|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24832695|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24832696|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
24832697|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
24832698|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24832699|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24832700|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24832701|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24832703|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
24617941|NCT01046214|Bupropion|bupropion|mesh-list
24449468|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
24449511|NCT00315874|Analgesics|analgesics|mesh-ancestor
25219262|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25042493|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
25219458|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25219459|NCT02662855|Favipiravir|favipiravir|mesh-list
25086088|NCT03292744|Vitamins|vitamins|mesh-ancestor
25273030|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25273031|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25273032|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25219695|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086517|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086518|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
25086523|NCT03288675|Serotonin|serotonin|mesh-list
25086538|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24761999|NCT01765829|Pimozide|pimozide|mesh-list
24630244|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24630255|NCT01110590|Urological Agents|urological agents|mesh-ancestor
24630256|NCT01110603|Paclitaxel|paclitaxel|mesh-list
24630449|NCT01111734|Expectorants|expectorants|mesh-ancestor
24630450|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
24630547|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24630609|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762238|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762239|NCT01767259|Diuretics|diuretics|mesh-ancestor
24762240|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
24762241|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553122|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25086808|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25086809|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25086810|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762291|NCT01767454|Ipilimumab|ipilimumab|mesh-list
24630864|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630865|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24630867|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219992|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219993|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
25086957|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25086958|NCT03284177|Calcium|calcium|mesh-list
25086959|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086960|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086961|NCT03284164|Tenofovir|tenofovir|mesh-list
25086962|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
25086963|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086964|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25086965|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25086966|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086967|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086997|NCT03283800|Copper|copper|mesh-list
25087004|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087005|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25087008|NCT03283202|Prednisone|prednisone|mesh-list
25220047|NCT02659033|Cefotaxime|cefotaxime|mesh-list
25087188|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
24437912|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087189|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25087190|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
24631224|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631236|NCT01116596|Acetaminophen|acetaminophen|mesh-list
25087244|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087245|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
24631539|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24631540|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
24631541|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505127|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25087358|NCT03279809|Aspirin|aspirin|mesh-list
25220161|NCT02658721|Analgesics|analgesics|mesh-ancestor
25087834|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087835|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220234|NCT02658396|Bortezomib|bortezomib|mesh-list
25220289|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
25220290|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220291|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25220292|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25220293|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25220294|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220295|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220309|NCT02657694|Velpatasvir|velpatasvir|mesh-list
25220310|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
25220311|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220312|NCT02657460|Cisplatin|cisplatin|mesh-list
25220313|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088356|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220434|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
25220436|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24741058|NCT01691495|PENTA|penta|mesh-list
25088641|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
25220707|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25273063|NCT02387242|Rifampin|rifampin|mesh-list
24589379|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24589380|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042682|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220830|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25220831|NCT02653742|Narcotics|narcotics|mesh-ancestor
25220832|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220833|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220849|NCT02653651|Ketamine|ketamine|mesh-list
25220850|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
25220851|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
24833026|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833027|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25088983|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089009|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089034|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089035|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089036|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089037|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089038|NCT03269591|Analgesics|analgesics|mesh-ancestor
25089039|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
25089040|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632194|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089116|NCT03268733|Folic Acid|folic acid|mesh-list
25089160|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
25089161|NCT03268278|Anesthetics|anesthetics|mesh-list
24632505|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632506|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24632507|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24632508|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
24632509|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24632510|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24632511|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24633044|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
24633045|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633046|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
24633090|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089497|NCT03265795|Ether|ether|mesh-list
25221318|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
25221319|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
25221320|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357694|NCT05407662|Diuretics|diuretics|mesh-ancestor
25221321|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25221322|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24538061|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
24538063|NCT00657410|Prednisone|prednisone|mesh-list
25221343|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221356|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
25273089|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
25221417|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24833372|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833373|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633389|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24633390|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
24633391|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633392|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633452|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633453|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633462|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24633463|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24633464|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
24633465|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633538|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24633539|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221594|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221595|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221597|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
25089633|NCT03264274|Growth Substances|growth substances|mesh-ancestor
25089634|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089635|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
25221618|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221620|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
25221622|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221626|NCT02649335|Propranolol|propranolol|mesh-list
24833767|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
24394837|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394838|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24394839|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394964|NCT00134745|Estrogens|estrogens|mesh-ancestor
25089736|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089738|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
24395178|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395248|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395249|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
24395250|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444126|NCT00296777|Citalopram|citalopram|mesh-list
24395267|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
25089752|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25089754|NCT03263208|Fludarabine|fludarabine|mesh-list
25089755|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25089756|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
24834093|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
24834182|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834183|NCT02177396|Valsartan|valsartan|mesh-list
25089779|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25089780|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25089781|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
25089783|NCT03262948|Paclitaxel|paclitaxel|mesh-list
25089853|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24396088|NCT00137787|Cefepime|cefepime|mesh-list
24834780|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24834781|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24834782|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24834924|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24396693|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24396694|NCT00139698|Diuretics|diuretics|mesh-ancestor
24982227|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982230|NCT03445858|Decitabine|decitabine|mesh-list
25089906|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
25089907|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619247|NCT01051583|Bevacizumab|bevacizumab|mesh-list
25089927|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222185|NCT02646072|Ketorolac|ketorolac|mesh-list
24397181|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
24397182|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24397208|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25090036|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547891|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
24397347|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397348|NCT00141388|Pregabalin|pregabalin|mesh-list
24397349|NCT00141388|Analgesics|analgesics|mesh-ancestor
25090081|NCT03261024|Nickel|nickel|mesh-list
25090083|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
25090084|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054761|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090101|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25042928|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25042929|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
25063153|NCT03029234|Hormones|hormones|mesh-ancestor
25054800|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
25090115|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25090116|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
24397769|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397772|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
24397773|NCT00142545|Apomorphine|apomorphine|mesh-list
24397775|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397776|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
24397777|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222408|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222409|NCT02644785|Coagulants|coagulants|mesh-ancestor
25222410|NCT02644694|Dexamethasone|dexamethasone|mesh-list
25222455|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222456|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222457|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25222458|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24835439|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24835475|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
24835512|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835513|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
24835514|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835515|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835597|NCT02183129|Diclofenac|diclofenac|mesh-list
25222598|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222600|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
25222601|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222602|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24835678|NCT02183220|Aspirin|aspirin|mesh-list
24398845|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25090258|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
25090259|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222617|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222619|NCT02644252|Protective Agents|protective agents|mesh-ancestor
25222620|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222621|NCT02644252|Vitamins|vitamins|mesh-ancestor
25222622|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
25222623|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
25222624|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
25222625|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222626|NCT02644226|Sevoflurane|sevoflurane|mesh-list
25222627|NCT02644226|Desflurane|desflurane|mesh-list
24835697|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090291|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090292|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
25090293|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090294|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25090295|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222635|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25042940|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25042955|NCT01345045|Pregabalin|pregabalin|mesh-list
25222677|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222678|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222679|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24401435|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222680|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25222690|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090455|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
25090460|NCT03257514|Vitamins|vitamins|mesh-ancestor
24835785|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
24835786|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24401827|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24835793|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402814|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25357846|NCT05404906|Azacitidine|azacitidine|mesh-list
24402815|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090596|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25090597|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
25090598|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090599|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090600|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402941|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
24402942|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402943|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402997|NCT00158990|Sertraline|sertraline|mesh-list
25090643|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25090644|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983583|NCT05183997|Verapamil|verapamil|mesh-list
25090681|NCT03254849|Empagliflozin|empagliflozin|mesh-list
25090682|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25222759|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25222760|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25222761|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222762|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222763|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
25222765|NCT02643550|Cetuximab|cetuximab|mesh-list
24403124|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403125|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
25222786|NCT02643407|Docetaxel|docetaxel|mesh-list
24403267|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403268|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222827|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24403471|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403472|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24403473|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24403474|NCT00160485|Glyburide|glyburide|mesh-list
24403475|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24403476|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403477|NCT00160498|Lercanidipine|lercanidipine|mesh-list
24403478|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24597669|NCT00950677|Exenatide|exenatide|mesh-list
24445329|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24445330|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24404361|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090806|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25090808|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24767168|NCT01799109|Albuterol|albuterol|mesh-list
24404818|NCT00164931|Omeprazole|omeprazole|mesh-list
24404819|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24404820|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24405403|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090857|NCT03253250|Adefovir|adefovir|mesh-list
25090858|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
25090859|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090860|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25090861|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24405698|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24405699|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405716|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405717|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405718|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24405719|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405943|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24405944|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24405945|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405947|NCT00168870|Treosulfan|treosulfan|mesh-list
24405948|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24406235|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24406236|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406237|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
24406704|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406807|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406808|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24407237|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
24408144|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090900|NCT03252665|Nicorandil|nicorandil|mesh-list
25090901|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
25090902|NCT03252665|Alprostadil|alprostadil|mesh-list
24408146|NCT00176735|Capecitabine|capecitabine|mesh-list
25090931|NCT03252496|Fentanyl|fentanyl|mesh-list
25223027|NCT02642263|Carbetocin|carbetocin|mesh-list
24409286|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24409313|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409314|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25091128|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
25091129|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
25091130|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25223289|NCT02640833|Venetoclax|venetoclax|mesh-list
25223312|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25223313|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25223317|NCT02640417|Vitamins|vitamins|mesh-ancestor
25223342|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223343|NCT02640365|Leucovorin|leucovorin|mesh-list
25223344|NCT02640365|Bevacizumab|bevacizumab|mesh-list
25223345|NCT02640365|Irinotecan|irinotecan|mesh-list
25223346|NCT02640365|Camptothecin|camptothecin|mesh-list
25223347|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25223348|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091254|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091255|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24446453|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25223358|NCT02640365|Antidotes|antidotes|mesh-ancestor
24984474|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24836609|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24836610|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836611|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836612|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836613|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25223554|NCT02638857|Epirubicin|epirubicin|mesh-list
25223580|NCT02638831|Ketorolac|ketorolac|mesh-list
25223582|NCT02638831|Ketoprofen|ketoprofen|mesh-list
24836734|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836736|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24836737|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
24472406|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411685|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24411686|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223793|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25223794|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
25223795|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223796|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25223797|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25223798|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
25223799|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25223800|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25223869|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
25223870|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223871|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223872|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25223873|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25223874|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
25223875|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25223876|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25273227|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106878|NCT03143933|Fentanyl|fentanyl|mesh-list
25091799|NCT03246555|Indapamide|indapamide|mesh-list
25224053|NCT02635230|Aspirin|aspirin|mesh-list
25091840|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
25091861|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25091910|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25091911|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091912|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091913|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25091915|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
25091955|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
25091956|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25091957|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25091958|NCT03245671|BB 1101|bb 1101|mesh-list
25091959|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091960|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
25091961|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
24412652|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412659|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412660|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091992|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091993|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25091994|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25092012|NCT03245333|Hormones|hormones|mesh-list
25092015|NCT03245307|Apatinib|apatinib|mesh-list
24412966|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412967|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
24412968|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412991|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412992|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413001|NCT00192842|Analgesics|analgesics|mesh-ancestor
24413002|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
24413003|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413004|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25224145|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25224146|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224148|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
25224149|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25224150|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25224151|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25224152|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
25224155|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837247|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055940|NCT03516903|Vitamins|vitamins|mesh-ancestor
25092099|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24413448|NCT00193895|Carboplatin|carboplatin|mesh-list
24413449|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413450|NCT00193921|Gemcitabine|gemcitabine|mesh-list
24413451|NCT00193921|Cisplatin|cisplatin|mesh-list
25092199|NCT03243864|Ceftazidime|ceftazidime|mesh-list
25092200|NCT03243864|Avibactam|avibactam|mesh-list
25092201|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25092202|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25092203|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092205|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092206|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413458|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413459|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413460|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413494|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
24413495|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
24413496|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413500|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
25092332|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
25092333|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092334|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25092335|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25092336|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
25092337|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092338|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092339|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25092414|NCT03241901|Lumefantrine|lumefantrine|mesh-list
25092483|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25092704|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25093010|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093011|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25093012|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
25093014|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25093018|NCT03237312|Hormones|hormones|mesh-list
25093019|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093020|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093021|NCT03237507|Paclitaxel|paclitaxel|mesh-list
25093022|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
25093023|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25093024|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758106|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
25093144|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093145|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093146|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
25093154|NCT03236961|Levofloxacin|levofloxacin|mesh-list
25093155|NCT03236961|Ertapenem|ertapenem|mesh-list
25094125|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25094315|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25224333|NCT02633696|Silymarin|silymarin|mesh-list
25094479|NCT03225924|Doxorubicin|doxorubicin|mesh-list
25095708|NCT03216876|Analgesics|analgesics|mesh-ancestor
25095821|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25095996|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096002|NCT03214653|Propofol|propofol|mesh-list
25096003|NCT03214653|Sevoflurane|sevoflurane|mesh-list
25096004|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25096005|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096006|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096007|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25096008|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
25096009|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
25096010|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25096011|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25096012|NCT03214627|Iron|iron|mesh-list
25096013|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25096014|NCT03214627|Hematinics|hematinics|mesh-list
25096015|NCT03214627|Trace Elements|trace elements|mesh-ancestor
25096016|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
25096017|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096037|NCT03214510|Fentanyl|fentanyl|mesh-list
25224447|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
25096070|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
25096071|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096072|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096073|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
25096075|NCT03214003|Etoposide|etoposide|mesh-list
25096076|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
25096077|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096078|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25096187|NCT03213548|Daminozide|daminozide|mesh-list
25096349|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25096350|NCT03212755|Antibodies|antibodies|mesh-list
25096351|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
24773075|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24773078|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
25096352|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
25096355|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25096356|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25096590|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
25096591|NCT03210558|Testosterone|testosterone|mesh-list
25096593|NCT03210558|Hormones|hormones|mesh-ancestor
25224564|NCT02632578|Vaccines|vaccines|mesh-list
25097166|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25097167|NCT03206658|Diuretics|diuretics|mesh-ancestor
25097168|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
25097169|NCT03206554|Ropivacaine|ropivacaine|mesh-list
25097170|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
25097171|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
25097172|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097173|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097269|NCT03204929|Copper|copper|mesh-list
25097272|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097733|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
25097734|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
25097735|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25097736|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
25097737|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
25098215|NCT03198403|Epinephrine|epinephrine|mesh-list
25098377|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098378|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25098692|NCT03196154|Insulin|insulin|mesh-list
25099733|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25099734|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25099735|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25099736|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
25099737|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099738|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099739|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838076|NCT02195180|Leucovorin|leucovorin|mesh-list
25099914|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25224848|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056521|NCT03511846|Capsaicin|capsaicin|mesh-list
25100891|NCT03178955|Etanercept|etanercept|mesh-list
24838271|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25101100|NCT03177720|Imipenem|imipenem|mesh-list
25101550|NCT03174041|Midazolam|midazolam|mesh-list
25102153|NCT03169959|Metformin|metformin|mesh-list
24838440|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
24838441|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838442|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102964|NCT03165123|Azithromycin|azithromycin|mesh-list
25103062|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25103067|NCT03164512|Cannabidiol|cannabidiol|mesh-list
25225108|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103597|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103928|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104768|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
25104871|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104872|NCT03150316|Dexamethasone|dexamethasone|mesh-list
25104873|NCT03150316|Lenalidomide|lenalidomide|mesh-list
25225265|NCT02628197|Vitamin D|vitamin d|mesh-list
24975521|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
24975522|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
24975523|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975634|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975635|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24975636|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
24431803|NCT00252928|Troclosene|troclosene|mesh-list
24975848|NCT02836899|Protective Agents|protective agents|mesh-ancestor
24975850|NCT02824575|Rebastinib|rebastinib|mesh-list
24975852|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795091|NCT03726229|Cholic Acids|cholic acids|mesh-list
24976179|NCT00673010|Iodine|iodine|mesh-list
24976550|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976551|NCT03171480|Isosorbide|isosorbide|mesh-list
24976665|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976666|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976667|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
24976668|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976669|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976693|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24976694|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976695|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414642|NCT00198354|Gemcitabine|gemcitabine|mesh-list
24976790|NCT05200312|Lenalidomide|lenalidomide|mesh-list
24839240|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24839242|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839252|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24977311|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24977360|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
24977361|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977362|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24977363|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24977364|NCT01673867|Docetaxel|docetaxel|mesh-list
24977365|NCT01673867|Nivolumab|nivolumab|mesh-list
24977366|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977367|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977368|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977369|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977370|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977371|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977372|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24977373|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24977374|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24977375|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977376|NCT01182727|Analgesics|analgesics|mesh-ancestor
24795219|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24795220|NCT03578276|Analgesics|analgesics|mesh-ancestor
24977722|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977794|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977795|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
24977796|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
24977797|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977798|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24415208|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
24415210|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415221|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
24415222|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415228|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24415229|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415257|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415258|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24415259|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
24415260|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415261|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415300|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415301|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415302|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24415303|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415305|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
24415306|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415307|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415677|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415686|NCT00200512|Emetics|emetics|mesh-ancestor
25225677|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225678|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225684|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
25225685|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
25225686|NCT02625376|Resveratrol|resveratrol|mesh-list
25225687|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
25225688|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839405|NCT02203643|Growth Substances|growth substances|mesh-ancestor
24839406|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
24839407|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
24839408|NCT02203656|Testosterone|testosterone|mesh-list
24839409|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
24839410|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
24839411|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24778467|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
24416374|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
24416382|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416383|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977963|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24977995|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24978003|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24978004|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
24978005|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24458269|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458272|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
24417186|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417187|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25225721|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225722|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
25225723|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
25225724|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225725|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
25225726|NCT02624973|Tamoxifen|tamoxifen|mesh-list
25225727|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
25225728|NCT02624973|Docetaxel|docetaxel|mesh-list
25225735|NCT02624973|Goserelin|goserelin|mesh-list
25225736|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225737|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
25225738|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358295|NCT05391750|Venetoclax|venetoclax|mesh-list
25225739|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839450|NCT02204501|Midazolam|midazolam|mesh-list
24839451|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24839452|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24978054|NCT05179512|Fluticasone|fluticasone|mesh-list
24839488|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839490|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839491|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
24839492|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839493|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24839494|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839495|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839500|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839502|NCT02204852|Eptifibatide|eptifibatide|mesh-list
24839503|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24839504|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
24839505|NCT02204878|Parecoxib|parecoxib|mesh-list
24839506|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25057152|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25057154|NCT03507166|Trastuzumab|trastuzumab|mesh-list
24417405|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24978127|NCT05178745|Fluorouracil|fluorouracil|mesh-list
24978129|NCT05178745|Aflibercept|aflibercept|mesh-list
24978130|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
24417425|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
24417426|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
24417427|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417509|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417510|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24417511|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
24417513|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
24417514|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417515|NCT00206661|Molgramostim|molgramostim|mesh-list
24417516|NCT00206661|Sargramostim|sargramostim|mesh-list
24417517|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
24417518|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417519|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417520|NCT00206674|Sargramostim|sargramostim|mesh-list
24417521|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
24417522|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417523|NCT00206700|Sargramostim|sargramostim|mesh-list
24417849|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
24417850|NCT00208117|Sertraline|sertraline|mesh-list
24417851|NCT00208117|Simvastatin|simvastatin|mesh-list
24417852|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24417853|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24417854|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
24417855|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417856|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24417858|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417897|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417960|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24991341|NCT05194904|Ketorolac|ketorolac|mesh-list
24418088|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
25225789|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
25225790|NCT02624726|Vitamins|vitamins|mesh-ancestor
25225791|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
25225792|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24839518|NCT02205034|Oxytocin|oxytocin|mesh-list
24839519|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
24839520|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24839521|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839522|NCT02205112|Levofloxacin|levofloxacin|mesh-list
24839523|NCT02205112|Ofloxacin|ofloxacin|mesh-list
24418089|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418191|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
24418192|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
24418193|NCT00208858|Topiramate|topiramate|mesh-list
24418194|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
24783654|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105720|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25105721|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105722|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
24418295|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24418396|NCT00209521|Fospropofol|fospropofol|mesh-list
24418397|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25225829|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225830|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
25225831|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25225832|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225834|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
25225845|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25225847|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225848|NCT02624453|Fluconazole|fluconazole|mesh-list
24839562|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24839563|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839565|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24839567|NCT02205255|Azithromycin|azithromycin|mesh-list
24533877|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25225869|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701908|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
24701909|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25225885|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225886|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225887|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24533986|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24533987|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534051|NCT00645892|Adalimumab|adalimumab|mesh-list
24534052|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534053|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534054|NCT00645905|Adalimumab|adalimumab|mesh-list
24534055|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449814|NCT00317096|Rituximab|rituximab|mesh-list
24534206|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24534207|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
24534208|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534209|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534210|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24534212|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
24839629|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534236|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24534237|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
24785509|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273311|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
25273312|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273313|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24534292|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24991637|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24991638|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24534430|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
24534546|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24534547|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24534548|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534549|NCT00647608|Propranolol|propranolol|mesh-list
24534592|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24460001|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25226045|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25226046|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857496|NCT02292069|Atorvastatin|atorvastatin|mesh-list
25226065|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226066|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226067|NCT02623036|Enalapril|enalapril|mesh-list
25226068|NCT02623036|Lisinopril|lisinopril|mesh-list
25226069|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25226070|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
25226071|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226078|NCT02623231|Citalopram|citalopram|mesh-list
25226079|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24534745|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24534746|NCT00647920|Adalimumab|adalimumab|mesh-list
24991911|NCT04731233|Triamcinolone|triamcinolone|mesh-list
25226110|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25226111|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226112|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
25226113|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25226114|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24811695|NCT02047799|Vitamins|vitamins|mesh-ancestor
25226164|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839923|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
25226195|NCT02622126|Atropine|atropine|mesh-list
25226196|NCT02622126|Ephedrine|ephedrine|mesh-list
25226197|NCT02622126|Morphine|morphine|mesh-list
25226256|NCT02621970|Cisplatin|cisplatin|mesh-list
25226257|NCT02621970|Docetaxel|docetaxel|mesh-list
25226258|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226259|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
25226260|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
25226261|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
25226263|NCT02621905|Itraconazole|itraconazole|mesh-list
25226301|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25226302|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
25226303|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
25226304|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
25226305|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
25226306|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534995|NCT00648388|Protective Agents|protective agents|mesh-ancestor
24534996|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25043427|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226426|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25226427|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25226428|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
24840536|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
25226545|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226546|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25226547|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25226548|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25226549|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24840675|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25226579|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226580|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226581|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25226582|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25226583|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24840820|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24840873|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043496|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043497|NCT01253603|Fluticasone|fluticasone|mesh-list
25043499|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
24535550|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535601|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452515|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24452516|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535936|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226762|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
25226763|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226764|NCT02619032|Fentanyl|fentanyl|mesh-list
25226765|NCT02619032|Remifentanil|remifentanil|mesh-list
25226766|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226767|NCT02619032|Narcotics|narcotics|mesh-ancestor
24841286|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460243|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24797788|NCT01958138|Propofol|propofol|mesh-list
25226897|NCT02617862|Anesthetics|anesthetics|mesh-list
25226905|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
25226906|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
25226907|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
25226988|NCT02617485|Rituximab|rituximab|mesh-list
25226989|NCT02617485|Doxorubicin|doxorubicin|mesh-list
25226990|NCT02617485|Vincristine|vincristine|mesh-list
25226992|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
25227023|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227025|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25227026|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24841723|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24841783|NCT02217956|Bevacizumab|bevacizumab|mesh-list
24841811|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
25043646|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043647|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058236|NCT03498261|Gabapentin|gabapentin|mesh-list
24857818|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
25273369|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842139|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842147|NCT02219789|Fulvestrant|fulvestrant|mesh-list
25058335|NCT03497715|Ibuprofen|ibuprofen|mesh-list
24539108|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539109|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540814|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24541315|NCT00672295|Paclitaxel|paclitaxel|mesh-list
25227336|NCT02615223|Hormones|hormones|mesh-list
25227360|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
25227362|NCT02615301|Vitamins|vitamins|mesh-list
25227427|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227428|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
25227449|NCT02614456|Interferons|interferons|mesh-list
25227450|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
25227451|NCT02614456|Nivolumab|nivolumab|mesh-list
25227452|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25227453|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227454|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25227455|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542662|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24542730|NCT00680134|Tavaborole|tavaborole|mesh-list
24542919|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543003|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543004|NCT00681525|Atorvastatin|atorvastatin|mesh-list
24543005|NCT00681525|Ezetimibe|ezetimibe|mesh-list
24543006|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
25227643|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
25227644|NCT02612896|Praziquantel|praziquantel|mesh-list
25227645|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
25273377|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25273378|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
25273379|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273381|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
25273382|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
25273383|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273384|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842929|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
24842934|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
25227728|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543160|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
25227800|NCT02612207|Bilirubin|bilirubin|mesh-list
25227834|NCT02612220|Hemostatics|hemostatics|mesh-list
25227835|NCT02612220|Coagulants|coagulants|mesh-ancestor
25227836|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25227856|NCT02611700|Cisplatin|cisplatin|mesh-list
25227857|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
25227858|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25227859|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227860|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25227861|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25227862|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843157|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
25227882|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227883|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227885|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
25227912|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
25227913|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25227914|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25227955|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
25227956|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25227957|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25227958|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108133|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
25227986|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25227987|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
25227988|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227989|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227990|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
25227991|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25227992|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25273391|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273392|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273393|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273394|NCT02385500|Urological Agents|urological agents|mesh-ancestor
25273396|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
25273397|NCT02385474|Protective Agents|protective agents|mesh-ancestor
25273399|NCT02385461|Heparin|heparin|mesh-list
25228040|NCT02610556|Cisplatin|cisplatin|mesh-list
25228041|NCT02610556|Docetaxel|docetaxel|mesh-list
24843565|NCT02228135|Hormones|hormones|mesh-ancestor
24843566|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843567|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25228128|NCT02609646|Piperacillin|piperacillin|mesh-list
25228129|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25228130|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24995651|NCT04961593|Caspofungin|caspofungin|mesh-list
24995655|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108138|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24995656|NCT04961580|Ceftazidime|ceftazidime|mesh-list
24869742|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24869743|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25228131|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228153|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25228154|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228158|NCT02609698|Aspirin|aspirin|mesh-list
24543991|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843732|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843734|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843735|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843736|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843801|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
25228294|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544171|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
24858006|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25228302|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
25228303|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25228305|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24544244|NCT00688077|Katacalcin|katacalcin|mesh-list
24996024|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447159|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447160|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24447161|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
24447174|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858023|NCT02294656|Ranibizumab|ranibizumab|mesh-list
25228472|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228473|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25228474|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
25228475|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
25228476|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228477|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228478|NCT02607774|Midazolam|midazolam|mesh-list
25228479|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25228480|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25228483|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25228577|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544715|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24858045|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228724|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228725|NCT02606409|Analgesics|analgesics|mesh-ancestor
25228726|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
25228727|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228728|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24844297|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043836|NCT01194960|Docetaxel|docetaxel|mesh-list
24544994|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544995|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228977|NCT02604992|Analgesics|analgesics|mesh-ancestor
24858206|NCT02295826|Dabigatran|dabigatran|mesh-list
24858309|NCT02296281|Analgesics|analgesics|mesh-ancestor
24858310|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
24858311|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858312|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844667|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844668|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844669|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24828406|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24828779|NCT02147678|Propofol|propofol|mesh-list
24844670|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24829132|NCT02150031|Epinephrine|epinephrine|mesh-list
24829133|NCT02150031|Racepinephrine|racepinephrine|mesh-list
24829134|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
24829135|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
24829136|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
24829137|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829138|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829139|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
24416109|NCT00202020|Cilostazol|cilostazol|mesh-list
25125802|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25125803|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25125804|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
25125805|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498950|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25125808|NCT03066466|Tacrolimus|tacrolimus|mesh-list
24434764|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
24434765|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435106|NCT00265031|Hormones|hormones|mesh-ancestor
24441560|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441561|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441562|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125935|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125937|NCT03065816|Antacids|antacids|mesh-ancestor
25125939|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25126016|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25126017|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460824|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25126102|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24552021|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24552350|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126588|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126634|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
24553635|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126908|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25127148|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25127224|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
24554863|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24554885|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
24554886|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554887|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554888|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24554889|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
24554890|NCT00738621|Hormones|hormones|mesh-ancestor
24555086|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25127357|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
25127358|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127359|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127360|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127361|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127362|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24555136|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24555137|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555185|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555231|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555232|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
24555233|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24555234|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24555235|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24555608|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555609|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
24555610|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24555611|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
24555613|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555648|NCT00742404|Hormones|hormones|mesh-ancestor
24556340|NCT00747110|Hormones|hormones|mesh-ancestor
24556366|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556367|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127446|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25127447|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
25127448|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556694|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556695|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
24556696|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556697|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556699|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24556700|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
24556701|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556819|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24556820|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24556821|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556822|NCT00749736|Vitamins|vitamins|mesh-ancestor
24556823|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
24556825|NCT00749814|Melatonin|melatonin|mesh-list
24557000|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
25127492|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25127494|NCT03055247|Analgesics|analgesics|mesh-ancestor
25127495|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
25127496|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127497|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127498|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127499|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557718|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557737|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557738|NCT00753740|Camptothecin|camptothecin|mesh-list
24557758|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
24557759|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24557760|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
24557761|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557762|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
24558326|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
24558327|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558328|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558329|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
24558330|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558331|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24558332|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25127685|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
25127686|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
25127689|NCT03053869|Diazepam|diazepam|mesh-list
25127925|NCT03051906|Durvalumab|durvalumab|mesh-list
25128303|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128304|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128305|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128306|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25129171|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25129172|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25129173|NCT03042871|Growth Substances|growth substances|mesh-ancestor
25129174|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129177|NCT03042546|Calcium|calcium|mesh-list
25129299|NCT03042013|Naquotinib|naquotinib|mesh-list
25129369|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25129511|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
24564503|NCT00776633|Aspirin|aspirin|mesh-list
25129859|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129860|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
25129861|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129862|NCT03037775|Nicotine|nicotine|mesh-list
25130131|NCT03036059|Ivermectin|ivermectin|mesh-list
25130756|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
24570278|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
24570279|NCT00804206|Bevacizumab|bevacizumab|mesh-list
24571153|NCT00808314|Regadenoson|regadenoson|mesh-list
25131729|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
25131731|NCT03023904|Nivolumab|nivolumab|mesh-list
25132213|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25132212|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
25132293|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
24574942|NCT00828776|Heparin|heparin|mesh-list
25133327|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133328|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133329|NCT03013322|Miotics|miotics|mesh-ancestor
25133330|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
25133331|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133332|NCT03013361|Bupivacaine|bupivacaine|mesh-list
24577105|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577128|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577129|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24577130|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
25133737|NCT03010579|Hematinics|hematinics|mesh-list
25133877|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25134359|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
25134544|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
25134545|NCT03005496|Hormones|hormones|mesh-ancestor
25134546|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578155|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
24578192|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
24578198|NCT00847314|Hormones|hormones|mesh-ancestor
25135625|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135659|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135663|NCT02996409|Lidocaine|lidocaine|mesh-list
25045874|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045875|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045877|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
25045881|NCT00902291|Gemcitabine|gemcitabine|mesh-list
25135731|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
25135732|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135733|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25137141|NCT02986503|Cisplatin|cisplatin|mesh-list
24580512|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580513|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137227|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137228|NCT02986594|Analgesics|analgesics|mesh-ancestor
25137385|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
25137448|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25137653|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137654|NCT02983214|Cilostazol|cilostazol|mesh-list
25137655|NCT02983214|Clopidogrel|clopidogrel|mesh-list
25137656|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25137657|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25137665|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
25137741|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25137742|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
24584585|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137829|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24586309|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24586385|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
24587425|NCT00894920|Biotin|biotin|mesh-list
24591030|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591031|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24591780|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591782|NCT00918593|Bleomycin|bleomycin|mesh-list
24593833|NCT00931138|Cytarabine|cytarabine|mesh-list
24597085|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24597290|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
24597485|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597528|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597530|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
24597573|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600299|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24600301|NCT01155388|Trace Elements|trace elements|mesh-ancestor
25138873|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25138874|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25138875|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25358902|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25138876|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138877|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25138878|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25138989|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
25138990|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
25138991|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25138992|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25138993|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046438|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
25139059|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861404|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24861405|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
24861406|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541674|NCT00674557|Growth Substances|growth substances|mesh-ancestor
24541675|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
24813697|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
24813698|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813700|NCT02059967|Carboplatin|carboplatin|mesh-list
24813701|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24813702|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139109|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139110|NCT02973620|Protective Agents|protective agents|mesh-ancestor
25139113|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
24444159|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24444160|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24444161|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24444162|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
24863556|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863558|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139158|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139160|NCT02973204|Sorafenib|sorafenib|mesh-list
25139161|NCT02973204|Octreotide|octreotide|mesh-list
25139162|NCT02973204|Lanreotide|lanreotide|mesh-list
25139163|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139181|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25139182|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25139183|NCT02972918|Simendan|simendan|mesh-list
25139184|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25139185|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
25139186|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24863668|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863669|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24863670|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
24863671|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863672|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863674|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
24863675|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
24863676|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863690|NCT03749616|Ibuprofen|ibuprofen|mesh-list
24863773|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25046471|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25046472|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
25046473|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046474|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046475|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813731|NCT02060032|Simvastatin|simvastatin|mesh-list
24813732|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24813733|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24813740|NCT02060149|Sulbactam|sulbactam|mesh-list
25139399|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
25139400|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863878|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863883|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863901|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863903|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25139441|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25139442|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25139443|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861889|NCT02321267|Aflibercept|aflibercept|mesh-list
24464113|NCT00363376|Olanzapine|olanzapine|mesh-list
24444917|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444919|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864134|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864135|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864137|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
24531322|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445076|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445077|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445078|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
24445079|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445080|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24445081|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
24544393|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544394|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
24544395|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544396|NCT00688896|Pravastatin|pravastatin|mesh-list
24544397|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
24864463|NCT04062279|Autoantibodies|autoantibodies|mesh-list
24864524|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24864525|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046517|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046519|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046520|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046521|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046522|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046523|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25139545|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139546|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139547|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25139548|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25139549|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25139550|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139551|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25139552|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25139554|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
24864990|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864998|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
24864999|NCT04989322|Pemetrexed|pemetrexed|mesh-list
24865000|NCT04989322|Lenvatinib|lenvatinib|mesh-list
25139611|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
25139612|NCT02970084|Vitamins|vitamins|mesh-ancestor
25139613|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
25139614|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139615|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24544925|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24544926|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544927|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544928|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
24544929|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139655|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139657|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25139658|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25139659|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24669252|NCT04164212|Vaccines|vaccines|mesh-list
24545080|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445955|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
24865449|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865451|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24865452|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865453|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24865454|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545352|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359073|NCT05371093|Prednisone|prednisone|mesh-list
24445989|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24445990|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
24445996|NCT00303524|Goserelin|goserelin|mesh-list
24814104|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24545602|NCT00694005|Sirolimus|sirolimus|mesh-list
25046568|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046569|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046571|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464599|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24866097|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24866098|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25046585|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046600|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
25046601|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25046602|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046603|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046604|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25046605|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046606|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046607|NCT00840073|Trandolapril|trandolapril|mesh-list
25139740|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25139741|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25139742|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
25139743|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
25139744|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810546|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
24606059|NCT00988780|Efavirenz|efavirenz|mesh-list
25139820|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139821|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25139822|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25139824|NCT02968498|Lactulose|lactulose|mesh-list
25139825|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25139826|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25139827|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139828|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
25139829|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
24866566|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
24688779|NCT02666794|Dsuvia|dsuvia|mesh-list
24866889|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866890|NCT04107038|Anesthetics|anesthetics|mesh-list
24866893|NCT03993717|Vaccines|vaccines|mesh-list
24867202|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446231|NCT00304200|Sunitinib|sunitinib|mesh-list
24867250|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24867252|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24867253|NCT02549092|Levodopa|levodopa|mesh-list
24867254|NCT02549092|Carbidopa|carbidopa|mesh-list
25139938|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25139939|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
24628650|NCT01100294|Vaccines|vaccines|mesh-list
25140096|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25140097|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
25140098|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
25140099|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25140100|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140101|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25140116|NCT02966665|Vitamins|vitamins|mesh-list
24868213|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868214|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24868215|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868217|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868247|NCT01489813|Genistein|genistein|mesh-list
24868248|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24548419|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
24548420|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
25046755|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25046756|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25046757|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046758|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046759|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
25046760|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25046761|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868956|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140381|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
25140382|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24869414|NCT03915860|Trifarotene|trifarotene|mesh-list
24869831|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870570|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870571|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25046837|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046838|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140633|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25141008|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
25141011|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141079|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
25141081|NCT02959762|Vitamin K|vitamin k|mesh-list
25089838|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25141234|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25141282|NCT02958566|Lidocaine|lidocaine|mesh-list
25141283|NCT02958566|Fentanyl|fentanyl|mesh-list
25141284|NCT02958566|Ketamine|ketamine|mesh-list
24879182|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
24879183|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
25141365|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141366|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24476539|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24476540|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476541|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24476542|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
25047020|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25141462|NCT02957851|Analgesics|analgesics|mesh-ancestor
25141565|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
25141861|NCT02954029|Hemostatics|hemostatics|mesh-list
25141862|NCT02954029|Coagulants|coagulants|mesh-ancestor
24880501|NCT03621553|Vitamin D|vitamin d|mesh-list
25141914|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
25141915|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
25141917|NCT02953457|Durvalumab|durvalumab|mesh-list
25141980|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141981|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047148|NCT00833495|Prednisolone|prednisolone|mesh-list
25142143|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
25142144|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25142145|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142146|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25142147|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142148|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
25142149|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
25142211|NCT02951975|Dexamethasone|dexamethasone|mesh-list
25142212|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142213|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
25142214|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
25142215|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142216|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142217|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142218|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
25142219|NCT02951975|Hormones|hormones|mesh-ancestor
25142220|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047207|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047210|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
25047211|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047212|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25047213|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
25047214|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470938|NCT00392522|Analgesics|analgesics|mesh-ancestor
24881524|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24881525|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24881564|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881565|NCT02101853|Antidotes|antidotes|mesh-ancestor
24881566|NCT02101853|Protective Agents|protective agents|mesh-ancestor
24881567|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
25142308|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142309|NCT02951039|Edoxaban|edoxaban|mesh-list
25142310|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25142311|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
25142391|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25142392|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25142393|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142394|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142395|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142397|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142398|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142399|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
25047257|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047258|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
25142427|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25142428|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142429|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142441|NCT02949895|Etoposide|etoposide|mesh-list
25142490|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142591|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25142592|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
25142593|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142594|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142595|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142596|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25142597|NCT02948283|Metformin|metformin|mesh-list
25142598|NCT02948283|Ritonavir|ritonavir|mesh-list
25142663|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25142664|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142665|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142666|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25142668|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
24881775|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142776|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142778|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25142779|NCT02947243|Narcotics|narcotics|mesh-ancestor
25142780|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142781|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882350|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882351|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882352|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
24882353|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882354|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24882355|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
25142840|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142841|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25142842|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
25142843|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142844|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142845|NCT02946801|Listerine|listerine|mesh-list
25142846|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
25142849|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
25142914|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142915|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882695|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24882697|NCT05111912|Hormones|hormones|mesh-ancestor
24471600|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25142916|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
25142917|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882843|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24882844|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705168|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
24882845|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24882846|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882847|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
24882848|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25142934|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142939|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
25047284|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25047290|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047291|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
25047292|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047294|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25047295|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
25359282|NCT05366868|Metformin|metformin|mesh-list
25047296|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047297|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047298|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25047299|NCT00829504|Ropinirole|ropinirole|mesh-list
25047300|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25047313|NCT00829426|Alprazolam|alprazolam|mesh-list
24883147|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142947|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24883309|NCT03991403|Carboplatin|carboplatin|mesh-list
24883310|NCT03991403|Pemetrexed|pemetrexed|mesh-list
24883311|NCT03991403|Atezolizumab|atezolizumab|mesh-list
24883312|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24816246|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25143275|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143331|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143332|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143333|NCT02943369|Ticagrelor|ticagrelor|mesh-list
25143334|NCT02943369|Cangrelor|cangrelor|mesh-list
25143344|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143345|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143346|NCT02943642|Vorinostat|vorinostat|mesh-list
25143359|NCT02943252|Tegafur|tegafur|mesh-list
25143457|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
25047369|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25143597|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143674|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25143675|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143676|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
25143677|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
25143678|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
25143682|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
25143822|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25143823|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
25143824|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
25143825|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143826|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25143827|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25143834|NCT02940535|Menotropins|menotropins|mesh-list
25144470|NCT02935764|Vitamins|vitamins|mesh-ancestor
25144840|NCT02934204|Temozolomide|temozolomide|mesh-list
25145016|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145017|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25145018|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25145019|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505251|NCT00540787|Quinidine|quinidine|mesh-list
25047659|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145503|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145504|NCT02929121|Doxycycline|doxycycline|mesh-list
25145505|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24506145|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
24506147|NCT00544219|Doxorubicin|doxorubicin|mesh-list
24506148|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25145579|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145581|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145661|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25145662|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25145663|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047726|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24487938|NCT00465751|Cathartics|cathartics|mesh-ancestor
24507774|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146588|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146589|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25146783|NCT02919072|Ropivacaine|ropivacaine|mesh-list
25147506|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25148324|NCT05214976|Paclitaxel|paclitaxel|mesh-list
25048326|NCT00711555|Aprepitant|aprepitant|mesh-list
25048403|NCT00708292|Hormones|hormones|mesh-ancestor
24798256|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798258|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24798259|NCT01961856|Clopidogrel|clopidogrel|mesh-list
24798260|NCT01961856|Ticagrelor|ticagrelor|mesh-list
25151124|NCT04885686|Thymol|thymol|mesh-list
25152466|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25153803|NCT02226276|Maytansine|maytansine|mesh-list
24986282|NCT02004275|Hormones|hormones|mesh-ancestor
24803888|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24998310|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998311|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998312|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24542710|NCT00679900|SR 46349B|sr 46349b|mesh-list
24949288|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949596|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949598|NCT04375033|Analgesics|analgesics|mesh-ancestor
24949599|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
24949600|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509537|NCT00560924|Hormones|hormones|mesh-ancestor
25061171|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
24772561|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772578|NCT01834508|Entecavir|entecavir|mesh-list
24772579|NCT01834508|Adefovir|adefovir|mesh-list
25068827|NCT03431649|Beraprost|beraprost|mesh-list
24798459|NCT01963754|Carticaine|carticaine|mesh-list
25003205|NCT03924986|Cisplatin|cisplatin|mesh-list
25003703|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24885344|NCT00225095|Protective Agents|protective agents|mesh-ancestor
24885346|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24850763|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24510813|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24510814|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24986706|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861318|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
24861321|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24796428|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
24796430|NCT01949935|Mupirocin|mupirocin|mesh-list
24990473|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24994567|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24997253|NCT05279898|Narcotics|narcotics|mesh-ancestor
25108204|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
24464485|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24511024|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511050|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
24816449|NCT02077010|Milrinone|milrinone|mesh-list
24845870|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845871|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24868082|NCT03829462|Irinotecan|irinotecan|mesh-list
24868083|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24814975|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24815530|NCT02070796|Rotigotine|rotigotine|mesh-list
24815531|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
24815532|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
24815533|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815534|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815535|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815536|NCT02071004|Aspirin|aspirin|mesh-list
24885805|NCT04537026|Dexamethasone|dexamethasone|mesh-list
24889275|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24878526|NCT01582191|Everolimus|everolimus|mesh-list
24879317|NCT04862338|Niacin|niacin|mesh-list
24900147|NCT04397549|Narcotics|narcotics|mesh-ancestor
24880342|NCT03829371|Prednisone|prednisone|mesh-list
24880343|NCT03829371|Lenalidomide|lenalidomide|mesh-list
24957326|NCT03845049|Aflibercept|aflibercept|mesh-list
24960190|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
24963481|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24963482|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24963483|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
24511865|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24511866|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
24965933|NCT03772613|Heparin|heparin|mesh-list
24763391|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765146|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512616|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512617|NCT00575874|Pioglitazone|pioglitazone|mesh-list
24512618|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24512620|NCT00575913|Alfuzosin|alfuzosin|mesh-list
24888334|NCT04506125|Analgesics|analgesics|mesh-ancestor
24888335|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
24888336|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818313|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24966374|NCT03768713|Suvorexant|suvorexant|mesh-list
24766628|NCT01795794|Omeprazole|omeprazole|mesh-list
24767209|NCT01799317|Vitamin D|vitamin d|mesh-list
24767763|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
24768043|NCT01805453|Losartan|losartan|mesh-list
25080625|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
24513268|NCT00580320|Dacarbazine|dacarbazine|mesh-list
24467640|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24620467|NCT01057264|Paclitaxel|paclitaxel|mesh-list
24769696|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24769698|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769700|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24769701|NCT01815268|Vaccines|vaccines|mesh-list
24769702|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
24769703|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769704|NCT01815294|Doxorubicin|doxorubicin|mesh-list
24769705|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24769706|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24907693|NCT04328493|Amebicides|amebicides|mesh-ancestor
24891138|NCT04475887|Iron|iron|mesh-list
24770853|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24770854|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24770855|NCT01822808|Hydralazine|hydralazine|mesh-list
24770856|NCT01822808|Isosorbide|isosorbide|mesh-list
24770857|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24891235|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
24774430|NCT01845493|Sulforaphane|sulforaphane|mesh-list
25081548|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893206|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24570220|NCT00803868|Varenicline|varenicline|mesh-list
25081827|NCT03326960|Propofol|propofol|mesh-list
24572543|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784311|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
24787448|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24788263|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
24788264|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24788265|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24788266|NCT01930552|Growth Substances|growth substances|mesh-ancestor
24788267|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
24788269|NCT01930591|Ticagrelor|ticagrelor|mesh-list
24790518|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082585|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24791339|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
24791340|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550681|NCT00721747|Doxorubicin|doxorubicin|mesh-list
24791900|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
24793752|NCT02542696|Emetics|emetics|mesh-ancestor
24968675|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
24973646|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24973647|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085331|NCT03299036|Doxorubicin|doxorubicin|mesh-list
25087457|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087459|NCT03279341|Cathartics|cathartics|mesh-ancestor
25087578|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25087579|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
25087580|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25087581|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416676|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087604|NCT03278431|Oxantel|oxantel|mesh-list
25087772|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
25087773|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087774|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087775|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
25087776|NCT03276832|Imiquimod|imiquimod|mesh-list
24763316|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
25089123|NCT03269162|Pemetrexed|pemetrexed|mesh-list
25091198|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25091199|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25092230|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092231|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25092381|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092383|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25092384|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
25092860|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092861|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25092862|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
25092863|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092889|NCT03238612|Clarithromycin|clarithromycin|mesh-list
25093040|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
25093267|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25093268|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
25093269|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
25093270|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
25093271|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24896321|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24896322|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420586|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24420587|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25359515|NCT05362916|Letermovir|letermovir|mesh-list
24896323|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
24896324|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24896325|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896326|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093662|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770182|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093663|NCT03232957|Morphine|morphine|mesh-list
25093664|NCT03232957|Bupivacaine|bupivacaine|mesh-list
25093665|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
25093666|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
25093667|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093668|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093669|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
24896591|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896592|NCT04434404|Protective Agents|protective agents|mesh-ancestor
24473685|NCT00403806|BB 1101|bb 1101|mesh-list
24421929|NCT00220649|Leucovorin|leucovorin|mesh-list
25094438|NCT03226340|Diuretics|diuretics|mesh-ancestor
25094439|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
24457068|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094593|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24896685|NCT04434170|Valsartan|valsartan|mesh-list
25094933|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095171|NCT03220490|Timolol|timolol|mesh-list
25095769|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24772531|NCT01834209|Prednisone|prednisone|mesh-list
25095998|NCT03214770|Calcium|calcium|mesh-list
24423179|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
25097595|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
25097596|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
25098124|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
25098632|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24516721|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897368|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897370|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24474461|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
24474463|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099660|NCT03188198|Etoposide|etoposide|mesh-list
25099661|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
25099662|NCT03188198|Vincristine|vincristine|mesh-list
25099686|NCT03188289|Chitosan|chitosan|mesh-list
24425703|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25099882|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099891|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
25099892|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099893|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
25099894|NCT03186755|Protective Agents|protective agents|mesh-ancestor
24503582|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
24424316|NCT00228852|Fludarabine|fludarabine|mesh-list
25100747|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100748|NCT03180125|Lidocaine|lidocaine|mesh-list
25100749|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
25100750|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100751|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
25100752|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101303|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101304|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25101305|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
25101309|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
25101310|NCT03175666|Bevacizumab|bevacizumab|mesh-list
25101311|NCT03175666|Fluorouracil|fluorouracil|mesh-list
25101312|NCT03175666|Capecitabine|capecitabine|mesh-list
25101716|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25101897|NCT03171831|Tacrolimus|tacrolimus|mesh-list
25102022|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102023|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102024|NCT03171220|Analgesics|analgesics|mesh-ancestor
25102025|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
24475755|NCT00411320|Dexamethasone|dexamethasone|mesh-list
25102497|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24428514|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102498|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
25102594|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25102595|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
25102596|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102597|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
25102598|NCT03167333|Protective Agents|protective agents|mesh-ancestor
25102599|NCT03167372|Imidacloprid|imidacloprid|mesh-list
24780134|NCT01881997|Fentanyl|fentanyl|mesh-list
25069197|NCT03428373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394688|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
24394689|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
24394690|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394691|NCT00134030|Interferons|interferons|mesh-list
24394692|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
24395233|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395234|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395235|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
24395236|NCT00135499|Hormones|hormones|mesh-ancestor
24428893|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24851409|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
24851410|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851411|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851412|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24851413|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851414|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
24851415|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851416|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851417|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24851418|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24851419|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24851420|NCT02256813|Vitamin K|vitamin k|mesh-list
24851421|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
24851422|NCT02256813|Midazolam|midazolam|mesh-list
24851423|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
24851424|NCT02256813|Caffeine|caffeine|mesh-list
24851425|NCT02256813|Omeprazole|omeprazole|mesh-list
24851431|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24851432|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851433|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25069223|NCT03428191|Analgesics|analgesics|mesh-ancestor
24395617|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395618|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395619|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455370|NCT01600079|Vaccines|vaccines|mesh-list
24395927|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
24395928|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24395929|NCT00137254|Insulin|insulin|mesh-list
24395930|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395960|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395961|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395962|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24396452|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396453|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
24396544|NCT00139243|Fluorouracil|fluorouracil|mesh-list
24396575|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396577|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462851|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774953|NCT01848873|Amlodipine|amlodipine|mesh-list
24774954|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24774955|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24774956|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396712|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24396713|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24396714|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24462854|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396946|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
24396947|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396948|NCT00140465|Clopidogrel|clopidogrel|mesh-list
24396949|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24396950|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24396979|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24396980|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397195|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397197|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397236|NCT00141167|Varenicline|varenicline|mesh-list
25241953|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241954|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25241955|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25241956|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25241958|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
25274050|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274051|NCT02381145|Protective Agents|protective agents|mesh-ancestor
25274052|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851476|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851477|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775094|NCT01850160|Valsartan|valsartan|mesh-list
25241982|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241983|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25241984|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25241990|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851485|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397752|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397753|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24397754|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
24397787|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397789|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
24397790|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397791|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459843|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24459844|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25242035|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
25242036|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25242037|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
25242038|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
25242039|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
25242040|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25242041|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25242042|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242043|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24398817|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24398818|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24400495|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25242090|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25242091|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25242092|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242093|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242094|NCT04979377|Androgens|androgens|mesh-ancestor
25242095|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25242096|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
25242097|NCT04974996|Prednisone|prednisone|mesh-list
25242098|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
25242099|NCT04974996|Rituximab|rituximab|mesh-list
25242100|NCT04974996|Doxorubicin|doxorubicin|mesh-list
25242101|NCT04974996|Vincristine|vincristine|mesh-list
25242104|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
25242135|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
25242136|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242137|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242138|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242139|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24400753|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
24400754|NCT00151255|Cytarabine|cytarabine|mesh-list
24400755|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
24400756|NCT00151255|Idarubicin|idarubicin|mesh-list
24400757|NCT00151255|Tretinoin|tretinoin|mesh-list
24400758|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400759|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
24426270|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24400871|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400874|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400909|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
24400910|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400911|NCT00151619|Amlodipine|amlodipine|mesh-list
24400912|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24400937|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24400938|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24400939|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400941|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790141|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155307|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155308|NCT05421065|Psilocybin|psilocybin|mesh-list
24406023|NCT00169026|Clozapine|clozapine|mesh-list
24406024|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406025|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406026|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406027|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406712|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406762|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406787|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406790|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24406791|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24406793|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242322|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242323|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242338|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25242339|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
24790249|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790250|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24790251|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
24790252|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409202|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24409230|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409231|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24409232|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24411915|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24411952|NCT00190515|Antidotes|antidotes|mesh-ancestor
24411953|NCT00190515|Protective Agents|protective agents|mesh-ancestor
24411954|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411955|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
24411956|NCT00190515|Vitamins|vitamins|mesh-ancestor
24411990|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24412487|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460078|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007380|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
25007381|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
24429902|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
24429903|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429904|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
24429905|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790379|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24432204|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435126|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435127|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24435128|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24435129|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24435161|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24435162|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24435163|NCT00265304|Analgesics|analgesics|mesh-ancestor
25242465|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25242466|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242467|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
24437814|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437815|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437886|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24438550|NCT00276133|Protective Agents|protective agents|mesh-ancestor
25242513|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242514|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25242515|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25242516|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242517|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
25242518|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25242519|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25069867|NCT03423472|Vitamin A|vitamin a|mesh-list
24439995|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440938|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440939|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441055|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24441056|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
24441057|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102622|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24441289|NCT00286988|Topiramate|topiramate|mesh-list
24444862|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
24444863|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
24851530|NCT02257008|Nelfinavir|nelfinavir|mesh-list
24851531|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24851532|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24851533|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
24441995|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24441996|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242576|NCT04358549|Favipiravir|favipiravir|mesh-list
25007518|NCT03417180|Analgesics|analgesics|mesh-ancestor
24442284|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442500|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24442502|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442503|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
24442504|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442505|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
24442506|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442507|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442508|NCT00291369|Analgesics|analgesics|mesh-ancestor
24442509|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
24442510|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242596|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242597|NCT04248335|Midazolam|midazolam|mesh-list
25242598|NCT04248335|Pantoprazole|pantoprazole|mesh-list
25242599|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25242600|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25242601|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242602|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242620|NCT04221828|Paclitaxel|paclitaxel|mesh-list
25242621|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24460541|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007661|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25007662|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007663|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
25007664|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007665|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25007666|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
25007667|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
25007668|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25007669|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25242692|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790650|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
24461155|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461156|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461157|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25007797|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461438|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
24461439|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461440|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443606|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
24510048|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551523|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551532|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24551534|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
25007934|NCT02430077|Cathartics|cathartics|mesh-ancestor
25007935|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25007936|NCT02420821|Bevacizumab|bevacizumab|mesh-list
25007937|NCT02420821|Sunitinib|sunitinib|mesh-list
25007938|NCT02420821|Atezolizumab|atezolizumab|mesh-list
25242813|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24779588|NCT01877122|Ibuprofen|ibuprofen|mesh-list
25070142|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070143|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851624|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24851625|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24553653|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24553654|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
24553655|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24553656|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24553657|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24553658|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24553661|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
24554082|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24554083|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24554084|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
24554085|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554088|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
24554092|NCT00734123|Hormones|hormones|mesh-ancestor
25008110|NCT01759836|Atorvastatin|atorvastatin|mesh-list
25359882|NCT05353439|Topotecan|topotecan|mesh-list
24554276|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
24555308|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
24555309|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24555310|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
25008207|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008208|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
25008209|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008210|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008211|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008212|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008213|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
25008214|NCT00958737|Antidotes|antidotes|mesh-ancestor
24555844|NCT00743912|Rifaximin|rifaximin|mesh-list
24555845|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555871|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555892|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24556460|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556461|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
24556462|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558440|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24558441|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24558442|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
24558443|NCT00757315|Triamcinolone|triamcinolone|mesh-list
24558444|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24558804|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558806|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
24558807|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558808|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558809|NCT05434377|Vitamin D|vitamin d|mesh-list
24558810|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
24558811|NCT05434377|Vitamins|vitamins|mesh-ancestor
25008459|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008461|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008462|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
25008463|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559453|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24559454|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24464825|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
25008484|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
24559702|NCT04507906|Nivolumab|nivolumab|mesh-list
24560204|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560205|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560206|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560208|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24560209|NCT03205137|Telmisartan|telmisartan|mesh-list
24560210|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24780774|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
24560211|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24560213|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24560214|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24560366|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560697|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24560698|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560782|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560783|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560784|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24560785|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
24561061|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24444877|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24444879|NCT00299559|Menthol|menthol|mesh-list
24444880|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
24444881|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
24444882|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24496259|NCT00504101|Bortezomib|bortezomib|mesh-list
24561309|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561310|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24561311|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
24561313|NCT00759421|Olanzapine|olanzapine|mesh-list
24561516|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
24561517|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562037|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562490|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24562491|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24562492|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24562699|NCT00767728|Mesalamine|mesalamine|mesh-list
24562700|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24562701|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24562702|NCT00767728|Analgesics|analgesics|mesh-ancestor
24562703|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
24562733|NCT00767975|Rifampin|rifampin|mesh-list
24562948|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25243088|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24563783|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563784|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563785|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25243114|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
24563939|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243121|NCT05357066|Analgesics|analgesics|mesh-ancestor
25243122|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
25243123|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243124|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
25243125|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25243126|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
25243127|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
25243142|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243143|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243144|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25274096|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25274097|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
25274098|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25274099|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25274100|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25274101|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
24851753|NCT02258828|Memantine|memantine|mesh-list
24564043|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24564044|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24564045|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564046|NCT00774969|Metronidazole|metronidazole|mesh-list
24564047|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564048|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564049|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24564162|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564163|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24564164|NCT00775359|Fenofibrate|fenofibrate|mesh-list
24555105|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24564175|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24564185|NCT00775541|Ascorbic Acid|ascorbic acid|mesh-list
24564186|NCT00775541|Vitamins|vitamins|mesh-ancestor
25243173|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25243175|NCT05355610|Gentamicins|gentamicins|mesh-list
24445215|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24445216|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24445217|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24851755|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24626426|NCT01087398|Methotrexate|methotrexate|mesh-list
24564362|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24564363|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564364|NCT00776113|Carvedilol|carvedilol|mesh-list
24564365|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24564366|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24555278|NCT00740948|Rituximab|rituximab|mesh-list
25243227|NCT05355441|Analgesics|analgesics|mesh-list
25243248|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
24564854|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25274127|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24564882|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
25008715|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
25008716|NCT04626024|Dasatinib|dasatinib|mesh-list
24584540|NCT00880828|Analgesics|analgesics|mesh-ancestor
24584541|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
24584542|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243326|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243327|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243328|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25243329|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25243330|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
25243331|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243376|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24565726|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565727|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
25243539|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25243543|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24566163|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566164|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
24566165|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566166|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24566167|NCT00784667|Cetuximab|cetuximab|mesh-list
25243560|NCT05290753|Erythromycin|erythromycin|mesh-list
25243561|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25243562|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25243563|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243564|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25243567|NCT05290220|Lenvatinib|lenvatinib|mesh-list
25274160|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25274161|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
25274162|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274163|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699828|NCT01449253|Bosentan|bosentan|mesh-list
24566239|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24566240|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566241|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25008823|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25008824|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
25008825|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008826|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008827|NCT04249258|Protective Agents|protective agents|mesh-ancestor
25243628|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25243629|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25243630|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25243631|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
25243632|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445591|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24445592|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445593|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445594|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
24445595|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445596|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445597|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
24445598|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445599|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24445663|NCT00301990|Aldesleukin|aldesleukin|mesh-list
25070985|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243837|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243839|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
25243900|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243901|NCT05162196|Niraparib|niraparib|mesh-list
25243902|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25243903|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243904|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243905|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243938|NCT05154279|Terlipressin|terlipressin|mesh-list
25243967|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25243968|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
25243969|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243970|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
25243971|NCT05130814|Protective Agents|protective agents|mesh-ancestor
25243972|NCT05129722|Empagliflozin|empagliflozin|mesh-list
25243973|NCT05129722|Eplerenone|eplerenone|mesh-list
25243974|NCT05129722|Bumetanide|bumetanide|mesh-list
24566750|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24566786|NCT00787969|Cladribine|cladribine|mesh-list
24566787|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24566788|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566789|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
24887865|NCT04511468|Antioxidants|antioxidants|mesh-ancestor
24566898|NCT00788463|Beclomethasone|beclomethasone|mesh-list
24566899|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566900|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
24566905|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24566930|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566931|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
24566932|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566933|NCT00788606|Bevacizumab|bevacizumab|mesh-list
24566934|NCT00788606|Rituximab|rituximab|mesh-list
24566935|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24566936|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566939|NCT00788606|Growth Substances|growth substances|mesh-ancestor
25109930|NCT03120962|Famciclovir|famciclovir|mesh-list
24566957|NCT00788749|Hormones|hormones|mesh-ancestor
24851917|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851918|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244089|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
25244090|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25244091|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244093|NCT05059535|Analgesics|analgesics|mesh-list
25244094|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24567058|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567059|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24567060|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
24784160|NCT01906749|Colchicine|colchicine|mesh-list
24567061|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
25244191|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
25244192|NCT04930237|Bisacodyl|bisacodyl|mesh-list
25244193|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
25244194|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
25244195|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25274222|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274223|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25274225|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
25274226|NCT02379793|Mineral Oil|mineral oil|mesh-list
25274227|NCT02379793|Emollients|emollients|mesh-ancestor
25274228|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
25274229|NCT02379767|Harmine|harmine|mesh-list
25274230|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
24851954|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
24851955|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851956|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244221|NCT04904536|Atorvastatin|atorvastatin|mesh-list
25244222|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24851958|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851959|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
24851960|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851964|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
25244312|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244313|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492750|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25244314|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25244315|NCT04840888|Analgesics|analgesics|mesh-ancestor
25244316|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
25244317|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244318|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25244319|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25244320|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25244321|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25244322|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25244323|NCT04836429|Trioxsalen|trioxsalen|mesh-list
25244333|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244412|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244422|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25244423|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
25244424|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244425|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
25244428|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
25244429|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25244430|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
25244431|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244459|NCT04731467|Nivolumab|nivolumab|mesh-list
25244460|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25244461|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244505|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244506|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25244507|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
25244508|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
25244520|NCT04688788|Fexofenadine|fexofenadine|mesh-list
25244521|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
25244523|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
25244524|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244525|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244587|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244588|NCT04644627|Gentamicins|gentamicins|mesh-list
25244589|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25244640|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25244641|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24852101|NCT02260544|Doxorubicin|doxorubicin|mesh-list
24852102|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24852103|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24852104|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852105|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24852106|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852107|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852109|NCT02260557|Selexipag|selexipag|mesh-list
25244727|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25244728|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25244729|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25244730|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244731|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244732|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244733|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25244734|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25244735|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24852123|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852124|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852125|NCT02260687|Aflibercept|aflibercept|mesh-list
24852126|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24852127|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24852128|NCT02260687|Growth Substances|growth substances|mesh-ancestor
24852129|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244769|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
25244770|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244771|NCT04463368|Nivolumab|nivolumab|mesh-list
25244772|NCT04463368|Ipilimumab|ipilimumab|mesh-list
25244815|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244816|NCT04420975|Nivolumab|nivolumab|mesh-list
25244817|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244818|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244819|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25244820|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852156|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852157|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24852158|NCT02261025|Aspirin|aspirin|mesh-list
24852159|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24852160|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24852161|NCT02261025|Analgesics|analgesics|mesh-ancestor
24445896|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24445897|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24445898|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445899|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852172|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852175|NCT02261064|Telmisartan|telmisartan|mesh-list
24852176|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24852177|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852178|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24852179|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852180|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852181|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24852182|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852183|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
24852184|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25008866|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25008867|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008868|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25008869|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24557241|NCT00751959|Poractant alfa|poractant alfa|mesh-list
25274294|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25274295|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25274296|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25274297|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274299|NCT02379000|Hormones|hormones|mesh-ancestor
25274301|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567180|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567181|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245017|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245018|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25245019|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25245020|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
25245021|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245022|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245023|NCT04293562|Cytarabine|cytarabine|mesh-list
25245024|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
25245025|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25245026|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25245064|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
25245065|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
25245066|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
25245067|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25245068|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245069|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25245070|NCT04293562|Protective Agents|protective agents|mesh-ancestor
24567270|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567271|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24567278|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
24567280|NCT00790439|Calcium heparin|calcium heparin|mesh-list
24567282|NCT00790439|Tacrolimus|tacrolimus|mesh-list
24567283|NCT00790439|Cyclosporins|cyclosporins|mesh-list
25245110|NCT04266275|Analgesics|analgesics|mesh-ancestor
25245111|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
25245112|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245141|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245143|NCT04249544|Pramipexole|pramipexole|mesh-list
25245144|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
25245145|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245146|NCT04249544|Protective Agents|protective agents|mesh-ancestor
25245147|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852297|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852298|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852299|NCT02261844|Resveratrol|resveratrol|mesh-list
24852300|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
24567412|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24567413|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567414|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567415|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25245237|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245238|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
25245239|NCT04202692|Protective Agents|protective agents|mesh-ancestor
25245240|NCT04202692|Antacids|antacids|mesh-ancestor
25245241|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245242|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25245243|NCT04179864|Prednisone|prednisone|mesh-list
25245244|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245245|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
25245246|NCT04179864|Hormones|hormones|mesh-ancestor
25245247|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072279|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
24567481|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24567482|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567483|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
24567484|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
24567485|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24567486|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
24567487|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24567573|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567583|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
24567584|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567585|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25245290|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245291|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245292|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25245293|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245319|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
24445904|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24852344|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24852345|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852347|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24852348|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24852349|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24852350|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852352|NCT02262299|Pirfenidone|pirfenidone|mesh-list
24957941|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
24567733|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
24567734|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567735|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24567736|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24567737|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567739|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567740|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24567741|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589430|NCT00907452|Lenalidomide|lenalidomide|mesh-list
25072393|NCT03401619|Calcitonin|calcitonin|mesh-list
25245513|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245515|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
25245516|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25245517|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245518|NCT03905928|Nicotine|nicotine|mesh-list
25245519|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25245520|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
25245521|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589659|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
25245641|NCT03815175|Analgesics|analgesics|mesh-ancestor
25245715|NCT03770455|Avelumab|avelumab|mesh-list
24568179|NCT00795106|Capsaicin|capsaicin|mesh-list
24590493|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24590494|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24568190|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568191|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568367|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24568368|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568369|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24888859|NCT04499898|Carvedilol|carvedilol|mesh-list
24568414|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
24568415|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512777|NCT00576550|Hormones|hormones|mesh-ancestor
25245972|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25245973|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
24591136|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591137|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
24591139|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568766|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24568767|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568768|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568769|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568770|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
24568771|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568772|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568773|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24568774|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568790|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
24568949|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568950|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
24568951|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568953|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246381|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24791908|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
24569589|NCT00801255|Lactams|lactams|mesh-list
24852580|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
24852581|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
24852582|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
24852583|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852584|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24960680|NCT03814759|Cisplatin|cisplatin|mesh-list
24501115|NCT00526877|Risperidone|risperidone|mesh-list
25009114|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25009115|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009116|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25009117|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009118|NCT03420508|Ensartinib|ensartinib|mesh-list
25009119|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009120|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009121|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246564|NCT02525757|Carboplatin|carboplatin|mesh-list
25246565|NCT02525757|Atezolizumab|atezolizumab|mesh-list
25246566|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246567|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246609|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24812375|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
24812376|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24812377|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812378|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
24592318|NCT00921245|Urological Agents|urological agents|mesh-ancestor
24592319|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
24592320|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24571193|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25246821|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25246836|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009293|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561079|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
25246989|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25246990|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246991|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
25246992|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246993|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246994|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25247003|NCT01345175|Rifaximin|rifaximin|mesh-list
25247013|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247033|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25247034|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25045242|NCT00981357|Analgesics|analgesics|mesh-ancestor
24574139|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
24594898|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594958|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24594962|NCT00936234|Vildagliptin|vildagliptin|mesh-list
24576326|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24576327|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
24576328|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
24576329|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
24576330|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
24576380|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
25009748|NCT05191264|Analgesics|analgesics|mesh-list
24564227|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24564228|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564275|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577116|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24577117|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24577118|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
24577119|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
24577120|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
24577121|NCT00842114|Interferons|interferons|mesh-list
24577123|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
24577483|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24577885|NCT00846235|Protective Agents|protective agents|mesh-ancestor
25247416|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595444|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
24579250|NCT00854035|Incretins|incretins|mesh-ancestor
25248186|NCT02533557|Lidocaine|lidocaine|mesh-list
25248224|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597912|NCT00952640|Vitamin A|vitamin a|mesh-list
25274465|NCT02377778|Thiopental|thiopental|mesh-list
24598537|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
24598540|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598693|NCT00957346|Misoprostol|misoprostol|mesh-list
24598756|NCT00958022|Etoposide|etoposide|mesh-list
25249053|NCT02528877|Sirolimus|sirolimus|mesh-list
25249274|NCT02527785|Irinotecan|irinotecan|mesh-list
25274478|NCT02377609|Tacrolimus|tacrolimus|mesh-list
25249525|NCT02526615|Metformin|metformin|mesh-list
25249636|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25249637|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25249638|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249659|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25274488|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
25274489|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274490|NCT02377635|Selenious Acid|selenious acid|mesh-list
25274491|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
25274492|NCT02377635|Trace Elements|trace elements|mesh-ancestor
25274493|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
25274494|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275659|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275660|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25275661|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
25275662|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
25275663|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249707|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
25249877|NCT02523898|Enclomiphene|enclomiphene|mesh-list
24793107|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
25250241|NCT02521441|Lenograstim|lenograstim|mesh-list
24602193|NCT00967603|Sunitinib|sunitinib|mesh-list
25250607|NCT02519322|Nivolumab|nivolumab|mesh-list
25274551|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
25250972|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
24604620|NCT00980473|Travoprost|travoprost|mesh-list
24671189|NCT01324180|Hormones|hormones|mesh-ancestor
24605238|NCT00984152|Efavirenz|efavirenz|mesh-list
24606176|NCT00989352|Procarbazine|procarbazine|mesh-list
24580632|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24580634|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
25251762|NCT02511210|Anesthetics|anesthetics|mesh-list
25251799|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
25251806|NCT02510911|Caffeine|caffeine|mesh-list
25252008|NCT02509468|Sirolimus|sirolimus|mesh-list
25252009|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252010|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922968|NCT04174261|Clopidogrel|clopidogrel|mesh-list
24923044|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
25274660|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252288|NCT02507583|Insulin|insulin|mesh-list
25252329|NCT02507609|Rocuronium|rocuronium|mesh-list
25252627|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
24924526|NCT04159155|Niraparib|niraparib|mesh-list
24924556|NCT04158934|Factor VIII|factor viii|mesh-list
25253021|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631467|NCT01118403|Ampicillin|ampicillin|mesh-list
25253367|NCT02501564|Naproxen|naproxen|mesh-list
25253511|NCT02500524|Permethrin|permethrin|mesh-list
25253662|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
25002247|NCT04792502|Growth Substances|growth substances|mesh-ancestor
25002248|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
24925704|NCT04148846|Dexamethasone|dexamethasone|mesh-list
24925706|NCT04148846|Theophylline|theophylline|mesh-list
24925707|NCT04148846|Gabapentin|gabapentin|mesh-list
24925708|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925709|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
24925728|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399123|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002272|NCT04752384|Buprenorphine|buprenorphine|mesh-list
24582912|NCT00872586|Diuretics|diuretics|mesh-ancestor
24582920|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
24502005|NCT00531986|Lopinavir|lopinavir|mesh-list
24926318|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926319|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926569|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
24584855|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584856|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
24584857|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
24524391|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
24524392|NCT04977453|Lenvatinib|lenvatinib|mesh-list
24524436|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
25254484|NCT02494856|Naproxen|naproxen|mesh-list
24524622|NCT04646837|Carboplatin|carboplatin|mesh-list
24524659|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
24524660|NCT04549207|Pamidronate|pamidronate|mesh-list
24524661|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24524662|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254682|NCT02493192|Analgesics|analgesics|mesh-ancestor
24524668|NCT04532463|Fluconazole|fluconazole|mesh-list
24524974|NCT04141644|Ipilimumab|ipilimumab|mesh-list
25255375|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24927546|NCT04132115|Meropenem|meropenem|mesh-list
24927547|NCT04132115|Tazobactam|tazobactam|mesh-list
24927548|NCT04132115|Linezolid|linezolid|mesh-list
24525760|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24525761|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011731|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011734|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
24402608|NCT00158002|Topiramate|topiramate|mesh-list
24526643|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
24526644|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526645|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255893|NCT02485444|Oxytocin|oxytocin|mesh-list
25255979|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255980|NCT02484885|Xenon|xenon|mesh-list
25255981|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25255982|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
25255983|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
25256032|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25256033|NCT02485106|Protective Agents|protective agents|mesh-ancestor
25256034|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256067|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25256068|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256069|NCT02484755|Gefitinib|gefitinib|mesh-list
25256070|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256071|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25256072|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256074|NCT02484248|Ketotifen|ketotifen|mesh-list
24526897|NCT00613717|Folic Acid|folic acid|mesh-list
24526899|NCT00613717|Iron|iron|mesh-list
24526900|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
24526901|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
24526959|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
24527014|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928492|NCT04121533|Vitamins|vitamins|mesh-ancestor
24928493|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
25012597|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
25256437|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
25256438|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256439|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25256440|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
25256441|NCT02482636|Vaccines|vaccines|mesh-list
24527249|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798814|NCT01965353|Lenalidomide|lenalidomide|mesh-list
25012704|NCT04559646|Hemostatics|hemostatics|mesh-list
25012705|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25012706|NCT04559646|Coagulants|coagulants|mesh-ancestor
25012707|NCT04546126|Dexamethasone|dexamethasone|mesh-list
25012708|NCT04546126|Cosyntropin|cosyntropin|mesh-list
25012709|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102762|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013092|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013093|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25013094|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013095|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25110485|NCT05463354|Vaccines|vaccines|mesh-list
25013427|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25013472|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25256493|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
25110578|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110579|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256505|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
24970589|NCT03732040|Fluorides|fluorides|mesh-list
25014104|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25014105|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25014106|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25014309|NCT04765644|Analgesics|analgesics|mesh-ancestor
24527440|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25014947|NCT03589729|Idarubicin|idarubicin|mesh-list
24586457|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25015209|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
25015210|NCT02950259|Omeprazole|omeprazole|mesh-list
25015335|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015336|NCT02581085|Vitamins|vitamins|mesh-ancestor
25015337|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
25015349|NCT02538666|Nivolumab|nivolumab|mesh-list
25015350|NCT02538666|Ipilimumab|ipilimumab|mesh-list
25015352|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412281|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527647|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527648|NCT00617877|Diuretics|diuretics|mesh-ancestor
24527657|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25016353|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016354|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016355|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016356|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016357|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016359|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016360|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016361|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016368|NCT00043108|Paclitaxel|paclitaxel|mesh-list
24817452|NCT02083991|Hormones|hormones|mesh-ancestor
25017073|NCT02668783|Analgesics|analgesics|mesh-ancestor
24928782|NCT04119037|Morphine|morphine|mesh-list
24928832|NCT04118699|Rifaximin|rifaximin|mesh-list
25018850|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018851|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018871|NCT03695952|Nivolumab|nivolumab|mesh-list
25019241|NCT03692416|Prednisone|prednisone|mesh-list
24928879|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
24527934|NCT00618657|Antibodies|antibodies|mesh-list
25257139|NCT02478047|Ramosetron|ramosetron|mesh-list
24760999|NCT01760655|Fludarabine|fludarabine|mesh-list
25022695|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25022696|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25022697|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022698|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
24587345|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022868|NCT03658746|Bismuth|bismuth|mesh-list
24505049|NCT00539396|Insulin|insulin|mesh-list
25257301|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25257302|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
25257303|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257304|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257305|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25257306|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
25257307|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
25023919|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
24587597|NCT00895778|Rocuronium|rocuronium|mesh-list
25024662|NCT03643666|Hormones|hormones|mesh-ancestor
24983124|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983125|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24983126|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24795820|NCT01946373|Fludarabine|fludarabine|mesh-list
25026614|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25026616|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25026617|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026618|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026619|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026620|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027086|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027087|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25027088|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25027089|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25027090|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25027091|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25027092|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25027654|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027655|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
25257595|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257596|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
25257597|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257598|NCT02476045|Antidotes|antidotes|mesh-ancestor
25257599|NCT02476045|Protective Agents|protective agents|mesh-ancestor
24929242|NCT04114188|Prednisolone|prednisolone|mesh-list
24929243|NCT04114188|Infliximab|infliximab|mesh-list
24929244|NCT04114188|Tacrolimus|tacrolimus|mesh-list
24929245|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
24929246|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24929247|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
24929248|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24929249|NCT04114188|Antibodies|antibodies|mesh-list
25028114|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
25028456|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028463|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029802|NCT03600623|Irinotecan|irinotecan|mesh-list
24588166|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24588167|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588205|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
25031655|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25031656|NCT03586674|Fenofibrate|fenofibrate|mesh-list
25031657|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25101630|NCT03173235|Vitamins|vitamins|mesh-ancestor
24598146|NCT00954200|Analgesics|analgesics|mesh-ancestor
25031706|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031707|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
25031709|NCT03586154|Analgesics|analgesics|mesh-ancestor
24929679|NCT04110028|Vitamins|vitamins|mesh-ancestor
24929680|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
24929681|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031847|NCT03585556|Prednisolone|prednisolone|mesh-list
25257971|NCT02474134|Interferon-beta|interferon-beta|mesh-list
25257972|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
25257973|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031944|NCT03585036|Analgesics|analgesics|mesh-ancestor
25113613|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929836|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24929878|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
24528551|NCT00621491|Warfarin|warfarin|mesh-list
24528552|NCT00621491|Anticoagulants|anticoagulants|mesh-list
24528553|NCT00621556|Secretin|secretin|mesh-list
24930042|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
24588231|NCT00901615|Growth Substances|growth substances|mesh-ancestor
24930194|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
24930196|NCT04104334|Remifentanil|remifentanil|mesh-list
25258516|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
25258547|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
25258548|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258549|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25258550|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25258552|NCT02470546|Metformin|metformin|mesh-list
25258559|NCT02470663|Antacids|antacids|mesh-ancestor
25258573|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258598|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258599|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930470|NCT04101708|Bismuth|bismuth|mesh-list
25258714|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24930833|NCT04096599|Fluorides|fluorides|mesh-list
24624959|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25036456|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24931036|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931037|NCT04094467|Leuprolide|leuprolide|mesh-list
24931038|NCT04094467|Cetrorelix|cetrorelix|mesh-list
24931039|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24931111|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259336|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
24931287|NCT04090801|Minoxidil|minoxidil|mesh-list
24625037|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259571|NCT02463383|Ibuprofen|ibuprofen|mesh-list
25259602|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25259635|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038900|NCT04349124|Nifedipine|nifedipine|mesh-list
24625071|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039663|NCT03721965|Hormones|hormones|mesh-ancestor
25040221|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040222|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
25040223|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25040224|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25040225|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
25040226|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
25040227|NCT03301051|Vaccines|vaccines|mesh-list
24625123|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607795|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260128|NCT02460354|Metformin|metformin|mesh-list
24932100|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24932101|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360793|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
24932102|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932103|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24932104|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24529586|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24529587|NCT00626769|Estrogens|estrogens|mesh-ancestor
24529588|NCT00626769|Hormones|hormones|mesh-ancestor
24529589|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673398|NCT01337518|Androgens|androgens|mesh-list
24674013|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
24674672|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260573|NCT02457806|Phenylephrine|phenylephrine|mesh-list
25260602|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
25260623|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25260624|NCT02457442|Remifentanil|remifentanil|mesh-list
24610744|NCT01004809|Dutasteride|dutasteride|mesh-list
24932510|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24676029|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24676215|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
24677469|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24677470|NCT01356511|Dexamethasone|dexamethasone|mesh-list
24677471|NCT01356511|Prednisone|prednisone|mesh-list
24677472|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677473|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
24677474|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
24932799|NCT04076826|Analgesics|analgesics|mesh-ancestor
24681778|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261149|NCT02455271|Eszopiclone|eszopiclone|mesh-list
25261503|NCT02453490|Fluorouracil|fluorouracil|mesh-list
25261589|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25261752|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
25261997|NCT02450214|Ketamine|ketamine|mesh-list
24684211|NCT01395927|Rifampin|rifampin|mesh-list
24934942|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934943|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25262236|NCT02449369|Acetaminophen|acetaminophen|mesh-list
25262370|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262429|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531335|NCT00635258|Ganirelix|ganirelix|mesh-list
25262781|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
25262782|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684749|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263108|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263109|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686483|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24686484|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24686486|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
24686684|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
24513551|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263747|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670730|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263992|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693391|NCT01420250|Bicalutamide|bicalutamide|mesh-list
24697963|NCT01438086|Mecasermin|mecasermin|mesh-list
24699722|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
24549646|NCT00716547|Analgesics|analgesics|mesh-ancestor
24635776|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24636155|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637826|NCT01153256|Analgesics|analgesics|mesh-ancestor
24638859|NCT01158846|Abciximab|abciximab|mesh-list
24640009|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24640010|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24640011|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640012|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24640013|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24640014|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
24640015|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640183|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
24640465|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24640467|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640468|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640732|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641712|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24641713|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25265109|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265132|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25265147|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25265148|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25265149|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25265150|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265164|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265209|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25265210|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265221|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449628|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24449629|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449630|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449631|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
24449632|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
24449633|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24449634|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
25265449|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265452|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25265517|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265519|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265544|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265545|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265546|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25265547|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25265548|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
24855998|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
24855999|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24856000|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
24856001|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812845|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
24812846|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812847|NCT02054949|Expectorants|expectorants|mesh-ancestor
24812850|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
24856122|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24856125|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25265639|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
24646311|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24646312|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24646313|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24646314|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265654|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265656|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
24856289|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24856329|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24856331|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646519|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
24856449|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24856451|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265714|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
25265715|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
24540150|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540151|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
24540152|NCT00666783|Palonosetron|palonosetron|mesh-list
24540153|NCT00666783|Granisetron|granisetron|mesh-list
24540154|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
24856461|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856462|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24856463|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856464|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24856465|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24856466|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24856468|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856469|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24856470|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24856471|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856473|NCT02284529|Fluorouracil|fluorouracil|mesh-list
24856474|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
24856475|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856476|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24856477|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856478|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856479|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
24646786|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646788|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24646859|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646860|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646861|NCT01205256|Analgesics|analgesics|mesh-ancestor
24646862|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
24646863|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646864|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
24646879|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856533|NCT02285374|Emtricitabine|emtricitabine|mesh-list
24856534|NCT02285374|Efavirenz|efavirenz|mesh-list
24856535|NCT02285374|Dolutegravir|dolutegravir|mesh-list
24856536|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25265768|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25265769|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25265770|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25265771|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25265772|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
25265773|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265774|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265775|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265776|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25265777|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646961|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646962|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646963|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24646965|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
24856548|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24856549|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24856550|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24856551|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25265784|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265785|NCT02431728|Protective Agents|protective agents|mesh-ancestor
25265786|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856615|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24856616|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24856617|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24856618|NCT02285751|Analgesics|analgesics|mesh-ancestor
24856619|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
24563247|NCT00770731|Bortezomib|bortezomib|mesh-list
24647140|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24647141|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647142|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
24647143|NCT01206530|Antidotes|antidotes|mesh-ancestor
24647144|NCT01206530|Protective Agents|protective agents|mesh-ancestor
24647145|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
24647147|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
24647148|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
24647149|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24647150|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24647151|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647152|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456774|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
24546734|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24546735|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045442|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045443|NCT00950885|Protective Agents|protective agents|mesh-ancestor
25045444|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045445|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647172|NCT01206803|Ganirelix|ganirelix|mesh-list
24856711|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24856713|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856714|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24856715|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24856716|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856717|NCT02286596|Heparin|heparin|mesh-list
24856718|NCT02286596|Dextrans|dextrans|mesh-list
24856719|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
24856728|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
24856729|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856730|NCT02286622|Deflazacort|deflazacort|mesh-list
24856731|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856732|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856733|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
24856734|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856735|NCT02286635|Clarithromycin|clarithromycin|mesh-list
24856736|NCT02286635|Rifampin|rifampin|mesh-list
24856737|NCT02286635|Deflazacort|deflazacort|mesh-list
24856738|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24647383|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647384|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647385|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24647386|NCT01208649|Incretins|incretins|mesh-ancestor
24647387|NCT01208649|Hormones|hormones|mesh-ancestor
24647389|NCT01208701|Atorvastatin|atorvastatin|mesh-list
24647458|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
24856766|NCT02286752|Neostigmine|neostigmine|mesh-list
24856767|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24856768|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856769|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856770|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
25265936|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265943|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
25265948|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265949|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265950|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265951|NCT02430298|Melatonin|melatonin|mesh-list
24647555|NCT01209416|Acipimox|acipimox|mesh-list
24647556|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24647557|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
24695172|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25265965|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265966|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547061|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547062|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24418676|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
24856823|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856824|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
24647648|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647652|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24647653|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
24647654|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24647655|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647656|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24647670|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24647679|NCT01210014|Astringents|astringents|mesh-ancestor
24856825|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
24856826|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
24647694|NCT01210066|Analgesics|analgesics|mesh-ancestor
24647695|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
24647696|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647697|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24647698|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24647699|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
24647700|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
24647701|NCT01210287|Lamivudine|lamivudine|mesh-list
24647704|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266032|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266033|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
24548935|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548936|NCT00712647|Provitamins|provitamins|mesh-ancestor
24548937|NCT00712647|Vitamins|vitamins|mesh-ancestor
24548938|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
24548939|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
24548940|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24648023|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648026|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
24648027|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24648028|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648232|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24648233|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24648236|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
24648237|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24648238|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648239|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648240|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24648379|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24648380|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648382|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25266094|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
25266095|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
25266096|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266097|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
25266098|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25266099|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
25266100|NCT02429817|Edetic Acid|edetic acid|mesh-list
24856914|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856915|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24856916|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856917|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856918|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856920|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24856940|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856941|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856942|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24856943|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24856944|NCT02288078|Dexamethasone|dexamethasone|mesh-list
24856945|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24856946|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856986|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856987|NCT02288338|Atorvastatin|atorvastatin|mesh-list
24856988|NCT02288338|Ezetimibe|ezetimibe|mesh-list
24459495|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648534|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
24857008|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857009|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
24857010|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
24857011|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695723|NCT02010385|Octreotide|octreotide|mesh-list
25266199|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266200|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266201|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
25266202|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266203|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266204|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25266217|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25266218|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
24648927|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648928|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24648930|NCT01217450|Antibodies|antibodies|mesh-list
24648931|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
24648932|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24648933|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
24649000|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
24857175|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857176|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24857180|NCT02289586|Narcotics|narcotics|mesh-ancestor
24857193|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24857194|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24857195|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
24857196|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25266243|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25266244|NCT02429440|Sargramostim|sargramostim|mesh-list
25266245|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24649697|NCT01221402|Vitamins|vitamins|mesh-ancestor
24649698|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
24649723|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24649724|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649917|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24649962|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24696264|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
24696265|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
24696266|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696267|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24696268|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24696271|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651294|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651295|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24651831|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651832|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24651833|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24651834|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
24696580|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651936|NCT01234792|Nicotine|nicotine|mesh-list
24652224|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652225|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
25266308|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25266309|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24652423|NCT01238185|Analgesics|analgesics|mesh-ancestor
24652424|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
24652446|NCT01238276|Cefazolin|cefazolin|mesh-list
24652922|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652926|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24652927|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24652928|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652935|NCT01241006|Dexamethasone|dexamethasone|mesh-list
24653189|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
24653332|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24653333|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24653334|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653335|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653336|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653528|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24653529|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
24653530|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
24653531|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653532|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653567|NCT01244269|Methylphenidate|methylphenidate|mesh-list
24653660|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24653859|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24653917|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653922|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24655110|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655111|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655117|NCT01254513|Hormones|hormones|mesh-ancestor
24655551|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655613|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656039|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656042|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25266407|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25266408|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25266409|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25266410|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266411|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266412|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
25266413|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449716|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24449717|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449718|NCT00316745|Antidotes|antidotes|mesh-ancestor
24656821|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656822|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24656823|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24656824|NCT01264315|Growth Substances|growth substances|mesh-ancestor
24656825|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
24656826|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656827|NCT01264328|Paclitaxel|paclitaxel|mesh-list
24656828|NCT01264328|Panitumumab|panitumumab|mesh-list
24656829|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24656830|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656831|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
24656832|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
24656833|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
24569728|NCT00801606|Zinc|zinc|mesh-list
24657167|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657168|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
24657169|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24657171|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657172|NCT01266057|Sirolimus|sirolimus|mesh-list
24657173|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
24657174|NCT01266057|Vorinostat|vorinostat|mesh-list
25266481|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
25266482|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658203|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
24658204|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24658205|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24658206|NCT01270932|Dexamethasone|dexamethasone|mesh-list
24658207|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
24658221|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
24658222|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658223|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658645|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24658677|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24698151|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24698152|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698153|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
24698154|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
24698155|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
24698156|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698157|NCT01439230|Donepezil|donepezil|mesh-list
24658863|NCT01274273|Growth Substances|growth substances|mesh-ancestor
25266537|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659025|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
24659026|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
24659027|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659028|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659029|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24659048|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659049|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24659130|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659131|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24659132|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
24659264|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659642|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24659643|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24659778|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659779|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24659780|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
24659781|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659782|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24659783|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659784|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
24660787|NCT01285817|Vinblastine|vinblastine|mesh-list
24660788|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660789|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
24660790|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661145|NCT01288157|Golimumab|golimumab|mesh-list
25266651|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
25266705|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266731|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266732|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25266817|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701119|NCT01457001|Vitamin D|vitamin d|mesh-list
24701120|NCT01457001|Vitamins|vitamins|mesh-list
25266883|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939781|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266902|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266903|NCT02425774|Prucalopride|prucalopride|mesh-list
25266904|NCT02425774|Laxatives|laxatives|mesh-ancestor
25266905|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266906|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25266907|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25266908|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
25266909|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466089|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
24804169|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
25266993|NCT02425241|Vaccines|vaccines|mesh-list
25266994|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
25266995|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863065|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
24428983|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
24429608|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24429609|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24429610|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
24429611|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24429613|NCT00244517|Analgesics|analgesics|mesh-ancestor
24825006|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825007|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24825009|NCT02126917|Analgesics|analgesics|mesh-ancestor
24825010|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
24825011|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825012|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
24430035|NCT00245934|Etanercept|etanercept|mesh-list
24430036|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24825103|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431963|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431964|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
24431965|NCT00253318|Hormones|hormones|mesh-ancestor
24602434|NCT00968877|Vitamin D|vitamin d|mesh-list
24432176|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432177|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432178|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24432179|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24432838|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24432839|NCT00256347|Narcotics|narcotics|mesh-ancestor
24432840|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432841|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433225|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25267094|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25267095|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267096|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434152|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
24434803|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24825467|NCT02128451|Fentanyl|fentanyl|mesh-list
25267143|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267144|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24437730|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267155|NCT02424071|Protective Agents|protective agents|mesh-ancestor
25267156|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267157|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267159|NCT02423954|Capecitabine|capecitabine|mesh-list
25267160|NCT02423954|Nivolumab|nivolumab|mesh-list
25267161|NCT02423954|Irinotecan|irinotecan|mesh-list
25267162|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25267178|NCT02423915|Vidarabine|vidarabine|mesh-list
25267189|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25267190|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
24440406|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267205|NCT02424045|Dexamethasone|dexamethasone|mesh-list
24825990|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825991|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25267213|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267215|NCT02424045|Hormones|hormones|mesh-ancestor
25267216|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267217|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25267218|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267219|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25267220|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
25267222|NCT02423837|Rituximab|rituximab|mesh-list
24826034|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826035|NCT02132000|Tamoxifen|tamoxifen|mesh-list
24826036|NCT02132000|Toremifene|toremifene|mesh-list
24826037|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25267254|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24826437|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267357|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267358|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267359|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25267360|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25267361|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267362|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24443936|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24826800|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24826824|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24826825|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24826826|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24826827|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24826828|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24826829|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
24826830|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
24826831|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24826832|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24676901|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25267383|NCT02422901|Protective Agents|protective agents|mesh-ancestor
24677522|NCT01356680|Hormones|hormones|mesh-ancestor
24444004|NCT00296530|Xhance|xhance|mesh-list
24444005|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24444006|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24444007|NCT00296530|Montelukast|montelukast|mesh-list
24444008|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24444009|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24444010|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
24826886|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444023|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24634786|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634787|NCT01135212|Candesartan|candesartan|mesh-list
25011018|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635045|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
24635827|NCT01141439|Xhance|xhance|mesh-list
24636498|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24637254|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637924|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637925|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
24637998|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637999|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24638517|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24638518|NCT01156883|Protective Agents|protective agents|mesh-ancestor
24968054|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24639494|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24639495|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24640226|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968468|NCT03751059|Hormones|hormones|mesh-ancestor
24643553|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643554|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643555|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24643584|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24643922|NCT01188005|Vitamins|vitamins|mesh-list
24644250|NCT01189864|Hormones|hormones|mesh-ancestor
24645172|NCT01196481|Carvedilol|carvedilol|mesh-list
24646436|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25012186|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25012187|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25012191|NCT01180374|Dronabinol|dronabinol|mesh-list
24648504|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
24648972|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
24649699|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649993|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012429|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110370|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110371|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
25110372|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650276|NCT01224860|Losartan|losartan|mesh-list
25012514|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651136|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24651144|NCT01229774|Diclofenac|diclofenac|mesh-list
24651468|NCT01231698|Esmolol|esmolol|mesh-list
24474651|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24652063|NCT01235637|Sufentanil|sufentanil|mesh-list
25012815|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012848|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012849|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
25012850|NCT04249323|Hormones|hormones|mesh-ancestor
24654017|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654018|NCT01246817|Sirolimus|sirolimus|mesh-list
24654019|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24654020|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013022|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25013023|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
25013024|NCT03822637|Albuterol|albuterol|mesh-list
25013025|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25013026|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25013027|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
25013028|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654100|NCT01247701|Busulfan|busulfan|mesh-list
24654288|NCT01248494|Dactolisib|dactolisib|mesh-list
25013078|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
24656587|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
24656588|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656589|NCT01262963|Dabrafenib|dabrafenib|mesh-list
24656594|NCT01263002|Adefovir|adefovir|mesh-list
24656636|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24656638|NCT01263171|Leucovorin|leucovorin|mesh-list
24657081|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
24657082|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110461|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970053|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
24970055|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
24970056|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013421|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24575094|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24658010|NCT01269853|Growth Substances|growth substances|mesh-ancestor
25013491|NCT02471144|Etanercept|etanercept|mesh-list
24659041|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24659043|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659044|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970330|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970331|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970332|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
24659890|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659891|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659892|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24659893|NCT01280240|Hematinics|hematinics|mesh-ancestor
24660106|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24660110|NCT01281787|Losartan|losartan|mesh-list
24660111|NCT01281787|Metoprolol|metoprolol|mesh-list
24660328|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
24660501|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660502|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660503|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24660504|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660505|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660506|NCT01283932|Pantoprazole|pantoprazole|mesh-list
24660507|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660508|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013708|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
24660719|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661482|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24661483|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661484|NCT01289743|Analgesics|analgesics|mesh-ancestor
24795499|NCT02220426|Xenon|xenon|mesh-list
24661794|NCT01291095|Cisplatin|cisplatin|mesh-list
25013894|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
24662336|NCT01294072|Curcumin|curcumin|mesh-list
24662623|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25014011|NCT05168644|Niclosamide|niclosamide|mesh-list
24663602|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663604|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663605|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663606|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24663607|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664400|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664401|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664402|NCT01306708|Amitriptyline|amitriptyline|mesh-list
24664403|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24664404|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
24664405|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24664406|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24979914|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
24665941|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24666082|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666083|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24666783|NCT01321021|Promethazine|promethazine|mesh-list
24666837|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24666838|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
24666839|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24666840|NCT01321125|Povidone|povidone|mesh-list
24666841|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666842|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
24666843|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
24666844|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
24666846|NCT01321138|Morphine|morphine|mesh-list
24667086|NCT01322152|Capecitabine|capecitabine|mesh-list
24667108|NCT01322204|Narcotics|narcotics|mesh-ancestor
24533938|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25110649|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110650|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110651|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25110652|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586423|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
24586426|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
25014601|NCT04214691|Analgesics|analgesics|mesh-ancestor
25014636|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
25014637|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014638|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014641|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
25014642|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
25014643|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24535193|NCT00648778|Loxapine|loxapine|mesh-list
24451137|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24451138|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451139|NCT00322296|Bexarotene|bexarotene|mesh-list
24451140|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451141|NCT00322400|Paclitaxel|paclitaxel|mesh-list
25014682|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25014683|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014746|NCT03926299|Hormones|hormones|mesh-ancestor
24535411|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535412|NCT00649103|Quinapril|quinapril|mesh-list
25014808|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014809|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
24535712|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24535714|NCT00649610|Analgesics|analgesics|mesh-ancestor
24535715|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
25015224|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25015226|NCT02950259|Analgesics|analgesics|mesh-ancestor
25015227|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
25015228|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015229|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25015456|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015458|NCT02372630|Hormones|hormones|mesh-ancestor
25015654|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24536386|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536387|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24536388|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426489|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
24536570|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25110780|NCT05370326|Analgesics|analgesics|mesh-ancestor
24536888|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451237|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537130|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016077|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016078|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016079|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016172|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016173|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016174|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016175|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016176|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016177|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537514|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24537515|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537516|NCT00655109|Fluticasone|fluticasone|mesh-list
24537517|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24795614|NCT01369147|Propofol|propofol|mesh-list
25016373|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
25016374|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
25110859|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25110860|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24973100|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973101|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
24537920|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25016529|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016546|NCT05091294|Anesthetics|anesthetics|mesh-list
25016648|NCT04895202|Siponimod|siponimod|mesh-list
25016696|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
24538339|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016769|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016770|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
24538650|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538651|NCT00660244|Anastrozole|anastrozole|mesh-list
25016938|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
25017045|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017046|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
25017047|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25017048|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25017106|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25017248|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017250|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25017346|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
24586826|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
24586827|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586828|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586829|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24586830|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586831|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
24586832|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017472|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
25017473|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
24539253|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
24539254|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539255|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539335|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539337|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
24539338|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
24539339|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539340|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539342|NCT00663377|Losartan|losartan|mesh-list
24539388|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24539389|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24539390|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539391|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539392|NCT00663598|Urological Agents|urological agents|mesh-ancestor
24539444|NCT00663897|Mosapride|mosapride|mesh-list
24539445|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24539448|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017762|NCT03704623|Acetaminophen|acetaminophen|mesh-list
25017763|NCT03704623|Parecoxib|parecoxib|mesh-list
25017801|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539466|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539467|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24539469|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24539470|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
24539471|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580618|NCT00862628|Rebamipide|rebamipide|mesh-list
24580626|NCT00862693|Calcitriol|calcitriol|mesh-list
24974401|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
24974402|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974403|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24974404|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539622|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
24539623|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539627|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25017860|NCT03703154|Tacrolimus|tacrolimus|mesh-list
24539664|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
24539710|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
24539711|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539712|NCT00665314|Plerixafor|plerixafor|mesh-list
25017953|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017967|NCT03702647|Ropivacaine|ropivacaine|mesh-list
24539853|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25018040|NCT03702387|Anesthetics|anesthetics|mesh-list
24539906|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539949|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539950|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25018181|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25018182|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25018183|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018184|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
25018185|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018186|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586894|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586895|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24586896|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24586897|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
24586898|NCT00892502|Bismuth|bismuth|mesh-list
24445061|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
24445062|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
24445063|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445064|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445065|NCT00300287|Vildagliptin|vildagliptin|mesh-list
24445066|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361702|NCT05305404|Hormones|hormones|mesh-ancestor
24445069|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
25018623|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018624|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018625|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25018626|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018627|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018628|NCT03698292|Metoclopramide|metoclopramide|mesh-list
25018629|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
25018630|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
25018683|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25018801|NCT03696901|Dalbavancin|dalbavancin|mesh-list
24975471|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975472|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24975474|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
24975475|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24982703|NCT00546754|Valsartan|valsartan|mesh-list
25018998|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018999|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25019219|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457892|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
24530832|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
24530833|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530834|NCT00632645|Olanzapine|olanzapine|mesh-list
24530835|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
25019220|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019301|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019302|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019761|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019762|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
25019764|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019765|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019766|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019767|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
25019768|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
25019769|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019841|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25019842|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020219|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
25020220|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25020221|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
25106604|NCT02129751|Bupropion|bupropion|mesh-list
25020238|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020264|NCT03681639|Cobalt|cobalt|mesh-list
24541840|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020322|NCT03681197|Enclomiphene|enclomiphene|mesh-list
25020323|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
25020324|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25020325|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020326|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25020327|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
24542405|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24542406|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542407|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
25020349|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
25020350|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
24542987|NCT00681343|Daclizumab|daclizumab|mesh-list
25020449|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020450|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020595|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25020596|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
25020597|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25020598|NCT03679013|Acetaminophen|acetaminophen|mesh-list
25020599|NCT03679013|Gabapentin|gabapentin|mesh-list
25020600|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25020620|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
25020621|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24977159|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24983683|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547027|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24547028|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547029|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547030|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
24547980|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548198|NCT00708318|Fentanyl|fentanyl|mesh-list
25020650|NCT03678649|Capecitabine|capecitabine|mesh-list
25020690|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
25020692|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
24550272|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24550293|NCT00720148|Sunitinib|sunitinib|mesh-list
24983768|NCT05163561|Vaccines|vaccines|mesh-list
25020931|NCT03676114|Ketamine|ketamine|mesh-list
25020932|NCT03676114|Analgesics|analgesics|mesh-ancestor
25020933|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
25020969|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25021101|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021102|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021104|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021105|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24983918|NCT05064488|Metformin|metformin|mesh-list
24448443|NCT00311870|Lisinopril|lisinopril|mesh-list
25021149|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
25021150|NCT03674385|Vitamins|vitamins|mesh-ancestor
25021151|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
25021152|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021153|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710061|NCT01508221|Vitamin E|vitamin e|mesh-list
25021359|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021908|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
25021909|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021910|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021911|NCT03667235|Glutaral|glutaral|mesh-list
25021912|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
25021913|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021914|NCT03667222|Minocycline|minocycline|mesh-list
25022342|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022343|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25022344|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25022346|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879175|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
24979181|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979183|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24466987|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
24466988|NCT00375869|Hematinics|hematinics|mesh-ancestor
24468488|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469757|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587441|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24587442|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24587529|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
24471277|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
24471278|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471279|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471282|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471695|NCT00396578|Vancomycin|vancomycin|mesh-list
25024729|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024730|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
25024731|NCT03643276|Hormones|hormones|mesh-ancestor
25024732|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024733|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25024734|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25024735|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24985872|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024822|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25024823|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25024824|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
25024825|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
25024826|NCT03642509|Apixaban|apixaban|mesh-list
25024827|NCT03642509|Edoxaban|edoxaban|mesh-list
25024828|NCT03642509|Dabigatran|dabigatran|mesh-list
25024829|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25024902|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024903|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025053|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025101|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025102|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474334|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24474335|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
25025488|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025650|NCT03635125|Nebivolol|nebivolol|mesh-list
25025651|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025652|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25025653|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
24590566|NCT00913237|Desipramine|desipramine|mesh-list
25025667|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
25025743|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25025744|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025745|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025746|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25025747|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
25025748|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25025749|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025752|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24590717|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590718|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
24590719|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590720|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
24590721|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025830|NCT03633630|Antacids|antacids|mesh-ancestor
24476160|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476161|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24476162|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476444|NCT00415064|Growth Substances|growth substances|mesh-ancestor
24476445|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
24476446|NCT00415090|Nevirapine|nevirapine|mesh-list
24476740|NCT00416377|Hormones|hormones|mesh-ancestor
25026090|NCT03631953|Trametinib|trametinib|mesh-list
25026192|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026193|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25026194|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026195|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25026196|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026197|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
25026218|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25026298|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
25026462|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026599|NCT03626506|Indapamide|indapamide|mesh-list
25112610|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
25112695|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25112696|NCT03934905|Protective Agents|protective agents|mesh-ancestor
25027295|NCT03620929|Estrogens|estrogens|mesh-ancestor
25027674|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25027696|NCT03617575|Lactoferrin|lactoferrin|mesh-list
25027697|NCT03617575|Fesoterodine|fesoterodine|mesh-list
25027698|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027810|NCT03616561|Apremilast|apremilast|mesh-list
24481376|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481377|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
24481627|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24481628|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481678|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25028142|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616616|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
25028143|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028145|NCT03613545|Rifaximin|rifaximin|mesh-list
25028146|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
25028147|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028148|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25028211|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028212|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028213|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482555|NCT00439530|Renal Agents|renal agents|mesh-ancestor
24482557|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24482558|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
24482559|NCT00439699|Memantine|memantine|mesh-list
24483654|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25028328|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028329|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028419|NCT03610932|Antioxidants|antioxidants|mesh-ancestor
25112980|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
25112981|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483877|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
25028496|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25028497|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028498|NCT03610139|Vitamin D|vitamin d|mesh-list
25028499|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
25028500|NCT03610139|Vitamins|vitamins|mesh-ancestor
25028501|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
25028502|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028503|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25028504|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484462|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25039942|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028571|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028572|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731516|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
24985487|NCT03294109|Bupivacaine|bupivacaine|mesh-list
25028594|NCT03609489|Apatinib|apatinib|mesh-list
25028595|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25028596|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
24485614|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25028654|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028685|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25028686|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25028687|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
24486355|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24486356|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25028816|NCT03607734|Amoxicillin|amoxicillin|mesh-list
25113070|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25113071|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029234|NCT03603899|Xenon|xenon|mesh-list
25029343|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029344|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25029433|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
24488515|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488516|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24488588|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25029831|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24488679|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029917|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25029936|NCT03599518|Gefitinib|gefitinib|mesh-list
25113254|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25113256|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
24488800|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24488801|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488802|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488803|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488804|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24488805|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24488806|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
24488860|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488861|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489117|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
24587959|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113303|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493055|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493056|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24493057|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
24493058|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493060|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24493181|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493186|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
25030252|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030332|NCT03596775|Analgesics|analgesics|mesh-ancestor
25030555|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
24588088|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
24588089|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588090|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588092|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24588149|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24588150|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
24588151|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588152|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588153|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25030608|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25030610|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030611|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
24495424|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495821|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
25030954|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25030955|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
25030956|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
25030957|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030958|NCT03591549|Fulvestrant|fulvestrant|mesh-list
25030959|NCT03591549|Goserelin|goserelin|mesh-list
25030960|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25030961|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030962|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25030964|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
25030967|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
24501280|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24501281|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24501308|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
24501309|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
24501312|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24501313|NCT00528060|Tenofovir|tenofovir|mesh-list
24501314|NCT00528060|Emtricitabine|emtricitabine|mesh-list
24501315|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24806074|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25031059|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24501566|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501567|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501568|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
24501569|NCT00529620|Piperaquine|piperaquine|mesh-list
24501570|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
24501700|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24501706|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24501957|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501958|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501959|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501960|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
24502021|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24502070|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
25113420|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113421|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25113422|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25113424|NCT02832544|Coagulants|coagulants|mesh-ancestor
25113425|NCT02832531|Aspirin|aspirin|mesh-list
25113426|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
25031086|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25031087|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25031088|NCT03590444|Growth Substances|growth substances|mesh-ancestor
25031089|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031090|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
25031091|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031092|NCT03590431|Iodine|iodine|mesh-list
25031093|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
25031094|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25031105|NCT03590210|Trabectedin|trabectedin|mesh-list
25031107|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031216|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25031219|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25031220|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031221|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031222|NCT03589066|Rotigotine|rotigotine|mesh-list
24502873|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502874|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502875|NCT04107675|Cyclosporine|cyclosporine|mesh-list
24502910|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502911|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25113512|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25113513|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113514|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
25113515|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
25113516|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
25113517|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113521|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113522|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113548|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24503016|NCT03713320|Vorinostat|vorinostat|mesh-list
24503017|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503018|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24503019|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503020|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503021|NCT03673787|Atezolizumab|atezolizumab|mesh-list
24503022|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503023|NCT03571802|Simvastatin|simvastatin|mesh-list
24503024|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24503025|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24503026|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
25031318|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031319|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031320|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
25031321|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031323|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
25031324|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031402|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25031403|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031404|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
25031405|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
25031413|NCT03587779|Sevoflurane|sevoflurane|mesh-list
24988278|NCT03556345|Trastuzumab|trastuzumab|mesh-list
24988279|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031571|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031577|NCT03586934|Meloxicam|meloxicam|mesh-list
25031578|NCT03586934|Morphine|morphine|mesh-list
25031579|NCT03586934|Oxycodone|oxycodone|mesh-list
25031580|NCT03586934|Tramadol|tramadol|mesh-list
25031581|NCT03586934|Hydrocodone|hydrocodone|mesh-list
25031582|NCT03586934|Ropivacaine|ropivacaine|mesh-list
25031583|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25031584|NCT03586934|Narcotics|narcotics|mesh-ancestor
25031585|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031677|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031678|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25031682|NCT03586323|Lidocaine|lidocaine|mesh-list
25031683|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
25031684|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
25031685|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031686|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031694|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
25031742|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25031743|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
25031744|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
25031745|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
25031746|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
25031747|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031748|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031749|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25031750|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25031754|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
25031813|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031814|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
25031815|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031816|NCT03585686|Cytarabine|cytarabine|mesh-list
25031817|NCT03585686|Vemurafenib|vemurafenib|mesh-list
25031818|NCT03585686|Cladribine|cladribine|mesh-list
25031896|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25032088|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032089|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504592|NCT00537121|Antidotes|antidotes|mesh-ancestor
24504593|NCT00537121|Protective Agents|protective agents|mesh-ancestor
24504595|NCT00537121|Vitamins|vitamins|mesh-ancestor
24504607|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24504608|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504609|NCT00537173|Growth Substances|growth substances|mesh-ancestor
24598789|NCT00958139|Permethrin|permethrin|mesh-list
24759129|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
25032372|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
25032523|NCT03580135|Propolis|propolis|mesh-list
25032627|NCT03579823|Adalimumab|adalimumab|mesh-list
24629581|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630993|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
24630994|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24630995|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
24630996|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24630997|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033127|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631519|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
24631520|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631521|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24631522|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
24631523|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24631524|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24631525|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033186|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24631526|NCT01118702|Methylphenidate|methylphenidate|mesh-list
24631737|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631738|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
24631739|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631741|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
24631742|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631743|NCT01119885|Fentanyl|fentanyl|mesh-list
24631744|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24633030|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24633031|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633032|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25033242|NCT03575000|Bromocriptine|bromocriptine|mesh-list
25033243|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25033244|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24443948|NCT00296348|Daclizumab|daclizumab|mesh-list
25033382|NCT03573934|Glucagon|glucagon|mesh-list
25033455|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033458|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396183|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396184|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24396185|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396186|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397175|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24397177|NCT00140998|Hormones|hormones|mesh-ancestor
24397178|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397225|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24398275|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
24398276|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033591|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25033688|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
25033761|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24401371|NCT00152815|Vitamins|vitamins|mesh-ancestor
25033876|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25033877|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
25033878|NCT03570359|Interferons|interferons|mesh-list
25033879|NCT03570359|Interferon-beta|interferon-beta|mesh-list
25033880|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
25033881|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033882|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
25033883|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033884|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
25033885|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033886|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25033887|NCT03570346|Hemay005|hemay005|mesh-list
25113896|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113897|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
25113898|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405800|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409862|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409864|NCT00183807|Celecoxib|celecoxib|mesh-list
25034130|NCT03567629|Vitamins|vitamins|mesh-ancestor
25034131|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
25034133|NCT03567447|Droxidopa|droxidopa|mesh-list
25034300|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25034330|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034331|NCT03565406|Nivolumab|nivolumab|mesh-list
25034332|NCT03565406|Ipilimumab|ipilimumab|mesh-list
24411129|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24411130|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007697|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443527|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439517|NCT00279162|Betamethasone|betamethasone|mesh-list
24460739|NCT00349401|Ketorolac|ketorolac|mesh-list
24411141|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411142|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411283|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24411284|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412036|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412037|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412038|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412039|NCT00190645|Analgesics|analgesics|mesh-ancestor
24412040|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
24412041|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412042|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412043|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412044|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
25034415|NCT03564704|Idarubicin|idarubicin|mesh-list
24412901|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24412902|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412969|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
25034540|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25034541|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25034542|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25034543|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25034563|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
24413861|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413862|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
24413863|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034639|NCT03563170|Sorafenib|sorafenib|mesh-list
25034640|NCT03563170|Avelumab|avelumab|mesh-list
24588611|NCT00903279|Retapamulin|retapamulin|mesh-list
25034641|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25034642|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588574|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24634267|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
24414696|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414725|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24601953|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25034927|NCT03560973|Gemcitabine|gemcitabine|mesh-list
25034928|NCT03560973|Ramucirumab|ramucirumab|mesh-list
25034929|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034930|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
25034931|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034932|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034933|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
25034935|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991864|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24991865|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25035263|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25035264|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25035265|NCT03557580|Diuretics|diuretics|mesh-ancestor
25035266|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
25035267|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035268|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
24416883|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416884|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24416885|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
24417035|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417766|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417768|NCT00207688|Infliximab|infliximab|mesh-list
24417802|NCT00207831|Tegafur|tegafur|mesh-list
24417803|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25035339|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035340|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25035341|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035343|NCT03556839|Paclitaxel|paclitaxel|mesh-list
25035344|NCT03556839|Bevacizumab|bevacizumab|mesh-list
25035345|NCT03556839|Carboplatin|carboplatin|mesh-list
24418443|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418636|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24418637|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418638|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
24418639|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418640|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24418641|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
24418642|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418643|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24588723|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588724|NCT00904085|Analgesics|analgesics|mesh-ancestor
24588725|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
24588726|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588727|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24588728|NCT00904098|Frovatriptan|frovatriptan|mesh-list
24588729|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24588730|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
24419324|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419593|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419594|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
24419878|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
24419879|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24419950|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
24419951|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419952|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24419953|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24419954|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035739|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25035812|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25035813|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25035814|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035815|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25035881|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035883|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035884|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423115|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24423116|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24423117|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
24423118|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
24424118|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
24797646|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24797664|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036370|NCT03547895|Silymarin|silymarin|mesh-list
25036859|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036860|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
25036861|NCT03542552|Nifedipine|nifedipine|mesh-list
25036862|NCT03542552|Analgesics|analgesics|mesh-ancestor
25037303|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25037304|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
25037305|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
25037309|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
25037396|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037397|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25037398|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
25037399|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
25037400|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25037401|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25037402|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25037403|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25037538|NCT03536611|Warfarin|warfarin|mesh-list
24430503|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
25037986|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037987|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24994538|NCT03869268|Analgesics|analgesics|mesh-ancestor
24434868|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434869|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
24434870|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24434871|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434872|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435081|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435082|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435180|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435181|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435182|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24435183|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24435184|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436302|NCT00269724|Oxybutynin|oxybutynin|mesh-list
24436524|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276050|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
25276053|NCT02367664|Vaccines|vaccines|mesh-list
25276126|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24436772|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436773|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
25276185|NCT02366481|Vitamins|vitamins|mesh-list
25276195|NCT02366481|Coagulants|coagulants|mesh-ancestor
25276196|NCT02366247|Adefovir|adefovir|mesh-list
25276197|NCT02366247|Thymalfasin|thymalfasin|mesh-list
25276198|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
24437221|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25276245|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276246|NCT02365909|Bupivacaine|bupivacaine|mesh-list
25276247|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
25276248|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
25276249|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276250|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276254|NCT02365857|Bupivacaine|bupivacaine|mesh-list
25038989|NCT04229368|Vitamins|vitamins|mesh-ancestor
25039056|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039110|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25039111|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
25039112|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
25039118|NCT04114136|Metformin|metformin|mesh-list
24566417|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276496|NCT02364752|Diuretics|diuretics|mesh-list
25276502|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
25276522|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
25039193|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039194|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25039195|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25039196|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25039197|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039198|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039206|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25039207|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
25039211|NCT04021862|Antibodies|antibodies|mesh-list
25039222|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039225|NCT03949673|Celecoxib|celecoxib|mesh-list
25039273|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276722|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276723|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
25276724|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25276901|NCT02361905|Leuprolide|leuprolide|mesh-list
25277201|NCT02359370|Lidocaine|lidocaine|mesh-list
25277217|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277243|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277312|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
25277417|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277418|NCT02358304|Calcitonin|calcitonin|mesh-list
25277419|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
25277420|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25277421|NCT02358304|Katacalcin|katacalcin|mesh-list
25277422|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277423|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277424|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25277474|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277475|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24701792|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
24701793|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24701794|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24701795|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
24701796|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701797|NCT01461031|Nefopam|nefopam|mesh-list
24701799|NCT01461031|Analgesics|analgesics|mesh-ancestor
25117497|NCT05115123|Analgesics|analgesics|mesh-ancestor
24702221|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702222|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24572216|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24703026|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277863|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277864|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277872|NCT02355197|Vitamins|vitamins|mesh-ancestor
24703405|NCT01471678|Dutasteride|dutasteride|mesh-list
24703459|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24703460|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24703461|NCT01471886|Analgesics|analgesics|mesh-ancestor
25278032|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
25362455|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278033|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278034|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
25278035|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25278036|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25278045|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
24704085|NCT01476488|Tacrolimus|tacrolimus|mesh-list
25278131|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25278132|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25278133|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
25278134|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278135|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
25278136|NCT02353182|Remifentanil|remifentanil|mesh-list
25278137|NCT02353182|Bupivacaine|bupivacaine|mesh-list
25278138|NCT02353182|Ropivacaine|ropivacaine|mesh-list
25278139|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
25278187|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
24704349|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704350|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704351|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24704352|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704353|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
24704354|NCT01477931|Bupropion|bupropion|mesh-list
24704554|NCT01478737|Dexamethasone|dexamethasone|mesh-list
25278266|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278267|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278268|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278269|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25278270|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24704727|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704728|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159193|NCT03969004|Cemiplimab|cemiplimab|mesh-list
24529541|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24705006|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
24705007|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705008|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160104|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
25279502|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
25279503|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
25279504|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279513|NCT02344641|Exenatide|exenatide|mesh-list
25279736|NCT02343393|Hydralazine|hydralazine|mesh-list
25160656|NCT02655562|Montelukast|montelukast|mesh-list
25280190|NCT02340169|Hormones|hormones|mesh-ancestor
25161694|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
25280986|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
25280987|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281100|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
25281285|NCT02332616|Protective Agents|protective agents|mesh-ancestor
24533140|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24533141|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
24533142|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433600|NCT00259168|Nateglinide|nateglinide|mesh-list
25281749|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281791|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25281792|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25281793|NCT02329132|Growth Substances|growth substances|mesh-ancestor
25281794|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281795|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
25281796|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281797|NCT02328950|Cytarabine|cytarabine|mesh-list
25281798|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
25281958|NCT02328443|Rifampin|rifampin|mesh-list
25281959|NCT02328443|Midazolam|midazolam|mesh-list
25281960|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25281961|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25281962|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281963|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281964|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25281969|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
25127097|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127098|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457956|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457957|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
25282016|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25282017|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
25282018|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25127330|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25127334|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25128444|NCT03047278|Cetirizine|cetirizine|mesh-list
24449733|NCT00316849|Sirolimus|sirolimus|mesh-list
25282430|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
25282431|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282432|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25282482|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
24708000|NCT01499251|Macitentan|macitentan|mesh-list
24708240|NCT01500837|Renal Agents|renal agents|mesh-ancestor
24708270|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24708271|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25282766|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133054|NCT03015519|Incretins|incretins|mesh-ancestor
25134282|NCT03007160|Diuretics|diuretics|mesh-ancestor
25283199|NCT04990284|Levodopa|levodopa|mesh-list
25135506|NCT02998437|Amoxicillin|amoxicillin|mesh-list
25283408|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283409|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283410|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25283418|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
25283419|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283500|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283504|NCT04278573|Vitamin D|vitamin d|mesh-list
24458209|NCT00337051|Propofol|propofol|mesh-list
25283770|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283771|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
25283772|NCT03821610|Melphalan|melphalan|mesh-list
25283773|NCT03821610|Fludarabine|fludarabine|mesh-list
24708668|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708669|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708671|NCT01501968|Colistin|colistin|mesh-list
24708672|NCT01501968|Vitamins|vitamins|mesh-ancestor
24708673|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
25283810|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
25283811|NCT03768414|Gemcitabine|gemcitabine|mesh-list
25283812|NCT03768414|Paclitaxel|paclitaxel|mesh-list
25141833|NCT02954484|Narcotics|narcotics|mesh-ancestor
25284011|NCT03181126|Venetoclax|venetoclax|mesh-list
25284012|NCT03181126|Navitoclax|navitoclax|mesh-list
25284013|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284214|NCT05080803|Aflibercept|aflibercept|mesh-list
25145330|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
25284336|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
25146448|NCT02921269|Atezolizumab|atezolizumab|mesh-list
25146449|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
25284670|NCT05084196|Melatonin|melatonin|mesh-list
25284697|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040814|NCT02813447|Sertraline|sertraline|mesh-list
25041096|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25041097|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041098|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286529|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
25286750|NCT03150368|Docetaxel|docetaxel|mesh-list
25044900|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044901|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
25287090|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
25114934|NCT03119714|Pemirolast|pemirolast|mesh-list
25115261|NCT03117530|Minocycline|minocycline|mesh-list
25288153|NCT04089150|Leucovorin|leucovorin|mesh-list
25288195|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288196|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25288198|NCT03789604|Antibodies|antibodies|mesh-list
25116237|NCT03109977|Pertuzumab|pertuzumab|mesh-list
25116834|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
25116954|NCT03105180|Sorbitol|sorbitol|mesh-list
25362613|NCT05284643|Bevacizumab|bevacizumab|mesh-list
25289420|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289421|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
25289655|NCT05084027|Venetoclax|venetoclax|mesh-list
25289656|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289657|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117970|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
25118387|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
25118786|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118788|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25290543|NCT04546620|Hormones|hormones|mesh-ancestor
24812738|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
24900636|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
25290942|NCT02632396|Rituximab|rituximab|mesh-list
25119396|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119397|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
25291440|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120033|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120034|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291520|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
25291521|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25291522|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
25291523|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291524|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291525|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25291526|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
24711638|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
24711950|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
24712265|NCT01519401|Estradiol|estradiol|mesh-list
25121152|NCT03104998|Ubiquinone|ubiquinone|mesh-list
24614735|NCT01026129|Lidocaine|lidocaine|mesh-list
24715285|NCT01535612|Insulin|insulin|mesh-list
24716467|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24717148|NCT01545947|Azacitidine|azacitidine|mesh-list
24718653|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24718654|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
24718659|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24505536|NCT00541359|Bortezomib|bortezomib|mesh-list
24718660|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
25121959|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122185|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122186|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122187|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122250|NCT03095222|Ketamine|ketamine|mesh-list
24720200|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720309|NCT01567657|Meperidine|meperidine|mesh-list
24720677|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720678|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720679|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24720680|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
24720681|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25122456|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122458|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
25122460|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721087|NCT01572116|Narcotics|narcotics|mesh-ancestor
24721542|NCT01575483|Saxagliptin|saxagliptin|mesh-list
24721543|NCT01575483|Incretins|incretins|mesh-ancestor
24721544|NCT01575483|Hormones|hormones|mesh-ancestor
24721762|NCT01576770|Lidocaine|lidocaine|mesh-list
24722107|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722892|NCT01583426|Paclitaxel|paclitaxel|mesh-list
24723571|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24723572|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25122780|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122781|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615837|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
24615838|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24615839|NCT01032109|Bevacizumab|bevacizumab|mesh-list
24615840|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24615841|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511619|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724480|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724481|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724482|NCT01593280|Analgesics|analgesics|mesh-ancestor
25122903|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122904|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25122905|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122907|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
25123039|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25123109|NCT03088072|Edoxaban|edoxaban|mesh-list
24727414|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123207|NCT03087162|Lansoprazole|lansoprazole|mesh-list
24616730|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
24616731|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729837|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729893|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616747|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730117|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
24730119|NCT01626222|Exemestane|exemestane|mesh-list
24731851|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731852|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123712|NCT03082183|Rifampin|rifampin|mesh-list
24617776|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617777|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
25077595|NCT03363659|Copper|copper|mesh-list
25124087|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
25124112|NCT03079427|Capecitabine|capecitabine|mesh-list
25124113|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124114|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25124115|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
24739682|NCT01683292|Emetics|emetics|mesh-ancestor
24740105|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740106|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24740107|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740108|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
24740109|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24740110|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740116|NCT01686464|Valacyclovir|valacyclovir|mesh-list
25124269|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24740522|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24740675|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
24741096|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741098|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
24741099|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24741100|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124479|NCT03076099|Analgesics|analgesics|mesh-ancestor
25124480|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
25124481|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741597|NCT05291130|Vitamin E|vitamin e|mesh-list
25124549|NCT03075241|Zolpidem|zolpidem|mesh-list
24742575|NCT05220826|Ethanol|ethanol|mesh-list
25124627|NCT03073928|Ropivacaine|ropivacaine|mesh-list
24954786|NCT03871972|Sirolimus|sirolimus|mesh-list
24743419|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743506|NCT04761159|Ketamine|ketamine|mesh-list
24743942|NCT04562831|Niacinamide|niacinamide|mesh-list
24408751|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
24744725|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124786|NCT03072485|Sirolimus|sirolimus|mesh-list
24747923|NCT03015792|Hormones|hormones|mesh-ancestor
24749526|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663274|NCT01299948|Prednisolone|prednisolone|mesh-list
25125034|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619304|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619305|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
24619306|NCT01051947|Metoprolol|metoprolol|mesh-list
24753459|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753460|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753461|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753462|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
24754663|NCT01722240|Incretins|incretins|mesh-ancestor
24755265|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755266|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
24755267|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24755268|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755319|NCT01725802|Levodopa|levodopa|mesh-list
24755750|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
24756183|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24756240|NCT01731782|Bupivacaine|bupivacaine|mesh-list
24756263|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756265|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24756266|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619708|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756630|NCT01734824|Teriparatide|teriparatide|mesh-list
24756631|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
24756632|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24756633|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756634|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24756635|NCT01734915|Iproplatin|iproplatin|mesh-list
24756636|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757076|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24757077|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757078|NCT01737671|Leucovorin|leucovorin|mesh-list
24757079|NCT01737671|Methotrexate|methotrexate|mesh-list
24757080|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24421783|NCT00220194|Leuprolide|leuprolide|mesh-list
24757081|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
24757082|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757083|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757103|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
25125249|NCT03070223|Pitavastatin|pitavastatin|mesh-list
25125250|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25125251|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25125252|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25125253|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
25125254|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125255|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125309|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24758641|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24758642|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758643|NCT01747135|Betadex|betadex|mesh-list
24758646|NCT01747148|Radavirsen|radavirsen|mesh-list
24829636|NCT02153541|Emollients|emollients|mesh-ancestor
25125526|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125527|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
25125528|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125529|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125530|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125531|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25125532|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407868|NCT00175747|Hormones|hormones|mesh-ancestor
24407869|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407870|NCT00175812|Tretinoin|tretinoin|mesh-list
24407871|NCT00175812|Theophylline|theophylline|mesh-list
24408079|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408080|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24408082|NCT00176527|Interferons|interferons|mesh-list
24409438|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25125630|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25125631|NCT03067753|Protective Agents|protective agents|mesh-ancestor
25125632|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25125633|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125634|NCT03067792|Leucovorin|leucovorin|mesh-list
25125635|NCT03067792|Docetaxel|docetaxel|mesh-list
25125636|NCT03067792|Fluorouracil|fluorouracil|mesh-list
25125637|NCT03067792|Irinotecan|irinotecan|mesh-list
24459963|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
25125658|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24413307|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413308|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
24413309|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
24413310|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413311|NCT00193531|Paclitaxel|paclitaxel|mesh-list
24413312|NCT00193531|Etoposide|etoposide|mesh-list
24698160|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698187|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24698189|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
24698663|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
24698199|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24698200|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698202|NCT01439750|Bortezomib|bortezomib|mesh-list
24698203|NCT01439750|Cladribine|cladribine|mesh-list
25010704|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24698641|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
24698642|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010762|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429662|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24429663|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24699213|NCT01445522|Veliparib|veliparib|mesh-list
24699215|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
24613011|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699774|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24700442|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700443|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
24700455|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701075|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701076|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701077|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701078|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
25010958|NCT02539160|Ticagrelor|ticagrelor|mesh-list
24701373|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
24701374|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701376|NCT01458626|Paroxetine|paroxetine|mesh-list
24701377|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24701378|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24701379|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24701385|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
24634175|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24634177|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
24634181|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634182|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819538|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819540|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
24819541|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24819563|NCT02096055|Idarubicin|idarubicin|mesh-list
24953435|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953437|NCT03884881|Imipenem|imipenem|mesh-list
24953438|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953439|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953440|NCT03885141|Zolpidem|zolpidem|mesh-list
24953441|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24953442|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24953452|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915823|NCT04248179|Ropivacaine|ropivacaine|mesh-list
24825479|NCT02128633|Listerine|listerine|mesh-list
24915989|NCT04246502|Trastuzumab|trastuzumab|mesh-list
24915990|NCT04246502|Pertuzumab|pertuzumab|mesh-list
24915991|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25065612|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065613|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065781|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065912|NCT04905121|Psilocybin|psilocybin|mesh-list
24916188|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24916194|NCT04243733|Pemetrexed|pemetrexed|mesh-list
25066069|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24819802|NCT02097329|TEMPO|tempo|mesh-list
24916527|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
24916528|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916635|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
24491360|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
24520490|NCT00630565|Sargramostim|sargramostim|mesh-list
24916543|NCT04239625|Retinol acetate|retinol acetate|mesh-list
24916544|NCT04239625|Vitamins|vitamins|mesh-ancestor
24916545|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
24916546|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916547|NCT04239625|Protective Agents|protective agents|mesh-ancestor
24916817|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916852|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24916853|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
24916854|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24916948|NCT04235569|Enoxaparin|enoxaparin|mesh-list
24917024|NCT04234997|Suvorexant|suvorexant|mesh-list
24819856|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24917204|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
24917264|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24917265|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24917266|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917267|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24917268|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25066541|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25066544|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917627|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24917629|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
24917631|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066835|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917845|NCT04225364|Paclitaxel|paclitaxel|mesh-list
24917945|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
24492799|NCT00488137|Prucalopride|prucalopride|mesh-list
24918248|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24918249|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24520853|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24520854|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
24918335|NCT04220528|Capecitabine|capecitabine|mesh-list
24826185|NCT02133105|Simendan|simendan|mesh-list
24617147|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066892|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066893|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
24493457|NCT00490997|Analgesics|analgesics|mesh-ancestor
24443341|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918817|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
24918818|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24918819|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826531|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
24826532|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
24918988|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24918989|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918990|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24437388|NCT00273507|Carboplatin|carboplatin|mesh-list
24437389|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24657191|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24494156|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24494157|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24494159|NCT00494104|Vitamin D|vitamin d|mesh-list
24437849|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437850|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437851|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24437852|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24437926|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
24919314|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919315|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24919326|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919327|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438206|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438208|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
24919458|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24919459|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24919460|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919461|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494462|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494463|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
24521292|NCT04898894|Methotrexate|methotrexate|mesh-list
24919551|NCT04210453|Ascorbic Acid|ascorbic acid|mesh-list
24919659|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
24919700|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919701|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919702|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24919703|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24919704|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
25067060|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067061|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25067062|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
25067063|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25067064|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067065|NCT03447470|Nivolumab|nivolumab|mesh-list
25067069|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067070|NCT03447184|Androgens|androgens|mesh-list
24919761|NCT04208581|Xhance|xhance|mesh-list
24443942|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443943|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443944|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494829|NCT00497237|Fluticasone|fluticasone|mesh-list
24919822|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919823|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
24919824|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24919825|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24919826|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24919827|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919828|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521486|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521487|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
24521488|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
24521489|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
24623830|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
24623831|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623832|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623837|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24521593|NCT04642651|Analgesics|analgesics|mesh-ancestor
24521594|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
24521595|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521596|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24521597|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24521598|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24521599|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
24521600|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521601|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919883|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24919908|NCT04207723|Paroxetine|paroxetine|mesh-list
24919946|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443989|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919947|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919951|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
24495175|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24495176|NCT00498953|Carboplatin|carboplatin|mesh-list
24495178|NCT00498953|Fluorouracil|fluorouracil|mesh-list
24495179|NCT00498953|Lapatinib|lapatinib|mesh-list
24495180|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24521673|NCT04605861|Liraglutide|liraglutide|mesh-list
24521674|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24521675|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521676|NCT04605861|Incretins|incretins|mesh-ancestor
24623878|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
24495210|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
24920082|NCT04205240|Daratumumab|daratumumab|mesh-list
24439105|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439107|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24439108|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439112|NCT00277602|Riluzole|riluzole|mesh-list
24920366|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920367|NCT04202978|Capecitabine|capecitabine|mesh-list
24620219|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620220|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620221|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
24522202|NCT04111926|Analgesics|analgesics|mesh-ancestor
25040206|NCT03318393|Heparin|heparin|mesh-list
24672971|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
24672972|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24673155|NCT01335646|Analgesics|analgesics|mesh-list
24673557|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673558|NCT01338896|Rotigotine|rotigotine|mesh-list
24673561|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673562|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456837|NCT00332384|Timolol|timolol|mesh-list
24675953|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
24440144|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610788|NCT01005160|Metformin|metformin|mesh-list
24676611|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676612|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
24676615|NCT01351428|Nifedipine|nifedipine|mesh-list
24854149|NCT02272270|Temozolomide|temozolomide|mesh-list
24676938|NCT01353378|Analgesics|analgesics|mesh-ancestor
24677173|NCT01354613|Amlodipine|amlodipine|mesh-list
24610968|NCT01005979|Rituximab|rituximab|mesh-list
24678832|NCT01364571|Vaccines|vaccines|mesh-list
24680069|NCT01372904|Hormones|hormones|mesh-ancestor
24680269|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
24681072|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
24681720|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24457302|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24457304|NCT00333944|Pralidoxime|pralidoxime|mesh-list
24682847|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24683095|NCT01389908|Olanzapine|olanzapine|mesh-list
24683158|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
24684428|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033615|NCT03572088|Terlipressin|terlipressin|mesh-list
24684429|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24684700|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
24685250|NCT00492167|Antibodies|antibodies|mesh-list
24686088|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
24683326|NCT01391260|Gefitinib|gefitinib|mesh-list
24687861|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24688490|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
24396192|NCT00138099|Dalteparin|dalteparin|mesh-list
24855367|NCT02279342|Febuxostat|febuxostat|mesh-list
24699943|NCT01449799|Xhance|xhance|mesh-list
24634344|NCT01132911|Bortezomib|bortezomib|mesh-list
24635632|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24635634|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636136|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24636137|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
24636138|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
24637522|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24638745|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639123|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690430|NCT01401933|Rifampin|rifampin|mesh-list
24641379|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24642265|NCT01178658|Melphalan|melphalan|mesh-list
24643451|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24643452|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643454|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643456|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24645771|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651339|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
24651340|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696457|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
24651623|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651624|NCT01232439|Aticaprant|aticaprant|mesh-list
24812990|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659351|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24533855|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533856|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533857|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24533858|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533859|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24534120|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
24534283|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
24450385|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24534519|NCT00647257|Losartan|losartan|mesh-list
24548886|NCT00712504|Sunitinib|sunitinib|mesh-list
24549480|NCT00715637|Cytarabine|cytarabine|mesh-list
24549501|NCT00715689|Hormones|hormones|mesh-list
24940217|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24940218|NCT04002635|Progesterone|progesterone|mesh-list
24940219|NCT04002635|Estrogens|estrogens|mesh-ancestor
24940220|NCT04002635|Hormones|hormones|mesh-ancestor
24550214|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450048|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701943|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24701944|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24702077|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
24702078|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
24702079|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24702080|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702081|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
24702082|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702083|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
24956414|NCT03854708|Hormones|hormones|mesh-ancestor
24702105|NCT01464060|Amoxicillin|amoxicillin|mesh-list
24702260|NCT01464944|Aspirin|aspirin|mesh-list
24702261|NCT01464944|Acetaminophen|acetaminophen|mesh-list
24702262|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24702263|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24487940|NCT00465907|Paclitaxel|paclitaxel|mesh-list
24702264|NCT01464944|Analgesics|analgesics|mesh-ancestor
24702265|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
24702266|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940494|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24703584|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703860|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703861|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24613501|NCT01019434|Sirolimus|sirolimus|mesh-list
24704333|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704334|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
24704602|NCT01479088|Cinacalcet|cinacalcet|mesh-list
24705745|NCT01486511|Hematinics|hematinics|mesh-ancestor
24705747|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
24706081|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24613668|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24613669|NCT01020279|Analgesics|analgesics|mesh-ancestor
24613670|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
24956792|NCT03851393|Citric Acid|citric acid|mesh-list
25050698|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
25050699|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
25050700|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706352|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706488|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706489|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706490|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24706491|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706492|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
24706895|NCT01492959|Insulin|insulin|mesh-list
24707495|NCT01496196|Coagulants|coagulants|mesh-ancestor
24707903|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
24940839|NCT03997006|Acefyllin piperazinate|acefyllin piperazinate|mesh-list
24940840|NCT03997006|Neostigmine|neostigmine|mesh-list
24613904|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613905|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
24709204|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710087|NCT01508364|Sorafenib|sorafenib|mesh-list
24710363|NCT01509976|Triclosan|triclosan|mesh-list
24711659|NCT01516567|Etoposide|etoposide|mesh-list
24711660|NCT01516567|Vincristine|vincristine|mesh-list
24940944|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833810|NCT02175888|Iron|iron|mesh-list
24715909|NCT01538953|Eusol|eusol|mesh-list
24716616|NCT01542723|Nadroparin|nadroparin|mesh-list
24716725|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
24717648|NCT01549158|Torsemide|torsemide|mesh-list
24941668|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24718040|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
24718041|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718043|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24718044|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718045|NCT01551628|BCT-100|bct-100|mesh-list
24718046|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718047|NCT01551641|Thalidomide|thalidomide|mesh-list
24718048|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718826|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24719350|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
24719968|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
24719969|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24720158|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24720184|NCT01566825|Analgesics|analgesics|mesh-ancestor
24720613|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721691|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24721692|NCT01576419|Analgesics|analgesics|mesh-ancestor
24721693|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
24721696|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615530|NCT01030094|Analgesics|analgesics|mesh-ancestor
24722305|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722306|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722307|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24723217|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
24724949|NCT01595815|Calcium|calcium|mesh-list
24512737|NCT00576433|Rituximab|rituximab|mesh-list
24725217|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
24616155|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
24726625|NCT01604811|Urological Agents|urological agents|mesh-ancestor
24616269|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24726970|NCT01607125|Vortioxetine|vortioxetine|mesh-list
24727136|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24727137|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24727138|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727164|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
24727165|NCT01608347|Folic Acid|folic acid|mesh-list
24727166|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
24727167|NCT01608347|Hematinics|hematinics|mesh-ancestor
24727168|NCT01608347|Vitamins|vitamins|mesh-ancestor
24727169|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
24648374|NCT01213888|Trientine|trientine|mesh-list
24727170|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727172|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
24727173|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
24727174|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727175|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727183|NCT01608373|Lidocaine|lidocaine|mesh-list
24616366|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616367|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24616368|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616369|NCT01036659|Coagulants|coagulants|mesh-ancestor
24616370|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
24841159|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616371|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
24616372|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24727778|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727779|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727780|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727783|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
24727784|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727785|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727786|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
24727787|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24727870|NCT01613092|Vancomycin|vancomycin|mesh-list
24727933|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727934|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727935|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24727936|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
24728047|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24728048|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24728049|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24728050|NCT01613963|Analgesics|analgesics|mesh-ancestor
24942166|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24942171|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
24942172|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728162|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24728179|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24728180|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24728181|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24728301|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24728303|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
24728304|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728305|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
24728415|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728417|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24728418|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
24728419|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728508|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24728509|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
24728510|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
24728511|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728512|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24728529|NCT01616888|Paclitaxel|paclitaxel|mesh-list
24728530|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24728531|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728563|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
24616503|NCT01037595|Turmeric extract|turmeric extract|mesh-list
24616507|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616509|NCT01037608|Analgesics|analgesics|mesh-ancestor
24616510|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
24616511|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616512|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818707|NCT02090400|Calcium|calcium|mesh-list
24855456|NCT02279628|Morphine|morphine|mesh-list
24729587|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24729665|NCT01623102|Bevacizumab|bevacizumab|mesh-list
24729667|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24787127|NCT01923831|Analgesics|analgesics|mesh-ancestor
24729670|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24942248|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
24729745|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
24729746|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729747|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729748|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
24729749|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729750|NCT01623713|Risperidone|risperidone|mesh-list
24616705|NCT01038882|Midazolam|midazolam|mesh-list
24729997|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730165|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730166|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
24730167|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24730168|NCT01626651|Ketoconazole|ketoconazole|mesh-list
24616837|NCT01039441|Bupivacaine|bupivacaine|mesh-list
24731581|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
25051004|NCT00451152|Anecortave|anecortave|mesh-list
24731633|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
24731749|NCT01636336|Progesterone|progesterone|mesh-list
24731894|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24732267|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732268|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
24942350|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
24942351|NCT03982004|Imiquimod|imiquimod|mesh-list
24855652|NCT02280525|Cytarabine|cytarabine|mesh-list
24732312|NCT01638780|Protective Agents|protective agents|mesh-ancestor
24732313|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732314|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732327|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
24732328|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
24942391|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732928|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24732929|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24732930|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732931|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732932|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24732933|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
24732934|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732935|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24732936|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
24732937|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24732938|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617270|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617271|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617272|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24733024|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733025|NCT01642979|Cyclosporine|cyclosporine|mesh-list
24733027|NCT01642979|Cyclosporins|cyclosporins|mesh-list
24733028|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
24733029|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819721|NCT02097017|Lidocaine|lidocaine|mesh-list
24733039|NCT01642979|Hormones|hormones|mesh-ancestor
24733257|NCT01644799|Lenalidomide|lenalidomide|mesh-list
24443201|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733435|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24733436|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24733437|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051063|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051064|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24617380|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24617381|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24617382|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24617383|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
24617385|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733697|NCT01647984|Vitamin E|vitamin e|mesh-list
24733698|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
24733699|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
24733700|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733701|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
24733702|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733703|NCT01647984|Protective Agents|protective agents|mesh-ancestor
24733704|NCT01648010|Mitomycins|mitomycins|mesh-list
24733705|NCT01648010|Mitomycin|mitomycin|mesh-list
24734004|NCT01650181|Selenium|selenium|mesh-list
24734495|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
24734496|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24734497|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
24734498|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942590|NCT03979469|Ketamine|ketamine|mesh-list
24734931|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
24734932|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734933|NCT01654913|Chrysarobin|chrysarobin|mesh-list
24734934|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24734935|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24734936|NCT01654913|Analgesics|analgesics|mesh-ancestor
24734937|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
24734938|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735335|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
24735336|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735337|NCT01656538|Paclitaxel|paclitaxel|mesh-list
24735338|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24735339|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942650|NCT03978988|Aspirin|aspirin|mesh-list
24735514|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735515|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24735516|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735517|NCT01657448|Methenamine|methenamine|mesh-list
24735518|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
24735520|NCT01657448|Methylene Blue|methylene blue|mesh-list
24735767|NCT01658462|Docetaxel|docetaxel|mesh-list
24736546|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736547|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
24943026|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943027|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
24943029|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943030|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
24943031|NCT03975205|Doxorubicin|doxorubicin|mesh-list
24943038|NCT03975036|Antibodies|antibodies|mesh-list
24736594|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24736595|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
24525339|NCT03633058|Ketamine|ketamine|mesh-list
24525340|NCT03633058|Analgesics|analgesics|mesh-ancestor
24525378|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
24736645|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24736646|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736662|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
24736797|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736798|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959092|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24737329|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737330|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
24943688|NCT03967938|Olaparib|olaparib|mesh-list
24737916|NCT01671774|Analgesics|analgesics|mesh-ancestor
24943821|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24738556|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738785|NCT01677403|Tobramycin|tobramycin|mesh-list
24738958|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24738959|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
24738960|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738961|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738962|NCT01678495|Plasminogen|plasminogen|mesh-list
24738963|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24738964|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24738965|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24738966|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943907|NCT03965949|Hormones|hormones|mesh-list
24739313|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739314|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
24739315|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739440|NCT01681550|Incretins|incretins|mesh-list
24739617|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
24739619|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740089|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
24740221|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740360|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
24740361|NCT01688024|Mitomycins|mitomycins|mesh-list
24740362|NCT01688024|Mitomycin|mitomycin|mesh-list
24740363|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24740364|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740365|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
24740367|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24740622|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
24740623|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24740624|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740625|NCT01689311|Alprostadil|alprostadil|mesh-list
24740754|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24741055|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24741056|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24741057|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741059|NCT01691495|Fondaparinux|fondaparinux|mesh-list
24741060|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24741061|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
24741062|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24741160|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741161|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741162|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
24943973|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
24943974|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
24741163|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741687|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24741986|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24742466|NCT05264896|Vitamins|vitamins|mesh-ancestor
24742772|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
24742773|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742774|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407970|NCT00176020|Niacin|niacin|mesh-list
24743339|NCT04871425|Ketamine|ketamine|mesh-list
24743343|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743817|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24743818|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24743819|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
24743820|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743821|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743824|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743826|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
24743917|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
24743918|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
24743928|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24743929|NCT04564885|Analgesics|analgesics|mesh-ancestor
24743950|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
24743951|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743952|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24743953|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
24743954|NCT04561375|Fentanyl|fentanyl|mesh-list
24743955|NCT04561375|Sufentanil|sufentanil|mesh-list
24743956|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24743957|NCT04561375|Narcotics|narcotics|mesh-ancestor
24744228|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744229|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24744230|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
24744231|NCT04417361|Erenumab|erenumab|mesh-list
24744232|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24744502|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24653193|NCT01242332|Pregabalin|pregabalin|mesh-list
24744711|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744712|NCT04180085|Abatacept|abatacept|mesh-list
24744713|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24744714|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744715|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744716|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24744717|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
24744718|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744719|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744886|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744887|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24744888|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744889|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
24653476|NCT01243996|Ibuprofen|ibuprofen|mesh-list
24744890|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24744930|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744932|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
24745092|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
24745093|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24745194|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24618559|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24618560|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24653670|NCT01244958|Rituximab|rituximab|mesh-list
24535286|NCT00648934|Topiramate|topiramate|mesh-list
24745382|NCT03796416|Misoprostol|misoprostol|mesh-list
24745383|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24745894|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24745895|NCT03529396|Analgesics|analgesics|mesh-ancestor
24745896|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
24944111|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051244|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944149|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
24857359|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
24745897|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746016|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24746017|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24746018|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24746019|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746020|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
24410503|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24746025|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24746026|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618569|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24618570|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24944153|NCT03962881|Vaccines|vaccines|mesh-list
24944154|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
24959952|NCT03820245|Lycopene|lycopene|mesh-list
24944155|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944156|NCT03962920|Tigecycline|tigecycline|mesh-list
24944157|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851164|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851165|NCT02255747|Lactulose|lactulose|mesh-list
24746365|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24746366|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746367|NCT05437471|Progestins|progestins|mesh-ancestor
24746368|NCT05437471|Hormones|hormones|mesh-ancestor
24746369|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
24746370|NCT05437432|Methamphetamine|methamphetamine|mesh-list
24746371|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24746372|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746373|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
24746374|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
24746485|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24746641|NCT04590586|Thalidomide|thalidomide|mesh-list
24746642|NCT04590586|Apremilast|apremilast|mesh-list
24746643|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24746644|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24746645|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24746798|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
24944187|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
24944188|NCT03962725|Ketamine|ketamine|mesh-list
24746859|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24747158|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24747160|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24747161|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24747162|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24747163|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24747164|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
24618670|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24618671|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24618672|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24747907|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747911|NCT03015792|Dexamethasone|dexamethasone|mesh-list
24944244|NCT03962283|Rifaximin|rifaximin|mesh-list
24748207|NCT02787551|Exenatide|exenatide|mesh-list
24748208|NCT02787551|Dulaglutide|dulaglutide|mesh-list
24538990|NCT00661635|Valdecoxib|valdecoxib|mesh-list
24944350|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944363|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
24944364|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24769568|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
24769569|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24769570|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24769571|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625898|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625904|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24625905|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24625906|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
24749471|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24749472|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
24749474|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
24749577|NCT00579527|Tacrolimus|tacrolimus|mesh-list
24749578|NCT00579527|Cyclosporins|cyclosporins|mesh-list
24749579|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
24749580|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24749581|NCT00579527|Daclizumab|daclizumab|mesh-list
24614276|NCT01023347|Paclitaxel|paclitaxel|mesh-list
24750127|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24750634|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750635|NCT01699776|Protective Agents|protective agents|mesh-ancestor
24750636|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594603|NCT00934739|Celecoxib|celecoxib|mesh-list
24751263|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751287|NCT01703325|Triamcinolone|triamcinolone|mesh-list
24751365|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24751411|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751427|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751428|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751429|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24751431|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
24751712|NCT01705639|Melatonin|melatonin|mesh-list
24752060|NCT01708005|Vitamin D|vitamin d|mesh-list
24857651|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
24715965|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24715966|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715967|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715968|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
24752198|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752199|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
24944494|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24752278|NCT01709682|Propafenone|propafenone|mesh-list
24752279|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24752280|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
24752306|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752307|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752308|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24752573|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
24752574|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24752575|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
24752816|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24752818|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
24752828|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24752829|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752832|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
24752833|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
24752834|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
24752835|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24752836|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
24944576|NCT03959397|Paclitaxel|paclitaxel|mesh-list
24944577|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24944578|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24944579|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752837|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24658464|NCT01271881|Heparin|heparin|mesh-list
24752965|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
24752966|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752967|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
24752968|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
24619245|NCT01051544|Factor VIII|factor viii|mesh-list
24619246|NCT01051544|Coagulants|coagulants|mesh-ancestor
24619261|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24619262|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619263|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
24619264|NCT01051648|Hormones|hormones|mesh-ancestor
24944599|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24944600|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
24944601|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619265|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417642|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
24417643|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
24718388|NCT01554813|Vaccines|vaccines|mesh-list
24753078|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24769803|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769804|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
24769805|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
24769806|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857749|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753217|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24753218|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753234|NCT01714297|Tinzaparin|tinzaparin|mesh-list
24753369|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24753370|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24753372|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753373|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24753374|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24753375|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24753377|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24753378|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944624|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24944626|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753482|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418113|NCT00208585|Sertraline|sertraline|mesh-list
24753484|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
24753485|NCT01715610|Clindamycin|clindamycin|mesh-list
24753486|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
24753487|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
24753495|NCT01715636|Tenofovir|tenofovir|mesh-list
24753556|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753557|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
24753558|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753563|NCT01715987|Tenofovir|tenofovir|mesh-list
24753564|NCT01715987|Entecavir|entecavir|mesh-list
24753566|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753567|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24753568|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24753569|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753571|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24753735|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418365|NCT00209469|Alendronate|alendronate|mesh-list
24753844|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753845|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753846|NCT01718093|Incretins|incretins|mesh-ancestor
24753909|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944684|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24753974|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24753975|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754076|NCT01718951|Golimumab|golimumab|mesh-list
24944690|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944691|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944692|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24944693|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
24754176|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944703|NCT03958396|Remifentanil|remifentanil|mesh-list
24619442|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944724|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24722500|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
24754410|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754436|NCT01720498|Remifentanil|remifentanil|mesh-list
24754437|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24754438|NCT01720498|Narcotics|narcotics|mesh-ancestor
24754441|NCT01720498|Analgesics|analgesics|mesh-ancestor
24754514|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
24754515|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754516|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
24605486|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605527|NCT00985777|Tocotrienols|tocotrienols|mesh-list
24605528|NCT00985777|Vitamins|vitamins|mesh-ancestor
24605529|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
24605530|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605531|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
24944761|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24944762|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
24944786|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
24944787|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944788|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24944789|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24944830|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944831|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944832|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24944833|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
24944834|NCT03956966|Hormones|hormones|mesh-ancestor
24857882|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857883|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542717|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
24770094|NCT01817894|Eflornithine|eflornithine|mesh-list
24770095|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944898|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857917|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754808|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
24754809|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
24754810|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754811|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24754812|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24944927|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24857933|NCT02294539|Losartan|losartan|mesh-list
24754958|NCT01724190|Vitamin D|vitamin d|mesh-list
24755053|NCT01724424|Melatonin|melatonin|mesh-list
24755196|NCT01725100|Trametinib|trametinib|mesh-list
24755282|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
24945027|NCT03954860|Coagulants|coagulants|mesh-ancestor
24945028|NCT03954873|Glucagon|glucagon|mesh-list
24945029|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24945031|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24945032|NCT03954873|Hormones|hormones|mesh-ancestor
24857955|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24857956|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
24857957|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543271|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543272|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619569|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24619583|NCT01053026|Olmesartan|olmesartan|mesh-list
24755429|NCT01726530|Fentanyl|fentanyl|mesh-list
24755430|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24755431|NCT01726530|Narcotics|narcotics|mesh-ancestor
24755432|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755433|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755434|NCT01726530|Analgesics|analgesics|mesh-ancestor
24755436|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755437|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24755438|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24755440|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
24755533|NCT01727050|Coagulants|coagulants|mesh-ancestor
24755534|NCT01727271|Interferons|interferons|mesh-list
24755535|NCT01727271|Tenofovir|tenofovir|mesh-list
24755536|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
24755783|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24420796|NCT00216827|Calcipotriene|calcipotriene|mesh-list
24756043|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
24661962|NCT01291602|Avibactam|avibactam|mesh-list
24756045|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
24756152|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756153|NCT01731301|Ribavirin|ribavirin|mesh-list
24756154|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
24756158|NCT01731327|Tofacitinib|tofacitinib|mesh-list
24756330|NCT01732367|Tenofovir|tenofovir|mesh-list
24421064|NCT00217555|Gemcitabine|gemcitabine|mesh-list
24756365|NCT01732744|Eusol|eusol|mesh-list
24407106|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945112|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24945113|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24770344|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24770345|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24619701|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619702|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24756599|NCT01734564|Poly I-C|poly i-c|mesh-list
24756791|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756792|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
24756939|NCT01736761|Ritonavir|ritonavir|mesh-list
24757173|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24757174|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
24757175|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757176|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
24757177|NCT01738243|Protective Agents|protective agents|mesh-ancestor
24757178|NCT01738282|Baclofen|baclofen|mesh-list
24757181|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24757281|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757284|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24757285|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24757286|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24757287|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757288|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24757289|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757290|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
24757291|NCT01739049|Liraglutide|liraglutide|mesh-list
24757294|NCT01739049|Incretins|incretins|mesh-ancestor
24757335|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730711|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24945147|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945161|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945162|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
24945163|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945164|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24757523|NCT01740921|Analgesics|analgesics|mesh-ancestor
24945166|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24945167|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945168|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858046|NCT02294955|Amiodarone|amiodarone|mesh-list
24422274|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757628|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663003|NCT01297894|Fosfomycin|fosfomycin|mesh-list
24757629|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757630|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24619835|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24619836|NCT01053949|Growth Substances|growth substances|mesh-ancestor
24619837|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
24619838|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663114|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
24619839|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619840|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
24619841|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24757780|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24757833|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757834|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757835|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757836|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24757837|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757838|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757915|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757916|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
24498553|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
24758187|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24758188|NCT01744262|Anesthetics|anesthetics|mesh-list
24758189|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758190|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758278|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24758279|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
24758280|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
24758281|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758282|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923342|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
24758414|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
24758415|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24758416|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24758417|NCT01745640|Growth Substances|growth substances|mesh-ancestor
24758418|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
24758420|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24758421|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24758530|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758531|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24758532|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
24758533|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758534|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758535|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
24758536|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758543|NCT01746719|Etodolac|etodolac|mesh-list
24758546|NCT01746719|Analgesics|analgesics|mesh-ancestor
24758625|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
24758626|NCT01747044|Milnacipran|milnacipran|mesh-list
24758713|NCT01747590|Zolpidem|zolpidem|mesh-list
24758714|NCT01747590|Alprazolam|alprazolam|mesh-list
24758866|NCT01748344|Cetirizine|cetirizine|mesh-list
24945444|NCT03950518|Levamisole|levamisole|mesh-list
25051393|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
25051411|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051412|NCT00406809|Navitoclax|navitoclax|mesh-list
25051413|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051414|NCT00406588|Levodopa|levodopa|mesh-list
25051415|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24396412|NCT00138970|Protective Agents|protective agents|mesh-ancestor
24398112|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
24945886|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945887|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
24945888|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24858735|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858736|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24399192|NCT00146900|Citalopram|citalopram|mesh-list
24399643|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399738|NCT00148551|Hormones|hormones|mesh-ancestor
24402856|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
24402858|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
24402859|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402860|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24459898|NCT00346801|Analgesics|analgesics|mesh-ancestor
24407558|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407559|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407560|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24407826|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
24408283|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24408284|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408285|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408286|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
24408287|NCT00177138|Tacrolimus|tacrolimus|mesh-list
24408288|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408289|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
24408290|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409348|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
24946466|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946467|NCT03939273|Metronidazole|metronidazole|mesh-list
24946468|NCT03939273|Vancomycin|vancomycin|mesh-list
24946469|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
24946470|NCT03939273|Fluconazole|fluconazole|mesh-list
24410062|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24410063|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24626028|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24626029|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24626030|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
24626031|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626032|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24626033|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24410660|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410661|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24946588|NCT03937258|Abrocitinib|abrocitinib|mesh-list
24946677|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946678|NCT03936036|Incretins|incretins|mesh-ancestor
24412725|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24412884|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412885|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
24413422|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24413424|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24413425|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24413426|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413427|NCT00193869|Dexamethasone|dexamethasone|mesh-list
24413428|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413429|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
24413430|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
24413431|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413432|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413433|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415105|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
24415106|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415107|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415108|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24415109|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415112|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415113|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24419667|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420198|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420199|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420202|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24423392|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423393|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24423394|NCT00225849|Aspirin|aspirin|mesh-list
24423428|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24424789|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424791|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24424966|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424967|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424968|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24424969|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425337|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24425338|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24425340|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24425934|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448240|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947200|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24947201|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24947202|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
24431051|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24431052|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432560|NCT00255424|Hematinics|hematinics|mesh-ancestor
24432561|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24460279|NCT00348010|Tramadol|tramadol|mesh-list
24460280|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24460281|NCT00348010|Narcotics|narcotics|mesh-ancestor
24433296|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433297|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24433314|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24433315|NCT00258115|Analgesics|analgesics|mesh-ancestor
24433316|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
24433317|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433369|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
24433892|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
24433893|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24433894|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435067|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
24435068|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24435069|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24435070|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24435071|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24435760|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
24435072|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435757|NCT00268151|Capecitabine|capecitabine|mesh-list
24435994|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436026|NCT00268710|Docetaxel|docetaxel|mesh-list
24436030|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436031|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436032|NCT00268723|Albuterol|albuterol|mesh-list
24436507|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436508|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24436509|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24436510|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
24436512|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
24436514|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24436520|NCT00270348|Ciclesonide|ciclesonide|mesh-list
24436809|NCT00271427|Trace Elements|trace elements|mesh-ancestor
24437397|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437741|NCT00274404|Valacyclovir|valacyclovir|mesh-list
24438160|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438161|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24438167|NCT00275106|Leucovorin|leucovorin|mesh-list
24439614|NCT00279565|Interferons|interferons|mesh-list
24460398|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24440250|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440251|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
24947459|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24947460|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
24440800|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24442383|NCT00290836|Thrombin|thrombin|mesh-list
24427573|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
25051549|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051550|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051551|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25051553|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
24460987|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460990|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
24550783|NCT00722293|Doxorubicin|doxorubicin|mesh-list
24552106|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24552107|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552120|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24552121|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24552128|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24553365|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553697|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
24553793|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553795|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24947828|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516229|NCT00601198|Leucovorin|leucovorin|mesh-list
24554237|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554510|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24554517|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24554518|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24554601|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554603|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24554692|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24947918|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24947919|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24947920|NCT03925285|Growth Substances|growth substances|mesh-ancestor
24947939|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24947940|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947941|NCT03924544|Mitomycins|mitomycins|mesh-list
24947962|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947963|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947964|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
24947965|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801976|NCT01986582|Protective Agents|protective agents|mesh-ancestor
24555058|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555059|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24555060|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24555061|NCT00739830|Sirolimus|sirolimus|mesh-list
24555209|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555211|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
24555212|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
24555213|NCT00740467|Busulfan|busulfan|mesh-list
24555214|NCT00740467|Fludarabine|fludarabine|mesh-list
24555215|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
24555216|NCT00740467|Cyclosporins|cyclosporins|mesh-list
24555217|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24555218|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627994|NCT01095991|Incretins|incretins|mesh-ancestor
24791291|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24555541|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24555542|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555543|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555544|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24555545|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
24555546|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
24555579|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24555585|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555586|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555587|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
24555588|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24555589|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
24556532|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24556533|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24556534|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24556535|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24556536|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
24556537|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24556538|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24556539|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
24556544|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
24556548|NCT00748059|Urological Agents|urological agents|mesh-ancestor
24556705|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24556706|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24556707|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24556708|NCT00749346|Pemetrexed|pemetrexed|mesh-list
24556709|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556710|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556712|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24556753|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
24556891|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556892|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556893|NCT00750217|Buprenorphine|buprenorphine|mesh-list
24556894|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24556895|NCT00750217|Narcotics|narcotics|mesh-ancestor
24557045|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
24557046|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557047|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557048|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557049|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557050|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557256|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24557257|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24557258|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
24557373|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24557374|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24557375|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
24557376|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557377|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557378|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24557379|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24557506|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24562365|NCT00766220|Irinotecan|irinotecan|mesh-list
24557508|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24557509|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
24557510|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24557511|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24557512|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
24557513|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557514|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
24557515|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24557556|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557557|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24557558|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24557559|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557560|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557561|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557562|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24557563|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24557746|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24557747|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24557823|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24557824|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
24671000|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557825|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557826|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
24557827|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557828|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948168|NCT03921684|Nivolumab|nivolumab|mesh-list
24948170|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
24558270|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
24558476|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558477|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671002|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
24558478|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558479|NCT00757458|Propofol|propofol|mesh-list
24559345|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559346|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559347|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
24559348|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24559349|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24802219|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24559381|NCT04984759|Primaquine|primaquine|mesh-list
24559412|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559413|NCT04875728|Cefazolin|cefazolin|mesh-list
24560580|NCT02311478|Trace Elements|trace elements|mesh-ancestor
24561366|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561719|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24963936|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
24948378|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948404|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948405|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24948406|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562160|NCT00764907|Vincristine|vincristine|mesh-list
24562161|NCT00764907|Daunorubicin|daunorubicin|mesh-list
24562162|NCT00764907|Asparaginase|asparaginase|mesh-list
24562163|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
24562460|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24562461|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
24562649|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
24562650|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24562651|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
24562652|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562653|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562654|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24562655|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24948434|NCT03919812|Vitamins|vitamins|mesh-ancestor
24802434|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24562716|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24562811|NCT00768456|Ropivacaine|ropivacaine|mesh-list
24562871|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
24562872|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562873|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24562874|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562875|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562876|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562877|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24562878|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
24562888|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
24563158|NCT00770445|Insulin|insulin|mesh-list
24563281|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563329|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563330|NCT00771147|Sorafenib|sorafenib|mesh-list
24563331|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563332|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24563333|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563342|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563344|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24563345|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
24563347|NCT00771251|Golimumab|golimumab|mesh-list
24563448|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
24563449|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
24964092|NCT03785613|Buprenorphine|buprenorphine|mesh-list
24564537|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565135|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565136|NCT00778908|Cisplatin|cisplatin|mesh-list
24565137|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565138|NCT00778973|Sertraline|sertraline|mesh-list
24565532|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565535|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24566060|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24567641|NCT00791856|Androgens|androgens|mesh-ancestor
24568467|NCT00796159|Olmesartan|olmesartan|mesh-list
24948653|NCT03918135|Analgesics|analgesics|mesh-ancestor
24572928|NCT00817258|Cisplatin|cisplatin|mesh-list
24949348|NCT04958746|Propofol|propofol|mesh-list
24949419|NCT04778982|Fulvestrant|fulvestrant|mesh-list
24949420|NCT04778982|Palbociclib|palbociclib|mesh-list
24803339|NCT01996085|Telmisartan|telmisartan|mesh-list
24775012|NCT01849406|Hormones|hormones|mesh-ancestor
24775013|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575956|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775287|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775288|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
24775289|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775290|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24775291|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24775292|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24575026|NCT00829023|Povidone|povidone|mesh-list
24950629|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24576680|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24576681|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24576682|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626217|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24951156|NCT03907800|Paclitaxel|paclitaxel|mesh-list
24581841|NCT00866515|Ketoconazole|ketoconazole|mesh-list
24582875|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24582877|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582878|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587516|NCT00895323|Antibodies|antibodies|mesh-list
24588103|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24589983|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24634904|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634905|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24591733|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24591734|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24591735|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
24591736|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597133|NCT00947336|Norfloxacin|norfloxacin|mesh-list
24777914|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
24777915|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24599320|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599375|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24599435|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599458|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599460|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24394417|NCT00133250|Abciximab|abciximab|mesh-list
24863218|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813638|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
24813639|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24813640|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
25052273|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25052274|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863569|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24863570|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052551|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052552|NCT00255099|Etravirine|etravirine|mesh-list
25052553|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25052554|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052555|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952276|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952277|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952278|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25052636|NCT00232141|Pregabalin|pregabalin|mesh-list
25052637|NCT00232141|Analgesics|analgesics|mesh-ancestor
25052638|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
25052732|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
25052733|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052734|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052735|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052736|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25052739|NCT00179400|Pioglitazone|pioglitazone|mesh-list
24709679|NCT01506713|Clopidogrel|clopidogrel|mesh-list
24863742|NCT03499119|Analgesics|analgesics|mesh-ancestor
24863743|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
24863744|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863745|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813749|NCT02060201|Saxagliptin|saxagliptin|mesh-list
24863821|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011589|NCT04647084|Lidocaine|lidocaine|mesh-list
25052793|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
25052794|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25052795|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24863884|NCT03084549|Ropivacaine|ropivacaine|mesh-list
24863885|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
24863886|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
24863887|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25011653|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
25011654|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25011655|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24813798|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543922|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25052824|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052825|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25052827|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
25052840|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25052841|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25052842|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25052843|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25052845|NCT00135369|Efavirenz|efavirenz|mesh-list
25052846|NCT00135369|Stavudine|stavudine|mesh-list
25052847|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24807122|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24601976|NCT00966836|Valganciclovir|valganciclovir|mesh-list
24864161|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
24864162|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864163|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24864164|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24864165|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24864166|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24864167|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24864213|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24544139|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544140|NCT00687388|Urological Agents|urological agents|mesh-ancestor
24544141|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24544145|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
25052880|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24864457|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864459|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864460|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544373|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24864509|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864511|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
25052932|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052933|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864658|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24864678|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
24864679|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864680|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864681|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
24864682|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864839|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864840|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864841|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052990|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25052991|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052992|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053072|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25053074|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25053075|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
25053077|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053078|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053080|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25053081|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25053082|NCT00108810|Analgesics|analgesics|mesh-ancestor
25053083|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
25053084|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053085|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053086|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25053136|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24936322|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
24865057|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24865059|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
24865060|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865061|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865062|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
24544947|NCT00691145|Tacrolimus|tacrolimus|mesh-list
24865093|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24865094|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25053203|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
25053204|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936327|NCT04042142|Hormones|hormones|mesh-ancestor
25053206|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053207|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25053208|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
25053209|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053218|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053267|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053268|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
25053269|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053270|NCT00079482|Analgesics|analgesics|mesh-ancestor
25053271|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
25053272|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053273|NCT00073866|Celecoxib|celecoxib|mesh-list
25053274|NCT00073866|Docetaxel|docetaxel|mesh-list
25053275|NCT00073866|Irinotecan|irinotecan|mesh-list
25053276|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053277|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053321|NCT00065728|Anecortave|anecortave|mesh-list
24445928|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24445929|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445930|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
24445931|NCT00303160|Ascorbic Acid|ascorbic acid|mesh-list
24445932|NCT00303160|Vitamins|vitamins|mesh-ancestor
24445933|NCT00303160|Micronutrients|micronutrients|mesh-ancestor
24445934|NCT00303160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445935|NCT00303160|Antioxidants|antioxidants|mesh-ancestor
24865255|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25053522|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053523|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053524|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053525|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
25053526|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25053527|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
25053530|NCT00006225|Protective Agents|protective agents|mesh-ancestor
25053674|NCT00004897|Fluorouracil|fluorouracil|mesh-list
25053675|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
25053676|NCT00004897|Calcium|calcium|mesh-list
25053677|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
25053678|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053679|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25053680|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053681|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
25053682|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053683|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445986|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445988|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25053698|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952343|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952344|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
24952346|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446005|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545443|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545444|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545448|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
24865522|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24865523|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
24865524|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24865525|NCT01291004|Diuretics|diuretics|mesh-ancestor
24712569|NCT01521481|Anesthetics|anesthetics|mesh-list
24865529|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
24865530|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
24865531|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865560|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053766|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053768|NCT00004231|Protective Agents|protective agents|mesh-ancestor
25053769|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
25053771|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
25053772|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053773|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053774|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
24808068|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865561|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545501|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
25053793|NCT00004182|Irinotecan|irinotecan|mesh-list
24545574|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24545575|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
24545576|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545577|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24545578|NCT00693862|Levodopa|levodopa|mesh-list
24545579|NCT00693862|Carbidopa|carbidopa|mesh-list
24545580|NCT00693862|Entacapone|entacapone|mesh-list
24545581|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24545582|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25053878|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
25053879|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053880|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053881|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053882|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053884|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053885|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
25053886|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053887|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015392|NCT02491099|Afatinib|afatinib|mesh-list
24446049|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24446050|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446053|NCT00303758|Fluorouracil|fluorouracil|mesh-list
24446054|NCT00303758|Calcium|calcium|mesh-list
24446055|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
24446056|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865784|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
24545705|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053948|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053949|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
25053950|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053951|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053952|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053954|NCT00002371|Zidovudine|zidovudine|mesh-list
25053955|NCT00002371|Stavudine|stavudine|mesh-list
24865887|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865888|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865889|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
24865890|NCT04558866|Testosterone|testosterone|mesh-list
24865895|NCT04558866|Hormones|hormones|mesh-ancestor
25054163|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25054164|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054165|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25054167|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24866007|NCT03959358|Growth Substances|growth substances|mesh-ancestor
24866008|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
24866009|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866010|NCT03954106|Defibrotide|defibrotide|mesh-list
25054249|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054251|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
25054252|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
25054253|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054254|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054255|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
24866015|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
24808995|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
24866070|NCT03717896|Thiamine|thiamine|mesh-list
24446172|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446173|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
25054325|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24808602|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24808603|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808604|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24808605|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24546081|NCT00696592|Growth Substances|growth substances|mesh-ancestor
24446189|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446190|NCT00304018|Prednisone|prednisone|mesh-list
24446191|NCT00304018|Fludarabine|fludarabine|mesh-list
24446193|NCT00304018|Etoposide|etoposide|mesh-list
25054420|NCT03529955|Apremilast|apremilast|mesh-list
25054421|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25054422|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054423|NCT03529955|Analgesics|analgesics|mesh-ancestor
25054424|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
25054425|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054426|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866171|NCT03276052|Bromides|bromides|mesh-list
24866263|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24866264|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
24866265|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866266|NCT01530997|Cisplatin|cisplatin|mesh-list
24866267|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054619|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054620|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054621|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25054622|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24866316|NCT05153928|Norethindrone|norethindrone|mesh-list
24866317|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
24866318|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24866319|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24866320|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24814323|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24814326|NCT02064010|Acamprosate|acamprosate|mesh-list
24867068|NCT03617718|Glycine|glycine|mesh-list
24867069|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
24867070|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867071|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867072|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867073|NCT03614728|Azacitidine|azacitidine|mesh-list
24867074|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
24867574|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24547572|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25055005|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
25055022|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
25055023|NCT03525522|Hormones|hormones|mesh-ancestor
25055025|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055051|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25055052|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055053|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809344|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
24809346|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24809347|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
24809348|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
25055145|NCT03523754|Misoprostol|misoprostol|mesh-list
25055146|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25055147|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
25055148|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24809430|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24809431|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
24809432|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809434|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24868866|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868867|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
24868868|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868895|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055180|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
25055182|NCT03523572|Trastuzumab|trastuzumab|mesh-list
24868896|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24868897|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055216|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24604623|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869075|NCT04831892|Isosorbide|isosorbide|mesh-list
24814661|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24721449|NCT01574261|Inositol|inositol|mesh-list
24610459|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
24610460|NCT01002157|Coagulants|coagulants|mesh-ancestor
24610461|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
24610462|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24691823|NCT01409174|Analgesics|analgesics|mesh-ancestor
25055339|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24977560|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
25055828|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055829|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055830|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
24939132|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055831|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25055832|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25055833|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24623337|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24623339|NCT01070927|R04929097|r04929097|mesh-list
24872013|NCT05400603|Irinotecan|irinotecan|mesh-list
24815041|NCT02068170|Levofloxacin|levofloxacin|mesh-list
24872992|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
25056139|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
24873234|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25056210|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056211|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056212|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24874208|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
24874220|NCT04864743|Factor VIII|factor viii|mesh-list
24815268|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
24815269|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815270|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24874699|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
24815313|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
24815314|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875897|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24875898|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24875899|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24875900|NCT03813147|Methotrexate|methotrexate|mesh-list
25056475|NCT03512496|Caffeine|caffeine|mesh-list
25056476|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25056477|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591404|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24876038|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24876041|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24876463|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
24876786|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877448|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815657|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
24878259|NCT01998529|Amifostine|amifostine|mesh-list
24878260|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952630|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952631|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25056685|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
25056686|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
24810984|NCT02044120|Irinotecan|irinotecan|mesh-list
24739877|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24879001|NCT05174845|Protective Agents|protective agents|mesh-ancestor
25028452|NCT03610685|Hormones|hormones|mesh-ancestor
24880484|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
24880485|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
24618225|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618226|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618227|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24881013|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24881015|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24881016|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24881018|NCT03122639|Atorvastatin|atorvastatin|mesh-list
24881282|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881283|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24881372|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881373|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881374|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
24881375|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
24881376|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881377|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881378|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741195|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741196|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
24741197|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405863|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881476|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881477|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24881478|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24881479|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881506|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24881507|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24881508|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
24881509|NCT02101853|Methotrexate|methotrexate|mesh-list
24881510|NCT02101853|Etoposide|etoposide|mesh-list
24881511|NCT02101853|Vincristine|vincristine|mesh-list
24741270|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24741271|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24881580|NCT02065596|Vidarabine|vidarabine|mesh-list
24881645|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881646|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
24881647|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881648|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
24741272|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405997|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405999|NCT00169000|Capecitabine|capecitabine|mesh-list
24406000|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406001|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
24816081|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816082|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816083|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25057145|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
24881815|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24881816|NCT01239797|Growth Substances|growth substances|mesh-ancestor
24881817|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
24881819|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
24881820|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881821|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881823|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24881824|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
24881989|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24881990|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
24881991|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881992|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881993|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24882017|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882019|NCT00006455|Protective Agents|protective agents|mesh-ancestor
24882020|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
24882026|NCT00003716|Rituximab|rituximab|mesh-list
24882188|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24882241|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882242|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24882243|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24882244|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
24882245|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24882246|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24882248|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
24882442|NCT05170828|Busulfan|busulfan|mesh-list
24623434|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623435|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24623436|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24623437|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24623438|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24882477|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882481|NCT05170217|Cannabidiol|cannabidiol|mesh-list
24882482|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
24882649|NCT05166668|Letrozole|letrozole|mesh-list
24882650|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882651|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24882652|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24882653|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882654|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882655|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24882656|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
24816131|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24816132|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24882834|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882835|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882836|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24882837|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25057264|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057265|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882838|NCT04929600|Amlodipine|amlodipine|mesh-list
24816147|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816149|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816150|NCT02074319|Methotrexate|methotrexate|mesh-list
24883107|NCT04484675|Milrinone|milrinone|mesh-list
24883108|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25033348|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033349|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
25033350|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033351|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883464|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24883465|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24393910|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24883481|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883482|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24883483|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24393940|NCT00131326|Hylan|hylan|mesh-list
24952736|NCT03892421|Rituximab|rituximab|mesh-list
24952737|NCT03892421|Carboplatin|carboplatin|mesh-list
24952738|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952739|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743738|NCT04640818|Rituximab|rituximab|mesh-list
25057544|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883719|NCT05093582|Cromakalim|cromakalim|mesh-list
24883720|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24883721|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24883722|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
24883723|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883724|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883784|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600322|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883856|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883857|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24883858|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24745192|NCT03924427|BMS-986165|bms-986165|mesh-list
24883907|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883908|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25057891|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
24883962|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883963|NCT03987919|Tirzepatide|tirzepatide|mesh-list
25057892|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058000|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25058036|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747651|NCT00316888|Cisplatin|cisplatin|mesh-list
24505214|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24505472|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24749595|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24618854|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618855|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618856|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
24749931|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506267|NCT00544518|Metformin|metformin|mesh-list
25058294|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
24884371|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506759|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24506793|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24506794|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
24506795|NCT00547092|Tadalafil|tadalafil|mesh-list
24506796|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
25058424|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
25058426|NCT03496831|Adalimumab|adalimumab|mesh-list
24625836|NCT01083953|Sevoflurane|sevoflurane|mesh-list
24625837|NCT01083953|Desflurane|desflurane|mesh-list
24625838|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24800202|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508658|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25059451|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059452|NCT03487783|Aripiprazole|aripiprazole|mesh-list
25059453|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25059454|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
24884934|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884941|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884942|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
24509736|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25040596|NCT02997657|Nicotine|nicotine|mesh-list
24510738|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944035|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060057|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25060146|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
24511124|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24885837|NCT04409041|Naltrexone|naltrexone|mesh-list
24886185|NCT02814695|Protective Agents|protective agents|mesh-ancestor
25060456|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060457|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25060458|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25060459|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25060460|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511639|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511640|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511641|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
24511642|NCT00569985|Carmustine|carmustine|mesh-list
24511643|NCT00569985|Etoposide|etoposide|mesh-list
24511658|NCT00570050|Insulin|insulin|mesh-list
24511739|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24511740|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
24511915|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886320|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060548|NCT03478605|Olanzapine|olanzapine|mesh-list
24512245|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24512256|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512257|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25060645|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24888668|NCT04501224|Tenofovir|tenofovir|mesh-list
25061113|NCT03473613|Calcium|calcium|mesh-list
24513154|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24513155|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24889687|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889688|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
24889691|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24953085|NCT03889145|Amlodipine|amlodipine|mesh-list
25061741|NCT03468907|Tenofovir|tenofovir|mesh-list
24892900|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24470066|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
24817089|NCT02080858|Apixaban|apixaban|mesh-list
24894636|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894637|NCT04438928|Micronutrients|micronutrients|mesh-list
24894638|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894639|NCT04438720|Nifedipine|nifedipine|mesh-list
24894640|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24894641|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24894642|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513922|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513923|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513924|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513925|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513926|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
24513927|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24513928|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521273|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514394|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514395|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24514396|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24514397|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514398|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
24514958|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
24514959|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514960|NCT00593619|Hematinics|hematinics|mesh-ancestor
24514961|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
24514962|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
24895446|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
24514992|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514993|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515006|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515007|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515008|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
24515009|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515010|NCT00593879|Mecamylamine|mecamylamine|mesh-list
24895500|NCT04006210|Carbidopa|carbidopa|mesh-list
24515251|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24515253|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24895941|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895942|NCT02794896|Fentanyl|fentanyl|mesh-list
24472972|NCT00401362|Naltrexone|naltrexone|mesh-list
24515338|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515339|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062540|NCT04370301|Melphalan|melphalan|mesh-list
24817382|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
24524623|NCT04646837|Durvalumab|durvalumab|mesh-list
24817390|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825150|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24817414|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817416|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
24817417|NCT02083575|Deferiprone|deferiprone|mesh-list
24817475|NCT02084303|Hematinics|hematinics|mesh-ancestor
24473374|NCT00402610|Rifampin|rifampin|mesh-list
24515682|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
24515683|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
24515684|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515685|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515686|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515687|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24896536|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817499|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24817500|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
24817501|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
24817502|NCT02084368|Bupivacaine|bupivacaine|mesh-list
24817503|NCT02084368|Ropivacaine|ropivacaine|mesh-list
24817504|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
24817505|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
24817506|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817507|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825206|NCT02127840|Racepinephrine|racepinephrine|mesh-list
24562537|NCT00766896|Aspirin|aspirin|mesh-list
25062669|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24896650|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
24896663|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896665|NCT04434105|Hormones|hormones|mesh-ancestor
24896666|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896667|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516019|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516020|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516021|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24516022|NCT00600301|Growth Substances|growth substances|mesh-ancestor
24516023|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516024|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
24516025|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24516026|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
24516027|NCT00600301|Hormones|hormones|mesh-ancestor
24516029|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473826|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473827|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
24516168|NCT00600847|Loratadine|loratadine|mesh-list
24457732|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896902|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24896903|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24896904|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
24897071|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897072|NCT04429711|Ivermectin|ivermectin|mesh-list
24474372|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063235|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25063236|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063237|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474734|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24474735|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24474736|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474737|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516793|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063279|NCT02457221|Hormones|hormones|mesh-ancestor
24577114|NCT00841945|Hormones|hormones|mesh-ancestor
24474960|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474961|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516975|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516976|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516977|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24897928|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
24898048|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24898049|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
24517022|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898317|NCT04415476|Hormones|hormones|mesh-ancestor
24898318|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898319|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898320|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24898321|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063358|NCT01968590|Vitamin D|vitamin d|mesh-list
25063359|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
25063360|NCT01968590|Vitamins|vitamins|mesh-ancestor
24898322|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898323|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
24898387|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
24898701|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898702|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24898703|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
24898709|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
24517252|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063432|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063433|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
24899109|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24476100|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
24476103|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476104|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517670|NCT00609154|Incretins|incretins|mesh-ancestor
24517671|NCT00609180|Antioxidants|antioxidants|mesh-list
24517794|NCT00610038|Glyburide|glyburide|mesh-list
24899149|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24899895|NCT04399070|Ketamine|ketamine|mesh-list
24900689|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901154|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24901155|NCT04388111|Narcotics|narcotics|mesh-ancestor
24901192|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24901193|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
25063946|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24519047|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
24901415|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642160|NCT01177904|Hormones|hormones|mesh-ancestor
24901984|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24901985|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24901986|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901987|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901988|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064087|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25064117|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24902726|NCT04371146|Reboxetine|reboxetine|mesh-list
24902727|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24902728|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902729|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24902730|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24902739|NCT04370977|Artesunate|artesunate|mesh-list
24902875|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902876|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24902877|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902926|NCT04368598|BB 1101|bb 1101|mesh-list
24903050|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902941|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902943|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903269|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24903270|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
24903392|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903271|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903272|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
24903381|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903874|NCT04360317|Docetaxel|docetaxel|mesh-list
24904005|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
24904155|NCT04358341|Doxorubicin|doxorubicin|mesh-list
24904156|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24904172|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24904173|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24904174|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
24904175|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904176|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24727221|NCT01608555|Tobramycin|tobramycin|mesh-list
24818441|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818442|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
24818443|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818444|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064219|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
25064220|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519349|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
24519350|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519351|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904837|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24904838|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
24904839|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826768|NCT02135887|Vitamins|vitamins|mesh-ancestor
24905319|NCT04348786|Antacids|antacids|mesh-ancestor
24905320|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
24905321|NCT04348877|Antibodies|antibodies|mesh-list
24905322|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
24905421|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905422|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
24905423|NCT04347980|Hormones|hormones|mesh-ancestor
24905425|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24905592|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24905656|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905657|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
24905658|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24646690|NCT01204801|Doxorubicin|doxorubicin|mesh-list
24905671|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826840|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
24905756|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
24519441|NCT01208662|Dexamethasone|dexamethasone|mesh-list
24818597|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818598|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24481590|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24481591|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
24481592|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24454124|NCT04392531|Cyclosporine|cyclosporine|mesh-list
24818613|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818614|NCT02089841|Lumefantrine|lumefantrine|mesh-list
24818615|NCT02089841|Artemether|artemether|mesh-list
24818616|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24818617|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
24818618|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905955|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064415|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064417|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25064418|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24826865|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906058|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24906059|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25064423|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
24906091|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
24906092|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906093|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24906094|NCT04342858|Listerine|listerine|mesh-list
24906095|NCT04342858|Fluorides|fluorides|mesh-list
24906096|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
24906097|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
24906098|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906099|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
24481878|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481879|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906339|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906380|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906383|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24906384|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729353|NCT01621256|Ancrod|ancrod|mesh-list
24906385|NCT04341155|Dexamethasone|dexamethasone|mesh-list
24906650|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906651|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24906652|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
24906700|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906701|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24906716|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24906717|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24906719|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
24906792|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24906793|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906795|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866568|NCT05259007|Amoxicillin|amoxicillin|mesh-list
24519499|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24818725|NCT02090504|Oxazepam|oxazepam|mesh-list
24906890|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24906891|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24906892|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
24906902|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906903|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
24906904|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906905|NCT04335786|Valsartan|valsartan|mesh-list
24906906|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24482384|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365198|NCT05214287|Nitrox|nitrox|mesh-list
24818766|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565774|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565775|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24565776|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24514391|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514392|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24907358|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25064493|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
25064494|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064495|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24907359|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907360|NCT04330872|Analgesics|analgesics|mesh-ancestor
24907483|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25064515|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
25064558|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24827032|NCT02137239|Prednisone|prednisone|mesh-list
24907966|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907967|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907969|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907970|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907971|NCT04325633|Analgesics|analgesics|mesh-ancestor
24648391|NCT01213992|Trace Elements|trace elements|mesh-ancestor
24524991|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524994|NCT04115644|Triamcinolone|triamcinolone|mesh-list
24530966|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24445773|NCT00302536|Tacrolimus|tacrolimus|mesh-list
24908090|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
24908092|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24908268|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24908269|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
24908270|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908271|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24908272|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24908307|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908308|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731245|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
24908413|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24908414|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908415|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908416|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908418|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
24908419|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908495|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24908496|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24908726|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908594|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908596|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24908597|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908598|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24908599|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24908600|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
24908717|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24908718|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
24908719|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24908722|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
24908723|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908895|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869001|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24548943|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24394580|NCT00133692|Trandolapril|trandolapril|mesh-list
24909203|NCT04312048|Diuretics|diuretics|mesh-ancestor
24909390|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24909646|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
24909647|NCT04306627|Amlodipine|amlodipine|mesh-list
24909648|NCT04306627|Perindopril|perindopril|mesh-list
25064703|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
24909803|NCT04305015|Analgesics|analgesics|mesh-ancestor
24519689|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24519690|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24910190|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24910191|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24910192|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24910193|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24910290|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
24519780|NCT05151471|Edaravone|edaravone|mesh-list
24910500|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
24910501|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24910502|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
24910503|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24910504|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910505|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
24910506|NCT04296422|Ibuprofen|ibuprofen|mesh-list
24910507|NCT04296422|Diclofenac|diclofenac|mesh-list
24910508|NCT04296422|Naproxen|naproxen|mesh-list
24910509|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24819032|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819034|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
25064826|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
25064827|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25064828|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
25064829|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064830|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827247|NCT02137993|Olanzapine|olanzapine|mesh-list
24827248|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
24656040|NCT01259531|Silodosin|silodosin|mesh-list
24910545|NCT04296695|Efavirenz|efavirenz|mesh-list
24910546|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
25064872|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
25064934|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910743|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910763|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485429|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485436|NCT00452985|Docetaxel|docetaxel|mesh-list
24819094|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065034|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911447|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911461|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911462|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24623729|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
24623730|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623731|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623732|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
25065196|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25065197|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24827505|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911994|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24911995|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911996|NCT04282200|Analgesics|analgesics|mesh-ancestor
24911997|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
24911998|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911999|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912187|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912188|NCT04278703|Analgesics|analgesics|mesh-ancestor
24819180|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912777|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24912831|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
24912832|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24912833|NCT04270994|Misoprostol|misoprostol|mesh-list
24912834|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24912835|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
24912927|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24912929|NCT04269954|Dalteparin|dalteparin|mesh-list
24912930|NCT04269954|Batroxobin|batroxobin|mesh-list
24912931|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
24912932|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24912933|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24913023|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25065282|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065283|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065284|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065285|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24913024|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24913025|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25065287|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25065288|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
24913140|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24913141|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882704|NCT05105672|Cisplatin|cisplatin|mesh-list
24819251|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819252|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24667113|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520078|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913378|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24913379|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24913972|NCT04259008|Manganese|manganese|mesh-list
24914085|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
24520440|NCT01928394|Ipilimumab|ipilimumab|mesh-list
24914448|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
24914449|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
24914450|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24914451|NCT04254822|Carvedilol|carvedilol|mesh-list
24914471|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914496|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
24914500|NCT04254523|Morphine|morphine|mesh-list
24914564|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24914565|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24914566|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24914601|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24914602|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829145|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829146|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24829147|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829719|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834334|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24834335|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
24834336|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834338|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834339|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24834340|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834341|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834342|NCT02177851|Iron|iron|mesh-list
24834343|NCT02177851|Trace Elements|trace elements|mesh-ancestor
24872670|NCT05275738|Niacin|niacin|mesh-list
25108288|NCT03133195|Calcium|calcium|mesh-list
25108289|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
25108290|NCT03133195|Vitamins|vitamins|mesh-ancestor
25108294|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25108296|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
25108297|NCT03133299|Vitamins|vitamins|mesh-ancestor
25108298|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
25108299|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108300|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25108301|NCT03133299|Hormones|hormones|mesh-ancestor
25108303|NCT03132688|Propofol|propofol|mesh-list
24837668|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24786308|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786309|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786310|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24786311|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
25108307|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25108308|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
25108309|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
24839958|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24840992|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840995|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
24841692|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24842481|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754906|NCT01723735|Ezetimibe|ezetimibe|mesh-list
24842510|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842511|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842512|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
24842514|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842515|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
24842516|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873746|NCT05033769|Paclitaxel|paclitaxel|mesh-list
24842517|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24842518|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843224|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24843225|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
24843226|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
24843227|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24873913|NCT04975334|Hormones|hormones|mesh-ancestor
24844633|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24844634|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24844636|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24844637|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24844638|NCT02233582|Analgesics|analgesics|mesh-ancestor
24757608|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
24844676|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24844677|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24844678|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24844679|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
24844680|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844865|NCT02234921|Imiquimod|imiquimod|mesh-list
24845229|NCT02237079|Estrogens|estrogens|mesh-list
24845230|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24845231|NCT02237079|Hormones|hormones|mesh-ancestor
24845368|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845369|NCT02237755|Citric Acid|citric acid|mesh-list
24845370|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
24874503|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
24874507|NCT04704661|Trastuzumab|trastuzumab|mesh-list
24859213|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24859214|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24859257|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24859258|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24859259|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24859264|NCT02302586|Morphine|morphine|mesh-list
24813236|NCT02057107|Cetuximab|cetuximab|mesh-list
24861837|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861838|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24861839|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24861840|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24861875|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
24849988|NCT02251184|Aspirin|aspirin|mesh-list
24544299|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867326|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24867327|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24867329|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867330|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24867332|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867333|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
24549874|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
24870074|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870075|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24870076|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
24870077|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24870078|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
24870131|NCT03761784|Tretinoin|tretinoin|mesh-list
24880395|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
24886749|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887560|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887561|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24887562|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887563|NCT04514835|Capecitabine|capecitabine|mesh-list
24887564|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465740|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
24887589|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
24888251|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888258|NCT04507607|Tenofovir|tenofovir|mesh-list
24815582|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24815583|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
24889474|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468431|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891325|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468599|NCT00382421|Aspirin|aspirin|mesh-list
24891340|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
24892247|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892248|NCT04464629|Prednisolone|prednisolone|mesh-list
24892249|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24892250|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
24892251|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24892252|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
24892328|NCT04464122|Somatostatin|somatostatin|mesh-list
24892761|NCT04459312|Antibodies|antibodies|mesh-list
24892762|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
24892763|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892764|NCT04459078|Apatinib|apatinib|mesh-list
25108788|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25108789|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
25108790|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108791|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108793|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25108838|NCT03130101|Insulin|insulin|mesh-list
25108839|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25108840|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108841|NCT03129646|Paromomycin|paromomycin|mesh-list
25108842|NCT03129646|Miltefosine|miltefosine|mesh-list
25108843|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25108844|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108845|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24878898|NCT00336063|Azacitidine|azacitidine|mesh-list
24878899|NCT00336063|Vorinostat|vorinostat|mesh-list
24817111|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817112|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24817113|NCT02081027|Protective Agents|protective agents|mesh-ancestor
24817114|NCT02081144|Nicotine|nicotine|mesh-list
24817115|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24471830|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
24894826|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
25108908|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25108909|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25108910|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
25108911|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108912|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108913|NCT03129256|Apatinib|apatinib|mesh-list
24817879|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899768|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24899769|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
24899770|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899771|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899772|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
24899773|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
24899774|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24812589|NCT02053727|Abatacept|abatacept|mesh-list
24891254|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24891255|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891256|NCT04473989|Teriparatide|teriparatide|mesh-list
24891257|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25109004|NCT03128203|Oxytocin|oxytocin|mesh-list
24901601|NCT04383275|Capecitabine|capecitabine|mesh-list
24901602|NCT04383275|Trastuzumab|trastuzumab|mesh-list
24901603|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24901604|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
24818147|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
24901606|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816900|NCT02079558|Oxytocin|oxytocin|mesh-list
24901730|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24901731|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901883|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
24902399|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902400|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902442|NCT04374188|Ofloxacin|ofloxacin|mesh-list
24891746|NCT04467931|Eplerenone|eplerenone|mesh-list
24818245|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24818306|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
24818307|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818308|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880786|NCT03336398|Ketamine|ketamine|mesh-list
24880811|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25109010|NCT03127800|Narcotics|narcotics|mesh-ancestor
24903198|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
24903199|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
24903200|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24903201|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24903202|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
24903203|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815952|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815953|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24815954|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24815955|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24815956|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815957|NCT02072811|Analgesics|analgesics|mesh-ancestor
24815958|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
24903421|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24903422|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
24903423|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903454|NCT04364022|Ritonavir|ritonavir|mesh-list
24903506|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24903507|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24903508|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24903509|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903693|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
24903694|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
24903695|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903696|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903697|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
24892655|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24903935|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903936|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
24903937|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
24903938|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903939|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903940|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903941|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
24904098|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904099|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904100|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24904101|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24904102|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
24904103|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818384|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513949|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24513950|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513951|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24513962|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513963|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24513996|NCT00587119|Budesonide|budesonide|mesh-list
24904203|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24894924|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
24894925|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894926|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894927|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24894928|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24894929|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
24894930|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904304|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
24904323|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904334|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24904335|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24904336|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24904337|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904338|NCT04356417|Antimalarials|antimalarials|mesh-list
24904339|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24904340|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24904405|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904407|NCT04355962|Sevoflurane|sevoflurane|mesh-list
24904483|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904484|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904485|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24904486|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904487|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904515|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
24904516|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24904517|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24787017|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24787018|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787019|NCT01923090|Finasteride|finasteride|mesh-list
25109086|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109087|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
25109088|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
25109089|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
25109091|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365633|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904775|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904776|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904778|NCT04353336|Filaricides|filaricides|mesh-ancestor
24904779|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
24904780|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
24904782|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
24904797|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24895806|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24895807|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
24895808|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895809|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895810|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24905381|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905382|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
24905383|NCT04347733|Hormones|hormones|mesh-ancestor
24905384|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905524|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
24905525|NCT04346823|Sevoflurane|sevoflurane|mesh-list
24905526|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24905527|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24905528|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
24905553|NCT04346407|Analgesics|analgesics|mesh-ancestor
24905554|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
24905555|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818564|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24818565|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24905556|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25075973|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25076366|NCT03373708|Goserelin|goserelin|mesh-list
25076367|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076531|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076533|NCT03372447|Pyridoxine|pyridoxine|mesh-list
24447953|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447954|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24447955|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
24447956|NCT00309920|Docetaxel|docetaxel|mesh-list
24516714|NCT00602901|Naproxen|naproxen|mesh-list
25076759|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
25076760|NCT03370705|Captopril|captopril|mesh-list
25076761|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25076762|NCT03370705|Atorvastatin|atorvastatin|mesh-list
25076763|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25076764|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24474440|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24474441|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
24474442|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24882851|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
24882852|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
24882853|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780296|NCT01883323|Interleukin-2|interleukin-2|mesh-list
24780297|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780298|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
24780299|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816153|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24816154|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076885|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076886|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076887|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
25076888|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076920|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
25076921|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25077067|NCT03368131|Capecitabine|capecitabine|mesh-list
25077137|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25077229|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077350|NCT03365479|Iloprost|iloprost|mesh-list
24454613|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24454614|NCT03878524|Growth Substances|growth substances|mesh-ancestor
25077425|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25077599|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
25077600|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077603|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
25077604|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077605|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25077606|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24902285|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902286|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902287|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902288|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24902289|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24902290|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902291|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902292|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24902294|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24818222|NCT02087527|Dexamethasone|dexamethasone|mesh-list
24818223|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818224|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
24448402|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25077870|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077871|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
25077872|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078008|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078009|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078010|NCT03359837|Insulin|insulin|mesh-list
25078011|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24905110|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
24905115|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
24954678|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
24954680|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954719|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954721|NCT03872570|Phenylephrine|phenylephrine|mesh-list
24954807|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24954808|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954809|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
24954810|NCT03871621|Metformin|metformin|mesh-list
24954811|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
24954812|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24954813|NCT03871621|Meglitinide|meglitinide|mesh-list
24954814|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24884172|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
24884173|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884174|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954882|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24954920|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954921|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954922|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
24884279|NCT02472964|Paclitaxel|paclitaxel|mesh-list
24519739|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24910876|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955023|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955024|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24955025|NCT03869398|Vitamins|vitamins|mesh-ancestor
24955026|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
24955027|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24955028|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
24955029|NCT03869047|Bupivacaine|bupivacaine|mesh-list
24955030|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
24955031|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
24955043|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955044|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955046|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078183|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
25078184|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955107|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24955118|NCT03868033|Denosumab|denosumab|mesh-list
24912457|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24912459|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955166|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24955167|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24955168|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955171|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
24955216|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
24955217|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
24955218|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
24955219|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449454|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449455|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
24819371|NCT02095054|Cetuximab|cetuximab|mesh-list
24955297|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811654|NCT02047552|Iron|iron|mesh-list
24955298|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
24955299|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955300|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24955301|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781071|NCT01887821|Artenimol|artenimol|mesh-list
24955335|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
24955336|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955338|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
24955339|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
24955340|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
24861116|NCT02315001|Liraglutide|liraglutide|mesh-list
24884629|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884630|NCT00092989|Montelukast|montelukast|mesh-list
24955358|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955360|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24955361|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24955362|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24955363|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24955364|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24884709|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24884710|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
24393226|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393228|NCT00129181|Levodopa|levodopa|mesh-list
24393229|NCT00129181|Carbidopa|carbidopa|mesh-list
24393230|NCT00129181|Cabergoline|cabergoline|mesh-list
24393231|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24393232|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24393233|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24393234|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
24393251|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24393252|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393253|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
24393254|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24955438|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24955439|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955440|NCT03865121|Nicotine|nicotine|mesh-list
24955441|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24955450|NCT03864978|Rifaximin|rifaximin|mesh-list
24955464|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955465|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393437|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
24393438|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
24393439|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24393440|NCT00130065|Hematinics|hematinics|mesh-ancestor
24393441|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
24393443|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
24393445|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
24393482|NCT00130195|Cytarabine|cytarabine|mesh-list
24393524|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393525|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24393526|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393527|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
24393528|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24393529|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24451998|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451999|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24452000|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24955583|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
24955595|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
24955596|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621045|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
24955608|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24955609|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24955612|NCT03863626|Diuretics|diuretics|mesh-ancestor
24393684|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24393685|NCT00130702|Gefitinib|gefitinib|mesh-list
24393686|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393687|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24393688|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393689|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393690|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
24393691|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
24393692|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393693|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393718|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393719|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24393720|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393721|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955682|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
24955683|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955684|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955686|NCT03862612|Anesthetics|anesthetics|mesh-list
24393892|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24955850|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24955851|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24955852|NCT03860636|Progestins|progestins|mesh-ancestor
24394009|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394010|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24394011|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394012|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394014|NCT00131703|Renal Agents|renal agents|mesh-ancestor
24394133|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
24394134|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394135|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394136|NCT00132275|Amoxicillin|amoxicillin|mesh-list
24394137|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
24394138|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
24394184|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955924|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
24955927|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
24626579|NCT01087879|Estradiol|estradiol|mesh-list
24626590|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24626591|NCT01087879|Progestins|progestins|mesh-ancestor
24626592|NCT01087983|Metformin|metformin|mesh-list
24626593|NCT01087983|Sirolimus|sirolimus|mesh-list
24626594|NCT01087983|Lapatinib|lapatinib|mesh-list
24626595|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626596|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626597|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24626598|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782033|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24782034|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
24782035|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24782036|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24782037|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
24956452|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24956453|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24956454|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
24956455|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24956456|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24956457|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24956472|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24922708|NCT04177173|Simvastatin|simvastatin|mesh-list
24782307|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956537|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
24956538|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956539|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956540|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24956541|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
24956542|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24956543|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
24956551|NCT03853538|Emollients|emollients|mesh-ancestor
25078325|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
25078326|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
25078327|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
24956633|NCT03852628|Buprenorphine|buprenorphine|mesh-list
24956731|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24956732|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
24956733|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956747|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24956748|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
24956749|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956750|NCT03851432|Metformin|metformin|mesh-list
24956751|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24782662|NCT01897324|Hormones|hormones|mesh-list
24956900|NCT03849664|Vitamins|vitamins|mesh-ancestor
24956901|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
24956902|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24957127|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957238|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24957239|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886363|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24957303|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24957304|NCT03845322|Analgesics|analgesics|mesh-ancestor
25078393|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24957305|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
24957306|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957307|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957308|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24957309|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24957310|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957311|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957312|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575287|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24575288|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24575289|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24575290|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24575291|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
24575292|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957493|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24957614|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24783467|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24783475|NCT01902186|Emtricitabine|emtricitabine|mesh-list
24958276|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25078476|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785253|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
24626805|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959340|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24959341|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959500|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959501|NCT03824834|Analgesics|analgesics|mesh-ancestor
24959502|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
24959504|NCT03824691|Durvalumab|durvalumab|mesh-list
24959586|NCT03823846|Dezocine|dezocine|mesh-list
24959587|NCT03823846|Analgesics|analgesics|mesh-ancestor
24959588|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
24959589|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609670|NCT00997750|Analgesics|analgesics|mesh-ancestor
24959856|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24959859|NCT03821623|Niacin|niacin|mesh-list
24959888|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24960051|NCT03819790|Gliclazide|gliclazide|mesh-list
24960054|NCT03819647|Stiripentol|stiripentol|mesh-list
24960173|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765514|NCT01789125|Nicotine|nicotine|mesh-list
24960696|NCT03814447|Fludarabine|fludarabine|mesh-list
24889883|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674543|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
24960844|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960845|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24960846|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24960847|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
24961009|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
24961010|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961109|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24675889|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961385|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24787637|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787638|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24961771|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24961773|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24961774|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
24961775|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961776|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961777|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961778|NCT03805568|Narcotics|narcotics|mesh-ancestor
24961779|NCT03805633|Pancrelipase|pancrelipase|mesh-list
24962260|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
24962261|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962296|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24962297|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962298|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962299|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24962300|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24962301|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
24962302|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
24962485|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24962486|NCT03799822|Vitamin K|vitamin k|mesh-list
24962487|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
24962488|NCT03799822|Vitamins|vitamins|mesh-ancestor
24962489|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
24962490|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962491|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24962492|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
24962494|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
24962668|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078788|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25078789|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078790|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24963246|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
24963412|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963562|NCT03790072|Fludarabine|fludarabine|mesh-list
24964040|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626931|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24626932|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24626933|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24626934|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
24964343|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
24893679|NCT04447378|PENTA|penta|mesh-list
24964642|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24964643|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25078961|NCT03351842|Cisplatin|cisplatin|mesh-list
24965149|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
24452730|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689172|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689173|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
24689174|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
24965345|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
24965646|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
24965647|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
24965650|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
24966029|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24966030|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
25079068|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079069|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
25079070|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
25079071|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079072|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25079073|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25079074|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25079075|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25079076|NCT03350633|Azathioprine|azathioprine|mesh-list
24966292|NCT03769818|BB 1101|bb 1101|mesh-list
24464725|NCT00366262|Analgesics|analgesics|mesh-ancestor
24464726|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
24966555|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966556|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966557|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966558|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966563|NCT03767036|Narcotics|narcotics|mesh-ancestor
25079147|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25079148|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079149|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25079150|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25079151|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079152|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079153|NCT03349866|Capecitabine|capecitabine|mesh-list
24966665|NCT03766594|Hematinics|hematinics|mesh-ancestor
24966670|NCT03766490|Gefitinib|gefitinib|mesh-list
24966914|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967051|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967052|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24967056|NCT03763084|Acetaminophen|acetaminophen|mesh-list
24967213|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967214|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
24627315|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
24627316|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627317|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627318|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24627319|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24627320|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24627379|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627380|NCT01092520|Gabapentin|gabapentin|mesh-list
24627381|NCT01092520|Analgesics|analgesics|mesh-ancestor
24627382|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
24627383|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465742|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627576|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
24627577|NCT01093807|Enalapril|enalapril|mesh-list
24627578|NCT01093807|Enalaprilat|enalaprilat|mesh-list
24627579|NCT01093807|Lercanidipine|lercanidipine|mesh-list
25079249|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965229|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965230|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965231|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
24965236|NCT03778593|Antidotes|antidotes|mesh-ancestor
24466031|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466032|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24466188|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24466189|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466418|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24466419|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24592819|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
24798976|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
24627918|NCT01095679|Baclofen|baclofen|mesh-list
24800434|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800435|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467098|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24467100|NCT00376272|Valsartan|valsartan|mesh-list
24467120|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467121|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24467122|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467123|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467124|NCT00376337|Micafungin|micafungin|mesh-list
24467125|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
24467126|NCT00376337|Clotrimazole|clotrimazole|mesh-list
24628097|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25079296|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
25079297|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
25079298|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24805905|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
24805906|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467593|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24467594|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
24806810|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
24806811|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806812|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467657|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468911|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468912|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24469211|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469212|NCT00384917|Ketoconazole|ketoconazole|mesh-list
24469628|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24469629|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469630|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079406|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
25079407|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079409|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470584|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
24471078|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
24471338|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24471339|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24811664|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
24471786|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
24472047|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24472048|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
24628628|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24628629|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628630|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474018|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24896914|NCT04432259|Dexamethasone|dexamethasone|mesh-list
24896915|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896916|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
24896917|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
24896918|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813670|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813671|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813672|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24813821|NCT02060604|Ketorolac|ketorolac|mesh-list
24813968|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813969|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
24813970|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
24813971|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813994|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
24814528|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814529|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
24814530|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
24814531|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
24814533|NCT02065128|Capsaicin|capsaicin|mesh-list
24472786|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24472787|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24472791|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628754|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628756|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
24628796|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
24628798|NCT01101412|Protective Agents|protective agents|mesh-ancestor
24628799|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24628800|NCT01101529|Aprepitant|aprepitant|mesh-list
24628801|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
24628802|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
24628803|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628804|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628805|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816490|NCT02077348|Hormones|hormones|mesh-list
24816491|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817293|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24817294|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24817305|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
24817307|NCT02082496|Liraglutide|liraglutide|mesh-list
24550489|NCT00720811|Lumefantrine|lumefantrine|mesh-list
24550490|NCT00720811|Artemether|artemether|mesh-list
24550491|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24550492|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550493|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550494|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24550495|NCT00720811|Analgesics|analgesics|mesh-ancestor
24446123|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24817436|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697549|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24446215|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
24474008|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24550554|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550555|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
24550556|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24550557|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24550558|NCT00721240|Montelukast|montelukast|mesh-list
24550562|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
24697809|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697810|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697840|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24550588|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
24550629|NCT00721526|Disulfiram|disulfiram|mesh-list
24819075|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819076|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24819630|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819631|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819632|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24819633|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
24819634|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698346|NCT01440673|Aprepitant|aprepitant|mesh-list
24811941|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819636|NCT02096315|Murepavadin|murepavadin|mesh-list
24819637|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774739|NCT01847612|Methylene Blue|methylene blue|mesh-list
24759773|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24759774|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
25079532|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079533|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079535|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
25079536|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25079537|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25079538|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079539|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759854|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759855|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
24565487|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
24759860|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759877|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24759879|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
24759880|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24759881|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
24474434|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24474435|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24760199|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
24760215|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24760216|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24760219|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25079613|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24700855|NCT01455506|Decitabine|decitabine|mesh-list
25079614|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079616|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24760640|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24760641|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24760643|NCT01759524|Clonidine|clonidine|mesh-list
24760644|NCT01759524|Bupivacaine|bupivacaine|mesh-list
24701272|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760646|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
25079678|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24760776|NCT01759940|Ropivacaine|ropivacaine|mesh-list
24760777|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760778|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
24760779|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760780|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760781|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
24760782|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760783|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24760784|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
24760786|NCT01760018|Desflurane|desflurane|mesh-list
24760828|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760829|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
24760830|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760831|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
24760832|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475702|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475703|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761003|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
24761004|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761005|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634755|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
24761063|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24761064|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761065|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24761066|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761141|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24761142|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
24761144|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24620125|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620126|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24620127|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620128|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620129|NCT01055522|Interleukin-2|interleukin-2|mesh-list
24620130|NCT01055522|Dacarbazine|dacarbazine|mesh-list
24620131|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476769|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24761455|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761456|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552275|NCT03728478|Analgesics|analgesics|mesh-ancestor
24478201|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761653|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24761654|NCT01763658|Antioxidants|antioxidants|mesh-list
24761655|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478825|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24479409|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
24899376|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24899377|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24761797|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761798|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761799|NCT01764828|Gemcitabine|gemcitabine|mesh-list
24761800|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24761801|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
24761940|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24761941|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24761942|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
24761943|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761944|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761945|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079876|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640482|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25079878|NCT03344393|Analgesics|analgesics|mesh-ancestor
25079879|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
25079880|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762007|NCT01765829|Ziprasidone|ziprasidone|mesh-list
24762370|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762666|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
24762669|NCT01769040|Rifaximin|rifaximin|mesh-list
24965959|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24965960|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965961|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24965962|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24965963|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763268|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763269|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763270|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24763271|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
24763272|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
24763273|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
24763274|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
24763275|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763276|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763277|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24763430|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763719|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
24763781|NCT01776788|Incretins|incretins|mesh-ancestor
24480619|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
24480620|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24763966|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24763967|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24763968|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24764014|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
24764016|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24764080|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24764081|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24764187|NCT01779882|Busulfan|busulfan|mesh-list
24764197|NCT01779908|Vitamin D|vitamin d|mesh-list
24764590|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
24764675|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24764676|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24764932|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764933|NCT01785108|Vitamin D|vitamin d|mesh-list
24764935|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
24765025|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24779524|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765798|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765799|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765800|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
24765801|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765802|NCT01790555|Analgesics|analgesics|mesh-ancestor
24765803|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
24765928|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765929|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24766089|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24766090|NCT01792570|Darunavir|darunavir|mesh-list
24766091|NCT01792570|Rilpivirine|rilpivirine|mesh-list
25080374|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
25080375|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966417|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
24766541|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24396510|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
24766671|NCT01796093|Digoxin|digoxin|mesh-list
24766905|NCT01797796|Capsaicin|capsaicin|mesh-list
24557986|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557987|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557988|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24557989|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24557990|NCT00755066|Fluticasone|fluticasone|mesh-list
24557992|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767024|NCT01798446|Axitinib|axitinib|mesh-list
24767291|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482292|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482293|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482294|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24482296|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
24767529|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767530|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767531|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767532|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
24767533|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558483|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558484|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482447|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
24482448|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482449|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24482450|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24482451|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24482452|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24482453|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657932|NCT01269541|Mupirocin|mupirocin|mesh-list
24767948|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767950|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24767951|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24767952|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767954|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24767955|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767956|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767957|NCT01804543|Ranolazine|ranolazine|mesh-list
24767958|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24767959|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25080523|NCT03337607|Analgesics|analgesics|mesh-ancestor
25080524|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
25080545|NCT03337581|Analgesics|analgesics|mesh-ancestor
24768115|NCT01805804|Valsartan|valsartan|mesh-list
24768219|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768224|NCT01806454|Calcium|calcium|mesh-list
24768304|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24768305|NCT01807286|Growth Substances|growth substances|mesh-ancestor
24768306|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
24768493|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24768570|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768571|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768681|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
24400442|NCT00150579|Amphetamine|amphetamine|mesh-list
24768684|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24768685|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
24768686|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768687|NCT01809925|Psyllium|psyllium|mesh-list
24769040|NCT01812239|Progesterone|progesterone|mesh-list
24769164|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769407|NCT01814163|Paclitaxel|paclitaxel|mesh-list
24769408|NCT01814163|Bevacizumab|bevacizumab|mesh-list
24451862|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24966756|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966758|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966759|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966760|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620457|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
24769430|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769431|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769432|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
24769448|NCT01814319|Probenecid|probenecid|mesh-list
24769511|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24769512|NCT01814501|Leucovorin|leucovorin|mesh-list
24769513|NCT01814501|Fluorouracil|fluorouracil|mesh-list
24769514|NCT01814501|Irinotecan|irinotecan|mesh-list
24769600|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769616|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769619|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24769620|NCT01814891|Vitamin A|vitamin a|mesh-list
24769842|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769843|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
24769844|NCT01816555|Vitamin D|vitamin d|mesh-list
24769847|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769848|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24770053|NCT01817699|Vitamin D|vitamin d|mesh-list
24770054|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
24770055|NCT01817699|Vitamins|vitamins|mesh-ancestor
24770056|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
24770057|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770058|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24539539|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25080873|NCT03335098|Hormones|hormones|mesh-ancestor
25080874|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770795|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24770796|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770797|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24770904|NCT01823081|Bevacizumab|bevacizumab|mesh-list
24770905|NCT01823081|Fasudil|fasudil|mesh-list
24770906|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24770907|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771307|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24771483|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
24771484|NCT01827540|Midazolam|midazolam|mesh-list
24771485|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24771486|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24771525|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771526|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
24771527|NCT01827722|Hormones|hormones|mesh-ancestor
24771663|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
24771706|NCT01828892|Vancomycin|vancomycin|mesh-list
24771730|NCT01829178|Protective Agents|protective agents|mesh-ancestor
24771732|NCT01829334|Fluorides|fluorides|mesh-list
24771733|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
24771734|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
24771735|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
24771736|NCT01829334|Protective Agents|protective agents|mesh-ancestor
24771737|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771738|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24771739|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771740|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
24771741|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24771742|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
24771743|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771744|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
24771853|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
24771854|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771855|NCT01830322|Gemcitabine|gemcitabine|mesh-list
24771856|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24771857|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
24771858|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771859|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771860|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
24771933|NCT01830517|Amlodipine|amlodipine|mesh-list
24771934|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771946|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771947|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24483374|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24483375|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24483376|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24483377|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24772103|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24772104|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772105|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24967084|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24967085|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967086|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967087|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24967091|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
24967092|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
25081024|NCT03333603|Esomeprazole|esomeprazole|mesh-list
25081025|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25081026|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081027|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25081028|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967093|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
25081029|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081030|NCT03333525|Insulin|insulin|mesh-list
24483414|NCT00443235|Growth Substances|growth substances|mesh-ancestor
24483416|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
24620643|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24620645|NCT01058174|Amphotericin B|amphotericin b|mesh-list
24620646|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24620647|NCT01058174|Caspofungin|caspofungin|mesh-list
24620648|NCT01058174|Micafungin|micafungin|mesh-list
24620649|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
24620650|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620651|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24620652|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24620653|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772305|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24620655|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24772138|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772139|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772140|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24772141|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
24772142|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772143|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24772144|NCT01831700|Protective Agents|protective agents|mesh-ancestor
24772145|NCT01831947|Ranibizumab|ranibizumab|mesh-list
24772219|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24772392|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772393|NCT01833572|Gefitinib|gefitinib|mesh-list
24772394|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909958|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
24483802|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
24483804|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483806|NCT00445081|Prednisolone|prednisolone|mesh-list
24772395|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24772704|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772706|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772707|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24772708|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773563|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773564|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773565|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24773679|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
24773759|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773761|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24773947|NCT01843088|Mannitol|mannitol|mesh-list
24773949|NCT01843088|Diuretics|diuretics|mesh-ancestor
24774028|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24774029|NCT01843309|Diuretics|diuretics|mesh-ancestor
24774030|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
25081240|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
24774095|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
24811856|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24774096|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774097|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774098|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
24774100|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
24774101|NCT01843868|Doxorubicin|doxorubicin|mesh-list
24774102|NCT01843868|Vincristine|vincristine|mesh-list
24565471|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565472|NCT00780728|Urological Agents|urological agents|mesh-ancestor
24565480|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565482|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24774228|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774229|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24774230|NCT01844648|Tropicamide|tropicamide|mesh-list
24774231|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
24774232|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
24774233|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774248|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774249|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774250|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
24774251|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24774312|NCT01845090|Antacids|antacids|mesh-ancestor
24774448|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24774449|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
24774453|NCT01845610|Manganese|manganese|mesh-list
24774560|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774561|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774562|NCT01846390|Gemcitabine|gemcitabine|mesh-list
24774563|NCT01846390|Dexamethasone|dexamethasone|mesh-list
24774564|NCT01846390|Romidepsin|romidepsin|mesh-list
24774565|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774660|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24774664|NCT01847326|Paclitaxel|paclitaxel|mesh-list
25067444|NCT03443778|Hormones|hormones|mesh-ancestor
25067499|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067500|NCT03443492|Leucovorin|leucovorin|mesh-list
25067501|NCT03443492|Gemcitabine|gemcitabine|mesh-list
25067502|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
24920857|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24920858|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24920860|NCT04197115|Vitamins|vitamins|mesh-list
24921086|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067640|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067641|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921140|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24921141|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921142|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921143|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921169|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921267|NCT04192916|Apixaban|apixaban|mesh-list
24921268|NCT04192916|Edoxaban|edoxaban|mesh-list
24921269|NCT04192916|Dabigatran|dabigatran|mesh-list
24921270|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24921276|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
24921277|NCT04192812|Leuprolide|leuprolide|mesh-list
24921278|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24921279|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
24921280|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24921284|NCT04192617|Methotrexate|methotrexate|mesh-list
24522723|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921411|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24921412|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24921413|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24921511|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24921627|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921632|NCT04188431|Dexamethasone|dexamethasone|mesh-list
24622779|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24622782|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
24622783|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953496|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953497|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953498|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24953499|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24953500|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623103|NCT01070225|Propranolol|propranolol|mesh-list
24922564|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
24624076|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24624077|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498207|NCT00513539|Trioxsalen|trioxsalen|mesh-list
24498208|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498209|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498210|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24498211|NCT00513552|Clarithromycin|clarithromycin|mesh-list
24624080|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24498243|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498244|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498245|NCT00513656|Analgesics|analgesics|mesh-ancestor
24498249|NCT00513786|Paclitaxel|paclitaxel|mesh-list
24522879|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24600468|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602407|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24608117|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24609558|NCT00997269|Vitamins|vitamins|mesh-ancestor
24672596|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672598|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
24672599|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672600|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672601|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24672602|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
24672603|NCT01332617|Hormones|hormones|mesh-ancestor
24672604|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673086|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673089|NCT01335321|Protective Agents|protective agents|mesh-ancestor
24673090|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24673771|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673772|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24673773|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673774|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673828|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24673831|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24673832|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
24673833|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676403|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
24678455|NCT01362010|Minocycline|minocycline|mesh-list
24683281|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
24684235|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24684666|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
24684667|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24684668|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24684669|NCT04835129|Growth Substances|growth substances|mesh-ancestor
24684670|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
24684672|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
24686352|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686353|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
24540186|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953885|NCT03880968|Etanercept|etanercept|mesh-list
24953576|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690120|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24690121|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24690122|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
24690372|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24690373|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
24690374|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690375|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690762|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690763|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
24690764|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24690765|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
24690795|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
24690796|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24690797|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
24690798|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690815|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
24612043|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24690972|NCT01404676|Glimepiride|glimepiride|mesh-list
24691292|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691402|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691403|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24691406|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
25069765|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069766|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
25069767|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692545|NCT01415128|Desipramine|desipramine|mesh-list
24692547|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24692548|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692549|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24692550|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692552|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24693066|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
24693067|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
24693068|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
24693070|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24693071|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24693425|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24693439|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24693440|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
24693444|NCT01420523|Maraviroc|maraviroc|mesh-list
24693445|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24693446|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24693447|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
24693448|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612343|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779465|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24779466|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779467|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24779468|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24626397|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24626398|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24626399|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
24626400|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626401|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24626403|NCT01087203|Analgesics|analgesics|mesh-ancestor
24626404|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
24694027|NCT01423500|Etoposide|etoposide|mesh-list
24540967|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24541031|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541032|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24541034|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24694533|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
24694534|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24694535|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694557|NCT05386160|Ranibizumab|ranibizumab|mesh-list
24694574|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24694575|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
24694576|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
24694577|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
24694578|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24694579|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070063|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25070064|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070066|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25070067|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25070068|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
24694804|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
24694805|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694806|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694807|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
24694808|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694809|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24694810|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24541250|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24541251|NCT00671645|Growth Substances|growth substances|mesh-ancestor
24541252|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694972|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
24694973|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24694974|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
24695142|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24695143|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
24695144|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24695145|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
24695160|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24695161|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24695578|NCT02860000|Fulvestrant|fulvestrant|mesh-list
24695579|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695580|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695581|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25070157|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25070158|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25070159|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25070160|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25070161|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070162|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070163|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24695784|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25070184|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070185|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
25070186|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
25070187|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
25070188|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070189|NCT03421119|Insulin|insulin|mesh-list
25070190|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24696228|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
24696229|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
24696230|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696231|NCT01428284|Canagliflozin|canagliflozin|mesh-list
24696232|NCT01428284|Probenecid|probenecid|mesh-list
24696233|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24696234|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696235|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24696623|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25070228|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25070229|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
25070230|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070231|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070232|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25070233|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
24823547|NCT02117752|Dapsone|dapsone|mesh-list
24541768|NCT00675194|Capecitabine|capecitabine|mesh-list
24541769|NCT00675194|Irinotecan|irinotecan|mesh-list
24541770|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070243|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25070244|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24832864|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832865|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832866|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
24696932|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696933|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696934|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
24696935|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24696961|NCT01432028|Estrogens|estrogens|mesh-ancestor
24696962|NCT01432028|Hormones|hormones|mesh-ancestor
24697116|NCT01432821|Apomorphine|apomorphine|mesh-list
24697435|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25070318|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
24697564|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24697565|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24697566|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
24626420|NCT01087359|Protective Agents|protective agents|mesh-ancestor
24698175|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
24698176|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
24543588|NCT00684385|Gefitinib|gefitinib|mesh-list
24698190|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24698191|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24698193|NCT01439438|Topiramate|topiramate|mesh-list
24698446|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698447|NCT01441232|Incretins|incretins|mesh-ancestor
24698448|NCT01441232|Hormones|hormones|mesh-ancestor
24698449|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25070449|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25070451|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25070452|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698548|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698550|NCT01441869|Hormones|hormones|mesh-ancestor
24698551|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24698584|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24698585|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698586|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698587|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698708|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698709|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
24698710|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698711|NCT01442701|Triclosan|triclosan|mesh-list
24698848|NCT01443169|Pregabalin|pregabalin|mesh-list
24699524|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24613029|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613031|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
24613032|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24613033|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
24613034|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699768|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700124|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
25071031|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25071032|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25071033|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
25071044|NCT03413371|Lidocaine|lidocaine|mesh-list
24700249|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24700250|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24953845|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
25071282|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071283|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071284|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25071379|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24547492|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547493|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
25071469|NCT03409367|Petrolatum|petrolatum|mesh-list
25071547|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071548|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071549|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25071551|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071552|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25071553|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071554|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071652|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
25071653|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071654|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25071655|NCT03406936|Midazolam|midazolam|mesh-list
25071656|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24953889|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
25071939|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
25072004|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953925|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24953926|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24953927|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953928|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24953929|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24953930|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953931|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953933|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953937|NCT03880487|Oxycodone|oxycodone|mesh-list
25072209|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072211|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25072212|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072213|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
25072214|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
25072215|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072216|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700718|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
24700734|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24700736|NCT01454635|Sertraline|sertraline|mesh-list
25072347|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25072348|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25072350|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25072433|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
25072467|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072468|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072470|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
24634419|NCT01133457|Finasteride|finasteride|mesh-list
25073026|NCT03397914|Polymyxins|polymyxins|mesh-list
24954037|NCT03879746|Paroxetine|paroxetine|mesh-list
25073196|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25073197|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25073379|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25073487|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
24637963|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638531|NCT01156948|Misoprostol|misoprostol|mesh-list
24638539|NCT01156961|Paclitaxel|paclitaxel|mesh-list
24640039|NCT01165814|Analgesics|analgesics|mesh-ancestor
24954117|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640507|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640508|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24640509|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25074027|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
25074028|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074029|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640893|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640894|NCT01170494|Vitamins|vitamins|mesh-ancestor
24640895|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
24640896|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640897|NCT01170507|Vitamin D|vitamin d|mesh-list
24640898|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
25074126|NCT03390595|Gemcitabine|gemcitabine|mesh-list
24642287|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074265|NCT03389451|Edetic Acid|edetic acid|mesh-list
25074266|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25074418|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
24954174|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954175|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074527|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25074528|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25074529|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25074530|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074531|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25075080|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075777|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25075092|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075093|NCT03383367|Protective Agents|protective agents|mesh-ancestor
25075475|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998446|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25075476|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075477|NCT03380871|Carboplatin|carboplatin|mesh-list
24998802|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
24643499|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24798300|NCT01962363|Vitamins|vitamins|mesh-ancestor
24839977|NCT02206789|Hormones|hormones|mesh-ancestor
24999247|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24999248|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24999249|NCT04850599|Growth Substances|growth substances|mesh-ancestor
24999250|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
24999251|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999255|NCT04839328|Hemay005|hemay005|mesh-list
24999256|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
24999257|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24999258|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24999908|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
24999909|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25048841|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048872|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644068|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24644069|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24644070|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644071|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25000452|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
25000488|NCT04374019|Ivermectin|ivermectin|mesh-list
25000686|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644278|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
24644279|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25000924|NCT05462613|Bevacizumab|bevacizumab|mesh-list
25000925|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000926|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000927|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25000936|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000937|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25000938|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048989|NCT00649025|Fluticasone|fluticasone|mesh-list
25048991|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644695|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
24644909|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645138|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25002592|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002593|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25002594|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25002595|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
25002596|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25002597|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002598|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24645862|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645950|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645995|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645996|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645997|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24645998|NCT01201161|Ranibizumab|ranibizumab|mesh-list
24646769|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24646770|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24646771|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
24646772|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24646821|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448298|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24463022|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24463028|NCT00358358|Hormones|hormones|mesh-ancestor
25003627|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
25003628|NCT03197064|Aprepitant|aprepitant|mesh-list
25003629|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
25003630|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
25003631|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004415|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24648683|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942284|NCT03982784|Narcotics|narcotics|mesh-ancestor
24798790|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798791|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798792|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
24650946|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798883|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652697|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652699|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
24652814|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24652823|NCT01240265|Vitamin D|vitamin d|mesh-list
24652832|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654152|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654153|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24654154|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654155|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654156|NCT01247961|Dexamethasone|dexamethasone|mesh-list
24654157|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
24654158|NCT01247961|BB 1101|bb 1101|mesh-list
24654159|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654160|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
24654172|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654346|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654347|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
24654348|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
24654349|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654408|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
24799050|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24846881|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846882|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
24846883|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654957|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654958|NCT01252420|Enoxaparin|enoxaparin|mesh-list
24654959|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
24654960|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24654961|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24655299|NCT01255579|Hormones|hormones|mesh-ancestor
24946564|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946731|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
24946732|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24946733|NCT03935984|Katacalcin|katacalcin|mesh-list
24946734|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24846984|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24655340|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655341|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655342|NCT01255956|Sirolimus|sirolimus|mesh-list
24655841|NCT01258439|Ritonavir|ritonavir|mesh-list
24656102|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656103|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
24656237|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947649|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24947650|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24947651|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24947652|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24656242|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24656243|NCT01260714|Etoposide|etoposide|mesh-list
24656244|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
24799119|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799120|NCT01967381|Methamphetamine|methamphetamine|mesh-list
24947890|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24656541|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466763|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656740|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656741|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656851|NCT01264354|Adefovir|adefovir|mesh-list
24799164|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799166|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24799168|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24467027|NCT00376038|Metformin|metformin|mesh-list
24467149|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467150|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102853|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25102854|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102855|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102856|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102857|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25102941|NCT03165396|Propofol|propofol|mesh-list
24902088|NCT04377646|Zinc|zinc|mesh-list
25103765|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103834|NCT03158246|Vitamins|vitamins|mesh-ancestor
25103835|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
25103864|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103960|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103966|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25103967|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469113|NCT00384592|Esomeprazole|esomeprazole|mesh-list
25104909|NCT03150524|Verapamil|verapamil|mesh-list
24911977|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25105482|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24520139|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976442|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976443|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
24976444|NCT03602235|Protective Agents|protective agents|mesh-ancestor
24914224|NCT04256642|Morphine|morphine|mesh-list
24472574|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24472597|NCT00399698|Risperidone|risperidone|mesh-list
24472601|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472603|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25105697|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105698|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
25105699|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
24533784|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24533785|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
24915289|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915290|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
24915291|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
24915292|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915293|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451089|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24534969|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534971|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24704887|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
24857658|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538276|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
24394243|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24538631|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
24538632|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538995|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539022|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539023|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542892|NCT00680732|Micronutrients|micronutrients|mesh-list
24542893|NCT00680732|Trace Elements|trace elements|mesh-list
24542894|NCT00680732|Chloroquine|chloroquine|mesh-list
24542895|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
24915810|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
24915812|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915813|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915814|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367227|NCT05148962|Vaccines|vaccines|mesh-list
25367228|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
24543617|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24543789|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543790|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
24916297|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24544177|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
24447095|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24447097|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
24916531|NCT04239560|Boron|boron|mesh-list
24916623|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858040|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
24425777|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
24443231|NCT00294099|Antacids|antacids|mesh-ancestor
24520598|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544895|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858067|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545078|NCT00691886|Analgesics|analgesics|mesh-ancestor
24794525|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24794526|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24794527|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24794529|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858355|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475041|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
24858359|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858360|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
24858362|NCT02296671|Fluorouracil|fluorouracil|mesh-list
24858382|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858548|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24858569|NCT02298283|Bleomycin|bleomycin|mesh-list
24917195|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24520723|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520724|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24520725|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24520727|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24520728|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520729|NCT05333744|Prednisone|prednisone|mesh-list
24520730|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520731|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
24520732|NCT05333744|Hormones|hormones|mesh-ancestor
24917244|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917245|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917246|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
24917247|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858650|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24858651|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24858652|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858653|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
24917423|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24917425|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24546390|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858847|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24546920|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24917623|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547476|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917694|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
24917695|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917696|NCT04227041|Capecitabine|capecitabine|mesh-list
24917697|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24917698|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
24917699|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917700|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800766|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24800767|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24800768|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24800769|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24917750|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24800770|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
24800771|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800818|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549034|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24549035|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549043|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24549175|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24801273|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
24477581|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24919473|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24919475|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919641|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
24494772|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494773|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919727|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919729|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919775|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
24919776|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24801562|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24801564|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24556756|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24521552|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24521626|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
24521627|NCT04629534|Vitamin D|vitamin d|mesh-list
24920444|NCT04202484|Tegafur|tegafur|mesh-list
25084882|NCT03302390|Lidocaine|lidocaine|mesh-list
24724266|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
24483352|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
24922376|NCT04181489|Hormones|hormones|mesh-ancestor
24922489|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
24922491|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922532|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624143|NCT01074905|Artesunate|artesunate|mesh-list
24802094|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802095|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
24601144|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24486137|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486138|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601433|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601434|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24393517|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
24802259|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601767|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601768|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601769|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601770|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601785|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24601786|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24601787|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24601788|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
24452256|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24802293|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24802323|NCT01989611|Tenofovir|tenofovir|mesh-list
24601964|NCT00966771|Copper|copper|mesh-list
24729281|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24602494|NCT00969085|Curcumin|curcumin|mesh-list
24602699|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602777|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602778|NCT00970957|Growth Substances|growth substances|mesh-ancestor
24603135|NCT00972660|Tacrolimus|tacrolimus|mesh-list
24603378|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603380|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603427|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
24464015|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24464178|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604315|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596983|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622558|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24443482|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24804290|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804323|NCT02002039|Hematinics|hematinics|mesh-ancestor
24804877|NCT02005653|Filaricides|filaricides|mesh-ancestor
24467343|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24606166|NCT00989300|Omeprazole|omeprazole|mesh-list
24606634|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
24467685|NCT00378456|Protective Agents|protective agents|mesh-ancestor
24467686|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
24606900|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24607297|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24467994|NCT00379431|Hormones|hormones|mesh-ancestor
24469164|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089298|NCT03267329|Telmisartan|telmisartan|mesh-list
24609026|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24672066|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
25367383|NCT05141721|Ipilimumab|ipilimumab|mesh-list
24503648|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24456936|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456937|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24673528|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24673743|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
24673744|NCT01339988|Busulfan|busulfan|mesh-list
24673900|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24673902|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
24673903|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
24673904|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673905|NCT01341080|Varenicline|varenicline|mesh-list
24673906|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24674334|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674335|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24674336|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674337|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458491|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24674388|NCT05249933|Benzocaine|benzocaine|mesh-list
24674389|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089613|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674723|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674724|NCT04721132|Bevacizumab|bevacizumab|mesh-list
24676652|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
24674727|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
24674730|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24674731|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
24674732|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675119|NCT03122847|Hormones|hormones|mesh-ancestor
24675120|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675125|NCT03078192|Xenon|xenon|mesh-list
24675749|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675750|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675751|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675752|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675753|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675756|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675782|NCT01345279|Topotecan|topotecan|mesh-list
24504855|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
24473992|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24676964|NCT01353469|Insulin|insulin|mesh-list
24677508|NCT01356680|Bleomycin|bleomycin|mesh-list
24677509|NCT01356680|Vinblastine|vinblastine|mesh-list
24396820|NCT00140075|Taxane|taxane|mesh-list
24908286|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24908287|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908288|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24908289|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908292|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24908580|NCT04319419|Micronutrients|micronutrients|mesh-list
24683923|NCT01394757|Ketamine|ketamine|mesh-list
24469738|NCT00386958|Povidone|povidone|mesh-list
24911043|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
24911044|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
24686897|NCT04525755|Nicotine|nicotine|mesh-list
24687255|NCT04164199|Capecitabine|capecitabine|mesh-list
24687909|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687916|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
24688599|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24914415|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24688971|NCT02520362|Denosumab|denosumab|mesh-list
24915512|NCT01583283|Lenalidomide|lenalidomide|mesh-list
24915566|NCT04250831|Chromium|chromium|mesh-list
24690472|NCT01402089|Sunitinib|sunitinib|mesh-list
24691152|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691153|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691155|NCT01405170|Hormones|hormones|mesh-ancestor
24691195|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24691760|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
24691762|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
24691763|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691764|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691766|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498864|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923296|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24923298|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923299|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923300|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24412255|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24923301|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
24923302|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
24692270|NCT01412515|Everolimus|everolimus|mesh-list
24692271|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693020|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930273|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930274|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24930275|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
24930428|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694076|NCT01423747|Treosulfan|treosulfan|mesh-list
24694077|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694078|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694079|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24694080|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
24414289|NCT00196755|Calcium|calcium|mesh-list
24694081|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932604|NCT04077957|Etanercept|etanercept|mesh-list
24932605|NCT04077957|Methotrexate|methotrexate|mesh-list
24625301|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625303|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
24625304|NCT01081561|Vitamins|vitamins|mesh-ancestor
24625305|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
24625306|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933894|NCT04066257|Bismuth|bismuth|mesh-list
24694708|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24694709|NCT05379374|Narcotics|narcotics|mesh-ancestor
24694710|NCT05379374|Analgesics|analgesics|mesh-ancestor
24934760|NCT04058899|Analgesics|analgesics|mesh-ancestor
24934761|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
24670743|NCT01998971|Analgesics|analgesics|mesh-ancestor
24670744|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
24670745|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
25091345|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25091346|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
25091347|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
25091349|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
25091350|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24748035|NCT02992418|Vaccines|vaccines|mesh-list
24670874|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24670875|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004924|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24518881|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518882|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24518883|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518884|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
24518892|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
24470788|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
24470790|NCT00391911|Protective Agents|protective agents|mesh-ancestor
24748766|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
24695084|NCT04638660|Phentolamine|phentolamine|mesh-list
24695085|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24695086|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24695087|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24695088|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24695089|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
24695090|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695091|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695146|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695148|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24695150|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24695152|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
24695153|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486519|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004951|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419600|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419679|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
24695227|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695228|NCT04199819|Entecavir|entecavir|mesh-list
24695229|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
24695230|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504031|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24504032|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504033|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24695307|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24695308|NCT03821649|Naloxone|naloxone|mesh-list
24695313|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
24695314|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
24695315|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
24695316|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695317|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695318|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
24695319|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695320|NCT03809767|Antibodies|antibodies|mesh-list
24612459|NCT01014104|Prednisolone|prednisolone|mesh-list
24612460|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
24612464|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
24612527|NCT01014338|Fosinopril|fosinopril|mesh-list
24612528|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24695331|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695333|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
24695334|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24695335|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695336|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695337|NCT03759028|Acetaminophen|acetaminophen|mesh-list
24695338|NCT03759028|Ibuprofen|ibuprofen|mesh-list
24695363|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
24695400|NCT03708198|Bupivacaine|bupivacaine|mesh-list
24695401|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
24695402|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
24695403|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695404|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695405|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
24695406|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695408|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24695409|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
24695410|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24695411|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695412|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
24695413|NCT03596424|Ketamine|ketamine|mesh-list
24695414|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24695415|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695449|NCT03512405|Blinatumomab|blinatumomab|mesh-list
24695450|NCT03512405|Antibodies|antibodies|mesh-list
24695451|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
24695452|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24695453|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
24695454|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24695455|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
24695456|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695457|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695458|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695459|NCT03507699|Nivolumab|nivolumab|mesh-list
24695460|NCT03507699|Ipilimumab|ipilimumab|mesh-list
24512204|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
24512205|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
24422263|NCT00221871|Analgesics|analgesics|mesh-ancestor
24422950|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
24422951|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512442|NCT00575068|Galiximab|galiximab|mesh-list
24423456|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583808|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24520336|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24520337|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520340|NCT02771249|Darunavir|darunavir|mesh-list
24520341|NCT02771249|Cobicistat|cobicistat|mesh-list
24521325|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25091949|NCT03245658|Nabiximols|nabiximols|mesh-list
24521328|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
24695552|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695553|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695554|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612529|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
24695555|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
24522759|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
24522760|NCT03253263|Mecasermin|mecasermin|mesh-list
24522763|NCT03205163|Factor VIII|factor viii|mesh-list
24695607|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695608|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695609|NCT02547662|Dexamethasone|dexamethasone|mesh-list
24695610|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
24695611|NCT02547662|Pomalidomide|pomalidomide|mesh-list
24695613|NCT02547662|Ichthammol|ichthammol|mesh-list
24695614|NCT02547662|BB 1101|bb 1101|mesh-list
24526347|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24526469|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527125|NCT00615160|Vatalanib|vatalanib|mesh-list
24530995|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530997|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530998|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24706113|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706114|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706115|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706504|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24706505|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24788843|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24788844|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24714372|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24714373|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614776|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723516|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725064|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
24725827|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24737740|NCT01670370|Gemcitabine|gemcitabine|mesh-list
24742923|NCT05103696|Propofol|propofol|mesh-list
24753190|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24753223|NCT01714206|Canagliflozin|canagliflozin|mesh-list
24753224|NCT01714206|Digoxin|digoxin|mesh-list
24753225|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24443187|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443188|NCT00293917|Tacrolimus|tacrolimus|mesh-list
24443189|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755482|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790133|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24790134|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
24398980|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24398981|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24398982|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24399009|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24399010|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408660|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24408661|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24425248|NCT00232492|Ketamine|ketamine|mesh-list
24426405|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24430477|NCT00247988|Carboplatin|carboplatin|mesh-list
24430567|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430568|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430569|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430570|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430583|NCT00248313|Sirolimus|sirolimus|mesh-list
24440576|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
24443373|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24437751|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437752|NCT00274430|Dexamethasone|dexamethasone|mesh-list
24437753|NCT00274430|Tadalafil|tadalafil|mesh-list
25007646|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
25007647|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460841|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24460846|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
24461162|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24461163|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24461164|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
25007887|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551509|NCT05373680|Empagliflozin|empagliflozin|mesh-list
24551510|NCT05373680|Biguanides|biguanides|mesh-list
24442343|NCT00290758|Genistein|genistein|mesh-list
25008005|NCT02339740|Vitamins|vitamins|mesh-list
24552841|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553134|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553135|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553136|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24553137|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24553138|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553139|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24555466|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555467|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24555526|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558029|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24558030|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008414|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559520|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559521|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562943|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24566038|NCT00784186|Misoprostol|misoprostol|mesh-list
24566692|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566693|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566694|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24569428|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24569429|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24558970|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24569485|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
24570127|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
24570440|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570441|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24571601|NCT00811005|Methoxsalen|methoxsalen|mesh-list
24573146|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573147|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24573148|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24574202|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24574203|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
24574204|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574205|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574207|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574208|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24574728|NCT00827177|Sorafenib|sorafenib|mesh-list
24575918|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
25009702|NCT05210140|Citalopram|citalopram|mesh-list
24576394|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576395|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
24576396|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576397|NCT00838266|Protective Agents|protective agents|mesh-ancestor
24576399|NCT00838305|Citalopram|citalopram|mesh-list
24576410|NCT00838357|Plerixafor|plerixafor|mesh-list
24576418|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632026|NCT01121744|Sirolimus|sirolimus|mesh-list
24576422|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
24576695|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576696|NCT00839826|Enoxaparin|enoxaparin|mesh-list
24576697|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
24576699|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
24576700|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24576701|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
24576702|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577156|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
24577157|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
24577158|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577159|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577192|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577193|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577194|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
25009804|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
24577900|NCT00846326|Phenylephrine|phenylephrine|mesh-list
24577901|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
24577902|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578596|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578598|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578616|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578617|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24578789|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25009942|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
24579081|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579683|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24580271|NCT00861250|Dexamethasone|dexamethasone|mesh-list
24580659|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25110119|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696302|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24583411|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24793471|NCT03427736|Ketorolac|ketorolac|mesh-list
24583717|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583718|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583787|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
24584224|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24584225|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24584376|NCT00880178|Vitamins|vitamins|mesh-ancestor
25010452|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24586740|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24584767|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584768|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585060|NCT00882960|Analgesics|analgesics|mesh-ancestor
24585575|NCT00886106|Analgesics|analgesics|mesh-ancestor
24585576|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
24588601|NCT00903227|Xhance|xhance|mesh-list
24612692|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
24612693|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612694|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24612695|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24612696|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
24612697|NCT01015183|Astringents|astringents|mesh-ancestor
24612698|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010508|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
25010509|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25010510|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25010511|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25010512|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010513|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010514|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010515|NCT03897244|Antacids|antacids|mesh-ancestor
24696823|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
24696824|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24696825|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
24696826|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24696830|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
25010615|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25010616|NCT03617731|Growth Substances|growth substances|mesh-ancestor
24397476|NCT00141648|Prednisolone|prednisolone|mesh-list
24696936|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697003|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24697004|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24697005|NCT01432106|Valsartan|valsartan|mesh-list
24697006|NCT01432106|Ramipril|ramipril|mesh-list
24697048|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697334|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24697335|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24697336|NCT01434173|Amoxicillin|amoxicillin|mesh-list
24697337|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
24697338|NCT01434173|Clarithromycin|clarithromycin|mesh-list
24697339|NCT01434173|Doxycycline|doxycycline|mesh-list
24697340|NCT01434173|Levofloxacin|levofloxacin|mesh-list
24697341|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
24697342|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
24697386|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697583|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
24697584|NCT01435707|Hormones|hormones|mesh-ancestor
24697585|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697586|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697587|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448939|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24657248|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657250|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24657291|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
24657302|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24657303|NCT01266707|Growth Substances|growth substances|mesh-ancestor
24657304|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
24657305|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657306|NCT01266720|Gemcitabine|gemcitabine|mesh-list
24657427|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657458|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24657459|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657460|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657461|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657462|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799212|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24799213|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
24799214|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799215|NCT01967875|Docetaxel|docetaxel|mesh-list
24799216|NCT01967875|Capecitabine|capecitabine|mesh-list
24799217|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799218|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
24657606|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24450471|NCT00319293|Metformin|metformin|mesh-list
24657769|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657907|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657908|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657910|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
24657974|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
24658278|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24658279|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
24658280|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
24658413|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
24658611|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658613|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
24658614|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049692|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24847352|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24847353|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
24847354|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
24658930|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658931|NCT01274624|Antidotes|antidotes|mesh-ancestor
24658932|NCT01274624|Protective Agents|protective agents|mesh-ancestor
24658933|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
24658934|NCT01274624|Vitamins|vitamins|mesh-ancestor
24658935|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
24659110|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659111|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
24659232|NCT01276431|Narcotics|narcotics|mesh-ancestor
25049731|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
25049732|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049733|NCT00576342|Timolol|timolol|mesh-list
25049734|NCT00576342|Dorzolamide|dorzolamide|mesh-list
25049735|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24799284|NCT01968044|Incretins|incretins|mesh-ancestor
24659367|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659368|NCT01277172|Rituximab|rituximab|mesh-list
24659369|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24659370|NCT01277172|Antibodies|antibodies|mesh-list
24659371|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
24659372|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24659373|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
24659472|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24659684|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24659685|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659686|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24659687|NCT01279291|Gemcitabine|gemcitabine|mesh-list
24659689|NCT01279291|Carboplatin|carboplatin|mesh-list
24950097|NCT02633059|BB 1101|bb 1101|mesh-list
24659901|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24659902|NCT01280526|Romidepsin|romidepsin|mesh-list
24659903|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24659904|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659905|NCT01280669|Sirolimus|sirolimus|mesh-list
24659906|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24659907|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799352|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24799353|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25049765|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049766|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049768|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049769|NCT00566202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24449183|NCT00314652|Buprenorphine|buprenorphine|mesh-list
24660007|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24660008|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24660009|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
24660010|NCT01281540|Cisapride|cisapride|mesh-list
24660053|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24799433|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799441|NCT01969032|Carboplatin|carboplatin|mesh-list
24799442|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799443|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607976|NCT03077698|Hormones|hormones|mesh-ancestor
24799481|NCT01969149|Exenatide|exenatide|mesh-list
24799482|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
24799483|NCT01969149|Incretins|incretins|mesh-list
24799484|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799485|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593338|NCT00928148|Amphetamine|amphetamine|mesh-list
24799487|NCT01969149|Hormones|hormones|mesh-ancestor
24799504|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799505|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799506|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25049794|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25049795|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
24799704|NCT01970553|Gemcitabine|gemcitabine|mesh-list
24660940|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24660941|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799785|NCT01971281|Paclitaxel|paclitaxel|mesh-list
24661411|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
24661412|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25049837|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25049838|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
25049839|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
25049840|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049841|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049842|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25049844|NCT00561743|Hormones|hormones|mesh-ancestor
24661559|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
24661560|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
24661561|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661563|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24661941|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799900|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799901|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
24799902|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799903|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
24799904|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24799905|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24799907|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
24622230|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
24622231|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662627|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662628|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24662629|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24662630|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24662631|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24662632|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951267|NCT03906669|Hormones|hormones|mesh-ancestor
24799931|NCT01972230|Remifentanil|remifentanil|mesh-list
24799932|NCT01972230|Sevoflurane|sevoflurane|mesh-list
24799933|NCT01972230|Propofol|propofol|mesh-list
24799934|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24662821|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
24662974|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663023|NCT01297998|Cisplatin|cisplatin|mesh-list
24663073|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24663074|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24663417|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663426|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
24663427|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24663428|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24663429|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24663430|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663440|NCT01301248|Cetuximab|cetuximab|mesh-list
24663548|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
24663653|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24663657|NCT01303029|Gemcitabine|gemcitabine|mesh-list
24663658|NCT01303029|Capecitabine|capecitabine|mesh-list
24663659|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24663660|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24664004|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
24848531|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24848532|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24664344|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664377|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664378|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664380|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24800310|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800311|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049984|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
24951636|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
24951637|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951638|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951639|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24951640|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24800368|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800369|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800370|NCT01975259|Incretins|incretins|mesh-ancestor
24759636|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24759637|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
24759638|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24759639|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24759640|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24951828|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24951829|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24951830|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24951831|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24664859|NCT01309074|Pregabalin|pregabalin|mesh-list
24664860|NCT01309074|Sertraline|sertraline|mesh-list
24664861|NCT01309074|Analgesics|analgesics|mesh-ancestor
24664937|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
24664938|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24664939|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
24665110|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935408|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935504|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452620|NCT05457959|Vaccines|vaccines|mesh-list
24935538|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935539|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935540|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24935541|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
24935542|NCT04049344|Decitabine|decitabine|mesh-list
24935543|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935544|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935561|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665391|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24665392|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050057|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665693|NCT01314209|Analgesics|analgesics|mesh-ancestor
24665694|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
24665695|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665696|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24665697|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24665698|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24665699|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
24935685|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935722|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935723|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24665982|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24665996|NCT01316718|Mesalamine|mesalamine|mesh-list
24666014|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666015|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24666016|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24666017|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935749|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
24935750|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24935751|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760232|NCT01756989|Thalidomide|thalidomide|mesh-list
24935752|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24935805|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24935806|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935807|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24935808|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935839|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24666388|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666526|NCT01319734|Ascorbic Acid|ascorbic acid|mesh-list
24666527|NCT01319734|Glyburide|glyburide|mesh-list
24666891|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24666892|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24666893|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667046|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667047|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
24667048|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24667056|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
24936020|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24936021|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
24667380|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24667381|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24812031|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24643168|NCT01184287|Ranpirnase|ranpirnase|mesh-list
25368058|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
24533593|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24936304|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24936405|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936406|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936408|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936409|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936410|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936411|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24850136|NCT02251847|Ezetimibe|ezetimibe|mesh-list
24936430|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24936450|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936454|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24936455|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24936456|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24936474|NCT04039828|Zinc|zinc|mesh-list
25050183|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25050184|NCT00532311|Simvastatin|simvastatin|mesh-list
25050185|NCT00532311|Pravastatin|pravastatin|mesh-list
24533826|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533827|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24533829|NCT00645255|Sibutramine|sibutramine|mesh-list
24444214|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444665|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952860|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
24952861|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952863|NCT03891433|Tazobactam|tazobactam|mesh-list
24952865|NCT03891433|Ertapenem|ertapenem|mesh-list
24936495|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
24936552|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
24936553|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936554|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24936555|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936556|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
24812063|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
24936610|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936611|NCT04038307|Acetaminophen|acetaminophen|mesh-list
24936612|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24936613|NCT04038307|Analgesics|analgesics|mesh-ancestor
24936614|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
24850301|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850302|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
24850303|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
25050253|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050255|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850343|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24850344|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
24850345|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
24850346|NCT02252770|Protective Agents|protective agents|mesh-ancestor
24850347|NCT02252796|Paclitaxel|paclitaxel|mesh-list
24850348|NCT02252796|Carboplatin|carboplatin|mesh-list
24953033|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953034|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953035|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24672021|NCT01329289|Bortezomib|bortezomib|mesh-list
24850377|NCT02252887|Gemcitabine|gemcitabine|mesh-list
24850378|NCT02252887|Trastuzumab|trastuzumab|mesh-list
24850379|NCT02252887|Pertuzumab|pertuzumab|mesh-list
24850380|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24850381|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
24936675|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936676|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
24936677|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936678|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936679|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24936680|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
24936682|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936701|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936702|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936703|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936704|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936705|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25050278|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24812123|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
24812124|NCT02049801|Cytarabine|cytarabine|mesh-list
24936766|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936768|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
24936769|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936797|NCT04035850|Vortioxetine|vortioxetine|mesh-list
24936798|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
24936799|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24936800|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24936801|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444757|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444758|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
24779176|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779177|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779178|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
24779180|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
24761683|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761685|NCT01763710|Paclitaxel|paclitaxel|mesh-list
24937081|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937165|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24937166|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
24937167|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
24850812|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850814|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
24953560|NCT03883984|Cysteamine|cysteamine|mesh-list
24953561|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
24953562|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953563|NCT03883776|Octreotide|octreotide|mesh-list
24533944|NCT00645515|Ziprasidone|ziprasidone|mesh-list
24937311|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937312|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937319|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
24444591|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533994|NCT00645632|Ifosfamide|ifosfamide|mesh-list
24534000|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534001|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24534016|NCT00645658|Androgens|androgens|mesh-ancestor
24534017|NCT00645658|Hormones|hormones|mesh-ancestor
24534023|NCT00645801|Lubiprostone|lubiprostone|mesh-list
24937380|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937381|NCT04029428|Octreotide|octreotide|mesh-list
24937382|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24937383|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24937393|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
24937394|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24534118|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24534119|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
24534121|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534132|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534170|NCT00646321|Budesonide|budesonide|mesh-list
24649339|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
24534201|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553177|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24553179|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24553180|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24553181|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
24553182|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553183|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553184|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24937727|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937728|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
24937729|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24937730|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24937732|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
24937772|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24937773|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937774|NCT04025593|Prednisone|prednisone|mesh-list
24937775|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
24937776|NCT04025593|Rituximab|rituximab|mesh-list
24937777|NCT04025593|Doxorubicin|doxorubicin|mesh-list
24937778|NCT04025593|Vincristine|vincristine|mesh-list
24937779|NCT04025593|Lenalidomide|lenalidomide|mesh-list
24937780|NCT04025593|Decitabine|decitabine|mesh-list
24851334|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851336|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
24851337|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
25368206|NCT05108428|Capecitabine|capecitabine|mesh-list
24534303|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24762632|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762633|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
24762636|NCT01768897|Vitamins|vitamins|mesh-ancestor
24937868|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
24937869|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
24937870|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851438|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
24534703|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
24534753|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24451060|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
24451061|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
24938072|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24938073|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938074|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451118|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938098|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938141|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938164|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938165|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24938166|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
24762959|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762960|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938285|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938286|NCT04020328|Prednisone|prednisone|mesh-list
24851680|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24851681|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24851682|NCT02258009|Growth Substances|growth substances|mesh-ancestor
24851683|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535281|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24535282|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24938307|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851705|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851706|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851707|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851708|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851709|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24652923|NCT01240941|Exemestane|exemestane|mesh-list
24938352|NCT04019496|Calcitonin|calcitonin|mesh-list
25050334|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25050335|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
25050336|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
25050337|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535525|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446232|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24938431|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
24938432|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24938433|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535665|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
24535666|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535667|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535668|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24446370|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938456|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
24535843|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24535848|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
24938496|NCT04018768|Narcotics|narcotics|mesh-ancestor
24938497|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938498|NCT04018378|Varenicline|varenicline|mesh-list
24938499|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24938500|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24938501|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535960|NCT00650065|Cetirizine|cetirizine|mesh-list
24536005|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536007|NCT00650182|Naltrexone|naltrexone|mesh-list
24536008|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24536009|NCT00650182|Narcotics|narcotics|mesh-ancestor
24536189|NCT00650455|Analgesics|analgesics|mesh-ancestor
24938563|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24938564|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
24938565|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
24536228|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536229|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536230|NCT00650481|Urological Agents|urological agents|mesh-ancestor
24536231|NCT00650494|Valacyclovir|valacyclovir|mesh-list
24536419|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24536420|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24536421|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536422|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938716|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536773|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938817|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938819|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24938820|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938919|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938920|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537197|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537198|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24537218|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537309|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
24537310|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
24537312|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537327|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24537328|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24537329|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
24537330|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955137|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24955138|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24955139|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050463|NCT00495885|Volinanserin|volinanserin|mesh-list
24538265|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
24538281|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538282|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24538283|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24538390|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24538391|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538392|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538393|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24538394|NCT00659100|Gabapentin|gabapentin|mesh-list
24538395|NCT00659100|Analgesics|analgesics|mesh-ancestor
24538396|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
24538397|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538398|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538399|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
24538400|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24939033|NCT04013880|Decitabine|decitabine|mesh-list
24939034|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24939035|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
24939036|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939037|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939051|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
24939052|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
24939053|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939054|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538541|NCT00659776|Hematinics|hematinics|mesh-ancestor
24538542|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24538543|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24538544|NCT00659841|Ciclesonide|ciclesonide|mesh-list
24939098|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939099|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939100|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
24939101|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939102|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939103|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
24939104|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
24538748|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538749|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
24538750|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538751|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939136|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24939137|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939138|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24939139|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
24939141|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955331|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
24451437|NCT00323778|Protective Agents|protective agents|mesh-ancestor
24538969|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24538970|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24538971|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24939214|NCT04012294|Allopurinol|allopurinol|mesh-list
24505697|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
24939267|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939268|NCT04011280|Varenicline|varenicline|mesh-list
24506409|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24506410|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
24506411|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24539148|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24939323|NCT04011098|Analgesics|analgesics|mesh-ancestor
24939324|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
24939327|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24507580|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507581|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24507582|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507583|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24507584|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539259|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539378|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474831|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509347|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24509348|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509349|NCT00559741|Antidotes|antidotes|mesh-ancestor
24509350|NCT00559741|Protective Agents|protective agents|mesh-ancestor
24509351|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
24509352|NCT00559741|Vitamins|vitamins|mesh-ancestor
24509353|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
24509584|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509586|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24509850|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24509851|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24509856|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510128|NCT00563485|Urological Agents|urological agents|mesh-ancestor
24510129|NCT00563524|Fezakinumab|fezakinumab|mesh-list
24510130|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
24510131|NCT00563589|Cyclosporine|cyclosporine|mesh-list
24510132|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
24510133|NCT00563589|Methotrexate|methotrexate|mesh-list
24510134|NCT00563589|Cyclosporins|cyclosporins|mesh-list
24510135|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24510136|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
24539886|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24539887|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24510788|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510789|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24510790|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
24510791|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24510792|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510817|NCT00565708|Aspirin|aspirin|mesh-list
24445106|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24445107|NCT00300404|Leucovorin|leucovorin|mesh-list
24540269|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540270|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24540271|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24444090|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24444091|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939405|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955587|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
24955588|NCT03863691|Amisulpride|amisulpride|mesh-list
24540665|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540666|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24540667|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24513376|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513381|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
24513382|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24513383|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24513384|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24541142|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541144|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24541566|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541567|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24541604|NCT00674089|Vitamins|vitamins|mesh-ancestor
24541605|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
24541606|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541608|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541609|NCT00674141|Dexamethasone|dexamethasone|mesh-list
24939605|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939607|NCT04008186|Repaglinide|repaglinide|mesh-list
24543039|NCT00681733|Protective Agents|protective agents|mesh-ancestor
24543050|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543051|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24543653|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
24543655|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24543835|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
24543836|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543837|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543838|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543839|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
25050528|NCT00488267|Ketoprofen|ketoprofen|mesh-list
24543936|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
24939707|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
24544579|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24521791|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521792|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
24521793|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
24521794|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521795|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24521796|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
24521799|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24939836|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
24939837|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
24939838|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764652|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625623|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
24625624|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24625625|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
24625626|NCT01082731|Artesunate|artesunate|mesh-list
24625627|NCT01082731|Lumefantrine|lumefantrine|mesh-list
24625629|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24625631|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
24625632|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24546195|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
24546224|NCT00697151|Analgesics|analgesics|mesh-ancestor
24546544|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24546545|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24546546|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546547|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
24546548|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24546549|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24546550|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24546568|NCT00699114|Acetaminophen|acetaminophen|mesh-list
24546888|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
24939921|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24547341|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24547342|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
24547456|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547457|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939994|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
24547629|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24547966|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547968|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24547969|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
24547971|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
24548139|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548140|NCT00707850|Ribavirin|ribavirin|mesh-list
24548141|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25050603|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050604|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25050605|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24956152|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24418433|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418434|NCT00209625|Leucovorin|leucovorin|mesh-list
24418435|NCT00209625|Fluorouracil|fluorouracil|mesh-list
24418436|NCT00209625|Irinotecan|irinotecan|mesh-list
24418437|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
24418438|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418439|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418440|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368510|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
24418691|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24418692|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418780|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
24418781|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978189|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24978190|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418852|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418853|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419027|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419028|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419031|NCT00210847|Narcotics|narcotics|mesh-ancestor
24419032|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419033|NCT00210860|Topiramate|topiramate|mesh-list
24419034|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
24419035|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419037|NCT00210873|Topiramate|topiramate|mesh-list
24978256|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978257|NCT04950426|Propranolol|propranolol|mesh-list
24978258|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24978259|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24978260|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
24978261|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978262|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978263|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978264|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24978266|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
24978307|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978308|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978309|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
24978310|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
24978311|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978312|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24978313|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
24978314|NCT04740294|Analgesics|analgesics|mesh-ancestor
24978315|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
24978318|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
24795362|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
24795363|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795364|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978398|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978399|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
24978400|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978401|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795411|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978484|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
24978485|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783714|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24420115|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24978684|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420544|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24420545|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420546|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795426|NCT02758847|Paclitaxel|paclitaxel|mesh-list
24978782|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978783|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
24978784|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
24978785|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978786|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978787|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24978788|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
24978815|NCT02774265|Analgesics|analgesics|mesh-ancestor
24978816|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
24978817|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421098|NCT00217659|Goserelin|goserelin|mesh-list
24421099|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24421100|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421101|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24421102|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24421103|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421104|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421105|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24421106|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
24421108|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421136|NCT00217815|Efungumab|efungumab|mesh-list
24978834|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24978835|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24978836|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
24978837|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
24422194|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24422195|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978938|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24978939|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
24978941|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978943|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
24422529|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795435|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795437|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795438|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24795439|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795450|NCT02581943|Carboplatin|carboplatin|mesh-list
24795451|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
24422817|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422820|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
24422821|NCT00223717|Aspirin|aspirin|mesh-list
24422822|NCT00223717|Losartan|losartan|mesh-list
24422823|NCT00223717|Metoprolol|metoprolol|mesh-list
24422824|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24422825|NCT00223717|Clonidine|clonidine|mesh-list
24422860|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24422861|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
24422862|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24423616|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424436|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
24425359|NCT00232817|Nicotine|nicotine|mesh-list
24425615|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24425616|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425617|NCT00233792|Sirolimus|sirolimus|mesh-list
24425618|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425619|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425620|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427232|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24427233|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24427234|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
24427235|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427236|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427427|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
24427428|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24427429|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
24427430|NCT00238173|Protective Agents|protective agents|mesh-ancestor
24427431|NCT00238173|Antidotes|antidotes|mesh-ancestor
24427432|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24427433|NCT00238173|Diuretics|diuretics|mesh-ancestor
24427434|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428184|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24428185|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24428226|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24428227|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
24979421|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24428878|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24428879|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428881|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24428907|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24429828|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24430019|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24430021|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
24430074|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25106003|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25106004|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25106005|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25106006|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106007|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106008|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25106009|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
24979484|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24979485|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
24979486|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
24979487|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979488|NCT04178603|Insulin|insulin|mesh-list
24979489|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24979490|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979491|NCT04170972|Insulin|insulin|mesh-list
24431598|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431599|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979564|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24979645|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783890|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783894|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
24434540|NCT00262769|Cisplatin|cisplatin|mesh-list
24434541|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434542|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434543|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
24434544|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434914|NCT00264277|Anticoagulants|anticoagulants|mesh-list
24434915|NCT00264277|Vitamins|vitamins|mesh-ancestor
24434916|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
24434917|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434918|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24434919|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24979741|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979742|NCT05241249|Gemcitabine|gemcitabine|mesh-list
24979743|NCT05241249|Paclitaxel|paclitaxel|mesh-list
24979744|NCT05241249|Bethanechol|bethanechol|mesh-list
24979745|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24979746|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979747|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436532|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24436533|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
24436534|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436535|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24979791|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
24437159|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437610|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979980|NCT04788017|Ziresovir|ziresovir|mesh-list
24438192|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
24438193|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980021|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24980022|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24980023|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980024|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
24980025|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
24980026|NCT04710732|Enoxaparin|enoxaparin|mesh-list
24439592|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24439593|NCT00279487|Gabapentin|gabapentin|mesh-list
24439594|NCT00279487|Analgesics|analgesics|mesh-ancestor
24439595|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
24442315|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24442316|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24442317|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
24442318|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442625|NCT00291785|Hematinics|hematinics|mesh-ancestor
24442626|NCT00291811|Plerixafor|plerixafor|mesh-list
24442627|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24442628|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24442629|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
24442720|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
24980260|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24980261|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
24980262|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24980324|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24980325|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980411|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24980818|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
24622033|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
24622034|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622035|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622036|NCT01065272|Dexamethasone|dexamethasone|mesh-list
24622037|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622038|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
24783984|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
24783985|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106113|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106114|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25106115|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24795634|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795635|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795636|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795637|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24795638|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24795639|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24981476|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981540|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
24981541|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981542|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24982004|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
24982005|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
24982006|NCT04463394|Coagulants|coagulants|mesh-ancestor
24982007|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24982008|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24982009|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982011|NCT04454476|Trametinib|trametinib|mesh-list
24982324|NCT03073785|Capecitabine|capecitabine|mesh-list
24982325|NCT03073785|Imidazole|imidazole|mesh-list
24982326|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
24982404|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982664|NCT01041807|Losartan|losartan|mesh-list
24795801|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24795802|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
24795803|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24795804|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982765|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
24982766|NCT00405964|Desloratadine|desloratadine|mesh-list
24982767|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24982920|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982921|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982922|NCT00307060|Diuretics|diuretics|mesh-ancestor
24982923|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982924|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982925|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25106509|NCT02631447|Ipilimumab|ipilimumab|mesh-list
25106510|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106511|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106512|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25106514|NCT02586831|Exenatide|exenatide|mesh-list
24983191|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
24983250|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24983252|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24983477|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24983478|NCT05185869|Gemcitabine|gemcitabine|mesh-list
24983479|NCT05185869|Paclitaxel|paclitaxel|mesh-list
24983480|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24983503|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983504|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24983505|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24983507|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24983508|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983509|NCT05185505|Bevacizumab|bevacizumab|mesh-list
24983510|NCT05185505|Atezolizumab|atezolizumab|mesh-list
24983511|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24444853|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24983559|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983560|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983561|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
24983589|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24983590|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983591|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
24983592|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
24983626|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24983627|NCT05183334|Narcotics|narcotics|mesh-ancestor
24795884|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
24795885|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
24795886|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24795887|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24795888|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445100|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445101|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445108|NCT00300404|Folic Acid|folic acid|mesh-list
24445109|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
24784499|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24784500|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24784501|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24784502|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784503|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24784504|NCT01908322|Sorafenib|sorafenib|mesh-list
24784505|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445745|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445746|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24445747|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445748|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24983744|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983745|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24983747|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983748|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24983749|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24983750|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
24983751|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24983891|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784557|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784568|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784569|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784570|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24784571|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
24784572|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106699|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106701|NCT00069238|Hormones|hormones|mesh-ancestor
24983957|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24983958|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983959|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
24795979|NCT01947114|Remifentanil|remifentanil|mesh-list
25106803|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106804|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106805|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24830488|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24984461|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
24984484|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984485|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984486|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24984574|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24984575|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
24984576|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984577|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24984578|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24984799|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106889|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
25106890|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784803|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784804|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
24784805|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24784806|NCT01910415|Ivacaftor|ivacaftor|mesh-list
24784807|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24784808|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784809|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24784810|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24784811|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784812|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831504|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
24985213|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24985214|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
24985215|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985238|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
24985239|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
24985240|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
24985241|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985264|NCT03532451|Nivolumab|nivolumab|mesh-list
24985265|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985266|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922982|NCT04173832|Amantadine|amantadine|mesh-list
24985296|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985297|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985298|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985330|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
24985331|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
24985459|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
24985461|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
24985674|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505677|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
24505850|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
24505851|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505852|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24505853|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505854|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505857|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
24622085|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622087|NCT01065610|Oxytocin|oxytocin|mesh-list
24986121|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
24507895|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
24509461|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24509462|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24509464|NCT00560443|Ketorolac|ketorolac|mesh-list
24509690|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24509694|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509695|NCT00561717|Cetirizine|cetirizine|mesh-list
24509998|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509999|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986391|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986392|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
24510477|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
24510480|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510481|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510648|NCT00565240|Letrozole|letrozole|mesh-list
24510859|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24510874|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
24510875|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
24510876|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24510877|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511166|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24784944|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784945|NCT01911299|Choline|choline|mesh-list
24986598|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986645|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986646|NCT05189093|Antibodies|antibodies|mesh-list
24986647|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24986648|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
24986813|NCT05160896|Growth Substances|growth substances|mesh-ancestor
24986814|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107052|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107053|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
25107054|NCT03142646|Fludarabine|fludarabine|mesh-list
25107055|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107056|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
25107057|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986878|NCT05017545|Abatacept|abatacept|mesh-list
24796566|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796567|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24796568|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
24796570|NCT01950884|Ezetimibe|ezetimibe|mesh-list
24987364|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813432|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24514480|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24514481|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24987522|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
24987523|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987524|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
24987525|NCT00924326|Vidarabine|vidarabine|mesh-list
24987526|NCT00924326|Aldesleukin|aldesleukin|mesh-list
24515067|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515068|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25107134|NCT03142165|Famotidine|famotidine|mesh-list
24987733|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
24987734|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987735|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987736|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24515853|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24515988|NCT00600210|Bevacizumab|bevacizumab|mesh-list
24796708|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796709|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24796720|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24796721|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24796722|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24796754|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
24796755|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24987774|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516231|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
24516232|NCT00601198|Amifostine|amifostine|mesh-list
24516233|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516234|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987886|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988321|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988031|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24988032|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24517227|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517229|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
24517275|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24517277|NCT00607074|Anthelmintics|anthelmintics|mesh-list
24517395|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517397|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
24517398|NCT00607685|Protective Agents|protective agents|mesh-ancestor
24988225|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
24988226|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
24988232|NCT03646461|Nivolumab|nivolumab|mesh-list
24988429|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
24517771|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517856|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24517858|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517859|NCT00610350|Protective Agents|protective agents|mesh-ancestor
24517860|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517862|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
24989069|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989070|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989073|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
24518323|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
24518324|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24518325|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
24518392|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989123|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
24989124|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989125|NCT04553419|Cephalexin|cephalexin|mesh-list
24989126|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522430|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24522431|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24863653|NCT04002037|Dexamethasone|dexamethasone|mesh-list
24989846|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24864013|NCT02229149|Docetaxel|docetaxel|mesh-list
24864014|NCT02229149|Capecitabine|capecitabine|mesh-list
24864015|NCT02229149|Trastuzumab|trastuzumab|mesh-list
24531299|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24990327|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990501|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797256|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24991034|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991035|NCT03029611|Paclitaxel|paclitaxel|mesh-list
24797317|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797318|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797322|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
24991374|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24991375|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991376|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797404|NCT01955460|Fludarabine|fludarabine|mesh-list
24797405|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
24797406|NCT01955460|Interleukin-2|interleukin-2|mesh-list
24797407|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797408|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
24991595|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991664|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24774722|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24865585|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
24785515|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785516|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
24785517|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
24785518|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
24785519|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107536|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797506|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797507|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24992127|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992129|NCT04351698|Montelukast|montelukast|mesh-list
24797540|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24797541|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24797543|NCT01956305|Metformin|metformin|mesh-list
24992749|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992750|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992819|NCT02828761|Calcium|calcium|mesh-list
25107719|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
25107723|NCT03137134|Crizotinib|crizotinib|mesh-list
24993002|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24993004|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24993236|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
24993237|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
24993403|NCT05005182|Hematinics|hematinics|mesh-ancestor
24993557|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993558|NCT05416762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24994258|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
24994259|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
24994265|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25107957|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25107958|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24995029|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
24995030|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24995031|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24995157|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995158|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24995159|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995160|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24995161|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
24995162|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24995163|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995168|NCT05417659|Niacin|niacin|mesh-list
25108050|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
25108051|NCT03134729|Ropivacaine|ropivacaine|mesh-list
25108052|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
25108053|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
25108099|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108100|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995463|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995464|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
24995533|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24995534|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24995535|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24798070|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24798071|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798072|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798073|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
24798074|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798075|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798076|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
24995929|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108155|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108156|NCT03134339|Nicotine|nicotine|mesh-list
24798144|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
24996213|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24996214|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
24996215|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
24996216|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24870249|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786158|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24786159|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
24786160|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786161|NCT01918254|Paclitaxel|paclitaxel|mesh-list
24786163|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24786164|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786165|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
24786166|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
24450034|NCT00317655|Analgesics|analgesics|mesh-ancestor
24996804|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24996930|NCT00265941|Cetuximab|cetuximab|mesh-list
24997024|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997025|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24997026|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24997027|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24997028|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24997108|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24997109|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
24997110|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856099|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856100|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856102|NCT02282787|Analgesics|analgesics|mesh-ancestor
24856103|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
24856104|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856105|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24856106|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24856107|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24857191|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857192|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24858155|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
24858156|NCT02295709|BB 1101|bb 1101|mesh-list
24858165|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800715|NCT01978015|Travoprost|travoprost|mesh-list
24800716|NCT01978015|Dextrans|dextrans|mesh-list
24622659|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
24803882|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
24803883|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24804673|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804674|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24804675|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804677|NCT02004314|Chloroquine|chloroquine|mesh-list
24806460|NCT02016001|Protective Agents|protective agents|mesh-ancestor
24806467|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108236|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24846658|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
24806468|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823595|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
24823646|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24823647|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
24823648|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823649|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823650|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24823651|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
24823653|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823667|NCT02118467|Norepinephrine|norepinephrine|mesh-list
24823668|NCT02118467|Synephrine|synephrine|mesh-list
24533801|NCT00645203|Cefdinir|cefdinir|mesh-list
24826071|NCT02132234|Analgesics|analgesics|mesh-ancestor
24451287|NCT00323011|Dalteparin|dalteparin|mesh-list
24451288|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
24451289|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24458389|NCT00337740|Propranolol|propranolol|mesh-list
24534383|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
24451385|NCT00323544|Tenofovir|tenofovir|mesh-list
24451390|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
24924503|NCT04159597|Upadacitinib|upadacitinib|mesh-list
24451657|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24459621|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394714|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394716|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
24459730|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24859198|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
24539408|NCT00663741|Sorafenib|sorafenib|mesh-list
24859193|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
24859194|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813312|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813314|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
24860053|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860054|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24860255|NCT02308553|Paclitaxel|paclitaxel|mesh-list
24860279|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860280|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
24860417|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24860418|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24860663|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24860664|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860665|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540997|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24860732|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860737|NCT02312297|Minocycline|minocycline|mesh-list
24860880|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
24860881|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860882|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24860933|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
24860934|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860935|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24860936|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860937|NCT02314013|Metronidazole|metronidazole|mesh-list
24860938|NCT02314013|Cephalosporins|cephalosporins|mesh-list
24860995|NCT02314312|Cyclosporine|cyclosporine|mesh-list
24860996|NCT02314312|Prednisolone|prednisolone|mesh-list
24860997|NCT02314312|Everolimus|everolimus|mesh-list
24608983|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608984|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24608985|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24608986|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24861135|NCT02315196|Doxorubicin|doxorubicin|mesh-list
24861136|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24541419|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24541420|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
24541421|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24541422|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24541423|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24861708|NCT02319577|Gefitinib|gefitinib|mesh-list
24861709|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24861903|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24861905|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861906|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24861907|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861908|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861909|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24861910|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862001|NCT02321878|Liraglutide|liraglutide|mesh-list
24862122|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
24862160|NCT02323438|Menthol|menthol|mesh-list
24862161|NCT02323438|Nicotine|nicotine|mesh-list
24862162|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24862163|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
24451640|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24451642|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
24451643|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542300|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542301|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24862524|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862525|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542312|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542313|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542314|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24542316|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542347|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542348|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542349|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24542350|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24542351|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24542352|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24542353|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862613|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24862614|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24862615|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24862616|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862617|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862618|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24542488|NCT00678977|Gemcitabine|gemcitabine|mesh-list
24542489|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542490|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24542491|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
25369261|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542492|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542493|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
24862745|NCT04600895|Favipiravir|favipiravir|mesh-list
24862746|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
24862749|NCT04558359|Giapreza|giapreza|mesh-list
24863018|NCT03729271|Lactulose|lactulose|mesh-list
24863019|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24863020|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863021|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863022|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
24863023|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24863024|NCT03696784|Fludarabine|fludarabine|mesh-list
24863025|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24863028|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24475357|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24475377|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
24475379|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
24475380|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
24475381|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475384|NCT00410306|Testosterone|testosterone|mesh-list
24475385|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
24475386|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
24806221|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806222|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24806225|NCT02014545|Lucanthone|lucanthone|mesh-list
24806256|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24475691|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
24475692|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806303|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
24806304|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24806305|NCT02014922|Laxatives|laxatives|mesh-ancestor
24806306|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806307|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
24475967|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
24475968|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806341|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
24475972|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806394|NCT02015598|Expectorants|expectorants|mesh-ancestor
24601255|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24601256|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24601257|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601258|NCT00963690|Hemostatics|hemostatics|mesh-list
24664995|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
24806408|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806498|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806503|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806605|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806606|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806608|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24475979|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24806906|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24806907|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806908|NCT02018796|Misoprostol|misoprostol|mesh-list
24806909|NCT02018796|Mifepristone|mifepristone|mesh-list
24806910|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24806911|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
24806912|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24806913|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807037|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
24807038|NCT02019381|Vitamins|vitamins|mesh-list
24807039|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
24807040|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476789|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477317|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477318|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24477319|NCT00418249|Protective Agents|protective agents|mesh-ancestor
24477334|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477528|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24477529|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477542|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477544|NCT00418925|Hormones|hormones|mesh-ancestor
24477703|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477704|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24477706|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477707|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24477739|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24477741|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
24477742|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477854|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24477855|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24477856|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
24477857|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477858|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
24477859|NCT00420563|Megestrol|megestrol|mesh-list
24477860|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477861|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
24477887|NCT00420615|Omeprazole|omeprazole|mesh-list
24478136|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
24478137|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478138|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478139|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24807226|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588215|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
24665379|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
24478475|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
24478476|NCT00423020|Hematinics|hematinics|mesh-ancestor
24478590|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24478591|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24478592|NCT00423696|Growth Substances|growth substances|mesh-ancestor
24478594|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
24807464|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807465|NCT02022254|Metformin|metformin|mesh-list
24807466|NCT02022254|Warfarin|warfarin|mesh-list
24589023|NCT00905216|Heparin|heparin|mesh-list
24479472|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24622732|NCT01068327|Leucovorin|leucovorin|mesh-list
24479668|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807540|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24807736|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24807737|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
24480104|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24480105|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24807754|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
24807755|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480351|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480352|NCT00430794|Spironolactone|spironolactone|mesh-list
24480410|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480411|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480413|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24480599|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480600|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480673|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24807885|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
24590264|NCT00911573|Vancomycin|vancomycin|mesh-list
24480967|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24480968|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24480969|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24480970|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
24480999|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24481000|NCT00433095|Trastuzumab|trastuzumab|mesh-list
24481001|NCT00433095|Vinorelbine|vinorelbine|mesh-list
24481002|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481003|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481004|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24481350|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24481351|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
24481352|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481353|NCT00434096|Rimonabant|rimonabant|mesh-list
24481354|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24481355|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24481356|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24481357|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667731|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482432|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482433|NCT00438984|Analgesics|analgesics|mesh-ancestor
24482434|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
24482435|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482436|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24482437|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24482438|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
24622847|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24482720|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482721|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24482722|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
24482723|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
24482724|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482725|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808192|NCT02025712|Everolimus|everolimus|mesh-list
24483232|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24483233|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
24483234|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24483235|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483236|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24483428|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
24483429|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483430|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483431|NCT00443508|Everolimus|everolimus|mesh-list
24483513|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483773|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24483845|NCT00445406|Bevacizumab|bevacizumab|mesh-list
24808462|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
24808464|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24808465|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24808466|NCT02027337|Cyproterone|cyproterone|mesh-list
24808467|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
24808468|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24808469|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24808470|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24808471|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
24808472|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24808473|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808474|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24484389|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
24484392|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484393|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484394|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24484395|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484417|NCT00448266|Thiotepa|thiotepa|mesh-list
24484418|NCT00448266|Carboplatin|carboplatin|mesh-list
24484419|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484530|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484531|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484532|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24484533|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24484534|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484940|NCT00450840|Simvastatin|simvastatin|mesh-list
24484962|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484963|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484964|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484965|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484966|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24485016|NCT00451113|Hormones|hormones|mesh-ancestor
24485063|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485064|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
24485065|NCT00451386|Ertapenem|ertapenem|mesh-list
24485066|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24485068|NCT00451399|Metformin|metformin|mesh-list
24808640|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808641|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
24485184|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24485185|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24485186|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24485187|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
24485188|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
24485189|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808701|NCT02028806|Leucovorin|leucovorin|mesh-list
24485529|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24485530|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24485531|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485532|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24485533|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485534|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24485864|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
24485865|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485866|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485867|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
24485868|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485902|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808925|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24808926|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808927|NCT02029937|Proflavine|proflavine|mesh-list
24486167|NCT00456677|Minocycline|minocycline|mesh-list
24486168|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486169|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486314|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486315|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24486316|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486317|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24486586|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24486587|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
24486589|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
24486590|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486591|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437557|NCT00274001|Nevirapine|nevirapine|mesh-list
24486592|NCT00458614|Lansoprazole|lansoprazole|mesh-list
24486788|NCT00460148|Ropinirole|ropinirole|mesh-list
24487100|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487102|NCT00461643|Citric Acid|citric acid|mesh-list
24487103|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
24487104|NCT00461643|Clomiphene|clomiphene|mesh-list
24487148|NCT00461747|Growth Substances|growth substances|mesh-ancestor
24487149|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487150|NCT00461799|Orlistat|orlistat|mesh-list
24487151|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604128|NCT00977301|Ritonavir|ritonavir|mesh-list
24487300|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24487302|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
24487721|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24487722|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24487723|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24487724|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
24809214|NCT02031965|Hormones|hormones|mesh-ancestor
24809277|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809279|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24488094|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488095|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488096|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24489084|NCT00471406|Verteporfin|verteporfin|mesh-list
24489121|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
24489122|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
24489123|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489124|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489126|NCT00471523|Clomiphene|clomiphene|mesh-list
24489127|NCT00471523|Enclomiphene|enclomiphene|mesh-list
24489128|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
24489236|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489237|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24489238|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24489354|NCT00472758|Sifalimumab|sifalimumab|mesh-list
24489893|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24490167|NCT00476918|Hormones|hormones|mesh-ancestor
24490891|NCT00480376|Renal Agents|renal agents|mesh-ancestor
24491876|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24491938|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
24491940|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
24491941|NCT00484692|Bupropion|bupropion|mesh-list
24491942|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24491943|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
24491944|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492535|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492536|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24604624|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493098|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493099|NCT00489593|Olanzapine|olanzapine|mesh-list
24493100|NCT00489593|Fluoxetine|fluoxetine|mesh-list
24493101|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
24809467|NCT02033941|Phenol|phenol|mesh-list
24809478|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24809479|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809480|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493716|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
24493812|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24494924|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24494925|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24495383|NCT00499850|Leucovorin|leucovorin|mesh-list
24496013|NCT00503126|Bivalirudin|bivalirudin|mesh-list
24496014|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
24496015|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24496016|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
24496017|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809927|NCT02036736|Desflurane|desflurane|mesh-list
24809928|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24809929|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601015|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496996|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497015|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24497244|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24497245|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497776|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497777|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497778|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24497781|NCT00511849|Sunitinib|sunitinib|mesh-list
24497782|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24497783|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498329|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24498330|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498331|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
24498332|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498333|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498334|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498371|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
24498911|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498912|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
24498913|NCT00516828|Cytarabine|cytarabine|mesh-list
24499709|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
24499710|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499711|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499712|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24499713|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24499714|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
24499988|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
24500025|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500109|NCT00522782|Budesonide|budesonide|mesh-list
24500382|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
24500383|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500384|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
24500386|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535678|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501109|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24501110|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24501205|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
24501206|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501207|NCT00527449|Carboplatin|carboplatin|mesh-list
24501639|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501640|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24502519|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
24502520|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
24502521|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502522|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24502792|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24502855|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24502857|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503185|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24503186|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503187|NCT02843230|Bevacizumab|bevacizumab|mesh-list
24503188|NCT02843230|Temozolomide|temozolomide|mesh-list
24503189|NCT02843230|Lomustine|lomustine|mesh-list
24503190|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24503191|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503192|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24503194|NCT02843230|Growth Substances|growth substances|mesh-ancestor
24810494|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24503614|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503615|NCT00532415|Triamcinolone|triamcinolone|mesh-list
24503616|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24503617|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24503717|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24503718|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504067|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
24504068|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504069|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504070|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
24504071|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504072|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504090|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
24504316|NCT00535340|Amibegron|amibegron|mesh-list
24504626|NCT00537472|Bupivacaine|bupivacaine|mesh-list
24759050|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24759051|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
24759052|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759053|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24759054|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24759207|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
24759209|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461380|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24461381|NCT00352183|Simvastatin|simvastatin|mesh-list
24461382|NCT00352183|Fenofibrate|fenofibrate|mesh-list
24629036|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
24629037|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
24537712|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537713|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
24537714|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629790|NCT01107951|Rituximab|rituximab|mesh-list
24811116|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24630851|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24630852|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24631446|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24631447|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
24631448|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631450|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24631451|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631496|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
24631498|NCT01118572|Etodolac|etodolac|mesh-list
24631499|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24632356|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632357|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24632358|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632359|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
24632360|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632380|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632381|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24632382|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
24633418|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24633419|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24633420|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24633421|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24633422|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
24633423|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672577|NCT01332604|Growth Substances|growth substances|mesh-ancestor
24395340|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24396173|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
24396271|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
24455456|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455457|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24455458|NCT00554515|Aldesleukin|aldesleukin|mesh-list
24397665|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24398031|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398032|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
24398070|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24811377|NCT02046499|Syntometrine|syntometrine|mesh-list
24811378|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
24398908|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399278|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24399279|NCT00147355|Analgesics|analgesics|mesh-ancestor
24811410|NCT02046577|Vitamins|vitamins|mesh-ancestor
24811418|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811421|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
24811422|NCT02046629|Teriflunomide|teriflunomide|mesh-list
24400016|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400017|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400018|NCT00149292|Olanzapine|olanzapine|mesh-list
24400019|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
24400020|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
24400878|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24400879|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
24811465|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811466|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
24675358|NCT00496834|Diuretics|diuretics|mesh-ancestor
24401298|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
24401299|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401300|NCT00152646|Clopidogrel|clopidogrel|mesh-list
24606921|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
24606922|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
24606923|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402096|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402097|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
24402098|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402099|NCT00154804|Paclitaxel|paclitaxel|mesh-list
24402100|NCT00154804|Cisplatin|cisplatin|mesh-list
24402101|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24402102|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402127|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
24403003|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403714|NCT00161304|Hormones|hormones|mesh-ancestor
24403802|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24403803|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404076|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24404077|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
24404162|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24404171|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24404172|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
24404174|NCT00162695|Etoposide|etoposide|mesh-list
24404179|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24404180|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404181|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404183|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404283|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24404284|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
24404285|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24404382|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
24404384|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404385|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404386|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404387|NCT00163332|Ciclesonide|ciclesonide|mesh-list
24404388|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
24404395|NCT00163345|Hormones|hormones|mesh-ancestor
24404433|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811551|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24811552|NCT02047162|Antacids|antacids|mesh-ancestor
24404445|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404522|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404523|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404524|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
24404525|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404526|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404527|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811578|NCT02047201|Docetaxel|docetaxel|mesh-list
24404561|NCT00164008|Pamidronate|pamidronate|mesh-list
24533421|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404595|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24404596|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24404599|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24404608|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404609|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404610|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
24404611|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
24404612|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24811583|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
24677172|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
24404613|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
24404614|NCT00164242|Galantamine|galantamine|mesh-list
24404615|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24404616|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404618|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
24404945|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
24404946|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404947|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404968|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24404969|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405102|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
24405103|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405104|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
24405189|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405190|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405191|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405192|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405194|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
24540570|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24405253|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405254|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
24405316|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
24405317|NCT00166465|Vitamins|vitamins|mesh-ancestor
24405318|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
24405319|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
24405320|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405321|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24405322|NCT00166478|Protective Agents|protective agents|mesh-ancestor
24405323|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405324|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24405325|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405768|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405769|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811817|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24540825|NCT00669773|Docetaxel|docetaxel|mesh-list
24445892|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540875|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
24406135|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24406136|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24406137|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24406142|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
24406190|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24406191|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406192|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
24406193|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406203|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406587|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406588|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
24406589|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406591|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406592|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565707|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
24565712|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406819|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407277|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24407278|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
24407583|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407584|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24407744|NCT00175357|Heroin|heroin|mesh-list
24407855|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407856|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407877|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407878|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407879|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
24407880|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407881|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407882|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
24820118|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820119|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
24408237|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408239|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408241|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24408242|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24408243|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408244|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408245|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
24408389|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24408390|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408428|NCT00177684|Amphotericin B|amphotericin b|mesh-list
24408591|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408740|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24408792|NCT00179686|Growth Substances|growth substances|mesh-ancestor
24409011|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409012|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542020|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542021|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409097|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409098|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24409100|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820639|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409376|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409402|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820887|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820888|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820889|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24820890|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820893|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24410550|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24410551|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410552|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410554|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24542632|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369955|NCT05048589|Vaccines|vaccines|mesh-list
24542633|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24542634|NCT00679640|Candesartan|candesartan|mesh-list
24542635|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542636|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24542637|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24821506|NCT02106130|Rebamipide|rebamipide|mesh-list
24542982|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542983|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412694|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412695|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24821976|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822027|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24822028|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822033|NCT02109510|Analgesics|analgesics|mesh-ancestor
24413696|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413698|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
24413699|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24413712|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
24822299|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822300|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822301|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
24822302|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
24822303|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24822319|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543396|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822447|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822449|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24415082|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
24415083|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
24415084|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415085|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24415086|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24822531|NCT02112422|Dexamethasone|dexamethasone|mesh-list
24822532|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
24822533|NCT02112422|BB 1101|bb 1101|mesh-list
24822534|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822535|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
24822536|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
24822537|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822541|NCT02112422|Hormones|hormones|mesh-ancestor
24822570|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
24822671|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822672|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
24822681|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
24416199|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416200|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416201|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416202|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24416203|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24416208|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24416209|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
24416210|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
24416212|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822822|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822827|NCT02113657|Ipilimumab|ipilimumab|mesh-list
24416775|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
24416776|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416777|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416778|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416780|NCT00204022|Azathioprine|azathioprine|mesh-list
24417622|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418137|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418138|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
24418162|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
24418163|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418183|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418184|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24418185|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24419022|NCT00210847|Acetaminophen|acetaminophen|mesh-list
24419024|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24419025|NCT00210847|Analgesics|analgesics|mesh-ancestor
24419082|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
24419083|NCT00211133|Hematinics|hematinics|mesh-ancestor
24419084|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
24419085|NCT00211146|Hematinics|hematinics|mesh-ancestor
24420392|NCT00215891|Ribavirin|ribavirin|mesh-list
24420393|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420394|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
24420395|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420396|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
24823158|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420698|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
24420699|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24420701|NCT00216619|Topiramate|topiramate|mesh-list
24420731|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
24420838|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420840|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
24421152|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421153|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24421154|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
24421156|NCT00217932|Valproic Acid|valproic acid|mesh-list
24823233|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823234|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421171|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421172|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
24421175|NCT00218075|Levodopa|levodopa|mesh-list
24421206|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421348|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421494|NCT00219375|Glycine|glycine|mesh-list
24421495|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24421496|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
24823271|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823272|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823273|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24823274|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24421594|NCT00219739|Cytarabine|cytarabine|mesh-list
24421639|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24823344|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
24422333|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
24422334|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
24823406|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24823407|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
24823408|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823409|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
24823410|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24823575|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24823577|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24823578|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24823579|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
24823580|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823581|NCT02117869|Furocoumarins|furocoumarins|mesh-list
24823582|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
24823583|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24579877|NCT00858455|Dolutegravir|dolutegravir|mesh-list
24422626|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823693|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24823694|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823695|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
24823696|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
24823697|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
24823698|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823699|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
24823806|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823807|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
24823808|NCT02119117|Vitamins|vitamins|mesh-ancestor
24823809|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
24423890|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423891|NCT00227331|Amoxicillin|amoxicillin|mesh-list
24824157|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24824158|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824159|NCT02122003|Sorafenib|sorafenib|mesh-list
24824160|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824161|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24824162|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824163|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824164|NCT02122055|Fentanyl|fentanyl|mesh-list
24824165|NCT02122055|Midazolam|midazolam|mesh-list
24824263|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24824264|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24424517|NCT00229593|ST 1435|st 1435|mesh-list
24425037|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
24425038|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425039|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425040|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24425041|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24425043|NCT00231764|Daclizumab|daclizumab|mesh-list
24425141|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425600|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425603|NCT00233779|Sirolimus|sirolimus|mesh-list
24425762|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425763|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24425764|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24425769|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
24425778|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425816|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426155|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
24426527|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426528|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24426530|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24426531|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426532|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426534|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
24824440|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24824441|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
24824443|NCT02123498|Omeprazole|omeprazole|mesh-list
24427285|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
24427286|NCT00237900|Vitamins|vitamins|mesh-ancestor
24427287|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
24427364|NCT00238056|Domperidone|domperidone|mesh-list
24427512|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824535|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24824536|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24824538|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
24824539|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824541|NCT02123979|Rotigotine|rotigotine|mesh-list
24427845|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427847|NCT00239109|Ziprasidone|ziprasidone|mesh-list
24427848|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
24427849|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
24427850|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427851|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427852|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427967|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427968|NCT00239395|Meloxicam|meloxicam|mesh-list
24427969|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24428134|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428135|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24428137|NCT00239629|Teriparatide|teriparatide|mesh-list
24627321|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824806|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824807|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24824809|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428430|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428436|NCT00240474|Amlodipine|amlodipine|mesh-list
24428437|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24428438|NCT00240474|Telmisartan|telmisartan|mesh-list
24428439|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428440|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24428441|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428455|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428549|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
24428551|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24428552|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
24428553|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428556|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24428691|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
24428692|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24428715|NCT00241046|Letrozole|letrozole|mesh-list
24428716|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428717|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24428718|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24428719|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428720|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428721|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24428880|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428882|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
24428883|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428884|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428885|NCT00241449|Tamoxifen|tamoxifen|mesh-list
24428886|NCT00241449|Fulvestrant|fulvestrant|mesh-list
24428887|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24428888|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
24774742|NCT01847664|Rifamycins|rifamycins|mesh-list
24774855|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774856|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24774857|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24774858|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24774859|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
24774860|NCT01848301|Acetylcholine|acetylcholine|mesh-list
24774886|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24775136|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775137|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24775139|NCT01850511|Phenylephrine|phenylephrine|mesh-list
24775147|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
24775698|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24775700|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24776181|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24776187|NCT01857011|Iron|iron|mesh-list
24776573|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24776574|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776815|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777094|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
24777096|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24777313|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24777314|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24777315|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24777316|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
24777317|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24777318|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24777324|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
24620939|NCT01060137|Analgesics|analgesics|mesh-ancestor
24620940|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
24778616|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24778617|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
24778618|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24778619|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24778620|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778623|NCT01871740|Enalaprilat|enalaprilat|mesh-list
24778624|NCT01871740|Maleic acid|maleic acid|mesh-list
24570692|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
24627623|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
24570693|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24570694|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487390|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
24487397|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487398|NCT00462956|Lapatinib|lapatinib|mesh-list
24487399|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487400|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24487408|NCT00463008|Methotrexate|methotrexate|mesh-list
24487704|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487705|NCT00464594|Metformin|metformin|mesh-list
24487775|NCT00464971|Estradiol|estradiol|mesh-list
24487776|NCT00464971|Estrogens|estrogens|mesh-ancestor
24487777|NCT00464971|Hormones|hormones|mesh-ancestor
24487778|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779575|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779577|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24487993|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
24487994|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779672|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24779673|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
24779674|NCT01877954|Hormones|hormones|mesh-ancestor
24779675|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779676|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25081873|NCT03326609|Ropivacaine|ropivacaine|mesh-list
25081874|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081875|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
25081876|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081877|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081878|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
25081879|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081880|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
25081884|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
24779827|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779828|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779829|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24780076|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24798707|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24798708|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25081900|NCT03326180|Bupivacaine|bupivacaine|mesh-list
24798711|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
24798712|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
25081902|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
25081903|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081904|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081905|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
25081906|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081907|NCT03326128|Bupropion|bupropion|mesh-list
25081908|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25081909|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
24780267|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780268|NCT01883232|Lidocaine|lidocaine|mesh-list
24780269|NCT01883232|Epinephrine|epinephrine|mesh-list
24780270|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
24780271|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
24780272|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780273|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780274|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
24488317|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488318|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
24780318|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
24572548|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24572549|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24572550|NCT00815399|Metformin|metformin|mesh-list
24572551|NCT00815399|Pioglitazone|pioglitazone|mesh-list
24780663|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780664|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780665|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24780779|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780781|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798979|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780782|NCT01886365|Insulin|insulin|mesh-list
24780783|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24780784|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572957|NCT00817375|Nortriptyline|nortriptyline|mesh-list
24572958|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
24572960|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24572961|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24798980|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24798981|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
24798982|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798983|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798985|NCT01966302|Beraprost|beraprost|mesh-list
24781310|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24781311|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781312|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781313|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24781314|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24781315|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24781316|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
24781317|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24781319|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
24781428|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
24781642|NCT01891084|Acetaminophen|acetaminophen|mesh-list
24781643|NCT01891084|Ibuprofen|ibuprofen|mesh-list
24781644|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781645|NCT01891084|Analgesics|analgesics|mesh-ancestor
24781646|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
24781647|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781648|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781700|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781767|NCT01891708|Bevacizumab|bevacizumab|mesh-list
24781768|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24489779|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24489781|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489792|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
24489793|NCT00475410|Coagulants|coagulants|mesh-ancestor
24489794|NCT00475462|Metoprolol|metoprolol|mesh-list
24489795|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24489797|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
24490475|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490476|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490477|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24782120|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24782121|NCT01894295|Vitamins|vitamins|mesh-ancestor
24782122|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
24782123|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490628|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24490629|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
24490630|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490631|NCT00479362|Aspirin|aspirin|mesh-list
24490632|NCT00479362|Warfarin|warfarin|mesh-list
24490633|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24490634|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24490947|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490948|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490949|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490950|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
24490951|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490952|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24782429|NCT01896180|Latanoprost|latanoprost|mesh-list
24491117|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491118|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491162|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24782521|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24627821|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24491538|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24920130|NCT04205344|Bupivacaine|bupivacaine|mesh-list
24920131|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
24782633|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782634|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24782666|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
24782667|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
24782668|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782670|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082141|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082144|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783087|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24491936|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491983|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
24491984|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491985|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491986|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491987|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492052|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24492059|NCT00485108|Hormones|hormones|mesh-ancestor
24783243|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
24783244|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783245|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783246|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492231|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492307|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492308|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
24783669|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24783671|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783672|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492446|NCT00486356|Carboplatin|carboplatin|mesh-list
24784219|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784220|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784222|NCT01906944|Hormones|hormones|mesh-ancestor
24785024|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786520|NCT01920516|Melphalan|melphalan|mesh-list
24786725|NCT01921374|Androgens|androgens|mesh-ancestor
24627932|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627933|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627934|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627935|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24627936|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621442|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24621443|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24621447|NCT01062477|Vaccines|vaccines|mesh-list
24787847|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787974|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24787975|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787976|NCT01928823|Renal Agents|renal agents|mesh-ancestor
24787977|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24787978|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
24787979|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24580228|NCT00861042|Lacosamide|lacosamide|mesh-list
24787980|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
24787981|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787982|NCT01928875|Anesthetics|anesthetics|mesh-list
24787985|NCT01928888|Famotidine|famotidine|mesh-list
24788127|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627999|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628000|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628002|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
24628003|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582796|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628132|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24628133|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24628134|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24792044|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792045|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24792046|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24792047|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24792058|NCT05412914|Propofol|propofol|mesh-list
24792059|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24792060|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924570|NCT04158674|Simendan|simendan|mesh-list
24792370|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24792371|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24792372|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24792374|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24792541|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24494199|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494201|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494202|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
24494306|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
24793594|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24793595|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793596|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793598|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24628177|NCT01096940|Simvastatin|simvastatin|mesh-list
25082730|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082732|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
25082733|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082734|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24495260|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495261|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
24967688|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24967689|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
24967690|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967691|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24967882|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967883|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
24967884|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
24967887|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24967888|NCT03755947|Venetoclax|venetoclax|mesh-list
24967889|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
24967890|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967900|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967972|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967973|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967974|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24967975|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
24967976|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
25082765|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24968194|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24968195|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968196|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
24793777|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
24793778|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082820|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25082821|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24968330|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968332|NCT03751761|Durvalumab|durvalumab|mesh-list
24793862|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498359|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498483|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498484|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498485|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24793908|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24793909|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793910|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24793911|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24969071|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24927390|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
24498878|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969213|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969214|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969215|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
24969431|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969433|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969434|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
24969435|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
24969436|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
24969650|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24969651|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25370560|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24969652|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969653|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969654|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
24969655|NCT03741426|Durvalumab|durvalumab|mesh-list
24969656|NCT03741426|Olaparib|olaparib|mesh-list
24969657|NCT03741426|Cediranib|cediranib|mesh-list
24501749|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24969880|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969881|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
24969882|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969957|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24969958|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969959|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24969960|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24969961|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24969962|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24969963|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25083086|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25083087|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083088|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083089|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25083090|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
25083092|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083121|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25083122|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25083123|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25083124|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24502210|NCT05317936|Venetoclax|venetoclax|mesh-list
24502229|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970292|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24502431|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502432|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24502433|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24502434|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24502435|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24502436|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502437|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502438|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
24502440|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
24970392|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24970393|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24970394|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970395|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928893|NCT04117750|Vitamin D|vitamin d|mesh-list
24970523|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
24929003|NCT04116411|Valganciclovir|valganciclovir|mesh-list
24502587|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24502588|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24502589|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24502590|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
24502591|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502593|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24807411|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807412|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
25083203|NCT03317457|Doxorubicin|doxorubicin|mesh-list
25083205|NCT03317457|Tremelimumab|tremelimumab|mesh-list
24794260|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794261|NCT05328141|Protective Agents|protective agents|mesh-ancestor
24794262|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794263|NCT05328141|Vitamins|vitamins|mesh-ancestor
24794264|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
24794265|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
24794266|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24794267|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25083227|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971183|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971184|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24971185|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
24971186|NCT03727620|Amoxicillin|amoxicillin|mesh-list
24971250|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
24971251|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
24971293|NCT03726775|Durvalumab|durvalumab|mesh-list
24971294|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971295|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971296|NCT03726749|Prednisone|prednisone|mesh-list
24971297|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
24971298|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971299|NCT03726749|Hormones|hormones|mesh-ancestor
24971300|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24971301|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971302|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24971528|NCT03725267|Protective Agents|protective agents|mesh-ancestor
24971529|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971530|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971532|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
24971533|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
24971534|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
24794332|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971615|NCT03723824|Grazoprevir|grazoprevir|mesh-list
24971642|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24971643|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24971644|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
24971645|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
24971646|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
24971664|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24971665|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24971680|NCT03723291|Tocopherols|tocopherols|mesh-list
24971804|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24971805|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24971806|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971807|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971808|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24503946|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24503947|NCT00533520|Growth Substances|growth substances|mesh-ancestor
24503948|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503949|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
24503950|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972186|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
24972187|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972189|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794460|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24972599|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972600|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24972601|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24972602|NCT03716427|Tolbutamide|tolbutamide|mesh-list
24972603|NCT03716427|Midazolam|midazolam|mesh-list
24972604|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
24972605|NCT03716427|Omeprazole|omeprazole|mesh-list
24972606|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24972610|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24972708|NCT03715634|Analgesics|analgesics|mesh-ancestor
24972709|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
24972710|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972711|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24972712|NCT03715582|Trimetazidine|trimetazidine|mesh-list
24972713|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
24972715|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24972716|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
24972727|NCT03715517|Morphine|morphine|mesh-list
24794502|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24794504|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
24972831|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
24972832|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24972833|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972834|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972835|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24972836|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24972927|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972928|NCT03713879|Indomethacin|indomethacin|mesh-list
24972929|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24972930|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24972931|NCT03713879|Analgesics|analgesics|mesh-ancestor
24972932|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
24972933|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972934|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972943|NCT03713762|Lidocaine|lidocaine|mesh-list
24973180|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587815|NCT00897221|Deferiprone|deferiprone|mesh-list
24587816|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24587817|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
24587818|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
24587828|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
24587829|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587830|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
24587831|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973285|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24973408|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24973409|NCT03709745|Ranibizumab|ranibizumab|mesh-list
24794625|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24794626|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973767|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973768|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
24973903|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973904|NCT03705780|Fentanyl|fentanyl|mesh-list
24973905|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24973906|NCT03705780|Narcotics|narcotics|mesh-ancestor
24973907|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973908|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973909|NCT03705780|Analgesics|analgesics|mesh-ancestor
24973910|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
24810866|NCT02043054|Incretins|incretins|mesh-ancestor
24974065|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
24974066|NCT05175430|Paroxetine|paroxetine|mesh-list
24461370|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461371|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461372|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
24974312|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24974556|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24974557|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974558|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974559|NCT04469491|Interferons|interferons|mesh-list
24974560|NCT04469491|Interferon Type I|interferon type i|mesh-list
24974561|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974562|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
24974568|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
24974569|NCT04394481|Ropivacaine|ropivacaine|mesh-list
24974584|NCT04394481|Analgesics|analgesics|mesh-ancestor
24462113|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
24462114|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
24462154|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24462155|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
24462156|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24462157|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24462158|NCT00355277|Analgesics|analgesics|mesh-ancestor
24974737|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
24974738|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
24974739|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
24974740|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974741|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24974742|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24974743|NCT05303324|Growth Substances|growth substances|mesh-ancestor
24974744|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974915|NCT05023369|Hormones|hormones|mesh-ancestor
25083352|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083353|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25083354|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24462516|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24462517|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462518|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462519|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24462520|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462521|NCT00356720|Azithromycin|azithromycin|mesh-list
24462529|NCT00356824|Artesunate|artesunate|mesh-list
24462555|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083723|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083780|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083781|NCT03312530|Atezolizumab|atezolizumab|mesh-list
25083782|NCT03312530|Venetoclax|venetoclax|mesh-list
25083783|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628851|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25084357|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084358|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25084438|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25084439|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
25084440|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084441|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
25084442|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
25084520|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25084521|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25084821|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084822|NCT03302845|Omeprazole|omeprazole|mesh-list
25084823|NCT03302845|Famotidine|famotidine|mesh-list
25084824|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25084825|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25085008|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
25085009|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
25085010|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085011|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629399|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24629400|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085249|NCT03299998|Anesthetics|anesthetics|mesh-list
25085250|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085251|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085252|NCT03299842|Fenfluramine|fenfluramine|mesh-list
25085253|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25085642|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085643|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25085644|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085646|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085647|NCT03296189|Dexamethasone|dexamethasone|mesh-list
25085648|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
25085649|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
25085773|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25085774|NCT03295214|Analgesics|analgesics|mesh-ancestor
25085775|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
24629924|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
24629925|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24629926|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25086414|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761760|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24761761|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086415|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086416|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086417|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
25086419|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25086420|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24630097|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25086672|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630280|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630281|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24630282|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24630283|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24630284|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
24631038|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
25087304|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
24631585|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088103|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088567|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25088569|NCT03545464|Hormones|hormones|mesh-ancestor
25088570|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631986|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24631988|NCT01121458|Clevidipine|clevidipine|mesh-list
25088816|NCT03271905|Bromides|bromides|mesh-list
25088949|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537484|NCT00654758|Growth Substances|growth substances|mesh-ancestor
24633237|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
24633238|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633239|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24633240|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24633241|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25089485|NCT03265899|Oxytocin|oxytocin|mesh-list
25089486|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
24633277|NCT01127906|Narcotics|narcotics|mesh-ancestor
24633278|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24633280|NCT01127906|Analgesics|analgesics|mesh-ancestor
25089548|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25089549|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633438|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370863|NCT05019703|Atezolizumab|atezolizumab|mesh-list
25089564|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25089565|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25089566|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25089567|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
24394717|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
25089676|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089677|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
25089678|NCT03263715|Hormones|hormones|mesh-ancestor
25089679|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089680|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089681|NCT03263650|Prednisone|prednisone|mesh-list
24395657|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24395658|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395659|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
24395660|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395661|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089910|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25089911|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
25089912|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089913|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089915|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25089916|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
24397079|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397080|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397081|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24397083|NCT00140751|Ritonavir|ritonavir|mesh-list
24397996|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397997|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397998|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397999|NCT00143195|Amlodipine|amlodipine|mesh-list
24398000|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24455467|NCT00107198|Doxorubicin|doxorubicin|mesh-list
24398069|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24398091|NCT00143442|Reboxetine|reboxetine|mesh-list
25090312|NCT03258684|Protective Agents|protective agents|mesh-ancestor
25090313|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
25090325|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402611|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402614|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
24403229|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403230|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24403231|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403272|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24403273|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24403274|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
24403275|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403276|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24403277|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24403278|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404540|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404541|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24405186|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
24405275|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408459|NCT00177853|Irinotecan|irinotecan|mesh-list
24408460|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24408461|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410055|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410081|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24410103|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
24410104|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
24411160|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
24411163|NCT00188045|Diuretics|diuretics|mesh-ancestor
24411164|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
25091467|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
24411721|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411722|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24411723|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091652|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
25091653|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
25091654|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25091696|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24412077|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412078|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412079|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412080|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412081|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412098|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412100|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
24412212|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412214|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25092059|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092061|NCT03244774|Fluorouracil|fluorouracil|mesh-list
25092062|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
25092063|NCT03244774|Apatinib|apatinib|mesh-list
25092064|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25092065|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092066|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
25092089|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
25092451|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092455|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
25093056|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
25093057|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093058|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25093059|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
25093060|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
25093061|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
25093062|NCT03237624|Coagulants|coagulants|mesh-ancestor
25093064|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093066|NCT03237260|Vedolizumab|vedolizumab|mesh-list
25093454|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093455|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
25093456|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
25093457|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
25093458|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561191|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25093460|NCT03234673|Tacrolimus|tacrolimus|mesh-list
25093537|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
25093538|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25093539|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093540|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093759|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
25093760|NCT03232216|Vitamins|vitamins|mesh-ancestor
25093761|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
25093762|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093763|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25093764|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093766|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25094224|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094225|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094605|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
25094606|NCT03224572|Vitamins|vitamins|mesh-ancestor
25094607|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
25094608|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094609|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
25094610|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094611|NCT03224572|Protective Agents|protective agents|mesh-ancestor
25094612|NCT03224871|Aldesleukin|aldesleukin|mesh-list
25094613|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
25094816|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094817|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25095547|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095855|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096052|NCT03214354|Sirolimus|sirolimus|mesh-list
25096286|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24773071|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
24773072|NCT01837446|Promethazine|promethazine|mesh-list
24773073|NCT01837446|Lidocaine|lidocaine|mesh-list
25096353|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413893|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24413894|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24413896|NCT00195572|Leucovorin|leucovorin|mesh-list
25096708|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096709|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25096710|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096711|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25096712|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097699|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
25097879|NCT03200600|BB 1101|bb 1101|mesh-list
25097880|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097881|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
25097882|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
25097883|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097884|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097885|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25098310|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25098311|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25098312|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098457|NCT03197298|Ticagrelor|ticagrelor|mesh-list
25098593|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098594|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098595|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25098596|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098634|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098637|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
25099128|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099130|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
25099131|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
25099132|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099133|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25099220|NCT03193112|S 20098|s 20098|mesh-list
25099492|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099493|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100126|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100191|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25100192|NCT03184870|Antidotes|antidotes|mesh-ancestor
25100680|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
25100681|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100682|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25101297|NCT03175679|Tegafur|tegafur|mesh-list
25101298|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101299|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101344|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
25101396|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101994|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25101995|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102085|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102086|NCT03170323|Cyclosporine|cyclosporine|mesh-list
25102698|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25102699|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102700|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102701|NCT03167034|Diuretics|diuretics|mesh-ancestor
25102798|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
25102817|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
25102818|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102820|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
25103572|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103573|NCT03160339|Vaccines|vaccines|mesh-list
25105377|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105378|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105379|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25105380|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24975158|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975167|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975620|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975621|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975622|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795024|NCT03891667|Disulfiram|disulfiram|mesh-list
24795025|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24795026|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24795027|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795028|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976021|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976022|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976023|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24976024|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914075|NCT04258423|Everolimus|everolimus|mesh-list
24976046|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24976562|NCT03164655|Bevacizumab|bevacizumab|mesh-list
24976563|NCT03164655|Cetuximab|cetuximab|mesh-list
24976564|NCT03164655|Panitumumab|panitumumab|mesh-list
24976565|NCT03164655|Fluorouracil|fluorouracil|mesh-list
24976566|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
24976567|NCT03164655|Irinotecan|irinotecan|mesh-list
24976568|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976653|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976655|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
24414611|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783519|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
24414719|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414720|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24414721|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414723|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
24414724|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977226|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977227|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977228|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977272|NCT02807805|Niclosamide|niclosamide|mesh-list
24977851|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24977852|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415806|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24415807|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415808|NCT00201253|Dimercaprol|dimercaprol|mesh-list
24415809|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
24415812|NCT00201305|Leucovorin|leucovorin|mesh-list
24415826|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
24415827|NCT00201305|Vitamins|vitamins|mesh-ancestor
24415828|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
24416466|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416468|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24416560|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416561|NCT00203385|Valproic Acid|valproic acid|mesh-list
24417291|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24978045|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978046|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978047|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978048|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24978049|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24978050|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978110|NCT05178953|Zinc|zinc|mesh-list
24418000|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418001|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418002|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24418003|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
24418004|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24418005|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
24418006|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
24418007|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533879|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857427|NCT02291666|Omeprazole|omeprazole|mesh-list
24451093|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24535377|NCT00649064|Ziprasidone|ziprasidone|mesh-list
24535909|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
24535910|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
24535911|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24536636|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24536650|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451223|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24451224|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
24451225|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
24451226|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
24451227|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24537906|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24857797|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24857798|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24857799|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857819|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857820|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24435497|NCT00266578|Xhance|xhance|mesh-list
24539272|NCT00663052|Etanercept|etanercept|mesh-list
24541158|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
24541159|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24541177|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24541178|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
24542302|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24542303|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542304|NCT00678236|Gentamicins|gentamicins|mesh-list
24542305|NCT00678236|Cimetidine|cimetidine|mesh-list
24542666|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
24543094|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24543095|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543103|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
24543161|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543162|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543164|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858004|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858005|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544236|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544237|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
24545425|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24545426|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545493|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447431|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447432|NCT00308477|Dexamethasone|dexamethasone|mesh-list
24546822|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
24546823|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546824|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24800639|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800640|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800641|NCT01977300|Valproic Acid|valproic acid|mesh-list
24551569|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552112|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24552116|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
24800874|NCT01978873|Vitamins|vitamins|mesh-ancestor
24800996|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24800997|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800998|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
24801003|NCT01980329|Maraviroc|maraviroc|mesh-list
24549111|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24801258|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801259|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
24801260|NCT01982201|Renal Agents|renal agents|mesh-ancestor
24801261|NCT01982396|Lamivudine|lamivudine|mesh-list
24801262|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24801263|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24801264|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549470|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24549471|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24549477|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24549478|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24549479|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549704|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24549707|NCT00717210|Temozolomide|temozolomide|mesh-list
24448206|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448696|NCT00312650|Doxorubicin|doxorubicin|mesh-list
24802057|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455146|NCT02645149|Trametinib|trametinib|mesh-list
24455147|NCT02645149|Ceritinib|ceritinib|mesh-list
24463372|NCT00360438|Rasburicase|rasburicase|mesh-list
24463965|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24463966|NCT00362895|Dexamethasone|dexamethasone|mesh-list
24452543|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24452545|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
24452688|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24452689|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
24452690|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
24452691|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
24596989|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24596990|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
24571290|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
24464289|NCT00364052|Valganciclovir|valganciclovir|mesh-list
24464290|NCT00364052|Ganciclovir|ganciclovir|mesh-list
24802711|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802712|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802713|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
24802731|NCT01992146|Naloxone|naloxone|mesh-list
24802732|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24802831|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
24802832|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802833|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
24802866|NCT01992796|Candesartan|candesartan|mesh-list
24802867|NCT01992796|Olmesartan|olmesartan|mesh-list
24802868|NCT01992796|Irbesartan|irbesartan|mesh-list
24573717|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24465558|NCT00370045|Eptifibatide|eptifibatide|mesh-list
24465559|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
24803044|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24803045|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803047|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24803048|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24803049|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24803050|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803051|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803052|NCT01994096|Caspofungin|caspofungin|mesh-list
24622597|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
24622598|NCT01067677|Promethazine|promethazine|mesh-list
24622599|NCT01067677|Ondansetron|ondansetron|mesh-list
24622600|NCT01067677|Metoclopramide|metoclopramide|mesh-list
24622601|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
24622602|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
24622603|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803402|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24803459|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24803460|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803461|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803462|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803463|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
24803464|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803628|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803629|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
24803635|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
24803643|NCT01997658|Hormones|hormones|mesh-ancestor
24622633|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
24622634|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622636|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24803784|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803785|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
24803786|NCT01998503|Hormones|hormones|mesh-ancestor
24803806|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
24803807|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24803808|NCT01998685|Narcotics|narcotics|mesh-ancestor
24803809|NCT01998685|Analgesics|analgesics|mesh-ancestor
24803810|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
24803831|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
24803832|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
24803833|NCT01998698|Protective Agents|protective agents|mesh-ancestor
24803834|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
24803987|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
24803988|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
24803989|NCT02000206|Analgesics|analgesics|mesh-ancestor
24803990|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
24804190|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804191|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804192|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
24804193|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599091|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599092|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
24599093|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
24599094|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
24599099|NCT05212012|Methadone|methadone|mesh-list
24804570|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804571|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804572|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24804605|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24804606|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804607|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804609|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
24576003|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576004|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576005|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
24576006|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576007|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24467201|NCT00376519|Cyclosporins|cyclosporins|mesh-list
24467202|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467203|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
24467204|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467205|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24467206|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24805128|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805129|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805131|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24805132|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24805133|NCT02007837|Analgesics|analgesics|mesh-ancestor
24805134|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
24805135|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805136|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467789|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
24467790|NCT00378716|Vitamins|vitamins|mesh-ancestor
24467791|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
24467792|NCT00378729|Metformin|metformin|mesh-list
24467793|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468101|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468589|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24468590|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24468591|NCT00382356|Dutasteride|dutasteride|mesh-list
24468667|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469517|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24469518|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24469520|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
24470231|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470232|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470273|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470274|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805408|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24471420|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24471421|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
24471422|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471423|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471424|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24471425|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
24471426|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
24471427|NCT00395239|Hormones|hormones|mesh-ancestor
24471428|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805482|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805483|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24805484|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805485|NCT02009592|Rifaximin|rifaximin|mesh-list
24805486|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24805487|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472063|NCT00397917|Folic Acid|folic acid|mesh-list
24805533|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24805534|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24805536|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24805740|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24805741|NCT02011958|Miltefosine|miltefosine|mesh-list
24805742|NCT02011958|Amebicides|amebicides|mesh-ancestor
24805743|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24805744|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24805745|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805746|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24805747|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
24445891|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446001|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600630|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
24600631|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600636|NCT00959621|Analgesics|analgesics|mesh-ancestor
24474063|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474064|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24600645|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24600646|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24474402|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474403|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
24474404|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474405|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24474406|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24805979|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24474496|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24806011|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24806012|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
24806013|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24806014|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24806015|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24806034|NCT02013362|Hematinics|hematinics|mesh-ancestor
24905777|NCT04345276|Ritonavir|ritonavir|mesh-list
24905892|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24905893|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109101|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109102|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
25109103|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109104|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25109105|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25109106|NCT03127124|Leucovorin|leucovorin|mesh-list
25109107|NCT03127124|Fluorouracil|fluorouracil|mesh-list
25109108|NCT03127124|Bevacizumab|bevacizumab|mesh-list
24905943|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905946|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
24906372|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906373|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906375|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
24906376|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906377|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906378|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
24906428|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24482286|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24482287|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24482288|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482289|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906943|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906945|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907003|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24907065|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907066|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24787113|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
24787114|NCT01923831|Dexamethasone|dexamethasone|mesh-list
24787115|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
24787116|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787117|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
24787118|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
24907454|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24907455|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24907456|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907457|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
24907458|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24907459|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24907464|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
24907840|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24907841|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907842|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
24907843|NCT04326959|Hormones|hormones|mesh-ancestor
24907844|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24483026|NCT00441519|Omeprazole|omeprazole|mesh-list
24787131|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24787133|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24787134|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24908028|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908029|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908031|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
24908341|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908342|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24908343|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908345|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
24908346|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
24908347|NCT04321837|Vitamins|vitamins|mesh-ancestor
24908348|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
24908611|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908613|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
24908868|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908869|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
24908870|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24908871|NCT04315831|Buprenorphine|buprenorphine|mesh-list
24908872|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24908873|NCT04315831|Narcotics|narcotics|mesh-ancestor
24908874|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908875|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908876|NCT04315831|Analgesics|analgesics|mesh-ancestor
24908877|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
24909042|NCT04313218|Carbetocin|carbetocin|mesh-list
24909043|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24909044|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
24909045|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24909046|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909047|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24909048|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24909049|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
24909050|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24909051|NCT04313374|Morphine|morphine|mesh-list
24909085|NCT04312880|Coagulants|coagulants|mesh-ancestor
24909336|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
24909338|NCT04310176|Bevacizumab|bevacizumab|mesh-list
24909496|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24909497|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24909498|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24909545|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24909546|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24910926|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
24910954|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24910955|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911086|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
24911149|NCT04290858|Protective Agents|protective agents|mesh-ancestor
24911151|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911152|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24911153|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
24911154|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911155|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485787|NCT00455039|Lapatinib|lapatinib|mesh-list
24912246|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24787200|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787202|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24787205|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
24913078|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913079|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819268|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819269|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24913234|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
24913235|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109275|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914762|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24914763|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914765|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24914766|NCT04252261|Protective Agents|protective agents|mesh-ancestor
24914767|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914768|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914769|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24914771|NCT04252521|Metoclopramide|metoclopramide|mesh-list
24914772|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
24915009|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24915021|NCT05251610|Oxytocin|oxytocin|mesh-list
24915051|NCT04938882|Ropivacaine|ropivacaine|mesh-list
24915052|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
24915053|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
24915054|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787237|NCT01924104|Heparin|heparin|mesh-list
24915507|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
24915508|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24490886|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916145|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916176|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24916177|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
24916179|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24916180|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916182|NCT04243850|Caffeine|caffeine|mesh-list
24916647|NCT04238702|Losartan|losartan|mesh-list
24916648|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24916649|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24916650|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25109343|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
25109344|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916651|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24916652|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109362|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24918087|NCT04223739|Amiodarone|amiodarone|mesh-list
24918088|NCT04223739|Landiolol|landiolol|mesh-list
24918089|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24918090|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
24744570|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
24918093|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918094|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24918131|NCT04223219|Narcotics|narcotics|mesh-ancestor
24918579|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24918580|NCT04218734|Metformin|metformin|mesh-list
24918581|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918625|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918626|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24918627|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24918629|NCT04217265|Misoprostol|misoprostol|mesh-list
24918630|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918631|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24617201|NCT01041625|Apremilast|apremilast|mesh-list
24617349|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
24617421|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920351|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
24920352|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24623919|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
24920491|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920492|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
24921071|NCT04194684|Paclitaxel|paclitaxel|mesh-list
24921072|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24921074|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
24921519|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921520|NCT04190004|Vasopressins|vasopressins|mesh-list
24921521|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
24921522|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
24921588|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921590|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921593|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24921945|NCT04185077|Coagulants|coagulants|mesh-ancestor
24921946|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24921947|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
24921981|NCT04184921|Osimertinib|osimertinib|mesh-list
24921982|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24921983|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24921984|NCT04184921|Analgesics|analgesics|mesh-ancestor
24921985|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
24921986|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921987|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497429|NCT00510016|Clonidine|clonidine|mesh-list
24497889|NCT00512395|Ropivacaine|ropivacaine|mesh-list
24497890|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24497891|NCT00512395|Narcotics|narcotics|mesh-ancestor
24497892|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497893|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497894|NCT00512395|Analgesics|analgesics|mesh-ancestor
24497903|NCT00512408|Androgens|androgens|mesh-ancestor
24923163|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923164|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923165|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24923213|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24923214|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498857|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923981|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24923982|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
24924036|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500442|NCT00524199|Mesna|mesna|mesh-list
24787496|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925330|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925331|NCT04151381|Protective Agents|protective agents|mesh-ancestor
24925333|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
24925334|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925335|NCT04150965|Thalidomide|thalidomide|mesh-list
24925336|NCT04150965|Dexamethasone|dexamethasone|mesh-list
24501510|NCT00529022|Carboplatin|carboplatin|mesh-list
24925846|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925847|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24925848|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24925849|NCT04147481|Anesthetics|anesthetics|mesh-list
24925850|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
24925851|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925867|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24927673|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
24927674|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504987|NCT00538876|Decitabine|decitabine|mesh-list
24929266|NCT04114149|Narcotics|narcotics|mesh-ancestor
24929267|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929268|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929269|NCT04114149|Analgesics|analgesics|mesh-ancestor
24929270|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
24929271|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929272|NCT04113772|Nitisinone|nitisinone|mesh-list
25109523|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25109524|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929983|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929984|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930478|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24930479|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24930480|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24930483|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24930484|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
24930485|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624880|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24624881|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624882|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
24624883|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24930683|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930684|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24930685|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24930686|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
24930687|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931475|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24507729|NCT00551733|Paclitaxel|paclitaxel|mesh-list
24931504|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
24931658|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
24931659|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24931661|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
25004604|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
24933400|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933437|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24933438|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
24933439|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933441|NCT04070729|Protective Agents|protective agents|mesh-ancestor
24625287|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24625288|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24509906|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933628|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24933798|NCT04067102|Carboplatin|carboplatin|mesh-list
24934601|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934724|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24934725|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24934726|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934727|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24934753|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24934764|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24934765|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24934766|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25004687|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25004688|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004689|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670547|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670548|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24670549|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670550|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670551|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
24670552|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
24670553|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24670554|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670555|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
24670556|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24670557|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670558|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
24670559|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670749|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24670750|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455587|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
24455588|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514755|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455665|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
24455685|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455686|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
24455687|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455688|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
24469658|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24469680|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24469681|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469683|NCT00386763|Artemether|artemether|mesh-list
24471101|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24483079|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483082|NCT00441740|Vinorelbine|vinorelbine|mesh-list
24749274|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
24457360|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004949|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25004950|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004966|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004967|NCT05200793|Incretins|incretins|mesh-ancestor
25004968|NCT05200793|Hormones|hormones|mesh-ancestor
25004969|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004970|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25004971|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
25004972|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004973|NCT05200663|Tamoxifen|tamoxifen|mesh-list
25004974|NCT05200663|Vitamin E|vitamin e|mesh-list
25004975|NCT05200663|Vitamins|vitamins|mesh-ancestor
25004976|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
24490709|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24490834|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490836|NCT00480272|Adalimumab|adalimumab|mesh-list
24490837|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490838|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
24490839|NCT00480272|Hormones|hormones|mesh-ancestor
24490840|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490871|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493548|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
24497085|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497087|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24457605|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498510|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24498511|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498512|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
24500882|NCT00526175|Asparaginase|asparaginase|mesh-list
24500883|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
24506778|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
24512497|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512498|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
24512500|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24513469|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24513470|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513471|NCT00581789|Growth Substances|growth substances|mesh-ancestor
24513472|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519622|NCT05332028|Fentanyl|fentanyl|mesh-list
24519623|NCT05332028|Bupivacaine|bupivacaine|mesh-list
24526032|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526055|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24528232|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24528233|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24528234|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24528235|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
24528236|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24528237|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24528238|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
24529731|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529786|NCT00627835|Cisplatin|cisplatin|mesh-list
25005437|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25005438|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25005439|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24702290|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702291|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24702292|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702293|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
24707146|NCT01494363|Irinotecan|irinotecan|mesh-list
24707147|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
24707148|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707737|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709305|NCT01505088|Citric Acid|citric acid|mesh-list
24709306|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
24709307|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24709308|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24709309|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24710262|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710263|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24710264|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710493|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710496|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710498|NCT01510990|Gefitinib|gefitinib|mesh-list
24710499|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710591|NCT01511198|Hormones|hormones|mesh-ancestor
24711224|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713075|NCT01524081|Cefuroxime|cefuroxime|mesh-list
24788880|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
24788881|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788883|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24714781|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714782|NCT01532856|Thalidomide|thalidomide|mesh-list
24714783|NCT01532856|Dexamethasone|dexamethasone|mesh-list
24714784|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
24714785|NCT01532856|Prednisone|prednisone|mesh-list
24714786|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
24714787|NCT01532856|Melphalan|melphalan|mesh-list
24714788|NCT01532856|BB 1101|bb 1101|mesh-list
25006025|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718085|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
24718874|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718875|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718876|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24718877|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24718878|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
24789219|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789221|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
24789222|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
24789223|NCT01935973|Trametinib|trametinib|mesh-list
24719410|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24719411|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719413|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24719442|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
24719443|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719610|NCT01562795|Hormones|hormones|mesh-ancestor
25006232|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
25006233|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25006234|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25006235|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24719886|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719887|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
24719888|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24615395|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615397|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24615398|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24720645|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720646|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24720647|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24721396|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721397|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721398|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789317|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
24789318|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789319|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24789320|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24722167|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
24722168|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24724218|NCT01591889|Tinidazole|tinidazole|mesh-list
24725627|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24725628|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24725629|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
24725630|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
24725631|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725632|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24725633|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24727152|NCT01608334|Fentanyl|fentanyl|mesh-list
24616385|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
24789603|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24789604|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789605|NCT01938144|Acetaminophen|acetaminophen|mesh-list
24789606|NCT01938144|Ibuprofen|ibuprofen|mesh-list
24789607|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789608|NCT01938144|Analgesics|analgesics|mesh-ancestor
24789609|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
24728381|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
24728382|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728383|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24728384|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24729413|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
24729445|NCT01621698|Atracurium|atracurium|mesh-list
24729446|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
24729447|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
24517573|NCT00608699|Vitamins|vitamins|mesh-ancestor
24729448|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729449|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729450|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
24729639|NCT01622881|Analgesics|analgesics|mesh-ancestor
24729640|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
24729641|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729642|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729698|NCT01623349|Olaparib|olaparib|mesh-list
24729779|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24729780|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24730435|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
24730436|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730437|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730438|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730439|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24730440|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24730441|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730448|NCT01628055|Antibodies|antibodies|mesh-list
24730800|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24730802|NCT01630564|Interleukin-2|interleukin-2|mesh-list
24730803|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730804|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730805|NCT01630564|Analgesics|analgesics|mesh-ancestor
24730806|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
24730807|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730808|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730840|NCT01630733|Docetaxel|docetaxel|mesh-list
24731551|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731552|NCT01635530|Doxycycline|doxycycline|mesh-list
24731605|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731606|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731607|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24731608|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24616963|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24616964|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24616966|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
24732302|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
24732303|NCT01638767|NuvaRing|nuvaring|mesh-list
24732336|NCT01638962|Indomethacin|indomethacin|mesh-list
24732337|NCT01638962|Etoricoxib|etoricoxib|mesh-list
24732338|NCT01638962|Meloxicam|meloxicam|mesh-list
24732339|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24732340|NCT01638962|Etodolac|etodolac|mesh-list
24732341|NCT01638962|Lornoxicam|lornoxicam|mesh-list
24732342|NCT01638962|Nabumetone|nabumetone|mesh-list
24732343|NCT01638962|Tenoxicam|tenoxicam|mesh-list
24733140|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734392|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24734613|NCT01652820|Carboplatin|carboplatin|mesh-list
24617610|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735956|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735957|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
24735958|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400466|NCT00150605|Analgesics|analgesics|mesh-ancestor
24617785|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617786|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737855|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24617788|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617789|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617790|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24617791|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
24737814|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737847|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
24737848|NCT01670812|Hormones|hormones|mesh-ancestor
24737850|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24742407|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24745423|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745424|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24745425|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24745426|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745427|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745476|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
24745928|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748452|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24748453|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748697|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748698|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748699|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748700|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
24748701|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24748702|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24748703|NCT02215980|Growth Substances|growth substances|mesh-ancestor
25007017|NCT04358133|Morphine|morphine|mesh-list
25007018|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25007019|NCT04358133|Narcotics|narcotics|mesh-ancestor
24460285|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
24750288|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24750455|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24750456|NCT01698645|Narcotics|narcotics|mesh-ancestor
24750457|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750458|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750459|NCT01698645|Analgesics|analgesics|mesh-ancestor
24750515|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24433909|NCT00260611|Docetaxel|docetaxel|mesh-list
24750517|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751753|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25007036|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007037|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007038|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24790107|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
24790108|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757447|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
24757450|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438934|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758692|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758693|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24758694|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24758716|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24758717|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758718|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24758883|NCT01748396|Calcitriol|calcitriol|mesh-list
24395405|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
24395406|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395408|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24395409|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
24395410|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
24455486|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401087|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401089|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
24420320|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24420321|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
24420322|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420323|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420324|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420325|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420326|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420327|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421728|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421729|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24421730|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24422173|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24422672|NCT00223509|Lamotrigine|lamotrigine|mesh-list
24425192|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425193|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
24425194|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
24425332|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24425333|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24425334|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
24790325|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790326|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24427782|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427783|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427784|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427785|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431360|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24428302|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
24428304|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
24432425|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432426|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
24432427|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432476|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24437901|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24439903|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439943|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
24439944|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24439945|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439947|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
24439978|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439981|NCT00281125|Vatalanib|vatalanib|mesh-list
24440446|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
24442008|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442138|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24442593|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24442594|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
24442595|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443033|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443034|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24443035|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443036|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24443047|NCT00293501|Tinzaparin|tinzaparin|mesh-list
24461106|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24443566|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461133|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461134|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461135|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24461432|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790798|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790799|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790801|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790802|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24553199|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553202|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
24554396|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24554397|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24554398|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555775|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555776|NCT00743587|Naproxen|naproxen|mesh-list
24555777|NCT00743587|Oxycodone|oxycodone|mesh-list
24556375|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24552544|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552545|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552546|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552547|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
24557077|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008485|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24559876|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24559877|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559878|NCT04187144|Renal Agents|renal agents|mesh-ancestor
24559879|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24561023|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
24561059|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24561509|NCT00761228|Apomorphine|apomorphine|mesh-list
24561511|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561512|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
24561513|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561514|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561515|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
24561759|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24561760|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561863|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
24561865|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24561884|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24561885|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
24561886|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
25109873|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109874|NCT03121690|Prednisone|prednisone|mesh-list
24564161|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
25109876|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
25109877|NCT03121690|Hormones|hormones|mesh-ancestor
25109878|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562502|NCT00766805|Diuretics|diuretics|mesh-ancestor
24562503|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
24562505|NCT00766818|Lopinavir|lopinavir|mesh-list
24564160|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24564217|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24564218|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
24564219|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24564220|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24564221|NCT00775632|Cyclosporine|cyclosporine|mesh-list
24564222|NCT00775632|Methotrexate|methotrexate|mesh-list
24564223|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
24564224|NCT00775632|Cyclosporins|cyclosporins|mesh-list
24564303|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564306|NCT00775827|Fenofibrate|fenofibrate|mesh-list
24564831|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24564832|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24564833|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
24564834|NCT00778024|Fluoxetine|fluoxetine|mesh-list
24564835|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24564883|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24564884|NCT00778089|Protective Agents|protective agents|mesh-ancestor
24564977|NCT00778297|Vaccines|vaccines|mesh-list
24565435|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565436|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
24565550|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24565551|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24565552|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24565554|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565555|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565556|NCT00781157|Protective Agents|protective agents|mesh-ancestor
24566219|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566220|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
24566221|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25008815|NCT04249258|Dobutamine|dobutamine|mesh-list
24791751|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24791752|NCT03148366|Antacids|antacids|mesh-ancestor
24893310|NCT04451447|SMOFlipid|smoflipid|mesh-list
24566222|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24556731|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24566235|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24566236|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
24566515|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566516|NCT00786240|Urological Agents|urological agents|mesh-ancestor
24566517|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24566518|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24566519|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24567002|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567003|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567004|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24567005|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24791803|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791804|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791805|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24791806|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791807|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
24791808|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791809|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24567199|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24567200|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567201|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24567202|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24567203|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
24567209|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24567660|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
24567661|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
24567662|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567663|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567727|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24567728|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24567729|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24567730|NCT00792337|Simvastatin|simvastatin|mesh-list
24567731|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24567732|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24567806|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24567807|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
24567808|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
24567809|NCT00792818|Ibuprofen|ibuprofen|mesh-list
24567810|NCT00792818|Curcumin|curcumin|mesh-list
24567811|NCT00792818|Turmeric extract|turmeric extract|mesh-list
24567812|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24567856|NCT00793195|SMOFlipid|smoflipid|mesh-list
24567857|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24567858|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24568417|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24568418|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568419|NCT00795925|Propiverine|propiverine|mesh-list
24671046|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671047|NCT01323335|Protective Agents|protective agents|mesh-ancestor
24568420|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
24443638|NCT00295594|Tacrolimus|tacrolimus|mesh-list
24568452|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
25008897|NCT03837873|Rituximab|rituximab|mesh-list
25008898|NCT03837873|Doxorubicin|doxorubicin|mesh-list
24569002|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569134|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569136|NCT00799149|Gabapentin|gabapentin|mesh-list
24569137|NCT00799149|Analgesics|analgesics|mesh-ancestor
24569138|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
24569139|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569480|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569481|NCT00800748|Ribavirin|ribavirin|mesh-list
24569482|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24569557|NCT00801086|Ethanol|ethanol|mesh-list
24791972|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24791973|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24791974|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791976|NCT02053363|Coagulants|coagulants|mesh-ancestor
24791977|NCT02035137|Irinotecan|irinotecan|mesh-list
24570264|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24571051|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24571053|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
24571054|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24571055|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571056|NCT00808002|Tenofovir|tenofovir|mesh-list
24571138|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
24571139|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571140|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24571141|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24571143|NCT00808223|Alefacept|alefacept|mesh-list
24571512|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571514|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571515|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24571516|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24571517|NCT00810563|Bupivacaine|bupivacaine|mesh-list
24571518|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
24571519|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
24571520|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571524|NCT00810589|Insulin|insulin|mesh-list
24571612|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571795|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571796|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24571797|NCT00811837|Narcotics|narcotics|mesh-ancestor
24571798|NCT00811837|Analgesics|analgesics|mesh-ancestor
24571799|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
24571800|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572372|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24572681|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572682|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24572683|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24572684|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572685|NCT00816283|Dasatinib|dasatinib|mesh-list
24572851|NCT00816959|Vinblastine|vinblastine|mesh-list
24572852|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24572853|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573052|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
24573053|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24792353|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
24792354|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25009439|NCT00799110|Vaccines|vaccines|mesh-list
25009440|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
25009445|NCT00697684|Clofarabine|clofarabine|mesh-list
24573173|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573174|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
24573175|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573176|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
24573177|NCT00818298|Ziprasidone|ziprasidone|mesh-list
24573178|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24573179|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
24573180|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573181|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573304|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
24573305|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24573306|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
24573307|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
24573448|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573449|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24573450|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24573451|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24573452|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573453|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561900|NCT00763646|Docetaxel|docetaxel|mesh-list
24573455|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
24573456|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24573457|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573458|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24573521|NCT00820547|Epirubicin|epirubicin|mesh-list
24573566|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573567|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
24573568|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
24573569|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573574|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573575|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573576|NCT00820885|Teduglutide|teduglutide|mesh-list
24573577|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573692|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24573693|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573694|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24573695|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24573696|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
24573697|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573725|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
24573727|NCT00821782|Azithromycin|azithromycin|mesh-list
24573819|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24573820|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
24573821|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24562182|NCT00764907|Hormones|hormones|mesh-ancestor
24562189|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24562190|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
24562191|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24574063|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24574064|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574065|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574066|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24574067|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24574068|NCT00823381|Resveratrol|resveratrol|mesh-list
24574383|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24574384|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
24574385|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24574387|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574388|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
24671093|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671095|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24671096|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
24671099|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24792516|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009526|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
25009528|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
24574433|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24574435|NCT00825188|Eplerenone|eplerenone|mesh-list
24574444|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
24574445|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574446|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24574447|NCT00825188|Diuretics|diuretics|mesh-ancestor
24574448|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
24574449|NCT00825201|Paclitaxel|paclitaxel|mesh-list
24574450|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24574451|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24574452|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630300|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24574520|NCT00825864|BB 1101|bb 1101|mesh-list
24574545|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574546|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
24574547|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574548|NCT00826163|Budesonide|budesonide|mesh-list
24574549|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574550|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24574551|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
24630412|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574715|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
24574716|NCT00827021|Hematinics|hematinics|mesh-list
24574717|NCT00827034|Warfarin|warfarin|mesh-list
24574718|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
24574719|NCT00827138|Rebastinib|rebastinib|mesh-list
24574720|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574721|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24574722|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574732|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574733|NCT00827216|Erythromycin|erythromycin|mesh-list
24574920|NCT00828529|Bedaquiline|bedaquiline|mesh-list
24574921|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
24574922|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574971|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
24574972|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574973|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24574974|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
24574975|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574976|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009577|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25009578|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25009579|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25009580|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25009581|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009582|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25009583|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575119|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575120|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
24575121|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24575122|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24671106|NCT01323569|Analgesics|analgesics|mesh-ancestor
24575123|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575124|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24575248|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24575249|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24575250|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24575251|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
24575252|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24575270|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
24575277|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
24575294|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24575367|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24575368|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
24575369|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575381|NCT00830895|Everolimus|everolimus|mesh-list
25109967|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671110|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
24575554|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
24575555|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
24575557|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
24575558|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24575559|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575686|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24575687|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
24580130|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
24575688|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24575689|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24575691|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575692|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
24576662|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24576663|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
24576664|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792827|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792829|NCT04605614|Trace Elements|trace elements|mesh-ancestor
24579046|NCT00853177|Lidocaine|lidocaine|mesh-list
25009943|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009944|NCT04827979|Daratumumab|daratumumab|mesh-list
25009946|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
25009947|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
25009948|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
24579074|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
24579075|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579076|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24579077|NCT00853216|Oxycodone|oxycodone|mesh-list
24579500|NCT00855608|Adalimumab|adalimumab|mesh-list
24580133|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580134|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580147|NCT00860899|Clonidine|clonidine|mesh-list
24580148|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
24580149|NCT00860899|Analgesics|analgesics|mesh-ancestor
24580150|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
24580165|NCT00860925|Clonidine|clonidine|mesh-list
24580214|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24581001|NCT00864188|Vitamins|vitamins|mesh-ancestor
24581002|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
24582613|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
24582614|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
24582615|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582680|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582681|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
24582722|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24582723|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582725|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
24583447|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583449|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583451|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
24583452|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
24583498|NCT00874809|Insulin|insulin|mesh-list
24583502|NCT00874861|Poly ICLC|poly iclc|mesh-list
24583663|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24583664|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25010428|NCT04066751|Ivacaftor|ivacaftor|mesh-list
24584268|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584690|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
24584691|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584717|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24584876|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584877|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25110168|NCT05464979|Midazolam|midazolam|mesh-list
24585528|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24585544|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24585545|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24585547|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
24585548|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24585550|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24585551|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011052|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
25011053|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
25011054|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25011055|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25011056|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
25011057|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
25011059|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
25011479|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011480|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
25011481|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
25011482|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011483|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25011484|NCT04958876|Naltrexone|naltrexone|mesh-list
25011485|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25011486|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25011487|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011814|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
25011815|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011816|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25011817|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011818|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25011819|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011820|NCT03706885|Efavirenz|efavirenz|mesh-list
25011821|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25011822|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25011823|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011858|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
25011859|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25011860|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25012047|NCT02335060|Expectorants|expectorants|mesh-ancestor
25012261|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012262|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25012263|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012264|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25012265|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
25012266|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25012267|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012609|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25012611|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012641|NCT04700423|Ivermectin|ivermectin|mesh-list
25012642|NCT04700423|Albendazole|albendazole|mesh-list
25012736|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24574791|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574793|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24574798|NCT00827450|Caffeine|caffeine|mesh-list
24969932|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586231|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586232|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25013617|NCT01775813|Metformin|metformin|mesh-list
25013618|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25013619|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013620|NCT01694069|Tazobactam|tazobactam|mesh-list
25013621|NCT01694069|Piperacillin|piperacillin|mesh-list
25013622|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25013623|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25013624|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013627|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013789|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013790|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25013835|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013836|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014364|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25014536|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
25014537|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014538|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015017|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25015018|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
25015019|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25015020|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
25015021|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015022|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015023|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
25015024|NCT03476330|Quercetin|quercetin|mesh-list
25015025|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
25015060|NCT03392441|Insulin|insulin|mesh-list
25015172|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25015173|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25015174|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015175|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015176|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25015583|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015584|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015585|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25015586|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
25015587|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25015588|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25015895|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
25015896|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015897|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015898|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015899|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25015900|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25015914|NCT00703014|Progesterone|progesterone|mesh-list
25015924|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015926|NCT00702845|Hormones|hormones|mesh-list
25015927|NCT00702845|Progesterone|progesterone|mesh-list
25016410|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016411|NCT05224999|Nivolumab|nivolumab|mesh-list
25016412|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25016413|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016414|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25016415|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016416|NCT05224687|Daptomycin|daptomycin|mesh-list
25017136|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
25017137|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017138|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017139|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25017140|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
25017141|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017142|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
25017143|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017144|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017387|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017389|NCT01267812|Bortezomib|bortezomib|mesh-list
25018006|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25018007|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018008|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018010|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
25018112|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25018113|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25018791|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018913|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25018916|NCT03695705|Norfloxacin|norfloxacin|mesh-list
25019272|NCT03692416|Protective Agents|protective agents|mesh-ancestor
25019315|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019316|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019317|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
25019318|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019319|NCT03691922|Epinephrine|epinephrine|mesh-list
25019320|NCT03691922|Racepinephrine|racepinephrine|mesh-list
25019321|NCT03691922|Bupivacaine|bupivacaine|mesh-list
25019322|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
25020122|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25020123|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25020124|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020180|NCT03682640|Insulin|insulin|mesh-list
25021790|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
25021791|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
25021792|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
25021793|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021794|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25021795|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
25021796|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021797|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022276|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022277|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25022280|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022281|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
25022282|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25022283|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
25022284|NCT03664388|Clopidogrel|clopidogrel|mesh-list
25022285|NCT03664388|Ticagrelor|ticagrelor|mesh-list
25023044|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
25023045|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023046|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023135|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25023136|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
25112043|NCT04527055|Tetracycline|tetracycline|mesh-list
25112046|NCT04527055|Bismuth|bismuth|mesh-list
25023228|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023229|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25023230|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023231|NCT03656614|Neostigmine|neostigmine|mesh-list
25023232|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25023233|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023234|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587444|NCT00894998|Heparin|heparin|mesh-list
25023837|NCT03651219|Apatinib|apatinib|mesh-list
25023838|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25023839|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25024076|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024077|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024078|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25024079|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25024080|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
25024081|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024083|NCT03648996|Allopurinol|allopurinol|mesh-list
25024609|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024610|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024714|NCT03643276|Vindesine|vindesine|mesh-list
25024715|NCT03643276|Asparaginase|asparaginase|mesh-list
25024717|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
25024774|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25024775|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
25024781|NCT03642665|Estradiol|estradiol|mesh-list
25024782|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25025246|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025247|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025249|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
25025250|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982100|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025620|NCT03635411|Vitamins|vitamins|mesh-ancestor
25025621|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
25025622|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025623|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25025624|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
25025625|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025626|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25025627|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
25025628|NCT03635398|Midazolam|midazolam|mesh-list
25025629|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25025630|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025631|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025632|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025887|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
25025888|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025889|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025890|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25025891|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25025892|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
25025893|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
25025894|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026026|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25026027|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026028|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026167|NCT03631602|Miconazole|miconazole|mesh-list
25026168|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026169|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25026170|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25026171|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25026172|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026173|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026183|NCT03631316|Valganciclovir|valganciclovir|mesh-list
25026397|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026398|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
25026399|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
25026400|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026401|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026402|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026704|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25026705|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026706|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026707|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026708|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25026709|NCT03625739|Renal Agents|renal agents|mesh-ancestor
25026710|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25026711|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25026713|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
25026846|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026865|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25026866|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25026867|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
25026868|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25027096|NCT03622827|Growth Substances|growth substances|mesh-ancestor
25027097|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027098|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
25027099|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027101|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027113|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027114|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25027115|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25027116|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25027117|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
25027118|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027131|NCT03622489|Analgesics|analgesics|mesh-ancestor
25027499|NCT03619785|Ibuprofen|ibuprofen|mesh-list
25027597|NCT03618589|Analgesics|analgesics|mesh-ancestor
25027598|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
25027631|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25027632|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25027633|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027634|NCT03618264|Dexamethasone|dexamethasone|mesh-list
25027635|NCT03618264|Ropivacaine|ropivacaine|mesh-list
25027793|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25027794|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027795|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25027796|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25027797|NCT03616691|Growth Substances|growth substances|mesh-ancestor
24593264|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593266|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
24593267|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25027836|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027837|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027838|NCT03616405|Antacids|antacids|mesh-ancestor
25027839|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25027840|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25027841|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25027842|NCT03616405|Renal Agents|renal agents|mesh-ancestor
25028086|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
25028204|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25028259|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028261|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24593817|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25028262|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25028263|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25029036|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25030278|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25030279|NCT03597308|Narcotics|narcotics|mesh-ancestor
25030280|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030281|NCT03597282|Nivolumab|nivolumab|mesh-list
25030282|NCT03597282|Ipilimumab|ipilimumab|mesh-list
25030283|NCT03597282|Poly ICLC|poly iclc|mesh-list
25030284|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25030285|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031204|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031440|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25031441|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25031442|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
25031443|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
25031444|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031446|NCT03587558|Carvedilol|carvedilol|mesh-list
25031447|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25032386|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25032387|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25032388|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032389|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032390|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25032391|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25032395|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
25033802|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25033803|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
25033804|NCT03571126|Olanzapine|olanzapine|mesh-list
25033805|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
25033835|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24588420|NCT00902655|Coagulants|coagulants|mesh-ancestor
24588421|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24588422|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
24588423|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588424|NCT00902681|Fesoterodine|fesoterodine|mesh-list
24588425|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24588426|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24588427|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
24588428|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588429|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588430|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588455|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034719|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25034724|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
25034730|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034731|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034732|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25034733|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
25034734|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
25034735|NCT03562923|Hormones|hormones|mesh-ancestor
25034736|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034737|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
25034738|NCT03562780|Acetaminophen|acetaminophen|mesh-list
24588643|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24588648|NCT00903825|Lidocaine|lidocaine|mesh-list
24588657|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588658|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588689|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
25035595|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
24588692|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24588693|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25035144|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035145|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035146|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
24992207|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24992208|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992209|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25035586|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035587|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25035588|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25035589|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
25035590|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25035591|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035592|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25035593|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25035594|NCT03554447|Protective Agents|protective agents|mesh-ancestor
25035697|NCT03553537|Vincristine|vincristine|mesh-list
25035698|NCT03553537|Decitabine|decitabine|mesh-list
25035699|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25036016|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036018|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
25036019|NCT03551067|Ketamine|ketamine|mesh-list
24992713|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
24992714|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992715|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25036091|NCT03550534|Antacids|antacids|mesh-ancestor
24992988|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992989|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24992990|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24992991|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25036497|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
25036498|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
25036499|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
25036502|NCT03547024|Estrogens|estrogens|mesh-ancestor
24588847|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588848|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24588849|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24588850|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588851|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588852|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588853|NCT00904475|Lidocaine|lidocaine|mesh-list
24588854|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588855|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
25037235|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037346|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037347|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037381|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24589087|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589088|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24589089|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24589091|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589092|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24589093|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589116|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24589117|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589118|NCT00905918|Vitamin E|vitamin e|mesh-list
24589119|NCT00905918|Vitamins|vitamins|mesh-ancestor
25039253|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039254|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
25039522|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25039524|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24634450|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
25040421|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040422|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25040423|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24608200|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24608201|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608202|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24608203|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24608403|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608915|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609742|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609743|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24609744|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
24609745|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853741|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
24670218|NCT03181100|Paclitaxel|paclitaxel|mesh-list
24609746|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609747|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24610100|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
24853780|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610119|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24610120|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24610121|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24610122|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610193|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672187|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24672188|NCT01330524|Growth Substances|growth substances|mesh-ancestor
24672426|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24672427|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
24672428|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24672429|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672430|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672717|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672718|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672912|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672914|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24672915|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672916|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672917|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24672918|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
24672919|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
24673429|NCT01338077|Omeprazole|omeprazole|mesh-list
24673430|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24673431|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673432|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24673433|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673434|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673435|NCT01338090|Bevacizumab|bevacizumab|mesh-list
24673436|NCT01338090|Everolimus|everolimus|mesh-list
24673437|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24456773|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610507|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
24610508|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610509|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610511|NCT01002768|Insulin|insulin|mesh-list
24674399|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24675040|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854095|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854096|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854097|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675138|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675139|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675140|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24675395|NCT00394355|Xhance|xhance|mesh-list
24676083|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676085|NCT01348009|Capecitabine|capecitabine|mesh-list
24676088|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
24676917|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676918|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24676919|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676921|NCT01353339|Ofloxacin|ofloxacin|mesh-list
24676922|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24676923|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676924|NCT01353339|Renal Agents|renal agents|mesh-ancestor
24676925|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24676928|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678213|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678216|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678217|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24678218|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
24678219|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678220|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24678221|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24678222|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610978|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24610980|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24678670|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854373|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854374|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24854375|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24854382|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24680522|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680523|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
24680526|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24680527|NCT01375322|Benazepril|benazepril|mesh-list
24680528|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24680529|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24854616|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681212|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681213|NCT01378949|Morphine|morphine|mesh-list
24681214|NCT01378949|Bupivacaine|bupivacaine|mesh-list
24681389|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681390|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24681391|NCT01380288|Protective Agents|protective agents|mesh-ancestor
24681392|NCT01380301|Miltefosine|miltefosine|mesh-list
24681393|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
24681908|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
24681909|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24681918|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681919|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
24682005|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24812646|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24682559|NCT01386710|Growth Substances|growth substances|mesh-ancestor
24682560|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682561|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
24682563|NCT01386736|Vitamins|vitamins|mesh-ancestor
24682564|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
24682565|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684506|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
24684771|NCT04415333|Butyric Acid|butyric acid|mesh-list
24684772|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
24684773|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
24685799|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685800|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
24685801|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
24685807|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685808|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24685908|NCT05142267|Naloxone|naloxone|mesh-list
24611643|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686595|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24855114|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24686786|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687333|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24688323|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
24641435|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
24688324|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24688325|NCT03137173|Cephalosporins|cephalosporins|mesh-list
24688326|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24688327|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688330|NCT03110107|Nivolumab|nivolumab|mesh-list
24688331|NCT03110107|Ipilimumab|ipilimumab|mesh-list
24688332|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24689733|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24689734|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24689735|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24689736|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
24692131|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24612361|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24696938|NCT01431924|Xhance|xhance|mesh-list
24699679|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24700593|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633903|NCT01131689|Sorafenib|sorafenib|mesh-list
24634868|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
24634869|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635470|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24635471|NCT01139645|Esomeprazole|esomeprazole|mesh-list
24635472|NCT01139645|Rabeprazole|rabeprazole|mesh-list
24635473|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24635474|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635475|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24635476|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635477|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636120|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24636121|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637024|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
24637535|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638921|NCT01159158|Nateglinide|nateglinide|mesh-list
24639936|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639937|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24639938|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639940|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24639941|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
24855619|NCT02280174|Hormones|hormones|mesh-ancestor
24640458|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641562|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
24641563|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
24641650|NCT01174810|Exenatide|exenatide|mesh-list
24642321|NCT01178996|Thymalfasin|thymalfasin|mesh-list
24642322|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
24642323|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642324|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
24642381|NCT01179152|Budesonide|budesonide|mesh-list
24642727|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
24642728|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642729|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642790|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
24642792|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24644161|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24644162|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24644163|NCT01189526|Growth Substances|growth substances|mesh-ancestor
24644164|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405302|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645421|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645422|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24645423|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24645450|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645787|NCT01199900|Prednisone|prednisone|mesh-list
24856022|NCT02282267|Gefitinib|gefitinib|mesh-list
24856176|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24856177|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24856196|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24856197|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
24856198|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856199|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856200|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
24856201|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856459|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856460|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646710|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
24646712|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646713|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24856489|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856490|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24646894|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24646895|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24646896|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
24646897|NCT01205464|Doxycycline|doxycycline|mesh-list
24646898|NCT01205464|Tetracycline|tetracycline|mesh-list
24646899|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646900|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646901|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
24856547|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24856576|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856577|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
24647214|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
24647215|NCT01206972|Enoxaparin|enoxaparin|mesh-list
24647216|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
24647217|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24647218|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
24647219|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24856704|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647294|NCT01207739|Clarithromycin|clarithromycin|mesh-list
24647295|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
24647296|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24647339|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
24647464|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24695113|NCT04425902|Digoxin|digoxin|mesh-list
24695114|NCT04425902|Midazolam|midazolam|mesh-list
24695115|NCT04425902|Caffeine|caffeine|mesh-list
24695116|NCT04425902|Omeprazole|omeprazole|mesh-list
24695117|NCT04425902|Pravastatin|pravastatin|mesh-list
24695118|NCT04425902|Montelukast|montelukast|mesh-list
24695119|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24647702|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24647703|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24695278|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
24647812|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647813|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648021|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24648022|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
24648024|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856903|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856904|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24459401|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
24648453|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24648454|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648457|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24648458|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24648459|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648460|NCT01214889|Vaccines|vaccines|mesh-list
24857046|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857047|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
24857048|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
24857051|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24857069|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857070|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857071|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24459562|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
24648777|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648779|NCT01216826|Everolimus|everolimus|mesh-list
24648832|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648834|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24648835|NCT01217086|Infliximab|infliximab|mesh-list
24648846|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
24648847|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648848|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
24649217|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649218|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
24649219|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649779|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24649780|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24649781|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24649782|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24649783|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649784|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24650074|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650075|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
24650076|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
24650256|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650259|NCT01224847|Tetracaine|tetracaine|mesh-list
24650260|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
24650261|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
24651352|NCT01231165|Aspirin|aspirin|mesh-list
24651353|NCT01231165|Amiloride|amiloride|mesh-list
24651354|NCT01231165|Clopidogrel|clopidogrel|mesh-list
24651357|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24652313|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
24652314|NCT01237769|Vitamins|vitamins|mesh-list
24652315|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
24652316|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652318|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24652319|NCT01237782|Propolis|propolis|mesh-list
24652426|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652427|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653184|NCT01242267|Growth Substances|growth substances|mesh-ancestor
24654906|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654907|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24654908|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
24654909|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24654910|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24654911|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813048|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657371|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
24657554|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24657555|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
24657556|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658593|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
24658594|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658595|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658596|NCT01272856|Abatacept|abatacept|mesh-list
24659385|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
24659448|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659449|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660810|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660811|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660812|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24660813|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24660814|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24660826|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24661668|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
24661755|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661756|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661757|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661758|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
24661759|NCT01290900|Ceftazidime|ceftazidime|mesh-list
24661760|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24661761|NCT01290900|Avibactam|avibactam|mesh-list
24661762|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661763|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661764|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24662395|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
24663718|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
24663719|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663720|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663721|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24663752|NCT01303601|Olanzapine|olanzapine|mesh-list
24666689|NCT01320475|Ketamine|ketamine|mesh-list
24666690|NCT01320475|Analgesics|analgesics|mesh-ancestor
24666691|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
24666712|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
24666713|NCT01320514|Coagulants|coagulants|mesh-ancestor
24666714|NCT01320579|Tacrolimus|tacrolimus|mesh-list
24666715|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24666716|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
24666718|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24533492|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24533493|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533494|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24533495|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24857385|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24857386|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857387|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
24533719|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
24701348|NCT01458600|Propranolol|propranolol|mesh-list
24922817|NCT04176224|Edaravone|edaravone|mesh-list
24533909|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533910|NCT00645424|Atorvastatin|atorvastatin|mesh-list
24533911|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24533912|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24533913|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
24533914|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533915|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24429100|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429101|NCT00242736|Esomeprazole|esomeprazole|mesh-list
24429102|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24429557|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429668|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
24430025|NCT00245921|Hormones|hormones|mesh-ancestor
24430026|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24430027|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430029|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
24430032|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24430033|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24430164|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430165|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430166|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430173|NCT00246285|Risperidone|risperidone|mesh-list
24430174|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430175|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
24430176|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430177|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430289|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24430290|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24430291|NCT00247026|Analgesics|analgesics|mesh-ancestor
24430292|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
24430293|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430531|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24431475|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431652|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24431653|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431654|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431655|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24431656|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431657|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24431658|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431659|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
24431661|NCT00252668|Methotrexate|methotrexate|mesh-list
24431662|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24431682|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24431683|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431684|NCT00252707|Docetaxel|docetaxel|mesh-list
24432136|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
24432137|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432138|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432139|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24432140|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432141|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
24432540|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24432541|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24432542|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24432940|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432941|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432942|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24432943|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24432944|NCT00257049|Levofloxacin|levofloxacin|mesh-list
24432945|NCT00257049|Ofloxacin|ofloxacin|mesh-list
24432946|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24432947|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432948|NCT00257049|Renal Agents|renal agents|mesh-ancestor
24433407|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433408|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433573|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433574|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24433575|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433576|NCT00259129|Sorafenib|sorafenib|mesh-list
24433577|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433578|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433579|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433846|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24433847|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24549549|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24549550|NCT00715871|Nicotine|nicotine|mesh-list
24549551|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24434531|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434532|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825286|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825287|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825288|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24825289|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24825357|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434860|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24434873|NCT00264186|Norepinephrine|norepinephrine|mesh-list
24434874|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
24434875|NCT00264186|Acetylcholine|acetylcholine|mesh-list
24434876|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24434877|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24434892|NCT00264212|Diuretics|diuretics|mesh-ancestor
24434893|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
24434924|NCT00264355|Cyclosporins|cyclosporins|mesh-list
24434925|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434926|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434927|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434928|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
24435261|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435297|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435299|NCT00265915|Sargramostim|sargramostim|mesh-list
24435300|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24435301|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435302|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
24825445|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24435504|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
24435505|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
24549906|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435667|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24549907|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24549908|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
24435668|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24435669|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435670|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435671|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24435934|NCT00268528|Methotrexate|methotrexate|mesh-list
24435935|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
24435936|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24435937|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
24435938|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24435939|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436226|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436227|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550151|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
24436616|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436618|NCT00270582|Docetaxel|docetaxel|mesh-list
24436619|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436620|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24436621|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
24436622|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436623|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
24436624|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436924|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436925|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
24436926|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24436927|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436929|NCT00272116|Vitamin A|vitamin a|mesh-list
24436930|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
24436931|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
24436933|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
24437712|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24437714|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
24437715|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24437717|NCT00274326|Satavaptan|satavaptan|mesh-list
24825627|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
24825628|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825629|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439116|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825683|NCT02129621|Spironolactone|spironolactone|mesh-list
24825684|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24825685|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
24702688|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
24439120|NCT00277602|Protective Agents|protective agents|mesh-ancestor
24439121|NCT00277641|Lamotrigine|lamotrigine|mesh-list
24439122|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
24439123|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24439124|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24439125|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439144|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
24439527|NCT00279240|Metformin|metformin|mesh-list
24439551|NCT00279344|Narcotics|narcotics|mesh-ancestor
24440261|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440262|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24440264|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825747|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24825749|NCT02130167|Atropine|atropine|mesh-list
24441401|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24441402|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24441403|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24441404|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441405|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441406|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441407|NCT00287352|Amantadine|amantadine|mesh-list
24441872|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24441873|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24441874|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441875|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441876|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441877|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441879|NCT00288717|Telmisartan|telmisartan|mesh-list
24442710|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
24442711|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442712|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442952|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442953|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
24442954|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442955|NCT00293358|Carboplatin|carboplatin|mesh-list
24442959|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442960|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24442961|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24442962|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24442963|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825916|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825917|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443080|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24825972|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443277|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443278|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24443279|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
24443280|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24443282|NCT00294385|Gemcitabine|gemcitabine|mesh-list
24826477|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
24826478|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826479|NCT02134470|Testosterone|testosterone|mesh-list
24826508|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
24826509|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
24708773|NCT01502904|Pitavastatin|pitavastatin|mesh-list
24443640|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
24443641|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443642|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443643|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826665|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24826666|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24826667|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24443743|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
24826670|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24443741|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443742|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24443843|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24443898|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24443899|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24443900|NCT00296127|Analgesics|analgesics|mesh-ancestor
24443901|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
24443902|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443903|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443904|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443905|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443906|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24443910|NCT00296179|Zolpidem|zolpidem|mesh-list
24443976|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443977|NCT00296465|Citric Acid|citric acid|mesh-list
24443978|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
24443979|NCT00296465|Clomiphene|clomiphene|mesh-list
24443980|NCT00296465|Enclomiphene|enclomiphene|mesh-list
24443995|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24443996|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24443997|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24443999|NCT00296478|Progestins|progestins|mesh-ancestor
24444000|NCT00296478|Hormones|hormones|mesh-ancestor
24826927|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
24826928|NCT02136875|Fluticasone|fluticasone|mesh-list
24826930|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24826931|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826932|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25373527|NCT04934683|Propofol|propofol|mesh-list
24826933|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
24826934|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447430|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
24447518|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24447519|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
24447520|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447521|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447523|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
24827847|NCT02142010|Paclitaxel|paclitaxel|mesh-list
24827848|NCT02142010|Cisplatin|cisplatin|mesh-list
24827849|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24827850|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827851|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
24827852|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
24827853|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
24827854|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827855|NCT02142036|Trastuzumab|trastuzumab|mesh-list
24828042|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828043|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828044|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828119|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24828309|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828310|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24828311|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828445|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828448|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
24447608|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
24447609|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24828581|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828692|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
24828742|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828743|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722462|NCT01580839|Plasminogen|plasminogen|mesh-list
24828814|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828816|NCT02147925|Metformin|metformin|mesh-list
24828826|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
24828827|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828828|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828829|NCT02147938|Tacrolimus|tacrolimus|mesh-list
24828830|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447752|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447753|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447754|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447755|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
24447756|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447757|NCT00309543|Antidotes|antidotes|mesh-ancestor
24828925|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828926|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828927|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24828928|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24828929|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828930|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24828931|NCT02148393|Estradiol|estradiol|mesh-list
24829223|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24447831|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447832|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24447833|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24447834|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24829596|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725758|NCT01599377|Tofacitinib|tofacitinib|mesh-list
24829598|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
24830199|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
24830200|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24830201|NCT02157792|Gemcitabine|gemcitabine|mesh-list
24830347|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24830348|NCT02158702|Growth Substances|growth substances|mesh-ancestor
24830349|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
24830541|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
24830726|NCT02160704|Enclomiphene|enclomiphene|mesh-list
24830728|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
24830729|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24830815|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24830816|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25373605|NCT04931342|Hormones|hormones|mesh-list
24830817|NCT02161653|Protective Agents|protective agents|mesh-ancestor
24830818|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
24830819|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24830821|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24830921|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830923|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
24449142|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24449143|NCT00314561|Pioglitazone|pioglitazone|mesh-list
24831585|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24832942|NCT02172443|Ipratropium|ipratropium|mesh-list
24832943|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832944|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
24832945|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832947|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24452066|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834505|NCT02179268|Sertraline|sertraline|mesh-list
24834619|NCT02180048|Caffeine|caffeine|mesh-list
24834620|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24834621|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834622|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24452316|NCT00327132|Amoxicillin|amoxicillin|mesh-list
24834655|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835140|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24835141|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24835142|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24835571|NCT02183103|Meloxicam|meloxicam|mesh-list
24836165|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24836166|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24836168|NCT02184299|Prednisone|prednisone|mesh-list
24836169|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836170|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
24836171|NCT02184299|Hormones|hormones|mesh-ancestor
24836175|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836939|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24836993|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24836998|NCT02188394|Bupivacaine|bupivacaine|mesh-list
24837047|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837048|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837049|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837050|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
24837052|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838413|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24838414|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
24841092|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
24842351|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842352|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842650|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24842651|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842652|NCT02222519|Bromides|bromides|mesh-list
24843081|NCT02225548|Tadalafil|tadalafil|mesh-list
24843480|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843482|NCT02227901|Tipifarnib|tipifarnib|mesh-list
24755890|NCT01729897|Fentanyl|fentanyl|mesh-list
24843645|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843646|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24843647|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24843648|NCT02228512|Growth Substances|growth substances|mesh-ancestor
24844439|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
24845125|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
24845762|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24845999|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846000|NCT02240459|Urological Agents|urological agents|mesh-ancestor
24846180|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
24846181|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846183|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24846184|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846185|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24846186|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24846774|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24846775|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
24846776|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
24846831|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24847413|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
24847414|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24847415|NCT02246855|Antibodies|antibodies|mesh-list
24847416|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
24847619|NCT02248142|Protective Agents|protective agents|mesh-ancestor
24847636|NCT02248168|Pramipexole|pramipexole|mesh-list
24847638|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847639|NCT02248168|Protective Agents|protective agents|mesh-ancestor
24847640|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488426|NCT00468533|Aripiprazole|aripiprazole|mesh-list
24488427|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
24488428|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24488429|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24488430|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24488431|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488432|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849386|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849417|NCT02248584|Protective Agents|protective agents|mesh-ancestor
24489490|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849470|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849471|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24849472|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24849473|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24849474|NCT02248792|Methotrexate|methotrexate|mesh-list
24849475|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24849476|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
24849800|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454179|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454180|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24454181|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491586|NCT00483093|Cisplatin|cisplatin|mesh-list
24491609|NCT00483158|Finafloxacin|finafloxacin|mesh-list
24849919|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849920|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849921|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24849922|NCT02251132|Ritonavir|ritonavir|mesh-list
24849923|NCT02251132|Erythromycin|erythromycin|mesh-list
24849924|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
24849925|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24849926|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
24444590|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493398|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24493399|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
24493400|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
24493401|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
24494870|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494872|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494873|NCT00497328|Antidotes|antidotes|mesh-ancestor
24851489|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24812254|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24495728|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495729|NCT00501722|Satavaptan|satavaptan|mesh-list
24851553|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851554|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24496499|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445317|NCT00301223|Pregabalin|pregabalin|mesh-list
24445318|NCT00301223|Analgesics|analgesics|mesh-ancestor
24445319|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
24445320|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445321|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445322|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
24445323|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24445324|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24496835|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24496836|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
24496837|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24445816|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24445817|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24445837|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812329|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812330|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812331|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24812332|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
24812333|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24812336|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
24445872|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24445873|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24445874|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24445875|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24589453|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
24589454|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24589455|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589629|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589630|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
24589631|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
24589632|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24589633|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591036|NCT00914693|Progestins|progestins|mesh-ancestor
24591856|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591857|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591858|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591859|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24591860|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24591861|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24594149|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24594150|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594988|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
24595051|NCT00936676|Protective Agents|protective agents|mesh-ancestor
24595052|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597596|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597597|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597598|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597599|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597600|NCT00950196|Analgesics|analgesics|mesh-ancestor
24597711|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
24598590|NCT00956748|Protective Agents|protective agents|mesh-ancestor
24598591|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24598677|NCT00957216|Ubiquinone|ubiquinone|mesh-list
24599247|NCT04919369|Tretinoin|tretinoin|mesh-list
24601377|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24853172|NCT02266329|Prazosin|prazosin|mesh-list
24601425|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24602923|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
24604442|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604525|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604526|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605290|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605291|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606705|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606706|NCT00991783|Protective Agents|protective agents|mesh-ancestor
24606707|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923241|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923242|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
24923243|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
24923244|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24923245|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924047|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
24924048|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924049|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500374|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523201|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925210|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925212|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
24925213|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925214|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925793|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925801|NCT04147754|Morphine|morphine|mesh-list
24925949|NCT04145856|Emollients|emollients|mesh-ancestor
24925950|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
24925951|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
24925952|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
24925953|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925958|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
24925959|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24925961|NCT04145804|Insulin|insulin|mesh-list
25373833|NCT04924101|Lenvatinib|lenvatinib|mesh-list
24502973|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24502974|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24502975|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502976|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927192|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24927193|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
24927194|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624591|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24624593|NCT01076842|Hormones|hormones|mesh-ancestor
24624595|NCT01076868|Primaquine|primaquine|mesh-list
24526438|NCT00611689|Vatalanib|vatalanib|mesh-list
24928616|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928617|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24928618|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624695|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24624697|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624699|NCT01077752|Acetaminophen|acetaminophen|mesh-list
24528326|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
24930217|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
24930219|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931137|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407676|NCT00175032|Lansoprazole|lansoprazole|mesh-list
24529453|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529459|NCT00626080|Insulin|insulin|mesh-list
24933229|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24934421|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24934793|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24935027|NCT04055480|Insulin|insulin|mesh-list
24935078|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
24531094|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24531095|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
24531096|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531097|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531098|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531099|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24531100|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531102|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531497|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531498|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531499|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532091|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24532092|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24532093|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24669787|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24455647|NCT00328393|Pioglitazone|pioglitazone|mesh-list
24455668|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455669|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416425|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24456718|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456003|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24456168|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456169|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24456170|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24456171|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515314|NCT00596219|Celecoxib|celecoxib|mesh-list
24456213|NCT00330707|Interferons|interferons|mesh-list
24449619|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24538361|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24456763|NCT00332137|Urological Agents|urological agents|mesh-ancestor
24539681|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
24539682|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539979|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539980|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
24546980|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24546981|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546983|NCT00701623|Calcium heparin|calcium heparin|mesh-list
24547015|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
24547016|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547017|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24449846|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
24449847|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24449848|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
24449849|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24449850|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449851|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
24466235|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
24456899|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24456900|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24456901|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24456902|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467395|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24467397|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424026|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
24424027|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424028|NCT00227682|Protective Agents|protective agents|mesh-ancestor
24424029|NCT00227682|Vitamins|vitamins|mesh-ancestor
24478275|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
24478369|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478371|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
24478372|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24478373|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24478374|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478375|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479262|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479263|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479264|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479265|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
24457096|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24457097|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24520869|NCT05288777|Trastuzumab|trastuzumab|mesh-list
24520870|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24520871|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24520872|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
24520873|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481093|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24481094|NCT00433277|Cyclosporins|cyclosporins|mesh-list
24481095|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481098|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
24482032|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24482033|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
24482034|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482035|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
24482036|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432492|NCT00254930|Risperidone|risperidone|mesh-list
24482961|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482962|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483014|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
24457312|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457313|NCT00333996|Dexamethasone|dexamethasone|mesh-list
24457314|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426702|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483407|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483408|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
24483486|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491953|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24495399|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
24495433|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495435|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
24495436|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24495468|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
24495469|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502000|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502001|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24502002|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24502903|NCT04049799|Analgesics|analgesics|mesh-ancestor
24512929|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512959|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524887|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
24524888|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24524889|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
24527889|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
24527891|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528086|NCT00619671|Rituximab|rituximab|mesh-list
24529442|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529443|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
24529454|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530923|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24530956|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530957|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530958|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530959|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532466|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532467|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24532468|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532556|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532884|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24457947|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24457951|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24457952|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
24457953|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
24457954|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457955|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701620|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703563|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24703564|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24703565|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24703566|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703567|NCT01472406|Pancrelipase|pancrelipase|mesh-list
24703568|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703569|NCT01472497|Pioglitazone|pioglitazone|mesh-list
24703572|NCT01472510|Ranibizumab|ranibizumab|mesh-list
24704646|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704648|NCT01479504|Docetaxel|docetaxel|mesh-list
24704650|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704651|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
24704652|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
24704653|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705178|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705179|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705180|NCT01482559|Protective Agents|protective agents|mesh-ancestor
24705181|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
24705182|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24705183|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
24705184|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705185|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
24705620|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24706738|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706739|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24706740|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24708060|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708108|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708109|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24708110|NCT01500018|Phentermine|phentermine|mesh-list
24708111|NCT01500018|Ketamine|ketamine|mesh-list
24708112|NCT01500018|Analgesics|analgesics|mesh-ancestor
24708113|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
24708114|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708389|NCT01501149|Pegaspargase|pegaspargase|mesh-list
24708390|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708397|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
24708398|NCT01501149|Hormones|hormones|mesh-ancestor
24708399|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708400|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24708401|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24614025|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708596|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708597|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708598|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
24708599|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24708600|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24708601|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24708602|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24710334|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
24614330|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614331|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
24712045|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24713254|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713256|NCT01524809|Insulin|insulin|mesh-list
24713967|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615015|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
24719022|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
24719023|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719024|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721295|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24722617|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24722618|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24722619|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24722620|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725761|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725762|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
24731068|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736024|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
24618002|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24740580|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24740581|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24740582|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740704|NCT01689987|Sirolimus|sirolimus|mesh-list
24741693|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24741695|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
24742791|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742792|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24743420|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
24743511|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24743599|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743601|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24743602|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743606|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
24751730|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24751731|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24751732|NCT01705769|Micronutrients|micronutrients|mesh-list
24751856|NCT01706874|Listerine|listerine|mesh-list
24751857|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24751858|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751859|NCT01706887|Amiloride|amiloride|mesh-list
24751860|NCT01706887|Diuretics|diuretics|mesh-ancestor
24751861|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
24751862|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751864|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24619216|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619217|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24619218|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24619219|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619220|NCT01051427|Hemostatics|hemostatics|mesh-list
24619221|NCT01051427|Surgiflo|surgiflo|mesh-list
24619222|NCT01051427|Coagulants|coagulants|mesh-ancestor
24619223|NCT01051479|Choline|choline|mesh-list
24619226|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
24752725|NCT01711697|Paclitaxel|paclitaxel|mesh-list
24619257|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619258|NCT01051648|Triamcinolone|triamcinolone|mesh-list
24619259|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24619260|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24619286|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753235|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24753236|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
24753679|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543973|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
24753758|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753759|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753887|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24753888|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753889|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
24619645|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24619646|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
24756835|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756836|NCT01736020|Analgesics|analgesics|mesh-ancestor
24756875|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756876|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24421592|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756877|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
24756878|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
24756879|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24756880|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24756881|NCT01736410|Trastuzumab|trastuzumab|mesh-list
24756950|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757653|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757654|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757655|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24757658|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757669|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24757671|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24757672|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
24757673|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
24757701|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
24757903|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
24757904|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757905|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24757997|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757998|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757999|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24758022|NCT01743300|Growth Substances|growth substances|mesh-ancestor
24758833|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24396245|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404160|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404194|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24405079|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459913|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
24408360|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414202|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414203|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414374|NCT00197340|Ropivacaine|ropivacaine|mesh-list
24415811|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415813|NCT00201305|Gemcitabine|gemcitabine|mesh-list
24423954|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423955|NCT00227513|Bortezomib|bortezomib|mesh-list
24430001|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
24431971|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431974|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
24441371|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
24441372|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24441373|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460991|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553288|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24554289|NCT00735280|Calcium heparin|calcium heparin|mesh-list
24554290|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
24554291|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24554292|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24554293|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554294|NCT00735345|Docetaxel|docetaxel|mesh-list
24555499|NCT00741780|Plerixafor|plerixafor|mesh-list
24555500|NCT00741780|Lenograstim|lenograstim|mesh-list
24557032|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24557033|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
24557034|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557035|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562596|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24562634|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24562637|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
24562709|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24562710|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24564941|NCT00778232|Gabapentin|gabapentin|mesh-list
24568899|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24571547|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24571548|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
24571549|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571550|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574268|NCT00824785|Epirubicin|epirubicin|mesh-list
24575341|NCT00830856|Lamivudine|lamivudine|mesh-list
24575342|NCT00830856|Nevirapine|nevirapine|mesh-list
24577112|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374211|NCT04912765|Nivolumab|nivolumab|mesh-list
24577115|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577122|NCT00842114|Prednisone|prednisone|mesh-list
24577125|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577126|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
24577136|NCT00842114|Hormones|hormones|mesh-ancestor
24580619|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24580620|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24580947|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583772|NCT00876850|Linezolid|linezolid|mesh-list
24587150|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24590057|NCT00910442|Antidotes|antidotes|mesh-ancestor
24592009|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24592010|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
24592012|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
24592013|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
24592014|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592015|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598449|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598451|NCT00956189|Amisulpride|amisulpride|mesh-list
24598452|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
24598453|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24598454|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24813606|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813607|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
24813609|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24813611|NCT02059655|Bimatoprost|bimatoprost|mesh-list
24813612|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24813613|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24543427|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24863610|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863611|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
24863612|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863617|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
24863622|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
24863623|NCT04182997|Hormones|hormones|mesh-ancestor
24863624|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863625|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24863682|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24863683|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24863684|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863685|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
24863686|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863688|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863708|NCT03599635|Bupivacaine|bupivacaine|mesh-list
24863993|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813832|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
24813833|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813834|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813836|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24813837|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813838|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813839|NCT02060656|Gemcitabine|gemcitabine|mesh-list
24813840|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
24813841|NCT02060656|Rituximab|rituximab|mesh-list
24864206|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864207|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864208|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24864209|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
24813859|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813860|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
24813861|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
24813862|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864405|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
24864406|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
24864430|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864431|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544349|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544350|NCT00688558|Simvastatin|simvastatin|mesh-list
24544351|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
24813898|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813900|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24813901|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813902|NCT02060929|Esketamine|esketamine|mesh-list
24813903|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
24864670|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24864671|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864672|NCT02802566|Vitamins|vitamins|mesh-list
24864675|NCT02799641|Lidocaine|lidocaine|mesh-list
24864760|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864761|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24864764|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24865032|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24865033|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865034|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24865035|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
24865036|NCT04920942|Ivermectin|ivermectin|mesh-list
24865037|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24545303|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
24865446|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865447|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24865448|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24865485|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865488|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865633|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24866201|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866202|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24866203|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24546232|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866209|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24866210|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866933|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867008|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867009|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867010|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867011|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867012|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24867013|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24446387|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24867496|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867986|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867987|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24867988|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867989|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24868589|NCT04194814|Betamethasone|betamethasone|mesh-list
24868882|NCT05158699|Phenylephrine|phenylephrine|mesh-list
24868883|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24868885|NCT05158699|BB 1101|bb 1101|mesh-list
24868930|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24868931|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24868932|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868933|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24869041|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24869175|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
24869176|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
24869177|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869178|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869267|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869268|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869269|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24814682|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24814683|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24814684|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24814685|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
24814689|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
24814690|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814691|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24814692|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24814693|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869514|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
24871546|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
24872056|NCT05399576|Nicorandil|nicorandil|mesh-list
24872057|NCT05399576|Verapamil|verapamil|mesh-list
24872058|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24872059|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24872060|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24815121|NCT02068209|Narcotics|narcotics|mesh-ancestor
24872228|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
24872857|NCT05439772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872858|NCT05439772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24873147|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24815177|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
24815178|NCT02068560|Coagulants|coagulants|mesh-ancestor
24815179|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24815180|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
24875209|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
24878160|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878507|NCT01587352|Vorinostat|vorinostat|mesh-list
24878508|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878544|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880187|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880188|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880285|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24880286|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881075|NCT03083405|Opipramol|opipramol|mesh-list
24881235|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
24881236|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
24881237|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881238|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
24881517|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
24881641|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24881642|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881643|NCT01887522|Vinblastine|vinblastine|mesh-list
24881644|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24882001|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882002|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882027|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882028|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882029|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
24882030|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882311|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882312|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24882682|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24882683|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882685|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882686|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882687|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24882753|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24816163|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
24816164|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816165|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24816166|NCT02074605|Interferons|interferons|mesh-list
24816167|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
24816169|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
24883154|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24883155|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883215|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
24883216|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883218|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24883916|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883917|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883918|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24883919|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24883920|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
24883921|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883986|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
24883987|NCT03730662|Tirzepatide|tirzepatide|mesh-list
24883988|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24505450|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24506634|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506635|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506717|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24506718|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24507468|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25374443|NCT04905654|Cromakalim|cromakalim|mesh-list
24507469|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507601|NCT00551096|Gemcitabine|gemcitabine|mesh-list
24507602|NCT00551096|Capecitabine|capecitabine|mesh-list
24507603|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24507604|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
24507605|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884756|NCT03629340|Metformin|metformin|mesh-list
24612387|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
24510774|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24885829|NCT04448717|Antibodies|antibodies|mesh-list
24464898|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887901|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24888119|NCT04508829|Antibodies|antibodies|mesh-list
24516363|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889404|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
24890014|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
24513224|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513225|NCT00579995|Antidotes|antidotes|mesh-ancestor
24513267|NCT00580320|Bortezomib|bortezomib|mesh-list
24890051|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24890053|NCT04486430|Analgesics|analgesics|mesh-ancestor
24890054|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
24890055|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890791|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24890793|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890794|NCT04479748|Dexamethasone|dexamethasone|mesh-list
24890795|NCT04479748|Prednisolone|prednisolone|mesh-list
24890796|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24890797|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
24890798|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24816856|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816857|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816858|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816859|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816861|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891247|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24891248|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891249|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24891250|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
24891269|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24891270|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
24891271|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891272|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891653|NCT04468139|Vitamins|vitamins|mesh-ancestor
24891654|NCT04468139|Micronutrients|micronutrients|mesh-ancestor
24891655|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891681|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
24891682|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891685|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24891686|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891687|NCT04468282|Vigabatrin|vigabatrin|mesh-list
24891792|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891793|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24891795|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
24892169|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
24513550|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513557|NCT00583349|Paclitaxel|paclitaxel|mesh-list
24892603|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892958|NCT04456712|Renal Agents|renal agents|mesh-ancestor
24471575|NCT00395941|Acitretin|acitretin|mesh-list
24894506|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
24894507|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894546|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
24894547|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
24894550|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
24894619|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894620|NCT04438733|Anastrozole|anastrozole|mesh-list
24894621|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24817257|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817258|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24817259|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817260|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24817261|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24817262|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24817263|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817264|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895127|NCT04955470|Analgesics|analgesics|mesh-ancestor
24895128|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
24895129|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895130|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895131|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24895134|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
24895317|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895318|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895320|NCT04537715|Rifampin|rifampin|mesh-list
24895321|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
24895322|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514981|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514982|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24514983|NCT00593710|Losartan|losartan|mesh-list
24514984|NCT00593710|Atenolol|atenolol|mesh-list
24514985|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24514986|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24515034|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895707|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895708|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895709|NCT03467113|Cannabidiol|cannabidiol|mesh-list
24895710|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
24895711|NCT03453684|Vancomycin|vancomycin|mesh-list
24895712|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24895713|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895827|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24895828|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24895829|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
24895830|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895831|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
24895832|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895833|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24895834|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25374600|NCT04902378|Insulin|insulin|mesh-list
24895898|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895899|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895900|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24895901|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24515407|NCT00596804|Veltuzumab|veltuzumab|mesh-list
24515408|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895974|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24895975|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24895976|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
24524597|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515504|NCT00598091|Gemcitabine|gemcitabine|mesh-list
24515505|NCT00598091|Dasatinib|dasatinib|mesh-list
24515506|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24515507|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
24896068|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24817444|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817451|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
24515701|NCT00598858|Prednisone|prednisone|mesh-list
24473566|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24516090|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516096|NCT00600600|Tigecycline|tigecycline|mesh-list
24896787|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896788|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24896789|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
24896790|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897129|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897130|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24897131|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897132|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516572|NCT00602498|Clarithromycin|clarithromycin|mesh-list
24478964|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
24516640|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516641|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
24516642|NCT00602693|Sirolimus|sirolimus|mesh-list
24516649|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516650|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24516686|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516687|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24516688|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
24516689|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
24516690|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516692|NCT00602849|Sertraline|sertraline|mesh-list
24516739|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516740|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
24516741|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516742|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897827|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
24897828|NCT04421742|Hormones|hormones|mesh-ancestor
24897829|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898285|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24898286|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24898324|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24475665|NCT00411034|Analgesics|analgesics|mesh-ancestor
24899029|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476205|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
24476343|NCT00414323|Citalopram|citalopram|mesh-list
24899585|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24899586|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24518385|NCT05132595|Esketamine|esketamine|mesh-list
24900750|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901006|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24901009|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901051|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24518776|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
24901583|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901584|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901585|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901586|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24901587|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
24482882|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519139|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519140|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24519143|NCT03245892|Carboplatin|carboplatin|mesh-list
24901904|NCT04380298|Analgesics|analgesics|mesh-ancestor
24902298|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24519278|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902310|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
24902311|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
24902312|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902313|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902430|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24902431|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902432|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24902433|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24902434|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24902481|NCT04373083|Cemiplimab|cemiplimab|mesh-list
24902482|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24902483|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902511|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
24818263|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24818264|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903117|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
24903118|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
24903119|NCT04366726|Abaloparatide|abaloparatide|mesh-list
24903120|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24903121|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903294|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904231|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904233|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24904234|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
24904235|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904597|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
24904850|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904851|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24904852|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24905703|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
24905704|NCT04345588|Hormones|hormones|mesh-ancestor
24905705|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905706|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24905984|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905985|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481676|NCT00436371|Amisulpride|amisulpride|mesh-list
24906242|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
24818636|NCT02089867|Ezetimibe|ezetimibe|mesh-list
24818655|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24818656|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
24818659|NCT02090036|Lumefantrine|lumefantrine|mesh-list
24818687|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
24818688|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818689|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818690|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24906636|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24906637|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24906638|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
24482145|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24906639|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24906641|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24906642|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24907000|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24907001|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907002|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907020|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907021|NCT04334512|Antioxidants|antioxidants|mesh-ancestor
24907022|NCT04334512|Protective Agents|protective agents|mesh-ancestor
24907024|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907025|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24907026|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907335|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24907337|NCT04331210|Diclofenac|diclofenac|mesh-list
25374741|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
24907338|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907339|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907341|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
24907342|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907415|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24907416|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907536|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907537|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
24907538|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
24907542|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
24908169|NCT04323514|Protective Agents|protective agents|mesh-ancestor
24908170|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
24908237|NCT04322552|Protective Agents|protective agents|mesh-ancestor
24908254|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24908463|NCT04319978|Dexamethasone|dexamethasone|mesh-list
24908464|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
24909448|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24909449|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24909450|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519589|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519590|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24519642|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519643|NCT05331781|Analgesics|analgesics|mesh-ancestor
24519644|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
24818913|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24818914|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818915|NCT02091830|Analgesics|analgesics|mesh-ancestor
24909669|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910238|NCT04301336|Narcotics|narcotics|mesh-ancestor
24909671|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24909789|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910233|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
24910235|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
24910236|NCT04301336|Simvastatin|simvastatin|mesh-list
24910237|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24910385|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
24910386|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485318|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24485319|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485320|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24485321|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24485322|NCT00452569|Growth Substances|growth substances|mesh-ancestor
24485323|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
24910697|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485450|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485451|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
24910819|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24910820|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24910821|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24910822|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
24910823|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
24485587|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
24911241|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
24911454|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24911455|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
24911457|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912121|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912122|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
24912123|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912124|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24912152|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486813|NCT00460213|Valsartan|valsartan|mesh-list
24912248|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912249|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
24912250|NCT04278547|Valganciclovir|valganciclovir|mesh-list
24912251|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
24912506|NCT04275245|Meplazumab|meplazumab|mesh-list
24913058|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24913112|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913494|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24913495|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
24913496|NCT04264286|Esmolol|esmolol|mesh-list
24915610|NCT04250116|Apixaban|apixaban|mesh-list
24916292|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24916918|NCT04235959|Incretins|incretins|mesh-ancestor
24917617|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24623780|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24623781|NCT01073644|Growth Substances|growth substances|mesh-ancestor
24623782|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616928|NCT01039948|Gefitinib|gefitinib|mesh-list
24617001|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
24617145|NCT01041235|Docetaxel|docetaxel|mesh-list
24918829|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24918830|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918831|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918832|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
24918833|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918834|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742153|NCT05293132|Vitamins|vitamins|mesh-ancestor
24919253|NCT04213170|Bevacizumab|bevacizumab|mesh-list
24919254|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919255|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919256|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24919257|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24920408|NCT04203485|Pemetrexed|pemetrexed|mesh-list
24921021|NCT04195321|Protective Agents|protective agents|mesh-ancestor
24921022|NCT04195074|Tenofovir|tenofovir|mesh-list
24921592|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
24921600|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921601|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921602|NCT04189666|Melatonin|melatonin|mesh-list
24622380|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24602972|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24603578|NCT00974584|Carboplatin|carboplatin|mesh-list
24603579|NCT00974584|Pemetrexed|pemetrexed|mesh-list
24603580|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24603581|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604478|NCT00979706|Interleukin-2|interleukin-2|mesh-list
24605573|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24605574|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24605575|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
24605740|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605741|NCT00987116|Prednisone|prednisone|mesh-list
24609481|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24609482|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
24609483|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
24609484|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
24609485|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
24609486|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609487|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609489|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24609796|NCT00998166|Growth Substances|growth substances|mesh-ancestor
24609797|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609798|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
24609853|NCT00998608|Risperidone|risperidone|mesh-list
24671453|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671456|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
24672097|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
24456534|NCT00331604|Insulin|insulin|mesh-list
24672443|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672444|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
24672462|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24672463|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
24672464|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673179|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673180|NCT01336010|Ribavirin|ribavirin|mesh-list
24673181|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24673182|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
24673184|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
24674945|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24674946|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675362|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24675363|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24675364|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24675365|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
24675366|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675367|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
24675368|NCT00496834|Protective Agents|protective agents|mesh-ancestor
24675371|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
24675612|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675665|NCT01344395|Ropivacaine|ropivacaine|mesh-list
24675836|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675837|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
24675838|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675839|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675842|NCT01345708|Hormones|hormones|mesh-ancestor
24676186|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24676187|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
24676188|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
24676232|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
24637853|NCT01153386|Treprostinil|treprostinil|mesh-list
24676233|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676234|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
24676235|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676523|NCT01350856|Artesunate|artesunate|mesh-list
24677679|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677699|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677700|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677701|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24677702|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24680441|NCT01374750|Cyclosporine|cyclosporine|mesh-list
24682101|NCT01384058|Ezetimibe|ezetimibe|mesh-list
24688545|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24689217|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24689218|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689238|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
24689239|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
24611883|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611884|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24689475|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
24689482|NCT01360593|Gemcitabine|gemcitabine|mesh-list
24690383|NCT01401192|Cisplatin|cisplatin|mesh-list
24690384|NCT01401192|Pemetrexed|pemetrexed|mesh-list
24690385|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690386|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24690387|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
24690918|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24691161|NCT01405235|Paclitaxel|paclitaxel|mesh-list
24692915|NCT01417364|Testosterone|testosterone|mesh-list
24692916|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
24693141|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693142|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24694278|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24694279|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24694280|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694281|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694773|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694775|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694776|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24694777|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24694778|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24612457|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24612458|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24612508|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612509|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24612510|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24612511|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612512|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612513|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612514|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24612515|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
24695534|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695535|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24695536|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24695537|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24695538|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
25374968|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24695539|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695540|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
24695541|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695542|NCT03142035|Dienogest|dienogest|mesh-list
24695801|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695802|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24695803|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24695812|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
24695813|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24695814|NCT01231906|Protective Agents|protective agents|mesh-ancestor
24695997|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695998|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24695999|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24696000|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24696001|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24696002|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24696003|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24696023|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612593|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24612595|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482283|NCT00438386|Aripiprazole|aripiprazole|mesh-list
24696750|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
24696751|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
24696752|NCT01431326|Rocuronium|rocuronium|mesh-list
24696753|NCT01431326|Sevelamer|sevelamer|mesh-list
24696754|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696755|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
24697091|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24697092|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24697148|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
24698178|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698179|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
24698180|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698253|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
24698254|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698580|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
24698597|NCT01442025|Infliximab|infliximab|mesh-list
24698745|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698746|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698747|NCT01442909|Docetaxel|docetaxel|mesh-list
24698748|NCT01442909|Pemetrexed|pemetrexed|mesh-list
24698749|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698750|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
24612914|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
24612978|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612979|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
24612980|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24612981|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24612982|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700171|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24700172|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24700173|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24700175|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
24700176|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700178|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24700179|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24700487|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
24700488|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700490|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
24700491|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24701340|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24701341|NCT01458548|Rituximab|rituximab|mesh-list
24701347|NCT01458600|Diclofenac|diclofenac|mesh-list
24635052|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24638303|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638304|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638305|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
24638732|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638733|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24638734|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24640334|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
24640335|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640336|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24640440|NCT01168063|Amoxicillin|amoxicillin|mesh-list
24640441|NCT01168063|Metronidazole|metronidazole|mesh-list
24640442|NCT01168063|Clarithromycin|clarithromycin|mesh-list
24640443|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24640444|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640445|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
24641878|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
24643079|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
24643080|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643081|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644677|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24644842|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644843|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
24644845|NCT01193452|Antidotes|antidotes|mesh-ancestor
24646367|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646368|NCT01203371|Naftopidil|naftopidil|mesh-list
24648262|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
24648263|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24648264|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24649365|NCT01219686|Citalopram|citalopram|mesh-list
24650043|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24650558|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650559|NCT01226446|Vitamin D|vitamin d|mesh-list
24650560|NCT01226446|Vitamins|vitamins|mesh-ancestor
24650809|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
24651581|NCT01232244|Incretins|incretins|mesh-ancestor
24651656|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
24651657|NCT01232803|Tenofovir|tenofovir|mesh-list
24651658|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
24651659|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651660|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24652187|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24652188|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652189|NCT01236950|Listerine|listerine|mesh-list
24652190|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24652191|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652192|NCT01236963|Listerine|listerine|mesh-list
24653720|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653721|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
24653760|NCT01245582|Sorafenib|sorafenib|mesh-list
24653761|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24653762|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
24670458|NCT02536755|Eliglustat|eliglustat|mesh-list
24653943|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655677|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655678|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655679|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24655680|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655681|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24655682|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655865|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
24655866|NCT01258491|Vitamins|vitamins|mesh-ancestor
24655867|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
24656185|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
24659185|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660325|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
24660326|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660462|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
24660463|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
24660464|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660465|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
24660466|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660467|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660468|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24660469|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
24660471|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660754|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24660755|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24660756|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24660757|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
24660758|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661050|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
24661153|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661154|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662768|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24664275|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24667071|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24667072|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24667073|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667075|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667829|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24667830|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24667831|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534171|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
24534172|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24534173|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534572|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24534573|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534963|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24535792|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
24536533|NCT00651599|Estradiol|estradiol|mesh-list
24536893|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536895|NCT00652821|Tramadol|tramadol|mesh-list
24536896|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24536897|NCT00652821|Narcotics|narcotics|mesh-ancestor
24537152|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
24537153|NCT00653744|Atorvastatin|atorvastatin|mesh-list
24445409|NCT00301535|Chrysarobin|chrysarobin|mesh-list
24451238|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537577|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537578|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
24537579|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537580|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24538253|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538254|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24538255|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538256|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24538928|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539211|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539212|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24539213|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
24539214|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
24539215|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24539861|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24539863|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
24539864|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
24539865|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24539866|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539867|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
24539921|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539922|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24539923|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540013|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540014|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540039|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540040|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24540041|NCT00666393|Fentanyl|fentanyl|mesh-list
24540042|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24540043|NCT00666393|Narcotics|narcotics|mesh-ancestor
24540123|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24540124|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24540125|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540178|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540179|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
24540180|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24540181|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540182|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540183|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
24445177|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24441071|NCT00285896|Incretins|incretins|mesh-ancestor
24445238|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
24444097|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444098|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24444110|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541426|NCT00672763|Vitamin D|vitamin d|mesh-list
24541427|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
24541428|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
24541429|NCT00672763|Vitamins|vitamins|mesh-list
24541430|NCT00672763|Calcium|calcium|mesh-list
24541431|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
24541432|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541435|NCT00672776|Paroxetine|paroxetine|mesh-list
24543287|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543890|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24543891|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24543892|NCT00685854|Growth Substances|growth substances|mesh-ancestor
24543893|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544470|NCT00689169|Rituximab|rituximab|mesh-list
24544981|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24544982|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544984|NCT00691275|Ondansetron|ondansetron|mesh-list
24546116|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545707|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24546462|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24546463|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
24547138|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24547139|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547146|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547147|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24547148|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
24547188|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547189|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547190|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547495|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24547496|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24548843|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24550149|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24550150|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550422|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
24550423|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550424|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550425|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24550426|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24443331|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24443332|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448709|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24448710|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393845|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
24393846|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393847|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393848|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24393849|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
24393965|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394044|NCT00131846|Diuretics|diuretics|mesh-list
24394045|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24394046|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
24463821|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24463823|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
24463897|NCT00362700|Clevudine|clevudine|mesh-list
24464238|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465237|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24465238|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465359|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
24465760|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24465761|NCT00370669|Bevacizumab|bevacizumab|mesh-list
24465762|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24465764|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466225|NCT00372645|Hematinics|hematinics|mesh-ancestor
24466226|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
24466227|NCT00372645|Vitamins|vitamins|mesh-ancestor
24466228|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
24466229|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466351|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466581|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466582|NCT00374075|Valproic Acid|valproic acid|mesh-list
24466583|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
24466584|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466586|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
24466709|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466921|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466922|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466923|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466924|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24467043|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24467044|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467045|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467046|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24467047|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24467048|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
24467049|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
24467061|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467062|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467063|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24467064|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
24467065|NCT00376077|Hormones|hormones|mesh-ancestor
24467066|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467183|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467216|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
24467217|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24467218|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24467219|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24468215|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468217|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468221|NCT00380575|Conivaptan|conivaptan|mesh-list
24468876|NCT00383812|Growth Substances|growth substances|mesh-ancestor
24468877|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468878|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
24468879|NCT00383851|Temozolomide|temozolomide|mesh-list
24468880|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24469019|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469020|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
24469021|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24469022|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24469023|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24469024|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469033|NCT00384410|Nabilone|nabilone|mesh-list
24469307|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469391|NCT00385606|Analgesics|analgesics|mesh-ancestor
24470008|NCT00388401|Alvimopan|alvimopan|mesh-list
24470998|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24471358|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
24471359|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
24471954|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24471955|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
24471956|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471966|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24471967|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
24471968|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
24472357|NCT00398957|Analgesics|analgesics|mesh-ancestor
24472358|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24472625|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24473726|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473727|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473728|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
24473729|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473770|NCT00404183|Hydrocodone|hydrocodone|mesh-list
24473772|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24473773|NCT00404183|Analgesics|analgesics|mesh-ancestor
24473918|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473919|NCT00404456|Protective Agents|protective agents|mesh-ancestor
24473920|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473921|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473922|NCT00404482|Cyclosporine|cyclosporine|mesh-list
24446217|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24474083|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24474084|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
24474085|NCT00404833|Chlorambucil|chlorambucil|mesh-list
24474086|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24446341|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446342|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24474224|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474225|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24474226|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24446486|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24474308|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474309|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24474310|NCT00405496|Difluprednate|difluprednate|mesh-list
24474311|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
24474312|NCT00405496|Hormones|hormones|mesh-ancestor
24474313|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474314|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474315|NCT00405535|Glycine|glycine|mesh-list
24446578|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24446584|NCT00305409|Sulfalene|sulfalene|mesh-list
24446585|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446586|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24446587|NCT00305409|Renal Agents|renal agents|mesh-ancestor
24446588|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
24474750|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
24474751|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474752|NCT00407264|Fluticasone|fluticasone|mesh-list
24474754|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474755|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24474756|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
24474757|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474758|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474759|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24474926|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474927|NCT00408187|Cyclosporine|cyclosporine|mesh-list
24475285|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24475286|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24475287|NCT00409760|Amlodipine|amlodipine|mesh-list
24475288|NCT00409760|Valsartan|valsartan|mesh-list
24475289|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24475290|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24475291|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475293|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24475514|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475515|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475517|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
24475518|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475525|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
24475526|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24475527|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
24475568|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475569|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
24475862|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
24475863|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475864|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475865|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24475867|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
24475868|NCT00411879|Epinephrine|epinephrine|mesh-list
24475869|NCT00411879|Racepinephrine|racepinephrine|mesh-list
24475947|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475949|NCT00412100|Naloxone|naloxone|mesh-list
24475950|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475951|NCT00412100|Narcotics|narcotics|mesh-ancestor
24475952|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446718|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476239|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476240|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476241|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476242|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
24476381|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
24476511|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476513|NCT00415324|Cisplatin|cisplatin|mesh-list
24476645|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476646|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
24476647|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24476648|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24476651|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476666|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
24476974|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24476975|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476976|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
24476977|NCT00416910|Fludarabine|fludarabine|mesh-list
24476978|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
24476979|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476980|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
24476981|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477101|NCT00417222|Olmesartan|olmesartan|mesh-list
24477150|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477151|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477152|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24477153|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
24477154|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477155|NCT00417677|Sirolimus|sirolimus|mesh-list
24477156|NCT00417677|Sunitinib|sunitinib|mesh-list
24477838|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477840|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
24477842|NCT00420537|Cyclosporins|cyclosporins|mesh-list
24477843|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477844|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477845|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477846|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
24477847|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477900|NCT00420667|Enoxaparin|enoxaparin|mesh-list
24477901|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
24477902|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24477958|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477959|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477960|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24477961|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24477962|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477964|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477966|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477967|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
24477968|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478361|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
24478362|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478363|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24478384|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
24478385|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
24478386|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24478387|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
24478767|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478768|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478769|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
24479200|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24479201|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479202|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
24479203|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24479204|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24479205|NCT00425997|Diuretics|diuretics|mesh-ancestor
24479228|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479362|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479366|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
24479367|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
24479368|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
24479369|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479370|NCT00426595|Omeprazole|omeprazole|mesh-list
24479371|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24479372|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479499|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479501|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24479502|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24479513|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479928|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479929|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479931|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479933|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479939|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479940|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480229|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480230|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24480231|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24480232|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24480233|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480234|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480236|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
24480622|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24480624|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480939|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480940|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24481514|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482059|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
24482080|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482082|NCT00437892|Atorvastatin|atorvastatin|mesh-list
24482083|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24482084|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24482085|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
24482090|NCT00437918|Acarbose|acarbose|mesh-list
24482620|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
24482621|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482622|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482623|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24482800|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24482801|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482802|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
24482803|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
24482804|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
24482805|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482807|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482808|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24482809|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
24482996|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
24482997|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482998|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24482999|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24483000|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483001|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483002|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24483059|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24483060|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
24483720|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483759|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24484207|NCT00447031|Bevacizumab|bevacizumab|mesh-list
24484208|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24484209|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24434821|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24484731|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485386|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
24485387|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485388|NCT00452881|Gemcitabine|gemcitabine|mesh-list
24485757|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485928|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24486027|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486028|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487173|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24487174|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
24487175|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487176|NCT00461890|Naltrexone|naltrexone|mesh-list
24487177|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24487178|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24487335|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487336|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24487337|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24487338|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24487339|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487912|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24487913|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24487914|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
24487924|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24487925|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
24488209|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488210|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488211|NCT00467181|Fenoldopam|fenoldopam|mesh-list
24488212|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24488213|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
24488214|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
24488215|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
24488216|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488903|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24488904|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
24488905|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24488906|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491217|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24491218|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
24491259|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24491260|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491711|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491712|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
24491713|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24491714|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491715|NCT00483782|Paclitaxel|paclitaxel|mesh-list
24491814|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24491815|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
24493581|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24494580|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
24495541|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
24497738|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24500830|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500831|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24500962|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
24500963|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
24500964|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500965|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24500966|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500967|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24501935|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24501936|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501937|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501947|NCT00531687|Paclitaxel|paclitaxel|mesh-list
24502374|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24502375|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502376|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24502652|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
24502693|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
24502694|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
24502695|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
24502696|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502697|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502698|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
24502699|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502700|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24502701|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24502995|NCT03924440|Nonoxynol|nonoxynol|mesh-list
24502996|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24502997|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24503000|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
24503001|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24503002|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24503003|NCT03741530|Glyburide|glyburide|mesh-list
24503004|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24503005|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503062|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503256|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503258|NCT02384850|Protective Agents|protective agents|mesh-ancestor
24503260|NCT02384850|Vitamins|vitamins|mesh-ancestor
24503532|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24503533|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24503534|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24503535|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24503536|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24503540|NCT00532194|Cediranib|cediranib|mesh-list
24503665|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24503692|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503693|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503694|NCT00532662|Ketamine|ketamine|mesh-list
24503776|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503938|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462425|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
24462426|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629237|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629238|NCT01103817|Vitamin D|vitamin d|mesh-list
24629239|NCT01103817|Vitamins|vitamins|mesh-ancestor
24629240|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
24630052|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630923|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
24631797|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24632232|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632234|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24632288|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24632289|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24632290|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24632292|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632293|NCT01123057|Riboflavin|riboflavin|mesh-list
24632294|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
24632295|NCT01123057|Vitamins|vitamins|mesh-ancestor
24633576|NCT01130077|Poly ICLC|poly iclc|mesh-list
24633577|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
24633581|NCT01130181|Vitamin D|vitamin d|mesh-list
25375653|NCT04872608|Letrozole|letrozole|mesh-list
24395290|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395291|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24395292|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
24395293|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395294|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395295|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24396066|NCT00137761|Docetaxel|docetaxel|mesh-list
24396722|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24398543|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398551|NCT00144846|Albuterol|albuterol|mesh-list
24398561|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24398562|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24398563|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
24398564|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403433|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
24403434|NCT00160342|Estrogens|estrogens|mesh-list
24403435|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
24403436|NCT00160342|Estrone|estrone|mesh-list
24403437|NCT00160342|Testosterone|testosterone|mesh-list
24403469|NCT00160407|Orlistat|orlistat|mesh-list
24451577|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451578|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404972|NCT00165204|Hormones|hormones|mesh-ancestor
24406268|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406269|NCT00169559|Fenofibrate|fenofibrate|mesh-list
24406270|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24406271|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
24406272|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505137|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
24407527|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407534|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24407942|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
24407943|NCT00175955|Levetiracetam|levetiracetam|mesh-list
24407944|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
24407945|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
24409633|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409634|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
24409635|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409636|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409637|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409698|NCT00182715|Vitamins|vitamins|mesh-ancestor
24410243|NCT00184938|Morphine|morphine|mesh-list
24410247|NCT00184938|Narcotics|narcotics|mesh-ancestor
24410248|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24410249|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410250|NCT00184938|Analgesics|analgesics|mesh-ancestor
24410931|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
24410932|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410933|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410934|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410935|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
24410937|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411964|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412411|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412412|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24412413|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24412414|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24412415|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24412416|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412436|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24412753|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
24412754|NCT00191971|Gemcitabine|gemcitabine|mesh-list
24412755|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412756|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
24412766|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
24412767|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
24413287|NCT00193466|Fludarabine|fludarabine|mesh-list
24413293|NCT00193505|Rituximab|rituximab|mesh-list
24413306|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413840|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
24413841|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413842|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413843|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413844|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413845|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24413846|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413865|NCT00195481|Sirolimus|sirolimus|mesh-list
24414307|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
24414308|NCT00196859|Capecitabine|capecitabine|mesh-list
24414309|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414310|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
24414312|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414318|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
24414337|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
24414344|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414345|NCT00197080|Ropinirole|ropinirole|mesh-list
24415295|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
24415296|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416511|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416512|NCT00203320|Etanercept|etanercept|mesh-list
24416513|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24416514|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24416570|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416571|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416572|NCT00203450|Zonisamide|zonisamide|mesh-list
24416704|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
24416705|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416714|NCT00203801|Artesunate|artesunate|mesh-list
24418209|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24418211|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
24418213|NCT00208923|Fludarabine|fludarabine|mesh-list
24418260|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24418261|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418265|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419077|NCT00211016|Doripenem|doripenem|mesh-list
24419078|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419079|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419080|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
24419081|NCT00211120|Hematinics|hematinics|mesh-ancestor
24419122|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24420146|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420147|NCT00215267|Praziquantel|praziquantel|mesh-list
24420148|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
24420149|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24420150|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420152|NCT00215280|Albendazole|albendazole|mesh-list
24420235|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420237|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420238|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420380|NCT00215839|Ribavirin|ribavirin|mesh-list
24420683|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24420754|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420755|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420756|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420757|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420758|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
24420759|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
24420765|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24420818|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420819|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420821|NCT00216866|Tinzaparin|tinzaparin|mesh-list
24420822|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24422959|NCT00224302|Analgesics|analgesics|mesh-ancestor
24425745|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
24428915|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430202|NCT00246402|Acipimox|acipimox|mesh-list
24436646|NCT00270777|Promethazine|promethazine|mesh-list
24436647|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
24436648|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
24436649|NCT00270777|Epinephrine|epinephrine|mesh-list
24436650|NCT00270777|Racepinephrine|racepinephrine|mesh-list
24436651|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
24437638|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24437639|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437640|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
24437641|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437642|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
24437643|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437644|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437645|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24438287|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24438288|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438422|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24438423|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
24438424|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
24438426|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25375798|NCT04868760|Ipilimumab|ipilimumab|mesh-list
24438459|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438460|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
24438461|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439824|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
24439825|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24439826|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24439828|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
24439829|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440348|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24440349|NCT00282503|Prednisolone|prednisolone|mesh-list
24440351|NCT00282503|Methoxsalen|methoxsalen|mesh-list
24441147|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24441189|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441272|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
24442891|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24442892|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
24442893|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24442894|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442895|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24442896|NCT00293150|Diuretics|diuretics|mesh-ancestor
24442897|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
24443316|NCT00294463|Progestins|progestins|mesh-ancestor
24443317|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
24443318|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
24527395|NCT00616382|Protective Agents|protective agents|mesh-ancestor
24443789|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24443806|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24443884|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24443885|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443886|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24443887|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24443888|NCT00296062|Growth Substances|growth substances|mesh-ancestor
24447078|NCT00307502|Ritonavir|ritonavir|mesh-list
24447091|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24447102|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24447103|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24447486|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447487|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447490|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447491|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447493|NCT00308607|Interferons|interferons|mesh-list
24448185|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24448186|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24448187|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448188|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448289|NCT00311051|Ramatroban|ramatroban|mesh-list
24449271|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
24449272|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
24449273|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449274|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449275|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449277|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24449278|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24450818|NCT00320697|Bupropion|bupropion|mesh-list
24453017|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24454037|NCT04507412|Dexamethasone|dexamethasone|mesh-list
24444418|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444865|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445043|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445044|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24445045|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24445049|NCT00300131|Everolimus|everolimus|mesh-list
24445907|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
24445908|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446030|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446033|NCT00303732|Everolimus|everolimus|mesh-list
24446034|NCT00303732|Vatalanib|vatalanib|mesh-list
24446035|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446036|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446096|NCT00303784|Hormones|hormones|mesh-ancestor
24446097|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446103|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446104|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24446105|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446369|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446371|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24446372|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24446374|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446443|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446444|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446445|NCT00304772|Fluconazole|fluconazole|mesh-list
24446446|NCT00304772|Micafungin|micafungin|mesh-list
24446707|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446747|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24505387|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505388|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505389|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24505390|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24505984|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505986|NCT00543634|Hormones|hormones|mesh-ancestor
24506154|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24506155|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
24506156|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506531|NCT00545831|Taurolidine|taurolidine|mesh-list
24506532|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506533|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24506534|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506535|NCT00545857|Pioglitazone|pioglitazone|mesh-list
24506536|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507682|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507684|NCT00551343|Exenatide|exenatide|mesh-list
24508374|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24509101|NCT00558480|Protective Agents|protective agents|mesh-ancestor
24509102|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24509103|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509105|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
24509106|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509107|NCT00558506|Abatacept|abatacept|mesh-list
24509108|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24509110|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509742|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511949|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24511950|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
24511951|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511952|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24511953|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511954|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
24511955|NCT00571740|Antidotes|antidotes|mesh-ancestor
24511958|NCT00571740|Vitamins|vitamins|mesh-ancestor
24512172|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24512190|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512191|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24512192|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
24512193|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512218|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512219|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24513349|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24513351|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513353|NCT00580905|Nitroprusside|nitroprusside|mesh-list
24514004|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
24514005|NCT00587119|Hormones|hormones|mesh-ancestor
24514006|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514007|NCT00587145|Docetaxel|docetaxel|mesh-list
24514008|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515175|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24515315|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24515316|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24515317|NCT00596219|Analgesics|analgesics|mesh-ancestor
24515318|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
24516518|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516519|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516832|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24517407|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517408|NCT00607750|Mecamylamine|mecamylamine|mesh-list
24517905|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24517906|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517909|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24517910|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
24517915|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517943|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24517955|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24519720|NCT05242874|Aprepitant|aprepitant|mesh-list
24519987|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24520059|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24520064|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520066|NCT03980769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520067|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24520564|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
24520565|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24520566|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520567|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521275|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24521276|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521277|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521278|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
24521279|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
24521280|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521818|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24521819|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521820|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24521821|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521822|NCT04480190|Gemcitabine|gemcitabine|mesh-list
24521823|NCT04480190|Fluorouracil|fluorouracil|mesh-list
24521824|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521825|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521826|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
24523410|NCT00887536|Bevacizumab|bevacizumab|mesh-list
24523411|NCT00887536|Docetaxel|docetaxel|mesh-list
24523412|NCT00887536|Doxorubicin|doxorubicin|mesh-list
24523413|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523414|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
24523415|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523416|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523489|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
24524297|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524298|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524299|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24524300|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
24526557|NCT00612157|Eszopiclone|eszopiclone|mesh-list
24526563|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
24526593|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526594|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
24526595|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24526596|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24526597|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24526657|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
24527469|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527470|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24527471|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24527472|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527473|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527474|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24527475|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24528455|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
24528456|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
24529548|NCT00626665|Tadalafil|tadalafil|mesh-list
24530702|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530705|NCT00631943|Analgesics|analgesics|mesh-ancestor
24531418|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
24531446|NCT00635921|Ziprasidone|ziprasidone|mesh-list
24531475|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24531476|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
24531477|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
24531478|NCT00636038|Beta Carotene|beta carotene|mesh-list
24531643|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
24531907|NCT00637559|Esomeprazole|esomeprazole|mesh-list
24531943|NCT00637637|Ritonavir|ritonavir|mesh-list
24531996|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531997|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
24531998|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532240|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24532241|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24532369|NCT00639587|Ketotifen|ketotifen|mesh-list
24532810|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532811|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532812|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
24532813|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532814|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24532815|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
24532816|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24532817|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24533074|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24533075|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
24533076|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
24533077|NCT00642161|Hormones|hormones|mesh-ancestor
24533078|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533079|NCT00642187|Budesonide|budesonide|mesh-list
24449878|NCT00317408|Dexamethasone|dexamethasone|mesh-list
24450208|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450209|NCT00317993|Simvastatin|simvastatin|mesh-list
24450211|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24450474|NCT00319306|Budesonide|budesonide|mesh-list
24450554|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450555|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24450556|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24450736|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450737|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450738|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450739|NCT00320307|Abacavir|abacavir|mesh-list
24450740|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24450951|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451283|NCT00323011|Folic Acid|folic acid|mesh-list
24451302|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24451303|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451304|NCT00323011|Antidotes|antidotes|mesh-ancestor
24451305|NCT00323011|Protective Agents|protective agents|mesh-ancestor
24451659|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451660|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24451661|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24451662|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451663|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24451664|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24451665|NCT00324467|Protective Agents|protective agents|mesh-ancestor
24451666|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25335114|NCT04085458|Coagulants|coagulants|mesh-ancestor
25339539|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
25339540|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
25339541|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
25339542|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339543|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25339546|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
25343000|NCT05556616|Daratumumab|daratumumab|mesh-list
25343001|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
25343002|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343003|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25343004|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25343076|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343077|NCT05556005|Trimetazidine|trimetazidine|mesh-list
25343078|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
25343087|NCT05555888|Capecitabine|capecitabine|mesh-list
25343088|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
25343089|NCT05555888|Antibodies|antibodies|mesh-list
25343090|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
25343091|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343158|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343159|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343160|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25343162|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
25343163|NCT05555641|Nafamostat|nafamostat|mesh-list
25343164|NCT05555641|Heparin|heparin|mesh-list
25343165|NCT05555641|Calcium heparin|calcium heparin|mesh-list
25343166|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
25343464|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
25343840|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343841|NCT05552196|Analgesics|analgesics|mesh-ancestor
25343842|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
25343843|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343844|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25343845|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25343847|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25344446|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
25344832|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
25345127|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
25345128|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
25345129|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345208|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
25345513|NCT05540834|Plasminogen|plasminogen|mesh-list
25345661|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345662|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25345663|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25345664|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
25345665|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
25345666|NCT05539872|Insulin|insulin|mesh-list
25345667|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25345668|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
25345669|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
25345670|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25345671|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25345672|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345673|NCT05539729|Vancomycin|vancomycin|mesh-list
25345674|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25345676|NCT05539521|Propofol|propofol|mesh-list
25345815|NCT05538247|Analgesics|analgesics|mesh-ancestor
25346272|NCT05535517|Emollients|emollients|mesh-list
25346420|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
25346421|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346422|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25346423|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25346424|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25346425|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
25346426|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346427|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346433|NCT05533892|Lenvatinib|lenvatinib|mesh-list
25346535|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25346536|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
25346537|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25346538|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346539|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25346540|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
25346541|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346542|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346543|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
25346544|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346545|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25346546|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346945|NCT05531383|Memantine|memantine|mesh-list
25347022|NCT05530655|Lisinopril|lisinopril|mesh-list
25347321|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25347322|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
25347414|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
25347415|NCT05527275|Analgesics|analgesics|mesh-ancestor
25347416|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
25347417|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347418|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347419|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347420|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25347421|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25347422|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347423|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347424|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
25347425|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25347426|NCT05527106|Vitamins|vitamins|mesh-ancestor
25347427|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
25347428|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347928|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25347929|NCT05523102|Analgesics|analgesics|mesh-ancestor
25347930|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
25347931|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347932|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347933|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
25347934|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25348306|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
25348700|NCT05517213|Etoposide|etoposide|mesh-list
25348846|NCT05516251|Topiramate|topiramate|mesh-list
25349592|NCT05511415|Analgesics|analgesics|mesh-ancestor
25350353|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
25350581|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
25350726|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350727|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350728|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25350729|NCT05504057|Analgesics|analgesics|mesh-ancestor
25350730|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
25350731|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350732|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
25350738|NCT05503901|Timolol|timolol|mesh-list
25350739|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25350740|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25350741|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25350742|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25350743|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
25350952|NCT05502211|Analgesics|analgesics|mesh-ancestor
25351255|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
25352092|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
25352317|NCT05493332|Vitamins|vitamins|mesh-ancestor
25352318|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
25353179|NCT05487599|Sirolimus|sirolimus|mesh-list
25353317|NCT05487196|Clonidine|clonidine|mesh-list
25353762|NCT05484167|Testosterone|testosterone|mesh-list
25353763|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
25353764|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
25353765|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353766|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353917|NCT05482373|Oleuropein|oleuropein|mesh-list
25354217|NCT05480111|Anesthetics|anesthetics|mesh-list
25354971|NCT05475613|Lenvatinib|lenvatinib|mesh-list
25355119|NCT05472506|Nivolumab|nivolumab|mesh-list
25355196|NCT05470868|Naphazoline|naphazoline|mesh-list
25355197|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25355198|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25355199|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
25355200|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355201|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355202|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355203|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
25355204|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25355500|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355502|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
25355952|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25355953|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355954|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355955|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25355956|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
25355957|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
25355958|NCT05453903|Azacitidine|azacitidine|mesh-list
25355959|NCT05453903|Venetoclax|venetoclax|mesh-list
25355960|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25355961|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
25355962|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355965|NCT05453825|Paclitaxel|paclitaxel|mesh-list
25356116|NCT05448378|Inositol|inositol|mesh-list
25356178|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356179|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25356180|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356182|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356328|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356329|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25356330|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25356331|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25356332|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356333|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356334|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
25356335|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
25356336|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
25356337|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25356635|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356636|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356637|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25356638|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
25356639|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356640|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356658|NCT05435911|Propofol|propofol|mesh-list
25356659|NCT05435911|Flumazenil|flumazenil|mesh-list
25356660|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25356661|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356662|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356663|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25356664|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
25356665|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
25356666|NCT05435911|Antidotes|antidotes|mesh-ancestor
25356668|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
25356935|NCT05427981|Analgesics|analgesics|mesh-ancestor
25356936|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
25356938|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25357013|NCT05425355|Acetaminophen|acetaminophen|mesh-list
25357014|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25357015|NCT05425355|Analgesics|analgesics|mesh-ancestor
25357016|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
25357017|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357018|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357019|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
25357029|NCT05424835|Capecitabine|capecitabine|mesh-list
25357030|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357031|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
25357033|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357165|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357166|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25357167|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25357171|NCT05420636|Paclitaxel|paclitaxel|mesh-list
25357172|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25357173|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357174|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
25357175|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
25357176|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
25357177|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357178|NCT05420337|Morphine|morphine|mesh-list
25357179|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25357180|NCT05420337|Narcotics|narcotics|mesh-ancestor
25357181|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357182|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357183|NCT05420337|Analgesics|analgesics|mesh-ancestor
25357184|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
25357185|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357186|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
25357187|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357188|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357189|NCT05419427|Denosumab|denosumab|mesh-list
25357239|NCT05418049|Memantine|memantine|mesh-list
25357467|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
25357468|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25357469|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
25357470|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25357471|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25357472|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25357473|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25357619|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357620|NCT05410301|Bevacizumab|bevacizumab|mesh-list
25357621|NCT05410301|Lomustine|lomustine|mesh-list
25357632|NCT05409066|Rituximab|rituximab|mesh-list
25358084|NCT05398484|Psilocybin|psilocybin|mesh-list
25358141|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
25358142|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358143|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358293|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25358294|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358296|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
25358297|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
25358298|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
25358299|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358300|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358301|NCT05391126|Irinotecan|irinotecan|mesh-list
25358302|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25358303|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358304|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358305|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358306|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358307|NCT05391061|Abrocitinib|abrocitinib|mesh-list
25358308|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358309|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358310|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358311|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25358312|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358313|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25358314|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358315|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
25358316|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25358317|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358374|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
25358375|NCT05388929|Methocarbamol|methocarbamol|mesh-list
25358376|NCT05388929|Narcotics|narcotics|mesh-ancestor
25358377|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358378|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358379|NCT05388929|Analgesics|analgesics|mesh-ancestor
25358380|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
25358598|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358599|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25358600|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358601|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
25358602|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25358603|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358604|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358605|NCT05382442|Antidotes|antidotes|mesh-ancestor
25358606|NCT05382442|Protective Agents|protective agents|mesh-ancestor
25358607|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
25358608|NCT05382442|Vitamins|vitamins|mesh-ancestor
25358609|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
25358610|NCT05382364|Tucatinib|tucatinib|mesh-list
25358611|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358612|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358613|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358614|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358827|NCT05378100|Midazolam|midazolam|mesh-list
25358903|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25358904|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358905|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358906|NCT05376579|Siponimod|siponimod|mesh-list
25358907|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25358908|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358909|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358910|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
25358911|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358912|NCT05376553|Cisplatin|cisplatin|mesh-list
25358982|NCT05372588|Vaccines|vaccines|mesh-list
25358983|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
25358984|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358985|NCT05372393|Anesthetics|anesthetics|mesh-list
25358988|NCT05372367|Rifampin|rifampin|mesh-list
25359053|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
25359054|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359055|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25359056|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25359057|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25359058|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25359059|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25359060|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25359283|NCT05366868|Vildagliptin|vildagliptin|mesh-list
25359284|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25359285|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359286|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25359287|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
25359288|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359289|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359300|NCT05366764|Albuterol|albuterol|mesh-list
25359301|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25359595|NCT05361941|Tobramycin|tobramycin|mesh-list
25359661|NCT05360732|Folfirinox|folfirinox|mesh-list
25359727|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359728|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359729|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359730|NCT05358834|Melatonin|melatonin|mesh-list
25359731|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
25376416|NCT04842682|Diazepam|diazepam|mesh-list
25359732|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359951|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25359952|NCT05351593|Growth Substances|growth substances|mesh-ancestor
25359953|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
25359954|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359955|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25359956|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
25359957|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359958|NCT05351346|Prednisone|prednisone|mesh-list
25359959|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
25359960|NCT05351346|Rituximab|rituximab|mesh-list
25359961|NCT05351346|Doxorubicin|doxorubicin|mesh-list
25359962|NCT05351346|Vincristine|vincristine|mesh-list
25359963|NCT05351346|Lenalidomide|lenalidomide|mesh-list
25359964|NCT05351346|Decitabine|decitabine|mesh-list
25359965|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25359966|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
25359967|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359968|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25359981|NCT05351346|Hormones|hormones|mesh-ancestor
25360486|NCT05338632|Naloxone|naloxone|mesh-list
25360487|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25360488|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360489|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
25360490|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360491|NCT05338619|Lazertinib|lazertinib|mesh-list
25360492|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25360493|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360494|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360495|NCT05338450|Clemastine|clemastine|mesh-list
25360496|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
25360794|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
25360795|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360796|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25360797|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360798|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360799|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
25360800|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360868|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
25361326|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
25361414|NCT05312866|Fentanyl|fentanyl|mesh-list
25361485|NCT05311436|Iron|iron|mesh-list
25361929|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25361930|NCT05301322|Vaccines|vaccines|mesh-list
25361940|NCT05300802|Analgesics|analgesics|mesh-ancestor
25362233|NCT05293665|Vaccines|vaccines|mesh-list
25362456|NCT05288348|Analgesics|analgesics|mesh-ancestor
25362457|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
25362458|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362459|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25362460|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25362461|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
25362462|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
25362463|NCT05288283|Cannabidiol|cannabidiol|mesh-list
25362464|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
25362465|NCT05288166|Prednisone|prednisone|mesh-list
25362466|NCT05288166|Prednisolone|prednisolone|mesh-list
25362467|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362468|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
25362469|NCT05288166|Hormones|hormones|mesh-ancestor
25362470|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362471|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362472|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362473|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362474|NCT05288023|Azithromycin|azithromycin|mesh-list
25362475|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25362476|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362477|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
25362547|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
25362548|NCT05286801|Atezolizumab|atezolizumab|mesh-list
25362549|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25362550|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25362551|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362552|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
25362553|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362554|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25362555|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362556|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
25362557|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
25376489|NCT04840823|Enoxacin|enoxacin|mesh-list
25362558|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362559|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25362614|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362615|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362616|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25363155|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
25363208|NCT05268003|Venetoclax|venetoclax|mesh-list
25363287|NCT05265975|Rituximab|rituximab|mesh-list
25363587|NCT05256823|Celecoxib|celecoxib|mesh-list
25364042|NCT05249972|Vitamins|vitamins|mesh-ancestor
25364121|NCT05248139|Hormones|hormones|mesh-ancestor
25364572|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364573|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25364574|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
25364575|NCT05235542|Paclitaxel|paclitaxel|mesh-list
25364648|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
25364649|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25364650|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
25364651|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
25364652|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364654|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25364802|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364803|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25364804|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
25364805|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25364806|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
25364807|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
25364808|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
25364809|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
25364810|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
25364811|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364812|NCT05227937|Amikacin|amikacin|mesh-list
25364813|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25364814|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364815|NCT05227742|Psilocybin|psilocybin|mesh-list
25364816|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
25364819|NCT05227664|Paclitaxel|paclitaxel|mesh-list
25364881|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25364882|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364883|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25364884|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364885|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364886|NCT05225155|Enoxaparin|enoxaparin|mesh-list
25364887|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
25364888|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25364889|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25364890|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364903|NCT05223829|Brexanolone|brexanolone|mesh-list
25364958|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25364959|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364960|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364961|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
25364962|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364963|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364972|NCT05221229|Liraglutide|liraglutide|mesh-list
25365337|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
25365338|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365339|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25365341|NCT05209308|Rituximab|rituximab|mesh-list
25365485|NCT05203822|Itraconazole|itraconazole|mesh-list
25365634|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
25365635|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365636|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365637|NCT05199818|Palonosetron|palonosetron|mesh-list
25365638|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
25365639|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
25365645|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
25365789|NCT05192889|Leucovorin|leucovorin|mesh-list
25365936|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25365937|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25365938|NCT05189535|Protective Agents|protective agents|mesh-ancestor
25365939|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365940|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
25365941|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25365942|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
25366542|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366543|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366544|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25366545|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
25366546|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366547|NCT05170256|Trastuzumab|trastuzumab|mesh-list
25366548|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366558|NCT05170113|Caffeine|caffeine|mesh-list
25366844|NCT05160922|Crizotinib|crizotinib|mesh-list
25367985|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
25368057|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368059|NCT05112601|Nivolumab|nivolumab|mesh-list
25368060|NCT05112601|Ipilimumab|ipilimumab|mesh-list
25368061|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368062|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368205|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368207|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25368208|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
25368209|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368509|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368511|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368512|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
25368584|NCT05094154|Penicillins|penicillins|mesh-list
25368594|NCT05093621|Torsemide|torsemide|mesh-list
25369189|NCT05073718|Analgesics|analgesics|mesh-ancestor
25369262|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25369263|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369264|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369265|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369266|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369413|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25369414|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369415|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369416|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369417|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25369418|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25369419|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25369420|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
25369421|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369422|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369423|NCT05063565|Durvalumab|durvalumab|mesh-list
25369424|NCT05063565|Tremelimumab|tremelimumab|mesh-list
25369425|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
25369426|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369427|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369428|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369452|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
25369453|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25369454|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
25369455|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369570|NCT05060627|Hormones|hormones|mesh-ancestor
25369646|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25369647|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369648|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
25369649|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
25369650|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
25369651|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25369652|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369653|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25369654|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369675|NCT05058612|Midodrine|midodrine|mesh-list
25369676|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
25369677|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
25369678|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369679|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369680|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25369681|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25369682|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25369683|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25369684|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25369797|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369798|NCT05053152|Relugolix|relugolix|mesh-list
25369799|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
25369800|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
25369801|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369802|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369803|NCT05052931|Paclitaxel|paclitaxel|mesh-list
25369804|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
25369805|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25369879|NCT05050942|Octreotide|octreotide|mesh-list
25369950|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25369951|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25369952|NCT05048719|Dulaglutide|dulaglutide|mesh-list
25369953|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25369954|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370051|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
25370052|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370053|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370054|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25370055|NCT05046431|Golimumab|golimumab|mesh-list
25370056|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25370057|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25370058|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25370059|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
25370060|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370061|NCT05045794|Liver Extracts|liver extracts|mesh-list
25370062|NCT05045794|Hematinics|hematinics|mesh-ancestor
25370063|NCT05045703|Vitamin A|vitamin a|mesh-list
25370064|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
25370065|NCT05045703|Vitamins|vitamins|mesh-ancestor
25370066|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
25370067|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370068|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
25370069|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370070|NCT05045703|Protective Agents|protective agents|mesh-ancestor
25370071|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25370072|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370073|NCT05044819|Cannabidiol|cannabidiol|mesh-list
25370258|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25370259|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25370260|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370261|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
25370262|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
25370334|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
25370559|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25370561|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370562|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
25370563|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25370564|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25370565|NCT05028348|Growth Substances|growth substances|mesh-ancestor
25370566|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
25370567|NCT05028153|Azithromycin|azithromycin|mesh-list
25370568|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25370569|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370591|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25370592|NCT05026736|Antibodies|antibodies|mesh-list
25370593|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
25370594|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25370595|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
25370596|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370597|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370598|NCT05026320|Diclofenac|diclofenac|mesh-list
25370599|NCT05026320|Naproxen|naproxen|mesh-list
25370602|NCT05026320|Analgesics|analgesics|mesh-ancestor
25370940|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
25370941|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370942|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370947|NCT05016869|Capecitabine|capecitabine|mesh-list
25371480|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371481|NCT04999761|Futibatinib|futibatinib|mesh-list
25371482|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371483|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25371484|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371635|NCT04994717|Blinatumomab|blinatumomab|mesh-list
25371703|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25371704|NCT04992026|Prednisone|prednisone|mesh-list
25371705|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
25371706|NCT04992026|Hormones|hormones|mesh-list
25371707|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25371708|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25371965|NCT04985890|UB-421|ub-421|mesh-list
25372396|NCT04972110|Olaparib|olaparib|mesh-list
25372397|NCT04972110|Niraparib|niraparib|mesh-list
25372398|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25372399|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372400|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372401|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372405|NCT04971499|Dapansutrile|dapansutrile|mesh-list
25372406|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
25372407|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372772|NCT04959331|Fosfomycin|fosfomycin|mesh-list
25372932|NCT04954287|Vaccines|vaccines|mesh-list
25373375|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373376|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373526|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373528|NCT04934683|Etomidate|etomidate|mesh-list
25373529|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25373530|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373531|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373532|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25373533|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
25373534|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
25373535|NCT04934072|Denosumab|denosumab|mesh-list
25373536|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25373537|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373538|NCT04933942|Lomustine|lomustine|mesh-list
25373757|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
25373758|NCT04926818|Ofatumumab|ofatumumab|mesh-list
25373759|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25374061|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25374062|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
25374063|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
25374066|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25374140|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
25374141|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25374142|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374143|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
25374145|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374436|NCT04906213|Empagliflozin|empagliflozin|mesh-list
25374437|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25374438|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374439|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25374440|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374441|NCT04905693|Treprostinil|treprostinil|mesh-list
25374442|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25374454|NCT04905446|Niacin|niacin|mesh-list
25374532|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
25374533|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374534|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
25374535|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25374536|NCT04904341|Protective Agents|protective agents|mesh-ancestor
25374537|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374538|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
25374539|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25374540|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25374541|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374542|NCT04903509|Acetaminophen|acetaminophen|mesh-list
25374543|NCT04903509|Liraglutide|liraglutide|mesh-list
25374544|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25374545|NCT04903509|Analgesics|analgesics|mesh-ancestor
25374546|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
25374547|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374548|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374549|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
25374550|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25374591|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25374592|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25374593|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25374594|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374595|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
25374596|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374597|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25374598|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25374599|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374601|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25374602|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374603|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25374604|NCT04902131|Menotropins|menotropins|mesh-list
25374605|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25374606|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
25374607|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374608|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374740|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25374742|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25374743|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25374744|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25374745|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
25374746|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374747|NCT04898075|Nicotine|nicotine|mesh-list
25374815|NCT04895592|Hormones|hormones|mesh-ancestor
25374816|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374817|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374969|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25374970|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25374971|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25374972|NCT04891419|Lidocaine|lidocaine|mesh-list
25374973|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
25374974|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
25374975|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25374976|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374977|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
25375522|NCT04877275|Hormones|hormones|mesh-ancestor
25376173|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
25376174|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25376178|NCT04849364|Capecitabine|capecitabine|mesh-list
25376179|NCT04849364|Atezolizumab|atezolizumab|mesh-list
25376797|NCT04831736|Ketamine|ketamine|mesh-list
25376861|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376862|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25376863|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25376864|NCT04829383|Growth Substances|growth substances|mesh-ancestor
25376865|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376866|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
25376867|NCT04829318|Esketamine|esketamine|mesh-list
25376868|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
25404156|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404157|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404158|NCT03681470|Dapsone|dapsone|mesh-list
25404159|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404160|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
25404161|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25404163|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25404164|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404165|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404166|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
25404167|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25404168|NCT03681184|Lumasiran|lumasiran|mesh-list
25404169|NCT03681184|Renal Agents|renal agents|mesh-ancestor
25404170|NCT03680508|Antibodies|antibodies|mesh-list
25404171|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
25404172|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
25404173|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404174|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
25404175|NCT03680092|Methotrexate|methotrexate|mesh-list
25404176|NCT03680092|Abatacept|abatacept|mesh-list
25404177|NCT03680092|Tacrolimus|tacrolimus|mesh-list
25404178|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404179|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
25404180|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404181|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404182|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25404183|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
25404184|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404185|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404186|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25404187|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25404188|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
25404189|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25376937|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
25376938|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376939|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376940|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376941|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
25376942|NCT04826588|Hormones|hormones|mesh-ancestor
25376943|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404190|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404191|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
25404192|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
25404193|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404194|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25404195|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25404196|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25404197|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404198|NCT03679949|Oxycodone|oxycodone|mesh-list
25404199|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25404200|NCT03679949|Narcotics|narcotics|mesh-ancestor
25404201|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25404202|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404203|NCT03679949|Analgesics|analgesics|mesh-ancestor
25404204|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
25404205|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404206|NCT03679676|Omalizumab|omalizumab|mesh-list
25404207|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25404208|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25404209|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
25404210|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
25404211|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25404213|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404214|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404215|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25404216|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
25404217|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25404218|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
25404219|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404220|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404221|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25404222|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
25404223|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
25404224|NCT03679312|Protective Agents|protective agents|mesh-ancestor
25404225|NCT03678675|Ketorolac|ketorolac|mesh-list
25404226|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25404227|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25404228|NCT03678675|Analgesics|analgesics|mesh-ancestor
25404229|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
25404230|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404231|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404232|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404233|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404236|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404237|NCT03677817|Lidocaine|lidocaine|mesh-list
25404238|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
25404239|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
25404240|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25404241|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404242|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
25404243|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404244|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25404245|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25404246|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25404247|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404248|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404249|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25404250|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404251|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377015|NCT04824053|Selenium|selenium|mesh-list
25404252|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25404253|NCT03677141|Prednisone|prednisone|mesh-list
25404254|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
25404255|NCT03677141|Doxorubicin|doxorubicin|mesh-list
25404256|NCT03677141|Vincristine|vincristine|mesh-list
25404257|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404258|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
25404259|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404260|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404261|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25404262|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
25404263|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404264|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404265|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25404266|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25404267|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25404268|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25404269|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404270|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404271|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
25404272|NCT03677141|Hormones|hormones|mesh-ancestor
25404273|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404274|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404275|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25404276|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
25404277|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
25404278|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
25404279|NCT03676556|Lidocaine|lidocaine|mesh-list
25404280|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
25404281|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
25404282|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25404283|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404284|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
25404285|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404286|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25404287|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25404288|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25404289|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404290|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404292|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404293|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404294|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25404295|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25404296|NCT03676192|Growth Substances|growth substances|mesh-ancestor
25404297|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404298|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
25404299|NCT03675737|Cisplatin|cisplatin|mesh-list
25404300|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
25404301|NCT03675737|Fluorouracil|fluorouracil|mesh-list
25404302|NCT03675737|Capecitabine|capecitabine|mesh-list
25404303|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
25404304|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404305|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404306|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
25404307|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404308|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404309|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404321|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404322|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
25404323|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404324|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404325|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404326|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
25404327|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404328|NCT03674112|Trastuzumab|trastuzumab|mesh-list
25404329|NCT03674112|Pertuzumab|pertuzumab|mesh-list
25404330|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404331|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404332|NCT03673462|Vaccines|vaccines|mesh-list
25404333|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
25404334|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404335|NCT03673072|Gemcitabine|gemcitabine|mesh-list
25404336|NCT03673072|Cisplatin|cisplatin|mesh-list
25404337|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404338|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404339|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
25404340|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404341|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
25404342|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404343|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404344|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404345|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
25404346|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404347|NCT03672643|Crizotinib|crizotinib|mesh-list
25404348|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404349|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25404350|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404351|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404352|NCT03672630|Azithromycin|azithromycin|mesh-list
25404353|NCT03672630|Rifampin|rifampin|mesh-list
25404354|NCT03672630|Ethambutol|ethambutol|mesh-list
25404355|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25404356|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404357|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25404358|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
25404359|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
25404360|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25404361|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404362|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404363|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25404364|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25404365|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25404366|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25404367|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25404368|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25404369|NCT03672539|Cytarabine|cytarabine|mesh-list
25404370|NCT03672539|Daunorubicin|daunorubicin|mesh-list
25404371|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
25404372|NCT03672539|Calicheamicins|calicheamicins|mesh-list
25404373|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404374|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
25404375|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404376|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404377|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
25404378|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404379|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404380|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
25404381|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404382|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25404383|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25404384|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25404385|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404386|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404387|NCT03671967|Meropenem|meropenem|mesh-list
25404388|NCT03671967|Tazobactam|tazobactam|mesh-list
25404389|NCT03671967|Piperacillin|piperacillin|mesh-list
25404390|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25404391|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25404392|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404393|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25404394|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404395|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404400|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404401|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404402|NCT03669718|Cemiplimab|cemiplimab|mesh-list
25404403|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404404|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404405|NCT03668119|Nivolumab|nivolumab|mesh-list
25404406|NCT03668119|Ipilimumab|ipilimumab|mesh-list
25404407|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404408|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404409|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404410|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404411|NCT03667703|Famotidine|famotidine|mesh-list
25404412|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25404413|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25404414|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25404415|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
25404416|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
25404417|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404418|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404419|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404420|NCT03666559|Azacitidine|azacitidine|mesh-list
25404421|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404422|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
25404423|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404424|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404425|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404426|NCT03666351|Losartan|losartan|mesh-list
25404427|NCT03666351|Amlodipine|amlodipine|mesh-list
25404428|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
25404429|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25404430|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25404431|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404432|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404433|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25404434|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404435|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
25404436|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25404437|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25404438|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25404440|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
25404441|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25404442|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
25404443|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404444|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404445|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
25404446|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404447|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404448|NCT03665441|Leucovorin|leucovorin|mesh-list
25404449|NCT03665441|Gemcitabine|gemcitabine|mesh-list
25404450|NCT03665441|Paclitaxel|paclitaxel|mesh-list
25404451|NCT03665441|Irinotecan|irinotecan|mesh-list
25404452|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25404453|NCT03665441|Asparaginase|asparaginase|mesh-list
25404454|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25404455|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404456|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
25404457|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
25404458|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
25404459|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404460|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404461|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
25404462|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
25404463|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404464|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404465|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404466|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
25404467|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404468|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25404469|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25404470|NCT03665441|Antidotes|antidotes|mesh-ancestor
25404471|NCT03665441|Protective Agents|protective agents|mesh-ancestor
25404472|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
25404473|NCT03665441|Vitamins|vitamins|mesh-ancestor
25404474|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
25404475|NCT03665038|Brexanolone|brexanolone|mesh-list
25404476|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
25404478|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404479|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404480|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
25404481|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
25404482|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
25404483|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404484|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404485|NCT03663543|Estrogens|estrogens|mesh-list
25404486|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25404487|NCT03663543|Hormones|hormones|mesh-ancestor
25404488|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404489|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404490|NCT03663205|Cisplatin|cisplatin|mesh-list
25404491|NCT03663205|Carboplatin|carboplatin|mesh-list
25404492|NCT03663205|Pemetrexed|pemetrexed|mesh-list
25404493|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377241|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25377242|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25377243|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377244|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25377245|NCT04809311|Hormones|hormones|mesh-ancestor
25377246|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377247|NCT04809311|Incretins|incretins|mesh-ancestor
25377251|NCT04809220|Dulaglutide|dulaglutide|mesh-list
25377252|NCT04809220|Biguanides|biguanides|mesh-list
25377253|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25377254|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25377255|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25377256|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377257|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377258|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377259|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
25404494|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404495|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404496|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25404497|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25404498|NCT03662659|Nivolumab|nivolumab|mesh-list
25404499|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404500|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404501|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404502|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404503|NCT03662074|Gemcitabine|gemcitabine|mesh-list
25404504|NCT03662074|Nivolumab|nivolumab|mesh-list
25404505|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404506|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
25404507|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404508|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404509|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
25404510|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404511|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404512|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404513|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
25404514|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404515|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404516|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404517|NCT03662022|Rifampin|rifampin|mesh-list
25404518|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25404519|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
25404520|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25404521|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404522|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
25404523|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25404524|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404525|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404526|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25404527|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25404528|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25404529|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25404530|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25404531|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25404532|NCT03661411|Aspirin|aspirin|mesh-list
25404533|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25404534|NCT03661411|Clopidogrel|clopidogrel|mesh-list
25377316|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377317|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25377318|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25377319|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
25377320|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377321|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377322|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25377323|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25377324|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377325|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377326|NCT04805125|Vaccines|vaccines|mesh-list
25377327|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
25404535|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25404536|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25404537|NCT03661411|Analgesics|analgesics|mesh-ancestor
25404614|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
25404538|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
25404539|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404540|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404541|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404542|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404543|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25404544|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25404545|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404546|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25404547|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25404548|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404549|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
25404573|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
25404574|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404575|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
25404576|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404592|NCT03660553|Insulin|insulin|mesh-list
25404593|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25404594|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
25404595|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
25404596|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
25404597|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25404598|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404599|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25404600|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
25404601|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
25404602|NCT03660046|Etonogestrel|etonogestrel|mesh-list
25404603|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25404604|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
25404605|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25404606|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404607|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25404608|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25404609|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25404610|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25404611|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25404612|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404613|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404615|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404616|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404617|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25404618|NCT03657433|Hematinics|hematinics|mesh-ancestor
25404619|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25404620|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25404621|NCT03656718|Nivolumab|nivolumab|mesh-list
25404622|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404623|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404624|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404625|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404626|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25404627|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
25404628|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404629|NCT03656549|Pemetrexed|pemetrexed|mesh-list
25404630|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404631|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404632|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404633|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25404634|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25404640|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404641|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
25404642|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404643|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404644|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404645|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
25404646|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404647|NCT03655717|Ethanol|ethanol|mesh-list
25404648|NCT03655717|Dronabinol|dronabinol|mesh-list
25404649|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25404650|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404651|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25404652|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404653|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
25404654|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25404655|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25404656|NCT03655717|Analgesics|analgesics|mesh-ancestor
25404657|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
25404658|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404659|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25404660|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25404661|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404662|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404664|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404665|NCT03654105|Aspirin|aspirin|mesh-list
25404666|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25404667|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25404668|NCT03654105|Analgesics|analgesics|mesh-ancestor
25404669|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
25404670|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404671|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404672|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404673|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404674|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25404675|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25404676|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404677|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25404678|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25404679|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404680|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
25404681|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
25404682|NCT03654040|Everolimus|everolimus|mesh-list
25404683|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404684|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
25404685|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404686|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404687|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25404688|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
25404689|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404690|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404691|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25404692|NCT03653507|Capecitabine|capecitabine|mesh-list
25404693|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
25404694|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404695|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
25404696|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404697|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404698|NCT03653364|Baloxavir|baloxavir|mesh-list
25404699|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
25404700|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404701|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377467|NCT04801797|Azacitidine|azacitidine|mesh-list
25377468|NCT04801797|Daunorubicin|daunorubicin|mesh-list
25377469|NCT04801797|Venetoclax|venetoclax|mesh-list
25377470|NCT04801797|Idarubicin|idarubicin|mesh-list
25377471|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377472|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
25377473|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377474|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377475|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
25377476|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377477|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377484|NCT04801589|Midazolam|midazolam|mesh-list
25404702|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404703|NCT03653247|Plerixafor|plerixafor|mesh-list
25404704|NCT03653247|Busulfan|busulfan|mesh-list
25404705|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
25404706|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404707|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404708|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
25404709|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404710|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25404711|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404712|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25404713|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25404714|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25404722|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404723|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
25404724|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404725|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404726|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
25404727|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25404728|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25404729|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25404730|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25404731|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
25404732|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25404733|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
25404734|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25404735|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
25404736|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25404737|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
25404739|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404740|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404741|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404742|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404743|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
25404744|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404745|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404746|NCT03652064|Dexamethasone|dexamethasone|mesh-list
25404747|NCT03652064|Lenalidomide|lenalidomide|mesh-list
25404748|NCT03652064|Bortezomib|bortezomib|mesh-list
25404749|NCT03652064|Daratumumab|daratumumab|mesh-list
25404750|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404751|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
25404752|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
25404753|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404754|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404755|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25404756|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
25404757|NCT03652064|Hormones|hormones|mesh-ancestor
25404758|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404759|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404760|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404761|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
25404762|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25404763|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25404764|NCT03652064|Growth Substances|growth substances|mesh-ancestor
25404765|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
25404766|NCT03651895|Metformin|metformin|mesh-list
25404767|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25404768|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404769|NCT03651128|Dexamethasone|dexamethasone|mesh-list
25404770|NCT03651128|Lenalidomide|lenalidomide|mesh-list
25404771|NCT03651128|Bortezomib|bortezomib|mesh-list
25404772|NCT03651128|Daratumumab|daratumumab|mesh-list
25404773|NCT03651128|Pomalidomide|pomalidomide|mesh-list
25404774|NCT03651128|Ixazomib|ixazomib|mesh-list
25404775|NCT03651128|Elotuzumab|elotuzumab|mesh-list
25404776|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404777|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
25404778|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
25404779|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404780|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404781|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25404782|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
25404783|NCT03651128|Hormones|hormones|mesh-ancestor
25404784|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404785|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404786|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404787|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
25404788|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25404789|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25404790|NCT03651128|Growth Substances|growth substances|mesh-ancestor
25404791|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
25404792|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
25404793|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404794|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404795|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
25404796|NCT03650764|Ramucirumab|ramucirumab|mesh-list
25404797|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404798|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404799|NCT03650114|Ofatumumab|ofatumumab|mesh-list
25404800|NCT03650114|Vaccines|vaccines|mesh-list
25404801|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25404802|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25404803|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
25404804|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404805|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404806|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25404807|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
25404808|NCT03649841|Prednisone|prednisone|mesh-list
25404809|NCT03649841|Cortisone|cortisone|mesh-list
25404810|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
25404811|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
25404812|NCT03649841|Hormones|hormones|mesh-list
25404813|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25404814|NCT03649841|Androgens|androgens|mesh-list
25404815|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
25404816|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404817|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
25404818|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404819|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404820|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404821|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404822|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25404823|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404824|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404825|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
25404826|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25404827|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
25404828|NCT03649841|Protective Agents|protective agents|mesh-ancestor
25404829|NCT03649841|Vitamins|vitamins|mesh-ancestor
25404830|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
25404831|NCT03649841|Estrogens|estrogens|mesh-ancestor
25404832|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
25404833|NCT03649724|Leuprolide|leuprolide|mesh-list
25404834|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25404835|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
25404836|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25404837|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404838|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404839|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404840|NCT03649659|Fluorides|fluorides|mesh-list
25404841|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
25377623|NCT04798469|Androgens|androgens|mesh-ancestor
25404842|NCT03649659|Protective Agents|protective agents|mesh-ancestor
25404843|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404844|NCT03649152|Proxigermanium|proxigermanium|mesh-list
25404845|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404846|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
25404847|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
25404848|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404850|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25404851|NCT03648021|Analgesics|analgesics|mesh-ancestor
25404852|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
25404853|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404854|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404855|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
25404856|NCT03647969|Nivolumab|nivolumab|mesh-list
25404857|NCT03647969|Ipilimumab|ipilimumab|mesh-list
25404858|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404859|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404860|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404861|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404862|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
25404863|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404864|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404865|NCT03647124|Lenalidomide|lenalidomide|mesh-list
25404866|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
25404867|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404868|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25404869|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25404870|NCT03647124|Growth Substances|growth substances|mesh-ancestor
25404871|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
25404872|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404873|NCT03646604|Upadacitinib|upadacitinib|mesh-list
25404874|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25404875|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25404876|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404877|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404878|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404886|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404888|NCT03644485|Tacrolimus|tacrolimus|mesh-list
25404889|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404890|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
25404891|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404892|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25404894|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404895|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25404896|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404897|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25404898|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
25404899|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25404900|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404901|NCT03644186|Paclitaxel|paclitaxel|mesh-list
25404902|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25404903|NCT03644186|Trastuzumab|trastuzumab|mesh-list
25404904|NCT03644186|Letrozole|letrozole|mesh-list
25404905|NCT03644186|Palbociclib|palbociclib|mesh-list
25404906|NCT03644186|Pertuzumab|pertuzumab|mesh-list
25404907|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25404908|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404909|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
25404910|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
25404911|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
25404912|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404913|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404914|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25404915|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25404916|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404917|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25404918|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
25404919|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404920|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404921|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25404922|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25404923|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25404924|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404925|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404926|NCT03643107|Prednisolone|prednisolone|mesh-list
25404927|NCT03643107|Irofulven|irofulven|mesh-list
25404928|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25404929|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
25404930|NCT03643107|Hormones|hormones|mesh-ancestor
25404931|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404932|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404933|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404934|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404935|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25404936|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
25404937|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404938|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
25404939|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25404940|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
25404941|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25404942|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404943|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25404944|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25404945|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25404946|NCT03641651|Frovatriptan|frovatriptan|mesh-list
25404947|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25404948|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
25404949|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404950|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404951|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404952|NCT03641560|Androgens|androgens|mesh-list
25404953|NCT03641560|Hormones|hormones|mesh-ancestor
25404954|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404955|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404956|NCT03641313|Irinotecan|irinotecan|mesh-list
25404957|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25404958|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25404959|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404965|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404966|NCT03640312|Candesartan|candesartan|mesh-list
25404967|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25404968|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25404969|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25404970|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404971|NCT03638375|Interferons|interferons|mesh-list
25404972|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
25404973|NCT03638375|Nivolumab|nivolumab|mesh-list
25404974|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404975|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404976|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404977|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404978|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
25404979|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404980|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
25404981|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404988|NCT03637075|Insulin|insulin|mesh-list
25404989|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25404990|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404991|NCT03636906|Vaccines|vaccines|mesh-list
25404992|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
25405221|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
25404993|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404994|NCT03635983|Nivolumab|nivolumab|mesh-list
25404995|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404996|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404997|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25404998|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404999|NCT03635892|Nivolumab|nivolumab|mesh-list
25405000|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405001|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405002|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405003|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405004|NCT03635567|Paclitaxel|paclitaxel|mesh-list
25405005|NCT03635567|Bevacizumab|bevacizumab|mesh-list
25405006|NCT03635567|Cisplatin|cisplatin|mesh-list
25405007|NCT03635567|Carboplatin|carboplatin|mesh-list
25405008|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
25405009|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405010|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405011|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405012|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405013|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405014|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405015|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405016|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25405017|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25405018|NCT03635567|Growth Substances|growth substances|mesh-ancestor
25405019|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405020|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
25405021|NCT03634839|Nicotine|nicotine|mesh-list
25405022|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25405023|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
25405024|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405025|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405026|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25405027|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25405028|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
25405029|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405030|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405031|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
25405032|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405033|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
25405035|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405036|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25405037|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
25405038|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405039|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405040|NCT03632720|Vaccines|vaccines|mesh-list
25405041|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
25405042|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405043|NCT03631199|Paclitaxel|paclitaxel|mesh-list
25405044|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25405045|NCT03631199|Cisplatin|cisplatin|mesh-list
25405046|NCT03631199|Carboplatin|carboplatin|mesh-list
25405047|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
25405048|NCT03631199|Pemetrexed|pemetrexed|mesh-list
25405049|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25405050|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405051|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405052|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405053|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405054|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405055|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405056|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405057|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405058|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25405059|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25405060|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
25405061|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405062|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
25405063|NCT03630991|Edetic Acid|edetic acid|mesh-list
25405064|NCT03630991|Calcium|calcium|mesh-list
25405065|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
25405066|NCT03630991|Succimer|succimer|mesh-list
25405067|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405068|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25405069|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25405070|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
25405071|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25405072|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
25405073|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
25405074|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405076|NCT03630991|Protective Agents|protective agents|mesh-ancestor
25405077|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25405078|NCT03630640|Nivolumab|nivolumab|mesh-list
25405079|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405080|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405081|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405082|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405083|NCT03630315|Bevacizumab|bevacizumab|mesh-list
25405084|NCT03630315|Ranibizumab|ranibizumab|mesh-list
25405085|NCT03630315|Aflibercept|aflibercept|mesh-list
25405086|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405087|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405088|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25405089|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25405090|NCT03630315|Growth Substances|growth substances|mesh-ancestor
25405091|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405092|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
25405093|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
25405094|NCT03630211|Thiotepa|thiotepa|mesh-list
25405095|NCT03630211|Rituximab|rituximab|mesh-list
25405096|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
25405097|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
25405098|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25405099|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
25405100|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25405101|NCT03630211|Antibodies|antibodies|mesh-list
25405102|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
25405103|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25405104|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405105|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
25405106|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405107|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405108|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405109|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
25405110|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405111|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405112|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405118|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405119|NCT03629613|Protective Agents|protective agents|mesh-ancestor
25405120|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405121|NCT03629288|Azithromycin|azithromycin|mesh-list
25405122|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25405123|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405124|NCT03629223|Tepotinib|tepotinib|mesh-list
25405125|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405126|NCT03628339|Tepotinib|tepotinib|mesh-list
25405127|NCT03628339|Midazolam|midazolam|mesh-list
25405128|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25405129|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25405130|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25405131|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405132|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25405133|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25405134|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25405135|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25405136|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
25405137|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
25405138|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
25405139|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
25405140|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405141|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405142|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405143|NCT03628209|Nivolumab|nivolumab|mesh-list
25405144|NCT03628209|Azacitidine|azacitidine|mesh-list
25405145|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405146|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405147|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405148|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405149|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405150|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
25405151|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405152|NCT03627741|Triamcinolone|triamcinolone|mesh-list
25405153|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25405154|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25405155|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25405156|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25405157|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
25405158|NCT03627741|Hormones|hormones|mesh-ancestor
25405159|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25405160|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405161|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405162|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
25405163|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405164|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405165|NCT03627715|Proxigermanium|proxigermanium|mesh-list
25405166|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377934|NCT04787744|Hormones|hormones|mesh-ancestor
25405167|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
25405168|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
25405169|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405170|NCT03626337|Thiamine|thiamine|mesh-list
25405171|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
25405172|NCT03626337|Vitamins|vitamins|mesh-ancestor
25405173|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
25405174|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405175|NCT03625726|Thrombin|thrombin|mesh-list
25405176|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
25405177|NCT03625726|Coagulants|coagulants|mesh-ancestor
25405178|NCT03623854|Nivolumab|nivolumab|mesh-list
25405179|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
25405180|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
25405181|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405182|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405183|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405184|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405185|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
25405186|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405187|NCT03623321|Pimavanserin|pimavanserin|mesh-list
25405188|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25405189|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25405190|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25405191|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25405192|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25405193|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405194|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25405199|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405200|NCT03623243|Siponimod|siponimod|mesh-list
25405201|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25405202|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405203|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405204|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
25405205|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405206|NCT03622593|Aflibercept|aflibercept|mesh-list
25405207|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25405208|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25405209|NCT03622593|Growth Substances|growth substances|mesh-ancestor
25405210|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405211|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
25405212|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405213|NCT03622580|Aflibercept|aflibercept|mesh-list
25405214|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25405215|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25405216|NCT03622580|Growth Substances|growth substances|mesh-ancestor
25405217|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405218|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
25405219|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405220|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25405222|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405223|NCT03620669|Durvalumab|durvalumab|mesh-list
25405224|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405225|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405226|NCT03620201|Atezolizumab|atezolizumab|mesh-list
25405227|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405228|NCT03620019|Denosumab|denosumab|mesh-list
25405229|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
25405230|NCT03620019|Nivolumab|nivolumab|mesh-list
25405231|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405232|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405233|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405234|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405235|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25405236|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405237|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25405238|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25405239|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
25405240|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405241|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405242|NCT03618654|Metformin|metformin|mesh-list
25405243|NCT03618654|Durvalumab|durvalumab|mesh-list
25405244|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
25405245|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25405246|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
25405247|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25405248|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405249|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405250|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405251|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
25405252|NCT03618641|Nivolumab|nivolumab|mesh-list
25405253|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405254|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405255|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405256|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405257|NCT03617445|Vancomycin|vancomycin|mesh-list
25405258|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25405259|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405260|NCT03616587|Everolimus|everolimus|mesh-list
25405261|NCT03616587|Palbociclib|palbociclib|mesh-list
25405262|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405263|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405264|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
25405265|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405266|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25405267|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405268|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405269|NCT03616574|Trifluridine|trifluridine|mesh-list
25405270|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
25405351|NCT03609593|Venetoclax|venetoclax|mesh-list
25405271|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405272|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
25405273|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405289|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405290|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405291|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405292|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405293|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405294|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
25405295|NCT03614949|Atezolizumab|atezolizumab|mesh-list
25405296|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405298|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25405300|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
25405301|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25405302|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25405303|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405304|NCT03611556|Leucovorin|leucovorin|mesh-list
25405305|NCT03611556|Gemcitabine|gemcitabine|mesh-list
25405306|NCT03611556|Paclitaxel|paclitaxel|mesh-list
25405307|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
25405308|NCT03611556|Fluorouracil|fluorouracil|mesh-list
25405309|NCT03611556|Durvalumab|durvalumab|mesh-list
25405310|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
25405311|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405312|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405313|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405314|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405315|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405316|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405317|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405318|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
25405319|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
25405320|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405321|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405322|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405323|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
25405324|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405325|NCT03611556|Antidotes|antidotes|mesh-ancestor
25405326|NCT03611556|Protective Agents|protective agents|mesh-ancestor
25405327|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
25405328|NCT03611556|Vitamins|vitamins|mesh-ancestor
25405329|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
25405330|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405331|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
25405332|NCT03610490|Fludarabine|fludarabine|mesh-list
25405333|NCT03610490|Interleukin-2|interleukin-2|mesh-list
25405334|NCT03610490|Mitogens|mitogens|mesh-list
25405335|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405336|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
25405337|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405338|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405339|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405340|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
25405341|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405342|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405343|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405344|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25405345|NCT03610490|Analgesics|analgesics|mesh-ancestor
25405346|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
25405347|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405348|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405349|NCT03609593|Rituximab|rituximab|mesh-list
25405350|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25405352|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405353|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405354|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
25405355|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405356|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405357|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405358|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
25405359|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405360|NCT03609580|Tamsulosin|tamsulosin|mesh-list
25405361|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25405362|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25405363|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25405364|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
25405365|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405366|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405374|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405376|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405377|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405378|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405379|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
25405380|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405381|NCT03609060|Dexamethasone|dexamethasone|mesh-list
25405382|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25405383|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
25405384|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
25405385|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405386|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405387|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25405388|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
25405389|NCT03609060|Hormones|hormones|mesh-ancestor
25405390|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25405391|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25405392|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405393|NCT03609047|Paclitaxel|paclitaxel|mesh-list
25405394|NCT03609047|Docetaxel|docetaxel|mesh-list
25405395|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
25405396|NCT03609047|Doxorubicin|doxorubicin|mesh-list
25405397|NCT03609047|Epirubicin|epirubicin|mesh-list
25405398|NCT03609047|Palbociclib|palbociclib|mesh-list
25405399|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405400|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405401|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405402|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405403|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405404|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405405|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405406|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
25405407|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405408|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405409|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405410|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
25405411|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405412|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25405413|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25405414|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25405415|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405416|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25405417|NCT03607890|Nivolumab|nivolumab|mesh-list
25405418|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405419|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405420|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405421|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378161|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
25405422|NCT03606967|Gemcitabine|gemcitabine|mesh-list
25405423|NCT03606967|Poly I-C|poly i-c|mesh-list
25405424|NCT03606967|Paclitaxel|paclitaxel|mesh-list
25405425|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25405426|NCT03606967|Carboplatin|carboplatin|mesh-list
25405427|NCT03606967|Durvalumab|durvalumab|mesh-list
25405428|NCT03606967|Tremelimumab|tremelimumab|mesh-list
25405429|NCT03606967|Ipilimumab|ipilimumab|mesh-list
25405430|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25405431|NCT03606967|Vaccines|vaccines|mesh-list
25405432|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
25405433|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25405434|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
25405435|NCT03606967|Poly ICLC|poly iclc|mesh-list
25405436|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
25405437|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405438|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405439|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405440|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405441|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405442|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405443|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405444|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405445|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
25405446|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
25405447|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405448|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405449|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405450|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405461|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405462|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25405463|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25405464|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25405465|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
25405466|NCT03606499|Ustekinumab|ustekinumab|mesh-list
25405467|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
25405468|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
25405469|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25405470|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25405471|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405472|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
25405473|NCT03606109|Coagulants|coagulants|mesh-ancestor
25405474|NCT03605927|Sirolimus|sirolimus|mesh-list
25405475|NCT03605927|Tacrolimus|tacrolimus|mesh-list
25405476|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405477|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
25405478|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405479|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25405480|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405481|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405482|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25405483|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405484|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25405485|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405486|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
25405487|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
25405488|NCT03605654|Tacrolimus|tacrolimus|mesh-list
25405489|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25405490|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
25405491|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405492|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25405493|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405494|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405495|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25405496|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405497|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25405498|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
25405499|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25405500|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405501|NCT03604991|Paclitaxel|paclitaxel|mesh-list
25405502|NCT03604991|Carboplatin|carboplatin|mesh-list
25405503|NCT03604991|Nivolumab|nivolumab|mesh-list
25405504|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25405506|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405507|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405508|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25378234|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25378235|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25378236|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25378237|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378238|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25378239|NCT04778358|Hormones|hormones|mesh-ancestor
25378240|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25405509|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405510|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405511|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405512|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405513|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405514|NCT03604978|Nivolumab|nivolumab|mesh-list
25405515|NCT03604978|Ipilimumab|ipilimumab|mesh-list
25405516|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405517|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405518|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405519|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405520|NCT03604653|Cisplatin|cisplatin|mesh-list
25405521|NCT03604653|Doxorubicin|doxorubicin|mesh-list
25405522|NCT03604653|Mitomycins|mitomycins|mesh-list
25405523|NCT03604653|Mitomycin|mitomycin|mesh-list
25405524|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405525|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25405526|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25405527|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25405528|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405529|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405530|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
25405531|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25405532|NCT03604406|Vaccines|vaccines|mesh-list
25405533|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
25405534|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405535|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
25405536|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25405537|NCT03604315|Fluorides|fluorides|mesh-list
25405539|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405540|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
25405541|NCT03604315|Protective Agents|protective agents|mesh-ancestor
25405542|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405543|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
25405544|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
25405545|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405546|NCT03603080|Metformin|metformin|mesh-list
25405547|NCT03603080|Topiramate|topiramate|mesh-list
25405548|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
25405549|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25405550|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405551|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
25405552|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25405553|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25405554|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25405555|NCT03602859|Niraparib|niraparib|mesh-list
25405556|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25405557|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405558|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405559|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405560|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
25405561|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25405562|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
25405563|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405564|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405565|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25405566|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
25405567|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25405568|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
25405569|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405570|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405571|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25405572|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
25405573|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
25405574|NCT03602781|Protective Agents|protective agents|mesh-ancestor
25405575|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
25405576|NCT03602612|Fludarabine|fludarabine|mesh-list
25405577|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405578|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
25405579|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405580|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405581|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405582|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
25405583|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405584|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405585|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405586|NCT03602560|Seladelpar|seladelpar|mesh-list
25405587|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25405588|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
25405589|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405590|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25405591|NCT03600883|Midazolam|midazolam|mesh-list
25405592|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25405593|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25405594|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25405595|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405596|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25405597|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25405598|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25405599|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25405600|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
25405601|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
25405602|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
25405603|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
25405604|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405605|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405606|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
25405607|NCT03600649|Topotecan|topotecan|mesh-list
25405608|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405609|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
25405610|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405611|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405612|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405613|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
25405853|NCT03591510|Etoposide|etoposide|mesh-list
25405614|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405615|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405616|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405617|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25405618|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25405619|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405621|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25405622|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405623|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405624|NCT03600350|Nivolumab|nivolumab|mesh-list
25405625|NCT03600350|Sargramostim|sargramostim|mesh-list
25405626|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405627|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405628|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405629|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405630|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
25405631|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405632|NCT03599622|BMS-986165|bms-986165|mesh-list
25405633|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25405634|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25405635|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405636|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405637|NCT03599453|Interferons|interferons|mesh-list
25405638|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
25405639|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
25405640|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25405641|NCT03599453|Poly I-C|poly i-c|mesh-list
25405642|NCT03599453|Celecoxib|celecoxib|mesh-list
25405643|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
25405644|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
25405645|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
25405646|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
25405647|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405648|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405649|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
25405650|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405651|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
25405652|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405653|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25405654|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25405655|NCT03599453|Analgesics|analgesics|mesh-ancestor
25405656|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
25405657|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405658|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25405659|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405660|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25405661|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25405662|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405663|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405664|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
25405665|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25405666|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
25405667|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
25405668|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405669|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
25405670|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25405671|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405672|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405673|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25405674|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405675|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405676|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
25405677|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405678|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405679|NCT03598595|Gemcitabine|gemcitabine|mesh-list
25405680|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
25405681|NCT03598595|Docetaxel|docetaxel|mesh-list
25405682|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405683|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
25405684|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405685|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405686|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
25405687|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405688|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405700|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25405701|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25405702|NCT03598309|Analgesics|analgesics|mesh-ancestor
25405703|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
25405704|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405705|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405706|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25405707|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405708|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405709|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405710|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405711|NCT03598257|Olaparib|olaparib|mesh-list
25405712|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25405713|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405714|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405715|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405716|NCT03597581|Bevacizumab|bevacizumab|mesh-list
25405717|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405718|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405719|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25405720|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25405721|NCT03597581|Growth Substances|growth substances|mesh-ancestor
25405722|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405723|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
25405724|NCT03596645|Golimumab|golimumab|mesh-list
25405725|NCT03596645|Infliximab|infliximab|mesh-list
25405726|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25405727|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25405728|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405729|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25405730|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25405731|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405732|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
25405733|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405734|NCT03595592|Paclitaxel|paclitaxel|mesh-list
25405735|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25405736|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
25405737|NCT03595592|Carboplatin|carboplatin|mesh-list
25405738|NCT03595592|Doxorubicin|doxorubicin|mesh-list
25405739|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25405740|NCT03595592|Trastuzumab|trastuzumab|mesh-list
25405741|NCT03595592|Atezolizumab|atezolizumab|mesh-list
25405742|NCT03595592|Pertuzumab|pertuzumab|mesh-list
25405743|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405744|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405745|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405746|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405747|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405748|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405749|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405750|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
25405751|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405752|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405753|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405754|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
25405755|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405756|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25405757|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25405758|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25405759|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405760|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405761|NCT03595124|Nivolumab|nivolumab|mesh-list
25405762|NCT03595124|Axitinib|axitinib|mesh-list
25405763|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405764|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405765|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405766|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405767|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25405768|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405769|NCT03594747|Paclitaxel|paclitaxel|mesh-list
25405770|NCT03594747|Carboplatin|carboplatin|mesh-list
25405771|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405772|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405773|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405774|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405775|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405776|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405777|NCT03594110|Empagliflozin|empagliflozin|mesh-list
25405778|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25405779|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405780|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25405781|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405782|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
25405783|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
25405784|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405785|NCT03593408|Fentanyl|fentanyl|mesh-list
25405786|NCT03593408|Midazolam|midazolam|mesh-list
25405787|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
25405788|NCT03593408|Morphine|morphine|mesh-list
25405789|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25405790|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25405791|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405792|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25405793|NCT03593408|Analgesics|analgesics|mesh-ancestor
25405794|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
25405795|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405796|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25405797|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25405798|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25405799|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
25405800|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405801|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405802|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25405803|NCT03593408|Narcotics|narcotics|mesh-ancestor
25405804|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25405805|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25405806|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
25405807|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
25405808|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25405809|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25405810|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25405811|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
25405812|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
25405813|NCT03593018|Gemcitabine|gemcitabine|mesh-list
25405814|NCT03593018|Azacitidine|azacitidine|mesh-list
25405815|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25405816|NCT03593018|Romidepsin|romidepsin|mesh-list
25405817|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405818|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
25405819|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405820|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405821|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
25405822|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405823|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405824|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405825|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
25405826|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405827|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405828|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
25405829|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25405830|NCT03592472|Abexinostat|abexinostat|mesh-list
25405831|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25405832|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405833|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405834|NCT03592277|Vitamins|vitamins|mesh-list
25405835|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
25405836|NCT03592277|Thiamine|thiamine|mesh-list
25405837|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
25405838|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405839|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
25405840|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405841|NCT03592277|Protective Agents|protective agents|mesh-ancestor
25405842|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
25405843|NCT03591861|Carmustine|carmustine|mesh-list
25405844|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405845|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
25405846|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405847|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405848|NCT03591770|Vaccines|vaccines|mesh-list
25405849|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
25405850|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405851|NCT03591510|Cytarabine|cytarabine|mesh-list
25405852|NCT03591510|Fludarabine|fludarabine|mesh-list
25405861|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405862|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405863|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
25405864|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405865|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405866|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25405867|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25405868|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405869|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
25405870|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405871|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25405872|NCT03591510|Analgesics|analgesics|mesh-ancestor
25405873|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
25405874|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405875|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25405876|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25405877|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405878|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405879|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
25405880|NCT03589339|Nivolumab|nivolumab|mesh-list
25405881|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405882|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405883|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405884|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405885|NCT03589326|Cytarabine|cytarabine|mesh-list
25405886|NCT03589326|Dexamethasone|dexamethasone|mesh-list
25405887|NCT03589326|Prednisone|prednisone|mesh-list
25405888|NCT03589326|Methotrexate|methotrexate|mesh-list
25405889|NCT03589326|Vincristine|vincristine|mesh-list
25405890|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
25405891|NCT03589326|Ponatinib|ponatinib|mesh-list
25405892|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378615|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25378616|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25378617|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25378618|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
25378619|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
25378620|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405893|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
25405894|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
25405895|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405896|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405897|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25405898|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
25405899|NCT03589326|Hormones|hormones|mesh-ancestor
25405900|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25405901|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25405902|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405903|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25405904|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
25405905|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25405906|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405907|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
25405908|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405909|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25405910|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405911|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25405912|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405913|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
25405914|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405915|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25405916|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
25405917|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405918|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25405919|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405920|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405921|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405922|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25405923|NCT03587961|Ivacaftor|ivacaftor|mesh-list
25405924|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25405925|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25405926|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405927|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25405928|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405929|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405930|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
25405931|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
25405932|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405933|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405934|NCT03587584|Bupivacaine|bupivacaine|mesh-list
25405935|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
25405945|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405946|NCT03586661|Niraparib|niraparib|mesh-list
25405947|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25405948|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405949|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405950|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405951|NCT03586609|Cytarabine|cytarabine|mesh-list
25405952|NCT03586609|Azacitidine|azacitidine|mesh-list
25405953|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25405954|NCT03586609|Venetoclax|venetoclax|mesh-list
25405955|NCT03586609|Cladribine|cladribine|mesh-list
25405956|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25405957|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
25405958|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405959|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405960|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
25405961|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25405962|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25405963|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
25405964|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405965|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405966|NCT03586414|Ubiquinone|ubiquinone|mesh-list
25405967|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
25405968|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405969|NCT03584373|Acetaminophen|acetaminophen|mesh-list
25405970|NCT03584373|Ketorolac|ketorolac|mesh-list
25405971|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25405972|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25405973|NCT03584373|Oxycodone|oxycodone|mesh-list
25405974|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25405975|NCT03584373|Analgesics|analgesics|mesh-ancestor
25405976|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
25405977|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405978|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405979|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
25405980|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25405981|NCT03584373|Narcotics|narcotics|mesh-ancestor
25405982|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25405983|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25405984|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25405985|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25405986|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25405987|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405988|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405989|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25405990|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25405991|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405992|NCT03583086|Nivolumab|nivolumab|mesh-list
25405993|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25405994|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405995|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405996|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405997|NCT03582722|Orlistat|orlistat|mesh-list
25405998|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405999|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406000|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25406001|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25406002|NCT03582176|Ketotifen|ketotifen|mesh-list
25406003|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
25406004|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
25406005|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25406006|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
25406007|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
25406008|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406009|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406010|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406011|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25406012|NCT03582033|Dexamethasone|dexamethasone|mesh-list
25406013|NCT03582033|Pomalidomide|pomalidomide|mesh-list
25406014|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25406015|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
25406016|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
25406017|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406018|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406019|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25406020|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
25406022|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406023|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25406024|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406025|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
25406026|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25406027|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25406028|NCT03582033|Growth Substances|growth substances|mesh-ancestor
25406029|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
25406031|NCT03581487|Ipilimumab|ipilimumab|mesh-list
25406032|NCT03581487|Tremelimumab|tremelimumab|mesh-list
25406033|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
25406034|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25406035|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
25406261|NCT03573024|Venetoclax|venetoclax|mesh-list
25406036|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406037|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406038|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
25406039|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406040|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406041|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406042|NCT03581292|Temozolomide|temozolomide|mesh-list
25406043|NCT03581292|Veliparib|veliparib|mesh-list
25406044|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25406045|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
25406046|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406047|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406048|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25406049|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406050|NCT03580408|Nivolumab|nivolumab|mesh-list
25406051|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406052|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406053|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406054|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406055|NCT03580369|Omalizumab|omalizumab|mesh-list
25406056|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25406057|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25406058|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
25406059|NCT03580356|Omalizumab|omalizumab|mesh-list
25406060|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25406061|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25406062|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
25406063|NCT03580317|Carbamazepine|carbamazepine|mesh-list
25406064|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
25406065|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
25406066|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25406067|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25406068|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406069|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25406070|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25406071|NCT03580317|Analgesics|analgesics|mesh-ancestor
25406072|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
25406073|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406074|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25406075|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25406076|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406077|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25406078|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25406080|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25406081|NCT03580187|Narcotics|narcotics|mesh-ancestor
25406082|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25406083|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406084|NCT03580187|Analgesics|analgesics|mesh-ancestor
25406085|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
25406086|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406087|NCT03580044|Aztreonam|aztreonam|mesh-list
25406088|NCT03580044|Avibactam|avibactam|mesh-list
25406089|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25406090|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406091|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25406092|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406093|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406094|NCT03579615|Insulin|insulin|mesh-list
25406095|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
25406096|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25406126|NCT03576755|Diuretics|diuretics|mesh-ancestor
25406127|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
25406128|NCT03576612|Valacyclovir|valacyclovir|mesh-list
25406130|NCT03576612|Nivolumab|nivolumab|mesh-list
25406131|NCT03576612|Temozolomide|temozolomide|mesh-list
25406132|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406133|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406134|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406135|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406136|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25406137|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
25406138|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
25406139|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406167|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25406168|NCT03575403|Methylphenidate|methylphenidate|mesh-list
25406169|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25406170|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406171|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25406172|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25378848|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
25406173|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25406174|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406175|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
25406176|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406177|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25406187|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406188|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406189|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
25406190|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406191|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25406192|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
25406193|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406194|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25406195|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25406196|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25406197|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406198|NCT03575052|Pimavanserin|pimavanserin|mesh-list
25406199|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25406200|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25406201|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25406202|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25406203|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25406204|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406205|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25406206|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25406207|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25406208|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
25406209|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406210|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406211|NCT03575013|Docetaxel|docetaxel|mesh-list
25406212|NCT03575013|Avelumab|avelumab|mesh-list
25406213|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406214|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406215|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406216|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406217|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406218|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406219|NCT03574779|Paclitaxel|paclitaxel|mesh-list
25406220|NCT03574779|Bevacizumab|bevacizumab|mesh-list
25406221|NCT03574779|Carboplatin|carboplatin|mesh-list
25406222|NCT03574779|Niraparib|niraparib|mesh-list
25406223|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406224|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406225|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406226|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406227|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406228|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406229|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406230|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25406231|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25406232|NCT03574779|Growth Substances|growth substances|mesh-ancestor
25406233|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406234|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
25406235|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25406236|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406237|NCT03573349|Ketamine|ketamine|mesh-list
25406238|NCT03573349|Analgesics|analgesics|mesh-ancestor
25406239|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
25406240|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406241|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406242|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25406243|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25406244|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
25406245|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
25406246|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25406247|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25406248|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25406249|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406250|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406251|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
25406252|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406253|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406254|NCT03573297|Cariprazine|cariprazine|mesh-list
25406255|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25406256|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25406257|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25406258|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406259|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25406260|NCT03573024|Azacitidine|azacitidine|mesh-list
25406264|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406265|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406266|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406267|NCT03572530|Azacitidine|azacitidine|mesh-list
25406268|NCT03572530|Decitabine|decitabine|mesh-list
25406269|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406270|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
25406271|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406272|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406273|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406274|NCT03572387|Azacitidine|azacitidine|mesh-list
25406275|NCT03572387|Tretinoin|tretinoin|mesh-list
25406276|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406277|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
25406278|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406279|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406280|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406281|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
25406282|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
25406283|NCT03570814|Azithromycin|azithromycin|mesh-list
25406284|NCT03570814|Ivermectin|ivermectin|mesh-list
25406285|NCT03570814|Albendazole|albendazole|mesh-list
25406286|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25406287|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406288|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25406290|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
25406291|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25406292|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25406293|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406294|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406295|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406296|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406297|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406298|NCT03570619|Nivolumab|nivolumab|mesh-list
25406299|NCT03570619|Ipilimumab|ipilimumab|mesh-list
25406300|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406301|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406302|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406303|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406304|NCT03568643|Amoxicillin|amoxicillin|mesh-list
25406305|NCT03568643|Azithromycin|azithromycin|mesh-list
25406306|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25406307|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406308|NCT03568383|Pyridoxine|pyridoxine|mesh-list
25406309|NCT03568383|Pyridoxal|pyridoxal|mesh-list
25406310|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
25406311|NCT03568383|Isoniazid|isoniazid|mesh-list
25406312|NCT03568383|Vitamins|vitamins|mesh-ancestor
25406313|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
25406314|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406315|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
25406316|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
25406317|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25406318|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406319|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25406320|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25406321|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
25406322|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406323|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25406324|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
25406325|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406326|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406327|NCT03567876|Venetoclax|venetoclax|mesh-list
25406328|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406329|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25406330|NCT03565991|Avelumab|avelumab|mesh-list
25406331|NCT03565991|Talazoparib|talazoparib|mesh-list
25406332|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406333|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379002|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
25406334|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25406335|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406336|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406337|NCT03565835|Prednisone|prednisone|mesh-list
25406338|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
25406339|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25406340|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
25406342|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406348|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406349|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
25406350|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25406351|NCT03565783|Cemiplimab|cemiplimab|mesh-list
25406352|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406353|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406354|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
25406355|NCT03565445|Nivolumab|nivolumab|mesh-list
25406356|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406357|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406358|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406359|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406360|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
25406361|NCT03564756|Vitamins|vitamins|mesh-ancestor
25406362|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
25406363|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406364|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
25406365|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406366|NCT03564756|Protective Agents|protective agents|mesh-ancestor
25406367|NCT03564691|Paclitaxel|paclitaxel|mesh-list
25406368|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25406369|NCT03564691|Cisplatin|cisplatin|mesh-list
25406370|NCT03564691|Carboplatin|carboplatin|mesh-list
25406371|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
25406372|NCT03564691|Pemetrexed|pemetrexed|mesh-list
25406373|NCT03564691|Lenvatinib|lenvatinib|mesh-list
25406374|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406375|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406376|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406377|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406378|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406379|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406380|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406381|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406382|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25406383|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25406384|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25406385|NCT03564678|Folic Acid|folic acid|mesh-list
25406386|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
25406387|NCT03564678|Vitamins|vitamins|mesh-ancestor
25406388|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
25406389|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406390|NCT03564678|Hematinics|hematinics|mesh-ancestor
25406391|NCT03564340|Cemiplimab|cemiplimab|mesh-list
25406392|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406393|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406394|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
25406395|NCT03563729|Nivolumab|nivolumab|mesh-list
25406396|NCT03563729|Ipilimumab|ipilimumab|mesh-list
25406397|NCT03563729|Trametinib|trametinib|mesh-list
25406398|NCT03563729|Dabrafenib|dabrafenib|mesh-list
25406399|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406400|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406401|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406402|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406403|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25406404|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406405|NCT03563716|Atezolizumab|atezolizumab|mesh-list
25406406|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406407|NCT03563248|Nivolumab|nivolumab|mesh-list
25406408|NCT03563248|Folfirinox|folfirinox|mesh-list
25406409|NCT03563248|Losartan|losartan|mesh-list
25406410|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406411|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406412|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406413|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406414|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25379087|NCT04749108|Folfirinox|folfirinox|mesh-list
25406415|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25406416|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25406417|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25406418|NCT03561259|Vorinostat|vorinostat|mesh-list
25406419|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25406420|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406421|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25406422|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406423|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406424|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25406432|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406433|NCT03559647|Atezolizumab|atezolizumab|mesh-list
25406434|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406435|NCT03559348|Leucovorin|leucovorin|mesh-list
25406436|NCT03559348|Gemcitabine|gemcitabine|mesh-list
25406437|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406438|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
25406439|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406440|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406441|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
25406442|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406443|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406444|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25406445|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
25406446|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406447|NCT03559348|Antidotes|antidotes|mesh-ancestor
25406448|NCT03559348|Protective Agents|protective agents|mesh-ancestor
25406449|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
25406450|NCT03559348|Vitamins|vitamins|mesh-ancestor
25406451|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
25406452|NCT03558867|Metformin|metformin|mesh-list
25406453|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25406454|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406455|NCT03558503|Mitomycins|mitomycins|mesh-list
25406456|NCT03558503|Mitomycin|mitomycin|mesh-list
25406457|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25406458|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406459|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
25406460|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406461|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25406462|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406463|NCT03557385|Adenosine|adenosine|mesh-list
25406464|NCT03557385|Analgesics|analgesics|mesh-ancestor
25406465|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
25406466|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406467|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406468|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25406469|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
25406470|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25406471|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
25406472|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
25406473|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406474|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406475|NCT03557008|Metronidazole|metronidazole|mesh-list
25406476|NCT03557008|Vancomycin|vancomycin|mesh-list
25406477|NCT03557008|Neomycin|neomycin|mesh-list
25406478|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406479|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25406480|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25406481|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25406482|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25406483|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406484|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406485|NCT03556332|Dexamethasone|dexamethasone|mesh-list
25406486|NCT03556332|Lenalidomide|lenalidomide|mesh-list
25406487|NCT03556332|Daratumumab|daratumumab|mesh-list
25406488|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25406489|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
25406490|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
25406491|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406492|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406493|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25406494|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
25406495|NCT03556332|Hormones|hormones|mesh-ancestor
25406571|NCT03548571|Temozolomide|temozolomide|mesh-list
25416014|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379155|NCT04745949|Prednisone|prednisone|mesh-list
25406496|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406497|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25406498|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406499|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
25406500|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25406501|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25406502|NCT03556332|Growth Substances|growth substances|mesh-ancestor
25406503|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25406504|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
25406505|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
25406506|NCT03555149|Bevacizumab|bevacizumab|mesh-list
25406507|NCT03555149|Atezolizumab|atezolizumab|mesh-list
25406508|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406523|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406524|NCT03553875|Memantine|memantine|mesh-list
25406525|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25406526|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25406527|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
25406528|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406529|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406530|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406531|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25406532|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25406533|NCT03553563|Esomeprazole|esomeprazole|mesh-list
25406534|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25406535|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25406536|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25406537|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406538|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406539|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
25406540|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25406541|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25406542|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406543|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
25406544|NCT03553186|Coagulants|coagulants|mesh-ancestor
25406545|NCT03552692|Venetoclax|venetoclax|mesh-list
25406546|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406547|NCT03552471|Rucaparib|rucaparib|mesh-list
25406548|NCT03552471|Maytansine|maytansine|mesh-list
25406549|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25406550|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406551|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406552|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406553|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406554|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406555|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406556|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406557|NCT03551522|Seladelpar|seladelpar|mesh-list
25406558|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25406559|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
25406560|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406561|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25406562|NCT03550794|Thiamine|thiamine|mesh-list
25406563|NCT03550794|Vitamins|vitamins|mesh-ancestor
25406564|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
25406565|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406566|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
25406572|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25406573|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
25406574|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406575|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406577|NCT03547973|Cisplatin|cisplatin|mesh-list
25406578|NCT03547973|Carboplatin|carboplatin|mesh-list
25406579|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
25406580|NCT03547973|Avelumab|avelumab|mesh-list
25406581|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406582|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406583|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
25406584|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406585|NCT03547973|Antiviral Agents|antiviral agents|mesh-ancestor
25406586|NCT03547973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406587|NCT03547973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406588|NCT03547973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25406589|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
25406590|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406591|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406592|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25406593|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25406594|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25406602|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25406604|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406605|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
25406606|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406607|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406608|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25406609|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
25406610|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406611|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
25406612|NCT03547271|Vaccines|vaccines|mesh-list
25406613|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25406614|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
25406615|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406616|NCT03547115|Venetoclax|venetoclax|mesh-list
25406617|NCT03547115|Voruciclib|voruciclib|mesh-list
25406618|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406619|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25406620|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406621|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406628|NCT03546608|Tepotinib|tepotinib|mesh-list
25406629|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406630|NCT03544567|Paclitaxel|paclitaxel|mesh-list
25406631|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406632|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406633|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406634|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406635|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406636|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406637|NCT03544281|Dexamethasone|dexamethasone|mesh-list
25406638|NCT03544281|Lenalidomide|lenalidomide|mesh-list
25406639|NCT03544281|Bortezomib|bortezomib|mesh-list
25406640|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25406641|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
25406642|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
25406643|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406644|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406645|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25406646|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
25406647|NCT03544281|Hormones|hormones|mesh-ancestor
25406648|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406649|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25406650|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406651|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
25406652|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25406653|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25406654|NCT03544281|Growth Substances|growth substances|mesh-ancestor
25406655|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25406656|NCT03543969|Vemurafenib|vemurafenib|mesh-list
25406657|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406658|NCT03543969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25406659|NCT03543969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406660|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406661|NCT03542175|Rucaparib|rucaparib|mesh-list
25406662|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25406663|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406664|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406665|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406666|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25406667|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25406668|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25406669|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
25406670|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406671|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25406672|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25406673|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406674|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
25406675|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25406676|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25406677|NCT03539445|Protective Agents|protective agents|mesh-ancestor
25406678|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406679|NCT03539198|Nivolumab|nivolumab|mesh-list
25406680|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406681|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406682|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406683|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406684|NCT03538938|Nicotine|nicotine|mesh-list
25406685|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25406686|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
25406687|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406688|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406689|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25406690|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25406691|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
25406692|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406693|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406694|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
25406695|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
25406696|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
25406697|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25406698|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25406699|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406700|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406701|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406702|NCT03537508|Vaccines|vaccines|mesh-list
25406703|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
25406704|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406705|NCT03537495|Linezolid|linezolid|mesh-list
25406706|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25406707|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406708|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25406709|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406710|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406711|NCT03536728|Eflornithine|eflornithine|mesh-list
25406712|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406713|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25406714|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25406715|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25406716|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406717|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25406718|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406719|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406720|NCT03536039|Prednisone|prednisone|mesh-list
25406721|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
25406722|NCT03536039|Rituximab|rituximab|mesh-list
25406723|NCT03536039|Doxorubicin|doxorubicin|mesh-list
25406724|NCT03536039|Vincristine|vincristine|mesh-list
25406725|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25406726|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
25406727|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406728|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25406729|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25406730|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
25406731|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406732|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406733|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25406734|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406735|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25406736|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25406737|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25406738|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406739|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25406740|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
25406741|NCT03536039|Hormones|hormones|mesh-ancestor
25406742|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406743|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25406744|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406749|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25406750|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406751|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406752|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406753|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25379390|NCT04739800|Paclitaxel|paclitaxel|mesh-list
25406754|NCT03534180|Venetoclax|venetoclax|mesh-list
25406755|NCT03534180|Romidepsin|romidepsin|mesh-list
25406756|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406757|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406758|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25406759|NCT03533582|Gemcitabine|gemcitabine|mesh-list
25406760|NCT03533582|Cisplatin|cisplatin|mesh-list
25406761|NCT03533582|Carboplatin|carboplatin|mesh-list
25406762|NCT03533582|Doxorubicin|doxorubicin|mesh-list
25406763|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25406764|NCT03533582|Fluorouracil|fluorouracil|mesh-list
25406765|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
25406766|NCT03533582|Irinotecan|irinotecan|mesh-list
25406767|NCT03533582|Etoposide|etoposide|mesh-list
25406768|NCT03533582|Vincristine|vincristine|mesh-list
25406769|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
25406770|NCT03533582|Sorafenib|sorafenib|mesh-list
25406771|NCT03533582|Daunorubicin|daunorubicin|mesh-list
25406772|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
25406773|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406774|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406775|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
25406776|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406777|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
25406778|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406779|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406780|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25406781|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
25406782|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406783|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25406784|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25406785|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25406786|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25406787|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406788|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406789|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406790|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406791|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25406792|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
25406793|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
25406794|NCT03533283|Atezolizumab|atezolizumab|mesh-list
25406795|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
25406796|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406797|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406798|NCT03532880|Olaparib|olaparib|mesh-list
25406799|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25406800|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406801|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406802|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406803|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25406804|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25406805|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25406806|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25406807|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406808|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406809|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
25406810|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406811|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25406812|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25406813|NCT03532399|Bivalirudin|bivalirudin|mesh-list
25406814|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
25406815|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25406816|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
25406817|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406818|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406819|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
25406820|NCT03532217|Nivolumab|nivolumab|mesh-list
25406821|NCT03532217|Ipilimumab|ipilimumab|mesh-list
25406822|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406823|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406824|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406900|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
25406825|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406826|NCT03531762|Tepotinib|tepotinib|mesh-list
25406827|NCT03531762|Omeprazole|omeprazole|mesh-list
25406828|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25406829|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25406830|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25406831|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406832|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406833|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406834|NCT03530683|Dexamethasone|dexamethasone|mesh-list
25406835|NCT03530683|Azacitidine|azacitidine|mesh-list
25406836|NCT03530683|Venetoclax|venetoclax|mesh-list
25406837|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25406838|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
25406839|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
25406840|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406841|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406842|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25406843|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
25406844|NCT03530683|Hormones|hormones|mesh-ancestor
25406845|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406846|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25406847|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406848|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406849|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
25406850|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406851|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406852|NCT03530397|Paclitaxel|paclitaxel|mesh-list
25406853|NCT03530397|Carboplatin|carboplatin|mesh-list
25406854|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
25406855|NCT03530397|Pemetrexed|pemetrexed|mesh-list
25406856|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406857|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406858|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406859|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406860|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406861|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406862|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406863|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406864|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25406865|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25406866|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
25406867|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25406868|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25406869|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406870|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25406871|NCT03530371|Analgesics|analgesics|mesh-ancestor
25406872|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
25406873|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406874|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25406875|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25406876|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25406877|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
25406878|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406879|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406880|NCT03529487|Phenylephrine|phenylephrine|mesh-list
25406881|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
25406882|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25406883|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25406884|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
25406885|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406886|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406887|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406888|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
25406889|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
25406890|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25406891|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
25406892|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25406893|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
25406894|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25406895|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
25406896|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25406897|NCT03529487|Protective Agents|protective agents|mesh-ancestor
25406898|NCT03529448|Temozolomide|temozolomide|mesh-list
25406899|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25406901|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406902|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406903|NCT03528902|Tamoxifen|tamoxifen|mesh-list
25406904|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25406905|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
25406906|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406907|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406908|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25406909|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406910|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25406911|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25406912|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25406913|NCT03528694|Durvalumab|durvalumab|mesh-list
25406914|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
25406915|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406916|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406917|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25406918|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
25406919|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406920|NCT03528408|Nivolumab|nivolumab|mesh-list
25406921|NCT03528408|Ipilimumab|ipilimumab|mesh-list
25406922|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406923|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406924|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25406925|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406926|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25406927|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
25406928|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406929|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406930|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406931|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25406932|NCT03527537|Insulin|insulin|mesh-list
25406933|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25406934|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406935|NCT03527147|Rituximab|rituximab|mesh-list
25406936|NCT03527147|Magrolimab|magrolimab|mesh-list
25406937|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
25406938|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406939|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406940|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
25406941|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406942|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25406943|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25406944|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25406945|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25406946|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
25406947|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406948|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25406949|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25406950|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406951|NCT03526250|Palbociclib|palbociclib|mesh-list
25406952|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406953|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25406954|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406955|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406956|NCT03525574|Ivacaftor|ivacaftor|mesh-list
25406957|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25406958|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25406959|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406960|NCT03525119|Vaccines|vaccines|mesh-list
25406961|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
25406962|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406963|NCT03524898|Gemcitabine|gemcitabine|mesh-list
25406964|NCT03524898|Paclitaxel|paclitaxel|mesh-list
25406965|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25406966|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406967|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
25406968|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
25406969|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406970|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406971|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406972|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
25406973|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
25406974|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406985|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406986|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25406987|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406988|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25406989|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
25406990|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406991|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25406992|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25406993|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406994|NCT03524235|Rituximab|rituximab|mesh-list
25406995|NCT03524235|Fludarabine|fludarabine|mesh-list
25406996|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25406997|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406998|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406999|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
25407000|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407001|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407002|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407003|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25407004|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
25407005|NCT03524092|Mirikizumab|mirikizumab|mesh-list
25407006|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407007|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407008|NCT03524092|Analgesics|analgesics|mesh-ancestor
25407009|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
25407010|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407011|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407012|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407013|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407014|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25407015|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25407016|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
25407017|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
25407018|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407019|NCT03523585|Capecitabine|capecitabine|mesh-list
25407020|NCT03523585|Trastuzumab|trastuzumab|mesh-list
25407021|NCT03523585|Lapatinib|lapatinib|mesh-list
25407173|NCT03513445|Ropivacaine|ropivacaine|mesh-list
25407022|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407023|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
25407024|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407025|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407026|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407027|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25407028|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407029|NCT03523429|Blinatumomab|blinatumomab|mesh-list
25407030|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407031|NCT03522298|GDC-0084|gdc-0084|mesh-list
25407032|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407033|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407034|NCT03522168|Risperidone|risperidone|mesh-list
25407035|NCT03522168|Aripiprazole|aripiprazole|mesh-list
25407036|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25407037|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
25407038|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407039|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407040|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407041|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25407042|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25407043|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407044|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25407045|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25407046|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
25407047|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
25407048|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
25407049|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25407050|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25407051|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25407052|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25407053|NCT03521232|Niclosamide|niclosamide|mesh-list
25407054|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
25407055|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25407056|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
25407057|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25407058|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407061|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407062|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407063|NCT03521193|Analgesics|analgesics|mesh-ancestor
25379681|NCT04730609|Analgesics|analgesics|mesh-ancestor
25379682|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
25379683|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379684|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25379685|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25379686|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25407064|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
25407065|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407066|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407067|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407068|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407069|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25407070|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25407071|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407072|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25407073|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25407074|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407075|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
25407076|NCT03521154|Osimertinib|osimertinib|mesh-list
25407077|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407078|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25407079|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407080|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407081|NCT03520790|Gemcitabine|gemcitabine|mesh-list
25407082|NCT03520790|Paclitaxel|paclitaxel|mesh-list
25407083|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25407084|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407085|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
25407086|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
25407087|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
25407088|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407089|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407090|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
25407091|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
25407092|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407093|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407094|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407095|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
25407174|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25407096|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407097|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25407098|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
25407099|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407100|NCT03519945|Mirikizumab|mirikizumab|mesh-list
25407101|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407102|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407103|NCT03519945|Analgesics|analgesics|mesh-ancestor
25407104|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
25407105|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407106|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407107|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407108|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407109|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25407110|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25407111|NCT03519646|Eliglustat|eliglustat|mesh-list
25407112|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407113|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407114|NCT03519256|Nivolumab|nivolumab|mesh-list
25407115|NCT03519256|Linrodostat|linrodostat|mesh-list
25407116|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407117|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407118|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25407119|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407120|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407121|NCT03518801|Cannabidiol|cannabidiol|mesh-list
25407122|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
25407123|NCT03518086|Mirikizumab|mirikizumab|mesh-list
25407124|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407125|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407126|NCT03518086|Analgesics|analgesics|mesh-ancestor
25407127|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
25407128|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407129|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407130|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407131|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407132|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25407133|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25407134|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
25407144|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407146|NCT03515837|Carboplatin|carboplatin|mesh-list
25407147|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
25407148|NCT03515837|Pemetrexed|pemetrexed|mesh-list
25407149|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25407150|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407151|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407152|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407153|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407154|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25407155|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25407156|NCT03515304|Evolocumab|evolocumab|mesh-list
25407157|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25407158|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25407159|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
25407160|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407161|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25407162|NCT03514589|Cosyntropin|cosyntropin|mesh-list
25407163|NCT03514589|Hormones|hormones|mesh-ancestor
25407164|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407165|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407171|NCT03513445|Epinephrine|epinephrine|mesh-list
25407172|NCT03513445|Morphine|morphine|mesh-list
25407175|NCT03513445|Narcotics|narcotics|mesh-ancestor
25407176|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407177|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407178|NCT03513445|Analgesics|analgesics|mesh-ancestor
25407179|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
25407180|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407181|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25407182|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25407183|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
25407184|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407185|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407186|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25407187|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25407188|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
25407189|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25407190|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
25407191|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
25407192|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
25407193|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25407194|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
25407195|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
25407196|NCT03511976|Methylphenidate|methylphenidate|mesh-list
25407197|NCT03511976|Amphetamine|amphetamine|mesh-list
25407198|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25407199|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407200|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25407201|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25407202|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25407203|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407204|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
25407205|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407206|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
25407207|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
25407208|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407209|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
25407210|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25407211|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
25407212|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25407213|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407214|NCT03511196|Prednisone|prednisone|mesh-list
25407215|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
25407216|NCT03511196|Androgens|androgens|mesh-list
25379836|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
25407217|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407219|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407220|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407221|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25407222|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407223|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
25407224|NCT03510884|Niacin|niacin|mesh-list
25407225|NCT03510884|Niacinamide|niacinamide|mesh-list
25407226|NCT03510884|Atorvastatin|atorvastatin|mesh-list
25407227|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25407228|NCT03510884|Simvastatin|simvastatin|mesh-list
25407229|NCT03510884|Ezetimibe|ezetimibe|mesh-list
25407230|NCT03510884|Pravastatin|pravastatin|mesh-list
25407231|NCT03510884|Lovastatin|lovastatin|mesh-list
25407232|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
25407233|NCT03510884|Fenofibrate|fenofibrate|mesh-list
25407234|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25407235|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25407236|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
25407237|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407238|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25407239|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25407240|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407241|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
25407242|NCT03510884|Vitamins|vitamins|mesh-ancestor
25407243|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
25407244|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407245|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
25407246|NCT03510468|Pyridoxine|pyridoxine|mesh-list
25407247|NCT03510468|Isoniazid|isoniazid|mesh-list
25407248|NCT03510468|Rifapentine|rifapentine|mesh-list
25407249|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
25407250|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25407251|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407252|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25407253|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25407254|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
25407255|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407256|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25407257|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
25407258|NCT03510468|Vitamins|vitamins|mesh-ancestor
25407259|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
25407260|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407261|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25407262|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
25407263|NCT03509012|Paclitaxel|paclitaxel|mesh-list
25407264|NCT03509012|Etoposide|etoposide|mesh-list
25407265|NCT03509012|Cisplatin|cisplatin|mesh-list
25407266|NCT03509012|Carboplatin|carboplatin|mesh-list
25407267|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
25407268|NCT03509012|Pemetrexed|pemetrexed|mesh-list
25407269|NCT03509012|Durvalumab|durvalumab|mesh-list
25407270|NCT03509012|Tremelimumab|tremelimumab|mesh-list
25407271|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25407272|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407273|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25407274|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
25407275|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
25407276|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407277|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25407278|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25407279|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407280|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25407281|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25407282|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407283|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25407284|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25407285|NCT03508921|Trimethoprim|trimethoprim|mesh-list
25407286|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
25407287|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25407288|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25407289|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407290|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
25407291|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25407292|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407293|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407294|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25407295|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25407296|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407314|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407315|NCT03508726|Protective Agents|protective agents|mesh-ancestor
25407316|NCT03507608|Flutamide|flutamide|mesh-list
25407317|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
25407318|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
25407319|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407320|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407321|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25407322|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407323|NCT03507413|Metformin|metformin|mesh-list
25407324|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25407325|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407326|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25407327|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25407328|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407329|NCT03506373|Ixazomib|ixazomib|mesh-list
25407330|NCT03506373|Glycine|glycine|mesh-list
25407331|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407332|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407333|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
25407334|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407335|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
25407336|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407337|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407338|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25407339|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25407340|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407341|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
25407342|NCT03505320|Leucovorin|leucovorin|mesh-list
25407343|NCT03505320|Folic Acid|folic acid|mesh-list
25407344|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
25407345|NCT03505320|Nivolumab|nivolumab|mesh-list
25407346|NCT03505320|Fluorouracil|fluorouracil|mesh-list
25407347|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
25407348|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
25407349|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407350|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407351|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
25407352|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407353|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407354|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407355|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
25407356|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407357|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25407358|NCT03505320|Antidotes|antidotes|mesh-ancestor
25407359|NCT03505320|Protective Agents|protective agents|mesh-ancestor
25407360|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
25407361|NCT03505320|Vitamins|vitamins|mesh-ancestor
25407362|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
25407363|NCT03505320|Hematinics|hematinics|mesh-ancestor
25407364|NCT03504423|Leucovorin|leucovorin|mesh-list
25407365|NCT03504423|Folic Acid|folic acid|mesh-list
25407366|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
25407367|NCT03504423|Irinotecan|irinotecan|mesh-list
25407368|NCT03504423|Folfirinox|folfirinox|mesh-list
25407369|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
25407370|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407371|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25407372|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25407373|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407374|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407375|NCT03504423|Antidotes|antidotes|mesh-ancestor
25407376|NCT03504423|Protective Agents|protective agents|mesh-ancestor
25407377|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407378|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
25407379|NCT03504423|Vitamins|vitamins|mesh-ancestor
25407380|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
25407381|NCT03504423|Hematinics|hematinics|mesh-ancestor
25407382|NCT03504410|Cytarabine|cytarabine|mesh-list
25407383|NCT03504410|Fludarabine|fludarabine|mesh-list
25407384|NCT03504410|Etoposide|etoposide|mesh-list
25407385|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
25407386|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407387|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407388|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
25407389|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407390|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407391|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
25407392|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407408|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407409|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407410|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407411|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407412|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
25407413|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407414|NCT03504397|Antidotes|antidotes|mesh-ancestor
25407415|NCT03504397|Protective Agents|protective agents|mesh-ancestor
25407416|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
25407417|NCT03504397|Vitamins|vitamins|mesh-ancestor
25407418|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
25407419|NCT03504397|Hematinics|hematinics|mesh-ancestor
25407420|NCT03503409|Ivosidenib|ivosidenib|mesh-list
25407421|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407422|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407423|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407424|NCT03503058|Chloroquine|chloroquine|mesh-list
25407425|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25407426|NCT03503058|Amebicides|amebicides|mesh-ancestor
25407427|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25407428|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25407429|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407430|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
25407431|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407432|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407433|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407434|NCT03503058|Analgesics|analgesics|mesh-ancestor
25407435|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
25407436|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407437|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407438|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407439|NCT03503058|Filaricides|filaricides|mesh-ancestor
25407440|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
25407441|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
25407442|NCT03502785|Atezolizumab|atezolizumab|mesh-list
25407443|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407444|NCT03502746|Nivolumab|nivolumab|mesh-list
25407445|NCT03502746|Ramucirumab|ramucirumab|mesh-list
25407446|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407447|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407448|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25407449|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407450|NCT03502031|Losartan|losartan|mesh-list
25407451|NCT03502031|Valsartan|valsartan|mesh-list
25407452|NCT03502031|Enalapril|enalapril|mesh-list
25407453|NCT03502031|Enalaprilat|enalaprilat|mesh-list
25407454|NCT03502031|Lisinopril|lisinopril|mesh-list
25407455|NCT03502031|Perindopril|perindopril|mesh-list
25407456|NCT03502031|Spironolactone|spironolactone|mesh-list
25407457|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25407458|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25407459|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25407460|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407461|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25407462|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25407463|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
25407464|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407465|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407466|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25407467|NCT03502031|Diuretics|diuretics|mesh-ancestor
25407468|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
25407469|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25407470|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
25407471|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407472|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25407473|NCT03502031|Protective Agents|protective agents|mesh-ancestor
25407474|NCT03502018|Bupivacaine|bupivacaine|mesh-list
25407475|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
25407476|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
25407477|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407478|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407479|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
25407480|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407481|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
25380066|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380067|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380068|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407482|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25407483|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
25407484|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407489|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407490|NCT03499249|Protective Agents|protective agents|mesh-ancestor
25407491|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407492|NCT03499249|Antidotes|antidotes|mesh-ancestor
25407493|NCT03498716|Paclitaxel|paclitaxel|mesh-list
25407494|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
25407495|NCT03498716|Doxorubicin|doxorubicin|mesh-list
25407496|NCT03498716|Atezolizumab|atezolizumab|mesh-list
25407497|NCT03498716|Epirubicin|epirubicin|mesh-list
25407498|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25407499|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407500|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
25407501|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
25407502|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
25407503|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407504|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407505|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
25407506|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407507|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407508|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25407509|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
25407510|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25407511|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25407512|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25407513|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25407514|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407515|NCT03498521|Gemcitabine|gemcitabine|mesh-list
25407516|NCT03498521|Bevacizumab|bevacizumab|mesh-list
25407517|NCT03498521|Carboplatin|carboplatin|mesh-list
25407518|NCT03498521|Trastuzumab|trastuzumab|mesh-list
25407519|NCT03498521|Atezolizumab|atezolizumab|mesh-list
25407520|NCT03498521|Olaparib|olaparib|mesh-list
25407521|NCT03498521|Pertuzumab|pertuzumab|mesh-list
25407522|NCT03498521|Vemurafenib|vemurafenib|mesh-list
25407523|NCT03498521|Ivosidenib|ivosidenib|mesh-list
25407524|NCT03498521|Entrectinib|entrectinib|mesh-list
25407525|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407526|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407527|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407528|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25407529|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25407530|NCT03498521|Growth Substances|growth substances|mesh-ancestor
25407531|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407532|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
25407533|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407534|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
25407535|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
25407536|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407537|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407538|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407539|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
25407540|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25407541|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25407542|NCT03498313|Estradiol|estradiol|mesh-list
25407543|NCT03498313|Progesterone|progesterone|mesh-list
25407544|NCT03498313|Estrogens|estrogens|mesh-ancestor
25407545|NCT03498313|Hormones|hormones|mesh-ancestor
25407546|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407547|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407548|NCT03498313|Progestins|progestins|mesh-ancestor
25407549|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25407550|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25407551|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
25407552|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407553|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407554|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407555|NCT03497975|Nalbuphine|nalbuphine|mesh-list
25407556|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25407557|NCT03497975|Narcotics|narcotics|mesh-ancestor
25407558|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407559|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407560|NCT03497975|Analgesics|analgesics|mesh-ancestor
25407561|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
25407562|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407563|NCT03496766|Tipifarnib|tipifarnib|mesh-list
25407564|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407565|NCT03496623|Treprostinil|treprostinil|mesh-list
25407566|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25407572|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407573|NCT03493165|Everolimus|everolimus|mesh-list
25407574|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407575|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407576|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
25407577|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407578|NCT03492658|Methotrexate|methotrexate|mesh-list
25407579|NCT03492658|Abatacept|abatacept|mesh-list
25407580|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25407581|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
25407582|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25407583|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407584|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407585|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
25407586|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407587|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407588|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
25407589|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407590|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25407591|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407592|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
25407593|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407594|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25407595|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25407596|NCT03492437|Tepotinib|tepotinib|mesh-list
25407597|NCT03492437|Dabigatran|dabigatran|mesh-list
25407598|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
25407599|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25407600|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
25407601|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407602|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407603|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
25407604|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407605|NCT03492177|Selexipag|selexipag|mesh-list
25407606|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25407607|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
25407608|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25407609|NCT03492112|Velpatasvir|velpatasvir|mesh-list
25407610|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
25407611|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407612|NCT03491683|Temozolomide|temozolomide|mesh-list
25407613|NCT03491683|Cemiplimab|cemiplimab|mesh-list
25407614|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25407615|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
25407616|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407617|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407618|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407619|NCT03491345|Avelumab|avelumab|mesh-list
25407620|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407621|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407622|NCT03488251|Gemcitabine|gemcitabine|mesh-list
25407623|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
25407624|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407625|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
25407626|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407627|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407628|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
25407629|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407630|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407631|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407632|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
25407633|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407634|NCT03487016|Gemcitabine|gemcitabine|mesh-list
25407635|NCT03487016|Paclitaxel|paclitaxel|mesh-list
25407636|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
25407637|NCT03487016|Irinotecan|irinotecan|mesh-list
25407638|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25407639|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407640|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
25407641|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
25407642|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
25407643|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407644|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407645|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
25407646|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
25407647|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407648|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407659|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407660|NCT03485417|Aripiprazole|aripiprazole|mesh-list
25407661|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25407662|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
25407663|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25407664|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25407665|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25407666|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407667|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407668|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
25407669|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
25407670|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407671|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407672|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25407673|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25407674|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
25407675|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25407676|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25407677|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25407678|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25407679|NCT03485209|Cisplatin|cisplatin|mesh-list
25407680|NCT03485209|Carboplatin|carboplatin|mesh-list
25407681|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
25407682|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
25407683|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407684|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407685|NCT03484520|Venetoclax|venetoclax|mesh-list
25407686|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407687|NCT03483883|Gemcitabine|gemcitabine|mesh-list
25407688|NCT03483883|Avelumab|avelumab|mesh-list
25407689|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407690|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
25407691|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407692|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407693|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
25407694|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407695|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407696|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407697|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
25407698|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407699|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407700|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25407701|NCT03483363|Bacitracin|bacitracin|mesh-list
25407702|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25407703|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407704|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
25407705|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25407706|NCT03483038|Irinotecan|irinotecan|mesh-list
25407707|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25407708|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25407709|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407710|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407711|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407712|NCT03483012|Atezolizumab|atezolizumab|mesh-list
25407713|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407714|NCT03482297|Midodrine|midodrine|mesh-list
25407715|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
25407716|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
25407717|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407718|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407719|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25407720|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25407721|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25407722|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25407723|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
25407724|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407725|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407726|NCT03482167|Niacinamide|niacinamide|mesh-list
25407727|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
25407728|NCT03482167|Vitamins|vitamins|mesh-ancestor
25407729|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
25407730|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407731|NCT03482102|Durvalumab|durvalumab|mesh-list
25407732|NCT03482102|Tremelimumab|tremelimumab|mesh-list
25407733|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407734|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407741|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407742|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
25407743|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25407744|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407745|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407746|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407747|NCT03480061|Analgesics|analgesics|mesh-ancestor
25407748|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
25407749|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407750|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25407751|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25407752|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25407753|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
25407754|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407755|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407756|NCT03479476|Metformin|metformin|mesh-list
25407757|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25407758|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407759|NCT03478878|Vitamin A|vitamin a|mesh-list
25407760|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
25407761|NCT03478878|Vitamins|vitamins|mesh-ancestor
25407762|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
25407763|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407764|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
25407765|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407766|NCT03478878|Protective Agents|protective agents|mesh-ancestor
25407767|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25407768|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407769|NCT03478865|Vitamin A|vitamin a|mesh-list
25407770|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
25407771|NCT03478865|Vitamins|vitamins|mesh-ancestor
25407772|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
25407773|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407774|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
25407775|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407776|NCT03478865|Protective Agents|protective agents|mesh-ancestor
25407777|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25407778|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407779|NCT03478514|Palbociclib|palbociclib|mesh-list
25407780|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407781|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25407782|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407783|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407784|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25407785|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25407786|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
25407787|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
25407788|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
25407789|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407790|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25407791|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
25407792|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
25407944|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407793|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407794|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
25407795|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407796|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407797|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25407798|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
25407799|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407800|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407801|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25407802|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407804|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25407805|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25407806|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407807|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
25407808|NCT03475342|Coagulants|coagulants|mesh-ancestor
25407809|NCT03475186|Ramipril|ramipril|mesh-list
25407810|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25407811|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
25407813|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407814|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25407816|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25407818|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407819|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
25407820|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407821|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407822|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25407823|NCT03474770|Protective Agents|protective agents|mesh-ancestor
25407824|NCT03474107|Paclitaxel|paclitaxel|mesh-list
25407825|NCT03474107|Docetaxel|docetaxel|mesh-list
25407826|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25407827|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407828|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25407829|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25407830|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25407831|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407832|NCT03473756|Atezolizumab|atezolizumab|mesh-list
25407833|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407834|NCT03473743|Cisplatin|cisplatin|mesh-list
25407835|NCT03473743|Carboplatin|carboplatin|mesh-list
25407836|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407837|NCT03473730|Daratumumab|daratumumab|mesh-list
25407838|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407839|NCT03473340|Pirfenidone|pirfenidone|mesh-list
25407840|NCT03473340|Analgesics|analgesics|mesh-ancestor
25407841|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
25407842|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407843|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407844|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407845|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407846|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407847|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407848|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407849|NCT03472885|Eculizumab|eculizumab|mesh-list
25407850|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25407851|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407852|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
25407853|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407854|NCT03472586|Nivolumab|nivolumab|mesh-list
25407855|NCT03472586|Ipilimumab|ipilimumab|mesh-list
25407856|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407857|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407858|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25407859|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407860|NCT03472560|Avelumab|avelumab|mesh-list
25407861|NCT03472560|Axitinib|axitinib|mesh-list
25407862|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407863|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407864|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25407865|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407866|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407867|NCT03472274|Cisplatin|cisplatin|mesh-list
25407868|NCT03472274|Durvalumab|durvalumab|mesh-list
25407869|NCT03472274|Tremelimumab|tremelimumab|mesh-list
25407870|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407871|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407872|NCT03471507|Diclofenac|diclofenac|mesh-list
25407873|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407874|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407875|NCT03471507|Analgesics|analgesics|mesh-ancestor
25407876|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
25407877|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407878|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407879|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407880|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407881|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25407882|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380479|NCT04687761|Venetoclax|venetoclax|mesh-list
25407883|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407884|NCT03471442|Bupivacaine|bupivacaine|mesh-list
25407885|NCT03471442|Ropivacaine|ropivacaine|mesh-list
25407886|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
25407887|NCT03471442|Anesthetics|anesthetics|mesh-list
25407888|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
25407889|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407890|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407891|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
25407892|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407893|NCT03471260|Azacitidine|azacitidine|mesh-list
25407894|NCT03471260|Venetoclax|venetoclax|mesh-list
25407898|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407899|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407900|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407902|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
25407903|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
25407904|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407905|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407906|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
25407907|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407908|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25407909|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25407910|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25407911|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25407912|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407913|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
25407914|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407915|NCT03470805|Olaparib|olaparib|mesh-list
25407916|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25407917|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407918|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407919|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407920|NCT03468985|Nivolumab|nivolumab|mesh-list
25407921|NCT03468985|Ipilimumab|ipilimumab|mesh-list
25407922|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407923|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407924|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25407925|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407926|NCT03467958|Ozanimod|ozanimod|mesh-list
25407927|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25407928|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407929|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407930|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
25407931|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407932|NCT03467750|Ketorolac|ketorolac|mesh-list
25407933|NCT03467750|Morphine|morphine|mesh-list
25407934|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25407935|NCT03467750|Narcotics|narcotics|mesh-ancestor
25407936|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25407937|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407938|NCT03467750|Analgesics|analgesics|mesh-ancestor
25407939|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
25407940|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407941|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407942|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407943|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407945|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25407946|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407947|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407948|NCT03467373|Prednisone|prednisone|mesh-list
25407949|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
25407950|NCT03467373|Rituximab|rituximab|mesh-list
25407951|NCT03467373|Doxorubicin|doxorubicin|mesh-list
25407952|NCT03467373|Vincristine|vincristine|mesh-list
25407953|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
25407954|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407955|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
25407956|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407957|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407958|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25407959|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
25416015|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407960|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407961|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407962|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25407963|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407964|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25407965|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25407966|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25407967|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407968|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407969|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
25407970|NCT03467373|Hormones|hormones|mesh-ancestor
25407971|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407986|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407987|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407988|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407989|NCT03464448|Teriflunomide|teriflunomide|mesh-list
25407990|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25407991|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407992|NCT03464448|Analgesics|analgesics|mesh-ancestor
25407993|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
25407994|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407995|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407996|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407997|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25407998|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25407999|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
25408001|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25408002|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408003|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408004|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
25408005|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408006|NCT03464045|Empagliflozin|empagliflozin|mesh-list
25408007|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25408008|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25408009|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408010|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25408011|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408012|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
25408013|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408014|NCT03462966|Rifaximin|rifaximin|mesh-list
25408015|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25408016|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408017|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25408018|NCT03462719|Venetoclax|venetoclax|mesh-list
25408019|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
25408020|NCT03462719|Chlorambucil|chlorambucil|mesh-list
25408021|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408022|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408023|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408024|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
25408025|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408026|NCT03462641|Flumazenil|flumazenil|mesh-list
25408027|NCT03462641|Antidotes|antidotes|mesh-ancestor
25408028|NCT03462641|Protective Agents|protective agents|mesh-ancestor
25408029|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408030|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
25408031|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
25408032|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408033|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408034|NCT03462342|Olaparib|olaparib|mesh-list
25408035|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25408036|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408037|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408038|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408039|NCT03461003|Losartan|losartan|mesh-list
25408040|NCT03461003|Amlodipine|amlodipine|mesh-list
25408041|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25408042|NCT03461003|Lisinopril|lisinopril|mesh-list
25408043|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25408044|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25408045|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25408046|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408047|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25408048|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408049|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
25408050|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25408051|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25408052|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25408053|NCT03461003|Diuretics|diuretics|mesh-ancestor
25408054|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
25408055|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25408056|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25408057|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
25408058|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408095|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25408096|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25408097|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408098|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408099|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25408100|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
25408101|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408102|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
25408103|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408104|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25408105|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25408106|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25408107|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
25408109|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25408110|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408139|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
25408140|NCT03456843|Docetaxel|docetaxel|mesh-list
25408141|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
25408142|NCT03456843|Hormones|hormones|mesh-list
25408143|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25408144|NCT03456843|Androgens|androgens|mesh-list
25408145|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
25408146|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408147|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408148|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408150|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408151|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408152|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408153|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
25408154|NCT03456843|Protective Agents|protective agents|mesh-ancestor
25408155|NCT03456843|Vitamins|vitamins|mesh-ancestor
25408156|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
25408157|NCT03456843|Estrogens|estrogens|mesh-ancestor
25408158|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408159|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
25408160|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
25408161|NCT03456687|Exenatide|exenatide|mesh-list
25408162|NCT03456687|Glucagon|glucagon|mesh-list
25408163|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25408164|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25408165|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408166|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25408167|NCT03456687|Incretins|incretins|mesh-ancestor
25408168|NCT03456687|Hormones|hormones|mesh-ancestor
25408169|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408170|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25408171|NCT03456102|Pravastatin|pravastatin|mesh-list
25408172|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25408173|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25408174|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
25408175|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408176|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25408177|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25408178|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408179|NCT03456076|Gemcitabine|gemcitabine|mesh-list
25408180|NCT03456076|Cisplatin|cisplatin|mesh-list
25408181|NCT03456076|Carboplatin|carboplatin|mesh-list
25408182|NCT03456076|Pemetrexed|pemetrexed|mesh-list
25408183|NCT03456076|Vinorelbine|vinorelbine|mesh-list
25408184|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408185|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25408186|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
25408187|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408188|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
25408189|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408190|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408191|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408192|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
25408193|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408194|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25408195|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25408196|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408197|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408198|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408199|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408200|NCT03456063|Gemcitabine|gemcitabine|mesh-list
25408201|NCT03456063|Paclitaxel|paclitaxel|mesh-list
25408202|NCT03456063|Cisplatin|cisplatin|mesh-list
25408203|NCT03456063|Carboplatin|carboplatin|mesh-list
25408204|NCT03456063|Pemetrexed|pemetrexed|mesh-list
25408205|NCT03456063|Atezolizumab|atezolizumab|mesh-list
25408206|NCT03456063|Antibodies|antibodies|mesh-list
25408207|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408208|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408209|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408210|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408211|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408212|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408213|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
25408214|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408215|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25408216|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
25408217|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
25408218|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408219|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408220|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408221|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25408222|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25408223|NCT03455829|Osimertinib|osimertinib|mesh-list
25408224|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408225|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25408226|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408466|NCT03439254|Cathartics|cathartics|mesh-ancestor
25408227|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408229|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408230|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25408231|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408232|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408233|NCT03455140|BCT-100|bct-100|mesh-list
25408234|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408235|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
25408236|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408237|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408238|NCT03454035|Palbociclib|palbociclib|mesh-list
25408239|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408240|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25408241|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408242|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408243|NCT03452137|Atezolizumab|atezolizumab|mesh-list
25408244|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408245|NCT03451851|Etanercept|etanercept|mesh-list
25408246|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25408247|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25408248|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25408250|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
25408251|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408252|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408253|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25408254|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408255|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25408256|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408257|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
25408258|NCT03451591|Cilostazol|cilostazol|mesh-list
25408259|NCT03451591|Isosorbide|isosorbide|mesh-list
25408260|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25408261|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25408262|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25408263|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
25408264|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408265|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408266|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25408267|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
25408268|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25408269|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25408270|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408271|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25408272|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
25408273|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25408274|NCT03451591|Protective Agents|protective agents|mesh-ancestor
25408275|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25408276|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25408277|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408278|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25408279|NCT03451591|Diuretics|diuretics|mesh-ancestor
25408280|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
25408281|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25408282|NCT03451331|Gemcitabine|gemcitabine|mesh-list
25408283|NCT03451331|Carboplatin|carboplatin|mesh-list
25408284|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
25408285|NCT03451331|Nivolumab|nivolumab|mesh-list
25408286|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408287|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25408288|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
25408289|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408290|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
25408291|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408292|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408293|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408294|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
25408295|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408296|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408297|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25408298|NCT03450707|Thiamine|thiamine|mesh-list
25408299|NCT03450707|Vitamins|vitamins|mesh-ancestor
25408300|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
25408301|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408302|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
25408303|NCT03450343|Azacitidine|azacitidine|mesh-list
25408306|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408307|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408308|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408309|NCT03450122|Aldesleukin|aldesleukin|mesh-list
25408310|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
25408311|NCT03450122|Interleukin-2|interleukin-2|mesh-list
25408312|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408313|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
25408314|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408315|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408316|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408317|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
25408318|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408319|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408320|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25408321|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25408322|NCT03450122|Analgesics|analgesics|mesh-ancestor
25408323|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
25408324|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408325|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25408552|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
25408326|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25408328|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408329|NCT03449108|Aldesleukin|aldesleukin|mesh-list
25408330|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
25408331|NCT03449108|Nivolumab|nivolumab|mesh-list
25408332|NCT03449108|Fludarabine|fludarabine|mesh-list
25408333|NCT03449108|Ipilimumab|ipilimumab|mesh-list
25408334|NCT03449108|Interleukin-2|interleukin-2|mesh-list
25408335|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408336|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
25408337|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408338|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408339|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408340|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
25408341|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408342|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408343|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25408344|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408345|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25408346|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25408347|NCT03449108|Analgesics|analgesics|mesh-ancestor
25408348|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
25408349|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408350|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25408351|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25408352|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
25408353|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408354|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
25408355|NCT03448393|Fludarabine|fludarabine|mesh-list
25408356|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408357|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
25408358|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408359|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408360|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408361|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
25408362|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408363|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408364|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25408365|NCT03448042|Trastuzumab|trastuzumab|mesh-list
25408366|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408367|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408368|NCT03447808|Daratumumab|daratumumab|mesh-list
25408369|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408370|NCT03447379|Aspirin|aspirin|mesh-list
25408371|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25408372|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25408373|NCT03447379|Analgesics|analgesics|mesh-ancestor
25408374|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
25408375|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408376|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408377|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25408378|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408379|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25408380|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25408381|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408394|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408395|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408396|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25408397|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408398|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408399|NCT03446040|Nivolumab|nivolumab|mesh-list
25408400|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408401|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408402|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25408403|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408404|NCT03446001|Methylene Blue|methylene blue|mesh-list
25408405|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408406|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408407|NCT03443128|Vinorelbine|vinorelbine|mesh-list
25408408|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408409|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408410|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408411|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408412|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408413|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408414|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
25408415|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25408416|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408417|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408418|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25408419|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25408420|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25408421|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408422|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408423|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25408424|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408425|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408426|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25408428|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25408429|NCT03440567|Avelumab|avelumab|mesh-list
25408430|NCT03440567|Carboplatin|carboplatin|mesh-list
25408431|NCT03440567|Etoposide|etoposide|mesh-list
25408432|NCT03440567|Ifosfamide|ifosfamide|mesh-list
25408433|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
25408434|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
25408435|NCT03440567|Antibodies|antibodies|mesh-list
25408436|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
25408437|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25408438|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
25408439|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
25408440|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408441|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408442|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408443|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408444|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25408445|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25408446|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408447|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408448|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408449|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
25408450|NCT03440385|Ozanimod|ozanimod|mesh-list
25408451|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25408452|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408453|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408454|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
25408455|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408456|NCT03440372|Ozanimod|ozanimod|mesh-list
25408457|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25408458|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408459|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408460|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
25408461|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408462|NCT03439267|Calcium|calcium|mesh-list
25408463|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25408464|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408465|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25408489|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408490|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25408491|NCT03437746|Protective Agents|protective agents|mesh-ancestor
25408492|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408493|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408494|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408495|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
25408496|NCT03437330|Empagliflozin|empagliflozin|mesh-list
25408497|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25408498|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408499|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25408500|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408501|NCT03436745|Zolpidem|zolpidem|mesh-list
25408502|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25408503|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25408504|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408505|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408506|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25408507|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
25408508|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
25408509|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408510|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408511|NCT03436563|Atezolizumab|atezolizumab|mesh-list
25408512|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408513|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
25408514|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408515|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408516|NCT03435718|Albendazole|albendazole|mesh-list
25408517|NCT03435718|Oxfendazole|oxfendazole|mesh-list
25408518|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
25408519|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25408520|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408521|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
25408522|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25408523|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25408524|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408525|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408526|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408527|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408528|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408529|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
25408530|NCT03435250|Gemcitabine|gemcitabine|mesh-list
25408531|NCT03435250|Paclitaxel|paclitaxel|mesh-list
25408532|NCT03435250|Docetaxel|docetaxel|mesh-list
25408533|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408534|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408535|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408536|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408537|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408538|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408539|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25408540|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
25408541|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
25408542|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408543|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408544|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408545|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
25408546|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408547|NCT03434678|Fentanyl|fentanyl|mesh-list
25408548|NCT03434678|Bupivacaine|bupivacaine|mesh-list
25408549|NCT03434678|Propofol|propofol|mesh-list
25408550|NCT03434678|Rocuronium|rocuronium|mesh-list
25408551|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
25408553|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408554|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408555|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
25408556|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408557|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25408558|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25408559|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
25408560|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25408562|NCT03434678|Analgesics|analgesics|mesh-ancestor
25408563|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25408564|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25408565|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25408566|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25408579|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408580|NCT03432650|Dexamethasone|dexamethasone|mesh-list
25408581|NCT03432650|Bupivacaine|bupivacaine|mesh-list
25408582|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25408583|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
25408584|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
25408585|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408586|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408587|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25408588|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
25408589|NCT03432650|Hormones|hormones|mesh-ancestor
25408590|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408591|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408592|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408593|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
25408594|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
25408595|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408596|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
25408597|NCT03431987|Ethanol|ethanol|mesh-list
25408598|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25408599|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408600|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408601|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408602|NCT03431350|Prednisone|prednisone|mesh-list
25408603|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
25408604|NCT03431350|Niraparib|niraparib|mesh-list
25408605|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25408606|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
25408607|NCT03431350|Hormones|hormones|mesh-ancestor
25408608|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408609|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408610|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408611|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408612|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25408613|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408614|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408615|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
25416016|NCT02975882|Sirolimus|sirolimus|mesh-list
25408616|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25408617|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25408618|NCT03431194|Midodrine|midodrine|mesh-list
25408619|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
25408620|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
25408621|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408622|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408623|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25408624|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25408625|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25408626|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25408627|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
25408628|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408629|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408630|NCT03431168|Azithromycin|azithromycin|mesh-list
25408631|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25408632|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25408633|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408634|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25408635|NCT03431168|Renal Agents|renal agents|mesh-ancestor
25408636|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
25408637|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25408638|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25408639|NCT03430947|Vemurafenib|vemurafenib|mesh-list
25408640|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408641|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25408642|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408797|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
25408643|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408644|NCT03429543|Empagliflozin|empagliflozin|mesh-list
25408645|NCT03429543|Linagliptin|linagliptin|mesh-list
25408646|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25408647|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408648|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25408649|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408650|NCT03429543|Incretins|incretins|mesh-ancestor
25408651|NCT03429543|Hormones|hormones|mesh-ancestor
25408652|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408653|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25408654|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
25408655|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408656|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
25408657|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25408658|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
25408659|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408660|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
25408661|NCT03429140|Protective Agents|protective agents|mesh-ancestor
25408663|NCT03426904|Fluorouracil|fluorouracil|mesh-list
25408664|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
25408665|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
25408666|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408667|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25408668|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408669|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408670|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
25408671|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408672|NCT03426904|Antidotes|antidotes|mesh-ancestor
25408673|NCT03426904|Protective Agents|protective agents|mesh-ancestor
25408674|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
25408675|NCT03426904|Vitamins|vitamins|mesh-ancestor
25408676|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
25408677|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
25408678|NCT03426891|Temozolomide|temozolomide|mesh-list
25408679|NCT03426891|Vorinostat|vorinostat|mesh-list
25408680|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25408681|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408682|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408683|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408684|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
25408685|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408686|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408687|NCT03426254|Talazoparib|talazoparib|mesh-list
25408688|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25408689|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416017|NCT02975882|Irinotecan|irinotecan|mesh-list
25408690|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408691|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408692|NCT03425643|Gemcitabine|gemcitabine|mesh-list
25408693|NCT03425643|Cisplatin|cisplatin|mesh-list
25408694|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
25408695|NCT03425643|Pemetrexed|pemetrexed|mesh-list
25408696|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408697|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25408698|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
25408699|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408700|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
25408750|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408751|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408752|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
25408753|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408754|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408755|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25408756|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
25408757|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408758|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
25408759|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408760|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408761|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408762|NCT03422328|Macitentan|macitentan|mesh-list
25408763|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25408764|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25408765|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408766|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25408767|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
25408768|NCT03420963|Etoposide|etoposide|mesh-list
25408769|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
25408770|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
25408771|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408772|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
25408773|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408774|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408775|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408777|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408778|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408779|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25408780|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408781|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25408782|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25408783|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408784|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
25408785|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
25408786|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408787|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408788|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408789|NCT03419364|Niacinamide|niacinamide|mesh-list
25408790|NCT03419364|Niacin|niacin|mesh-list
25408791|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
25408792|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
25408793|NCT03419364|Vitamins|vitamins|mesh-ancestor
25408794|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
25408795|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408798|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408799|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25408800|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
25408801|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
25408802|NCT03417492|Citric Acid|citric acid|mesh-list
25408803|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
25408804|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
25408805|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25408806|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
25408807|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
25408808|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408809|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
25408810|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25408811|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25408812|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408813|NCT03417492|Urological Agents|urological agents|mesh-ancestor
25408814|NCT03417401|Plasminogen|plasminogen|mesh-list
25408815|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25408816|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25408817|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25408818|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408819|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
25408820|NCT03417193|Anesthetics|anesthetics|mesh-list
25408821|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408822|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408823|NCT03417193|Narcotics|narcotics|mesh-ancestor
25408824|NCT03417193|Analgesics|analgesics|mesh-ancestor
25408825|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
25408826|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408827|NCT03416530|TIC10 compound|tic10 compound|mesh-list
25408828|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408829|NCT03416374|Dexamethasone|dexamethasone|mesh-list
25408830|NCT03416374|Lenalidomide|lenalidomide|mesh-list
25408831|NCT03416374|Bortezomib|bortezomib|mesh-list
25408832|NCT03416374|Ixazomib|ixazomib|mesh-list
25408833|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25408834|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
25408835|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
25408836|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408837|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408838|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25408839|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
25408840|NCT03416374|Hormones|hormones|mesh-ancestor
25408841|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408842|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408843|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408844|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
25408845|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25408846|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25408847|NCT03416374|Growth Substances|growth substances|mesh-ancestor
25408848|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
25408849|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
25408850|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408851|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408852|NCT03415828|Ethanol|ethanol|mesh-list
25408853|NCT03415828|Prednisolone|prednisolone|mesh-list
25408854|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25408855|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
25408856|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25408863|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408864|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408865|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408866|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408867|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
25408868|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
25408869|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408870|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25408871|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25408872|NCT03415828|Protective Agents|protective agents|mesh-ancestor
25408873|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25408874|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408875|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408876|NCT03414684|Carboplatin|carboplatin|mesh-list
25408877|NCT03414684|Nivolumab|nivolumab|mesh-list
25408878|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408879|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408880|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25408881|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408882|NCT03414658|Trastuzumab|trastuzumab|mesh-list
25408883|NCT03414658|Avelumab|avelumab|mesh-list
25408884|NCT03414658|Vinorelbine|vinorelbine|mesh-list
25408885|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408886|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408887|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408888|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408889|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408890|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408891|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408892|NCT03412877|Aldesleukin|aldesleukin|mesh-list
25408893|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
25408894|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
25408895|NCT03412877|Fludarabine|fludarabine|mesh-list
25408896|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408897|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
25408898|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408899|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408900|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408901|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
25408902|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408903|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408904|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25408905|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408906|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25408907|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25408908|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
25408909|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408910|NCT03412565|Dexamethasone|dexamethasone|mesh-list
25408911|NCT03412565|Prednisone|prednisone|mesh-list
25408912|NCT03412565|Lenalidomide|lenalidomide|mesh-list
25408913|NCT03412565|Bortezomib|bortezomib|mesh-list
25408914|NCT03412565|Melphalan|melphalan|mesh-list
25408915|NCT03412565|Daratumumab|daratumumab|mesh-list
25408916|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25408917|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
25408918|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
25408919|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408920|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408921|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25408922|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
25408923|NCT03412565|Hormones|hormones|mesh-ancestor
25408924|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408925|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408926|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408927|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
25408928|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25408929|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25408930|NCT03412565|Growth Substances|growth substances|mesh-ancestor
25408931|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
25408932|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408933|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
25408934|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408935|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25408936|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408937|NCT03410615|Cisplatin|cisplatin|mesh-list
25408938|NCT03410615|Durvalumab|durvalumab|mesh-list
25408946|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408947|NCT03409588|Riociguat|riociguat|mesh-list
25408948|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
25408949|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408950|NCT03407144|Prednisone|prednisone|mesh-list
25408951|NCT03407144|Prednisolone|prednisolone|mesh-list
25408952|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
25408953|NCT03407144|Dacarbazine|dacarbazine|mesh-list
25408954|NCT03407144|Doxorubicin|doxorubicin|mesh-list
25408955|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
25408957|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
25408958|NCT03407144|Vincristine|vincristine|mesh-list
25408959|NCT03407144|Bleomycin|bleomycin|mesh-list
25408960|NCT03407144|Vinblastine|vinblastine|mesh-list
25408961|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408962|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
25408963|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408964|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25408965|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25408966|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
25408967|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408968|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408969|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25408970|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25408971|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25408972|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25408973|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408974|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408975|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25408976|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
25408977|NCT03407144|Hormones|hormones|mesh-ancestor
25408978|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25408979|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25408980|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25408981|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
25408982|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
25408983|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408984|NCT03406897|Vitamin D|vitamin d|mesh-list
25408985|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
25408986|NCT03406897|Vitamins|vitamins|mesh-ancestor
25408987|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
25408988|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408989|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25408990|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25408991|NCT03406650|Durvalumab|durvalumab|mesh-list
25408992|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408993|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408994|NCT03406507|Ravulizumab|ravulizumab|mesh-list
25408995|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25408996|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408997|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
25408998|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408999|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
25409000|NCT03405792|Temozolomide|temozolomide|mesh-list
25409001|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409002|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409003|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409004|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
25409005|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409006|NCT03404791|Gemcitabine|gemcitabine|mesh-list
25409007|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409008|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
25409009|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409010|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409011|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
25409012|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409013|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409014|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409015|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
25409016|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409017|NCT03404193|Decitabine|decitabine|mesh-list
25409018|NCT03404193|Venetoclax|venetoclax|mesh-list
25409019|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409020|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
25409021|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409022|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409041|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409042|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25409043|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25409044|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25409045|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25409046|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409047|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25409048|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25409049|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25409050|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25409051|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
25409052|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409053|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409054|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25409055|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25409056|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
25409057|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25409058|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25409059|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
25409060|NCT03401060|Denosumab|denosumab|mesh-list
25409061|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25409062|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409063|NCT03400826|Simvastatin|simvastatin|mesh-list
25409064|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25409065|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25409066|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
25409067|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409068|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25409069|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25409070|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409071|NCT03399318|Acetaminophen|acetaminophen|mesh-list
25409072|NCT03399318|Ibuprofen|ibuprofen|mesh-list
25409073|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25409074|NCT03399318|Analgesics|analgesics|mesh-ancestor
25409075|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
25409076|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409077|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409078|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
25409079|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25409080|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409081|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409082|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25409083|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409158|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
25409084|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409085|NCT03398252|Doxazosin|doxazosin|mesh-list
25409086|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25409087|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25409088|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25409089|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25409090|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
25409091|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409092|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409093|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409094|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25409095|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
25409096|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409097|NCT03396588|Clonidine|clonidine|mesh-list
25409098|NCT03396588|Morphine|morphine|mesh-list
25409099|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25409100|NCT03396588|Narcotics|narcotics|mesh-ancestor
25409101|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25409102|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409103|NCT03396588|Analgesics|analgesics|mesh-ancestor
25409104|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
25409105|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409106|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25409107|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
25409108|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
25409109|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25409110|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25409111|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25409112|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25409113|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409114|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409115|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
25409116|NCT03396575|Fludarabine|fludarabine|mesh-list
25409117|NCT03396575|Vaccines|vaccines|mesh-list
25409118|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
25409119|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409120|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409121|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409122|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409123|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
25409124|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409125|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409126|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25409127|NCT03396445|Paclitaxel|paclitaxel|mesh-list
25409128|NCT03396445|Carboplatin|carboplatin|mesh-list
25409129|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
25409130|NCT03396445|Pemetrexed|pemetrexed|mesh-list
25409131|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25409132|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409133|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409134|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409135|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409136|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409137|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409138|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409139|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25409140|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25409141|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25409142|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25409143|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25409144|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25409145|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409146|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25409147|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25409148|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25409149|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25409150|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
25409151|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409152|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409153|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25409154|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25409155|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
25409156|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25409157|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25409159|NCT03395899|Bevacizumab|bevacizumab|mesh-list
25409160|NCT03395899|Atezolizumab|atezolizumab|mesh-list
25409161|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409162|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409163|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25409164|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25409165|NCT03395899|Growth Substances|growth substances|mesh-ancestor
25409166|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409167|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
25409168|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25409169|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25409170|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25409171|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25409172|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409173|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25409174|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25409175|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25409176|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25409177|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
25409178|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409179|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409180|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25409181|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25409182|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
25409183|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25409184|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25409185|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
25409186|NCT03395197|Talazoparib|talazoparib|mesh-list
25409187|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25409189|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409190|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409191|NCT03395184|PF-06700841|pf-06700841|mesh-list
25409192|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25409193|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409194|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409195|NCT03394027|TIC10 compound|tic10 compound|mesh-list
25409196|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409197|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
25409198|NCT03393845|Fulvestrant|fulvestrant|mesh-list
25409199|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409200|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409201|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25409202|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25409203|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25409204|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
25409205|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409206|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409207|NCT03392246|Osimertinib|osimertinib|mesh-list
25409208|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409209|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25409210|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409211|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409212|NCT03390504|Docetaxel|docetaxel|mesh-list
25409213|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
25409214|NCT03390504|Mitogens|mitogens|mesh-list
25409215|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409216|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409217|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409218|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409219|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409220|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409221|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25409222|NCT03390296|Avelumab|avelumab|mesh-list
25409223|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
25409224|NCT03390296|Azacitidine|azacitidine|mesh-list
25409225|NCT03390296|Venetoclax|venetoclax|mesh-list
25409226|NCT03390296|Calicheamicins|calicheamicins|mesh-list
25409227|NCT03390296|Antibodies|antibodies|mesh-list
25409228|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
25409229|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25409230|NCT03390296|Maleic acid|maleic acid|mesh-list
25409231|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
25409232|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409233|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409234|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409235|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
25409236|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409237|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409238|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409239|NCT03389750|Oxymorphone|oxymorphone|mesh-list
25409240|NCT03389750|Morphine|morphine|mesh-list
25409241|NCT03389750|Oxycodone|oxycodone|mesh-list
25409242|NCT03389750|Hydromorphone|hydromorphone|mesh-list
25409243|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25409244|NCT03389750|Narcotics|narcotics|mesh-ancestor
25409245|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25409246|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409247|NCT03389750|Analgesics|analgesics|mesh-ancestor
25409248|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
25409249|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409250|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25409251|NCT03388632|Nivolumab|nivolumab|mesh-list
25409252|NCT03388632|Ipilimumab|ipilimumab|mesh-list
25409253|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409254|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409255|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409256|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409257|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
25409258|NCT03388008|Prednisone|prednisone|mesh-list
25409259|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
25409260|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25409261|NCT03388008|Abatacept|abatacept|mesh-list
25409262|NCT03388008|Tacrolimus|tacrolimus|mesh-list
25409263|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
25409264|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409265|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
25409266|NCT03388008|Hormones|hormones|mesh-ancestor
25409267|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409268|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409269|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25409270|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409271|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409272|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
25409273|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25409274|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409275|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409276|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409277|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25409278|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
25409279|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25409280|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409281|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
25409282|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
25409283|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409284|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25409285|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25409286|NCT03388008|Protective Agents|protective agents|mesh-ancestor
25409287|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409288|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409289|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25409290|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409291|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409292|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25409293|NCT03387579|SMOFlipid|smoflipid|mesh-list
25409294|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25409295|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25409296|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25409297|NCT03387501|Mitogens|mitogens|mesh-list
25409298|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409299|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409300|NCT03387423|Tofacitinib|tofacitinib|mesh-list
25409301|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25409302|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409303|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409304|NCT03386929|Palbociclib|palbociclib|mesh-list
25409305|NCT03386929|Avelumab|avelumab|mesh-list
25409306|NCT03386929|Axitinib|axitinib|mesh-list
25409307|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409308|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25409309|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409538|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
25409310|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409311|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409312|NCT03386578|Tenofovir|tenofovir|mesh-list
25409313|NCT03386578|Emtricitabine|emtricitabine|mesh-list
25409314|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25409315|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
25409316|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409317|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25409318|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25409319|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409320|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409321|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25409322|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25409323|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
25409324|NCT03386539|Everolimus|everolimus|mesh-list
25409325|NCT03386539|Tacrolimus|tacrolimus|mesh-list
25409326|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409327|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
25409328|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409329|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25409330|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409331|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409332|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409333|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409334|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25409335|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
25409336|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25409337|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409338|NCT03384914|Vaccines|vaccines|mesh-list
25409339|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
25409349|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409350|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409351|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25409352|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25409353|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
25409355|NCT03384654|Prednisone|prednisone|mesh-list
25409356|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
25409357|NCT03384654|Doxorubicin|doxorubicin|mesh-list
25409358|NCT03384654|Methotrexate|methotrexate|mesh-list
25409359|NCT03384654|Vincristine|vincristine|mesh-list
25409360|NCT03384654|Asparaginase|asparaginase|mesh-list
25409361|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
25409362|NCT03384654|Daratumumab|daratumumab|mesh-list
25409363|NCT03384654|Pegaspargase|pegaspargase|mesh-list
25409364|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409365|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
25409366|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409367|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409368|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409369|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
25409370|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409371|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409372|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25409373|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409374|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25409375|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25409376|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409377|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409378|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
25409379|NCT03384654|Hormones|hormones|mesh-ancestor
25409380|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409381|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25409382|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25409383|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
25409384|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25409385|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409386|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
25409387|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
25409388|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25409389|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25409390|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
25409391|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409392|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25409393|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409394|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409395|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409396|NCT03384641|Bedaquiline|bedaquiline|mesh-list
25409397|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
25409398|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25409399|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409400|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
25409401|NCT03384537|Listerine|listerine|mesh-list
25409402|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25409403|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409404|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
25409406|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409407|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
25409408|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409409|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409410|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409411|NCT03383458|Nivolumab|nivolumab|mesh-list
25409412|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409413|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409414|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409415|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409416|NCT03382561|Cisplatin|cisplatin|mesh-list
25409417|NCT03382561|Carboplatin|carboplatin|mesh-list
25409418|NCT03382561|Nivolumab|nivolumab|mesh-list
25409419|NCT03382561|Etoposide|etoposide|mesh-list
25409420|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
25409421|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
25409422|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409423|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409424|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409425|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409440|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409441|NCT03382106|Urological Agents|urological agents|mesh-ancestor
25409442|NCT03380546|Insulin|insulin|mesh-list
25409443|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25409444|NCT03380546|Acarbose|acarbose|mesh-list
25409445|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
25409446|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25409447|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409448|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25409449|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409450|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409451|NCT03379051|Lenalidomide|lenalidomide|mesh-list
25409452|NCT03379051|Venetoclax|venetoclax|mesh-list
25409453|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
25409454|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409455|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25409456|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25409457|NCT03379051|Growth Substances|growth substances|mesh-ancestor
25409458|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
25409459|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409460|NCT03377491|Gemcitabine|gemcitabine|mesh-list
25409461|NCT03377491|Paclitaxel|paclitaxel|mesh-list
25409539|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409462|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25409463|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409464|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409465|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409466|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409467|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409468|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409469|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
25409470|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
25409471|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409472|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409473|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409474|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
25409475|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409476|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
25416018|NCT02975882|Camptothecin|camptothecin|mesh-list
25381813|NCT04641195|Vitamins|vitamins|mesh-list
25381814|NCT04641195|Zinc|zinc|mesh-list
25381815|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
25381816|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381817|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25381818|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25381819|NCT04641195|Trace Elements|trace elements|mesh-ancestor
25381820|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
25381821|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381822|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25381823|NCT04641026|Protective Agents|protective agents|mesh-ancestor
25381824|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409477|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25409478|NCT03377478|Velpatasvir|velpatasvir|mesh-list
25409479|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
25409480|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409481|NCT03376477|Lenalidomide|lenalidomide|mesh-list
25409482|NCT03376477|Molgramostim|molgramostim|mesh-list
25409483|NCT03376477|Vaccines|vaccines|mesh-list
25409484|NCT03376477|Sargramostim|sargramostim|mesh-list
25409485|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25409486|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
25409487|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409488|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25409489|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25409490|NCT03376477|Growth Substances|growth substances|mesh-ancestor
25409491|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
25409492|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409493|NCT03375788|Hormones|hormones|mesh-list
25409494|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25409495|NCT03375788|Tesamorelin|tesamorelin|mesh-list
25409496|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409497|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409498|NCT03375788|Growth Substances|growth substances|mesh-ancestor
25409499|NCT03375307|Olaparib|olaparib|mesh-list
25409500|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25409501|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409502|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409503|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409504|NCT03375242|Crizotinib|crizotinib|mesh-list
25409505|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409506|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25409507|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409508|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409509|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
25409510|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409511|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409512|NCT03373851|Sufentanil|sufentanil|mesh-list
25409513|NCT03373851|Dsuvia|dsuvia|mesh-list
25409514|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25409515|NCT03373851|Narcotics|narcotics|mesh-ancestor
25409532|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409533|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409534|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
25409535|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409536|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25409537|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409540|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25409541|NCT03371017|Gemcitabine|gemcitabine|mesh-list
25409542|NCT03371017|Carboplatin|carboplatin|mesh-list
25409543|NCT03371017|Capecitabine|capecitabine|mesh-list
25409544|NCT03371017|Atezolizumab|atezolizumab|mesh-list
25409545|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409546|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409547|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
25409548|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409549|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
25409550|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409551|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409552|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409553|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
25409554|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409555|NCT03370510|Oxytocin|oxytocin|mesh-list
25409556|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
25409557|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25409558|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409559|NCT03370276|Nivolumab|nivolumab|mesh-list
25409560|NCT03370276|Cetuximab|cetuximab|mesh-list
25409561|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409562|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409563|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409564|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409565|NCT03369041|Irinotecan|irinotecan|mesh-list
25409566|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25409567|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25409568|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409569|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409570|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409571|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
25409572|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409573|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409574|NCT03367533|Ketamine|ketamine|mesh-list
25409575|NCT03367533|Analgesics|analgesics|mesh-ancestor
25409576|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
25409577|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409578|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409579|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25409580|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25409581|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
25409582|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
25409583|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25409584|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25409585|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25409586|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409587|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409588|NCT03367013|Lactoferrin|lactoferrin|mesh-list
25409589|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409590|NCT03366766|Gemcitabine|gemcitabine|mesh-list
25409591|NCT03366766|Cisplatin|cisplatin|mesh-list
25409592|NCT03366766|Nivolumab|nivolumab|mesh-list
25409593|NCT03366766|Pemetrexed|pemetrexed|mesh-list
25409594|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409595|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409596|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
25409597|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409598|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
25409599|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409600|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409601|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409602|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
25409603|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409604|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409605|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409606|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25409607|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25409608|NCT03366298|Epinephrine|epinephrine|mesh-list
25409609|NCT03366298|Racepinephrine|racepinephrine|mesh-list
25409615|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409616|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409617|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25409618|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25409619|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
25409620|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409621|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25409622|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
25409623|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
25409624|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
25409625|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25409626|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
25409628|NCT03366155|Cetuximab|cetuximab|mesh-list
25409629|NCT03366155|Panitumumab|panitumumab|mesh-list
25381964|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25381965|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409630|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409631|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25409632|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25409633|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409634|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409635|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409636|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
25409637|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25409638|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25409639|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409641|NCT03364491|Coagulants|coagulants|mesh-ancestor
25409642|NCT03364036|Cladribine|cladribine|mesh-list
25409643|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409644|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409645|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
25409646|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409647|NCT03363464|Empagliflozin|empagliflozin|mesh-list
25409648|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25409649|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25409650|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409651|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25409652|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409653|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
25409654|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409655|NCT03361735|Leuprolide|leuprolide|mesh-list
25409656|NCT03361735|Goserelin|goserelin|mesh-list
25409657|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25409658|NCT03361735|Hormones|hormones|mesh-list
25409659|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409660|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409661|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25409662|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
25409663|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25409664|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25409665|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409666|NCT03361306|Elotuzumab|elotuzumab|mesh-list
25409667|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409668|NCT03359538|Sirolimus|sirolimus|mesh-list
25409669|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25409670|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409671|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409672|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409673|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
25409674|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409675|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
25409676|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409677|NCT03358563|Docetaxel|docetaxel|mesh-list
25409678|NCT03358563|Bicalutamide|bicalutamide|mesh-list
25409679|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25409680|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409681|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409682|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409683|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409684|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409685|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
25409686|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
25409687|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409688|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409689|NCT03358563|Hematinics|hematinics|mesh-ancestor
25409690|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25409700|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409701|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409702|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409703|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
25409704|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409706|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
25409707|NCT03356860|Durvalumab|durvalumab|mesh-list
25409708|NCT03356860|Epirubicin|epirubicin|mesh-list
25409709|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25409710|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409711|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409712|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409713|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409714|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409715|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409716|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
25409717|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409718|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409719|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409720|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
25409721|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25409722|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409723|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409724|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25409725|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25409726|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409727|NCT03353831|Bevacizumab|bevacizumab|mesh-list
25409728|NCT03353831|Atezolizumab|atezolizumab|mesh-list
25409729|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409730|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409731|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25409732|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25409733|NCT03353831|Growth Substances|growth substances|mesh-ancestor
25409734|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409735|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
25409737|NCT03352765|Melphalan|melphalan|mesh-list
25409738|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25409739|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409740|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409741|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
25409742|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409743|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409744|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409745|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
25409746|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409747|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25409748|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409749|NCT03351647|Ustekinumab|ustekinumab|mesh-list
25409750|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
25409751|NCT03350451|Lumasiran|lumasiran|mesh-list
25409752|NCT03350451|Renal Agents|renal agents|mesh-ancestor
25409753|NCT03350386|Oxaprozin|oxaprozin|mesh-list
25409754|NCT03350386|Dotinurad|dotinurad|mesh-list
25409755|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
25409756|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
25409757|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409758|NCT03350386|Renal Agents|renal agents|mesh-ancestor
25409759|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25409760|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25409761|NCT03350386|Analgesics|analgesics|mesh-ancestor
25409762|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
25409763|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409764|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409765|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409766|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25409767|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409768|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409769|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
25409770|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
25409771|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409772|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
25409773|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409774|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409775|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409777|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409778|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409779|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25409780|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409782|NCT03348969|Mitomycin|mitomycin|mesh-list
25409783|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25409784|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409785|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
25409786|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409787|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25382129|NCT04629248|Hormones|hormones|mesh-ancestor
25409788|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409789|NCT03347786|Verapamil|verapamil|mesh-list
25409790|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25409791|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25409792|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25409793|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409794|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25409795|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409796|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
25409797|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
25409798|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409799|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409800|NCT03345836|Upadacitinib|upadacitinib|mesh-list
25409801|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25409802|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25409803|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409804|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409805|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409806|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25409807|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409808|NCT03343054|Talazoparib|talazoparib|mesh-list
25409809|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25409810|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409811|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409812|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409813|NCT03342911|Paclitaxel|paclitaxel|mesh-list
25409814|NCT03342911|Carboplatin|carboplatin|mesh-list
25409815|NCT03342911|Nivolumab|nivolumab|mesh-list
25409816|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25409817|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409818|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409819|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409820|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409821|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409822|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409823|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409824|NCT03342404|Luspatercept|luspatercept|mesh-list
25409825|NCT03342404|Hematinics|hematinics|mesh-ancestor
25409826|NCT03340909|Prednisolone|prednisolone|mesh-list
25409827|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409828|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
25409829|NCT03340909|Hormones|hormones|mesh-ancestor
25409830|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409831|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409832|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25409833|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409834|NCT03340675|Ifetroban|ifetroban|mesh-list
25409835|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25409836|NCT03340506|Trametinib|trametinib|mesh-list
25409837|NCT03340506|Dabrafenib|dabrafenib|mesh-list
25409838|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409839|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25409840|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409841|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409842|NCT03340064|Levetiracetam|levetiracetam|mesh-list
25409843|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
25409844|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
25409845|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
25409846|NCT03339596|Hematinics|hematinics|mesh-ancestor
25409847|NCT03339128|Eluxadoline|eluxadoline|mesh-list
25409848|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25409849|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25409850|NCT03338998|Siponimod|siponimod|mesh-list
25409851|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25410086|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25409852|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409853|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409854|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
25409855|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409856|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
25409857|NCT03338972|Fludarabine|fludarabine|mesh-list
25409858|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409859|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
25409860|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382205|NCT04627870|Paclitaxel|paclitaxel|mesh-list
25409861|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409862|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409863|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
25409864|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409865|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409866|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25409868|NCT03338790|Docetaxel|docetaxel|mesh-list
25409869|NCT03338790|Nivolumab|nivolumab|mesh-list
25409870|NCT03338790|Rucaparib|rucaparib|mesh-list
25409871|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409872|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409873|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409874|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409875|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409876|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409877|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
25409878|NCT03338790|Hormones|hormones|mesh-ancestor
25409879|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409880|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409881|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25409882|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409883|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409884|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25409885|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409886|NCT03338244|Azithromycin|azithromycin|mesh-list
25409887|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25409888|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409889|NCT03337724|Paclitaxel|paclitaxel|mesh-list
25409890|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25409891|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409892|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409893|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409894|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409895|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409896|NCT03337698|Linagliptin|linagliptin|mesh-list
25409897|NCT03337698|Gemcitabine|gemcitabine|mesh-list
25409898|NCT03337698|Bevacizumab|bevacizumab|mesh-list
25409899|NCT03337698|Carboplatin|carboplatin|mesh-list
25409900|NCT03337698|Docetaxel|docetaxel|mesh-list
25409901|NCT03337698|Pemetrexed|pemetrexed|mesh-list
25409902|NCT03337698|Atezolizumab|atezolizumab|mesh-list
25409903|NCT03337698|Evolocumab|evolocumab|mesh-list
25409904|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409905|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409906|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25409907|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25409908|NCT03337698|Growth Substances|growth substances|mesh-ancestor
25409909|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409910|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
25409911|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25409912|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
25409913|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409914|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
25409915|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409916|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409917|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409918|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
25409919|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409920|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
25409921|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
25409922|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25409923|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25409924|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25409925|NCT03337698|Incretins|incretins|mesh-ancestor
25409926|NCT03337698|Hormones|hormones|mesh-ancestor
25409927|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410087|NCT03330821|Pevonedistat|pevonedistat|mesh-list
25409945|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25409946|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
25409947|NCT03336203|Protective Agents|protective agents|mesh-ancestor
25409948|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409949|NCT03336073|Dexamethasone|dexamethasone|mesh-list
25409950|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
25409951|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409952|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
25382272|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382273|NCT04626128|Aflibercept|aflibercept|mesh-list
25382274|NCT04626128|Axitinib|axitinib|mesh-list
25382275|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25382276|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25382277|NCT04626128|Growth Substances|growth substances|mesh-ancestor
25382278|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382279|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
25382280|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382281|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382282|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382284|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
25409953|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409954|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409955|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409956|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
25409957|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409958|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409959|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25409960|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409961|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
25409962|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
25409963|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409964|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25409965|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
25409966|NCT03336073|Hormones|hormones|mesh-ancestor
25409967|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409968|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25409969|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
25409970|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25409971|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25409972|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25409973|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25409974|NCT03335540|Nivolumab|nivolumab|mesh-list
25409975|NCT03335540|Ipilimumab|ipilimumab|mesh-list
25409976|NCT03335540|Linrodostat|linrodostat|mesh-list
25409977|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409978|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409979|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25409980|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409981|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409992|NCT03334305|Vaccines|vaccines|mesh-list
25409993|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
25409994|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409995|NCT03334253|Atropine|atropine|mesh-list
25409996|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25409997|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25409998|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25409999|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25410000|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
25410001|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410002|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410003|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25410004|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
25410005|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
25410006|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
25410007|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25410008|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25410009|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
25410010|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410011|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410012|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25410013|NCT03333668|Guanfacine|guanfacine|mesh-list
25410014|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25410015|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25410016|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410017|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25410018|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25410019|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25410020|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410021|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
25410022|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410023|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410024|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25410025|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25410026|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25410027|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
25410028|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
25410029|NCT03333486|Fludarabine|fludarabine|mesh-list
25410030|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
25410031|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410032|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
25410033|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410034|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410035|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410036|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
25410037|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410038|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410039|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25410040|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410041|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
25410042|NCT03332797|Palbociclib|palbociclib|mesh-list
25410043|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410044|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25410045|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410046|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410047|NCT03332095|Tenofovir|tenofovir|mesh-list
25410048|NCT03332095|Lamivudine|lamivudine|mesh-list
25410049|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25410050|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
25410051|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410052|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25410053|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25410054|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410055|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410056|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25410057|NCT03331341|Doxorubicin|doxorubicin|mesh-list
25410058|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25410059|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
25410060|NCT03331341|Dacarbazine|dacarbazine|mesh-list
25410061|NCT03331341|Vinblastine|vinblastine|mesh-list
25410062|NCT03331341|Imidazole|imidazole|mesh-list
25410063|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25410064|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410065|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25410066|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25410067|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410068|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410069|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410070|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410071|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
25410072|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25410073|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25410074|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25410075|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
25410076|NCT03331198|Venetoclax|venetoclax|mesh-list
25410077|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410078|NCT03330847|Olaparib|olaparib|mesh-list
25410079|NCT03330847|Adavosertib|adavosertib|mesh-list
25410080|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25410081|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410082|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410083|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410084|NCT03330821|Cytarabine|cytarabine|mesh-list
25410085|NCT03330821|Idarubicin|idarubicin|mesh-list
25410088|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410089|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
25416019|NCT02975882|Temozolomide|temozolomide|mesh-list
25410090|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410091|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410092|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
25410093|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410094|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410095|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
25410096|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410097|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25410098|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25410099|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25410100|NCT03330405|Avelumab|avelumab|mesh-list
25410101|NCT03330405|Talazoparib|talazoparib|mesh-list
25410102|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25410103|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410104|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410105|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
25410106|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410107|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25410108|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410109|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410110|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
25410111|NCT03330028|Promethazine|promethazine|mesh-list
25410112|NCT03330028|Dexamethasone|dexamethasone|mesh-list
25410113|NCT03330028|Paclitaxel|paclitaxel|mesh-list
25410114|NCT03330028|Cisplatin|cisplatin|mesh-list
25410115|NCT03330028|Mitomycins|mitomycins|mesh-list
25410116|NCT03330028|Mitomycin|mitomycin|mesh-list
25410117|NCT03330028|Famotidine|famotidine|mesh-list
25410118|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25410119|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410120|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
25410121|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25410122|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25410123|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410124|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25410125|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
25410126|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
25410127|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410128|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410129|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25410130|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
25410131|NCT03330028|Hormones|hormones|mesh-ancestor
25410132|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410133|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25410134|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25410135|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
25410136|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25410137|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410138|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25410139|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25410140|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410141|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
25410142|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
25410143|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
25410144|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25410145|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
25410146|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
25410147|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410148|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25410149|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
25410150|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
25410151|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25410152|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25410153|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
25410154|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25410155|NCT03329001|Niraparib|niraparib|mesh-list
25410156|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25410157|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410158|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410159|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410160|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
25410161|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410162|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
25410163|NCT03328104|Etoposide|etoposide|mesh-list
25410164|NCT03328104|Everolimus|everolimus|mesh-list
25410165|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410166|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
25410167|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410168|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410169|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410170|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
25410171|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410172|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410173|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25410174|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25410175|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25410176|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25410177|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410178|NCT03328026|Interferons|interferons|mesh-list
25410179|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
25410180|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410181|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
25410182|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410183|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410184|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410185|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
25410186|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410187|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410188|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25410189|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
25410190|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410191|NCT03327805|Choline|choline|mesh-list
25410192|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
25410193|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25410194|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
25410195|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410196|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25410197|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25410198|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
25410199|NCT03326921|Vidarabine|vidarabine|mesh-list
25410200|NCT03326921|Fludarabine|fludarabine|mesh-list
25410201|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
25410202|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410203|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410204|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
25410205|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410206|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410207|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
25410208|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410209|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
25410210|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410211|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
25410212|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25410213|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410214|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410215|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25410216|NCT03325972|Analgesics|analgesics|mesh-ancestor
25410217|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
25410218|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410219|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25410220|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25410221|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25410222|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
25410223|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410375|NCT03321981|Trastuzumab|trastuzumab|mesh-list
25410224|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410225|NCT03325712|Midazolam|midazolam|mesh-list
25410226|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25410227|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25410228|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410229|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410230|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25410231|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25410232|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25410233|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25410234|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
25410235|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
25410236|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
25410237|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
25410315|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
25410238|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410239|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382573|NCT04616248|Protective Agents|protective agents|mesh-ancestor
25382574|NCT04616014|Insulin|insulin|mesh-list
25382575|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25382576|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25410240|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
25410241|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25410242|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410243|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410244|NCT03325166|Hematinics|hematinics|mesh-ancestor
25410245|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25410246|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25410247|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
25410248|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410249|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410250|NCT03324984|Bupivacaine|bupivacaine|mesh-list
25410251|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
25410252|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
25410253|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
25410254|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410255|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410256|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
25410257|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410258|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
25410259|NCT03324113|Promethazine|promethazine|mesh-list
25410260|NCT03324113|Dexamethasone|dexamethasone|mesh-list
25410261|NCT03324113|Naphazoline|naphazoline|mesh-list
25410262|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25410263|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25410264|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
25410265|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
25410266|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410267|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410268|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25410269|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
25410271|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410272|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25410273|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410274|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25410275|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25410276|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25410277|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410278|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
25410279|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
25410280|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
25410281|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25410282|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
25410283|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
25410284|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410285|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410286|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25410287|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
25410288|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
25410289|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25410290|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25410291|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25410292|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
25410293|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25410294|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
25410295|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
25410296|NCT03323866|Budesonide|budesonide|mesh-list
25410297|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25410298|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25410299|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
25410300|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410301|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410302|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25410303|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
25410304|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
25410306|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410307|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
25410308|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25410309|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
25410310|NCT03323476|Prednisone|prednisone|mesh-list
25382653|NCT04613453|Midazolam|midazolam|mesh-list
25410311|NCT03323476|Rituximab|rituximab|mesh-list
25410312|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25410313|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410314|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410316|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410317|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410318|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25410319|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25410320|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
25410321|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25410322|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410323|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410324|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410325|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25410326|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
25410327|NCT03323476|Hormones|hormones|mesh-ancestor
25410328|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410329|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25410330|NCT03323463|Cisplatin|cisplatin|mesh-list
25410331|NCT03323463|Carboplatin|carboplatin|mesh-list
25410332|NCT03323463|Fluorouracil|fluorouracil|mesh-list
25410333|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410334|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
25410335|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410336|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410337|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410338|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
25410339|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410340|NCT03323437|Risperidone|risperidone|mesh-list
25410341|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25410342|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
25410343|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410344|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410345|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410346|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25410347|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25410348|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410349|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25410350|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25410351|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
25410352|NCT03323346|Disulfiram|disulfiram|mesh-list
25410353|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25410354|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25410355|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410356|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410357|NCT03323034|Irinotecan|irinotecan|mesh-list
25410358|NCT03323034|Temozolomide|temozolomide|mesh-list
25410359|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25410360|NCT03323034|Pevonedistat|pevonedistat|mesh-list
25410361|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25410362|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25410363|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410364|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410365|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410366|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
25410367|NCT03322995|Fluorouracil|fluorouracil|mesh-list
25410368|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
25410369|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410370|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410371|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410372|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410373|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
25410374|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410376|NCT03321981|Letrozole|letrozole|mesh-list
25410377|NCT03321981|Vinorelbine|vinorelbine|mesh-list
25410378|NCT03321981|Fulvestrant|fulvestrant|mesh-list
25410379|NCT03321981|Exemestane|exemestane|mesh-list
25410380|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410381|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410382|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25410383|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25410384|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410385|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382726|NCT04609046|Rituximab|rituximab|mesh-list
25410386|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25410387|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
25410388|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410389|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410390|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25410394|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25410395|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25410396|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
25410397|NCT03321630|Lenvatinib|lenvatinib|mesh-list
25410398|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410399|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410400|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25410401|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410402|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410403|NCT03321526|Norepinephrine|norepinephrine|mesh-list
25410404|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25410405|NCT03321526|Serotonin|serotonin|mesh-list
25410406|NCT03321526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25410407|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
25410408|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25410409|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25410410|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25410411|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410412|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410413|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25410414|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25410415|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25410416|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410417|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410418|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
25410419|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
25410420|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410421|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25410422|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25410423|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
25410424|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25410425|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25410426|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
25410427|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410428|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410429|NCT03319537|Cisplatin|cisplatin|mesh-list
25410430|NCT03319537|Pemetrexed|pemetrexed|mesh-list
25410431|NCT03319537|Pevonedistat|pevonedistat|mesh-list
25410432|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410433|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410434|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410435|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25410436|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25410437|NCT03318952|Lidocaine|lidocaine|mesh-list
25410438|NCT03318952|Carticaine|carticaine|mesh-list
25410439|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-ancestor
25410440|NCT03318952|Anesthetics|anesthetics|mesh-ancestor
25410441|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410442|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410443|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
25410444|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410445|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25410446|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25410447|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25410448|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25410449|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410450|NCT03318900|Aldesleukin|aldesleukin|mesh-list
25410451|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
25410452|NCT03318900|Interleukin-2|interleukin-2|mesh-list
25410453|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25410454|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
25410455|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410456|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
25410457|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410458|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410459|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410460|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
25382800|NCT04607772|Lenalidomide|lenalidomide|mesh-list
25410461|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410462|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410463|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25410689|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
25410464|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25410465|NCT03318900|Analgesics|analgesics|mesh-ancestor
25410466|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
25410467|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410469|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25410470|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
25410471|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410472|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
25410473|NCT03318861|Fludarabine|fludarabine|mesh-list
25410474|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410475|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
25410476|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410477|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410478|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410479|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
25410480|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410481|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410482|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25410483|NCT03318133|Anesthetics|anesthetics|mesh-list
25410484|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410485|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410486|NCT03318094|Nitroprusside|nitroprusside|mesh-list
25410487|NCT03318094|Phentolamine|phentolamine|mesh-list
25410488|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
25410489|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
25410490|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410491|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
25410492|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25410493|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410494|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
25410495|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410496|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410497|NCT03317535|Anesthetics|anesthetics|mesh-list
25410498|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410499|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410501|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25410502|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25410503|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410504|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410505|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410506|NCT03317158|Gemcitabine|gemcitabine|mesh-list
25410507|NCT03317158|Docetaxel|docetaxel|mesh-list
25410508|NCT03317158|Durvalumab|durvalumab|mesh-list
25410509|NCT03317158|Tremelimumab|tremelimumab|mesh-list
25410510|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25410511|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
25410512|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410513|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
25410514|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410515|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410516|NCT03317158|Antiviral Agents|antiviral agents|mesh-ancestor
25410517|NCT03317158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410518|NCT03317158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410519|NCT03317158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410520|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
25410521|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410522|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
25410523|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
25410524|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
25410525|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410526|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25410527|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
25410528|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410529|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410530|NCT03316118|Bupivacaine|bupivacaine|mesh-list
25410531|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
25410532|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
25410533|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410534|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410535|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
25410536|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410537|NCT03315910|Nicotine|nicotine|mesh-list
25410538|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25410539|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
25410540|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410541|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410542|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25410543|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25410544|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
25410545|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410546|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410548|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410549|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25410550|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25410551|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410552|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25410553|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410554|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
25410555|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410556|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410558|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410559|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25410560|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410561|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410562|NCT03312400|Danazol|danazol|mesh-list
25410563|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25410564|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
25410565|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410566|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410567|NCT03311958|Nivolumab|nivolumab|mesh-list
25410568|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410569|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410570|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25410571|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410572|NCT03311594|Ethanol|ethanol|mesh-list
25410573|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25410574|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410575|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410576|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410577|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25410578|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
25410579|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410580|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
25410581|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410582|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410583|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410584|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
25410585|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410586|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410587|NCT03310619|Nivolumab|nivolumab|mesh-list
25410588|NCT03310619|Durvalumab|durvalumab|mesh-list
25410589|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410590|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410591|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25410592|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410593|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
25410594|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
25410595|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
25410596|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
25410597|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410598|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410599|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
25410600|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410601|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
25410602|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
25410603|NCT03308942|Niraparib|niraparib|mesh-list
25410604|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410605|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410606|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25410607|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410608|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410609|NCT03308916|Liver Extracts|liver extracts|mesh-list
25410610|NCT03308916|Hematinics|hematinics|mesh-ancestor
25410611|NCT03308786|Aldesleukin|aldesleukin|mesh-list
25410612|NCT03308786|Interleukin-2|interleukin-2|mesh-list
25410613|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410614|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25410615|NCT03308786|Analgesics|analgesics|mesh-ancestor
25410616|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
25410617|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410618|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410619|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25410620|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25410621|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
25410622|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410623|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
25410624|NCT03308448|Hematinics|hematinics|mesh-ancestor
25410625|NCT03307785|Paclitaxel|paclitaxel|mesh-list
25410626|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25410627|NCT03307785|Bevacizumab|bevacizumab|mesh-list
25410628|NCT03307785|Carboplatin|carboplatin|mesh-list
25410629|NCT03307785|Pemetrexed|pemetrexed|mesh-list
25410630|NCT03307785|Niraparib|niraparib|mesh-list
25410631|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25410632|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410633|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
25410634|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
25410635|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
25410636|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410637|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410638|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25410639|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25410640|NCT03307785|Growth Substances|growth substances|mesh-ancestor
25410641|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410642|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
25410643|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410644|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25410645|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25410646|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25410647|NCT03306264|Decitabine|decitabine|mesh-list
25410648|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410649|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
25410650|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410651|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410652|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410653|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
25410654|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410655|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410656|NCT03302910|Torsemide|torsemide|mesh-list
25410657|NCT03302910|Furosemide|furosemide|mesh-list
25410658|NCT03302910|Bumetanide|bumetanide|mesh-list
25410659|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
25410660|NCT03302910|Diuretics|diuretics|mesh-list
25410661|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25410662|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
25410663|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410664|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25410665|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410666|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
25410667|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410668|NCT03302195|Heparin|heparin|mesh-list
25410669|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
25410670|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25410671|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25410672|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410673|NCT03301896|Spartalizumab|spartalizumab|mesh-list
25410674|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25410675|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410676|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410677|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
25410678|NCT03301636|Nivolumab|nivolumab|mesh-list
25410679|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410680|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410681|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25410682|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410683|NCT03301506|Seladelpar|seladelpar|mesh-list
25410684|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25410685|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
25410686|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410687|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25410688|NCT03301415|Valganciclovir|valganciclovir|mesh-list
25410690|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410691|NCT03301220|Daratumumab|daratumumab|mesh-list
25410692|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410693|NCT03300557|Exemestane|exemestane|mesh-list
25410694|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410695|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25410696|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25410697|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410698|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410699|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25410700|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
25410701|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410702|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410703|NCT03300427|Valsartan|valsartan|mesh-list
25410704|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25410705|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410706|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25410707|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25410708|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410709|NCT03299049|Rilpivirine|rilpivirine|mesh-list
25410710|NCT03299049|Cabotegravir|cabotegravir|mesh-list
25410711|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25410712|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25410713|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410714|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410715|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
25410716|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410717|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25410718|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25410719|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25410720|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25410721|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25410722|NCT03298945|Laxatives|laxatives|mesh-ancestor
25410723|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25410724|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25410725|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25410726|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25410727|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410728|NCT03298802|Diuretics|diuretics|mesh-ancestor
25410729|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
25410730|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410731|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25410732|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25410733|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410734|NCT03297606|Nivolumab|nivolumab|mesh-list
25410735|NCT03297606|Trastuzumab|trastuzumab|mesh-list
25410736|NCT03297606|Ipilimumab|ipilimumab|mesh-list
25410737|NCT03297606|Pertuzumab|pertuzumab|mesh-list
25410738|NCT03297606|Sunitinib|sunitinib|mesh-list
25410739|NCT03297606|Dasatinib|dasatinib|mesh-list
25410740|NCT03297606|Olaparib|olaparib|mesh-list
25410741|NCT03297606|Palbociclib|palbociclib|mesh-list
25410742|NCT03297606|Axitinib|axitinib|mesh-list
25410743|NCT03297606|Vemurafenib|vemurafenib|mesh-list
25410744|NCT03297606|Crizotinib|crizotinib|mesh-list
25410745|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410746|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410747|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25410748|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410749|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25410750|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410751|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25410752|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25410753|NCT03297606|Growth Substances|growth substances|mesh-ancestor
25410760|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
25410761|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410762|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25410763|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25410764|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410765|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410766|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
25410767|NCT03294954|Fludarabine|fludarabine|mesh-list
25410768|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410769|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
25410770|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410771|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410772|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410773|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
25410774|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410775|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410776|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25410782|NCT03294083|Cemiplimab|cemiplimab|mesh-list
25410783|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410784|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410785|NCT03292926|Dexamethasone|dexamethasone|mesh-list
25410786|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
25410787|NCT03292926|Bupivacaine|bupivacaine|mesh-list
25410788|NCT03292926|BB 1101|bb 1101|mesh-list
25410789|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25410790|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
25410791|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
25410792|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410793|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410794|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25410795|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
25410796|NCT03292926|Hormones|hormones|mesh-ancestor
25410797|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410798|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25410799|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410800|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
25410801|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410802|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410803|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
25410804|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
25410805|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410806|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
25410807|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25410808|NCT03290937|Cetuximab|cetuximab|mesh-list
25410809|NCT03290937|Irinotecan|irinotecan|mesh-list
25410810|NCT03290937|Camptothecin|camptothecin|mesh-list
25410811|NCT03290937|Antibodies|antibodies|mesh-list
25410812|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
25410813|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25410814|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
25410815|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
25410816|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410817|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410818|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25410819|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25410820|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410821|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410822|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25410823|NCT03290794|Aflibercept|aflibercept|mesh-list
25410824|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25410825|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25410826|NCT03290794|Growth Substances|growth substances|mesh-ancestor
25410827|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410828|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
25410829|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410830|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
25410831|NCT03290612|Vitamins|vitamins|mesh-ancestor
25410832|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
25410833|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410834|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
25410835|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410836|NCT03290612|Protective Agents|protective agents|mesh-ancestor
25410837|NCT03290391|Naltrexone|naltrexone|mesh-list
25410838|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25410839|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25410840|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410995|NCT03281954|Atezolizumab|atezolizumab|mesh-list
25410841|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
25410842|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410844|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
25410845|NCT03289949|Ketanserin|ketanserin|mesh-list
25410846|NCT03289949|Psilocybin|psilocybin|mesh-list
25410847|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
25410848|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410849|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25410850|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25410851|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25410852|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25410853|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
25410854|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410855|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410856|NCT03288974|Pomalidomide|pomalidomide|mesh-list
25410857|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
25410858|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410859|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25410860|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25410861|NCT03288974|Growth Substances|growth substances|mesh-ancestor
25410862|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
25410863|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410864|NCT03287947|Nintedanib|nintedanib|mesh-list
25410865|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410866|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25410867|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410868|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410869|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
25410870|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25410871|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410872|NCT03287089|Renal Agents|renal agents|mesh-ancestor
25410873|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25410874|NCT03286634|Cytarabine|cytarabine|mesh-list
25410875|NCT03286634|Prednisolone|prednisolone|mesh-list
25410876|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
25410877|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
25410878|NCT03286634|Methotrexate|methotrexate|mesh-list
25410879|NCT03286634|Vincristine|vincristine|mesh-list
25410880|NCT03286634|Daunorubicin|daunorubicin|mesh-list
25410881|NCT03286634|Epirubicin|epirubicin|mesh-list
25410882|NCT03286634|Asparaginase|asparaginase|mesh-list
25410883|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
25410884|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410885|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
25410886|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410887|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410888|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25410889|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
25410890|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410891|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410892|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25410893|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25410894|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
25410895|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25410896|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25410897|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
25410898|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
25410899|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410900|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25410901|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25410902|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
25410903|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410904|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25410905|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
25410906|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
25410907|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
25410908|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25410909|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
25410910|NCT03286634|Hormones|hormones|mesh-ancestor
25410911|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410912|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25410913|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25410914|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25410915|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25410916|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25410917|NCT03286556|Autoantibodies|autoantibodies|mesh-list
25410918|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25410919|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
25410920|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410921|NCT03285321|Nivolumab|nivolumab|mesh-list
25410922|NCT03285321|Ipilimumab|ipilimumab|mesh-list
25410923|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410924|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410925|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25410926|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410927|NCT03284957|Everolimus|everolimus|mesh-list
25410928|NCT03284957|Palbociclib|palbociclib|mesh-list
25410929|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410930|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25410931|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
25410932|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410933|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25410934|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410935|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410936|NCT03284463|Glyburide|glyburide|mesh-list
25410957|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25410958|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25410959|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
25410960|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410961|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410962|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25410963|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25410964|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25410965|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25410966|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25410967|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25410968|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25410969|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
25410970|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
25410971|NCT03283917|Dexamethasone|dexamethasone|mesh-list
25410972|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
25410973|NCT03283917|Daratumumab|daratumumab|mesh-list
25410974|NCT03283917|Ixazomib|ixazomib|mesh-list
25410975|NCT03283917|Ichthammol|ichthammol|mesh-list
25410976|NCT03283917|BB 1101|bb 1101|mesh-list
25410977|NCT03283917|Glycine|glycine|mesh-list
25410978|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25410979|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
25410980|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
25410981|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410982|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410983|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25410984|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
25410985|NCT03283917|Hormones|hormones|mesh-ancestor
25410986|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25410987|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25410988|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25410989|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
25410990|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410991|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410992|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
25410993|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
25410994|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25410996|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411028|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25411029|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411030|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25411031|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25411032|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25411033|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411034|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
25411035|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411036|NCT03280160|Ofatumumab|ofatumumab|mesh-list
25411037|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411038|NCT03280017|Ketamine|ketamine|mesh-list
25411039|NCT03280017|Analgesics|analgesics|mesh-ancestor
25411040|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
25411041|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411042|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411043|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25411044|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25411045|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
25411046|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
25411047|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411048|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25411049|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25411050|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411051|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411052|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25411053|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25411054|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411055|NCT03279250|Prednisone|prednisone|mesh-list
25411056|NCT03279250|Cortisone|cortisone|mesh-list
25411057|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
25411058|NCT03279250|Hormones|hormones|mesh-list
25411059|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25411060|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411061|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
25411062|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25411063|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411064|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25411065|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411066|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25411067|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411068|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411069|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
25411070|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25411071|NCT03278717|Olaparib|olaparib|mesh-list
25411072|NCT03278717|Cediranib|cediranib|mesh-list
25411073|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25411074|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411075|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411076|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411077|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25411078|NCT03278509|Metoprolol|metoprolol|mesh-list
25411079|NCT03278509|Bisoprolol|bisoprolol|mesh-list
25411080|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25411081|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25411082|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
25411083|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
25411084|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411085|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411086|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25411087|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25411088|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25411089|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
25411090|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411091|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411092|NCT03277196|Ivacaftor|ivacaftor|mesh-list
25411093|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25411094|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25411095|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411096|NCT03275597|Durvalumab|durvalumab|mesh-list
25411097|NCT03275597|Tremelimumab|tremelimumab|mesh-list
25411098|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411099|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411100|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
25411101|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411102|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411103|NCT03274492|Prednisone|prednisone|mesh-list
25411104|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
25411105|NCT03274492|Rituximab|rituximab|mesh-list
25411106|NCT03274492|Doxorubicin|doxorubicin|mesh-list
25411107|NCT03274492|Vincristine|vincristine|mesh-list
25411108|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25411109|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
25411110|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411111|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
25411112|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411113|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25411114|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25411115|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
25411116|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411117|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411118|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25411119|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411120|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25411121|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25411122|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25411123|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411124|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411125|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
25411126|NCT03274492|Hormones|hormones|mesh-ancestor
25411127|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383404|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383405|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411128|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25411129|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25411130|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411131|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411132|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411133|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25411134|NCT03274466|Laxatives|laxatives|mesh-ancestor
25411135|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411136|NCT03274401|Anticoagulants|anticoagulants|mesh-list
25411137|NCT03274258|Nivolumab|nivolumab|mesh-list
25411138|NCT03274258|Ipilimumab|ipilimumab|mesh-list
25411139|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411140|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411141|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411142|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411143|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
25411144|NCT03273153|Atezolizumab|atezolizumab|mesh-list
25411145|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411223|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25411146|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411147|NCT03272217|Bevacizumab|bevacizumab|mesh-list
25411148|NCT03272217|Atezolizumab|atezolizumab|mesh-list
25411149|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411150|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411151|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25411152|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25411153|NCT03272217|Growth Substances|growth substances|mesh-ancestor
25411154|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411155|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
25411156|NCT03271372|Avelumab|avelumab|mesh-list
25411157|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25411158|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411159|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411160|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
25411161|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411162|NCT03269994|Tazobactam|tazobactam|mesh-list
25411163|NCT03269994|Piperacillin|piperacillin|mesh-list
25411164|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25411165|NCT03269994|Cefoxitin|cefoxitin|mesh-list
25411236|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
25411237|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411238|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411239|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
25411240|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
25411241|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25411242|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25411243|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
25411244|NCT03267277|Antidotes|antidotes|mesh-ancestor
25411245|NCT03267277|Protective Agents|protective agents|mesh-ancestor
25411246|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411247|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
25411248|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411249|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
25411250|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25411251|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411252|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
25411253|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
25411254|NCT03266081|Bupivacaine|bupivacaine|mesh-list
25411255|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
25411256|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
25411257|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411258|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411259|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
25411260|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411261|NCT03263481|Secretin|secretin|mesh-list
25411262|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411263|NCT03263481|Hormones|hormones|mesh-ancestor
25411264|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25411265|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411266|NCT03262935|Capecitabine|capecitabine|mesh-list
25411267|NCT03262935|Trastuzumab|trastuzumab|mesh-list
25411268|NCT03262935|Vinorelbine|vinorelbine|mesh-list
25411269|NCT03262935|Lapatinib|lapatinib|mesh-list
25411270|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411271|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
25411272|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411273|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411274|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411275|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25411276|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411277|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411278|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411279|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25411280|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411281|NCT03262779|Nivolumab|nivolumab|mesh-list
25411282|NCT03262779|Ipilimumab|ipilimumab|mesh-list
25411283|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411284|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411285|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411286|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411288|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25411290|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
25411291|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
25411292|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411293|NCT03262103|Laxatives|laxatives|mesh-ancestor
25411294|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411295|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
25411296|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411297|NCT03261570|Digoxin|digoxin|mesh-list
25411298|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25411299|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25411300|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25411301|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411302|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411303|NCT03261570|Protective Agents|protective agents|mesh-ancestor
25411304|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411305|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25411306|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
25411307|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411308|NCT03259503|Gemcitabine|gemcitabine|mesh-list
25411309|NCT03259503|Rituximab|rituximab|mesh-list
25411310|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25411311|NCT03259503|Melphalan|melphalan|mesh-list
25411312|NCT03259503|Busulfan|busulfan|mesh-list
25411313|NCT03259503|Olaparib|olaparib|mesh-list
25411314|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
25411315|NCT03259503|Vorinostat|vorinostat|mesh-list
25411316|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25411317|NCT03259503|Antibodies|antibodies|mesh-list
25411318|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
25411319|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25411320|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
25411321|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411334|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25411335|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25411336|NCT03259074|Adalimumab|adalimumab|mesh-list
25411337|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411338|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25411339|NCT03258593|Durvalumab|durvalumab|mesh-list
25411340|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411341|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411342|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25411343|NCT03258554|Cetuximab|cetuximab|mesh-list
25411344|NCT03258554|Durvalumab|durvalumab|mesh-list
25411345|NCT03258554|Antibodies|antibodies|mesh-list
25411346|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
25411347|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25411348|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
25411349|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
25411350|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411351|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411352|NCT03257761|Durvalumab|durvalumab|mesh-list
25411353|NCT03257761|Guadecitabine|guadecitabine|mesh-list
25411354|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411355|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411369|NCT03255629|Glucagon|glucagon|mesh-list
25411370|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25411371|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411372|NCT03255629|Hormones|hormones|mesh-ancestor
25411373|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25411374|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411375|NCT03255629|Incretins|incretins|mesh-ancestor
25411376|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
25411377|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411378|NCT03255252|Cisplatin|cisplatin|mesh-list
25411379|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411380|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25411381|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
25411382|NCT03255174|Coagulants|coagulants|mesh-ancestor
25411383|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
25411384|NCT03254589|Methotrexate|methotrexate|mesh-list
25411385|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25411386|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
25411387|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25411388|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411389|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411390|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
25411391|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411392|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411393|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
25411394|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411395|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25411396|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411397|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
25411398|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25411473|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25411399|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25411400|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411401|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25411402|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25411403|NCT03254589|Analgesics|analgesics|mesh-ancestor
25411404|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
25411405|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411406|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411407|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411408|NCT03254485|Praliciguat|praliciguat|mesh-list
25411409|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25411410|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
25411411|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411412|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411413|NCT03253796|Golimumab|golimumab|mesh-list
25411414|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25411415|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411416|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411417|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
25411418|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411419|NCT03253679|Adavosertib|adavosertib|mesh-list
25411420|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411421|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411422|NCT03252938|Avelumab|avelumab|mesh-list
25411423|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411424|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411425|NCT03252756|Cannabidiol|cannabidiol|mesh-list
25411426|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
25411427|NCT03252587|BMS-986165|bms-986165|mesh-list
25411428|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25411429|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25411430|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411431|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411432|NCT03251300|Mirabegron|mirabegron|mesh-list
25411433|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25411434|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25411435|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25411436|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
25411437|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411438|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411439|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411440|NCT03251300|Urological Agents|urological agents|mesh-ancestor
25411441|NCT03250377|Brivaracetam|brivaracetam|mesh-list
25411442|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
25411443|NCT03250273|Nivolumab|nivolumab|mesh-list
25411444|NCT03250273|Entinostat|entinostat|mesh-list
25411445|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411446|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411447|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411448|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411449|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25411450|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411451|NCT03249558|Morphine|morphine|mesh-list
25411452|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25411453|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25411454|NCT03249558|Narcotics|narcotics|mesh-ancestor
25411455|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411456|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411457|NCT03249558|Analgesics|analgesics|mesh-ancestor
25411458|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
25411459|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411460|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25411461|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25411462|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25411463|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411464|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411465|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
25411466|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25411467|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
25411468|NCT03249181|Dolutegravir|dolutegravir|mesh-list
25411469|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25411470|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25411471|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411472|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411474|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25411475|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
25411476|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411477|NCT03248479|Azacitidine|azacitidine|mesh-list
25411478|NCT03248479|Magrolimab|magrolimab|mesh-list
25411479|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411480|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
25411481|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411482|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411483|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411484|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411485|NCT03248063|Cefazolin|cefazolin|mesh-list
25411486|NCT03248063|Cloxacillin|cloxacillin|mesh-list
25411487|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25411488|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411489|NCT03247582|Edoxaban|edoxaban|mesh-list
25411490|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25411491|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
25411492|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25411493|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
25411494|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411495|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411496|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
25411497|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
25411498|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
25411499|NCT03247088|Busulfan|busulfan|mesh-list
25411500|NCT03247088|Fludarabine|fludarabine|mesh-list
25411501|NCT03247088|Sorafenib|sorafenib|mesh-list
25411502|NCT03247088|Tacrolimus|tacrolimus|mesh-list
25411503|NCT03247088|Lenograstim|lenograstim|mesh-list
25411504|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411505|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
25411506|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411507|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25411508|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25411509|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
25411510|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411511|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411512|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25411513|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25411514|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411515|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25411516|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25411517|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25411518|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
25411519|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25411520|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411521|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25411522|NCT03246828|Gliclazide|gliclazide|mesh-list
25411523|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25411524|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411525|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
25411526|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25411527|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
25411528|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411529|NCT03246074|Paclitaxel|paclitaxel|mesh-list
25411530|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25411531|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411532|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411533|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411534|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411535|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411536|NCT03245541|Durvalumab|durvalumab|mesh-list
25411537|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411538|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411539|NCT03245437|Oxytocin|oxytocin|mesh-list
25411540|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
25411541|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25411542|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411543|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
25411544|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411545|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411546|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
25411547|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25411548|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411549|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25411550|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25411551|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411552|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411553|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411554|NCT03243019|Sirolimus|sirolimus|mesh-list
25411555|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25411556|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411557|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25411558|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411559|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
25411560|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411561|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
25411562|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411563|NCT03242915|Carboplatin|carboplatin|mesh-list
25411564|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
25411565|NCT03242915|Pemetrexed|pemetrexed|mesh-list
25411566|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411567|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411568|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411569|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411570|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25411571|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25411572|NCT03241186|Nivolumab|nivolumab|mesh-list
25411573|NCT03241186|Ipilimumab|ipilimumab|mesh-list
25411574|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411575|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411576|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411577|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411578|NCT03241173|Nivolumab|nivolumab|mesh-list
25411579|NCT03241173|Ipilimumab|ipilimumab|mesh-list
25411580|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411581|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411582|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411583|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411584|NCT03240835|Cisplatin|cisplatin|mesh-list
25411585|NCT03240835|Docetaxel|docetaxel|mesh-list
25411586|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411587|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411588|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411589|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411590|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411591|NCT03240809|Brodalumab|brodalumab|mesh-list
25411592|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25411593|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
25411594|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
25411595|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411596|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
25411597|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25411598|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411599|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411600|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
25411601|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25411602|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411603|NCT03239210|Ondansetron|ondansetron|mesh-list
25411604|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
25411605|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
25411606|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411607|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411608|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411609|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
25411610|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
25411611|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25411612|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
25411613|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411614|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411615|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25411616|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25411617|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411618|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25411619|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25411620|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25411621|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25411622|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411623|NCT03238365|Nivolumab|nivolumab|mesh-list
25411624|NCT03238365|Tadalafil|tadalafil|mesh-list
25411625|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411626|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411627|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411628|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411629|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
25411630|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25411631|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25411632|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411633|NCT03238365|Urological Agents|urological agents|mesh-ancestor
25411634|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
25411635|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
25411636|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411637|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411638|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411639|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
25411640|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
25411641|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
25411642|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25411643|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
25411644|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411645|NCT03238300|Expectorants|expectorants|mesh-ancestor
25411646|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
25411647|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25411648|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
25411649|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411650|NCT03238300|Protective Agents|protective agents|mesh-ancestor
25411651|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411652|NCT03238300|Antidotes|antidotes|mesh-ancestor
25411653|NCT03238027|Durvalumab|durvalumab|mesh-list
25411654|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411655|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411656|NCT03237780|Atezolizumab|atezolizumab|mesh-list
25411657|NCT03237780|Halichondrin B|halichondrin b|mesh-list
25411658|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25411659|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411660|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
25411661|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411662|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411663|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411664|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411665|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411666|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
25411667|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411668|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411669|NCT03237390|Gemcitabine|gemcitabine|mesh-list
25411670|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411672|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411673|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411674|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
25411675|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411676|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411677|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411678|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
25411679|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411680|NCT03237286|Ketamine|ketamine|mesh-list
25411681|NCT03237286|Analgesics|analgesics|mesh-ancestor
25411682|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
25411683|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411684|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411685|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25411686|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25411687|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
25411688|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
25411689|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411690|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25411691|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25411692|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411693|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411694|NCT03236428|Daratumumab|daratumumab|mesh-list
25411695|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411696|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25411697|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
25411698|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25411699|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25411700|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25411701|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
25411702|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411856|NCT03224507|Dexamethasone|dexamethasone|mesh-list
25411703|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411704|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411705|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25411706|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25411707|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25411708|NCT03234972|Dexamethasone|dexamethasone|mesh-list
25411709|NCT03234972|Bortezomib|bortezomib|mesh-list
25411710|NCT03234972|Daratumumab|daratumumab|mesh-list
25411711|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411712|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
25411713|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
25411714|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411715|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411716|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411717|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
25411718|NCT03234972|Hormones|hormones|mesh-ancestor
25411719|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25411720|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25411721|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411722|NCT03234907|Vedolizumab|vedolizumab|mesh-list
25411723|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411724|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
25411725|NCT03233724|Decitabine|decitabine|mesh-list
25411726|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
25411727|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411728|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411729|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411730|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
25411731|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411732|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411733|NCT03233711|Nivolumab|nivolumab|mesh-list
25411734|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411735|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411736|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411737|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411738|NCT03233633|Cannabidiol|cannabidiol|mesh-list
25411739|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
25411740|NCT03233139|Gemcitabine|gemcitabine|mesh-list
25411741|NCT03233139|Paclitaxel|paclitaxel|mesh-list
25411742|NCT03233139|Pemetrexed|pemetrexed|mesh-list
25411743|NCT03233139|Ipilimumab|ipilimumab|mesh-list
25411744|NCT03233139|Cemiplimab|cemiplimab|mesh-list
25411745|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25411746|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411747|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411748|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411749|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411750|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383928|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25383929|NCT04565301|Dexamethasone|dexamethasone|mesh-list
25383930|NCT04565301|Neostigmine|neostigmine|mesh-list
25383931|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383933|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
25411751|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411752|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
25411753|NCT03233139|Antiviral Agents|antiviral agents|mesh-ancestor
25411754|NCT03233139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411755|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411756|NCT03233139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411757|NCT03233139|Immunologic Factors|immunologic factors|mesh-ancestor
25411758|NCT03233139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411759|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25411760|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25411761|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411762|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411763|NCT03232593|Atezolizumab|atezolizumab|mesh-list
25411764|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411765|NCT03232073|Ponesimod|ponesimod|mesh-list
25411766|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25411767|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411768|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411769|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
25411770|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411771|NCT03231722|Leucovorin|leucovorin|mesh-list
25411772|NCT03231722|Fluorouracil|fluorouracil|mesh-list
25411773|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
25411774|NCT03231722|Irinotecan|irinotecan|mesh-list
25411775|NCT03231722|Panitumumab|panitumumab|mesh-list
25411776|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
25411777|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
25411778|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411857|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
25411779|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411780|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411781|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411782|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
25411783|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411784|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25411785|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25411786|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411787|NCT03231722|Antidotes|antidotes|mesh-ancestor
25411788|NCT03231722|Protective Agents|protective agents|mesh-ancestor
25411789|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
25411790|NCT03231722|Vitamins|vitamins|mesh-ancestor
25411791|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
25411792|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411793|NCT03229798|Sumatriptan|sumatriptan|mesh-list
25411794|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25411795|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25411796|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25411797|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
25411798|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411799|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411800|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411801|NCT03229174|Droxidopa|droxidopa|mesh-list
25411802|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25411803|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25411804|NCT03228537|Cisplatin|cisplatin|mesh-list
25411805|NCT03228537|Pemetrexed|pemetrexed|mesh-list
25411806|NCT03228537|Atezolizumab|atezolizumab|mesh-list
25411807|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25411808|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411809|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411810|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411811|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25411812|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25411813|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
25411814|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411815|NCT03227926|Panitumumab|panitumumab|mesh-list
25411816|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384005|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384006|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384007|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25384008|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
25384010|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411817|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411818|NCT03227562|Risperidone|risperidone|mesh-list
25411819|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25411820|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
25411821|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411822|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411823|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411824|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25411825|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25411826|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411827|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25411828|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25411829|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
25411830|NCT03226418|Cytarabine|cytarabine|mesh-list
25411831|NCT03226418|Azacitidine|azacitidine|mesh-list
25411832|NCT03226418|Decitabine|decitabine|mesh-list
25411833|NCT03226418|Daunorubicin|daunorubicin|mesh-list
25411834|NCT03226418|Venetoclax|venetoclax|mesh-list
25411835|NCT03226418|Idarubicin|idarubicin|mesh-list
25411836|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411837|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
25411838|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411839|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411840|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
25411841|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411842|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411843|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
25411844|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411845|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411846|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25411847|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25411848|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25411849|NCT03226301|Venetoclax|venetoclax|mesh-list
25411850|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411851|NCT03224767|Vemurafenib|vemurafenib|mesh-list
25411852|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411853|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25411854|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411855|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411862|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411863|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
25411864|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
25411865|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411866|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411867|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411868|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
25411869|NCT03224507|Hormones|hormones|mesh-ancestor
25411870|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25411871|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25411872|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411873|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
25411874|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411875|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411876|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
25411877|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25411878|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25411879|NCT03224507|Growth Substances|growth substances|mesh-ancestor
25411880|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
25411881|NCT03223779|Trifluridine|trifluridine|mesh-list
25411882|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
25411883|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411884|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
25411885|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411886|NCT03223610|Prednisone|prednisone|mesh-list
25411887|NCT03223610|Lenalidomide|lenalidomide|mesh-list
25411888|NCT03223610|Venetoclax|venetoclax|mesh-list
25411889|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
25411890|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25411891|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
25411892|NCT03223610|Hormones|hormones|mesh-ancestor
25411893|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25411894|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411895|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25411896|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411897|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
25411898|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25411977|NCT03220477|Guadecitabine|guadecitabine|mesh-list
25411899|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25411900|NCT03223610|Growth Substances|growth substances|mesh-ancestor
25411901|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
25411902|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411903|NCT03223376|Paclitaxel|paclitaxel|mesh-list
25411904|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25411905|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25411906|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411907|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411908|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411909|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411910|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411911|NCT03222609|Navitoclax|navitoclax|mesh-list
25411912|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411913|NCT03222076|Nivolumab|nivolumab|mesh-list
25411914|NCT03222076|Ipilimumab|ipilimumab|mesh-list
25411915|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411916|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411917|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25411918|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411919|NCT03221842|Complement C1s|complement c1s|mesh-list
25411920|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25411921|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25411922|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
25411923|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411924|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25411925|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411926|NCT03221426|Leucovorin|leucovorin|mesh-list
25411927|NCT03221426|Cisplatin|cisplatin|mesh-list
25411928|NCT03221426|Docetaxel|docetaxel|mesh-list
25411929|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
25411930|NCT03221426|Fluorouracil|fluorouracil|mesh-list
25411931|NCT03221426|Capecitabine|capecitabine|mesh-list
25411932|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
25411933|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411934|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
25411935|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
25411936|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
25411937|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411938|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411939|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
25411940|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411941|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411942|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
25411943|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411944|NCT03221426|Antidotes|antidotes|mesh-ancestor
25411945|NCT03221426|Protective Agents|protective agents|mesh-ancestor
25411946|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
25411947|NCT03221426|Vitamins|vitamins|mesh-ancestor
25411948|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
25411949|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
25411950|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25411951|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
25411952|NCT03220776|Gabapentin|gabapentin|mesh-list
25411953|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25411954|NCT03220776|Analgesics|analgesics|mesh-ancestor
25411955|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
25411956|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25411957|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411958|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
25411959|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25411960|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25411961|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25411962|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25411963|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25411964|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25411965|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25411966|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411967|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
25411968|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
25411969|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411970|NCT03220776|Expectorants|expectorants|mesh-ancestor
25411971|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
25411972|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25411973|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
25411974|NCT03220776|Protective Agents|protective agents|mesh-ancestor
25411975|NCT03220776|Antidotes|antidotes|mesh-ancestor
25411976|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
25411978|NCT03220477|Mocetinostat|mocetinostat|mesh-list
25411979|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411980|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411981|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25411982|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411983|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411984|NCT03220035|Vemurafenib|vemurafenib|mesh-list
25411985|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411986|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25411987|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411988|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411989|NCT03220022|Prednisone|prednisone|mesh-list
25411990|NCT03220022|Cortisone|cortisone|mesh-list
25411991|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
25411992|NCT03220022|Rituximab|rituximab|mesh-list
25411993|NCT03220022|Doxorubicin|doxorubicin|mesh-list
25411994|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25411995|NCT03220022|Etoposide|etoposide|mesh-list
25411996|NCT03220022|Vincristine|vincristine|mesh-list
25411997|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
25411998|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
25411999|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25412000|NCT03220022|Antibodies|antibodies|mesh-list
25412001|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
25412002|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25412003|NCT03220022|Lenograstim|lenograstim|mesh-list
25412004|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412005|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
25412006|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412007|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412008|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412009|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
25412010|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412011|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412012|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412013|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25412014|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25412015|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25412016|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412017|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412018|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
25412020|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25412021|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25412022|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412023|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25412024|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25412025|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25412026|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25412027|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
25412028|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
25412029|NCT03219476|Tamoxifen|tamoxifen|mesh-list
25412030|NCT03219476|Letrozole|letrozole|mesh-list
25412031|NCT03219476|Anastrozole|anastrozole|mesh-list
25412032|NCT03219476|Exemestane|exemestane|mesh-list
25412033|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412034|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25412035|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25412036|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412037|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412038|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25412039|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
25412040|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25412041|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412042|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25412043|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25412044|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25412045|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25412046|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
25412047|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
25412048|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
25412049|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412050|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412051|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412052|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412053|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
25412054|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412055|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412056|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412057|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412058|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
25412059|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
25412060|NCT03219359|Vedolizumab|vedolizumab|mesh-list
25412061|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
25412062|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412063|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
25412064|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412065|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412066|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412067|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
25412068|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412069|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412070|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412071|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412072|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
25412073|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
25412074|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412075|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412076|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
25412077|NCT03219359|Hormones|hormones|mesh-ancestor
25412078|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25412079|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25412080|NCT03219359|Protective Agents|protective agents|mesh-ancestor
25412081|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
25412082|NCT03219177|Narcotics|narcotics|mesh-ancestor
25412083|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412084|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412085|NCT03219177|Analgesics|analgesics|mesh-ancestor
25412086|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
25412087|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412088|NCT03219086|Bupivacaine|bupivacaine|mesh-list
25412089|NCT03219086|Prilocaine|prilocaine|mesh-list
25412090|NCT03219086|Anesthetics|anesthetics|mesh-list
25412091|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
25412092|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412093|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412094|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
25412095|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412096|NCT03218800|Ertapenem|ertapenem|mesh-list
25412097|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25412098|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412099|NCT03218683|Venetoclax|venetoclax|mesh-list
25412100|NCT03218683|AZD5991|azd5991|mesh-list
25412101|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412102|NCT03218488|Ustekinumab|ustekinumab|mesh-list
25412103|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
25412104|NCT03217812|Prednisone|prednisone|mesh-list
25412105|NCT03217812|Bortezomib|bortezomib|mesh-list
25412106|NCT03217812|Melphalan|melphalan|mesh-list
25412107|NCT03217812|Daratumumab|daratumumab|mesh-list
25412108|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412109|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
25412110|NCT03217812|Hormones|hormones|mesh-ancestor
25412111|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25412112|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412113|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25412114|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412115|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412116|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
25412117|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412118|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412119|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412120|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
25412121|NCT03217747|Avelumab|avelumab|mesh-list
25412122|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25412123|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
25412124|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412125|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412126|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
25412127|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412128|NCT03217591|Praliciguat|praliciguat|mesh-list
25412129|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25412130|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
25412136|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25412137|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412138|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25412139|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412140|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412141|NCT03216967|Everolimus|everolimus|mesh-list
25412142|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412143|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412144|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
25412145|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412146|NCT03215511|Selitrectinib|selitrectinib|mesh-list
25412147|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412148|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412149|NCT03215030|Dexamethasone|dexamethasone|mesh-list
25412150|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412151|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
25412152|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
25412153|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412154|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412155|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412156|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
25412157|NCT03215030|Hormones|hormones|mesh-ancestor
25412158|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25412159|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25412160|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412161|NCT03215017|Loperamide|loperamide|mesh-list
25412162|NCT03215017|Sorbitol|sorbitol|mesh-list
25412163|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
25412164|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412165|NCT03215017|Cathartics|cathartics|mesh-ancestor
25412166|NCT03214250|Gemcitabine|gemcitabine|mesh-list
25412167|NCT03214250|Paclitaxel|paclitaxel|mesh-list
25412168|NCT03214250|Nivolumab|nivolumab|mesh-list
25412169|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412170|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412171|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
25412172|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
25412173|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
25412252|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25412174|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412175|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412176|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
25412177|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
25412178|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412179|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412180|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412181|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
25412182|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412183|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412184|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25412190|NCT03212989|Vorinostat|vorinostat|mesh-list
25412191|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412192|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25412193|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412194|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412195|NCT03212742|Temozolomide|temozolomide|mesh-list
25412196|NCT03212742|Olaparib|olaparib|mesh-list
25412197|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412198|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
25412199|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412200|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412201|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25412202|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412203|NCT03212274|Olaparib|olaparib|mesh-list
25412204|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25412205|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412281|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
25412206|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412207|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412209|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
25412210|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
25412211|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412212|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412213|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
25412214|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412215|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
25412216|NCT03211416|Sorafenib|sorafenib|mesh-list
25412217|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412448|NCT03194932|Methotrexate|methotrexate|mesh-list
25412218|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412219|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25412220|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412221|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412222|NCT03209401|Carboplatin|carboplatin|mesh-list
25412223|NCT03209401|Niraparib|niraparib|mesh-list
25412224|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412225|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25412226|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412227|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412228|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
25412229|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412230|NCT03207958|Belimumab|belimumab|mesh-list
25412231|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412232|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
25412233|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412234|NCT03207867|Spartalizumab|spartalizumab|mesh-list
25412235|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25412236|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412237|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412238|NCT03207451|Aspirin|aspirin|mesh-list
25412239|NCT03207451|Clopidogrel|clopidogrel|mesh-list
25412240|NCT03207451|Vorapaxar|vorapaxar|mesh-list
25412241|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25412242|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25412243|NCT03207451|Analgesics|analgesics|mesh-ancestor
25412244|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
25412245|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412246|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412247|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412248|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412249|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25412250|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25412251|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412253|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25412254|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412255|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
25412256|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25412257|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25412258|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25412259|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
25412260|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25412261|NCT03206203|Carboplatin|carboplatin|mesh-list
25412262|NCT03206203|Atezolizumab|atezolizumab|mesh-list
25412263|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412264|NCT03204786|Vasopressins|vasopressins|mesh-list
25412265|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
25412266|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
25412267|NCT03204786|Coagulants|coagulants|mesh-ancestor
25412268|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25412269|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25412270|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
25412271|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412272|NCT03204396|Dulaglutide|dulaglutide|mesh-list
25412273|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25412274|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412275|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
25412276|NCT03204188|Fludarabine|fludarabine|mesh-list
25412277|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412278|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412279|NCT03203850|Deferasirox|deferasirox|mesh-list
25384466|NCT04546009|Palbociclib|palbociclib|mesh-list
25384467|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384468|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25412280|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25412282|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
25412283|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412284|NCT03201965|Dexamethasone|dexamethasone|mesh-list
25412285|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
25412287|NCT03201965|Daratumumab|daratumumab|mesh-list
25412288|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412289|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
25412290|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412291|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412292|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412293|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
25412371|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412294|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412295|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412296|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412297|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412298|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
25412299|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
25412300|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412301|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412302|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
25412303|NCT03201965|Hormones|hormones|mesh-ancestor
25412304|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25412305|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25412306|NCT03201562|Tropicamide|tropicamide|mesh-list
25412307|NCT03201562|Aceclidine|aceclidine|mesh-list
25412308|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
25412309|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
25412310|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412311|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412312|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25412313|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25412314|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
25412315|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25412316|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412317|NCT03201562|Miotics|miotics|mesh-ancestor
25412318|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25412319|NCT03199924|Diclofenac|diclofenac|mesh-list
25412320|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25412321|NCT03199924|Lidocaine|lidocaine|mesh-list
25412322|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
25412323|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
25412324|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
25412325|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412326|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412327|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
25412328|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412329|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25412330|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25412331|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25412332|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25412333|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412334|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25412335|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25412336|NCT03199924|Analgesics|analgesics|mesh-ancestor
25412337|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412338|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25412339|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412340|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
25412341|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25412342|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25412343|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
25412344|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25412345|NCT03199885|Paclitaxel|paclitaxel|mesh-list
25412346|NCT03199885|Docetaxel|docetaxel|mesh-list
25412347|NCT03199885|Trastuzumab|trastuzumab|mesh-list
25412348|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25412349|NCT03199885|Atezolizumab|atezolizumab|mesh-list
25412350|NCT03199885|Pertuzumab|pertuzumab|mesh-list
25412351|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25412352|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25412353|NCT03199885|Antibodies|antibodies|mesh-list
25412354|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
25412355|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25412356|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412357|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412358|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
25412359|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
25412360|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
25412361|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412362|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
25412363|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412364|NCT03199300|Cisplatin|cisplatin|mesh-list
25412365|NCT03199300|Trastuzumab|trastuzumab|mesh-list
25412366|NCT03199300|Bleomycin|bleomycin|mesh-list
25412367|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412368|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412369|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25412370|NCT03199040|Durvalumab|durvalumab|mesh-list
25412372|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412373|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
25412374|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
25412375|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412376|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412377|NCT03198351|Teriflunomide|teriflunomide|mesh-list
25412378|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25412379|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25412380|NCT03198351|Analgesics|analgesics|mesh-ancestor
25412381|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
25412382|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412383|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412384|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412385|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412386|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412387|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
25412388|NCT03198078|Aripiprazole|aripiprazole|mesh-list
25412389|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
25412390|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
25412391|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25412392|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25412393|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25412394|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412395|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412396|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
25412397|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
25412398|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25412399|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412400|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25412401|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25412402|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
25412403|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25412404|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25412405|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25412406|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25412407|NCT03197935|Paclitaxel|paclitaxel|mesh-list
25412408|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
25412412|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412413|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412414|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
25412415|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
25412416|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
25412417|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412418|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412419|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
25412420|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412421|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412422|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412423|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
25412424|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412425|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25412426|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25412427|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25412428|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412429|NCT03197662|Oxytocin|oxytocin|mesh-list
25412430|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
25412431|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25412432|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412433|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
25412434|NCT03197506|Temozolomide|temozolomide|mesh-list
25412435|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412436|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412437|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412438|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
25412439|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412440|NCT03195478|Nivolumab|nivolumab|mesh-list
25412441|NCT03195478|Ipilimumab|ipilimumab|mesh-list
25412442|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412443|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412444|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25412445|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412446|NCT03194932|Cytarabine|cytarabine|mesh-list
25412447|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
25412449|NCT03194932|Azacitidine|azacitidine|mesh-list
25412450|NCT03194932|Venetoclax|venetoclax|mesh-list
25412451|NCT03194932|Idarubicin|idarubicin|mesh-list
25412452|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25412453|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
25412454|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25412455|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412456|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412457|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
25412458|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412459|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412460|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
25412461|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412462|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25412463|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412464|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
25412465|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412466|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25412467|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
25412468|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412469|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412470|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25412471|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25412472|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25412473|NCT03194893|Crizotinib|crizotinib|mesh-list
25412474|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412475|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25412476|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412477|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412478|NCT03194542|Luspatercept|luspatercept|mesh-list
25412479|NCT03194542|Hematinics|hematinics|mesh-ancestor
25412480|NCT03194126|Misoprostol|misoprostol|mesh-list
25412481|NCT03194126|Mifepristone|mifepristone|mesh-list
25412482|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25412483|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
25412484|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25412485|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412486|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25412487|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412488|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
25412489|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25412490|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25412491|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25412492|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25412493|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
25412494|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25412495|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25412496|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
25412497|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25412498|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
25412499|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25412500|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25412501|NCT03193866|Interferons|interferons|mesh-list
25412502|NCT03193866|Interferon-beta|interferon-beta|mesh-list
25412503|NCT03193866|Rituximab|rituximab|mesh-list
25412504|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
25412505|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
25412506|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25412507|NCT03193866|Natalizumab|natalizumab|mesh-list
25412508|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25412509|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
25412510|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412511|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412512|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
25412513|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412514|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412515|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
25412516|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412517|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25412518|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412519|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412520|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
25412521|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25412522|NCT03193190|Leucovorin|leucovorin|mesh-list
25412523|NCT03193190|Gemcitabine|gemcitabine|mesh-list
25412524|NCT03193190|Paclitaxel|paclitaxel|mesh-list
25412525|NCT03193190|Bevacizumab|bevacizumab|mesh-list
25412526|NCT03193190|Fluorouracil|fluorouracil|mesh-list
25412527|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
25412528|NCT03193190|Atezolizumab|atezolizumab|mesh-list
25412529|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412530|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412531|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25412532|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25412533|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25412534|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412535|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412536|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25412537|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25412538|NCT03193190|Growth Substances|growth substances|mesh-ancestor
25412539|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412540|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
25412541|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412542|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
25412543|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
25412544|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412545|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412546|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412547|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
25412548|NCT03193190|Antidotes|antidotes|mesh-ancestor
25412549|NCT03193190|Protective Agents|protective agents|mesh-ancestor
25412550|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
25412551|NCT03193190|Vitamins|vitamins|mesh-ancestor
25412552|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
25412553|NCT03191786|Gemcitabine|gemcitabine|mesh-list
25412554|NCT03191786|Atezolizumab|atezolizumab|mesh-list
25412555|NCT03191786|Vinorelbine|vinorelbine|mesh-list
25412556|NCT03191786|Antibodies|antibodies|mesh-list
25412557|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25412558|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
25412559|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412560|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412561|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
25412562|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412563|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412564|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
25412565|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412566|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412567|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412568|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412569|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
25412570|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
25412571|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
25412572|NCT03191149|Osimertinib|osimertinib|mesh-list
25412573|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412574|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25412575|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412576|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412577|NCT03190954|Raclopride|raclopride|mesh-list
25412578|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25412579|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25412580|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412581|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412582|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25412583|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25412584|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
25412585|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25412586|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412587|NCT03190941|Aldesleukin|aldesleukin|mesh-list
25412588|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
25412589|NCT03190941|Fludarabine|fludarabine|mesh-list
25412590|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412591|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
25412592|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412593|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412594|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412595|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
25412596|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412597|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412598|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412599|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25412600|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25412601|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
25412602|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412604|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412605|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25412606|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412607|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412608|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
25412609|NCT03190265|Nivolumab|nivolumab|mesh-list
25412610|NCT03190265|Ipilimumab|ipilimumab|mesh-list
25412611|NCT03190265|Pancrelipase|pancrelipase|mesh-list
25412612|NCT03190265|Vaccines|vaccines|mesh-list
25412613|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
25412614|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412615|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412616|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412617|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412618|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
25412619|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412620|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412621|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412622|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412623|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25412624|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412625|NCT03188432|Carboplatin|carboplatin|mesh-list
25412626|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412627|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25412628|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25412629|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25412630|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412631|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25412632|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25412633|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412634|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25412635|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25412636|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25412637|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412638|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
25412639|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25412640|NCT03187106|Metronidazole|metronidazole|mesh-list
25412641|NCT03187106|Cephalexin|cephalexin|mesh-list
25412644|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25412645|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25412646|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25412647|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25412648|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412649|NCT03186326|Bevacizumab|bevacizumab|mesh-list
25412650|NCT03186326|Cetuximab|cetuximab|mesh-list
25412651|NCT03186326|Avelumab|avelumab|mesh-list
25412652|NCT03186326|Panitumumab|panitumumab|mesh-list
25412653|NCT03186326|Aflibercept|aflibercept|mesh-list
25412654|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412655|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412656|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25412657|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25412658|NCT03186326|Growth Substances|growth substances|mesh-ancestor
25412659|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412660|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
25412661|NCT03186209|Benralizumab|benralizumab|mesh-list
25412662|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25412663|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
25412664|NCT03186027|Ascorbic Acid|ascorbic acid|mesh-list
25412665|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
25412666|NCT03186027|Ubiquinone|ubiquinone|mesh-list
25412667|NCT03186027|Vitamins|vitamins|mesh-ancestor
25412668|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
25412669|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412670|NCT03186027|Antioxidants|antioxidants|mesh-ancestor
25412671|NCT03186027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412672|NCT03186027|Protective Agents|protective agents|mesh-ancestor
25412673|NCT03185819|Midazolam|midazolam|mesh-list
25412674|NCT03185819|Esketamine|esketamine|mesh-list
25412675|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25412676|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25412677|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412678|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412679|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25412680|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25412681|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25412682|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25412683|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
25412685|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
25412686|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
25412687|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25412688|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412689|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
25412690|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25412691|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412692|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412693|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412694|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
25412695|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
25412696|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412697|NCT03182244|Cytarabine|cytarabine|mesh-list
25412698|NCT03182244|Fludarabine|fludarabine|mesh-list
25412699|NCT03182244|Etoposide|etoposide|mesh-list
25412700|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
25412701|NCT03182244|Lenograstim|lenograstim|mesh-list
25412702|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412703|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412704|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
25412705|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412706|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412707|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
25412708|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412709|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412710|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25412711|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25412712|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412713|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
25412714|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412715|NCT03182244|Analgesics|analgesics|mesh-ancestor
25412716|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
25412717|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412718|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25412723|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412724|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
25412725|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412726|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412727|NCT03180034|Vaccines|vaccines|mesh-list
25412728|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
25412729|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412730|NCT03179995|Octreotide|octreotide|mesh-list
25412731|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412732|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25412733|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412734|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
25412735|NCT03179930|Entinostat|entinostat|mesh-list
25412736|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412737|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412738|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25412739|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412740|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412741|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
25412742|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412743|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412744|NCT03178552|Gemcitabine|gemcitabine|mesh-list
25412745|NCT03178552|Bevacizumab|bevacizumab|mesh-list
25412746|NCT03178552|Cisplatin|cisplatin|mesh-list
25412747|NCT03178552|Carboplatin|carboplatin|mesh-list
25412748|NCT03178552|Docetaxel|docetaxel|mesh-list
25412749|NCT03178552|Pemetrexed|pemetrexed|mesh-list
25412750|NCT03178552|Atezolizumab|atezolizumab|mesh-list
25412751|NCT03178552|Vemurafenib|vemurafenib|mesh-list
25412752|NCT03178552|Entrectinib|entrectinib|mesh-list
25412753|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412754|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412755|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25412756|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25412757|NCT03178552|Growth Substances|growth substances|mesh-ancestor
25412758|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412759|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
25412760|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412761|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
25412762|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412763|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
25412764|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412765|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412766|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412767|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
25412768|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
25412769|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
25412770|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
25412771|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25412772|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25412773|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25412774|NCT03178149|Tacrolimus|tacrolimus|mesh-list
25412775|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412776|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
25412777|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412778|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25412779|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412780|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412781|NCT03176277|Venetoclax|venetoclax|mesh-list
25412782|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412783|NCT03176173|Immunologic Factors|immunologic factors|mesh-list
25412784|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412785|NCT03176134|Tedizolid|tedizolid|mesh-list
25412786|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
25412787|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25412788|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412789|NCT03175549|Apremilast|apremilast|mesh-list
25412790|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25412791|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25412792|NCT03175549|Analgesics|analgesics|mesh-ancestor
25412793|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
25412794|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412795|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412796|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25412797|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412798|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25412799|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25412800|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412801|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412803|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25412804|NCT03175432|Atezolizumab|atezolizumab|mesh-list
25412805|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
25412806|NCT03175432|Antibodies|antibodies|mesh-list
25412807|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
25412808|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25412809|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
25412810|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412811|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25412812|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25412813|NCT03175432|Growth Substances|growth substances|mesh-ancestor
25412814|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412815|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
25412816|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
25412817|NCT03174197|Temozolomide|temozolomide|mesh-list
25412818|NCT03174197|Atezolizumab|atezolizumab|mesh-list
25412819|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25412820|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412821|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
25412822|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412823|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412824|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
25412825|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412826|NCT03174132|Lidocaine|lidocaine|mesh-list
25412827|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
25412828|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
25412829|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
25412830|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412831|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412832|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
25412833|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412834|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25412835|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25412836|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25412837|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25412838|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412839|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25412840|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
25412841|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
25412842|NCT03174132|Protective Agents|protective agents|mesh-ancestor
25412843|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
25412844|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25412845|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412846|NCT03173612|Cytarabine|cytarabine|mesh-list
25412847|NCT03173612|Etoposide|etoposide|mesh-list
25412848|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
25412849|NCT03173612|Idarubicin|idarubicin|mesh-list
25412850|NCT03173612|Dasatinib|dasatinib|mesh-list
25412851|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
25412852|NCT03173612|Lenograstim|lenograstim|mesh-list
25412853|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25412854|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412855|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25412856|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25412857|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412858|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412859|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412860|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
25412861|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
25412862|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412863|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412864|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
25412865|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412866|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25412867|NCT03173612|Analgesics|analgesics|mesh-ancestor
25412868|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
25412869|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412870|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25412871|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25412872|NCT03173248|Azacitidine|azacitidine|mesh-list
25412873|NCT03173248|Ivosidenib|ivosidenib|mesh-list
25412874|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412875|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
25412876|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412877|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412878|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412879|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
25412880|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412881|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412882|NCT03170518|Canagliflozin|canagliflozin|mesh-list
25412883|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25412884|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412885|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25412886|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412887|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
25412888|NCT03169881|Hematinics|hematinics|mesh-ancestor
25412889|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25412890|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25412891|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412892|NCT03167905|Fentanyl|fentanyl|mesh-list
25412893|NCT03167905|Meperidine|meperidine|mesh-list
25412894|NCT03167905|Remifentanil|remifentanil|mesh-list
25412895|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
25412896|NCT03167905|Ropivacaine|ropivacaine|mesh-list
25412897|NCT03167905|Entonox|entonox|mesh-list
25412898|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
25412899|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
25412900|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412901|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412902|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
25412903|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25412904|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25412905|NCT03167905|Narcotics|narcotics|mesh-ancestor
25412906|NCT03167905|Analgesics|analgesics|mesh-ancestor
25412907|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25412908|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25412909|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
25412910|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25412911|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25412912|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25412913|NCT03167619|Durvalumab|durvalumab|mesh-list
25412914|NCT03167619|Olaparib|olaparib|mesh-list
25412915|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412916|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412917|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25412918|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412919|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412920|NCT03165942|Ethanol|ethanol|mesh-list
25412921|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25412922|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412923|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25412924|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412925|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
25412926|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412927|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
25412928|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412929|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412930|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25412931|NCT03165292|Topotecan|topotecan|mesh-list
25412932|NCT03165292|Thiotepa|thiotepa|mesh-list
25412933|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25412934|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25412935|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412936|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412937|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412938|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25412939|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
25412940|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412941|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412942|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
25412943|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412944|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
25412945|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
25412946|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25412947|NCT03164772|Durvalumab|durvalumab|mesh-list
25412948|NCT03164772|Tremelimumab|tremelimumab|mesh-list
25412949|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25412991|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25412992|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
25412993|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412994|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412995|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
25412996|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412997|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25412998|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25412999|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
25413000|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413001|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25413002|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413003|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25413004|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25413005|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
25413006|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413007|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413008|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413009|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413010|NCT03164057|Analgesics|analgesics|mesh-ancestor
25413011|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
25413012|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413013|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25413014|NCT03164057|Protective Agents|protective agents|mesh-ancestor
25413015|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413016|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413017|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
25413018|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413019|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413020|NCT03163667|Everolimus|everolimus|mesh-list
25413021|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413022|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413023|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
25413024|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413025|NCT03162731|Nivolumab|nivolumab|mesh-list
25413026|NCT03162731|Ipilimumab|ipilimumab|mesh-list
25413027|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413028|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413029|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25413030|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413031|NCT03162627|Olaparib|olaparib|mesh-list
25413032|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25413033|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413034|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413035|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413036|NCT03162432|Vitamin D|vitamin d|mesh-list
25413037|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
25413038|NCT03162432|Vitamins|vitamins|mesh-ancestor
25413039|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
25413040|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413041|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25413042|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25413043|NCT03162224|Durvalumab|durvalumab|mesh-list
25413044|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413045|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413046|NCT03161522|Fluorouracil|fluorouracil|mesh-list
25413047|NCT03161522|Capecitabine|capecitabine|mesh-list
25413048|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
25413049|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413059|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413060|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
25413061|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413062|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25413063|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25413064|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25413065|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25413066|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413067|NCT03158688|Dexamethasone|dexamethasone|mesh-list
25413068|NCT03158688|Daratumumab|daratumumab|mesh-list
25413069|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413070|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
25413071|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
25413072|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413073|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413074|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25413075|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
25413076|NCT03158688|Hormones|hormones|mesh-ancestor
25413077|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413078|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413079|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413080|NCT03158129|Cisplatin|cisplatin|mesh-list
25413081|NCT03158129|Carboplatin|carboplatin|mesh-list
25413082|NCT03158129|Docetaxel|docetaxel|mesh-list
25413083|NCT03158129|Nivolumab|nivolumab|mesh-list
25413084|NCT03158129|Pemetrexed|pemetrexed|mesh-list
25413085|NCT03158129|Ipilimumab|ipilimumab|mesh-list
25413086|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413087|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413088|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413089|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413090|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413091|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413092|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25413093|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413094|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25413095|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25413096|NCT03156790|Asparaginase|asparaginase|mesh-list
25413097|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413108|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
25413109|NCT03154749|Carboplatin|carboplatin|mesh-list
25413110|NCT03154749|Docetaxel|docetaxel|mesh-list
25413111|NCT03154749|Epirubicin|epirubicin|mesh-list
25413112|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413113|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
25413114|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413115|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413116|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413117|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
25413118|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413119|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413120|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413121|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413122|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413123|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413124|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413125|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25413126|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25413127|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413128|NCT03153319|Adalimumab|adalimumab|mesh-list
25413129|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413130|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413131|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
25413132|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413133|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413134|NCT03153137|Macitentan|macitentan|mesh-list
25413135|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25413136|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25413137|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413138|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25413140|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25413141|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25413142|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
25413143|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25413144|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413145|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413146|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25413147|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25413148|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
25413149|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
25413150|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413151|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
25413152|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413153|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413154|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413155|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
25413156|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413157|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413158|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413159|NCT03151811|Dexamethasone|dexamethasone|mesh-list
25413160|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
25413162|NCT03151811|Pomalidomide|pomalidomide|mesh-list
25413163|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413164|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
25413165|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
25413166|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413167|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413168|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25413169|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
25413170|NCT03151811|Hormones|hormones|mesh-ancestor
25413171|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413172|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413173|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413174|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413175|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
25413176|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413177|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413178|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413179|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
25413180|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25413181|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25413182|NCT03151811|Growth Substances|growth substances|mesh-ancestor
25413183|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
25413184|NCT03151343|Empagliflozin|empagliflozin|mesh-list
25413185|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25413186|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413187|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25385311|NCT04524455|Hormones|hormones|mesh-ancestor
25413188|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413189|NCT03150056|Prednisone|prednisone|mesh-list
25413190|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413191|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
25413192|NCT03150056|Hormones|hormones|mesh-ancestor
25413193|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413194|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413195|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413196|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413197|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
25413198|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413199|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413201|NCT03149029|Trametinib|trametinib|mesh-list
25413202|NCT03149029|Dabrafenib|dabrafenib|mesh-list
25413208|NCT03148795|Talazoparib|talazoparib|mesh-list
25413209|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25413210|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413211|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413212|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413213|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
25413214|NCT03148457|Apixaban|apixaban|mesh-list
25413215|NCT03148457|Edoxaban|edoxaban|mesh-list
25413216|NCT03148457|Dabigatran|dabigatran|mesh-list
25413217|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25413218|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
25413219|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25413220|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
25413221|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413222|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413223|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
25413224|NCT03148418|Atezolizumab|atezolizumab|mesh-list
25413225|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413226|NCT03147287|Fulvestrant|fulvestrant|mesh-list
25413227|NCT03147287|Palbociclib|palbociclib|mesh-list
25413228|NCT03147287|Avelumab|avelumab|mesh-list
25413229|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413230|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413231|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25413232|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25413233|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
25413234|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413235|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413236|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413237|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413238|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413239|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413240|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25413241|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413242|NCT03143985|Pomalidomide|pomalidomide|mesh-list
25413243|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
25413244|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413245|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25413246|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25413247|NCT03143985|Growth Substances|growth substances|mesh-ancestor
25413248|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
25413249|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413255|NCT03142321|Vedolizumab|vedolizumab|mesh-list
25413256|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25413257|NCT03141424|Fluticasone|fluticasone|mesh-list
25413258|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
25413259|NCT03141424|Ciclesonide|ciclesonide|mesh-list
25413260|NCT03141424|Budesonide|budesonide|mesh-list
25413261|NCT03141424|Beclomethasone|beclomethasone|mesh-list
25413262|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413263|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25413264|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
25413265|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413266|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413267|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25413268|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
25413269|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
25413270|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25413271|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
25413272|NCT03141424|Hormones|hormones|mesh-ancestor
25413273|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413274|NCT03141177|Nivolumab|nivolumab|mesh-list
25413275|NCT03141177|Ipilimumab|ipilimumab|mesh-list
25413276|NCT03141177|Sunitinib|sunitinib|mesh-list
25413277|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413278|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413279|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25413280|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413281|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25413282|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25413283|NCT03141177|Growth Substances|growth substances|mesh-ancestor
25413284|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413285|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
25413286|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413287|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413288|NCT03140176|Sunitinib|sunitinib|mesh-list
25413289|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413290|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25413291|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25413292|NCT03140176|Growth Substances|growth substances|mesh-ancestor
25413293|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413294|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
25413295|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413296|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413297|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413298|NCT03138889|Paclitaxel|paclitaxel|mesh-list
25413299|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25413300|NCT03138889|Cisplatin|cisplatin|mesh-list
25413301|NCT03138889|Carboplatin|carboplatin|mesh-list
25413302|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
25413303|NCT03138889|Pemetrexed|pemetrexed|mesh-list
25413304|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413305|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413306|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413307|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413308|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413309|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413310|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413311|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413312|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25413313|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25413314|NCT03136497|Rituximab|rituximab|mesh-list
25413315|NCT03136497|Venetoclax|venetoclax|mesh-list
25413316|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413317|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413318|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
25413319|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413320|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413321|NCT03136146|Dexamethasone|dexamethasone|mesh-list
25413322|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
25413323|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
25413324|NCT03136146|Rituximab|rituximab|mesh-list
25413325|NCT03136146|Etoposide|etoposide|mesh-list
25413326|NCT03136146|Vincristine|vincristine|mesh-list
25413327|NCT03136146|Bortezomib|bortezomib|mesh-list
25413328|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
25413329|NCT03136146|Clofarabine|clofarabine|mesh-list
25413330|NCT03136146|Ofatumumab|ofatumumab|mesh-list
25413331|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
25413332|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25413333|NCT03136146|Antibodies|antibodies|mesh-list
25413334|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
25413335|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25413336|NCT03136146|Lenograstim|lenograstim|mesh-list
25413337|NCT03136146|BB 1101|bb 1101|mesh-list
25413338|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413339|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
25413340|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413341|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413342|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413343|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
25413344|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413345|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413346|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413347|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413348|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
25413349|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
25413350|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413351|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25413352|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
25413353|NCT03136146|Hormones|hormones|mesh-ancestor
25385462|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25385463|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385464|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385465|NCT04519619|Aflibercept|aflibercept|mesh-list
25385466|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25385467|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25385468|NCT04519619|Growth Substances|growth substances|mesh-ancestor
25385469|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385470|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
25385471|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385472|NCT04518306|Amlodipine|amlodipine|mesh-list
25385473|NCT04518306|Telmisartan|telmisartan|mesh-list
25385474|NCT04518306|Indapamide|indapamide|mesh-list
25385475|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25385476|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25385477|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385478|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385479|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25385480|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385481|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
25413354|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413355|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413356|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
25413357|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413358|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413359|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25413360|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25413361|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25413362|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413363|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413365|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25413366|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
25413367|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
25413368|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
25413370|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
25413371|NCT03136055|Irinotecan|irinotecan|mesh-list
25413372|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413373|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413374|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413375|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413376|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413377|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413378|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413379|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25413380|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25413381|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413382|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
25413383|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25413384|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
25413385|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413386|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413387|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25413388|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
25413389|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25413390|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
25413391|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413392|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25413393|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25413394|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
25413395|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
25413396|NCT03135860|Protective Agents|protective agents|mesh-ancestor
25413397|NCT03133546|Bevacizumab|bevacizumab|mesh-list
25413398|NCT03133546|Osimertinib|osimertinib|mesh-list
25413399|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413400|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413401|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25413402|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25413403|NCT03133546|Growth Substances|growth substances|mesh-ancestor
25413404|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413405|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
25413406|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413407|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413408|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413409|NCT03133325|Lidocaine|lidocaine|mesh-list
25413410|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
25413411|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
25413412|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413413|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413414|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
25413415|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413416|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25413417|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25413418|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25413419|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25413420|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413421|NCT03132467|Durvalumab|durvalumab|mesh-list
25413422|NCT03132467|Ipilimumab|ipilimumab|mesh-list
25413423|NCT03132467|Tremelimumab|tremelimumab|mesh-list
25413424|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
25413425|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25413426|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
25413427|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413428|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413429|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
25413430|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413431|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25413663|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
25413432|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413433|NCT03132116|Gentamicins|gentamicins|mesh-list
25413434|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25413435|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413436|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25413437|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413438|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413441|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413442|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413443|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413444|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413445|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413446|NCT03131219|Ravulizumab|ravulizumab|mesh-list
25413447|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25413448|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413449|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
25413450|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413451|NCT03130959|Nivolumab|nivolumab|mesh-list
25413452|NCT03130959|Ipilimumab|ipilimumab|mesh-list
25413453|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413454|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413455|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25413456|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413457|NCT03129828|Bortezomib|bortezomib|mesh-list
25413458|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413459|NCT03129360|Levetiracetam|levetiracetam|mesh-list
25413460|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
25413461|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
25413462|NCT03128879|Venetoclax|venetoclax|mesh-list
25413463|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
25413464|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413465|NCT03128619|Letrozole|letrozole|mesh-list
25413466|NCT03128619|Palbociclib|palbociclib|mesh-list
25413467|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413468|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25413469|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25413470|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413471|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413472|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25413473|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
25413474|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413475|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413476|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413477|NCT03128034|Cyclosporine|cyclosporine|mesh-list
25413478|NCT03128034|Sirolimus|sirolimus|mesh-list
25413479|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
25413480|NCT03128034|Fludarabine|fludarabine|mesh-list
25413481|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
25413482|NCT03128034|Cyclosporins|cyclosporins|mesh-list
25413483|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413484|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25413485|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
25413486|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413487|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413488|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
25413489|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413490|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413491|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
25413492|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413493|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
25413494|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413495|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25413496|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413497|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25413498|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
25413499|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25413500|NCT03127384|Lidocaine|lidocaine|mesh-list
25413501|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
25413502|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
25413503|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413504|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413505|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
25413506|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413507|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25413508|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25413509|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25413510|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25413511|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413512|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
25413513|NCT03126916|Melphalan|melphalan|mesh-list
25413514|NCT03126916|Busulfan|busulfan|mesh-list
25413515|NCT03126916|Thiotepa|thiotepa|mesh-list
25413516|NCT03126916|Carboplatin|carboplatin|mesh-list
25413517|NCT03126916|Doxorubicin|doxorubicin|mesh-list
25413529|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413530|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
25413531|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413532|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413533|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413534|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
25413535|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413536|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413537|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413538|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413539|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25413540|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25413541|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413542|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413543|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413544|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413545|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413546|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25413547|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
25413548|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25413549|NCT03126916|Protective Agents|protective agents|mesh-ancestor
25413550|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25413551|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
25413552|NCT03126630|Maytansine|maytansine|mesh-list
25413553|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413554|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413555|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413556|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413557|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413558|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413559|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413560|NCT03126214|Warfarin|warfarin|mesh-list
25413561|NCT03126214|Anticoagulants|anticoagulants|mesh-list
25413562|NCT03125902|Paclitaxel|paclitaxel|mesh-list
25413563|NCT03125902|Atezolizumab|atezolizumab|mesh-list
25413564|NCT03125902|Antibodies|antibodies|mesh-list
25413565|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25413566|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413567|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413568|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413569|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413570|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413571|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413572|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
25413573|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413574|NCT03122652|Teriflunomide|teriflunomide|mesh-list
25413575|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25413576|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25413577|NCT03122652|Analgesics|analgesics|mesh-ancestor
25413578|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
25413579|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413580|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413581|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413582|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413583|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413584|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
25413585|NCT03122444|Imipramine|imipramine|mesh-list
25413664|NCT03117751|Vincristine|vincristine|mesh-list
25413586|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25413587|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
25413588|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25413589|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25413590|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25413591|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25413592|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413593|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25413594|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25413595|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413596|NCT03122301|Bupivacaine|bupivacaine|mesh-list
25413597|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
25413598|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
25413599|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413600|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413601|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
25413602|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413605|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25413606|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25413607|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25413608|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413609|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413610|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25413611|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25413612|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25413613|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
25413614|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25413615|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413616|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25413617|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25413618|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413619|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
25413620|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25413621|NCT03118674|Ledipasvir|ledipasvir|mesh-list
25413622|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
25413623|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413624|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
25413625|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
25413626|NCT03118492|Melphalan|melphalan|mesh-list
25413627|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
25413628|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25413629|NCT03118492|Fludarabine|fludarabine|mesh-list
25413630|NCT03118492|Tacrolimus|tacrolimus|mesh-list
25413631|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413632|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
25413633|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413634|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413635|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413636|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
25413637|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413638|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413639|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413640|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25413641|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413642|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413643|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25413644|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
25413645|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25413646|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413647|NCT03117816|Interferons|interferons|mesh-list
25413648|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
25413649|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
25413650|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413651|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
25413652|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413653|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
25413654|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413655|NCT03117751|Cytarabine|cytarabine|mesh-list
25413656|NCT03117751|Dexamethasone|dexamethasone|mesh-list
25413657|NCT03117751|Prednisone|prednisone|mesh-list
25413658|NCT03117751|Prednisolone|prednisolone|mesh-list
25413659|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
25413660|NCT03117751|Doxorubicin|doxorubicin|mesh-list
25413661|NCT03117751|Methotrexate|methotrexate|mesh-list
25413662|NCT03117751|Etoposide|etoposide|mesh-list
25413666|NCT03117751|Daunorubicin|daunorubicin|mesh-list
25413667|NCT03117751|Dasatinib|dasatinib|mesh-list
25413668|NCT03117751|Asparaginase|asparaginase|mesh-list
25413669|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
25413670|NCT03117751|Vorinostat|vorinostat|mesh-list
25413671|NCT03117751|Idarubicin|idarubicin|mesh-list
25413672|NCT03117751|Clofarabine|clofarabine|mesh-list
25413673|NCT03117751|Pegaspargase|pegaspargase|mesh-list
25413674|NCT03117751|Thioguanine|thioguanine|mesh-list
25413675|NCT03117751|Blinatumomab|blinatumomab|mesh-list
25413676|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
25413677|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413678|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
25413679|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413680|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413681|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413682|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
25413683|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413684|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413685|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413686|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413689|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413690|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25413692|NCT03117751|Hormones|hormones|mesh-ancestor
25413693|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413694|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413695|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413696|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25413697|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25413698|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413699|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25413700|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
25413701|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25413702|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25413703|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
25413704|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
25413705|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25413706|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25413707|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413708|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
25413709|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413710|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413711|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413712|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413713|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413714|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25413715|NCT03115424|Liraglutide|liraglutide|mesh-list
25413716|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25413717|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413718|NCT03115424|Incretins|incretins|mesh-ancestor
25413719|NCT03115424|Hormones|hormones|mesh-ancestor
25413720|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413721|NCT03115151|Fentanyl|fentanyl|mesh-list
25413722|NCT03115151|Hydromorphone|hydromorphone|mesh-list
25413723|NCT03115151|Bupivacaine|bupivacaine|mesh-list
25413724|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
25413725|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
25413726|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413727|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413728|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
25413729|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413730|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25413731|NCT03115151|Narcotics|narcotics|mesh-ancestor
25413732|NCT03115151|Analgesics|analgesics|mesh-ancestor
25413733|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25413734|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25413735|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
25413736|NCT03114319|Nazartinib|nazartinib|mesh-list
25413737|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413738|NCT03112174|Venetoclax|venetoclax|mesh-list
25413739|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413740|NCT03111537|Nicotine|nicotine|mesh-list
25413741|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25413742|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
25413743|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413744|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413745|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25413746|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25413747|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
25413748|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25413749|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413750|NCT03111485|Levodopa|levodopa|mesh-list
25413751|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25413752|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25413753|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25413755|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25413756|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413757|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413758|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25413759|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
25413760|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
25413761|NCT03110926|Leucovorin|leucovorin|mesh-list
25413762|NCT03110926|Paclitaxel|paclitaxel|mesh-list
25413763|NCT03110926|Carboplatin|carboplatin|mesh-list
25413764|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
25413765|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413766|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413767|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413768|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413769|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413770|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413771|NCT03110926|Antidotes|antidotes|mesh-ancestor
25413772|NCT03110926|Protective Agents|protective agents|mesh-ancestor
25413773|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413774|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
25413775|NCT03110926|Vitamins|vitamins|mesh-ancestor
25413776|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
25413777|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
25413778|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413779|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413780|NCT03108131|Atezolizumab|atezolizumab|mesh-list
25413781|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25413782|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413783|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
25413784|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413785|NCT03105518|Acetaminophen|acetaminophen|mesh-list
25413786|NCT03105518|Fentanyl|fentanyl|mesh-list
25413787|NCT03105518|Oxycodone|oxycodone|mesh-list
25413788|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25413789|NCT03105518|Narcotics|narcotics|mesh-ancestor
25413790|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413791|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413792|NCT03105518|Analgesics|analgesics|mesh-ancestor
25413793|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
25413794|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413795|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25413796|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25413797|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
25413798|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
25413799|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25413800|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
25413801|NCT03104439|Nivolumab|nivolumab|mesh-list
25413802|NCT03104439|Ipilimumab|ipilimumab|mesh-list
25413803|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413804|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413805|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25413806|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413807|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25413808|NCT03101930|Liraglutide|liraglutide|mesh-list
25413809|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25413810|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413811|NCT03101930|Incretins|incretins|mesh-ancestor
25413812|NCT03101930|Hormones|hormones|mesh-ancestor
25413813|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413814|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25413815|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
25413816|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413817|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413818|NCT03101501|Mitomycins|mitomycins|mesh-list
25413819|NCT03101501|Mitomycin|mitomycin|mesh-list
25413820|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413821|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413822|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
25413823|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413824|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25413825|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413827|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413828|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413829|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413830|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413831|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
25413832|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25413833|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
25413834|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413835|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
25413836|NCT03101163|Protective Agents|protective agents|mesh-ancestor
25413837|NCT03100253|Adalimumab|adalimumab|mesh-list
25413838|NCT03100253|Etanercept|etanercept|mesh-list
25413839|NCT03100253|Golimumab|golimumab|mesh-list
25413840|NCT03100253|Infliximab|infliximab|mesh-list
25413841|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
25413842|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25413843|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413844|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
25413848|NCT03100253|Analgesics|analgesics|mesh-ancestor
25413849|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
25413850|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413851|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413852|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413853|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
25413854|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25413855|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
25413856|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413857|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413858|NCT03099499|TIC10 compound|tic10 compound|mesh-list
25413859|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413860|NCT03099356|Sirolimus|sirolimus|mesh-list
25413861|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
25413862|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413863|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
25413864|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413865|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25413866|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25413867|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
25413868|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413869|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413870|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25413871|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25413872|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413873|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25413874|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
25413875|NCT03099174|Letrozole|letrozole|mesh-list
25413876|NCT03099174|Fulvestrant|fulvestrant|mesh-list
25413877|NCT03099174|Anastrozole|anastrozole|mesh-list
25413878|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413879|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25413880|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25413881|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413882|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413883|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25413884|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
25413885|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25413886|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413887|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413888|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25413889|NCT03097783|Lidocaine|lidocaine|mesh-list
25413890|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
25413891|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
25413892|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413893|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413894|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
25413895|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413907|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413908|NCT03095352|Carboplatin|carboplatin|mesh-list
25413909|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
25413910|NCT03095352|Trastuzumab|trastuzumab|mesh-list
25413911|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413912|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413913|NCT03095274|Durvalumab|durvalumab|mesh-list
25413914|NCT03095274|Tremelimumab|tremelimumab|mesh-list
25413915|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413916|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413917|NCT03095118|Daratumumab|daratumumab|mesh-list
25413918|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413919|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
25413920|NCT03094637|Azacitidine|azacitidine|mesh-list
25413921|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413922|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413923|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25413924|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
25413925|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413926|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413930|NCT03093064|Natalizumab|natalizumab|mesh-list
25413932|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413933|NCT03092856|Axitinib|axitinib|mesh-list
25413934|NCT03092856|Antibodies|antibodies|mesh-list
25413935|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
25413936|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413937|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413938|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413939|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413940|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413941|NCT03092674|Cytarabine|cytarabine|mesh-list
25413942|NCT03092674|Nivolumab|nivolumab|mesh-list
25413943|NCT03092674|Azacitidine|azacitidine|mesh-list
25413944|NCT03092674|Decitabine|decitabine|mesh-list
25413945|NCT03092674|Midostaurin|midostaurin|mesh-list
25413946|NCT03092674|Staurosporine|staurosporine|mesh-list
25413947|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413948|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413949|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25413950|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413951|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25413952|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
25413953|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
25413954|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413955|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413956|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
25413957|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413958|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413959|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413984|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413985|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
25413986|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413987|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413988|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413990|NCT03090776|Analgesics|analgesics|mesh-ancestor
25413991|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
25413992|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25413993|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413994|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25413995|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25413996|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
25413997|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
25413998|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413999|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25414000|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25414001|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414002|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414003|NCT03090152|Bupivacaine|bupivacaine|mesh-list
25414004|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
25414005|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
25414006|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25414007|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414008|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
25414009|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414010|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
25414011|NCT03089905|Remifentanil|remifentanil|mesh-list
25414012|NCT03089905|Sevoflurane|sevoflurane|mesh-list
25414013|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25414014|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25414015|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414016|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25414017|NCT03089905|Analgesics|analgesics|mesh-ancestor
25414018|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
25414019|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414020|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25414021|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25414022|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25414023|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
25414024|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414025|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414026|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25414027|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25414028|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
25414029|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
25414030|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25414031|NCT03089905|Narcotics|narcotics|mesh-ancestor
25414034|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25414035|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25414036|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414037|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414038|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414039|NCT03088540|Gemcitabine|gemcitabine|mesh-list
25414040|NCT03088540|Paclitaxel|paclitaxel|mesh-list
25414041|NCT03088540|Cisplatin|cisplatin|mesh-list
25414042|NCT03088540|Carboplatin|carboplatin|mesh-list
25414043|NCT03088540|Pemetrexed|pemetrexed|mesh-list
25414044|NCT03088540|Cemiplimab|cemiplimab|mesh-list
25414045|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414046|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414047|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414048|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414049|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414050|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414051|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414052|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
25414053|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
25414054|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414055|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414056|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414057|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
25414058|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414059|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25414060|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25414061|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414062|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
25386147|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25386148|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25386149|NCT04495855|Dienogest|dienogest|mesh-list
25386150|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25386151|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
25386152|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25386153|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25386154|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25386155|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25386156|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25386157|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25386158|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
25414063|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414064|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414065|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
25414066|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414067|NCT03087903|Protective Agents|protective agents|mesh-ancestor
25414068|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414069|NCT03087708|Naloxegol|naloxegol|mesh-list
25414070|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25414071|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414072|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
25414073|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414074|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
25414075|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414076|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414077|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25414078|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414079|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414080|NCT03085914|Leucovorin|leucovorin|mesh-list
25414081|NCT03085914|Gemcitabine|gemcitabine|mesh-list
25414082|NCT03085914|Paclitaxel|paclitaxel|mesh-list
25414083|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25414084|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
25414085|NCT03085914|Carboplatin|carboplatin|mesh-list
25414086|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
25414087|NCT03085914|Fluorouracil|fluorouracil|mesh-list
25414088|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
25414089|NCT03085914|Pemetrexed|pemetrexed|mesh-list
25414090|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414091|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414092|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414093|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414094|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414095|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414096|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414097|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
25414098|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414099|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414100|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414101|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
25414102|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25414103|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414104|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
25414105|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
25414106|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414107|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414108|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414109|NCT03085914|Antidotes|antidotes|mesh-ancestor
25414110|NCT03085914|Protective Agents|protective agents|mesh-ancestor
25414114|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25414115|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25414116|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
25414117|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
25414118|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414119|NCT03084939|Capecitabine|capecitabine|mesh-list
25414120|NCT03084939|Trastuzumab|trastuzumab|mesh-list
25414121|NCT03084939|Lapatinib|lapatinib|mesh-list
25414122|NCT03084939|Maytansine|maytansine|mesh-list
25414123|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25414124|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414125|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
25414126|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414127|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414128|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414129|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25414130|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414131|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414132|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414133|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414134|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414135|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
25414136|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414137|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414138|NCT03084471|Durvalumab|durvalumab|mesh-list
25414139|NCT03084471|Tremelimumab|tremelimumab|mesh-list
25414140|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25414141|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414142|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414143|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
25414144|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414145|NCT03083665|Brivaracetam|brivaracetam|mesh-list
25414146|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
25414147|NCT03083431|Propranolol|propranolol|mesh-list
25414148|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25414149|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25414150|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
25414151|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414152|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414153|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414154|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25414155|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25414156|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
25414157|NCT03082677|Ixazomib|ixazomib|mesh-list
25414158|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414159|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
25414160|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414161|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414162|NCT03082014|Losartan|losartan|mesh-list
25414163|NCT03082014|Atenolol|atenolol|mesh-list
25414164|NCT03082014|Amlodipine|amlodipine|mesh-list
25414165|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25414166|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25414167|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25414168|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414169|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25414170|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414171|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
25414172|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25414173|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25414174|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25414175|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
25414176|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
25414177|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414178|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25414179|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25414180|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25414181|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
25414182|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414183|NCT03081910|Cyclophosphamide|cyclophosphamide|mesh-list
25414184|NCT03081910|Rituximab|rituximab|mesh-list
25414185|NCT03081910|Fludarabine|fludarabine|mesh-list
25414186|NCT03081910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25414187|NCT03081910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414188|NCT03081910|Immunologic Factors|immunologic factors|mesh-ancestor
25414189|NCT03081910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414191|NCT03081910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414192|NCT03081910|Alkylating Agents|alkylating agents|mesh-ancestor
25414193|NCT03081910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414194|NCT03081910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414195|NCT03081910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25414196|NCT03081910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414197|NCT03081689|Paclitaxel|paclitaxel|mesh-list
25414198|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25414199|NCT03081689|Carboplatin|carboplatin|mesh-list
25414200|NCT03081689|Nivolumab|nivolumab|mesh-list
25414201|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414202|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414203|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414204|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414205|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414206|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414207|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414208|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414209|NCT03081143|Paclitaxel|paclitaxel|mesh-list
25414210|NCT03081143|Ramucirumab|ramucirumab|mesh-list
25414211|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414212|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414213|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414214|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414215|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414216|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414217|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
25414218|NCT03079167|Hematinics|hematinics|mesh-ancestor
25414219|NCT03079011|Letrozole|letrozole|mesh-list
25414220|NCT03079011|Fulvestrant|fulvestrant|mesh-list
25414221|NCT03079011|Palbociclib|palbociclib|mesh-list
25414222|NCT03079011|Anastrozole|anastrozole|mesh-list
25414223|NCT03079011|Exemestane|exemestane|mesh-list
25414224|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25414225|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414226|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25414227|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414228|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414229|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25414230|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
25414231|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414232|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414233|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414234|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25414235|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25414236|NCT03077542|Sirolimus|sirolimus|mesh-list
25414237|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
25414238|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
25414239|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
25414240|NCT03077542|Pentostatin|pentostatin|mesh-list
25414241|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414242|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
25414243|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414244|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414245|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414246|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
25414247|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414248|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414249|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25414250|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25414251|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414252|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25414253|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
25414254|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414255|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
25414256|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414257|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25414258|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25414259|NCT03077451|Nelfinavir|nelfinavir|mesh-list
25414260|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25414261|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25414262|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
25414263|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414264|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414265|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25414274|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25414275|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414276|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414277|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414279|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414280|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414282|NCT03075527|Tremelimumab|tremelimumab|mesh-list
25414283|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414284|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414285|NCT03074513|Bevacizumab|bevacizumab|mesh-list
25414516|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414286|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25414287|NCT03074513|Atezolizumab|atezolizumab|mesh-list
25414288|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
25414289|NCT03074513|Antibodies|antibodies|mesh-list
25414290|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
25414291|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25414292|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
25414293|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414294|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25414295|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25414296|NCT03074513|Growth Substances|growth substances|mesh-ancestor
25414297|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414298|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
25414299|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
25414300|NCT03074045|Drospirenone|drospirenone|mesh-list
25414301|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
25414302|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25414303|NCT03074045|Estradiol|estradiol|mesh-list
25414304|NCT03074045|Estrogens|estrogens|mesh-ancestor
25414305|NCT03074045|Hormones|hormones|mesh-ancestor
25414306|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414307|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414308|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25414309|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
25414310|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25414311|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25414312|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25414313|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25414314|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25414315|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25414316|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
25414317|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25414318|NCT03074045|Diuretics|diuretics|mesh-ancestor
25414319|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
25414328|NCT03072238|Prednisone|prednisone|mesh-list
25414329|NCT03072238|Prednisolone|prednisolone|mesh-list
25414330|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25414331|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
25414332|NCT03072238|Hormones|hormones|mesh-ancestor
25414333|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414334|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414335|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414336|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414337|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
25414338|NCT03071861|Hematinics|hematinics|mesh-ancestor
25414339|NCT03070886|Docetaxel|docetaxel|mesh-list
25414340|NCT03070886|Leuprolide|leuprolide|mesh-list
25414341|NCT03070886|Goserelin|goserelin|mesh-list
25414342|NCT03070886|Bicalutamide|bicalutamide|mesh-list
25414343|NCT03070886|Flutamide|flutamide|mesh-list
25414345|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414346|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414347|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414348|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414349|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414350|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25414351|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
25414352|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25414353|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414354|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414355|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
25414356|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
25414357|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414358|NCT03069976|Metronidazole|metronidazole|mesh-list
25414359|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414360|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25414361|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25414362|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25414363|NCT03069937|Docetaxel|docetaxel|mesh-list
25414364|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414365|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414366|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414367|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414368|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414369|NCT03069326|Thalidomide|thalidomide|mesh-list
25414370|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414371|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
25414372|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414373|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
25414374|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25414375|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414376|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25414377|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25414378|NCT03069326|Growth Substances|growth substances|mesh-ancestor
25414379|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
25414380|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414381|NCT03067181|Cisplatin|cisplatin|mesh-list
25414382|NCT03067181|Carboplatin|carboplatin|mesh-list
25414383|NCT03067181|Etoposide|etoposide|mesh-list
25414384|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
25414385|NCT03067181|Bleomycin|bleomycin|mesh-list
25414386|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
25414387|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414388|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414389|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25414390|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25414391|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414392|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414393|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25414394|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
25414395|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
25414396|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414397|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414398|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414399|NCT03067051|Verteporfin|verteporfin|mesh-list
25414400|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25414401|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
25414402|NCT03066648|Azacitidine|azacitidine|mesh-list
25414403|NCT03066648|Decitabine|decitabine|mesh-list
25414404|NCT03066648|Spartalizumab|spartalizumab|mesh-list
25414405|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414406|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
25414407|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414408|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414409|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414410|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414411|NCT03065335|Ketamine|ketamine|mesh-list
25414412|NCT03065335|Analgesics|analgesics|mesh-ancestor
25414413|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
25414414|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414415|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414416|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25414417|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25414418|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
25414419|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
25414420|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25414573|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414421|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25414422|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25414423|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414424|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414426|NCT03064867|Carboplatin|carboplatin|mesh-list
25414427|NCT03064867|Etoposide|etoposide|mesh-list
25414428|NCT03064867|Ifosfamide|ifosfamide|mesh-list
25414429|NCT03064867|Venetoclax|venetoclax|mesh-list
25414430|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414505|NCT03063021|Expectorants|expectorants|mesh-ancestor
25414431|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414432|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
25414433|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414434|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414435|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414436|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25414437|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25414438|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414439|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414594|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25414440|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414441|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
25414442|NCT03064854|Gemcitabine|gemcitabine|mesh-list
25414443|NCT03064854|Paclitaxel|paclitaxel|mesh-list
25414444|NCT03064854|Cisplatin|cisplatin|mesh-list
25414445|NCT03064854|Carboplatin|carboplatin|mesh-list
25414446|NCT03064854|Pemetrexed|pemetrexed|mesh-list
25414447|NCT03064854|Spartalizumab|spartalizumab|mesh-list
25414448|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414449|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414450|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414451|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414452|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414453|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414454|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414455|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
25414456|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
25414457|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414458|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414459|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414460|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
25414461|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414462|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25414463|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25414464|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414465|NCT03064568|Misoprostol|misoprostol|mesh-list
25414466|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25414467|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
25414468|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25414469|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414470|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25414471|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25414472|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
25414473|NCT03064126|Paclitaxel|paclitaxel|mesh-list
25414474|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25414475|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414476|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414477|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414478|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414479|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414480|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414481|NCT03063632|Interferons|interferons|mesh-list
25414482|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
25414483|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
25414484|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414485|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414486|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
25414487|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414488|NCT03063619|Tamoxifen|tamoxifen|mesh-list
25414489|NCT03063619|Afimoxifene|afimoxifene|mesh-list
25414490|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25414491|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
25414492|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414493|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414494|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414495|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414496|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25414497|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25414498|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25414499|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
25414500|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25414501|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
25414502|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25414503|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
25414504|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414506|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
25414507|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25414508|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
25414509|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414510|NCT03063021|Protective Agents|protective agents|mesh-ancestor
25414511|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414512|NCT03063021|Antidotes|antidotes|mesh-ancestor
25414514|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414515|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25414517|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414518|NCT03061539|Nivolumab|nivolumab|mesh-list
25414519|NCT03061539|Ipilimumab|ipilimumab|mesh-list
25414520|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414521|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414522|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414523|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414524|NCT03060473|Amoxicillin|amoxicillin|mesh-list
25414525|NCT03060473|Azithromycin|azithromycin|mesh-list
25414526|NCT03060473|Erythromycin|erythromycin|mesh-list
25414527|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
25414528|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25414529|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
25414530|NCT03060473|Ampicillin|ampicillin|mesh-list
25414531|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25414532|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414533|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25414534|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25414535|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414536|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414537|NCT03060083|Nicotine|nicotine|mesh-list
25414538|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25414539|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
25414540|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414541|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414542|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25414543|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25414544|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
25414545|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414546|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414547|NCT03059940|Nicotine|nicotine|mesh-list
25414548|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
25414549|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25414550|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
25414551|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414552|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414553|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25414554|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25414555|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
25414556|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414557|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414558|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
25414559|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
25414560|NCT03059004|TEMPO|tempo|mesh-list
25414561|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
25414562|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414563|NCT03059004|Protective Agents|protective agents|mesh-ancestor
25414564|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414565|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
25414566|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25414567|NCT03057847|Velpatasvir|velpatasvir|mesh-list
25414568|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
25414569|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414570|NCT03057600|Paclitaxel|paclitaxel|mesh-list
25414571|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414572|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414576|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414577|NCT03056833|Paclitaxel|paclitaxel|mesh-list
25414578|NCT03056833|Carboplatin|carboplatin|mesh-list
25414579|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414580|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414581|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414582|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414583|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414584|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414585|NCT03056755|Letrozole|letrozole|mesh-list
25414586|NCT03056755|Fulvestrant|fulvestrant|mesh-list
25414587|NCT03056755|Leuprolide|leuprolide|mesh-list
25414588|NCT03056755|Goserelin|goserelin|mesh-list
25414589|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414590|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25414591|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25414592|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414593|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414595|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25386686|NCT04471818|Ketamine|ketamine|mesh-list
25414596|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414597|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414598|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414599|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25414600|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25414601|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
25414602|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25414603|NCT03056339|Vidarabine|vidarabine|mesh-list
25414604|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
25414605|NCT03056339|Fludarabine|fludarabine|mesh-list
25414606|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
25414607|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414608|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
25414609|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414610|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414611|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414612|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
25414613|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414614|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414615|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25414616|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414617|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
25414618|NCT03056339|Antiviral Agents|antiviral agents|mesh-ancestor
25414619|NCT03056339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414620|NCT03056001|Doxorubicin|doxorubicin|mesh-list
25414621|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
25414622|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25414623|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414624|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25414625|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25414626|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414627|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414628|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414629|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
25414630|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25414631|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
25414632|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414633|NCT03055377|Expectorants|expectorants|mesh-ancestor
25414634|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
25414635|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25414636|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
25414637|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414638|NCT03055377|Protective Agents|protective agents|mesh-ancestor
25414639|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414640|NCT03055377|Antidotes|antidotes|mesh-ancestor
25414641|NCT03055013|Nivolumab|nivolumab|mesh-list
25414642|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414643|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414644|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414645|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414646|NCT03054831|Oxycodone|oxycodone|mesh-list
25414647|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25414648|NCT03054831|Narcotics|narcotics|mesh-ancestor
25414649|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25414650|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414651|NCT03054831|Analgesics|analgesics|mesh-ancestor
25414652|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
25414653|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414654|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
25414655|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414656|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
25414657|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414733|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
25414658|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414659|NCT03049462|Ascorbic Acid|ascorbic acid|mesh-list
25414660|NCT03049462|Mirabegron|mirabegron|mesh-list
25414661|NCT03049462|Vitamins|vitamins|mesh-ancestor
25414662|NCT03049462|Micronutrients|micronutrients|mesh-ancestor
25414663|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414664|NCT03049462|Antioxidants|antioxidants|mesh-ancestor
25414665|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414666|NCT03049462|Protective Agents|protective agents|mesh-ancestor
25414667|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25414668|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25414669|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25414670|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
25414671|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414672|NCT03049462|Urological Agents|urological agents|mesh-ancestor
25414674|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25414675|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25414676|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
25414677|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414678|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414679|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414680|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25414681|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25414682|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
25414683|NCT03048825|Colchicine|colchicine|mesh-list
25414684|NCT03048825|Spironolactone|spironolactone|mesh-list
25414685|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
25414686|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414687|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414688|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414689|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414690|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414691|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414692|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25414693|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
25414694|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414695|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414696|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25414697|NCT03048825|Diuretics|diuretics|mesh-ancestor
25414698|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
25414699|NCT03047993|Azacitidine|azacitidine|mesh-list
25414700|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414701|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
25414702|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414703|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414704|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414705|NCT03047928|Nivolumab|nivolumab|mesh-list
25414706|NCT03047928|Vaccines|vaccines|mesh-list
25414707|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
25414708|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414709|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414710|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414711|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414712|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414713|NCT03047005|Naltrexone|naltrexone|mesh-list
25414714|NCT03047005|Bupropion|bupropion|mesh-list
25414715|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25414716|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25414717|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414718|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
25414719|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414720|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25414721|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
25414722|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25414723|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25414724|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25414725|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25414726|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414727|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
25414728|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414729|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25414730|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25414731|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414732|NCT03046251|Natalizumab|natalizumab|mesh-list
25414734|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414735|NCT03045029|Treprostinil|treprostinil|mesh-list
25414736|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25414737|NCT03044977|Octreotide|octreotide|mesh-list
25414738|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25414739|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414740|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414741|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
25414742|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25414743|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
25414744|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414745|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414746|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25414747|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
25414748|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25414749|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
25414750|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414751|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414752|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25414753|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
25414754|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
25414755|NCT03044314|Protective Agents|protective agents|mesh-ancestor
25414756|NCT03043950|Panitumumab|panitumumab|mesh-list
25414757|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414758|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414759|NCT03043872|Cisplatin|cisplatin|mesh-list
25414760|NCT03043872|Carboplatin|carboplatin|mesh-list
25414761|NCT03043872|Etoposide|etoposide|mesh-list
25414762|NCT03043872|Durvalumab|durvalumab|mesh-list
25414763|NCT03043872|Tremelimumab|tremelimumab|mesh-list
25414764|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414765|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414766|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25414767|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25414768|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414769|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414770|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414771|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
25414772|NCT03043664|Lanreotide|lanreotide|mesh-list
25414773|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414774|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414775|NCT03043599|Nivolumab|nivolumab|mesh-list
25414776|NCT03043599|Ipilimumab|ipilimumab|mesh-list
25414777|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414778|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414779|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414780|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414781|NCT03043053|Oxytocin|oxytocin|mesh-list
25414782|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
25414783|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25414784|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414785|NCT03041688|Decitabine|decitabine|mesh-list
25414786|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25414787|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
25414788|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414789|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414790|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414791|NCT03038672|Nivolumab|nivolumab|mesh-list
25414792|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
25414793|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
25414794|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25414795|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414796|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414797|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414798|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414799|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
25414800|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414801|NCT03038100|Paclitaxel|paclitaxel|mesh-list
25414802|NCT03038100|Bevacizumab|bevacizumab|mesh-list
25414806|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414807|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414808|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414809|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414810|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414822|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25414823|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414824|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414825|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
25414826|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25414827|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25414828|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414829|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414830|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
25414831|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
25414832|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414833|NCT03036930|Vaccines|vaccines|mesh-list
25386912|NCT04460937|Adavosertib|adavosertib|mesh-list
25414834|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
25414835|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414836|NCT03036904|Prednisone|prednisone|mesh-list
25414837|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
25414838|NCT03036904|Rituximab|rituximab|mesh-list
25414839|NCT03036904|Doxorubicin|doxorubicin|mesh-list
25414840|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25414841|NCT03036904|Etoposide|etoposide|mesh-list
25414842|NCT03036904|Vincristine|vincristine|mesh-list
25414843|NCT03036904|Venetoclax|venetoclax|mesh-list
25414844|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414845|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
25414846|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414847|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414848|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414849|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
25414850|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414851|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414852|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25414853|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414854|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25414855|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25414856|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25414857|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414858|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25414859|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
25414860|NCT03036904|Hormones|hormones|mesh-ancestor
25414861|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414862|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414863|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414864|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
25414865|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25414866|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25414867|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
25414868|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
25414869|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25414870|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414871|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414872|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
25414873|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25414874|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25414875|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414898|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414899|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25414900|NCT03033758|Budesonide|budesonide|mesh-list
25414901|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
25414902|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25414903|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25414904|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
25414905|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414906|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414907|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25414908|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25414909|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
25414910|NCT03033758|Hormones|hormones|mesh-ancestor
25414911|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414912|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25414913|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25414914|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25414916|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25414917|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414919|NCT03033576|Ipilimumab|ipilimumab|mesh-list
25414920|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414921|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414922|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25414923|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414924|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
25414925|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
25414926|NCT03032783|Tacrolimus|tacrolimus|mesh-list
25414927|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25414928|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
25414929|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414930|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25414931|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25414932|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
25414933|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414934|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414935|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25414936|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25414937|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414938|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25414939|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25414940|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
25414941|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25414942|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414943|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
25414944|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25414945|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
25414946|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414947|NCT03032601|Expectorants|expectorants|mesh-ancestor
25414948|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
25414949|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25414950|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
25414951|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414952|NCT03032601|Protective Agents|protective agents|mesh-ancestor
25414953|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414954|NCT03032601|Antidotes|antidotes|mesh-ancestor
25414955|NCT03032172|Risdiplam|risdiplam|mesh-list
25414956|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25414957|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414958|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414959|NCT03031730|Dexamethasone|dexamethasone|mesh-list
25414960|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
25414961|NCT03031730|Lenalidomide|lenalidomide|mesh-list
25414962|NCT03031730|Ichthammol|ichthammol|mesh-list
25414963|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25414964|NCT03031730|BB 1101|bb 1101|mesh-list
25414965|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25414966|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
25414967|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
25414968|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25414969|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414970|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25414971|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
25414972|NCT03031730|Hormones|hormones|mesh-ancestor
25415045|NCT03025256|Nivolumab|nivolumab|mesh-list
25414973|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25414974|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25414975|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414976|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
25414977|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25414978|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414979|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
25414980|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25414981|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25414982|NCT03031730|Growth Substances|growth substances|mesh-ancestor
25414983|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
25414984|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
25414985|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
25414986|NCT03030378|Interleukin-12|interleukin-12|mesh-list
25414987|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414988|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414989|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25414990|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
25414991|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414992|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25414993|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25414994|NCT03030378|Growth Substances|growth substances|mesh-ancestor
25414995|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
25414996|NCT03029429|Theophylline|theophylline|mesh-list
25414997|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25414998|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
25414999|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415000|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415001|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25415002|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
25415003|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25415004|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415005|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415006|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
25415007|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25415008|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25415009|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
25415010|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415011|NCT03029169|Amiodarone|amiodarone|mesh-list
25415012|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25415013|NCT03029169|Propafenone|propafenone|mesh-list
25415014|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
25415015|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25415016|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25415017|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415018|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25415019|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25415020|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25415021|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415022|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25415023|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25415024|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25415025|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25415026|NCT03028857|Choline|choline|mesh-list
25415027|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
25415028|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25415029|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
25415030|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415031|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25415032|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25415033|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
25415034|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
25415035|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25415111|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25415036|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415037|NCT03027388|LB100|lb100|mesh-list
25415038|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415039|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415040|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415041|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25415042|NCT03025828|Hormones|hormones|mesh-ancestor
25415043|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415044|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415046|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415047|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415048|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25415049|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415050|NCT03024996|Atezolizumab|atezolizumab|mesh-list
25415051|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415052|NCT03024489|Cetuximab|cetuximab|mesh-list
25415053|NCT03024489|Palbociclib|palbociclib|mesh-list
25415054|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415055|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415056|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25415057|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415058|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415059|NCT03022578|Lomustine|lomustine|mesh-list
25415060|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415061|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
25415140|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25415062|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415063|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415065|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415066|NCT03021486|Haloperidol|haloperidol|mesh-list
25415067|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
25415068|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
25415069|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
25415070|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
25415071|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415072|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415073|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25415074|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25415075|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25415076|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25415077|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25415078|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25415079|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
25415080|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415081|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415082|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25415083|NCT03020303|Spironolactone|spironolactone|mesh-list
25415084|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25415085|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415086|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415087|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415088|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25415089|NCT03020303|Diuretics|diuretics|mesh-ancestor
25415090|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
25415091|NCT03018704|Topiramate|topiramate|mesh-list
25415092|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
25415093|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25415094|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415095|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
25415096|NCT03018288|Temozolomide|temozolomide|mesh-list
25415097|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415098|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415099|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415100|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
25415101|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415102|NCT03017872|Ritonavir|ritonavir|mesh-list
25415103|NCT03017872|Darunavir|darunavir|mesh-list
25415104|NCT03017872|Dolutegravir|dolutegravir|mesh-list
25415105|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25415106|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25415107|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
25415108|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415109|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415110|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25415112|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
25415113|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415114|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25415115|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25415116|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25415117|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25415118|NCT03017833|Metformin|metformin|mesh-list
25415119|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25415120|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415121|NCT03017326|Gemcitabine|gemcitabine|mesh-list
25415122|NCT03017326|Carboplatin|carboplatin|mesh-list
25415123|NCT03017326|Doxorubicin|doxorubicin|mesh-list
25415124|NCT03017326|Fluorouracil|fluorouracil|mesh-list
25415125|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
25415126|NCT03017326|Irinotecan|irinotecan|mesh-list
25415127|NCT03017326|Etoposide|etoposide|mesh-list
25415128|NCT03017326|Vincristine|vincristine|mesh-list
25415129|NCT03017326|Sorafenib|sorafenib|mesh-list
25415130|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415131|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415132|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
25415133|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415134|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
25415135|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415136|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415137|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415138|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
25415139|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415141|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25415142|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25415143|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25415144|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415145|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415146|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415147|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415148|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25415149|NCT03016312|Atezolizumab|atezolizumab|mesh-list
25415150|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415151|NCT03015259|Budesonide|budesonide|mesh-list
25415152|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
25415153|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25415154|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415155|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25415156|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
25415157|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415158|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415159|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25415160|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
25415161|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
25415162|NCT03015259|Hormones|hormones|mesh-ancestor
25415163|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415164|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25415165|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25415166|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25415167|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
25415168|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415169|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415170|NCT03012880|Dexamethasone|dexamethasone|mesh-list
25415171|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
25415172|NCT03012880|Lenalidomide|lenalidomide|mesh-list
25415173|NCT03012880|Daratumumab|daratumumab|mesh-list
25415174|NCT03012880|Ixazomib|ixazomib|mesh-list
25415175|NCT03012880|Ichthammol|ichthammol|mesh-list
25415176|NCT03012880|BB 1101|bb 1101|mesh-list
25415177|NCT03012880|Glycine|glycine|mesh-list
25415178|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415179|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
25415180|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
25415181|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415182|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415183|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25415184|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
25415185|NCT03012880|Hormones|hormones|mesh-ancestor
25415186|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415187|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415188|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415189|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
25415190|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25415191|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25415192|NCT03012880|Growth Substances|growth substances|mesh-ancestor
25415193|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
25415194|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415195|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
25415196|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415197|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
25415198|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
25415199|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415200|NCT03012529|Riboflavin|riboflavin|mesh-list
25415201|NCT03012529|Rifampin|rifampin|mesh-list
25415202|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25415203|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
25415204|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25415205|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415206|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
25415207|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25415208|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415209|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415210|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25415211|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25415212|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25415213|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25415214|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25415215|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25415219|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415220|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25415221|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
25415222|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
25415223|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
25415224|NCT03012360|Linezolid|linezolid|mesh-list
25415225|NCT03012360|Imipenem|imipenem|mesh-list
25415226|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25415227|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415228|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25415229|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25415230|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415231|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415232|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415233|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25415234|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25415235|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25415236|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
25415237|NCT03012100|Vaccines|vaccines|mesh-list
25415238|NCT03012100|Sargramostim|sargramostim|mesh-list
25415239|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
25415240|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415241|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415242|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415243|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415244|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
25415245|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415246|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415247|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415248|NCT03010917|Ethanol|ethanol|mesh-list
25415249|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25415250|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415251|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25415252|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415253|NCT03009981|Prednisone|prednisone|mesh-list
25415254|NCT03009981|Leuprolide|leuprolide|mesh-list
25415255|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
25415256|NCT03009981|Bicalutamide|bicalutamide|mesh-list
25415257|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415258|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
25415259|NCT03009981|Hormones|hormones|mesh-ancestor
25415260|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415261|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415262|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415263|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415264|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25415265|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
25415266|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25415267|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25415268|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415269|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415270|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415271|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25415272|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
25415273|NCT03008408|Everolimus|everolimus|mesh-list
25415275|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415276|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415277|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
25415278|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415279|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25415280|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25415281|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415282|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415283|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25415284|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415285|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415286|NCT03008382|Metoprolol|metoprolol|mesh-list
25415287|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25415288|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25415289|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
25415290|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
25415291|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415292|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415293|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25415368|NCT03007147|Leucovorin|leucovorin|mesh-list
25415294|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25415295|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25415296|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
25415297|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415298|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415299|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25415300|NCT03008278|Olaparib|olaparib|mesh-list
25415301|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25415302|NCT03008278|Ramucirumab|ramucirumab|mesh-list
25415303|NCT03008278|Antibodies|antibodies|mesh-list
25415304|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
25415305|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25415306|NCT03008278|Lexatumumab|lexatumumab|mesh-list
25415307|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
25415308|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415309|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25387366|NCT04440371|Tacrolimus|tacrolimus|mesh-list
25415310|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415311|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415312|NCT03008005|Dronabinol|dronabinol|mesh-list
25415313|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
25415314|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415315|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25415316|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25415317|NCT03008005|Analgesics|analgesics|mesh-ancestor
25415318|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
25415319|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415320|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25415321|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25415322|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415323|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415324|NCT03008005|Hormones|hormones|mesh-ancestor
25415325|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415326|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
25415327|NCT03007732|Prednisone|prednisone|mesh-list
25415328|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
25415329|NCT03007732|Leuprolide|leuprolide|mesh-list
25415330|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
25415331|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
25415332|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25415333|NCT03007732|Androgens|androgens|mesh-list
25415334|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415335|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415336|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415337|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
25415338|NCT03007732|Hormones|hormones|mesh-ancestor
25415339|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415418|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
25415340|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415341|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415342|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25415343|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
25415344|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25415345|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25415346|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415347|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415348|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415349|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25415350|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
25415351|NCT03007732|Protective Agents|protective agents|mesh-ancestor
25415352|NCT03007732|Vitamins|vitamins|mesh-ancestor
25415353|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
25415354|NCT03007732|Estrogens|estrogens|mesh-ancestor
25415355|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
25415356|NCT03007420|Lidocaine|lidocaine|mesh-list
25415357|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
25415358|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
25415359|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25415360|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415361|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
25415362|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415363|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25415364|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25415365|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25415366|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25415367|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415374|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25415375|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25415376|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25415377|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
25415378|NCT03007147|Ifosfamide|ifosfamide|mesh-list
25415379|NCT03007147|Doxorubicin|doxorubicin|mesh-list
25415380|NCT03007147|Methotrexate|methotrexate|mesh-list
25415381|NCT03007147|Etoposide|etoposide|mesh-list
25415382|NCT03007147|Vincristine|vincristine|mesh-list
25415383|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
25415384|NCT03007147|Daunorubicin|daunorubicin|mesh-list
25415385|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
25415386|NCT03007147|Pegaspargase|pegaspargase|mesh-list
25415387|NCT03007147|Thioguanine|thioguanine|mesh-list
25415388|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
25415389|NCT03007147|Razoxane|razoxane|mesh-list
25415390|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
25387444|NCT04439253|Crizotinib|crizotinib|mesh-list
25415391|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415392|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
25415393|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415394|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415395|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415396|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
25415397|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415398|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415399|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415400|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415401|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
25415402|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
25415403|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415404|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25415405|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
25415406|NCT03007147|Hormones|hormones|mesh-ancestor
25415407|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415408|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415409|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25415410|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25415411|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25415412|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415413|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25415414|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
25415415|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25415416|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415417|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
25415419|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25415420|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25415421|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415422|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
25415423|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415424|NCT03007147|Antidotes|antidotes|mesh-ancestor
25415425|NCT03007147|Protective Agents|protective agents|mesh-ancestor
25415426|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
25415427|NCT03007147|Vitamins|vitamins|mesh-ancestor
25415428|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
25415429|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415430|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415431|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415432|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25415433|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25415434|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25415435|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
25415436|NCT03006926|Lenvatinib|lenvatinib|mesh-list
25415437|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415438|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415439|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25415440|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415441|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415442|NCT03006848|Avelumab|avelumab|mesh-list
25415443|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415444|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415445|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
25415446|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
25415447|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
25415448|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415449|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415450|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415451|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415452|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
25415453|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415454|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415455|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415456|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415457|NCT03006172|Metformin|metformin|mesh-list
25415458|NCT03006172|Trastuzumab|trastuzumab|mesh-list
25415459|NCT03006172|Pertuzumab|pertuzumab|mesh-list
25415460|NCT03006172|Letrozole|letrozole|mesh-list
25415461|NCT03006172|Fulvestrant|fulvestrant|mesh-list
25415462|NCT03006172|Palbociclib|palbociclib|mesh-list
25415463|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25415464|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415465|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415466|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415467|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25415468|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25415469|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415470|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415471|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25415472|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415473|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415474|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415475|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25415476|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25415477|NCT03005782|Cemiplimab|cemiplimab|mesh-list
25415478|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415479|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415480|NCT03005366|Flecainide|flecainide|mesh-list
25415481|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25415482|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25415483|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25415484|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25415485|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415486|NCT03004833|Nivolumab|nivolumab|mesh-list
25415487|NCT03004833|Doxorubicin|doxorubicin|mesh-list
25415488|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25415489|NCT03004833|Dacarbazine|dacarbazine|mesh-list
25415490|NCT03004833|Vinblastine|vinblastine|mesh-list
25415491|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415492|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415493|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25415647|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
25415494|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415495|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25415496|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25415497|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25415498|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415499|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415500|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
25415501|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415502|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415503|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415504|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415505|NCT03004287|Thalidomide|thalidomide|mesh-list
25415506|NCT03004287|Dexamethasone|dexamethasone|mesh-list
25415507|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
25415508|NCT03004287|Melphalan|melphalan|mesh-list
25415509|NCT03004287|Doxorubicin|doxorubicin|mesh-list
25415510|NCT03004287|Etoposide|etoposide|mesh-list
25415511|NCT03004287|Lenalidomide|lenalidomide|mesh-list
25415512|NCT03004287|Bortezomib|bortezomib|mesh-list
25415513|NCT03004287|Daratumumab|daratumumab|mesh-list
25415514|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415515|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
25415516|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415517|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415518|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415519|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
25415520|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415521|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415522|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415523|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415524|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
25415525|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
25415526|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415527|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25415530|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415531|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415532|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25415533|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25415534|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25415535|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415536|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415537|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25415538|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25415539|NCT03004287|Growth Substances|growth substances|mesh-ancestor
25415540|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
25415541|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
25415542|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25415543|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415544|NCT03004001|Atorvastatin|atorvastatin|mesh-list
25415545|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25415546|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25415547|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25415548|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
25415549|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415550|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25415551|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25415552|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415553|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
25415554|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415555|NCT03003520|Prednisone|prednisone|mesh-list
25415556|NCT03003520|Prednisolone|prednisolone|mesh-list
25415557|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
25415558|NCT03003520|Rituximab|rituximab|mesh-list
25415559|NCT03003520|Doxorubicin|doxorubicin|mesh-list
25415560|NCT03003520|Vincristine|vincristine|mesh-list
25415561|NCT03003520|Lenalidomide|lenalidomide|mesh-list
25415562|NCT03003520|Durvalumab|durvalumab|mesh-list
25415563|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415564|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
25415565|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415566|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415567|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415568|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
25415569|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415570|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415571|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415572|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415573|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25415574|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25415575|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25415576|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415577|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415578|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
25415579|NCT03003520|Hormones|hormones|mesh-ancestor
25415580|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415581|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415582|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415583|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415584|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415585|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415586|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25415587|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25415588|NCT03003520|Growth Substances|growth substances|mesh-ancestor
25415589|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
25415590|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
25415591|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415592|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415593|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
25415594|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25415595|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
25415596|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415597|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
25415598|NCT03003130|Protective Agents|protective agents|mesh-ancestor
25415599|NCT03000439|Tofacitinib|tofacitinib|mesh-list
25415600|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25415601|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415602|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415603|NCT03000387|Nicotine|nicotine|mesh-list
25415604|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25415606|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415607|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415608|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25415609|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25415610|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
25415611|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415612|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415613|NCT02999984|Busulfan|busulfan|mesh-list
25415614|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
25415615|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415616|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415617|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
25415618|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415619|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415620|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415621|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415622|NCT02999477|Paclitaxel|paclitaxel|mesh-list
25415623|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
25415624|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415625|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415626|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415627|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415628|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415629|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415630|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415631|NCT02998528|Gemcitabine|gemcitabine|mesh-list
25415632|NCT02998528|Paclitaxel|paclitaxel|mesh-list
25415633|NCT02998528|Vinorelbine|vinorelbine|mesh-list
25415634|NCT02998528|Docetaxel|docetaxel|mesh-list
25415635|NCT02998528|Cisplatin|cisplatin|mesh-list
25415636|NCT02998528|Carboplatin|carboplatin|mesh-list
25415637|NCT02998528|Nivolumab|nivolumab|mesh-list
25415638|NCT02998528|Pemetrexed|pemetrexed|mesh-list
25415639|NCT02998528|Ipilimumab|ipilimumab|mesh-list
25415640|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415641|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415642|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415643|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415644|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415645|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415646|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415699|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415700|NCT02994927|Prednisone|prednisone|mesh-list
25415701|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
25415702|NCT02994927|Rituximab|rituximab|mesh-list
25415703|NCT02994927|Azathioprine|azathioprine|mesh-list
25415704|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415705|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
25415706|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415707|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415708|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415709|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
25415710|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415711|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415712|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415713|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415714|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415715|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
25415716|NCT02994927|Hormones|hormones|mesh-ancestor
25415717|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415718|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415719|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
25415720|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415721|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25415722|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25415723|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
25415798|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415724|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415725|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25415726|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415727|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25415728|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415730|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415731|NCT02992756|Mitogens|mitogens|mesh-list
25415732|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415958|NCT02980510|Folic Acid|folic acid|mesh-list
25415733|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415734|NCT02991482|Gemcitabine|gemcitabine|mesh-list
25415735|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
25415736|NCT02991482|Vinorelbine|vinorelbine|mesh-list
25415737|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415738|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
25415739|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415740|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415741|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
25415742|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415743|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415744|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415745|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
25415746|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415747|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415748|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415749|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415750|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415751|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415752|NCT02989662|Mifepristone|mifepristone|mesh-list
25415753|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25415754|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
25415755|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25415756|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415757|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25415758|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25415759|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25415760|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
25415761|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25415762|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25415763|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415764|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415765|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
25415766|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25415767|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25415768|NCT02989584|Gemcitabine|gemcitabine|mesh-list
25415769|NCT02989584|Cisplatin|cisplatin|mesh-list
25415770|NCT02989584|Atezolizumab|atezolizumab|mesh-list
25415771|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415772|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415773|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
25415774|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415775|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
25415776|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415777|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415778|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415779|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
25415780|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415781|NCT02989402|Rivastigmine|rivastigmine|mesh-list
25415782|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25415783|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415784|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415785|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
25415786|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415787|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415788|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25415789|NCT02989402|Protective Agents|protective agents|mesh-ancestor
25415790|NCT02987998|Cisplatin|cisplatin|mesh-list
25415791|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
25415792|NCT02987998|Etoposide|etoposide|mesh-list
25415793|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415794|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415795|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415796|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25415797|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25415799|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415800|NCT02987543|Olaparib|olaparib|mesh-list
25415801|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
25415802|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25415803|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415804|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415805|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415882|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415959|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
25415806|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25415807|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415808|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415809|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415810|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25415811|NCT02987257|Cyclosporine|cyclosporine|mesh-list
25415812|NCT02987257|Etanercept|etanercept|mesh-list
25415813|NCT02987257|Cyclosporins|cyclosporins|mesh-list
25415814|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415815|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387824|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
25387825|NCT04424654|Testosterone|testosterone|mesh-list
25387826|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
25415816|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415817|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
25415818|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415819|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
25415820|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415821|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
25415822|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25415823|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25415824|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25415825|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25415826|NCT02987257|Analgesics|analgesics|mesh-ancestor
25415827|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
25415828|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415829|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415830|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25415831|NCT02985957|Prednisone|prednisone|mesh-list
25415832|NCT02985957|Nivolumab|nivolumab|mesh-list
25415833|NCT02985957|Ipilimumab|ipilimumab|mesh-list
25415834|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415835|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
25415836|NCT02985957|Hormones|hormones|mesh-ancestor
25415837|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415838|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415839|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415840|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415841|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415842|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25415843|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415844|NCT02985749|Oxytocin|oxytocin|mesh-list
25415845|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
25415846|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25415847|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415848|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
25415849|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25415850|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
25415851|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415852|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
25415853|NCT02984228|Protective Agents|protective agents|mesh-ancestor
25415854|NCT02983071|Fulvestrant|fulvestrant|mesh-list
25415855|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415856|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415857|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25415858|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25415859|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
25415860|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415861|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415862|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
25415863|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25415864|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415865|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25415866|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415867|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
25415868|NCT02981628|Leucovorin|leucovorin|mesh-list
25415869|NCT02981628|Folic Acid|folic acid|mesh-list
25415870|NCT02981628|Cytarabine|cytarabine|mesh-list
25415871|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
25415872|NCT02981628|Methotrexate|methotrexate|mesh-list
25415873|NCT02981628|Vincristine|vincristine|mesh-list
25415874|NCT02981628|Asparaginase|asparaginase|mesh-list
25415875|NCT02981628|Pegaspargase|pegaspargase|mesh-list
25415876|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25415877|NCT02981628|Calcium|calcium|mesh-list
25415878|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
25415879|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415880|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
25415881|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415883|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415884|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
25415885|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415886|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415887|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415888|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25415889|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25415890|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25415891|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
25415892|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25415893|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415894|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
25415895|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
25415896|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415897|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25415898|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25415899|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
25415900|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415901|NCT02981628|Antidotes|antidotes|mesh-ancestor
25415902|NCT02981628|Protective Agents|protective agents|mesh-ancestor
25415903|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
25415904|NCT02981628|Vitamins|vitamins|mesh-ancestor
25415905|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
25415906|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25415907|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
25415908|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
25415909|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
25415910|NCT02981628|Hematinics|hematinics|mesh-ancestor
25415911|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415912|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25415913|NCT02981173|Psilocybin|psilocybin|mesh-list
25415914|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
25415915|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415916|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25415917|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
25415918|NCT02981069|Exenatide|exenatide|mesh-list
25415919|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25415920|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415921|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25415922|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415923|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25415924|NCT02981069|Incretins|incretins|mesh-ancestor
25415925|NCT02981069|Hormones|hormones|mesh-ancestor
25415926|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415927|NCT02980835|Dexamethasone|dexamethasone|mesh-list
25415928|NCT02980835|Epinephrine|epinephrine|mesh-list
25415929|NCT02980835|Ropivacaine|ropivacaine|mesh-list
25415930|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25415931|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
25415932|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
25415933|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415934|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415935|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25415936|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
25415937|NCT02980835|Hormones|hormones|mesh-ancestor
25415938|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25415939|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25415940|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415941|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
25415942|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
25415943|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25415944|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
25415945|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25415946|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25415947|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
25415948|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416025|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25415949|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415950|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25415951|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25415952|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25415953|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
25415955|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
25415956|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25415957|NCT02980510|Leucovorin|leucovorin|mesh-list
25415964|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415965|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25416023|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416024|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416026|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
25416027|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25416028|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416029|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25416030|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
25416031|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416032|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
25416033|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416034|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416035|NCT02975310|Anesthetics|anesthetics|mesh-list
25416036|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25416037|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416038|NCT02974725|Trametinib|trametinib|mesh-list
25416039|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416040|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416041|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416042|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416044|NCT02974257|Vitamins|vitamins|mesh-ancestor
25416045|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
25416046|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416047|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
25416048|NCT02973789|Docetaxel|docetaxel|mesh-list
25416049|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25416050|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416051|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416052|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416053|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416054|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416055|NCT02972840|Rituximab|rituximab|mesh-list
25416056|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25416057|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
25416058|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416059|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416060|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
25416061|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416062|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416063|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416064|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
25416065|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416066|NCT02972424|Teriparatide|teriparatide|mesh-list
25416067|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25416068|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416069|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25416070|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
25416071|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25416072|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
25416073|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416074|NCT02972398|Expectorants|expectorants|mesh-ancestor
25416075|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
25416076|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25416077|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
25416078|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416079|NCT02972398|Protective Agents|protective agents|mesh-ancestor
25416080|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416081|NCT02972398|Antidotes|antidotes|mesh-ancestor
25416082|NCT02972294|Iron|iron|mesh-list
25416083|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
25416084|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25416085|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
25416086|NCT02972294|Trace Elements|trace elements|mesh-ancestor
25416087|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
25416088|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416089|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25416090|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25416091|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416092|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
25416093|NCT02972294|Coagulants|coagulants|mesh-ancestor
25416094|NCT02972294|Hematinics|hematinics|mesh-ancestor
25416095|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
25416096|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416097|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416098|NCT02971683|Abatacept|abatacept|mesh-list
25416099|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416100|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416101|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416102|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416103|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
25416104|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416105|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416106|NCT02970981|Nivolumab|nivolumab|mesh-list
25416107|NCT02970981|Ipilimumab|ipilimumab|mesh-list
25416108|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416109|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416110|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416185|NCT02965963|Dopamine|dopamine|mesh-list
25416111|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416112|NCT02969798|Metformin|metformin|mesh-list
25416113|NCT02969798|Pioglitazone|pioglitazone|mesh-list
25416114|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
25416115|NCT02969798|Saxagliptin|saxagliptin|mesh-list
25416117|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416118|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25416119|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416120|NCT02969798|Incretins|incretins|mesh-ancestor
25416121|NCT02969798|Hormones|hormones|mesh-ancestor
25416122|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25416123|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25416124|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
25416125|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416126|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
25416127|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25416128|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25416129|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25416130|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25416131|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416132|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
25416133|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416134|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416135|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25416136|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416137|NCT02968212|Clofazimine|clofazimine|mesh-list
25416138|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25416139|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
25416140|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25416141|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416142|NCT02967692|Trametinib|trametinib|mesh-list
25416143|NCT02967692|Dabrafenib|dabrafenib|mesh-list
25416144|NCT02967692|Spartalizumab|spartalizumab|mesh-list
25416145|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416146|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416147|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416148|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416149|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416150|NCT02967289|Irinotecan|irinotecan|mesh-list
25416151|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25416152|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25416153|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416154|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416155|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416156|NCT02967133|Paclitaxel|paclitaxel|mesh-list
25416157|NCT02967133|Nivolumab|nivolumab|mesh-list
25416158|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416159|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416160|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416161|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416162|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416163|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416164|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416165|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416166|NCT02966782|Azacitidine|azacitidine|mesh-list
25416167|NCT02966782|Venetoclax|venetoclax|mesh-list
25416168|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416169|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
25416170|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416171|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416172|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416173|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
25416174|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25416175|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25416176|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25416177|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25416178|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25416179|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416180|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
25416181|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416182|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416183|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25416184|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416186|NCT02965963|Metoclopramide|metoclopramide|mesh-list
25416187|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
25416188|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
25416189|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416190|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416191|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25416196|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416198|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
25416199|NCT02965963|Protective Agents|protective agents|mesh-ancestor
25416200|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
25416201|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416202|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
25416203|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416204|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416205|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416206|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
25416207|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416208|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416209|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25416211|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25416212|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25416213|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416214|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
25416215|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416216|NCT02965703|Aspirin|aspirin|mesh-list
25416217|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25416218|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25416219|NCT02965703|Analgesics|analgesics|mesh-ancestor
25416220|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
25416221|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416222|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416223|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25416224|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416225|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25416226|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25416227|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416228|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25416229|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25416230|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416231|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
25416232|NCT02965027|Prazosin|prazosin|mesh-list
25416233|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25416234|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25416235|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25416236|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25416237|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
25416238|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416239|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416240|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416241|NCT02964182|Nicotine|nicotine|mesh-list
25416242|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25416243|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
25416244|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416245|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416246|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25416247|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25416248|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
25416249|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416250|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416251|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
25416252|NCT02963090|Topotecan|topotecan|mesh-list
25416253|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416254|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416255|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25416256|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25416257|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416258|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416264|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
25416265|NCT02962401|Idelalisib|idelalisib|mesh-list
25416266|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416282|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25416297|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
25416298|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416299|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416300|NCT02959164|Gemcitabine|gemcitabine|mesh-list
25416302|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416303|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
25416304|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416305|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416306|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
25416307|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416308|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416309|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416310|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
25416311|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416312|NCT02957968|Paclitaxel|paclitaxel|mesh-list
25416313|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
25416314|NCT02957968|Carboplatin|carboplatin|mesh-list
25416315|NCT02957968|Doxorubicin|doxorubicin|mesh-list
25416316|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
25416317|NCT02957968|Decitabine|decitabine|mesh-list
25416318|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416319|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416320|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416321|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416322|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416323|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416324|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416325|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
25416326|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416327|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416328|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416329|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
25416330|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25416331|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25416332|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25416333|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25416334|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416335|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416336|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416337|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
25416338|NCT02956590|Pitavastatin|pitavastatin|mesh-list
25416339|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25416340|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25416341|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25416343|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416344|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416345|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25416346|NCT02955654|Aripiprazole|aripiprazole|mesh-list
25416347|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
25416348|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25416349|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25416350|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25416351|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25416352|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416353|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
25416354|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
25416355|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416356|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416357|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25416358|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25416359|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
25416360|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25416361|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25416362|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25416363|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25416364|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
25416365|NCT02955290|Nivolumab|nivolumab|mesh-list
25416366|NCT02955290|Vaccines|vaccines|mesh-list
25416367|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25416368|NCT02955290|Mitogens|mitogens|mesh-list
25416369|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
25416370|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416371|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416372|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416373|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416374|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416375|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416376|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25416377|NCT02954887|Cannabidiol|cannabidiol|mesh-list
25416378|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
25416379|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
25416380|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416381|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416382|NCT02954536|Cisplatin|cisplatin|mesh-list
25416383|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
25416384|NCT02954536|Fluorouracil|fluorouracil|mesh-list
25416385|NCT02954536|Capecitabine|capecitabine|mesh-list
25416386|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
25416387|NCT02954536|Trastuzumab|trastuzumab|mesh-list
25416388|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416389|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416390|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
25416391|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416392|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416393|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416394|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
25416395|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416396|NCT02954081|Apremilast|apremilast|mesh-list
25416397|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25416398|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25416399|NCT02954081|Analgesics|analgesics|mesh-ancestor
25416400|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
25416401|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416402|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416403|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25416404|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416405|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25416406|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25416407|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416408|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416410|NCT02954055|Vinorelbine|vinorelbine|mesh-list
25416411|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25416412|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
25416413|NCT02954055|Capecitabine|capecitabine|mesh-list
25416414|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416415|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416416|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416417|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416418|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416920|NCT02912715|Paclitaxel|paclitaxel|mesh-list
25416419|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416420|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416421|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
25416422|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416423|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416424|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416425|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
25416426|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25416427|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416428|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
25416429|NCT02953548|Cannabidiol|cannabidiol|mesh-list
25416430|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
25416431|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
25416432|NCT02952222|Propofol|propofol|mesh-list
25416433|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25416434|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25416435|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416436|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25416437|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
25416438|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
25416439|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25416440|NCT02952222|Analgesics|analgesics|mesh-ancestor
25416441|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
25416442|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416443|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25416444|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25416445|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25416446|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
25416447|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416448|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416449|NCT02951767|Atezolizumab|atezolizumab|mesh-list
25416450|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416451|NCT02949128|Ravulizumab|ravulizumab|mesh-list
25416452|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25416453|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416454|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
25416455|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416456|NCT02948543|Mitomycins|mitomycins|mesh-list
25416457|NCT02948543|Mitomycin|mitomycin|mesh-list
25416458|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25416459|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416460|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
25416461|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416462|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25416463|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416464|NCT02947386|Nivolumab|nivolumab|mesh-list
25416465|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
25416466|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416467|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416468|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416469|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416470|NCT02947347|Rituximab|rituximab|mesh-list
25416471|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416472|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416473|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
25416474|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416475|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416476|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25416477|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
25416478|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25416479|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416480|NCT02947126|Antidotes|antidotes|mesh-ancestor
25416481|NCT02947126|Protective Agents|protective agents|mesh-ancestor
25416482|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416483|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
25416484|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
25416485|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25416486|NCT02946996|Metformin|metformin|mesh-list
25416487|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25416488|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416489|NCT02946463|Eculizumab|eculizumab|mesh-list
25416490|NCT02946463|Ravulizumab|ravulizumab|mesh-list
25416491|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25416492|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416493|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
25417310|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416494|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416495|NCT02946125|Phenylephrine|phenylephrine|mesh-list
25416496|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
25416497|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25416498|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25416499|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
25416500|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
25416501|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416502|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416503|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
25416504|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25416505|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
25416506|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
25416507|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25416508|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25416509|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25416510|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
25416511|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416512|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416513|NCT02946125|Protective Agents|protective agents|mesh-ancestor
25416514|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25416515|NCT02944071|Paclitaxel|paclitaxel|mesh-list
25416516|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416517|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416518|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416519|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416520|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416521|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416522|NCT02943733|Temozolomide|temozolomide|mesh-list
25416523|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416524|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
25416525|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416526|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416527|NCT02942290|Azacitidine|azacitidine|mesh-list
25416528|NCT02942290|Venetoclax|venetoclax|mesh-list
25416529|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416530|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
25416531|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416532|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416533|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416534|NCT02941783|Factor VIII|factor viii|mesh-list
25416535|NCT02941783|Coagulants|coagulants|mesh-ancestor
25416536|NCT02938520|Rilpivirine|rilpivirine|mesh-list
25416537|NCT02938520|Cabotegravir|cabotegravir|mesh-list
25416538|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25416539|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25416540|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416541|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416542|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
25416543|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416544|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25416545|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25416546|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25416547|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25416548|NCT02938442|Paclitaxel|paclitaxel|mesh-list
25416549|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25416550|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
25416551|NCT02938442|Doxorubicin|doxorubicin|mesh-list
25416552|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25416553|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25416554|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
25416555|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416556|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416557|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416558|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416559|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416560|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416561|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416562|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
25416563|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416564|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416565|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416566|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
25416567|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25416568|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25416569|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25416570|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25416571|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416572|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25416573|NCT02937818|Carboplatin|carboplatin|mesh-list
25416575|NCT02937818|Olaparib|olaparib|mesh-list
25416576|NCT02937818|Tremelimumab|tremelimumab|mesh-list
25416577|NCT02937818|Adavosertib|adavosertib|mesh-list
25416578|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416579|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416580|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25416581|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416582|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416583|NCT02937272|Gemcitabine|gemcitabine|mesh-list
25416584|NCT02937272|Paclitaxel|paclitaxel|mesh-list
25416585|NCT02937272|Cisplatin|cisplatin|mesh-list
25416586|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416587|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416588|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416589|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416590|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416591|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416592|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416593|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
25416594|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
25416595|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416596|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416597|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416598|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
25416599|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416600|NCT02936102|Spartalizumab|spartalizumab|mesh-list
25416601|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416602|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416603|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416604|NCT02935634|Nivolumab|nivolumab|mesh-list
25416605|NCT02935634|Ipilimumab|ipilimumab|mesh-list
25416606|NCT02935634|Rucaparib|rucaparib|mesh-list
25416607|NCT02935634|Linrodostat|linrodostat|mesh-list
25416608|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416609|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416610|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416611|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416612|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25416613|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416614|NCT02935374|Amoxicillin|amoxicillin|mesh-list
25416615|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
25416616|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
25416617|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25416618|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416619|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25416620|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416621|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416622|NCT02935361|Atezolizumab|atezolizumab|mesh-list
25416623|NCT02935361|Guadecitabine|guadecitabine|mesh-list
25416624|NCT02935361|Azacitidine|azacitidine|mesh-list
25416625|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25416626|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416627|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
25416628|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416629|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416630|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
25416650|NCT02932410|Macitentan|macitentan|mesh-list
25416651|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25416652|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25416653|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416654|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25416655|NCT02930902|Gemcitabine|gemcitabine|mesh-list
25416656|NCT02930902|Paclitaxel|paclitaxel|mesh-list
25416657|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25416658|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
25416659|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416660|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416661|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416662|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416663|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416664|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416670|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416671|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
25416672|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416673|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416674|NCT02928406|Atezolizumab|atezolizumab|mesh-list
25416675|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416699|NCT02927769|Nivolumab|nivolumab|mesh-list
25416700|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25416701|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25416702|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416703|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416704|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416705|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416706|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416707|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
25416714|NCT02926690|OTS167|ots167|mesh-list
25416715|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416716|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416717|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416718|NCT02926222|Lomustine|lomustine|mesh-list
25416719|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416720|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
25416721|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416722|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416723|NCT02925650|Phenserine|phenserine|mesh-list
25416724|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25416725|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416726|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416727|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
25416728|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416729|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416730|NCT02925234|Bevacizumab|bevacizumab|mesh-list
25416731|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
25416732|NCT02925234|Nivolumab|nivolumab|mesh-list
25416733|NCT02925234|Trastuzumab|trastuzumab|mesh-list
25416734|NCT02925234|Ipilimumab|ipilimumab|mesh-list
25416735|NCT02925234|Durvalumab|durvalumab|mesh-list
25416736|NCT02925234|Pertuzumab|pertuzumab|mesh-list
25416737|NCT02925234|Panitumumab|panitumumab|mesh-list
25416738|NCT02925234|Sunitinib|sunitinib|mesh-list
25416739|NCT02925234|Atezolizumab|atezolizumab|mesh-list
25416740|NCT02925234|Olaparib|olaparib|mesh-list
25416741|NCT02925234|Lenvatinib|lenvatinib|mesh-list
25416742|NCT02925234|Palbociclib|palbociclib|mesh-list
25416743|NCT02925234|Trametinib|trametinib|mesh-list
25416744|NCT02925234|Axitinib|axitinib|mesh-list
25416745|NCT02925234|Afatinib|afatinib|mesh-list
25416746|NCT02925234|Vemurafenib|vemurafenib|mesh-list
25416747|NCT02925234|Dabrafenib|dabrafenib|mesh-list
25416748|NCT02925234|Crizotinib|crizotinib|mesh-list
25416749|NCT02925234|Talazoparib|talazoparib|mesh-list
25416750|NCT02925234|Rucaparib|rucaparib|mesh-list
25416751|NCT02925234|Entrectinib|entrectinib|mesh-list
25416752|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416753|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416754|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25416755|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25416756|NCT02925234|Growth Substances|growth substances|mesh-ancestor
25416757|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416758|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
25416759|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416760|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416761|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416762|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416763|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25416764|NCT02923947|Osimertinib|osimertinib|mesh-list
25416765|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416766|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416767|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416768|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416769|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25416770|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416771|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416772|NCT02921919|Talazoparib|talazoparib|mesh-list
25416773|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25416774|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416775|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416776|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416777|NCT02921256|Leucovorin|leucovorin|mesh-list
25416778|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
25416779|NCT02921256|Fluorouracil|fluorouracil|mesh-list
25416780|NCT02921256|Capecitabine|capecitabine|mesh-list
25416781|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
25416782|NCT02921256|Veliparib|veliparib|mesh-list
25416783|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416784|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416785|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
25416786|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416787|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416788|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416789|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
25416790|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416791|NCT02921256|Antidotes|antidotes|mesh-ancestor
25416792|NCT02921256|Protective Agents|protective agents|mesh-ancestor
25416793|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
25416794|NCT02921256|Vitamins|vitamins|mesh-ancestor
25416795|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
25416950|NCT02912559|Hematinics|hematinics|mesh-ancestor
25416796|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25416797|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416798|NCT02919787|Irinotecan|irinotecan|mesh-list
25416799|NCT02919787|Fluorouracil|fluorouracil|mesh-list
25416800|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
25388668|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
25416801|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25416802|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25416803|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416804|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416805|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416806|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
25416807|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416808|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416809|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
25416810|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416811|NCT02918721|Lidocaine|lidocaine|mesh-list
25416812|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
25416813|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25416814|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
25416815|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25416816|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416817|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
25416818|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416819|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25416820|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25416821|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25416822|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25416823|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416824|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25416825|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
25416826|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
25416827|NCT02918721|Protective Agents|protective agents|mesh-ancestor
25416828|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
25416829|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
25416830|NCT02918292|Fludarabine|fludarabine|mesh-list
25416831|NCT02918292|Tacrolimus|tacrolimus|mesh-list
25416832|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
25416833|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25416834|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416835|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
25416836|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416837|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416838|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25416839|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
25416840|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416841|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416842|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25416843|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25416844|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416845|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25416846|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25416847|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
25416848|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25416849|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416850|NCT02916771|Dexamethasone|dexamethasone|mesh-list
25416851|NCT02916771|Lenalidomide|lenalidomide|mesh-list
25416852|NCT02916771|Ixazomib|ixazomib|mesh-list
25416853|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25416854|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
25416855|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
25416856|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416857|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416858|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25416859|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
25416860|NCT02916771|Hormones|hormones|mesh-ancestor
25416939|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
25416861|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25416862|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25416863|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416864|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
25416865|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25416866|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25416867|NCT02916771|Growth Substances|growth substances|mesh-ancestor
25416868|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
25416869|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
25416870|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416871|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416874|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416875|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416876|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25416877|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416878|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416880|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
25416881|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416882|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416883|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
25416884|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416885|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25416886|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416887|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416888|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416889|NCT02914366|Ambroxol|ambroxol|mesh-list
25416890|NCT02914366|Expectorants|expectorants|mesh-ancestor
25416891|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
25416892|NCT02913313|Nivolumab|nivolumab|mesh-list
25416893|NCT02913313|Ipilimumab|ipilimumab|mesh-list
25416894|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416895|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416896|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416897|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416898|NCT02913196|Prednisone|prednisone|mesh-list
25416899|NCT02913196|Docetaxel|docetaxel|mesh-list
25416900|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
25416901|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416902|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416903|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416904|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416905|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416906|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25416907|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
25416908|NCT02913196|Hormones|hormones|mesh-ancestor
25416909|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25416910|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416911|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25416912|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25416913|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416914|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
25416915|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25416916|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
25416917|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25416918|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
25416919|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416921|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416922|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416923|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416924|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416925|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416926|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416927|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
25416928|NCT02912559|Leucovorin|leucovorin|mesh-list
25416929|NCT02912559|Folic Acid|folic acid|mesh-list
25416930|NCT02912559|Fluorouracil|fluorouracil|mesh-list
25416931|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
25416932|NCT02912559|Atezolizumab|atezolizumab|mesh-list
25416933|NCT02912559|Calcium|calcium|mesh-list
25416934|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25416935|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
25416936|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25416937|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416938|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25416940|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416941|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416942|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416943|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25416944|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
25416946|NCT02912559|Protective Agents|protective agents|mesh-ancestor
25416947|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
25416948|NCT02912559|Vitamins|vitamins|mesh-ancestor
25416949|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
25416951|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
25416952|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25416953|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25416954|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416955|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
25416956|NCT02911831|Coagulants|coagulants|mesh-ancestor
25416957|NCT02910700|Nivolumab|nivolumab|mesh-list
25416958|NCT02910700|Trametinib|trametinib|mesh-list
25416959|NCT02910700|Dabrafenib|dabrafenib|mesh-list
25416960|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416961|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416962|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416963|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416964|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416965|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416966|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
25416967|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
25416968|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416969|NCT02910531|Protective Agents|protective agents|mesh-ancestor
25416970|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416971|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
25416972|NCT02910531|Vitamins|vitamins|mesh-ancestor
25416973|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
25416974|NCT02908685|Risdiplam|risdiplam|mesh-list
25416975|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25416976|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416977|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416978|NCT02908672|Atezolizumab|atezolizumab|mesh-list
25416979|NCT02908672|Vemurafenib|vemurafenib|mesh-list
25416980|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25416981|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416982|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
25416983|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416984|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25416985|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416986|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416987|NCT02908477|Cisplatin|cisplatin|mesh-list
25416988|NCT02908477|Docetaxel|docetaxel|mesh-list
25416989|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416990|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
25416991|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
25416992|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
25416993|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416994|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
25416995|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416996|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416997|NCT02906761|Aspirin|aspirin|mesh-list
25416998|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25416999|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25417000|NCT02906761|Analgesics|analgesics|mesh-ancestor
25417001|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
25417002|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417003|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417004|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417005|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417006|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25417007|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25417008|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417009|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25417010|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25417011|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417012|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
25417013|NCT02905799|Resveratrol|resveratrol|mesh-list
25417014|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
25417015|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417016|NCT02905799|Protective Agents|protective agents|mesh-ancestor
25417017|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417018|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417019|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25417022|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25417023|NCT02905591|Carboplatin|carboplatin|mesh-list
25417024|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417025|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417026|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417027|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417028|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417029|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417031|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
25417032|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417033|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
25417034|NCT02905591|Protective Agents|protective agents|mesh-ancestor
25417035|NCT02905318|Palbociclib|palbociclib|mesh-list
25417036|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417037|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417038|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417039|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417040|NCT02905110|Methotrexate|methotrexate|mesh-list
25417041|NCT02905110|Etoposide|etoposide|mesh-list
25417042|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25417043|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
25417044|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25417045|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417046|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417047|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
25417048|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417049|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417050|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25417051|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417052|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25417053|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417054|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
25417055|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417056|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417057|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417058|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25417059|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417060|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
25417061|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417062|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417063|NCT02902484|Nintedanib|nintedanib|mesh-list
25417064|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417065|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417066|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417067|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417068|NCT02902029|Atezolizumab|atezolizumab|mesh-list
25417069|NCT02902029|Vemurafenib|vemurafenib|mesh-list
25417070|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417071|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417072|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417073|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417074|NCT02901548|Durvalumab|durvalumab|mesh-list
25417075|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417076|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417077|NCT02901184|Spironolactone|spironolactone|mesh-list
25417078|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25417079|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
25417080|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417081|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417082|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25417083|NCT02901184|Diuretics|diuretics|mesh-ancestor
25417084|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
25417085|NCT02899299|Cisplatin|cisplatin|mesh-list
25417086|NCT02899299|Carboplatin|carboplatin|mesh-list
25417087|NCT02899299|Nivolumab|nivolumab|mesh-list
25417088|NCT02899299|Pemetrexed|pemetrexed|mesh-list
25417089|NCT02899299|Ipilimumab|ipilimumab|mesh-list
25417090|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417091|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417092|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417093|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417094|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417095|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25417096|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417097|NCT02899052|Dexamethasone|dexamethasone|mesh-list
25417098|NCT02899052|Venetoclax|venetoclax|mesh-list
25417099|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417100|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
25417101|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
25417102|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417103|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417104|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417105|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
25417106|NCT02899052|Hormones|hormones|mesh-ancestor
25417107|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417108|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25388974|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388975|NCT04374630|Paclitaxel|paclitaxel|mesh-list
25388976|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25388977|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25388978|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
25388979|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
25388980|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
25388981|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25388982|NCT04374474|Budesonide|budesonide|mesh-list
25388983|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388984|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25388985|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
25388986|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417109|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417110|NCT02898259|Rituximab|rituximab|mesh-list
25417111|NCT02898259|Lenalidomide|lenalidomide|mesh-list
25417112|NCT02898259|Ixazomib|ixazomib|mesh-list
25417113|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417114|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417115|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
25417116|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417117|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417118|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25417119|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25417120|NCT02898259|Growth Substances|growth substances|mesh-ancestor
25417121|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
25417122|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
25417123|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417124|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417125|NCT02893423|Ropivacaine|ropivacaine|mesh-list
25417126|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
25417127|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
25417128|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25417129|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417130|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
25417131|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417132|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25417133|NCT02893293|Hematinics|hematinics|mesh-ancestor
25417134|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25417135|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25417136|NCT02891603|Sirolimus|sirolimus|mesh-list
25417137|NCT02891603|Tacrolimus|tacrolimus|mesh-list
25417138|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417139|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
25417140|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417141|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25417142|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417143|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417144|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25417145|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417146|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25417147|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417148|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
25417149|NCT02891226|Mirikizumab|mirikizumab|mesh-list
25417150|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25417151|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25417152|NCT02891226|Analgesics|analgesics|mesh-ancestor
25417153|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
25417154|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417155|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417156|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417157|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417158|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25417159|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417161|NCT02890355|Leucovorin|leucovorin|mesh-list
25417162|NCT02890355|Folic Acid|folic acid|mesh-list
25417163|NCT02890355|Fluorouracil|fluorouracil|mesh-list
25417164|NCT02890355|Irinotecan|irinotecan|mesh-list
25417165|NCT02890355|Veliparib|veliparib|mesh-list
25417166|NCT02890355|Camptothecin|camptothecin|mesh-list
25417167|NCT02890355|Calcium|calcium|mesh-list
25417168|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
25417169|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25417327|NCT02881086|Asparaginase|asparaginase|mesh-list
25417170|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417171|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25417172|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
25417173|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417174|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417175|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417176|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417177|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
25417178|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25417179|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417180|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417181|NCT02890355|Antidotes|antidotes|mesh-ancestor
25417182|NCT02890355|Protective Agents|protective agents|mesh-ancestor
25417183|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
25417184|NCT02890355|Vitamins|vitamins|mesh-ancestor
25417185|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
25417186|NCT02890355|Hematinics|hematinics|mesh-ancestor
25417187|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25417188|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417189|NCT02889523|Prednisolone|prednisolone|mesh-list
25417190|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
25417191|NCT02889523|Rituximab|rituximab|mesh-list
25417192|NCT02889523|Doxorubicin|doxorubicin|mesh-list
25417193|NCT02889523|Vincristine|vincristine|mesh-list
25417194|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417195|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
25417196|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417197|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417198|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25417199|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
25417200|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417201|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417202|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25417203|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417204|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25417205|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25417206|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417207|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417208|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417209|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417210|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417211|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417212|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417213|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
25417214|NCT02889523|Hormones|hormones|mesh-ancestor
25417215|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417216|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25417217|NCT02886962|Vitamin K|vitamin k|mesh-list
25417218|NCT02886962|Vitamins|vitamins|mesh-ancestor
25417219|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
25417220|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417221|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25417222|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25417223|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417224|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
25417225|NCT02886962|Coagulants|coagulants|mesh-ancestor
25417226|NCT02884245|Estrogens|estrogens|mesh-list
25417227|NCT02884245|Hormones|hormones|mesh-ancestor
25417228|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417229|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417244|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25417245|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25417246|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25417247|NCT02883049|Cortisone|cortisone|mesh-list
25417248|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
25389128|NCT04360135|Acetaminophen|acetaminophen|mesh-list
25389129|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389130|NCT04360135|Analgesics|analgesics|mesh-ancestor
25389131|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
25389132|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389133|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389134|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
25389135|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25417249|NCT02883049|Doxorubicin|doxorubicin|mesh-list
25417250|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25417251|NCT02883049|Methotrexate|methotrexate|mesh-list
25417252|NCT02883049|Etoposide|etoposide|mesh-list
25417253|NCT02883049|Vincristine|vincristine|mesh-list
25417254|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
25417255|NCT02883049|Daunorubicin|daunorubicin|mesh-list
25417256|NCT02883049|Dasatinib|dasatinib|mesh-list
25417257|NCT02883049|Asparaginase|asparaginase|mesh-list
25417258|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
25417259|NCT02883049|Clofarabine|clofarabine|mesh-list
25417260|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
25417261|NCT02883049|Pegaspargase|pegaspargase|mesh-list
25417262|NCT02883049|Thioguanine|thioguanine|mesh-list
25417263|NCT02883049|BB 1101|bb 1101|mesh-list
25417264|NCT02883049|Calcium|calcium|mesh-list
25417265|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
25417266|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
25417267|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417268|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
25417269|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417270|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417271|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25417272|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
25417273|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417274|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417275|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25417276|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417277|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
25417278|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
25417279|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417280|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417281|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
25417282|NCT02883049|Hormones|hormones|mesh-ancestor
25417283|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417284|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25417285|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
25417286|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417287|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25417288|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25417289|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417290|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25417291|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25417292|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25417293|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
25417294|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25417295|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417296|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
25417297|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
25417298|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25417299|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417300|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417301|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
25417302|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417303|NCT02883049|Antidotes|antidotes|mesh-ancestor
25417304|NCT02883049|Protective Agents|protective agents|mesh-ancestor
25417305|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
25417306|NCT02883049|Vitamins|vitamins|mesh-ancestor
25417307|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
25417308|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417309|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417311|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417312|NCT02883049|Hematinics|hematinics|mesh-ancestor
25417313|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
25417314|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25417315|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25417316|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417317|NCT02881086|Cytarabine|cytarabine|mesh-list
25417318|NCT02881086|Dexamethasone|dexamethasone|mesh-list
25417319|NCT02881086|Prednisolone|prednisolone|mesh-list
25417320|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
25417321|NCT02881086|Rituximab|rituximab|mesh-list
25417322|NCT02881086|Methotrexate|methotrexate|mesh-list
25417323|NCT02881086|Fludarabine|fludarabine|mesh-list
25417324|NCT02881086|Vincristine|vincristine|mesh-list
25417325|NCT02881086|Doxorubicin|doxorubicin|mesh-list
25417326|NCT02881086|Daunorubicin|daunorubicin|mesh-list
25417328|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
25417329|NCT02881086|Idarubicin|idarubicin|mesh-list
25417330|NCT02881086|Pegaspargase|pegaspargase|mesh-list
25417331|NCT02881086|Vindesine|vindesine|mesh-list
25417332|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417333|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
25417334|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417335|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417336|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25417337|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
25417414|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
25417338|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417339|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417340|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25417341|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417342|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417343|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
25417344|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
25417345|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417346|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417347|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
25417348|NCT02881086|Hormones|hormones|mesh-ancestor
25417349|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417350|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25417351|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25417352|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
25417353|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25417354|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417355|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
25417356|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25417357|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417358|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25417359|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417360|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
25417361|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417362|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417363|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417364|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417365|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417366|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25417367|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25417368|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417369|NCT02880982|Vitamin D|vitamin d|mesh-list
25417370|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
25417371|NCT02880982|Vitamins|vitamins|mesh-ancestor
25417372|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
25417373|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417374|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25417375|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25417376|NCT02880956|Tilavonemab|tilavonemab|mesh-list
25417377|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
25417378|NCT02880020|Nivolumab|nivolumab|mesh-list
25417379|NCT02880020|Ipilimumab|ipilimumab|mesh-list
25417380|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417381|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417382|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417383|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417384|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25417385|NCT02879695|Nivolumab|nivolumab|mesh-list
25417386|NCT02879695|Ipilimumab|ipilimumab|mesh-list
25417387|NCT02879695|Blinatumomab|blinatumomab|mesh-list
25417388|NCT02879695|Antibodies|antibodies|mesh-list
25417389|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
25417394|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417395|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417396|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417397|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417398|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417399|NCT02879617|Durvalumab|durvalumab|mesh-list
25417400|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417401|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417402|NCT02879318|Gemcitabine|gemcitabine|mesh-list
25417403|NCT02879318|Paclitaxel|paclitaxel|mesh-list
25417404|NCT02879318|Durvalumab|durvalumab|mesh-list
25417405|NCT02879318|Tremelimumab|tremelimumab|mesh-list
25417406|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417407|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417408|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417409|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417410|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417411|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417412|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417413|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
25417415|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417416|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417417|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417418|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
25417419|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417420|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417422|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
25417423|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25417424|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417425|NCT02876211|Vitamin D|vitamin d|mesh-list
25417426|NCT02876211|Vitamins|vitamins|mesh-ancestor
25417427|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
25417428|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417429|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25417430|NCT02875223|Itraconazole|itraconazole|mesh-list
25417431|NCT02875223|Rifampin|rifampin|mesh-list
25417432|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
25417433|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
25417434|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417435|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25417436|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25417437|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417438|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417439|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25417440|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
25417441|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417442|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417443|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25417444|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25417445|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
25417446|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25417447|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
25417448|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417449|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25417450|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25417451|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25417452|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25417453|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25417454|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25417455|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417456|NCT02873806|Tobramycin|tobramycin|mesh-list
25417457|NCT02873806|Dexamethasone|dexamethasone|mesh-list
25417458|NCT02873806|Travoprost|travoprost|mesh-list
25417459|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417460|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
25417461|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
25417462|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417463|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417464|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417465|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
25417466|NCT02873806|Hormones|hormones|mesh-ancestor
25417467|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417468|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25417469|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417470|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25417471|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25417472|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417473|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
25417474|NCT02872259|Trametinib|trametinib|mesh-list
25417475|NCT02872259|Dabrafenib|dabrafenib|mesh-list
25417476|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417477|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417478|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417479|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417632|NCT02859402|Fludarabine|fludarabine|mesh-list
25417480|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417481|NCT02872116|Leucovorin|leucovorin|mesh-list
25417482|NCT02872116|Fluorouracil|fluorouracil|mesh-list
25417483|NCT02872116|Capecitabine|capecitabine|mesh-list
25417484|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
25417485|NCT02872116|Nivolumab|nivolumab|mesh-list
25417486|NCT02872116|Ipilimumab|ipilimumab|mesh-list
25417487|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
25417488|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417489|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417490|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417491|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417492|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
25417493|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417494|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417495|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417497|NCT02872116|Protective Agents|protective agents|mesh-ancestor
25417498|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
25417499|NCT02872116|Vitamins|vitamins|mesh-ancestor
25417500|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
25417501|NCT02871791|Everolimus|everolimus|mesh-list
25417502|NCT02871791|Palbociclib|palbociclib|mesh-list
25417503|NCT02871791|Exemestane|exemestane|mesh-list
25417504|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417505|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417506|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
25417507|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417508|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417509|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417510|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417511|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25417512|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25417513|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25417514|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
25417515|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417516|NCT02869789|Nivolumab|nivolumab|mesh-list
25417517|NCT02869789|Ipilimumab|ipilimumab|mesh-list
25417518|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417519|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417520|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417521|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417522|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
25417523|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25417524|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25417525|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417526|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
25417527|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25417528|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25417529|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25417530|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
25417531|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25417532|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417533|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417534|NCT02866006|Topotecan|topotecan|mesh-list
25417535|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25417536|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417537|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417538|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417539|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417540|NCT02865811|Doxorubicin|doxorubicin|mesh-list
25417541|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25417542|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
25417543|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25417544|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417545|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25417546|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25389433|NCT04340141|Protective Agents|protective agents|mesh-ancestor
25389434|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
25389435|NCT04340141|Vitamins|vitamins|mesh-ancestor
25389436|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
25389437|NCT04340076|Ixekizumab|ixekizumab|mesh-list
25389438|NCT04340076|Brodalumab|brodalumab|mesh-list
25417547|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417548|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417549|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417551|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417552|NCT02864914|Empagliflozin|empagliflozin|mesh-list
25417553|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25417554|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25417633|NCT02859402|Busulfan|busulfan|mesh-list
25417555|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417556|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25417557|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417558|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
25417559|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417560|NCT02864394|Docetaxel|docetaxel|mesh-list
25417561|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
25417562|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417563|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417564|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417565|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417566|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417567|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417568|NCT02864147|Imiquimod|imiquimod|mesh-list
25417569|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25417570|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
25417571|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417572|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417573|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
25417574|NCT02863991|TIC10 compound|tic10 compound|mesh-list
25417575|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417576|NCT02862457|Paclitaxel|paclitaxel|mesh-list
25417577|NCT02862457|Cisplatin|cisplatin|mesh-list
25417578|NCT02862457|Carboplatin|carboplatin|mesh-list
25417579|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
25417580|NCT02862457|Pemetrexed|pemetrexed|mesh-list
25417581|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417582|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417583|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417584|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417585|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417586|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417587|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417588|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417589|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25417590|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417591|NCT02862132|Vedolizumab|vedolizumab|mesh-list
25417592|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417593|NCT02861573|Dexamethasone|dexamethasone|mesh-list
25417594|NCT02861573|Prednisone|prednisone|mesh-list
25417595|NCT02861573|Carboplatin|carboplatin|mesh-list
25417596|NCT02861573|Docetaxel|docetaxel|mesh-list
25417597|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
25417598|NCT02861573|Etoposide|etoposide|mesh-list
25417599|NCT02861573|Olaparib|olaparib|mesh-list
25417600|NCT02861573|Lenvatinib|lenvatinib|mesh-list
25417601|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
25417602|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25417603|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
25417604|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
25417605|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417606|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417607|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417608|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
25417609|NCT02861573|Hormones|hormones|mesh-ancestor
25417610|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417611|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25417612|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417613|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417614|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389511|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25389512|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25389513|NCT04338022|Analgesics|analgesics|mesh-ancestor
25389514|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
25389515|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389516|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389517|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25389518|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25389521|NCT04337970|Axitinib|axitinib|mesh-list
25417615|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417616|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417617|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417618|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417619|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25417620|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417621|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417622|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25417623|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417624|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25417625|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
25417626|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25417628|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417629|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
25417630|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417631|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417634|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417635|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417636|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417637|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
25417638|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417639|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
25417716|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
25417640|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25417641|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25417642|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
25417643|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25417644|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
25417645|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25417646|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417647|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25417648|NCT02858310|Aldesleukin|aldesleukin|mesh-list
25417649|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
25417650|NCT02858310|Fludarabine|fludarabine|mesh-list
25417651|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417652|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
25417653|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417654|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417655|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25417656|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
25417657|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417658|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417659|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25417660|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25417661|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25417662|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
25417663|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417664|NCT02857270|Gemcitabine|gemcitabine|mesh-list
25417666|NCT02857270|Cetuximab|cetuximab|mesh-list
25417667|NCT02857270|Midazolam|midazolam|mesh-list
25417668|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417669|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417670|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417671|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417672|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417673|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417674|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417675|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
25417676|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
25417677|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417678|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417679|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417680|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
25417681|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417682|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25417683|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25417684|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25417685|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25417686|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25417687|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25417688|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25417689|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
25417690|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
25417691|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
25417692|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
25417693|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25417694|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417695|NCT02856893|Gefitinib|gefitinib|mesh-list
25417696|NCT02856893|Osimertinib|osimertinib|mesh-list
25417697|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417698|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417700|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417701|NCT02856581|Varenicline|varenicline|mesh-list
25417702|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25417703|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25417704|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
25417705|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25417706|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417707|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417708|NCT02854436|Niraparib|niraparib|mesh-list
25417709|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25417710|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417711|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417712|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417713|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
25417714|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417715|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417717|NCT02853331|Sunitinib|sunitinib|mesh-list
25417718|NCT02853331|Axitinib|axitinib|mesh-list
25417719|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417720|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417721|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25417722|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25417723|NCT02853331|Growth Substances|growth substances|mesh-ancestor
25417724|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417725|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
25417726|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25417727|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417728|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417729|NCT02853305|Gemcitabine|gemcitabine|mesh-list
25417730|NCT02853305|Cisplatin|cisplatin|mesh-list
25417731|NCT02853305|Carboplatin|carboplatin|mesh-list
25417732|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
25417733|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417734|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417735|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
25417736|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417737|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
25417738|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417739|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417740|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417741|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
25417742|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417743|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417744|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
25417745|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25417746|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25417747|NCT02852005|Vaccines|vaccines|mesh-list
25417748|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
25417749|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417750|NCT02849899|Vildagliptin|vildagliptin|mesh-list
25417751|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25417752|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417753|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25417754|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
25417755|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417756|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417757|NCT02849639|Scopolamine|scopolamine|mesh-list
25417758|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25417759|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25417760|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
25417761|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
25417762|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417763|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417764|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25417765|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
25417766|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25417767|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
25417768|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25417769|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417770|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25417771|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
25417772|NCT02849496|Atezolizumab|atezolizumab|mesh-list
25417773|NCT02849496|Olaparib|olaparib|mesh-list
25417774|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25417775|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25417783|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417784|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
25417785|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417787|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25417788|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
25417789|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
25417790|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25417791|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417792|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
25417793|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25417794|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25417795|NCT02846623|Atezolizumab|atezolizumab|mesh-list
25417796|NCT02846623|Venetoclax|venetoclax|mesh-list
25417797|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
25417798|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25417799|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417800|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
25417801|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417802|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417803|NCT02846376|Nivolumab|nivolumab|mesh-list
25417804|NCT02846376|Ipilimumab|ipilimumab|mesh-list
25417805|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417806|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417807|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417808|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417809|NCT02844816|Atezolizumab|atezolizumab|mesh-list
25417810|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25417811|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417812|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
25417813|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417814|NCT02842749|Everolimus|everolimus|mesh-list
25417815|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417816|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417817|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
25417818|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417829|NCT02839707|Bevacizumab|bevacizumab|mesh-list
25417830|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25417831|NCT02839707|Doxorubicin|doxorubicin|mesh-list
25417832|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25417833|NCT02839707|Atezolizumab|atezolizumab|mesh-list
25417834|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
25417835|NCT02839707|Antibodies|antibodies|mesh-list
25417836|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
25417837|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25417838|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
25417839|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417840|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25417841|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25417842|NCT02839707|Growth Substances|growth substances|mesh-ancestor
25417843|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417844|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
25417845|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
25417846|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25417847|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25417848|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25417849|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417850|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417851|NCT02839642|Rivastigmine|rivastigmine|mesh-list
25417852|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25417853|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417854|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417862|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25417863|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417864|NCT02834975|Paclitaxel|paclitaxel|mesh-list
25417865|NCT02834975|Carboplatin|carboplatin|mesh-list
25417866|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
25417867|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417868|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417869|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417870|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417871|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417872|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417873|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417880|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
25417881|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
25417882|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25417883|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25417884|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417885|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417886|NCT02832570|Urological Agents|urological agents|mesh-ancestor
25417887|NCT02831764|Tenofovir|tenofovir|mesh-list
25417888|NCT02831764|Lamivudine|lamivudine|mesh-list
25417889|NCT02831764|Emtricitabine|emtricitabine|mesh-list
25417890|NCT02831764|Dolutegravir|dolutegravir|mesh-list
25417891|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
25417892|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417893|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25417894|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417895|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417896|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417897|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25417898|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25417899|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25417900|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25417901|NCT02831673|Tenofovir|tenofovir|mesh-list
25417902|NCT02831673|Lamivudine|lamivudine|mesh-list
25417903|NCT02831673|Emtricitabine|emtricitabine|mesh-list
25417904|NCT02831673|Dolutegravir|dolutegravir|mesh-list
25417905|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
25417906|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417907|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25417908|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25417909|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417910|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417911|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25417912|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25417913|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25417914|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25417915|NCT02830724|Aldesleukin|aldesleukin|mesh-list
25417916|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
25417917|NCT02830724|Fludarabine|fludarabine|mesh-list
25417918|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417919|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
25417920|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417921|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25417922|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25417923|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
25417924|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417925|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417926|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25417927|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25417928|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25417929|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
25417930|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417931|NCT02829931|Bevacizumab|bevacizumab|mesh-list
25417932|NCT02829931|Nivolumab|nivolumab|mesh-list
25417934|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25389812|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25389815|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417935|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417936|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25417937|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25417938|NCT02829931|Growth Substances|growth substances|mesh-ancestor
25417939|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417940|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
25417941|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417942|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417944|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25417945|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417946|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25418023|NCT02822378|Vitamins|vitamins|mesh-ancestor
25417947|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417948|NCT02829723|Spartalizumab|spartalizumab|mesh-list
25417949|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25417950|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417951|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417952|NCT02827201|Gemcitabine|gemcitabine|mesh-list
25417953|NCT02827201|Paclitaxel|paclitaxel|mesh-list
25417954|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25417955|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417956|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
25417957|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
25417958|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
25417959|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417960|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25417961|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
25417962|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
25417963|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25417964|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417965|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25417966|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
25417967|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417968|NCT02825160|Iloprost|iloprost|mesh-list
25417969|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25417970|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
25417971|NCT02824627|Oxytocin|oxytocin|mesh-list
25417972|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
25417973|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25417974|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417975|NCT02824276|Morphine|morphine|mesh-list
25417976|NCT02824276|Oxycodone|oxycodone|mesh-list
25417977|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25417978|NCT02824276|Narcotics|narcotics|mesh-ancestor
25417979|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25417980|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417981|NCT02824276|Analgesics|analgesics|mesh-ancestor
25417982|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
25417983|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417984|NCT02823665|Atropine|atropine|mesh-list
25417985|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25417986|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25417987|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25417988|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
25417989|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25417990|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417991|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25417992|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
25417993|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
25417994|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
25417995|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25417996|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25417997|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
25417998|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25417999|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418000|NCT02823353|Fenofibrate|fenofibrate|mesh-list
25418001|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25418002|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
25418003|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418004|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25389890|NCT04320914|Analgesics|analgesics|mesh-ancestor
25418005|NCT02823145|Fenfluramine|fenfluramine|mesh-list
25418006|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25418007|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25418008|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25418009|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418010|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418011|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
25418012|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418013|NCT02822573|Donepezil|donepezil|mesh-list
25418014|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25418015|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418016|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418017|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
25418018|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418019|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418020|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
25418021|NCT02822378|Vitamin D|vitamin d|mesh-list
25418022|NCT02822378|Calcium|calcium|mesh-list
25418024|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
25418025|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418026|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25418027|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25418028|NCT02821832|Rifampin|rifampin|mesh-list
25418029|NCT02821832|Isoniazid|isoniazid|mesh-list
25418030|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
25418031|NCT02821832|Ethambutol|ethambutol|mesh-list
25418032|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25418033|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
25418034|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25418035|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418036|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
25418037|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25418038|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418039|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418040|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25418041|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25418042|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25418043|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25418044|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25418045|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25418046|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25418047|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25418048|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
25418049|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25418050|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
25418051|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418052|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418053|NCT02819596|Durvalumab|durvalumab|mesh-list
25418054|NCT02819596|Tremelimumab|tremelimumab|mesh-list
25418055|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418056|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418057|NCT02818894|Lidocaine|lidocaine|mesh-list
25418058|NCT02818894|Bupivacaine|bupivacaine|mesh-list
25418059|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
25418060|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
25418061|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25418062|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418063|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
25418064|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418065|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25418066|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25418067|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25418068|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25418069|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418070|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
25418071|NCT02816021|Azacitidine|azacitidine|mesh-list
25418072|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418073|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418074|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418075|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
25418076|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418077|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418078|NCT02815540|Cannabidiol|cannabidiol|mesh-list
25418079|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
25418080|NCT02813785|Docetaxel|docetaxel|mesh-list
25418081|NCT02813785|Atezolizumab|atezolizumab|mesh-list
25418082|NCT02813785|Antibodies|antibodies|mesh-list
25418083|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
25418084|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418085|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418086|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418087|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418088|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418089|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418100|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418101|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418102|NCT02811510|Hormones|hormones|mesh-ancestor
25418103|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418104|NCT02811133|Inositol|inositol|mesh-list
25418105|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
25418106|NCT02811133|Vitamins|vitamins|mesh-ancestor
25418107|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
25418108|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418109|NCT02809690|Clevudine|clevudine|mesh-list
25418110|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
25418111|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418112|NCT02808871|Pirfenidone|pirfenidone|mesh-list
25418113|NCT02808871|Analgesics|analgesics|mesh-ancestor
25418114|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
25418115|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418116|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418117|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25418118|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25418119|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25418120|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418121|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418122|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
25418123|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418124|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
25418125|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
25418126|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
25418127|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25418128|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418139|NCT02798536|Paclitaxel|paclitaxel|mesh-list
25418140|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25418141|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418142|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418143|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418144|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418145|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418146|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
25418147|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25418148|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25418149|NCT02798523|Prednisolone|prednisolone|mesh-list
25418150|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
25418151|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
25418152|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25418153|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
25418154|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25418155|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
25418156|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
25418157|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418158|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418159|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418160|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
25418161|NCT02798523|Hormones|hormones|mesh-ancestor
25418162|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418163|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25418164|NCT02798523|Protective Agents|protective agents|mesh-ancestor
25418165|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418166|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418168|NCT02797470|Etoposide|etoposide|mesh-list
25418169|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
25418170|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
25418171|NCT02797470|Melphalan|melphalan|mesh-list
25418172|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
25418173|NCT02797470|Carmustine|carmustine|mesh-list
25418174|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25418175|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25418176|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418177|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25418178|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25418179|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418180|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418181|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418210|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418211|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418213|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418214|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418215|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418216|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418245|NCT02794428|Eflornithine|eflornithine|mesh-list
25418246|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418247|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25418248|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25418249|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25418250|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418251|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25418252|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418253|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418255|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
25418256|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418257|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25418258|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25418259|NCT02792257|Analgesics|analgesics|mesh-ancestor
25418260|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
25418261|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418262|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25418263|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25418264|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418265|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418266|NCT02792257|Hormones|hormones|mesh-ancestor
25418267|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418268|NCT02792088|Tenofovir|tenofovir|mesh-list
25418269|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
25418270|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418271|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25418272|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25418273|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418274|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418275|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25418276|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25418277|NCT02790710|Propranolol|propranolol|mesh-list
25418278|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25418279|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25418280|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
25418281|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418282|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418283|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418284|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25418285|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25418286|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
25418287|NCT02789878|Prednisone|prednisone|mesh-list
25418288|NCT02789878|Goserelin|goserelin|mesh-list
25418289|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25418290|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
25418291|NCT02789878|Hormones|hormones|mesh-ancestor
25418292|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418293|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418294|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418295|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418296|NCT02788708|Paclitaxel|paclitaxel|mesh-list
25418297|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25418298|NCT02788708|Lenvatinib|lenvatinib|mesh-list
25418299|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25418300|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418301|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418302|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418303|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418304|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418305|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418306|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418307|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
25418308|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418309|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418310|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25418311|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25418312|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25418313|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25418314|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418315|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
25418316|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418317|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418318|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25418319|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418320|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418321|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418323|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
25418324|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25418325|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25418326|NCT02784210|Prednisolone|prednisolone|mesh-list
25418327|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
25418328|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25418329|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
25418330|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25418331|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
25418332|NCT02784210|Hormones|hormones|mesh-ancestor
25418333|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418482|NCT02773030|Dexamethasone|dexamethasone|mesh-list
25418334|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418335|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418336|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418337|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
25418338|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
25418339|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418340|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418341|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25418342|NCT02784210|Protective Agents|protective agents|mesh-ancestor
25418344|NCT02783625|Romidepsin|romidepsin|mesh-list
25418345|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418346|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25418347|NCT02782663|Upadacitinib|upadacitinib|mesh-list
25418348|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25418349|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418350|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418351|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418352|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418353|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
25418354|NCT02782546|Tacrolimus|tacrolimus|mesh-list
25418355|NCT02782546|Lenograstim|lenograstim|mesh-list
25418356|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418357|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
25418358|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418359|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25418360|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418361|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418362|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25418363|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418364|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25418365|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
25418366|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25418367|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418368|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25418369|NCT02782104|Esketamine|esketamine|mesh-list
25418370|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
25418371|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25418372|NCT02781883|Decitabine|decitabine|mesh-list
25418373|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418374|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
25418375|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418376|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418377|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418378|NCT02781792|Temozolomide|temozolomide|mesh-list
25418379|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418380|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
25418381|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418382|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418383|NCT02781506|Nivolumab|nivolumab|mesh-list
25418384|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418385|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418386|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25418387|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418388|NCT02780128|Ceritinib|ceritinib|mesh-list
25418389|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418390|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418391|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418392|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418394|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25418395|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418396|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
25418397|NCT02779751|Anastrozole|anastrozole|mesh-list
25418398|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418399|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418701|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
25418400|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418401|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25418402|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25418403|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418404|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418405|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25418406|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
25418407|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418442|NCT02775903|Azacitidine|azacitidine|mesh-list
25418443|NCT02775903|Durvalumab|durvalumab|mesh-list
25418444|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418445|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
25418446|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418447|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418448|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418449|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418450|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
25418451|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418452|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418453|NCT02775695|Doxycycline|doxycycline|mesh-list
25418454|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25418455|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418456|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
25418457|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25418458|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25418459|NCT02775435|Paclitaxel|paclitaxel|mesh-list
25418460|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25418461|NCT02775435|Carboplatin|carboplatin|mesh-list
25418462|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
25418463|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25418464|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418465|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418466|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418467|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418468|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418469|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418470|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
25418471|NCT02773732|Etoposide|etoposide|mesh-list
25418472|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25418473|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418474|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25418475|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25418476|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418477|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418478|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25418479|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418480|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25418481|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25418485|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25418487|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
25418488|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418489|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418490|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418491|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
25418492|NCT02773030|Hormones|hormones|mesh-ancestor
25418493|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418494|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418495|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418496|NCT02772081|Poractant alfa|poractant alfa|mesh-list
25418497|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25418498|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
25418499|NCT02772003|Interleukin-12|interleukin-12|mesh-list
25418500|NCT02772003|Vaccines|vaccines|mesh-list
25418501|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
25418502|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418503|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25418504|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25418505|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25418506|NCT02772003|Growth Substances|growth substances|mesh-ancestor
25418507|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
25418508|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418509|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
25418510|NCT02771197|Fludarabine|fludarabine|mesh-list
25418511|NCT02771197|Melphalan|melphalan|mesh-list
25418512|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418513|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418514|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418515|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418516|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
25418517|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418518|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418519|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
25418520|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25418521|NCT02770716|Terlipressin|terlipressin|mesh-list
25418522|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25418523|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25418524|NCT02769962|Olaparib|olaparib|mesh-list
25418525|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25418526|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418527|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418528|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418529|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
25418530|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418531|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
25418532|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418533|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418534|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25418535|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
25418536|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418537|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418538|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
25418539|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418540|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418541|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
25418542|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
25418543|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418544|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
25418545|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418546|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418547|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418548|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
25418549|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418550|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418551|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25418552|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418554|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25418555|NCT02766478|Protective Agents|protective agents|mesh-ancestor
25418556|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418557|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418558|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418559|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418560|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418561|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
25418562|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25418563|NCT02766478|Estrogens|estrogens|mesh-ancestor
25418564|NCT02766478|Hormones|hormones|mesh-ancestor
25418565|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418566|NCT02766465|Sirolimus|sirolimus|mesh-list
25418567|NCT02766465|Methotrexate|methotrexate|mesh-list
25418568|NCT02766465|Fludarabine|fludarabine|mesh-list
25418569|NCT02766465|Melphalan|melphalan|mesh-list
25418570|NCT02766465|Busulfan|busulfan|mesh-list
25418571|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
25418572|NCT02766465|Tacrolimus|tacrolimus|mesh-list
25418573|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25418574|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
25418575|NCT02766465|Lenograstim|lenograstim|mesh-list
25418576|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25418577|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
25418578|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25418579|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418580|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418581|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
25418582|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418583|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418584|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
25418585|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418586|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25418587|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418588|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
25418589|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418590|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25418591|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25418592|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25418593|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418594|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25418595|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
25418596|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418597|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
25418598|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25418599|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25418600|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418601|NCT02763566|Letrozole|letrozole|mesh-list
25418602|NCT02763566|Fulvestrant|fulvestrant|mesh-list
25418603|NCT02763566|Anastrozole|anastrozole|mesh-list
25418604|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418605|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25418606|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25418607|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418608|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418609|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25418610|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
25418611|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418612|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418613|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418614|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25418615|NCT02763319|Rituximab|rituximab|mesh-list
25418616|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25418617|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418618|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418619|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
25418620|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418621|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418622|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418623|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
25418624|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418625|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
25418626|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418627|NCT02761057|Sunitinib|sunitinib|mesh-list
25418628|NCT02761057|Crizotinib|crizotinib|mesh-list
25418629|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418630|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25418631|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25418632|NCT02761057|Growth Substances|growth substances|mesh-ancestor
25418633|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418634|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
25418635|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418637|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418638|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
25418639|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25418640|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
25418641|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418642|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418643|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25418644|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
25418645|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25418646|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
25418647|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418648|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418649|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25418650|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
25418651|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
25418652|NCT02760329|Protective Agents|protective agents|mesh-ancestor
25418653|NCT02759419|Riociguat|riociguat|mesh-list
25418654|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
25418655|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418656|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
25418657|NCT02757885|Thiotepa|thiotepa|mesh-list
25418658|NCT02757885|Fludarabine|fludarabine|mesh-list
25418659|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
25418660|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
25418661|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25418662|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
25418663|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418664|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
25418665|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418666|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418667|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418668|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
25418669|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418670|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418671|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25418672|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418673|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
25418674|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
25418675|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418676|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25418677|NCT02757859|Pancrelipase|pancrelipase|mesh-list
25418678|NCT02757859|Pancreatin|pancreatin|mesh-list
25418679|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418680|NCT02756962|Cytarabine|cytarabine|mesh-list
25418681|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418682|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
25418683|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418684|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418685|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
25418686|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418687|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418688|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
25418766|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418689|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418691|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418692|NCT02755597|Dexamethasone|dexamethasone|mesh-list
25418693|NCT02755597|Bortezomib|bortezomib|mesh-list
25418694|NCT02755597|Venetoclax|venetoclax|mesh-list
25418695|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25418696|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
25418697|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
25418698|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418699|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418700|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418702|NCT02755597|Hormones|hormones|mesh-ancestor
25418703|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418704|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418705|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418706|NCT02754856|Durvalumab|durvalumab|mesh-list
25418707|NCT02754856|Ipilimumab|ipilimumab|mesh-list
25418708|NCT02754856|Tremelimumab|tremelimumab|mesh-list
25418709|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
25418710|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25418711|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
25418712|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418713|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418714|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
25418715|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418716|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25418717|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418718|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25418719|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25418720|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418721|NCT02753686|Tamoxifen|tamoxifen|mesh-list
25418722|NCT02753686|Everolimus|everolimus|mesh-list
25418723|NCT02753686|Letrozole|letrozole|mesh-list
25418724|NCT02753686|Fulvestrant|fulvestrant|mesh-list
25418725|NCT02753686|Anastrozole|anastrozole|mesh-list
25418726|NCT02753686|Exemestane|exemestane|mesh-list
25418727|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418728|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418729|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
25418730|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418731|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25418732|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25418733|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418734|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418735|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25418736|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
25418737|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418738|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418739|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25418740|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25418741|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25418742|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25418743|NCT02753283|Vitamin D|vitamin d|mesh-list
25418744|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
25418745|NCT02753283|Denosumab|denosumab|mesh-list
25418746|NCT02753283|Calcium|calcium|mesh-list
25418747|NCT02753283|Vitamins|vitamins|mesh-ancestor
25418748|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
25418749|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418750|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25418751|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25418752|NCT02752685|Paclitaxel|paclitaxel|mesh-list
25418753|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
25418754|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25418755|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418756|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418757|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418758|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418759|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418760|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418761|NCT02752035|Azacitidine|azacitidine|mesh-list
25418762|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418763|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
25418764|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418765|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418768|NCT02749526|Tegafur|tegafur|mesh-list
25418769|NCT02749526|Endostar protein|endostar protein|mesh-list
25418770|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418771|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418772|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
25418773|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418774|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25418775|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25418776|NCT02749526|Growth Substances|growth substances|mesh-ancestor
25418853|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25418777|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418778|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
25418779|NCT02748369|Glucagon|glucagon|mesh-list
25418780|NCT02748369|Hormones|hormones|mesh-list
25418781|NCT02748369|Somatostatin|somatostatin|mesh-list
25418782|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418783|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418784|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418785|NCT02747043|Rituximab|rituximab|mesh-list
25418786|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418787|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418788|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
25418789|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418790|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418796|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418797|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418798|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418799|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418800|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25418801|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25418802|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25418803|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418804|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25418805|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25418806|NCT02744612|Antibodies|antibodies|mesh-list
25418807|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
25418808|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25418809|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
25418810|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
25418811|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418812|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418813|NCT02743806|Vedolizumab|vedolizumab|mesh-list
25418814|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25418815|NCT02743598|Liraglutide|liraglutide|mesh-list
25418816|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25418817|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418818|NCT02743598|Incretins|incretins|mesh-ancestor
25418819|NCT02743598|Hormones|hormones|mesh-ancestor
25418820|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418821|NCT02743494|Nivolumab|nivolumab|mesh-list
25418822|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418823|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418824|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25418825|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418826|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
25418827|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
25418828|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25418829|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
25418830|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418831|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
25418832|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418833|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418834|NCT02741570|Cisplatin|cisplatin|mesh-list
25418835|NCT02741570|Carboplatin|carboplatin|mesh-list
25418836|NCT02741570|Fluorouracil|fluorouracil|mesh-list
25418837|NCT02741570|Nivolumab|nivolumab|mesh-list
25418838|NCT02741570|Cetuximab|cetuximab|mesh-list
25418839|NCT02741570|Ipilimumab|ipilimumab|mesh-list
25418840|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418841|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
25418842|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418843|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418844|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418845|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
25418846|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418847|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418848|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25418849|NCT02741323|Maraviroc|maraviroc|mesh-list
25418850|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25418851|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25418852|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418854|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25418855|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
25418856|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418857|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25418858|NCT02740985|Docetaxel|docetaxel|mesh-list
25418859|NCT02740985|Durvalumab|durvalumab|mesh-list
25418860|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
25418861|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418862|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418863|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418864|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418865|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418866|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418867|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25418868|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418869|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
25418870|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418871|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418872|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25418873|NCT02740595|Nicotine|nicotine|mesh-list
25418874|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25418875|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
25418876|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418877|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418878|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25418879|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25418880|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
25418881|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418882|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418883|NCT02738866|Fulvestrant|fulvestrant|mesh-list
25418884|NCT02738866|Palbociclib|palbociclib|mesh-list
25418885|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25418886|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418887|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25418888|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25418889|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
25418890|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25418891|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418892|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25418893|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418894|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418895|NCT02737787|Nivolumab|nivolumab|mesh-list
25418896|NCT02737787|Vaccines|vaccines|mesh-list
25418897|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
25418898|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418899|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418900|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418901|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25418902|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418903|NCT02735122|Acetaminophen|acetaminophen|mesh-list
25418904|NCT02735122|Ibuprofen|ibuprofen|mesh-list
25418905|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25418906|NCT02735122|Analgesics|analgesics|mesh-ancestor
25418907|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
25418908|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418909|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418910|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
25418911|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25418912|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25418913|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25418914|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25418915|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418916|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418917|NCT02734004|Bevacizumab|bevacizumab|mesh-list
25418918|NCT02734004|Durvalumab|durvalumab|mesh-list
25418919|NCT02734004|Olaparib|olaparib|mesh-list
25418920|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418921|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418922|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25418923|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25418924|NCT02734004|Growth Substances|growth substances|mesh-ancestor
25418925|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418926|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
25418927|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25418928|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418929|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418930|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
25418931|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25418932|NCT02730715|Basiliximab|basiliximab|mesh-list
25418933|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
25418934|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418935|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418936|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
25418937|NCT02730546|Leucovorin|leucovorin|mesh-list
25418938|NCT02730546|Folic Acid|folic acid|mesh-list
25418939|NCT02730546|Paclitaxel|paclitaxel|mesh-list
25418940|NCT02730546|Carboplatin|carboplatin|mesh-list
25418941|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
25418942|NCT02730546|Fluorouracil|fluorouracil|mesh-list
25418943|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
25418944|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25418945|NCT02730546|Calcium|calcium|mesh-list
25418946|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
25418947|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25418948|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418949|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418950|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418951|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418952|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418953|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25418954|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418955|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25418956|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418957|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
25418958|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25418959|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418960|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
25418961|NCT02730546|Antidotes|antidotes|mesh-ancestor
25418962|NCT02730546|Protective Agents|protective agents|mesh-ancestor
25418963|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
25418964|NCT02730546|Vitamins|vitamins|mesh-ancestor
25418965|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
25418966|NCT02730546|Hematinics|hematinics|mesh-ancestor
25418967|NCT02729025|Evolocumab|evolocumab|mesh-list
25418968|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25418969|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25418970|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
25418971|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418972|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25418973|NCT02728102|Lenalidomide|lenalidomide|mesh-list
25418974|NCT02728102|Melphalan|melphalan|mesh-list
25418975|NCT02728102|Molgramostim|molgramostim|mesh-list
25418976|NCT02728102|Vaccines|vaccines|mesh-list
25418977|NCT02728102|Sargramostim|sargramostim|mesh-list
25418978|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
25418979|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418980|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25418981|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25418982|NCT02728102|Growth Substances|growth substances|mesh-ancestor
25418983|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
25418984|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418985|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418986|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
25418987|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418988|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25418989|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418990|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
25418991|NCT02727387|Temozolomide|temozolomide|mesh-list
25418992|NCT02727387|Melphalan|melphalan|mesh-list
25418993|NCT02727387|Busulfan|busulfan|mesh-list
25418994|NCT02727387|Ifosfamide|ifosfamide|mesh-list
25418995|NCT02727387|Irinotecan|irinotecan|mesh-list
25418996|NCT02727387|Etoposide|etoposide|mesh-list
25418997|NCT02727387|Vincristine|vincristine|mesh-list
25418998|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418999|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
25419000|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419001|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419002|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25419003|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
25419004|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419005|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419006|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25419007|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25419008|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25419009|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419010|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419011|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25419012|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419013|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419014|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419015|NCT02726711|Trimethaphan|trimethaphan|mesh-list
25419016|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
25419017|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25419018|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25419019|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25419020|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
25419021|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419022|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419023|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25419024|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25419025|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
25419026|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419027|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419028|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
25419029|NCT02725567|Ivacaftor|ivacaftor|mesh-list
25419030|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25419031|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25419032|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419033|NCT02725424|Docetaxel|docetaxel|mesh-list
25419034|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
25419035|NCT02725424|Trastuzumab|trastuzumab|mesh-list
25419036|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419037|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419038|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419039|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419040|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419041|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419042|NCT02725060|Phenylephrine|phenylephrine|mesh-list
25419043|NCT02725060|Isoproterenol|isoproterenol|mesh-list
25419044|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
25419045|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25419046|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
25419047|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
25419048|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419049|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419050|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
25419051|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25419052|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
25419053|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
25419054|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25419055|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25419056|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25419057|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
25419058|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419059|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419060|NCT02725060|Protective Agents|protective agents|mesh-ancestor
25419061|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25419062|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25419063|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25419064|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
25419065|NCT02724579|Lomustine|lomustine|mesh-list
25419066|NCT02724579|Cisplatin|cisplatin|mesh-list
25419067|NCT02724579|Vincristine|vincristine|mesh-list
25419068|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419069|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
25419070|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419071|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419072|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25419073|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
25419074|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419075|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419076|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25419077|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419078|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419079|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419080|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419081|NCT02723994|Leucovorin|leucovorin|mesh-list
25419082|NCT02723994|Cytarabine|cytarabine|mesh-list
25419083|NCT02723994|Dexamethasone|dexamethasone|mesh-list
25419084|NCT02723994|Prednisone|prednisone|mesh-list
25419085|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
25419086|NCT02723994|Doxorubicin|doxorubicin|mesh-list
25419087|NCT02723994|Methotrexate|methotrexate|mesh-list
25419088|NCT02723994|Vincristine|vincristine|mesh-list
25419089|NCT02723994|Asparaginase|asparaginase|mesh-list
25419090|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
25419091|NCT02723994|Pegaspargase|pegaspargase|mesh-list
25419092|NCT02723994|Thioguanine|thioguanine|mesh-list
25419093|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
25419094|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419095|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
25419096|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419097|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419098|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25419099|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
25419100|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419101|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419102|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25419103|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419106|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419107|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25419108|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
25419109|NCT02723994|Hormones|hormones|mesh-ancestor
25419110|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419111|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419112|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25419113|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25419114|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25419115|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419116|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25419117|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
25419118|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25419119|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419120|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
25419121|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
25419122|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25419123|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25419124|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
25419125|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419126|NCT02723994|Antidotes|antidotes|mesh-ancestor
25419127|NCT02723994|Protective Agents|protective agents|mesh-ancestor
25419128|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
25419129|NCT02723994|Vitamins|vitamins|mesh-ancestor
25419130|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
25419131|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419132|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419133|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419134|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419135|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
25419136|NCT02723162|Varenicline|varenicline|mesh-list
25419137|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25419138|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25419139|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25419140|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
25419141|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419142|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419143|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419144|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
25419145|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419146|NCT02723162|Expectorants|expectorants|mesh-ancestor
25419147|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
25419148|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25419149|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
25419150|NCT02723162|Protective Agents|protective agents|mesh-ancestor
25419151|NCT02723162|Antidotes|antidotes|mesh-ancestor
25419153|NCT02721537|Niacin|niacin|mesh-list
25419154|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
25419155|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
25419156|NCT02721537|Vitamins|vitamins|mesh-ancestor
25419157|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
25419158|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419159|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25419160|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
25419161|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419162|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25419163|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
25419165|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25419166|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
25419167|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419168|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419169|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25419170|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25419171|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
25419172|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419173|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419174|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25419175|NCT02720094|Cabotegravir|cabotegravir|mesh-list
25419176|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25419177|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25419178|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419179|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419180|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
25419181|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419182|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25419183|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25419184|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25419185|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25419187|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
25419188|NCT02720068|Fluorouracil|fluorouracil|mesh-list
25419189|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
25419190|NCT02720068|Irinotecan|irinotecan|mesh-list
25419191|NCT02720068|Lenvatinib|lenvatinib|mesh-list
25419192|NCT02720068|Calcium|calcium|mesh-list
25419193|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
25419194|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25419195|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419196|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419197|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419198|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
25419199|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419200|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419201|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419202|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
25419203|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25419204|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25419205|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419206|NCT02720068|Antidotes|antidotes|mesh-ancestor
25419207|NCT02720068|Protective Agents|protective agents|mesh-ancestor
25419208|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
25419209|NCT02720068|Vitamins|vitamins|mesh-ancestor
25419210|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
25419211|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419212|NCT02719613|Dexamethasone|dexamethasone|mesh-list
25419213|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
25419214|NCT02719613|Nivolumab|nivolumab|mesh-list
25419215|NCT02719613|Lenalidomide|lenalidomide|mesh-list
25419216|NCT02719613|Bortezomib|bortezomib|mesh-list
25419217|NCT02719613|Pomalidomide|pomalidomide|mesh-list
25419218|NCT02719613|Elotuzumab|elotuzumab|mesh-list
25419219|NCT02719613|BB 1101|bb 1101|mesh-list
25419220|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419221|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
25419222|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
25419223|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419224|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419225|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25419226|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
25419227|NCT02719613|Hormones|hormones|mesh-ancestor
25419228|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419229|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419230|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419231|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
25419232|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419233|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419234|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419235|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25419236|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
25419237|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25419238|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25419239|NCT02719613|Growth Substances|growth substances|mesh-ancestor
25419240|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
25419241|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25419242|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25419243|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25419244|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25419245|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419246|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
25419247|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419248|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419249|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25419250|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419251|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
25419252|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25419253|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
25419254|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419255|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419256|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
25419257|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419258|NCT02717507|Carvedilol|carvedilol|mesh-list
25419259|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25419260|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25419262|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419263|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419264|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419265|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25419266|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
25419267|NCT02717507|Protective Agents|protective agents|mesh-ancestor
25419268|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25419269|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25419270|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25419271|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
25419272|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25419273|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25419274|NCT02717455|Panobinostat|panobinostat|mesh-list
25419275|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419276|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25419277|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419278|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419279|NCT02716974|Docetaxel|docetaxel|mesh-list
25419280|NCT02716974|Leuprolide|leuprolide|mesh-list
25419281|NCT02716974|Bicalutamide|bicalutamide|mesh-list
25419282|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419283|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419284|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419285|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419286|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419287|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25419288|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
25419289|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25419290|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419291|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419292|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
25419293|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
25419294|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419295|NCT02716311|Cetuximab|cetuximab|mesh-list
25419296|NCT02716311|Afatinib|afatinib|mesh-list
25419297|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419298|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419299|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419300|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419301|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419302|NCT02714439|Proflavine|proflavine|mesh-list
25419303|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25419304|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419305|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
25419306|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
25419307|NCT02714062|Topiramate|topiramate|mesh-list
25419308|NCT02714062|Phentermine|phentermine|mesh-list
25419309|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
25419310|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25419311|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419312|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25419313|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
25419314|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25419315|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
25419316|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
25419317|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419318|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25419319|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419320|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419321|NCT02713997|Etanercept|etanercept|mesh-list
25419322|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25419323|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
25419324|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25419325|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25419326|NCT02713997|Analgesics|analgesics|mesh-ancestor
25419327|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
25419328|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419329|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419330|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419331|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419332|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25419333|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419334|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
25419335|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25419336|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25419339|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419340|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25419341|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
25419342|NCT02713373|Cetuximab|cetuximab|mesh-list
25419343|NCT02713373|Antibodies|antibodies|mesh-list
25419344|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
25419345|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25391115|NCT04265534|Pemetrexed|pemetrexed|mesh-list
25419346|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
25419347|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419348|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419349|NCT02712801|Ritonavir|ritonavir|mesh-list
25419350|NCT02712801|Lopinavir|lopinavir|mesh-list
25419351|NCT02712801|Lamivudine|lamivudine|mesh-list
25419352|NCT02712801|Zidovudine|zidovudine|mesh-list
25419353|NCT02712801|Nevirapine|nevirapine|mesh-list
25419354|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25419355|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25419356|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
25419357|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419358|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419359|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25419360|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25419361|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
25419362|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419363|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25419364|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25419365|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25419366|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25419367|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
25419368|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25419369|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25419370|NCT02712723|Letrozole|letrozole|mesh-list
25419371|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419372|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25419373|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25419374|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419375|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419376|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25419377|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
25419378|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419379|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419380|NCT02709655|Vortioxetine|vortioxetine|mesh-list
25419381|NCT02709655|Fluoxetine|fluoxetine|mesh-list
25419382|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25419383|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25419384|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25419385|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419386|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419387|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
25419388|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419389|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25419390|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
25419391|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25419392|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25419393|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25419394|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419395|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25419396|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25419397|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25419398|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25419399|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25419400|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25419401|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25419402|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25419403|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
25419404|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419405|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
25419406|NCT02707588|Cetuximab|cetuximab|mesh-list
25419407|NCT02707588|Antibodies|antibodies|mesh-list
25419408|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
25419409|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
25419410|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419411|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419412|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419415|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25419416|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419417|NCT02706951|Methotrexate|methotrexate|mesh-list
25419418|NCT02706951|Upadacitinib|upadacitinib|mesh-list
25419419|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25419420|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
25419421|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25419422|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419423|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419424|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
25419425|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419426|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419427|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
25419428|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419429|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25419430|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419431|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
25419432|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419433|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25419434|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25419435|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419436|NCT02706678|Tacrolimus|tacrolimus|mesh-list
25419437|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419438|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
25419439|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419440|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25419441|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419442|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419443|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
25419444|NCT02706405|Fludarabine|fludarabine|mesh-list
25419445|NCT02706405|Durvalumab|durvalumab|mesh-list
25419446|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
25419447|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25419448|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
25419449|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419450|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
25419451|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419452|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419453|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25419454|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
25419455|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419456|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419457|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25419458|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419459|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
25419460|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419461|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419462|NCT02705300|Leucovorin|leucovorin|mesh-list
25419463|NCT02705300|Tocotrienols|tocotrienols|mesh-list
25419464|NCT02705300|Vitamin E|vitamin e|mesh-list
25419465|NCT02705300|Tocopherols|tocopherols|mesh-list
25419466|NCT02705300|Fluorouracil|fluorouracil|mesh-list
25419467|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
25419468|NCT02705300|Irinotecan|irinotecan|mesh-list
25419469|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
25419470|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419471|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
25419472|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419473|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419474|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419475|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419476|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
25419477|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25419478|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25419479|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419480|NCT02705300|Antidotes|antidotes|mesh-ancestor
25419481|NCT02705300|Protective Agents|protective agents|mesh-ancestor
25419482|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
25419483|NCT02705300|Vitamins|vitamins|mesh-ancestor
25419484|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
25419485|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
25419486|NCT02705196|Gemcitabine|gemcitabine|mesh-list
25419487|NCT02705196|Paclitaxel|paclitaxel|mesh-list
25419488|NCT02705196|Atezolizumab|atezolizumab|mesh-list
25419489|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419490|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419491|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419492|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419494|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419495|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419496|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
25419497|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
25419498|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25391269|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
25391270|NCT04257682|Mepivacaine|mepivacaine|mesh-list
25419499|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419500|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419501|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
25419502|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419503|NCT02705105|Nivolumab|nivolumab|mesh-list
25419504|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
25419505|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419506|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419507|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25419508|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419509|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
25419510|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419511|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419512|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419513|NCT02703948|Lidocaine|lidocaine|mesh-list
25419514|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
25419515|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
25419516|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25419517|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419518|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
25419519|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419520|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25419521|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25419522|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25419523|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25419524|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419525|NCT02703610|Acetaminophen|acetaminophen|mesh-list
25419526|NCT02703610|Ibuprofen|ibuprofen|mesh-list
25419527|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25419528|NCT02703610|Oxycodone|oxycodone|mesh-list
25419529|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25419530|NCT02703610|Analgesics|analgesics|mesh-ancestor
25419531|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
25419532|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419533|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419534|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
25419535|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25419536|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419537|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419538|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25419539|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419540|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419541|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25419542|NCT02703610|Narcotics|narcotics|mesh-ancestor
25419543|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25419544|NCT02700048|Naloxone|naloxone|mesh-list
25419545|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25419546|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419547|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
25419548|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419549|NCT02697227|Nicotine|nicotine|mesh-list
25419550|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25419551|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
25419552|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419553|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419554|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25419555|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25419556|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
25419557|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419558|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419559|NCT02696096|Buprenorphine|buprenorphine|mesh-list
25419560|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25419561|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25419562|NCT02696096|Narcotics|narcotics|mesh-ancestor
25419563|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25419564|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419565|NCT02696096|Analgesics|analgesics|mesh-ancestor
25419566|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
25419567|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419585|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391349|NCT04252612|Pramlintide|pramlintide|mesh-list
25391350|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25391351|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391352|NCT04252586|Cannabidiol|cannabidiol|mesh-list
25391353|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
25391354|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
25391359|NCT04251910|Analgesics|analgesics|mesh-ancestor
25419586|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419587|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25419588|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419589|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
25419590|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419591|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25419592|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25419593|NCT02693535|Growth Substances|growth substances|mesh-ancestor
25419594|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
25419595|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419596|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419597|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25419598|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25419599|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25419600|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
25419602|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25419603|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419604|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419605|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419606|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419607|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419608|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419609|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
25419610|NCT02689284|Margetuximab|margetuximab|mesh-list
25419611|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25419612|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419613|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419614|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
25419615|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419616|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
25419617|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
25419618|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25419619|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
25419697|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25419620|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419621|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
25419622|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419623|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419624|NCT02688647|Belumosudil|belumosudil|mesh-list
25419625|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419626|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419627|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419628|NCT02688556|Cyclosporine|cyclosporine|mesh-list
25419629|NCT02688556|Cyclosporins|cyclosporins|mesh-list
25419630|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419631|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419632|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419633|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
25419634|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419635|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
25419636|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419637|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
25419638|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419639|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25419640|NCT02688140|Cytarabine|cytarabine|mesh-list
25419641|NCT02688140|Methotrexate|methotrexate|mesh-list
25419642|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
25419643|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
25419644|NCT02688140|Idarubicin|idarubicin|mesh-list
25419645|NCT02688140|Tretinoin|tretinoin|mesh-list
25419646|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
25419647|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25419648|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
25419649|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25419650|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419651|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419652|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
25419653|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419654|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419655|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
25419656|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419657|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25419658|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419661|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25419662|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
25419663|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419664|NCT02688140|Analgesics|analgesics|mesh-ancestor
25419665|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
25419666|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419667|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25419668|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25419669|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25419670|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
25419671|NCT02685826|Dexamethasone|dexamethasone|mesh-list
25419672|NCT02685826|Lenalidomide|lenalidomide|mesh-list
25419673|NCT02685826|Durvalumab|durvalumab|mesh-list
25419674|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419675|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
25419676|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
25419677|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419678|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419679|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25419680|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
25419681|NCT02685826|Hormones|hormones|mesh-ancestor
25419682|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419683|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419684|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419685|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
25419686|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25419687|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25419688|NCT02685826|Growth Substances|growth substances|mesh-ancestor
25419689|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
25419690|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419691|NCT02685735|Gabapentin|gabapentin|mesh-list
25419692|NCT02685735|Analgesics|analgesics|mesh-ancestor
25419693|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
25419694|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419695|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419696|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
25419698|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25419699|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25419700|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25419701|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25419702|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25419703|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419704|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419705|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
25419706|NCT02684578|Metformin|metformin|mesh-list
25419707|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25419708|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419709|NCT02684474|HBOC 201|hboc 201|mesh-list
25419710|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
25419711|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
25419712|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25419713|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419714|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419715|NCT02684058|Carboplatin|carboplatin|mesh-list
25419716|NCT02684058|Vincristine|vincristine|mesh-list
25419717|NCT02684058|Trametinib|trametinib|mesh-list
25419718|NCT02684058|Dabrafenib|dabrafenib|mesh-list
25419719|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419720|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419721|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419722|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419723|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419724|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419725|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419726|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419727|NCT02684032|Letrozole|letrozole|mesh-list
25419728|NCT02684032|Fulvestrant|fulvestrant|mesh-list
25419729|NCT02684032|Palbociclib|palbociclib|mesh-list
25419730|NCT02684032|Gedatolisib|gedatolisib|mesh-list
25419731|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419732|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25419733|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25419734|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419735|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419736|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25419737|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
25419738|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419739|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419740|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419741|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25419742|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419743|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
25419744|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
25419745|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25419746|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25419747|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419748|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419749|NCT02682147|Urological Agents|urological agents|mesh-ancestor
25419750|NCT02680314|Methotrexate|methotrexate|mesh-list
25419751|NCT02680314|Misoprostol|misoprostol|mesh-list
25419752|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25419753|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
25419754|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25419755|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419756|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419757|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
25419758|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419759|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419760|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
25419761|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419779|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419780|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25419781|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25419782|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419783|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419784|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419786|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419787|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
25419788|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419789|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419790|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419791|NCT02677038|Olaparib|olaparib|mesh-list
25419792|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25419793|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419794|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419795|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419796|NCT02675829|Trastuzumab|trastuzumab|mesh-list
25419797|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25419798|NCT02675829|Maytansine|maytansine|mesh-list
25419799|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419800|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419801|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419802|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419803|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419804|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419805|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419822|NCT02675231|Trastuzumab|trastuzumab|mesh-list
25419823|NCT02675231|Fulvestrant|fulvestrant|mesh-list
25419824|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419825|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419826|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419827|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25419828|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25419829|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
25419830|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419831|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419832|NCT02672917|Folfirinox|folfirinox|mesh-list
25419833|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419834|NCT02670707|Cytarabine|cytarabine|mesh-list
25419835|NCT02670707|Prednisone|prednisone|mesh-list
25419836|NCT02670707|Vinblastine|vinblastine|mesh-list
25419837|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419838|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
25419839|NCT02670707|Hormones|hormones|mesh-ancestor
25419840|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419841|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419842|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419843|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419844|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419846|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419847|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
25419848|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25419849|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419850|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
25419851|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419852|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419853|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419854|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419856|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25419857|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419858|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
25419859|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419860|NCT02668666|Tamoxifen|tamoxifen|mesh-list
25419861|NCT02668666|Palbociclib|palbociclib|mesh-list
25419862|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25419863|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
25419864|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419865|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419866|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419867|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419868|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25419869|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25419870|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25419871|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25419872|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419873|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419874|NCT02667587|Nivolumab|nivolumab|mesh-list
25419875|NCT02667587|Temozolomide|temozolomide|mesh-list
25419876|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419877|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419878|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25419879|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419880|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25419881|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
25419882|NCT02666742|Aspirin|aspirin|mesh-list
25419883|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
25419884|NCT02666742|Edoxaban|edoxaban|mesh-list
25419885|NCT02666742|Dabigatran|dabigatran|mesh-list
25419886|NCT02666742|Anticoagulants|anticoagulants|mesh-list
25419887|NCT02666742|Coagulants|coagulants|mesh-list
25419888|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25419889|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25419890|NCT02666742|Analgesics|analgesics|mesh-ancestor
25419891|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
25419892|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419893|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419894|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419895|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419896|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25419897|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25419898|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419899|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25419900|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25419901|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419902|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
25419903|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25419904|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
25419905|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25419906|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
25419907|NCT02664181|Nivolumab|nivolumab|mesh-list
25419908|NCT02664181|Decitabine|decitabine|mesh-list
25419909|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
25391679|NCT04240002|Cytarabine|cytarabine|mesh-list
25419910|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419911|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419912|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25419913|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419914|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25419915|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
25419916|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419917|NCT02663518|Rituximab|rituximab|mesh-list
25419918|NCT02663518|Nivolumab|nivolumab|mesh-list
25419919|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
25419920|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419921|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419923|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419924|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419925|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25419926|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419927|NCT02661932|Letrozole|letrozole|mesh-list
25419928|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419929|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25419930|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25419931|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419932|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419933|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25419934|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
25419935|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419936|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419937|NCT02661503|Dexamethasone|dexamethasone|mesh-list
25419938|NCT02661503|Prednisone|prednisone|mesh-list
25419939|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
25419940|NCT02661503|Dacarbazine|dacarbazine|mesh-list
25419941|NCT02661503|Doxorubicin|doxorubicin|mesh-list
25419942|NCT02661503|Etoposide|etoposide|mesh-list
25419943|NCT02661503|Vincristine|vincristine|mesh-list
25419944|NCT02661503|Bleomycin|bleomycin|mesh-list
25419945|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25419946|NCT02661503|Procarbazine|procarbazine|mesh-list
25419947|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419948|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
25419949|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419950|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419951|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25419952|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
25419953|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419954|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419955|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25419956|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25419957|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
25419958|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
25419959|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419960|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25419961|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
25419962|NCT02661503|Hormones|hormones|mesh-ancestor
25419963|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25419964|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25419965|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25419966|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25419967|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25419968|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419969|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25419970|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
25419971|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
25419972|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419973|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419974|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
25419975|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25419976|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25419977|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
25419978|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25419979|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25419980|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419981|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
25419982|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419983|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419984|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25419985|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419986|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
25419987|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
25419988|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
25419989|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25419990|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25419991|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
25419992|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25419993|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25419994|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419995|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
25419996|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419997|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25419999|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420000|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
25420001|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
25420002|NCT02659930|Doxorubicin|doxorubicin|mesh-list
25420003|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25420004|NCT02659930|Pomalidomide|pomalidomide|mesh-list
25420005|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420006|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420007|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25420008|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420009|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420010|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420011|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
25420012|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420013|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25420014|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25420015|NCT02659930|Growth Substances|growth substances|mesh-ancestor
25420016|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
25420017|NCT02659059|Paclitaxel|paclitaxel|mesh-list
25420018|NCT02659059|Cisplatin|cisplatin|mesh-list
25420019|NCT02659059|Carboplatin|carboplatin|mesh-list
25420020|NCT02659059|Nivolumab|nivolumab|mesh-list
25420021|NCT02659059|Pemetrexed|pemetrexed|mesh-list
25420022|NCT02659059|Ipilimumab|ipilimumab|mesh-list
25420023|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420024|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420025|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420026|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420027|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420028|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420029|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420030|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420031|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420032|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25420033|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25420034|NCT02658981|Nivolumab|nivolumab|mesh-list
25420035|NCT02658981|Antibodies|antibodies|mesh-list
25420036|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25420037|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
25420038|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420039|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420040|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420041|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420042|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420043|NCT02658890|Nivolumab|nivolumab|mesh-list
25420044|NCT02658890|Ipilimumab|ipilimumab|mesh-list
25420045|NCT02658890|Linrodostat|linrodostat|mesh-list
25420046|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420047|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420048|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420049|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420050|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420051|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
25420052|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420053|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420054|NCT02657343|Trastuzumab|trastuzumab|mesh-list
25420055|NCT02657343|Fulvestrant|fulvestrant|mesh-list
25420056|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420057|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420058|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25420059|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25420060|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25391824|NCT04230980|Gabapentin|gabapentin|mesh-list
25420061|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
25420062|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25420063|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420064|NCT02656017|Metformin|metformin|mesh-list
25420065|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25420066|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420067|NCT02655601|Manganese|manganese|mesh-list
25420068|NCT02655601|Temozolomide|temozolomide|mesh-list
25420069|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420070|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
25420146|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25420071|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420072|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420073|NCT02655601|Trace Elements|trace elements|mesh-ancestor
25420075|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420076|NCT02652455|Aldesleukin|aldesleukin|mesh-list
25420077|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
25420078|NCT02652455|Nivolumab|nivolumab|mesh-list
25420079|NCT02652455|Fludarabine|fludarabine|mesh-list
25420080|NCT02652455|Interleukin-2|interleukin-2|mesh-list
25420081|NCT02652455|Antibodies|antibodies|mesh-list
25420082|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
25420083|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
25420084|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420085|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
25420086|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420087|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420088|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420089|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
25420090|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420091|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420092|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25420093|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420094|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420095|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25420096|NCT02652455|Analgesics|analgesics|mesh-ancestor
25420097|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
25420098|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420099|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25420100|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25420101|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
25420102|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420103|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
25420104|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25420105|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
25420106|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420107|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420108|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25420109|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
25420110|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25420111|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
25420112|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420113|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25420114|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25420115|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
25420116|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
25420117|NCT02652429|Protective Agents|protective agents|mesh-ancestor
25420118|NCT02652260|Tenofovir|tenofovir|mesh-list
25420119|NCT02652260|Lamivudine|lamivudine|mesh-list
25420120|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25420121|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
25420122|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420123|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25420124|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25420125|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420126|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420127|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25420128|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25420129|NCT02652247|Dimercaprol|dimercaprol|mesh-list
25420130|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
25420131|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
25420132|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420133|NCT02651662|Cemiplimab|cemiplimab|mesh-list
25420134|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420135|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420136|NCT02650921|Lidocaine|lidocaine|mesh-list
25420137|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
25420138|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
25420139|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25420140|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420141|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
25420142|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420143|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25420144|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25420145|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25420147|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420148|NCT02650401|Entrectinib|entrectinib|mesh-list
25420149|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420150|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420151|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420152|NCT02649790|Dexamethasone|dexamethasone|mesh-list
25420153|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25420154|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
25420155|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
25420156|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420157|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420158|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25420159|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
25420160|NCT02649790|Hormones|hormones|mesh-ancestor
25420161|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25420162|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25420163|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420164|NCT02649764|Cytarabine|cytarabine|mesh-list
25420165|NCT02649764|Fludarabine|fludarabine|mesh-list
25420166|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
25420167|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420168|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420169|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
25420170|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420171|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420172|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
25420173|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420174|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
25420175|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420176|NCT02647385|Lidocaine|lidocaine|mesh-list
25420177|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
25420178|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
25420179|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25420180|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420181|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
25420182|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420183|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25420184|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25420185|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25420186|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25420187|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420188|NCT02644967|Ipilimumab|ipilimumab|mesh-list
25420189|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420190|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420191|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420192|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420193|NCT02642042|Docetaxel|docetaxel|mesh-list
25420194|NCT02642042|Trametinib|trametinib|mesh-list
25420195|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420196|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420197|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420198|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420199|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420200|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420201|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420202|NCT02639273|Nalmefene|nalmefene|mesh-list
25420203|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25420204|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420205|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
25420206|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420207|NCT02635555|Phenylephrine|phenylephrine|mesh-list
25420208|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
25420209|NCT02635555|Ephedrine|ephedrine|mesh-list
25420210|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25420211|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
25420212|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
25420213|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420214|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420215|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
25420216|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25420217|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
25420218|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
25420219|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25420220|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25420221|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25420222|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
25420223|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25420224|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420225|NCT02635555|Protective Agents|protective agents|mesh-ancestor
25420226|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25420227|NCT02635061|Nivolumab|nivolumab|mesh-list
25420228|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420229|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420230|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420231|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420232|NCT02634333|Aflibercept|aflibercept|mesh-list
25420233|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
25420234|NCT02634333|Mitogens|mitogens|mesh-list
25420235|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25420236|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25420237|NCT02634333|Growth Substances|growth substances|mesh-ancestor
25420238|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420239|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
25420240|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420241|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420242|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420243|NCT02634008|Ritonavir|ritonavir|mesh-list
25420244|NCT02634008|Ribavirin|ribavirin|mesh-list
25420245|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25420246|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25420247|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
25420248|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420249|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420250|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25420251|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25420252|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
25420253|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420254|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25420255|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25420256|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
25420257|NCT02632721|Decitabine|decitabine|mesh-list
25420258|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420259|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
25420260|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420261|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420262|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420263|NCT02632708|Cytarabine|cytarabine|mesh-list
25420264|NCT02632708|Etoposide|etoposide|mesh-list
25420265|NCT02632708|Daunorubicin|daunorubicin|mesh-list
25420266|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
25420267|NCT02632708|Idarubicin|idarubicin|mesh-list
25420268|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420269|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420270|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25420271|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420272|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420273|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420274|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420275|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
25420276|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
25420277|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420278|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420279|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
25420280|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420281|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420282|NCT02632708|Analgesics|analgesics|mesh-ancestor
25420283|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
25420284|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420285|NCT02631733|Irinotecan|irinotecan|mesh-list
25420286|NCT02631733|Veliparib|veliparib|mesh-list
25420287|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25420288|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25420289|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420290|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420291|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420292|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420293|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25420294|NCT02631733|Hematinics|hematinics|mesh-ancestor
25420295|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25420296|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25420297|NCT02630459|Erenumab|erenumab|mesh-list
25420298|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25420299|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25420300|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420302|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
25420303|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420304|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420305|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
25420306|NCT02630316|Treprostinil|treprostinil|mesh-list
25420307|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25420308|NCT02630069|Choline|choline|mesh-list
25420309|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25420310|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
25420311|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25420312|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
25420313|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420314|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25420315|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25420316|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
25420317|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
25420318|NCT02630043|Tolcapone|tolcapone|mesh-list
25420319|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420320|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25420321|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25420322|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25420323|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420324|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420325|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
25420326|NCT02629809|Fludarabine|fludarabine|mesh-list
25420327|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
25420328|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
25420329|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420330|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
25420331|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420332|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420333|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420334|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
25420335|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420336|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420337|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25420338|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420339|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
25420340|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420341|NCT02629419|Amphotericin B|amphotericin b|mesh-list
25420342|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25420343|NCT02629419|Amebicides|amebicides|mesh-ancestor
25420344|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25420345|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25420346|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420347|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25420348|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
25420349|NCT02629120|Sirolimus|sirolimus|mesh-list
25420350|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
25420351|NCT02629120|Busulfan|busulfan|mesh-list
25420352|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
25420353|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420354|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
25420355|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420356|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420357|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420358|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
25420359|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420360|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420361|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25420362|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25420363|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420364|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420365|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
25420366|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420367|NCT02628626|Clonidine|clonidine|mesh-list
25420368|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25420369|NCT02628626|Analgesics|analgesics|mesh-ancestor
25420370|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
25420371|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420372|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420373|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25420374|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
25420375|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
25420376|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25420377|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25420380|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25420381|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420382|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25420383|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25420384|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
25420385|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25420386|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
25420387|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25420388|NCT02627846|Lidocaine|lidocaine|mesh-list
25420389|NCT02627846|Epinephrine|epinephrine|mesh-list
25420390|NCT02627846|Racepinephrine|racepinephrine|mesh-list
25420391|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25420392|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
25420393|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
25420394|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
25420395|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
25420396|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25420397|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420398|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
25420399|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420400|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25420401|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25420402|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25420403|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25420404|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420405|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25420406|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25420407|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
25420408|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25420409|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25420410|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25420411|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
25420412|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25420413|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
25420414|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
25420415|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
25420416|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25420417|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25420418|NCT02627274|Trastuzumab|trastuzumab|mesh-list
25420419|NCT02627274|Cetuximab|cetuximab|mesh-list
25420420|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420421|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420422|NCT02626455|Prednisone|prednisone|mesh-list
25420423|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
25420424|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25420425|NCT02626455|Rituximab|rituximab|mesh-list
25420426|NCT02626455|Doxorubicin|doxorubicin|mesh-list
25420427|NCT02626455|Vincristine|vincristine|mesh-list
25420428|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420429|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
25420430|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420431|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420432|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420433|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
25420434|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420435|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420436|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25420437|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420438|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420439|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25420440|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420441|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420442|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25420443|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
25420444|NCT02626455|Hormones|hormones|mesh-ancestor
25420445|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25420446|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25420447|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420448|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420449|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420450|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420451|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
25420452|NCT02625480|Fludarabine|fludarabine|mesh-list
25420453|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420454|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
25420455|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420457|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420458|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
25420459|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420460|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420461|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25420462|NCT02624908|Canagliflozin|canagliflozin|mesh-list
25420463|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25420464|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420465|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25420466|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420467|NCT02624544|Desonide|desonide|mesh-list
25420468|NCT02624544|Esomeprazole|esomeprazole|mesh-list
25420469|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25420470|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25420471|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25420472|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420473|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420474|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25420475|NCT02622386|Riboflavin|riboflavin|mesh-list
25420476|NCT02622386|Vitamins|vitamins|mesh-ancestor
25420477|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
25420478|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420479|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
25420480|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25420481|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
25420482|NCT02621021|Aldesleukin|aldesleukin|mesh-list
25420483|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
25420484|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
25420485|NCT02621021|Fludarabine|fludarabine|mesh-list
25420486|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420487|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
25420488|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420489|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420490|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420491|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
25420492|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420493|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420494|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25420495|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420496|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25420497|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25420498|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
25420499|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420500|NCT02620761|Fenoldopam|fenoldopam|mesh-list
25420501|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25420502|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
25420503|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
25420504|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
25420505|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25420506|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420507|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420508|NCT02620280|Paclitaxel|paclitaxel|mesh-list
25420509|NCT02620280|Carboplatin|carboplatin|mesh-list
25420510|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25420511|NCT02620280|Atezolizumab|atezolizumab|mesh-list
25420512|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420513|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420514|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420515|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420516|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420517|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420518|NCT02620189|Adalimumab|adalimumab|mesh-list
25420519|NCT02620189|Etanercept|etanercept|mesh-list
25420520|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
25420521|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25420522|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420523|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25420524|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25420525|NCT02620189|Analgesics|analgesics|mesh-ancestor
25420526|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
25420527|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420528|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420529|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25420530|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420531|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
25420533|NCT02619682|Ixazomib|ixazomib|mesh-list
25420534|NCT02619682|Glycine|glycine|mesh-list
25420536|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420537|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25420538|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25420539|NCT02619682|Growth Substances|growth substances|mesh-ancestor
25420540|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
25420541|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420542|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420543|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
25420544|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420545|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
25420546|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25420547|NCT02617277|Durvalumab|durvalumab|mesh-list
25420548|NCT02617277|Adavosertib|adavosertib|mesh-list
25420549|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420550|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420551|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420552|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420553|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
25420554|NCT02616302|Lansoprazole|lansoprazole|mesh-list
25420555|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25420556|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25420557|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25420558|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420559|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420560|NCT02615691|Factor VIII|factor viii|mesh-list
25420561|NCT02615691|BAX 855|bax 855|mesh-list
25420562|NCT02615691|Coagulants|coagulants|mesh-ancestor
25420563|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
25420564|NCT02615184|Lansoprazole|lansoprazole|mesh-list
25420565|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25420566|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25420567|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25420568|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420569|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420570|NCT02614794|Capecitabine|capecitabine|mesh-list
25420571|NCT02614794|Trastuzumab|trastuzumab|mesh-list
25420572|NCT02614794|Tucatinib|tucatinib|mesh-list
25420573|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420574|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
25420575|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420576|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420577|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420578|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420579|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420580|NCT02614534|Mitomycins|mitomycins|mesh-list
25420581|NCT02614534|Mitomycin|mitomycin|mesh-list
25420582|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420583|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420584|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
25420585|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420586|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25420587|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420588|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
25420589|NCT02614066|Fludarabine|fludarabine|mesh-list
25420590|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420591|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
25420592|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420593|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420594|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420595|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
25420596|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420597|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420598|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25420599|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
25420600|NCT02612311|Chlorambucil|chlorambucil|mesh-list
25420601|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420602|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420603|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420604|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
25420605|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420607|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
25420608|NCT02611323|Venetoclax|venetoclax|mesh-list
25420609|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420610|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420611|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
25420836|NCT02594371|Paclitaxel|paclitaxel|mesh-list
25420612|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420613|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420614|NCT02611037|Gemcitabine|gemcitabine|mesh-list
25420615|NCT02611037|Cisplatin|cisplatin|mesh-list
25420616|NCT02611037|Methotrexate|methotrexate|mesh-list
25420617|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420618|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420619|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
25420620|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420621|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
25420622|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420623|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420624|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420625|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
25420626|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420627|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25420628|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
25420629|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25420630|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
25420631|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25420632|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420633|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25420634|NCT02610777|Azacitidine|azacitidine|mesh-list
25420635|NCT02610777|Pevonedistat|pevonedistat|mesh-list
25420636|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420637|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
25420638|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420639|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420640|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420641|NCT02609776|Carboplatin|carboplatin|mesh-list
25420642|NCT02609776|Pemetrexed|pemetrexed|mesh-list
25420643|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25420644|NCT02609776|Lazertinib|lazertinib|mesh-list
25420645|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25420646|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420647|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420648|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420649|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25420650|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25420651|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420652|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420653|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
25420654|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420655|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
25420656|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420657|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25420658|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420659|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420660|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
25420661|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25420662|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420663|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25420664|NCT02608268|Decitabine|decitabine|mesh-list
25420665|NCT02608268|Spartalizumab|spartalizumab|mesh-list
25420666|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420667|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
25420668|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420669|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420670|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420671|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420672|NCT02608216|Paclitaxel|paclitaxel|mesh-list
25420673|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420674|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420675|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420676|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420677|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420678|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420680|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420681|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420682|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420683|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420684|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
25420685|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25420686|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25420687|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420688|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
25420689|NCT02606045|Coagulants|coagulants|mesh-ancestor
25420690|NCT02604537|Ketorolac|ketorolac|mesh-list
25420691|NCT02604537|Betamethasone|betamethasone|mesh-list
25420692|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25420693|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25420694|NCT02604537|Analgesics|analgesics|mesh-ancestor
25420695|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
25420696|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420697|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420698|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25420699|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420700|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25420701|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420702|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420703|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
25420704|NCT02604537|Hormones|hormones|mesh-ancestor
25420705|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25420706|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25420707|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
25420708|NCT02603432|Avelumab|avelumab|mesh-list
25420709|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25420710|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420711|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420712|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
25420713|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420714|NCT02603328|Atorvastatin|atorvastatin|mesh-list
25420715|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25420716|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25420717|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
25420718|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420719|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25420720|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25420721|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420722|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
25420723|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
25420724|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25420725|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25420726|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420727|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420728|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420729|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420730|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
25420731|NCT02600949|Imiquimod|imiquimod|mesh-list
25420732|NCT02600949|Vaccines|vaccines|mesh-list
25420733|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420734|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420735|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25420736|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
25420737|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420738|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
25420739|NCT02599714|Fulvestrant|fulvestrant|mesh-list
25420740|NCT02599714|Palbociclib|palbociclib|mesh-list
25420741|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25420742|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420892|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
25392498|NCT04214678|Hormones|hormones|mesh-ancestor
25420743|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25420744|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25420745|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
25420746|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25420747|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420748|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420749|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420750|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420751|NCT02599454|Atezolizumab|atezolizumab|mesh-list
25420752|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420753|NCT02598726|Curcumin|curcumin|mesh-list
25420754|NCT02598726|Piperine|piperine|mesh-list
25420755|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25420756|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25420757|NCT02598726|Analgesics|analgesics|mesh-ancestor
25420758|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
25420759|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420760|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420761|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25420762|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420763|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420764|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420765|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420766|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25420767|NCT02598661|Imetelstat|imetelstat|mesh-list
25420768|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
25420769|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420770|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420771|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420772|NCT02596685|Nicotine|nicotine|mesh-list
25420773|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25420774|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
25420775|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25420776|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420777|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25420778|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25420779|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
25420780|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25420781|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420782|NCT02595944|Nivolumab|nivolumab|mesh-list
25420783|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420784|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420785|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420786|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420787|NCT02595931|Irinotecan|irinotecan|mesh-list
25420788|NCT02595931|Camptothecin|camptothecin|mesh-list
25420789|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25420790|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420791|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420792|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420793|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420794|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420795|NCT02595905|Cisplatin|cisplatin|mesh-list
25420796|NCT02595905|Veliparib|veliparib|mesh-list
25420797|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420798|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25420799|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420800|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420801|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
25420802|NCT02595879|Cisplatin|cisplatin|mesh-list
25420803|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25420804|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420805|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25420806|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420807|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
25420808|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
25420809|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420810|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
25420811|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420812|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420813|NCT02595424|Cisplatin|cisplatin|mesh-list
25420814|NCT02595424|Carboplatin|carboplatin|mesh-list
25420815|NCT02595424|Capecitabine|capecitabine|mesh-list
25392573|NCT04210115|Vitamins|vitamins|mesh-ancestor
25420816|NCT02595424|Etoposide|etoposide|mesh-list
25420817|NCT02595424|Temozolomide|temozolomide|mesh-list
25420818|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420819|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420820|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
25420821|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420822|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420823|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25420824|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420825|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420826|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25420827|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
25420828|NCT02594735|Abatacept|abatacept|mesh-list
25420829|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25420830|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420831|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420832|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420833|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
25420834|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420835|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420837|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25420838|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420839|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420840|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420841|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420842|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420843|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420845|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
25420846|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25420847|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420848|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420849|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420850|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420851|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420852|NCT02593110|Telmisartan|telmisartan|mesh-list
25420853|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25420854|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25420855|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25420856|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420857|NCT02592317|Pioglitazone|pioglitazone|mesh-list
25420858|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25420859|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25420860|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25420861|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
25420862|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420863|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25420864|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25420865|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420866|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25420867|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420868|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
25420869|NCT02591251|Povidone|povidone|mesh-list
25420870|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25420871|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
25420872|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
25420873|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25420874|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420875|NCT02589600|Vitamin D|vitamin d|mesh-list
25420876|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
25420877|NCT02589600|Calcium|calcium|mesh-list
25420878|NCT02589600|Vitamins|vitamins|mesh-ancestor
25420879|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
25420880|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420881|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25420882|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25420883|NCT02588443|Gemcitabine|gemcitabine|mesh-list
25420884|NCT02588443|Paclitaxel|paclitaxel|mesh-list
25420885|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420886|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420887|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420888|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420889|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420890|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420891|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420893|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
25420894|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420895|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420896|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420897|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
25420898|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420899|NCT02588105|Leucovorin|leucovorin|mesh-list
25420900|NCT02588105|Folic Acid|folic acid|mesh-list
25420901|NCT02588105|Fluorouracil|fluorouracil|mesh-list
25420902|NCT02588105|Irinotecan|irinotecan|mesh-list
25420903|NCT02588105|Olaparib|olaparib|mesh-list
25420904|NCT02588105|AZD0156|azd0156|mesh-list
25420905|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
25420906|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
25420907|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420908|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420909|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420910|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420911|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
25420912|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420913|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25420914|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420915|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420916|NCT02588105|Antidotes|antidotes|mesh-ancestor
25420917|NCT02588105|Protective Agents|protective agents|mesh-ancestor
25420918|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
25420919|NCT02588105|Vitamins|vitamins|mesh-ancestor
25420920|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
25420921|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25420922|NCT02588105|Hematinics|hematinics|mesh-ancestor
25420923|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420924|NCT02587325|Sirolimus|sirolimus|mesh-list
25420925|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25420926|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420927|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420928|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420929|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
25420930|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420931|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
25420932|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420933|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
25420934|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25420935|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
25420936|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25420937|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420938|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25420939|NCT02586623|Droxidopa|droxidopa|mesh-list
25420940|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25420941|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25420942|NCT02584933|Ceritinib|ceritinib|mesh-list
25420943|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420944|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420945|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420946|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420947|NCT02584634|Avelumab|avelumab|mesh-list
25420948|NCT02584634|Crizotinib|crizotinib|mesh-list
25420949|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25420950|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420951|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25420952|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420953|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420954|NCT02584478|Paclitaxel|paclitaxel|mesh-list
25420955|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25420956|NCT02584478|Carboplatin|carboplatin|mesh-list
25420957|NCT02584478|Doxorubicin|doxorubicin|mesh-list
25420958|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25420959|NCT02584478|Topotecan|topotecan|mesh-list
25420960|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25420961|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420962|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
25420963|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
25420964|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
25420965|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420966|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420967|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25420968|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420969|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420970|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25420971|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
25420972|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25420973|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
25420974|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420975|NCT02583672|Expectorants|expectorants|mesh-ancestor
25420976|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
25420977|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25420978|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
25420979|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420980|NCT02583672|Protective Agents|protective agents|mesh-ancestor
25420981|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420982|NCT02583672|Antidotes|antidotes|mesh-ancestor
25420983|NCT02582359|Cytarabine|cytarabine|mesh-list
25420984|NCT02582359|Daunorubicin|daunorubicin|mesh-list
25420985|NCT02582359|Ixazomib|ixazomib|mesh-list
25420986|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25420987|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
25420988|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25420989|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420990|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
25420991|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25420992|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25420993|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
25420994|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25420995|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25420996|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25420997|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25420998|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25420999|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
25421000|NCT02581137|Metformin|metformin|mesh-list
25421001|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25421002|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421003|NCT02580058|Doxorubicin|doxorubicin|mesh-list
25421004|NCT02580058|Avelumab|avelumab|mesh-list
25421005|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25421006|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421007|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25421008|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421009|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421010|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421011|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421012|NCT02579096|Allopurinol|allopurinol|mesh-list
25421013|NCT02579096|Febuxostat|febuxostat|mesh-list
25421014|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
25421015|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421016|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421017|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
25421018|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421019|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25421020|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
25421021|NCT02579096|Protective Agents|protective agents|mesh-ancestor
25421022|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421023|NCT02579044|Everolimus|everolimus|mesh-list
25421024|NCT02579044|Lonafarnib|lonafarnib|mesh-list
25421025|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421026|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421027|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
25421028|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421029|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421030|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421031|NCT02578680|Folic Acid|folic acid|mesh-list
25421032|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
25421033|NCT02578680|Hydroxocobalamin|hydroxocobalamin|mesh-list
25421034|NCT02578680|Dexamethasone|dexamethasone|mesh-list
25421035|NCT02578680|Carboplatin|carboplatin|mesh-list
25421036|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
25421037|NCT02578680|Pemetrexed|pemetrexed|mesh-list
25421038|NCT02578680|Vitamins|vitamins|mesh-ancestor
25421039|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
25421040|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421041|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421042|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421043|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
25421044|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
25421045|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421046|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25421047|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
25421048|NCT02578680|Hormones|hormones|mesh-ancestor
25421049|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421050|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25421051|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421052|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421053|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421054|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25421055|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25421056|NCT02578680|Hematinics|hematinics|mesh-ancestor
25421057|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
25421059|NCT02577406|Azacitidine|azacitidine|mesh-list
25421060|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421061|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
25421062|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421063|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421064|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
25421065|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421066|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421067|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
25421068|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421069|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421072|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421073|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25421074|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25421075|NCT02576912|Analgesics|analgesics|mesh-ancestor
25421076|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
25421077|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421078|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25421079|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25421080|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421081|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421083|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421084|NCT02576509|Nivolumab|nivolumab|mesh-list
25421085|NCT02576509|Sorafenib|sorafenib|mesh-list
25421086|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421087|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421088|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25421089|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421090|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421091|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421092|NCT02575794|Masoprocol|masoprocol|mesh-list
25421093|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
25421094|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421095|NCT02575794|Protective Agents|protective agents|mesh-ancestor
25421096|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421097|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25421098|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421099|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25421100|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25421101|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25421102|NCT02575794|Analgesics|analgesics|mesh-ancestor
25421103|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
25421104|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421105|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421106|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421107|NCT02573896|Lenalidomide|lenalidomide|mesh-list
25421108|NCT02573896|Dinutuximab|dinutuximab|mesh-list
25421109|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
25421110|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421111|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25421112|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25421113|NCT02573896|Growth Substances|growth substances|mesh-ancestor
25421114|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
25421115|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421116|NCT02573337|Lidocaine|lidocaine|mesh-list
25421117|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
25421118|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
25421119|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25421120|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421121|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
25421122|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421123|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25421124|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25421125|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25421126|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25421127|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421128|NCT02570542|Cytarabine|cytarabine|mesh-list
25421129|NCT02570542|Plerixafor|plerixafor|mesh-list
25421130|NCT02570542|Etoposide|etoposide|mesh-list
25421131|NCT02570542|Melphalan|melphalan|mesh-list
25421132|NCT02570542|Carmustine|carmustine|mesh-list
25421133|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421134|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421135|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25421136|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421137|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421138|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421139|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421140|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
25421141|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
25421142|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421143|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421144|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
25421145|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421146|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25421147|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
25421148|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25421149|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25421150|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25421151|NCT02568267|Entrectinib|entrectinib|mesh-list
25421152|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421153|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421154|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421155|NCT02567435|Sirolimus|sirolimus|mesh-list
25421156|NCT02567435|Dactinomycin|dactinomycin|mesh-list
25421157|NCT02567435|Cactinomycin|cactinomycin|mesh-list
25421158|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
25421159|NCT02567435|Irinotecan|irinotecan|mesh-list
25421160|NCT02567435|Vincristine|vincristine|mesh-list
25421161|NCT02567435|Vinorelbine|vinorelbine|mesh-list
25421162|NCT02567435|Camptothecin|camptothecin|mesh-list
25421163|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421164|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
25421165|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421166|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421167|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25421168|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
25421169|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421170|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421171|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25421172|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25421173|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421174|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421175|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421176|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421177|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421178|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421179|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25421180|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421181|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25421182|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
25421183|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25421184|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25421185|NCT02567422|Cisplatin|cisplatin|mesh-list
25421186|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421187|NCT02565108|Cannabidiol|cannabidiol|mesh-list
25421188|NCT02565108|Clobazam|clobazam|mesh-list
25421189|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
25421190|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25421191|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25421192|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25421193|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421194|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25421195|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25421196|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
25421197|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
25421198|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421199|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421200|NCT02564978|Minocycline|minocycline|mesh-list
25421201|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25421202|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421204|NCT02564952|Clobazam|clobazam|mesh-list
25421205|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
25421206|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25421207|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25421208|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25421209|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421210|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25421211|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25421212|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
25421213|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
25421214|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421215|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421216|NCT02563925|Durvalumab|durvalumab|mesh-list
25421217|NCT02563925|Tremelimumab|tremelimumab|mesh-list
25421218|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421219|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421220|NCT02563002|Bevacizumab|bevacizumab|mesh-list
25421221|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
25421222|NCT02563002|Cetuximab|cetuximab|mesh-list
25421223|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421224|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421225|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25421226|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25421227|NCT02563002|Growth Substances|growth substances|mesh-ancestor
25421228|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421229|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
25421230|NCT02562443|ON 01910|on 01910|mesh-list
25421231|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421232|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421233|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421234|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421235|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
25421236|NCT02562365|Carboplatin|carboplatin|mesh-list
25421237|NCT02562365|Etoposide|etoposide|mesh-list
25421238|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421239|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
25421240|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421241|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421242|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25421243|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
25421244|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421245|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421246|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25421247|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421248|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25421249|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421250|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421251|NCT02562235|Riociguat|riociguat|mesh-list
25421252|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
25421253|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421254|NCT02559778|Eflornithine|eflornithine|mesh-list
25421255|NCT02559778|Sorafenib|sorafenib|mesh-list
25421256|NCT02559778|Dasatinib|dasatinib|mesh-list
25421257|NCT02559778|Vorinostat|vorinostat|mesh-list
25421258|NCT02559778|Ceritinib|ceritinib|mesh-list
25421259|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421260|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421261|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421262|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421263|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25421264|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25421265|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25421266|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25421267|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421268|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25421269|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
25421270|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421271|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421272|NCT02556424|Dexamethasone|dexamethasone|mesh-list
25421273|NCT02556424|Triamcinolone|triamcinolone|mesh-list
25421274|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421275|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
25421276|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
25421277|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421278|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421279|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25421280|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
25421281|NCT02556424|Hormones|hormones|mesh-ancestor
25421282|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421283|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25421284|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421285|NCT02555787|Tacrolimus|tacrolimus|mesh-list
25421286|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421287|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
25421288|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421289|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25421290|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421291|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421293|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
25421294|NCT02553447|Vitamins|vitamins|mesh-ancestor
25421295|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
25421296|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421297|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25421298|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25421299|NCT02552641|Amoxicillin|amoxicillin|mesh-list
25421300|NCT02552641|Clarithromycin|clarithromycin|mesh-list
25421301|NCT02552641|Esomeprazole|esomeprazole|mesh-list
25421302|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25421303|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421304|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25421305|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25421306|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25421307|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421308|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421309|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25421310|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25421311|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25421312|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
25421313|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421314|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
25421315|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421316|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421317|NCT02551237|Capecitabine|capecitabine|mesh-list
25421318|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421319|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
25421320|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421321|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421322|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
25421323|NCT02550652|Prednisone|prednisone|mesh-list
25421324|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
25421325|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
25421326|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421327|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
25421328|NCT02550652|Hormones|hormones|mesh-ancestor
25421329|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421330|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421331|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25421332|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421333|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25421334|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25421335|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
25421336|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25421337|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421338|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421339|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421340|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
25421341|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
25421342|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421343|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25421344|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25421345|NCT02550652|Protective Agents|protective agents|mesh-ancestor
25421346|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421347|NCT02549898|Cilostazol|cilostazol|mesh-list
25421348|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25421349|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25421350|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
25421351|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421352|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421431|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
25421353|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25421354|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
25421355|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25421356|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25421357|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421358|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25421359|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
25421360|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25421361|NCT02549898|Protective Agents|protective agents|mesh-ancestor
25421362|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25421363|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25421364|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421365|NCT02549898|Hematinics|hematinics|mesh-ancestor
25421366|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25421367|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25421368|NCT02549833|Poly I-C|poly i-c|mesh-list
25421369|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25421370|NCT02549833|Poly ICLC|poly iclc|mesh-list
25421371|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
25421372|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
25421373|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421374|NCT02549833|Laxatives|laxatives|mesh-ancestor
25421375|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25421377|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421378|NCT02548559|Cannabidiol|cannabidiol|mesh-list
25421379|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
25421381|NCT02548364|Calcifediol|calcifediol|mesh-list
25421382|NCT02548364|Vitamins|vitamins|mesh-ancestor
25421383|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
25421384|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421385|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25421386|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
25421387|NCT02546986|Azacitidine|azacitidine|mesh-list
25421389|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421390|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421391|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421392|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
25421393|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421394|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421395|NCT02544763|Cannabidiol|cannabidiol|mesh-list
25421396|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
25421397|NCT02543983|Ketamine|ketamine|mesh-list
25421398|NCT02543983|Analgesics|analgesics|mesh-ancestor
25421399|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
25421400|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421401|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421402|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25421403|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25421404|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
25421405|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
25421406|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25421407|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25421408|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25421409|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421410|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421411|NCT02543944|Clonidine|clonidine|mesh-list
25421412|NCT02543944|Naltrexone|naltrexone|mesh-list
25421413|NCT02543944|Buprenorphine|buprenorphine|mesh-list
25421414|NCT02543944|Gabapentin|gabapentin|mesh-list
25421415|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25421416|NCT02543944|Narcotics|narcotics|mesh-ancestor
25421417|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25421418|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421419|NCT02543944|Analgesics|analgesics|mesh-ancestor
25421420|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
25421421|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421422|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25421423|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
25421424|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25421425|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25421426|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25421427|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25421428|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25421429|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421430|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421432|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25421433|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25421434|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
25421435|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
25421436|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25421437|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25421438|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25421439|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
25421440|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25421441|NCT02542969|Simvastatin|simvastatin|mesh-list
25421442|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25421443|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25421444|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
25421445|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421446|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25421447|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25421448|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421449|NCT02542293|Gemcitabine|gemcitabine|mesh-list
25421450|NCT02542293|Paclitaxel|paclitaxel|mesh-list
25421451|NCT02542293|Cisplatin|cisplatin|mesh-list
25421452|NCT02542293|Carboplatin|carboplatin|mesh-list
25421453|NCT02542293|Pemetrexed|pemetrexed|mesh-list
25421454|NCT02542293|Durvalumab|durvalumab|mesh-list
25421455|NCT02542293|Tremelimumab|tremelimumab|mesh-list
25421456|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421457|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421458|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421459|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421460|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421461|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421462|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421463|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
25421464|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
25421465|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421466|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421467|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421468|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
25421469|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421470|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25421471|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25421472|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421473|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
25421475|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421476|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421477|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25421478|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421479|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421480|NCT02538484|Letrozole|letrozole|mesh-list
25421481|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421482|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25421483|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25421484|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421485|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421486|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25421487|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
25421488|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421489|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421490|NCT02538198|Lenalidomide|lenalidomide|mesh-list
25421491|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
25421492|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421493|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25421494|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25421495|NCT02538198|Growth Substances|growth substances|mesh-ancestor
25421496|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
25421497|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421498|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
25421499|NCT02537509|Vitamin D|vitamin d|mesh-list
25421500|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25421501|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421502|NCT02537509|Vitamins|vitamins|mesh-ancestor
25421503|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
25421504|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25421505|NCT02537418|Durvalumab|durvalumab|mesh-list
25421506|NCT02537418|Tremelimumab|tremelimumab|mesh-list
25421507|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421508|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421509|NCT02536300|Idelalisib|idelalisib|mesh-list
25421510|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421511|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421512|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421513|NCT02535533|Selenium|selenium|mesh-list
25421514|NCT02535533|Axitinib|axitinib|mesh-list
25421515|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421516|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421517|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421518|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421519|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
25421520|NCT02535533|Protective Agents|protective agents|mesh-ancestor
25421521|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421522|NCT02535533|Trace Elements|trace elements|mesh-ancestor
25421523|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
25421524|NCT02531516|Bicalutamide|bicalutamide|mesh-list
25421525|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
25421526|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
25421527|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421528|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421529|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421530|NCT02531308|Metformin|metformin|mesh-list
25421531|NCT02531308|Prednisone|prednisone|mesh-list
25421536|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421537|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
25421538|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421539|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421540|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25421541|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
25421542|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421543|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421544|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25421545|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421546|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25421547|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25421548|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25421549|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421550|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421551|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421552|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
25421553|NCT02531308|Hormones|hormones|mesh-ancestor
25421554|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421555|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25421556|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421557|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421558|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421559|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421560|NCT02531126|Ozanimod|ozanimod|mesh-list
25421561|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25421562|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421563|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421564|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
25421565|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421566|NCT02530463|Nivolumab|nivolumab|mesh-list
25421567|NCT02530463|Ipilimumab|ipilimumab|mesh-list
25421568|NCT02530463|Azacitidine|azacitidine|mesh-list
25421569|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421570|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421571|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25421572|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421573|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421574|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
25421575|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421576|NCT02530034|Antibodies|antibodies|mesh-list
25421577|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25421578|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
25421579|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421580|NCT02527434|Durvalumab|durvalumab|mesh-list
25421581|NCT02527434|Tremelimumab|tremelimumab|mesh-list
25421582|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25421583|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421584|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421585|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
25421586|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421587|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
25421588|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25421589|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25421590|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
25393329|NCT04188223|Vaccines|vaccines|mesh-list
25421591|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421592|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25421593|NCT02524275|Docetaxel|docetaxel|mesh-list
25421594|NCT02524275|Capecitabine|capecitabine|mesh-list
25421595|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421596|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421597|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421598|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421599|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421600|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421601|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
25421602|NCT02523976|Cytarabine|cytarabine|mesh-list
25421603|NCT02523976|Dexamethasone|dexamethasone|mesh-list
25421604|NCT02523976|Prednisone|prednisone|mesh-list
25421605|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
25421606|NCT02523976|Methotrexate|methotrexate|mesh-list
25421607|NCT02523976|Etoposide|etoposide|mesh-list
25421608|NCT02523976|Vincristine|vincristine|mesh-list
25421609|NCT02523976|Daunorubicin|daunorubicin|mesh-list
25421610|NCT02523976|Dasatinib|dasatinib|mesh-list
25421611|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
25421612|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
25421613|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421614|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
25421615|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421616|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421617|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25421618|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
25421619|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421620|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421621|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25421622|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421623|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
25421624|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
25421625|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421626|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25421627|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
25421628|NCT02523976|Hormones|hormones|mesh-ancestor
25421629|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421630|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25421631|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25421632|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
25421633|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25421634|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421635|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
25421636|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
25421637|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421638|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25421639|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25421640|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421641|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25421642|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421643|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
25421644|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421645|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421646|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421647|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421648|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25421649|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421650|NCT02523976|Analgesics|analgesics|mesh-ancestor
25421651|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
25421652|NCT02523469|Nivolumab|nivolumab|mesh-list
25421653|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421654|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421655|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25421656|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421657|NCT02523040|Lenalidomide|lenalidomide|mesh-list
25421658|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
25421659|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421660|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25421661|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25421662|NCT02523040|Growth Substances|growth substances|mesh-ancestor
25421663|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
25421664|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421665|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
25421666|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421667|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421668|NCT02521493|Cytarabine|cytarabine|mesh-list
25421669|NCT02521493|Etoposide|etoposide|mesh-list
25421670|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
25421671|NCT02521493|Daunorubicin|daunorubicin|mesh-list
25421672|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
25421673|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
25421674|NCT02521493|Asparaginase|asparaginase|mesh-list
25421675|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
25421676|NCT02521493|Thioguanine|thioguanine|mesh-list
25421677|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
25421678|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421679|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421680|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25421681|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421682|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421683|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421684|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421685|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
25421686|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
25421687|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421688|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421690|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421691|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25421693|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
25421694|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421695|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25421696|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
25421697|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
25421698|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421699|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421700|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421701|NCT02521311|Clemastine|clemastine|mesh-list
25421702|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
25421703|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25421704|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25421705|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
25421706|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
25421707|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421708|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421709|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421710|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25421711|NCT02520778|Osimertinib|osimertinib|mesh-list
25421712|NCT02520778|Navitoclax|navitoclax|mesh-list
25421713|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421714|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421715|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421716|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421717|NCT02520154|Paclitaxel|paclitaxel|mesh-list
25421718|NCT02520154|Carboplatin|carboplatin|mesh-list
25421719|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
25421720|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25421721|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421722|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421723|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421724|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421725|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421726|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421727|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421728|NCT02519452|Daratumumab|daratumumab|mesh-list
25421729|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421730|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
25421731|NCT02518945|Liraglutide|liraglutide|mesh-list
25421732|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25421733|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421734|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25421735|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421736|NCT02518945|Incretins|incretins|mesh-ancestor
25421737|NCT02518945|Hormones|hormones|mesh-ancestor
25422047|NCT02494583|Capecitabine|capecitabine|mesh-list
25421738|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421739|NCT02516670|Vitamins|vitamins|mesh-list
25421740|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
25421741|NCT02516670|Docetaxel|docetaxel|mesh-list
25421742|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
25421743|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421744|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421745|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421746|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421747|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421748|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421749|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
25421750|NCT02516670|Protective Agents|protective agents|mesh-ancestor
25421751|NCT02514382|Dexamethasone|dexamethasone|mesh-list
25421752|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
25421753|NCT02514382|Bortezomib|bortezomib|mesh-list
25421754|NCT02514382|Ichthammol|ichthammol|mesh-list
25421755|NCT02514382|BB 1101|bb 1101|mesh-list
25421756|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421757|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
25421758|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
25421759|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421760|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421761|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25421762|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
25421763|NCT02514382|Hormones|hormones|mesh-ancestor
25421764|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421765|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25421766|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421767|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
25421768|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421769|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421770|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25421771|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
25421772|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25421773|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25421774|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421775|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
25421776|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
25421777|NCT02513563|Paclitaxel|paclitaxel|mesh-list
25421778|NCT02513563|Carboplatin|carboplatin|mesh-list
25421779|NCT02513563|Adavosertib|adavosertib|mesh-list
25421780|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421781|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421782|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421783|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421784|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421785|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421786|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421787|NCT02513485|Levodopa|levodopa|mesh-list
25421788|NCT02513485|Carbidopa|carbidopa|mesh-list
25421789|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25421790|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25421791|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
25421792|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421793|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421794|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421795|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25421796|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421797|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25421798|NCT02511028|Hematinics|hematinics|mesh-ancestor
25421799|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25421800|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25421801|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
25421802|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25421803|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25421804|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25421805|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421806|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
25421807|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25421808|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421809|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
25421810|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25421811|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421812|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421813|NCT02507687|Bimatoprost|bimatoprost|mesh-list
25422199|NCT02478320|Ilorasertib|ilorasertib|mesh-list
25421814|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25421815|NCT02507336|Thalidomide|thalidomide|mesh-list
25421816|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421817|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
25421818|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421819|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
25393557|NCT04177082|Riboflavin|riboflavin|mesh-list
25421820|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25421978|NCT02495077|Infliximab|infliximab|mesh-list
25421821|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421822|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25421823|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25421824|NCT02507336|Growth Substances|growth substances|mesh-ancestor
25421825|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
25421826|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421827|NCT02506153|Interferons|interferons|mesh-list
25421828|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
25421829|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
25421830|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
25421831|NCT02506153|Ipilimumab|ipilimumab|mesh-list
25421832|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421833|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421834|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
25421835|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421836|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25421837|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421838|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
25421839|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421840|NCT02505984|Oxytocin|oxytocin|mesh-list
25421842|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25421843|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421844|NCT02504489|Docetaxel|docetaxel|mesh-list
25421845|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421846|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421847|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421848|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421849|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421850|NCT02504151|Cannabidiol|cannabidiol|mesh-list
25421851|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
25421852|NCT02503358|Paclitaxel|paclitaxel|mesh-list
25421853|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25421854|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421855|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421856|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421857|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421858|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421859|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421860|NCT02502786|Antibodies|antibodies|mesh-list
25421861|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
25421862|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421863|NCT02502266|Paclitaxel|paclitaxel|mesh-list
25421864|NCT02502266|Doxorubicin|doxorubicin|mesh-list
25421865|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25421866|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25421867|NCT02502266|Topotecan|topotecan|mesh-list
25421868|NCT02502266|Olaparib|olaparib|mesh-list
25421869|NCT02502266|Cediranib|cediranib|mesh-list
25421870|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25421871|NCT02502266|Maleic acid|maleic acid|mesh-list
25421872|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421873|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421874|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421875|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421876|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421877|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421878|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25421879|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25421880|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25421881|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421882|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25421883|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421884|NCT02500576|Aldesleukin|aldesleukin|mesh-list
25421885|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
25421886|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
25421887|NCT02500576|Fludarabine|fludarabine|mesh-list
25421888|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
25421889|NCT02500576|Interleukin-2|interleukin-2|mesh-list
25421890|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421891|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
25421892|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421893|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421894|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25421895|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
25393629|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393630|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393631|NCT04176055|Haloperidol|haloperidol|mesh-list
25393632|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
25393633|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
25393634|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
25393635|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393636|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393637|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25393638|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25393639|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25393640|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25393641|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25393658|NCT04175912|Paclitaxel|paclitaxel|mesh-list
25421896|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421897|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421898|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25421899|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421900|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421901|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
25421902|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25421903|NCT02500576|Analgesics|analgesics|mesh-ancestor
25421904|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
25421905|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421906|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25421907|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25421908|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
25421909|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421910|NCT02500407|Atezolizumab|atezolizumab|mesh-list
25421911|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421912|NCT02499328|Durvalumab|durvalumab|mesh-list
25421913|NCT02499328|Tremelimumab|tremelimumab|mesh-list
25421914|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421915|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421916|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
25421917|NCT02498912|Fludarabine|fludarabine|mesh-list
25421918|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421919|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
25421920|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421921|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25421922|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25421923|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
25421924|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421925|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421926|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25421927|NCT02498613|Misonidazole|misonidazole|mesh-list
25421928|NCT02498613|Olaparib|olaparib|mesh-list
25421929|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25421930|NCT02498613|Cediranib|cediranib|mesh-list
25421931|NCT02498613|Maleic acid|maleic acid|mesh-list
25421932|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421933|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421934|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421935|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25421936|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25421937|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25421938|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421939|NCT02498600|Nivolumab|nivolumab|mesh-list
25421940|NCT02498600|Ipilimumab|ipilimumab|mesh-list
25421941|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25421942|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421943|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25421944|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421945|NCT02496780|Insulin|insulin|mesh-list
25421946|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25421947|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
25421948|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
25421949|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25421950|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421951|NCT02495896|Gemcitabine|gemcitabine|mesh-list
25421952|NCT02495896|Paclitaxel|paclitaxel|mesh-list
25421953|NCT02495896|Docetaxel|docetaxel|mesh-list
25421954|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25421955|NCT02495896|Cisplatin|cisplatin|mesh-list
25421956|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25421957|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421958|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421959|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
25421960|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
25421961|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421962|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25421963|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
25421964|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
25421965|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25421966|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421967|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421968|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
25421969|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421970|NCT02495077|Acetaminophen|acetaminophen|mesh-list
25421971|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
25421972|NCT02495077|Promethazine|promethazine|mesh-list
25421974|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
25421975|NCT02495077|Prednisone|prednisone|mesh-list
25421976|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
25421977|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25421979|NCT02495077|Tacrolimus|tacrolimus|mesh-list
25421980|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
25421981|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25421982|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25421983|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
25421984|NCT02495077|Hormones|hormones|mesh-ancestor
25421985|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25421986|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25421987|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25421988|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421989|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25421990|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
25421991|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25421992|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421993|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421994|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25421995|NCT02495077|Analgesics|analgesics|mesh-ancestor
25421996|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
25421997|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25421998|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
25422152|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
25421999|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25422000|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25422001|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
25422002|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25422003|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422004|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
25422005|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
25422006|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422007|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25422008|NCT02495077|Protective Agents|protective agents|mesh-ancestor
25422009|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
25422010|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25422011|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25422012|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25422013|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25422014|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
25422015|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
25422016|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25422017|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
25422018|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
25422019|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25422020|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25422021|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
25422022|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25422023|NCT02494986|Rilpivirine|rilpivirine|mesh-list
25422024|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25422025|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422026|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422027|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422028|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
25422029|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422030|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25422031|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25422032|NCT02494921|Prednisone|prednisone|mesh-list
25422033|NCT02494921|Docetaxel|docetaxel|mesh-list
25422034|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422035|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422036|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422037|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422038|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422039|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422040|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
25422041|NCT02494921|Hormones|hormones|mesh-ancestor
25422042|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422043|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422044|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422045|NCT02494583|Cisplatin|cisplatin|mesh-list
25422046|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
25422048|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422049|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422050|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422051|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
25422052|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422053|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
25422054|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25422055|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25422056|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25422057|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25422058|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422059|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
25422060|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25422061|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422062|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25422063|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422064|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25422065|NCT02493322|Olmesartan|olmesartan|mesh-list
25422066|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25422067|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
25422068|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25422069|NCT02493322|Diuretics|diuretics|mesh-ancestor
25422070|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
25422071|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422072|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25422073|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25422074|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422075|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25422076|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25422077|NCT02491632|Dexamethasone|dexamethasone|mesh-list
25422078|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
25422079|NCT02491632|Ichthammol|ichthammol|mesh-list
25422080|NCT02491632|BB 1101|bb 1101|mesh-list
25422081|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422082|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
25422083|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
25422084|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422085|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422086|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422087|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
25422088|NCT02491632|Hormones|hormones|mesh-ancestor
25422089|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422090|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422091|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422092|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
25422093|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422094|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422095|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
25422096|NCT02489695|Axitinib|axitinib|mesh-list
25422097|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422098|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422099|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422100|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422101|NCT02489318|Androgens|androgens|mesh-list
25422102|NCT02489318|Hormones|hormones|mesh-ancestor
25422103|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422104|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422105|NCT02488759|Nivolumab|nivolumab|mesh-list
25422106|NCT02488759|Ipilimumab|ipilimumab|mesh-list
25422107|NCT02488759|Daratumumab|daratumumab|mesh-list
25422108|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422109|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422110|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25422111|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422112|NCT02486718|Gemcitabine|gemcitabine|mesh-list
25422113|NCT02486718|Cisplatin|cisplatin|mesh-list
25422114|NCT02486718|Docetaxel|docetaxel|mesh-list
25422115|NCT02486718|Pemetrexed|pemetrexed|mesh-list
25422116|NCT02486718|Atezolizumab|atezolizumab|mesh-list
25422117|NCT02486718|Vinorelbine|vinorelbine|mesh-list
25422118|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422119|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422120|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
25422121|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422122|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
25422123|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422124|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422125|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422126|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
25422127|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422128|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422129|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422130|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422131|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25422132|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422133|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422134|NCT02484443|Dinutuximab|dinutuximab|mesh-list
25422135|NCT02484443|Sargramostim|sargramostim|mesh-list
25422136|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
25422137|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422138|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422139|NCT02484404|Durvalumab|durvalumab|mesh-list
25422140|NCT02484404|Olaparib|olaparib|mesh-list
25422141|NCT02484404|Cediranib|cediranib|mesh-list
25422142|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422143|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422144|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25422145|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422146|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422147|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422148|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
25422149|NCT02484391|Cytarabine|cytarabine|mesh-list
25422150|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
25422151|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422153|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422154|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422155|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
25422156|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422157|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422158|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
25422159|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422160|NCT02484391|Analgesics|analgesics|mesh-ancestor
25422161|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
25422162|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422163|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422164|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422165|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422166|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
25422167|NCT02484391|Protective Agents|protective agents|mesh-ancestor
25422168|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
25422169|NCT02484391|Vitamins|vitamins|mesh-ancestor
25422170|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
25422171|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25422172|NCT02483936|Olmesartan|olmesartan|mesh-list
25422173|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25422174|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
25422175|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25422176|NCT02483936|Diuretics|diuretics|mesh-ancestor
25422177|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
25422178|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422179|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25422180|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25422181|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422182|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25422183|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25422184|NCT02479451|Theophylline|theophylline|mesh-list
25422185|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25422186|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
25422187|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422188|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422189|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25422190|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
25422191|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25422192|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422193|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422194|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
25422195|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25422196|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25422197|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
25422198|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25422209|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422210|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422211|NCT02476968|Olaparib|olaparib|mesh-list
25422212|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25422213|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422214|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422215|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422216|NCT02476786|Tamoxifen|tamoxifen|mesh-list
25422217|NCT02476786|Fulvestrant|fulvestrant|mesh-list
25422218|NCT02476786|Anastrozole|anastrozole|mesh-list
25422219|NCT02476786|Goserelin|goserelin|mesh-list
25422220|NCT02476786|Exemestane|exemestane|mesh-list
25422221|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25422222|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
25422223|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422224|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422225|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422226|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422227|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25422228|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25422229|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25422230|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25422231|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25422232|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25422233|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422234|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422235|NCT02473497|Crizotinib|crizotinib|mesh-list
25422236|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422237|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422238|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422239|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422240|NCT02469519|Dexamethasone|dexamethasone|mesh-list
25422241|NCT02469519|Betamethasone|betamethasone|mesh-list
25422242|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422243|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
25422244|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
25422245|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422246|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422247|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422248|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
25422249|NCT02469519|Hormones|hormones|mesh-ancestor
25422250|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422251|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422252|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422253|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25422254|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
25422255|NCT02466971|Cisplatin|cisplatin|mesh-list
25422256|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422257|NCT02466334|Calcitonin|calcitonin|mesh-list
25422258|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
25422259|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25422260|NCT02466334|Katacalcin|katacalcin|mesh-list
25422261|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25422262|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422263|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25422264|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
25422325|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422327|NCT02464696|Protective Agents|protective agents|mesh-ancestor
25422328|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422329|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422330|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
25422331|NCT02464410|Narcotics|narcotics|mesh-ancestor
25422332|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25422333|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422334|NCT02464410|Analgesics|analgesics|mesh-ancestor
25422335|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
25422336|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422337|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
25422338|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422339|NCT02462421|Canagliflozin|canagliflozin|mesh-list
25422340|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25422341|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422342|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25422343|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422344|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
25422345|NCT02461537|Analgesics|analgesics|mesh-ancestor
25422346|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
25422347|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422348|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422349|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422350|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422351|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422352|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422427|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
25422353|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422355|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25422356|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422357|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
25422358|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25422359|NCT02460445|Cyproterone|cyproterone|mesh-list
25422435|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
25422360|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25422361|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25422362|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25422363|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
25422364|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25422365|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422366|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25422367|NCT02460445|Estrogens|estrogens|mesh-ancestor
25422368|NCT02460445|Hormones|hormones|mesh-ancestor
25422369|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422370|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
25422372|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422373|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25422374|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
25422375|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422376|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422377|NCT02456857|Bevacizumab|bevacizumab|mesh-list
25422378|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25422379|NCT02456857|Doxorubicin|doxorubicin|mesh-list
25422380|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25422381|NCT02456857|Everolimus|everolimus|mesh-list
25422382|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
25422383|NCT02456857|Antibodies|antibodies|mesh-list
25422384|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
25422385|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25422386|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
25422387|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422388|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25422389|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25422390|NCT02456857|Growth Substances|growth substances|mesh-ancestor
25422391|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422392|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
25422393|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
25422394|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25422395|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422396|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422397|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422398|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422399|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422400|NCT02456740|Erenumab|erenumab|mesh-list
25422401|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25422402|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422403|NCT02456740|Analgesics|analgesics|mesh-ancestor
25422404|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
25422405|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422406|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422407|NCT02456532|Zolpidem|zolpidem|mesh-list
25422408|NCT02456532|Eszopiclone|eszopiclone|mesh-list
25422409|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25422410|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25422411|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25422412|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422413|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25422414|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
25422415|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
25422416|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25422417|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422418|NCT02455687|Budesonide|budesonide|mesh-list
25422419|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
25422420|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422421|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25422422|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
25422423|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422424|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422425|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25422426|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
25422428|NCT02455687|Hormones|hormones|mesh-ancestor
25422429|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422430|NCT02455687|Analgesics|analgesics|mesh-ancestor
25422431|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
25422432|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
25422433|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25422434|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25422436|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25422437|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25422438|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422439|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25422440|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
25422441|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25422442|NCT02454933|Durvalumab|durvalumab|mesh-list
25422443|NCT02454933|Osimertinib|osimertinib|mesh-list
25422444|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422445|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422446|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422447|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422526|NCT02446457|Growth Substances|growth substances|mesh-ancestor
25422448|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422450|NCT02453282|Paclitaxel|paclitaxel|mesh-list
25422451|NCT02453282|Cisplatin|cisplatin|mesh-list
25422452|NCT02453282|Carboplatin|carboplatin|mesh-list
25422453|NCT02453282|Pemetrexed|pemetrexed|mesh-list
25422454|NCT02453282|Durvalumab|durvalumab|mesh-list
25422455|NCT02453282|Tremelimumab|tremelimumab|mesh-list
25422456|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25422457|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422458|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422459|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422460|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422461|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422462|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422463|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422464|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
25422465|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
25422466|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422467|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422468|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422469|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
25422470|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422471|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25422472|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422473|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422474|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
25422475|NCT02448225|Fluorides|fluorides|mesh-list
25422476|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25422477|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
25422478|NCT02448225|Protective Agents|protective agents|mesh-ancestor
25422479|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422480|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25422481|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422482|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
25422483|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
25422484|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422485|NCT02446600|Gemcitabine|gemcitabine|mesh-list
25422486|NCT02446600|Paclitaxel|paclitaxel|mesh-list
25422487|NCT02446600|Carboplatin|carboplatin|mesh-list
25422488|NCT02446600|Doxorubicin|doxorubicin|mesh-list
25422489|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25422490|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25422491|NCT02446600|Olaparib|olaparib|mesh-list
25422492|NCT02446600|Cediranib|cediranib|mesh-list
25422493|NCT02446600|Maleic acid|maleic acid|mesh-list
25422494|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422495|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422496|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422497|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422498|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422499|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422500|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422501|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
25422502|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
25422503|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422504|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422505|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422506|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
25422507|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422508|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25422509|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422510|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422511|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25422512|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422513|NCT02446457|Rituximab|rituximab|mesh-list
25422514|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25422515|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
25422516|NCT02446457|Lenalidomide|lenalidomide|mesh-list
25422517|NCT02446457|Antibodies|antibodies|mesh-list
25422518|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
25422519|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25422520|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
25422521|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422522|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422523|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25422524|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25422525|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25422531|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422532|NCT02445651|Expectorants|expectorants|mesh-ancestor
25422533|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
25422534|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25422535|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
25422536|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422537|NCT02445651|Protective Agents|protective agents|mesh-ancestor
25422538|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422539|NCT02445651|Antidotes|antidotes|mesh-ancestor
25422540|NCT02444546|Sargramostim|sargramostim|mesh-list
25422541|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
25422542|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422543|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
25422544|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25422545|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25422546|NCT02444429|Prednisolone|prednisolone|mesh-list
25422547|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
25422548|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25422549|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
25422550|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422551|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
25422552|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
25422553|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422554|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422555|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422556|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
25422557|NCT02444429|Hormones|hormones|mesh-ancestor
25422558|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422559|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25422560|NCT02444429|Protective Agents|protective agents|mesh-ancestor
25422561|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422562|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422563|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
25422564|NCT02443324|Ramucirumab|ramucirumab|mesh-list
25422565|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422566|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422567|NCT02443077|Cytarabine|cytarabine|mesh-list
25422568|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
25422569|NCT02443077|Melphalan|melphalan|mesh-list
25422570|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
25422571|NCT02443077|Carmustine|carmustine|mesh-list
25422572|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25422573|NCT02443077|Etoposide|etoposide|mesh-list
25422574|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
25422575|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
25422576|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422577|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
25422578|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422579|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25422580|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25422581|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
25422582|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422583|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422584|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25422585|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422586|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422587|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422588|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422589|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422590|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
25422592|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422593|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
25422594|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
25422595|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422596|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422597|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422598|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
25422599|NCT02442180|Prednisolone|prednisolone|mesh-list
25422600|NCT02442180|Lenograstim|lenograstim|mesh-list
25422601|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25422602|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
25422603|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422604|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422605|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
25422606|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
25422607|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422608|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422609|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
25422611|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422612|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25422613|NCT02442180|Protective Agents|protective agents|mesh-ancestor
25422614|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422615|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422616|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
25422617|NCT02439450|Nivolumab|nivolumab|mesh-list
25422618|NCT02439450|Pemetrexed|pemetrexed|mesh-list
25422619|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422620|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422621|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25422622|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422623|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422624|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25422625|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422626|NCT02437318|Fulvestrant|fulvestrant|mesh-list
25422627|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422628|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422629|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25422630|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25422631|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
25422632|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422633|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422634|NCT02437110|Ritonavir|ritonavir|mesh-list
25422635|NCT02437110|Darunavir|darunavir|mesh-list
25422636|NCT02437110|Tenofovir|tenofovir|mesh-list
25422637|NCT02437110|Dolutegravir|dolutegravir|mesh-list
25422638|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25422639|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25422640|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
25422641|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422642|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422643|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25422644|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25422645|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
25422646|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422647|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25422648|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25422649|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25422650|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422651|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25422652|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25422653|NCT02434081|Nivolumab|nivolumab|mesh-list
25422654|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422655|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422656|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25422657|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422658|NCT02432846|Sunitinib|sunitinib|mesh-list
25422659|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422660|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25422661|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25422662|NCT02432846|Growth Substances|growth substances|mesh-ancestor
25422663|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422664|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
25422665|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422666|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422667|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422668|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
25422669|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25422670|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
25422671|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422672|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
25422673|NCT02432742|Protective Agents|protective agents|mesh-ancestor
25422674|NCT02432274|Etoposide|etoposide|mesh-list
25422675|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
25422676|NCT02432274|Ifosfamide|ifosfamide|mesh-list
25422677|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
25422678|NCT02432274|Lenvatinib|lenvatinib|mesh-list
25422679|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422680|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422681|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422682|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422683|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422684|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422685|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25422686|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
25422687|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422688|NCT02431247|Tenofovir|tenofovir|mesh-list
25422689|NCT02431247|Emtricitabine|emtricitabine|mesh-list
25422690|NCT02431247|Darunavir|darunavir|mesh-list
25422691|NCT02431247|Cobicistat|cobicistat|mesh-list
25422692|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25422693|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25422694|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
25422695|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422696|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25422697|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422698|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422699|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422700|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25422701|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25422702|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25422703|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25422704|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
25422705|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25422706|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25422707|NCT02429557|Midodrine|midodrine|mesh-list
25394399|NCT04141696|Midazolam|midazolam|mesh-list
25422708|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
25422709|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
25422710|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422711|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422712|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25422713|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25422714|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25422715|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25422716|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
25422717|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25422718|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422719|NCT02428985|Riociguat|riociguat|mesh-list
25422720|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
25422721|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422722|NCT02427620|Cytarabine|cytarabine|mesh-list
25422723|NCT02427620|Dexamethasone|dexamethasone|mesh-list
25422724|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
25422725|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
25422726|NCT02427620|Rituximab|rituximab|mesh-list
25422727|NCT02427620|Doxorubicin|doxorubicin|mesh-list
25422728|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25422729|NCT02427620|Methotrexate|methotrexate|mesh-list
25422730|NCT02427620|Vincristine|vincristine|mesh-list
25422731|NCT02427620|Daunorubicin|daunorubicin|mesh-list
25422732|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25422733|NCT02427620|Antibodies|antibodies|mesh-list
25422734|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
25422735|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25422736|NCT02427620|BB 1101|bb 1101|mesh-list
25422737|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422738|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
25422739|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422740|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25422741|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25422742|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
25422743|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422744|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422745|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25422746|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422747|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
25422748|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
25422749|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422750|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422751|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
25422752|NCT02427620|Hormones|hormones|mesh-ancestor
25422753|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422754|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422755|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
25422756|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422757|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25422758|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422759|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422760|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25422762|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25422763|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422764|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
25422765|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
25422766|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25422767|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422768|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
25422769|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422770|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422771|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422772|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422773|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422774|NCT02426125|Docetaxel|docetaxel|mesh-list
25422775|NCT02426125|Ramucirumab|ramucirumab|mesh-list
25422776|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422777|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422778|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422779|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422780|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422781|NCT02425566|Trimethaphan|trimethaphan|mesh-list
25422782|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
25422783|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
25422784|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
25422785|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25422786|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25422787|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25422788|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
25422789|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422790|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422791|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25422792|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25422793|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
25422794|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25422795|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422796|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25422797|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422798|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422799|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422800|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422801|NCT02422615|Fulvestrant|fulvestrant|mesh-list
25422802|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422803|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422804|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25422805|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25422806|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
25422807|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422808|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422809|NCT02422498|Cisplatin|cisplatin|mesh-list
25422810|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422811|NCT02422381|Gemcitabine|gemcitabine|mesh-list
25422812|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
25422813|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422814|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
25422815|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422816|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422817|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
25422818|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422819|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422820|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422821|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
25422822|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422823|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422824|NCT02421939|Cytarabine|cytarabine|mesh-list
25422825|NCT02421939|Fludarabine|fludarabine|mesh-list
25422826|NCT02421939|Etoposide|etoposide|mesh-list
25422827|NCT02421939|Azacitidine|azacitidine|mesh-list
25422828|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
25422829|NCT02421939|Idarubicin|idarubicin|mesh-list
25422830|NCT02421939|Lenograstim|lenograstim|mesh-list
25422831|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422832|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422833|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
25422834|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422835|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422836|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
25422837|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422838|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422839|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422840|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422841|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422842|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
25422843|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422844|NCT02421939|Analgesics|analgesics|mesh-ancestor
25422845|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
25422846|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422847|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25422848|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25422849|NCT02420860|Lenalidomide|lenalidomide|mesh-list
25422850|NCT02420860|Elotuzumab|elotuzumab|mesh-list
25422851|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
25422852|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422853|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25422854|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25422855|NCT02420860|Growth Substances|growth substances|mesh-ancestor
25422856|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
25422857|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422858|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
25422859|NCT02420314|Paclitaxel|paclitaxel|mesh-list
25422860|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25394538|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
25394539|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25422861|NCT02420314|Carboplatin|carboplatin|mesh-list
25422862|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422863|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422864|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422865|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422866|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422867|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422868|NCT02420314|Vitamins|vitamins|mesh-ancestor
25422869|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
25422870|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422871|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
25422872|NCT02420314|Protective Agents|protective agents|mesh-ancestor
25422873|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
25422874|NCT02419495|Leucovorin|leucovorin|mesh-list
25422875|NCT02419495|Folic Acid|folic acid|mesh-list
25422876|NCT02419495|Paclitaxel|paclitaxel|mesh-list
25422877|NCT02419495|Camptothecin|camptothecin|mesh-list
25422878|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
25422879|NCT02419495|Carboplatin|carboplatin|mesh-list
25422880|NCT02419495|Doxorubicin|doxorubicin|mesh-list
25422881|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25422882|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
25422883|NCT02419495|Fluorouracil|fluorouracil|mesh-list
25422884|NCT02419495|Capecitabine|capecitabine|mesh-list
25422885|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
25422886|NCT02419495|Nivolumab|nivolumab|mesh-list
25422887|NCT02419495|Irinotecan|irinotecan|mesh-list
25422888|NCT02419495|Pemetrexed|pemetrexed|mesh-list
25422889|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25422890|NCT02419495|Ipilimumab|ipilimumab|mesh-list
25422891|NCT02419495|Daunorubicin|daunorubicin|mesh-list
25422892|NCT02419495|Topotecan|topotecan|mesh-list
25422893|NCT02419495|Olaparib|olaparib|mesh-list
25422895|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
25422896|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25422897|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422898|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
25422899|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
25422900|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422901|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422902|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422903|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
25422904|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422905|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25422906|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25422907|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
25422908|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25422909|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25422910|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25422911|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25422912|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422913|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25422914|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25422915|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25422916|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
25422917|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422918|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25422919|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25422920|NCT02419495|Antidotes|antidotes|mesh-ancestor
25422921|NCT02419495|Protective Agents|protective agents|mesh-ancestor
25422922|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
25422923|NCT02419495|Vitamins|vitamins|mesh-ancestor
25422924|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
25422925|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25422926|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25422927|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25422928|NCT02419495|Hematinics|hematinics|mesh-ancestor
25422929|NCT02418195|Ketamine|ketamine|mesh-list
25422930|NCT02418195|Analgesics|analgesics|mesh-ancestor
25422931|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
25422932|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422933|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422934|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25422935|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25422936|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
25422937|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
25422938|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25422939|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25422940|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25422941|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25422942|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422943|NCT02415413|Dexamethasone|dexamethasone|mesh-list
25422944|NCT02415413|Lenalidomide|lenalidomide|mesh-list
25422945|NCT02415413|Melphalan|melphalan|mesh-list
25422946|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422947|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
25422948|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
25422949|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422950|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422951|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422952|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
25422953|NCT02415413|Hormones|hormones|mesh-ancestor
25422954|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422955|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422956|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422957|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
25422958|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25422959|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25422960|NCT02415413|Growth Substances|growth substances|mesh-ancestor
25422961|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
25422962|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25422963|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
25422964|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422965|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25422966|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422967|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
25422968|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422969|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422970|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422971|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422972|NCT02412878|Dexamethasone|dexamethasone|mesh-list
25422973|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422974|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
25422975|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
25422976|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422977|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422978|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422979|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
25422980|NCT02412878|Hormones|hormones|mesh-ancestor
25422981|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25422982|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25422983|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422984|NCT02412670|Gemcitabine|gemcitabine|mesh-list
25422985|NCT02412670|Cisplatin|cisplatin|mesh-list
25422986|NCT02412670|Carboplatin|carboplatin|mesh-list
25422987|NCT02412670|Doxorubicin|doxorubicin|mesh-list
25422988|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25422989|NCT02412670|Methotrexate|methotrexate|mesh-list
25422990|NCT02412670|Vinblastine|vinblastine|mesh-list
25422991|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422992|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25422993|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
25422994|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422996|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25422997|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422998|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25422999|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
25423000|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423001|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423002|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423003|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423004|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25423005|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
25423006|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423007|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25423008|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25423009|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423010|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25423011|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423012|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423013|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423014|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423015|NCT02412306|Blinatumomab|blinatumomab|mesh-list
25423016|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423017|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
25423018|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423019|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423020|NCT02408861|Nivolumab|nivolumab|mesh-list
25423021|NCT02408861|Ipilimumab|ipilimumab|mesh-list
25423022|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423023|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423024|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25423025|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423026|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
25423027|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25423028|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
25423029|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423030|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423031|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25423032|NCT02408549|Lacosamide|lacosamide|mesh-list
25423033|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
25423034|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25423035|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25423036|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25423037|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423038|NCT02407236|Ustekinumab|ustekinumab|mesh-list
25423039|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
25423040|NCT02404870|Canagliflozin|canagliflozin|mesh-list
25423041|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25423042|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423043|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25423044|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423045|NCT02404441|Spartalizumab|spartalizumab|mesh-list
25423046|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25423047|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423122|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
25423048|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423050|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
25423051|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
25423052|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25423053|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423054|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
25423055|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423056|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25423057|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25423058|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25423059|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25423060|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423061|NCT02403778|Ipilimumab|ipilimumab|mesh-list
25423062|NCT02403778|Tretinoin|tretinoin|mesh-list
25423063|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423064|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423065|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25423066|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423067|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
25423068|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
25423071|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25423072|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
25423073|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423074|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25423075|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25423076|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423077|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423078|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25423079|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25423080|NCT02403323|Etrolizumab|etrolizumab|mesh-list
25423081|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423082|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
25423083|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423084|NCT02402439|Pancrelipase|pancrelipase|mesh-list
25423085|NCT02402439|Pancreatin|pancreatin|mesh-list
25423086|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423087|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25423088|NCT02401503|Venetoclax|venetoclax|mesh-list
25423089|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
25423090|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423091|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
25423092|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423093|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423094|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423095|NCT02400814|Atezolizumab|atezolizumab|mesh-list
25423096|NCT02400814|Antibodies|antibodies|mesh-list
25423097|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25423098|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
25423099|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423100|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423101|NCT02400242|Dexamethasone|dexamethasone|mesh-list
25423102|NCT02400242|Pomalidomide|pomalidomide|mesh-list
25423103|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25423104|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423105|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
25423106|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
25423107|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423108|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423109|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423110|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
25423111|NCT02400242|Hormones|hormones|mesh-ancestor
25423112|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423113|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423114|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423115|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
25423116|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25423117|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25423118|NCT02400242|Growth Substances|growth substances|mesh-ancestor
25423119|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25423120|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423121|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423123|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
25423124|NCT02399449|Hematinics|hematinics|mesh-ancestor
25423125|NCT02398240|Rituximab|rituximab|mesh-list
25423126|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25423127|NCT02398240|Doxorubicin|doxorubicin|mesh-list
25423128|NCT02398240|Vincristine|vincristine|mesh-list
25423129|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423130|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423131|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
25423132|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423133|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423134|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423135|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423136|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423137|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423138|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423139|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423140|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423141|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423142|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423143|NCT02397096|Ritonavir|ritonavir|mesh-list
25423144|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25423145|NCT02397096|Tenofovir|tenofovir|mesh-list
25423146|NCT02397096|Lamivudine|lamivudine|mesh-list
25423147|NCT02397096|Cobicistat|cobicistat|mesh-list
25423149|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25423150|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
25423151|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25423152|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423153|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423154|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25423155|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25423156|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
25423157|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423158|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25423159|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25423160|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25423161|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25423163|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25423164|NCT02395497|Tacrolimus|tacrolimus|mesh-list
25423165|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
25423166|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423167|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423168|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25423169|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423170|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423171|NCT02394769|Aspirin|aspirin|mesh-list
25423172|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25423173|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25423174|NCT02394769|Analgesics|analgesics|mesh-ancestor
25423175|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
25423176|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423177|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423178|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423179|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423180|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25423181|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25423182|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423183|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25423184|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25423185|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423186|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
25423187|NCT02394535|Paclitaxel|paclitaxel|mesh-list
25423188|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25423189|NCT02394535|Capecitabine|capecitabine|mesh-list
25423190|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423191|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423192|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423193|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423194|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423195|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423196|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423197|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
25423198|NCT02393859|Dexamethasone|dexamethasone|mesh-list
25423199|NCT02393859|Methotrexate|methotrexate|mesh-list
25423200|NCT02393859|Daunorubicin|daunorubicin|mesh-list
25423201|NCT02393859|Ifosfamide|ifosfamide|mesh-list
25423202|NCT02393859|Asparaginase|asparaginase|mesh-list
25423203|NCT02393859|Blinatumomab|blinatumomab|mesh-list
25423204|NCT02393859|Pegaspargase|pegaspargase|mesh-list
25423205|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423206|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
25423207|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
25423208|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423209|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423210|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423211|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
25423212|NCT02393859|Hormones|hormones|mesh-ancestor
25423213|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423214|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423215|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423216|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25423217|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
25423218|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423219|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423220|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
25423221|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423222|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
25423223|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423224|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25423225|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423226|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
25423227|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423228|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25423229|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423230|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423231|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423232|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423233|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
25423234|NCT02393690|Iodine|iodine|mesh-list
25423235|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
25423236|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25423237|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423238|NCT02393690|Trace Elements|trace elements|mesh-ancestor
25423239|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
25423240|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423241|NCT02393157|Carboplatin|carboplatin|mesh-list
25394926|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
25423242|NCT02393157|Etoposide|etoposide|mesh-list
25423243|NCT02393157|Ifosfamide|ifosfamide|mesh-list
25423244|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
25423245|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423246|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423247|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423248|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423249|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423250|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423251|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423252|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
25423253|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423254|NCT02392572|TIC10 compound|tic10 compound|mesh-list
25423255|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423256|NCT02390869|Rituximab|rituximab|mesh-list
25423257|NCT02390869|Lenalidomide|lenalidomide|mesh-list
25423258|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423259|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423260|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
25423261|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423262|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423263|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25423264|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25423265|NCT02390869|Growth Substances|growth substances|mesh-ancestor
25423266|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
25423267|NCT02389946|Sirolimus|sirolimus|mesh-list
25423268|NCT02389946|Everolimus|everolimus|mesh-list
25423269|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423270|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423271|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
25423272|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423273|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25423274|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423275|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423276|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
25423277|NCT02389309|Sirolimus|sirolimus|mesh-list
25423278|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
25423279|NCT02389309|Dasatinib|dasatinib|mesh-list
25423280|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423281|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
25423282|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423283|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423284|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423285|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
25423286|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423287|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423288|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25423289|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25423290|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423291|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423292|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
25423293|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25423294|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423295|NCT02388906|Nivolumab|nivolumab|mesh-list
25423296|NCT02388906|Ipilimumab|ipilimumab|mesh-list
25423297|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423298|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423299|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25423376|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
25423300|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423301|NCT02388178|Fluorides|fluorides|mesh-list
25423302|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
25423303|NCT02388178|Protective Agents|protective agents|mesh-ancestor
25423304|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423305|NCT02387203|Amoxicillin|amoxicillin|mesh-list
25423306|NCT02387203|Clarithromycin|clarithromycin|mesh-list
25423307|NCT02387203|Lansoprazole|lansoprazole|mesh-list
25423308|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25423309|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423310|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25423311|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423312|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423313|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25423314|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25395001|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
25423315|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25423316|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423317|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25423318|NCT02386800|Panobinostat|panobinostat|mesh-list
25423319|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423320|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25423321|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423322|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423323|NCT02385110|Dexamethasone|dexamethasone|mesh-list
25423324|NCT02385110|Methotrexate|methotrexate|mesh-list
25423325|NCT02385110|Etoposide|etoposide|mesh-list
25423326|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
25423327|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423328|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
25423329|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
25423330|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423331|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423332|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423333|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
25423334|NCT02385110|Hormones|hormones|mesh-ancestor
25423335|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423336|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423337|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423338|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25423339|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
25423340|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423341|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423342|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
25423343|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423344|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25423345|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423346|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25423347|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423348|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
25423349|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423350|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25423351|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423352|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423353|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423354|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423356|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
25423357|NCT02384668|Vitamins|vitamins|mesh-ancestor
25423358|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
25423359|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423360|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25423361|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25423362|NCT02384083|Dexamethasone|dexamethasone|mesh-list
25423363|NCT02384083|Pomalidomide|pomalidomide|mesh-list
25423364|NCT02384083|Filanesib|filanesib|mesh-list
25423365|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423366|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
25423367|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
25423368|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423369|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423370|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423371|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
25423372|NCT02384083|Hormones|hormones|mesh-ancestor
25423373|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423374|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423375|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423377|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25423378|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25423379|NCT02384083|Growth Substances|growth substances|mesh-ancestor
25423380|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
25423381|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423382|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423383|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423384|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
25423385|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423386|NCT02381535|Cisplatin|cisplatin|mesh-list
25423387|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423388|NCT02380573|Methylene Blue|methylene blue|mesh-list
25423389|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395073|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25395074|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25395075|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
25395076|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25395077|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395078|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25395079|NCT04105946|Narcotics|narcotics|mesh-ancestor
25395080|NCT04104646|Morphine|morphine|mesh-list
25395081|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25395082|NCT04104646|Narcotics|narcotics|mesh-ancestor
25395083|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25395084|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395085|NCT04104646|Analgesics|analgesics|mesh-ancestor
25395086|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
25395087|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25395088|NCT04102618|Trastuzumab|trastuzumab|mesh-list
25423390|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423391|NCT02379416|Paclitaxel|paclitaxel|mesh-list
25423392|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423393|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423394|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423395|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423396|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423397|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423398|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25423399|NCT02379377|Fluorides|fluorides|mesh-list
25423400|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25423401|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423402|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
25423403|NCT02379377|Protective Agents|protective agents|mesh-ancestor
25423404|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423405|NCT02376790|Etanercept|etanercept|mesh-list
25423406|NCT02376790|Methotrexate|methotrexate|mesh-list
25423407|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25423408|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
25423409|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423410|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423411|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423412|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
25423413|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423414|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423415|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25423416|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423417|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25423418|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423419|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
25423420|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423421|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25423428|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25423429|NCT02375204|Paclitaxel|paclitaxel|mesh-list
25423430|NCT02375204|Etoposide|etoposide|mesh-list
25423431|NCT02375204|Cisplatin|cisplatin|mesh-list
25423432|NCT02375204|Carboplatin|carboplatin|mesh-list
25423433|NCT02375204|Ifosfamide|ifosfamide|mesh-list
25423434|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
25423435|NCT02375204|Lenograstim|lenograstim|mesh-list
25423436|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423437|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423438|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423439|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423440|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423441|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423442|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423443|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423444|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423445|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25423446|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
25423447|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423448|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423449|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
25423450|NCT02370329|Interferons|interferons|mesh-list
25423451|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
25423452|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
25423453|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25423454|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25423455|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423456|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
25423457|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423458|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
25423459|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423461|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423462|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423463|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423464|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423465|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423466|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423467|NCT02369484|Afatinib|afatinib|mesh-list
25423468|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423469|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25423470|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423471|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423478|NCT02365766|Gemcitabine|gemcitabine|mesh-list
25423479|NCT02365766|Cisplatin|cisplatin|mesh-list
25423480|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
25423481|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423482|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423483|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
25423484|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423485|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
25423486|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423487|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423488|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423489|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
25423490|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423491|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423492|NCT02365597|Metformin|metformin|mesh-list
25423493|NCT02365597|Midazolam|midazolam|mesh-list
25423494|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25423495|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423496|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25423497|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25423498|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25423499|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25423500|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25423501|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25423502|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25423503|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
25423504|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
25423505|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
25423506|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
25423507|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25423508|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423509|NCT02363374|Leucovorin|leucovorin|mesh-list
25423510|NCT02363374|Folic Acid|folic acid|mesh-list
25423511|NCT02363374|Fluorouracil|fluorouracil|mesh-list
25423512|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
25423513|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
25423514|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
25423515|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423516|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423517|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423518|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423519|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
25423520|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423521|NCT02363374|Antidotes|antidotes|mesh-ancestor
25423522|NCT02363374|Protective Agents|protective agents|mesh-ancestor
25423523|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
25423524|NCT02363374|Vitamins|vitamins|mesh-ancestor
25423525|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
25423526|NCT02363374|Hematinics|hematinics|mesh-ancestor
25423527|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25423528|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25423529|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423530|NCT02363335|Incretins|incretins|mesh-ancestor
25423531|NCT02363335|Hormones|hormones|mesh-ancestor
25423532|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423533|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25423534|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
25423535|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423536|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423537|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
25423538|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423539|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423540|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
25423541|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423542|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423543|NCT02362503|Fostemsavir|fostemsavir|mesh-list
25423545|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25423546|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
25423547|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423548|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25423549|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25423550|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423551|NCT02359968|Paclitaxel|paclitaxel|mesh-list
25423552|NCT02359968|Fluorouracil|fluorouracil|mesh-list
25423553|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
25423554|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423555|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423556|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423557|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423558|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423559|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423560|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
25423561|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423562|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423563|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
25423564|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423565|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
25423566|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423567|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423568|NCT02358967|Vitamin E|vitamin e|mesh-list
25423569|NCT02358967|Tocopherols|tocopherols|mesh-list
25423570|NCT02358967|Tocotrienols|tocotrienols|mesh-list
25423571|NCT02358967|Vitamins|vitamins|mesh-ancestor
25423572|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
25423573|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423574|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
25423575|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423576|NCT02358967|Protective Agents|protective agents|mesh-ancestor
25423577|NCT02358538|Ganaxolone|ganaxolone|mesh-list
25423578|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
25423579|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25423580|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423581|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423582|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
25423583|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
25423584|NCT02358031|Cisplatin|cisplatin|mesh-list
25423585|NCT02358031|Carboplatin|carboplatin|mesh-list
25423586|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
25423587|NCT02358031|Cetuximab|cetuximab|mesh-list
25423588|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423589|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423590|NCT02356159|Rituximab|rituximab|mesh-list
25423591|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423592|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423593|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
25423594|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423595|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423596|NCT02354586|Niraparib|niraparib|mesh-list
25423597|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25423598|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423599|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423600|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423601|NCT02354131|Bevacizumab|bevacizumab|mesh-list
25395303|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25395304|NCT04094090|Riboflavin|riboflavin|mesh-list
25395305|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
25395306|NCT04094090|Vitamins|vitamins|mesh-ancestor
25395307|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
25395308|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395309|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25395310|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
25395311|NCT04093362|Gemcitabine|gemcitabine|mesh-list
25395312|NCT04093362|Cisplatin|cisplatin|mesh-list
25395313|NCT04093362|Futibatinib|futibatinib|mesh-list
25395314|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395315|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25395316|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
25395317|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25395318|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
25395319|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25395320|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25395321|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25395322|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
25395323|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395324|NCT04093323|Interferons|interferons|mesh-list
25395325|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
25395326|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
25395327|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25395328|NCT04093323|Celecoxib|celecoxib|mesh-list
25395329|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25423602|NCT02354131|Niraparib|niraparib|mesh-list
25423603|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423604|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423605|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25423606|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25423607|NCT02354131|Growth Substances|growth substances|mesh-ancestor
25423608|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423609|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
25423610|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25423611|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423612|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423613|NCT02354014|Bedaquiline|bedaquiline|mesh-list
25423614|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
25423615|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
25423616|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25423617|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423618|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
25423619|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25423620|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25423621|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25423622|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25423623|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423624|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
25423625|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25423626|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423627|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25423628|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423629|NCT02352337|Gemcitabine|gemcitabine|mesh-list
25423630|NCT02352337|Folfirinox|folfirinox|mesh-list
25423631|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423632|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
25423633|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423634|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423635|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
25423636|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423637|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423638|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423639|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
25423640|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423641|NCT02352090|Dienogest|dienogest|mesh-list
25423642|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25423643|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25423644|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25423645|NCT02352090|Estradiol|estradiol|mesh-list
25423646|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25423647|NCT02352090|Nandrolone|nandrolone|mesh-list
25423648|NCT02352090|Estrogens|estrogens|mesh-ancestor
25423649|NCT02352090|Hormones|hormones|mesh-ancestor
25423650|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423651|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423652|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25423653|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
25423654|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423655|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25423656|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25423657|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25423658|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25423659|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
25423660|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423661|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423662|NCT02352090|Androgens|androgens|mesh-ancestor
25423663|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
25423664|NCT02349867|Gemcitabine|gemcitabine|mesh-list
25423665|NCT02349867|Sorafenib|sorafenib|mesh-list
25423666|NCT02349867|Vorinostat|vorinostat|mesh-list
25423667|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423668|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
25423669|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423670|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423671|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
25423672|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423673|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423674|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423675|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
25423676|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423677|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25423678|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25423679|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
25423680|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25423681|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
25423682|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423683|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423684|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25423685|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25423686|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25423687|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
25423688|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423689|NCT02348008|Bevacizumab|bevacizumab|mesh-list
25423690|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
25423691|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423692|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423693|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25423694|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25423695|NCT02348008|Growth Substances|growth substances|mesh-ancestor
25423696|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423697|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
25423702|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25423703|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
25423704|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25395456|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
25395457|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25395458|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25395459|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25395460|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
25423705|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423706|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423707|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423708|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
25423709|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
25423710|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423711|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
25423712|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25423713|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
25423714|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25423715|NCT02344472|Paclitaxel|paclitaxel|mesh-list
25423716|NCT02344472|Vinorelbine|vinorelbine|mesh-list
25423717|NCT02344472|Docetaxel|docetaxel|mesh-list
25423718|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25423719|NCT02344472|Capecitabine|capecitabine|mesh-list
25423720|NCT02344472|Trastuzumab|trastuzumab|mesh-list
25423721|NCT02344472|Letrozole|letrozole|mesh-list
25423722|NCT02344472|Fulvestrant|fulvestrant|mesh-list
25423723|NCT02344472|Anastrozole|anastrozole|mesh-list
25423724|NCT02344472|Pertuzumab|pertuzumab|mesh-list
25423725|NCT02344472|Exemestane|exemestane|mesh-list
25423726|NCT02344472|Goserelin|goserelin|mesh-list
25423727|NCT02344472|Leuprolide|leuprolide|mesh-list
25423728|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423729|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423730|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423731|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423732|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423733|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423734|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423735|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
25423809|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423736|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423737|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25423738|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25423739|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423740|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25423741|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
25423742|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423743|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423744|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423745|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25423746|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25423747|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
25423748|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423749|NCT02344290|Pitavastatin|pitavastatin|mesh-list
25423750|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25423751|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25423752|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25423753|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
25423754|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423755|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423756|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25423757|NCT02344186|Liraglutide|liraglutide|mesh-list
25423758|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25423759|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423760|NCT02344186|Incretins|incretins|mesh-ancestor
25423761|NCT02344186|Hormones|hormones|mesh-ancestor
25423762|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423763|NCT02341625|Nivolumab|nivolumab|mesh-list
25423764|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423765|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423766|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25423767|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423768|NCT02339571|Nivolumab|nivolumab|mesh-list
25423769|NCT02339571|Ipilimumab|ipilimumab|mesh-list
25423770|NCT02339571|Sargramostim|sargramostim|mesh-list
25423771|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423772|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423773|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25423774|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423775|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
25423776|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423778|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25423779|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25423780|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25423781|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423782|NCT02337985|Prednisone|prednisone|mesh-list
25423783|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
25423784|NCT02337985|Rituximab|rituximab|mesh-list
25423785|NCT02337985|Doxorubicin|doxorubicin|mesh-list
25423786|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25423787|NCT02337985|Etoposide|etoposide|mesh-list
25423788|NCT02337985|Vincristine|vincristine|mesh-list
25423789|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423790|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
25423791|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423792|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423793|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423794|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
25423795|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423796|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423797|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25423798|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423799|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423800|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423801|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423802|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423803|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423804|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
25423805|NCT02337985|Hormones|hormones|mesh-ancestor
25423806|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423807|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423808|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423810|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423811|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423813|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423814|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423815|NCT02335411|Cisplatin|cisplatin|mesh-list
25423816|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
25423817|NCT02335411|Capecitabine|capecitabine|mesh-list
25423818|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423819|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423820|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423821|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
25423822|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423823|NCT02334735|Vaccines|vaccines|mesh-list
25423824|NCT02334735|Poly ICLC|poly iclc|mesh-list
25423825|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25423826|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
25423827|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423828|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
25423829|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25423830|NCT02333370|Tamoxifen|tamoxifen|mesh-list
25423831|NCT02333370|Letrozole|letrozole|mesh-list
25423832|NCT02333370|Fulvestrant|fulvestrant|mesh-list
25423833|NCT02333370|Goserelin|goserelin|mesh-list
25423834|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423835|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25423836|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25423837|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423838|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423839|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25423840|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
25423841|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25423842|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423843|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423844|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25423845|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25423846|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25423847|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25423848|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
25423849|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423850|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423851|NCT02332577|Amoxicillin|amoxicillin|mesh-list
25423852|NCT02332577|Pristinamycin|pristinamycin|mesh-list
25423853|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25423854|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423857|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25423858|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423859|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423860|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423861|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423862|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423863|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423864|NCT02327455|Dobutamine|dobutamine|mesh-list
25423865|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25423866|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
25423867|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
25423868|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423869|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423870|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25423871|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25423872|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25423873|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
25423874|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25423875|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423876|NCT02327455|Protective Agents|protective agents|mesh-ancestor
25423877|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25423878|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25423879|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423880|NCT02323698|Caffeine|caffeine|mesh-list
25423881|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25423882|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423883|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25423884|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423885|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423886|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25423887|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25423888|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
25423889|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25423890|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
25423891|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25423892|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25423893|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25423894|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25423895|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423896|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
25423897|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25423898|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423899|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25423900|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423902|NCT02320435|Pertuzumab|pertuzumab|mesh-list
25423903|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423904|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423905|NCT02319837|Leuprolide|leuprolide|mesh-list
25423906|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25423907|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
25423908|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25423909|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423910|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25423911|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423912|NCT02317874|Paclitaxel|paclitaxel|mesh-list
25423913|NCT02317874|Carboplatin|carboplatin|mesh-list
25423914|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25423915|NCT02317874|Talazoparib|talazoparib|mesh-list
25423916|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423917|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423918|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423919|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423920|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423921|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423922|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25395708|NCT04081389|Analgesics|analgesics|mesh-ancestor
25423923|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423924|NCT02316171|Mitomycins|mitomycins|mesh-list
25423925|NCT02316171|Mitomycin|mitomycin|mesh-list
25423926|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423927|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423928|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
25423929|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423930|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25423934|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423935|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
25423936|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423938|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423939|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423940|NCT02311920|Nivolumab|nivolumab|mesh-list
25423941|NCT02311920|Ipilimumab|ipilimumab|mesh-list
25423942|NCT02311920|Temozolomide|temozolomide|mesh-list
25423943|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25423944|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423945|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25423946|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423947|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423948|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
25423949|NCT02310321|Cytarabine|cytarabine|mesh-list
25423950|NCT02310321|Idarubicin|idarubicin|mesh-list
25423951|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25423952|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
25423953|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423954|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423955|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
25423956|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25423957|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423958|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
25423959|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423960|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423961|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423962|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423963|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423964|NCT02308280|Bortezomib|bortezomib|mesh-list
25423965|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423966|NCT02307812|Paclitaxel|paclitaxel|mesh-list
25423967|NCT02307812|Ramucirumab|ramucirumab|mesh-list
25423968|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423969|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423970|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
25423971|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
25423972|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25423973|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423974|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
25423975|NCT02306161|Ifosfamide|ifosfamide|mesh-list
25423976|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
25423977|NCT02306161|Doxorubicin|doxorubicin|mesh-list
25423978|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25423979|NCT02306161|Etoposide|etoposide|mesh-list
25423980|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
25423981|NCT02306161|Vincristine|vincristine|mesh-list
25423982|NCT02306161|Daunorubicin|daunorubicin|mesh-list
25423983|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
25423984|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25423985|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25423986|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
25423987|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423988|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423989|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25423990|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
25423991|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423992|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25423993|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25423994|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25423995|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25423996|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25423997|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25423998|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25423999|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424000|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424001|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424002|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
25424003|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
25424004|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25424005|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25424006|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424007|NCT02304783|Acetaminophen|acetaminophen|mesh-list
25424008|NCT02304783|Piroxicam|piroxicam|mesh-list
25424009|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25424010|NCT02304783|Analgesics|analgesics|mesh-ancestor
25424011|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
25424012|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424013|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424014|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
25424015|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25424016|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424017|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424018|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25424019|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424020|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424021|NCT02304458|Nivolumab|nivolumab|mesh-list
25424022|NCT02304458|Ipilimumab|ipilimumab|mesh-list
25424023|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424024|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424025|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25424026|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424027|NCT02300922|Antibodies|antibodies|mesh-list
25424028|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
25424029|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424030|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
25424031|NCT02299414|Nifedipine|nifedipine|mesh-list
25424032|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25424033|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25424034|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424035|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25424036|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424037|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
25424038|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
25424039|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25424040|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
25424041|NCT02298959|Aflibercept|aflibercept|mesh-list
25424042|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
25424043|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424044|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424045|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25424046|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25424047|NCT02298959|Growth Substances|growth substances|mesh-ancestor
25424048|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424049|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
25424050|NCT02298257|Doxorubicin|doxorubicin|mesh-list
25424051|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25424052|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25424053|NCT02298257|Dacarbazine|dacarbazine|mesh-list
25424054|NCT02298257|Vinblastine|vinblastine|mesh-list
25424055|NCT02298257|Antibodies|antibodies|mesh-list
25424056|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
25424057|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25424058|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
25424059|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
25424060|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424061|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25424062|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424063|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25424064|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25424065|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424066|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424067|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424068|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424069|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
25424070|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25424071|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424072|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424073|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424074|NCT02297698|Trastuzumab|trastuzumab|mesh-list
25424075|NCT02297698|Sargramostim|sargramostim|mesh-list
25424076|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424077|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424078|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
25424079|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424080|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
25424081|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25424082|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
25424083|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25424084|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25424238|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424085|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424086|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
25424087|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424088|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424089|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25424090|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
25424091|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
25424092|NCT02297503|Protective Agents|protective agents|mesh-ancestor
25424093|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25424094|NCT02296125|Gefitinib|gefitinib|mesh-list
25424095|NCT02296125|Osimertinib|osimertinib|mesh-list
25424096|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424097|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25424098|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424099|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424100|NCT02293954|Antibodies|antibodies|mesh-list
25424101|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25424102|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
25424103|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424104|NCT02292979|Doxorubicin|doxorubicin|mesh-list
25424105|NCT02292979|Bleomycin|bleomycin|mesh-list
25424106|NCT02292979|Dacarbazine|dacarbazine|mesh-list
25424107|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25424109|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25424110|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424111|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25424112|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25424113|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424114|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424115|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424116|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
25424117|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424118|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25424119|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424120|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424121|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424122|NCT02288195|Capecitabine|capecitabine|mesh-list
25424123|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
25424124|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424125|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
25424126|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424127|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424128|NCT02287233|Cytarabine|cytarabine|mesh-list
25424129|NCT02287233|Venetoclax|venetoclax|mesh-list
25424130|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424131|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
25424132|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424133|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424134|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
25424135|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424136|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424137|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
25424138|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424139|NCT02285959|Bevacizumab|bevacizumab|mesh-list
25424140|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424141|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424142|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25424143|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25424144|NCT02285959|Growth Substances|growth substances|mesh-ancestor
25424145|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424146|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
25424147|NCT02285140|Vancomycin|vancomycin|mesh-list
25424148|NCT02285140|Cefazolin|cefazolin|mesh-list
25424149|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25424150|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424151|NCT02285062|Prednisone|prednisone|mesh-list
25424152|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
25424153|NCT02285062|Rituximab|rituximab|mesh-list
25424154|NCT02285062|Doxorubicin|doxorubicin|mesh-list
25424155|NCT02285062|Vincristine|vincristine|mesh-list
25424156|NCT02285062|Lenalidomide|lenalidomide|mesh-list
25424157|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424158|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
25424159|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424160|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424161|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424162|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
25424163|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424164|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424165|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25424166|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424167|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25424168|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25424169|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25424170|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424171|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424172|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
25424173|NCT02285062|Hormones|hormones|mesh-ancestor
25424174|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424175|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424176|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25424177|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424178|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424179|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424180|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25424181|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25424182|NCT02285062|Growth Substances|growth substances|mesh-ancestor
25424183|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
25424184|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
25424185|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25424186|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
25424187|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
25424188|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
25424189|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25424190|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424191|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25424192|NCT02282358|Mocetinostat|mocetinostat|mesh-list
25424193|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25424194|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424195|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424196|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
25424197|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
25424198|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25424199|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25424200|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424201|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25424202|NCT02282319|Analgesics|analgesics|mesh-ancestor
25424203|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
25424204|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424205|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25424206|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25424207|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25424208|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
25424209|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424210|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424211|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
25424212|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
25424213|NCT02281084|Azacitidine|azacitidine|mesh-list
25424214|NCT02281084|Durvalumab|durvalumab|mesh-list
25424215|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424216|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
25424217|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424218|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424219|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424220|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424221|NCT02279654|Lenalidomide|lenalidomide|mesh-list
25424222|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
25424223|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424224|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25424225|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25424226|NCT02279654|Growth Substances|growth substances|mesh-ancestor
25424227|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
25424228|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424229|NCT02278965|Metformin|metformin|mesh-list
25424230|NCT02278965|Biguanides|biguanides|mesh-list
25424231|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25424232|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424233|NCT02278601|Fentanyl|fentanyl|mesh-list
25424234|NCT02278601|Ropivacaine|ropivacaine|mesh-list
25424235|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
25424236|NCT02278601|Anesthetics|anesthetics|mesh-list
25424237|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25424239|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
25424240|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424241|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25424242|NCT02278601|Narcotics|narcotics|mesh-ancestor
25424243|NCT02278601|Analgesics|analgesics|mesh-ancestor
25424244|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25424245|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25424246|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
25424247|NCT02278120|Tamoxifen|tamoxifen|mesh-list
25424248|NCT02278120|Letrozole|letrozole|mesh-list
25424249|NCT02278120|Anastrozole|anastrozole|mesh-list
25424250|NCT02278120|Goserelin|goserelin|mesh-list
25424251|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424252|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25424253|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25424254|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424255|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424256|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25424257|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
25424258|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424259|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424260|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424261|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25424262|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25424263|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25424265|NCT02277444|Methotrexate|methotrexate|mesh-list
25424266|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25424267|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
25424268|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25424269|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424270|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424271|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
25424272|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424273|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424274|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
25424275|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424276|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25424277|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424278|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
25424279|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424280|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25424281|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25424282|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424283|NCT02275780|Ritonavir|ritonavir|mesh-list
25424284|NCT02275780|Darunavir|darunavir|mesh-list
25424285|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25424286|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25424287|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25424288|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
25424289|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424290|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424291|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25424292|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25424293|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
25424294|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424295|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25424296|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25424297|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25424298|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25424299|NCT02275533|Nivolumab|nivolumab|mesh-list
25424300|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424301|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424302|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25424303|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424304|NCT02274415|Vaccines|vaccines|mesh-list
25424305|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25424306|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
25424307|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424308|NCT02272790|Gemcitabine|gemcitabine|mesh-list
25424309|NCT02272790|Paclitaxel|paclitaxel|mesh-list
25424310|NCT02272790|Carboplatin|carboplatin|mesh-list
25424311|NCT02272790|Adavosertib|adavosertib|mesh-list
25424312|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25424313|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424332|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424333|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424334|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424335|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424336|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424337|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424338|NCT02268695|Cisplatin|cisplatin|mesh-list
25424339|NCT02268695|Docetaxel|docetaxel|mesh-list
25424340|NCT02268695|Cetuximab|cetuximab|mesh-list
25424341|NCT02268695|Lenograstim|lenograstim|mesh-list
25424342|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424343|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424344|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424345|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424346|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424347|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424348|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25424349|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
25424350|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424351|NCT02268656|Propofol|propofol|mesh-list
25424352|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25424353|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25424354|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424355|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25424356|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
25424357|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
25424358|NCT02264678|Carboplatin|carboplatin|mesh-list
25424359|NCT02264678|Durvalumab|durvalumab|mesh-list
25424360|NCT02264678|Olaparib|olaparib|mesh-list
25424361|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424362|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424363|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25424364|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424365|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424366|NCT02259621|Paclitaxel|paclitaxel|mesh-list
25424367|NCT02259621|Carboplatin|carboplatin|mesh-list
25424368|NCT02259621|Nivolumab|nivolumab|mesh-list
25424369|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25424370|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424371|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424372|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424373|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424374|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424375|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424376|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25424391|NCT02257736|Prednisone|prednisone|mesh-list
25424392|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
25424393|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424394|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
25424395|NCT02257736|Hormones|hormones|mesh-ancestor
25424396|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424397|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424398|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424399|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424400|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25424401|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424402|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424403|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
25424404|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25424405|NCT02257528|Nivolumab|nivolumab|mesh-list
25424406|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424407|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425244|NCT02157883|Itraconazole|itraconazole|mesh-list
25424408|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25424409|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424411|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424412|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
25424413|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424414|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424415|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424416|NCT02255799|Donepezil|donepezil|mesh-list
25424417|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25424418|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424419|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424420|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
25424421|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424422|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424423|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
25424424|NCT02254278|Cisplatin|cisplatin|mesh-list
25424425|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424426|NCT02253316|Dexamethasone|dexamethasone|mesh-list
25424427|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
25424428|NCT02253316|Lenalidomide|lenalidomide|mesh-list
25424429|NCT02253316|Ixazomib|ixazomib|mesh-list
25424430|NCT02253316|BB 1101|bb 1101|mesh-list
25424431|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424432|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
25424433|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
25424434|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424435|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424436|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25424437|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
25424438|NCT02253316|Hormones|hormones|mesh-ancestor
25424439|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424440|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424441|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424442|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
25424443|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424444|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424445|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
25424446|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25424447|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25424448|NCT02253316|Growth Substances|growth substances|mesh-ancestor
25424449|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
25424450|NCT02252172|Dexamethasone|dexamethasone|mesh-list
25424451|NCT02252172|Lenalidomide|lenalidomide|mesh-list
25424452|NCT02252172|Daratumumab|daratumumab|mesh-list
25424453|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25424454|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424455|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
25424456|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
25424457|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424458|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424459|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25424460|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
25424461|NCT02252172|Hormones|hormones|mesh-ancestor
25424462|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424463|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424464|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424465|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
25424466|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25424467|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25424474|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424475|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424476|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424477|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424478|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424479|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424480|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25424481|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
25424482|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25424483|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424484|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424485|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
25424486|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
25424487|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424488|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25424489|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424490|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
25424491|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424492|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25424494|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
25424495|NCT02250937|Busulfan|busulfan|mesh-list
25424496|NCT02250937|Venetoclax|venetoclax|mesh-list
25424497|NCT02250937|Cladribine|cladribine|mesh-list
25424498|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25424499|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424500|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424501|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
25424502|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424503|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424504|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
25424505|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424506|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
25424507|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424508|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25424509|NCT02249104|Adapalene|adapalene|mesh-list
25424510|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25424511|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25424512|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
25424513|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25424514|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25424515|NCT02249104|Analgesics|analgesics|mesh-ancestor
25424516|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
25424517|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424518|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424519|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424520|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424521|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25424522|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25424523|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25424524|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25424525|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25424526|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
25424527|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424528|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424529|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424530|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
25424531|NCT02248701|Finasteride|finasteride|mesh-list
25424532|NCT02248701|Testosterone|testosterone|mesh-list
25424533|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
25424534|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
25424535|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25424536|NCT02248701|Androgens|androgens|mesh-ancestor
25424537|NCT02248701|Hormones|hormones|mesh-ancestor
25424538|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424539|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424540|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424541|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424542|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
25424543|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25424544|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25424545|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424546|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424547|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
25424548|NCT02248701|Urological Agents|urological agents|mesh-ancestor
25424555|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424556|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
25424557|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424558|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424559|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424560|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
25424561|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424562|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424563|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25424564|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424565|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
25424566|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25424567|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424568|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25424569|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25424570|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
25424571|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25424572|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25396296|NCT04060030|Leucovorin|leucovorin|mesh-list
25396297|NCT04060030|Calcium|calcium|mesh-list
25396298|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
25424573|NCT02246621|Letrozole|letrozole|mesh-list
25424574|NCT02246621|Anastrozole|anastrozole|mesh-list
25424575|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424576|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25424577|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25424578|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424579|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424580|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25424581|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
25424582|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424583|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424584|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424585|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
25424586|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25424587|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25424588|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25424589|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25424590|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424591|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25424592|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424593|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424594|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25424595|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424596|NCT02233829|Dopamine|dopamine|mesh-list
25424597|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25424598|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
25424599|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
25424600|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424601|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424602|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
25424603|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424604|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424605|NCT02233829|Protective Agents|protective agents|mesh-ancestor
25424606|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
25424607|NCT02232152|Fluorouracil|fluorouracil|mesh-list
25424608|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
25424609|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424610|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424611|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424612|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424613|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
25424614|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424615|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
25424616|NCT02232152|Protective Agents|protective agents|mesh-ancestor
25424617|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
25424618|NCT02232152|Vitamins|vitamins|mesh-ancestor
25424619|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
25424620|NCT02230969|Interferons|interferons|mesh-list
25424621|NCT02230969|Interferon-beta|interferon-beta|mesh-list
25424622|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
25424623|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424624|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
25424625|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424626|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
25424627|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424628|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25424629|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
25424632|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424633|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424634|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25424635|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25424636|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
25424637|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25424638|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25424639|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
25424640|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424718|NCT02223208|Prednisone|prednisone|mesh-list
25424641|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424642|NCT02229656|Olaparib|olaparib|mesh-list
25424643|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25424644|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424645|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424646|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424647|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25424648|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
25424649|NCT02227992|Coagulants|coagulants|mesh-ancestor
25424650|NCT02226159|Dexamethasone|dexamethasone|mesh-list
25424651|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
25424652|NCT02226159|Lidocaine|lidocaine|mesh-list
25424653|NCT02226159|BB 1101|bb 1101|mesh-list
25424654|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424655|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
25424656|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
25424657|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424658|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424659|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25424660|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
25424661|NCT02226159|Hormones|hormones|mesh-ancestor
25424662|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424663|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424664|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424665|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
25424666|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424667|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424668|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
25424669|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
25424670|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25424671|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
25424672|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25424673|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25424674|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25424675|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25424676|NCT02225275|Lenalidomide|lenalidomide|mesh-list
25424677|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
25424678|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
25424679|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424680|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25424681|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25424682|NCT02225275|Growth Substances|growth substances|mesh-ancestor
25424683|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25424684|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424685|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424686|NCT02224781|Nivolumab|nivolumab|mesh-list
25424687|NCT02224781|Ipilimumab|ipilimumab|mesh-list
25424688|NCT02224781|Trametinib|trametinib|mesh-list
25424689|NCT02224781|Dabrafenib|dabrafenib|mesh-list
25424690|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25424691|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424692|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424693|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25424694|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424695|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25424696|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424697|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25424698|NCT02224781|Protective Agents|protective agents|mesh-ancestor
25424699|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424700|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25424701|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
25424702|NCT02224703|Cannabidiol|cannabidiol|mesh-list
25424703|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
25424704|NCT02224690|Cannabidiol|cannabidiol|mesh-list
25424705|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
25424706|NCT02224560|Cannabidiol|cannabidiol|mesh-list
25424707|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
25424709|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25424710|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
25424711|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425245|NCT02157883|Osimertinib|osimertinib|mesh-list
25424712|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424713|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25424714|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25424715|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
25424716|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424717|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424719|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
25424720|NCT02223208|Doxorubicin|doxorubicin|mesh-list
25424721|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25424722|NCT02223208|Etoposide|etoposide|mesh-list
25424723|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
25396450|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
25396451|NCT04048863|Imidacloprid|imidacloprid|mesh-list
25396452|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
25396453|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25396454|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396455|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396456|NCT04047836|Nicotine|nicotine|mesh-list
25396482|NCT04047446|Hormones|hormones|mesh-ancestor
25424724|NCT02223208|Romidepsin|romidepsin|mesh-list
25424725|NCT02223208|Vincristine|vincristine|mesh-list
25424726|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424727|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
25424728|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424729|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424730|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424731|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
25424732|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424733|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424734|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25424735|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25424736|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25424737|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25424738|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424739|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424740|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
25424741|NCT02223208|Hormones|hormones|mesh-ancestor
25424742|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424743|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424744|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25424745|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424746|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424747|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424748|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
25424749|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424750|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424751|NCT02220894|Paclitaxel|paclitaxel|mesh-list
25424752|NCT02220894|Carboplatin|carboplatin|mesh-list
25424753|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
25424754|NCT02220894|Pemetrexed|pemetrexed|mesh-list
25424755|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25424756|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424757|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
25424758|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
25424759|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
25424760|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424761|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424762|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424763|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25424764|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25424765|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
25424766|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25424767|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25424768|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25424769|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424770|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
25424771|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
25424772|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
25424773|NCT02219373|Gabapentin|gabapentin|mesh-list
25424774|NCT02219373|Analgesics|analgesics|mesh-ancestor
25424775|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
25424776|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424777|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424778|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
25424779|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25424780|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25424781|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25424782|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25424783|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25424784|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25424990|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25424785|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25424786|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424787|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
25424788|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25424789|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25424790|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25424791|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25424792|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25424793|NCT02217709|Phenelzine|phenelzine|mesh-list
25424794|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
25424795|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25424796|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25424797|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424798|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424799|NCT02213575|Minocycline|minocycline|mesh-list
25424800|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25424801|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424802|NCT02213107|Dutasteride|dutasteride|mesh-list
25424803|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25424804|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25424805|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424806|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424807|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
25424808|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424809|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424810|NCT02211755|Bortezomib|bortezomib|mesh-list
25424811|NCT02211755|Clofarabine|clofarabine|mesh-list
25424812|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424813|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424814|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
25424815|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424816|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
25424817|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
25424818|NCT02209636|Vitamins|vitamins|mesh-ancestor
25424819|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
25424820|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424821|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
25424822|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424823|NCT02209636|Protective Agents|protective agents|mesh-ancestor
25424824|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
25424825|NCT02205515|Everolimus|everolimus|mesh-list
25424826|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424827|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424828|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
25424829|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424830|NCT02203526|Cytarabine|cytarabine|mesh-list
25424831|NCT02203526|Isavuconazole|isavuconazole|mesh-list
25424832|NCT02203526|Rituximab|rituximab|mesh-list
25424833|NCT02203526|Methotrexate|methotrexate|mesh-list
25424834|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424835|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424836|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
25424837|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424838|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424839|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25424840|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
25424841|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25424842|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424843|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
25424844|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424845|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
25424846|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424847|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25424848|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424849|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25424850|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
25424851|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424852|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
25424853|NCT02201992|Crizotinib|crizotinib|mesh-list
25424854|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424855|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25424856|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424857|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424858|NCT02200445|Aldesleukin|aldesleukin|mesh-list
25424859|NCT02200445|Interleukin-2|interleukin-2|mesh-list
25424860|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424861|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25424862|NCT02200445|Analgesics|analgesics|mesh-ancestor
25424863|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
25424864|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424884|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25424885|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424886|NCT02196181|Trametinib|trametinib|mesh-list
25424887|NCT02196181|Dabrafenib|dabrafenib|mesh-list
25424888|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25424889|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424890|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25424891|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424892|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424893|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25424894|NCT02196181|Protective Agents|protective agents|mesh-ancestor
25424895|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424896|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25424897|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
25424898|NCT02195479|Dexamethasone|dexamethasone|mesh-list
25424899|NCT02195479|Prednisone|prednisone|mesh-list
25424900|NCT02195479|Melphalan|melphalan|mesh-list
25424901|NCT02195479|Bortezomib|bortezomib|mesh-list
25424902|NCT02195479|Daratumumab|daratumumab|mesh-list
25424903|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25424904|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25424905|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
25424906|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
25424907|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424908|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424909|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25424910|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
25424911|NCT02195479|Hormones|hormones|mesh-ancestor
25424912|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424913|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25424914|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424915|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424916|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
25424917|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424918|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25424919|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424920|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
25424955|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424956|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424957|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
25424959|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25424960|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25424961|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424962|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
25424963|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424964|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424965|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25424966|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
25424967|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424968|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424969|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25424970|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25424971|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25424972|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25424973|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424974|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424975|NCT02188264|Cyclosporine|cyclosporine|mesh-list
25424976|NCT02188264|Cyclosporins|cyclosporins|mesh-list
25424977|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424978|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424979|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424980|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
25424981|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424982|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
25424983|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424984|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
25424985|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25424986|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25424987|NCT02188121|Losartan|losartan|mesh-list
25424988|NCT02188121|Simvastatin|simvastatin|mesh-list
25424989|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25424992|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424993|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25424994|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25424995|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424996|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25424997|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25424998|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25424999|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25425000|NCT02186834|Dexamethasone|dexamethasone|mesh-list
25425001|NCT02186834|Doxorubicin|doxorubicin|mesh-list
25425002|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25425003|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425004|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
25425005|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
25425006|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425007|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425008|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25425009|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
25425010|NCT02186834|Hormones|hormones|mesh-ancestor
25425011|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425012|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425013|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425014|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425015|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425016|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425017|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425018|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425019|NCT02185560|Sorafenib|sorafenib|mesh-list
25425020|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425021|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425022|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425023|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425024|NCT02185209|Amoxicillin|amoxicillin|mesh-list
25425025|NCT02185209|Metronidazole|metronidazole|mesh-list
25425026|NCT02185209|Penicillin V|penicillin v|mesh-list
25425027|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25425028|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425029|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25425030|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25425031|NCT02184195|Olaparib|olaparib|mesh-list
25425032|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25425033|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425034|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425035|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425036|NCT02180867|Doxorubicin|doxorubicin|mesh-list
25425037|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25425038|NCT02180867|Daunorubicin|daunorubicin|mesh-list
25425039|NCT02180867|Ifosfamide|ifosfamide|mesh-list
25425040|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
25425041|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425042|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425043|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425044|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425045|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425046|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425047|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425048|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
25425049|NCT02180711|Rituximab|rituximab|mesh-list
25425050|NCT02180711|Lenalidomide|lenalidomide|mesh-list
25425051|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
25425052|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425053|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425054|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
25425055|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425056|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425057|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25425058|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25425059|NCT02180711|Growth Substances|growth substances|mesh-ancestor
25425060|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
25425061|NCT02177578|Temozolomide|temozolomide|mesh-list
25425062|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425063|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
25425064|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425065|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425066|NCT02177071|Methotrexate|methotrexate|mesh-list
25425070|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25425071|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
25425072|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25425073|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425074|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425075|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
25425076|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425077|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425078|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425079|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425080|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25425081|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425082|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
25425083|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425084|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25425085|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25425086|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
25425087|NCT02176967|Carboplatin|carboplatin|mesh-list
25425088|NCT02176967|Doxorubicin|doxorubicin|mesh-list
25425089|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25425090|NCT02176967|Etoposide|etoposide|mesh-list
25425091|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
25425092|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
25425093|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425094|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
25425095|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425096|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425097|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425098|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
25425099|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425100|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425101|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25425102|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425103|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425104|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425105|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425106|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425107|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
25425108|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425109|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425110|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425111|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425113|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425114|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
25425115|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425116|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425117|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425118|NCT02169310|Raclopride|raclopride|mesh-list
25425119|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25425120|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25425121|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25425122|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425123|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25425124|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25425125|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
25425126|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425127|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425128|NCT02169089|Spironolactone|spironolactone|mesh-list
25425129|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25425130|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
25425131|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425132|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425133|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25425134|NCT02169089|Diuretics|diuretics|mesh-ancestor
25425135|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
25425136|NCT02166463|Prednisone|prednisone|mesh-list
25425137|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
25425138|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25425139|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25425140|NCT02166463|Prednisolone|prednisolone|mesh-list
25425141|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
25425142|NCT02166463|Cortisone|cortisone|mesh-list
25425143|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
25425144|NCT02166463|Doxorubicin|doxorubicin|mesh-list
25425145|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25425146|NCT02166463|Etoposide|etoposide|mesh-list
25425152|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25425153|NCT02166463|Antibodies|antibodies|mesh-list
25425154|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
25425155|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25425156|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
25425157|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25425158|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
25425159|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425160|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
25425161|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425162|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425163|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425164|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
25425165|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425166|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425167|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25425168|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425169|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425170|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425171|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425172|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425173|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
25425174|NCT02166463|Hormones|hormones|mesh-ancestor
25425328|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425175|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425176|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425177|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425178|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425179|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425180|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425181|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
25425182|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
25425183|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425184|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25425185|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25425186|NCT02166463|Protective Agents|protective agents|mesh-ancestor
25425187|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
25425188|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425189|NCT02165007|Sirolimus|sirolimus|mesh-list
25425190|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25425191|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425192|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425193|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425194|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
25425195|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425196|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
25425197|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425198|NCT02163733|Osimertinib|osimertinib|mesh-list
25425199|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425200|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425201|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425202|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425203|NCT02162667|Trastuzumab|trastuzumab|mesh-list
25425204|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425205|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425206|NCT02160015|Rituximab|rituximab|mesh-list
25425207|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25425208|NCT02160015|Lenalidomide|lenalidomide|mesh-list
25425209|NCT02160015|Antibodies|antibodies|mesh-list
25425210|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
25425211|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25425212|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
25425213|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425214|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425215|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425216|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25425217|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25425218|NCT02160015|Growth Substances|growth substances|mesh-ancestor
25425219|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
25425220|NCT02159989|Aflibercept|aflibercept|mesh-list
25425221|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
25396912|NCT04025489|Vitamin D|vitamin d|mesh-list
25425222|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25425223|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25425224|NCT02159989|Growth Substances|growth substances|mesh-ancestor
25425225|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425226|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
25425227|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425228|NCT02159755|Palbociclib|palbociclib|mesh-list
25425229|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425230|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425231|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425232|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425233|NCT02158234|Cisplatin|cisplatin|mesh-list
25425234|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
25425235|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425236|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425237|NCT02157974|Exenatide|exenatide|mesh-list
25425238|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25425239|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425240|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25425241|NCT02157974|Incretins|incretins|mesh-ancestor
25425242|NCT02157974|Hormones|hormones|mesh-ancestor
25425243|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425246|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
25425247|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425248|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25425249|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25425250|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425251|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425252|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25425253|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
25425254|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425255|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425256|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25425257|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425258|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425259|NCT02157610|Nicotine|nicotine|mesh-list
25425260|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25425261|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
25425262|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425263|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425264|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25425265|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25425266|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
25425267|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425268|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425269|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
25425270|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425271|NCT02157051|Vaccines|vaccines|mesh-list
25425272|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
25425273|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425274|NCT02156739|Edetic Acid|edetic acid|mesh-list
25425275|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
25425276|NCT02156739|Antidotes|antidotes|mesh-ancestor
25425277|NCT02156739|Protective Agents|protective agents|mesh-ancestor
25425278|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425279|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
25425280|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
25425281|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425282|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25425283|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
25425284|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25425285|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25425286|NCT02154490|Nivolumab|nivolumab|mesh-list
25425287|NCT02154490|Ipilimumab|ipilimumab|mesh-list
25425288|NCT02154490|Durvalumab|durvalumab|mesh-list
25425289|NCT02154490|Rilotumumab|rilotumumab|mesh-list
25425290|NCT02154490|Docetaxel|docetaxel|mesh-list
25425291|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25425292|NCT02154490|Palbociclib|palbociclib|mesh-list
25425293|NCT02154490|Tremelimumab|tremelimumab|mesh-list
25425294|NCT02154490|Talazoparib|talazoparib|mesh-list
25425295|NCT02154490|Antibodies|antibodies|mesh-list
25425296|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
25425297|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25425298|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
25425299|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
25425300|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425301|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425302|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425303|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425304|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425305|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425306|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25425307|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425308|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425309|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25425310|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
25425311|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25425312|NCT02153580|Fludarabine|fludarabine|mesh-list
25425313|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
25425314|NCT02153580|Etoposide|etoposide|mesh-list
25425315|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
25425316|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
25425317|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425318|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
25425319|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425320|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425321|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425322|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
25425323|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425324|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425325|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25425326|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425327|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
25425329|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425330|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425331|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425332|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
25425333|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425334|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425335|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425336|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425337|NCT02152982|Temozolomide|temozolomide|mesh-list
25425338|NCT02152982|Veliparib|veliparib|mesh-list
25425339|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425340|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
25425341|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425342|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425343|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25425344|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425345|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25425346|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425347|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425348|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425349|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425350|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
25425351|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425352|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
25425353|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425354|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425355|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25425356|NCT02144584|Memantine|memantine|mesh-list
25425357|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25425358|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25425359|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
25425360|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425361|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425362|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425363|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25425364|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25425365|NCT02143414|Prednisone|prednisone|mesh-list
25425366|NCT02143414|Cortisone|cortisone|mesh-list
25425367|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25425368|NCT02143414|Methotrexate|methotrexate|mesh-list
25425369|NCT02143414|Vincristine|vincristine|mesh-list
25425370|NCT02143414|Dasatinib|dasatinib|mesh-list
25425371|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
25425372|NCT02143414|Blinatumomab|blinatumomab|mesh-list
25425373|NCT02143414|Antibodies|antibodies|mesh-list
25425374|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
25425375|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25425376|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
25425377|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25425378|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
25425379|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425380|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425381|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425382|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
25425383|NCT02143414|Hormones|hormones|mesh-ancestor
25425385|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425386|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25425387|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
25425388|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25425389|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425390|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
25425391|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425392|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425393|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425394|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25425395|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425396|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425397|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25425398|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425399|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425400|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425401|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425402|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425403|NCT02143401|Sorafenib|sorafenib|mesh-list
25425404|NCT02143401|Navitoclax|navitoclax|mesh-list
25425405|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425406|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425407|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425408|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425409|NCT02143388|Cisplatin|cisplatin|mesh-list
25425410|NCT02143388|Capecitabine|capecitabine|mesh-list
25425411|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425412|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425413|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
25425414|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425415|NCT02143219|Leucovorin|leucovorin|mesh-list
25425416|NCT02143219|Folic Acid|folic acid|mesh-list
25425417|NCT02143219|Irinotecan|irinotecan|mesh-list
25425418|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
25425419|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
25425420|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25425421|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425422|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425423|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425424|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425425|NCT02143219|Antidotes|antidotes|mesh-ancestor
25425426|NCT02143219|Protective Agents|protective agents|mesh-ancestor
25425427|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425428|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
25425429|NCT02143219|Vitamins|vitamins|mesh-ancestor
25425430|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
25425431|NCT02143219|Hematinics|hematinics|mesh-ancestor
25425432|NCT02141542|Tremelimumab|tremelimumab|mesh-list
25425433|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425436|NCT02140151|Ranibizumab|ranibizumab|mesh-list
25425437|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25425438|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25425439|NCT02140151|Growth Substances|growth substances|mesh-ancestor
25425440|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425441|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
25425442|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425443|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
25425444|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25425445|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25425446|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425447|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
25425448|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425449|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425450|NCT02136134|Dexamethasone|dexamethasone|mesh-list
25425451|NCT02136134|Bortezomib|bortezomib|mesh-list
25425452|NCT02136134|Daratumumab|daratumumab|mesh-list
25425453|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425454|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
25425455|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
25425456|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25397130|NCT04016805|Venetoclax|venetoclax|mesh-list
25425457|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425458|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25425459|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
25425460|NCT02136134|Hormones|hormones|mesh-ancestor
25425461|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425462|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425463|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425464|NCT02135874|Cytarabine|cytarabine|mesh-list
25425465|NCT02135874|Dexamethasone|dexamethasone|mesh-list
25425466|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
25425467|NCT02135874|Rituximab|rituximab|mesh-list
25425468|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25425469|NCT02135874|Vincristine|vincristine|mesh-list
25425470|NCT02135874|Sorafenib|sorafenib|mesh-list
25425471|NCT02135874|Idarubicin|idarubicin|mesh-list
25425472|NCT02135874|Clofarabine|clofarabine|mesh-list
25425473|NCT02135874|Antibodies|antibodies|mesh-list
25425474|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
25425475|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25425476|NCT02135874|BB 1101|bb 1101|mesh-list
25425477|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
25425478|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425479|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425480|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425481|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425482|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
25425483|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
25425560|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
25425484|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425485|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25425486|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
25425487|NCT02135874|Hormones|hormones|mesh-ancestor
25425488|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425489|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425490|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
25425491|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425492|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425493|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425494|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
25425495|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
25425496|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425497|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425498|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425499|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425500|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425501|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425502|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425503|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425504|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425505|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425506|NCT02135315|Isosorbide|isosorbide|mesh-list
25425507|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25425508|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25425509|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25425510|NCT02135315|Diuretics|diuretics|mesh-ancestor
25425511|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
25425512|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425513|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
25425514|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25425515|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425516|NCT02135133|Ofatumumab|ofatumumab|mesh-list
25425517|NCT02135133|Idelalisib|idelalisib|mesh-list
25425518|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425519|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425520|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425521|NCT02135042|Gemcitabine|gemcitabine|mesh-list
25425522|NCT02135042|Paclitaxel|paclitaxel|mesh-list
25425523|NCT02135042|Cisplatin|cisplatin|mesh-list
25425524|NCT02135042|Fluorouracil|fluorouracil|mesh-list
25425525|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25425526|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425527|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425528|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425529|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425530|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425531|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425532|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425533|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
25425534|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
25425535|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425536|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425537|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425539|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425540|NCT02134925|Poly ICLC|poly iclc|mesh-list
25425541|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
25425542|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
25425543|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425544|NCT02133196|Aldesleukin|aldesleukin|mesh-list
25425545|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
25425546|NCT02133196|Fludarabine|fludarabine|mesh-list
25425547|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425548|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
25425549|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425550|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425551|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425552|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
25425553|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425554|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425555|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25425556|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25425557|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25425558|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
25425559|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425561|NCT02130466|Trametinib|trametinib|mesh-list
25425562|NCT02130466|Dabrafenib|dabrafenib|mesh-list
25425563|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425564|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425565|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425566|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425567|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425568|NCT02130453|Regadenoson|regadenoson|mesh-list
25425569|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25425570|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25425571|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
25425572|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
25425573|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425574|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425575|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425576|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
25425577|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25425578|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
25425579|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425580|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
25425581|NCT02127723|Protective Agents|protective agents|mesh-ancestor
25425582|NCT02127073|Oxytocin|oxytocin|mesh-list
25425583|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
25425584|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25425585|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425586|NCT02126969|Carboplatin|carboplatin|mesh-list
25425587|NCT02126969|Docetaxel|docetaxel|mesh-list
25425588|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425589|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425590|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425591|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425592|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425593|NCT02125461|Durvalumab|durvalumab|mesh-list
25425594|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425595|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425596|NCT02124421|Paclitaxel|paclitaxel|mesh-list
25425597|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25425598|NCT02124421|Cisplatin|cisplatin|mesh-list
25425599|NCT02124421|Carboplatin|carboplatin|mesh-list
25425600|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425601|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425602|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425603|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425604|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425605|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425606|NCT02123758|Prednisone|prednisone|mesh-list
25425607|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
25425608|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425609|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
25425610|NCT02123758|Hormones|hormones|mesh-ancestor
25425611|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397301|NCT04008030|Vitamins|vitamins|mesh-ancestor
25425612|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425613|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425614|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425615|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25425617|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425618|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
25425619|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25425620|NCT02122562|Ketamine|ketamine|mesh-list
25425621|NCT02122562|Analgesics|analgesics|mesh-ancestor
25425622|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
25425623|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425624|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425625|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25425626|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25425627|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
25425628|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
25425629|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25425630|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25425706|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
25425631|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25425632|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425633|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425634|NCT02120352|Rilpivirine|rilpivirine|mesh-list
25425635|NCT02120352|Cabotegravir|cabotegravir|mesh-list
25425636|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25425637|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25425638|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425639|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425640|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
25425641|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425642|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25425643|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25425644|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25425645|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25425646|NCT02119416|Caffeine|caffeine|mesh-list
25425647|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25425648|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425649|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25425650|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425651|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425652|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25425653|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25425654|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
25425655|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425656|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25425657|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425658|NCT02117791|Riociguat|riociguat|mesh-list
25425659|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
25425660|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425661|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
25425662|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425663|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425664|NCT02117167|Pemetrexed|pemetrexed|mesh-list
25425665|NCT02117167|Durvalumab|durvalumab|mesh-list
25425666|NCT02117167|Olaparib|olaparib|mesh-list
25425667|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425668|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425669|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425670|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25425671|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25425672|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425673|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25425674|NCT02115373|Tepotinib|tepotinib|mesh-list
25425675|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425676|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
25425677|NCT02114229|Cisplatin|cisplatin|mesh-list
25425678|NCT02114229|Carboplatin|carboplatin|mesh-list
25425679|NCT02114229|Methotrexate|methotrexate|mesh-list
25425680|NCT02114229|Etoposide|etoposide|mesh-list
25425681|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
25425682|NCT02114229|Vincristine|vincristine|mesh-list
25425683|NCT02114229|Topotecan|topotecan|mesh-list
25425684|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425685|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
25425686|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425687|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425688|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425689|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
25425690|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425691|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425692|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25425693|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25425694|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
25425695|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25425696|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425697|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
25425698|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425699|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425700|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25425701|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25425702|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425703|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425704|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425705|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
25425707|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
25425708|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25425709|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25425710|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
25425711|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25425712|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
25425713|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25425714|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425715|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25425716|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425717|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425719|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425720|NCT02108652|Atezolizumab|atezolizumab|mesh-list
25425721|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425722|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
25425723|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25425724|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25425725|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25425726|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25425727|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425728|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
25425729|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425730|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425731|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25425732|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425733|NCT02107976|Ascorbic Acid|ascorbic acid|mesh-list
25425734|NCT02107976|Vitamins|vitamins|mesh-ancestor
25425735|NCT02107976|Micronutrients|micronutrients|mesh-ancestor
25425736|NCT02107976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425737|NCT02107976|Antioxidants|antioxidants|mesh-ancestor
25425738|NCT02107976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425739|NCT02107976|Protective Agents|protective agents|mesh-ancestor
25425740|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
25425741|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425742|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
25425743|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425744|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425745|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425746|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
25425747|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425748|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425749|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25425750|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
25425751|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25425752|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25425753|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25425754|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25425755|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425756|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
25425757|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425758|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425759|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25397447|NCT04003246|Durvalumab|durvalumab|mesh-list
25425760|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425761|NCT02105766|Sirolimus|sirolimus|mesh-list
25425762|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
25425763|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
25425764|NCT02105766|Pentostatin|pentostatin|mesh-list
25425765|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425767|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425768|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25425769|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425770|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
25425771|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425772|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425773|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25425774|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25425775|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425776|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425777|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
25425778|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425779|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25425780|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425782|NCT02104986|Ifosfamide|ifosfamide|mesh-list
25425783|NCT02104986|Bleomycin|bleomycin|mesh-list
25425784|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426388|NCT02003222|Dexamethasone|dexamethasone|mesh-list
25425785|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25425786|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
25425787|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425788|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425789|NCT02101944|Dexamethasone|dexamethasone|mesh-list
25425790|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
25425791|NCT02101944|Ichthammol|ichthammol|mesh-list
25425792|NCT02101944|BB 1101|bb 1101|mesh-list
25425793|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425794|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
25425795|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
25425796|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425797|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425798|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25425799|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
25425800|NCT02101944|Hormones|hormones|mesh-ancestor
25425801|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425802|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425803|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425804|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
25425805|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425806|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425807|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425808|NCT02101775|Gemcitabine|gemcitabine|mesh-list
25425809|NCT02101775|Adavosertib|adavosertib|mesh-list
25425810|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25425811|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
25425812|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425813|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425814|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
25425815|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425816|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425817|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425818|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
25425819|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425820|NCT02099591|Naloxegol|naloxegol|mesh-list
25425821|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25425822|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425823|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
25425824|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425825|NCT02099123|Atorvastatin|atorvastatin|mesh-list
25425826|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25425827|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25425828|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
25425829|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425830|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25425831|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25425832|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425833|NCT02099058|Nivolumab|nivolumab|mesh-list
25425834|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25425835|NCT02099058|Osimertinib|osimertinib|mesh-list
25425836|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25425837|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425838|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425839|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25425840|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425940|NCT02076009|Growth Substances|growth substances|mesh-ancestor
25425841|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425842|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425843|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
25425844|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425845|NCT02098876|Everolimus|everolimus|mesh-list
25425846|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425847|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25425848|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
25425849|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425850|NCT02098343|Carboplatin|carboplatin|mesh-list
25425851|NCT02098343|Doxorubicin|doxorubicin|mesh-list
25425852|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25425853|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425854|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25425855|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25425866|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425867|NCT02091375|Cannabidiol|cannabidiol|mesh-list
25425868|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
25425869|NCT02091206|Cannabidiol|cannabidiol|mesh-list
25425870|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
25425871|NCT02091141|Trastuzumab|trastuzumab|mesh-list
25425872|NCT02091141|Pertuzumab|pertuzumab|mesh-list
25425873|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25425874|NCT02091141|Atezolizumab|atezolizumab|mesh-list
25425875|NCT02091141|Vemurafenib|vemurafenib|mesh-list
25425876|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425877|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425878|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425879|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425880|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425881|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
25425882|NCT02089685|Ipilimumab|ipilimumab|mesh-list
25425883|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425884|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425885|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25425886|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425898|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
25425899|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25425900|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25425901|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25425902|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
25425903|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25425904|NCT02080221|Leucovorin|leucovorin|mesh-list
25425905|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
25425906|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425907|NCT02080221|Antidotes|antidotes|mesh-ancestor
25425908|NCT02080221|Protective Agents|protective agents|mesh-ancestor
25425909|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425910|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
25425911|NCT02080221|Vitamins|vitamins|mesh-ancestor
25425912|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
25425913|NCT02079740|Trametinib|trametinib|mesh-list
25425914|NCT02079740|Navitoclax|navitoclax|mesh-list
25425915|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425916|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425917|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425918|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425919|NCT02079181|Fluorides|fluorides|mesh-list
25425920|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
25425921|NCT02079181|Protective Agents|protective agents|mesh-ancestor
25425922|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425923|NCT02076009|Dexamethasone|dexamethasone|mesh-list
25425924|NCT02076009|Lenalidomide|lenalidomide|mesh-list
25425925|NCT02076009|Daratumumab|daratumumab|mesh-list
25425926|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25425927|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
25425928|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
25425929|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425930|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425931|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25425932|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
25425933|NCT02076009|Hormones|hormones|mesh-ancestor
25426232|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25425934|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425935|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25425936|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425937|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
25425938|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25425939|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25425943|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425944|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425945|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425946|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425947|NCT02074839|Ivosidenib|ivosidenib|mesh-list
25425948|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425949|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425950|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425951|NCT02073994|Ivosidenib|ivosidenib|mesh-list
25425952|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425953|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425954|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425955|NCT02071394|Xenon|xenon|mesh-list
25425956|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25425957|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
25425958|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
25425959|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25425960|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425961|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25425962|NCT02070705|Hematinics|hematinics|mesh-ancestor
25425963|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25425964|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25425965|NCT02070549|Trametinib|trametinib|mesh-list
25425966|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425967|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425968|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425969|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425970|NCT02069730|Androgens|androgens|mesh-list
25425971|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
25425972|NCT02069730|Hormones|hormones|mesh-ancestor
25425973|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425974|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425975|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
25425976|NCT02069366|Dronabinol|dronabinol|mesh-list
25425977|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
25425978|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425979|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25425980|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25425981|NCT02069366|Analgesics|analgesics|mesh-ancestor
25425982|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
25425983|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25425984|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25425985|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25425986|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25425987|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425988|NCT02069366|Hormones|hormones|mesh-ancestor
25425989|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425990|NCT02068586|Sunitinib|sunitinib|mesh-list
25425991|NCT02068586|Valproic Acid|valproic acid|mesh-list
25425992|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425993|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25425994|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25425995|NCT02068586|Growth Substances|growth substances|mesh-ancestor
25425996|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25425997|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
25425998|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425999|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426000|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426001|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
25426002|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
25426003|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426004|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
25426005|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25426006|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25426007|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25426008|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
25426009|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25397661|NCT03991884|Prednisone|prednisone|mesh-list
25397662|NCT03991884|Cortisone|cortisone|mesh-list
25397663|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
25397664|NCT03991884|Doxorubicin|doxorubicin|mesh-list
25397665|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25397666|NCT03991884|Etoposide|etoposide|mesh-list
25397667|NCT03991884|Vincristine|vincristine|mesh-list
25397668|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
25397669|NCT03991884|Daunorubicin|daunorubicin|mesh-list
25426011|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426012|NCT02068092|Protective Agents|protective agents|mesh-ancestor
25426013|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426014|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25426015|NCT02066415|Erenumab|erenumab|mesh-list
25426016|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25426093|NCT02057133|Trastuzumab|trastuzumab|mesh-list
25426017|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426018|NCT02066415|Analgesics|analgesics|mesh-ancestor
25426019|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
25426020|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426021|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426022|NCT02065765|Ramucirumab|ramucirumab|mesh-list
25426023|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426024|NCT02064673|Curcumin|curcumin|mesh-list
25426025|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25426026|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25426027|NCT02064673|Analgesics|analgesics|mesh-ancestor
25426028|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
25426029|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426030|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426031|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426032|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426033|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426034|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426035|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426036|NCT02063022|Dactinomycin|dactinomycin|mesh-list
25426037|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
25426038|NCT02063022|Melphalan|melphalan|mesh-list
25426039|NCT02063022|Busulfan|busulfan|mesh-list
25426040|NCT02063022|Ifosfamide|ifosfamide|mesh-list
25426041|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
25426042|NCT02063022|Doxorubicin|doxorubicin|mesh-list
25426043|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25426044|NCT02063022|Etoposide|etoposide|mesh-list
25426045|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
25426046|NCT02063022|Vincristine|vincristine|mesh-list
25426047|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426048|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
25426049|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426050|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426051|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426052|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
25426053|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426054|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426055|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426056|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25426057|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426058|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426059|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426060|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25426061|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25426062|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25426063|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25426064|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25426065|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426066|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25426067|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25426068|NCT02062463|Budesonide|budesonide|mesh-list
25426069|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
25426070|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25426071|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426072|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25426073|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
25426074|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426075|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426076|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25426077|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
25426078|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
25426079|NCT02062463|Hormones|hormones|mesh-ancestor
25426080|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426081|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25426082|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25426083|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25426084|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
25426085|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426086|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426088|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426089|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426090|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426091|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426092|NCT02057133|Tamoxifen|tamoxifen|mesh-list
25426101|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426102|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426103|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426104|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
25426105|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426106|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25426107|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25426108|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426109|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426110|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25426111|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
25426112|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426113|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426114|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25426115|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25426116|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25426117|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25426118|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
25426119|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426120|NCT02055963|Minocycline|minocycline|mesh-list
25426121|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25426122|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426123|NCT02053909|Aspirin|aspirin|mesh-list
25426124|NCT02053909|Ticagrelor|ticagrelor|mesh-list
25426125|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25426126|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25426127|NCT02053909|Analgesics|analgesics|mesh-ancestor
25426128|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
25426129|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426130|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426131|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426132|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426133|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25426134|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25426135|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426136|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25426137|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25426138|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426139|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
25426140|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25426141|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25426142|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25426143|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
25426144|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426145|NCT02051218|Denosumab|denosumab|mesh-list
25426146|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25426147|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426148|NCT02049593|Irinotecan|irinotecan|mesh-list
25426149|NCT02049593|Temozolomide|temozolomide|mesh-list
25426150|NCT02049593|Talazoparib|talazoparib|mesh-list
25426151|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25426152|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25426153|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426154|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426155|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426156|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426157|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426158|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
25426160|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426161|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426162|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
25426389|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
25426163|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426164|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
25426165|NCT02048813|Rituximab|rituximab|mesh-list
25426166|NCT02048813|Fludarabine|fludarabine|mesh-list
25426167|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
25426168|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25426169|NCT02048813|Antibodies|antibodies|mesh-list
25426170|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
25426171|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25426172|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426173|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
25426174|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426176|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426177|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
25426178|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426179|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426180|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426181|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25426182|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
25426184|NCT02043678|Prednisolone|prednisolone|mesh-list
25426185|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25426186|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426187|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
25426188|NCT02043678|Hormones|hormones|mesh-ancestor
25426189|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426190|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426191|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426192|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426193|NCT02043457|Hormones|hormones|mesh-list
25426194|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426195|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426196|NCT02042391|Cytarabine|cytarabine|mesh-list
25426197|NCT02042391|Prednisone|prednisone|mesh-list
25426198|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
25426199|NCT02042391|Rituximab|rituximab|mesh-list
25426200|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
25426201|NCT02042391|Doxorubicin|doxorubicin|mesh-list
25426202|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25426203|NCT02042391|Vincristine|vincristine|mesh-list
25426204|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426205|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
25426206|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426207|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426208|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426209|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
25426210|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426211|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426212|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426213|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426214|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426215|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
25426216|NCT02042391|Hormones|hormones|mesh-ancestor
25426217|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426218|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426219|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25426220|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
25426221|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
25426222|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426223|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25426224|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426225|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426226|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25397895|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
25426227|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25426228|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
25426229|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
25426230|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
25426231|NCT02040376|Metformin|metformin|mesh-list
25426233|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426234|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
25426235|NCT02037126|Promethazine|promethazine|mesh-list
25426236|NCT02037126|Psilocybin|psilocybin|mesh-list
25426237|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25426238|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25426390|NCT02003222|Prednisone|prednisone|mesh-list
25426239|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25426240|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426241|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
25426242|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
25426243|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
25426244|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426245|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
25426246|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
25426247|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426248|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25426249|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
25426250|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
25426251|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426252|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426253|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25426254|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
25426255|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
25426256|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
25426257|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25426258|NCT02035787|Metformin|metformin|mesh-list
25426259|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25426260|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426261|NCT02034981|Crizotinib|crizotinib|mesh-list
25426262|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426263|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426264|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426265|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426266|NCT02032823|Olaparib|olaparib|mesh-list
25426267|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25426268|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426269|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426270|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426271|NCT02031419|Rituximab|rituximab|mesh-list
25426272|NCT02031419|Spebrutinib|spebrutinib|mesh-list
25426273|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426274|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426275|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
25426276|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426277|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426278|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426279|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426280|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426281|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25426282|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25426283|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
25426284|NCT02030028|Hormones|hormones|mesh-ancestor
25426285|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426286|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426287|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426288|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426289|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
25426290|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426291|NCT02024087|Sorafenib|sorafenib|mesh-list
25426292|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426293|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426294|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426295|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426296|NCT02023463|Leuprolide|leuprolide|mesh-list
25426297|NCT02023463|Goserelin|goserelin|mesh-list
25426298|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25426299|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
25426300|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25426301|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426302|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426303|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426304|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
25426305|NCT02022709|Sertraline|sertraline|mesh-list
25426306|NCT02022709|Fluoxetine|fluoxetine|mesh-list
25426307|NCT02022709|Paroxetine|paroxetine|mesh-list
25426308|NCT02022709|Citalopram|citalopram|mesh-list
25426309|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
25426310|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25426311|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25426312|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25426313|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25426314|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426315|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426316|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
25426317|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426318|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25426319|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25426320|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25426321|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426322|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25426323|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25426324|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25426325|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25426326|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25426328|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
25426329|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25426330|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426331|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25426332|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426333|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426334|NCT02020070|Ipilimumab|ipilimumab|mesh-list
25426335|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426336|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426337|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25426338|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426339|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25426340|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
25426341|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426342|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426343|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426344|NCT02019641|beta-Aminoethyl Isothiourea|beta-aminoethyl isothiourea|mesh-list
25426345|NCT02019641|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25426346|NCT02019641|Protective Agents|protective agents|mesh-ancestor
25426347|NCT02019641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426348|NCT02016924|Cobicistat|cobicistat|mesh-list
25426349|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426350|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426351|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25426352|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25426353|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
25426354|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426355|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25426356|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25426357|NCT02015117|Trametinib|trametinib|mesh-list
25426358|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426359|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426360|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426361|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426362|NCT02015013|Plerixafor|plerixafor|mesh-list
25426363|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25426364|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25426365|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
25426366|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426367|NCT02013648|Cytarabine|cytarabine|mesh-list
25426368|NCT02013648|Daunorubicin|daunorubicin|mesh-list
25426369|NCT02013648|Dasatinib|dasatinib|mesh-list
25426370|NCT02013648|Idarubicin|idarubicin|mesh-list
25426371|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25426372|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
25426373|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426374|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426375|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
25426376|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426377|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426378|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
25426379|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426380|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25426381|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426382|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426383|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426384|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426385|NCT02006628|Cannabidiol|cannabidiol|mesh-list
25426386|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
25426387|NCT02003222|Cytarabine|cytarabine|mesh-list
25426392|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
25426393|NCT02003222|Rituximab|rituximab|mesh-list
25426394|NCT02003222|Methotrexate|methotrexate|mesh-list
25426395|NCT02003222|Etoposide|etoposide|mesh-list
25426396|NCT02003222|Vincristine|vincristine|mesh-list
25426397|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
25426398|NCT02003222|Daunorubicin|daunorubicin|mesh-list
25426399|NCT02003222|Asparaginase|asparaginase|mesh-list
25426400|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
25426401|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
25426402|NCT02003222|Pegaspargase|pegaspargase|mesh-list
25426403|NCT02003222|Blinatumomab|blinatumomab|mesh-list
25426404|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25426405|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
25426406|NCT02003222|Antibodies|antibodies|mesh-list
25426407|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
25426411|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426412|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
25426413|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426414|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426415|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426416|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
25426417|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426418|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426419|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426420|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426421|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
25426422|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
25426423|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426424|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426425|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
25426426|NCT02003222|Hormones|hormones|mesh-ancestor
25426427|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426428|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426429|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
25426430|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426431|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25426432|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
25426433|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25426434|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25426435|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
25426436|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
25426437|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25426438|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25426439|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25426440|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426441|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426442|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
25426443|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426444|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
25426445|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
25426446|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
25426447|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25426448|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
25426449|NCT02003144|Eculizumab|eculizumab|mesh-list
25426450|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25426451|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426452|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
25426453|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426454|NCT02000427|Blinatumomab|blinatumomab|mesh-list
25426455|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426456|NCT02000089|Secretin|secretin|mesh-list
25426457|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426458|NCT02000089|Hormones|hormones|mesh-ancestor
25426459|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426460|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426461|NCT01997840|Dexamethasone|dexamethasone|mesh-list
25426462|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
25426463|NCT01997840|Pomalidomide|pomalidomide|mesh-list
25426464|NCT01997840|Ricolinostat|ricolinostat|mesh-list
25426465|NCT01997840|BB 1101|bb 1101|mesh-list
25426466|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426467|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
25426468|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
25426469|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426470|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426471|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426472|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
25426473|NCT01997840|Hormones|hormones|mesh-ancestor
25426474|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426475|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426476|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426477|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
25426478|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426479|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426480|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
25426481|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25426482|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25426483|NCT01997840|Growth Substances|growth substances|mesh-ancestor
25426484|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
25426485|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25426488|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25426489|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25426490|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426491|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25426492|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426493|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25426494|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25426495|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25426496|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25426497|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25426498|NCT01993719|Aldesleukin|aldesleukin|mesh-list
25426499|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
25426500|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
25426501|NCT01993719|Fludarabine|fludarabine|mesh-list
25426502|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426503|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
25426504|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426505|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426506|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426507|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
25426508|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426509|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426510|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426511|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426512|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25426513|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25426514|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
25426515|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426516|NCT01992952|Fulvestrant|fulvestrant|mesh-list
25426517|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426518|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426519|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25426520|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25426521|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
25426522|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426523|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426524|NCT01991457|Fludarabine|fludarabine|mesh-list
25426525|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426526|NCT01990196|Dasatinib|dasatinib|mesh-list
25426527|NCT01990196|Trametinib|trametinib|mesh-list
25426528|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426529|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426530|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426531|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426532|NCT01989780|Paclitaxel|paclitaxel|mesh-list
25426533|NCT01989780|Bevacizumab|bevacizumab|mesh-list
25426534|NCT01989780|Letrozole|letrozole|mesh-list
25426535|NCT01989780|Fulvestrant|fulvestrant|mesh-list
25426536|NCT01989780|Anastrozole|anastrozole|mesh-list
25426537|NCT01989780|Exemestane|exemestane|mesh-list
25426538|NCT01989780|Goserelin|goserelin|mesh-list
25426539|NCT01989780|Leuprolide|leuprolide|mesh-list
25426614|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
25426540|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25426541|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426542|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
25426543|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
25426544|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
25426545|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426774|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
25426546|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426547|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25426548|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25426549|NCT01989780|Growth Substances|growth substances|mesh-ancestor
25426550|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426551|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
25426552|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25426553|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25426554|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426555|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25426556|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
25426557|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426558|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426559|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25426560|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25426562|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25426564|NCT01989585|Dabrafenib|dabrafenib|mesh-list
25426565|NCT01989585|Navitoclax|navitoclax|mesh-list
25426566|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426567|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426568|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426569|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426570|NCT01988493|Sorafenib|sorafenib|mesh-list
25426571|NCT01988493|Tepotinib|tepotinib|mesh-list
25426572|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426573|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426574|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426575|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426576|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
25426577|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25426578|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426579|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25426580|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426581|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25426582|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25426583|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25426584|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
25426585|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426586|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426587|NCT01982955|Cisplatin|cisplatin|mesh-list
25426588|NCT01982955|Carboplatin|carboplatin|mesh-list
25426589|NCT01982955|Pemetrexed|pemetrexed|mesh-list
25426590|NCT01982955|Gefitinib|gefitinib|mesh-list
25426591|NCT01982955|Tepotinib|tepotinib|mesh-list
25426592|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426593|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426594|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426595|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25426596|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25426597|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426598|NCT01980823|Metformin|metformin|mesh-list
25426599|NCT01980823|Atorvastatin|atorvastatin|mesh-list
25426600|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25426601|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426602|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25426603|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25426604|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
25426605|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426606|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25426607|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25426608|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426609|NCT01979536|Cytarabine|cytarabine|mesh-list
25426610|NCT01979536|Dexamethasone|dexamethasone|mesh-list
25426611|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
25426612|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
25426613|NCT01979536|Ifosfamide|ifosfamide|mesh-list
25426615|NCT01979536|Doxorubicin|doxorubicin|mesh-list
25426616|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25426617|NCT01979536|Methotrexate|methotrexate|mesh-list
25426618|NCT01979536|Etoposide|etoposide|mesh-list
25426619|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
25426620|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25426621|NCT01979536|Crizotinib|crizotinib|mesh-list
25426622|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
25426623|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25426624|NCT01979536|Antibodies|antibodies|mesh-list
25426625|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
25426626|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25426627|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
25426628|NCT01979536|BB 1101|bb 1101|mesh-list
25426629|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426630|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
25426631|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426632|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426633|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426634|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
25426635|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426636|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426637|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426638|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426639|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
25426640|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
25426641|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426642|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426643|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
25426644|NCT01979536|Hormones|hormones|mesh-ancestor
25426645|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426646|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426647|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
25426648|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426649|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25426650|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426651|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426652|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25426653|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
25426654|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25426655|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25426656|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
25426657|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
25426658|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25426659|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25426660|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25426661|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
25426662|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426663|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426664|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
25426665|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
25426666|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
25426667|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
25426668|NCT01976585|Poly ICLC|poly iclc|mesh-list
25426669|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
25426670|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
25426671|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426672|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25426673|NCT01976065|Metronidazole|metronidazole|mesh-list
25426674|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
25426675|NCT01976065|Minocycline|minocycline|mesh-list
25426676|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426677|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25426678|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25426679|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426680|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426681|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426682|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426683|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426684|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25426685|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25426686|NCT01975272|Iron|iron|mesh-list
25426687|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
25426688|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
25426689|NCT01975272|Trace Elements|trace elements|mesh-ancestor
25426690|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
25426691|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426692|NCT01975272|Hematinics|hematinics|mesh-ancestor
25426693|NCT01974440|Prednisone|prednisone|mesh-list
25398352|NCT03959488|Palivizumab|palivizumab|mesh-list
25426694|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
25426695|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25426696|NCT01974440|Rituximab|rituximab|mesh-list
25426697|NCT01974440|Doxorubicin|doxorubicin|mesh-list
25426698|NCT01974440|Vincristine|vincristine|mesh-list
25426699|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426700|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
25426701|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426702|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426703|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426704|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
25426705|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426706|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426707|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426708|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426709|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25426710|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426711|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426712|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426713|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426714|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
25426715|NCT01974440|Hormones|hormones|mesh-ancestor
25426716|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426717|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426718|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25426719|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
25426720|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
25426721|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
25426722|NCT01972919|Gemcitabine|gemcitabine|mesh-list
25426723|NCT01972919|Capecitabine|capecitabine|mesh-list
25426724|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25426725|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
25426726|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426727|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426728|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
25426729|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426730|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426731|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426732|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
25426733|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426734|NCT01970501|Metoprolol|metoprolol|mesh-list
25426735|NCT01970501|Bucindolol|bucindolol|mesh-list
25426736|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25426737|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25426738|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
25426739|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
25426740|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426741|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426742|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25426743|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25426744|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25426745|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
25426746|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426747|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426748|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
25426749|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
25426750|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25426751|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25426752|NCT01969643|Trastuzumab|trastuzumab|mesh-list
25426753|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426754|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426755|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
25426756|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25426757|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
25426758|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25426759|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426760|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25426761|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25426762|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25426763|NCT01958021|Letrozole|letrozole|mesh-list
25426764|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426765|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25426766|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25426767|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426768|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426769|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25426770|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
25426771|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426772|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426773|NCT01955499|Lenalidomide|lenalidomide|mesh-list
25426775|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426776|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25426777|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25426778|NCT01955499|Growth Substances|growth substances|mesh-ancestor
25426779|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
25426780|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426781|NCT01953926|Trastuzumab|trastuzumab|mesh-list
25426782|NCT01953926|Fulvestrant|fulvestrant|mesh-list
25426783|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426784|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426785|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426786|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25426787|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25426788|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
25426789|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426790|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426791|NCT01953588|Fulvestrant|fulvestrant|mesh-list
25426792|NCT01953588|Anastrozole|anastrozole|mesh-list
25426793|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426794|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426795|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25426796|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25426797|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
25426798|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426799|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426800|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25426801|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25426802|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426803|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426805|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25426806|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
25426807|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426808|NCT01952574|Erenumab|erenumab|mesh-list
25426809|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25426810|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25426811|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426812|NCT01952574|Analgesics|analgesics|mesh-ancestor
25426813|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
25426814|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426815|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426816|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
25426817|NCT01951417|Adapalene|adapalene|mesh-list
25426818|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25426819|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
25426820|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25426821|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25426822|NCT01951417|Analgesics|analgesics|mesh-ancestor
25426823|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
25426824|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426825|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426826|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426827|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426828|NCT01950520|Topiramate|topiramate|mesh-list
25426829|NCT01950520|Phentermine|phentermine|mesh-list
25426830|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
25426831|NCT01950520|Propranolol|propranolol|mesh-list
25426832|NCT01950520|Pindolol|pindolol|mesh-list
25426833|NCT01950520|Naltrexone|naltrexone|mesh-list
25426834|NCT01950520|Caffeine|caffeine|mesh-list
25426835|NCT01950520|Dantrolene|dantrolene|mesh-list
25426836|NCT01950520|Mirabegron|mirabegron|mesh-list
25426837|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25426838|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25426839|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426840|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
25426841|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426842|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25426843|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25426844|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426845|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426846|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25426847|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25426848|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
25427005|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
25426849|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426850|NCT01950520|Analgesics|analgesics|mesh-ancestor
25426851|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
25426852|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25426853|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25426854|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
25426855|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25426856|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25426857|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25426858|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
25426859|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25426860|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25426861|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25426862|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
25426863|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25426864|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
25426865|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25426866|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25426867|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25426874|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25426875|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
25426876|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25426877|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25426878|NCT01950390|Bevacizumab|bevacizumab|mesh-list
25426879|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25426880|NCT01950390|Ipilimumab|ipilimumab|mesh-list
25426881|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
25426882|NCT01950390|Antibodies|antibodies|mesh-list
25426883|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
25426884|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25426885|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
25426886|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426887|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25426888|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25426889|NCT01950390|Growth Substances|growth substances|mesh-ancestor
25426890|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426891|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
25426892|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
25426893|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25426894|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426895|NCT01949662|Lorazepam|lorazepam|mesh-list
25426896|NCT01949662|Haloperidol|haloperidol|mesh-list
25426897|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
25426898|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
25426899|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
25426900|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426901|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426902|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426903|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25426904|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25426905|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25426906|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25426907|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25426908|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
25426909|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426910|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426911|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25426912|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
25426913|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25426914|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25426915|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
25426916|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
25426917|NCT01949337|Prednisone|prednisone|mesh-list
25426918|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426919|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
25426920|NCT01949337|Hormones|hormones|mesh-ancestor
25426921|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426922|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426923|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426924|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426925|NCT01947023|Lapatinib|lapatinib|mesh-list
25426926|NCT01947023|Dabrafenib|dabrafenib|mesh-list
25426927|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426928|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426929|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426930|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426931|NCT01946529|Sirolimus|sirolimus|mesh-list
25426932|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
25426933|NCT01946529|Temozolomide|temozolomide|mesh-list
25426934|NCT01946529|Ifosfamide|ifosfamide|mesh-list
25426935|NCT01946529|Bevacizumab|bevacizumab|mesh-list
25426936|NCT01946529|Doxorubicin|doxorubicin|mesh-list
25426937|NCT01946529|Etoposide|etoposide|mesh-list
25426938|NCT01946529|Vincristine|vincristine|mesh-list
25426939|NCT01946529|Sorafenib|sorafenib|mesh-list
25426940|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25426941|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
25426942|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426943|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25426944|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426945|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
25426946|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426947|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426948|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25426949|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25426950|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25426951|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25426954|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25426955|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25426956|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25426957|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25426958|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25426959|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
25426960|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
25426961|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
25426962|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25426963|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25426964|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25426965|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
25426966|NCT01946477|Dexamethasone|dexamethasone|mesh-list
25426967|NCT01946477|Daratumumab|daratumumab|mesh-list
25426968|NCT01946477|Pomalidomide|pomalidomide|mesh-list
25426969|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25426970|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
25426971|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
25426972|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426973|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426974|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25426975|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
25426976|NCT01946477|Hormones|hormones|mesh-ancestor
25426977|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25426978|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25426979|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426980|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
25426981|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25426982|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25426983|NCT01946477|Growth Substances|growth substances|mesh-ancestor
25426984|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
25426985|NCT01943994|Psilocybin|psilocybin|mesh-list
25426986|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25426987|NCT01943994|Nicotine|nicotine|mesh-list
25426988|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25426989|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
25426990|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426991|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426992|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25426993|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25426994|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
25426995|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25427073|NCT01927744|Docetaxel|docetaxel|mesh-list
25426996|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426997|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
25426998|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25426999|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25427000|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
25427001|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25427002|NCT01942694|Vitamin D|vitamin d|mesh-list
25427003|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
25427004|NCT01942694|Vitamins|vitamins|mesh-ancestor
25427006|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427007|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25427008|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25427010|NCT01942135|Palbociclib|palbociclib|mesh-list
25427011|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427012|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427013|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25427014|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25427015|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
25427016|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427017|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427018|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427019|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427020|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427021|NCT01938248|Aspirin|aspirin|mesh-list
25427022|NCT01938248|Apixaban|apixaban|mesh-list
25427023|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25427024|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25427025|NCT01938248|Analgesics|analgesics|mesh-ancestor
25427026|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
25427027|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427028|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427029|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427030|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427032|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25427033|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427034|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25427035|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25427036|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427037|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
25427038|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25427039|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
25427040|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25427041|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
25427042|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
25427043|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25427044|NCT01933932|Docetaxel|docetaxel|mesh-list
25427045|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427046|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427047|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427048|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427049|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427050|NCT01932125|Bevacizumab|bevacizumab|mesh-list
25427051|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427052|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427053|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427054|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427055|NCT01932125|Growth Substances|growth substances|mesh-ancestor
25427056|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427057|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427058|NCT01931033|Oxytocin|oxytocin|mesh-list
25427059|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
25427060|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25427061|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427062|NCT01928576|Nivolumab|nivolumab|mesh-list
25427063|NCT01928576|Azacitidine|azacitidine|mesh-list
25427064|NCT01928576|Entinostat|entinostat|mesh-list
25427065|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427066|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427067|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25427068|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427069|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427070|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
25427071|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427072|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25427074|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25427075|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427076|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427077|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427078|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427079|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427080|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427081|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427082|NCT01924533|Paclitaxel|paclitaxel|mesh-list
25427083|NCT01924533|Olaparib|olaparib|mesh-list
25427084|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427085|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427086|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427087|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427088|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427089|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427090|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25427091|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427092|NCT01924260|Gemcitabine|gemcitabine|mesh-list
25427093|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427094|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
25427095|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427096|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427097|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
25427098|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427099|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427100|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427101|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
25427102|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427103|NCT01924052|Calcitonin|calcitonin|mesh-list
25427104|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25427105|NCT01924052|Katacalcin|katacalcin|mesh-list
25427106|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25427107|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427108|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25427109|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
25427111|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427112|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427113|NCT01921335|Trastuzumab|trastuzumab|mesh-list
25427114|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427115|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427116|NCT01920932|Prednisone|prednisone|mesh-list
25427117|NCT01920932|Prednisolone|prednisolone|mesh-list
25427118|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
25427119|NCT01920932|Dacarbazine|dacarbazine|mesh-list
25427120|NCT01920932|Doxorubicin|doxorubicin|mesh-list
25427121|NCT01920932|Etoposide|etoposide|mesh-list
25427122|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25427123|NCT01920932|Imidazole|imidazole|mesh-list
25427124|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427125|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
25427126|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427127|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427128|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427129|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
25427130|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427131|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427132|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427133|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427134|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25427135|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25427136|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427137|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427138|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
25427139|NCT01920932|Hormones|hormones|mesh-ancestor
25427140|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427141|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427142|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427143|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427144|NCT01920737|Leucovorin|leucovorin|mesh-list
25427145|NCT01920737|Cytarabine|cytarabine|mesh-list
25427146|NCT01920737|Dexamethasone|dexamethasone|mesh-list
25427147|NCT01920737|Prednisone|prednisone|mesh-list
25427148|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
25427149|NCT01920737|Methotrexate|methotrexate|mesh-list
25427150|NCT01920737|Vincristine|vincristine|mesh-list
25427151|NCT01920737|Daunorubicin|daunorubicin|mesh-list
25427152|NCT01920737|Asparaginase|asparaginase|mesh-list
25427153|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
25427154|NCT01920737|Pegaspargase|pegaspargase|mesh-list
25427155|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427156|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
25427157|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427158|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427159|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427160|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
25427161|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427162|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427163|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427164|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427165|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
25427166|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
25427167|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427168|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25427169|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
25427170|NCT01920737|Hormones|hormones|mesh-ancestor
25427171|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427172|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427173|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25427174|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
25427175|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25427176|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427177|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
25427178|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
25427179|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427180|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25427181|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25427182|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
25427183|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427184|NCT01920737|Antidotes|antidotes|mesh-ancestor
25427189|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427190|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427191|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427192|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427193|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427194|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25427195|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25427197|NCT01920061|Docetaxel|docetaxel|mesh-list
25427198|NCT01920061|Gedatolisib|gedatolisib|mesh-list
25427199|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427200|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427201|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427202|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427203|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427204|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427205|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427206|NCT01919619|Lenalidomide|lenalidomide|mesh-list
25427207|NCT01919619|Ipilimumab|ipilimumab|mesh-list
25427208|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
25427209|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427210|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427211|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427212|NCT01919619|Growth Substances|growth substances|mesh-ancestor
25427213|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427214|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427215|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427216|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25427217|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427218|NCT01916278|Lidocaine|lidocaine|mesh-list
25427219|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
25427220|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
25427221|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25427222|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427223|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
25427224|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427225|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25427226|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25427270|NCT01908777|Etoposide|etoposide|mesh-list
25427271|NCT01908777|Melphalan|melphalan|mesh-list
25427272|NCT01908777|Carmustine|carmustine|mesh-list
25427273|NCT01908777|Romidepsin|romidepsin|mesh-list
25427274|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427275|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427276|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25427277|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25427278|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427279|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427280|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427281|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
25427282|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
25427283|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427284|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427285|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
25427286|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427287|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427288|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
25427289|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427290|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427291|NCT01907191|Bupivacaine|bupivacaine|mesh-list
25427292|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
25427293|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
25427294|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25427295|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427296|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
25427297|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427298|NCT01906853|Vaccines|vaccines|mesh-list
25427299|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
25427300|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
25427301|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427302|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25427303|NCT01905046|Metformin|metformin|mesh-list
25427304|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25427305|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427306|NCT01903473|Sirolimus|sirolimus|mesh-list
25427307|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25427308|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427309|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427310|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427311|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
25427312|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427313|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
25427314|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427315|NCT01902290|Brodalumab|brodalumab|mesh-list
25427316|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
25427317|NCT01902173|Trametinib|trametinib|mesh-list
25427318|NCT01902173|Dabrafenib|dabrafenib|mesh-list
25427319|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25427320|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427321|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427322|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427323|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427324|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25427325|NCT01902173|Protective Agents|protective agents|mesh-ancestor
25427326|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427327|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25427328|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
25427329|NCT01900574|Golimumab|golimumab|mesh-list
25427330|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25427331|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427332|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427333|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
25427334|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427335|NCT01898494|Cisplatin|cisplatin|mesh-list
25427336|NCT01898494|Carboplatin|carboplatin|mesh-list
25427337|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427338|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
25427339|NCT01897454|Leucovorin|leucovorin|mesh-list
25427340|NCT01897454|Folic Acid|folic acid|mesh-list
25427341|NCT01897454|Gemcitabine|gemcitabine|mesh-list
25427342|NCT01897454|Fluorouracil|fluorouracil|mesh-list
25427343|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
25427344|NCT01897454|Irinotecan|irinotecan|mesh-list
25427345|NCT01897454|Camptothecin|camptothecin|mesh-list
25427346|NCT01897454|Calcium|calcium|mesh-list
25427347|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
25427348|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427349|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
25427350|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427351|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427352|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
25427353|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427354|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427355|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427356|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
25427357|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427358|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25427359|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25427360|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25427361|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25427362|NCT01897454|Antidotes|antidotes|mesh-ancestor
25427363|NCT01897454|Protective Agents|protective agents|mesh-ancestor
25427364|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
25427365|NCT01897454|Vitamins|vitamins|mesh-ancestor
25427366|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
25427367|NCT01897454|Hematinics|hematinics|mesh-ancestor
25427368|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427369|NCT01897441|Paclitaxel|paclitaxel|mesh-list
25427370|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
25427371|NCT01897441|Doxorubicin|doxorubicin|mesh-list
25427372|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25427373|NCT01897441|Trastuzumab|trastuzumab|mesh-list
25427374|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25427375|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25427376|NCT01897441|Antibodies|antibodies|mesh-list
25427377|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
25427378|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427379|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427380|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427381|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427382|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427383|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427384|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427385|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427386|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
25427387|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427389|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427390|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
25427391|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427392|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427393|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25427394|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25427395|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427396|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25427399|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25427400|NCT01896999|Antibodies|antibodies|mesh-list
25427401|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
25427402|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427403|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
25427404|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
25427405|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427406|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427407|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25427408|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427409|NCT01893567|Clobetasol|clobetasol|mesh-list
25427410|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427411|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
25427412|NCT01893567|Hormones|hormones|mesh-ancestor
25427413|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427414|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427415|NCT01892722|Interferons|interferons|mesh-list
25427416|NCT01892722|Interferon-beta|interferon-beta|mesh-list
25427417|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
25427418|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25427419|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427420|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
25427421|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427422|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
25427423|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427424|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25427425|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25427426|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427427|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427428|NCT01892527|Cetuximab|cetuximab|mesh-list
25427429|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427430|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427431|NCT01892371|Cytarabine|cytarabine|mesh-list
25427432|NCT01892371|Azacitidine|azacitidine|mesh-list
25427433|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427434|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
25427435|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427436|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427437|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
25427438|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427439|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427440|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
25427441|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427442|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427443|NCT01886872|Rituximab|rituximab|mesh-list
25427444|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25427445|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25427446|NCT01886872|Antibodies|antibodies|mesh-list
25427447|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
25427448|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427449|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
25427450|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427451|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427452|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427453|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427454|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
25427455|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427456|NCT01886859|Lenalidomide|lenalidomide|mesh-list
25427457|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
25427458|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427459|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427460|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427461|NCT01886859|Growth Substances|growth substances|mesh-ancestor
25427462|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427463|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427464|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
25427465|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
25427466|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
25427467|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427468|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427469|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25427470|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25427471|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
25427472|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
25427473|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25427474|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427475|NCT01884740|Bevacizumab|bevacizumab|mesh-list
25427477|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427478|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427479|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427480|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427481|NCT01884740|Growth Substances|growth substances|mesh-ancestor
25427482|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427483|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427484|NCT01879085|Gemcitabine|gemcitabine|mesh-list
25427486|NCT01879085|Vorinostat|vorinostat|mesh-list
25427487|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427488|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
25427489|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427490|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427491|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
25427492|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427493|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427494|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427495|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
25427496|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427497|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427498|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427499|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427500|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25427501|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
25427502|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25427503|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
25427504|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427505|NCT01878669|Expectorants|expectorants|mesh-ancestor
25427506|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
25427507|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25427508|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
25427509|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427510|NCT01878669|Protective Agents|protective agents|mesh-ancestor
25427511|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427512|NCT01878669|Antidotes|antidotes|mesh-ancestor
25427513|NCT01876628|Clindamycin|clindamycin|mesh-list
25427514|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
25427515|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
25427516|NCT01876628|Floxacillin|floxacillin|mesh-list
25427517|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25427518|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427519|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25427520|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427521|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427522|NCT01873131|Timolol|timolol|mesh-list
25427523|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25427524|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25427525|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
25427526|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25427527|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427528|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427529|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25427530|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25427531|NCT01872715|Doxycycline|doxycycline|mesh-list
25427532|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25427533|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427534|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
25427535|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25427536|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25427537|NCT01871571|Leucovorin|leucovorin|mesh-list
25427548|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427549|NCT01871571|Growth Substances|growth substances|mesh-ancestor
25427550|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427551|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427552|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
25427553|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
25427554|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427555|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427556|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427558|NCT01871571|Protective Agents|protective agents|mesh-ancestor
25427559|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
25427560|NCT01871571|Vitamins|vitamins|mesh-ancestor
25427561|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
25427562|NCT01867333|Metronidazole|metronidazole|mesh-list
25427563|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427564|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25427565|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25427566|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25427576|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25427577|NCT01865812|Cathartics|cathartics|mesh-ancestor
25427578|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25427579|NCT01865110|Prednisone|prednisone|mesh-list
25427580|NCT01865110|Rituximab|rituximab|mesh-list
25427581|NCT01865110|Lenalidomide|lenalidomide|mesh-list
25427582|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
25427583|NCT01865110|Vincristine|vincristine|mesh-list
25427584|NCT01865110|Doxorubicin|doxorubicin|mesh-list
25427585|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427586|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427587|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
25427588|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427589|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427590|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427591|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427592|NCT01865110|Growth Substances|growth substances|mesh-ancestor
25427593|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427594|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427595|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427596|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
25427597|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427598|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427599|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427600|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
25427601|NCT01865110|Hormones|hormones|mesh-ancestor
25427602|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427603|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427604|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427605|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427606|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427607|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427608|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427609|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25427610|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25427611|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427612|NCT01864772|Cetuximab|cetuximab|mesh-list
25427613|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427614|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427615|NCT01864018|Dexamethasone|dexamethasone|mesh-list
25427616|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
25427617|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
25427618|NCT01864018|Ixazomib|ixazomib|mesh-list
25427619|NCT01864018|Ichthammol|ichthammol|mesh-list
25427620|NCT01864018|BB 1101|bb 1101|mesh-list
25427621|NCT01864018|Glycine|glycine|mesh-list
25427622|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427623|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
25427624|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427625|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427626|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427627|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
25427628|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427629|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427630|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427631|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427632|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
25427633|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
25427634|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427635|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25427636|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
25427637|NCT01864018|Hormones|hormones|mesh-ancestor
25427638|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427639|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427640|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
25427644|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25427645|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
25427646|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
25427647|NCT01861106|Busulfan|busulfan|mesh-list
25427648|NCT01861106|Fludarabine|fludarabine|mesh-list
25427649|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
25427650|NCT01861106|Tacrolimus|tacrolimus|mesh-list
25427651|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25427652|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427653|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
25427654|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427655|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427656|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427657|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
25427658|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427659|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427660|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427661|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427662|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
25427663|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25427664|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427665|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427666|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25427667|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
25427668|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25427669|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427670|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25427671|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427672|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427673|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427674|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427675|NCT01856478|Methotrexate|methotrexate|mesh-list
25427676|NCT01856478|Afatinib|afatinib|mesh-list
25427677|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25427678|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
25427679|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25427680|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427681|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427682|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
25427683|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427684|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427685|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25427686|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427687|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25427688|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427689|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
25427690|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427691|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25427692|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427693|NCT01856192|Prednisone|prednisone|mesh-list
25427694|NCT01856192|Cortisone|cortisone|mesh-list
25427695|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
25427696|NCT01856192|Rituximab|rituximab|mesh-list
25427697|NCT01856192|Doxorubicin|doxorubicin|mesh-list
25427698|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25427699|NCT01856192|Vincristine|vincristine|mesh-list
25427700|NCT01856192|Lenalidomide|lenalidomide|mesh-list
25427701|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25427702|NCT01856192|Antibodies|antibodies|mesh-list
25427703|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
25427704|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427705|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427706|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
25427707|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427708|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427709|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427710|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
25427711|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427712|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427713|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427714|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427715|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25427716|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25427717|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427718|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427719|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
25427720|NCT01856192|Hormones|hormones|mesh-ancestor
25427721|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427722|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427723|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427724|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427725|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427726|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427727|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427728|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427729|NCT01856192|Growth Substances|growth substances|mesh-ancestor
25427730|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427731|NCT01853826|Afatinib|afatinib|mesh-list
25427732|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427733|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427734|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427735|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427736|NCT01852071|Busulfan|busulfan|mesh-list
25427737|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
25427738|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427739|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427740|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
25427741|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427742|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427743|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427744|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427745|NCT01851642|Albuterol|albuterol|mesh-list
25427746|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25427747|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
25427748|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427749|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427750|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25427751|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
25427752|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
25427753|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25427754|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25427755|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25427756|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25427757|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
25427758|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25427759|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427760|NCT01850524|Dexamethasone|dexamethasone|mesh-list
25427761|NCT01850524|Lenalidomide|lenalidomide|mesh-list
25427762|NCT01850524|Ixazomib|ixazomib|mesh-list
25427763|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427764|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
25427765|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
25427766|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427767|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427768|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25427769|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
25427770|NCT01850524|Hormones|hormones|mesh-ancestor
25427771|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427772|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427773|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427774|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
25427775|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427776|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427777|NCT01850524|Growth Substances|growth substances|mesh-ancestor
25427778|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427779|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
25427780|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427781|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427782|NCT01849146|Temozolomide|temozolomide|mesh-list
25427783|NCT01849146|Adavosertib|adavosertib|mesh-list
25427784|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427785|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
25427786|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427787|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427788|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427789|NCT01846663|Rifaximin|rifaximin|mesh-list
25427790|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25427791|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427792|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25427793|NCT01844986|Olaparib|olaparib|mesh-list
25427794|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25427804|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427805|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427806|NCT01843374|Tremelimumab|tremelimumab|mesh-list
25427807|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427808|NCT01842399|Resveratrol|resveratrol|mesh-list
25427809|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
25427810|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427811|NCT01842399|Protective Agents|protective agents|mesh-ancestor
25427812|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427813|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427814|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25427815|NCT01842386|Rituximab|rituximab|mesh-list
25427816|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427817|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427818|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
25427819|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427820|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427821|NCT01840046|Interleukin-2|interleukin-2|mesh-list
25427822|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427823|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25427824|NCT01840046|Analgesics|analgesics|mesh-ancestor
25427825|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
25427826|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427827|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427828|NCT01835145|Temozolomide|temozolomide|mesh-list
25427829|NCT01835145|Dacarbazine|dacarbazine|mesh-list
25427830|NCT01835145|Imidazole|imidazole|mesh-list
25427831|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427832|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
25427833|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427834|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427835|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427836|NCT01829568|Rituximab|rituximab|mesh-list
25427837|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25427838|NCT01829568|Lenalidomide|lenalidomide|mesh-list
25427839|NCT01829568|Antibodies|antibodies|mesh-list
25427840|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
25427841|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427842|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
25427843|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427844|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427845|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427846|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427847|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427848|NCT01829568|Growth Substances|growth substances|mesh-ancestor
25427849|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427860|NCT01824836|Anastrozole|anastrozole|mesh-list
25427861|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427862|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427863|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25427864|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25427865|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427866|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427867|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25427868|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
25427869|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427870|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427871|NCT01823198|Aldesleukin|aldesleukin|mesh-list
25427876|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427877|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427879|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427880|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427881|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
25427882|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427883|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
25427884|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427885|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427886|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25427887|NCT01823198|Analgesics|analgesics|mesh-ancestor
25427888|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
25427889|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427890|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25427891|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25427892|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
25427893|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427894|NCT01822314|Paclitaxel|paclitaxel|mesh-list
25427895|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25427896|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427897|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427898|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427899|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427900|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427901|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427902|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25427903|NCT01816971|Dexamethasone|dexamethasone|mesh-list
25427904|NCT01816971|Lenalidomide|lenalidomide|mesh-list
25427905|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25427906|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
25427907|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
25427908|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427909|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427910|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25427911|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
25427912|NCT01816971|Hormones|hormones|mesh-ancestor
25427913|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427914|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25427915|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427916|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
25427917|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427918|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25427919|NCT01816971|Growth Substances|growth substances|mesh-ancestor
25427920|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
25427921|NCT01810913|Cisplatin|cisplatin|mesh-list
25427922|NCT01810913|Docetaxel|docetaxel|mesh-list
25427923|NCT01810913|Cetuximab|cetuximab|mesh-list
25427924|NCT01810913|Atezolizumab|atezolizumab|mesh-list
25427925|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25427926|NCT01810913|Antibodies|antibodies|mesh-list
25427927|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
25427928|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427929|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
25427930|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427931|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427932|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427933|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427934|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427935|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427936|NCT01810588|Vidarabine|vidarabine|mesh-list
25427937|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
25427938|NCT01810588|Rituximab|rituximab|mesh-list
25427939|NCT01810588|Fludarabine|fludarabine|mesh-list
25427940|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
25427941|NCT01810588|Melphalan|melphalan|mesh-list
25427942|NCT01810588|Tacrolimus|tacrolimus|mesh-list
25427943|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25427944|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
25427945|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25427946|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427947|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
25427948|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427949|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427950|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427951|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
25427952|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427953|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427954|NCT01810588|Antiviral Agents|antiviral agents|mesh-ancestor
25427955|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25427956|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25427957|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427958|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25427959|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25427960|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
25427961|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25427962|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25427963|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
25427964|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25427965|NCT01809691|Bicalutamide|bicalutamide|mesh-list
25427966|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
25427967|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
25427968|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427969|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427970|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427971|NCT01807455|Lidocaine|lidocaine|mesh-list
25427972|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
25427973|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
25427974|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25427975|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427976|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
25427977|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25427978|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25427979|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25427980|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25427981|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25427982|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427983|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427984|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
25427985|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427986|NCT01804790|Capecitabine|capecitabine|mesh-list
25427987|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25427988|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
25427989|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427990|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427991|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
25427992|NCT01804634|Melphalan|melphalan|mesh-list
25427993|NCT01804634|Fludarabine|fludarabine|mesh-list
25427994|NCT01804634|Tacrolimus|tacrolimus|mesh-list
25427995|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427996|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
25427997|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25427998|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25427999|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428000|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
25428001|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428002|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428003|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428004|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25428005|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428006|NCT01802632|Osimertinib|osimertinib|mesh-list
25428007|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428008|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25399567|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
25428009|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428010|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428011|NCT01799538|Albuterol|albuterol|mesh-list
25428012|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25428013|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
25428014|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428015|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428016|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25428017|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
25428018|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
25428019|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25428020|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25428021|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25428022|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25428023|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
25428024|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428025|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428026|NCT01797523|Metformin|metformin|mesh-list
25428030|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428031|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428032|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428033|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
25428034|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25428035|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25428036|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428037|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428038|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25428039|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
25428040|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428041|NCT01796002|Romidepsin|romidepsin|mesh-list
25428042|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25428043|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428044|NCT01792687|Prednisone|prednisone|mesh-list
25428045|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
25428046|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428047|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
25428048|NCT01792687|Hormones|hormones|mesh-ancestor
25428049|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428050|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428051|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428052|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428053|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25428054|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428055|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428056|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
25428057|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25428058|NCT01791985|Letrozole|letrozole|mesh-list
25428059|NCT01791985|Anastrozole|anastrozole|mesh-list
25428060|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428061|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25428062|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25428063|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428064|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428065|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25428066|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
25428067|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428068|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428069|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428070|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25428072|NCT01787500|Irinotecan|irinotecan|mesh-list
25428073|NCT01787500|Camptothecin|camptothecin|mesh-list
25428074|NCT01787500|Vemurafenib|vemurafenib|mesh-list
25428075|NCT01787500|Antibodies|antibodies|mesh-list
25428076|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
25428077|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25428078|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
25428079|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428080|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428081|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25428082|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25428083|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428084|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399642|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
25399643|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25399644|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399645|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25399652|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
25428085|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428086|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428087|NCT01787487|Azacitidine|azacitidine|mesh-list
25428088|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428089|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
25428090|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428091|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428092|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428093|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
25428094|NCT01783535|Carboplatin|carboplatin|mesh-list
25428095|NCT01783535|Doxorubicin|doxorubicin|mesh-list
25428096|NCT01783535|Etoposide|etoposide|mesh-list
25428097|NCT01783535|Vincristine|vincristine|mesh-list
25428098|NCT01783535|Topotecan|topotecan|mesh-list
25428099|NCT01783535|Lenograstim|lenograstim|mesh-list
25428100|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428101|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
25428102|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428103|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428104|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428105|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
25428106|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428107|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428108|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428109|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25428110|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25428111|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25428112|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428113|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428114|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25428115|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428116|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428117|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428118|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25428119|NCT01782352|Vitamin D|vitamin d|mesh-list
25428120|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
25428121|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
25428122|NCT01782352|Vitamins|vitamins|mesh-list
25428123|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
25428124|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428125|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25428126|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25428127|NCT01776840|Rituximab|rituximab|mesh-list
25428128|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25428129|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428130|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428131|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
25428132|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428133|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428134|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428135|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
25428136|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428137|NCT01772472|Trastuzumab|trastuzumab|mesh-list
25428138|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25428139|NCT01772472|Maytansine|maytansine|mesh-list
25428140|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428141|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428142|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428143|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428144|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428145|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428146|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428147|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25428148|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25428149|NCT01771107|Doxorubicin|doxorubicin|mesh-list
25428150|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25428151|NCT01771107|Dacarbazine|dacarbazine|mesh-list
25428152|NCT01771107|Vinblastine|vinblastine|mesh-list
25428153|NCT01771107|Antibodies|antibodies|mesh-list
25428154|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
25428155|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25428156|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
25428157|NCT01771107|Imidazole|imidazole|mesh-list
25428158|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
25428159|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428160|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428161|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25428162|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25428163|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25428164|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428165|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428166|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428167|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
25428168|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428169|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428170|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428171|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428172|NCT01767194|Sirolimus|sirolimus|mesh-list
25428173|NCT01767194|Irinotecan|irinotecan|mesh-list
25428174|NCT01767194|Camptothecin|camptothecin|mesh-list
25428175|NCT01767194|Temozolomide|temozolomide|mesh-list
25428176|NCT01767194|Dinutuximab|dinutuximab|mesh-list
25428177|NCT01767194|Sargramostim|sargramostim|mesh-list
25428178|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25428179|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25428180|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428181|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428182|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428183|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428184|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
25428185|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25428186|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428187|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25428188|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
25428189|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428190|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
25428191|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428192|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428193|NCT01763580|Prednisolone|prednisolone|mesh-list
25428194|NCT01763580|Tacrolimus|tacrolimus|mesh-list
25428195|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428196|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
25428197|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428198|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25428199|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428200|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428201|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428202|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
25428203|NCT01763580|Hormones|hormones|mesh-ancestor
25428204|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428205|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428206|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428207|NCT01760447|Metformin|metformin|mesh-list
25428208|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25428209|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25428210|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428211|NCT01760447|Incretins|incretins|mesh-ancestor
25428212|NCT01760447|Hormones|hormones|mesh-ancestor
25428213|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428214|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25428215|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
25428216|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428217|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428218|NCT01757535|Azacitidine|azacitidine|mesh-list
25428219|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428220|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
25428221|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428222|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428223|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428224|NCT01750281|Docetaxel|docetaxel|mesh-list
25428225|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399796|NCT03891706|Analgesics|analgesics|mesh-ancestor
25428226|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428227|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428228|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428229|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428231|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25428232|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25428233|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25428234|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428235|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
25428236|NCT01748175|Hormones|hormones|mesh-ancestor
25428237|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428238|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428239|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428240|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
25428241|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428242|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428243|NCT01748149|Vemurafenib|vemurafenib|mesh-list
25428244|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428245|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428246|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428247|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428248|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
25428249|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25428250|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25428251|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
25428252|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428253|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428254|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428255|NCT01747577|Urological Agents|urological agents|mesh-ancestor
25428258|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428259|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428260|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428261|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428262|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428263|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428264|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428265|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428266|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428267|NCT01745757|Growth Substances|growth substances|mesh-ancestor
25428268|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428269|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428270|NCT01743950|Bevacizumab|bevacizumab|mesh-list
25428271|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428272|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428273|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428274|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428275|NCT01743950|Growth Substances|growth substances|mesh-ancestor
25428276|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428277|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428278|NCT01743872|Dextrans|dextrans|mesh-list
25428279|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
25428280|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
25428281|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
25428282|NCT01740557|Aldesleukin|aldesleukin|mesh-list
25428283|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
25428284|NCT01740557|Fludarabine|fludarabine|mesh-list
25428285|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
25428286|NCT01740557|Interleukin-2|interleukin-2|mesh-list
25428287|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428288|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
25428289|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428290|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428291|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428292|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
25428293|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428294|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428295|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428296|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428297|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
25428298|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25428299|NCT01740557|Analgesics|analgesics|mesh-ancestor
25428300|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
25399869|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399870|NCT03889275|Durvalumab|durvalumab|mesh-list
25399871|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399872|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399881|NCT03887702|Tenofovir|tenofovir|mesh-list
25399882|NCT03887702|Entecavir|entecavir|mesh-list
25399883|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
25399884|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399887|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428301|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428302|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25428303|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25428304|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
25428305|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428306|NCT01740492|Ketamine|ketamine|mesh-list
25428307|NCT01740492|Analgesics|analgesics|mesh-ancestor
25428308|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
25428309|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428310|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428311|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25428312|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25428313|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
25428314|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
25428315|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25428316|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25428317|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25428318|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428319|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428320|NCT01740427|Letrozole|letrozole|mesh-list
25428321|NCT01740427|Palbociclib|palbociclib|mesh-list
25428322|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428323|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25428324|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25428325|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428326|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428327|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25428328|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
25428329|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428330|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428331|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428332|NCT01738139|Ipilimumab|ipilimumab|mesh-list
25428334|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428335|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428336|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25428337|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428338|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428339|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428341|NCT01734928|Dexamethasone|dexamethasone|mesh-list
25428342|NCT01734928|Bortezomib|bortezomib|mesh-list
25428343|NCT01734928|Pomalidomide|pomalidomide|mesh-list
25428344|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428345|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
25428346|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
25428347|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428348|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428349|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25428350|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
25428351|NCT01734928|Hormones|hormones|mesh-ancestor
25428352|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428353|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428354|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428355|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
25428356|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428357|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428358|NCT01734928|Growth Substances|growth substances|mesh-ancestor
25428359|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
25399949|NCT03879629|Carvedilol|carvedilol|mesh-list
25428360|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428361|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
25428362|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25428363|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428364|NCT01730118|Mitogens|mitogens|mesh-list
25428365|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428366|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428367|NCT01729091|Lenalidomide|lenalidomide|mesh-list
25428368|NCT01729091|Melphalan|melphalan|mesh-list
25428369|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
25428370|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25428371|NCT01729091|Elotuzumab|elotuzumab|mesh-list
25428372|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
25428373|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428374|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428375|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428376|NCT01729091|Growth Substances|growth substances|mesh-ancestor
25428377|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428378|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428379|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428380|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
25428381|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428382|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428383|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428385|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
25428386|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428387|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25428388|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428389|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428390|NCT01723774|Anastrozole|anastrozole|mesh-list
25428391|NCT01723774|Goserelin|goserelin|mesh-list
25428392|NCT01723774|Palbociclib|palbociclib|mesh-list
25428393|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428394|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428395|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25428396|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25428397|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428398|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428399|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25428400|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
25428401|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428402|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428403|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428404|NCT01722708|Metronidazole|metronidazole|mesh-list
25428405|NCT01722708|Clindamycin|clindamycin|mesh-list
25428406|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
25428407|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
25428408|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428409|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25428412|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25428413|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428414|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428415|NCT01719237|Ropivacaine|ropivacaine|mesh-list
25428416|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
25428417|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
25428418|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
25428419|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25428420|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428421|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
25428422|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428423|NCT01718743|Lenalidomide|lenalidomide|mesh-list
25428424|NCT01718743|Ixazomib|ixazomib|mesh-list
25428425|NCT01718743|Glycine|glycine|mesh-list
25428426|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
25428427|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428428|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428429|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428430|NCT01718743|Growth Substances|growth substances|mesh-ancestor
25428431|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428432|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428433|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428434|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
25428435|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428436|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
25428437|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428438|NCT01716806|Nivolumab|nivolumab|mesh-list
25428439|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25428440|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25428441|NCT01716806|Dacarbazine|dacarbazine|mesh-list
25428442|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428443|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428444|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25428445|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428446|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428447|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
25428448|NCT01712815|Clevudine|clevudine|mesh-list
25428449|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
25428450|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428452|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25428453|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
25428454|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428455|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428456|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25428457|NCT01712620|Diuretics|diuretics|mesh-ancestor
25428458|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
25428459|NCT01711632|Vemurafenib|vemurafenib|mesh-list
25428460|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428461|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428462|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428463|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428464|NCT01711554|Vitamin A|vitamin a|mesh-list
25428465|NCT01711554|Lenalidomide|lenalidomide|mesh-list
25428466|NCT01711554|Tretinoin|tretinoin|mesh-list
25428467|NCT01711554|Dinutuximab|dinutuximab|mesh-list
25428468|NCT01711554|Isotretinoin|isotretinoin|mesh-list
25428469|NCT01711554|Vitamins|vitamins|mesh-ancestor
25428470|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
25428471|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428472|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
25428473|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428474|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428475|NCT01711554|Growth Substances|growth substances|mesh-ancestor
25428476|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428477|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428478|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
25428479|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
25428480|NCT01711541|Paclitaxel|paclitaxel|mesh-list
25428481|NCT01711541|Cisplatin|cisplatin|mesh-list
25428482|NCT01711541|Carboplatin|carboplatin|mesh-list
25428483|NCT01711541|Fluorouracil|fluorouracil|mesh-list
25428484|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25428485|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
25428486|NCT01711541|Veliparib|veliparib|mesh-list
25428487|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428488|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428489|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428490|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428492|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428493|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
25428494|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428495|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428496|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
25428497|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428498|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
25428499|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428500|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25428501|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25428502|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25428503|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428504|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428505|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428506|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428507|NCT01708941|Interferons|interferons|mesh-list
25428508|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
25428509|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
25428510|NCT01708941|Ipilimumab|ipilimumab|mesh-list
25428511|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428512|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
25428513|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428514|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428515|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400097|NCT03870438|Lamivudine|lamivudine|mesh-list
25428516|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428517|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
25428518|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428519|NCT01706939|Carboplatin|carboplatin|mesh-list
25428520|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428521|NCT01702831|Lenalidomide|lenalidomide|mesh-list
25428522|NCT01702831|Melphalan|melphalan|mesh-list
25428523|NCT01702831|Busulfan|busulfan|mesh-list
25428524|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
25428525|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428526|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428527|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428528|NCT01702831|Growth Substances|growth substances|mesh-ancestor
25428529|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428530|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428610|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
25428531|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428532|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
25428533|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428534|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428535|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428536|NCT01701986|Gemcitabine|gemcitabine|mesh-list
25428537|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
25428539|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25428540|NCT01701986|Busulfan|busulfan|mesh-list
25428541|NCT01701986|Clofarabine|clofarabine|mesh-list
25428542|NCT01701986|Antibodies|antibodies|mesh-list
25428543|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
25428544|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25428545|NCT01701986|Tacrolimus|tacrolimus|mesh-list
25428546|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
25428547|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25428548|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
25428549|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428550|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428551|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428552|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428553|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
25428554|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428555|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
25428556|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428557|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428558|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428559|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25428560|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25428561|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25428562|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
25428563|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25428564|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
25428565|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428566|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428567|NCT01700946|Cytarabine|cytarabine|mesh-list
25428571|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25428572|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25428573|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25428574|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
25428575|NCT01700946|Rituximab|rituximab|mesh-list
25428576|NCT01700946|Methotrexate|methotrexate|mesh-list
25428577|NCT01700946|Etoposide|etoposide|mesh-list
25428578|NCT01700946|Vincristine|vincristine|mesh-list
25428579|NCT01700946|Interleukin-2|interleukin-2|mesh-list
25428580|NCT01700946|Asparaginase|asparaginase|mesh-list
25428581|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
25428582|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
25428583|NCT01700946|Clofarabine|clofarabine|mesh-list
25428584|NCT01700946|Vinblastine|vinblastine|mesh-list
25428585|NCT01700946|Pegaspargase|pegaspargase|mesh-list
25428586|NCT01700946|Teniposide|teniposide|mesh-list
25428587|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428588|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
25428589|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428590|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428591|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428592|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
25428593|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428594|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428595|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428596|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428597|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428598|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
25428599|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
25428600|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428601|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25428602|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
25428603|NCT01700946|Hormones|hormones|mesh-ancestor
25428604|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428605|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428606|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25428607|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
25428608|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25428609|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428611|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25428612|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428613|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25428614|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25428615|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428616|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25428617|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25428618|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
25428619|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428620|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428621|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428622|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428623|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25428625|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
25428626|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25428627|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25428628|NCT01697566|Metformin|metformin|mesh-list
25428629|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25428630|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428631|NCT01695941|Rituximab|rituximab|mesh-list
25428632|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25428633|NCT01695941|Bortezomib|bortezomib|mesh-list
25428634|NCT01695941|Antibodies|antibodies|mesh-list
25428635|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
25428636|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25428637|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
25428638|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428639|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428640|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428641|NCT01688492|Ipilimumab|ipilimumab|mesh-list
25428642|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428643|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428644|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25428645|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428646|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
25428647|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25428648|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25428649|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25428727|NCT01668784|Everolimus|everolimus|mesh-list
25428650|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25428651|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428652|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
25428653|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428654|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428655|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25428656|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428657|NCT01682083|Trametinib|trametinib|mesh-list
25428658|NCT01682083|Dabrafenib|dabrafenib|mesh-list
25428659|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428660|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428661|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428662|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428663|NCT01678131|Ribavirin|ribavirin|mesh-list
25428664|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25428665|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
25428666|NCT01678131|Liver Extracts|liver extracts|mesh-list
25428667|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
25428668|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428669|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
25428670|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428671|NCT01678131|Hematinics|hematinics|mesh-ancestor
25428672|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428673|NCT01677858|Dexamethasone|dexamethasone|mesh-list
25428674|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428675|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
25428676|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
25428677|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428678|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428679|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25428680|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
25428681|NCT01677858|Hormones|hormones|mesh-ancestor
25428682|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428683|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428684|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428685|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
25428686|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428687|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428688|NCT01676402|Vaccines|vaccines|mesh-list
25428689|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
25428690|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428691|NCT01673217|Doxorubicin|doxorubicin|mesh-list
25428692|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25428693|NCT01673217|Decitabine|decitabine|mesh-list
25428694|NCT01673217|Azacitidine|azacitidine|mesh-list
25428695|NCT01673217|Vaccines|vaccines|mesh-list
25428696|NCT01673217|Sargramostim|sargramostim|mesh-list
25428697|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
25428698|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
25428699|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428700|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25428701|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428702|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25428703|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25428704|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428705|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428706|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428707|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
25428708|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25428709|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25428710|NCT01668849|Fentanyl|fentanyl|mesh-list
25428711|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25428712|NCT01668849|Narcotics|narcotics|mesh-ancestor
25428713|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25428714|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428715|NCT01668849|Analgesics|analgesics|mesh-ancestor
25428716|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
25428717|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428718|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25428719|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25428720|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
25428721|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
25428722|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25428723|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25428724|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428725|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428726|NCT01668784|Nivolumab|nivolumab|mesh-list
25428728|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428729|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428730|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25428731|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428732|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428733|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
25428734|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428735|NCT01665144|Siponimod|siponimod|mesh-list
25428736|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25428737|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428738|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428739|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
25428740|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428741|NCT01662050|Cytarabine|cytarabine|mesh-list
25428742|NCT01662050|Rituximab|rituximab|mesh-list
25428743|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25428744|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428745|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428746|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
25428747|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428748|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428749|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428750|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
25428751|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428752|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
25428753|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428754|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428755|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428756|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
25428757|NCT01659853|Azelaic acid|azelaic acid|mesh-list
25428758|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25428759|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25428760|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25428761|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25428762|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25428763|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
25428764|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428765|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428766|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428767|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428768|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
25428769|NCT01659658|Thalidomide|thalidomide|mesh-list
25428770|NCT01659658|Dexamethasone|dexamethasone|mesh-list
25428771|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
25428772|NCT01659658|Melphalan|melphalan|mesh-list
25428773|NCT01659658|Lenalidomide|lenalidomide|mesh-list
25428774|NCT01659658|Ixazomib|ixazomib|mesh-list
25428775|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428776|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
25428777|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428778|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428779|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428780|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
25428781|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428782|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428783|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428784|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428785|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
25428786|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
25428787|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428788|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25428789|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
25428790|NCT01659658|Hormones|hormones|mesh-ancestor
25428791|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25428792|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25428793|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428794|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428795|NCT01659658|Growth Substances|growth substances|mesh-ancestor
25428796|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428797|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
25428798|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25428799|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428800|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
25428801|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428802|NCT01659307|Aspirin|aspirin|mesh-list
25428803|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25428804|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25428805|NCT01659307|Analgesics|analgesics|mesh-ancestor
25428806|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
25428807|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428808|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428809|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428810|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428811|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25428812|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25428813|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428814|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25428815|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25428816|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428817|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
25428818|NCT01657591|Vemurafenib|vemurafenib|mesh-list
25428819|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428820|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428821|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428822|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428823|NCT01653678|Vitamin D|vitamin d|mesh-list
25428824|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
25428825|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
25428826|NCT01653678|Vitamins|vitamins|mesh-list
25428827|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
25428828|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428829|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25428830|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25428831|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
25428832|NCT01652872|Hematinics|hematinics|mesh-ancestor
25428833|NCT01652469|Docetaxel|docetaxel|mesh-list
25428834|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25428835|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428836|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428837|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428838|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428839|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428840|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428841|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428842|NCT01650701|Rituximab|rituximab|mesh-list
25428843|NCT01650701|Lenalidomide|lenalidomide|mesh-list
25428844|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25428845|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25428846|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428847|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
25428848|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428849|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428850|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25428851|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25428852|NCT01650701|Growth Substances|growth substances|mesh-ancestor
25428853|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
25428854|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428855|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
25428856|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428857|NCT01650558|Chloroquine|chloroquine|mesh-list
25428858|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25428859|NCT01650558|Amebicides|amebicides|mesh-ancestor
25428860|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25428861|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25428862|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428863|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
25428864|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25428865|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25428866|NCT01650558|Renal Agents|renal agents|mesh-ancestor
25428867|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25428868|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25428869|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25428870|NCT01647932|Diuretics|diuretics|mesh-ancestor
25428871|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
25428872|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428873|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25428874|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25428875|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428876|NCT01639690|Busulfan|busulfan|mesh-list
25428877|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
25428878|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428879|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428880|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
25428881|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428882|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25428883|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428884|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428885|NCT01639131|Gemcitabine|gemcitabine|mesh-list
25428886|NCT01639131|Docetaxel|docetaxel|mesh-list
25428887|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25428888|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
25428889|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428890|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428891|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
25428892|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428893|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428894|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25428895|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
25428896|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428897|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428898|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428899|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428900|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25428901|NCT01638533|Romidepsin|romidepsin|mesh-list
25428902|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428903|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25428904|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428905|NCT01631617|Doxycycline|doxycycline|mesh-list
25428906|NCT01631617|Cephalexin|cephalexin|mesh-list
25428907|NCT01631617|Trimethoprim|trimethoprim|mesh-list
25428908|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
25428909|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25428911|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25428912|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428914|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25428915|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25428916|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25428917|NCT01631617|Renal Agents|renal agents|mesh-ancestor
25428918|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25428919|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428920|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428921|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25428922|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25428923|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25428924|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
25428925|NCT01625611|Naltrexone|naltrexone|mesh-list
25428926|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25428927|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25428928|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428929|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
25428930|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428931|NCT01625286|Paclitaxel|paclitaxel|mesh-list
25428932|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25428933|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25428934|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428935|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
25428936|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
25428937|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
25428938|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428939|NCT01624285|Sorafenib|sorafenib|mesh-list
25428940|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428941|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428942|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428943|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428944|NCT01621906|Alovudine|alovudine|mesh-list
25428945|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
25428946|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25428947|NCT01620788|Losartan|losartan|mesh-list
25428948|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25428949|NCT01620788|Indapamide|indapamide|mesh-list
25428950|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25428951|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25428952|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25428953|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25428954|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428955|NCT01620788|Diuretics|diuretics|mesh-ancestor
25428957|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428958|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25428959|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25428960|NCT01619111|Lapatinib|lapatinib|mesh-list
25428961|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428962|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25428963|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428964|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428965|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25428966|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25428967|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428968|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25428969|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25428970|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25428971|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428972|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
25428973|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428974|NCT01615510|Tapentadol|tapentadol|mesh-list
25428975|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25428976|NCT01615510|Narcotics|narcotics|mesh-ancestor
25428977|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25428978|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428979|NCT01615510|Analgesics|analgesics|mesh-ancestor
25428980|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
25428981|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428982|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25428983|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25428984|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25428985|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25428986|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
25428987|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25428988|NCT01615029|Dexamethasone|dexamethasone|mesh-list
25428989|NCT01615029|Lenalidomide|lenalidomide|mesh-list
25428990|NCT01615029|Daratumumab|daratumumab|mesh-list
25428991|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25428992|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25428993|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
25428994|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
25428995|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25428996|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25428997|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25428998|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
25428999|NCT01615029|Hormones|hormones|mesh-ancestor
25429000|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429001|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429002|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429003|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
25429004|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429005|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429006|NCT01615029|Growth Substances|growth substances|mesh-ancestor
25429007|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429008|NCT01613118|Irbesartan|irbesartan|mesh-list
25429009|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25429010|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25429011|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25429012|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429013|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
25429014|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25429015|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
25429016|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25429017|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
25429018|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429019|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429020|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
25429021|NCT01603407|Prednisone|prednisone|mesh-list
25429022|NCT01603407|Deflazacort|deflazacort|mesh-list
25429023|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429024|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
25429025|NCT01603407|Hormones|hormones|mesh-ancestor
25429026|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429027|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429028|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429029|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429036|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25429037|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25429038|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
25429039|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429040|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429041|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25429042|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25429043|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429044|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429045|NCT01598311|Vancomycin|vancomycin|mesh-list
25429046|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429047|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429048|NCT01597414|Trastuzumab|trastuzumab|mesh-list
25429049|NCT01597414|Pertuzumab|pertuzumab|mesh-list
25429050|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25429051|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429052|NCT01597388|Fulvestrant|fulvestrant|mesh-list
25429053|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429054|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429055|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25429056|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25400625|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
25400626|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400627|NCT03845517|PF-06700841|pf-06700841|mesh-list
25400628|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25400629|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400630|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400631|NCT03845166|Atezolizumab|atezolizumab|mesh-list
25400632|NCT03845166|Avelumab|avelumab|mesh-list
25400633|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400634|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400635|NCT03844256|Capecitabine|capecitabine|mesh-list
25400636|NCT03844256|Nivolumab|nivolumab|mesh-list
25400637|NCT03844256|Ipilimumab|ipilimumab|mesh-list
25400638|NCT03844256|Mitomycins|mitomycins|mesh-list
25400639|NCT03844256|Mitomycin|mitomycin|mesh-list
25400640|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400641|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
25400642|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400643|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429057|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
25429134|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
25429058|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429059|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429066|NCT01592370|Dexamethasone|dexamethasone|mesh-list
25429067|NCT01592370|Nivolumab|nivolumab|mesh-list
25429068|NCT01592370|Ipilimumab|ipilimumab|mesh-list
25429069|NCT01592370|Daratumumab|daratumumab|mesh-list
25429070|NCT01592370|Pomalidomide|pomalidomide|mesh-list
25429071|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429072|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
25429073|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
25429074|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429075|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429076|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429077|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
25429078|NCT01592370|Hormones|hormones|mesh-ancestor
25429079|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429080|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429081|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429082|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25429083|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25429084|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429085|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
25429086|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429087|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429088|NCT01592370|Growth Substances|growth substances|mesh-ancestor
25429089|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429090|NCT01591577|Temozolomide|temozolomide|mesh-list
25429091|NCT01591577|Lapatinib|lapatinib|mesh-list
25429092|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429093|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
25429094|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429095|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429096|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25429097|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429098|NCT01590017|Cisplatin|cisplatin|mesh-list
25429099|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429100|NCT01582009|Everolimus|everolimus|mesh-list
25400702|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25400703|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
25400704|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25400705|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
25400706|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25400707|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400708|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
25400709|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400710|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25400711|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400712|NCT03841617|Hormones|hormones|mesh-list
25400713|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400714|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400715|NCT03841357|Abatacept|abatacept|mesh-list
25400716|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25400717|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25400718|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25400719|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429101|NCT01582009|Panobinostat|panobinostat|mesh-list
25429102|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25429103|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429182|NCT01572506|Vitamins|vitamins|mesh-ancestor
25429106|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429107|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429108|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429109|NCT01575925|Thalidomide|thalidomide|mesh-list
25429110|NCT01575925|Dexamethasone|dexamethasone|mesh-list
25429111|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
25429112|NCT01575925|Pomalidomide|pomalidomide|mesh-list
25429113|NCT01575925|BB 1101|bb 1101|mesh-list
25429114|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429115|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
25429116|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
25429117|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429118|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429119|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429120|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
25429121|NCT01575925|Hormones|hormones|mesh-ancestor
25429122|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429123|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429124|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429125|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
25429126|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429127|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429128|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
25429129|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429130|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429131|NCT01575925|Growth Substances|growth substances|mesh-ancestor
25429132|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429133|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429135|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429136|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429137|NCT01575834|Denosumab|denosumab|mesh-list
25429138|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25400779|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400780|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25400781|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
25400782|NCT03839940|Hormones|hormones|mesh-ancestor
25400783|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25400784|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25400788|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
25429139|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429142|NCT01573780|Gemcitabine|gemcitabine|mesh-list
25429143|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429144|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
25429145|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429146|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429147|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
25429148|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429149|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429150|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429151|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
25429152|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429153|NCT01572662|Vidarabine|vidarabine|mesh-list
25429154|NCT01572662|Methotrexate|methotrexate|mesh-list
25429155|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
25429156|NCT01572662|Fludarabine|fludarabine|mesh-list
25429157|NCT01572662|Busulfan|busulfan|mesh-list
25429158|NCT01572662|Tacrolimus|tacrolimus|mesh-list
25429159|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25429160|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
25429161|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25429162|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429163|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429164|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
25429165|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429166|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429167|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
25429168|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429169|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25429170|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429171|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
25429172|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429173|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25429174|NCT01572662|Antiviral Agents|antiviral agents|mesh-ancestor
25429175|NCT01572662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429176|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25429177|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
25429178|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429179|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25429181|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
25429184|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429185|NCT01572480|Dexamethasone|dexamethasone|mesh-list
25429186|NCT01572480|Lenalidomide|lenalidomide|mesh-list
25429187|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429188|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
25429189|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
25429190|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429191|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429192|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429193|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
25429194|NCT01572480|Hormones|hormones|mesh-ancestor
25429195|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429196|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429197|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429198|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
25429199|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429200|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429201|NCT01572480|Growth Substances|growth substances|mesh-ancestor
25429202|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429203|NCT01568866|Dexamethasone|dexamethasone|mesh-list
25429204|NCT01568866|Bortezomib|bortezomib|mesh-list
25400857|NCT03835533|Nivolumab|nivolumab|mesh-list
25400858|NCT03835533|Poly ICLC|poly iclc|mesh-list
25400866|NCT03834948|Paclitaxel|paclitaxel|mesh-list
25429205|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429206|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
25429207|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
25429208|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429209|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429210|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429211|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
25429212|NCT01568866|Hormones|hormones|mesh-ancestor
25429441|NCT01522976|Azacitidine|azacitidine|mesh-list
25429213|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429214|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429215|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429216|NCT01566695|Azacitidine|azacitidine|mesh-list
25429217|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429218|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
25429219|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429220|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429221|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429222|NCT01562028|Bevacizumab|bevacizumab|mesh-list
25429223|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25429224|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25429225|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429226|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429227|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429228|NCT01562028|Growth Substances|growth substances|mesh-ancestor
25429229|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429230|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429231|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25429232|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429233|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429235|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25429236|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25429237|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
25429238|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25429239|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429240|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429241|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25429242|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25429243|NCT01555268|Cytarabine|cytarabine|mesh-list
25429244|NCT01555268|Trebananib|trebananib|mesh-list
25429245|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429246|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
25429247|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429248|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429249|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
25429250|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429251|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429252|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
25429253|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429254|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429255|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429256|NCT01555268|Growth Substances|growth substances|mesh-ancestor
25429257|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429258|NCT01553214|Dexamethasone|dexamethasone|mesh-list
25429259|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429260|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
25429261|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
25429262|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429263|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429264|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429265|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
25429266|NCT01553214|Hormones|hormones|mesh-ancestor
25429267|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429268|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429269|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429270|NCT01553149|Lenalidomide|lenalidomide|mesh-list
25429271|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
25429272|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429273|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429274|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429275|NCT01553149|Growth Substances|growth substances|mesh-ancestor
25429276|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429277|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429278|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
25429279|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429280|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
25429281|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429282|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429283|NCT01547260|Gemcitabine|gemcitabine|mesh-list
25429284|NCT01547260|Lenalidomide|lenalidomide|mesh-list
25429285|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429286|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
25429287|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429288|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429289|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
25429290|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429291|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429292|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429293|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
25429294|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429295|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429296|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429297|NCT01547260|Growth Substances|growth substances|mesh-ancestor
25429298|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429299|NCT01546987|Leuprolide|leuprolide|mesh-list
25429300|NCT01546987|Goserelin|goserelin|mesh-list
25429301|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25429302|NCT01546987|Flutamide|flutamide|mesh-list
25429303|NCT01546987|Bicalutamide|bicalutamide|mesh-list
25429304|NCT01546987|Buserelin|buserelin|mesh-list
25429305|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25429306|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
25429307|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25429308|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429309|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429310|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429311|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-ancestor
25429312|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
25429313|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429314|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
25429315|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25429316|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
25429317|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25429318|NCT01543763|Abexinostat|abexinostat|mesh-list
25429319|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25429320|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429321|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429322|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25429323|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25429324|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25429325|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429326|NCT01542879|Hematinics|hematinics|mesh-ancestor
25429327|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25429328|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25429329|NCT01538966|Octreotide|octreotide|mesh-list
25429330|NCT01538966|Lanreotide|lanreotide|mesh-list
25429331|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429332|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429333|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429334|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
25429335|NCT01535053|Leucovorin|leucovorin|mesh-list
25429341|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25429342|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429343|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25429344|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25429345|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
25429346|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25429347|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429348|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
25429349|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429350|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429351|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
25429352|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429353|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25429354|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429355|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
25429356|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429357|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25429358|NCT01535053|Antidotes|antidotes|mesh-ancestor
25429359|NCT01535053|Protective Agents|protective agents|mesh-ancestor
25429360|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
25429361|NCT01535053|Vitamins|vitamins|mesh-ancestor
25429362|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
25429363|NCT01535053|Hematinics|hematinics|mesh-ancestor
25429364|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429365|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429366|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25429367|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25429368|NCT01530009|Amoxicillin|amoxicillin|mesh-list
25429369|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429448|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429370|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429371|NCT01528046|Metformin|metformin|mesh-list
25429372|NCT01528046|Irinotecan|irinotecan|mesh-list
25429373|NCT01528046|Camptothecin|camptothecin|mesh-list
25429374|NCT01528046|Vincristine|vincristine|mesh-list
25429375|NCT01528046|Temozolomide|temozolomide|mesh-list
25429376|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25429377|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429378|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25429379|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25429380|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429381|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429382|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429383|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25429384|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25429385|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25429386|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25429387|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429388|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
25429389|NCT01525069|Gemcitabine|gemcitabine|mesh-list
25429390|NCT01525069|Dexamethasone|dexamethasone|mesh-list
25429391|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
25429392|NCT01525069|Floxuridine|floxuridine|mesh-list
25429393|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429394|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
25429395|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
25429396|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429397|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429398|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429399|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
25429400|NCT01525069|Hormones|hormones|mesh-ancestor
25429401|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429402|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429403|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429404|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429405|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
25429406|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429407|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
25429408|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429409|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429410|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429411|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
25429412|NCT01523977|Prednisone|prednisone|mesh-list
25429413|NCT01523977|Doxorubicin|doxorubicin|mesh-list
25429414|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
25429415|NCT01523977|Vincristine|vincristine|mesh-list
25429416|NCT01523977|Everolimus|everolimus|mesh-list
25429417|NCT01523977|Asparaginase|asparaginase|mesh-list
25429420|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25429421|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429422|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25429423|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25429424|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429425|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429426|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429427|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
25429428|NCT01523977|Hormones|hormones|mesh-ancestor
25429429|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429430|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429431|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429432|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25429433|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
25429434|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
25429435|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
25429436|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429437|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
25429438|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25429439|NCT01523977|Protective Agents|protective agents|mesh-ancestor
25429440|NCT01522976|Lenalidomide|lenalidomide|mesh-list
25429442|NCT01522976|Vorinostat|vorinostat|mesh-list
25429443|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
25429444|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429445|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429446|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429447|NCT01522976|Growth Substances|growth substances|mesh-ancestor
25429449|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429450|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429451|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
25429452|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429453|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429454|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25429455|NCT01522456|Tretinoin|tretinoin|mesh-list
25429456|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
25429457|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429458|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
25429459|NCT01521403|Metronidazole|metronidazole|mesh-list
25429460|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429461|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429462|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25429463|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25429464|NCT01517711|Tramadol|tramadol|mesh-list
25429465|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25429466|NCT01517711|Narcotics|narcotics|mesh-ancestor
25429467|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25429468|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429469|NCT01517711|Analgesics|analgesics|mesh-ancestor
25429470|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
25429471|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429472|NCT01517243|Sirolimus|sirolimus|mesh-list
25429473|NCT01517243|Sunitinib|sunitinib|mesh-list
25429474|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429475|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429476|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429477|NCT01517243|Growth Substances|growth substances|mesh-ancestor
25429478|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429479|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429480|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25429481|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429482|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429483|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429484|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429485|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25429486|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
25429487|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429488|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
25429489|NCT01516606|Clarithromycin|clarithromycin|mesh-list
25429490|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429491|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429492|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25429493|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429494|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429495|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25429496|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25429498|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429499|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
25429500|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429501|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429502|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
25429503|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429504|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429505|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
25429506|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429507|NCT01515527|Cytarabine|cytarabine|mesh-list
25429508|NCT01515527|Decitabine|decitabine|mesh-list
25429509|NCT01515527|Cladribine|cladribine|mesh-list
25429510|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429511|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
25429512|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429513|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429514|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
25429515|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429516|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429517|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
25429518|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429519|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429520|NCT01514344|Rituximab|rituximab|mesh-list
25429521|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25429522|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429523|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
25429524|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429525|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429526|NCT01506856|Paclitaxel|paclitaxel|mesh-list
25429527|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25429528|NCT01506856|Carboplatin|carboplatin|mesh-list
25429529|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25429530|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429531|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
25429532|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
25429533|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
25429534|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429535|NCT01504815|Cisplatin|cisplatin|mesh-list
25429536|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429537|NCT01500551|Tofacitinib|tofacitinib|mesh-list
25429538|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25429539|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429540|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429541|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
25429542|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25429543|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25429544|NCT01496976|Prednisolone|prednisolone|mesh-list
25429545|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
25429546|NCT01496976|Lenalidomide|lenalidomide|mesh-list
25429547|NCT01496976|Ofatumumab|ofatumumab|mesh-list
25429548|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25429549|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
25429550|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
25429551|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429552|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429553|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429554|NCT01496976|Growth Substances|growth substances|mesh-ancestor
25429555|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429556|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429557|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429558|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
25429559|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
25429560|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429561|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429562|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
25429563|NCT01496976|Hormones|hormones|mesh-ancestor
25429564|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429565|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25429566|NCT01496976|Protective Agents|protective agents|mesh-ancestor
25429567|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429568|NCT01490502|Vitamin D|vitamin d|mesh-list
25429569|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
25429570|NCT01490502|Vitamins|vitamins|mesh-ancestor
25429571|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
25429572|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429573|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25429574|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25429577|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429578|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
25429579|NCT01485861|Hormones|hormones|mesh-ancestor
25429580|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429581|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429582|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429583|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429584|NCT01485614|Metformin|metformin|mesh-list
25429585|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25429586|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25429587|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429588|NCT01485614|Incretins|incretins|mesh-ancestor
25429589|NCT01485614|Hormones|hormones|mesh-ancestor
25429590|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429591|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25429592|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
25429593|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429594|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429595|NCT01476501|Vitamin D|vitamin d|mesh-list
25429596|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
25429597|NCT01476501|Vitamins|vitamins|mesh-ancestor
25429598|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
25429599|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429600|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25429601|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25429602|NCT01464034|Dexamethasone|dexamethasone|mesh-list
25429603|NCT01464034|Pomalidomide|pomalidomide|mesh-list
25429604|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429605|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
25429606|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
25429607|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429608|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429609|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429610|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
25429611|NCT01464034|Hormones|hormones|mesh-ancestor
25429612|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429613|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429614|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429615|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
25429616|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429617|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429618|NCT01464034|Growth Substances|growth substances|mesh-ancestor
25429619|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429620|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25429621|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25429622|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429623|NCT01460654|Alendronate|alendronate|mesh-list
25429624|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
25429625|NCT01460654|Testosterone|testosterone|mesh-list
25429626|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
25429627|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
25429628|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25429629|NCT01460654|Androgens|androgens|mesh-ancestor
25429630|NCT01460654|Hormones|hormones|mesh-ancestor
25429631|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429632|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429633|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429634|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429635|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
25429636|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25429637|NCT01459484|Cisplatin|cisplatin|mesh-list
25429638|NCT01459484|Doxorubicin|doxorubicin|mesh-list
25429639|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25429640|NCT01459484|Methotrexate|methotrexate|mesh-list
25429641|NCT01459484|Ifosfamide|ifosfamide|mesh-list
25429642|NCT01459484|Mifamurtide|mifamurtide|mesh-list
25429643|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
25429644|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429645|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25429646|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25429647|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25429648|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429649|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429650|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25429651|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
25429958|NCT01409200|Protective Agents|protective agents|mesh-ancestor
25429654|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429655|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
25429656|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25429657|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25429658|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429659|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
25429660|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429661|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25429662|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429663|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
25429664|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25429665|NCT01458366|Carboplatin|carboplatin|mesh-list
25429666|NCT01458366|Etoposide|etoposide|mesh-list
25429667|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
25429668|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25429669|NCT01458366|Ofatumumab|ofatumumab|mesh-list
25429670|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429671|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25429672|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25429673|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25429674|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429675|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429676|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429677|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
25429678|NCT01445509|Bevacizumab|bevacizumab|mesh-list
25429679|NCT01445509|Dasatinib|dasatinib|mesh-list
25429680|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25429681|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429682|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429683|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429684|NCT01445509|Growth Substances|growth substances|mesh-ancestor
25429685|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429686|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429687|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25429688|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429689|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429690|NCT01444040|Travoprost|travoprost|mesh-list
25429691|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25429692|NCT01439880|Evolocumab|evolocumab|mesh-list
25429693|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25429694|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25429695|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
25429696|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429697|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25429701|NCT01431755|Lidocaine|lidocaine|mesh-list
25429702|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
25429703|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
25429704|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
25429705|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25429706|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429707|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
25429708|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429709|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25429710|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25429711|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25429712|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25429713|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429714|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25429715|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
25429716|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
25429717|NCT01431755|Protective Agents|protective agents|mesh-ancestor
25429718|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
25429719|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429720|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
25429721|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429722|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429723|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429724|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
25429725|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429959|NCT01409200|Vitamins|vitamins|mesh-ancestor
25429726|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429727|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25429728|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
25429729|NCT01428973|Sirolimus|sirolimus|mesh-list
25429730|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25429731|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429732|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25429733|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
25429734|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429735|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429736|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429737|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429738|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
25429739|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429740|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
25429741|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429742|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
25429743|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25429744|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
25429745|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401392|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401393|NCT03814109|Niacin|niacin|mesh-list
25401394|NCT03814109|Indapamide|indapamide|mesh-list
25401395|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25401396|NCT03814109|Diuretics|diuretics|mesh-ancestor
25401397|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
25401398|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429746|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
25429747|NCT01428024|Protective Agents|protective agents|mesh-ancestor
25429748|NCT01426269|Metronidazole|metronidazole|mesh-list
25429749|NCT01426269|Doxycycline|doxycycline|mesh-list
25429750|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429751|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25429752|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25429753|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25429754|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
25429755|NCT01424982|Cytarabine|cytarabine|mesh-list
25429756|NCT01424982|Dexamethasone|dexamethasone|mesh-list
25429757|NCT01424982|Prednisone|prednisone|mesh-list
25429758|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
25429759|NCT01424982|Cortisone|cortisone|mesh-list
25429760|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
25429761|NCT01424982|Rituximab|rituximab|mesh-list
25429762|NCT01424982|Doxorubicin|doxorubicin|mesh-list
25429763|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25429764|NCT01424982|Methotrexate|methotrexate|mesh-list
25429765|NCT01424982|Vincristine|vincristine|mesh-list
25429766|NCT01424982|Daunorubicin|daunorubicin|mesh-list
25429767|NCT01424982|Ponatinib|ponatinib|mesh-list
25429768|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25429769|NCT01424982|Antibodies|antibodies|mesh-list
25429770|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
25429771|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25429772|NCT01424982|BB 1101|bb 1101|mesh-list
25429773|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429774|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
25429775|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429776|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429777|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429778|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
25429779|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429780|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429781|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25429782|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429783|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
25429784|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
25429785|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429786|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429787|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
25429788|NCT01424982|Hormones|hormones|mesh-ancestor
25429789|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429790|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429791|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25429792|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25429793|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25429794|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429795|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25429796|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
25429797|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25429798|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429799|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
25429800|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
25429801|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25429802|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25429803|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
25429804|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429805|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25429806|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25429807|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25429808|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
25429809|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
25429810|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25429811|NCT01422759|Spironolactone|spironolactone|mesh-list
25429812|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25429813|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
25429814|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429815|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429816|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25429817|NCT01422759|Diuretics|diuretics|mesh-ancestor
25429818|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
25429819|NCT01422746|Metformin|metformin|mesh-list
25429820|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25429821|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429822|NCT01421810|Dexamethasone|dexamethasone|mesh-list
25429823|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429824|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
25429825|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
25429826|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429827|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429828|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429829|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
25429830|NCT01421810|Hormones|hormones|mesh-ancestor
25429831|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429832|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429833|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429834|NCT01421797|Dexamethasone|dexamethasone|mesh-list
25429835|NCT01421797|Cosyntropin|cosyntropin|mesh-list
25429836|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429837|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
25429838|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
25429839|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429840|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429841|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429842|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
25429843|NCT01421797|Hormones|hormones|mesh-ancestor
25429844|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429845|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429846|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429847|NCT01420926|Bortezomib|bortezomib|mesh-list
25429848|NCT01420926|Decitabine|decitabine|mesh-list
25429849|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429850|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25429851|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
25429852|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429853|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429854|NCT01419834|Antibodies|antibodies|mesh-list
25429855|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25429856|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
25429857|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429858|NCT01419561|Zidovudine|zidovudine|mesh-list
25429859|NCT01419561|Rituximab|rituximab|mesh-list
25429860|NCT01419561|Doxorubicin|doxorubicin|mesh-list
25429861|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25429862|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25429863|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429864|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
25429865|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429866|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429867|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25429868|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25429869|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25429870|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429871|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429872|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
25429873|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25429874|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25429875|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
25429876|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25429877|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25429878|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25429879|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25429880|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25429881|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429882|NCT01415882|Dexamethasone|dexamethasone|mesh-list
25429883|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
25429884|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
25429885|NCT01415882|Daratumumab|daratumumab|mesh-list
25429886|NCT01415882|Ixazomib|ixazomib|mesh-list
25429887|NCT01415882|Ichthammol|ichthammol|mesh-list
25429888|NCT01415882|BB 1101|bb 1101|mesh-list
25429889|NCT01415882|Glycine|glycine|mesh-list
25429890|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429891|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
25429892|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429893|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429894|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429895|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
25429896|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429897|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429898|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25429899|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25429900|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
25429901|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
25429902|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25429903|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25429904|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
25429905|NCT01415882|Hormones|hormones|mesh-ancestor
25429906|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429907|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429908|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
25429909|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429910|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
25429912|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25429913|NCT01415752|Rituximab|rituximab|mesh-list
25429914|NCT01415752|Lenalidomide|lenalidomide|mesh-list
25429915|NCT01415752|Bortezomib|bortezomib|mesh-list
25429916|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25429917|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25429918|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429919|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
25429920|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429921|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25429922|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25429923|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25429924|NCT01415752|Growth Substances|growth substances|mesh-ancestor
25429925|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
25429926|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25429927|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
25429928|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429929|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25429930|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25429931|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429932|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25429933|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25429934|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25429935|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429936|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
25429937|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25429938|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
25429939|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25429940|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
25429941|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429942|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
25429943|NCT01412190|Protective Agents|protective agents|mesh-ancestor
25429944|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
25429945|NCT01409200|Axitinib|axitinib|mesh-list
25429946|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
25429947|NCT01409200|Hormones|hormones|mesh-list
25429948|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25429949|NCT01409200|Androgens|androgens|mesh-list
25429950|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
25429951|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25429952|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429953|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429954|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25429955|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25429956|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429957|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
25429996|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25429997|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25429998|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25429999|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430000|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430001|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430002|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25430003|NCT01393522|Analgesics|analgesics|mesh-ancestor
25430004|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
25430005|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430006|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
25430007|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25430008|NCT01391962|Sunitinib|sunitinib|mesh-list
25430009|NCT01391962|Cediranib|cediranib|mesh-list
25430010|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430011|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430012|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430013|NCT01391962|Growth Substances|growth substances|mesh-ancestor
25430014|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430015|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
25430016|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430017|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430018|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430019|NCT01386385|Paclitaxel|paclitaxel|mesh-list
25430020|NCT01386385|Carboplatin|carboplatin|mesh-list
25430021|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25430022|NCT01386385|Veliparib|veliparib|mesh-list
25430023|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430024|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430025|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430026|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430027|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430028|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430029|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25430030|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430031|NCT01384513|Vidarabine|vidarabine|mesh-list
25430032|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
25430033|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
25430034|NCT01384513|Busulfan|busulfan|mesh-list
25430035|NCT01384513|Fludarabine|fludarabine|mesh-list
25430036|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
25430037|NCT01384513|Tacrolimus|tacrolimus|mesh-list
25430038|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430039|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
25430040|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430041|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430042|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430043|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
25430044|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430045|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430046|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430047|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430048|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
25430049|NCT01384513|Antiviral Agents|antiviral agents|mesh-ancestor
25430050|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430051|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25430052|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430053|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430054|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25430055|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
25430056|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25430057|NCT01375829|Sirolimus|sirolimus|mesh-list
25430058|NCT01375829|Epothilone B|epothilone b|mesh-list
25430059|NCT01375829|Epothilones|epothilones|mesh-list
25430060|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25430061|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430062|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430063|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430064|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
25430065|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430066|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
25430067|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430068|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430069|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430070|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430071|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430072|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
25430073|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
25430074|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25430075|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25430076|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
25430077|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430079|NCT01371981|Etoposide|etoposide|mesh-list
25430080|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
25430081|NCT01371981|Daunorubicin|daunorubicin|mesh-list
25430082|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
25430083|NCT01371981|Bortezomib|bortezomib|mesh-list
25430084|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
25430085|NCT01371981|Sorafenib|sorafenib|mesh-list
25430086|NCT01371981|Asparaginase|asparaginase|mesh-list
25430087|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430088|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430089|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430090|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430091|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430092|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430093|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430094|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
25430095|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
25430096|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430097|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430098|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
25430099|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430100|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430101|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430102|NCT01371981|Analgesics|analgesics|mesh-ancestor
25430103|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
25430104|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430105|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
25430106|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
25430107|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430108|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430109|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430110|NCT01371201|Sunitinib|sunitinib|mesh-list
25430111|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430112|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430113|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430114|NCT01371201|Growth Substances|growth substances|mesh-ancestor
25430115|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430116|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
25430117|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430119|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430120|NCT01366144|Paclitaxel|paclitaxel|mesh-list
25430121|NCT01366144|Carboplatin|carboplatin|mesh-list
25430122|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25430123|NCT01366144|Veliparib|veliparib|mesh-list
25430124|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430125|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430126|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430127|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430128|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430129|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430130|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25430131|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430132|NCT01364597|Brivaracetam|brivaracetam|mesh-list
25430133|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
25430134|NCT01364051|Cediranib|cediranib|mesh-list
25430135|NCT01364051|Maleic acid|maleic acid|mesh-list
25430136|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430137|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430138|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430139|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430140|NCT01359592|Prednisone|prednisone|mesh-list
25430141|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
25430142|NCT01359592|Rituximab|rituximab|mesh-list
25430143|NCT01359592|Doxorubicin|doxorubicin|mesh-list
25430144|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25430145|NCT01359592|Vincristine|vincristine|mesh-list
25430146|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25430147|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430148|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
25430149|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430150|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430151|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430152|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
25430153|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430154|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430155|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430156|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401778|NCT03794349|Eflornithine|eflornithine|mesh-list
25401779|NCT03794349|Irinotecan|irinotecan|mesh-list
25401780|NCT03794349|Camptothecin|camptothecin|mesh-list
25401781|NCT03794349|Temozolomide|temozolomide|mesh-list
25401782|NCT03794349|Dinutuximab|dinutuximab|mesh-list
25401783|NCT03794349|Sargramostim|sargramostim|mesh-list
25401784|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25401799|NCT03794037|Montelukast|montelukast|mesh-list
25430157|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430158|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430159|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430160|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430161|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430162|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
25430163|NCT01359592|Hormones|hormones|mesh-ancestor
25430164|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430165|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430166|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430167|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430168|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430169|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430170|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25430171|NCT01358669|Denosumab|denosumab|mesh-list
25430172|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25430173|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430174|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
25430175|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430176|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430177|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430178|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430179|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430180|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430181|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430182|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430183|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430184|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430185|NCT01357772|Tamoxifen|tamoxifen|mesh-list
25430186|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25430187|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
25430188|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430189|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430190|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430191|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430192|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25430193|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25430194|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25430195|NCT01356290|Cytarabine|cytarabine|mesh-list
25430196|NCT01356290|Thalidomide|thalidomide|mesh-list
25430197|NCT01356290|Celecoxib|celecoxib|mesh-list
25430198|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
25430199|NCT01356290|Bevacizumab|bevacizumab|mesh-list
25430200|NCT01356290|Etoposide|etoposide|mesh-list
25430201|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
25430202|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
25430203|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430204|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
25430205|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430206|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430207|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430208|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
25430432|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
25430209|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430210|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430211|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430212|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25430213|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430214|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430215|NCT01356290|Growth Substances|growth substances|mesh-ancestor
25430216|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
25401860|NCT03792763|Denosumab|denosumab|mesh-list
25430217|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430218|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430219|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430220|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430221|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430222|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
25430223|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
25430224|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430225|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25430226|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25430227|NCT01356290|Analgesics|analgesics|mesh-ancestor
25430228|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
25430229|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430230|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430231|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25430232|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25430233|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
25430234|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25430235|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25430236|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25430237|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25430238|NCT01354353|Aripiprazole|aripiprazole|mesh-list
25430239|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
25430240|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25430241|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25430242|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25430243|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25430244|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430245|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
25430246|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
25430247|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430248|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430249|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25430250|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25430251|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
25430252|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25430253|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25430254|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25430255|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25430256|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
25430257|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430258|NCT01352962|Gemcitabine|gemcitabine|mesh-list
25430259|NCT01352962|Carboplatin|carboplatin|mesh-list
25430260|NCT01352962|Lenalidomide|lenalidomide|mesh-list
25430261|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430262|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430263|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
25430264|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430265|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
25430266|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430267|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430268|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430269|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
25430270|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430271|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430272|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430273|NCT01352962|Growth Substances|growth substances|mesh-ancestor
25430274|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
25430275|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25430276|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25430277|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430278|NCT01351896|Lenalidomide|lenalidomide|mesh-list
25430279|NCT01351896|Vaccines|vaccines|mesh-list
25430280|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25430281|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
25430282|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430283|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430284|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430285|NCT01351896|Growth Substances|growth substances|mesh-ancestor
25430286|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
25430287|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430289|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
25430290|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
25430291|NCT01351805|Vitamins|vitamins|mesh-list
25401926|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401927|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401928|NCT03786783|Vitamin A|vitamin a|mesh-list
25401929|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
25401930|NCT03786783|Melphalan|melphalan|mesh-list
25401931|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
25401932|NCT03786783|Thiotepa|thiotepa|mesh-list
25401933|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25401934|NCT03786783|Cisplatin|cisplatin|mesh-list
25401935|NCT03786783|Carboplatin|carboplatin|mesh-list
25401936|NCT03786783|Doxorubicin|doxorubicin|mesh-list
25401937|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25401938|NCT03786783|Etoposide|etoposide|mesh-list
25401939|NCT03786783|Vincristine|vincristine|mesh-list
25430292|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
25430293|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430294|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25430295|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25430296|NCT01351103|Spartalizumab|spartalizumab|mesh-list
25430297|NCT01351103|LGK974|lgk974|mesh-list
25430298|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25430299|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430300|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430301|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430302|NCT01349881|Eflornithine|eflornithine|mesh-list
25430303|NCT01349881|Sulindac|sulindac|mesh-list
25430304|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430305|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25430306|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25430307|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25430308|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430309|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25430310|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430311|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430312|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25430313|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25430314|NCT01349881|Analgesics|analgesics|mesh-ancestor
25430315|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
25430316|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430317|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430318|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430319|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430320|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25430321|NCT01349101|Vidarabine|vidarabine|mesh-list
25430322|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
25430323|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
25430324|NCT01349101|Busulfan|busulfan|mesh-list
25430325|NCT01349101|Fludarabine|fludarabine|mesh-list
25430326|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
25430327|NCT01349101|Tacrolimus|tacrolimus|mesh-list
25430328|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430329|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
25430330|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430331|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430332|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430333|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
25430334|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430335|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430336|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430337|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430338|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
25430339|NCT01349101|Antiviral Agents|antiviral agents|mesh-ancestor
25430340|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430341|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25430342|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430343|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430344|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25430345|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
25430346|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25430347|NCT01344200|Celecoxib|celecoxib|mesh-list
25430348|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25430349|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25430350|NCT01344200|Analgesics|analgesics|mesh-ancestor
25430351|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
25430352|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430353|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430354|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430355|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430356|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25430357|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25430358|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430359|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430360|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
25430361|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25430362|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430363|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430439|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
25430364|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25430365|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25430366|NCT01337349|Protective Agents|protective agents|mesh-ancestor
25430367|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430368|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
25430369|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25430370|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
25430371|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
25430372|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430373|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430374|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430375|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430376|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430377|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430378|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430379|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430380|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430381|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430382|NCT01332968|Prednisone|prednisone|mesh-list
25430383|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
25430384|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25430385|NCT01332968|Rituximab|rituximab|mesh-list
25430386|NCT01332968|Doxorubicin|doxorubicin|mesh-list
25430387|NCT01332968|Vincristine|vincristine|mesh-list
25430388|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
25430389|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430390|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
25430391|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430392|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430393|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430394|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
25430395|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430396|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430397|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430398|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25430399|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430400|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430401|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430402|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430403|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430404|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
25430405|NCT01332968|Hormones|hormones|mesh-ancestor
25430406|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430407|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430408|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430409|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430410|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430411|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430412|NCT01331148|Vitamin D|vitamin d|mesh-list
25430413|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
25430414|NCT01331148|Vitamins|vitamins|mesh-ancestor
25430415|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
25430416|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430417|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25430948|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
25430418|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25430419|NCT01328093|Aripiprazole|aripiprazole|mesh-list
25430420|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
25430421|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25430422|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25430423|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25430424|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25430425|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430426|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
25430427|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
25430428|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430429|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430430|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25430431|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25430433|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25430434|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25430435|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25430436|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25430437|NCT01327781|Tamoxifen|tamoxifen|mesh-list
25430438|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25430440|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430441|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430442|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430443|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430444|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25430445|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25430446|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25430448|NCT01327651|Emtricitabine|emtricitabine|mesh-list
25430449|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
25430450|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430451|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25430452|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25430453|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430454|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430455|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25430456|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25430457|NCT01319981|Cytarabine|cytarabine|mesh-list
25430458|NCT01319981|Dexamethasone|dexamethasone|mesh-list
25430459|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
25430460|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25430461|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25430462|NCT01319981|Prednisolone|prednisolone|mesh-list
25430463|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
25430464|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
25430465|NCT01319981|Rituximab|rituximab|mesh-list
25430466|NCT01319981|Doxorubicin|doxorubicin|mesh-list
25430467|NCT01319981|Methotrexate|methotrexate|mesh-list
25430468|NCT01319981|Vincristine|vincristine|mesh-list
25430469|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
25430470|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25430471|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
25430472|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430473|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
25430474|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430475|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430476|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430477|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
25430478|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430479|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430480|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430481|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25430482|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430483|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
25430484|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
25430485|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430486|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25430487|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
25430488|NCT01319981|Hormones|hormones|mesh-ancestor
25430489|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430490|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430491|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430492|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430493|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25402165|NCT03777813|Leucovorin|leucovorin|mesh-list
25430494|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430495|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25430496|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
25430497|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25430498|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430499|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
25430500|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
25430501|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25430502|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25430503|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
25430504|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430505|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430506|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430507|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430508|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430509|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25430510|NCT01319981|Protective Agents|protective agents|mesh-ancestor
25430511|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430512|NCT01319565|Aldesleukin|aldesleukin|mesh-list
25430513|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
25430514|NCT01319565|Fludarabine|fludarabine|mesh-list
25430515|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430516|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
25430517|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430518|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430519|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430520|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
25430521|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430522|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430523|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430524|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25430525|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25430526|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
25430527|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430528|NCT01314118|Prednisone|prednisone|mesh-list
25430529|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
25430530|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430531|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
25430532|NCT01314118|Hormones|hormones|mesh-ancestor
25430533|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430534|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430535|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430536|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430537|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25430538|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430539|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430540|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
25430541|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25430542|NCT01313702|Atenolol|atenolol|mesh-list
25430543|NCT01313702|Lisinopril|lisinopril|mesh-list
25430544|NCT01313702|Simvastatin|simvastatin|mesh-list
25430545|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25430546|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25430547|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
25430548|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430549|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25430550|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25430551|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430552|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25430553|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
25430554|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25430555|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25430556|NCT01313702|Protective Agents|protective agents|mesh-ancestor
25430557|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430558|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25430559|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
25430560|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
25430561|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430562|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25430563|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25430564|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25430565|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
25430566|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430567|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
25430568|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430569|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430570|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430571|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430572|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430573|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430574|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430575|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430576|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430577|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430578|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
25430579|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430580|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430581|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430582|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430583|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430584|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430585|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430586|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430587|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430588|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430589|NCT01308619|Doxycycline|doxycycline|mesh-list
25430590|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25430591|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430592|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
25430593|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25430594|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25430595|NCT01307605|Rituximab|rituximab|mesh-list
25430596|NCT01307605|Lenalidomide|lenalidomide|mesh-list
25430597|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25430598|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430599|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
25430600|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430601|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430602|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430603|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430604|NCT01307605|Growth Substances|growth substances|mesh-ancestor
25430605|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
25430606|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25430607|NCT01306045|Sunitinib|sunitinib|mesh-list
25430608|NCT01306045|Lapatinib|lapatinib|mesh-list
25430609|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430610|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430611|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430612|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430613|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430614|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430615|NCT01306045|Growth Substances|growth substances|mesh-ancestor
25430616|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430617|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
25430618|NCT01306019|Busulfan|busulfan|mesh-list
25430619|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
25430620|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430621|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430622|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
25430623|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430624|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430625|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430626|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430627|NCT01305499|Azacitidine|azacitidine|mesh-list
25430628|NCT01305499|Entinostat|entinostat|mesh-list
25430629|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430630|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
25430631|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430632|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430633|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430634|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25430635|NCT01303341|Sorafenib|sorafenib|mesh-list
25430636|NCT01303341|Riluzole|riluzole|mesh-list
25430637|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430638|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430639|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430640|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430641|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
25430642|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25430643|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25430644|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430645|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430646|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25430647|NCT01303341|Protective Agents|protective agents|mesh-ancestor
25430648|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
25430649|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25430650|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25430651|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430652|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25430653|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25430654|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
25430655|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25430656|NCT01294020|Tacrolimus|tacrolimus|mesh-list
25430657|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430658|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
25430659|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430660|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25430661|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430662|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430663|NCT01288911|Bicalutamide|bicalutamide|mesh-list
25430664|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
25430665|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
25430666|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430667|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430668|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430669|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
25430670|NCT01286272|Bortezomib|bortezomib|mesh-list
25430671|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25430672|NCT01286272|Ofatumumab|ofatumumab|mesh-list
25430673|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25430674|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25430675|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430676|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430677|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
25430678|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430679|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25430680|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
25430681|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
25430682|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430683|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
25430684|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430685|NCT01276600|Tenofovir|tenofovir|mesh-list
25430686|NCT01276600|Emtricitabine|emtricitabine|mesh-list
25430687|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
25430688|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430689|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25430690|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25430691|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430692|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430693|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25430694|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25430695|NCT01275677|Paclitaxel|paclitaxel|mesh-list
25430696|NCT01275677|Docetaxel|docetaxel|mesh-list
25430697|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
25430698|NCT01275677|Doxorubicin|doxorubicin|mesh-list
25430699|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25430700|NCT01275677|Trastuzumab|trastuzumab|mesh-list
25430701|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25430702|NCT01275677|Daunorubicin|daunorubicin|mesh-list
25430703|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25430704|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25430705|NCT01275677|Antibodies|antibodies|mesh-list
25430706|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
25430707|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25430708|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430709|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430710|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430711|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430712|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430713|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430714|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430715|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
25430716|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430717|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430718|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25402378|NCT03770286|Protective Agents|protective agents|mesh-ancestor
25402379|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25402380|NCT03769766|Curcumin|curcumin|mesh-list
25402381|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25402382|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25430719|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
25430720|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430721|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430722|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430723|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430724|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430725|NCT01273610|Trastuzumab|trastuzumab|mesh-list
25430726|NCT01273610|Lapatinib|lapatinib|mesh-list
25430727|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25430728|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430729|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430730|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430731|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430732|NCT01272037|Tamoxifen|tamoxifen|mesh-list
25430733|NCT01272037|Letrozole|letrozole|mesh-list
25430734|NCT01272037|Anastrozole|anastrozole|mesh-list
25430735|NCT01272037|Exemestane|exemestane|mesh-list
25430736|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430737|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430738|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25430739|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25430740|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430741|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25430742|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
25430743|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430744|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430745|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430746|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25430747|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25430748|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25430749|NCT01265849|Indomethacin|indomethacin|mesh-list
25430750|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
25430751|NCT01265849|Cisplatin|cisplatin|mesh-list
25430752|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430753|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
25430754|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430755|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430756|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430757|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
25430758|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430759|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430760|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430761|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25430762|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25430763|NCT01265849|Analgesics|analgesics|mesh-ancestor
25430764|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
25430765|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430766|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430767|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
25430768|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
25430769|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25430770|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25430771|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430772|NCT01263769|Axitinib|axitinib|mesh-list
25430773|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430774|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430775|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430776|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430777|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
25430778|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430779|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430780|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430781|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430782|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430783|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430784|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430785|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430786|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430787|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430788|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
25430789|NCT01256398|Leucovorin|leucovorin|mesh-list
25430790|NCT01256398|Folic Acid|folic acid|mesh-list
25430791|NCT01256398|Cytarabine|cytarabine|mesh-list
25430792|NCT01256398|Dexamethasone|dexamethasone|mesh-list
25430793|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
25430794|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
25430795|NCT01256398|Melphalan|melphalan|mesh-list
25430796|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
25430797|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25430798|NCT01256398|Methotrexate|methotrexate|mesh-list
25430799|NCT01256398|Fludarabine|fludarabine|mesh-list
25430800|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
25430801|NCT01256398|Etoposide|etoposide|mesh-list
25430802|NCT01256398|Vincristine|vincristine|mesh-list
25430803|NCT01256398|Daunorubicin|daunorubicin|mesh-list
25430804|NCT01256398|Dasatinib|dasatinib|mesh-list
25430805|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
25430806|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
25430807|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
25430808|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25430809|NCT01256398|Tacrolimus|tacrolimus|mesh-list
25430810|NCT01256398|Antibodies|antibodies|mesh-list
25430811|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
25430812|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25430813|NCT01256398|Lenograstim|lenograstim|mesh-list
25430814|NCT01256398|BB 1101|bb 1101|mesh-list
25430815|NCT01256398|Calcium|calcium|mesh-list
25430816|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
25430817|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430818|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
25430819|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430820|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430821|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430822|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
25430823|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430824|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430825|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25430826|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430827|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
25430828|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
25430829|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430830|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25430831|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
25430832|NCT01256398|Hormones|hormones|mesh-ancestor
25430833|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430834|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25430835|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
25430836|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430837|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25430838|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25430839|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25430840|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
25430841|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25430842|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430843|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
25430844|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
25430845|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25430846|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25430847|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25430848|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430849|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430850|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
25430851|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430852|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25430853|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25430854|NCT01256398|Antidotes|antidotes|mesh-ancestor
25430855|NCT01256398|Protective Agents|protective agents|mesh-ancestor
25430856|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
25430857|NCT01256398|Vitamins|vitamins|mesh-ancestor
25430858|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
25430859|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
25430860|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
25430861|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
25430862|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430863|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430864|NCT01256398|Hematinics|hematinics|mesh-ancestor
25430865|NCT01253070|Cytarabine|cytarabine|mesh-list
25430866|NCT01253070|Sorafenib|sorafenib|mesh-list
25430867|NCT01253070|Daunorubicin|daunorubicin|mesh-list
25430868|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430869|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
25430870|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430871|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430872|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
25430873|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430874|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430875|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
25430876|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430877|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430878|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430879|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430880|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430881|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430882|NCT01252719|Vancomycin|vancomycin|mesh-list
25430883|NCT01252719|Oritavancin|oritavancin|mesh-list
25430884|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25430885|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430886|NCT01251861|Bicalutamide|bicalutamide|mesh-list
25430887|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
25430888|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
25430889|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25430890|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431043|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
25430891|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430892|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
25430893|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430894|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430969|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
25430895|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430896|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430897|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430898|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430899|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430900|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430901|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430902|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430903|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
25430904|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430905|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430906|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430907|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430908|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430909|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430910|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430911|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430912|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430913|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430914|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
25430915|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430916|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430917|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430918|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430919|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430920|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430921|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430922|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430923|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430924|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430925|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
25430926|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25430927|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25430928|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25430929|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25430930|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430931|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
25430932|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25430933|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430934|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25430935|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430936|NCT01241708|Bortezomib|bortezomib|mesh-list
25430937|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430938|NCT01238211|Cytarabine|cytarabine|mesh-list
25430939|NCT01238211|Daunorubicin|daunorubicin|mesh-list
25430940|NCT01238211|Dasatinib|dasatinib|mesh-list
25430941|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25430942|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
25430943|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430944|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430945|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
25430946|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25430947|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25430949|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430950|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25430951|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25430952|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25430953|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430954|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25430955|NCT01236560|Bevacizumab|bevacizumab|mesh-list
25430956|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25430957|NCT01236560|Temozolomide|temozolomide|mesh-list
25430958|NCT01236560|Vorinostat|vorinostat|mesh-list
25430959|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
25430960|NCT01236560|Antibodies|antibodies|mesh-list
25430961|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
25430962|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25430963|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
25430964|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430965|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430966|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25430967|NCT01236560|Growth Substances|growth substances|mesh-ancestor
25430968|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430970|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
25430971|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25430972|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
25430973|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430974|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25430975|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430976|NCT01230411|Ibuprofen|ibuprofen|mesh-list
25430977|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25430978|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25430979|NCT01230411|Analgesics|analgesics|mesh-ancestor
25430980|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
25430981|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25430982|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25430983|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25430984|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25430985|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25430986|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25430987|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25430988|NCT01229943|Bevacizumab|bevacizumab|mesh-list
25430989|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25430990|NCT01229943|Everolimus|everolimus|mesh-list
25430991|NCT01229943|Octreotide|octreotide|mesh-list
25430992|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
25430993|NCT01229943|Antibodies|antibodies|mesh-list
25430994|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
25430995|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25430996|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
25430997|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25430998|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25430999|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431000|NCT01229943|Growth Substances|growth substances|mesh-ancestor
25431001|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431002|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431003|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
25431004|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431005|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25431006|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25431007|NCT01226563|Calcium|calcium|mesh-list
25431008|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25431009|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431010|NCT01219257|Adalimumab|adalimumab|mesh-list
25431011|NCT01219257|Etanercept|etanercept|mesh-list
25431012|NCT01219257|Golimumab|golimumab|mesh-list
25431013|NCT01219257|Infliximab|infliximab|mesh-list
25431014|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431015|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431016|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431017|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25431018|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25431019|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25431020|NCT01219257|Analgesics|analgesics|mesh-ancestor
25431021|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
25431022|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431023|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431024|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431025|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
25431026|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25431029|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431030|NCT01212822|Fluorouracil|fluorouracil|mesh-list
25431031|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
25431032|NCT01212822|Antibodies|antibodies|mesh-list
25431033|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
25431034|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431035|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
25431036|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431037|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431038|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431039|NCT01212822|Growth Substances|growth substances|mesh-ancestor
25431040|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431041|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431042|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
25431044|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431045|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431046|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431047|NCT01212822|Antidotes|antidotes|mesh-ancestor
25431048|NCT01212822|Protective Agents|protective agents|mesh-ancestor
25431049|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
25431051|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
25431052|NCT01209949|Adapalene|adapalene|mesh-list
25431053|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25431054|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431055|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25431056|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25431057|NCT01209949|Analgesics|analgesics|mesh-ancestor
25431058|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
25431059|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431060|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431061|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431062|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431063|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
25431064|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25431065|NCT01209871|Antibodies|antibodies|mesh-list
25431066|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
25431067|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431068|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
25431069|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25431070|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25431071|NCT01209364|Prednisolone|prednisolone|mesh-list
25431072|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
25431073|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25431074|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
25431075|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431076|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
25431077|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
25431078|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431079|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431080|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25431081|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
25431082|NCT01209364|Hormones|hormones|mesh-ancestor
25431083|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431084|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25431085|NCT01209364|Protective Agents|protective agents|mesh-ancestor
25431086|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25431087|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431088|NCT01198067|Pomalidomide|pomalidomide|mesh-list
25431089|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
25431090|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431091|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431092|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431093|NCT01198067|Growth Substances|growth substances|mesh-ancestor
25431094|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431095|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431096|NCT01196390|Paclitaxel|paclitaxel|mesh-list
25431097|NCT01196390|Carboplatin|carboplatin|mesh-list
25431098|NCT01196390|Trastuzumab|trastuzumab|mesh-list
25431099|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25431100|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25431101|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431102|NCT01196390|Antibodies|antibodies|mesh-list
25431103|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
25431104|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431105|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431106|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431107|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431108|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431110|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431111|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
25431112|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431113|NCT01192568|Oxybutynin|oxybutynin|mesh-list
25431114|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
25431115|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
25431116|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431117|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431118|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25431119|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25431120|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
25431121|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25431122|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431123|NCT01192568|Urological Agents|urological agents|mesh-ancestor
25431124|NCT01189643|Bevacizumab|bevacizumab|mesh-list
25431125|NCT01189643|Irinotecan|irinotecan|mesh-list
25431126|NCT01189643|Temozolomide|temozolomide|mesh-list
25431127|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431128|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431129|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431130|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431131|NCT01189643|Growth Substances|growth substances|mesh-ancestor
25431132|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431133|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431134|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25431135|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431136|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431137|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431138|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431139|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
25431140|NCT01176461|Nivolumab|nivolumab|mesh-list
25431141|NCT01176461|Vaccines|vaccines|mesh-list
25431142|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25431143|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
25431144|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431145|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431146|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431147|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25431148|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431149|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25431150|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
25431151|NCT01176006|Busulfan|busulfan|mesh-list
25431152|NCT01176006|Fludarabine|fludarabine|mesh-list
25431153|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
25431154|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431155|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
25431156|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431157|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431158|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431159|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
25431160|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431161|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431162|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431163|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431164|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
25431165|NCT01174121|Aldesleukin|aldesleukin|mesh-list
25431166|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
25431167|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
25431168|NCT01174121|Fludarabine|fludarabine|mesh-list
25431169|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431170|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
25431171|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431172|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431173|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431174|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
25431175|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431176|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431177|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431178|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431179|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25431180|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25431181|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
25431182|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431183|NCT01168219|Methotrexate|methotrexate|mesh-list
25431184|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
25431190|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25431191|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
25431192|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25431193|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431194|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431195|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
25431196|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431425|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431197|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431198|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431199|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431200|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25431201|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431202|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
25431203|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431204|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25431205|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25431206|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
25431207|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431208|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431210|NCT01167712|Bevacizumab|bevacizumab|mesh-list
25431211|NCT01167712|Carboplatin|carboplatin|mesh-list
25431212|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25431213|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431214|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
25431215|NCT01167712|Antibodies|antibodies|mesh-list
25431216|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
25431217|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431218|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
25431219|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431220|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431221|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431222|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431223|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431224|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431225|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431226|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431227|NCT01167712|Growth Substances|growth substances|mesh-ancestor
25431228|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431229|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431230|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
25431231|NCT01149083|Carboplatin|carboplatin|mesh-list
25431232|NCT01149083|Veliparib|veliparib|mesh-list
25431233|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431234|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25431235|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431236|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431237|NCT01145495|Rituximab|rituximab|mesh-list
25431238|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431239|NCT01145495|Lenalidomide|lenalidomide|mesh-list
25431240|NCT01145495|Antibodies|antibodies|mesh-list
25431241|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
25431242|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431243|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
25431244|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431245|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431246|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431247|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431248|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431249|NCT01145495|Growth Substances|growth substances|mesh-ancestor
25431250|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431251|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
25431252|NCT01145209|Fludarabine|fludarabine|mesh-list
25431253|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
25431254|NCT01145209|Ofatumumab|ofatumumab|mesh-list
25431255|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431256|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
25431257|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431258|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431259|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431260|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
25431261|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431262|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431263|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431264|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431265|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
25431267|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25431268|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431269|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431270|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431271|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431272|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431273|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431426|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431274|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431275|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
25431276|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431277|NCT01139047|Metronidazole|metronidazole|mesh-list
25431278|NCT01139047|Azelaic acid|azelaic acid|mesh-list
25431279|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431280|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25431281|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25431282|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25431283|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431284|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431285|NCT01139008|Metronidazole|metronidazole|mesh-list
25431286|NCT01139008|Azelaic acid|azelaic acid|mesh-list
25431287|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431288|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25431289|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25431290|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25431291|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431292|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431294|NCT01134614|Sargramostim|sargramostim|mesh-list
25431295|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431296|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431297|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25431298|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431299|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
25431300|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431301|NCT01131182|Metformin|metformin|mesh-list
25431302|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25431303|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25431304|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431305|NCT01131182|Incretins|incretins|mesh-ancestor
25431306|NCT01131182|Hormones|hormones|mesh-ancestor
25431307|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431308|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25431309|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
25431310|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431311|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431312|NCT01130519|Bevacizumab|bevacizumab|mesh-list
25431313|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25431314|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431315|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431316|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431317|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431318|NCT01130519|Growth Substances|growth substances|mesh-ancestor
25431319|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431320|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431321|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431322|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431323|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431324|NCT01126736|Pemetrexed|pemetrexed|mesh-list
25431325|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431326|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431327|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431328|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25402989|NCT03740165|Olaparib|olaparib|mesh-list
25431329|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25431330|NCT01125436|Vitamin D|vitamin d|mesh-list
25431331|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
25431332|NCT01125436|Vitamins|vitamins|mesh-ancestor
25431333|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
25431334|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431335|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25431336|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25431337|NCT01121588|Crizotinib|crizotinib|mesh-list
25431338|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431339|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431340|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431341|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431342|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
25431343|NCT01119066|Melphalan|melphalan|mesh-list
25431344|NCT01119066|Busulfan|busulfan|mesh-list
25431345|NCT01119066|Thiotepa|thiotepa|mesh-list
25431346|NCT01119066|Fludarabine|fludarabine|mesh-list
25431347|NCT01119066|Clofarabine|clofarabine|mesh-list
25431348|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431349|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
25431350|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431351|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431504|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431352|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431353|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
25431354|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431355|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431356|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431357|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431358|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
25431359|NCT01113476|Gemcitabine|gemcitabine|mesh-list
25431360|NCT01113476|Paclitaxel|paclitaxel|mesh-list
25431361|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25431362|NCT01113476|Bevacizumab|bevacizumab|mesh-list
25431363|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431364|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431365|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431366|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431367|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431368|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431369|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431370|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431371|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431372|NCT01113476|Growth Substances|growth substances|mesh-ancestor
25431373|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431374|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431375|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431376|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
25431377|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
25431378|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431379|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431380|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431381|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
25431382|NCT01112306|Selexipag|selexipag|mesh-list
25431383|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25431384|NCT01107236|Naproxen|naproxen|mesh-list
25431385|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25431386|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25431387|NCT01107236|Analgesics|analgesics|mesh-ancestor
25431388|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
25431389|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431390|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431391|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431392|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431393|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
25431394|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25431395|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431396|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431397|NCT01093612|Copper|copper|mesh-list
25431398|NCT01093612|Trastuzumab|trastuzumab|mesh-list
25431399|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431400|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431401|NCT01093612|Trace Elements|trace elements|mesh-ancestor
25431402|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
25431403|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431404|NCT01093326|Ponesimod|ponesimod|mesh-list
25431405|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25431406|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431407|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431408|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
25431409|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431410|NCT01081262|Paclitaxel|paclitaxel|mesh-list
25431411|NCT01081262|Bevacizumab|bevacizumab|mesh-list
25431412|NCT01081262|Carboplatin|carboplatin|mesh-list
25431413|NCT01081262|Capecitabine|capecitabine|mesh-list
25431414|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
25431415|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25431416|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431417|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
25431418|NCT01081262|Antibodies|antibodies|mesh-list
25431419|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
25431420|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431421|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
25431422|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431423|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431424|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431427|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431428|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431429|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431430|NCT01081262|Growth Substances|growth substances|mesh-ancestor
25431431|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431432|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431433|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
25431434|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431436|NCT01080391|Dexamethasone|dexamethasone|mesh-list
25431437|NCT01080391|Lenalidomide|lenalidomide|mesh-list
25431438|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431439|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
25431440|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
25431441|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431442|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431443|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25431444|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
25431445|NCT01080391|Hormones|hormones|mesh-ancestor
25431446|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431447|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25431448|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431449|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
25431450|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431451|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431452|NCT01080391|Growth Substances|growth substances|mesh-ancestor
25431453|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431454|NCT01067287|Pidilizumab|pidilizumab|mesh-list
25431455|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431456|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431457|NCT01066858|Tenofovir|tenofovir|mesh-list
25431458|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
25431459|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431460|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25431461|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25431462|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431463|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431464|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25431465|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25431466|NCT01065454|Riociguat|riociguat|mesh-list
25431467|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
25431468|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431469|NCT01064648|Cisplatin|cisplatin|mesh-list
25431470|NCT01064648|Pemetrexed|pemetrexed|mesh-list
25431471|NCT01064648|Cediranib|cediranib|mesh-list
25431472|NCT01064648|Maleic acid|maleic acid|mesh-list
25431473|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431474|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431475|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431476|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25431477|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25431478|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431479|NCT01064479|Cisplatin|cisplatin|mesh-list
25431480|NCT01064479|Carboplatin|carboplatin|mesh-list
25431481|NCT01064479|Docetaxel|docetaxel|mesh-list
25431482|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25403140|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25403141|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25403142|NCT03736538|Analgesics|analgesics|mesh-ancestor
25403143|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
25403144|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25403145|NCT03735875|Venetoclax|venetoclax|mesh-list
25403146|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403147|NCT03735628|Nivolumab|nivolumab|mesh-list
25403148|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25403149|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431483|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431484|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431485|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431486|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431487|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431488|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431489|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431490|NCT01064466|Etoposide|etoposide|mesh-list
25431491|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
25431492|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431493|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431494|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25431495|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431497|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431498|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
25431500|NCT01064375|Sargramostim|sargramostim|mesh-list
25431501|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431502|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
25431503|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431505|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431506|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
25431507|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431508|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431509|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431510|NCT01063517|Paclitaxel|paclitaxel|mesh-list
25431511|NCT01063517|Olaparib|olaparib|mesh-list
25431512|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431513|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431514|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431515|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431516|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431517|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431518|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25431519|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431520|NCT01061411|Sunitinib|sunitinib|mesh-list
25431521|NCT01061411|Dalteparin|dalteparin|mesh-list
25431522|NCT01061411|Tinzaparin|tinzaparin|mesh-list
25431523|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25431524|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431525|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431526|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431527|NCT01061411|Growth Substances|growth substances|mesh-ancestor
25431528|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431529|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431530|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431531|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431532|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431533|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
25431534|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25431535|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25431536|NCT01059786|Rituximab|rituximab|mesh-list
25431537|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25431538|NCT01059786|Pentostatin|pentostatin|mesh-list
25431539|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431540|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431541|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
25431542|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431543|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431544|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431545|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
25431546|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431547|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25431548|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431549|NCT01046825|Leucovorin|leucovorin|mesh-list
25431550|NCT01046825|Folic Acid|folic acid|mesh-list
25431551|NCT01046825|Cytarabine|cytarabine|mesh-list
25431552|NCT01046825|Prednisone|prednisone|mesh-list
25431553|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
25431554|NCT01046825|Doxorubicin|doxorubicin|mesh-list
25431555|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25431556|NCT01046825|Rituximab|rituximab|mesh-list
25431557|NCT01046825|Rasburicase|rasburicase|mesh-list
25431558|NCT01046825|Lenograstim|lenograstim|mesh-list
25431559|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
25431560|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431561|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
25431562|NCT01046825|Hormones|hormones|mesh-ancestor
25431563|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431564|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431565|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25431566|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431567|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25431568|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
25431569|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431570|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431571|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431572|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
25431573|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431600|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431601|NCT01046396|Adapalene|adapalene|mesh-list
25431602|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25431603|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25431604|NCT01046396|Analgesics|analgesics|mesh-ancestor
25431605|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
25431606|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431607|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431608|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431609|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431610|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431611|NCT01039285|Poractant alfa|poractant alfa|mesh-list
25431612|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25431613|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
25431641|NCT01026012|Regadenoson|regadenoson|mesh-list
25431642|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25431643|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25431644|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
25431645|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
25431646|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25431647|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431648|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431649|NCT01015833|Doxorubicin|doxorubicin|mesh-list
25431650|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25431652|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25431653|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431654|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25431655|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431656|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431657|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431658|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431659|NCT01014936|Tepotinib|tepotinib|mesh-list
25431660|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431661|NCT01013649|Gemcitabine|gemcitabine|mesh-list
25431662|NCT01013649|Fluorouracil|fluorouracil|mesh-list
25431663|NCT01013649|Capecitabine|capecitabine|mesh-list
25431664|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25431665|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431666|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
25431667|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431668|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431669|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
25431670|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431671|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431672|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431673|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
25431674|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431675|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431676|NCT01012817|Topotecan|topotecan|mesh-list
25431677|NCT01012817|Veliparib|veliparib|mesh-list
25431678|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25431679|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431680|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431681|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431682|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431683|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25431684|NCT01005745|Aldesleukin|aldesleukin|mesh-list
25431685|NCT01005745|Interleukin-2|interleukin-2|mesh-list
25431686|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431687|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25431688|NCT01005745|Analgesics|analgesics|mesh-ancestor
25431689|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
25431690|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431691|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431692|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25431693|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25431694|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
25431695|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431696|NCT01004978|Cisplatin|cisplatin|mesh-list
25431697|NCT01004978|Doxorubicin|doxorubicin|mesh-list
25431698|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25431699|NCT01004978|Sorafenib|sorafenib|mesh-list
25431700|NCT01004978|Mitomycins|mitomycins|mesh-list
25431701|NCT01004978|Mitomycin|mitomycin|mesh-list
25431702|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431703|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25431704|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25431705|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431706|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431707|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431708|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431709|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
25431710|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25431711|NCT01002820|Ganaxolone|ganaxolone|mesh-list
25431712|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
25431713|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25431714|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431715|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431716|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
25431717|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
25431718|NCT01001377|Cetuximab|cetuximab|mesh-list
25431719|NCT01001377|Panitumumab|panitumumab|mesh-list
25431720|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431721|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431722|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
25431723|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25431724|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
25431725|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25431726|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431727|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25431728|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25431731|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25431732|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25431733|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25431734|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25431735|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
25431736|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431737|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431738|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25431739|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
25431740|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
25431741|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
25431742|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25431743|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25431744|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
25431745|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25431746|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431747|NCT00992901|Incretins|incretins|mesh-ancestor
25431748|NCT00992901|Hormones|hormones|mesh-ancestor
25431749|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431750|NCT00988637|Calcitriol|calcitriol|mesh-list
25431751|NCT00988637|Clobetasol|clobetasol|mesh-list
25431752|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25431753|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431754|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25431755|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25431756|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431757|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25431758|NCT00988637|Vitamins|vitamins|mesh-ancestor
25431759|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
25431760|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25431761|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431762|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
25431763|NCT00988637|Hormones|hormones|mesh-ancestor
25431764|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431765|NCT00981162|Everolimus|everolimus|mesh-list
25431766|NCT00981162|Sorafenib|sorafenib|mesh-list
25431767|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431768|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431769|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
25431770|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431771|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431772|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431773|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431774|NCT00980538|Etravirine|etravirine|mesh-list
25431775|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25431776|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25431777|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431778|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431779|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
25431780|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431781|NCT00980460|Sirolimus|sirolimus|mesh-list
25431782|NCT00980460|Cisplatin|cisplatin|mesh-list
25431783|NCT00980460|Doxorubicin|doxorubicin|mesh-list
25431784|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25431785|NCT00980460|Fluorouracil|fluorouracil|mesh-list
25431786|NCT00980460|Irinotecan|irinotecan|mesh-list
25431787|NCT00980460|Vincristine|vincristine|mesh-list
25431788|NCT00980460|Camptothecin|camptothecin|mesh-list
25431789|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
25431790|NCT00980460|Razoxane|razoxane|mesh-list
25431791|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
25431792|NCT00980460|Liver Extracts|liver extracts|mesh-list
25431793|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431794|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25431795|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25431796|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431797|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431798|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431799|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
25431800|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431801|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431802|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
25431803|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431804|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25431805|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431806|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431810|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25431811|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431812|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
25431813|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25431814|NCT00980460|Protective Agents|protective agents|mesh-ancestor
25431815|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25431817|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25431818|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25431819|NCT00978458|Temozolomide|temozolomide|mesh-list
25431820|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431821|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
25431822|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431823|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431824|NCT00977977|Cyclosporine|cyclosporine|mesh-list
25431825|NCT00977977|Rituximab|rituximab|mesh-list
25431826|NCT00977977|Cyclosporins|cyclosporins|mesh-list
25431827|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431828|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403450|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
25431829|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
25431830|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431831|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431832|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431833|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431834|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431835|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
25431836|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431837|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
25431838|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25431839|NCT00977574|Sirolimus|sirolimus|mesh-list
25431840|NCT00977574|Paclitaxel|paclitaxel|mesh-list
25431841|NCT00977574|Epothilones|epothilones|mesh-list
25431842|NCT00977574|Epothilone B|epothilone b|mesh-list
25431843|NCT00977574|Bevacizumab|bevacizumab|mesh-list
25431844|NCT00977574|Carboplatin|carboplatin|mesh-list
25431845|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25431846|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431847|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
25431848|NCT00977574|Antibodies|antibodies|mesh-list
25431849|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
25431850|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431851|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
25431852|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431853|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431854|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431855|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431856|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431857|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431858|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431859|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431860|NCT00977574|Growth Substances|growth substances|mesh-ancestor
25431861|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431862|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431863|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
25431864|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25431865|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431866|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25431867|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
25431868|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431869|NCT00972478|Prednisone|prednisone|mesh-list
25431870|NCT00972478|Cortisone|cortisone|mesh-list
25431871|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
25431872|NCT00972478|Rituximab|rituximab|mesh-list
25431873|NCT00972478|Doxorubicin|doxorubicin|mesh-list
25431874|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25431875|NCT00972478|Vincristine|vincristine|mesh-list
25431876|NCT00972478|Vorinostat|vorinostat|mesh-list
25431877|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431878|NCT00972478|Antibodies|antibodies|mesh-list
25431879|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
25431880|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431881|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431882|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
25431883|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431884|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431885|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25431886|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
25431887|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431888|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431889|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431890|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25431891|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25431892|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431893|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431894|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431895|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
25431897|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431898|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25431899|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25431900|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431901|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431902|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431903|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25431904|NCT00970684|Gemcitabine|gemcitabine|mesh-list
25431905|NCT00970684|Bevacizumab|bevacizumab|mesh-list
25431906|NCT00970684|Docetaxel|docetaxel|mesh-list
25431907|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431908|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431909|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431910|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431911|NCT00970684|Growth Substances|growth substances|mesh-ancestor
25431912|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431913|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431914|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431915|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
25431916|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431917|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
25431918|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431919|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431920|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431921|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
25431922|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
25431923|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
25431924|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431925|NCT00967785|Plerixafor|plerixafor|mesh-list
25431926|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25431927|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25431928|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
25431929|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431930|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
25431931|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
25431932|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25431933|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25431934|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431935|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431936|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431937|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431938|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25431939|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431940|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431941|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431942|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431943|NCT00942331|Gemcitabine|gemcitabine|mesh-list
25431944|NCT00942331|Bevacizumab|bevacizumab|mesh-list
25431945|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25431946|NCT00942331|Cisplatin|cisplatin|mesh-list
25431947|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
25431948|NCT00942331|Antibodies|antibodies|mesh-list
25431949|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
25431950|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25431951|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
25431952|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431953|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431954|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431955|NCT00942331|Growth Substances|growth substances|mesh-ancestor
25431956|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431957|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431958|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
25431959|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431960|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
25431961|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431962|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
25431963|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431964|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431965|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431966|NCT00936832|Leucovorin|leucovorin|mesh-list
25431967|NCT00936832|Fluorouracil|fluorouracil|mesh-list
25431969|NCT00936832|Sunitinib|sunitinib|mesh-list
25431970|NCT00936832|Calcium|calcium|mesh-list
25431971|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
25431972|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25431973|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431974|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
25431975|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431976|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431977|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431978|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25431979|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
25431980|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25431981|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431982|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431983|NCT00936832|Antidotes|antidotes|mesh-ancestor
25431984|NCT00936832|Protective Agents|protective agents|mesh-ancestor
25431985|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
25431986|NCT00936832|Vitamins|vitamins|mesh-ancestor
25431987|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
25431988|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25431989|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25431990|NCT00936832|Growth Substances|growth substances|mesh-ancestor
25431991|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
25431992|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25431993|NCT00923013|Rituximab|rituximab|mesh-list
25431994|NCT00923013|Cladribine|cladribine|mesh-list
25431995|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431996|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25431997|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
25431998|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431999|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432000|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432001|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25432002|NCT00907283|Deferiprone|deferiprone|mesh-list
25432003|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25432004|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
25432005|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
25432006|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432007|NCT00907101|Adapalene|adapalene|mesh-list
25432008|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25432009|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25432010|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432011|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25432012|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25432013|NCT00907101|Analgesics|analgesics|mesh-ancestor
25432014|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
25432015|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432016|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432017|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432018|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432019|NCT00903110|Mecasermin|mecasermin|mesh-list
25432020|NCT00903110|Growth Substances|growth substances|mesh-ancestor
25432021|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432022|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
25432023|NCT00896532|Denosumab|denosumab|mesh-list
25432024|NCT00896532|Alendronate|alendronate|mesh-list
25432025|NCT00896532|Teriparatide|teriparatide|mesh-list
25432026|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25432027|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25432028|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432029|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25432030|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
25432031|NCT00892281|Doxycycline|doxycycline|mesh-list
25432032|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432033|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432034|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
25432035|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25432036|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25432037|NCT00885664|Ritonavir|ritonavir|mesh-list
25432038|NCT00885664|Lopinavir|lopinavir|mesh-list
25432039|NCT00885664|Tenofovir|tenofovir|mesh-list
25432040|NCT00885664|Emtricitabine|emtricitabine|mesh-list
25432041|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25432042|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25432043|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25432122|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432046|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432047|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25432048|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25432049|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
25432050|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432051|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25432052|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25432053|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25432054|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25432056|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432057|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
25432058|NCT00881868|Hormones|hormones|mesh-ancestor
25432059|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432060|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432061|NCT00880594|Desipramine|desipramine|mesh-list
25432062|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25432063|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
25432064|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25432065|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432066|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432067|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25432068|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25432069|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25432070|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
25432071|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25432072|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432073|NCT00878254|Leucovorin|leucovorin|mesh-list
25432074|NCT00878254|Cytarabine|cytarabine|mesh-list
25432075|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
25432076|NCT00878254|Ifosfamide|ifosfamide|mesh-list
25432077|NCT00878254|Rituximab|rituximab|mesh-list
25432078|NCT00878254|Doxorubicin|doxorubicin|mesh-list
25432079|NCT00878254|Methotrexate|methotrexate|mesh-list
25432080|NCT00878254|Etoposide|etoposide|mesh-list
25432081|NCT00878254|Vincristine|vincristine|mesh-list
25432082|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432083|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
25432084|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432085|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432086|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432087|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
25432088|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432089|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432090|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432091|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25432092|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432093|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432094|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432095|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432096|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25432097|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
25432098|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25432099|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25432100|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
25432101|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432102|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25432103|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25432104|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432105|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
25432106|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432107|NCT00878254|Antidotes|antidotes|mesh-ancestor
25432108|NCT00878254|Protective Agents|protective agents|mesh-ancestor
25432109|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
25432110|NCT00878254|Vitamins|vitamins|mesh-ancestor
25432111|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
25432112|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432113|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432114|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432115|NCT00878163|Gemcitabine|gemcitabine|mesh-list
25432116|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25432117|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25432118|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
25432119|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432120|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432124|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432125|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
25432126|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432127|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25432128|NCT00877500|Epothilones|epothilones|mesh-list
25432129|NCT00877500|Epothilone B|epothilone b|mesh-list
25432130|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432131|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432132|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432133|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432134|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432135|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
25432136|NCT00875004|Hematinics|hematinics|mesh-ancestor
25432137|NCT00869232|Thalidomide|thalidomide|mesh-list
25432138|NCT00869232|Dexamethasone|dexamethasone|mesh-list
25432139|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
25432140|NCT00869232|Melphalan|melphalan|mesh-list
25432141|NCT00869232|Cisplatin|cisplatin|mesh-list
25432142|NCT00869232|Doxorubicin|doxorubicin|mesh-list
25403753|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403754|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25403755|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432143|NCT00869232|Etoposide|etoposide|mesh-list
25432144|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25432145|NCT00869232|Bortezomib|bortezomib|mesh-list
25432146|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432147|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
25432148|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432149|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432150|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432151|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
25432152|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432153|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432154|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432155|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432156|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
25432157|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
25432158|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432159|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25432160|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
25432161|NCT00869232|Hormones|hormones|mesh-ancestor
25432162|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432163|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25432164|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432165|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432166|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432167|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432168|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432169|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
25432170|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432171|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432172|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432173|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432174|NCT00869232|Growth Substances|growth substances|mesh-ancestor
25432175|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432176|NCT00866840|Riluzole|riluzole|mesh-list
25432177|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
25432178|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25432179|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25432180|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25432181|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432182|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432183|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25432184|NCT00866840|Protective Agents|protective agents|mesh-ancestor
25432185|NCT00862433|Vitamins|vitamins|mesh-list
25432186|NCT00862433|Vitamin E|vitamin e|mesh-list
25432187|NCT00862433|Tocopherols|tocopherols|mesh-list
25432188|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
25432189|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
25432190|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432191|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
25432192|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432193|NCT00862433|Protective Agents|protective agents|mesh-ancestor
25432194|NCT00861705|Paclitaxel|paclitaxel|mesh-list
25432195|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
25432196|NCT00861705|Bevacizumab|bevacizumab|mesh-list
25432197|NCT00861705|Carboplatin|carboplatin|mesh-list
25432198|NCT00861705|Doxorubicin|doxorubicin|mesh-list
25432199|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25432200|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25432353|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25432277|NCT00840853|Analgesics|analgesics|mesh-ancestor
25432201|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25432203|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
25432204|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25432205|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
25432206|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
25432207|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432208|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432209|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432210|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432211|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432212|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432213|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432214|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
25432215|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432216|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432217|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432218|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
25432219|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432220|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432221|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432222|NCT00861705|Growth Substances|growth substances|mesh-ancestor
25432223|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432224|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432225|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432226|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432227|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432228|NCT00845026|Olanzapine|olanzapine|mesh-list
25432229|NCT00845026|Risperidone|risperidone|mesh-list
25432230|NCT00845026|Aripiprazole|aripiprazole|mesh-list
25432231|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25432232|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
25432233|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25432234|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432235|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432236|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25432237|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25432238|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25432239|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25432240|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25432241|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
25432242|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
25432243|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
25432244|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432245|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25432246|NCT00845026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25432247|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25432248|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25432249|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
25432250|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
25432251|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25432252|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25432253|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25432254|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25432255|NCT00843882|Lenalidomide|lenalidomide|mesh-list
25432256|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
25432257|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
25432258|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432259|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432260|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432261|NCT00843882|Growth Substances|growth substances|mesh-ancestor
25432262|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432263|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432264|NCT00843882|Hematinics|hematinics|mesh-ancestor
25432265|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25432266|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432267|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
25432268|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25432269|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
25432270|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25432271|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25432272|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25432273|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432274|NCT00840853|Acetaminophen|acetaminophen|mesh-list
25432275|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
25432276|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25432278|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
25432279|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432280|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432281|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
25432282|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25432283|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25432284|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25432285|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
25432286|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
25432287|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
25432288|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
25432289|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25432290|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25432291|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
25432292|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
25432293|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25432294|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432295|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25432296|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
25432297|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25432298|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432299|NCT00836810|Prednisone|prednisone|mesh-list
25432300|NCT00836810|Prednisolone|prednisolone|mesh-list
25432301|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432302|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
25432303|NCT00836810|Hormones|hormones|mesh-ancestor
25432304|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432305|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432306|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25432307|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432308|NCT00822120|Prednisone|prednisone|mesh-list
25432309|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
25432310|NCT00822120|Dacarbazine|dacarbazine|mesh-list
25432311|NCT00822120|Doxorubicin|doxorubicin|mesh-list
25432312|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25432313|NCT00822120|Etoposide|etoposide|mesh-list
25432314|NCT00822120|Vincristine|vincristine|mesh-list
25432315|NCT00822120|Bleomycin|bleomycin|mesh-list
25432316|NCT00822120|Vinblastine|vinblastine|mesh-list
25432317|NCT00822120|Procarbazine|procarbazine|mesh-list
25432318|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432319|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
25432320|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432321|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432322|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432323|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
25432324|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432325|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432326|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432327|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432328|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432329|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432330|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432331|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432332|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
25432333|NCT00822120|Hormones|hormones|mesh-ancestor
25432334|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432335|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25432336|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432337|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432338|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432339|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432340|NCT00820846|Vaccines|vaccines|mesh-list
25432341|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
25432342|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432343|NCT00819780|Bevacizumab|bevacizumab|mesh-list
25432344|NCT00819780|Panitumumab|panitumumab|mesh-list
25432345|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25432346|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432347|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432348|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432349|NCT00819780|Growth Substances|growth substances|mesh-ancestor
25432350|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432351|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432352|NCT00819221|Doxorubicin|doxorubicin|mesh-list
25432354|NCT00819221|Olaparib|olaparib|mesh-list
25432355|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432356|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432357|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432358|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432359|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432360|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432361|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25432362|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
25432363|NCT00813423|Sunitinib|sunitinib|mesh-list
25432364|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432365|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432366|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432367|NCT00813423|Growth Substances|growth substances|mesh-ancestor
25432368|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432369|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432370|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25432371|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432372|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432373|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
25432374|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25432375|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25432376|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432377|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432378|NCT00801489|Cytarabine|cytarabine|mesh-list
25432379|NCT00801489|Fludarabine|fludarabine|mesh-list
25432380|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
25432381|NCT00801489|Decitabine|decitabine|mesh-list
25432382|NCT00801489|Idarubicin|idarubicin|mesh-list
25432383|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
25432384|NCT00801489|Calicheamicins|calicheamicins|mesh-list
25432385|NCT00801489|Lenograstim|lenograstim|mesh-list
25432386|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432387|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25432388|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
25432389|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432390|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432391|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
25432392|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432393|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
25432394|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432395|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25432396|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432397|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432398|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432399|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432400|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25432401|NCT00799864|Tenofovir|tenofovir|mesh-list
25432402|NCT00799864|Lamivudine|lamivudine|mesh-list
25432403|NCT00799864|Zidovudine|zidovudine|mesh-list
25432404|NCT00799864|Emtricitabine|emtricitabine|mesh-list
25432405|NCT00799864|Abacavir|abacavir|mesh-list
25432406|NCT00799864|Rilpivirine|rilpivirine|mesh-list
25432407|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
25432408|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432409|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25432410|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25432411|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432412|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432413|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25432414|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25432415|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
25432416|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
25432417|NCT00792948|Leucovorin|leucovorin|mesh-list
25432418|NCT00792948|Folic Acid|folic acid|mesh-list
25432419|NCT00792948|Cytarabine|cytarabine|mesh-list
25432420|NCT00792948|Sirolimus|sirolimus|mesh-list
25432421|NCT00792948|Dexamethasone|dexamethasone|mesh-list
25432422|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
25432423|NCT00792948|Prednisone|prednisone|mesh-list
25432424|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
25432425|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25432426|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25432427|NCT00792948|Prednisolone|prednisolone|mesh-list
25432428|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
25432429|NCT00792948|Cortisone|cortisone|mesh-list
25432430|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
25432431|NCT00792948|Doxorubicin|doxorubicin|mesh-list
25432432|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25432433|NCT00792948|Methotrexate|methotrexate|mesh-list
25432434|NCT00792948|Etoposide|etoposide|mesh-list
25432435|NCT00792948|Vincristine|vincristine|mesh-list
25432436|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
25432441|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25432442|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
25432443|NCT00792948|BB 1101|bb 1101|mesh-list
25432444|NCT00792948|Calcium|calcium|mesh-list
25432445|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
25432446|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432447|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
25432448|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432449|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432450|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432451|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
25432452|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432453|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432454|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432455|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432456|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
25432457|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
25432458|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432459|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25432460|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
25432461|NCT00792948|Hormones|hormones|mesh-ancestor
25432462|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432463|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25432464|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
25432465|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432466|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432467|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432468|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432469|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25432470|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25432471|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25432472|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
25432473|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25432474|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25432475|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
25432476|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432477|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25432478|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25432479|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432480|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
25432481|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432482|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25432483|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25432484|NCT00792948|Antidotes|antidotes|mesh-ancestor
25432485|NCT00792948|Protective Agents|protective agents|mesh-ancestor
25432486|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
25432487|NCT00792948|Vitamins|vitamins|mesh-ancestor
25432488|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
25432489|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432490|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432491|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432492|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432493|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
25432494|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25432495|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25432496|NCT00792948|Hematinics|hematinics|mesh-ancestor
25432497|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
25432498|NCT00789399|PENTA|penta|mesh-list
25432499|NCT00789399|Fondaparinux|fondaparinux|mesh-list
25432500|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25432501|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
25432502|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25432503|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
25432504|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432505|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432506|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
25432507|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25432508|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25432509|NCT00785291|Paclitaxel|paclitaxel|mesh-list
25432510|NCT00785291|Epothilones|epothilones|mesh-list
25432511|NCT00785291|Epothilone B|epothilone b|mesh-list
25432512|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25432513|NCT00785291|Bevacizumab|bevacizumab|mesh-list
25432514|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25432515|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
25432517|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
25432518|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25432519|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
25432520|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432521|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432522|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432523|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432524|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432525|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432526|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432527|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432528|NCT00785291|Growth Substances|growth substances|mesh-ancestor
25432529|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432530|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432531|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
25432532|NCT00784823|Bortezomib|bortezomib|mesh-list
25432533|NCT00784823|Melphalan|melphalan|mesh-list
25432534|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432535|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432536|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
25432537|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432538|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432539|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432540|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
25432541|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432542|NCT00781612|Paclitaxel|paclitaxel|mesh-list
25432543|NCT00781612|Maytansine|maytansine|mesh-list
25432544|NCT00781612|Docetaxel|docetaxel|mesh-list
25432545|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25432546|NCT00781612|Trastuzumab|trastuzumab|mesh-list
25432547|NCT00781612|Atezolizumab|atezolizumab|mesh-list
25432548|NCT00781612|Pertuzumab|pertuzumab|mesh-list
25432549|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432550|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432551|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432552|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432553|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432554|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432555|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25432556|NCT00777582|Olaparib|olaparib|mesh-list
25432557|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25432558|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432559|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432560|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432561|NCT00777140|Deferoxamine|deferoxamine|mesh-list
25432562|NCT00777140|Siderophores|siderophores|mesh-ancestor
25432563|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25432564|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
25432565|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
25432566|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432567|NCT00773357|Guanfacine|guanfacine|mesh-list
25432568|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25432569|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25432570|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25432571|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25432572|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25432573|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25432574|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432575|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432576|NCT00770809|Paclitaxel|paclitaxel|mesh-list
25432577|NCT00770809|Trastuzumab|trastuzumab|mesh-list
25432578|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25432579|NCT00770809|Lapatinib|lapatinib|mesh-list
25432580|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25432581|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25432582|NCT00770809|Antibodies|antibodies|mesh-list
25432583|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
25432584|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25432585|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432586|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432587|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432588|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432589|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432590|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432591|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
25432592|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432593|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25432594|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432672|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432595|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25432596|NCT00769379|Trastuzumab|trastuzumab|mesh-list
25432597|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25432598|NCT00769379|Antibodies|antibodies|mesh-list
25432599|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
25432600|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25432601|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
25432602|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432603|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432604|NCT00763555|Calcitriol|calcitriol|mesh-list
25432605|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25432606|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432607|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25432608|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25432609|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432610|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25432611|NCT00763555|Vitamins|vitamins|mesh-ancestor
25432612|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
25432613|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25432614|NCT00754364|Gemcitabine|gemcitabine|mesh-list
25432615|NCT00754364|Carboplatin|carboplatin|mesh-list
25432616|NCT00754364|Pemetrexed|pemetrexed|mesh-list
25432617|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432618|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25432619|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
25432620|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432621|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
25432622|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432623|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432624|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432625|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
25432626|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432627|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25432628|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25432629|NCT00750841|Cediranib|cediranib|mesh-list
25432630|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432631|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25432632|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432633|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432634|NCT00738582|Cisplatin|cisplatin|mesh-list
25432635|NCT00738582|Pemetrexed|pemetrexed|mesh-list
25432636|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432637|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432638|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432639|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25432640|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25432641|NCT00734877|Thalidomide|thalidomide|mesh-list
25432642|NCT00734877|Dexamethasone|dexamethasone|mesh-list
25432643|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
25432644|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
25432645|NCT00734877|Melphalan|melphalan|mesh-list
25432646|NCT00734877|Cisplatin|cisplatin|mesh-list
25432647|NCT00734877|Etoposide|etoposide|mesh-list
25432648|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
25432649|NCT00734877|Doxorubicin|doxorubicin|mesh-list
25432650|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25432651|NCT00734877|Bortezomib|bortezomib|mesh-list
25432652|NCT00734877|BB 1101|bb 1101|mesh-list
25432653|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432654|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
25432655|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432656|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432657|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432658|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
25432659|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432660|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432661|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432662|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432663|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
25432664|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
25432665|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432666|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25432667|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
25432668|NCT00734877|Hormones|hormones|mesh-ancestor
25432669|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432670|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25432671|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
25432673|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432674|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25432675|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25432676|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432677|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
25432678|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432679|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404291|NCT03676192|Bevacizumab|bevacizumab|mesh-list
25432680|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432681|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432682|NCT00734877|Growth Substances|growth substances|mesh-ancestor
25432683|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432684|NCT00733954|Clobetasol|clobetasol|mesh-list
25432685|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432686|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
25432687|NCT00733954|Hormones|hormones|mesh-ancestor
25432688|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432689|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432690|NCT00731731|Temozolomide|temozolomide|mesh-list
25432691|NCT00731731|Vorinostat|vorinostat|mesh-list
25432692|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432693|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
25432694|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432695|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432696|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25432697|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432698|NCT00720785|Bortezomib|bortezomib|mesh-list
25432699|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432700|NCT00719888|Cyclosporine|cyclosporine|mesh-list
25432701|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
25432702|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
25432703|NCT00719888|Thiotepa|thiotepa|mesh-list
25432704|NCT00719888|Fludarabine|fludarabine|mesh-list
25432705|NCT00719888|Cyclosporins|cyclosporins|mesh-list
25432706|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432707|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
25432708|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432709|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432710|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432711|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
25432712|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432713|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432714|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432715|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432716|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
25432717|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432718|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432719|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25432720|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432721|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25432722|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
25432723|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432724|NCT00716443|Lidocaine|lidocaine|mesh-list
25432725|NCT00716443|Tetracaine|tetracaine|mesh-list
25432726|NCT00716443|Benzocaine|benzocaine|mesh-list
25432727|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
25432728|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
25432729|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25432730|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432731|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
25432732|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432733|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25432734|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25432735|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25432736|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25432737|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432738|NCT00694850|Riociguat|riociguat|mesh-list
25432739|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
25432892|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
25432740|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432741|NCT00687765|Temozolomide|temozolomide|mesh-list
25432743|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432744|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
25432745|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432746|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432747|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25432753|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432754|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25432755|NCT00679783|Olaparib|olaparib|mesh-list
25432756|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25432757|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432758|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432759|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432760|NCT00679042|Exenatide|exenatide|mesh-list
25432761|NCT00679042|Sirolimus|sirolimus|mesh-list
25432762|NCT00679042|Etanercept|etanercept|mesh-list
25432763|NCT00679042|Tacrolimus|tacrolimus|mesh-list
25432764|NCT00679042|Basiliximab|basiliximab|mesh-list
25432765|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432766|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
25432767|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432768|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25432769|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432770|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432771|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432772|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432773|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432774|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432775|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
25432776|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25432777|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25432778|NCT00679042|Analgesics|analgesics|mesh-ancestor
25432779|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
25432780|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432781|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432782|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432783|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25432784|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25432785|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25432786|NCT00679042|Incretins|incretins|mesh-ancestor
25432787|NCT00679042|Hormones|hormones|mesh-ancestor
25432788|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432789|NCT00671749|Clindamycin|clindamycin|mesh-list
25432790|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
25432791|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
25432792|NCT00671749|Adapalene|adapalene|mesh-list
25432793|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25432794|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432795|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432796|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25432797|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432798|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432799|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432800|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25432801|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25432802|NCT00671749|Analgesics|analgesics|mesh-ancestor
25432803|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
25432804|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432805|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432806|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432807|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432808|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25432809|NCT00669071|Tretinoin|tretinoin|mesh-list
25432810|NCT00669071|Hydroquinone|hydroquinone|mesh-list
25432811|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432812|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
25432813|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432814|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432815|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
25432816|NCT00669071|Hormones|hormones|mesh-ancestor
25432817|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432818|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432819|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
25432820|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432821|NCT00669071|Protective Agents|protective agents|mesh-ancestor
25432822|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25432823|NCT00668655|Metronidazole|metronidazole|mesh-list
25432824|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432825|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432826|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25432827|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25432828|NCT00667251|Paclitaxel|paclitaxel|mesh-list
25432829|NCT00667251|Docetaxel|docetaxel|mesh-list
25432832|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432833|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432834|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432835|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432836|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25404439|NCT03666351|Diuretics|diuretics|mesh-ancestor
25432837|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432838|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25432839|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25432840|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432841|NCT00658814|Azacitidine|azacitidine|mesh-list
25432842|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
25432843|NCT00658814|Calicheamicins|calicheamicins|mesh-list
25432844|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25432845|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
25432846|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432847|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432848|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432849|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25432850|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25432851|NCT00658788|Calcitriol|calcitriol|mesh-list
25432852|NCT00658788|Clobetasol|clobetasol|mesh-list
25432853|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25432854|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432855|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25432856|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25432857|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432858|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25432859|NCT00658788|Vitamins|vitamins|mesh-ancestor
25432860|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
25432861|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25432862|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432863|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
25432864|NCT00658788|Hormones|hormones|mesh-ancestor
25432865|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432866|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25432867|NCT00650143|Lenograstim|lenograstim|mesh-list
25432868|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25432869|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432870|NCT00650143|Incretins|incretins|mesh-ancestor
25432871|NCT00650143|Hormones|hormones|mesh-ancestor
25432872|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432873|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25432874|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
25432875|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432876|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432877|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25432878|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
25432879|NCT00647556|Adapalene|adapalene|mesh-list
25432880|NCT00647556|Tretinoin|tretinoin|mesh-list
25432881|NCT00647556|Emollients|emollients|mesh-list
25432882|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25432883|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25432884|NCT00647556|Analgesics|analgesics|mesh-ancestor
25432885|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
25432886|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25432887|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432888|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432889|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432890|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432891|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432893|NCT00644280|Ranibizumab|ranibizumab|mesh-list
25432894|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432895|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432896|NCT00644280|Growth Substances|growth substances|mesh-ancestor
25432897|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432898|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432899|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432900|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
25432901|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25432902|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25432903|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
25432904|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
25432905|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25432906|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432907|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
25432910|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432911|NCT00637624|Expectorants|expectorants|mesh-ancestor
25432912|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
25432913|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25432914|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
25432915|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432916|NCT00637624|Protective Agents|protective agents|mesh-ancestor
25432917|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432918|NCT00637624|Antidotes|antidotes|mesh-ancestor
25432919|NCT00635700|Ziprasidone|ziprasidone|mesh-list
25432920|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25432921|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
25432922|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25432923|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432924|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432925|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25432926|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25432927|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25432928|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25432929|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25432930|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
25432931|NCT00625378|Sorafenib|sorafenib|mesh-list
25432932|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432933|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25432934|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432935|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432936|NCT00609791|Paclitaxel|paclitaxel|mesh-list
25432937|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25432938|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25432939|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432940|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
25432941|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
25432942|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
25432943|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432944|NCT00608725|Propranolol|propranolol|mesh-list
25432945|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25432946|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25432947|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
25432948|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25432949|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432950|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432951|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25432952|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25432953|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
25432954|NCT00606346|Infliximab|infliximab|mesh-list
25432955|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
25432956|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25432957|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432958|NCT00602641|Thalidomide|thalidomide|mesh-list
25432959|NCT00602641|Prednisone|prednisone|mesh-list
25432960|NCT00602641|Cortisone|cortisone|mesh-list
25432961|NCT00602641|Lenalidomide|lenalidomide|mesh-list
25432962|NCT00602641|Melphalan|melphalan|mesh-list
25432963|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
25432964|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25432965|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25432966|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
25432967|NCT00602641|Hormones|hormones|mesh-ancestor
25432968|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25432969|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432970|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25432971|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25432972|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
25432973|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25432974|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25432975|NCT00602641|Growth Substances|growth substances|mesh-ancestor
25432976|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
25432977|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432978|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
25432979|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432980|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25432981|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432982|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
25432983|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25432984|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432985|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
25432990|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25432991|NCT00602459|Antibodies|antibodies|mesh-list
25432992|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
25432993|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25432994|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25432995|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
25432996|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25432997|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432998|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25432999|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
25433000|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433001|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433002|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433003|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433004|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
25433005|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25433006|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433007|NCT00602459|Growth Substances|growth substances|mesh-ancestor
25433008|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433009|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25433010|NCT00602030|Entinostat|entinostat|mesh-list
25433011|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433012|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25433013|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433014|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433015|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25433016|NCT00601900|Tamoxifen|tamoxifen|mesh-list
25433017|NCT00601900|Bevacizumab|bevacizumab|mesh-list
25433018|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25433019|NCT00601900|Letrozole|letrozole|mesh-list
25433020|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
25433021|NCT00601900|Antibodies|antibodies|mesh-list
25433022|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
25433023|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25433024|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
25433025|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433026|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25433027|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433028|NCT00601900|Growth Substances|growth substances|mesh-ancestor
25433029|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433030|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433031|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
25433032|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433033|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25433034|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25433035|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433036|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25433037|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
25433038|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433039|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433040|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25433041|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25433042|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25433043|NCT00600496|Sirolimus|sirolimus|mesh-list
25433044|NCT00600496|Docetaxel|docetaxel|mesh-list
25433045|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25433046|NCT00600496|Dacarbazine|dacarbazine|mesh-list
25433047|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433048|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433049|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433050|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433051|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433052|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25433053|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433054|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25433055|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433056|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433057|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
25433058|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433059|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
25433060|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433061|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433062|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
25433063|NCT00595933|Muramidase|muramidase|mesh-list
25433064|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433066|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25433067|NCT00588770|Cisplatin|cisplatin|mesh-list
25433068|NCT00588770|Carboplatin|carboplatin|mesh-list
25433069|NCT00588770|Docetaxel|docetaxel|mesh-list
25404663|NCT03655717|Hormones|hormones|mesh-ancestor
25433070|NCT00588770|Fluorouracil|fluorouracil|mesh-list
25433071|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
25433072|NCT00588770|Antibodies|antibodies|mesh-list
25433073|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
25433074|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25433075|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
25433076|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433077|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25433078|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433079|NCT00588770|Growth Substances|growth substances|mesh-ancestor
25433080|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433081|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433082|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
25433083|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433084|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433085|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433086|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433087|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
25433088|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433089|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433090|NCT00580489|Fentanyl|fentanyl|mesh-list
25433091|NCT00580489|Morphine|morphine|mesh-list
25433092|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25433093|NCT00580489|Narcotics|narcotics|mesh-ancestor
25433094|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25433095|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433096|NCT00580489|Analgesics|analgesics|mesh-ancestor
25433097|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
25433098|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433099|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25433100|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25433101|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
25433102|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
25433103|NCT00576654|Irinotecan|irinotecan|mesh-list
25433104|NCT00576654|Camptothecin|camptothecin|mesh-list
25433105|NCT00576654|Veliparib|veliparib|mesh-list
25433106|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25433107|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433108|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433109|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433110|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433111|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25433112|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433113|NCT00575718|Nicotine|nicotine|mesh-list
25433114|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25433115|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
25433116|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433117|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433118|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25433119|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25433120|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
25433121|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25433201|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25433122|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433123|NCT00574496|Gemcitabine|gemcitabine|mesh-list
25433124|NCT00574496|Cyclosporine|cyclosporine|mesh-list
25433125|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
25433126|NCT00574496|Prednisone|prednisone|mesh-list
25433127|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
25433128|NCT00574496|Melphalan|melphalan|mesh-list
25433129|NCT00574496|Ifosfamide|ifosfamide|mesh-list
25433130|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
25433131|NCT00574496|Methotrexate|methotrexate|mesh-list
25433132|NCT00574496|Fludarabine|fludarabine|mesh-list
25433133|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
25433134|NCT00574496|Vincristine|vincristine|mesh-list
25433135|NCT00574496|Vinorelbine|vinorelbine|mesh-list
25433136|NCT00574496|Procarbazine|procarbazine|mesh-list
25433137|NCT00574496|Cyclosporins|cyclosporins|mesh-list
25433138|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433139|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
25433140|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433141|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433142|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433143|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
25433221|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
25433144|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433145|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404738|NCT03652961|Abatacept|abatacept|mesh-list
25433146|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433147|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433148|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
25433149|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
25433150|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433151|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433152|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433153|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
25433154|NCT00574496|Hormones|hormones|mesh-ancestor
25433155|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433156|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433157|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25433158|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
25433159|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25433160|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433161|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25433162|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25433163|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433164|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433165|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433166|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433167|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
25433168|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25433169|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433170|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25433171|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
25433172|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25433173|NCT00569127|Interferons|interferons|mesh-list
25433174|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
25433175|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
25433176|NCT00569127|Bevacizumab|bevacizumab|mesh-list
25433177|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25433178|NCT00569127|Octreotide|octreotide|mesh-list
25433179|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
25433180|NCT00569127|Antibodies|antibodies|mesh-list
25433181|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
25433182|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25433183|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
25433184|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433185|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25433186|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433187|NCT00569127|Growth Substances|growth substances|mesh-ancestor
25433188|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433189|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433190|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
25433191|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
25433192|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433193|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433194|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433195|NCT00565851|Gemcitabine|gemcitabine|mesh-list
25433196|NCT00565851|Paclitaxel|paclitaxel|mesh-list
25433197|NCT00565851|Docetaxel|docetaxel|mesh-list
25433198|NCT00565851|Bevacizumab|bevacizumab|mesh-list
25433199|NCT00565851|Carboplatin|carboplatin|mesh-list
25433200|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25433361|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
25433202|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
25433203|NCT00565851|Antibodies|antibodies|mesh-list
25433204|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
25433205|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25433206|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
25433207|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433208|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433209|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433210|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433211|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433212|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433213|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25433214|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433215|NCT00565851|Growth Substances|growth substances|mesh-ancestor
25433216|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433217|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433218|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
25433219|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433220|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
25433222|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433223|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433224|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433225|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
25433227|NCT00557193|Folic Acid|folic acid|mesh-list
25433228|NCT00557193|Cytarabine|cytarabine|mesh-list
25433229|NCT00557193|Dexamethasone|dexamethasone|mesh-list
25433230|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
25433231|NCT00557193|Prednisone|prednisone|mesh-list
25433232|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
25433233|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25433234|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25433235|NCT00557193|Prednisolone|prednisolone|mesh-list
25433236|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
25433237|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
25433238|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25433239|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25433240|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25433241|NCT00557193|Cortisone|cortisone|mesh-list
25433242|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
25433243|NCT00557193|Methotrexate|methotrexate|mesh-list
25433244|NCT00557193|Etoposide|etoposide|mesh-list
25433245|NCT00557193|Vincristine|vincristine|mesh-list
25433246|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
25433247|NCT00557193|Daunorubicin|daunorubicin|mesh-list
25433248|NCT00557193|Asparaginase|asparaginase|mesh-list
25433249|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
25433250|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
25433251|NCT00557193|Pegaspargase|pegaspargase|mesh-list
25433252|NCT00557193|Lenograstim|lenograstim|mesh-list
25433253|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25433254|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
25433255|NCT00557193|BB 1101|bb 1101|mesh-list
25433256|NCT00557193|Calcium|calcium|mesh-list
25433257|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
25433258|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433259|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
25433260|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433261|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433262|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433263|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
25433264|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433265|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433266|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433267|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433268|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
25433269|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
25433270|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433271|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433272|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
25433273|NCT00557193|Hormones|hormones|mesh-ancestor
25433274|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433275|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433276|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
25433277|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433278|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25433279|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25433280|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25433281|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
25433282|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25433283|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433284|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
25433285|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433286|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25433287|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25433288|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433289|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25433290|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433291|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
25433292|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433293|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25433294|NCT00557193|Antidotes|antidotes|mesh-ancestor
25433295|NCT00557193|Protective Agents|protective agents|mesh-ancestor
25433296|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
25433297|NCT00557193|Vitamins|vitamins|mesh-ancestor
25433298|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
25433299|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433300|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433301|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433302|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25433303|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433304|NCT00557193|Hematinics|hematinics|mesh-ancestor
25433305|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
25433306|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
25433307|NCT00556374|Denosumab|denosumab|mesh-list
25433308|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25433309|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25433310|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433311|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25433312|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433313|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433314|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25433315|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
25433316|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433317|NCT00549848|Cytarabine|cytarabine|mesh-list
25433318|NCT00549848|Dexamethasone|dexamethasone|mesh-list
25433319|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
25433320|NCT00549848|Prednisone|prednisone|mesh-list
25433321|NCT00549848|Prednisolone|prednisolone|mesh-list
25433322|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
25433323|NCT00549848|Doxorubicin|doxorubicin|mesh-list
25433324|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25433325|NCT00549848|Methotrexate|methotrexate|mesh-list
25433326|NCT00549848|Etoposide|etoposide|mesh-list
25433327|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
25433328|NCT00549848|Vincristine|vincristine|mesh-list
25433329|NCT00549848|Daunorubicin|daunorubicin|mesh-list
25433330|NCT00549848|Dasatinib|dasatinib|mesh-list
25433331|NCT00549848|Asparaginase|asparaginase|mesh-list
25433332|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
25433333|NCT00549848|Clofarabine|clofarabine|mesh-list
25433334|NCT00549848|Pegaspargase|pegaspargase|mesh-list
25433335|NCT00549848|Thioguanine|thioguanine|mesh-list
25433336|NCT00549848|BB 1101|bb 1101|mesh-list
25433337|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433338|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
25433339|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433340|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433341|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433342|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
25433343|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433344|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433345|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433346|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433347|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
25433348|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
25433349|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433350|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433351|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
25433352|NCT00549848|Hormones|hormones|mesh-ancestor
25433353|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433354|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433355|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
25433356|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433357|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433358|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25433359|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433360|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25433362|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25433363|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433364|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
25433365|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433366|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25433367|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25433368|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433369|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
25433370|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433371|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433372|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433373|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433374|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25433375|NCT00547196|Cyclosporine|cyclosporine|mesh-list
25433376|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
25433377|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
25433378|NCT00547196|Melphalan|melphalan|mesh-list
25433379|NCT00547196|Busulfan|busulfan|mesh-list
25433380|NCT00547196|Fludarabine|fludarabine|mesh-list
25433381|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
25433382|NCT00547196|Cyclosporins|cyclosporins|mesh-list
25433383|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433385|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433386|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433387|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433388|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
25433389|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433390|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433391|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433392|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433393|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
25433394|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433395|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
25433396|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433397|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433398|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25433399|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433400|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25433401|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
25433402|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25433404|NCT00542451|Trastuzumab|trastuzumab|mesh-list
25433405|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433406|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433407|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433408|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433409|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433410|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433411|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433412|NCT00530062|Albuterol|albuterol|mesh-list
25433413|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25433414|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
25433415|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433416|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433417|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25433418|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
25433419|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
25433420|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25433421|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25433422|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25433423|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25433424|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25433425|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25433426|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433427|NCT00523341|Denosumab|denosumab|mesh-list
25433428|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25433429|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433430|NCT00520767|Dexamethasone|dexamethasone|mesh-list
25433431|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
25433432|NCT00520767|Bortezomib|bortezomib|mesh-list
25433433|NCT00520767|Melphalan|melphalan|mesh-list
25433434|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25433435|NCT00520767|BB 1101|bb 1101|mesh-list
25433436|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433437|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
25433438|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
25433439|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433440|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433441|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433442|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
25433443|NCT00520767|Hormones|hormones|mesh-ancestor
25433444|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433445|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433446|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433447|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
25433448|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433449|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433450|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433451|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
25433452|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433453|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433454|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
25433455|NCT00516724|Paclitaxel|paclitaxel|mesh-list
25433456|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25433457|NCT00516724|Carboplatin|carboplatin|mesh-list
25433458|NCT00516724|Olaparib|olaparib|mesh-list
25433459|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25433460|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433461|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433462|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433463|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433464|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433465|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433466|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433468|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25433469|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433470|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433471|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433472|NCT00505063|Vaccines|vaccines|mesh-list
25433473|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25433474|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
25433475|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433476|NCT00501826|Cytarabine|cytarabine|mesh-list
25433477|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
25433478|NCT00501826|Dexamethasone|dexamethasone|mesh-list
25433479|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
25433480|NCT00501826|Prednisone|prednisone|mesh-list
25433481|NCT00501826|Cortisone|cortisone|mesh-list
25433482|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
25433483|NCT00501826|Doxorubicin|doxorubicin|mesh-list
25433484|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25433485|NCT00501826|Methotrexate|methotrexate|mesh-list
25433486|NCT00501826|Vincristine|vincristine|mesh-list
25433487|NCT00501826|Asparaginase|asparaginase|mesh-list
25433488|NCT00501826|Venetoclax|venetoclax|mesh-list
25433489|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
25433490|NCT00501826|Pegaspargase|pegaspargase|mesh-list
25433491|NCT00501826|BB 1101|bb 1101|mesh-list
25433492|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433493|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
25433494|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433495|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433496|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433497|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
25433498|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433499|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433500|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433501|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433502|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
25433503|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
25433504|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433505|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433506|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
25433507|NCT00501826|Hormones|hormones|mesh-ancestor
25433508|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433509|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433510|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
25433511|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433512|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433513|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25433514|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433592|NCT00469183|Tretinoin|tretinoin|mesh-list
25433515|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25433516|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
25433517|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25433518|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433519|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
25433520|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433521|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25433522|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25433523|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
25433524|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433525|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433526|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433527|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433528|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433530|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433531|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433532|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
25433533|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433534|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433535|NCT00479128|Gemcitabine|gemcitabine|mesh-list
25433536|NCT00479128|Doxorubicin|doxorubicin|mesh-list
25433539|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433540|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
25433541|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433542|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433543|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
25433544|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433545|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433546|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433547|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
25433548|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433549|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433550|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25433551|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433552|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25433553|NCT00472966|Tretinoin|tretinoin|mesh-list
25433554|NCT00472966|Glycolic acid|glycolic acid|mesh-list
25433555|NCT00472966|Hydroquinone|hydroquinone|mesh-list
25433556|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433557|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
25433558|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433559|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433560|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
25433561|NCT00472966|Hormones|hormones|mesh-ancestor
25433562|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433563|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433564|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
25433565|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433566|NCT00472966|Protective Agents|protective agents|mesh-ancestor
25433567|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25433568|NCT00470704|Trastuzumab|trastuzumab|mesh-list
25433569|NCT00470704|Lapatinib|lapatinib|mesh-list
25433570|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433571|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433572|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25433573|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433574|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433575|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
25433576|NCT00469755|Adapalene|adapalene|mesh-list
25433577|NCT00469755|Tazarotene|tazarotene|mesh-list
25433578|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25433579|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25433580|NCT00469755|Analgesics|analgesics|mesh-ancestor
25433581|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
25433582|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433583|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433584|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433585|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433586|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433587|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
25433588|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
25433589|NCT00469755|Vitamins|vitamins|mesh-ancestor
25433590|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
25433591|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25433593|NCT00469183|Hydroquinone|hydroquinone|mesh-list
25433594|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433595|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
25433596|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433597|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433598|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
25433599|NCT00469183|Hormones|hormones|mesh-ancestor
25433600|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433601|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433602|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
25433603|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433604|NCT00469183|Protective Agents|protective agents|mesh-ancestor
25433605|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25433606|NCT00468715|Bicalutamide|bicalutamide|mesh-list
25433607|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
25433608|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
25433609|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433610|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433611|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433612|NCT00453531|Acetylcholine|acetylcholine|mesh-list
25433613|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
25433614|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25433615|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
25433616|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25433617|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433618|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433620|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
25433621|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
25433622|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25433623|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433624|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
25433625|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433626|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
25433627|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433628|NCT00437255|Betamethasone|betamethasone|mesh-list
25433629|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
25433630|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25433631|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
25433632|NCT00437255|Clobetasol|clobetasol|mesh-list
25433633|NCT00437255|Calcipotriene|calcipotriene|mesh-list
25433634|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25433635|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433636|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
25433637|NCT00437255|Hormones|hormones|mesh-ancestor
25433638|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433639|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433640|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25433641|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
25433642|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433643|NCT00437216|Clobetasol|clobetasol|mesh-list
25433644|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433645|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
25433646|NCT00437216|Hormones|hormones|mesh-ancestor
25433647|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433648|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433649|NCT00436566|Paclitaxel|paclitaxel|mesh-list
25433650|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
25433651|NCT00436566|Doxorubicin|doxorubicin|mesh-list
25433652|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25433653|NCT00436566|Trastuzumab|trastuzumab|mesh-list
25433654|NCT00436566|Lapatinib|lapatinib|mesh-list
25433655|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433656|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433657|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433658|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433659|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433660|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433661|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433662|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
25433663|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433664|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433665|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433666|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
25433667|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433668|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433669|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25433670|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433671|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433672|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433673|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25433674|NCT00436540|Clobetasol|clobetasol|mesh-list
25433675|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433676|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
25433677|NCT00436540|Hormones|hormones|mesh-ancestor
25433678|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433679|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433680|NCT00436527|Metronidazole|metronidazole|mesh-list
25433681|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433682|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25433683|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25433684|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25433685|NCT00433511|Paclitaxel|paclitaxel|mesh-list
25433686|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
25433687|NCT00433511|Bevacizumab|bevacizumab|mesh-list
25433688|NCT00433511|Doxorubicin|doxorubicin|mesh-list
25433689|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25433690|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25433691|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25433692|NCT00433511|Antibodies|antibodies|mesh-list
25433696|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
25433697|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433698|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433699|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433700|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433701|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433702|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433703|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433704|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
25433705|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433706|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433707|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433708|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
25433709|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433710|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25433711|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433712|NCT00433511|Growth Substances|growth substances|mesh-ancestor
25433713|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433714|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433715|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25433716|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433717|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433718|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25433719|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25433720|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25433721|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25433722|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433723|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25433724|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433725|NCT00425230|Analgesics|analgesics|mesh-ancestor
25433726|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
25433727|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433728|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
25433729|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25433730|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
25433732|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433733|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25433734|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433735|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433736|NCT00412594|Rituximab|rituximab|mesh-list
25433737|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25433738|NCT00412594|Cladribine|cladribine|mesh-list
25433739|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25433740|NCT00412594|Antibodies|antibodies|mesh-list
25433741|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
25433742|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25433743|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
25433823|NCT00408005|Hormones|hormones|mesh-ancestor
25433744|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433745|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433746|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433747|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433748|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433749|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
25433750|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433751|NCT00410956|Dexamethasone|dexamethasone|mesh-list
25433752|NCT00410956|Bevacizumab|bevacizumab|mesh-list
25433753|NCT00410956|Floxuridine|floxuridine|mesh-list
25433754|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433755|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433756|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25433757|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433758|NCT00410956|Growth Substances|growth substances|mesh-ancestor
25433759|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433760|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433761|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433762|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
25433763|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
25433764|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433765|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433766|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
25433767|NCT00410956|Hormones|hormones|mesh-ancestor
25433768|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433769|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433770|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433771|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
25433772|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433773|NCT00408447|Fludarabine|fludarabine|mesh-list
25433774|NCT00408447|Busulfan|busulfan|mesh-list
25433775|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
25433776|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433777|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433778|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433779|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
25433780|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433781|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
25433782|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433783|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433784|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433785|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
25433786|NCT00408005|Leucovorin|leucovorin|mesh-list
25433787|NCT00408005|Folic Acid|folic acid|mesh-list
25433788|NCT00408005|Cytarabine|cytarabine|mesh-list
25433789|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
25433790|NCT00408005|Dexamethasone|dexamethasone|mesh-list
25433791|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
25433792|NCT00408005|Prednisone|prednisone|mesh-list
25433793|NCT00408005|Cortisone|cortisone|mesh-list
25433794|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
25433795|NCT00408005|Doxorubicin|doxorubicin|mesh-list
25433796|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25433797|NCT00408005|Methotrexate|methotrexate|mesh-list
25433798|NCT00408005|Vincristine|vincristine|mesh-list
25433799|NCT00408005|Daunorubicin|daunorubicin|mesh-list
25433800|NCT00408005|Asparaginase|asparaginase|mesh-list
25433801|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
25433802|NCT00408005|Pegaspargase|pegaspargase|mesh-list
25433803|NCT00408005|Thioguanine|thioguanine|mesh-list
25433804|NCT00408005|BB 1101|bb 1101|mesh-list
25433805|NCT00408005|Calcium|calcium|mesh-list
25433806|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
25433807|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
25433808|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433809|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
25433810|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433811|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433812|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433813|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
25433814|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433815|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433816|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25433817|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25433818|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
25433819|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
25433820|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433821|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433822|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
25433900|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433824|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433825|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25433826|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
25433827|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433828|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25433829|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25433830|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25433831|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25433832|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25433833|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25433834|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
25433835|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25433836|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433837|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
25433838|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
25433839|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25433840|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25433841|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
25433842|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433843|NCT00408005|Antidotes|antidotes|mesh-ancestor
25433844|NCT00408005|Protective Agents|protective agents|mesh-ancestor
25433845|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
25433846|NCT00408005|Vitamins|vitamins|mesh-ancestor
25433847|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
25433848|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433849|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433850|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433851|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433852|NCT00408005|Hematinics|hematinics|mesh-ancestor
25433853|NCT00394147|Gemcitabine|gemcitabine|mesh-list
25433854|NCT00394147|Pemetrexed|pemetrexed|mesh-list
25433855|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433856|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
25433857|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433858|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433859|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
25433860|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433861|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433862|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433863|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
25433864|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433865|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25433866|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25433867|NCT00392353|Azacitidine|azacitidine|mesh-list
25433868|NCT00392353|Vorinostat|vorinostat|mesh-list
25433869|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433870|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
25433871|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433872|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433873|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433874|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25433875|NCT00389610|Pancrelipase|pancrelipase|mesh-list
25433876|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25433877|NCT00383708|Lanreotide|lanreotide|mesh-list
25433878|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433879|NCT00373217|Paclitaxel|paclitaxel|mesh-list
25433880|NCT00373217|Carboplatin|carboplatin|mesh-list
25433881|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433882|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433883|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433884|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433885|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433886|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433887|NCT00364013|Panitumumab|panitumumab|mesh-list
25433888|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433889|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433890|NCT00353158|Doxycycline|doxycycline|mesh-list
25433891|NCT00353158|Voriconazole|voriconazole|mesh-list
25433892|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25433893|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433894|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
25433895|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25433896|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25433897|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
25433898|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25433899|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25433901|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433902|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25433903|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
25433904|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433905|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433906|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25433907|NCT00345839|Cinacalcet|cinacalcet|mesh-list
25433908|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25433909|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433910|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25433911|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
25433912|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25433913|NCT00339183|Panitumumab|panitumumab|mesh-list
25433914|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25433915|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433916|NCT00338377|Vidarabine|vidarabine|mesh-list
25433917|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
25433918|NCT00338377|Fludarabine|fludarabine|mesh-list
25433919|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
25433920|NCT00338377|Interleukin-2|interleukin-2|mesh-list
25433921|NCT00338377|Mesna|mesna|mesh-list
25433922|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433923|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
25433924|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433926|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25433927|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
25433928|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433929|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433930|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25405505|NCT03604991|Ipilimumab|ipilimumab|mesh-list
25433931|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433932|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
25433933|NCT00338377|Antiviral Agents|antiviral agents|mesh-ancestor
25433934|NCT00338377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433935|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25433936|NCT00338377|Analgesics|analgesics|mesh-ancestor
25433937|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
25433938|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433939|NCT00338377|Protective Agents|protective agents|mesh-ancestor
25433940|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
25433941|NCT00332605|Naltrexone|naltrexone|mesh-list
25433942|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25433943|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25433944|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25433945|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433946|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
25433947|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25433948|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
25433949|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433950|NCT00332605|Expectorants|expectorants|mesh-ancestor
25433951|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
25433952|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25433953|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
25433954|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433955|NCT00332605|Protective Agents|protective agents|mesh-ancestor
25433956|NCT00332605|Antidotes|antidotes|mesh-ancestor
25433957|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
25433958|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
25433959|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25433960|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
25433961|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433962|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433963|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25433964|NCT00324805|Gemcitabine|gemcitabine|mesh-list
25433965|NCT00324805|Bevacizumab|bevacizumab|mesh-list
25433966|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25433967|NCT00324805|Cisplatin|cisplatin|mesh-list
25433968|NCT00324805|Docetaxel|docetaxel|mesh-list
25433969|NCT00324805|Pemetrexed|pemetrexed|mesh-list
25433970|NCT00324805|Vinorelbine|vinorelbine|mesh-list
25433971|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
25433972|NCT00324805|Antibodies|antibodies|mesh-list
25433973|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
25433974|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25433975|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
25433976|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25433977|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25434203|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433978|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25433979|NCT00324805|Growth Substances|growth substances|mesh-ancestor
25433980|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433981|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
25433982|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
25433983|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433984|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
25433985|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433986|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
25433987|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25433988|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433989|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25433990|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
25433991|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
25433992|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
25433993|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25433994|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25433995|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25433996|NCT00323063|Gemcitabine|gemcitabine|mesh-list
25433997|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
25433998|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25433999|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
25434000|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434001|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434002|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
25434003|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434004|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434005|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434006|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
25434007|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434008|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25434009|NCT00310180|Tamoxifen|tamoxifen|mesh-list
25434010|NCT00310180|Letrozole|letrozole|mesh-list
25434011|NCT00310180|Anastrozole|anastrozole|mesh-list
25434012|NCT00310180|Exemestane|exemestane|mesh-list
25434013|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434014|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434015|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25434016|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25434017|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434018|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25434019|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
25434020|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434021|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434022|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434023|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25434024|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25434025|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25434026|NCT00302952|Lovastatin|lovastatin|mesh-list
25434027|NCT00302952|L 647318|l 647318|mesh-list
25434028|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
25434029|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25434030|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25434031|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
25434032|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434033|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25434034|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25434035|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434036|NCT00291525|Warfarin|warfarin|mesh-list
25434037|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
25434038|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
25434039|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25434040|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25434041|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25434042|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434043|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434044|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
25434045|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434046|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434047|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25434048|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434049|NCT00280761|Fluorouracil|fluorouracil|mesh-list
25434050|NCT00280761|Capecitabine|capecitabine|mesh-list
25434051|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
25434202|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434052|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434053|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25434054|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434055|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434056|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
25434057|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434058|NCT00278915|Fulvestrant|fulvestrant|mesh-list
25434059|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434060|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434061|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25434062|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25434063|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
25434064|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434065|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434066|NCT00276978|Aripiprazole|aripiprazole|mesh-list
25434067|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
25434068|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434069|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25434070|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25434071|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434072|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434073|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
25434074|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
25434075|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434076|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434077|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25434078|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25434079|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
25434080|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25434081|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25434082|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25434083|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25434084|NCT00273624|Olanzapine|olanzapine|mesh-list
25434085|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
25434086|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
25434087|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434088|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434089|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434090|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25434091|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25434092|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434093|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434094|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25434095|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25434096|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434097|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434098|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434099|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
25434100|NCT00262470|Indomethacin|indomethacin|mesh-list
25434101|NCT00262470|Octreotide|octreotide|mesh-list
25434102|NCT00262470|Propranolol|propranolol|mesh-list
25434103|NCT00262470|Clonidine|clonidine|mesh-list
25434104|NCT00262470|Mecamylamine|mecamylamine|mesh-list
25434105|NCT00262470|Acetazolamide|acetazolamide|mesh-list
25434106|NCT00262470|Isosorbide|isosorbide|mesh-list
25434107|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25434108|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25434109|NCT00262470|Midodrine|midodrine|mesh-list
25434110|NCT00262470|Memantine|memantine|mesh-list
25434111|NCT00262470|Entacapone|entacapone|mesh-list
25434112|NCT00262470|Melatonin|melatonin|mesh-list
25434113|NCT00262470|Modafinil|modafinil|mesh-list
25434114|NCT00262470|Sertraline|sertraline|mesh-list
25434115|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25434116|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
25434117|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434118|NCT00262470|Protective Agents|protective agents|mesh-ancestor
25434119|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434120|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434121|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25434122|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25434123|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
25434124|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434125|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25434126|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25434127|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
25434128|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
25434129|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434130|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25434131|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25434132|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434133|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
25434134|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25434135|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25434136|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
25434137|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25434138|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25434139|NCT00262470|Analgesics|analgesics|mesh-ancestor
25434140|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
25434141|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434142|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
25434143|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
25434144|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25434145|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25434146|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25434147|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434148|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434149|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434150|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25434151|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25434231|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
25434152|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25434153|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25434154|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25434155|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25434156|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25434157|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434158|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434159|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
25434160|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
25434161|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25434162|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25434163|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434164|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
25434165|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25434166|NCT00262470|Diuretics|diuretics|mesh-ancestor
25434167|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
25434168|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
25434169|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25434170|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25434171|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25434172|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25434173|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25434174|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25434175|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25434176|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25434177|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
25434178|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
25434179|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25434180|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25434181|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25434182|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434183|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434184|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
25434185|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434186|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434187|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25434188|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434189|NCT00256399|Alfuzosin|alfuzosin|mesh-list
25434190|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25434191|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25434192|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25434193|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
25434194|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434195|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434196|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434197|NCT00256399|Urological Agents|urological agents|mesh-ancestor
25434198|NCT00254384|Cisplatin|cisplatin|mesh-list
25434199|NCT00254384|Docetaxel|docetaxel|mesh-list
25434200|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25434201|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434204|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
25434205|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434206|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25434207|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434209|NCT00217737|Leucovorin|leucovorin|mesh-list
25434210|NCT00217737|Folic Acid|folic acid|mesh-list
25434211|NCT00217737|Bevacizumab|bevacizumab|mesh-list
25434212|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25434213|NCT00217737|Fluorouracil|fluorouracil|mesh-list
25434214|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
25434215|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
25434216|NCT00217737|Antibodies|antibodies|mesh-list
25434217|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
25434218|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25434219|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
25434220|NCT00217737|Calcium|calcium|mesh-list
25434221|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
25434222|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434223|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25434224|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25434225|NCT00217737|Growth Substances|growth substances|mesh-ancestor
25434226|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434227|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
25434228|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
25434229|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25434230|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25434232|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434233|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25434234|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434235|NCT00217737|Antidotes|antidotes|mesh-ancestor
25434236|NCT00217737|Protective Agents|protective agents|mesh-ancestor
25434237|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
25434238|NCT00217737|Vitamins|vitamins|mesh-ancestor
25434239|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
25434240|NCT00217737|Hematinics|hematinics|mesh-ancestor
25434241|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
25434242|NCT00212147|Anesthetics|anesthetics|mesh-list
25434243|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434244|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434245|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25434246|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
25434247|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25434248|NCT00212147|Analgesics|analgesics|mesh-ancestor
25434249|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
25434250|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434251|NCT00199108|Dexamethasone|dexamethasone|mesh-list
25434252|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434253|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
25434254|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
25434255|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434256|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434257|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434258|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
25434259|NCT00199108|Hormones|hormones|mesh-ancestor
25434260|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434261|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434262|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434263|NCT00199082|Cytarabine|cytarabine|mesh-list
25434264|NCT00199082|Dexamethasone|dexamethasone|mesh-list
25434265|NCT00199082|Prednisolone|prednisolone|mesh-list
25434266|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
25434267|NCT00199082|Ifosfamide|ifosfamide|mesh-list
25434268|NCT00199082|Rituximab|rituximab|mesh-list
25434269|NCT00199082|Methotrexate|methotrexate|mesh-list
25434270|NCT00199082|Vincristine|vincristine|mesh-list
25434271|NCT00199082|Doxorubicin|doxorubicin|mesh-list
25434272|NCT00199082|Vindesine|vindesine|mesh-list
25434273|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434274|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
25434275|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434276|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434277|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434278|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
25434279|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434280|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434281|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434282|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434283|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434284|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
25434285|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
25434286|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434287|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434288|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
25434289|NCT00199082|Hormones|hormones|mesh-ancestor
25434290|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434291|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434292|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25434293|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
25434294|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25434295|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25434296|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
25434297|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25434298|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434299|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25434300|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25434301|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
25434302|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434303|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25434304|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434305|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
25434306|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
25434307|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434308|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25434309|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25434311|NCT00198991|Dexamethasone|dexamethasone|mesh-list
25434312|NCT00198991|Prednisolone|prednisolone|mesh-list
25434313|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
25434314|NCT00198991|Methotrexate|methotrexate|mesh-list
25434315|NCT00198991|Fludarabine|fludarabine|mesh-list
25434316|NCT00198991|Etoposide|etoposide|mesh-list
25434317|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
25434318|NCT00198991|Vincristine|vincristine|mesh-list
25434319|NCT00198991|Doxorubicin|doxorubicin|mesh-list
25434320|NCT00198991|Daunorubicin|daunorubicin|mesh-list
25434321|NCT00198991|Asparaginase|asparaginase|mesh-list
25434322|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
25434323|NCT00198991|Idarubicin|idarubicin|mesh-list
25434324|NCT00198991|Thioguanine|thioguanine|mesh-list
25434325|NCT00198991|Cladribine|cladribine|mesh-list
25434326|NCT00198991|Vindesine|vindesine|mesh-list
25434327|NCT00198991|Teniposide|teniposide|mesh-list
25434328|NCT00198991|Pegaspargase|pegaspargase|mesh-list
25434329|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434330|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
25434331|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434332|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434333|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434334|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
25434335|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434336|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434337|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434338|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434339|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
25434340|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
25434341|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434342|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434343|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
25434344|NCT00198991|Hormones|hormones|mesh-ancestor
25434345|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434346|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434347|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25434348|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
25434349|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25434350|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25434351|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
25434352|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
25434353|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434354|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25434355|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25434356|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25434357|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25434358|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25434359|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
25434360|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434361|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434362|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25434363|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25434364|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434365|NCT00194090|Celecoxib|celecoxib|mesh-list
25434366|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25434367|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25434368|NCT00194090|Analgesics|analgesics|mesh-ancestor
25434369|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
25434370|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434371|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434372|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434373|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434374|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25434375|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25434376|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434377|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434378|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
25434379|NCT00163566|Androgens|androgens|mesh-ancestor
25434380|NCT00163566|Hormones|hormones|mesh-ancestor
25434381|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434382|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434383|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25434384|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25434385|NCT00160173|Estradiol|estradiol|mesh-list
25434386|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25434389|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434390|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434391|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25434392|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
25434393|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25434394|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25434396|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434397|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434398|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25434399|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25434400|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434401|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434402|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25434403|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
25434404|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434405|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434406|NCT00127127|Vorinostat|vorinostat|mesh-list
25434407|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434408|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25434409|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434410|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434411|NCT00119366|Iodine|iodine|mesh-list
25434412|NCT00119366|Cyclosporine|cyclosporine|mesh-list
25434413|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
25434414|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25434415|NCT00119366|Fludarabine|fludarabine|mesh-list
25434416|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
25434417|NCT00119366|Antibodies|antibodies|mesh-list
25434418|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
25434419|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25434420|NCT00119366|Cyclosporins|cyclosporins|mesh-list
25434421|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
25434422|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434423|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434424|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25434425|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
25434426|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434427|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434428|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434429|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
25434430|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434431|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25434432|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434433|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25434434|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434435|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25434513|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434436|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
25434437|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25434438|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25434439|NCT00119366|Trace Elements|trace elements|mesh-ancestor
25434440|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
25434441|NCT00114101|Lenalidomide|lenalidomide|mesh-list
25434442|NCT00114101|Melphalan|melphalan|mesh-list
25434443|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
25434444|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25434445|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
25434446|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434447|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25434448|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25434449|NCT00114101|Growth Substances|growth substances|mesh-ancestor
25434450|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
25434451|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434452|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434453|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
25434454|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434455|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434456|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434457|NCT00113763|Panitumumab|panitumumab|mesh-list
25434458|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434459|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434460|NCT00101101|Aldesleukin|aldesleukin|mesh-list
25434461|NCT00101101|Dexamethasone|dexamethasone|mesh-list
25434462|NCT00101101|Prednisone|prednisone|mesh-list
25434467|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434468|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
25434469|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434470|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434471|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434472|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
25434473|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434474|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434475|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434476|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434477|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
25434478|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
25434479|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434480|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434481|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
25434482|NCT00101101|Hormones|hormones|mesh-ancestor
25434483|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434484|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434485|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434486|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25434487|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25434488|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434489|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25434490|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434491|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
25434492|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
25434493|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25434494|NCT00101101|Analgesics|analgesics|mesh-ancestor
25434495|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
25434496|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25434497|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25434498|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
25434499|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434500|NCT00099437|Fulvestrant|fulvestrant|mesh-list
25434501|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434502|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434503|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25434504|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25434505|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
25434506|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434507|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434508|NCT00099086|Docetaxel|docetaxel|mesh-list
25434509|NCT00099086|Leuprolide|leuprolide|mesh-list
25434510|NCT00099086|Goserelin|goserelin|mesh-list
25434511|NCT00099086|Bicalutamide|bicalutamide|mesh-list
25434512|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434514|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
25434515|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
25434516|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434517|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25434518|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
25434519|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25434520|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434521|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434522|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
25434523|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
25434524|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434526|NCT00098475|Dexamethasone|dexamethasone|mesh-list
25434527|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
25434528|NCT00098475|Lenalidomide|lenalidomide|mesh-list
25434529|NCT00098475|Ichthammol|ichthammol|mesh-list
25434530|NCT00098475|BB 1101|bb 1101|mesh-list
25434531|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434532|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
25434533|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
25434534|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434535|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434536|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434537|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
25434538|NCT00098475|Hormones|hormones|mesh-ancestor
25434539|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434540|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434541|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434542|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
25434543|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434773|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
25434544|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434545|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
25434546|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25434547|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25434548|NCT00098475|Growth Substances|growth substances|mesh-ancestor
25434549|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
25434550|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434551|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
25434552|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25434553|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434554|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25434555|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
25434556|NCT00097474|Melatonin|melatonin|mesh-list
25434557|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434558|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
25434559|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434560|NCT00097474|Protective Agents|protective agents|mesh-ancestor
25434561|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434562|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434563|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
25434564|NCT00093015|Hematinics|hematinics|mesh-ancestor
25434565|NCT00092534|Vaccines|vaccines|mesh-list
25434566|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
25434567|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434568|NCT00092222|Interferons|interferons|mesh-list
25434569|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
25434570|NCT00092222|Zidovudine|zidovudine|mesh-list
25434571|NCT00092222|Valganciclovir|valganciclovir|mesh-list
25434572|NCT00092222|Sirolimus|sirolimus|mesh-list
25434573|NCT00092222|Prednisone|prednisone|mesh-list
25434574|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
25434575|NCT00092222|Rituximab|rituximab|mesh-list
25434576|NCT00092222|Doxorubicin|doxorubicin|mesh-list
25434577|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25434578|NCT00092222|Etoposide|etoposide|mesh-list
25434579|NCT00092222|Vincristine|vincristine|mesh-list
25434580|NCT00092222|Bortezomib|bortezomib|mesh-list
25434581|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434582|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
25434583|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434584|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434585|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434586|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
25434587|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434588|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434589|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434590|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434591|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434592|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25434593|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25434594|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434595|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434596|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
25434597|NCT00092222|Hormones|hormones|mesh-ancestor
25434598|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434599|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434600|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25434601|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
25434602|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434603|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434604|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
25434605|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
25434606|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25434607|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
25434608|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
25434609|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25434610|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25434611|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25434612|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25434613|NCT00089791|Denosumab|denosumab|mesh-list
25434614|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25434615|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434616|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
25434617|NCT00087178|Doxorubicin|doxorubicin|mesh-list
25434618|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25434619|NCT00087178|Fluorouracil|fluorouracil|mesh-list
25434620|NCT00087178|Epirubicin|epirubicin|mesh-list
25434621|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434622|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
25434623|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434624|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434625|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434626|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
25434627|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434628|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434629|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434630|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434631|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25434632|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25434633|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434634|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
25434635|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25434636|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25434637|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25434638|NCT00080756|Estradiol|estradiol|mesh-list
25434639|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25434640|NCT00080756|Testosterone|testosterone|mesh-list
25434641|NCT00080756|Deslorelin|deslorelin|mesh-list
25434642|NCT00080756|Estrogens|estrogens|mesh-ancestor
25434643|NCT00080756|Hormones|hormones|mesh-ancestor
25434644|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434645|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434646|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25434647|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
25434648|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25434649|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25434650|NCT00080756|Androgens|androgens|mesh-ancestor
25434651|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434652|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434653|NCT00074412|Nevirapine|nevirapine|mesh-list
25434654|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25434655|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25434656|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434657|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434658|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
25434659|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434660|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25434661|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25434662|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25434663|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25434664|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25434665|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25434666|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25434819|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
25434667|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434668|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434669|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434670|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434672|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
25434673|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434674|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
25434675|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434676|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
25434677|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
25434678|NCT00070499|Dasatinib|dasatinib|mesh-list
25434679|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434680|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25434681|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434682|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434683|NCT00065676|Quercetin|quercetin|mesh-list
25434684|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
25434685|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434686|NCT00065676|Protective Agents|protective agents|mesh-ancestor
25434687|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434688|NCT00061568|Sirolimus|sirolimus|mesh-list
25434689|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
25434690|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25434691|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434692|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434693|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434694|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
25434695|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434696|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
25434697|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434698|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434699|NCT00054314|IDN 5109|idn 5109|mesh-list
25434700|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434701|NCT00048295|Alicaforsen|alicaforsen|mesh-list
25434702|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25434703|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434704|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
25434705|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434706|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
25434707|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434708|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25434709|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434710|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434711|NCT00026312|Vitamin A|vitamin a|mesh-list
25434712|NCT00026312|Aldesleukin|aldesleukin|mesh-list
25434713|NCT00026312|Interleukin-2|interleukin-2|mesh-list
25434714|NCT00026312|Tretinoin|tretinoin|mesh-list
25434715|NCT00026312|Dinutuximab|dinutuximab|mesh-list
25434716|NCT00026312|Isotretinoin|isotretinoin|mesh-list
25434717|NCT00026312|Sargramostim|sargramostim|mesh-list
25434718|NCT00026312|Vitamins|vitamins|mesh-ancestor
25434719|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
25434720|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434721|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434722|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25434723|NCT00026312|Analgesics|analgesics|mesh-ancestor
25434724|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
25434725|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434726|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
25434727|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25434728|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25434729|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
25434730|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434731|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
25434732|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
25434733|NCT00018057|Fluoxetine|fluoxetine|mesh-list
25434734|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25434735|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25434736|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434737|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434738|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434739|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
25434740|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434741|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25434742|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
25434743|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434744|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25434745|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25434746|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434747|NCT00006721|Prednisone|prednisone|mesh-list
25434748|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
25434749|NCT00006721|Rituximab|rituximab|mesh-list
25434750|NCT00006721|Doxorubicin|doxorubicin|mesh-list
25434751|NCT00006721|Vincristine|vincristine|mesh-list
25434752|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434753|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
25434754|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434755|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434756|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434757|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
25434758|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434759|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434760|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434761|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434762|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434763|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25434764|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25434765|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434766|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434767|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
25434768|NCT00006721|Hormones|hormones|mesh-ancestor
25434769|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434770|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434771|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25434772|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434782|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434783|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
25434784|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434785|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434786|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25434787|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
25434788|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434789|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434790|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25434791|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434792|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25434793|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25434794|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25434795|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434796|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434797|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
25434798|NCT00006436|Hormones|hormones|mesh-ancestor
25434799|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434800|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434801|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25434802|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
25434803|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
25434804|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
25434805|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
25434806|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
25434807|NCT00001521|Letrozole|letrozole|mesh-list
25434808|NCT00001521|Flutamide|flutamide|mesh-list
25434809|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434810|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25434811|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25434812|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434813|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434814|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25434815|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
25434816|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434817|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434818|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25434820|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434821|NCT00001481|Estradiol|estradiol|mesh-list
25434822|NCT00001481|Progesterone|progesterone|mesh-list
25434823|NCT00001481|Estrogens|estrogens|mesh-ancestor
25434824|NCT00001481|Hormones|hormones|mesh-ancestor
25434825|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434826|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434827|NCT00001481|Progestins|progestins|mesh-ancestor
25434828|NCT00001379|Interferons|interferons|mesh-list
25434829|NCT00001379|Rituximab|rituximab|mesh-list
25434830|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434831|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
25434832|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434833|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434834|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
25434835|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434836|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434837|NCT00001337|Rituximab|rituximab|mesh-list
25434838|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434839|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434840|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
25434841|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434842|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25434843|NCT00001309|Ascorbic Acid|ascorbic acid|mesh-list
25434844|NCT00001309|Vitamins|vitamins|mesh-ancestor
25434845|NCT00001309|Micronutrients|micronutrients|mesh-ancestor
25434846|NCT00001309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434847|NCT00001309|Antioxidants|antioxidants|mesh-ancestor
25434848|NCT00001309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434849|NCT00001309|Protective Agents|protective agents|mesh-ancestor
25434850|NCT00000588|Pyridoxal|pyridoxal|mesh-list
25434851|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
25434852|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
25434853|NCT00000588|Vitamins|vitamins|mesh-ancestor
25434854|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
25434855|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434856|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
25434857|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
25434858|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406576|NCT03547973|Gemcitabine|gemcitabine|mesh-list
25407803|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
25408327|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
25408561|NCT03434678|Narcotics|narcotics|mesh-ancestor
25408701|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408702|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408703|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408704|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
25408705|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408706|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408707|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25408708|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25408734|NCT03422822|Abrocitinib|abrocitinib|mesh-list
25408735|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25408736|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408737|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408738|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25408739|NCT03422536|Cetuximab|cetuximab|mesh-list
25408740|NCT03422536|Antibodies|antibodies|mesh-list
25408741|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
25408742|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25408743|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
25408744|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408745|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408746|NCT03422523|Gemcitabine|gemcitabine|mesh-list
25408747|NCT03422523|Rituximab|rituximab|mesh-list
25408748|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
25408749|NCT03422523|Atezolizumab|atezolizumab|mesh-list
25409696|NCT03358472|Cetuximab|cetuximab|mesh-list
25409781|NCT03348969|Mitomycins|mitomycins|mesh-list
25410305|NCT03323866|Hormones|hormones|mesh-ancestor
25410754|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410755|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
25410756|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25410757|NCT03296813|Torsemide|torsemide|mesh-list
25410758|NCT03296813|Furosemide|furosemide|mesh-list
25410759|NCT03296813|Diuretics|diuretics|mesh-ancestor
25411289|NCT03262103|Poly ICLC|poly iclc|mesh-list
25411671|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
25412131|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25412132|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25412133|NCT03217565|Tedizolid|tedizolid|mesh-list
25412134|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
25412135|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
25412208|NCT03211949|Mepivacaine|mepivacaine|mesh-list
25412286|NCT03201965|Bortezomib|bortezomib|mesh-list
25412974|NCT03164057|Azacitidine|azacitidine|mesh-list
25413050|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25413051|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413052|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413053|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
25413054|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413055|NCT03160716|Lidocaine|lidocaine|mesh-list
25413056|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
25413057|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
25413058|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25413203|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25413204|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413205|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25413206|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413207|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413665|NCT03117751|Bortezomib|bortezomib|mesh-list
25413826|NCT03101254|Vemurafenib|vemurafenib|mesh-list
25413896|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25413897|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25413898|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25413899|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25413900|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25413901|NCT03096418|Paclitaxel|paclitaxel|mesh-list
25413902|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25413903|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413904|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
25413905|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
25413906|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
25413979|NCT03091192|Sunitinib|sunitinib|mesh-list
25413980|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25413981|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25413982|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25413983|NCT03091192|Growth Substances|growth substances|mesh-ancestor
25413989|NCT03090776|Ketamine|ketamine|mesh-list
25414278|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
25414513|NCT03062943|Nintedanib|nintedanib|mesh-list
25414811|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414812|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414813|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25414814|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25414815|NCT03038100|Growth Substances|growth substances|mesh-ancestor
25414816|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414817|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
25414818|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
25414819|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
25414821|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414893|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
25414894|NCT03035331|Vaccines|vaccines|mesh-list
25414895|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
25414896|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414897|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415648|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
25415649|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415650|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415651|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415652|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
25415653|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415654|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415655|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25415656|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25415657|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25415685|NCT02996721|Vitamin D|vitamin d|mesh-list
25415686|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
25415687|NCT02996721|Vitamins|vitamins|mesh-ancestor
25415688|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
25415689|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415690|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25415691|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25415692|NCT02996110|Nivolumab|nivolumab|mesh-list
25415693|NCT02996110|Ipilimumab|ipilimumab|mesh-list
25415694|NCT02996110|Linrodostat|linrodostat|mesh-list
25415695|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415696|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25415697|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25415698|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415729|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
25415954|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
25416409|NCT02954055|Paclitaxel|paclitaxel|mesh-list
25416631|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416632|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416633|NCT02933697|Apixaban|apixaban|mesh-list
25416634|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
25416635|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25416636|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
25416637|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25416638|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
25416639|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416872|NCT02915523|Avelumab|avelumab|mesh-list
25416873|NCT02915523|Entinostat|entinostat|mesh-list
25416640|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416641|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
25416642|NCT02933255|Nivolumab|nivolumab|mesh-list
25416643|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25416644|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416645|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25416646|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416647|NCT02932475|Metformin|metformin|mesh-list
25416648|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25416649|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416945|NCT02912559|Antidotes|antidotes|mesh-ancestor
25417020|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
25417665|NCT02857270|Paclitaxel|paclitaxel|mesh-list
25417786|NCT02848560|Xenon|xenon|mesh-list
25417943|NCT02829918|Nivolumab|nivolumab|mesh-list
25418090|NCT02811510|Dronabinol|dronabinol|mesh-list
25418091|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
25418092|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418093|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25418094|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25418095|NCT02811510|Analgesics|analgesics|mesh-ancestor
25418096|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
25418097|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418098|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25418099|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25418167|NCT02797470|Cytarabine|cytarabine|mesh-list
25418254|NCT02792257|Dronabinol|dronabinol|mesh-list
25418322|NCT02784210|Prednisone|prednisone|mesh-list
25418393|NCT02780024|Metformin|metformin|mesh-list
25418553|NCT02766478|Genistein|genistein|mesh-list
25418690|NCT02756897|Venetoclax|venetoclax|mesh-list
25418767|NCT02749526|Cisplatin|cisplatin|mesh-list
25419152|NCT02721537|Niacinamide|niacinamide|mesh-list
25419762|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25419763|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25419764|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
25419765|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25419766|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25419767|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25419768|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25419769|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
25419770|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
25419771|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25419772|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419773|NCT02679755|Letrozole|letrozole|mesh-list
25419774|NCT02679755|Palbociclib|palbociclib|mesh-list
25419775|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419776|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25419777|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25419778|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25419785|NCT02677922|Azacitidine|azacitidine|mesh-list
25421058|NCT02577406|Cytarabine|cytarabine|mesh-list
25421203|NCT02564952|Cannabidiol|cannabidiol|mesh-list
25421973|NCT02495077|Loratadine|loratadine|mesh-list
25422200|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422201|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25422202|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422203|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422204|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
25422205|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25422206|NCT02477644|Olaparib|olaparib|mesh-list
25422207|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25422208|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422302|NCT02464969|Apixaban|apixaban|mesh-list
25422303|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25422304|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
25422305|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25422306|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
25422307|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25422308|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25422309|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
25422310|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
25422311|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25422312|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25422313|NCT02464696|Prednisolone|prednisolone|mesh-list
25422314|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
25422315|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25422316|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
25422317|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25422318|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
25422319|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
25422320|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25422321|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422322|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25422323|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
25422324|NCT02464696|Hormones|hormones|mesh-ancestor
25422326|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25422354|NCT02460874|Glyburide|glyburide|mesh-list
25422610|NCT02442180|Hormones|hormones|mesh-ancestor
25422894|NCT02419495|Calcium|calcium|mesh-list
25423422|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25423423|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25423424|NCT02376790|Analgesics|analgesics|mesh-ancestor
25423425|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
25423426|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423427|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25423901|NCT02320435|Trastuzumab|trastuzumab|mesh-list
25424108|NCT02292979|Vinblastine|vinblastine|mesh-list
25424264|NCT02277444|Golimumab|golimumab|mesh-list
25424410|NCT02257138|Decitabine|decitabine|mesh-list
25424865|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424866|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25424867|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25424868|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
25424869|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424870|NCT02197234|Osimertinib|osimertinib|mesh-list
25424871|NCT02197234|Simvastatin|simvastatin|mesh-list
25424872|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25424873|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25424874|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
25424875|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424876|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25424877|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25424878|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424879|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424880|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25424881|NCT02196961|Nivolumab|nivolumab|mesh-list
25424882|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25424883|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424949|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25424950|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25424951|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424952|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25424953|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424954|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25424958|NCT02191930|Doxorubicin|doxorubicin|mesh-list
25425112|NCT02172872|Decitabine|decitabine|mesh-list
25425781|NCT02104986|Cisplatin|cisplatin|mesh-list
25425856|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25425857|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425858|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425859|NCT02094261|Osimertinib|osimertinib|mesh-list
25425860|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425861|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25425862|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25425863|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25425864|NCT02091960|Trastuzumab|trastuzumab|mesh-list
25425865|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25425942|NCT02075840|Crizotinib|crizotinib|mesh-list
25426010|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
25426087|NCT02059265|Dasatinib|dasatinib|mesh-list
25426159|NCT02049047|Everolimus|everolimus|mesh-list
25426391|NCT02003222|Cortisone|cortisone|mesh-list
25426563|NCT01989585|Trametinib|trametinib|mesh-list
25426804|NCT01953510|Vaccines|vaccines|mesh-list
25427227|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25427228|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25427229|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427230|NCT01912625|Paclitaxel|paclitaxel|mesh-list
25427231|NCT01912625|Carboplatin|carboplatin|mesh-list
25427232|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25427234|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25427235|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427236|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
25427237|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
25427238|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
25427239|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427240|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427241|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427264|NCT01909453|Vemurafenib|vemurafenib|mesh-list
25427265|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427266|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25427267|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427268|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427269|NCT01908777|Cytarabine|cytarabine|mesh-list
25427398|NCT01896999|Ipilimumab|ipilimumab|mesh-list
25427476|NCT01884740|Cetuximab|cetuximab|mesh-list
25427538|NCT01871571|Bevacizumab|bevacizumab|mesh-list
25427539|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25427540|NCT01871571|Fluorouracil|fluorouracil|mesh-list
25427541|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
25427542|NCT01871571|Antibodies|antibodies|mesh-list
25427543|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
25427544|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25427546|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427547|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25427557|NCT01871571|Antidotes|antidotes|mesh-ancestor
25428071|NCT01787500|Cetuximab|cetuximab|mesh-list
25428451|NCT01712620|Spironolactone|spironolactone|mesh-list
25428538|NCT01701986|Rituximab|rituximab|mesh-list
25428624|NCT01700946|Analgesics|analgesics|mesh-ancestor
25428910|NCT01631617|Eusol|eusol|mesh-list
25428913|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
25429234|NCT01555697|Memantine|memantine|mesh-list
25430288|NCT01351805|Vitamin D|vitamin d|mesh-list
25432202|NCT00861705|Antibodies|antibodies|mesh-list
25432516|NCT00785291|Antibodies|antibodies|mesh-list
25432742|NCT00687765|Iniparib|iniparib|mesh-list
25432987|NCT00602459|Fludarabine|fludarabine|mesh-list
25433226|NCT00557193|Leucovorin|leucovorin|mesh-list
25433529|NCT00493467|Rituximab|rituximab|mesh-list
25404093|NCT03684980|Protective Agents|protective agents|mesh-ancestor
25404058|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404059|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404060|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404061|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25404062|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25404063|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
25404064|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404065|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404066|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25404067|NCT03685149|Flecainide|flecainide|mesh-list
25404068|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25404069|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25404070|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25404071|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404072|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404073|NCT03684980|Leucovorin|leucovorin|mesh-list
25404074|NCT03684980|Rituximab|rituximab|mesh-list
25404075|NCT03684980|Methotrexate|methotrexate|mesh-list
25404076|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25404077|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404078|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
25404079|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404080|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404081|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25404082|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
25404083|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25404084|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404085|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
25404086|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404087|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
25404088|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404089|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25404090|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404091|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25404092|NCT03684980|Antidotes|antidotes|mesh-ancestor
25404559|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404560|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404561|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404562|NCT03661138|Upadacitinib|upadacitinib|mesh-list
25404563|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25404564|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25404565|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404566|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404567|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404568|NCT03660930|Sirolimus|sirolimus|mesh-list
25404569|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25404570|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404571|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25404572|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404887|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
25404960|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404961|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404962|NCT03640481|Belumosudil|belumosudil|mesh-list
25404963|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25404964|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405297|NCT03614741|Tinzaparin|tinzaparin|mesh-list
25405375|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
25405620|NCT03600441|Abexinostat|abexinostat|mesh-list
25406030|NCT03581487|Durvalumab|durvalumab|mesh-list
25406103|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406104|NCT03579316|Olaparib|olaparib|mesh-list
25406105|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25406106|NCT03579316|Adavosertib|adavosertib|mesh-list
25406107|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406108|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406109|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406110|NCT03578367|Niacinamide|niacinamide|mesh-list
25406111|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
25406112|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406113|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25406114|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406115|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406116|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
25406117|NCT03578367|Vitamins|vitamins|mesh-ancestor
25406118|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
25406119|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406120|NCT03576755|Spironolactone|spironolactone|mesh-list
25406121|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25406122|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25406123|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406124|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406125|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25406129|NCT03576612|Acyclovir|acyclovir|mesh-list
25406519|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406520|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406521|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25406522|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25406596|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406598|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25406599|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25406600|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25406601|NCT03547622|Galantamine|galantamine|mesh-list
25406603|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407140|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407141|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
25407142|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
25407143|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25407145|NCT03515837|Cisplatin|cisplatin|mesh-list
25407901|NCT03471182|Cocaine|cocaine|mesh-list
25408000|NCT03464097|Ozanimod|ozanimod|mesh-list
25408071|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408072|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408073|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
25408074|NCT03458598|Narcotics|narcotics|mesh-ancestor
25408075|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25408076|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408077|NCT03458598|Analgesics|analgesics|mesh-ancestor
25408078|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
25408079|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408080|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
25408081|NCT03458455|Nivolumab|nivolumab|mesh-list
25408082|NCT03458455|Ipilimumab|ipilimumab|mesh-list
25408083|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408084|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408085|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25408086|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408087|NCT03458221|Itraconazole|itraconazole|mesh-list
25408088|NCT03458221|Everolimus|everolimus|mesh-list
25408089|NCT03458221|Letrozole|letrozole|mesh-list
25408090|NCT03458221|Bicalutamide|bicalutamide|mesh-list
25408091|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25408092|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408093|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
25408249|NCT03451851|Analgesics|analgesics|mesh-ancestor
25408094|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408108|NCT03457818|Denosumab|denosumab|mesh-list
25408228|NCT03455270|Palbociclib|palbociclib|mesh-list
25408662|NCT03426904|Leucovorin|leucovorin|mesh-list
25409354|NCT03384654|Cytarabine|cytarabine|mesh-list
25409627|NCT03366155|Irinotecan|irinotecan|mesh-list
25409705|NCT03356860|Paclitaxel|paclitaxel|mesh-list
25409935|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409936|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
25409937|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25409938|NCT03336203|Allopurinol|allopurinol|mesh-list
25409939|NCT03336203|Febuxostat|febuxostat|mesh-list
25409940|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
25409941|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409942|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409943|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
25409944|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25410270|NCT03324113|Hormones|hormones|mesh-ancestor
25410557|NCT03313180|Nintedanib|nintedanib|mesh-list
25410938|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410939|NCT03284385|Adavosertib|adavosertib|mesh-list
25410940|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410941|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25410942|NCT03284307|Midazolam|midazolam|mesh-list
25410943|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
25410944|NCT03284307|Ketamine|ketamine|mesh-list
25410945|NCT03284307|Propofol|propofol|mesh-list
25410946|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25410947|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25410948|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25410949|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25410950|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
25410951|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
25410952|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25410953|NCT03284307|Analgesics|analgesics|mesh-ancestor
25410954|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
25410955|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410956|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25411023|NCT03281304|Tofacitinib|tofacitinib|mesh-list
25411024|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25411025|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411026|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411027|NCT03280251|Methylphenidate|methylphenidate|mesh-list
25411166|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25411167|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411168|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25411169|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411170|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411207|NCT03268954|Azacitidine|azacitidine|mesh-list
25411208|NCT03268954|Pevonedistat|pevonedistat|mesh-list
25411209|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411210|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
25411287|NCT03262103|Poly I-C|poly i-c|mesh-list
25411211|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411212|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411213|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411214|NCT03267836|Avelumab|avelumab|mesh-list
25411215|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25411216|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411217|NCT03267680|Indomethacin|indomethacin|mesh-list
25411218|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
25411219|NCT03267680|Omeprazole|omeprazole|mesh-list
25411220|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411221|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
25411222|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25411224|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25411225|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
25411226|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411227|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411228|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25411229|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25411230|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25411231|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25411232|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411233|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25411234|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25411235|NCT03267680|Analgesics|analgesics|mesh-ancestor
25411322|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25411323|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25411324|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25411325|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
25411326|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25411327|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
25411328|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25411329|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25411330|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25411331|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25411332|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
25411333|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25412019|NCT03220022|Hormones|hormones|mesh-ancestor
25412642|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25412643|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25412722|NCT03180502|Temozolomide|temozolomide|mesh-list
25412802|NCT03175432|Bevacizumab|bevacizumab|mesh-list
25412950|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25412971|NCT03164057|Cytarabine|cytarabine|mesh-list
25412972|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
25412973|NCT03164057|Methotrexate|methotrexate|mesh-list
25412975|NCT03164057|Decitabine|decitabine|mesh-list
25412976|NCT03164057|Fludarabine|fludarabine|mesh-list
25412977|NCT03164057|Etoposide|etoposide|mesh-list
25412978|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
25412979|NCT03164057|Sorafenib|sorafenib|mesh-list
25412980|NCT03164057|Daunorubicin|daunorubicin|mesh-list
25412981|NCT03164057|Asparaginase|asparaginase|mesh-list
25412982|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
25412983|NCT03164057|Idarubicin|idarubicin|mesh-list
25412984|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
25412985|NCT03164057|Razoxane|razoxane|mesh-list
25412986|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
25413139|NCT03152786|Propranolol|propranolol|mesh-list
25412987|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25412988|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
25412989|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25412990|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25413200|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
25413691|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
25413845|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25413846|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25413847|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25414266|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25414267|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
25414268|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414269|NCT03076554|Avelumab|avelumab|mesh-list
25414270|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25414271|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25414272|NCT03076203|Niraparib|niraparib|mesh-list
25414273|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25414281|NCT03075527|Durvalumab|durvalumab|mesh-list
25414425|NCT03064867|Rituximab|rituximab|mesh-list
25414918|NCT03033576|Nivolumab|nivolumab|mesh-list
25415064|NCT03021642|Tepotinib|tepotinib|mesh-list
25416043|NCT02974257|Thiamine|thiamine|mesh-list
25416192|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25416193|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25416194|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
25416195|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416197|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25416267|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25416268|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25416269|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25416270|NCT02962050|Capsaicin|capsaicin|mesh-list
25416271|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
25416272|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
25416273|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
25416274|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25416275|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416276|NCT02960659|Metformin|metformin|mesh-list
25416277|NCT02960659|Liraglutide|liraglutide|mesh-list
25416278|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25416279|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416280|NCT02960659|Incretins|incretins|mesh-ancestor
25416281|NCT02960659|Hormones|hormones|mesh-ancestor
25416301|NCT02959164|Decitabine|decitabine|mesh-list
25416574|NCT02937818|Durvalumab|durvalumab|mesh-list
25416665|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25416666|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
25416667|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
25416668|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25416669|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417021|NCT02905591|Paclitaxel|paclitaxel|mesh-list
25417160|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
25417236|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
25417237|NCT02883049|Leucovorin|leucovorin|mesh-list
25417238|NCT02883049|Folic Acid|folic acid|mesh-list
25417239|NCT02883049|Cytarabine|cytarabine|mesh-list
25417240|NCT02883049|Dexamethasone|dexamethasone|mesh-list
25417241|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
25417242|NCT02883049|Prednisone|prednisone|mesh-list
25417243|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
25417550|NCT02864992|Tepotinib|tepotinib|mesh-list
25417627|NCT02861300|Capecitabine|capecitabine|mesh-list
25417776|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25417777|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417778|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25417779|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
25417780|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417781|NCT02849470|Complement Factor H|complement factor h|mesh-list
25417782|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25417856|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25417857|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417858|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25417859|NCT02839642|Protective Agents|protective agents|mesh-ancestor
25417860|NCT02835131|Pasireotide|pasireotide|mesh-list
25417861|NCT02835131|Hormones|hormones|mesh-ancestor
25418184|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418185|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25418186|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
25418187|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418188|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25418189|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
25418190|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25418191|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
25418192|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
25418193|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
25418194|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
25418195|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
25418196|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25418197|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25418198|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25418199|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
25418200|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25418201|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418202|NCT02796391|Nicotine|nicotine|mesh-list
25418203|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25418204|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
25418205|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25418206|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418207|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25418208|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25418209|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
25418212|NCT02795156|Afatinib|afatinib|mesh-list
25418343|NCT02783625|Bortezomib|bortezomib|mesh-list
25418408|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418426|NCT02777580|Tenecteplase|tenecteplase|mesh-list
25418427|NCT02777580|Clopidogrel|clopidogrel|mesh-list
25418428|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25418429|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25418430|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25418431|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25418432|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
25418433|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25418434|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25418435|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418436|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25418437|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25418438|NCT02777385|Cisplatin|cisplatin|mesh-list
25418439|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
25418440|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25418441|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25418486|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
25419186|NCT02720068|Leucovorin|leucovorin|mesh-list
25419601|NCT02689427|Paclitaxel|paclitaxel|mesh-list
25420844|NCT02594111|Colchicine|colchicine|mesh-list
25421082|NCT02576912|Hormones|hormones|mesh-ancestor
25421380|NCT02548364|Vitamin D|vitamin d|mesh-list
25421474|NCT02538510|Vorinostat|vorinostat|mesh-list
25421692|NCT02521493|Analgesics|analgesics|mesh-ancestor
25422449|NCT02453282|Gemcitabine|gemcitabine|mesh-list
25423162|NCT02395497|Antibodies|antibodies|mesh-list
25423937|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
25424317|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25424318|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25424319|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
25424320|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
25424321|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25424322|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424323|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424324|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
25424325|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25424326|NCT02270814|Paclitaxel|paclitaxel|mesh-list
25424327|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25424328|NCT02270814|Cisplatin|cisplatin|mesh-list
25424329|NCT02270814|Carboplatin|carboplatin|mesh-list
25424330|NCT02270814|Cetuximab|cetuximab|mesh-list
25424331|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25425384|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425718|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
25426183|NCT02043678|Prednisone|prednisone|mesh-list
25426327|NCT02022280|Lansoprazole|lansoprazole|mesh-list
25427110|NCT01922076|Adavosertib|adavosertib|mesh-list
25427196|NCT01920061|Cisplatin|cisplatin|mesh-list
25427485|NCT01879085|Docetaxel|docetaxel|mesh-list
25427796|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427797|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427798|NCT01844518|Abatacept|abatacept|mesh-list
25427799|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25427800|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427801|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427802|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25427803|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
25427878|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
25428340|NCT01734928|Thalidomide|thalidomide|mesh-list
25429030|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429031|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
25429032|NCT01602380|Fulvestrant|fulvestrant|mesh-list
25429033|NCT01602380|Anastrozole|anastrozole|mesh-list
25429034|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429035|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429104|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25429105|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
25429652|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25429653|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429962|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25429963|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
25429964|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
25429983|NCT01407562|Paclitaxel|paclitaxel|mesh-list
25429984|NCT01407562|Carboplatin|carboplatin|mesh-list
25429985|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25429986|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429987|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
25429988|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
25429989|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25429990|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429991|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25429992|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
25429993|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429994|NCT01393522|Milnacipran|milnacipran|mesh-list
25429995|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
25431293|NCT01134614|Ipilimumab|ipilimumab|mesh-list
25431499|NCT01064375|Molgramostim|molgramostim|mesh-list
25431574|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25431575|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25431576|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25431577|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25431578|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25431579|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25431580|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25431581|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
25431582|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
25431583|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431584|NCT01046825|Antidotes|antidotes|mesh-ancestor
25431585|NCT01046825|Protective Agents|protective agents|mesh-ancestor
25431586|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
25431587|NCT01046825|Vitamins|vitamins|mesh-ancestor
25431588|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
25431589|NCT01046825|Hematinics|hematinics|mesh-ancestor
25431590|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
25431591|NCT01046565|Adapalene|adapalene|mesh-list
25431592|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25431593|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25431594|NCT01046565|Analgesics|analgesics|mesh-ancestor
25431595|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
25431596|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25431597|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431598|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25431599|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25431896|NCT00972478|Hormones|hormones|mesh-ancestor
25433403|NCT00542451|Paclitaxel|paclitaxel|mesh-list
25433467|NCT00516373|Olaparib|olaparib|mesh-list
25433619|NCT00452023|Interferons|interferons|mesh-list
25433731|NCT00419367|Vorinostat|vorinostat|mesh-list
25434310|NCT00198991|Cytarabine|cytarabine|mesh-list
25434395|NCT00136695|Anastrozole|anastrozole|mesh-list
25434859|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
